PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Ojji, DB; Lecour, S; Atherton, JJ; Blauwet, LA; Alfa, J; Sliwa, K				Ojji, Dike B.; Lecour, Sandrine; Atherton, John J.; Blauwet, Lori A.; Alfa, Jacob; Sliwa, Karen			Right Ventricular Systolic Dysfunction Is Common in Hypertensive Heart Failure: A Prospective Study in Sub-Saharan Africa	PLOS ONE			English	Article							LONG-TERM MORTALITY; ECHOCARDIOGRAPHIC-ASSESSMENT; INDEPENDENT PREDICTOR; HYPERTROPHY; SURVIVAL; ADULTS; SOWETO	Introduction Right ventricular (RV) systolic dysfunction is now recognized widely as a strong and independent predictor of adverse outcomes in patients with heart failure (HF). Reduction of RV systolic function more closely predicts impaired exercise tolerance and poor survival than does left ventricular (LV) systolic function. In spite of this, there is a dearth of data on RV function in hypertensive HF which is the commonest form of HF in sub-Saharan Africa. We therefore conducted a prospective cohort study of hypertensive HF patients presenting to the University of Abuja Teaching Hospital, Abuja, Nigeria over an 8 year period. Methods Each subject had transthoracic echocardiography performed on them according to the guidelines of American Society of Echocardiography. RV systolic function was defined as a tricuspid annular plane systolic excursion (TAPSE) <15mm using M-mode echocardiography. Results RV systolic dysfunction was identified in 272 (44.5%) of the 611 subjects that were studied. Subjects with TAPSE less than 15mm had worse prognosis compared to those with TAPSE >= 15mm. There was a significant correlation between TAPSE and other adverse prognostic markers including left and right atrial area, LV size, LV mass, LV ejection fraction, restrictive mitral inflow and RV systolic pressure (RVSP). However, LV ejection fraction and right atrial area were the only independent determinants of RV systolic dysfunction. Conclusions Hypertensive HF is a major cause of RV systolic dysfunction even in a population with a low prevalence of coronary artery disease, and RV systolic dysfunction is associated with poor prognosis in hypertensive HF. Detailed assessment of RV function should therefore be part of the echocardiography evaluation of patients with hypertensive HF.	[Ojji, Dike B.; Alfa, Jacob] Univ Abuja Teaching Hosp, Dept Med, Cardiol Unit, Gwagwalada, Abuja, Nigeria; [Ojji, Dike B.; Lecour, Sandrine; Sliwa, Karen] Univ Cape Town, Dept Med, Hatter Inst Cardiovasc Res Africa, Fac Hlth Sci, ZA-7925 Cape Town, South Africa; [Atherton, John J.] Royal Brisbane & Women Hosp, Dept Cardiol, Brisbane, Qld, Australia; [Atherton, John J.] Univ Queensland, Sch Med, Brisbane, Qld, Australia; [Blauwet, Lori A.] Mayo Clin, Div Cardiovasc Dis, Rochester, MN USA	University of Cape Town; Royal Brisbane & Women's Hospital; University of Queensland; Mayo Clinic	Ojji, DB (corresponding author), Univ Abuja Teaching Hosp, Dept Med, Cardiol Unit, Gwagwalada, Abuja, Nigeria.; Ojji, DB (corresponding author), Univ Cape Town, Dept Med, Hatter Inst Cardiovasc Res Africa, Fac Hlth Sci, ZA-7925 Cape Town, South Africa.	dikeojji@yahoo.co.uk	Atherton, John J/B-9994-2011	Atherton, John J/0000-0003-2271-578X; , sandrine/0000-0003-1942-8974				Akintunde AA, 2010, CARDIOVASC J AFR, V21, P252, DOI CVJ-21.007; [Anonymous], 1964, DIS HEART BLOOD VESS; Atherton JJ, 1997, LANCET, V349, P1720, DOI 10.1016/S0140-6736(96)05109-4; Damasceno A, 2012, ARCH INTERN MED, V172, P1386, DOI 10.1001/archinternmed.2012.3310; de Groote P, 1998, J AM COLL CARDIOL, V32, P948, DOI 10.1016/S0735-1097(98)00337-4; Devereux RB, 2001, HYPERTENSION, V38, P417, DOI 10.1161/01.HYP.38.3.417; DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X; Dini FL, 2012, EUR J HEART FAIL, V14, P287, DOI 10.1093/eurjhf/hfr176; Drazner MH, 2005, HYPERTENSION, V46, P124, DOI 10.1161/01.HYP.0000169972.96201.8e; Field ME, 2006, J CARD FAIL, V12, P616, DOI 10.1016/j.cardfail.2006.06.472; Ghio S, 2000, AM J CARDIOL, V85, P837, DOI 10.1016/S0002-9149(99)00877-2; Ghio Stefano, 2005, Ital Heart J, V6, P852; Guglin Maya, 2012, Congest Heart Fail, V18, P278, DOI 10.1111/j.1751-7133.2012.00289.x; Isezuo A S, 2003, Afr J Med Med Sci, V32, P143; JUILLIERE Y, 1994, AM J CARDIOL, V73, P588, DOI 10.1016/0002-9149(94)90339-5; Jurcut R, 2010, EUR J ECHOCARDIOGR, V11, P81, DOI 10.1093/ejechocard/jep234; Karaye KM, 2010, CARDIOVASC J AFR, V21, P186; Kizer JR, 2004, HYPERTENSION, V43, P1182, DOI 10.1161/01.HYP.0000128738.94190.9f; Kjaergaard J, 2007, EUR J HEART FAIL, V9, P610, DOI 10.1016/j.ejheart.2007.03.001; La Gerche A, 2008, HEART, V94, P860, DOI 10.1136/hrt.2006.101063; Lopez-Candales A, 2006, AM J CARDIOL, V98, P973, DOI 10.1016/j.amjcard.2006.04.041; National High Blood Pressure Education Program, 2004, 045230 NAT HIGHBL PR; Ojji DB, 2014, J HUM HYPERTENS, V28, P432, DOI 10.1038/jhh.2013.130; Ojji D, 2015, AM J HYPERTENS, V28, P924, DOI 10.1093/ajh/hpu247; Ojji D, 2013, EUR J HEART FAIL, V15, P835, DOI 10.1093/eurjhf/hft061; Palmieri V, 1999, J AM COLL CARDIOL, V34, P1625, DOI 10.1016/S0735-1097(99)00396-4; SAHN DJ, 1978, CIRCULATION, V58, P1072, DOI 10.1161/01.CIR.58.6.1072; Shah RV, 2009, CIRC-HEART FAIL, V2, P311, DOI 10.1161/CIRCHEARTFAILURE.108.833707; Stewart S, 2011, EUR J HEART FAIL, V13, P1070, DOI 10.1093/eurjhf/hfr108; Stewart S, 2008, CIRCULATION, V118, P2360, DOI 10.1161/CIRCULATIONAHA.108.786244; Swedberg K, 2005, EUR HEART J, V26, P1115, DOI 10.1093/eurheartj/ehi204; TEICHHOLZ LE, 1976, AM J CARDIOL, V37, P7, DOI 10.1016/0002-9149(76)90491-4	32	8	9	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153479	10.1371/journal.pone.0153479	http://dx.doi.org/10.1371/journal.pone.0153479			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073856	Green Published, gold, Green Submitted			2022-12-27	WOS:000374131200098
J	Tang, FR; Wang, JW; Tang, Z; Kang, M; Deng, QL; Yu, JM				Tang, Furong; Wang, Jiwei; Tang, Zheng; Kang, Mei; Deng, Qinglong; Yu, Jinming			Accuracy of McMonnies Questionnaire as a Screening Tool for Chinese Ophthalmic Outpatients	PLOS ONE			English	Article							DRY EYE DISEASE; RISK-FACTORS; SYMPTOMS; PREVALENCE; POPULATION; SIGNS; ASSOCIATION; DIAGNOSIS; VALIDITY; TESTS	Objective To evaluate the accuracy of the McMonnies questionnaire (MQ) as a screening tool for dry eye (DE) among Chinese ophthalmic outpatients. Methods We recruited 27718 cases from 94 hospitals (research centers), randomly selected from 45 cities in 23 provinces from July to November in 2013. Only symptomatic outpatients were included and they were in a high risk of DE. Outpatients meeting the criteria filled out questionnaires and then underwent clinical examinations by qualified medical practitioners. We mainly evaluated sensitivity, specificity, diagnostic odds ratio (DOR), and area under the receiver-operating characteristic curve (AUC) to evaluate the accuracy of the questionnaire in the diagnosis of dry eye. Results Of all the subjects included in the study, sensitivity, specificity, and DOR were 0.77, 0.86 and 20.6, respectively. AUC was 0.865 with a 95% CI (0.861, 0.869). The prevalence of DE among the outpatients claiming "constantly" as the frequency of symptom was over 90%. Scratchiness was a more accurate diagnostic indication than dryness, soreness, grittiness or burning. Different cut points of McMonnies Index (MI) scores can be utilized to optimize the screening results. Conclusions MQ can be an effective screening tool for dry eye. We can take full advantage of MI score during the screening process.	[Tang, Furong; Wang, Jiwei; Tang, Zheng; Kang, Mei; Deng, Qinglong; Yu, Jinming] Fudan Univ, Inst Epidemiol & Hlth Stat, Sch Publ Hlth, Shanghai 200433, Peoples R China; [Tang, Furong; Yu, Jinming] Fudan Univ, Collaborat Innovat Ctr Social Risks Governance Hl, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Yu, JM (corresponding author), Fudan Univ, Inst Epidemiol & Hlth Stat, Sch Publ Hlth, Shanghai 200433, Peoples R China.; Yu, JM (corresponding author), Fudan Univ, Collaborat Innovat Ctr Social Risks Governance Hl, Shanghai 200433, Peoples R China.	jmy@fudan.edu.cn						ANDERSON JA, 1972, Q J MED, V41, P175; [Anonymous], 2007, OCULAR SURFACE, V5, P75; BandeenRoche R, 1997, INVEST OPHTH VIS SCI, V38, P2469; Begley CG, 2002, CORNEA, V21, P664, DOI 10.1097/00003226-200210000-00007; Bhatnagar KR, 2015, INT J OPHTHALMOL-CHI, V8, P174, DOI 10.3980/j.issn.2222-3959.2015.01.31; Bron AJ, 2007, OCUL SURF, V5, P108; Chia EM, 2003, CLIN EXP OPHTHALMOL, V31, P229, DOI 10.1046/j.1442-9071.2003.00634.x; Davidson M, 2002, AUST J PHYSIOTHER, V48, P227, DOI 10.1016/S0004-9514(14)60228-2; Doughty MJ, 1997, OPTOMETRY VISION SCI, V74, P624, DOI 10.1097/00006324-199708000-00023; HALDANE JBS, 1956, ANN HUM GENET, V20, P309; Johnson ME, 2009, OCUL SURF, V7, P199, DOI 10.1016/S1542-0124(12)70187-8; Korb DR, 2000, CORNEA, V19, P483, DOI 10.1097/00003226-200007000-00016; Lee AJ, 2002, BRIT J OPHTHALMOL, V86, P1347, DOI 10.1136/bjo.86.12.1347; Lin PY, 2003, OPHTHALMOLOGY, V110, P1096, DOI 10.1016/S0161-6420(03)00262-8; LITTENBERG B, 1993, MED DECIS MAKING, V13, P313, DOI 10.1177/0272989X9301300408; McCarty CA, 1998, OPHTHALMOLOGY, V105, P1114, DOI 10.1016/S0161-6420(98)96016-X; McMonnies C, 1998, ADV EXP MED BIOL, V438, P835; McMonnies C W, 1987, J Am Optom Assoc, V58, P296; McMonnies C W, 1986, J Am Optom Assoc, V57, P512; McMonnies C W, 1987, J Am Optom Assoc, V58, P588; Moss SE, 2000, ARCH OPHTHALMOL-CHIC, V118, P1264; Nichols KK, 2006, OCUL SURF, V4, P137, DOI 10.1016/S1542-0124(12)70040-X; Nichols KK, 2004, CORNEA, V23, P762, DOI 10.1097/01.ico.0000133997.07144.9e; Nichols KK, 2004, CORNEA, V23, P365, DOI 10.1097/00003226-200405000-00010; Oden NL, 1998, ADV EXP MED BIOL, V438, P807; Pult H, 2011, EYE, V25, P502, DOI 10.1038/eye.2010.228; Schaumberg DA, 2003, AM J OPHTHALMOL, V136, P318, DOI 10.1016/S0002-9394(03)00218-6; Schein OD, 1997, OPHTHALMOLOGY, V104, P1395, DOI 10.1016/S0161-6420(97)30125-0; Schein OD, 1997, AM J OPHTHALMOL, V124, P723, DOI 10.1016/S0002-9394(14)71688-5; Schiffman RM, 2000, ARCH OPHTHALMOL-CHIC, V118, P615, DOI 10.1001/archopht.118.5.615; Shimmura S, 1999, CORNEA, V18, P408, DOI 10.1097/00003226-199907000-00003; Simpson TL, 2008, OPTOMETRY VISION SCI, V85, P692, DOI 10.1097/OPX.0b013e318181ae36; Sullivan BD, 2014, ACTA OPHTHALMOL, V92, P161, DOI 10.1111/aos.12012; Uchino M, 2011, OPHTHALMOLOGY, V118, P2361, DOI 10.1016/j.ophtha.2011.05.029	34	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153047	10.1371/journal.pone.0153047	http://dx.doi.org/10.1371/journal.pone.0153047			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073922	Green Submitted, Green Published, gold			2022-12-27	WOS:000374131200047
J	King, AJ; Sonsma, JA; Vriend, HJ; van der Sande, MAB; Feltkamp, MC; Boot, HJ; Koopmans, MPG				King, Audrey J.; Sonsma, Jan A.; Vriend, Henrike J.; van der Sande, Marianne A. B.; Feltkamp, Mariet C.; Boot, Hein J.; Koopmans, Marion P. G.		Med Microbiological Labs Municipal	Genetic Diversity in the Major Capsid L1 Protein of HPV-16 and HPV-18 in the Netherlands	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS TYPE-16; VARIANTS; RISK; POLYMORPHISM; PERSISTENCE; INFECTIONS; WOMEN	Objectives Intratypic molecular variants of human papillomavirus (HPV) type-16 and -18 exist. In the Netherlands, a bivalent vaccine, composed of recombinant L1 proteins from HPV-16 and -18, is used to prevent cervical cancer since 2009. Long-term vaccination could lead to changes in HPV-16 and -18 virus population, thereby hampering vaccination strategies. We determined the genetic diversity of the L1 gene in HPV-16 and -18 viral strains circulating in the Netherlands at the start of vaccination in order to understand the baseline genetic diversity in the Dutch population. Methods DNA sequences of the L1 gene were determined in HPV-16 (n = 241) and HPV-18 (n = 108) positive anogenital samples collected in 2009 and 2011 among Dutch 16-to 24-year old female and male attendees of the sexually transmitted infection (STI) clinics. Phylogenetic analysis was performed and sequences were compared to reference sequences HPV-16 (AF536179) and HPV-18 (X05015) using BioNumerics 7.1. Results For HPV-16, ninety-five single nucleotide polymorphism (SNPs) were identified, twentyseven (28%) were non-synonymous variations. For HPV-18, seventy-one SNPs were identified, twenty-nine (41%) were non-synonymous. The majority of the non-silent variations were located in sequences encoding alpha helix, beta sheet or surface loops, in particular in the immunodominant FG loop, and may influence the protein secondary structure and immune recognition. Conclusions This study provides unique pre-vaccination/baseline data on the genetic L1 diversity of HPV-16 and - 18 viruses circulating in the Netherlands among adolescents and young adults.	[King, Audrey J.; Sonsma, Jan A.; Vriend, Henrike J.; van der Sande, Marianne A. B.; Boot, Hein J.; Koopmans, Marion P. G.] Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control, Bilthoven, Netherlands; [van der Sande, Marianne A. B.] Univ Med Ctr, Julius Ctr Primary Care & Publ Hlth, Utrecht, Netherlands; [Feltkamp, Mariet C.] Leiden Univ, Med Ctr, Dept Med Microbiol, Leiden, Netherlands	Netherlands National Institute for Public Health & the Environment; Utrecht University; Utrecht University Medical Center; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	King, AJ (corresponding author), Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control, Bilthoven, Netherlands.	audrey.king@rivm.nl	Koopmans, Marion/Y-9170-2019; Feltkamp, Mariet/A-3788-2010	Koopmans, Marion/0000-0002-5204-2312; Feltkamp, Mariet/0000-0001-5993-9846; van der Sande, Marianne AB/0000-0002-4778-6739	Ministry of Health, Welfare and Sport, the Netherlands	Ministry of Health, Welfare and Sport, the Netherlands	This work was supported by the Ministry of Health, Welfare and Sport, the Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernard HU, 2006, INT J CANCER, V118, P1071, DOI 10.1002/ijc.21655; Bishop B, 2007, J BIOL CHEM, V282, P31803, DOI 10.1074/jbc.M706380200; Burk RD, 2003, CANCER RES, V63, P7215; Burk RD, 2013, VIROLOGY, V445, P232, DOI 10.1016/j.virol.2013.07.018; Chen ZG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072565; Christensen ND, 1996, VIROLOGY, V223, P174, DOI 10.1006/viro.1996.0466; Cornet I, 2013, INFECT AGENTS CANCER, V8, DOI 10.1186/1750-9378-8-4; Cornut G, 2010, J MED VIROL, V82, P1168, DOI 10.1002/jmv.21777; de Sanjose S, 2010, LANCET ONCOL, V11, P1048, DOI 10.1016/S1470-2045(10)70230-8; Frati E, 2011, INFECT GENET EVOL, V11, P2119, DOI 10.1016/j.meegid.2011.06.014; Gagnon S, 2007, JAIDS-J ACQ IMM DEF, V44, P61, DOI 10.1097/01.qai.0000247226.45375.01; HO L, 1993, J VIROL, V67, P6413, DOI 10.1128/JVI.67.11.6413-6423.1993; KORBER B, 2000, COMPUTATIONAL ANAL H, P55, DOI DOI 10.1007/B112102; Malagon T, 2012, LANCET INFECT DIS, V12, P781, DOI 10.1016/S1473-3099(12)70187-1; Mollers M, 2013, VACCINE, V31, P394, DOI 10.1016/j.vaccine.2012.10.087; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; NEI M, 1986, MOL BIOL EVOL, V3, P418; Pastrana DV, 2001, VIROLOGY, V279, P361, DOI 10.1006/viro.2000.0702; Rector A, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r57; Roden RBS, 1997, J VIROL, V71, P6247, DOI 10.1128/JVI.71.8.6247-6252.1997; Schiffman M, 2010, OBSTET GYNECOL, V116, P177, DOI 10.1097/AOG.0b013e3181e4629f; Stewart ACM, 1996, J VIROL, V70, P3127, DOI 10.1128/JVI.70.5.3127-3136.1996; Varsani A, 2006, VIRUS RES, V122, P154, DOI 10.1016/j.virusres.2006.07.012; Villa LL, 2000, J GEN VIROL, V81, P2959, DOI 10.1099/0022-1317-81-12-2959; Vriend HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060696; Vriend HJ, 2012, SEX TRANSM DIS, V39, P72, DOI 10.1097/OLQ.0b013e318235b3b0; Xi LF, 2007, CANCER EPIDEM BIOMAR, V16, P4, DOI 10.1158/1055-9965.EPI-06-0670; Xi LF, 2006, J NATL CANCER I, V98, P1045, DOI 10.1093/jnci/djj297; Yue YF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055204	29	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0152782	10.1371/journal.pone.0152782	http://dx.doi.org/10.1371/journal.pone.0152782			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27070907	Green Published, gold, Green Submitted			2022-12-27	WOS:000373900700016
J	Mastantuono, T; Starita, N; Sapio, D; D'Avanzo, SA; Di Maro, M; Muscariello, E; Paterni, M; Colantuoni, A; Lapi, D				Mastantuono, Teresa; Starita, Noemy; Sapio, Daniela; D'Avanzo, Sabato Andrea; Di Maro, Martina; Muscariello, Espedita; Paterni, Marco; Colantuoni, Antonio; Lapi, Dominga			The Effects of Vaccinium myrtillus Extract on Hamster Pial Microcirculation during Hypoperfusion-Reperfusion Injury	PLOS ONE			English	Article							CHEEK-POUCH MICROCIRCULATION; IN-VITRO; BEHAVIORAL DEFICITS; OXIDANT STRESS; BRAIN-DAMAGE; RATS; FENTANYL; ANTHOCYANINS; BLUEBERRY; ARTERY	Introduction The present study was aimed to assess the in vivo hamster pial microvessel alterations due to 30 min transient bilateral common carotid artery occlusion (BCCAO) and reperfusion (60 min); moreover, the neuroprotective effects of Vaccinium myrtillus extract, containing 34.7% of anthocyanins, were investigated. Materials and Methods Two groups of male hamsters were used: the first fed with control diet and the other with Vaccinium myrtillus supplemented diet. Hamster pial microcirculation was visualized by fluorescence microscopy through an open cranial window. Pial arterioles were classified according to Strahler's method. Results In age-matched control diet-fed hamsters, BCCAO caused a decrease in diameter of all arterioles. At the end of reperfusion, the reduction of diameter in order 3 arterioles was by 8.4 +/- 3.1%, 10.8 +/- 2.3% and 12.1 +/- 1.1% of baseline in the 2, 4 and 6 month control diet-fed hamsters, respectively. Microvascular permeability and leukocyte adhesion were markedly enhanced, while perfused capillary length (PCL) decreased. The response to acetylcholine and papaverine topical application was impaired; 2'-7'-dichlorofluoresceine-diacetate assay demonstrated a significant ROS production. At the end of BCCAO, in age-matched Vaccinium myrtillussupplemented diet-fed hamsters, the arteriolar diameter did not significantly change compared to baseline. After 60 min reperfusion, order 3 arterioles dilated by 9.3 +/- 2.4%, 10.6 +/- 3.1% and 11.8 +/- 2.7% of baseline in the 2, 4 and 6 month Vaccinium myrtillus supplemented diet-fed hamsters, respectively. Microvascular leakage and leukocyte adhesion were significantly reduced in all groups according to the time-dependent treatment, when compared with the age-matched control diet-fed hamsters. Similarly, the reduction in PCL was progressively prevented. Finally, the response to acetylcholine and papaverine topical application was preserved and there was no significant increase in ROS production in all groups. Conclusions In conclusion, Vaccinium myrtillusextract protected pial microcirculation during hypoperfusion-reperfusion, preventing vasoconstriction, microvascular permeability, leukocyte adhesion, reduction in PCL and preserving the endothelium function.	[Mastantuono, Teresa; Starita, Noemy; Sapio, Daniela; D'Avanzo, Sabato Andrea; Di Maro, Martina; Muscariello, Espedita; Colantuoni, Antonio; Lapi, Dominga] Univ Naples Federico II, Sch Med, Dept Clin Med & Surg, Naples, Italy; [Paterni, Marco] CNR, Inst Clin Physiol, Via Savi 8, I-56100 Pisa, Italy	University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR)	Lapi, D (corresponding author), Univ Naples Federico II, Sch Med, Dept Clin Med & Surg, Naples, Italy.	d.lapi@dfb.unipi.it	Starita, Noemy/AHC-7586-2022; Paterni, Marco/AAX-9367-2020	Starita, Noemy/0000-0002-5169-7640; Muscariello, Espedita/0000-0002-4678-562X; Colantuoni, Antonio/0000-0003-1152-5630; Mastantuono, Teresa/0000-0002-5626-553X; Paterni, Marco/0000-0002-9799-7059				[Anonymous], [No title captured], DOI DOI 10.1201/B10787-5; BEDERSON JB, 1986, STROKE, V17, P1304, DOI 10.1161/01.STR.17.6.1304; BERTUGLIA S, 1995, PHARMACOL RES, V31, P183, DOI 10.1016/1043-6618(95)80016-6; Bornsek SM, 2012, FOOD CHEM, V134, P1878, DOI 10.1016/j.foodchem.2012.03.092; Brookes ZLS, 2003, ANESTH ANALG, V96, P456, DOI 10.1097/00000539-200302000-00030; Cai H, 2000, CIRC RES, V87, P840, DOI 10.1161/01.RES.87.10.840; Chan PH, 1996, STROKE, V27, P1124, DOI 10.1161/01.STR.27.6.1124; Colantuoni A, 2005, J VASC RES, V42, P55, DOI 10.1159/000083092; COLANTUONI A, 1984, INT J MICROCIRC, V3, P13; FISCHER S, 1995, ANESTHESIOLOGY, V82, P451, DOI 10.1097/00000542-199502000-00015; Fraser PA, 2011, FREE RADICAL BIO MED, V51, P967, DOI 10.1016/j.freeradbiomed.2011.06.003; Gursoy S, 2006, EUR J ANAESTH, V23, P496, DOI 10.1017/S0265021506000172; HELFAER MA, 1990, STROKE, V21, P795, DOI 10.1161/01.STR.21.5.795; Heo JH, 2005, FREE RADICAL BIO MED, V39, P51, DOI 10.1016/j.freeradbiomed.2005.03.035; HUDETZ AG, 1995, AM J PHYSIOL-HEART C, V268, pH2202, DOI 10.1152/ajpheart.1995.268.6.H2202; KASSAB GS, 1993, AM J PHYSIOL, V265, pH350, DOI 10.1152/ajpheart.1993.265.1.H350; Kaye Alan D, 2006, Am J Ther, V13, P478, DOI 10.1097/01.mjt.0000178338.43545.3a; Lapi D, 2008, J VASC RES, V45, P69, DOI 10.1159/000109078; Lapi D, 2015, MICROCIRCULATION, V22, P79, DOI 10.1111/micc.12175; Lee SG, 2014, J NUTR BIOCHEM, V25, P404, DOI 10.1016/j.jnutbio.2013.12.001; Leinonen JS, 2000, STROKE, V31, P33, DOI 10.1161/01.STR.31.1.33; Malin DH, 2011, NUTRITION, V27, P338, DOI 10.1016/j.nut.2010.05.001; MORII S, 1986, J CEREBR BLOOD F MET, V6, P34, DOI 10.1038/jcbfm.1986.5; NGAI AC, 1988, AM J PHYSIOL, V254, pH133, DOI 10.1152/ajpheart.1988.254.1.H133; Phillips SA, 2005, AM J PHYSIOL-REG I, V288, pR522, DOI 10.1152/ajpregu.00655.2004; Prior RL, 2000, J AOAC INT, V83, P950; Sahin AE, 2005, J CARDIOTHOR VASC AN, V19, P197, DOI 10.1053/j.jvca.2005.01.031; Sweeney MI, 2002, NUTR NEUROSCI, V5, P427, DOI 10.1080/1028415021000055970; Vepsalainen S, 2013, J NUTR BIOCHEM, V24, P360, DOI 10.1016/j.jnutbio.2012.07.006; Wang LS, 2008, CANCER LETT, V269, P281, DOI 10.1016/j.canlet.2008.05.020; Watanabe Shigeru, 1998, Keio Journal of Medicine, V47, P92; Youdim KA, 2000, BBA-GEN SUBJECTS, V1523, P117, DOI 10.1016/S0304-4165(00)00109-4; Ziche M, 2001, METH MOLEC MED, V46, P131, DOI 10.1385/1-59259-143-4:131	35	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0150659	10.1371/journal.pone.0150659	http://dx.doi.org/10.1371/journal.pone.0150659			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27070318	Green Published, gold, Green Submitted			2022-12-27	WOS:000373900700004
J	Murray, M				Murray, Mike			Does Poor Quality Schooling and/or Teacher Quality Hurt Black South African Students Enrolling for a Degree at the University of KwaZulu-Natal?	PLOS ONE			English	Article							ACADEMIC DEVELOPMENT; PERFORMANCE; ACHIEVEMENT; MAINSTREAM; ECONOMICS; COURSES; LEVEL	A Abstract Wealthy schools appoint better qualified teachers, less wealthy schools under qualified teachers. Added to this mix is a powerful teacher's union whose policies attempt to entrench the job security of teachers in the less wealthy schools irrespective of whether they can teach their subjects or not. Can one isolate these effects from that of other socio-demographic factors that may also be affecting the performance of students when they enrol for a degree at the University of KwaZulu-Natal (UKZN)? An outcome variable that subtracts the number of courses that have been failed from the number of courses that have been passed, dividing this by the total number of years that they have spent studying for a particular degree will be used as a response variable for this paper. Objectives The system of secondary education in South Africa is highly polarized. On the one hand, we have a group of mainly Black African students, forming about 80% of the total student population, that come from a vastly under-resourced rural or township based community. On the other hand, we have a group of predominantly White and Indian students who are able to attend a far better resourced set of private schools. Added to this mix, we have 240,000 of South Africa's total number of 390,000 primary and secondary school teachers who belong to a powerful teacher's union which enjoys a strong political alliance with the ruling party in South Africa. With most of their union members teaching in the less wealthy schools in South Africa, 'school background' now includes a politically motivated component that focuses on teacher self-interest rather than the education of the child. What sort of effect does school background have on the performance of students when they enter an institution of higher learning? More importantly, can one isolate the effect of school background from that of other possibly confounding factors such as gender, financial aid and the receipt of some form of residence based accommodation that will also impact on their performance while at university? Method A total of 6,183 students enrolling for a degree at the University of KwaZulu-Natal (UKZN) over the period 2008 to 2012 were used a dataset for this study. Permission to use this dataset was given by the Teaching and Learning Office at UKZN. The database that was used for this study was obtained from the Division of Management Information (DMI) office at UKZN. The percentage based marks that students have managed to record for Mathematics, English, Biology and Accounting in their school leaving exams together with some other important but observable socio-economic factors were included in a regression model to determine how students will perform at UKZN. Socio-economic variables relating to gender, race and whether they have receivd some form of financial aid or residence based accommodation while studying at university were also included as predictor variables in our regression based model structure. Results and Conclusions An interaction effect associated with being a Black African student who has been privileged enough to attend a quintile five school was found to be significant. A main effect associated with being able to attend a more privileged quintile 5 school however was found to be nonsignificant even after an adjustment has been made for gender, race, the receipt of some form of financial aid and residence based accommodation. Given that UKZN already has a number of bridging programs in place that target students who have come from a less privileged background, for university based policymakers, this result may help to justify the targeted selection of Black African students from the less privileged schools that is taking place. Because some of the disparity in matric performance that we are observing may also be associated with teacher competency and the protective influence of a powerful teacher's union, this paper may also help to highlight some of the economic costs related with having under-prepared students. "A mind is a terrible thing to waste"-United Negro College Fund.	[Murray, Mike] Univ KwaZulu Natal, Sch Math Stat & Comp Sci, Westville Campus, Durban, Kwazulu Natal, South Africa	University of Kwazulu Natal	Murray, M (corresponding author), Univ KwaZulu Natal, Sch Math Stat & Comp Sci, Westville Campus, Durban, Kwazulu Natal, South Africa.	murraym@ukzn.ac.za		Murray, Mike/0000-0001-6329-821X				Bloch G., 2009, TOXIC MIX WHATS WRON; Caldas S.J., 2004, J EDUC RES, V90, P269; Chiu MM, 2007, J FAM PSYCHOL, V21, P510, DOI 10.1037/0893-3200.21.3.510; Du Plessis A., 2005, S AFR J HIGH EDUC, V19, P684, DOI https://doi.org/10.4314/sajhe.v19i4.25656; Eiselen R, 2007, S AFRICAN J HIGHER E, V21, P38; Eweniyi G., 2005, IMPACT FAMILY STRUCT; Fleisch B., 2008, PRIMARY ED CRISIS WH; HEFCE (Higher Education Funding Council for England), 201403 HEFCE; Hoare A, 2011, STUD HIGH EDUC, V36, P21, DOI 10.1080/03075070903414297; Howie S., 2012, S AFRICAN CHILDREN R; Ichado S. M., 1998, J RES COUNSELING PSY, V4, P84; James Coleman, 1966, EQUALITY ED OPPORTUN; Jawitz J, 1995, S AFRICAN J HIGHER E, V9, P10; Mitchell G, 1997, S AFR J SCI, V93, P382; Murray M, 2014, S AFR J SCI, V110, DOI 10.1590/sajs.2014/20140008; Ogg T, 2009, BRIT EDUC RES J, V35, P781, DOI 10.1080/01411920903165611; PARK KH, 1990, J ECON EDUC, V21, P101, DOI 10.2307/1181978; Parker K, 2006, S AFR J ECON, V74, P137, DOI 10.1111/j.1813-6982.2006.00054.x; PEERS IS, 1994, BRIT J EDUC PSYCHOL, V64, P1, DOI 10.1111/j.2044-8279.1994.tb01081.x; Reddy V., 2003, MATH SCI ACHIEVEMENT; Rothman S., 2003, AM ED RES ASS 21 25; SIEGFRIED JJ, 1979, J ECON LIT, V17, P923; Smith J, 2005, ECON EDUC REV, V24, P549, DOI 10.1016/j.econedurev.2004.07.016; Smith L, 2007, S AFR J ECON, V75, P99, DOI 10.1111/j.1813-6982.2007.00102.x; Smith LC, 2009, S AFR J ECON, V77, P162, DOI 10.1111/j.1813-6982.2009.01195.x; Spaul N., 2013, S AFRICAS ED CRISIS; Sutton Trust, 2010, COMPR PUP OUTP IND G; TAY RS, 1994, J ECON EDUC, V25, P291, DOI 10.2307/1182977; Tewari D.D., 2014, INT J EDUC SCI, V6, P233, DOI [https://doi.org/10.1080/09751122.2014.11890565, DOI 10.1080/09751122.2014.11890565]; The Sutton Trust, 2010, RESP NEW LANDSC U AC; Thiele T, 2016, STUD HIGH EDUC, V41, P1424, DOI 10.1080/03075079.2014.974528; Tomul E, 2012, EDUC ASSESS EVAL ACC, V24, P175, DOI 10.1007/s11092-012-9149-3; van der Berg S, 2007, J AFR ECON, V16, P849, DOI 10.1093/jae/ejm017; Van Eeden R., 2001, S AFRICAN J HIGHER E, V15, P171, DOI DOI 10.4314/SAJHE.V15I1.25392; Van Walbeek C., 2004, S AFRICAN J EC, V72, P11; Walstad W, 1999, AM ECON REV, V89, P350, DOI 10.1257/aer.89.2.350; WILLIAMS ML, 1992, J ECON EDUC, V23, P219, DOI 10.2307/1183224; Zimdars A., 2007, THESIS U OXFORD DEP	38	5	5	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0153091	10.1371/journal.pone.0153091	http://dx.doi.org/10.1371/journal.pone.0153091			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ0NI	27070652	Green Submitted, Green Published, gold			2022-12-27	WOS:000373900700030
J	Nespeca, M; Giorgetti, C; Nobile, S; Ferrini, I; Simonato, M; Verlato, G; Cogo, P; Carnielli, VP				Nespeca, Matteo; Giorgetti, Chiara; Nobile, Stefano; Ferrini, Ilaria; Simonato, Manuela; Verlato, Giovanna; Cogo, Paola; Carnielli, Virgilio Paolo			Does Whole-Body Hypothermia in Neonates with Hypoxic-Ischemic Encephalopathy Affect Surfactant Disaturated-Phosphatidylcholine Kinetics?	PLOS ONE			English	Article							PERINATAL ASPHYXIAL ENCEPHALOPATHY; RESPIRATORY-DISTRESS-SYNDROME; CRITICALLY-ILL INFANTS; STABLE-ISOTOPES; SYSTEMIC HYPOTHERMIA; NEWBORN-INFANTS; TRIAL	Background It is unknown whether Whole-Body Hypothermia (WBH) affects pulmonary function. In vitro studies, at relatively low temperatures, suggest that hypothermia may induce significant changes to the surfactant composition. The effect of WBH on surfactant kinetics in newborn infants is unknown. We studied in vivo kinetics of disaturated-phosphatidylcholine (DSPC) in asphyxiated newborns during WBH and in normothermic controls (NTC) with no or mild asphyxia. Both groups presented no clinically apparent lung disease. Methods Twenty-seven term or near term newborns requiring mechanical ventilation were studied (GA 38.6 +/- 2.2 wks). Fifteen during WBH and twelve NTC. All infants received an intra-tracheal dose of C-13 labelled DSPC and tracheal aspirate were performed. DSPC amount, DSPC half-life (HL) and pool size (PS) were calculated. Results DSPC amount in tracheal aspirates was 0.42 [0.22-0.54] and 0.36 [0.10-0.58] mg/ml in WBH and NTC respectively (p = 0.578). DSPC HL was 24.9 [15.7-52.5] and 25.3 [15.8-59.3] h (p = 0.733) and DSPC PS was 53.2 [29.4-91.6] and 40.2 [29.8-64.6] mg/kg (p = 0.598) in WBH and NTC respectively. Conclusions WBH does not alter DSPC HL and PS in newborn infants with no clinical apparent lung disease.	[Nespeca, Matteo; Giorgetti, Chiara; Nobile, Stefano; Carnielli, Virgilio Paolo] Polytech Univ Marche, Dept Clin Sci, Div Neonatol, Ancona, Italy; [Nespeca, Matteo; Giorgetti, Chiara; Nobile, Stefano; Carnielli, Virgilio Paolo] Azienda Osped Univ Ospedali Riuniti, Ancona, Italy; [Ferrini, Ilaria; Verlato, Giovanna] Univ Padua, Dept Womens & Childrens Hlth, Padua, Italy; [Simonato, Manuela] Pediat Res Inst Citta della Speranza, Padua, Italy; [Cogo, Paola] Univ Udine, Dept Expt & Clin Med, I-33100 Udine, Italy	Marche Polytechnic University; University of Padua; Fondazione Citta della Speranza; University of Udine	Carnielli, VP (corresponding author), Polytech Univ Marche, Dept Clin Sci, Div Neonatol, Ancona, Italy.; Carnielli, VP (corresponding author), Azienda Osped Univ Ospedali Riuniti, Ancona, Italy.	v.carnielli@univpm.it	Cogo, Paola P/J-6918-2018; nobile, stefano/G-9775-2017; Simonato, Manuela/AAX-5656-2020	Cogo, Paola P/0000-0002-6235-140X; nobile, stefano/0000-0002-5304-1485; Simonato, Manuela/0000-0002-2745-7305				Azzopardi D, 2008, BMC PEDIATR, V8, DOI 10.1186/1471-2431-8-17; Azzopardi DV, 2009, NEW ENGL J MED, V361, P1349, DOI 10.1056/NEJMoa0900854; Ball MK, 2010, RESUSCITATION, V81, P749, DOI 10.1016/j.resuscitation.2009.12.007; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Cogo PE, 2008, PEDIATR RES, V63, P433, DOI 10.1203/PDR.0b013e3181659759; Cogo PE, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-13; Cogo PE, 1999, PEDIATR RES, V45, P242, DOI 10.1203/00006450-199902000-00015; Cogo PE, 2003, PEDIATR RES, V54, P653, DOI 10.1203/01.PDR.0000084344.42409.C6; Cogo PE, 1997, PEDIATR RES, V41, P178, DOI 10.1203/00006450-199702000-00004; Dassios T, 2014, ACTA PAEDIATR, V103, P157, DOI 10.1111/apa.12476; De Luca D, 2014, EUR RESPIR J, V44, P1708, DOI 10.1183/09031936.00117714; Duan M, 2011, RESP CARE, V56, P1956, DOI 10.4187/respcare.01211; Gluckman PD, 2005, LANCET, V365, P663, DOI 10.1016/S0140-6736(05)17946-X; Howard FB, 2010, INT J MOL SCI, V11, P754, DOI 10.3390/ijms11020754; JONES PJH, 1991, CLIN SCI, V80, P277, DOI 10.1042/cs0800277; Lapointe Anie, 2011, J Pediatr, V158, pe19, DOI 10.1016/j.jpeds.2010.11.008; Lista G, 2011, J MATERN-FETAL NEO M, V24, P67, DOI 10.3109/14767058.2011.607615; MARTINANCEL A, 1995, J PEDIATR-US, V127, P786, DOI 10.1016/S0022-3476(95)70174-5; Nagle JF, 2000, CURR OPIN STRUC BIOL, V10, P474, DOI 10.1016/S0959-440X(00)00117-2; Perez-Gil J, 2008, BBA-BIOMEMBRANES, V1778, P1676, DOI 10.1016/j.bbamem.2008.05.003; Pietrini D, 2012, EUR J PEDIATR, V171, P1855, DOI 10.1007/s00431-012-1769-6; Shankaran S, 2005, NEW ENGL J MED, V353, P1574, DOI 10.1056/NEJMcps050929; Simbruner G, 2010, PEDIATRICS, V126, pE771, DOI 10.1542/peds.2009-2441; Suri LNM, 2012, BBA-BIOMEMBRANES, V1818, P1581, DOI 10.1016/j.bbamem.2012.02.021; SUWABE A, 1992, J BIOL CHEM, V267, P19884; Torresin M, 2000, AM J RESP CRIT CARE, V161, P1584, DOI 10.1164/ajrccm.161.5.9905088	26	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0153328	10.1371/journal.pone.0153328	http://dx.doi.org/10.1371/journal.pone.0153328			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27070307	gold, Green Published, Green Submitted			2022-12-27	WOS:000373900700052
J	Noroozi, M; Zakaria, A; Radiman, S; Wahab, ZA				Noroozi, Monir; Zakaria, Azmi; Radiman, Shahidan; Wahab, Zaidan Abdul			Environmental Synthesis of Few Layers Graphene Sheets Using Ultrasonic Exfoliation with Enhanced Electrical and Thermal Properties	PLOS ONE			English	Article							LIQUID-PHASE EXFOLIATION; HIGH-YIELD PRODUCTION; SHEAR EXFOLIATION; GRAPHITE; CONDUCTIVITY; DISPERSIONS; REDUCTION; NANOSHEETS; NANOTUBES; FILMS	In this paper, we report how few layers graphene that can be produced in large quantity with low defect ratio from exfoliation of graphite by using a high intensity probe sonication in water containing liquid hand soap and PVP. It was founded that the graphene powder obtained by this simple exfoliation method after the heat treatment had an excellent exfoliation into a single or layered graphene sheets. The UV-visible spectroscopy, FESEM, TEM, X-ray powder diffraction and Raman spectroscopy was used to analyse the graphene product. The thermal diffusivity of the samples was analysed using a highly accurate thermal-wave cavity photothermal technique. The data obtained showed excellent enhancement in the thermal diffusivity of the graphene dispersion. This well-dispersed graphene was then used to fabricate an electrically conductive polymer-graphene film composite. The results demonstrated that this low cost and environmental friendly technique allowed to the production of high quality layered graphene sheets, improved the thermal and electrical properties. This may find use in the wide range of applications based on graphene.	[Noroozi, Monir; Zakaria, Azmi; Wahab, Zaidan Abdul] Univ Putra Malaysia, Fac Sci, Dept Phys, Serdang 43400, Selangor, Malaysia; [Radiman, Shahidan] Univ Kebangsaan Malaysia, Fac Sci & Technol, Sch Appl Phys, Bangi 43600, Selangor, Malaysia	Universiti Putra Malaysia; Universiti Kebangsaan Malaysia	Noroozi, M; Zakaria, A (corresponding author), Univ Putra Malaysia, Fac Sci, Dept Phys, Serdang 43400, Selangor, Malaysia.	monir.noroozi@gmail.com; azmizak@gmail.com			Ministry of Education [01-02-13-134FR]	Ministry of Education	This work was supported by the Ministry of Education under Fundamental Research Grant Scheme of No. 01-02-13-134FR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdolhosseinzadeh S, 2015, SCI REP-UK, V5, DOI 10.1038/srep10160; Akhavan O, 2010, CARBON, V48, P509, DOI 10.1016/j.carbon.2009.09.069; Alofi A, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.115421; American Cleaning Institute, 2015, SOAPS DET CHEM; Assael MJ, 2005, INT J THERMOPHYS, V26, P647, DOI 10.1007/s10765-005-5569-3; Baby TT, 2010, J APPL PHYS, V108, DOI 10.1063/1.3516289; Bae S, 2010, NAT NANOTECHNOL, V5, P574, DOI [10.1038/NNANO.2010.132, 10.1038/nnano.2010.132]; Balderas-Lopez JA, 2000, REV SCI INSTRUM, V71, P2933, DOI 10.1063/1.1150713; Becerril HA, 2008, ACS NANO, V2, P463, DOI 10.1021/nn700375n; Bonaccorso F, 2012, MATER TODAY, V15, P564, DOI 10.1016/S1369-7021(13)70014-2; Calizo I, 2007, NANO LETT, V7, P2645, DOI 10.1021/nl071033g; Cao BY, 2016, CARBON, V96, P711, DOI 10.1016/j.carbon.2015.09.097; Chabot V, 2013, SCI REP-UK, V3, DOI 10.1038/srep01378; Chaturvedi S, 2012, J SAUDI CHEM SOC, V16, P307, DOI 10.1016/j.jscs.2011.01.015; Chen IWP, 2013, J MATER CHEM C, V1, P5970, DOI 10.1039/c3tc31014k; Ciesielski A, 2014, CHEM SOC REV, V43, P381, DOI 10.1039/c3cs60217f; Davidsohn AS, 2013, SOAP DETERGENT CHEM; Dorgan VE, 2013, NANO LETT, V13, P4581, DOI 10.1021/nl400197w; Fugallo G, 2014, NANO LETT, V14, P6109, DOI 10.1021/nl502059f; Haar S, 2015, SMALL, V11, P1691, DOI 10.1002/smll.201402745; Hamilton CE, 2009, NANO LETT, V9, P3460, DOI 10.1021/nl9016623; Hernandez Y, 2008, NAT NANOTECHNOL, V3, P563, DOI 10.1038/nnano.2008.215; Jobst J, 2010, MATER SCI FORUM, V645-648, P637, DOI 10.4028/www.scientific.net/MSF.645-648.637; Kashyap S, 2014, J NANOPARTICLES, V2014, P1, DOI [10.1155/2014/640281, DOI 10.1155/2014/640281]; Khan U, 2010, SMALL, V6, P864, DOI 10.1002/smll.200902066; Krishnamoorthy K, 2013, ULTRASON SONOCHEM, V20, P644, DOI 10.1016/j.ultsonch.2012.09.007; Kuang YD, 2015, NANO LETT, V15, P6121, DOI 10.1021/acs.nanolett.5b02403; Lee GJ, 2014, J MATER SCI, V49, P1506, DOI 10.1007/s10853-013-7831-6; Lee J, 2014, NAT NANOTECHNOL, V9, P101, DOI 10.1038/nnano.2013.297; Li C, 2008, COMPOS SCI TECHNOL, V68, P1227, DOI 10.1016/j.compscitech.2008.01.006; Li J, 2012, J MATER CHEM, V22, P8426, DOI 10.1039/c2jm16386a; Lin H, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/41/415706; Lotya M, 2010, ACS NANO, V4, P3155, DOI 10.1021/nn1005304; Lotya M, 2009, J AM CHEM SOC, V131, P3611, DOI 10.1021/ja807449u; Mattevi C, 2011, J MATER CHEM, V21, P3324, DOI 10.1039/c0jm02126a; Mehrali M, 2014, NANOSCALE RES LETT, V9, DOI 10.1186/1556-276X-9-15; Nicolosi V, 2013, SCIENCE, V340, P1420, DOI 10.1126/science.1226419; Noroozi M, 2014, NANOSCALE RES LETT, V9, P1, DOI 10.1186/1556-276X-9-645; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; Ou EC, 2013, RSC ADV, V3, P9490, DOI 10.1039/c3ra40602d; Park S, 2009, NAT NANOTECHNOL, V4, P217, DOI [10.1038/nnano.2009.58, 10.1038/NNANO.2009.58]; Parviz D, 2012, ACS NANO, V6, P8857, DOI 10.1021/nn302784m; Paton KR, 2014, NAT MATER, V13, P624, DOI [10.1038/nmat3944, 10.1038/NMAT3944]; Ruecha N, 2014, BIOSENS BIOELECTRON, V52, P13, DOI 10.1016/j.bios.2013.08.018; Sen Gupta S, 2011, J APPL PHYS, V110, DOI 10.1063/1.3650456; SHEN J, 1995, REV SCI INSTRUM, V66, P4999, DOI 10.1063/1.1146123; Shin HJ, 2009, ADV FUNCT MATER, V19, P1987, DOI 10.1002/adfm.200900167; Stankovich S, 2007, CARBON, V45, P1558, DOI 10.1016/j.carbon.2007.02.034; Sur UK, 2012, INT J ELECTROCHEM, V2012, DOI 10.1155/2012/237689; Vandana S, 2015, INT J ENG TRENDS TEC, V26, P1; Varrla E, 2014, NANOSCALE, V6, P11810, DOI 10.1039/c4nr03560g; Wajid AS, 2012, CARBON, V50, P526, DOI 10.1016/j.carbon.2011.09.008; Ye ZQ, 2015, CARBON, V93, P915, DOI 10.1016/j.carbon.2015.06.008; Yigen S, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.241411; Yoon D, 2009, J KOREAN PHYS SOC, V55, P1299, DOI 10.3938/jkps.55.1299; Yu AP, 2007, J PHYS CHEM C, V111, P7565, DOI 10.1021/jp071761s; Yu W, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/5/055705; Zhu HT, 2010, SCI CHINA TECHNOL SC, V53, P360, DOI 10.1007/s11431-010-0032-5	58	31	31	3	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2016	11	4							e0152699	10.1371/journal.pone.0152699	http://dx.doi.org/10.1371/journal.pone.0152699			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0KH	27064575	Green Submitted, Green Published, gold			2022-12-27	WOS:000373891000016
J	Souza, CE; Camargo, LB; Pinter, A; Donalisio, MR				Souza, Celso Eduardo; Camargo, Luciana Bonato; Pinter, Adriano; Donalisio, Maria Rita			High Seroprevalence for Rickettsia rickettsii in Equines Suggests Risk of Human Infection in Silent Areas for the Brazilian Spotted Fever	PLOS ONE			English	Article							TICKS AMBLYOMMA-CAJENNENSE; CAPYBARAS HYDROCHOERUS-HYDROCHAERIS; SAO-PAULO; SOUTHERN BRAZIL; NONENDEMIC AREA; ENDEMIC AREA; STATE; HORSES; TRANSMISSION; ANTIBODIES	Equines play a role in the epidemiology of Brazilian spotted fever (BSF) since they are a primary host for the tick Amblyomma sculptum. We studied the seroprevalence for three species of Rickettsia in equines in four endemic (with human cases) and in four non-endemic areas (no human cases) in the Piracicaba River Basin, Sao Paulo, Brazil. A serological survey of 504 equines was performed: around 63 animals were sampled in each area and tested through indirect immunofluorescence assay for R. rickettsii, R. parkeri, and R. bellii in 2012-2013. Blood samples were seropositive for 183 equines (36.3%) in which 73 (39.9%) were from non-endemic areas. In the studied sites equines were highly exposed to Rickettsia infection ranging from 6.1% to 54.7%, with Geometric Mean Titers greater in endemic area (p = 0.012). Results suggest that Rickettsia may be more widespread than the surveillance of BSF has detected. These results highlight the need to include data on the seroprevalence of sentinel animals to improve human diagnoses and surveillance in areas with no reported human cases.	[Souza, Celso Eduardo; Pinter, Adriano] Superintendence Control Endem Dis, Reference Rickettsial Dis Lab, Sao Paulo, Brazil; [Camargo, Luciana Bonato; Donalisio, Maria Rita] Univ Estadual Campinas, Dept Publ Hlth, Sao Paulo, Brazil	Universidade Estadual de Campinas	Donalisio, MR (corresponding author), Univ Estadual Campinas, Dept Publ Hlth, Sao Paulo, Brazil.	rita.donalisio@gmail.com	Donalisio, Maria Rita/C-5263-2012; Donalisio, Maria Rita/Z-3934-2019; Pinter, Adriano/B-9827-2012; Pinter, Adriano/AAG-6459-2019	Donalisio, Maria Rita/0000-0003-4457-9897; Donalisio, Maria Rita/0000-0003-4457-9897; Pinter, Adriano/0000-0003-4596-3268; Pinter, Adriano/0000-0003-4596-3268	National Counsel of Technological and Scientific Development (CNPq) [472573/2011-0]; Sao Paulo Research Foundation (FAPESP) [2012/02447-0]	National Counsel of Technological and Scientific Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by the National Counsel of Technological and Scientific Development (CNPq), Grant: 472573/2011-0 and Sao Paulo Research Foundation (FAPESP), Grant: 2012/02447-0.	Batista FG, 2010, REV BRAS PARASITOL V, V19, P205, DOI 10.1590/S1984-29612010000400003; Cardoso Luciane Daniele, 2006, Cad. Saúde Pública, V22, P495, DOI 10.1590/S0102-311X2006000300004; de Souza CE, 2008, CIENC RURAL, V38, P1694, DOI 10.1590/S0103-84782008000600031; Freitas MCDD, 2010, REV BRAS PARASITOL V, V19, P130, DOI 10.4322/rbpv.01902012; Fortes FS, 2011, PESQUI VET BRASIL, V31, P1014, DOI 10.1590/S0100-736X2011001100013; Horta MC, 2009, VECTOR-BORNE ZOONOT, V9, P109, DOI 10.1089/vbz.2008.0114; Horta MC, 2004, AM J TROP MED HYG, V71, P93, DOI 10.4269/ajtmh.2004.71.93; Krawczak FS, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-7; Labruna MB, 2009, ANN NY ACAD SCI, V1166, P156, DOI 10.1111/j.1749-6632.2009.04516.x; Labruna MB, 2004, J CLIN MICROBIOL, V42, P90, DOI 10.1128/JCM.42.1.90-98.2004; Labruna MB, 2002, VET PARASITOL, V105, P65, DOI 10.1016/S0304-4017(01)00649-5; Moraes Filho J., 2009, Brazilian Journal of Veterinary Research and Animal Science, V46, P85; Moreira J.A., 1935, BRAS MED, V44, P465; Pacheco RC, 2009, REV SOC BRAS MED TRO, V42, P351, DOI 10.1590/S0037-86822009000300023; Pinter A, 2006, ANN NY ACAD SCI, V1078, P523, DOI 10.1196/annals.1374.103; Sangioni LA, 2005, EMERG INFECT DIS, V11, P265, DOI 10.3201/eid1102.040656; Silveira I, 2007, EMERG INFECT DIS, V13, P1111, DOI 10.3201/eid1307.061397; Souza CE, 2009, VET PARASITOL, V161, P116, DOI 10.1016/j.vetpar.2008.12.010; WALKER DH, 1989, CLIN MICROBIOL REV, V2, P227, DOI 10.1128/CMR.2.3.227-240.1989	19	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2016	11	4							e0153303	10.1371/journal.pone.0153303	http://dx.doi.org/10.1371/journal.pone.0153303			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0KH	27064788	Green Published, gold, Green Submitted			2022-12-27	WOS:000373891000042
J	Valverde, A; De Maayer, P; Oberholster, T; Henschel, J; Louw, MK; Cowan, D				Valverde, Angel; De Maayer, Pieter; Oberholster, Tanzelle; Henschel, Joh; Louw, Michele K.; Cowan, Don			Specific Microbial Communities Associate with the Rhizosphere of Welwitschia mirabilis, a Living Fossil	PLOS ONE			English	Article							PYROSEQUENCING REVEALS; BACTERIAL COMMUNITY; PLANT DIVERSITY; SOIL MICROBES; PATTERNS; ROOTS	Welwitschia mirabilis is an ancient and rare plant distributed along the western coast of Namibia and Angola. Several aspects of Welwitschia biology and ecology have been investigated, but very little is known about the microbial communities associated with this plant. This study reports on the bacterial and fungal communities inhabiting the rhizosphere of W. mirabilis and the surrounding bulk soil. Rhizosphere communities were dominated by sequences of Alphaproteobacteria and Euromycetes, while Actinobacteria, Alphaproteobacteria, and fungi of the class Dothideomycetes jointly dominated bulk soil communities. Although microbial communities within the rhizosphere and soil samples were highly variable, very few "species" (OTUs defined at a 97% identity cut-off) were shared between these two environments. There was a small 'core' rhizosphere bacterial community (formed by Nitratireductor, Steroidobacter, Pseudonocardia and three Phylobacteriaceae) that together with Rhizophagus, an arbuscular mycorrhizal fungus, and other putative plant growth-promoting microbes may interact synergistically to promote Welwitschia growth.	[Valverde, Angel; De Maayer, Pieter; Oberholster, Tanzelle; Cowan, Don] Univ Pretoria, Dept Genet, Ctr Microbial Ecol & Genom, ZA-0002 Pretoria, South Africa; [Henschel, Joh] Gobabeb Res & Training Ctr, Namib Ecol Restorat & Monitoring Unit, Walvis Bay, Namibia; [Henschel, Joh] SAEON Arid Lands Node, Hadison Pk, Kimberley, South Africa; [Louw, Michele K.] Swakop Uranium, Swakopmund, Namibia	University of Pretoria; National Research Foundation - South Africa; South African Environmental Observation Network (SAEON)	Valverde, A (corresponding author), Univ Pretoria, Dept Genet, Ctr Microbial Ecol & Genom, ZA-0002 Pretoria, South Africa.	angel.valverde@up.ac.za	De Maayer, Pieter/AAC-2732-2020; Henschel, Joh R/ABE-5970-2021; Valverde, Angel/C-1308-2009; Oberholster, Tanzelle/C-5214-2015; Cowan, Don/E-3991-2012	Valverde, Angel/0000-0003-0439-9605; Oberholster, Tanzelle/0000-0002-6433-9404; Henschel, Joh/0000-0001-7122-2768; Cowan, Don/0000-0001-8059-861X; De Maayer, Pieter/0000-0001-8550-642X	National Research Foundation, South Africa	National Research Foundation, South Africa(National Research Foundation - South Africa)	This work was supported by funding from the National Research Foundation, South Africa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Swakop Uranium provided support in the form of salaries for MKL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Barke J, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-109; Bever JD, 2012, ANNU REV MICROBIOL, V66, P265, DOI 10.1146/annurev-micro-092611-150107; BORNMAN C H, 1972, Madoqua, V1, P53; Bulgarelli D, 2013, ANNU REV PLANT BIOL, V64, P807, DOI 10.1146/annurev-arplant-050312-120106; Bulgarelli D, 2012, NATURE, V488, P91, DOI 10.1038/nature11336; Burke C, 2011, P NATL ACAD SCI USA, V108, P14288, DOI 10.1073/pnas.1101591108; Burke C, 2011, ISME J, V5, P590, DOI 10.1038/ismej.2010.164; Chaw SM, 2000, P NATL ACAD SCI USA, V97, P4086, DOI 10.1073/pnas.97.8.4086; Coats VC, 2014, MOL ECOL, V23, P1318, DOI 10.1111/mec.12544; Cooper-Driver GA, 2000, J ARID ENVIRON, V46, P181, DOI 10.1006/jare.2000.0660; Dilcher DL, 2005, AM J BOT, V92, P1294, DOI 10.3732/ajb.92.8.1294; Fierer N, 2007, ECOLOGY, V88, P1354, DOI 10.1890/05-1839; Fierer N, 2012, P NATL ACAD SCI USA, V109, P21390, DOI 10.1073/pnas.1215210110; Hartmann M, 2012, ISME J, V6, P2199, DOI 10.1038/ismej.2012.84; Henschel JR, 2000, PLANT ECOL, V150, P7, DOI 10.1023/A:1026512608982; JACOBSON KM, 1993, MYCORRHIZA, V3, P13, DOI 10.1007/BF00213462; Jorquera MA, 2012, MICROB ECOL, V64, P1008, DOI 10.1007/s00248-012-0071-5; Lundberg DS, 2012, NATURE, V488, P86, DOI 10.1038/nature11237; Mendes LW, 2014, ISME J, V8, P1577, DOI 10.1038/ismej.2014.17; Mendes R, 2013, FEMS MICROBIOL REV, V37, P634, DOI 10.1111/1574-6976.12028; Ogut M, 2010, BIOL FERT SOILS, V46, P707, DOI 10.1007/s00374-010-0475-7; Panhwar QA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097241; Parniske M, 2008, NAT REV MICROBIOL, V6, P763, DOI 10.1038/nrmicro1987; Peiffer JA, 2013, P NATL ACAD SCI USA, V110, P6548, DOI 10.1073/pnas.1302837110; Philippot L, 2013, NAT REV MICROBIOL, V11, P789, DOI 10.1038/nrmicro3109; Prober SM, 2015, ECOL LETT, V18, P85, DOI 10.1111/ele.12381; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schloss PD, 2004, MICROBIOL MOL BIOL R, V68, P686, DOI 10.1128/MMBR.68.4.686-691.2004; Stafford WHL, 2005, ENVIRON MICROBIOL, V7, P1755, DOI 10.1111/j.1462-2920.2005.00929.x; Tedersoo L, 2014, SCIENCE, V346, P1078, DOI 10.1126/science.1256688; Uroz S, 2010, ENV MICROBIOL REP, V2, P281, DOI 10.1111/j.1758-2229.2009.00117.x; Valverde A, 2015, MOL ECOL, V24, P812, DOI 10.1111/mec.13068; van der Heijden MGA, 2008, ECOL LETT, V11, P296, DOI 10.1111/j.1461-0248.2007.01139.x; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Zarraonaindia I, 2015, MBIO, V6, DOI 10.1128/mBio.02527-14	37	24	24	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2016	11	4							e0153353	10.1371/journal.pone.0153353	http://dx.doi.org/10.1371/journal.pone.0153353			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0KH	27064484	Green Published, gold, Green Submitted			2022-12-27	WOS:000373891000051
J	Soliman, MK; Sadiq, MA; Agarwal, A; Sarwar, S; Hassan, M; Hanout, M; Graf, F; High, R; Do, DV; Nguyen, QD; Sepah, YJ				Soliman, Mohamed Kamel; Sadiq, Mohammad Ali; Agarwal, Aniruddha; Sarwar, Salman; Hassan, Muhammad; Hanout, Mostafa; Graf, Frank; High, Robin; Do, Diana V.; Quan Dong Nguyen; Sepah, Yasir J.			High-Resolution Imaging of Parafoveal Cones in Different Stages of Diabetic Retinopathy Using Adaptive Optics Fundus Camera	PLOS ONE			English	Article							PHOTORECEPTOR PACKING DENSITY; ECCENTRICITY; VARIABILITY; VISION; IDENTIFICATION	Purpose To assess cone density as a marker of early signs of retinopathy in patients with type II diabetes mellitus. Methods An adaptive optics (AO) retinal camera (rtx1 (TM); Imagine Eyes, Orsay, France) was used to acquire images of parafoveal cones from patients with type II diabetes mellitus with or without retinopathy and from healthy controls with no known systemic or ocular disease. Cone mosaic was captured at 0 degrees and 2 degrees eccentricities along the horizontal and vertical meridians. The density of the parafoveal cones was calculated within 100x100-mu m squares located at 500-mu m from the foveal center along the orthogonal meridians. Manual corrections of the automated counting were then performed by 2 masked graders. Cone density measurements were evaluated with ANOVA that consisted of one between-subjects factor, stage of retinopathy and the within-subject factors. The ANOVA model included a complex covariance structure to account for correlations between the levels of the within-subject factors. Results Ten healthy participants (20 eyes) and 25 patients (29 eyes) with type II diabetes mellitus were recruited in the study. The mean (+/- standard deviation [SD]) age of the healthy participants (Control group), patients with diabetes without retinopathy (No DR group), and patients with diabetic retinopathy (DR group) was 55 +/- 8, 53 +/- 8, and 52 +/- 9 years, respectively. The cone density was significantly lower in the moderate nonproliferative diabetic retinopathy (NPDR) and severe NPDR/proliferative DR groups compared to the Control, No DR, and mild NPDR groups (P < 0.05). No correlation was found between cone density and the level of hemoglobin A(1c) (HbA(1c)) or the duration of diabetes. Conclusions The extent of photoreceptor loss on AO imaging may correlate positively with severity of DR in patients with type II diabetes mellitus. Photoreceptor loss may be more pronounced among patients with advanced stages of DR due to higher risk of macular edema and its sequelae.	[Soliman, Mohamed Kamel; Sadiq, Mohammad Ali; Agarwal, Aniruddha; Sarwar, Salman; Hassan, Muhammad; Hanout, Mostafa; Graf, Frank; Do, Diana V.; Quan Dong Nguyen; Sepah, Yasir J.] Univ Nebraska Med Ctr, Stanley M Truhlsen Eye Inst, Ocular Imaging Reading & Res Ctr, Omaha, NE USA; [Soliman, Mohamed Kamel] Assiut Univ, Dept Ophthalmol, Assiut, Egypt; [High, Robin] Univ Nebraska Med Ctr, Coll Publ Hlth, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center; Egyptian Knowledge Bank (EKB); Assiut University; University of Nebraska System; University of Nebraska Medical Center	Sepah, YJ (corresponding author), Univ Nebraska Med Ctr, Stanley M Truhlsen Eye Inst, Ocular Imaging Reading & Res Ctr, Omaha, NE USA.	yasir.sepah@unmc.edu	Hanout, Mostafa/Q-6840-2017; Soliman, Mohamed/M-4243-2019	Hanout, Mostafa/0000-0001-7829-9776; Soliman, Mohamed/0000-0003-1671-8925	Stanley M. Truhlsen Eye Institute at the University of Nebraska Medical Center from Research to Prevent Blindness (RPB); Otis Glebe Foundation, Omaha, Nebraska, USA	Stanley M. Truhlsen Eye Institute at the University of Nebraska Medical Center from Research to Prevent Blindness (RPB); Otis Glebe Foundation, Omaha, Nebraska, USA	This work was supported by The Stanley M. Truhlsen Eye Institute at the University of Nebraska Medical Center has received an unrestricted grant from Research to Prevent Blindness (RPB). The rtx1 (TM) adaptive optics imaging device employed in this study has been acquired by the Stanley M. Truhlsen Eye Institute, University of Nebraska Medical Center, with generous support from Otis Glebe Foundation, Omaha, Nebraska, USA.	AHNELT PK, 1987, J COMP NEUROL, V255, P18, DOI 10.1002/cne.902550103; Alvarez Y, 2010, DIS MODEL MECH, V3, P236, DOI 10.1242/dmm.003772; Barber AJ, 2003, PROG NEURO-PSYCHOPH, V27, P283, DOI 10.1016/S0278-5846(03)00023-X; Bearse MA, 2004, INVEST OPHTH VIS SCI, V45, P296, DOI 10.1167/iovs.03-0424; BENNETT AG, 1994, GRAEF ARCH CLIN EXP, V232, P361, DOI 10.1007/BF00175988; Carroll J, 2009, P NATL ACAD SCI USA, V106, P20948, DOI 10.1073/pnas.0910128106; Chui TYP, 2008, INVEST OPHTH VIS SCI, V49, P4679, DOI 10.1167/iovs.08-2135; Chui TYP, 2008, J OPT SOC AM A, V25, P3021, DOI 10.1364/JOSAA.25.003021; CURCIO CA, 1992, VISUAL NEUROSCI, V9, P169, DOI 10.1017/S0952523800009639; CURCIO CA, 1987, SCIENCE, V236, P579, DOI 10.1126/science.3576186; CURCIO CA, 1990, J COMP NEUROL, V292, P497, DOI 10.1002/cne.902920402; Dabir S, 2014, EYE, V28, P1488, DOI 10.1038/eye.2014.229; DALEY ML, 1987, DIABETES CARE, V10, P777, DOI 10.2337/diacare.10.6.777; Dees EW, 2011, BIOMED OPT EXPRESS, V2, P1351, DOI 10.1364/BOE.2.001351; Du Y, 2013, P NATL ACAD SCI USA, V110, P16586, DOI 10.1073/pnas.1314575110; Fletcher EL, 2007, CURR PHARM DESIGN, V13, P2699, DOI 10.2174/138161207781662920; Fletcher Erica L, 2005, Clin Exp Optom, V88, P132; Garnier MB, 2014, CLIN EXP OPHTHALMOL, V42, P833, DOI 10.1111/ceo.12356; KLEIN R, 1995, OPHTHALMOLOGY, V102, P7; Kurihara T, 2012, J CLIN INVEST, V122, P4213, DOI 10.1172/JCI65157; Li KY, 2010, INVEST OPHTH VIS SCI, V51, P6858, DOI 10.1167/iovs.10-5499; Liang JZ, 1997, J OPT SOC AM A, V14, P2884, DOI 10.1364/JOSAA.14.002884; Lieth E, 2000, CLIN EXP OPHTHALMOL, V28, P3, DOI 10.1046/j.1442-9071.2000.00222.x; Lombardo M, 2014, RETINA-J RET VIT DIS, V34, P546, DOI 10.1097/IAE.0b013e3182a10850; Mrejen S, 2014, OSLI RETINA, V45, P562, DOI 10.3928/23258160-20141118-12; Murakami T, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/920713; Osterberg G., 1935, TOPOGRAPHY OF THE LA; Park SP, 2013, EXP EYE RES, V108, P1, DOI 10.1016/j.exer.2012.12.011; Pinhas A, 2014, INVEST OPHTH VIS SCI, V55, P8056, DOI 10.1167/iovs.14-15136; Saint-Geniez M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003554; SOKOL S, 1985, ARCH OPHTHALMOL-CHIC, V103, P51; Song HX, 2011, INVEST OPHTH VIS SCI, V52, P7376, DOI 10.1167/iovs.11-7199; Tan W, 2015, INVEST OPHTH VIS SCI, V56, P6339, DOI 10.1167/iovs.15-16817; Tarr Joanna M, 2013, ISRN Ophthalmol, V2013, P343560, DOI 10.1155/2013/343560; van Dijk HW, 2009, INVEST OPHTH VIS SCI, V50, P3404, DOI 10.1167/iovs.08-3143; Verma A, 2009, EYE, V23, P1824, DOI 10.1038/eye.2009.184; Wagner-Schuman M, 2010, VISION RES, V50, P2396, DOI 10.1016/j.visres.2010.09.015; YUODELIS C, 1986, VISION RES, V26, P847, DOI 10.1016/0042-6989(86)90143-4	38	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2016	11	4							e0152788	10.1371/journal.pone.0152788	http://dx.doi.org/10.1371/journal.pone.0152788			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6JK	27057752	gold, Green Published, Green Submitted			2022-12-27	WOS:000373604800011
J	Bertoluci, G; Masset, G; Gomy, C; Mottet, J; Darmon, N				Bertoluci, Gwenola; Masset, Gabriel; Gomy, Catherine; Mottet, Julien; Darmon, Nicole			How to Build a Standardized Country-Specific Environmental Food Database for Nutritional Epidemiology Studies	PLOS ONE			English	Article							GREENHOUSE-GAS EMISSIONS; SELF-SELECTED DIETS; LIFE-CYCLE; LAND-USE; ENERGY; QUALITY; HEALTH; MEAT; SUSTAINABILITY; FOOTPRINT	There is a lack of standardized country-specific environmental data to combine with nutritional and dietary data for assessing the environmental impact of individual diets in epidemiology surveys, which are consequently reliant on environmental food datasets based on values retrieved from a heterogeneous literature. The aim of this study was to compare and assess the relative strengths and limits of a database of food greenhouse gas emissions (GHGE) values estimated with a hybrid method combining input/output and LCA approaches, with a dataset of GHGE values retrieved from the literature. France is the geographical perimeter considered in this study, but the methodology could be applied to other countries. The GHGE of 402 foodstuffs, representative of French diet, were estimated using the hybrid method. In parallel, the GHGE of individual foods were collected from existing literature. Median per-food-category GHGE values from the hybrid method and the reviewed literature were found to correlate strongly (Spearman correlation was 0.83), showing similar rankings of food categories. Median values were significantly different for only 5 (out of 29) food categories, including the ruminant meats category for which the hybrid method gave lower estimates than those from existing literature. Analysis also revealed that literature values came from heterogeneous studies that were not always sourced and that were conducted under different LCA modeling hypotheses. In contrast, the hybrid method helps build reliably-sourced, representative national standards for product-based datasets. We anticipate this hybrid method to be a starting point for better environmental impact assessments of diets.	[Bertoluci, Gwenola] Cent Supelec, Lab Genie Ind, Grande Voie Vignes, F-92290 Chatenay Malabry, France; [Bertoluci, Gwenola] SESG UFR MIDEAL, AgroParisTech, Massy, France; [Masset, Gabriel; Darmon, Nicole] Aix Marseille Univ, Unite Mixte Rech UMR Nutr Obes & Risk Thrombosis, Inst Natl Rech Agron 1260, Inst Natl Sante & Rech Med 1062, F-13385 Marseille, France; [Gomy, Catherine] BIO Deloitte, F-92200 Neuilly Sur Seine, France; [Mottet, Julien] AgroParisTech, UMR GENIAL, INRA1145, Cnam, Massy, France; [Bertoluci, Gwenola] AgroParisTech, UFR MIDEAL, 1 Ave Olympiades, F-91744 Massy, France	UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Deloitte Touche Tohmatsu Limited; AgroParisTech; heSam Universite; Conservatoire National Arts & Metiers (CNAM); INRAE; AgroParisTech	Bertoluci, G (corresponding author), Cent Supelec, Lab Genie Ind, Grande Voie Vignes, F-92290 Chatenay Malabry, France.; Bertoluci, G (corresponding author), SESG UFR MIDEAL, AgroParisTech, Massy, France.; Bertoluci, G (corresponding author), AgroParisTech, UFR MIDEAL, 1 Ave Olympiades, F-91744 Massy, France.	gwenola.bertoluci@agroparistech.fr	Bris, Gwenola Yannou-Le/L-4119-2015; Masset, Gabriel/I-4636-2019	Bris, Gwenola Yannou-Le/0000-0002-3279-9473; Masset, Gabriel/0000-0001-6977-0247	French National Research Agency under the OCAD project [558, ANR-11-ALID-0002]; Daniel and Nina Carasso Foundation under AVASUN project	French National Research Agency under the OCAD project(French National Research Agency (ANR)); Daniel and Nina Carasso Foundation under AVASUN project	This work was supported by the French National Research Agency under the OCAD project (grant 558 number ANR-11-ALID-0002). GM was supported by a grant from the Daniel and Nina Carasso Foundation, under the AVASUN project. The funders had no role in the design analysis or writing of this article. One of the authors was employed by a commercial company: "Bio by Deloitte" but the society was a partner and any salary or funding has been received from that company. Its participation is related to the work conducted at different steps of the study by C. Gomy, who Conceived and designed the experiments, Analyzed the data, and Contributed to the writing of the manuscript.	AFNOR, 2015, GEN PRINC ENV COMM M; Andersson K., 1998, CLEANER PRODUCTION, V6, P277, DOI DOI 10.1016/S0959-6526(98)00027-4; Andriankaja H, 2013, J ENG DESIGN, V24, P1, DOI 10.1080/09544828.2012.665226; [Anonymous], 2006, 14044 ISO; Aston LM, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001072; Audsley E., 2009, LOW CAN WE GO ASSESS; Biesbroek S, 2014, ENVIRON HEALTH-GLOB, V13, DOI 10.1186/1476-069X-13-27; Boeing H, 2013, EUR J CLIN NUTR, V67, P424, DOI 10.1038/ejcn.2013.47; Briggs ADM, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003543; Carlsson-Kanyama A, 2003, ECOL ECON, V44, P293, DOI 10.1016/S0921-8009(02)00261-6; Carlsson-Kanyama A, 2009, AM J CLIN NUTR, V89, pS1704, DOI 10.3945/ajcn.2009.26736AA; Coley D, 2009, FOOD POLICY, V34, P150, DOI 10.1016/j.foodpol.2008.11.001; Darmon N, 2015, NUTR REV, V73, P643, DOI 10.1093/nutrit/nuv027; Dolle J, 2011, COMP GAZ EFFET SERRE; Elmadfa I, 2010, EUR J CLIN NUTR, V64, pS4, DOI 10.1038/ejcn.2010.202; European Commission, 2010, ILCD HDB GEN GUID LI; European Food SCP Round Table, 2012, CONT ENV IMPR FIN RE; European Food SCP Round Table, 2012, ENV ASS FOOD DRINK P; Fanzo J, 2015, TECHNICAL BRIEF METR; Food and Agriculture Organization, 2012, ANN 1 INT SCI S BIOD; Hoolohan C, 2013, ENERG POLICY, V63, P1065, DOI 10.1016/j.enpol.2013.09.046; Hou DY, 2014, J CLEAN PROD, V83, P87, DOI 10.1016/j.jclepro.2014.07.062; Huppes G, 2008, ENV IMPACTS DIET CHA; Joyanes M, 2006, CRIT REV FOOD SCI, V46, P329, DOI 10.1080/10408390600688156; Le Pochat S, 2007, J CLEAN PROD, V15, P671, DOI 10.1016/j.jclepro.2006.01.004; Lee A, 2013, OBES REV, V14, P82, DOI 10.1111/obr.12078; Lenzen M., 2000, J IND ECOL, V4, P127, DOI DOI 10.1162/10881980052541981; Leontief W., 1966, INPUT OUTPUT EC; Macdiarmid JI, 2012, AM J CLIN NUTR, V96, P632, DOI 10.3945/ajcn.112.038729; Masset G, 2014, AM J CLIN NUTR, V99, P1460, DOI 10.3945/ajcn.113.077958; Masset G, 2014, J ACAD NUTR DIET, V114, P862, DOI 10.1016/j.jand.2014.02.002; Monsivais P, 2015, AM J CLIN NUTR; Nelson M, 1997, DESIGN CONCEPTS NUTR; Ogino A, 2007, ANIM SCI J, V78, P424, DOI 10.1111/j.1740-0929.2007.00457.x; Pairotti MB, 2015, J CLEAN PROD, V103, P507, DOI 10.1016/j.jclepro.2013.12.082; Paloviita A, 2002, 14 INT C INP OUTP TE; Payen S, 2015, J CLEAN PROD, V87, P139, DOI 10.1016/j.jclepro.2014.10.007; Pradhan P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062228; Roy P, 2012, J ENVIRON MANAGE, V93, P218, DOI 10.1016/j.jenvman.2011.09.017; Salomone R, 2012, J CLEAN PROD, V28, P88, DOI 10.1016/j.jclepro.2011.10.004; Scarborough P, 2014, CLIMATIC CHANGE, V125, P179, DOI 10.1007/s10584-014-1169-1; Schrodera H, 2016, BRIT J NUTR S1  0113, V2016, P1; Soret S, 2014, AM J CLIN NUTR, V100, p490S, DOI 10.3945/ajcn.113.071589; Temme EHM, 2013, PUBLIC HEALTH NUTR, V16, P1900, DOI 10.1017/S1368980013000232; Tilman D, 2014, NATURE, V515, P518, DOI 10.1038/nature13959; Vazquez-Rowe I, 2013, J CLEAN PROD, V44, P200, DOI 10.1016/j.jclepro.2012.11.049; Vieux F, 2012, ECOL ECON, V75, P91, DOI 10.1016/j.ecolecon.2012.01.003; Vieux F, 2013, AM J CLIN NUTR, V97, P569, DOI 10.3945/ajcn.112.035105; Wiedmann T, 2009, ECOL ECON, V69, P211, DOI 10.1016/j.ecolecon.2009.08.026; Wiedmann TO, 2011, ENVIRON SCI TECHNOL, V45, P5900, DOI 10.1021/es2007287; Williams AG, 2006, DETERMINING ENV BURD	51	19	19	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0150617	10.1371/journal.pone.0150617	http://dx.doi.org/10.1371/journal.pone.0150617			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DI6KO	27054565	Green Published, gold			2022-12-27	WOS:000373608000004
J	Beukhof, CM; Medici, M; van den Beld, AW; Hollenbach, B; Hoeg, A; Visser, WE; de Herder, WW; Visser, TJ; Schomburg, L; Peeters, RP				Beukhof, Carolien M.; Medici, Marco; van den Beld, Annewieke W.; Hollenbach, Birgit; Hoeg, Antonia; Visser, W. Edward; de Herder, Wouter W.; Visser, Theo J.; Schomburg, Lutz; Peeters, Robin P.			Selenium Status Is Positively Associated with Bone Mineral Density in Healthy Aging European Men	PLOS ONE			English	Article							PROSTATE-CANCER RISK; ELDERLY-MEN; POSTMENOPAUSAL WOMEN; THYROID-HORMONES; PLASMA SELENIUM; SELENOPROTEIN-P; POPULATION; MORTALITY; ZINC; SUPPLEMENTATION	Objective It is still a matter of debate if subtle changes in selenium (Se) status affect thyroid function tests (TFTs) and bone mineral density (BMD). This is particularly relevant for the elderly, whose nutritional status is more vulnerable. Design and Methods We investigated Se status in a cohort of 387 healthy elderly men (median age 77 yrs; inter quartile range 75-80 yrs) in relation to TFTs and BMD. Se status was determined by measuring both plasma selenoprotein P (SePP) and Se. Results The overall Se status in our population was low normal with only 0.5% (2/387) of subjects meeting the criteria for Se deficiency. SePP and Se levels were not associated with thyroid stimulating hormone (TSH), free thyroxine (FT4), thyroxine (T4), triiodothyronine (T3) or reverse triiodothyronine (rT3) levels. The T3/T4 and T3/rT3 ratios, reflecting peripheral metabolism of thyroid hormone, were not associated with Se status either. SePP and Se were positively associated with total BMD and femoral trochanter BMD. Se, but not SePP, was positively associated with femoral neck and ward's BMD. Multivariate linear analyses showed that these associations remain statistically significant in a model including TSH, FT4, body mass index, physical performance score, age, smoking, diabetes mellitus and number of medication use. Conclusion Our study demonstrates that Se status, within the normal European marginally supplied range, is positively associated with BMD in healthy aging men, independent of thyroid function. Thyroid function tests appear unaffected by Se status in this population.	[Beukhof, Carolien M.; Medici, Marco; van den Beld, Annewieke W.; Visser, W. Edward; de Herder, Wouter W.; Visser, Theo J.; Peeters, Robin P.] Erasmus MC, Rotterdam Thyroid Ctr, Dept Internal Med, Rotterdam, Netherlands; [Hollenbach, Birgit; Hoeg, Antonia; Schomburg, Lutz] Charite, Inst Expt Endokrinol, D-13353 Berlin, Germany	Erasmus University Rotterdam; Erasmus MC; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Schomburg, L (corresponding author), Charite, Inst Expt Endokrinol, D-13353 Berlin, Germany.	lutz.schomburg@charite.de	de+Herder, Wouter/AAN-8429-2021; Medici, Marco/U-2777-2018; Schomburg, Lutz/D-8096-2013; Visser, W. Edward/C-4062-2015	Schomburg, Lutz/0000-0001-9445-1555; Visser, W. Edward/0000-0002-5248-863X; Peeters, Robin/0000-0001-7732-9371	Deutsche Forschungsgemeinschaft - DFG [SPP1629, Scho849/4-1]	Deutsche Forschungsgemeinschaft - DFG(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft - DFG (SPP1629; Scho849/4-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen NE, 2008, AM J CLIN NUTR, V88, P1567, DOI 10.3945/ajcn.2008.26205; American Diabetes Association, 2015, CLIN DIABETES, V33, P97, DOI DOI 10.2337/DIACLIN.33.2.97; Arikan DC, 2011, BIOL TRACE ELEM RES, V144, P407, DOI 10.1007/s12011-011-9109-7; Bianco AC, 2002, ENDOCR REV, V23, P38, DOI 10.1210/er.23.1.38; Brugts MP, 2008, J CLIN ENDOCR METAB, V93, P2515, DOI 10.1210/jc.2007-1633; Cao JJ, 2012, J NUTR, V142, P1526, DOI 10.3945/jn.111.157040; CONTEMPRE B, 1992, CLIN ENDOCRINOL, V36, P579, DOI 10.1111/j.1365-2265.1992.tb02268.x; Di Cosmo C, 2009, J CLIN ENDOCR METAB, V94, P4003, DOI 10.1210/jc.2009-0686; Duntas LH, 2010, J CLIN ENDOCR METAB, V95, P5180, DOI 10.1210/jc.2010-0191; Geybels MS, 2013, JNCI-J NATL CANCER I, V105, P1394, DOI 10.1093/jnci/djt186; GOODWIN JS, 1983, JAMA-J AM MED ASSOC, V249, P2917, DOI 10.1001/jama.249.21.2917; GURALNIK JM, 1994, AGING-CLIN EXP RES, V6, P410, DOI 10.1007/BF03324272; Hoeflich J, 2010, BRIT J NUTR, V104, P1601, DOI 10.1017/S0007114510002618; Hoeg A, 2012, J CLIN ENDOCR METAB, V97, P4061, DOI 10.1210/jc.2012-2121; Hollenbach B, 2008, J TRACE ELEM MED BIO, V22, P24, DOI 10.1016/j.jtemb.2007.11.003; KOK FJ, 1987, AM J EPIDEMIOL, V125, P12, DOI 10.1093/oxfordjournals.aje.a114493; Liu HM, 2012, BIOL TRACE ELEM RES, V150, P441, DOI 10.1007/s12011-012-9488-4; Liu SZ, 2009, BIOL TRACE ELEM RES, V131, P205, DOI 10.1007/s12011-009-8363-4; Looker AC B L, 2013, VITAL HLTH STAT, V11; Moreno-Reyes R, 1998, NEW ENGL J MED, V339, P1112, DOI 10.1056/NEJM199810153391604; Odabasi E, 2008, ANN ACAD MED SINGAP, V37, P564; Olivieri O, 1996, BIOL TRACE ELEM RES, V51, P31, DOI 10.1007/BF02790145; Peeters RP, 2003, J CLIN ENDOCR METAB, V88, P2880, DOI 10.1210/jc.2002-021592; Pietschmann N, 2014, METALLOMICS, V6, P1043, DOI 10.1039/c4mt00003j; Rasmussen LB, 2009, J TRACE ELEM MED BIO, V23, P265, DOI 10.1016/j.jtemb.2009.03.009; Rayman M. P., 2013, FREE RADICAL BIOL ME; Rayman MP, 2008, AM J CLIN NUTR, V87, P370, DOI 10.1093/ajcn/87.2.370; Riese C, 2006, ENDOCRINOLOGY, V147, P5883, DOI 10.1210/en.2006-0689; Schoenmakers E, 2010, J CLIN INVEST, V120, P4220, DOI 10.1172/JCI43653; Schomburg L, 2006, ENDOCRINOLOGY, V147, P1306, DOI 10.1210/en.2005-1089; Schomburg L, 2012, NAT REV ENDOCRINOL, V8, P160, DOI 10.1038/nrendo.2011.174; Schomburg L, 2009, BBA-GEN SUBJECTS, V1790, P1453, DOI 10.1016/j.bbagen.2009.03.015; Schweizer U, 2004, J NUTR, V134, P707, DOI 10.1093/jn/134.4.707; Tuomilehto J, 2003, DIABETES CARE, V26, P61; Ubink-Veltmaat LJ, 2003, EUR J EPIDEMIOL, V18, P793, DOI 10.1023/A:1025369623365; van den Beld AW, 2005, J CLIN ENDOCR METAB, V90, P6403, DOI 10.1210/jc.2005-0872; van den Beld AW, 2003, AM J EPIDEMIOL, V157, P25, DOI 10.1093/aje/kwf160; Zhang JJ, 2006, AM J EPIDEMIOL, V163, P9, DOI 10.1093/aje/kwj005	39	38	39	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0152748	10.1371/journal.pone.0152748	http://dx.doi.org/10.1371/journal.pone.0152748			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27055238	Green Published, Green Submitted, gold			2022-12-27	WOS:000373608000041
J	Cunningham, D; Shearer, DA; Drawer, S; Eager, R; Taylor, N; Cook, C; Kilduff, LP				Cunningham, Daniel; Shearer, David A.; Drawer, Scott; Eager, Robin; Taylor, Neil; Cook, Christian; Kilduff, Liam P.			Movement Demands of Elite U20 International Rugby Union Players	PLOS ONE			English	Article							GLOBAL POSITIONING SYSTEM; TIME-MOTION ANALYSIS; PROFESSIONAL RUGBY; MATCH-PLAY; PHYSIOLOGICAL DEMANDS; PHYSICAL DEMANDS; SOCCER PLAYERS; GAME DEMANDS; SPEED; REHABILITATION	The purpose of this study was to quantify movement demands of elite international age grade (U20) rugby union players during competitive tournament match play. Forty elite professional players from an U20 international performance squad were monitored using 10Hz global positioning systems (GPS) during 15 international tournament matches during the 2014/15 and 2015/16 seasons. Data on distances, velocities, accelerations, decelerations, high metabolic load (HML) distance and efforts, and number of sprints were derived. Data files from players who played over 60 min (n = 161) were separated firstly into Forwards and Backs, and more specifically into six positional groups; FR-Front Row (prop & hooker), SR-Second Row, BR-Back Row (Flankers & No. 8), HB-Half Backs (scrum half & outside half), MF-Midfield (centres), B3-Back Three (wings & full back) for match analysis. Analysis revealed significant differences between forwards and backs positions. Backs scored higher on all variables measured with the exception of number of moderate accelerations, decelerations (no difference). The centres covered the greatest total distance with the front row covering the least (6.51 +/- 0.71 vs 4.97 +/- 0.75 km, p < 0.001). The front row also covered the least high speed running (HSR) distance compared to the back three (211.6 +/- 112.7 vs 728.4 +/- 150.2 m, p < 0.001) who covered the most HSR distance, affirming that backs cover greater distances but forwards have greater contact loads. These findings highlight for the first time differences in the movement characteristics of elite age grade rugby union players specific to positional roles.	[Cunningham, Daniel; Cook, Christian; Kilduff, Liam P.] Swansea Univ, Coll Engn, Appl Sport Technol Exercise & Med Res Ctr A STEM, Swansea, W Glam, Wales; [Shearer, David A.] Univ South Wales, Dept Psychol, Pontypridd, Wales; [Drawer, Scott; Eager, Robin; Taylor, Neil] Rugby Football Union, Greater London, England	Swansea University; University of South Wales	Kilduff, LP (corresponding author), Swansea Univ, Coll Engn, Appl Sport Technol Exercise & Med Res Ctr A STEM, Swansea, W Glam, Wales.	l.kilduff@swansea.ac.uk	Shearer, David/K-8025-2019	Shearer, David/0000-0002-5877-8160; Cunningham, Dan/0000-0002-5249-0609; Cook, Christian/0000-0001-9677-0306	Rugby Football Union	Rugby Football Union	The authors received no specific funding for this work and no authors have any financial or other interest in the products or distributor of the products named in the study. The Rugby Football Union provided support in the form of salaries for authors SD, RE, and NT, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abt G, 2009, J SPORT SCI, V27, P893, DOI 10.1080/02640410902998239; Argus CK, 2012, J STRENGTH COND RES, V26, P2698, DOI 10.1519/JSC.0b013e318241382a; Austin D, 2011, J SCI MED SPORT, V14, P259, DOI 10.1016/j.jsams.2011.01.003; Austin DJ, 2013, J STRENGTH COND RES, V27, P14, DOI 10.1519/JSC.0b013e31824e108c; Barr MJ, 2014, J STRENGTH COND RES, V28, P2724, DOI 10.1519/JSC.0000000000000364; Batterham AM, 2006, INT J SPORT PHYSIOL, V1, P50, DOI 10.1123/ijspp.1.1.50; Cahill N, 2013, J SPORT SCI, V31, P229, DOI 10.1080/02640414.2012.727456; Castellano J, 2011, J SPORT SCI MED, V10, P233; Coughlan GF, 2011, J ORTHOP SPORT PHYS, V41, P600, DOI 10.2519/jospt.2011.3508; Cunniffe B, 2009, J STRENGTH COND RES, V23, P1195, DOI 10.1519/JSC.0b013e3181a3928b; Deutsch MU, 2007, J SPORT SCI, V25, P461, DOI 10.1080/02640410600631298; DOCHERTY D, 1988, J HUM MOVEMENT STUD, V14, P269; Duthie G, 2005, J SPORT SCI, V23, P523, DOI 10.1080/02640410410001730188; Eaton C, 2006, PHYS THER SPORT, V7, P22, DOI 10.1016/j.ptsp.2005.08.006; Gabbett TJ, 2012, J SCI MED SPORT, V15, P80, DOI 10.1016/j.jsams.2011.07.004; Gabbett TJ, 2011, J SCI MED SPORT, V14, P204, DOI 10.1016/j.jsams.2010.12.002; Gabbett TJ., 2015, J STRENGTH COND RES; Hansen KT, 2011, J STRENGTH COND RES, V25, P2382, DOI 10.1519/JSC.0b013e318201bf48; Harley JA, 2010, J SPORT SCI, V28, P1391, DOI 10.1080/02640414.2010.510142; Hartwig TB, 2011, J STRENGTH COND RES, V25, P966, DOI 10.1519/JSC.0b013e3181d09e24; Higham DG, 2012, J SCI MED SPORT, V15, P277, DOI 10.1016/j.jsams.2011.11.256; Jones MR, 2015, EUR J SPORT SCI, V15, P488, DOI 10.1080/17461391.2015.1010106; Jones MR, 2014, BMC SPORTS SCI MED R, V6, DOI 10.1186/2052-1847-6-38; Lindsay A, 2015, EUR J SPORT SCI, V15, P480, DOI 10.1080/17461391.2015.1025858; Lloyd RS, 2015, J STRENGTH COND RES, V29, P1439, DOI 10.1519/JSC.0000000000000756; McLellan CP, 2011, J STRENGTH COND RES, V25, P1703, DOI 10.1519/JSC.0b013e3181ddf678; Mohr M, 2003, J SPORT SCI, V21, P519, DOI 10.1080/0264041031000071182; Quarrie KL, 2013, J SCI MED SPORT, V16, P353, DOI 10.1016/j.jsams.2012.08.005; Quarrie KL, 2000, J SPORT SCI, V18, P237; Randers MB, 2010, J SPORT SCI, V28, P171, DOI 10.1080/02640410903428525; Reardon C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133410; Roberts SP, 2008, J SPORT SCI, V26, P825, DOI 10.1080/02640410801942122; Varley MC, 2012, J SPORT SCI, V30, P121, DOI 10.1080/02640414.2011.627941; West DJ, 2014, J STRENGTH COND RES, V28, P194, DOI 10.1519/JSC.0b013e318291b726	34	29	30	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153275	10.1371/journal.pone.0153275	http://dx.doi.org/10.1371/journal.pone.0153275			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27055230	Green Published, Green Submitted, gold			2022-12-27	WOS:000373608000113
J	D'Ulivo, L; Feng, YL				D'Ulivo, Lucia; Feng, Yong-Lai			A Novel Open Tubular Capillary Electrochromatographic Method for Differentiating the DNA Interaction Affinity of Environmental Contaminants	PLOS ONE			English	Article							POLAR STATIONARY PHASES; LIQUID-CHROMATOGRAPHY; CHEMICAL CARCINOGENESIS; INTERACTION POTENCY; RECENT PROGRESS; ELECTROPHORESIS; CEC; COLUMNS; SURFACE; TOOL	The interaction of chemicals with DNA may lead to genotoxicity, mutation or carcinogenicity. A simple open tubular capillary electrochromatographic method is proposed to rapidly assess the interaction affinity of three environmental contaminants (1,4-phenylenediamine, pyridine and 2,4-diaminotoluene) to DNA by measuring their retention in the capillaries coated with DNA probes. DNA oligonucleotide probes were immobilized on the inner wall of a fused silica capillary that was first derivatized with 3-(aminopropyl)-triethoxysilane (APTES). The difference in retention times and factors was considered as the difference in interaction affinity of the contaminants to the DNA probes. The interaction of the contaminants with both double-stranded (dsDNA) and single-stranded DNA (ssDNA) coatings was compared. Retention factors of 1,4-phenylenediamine, pyridine and 2,4-diaminotoluene in the capillary coated with ssDNA probe were 0.29, 0.42, and 0.44, respectively. A similar trend was observed in the capillary coated with dsDNA, indicating that 2,4-diaminotoluene has the highest affinity among the three contaminants. The relative standard deviation (RSD) for the retention factors was in the range of 0.05-0.69% (n = 3). The results demonstrated that the developed technique could be applied for preliminary screening purpose to provide DNA interaction affinity information of various environmental contaminants.	[D'Ulivo, Lucia; Feng, Yong-Lai] Hlth Canada, Environm & Radiat Hlth Sci Directorate, Environm Hlth Sci & Res Bur, Exposure & Biomonitoring Div, Ottawa, ON K1A 0L2, Canada	Health Canada	Feng, YL (corresponding author), Hlth Canada, Environm & Radiat Hlth Sci Directorate, Environm Hlth Sci & Res Bur, Exposure & Biomonitoring Div, Ottawa, ON K1A 0L2, Canada.	yong-lai.feng@hc-sc.gc.ca			Natural Sciences and Engineering Research Council (NSERC) Canada; Health Canada; Canadian Government under the Chemicals Management Plan (CMP)	Natural Sciences and Engineering Research Council (NSERC) Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Health Canada; Canadian Government under the Chemicals Management Plan (CMP)	Dr. D'Ulivo is grateful to Natural Sciences and Engineering Research Council (NSERC) Canada and Health Canada for financial support in the form of post-doctoral fellowship. The Canadian Government under the Chemicals Management Plan (CMP) financially supported this project.	[Anonymous], 1987, IARC MONOGRAPH S7, V7, P83; [Anonymous], 1987, IARC MONOGRAPH S7, V7, P125; Bolt HM, 2007, CRIT REV TOXICOL, V37, P521, DOI 10.1080/10408440701385671; Chen J, 2008, ANAL CHEM, V80, P5103, DOI 10.1021/ac800294f; Choudhary G, 1997, J CHROMATOGR A, V781, P161, DOI 10.1016/S0021-9673(97)00626-2; CREGO AL, 1993, ANAL CHEM, V65, P1615, DOI 10.1021/ac00059a022; D'Ulivo L, 2010, ANAL CHIM ACTA, V664, P185, DOI 10.1016/j.aca.2010.02.013; D'Ulivo L, 2009, ELECTROPHORESIS, V30, P3838, DOI 10.1002/elps.200900245; Deng N, 2012, ANAL CHEM, V84, P10186, DOI 10.1021/ac302779u; Dong XL, 2009, ELECTROPHORESIS, V30, P141, DOI 10.1002/elps.200800412; Feng YL, 2009, ENVIRON TOXICOL CHEM, V28, P2044, DOI 10.1897/09-015.1; Galievsky VA, 2015, ANAL CHEM, V87, P157, DOI 10.1021/ac504219r; Garner RC, 1998, MUTAT RES-FUND MOL M, V402, P67; Gavina JMA, 2011, J ENVIRON MONITOR, V13, P3145, DOI 10.1039/c1em10511f; Hodgson RJ, 2004, ANAL CHEM, V76, P2780, DOI 10.1021/ac0352124; Jinno K, 2000, J CHROMATOGR A, V887, P479, DOI 10.1016/S0021-9673(99)01198-X; Kuldvee R, 2006, ANAL CHEM, V78, P2665, DOI 10.1021/ac052006i; Luch A, 2005, NAT REV CANCER, V5, P113, DOI 10.1038/nrc1546; Martma K, 2011, ELECTROPHORESIS, V32, P1054, DOI 10.1002/elps.201000569; Martma K, 2010, ELECTROPHORESIS, V31, P1586, DOI 10.1002/elps.200900587; Ornskov E, 2002, ELECTROPHORESIS, V23, P3381, DOI 10.1002/1522-2683(200210)23:19<3381::AID-ELPS3381>3.0.CO;2-4; Ou JJ, 2007, ELECTROPHORESIS, V28, P148, DOI 10.1002/elps.200600298; PEZZUTO JM, 1991, J NAT PROD, V54, P1522, DOI 10.1021/np50078a006; Pyridine, 2000, IARC MONOGRAPH, V77, P503; Rathore AS, 2002, ELECTROPHORESIS, V23, P1211, DOI 10.1002/1522-2683(200205)23:9<1211::AID-ELPS1211>3.0.CO;2-B; Ravelet C, 2006, J CHROMATOGR A, V1117, P1, DOI 10.1016/j.chroma.2006.03.101; Tanious AF, 1992, BIOCHEMISTRY-US, V31, P11632; Toyoda-Hokaiwado N, 2010, TOXICOL SCI, V114, P71, DOI 10.1093/toxsci/kfp306; VanderNoot VA, 1998, ELECTROPHORESIS, V19, P437, DOI 10.1002/elps.1150190313; WADDELL TG, 1981, J AM CHEM SOC, V103, P5303, DOI 10.1021/ja00408a005; Wang J, 1996, ANAL CHEM, V68, P4365, DOI 10.1021/ac960650e; Wiedmer SK, 2005, ELECTROPHORESIS, V26, P1920, DOI 10.1002/elps.200410277; Wiedmer SK, 2008, ANAL BIOCHEM, V373, P26, DOI 10.1016/j.ab.2007.08.033	33	4	4	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153081	10.1371/journal.pone.0153081	http://dx.doi.org/10.1371/journal.pone.0153081			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27055261	gold, Green Submitted, Green Published			2022-12-27	WOS:000373608000074
J	Li, Y; An, ZJ; Yin, DP; Liu, YM; Huang, ZY; Xu, JF; Ma, YJ; Tu, QF; Li, Q; Wang, HQ				Li, Yan; An, Zhijie; Yin, Dapeng; Liu, Yanmin; Huang, Zhuoying; Xu, Jianfang; Ma, Yujie; Tu, Qiufeng; Li, Qi; Wang, Huaqing			Disease Burden Due to Herpes Zoster among Population Aged >= 50 Years Old in China: A Community Based Retrospective Survey	PLOS ONE			English	Article							POSTHERPETIC NEURALGIA; RISK-FACTORS; EPIDEMIOLOGY; GENDER	Objective To understand the disease burden due to Herpes Zoster (HZ) among people aged >= 50 years old in China and provide baseline data for future similar studies, and provide evidence for development of herpes zoster vaccination strategy. Methods Retrospective cohort study was conducted in 4 townships and one community. A questionnaire was used to collect information on incidence and cost of HZ among people aged >= 50 years old. Results The cumulative incidence rate was 22.6/1,000 among people aged >= 50 years old. The average annual incidence rate of HZ was 3.43/1,000 among people aged >= 50 years old in 2010-2012. Cumulative incidence and average annual incidence rate increased with age: the cumulative incidence of HZ among people aged >= 80 years old was 3.34 times of that among 50-years old (52.3/1000vs15.7/1,000); average annual incidence rate rises from 2.66/1,000 among 50-years old to 8.55/1,000 among 80-year old. Cumulative incidence and average annual incidence rate for females were higher than that for males (cumulative incidence, 26.5/1000vs18.7/1,000; annual incidence rate, 3.95/1000vs2.89/1,000). Cumulative incidence and average annual incidence rate in urban were higher than in rural (cumulative incidence, 39.5/1000vs 17.2/1,000; annual incidence rate, 7.65/1000vs2.06/1,000). The hospitalization rate of HZ was 4.53%. And with the increase of age, the rate has an increasing trend. HZ costs 945,709.5 RMB in total, corresponding to 840.6 RMB per patient with a median cost of 385 RMB (interquartile range 171.7-795.6). Factors associated with cost included the first onset year, area, whether hospitalized and whether sequelae left. Conclusion Incidence rate, complications, hospitalization rate and average cost of HZ increase with age. We recommend that the HZ vaccinations should target people aged >= 50 years old if Zoster vaccine is licensed in China.	[Li, Yan; An, Zhijie; Yin, Dapeng; Liu, Yanmin; Wang, Huaqing] Chinese Ctr Dis Control & Prevent, Natl Immunizat Program, Beijing, Peoples R China; [Huang, Zhuoying] Shanghai Municipal Ctr Dis Control & Prevent, Immunizat Program Dept, Shanghai, Peoples R China; [Xu, Jianfang] Danyang Cty Ctr Dis Control & Prevent, Immunizat Program Dept, Zhenjiang, Jiangsu, Peoples R China; [Ma, Yujie] Heilongjiang Prov Ctr Dis Control & Prevent, Immunizat Program Dept, Haerbin, Heilongjiang, Peoples R China; [Tu, Qiufeng] Jiangxi Prov Ctr Dis Control & Prevent, Immunizat Program Dept, Nanchang, Jiangxi, Peoples R China; [Li, Qi] Hebei Prov Ctr Dis Control & Prevent, Immunizat Program Dept, Shijiazhuang, Hebei, Peoples R China	Chinese Center for Disease Control & Prevention; Shanghai Center for Disease Control & Prevention	Wang, HQ (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Immunizat Program, Beijing, Peoples R China.	hqwang@vip.sina.com	ma, yujie/GYA-3957-2022	Li, Yan/0000-0002-7365-6348; An, Zhijie/0000-0002-1552-6684	China 12th five-year national science and technology major projects [2012ZX10004-703]	China 12th five-year national science and technology major projects	The article was funded by China 12th five-year national science and technology major projects (2012ZX10004-703). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, ZOSTAVAX EUROPEAN PU; Australian Technical Advisory Group on Immunisation (ATAGI), 2008, SYST REV SAF IMM GEN; Bennett GJ, 1998, HOSP PRACT, V33, P95, DOI 10.3810/hp.1998.10.114; Brisson M, 2001, EPIDEMIOL INFECT, V127, P305, DOI 10.1017/S0950268801005921; China Statistics Press, TABULATION 2010 POPU, P268; Choi WS, 2010, J CLIN VIROL, V47, P325, DOI 10.1016/j.jcv.2010.01.003; Fang Jie, 2014, J LIAONING U TRADITI, V16, P177; Feng XY, 2000, CHINA J MODERN MED, V10, P50; Fleming DM, 2004, EPIDEMIOL INFECT, V132, P1, DOI 10.1017/S0950268803001523; Harpaz Rafael, 2007, Morbidity and Mortality Weekly Report, V57, P1; HOPESIMPSON RE, 1965, P ROY SOC MED, V58, P9, DOI 10.1177/003591576505800106; Johnson BH, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1262-8; Jung BF, 2004, NEUROLOGY, V62, P1545, DOI 10.1212/01.WNL.0000123261.00004.29; Jung HS, 2015, KOREAN J PAIN, V28, P193, DOI 10.3344/kjp.2015.28.3.193; Kawai K, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-004833; Kim YJ, 2014, J KOREAN MED SCI, V29, P1706, DOI [10.3346/jkms.2014.29.12.1706, 10.3346/jkms.2014.29.8.1178]; Lin YH, 2010, VACCINE, V28, P1217, DOI 10.1016/j.vaccine.2009.11.029; Mullooly JP, 2005, EPIDEMIOL INFECT, V133, P245, DOI 10.1017/S095026880400281X; Opstelten W, 2006, ANN EPIDEMIOL, V16, P692, DOI 10.1016/j.annepidem.2005.12.002; Oxman MN, 2005, NEW ENGL J MED, V352, P2271, DOI 10.1056/NEJMoa051016; Pinchinat S, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-170; PLOTKIN Stanley A., VACCINES, P977; RAGOZZINO MW, 1982, MEDICINE, V61, P310, DOI 10.1097/00005792-198209000-00003; Schmader KE, 2007, CLIN J PAIN, V23, P490, DOI 10.1097/AJP.0b013e318065b6c9; Scott Fiona T., 2003, Journal of Medical Virology, V70, pS24, DOI 10.1002/jmv.10316; Stein AN, 2009, VACCINE, V27, P520, DOI 10.1016/j.vaccine.2008.11.012; Takao Y, 2015, J EPIDEMIOL, V25, P617, DOI 10.2188/jea.JE20140210; Thomas SL, 2004, LANCET INFECT DIS, V4, P26, DOI 10.1016/S1473-3099(03)00857-0; Volpi A, 2005, AM J CLIN DERMATOL, V6, P317, DOI 10.2165/00128071-200506050-00005; Wang Fu-bin, 2004, CHINESE GEN PRACTICE, V7, P1493; Zhu Q, HUMAN VACCINES IMMUN, V11, P2113	31	22	38	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0152660	10.1371/journal.pone.0152660	http://dx.doi.org/10.1371/journal.pone.0152660			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27055179	Green Published, Green Submitted, gold			2022-12-27	WOS:000373608000032
J	Odagiri, H; Baba, T; Nishio, Y; Iizuka, O; Matsuda, M; Inoue, K; Kikuchi, A; Hasegawa, T; Aoki, M; Takeda, A; Taki, Y; Mori, E				Odagiri, Hayato; Baba, Toru; Nishio, Yoshiyuki; Iizuka, Osamu; Matsuda, Minoru; Inoue, Kentaro; Kikuchi, Akio; Hasegawa, Takafumi; Aoki, Masashi; Takeda, Atsushi; Taki, Yasuyuki; Mori, Etsuro			On the Utility of MIBG SPECT/CT in Evaluating Cardiac Sympathetic Dysfunction in Lewy Body Diseases	PLOS ONE			English	Article							NORMAL-PRESSURE HYDROCEPHALUS; MYOCARDIAL SCINTIGRAPHY; DIAGNOSIS; DEMENTIA; MANAGEMENT; ACCURACY; BODIES	Background Abnormal cardiac uptake of I-123-metaiodobenzylguanidine (I-123-MIBG) is a diagnostic marker of Lewy body diseases (LBDs), e.g., Parkinson's disease (PD) and dementia with Lewy bodies (DLB). Planar imaging is generally used to assess cardiac sympathetic dysfunction in I-123-MIBG scintigraphy; however, its clinical utility requires further improvement. We hypothesized that the co-registration of single-photon emission tomography (SPECT) and computed tomography (CT) images would improve the diagnostic accuracy of I-123-MIBG cardiac scintigraphy for LBDs. This study sought to evaluate the effects of SPECT/CT imaging on I-123-MIBG cardiac scintigraphy for diagnosing LBDs. Methods We retrospectively investigated data of 54 patients (consecutive 18 patients in each PD, DLB, and idiopathic normal pressure hydrocephalus [iNPH] groups) who underwent I-123-MIBG cardiac scintigraphy (planar and SPECT/CT) because of suspected LBDs at the Tohoku University hospital from June 2012 to June 2015. We compared the diagnostic accuracies of the conventional planar I-123-MIBG method and SPECT/CT methods (manual and semi-automatic). Results In the conventional planar analysis, I-123-MIBG uptake decreased only in the DLB group compared with the iNPH group. In contrast, the SPECT/CT analysis revealed significantly lower I-123-MIBG uptake in both the PD and DLB groups compared with the iNPH group. Furthermore, a receiver operating characteristic analysis revealed that both the manual and semi-automatic SPECT/CT methods were superior to the conventional planar method in differentiating the 3 disorders. Conclusions SPECT/CT I-123-MIBG cardiac scintigraphy can detect mild cardiac sympathetic dysfunction in LDBs. Our results suggest that the SPECT/CT technique improves diagnostic accuracy for LBDs.	[Odagiri, Hayato; Baba, Toru; Nishio, Yoshiyuki; Iizuka, Osamu; Matsuda, Minoru; Mori, Etsuro] Tohoku Univ, Grad Sch Med, Dept Behav Neurol & Cognit Neurosci, Sendai, Miyagi 980, Japan; [Odagiri, Hayato] Tohoku Univ Hosp, Dept Diagnost Radiol, Sendai, Miyagi, Japan; [Inoue, Kentaro; Taki, Yasuyuki] Tohoku Univ, Dept Radiol & Nucl Med, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan; [Kikuchi, Akio; Hasegawa, Takafumi; Aoki, Masashi] Tohoku Univ, Grad Sch Med, Dept Neurol, Sendai, Miyagi 980, Japan; [Takeda, Atsushi] Sendai Nishitaga Natl Hosp, Sendai, Miyagi, Japan	Tohoku University; Tohoku University; Tohoku University; Tohoku University	Baba, T (corresponding author), Tohoku Univ, Grad Sch Med, Dept Behav Neurol & Cognit Neurosci, Sendai, Miyagi 980, Japan.	t-baba@med.tohoku.ac.jp	Hasegawa, Takafumi/I-6668-2017; Perry, George/A-8611-2009	Perry, George/0000-0002-6547-0172; Baba, Toru/0000-0003-0936-2510	Grants-in-Aid for Scientific Research [26461263, 15H01550] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		ADAMS RD, 1965, NEW ENGL J MED, V273, P117, DOI 10.1056/NEJM196507152730301; Braune S, 2001, CLIN AUTON RES, V11, P351, DOI 10.1007/BF02292766; Chiaravalloti A, 2013, ANN NUCL MED, V27, P444, DOI 10.1007/s12149-013-0702-z; Chung EJ, 2015, J MOV DISORD, V8, P55, DOI 10.14802/jmd.15015; Fujishiro H, 2012, J NEUROL SCI, V315, P115, DOI 10.1016/j.jns.2011.11.012; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Ishibashi K, 2010, EUR J NUCL MED MOL I, V37, P3, DOI 10.1007/s00259-009-1202-1; Jacobson AF, 2015, J NUCL CARDIOL, V22, P980, DOI 10.1007/s12350-015-0170-z; Litvan I, 1998, ARCH NEUROL-CHICAGO, V55, P969, DOI 10.1001/archneur.55.7.969; Malm J, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-22; McKeith IG, 2005, NEUROLOGY, V65, P1863, DOI 10.1212/01.wnl.0000187889.17253.b1; Meyer-Rochow GY, 2010, ANN SURG ONCOL, V17, P392, DOI 10.1245/s10434-009-0850-5; Mori E, 2012, NEUROL MED-CHIR, V52, P775, DOI 10.2176/nmc.52.775; Nakajima K, 2008, Q J NUCL MED MOL IM, V52, P378; Oda H, 2013, NEUROLOGY, V81, P1741, DOI 10.1212/01.wnl.0000435553.67953.81; Orimo S, 1999, J NEUROL NEUROSUR PS, V67, P189, DOI 10.1136/jnnp.67.2.189; Orimo S, 2005, ACTA NEUROPATHOL, V109, P583, DOI 10.1007/s00401-005-0995-7; Orimo S, 2008, BRAIN, V131, P642, DOI 10.1093/brain/awm302; Rozovsky K, 2008, AM J ROENTGENOL, V190, P1085, DOI 10.2214/AJR.07.2107; Tsujikawa K, 2015, J NEUROL NEUROSUR PS, V86, P945, DOI 10.1136/jnnp-2015-310327; Yoshita M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120540	21	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0152746	10.1371/journal.pone.0152746	http://dx.doi.org/10.1371/journal.pone.0152746			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27055151	gold, Green Published			2022-12-27	WOS:000373608000040
J	Roumelioti, ME; Nolin, T; Unruh, ML; Argyropoulos, C				Roumelioti, Maria Eleni; Nolin, Thomas; Unruh, Mark L.; Argyropoulos, Christos			Revisiting the Middle Molecule Hypothesis of Uremic Toxicity: A Systematic Review of Beta 2 Microglobulin Population Kinetics and Large Scale Modeling of Hemodialysis Trials In Silico	PLOS ONE			English	Review							RESIDUAL RENAL-FUNCTION; DIALYSIS-RELATED AMYLOIDOSIS; GLOMERULAR-FILTRATION RATE; HIGH-FLUX HEMODIALYSIS; SERUM BETA(2)-MICROGLOBULIN LEVEL; POST-DILUTION HEMODIAFILTRATION; PERIPHERAL ARTERIAL-DISEASE; PROTEIN-BOUND SOLUTES; ALL-CAUSE MORTALITY; ONLINE HEMODIAFILTRATION	Background Beta-2 Microglobulin (beta 2M) is a prototypical "middle molecule" uremic toxin that has been associated with a higher risk of death in hemodialysis patients. A quantitative description of the relative importance of factors determining beta 2M concentrations among patients with impaired kidney function is currently lacking. Methods Herein we undertook a systematic review of existing studies reporting patient level data concerning generation, elimination and distribution of beta M-2 in order to develop a population model of beta M-2 kinetics. We used this model and previously determined relationships between predialysis beta M-2 concentration and survival, to simulate the population distribution of predialysis beta M-2 and the associated relative risk (RR) of death in patients receiving conventional thrice-weekly hemodialysis with low flux (LF) and high flux (HF) dialyzers, short (SD) and long daily (LD) HF hemodialysis sessions and on-line hemodiafiltration at different levels of residual renal function (RRF). Results We identified 9 studies of 106 individuals and 156 evaluations of or more compartmental kinetic parameters of beta M-2. These studies used a variety of experimental methods to determine beta M-2 kinetics ranging from isotopic dilution to profiling of intra/inter dialytic concentration changes. Most of the patients (74/106) were on dialysis with minimal RRF, thus facilitating the estimation of non-renal elimination kinetics of beta M-2. In large scale (N = 10000) simulations of individuals drawn from the population of beta M-2 kinetic parameters, we found that, higher dialytic removal materially affects beta M-2 exposures only when RRF (renal clearance of beta M-2) was below 2 ml/min. In patients initiating conventional HF hemodialysis, total loss of RRF was predicted to be associated with a RR of death of more than 20%. Hemodiafiltration and daily dialysis may decrease the high risk of death of anuric patients by 10% relative to conventional, thrice weekly HF dialysis. Only daily long sessions of hemodialysis consistently reduced mortality risk between 7-19% across the range of beta M-2 generation rate. Conclusions Preservation of RRF should be considered one of the therapeutic goals of hemodialysis practice. Randomized controlled trials of novel dialysis modalities may require large sample sizes to detect an effect on clinical outcomes even if they enroll anuric patients. The developed population model for beta M-2 may allow personalization of hemodialysis prescription and/or facilitate the design of such studies by identifying patients with higher beta M-2 generation rate.	[Roumelioti, Maria Eleni; Unruh, Mark L.; Argyropoulos, Christos] Univ New Mexico, Sch Med, Hlth Sci Ctr, Div Nephrol,Dept Internal Med, Albuquerque, NM 87131 USA; [Nolin, Thomas] Univ Pittsburgh, Sch Pharm, Dept Pharm & Therapeut, Pittsburgh, PA 15261 USA; [Nolin, Thomas] Univ Pittsburgh, Sch Med, Dept Pharm & Therapeut, Pittsburgh, PA USA; [Nolin, Thomas] Univ Pittsburgh, Sch Pharm, Dept Med, Renal Electrolyte Div, Pittsburgh, PA USA; [Nolin, Thomas] Univ Pittsburgh, Sch Med, Dept Med, Renal Electrolyte Div, Pittsburgh, PA 15213 USA	University of New Mexico; University of New Mexico's Health Sciences Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Argyropoulos, C (corresponding author), Univ New Mexico, Sch Med, Hlth Sci Ctr, Div Nephrol,Dept Internal Med, Albuquerque, NM 87131 USA.	argchris@hotmail.com	Nolin, Thomas/AAB-7311-2020; Argyropoulos, Christos/I-2803-2019	Nolin, Thomas/0000-0003-4339-1382; Argyropoulos, Christos/0000-0002-9679-7805				ACCHIARDO S, 1989, AM J KIDNEY DIS, V13, P70, DOI 10.1016/S0272-6386(89)80119-2; AMICI G, 1993, NEPHRON, V65, P469, DOI 10.1159/000187533; Amighi J, 2011, STROKE, V42, P1826, DOI 10.1161/STROKEAHA.110.600312; Astor BC, 2012, AM J KIDNEY DIS, V59, P653, DOI 10.1053/j.ajkd.2011.11.042; BAILEY RR, 1978, NEW ZEAL MED J, V87, P168; Bammens B, 2003, KIDNEY INT, V64, P2238, DOI 10.1046/j.1523-1755.2003.00310.x; Bianchi C, 2001, RENAL FAILURE, V23, P419, DOI 10.1081/JDI-100104725; Blankestijn PJ, 2010, KIDNEY INT, V77, P581, DOI 10.1038/ki.2009.541; Brown P H, 1988, Nephrol Dial Transplant, V3, P169; CAMPISTOL JM, 1993, AM J KIDNEY DIS, V22, P691, DOI 10.1016/S0272-6386(12)80432-X; CHANARD J, 1993, KIDNEY INT, V43, pS83; Chertow GM, 2010, NEW ENGL J MED, V363, P2287, DOI 10.1056/NEJMoa1001593; Cheung AK, 1999, J AM SOC NEPHROL, V10, P117; Cheung AK, 2008, CLIN J AM SOC NEPHRO, V3, P69, DOI 10.2215/CJN.02340607; Cheung AK, 2006, J AM SOC NEPHROL, V17, P546, DOI 10.1681/ASN.2005020132; Cianciolo G, 2007, INT J ARTIF ORGANS, V30, P864, DOI 10.1177/039139880703001003; COX JH, 1990, SCIENCE, V247, P715, DOI 10.1126/science.2137259; Danesh F, 2001, SEMIN DIALYSIS, V14, P80, DOI 10.1046/j.1525-139x.2001.00035.x; Daugirdas JT, 2013, KIDNEY INT; Dobre M, 2013, CLIN J AM SOC NEPHRO, V8, P322, DOI 10.2215/CJN.04260412; Donadio C, 2001, J PHARMACEUT BIOMED, V24, P835, DOI 10.1016/S0731-7085(00)00550-1; Eknoyan G, 2002, NEW ENGL J MED, V347, P2010, DOI 10.1056/NEJMoa021583; Eloot S, 2012, SEMIN DIALYSIS, V25, P505, DOI 10.1111/j.1525-139X.2012.01107.x; Eloot S, 2012, NEPHROL DIAL TRANSPL, V27, P3278, DOI 10.1093/ndt/gfs060; FLOEGE J, 1991, J LAB CLIN MED, V118, P153; Foster MC, 2013, AM J KIDNEY DIS; FRANCOIS B, 1982, NEPHROLOGIE, V3, P116; Fry AC, 2007, BLOOD PURIFICAT, V25, P295, DOI 10.1159/000104870; Fung ET, 2008, VASC MED, V13, P217, DOI 10.1177/1358863X08089276; Gohh R., 2013, R I MED J, V104, P14; GOTCH F, 1989, CONTRIB NEPHROL, V74, P132; Grooteman MPC, 2012, J AM SOC NEPHROL, V23, P1087, DOI 10.1681/ASN.2011121140; Haufe CC, 2001, KIDNEY INT, V59, pS177, DOI 10.1046/j.1523-1755.2001.59780177.x; Hiatt WR, 2012, VASC MED, V17, P386, DOI 10.1177/1358863X12463491; Jadoul M, 2001, SEMIN DIALYSIS, V14, P86, DOI 10.1046/j.1525-139x.2001.00037.x; JAHN B, 1991, KIDNEY INT, V40, P285, DOI 10.1038/ki.1991.212; JUNG K, 1987, J CLIN CHEM CLIN BIO, V25, P499; Kals J, 2011, SCAND J CLIN LAB INV, V71, P257, DOI 10.3109/00365513.2011.558108; KANAMORI T, 1995, KIDNEY INT, V47, P1453, DOI 10.1038/ki.1995.203; KARLSSON FA, 1980, EUR J CLIN INVEST, V10, P293, DOI 10.1111/j.1365-2362.1980.tb00036.x; KARLSSON FA, 1980, SCAND J CLIN LAB INV, V40, P27; Kazama JJ, 2006, J BONE MINER METAB, V24, P182, DOI 10.1007/s00774-005-0669-5; Kim KM, 2011, CLIN NEPHROL, V75, P458, DOI 10.5414/CNP75458; Kiss E, 2005, AM J ROENTGENOL, V185, P1460, DOI 10.2214/AJR.04.1309; Lee C J, 1994, ASAIO J, V40, P62; Lesko LJ, 2012, CLIN PHARMACOL THER, V92, P458, DOI 10.1038/clpt.2012.113; Leypoldt JK, 1997, ASAIO J, V43, P904, DOI 10.1097/00002480-199711000-00011; Liabeuf S, 2012, KIDNEY INT, V82, P1297, DOI 10.1038/ki.2012.301; Locatelli F, 2009, J AM SOC NEPHROL, V20, P645, DOI 10.1681/ASN.2008060590; Maduell F, 2013, J AM SOC NEPHROL, V24, P487, DOI 10.1681/ASN.2012080875; Maduell F, 2012, NEPHROL DIAL TRANSPL, V27, P1619, DOI 10.1093/ndt/gfr491; MAEDA K, 1990, NEPHRON, V56, P118, DOI 10.1159/000186118; MCCARTHY JT, 1994, J LAB CLIN MED, V123, P495; Meert N, 2011, NEPHROL DIAL TRANSPL, V26, P2624, DOI 10.1093/ndt/gfq803; Nead KT, 2013, AM J CARDIOL, V111, P851, DOI 10.1016/j.amjcard.2012.11.055; ODELL RA, 1991, KIDNEY INT, V39, P909, DOI 10.1038/ki.1991.114; Ok E, 2013, NEPHROL DIAL TRANSPL, V28, P192, DOI 10.1093/ndt/gfs407; Okuno S, 2009, NEPHROL DIAL TRANSPL, V24, P571, DOI 10.1093/ndt/gfn521; Pan HQ, 2013, DATABASE-OXFORD, DOI 10.1093/database/bas058; Pearl J, 2009, STAT SURV, V3, P96, DOI 10.1214/09-SS057; Penne EL, 2010, CLIN J AM SOC NEPHRO, V5, P80, DOI 10.2215/CJN.03340509; PERARNAU B, 1990, NATURE, V346, P751, DOI 10.1038/346751a0; RAVNSKOV U, 1972, SCAND J CLIN LAB INV, V30, P71, DOI 10.3109/00365517209081093; Rocco MV, 2011, KIDNEY INT, V80, P1080, DOI 10.1038/ki.2011.213; RUBIN DB, 1974, J EDUC PSYCHOL, V66, P688, DOI 10.1037/h0037350; Schiffl H, 2013, INT UROL NEPHROL, V45, P1389, DOI 10.1007/s11255-012-0336-4; SCHOELS M, 1993, AM J KIDNEY DIS, V21, P394, DOI 10.1016/S0272-6386(12)80267-8; Shafi T, 2012, CLIN J AM SOC NEPHRO, V7, P1435, DOI 10.2215/CJN.02240312; Shin MJ, 2012, CLIN EXP NEPHROL, V16, P456, DOI 10.1007/s10157-011-0583-1; Sirich TL, 2012, NEPHROL DIAL TRANSPL, V27, P1574, DOI 10.1093/ndt/gfr691; Stiller S, 2002, INT J ARTIF ORGANS, V25, P411, DOI 10.1177/039139880202500511; Takesawa S, 1988, JPN J ARTIF ORGANS, V17, P42; Tattersall J, 2007, CONTRIB NEPHROL, V158, P201, DOI 10.1159/000107251; Turner CF, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar043; van der Wal WM, 2011, NEPHROL DIAL TRANSPL, V26, P2978, DOI 10.1093/ndt/gfq856; Vanholder R, 2008, J NEPHROL, V21, P146; Vanholder R, 2009, SEMIN DIALYSIS, V22, P323, DOI 10.1111/j.1525-139X.2009.00574.x; Vilar E, 2011, SEMIN DIALYSIS, V24, P487, DOI 10.1111/j.1525-139X.2011.00968.x; VINCENT C, 1992, KIDNEY INT, V42, P1434, DOI 10.1038/ki.1992.438; VINCENT C, 1980, ACTA CLIN BELG, V35, P2; Ward RA, 2000, J AM SOC NEPHROL, V11, P2344, DOI 10.1681/ASN.V11122344; Ward RA, 2006, KIDNEY INT, V69, P1431, DOI 10.1038/sj.ki.5000048; WIBELL LB, 1976, ACTA CLIN BELG, V31, P14; Wilson AM, 2007, CIRCULATION, V116, P1396, DOI 10.1161/CIRCULATIONAHA.106.683722; Winchester JF, 2003, ADV RENAL REPLACE TH, V10, P279, DOI 10.1053/j.arrt.2003.11.003; Wizemann V, 2000, NEPHROL DIAL TRANSPL, V15, P43, DOI 10.1093/oxfordjournals.ndt.a027963; Xu XQ, 2001, ASAIO J, V47, P623, DOI 10.1097/00002480-200111000-00011; Yamamoto S, 2005, BBA-PROTEINS PROTEOM, V1753, P4, DOI 10.1016/j.bbapap.2005.09.006; Zhang LP, 2008, AAPS J, V10, P552, DOI 10.1208/s12248-008-9062-3; Zingraff J, 1988, Nephrol Dial Transplant, V3, P284; Zumrutdal A, 2005, NEPHROLOGY, V10, P453, DOI 10.1111/j.1440-1797.2005.00475.x	91	20	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153157	10.1371/journal.pone.0153157	http://dx.doi.org/10.1371/journal.pone.0153157			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27055286	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000373608000089
J	Treat, AC; Wheeler, DS; Stolz, DB; Tsang, M; Friedman, PA; Romero, G				Treat, Anny Caceres; Wheeler, David S.; Stolz, Donna B.; Tsang, Michael; Friedman, Peter A.; Romero, Guillermo			The PDZ Protein Na+/H+ Exchanger Regulatory Factor-1 (NHERF1) Regulates Planar Cell Polarity and Motile Cilia Organization	PLOS ONE			English	Article							PARATHYROID-HORMONE; ASYMMETRIC LOCALIZATION; APICAL MEMBRANE; RECEPTOR; BETA; PHOSPHORYLATION; CILIOGENESIS; ASSOCIATION; DYNAMICS; SIGNALS	Directional flow of the cerebrospinal fluid requires coordinated movement of the motile cilia of the ependymal epithelium that lines the cerebral ventricles. Here we report that mice lacking the Na+/H+ Exchanger Regulatory Factor 1 (NHERF1/Slc9a3r1, also known as EBP50) develop profound communicating hydrocephalus associated with fewer and disorganized ependymal cilia. Knockdown of NHERF1/slc9a3r1 in zebrafish embryos also causes severe hydrocephalus of the hindbrain and impaired ciliogenesis in the otic vesicle. Ultrastructural analysis did not reveal defects in the shape or organization of individual cilia. Similar phenotypes have been described in animals with deficiencies in Wnt signaling and the Planar Cell Polarity (PCP) pathway. We show that NHERF1 binds the PCP core genes Frizzled (Fzd) and Vangl. We further show that NHERF1 assembles a ternary complex with Fzd4 and Vangl2 and promotes translocation of Vangl2 to the plasma membrane, in particular to the apical surface of ependymal cells. Taken together, these results strongly support an important role for NHERF1 in the regulation of PCP signaling and the development of functional motile cilia.	[Treat, Anny Caceres; Wheeler, David S.; Friedman, Peter A.; Romero, Guillermo] Univ Pittsburgh, Pittsburgh Sch Med, Dept Pharmacol & Chem Biol, Lab GPCR Biol, Pittsburgh, PA USA; [Wheeler, David S.] Univ Pittsburgh, Sch Med, Med Scientist Training Program, Pittsburgh, PA USA; [Stolz, Donna B.] Univ Pittsburgh, Sch Med, Dept Cell Biol, Pittsburgh, PA USA; [Tsang, Michael] Univ Pittsburgh, Sch Med, Dept Dev Biol, Pittsburgh, PA USA; [Friedman, Peter A.] Univ Pittsburgh, Sch Med, Dept Biol Struct, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Romero, G (corresponding author), Univ Pittsburgh, Pittsburgh Sch Med, Dept Pharmacol & Chem Biol, Lab GPCR Biol, Pittsburgh, PA USA.	ggr@pitt.edu	Tsang, Michael W/I-9305-2014; Tsang, Michael/AAG-9338-2020; Tsang, Michael/ABV-0504-2022	Tsang, Michael W/0000-0001-7123-0063; Tsang, Michael/0000-0001-7123-0063	National Institute of Diabetes and Digestive and Kidney Diseases [DK079864, DK069998, DK083211]; National Institute of General Medical Sciences [T32GM008424]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK079864, F30DK083211, R01DK069998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008424] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institute of Diabetes and Digestive and Kidney Diseases (www.niddk.nih.gov) grants DK079864 (GR), DK069998 (PAF) and DK083211 (DSW), and National Institute of General Medical Sciences (www.nigms.nih.gov) T32GM008424 (ACT and DSW).	[Anonymous], 1989, POSTGRAD MED; Banizs B, 2005, DEVELOPMENT, V132, P5329, DOI 10.1242/dev.02153; Borovina A, 2010, NAT CELL BIOL, V12, P407, DOI 10.1038/ncb2042; Boutin C, 2014, P NATL ACAD SCI USA, V111, pE3129, DOI 10.1073/pnas.1404988111; Bryant DM, 2014, DEV CELL, V31, P171, DOI 10.1016/j.devcel.2014.08.027; Clark MA, 2007, FEBS LETT, V581, P764, DOI 10.1016/j.febslet.2007.01.045; Ferkol TW, 2012, J PEDIATR-US, V160, P366, DOI 10.1016/j.jpeds.2011.11.024; Flynt AS, 2010, CELL CYCLE, V9, P235, DOI 10.4161/cc.9.2.10434; Francis SS, 2011, J CELL BIOL, V193, P219, DOI 10.1083/jcb.201009001; Garbett D, 2010, J CELL BIOL, V191, P397, DOI 10.1083/jcb.201004115; Guerra L, 2005, J BIOL CHEM, V280, P40925, DOI 10.1074/jbc.M505103200; Guirao B, 2010, NAT CELL BIOL, V12, P341, DOI 10.1038/ncb2040; Hoque MT, 2009, BIOCHEM BIOPH RES CO, V379, P60, DOI 10.1016/j.bbrc.2008.12.014; Ibanez-Tallon I, 2004, HUM MOL GENET, V13, P2133, DOI 10.1093/hmg/ddh219; Ibanez-Tallon I, 2002, HUM MOL GENET, V11, P715, DOI 10.1093/hmg/11.6.715; Karim Z, 2008, NEW ENGL J MED, V359, P1128, DOI 10.1056/NEJMc086284; Kinlough CL, 2011, J BIOL CHEM, V286, P39072, DOI 10.1074/jbc.M111.289504; Kreimann EL, 2007, ONCOGENE, V26, P5290, DOI 10.1038/sj.onc.1210336; Lechtreck KF, 2008, J CELL BIOL, V180, P633, DOI 10.1083/jcb.200710162; Mahon MJ, 2004, J BIOL CHEM, V279, P23550, DOI 10.1074/jbc.M313229200; Molina JR, 2012, ONCOGENE, V31, P1264, DOI 10.1038/onc.2011.324; Montcouquiol M, 2006, J NEUROSCI, V26, P5265, DOI 10.1523/JNEUROSCI.4680-05.2006; Morales FC, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.131; Morales FC, 2004, P NATL ACAD SCI USA, V101, P17705, DOI 10.1073/pnas.0407974101; Pan JH, 2007, J CELL SCI, V120, P1868, DOI 10.1242/jcs.005306; Romero G, 2011, ADV PHARMACOL, V62, P279, DOI 10.1016/B978-0-12-385952-5.00003-8; Shenolikar S, 2002, P NATL ACAD SCI USA, V99, P11470, DOI 10.1073/pnas.162232699; Spassky N, 2005, J NEUROSCI, V25, P10, DOI 10.1523/JNEUROSCI.1108-04.2005; Sun LC, 2016, FASEB J, V30, P578, DOI 10.1096/fj.15-275586; Tissir F, 2010, NAT NEUROSCI, V13, P700, DOI 10.1038/nn.2555; Wang B, 2012, J BIOL CHEM, V287, P24148, DOI 10.1074/jbc.M112.369405; Wang B, 2010, J BIOL CHEM, V285, P26976, DOI 10.1074/jbc.M110.147785; Wehbi VL, 2013, P NATL ACAD SCI USA, V110, P1530, DOI 10.1073/pnas.1205756110; Weinman EJ, 2007, J CLIN INVEST, V117, P3412, DOI 10.1172/JCI32738; Weinman EJ, 2003, FEBS LETT, V536, P141, DOI 10.1016/S0014-5793(03)00043-7; WEINMAN EJ, 1995, J CLIN INVEST, V95, P2143, DOI 10.1172/JCI117903; Weinman EJ, 1998, J CLIN INVEST, V101, P2199, DOI 10.1172/JCI204; Wheeler DS, 2011, ONCOGENE, V30, P32, DOI 10.1038/onc.2010.389; Wheeler D, 2008, MOL ENDOCRINOL, V22, P1163, DOI 10.1210/me.2007-0461; Wheeler D, 2007, J BIOL CHEM, V282, P25076, DOI 10.1074/jbc.M701544200; Wong HC, 2003, MOL CELL, V12, P1251, DOI 10.1016/S1097-2765(03)00427-1; Yao R, 2004, ONCOGENE, V23, P6023, DOI 10.1038/sj.onc.1207817; Yin HF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031988; Yu A, 2007, DEV CELL, V12, P129, DOI 10.1016/j.devcel.2006.10.015; Znosko WA, 2010, DEV BIOL, V342, P11, DOI 10.1016/j.ydbio.2010.03.011	45	9	9	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153144	10.1371/journal.pone.0153144	http://dx.doi.org/10.1371/journal.pone.0153144			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27055101	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000373608000087
J	Hammes, M; Boghosian, M; Cassel, K; Watson, S; Funaki, B; Doshi, T; Akherat, SMJM; Hines, J; Coe, F				Hammes, Mary; Boghosian, Michael; Cassel, Kevin; Watson, Sydeaka; Funaki, Brian; Doshi, Taral; Akherat, S. M. Javid Mahmoudzadeh; Hines, Jane; Coe, Fredric			Increased Inlet Blood Flow Velocity Predicts Low Wall Shear Stress in the Cephalic Arch of Patients with Brachiocephalic Fistula Access	PLOS ONE			English	Article							ARTERIOVENOUS-FISTULAS; STENOSIS; HEMODIALYSIS; HEMODYNAMICS; HYPERPLASIA; PLACEMENT; FAILURE	Background An autogenous arteriovenous fistula is the optimal vascular access for hemodialysis. In the case of brachiocephalic fistula, cephalic arch stenosis commonly develops leading to access failure. We have hypothesized that a contribution to fistula failure is low wall shear stress resulting from post-fistula creation hemodynamic changes that occur in the cephalic arch. Methods Twenty-two subjects with advanced renal failure had brachiocephalic fistulae placed. The following procedures were performed at mapping (pre-operative) and at fistula maturation (8-32 weeks post-operative): venogram, Doppler to measure venous blood flow velocity, and whole blood viscosity. Geometric and computational modeling was performed to determine wall shear stress and other geometric parameters. The relationship between hemodynamic parameters and clinical findings was examined using univariate analysis and linear regression. Results The percent low wall shear stress was linearly related to the increase in blood flow velocity (p < 0.01). This relationship was more significant in non-diabetic patients (p < 0.01) than diabetic patients. The change in global measures of arch curvature and asymmetry also evolve with time to maturation (p < 0.05). Conclusions The curvature and hemodynamic changes during fistula maturation increase the percentage of low wall shear stress regions within the cephalic arch. Low wall shear stress may contribute to subsequent neointimal hyperplasia and resultant cephalic arch stenosis. If this hypothesis remains tenable with further studies, ways of protecting the arch through control of blood flow velocity may need to be developed.	[Hammes, Mary; Hines, Jane; Coe, Fredric] Univ Chicago, Dept Med, Nephrol Sect, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Boghosian, Michael; Cassel, Kevin; Akherat, S. M. Javid Mahmoudzadeh] IIT, Dept Mech Mat & Aerosp Engn, Chicago, IL 60616 USA; [Watson, Sydeaka] Univ Chicago, Dept Publ Hlth Sci, Biostat Lab, Chicago, IL 60637 USA; [Funaki, Brian; Doshi, Taral] Univ Chicago, Dept Radiol, Chicago, IL 60637 USA	University of Chicago; Illinois Institute of Technology; University of Chicago; University of Chicago	Hammes, M (corresponding author), Univ Chicago, Dept Med, Nephrol Sect, 5841 S Maryland Ave, Chicago, IL 60637 USA.	mhammes@medicine.bsd.uchicago.edu		Hammes, Mary/0000-0002-2524-6432	National Institutes of Health (NIH) [RO1DK090769]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090769] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This publication was made possible by the National Institute of Diabetes and Digestive Diseases (NIDDK) and the National Institutes of Health (NIH) under award number RO1DK090769. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIDDK or the NIH.	Achneck HE, 2010, SEMIN DIALYSIS, V23, P25, DOI 10.1111/j.1525-139X.2009.00651.x; Baskurt OK, 2009, CLIN HEMORHEOL MICRO, V42, P75, DOI 10.3233/CH-2009-1202; Bennett S, 2015, J VASC ACCESS, V16, P13, DOI 10.5301/jva.5000291; Boghosian M, 2014, MED ENG PHYS, V36, P822, DOI 10.1016/j.medengphy.2014.03.001; Corpataux JM, 2002, NEPHROL DIAL TRANSPL, V17, P1057, DOI 10.1093/ndt/17.6.1057; Dixon BS, 2006, KIDNEY INT, V70, P1413, DOI 10.1038/sj.ki.5001747; Hahn C, 2009, NAT REV MOL CELL BIO, V10, P53, DOI 10.1038/nrm2596; Hammes M, 2008, HEMODIAL INT, V12, P85, DOI 10.1111/j.1542-4758.2008.00246.x; Hammes MS, 2009, NEPHROL DIAL TRANSPL, V24, P2190, DOI 10.1093/ndt/gfp062; Jaberi A, 2007, J VASC ACCESS, V8, P287, DOI 10.1177/112972980700800412; Jackson AJ., 2014, J VASC MED SURG, V2, P154, DOI [10.4172/2329-6925.1000154, DOI 10.4172/2329-6925.1000154]; Jia L, 2015, NEPHROLOGY, V20, P335, DOI 10.1111/nep.12394; Kian K, 2008, SEMIN DIALYSIS, V21, P78, DOI 10.1111/j.1525-139X.2007.00387.x; KOLLURU GK, 2012, INT J VASC MED, DOI DOI 10.1155/2012/918267; Kroll MH, 1996, BLOOD, V88, P1525; Lee KW, 2002, MED ENG PHYS, V24, P575, DOI 10.1016/S1350-4533(02)00048-6; Lee T, 2009, ADV CHRONIC KIDNEY D, V16, P329, DOI 10.1053/j.ackd.2009.06.009; Lehoux S, 1998, HYPERTENSION, V32, P338, DOI 10.1161/01.HYP.32.2.338; Lok CE, 2006, J AM SOC NEPHROL, V17, P3204, DOI 10.1681/ASN.2006030190; Mahmoudzadeh Akherat S. M. J., 2013, THESIS ILLINOIS I TE; Niyyar VD, 2009, ADV CHRONIC KIDNEY D, V16, P316, DOI 10.1053/j.ackd.2009.06.007; Owens CD, 2010, J VASC SURG, V51, P736, DOI 10.1016/j.jvs.2009.07.102; Rajan DK, 2003, J VASC INTERV RADIOL, V14, P567, DOI 10.1097/01.RVI.0000071090.76348.BC; Rothuizen TC, 2013, NEPHROL DIAL TRANSPL, V28, P1085, DOI 10.1093/ndt/gft068; Scheerder D, 1994, AM HEART J, V127, P243; Sigovan M, 2013, ANN BIOMED ENG, V41, P657, DOI 10.1007/s10439-012-0703-4; Sivananthan G, 2014, J VASC ACCESS, V15, P157, DOI 10.5301/jva.5000203; Traub O, 1998, ARTERIOSCL THROM VAS, V18, P677, DOI 10.1161/01.ATV.18.5.677; TURITTO VT, 1982, PROG HEMOST THROMB, V6, P139; Van Tricht I, 2005, ANN BIOMED ENG, V33, P1142, DOI 10.1007/s10439-005-5367-X; Vazquez MA, 2009, CURR OPIN NEPHROL HY, V18, P116, DOI 10.1097/MNH.0b013e328325d635; Wang F, 2014, J SHANGHAI JIATONG U, V17, P761; WOMERSLEY JR, 1955, J PHYSIOL-LONDON, V127, P553, DOI 10.1113/jphysiol.1955.sp005276; Wood NB, 2006, J APPL PHYSIOL, V101, P1412, DOI 10.1152/japplphysiol.00051.2006	34	17	20	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0152873	10.1371/journal.pone.0152873	http://dx.doi.org/10.1371/journal.pone.0152873			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27074019	Green Published, Green Submitted, gold			2022-12-27	WOS:000374131200040
J	Karuppagounder, V; Giridharan, VV; Arumugam, S; Sreedhar, R; Palaniyandi, SS; Krishnamurthy, P; Quevedo, J; Watanabe, K; Konishi, T; Thandavarayan, RA				Karuppagounder, Vengadeshprabhu; Giridharan, Vijayasree V.; Arumugam, Somasundaram; Sreedhar, Remya; Palaniyandi, Suresh S.; Krishnamurthy, Prasanna; Quevedo, Joao; Watanabe, Kenichi; Konishi, Tetsuya; Thandavarayan, Rajarajan A.			Modulation of Macrophage Polarization and HMGB1-TLR2/TLR4 Cascade Plays a Crucial Role for Cardiac Remodeling in Senescence-Accelerated Prone Mice	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; DAUNORUBICIN-INDUCED NEPHROTOXICITY; MYOCARDIAL-ISCHEMIA; ATOPIC-DERMATITIS; OXIDATIVE STRESS; HEART-DISEASE; HMGB1; INFLAMMATION; DYSFUNCTION; RECEPTOR	The aim of this study was to investigate the role of macrophage polarization in aging heart. Macrophage differentiation is pathogenically linked to many inflammatory and immune disorders. It is often preceded by myocardial inflammation, which is characterized by increased cardiac damage and pro-inflammatory cytokine levels. Therefore, we investigated the hypothesis that senescence accelerated-prone (SAMP8) mice cardiac tissue would develop macrophage polarization compared with senescence-resistant control (SAMR1) mice. Both SAMP8 and SAMR1 mice were sacrificed when they became six month old. We evaluated, histo-pathological changes and modifications in protein expression by Western blotting and immuno-histochemical staining for M1 and M2 macrophage markers, high mobility group protein (HMG) B1 and its cascade proteins, pro-inflammatory factors and inflammatory cytokines in cardiac tissue. We observed significant upregulation of HMGB1, toll-like receptor (TLR) 2, TLR4, nuclear factor (NF)kappa B p65, tumor necrosis factor (TNF) alpha, cyclooxygenase (COX) 2, interferon (IFN)gamma, interleukin (IL)-1 beta, IL-6 and M1 like macrophage specific marker cluster of differentiation (CD) 68 expressions in SAMP8 heart. In contrast, M2 macrophage specific marker CD36, and IL-10 expressions were down-regulated in SAMP8 mice. The results from the study demonstrated that, HMGB1-TLR2/TLR4 signaling cascade and induction of phenotypic switching to M1 macrophage polarization in SAMP8 mice heart would be one of the possible reasons behind the cardiac dysfunction and thus it could become an important therapeutic target to improve the age related cardiac dysfunction.	[Karuppagounder, Vengadeshprabhu; Arumugam, Somasundaram; Sreedhar, Remya; Watanabe, Kenichi] Niigata Univ Pharm & Appl Life Sci, Fac Pharmaceut Sci, Dept Clin Pharmacol, Niigata 9568603, Japan; [Giridharan, Vijayasree V.; Quevedo, Joao] Univ Texas Hlth Sci Ctr Houston, Dept Psychiat & Behav Sci, Houston, TX 77054 USA; [Palaniyandi, Suresh S.] Henry Ford Hlth Syst, Div Hypertens & Vasc Res, Detroit, MI 48202 USA; [Krishnamurthy, Prasanna; Thandavarayan, Rajarajan A.] Houston Methodist Res Inst, Dept Cardiovasc Sci, Houston, TX 77030 USA; [Konishi, Tetsuya] NUPALS Liaison RD Promot Div, Basic Studies Generat Funct Foods 2, Akiha Ku, Higashijima 265-1, Niigata, Japan; [Konishi, Tetsuya] Changchun Univ Chinese Med, Bosuo Rd 1035 Jingyue Econ Dev Dist, Changchun, Peoples R China	Niigata University; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; Henry Ford Health System; Henry Ford Hospital; The Methodist Hospital System; The Methodist Hospital - Houston; Changchun University of Chinese Medicine	Thandavarayan, RA (corresponding author), Houston Methodist Res Inst, Dept Cardiovasc Sci, Houston, TX 77030 USA.	atrajarajan@gmail.com	de Quevedo, João Luciano/E-5491-2013; Karuppagounder, Vengadeshprabhu/AAC-6623-2019; Arumugam, S./AAT-7570-2020	de Quevedo, João Luciano/0000-0003-3114-6611; KRISHNAMURTHY, PRASANNA/0000-0002-4842-6364; Arumugam, Somasundaram/0000-0002-2096-2552; KARUPPA GOUNDER, VENGADESHPRABHU/0000-0003-1511-7810	Promotion and Mutual Aid Corporation for Private Schools, Japan; National Institutes of Health (NIH) grant [1R01HL116729]; AHA post-doctoral fellowship [15POST25710392]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL116729] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572] Funding Source: NIH RePORTER	Promotion and Mutual Aid Corporation for Private Schools, Japan(Promotion and Mutual Aid Corporation for Private Schools of Japan); National Institutes of Health (NIH) grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA post-doctoral fellowship(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	TK was supported by The Promotion and Mutual Aid Corporation for Private Schools, Japan; PK was supported by National Institutes of Health (NIH) grant 1R01HL116729, RAT was supported by AHA post-doctoral fellowship 15POST25710392. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrassy M, 2008, CIRCULATION, V117, P3216, DOI 10.1161/CIRCULATIONAHA.108.769331; Azzawi M, 2005, HISTOPATHOLOGY, V46, P314, DOI 10.1111/j.1365-2559.2005.02075.x; Chinetti-Gbaguidi G, 2011, CURR OPIN LIPIDOL, V22, P365, DOI 10.1097/MOL.0b013e32834a77b4; Csiszar A, 2002, CIRC RES, V90, P1159, DOI 10.1161/01.RES.0000020401.61826.EA; Csiszar A, 2008, J APPL PHYSIOL, V105, P1333, DOI 10.1152/japplphysiol.90470.2008; Cucak H, 2015, INT IMMUNOPHARMACOL, V25, P30, DOI 10.1016/j.intimp.2015.01.003; de Haan JJ, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/206039; Favre J, 2007, ARTERIOSCL THROM VAS, V27, P1064, DOI 10.1161/ATVBAHA.107.140723; Forman K, 2011, J GERONTOL A-BIOL, V66, P823, DOI 10.1093/gerona/glr083; Gan W, 2012, FREE RADICAL BIO MED, V52, P1700, DOI 10.1016/j.freeradbiomed.2012.02.016; Gounder VK, 2014, INT IMMUNOPHARMACOL, V18, P282, DOI 10.1016/j.intimp.2013.11.018; Gullestad L, 2012, CARDIOLOGY, V122, P23, DOI 10.1159/000338166; Han XB, 2010, FASEB J, V24, P2869, DOI 10.1096/fj.09-148155; Hao QQ, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/270930; Hosokawa M, 1997, EXP GERONTOL, V32, P111, DOI 10.1016/S0531-5565(96)00078-2; Jackaman C, 2013, AGING CELL, V12, P345, DOI 10.1111/acel.12062; Johnson FB, 1999, CELL, V96, P291, DOI 10.1016/S0092-8674(00)80567-X; Karuppagounder V, 2015, INT IMMUNOPHARMACOL, V28, P154, DOI 10.1016/j.intimp.2015.05.050; Karuppagounder V, 2015, EXP DERMATOL, V24, P418, DOI 10.1111/exd.12685; Karuppagounder V, 2014, INT IMMUNOPHARMACOL, V23, P617, DOI 10.1016/j.intimp.2014.10.014; Ma YG, 2015, CARDIOVASC RES, V106, P421, DOI 10.1093/cvr/cvv128; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Moslehi J, 2012, CIRC RES, V110, P1226, DOI 10.1161/CIRCRESAHA.111.246868; Odden MC, 2011, AM J MED, V124, P827, DOI 10.1016/j.amjmed.2011.04.010; Oyama J, 2004, CIRCULATION, V109, P784, DOI 10.1161/01.CIR.0000112575.66565.84; Qin YH, 2009, J IMMUNOL, V183, P6244, DOI 10.4049/jimmunol.0900390; Qiu YR, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004011; Ranganathan PV, 2013, AM J PHYSIOL-RENAL, V304, pF948, DOI 10.1152/ajprenal.00580.2012; Reed AL, 2011, AM J PHYSIOL-HEART C, V301, pH824, DOI 10.1152/ajpheart.00407.2010; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Saito H, 2001, J BIOL CHEM, V276, P29307, DOI 10.1074/jbc.M103740200; Shioi T, 2012, J CARDIOL, V60, P423, DOI 10.1016/j.jjcc.2012.07.015; Stoger JL, 2012, ATHEROSCLEROSIS, V225, P461, DOI 10.1016/j.atherosclerosis.2012.09.013; Takahashi M, 2008, CARDIOVASC RES, V80, P5, DOI 10.1093/cvr/cvn212; TAKEDA T, 1981, MECH AGEING DEV, V17, P183, DOI 10.1016/0047-6374(81)90084-1; Tang DL, 2011, ANTIOXID REDOX SIGN, V14, P1315, DOI 10.1089/ars.2010.3356; van Beijnum JR, 2008, ANGIOGENESIS, V11, P91, DOI 10.1007/s10456-008-9093-5; Wang WK, 2014, J CELL MOL MED, V18, P2311, DOI 10.1111/jcmm.12399; Xu H, 2010, J IMMUNOL, V184, P1492, DOI 10.4049/jimmunol.0902660	39	41	47	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0152922	10.1371/journal.pone.0152922	http://dx.doi.org/10.1371/journal.pone.0152922			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27070323	Green Published, Green Submitted, gold			2022-12-27	WOS:000373900700020
J	Hanson, DL; Song, RG; Masciotra, S; Hernandez, A; Dobbs, TL; Parekh, BS; Owen, SM; Green, TA				Hanson, Debra L.; Song, Ruiguang; Masciotra, Silvina; Hernandez, Angela; Dobbs, Trudy L.; Parekh, Bharat S.; Owen, S. Michele; Green, Timothy A.			Mean Recency Period for Estimation of HIV-1 Incidence with the BED-Capture EIA and Bio-Rad Avidity in Persons Diagnosed in the United States with Subtype B	PLOS ONE			English	Article							TYPE-1 INCIDENCE; INFECTION; ASSAY; SURVEILLANCE	HIV incidence estimates are used to monitor HIV-1 infection in the United States. Use of laboratory biomarkers that distinguish recent from longstanding infection to quantify HIV incidence rely on having accurate knowledge of the average time that individuals spend in a transient state of recent infection between seroconversion and reaching a specified biomarker cutoff value. This paper describes five estimation procedures from two general statistical approaches, a survival time approach and an approach that fits binomial models of the probability of being classified as recently infected, as a function of time since seroconversion. We compare these procedures for estimating the mean duration of recent infection (MDRI) for two biomarkers used by the U.S. National HIV Surveillance System for determination of HIV incidence, the Aware BED EIA HIV-1 incidence test (BED) and the avidity-based, modified Bio-Rad HIV-1/HIV-2 plus O ELISA (BRAI) assay. Collectively, 953 specimens from 220 HIV-1 subtype B seroconverters, taken from 5 cohorts, were tested with a biomarker assay. Estimates of MDRI using the non-parametric survival approach were 198.4 days (SD 13.0) for BED and 239.6 days (SD 13.9) for BRAI using cutoff values of 0.8 normalized optical density and 30%, respectively. The probability of remaining in the recent state as a function of time since seroconversion, based upon this revised statistical approach, can be applied in the calculation of annual incidence in the United States.	[Hanson, Debra L.; Song, Ruiguang; Green, Timothy A.] Ctr Dis Control & Prevent, Quantitat Sci & Data Management Branch, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA USA; [Masciotra, Silvina; Owen, S. Michele] Ctr Dis Control & Prevent, Branch Lab, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA USA; [Hernandez, Angela] Ctr Dis Control & Prevent, HIV Incidence & Case Surveillance Branch, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA USA; [Dobbs, Trudy L.; Parekh, Bharat S.] Ctr Dis Control & Prevent, Int Lab Branch, Div Global HIV & AIDS, Ctr Global Hlth, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Hanson, DL (corresponding author), Ctr Dis Control & Prevent, Quantitat Sci & Data Management Branch, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA USA.	dhanson@cdc.gov		PAREKH, BHARAT/0000-0002-1088-4263				AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; [Anonymous], EV BIOR GS HIV 1 HIV; BRESLOW NE, 1993, J AM STAT ASSOC, V88, P9, DOI 10.1080/01621459.1993.10594284; Brookmeyer R, 2013, AM J EPIDEMIOL, V177, P264, DOI 10.1093/aje/kws436; Brookmeyer R, 2010, EPIDEMIOL REV, V32, P26, DOI 10.1093/epirev/mxq002; Burchell AN, 2003, INT J STD AIDS, V14, P601, DOI 10.1258/095646203322301059; Centers for Disease Control and Prevention, 2012, EST HIV INC US 2007; Centers for Disease Control and Prevention. HIV testing survey, 2002, 5 CDCP US DEP HHS; Dobbs T, 2004, J CLIN MICROBIOL, V42, P2623, DOI 10.1128/JCM.42.6.2623-2628.2004; Duong YT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033328; Efron B, 1967, P 5 BERK S MATH STAT, P831; Flynn MN, 2005, J INFECT DIS, V191, P654, DOI 10.1086/428404; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; Hargrove J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049661; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; Hauser A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098038; Hurvich CM, 1998, J ROY STAT SOC B, V60, P271, DOI 10.1111/1467-9868.00125; Janssen RS, 1998, JAMA-J AM MED ASSOC, V280, P42, DOI 10.1001/jama.280.1.42; Karon JM, 2008, STAT MED, V27, P4617, DOI 10.1002/sim.3144; Kassanjee R, 2014, AIDS, V28, P2439, DOI 10.1097/QAD.0000000000000429; Kassanjee R, 2012, EPIDEMIOLOGY, V23, P721, DOI 10.1097/EDE.0b013e3182576c07; Keating SM, 2012, J CLIN MICROBIOL, V50, P3968, DOI 10.1128/JCM.01454-12; Koblin BA, 1998, AIDS, V12, P785, DOI 10.1097/00002030-199807000-00015; Lansky A, 2007, PUBLIC HEALTH REP, V122, P24, DOI 10.1177/00333549071220S105; Mastro Timothy D, 2010, J HIV AIDS Surveill Epidemiol, V2, P1; McDougal JS, 2006, AIDS RES HUM RETROV, V22, P945, DOI 10.1089/aid.2006.22.945; Oster Alexandra M., 2011, Morbidity and Mortality Weekly Report, V60, P694; Parekh BS, 2011, AIDS RES HUM RETROV, V27, P265, DOI 10.1089/aid.2010.0159; Parekh BS, 2002, AIDS RES HUM RETROV, V18, P295, DOI 10.1089/088922202753472874; POLK BF, 1987, NEW ENGL J MED, V316, P61, DOI 10.1056/NEJM198701083160201; Prejean J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017502	31	17	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2016	11	4							e0152327	10.1371/journal.pone.0152327	http://dx.doi.org/10.1371/journal.pone.0152327			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0KH	27065005	gold, Green Submitted, Green Published			2022-12-27	WOS:000373891000010
J	Wu, ZZ; Bin, SY; He, HL; Wang, ZB; Li, M; Lin, JT				Wu, Zhongzhen; Bin, Shuying; He, Hualiang; Wang, Zhengbing; Li, Mei; Lin, Jintian			Differential Expression Analysis of Chemoreception Genes in the Striped Flea Beetle Phyllotreta striolata Using a Transcriptomic Approach	PLOS ONE			English	Article							ODORANT-BINDING-PROTEINS; CANDIDATE CHEMOSENSORY GENES; CARBON-DIOXIDE DETECTION; RNA-SEQ DATA; ANTENNAL TRANSCRIPTOME; PHEROMONE-BINDING; MOLECULAR-BASIS; ANOPHELES-GAMBIAE; SOLUBLE-PROTEINS; MAXILLARY PALP	Olfactory transduction is a process by which olfactory sensory neurons (OSNs) transform odor information into neuronal electrical signals. This process begins with the binding of odor molecules to receptor proteins on olfactory receptor neuron (ORN) dendrites. The major molecular components involved in olfaction include odorant-binding proteins (OBPs), chemosensory proteins (CSPs), odorant receptors (ORs), gustatory receptors (GRs), ionotropic receptors (IRs), sensory neuron membrane proteins (SNMPs) and odorant-degrading enzymes (ODEs). More importantly, as potential molecular targets, chemosensory proteins are used to identify novel attractants or repellants for environmental-friendly pest management. In this study we analyzed the transcriptome of the flea beetle, Phyllotreta striolata (Coleoptera, Chrysomelidae), a serious pest of Brassicaceae crops, to better understand the molecular mechanisms of olfactory recognition in this pest. The analysis of transcriptomes from the antennae and terminal abdomens of specimens of both sexes identified transcripts from several key molecular components of chemoreception including 73 ORs, 36 GRs, 49 IRs, 2 SNMPs, 32 OBPs, 8 CSPs, and four candidate odorant degrading enzymes (ODEs): 143 cytochrome P450s (CYPs), 68 esterases (ESTs), 27 glutathione S-transferases (GSTs) and 8 UDP-glycosyltransferases (UGTs). Bioinformatic analyses indicated that a large number of chemosensory genes were up-regulated in the antennae. This was consistent with a potential role in olfaction. To validate the differential abundance analyses, the expression of 19 genes encoding various ORs, CSPs, and OBPs was assessed via qRT-PCR between non-chemosensory tissue and antennae. Consistent with the bioinformatic analyses, transcripts for all of the genes in the qRT-PCR subset were elevated in antennae. These findings provide the first insights into the molecular basis of chemoreception in the striped flea beetle.	[Wu, Zhongzhen; Bin, Shuying; He, Hualiang; Wang, Zhengbing; Li, Mei; Lin, Jintian] Zhongkai Univ Agr & Engn, Inst Management Invas Alien Species, 314 Yingdong Teaching Bldg, Guangzhou 510225, Guangdong, Peoples R China	Zhongkai University of Agriculture & Engineering	Lin, JT (corresponding author), Zhongkai Univ Agr & Engn, Inst Management Invas Alien Species, 314 Yingdong Teaching Bldg, Guangzhou 510225, Guangdong, Peoples R China.	linjtian@163.com		Wang, Zhengbing/0000-0003-4460-0369	National Natural Science Foundation of China [31272072]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported financially by the National Natural Science Foundation of China (31272072).	Abdel-Latief M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001319; Ai M, 2010, NATURE, V468, P691, DOI 10.1038/nature09537; Andersen CL, 2006, J ECON ENTOMOL, V99, P803, DOI 10.1603/0022-0493-99.3.803; Andersson MN, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-501; Andersson MN, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-198; Angeli S, 1999, EUR J BIOCHEM, V262, P745, DOI 10.1046/j.1432-1327.1999.00438.x; Benton R, 2007, NATURE, V450, P289, DOI 10.1038/nature06328; Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; Bohbot J, 1998, BIOCHEM BIOPH RES CO, V253, P489, DOI 10.1006/bbrc.1998.9806; Boyle SM, 2013, ELIFE, V2, DOI 10.7554/eLife.01120; Bozzolan F, 2014, INSECT MOL BIOL, V23, P539, DOI 10.1111/imb.12100; Chen HL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114238; Choo YM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067794; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; Clyne PJ, 2000, SCIENCE, V287, P1830, DOI 10.1126/science.287.5459.1830; Costa-da-Silva AL, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-364; Dani FR, 2011, CHEM SENSES, V36, P335, DOI 10.1093/chemse/bjq137; Dippel S, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1141; Engsontia P, 2008, INSECT BIOCHEM MOLEC, V38, P387, DOI 10.1016/j.ibmb.2007.10.005; Feyereisen R, 2012, INSECT MOLECULAR BIOLOGY AND BIOCHEMISTRY, P236, DOI 10.1016/B978-0-12-384747-8.10008-X; Foret S, 2006, GENOME RES, V16, P1404, DOI 10.1101/gr.5075706; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; GRANT AJ, 1995, J COMP PHYSIOL A, V177, P389, DOI 10.1007/BF00187475; Grosse-Wilde E, 2011, P NATL ACAD SCI USA, V108, P7449, DOI 10.1073/pnas.1017963108; Gu SH, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-636; Gu XC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125159; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Heikertinger F, 1941, KOLEOPTEROLOGISCHE R, V27, P69; Heikertinger F, 1941, KOLEOPTEROLOGISCHE R, V27, P15; Hekmat-Scafe DS, 2002, GENOME RES, V12, P1357, DOI 10.1101/gr.239402; Iovinella I, 2011, J PROTEOME RES, V10, P3439, DOI 10.1021/pr2000754; Ishida Y, 2005, P NATL ACAD SCI USA, V102, P14075, DOI 10.1073/pnas.0505340102; Ishida Y, 2008, P NATL ACAD SCI USA, V105, P9076, DOI 10.1073/pnas.0802610105; Ishida Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051779; Jacquin-Joly E, 2001, CHEM SENSES, V26, P833, DOI 10.1093/chemse/26.7.833; Jin X, 2008, P NATL ACAD SCI USA, V105, P10996, DOI 10.1073/pnas.0803309105; Jones PL, 2011, P NATL ACAD SCI USA, V108, P8821, DOI 10.1073/pnas.1102425108; Jones WD, 2007, NATURE, V445, P86, DOI 10.1038/nature05466; Kain P, 2013, NATURE, V502, P507, DOI 10.1038/nature12594; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Keeling CI, 2013, INSECT BIOCHEM MOLEC, V43, P1142, DOI 10.1016/j.ibmb.2013.10.001; Kirkness EF, 2010, P NATL ACAD SCI USA, V107, P12168, DOI 10.1073/pnas.1003379107; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kwon JY, 2007, P NATL ACAD SCI USA, V104, P3574, DOI 10.1073/pnas.0700079104; LAZARD D, 1991, NATURE, V349, P790, DOI 10.1038/349790a0; Leal WS, 2013, P NATL ACAD SCI USA, V110, P18704, DOI 10.1073/pnas.1316059110; Leal WS, 2005, P NATL ACAD SCI USA, V102, P5386, DOI 10.1073/pnas.0501447102; Leal WS, 1999, FEBS LETT, V464, P85, DOI 10.1016/S0014-5793(99)01683-X; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li H, 2014, J INSECT SCI, V14, DOI 10.1093/jis/14.1.57; Li J, 2007, FUJIAN J AGR SCI, V22, P15; Li S, 2008, BIOCHEM BIOPH RES CO, V372, P464, DOI 10.1016/j.bbrc.2008.05.064; Li X, 2015, PLOS ONE, V10; Li XM, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2236-3; Liu CC, 2014, ARCH INSECT BIOCHEM, V85, P114, DOI 10.1002/arch.21150; Liu S, 2015, COMP BIOCHEM PHYS D, V13, P44, DOI 10.1016/j.cbd.2015.01.004; Liu YL, 2014, J EXP BIOL, V217, P1821, DOI 10.1242/jeb.102020; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maibeche-Coisne M, 2004, P NATL ACAD SCI USA, V101, P11459, DOI 10.1073/pnas.0403537101; Mameli M, 1996, INSECT BIOCHEM MOLEC, V26, P875, DOI 10.1016/S0965-1748(96)00055-0; Mamidala P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056555; Marinotti O, 2014, BMC DEV BIOL, V14, DOI 10.1186/1471-213X-14-15; Menuz K, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004810; Merlin C, 2005, BIOCHEM BIOPH RES CO, V332, P4, DOI 10.1016/j.bbrc.2005.04.084; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nei M, 2008, NAT REV GENET, V9, P951, DOI 10.1038/nrg2480; Nichols Z, 2008, INSECT BIOCHEM MOLEC, V38, P398, DOI 10.1016/j.ibmb.2007.11.003; Omondi BA, 2015, J EXP BIOL, V218, P2482, DOI 10.1242/jeb.116798; Pelosi P, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00320; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pitts RJ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-271; Potter CJ, 2014, CELL, V156, P878, DOI 10.1016/j.cell.2014.02.003; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Qiao R, 2009, J CHANGJIANG VEG, V6, P67; Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784; Rogers ME, 1999, J EXP BIOL, V202, P1625; Sandler BH, 2000, CHEM BIOL, V7, P143, DOI 10.1016/S1074-5521(00)00078-8; Scaloni A, 1999, BIOCHEM BIOPH RES CO, V266, P386, DOI 10.1006/bbrc.1999.1791; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Sun YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030040; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Vieira FG, 2011, GENOME BIOL EVOL, V3, P476, DOI 10.1093/gbe/evr033; Vogt R.G., 2005, P753; VOGT RG, 1985, P NATL ACAD SCI USA, V82, P8827, DOI 10.1073/pnas.82.24.8827; Vogt RG, 2009, INSECT BIOCHEM MOLEC, V39, P448, DOI 10.1016/j.ibmb.2009.03.007; Wan XL, 2015, SCI REP-UK, V5, DOI 10.1038/srep17320; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang Y, 2016, PLOS ONE, V11; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wei JL, 2008, HUNAN AGR SCI, V3, P108; Wojtasek H, 1999, FEBS LETT, V458, P333, DOI 10.1016/S0014-5793(99)01178-3; Xu PX, 2005, NEURON, V45, P193, DOI 10.1016/j.neuron.2004.12.031; Xu YL, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-632; Younus F, 2014, INSECT BIOCHEM MOLEC, V53, P30, DOI 10.1016/j.ibmb.2014.07.003; Zhang MX, 2000, PLANT PROT, V27, P1; Zhang YLV, 2013, SCIENCE, V340, P1334, DOI 10.1126/science.1234133; Zhou XH, 2013, BIOL CHEM, V394, P43, DOI 10.1515/hsz-2012-0114; Zhou XF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002930; Zhu JY, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/491748	101	31	36	5	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2016	11	4							e0153067	10.1371/journal.pone.0153067	http://dx.doi.org/10.1371/journal.pone.0153067			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0KH	27064483	Green Submitted, Green Published, gold			2022-12-27	WOS:000373891000027
J	Riu, M; Chiarello, P; Terradas, R; Sala, M; Garcia-Alzorriz, E; Castells, X; Grau, S; Cots, F				Riu, Marta; Chiarello, Pietro; Terradas, Roser; Sala, Maria; Garcia-Alzorriz, Enric; Castells, Xavier; Grau, Santiago; Cots, Francesc			Cost Attributable to Nosocomial Bacteremia. Analysis According to Microorganism and Antimicrobial Sensitivity in a University Hospital in Barcelona	PLOS ONE			English	Article							BLOOD-STREAM INFECTIONS; SUSCEPTIBLE STAPHYLOCOCCUS-AUREUS; CARE-ACQUIRED INFECTION; PSEUDOMONAS-AERUGINOSA; RISK-FACTORS; RESISTANT; IMPACT; INTERVENTION; LENGTH; STAY	Aim To calculate the incremental cost of nosocomial bacteremia caused by the most common organisms, classified by their antimicrobial susceptibility. Methods We selected patients who developed nosocomial bacteremia caused by Staphylococcus aureus, Escherichia coli, Klebsiella pneumoniae, or Pseudomonas aeruginosa. These microorganisms were analyzed because of their high prevalence and they frequently present multidrug resistance. A control group consisted of patients classified within the same allpatient refined-diagnosis related group without bacteremia. Our hospital has an established cost accounting system (full-costing) that uses activity-based criteria to analyze cost distribution. A logistic regression model was fitted to estimate the probability of developing bacteremia for each admission (propensity score) and was used for propensity score matching adjustment. Subsequently, the propensity score was included in an econometric model to adjust the incremental cost of patients who developed bacteremia, as well as differences in this cost, depending on whether the microorganism was multidrug-resistant or multidrug-sensitive. Results A total of 571 admissions with bacteremia matched the inclusion criteria and 82,022 were included in the control group. The mean cost was (sic)25,891 for admissions with bacteremia and (sic)6,750 for those without bacteremia. The mean incremental cost was estimated at (sic)15,151 (CI, (sic)11,570 to (sic)18,733). Multidrug-resistant P. aeruginosa bacteremia had the highest mean incremental cost, (sic)44,709 (CI, (sic)34,559 to (sic)54,859). Antimicrobial-susceptible E. coli nosocomial bacteremia had the lowest mean incremental cost, (sic)10,481 (CI, (sic)8,752 to (sic)12,210). Despite their lower cost, episodes of antimicrobial-susceptible E. coli nosocomial bacteremia had a major impact due to their high frequency. Conclusions Adjustment of hospital cost according to the organism causing bacteremia and antibiotic sensitivity could improve prevention strategies and allow their prioritization according to their overall impact and costs. Infection reduction is a strategy to reduce resistance.	[Riu, Marta; Chiarello, Pietro; Sala, Maria; Garcia-Alzorriz, Enric; Castells, Xavier; Cots, Francesc] IMIM Hosp Mar Med Res Inst, Barcelona, Spain; [Riu, Marta; Chiarello, Pietro; Terradas, Roser; Grau, Santiago] Univ Autonoma Barcelona, E-08193 Barcelona, Spain; [Terradas, Roser] Hosp del Mar, Sch Nursing, Barcelona, Spain; [Sala, Maria; Castells, Xavier] Hosp del Mar, Dept Epidemiol & Evaluat, Barcelona, Spain; [Sala, Maria; Castells, Xavier] Redissec Red Invest Serv Sanitarios Enfermedades, Madrid, Spain; [Grau, Santiago] Hosp del Mar, Dept Pharm, Barcelona, Spain	Institut Hospital del Mar d'Investigacions Mediques (IMIM); Autonomous University of Barcelona; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar	Riu, M (corresponding author), IMIM Hosp Mar Med Res Inst, Barcelona, Spain.; Riu, M (corresponding author), Univ Autonoma Barcelona, E-08193 Barcelona, Spain.	20138@hospitaldelmar.cat	Buron, Andrea/E-5705-2016; Castells, Xavier/S-7798-2016; Serra, Maria Sala/O-9420-2019; Sala, Maria/H-2562-2013	Buron, Andrea/0000-0003-3590-1303; Castells, Xavier/0000-0002-2528-0382; Serra, Maria Sala/0000-0002-9955-8746; Sala, Maria/0000-0002-9955-8746; Riu, Marta/0000-0003-4702-3472; Cots, Francesc/0000-0003-0238-8902; Chiarello, Pietro/0000-0001-7019-6000; Terradas-Robledo, Roser/0000-0002-7689-1183				Allue N, 2014, GAC SANIT, V28, P48, DOI 10.1016/j.gaceta.2013.06.004; Ben-David D, 2009, INFECT CONT HOSP EP, V30, P453, DOI 10.1086/596731; Beyersmann J, 2009, INFECT CONT HOSP EP, V30, P273, DOI 10.1086/596020; Burden AR, 2012, J CLIN ANESTH, V24, P555, DOI 10.1016/j.jclinane.2012.04.006; Carlet J., 2014, WORLD ALLIANCE ANTIB; Farinas MC, 2013, ENFERM INFEC MICR CL, V31, P402, DOI 10.1016/j.eimc.2013.03.016; Cohen B, 2010, MED CARE, V48, P767, DOI 10.1097/MLR.0b013e3181e358b9; Cots F, 2010, COST ACTIVITAT ASSIS; Cots F, 2012, GEST EVALUACION COST, V13, P369; Defez C, 2008, J HOSP INFECT, V68, P130, DOI 10.1016/j.jhin.2007.11.005; Disease EC for, 2009, BACT CHALL TIM REACT; European Centre for Disease Prevention and Control, 2012, ANT RES SURV EUR 201; Filice GA, 2010, INFECT CONT HOSP EP, V31, P365, DOI 10.1086/651094; Freixas N, 2013, CLIN MICROBIOL INFEC, V19, P838, DOI 10.1111/1469-0691.12049; Fukuda H, 2011, J HOSP INFECT, V77, P93, DOI 10.1016/j.jhin.2010.10.006; Ghadiri H, 2012, CRIT CARE RES PRACT, V2012, DOI 10.1155/2012/890797; Goto M, 2013, CLIN MICROBIOL INFEC, V19, P501, DOI 10.1111/1469-0691.12195; Graves N, 2007, INFECT CONT HOSP EP, V28, P280, DOI 10.1086/512642; Greene LLR, 2013, INFECT CONTROL TODAY; Harbarth S, 2003, J HOSP INFECT, V54, P258, DOI 10.1016/S0195-6701(03)00150-6; Hoenigl M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104702; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Instituto Nacional de Estadistica, IND PREC CONS; Jensen US, 2011, CLIN MICROBIOL INFEC, V17, P1148, DOI 10.1111/j.1469-0691.2011.03587.x; Kilgore Meredith, 2008, Am J Infect Control, V36, DOI 10.1016/j.ajic.2008.10.004; Kurth T, 2006, AM J EPIDEMIOL, V163, P262, DOI 10.1093/aje/kwj047; Lautenbach E, 2010, INFECT CONT HOSP EP, V31, P47, DOI 10.1086/649021; Lee SY, 2006, INFECT CONT HOSP EP, V27, P1226, DOI 10.1086/507962; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Morales E, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-122; Neidell MJ, 2012, CLIN INFECT DIS, V55, P807, DOI 10.1093/cid/cis552; Nielsen KL, 2012, J ANTIMICROB CHEMOTH, V67, P1325, DOI 10.1093/jac/dks051; Park SY, 2011, INFECTION, V39, P141, DOI 10.1007/s15010-011-0100-1; Pirson M, 2005, J HOSP INFECT, V59, P33, DOI 10.1016/j.jhin.2004.07.006; Pronovost P, 2006, NEW ENGL J MED, V355, P2725, DOI 10.1056/NEJMoa061115; Riu M, 2015, ENFERM INFEC MICR CL, P5; Riu M, 2012, ENFERM INFEC MICR CL, V30, P137, DOI 10.1016/j.eimc.2011.11.006; Roberts RR, 2010, MED CARE, V48, P1026, DOI 10.1097/MLR.0b013e3181ef60a2; Roberts RR, 2009, CLIN INFECT DIS, V49, P1175, DOI 10.1086/605630; Rodriguez-Bano J, 2010, J CLIN MICROBIOL, V48, P1726, DOI 10.1128/JCM.02353-09; Rubio-Terres C, 2010, CLIN MICROBIOL INFEC, V16, P722, DOI 10.1111/j.1469-0691.2009.02902.x; Schwaber MJ, 2007, J ANTIMICROB CHEMOTH, V60, P913, DOI 10.1093/jac/dkm318; Septimus E, 2014, INFECT CONT HOSP EP, V35, P797, DOI [10.1086/676535, 10.1017/S0899823X00193808]; Tansarli GS, 2013, EXPERT REV ANTI-INFE, V11, P321, DOI [10.1586/eri.13.4, 10.1586/ERI.13.4]; Terradas R, 2011, ENFERM INFEC MICR CL, V29, P14, DOI 10.1016/j.eimc.2010.06.007; US Department of Health and Human Services Centers for Disease Control and Prevention., 2013, ANT RES THREATS US; Yilmaz G, 2007, INFECT CONT HOSP EP, V28, P689, DOI 10.1086/517976	47	20	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153076	10.1371/journal.pone.0153076	http://dx.doi.org/10.1371/journal.pone.0153076			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27055117	Green Published, gold			2022-12-27	WOS:000373608000072
J	Shah, JS; Soon, PS; Marsh, DJ				Shah, Jaynish S.; Soon, Patsy S.; Marsh, Deborah J.			Comparison of Methodologies to Detect Low Levels of Hemolysis in Serum for Accurate Assessment of Serum microRNAs	PLOS ONE			English	Article							CIRCULATING MICRORNAS; OVARIAN-CANCER; POTENTIAL BIOMARKER; BODY-FLUIDS; PLASMA; SIGNATURES; IDENTIFICATION; QUALITY; GENES	microRNAs have emerged as powerful regulators of many biological processes, and their expression in many cancer tissues has been shown to correlate with clinical parameters such as cancer type and prognosis. Present in a variety of biological fluids, microRNAs have been described as a 'gold mine' of potential noninvasive biomarkers. Release of microRNA content of blood cells upon hemolysis dramatically alters the microRNA profile in blood, potentially affecting levels of a significant number of proposed biomarker microRNAs and, consequently, accuracy of serum or plasma-based tests. Several methods to detect low levels of hemolysis have been proposed; however, a direct comparison assessing their sensitivities is currently lacking. In this study, we evaluated the sensitivities of four methods to detect hemolysis in serum (listed in the order of sensitivity): measurement of hemoglobin using a Coulter (R) AcT diff (TM) Analyzer, visual inspection, the absorbance of hemoglobin measured by spectrophotometry at 414 nm and the ratio of red blood cell-enriched miR-451a to the reference microRNA miR-23a-3p. The miR ratio detected hemolysis down to approximately 0.001%, whereas the Coulter (R) AcT diff (TM) Analyzer was unable to detect hemolysis lower than 1%. The spectrophotometric method could detect down to 0.004% hemolysis, and correlated with the miR ratio. Analysis of hemolysis in a cohort of 86 serum samples from cancer patients and healthy controls showed that 31 of 86 (36%) were predicted by the miR ratio to be hemolyzed, whereas only 8 of these samples (9%) showed visible pink discoloration. Using receiver operator characteristic (ROC) analyses, we identified absorbance cutoffs of 0.072 and 0.3 that could identify samples with low and high levels of hemolysis, respectively. Overall, this study will assist researchers in the selection of appropriate methodologies to test for hemolysis in serum samples prior to quantifying expression of microRNAs.	[Shah, Jaynish S.; Marsh, Deborah J.] Univ Sydney, Royal N Shore Hosp, Kolling Inst Med Res, Hormones & Canc Grp, St Leonards, NSW 2065, Australia; [Soon, Patsy S.] Univ New S Wales, South Western Sydney Clin Sch, POB 1, Kensington, NSW 2033, Australia; [Soon, Patsy S.] Bankstown Hosp, Dept Surg, Bankstown, NSW, Australia; [Soon, Patsy S.] Liverpool Hosp, Ingham Inst Appl Med Res, Med Oncol Grp, Liverpool, NSW, Australia	Royal North Shore Hospital; University of Sydney; Kolling Institute of Medical Research; University of New South Wales Sydney; Ingham Institute for Applied Medical Research; Liverpool Hospital	Marsh, DJ (corresponding author), Univ Sydney, Royal N Shore Hosp, Kolling Inst Med Res, Hormones & Canc Grp, St Leonards, NSW 2065, Australia.	deborah.marsh@sydney.edu.au	Marsh, Deborah J/I-1491-2014	Marsh, Deborah J/0000-0001-5899-4931; Shah, Jaynish/0000-0002-1089-7355	Ovarian Cancer Research Foundation (Australia); University of Sydney Cancer Research Fund; Australian Postgraduate Award; Northern Clinical School Top-Up Scholarship; Australian Research Council (ARC) [FT100100489]; National Health and Medical Research Council (NHMRC) [APP1004799]	Ovarian Cancer Research Foundation (Australia); University of Sydney Cancer Research Fund(University of Sydney); Australian Postgraduate Award(Australian Government); Northern Clinical School Top-Up Scholarship; Australian Research Council (ARC)(Australian Research Council); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by Ovarian Cancer Research Foundation (Australia) and the University of Sydney Cancer Research Fund [DJM] (http://www.ocrf.com.au/); Australian Postgraduate Award and Northern Clinical School Top-Up Scholarship [JSS]; Australian Research Council (ARC) (ARC Future Fellowship [FT100100489]) and National Health and Medical Research Council (NHMRC) (NHMRC Senior Research Fellowship [APP1004799]) [DJM]. (http://www.arc.gov.au) & (https://www.nhmrc.gov.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Becker N, 2013, CLIN BIOCHEM, V46, P861, DOI 10.1016/j.clinbiochem.2013.02.015; Blondal T, 2013, METHODS, V59, pS1, DOI 10.1016/j.ymeth.2012.09.015; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chang KH, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-173; Cortez MA, 2011, NAT REV CLIN ONCOL, V8, P467, DOI 10.1038/nrclinonc.2011.76; Cortez MA, 2009, EXPERT OPIN BIOL TH, V9, P703, DOI [10.1517/14712590902932889, 10.1517/14712590902932889 ]; Davoren PA, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-76; Ding XF, 2012, MOL MED REP, V5, P1428, DOI 10.3892/mmr.2012.838; Hawkins RC, 2010, CLIN CHEM LAB MED, V48, P1049, DOI 10.1515/CCLM.2010.224; Iorio MV, 2007, CANCER RES, V67, P8699, DOI 10.1158/0008-5472.CAN-07-1936; Kirschner Michaela B., 2013, Frontiers in Genetics, V4, P94, DOI 10.3389/fgene.2013.00094; Kirschner MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024145; Kosaka N, 2010, CANCER SCI, V101, P2087, DOI 10.1111/j.1349-7006.2010.01650.x; Lin SB, 2015, NAT REV CANCER, V15, P321, DOI 10.1038/nrc3932; Lippi G, 2009, CLIN CHEM LAB MED, V47, P616, DOI 10.1515/CCLM.2009.132; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; McDonald JS, 2011, CLIN CHEM, V57, P833, DOI 10.1373/clinchem.2010.157198; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; NOE DA, 1984, CLIN CHEM, V30, P627; Pritchard CC, 2012, CANCER PREV RES, V5, P492, DOI 10.1158/1940-6207.CAPR-11-0370; Qiu ZH, 2014, EXPERT OPIN INV DRUG, V23, P347, DOI 10.1517/13543784.2014.867327; Resnick KE, 2009, GYNECOL ONCOL, V112, P55, DOI 10.1016/j.ygyno.2008.08.036; Schickel R, 2008, ONCOGENE, V27, P5959, DOI 10.1038/onc.2008.274; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Taylor DD, 2008, GYNECOL ONCOL, V110, P13, DOI 10.1016/j.ygyno.2008.04.033; Turchinovich A, 2011, NUCLEIC ACIDS RES; Vickers KC, 2011, NAT CELL BIOL, V13, P423, DOI 10.1038/ncb2210; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang J, 2014, MOLECULES, V19, P1912, DOI 10.3390/molecules19021912; Weber JA, 2010, CLIN CHEM, V56, P1733, DOI 10.1373/clinchem.2010.147405; Witwer KW, 2015, CLIN CHEM, V61, P56, DOI 10.1373/clinchem.2014.221341	32	117	118	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153200	10.1371/journal.pone.0153200	http://dx.doi.org/10.1371/journal.pone.0153200			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27054342	Green Published, Green Submitted, gold			2022-12-27	WOS:000373608000099
J	Zhu, H				Zhu, Hua			Biogeographical Evidences Help Revealing the Origin of Hainan Island	PLOS ONE			English	Article							PLANT GEOGRAPHY; CHINA; CONSERVATION; EOCENE; CEYLON; BASIN; LIGHT	Both the continental or island origin of Hainan, and the Indo-Malaysian or East Asian affinity of its flora, are debatable. In this study, 196 families, 1283 genera and 3894 species of Hainan plants were recognized. Patterns of seed plant distribution were quantified at the generic and the family levels. The floras of Vietnam, and the adjacent Guangxi and Guangdong provinces of mainland China, were compared with Hainan. The results showed that the flora of Hainan Island is dominated by families and genera with tropical distributions. Among its floristic elements, tropical Asian distributions make up 23.85% of the total flora, while East Asian distributions contribute only 3.74%. There are only 7 genera and c. 10% of species endemic to Hainan Island. The Hainan flora has strong similarities to the flora of Vietnam at the family and the generic levels, and also to the flora of Guangxi, but less with the adjacent Guangdong province. The main conclusions are: Hainan's flora is tropical in nature with a strongly tropical Asian affinity, and it has very low endemism at the generic and species levels, which implies a continental origin. We conjecture that Hainan Island could have been adjacent to northern Vietnam and the Guangxi at least in Eocene. This suggestion is supported by palaeobotanical, palaeomagnetic and volcanism studies.	[Zhu, Hua] Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Ctr Integrat Conservat, Kunming, Yunnan, Peoples R China	Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS	Zhu, H (corresponding author), Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Ctr Integrat Conservat, Kunming, Yunnan, Peoples R China.	zhuh@xtbg.ac.cn	Hua, Zhu/AFO-6233-2022		National Natural Science Foundation of China [41471051, 41071040, 31170195]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Science Foundation of China, No. 41471051, 41071040, 31170195.	ASHTON PS, 1987, J BIOGEOGR, V14, P249, DOI 10.2307/2844895; Balakrishnan CN, 2003, MOL ECOL, V12, P1, DOI 10.1046/j.1365-294X.2003.01751.x; Carlquist S, 1980, HAWAII NATURAL HIST; Chan L. T., 1999, SOME BASIC CHARACTER; Chase MW, 2009, BOT J LINN SOC, V161, P122, DOI 10.1111/j.1095-8339.2009.01002.x; Chu X. N., 1996, FEED IND MAGAZINE, V17, P17; Francisco-Ortega J, 2010, BOT REV, V76, P295, DOI 10.1007/s12229-010-9054-8; Francisco-Ortega J, 2010, BOT REV, V76, P346, DOI 10.1007/s12229-010-9055-7; [付璐露 FU Lulu], 2010, [地质学报, Acta Geologica Sinica], V84, P183; Guangdong Institute of Botany, 1976, VEG GUANGD, P41; GUNATILLEKE CVS, 1987, J BIOGEOGR, V14, P295, DOI 10.2307/2844940; GUNATILLEKE IAUN, 1990, CONSERV BIOL, V4, P21, DOI 10.1111/j.1523-1739.1990.tb00262.x; Guo K, 2014, FLORA VEGETATION GEO; Haston E, 2009, BOT J LINN SOC, V161, P128, DOI 10.1111/j.1095-8339.2009.00996.x; Jin Jian-hua, 2008, Xibei Zhiwu Xuebao, V28, P2125; Jin JH, 2009, REV PALAEOBOT PALYNO, V155, P80, DOI 10.1016/j.revpalbo.2009.02.003; Jin JH, 2009, REV PALAEOBOT PALYNO, V153, P150, DOI 10.1016/j.revpalbo.2008.07.010; LI ZX, 1995, GEOPHYS RES LETT, V22, P3071, DOI 10.1029/95GL03169; Liang G.H., 2013, ACTA GEOL SIN-ENGL, V87, P73; Lin XD., 1987, TROPICAL GEOGRAPHY Q, V7, P338; Liu YY, 1999, TECTONOPHYSICS, V301, P133, DOI 10.1016/S0040-1951(98)00216-9; [马云 Ma Yun], 2014, [吉林大学学报. 地球科学版, Journal of Jilin University. Earth Science Edition], V44, P1727; McShea WJ, 2005, BIOL CONSERV, V125, P101, DOI 10.1016/j.biocon.2005.03.013; Mo YQ., 1987, J NANJING UNIV NAT S, V23, P521; Qin HN, 2010, CHECKLIST VASCULAR P, P1; RANGIN C, 1995, TECTONOPHYSICS, V243, P209, DOI 10.1016/0040-1951(94)00207-P; Wu CY., 1996, P 1 INT S FLOR CHAR, P3, DOI DOI 10.1111/JSE.12037; Wu TeLin, 1996, Journal of Tropical and Subtropical Botany, V4, P1; Wu Z.Y., 2006, AREAL TYPES SEED PLA; Wu .Z.Y., 2010, FLORISTICS SEED PLAN; Wu Zheng-Yi, 2003, Acta Botanica Yunnanica, V25, P245; Wu Zhongliang, 1991, Acta Seismologica Sinica, V13, P1; Xing FW, 2012, INVENTORY PLANT SPEC, P1; Yan P, 2006, J ASIAN EARTH SCI, V27, P647, DOI 10.1016/j.jseaes.2005.06.005; Yao Q.Y., 1980, PHYSL MOL PLANT P GE, V1, P21; Yao YF, 2009, CLIMATIC CHANGE, V92, P169, DOI 10.1007/s10584-008-9457-2; Ye HG, 2005, CHECKLIST GUANGDONG, P1; Zhang CC, 1983, ACTA SCI NATURALIUM, V1983, P67; Zhang H., 1990, NE SEISMOLOGICAL RES, V6, P63; Zhang HD, 2001, ECOLOGIC SCI, V20, P1; Zhang HN, 1987, ACTA OCEANOL SIN, V9, P594; Zhang JW, 2015, REV PALAEOBOT PALYNO, V215, P57, DOI 10.1016/j.revpalbo.2014.11.006; Zhao Huan-ting, 2007, Marine Geology & Quaternary Geology, V27, P33; [赵炜 ZHAO Wei], 2009, [吉林大学学报. 地球科学版, Journal of Jilin University. Earth Science Edition], V39, P379; Zhu H., 2004, Telopea, V10, P639; [朱华 Zhu Hua], 2003, [中山大学学报. 自然科学版, Acta Scientiarum Naturalium Universitatis Sunyatseni], V42, P98	46	55	67	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0151941	10.1371/journal.pone.0151941	http://dx.doi.org/10.1371/journal.pone.0151941			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27055236	gold, Green Published, Green Submitted			2022-12-27	WOS:000373608000009
J	Suntharalingam, S; Stecker, FF; Guberina, N; Ringelstein, A; Schlosser, T; Theysohn, JM; Forsting, M; Nassenstein, K				Suntharalingam, Saravanabavaan; Stecker, Franz Ferdinand; Guberina, Nika; Ringelstein, Adrian; Schlosser, Thomas; Theysohn, Jens Matthias; Forsting, Michael; Nassenstein, Kai			How Much Is the Dose Varying between Follow-Up CT-Examinations Performed on the Same Scanner with the Same Imaging Protocol?	PLOS ONE			English	Article							DIAGNOSTIC REFERENCE LEVELS; TUBE VOLTAGE SELECTION; COMPUTED-TOMOGRAPHY; QUALITY; REDUCTION; OPTIMIZATION; ANGIOGRAPHY; STRATEGIES; IMPACT	Purpose To investigate the dose variation between follow-up CT examinations, when a patient is examined several times on the same scanner with the identical scan protocol which comprised automated exposure control. Material and Methods This retrospective study was approved by the local ethics committee. The volume computed tomography dose index (CTDIvol) and the dose-length-product (DLP) were recorded for 60 cancer patients (29 male, 31 female, mean age 60.1 years), who received 3 follow-up CT examinations each composed of a non-enhanced scan of the liver (LI-CT) and a contrast-enhanced scan of chest (CH-CT) and abdomen (AB-CT). Each examination was performed on the same scanner (Siemens Definition FLASH) equipped with automated exposure control (CARE Dose 4D and CARE KV) using the identical scan protocol. Results The median percentage difference in DLP between follow-up examinations was 9.6% for CH-CT, 10.3% for LI-CT, and 10.1% for AB-CT; the median percentage difference in CTDIvol 8.3% for CH-CT, 7.4% for LI-CT and 7.7% for AB-CT (p<0.0001 for all values). The maximum difference in DLP between follow-up examinations was 67.5% for CH-CT, 50.8% for LI-CT and 74.3% for AB-CT; the maximum difference in CTDIvol 62.9% for CH-CT, 47.2% for LI-CT, and 49% for AB-CT. Conclusion A significant variance in the radiation dose occurs between follow-up CT examinations when the same CT scanner and the identical imaging protocol are used in combination with automated exposure control.	[Suntharalingam, Saravanabavaan; Stecker, Franz Ferdinand; Guberina, Nika; Ringelstein, Adrian; Schlosser, Thomas; Theysohn, Jens Matthias; Forsting, Michael; Nassenstein, Kai] Univ Hosp Essen, Dept Diagnost & Intervent Radiol & Neuroradiol, Essen, Germany	University of Duisburg Essen	Suntharalingam, S (corresponding author), Univ Hosp Essen, Dept Diagnost & Intervent Radiol & Neuroradiol, Essen, Germany.	Saravanabavaan.Suntharalingam@uk-essen.de						Aldrich JE, 2006, CAN ASSOC RADIOL J, V57, P79; American Association of Physicists in Medicine (AAPM), 2011, REPORT AAPM TASK GRO; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Christner JA, 2010, AM J ROENTGENOL, V194, pW49, DOI 10.2214/AJR.09.2878; Dougeni E, 2012, EUR J RADIOL, V81, pE665, DOI 10.1016/j.ejrad.2011.05.025; Frellesen C, 2014, EUR RADIOL, V24, P1725, DOI 10.1007/s00330-014-3197-7; Harri PA, 2014, AM J ROENTGENOL, V203, P377, DOI 10.2214/AJR.13.11608; Hatziioannou K, 2003, BRIT J RADIOL, V76, P541, DOI 10.1259/bjr/60897046; Ibrahim M, 2014, AM J NEURORADIOL, V35, P619, DOI 10.3174/ajnr.A3473; Kaasalainen T, 2014, AM J ROENTGENOL, V203, P123, DOI 10.2214/AJR.13.12028; Kalra MK, 2004, RADIOLOGY, V230, P619, DOI 10.1148/radiol.2303021726; Koller CJ, 2003, BRIT J RADIOL, V76, P798, DOI 10.1259/bjr/33117342; Kordolaimi SD, 2013, J COMPUT ASSIST TOMO, V37, P924, DOI 10.1097/RCT.0b013e318282d95a; Krazinski AW, 2014, EUR RADIOL, V24, P2677, DOI 10.1007/s00330-014-3312-9; Lee EJ, 2009, AM J NEURORADIOL, V30, P1754, DOI 10.3174/ajnr.A1675; Lee S, 2011, ACTA RADIOL, V52, P1101, DOI 10.1258/ar.2011.100295; Marin JR, 2015, ACAD EMERG MED, V22, P1499, DOI 10.1111/acem.12822; McNitt-Gray MF, 2002, RADIOGRAPHICS, V22, P1541, DOI 10.1148/rg.226025128; Menke J, 2005, RADIOLOGY, V236, P565, DOI 10.1148/radiol.2362041327; Mettler FA, 2009, RADIOLOGY, V253, P520, DOI 10.1148/radiol.2532082010; NRCP National Council on Radiation Protection and Measurements, 2009, 160 NRCP; Raman SP, 2013, J AM COLL RADIOL, V10, P37, DOI 10.1016/j.jacr.2012.06.025; Russell MT, 2008, AM J NEURORADIOL, V29, P727, DOI 10.3174/ajnr.A0891; Schneider A, 2010, DTSCH ARZTEBL INT, V107, P776, DOI [10.3238/arztebl.2010.0799, 10.3238/arztebl.2010.0776]; Schueller-Weidekamm C, 2006, RADIOLOGY, V241, P899, DOI 10.1148/radiol.2413040128; Shrimpton PC, 2006, BRIT J RADIOL, V79, P968, DOI 10.1259/bjr/93277434; Tzedakis A, 2005, MED PHYS, V32, P1621, DOI 10.1118/1.1924309; Verdun FR, 2008, EUR RADIOL, V18, P1980, DOI 10.1007/s00330-008-0963-4; Winklehner A, 2015, EUR RADIOL, V25, P2346, DOI 10.1007/s00330-015-3632-4; Winklehner A, 2011, EUR RADIOL, V21, P2521, DOI 10.1007/s00330-011-2227-y	30	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0152961	10.1371/journal.pone.0152961	http://dx.doi.org/10.1371/journal.pone.0152961			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050659	Green Submitted, Green Published, gold			2022-12-27	WOS:000373603500072
J	Bernard, JB; Aguilar, C; Castet, E				Bernard, Jean-Baptiste; Aguilar, Carlos; Castet, Eric			A New Font, Specifically Designed for Peripheral Vision, Improves Peripheral Letter and Word Recognition, but Not Eye-Mediated Reading Performance	PLOS ONE			English	Article							LETTER IDENTIFICATION; SIMULATED SCOTOMAS; VISUAL SPAN; SPEED; PSYCHOPHYSICS; CONFUSION; SIMILARITY; LEGIBILITY; CHARACTERS; MOVEMENTS	Reading speed is dramatically reduced when readers cannot use their central vision. This is because low visual acuity and crowding negatively impact letter recognition in the periphery. In this study, we designed a new font (referred to as the Eido font) in order to reduce inter-letter similarity and consequently to increase peripheral letter recognition performance. We tested this font by running five experiments that compared the Eido font with the standard Courier font. Letter spacing and x-height were identical for the two monospaced fonts. Six normally-sighted subjects used exclusively their peripheral vision to run two aloud reading tasks (with eye movements), a letter recognition task (without eye movements), a word recognition task (without eye movements) and a lexical decision task. Results show that reading speed was not significantly different between the Eido and the Courier font when subjects had to read single sentences with a round simulated gaze-contingent central scotoma (10 degrees diameter). In contrast, Eido significantly decreased perceptual errors in peripheral crowded letter recognition (-30% errors on average for letters briefly presented at 6 degrees eccentricity) and in peripheral word recognition (-32% errors on average for words briefly presented at 6 degrees eccentricity).	[Bernard, Jean-Baptiste; Aguilar, Carlos; Castet, Eric] Aix Marseille Univ, Marseille, France; [Bernard, Jean-Baptiste; Aguilar, Carlos; Castet, Eric] CNRS, Lab Psychol Cognit, UMR 7920, Federat Rech 3C, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Bernard, JB (corresponding author), Aix Marseille Univ, Marseille, France.; Bernard, JB (corresponding author), CNRS, Lab Psychol Cognit, UMR 7920, Federat Rech 3C, Marseille, France.	jean-baptiste.bernard@univ-amu.fr			Agence Nationale de la recherche low vision [ANR-11-BSH2-0005]; ANR low vision [ANR-11-BSH2-0005]	Agence Nationale de la recherche low vision(French National Research Agency (ANR)); ANR low vision(French National Research Agency (ANR))	This study was funded by: Agence Nationale de la recherche low vision ANR-11-BSH2-0005; This work was supported by the ANR low vision ANR-11-BSH2-0005.	Aguilar C, 2011, VISION RES, V51, P997, DOI 10.1016/j.visres.2011.02.010; Beckmann PJ, 2002, J OPT SOC AM A, V19, P2349, DOI 10.1364/JOSAA.19.002349; Bernard JB, 2007, VISION RES, V47, P3447, DOI 10.1016/j.visres.2007.10.005; Bernard JB, 2013, VISION RES, V84, P33, DOI 10.1016/j.visres.2013.03.005; Bernard JB, 2012, VISION RES, V66, P17, DOI 10.1016/j.visres.2012.06.012; Bernard JB, 2011, J VISION, V11, DOI 10.1167/11.8.1; Blackmore-Wright S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080325; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; BOUMA H, 1971, VISION RES, V11, P459, DOI 10.1016/0042-6989(71)90087-3; BOUMA H, 1970, NATURE, V226, P177, DOI 10.1038/226177a0; Calabrese A, 2014, INVEST OPHTH VIS SCI, V55, P3638, DOI 10.1167/iovs.13-13408; Carver R. P., 1990, READING RATE REV RES; Chanceaux M, 2014, J VISION, V14, DOI 10.1167/14.6.7; Cheung SH, 2005, VISUAL NEUROSCI, V22, P187, DOI 10.1017/S0952523805222071; Cheung SH, 2008, INVEST OPHTH VIS SCI, V49, P828, DOI 10.1167/iovs.07-0555; Chung STL, 2004, OPTOMETRY VISION SCI, V81, P525, DOI 10.1097/00006324-200407000-00014; Chung STL, 2004, VISION RES, V44, P695, DOI 10.1016/j.visres.2003.09.028; Chung STL, 2002, INVEST OPHTH VIS SCI, V43, P1270; Chung STL, 1998, VISION RES, V38, P2949, DOI 10.1016/S0042-6989(98)00072-8; Chung STL, 2012, OPTOMETRY VISION SCI, V89, P1288, DOI 10.1097/OPX.0b013e318264c9dd; Chung STL, 2009, VISION RES, V49, P2782, DOI 10.1016/j.visres.2009.08.013; Coates D, 2013, AM AC OPHT ANN M OCT; COLTHEART M, 1974, B PSYCHONOMIC SOC, V3, P102; DUNNRANK.P, 1968, J VERB LEARN VERB BE, V7, P990, DOI 10.1016/S0022-5371(68)80057-X; Freeman J, 2012, ATTEN PERCEPT PSYCHO, V74, P379, DOI 10.3758/s13414-011-0229-0; Fromer R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121986; Gauthier I, 2006, PERCEPTION, V35, P541, DOI 10.1068/p5313; GERVAIS MJ, 1984, J EXP PSYCHOL HUMAN, V10, P655, DOI 10.1037/0096-1523.10.5.655; GEYER LH, 1977, PERCEPT PSYCHOPHYS, V22, P487, DOI 10.3758/BF03199515; GEYER LH, 1973, PERCEPT PSYCHOPHYS, V14, P471, DOI 10.3758/BF03211185; GRAINGER J, 1990, J MEM LANG, V29, P228, DOI 10.1016/0749-596X(90)90074-A; Harrison WJ, 2013, J NEUROSCI, V33, P2927, DOI 10.1523/JNEUROSCI.4172-12.2013; Higgins E, 2015, ATTEN PERCEPT PSYCHO, V77, P3, DOI 10.3758/s13414-014-0751-y; KUENNAPA.T, 1969, PERCEPT MOTOR SKILL, V28, P3, DOI 10.2466/pms.1969.28.1.3; LEGGE GE, 1985, VISION RES, V25, P239, DOI 10.1016/0042-6989(85)90117-8; LEGGE GE, 1989, OPTOMETRY VISION SCI, V66, P843, DOI 10.1097/00006324-198912000-00008; Legge GE, 2001, VISION RES, V41, P725, DOI 10.1016/S0042-6989(00)00295-9; Legge GE, 2007, J VISION, V7, DOI 10.1167/7.2.9; Legge GE, 2011, J VISION, V11, DOI 10.1167/11.5.8; Levi DM, 2008, VISION RES, V48, P635, DOI 10.1016/j.visres.2007.12.009; Liu L, 2001, OPTOMETRY VISION SCI, V78, P50, DOI 10.1097/00006324-200101010-00014; LOOMIS JM, 1982, PERCEPT PSYCHOPHYS, V31, P41, DOI 10.3758/BF03206199; MacKeben M, 2000, VISUAL IMPAIRMENT RE, V2, P95, DOI [10.1076/vimr.2.2.95.4427, DOI 10.1076/VIMR.2.2.95.4427]; MCCONKIE GW, 1975, PERCEPT PSYCHOPHYS, V17, P578, DOI 10.3758/BF03203972; Mueller ST, 2012, ACTA PSYCHOL, V139, P19, DOI 10.1016/j.actpsy.2011.09.014; Paterson KB, 2010, MEM COGNITION, V38, P502, DOI 10.3758/MC.38.4.502; Pelli DG, 2007, J VISION, V7, DOI 10.1167/7.2.i; Pelli DG, 2006, VISION RES, V46, P4646, DOI 10.1016/j.visres.2006.04.023; Pelli DG, 2004, J VISION, V4, P1136, DOI 10.1167/4.12.12; Pelli DG, 2003, NATURE, V423, P752, DOI 10.1038/nature01516; Perea M, 2015, COGNITION, V142, P39, DOI 10.1016/j.cognition.2015.05.007; Pinheiro J, 2000, MIXED EFFECTS MODELS; R Core Team, 2021, R LANGUAGE ENV STAT; Reich LN, 2000, OPTOMETRY VISION SCI, V77, P270, DOI 10.1097/00006324-200005000-00014; Reingold EM, 2010, J EXP PSYCHOL HUMAN, V36, P1677, DOI 10.1037/a0019959; Risse S, 2014, J VISION, V14, DOI 10.1167/14.8.11; Sanocki T, 2012, ATTEN PERCEPT PSYCHO, V74, P132, DOI 10.3758/s13414-011-0220-9; Scherlen AC, 2008, VISION RES, V48, P1870, DOI 10.1016/j.visres.2008.06.005; Schotter ER, 2012, ATTEN PERCEPT PSYCHO, V74, P5, DOI 10.3758/s13414-011-0219-2; STRASBURGER H, 1991, PERCEPT PSYCHOPHYS, V49, P495, DOI 10.3758/BF03212183; Strasburger H, 2005, J VISION, V5, P1024, DOI 10.1167/5.11.8; Strasburger H, 2013, J VISION, V13, DOI 10.1167/13.1.24; Wang H, 2014, J VISION, V14, DOI 10.1167/14.8.6; Watson AB, 2012, J VISION, V12, DOI 10.1167/12.10.19; Watson AB, 2008, J VISION, V8, DOI 10.1167/8.4.17; WHITE JM, 1990, INVEST OPHTH VIS SCI, V31, P1149; WHITTAKER SG, 1991, VISION RES, V31, P2209, DOI 10.1016/0042-6989(91)90173-3; Yu DY, 2014, J VISION, V14, DOI 10.1167/14.6.3; Yu DY, 2010, VISION RES, V50, P860, DOI 10.1016/j.visres.2010.02.006; Yu DY, 2007, J VISION, V7, DOI 10.1167/7.2.2; Zhang JY, 2007, INVEST OPHTH VIS SCI, V48, P2383, DOI 10.1167/iovs.06-1195; Zhang JY, 2012, J VISION, V12, DOI 10.1167/12.7.5	72	19	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0152506	10.1371/journal.pone.0152506	http://dx.doi.org/10.1371/journal.pone.0152506			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ3UC	27074013	Green Published, Green Submitted, gold			2022-12-27	WOS:000374131200028
J	Yang, RY; Xue, HT; Yu, L; Velayos-Baeza, A; Monaco, AP; Liu, FT				Yang, Ri-Yao; Xue, Huiting; Yu, Lan; Velayos-Baeza, Antonio; Monaco, Anthony P.; Liu, Fu-Tong			Identification of VPS13C as a Galectin-12-Binding Protein That Regulates Galectin-12 Protein Stability and Adipogenesis	PLOS ONE			English	Article							QUALITY-CONTROL; LIPID DROPLETS; TRANSCRIPTIONAL COMPLEX; INSULIN-RESISTANCE; GLYCEMIC TRAITS; AUTOPHAGY; CELLS; EXPRESSION; SECRETION; DISEASE	Galectin-12, a member of the galectin family of beta-galactoside-binding animal lectins, is preferentially expressed in adipocytes and required for adipocyte differentiation in vitro. This protein was recently found to regulate lipolysis, whole body adiposity, and glucose homeostasis in vivo. Here we identify VPS13C, a member of the VPS13 family of vacuolar protein sorting-associated proteins highly conserved throughout eukaryotic evolution, as a major galectin-12-binding protein. VPS13C is upregulated during adipocyte differentiation, and is required for galectin-12 protein stability. Knockdown of Vps13c markedly reduces the steady-state levels of galectin-12 by promoting its degradation through primarily the lysosomal pathway, and impairs adipocyte differentiation. Our studies also suggest that VPS13C may have a broader role in protein quality control. The regulation of galectin-12 stability by VPS13C could potentially be exploited for therapeutic intervention of obesity and related metabolic diseases.	[Yang, Ri-Yao; Xue, Huiting; Yu, Lan; Liu, Fu-Tong] Univ Calif Davis, Sch Med, Dept Dermatol, Sacramento, CA 95817 USA; [Xue, Huiting] NE Normal Univ, Sch Life Sci, Changchun 130024, Peoples R China; [Velayos-Baeza, Antonio; Monaco, Anthony P.] Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Liu, Fu-Tong] Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan; [Yang, Ri-Yao] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA	University of California System; University of California Davis; Northeast Normal University - China; University of Oxford; Wellcome Centre for Human Genetics; Academia Sinica - Taiwan; University of Texas System; UTMD Anderson Cancer Center	Yang, RY; Liu, FT (corresponding author), Univ Calif Davis, Sch Med, Dept Dermatol, Sacramento, CA 95817 USA.; Liu, FT (corresponding author), Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan.; Yang, RY (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA.	ryang@mdanderson.org; ftliu@ibms.sinica.edu.tw	Yang, Riyao/R-7593-2019; Liu, FU-TONG/A-5749-2019; Velayos-Baeza, Antonio/K-6310-2019; Monaco, Anthony P/A-4495-2010	Yang, Riyao/0000-0002-0278-4385; Liu, FU-TONG/0000-0002-3354-1001; Velayos-Baeza, Antonio/0000-0002-7717-4477; Monaco, Anthony P/0000-0001-7480-3197	National Institutes of Health [R01 AI020958, R01 AR56343]; Harrison Endowed Chair for Diabetes Research Award; Wellcome Trust [075491/Z/04]; Advocacy for Neuroacanthocytosis Patients; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI020958] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056343] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harrison Endowed Chair for Diabetes Research Award; Wellcome Trust(Wellcome TrustEuropean Commission); Advocacy for Neuroacanthocytosis Patients; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This research was supported by National Institutes of Health Grant R01 AI020958 and R01 AR56343 (to FTL), the Harrison Endowed Chair for Diabetes Research Award (to RYY), the Wellcome Trust core grant 075491/Z/04 and the Advocacy for Neuroacanthocytosis Patients (to APM and AVB).	Alexeyev MF, 2010, MOL BIOL REP, V37, P1987, DOI 10.1007/s11033-009-9647-7; An CH, 2012, HUM PATHOL, V43, P40, DOI 10.1016/j.humpath.2010.03.015; Berrow NS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm047; Bird LE, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-13; Boscher C, 2011, CURR OPIN CELL BIOL, V23, P383, DOI 10.1016/j.ceb.2011.05.001; Bras J, 2015, CELL, V160, P570, DOI 10.1016/j.cell.2015.01.019; Brasaemle DL, 2006, CURR PROTOC CELL BIO, P3151; Brickner JH, 1997, J CELL BIOL, V139, P23, DOI 10.1083/jcb.139.1.23; Buchberger A, 2010, MOL CELL, V40, P238, DOI 10.1016/j.molcel.2010.10.001; Delacour D, 2009, TRAFFIC, V10, P1405, DOI 10.1111/j.1600-0854.2009.00960.x; Filimonenko M, 2010, MOL CELL, V38, P265, DOI 10.1016/j.molcel.2010.04.007; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Furukawa T, 2011, SCI REP-UK, V1, DOI 10.1038/srep00161; Grarup N, 2011, DIABETOLOGIA, V54, P789, DOI 10.1007/s00125-010-2031-2; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Hotta K, 2001, J BIOL CHEM, V276, P34089, DOI 10.1074/jbc.M105097200; Hsu DK, 2015, METHODS MOL BIOL, V1207, P451, DOI 10.1007/978-1-4939-1396-1_29; Huttlin EL, 2015, CELL, V162, P425, DOI 10.1016/j.cell.2015.06.043; Huyghe JR, 2013, NAT GENET, V45, P197, DOI 10.1038/ng.2507; Isakson P, 2013, CELL DEATH DIFFER, V20, P12, DOI 10.1038/cdd.2012.66; Kaganovich D, 2008, NATURE, V454, P1088, DOI 10.1038/nature07195; Kajimura S, 2008, GENE DEV, V22, P1397, DOI 10.1101/gad.1666108; Kajimura S, 2009, NATURE, V460, P1154, DOI 10.1038/nature08262; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Lamark Trond, 2012, Int J Cell Biol, V2012, P736905, DOI 10.1155/2012/736905; Liu FT, 2005, NAT REV CANCER, V5, P29, DOI 10.1038/nrc1527; Liu FT, 2002, BBA-GEN SUBJECTS, V1572, P263, DOI 10.1016/S0304-4165(02)00313-6; Manning AK, 2012, NAT GENET, V44, P659, DOI 10.1038/ng.2274; McCray BA, 2010, HUM MOL GENET, V19, P1033, DOI 10.1093/hmg/ddp567; Meda SA, 2012, NEUROIMAGE, V60, P1608, DOI 10.1016/j.neuroimage.2011.12.076; Mehul B, 1997, J CELL SCI, V110, P1169; Menon RP, 1999, EUR J BIOCHEM, V264, P569, DOI 10.1046/j.1432-1327.1999.00671.x; Moldavski O, 2015, DEV CELL, V33, P603, DOI 10.1016/j.devcel.2015.04.015; Munoz-Braceras S, 2015, AUTOPHAGY, V11, P918, DOI 10.1080/15548627.2015.1034413; Nalls MA, 2014, NAT GENET, V46, P989, DOI 10.1038/ng.3043; Park JS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124836; Rabinovich GA, 2012, IMMUNITY, V36, P322, DOI 10.1016/j.immuni.2012.03.004; Saxena R, 2010, NAT GENET, V42, P142, DOI 10.1038/ng.521; Schekman R, 2011, CELL            0909; Scott RA, 2012, NAT GENET, V44, P991, DOI 10.1038/ng.2385; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Strawbridge RJ, 2011, DIABETES, V60, P2624, DOI 10.2337/db11-0415; Thurston TLM, 2012, NATURE, V482, P414, DOI 10.1038/nature10744; Velayos-Baeza A, 2004, GENOMICS, V84, P536, DOI 10.1016/j.ygeno.2004.04.012; Velikkakath AKG, 2012, MOL BIOL CELL, V23, P896, DOI 10.1091/mbc.E11-09-0785; Wang CH, 2015, BBA-MOL BASIS DIS, V1852, P188, DOI 10.1016/j.bbadis.2014.07.028; Watanabe Y, 2012, J BIOL CHEM; Williams A, 2006, CURR TOP DEV BIOL, V76, P89, DOI 10.1016/S0070-2153(06)76003-3; Windholz J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022101; Wolff S, 2014, CELL, V157, P52, DOI 10.1016/j.cell.2014.03.007; Wu C, 2014, IMMUNITY, V41, P270, DOI 10.1016/j.immuni.2014.06.011; Yang RY, 2012, ADIPOCYTE, V1, P96, DOI 10.4161/adip.19465; Yang RY, 2011, P NATL ACAD SCI USA, V108, P18696, DOI 10.1073/pnas.1109065108; Yang Ri-Yao, 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000719; Yang RY, 1996, P NATL ACAD SCI USA, V93, P6737, DOI 10.1073/pnas.93.13.6737; Yang RY, 2004, J BIOL CHEM, V279, P29761, DOI 10.1074/jbc.M401303200; Yang RY, 2001, J BIOL CHEM, V276, P20252, DOI 10.1074/jbc.M010914200; Zebisch K, 2012, ANAL BIOCHEM, V425, P88, DOI 10.1016/j.ab.2012.03.005	58	30	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153534	10.1371/journal.pone.0153534	http://dx.doi.org/10.1371/journal.pone.0153534			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073999	Green Published, gold			2022-12-27	WOS:000374131200104
J	Dolezal, AG; Carrillo-Tripp, J; Miller, WA; Bonning, BC; Toth, AL				Dolezal, Adam G.; Carrillo-Tripp, Jimena; Miller, W. Allen; Bonning, Bryony C.; Toth, Amy L.			Intensively Cultivated Landscape and Varroa Mite Infestation Are Associated with Reduced Honey Bee Nutritional State	PLOS ONE			English	Article							DEFORMED WING VIRUS; DIVISION-OF-LABOR; JUVENILE-HORMONE; HABITAT LOSS; PROTEIN; POLLEN; VITELLOGENIN; HYMENOPTERA; INFECTIONS; DESTRUCTOR	As key pollinators, honey bees are crucial to many natural and agricultural ecosystems. An important factor in the health of honey bees is the availability of diverse floral resources. However, inmany parts of the world, high-intensity agriculture could result in a reduction in honey bee forage. Previous studies have investigated how the landscape surrounding honey bee hives affects some aspects of honey bee health, but to our knowledge there have been no investigations of the effects of intensively cultivated landscapes on indicators of individual bee health such as nutritional physiology and pathogen loads. Furthermore, agricultural landscapes in different regions vary greatly in forage and land management, indicating a need for additional information on the relationship between honey bee health and landscape cultivation. Here, we add to this growing body of information by investigating differences in nutritional physiology between honey bees kept in areas of comparatively low and high cultivation in an area generally high agricultural intensity in the Midwestern United States. We focused on bees collected directly before winter, because overwintering stress poses one of the most serious problems for honey bees in temperate climates. We found that honey bees kept in areas of lower cultivation exhibited higher lipid levels than those kept in areas of high cultivation, but this effect was observed only in colonies that were free of Varroa mites. Furthermore, we found that the presence of mites was associated with lower lipid levels and higher titers of deformed wing virus (DWV), as well as a non-significant trend towards higher overwinter losses. Overall, these results show that mite infestation interacts with landscape, obscuring the effects of landscape alone and suggesting that the benefits of improved foraging landscape could be lost without adequate control of mite infestations.	[Dolezal, Adam G.; Toth, Amy L.] Iowa State Univ, Dept Ecol Evolut & Organismal Biol, Ames, IA USA; [Carrillo-Tripp, Jimena; Miller, W. Allen] Iowa State Univ, Dept Plant Pathol & Microbiol, Ames, IA USA; [Bonning, Bryony C.; Toth, Amy L.] Iowa State Univ, Dept Entomol, Ames, IA USA	Iowa State University; Iowa State University; Iowa State University	Dolezal, AG (corresponding author), Iowa State Univ, Dept Ecol Evolut & Organismal Biol, Ames, IA USA.	adolezal@gmail.com			United Stated Department of Agriculture-Agriculture and Food Research Initiative [2011-04894]; Iowa State University Center for Virus-Insect Interactions (CVII)	United Stated Department of Agriculture-Agriculture and Food Research Initiative; Iowa State University Center for Virus-Insect Interactions (CVII)	Funded by United Stated Department of Agriculture-Agriculture and Food Research Initiative #2011-04894 and Iowa State University Center for Virus-Insect Interactions (CVII). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaux C, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-496; Alaux C, 2010, BIOL LETTERS, V6, P562, DOI 10.1098/rsbl.2009.0986; Amdam GV, 2005, EXP GERONTOL, V40, P939, DOI 10.1016/j.exger.2005.08.004; Amdam GV, 2004, EXP GERONTOL, V39, P767, DOI 10.1016/j.exger.2004.02.010; Aronstein K, 2012, AM BEE J, V152, P789; Basualdo M, 2013, J ECON ENTOMOL, V106, P1553, DOI 10.1603/EC12466; Beekman M, 2000, FUNCT ECOL, V14, P490, DOI 10.1046/j.1365-2435.2000.00443.x; Bond J, 2014, EC RES SERVICE SITUA; Bowen-Walker PL, 2001, ENTOMOL EXP APPL, V101, P207, DOI 10.1023/A:1019254727879; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brodschneider R, 2010, APIDOLOGIE, V41, P278, DOI 10.1051/apido/2010012; Calderone NW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037235; Caron D, 2011, AM BEE J, V151, P73; Carrillo-Tripp J, 2016, SCI REP-UK, V6, DOI 10.1038/srep22265; Claassen R., 2011, 120 USDA EC RES SERV; Couvillon MJ, 2014, CURR BIOL, V24, P1212, DOI 10.1016/j.cub.2014.03.072; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; CRAILSHEIM K, 1989, J INSECT PHYSIOL, V35, P595, DOI 10.1016/0022-1910(89)90121-2; Dainat B, 2012, APPL ENVIRON MICROB, V78, P981, DOI 10.1128/AEM.06537-11; De Jong D, 2009, J APICULT RES, V48, P34, DOI 10.3896/IBRA.1.48.1.08; de Miranda JR, 2010, J INVERTEBR PATHOL, V103, pS48, DOI 10.1016/j.jip.2009.06.012; DeGrandi-Hoffman G, 2015, CURR OPIN INSECT SCI, V10, P170, DOI 10.1016/j.cois.2015.05.007; DeGrandi-Hoffman G, 2010, J INSECT PHYSIOL, V56, P1184, DOI 10.1016/j.jinsphys.2010.03.017; Di Pasquale G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072016; Doke MA, 2015, CURR OPIN INSECT SCI, V10, P185, DOI 10.1016/j.cois.2015.05.014; Donkersley P, 2014, ECOL EVOL, V4, P4195, DOI 10.1002/ece3.1293; Duke SO, 2008, PEST MANAG SCI, V64, P319, DOI 10.1002/ps.1518; FLURI P, 1982, J INSECT PHYSIOL, V28, P61, DOI 10.1016/0022-1910(82)90023-3; Gallant AL, 2007, COPEIA, P967, DOI 10.1643/0045-8511(2007)7[967:GROHLA]2.0.CO;2; Genersch E, 2010, VET RES, V41, DOI 10.1051/vetres/2010027; Genersch E, 2010, APIDOLOGIE, V41, P332, DOI 10.1051/apido/2010014; Grixti JC, 2009, BIOL CONSERV, V142, P75, DOI 10.1016/j.biocon.2008.09.027; Hartzler RG, 2010, CROP PROT, V29, P1542, DOI 10.1016/j.cropro.2010.07.018; HAYDAK MH, 1970, ANNU REV ENTOMOL, V15, P143, DOI 10.1146/annurev.en.15.010170.001043; Hou CS, 2014, VIRUSES-BASEL, V6, P2012, DOI 10.3390/v6052012; Klowden M.J., 2007, PHYSL SYSTEMS INSECT; Lee KV, 2015, APIDOLOGIE, V46, P292, DOI 10.1007/s13592-015-0356-z; Lee K, 2010, AM BEE J, V150, P1151; Locke B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099998; Mattila HR, 2001, INSECT SOC, V48, P88, DOI 10.1007/PL00001764; Munch D, 2010, FEBS LETT, V584, P2496, DOI 10.1016/j.febslet.2010.04.007; Mutti NS, 2011, J EXP BIOL, V214, P3977, DOI 10.1242/jeb.061499; Naug D, 2009, BIOL CONSERV, V142, P2369, DOI 10.1016/j.biocon.2009.04.007; Nazzi F, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002735; Nilsen KA, 2011, J EXP BIOL, V214, P1488, DOI 10.1242/jeb.050393; Odoux JF, 2014, J APICULT RES, V53, P57, DOI 10.3896/IBRA.1.53.1.05; Ricketts TH, 2008, ECOL LETT, V11, P499, DOI 10.1111/j.1461-0248.2008.01157.x; ROBINSON GE, 1992, ANNU REV ENTOMOL, V37, P637, DOI 10.1146/annurev.en.37.010192.003225; Rosenkranz P, 2010, J INVERTEBR PATHOL, V103, pS96, DOI 10.1016/j.jip.2009.07.016; Runckel C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020656; Sande SO, 2009, BIOL CONSERV, V142, P2703, DOI 10.1016/j.biocon.2009.06.023; Schmehl DR, 2014, J INSECT PHYSIOL, V71, P177, DOI 10.1016/j.jinsphys.2014.10.002; SCHMIDT JO, 1987, ANN ENTOMOL SOC AM, V80, P176, DOI 10.1093/aesa/80.2.176; SEELEY TD, 1985, ECOL ENTOMOL, V10, P81, DOI 10.1111/j.1365-2311.1985.tb00537.x; Shen MQ, 2005, VIROLOGY, V342, P141, DOI 10.1016/j.virol.2005.07.012; Spivak M, 2011, ENVIRON SCI TECHNOL, V45, P34, DOI 10.1021/es101468w; Sponsler DB, 2015, PEERJ, V3, DOI 10.7717/peerj.838; Toth AL, 2005, ANIM BEHAV, V69, P427, DOI 10.1016/j.anbehav.2004.03.017; van Dooremalen C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036285; vanEngelsdorp D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006481; Wang Y, 2012, J EXP BIOL, V215, P124, DOI 10.1242/jeb.060889; Westphal C, 2003, ECOL LETT, V6, P961, DOI 10.1046/j.1461-0248.2003.00523.x	62	38	41	0	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0153531	10.1371/journal.pone.0153531	http://dx.doi.org/10.1371/journal.pone.0153531			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27070422	Green Published, Green Submitted, gold			2022-12-27	WOS:000373900700077
J	Yetman, MJ; Fowler, SW; Jankowsky, JL				Yetman, Michael J.; Fowler, Stephanie W.; Jankowsky, Joanna L.			Humanized Tau Mice with Regionalized Amyloid Exhibit Behavioral Deficits but No Pathological Interaction	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; MOUSE MODEL; TRANSGENIC MICE; A-BETA; ANIMAL-MODELS; NEUROFIBRILLARY TANGLES; CASCADE HYPOTHESIS; GENETIC MODULATION; KNOCKOUT MICE; SYNAPSE LOSS	Alzheimer's disease (AD) researchers have struggled for decades to draw a causal link between extracellular A beta aggregation and intraneuronal accumulation of microtubule-associated protein tau. The amyloid cascade hypothesis posits that A beta deposition promotes tau hyperphosphorylation, tangle formation, cell loss, vascular damage, and dementia. While the genetics of familial AD and the pathological staging of sporadic disease support this sequence of events, attempts to examine the molecular mechanism in transgenic animal models have largely relied on models of other inherited tauopathies as the basis for testing the interaction with A beta. In an effort to more accurately model the relationship between A beta and wild-type tau in AD, we intercrossed mice that overproduce human A beta with a tau substitution model in which all 6 isoforms of the human protein are expressed in animals lacking murine tau. We selected an amyloid model in which pathology was biased towards the entorhinal region so that we could further examine whether the anticipated changes in tau phosphorylation occurred at the site of A beta deposition or in synaptically connected regions. We found that A beta and tau had independent effects on locomotion, learning, and memory, but found no behavioral evidence for an interaction between the two transgenes. Moreover, we saw no indication of amyloid-induced changes in the phosphorylation or aggregation of human tau either within the entorhinal area or elsewhere. These findings suggest that robust amyloid pathology within the medial temporal lobe has little effect on the metabolism of wild type human tau in this model.	[Yetman, Michael J.; Fowler, Stephanie W.; Jankowsky, Joanna L.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Jankowsky, Joanna L.] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [Jankowsky, Joanna L.] Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Jankowsky, JL (corresponding author), Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA.; Jankowsky, JL (corresponding author), Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA.; Jankowsky, JL (corresponding author), Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA.	jankowsk@bcm.edu		Fowler, Stephanie/0000-0002-0785-4274	NIH training grant [T32 AG000183]; NATIONAL INSTITUTE ON AGING [T32AG000183] Funding Source: NIH RePORTER	NIH training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by NIH training grant T32 AG000183 (MJY) and by a gift from the Robert A. and Rene E. Belfer Family Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andorfer C, 2005, J NEUROSCI, V25, P5446, DOI 10.1523/JNEUROSCI.4637-04.2005; Andorfer C, 2003, J NEUROCHEM, V86, P582, DOI 10.1046/j.1471-4159.2003.01879.x; Bailey RM, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-8; Bhaskar K, 2010, NEURON, V68, P19, DOI 10.1016/j.neuron.2010.08.023; Bolmont T, 2007, AM J PATHOL, V171, P2012, DOI 10.2353/ajpath.2007.070403; Boutajangout A, 2010, J NEUROSCI, V30, P16559, DOI 10.1523/JNEUROSCI.4363-10.2010; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Braidy N, 2015, CURR OPIN PSYCHIATR, V28, P155, DOI 10.1097/YCO.0000000000000137; Brich J, 2003, J NEUROSCI, V23, P187; Chabrier MA, 2014, NEUROBIOL DIS, V64, P107, DOI 10.1016/j.nbd.2014.01.007; Cheng JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115765; Chia R, 2005, NAT GENET, V37, P1181, DOI 10.1038/ng1665; Coomaraswamy J, 2010, P NATL ACAD SCI USA, V107, P7969, DOI 10.1073/pnas.1001056107; Duff K, 2000, NEUROBIOL DIS, V7, P87, DOI 10.1006/nbdi.1999.0279; Forny-Germano L, 2014, J NEUROSCI, V34, P13629, DOI 10.1523/JNEUROSCI.1353-14.2014; Fowler SW, 2014, J NEUROSCI, V34, P7871, DOI 10.1523/JNEUROSCI.0572-14.2014; Franklin K.B.J., 2008, MOUSE BRAIN STEREOTA; FRAUTSCHY SA, 1991, P NATL ACAD SCI USA, V88, P8362, DOI 10.1073/pnas.88.19.8362; Geula C, 1998, NAT MED, V4, P827, DOI 10.1038/nm0798-827; GomezIsla T, 1996, J NEUROSCI, V16, P4491; Gotz J, 2001, SCIENCE, V293, P1491, DOI 10.1126/science.1062097; Gotz J, 2008, NAT REV NEUROSCI, V9, P532, DOI 10.1038/nrn2420; Guo QX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080706; Hanes J, 2009, J NEUROCHEM, V108, P1167, DOI 10.1111/j.1471-4159.2009.05869.x; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Herrup K, 2015, NAT NEUROSCI, V18, P794, DOI 10.1038/nn.4017; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Ikegami S, 2000, NEUROSCI LETT, V279, P129, DOI 10.1016/S0304-3940(99)00964-7; Janke C, 1999, MOL BRAIN RES, V68, P119, DOI 10.1016/S0169-328X(99)00079-0; Jankowsky JL, 2005, PLOS MED, V2, P1318, DOI 10.1371/journal.pmed.0020355; Kelleher I, 2007, J NEUROCHEM, V103, P2256, DOI 10.1111/j.1471-4159.2007.04930.x; KOWALL NW, 1992, NEUROBIOL AGING, V13, P537, DOI 10.1016/0197-4580(92)90053-Z; Lei P, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-29; Lei P, 2012, NAT MED, V18, P291, DOI 10.1038/nm.2613; Lewis J, 2000, NAT GENET, V25, P402, DOI 10.1038/78078; Lewis J, 2001, SCIENCE, V293, P1487, DOI 10.1126/science.1058189; Li ZY, 2014, NEUROBIOL AGING, V35, P2617, DOI 10.1016/j.neurobiolaging.2014.05.001; Ma QL, 2014, J NEUROSCI, V34, P7124, DOI 10.1523/JNEUROSCI.3439-13.2014; Maphis N, 2015, BRAIN, V138, P1738, DOI 10.1093/brain/awv081; Matsuki T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031152; Morris M, 2013, NEUROBIOL AGING, V34, P1523, DOI 10.1016/j.neurobiolaging.2012.12.003; Morris M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029257; Oddo S, 2007, J NEUROCHEM, V102, P1053, DOI 10.1111/j.1471-4159.2007.04607.x; Ojo JO, 2013, J NEUROPATH EXP NEUR, V72, P137, DOI 10.1097/NEN.0b013e3182814cdf; Polydoro M, 2009, J NEUROSCI, V29, P10741, DOI 10.1523/JNEUROSCI.1065-09.2009; Pooler AM, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0199-x; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Ramsden M, 2005, J NEUROSCI, V25, P10637, DOI 10.1523/JNEUROSCI.3279-05.2005; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Roberson ED, 2011, J NEUROSCI, V31, P700, DOI 10.1523/JNEUROSCI.4152-10.2011; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Sigurdsson EM, 1997, J NEUROPATH EXP NEUR, V56, P714; Sigurdsson EM, 1996, NEUROBIOL AGING, V17, P893, DOI 10.1016/S0197-4580(96)00169-8; Small SA, 2008, NEURON, V60, P534, DOI 10.1016/j.neuron.2008.11.007; Takuma H, 2003, DEV BRAIN RES, V142, P121, DOI 10.1016/S0165-3806(03)00056-7; Tucker KL, 2001, NAT NEUROSCI, V4, P29, DOI 10.1038/82868; Urlinger S, 2000, P NATL ACAD SCI USA, V97, P7963, DOI 10.1073/pnas.130192197; Yasuda M, 2006, NEURON, V50, P309, DOI 10.1016/j.neuron.2006.03.035; Yetman MJ, 2016, BRAIN STRUCT FUNCT, V221, P2231, DOI 10.1007/s00429-015-1040-9; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010; Zou K, 2003, J NEUROCHEM, V87, P609, DOI 10.1046/j.1471-4159.2003.02018.x	61	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0153724	10.1371/journal.pone.0153724	http://dx.doi.org/10.1371/journal.pone.0153724			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27070146	Green Published, gold			2022-12-27	WOS:000373900700083
J	Rivera-Lopez, R; Jimenez-Jaimez, J; Sabio, JM; Zamora-Pasadas, M; Vargas-Hitos, JA; Martinez-Bordonado, J; Navarrete-Navarrete, N; Fernandez, RR; Sanchez-Cantalejo, E; Jimenez-Alonso, J				Rivera-Lopez, Ricardo; Jimenez-Jaimez, Juan; Mario Sabio, Jose; Zamora-Pasadas, Monica; Antonio Vargas-Hitos, Jose; Martinez-Bordonado, Josefina; Navarrete-Navarrete, Nuria; Rivera Fernandez, Ricardo; Sanchez-Cantalejo, E.; Jimenez-Alonso, Juan			Relationship between QT Interval Length and Arterial Stiffness in Systemic Lupus Erythematosus (SLE): A Cross-Sectional Case-Control Study	PLOS ONE			English	Article							PULSE-WAVE VELOCITY; ALL-CAUSE MORTALITY; SUBCLINICAL ATHEROSCLEROSIS; RHEUMATOID-ARTHRITIS; AORTIC STIFFNESS; RISK; PROLONGATION; ASSOCIATION; PREDICTION; DISEASE	Introduction and Objectives The QT interval on the electrocardiogram has been shown to be longer in patients with systemic lupus erythematosus (SLE) compared to that of the general population. The clinical significance of this finding is unknown. The aim of this study was to assess the relationship between QT interval and subclinical atherosclerosis, measured by carotid-femoral pulse-wave velocity. Material and Methods 93 patients with SLE and 109 healthy women with similar basal characteristics were studied. All patients underwent a 12-lead electrocardiogram, and corrected QT interval (QTc) was measured using the Bazett's formula. The presence of atherosclerosis was evaluated by carotid-femoral pulse-wave velocity. Results Clinical basal characteristics were similar in both groups. QTc interval was 415 +/- 21.4 milliseconds in all patients, and 407 +/- 19.1 milliseconds in the control group (p = 0.007). There was a positive correlation between QTc interval and carotid-femoral pulse-wave velocity (r = 0.235; p = 0.02) in patients with SLE. This association was independent of hypertension and age in a multivariate analysis. Conclusion QTc interval measured by electrocardiogram is prolonged in SLE patients; it is related to subclinical atherosclerosis, measured by carotid-femoral pulse-wave velocity. This measure may help stratify risk in routine clinical practice and select the patients that might benefit from a more aggressive therapy in the prevention of cardiovascular events.	[Rivera-Lopez, Ricardo; Jimenez-Jaimez, Juan] Granada Univ Hosp, Granada Inst Biohlth Res, Cardiol Clin Management Unit, Granada, Spain; [Mario Sabio, Jose; Zamora-Pasadas, Monica; Antonio Vargas-Hitos, Jose; Martinez-Bordonado, Josefina; Navarrete-Navarrete, Nuria; Jimenez-Alonso, Juan] Granada Univ Hosp, Granada Inst Biohlth Res, Dept Internal Med, System Autoinmune Dis Unit, Granada, Spain; [Rivera Fernandez, Ricardo] Serrania Hosp, Intens Care Unit, Ronda, Malaga, Spain; [Sanchez-Cantalejo, E.] Andalusian Sch Publ Hlth, Granada, Spain; [Sanchez-Cantalejo, E.] CIBERESP, Madrid, Spain; [Sanchez-Cantalejo, E.] Inst Invest Biosanitaria Granada Granada Ibs, Granada, Spain	Escuela Andaluza de Salud Publica; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP	Rivera-Lopez, R (corresponding author), Granada Univ Hosp, Granada Inst Biohlth Res, Cardiol Clin Management Unit, Granada, Spain.	rfriveralopez@gmail.com	Stefanadis, Christodoulos/ABH-2232-2020; Vargas-Hitos, José Antonio/ABG-4532-2020; Rivera-Fernandez, Ricardo/M-1724-2013	Stefanadis, Christodoulos/0000-0001-5974-6454; Vargas-Hitos, José Antonio/0000-0002-0596-8710; Rivera-Fernandez, Ricardo/0000-0001-7383-4901; Rivera-Lopez, Ricardo/0000-0002-0787-9383				Adlan AM, 2015, J RHEUMATOL, V42, P421, DOI 10.3899/jrheum.140861; Bazett HC, 1920, HEART-J STUD CIRC, V7, P353; Blacher J, 1999, HYPERTENSION, V33, P1111, DOI 10.1161/01.HYP.33.5.1111; Bourre-Tessier J, 2015, ARTHRIT CARE RES, V67, P128, DOI 10.1002/acr.22370; Bourre-Tessier J, 2011, ARTHRIT CARE RES, V63, P1031, DOI 10.1002/acr.20470; Calvet D, 2014, INT J STROKE, V9, P291, DOI 10.1111/ijs.12015; Cardoso CRL, 2005, LUPUS, V14, P846, DOI 10.1191/0961203305lu2225oa; Castejon R, 2014, RHEUMATOLOGY, V53, P631, DOI 10.1093/rheumatology/ket367; COWAN JC, 1988, AM J CARDIOL, V61, P83, DOI 10.1016/0002-9149(88)91309-4; Cox AJ, 2014, DIABETES CARE, V37, P1454, DOI 10.2337/dc13-1257; Dekker JM, 2004, J AM COLL CARDIOL, V43, P565, DOI 10.1016/j.jacc.2003.09.040; Elming H, 1998, EUR HEART J, V19, P1391, DOI 10.1053/euhj.1998.1094; Festa A, 1999, STROKE, V30, P1566, DOI 10.1161/01.STR.30.8.1566; Gladman D, 1996, ARTHRITIS RHEUM, V39, P363, DOI 10.1002/art.1780390303; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Panoulas VF, 2014, RHEUMATOLOGY, V53, P131, DOI 10.1093/rheumatology/ket338; Petri M, 2005, NEW ENGL J MED, V353, P2550, DOI 10.1056/NEJMoa051135; Postema PG, 2008, HEART RHYTHM, V5, P1015, DOI 10.1016/j.hrthm.2008.03.037; Postema PG, 2014, CURR CARDIOL REV, V10, P287, DOI 10.2174/1573403X10666140514103612; Sacre K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094511; Soliman EZ, 2012, J AM COLL CARDIOL, V59, P1460, DOI 10.1016/j.jacc.2012.01.025; Thomas G, 2014, ARTHRITIS RHEUMATOL, V66, P2503, DOI 10.1002/art.38731; Urowitz MB, 2008, J RHEUMATOL, V35, P2152, DOI 10.3899/jrheum.080214; Van Bortel LM, 2012, J HYPERTENS, V30, P445, DOI 10.1097/HJH.0b013e32834fa8b0; Vlachopoulos C, 2010, J AM COLL CARDIOL, V55, P1318, DOI 10.1016/j.jacc.2009.10.061	26	9	10	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2016	11	4							e0152291	10.1371/journal.pone.0152291	http://dx.doi.org/10.1371/journal.pone.0152291			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0KH	27064990	Green Submitted, gold, Green Published			2022-12-27	WOS:000373891000009
J	Schmidt, C; Pester, B; Schmid-Hertel, N; Witte, H; Wismuller, A; Leistritz, L				Schmidt, Christoph; Pester, Britta; Schmid-Hertel, Nicole; Witte, Herbert; Wismueller, Axel; Leistritz, Lutz			A Multivariate Granger Causality Concept towards Full Brain Functional Connectivity	PLOS ONE			English	Article							NETWORKS; MODELS	Detecting changes of spatially high-resolution functional connectivity patterns in the brain is crucial for improving the fundamental understanding of brain function in both health and disease, yet still poses one of the biggest challenges in computational neuroscience. Currently, classical multivariate Granger Causality analyses of directed interactions between single process components in coupled systems are commonly restricted to spatially low-dimensional data, which requires a pre-selection or aggregation of time series as a preprocessing step. In this paper we propose a new fully multivariate Granger Causality approach with embedded dimension reduction that makes it possible to obtain a representation of functional connectivity for spatially high-dimensional data. The resulting functional connectivity networks may consist of several thousand vertices and thus contain more detailed information compared to connectivity networks obtained from approaches based on particular regions of interest. Our large scale Granger Causality approach is applied to synthetic and resting state fMRI data with a focus on how well network community structure, which represents a functional segmentation of the network, is preserved. It is demonstrated that a number of different community detection algorithms, which utilize a variety of algorithmic strategies and exploit topological features differently, reveal meaningful information on the underlying network module structure.	[Schmidt, Christoph; Pester, Britta; Witte, Herbert; Leistritz, Lutz] Univ Jena, Jena Univ Hosp, Inst Med Stat Comp Sci & Documentat, Jena, Germany; [Schmid-Hertel, Nicole] Univ Jena, Jena Univ Hosp, Inst Anat 1, Jena, Germany; [Wismueller, Axel] Univ Rochester, Med Ctr, Dept Biomed Engn, Dept Imaging Sci, Rochester, NY 14642 USA	Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; University of Rochester	Pester, B (corresponding author), Univ Jena, Jena Univ Hosp, Inst Med Stat Comp Sci & Documentat, Jena, Germany.	Britta.Pester@med.uni-jena.de		Schmidt, Christoph/0000-0002-5442-551X	Federal Ministry of Education and Research (Germany) [01GQ1202]; NIH (USA) [1R01DA034977-01]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA034977] Funding Source: NIH RePORTER	Federal Ministry of Education and Research (Germany)(Federal Ministry of Education & Research (BMBF)); NIH (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by the grant 01GQ1202 of the Federal Ministry of Education and Research (Germany), as well as by the NIH grant 1R01DA034977-01 (USA).	Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Clauset A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066111; Dasgupta S., 2006, ALGORITHMS; Dongen  S., 2000, PERFORMANCE CRITERIA; Ferrarini L, 2009, HUM BRAIN MAPP, V30, P2220, DOI 10.1002/hbm.20663; Fleiss, 1981, MEASUREMENT INTERRAT, P223; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Garg R, 2011, NEUROIMAGE, V58, P416, DOI 10.1016/j.neuroimage.2011.02.074; Goebel R, 2003, MAGN RESON IMAGING, V21, P1251, DOI 10.1016/j.mri.2003.08.026; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Hemmelmann D, 2009, NEUROIMAGE, V45, P722, DOI 10.1016/j.neuroimage.2008.12.065; HUBERT L, 1985, J CLASSIF, V2, P193, DOI 10.1007/BF01908075; Jolliffe I., 2005, SPRINGERLINK PRINCIP, DOI 10.1007/b98835; Khalid A, 2014, NEUROIMAGE, V101, P351, DOI 10.1016/j.neuroimage.2014.07.040; Lee H, 2012, IEEE T MED IMAGING, V31, P2267, DOI 10.1109/TMI.2012.2219590; Leicht EA, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.118703; Leistritz L, 2013, PHILOS T R SOC A, V371, DOI 10.1098/rsta.2011.0616; Leistritz L, 2013, PLOS ONE, P8; Leistritz L, 2016, P IEEE, V104, P262, DOI 10.1109/JPROC.2015.2497144; Levenshtein VI, 1966, SOV PHYS DOKL, V10, P707; Liao W, 2011, NEUROIMAGE, V54, P2683, DOI 10.1016/j.neuroimage.2010.11.007; Liitkepohl H, 2007, NEW INTRO MULTIPLE T; Londei Alessandro, 2006, Cogn Process, V7, P42, DOI 10.1007/s10339-005-0019-5; Meila M, 2007, J MULTIVARIATE ANAL, V98, P873, DOI 10.1016/j.jmva.2006.11.013; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman MEJ, 2012, NAT PHYS, V8, P25, DOI 10.1038/nphys2162; Penny WD, 2004, NEUROIMAGE, V22, P1157, DOI 10.1016/j.neuroimage.2004.03.026; Pester B, 2013, BIOMEDICAL ENG; Pons P, 2005, LECT NOTES COMPUT SC, V3733, P284; RAND WM, 1971, J AM STAT ASSOC, V66, P846, DOI 10.2307/2284239; Reichardt J, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.016110; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; Schelter B, 2006, J NEUROSCI METH, V152, P210, DOI 10.1016/j.jneumeth.2005.09.001; Schmidt C, 2014, IEEE ENG MED BIO, P2797, DOI 10.1109/EMBC.2014.6944204; Seth AK, 2005, NETWORK-COMP NEURAL, V16, P35, DOI 10.1080/09548980500238756; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Sporns O, 2014, NAT NEUROSCI, V17, P652, DOI 10.1038/nn.3690; Stephan KE, 2010, NEUROIMAGE, V49, P3099, DOI 10.1016/j.neuroimage.2009.11.015; Stephan KE, 2008, NEUROIMAGE, V42, P649, DOI 10.1016/j.neuroimage.2008.04.262; Valdes-Sosa PA, 2005, PHILOS T R SOC B, V360, P969, DOI 10.1098/rstb.2005.1654; Valdes-Sosa PA, 2004, NEUROINFORMATICS, V2, P239, DOI 10.1385/NI:2:2:239; van Wijk BCM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013701; Warrens MJ, 2008, J CLASSIF, V25, P177, DOI 10.1007/s00357-008-9023-7; Zhou ZY, 2009, BRAIN RES, V1289, P22, DOI 10.1016/j.brainres.2009.06.096	45	42	42	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2016	11	4							e0153105	10.1371/journal.pone.0153105	http://dx.doi.org/10.1371/journal.pone.0153105			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0KH	27064897	Green Submitted, Green Published, gold			2022-12-27	WOS:000373891000031
J	Hammarstrom, A; Wiklund, M; Stalnacke, BM; Lehti, A; Haukenes, I; Fjellman-Wiklund, A				Hammarstrom, Anne; Wiklund, Maria; Stalnacke, Britt-Marie; Lehti, Arja; Haukenes, Inger; Fjellman-Wiklund, Anncristine			Developing a Tool for Increasing the Awareness about Gendered and Intersectional Processes in the Clinical Assessment of Patients - A Study of Pain Rehabilitation	PLOS ONE			English	Article							HEALTH-CARE; BIAS; DIAGNOSIS; FRAMEWORK; WOMEN	Objective There is a need for tools addressing gender inequality in the everyday clinical work in health care. The aim of our paper was to develop a tool for increasing the awareness of gendered and intersectional processes in clinical assessment of patients, based on a study of pain rehabilitation. Methods In the overarching project named "Equal care in rehabilitation" we used multiple methods (both quantitative and qualitative) in five sub studies. With a novel approach we used Grounded Theory in order to synthesize the results from our sub studies, in order to develop the gender equality tool. The gender equality tool described and developed in this article is thus based on results from sub studies about the processes of assessment and selection of patients in pain rehabilitation. Inspired by some questions in earlier tools, we posed open ended questions and inductively searched for findings and concepts relating to gendered and social selection processes in pain rehabilitation, in each of our sub studies. Through this process, the actual gender equality tool was developed as 15 questions about the process of assessing and selecting patients to pain rehabilitation. As a more comprehensive way of understanding the tool, we performed a final step of the GT analyses. Here we synthesized the results of the tool into a comprehensive model with two dimensions in relation to several possible discrimination axes. Results The process of assessing and selecting patients was visualized as a funnel, a top down process governed by gendered attitudes, rules and structures. We found that the clinicians judged inner and outer characteristics and status of patients in a gendered and intersectional way in the process of clinical decision-making which thus can be regarded as ( potentially) biased with regard to gender, socio-economic status, ethnicity and age. Implications The clinical implications of our tool are that the tool can be included in the systematic routine of clinical assessment of patients for both awareness raising and as a base for avoiding gender bias in clinical decision-making. The tool could also be used in team education for health professionals as an instrument for critical reflection on gender bias. Conclusions Thus, tools for clinical assessment can be developed from empirical studies in various clinical settings. However, such a micro-level approach must be understood from a broader societal perspective including gender relations on both the macro-and the meso-level.	[Hammarstrom, Anne] Umea Univ, Unit Social Med, Dept Publ Hlth & Clin Med, Umea, Sweden; [Hammarstrom, Anne] Umea Univ, Umea Ctr Gender Studies Med, Umea, Sweden; [Wiklund, Maria; Fjellman-Wiklund, Anncristine] Umea Univ, Dept Community Med & Rehabil, Physiotherapy, Umea, Sweden; [Stalnacke, Britt-Marie] Umea Univ, Dept Community Med & Rehabil, Rehabil Med, Umea, Sweden; [Lehti, Arja] Umea Univ, Unit Profess Dev, Dept Clin Sci, Umea, Sweden; [Haukenes, Inger] Norwegian Inst Publ Hlth, Div Mental Hlth, Dept Publ Mental Hlth, Kalfarveien 31, Bergen, Norway; [Haukenes, Inger] Uni Res Hlth, Res Unit Gen Practice, Kalfarveien 31, Bergen, Norway	Umea University; Umea University; Umea University; Umea University; Umea University; Norwegian Institute of Public Health (NIPH)	Hammarstrom, A (corresponding author), Umea Univ, Unit Social Med, Dept Publ Hlth & Clin Med, Umea, Sweden.; Hammarstrom, A (corresponding author), Umea Univ, Umea Ctr Gender Studies Med, Umea, Sweden.	anne.hammarstrom@umu.se		Hammarstrom, Anne/0000-0002-4095-7961	Swedish Research Council [344-2009-5839, 344-2011-5478:]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by the Swedish Research Council (grant no: 344-2009-5839 as well as grant no 344-2011-5478:). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annandale E., 2010, PALGRAVE HDB GENDER; [Anonymous], HLTH PORTF SEX GEND; [Anonymous], 2007, QUALITATIVE METHODOL; Bacchi C, 2008, ANAL POLICY WHATS PR; Bacchi C, 2009, NORA, V17, P2, DOI 10.1080/08038740802689133; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Bosner S, 2011, BMC FAM PRACT, V12, DOI 10.1186/1471-2296-12-45; Borkhoff CM, 2008, CAN MED ASSOC J, V178, P681, DOI 10.1503/cmaj.071168; Bugiardini R, 2010, CURR VASC PHARMACOL, V8, P276, DOI 10.2174/157016110790887018; Butler Judith, 1990, GENDER TROUBLE FEMIN; Chang AM, 2007, ACAD EMERG MED, V14, P599, DOI 10.1197/j.aem.2007.03.1355; Connell R.W., 2002, GENDER; Connell R. W., 1995, MASCULINITIES; Connell RW, 2005, GENDER SOC, V19, P829, DOI 10.1177/0891243205278639; Council of Europe, 2008, REC CM REC 2008 1 CO; Eichler M, 2006, CAN J PUBLIC HEALTH, V97, P63, DOI 10.1007/BF03405218; Glaser B., 2001, GROUNDED THEORY PERS; Glaser B.G., 1968, DISCOV GROUNDED THEO; Government of South Australia, 2008, S AUSTR GEND AN; Hamberg K, 2004, SCAND J PUBLIC HEALT, V32, P144, DOI 10.1080/14034940310015401; Hamberg K, 2008, WOMENS HEALTH, V4, P237, DOI 10.2217/17455057.4.3.237; Hammarstrom A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097134; Hammarstrom A, 2014, J EPIDEMIOL COMMUN H, V68, P185, DOI 10.1136/jech-2013-202572; Hankivsky O, 2012, SOC SCI MED, V74, P1712, DOI 10.1016/j.socscimed.2011.11.029; Haukenes I, 2015, EUR J PAIN, V19, P826, DOI 10.1002/ejp.609; Holli AM, 2005, NORA, V13, P148, DOI 10.1080/08038740600590442; Karim F, 2007, HEALTH POLICY PLANN, V22, P329, DOI 10.1093/heapol/czm026; Kuhlman E, 2010, PALGRAVE HDB GENDER; Lehti A, 2017, SCAND J CARING SCI, V31, P45, DOI 10.1111/scs.12312; Merrick D, 2012, J REHABIL MED, V44, P764, DOI 10.2340/16501977-1022; Morse JM, 2014, QUAL HEALTH RES, V24, P3, DOI 10.1177/1049732313513656; Noone JH, 2008, SOCIOL HEALTH ILL, V30, P711, DOI 10.1111/j.1467-9566.2008.01095.x; Nyberg F, 2008, INT J DERMATOL, V47, P144, DOI 10.1111/j.1365-4632.2008.03485.x; Nyberg V, 2011, J REHABIL MED, V43, P50, DOI 10.2340/16501977-0631; Patton M, 2015, UTILIZATION FOCUSED, VFourth; Raine R, 2000, J Health Serv Res Policy, V5, P237; Risberg Gunilla., 2004, I AM SOLELY PROFESSI; Ruiz-Cantero MT, 2007, J EPIDEMIOL COMMUN H, V61, P46, DOI 10.1136/jech.2007.062034; Seymour-Smith S, 2002, J HEALTH PSYCHOL, V7, P253, DOI 10.1177/1359105302007003220; Shields SA, 2008, SEX ROLES, V59, P301, DOI 10.1007/s11199-008-9501-8; Stalnacke BM, 2015, J REHABIL MED, V47, P365, DOI 10.2340/16501977-1936; Stenberg G, 2012, J REHABIL MED, V44, P163, DOI 10.2340/16501977-0912; Victorian Women's Health and Wellbeing Strategy Diversity Unit, 2008, GEND DIV LENS HLTH H; West C, 1987, GENDER SOC, V1, P125, DOI 10.1177/0891243287001002002; Wijnhoven HAH, 2006, CLIN J PAIN, V22, P717, DOI 10.1097/01.ajp.0000210912.95664.53; Wiklund M, ACCESS REHAB N UNPUB; World Health Organisation, 2008, CLOS GAP GEN; World Health Organization, 2002, GEND AN HLTH REV SEL; World Health Organization (WHO), 2002, WHO GEND POL; Zbierajewski-Eischeid SJ, 2009, DIMENS CRIT CARE NUR, V28, P1, DOI 10.1097/01.DCC.0000325090.93411.ce	50	9	9	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0152735	10.1371/journal.pone.0152735	http://dx.doi.org/10.1371/journal.pone.0152735			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DI6KO	27055029	Green Accepted, Green Published, gold			2022-12-27	WOS:000373608000039
J	Howcroft, J; Lemaire, ED; Kofman, J				Howcroft, Jennifer; Lemaire, Edward D.; Kofman, Jonathan			Wearable-Sensor-Based Classification Models of Faller Status in Older Adults	PLOS ONE			English	Article							LOCAL DYNAMIC STABILITY; MULTIVARIATE TIME-SERIES; GAIT STABILITY; RISK-ASSESSMENT; ACCELERATION PATTERNS; SPACE RECONSTRUCTION; NETWORK ANALYSIS; COMPLEX NETWORK; WALKING; VARIABILITY	Wearable sensors have potential for quantitative, gait-based, point-of-care fall risk assessment that can be easily and quickly implemented in clinical-care and older-adult living environments. This investigation generated models for wearable-sensor based fall-risk classification in older adults and identified the optimal sensor type, location, combination, and modelling method; for walking with and without a cognitive load task. A convenience sample of 100 older individuals (75.5 +/- 6.7 years; 76 non-fallers, 24 fallers based on 6 month retrospective fall occurrence) walked 7.62 m under single-task and dual-task conditions while wearing pressure-sensing insoles and tri-axial accelerometers at the head, pelvis, and left and right shanks. Participants also completed the Activities-specific Balance Confidence scale, Community Health Activities Model Program for Seniors questionnaire, six minute walk test, and ranked their fear of falling. Fall risk classification models were assessed for all sensor combinations and three model types: multi-layer perceptron neural network, naive Bayesian, and support vector machine. The best performing model was a multi-layer perceptron neural network with input parameters from pressure-sensing insoles and head, pelvis, and left shank accelerometers (accuracy = 84%, F1 score = 0.600, MCC score = 0.521). Head sensor-based models had the best performance of the single-sensor models for single-task gait assessment. Single-task gait assessment models outperformed models based on dual-task walking or clinical assessment data. Support vector machines and neural networks were the best modelling technique for fall risk classification. Fall risk classification models developed for point-of-care environments should be developed using support vector machines and neural networks, with a multi-sensor single-task gait assessment.	[Howcroft, Jennifer; Kofman, Jonathan] Univ Waterloo, Dept Syst Design Engn, Waterloo, ON N2L 3G1, Canada; [Lemaire, Edward D.] Ottawa Hosp, Res Inst, Ctr Rehabil Res & Dev, Ottawa, ON, Canada; [Lemaire, Edward D.] Univ Ottawa, Fac Med, Ottawa, ON, Canada	University of Waterloo; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa	Lemaire, ED (corresponding author), Ottawa Hosp, Res Inst, Ctr Rehabil Res & Dev, Ottawa, ON, Canada.; Lemaire, ED (corresponding author), Univ Ottawa, Fac Med, Ottawa, ON, Canada.	elemaire@toh.ca		Lemaire, Edward/0000-0003-4693-2623	Natural Sciences and Engineering Research Council of Canada (NSERC); Ontario Ministry of Training, Colleges and Universities; University of Waterloo	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Ministry of Training, Colleges and Universities; University of Waterloo	This work was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC); the Ontario Ministry of Training, Colleges and Universities; and the University of Waterloo.	ASHLEY M J, 1977, Age and Ageing, V6, P211, DOI 10.1093/ageing/6.4.211; Beauchet O, 2008, GERONTOLOGY, V54, P217, DOI 10.1159/000127318; Biswas A, 2008, J BIOMECH, V41, P1574, DOI 10.1016/j.jbiomech.2008.02.009; Bootsma-van der Wiel A, 2003, J AM GERIATR SOC, V51, P1466, DOI 10.1046/j.1532-5415.2003.51468.x; Caby B, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-1; Egret CI, 2003, INT J SPORTS MED, V24, P465; FRASER AM, 1986, PHYS REV A, V33, P1134, DOI 10.1103/PhysRevA.33.1134; Gao ZK, 2015, EPL-EUROPHYS LETT, V109, DOI 10.1209/0295-5075/109/30005; Gao ZK, 2015, EXP THERM FLUID SCI, V60, P157, DOI 10.1016/j.expthermflusci.2014.09.008; Gao ZK, 2012, NONLINEAR ANAL-REAL, V13, P947, DOI 10.1016/j.nonrwa.2011.08.029; Giansanti D, 2009, TELEMED J E-HEALTH, V15, P296, DOI 10.1089/tmj.2008.0106; Greene BR, 2014, PHYSIOL MEAS, V35, P2053, DOI 10.1088/0967-3334/35/10/2053; GUYATT GH, 1985, CAN MED ASSOC J, V132, P919; Hausdorff JM, 2008, J GERONTOL A-BIOL, V63, P1335, DOI 10.1093/gerona/63.12.1335; Hens AB, 2012, EXPERT SYST APPL, V39, P6774, DOI 10.1016/j.eswa.2011.12.057; Hou FZ, 2014, EPL-EUROPHYS LETT, V107, DOI 10.1209/0295-5075/107/58001; Howcroft J, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-91; Ijmker T, 2012, GAIT POSTURE, V35, P126, DOI 10.1016/j.gaitpost.2011.08.022; Kendell C, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-24; KENNEL MB, 1992, PHYS REV A, V45, P3403, DOI 10.1103/PhysRevA.45.3403; Kojima M, 2008, J PHYS THER SCI, V20, P243, DOI 10.1589/jpts.20.243; Lalkhen AG, 2008, BJA EDUC, V8, P221, DOI 10.1093/bjaceaccp/mkn041; Lamoth CJ, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-2; Latt MD, 2009, J GERONTOL A-BIOL, V64, P700, DOI 10.1093/gerona/glp009; Lee RYW, 2011, AGE AGEING, V40, P690, DOI [10.1093/ageing/afr050, 10.1155/2011/653570]; Lehnertz K, 2014, PHYSICA D, V267, P7, DOI 10.1016/j.physd.2013.06.009; Li X, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.062901; Liu C, 2010, PHYSICA A, V389, P2675, DOI 10.1016/j.physa.2010.02.043; Liu J, 2008, IEEE T AUTOM SCI ENG, V5, P696, DOI 10.1109/TASE.2008.923821; Marschollek M, 2011, METHOD INFORM MED, V50, P420, DOI 10.3414/ME10-01-0040; Martin FC, 2011, CAN J AGING, V30, P33, DOI 10.1017/S0714980810000747; Masud T, 2001, AGE AGEING, V30, P3, DOI 10.1093/ageing/30.suppl_4.3; MATTHEWS BW, 1975, BIOCHIM BIOPHYS ACTA, V405, P442, DOI 10.1016/0005-2795(75)90109-9; Menz HB, 2003, J GERONTOL A-BIOL, V58, P446, DOI 10.1093/gerona/58.5.M446; Montero-Odasso M, 2014, J GERONTOL A-BIOL, V69, P1415, DOI 10.1093/gerona/glu155; POWELL LE, 1995, J GERONTOL A-BIOL, V50, pM28, DOI 10.1093/gerona/50A.1.M28; Rao SS, 2005, AM FAM PHYSICIAN, V72, P81; Rende B, 2002, NEUROPSYCHOLOGY, V16, P309, DOI 10.1037//0894-4105.16.3.309; Rispens SM, 2015, JMIR RES PROTOC, V4, DOI 10.2196/resprot.3931; Sadeghi H, 2000, GAIT POSTURE, V12, P34, DOI 10.1016/S0966-6362(00)00070-9; Siggiridou E, 2014, SENSORS-BASEL, V14, P12585, DOI 10.3390/s140712585; SMIDT GL, 1971, AMER J PHYSICAL MED, V50, P285; Stevens JA, 2006, INJURY PREV, V12, P290, DOI 10.1136/ip.2005.011015; Stewart AL, 2001, MED SCI SPORT EXER, V33, P1126, DOI 10.1097/00005768-200107000-00010; Toebes MJP, 2012, GAIT POSTURE, V36, P527, DOI 10.1016/j.gaitpost.2012.05.016; Van Rijsbergen C, 1980, INFORM RETRIEVAL; van Schooten KS, 2015, J GERONTOL A-BIOL, V70, P608, DOI 10.1093/gerona/glu225; van Schooten KS, 2013, J BIOMECH, V46, P137, DOI 10.1016/j.jbiomech.2012.10.032; Weiss A, 2013, NEUROREHAB NEURAL RE, V27, P742, DOI 10.1177/1545968313491004; Winter DA., 1987, BIOMECHANICS MOTOR C; YACK HJ, 1993, J GERONTOL, V48, pM225, DOI 10.1093/geronj/48.5.M225; Zanin M, 2012, SCI REP-UK, V2, DOI 10.1038/srep00630	52	40	40	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153240	10.1371/journal.pone.0153240	http://dx.doi.org/10.1371/journal.pone.0153240			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DI6KO	27054878	Green Published, gold			2022-12-27	WOS:000373608000110
J	Kundacina, N; Shi, MH; Pollack, GH				Kundacina, Nenad; Shi, Minghui; Pollack, Gerald H.			Effect of Local and General Anesthetics on Interfacial Water	PLOS ONE			English	Article							HYPOTHESIS	Background Water undergoes structural change as it interfaces with hydrophilic surfaces, including the many hydrophilic surfaces within the cell. This interfacial water has become known as "Exclusion Zone (EZ) water" or "fourth-phase water" [ 1]. Methods We tested the hypothesis that anesthetics diminish the amount of EZ water, and that this change may correlate with functional changes in anesthesia. By using the local anesthetics Lidocaine and Bupivacaine as well as a general inhalational anesthetic, Isoflurane, we tracked the EZ size as these anesthetics were introduced. Results All three anesthetics diminished EZ size in a concentration-dependent manner at concentrations of 0.18 mM and greater for Bupivacaine, 0.85 mM and greater for Lidocaine, and 0.2% for Isoflurane. At extremely low (micromolar) concentrations, however, all three anesthetics increased EZ size. Conclusions The sharp increase of EZ size associated with micromolar anesthetic concentrations follows a similar pattern to induction of general anesthesia, from the excitation stage (Stage II) to the depression and overdose stages of surgical anesthesia (Stages III and IV). The results are consistent with the hypothesis that anesthetics may act on water, a fundamental organizational component common to all cells.	[Kundacina, Nenad; Shi, Minghui; Pollack, Gerald H.] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA; [Pollack, Gerald H.] Univ Washington, Box 355061, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Kundacina, N (corresponding author), Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.	nenadkundacina1@gmail.com			NIH [5 R01 GM093842]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093842] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH Transformative Grant 5 R01 GM093842, Website: http://www.nih.gov/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors acknowledge the advice of Philippe Housmans, Stuart Hameroff, and Walter Folger in the preparation and execution of this work, and support from NIH Transformative Grant 5 R01 GM093842.	Franks NP, NATURE, V300, P487; GIANELLY R, 1967, NEW ENGL J MED, V277, P1215, DOI 10.1056/NEJM196712072772301; KATOH T, 1992, BRIT J ANAESTH, V69, P259, DOI 10.1093/bja/69.3.259; Keil RL, 1996, MOL CELL BIOL, V16, P3446; Koblin DD, ANESTH ANALG, V79, P1043; Meyer H.H., 1899, ARCH EXP PATHOL PH, V42, P111; MILLER KW, 1973, MOL PHARMACOL, V9, P131; Overton C. E., 1901, STUDIEN NARKOSE ZUGL; Pauling L., SCIENCE, V7, P15; Pollack G., 2013, EDGESCIENCE; Pollack G.H., 2001, CELLS GELS ENGINES L; Rajaram S, 1999, GENETICS, V153, P1673; REYNOLDS F, 1971, BRIT J ANAESTH, V43, P567, DOI 10.1093/bja/43.6.567; Wang HJ, 2013, J PHYS CHEM B, V117, P12007, DOI 10.1021/jp407115j; Ypma RE, 2015, UNDERSEA HYPERBAR M, V42, P257; Zheng J, ADV COLLOID INTERFAC, V127, P19	16	9	9	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0152127	10.1371/journal.pone.0152127	http://dx.doi.org/10.1371/journal.pone.0152127			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27054588	gold, Green Published, Green Submitted			2022-12-27	WOS:000373608000012
J	Liu, Y; Li, XM; Xie, C; Luo, XZ; Bao, YG; Wu, B; Hu, YC; Zhong, Z; Liu, C; Li, MJ				Liu, Yan; Li, Xuemei; Xie, Chen; Luo, Xiuzhen; Bao, Yonggang; Wu, Bin; Hu, Yuchi; Zhong, Zhong; Liu, Chang; Li, MinJie			Prevention Effects and Possible Molecular Mechanism of Mulberry Leaf Extract and its Formulation on Rats with Insulin-Insensitivity	PLOS ONE			English	Article							MORUS-ALBA L.; OXIDATIVE STRESS; IN-VIVO; GLUCOSE; DIET; EXPRESSION; 4-HYDROXYISOLEUCINE; STREPTOZOTOCIN; LIPOGENESIS; ADIPOCYTES	For centuries, mulberry leaf has been used in traditional Chinese medicine for the treatment of diabetes. This study aims to test the prevention effects of a proprietary mulberry leaf extract (MLE) and a formula consisting of MLE, fenugreek seed extract, and cinnamon cassia extract (MLEF) on insulin resistance development in animals. MLE was refined to contain 5% 1-deoxynojirimycin by weight. MLEF was formulated by mixing MLE with cinnamon cassia extract and fenugreek seed extract at a 6:5:3 ratio (by weight). First, the acute toxicity effects of MLE on ICR mice were examined at 5 g/kg BW dose. Second, two groups of normal rats were administrated with water or 150 mg/kg BW MLE per day for 29 days to evaluate MLE's effect on normal animals. Third, to examine the effects of MLE and MLEF on model animals, sixty SD rats were divided into five groups, namely, (1) normal, (2) model, (3) high-dose MLE (75 mg/kg BW) treatment; (4) low-dose MLE (15 mg/kg BW) treatment; and (5) MLEF (35 mg/kg BW) treatment. On the second week, rats in groups (2)-(5) were switched to high-energy diet for three weeks. Afterward, the rats were injected (ip) with a single dose of 105 mg/kg BW alloxan. After four more days, fasting blood glucose, post-prandial blood glucose, serum insulin, cholesterol, and triglyceride levels were measured. Last, liver lysates from animals were screened with 650 antibodies for changes in the expression or phosphorylation levels of signaling proteins. The results were further validated by Western blot analysis. We found that the maximum tolerance dose of MLE was greater than 5 g/kg in mice. The MLE at a 150 mg/kg BW dose showed no effect on fast blood glucose levels in normal rats. The MLE at a 75 mg/kg BW dose and MLEF at a 35 mg/kg BW dose, significantly (p < 0.05) reduced fast blood glucose levels in rats with impaired glucose and lipid metabolism. In total, 34 proteins with significant changes in expression and phosphorylation levels were identified. The changes of JNK, IRS1, and PDK1 were confirmed by western blot analysis. In conclusion, this study demonstrated the potential protective effects of MLE and MLEF against hyperglycemia induced by high-energy diet and toxic chemicals in rats for the first time. The most likely mechanism is the promotion of IRS1 phosphorylation, which leads to insulin sensitivity restoration.	[Liu, Yan; Li, MinJie] Res & Dev Ctr Amway China, Shanghai, Peoples R China; [Li, Xuemei; Hu, Yuchi] Beijing Ctr Hlth Food & Cosmet Control, Beijing Inst Drug Control, Beijing, Peoples R China; [Zhong, Zhong] Bot Century Beijing Co Ltd, Beijing, Peoples R China; [Bao, Yonggang] Beijing Pepnoch Co Ltd, Beijing, Peoples R China; [Xie, Chen; Luo, Xiuzhen; Wu, Bin; Liu, Chang] Chinese Acad Med Sci, Inst Med Plant Dev, 151 Malianwa North Rd, Beijing 100193, Peoples R China; [Xie, Chen; Luo, Xiuzhen; Wu, Bin; Liu, Chang] Peking Union Med Coll, 151 Malianwa North Rd, Beijing 100193, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Li, MJ (corresponding author), Res & Dev Ctr Amway China, Shanghai, Peoples R China.; Liu, C (corresponding author), Peking Union Med Coll, 151 Malianwa North Rd, Beijing 100193, Peoples R China.	cliu@implad.ac.cn; Liz.Li@amway.com	Liu, Chang/A-1148-2014		Botanic Century (Beijing) Co., Ltd.	Botanic Century (Beijing) Co., Ltd.	The authors YL and MJL are paid employees of Amway, China. The author YGB is a paid employee of Beijing Pepnoch Co., Ltd. The author Zhong Zhong is a paid employee of Botanic Century (Beijing) Co., Ltd. The funder provided support in the form of salaries for authors (YL, YGB, ZZ and MJL), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Andallu B, 2007, J MED FOOD, V10, P41, DOI 10.1089/jmf.2005.034; Andallu B, 2001, CLIN CHIM ACTA, V314, P47, DOI 10.1016/S0009-8981(01)00632-5; [Anonymous], 2012, METH EV ASS ANT FUNC; Bouderba S, 2014, J DIABETES, V6, P184, DOI 10.1111/1753-0407.12083; Broca C, 1999, AM J PHYSIOL-ENDOC M, V277, pE617, DOI 10.1152/ajpendo.1999.277.4.E617; Dong XC, 2006, J CLIN INVEST, V116, P101, DOI 10.1172/JCI25735; Fritsche L, 2008, CURR MED CHEM, V15, P1316, DOI 10.2174/092986708784534956; Jaiswal N, 2012, EUR J NUTR, V51, P893, DOI 10.1007/s00394-012-0374-9; Kimura T, 2007, J AGR FOOD CHEM, V55, P5869, DOI 10.1021/jf062680g; Kobayashi Y, 2010, BIOSCI BIOTECH BIOCH, V74, P2385, DOI 10.1271/bbb.100392; Lee YJ, 2011, AM J CHINESE MED, V39, P39, DOI 10.1142/S0192415X11008634; Leiter Edward H, 2013, Curr Protoc Mouse Biol, V3, P9; Lim HH, 2013, EXP BIOL MED, V238, P1160, DOI 10.1177/1535370213498982; Liu YN, 2014, NUTR RES, V34, P450, DOI 10.1016/j.nutres.2014.04.007; Lu ZL, 2011, PHYTOMEDICINE, V18, P298, DOI 10.1016/j.phymed.2010.08.008; Naowaboot J, 2012, AM J CHINESE MED, V40, P163, DOI 10.1142/S0192415X12500139; Pelech S, 2008, J PROTEOME RES, V7, P2860, DOI 10.1021/pr800082a; Qin B, 2010, HORM METAB RES, V42, P187, DOI 10.1055/s-0029-1242746; Qin BL, 2003, DIABETES RES CLIN PR, V62, P139, DOI 10.1016/S0168-8227(03)00173-6; Rowland AF, 2011, TRAFFIC, V12, P672, DOI 10.1111/j.1600-0854.2011.01178.x; Sauvaire Y, 1998, DIABETES, V47, P206, DOI 10.2337/diabetes.47.2.206; SHEPHERD PR, 1995, BIOCHEM J, V305, P25, DOI 10.1042/bj3050025; Verspohl EJ, 2005, PHYTOTHER RES, V19, P203, DOI 10.1002/ptr.1643; Yu Hai, 2013, Zhongguo Zhong Xi Yi Jie He Za Zhi, V33, P1394	24	20	20	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0152728	10.1371/journal.pone.0152728	http://dx.doi.org/10.1371/journal.pone.0152728			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27054886	Green Submitted, Green Published, gold			2022-12-27	WOS:000373608000038
J	Ma, J; Cheng, ZJ; Chen, J; Shen, JB; Zhang, BC; Ren, YL; Ding, Y; Zhou, YH; Zhang, H; Zhou, KN; Wang, JL; Lei, CL; Zhang, X; Guo, XP; Gao, H; Bao, YQ; Wan, JM				Ma, Jin; Cheng, Zhijun; Chen, Jun; Shen, Jinbo; Zhang, Baocai; Ren, Yulong; Ding, Yu; Zhou, Yihua; Zhang, Huan; Zhou, Kunneng; Wang, Jiu-Lin; Lei, Cailin; Zhang, Xin; Guo, Xiuping; Gao, He; Bao, Yiqun; Wan, Jian-Min			Phosphatidylserine Synthase Controls Cell Elongation Especially in the Uppermost Internode in Rice by Regulation of Exocytosis	PLOS ONE			English	Article							VACUOLAR SORTING RECEPTORS; PLASMA-MEMBRANE; ENDOPLASMIC-RETICULUM; ANCHORED PROTEIN; ARABIDOPSIS; CELLULOSE; EXPRESSION; GENE; MUTANT; IDENTIFICATION	The uppermost internode is one of the fastest elongating organs in rice, and is expected to require an adequate supply of cell-wall materials and enzymes to the cell surface to enhance mechanical strength. Although it has been reported that the phenotype of shortened uppermost internode 1 (sui1) is caused by mutations in PHOSPHATIDYLSERINE SYNTHASE (OsPSS), the underlying mechanism remains unclear. Here we show that the OsPSS-1, as a gene expressed predominantly in elongating cells, regulates post-Golgi vesicle secretion to intercellular spaces. Mutation of OsPSS-1 leads to compromised delivery of CESA4 and secGFP towards the cell surface, resulting in weakened intercellular adhesion and disorganized cell arrangement in parenchyma. The phenotype of sui1-4 is caused largely by the reduction in cellulose contents in the whole plant and detrimental delivery of pectins in the uppermost internode. We found that OsPSS-1 and its potential product PS (phosphatidylserine) localized to organelles associated with exocytosis. These results together suggest that OsPSS-1 plays a potential role in mediating cell expansion by regulating secretion of cell wall components.	[Ma, Jin; Cheng, Zhijun; Chen, Jun; Ren, Yulong; Wang, Jiu-Lin; Lei, Cailin; Zhang, Xin; Guo, Xiuping; Wan, Jian-Min] Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing 100193, Peoples R China; [Shen, Jinbo; Ding, Yu] Chinese Univ Hong Kong, Ctr Cell & Dev Biol, Sch Life Sci, Hong Kong, Hong Kong, Peoples R China; [Zhang, Baocai; Zhou, Yihua] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Genom, Beijing, Peoples R China; [Zhang, Baocai; Zhou, Yihua] Chinese Acad Sci, Inst Genet & Dev Biol, Natl Ctr Plant Gene Res, Beijing, Peoples R China; [Zhang, Huan; Zhou, Kunneng; Gao, He; Bao, Yiqun; Wan, Jian-Min] Nanjing Agr Univ, Jiangsu Plant Gene Engn Res Ctr, Natl Key Lab Crop Genet & Germplasm Enhancement, Nanjing, Jiangsu, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Chinese University of Hong Kong; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Nanjing Agricultural University	Cheng, ZJ; Wan, JM (corresponding author), Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing 100193, Peoples R China.	chengzhijun@caas.cn; wanjianmin@caas.cn	Zhang, Baocai/AFS-9696-2022; Ren, Yulong/HHC-8217-2022; Zhang, Baocai/AFW-3565-2022; Ding, yu/GWV-1732-2022; Ding, Yu/AAE-8957-2021; Cheng, Zhijun/HDN-7780-2022; Jinbo, Shen/I-8162-2016	Zhang, Baocai/0000-0002-3239-7263; SHEN, Jinbo/0000-0002-0412-5586	National Natural Science Foundation of China [91535302, 31571629]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding was provided by the National Natural Science Foundation of China, grant numbers: 91535302, 31571629 (http://www.nsfc.gov.cn/), to ZJC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; ATKINSON K, 1980, J BIOL CHEM, V255, P6653; BEVERS EM, 1982, EUR J BIOCHEM, V122, P429, DOI 10.1111/j.1432-1033.1982.tb05898.x; Boursiac Y, 2005, PLANT PHYSIOL, V139, P790, DOI 10.1104/pp.105.065029; Chen YL, 2010, MOL MICROBIOL, V75, P1112, DOI 10.1111/j.1365-2958.2009.07018.x; Chiba S, 2013, EMBO J, V32, P874, DOI 10.1038/emboj.2013.32; Chong YT, 2010, NEW PHYTOL, V185, P401, DOI 10.1111/j.1469-8137.2009.03070.x; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; Crowell EF, 2009, PLANT CELL, V21, P1141, DOI 10.1105/tpc.108.065334; Cvrckova F, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00159; Delhaize E, 1999, J BIOL CHEM, V274, P7082, DOI 10.1074/jbc.274.11.7082; Dettmer J, 2011, CURR OPIN CELL BIOL, V23, P686, DOI 10.1016/j.ceb.2011.09.006; FADOK VA, 1992, J IMMUNOL, V148, P2207; French AP, 2008, NAT PROTOC, V3, P619, DOI 10.1038/nprot.2008.31; Gomord V, 1997, PLANT J, V11, P313, DOI 10.1046/j.1365-313X.1997.11020313.x; Gu Y, 2010, P NATL ACAD SCI USA, V107, P12866, DOI 10.1073/pnas.1007092107; Guan HZ, 2011, CHINESE SCI BULL, V56, P1476, DOI 10.1007/s11434-011-4552-9; Guillotin SE, 2005, CARBOHYD POLYM, V60, P391, DOI 10.1016/j.carbpol.2005.02.001; Gutierrez L, 2009, PLANT CELL, V21, P3119, DOI 10.1105/tpc.108.064758; HAMAMATSU S, 1994, FEBS LETT, V348, P33, DOI 10.1016/0014-5793(94)00576-1; Harholt J, 2006, PLANT PHYSIOL, V140, P49, DOI 10.1104/pp.105.072744; He B, 2009, CURR OPIN CELL BIOL, V21, P537, DOI 10.1016/j.ceb.2009.04.007; Heu M. H., 1986, Rice genetics. Proceedings of the International Rice Genetics Symposium, 27-31 May, 1985, Manila, Philippines., P317, DOI 10.1142/9789812814265_0028; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Hoshikawa K., 1989, GROWING RICE PLANT A; Iwai H, 2002, P NATL ACAD SCI USA, V99, P16319, DOI 10.1073/pnas.252530499; Jefferson RA, 1987, PLANT MOL BIOL REP, V5, P387, DOI [DOI 10.1007/BF02667740, 10.1007/bf02667740]; Keegstra K, 2010, PLANT PHYSIOL, V154, P483, DOI 10.1104/pp.110.161240; Ketelaar T, 2003, PLANT CELL, V15, P285, DOI 10.1105/tpc.007039; Kim MJ, 2006, J GEN VIROL, V87, P3425, DOI 10.1099/vir.0.82252-0; KNOX JP, 1990, PLANTA, V181, P512, DOI 10.1007/BF00193004; Kong YZ, 2015, PLANT PHYSIOL, V167, P1296, DOI 10.1104/pp.114.255943; KOOPMAN G, 1994, BLOOD, V84, P1415, DOI 10.1182/blood.V84.5.1415.1415; Krupkova E, 2007, PLANT J, V50, P735, DOI 10.1111/j.1365-313X.2007.03123.x; Lam SK, 2007, PLANT CELL, V19, P296, DOI 10.1105/tpc.106.045708; Lee S, 2012, GENES CELLS, V17, P728, DOI 10.1111/j.1365-2443.2012.01622.x; Lei L, 2015, PLANT CELL, V27, P2926, DOI 10.1105/tpc.15.00442; Leventis PA, 2010, ANNU REV BIOPHYS, V39, P407, DOI 10.1146/annurev.biophys.093008.131234; Lindeboom J, 2008, J MICROSC-OXFORD, V231, P192, DOI 10.1111/j.1365-2818.2008.02035.x; Liu JL, 2007, MOL BIOL CELL, V18, P4483, DOI 10.1091/mbc.E07-05-0461; Maekawa M, 1986, RICE GENETICS NEWSLE, V3; Matsuo Y, 2007, EUKARYOT CELL, V6, P2092, DOI 10.1128/EC.00300-07; Miao YS, 2007, NAT PROTOC, V2, P2348, DOI 10.1038/nprot.2007.360; Miao YS, 2006, PLANT PHYSIOL, V142, P945, DOI 10.1104/pp.106.083618; Mizuno-Yamasaki E, 2010, DEV CELL, V18, P828, DOI 10.1016/j.devcel.2010.03.016; Nebenfuhr A, 1999, PLANT PHYSIOL, V121, P1127, DOI 10.1104/pp.121.4.1127; Nicol F, 1998, EMBO J, V17, P5563, DOI 10.1093/emboj/17.19.5563; Pike LJ, 2002, BIOCHEMISTRY-US, V41, P2075, DOI 10.1021/bi0156557; Roudier F, 2005, PLANT CELL, V17, P1749, DOI 10.1105/tpc.105.031732; Schindelman G, 2001, GENE DEV, V15, P1115, DOI 10.1101/gad.879101; Shen JB, 2013, PLANT J, V75, P1003, DOI 10.1111/tpj.12257; Shevell DE, 2000, PLANT CELL, V12, P2047, DOI 10.1105/tpc.12.11.2047; Uchida Y, 2011, P NATL ACAD SCI USA, V108, P15846, DOI 10.1073/pnas.1109101108; UPDEGRAFF DM, 1969, ANAL BIOCHEM, V32, P420, DOI 10.1016/S0003-2697(69)80009-6; Vance JE, 2008, J LIPID RES, V49, P1377, DOI 10.1194/jlr.R700020-JLR200; Wang JA, 2010, PLANT CELL, V22, P4009, DOI 10.1105/tpc.110.080697; WILLIAMSON P, 1995, BIOCHEMISTRY-US, V34, P10448, DOI 10.1021/bi00033a017; Wolf S, 2009, MOL PLANT, V2, P851, DOI 10.1093/mp/ssp066; Worden N, 2012, J INTEGR PLANT BIOL, V54, P875, DOI 10.1111/j.1744-7909.2012.01179.x; Wu B, 2012, PLANT PHYSIOL, V159, P1440, DOI 10.1104/pp.112.195529; Wu ZM, 2007, PLANT PHYSIOL, V145, P29, DOI 10.1104/pp.107.100321; Xiao Hui-hai, 2007, Zhongguo Shuidao Kexue, V21, P537; Yamaoka Y, 2011, PLANT J, V67, P648, DOI 10.1111/j.1365-313X.2011.04624.x; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066; Yin HF, 2013, PLANTA, V237, P15, DOI 10.1007/s00425-012-1736-5; Zhang BC, 2009, PLANT MOL BIOL, V71, P509, DOI 10.1007/s11103-009-9536-4; Zhang Y, 2010, J INTEGR PLANT BIOL, V52, P138, DOI 10.1111/j.1744-7909.2010.00929.x; Zheng HQ, 2004, PLANT J, V37, P398, DOI 10.1046/j.1365-313X.2003.01969.x; Zhou HL, 2006, PLANT MOL BIOL, V60, P137, DOI 10.1007/s11103-005-2972-x; Zhou YH, 2009, PLANT J, V57, P446, DOI 10.1111/j.1365-313X.2008.03703.x; Zhu L, 2011, PLANT MOL BIOL, V77, P475, DOI 10.1007/s11103-011-9825-6; Zhu YY, 2006, PLANT CELL, V18, P442, DOI 10.1105/tpc.105.038455	72	8	10	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153119	10.1371/journal.pone.0153119	http://dx.doi.org/10.1371/journal.pone.0153119			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27055010	gold, Green Published			2022-12-27	WOS:000373608000079
J	Mantaj, J; Jackson, PJM; Karu, K; Rahman, KM; Thurston, DE				Mantaj, Julia; Jackson, Paul J. M.; Karu, Kersti; Rahman, Khondaker M.; Thurston, David E.			Covalent Bonding of Pyrrolobenzodiazepines (PBDs) to Terminal Guanine Residues within Duplex and Hairpin DNA Fragments	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; ANTITUMOR ANTIBIOTICS; POLYAMIDE CONJUGATE; REPAIR PATHWAYS; AGENT SJG-136; PHASE-I; SEQUENCE; BINDING; DRUG; ANTHRAMYCIN	Pyrrolobenzodiazepines (PBDs) are covalent-binding DNA-interactive agents with growing importance as payloads in Antibody Drug Conjugates (ADCs). Until now, PBDs were thought to covalently bond to C2-NH2 groups of guanines in the DNA-minor groove across a three-base-pair recognition sequence. Using HPLC/MS methodology with designed hairpin and duplex oligonucleotides, we have now demonstrated that the PBD Dimer SJG-136 and the C8-conjugated PBD Monomer GWL-78 can covalently bond to a terminal guanine of DNA, with the PBD skeleton spanning only two base pairs. Control experiments with the non-C8-conjugated anthramycin along with molecular dynamics simulations suggest that the C8-substituent of a PBD Monomer, or one-half of a PBD Dimer, may provide stability for the adduct. This observation highlights the importance of PBD C8-substituents, and also suggests that PBDs may bind to terminal guanines within stretches of DNA in cells, thus representing a potentially novel mechanism of action at the end of DNA strand breaks.	[Mantaj, Julia; Rahman, Khondaker M.; Thurston, David E.] Kings Coll London, Inst Pharmaceut Sci, 7 Trinity St, London SE1 1DB, England; [Jackson, Paul J. M.; Rahman, Khondaker M.; Thurston, David E.] Femtogenix Ltd, Britannia House,7 Trinity St, London SE1 1DB, England; [Karu, Kersti] UCL, Chem Mass Spectrometry Facil, Dept Chem, Christopher Ingold Bldg,20 Gordon St, London WC1H 0AJ, England	University of London; King's College London; University of London; University College London	Rahman, KM; Thurston, DE (corresponding author), Kings Coll London, Inst Pharmaceut Sci, 7 Trinity St, London SE1 1DB, England.; Rahman, KM; Thurston, DE (corresponding author), Femtogenix Ltd, Britannia House,7 Trinity St, London SE1 1DB, England.	k.miraz.rahman@kcl.ac.uk; david.thurston@kcl.ac.uk	Rahman, Miraz/M-2749-2017	Rahman, Miraz/0000-0001-8566-8648; MANTAJ, JULIA/0000-0002-1155-5664	Femtogenix Ltd; King's College London	Femtogenix Ltd; King's College London	The funder (Femtogenix Ltd) provided support (in part) in the form of salaries for Paul J. M. Jackson (PJMJ) and Julia Mantaj (JM), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. David E. Thurston (DET) and Khondaker M. Rahman (KMR) received a full salary from King's College London, as did Kirsty Karu from Imperial College London. Paul Jackson (PJ) received the balance of his salary from King's College London, and Julia Mantaj was a self-funded PhD student during most of the period of the study.	Andreassen PR, 2009, CURR CANCER DRUG TAR, V9, P101, DOI 10.2174/156800909787314011; Antonow D, 2011, CHEM REV, V111, P2815, DOI 10.1021/cr100120f; Brucoli F, 2013, J MED CHEM, V56, P6339, DOI 10.1021/jm4001852; Case D.A., 2022, AMBER 2020; Cipolla L, 2009, ANTI-CANCER AGENT ME, V9, P1, DOI 10.2174/187152009787047743; Clingen PH, 2005, NUCLEIC ACIDS RES, V33, P3283, DOI 10.1093/nar/gki639; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Gregson SJ, 2001, J MED CHEM, V44, P737, DOI 10.1021/jm001064n; Helleday T, 2008, NAT REV CANCER, V8, P193, DOI 10.1038/nrc2342; HERTZBERG RP, 1986, BIOCHEMISTRY-US, V25, P1249, DOI 10.1021/bi00354a009; Hochhauser D, 2009, CLIN CANCER RES, V15, P2140, DOI 10.1158/1078-0432.CCR-08-1315; Hsieh MC, 2011, TOXICOL APPL PHARM, V255, P150, DOI 10.1016/j.taap.2011.06.008; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jackson PJM, 2014, ACS CHEM BIOL, V9, P2432, DOI 10.1021/cb5002203; Janjigian YY, 2010, CANCER CHEMOTH PHARM, V65, P833, DOI 10.1007/s00280-009-1088-4; Jeffrey SC, 2013, BIOCONJUGATE CHEM, V24, P1256, DOI 10.1021/bc400217g; JENKINS TC, 1994, J MED CHEM, V37, P4529, DOI 10.1021/jm00052a012; Kamal A, 2009, BIOORGAN MED CHEM, V17, P1557, DOI 10.1016/j.bmc.2008.12.068; Kamal Ahmed, 2002, Current Medicinal Chemistry - Anti-Cancer Agents, V2, P215, DOI 10.2174/1568011023354119; KOPKA ML, 1985, J MOL BIOL, V183, P553, DOI 10.1016/0022-2836(85)90171-8; KOPKA ML, 1994, BIOCHEMISTRY-US, V33, P13593, DOI 10.1021/bi00250a011; Kotecha M, 2008, MOL CANCER THER, V7, P1319, DOI 10.1158/1535-7163.MCT-07-0475; Mantaj J, 2013, AM ASS CANC RES ANN; Martin C, 2005, BIOCHEMISTRY-US, V44, P4135, DOI 10.1021/bi0479813; Narayanaswamy M, 2008, ANAL BIOCHEM, V374, P173, DOI 10.1016/j.ab.2007.11.018; Narendran A, 2010, PEDIATR BLOOD CANCER, V54, P814; Perez A, 2007, BIOPHYS J, V92, P3817, DOI 10.1529/biophysj.106.097782; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PUVVADA MS, 1993, NUCLEIC ACIDS RES, V21, P3671, DOI 10.1093/nar/21.16.3671; Puvvada MS, 1997, BIOCHEMISTRY-US, V36, P2478, DOI 10.1021/bi952490r; Rahman KM, 2013, J MED CHEM, V56, P2911, DOI 10.1021/jm301882a; Rahman KM, 2011, J AM CHEM SOC, V133, P19376, DOI 10.1021/ja205395r; Rahman KM, 2011, NUCLEIC ACIDS RES, V39, P5800, DOI 10.1093/nar/gkr122; Rahman KM, 2011, ORG BIOMOL CHEM, V9, P1632, DOI 10.1039/c0ob00762e; Rahman KM, 2010, ACS MED CHEM LETT, V1, P427, DOI 10.1021/ml100131b; Rahman KM, 2009, J AM CHEM SOC, V131, P13756, DOI 10.1021/ja902986x; RAO SN, 1986, J MED CHEM, V29, P2484, DOI 10.1021/jm00162a011; Stein EM, 2014, 56 ASH ANN M EXP 6 9; Sutherland MSK, 2013, BLOOD, V122, P1455, DOI 10.1182/blood-2013-03-491506; Thurston D. E., 1993, MOL ASPECTS ANTICANC, P54; THURSTON DE, 1994, CHEM REV, V94, P433, DOI 10.1021/cr00026a006; Thurston DE, 2006, CHEM PHARM ANTICANCE, V1, P281; Wells G, 2006, J MED CHEM, V49, P5442, DOI 10.1021/jm051199z	43	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0152303	10.1371/journal.pone.0152303	http://dx.doi.org/10.1371/journal.pone.0152303			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27055050	Green Published, gold, Green Submitted			2022-12-27	WOS:000373608000015
J	Sontakke, P; Koczula, KM; Jaques, J; Wierenga, ATJ; Brouwers-Vos, AZ; Pruis, M; Gunther, UL; Vellenga, E; Schuringa, JJ				Sontakke, Pallavi; Koczula, Katarzyna M.; Jaques, Jennifer; Wierenga, Albertus T. J.; Brouwers-Vos, Annet Z.; Pruis, Maurien; Guenther, Ulrich L.; Vellenga, Edo; Schuringa, Jan Jacob			Hypoxia-Like Signatures Induced by BCR-ABL Potentially Alter the Glutamine Uptake for Maintaining Oxidative Phosphorylation	PLOS ONE			English	Article							CHRONIC MYELOID-LEUKEMIA; GENE-EXPRESSION; SELF-RENEWAL; ENFORCED EXPRESSION; UP-REGULATION; CELL-GROWTH; STEM-CELLS; SURVIVAL; PROLIFERATION; CARBOXYLATION	The Warburg effect is probably the most prominent metabolic feature of cancer cells, although little is known about the underlying mechanisms and consequences. Here, we set out to study these features in detail in a number of leukemia backgrounds. The transcriptomes of human CB CD34(+) cells transduced with various oncogenes, including BCR-ABL, MLL-AF9, FLT3-ITD, NUP98-HOXA9, STAT5A and KRAS(G12V) were analyzed in detail. Our data indicate that in particular BCR-ABL, KRAS(G12V) and STAT5 could impose hypoxic signaling under normoxic conditions. This coincided with an upregulation of glucose importers SLC2A1/3, hexokinases and HIF1 and 2. NMR-based metabolic profiling was performed in CB CD34(+) cells transduced with BCR-ABL versus controls, both cultured under normoxia and hypoxia. Lactate and pyruvate levels were increased in BCR-ABL-expressing cells even under normoxia, coinciding with enhanced glutaminolysis which occurred in an HIF1/2-dependent manner. Expression of the glutamine importer SLC1A5 was increased in BCR-ABL(+) cells, coinciding with an increased susceptibility to the glutaminase inhibitor BPTES. Oxygen consumption rates also decreased upon BPTES treatment, indicating a glutamine dependency for oxidative phosphorylation. The current study suggests that BCR-ABL-positive cancer cells make use of enhanced glutamine metabolism to maintain TCA cell cycle activity in glycolytic cells.	[Sontakke, Pallavi; Jaques, Jennifer; Wierenga, Albertus T. J.; Brouwers-Vos, Annet Z.; Pruis, Maurien; Vellenga, Edo; Schuringa, Jan Jacob] Univ Groningen, Univ Med Ctr Groningen, Canc Res Ctr Groningen, Dept Expt Hematol, Groningen, Netherlands; [Koczula, Katarzyna M.; Guenther, Ulrich L.] Univ Birmingham, Inst Canc & Genom Sci, Birmingham, W Midlands, England; [Wierenga, Albertus T. J.] Univ Groningen, Univ Med Ctr Groningen, Dept Lab Med, Groningen, Netherlands	University of Groningen; University of Birmingham; University of Groningen	Schuringa, JJ (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Canc Res Ctr Groningen, Dept Expt Hematol, Groningen, Netherlands.	j.j.schuringa@umcg.nl		Sontakke, Pallavi/0000-0001-5170-6271	Dutch Cancer society [2009-4411]; METAFLUX MarieCurie Initial Training Network from the EU [FP7-PEOPLE-2010-ITN-364780]	Dutch Cancer society(KWF Kankerbestrijding); METAFLUX MarieCurie Initial Training Network from the EU	This work was supported by a grant from Dutch Cancer society (2009-4411). Katarzyna M. Koczula was funded by the METAFLUX MarieCurie Initial Training Network (FP7-PEOPLE-2010-ITN-364780) from the EU held by ULG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. URL Dutch Cancer Foundation: https://www.kwf.nl/Pages/default.aspx. URL EU ITN: http://ec.europa.eu/research/mariecurieactions/about-msca/actions/itn/index_en.htm.	Ahmed W, 2013, CURR HEMATOL MALIG R, V8, P71, DOI 10.1007/s11899-012-0150-1; Alcalay M, 2005, BLOOD, V106, P899, DOI 10.1182/blood-2005-02-0560; Boren J, 2001, J BIOL CHEM, V276, P37747; Cea M, 2013, CURR CANCER DRUG TAR, V13, P711, DOI 10.2174/15680096113139990085; Chalandon Y, 2004, LEUKEMIA, V18, P1006, DOI 10.1038/sj.leu.2403335; Chalandon Y, 2002, BLOOD, V99, P3197, DOI 10.1182/blood.V99.9.3197; Chung KY, 2006, CANCER RES, V66, P11781, DOI 10.1158/0008-5472.CAN-06-0706; Chung KY, 2005, BLOOD, V105, P77, DOI 10.1182/blood-2003-12-4445; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Emadi A, 2013, EXP HEMATOL; Emadi A, 2014, EXP HEMATOL, V42, P247, DOI 10.1016/j.exphem.2013.12.001; Fatrai S, 2011, BLOOD, V117, P3320, DOI 10.1182/blood-2010-08-303669; Fatrai S, 2011, J BIOL CHEM, V286, P6061, DOI 10.1074/jbc.M110.201848; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Gottschalk S, 2004, CLIN CANCER RES, V10, P6661, DOI 10.1158/1078-0432.CCR-04-0039; Horton SJ, 2013, LEUKEMIA, V27, P1116, DOI 10.1038/leu.2012.343; Kaluz S, 2008, CLIN CHIM ACTA, V395, P6, DOI 10.1016/j.cca.2008.05.002; Le A, 2012, CELL METAB, V15, P110, DOI 10.1016/j.cmet.2011.12.009; Ludwig C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-366; Melo JV, 2007, NAT REV CANCER, V7, P441, DOI 10.1038/nrc2147; Mullen AR, 2012, NATURE, V481, P385, DOI 10.1038/nature10642; NOWELL PC, 1961, JNCI-J NATL CANCER I, V27, P1013; Oburoglu L, 2014, CELL STEM CELL; Ren R, 2005, NAT REV CANCER, V5, P172, DOI 10.1038/nrc1567; Rizo A, 2010, BLOOD, V116, P4621, DOI 10.1182/blood-2010-02-270660; Rouault-Pierre K, 2013, CELL STEM CELL, V13, P549, DOI 10.1016/j.stem.2013.08.011; ROWLEY JD, 1973, NATURE, V243, P290, DOI 10.1038/243290a0; Schuringa JJ, 2004, STEM CELLS, V22, P1191, DOI 10.1634/stemcells.2004-0033; Schuringa JJ, 2004, J EXP MED, V200, P623, DOI 10.1084/jem.20041024; Semenza GL, 2007, BIOCHEM J, V405, P1, DOI 10.1042/BJ20070389; SHTIVELMAN E, 1985, NATURE, V315, P550, DOI 10.1038/315550a0; Sinclair A, 2013, BRIT J PHARMACOL, V169, P1693, DOI 10.1111/bph.12183; Takubo K, 2013, CELL STEM CELL, V12, P49, DOI 10.1016/j.stem.2012.10.011; Van Etten RA, 2002, ONCOGENE, V21, P8643, DOI 10.1038/sj.onc.1206091; Verhaak RGW, 2005, BLOOD, V106, P3747, DOI 10.1182/blood-2005-05-2168; Wang Y, 2011, CELL STEM CELL, V8, P399, DOI 10.1016/j.stem.2011.02.006; Wierenga ATJ, 2008, MOL CELL BIOL, V28, P6668, DOI 10.1128/MCB.01025-08; Wierenga ATJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093494; Wierenga ATJ, 2010, BLOOD, V115, P4367, DOI 10.1182/blood-2009-10-250894; Wise DR, 2011, P NATL ACAD SCI USA, V108, P19611, DOI 10.1073/pnas.1117773108; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Woolthuis CM, 2012, LEUKEMIA, V26, P848, DOI 10.1038/leu.2011.277; Yu WM, 2013, CELL STEM CELL, V12, P62, DOI 10.1016/j.stem.2012.11.022; Zhang HJ, 2012, BLOOD, V119, P2595, DOI 10.1182/blood-2011-10-387381; Zhao F, 2010, ONCOGENE, V29, P2962, DOI 10.1038/onc.2010.67	45	15	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153226	10.1371/journal.pone.0153226	http://dx.doi.org/10.1371/journal.pone.0153226			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27055152	Green Published, Green Submitted, gold			2022-12-27	WOS:000373608000104
J	Twabela, AT; Mweene, AS; Masumu, JM; Muma, JB; Lombe, BP; Hankanga, C				Twabela, Augustin Tshibwabwa; Mweene, Aaron Simanyengwe; Masumu, Justin Mulumbu; Muma, John Bwalya; Lombe, Boniface Pongombo; Hankanga, Careen			Overview of Animal Rabies in Kinshasa Province in the Democratic Republic of Congo	PLOS ONE			English	Article							AFRICA	Introduction Rabies is one of the major public health problems mostly affecting developing countries in Africa and Asia where 99.9% of all rabies related human deaths are recorded each year. In Democratic Republic of Congo, repeated outbreaks have been reported. Despite this, there is little reliable epidemiological data about rabies in the country for the development of effective control strategies. Materials and Methods A retrospective study was carried out in Kinshasa Province during a period of five years (2009-2013) to describe the proportion of rabid animals and the species involved in rabies transmission and maintenance. The survey also aimed at describing the spatial-temporal distribution of rabies. To gather information, the daily registers of institutions involved in rabies diagnosis were reviewed and each rabies case was traced back to area of occurrence for collection of geographic coordinates. Results and Discussion A total of 5,053 attacks were registered involving six animal species including dog, cat, monkey, rabbit, rat, and pig. Based on clinical observations, rabies was reported in dogs and cats while data obtained from the laboratory confirmed rabies cases included dogs, cats and a goat. The annual distribution showed a significant decrease of rabies cases from 2009 up to 2011 and a later increase up to 2013. There was no difference in rabies occurrence between seasons (p = 0.721). Rabies cases were three times higher in peri-urban zone than in urban zone OR = 3.4 (95% CI: 2.3-5.1). The positive proportion of rabies was 2.6% (95% CI: 2.1-3) based on clinical evidence and 65.9%(95% CI: 50-79.5) for laboratory confirmed cases. Conclusion and Suggestion This study confirms the endemicity of rabies in Kinshasa where occurrence of rabies cases was related to human population density and lifestyle. In order to control rabies, there is need to set up a surveillance program and implement efficient mass vaccination campaigns of susceptible animals.	[Twabela, Augustin Tshibwabwa; Masumu, Justin Mulumbu; Lombe, Boniface Pongombo] Vet Lab Kinshasa, Kinshasa, DEM REP CONGO; [Mweene, Aaron Simanyengwe; Muma, John Bwalya; Hankanga, Careen] Univ Zambia, Sch Vet Med, Lusaka, Zambia; [Masumu, Justin Mulumbu; Lombe, Boniface Pongombo] Univ Pedag Natl, Kinshasa, DEM REP CONGO	University of Zambia	Twabela, AT (corresponding author), Vet Lab Kinshasa, Kinshasa, DEM REP CONGO.	ttaugusha@yahoo.fr	Muma, John/R-9602-2019	Muma, John/0000-0001-6180-4051; TSHIBWABWA TWABELA, Augustin/0000-0003-0695-2734	Welcome Trust [WT087546MA]; Southern African Centre for Infectious Diseases Surveillance (SACIDS)	Welcome Trust(Wellcome Trust); Southern African Centre for Infectious Diseases Surveillance (SACIDS)	This work was supported by the Welcome Trust, Grant number WT087546MA; under the sponsorship of Southern African Centre for Infectious Diseases Surveillance (SACIDS); for a Master programme in One Health Analytical Epidemiology. SACIDS website: www.sacids.org. Welcome Trust website: www.wellcome.ac.uk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acha P. N., 1985, Rabies in the tropics. Proceedings of an international conference on rabies control in the tropics, Tunis, Oct. 3-6, 1983, P343; Alan CJ, 2007, HUMAN DIS, P309; Anderson Roy M, 1992, INFECT DIS HUMANS DY; [Anonymous], 1992, WHO TECH REP SER, P1; [Anonymous], 2012, AGA ACTION FAO TAKIN; [Anonymous], 2014, ANN STAT; Cliquet F, 2004, REV SCI TECH OIE, V23, P625, DOI 10.20506/rst.23.2.1514; Coetzee P, 2007, VIRUS RES, V126, P186, DOI 10.1016/j.virusres.2007.02.020; Deressa A, 2010, ETHIOP J HEALTH DEV, V24; Gsell AS, 2012, BMC VET RES, V8, P1, DOI 10.1186/1746-6148-8-236; Hanlon C.A., 2007, RABIES, P201, DOI DOI 10.1016/B978-012369366-2/50007-5; Kitala PM, 2000, PREV VET MED, V44, P73, DOI 10.1016/S0167-5877(99)00114-2; Knobel DL, 2005, B WORLD HEALTH ORGAN, V83, P360; Lembo T, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000626; Munang'andu HM, 2011, ZOONOSES PUBLIC HLTH, V58, P21, DOI 10.1111/j.1863-2378.2010.01368.x; Muyila DI, 2014, PATHOG GLOB HEALTH, V108, P317, DOI 10.1179/2047773214Y.0000000161; Pauwels L, 1993, NZAYILU N TI GUIDE A; Rupprecht CE, 2002, LANCET INFECT DIS, V2, P327, DOI 10.1016/S1473-3099(02)00287-6; SEGANTI L, 1990, ACTA VIROL, V34, P155; Swai E S, 2010, Tanzan J Health Res, V12, P80	20	11	11	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0150403	10.1371/journal.pone.0150403	http://dx.doi.org/10.1371/journal.pone.0150403			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27054328	gold, Green Published, Green Submitted			2022-12-27	WOS:000373608000003
J	Van Uem, JMT; Walgaard, S; Ainsworth, E; Hasmann, SE; Heger, T; Nussbaum, S; Hobert, MA; Mico-Amigo, EM; Van Lummel, RC; Berg, D; Maetzler, W				Van Uem, Janet M. T.; Walgaard, Stefan; Ainsworth, Erik; Hasmann, Sandra E.; Heger, Tanja; Nussbaum, Susanne; Hobert, Markus A.; Mico-Amigo, Encarnacion M.; Van Lummel, Rob C.; Berg, Daniela; Maetzler, Walter			Quantitative Timed-Up-and-Go Parameters in Relation to Cognitive Parameters and Health-Related Quality of Life in Mild-to-Moderate Parkinson's Disease	PLOS ONE			English	Article							INSTRUMENTAL ACTIVITIES; POSTURAL INSTABILITY; GAIT; IMPAIRMENT; WALKING; COORDINATION; DISABILITY; MOVEMENTS; BALANCE; HEAD	Introduction The instrumented-Timed-Up-and-Go test (iTUG) provides detailed information about the following movement patterns: sit-to-walk (siwa), straight walking, turning and walk-to-sit (wasi). We were interested in the relative contributions of respective iTUG sub-phases to specific clinical deficits most relevant for daily life in Parkinson's disease (PD). More specifically, we investigated which condition-fast speed (FS) or convenient speed (CS)-differentiates best between mild-to moderate-stage PD patients and controls, which parameters of the iTUG sub-phases are significantly different between PD patients and controls, and how the iTUG parameters associate with cognitive parameters (with particular focus on cognitive flexibility and working memory) and Health-Related-Quality of Life (HRQoL). Methods Twenty-eight PD participants (65.1 +/- 7.1 years, H&Y stage 1-3, medication OFF state) and 20 controls (66.1 +/- 7.5 years) performed an iTUG (DynaPort (R), McRoberts BV, The Netherlands) under CS and FS conditions. The PD Questionnaire 39 (PDQ-39) was employed to assess HRQoL. General cognitive and executive functions were assessed using the Montreal Cognitive Assessment and the Trail Making Test. Results The total iTUG duration and sub-phases durations under FS condition differentiated PD patients slightly better from controls, compared to the CS condition. The following subphases were responsible for the observed longer total duration PD patients needed to perform the iTUG: siwa, turn and wasi. None of the iTUG parameters correlated relevantly with general cognitive function. Turning duration and wasi maximum flexion velocity correlated strongest with executive function. Walking back duration correlated strongest with HRQoL. Discussion This study confirms that mild- to moderate-stage PD patients need more time to perform the iTUG than controls, and adds the following aspects to current literature: FS may be more powerful than CS to delineate subtle movement deficits in mild- to moderate-stage PD patients; correlation levels of intra-individual siwa and wasi parameters may be interesting surrogate markers for the level of automaticity of performed movements; and sub-phases and kinematic parameters of the iTUG may have the potential to reflect executive functioning and HRQoL aspects of PD patients.	[Van Uem, Janet M. T.; Hasmann, Sandra E.; Heger, Tanja; Nussbaum, Susanne; Hobert, Markus A.; Berg, Daniela; Maetzler, Walter] Univ Tubingen, Ctr Neurol, Dept Neurodegenerat, Hertie Inst Clin Brain Res, Tubingen, Germany; [Van Uem, Janet M. T.; Hasmann, Sandra E.; Heger, Tanja; Nussbaum, Susanne; Hobert, Markus A.; Berg, Daniela; Maetzler, Walter] German Ctr Neurodegenerat Dis, DZNE, Tubingen, Germany; [Walgaard, Stefan; Ainsworth, Erik; Mico-Amigo, Encarnacion M.; Van Lummel, Rob C.] McRoberts, The Hague, Netherlands; [Mico-Amigo, Encarnacion M.] Vrije Univ Amsterdam, Dept Human Movement Sci, MOVE Res Inst Amsterdam, Amsterdam, Netherlands	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Vrije Universiteit Amsterdam	Van Uem, JMT (corresponding author), Univ Tubingen, Ctr Neurol, Dept Neurodegenerat, Hertie Inst Clin Brain Res, Tubingen, Germany.; Van Uem, JMT (corresponding author), German Ctr Neurodegenerat Dis, DZNE, Tubingen, Germany.	Janet.uem@uni-tuebingen.de	Maetzler, Walter/A-6796-2011; Berg, Daniela/A-8728-2019; Maetzler, Walter/AAE-5831-2020; Hobert, Markus A./AAR-3234-2020	Maetzler, Walter/0000-0002-5945-4694; Berg, Daniela/0000-0001-5796-5442; Maetzler, Walter/0000-0002-5945-4694; Hobert, Markus A./0000-0002-7558-8107; Mico-Amigo, M. Encarna/0000-0002-8968-6373	Seventh Framework EU projects Moving beyond [316639]; Deutsche Forschungsgemeinschaft; Open Access Publishing Fund of Tuebingen University, Tuebingen, Germany	Seventh Framework EU projects Moving beyond; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publishing Fund of Tuebingen University, Tuebingen, Germany	The present research is part of the Seventh Framework EU projects Moving beyond (no. 316639), http://www.moving-beyond.eu. We acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of Tuebingen University, Tuebingen, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank all participants for their contribution to this study. We acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of Tuebingen University, Tuebingen, Germany.	Aarsland D, 2009, NEUROLOGY, V72, P1121, DOI 10.1212/01.wnl.0000338632.00552.cb; AGOSTINO R, 1992, BRAIN, V115, P1481, DOI 10.1093/brain/115.5.1481; Ayan C, 2013, ARCH GERONTOL GERIAT, V56, P44, DOI 10.1016/j.archger.2012.06.002; Balash Y, 2005, J NEUROL, V252, P1310, DOI 10.1007/s00415-005-0855-3; Beilock SL, 2001, J EXP PSYCHOL GEN, V130, P701, DOI 10.1037/0096-3445.130.4.701; BENECKE R, 1987, BRAIN, V110, P361, DOI 10.1093/brain/110.2.361; Bernstein N, 1967, COORDINATION REGULAT; Bloem BR, 1998, J NEUROL, V245, P669, DOI 10.1007/s004150050265; Buchman AS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086262; Buckley TA, 2008, MOVEMENT DISORD, V23, P1274, DOI 10.1002/mds.22079; Cahn DA, 1998, ARCH CLIN NEUROPSYCH, V13, P575, DOI 10.1016/S0887-6177(98)00024-9; Cheng FY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093572; Crenna P, 2007, GAIT POSTURE, V26, P172, DOI 10.1016/j.gaitpost.2007.04.010; Dancey C., 2004, STAT MATH PSYCHOL US; Dewey DC, 2014, J NEUROL SCI, V345, P131, DOI 10.1016/j.jns.2014.07.026; Dillmann U, 2014, GAIT POSTURE, V39, P882, DOI 10.1016/j.gaitpost.2013.11.021; Disbrow EA, 2013, J PARKINSON DIS, V3, P181, DOI 10.3233/JPD-130181; Ellis T, 2011, PARKINSONISM RELAT D, V17, P693, DOI 10.1016/j.parkreldis.2011.07.004; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Franzen E, 2009, EXP NEUROL, V219, P430, DOI 10.1016/j.expneurol.2009.06.013; Fuller JR, 2007, GAIT POSTURE, V25, P393, DOI 10.1016/j.gaitpost.2006.05.013; Gill DJ, 2008, MOVEMENT DISORD, V23, P1043, DOI 10.1002/mds.22017; Goetz CG, 2007, MOVEMENT DISORD, V22, P41, DOI 10.1002/mds.21198; Grasso R, 1998, NEUROSCI LETT, V253, P115, DOI 10.1016/S0304-3940(98)00625-9; Hasmann SE, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00286; Higginson CI, 2013, J CLIN EXP NEUROPSYC, V35, P530, DOI 10.1080/13803395.2013.798397; Hobert MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027831; Huxham F, 2008, MOVEMENT DISORD, V23, P1391, DOI 10.1002/mds.21943; Jacobs JV, 2005, EXP BRAIN RES, V166, P78, DOI 10.1007/s00221-005-2346-2; JANKOVIC J, 1990, NEUROLOGY, V40, P1529, DOI 10.1212/WNL.40.10.1529; Jenkinson C, 1998, PARKINSONS DIS QUEST, P1; Kelly VE, 2015, PARKINSONISM RELAT D, V21, P692, DOI 10.1016/j.parkreldis.2015.04.002; Keus SH., 2014, EUROPEAN PHYSIOTHERA; Kim HF, 2015, BRAIN, V138, P1776, DOI 10.1093/brain/awv134; Litvan I, 2012, MOVEMENT DISORD, V27, P349, DOI 10.1002/mds.24893; Maetzler W, 2013, MOVEMENT DISORD, V28, P1576, DOI 10.1002/mds.25682; Maetzler W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032240; Maetzler W, 2012, MOVEMENT DISORD, V27, P627, DOI 10.1002/mds.24973; Mancini M, 2012, GAIT POSTURE, V36, P471, DOI 10.1016/j.gaitpost.2012.04.010; Marras C, 2008, MOVEMENT DISORD, V23, P653, DOI 10.1002/mds.21853; Milman U, 2014, J PARKINSON DIS, V4, P37, DOI 10.3233/JPD-130321; Mirelman A, 2011, ANN NEUROL, V69, P193, DOI 10.1002/ana.22165; Morris ME, 2001, CLIN BIOMECH, V16, P459, DOI 10.1016/S0268-0033(01)00035-3; Morris S, 2001, RES REPORT RELIABILI, P810; Muslimovic D, 2008, NEUROLOGY, V70, P2241, DOI 10.1212/01.wnl.0000313835.33830.80; Panyakaew P, 2013, J NEURAL TRANSM, V120, P1665, DOI 10.1007/s00702-013-1051-8; Peto V, 1998, J NEUROL, V245, pS10, DOI 10.1007/PL00007730; Plotnik M, 2007, EXP BRAIN RES, V181, P561, DOI 10.1007/s00221-007-0955-7; Roemmich RT, 2013, CLIN BIOMECH, V28, P93, DOI 10.1016/j.clinbiomech.2012.09.005; Salarian A, 2010, IEEE T NEUR SYS REH, V18, P303, DOI 10.1109/TNSRE.2010.2047606; Scalzo PL, 2012, ARQ NEURO-PSIQUIAT, V70, P119, DOI 10.1590/S0004-282X2012000200009; Shulman LM, 2010, MOVEMENT DISORD, V25, pS131, DOI 10.1002/mds.22789; Siepel FJ, 2014, MOVEMENT DISORD, V29, P1802, DOI 10.1002/mds.26051; Smulders K, 2013, PARKINSONISM RELAT D, V19, P126, DOI 10.1016/j.parkreldis.2012.06.010; Soh SE, 2013, QUAL LIFE RES, V22, P1543, DOI 10.1007/s11136-012-0289-1; Soh SE, 2011, PARKINSONISM RELAT D, V17, P1, DOI 10.1016/j.parkreldis.2010.08.012; Spildooren J, 2013, MOVEMENT DISORD, V28, P619, DOI 10.1002/mds.25285; Stack E, 2008, DISABIL REHABIL, V30, P1222, DOI 10.1080/09638280701829938; Stegemoller EL, 2014, ARCH PHYS MED REHAB, V95, P649, DOI 10.1016/j.apmr.2013.10.031; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; van Uem JMT, 2016, NEUROSCI BIOBEHAV R, V61, P26, DOI 10.1016/j.neubiorev.2015.11.014; van Uem JMT, J PARKINSONS DIS; Walgaard S, J BIOTECHNOLOGY; Wang YQ, 2015, J CLIN NEUROSCI, V22, P981, DOI 10.1016/j.jocn.2014.11.030; Weiss A, 2010, MED ENG PHYS, V32, P119, DOI 10.1016/j.medengphy.2009.10.015; Williamson R, 2001, MED BIOL ENG COMPUT, V39, P294, DOI 10.1007/BF02345283; Wood-Dauphinee, 1999, JOUNAL CLIN EPIMEMIO, V52, P355; Wu T, 2005, BRAIN, V128, P2250, DOI 10.1093/brain/awh569; Wu T, 2015, NEUROBIOL DIS, V82, P226, DOI 10.1016/j.nbd.2015.06.014; Wu T, 2015, CEREB CORTEX, V25, P3330, DOI 10.1093/cercor/bhu135; Wu T, 2010, NEUROIMAGE, V49, P2581, DOI 10.1016/j.neuroimage.2009.10.051; Wulf G, 2001, PSYCHON B REV, V8, P648, DOI 10.3758/BF03196201	72	25	25	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0151997	10.1371/journal.pone.0151997	http://dx.doi.org/10.1371/journal.pone.0151997			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DI6KO	27055262	gold, Green Published, Green Submitted			2022-12-27	WOS:000373608000010
J	Brureau, L; Moningo, D; Emeville, E; Ferdinand, S; Punga, A; Lufuma, S; Blanchet, P; Romana, M; Multigner, L				Brureau, Laurent; Moningo, Dieudonne; Emeville, Elise; Ferdinand, Severine; Punga, Augustin; Lufuma, Simon; Blanchet, Pascal; Romana, Marc; Multigner, Luc			Polymorphisms of Estrogen Metabolism-Related Genes and Prostate Cancer Risk in Two Populations of African Ancestry	PLOS ONE			English	Article							COMT VAL158MET POLYMORPHISM; CYP17 GENE; TEA POLYPHENOLS; NO ASSOCIATION; HORMONE-LEVELS; REPEAT; MEN; AGGRESSIVENESS; COMBINATION; EXPRESSION	Background Estrogens are thought to play a critical role in prostate carcinogenesis. It has been suggested that polymorphisms of genes encoding enzymes involved in estrogen metabolism are risk factors for prostate cancer. However, few studies have been performed on populations of African ancestry, which are known to have a high risk of prostate cancer. Objective We investigated whether functional polymorphisms of CYP17, CYP19, CYP1B1, COMT and UGT1A1 affected the risk of prostate cancer in two different populations of African ancestry. Methods In Guadeloupe (French West Indies), we compared 498 prostate cancer patients and 565 control subjects. In Kinshasa (Democratic Republic of Congo), 162 prostate cancer patients were compared with 144 controls. Gene polymorphisms were determined by the SNaPshot technique or short tandem repeat PCR analysis. Logistic regression was used to estimate adjusted odds ratios (OR) and 95% confidence intervals (CI). Results The AA genotype and the A allele of rs4680 (COMT) appeared to be inversely associated with the risk of prostate cancer in adjusted models for both Afro-Caribbean and native African men. For the A allele, a significant inverse association was observed among cases with low-grade Gleason scores and localized clinical stage, in both populations. Conclusions These preliminary results support the hypothesis that polymorphisms of genes encoding enzymes involved in estrogen metabolism may modulate the risk of prostate cancer in populations of African ancestry.	[Brureau, Laurent; Emeville, Elise; Blanchet, Pascal; Multigner, Luc] INSERM, U1085, IRSET, Pointe A Pitre, Guadeloupe, France; [Brureau, Laurent; Blanchet, Pascal] CHU Pointe A Pitre, Serv Urol, Pointe A Pitre, Guadeloupe, France; [Brureau, Laurent; Ferdinand, Severine; Blanchet, Pascal; Romana, Marc] Univ Antilles, Pointe A Pitre, Guadeloupe, France; [Moningo, Dieudonne; Punga, Augustin; Lufuma, Simon] Clin Univ Kinshasa, Serv Urol, Kinshasa, DEM REP CONGO; [Emeville, Elise; Multigner, Luc] Univ Rennes 1, Rennes, France; [Ferdinand, Severine; Romana, Marc] INSERM, U1134, Pointe A Pitre, Guadeloupe, France	Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Guadeloupe; Universite des Antilles; Universite de Kinshasa; Universite de Rennes; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Multigner, L (corresponding author), INSERM, U1085, IRSET, Pointe A Pitre, Guadeloupe, France.; Multigner, L (corresponding author), Univ Rennes 1, Rennes, France.	luc.multigner@inserm.fr	Multigner, Luc/AAA-6214-2020; Multigner, Luc/I-2926-2015; Romana, Marc/K-6442-2017	Multigner, Luc/0000-0003-3205-8568; Multigner, Luc/0000-0003-3205-8568; Romana, Marc/0000-0002-8715-9836; FERDINAND, Severine/0000-0001-8258-5089	French Health Directorate; Ligue contre le cancer	French Health Directorate; Ligue contre le cancer(Ligue nationale contre le cancer)	This work was supported by the French Health Directorate (LM) (no grant number), and Ligue contre le cancer (EE) (a doctoral fellowship). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, CANCER FACTS FIGURES; Ben-Shlomo Y, 2008, EUR UROL, V53, P99, DOI 10.1016/j.eururo.2007.02.047; Beuten J, 2009, CANCER EPIDEM BIOMAR, V18, P1869, DOI 10.1158/1055-9965.EPI-09-0076; Bosland M C, 2000, J Natl Cancer Inst Monogr, P39; BOSMA PJ, 1995, NEW ENGL J MED, V333, P1171, DOI 10.1056/NEJM199511023331802; Cancel-Tassin G, 2005, BJU INT, V96, P1380, DOI 10.1111/j.1464-410X.2005.05836.x; Carruba G, 2007, J CELL BIOCHEM, V102, P899, DOI 10.1002/jcb.21529; Center MM, 2012, EUR UROL, V61, P1079, DOI 10.1016/j.eururo.2012.02.054; Cheng ZQ, 1998, TOXICOL SCI, V45, P52, DOI 10.1006/toxs.1998.2494; Cicek MS, 2004, PROSTATE, V59, P69, DOI 10.1002/pros.10358; Cui LL, 2012, MOL BIOL REP, V39, P7465, DOI 10.1007/s11033-012-1579-y; Cussenot O, 2007, J CLIN ONCOL, V25, P3596, DOI 10.1200/JCO.2007.11.0908; Damber JE, 2008, LANCET, V371, P1710, DOI 10.1016/S0140-6736(08)60729-1; dos Santos A, 2002, PROSTATE CANCER P D, V5, P28, DOI 10.1038/sj/pcan/4500550; Hanna IH, 2000, CANCER RES, V60, P3440; Hsing AW, 2006, FRONT BIOSCI-LANDMRK, V11, P1388, DOI 10.2741/1891; Inoue-Choi M, 2010, INT J MOL EPIDEMIOL, V1, P114; Karatzas A, 2010, CANCER EPIDEMIOL, V34, P345, DOI 10.1016/j.canep.2010.02.009; Kittles RA, 2001, CANCER EPIDEM BIOMAR, V10, P943; La surveillance des cancers dans les Antilles et en Guyane, 2011, BULLETIN DE VEILLE S; Li L, 2004, CANCER EPIDEM BIOMAR, V13, P2280; LOTTA T, 1995, BIOCHEMISTRY-US, V34, P4202, DOI 10.1021/bi00013a008; Lunn RM, 1999, CARCINOGENESIS, V20, P1727, DOI 10.1093/carcin/20.9.1727; Morgan TO, 1996, NEW ENGL J MED, V335, P304, DOI 10.1056/NEJM199608013350502; Multigner L, 2010, J CLIN ONCOL, V28, P3457, DOI 10.1200/JCO.2009.27.2153; Olson SH, 2007, AM J EPIDEMIOL, V165, P235, DOI 10.1093/aje/kwk015; Ragin CC, 2010, GENET MED, V12, P12, DOI 10.1097/GIM.0b013e3181c8e160; Rogan EG, 2004, ADV CLIN CHEM, V38, P135, DOI 10.1016/S0065-2423(04)38005-4; Rothman K., 1998, MODERN EPIDEMIOLOGY, P253; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Sarma AV, 2008, PROSTATE, V68, P296, DOI 10.1002/pros.20696; Sharp L, 2004, AM J EPIDEMIOL, V160, P729, DOI 10.1093/aje/kwh287; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Stanford JL, 2002, CANCER EPIDEM BIOMAR, V11, P243; Suzuki K, 2003, ANTICANCER RES, V23, P4941; Taioli E, 2013, PROSTATE, V73, P668, DOI 10.1002/pros.22612; Tang L, 2011, CARCINOGENESIS, V32, P1500, DOI 10.1093/carcin/bgr139; Tsuchiya N, 2006, J CLIN ONCOL, V24, P1982, DOI 10.1200/JCO.2005.02.9439; Wang F, 2011, PROSTATE, V71, P1167, DOI 10.1002/pros.21332; Wu AH, 2003, CANCER RES, V63, P7526; Xiao L, 2013, MOL BIOL REP, V40, P1835, DOI 10.1007/s11033-012-2238-z; Yuen MT, 2005, INT J ONCOL, V27, P1685; Zhang HT, 2013, UROL INT, V91, P213, DOI 10.1159/000345633; Zhu BT, 2000, DRUG METAB DISPOS, V28, P1024; Zhu GS, 2004, PSYCHOPHARMACOLOGY, V177, P178, DOI 10.1007/s00213-004-1938-z; Zou LW, 2013, GENET TEST MOL BIOMA, V17, P78, DOI 10.1089/gtmb.2012.0216	46	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153609	10.1371/journal.pone.0153609	http://dx.doi.org/10.1371/journal.pone.0153609			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27074016	gold, Green Published, Green Submitted			2022-12-27	WOS:000374131200111
J	Cho, H; Yu, H; Shin, E; Kim, YH; Park, SK; Jo, MW				Cho, Hyungjin; Yu, Hoon; Shin, Eunhye; Kim, Young Hoon; Park, Su-Kil; Jo, Min-Woo			Risk Factors for Graft Failure and Death following Geriatric Renal Transplantation	PLOS ONE			English	Article							QUALITY-OF-LIFE; CYTOMEGALOVIRUS-INFECTION; KIDNEY-TRANSPLANTATION; ELDERLY-PATIENTS; RECIPIENTS; AGE; SURVIVAL; EXPERIENCE; MORTALITY; DIALYSIS	Background Population aging is a major health concern in Asian countries and it has affected the age distribution of patients with end-stage renal disease (ESRD). As a consequence, the need for kidney transplantation in the geriatric population has increased, but the shortage of donors is an obstacle for geriatric renal transplantation. The aim of this study was to evaluate risk factors for graft failure and death in geriatric renal transplantation. Methods Kidney transplantations performed in a tertiary hospital in South Korea from May 1995 to December 2014 were retrospectively reviewed. Recipients younger than 60 years of age or who underwent other organ transplantations were excluded. The Kaplan-Meier method was used to assess patient and graft survival. A Cox regression analysis was used to evaluate risk factors for graft failure and patient death. Results A total of 229 kidney transplantation patients were included. Graft survival at 1, 5, and 10 years were 93.2%, 82.9%, and 61.2% respectively. Patient survival at 1, 5, and 10 years were 94.6%, 86.9%, and 68.8%, respectively. According to the Cox multivariate analysis, ABO incompatibility (hazard ratio [HR] 3.91, p < 0.002), DGF (HR 3.544, p < 0.004), CMV infection (HR 2.244, p < 0.011), and HBV infection (HR 6.349, p < 0.015) were independent risk factors for graft survival. Recipient age (HR 1.128, p < 0.024), ABO incompatibility (HR 3.014, p < 0.025), CMV infection (HR 2.532, p < 0.010), and the number of HLA mismatches (HR 1.425, p < 0.007) were independent risk factors for patient death. Conclusion Kidney transplantation in the geriatric population showed good clinical outcomes. ABO incompatibility, DGF, CMV infection, and HBV infection were risk factors for graft failure and the recipient age, ABO incompatibility, CMV infection, and the number of HLA mismatches were risk factors for patient death in geriatric renal transplantation.	[Cho, Hyungjin; Yu, Hoon; Park, Su-Kil] Univ Ulsan, Coll Med, Asan Med Ctr, Div Nephrol,Dept Internal Med, Seoul, South Korea; [Shin, Eunhye] Natl Rehabil Ctr, Dept Internal Med, Seoul, South Korea; [Kim, Young Hoon] Asan Med Ctr, Dept Surg, Seoul, South Korea; [Kim, Young Hoon] Univ Ulsan, Coll Med, Seoul, South Korea; [Jo, Min-Woo] Univ Ulsan, Coll Med, Dept Prevent Med, Seoul, South Korea	University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; University of Ulsan; University of Ulsan	Jo, MW (corresponding author), Univ Ulsan, Coll Med, Dept Prevent Med, Seoul, South Korea.	mdjominwoo@gmail.com						[Anonymous], 2014, ANN REP TRANSPL 2013; Boesmueller C, 2011, TRANSPLANTATION, V92, P210, DOI 10.1097/TP.0b013e318222ca2f; Castle SC, 2000, CLIN INFECT DIS, V31, P578, DOI 10.1086/313947; Cornella C, 2008, TRANSPL P, V40, P1865, DOI 10.1016/j.transproceed.2008.05.050; Eckardt KU, 2009, AM J TRANSPLANT, V9, pS1, DOI 10.1111/j.1600-6143.2009.02834.x; FIETZE E, 1994, TRANSPLANTATION, V58, P675; Hatakeyama S, 2013, THESCIENTIFICWORLDJO; Heldal K, 2008, NEPHROL DIAL TRANSPL, V23, P1026, DOI 10.1093/ndt/gfm719; Huang H, 2014, JAMA-J AM MED ASSOC, V312, P2521, DOI 10.1001/jama.2014.15704; Kinsella K, 2009, INT POPULATION REPOR; Lai XQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112938; Meier-Kriesche HU, 2001, KIDNEY INT, V59, P1539, DOI 10.1046/j.1523-1755.2001.0590041539.x; Ojo AO, 1997, TRANSPLANTATION, V63, P968, DOI 10.1097/00007890-199704150-00011; Oniscu GC, 2004, NEPHROL DIAL TRANSPL, V19, P945, DOI 10.1093/ndt/gfh022; Opelz G, 2015, TRANSPLANTATION, V99, P400, DOI 10.1097/TP.0000000000000312; REINKE P, 1994, LANCET, V344, P1737, DOI 10.1016/S0140-6736(94)92887-8; Sagedal S, 2004, KIDNEY INT, V66, P329, DOI 10.1111/j.1523-1755.2004.00735.x; Sagedal S, 2007, CLIN TRANSPLANT, V21, P309, DOI 10.1111/j.1399-0012.2006.00639.x; Shin E, 2015, TRANSPL P, V47, P1720, DOI 10.1016/j.transproceed.2015.05.026; Shrestha LB, 2000, HEALTH AFFAIR, V19, P204, DOI 10.1377/hlthaff.19.3.204; Trouillhet I, 2005, TRANSPLANTATION, V80, P989, DOI 10.1097/01.TP.0000173822.05877.D7; Uchida J, 2012, INT UROL NEPHROL, V44, P1563, DOI 10.1007/s11255-012-0231-z; van der Bij W, 2001, CLIN INFECT DIS, V33, pS32, DOI 10.1086/320902; Veroux M, 2012, NEPHROL DIAL TRANSPL, V27, P1663, DOI 10.1093/ndt/gfr524; Weber M, 2014, J AM GERIATR SOC, V62, P1877, DOI 10.1111/jgs.13065; Wolfe RA, 1999, NEW ENGL J MED, V341, P1725, DOI 10.1056/NEJM199912023412303	26	16	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153410	10.1371/journal.pone.0153410	http://dx.doi.org/10.1371/journal.pone.0153410			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27074003	Green Published, gold, Green Submitted			2022-12-27	WOS:000374131200087
J	Rosenthal, J; Belfort, G; Isaacson, D				Rosenthal, Joseph; Belfort, Georges; Isaacson, David			Early Treatment Critical: Bexarotene Reduces Amyloid-Beta Burden In Silico	PLOS ONE			English	Article							AD MOUSE MODELS; ALZHEIMERS-DISEASE; REVERSE DEFICITS; PATHOLOGY; MICE	Amyloid-beta peptides have long been implicated in the pathology of Alzheimer's disease. Bexarotene, a drug approved by the U.S. Food and Drug Administration for treating a class of non-Hodgkin's lymphoma, has been reported to facilitate the removal of amyloid-beta. We have developed a mathematical model to explore the efficacy of bexarotene treatment in reducing amyloid-beta load, and simulate amyloid-beta production throughout the lifespan of diseased mice. Both aspects of the model are based on and consistent with previous experimental results. Beyond what is known empirically, our model shows that low dosages of bexarotene are unable to reverse symptoms in diseased mice, but dosages at and above an age-dependent critical concentration can recover healthy brain cells. Further, early treatment was shown to have significantly improved efficacy versus treatment in older mice. Relevance with respect to bexarotene-based amyloid-beta-clearance mechanism and direct treatment for Alzheimer's disease is emphasized.	[Rosenthal, Joseph; Isaacson, David] Rensselaer Polytech Inst, Dept Math Sci, Troy, NY 12180 USA; [Belfort, Georges] Rensselaer Polytech Inst, Howard P Isermann Dept Chem & Biol Engn, Troy, NY 12180 USA; [Belfort, Georges] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA; [Rosenthal, Joseph] SURVICE Engn, Appl Technol Operat, Pittsburgh, PA USA	Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute	Rosenthal, J (corresponding author), Rensselaer Polytech Inst, Dept Math Sci, Troy, NY 12180 USA.; Belfort, G (corresponding author), Rensselaer Polytech Inst, Howard P Isermann Dept Chem & Biol Engn, Troy, NY 12180 USA.; Belfort, G (corresponding author), Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA.; Rosenthal, J (corresponding author), SURVICE Engn, Appl Technol Operat, Pittsburgh, PA USA.	joseph.rosenthal@survice.com; belfog@rpi.edu		Rosenthal, Joseph/0000-0001-8500-4032	Rensselaer Polytechnic Institute (RPI) [140124]	Rensselaer Polytechnic Institute (RPI)	GB acknowledges Rensselaer Polytechnic Institute for financial support from his endowed chair (RPI# 140124). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the reviewers for pointing out that the critical dosage of bexarotene increases exponentially with mouse age, and Dr. Lawrence T. Friedhoff for advice and helpful discussion. GB acknowledges RPI for financial support from his endowed chair (RPI# 140124).	Balducci C, 2015, J ALZHEIMERS DIS, V46, P471, DOI 10.3233/JAD-150029; Boehm-Cagan A, 2014, J NEUROSCI, V34, P7293, DOI 10.1523/JNEUROSCI.5198-13.2014; Cramer PE, 2012, SCIENCE, V335, P1503, DOI 10.1126/science.1217697; Cummings JL, 2016, ALZHEIMERS RES THER, V8, DOI 10.1186/s13195-016-0173-2; Edelstein-Keshet L., 1988, MATH MODELS BIOL; Fitz NF, 2013, SCIENCE, V340, DOI 10.1126/science.1235809; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Keener J., 2009, MATH PHYSL; LaClair KD, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-18; Landreth GE, 2013, SCIENCE, V340, DOI 10.1126/science.1234114; Pierrot N, 2016, J ALZHEIMERS DIS, V49, P271, DOI 10.3233/JAD-150405; Price AR, 2013, SCIENCE, V340, DOI 10.1126/science.1234089; Tesseur I, 2013, SCIENCE, V340, DOI 10.1126/science.1233937; Trinchese F, 2004, ANN NEUROL, V55, P801, DOI 10.1002/ana.20101; Veeraraghavalu K, 2013, SCIENCE, V340, DOI 10.1126/science.1235505	15	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153150	10.1371/journal.pone.0153150	http://dx.doi.org/10.1371/journal.pone.0153150			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073866	gold, Green Published			2022-12-27	WOS:000374131200054
J	Lewis, SC; Bhattacharya, S; Wu, O; Vincent, K; Jack, SA; Critchley, HOD; Porter, MA; Cranley, D; Wilson, JA; Horne, AW				Lewis, Steff C.; Bhattacharya, Siladitya; Wu, Olivia; Vincent, Katy; Jack, Stuart A.; Critchley, Hilary O. D.; Porter, Maureen A.; Cranley, Denise; Wilson, John A.; Horne, Andrew W.			Gabapentin for the Management of Chronic Pelvic Pain in Women (GaPP1): A Pilot Randomised Controlled Trial	PLOS ONE			English	Article								Chronic pelvic pain (CPP) affects 2.1-24% of women. Frequently, no underlying pathology is identified, and the pain is difficult to manage. Gabapentin is prescribed for CPP despite no robust evidence of efficacy. We performed a pilot trial in two UK centres to inform the planning of a future multicentre RCT to evaluate gabapentin in CPP management. Our primary objective was to determine levels of participant recruitment and retention. Secondary objectives included estimating potential effectiveness, acceptability to participants of trial methodology, and cost-effectiveness of gabapentin. Women with CPP and no obvious pelvic pathology were assigned to an increasing regimen of gabapentin (300-2700 mg daily) or placebo. We calculated the proportion of eligible women randomised, and of randomised participants who were followed up to six months. The analyses by treatment group were by intention-to-treat. Interviews were conducted to evaluate women's experiences of the trial. A probabilistic decision analytical model was used to estimate cost-effectiveness. Between September 2012-2013, 47 women (34% of those eligible) were randomised (22 to gabapentin, 25 to placebo), and 25 (53%) completed six-month follow-up. Participants on gabapentin had less pain (BPI difference 1.72 points, 95% CI: 0.07-3.36), and an improvement in mood (HADS difference 4.35 points, 95% CI: 1.97-6.73) at six months than those allocated placebo. The majority of participants described their trial experience favorably. At the UK threshold for willingness-to-pay, the probabilities of gabapentin or no treatment being cost-effective are similar. A pilot trial assessing gabapentin for CPP was feasible, but uncertainty remains, highlighting the need for a large definitive trial.	[Lewis, Steff C.] Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh, Lothian, Scotland; [Bhattacharya, Siladitya; Porter, Maureen A.] Univ Aberdeen, Appl Hlth Sci, Aberdeen, Grampian, Scotland; [Wu, Olivia] Univ Glasgow, Hlth Econ & Hlth Technol Assessment Inst Hlth & W, Glasgow, Lanark, Scotland; [Vincent, Katy] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Obstet & Gynaecol, Oxford OX3 9DU, England; [Jack, Stuart A.] Aberdeen Royal Infirm, Gynaecol, Aberdeen, Grampian, Scotland; [Critchley, Hilary O. D.; Horne, Andrew W.] Univ Edinburgh, MRC Ctr Reprod Hlth, Edinburgh, Lothian, Scotland; [Cranley, Denise] Univ Edinburgh, MRC Ctr Regenerat Med, Edinburgh, Lothian, Scotland; [Wilson, John A.] Royal Infirm Edinburgh NHS Trust, Dept Anaesthesia & Pain Med, Edinburgh, Lothian, Scotland	University of Edinburgh; University of Aberdeen; University of Glasgow; University of Oxford; University of Aberdeen; University of Edinburgh; University of Edinburgh; Royal Infirmary of Edinburgh; University of Edinburgh	Horne, AW (corresponding author), Univ Edinburgh, MRC Ctr Reprod Hlth, Edinburgh, Lothian, Scotland.	andrew.horne@ed.ac.uk	Wu, Olivia/A-5011-2010; Wu, Olivia/AAH-4621-2019	Wu, Olivia/0000-0002-0570-6016; Wu, Olivia/0000-0002-0570-6016; Lewis, Steff/0000-0003-1210-2314; CRITCHLEY, HILARY/0000-0003-1913-4044	Chief Scientist's Office of Scotland, UK [CZH/4/688]; National Institute for Health Research [13/52/04] Funding Source: researchfish; Wellbeing of Women [RG1436] Funding Source: researchfish; Chief Scientist Office [CZH/4/688] Funding Source: researchfish	Chief Scientist's Office of Scotland, UK; National Institute for Health Research(National Institute for Health Research (NIHR)); Wellbeing of Women(Wellbeing of Women (WoW)); Chief Scientist Office	The study was funded by a project grant to AH SB OW HC MP JW and SL from the Chief Scientist's Office of Scotland, UK (CZH/4/688) (http://www.cso.scot.nhs.uk/grants).	[Anonymous], 2012, INITIAL MANAGEMENT C; Cheong Y, 2006, BEST PRACT RES CL OB, V20, P695, DOI 10.1016/j.bpobgyn.2006.04.004; Daniels JP, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4834; Horne AW, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001297; Latthe P, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-177; Manca A, 2005, HEALTH ECON, V14, P487, DOI 10.1002/hec.944; Moore RA, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007938.pub3; Sator-Katzenschlager SM, 2005, WIEN KLIN WOCHENSCHR, V117, P761, DOI 10.1007/s00508-005-0464-2; Stones W, 2000, COCHRANE DB SYST REV	9	30	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0153037	10.1371/journal.pone.0153037	http://dx.doi.org/10.1371/journal.pone.0153037			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27070434	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000373900700029
J	Liu, QH; Babadjouni, R; Radwanski, R; Cheng, H; Patel, A; Hodis, DM; He, SH; Baumbacher, P; Russin, JJ; Morgan, TE; Sioutas, C; Finch, CE; Mack, WJ				Liu, Qinghai; Babadjouni, Robin; Radwanski, Ryan; Cheng, Hank; Patel, Arati; Hodis, Drew M.; He, Shuhan; Baumbacher, Peter; Russin, Jonathan J.; Morgan, Todd E.; Sioutas, Constantinos; Finch, Caleb E.; Mack, William J.			Stroke Damage Is Exacerbated by Nano-Size Particulate Matter in a Mouse Model	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; AMBIENT AIR-POLLUTION; OXIDATIVE STRESS; ULTRAFINE PARTICLES; POLLUTANTS; EXHAUST; MARKERS; NEURONS; RISK; NEUROINFLAMMATION	This study examines the effects of nano-size particulate matter (nPM) exposure in the setting of murine reperfused stroke. Particulate matter is a potent source of inflammation and oxidative stress. These processes are known to influence stroke progression through recruitment of marginally viable penumbral tissue into the ischemic core. nPM was collected in an urban area in central Los Angeles, impacted primarily by traffic emissions. Re-aerosolized nPM or filtered air was then administered to mice through whole body exposure chambers for forty-five cumulative hours. Exposed mice then underwent middle cerebral artery occlusion/reperfusion. Following cerebral ischemia/reperfusion, mice exposed to nPM exhibited significantly larger infarct volumes and less favorable neurological deficit scores when compared to mice exposed to filtered air. Mice exposed to nPM also demonstrated increases in markers of inflammation and oxidative stress in the region of the ischemic core. The findings suggest a detrimental effect of urban airborne particulate matter exposure in the setting of acute ischemic stroke.	[Liu, Qinghai; Babadjouni, Robin; Radwanski, Ryan; Patel, Arati; Hodis, Drew M.; He, Shuhan; Mack, William J.] Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA 90033 USA; [Baumbacher, Peter; Russin, Jonathan J.; Mack, William J.] Univ So Calif, Keck Sch Med, Dept Neurosurg, Los Angeles, CA 90033 USA; [Cheng, Hank; Morgan, Todd E.; Finch, Caleb E.] Univ So Calif, Davis Sch Gerontol, Los Angeles, CA USA; [Sioutas, Constantinos] Univ So Calif, Viterbi Sch Engn, Los Angeles, CA USA; [Finch, Caleb E.] Univ So Calif, Dept Neurobiol, Los Angeles, CA USA	University of Southern California; University of Southern California; University of Southern California; University of Southern California; University of Southern California	Mack, WJ (corresponding author), Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA 90033 USA.	William.Mack@med.usc.edu	Sioutas, Constantinos/R-1968-2019; Radwanski, Ryan E./AAP-1255-2020; He, Shuhan/AAF-1764-2020; Finch, Caleb/AAA-7250-2022	Radwanski, Ryan E./0000-0003-1389-4691; He, Shuhan/0000-0002-9902-5077; Cheng, Hank/0000-0003-3793-0394; Sioutas, Constantinos/0000-0001-5146-0857	National Institutes of Health/ National Institute of Environmental Health Science Southern California Environmental Health Sciences Center (SCEHSC) [5P30ES007048]; SC CTSI (NIH/NCRR/NCATS) [KL2TR000131]; NIH/NIEHS [R01ES024936]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES024936, P30ES007048] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005142] Funding Source: NIH RePORTER	National Institutes of Health/ National Institute of Environmental Health Science Southern California Environmental Health Sciences Center (SCEHSC); SC CTSI (NIH/NCRR/NCATS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIH/NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by a grant through the National Institutes of Health/ National Institute of Environmental Health Science Southern California Environmental Health Sciences Center (SCEHSC): grant # 5P30ES007048, a grant through the SC CTSI (NIH/NCRR/NCATS) grant # KL2TR000131, and a grant through the NIH/NIEHS: grant # R01ES024936. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo JA, 2009, PART FIBRE TOXICOL, V6, DOI 10.1186/1743-8977-6-24; Arenillas JF, 2002, STROKE, V33, P2197, DOI 10.1161/01.STR.0000027861.75884.DF; Block ML, 2009, TRENDS NEUROSCI, V32, P506, DOI 10.1016/j.tins.2009.05.009; Block ML, 2004, FASEB J, V18, P1618, DOI 10.1096/fj.04-1945fje; Bos I, 2012, INHAL TOXICOL, V24, P676, DOI 10.3109/08958378.2012.714004; Calderon-Garciduenas L, 2002, TOXICOL PATHOL, V30, P373, DOI 10.1080/01926230252929954; Campbell A, 2005, NEUROTOXICOLOGY, V26, P133, DOI 10.1016/j.neuro.2004.08.003; Campbell A, 2009, J NANOSCI NANOTECHNO, V9, P5099, DOI 10.1166/jnn.2009.GR07; Cheng HS A., ENV HLTH PE IN PRESS; Choi K, 2009, CURR NEUROVASC RES, V6, P213, DOI 10.2174/156720209789630375; Clark WM, 1997, NEUROL RES, V19, P641; Connolly ES, 1996, NEUROSURGERY, V38, P523, DOI 10.1097/00006123-199603000-00021; Craig L, 2008, J TOXICOL ENV HEAL A, V71, P588, DOI 10.1080/15287390801997732; Davis DA, 2013, J NEUROCHEM, V127, P509, DOI 10.1111/jnc.12395; Davis DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064128; Ducruet AF, 2008, J CEREBR BLOOD F MET, V28, P1048, DOI 10.1038/sj.jcbfm.9600608; Fruin S, 2008, ATMOS ENVIRON, V42, P207, DOI 10.1016/j.atmosenv.2007.09.057; Gerlofs-Nijland ME, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-12; Gidday JM, 2005, AM J PHYSIOL-HEART C, V289, pH558, DOI 10.1152/ajpheart.01275.2004; Guo L, 2014, CHEM RES TOXICOLOGY; Hong YC, 2002, STROKE, V33, P2165, DOI 10.1161/01.STR.0000026865.52610.5B; Iannuzzi A, 2010, CARDIOL YOUNG, V20, P186, DOI 10.1017/S1047951109992010; Kam W, 2012, ATMOS ENVIRON, V55, P90, DOI 10.1016/j.atmosenv.2012.03.028; Kam W, 2012, ATMOS ENVIRON, V61, P378, DOI 10.1016/j.atmosenv.2012.07.072; Kim GH, 2008, NEUROSURGERY, V63, P122, DOI 10.1227/01.NEU.0000335079.70222.8D; Kunzli N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009096; Levesque S, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-105; Levesque S, 2011, ENVIRON HEALTH PERSP, V119, P1149, DOI 10.1289/ehp.1002986; Li N, 2003, ENVIRON HEALTH PERSP, V111, P455, DOI 10.1289/ehp.6000; Li RS, 2013, J LIPID RES, V54, P1608, DOI 10.1194/jlr.M035014; Li R, 2009, FREE RADICAL BIO MED, V46, P775, DOI 10.1016/j.freeradbiomed.2008.11.025; Li Y, 1998, STROKE, V29, P1972, DOI 10.1161/01.STR.29.9.1972; Liu QY, 2013, PROCEEDINGS OF THE 2013 INTERNATIONAL CONFERENCE ON ENERGY, P8; Mack WJ, 2006, J NEUROSCI RES, V83, P883, DOI 10.1002/jnr.20775; Misra C, 2002, J AEROSOL SCI, V33, P735, DOI 10.1016/S0021-8502(01)00210-5; Mocco J, 2006, CIRC RES, V99, P209, DOI 10.1161/01.RES.0000232544.90675.42; Morgan TE, 2011, ENVIRON HEALTH PERSP, V119, P1003, DOI 10.1289/ehp.1002973; Ning Z, 2007, ENVIRON SCI TECHNOL, V41, P6000, DOI 10.1021/es070653g; Schauer JJ, 2003, J EXPO ANAL ENV EPID, V13, P443, DOI 10.1038/sj.jea.7500298; Shah ASV, 2015, BMJ-BRIT MED J, V350, DOI [10.1136/bmj.i4851, 10.1136/bmj.h1295]; Shin HH, 2014, EPIDEMIOLOGY, V25, P835, DOI 10.1097/EDE.0000000000000162; Wang Y, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000983; Wellenius GA, 2012, ARCH INTERN MED, V172, P229, DOI 10.1001/archinternmed.2011.732; Wilker EH, 2013, J STROKE CEREBROVASC, V22, pE366, DOI 10.1016/j.jstrokecerebrovasdis.2013.03.034; Yilmaz G, 2010, NEUROMOL MED, V12, P193, DOI 10.1007/s12017-009-8074-1	45	19	19	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0153376	10.1371/journal.pone.0153376	http://dx.doi.org/10.1371/journal.pone.0153376			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27071057	Green Submitted, Green Published, gold			2022-12-27	WOS:000373900700058
J	Malinverni, S; Libois, A; Gennotte, AF; La Morte, C; Mols, P				Malinverni, Stefano; Libois, Agnes; Gennotte, Anne-Francoise; La Morte, Cecile; Mols, Pierre			Prescription of Non-Occupational Post-Exposure HIV Prophylaxis by Emergency Physicians: An Analysis on Accuracy of Prescription and Compliance	PLOS ONE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; ANTIRETROVIRAL THERAPY; INFECTION; ADHERENCE; METAANALYSIS; PREVENTION; MACAQUES; EXPOSURE; VICTIMS; IMPACT	We conducted a retrospective analysis of data from a prospective nPEP (non-Occupational Post Exposure Prophylaxis) registry based on patients consulting at one academic Emergency department located in Brussels, Belgium. We review here 1,357 cases consulting from January 2011 to December 2013. The objective of the study is to determine whether emergency physicians prescribe nPEP according to national guideline with support from IDS (infectious disease specialists). As this intervention has a high cost we wanted to verify correct allocation of treatment to high risk patients. Moreover we wanted to determine whether compliance to nPEP when prescribed by an Emergency Physician was different from literature reports. Finally we wanted to describe the population consulting for nPEP at our center. Emergency physicians prescribed nPEP more frequently in high risk exposures (98.6%) compared to intermediate risk exposures (53.2%); adequately allocating resources from a public health perspective. Appropriateness of prescription when evaluated according to nPEP Belgian guidelines was 98.8%. Compliance with nPEP prescribed by Emergency physicians was 60% in our study. Compliance was the highest in MSM (Men who have Sex with Men) while sexual assault victims showed the lowest compliance. Altogether this study suggests that Emergency physicians can safely and adequately prescribe nPEP when supported by a comprehensive guideline. Recognizing intrinsic differences within heterogeneous populations consulting for nPEP may improve compliance to this high-cost public health intervention.	[Malinverni, Stefano; Mols, Pierre] Univ Libre Bruxelles, Ctr Hosp Univ St Pierre, Dept Emergency Med, Brussels, Belgium; [Libois, Agnes; Gennotte, Anne-Francoise; La Morte, Cecile] Univ Libre Bruxelles, Ctr Hosp Univ St Pierre, Dept Infect Dis, Brussels, Belgium	Universite Libre de Bruxelles; Vrije Universiteit Brussel; Universite Libre de Bruxelles; Vrije Universiteit Brussel	Malinverni, S (corresponding author), Univ Libre Bruxelles, Ctr Hosp Univ St Pierre, Dept Emergency Med, Brussels, Belgium.	stefano_malinverni@stpierre-bru.be	Libois, Agnès/AAQ-2077-2021	LIBOIS, Agnes/0000-0002-6078-878X; Malinverni, Stefano/0000-0003-3840-0491				Al-Dakkak I, 2013, AIDS CARE, V25, P400, DOI 10.1080/09540121.2012.712667; Arnsten JH, 2002, J GEN INTERN MED, V17, P377, DOI 10.1007/s11606-002-0044-3; Benn P, 2011, INT J STD AIDS, V22, P695, DOI 10.1258/ijsa.2011.171011; Bogoch II, 2015, CLIN INFECT DIS S3, V60, pS182; Bryant J, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13140; Cardo DM, 1997, NEW ENGL J MED, V337, P1485, DOI 10.1056/NEJM199711203372101; Chacko L, 2012, SEX TRANSM INFECT, V88, P335, DOI 10.1136/sextrans-2011-050371; Ford N, 2015, CLIN INFECT DIS, V60, pS182, DOI 10.1093/cid/civ093; Ford N, 2014, AIDS, V28, P2721, DOI 10.1097/QAD.0000000000000505; Katz IT, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.3.18640; Kuhar DT, 2013, INFECT CONT HOSP EP, V34, P875, DOI 10.1086/672271; ROTHBAUM BO, 1992, J TRAUMA STRESS, V5, P455, DOI 10.1007/BF00977239; Spira AI, 1996, J EXP MED, V183, P215, DOI 10.1084/jem.183.1.215; TSAI CC, 1995, SCIENCE, V270, P1197, DOI 10.1126/science.270.5239.1197; Tsai CC, 1998, J VIROL, V72, P4265, DOI 10.1128/JVI.72.5.4265-4273.1998; Tucker JS, 2003, AM J MED, V114, P573, DOI 10.1016/S0002-9343(03)00093-7	16	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0153021	10.1371/journal.pone.0153021	http://dx.doi.org/10.1371/journal.pone.0153021			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27070319	Green Published, gold, Green Submitted			2022-12-27	WOS:000373900700028
J	Raes, F; Sobilo, J; Le Mee, M; Retif, S; Natkunarajah, S; Lerondel, S; Le Pape, A				Raes, Florian; Sobilo, Julien; Le Mee, Marilyne; Retif, Stephanie; Natkunarajah, Sharuja; Lerondel, Stephanie; Le Pape, Alain			High Resolution Ultrasound and Photoacoustic Imaging of Orthotopic Lung Cancer in Mice: New Perspectives for Onco-Pharmacology	PLOS ONE			English	Article							SOFT-TISSUE; HYPOXIA; TUMOR; COMBINATION; TH-302; TOOL	Objectives We have developed a relevant preclinical model associated with a specific imaging protocol dedicated to onco-pharmacology studies in mice. Materials and Methods We optimized both the animal model and an ultrasound imaging procedure to follow up longitudinally the lung tumor growth in mice. Moreover we proposed to measure by photoacoustic imaging the intratumoral hypoxia, which is a crucial parameter responsible for resistance to therapies. Finally, we compared ultrasound data to x-ray micro computed tomography and volumetric measurements to validate the relevance of this approach on the NCI-H460 human orthotopic lung tumor. Results This study demonstrates the ability of ultrasound imaging to detect and monitor the in vivo orthotopic lung tumor growth by high resolution ultrasound imaging. This approach enabled us to characterize key biological parameters such as oxygenation, perfusion status and vascularization of tumors. Conclusion Such an experimental approach has never been reported previously and it would provide a nonradiative tool for assessment of anticancer therapeutic efficacy in mice. Considering the absence of ultrasound propagation through the lung parenchyma, this strategy requires the implantation of tumors strictly located in the superficial posterior part of the lung.	[Raes, Florian; Sobilo, Julien; Le Mee, Marilyne; Retif, Stephanie; Natkunarajah, Sharuja; Lerondel, Stephanie; Le Pape, Alain] CNRS Orleans, CIPA, PHENOMIN TAAM UPS44, Orleans, France; [Le Pape, Alain] Univ Tours, INSERM, U1100, CEPR, F-37041 Tours, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours	Raes, F (corresponding author), CNRS Orleans, CIPA, PHENOMIN TAAM UPS44, Orleans, France.	florian.raes@cnrs-orleans.fr	Raes, Florian/ABD-8845-2020	Raes, Florian/0000-0003-2898-995X				Andouard S, 2011, COMMUNICATION; Borad MJ, 2015, J CLIN ONCOL, V33, P1475, DOI 10.1200/JCO.2014.55.7504; Brulle L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052653; Chawla SP, 2014, J CLIN ONCOL, V32, P3299, DOI 10.1200/JCO.2013.54.3660; Colella S, 2014, ENDOSC ULTRASOUND, V3, P205, DOI 10.4103/2303-9027.144510; Foster FS, 2011, INTERFACE FOCUS, V1, P576, DOI 10.1098/rsfs.2011.0037; Fushiki H, 2013, ANTICANCER RES, V33, P4741; Gagnadoux F, 2005, EUR RESPIR J, V26, P657, DOI 10.1183/09031936.05.00017305; Gargani L, 2011, CARDIOVASC ULTRASOUN, V9, DOI 10.1186/1476-7120-9-6; Graves EE, 2010, CLIN CANCER RES, V16, P4843, DOI 10.1158/1078-0432.CCR-10-1206; Hyvelin JM, 2013, INVEST RADIOL, V48, P570, DOI 10.1097/RLI.0b013e318289f854; Jiang YY, 2015, LUNG CANCER, V90, P191, DOI 10.1016/j.lungcan.2015.08.009; Kagadis GC, 2010, MED PHYS, V37, P6421, DOI 10.1118/1.3515456; Kaneko OF, 2012, QUANT IMAGING MED SU, V2, P87, DOI 10.3978/j.issn.2223-4292.2012.06.06; Khalil Ashraf A, 2013, Int J Mol Imaging, V2013, P287697, DOI 10.1155/2013/287697; Le QT, 2006, CLIN CANCER RES, V12, P1507, DOI 10.1158/1078-0432.CCR-05-2049; Lerondel S., 2013, CURRENT MOL IMAGING, V2, P18, DOI [10.2174/2211555211302010004, DOI 10.2174/2211555211302010004]; Lichtenstein DA, 2014, ANN INTENSIVE CARE, V4, DOI 10.1186/2110-5820-4-1; Maillet A, 2011, PHARM RES-DORDR, V28, P2147, DOI 10.1007/s11095-011-0442-5; Needles A., 2010, 2010 International Ultrasonics Symposium, P390, DOI 10.1109/ULTSYM.2010.0095; Paulus MJ, 2000, NEOPLASIA, V2, P62, DOI 10.1038/sj.neo.7900069; Peeters SGJA, 2015, CLIN CANCER RES, V21, P2984, DOI 10.1158/1078-0432.CCR-15-0018; van Rooij T, 2015, INT J HYPERTHER, V31, P90, DOI 10.3109/02656736.2014.997809; Wallace MB, 2008, JAMA-J AM MED ASSOC, V299, P540, DOI 10.1001/jama.299.5.540; Walsh JC, 2014, ANTIOXID REDOX SIGN, V21, P1516, DOI 10.1089/ars.2013.5378; Wathen CA, 2013, SENSORS-BASEL, V13, P6957, DOI 10.3390/s130606957; Willekens I, 2010, CONTRAST MEDIA MOL I, V5, P201, DOI 10.1002/cmmi.394; Zegers CML, 2014, CLIN CANCER RES, V20, P6389, DOI 10.1158/1078-0432.CCR-14-1524	28	28	28	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0153532	10.1371/journal.pone.0153532	http://dx.doi.org/10.1371/journal.pone.0153532			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27070548	Green Published, Green Submitted, gold			2022-12-27	WOS:000373900700078
J	Bueno, C; Tabares-Seisdedos, R; Moraleda, JM; Martinez, S				Bueno, Carlos; Tabares-Seisdedos, Rafael; Moraleda, Jose M.; Martinez, Salvador			Rett Syndrome Mutant Neural Cells Lacks MeCP2 Immunoreactive Bands	PLOS ONE			English	Article							CHROMATIN; BINDING; PROTEIN; DNA; LOCALIZATION; EXPRESSION; COMPLEX; FORM	Dysfunctions of MeCP2 protein lead to various neurological disorders such as Rett syndrome and Autism. The exact functions of MeCP2 protein is still far from clear. At a molecular level, there exist contradictory data. MeCP2 protein is considered a single immunoreactive band around 75 kDa by western-blot analysis but several reports have revealed the existence of multiple MeCP2 immunoreactive bands above and below the level where MeCP2 is expected. MeCP2 immunoreactive bands have been interpreted in different ways. Some researchers suggest that multiple MeCP2 immunoreactive bands are unidentified proteins that cross-react with the MeCP2 antibody or degradation product of MeCP2, while others suggest that MeCP2 post-transcriptional processing generates multiple molecular forms linked to cell signaling, but so far they have not been properly analyzed in relation to Rett syndrome experimental models. The purpose of this study is to advance understanding of multiple MeCP2 immunoreactive bands in control neural cells and p. T158M MeCP2e1 mutant cells. We have generated stable wild-type and p. T158M MeCP2e1-RFP mutant expressing cells. Application of N- and C-terminal MeCP2 antibodies, and also, RFP antibody minimized concerns about nonspecific cross-reactivity, since they react with the same antigen at different epitopes. We report the existence of multiple MeCP2 immunoreactive bands in control cells, stable wild-type and p. T158M MeCP2e1-RFP mutant expressing cells. Also, MeCP2 immunoreactive bands differences were found between wild-type and p. T158M MeCP2e1-RFP mutant expressing cells. Slower migration phosphorylated band around 70kDa disappeared in p. T158M MeCP2e1-RFP mutant expressing cells. These data suggest that threonine 158 could represent an important phosphorylation site potentially involved in protein function. Our results clearly indicate that MeCP2 antibodies have no cross-reactivity with similar epitopes on others proteins, supporting the idea that MeCP2 may exist in multiple different molecular forms and that molecular pattern variations derived from altered post-transcriptional processing may underlay Rett syndrome physiophatology	[Bueno, Carlos; Martinez, Salvador] Univ Murcia, IMIB Arrixaca, Murcia, Spain; [Bueno, Carlos; Moraleda, Jose M.; Martinez, Salvador] Univ Murcia, Fac Med, Murcia, Spain; [Bueno, Carlos; Tabares-Seisdedos, Rafael; Martinez, Salvador] CIBERSAM, Murcia, Spain; [Moraleda, Jose M.; Martinez, Salvador] Univ Murcia, Hosp Univ Virgen de la Arrixaca, Cell Therapy Unit, IMIB Arrixaca, Murcia, Spain; [Tabares-Seisdedos, Rafael] Univ Valencia, Dept Med, Teaching Unit Psychiat & Psychol Med, Valencia, Spain; [Martinez, Salvador] UMH, CSIC, Inst Neurociencias, Alacant 03550, Spain	Hospital Clinico Universitario Virgen de la Arrixaca; University of Murcia; University of Murcia; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; Hospital Clinico Universitario Virgen de la Arrixaca; University of Murcia; University of Valencia; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN)	Martinez, S (corresponding author), Univ Murcia, IMIB Arrixaca, Murcia, Spain.; Martinez, S (corresponding author), Univ Murcia, Fac Med, Murcia, Spain.; Martinez, S (corresponding author), CIBERSAM, Murcia, Spain.; Martinez, S (corresponding author), Univ Murcia, Hosp Univ Virgen de la Arrixaca, Cell Therapy Unit, IMIB Arrixaca, Murcia, Spain.; Martinez, S (corresponding author), UMH, CSIC, Inst Neurociencias, Alacant 03550, Spain.	smartinez@umh.es	Moraleda, José María/AAB-4119-2020; Tabares-Seisdedos, Rafael/H-6432-2013	Tabares-Seisdedos, Rafael/0000-0002-1089-2204	EUCOMMTOOLS [261492]; Spanish MICINN [BFU-2008-00588]; CONSOLIDER [CSD2007-00023];  [SAF2014-59347-C2-1-R]	EUCOMMTOOLS; Spanish MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); CONSOLIDER(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); 	This work was supported by the grants: EUCOMMTOOLS (Contract 261492), Spanish MICINN BFU-2008-00588, CONSOLIDER (CSD2007-00023) and SAF2014-59347-C2-1-R. Institute of Health Carlos III, TERCEL and CIBERSAM, Generalitat Valenciana (PROMETEO 2009/028 and 11/2011/042). Fundacion Alicia Koplowitz-2009.	Archer H, 2007, J MED GENET, V44, P148, DOI 10.1136/jmg.2006.045260; Ausio J, 2014, TRENDS MOL MED, V20, P487, DOI 10.1016/j.molmed.2014.03.004; Ballas N, 2009, NAT NEUROSCI, V12, P311, DOI 10.1038/nn.2275; Bellini E, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00236; Chahrour M, 2007, NEURON, V56, P422, DOI 10.1016/j.neuron.2007.10.001; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389; Hite KC, 2009, BIOCHEM CELL BIOL, V87, P219, DOI 10.1139/O08-115; Jarrar MH, 2003, J CHILD NEUROL, V18, P675, DOI 10.1177/08830738030180101001; Jordan C, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-36; Kaddoum L, 2013, F1000RES; Klose RJ, 2004, J BIOL CHEM, V279, P46490, DOI 10.1074/jbc.M408284200; Kriaucionis S, 2004, NUCLEIC ACIDS RES, V32, P1818, DOI 10.1093/nar/gkh349; LEWIS JD, 1992, CELL, V69, P905, DOI 10.1016/0092-8674(92)90610-O; Liyanage VRB, 2014, NEUROMOL MED, V16, P231, DOI 10.1007/s12017-014-8295-9; Lyst MJ, 2015, NAT REV GENET, V16, P261, DOI 10.1038/nrg3897; Mnatzakanian GN, 2004, NAT GENET, V36, P339, DOI 10.1038/ng1327; Nan XS, 1996, MOL CELL BIOL, V16, P414; Nan XS, 1997, CELL, V88, P471, DOI 10.1016/S0092-8674(00)81887-5; Shahbazian MD, 2002, HUM MOL GENET, V11, P115, DOI 10.1093/hmg/11.2.115; Shaw G, 2002, FASEB J, V16, P869, DOI 10.1096/fj.01-0995fje; Sigh J, 2008, NUCLEIC ACIDS RES, V36, P6035, DOI [10.1093/nar/gkn591, DOI 10.1093/NAR/GKN591]; Stuss DP, 2013, NUCLEIC ACIDS RES, V41, P4888, DOI 10.1093/nar/gkt213; Tai DJC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10552; Traynor Jeff, 2002, BMC Med Genet, V3, P12, DOI 10.1186/1471-2350-3-12	25	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2016	11	4							e0153262	10.1371/journal.pone.0153262	http://dx.doi.org/10.1371/journal.pone.0153262			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0KH	27064487	gold, Green Submitted, Green Published			2022-12-27	WOS:000373891000039
J	Dekker, M; Pasch, A; van der Sande, F; Konings, C; Bachtler, M; Dionisi, M; Meier, M; Kooman, J; Canaud, B				Dekker, Marijke; Pasch, Andreas; van der Sande, Frank; Konings, Constantijn; Bachtler, Matthias; Dionisi, Mauro; Meier, Matthias; Kooman, Jeroen; Canaud, Bernard			High-Flux Hemodialysis and High-Volume Hemodiafiltration Improve Serum Calcification Propensity	PLOS ONE			English	Article							ALL-CAUSE MORTALITY; FETUIN-MINERAL COMPLEX; CHRONIC KIDNEY-DISEASE; STAGE RENAL-DISEASE; CALCIUM-PHOSPHATE; ONLINE HEMODIAFILTRATION; VASCULAR CALCIFICATION; CALCIPROTEIN PARTICLES; PREDIALYSIS CKD; INHIBITION	Background Calciprotein particles (CPPs) may play an important role in the calcification process. The calcification propensity of serum (T-50) is highly predictive of all-cause mortality in chronic kidney disease patients. Whether T-50 is therapeutically improvable, by high-flux hemodialysis (HD) or hemodiafiltration (HDF), has not been studied yet. Methods We designed a cross-sectional single center study, and included stable prevalent in-center dialysis patients on HD or HDF. Patients were divided into two groups based on dialysis modality, were on a thrice-weekly schedule, had a dialysis vintage of > 3 months and vascular access providing a blood flow rate > 300 ml/min. Calcification propensity of serum was measured by the time of transformation from primary to secondary CPP (T-50 test), by time-resolved nephelometry. Results We included 64 patients, mean convective volume was 21.7L (SD 3.3L). In the pooled analysis, T-50 levels increased in both the HD and HDF group with pre-and post-dialysis (mean (SD)) of 244(64) - 301(57) and 253(55) - 304(61) min respectively (P = 0.43(HD vs. HDF)). The mean increase in T-50 was 26.29% for HD and 21.97% for HDF patients (P = 0.61 (HD vs. HDF)). The delta values (.) of calcium, phosphate and serum albumin were equal in both groups. Baseline T-50 was negatively correlated with phosphate, and positively correlated with serum magnesium and fetuin-A. The Delta T-50 was mostly influenced by Delta phosphate (r = -0.342; P = 0.002 HD and r = -0.396; P<0.001 HDF) in both groups. Conclusions HD and HDF patients present with same baseline T50 calcification propensity values pre-dialysis. Calcification propensity is significantly improved during both HD and HDF sessions without significant differences between both modalities.	[Dekker, Marijke; van der Sande, Frank; Kooman, Jeroen] Maastricht Univ, Med Ctr, Div Nephrol, Dept Internal Med, NL-6200 MD Maastricht, Netherlands; [Dekker, Marijke; Konings, Constantijn] Catharina Hosp, Div Nephrol, Dept Internal Med, Eindhoven, Netherlands; [Pasch, Andreas] Univ Hosp Bern, Dept Clin Chem, CH-3010 Bern, Switzerland; [Pasch, Andreas; Bachtler, Matthias] Univ Bern, Dept Clin Res, Bern, Switzerland; [Pasch, Andreas; Dionisi, Mauro; Meier, Matthias] Calciscon AG, Bern, Switzerland; [Canaud, Bernard] Fresenius Med Care, Bad Homburg, Germany	Maastricht University; Catharina Hospital; University of Bern; University Hospital of Bern; University of Bern	Dekker, M (corresponding author), Maastricht Univ, Med Ctr, Div Nephrol, Dept Internal Med, NL-6200 MD Maastricht, Netherlands.; Dekker, M (corresponding author), Catharina Hosp, Div Nephrol, Dept Internal Med, Eindhoven, Netherlands.	marijke.dekker@mumc.nl			Fresenius MC, Bad Homburg, Germany; Calciscon AG	Fresenius MC, Bad Homburg, Germany; Calciscon AG	This study was supported by an unrestricted grant from Fresenius MC, Bad Homburg, Germany who provided support in the form of salaries for author BC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Calciscon AG provided support in the form of salaries for authors AP, M. Dionisi and MM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	BERGSTROM J, 1987, LANCET, V1, P628; Brandenburg VM, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-219; Charitaki E, 2014, NEPHRON CLIN PRACT, V128, P185, DOI 10.1159/000368242; Charitaki E, 2014, HEMODIAL INT, V18, P391, DOI 10.1111/hdi.12119; Cornelis T, 2014, AM J KIDNEY DIS OFFI; Davenport A, 2010, NEPHROL DIAL TRANSPL, V25, P897, DOI 10.1093/ndt/gfp560; Grooteman MPC, 2012, J AM SOC NEPHROL, V23, P1087, DOI 10.1681/ASN.2011121140; Guerin AP, 2000, NEPHROL DIAL TRANSPL, V15, P1014, DOI 10.1093/ndt/15.7.1014; Hamano T, 2010, J AM SOC NEPHROL, V21, P1998, DOI 10.1681/ASN.2009090944; Heiss A, 2007, BIOINTERPHASES, V2, P16, DOI 10.1116/1.2714924; Heiss A, 2003, J BIOL CHEM, V278, P13333, DOI 10.1074/jbc.M210868200; Heiss A, 2010, BIOPHYS J, V99, P3986, DOI 10.1016/j.bpj.2010.10.030; Jahnen-Dechent W, 2008, J MOL MED, V86, P379, DOI 10.1007/s00109-007-0294-y; Kuro-o M, 2013, NAT REV NEPHROL, V9, P650, DOI 10.1038/nrneph.2013.111; London GM, 2003, NEPHROL DIAL TRANSPL, V18, P1731, DOI 10.1093/ndt/gfg414; Lornoy W, 2006, J RENAL NUTR, V16, P47, DOI 10.1053/j.jrn.2005.10.008; Maduell F, 2013, J AM SOC NEPHROL, V24, P487, DOI 10.1681/ASN.2012080875; Matsui I, 2009, KIDNEY INT, V75, P915, DOI 10.1038/ki.2008.700; Moe SM, 2004, CIRC RES, V95, P560, DOI 10.1161/01.RES.0000141775.67189.98; Morena M, 2015, NEPHROLOGY DIALYSIS; Mostovaya IM, 2014, CLIN J AM SOC NEPHRO, V9, P520, DOI 10.2215/CJN.07140713; Palmer SC, 2011, JAMA-J AM MED ASSOC, V305, P1119, DOI 10.1001/jama.2011.308; Pasch A, 2012, J AM SOC NEPHROL, V23, P1744, DOI 10.1681/ASN.2012030240; Patrier L, 2013, J NEPHROL, V26, P342, DOI 10.5301/jn.5000150; Penne EL, 2010, AM J KIDNEY DIS, V55, P77, DOI 10.1053/j.ajkd.2009.09.023; Price PA, 2003, J BIOL CHEM, V278, P22144, DOI 10.1074/jbc.M300744200; Rochette CN, 2009, CHEMBIOCHEM, V10, P735, DOI 10.1002/cbic.200800719; Salem S, 2012, AM J NEPHROL, V35, P31, DOI 10.1159/000334742; Smith ER, 2014, J AM SOC NEPHROL, V25, P339, DOI 10.1681/ASN.2013060635; Smith ER, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060904; Smith ER, 2012, NEPHROL DIAL TRANSPL, V27, P1957, DOI 10.1093/ndt/gfr609; Susantitaphong P, 2013, NEPHROL DIAL TRANSPL, V28, P2859, DOI 10.1093/ndt/gft396	32	22	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2016	11	4							e0151508	10.1371/journal.pone.0151508	http://dx.doi.org/10.1371/journal.pone.0151508			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0KH	27064679	gold, Green Published, Green Submitted			2022-12-27	WOS:000373891000005
J	Mueller, KL; Murray, JC; Michaelson, JJ; Christiansen, MH; Reilly, S; Tomblin, JB				Mueller, Kathryn L.; Murray, Jeffrey C.; Michaelson, Jacob J.; Christiansen, Morten H.; Reilly, Sheena; Tomblin, J. Bruce			Common Genetic Variants in FOXP2 Are Not Associated with Individual Differences in Language Development	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; INHERITED SPEECH; CHILDHOOD APRAXIA; IMPAIRMENT; DELETION; SUSCEPTIBILITY; LINKAGE; TARGETS; FAMILY; AUTISM	Much of our current knowledge regarding the association of FOXP2 with speech and language development comes from singleton and small family studies where a small number of rare variants have been identified. However, neither genome-wide nor gene-specific studies have provided evidence that common polymorphisms in the gene contribute to individual differences in language development in the general population. One explanation for this inconsistency is that previous studies have been limited to relatively small samples of individuals with low language abilities, using low density gene coverage. The current study examined the association between common variants in FOXP2 and a quantitative measure of language ability in a population-based cohort of European decent (n = 812). No significant associations were found for a panel of 13 SNPs that covered the coding region of FOXP2 and extended into the promoter region. Power analyses indicated we should have been able to detect a QTL variance of 0.02 for an associated allele with MAF of 0.2 or greater with 80% power. This suggests that, if a common variant associated with language ability in this gene does exist, it is likely of small effect. Our findings lead us to conclude that while genetic variants in FOXP2 may be significant for rare forms of language impairment, they do not contribute appreciably to individual variation in the normal range as found in the general population.	[Mueller, Kathryn L.] Murdoch Childrens Inst, Hearing Language & Literacy, Melbourne, Vic, Australia; [Mueller, Kathryn L.; Tomblin, J. Bruce] Univ Iowa, Dept Commun Sci & Disorders, Iowa City, IA USA; [Murray, Jeffrey C.] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; [Michaelson, Jacob J.] Univ Iowa, Dept Psychiat, Iowa City, IA 52242 USA; [Christiansen, Morten H.] Cornell Univ, Dept Psychol, New York, NY 10021 USA; [Reilly, Sheena] Menzies Hlth Inst, Gold Coast, Qld, Australia	University of Iowa; University of Iowa; University of Iowa; Cornell University; Menzies Health Institute Queensland	Mueller, KL (corresponding author), Murdoch Childrens Inst, Hearing Language & Literacy, Melbourne, Vic, Australia.; Mueller, KL (corresponding author), Univ Iowa, Dept Commun Sci & Disorders, Iowa City, IA USA.	kathryn-mueller@uiowa.edu	Reilly, Sheena/A-7035-2016	Reilly, Sheena/0000-0001-6506-4767; Michaelson, Jacob/0000-0001-9713-0992	National Institute on Deafness and Other Communication Disorders [DC00496, DC02746]; National Health and Medical Research Council Centre of Research Excellence [APP1023493]; Victorian Government; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000496, P50DC002746] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Health and Medical Research Council Centre of Research Excellence; Victorian Government; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This research was supported by grants DC00496 and DC02746 from the National Institute on Deafness and Other Communication Disorders. Dr Mueller is funded in part by the National Health and Medical Research Council Centre of Research Excellence Grant (APP1023493) and the Victorian Government's Operational Infrastructure Support Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addis L, 2010, GENES BRAIN BEHAV, V9, P545, DOI 10.1111/j.1601-183X.2010.00583.x; Alarcon M, 2008, AM J HUM GENET, V82, P150, DOI 10.1016/j.ajhg.2007.09.005; Alcock KJ, 2000, BRAIN LANG, V75, P17, DOI 10.1006/brln.2000.2322; Ayub Q, 2013, AM J HUM GENET, V92, P696, DOI 10.1016/j.ajhg.2013.03.019; Bartlett CW, 2004, HUM HERED, V57, P10, DOI 10.1159/000077385; Bartlett CW, 2002, AM J HUM GENET, V71, P45, DOI 10.1086/341095; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Bruce HA, 2002, HUM GENET, V111, P136, DOI 10.1007/s00439-002-0768-5; Chen X, 2012, GENOMICS, V99, P323, DOI 10.1016/j.ygeno.2012.04.003; Culatta B., 1983, LANG SPEECH HEAR SER, V14, P66, DOI DOI 10.1044/0161-1461.1402.66; Dunn L.M., 2007, PEABODY PICTURE VOCA, DOI DOI 10.1037/T15144-000; Dunn L.M., 1981, PEABODY PICTURE VOCA; Eicher JD, 2013, GENES BRAIN BEHAV, V12, P792, DOI 10.1111/gbb.12085; Enard W, 2002, NATURE, V418, P869, DOI 10.1038/nature01025; Enard W, 2011, CURR OPIN NEUROBIOL, V21, P415, DOI 10.1016/j.conb.2011.04.008; Falcaro M, 2008, GENES BRAIN BEHAV, V7, P393, DOI 10.1111/j.1601-183X.2007.00364.x; Feuk L, 2006, AM J HUM GENET, V79, P965, DOI 10.1086/508902; Fisher SE, 1998, NAT GENET, V18, P168, DOI 10.1038/ng0298-168; Fisher SE, 2009, TRENDS GENET, V25, P166, DOI 10.1016/j.tig.2009.03.002; FLETCHER P, 1990, NATURE, V346, P226, DOI 10.1038/346226a0; French CA, 2012, MOL PSYCHIATR, V17, P1077, DOI 10.1038/mp.2011.105; Gialluisi A, 2014, GENES BRAIN BEHAV, V13, P686, DOI 10.1111/gbb.12158; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Goldstein BA, 2011, STAT APPL GENET MOL, V10, DOI 10.2202/1544-6115.1691; GOPNIK M, 1990, NATURE, V344, P715, DOI 10.1038/344715a0; Gopnik M., 1990, LANG ACQUIS, V1, P139, DOI DOI 10.1207/S15327817LA0102_1; Graham SA, 2013, CURR OPIN NEUROBIOL, V23, P43, DOI 10.1016/j.conb.2012.11.006; Harlaar N, 2014, J SPEECH LANG HEAR R, V57, P96, DOI 10.1044/1092-4388(2013/12-0303); Hoover H, 2001, IOWA TESTS INTERPRET; HURST JA, 1990, DEV MED CHILD NEUROL, V32, P352; Jorgensen TJ, 2009, AM J EPIDEMIOL, V170, P986, DOI 10.1093/aje/kwp242; Karolchik D, 2009, CURRENT PROTOCOLS BI; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Konopka G, 2012, NEURON, V75, P601, DOI 10.1016/j.neuron.2012.05.034; Laffin JJS, 2012, GENET MED, V14, P928, DOI 10.1038/gim.2012.72; Lai CSL, 2001, NATURE, V413, P519, DOI 10.1038/35097076; Lennon PA, 2007, AM J MED GENET A, V143A, P791, DOI 10.1002/ajmg.a.31632; Leonard LB, 2014, CHILDREN WITH SPECIFIC LANGUAGE IMPAIRMENT, 2ND EDITION, P1; Li SR, 2004, MOL CELL BIOL, V24, P809, DOI 10.1128/MCB.24.2.809-822.2004; Lieberman P, 2002, YEARB PHYS ANTHROPOL, V45, P36, DOI 10.1002/ajpa.10171; Liegeois F, 2003, NAT NEUROSCI, V6, P1230, DOI 10.1038/nn1138; Liegeois F, 2011, EUR J PAEDIATR NEURO, V15, P283, DOI 10.1016/j.ejpn.2011.04.006; Luciano M, 2013, GENES BRAIN BEHAV, V12, P645, DOI 10.1111/gbb.12053; MacDermot KD, 2005, AM J HUM GENET, V76, P1074, DOI 10.1086/430841; McKean C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134251; Meaburn E, 2002, NEUROREPORT, V13, P1075, DOI 10.1097/00001756-200206120-00020; Michaelson JJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-502; Monaco AP, 2007, ANN HUM GENET, V71, P660, DOI 10.1111/j.1469-1809.2007.00361.x; Newbury DF, 2011, BEHAV GENET, V41, P90, DOI 10.1007/s10519-010-9424-3; Newbury DF, 2004, AM J HUM GENET, V74, P1225, DOI 10.1086/421529; Newbury DF, 2002, AM J HUM GENET, V70, P1318, DOI 10.1086/339931; Newbury DF, 2002, AM J HUM GENET, V70, P384; Newbury DF, 2014, GENES-BASEL, V5, P285, DOI 10.3390/genes5020285; Newcomer P. L., 1988, TEST LANGUAGE DEV 2; Nudel R, 2014, GENES BRAIN BEHAV, V13, P418, DOI 10.1111/gbb.12127; O'Brien EK, 2003, AM J HUM GENET, V72, P1536, DOI 10.1086/375403; Palka C, 2012, PEDIATRICS, V129, pE183, DOI 10.1542/peds.2010-2094; Peter B, 2011, J NEURODEV DISORD, V3, P39, DOI 10.1007/s11689-010-9065-0; PURCELL S, 2003, BIOINFORMATICS, V19, P149, DOI [DOI 10.1093/BIOINFORMATICS/19.1.149, 10.1093/bioinformatics/19.1.149]; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Reimers-Kipping S, 2011, NEUROSCIENCE, V175, P75, DOI 10.1016/j.neuroscience.2010.11.042; Rice GM, 2012, AM J MED GENET A, V158A, P174, DOI 10.1002/ajmg.a.34354; Rice ML, 2009, J NEURODEV DISORD, V1, P264, DOI 10.1007/s11689-009-9031-x; RICHARDS B, 1993, HUM MOL GENET, V2, P159, DOI 10.1093/hmg/2.2.159; Roll P, 2010, HUM MOL GENET, V19, P4848, DOI 10.1093/hmg/ddq415; Schreiweis C, 2014, P NATL ACAD SCI USA, V111, P14253, DOI 10.1073/pnas.1414542111; Shu WG, 2001, J BIOL CHEM, V276, P27488, DOI 10.1074/jbc.M100636200; Spiteri E, 2007, AM J HUM GENET, V81, P1144, DOI 10.1086/522237; St Pourcain B, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5831; Thorisson GA, 2005, GENOME RES, V15, P1592, DOI 10.1101/gr.4413105; Tomblin JB, 2006, J SPEECH LANG HEAR R, V49, P1193, DOI 10.1044/1092-4388(2006/086); Tomblin JB, 2009, J SPEECH LANG HEAR R, V52, P1157, DOI 10.1044/1092-4388(2009/07-0162); Tomblin JB, 1997, J SPEECH LANG HEAR R, V40, P1245, DOI 10.1044/jslhr.4006.1245; Tomblin JB, 1996, J SPEECH HEAR RES, V39, P1284, DOI 10.1044/jshr.3906.1284; Tomblin JB, 2014, UNDERSTANDING INDIVI; Tomblin JB, 2014, UNDERSTANDING INDIVI, P11; Turner SJ, 2013, AM J MED GENET A, V161, P2321, DOI 10.1002/ajmg.a.36055; Vargha-Khadem F, 1998, P NATL ACAD SCI USA, V95, P12695, DOI 10.1073/pnas.95.21.12695; VARGHAKHADEM F, 1995, P NATL ACAD SCI USA, V92, P930, DOI 10.1073/pnas.92.3.930; VARGHAKHADEM F, 1990, NATURE, V346, P226, DOI 10.1038/346226c0; Vernes SC, 2008, NEW ENGL J MED, V359, P2337, DOI 10.1056/NEJMoa0802828; Vernes SC, 2007, AM J HUM GENET, V81, P1232, DOI 10.1086/522238; Vernes SC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002145; Watkins KE, 1999, AM J HUM GENET, V65, P1215, DOI 10.1086/302631; Wechsler D., 1991, WISC 3 WECHSLER INTE; Weschler D., 1967, WECHSLER PRESCHOOL P; Whitehouse AJO, 2012, GENES BRAIN BEHAV, V11, P501, DOI 10.1111/j.1601-183X.2012.00806.x; Wiig E., 1992, CLIN EVALUATION LANG; Wiszniewski W, 2013, AM J HUM GENET, V93, P197, DOI 10.1016/j.ajhg.2013.05.027; Zeesman S, 2006, AM J MED GENET A, V140A, P509, DOI 10.1002/ajmg.a.31110; Zilina O, 2012, AM J MED GENET A, V158A, P254, DOI 10.1002/ajmg.a.34378	91	13	13	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2016	11	4							e0152576	10.1371/journal.pone.0152576	http://dx.doi.org/10.1371/journal.pone.0152576			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0KH	27064276	gold, Green Published			2022-12-27	WOS:000373891000013
J	Whop, LJ; Baade, P; Garvey, G; Cunningham, J; Brotherton, JML; Lokuge, K; Valery, PC; O'Connell, DL; Canfell, K; Diaz, A; Roder, D; Gertig, DM; Moore, SP; Condon, JR				Whop, Lisa J.; Baade, Peter; Garvey, Gail; Cunningham, Joan; Brotherton, Julia M. L.; Lokuge, Kamalini; Valery, Patricia C.; O'Connell, Dianne L.; Canfell, Karen; Diaz, Abbey; Roder, David; Gertig, Dorota M.; Moore, Suzanne P.; Condon, John R.			Cervical Abnormalities Are More Common among Indigenous than Other Australian Women: A Retrospective Record-Linkage Study, 2000-2011	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS INFECTION; COLLABORATIVE REANALYSIS; HORMONAL CONTRACEPTIVES; VACCINATION PROGRAM; INDIVIDUAL DATA; CANCER; DISEASE; RISK	Indigenous Australian women have much higher incidence of cervical cancer compared to non-Indigenous women. Despite an organised cervical screening program introduced 25 years ago, a paucity of Indigenous-identified data in Pap Smear Registers remains. Prevalence of cervical abnormalities detected among the screened Indigenous population has not previously been reported. We conducted a retrospective cohort study of population-based linked health records for 1,334,795 female Queensland residents aged 20-69 years who had one or more Pap smears during 2000-2011; from linked hospital records 23,483 were identified as Indigenous. Prevalence was calculated separately for Indigenous and non-Indigenous women, for cytology-detected low-grade (cLGA) and high-grade abnormalities (cHGA), and histologically confirmed high-grade abnormalities (hHGA). Odds ratios (OR) were estimated from logistic regression analysis. In 2010-2011 the prevalence of hHGA among Indigenous women (16.6 per 1000 women screened, 95% confidence interval [CI] 14.6-18.9) was twice that of non-Indigenous women (7.5 per 1000 women screened, CI 7.3-7.7). Adjusted for age, area-level disadvantage and place of residence, Indigenous women had higher prevalence of cLGA (OR 1.4, CI 1.3-1.4), cHGA (OR 2.2, CI 2.1-2.3) and hHGA (OR 2.0, CI 1.9-2.1). Our findings show that Indigenous women recorded on the Pap Smear Register have much higher prevalence for cLGA, cHGA and hHGA compared to non-Indigenous women. The renewed cervical screening program, to be implemented in 2017, offers opportunities to reduce the burden of abnormalities and invasive cancer among Indigenous women and address long-standing data deficiencies.	[Whop, Lisa J.; Garvey, Gail; Cunningham, Joan; Valery, Patricia C.; Diaz, Abbey; Moore, Suzanne P.; Condon, John R.] Charles Darwin Univ, Epidemiol & Hlth Syst Div, Menzies Sch Hlth Res, Darwin, NT 0909, Australia; [Baade, Peter] Canc Council Queensland, Brisbane, Qld, Australia; [Brotherton, Julia M. L.] Victorian Cytol Serv Inc, Melbourne, Vic, Australia; [Brotherton, Julia M. L.; Gertig, Dorota M.] Univ Melbourne, Sch Populat & Global Hlth, Melbourne, Vic, Australia; [Lokuge, Kamalini] Australian Natl Univ, Natl Ctr Epidemiol & Publ Hlth, Canberra, ACT, Australia; [Valery, Patricia C.] QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia; [O'Connell, Dianne L.; Canfell, Karen] Canc Council New South Wales, Canc Res Div, Sydney, NSW, Australia; [O'Connell, Dianne L.; Canfell, Karen] Univ Sydney, Sch Publ Hlth, Sydney, NSW 2006, Australia; [O'Connell, Dianne L.] Univ Newcastle, Sch Med & Publ Hlth, Newcastle, NSW 2300, Australia; [Roder, David] Univ S Australia, Ctr Populat Hlth Res, Adelaide, SA 5001, Australia	Charles Darwin University; Menzies School of Health Research; Cancer Council Queensland; University of Melbourne; Australian National University; QIMR Berghofer Medical Research Institute; Cancer Council New South Wales; University of Sydney; University of Newcastle; University of South Australia	Whop, LJ (corresponding author), Charles Darwin Univ, Epidemiol & Hlth Syst Div, Menzies Sch Hlth Res, Darwin, NT 0909, Australia.	lisa.whop@menzies.edu.au	Baade, Peter/C-4113-2009; Moore, Suzanne/AAC-3801-2021; Valery, Patricia/AAV-5448-2020; Condon, John R/N-2281-2013; Roder, David/B-7038-2013; Cunningham, Joan/E-6339-2012; Gertig, Dorota/Z-1087-2019	Valery, Patricia/0000-0002-8823-3006; Condon, John R/0000-0003-4952-0990; Roder, David/0000-0001-6442-4409; Cunningham, Joan/0000-0002-1012-0909; Baade, Peter/0000-0001-8576-8868; Garvey, Gail/0000-0001-5065-5716; Diaz, Abbey/0000-0002-8637-311X; Canfell, Karen/0000-0002-6443-6618; Moore, Suzanne/0000-0002-8045-0305; Whop, Lisa/0000-0003-4816-2933; Lokuge, Kamalini/0000-0002-6287-1296	Sidney Myer Health Scholarship; Menzies Enhanced Living Top-up; Lowitja Institute; National Health & Medical Research Council (NHMRC) [1058244]; NHMRC [1083090, 104559]; National Health and Medical Research Council (NHMRC) [1055587]; Centre of Research Excellence in Discovering Indigenous Strategies to improve Cancer Outcomes Via Engagement, Research Translation and Training (DISCOVER-TT CRE - NHMRC) [1041111]; Strategic Research Partnership to improve Cancer control for Indigenous Australians (STREP Ca-CIndA - Cancer Council NSW) [SRP 13-01]; Cancer Council WA	Sidney Myer Health Scholarship; Menzies Enhanced Living Top-up; Lowitja Institute; National Health & Medical Research Council (NHMRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Centre of Research Excellence in Discovering Indigenous Strategies to improve Cancer Outcomes Via Engagement, Research Translation and Training (DISCOVER-TT CRE - NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Strategic Research Partnership to improve Cancer control for Indigenous Australians (STREP Ca-CIndA - Cancer Council NSW); Cancer Council WA(Cancer Council Western Australia)	LJ Whop is supported by a Sidney Myer Health Scholarship, Menzies Enhanced Living Top-up and a student scholarship funded by the Lowitja Institute. J Cunningham was supported by a National Health & Medical Research Council (NHMRC) Research Fellowship [#1058244]. PC Valery was supported by a NHMRC Career Development Fellowship [#1083090]. A Diaz is supported by a National Health and Medical Research Council (NHMRC) Training Scholarship for Indigenous Australian Health Research (No. 1055587). The National Indigenous Cervical Screening Project is funded by a NHMRC Project Grant [#104559]. This study was undertaken under the auspices of the Centre of Research Excellence in Discovering Indigenous Strategies to improve Cancer Outcomes Via Engagement, Research Translation and Training (DISCOVER-TT CRE, funded by the NHMRC [#1041111]), and the Strategic Research Partnership to improve Cancer control for Indigenous Australians (STREP Ca-CIndA, funded through Cancer Council NSW [SRP 13-01] with supplementary funding from Cancer Council WA). We also acknowledge the ongoing support of the Lowitja Institute, Australia's National Institute for Aboriginal and Torres Strait Islander Health Research. The views expressed in this publication are those of the authors and do not necessarily reflect the views of the funding agencies. Funding bodies have no role in the study design, data collection, access, analysis or interpretation or decision to publish.	ABS, 2011, SOCIO EC INDEXES ARE; AIHW,, 2020, AB TORR STRAIT ISL H; Appleby P, 2007, LANCET, V370, P1609, DOI 10.1016/S0140-6736(07)61684-5; Arbyn M, 2014, LANCET ONCOL, V15, P172, DOI 10.1016/S1470-2045(13)70570-9; Australian Bureau of Statistics, 2011, PAT EXP AUSTR SUMM F; Australian Government Department of Health, 2015, OV REN; Australian Government Department of Health, 2013, NAT CERV SCREEN PROG; Australian Institute of Health and Welfare, 2014, CANC SER AIHW, V82; Australian Institute of Health and Welfare, 2013, IND ID HOSP SEP DAT; Australian Institute of Health and Welfare, 2015, CANC SER AIHW; Australian Institute of Health and Welfare, 2013, INCL IND STAT PATH R; Australian Institute of Health and Welfare, 2011, PRINC US DIR AG STAN; Australian Institute of Health and Welfare (AIHW), 2004, RUR REG REM HLTH GUI; Australian Institute of Health and Welfare and Australian Bureau of Statistics, 2012, NAT BEST PRACT GUID; Brotherton JML, 2015, CANCER CAUSE CONTROL, V26, P953, DOI 10.1007/s10552-015-0568-6; Brotherton JML, 2013, MED J AUSTRALIA, V199, P614, DOI 10.5694/mja13.10272; Carter JR, 2011, AUST NZ J OBSTET GYN, V51, P103, DOI 10.1111/j.1479-828X.2010.01269.x; Franceschi S, 2009, BRIT J CANCER, V101, P865, DOI 10.1038/sj.bjc.6605224; Garland SM, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-104; Jensen KE, 2013, BRIT J CANCER, V108, P234, DOI 10.1038/bjc.2012.513; McCredie MRE, 2008, LANCET ONCOL, V9, P425, DOI 10.1016/S1470-2045(08)70103-7; MSAC (Medical Services Advisory Committee), 2014, NAT CERV SCREEN PROG; National Health and Medical Research Council, 2005, SCREEN PREV CERV CAN; Rajkumar T, 2006, INT J CANCER, V118, P1481; Sasieni P, 2009, BRIT MED J, V339, pb2968, DOI DOI 10.1136/BMJ.B2968; Schiffman M, 2007, LANCET, V370, P890, DOI [10.1016/S0140-6736(07)61416-0, 10.1016/S0140-6736(13)60022-7]; Schiffman M, 2013, CANCER EPIDEM BIOMAR, V22, P553, DOI 10.1158/1055-9965.EPI-12-1406; Sellors JW, 2003, INTRO CERVICAL INTRA; Smith JS, 2003, LANCET, V361, P1159, DOI 10.1016/S0140-6736(03)12949-2; Smith MA, 2015, J INFECT DIS, V211, P91, DOI 10.1093/infdis/jiu370; StataCorp, 2015, STAT SOFTW REL 14; Ward J., 2014, RESULTS 2 AUSTR SURV, V14; Whop LJ, 2014, EUR J CANCER CARE, V23, P716, DOI 10.1111/ecc.12244; Whop LJ, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009540; Whop LJ, 2016, CANCER; Wright TC, 2006, INT J GYNECOL OBSTET, V95, pS239, DOI 10.1016/S0020-7292(06)60039-8; Zhang X, 2012, WOMENS CANC CANC SCR; Zhang X., 2014, CANC NO TERRITORY 19; Zhang XH, 2011, AUST NZ J PUBL HEAL, V35, P477, DOI 10.1111/j.1753-6405.2011.00762.x	39	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2016	11	4							e0150473	10.1371/journal.pone.0150473	http://dx.doi.org/10.1371/journal.pone.0150473			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0KH	27064273	Green Accepted, Green Published, gold			2022-12-27	WOS:000373891000001
J	Cardinali, I; Lancioni, H; Giontella, A; Capodiferro, MR; Capomaccio, S; Buttazzoni, L; Biggio, GP; Cherchi, R; Albertini, E; Olivieri, A; Cappelli, K; Achilli, A; Silvestrelli, M				Cardinali, Irene; Lancioni, Hovirag; Giontella, Andrea; Capodiferro, Marco Rosario; Capomaccio, Stefano; Buttazzoni, Luca; Biggio, Giovanni Paolo; Cherchi, Raffaele; Albertini, Emidio; Olivieri, Anna; Cappelli, Katia; Achilli, Alessandro; Silvestrelli, Maurizio			An Overview of Ten Italian Horse Breeds through Mitochondrial DNA	PLOS ONE			English	Article							LOOP SEQUENCE VARIATION; GENETIC-ANALYSIS; MATERNAL LINES; DAM LINES; DIVERSITY; LINEAGES; ORIGINS; GENOMES; DOMESTICATION; POPULATIONS	Background The climatic and cultural diversity of the Italian Peninsula triggered, over time, the development of a great variety of horse breeds, whose origin and history are still unclear. To clarify this issue, analyses on phenotypic traits and genealogical data were recently coupled with molecular screening. Methodology To provide a comprehensive overview of the horse genetic variability in Italy, we produced and phylogenetically analyzed 407 mitochondrial DNA (mtDNA) control-region sequences from ten of the most important Italian riding horse and pony breeds: Bardigiano, Esperia, Giara, Lipizzan, Maremmano, Monterufolino, Murgese, Sarcidano, Sardinian Anglo-Arab, and Tolfetano. A collection of 36 Arabian horses was also evaluated to assess the genetic consequences of their common use for the improvement of some local breeds. Conclusions In Italian horses, all previously described domestic mtDNA haplogroups were detected as well as a high haplotype diversity. These findings indicate that the ancestral local mares harbored an extensive genetic diversity. Moreover, the limited haplotype sharing (11%) with the Arabian horse reveals that its impact on the autochthonous mitochondrial gene pools during the final establishment of pure breeds was marginal, if any. The only significant signs of genetic structure and differentiation were detected in the geographically most isolated contexts (i. e. Monterufolino and Sardinian breeds). Such a geographic effect was also confirmed in a wider breed setting, where the Italian pool stands in an intermediate position together with most of the other Mediterranean stocks. However, some notable exceptions and peculiar genetic proximities lend genetic support to historical theories about the origin of specific Italian breeds.	[Cardinali, Irene; Lancioni, Hovirag; Achilli, Alessandro] Univ Perugia, Dipartimento Chim Biol & Biotecnol, I-06100 Perugia, Italy; [Giontella, Andrea; Capomaccio, Stefano; Cappelli, Katia; Silvestrelli, Maurizio] Univ Perugia, Dipartimento Med Vet, Ctr Studio Cavallo Sport, I-06100 Perugia, Italy; [Capodiferro, Marco Rosario; Olivieri, Anna; Achilli, Alessandro] Univ Pavia, Dipartimento Biol & Biotecnol L Spallanzani, Via Palestro 3, I-27100 Pavia, Italy; [Buttazzoni, Luca] Ctr Ric Prod Carni & Miglioramento Genet, Sede Cent Monterotondo, Rome, Italy; [Biggio, Giovanni Paolo; Cherchi, Raffaele] Agenzia Ric Agr AGRIS Sardegna, Sassari, Italy; [Albertini, Emidio] Univ Perugia, Dipartimento Sci Agr Alimentari & Ambientali, I-06100 Perugia, Italy	University of Perugia; University of Perugia; University of Pavia; University of Perugia	Achilli, A (corresponding author), Univ Perugia, Dipartimento Chim Biol & Biotecnol, I-06100 Perugia, Italy.; Achilli, A (corresponding author), Univ Pavia, Dipartimento Biol & Biotecnol L Spallanzani, Via Palestro 3, I-27100 Pavia, Italy.	alessandro.achilli@unipv.it	Achilli, Alessandro/I-9236-2012; Albertini, Emidio/F-7393-2014; Cardinali, Irene/R-8751-2017; OLIVIERI, ANNA/I-9235-2012; Giontella, Andrea/O-2279-2017; Capomaccio, Stefano/K-6042-2015; Capodiferro, Marco Rosario/AAQ-4941-2020; Lancioni, Hovirag/F-9067-2014	Achilli, Alessandro/0000-0001-6871-3451; OLIVIERI, ANNA/0000-0002-3941-8098; Giontella, Andrea/0000-0003-3615-0978; Capomaccio, Stefano/0000-0002-0004-9272; Capodiferro, Marco Rosario/0000-0003-2494-5423; Lancioni, Hovirag/0000-0001-5514-1853; Albertini, Emidio/0000-0003-2585-5649	Italian Ministry of Education, University and Research [FIR2012-RBFR126B8I, PRIN2012-2012JA4BTY]; AGRIS Sardegna: "Monitoraggio delle caratteristiche dell'allevamento del cavallo sportivo in Sardegna e creazione della banca dati per gli indici genetici"; CRA-PCM: "Allevamento Statale Cavallo Lipizzano: conservazione e valorizzazione"	Italian Ministry of Education, University and Research(Ministry of Education, Universities and Research (MIUR)); AGRIS Sardegna: "Monitoraggio delle caratteristiche dell'allevamento del cavallo sportivo in Sardegna e creazione della banca dati per gli indici genetici"; CRA-PCM: "Allevamento Statale Cavallo Lipizzano: conservazione e valorizzazione"	This study received support from the Italian Ministry of Education, University and Research: FIR2012-RBFR126B8I (to AA and AO) and PRIN2012-2012JA4BTY (to AA); AGRIS Sardegna: "Monitoraggio delle caratteristiche dell'allevamento del cavallo sportivo in Sardegna e creazione della banca dati per gli indici genetici"; CRA-PCM: "Allevamento Statale Cavallo Lipizzano: conservazione e valorizzazione".	Achilli A, 2008, CURR BIOL, V18, pR157, DOI 10.1016/j.cub.2008.01.019; Achilli A, 2007, AM J HUM GENET, V80, P759, DOI 10.1086/512822; Achilli A, 2012, P NATL ACAD SCI USA, V109, P2449, DOI 10.1073/pnas.1111637109; Alvarez I, 2013, SPAN J AGRIC RES, V11, P702, DOI 10.5424/sjar/2013113-4127; Bigi D, 2014, ANIM GENET, V45, P593, DOI 10.1111/age.12156; Bigi D, 2008, ATLANTE RAZZE AUTOCT; Bigi D, 2012, J HERED, V103, P134, DOI 10.1093/jhered/esr121; Bongianni, 1988, SIMON SCHUSTERS GUID; Bowling AT, 2000, ANIM GENET, V31, P1, DOI 10.1046/j.1365-2052.2000.00558.x; Cieslak M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015311; Colli L, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2342-2; Cothran EG, 2005, GENET MOL BIOL, V28, P677, DOI 10.1590/S1415-47572005000500006; Cozzi MC, 2004, GENET SEL EVOL, V36, P663, DOI 10.1051/gse:2004023; Di Stasio L, 2008, ITAL J ANIM SCI, V7, P243; Dovc P, 2006, REPROD DOMEST ANIM, V41, P280, DOI 10.1111/j.1439-0531.2006.00726.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Felicetti M, 2010, ANIM GENET, V41, P53, DOI 10.1111/j.1365-2052.2010.02102.x; Glazewska I, 2007, GENET SEL EVOL, V39, P609, DOI 10.1051/gse:2007025; Glazewska I, 2010, LIVEST SCI, V129, P49, DOI 10.1016/j.livsci.2009.12.009; Guastella AM, 2011, J HERED, V102, P753, DOI 10.1093/jhered/esr091; Hill EW, 2002, ANIM GENET, V33, P287, DOI 10.1046/j.1365-2052.2002.00870.x; Ivankovic A, 2009, CZECH J ANIM SCI, V54, P101, DOI 10.17221/1678-CJAS; Jansen T, 2002, P NATL ACAD SCI USA, V99, P10905, DOI 10.1073/pnas.152330099; Kakoi H, 2007, BIOCHEM GENET, V45, P375, DOI 10.1007/s10528-007-9083-0; Kavar T, 2002, GENET SEL EVOL, V34, P635, DOI [10.1186/1297-9686-34-5-635, 10.1051/gse:2002028]; Khanshour AM, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-83; Lancioni H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073712; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lindgren G, 2004, NAT GENET, V36, P335, DOI 10.1038/ng1326; Lippold S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1447; Lopes MS, 2005, ANIM GENET, V36, P196, DOI 10.1111/j.1365-2052.2005.01279.x; Maretto F, 2009, ITAL J ANIM SCI, V8, P95, DOI 10.4081/ijas.2009.s3.95; McGahern A, 2006, ANIM GENET, V37, P494, DOI 10.1111/j.1365-2052.2006.01495.x; Morelli L, 2014, GENET MOL RES, V13, P8241, DOI 10.4238/2014.October.20.1; Moridi M, 2013, ANIM GENET, V44, P209, DOI 10.1111/j.1365-2052.2012.02389.x; Outram AK, 2009, SCIENCE, V323, P1332, DOI 10.1126/science.1168594; Pieragostini E, 2005, ITAL J ANIM SCI, V4, P197; Royo LJ, 2005, J HERED, V96, P663, DOI 10.1093/jhered/esi116; Vila C, 2001, SCIENCE, V291, P474, DOI 10.1126/science.291.5503.474; Vilstrup JT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055950; Wallner B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060015; Warmuth V, 2012, P NATL ACAD SCI USA, V109, P8202, DOI 10.1073/pnas.1111122109; XU XF, 1994, GENE, V148, P357, DOI 10.1016/0378-1119(94)90713-7; Yue XP, 2012, ANIM GENET, V43, P624, DOI 10.1111/j.1365-2052.2011.02298.x; Zechner P, 2002, LIVEST PROD SCI, V77, P137, DOI 10.1016/S0301-6226(02)00079-9; Zuccaro A, 2009, ITAL J ANIM SCI, V8, P180, DOI 10.4081/ijas.2009.s2.180	46	23	24	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153004	10.1371/journal.pone.0153004	http://dx.doi.org/10.1371/journal.pone.0153004			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27054850	Green Published, gold, Green Submitted			2022-12-27	WOS:000373608000062
J	Diaz-Nieto, LM; D'Alessio, C; Perotti, MA; Beron, CM				Diaz-Nieto, Leonardo M.; D'Alessio, Cecilia; Perotti, M. Alejandra; Beron, Corina M.			Culex pipiens Development Is Greatly Influenced by Native Bacteria and Exogenous Yeast	PLOS ONE			English	Article							AEDES-AEGYPTI DIPTERA; GUT MICROBIOTA; CULICIDAE; MOSQUITOS; OVIPOSITION; MIDGUT; MICROORGANISMS; BEHAVIOR; VIRUS; FOOD	Culex pipiens is the most cosmopolitan mosquito of the Pipiens Assemblage. By studying the nature of interactions between this species and microorganisms common to its breeding environment we can unravel important pitfalls encountered during development. We tested the survival rate of larval stages, pupae and adults of a Cx. pipiens colony exposed to a variety of microorganisms in laboratory conditions and assessed the transmission to offspring (F1) by those organisms that secured development up to adulthood. Three complementary experiments were designed to: 1) explore the nutritional value of yeasts and other microorganisms during Cx. pipiens development; 2) elucidate the transstadial transmission of yeast to the host offspring; and 3) to examine the relevance of all these microorganisms in female choice for oviposition-substratum. The yeast Saccharomyces cerevisiae proved to be the most nutritional diet, but despite showing the highest survival rates, vertical transmission to F1 was never confirmed. In addition, during the oviposition trials, none of the gravid females was attracted to the yeast substratum. Notably, the two native bacterial strains, Klebsiella sp. and Aeromonas sp., were the preferred oviposition media, the same two bacteria that managed to feed neonates until molting into 2nd instar larvae. Our results not only suggest that Klebsiella sp. or Aeromonas sp. serve as attractants for oviposition habitat selection, but also nurture the most fragile instar, L1, to assure molting into a more resilient stage, L2, while yeast proves to be the most supportive diet for completing development. These experiments unearthed survival traits that might be considered in the future development of strategies of Cx. pipiens control. These studies can be extended to other members of the Pipiens Assemblage.	[Diaz-Nieto, Leonardo M.; Beron, Corina M.] Consejo Nacl Invest Cient & Tecn, Inst Invest Biodiversidad & Biotecnol INBIOTEC, Mar Del Plata, Buenos Aires, Argentina; [Diaz-Nieto, Leonardo M.; Beron, Corina M.] FIBA, Mar Del Plata, Buenos Aires, Argentina; [D'Alessio, Cecilia] Consejo Nacl Invest Cient & Tecn, IIBBA, Fdn Inst Leloir, RA-1033 Buenos Aires, DF, Argentina; [D'Alessio, Cecilia] UBA, Fac Ciencias Exactas & Nat, Buenos Aires, DF, Argentina; [Perotti, M. Alejandra] Univ Reading, Sch Biol Sci, Ecol & Evolutionary Biol, Reading, Berks, England	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Leloir Institute; University of Buenos Aires; University of Reading	Beron, CM (corresponding author), Consejo Nacl Invest Cient & Tecn, Inst Invest Biodiversidad & Biotecnol INBIOTEC, Mar Del Plata, Buenos Aires, Argentina.; Beron, CM (corresponding author), FIBA, Mar Del Plata, Buenos Aires, Argentina.	cberon@fiba.org.ar	Nieto, Leonardo Díaz/AAK-8763-2020	Nieto, Leonardo Díaz/0000-0003-4661-7084; Beron, Corina/0000-0002-0365-3571; D'Alessio, Cecilia/0000-0001-7371-5080	Agencia Nacional de Promocion Cientifica y Tecnologica [ANPCyT PICT-2013-0431]; Universidad Nacional de Mar del Plata [15/E692-EXA742]; CONICET [112 20110100963]	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Universidad Nacional de Mar del Plata(National University of La Plata); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported by Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT PICT-2013-0431) CMB, Universidad Nacional de Mar del Plata (15/E692-EXA742) CMB, and CONICET (PIP 2012 No 112 20110100963) CMB.	[Anonymous], 1992, BIOL MOSQUITOES DEV; [Anonymous], 2003, MOSQUITOES THEIR CON; Balestrino F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091914; Buchner P., 1965, ENDOSYMBIOSIS ANIMAL; Chapman R.F., 1998, INSECTS STRUCTURE FU, V4th ed.; Chavshin AR, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-419; Coon KL, 2014, MOL ECOL, V23, P2727, DOI 10.1111/mec.12771; DeMaio J, 1996, AM J TROP MED HYG, V54, P219, DOI 10.4269/ajtmh.1996.54.219; Douglas AE, 2014, J MOL BIOL, V426, P3830, DOI 10.1016/j.jmb.2014.04.005; Duguma D, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0475-8; Duguma D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072522; Farajollahi A, 2011, INFECT GENET EVOL, V11, P1577, DOI 10.1016/j.meegid.2011.08.013; Gibson CM, 2010, ECOL LETT, V13, P223, DOI 10.1111/j.1461-0248.2009.01416.x; Gusmao DS, 2010, ACTA TROP, V115, P275, DOI 10.1016/j.actatropica.2010.04.011; Gusmao DS, 2007, MEM I OSWALDO CRUZ, V102, P919, DOI 10.1590/S0074-02762007000800005; HOWLAND L. J., 1930, BULL ENT RES [LONDON], V21, P431, DOI 10.1017/S0007485300024779; IBM Corp, 2011, IBM SPSS STAT WIND V; Ignatova E. A., 1996, Mikrobiolohichnyi Zhurnal, V58, P12; Khan I, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-90; Laird M., 1988, NATURAL HIST LARVAL; Lam K, 2007, ANIM BEHAV, V74, P81, DOI 10.1016/j.anbehav.2006.11.013; Lindh JM, 2008, ACTA TROP, V107, P242, DOI 10.1016/j.actatropica.2008.06.008; Marten GG, 2007, J AM MOSQUITO CONTR, V23, P177, DOI 10.2987/8756-971X(2007)23[177:LA]2.0.CO;2; MERRITT RW, 1992, ANNU REV ENTOMOL, V37, P349, DOI 10.1146/annurev.en.37.010192.002025; Micieli MV, 2013, J MED ENTOMOL, V50, P853, DOI 10.1603/ME12226; Muturi EJ, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1299-6; Nikoh N, 2000, MOL BIOL EVOL, V17, P629, DOI 10.1093/oxfordjournals.molbev.a026341; Osei-Poku J, 2012, MOL ECOL, V21, P5138, DOI 10.1111/j.1365-294X.2012.05759.x; Pidiyar VJ, 2004, AM J TROP MED HYG, V70, P597, DOI 10.4269/ajtmh.2004.70.597; Ponnusamy L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024409; Rejmankova E, 2005, J MED ENTOMOL, V42, P95, DOI 10.1603/0022-2585(2005)042[0095:VSFLHM]2.0.CO;2; Rejmankova Eliska, 2000, Aquatic Ecology, V34, P413, DOI 10.1023/A:1011416006562; Ricci I, 2012, CURR OPIN MICROBIOL, V15, P278, DOI 10.1016/j.mib.2012.03.004; Ricci I, 2011, ENVIRON MICROBIOL, V13, P911, DOI 10.1111/j.1462-2920.2010.02395.x; Ricci I, 2011, ANTON LEEUW INT J G, V99, P43, DOI 10.1007/s10482-010-9532-3; Rippka R, 1988, METHOD ENZYMOL, V167, P3; Rossi Gustavo C., 2015, Check List, V11, P1712; Sambrook J., 2001, MOL CLONING LAB MANU; Flores FS, 2010, VECTOR-BORNE ZOONOT, V10, P999, DOI 10.1089/vbz.2009.0136; Smith TW, 1998, J AM MOSQUITO CONTR, V14, P72; Spinelli, 2002, DIPTEROS VECTORES CU; Stata Corp, 2015, STAT STAT SOFTW REL; Sumba Leunita A., 2004, International Journal of Tropical Insect Science, V24, P260, DOI 10.1079/IJT200433; Terenius O, 2008, J MED ENTOMOL, V45, P172, DOI 10.1603/0022-2585(2008)45[172:SRGSFB]2.0.CO;2; THIERY I, 1991, APPL ENVIRON MICROB, V57, P1354, DOI 10.1128/AEM.57.5.1354-1359.1991; Trexler JD, 2003, J MED ENTOMOL, V40, P841, DOI 10.1603/0022-2585-40.6.841; Vega Fernando E., 2005, P211; Vinogradova E.B., 2000, CULEX PIPIENS PIPIEN; Wang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024767; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991	50	28	29	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153133	10.1371/journal.pone.0153133	http://dx.doi.org/10.1371/journal.pone.0153133			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27055276	Green Published, Green Accepted, gold			2022-12-27	WOS:000373608000082
J	Garcia, M; Misplon, JA; Price, GE; Lo, CY; Epstein, SL				Garcia, Mayra; Misplon, Julia A.; Price, Graeme E.; Lo, Chia-Yun; Epstein, Suzanne L.			Age Dependence of Immunity Induced by a Candidate Universal Influenza Vaccine in Mice	PLOS ONE			English	Article							T-CELL REPERTOIRE; A VACCINE; VIRUS; ANTIBODY; PROTEIN; NUCLEOPROTEIN; PROTECTION; ADENOVIRUS; RESPONSES; IMMUNOSENESCENCE	Influenza has a major impact on the elderly due to increased susceptibility to infection with age and poor response to current vaccines. We have studied universal influenza vaccine candidates based on influenza A nucleoprotein and matrix 2 (A/NP+M2). Long-lasting protection against influenza virus strains of divergent subtypes is induced, especially with mucosal immunization. Here, we tested universal vaccination in BALB/c mice of different ages. Vaccination used intramuscular DNA priming to A/NP+M2 followed by intranasal (i.n.) boosting with recombinant adenoviruses (rAd) expressing the same antigens, or only A/NP + M2-rAd given i.n. Antigen-specific systemic antibody responses were induced in young, middle-aged, and elderly mice (2, 11-17, and 20 months old, respectively), but decreased with age. Antibody responses in bronchoalveolar lavage (BAL) were detected only in young mice. Antigen-specific T cell responses were seen in young and middle-aged but not elderly mice. A/NP+M2 vaccination by the two regimens above protected against stringent challenge in young and middle-aged mice, but not in elderly mice. However, mice vaccinated with A/NP-rAd or A/M2-rAd during their youth were partially protected against challenge 16 months later when they were elderly. In addition, a regimen of two doses of A/NP+ M2-rAd given i.n. one month apart beginning in old age protected elderly mice against stringent challenge. This study highlights the potential benefit of cross-protective vaccines through middle age, and suggests that their performance might be enhanced in elderly individuals who had been exposed to influenza antigens early in life, as most humans have been, or by a two-dose rAd regimen given later in life.	[Garcia, Mayra; Misplon, Julia A.; Price, Graeme E.; Lo, Chia-Yun; Epstein, Suzanne L.] US FDA, Div Cellular & Gene Therapies, Ctr Biol Evaluat & Res, Silver Spring, MD USA; [Garcia, Mayra] US FDA, Div Microbiol Devices, Ctr Devices & Radiol Hlth, Silver Spring, MD USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Epstein, SL (corresponding author), US FDA, Div Cellular & Gene Therapies, Ctr Biol Evaluat & Res, Silver Spring, MD USA.	Suzanne.Epstein@fda.hhs.gov		Misplon, Julia/0000-0001-9614-5922; Epstein, Suzanne/0000-0002-6311-6890	FDA, CBER; NIH [HHSN272201300006C]	FDA, CBER; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by FDA, CBER intramural research funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript, other than in conducting manuscript clearance.; We acknowledge Dr. Mary Quirion (a former member of this lab) for preliminary experiments that led to this project, and Dr. S. Mark Tompkins (now on the faculty at the University of Georgia) who constructed the pAd/CMV/V5-GW/lacZ vector when he was a member of this lab. We acknowledge the NIH Tetramer Core Facility (contract HHSN272201300006C) for provision of NP<INF>147-155</INF>-H2-K<SUP>d</SUP> Tetramer-APC. We thank Anthony Ferrine, Mary Belcher and the CBER animal facility staff for expert care of experimental animals; Hang Xie and Zhiping Ye for providing A/Mexico/4108/2009 (H1N1); Maryna Eichelberger for providing aged mice; Howard Mostowski and Heba Degheidy for flow cytometry assistance; and Maryna Eichelberger and Andrew Byrnes for helpful comments on the manuscript.	BENDER BS, 1990, MECH AGEING DEV, V55, P1, DOI 10.1016/0047-6374(90)90101-K; Bernstein ED, 1998, VACCINE, V16, P1722, DOI 10.1016/S0264-410X(98)00140-6; Berthoud TK, 2011, CLIN INFECT DIS, V52, P1, DOI 10.1093/cid/ciq015; Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5; Bodewes R, 2010, J GEN VIROL, V91, P1743, DOI 10.1099/vir.0.020784-0; Bodewes R, 2009, LANCET INFECT DIS, V9, P784, DOI 10.1016/S1473-3099(09)70263-4; Carragher DM, 2008, J IMMUNOL, V181, P4168, DOI 10.4049/jimmunol.181.6.4168; Carrat F, 2006, EPIDEMIOL INFECT, V134, P63, DOI 10.1017/S0950268805005479; Chen WH, 2011, VACCINE, V29, P2865, DOI 10.1016/j.vaccine.2011.02.017; Colloca S, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3002925; Croyle MA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003548; Deng YP, 2004, J IMMUNOL, V172, P3437, DOI 10.4049/jimmunol.172.6.3437; Deng YP, 1997, J IMMUNOL, V158, P1507; EFFROS RB, 1983, IMMUNOLOGY, V49, P387; EFFROS RB, 1983, CELL IMMUNOL, V81, P298, DOI 10.1016/0008-8749(83)90237-X; Eliasson DG, 2008, VACCINE, V26, P1243, DOI 10.1016/j.vaccine.2007.12.027; Epstein SL, 2000, INT IMMUNOL, V12, P91, DOI 10.1093/intimm/12.1.91; Epstein SL, 2005, VACCINE, V23, P5404, DOI 10.1016/j.vaccine.2005.04.047; Epstein SL, 2002, EMERG INFECT DIS, V8, P796; Epstein SL, 2010, EXPERT REV VACCINES, V9, P1325, DOI 10.1586/ERV.10.123; Falcon AM, 2005, J GEN VIROL, V86, P2817, DOI 10.1099/vir.0.80991-0; Flurkey KM, 2007, MOUSE BIOMEDICAL RES, V2nd, P637; GAO XM, 1989, J IMMUNOL, V143, P3007; Gerdil C, 2003, VACCINE, V21, P1776, DOI 10.1016/S0264-410X(03)00071-9; Goodwin K, 2006, VACCINE, V24, P1159, DOI 10.1016/j.vaccine.2005.08.105; Haq K, 2014, CURR OPIN IMMUNOL, V29, P38, DOI 10.1016/j.coi.2014.03.008; Jegaskanda S, 2013, J IMMUNOL, V190, P1837, DOI 10.4049/jimmunol.1201574; KEREN G, 1988, J MED VIROL, V25, P85, DOI 10.1002/jmv.1890250112; Lo CY, 2008, VACCINE, V26, P2062, DOI 10.1016/j.vaccine.2008.02.047; Mbawuike Innocent N., 1993, Viral Immunology, V6, P55, DOI 10.1089/vim.1993.6.55; McElhaney JE, 2011, AGEING RES REV, V10, P379, DOI 10.1016/j.arr.2010.10.008; McElhaney Janet E, 2008, Aging health, V4, P603, DOI 10.2217/1745509X.4.6.603; Neirynck S, 1999, NAT MED, V5, P1157, DOI 10.1038/13484; Parzych EM, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/876314; PATEL HR, 1992, EUR J IMMUNOL, V22, P253, DOI 10.1002/eji.1830220137; POWERS DC, 1993, J INFECT DIS, V167, P584, DOI 10.1093/infdis/167.3.584; Price GE, 2014, J VIROL; Price GE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013162; Price GE, 2009, VACCINE, V27, P6512, DOI 10.1016/j.vaccine.2009.08.053; REED L. J., 1938, AMER JOUR HYG, V27, P493; Sambhara S, 2009, CURR TOP MICROBIOL, V333, P413, DOI 10.1007/978-3-540-92165-3_20; Schwartzman LM, 2015, MBIO, V6, DOI 10.1128/mBio.01044-15; Simonsen L, 2005, ARCH INTERN MED, V165, P265, DOI 10.1001/archinte.165.3.265; SMEENK CA, 1994, J VIROL, V68, P530, DOI 10.1128/JVI.68.1.530-534.1994; Soboleski MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021937; Song KM, 2010, P NATL ACAD SCI USA, V107, P22213, DOI 10.1073/pnas.1015536108; TANNOCK GA, 1987, ARCH VIROL, V92, P121, DOI 10.1007/BF01310067; Thompson M. G., 2010, MMWR-MORBID MORTAL W, V59, P1057; THOMPSON WR, 1947, BACTERIOL REV, V11, P115, DOI 10.1128/MMBR.11.2.115-145.1947; Tompkins SM, 2007, EMERG INFECT DIS, V13, P426, DOI 10.3201/eid1303.061125; TREANOR JJ, 1990, J VIROL, V64, P1375, DOI 10.1128/JVI.64.3.1375-1377.1990; Tritel M, 2003, J IMMUNOL, V171, P2538, DOI 10.4049/jimmunol.171.5.2538; ULMER JB, 1993, SCIENCE, V259, P1745, DOI 10.1126/science.8456302; Valkenburg SA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002544; Vitelli A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055435; Watkinson RE, 2014, J CLIN IMMUNOL, V34, pS30, DOI 10.1007/s10875-014-0017-4; WEIL CS, 1952, BIOMETRICS, V8, P249, DOI 10.2307/3001557; Yager EJ, 2008, J EXP MED, V205, P711, DOI 10.1084/jem.20071140; Zhou DM, 2010, MOL THER, V18, P2182, DOI 10.1038/mt.2010.202	59	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153195	10.1371/journal.pone.0153195	http://dx.doi.org/10.1371/journal.pone.0153195			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27055234	Green Published, gold			2022-12-27	WOS:000373608000097
J	Gardner, SN; McLoughlin, K; Be, NA; Allen, J; Weaver, SC; Forrester, N; Guerbois, M; Jaing, C				Gardner, Shea N.; McLoughlin, Kevin; Be, Nicholas A.; Allen, Jonathan; Weaver, Scott C.; Forrester, Naomi; Guerbois, Mathilde; Jaing, Crystal			Characterization of Genetic Variability of Venezuelan Equine Encephalitis Viruses	PLOS ONE			English	Article							ENCEPHALOMYELITIS VIRUS; HIGH-ACCURACY; EMERGENCE; EVOLUTION; PANAMA; TREES	Venezuelan equine encephalitis virus (VEEV) is a mosquito-borne alphavirus that has caused large outbreaks of severe illness in both horses and humans. New approaches are needed to rapidly infer the origin of a newly discovered VEEV strain, estimate its equine amplification and resultant epidemic potential, and predict human virulence phenotype. We performed whole genome single nucleotide polymorphism (SNP) analysis of all available VEE antigenic complex genomes, verified that a SNP-based phylogeny accurately captured the features of a phylogenetic tree based on multiple sequence alignment, and developed a high resolution genome-wide SNP microarray. We used the microarray to analyze a broad panel of VEEV isolates, found excellent concordance between array-and sequence-based SNP calls, genotyped unsequenced isolates, and placed them on a phylogeny with sequenced genomes. The microarray successfully genotyped VEEV directly from tissue samples of an infected mouse, bypassing the need for viral isolation, culture and genomic sequencing. Finally, we identified genomic variants associated with serotypes and host species, revealing a complex relationship between genotype and phenotype.	[Gardner, Shea N.; McLoughlin, Kevin; Allen, Jonathan] Lawrence Livermore Natl Lab, Computat, Livermore, CA USA; [Be, Nicholas A.; Jaing, Crystal] Lawrence Livermore Natl Lab, Phys & Life Sci, Livermore, CA USA; [Weaver, Scott C.; Forrester, Naomi; Guerbois, Mathilde] Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA; [Weaver, Scott C.; Forrester, Naomi; Guerbois, Mathilde] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA; [Weaver, Scott C.; Forrester, Naomi; Guerbois, Mathilde] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA	United States Department of Energy (DOE); Lawrence Livermore National Laboratory; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Jaing, C (corresponding author), Lawrence Livermore Natl Lab, Phys & Life Sci, Livermore, CA USA.	jaing2@llnl.gov	Weaver, Scott C/D-6490-2011	Weaver, Scott C/0000-0001-8016-8556; Allen, Jonathan/0000-0002-4359-8263; Jaing, Crystal/0000-0001-9933-3005	Defense Threat Reduction Agency; Lawrence Livermore National Laboratory [DTRA10027IA-2359]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R24AI120942] Funding Source: NIH RePORTER	Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); Lawrence Livermore National Laboratory(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding was provided by the Defense Threat Reduction Agency under Interagency Agreement with Lawrence Livermore National Laboratory (DTRA10027IA-2359). CJ and SW received funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar PV, 2004, EMERG INFECT DIS, V10, P880, DOI 10.3201/eid1005.030634; Anishchenko M, 2006, P NATL ACAD SCI USA, V103, P4994, DOI 10.1073/pnas.0509961103; BERGE TO, 1961, AM J HYG, V73, P209, DOI 10.1093/oxfordjournals.aje.a120178; Brault AC, 2002, J VIROL, V76, P1718, DOI 10.1128/JVI.76.4.1718-1730.2002; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ferro C, 2008, BIOMEDICA, V28, P234, DOI 10.7705/biomedica.v28i2.94; Forshey BM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000787; Gardner SN, 2013, J MICROBIOL METH, V94, P303, DOI 10.1016/j.mimet.2013.07.006; Gardner SN, 2010, J FORENSIC RES, V01, P2, DOI [10.4172/2157-7145.1000107, DOI 10.4172/2157-7145.1000107]; Huson DH, 2012, SYST BIOL, V61, P1061, DOI 10.1093/sysbio/sys062; Jaing C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002163; JOHNSON KM, 1968, AM J TROP MED HYG, V17, P432, DOI 10.4269/ajtmh.1968.17.432; Kolaczkowski B, 2004, NATURE, V431, P980, DOI 10.1038/nature02917; Price M.N., FAST TREE COMP TOOLS; Quiroz E, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000472; Team RC, 2014, R LANG ENV STAT COMP; Therneau T, MVPART MULTIVARIATE; Venables WN., 2002, MODERN APPL STAT S 4; Venkatachalam B, 2010, IEEE ACM T COMPUT BI, V7, P588, DOI 10.1109/TCBB.2010.57; Vilcarromero S, 2010, EMERG INFECT DIS, V16, P553, DOI 10.3201/eid1603.090970; Vilcarrornero S, 2009, EMERG INFECT DIS, V15, P323, DOI 10.3201/eid1502.081018; Watts DM, 1997, AM J TROP MED HYG, V56, P661, DOI 10.4269/ajtmh.1997.56.661; Watts DM, 1998, AM J TROP MED HYG, V58, P35, DOI 10.4269/ajtmh.1998.58.35; Weaver SC, 2004, NAT REV MICROBIOL, V2, P789, DOI 10.1038/nrmicro1006; Weaver SC, 2004, ANNU REV ENTOMOL, V49, P141, DOI 10.1146/annurev.ento.49.061802.123422; Weaver SC, 1999, AM J TROP MED HYG, V60, P441, DOI 10.4269/ajtmh.1999.60.441; Wolfe DN, 2014, AM J TROP MED HYG, V91, P442, DOI 10.4269/ajtmh.14-0055	27	5	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0152604	10.1371/journal.pone.0152604	http://dx.doi.org/10.1371/journal.pone.0152604			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27054586	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000373608000028
J	Houmani, N; Garcia-Salicetti, S				Houmani, Nesma; Garcia-Salicetti, Sonia			On Hunting Animals of the Biometric Menagerie for Online Signature	PLOS ONE			English	Article								Individuals behave differently regarding to biometric authentication systems. This fact was formalized in the literature by the concept of Biometric Menagerie, defining and labeling user groups with animal names in order to reflect their characteristics with respect to biometric systems. This concept was illustrated for face, fingerprint, iris, and speech modalities. The present study extends the Biometric Menagerie to online signatures, by proposing a novel methodology that ties specific quality measures for signatures to categories of the Biometric Menagerie. Such measures are combined for retrieving automatically writer categories of the extended version of the Biometric Menagerie. Performance analysis with different types of classifiers shows the pertinence of our approach on the well-known MCYT-100 database.	[Houmani, Nesma] Univ Paris Saclay, Telecom SudParis, 9 Rue Charles Fourier, F-91011 Evry, France; [Garcia-Salicetti, Sonia] Univ Paris Saclay, CNRS, Telecom SudParis, SAMOVAR, 9 Rue Charles Fourier, F-91011 Evry, France	IMT - Institut Mines-Telecom; Institut Polytechnique de Paris; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); IMT - Institut Mines-Telecom; Institut Polytechnique de Paris; UDICE-French Research Universities; Universite Paris Saclay	Houmani, N (corresponding author), Univ Paris Saclay, Telecom SudParis, 9 Rue Charles Fourier, F-91011 Evry, France.	nesma.houmani@telecom-sudparis.eu						Ahmad SMS, 2010, P 10 INT C INF SCI S, V10.1109/ISSPA.2010.5605415, DOI DOI 10.1109/ISSPA.2010.5605415; Alonso-Fernandez F, 2007, IEEE IMAGE PROC, P369; Alonso-Fernandez F., 2008, THESIS U POLITECNICA; Alonso-Fernandez F., 2007, BIOMETRICS THEORY AP, P1, DOI [10.1109/BCC.2007.4430548, DOI 10.1109/BCC.2007.4430548]; [Anonymous], 1993, PRENTICE HALL SIGNAL; Bouletreau V, 1998, INT C PATT RECOG, P1758, DOI 10.1109/ICPR.1998.712067; Brault J.-J., 1989, Proceedings. 1989 International Carnahan Conference on Security Technology (Cat. No.89CH2774-8), P127, DOI 10.1109/CCST.1989.751966; BRAULT JJ, 1993, IEEE T SYST MAN CYB, V23, P400, DOI 10.1109/21.229453; Cao SJ, 2014, INFORM SCIENCES, V278, P22, DOI 10.1016/j.ins.2014.03.133; Chen ZQ, 2014, ENTROPY-SWITZ, V16, P5416, DOI 10.3390/e16105416; Cover TM, 2006, ELEMENTS OF INFORMAT; Doddington G., 1998, P INT C SPOK LANG PR; Dudoit S, 2002, GENOME BIOL, V3; Fierrez-Aguilar J, 2005, LECT NOTES COMPUT SC, V3546, P523; Garcia S, 2009, EURASIP J EMBED SYST, DOI [10.1155/2009/574716, 10.1155/2009/964746]; Garcia-Salicetti S, 2008, P IEEE BIOM S, DOI [10.1109/BSYM.2008.4655527, DOI 10.1109/BSYM.2008.4655527]; Garcia-Salicetti S, 2009, GUIDE BIOMETRIC REFE, P125; Halkidi M, 2001, J INTELL INF SYST, V17, P107, DOI 10.1023/A:1012801612483; Holzinger Andreas, 2014, Interactive Knowledge Discovery and Data Mining in Biomedical Informatics. State-of-the-Art and Future Challenges: LNCS 8401, P209, DOI 10.1007/978-3-662-43968-5_12; Houmani N, 2012, PATTERN RECOGN, V45, P993, DOI 10.1016/j.patcog.2011.08.008; Houmani N, 2011, THESIS TELECOM SUDPA; Houmani N., 2014, SIGNAL IMAGE PROCESS, P255, DOI [DOI 10.1007/978-3-642-54080-6_10, 10.1007/978-3-642-54080-6_10]; Houmani N., 2011, 2011 INT JOINT C BIO, P1, DOI DOI 10.1109/IJCB.2011.6117487; Houmani N, 2008, P IEEE 2 INT C BIOM, DOI [10.1109/BTAS.2008.4699362, DOI 10.1109/BTAS.2008.4699362]; HUBERT L, 1976, BRIT J MATH STAT PSY, V29, P190, DOI 10.1111/j.2044-8317.1976.tb00714.x; Islam T, 2012, INT CONF FRONT HAND, P791, DOI 10.1109/ICFHR.2012.240; Jain A.K., 2008, HDB BIOMETRICS; Jain AK, 1999, ACM COMPUT SURV, V31, P264, DOI 10.1145/331499.331504; Ortega-Garcia J, 2003, IEE P-VIS IMAGE SIGN, V150, P395, DOI 10.1049/ip-vis:20031078; Ortega-Garcia J, 2010, IEEE T PATTERN ANAL, V32, P1097, DOI 10.1109/TPAMI.2009.76; Paone J, 2011, P IEEE INT WORKSH IN, P1, DOI [10.1109/WIFS.2011.6123158, DOI 10.1109/WIFS.2011.6123158]; Poh N, 2009, P 3 INT C ADV BIOM, P816; Poh N., 2010, P IEEE C COMP VIS PA, P38, DOI DOI 10.1109/CVPRW.2010.5543235; Poh N, 2006, P 2 WORKSH MULT US A; Poh N, 2008, 2008 BIOMETRICS SYMPOSIUM (BSYM), P17, DOI 10.1109/BSYM.2008.4655517; Tan P., 2006, INTRO DATA MINING; Wittman M, 2006, P IEEE C COMP VIS PA, DOI [10.1109/CVPRW.2006.71, DOI 10.1109/CVPRW.2006.71]; Yager N, 2007, P IEEE WORKSH AUT ID, DOI [10.1109/AUTOID.2007.380583, DOI 10.1109/AUTOID.2007.380583]; Yager N, 2010, IEEE T PATTERN ANAL, V32, P220, DOI 10.1109/TPAMI.2008.291; Yeung DY, 2004, LECT NOTES COMPUT SC, V3072, P16	40	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0151691	10.1371/journal.pone.0151691	http://dx.doi.org/10.1371/journal.pone.0151691			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27054836	Green Published, gold, Green Submitted			2022-12-27	WOS:000373608000006
J	Sepulveda, D; Lorenzen, N				Sepulveda, Dagoberto; Lorenzen, Niels			Can VHS Virus Bypass the Protective Immunity Induced by DNA Vaccination in Rainbow Trout?	PLOS ONE			English	Article							VIRAL HEMORRHAGIC SEPTICEMIA; HEMATOPOIETIC NECROSIS VIRUS; ONCORHYNCHUS-MYKISS; FISH RHABDOVIRUS; EGTVED VIRUS; GENE; GLYCOPROTEIN; EXPRESSION; IMMUNIZATION; INJECTION	DNA vaccines encoding viral glycoproteins have been very successful for induction of protective immunity against diseases caused by rhabdoviruses in cultured fish species. However, the vaccine concept is based on a single viral gene and since RNA viruses are known to possess high variability and adaptation capacity, this work aimed at evaluating whether viral haemorrhagic septicaemia virus (VHSV), an RNA virus and member of Rhabdoviridae family, was able to evade the protective immune response induced by the DNA vaccination of rainbow trout. The experiments comprised repeated passages of a highly pathogenic VHSV isolate in a fish cell line in the presence of neutralizing fish serum (in vitro approach), and in rainbow trout immunized with the VHS DNA vaccine (in vivo approach). For the in vitro approach, the virus collected from the last passage (passaged virus) was as sensitive as the parental virus to serum neutralization, suggesting that the passaging did not promote the selection of virus populations able to bypass the neutralization by serum antibodies. Also, in the in vivo approach, where virus was passaged several times in vaccinated fish, no increased virulence nor increased persistence in vaccinated fish was observed in comparison with the parental virus. However, some of the vaccinated fish did get infected and could transmit the infection to naive cohabitant fish. The results demonstrated that the DNA vaccine induced a robust protection, but also that the immunity was non-sterile. It is consequently important not to consider vaccinated fish as virus free in veterinary terms.	[Sepulveda, Dagoberto; Lorenzen, Niels] Aarhus Univ, Dept Anim Sci, Aarhus, Denmark	Aarhus University	Lorenzen, N (corresponding author), Aarhus Univ, Dept Anim Sci, Aarhus, Denmark.	niels.lorenzen@anis.au.dk	; Lorenzen, Niels/L-3967-2017	Sepulveda, Dagoberto/0000-0001-8553-5861; Lorenzen, Niels/0000-0002-6946-3252	Chilean National Scholarship Program for Graduate Studies Conicyt; European Commission [FP7311993]	Chilean National Scholarship Program for Graduate Studies Conicyt; European Commission(European CommissionEuropean Commission Joint Research Centre)	This study was supported by Chilean National Scholarship Program for Graduate Studies Conicyt for DS, and by the European Commission contract FP7311993 TargetFish.	AHNE W, 1986, J APPL ICHTHYOL, V2, P187, DOI 10.1111/j.1439-0426.1986.tb00427.x; Ammayappan A, 2011, J VIROL, V85, P8393, DOI 10.1128/JVI.00597-11; BEARZOTTI M, 1995, VET RES, V26, P413; Boudinot P, 1999, J VIROL, V73, P1846, DOI 10.1128/JVI.73.3.1846-1852.1999; Boudinot P, 1998, VIROLOGY, V249, P297, DOI 10.1006/viro.1998.9322; Boudinot P, 2001, FISH SHELLFISH IMMUN, V11, P383, DOI 10.1006/fsim.2000.0326; Castro R, 2014, VACCINE, V32, P1160, DOI 10.1016/j.vaccine.2013.11.062; DEKINKELIN P, 1995, VET RES, V26, P379; Domingo E, 2001, QUASISPECIES RNA VIR; Einer-Jensen K, 2009, VACCINE, V27, P1248, DOI 10.1016/j.vaccine.2008.12.007; Fijan N, 1983, ANN I PASTEUR VIROLO; Heppell J, 1998, FISH SHELLFISH IMMUN, V8, P271, DOI 10.1006/fsim.1997.0133; Huang CJ, 1996, J GEN VIROL, V77, P3033, DOI 10.1099/0022-1317-77-12-3033; JORGENSEN PEV, 1982, J FISH DIS, V5, P47, DOI 10.1111/j.1365-2761.1982.tb00455.x; Kim CH, 2000, J VIROL, V74, P7048, DOI 10.1128/JVI.74.15.7048-7054.2000; Kurath G., 2007, CAB Reviews: Perspectives in Agriculture, Veterinary Science, Nutrition and Natural Resources, V2, DOI 10.1079/PAVSNNR20072048; LaPatra SE, 2001, VACCINE, V19, P4011, DOI 10.1016/S0264-410X(01)00113-X; Lorenzen E, 2000, J AQUAT ANIM HEALTH, V12, P167, DOI 10.1577/1548-8667(2000)012&lt;0167:FVORTA&gt;2.0.CO;2; Lorenzen E, 2009, VACCINE, V27, P3870, DOI 10.1016/j.vaccine.2009.04.012; Lorenzen N, 2000, NAT BIOTECHNOL, V18, P1177, DOI 10.1038/81169; Lorenzen N, 1999, VIRUS RES, V63, P19, DOI 10.1016/S0168-1702(99)00054-4; Lorenzen N, 1999, AQUACULTURE, V172, P41, DOI 10.1016/S0044-8486(98)00443-8; LORENZEN N, 1990, J GEN VIROL, V71, P561, DOI 10.1099/0022-1317-71-3-561; Lorenzen N, 1998, FISH SHELLFISH IMMUN, V8, P261, DOI 10.1006/fsim.1997.0134; Lorenzen N, 2002, DEV COMP IMMUNOL, V26, P173, DOI 10.1016/S0145-305X(01)00059-3; Lorenzen N, 2001, FISH SHELLFISH IMMUN, V11, P585, DOI 10.1006/fsim.2001.0337; Lorenzen N, 1996, DEV BIOL STAND, V90, P201; McLauchlan PE, 2003, FISH SHELLFISH IMMUN, V15, P39, DOI 10.1016/S1050-4648(02)00137-7; Purcell MK, 2006, MOL IMMUNOL, V43, P2089, DOI 10.1016/j.molimm.2005.12.005; Purcell MK, 2004, FISH SHELLFISH IMMUN, V17, P447, DOI 10.1016/j.fsi.2004.04.017; Read AF, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002198; Reading SA, 2007, ARCH VIROL, V152, P1047, DOI 10.1007/s00705-006-0923-8; REED L. J., 1938, AMER JOUR HYG, V27, P493; Salonius K, 2007, CURR OPIN INVEST DR, V8, P635; Schonherz AA, 2015, VET RES; Skall HF, 2005, J FISH DIS, V28, P509, DOI 10.1111/j.1365-2761.2005.00654.x; Sommerset I, 2003, VACCINE, V21, P4661, DOI 10.1016/S0264-410X(03)00526-7; Tafalla C, 2007, FISH SHELLFISH IMMUN, V23, P210, DOI 10.1016/j.fsi.2006.10.009; Utke K, 2008, DEV COMP IMMUNOL, V32, P239, DOI 10.1016/j.dci.2007.05.010; Walker P, 2000, 7 INT COMM TAX VIR; WOLF K, 1966, SCIENCE, V151, P1004, DOI 10.1126/science.151.3713.1004	41	7	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153306	10.1371/journal.pone.0153306	http://dx.doi.org/10.1371/journal.pone.0153306			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27054895	gold, Green Published			2022-12-27	WOS:000373608000118
J	Wu, SH; Fisher-Hoch, SP; Reininger, B; McCormick, JB				Wu, Shenghui; Fisher-Hoch, Susan P.; Reininger, Belinda; McCormick, Joseph B.			Recommended Levels of Physical Activity Are Associated with Reduced Risk of the Metabolic Syndrome in Mexican-Americans	PLOS ONE			English	Article							INSULIN-RESISTANCE; PREVALENCE; EXERCISE; RELIABILITY; COMMUNITY; OBESITY; WEIGHT; DIET	Purpose To measure the association between physical activity and the metabolic syndrome risk in Mexican-Americans. Methods Participants were drawn from the Cameron County Hispanic Cohort (n = 3,414), a randomly selected Mexican-American cohort in Texas on the US-Mexico border. Moderate and vigorous physical activity was assessed using reliable and validated instruments. The metabolic syndrome was defined as having 3 or more metabolic abnormalities. Results One thousand five hundred and twenty-four participants of the cohort (45.02%) were found to have the metabolic syndrome. Compared to participants who did not meet US physical activity guidelines, participants who met physical activity guidelines of 150 moderate and vigorous minutes per week (>= 600 MET adjusted minutes) had 36% lower risk for the metabolic syndrome (OR = 0.64; 95% CI: 0.42-0.98), and participants with total minutes per week of moderate and vigorous/strenuous activity greater than 743 MET adjusted minutes had 37% lower risk for the metabolic syndrome (OR = 0.63; 95% CI: 0.42-0.94) compared with their counterparts, after adjusting for age, gender, annual household income, body mass index, smoking and alcohol drinking status, total portions of fruit and vegetable intake, census tracts and blocks, and survey version for physical activity. Conclusions Meeting or exceeding physical activity guidelines significantly was inversely associated with the risk for the metabolic syndrome in Mexican-Americans. Improving levels of physical activity appears to be an effective target for the metabolic syndrome prevention and control among Mexican-Americans independent of other factors.	[Wu, Shenghui] Univ Texas Hlth Sci Ctr San Antonio, Dept Epidemiol & Biostat, Laredo Campus, Laredo, TX USA; [Fisher-Hoch, Susan P.; McCormick, Joseph B.] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Div Epidemiol, Brownsville Campus, Brownsville, TX USA; [Reininger, Belinda] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Div Hlth Promot & Hlth Behav, Brownsville Campus, Brownsville, TX USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston	McCormick, JB (corresponding author), Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Div Epidemiol, Brownsville Campus, Brownsville, TX USA.	Joseph.b.mccormick@uth.tmc.edu		McCormick, Joseph/0000-0002-5844-8102	National Institute on Minority Health and Health Disparities [MD000170 P2]; National Center for Advancing Translational Science [CTSA UL1 TR000371]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000371] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [P20MD000170] Funding Source: NIH RePORTER	National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); National Center for Advancing Translational Science; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by the National Institute on Minority Health and Health Disparities (http://www.nimhd.nih.gov/), Grant # MD000170 P2 and the National Center for Advancing Translational Science (http://www.ncats.nih.gov/), Grant # CTSA UL1 TR000371. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauman A, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-21; Carroll S, 2004, SPORTS MED, V34, P371, DOI 10.2165/00007256-200434060-00004; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Dang MM, 2009, THESIS U TEXAS HLTH; Fisher-Hoch SP, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.110298; Fisher-Hoch SP, 2010, PREV CHRONIC DIS, V7; Ford ES, 2010, J DIABETES, V2, P180, DOI 10.1111/j.1753-0407.2010.00078.x; Ford ES, 2005, OBES RES, V13, P608, DOI 10.1038/oby.2005.65; GOFIN G, 2015, MED SCI SPORTS EXERC, V29, pS36; Groop L, 2000, BRIT J NUTR, V83, pS39; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Hagberg JM, 2000, SPORTS MED, V30, P193, DOI 10.2165/00007256-200030030-00004; Hallal PC, 2010, J PHYS ACT HEALTH, V7, pS259, DOI 10.1123/jpah.7.s2.s259; Harrell FE, 2001, REGRESSION MODELING; He D, 2014, ENDOCRINE, V46, P231, DOI 10.1007/s12020-013-0110-0; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Meigs JB, 2002, AM J MANAG CARE, V8, pS283; Mendez-Hernandez P, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-276; RAUH MJD, 1992, INT J EPIDEMIOL, V21, P966, DOI 10.1093/ije/21.5.966; Reininger BM, 2015, SOC SCI MED, V143, P98, DOI 10.1016/j.socscimed.2015.08.029; Reininger BM, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1850-y; Ross R, 2000, ANN INTERN MED, V133, P92, DOI 10.7326/0003-4819-133-2-200007180-00008; Torjesen PA, 1997, DIABETES CARE, V20, P26, DOI 10.2337/diacare.20.1.26; US Department of Agriculture, 2013, CHOOS MY PLAT VEG; US Department of Agriculture, 2013, CHOOS MY PLAT FOOD G; USDHHS, 2008, PHYS ACT GUID AM; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; Wildman RP, 2008, ARCH INTERN MED, V168, P1617, DOI 10.1001/archinte.168.15.1617; Zhu SK, 2004, METABOLISM, V53, P1503, DOI 10.1016/j.metabol.2004.04.017; Zimmet P, 2005, J ATHEROSCLER THROMB, V12, P295, DOI 10.5551/jat.12.295	30	24	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0152896	10.1371/journal.pone.0152896	http://dx.doi.org/10.1371/journal.pone.0152896			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27054324	Green Published, Green Submitted, gold			2022-12-27	WOS:000373608000051
J	Pogorelko, GV; Kambakam, S; Nolan, T; Foudree, A; Zabotina, OA; Rodermel, SR				Pogorelko, Gennady V.; Kambakam, Sekhar; Nolan, Trevor; Foudree, Andrew; Zabotina, Olga A.; Rodermel, Steven R.			Impaired Chloroplast Biogenesis in Immutans, an Arabidopsis Variegation Mutant, Modifies Developmental Programming, Cell Wall Composition and Resistance to Pseudomonas syringae	PLOS ONE			English	Article							TERMINAL OXIDASE; PLASTID SIGNALS; GENE-EXPRESSION; WILD-TYPE; PHOTOSYNTHESIS; STRESS; WHITE; DIFFERENTIATION; MORPHOGENESIS; TRANSCRIPTION	The immutans (im) variegation mutation of Arabidopsis has green-and white-sectored leaves due to action of a nuclear recessive gene. IM codes for PTOX, a plastoquinol oxidase in plastid membranes. Previous studies have revealed that the green and white sectors develop into sources (green tissues) and sinks (white tissues) early in leaf development. In this report we focus on white sectors, and show that their transformation into effective sinks involves a sharp reduction in plastid number and size. Despite these reductions, cells in the white sectors have near-normal amounts of plastid RNA and protein, and surprisingly, a marked amplification of chloroplast DNA. The maintenance of protein synthesis capacity in the white sectors might poise plastids for their development into other plastid types. The green and white im sectors have different cell wall compositions: whereas cell walls in the green sectors resemble those in wild type, cell walls in the white sectors have reduced lignin and cellulose microfibrils, as well as alterations in galactomannans and the decoration of xyloglucan. These changes promote susceptibility to the pathogen Pseudomonas syringae. Enhanced susceptibility can also be explained by repressed expression of some, but not all, defense genes. We suggest that differences in morphology, physiology and biochemistry between the green and white sectors is caused by a reprogramming of leaf development that is coordinated, in part, by mechanisms of retrograde (plastid-to-nucleus) signaling, perhaps mediated by ROS. We conclude that variegation mutants offer a novel system to study leaf developmental programming, cell wall metabolism and host-pathogen interactions.	[Pogorelko, Gennady V.; Kambakam, Sekhar; Nolan, Trevor; Foudree, Andrew; Rodermel, Steven R.] Iowa State Univ, Dept Genet Dev & Cell Biol, Ames, IA 50011 USA; [Pogorelko, Gennady V.] Russian Acad Sci, NI Vavilov Inst Gen Genet, Lab Funct Genom, Gubkina St 3, Moscow 119991, Russia; [Zabotina, Olga A.] Iowa State Univ, Roy J Carver Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA	Iowa State University; Russian Academy of Sciences; Vavilov Institute of General Genetics; Iowa State University	Rodermel, SR (corresponding author), Iowa State Univ, Dept Genet Dev & Cell Biol, Ames, IA 50011 USA.	rodermel@iastate.edu	Pogorelko, Gennady/K-2721-2018; Nolan, Trevor/AAB-5319-2022	Nolan, Trevor/0000-0003-1362-2557	Energy Biosciences [DF-FG02-94ER20147]; U.S. Department of Energy (Energy Biosciences) [DF-FG02-94ER20147]	Energy Biosciences; U.S. Department of Energy (Energy Biosciences)(United States Department of Energy (DOE))	This work was supported by Energy Biosciences, Grant DF-FG02-94ER20147.; This work was supported by the U.S. Department of Energy (Energy Biosciences; Grant DF-FG02-94ER20147 to S.R.R.). We thank Marena Bartz for her technical assistance in the manuscript preparation.	Aluru MR, 2007, PHOTOSYNTH RES, V91, P11, DOI 10.1007/s11120-005-9021-0; Aluru MR, 2006, J EXP BOT, V57, P1871, DOI 10.1093/jxb/erj008; Aluru MR, 2009, PLANT PHYSIOL, V150, P904, DOI 10.1104/pp.109.135780; Aluru MR, 2001, PLANT PHYSIOL, V127, P67, DOI 10.1104/pp.127.1.67; Bailey-Serres J, 2006, PLANT PHYSIOL, V141, P311, DOI 10.1104/pp.104.900191; Brautigam A, 2009, MOL PLANT, V2, P1247, DOI 10.1093/mp/ssp070; Carol P, 1999, PLANT CELL, V11, P57, DOI 10.1105/tpc.11.1.57; Dietzel L, 2015, MOL PLANT, V8, P1237, DOI 10.1016/j.molp.2015.03.004; Ellinger D, 2013, PLANT PHYSIOL, V161, P1433, DOI 10.1104/pp.112.211011; Foudree A, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00260; Fraser CM, 2011, THE PHENYLPROPANOID; Heyno E, 2009, J BIOL CHEM, V284, P31174, DOI 10.1074/jbc.M109.021667; HORNER HT, 1980, AM J BOT, V67, P1347, DOI 10.2307/2442137; Ivanov AG, 2012, PHOTOSYNTH RES, V113, P191, DOI 10.1007/s11120-012-9769-y; Jarvis P, 2013, NAT REV MOL CELL BIO, V14, P787, DOI 10.1038/nrm3702; Jonak C, 2002, CURR OPIN PLANT BIOL, V5, P415, DOI 10.1016/S1369-5266(02)00285-6; Jung HS, 2013, P NATL ACAD SCI USA, V110, P14474, DOI 10.1073/pnas.1311632110; KAPUSCINSKI J, 1995, BIOTECH HISTOCHEM, V70, P220, DOI 10.3109/10520299509108199; Kato Y, 2007, PLANT PHYSIOL, V144, P952, DOI 10.1104/pp.107.099002; Kim CH, 2013, PHOTOSYNTH RES, V116, P455, DOI 10.1007/s11120-013-9876-4; Kim CH, 2013, MOL PLANT, V6, P1580, DOI 10.1093/mp/sst020; Leon P, 2013, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00304; Lionetti V, 2012, J PLANT PHYSIOL, V169, P1623, DOI 10.1016/j.jplph.2012.05.006; Lopez-Juez E, 2009, NEW PHYTOL, V182, P287, DOI 10.1111/j.1469-8137.2009.02808.x; McDonald AE, 2011, BBA-BIOENERGETICS, V1807, P954, DOI 10.1016/j.bbabio.2010.10.024; Meehan L, 1996, PLANT PHYSIOL, V112, P953, DOI 10.1104/pp.112.3.953; Miedes E, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00358; Mittler R, 2004, TRENDS PLANT SCI, V9, P490, DOI 10.1016/j.tplants.2004.08.009; MULLET JE, 1988, ANNU REV PLANT PHYS, V39, P475, DOI 10.1146/annurev.arplant.39.1.475; Okegawa Y, 2010, PLANT J, V63, P458, DOI 10.1111/j.1365-313X.2010.04252.x; Pang SL, 2014, GENET MOL RES, V13, P7217, DOI 10.4238/2014.September.5.7; Pattathil S, 2010, PLANT PHYSIOL, V153, P514, DOI 10.1104/pp.109.151985; Peltier G, 2002, ANNU REV PLANT BIOL, V53, P523, DOI 10.1146/annurev.arplant.53.100301.135242; Peng LW, 2012, PLANT CELL, V24, P202, DOI 10.1105/tpc.111.090597; Petrillo E, 2014, RNA BIOL, V11, P1215, DOI 10.4161/15476286.2014.972852; Pfannschmidt T, 2003, ANTIOXID REDOX SIGN, V5, P95, DOI 10.1089/152308603321223586; Pitzschke A, 2009, MOL PLANT, V2, P120, DOI 10.1093/mp/ssn079; Ploscher M, 2011, J PROTEOMICS, V74, P1256, DOI 10.1016/j.jprot.2011.03.020; Pogorelko G, 2011, PLANT MOL BIOL, V77, P433, DOI 10.1007/s11103-011-9822-9; Putarjunan A, 2014, PLANT PHYSIOL, V166, P2115, DOI 10.1104/pp.114.250647; Putarjunan A, 2013, PHOTOSYNTH RES, V116, P437, DOI 10.1007/s11120-013-9855-9; Pyke K, 1999, CRIT REV PLANT SCI, V18, P527, DOI 10.1016/S0735-2689(99)00390-1; REDEI GP, 1963, SCIENCE, V139, P767, DOI 10.1126/science.139.3556.767; Rodermel S, 2001, TRENDS PLANT SCI, V6, P471, DOI 10.1016/S1360-1385(01)02085-4; Rosso D, 2006, PLANT PHYSIOL, V142, P574, DOI 10.1104/pp.106.085886; Rosso D, 2009, PLANT CELL, V21, P3473, DOI 10.1105/tpc.108.062752; Ruckle ME, 2007, PLANT CELL, V19, P3944, DOI 10.1105/tpc.107.054312; Rumeau D, 2007, PLANT CELL ENVIRON, V30, P1041, DOI 10.1111/j.1365-3040.2007.01675.x; Schiff H., 1866, LIEBIGS ANN CHEM, V140, P92, DOI DOI 10.1002/JLAC.18661400106; Schilmiller AL, 2009, PLANT J, V60, P771, DOI 10.1111/j.1365-313X.2009.03996.x; SMITH LG, 1992, PLANT CELL, V4, P1017, DOI 10.1105/tpc.4.9.1017; Sridharan Gokul, 2012, J Oral Maxillofac Pathol, V16, P251, DOI 10.4103/0973-029X.99081; Stessman D, 2002, PHOTOSYNTH RES, V72, P27, DOI 10.1023/A:1016043003839; Terry MJ, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00014; WETZEL CM, 1994, PLANT J, V6, P161, DOI 10.1046/j.1365-313X.1994.6020161.x; WIDHOLM JM, 1972, STAIN TECHNOL, V47, P189, DOI 10.3109/10520297209116483; Wu DY, 1999, PLANT CELL, V11, P43, DOI 10.1105/tpc.11.1.43; Yu F, 2007, PLANT CELL ENVIRON, V30, P350, DOI 10.1111/j.1365-3040.2006.01630.x; Yu QJ, 2014, BBA-BIOENERGETICS, V1837, P1284, DOI 10.1016/j.bbabio.2014.04.007; Zabotina OA, 2008, PLANT J, V56, P101, DOI 10.1111/j.1365-313X.2008.03580.x; Zhu SF, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002318	61	15	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0150983	10.1371/journal.pone.0150983	http://dx.doi.org/10.1371/journal.pone.0150983			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050746	gold, Green Published, Green Submitted			2022-12-27	WOS:000373603500004
J	Herrera, AC; de Oca, MM; Varela, MVL; Aguirre, C; Schiavi, E; Jardim, JR				Casas Herrera, Alejandro; Montes de Oca, Maria; Lopez Varela, Maria Victorina; Aguirre, Carlos; Schiavi, Eduardo; Jardim, Jose R.		PUMA Team	COPD Underdiagnosis and Misdiagnosis in a High-Risk Primary Care Population in Four Latin American Countries. A Key to Enhance Disease Diagnosis: The PUMA Study	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; REFERENCE VALUES; PREVALENCE; SPIROMETRY; CITIES; SPAIN	Background Acknowledgement of COPD underdiagnosis and misdiagnosis in primary care can contribute to improved disease diagnosis. PUMA is an international primary care study in Argentina, Colombia, Venezuela and Uruguay. Objectives To assess COPD underdiagnosis and misdiagnosis in primary care and identify factors associated with COPD underdiagnosis in this setting. Methods COPD was defined as post-bronchodilator (post-BD) forced expiratory volume in 1 second/forced vital capacity (FEV1/FVC) <0.70 and the lower limit of normal (LLN). Prior diagnosis was self-reported physician diagnosis of emphysema, chronic bronchitis, or COPD. Those patients with spirometric COPD were considered to have correct prior diagnosis, while those without spirometric criteria had misdiagnosis. Individuals with spirometric criteria without previous diagnosis were considered as underdiagnosed. Results 1,743 patients were interviewed, 1,540 completed spirometry, 309 (post-BD FEV1/FVC <0.70) and 226 (LLN) had COPD. Underdiagnosis using post-BD FEV1/FVC <0.70 was 77% and 73% by LLN. Overall, 102 patients had a prior COPD diagnosis, 71/102 patients 69.6%) had a prior correct diagnosis and 31/102 (30.4%) had a misdiagnosis defined by post-BD FEV1/FVC >= 0.70. Underdiagnosis was associated with higher body mass index (>= 30 kg/m(2)), milder airway obstruction (GOLD I-II), black skin color, absence of dyspnea, wheezing, no history of exacerbations or hospitalizations in the past-year. Those not visiting a doctor in the last year or only visiting a GP had more risk of underdiagnosis. COPD underdiagnosis (65.8%) and misdiagnosis (26.4%) were less prevalent in those with previous spirometry. Conclusions COPD underdiagnosis is a major problem in primary care. Availability of spirometry should be a priority in this setting.	[Casas Herrera, Alejandro] Univ Rosario, Escuela Med & Ciencias Salud, Fdn Neumol Colombiana, Bogota, Colombia; [Montes de Oca, Maria] Cent Univ Venezuela, Fac Med, Hosp Univ Caracas, Serv Neumonol, Caracas 1030, Venezuela; [Lopez Varela, Maria Victorina] Univ Republica, Fac Med, Hosp Maciel, Montevideo, Uruguay; [Aguirre, Carlos] Fdn Neumol Colombiana, Bogota, Colombia; [Schiavi, Eduardo] Hosp Rehabil Resp Maria Ferrer, Finochietto 849, Buenos Aires, DF, Argentina; [Jardim, Jose R.] Univ Fed Sao Paulo, Escola Paulista Med, Sao Paulo, Brazil	Universidad del Rosario; University of Central Venezuela; Universidad de la Republica, Uruguay; Universidade Federal de Sao Paulo (UNIFESP)	Herrera, AC (corresponding author), Univ Rosario, Escuela Med & Ciencias Salud, Fdn Neumol Colombiana, Bogota, Colombia.	acasas@neumologica.org	Jardim, Jose R/E-3205-2016; de, Maria Montes/AAP-7687-2021		AstraZeneca Latin America; AstraZeneca	AstraZeneca Latin America(AstraZeneca); AstraZeneca(AstraZeneca)	This observational study was sponsored by AstraZeneca Latin America. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Editorial support was provided by Ian Wright and funded by AstraZeneca.	Arne M, 2010, RESP MED, V104, P550, DOI 10.1016/j.rmed.2009.10.023; Bednarek M, 2008, THORAX, V63, P402, DOI 10.1136/thx.2007.085456; Caramori G, 2005, Monaldi Arch Chest Dis, V63, P6; Diez JD, 2003, ARCH BRONCONEUMOL, V39, P203; Hill K, 2010, CAN MED ASSOC J, V182, P673, DOI 10.1503/cmaj.091784; Hueto J, 2006, ARCH BRONCONEUMOL, V42, P326, DOI 10.1016/S1579-2129(06)60541-7; Kurmi OP, 2013, BMJ OPEN RESPIR RES, V1, DOI 10.1136/bmjresp-2014-000025; Lamprecht B, 2015, CHEST, V148, P971, DOI 10.1378/chest.14-2535; Menezes AMB, 2005, LANCET, V366, P1875, DOI 10.1016/S0140-6736(05)67632-5; Perez-Padilla R, 2007, ARCH BRONCONEUMOL, V43, P530, DOI 10.1157/13110877; Perez-Padilla Rogelio, 2007, COPD, V4, P113, DOI 10.1080/15412550701341012; Perez-Padilla R, 2006, ARCH BRONCONEUMOL, V42, P317, DOI 10.1157/13090581; Schiavi E, 2014, ARCH BRONCONEUMOL, V50, P469, DOI 10.1016/j.arbres.2014.03.006; Talamo C, 2007, CHEST, V131, P60, DOI 10.1378/chest.06-1149; Vandevoorde J, 2007, RESP MED, V101, P525, DOI 10.1016/j.rmed.2006.06.027; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; Yu WC, 2013, INT J CHRONIC OBSTR, V8, P389, DOI 10.2147/COPD.S48659	17	42	42	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0152266	10.1371/journal.pone.0152266	http://dx.doi.org/10.1371/journal.pone.0152266			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073880	Green Published, Green Submitted, gold			2022-12-27	WOS:000374131200018
J	Kim, JH; Huh, YH; Kim, HR				Kim, Ju Hwan; Huh, Yang Hoon; Kim, Hak Rim			Induction of Autophagy in the Striatum and Hypothalamus of Mice after 835 MHz Radiofrequency Exposure	PLOS ONE			English	Article							MOBILE PHONE; ELECTROMAGNETIC-FIELDS; COGNITIVE IMPAIRMENT; CELL SURVIVAL; DISEASE; LC3; APOPTOSIS; BRAIN; PERFORMANCE; ACTIVATION	The extensive use of wireless mobile phones and associated communication devices has led to increasing public concern about potential biological health-related effects of the exposure to electromagnetic fields (EMFs). EMFs emitted by a mobile phone have been suggested to influence neuronal functions in the brain and affect behavior. However, the affects and phenotype of EMFs exposure are unclear. We applied radiofrequency (RF) of 835 MHz at a specific absorption rate (SAR) of 4.0 W/kg for 5 hours/day for 4 and 12 weeks to clarify the biological effects on mouse brain. Interestingly, microarray data indicated that a variety of autophagic related genes showed fold-change within small range after 835 MHz RF exposure. qRT-PCR revealed significant up-regulation of the autophagic genes Atg5, LC3A and LC3B in the striatum and hypothalamus after a 12-week RF. In parallel, protein expression of LC3B-II was also increased in both brain regions. Autophagosomes were observed in the striatum and hypothalamus of RF-exposed mice, based on neuronal transmission electron microscopy. Taken together, the results indicate that RF exposure of the brain can induce autophagy in neuronal tissues, providing insight into the protective mechanism or adaptation to RF stress.	[Kim, Ju Hwan; Kim, Hak Rim] Dankook Univ, Dept Pharmacol, Coll Med, Cheonan, Chungnam, South Korea; [Huh, Yang Hoon] Korea Basic Sci Inst, Nanobio EM Res Grp, Gwahak Ro, Daejeon, South Korea	Dankook University; Korea Basic Science Institute (KBSI)	Kim, HR (corresponding author), Dankook Univ, Dept Pharmacol, Coll Med, Cheonan, Chungnam, South Korea.	hrkim@dankook.ac.kr			Basic Science Research Program through National Research Foundation of Korea (NRF) - Ministry of Science, ICT, and Future Planning [NRF-2014R1A2A2A04003616]	Basic Science Research Program through National Research Foundation of Korea (NRF) - Ministry of Science, ICT, and Future Planning	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT, and Future Planning (NRF-2014R1A2A2A04003616).	Abdel-Rassoul G, 2007, NEUROTOXICOLOGY, V28, P434, DOI 10.1016/j.neuro.2006.07.012; Arendash GW, 2010, J ALZHEIMERS DIS, V19, P191, DOI 10.3233/JAD-2010-1228; Baehrecke EH, 2005, NAT REV MOL CELL BIO, V6, P505, DOI 10.1038/nrm1666; Banaceur S, 2013, BEHAV BRAIN RES, V240, P197, DOI 10.1016/j.bbr.2012.11.021; Barron J, 2010, HLTH NEWSLETTER EN 1; Biran J, 2015, FRONT NEUROANAT, V9, DOI 10.3389/fnana.2015.00047; Bourthoumieu S, 2013, BIOELECTROMAGNETICS, V34, P52, DOI 10.1002/bem.21744; Chen S, 2012, BRAIN PATHOL, V22, P110, DOI 10.1111/j.1750-3639.2011.00546.x; Chen YQ, 2011, J CELL SCI, V124, P161, DOI 10.1242/jcs.064576; Christ A, 2010, PHYS MED BIOL, V55, P1767, DOI 10.1088/0031-9155/55/7/001; Chughtai B, 2009, INTERNET J UROL, V6, P1; Consales C, 2012, INT J CELL BIOL; Cuervo AM, 2004, TRENDS CELL BIOL, V14, P70, DOI 10.1016/j.tcb.2003.12.002; Dubreuil D, 2002, BEHAV BRAIN RES, V129, P203, DOI 10.1016/S0166-4328(01)00344-8; Gherardini L, 2014, INT J MOL SCI, V15, P5366, DOI 10.3390/ijms15045366; Greenway FL, 2015, INT J OBESITY, V39, P1188, DOI 10.1038/ijo.2015.59; Hamblin DL, 2002, INT J RADIAT BIOL, V78, P659, DOI 10.1080/09553000210132298; Humphries P, 2008, EUR J CLIN NUTR, V62, P451, DOI 10.1038/sj.ejcn.1602866; Hutter HP, 2006, OCCUP ENVIRON MED, V63, P307, DOI 10.1136/oem.2005.020784; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Kleinlogel H, 2008, BIOELECTROMAGNETICS, V29, P488, DOI 10.1002/bem.20418; Koivisto M, 2000, NEUROREPORT, V11, P1641, DOI 10.1097/00001756-200006050-00009; Koivisto M, 2000, NEUROREPORT; Kokturk S, 2013, EXP THER MED, V6, P52, DOI 10.3892/etm.2013.1123; Leszczynski D, 2002, DIFFERENTIATION, V70, P120, DOI 10.1046/j.1432-0436.2002.700207.x; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Marchesi N, 2014, J CELL PHYSIOL, V229, P1776, DOI 10.1002/jcp.24631; Marino G, 2014, NAT REV MOL CELL BIO, V15, P81, DOI 10.1038/nrm3735; Markov MS, 2007, ELECTROMAGN BIOL MED, V26, P257, DOI 10.1080/15368370701580806; Martiny K, 2010, BIOL PSYCHIAT, V68, P163, DOI 10.1016/j.biopsych.2010.02.017; Maskey D, 2010, BRAIN RES, V1313, P232, DOI 10.1016/j.brainres.2009.11.079; Maskey D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3130; Mehrpour M, 2012, ATLAS GENETICS CYTOG; Meijer AJ, 2004, INT J BIOCHEM CELL B, V36, P2445, DOI 10.1016/j.biocel.2004.02.002; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Nassif M, 2014, AUTOPHAGY, V10, P1256, DOI 10.4161/auto.28784; Nittby Henrietta, 2009, Pathophysiology, V16, P103, DOI 10.1016/j.pathophys.2009.01.001; Nixon RA, 2013, NAT MED, V19, P983, DOI 10.1038/nm.3232; Pardo JCT, 2012, ELECTROMAGN BIOL MED, V31, P1, DOI 10.3109/15368378.2011.596251; Park MR, 2013, SCI REP-UK, V3, DOI 10.1038/srep01384; Pua HH, 2007, J EXP MED, V204, P25, DOI 10.1084/jem.20061303; Pyo JO, 2012, EXP MOL MED, V44, P73, DOI 10.3858/emm.2012.44.2.029; Salford LG, 2003, ENVIRON HEALTH PERSP, V111, P881, DOI 10.1289/ehp.6039; Salminen A, 2013, AGEING RES REV, V12, P520, DOI 10.1016/j.arr.2012.11.004; Santini R, 2002, PATHOL BIOL, V50, P369, DOI 10.1016/S0369-8114(02)00311-5; Scherz-Shouval R, 2010, P NATL ACAD SCI USA, V107, P18511, DOI 10.1073/pnas.1006124107; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Surmeier DJ, 2014, CURR OPIN NEUROBIOL, V29, P109, DOI 10.1016/j.conb.2014.07.008; Tanida I, 2004, INT J BIOCHEM CELL B, V36, P2503, DOI 10.1016/j.biocel.2004.05.009; Taylor SB, 2013, SUBST ABUSE REHABIL, V4, P29, DOI 10.2147/SAR.S39684; Tooze SA, 2010, NAT CELL BIOL, V12, P831, DOI 10.1038/ncb0910-831; Tyler Christina R, 2014, Curr Environ Health Rep, V1, P132; Walker FO, 2007, LANCET, V369, P218, DOI 10.1016/S0140-6736(07)60111-1; Winslow AR, 2010, J CELL BIOL, V190, P1023, DOI 10.1083/jcb.201003122; Yager LM, 2015, NEUROSCIENCE, V301, P529, DOI 10.1016/j.neuroscience.2015.06.033; Yang C, 2008, AM J PHYSIOL-RENAL, V294, pF777, DOI 10.1152/ajprenal.00590.2007	58	11	11	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153308	10.1371/journal.pone.0153308	http://dx.doi.org/10.1371/journal.pone.0153308			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073885	Green Submitted, Green Published, gold			2022-12-27	WOS:000374131200073
J	Lilly, DG; Latham, SL; Webb, CE; Doggett, SL				Lilly, David G.; Latham, Sharissa L.; Webb, Cameron E.; Doggett, Stephen L.			Cuticle Thickening in a Pyrethroid-Resistant Strain of the Common Bed Bug, Cimex lectularius L. (Hemiptera: Cimicidae)	PLOS ONE			English	Article							COLORADO POTATO BEETLE; INSECTICIDE RESISTANCE; CUTICULAR PENETRATION; HELICOVERPA-ARMIGERA; GERMAN-COCKROACH; MUSCA-DOMESTICA; HOUSE FLY; DELTAMETHRIN; MECHANISMS; STARVATION	Thickening of the integument as a mechanism of resistance to insecticides is a well recognised phenomenon in the insect world and, in recent times, has been found in insects exhibiting pyrethroid-resistance. Resistance to pyrethroid insecticides in the common bed bug, Cimex lectularius L., is widespread and has been frequently inferred as a reason for the pest's resurgence. Overexpression of cuticle depositing proteins has been demonstrated in pyrethroid-resistant bed bugs although, to date, no morphological analysis of the cuticle has been undertaken in order to confirm a phenotypic link. This paper describes examination of the cuticle thickness of a highly pyrethroid-resistant field strain collected in Sydney, Australia, in response to time-to-knockdown upon forced exposure to a pyrethroid insecticide. Mean cuticle thickness was positively correlated to time-to-knockdown, with significant differences observed between bugs knocked-down at 2 hours, 4 hours, and those still unaffected at 24 hours. Further analysis also demonstrated that the 24 hours survivors possessed a statistically significantly thicker cuticle when compared to a pyrethroid-susceptible strain of C. lectularius. This study demonstrates that cuticle thickening is present within a pyrethroid-resistant strain of C. lectularius and that, even within a stable resistant strain, cuticle thickness will vary according to time-to-knockdown upon exposure to an insecticide. This response should thus be considered in future studies on the cuticle of insecticide-resistant bed bugs and, potentially, other insects.	[Lilly, David G.; Webb, Cameron E.; Doggett, Stephen L.] Univ Sydney, Dept Med Entomol, Westmead, NSW 2415, Australia; [Lilly, David G.; Webb, Cameron E.; Doggett, Stephen L.] Westmead Hosp, Pathol West ICPMR Westmead, Westmead, NSW 2415, Australia; [Latham, Sharissa L.] Univ Sydney, Australian Ctr Microscopy & Microanal, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney; University of Sydney	Doggett, SL (corresponding author), Univ Sydney, Dept Med Entomol, Westmead, NSW 2415, Australia.; Doggett, SL (corresponding author), Westmead Hosp, Pathol West ICPMR Westmead, Westmead, NSW 2415, Australia.	stephen.doggett@health.nsw.gov.au	Latham, Sharissa/B-2353-2016	Latham, Sharissa/0000-0003-1128-5315; Webb, Cameron/0000-0003-1029-5140	Australian Postgraduate Award from Department of Industry, Innovation, Science, Research and Tertiary Education, Australian Government; Bayer CropScience Pty Ltd, Australia; Bayer CropScience Pty Ltd; University of Sydney	Australian Postgraduate Award from Department of Industry, Innovation, Science, Research and Tertiary Education, Australian Government; Bayer CropScience Pty Ltd, Australia; Bayer CropScience Pty Ltd; University of Sydney(University of Sydney)	The study was largely funded by an Australian Postgraduate Award from the Department of Industry, Innovation, Science, Research and Tertiary Education, Australian Government and administered by the University of Sydney as a student stipend. Partial funding through a postgraduate industry grant was received from Bayer CropScience Pty Ltd, Australia (www.bayercropscience.com.au) and was administered by the University of Sydney. DGL received partial funding from Bayer CropScience Pty Ltd. DGL, CEW and SLD received insecticide for use in this study free of charge from Syngenta Crop Protection Pty Limited. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelman ZN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026228; Ahmad M, 2006, PEST MANAG SCI, V62, P805, DOI 10.1002/ps.1225; Alyokhin A, 2008, AM J POTATO RES, V85, P395, DOI 10.1007/s12230-008-9052-0; ARGENTINE JA, 1994, PESTIC BIOCHEM PHYS, V48, P63, DOI 10.1006/pest.1994.1008; Balvin O, 2012, PARASITOL RES, V111, P457, DOI 10.1007/s00436-012-2862-5; Boase C., 2006, PROFESSIONAL PES SUM, V8, P6; Choe DH, 2014, J ECON ENTOMOL, V107, P1206, DOI 10.1603/EC13478; Dang K, 2015, PEST MANAG SCI, V71, P914, DOI 10.1002/ps.3861; Dang K, 2015, PEST MANAG SCI, V71, P1015, DOI 10.1002/ps.3880; Dang K, 2015, AUSTRAL ENTOMOL, V54, P191, DOI 10.1111/aen.12109; DeVries ZC, 2015, INSECTS, V6, P102, DOI 10.3390/insects6010102; DeVries ZC, 2015, PHYSIOL BIOCHEM ZOOL, V88, P53, DOI 10.1086/679499; Doggett S, 2004, ENVIRON HEALTH-GLOB, V4, P30; Doggett SL, 2012, CLIN MICROBIOL REV, V25, P164, DOI 10.1128/CMR.05015-11; Feldlaufer MF, 2013, J ECON ENTOMOL, V106, P988, DOI 10.1603/EC12378; Feyereisen R, 1995, TOXICOL LETT, V82-3, P83, DOI 10.1016/0378-4274(95)03470-6; ffrench-Constant RH, 2004, TRENDS GENET, V20, P163, DOI 10.1016/j.tig.2004.01.003; FINE BC, 1963, NATURE, V199, P927, DOI 10.1038/199927b0; FORGASH AJ, 1962, J ECON ENTOMOL, V55, P544, DOI 10.1093/jee/55.4.544; GEORGHIOU G, 1961, J ECON ENTOMOL, V54, P132, DOI 10.1093/jee/54.1.132; GUNNING RV, 1991, PESTIC SCI, V33, P473, DOI 10.1002/ps.2780330410; Hoy MA, 1998, PHILOS T ROY SOC B, V353, P1787, DOI 10.1098/rstb.1998.0331; Kilpinen O, 2011, PARASITOL RES, V109, P1461, DOI 10.1007/s00436-011-2423-3; Koganemaru R, 2013, PESTIC BIOCHEM PHYS, V106, P190, DOI 10.1016/j.pestbp.2013.01.001; Lilly DG, 2015, AUSTRAL ENTOMOL, V54, P96, DOI 10.1111/aen.12098; Mamidala P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-6; MATSUMURA F., 1963, MOSQUITO NEWS, V23, P26; MATSUMURA F., 1961, MOSQUITO NEWS, V21, P192; MCDONALD IC, 1968, J ECON ENTOMOL, V61, P670, DOI 10.1093/jee/61.3.670; Moore DJ, 2006, J ECON ENTOMOL, V99, P2080, DOI 10.1603/0022-0493-99.6.2080; Myamba J, 2002, MED VET ENTOMOL, V16, P448, DOI 10.1046/j.1365-2915.2002.00389.x; OPPENOORTH FJ, 1984, PESTIC BIOCHEM PHYS, V22, P187, DOI 10.1016/0048-3575(84)90088-9; PATIL VL, 1979, PESTIC SCI, V10, P399, DOI 10.1002/ps.2780100506; PATIL VL, 1978, CHEMOSPHERE, V7, P707, DOI 10.1016/0045-6535(78)90107-8; PLAPP FW, 1968, J ECON ENTOMOL, V61, P1298; Rasband WS, 1997, IMAGEJ IMAGE J; Romero A, 2007, J MED ENTOMOL, V44, P175, DOI 10.1603/0022-2585(2007)44[175:IRITBB]2.0.CO;2; Romero A, 2010, PEST MANAG SCI, V66, P1243, DOI 10.1002/ps.2002; Romero A, 2009, J ECON ENTOMOL, V102, P2310, DOI 10.1603/029.102.0637; SAWICKI R. M., 1970, Pesticide Science, V1, DOI 10.1002/ps.2780010302; SAWICKI R. M., 1970, Pesticide Science, V1, P213, DOI 10.1002/ps.2780010512; Sawicki R.M., 1987, COMBATING RESISTANCE, P105; Scott J.G., 1990, PESTICIDE RESISTANCE, P39, DOI DOI 10.1007/978-1-4684-6429-0_3; SELLERS L G, 1973, Environmental Entomology, V2, P296, DOI 10.1093/ee/2.2.296; Tawatsin A, 2011, J MED ENTOMOL, V48, P1023, DOI 10.1603/ME11003; Terriere LC, 1980, BIOCH TOXICOLOGY INS; Usinger R. L., 1966, MONOGRAPH CIMICIDAE; Valles SM, 2000, PESTIC BIOCHEM PHYS, V66, P195, DOI 10.1006/pest.1999.2462; VINSON SB, 1966, J ECON ENTOMOL, V59, P600, DOI 10.1093/jee/59.3.600; VINSON SB, 1971, J ECON ENTOMOL, V64, P1387, DOI 10.1093/jee/64.6.1387; Wang CL, 2011, URBAN PEST MANAGEMENT: AN ENVIRONMENTAL PERSPECTIVE, P44, DOI 10.1079/9781845938031.0044; Wiesmann VR, 1947, MITT SCHWEIZ ENTOMOL, V20, P484; Wood OR, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-67; Yoon KS, 2008, J MED ENTOMOL, V45, P1092, DOI 10.1603/0022-2585(2008)45[1092:BAMAOD]2.0.CO;2; Yu S., 2008, TOXICOLOGY BIOCH INS, DOI 10.1201/9781420059762; Yu SJ, 1996, PESTIC BIOCHEM PHYS, V56, P69, DOI 10.1006/pest.1996.0060; Zhang X., 2013, SCI REP, V3; Zhu F, 2010, ARCH INSECT BIOCHEM, V73, P245, DOI 10.1002/arch.20355; Zhu F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039782	59	59	62	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153302	10.1371/journal.pone.0153302	http://dx.doi.org/10.1371/journal.pone.0153302			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073871	gold, Green Published, Green Submitted			2022-12-27	WOS:000374131200072
J	Mobashsher, AT; Bialkowski, KS; Abbosh, AM; Crozier, S				Mobashsher, A. T.; Bialkowski, K. S.; Abbosh, A. M.; Crozier, S.			Design and Experimental Evaluation of a Non-Invasive Microwave Head Imaging System for Intracranial Haemorrhage Detection	PLOS ONE			English	Article							INTRACEREBRAL HEMORRHAGE; WIDE-BAND; TIME-DOMAIN; ANTENNA; STROKE; PLANE; PERFORMANCE; TOMOGRAPHY; DIAGNOSIS; PROTOTYPE	An intracranial haemorrhage is a life threatening medical emergency, yet only a fraction of the patients receive treatment in time, primarily due to the transport delay in accessing diagnostic equipment in hospitals such as Magnetic Resonance Imaging or Computed Tomography. A mono-static microwave head imaging system that can be carried in an ambulance for the detection and localization of intracranial haemorrhage is presented. The system employs a single ultra-wideband antenna as sensing element to transmit signals in low microwave frequencies towards the head and capture backscattered signals. The compact and low-profile antenna provides stable directional radiation patterns over the operating bandwidth in both near and far-fields. Numerical analysis of the head imaging system with a realistic head model in various situations is performed to realize the scattering mechanism of haemorrhage. A modified delay-and-summation back-projection algorithm, which includes effects of surface waves and a distance-dependent effective permittivity model, is proposed for signal and image post-processing. The efficacy of the automated head imaging system is evaluated using a 3D-printed human head phantom with frequency dispersive dielectric properties including emulated haemorrhages with different sizes located at different depths. Scattered signals are acquired with a compact transceiver in a mono-static circular scanning profile. The reconstructed images demonstrate that the system is capable of detecting haemorrhages as small as 1 cm(3). While quantitative analyses reveal that the quality of images gradually degrades with the increase of the haemorrhage's depth due to the reduction of signal penetration inside the head; rigorous statistical analysis suggests that substantial improvement in image quality can be obtained by increasing the data samples collected around the head. The proposed head imaging prototype along with the processing algorithm demonstrates its feasibility for potential use in ambulances as an effective and low cost diagnostic tool to assure timely triaging of intracranial hemorrhage patients.	[Mobashsher, A. T.; Bialkowski, K. S.; Abbosh, A. M.; Crozier, S.] Univ Queensland, Sch ITEE, Brisbane, Qld 4072, Australia	University of Queensland	Mobashsher, AT (corresponding author), Univ Queensland, Sch ITEE, Brisbane, Qld 4072, Australia.	a.mobashsher@uq.edu.au	Mobashsher, Ahmed Toaha/H-6341-2019; Abbosh, Amin/C-3944-2009	Mobashsher, Ahmed Toaha/0000-0002-6351-8136; Abbosh, Amin/0000-0002-8015-5883; Crozier, Stuart/0000-0003-4036-2930; Bialkowski, Konstanty/0000-0002-3461-0371	Australian Research Council (ARC) [DP150103425]	Australian Research Council (ARC)(Australian Research Council)	Australian Research Council (ARC) via the Discovery Grant DP150103425.	Adeoye O, 2010, NAT REV NEUROL, V6, P593, DOI 10.1038/nrneurol.2010.146; Al-Joumayly MA, 2010, IEEE ANTENN WIREL PR, V9, P268, DOI 10.1109/LAWP.2010.2045871; Balami JS, 2012, LANCET NEUROL, V11, P101, DOI 10.1016/S1474-4422(11)70264-2; Barai A, 2012, MEAS SCI TECHNOL, V23, DOI 10.1088/0957-0233/23/8/085501; Bermingham S L, 2014, Ont Health Technol Assess Ser, V14, P1; Best SR, 2004, IEEE ANTENN PROPAG M, V46, P13, DOI 10.1109/MAP.2004.1305530; Birenbaum Dale, 2010, J Emerg Trauma Shock, V3, P52, DOI 10.4103/0974-2700.58662; Bourqui J, 2012, INT J BIOMED IMAGING, V2012, DOI 10.1155/2012/851234; Bourqui J, 2012, INT J BIOMED IMAGING, V2012, DOI 10.1155/2012/562563; Bourqui J, 2012, IEEE ANTENN WIREL PR, V11, P1614, DOI 10.1109/LAWP.2012.2235814; Chalela JA, 2007, LANCET, V369, P293, DOI 10.1016/S0140-6736(07)60151-2; Chiappe M, 2006, IEEE T INSTRUM MEAS, V55, P1885, DOI 10.1109/TIM.2006.884289; Dai M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055020; Elsherbini A, 2013, IEEE T ANTENN PROPAG, V61, P1055, DOI 10.1109/TAP.2012.2229951; Gabriel S, 1996, PHYS MED BIOL, V41, P2271, DOI 10.1088/0031-9155/41/11/003; Gao FQ, 2015, IEEE T ANTENN PROPAG, V63, P3540, DOI 10.1109/TAP.2015.2436406; Granot Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002075; Greenberg CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048458; Honner SK, 2011, J EMERG MED, V41, P355, DOI 10.1016/j.jemermed.2009.02.001; Huisman TAGM, 2005, EUR RADIOL, V15, P434, DOI 10.1007/s00330-004-2615-7; Jadoon KZ, 2011, IEEE T GEOSCI REMOTE, V49, P1649, DOI 10.1109/TGRS.2010.2089691; Jalilvand M, 2014, ELECTRON LETT, V50, P255, DOI 10.1049/el.2013.4078; Keysight Technologies, KEYS MICR TRANSC N70; Khotanlou H, 2009, FUZZY SET SYST, V160, P1457, DOI 10.1016/j.fss.2008.11.016; Kidwell CS, 2008, LANCET NEUROL, V7, P256, DOI 10.1016/S1474-4422(08)70041-3; Koohestani M, 2014, IEEE T ANTENN PROPAG, V62, P1888, DOI 10.1109/TAP.2014.2298886; Korfhagen JJ, 2013, J NEUROSCI METH, V213, P132, DOI 10.1016/j.jneumeth.2012.12.007; Kremer PHC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142338; Li XY, 2014, IEEE T ANTENN PROPAG, V62, P1808, DOI 10.1109/TAP.2013.2297158; Lin JC, 2006, IEEE ANTENN PROPAG M, V48, P157, DOI 10.1109/MAP.2006.1645601; Mahmood Q., 2015, J ELECTROMAGN ANAL A, V7, P152, DOI DOI 10.4236/JEMAA.2015.75017; Meaney PM, 2012, INT J BIOMED IMAGING, V2012, DOI 10.1155/2012/697253; Meaney PM, 2000, IEEE T MICROW THEORY, V48, P1841, DOI 10.1109/22.883861; Mobashsher AT, 2015, ELECTRON LETT, V51, P2076, DOI 10.1049/el.2015.2763; Mobashsher AT, 2014, IEEE ANTENN WIREL PR, V13, DOI 10.1109/LAWP.2014.2340409; Mobashsher AT, 2014, ELECTRON LETT, V50, P850, DOI 10.1049/el.2014.0616; Mobashsher A T, 2013, P IEEE MTT S INT MIC, P1, DOI DOI 10.1109/IMWS-BIO.2013.6756149; Mobashsher AT, 2015, IEEE MICROW MAG, V16, P42, DOI 10.1109/MMM.2015.2419772; Mobashsher AT, 2016, IEEE ANTENN WIREL PR, V15, P1618, DOI 10.1109/LAWP.2016.2519527; Mobashsher AT, 2016, SCI REP-UK, V6, DOI 10.1038/srep20459; Mobashsher AT, 2015, IEEE ANTENN PROPAG M, V57, P153, DOI 10.1109/MAP.2015.2414488; Mobashsher AT, 2014, IEEE T MICROW THEORY, V62, P1826, DOI 10.1109/TMTT.2014.2342669; Mobashsher AT, 2014, IEEE ANTENN WIREL PR, V13, P798, DOI 10.1109/LAWP.2014.2318035; Mustafa S, 2014, IEEE T ANTENN PROPAG, V62, P1354, DOI 10.1109/TAP.2013.2296323; Naidech AM, 2011, AM J RESP CRIT CARE, V184, P998, DOI 10.1164/rccm.201103-0475CI; Palmer PE, 2011, DIAGN IMAG CLIN MED; Pan WC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128127; Persson M, 2014, IEEE T BIO-MED ENG, V61, P2806, DOI 10.1109/TBME.2014.2330554; Presson N, 2015, MIL MED, V180, P109, DOI 10.7205/MILMED-D-14-00413; Prima S, 2002, IEEE T MED IMAGING, V21, P122, DOI 10.1109/42.993131; Semenov S., 2014, P 2014 IEEE C ANT ME, P1, DOI DOI 10.1109/CAMA.2014.7003417; Semenov SY, 2008, INT J ANTENN PROPAG, V2008, DOI 10.1155/2008/254830; Specogna AV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096743; Tsai YH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105970; Veluw SJV, 2014, J CEREB BLOOD FLOW M, V34, P1104, DOI [10.1038/jcbfm.2014.73, DOI 10.1038/JCBFM.2014.73]; Volkau I, 2006, MED IMAGE ANAL, V10, P863, DOI 10.1016/j.media.2006.07.005; WOODY CD, 1967, MED BIOL ENG, V5, P539, DOI 10.1007/BF02474247	57	59	59	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0152351	10.1371/journal.pone.0152351	http://dx.doi.org/10.1371/journal.pone.0152351			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073994	Green Published, gold, Green Submitted			2022-12-27	WOS:000374131200021
J	Piulachs, X; Alemany, R; Guillen, M				Piulachs, Xavier; Alemany, Ramon; Guillen, Montserrat			Joint Modelling of Survival and Emergency Medical Care Usage in Spanish Insureds Aged 65+	PLOS ONE			English	Article							LONGITUDINAL DATA; PROSTATE-CANCER; ERROR; TOOL	Background We study the longevity and medical resource usage of a large sample of insureds aged 65 years or older drawn from a large health insurance dataset. Yearly counts of each subject's emergency room and ambulance service use and hospital admissions are made. Occurrence of mortality is also monitored. The study aims to capture the simultaneous dependence between their demand for healthcare and survival. Methods We demonstrate the benefits of taking a joint approach to modelling longitudinal and survival processes by using a large dataset from a Spanish medical mutual company. This contains historical insurance information for 39,137 policyholders aged 65+ (39.5% men and 60.5% women) across the eight-year window of the study. The joint model proposed incorporates information on longitudinal demand for care in a weighted cumulative effect that places greater emphasis on more recent than on past service demand. Results A strong significant and positive relationship between the exponentially weighted demand for emergency, ambulance and hospital services is found with risk of death (alpha = 1.462, p < 0.001). Alternative weighting specifications are tested, but in all cases they show that a joint approach indicates a close connection between health care demand and time-todeath. Additionally, the model allows us to predict individual survival curves dynamically as new information on demand for services becomes known. Conclusions The joint model fitted demonstrates the utility of analysing demand for medical services and survival simultaneously. Likewise, it allows the personalized prediction of survival in advanced age subjects.	[Piulachs, Xavier; Alemany, Ramon; Guillen, Montserrat] Univ Barcelona, Dept Econometr, Riskctr IREA, Barcelona, Spain	University of Barcelona	Guillen, M (corresponding author), Univ Barcelona, Dept Econometr, Riskctr IREA, Barcelona, Spain.	mguillen@ub.edu	Leira, Ramon Alemany/N-9694-2013; Guillen, Montserrat/E-1407-2011	Guillen, Montserrat/0000-0002-2644-6268; Alemany Leira, Ramon/0000-0002-8985-0030	Spanish Ministry of Economy and Competitiveness/FEDER [ECO2013-48326-C2-1-P]	Spanish Ministry of Economy and Competitiveness/FEDER	MG thanks ICREA Academia program. All authors were supported by the Spanish Ministry of Economy and Competitiveness/FEDER ECO2013-48326-C2-1-P. The funders had no role in study design, datacollection and analysis, decision to publish, or preparation of the manuscript.	Abrahamowicz M, 2012, STAT MED, V31, P1014, DOI 10.1002/sim.4343; Barrett J, 2015, J R STAT SOC B, V77, P131, DOI 10.1111/rssb.12060; Bird Chloe E, 2002, J Palliat Med, V5, P705, DOI 10.1089/109662102320880525; Cameron KA, 2010, J WOMENS HEALTH, V19, P1643, DOI 10.1089/jwh.2009.1701; COX DR, 1972, J R STAT SOC B, V34, P187; Dendukuri N, 2004, J AM GERIATR SOC, V52, P290, DOI 10.1111/j.1532-5415.2004.52073.x; Faucett CL, 1996, STAT MED, V15, P1663, DOI 10.1002/(SICI)1097-0258(19960815)15:15<1663::AID-SIM294>3.0.CO;2-1; Hauptmann M, 2000, BIOMETRICS, V56, P1105, DOI 10.1111/j.0006-341X.2000.01105.x; Henderson R, 2000, Biostatistics, V1, P465, DOI 10.1093/biostatistics/1.4.465; Hogan J W, 1998, Stat Methods Med Res, V7, P28; Hsieh F, 2006, BIOMETRICS, V62, P1037, DOI 10.1111/j.1541-0420.2006.00570.x; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Proust-Lima C, 2009, BIOSTATISTICS, V10, P535, DOI 10.1093/biostatistics/kxp009; R Core Team, 2013, R LANG ENV STAT COMP; Rizopoulos D., 2014, PREPRINT; Rizopoulos D, 2011, BIOMETRICS, V67, P819, DOI 10.1111/j.1541-0420.2010.01546.x; Rizopoulos JM, 2010, J STAT SOFT, V35; Samaras N, 2010, ANN EMERG MED, V56, P261, DOI 10.1016/j.annemergmed.2010.04.015; Sweeting MJ, 2011, BIOMETRICAL J, V53, P750, DOI 10.1002/bimj.201100052; TSIATIS AA, 1995, J AM STAT ASSOC, V90, P27, DOI 10.2307/2291126; Verbeke G, 2000, LINEAR MIXED MODELS; Wulfsohn MS, 1997, BIOMETRICS, V53, P330, DOI 10.2307/2533118; Yu MG, 2008, J AM STAT ASSOC, V103, P178, DOI 10.1198/016214507000000400	23	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153234	10.1371/journal.pone.0153234	http://dx.doi.org/10.1371/journal.pone.0153234			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073868	Green Published, Green Submitted, gold			2022-12-27	WOS:000374131200063
J	Costa, R; Pereira, G; Garrido, I; Tavares-de-Sousa, MM; Espinosa, F				Costa, Rita; Pereira, Graca; Garrido, Inmaculada; Tavares-de-Sousa, Manuel Maria; Espinosa, Francisco			Comparison of RAPD, ISSR, and AFLP Molecular Markers to Reveal and Classify Orchardgrass (Dactylis glomerata L.) Germplasm Variations	PLOS ONE			English	Article							GENETIC DIVERSITY; POPULATIONS; ORCHID; GRASS	Three different DNA-based techniques, Random Amplified Polymorphic DNA (RAPD), Inter Simple Sequence Repeat (ISSR) and Amplified Fragment Length Polymorphism (AFLP) markers, were used for fingerprinting Dactylis glomerata genotypes and for detecting genetic variation between the three different subspecies. In this study, RAPD assays produced 97 bands, of which 40 were polymorphic (41.2%). The ISSR primers amplified 91 bands, and 54 showed polymorphism (59.3%). Finally, the AFLP showed 100 bands, of which 92 were polymorphic (92%). The fragments were scored as present (1) or absent (0), and those readings were entered in a computer file as a binary matrix (one for each marker). Three cluster analyses were performed to express-in the form of dendrograms-the relationships among the genotypes and the genetic variability detected. All DNA-based techniques used were able to amplify all of the genotypes. There were highly significant correlation coefficients between cophenetic matrices based on the genetic distance for the RAPD, ISSR, AFLP, and combined RAPD-ISSR-AFLP data (0.68, 0.78, 0.70, and 0.70, respectively). Two hypotheses were formulated to explain these results; both of them are in agreement with the results obtained using these three types of molecular markers. We conclude that when we study genotypes close related, the analysis of variability could require more than one DNA-based technique; in fact, the genetic variation present in different sources could interfere or combine with the more or less polymorphic ability, as our results showed for RAPD, ISSR and AFLP markers. Our results indicate that AFLP seemed to be the best-suited molecular assay for fingerprinting and assessing genetic relationship among genotypes of Dactylis glomerata.	[Costa, Rita; Pereira, Graca; Tavares-de-Sousa, Manuel Maria] INIAV Polo Elvas, Unidade Estrateg Invest, Estrada Gil Vaz 6, P-7351901 Elvas, Portugal; [Costa, Rita; Pereira, Graca; Tavares-de-Sousa, Manuel Maria] INIAV Polo Elvas, Serv Biotecnol & Recursos Genet, Estrada Gil Vaz 6, P-7351901 Elvas, Portugal; [Garrido, Inmaculada; Espinosa, Francisco] Univ Extremadura, Fac Ciencias, Area Fisiol Vegetal, Avda Elvas S-N, E-06006 Badajoz, Spain	Universidad de Extremadura	Espinosa, F (corresponding author), Univ Extremadura, Fac Ciencias, Area Fisiol Vegetal, Avda Elvas S-N, E-06006 Badajoz, Spain.	espinosa@unex.es	Pereira, Graca/P-4946-2015; Espinosa, Francisco/I-8205-2018	Pereira, Graca/0000-0002-8966-0931; Espinosa, Francisco/0000-0002-6467-0359; GARRIDO CARBALLO, INMACULADA/0000-0002-2367-0985; Pereira da Costa, Ana Rita/0000-0002-2796-4278	regional Government of Extremadura/FEDER [GR15138]; Project Promocao Gestao Integrada, Conservacao e Sustentabilidades de Montados (PARIPIPI), Portugal	regional Government of Extremadura/FEDER; Project Promocao Gestao Integrada, Conservacao e Sustentabilidades de Montados (PARIPIPI), Portugal	RC, GP and MMT-S thank Project Promocao Gestao Integrada, Conservacao e Sustentabilidades de Montados (PARIPIPI), Portugal; IG and FE thank the regional Government of Extremadura/FEDER by the support to the research Group FBCMP (GR15138). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal M, 2008, PLANT CELL REP, V27, P617, DOI 10.1007/s00299-008-0507-z; Bahulikar Rahul A., 2004, BMC Ecology, V4, P12, DOI 10.1186/1472-6785-4-12; Bhattacharyya P, 2015, PLANT SYST EVOL, V301, P201, DOI 10.1007/s00606-014-1065-1; Biswas MK, 2011, SCI HORTIC-AMSTERDAM, V129, P798, DOI 10.1016/j.scienta.2011.06.015; Branco CJS, 2007, J APPL GENET, V48, P107, DOI 10.1007/BF03194667; Carnide V, 1994, PASTAGENS FORRAGENS, V14, P1; Costa R, 2005, RECENT ADV GENETICS, V4, P121; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Farinho M, 2004, THEOR APPL GENET, V109, P1392, DOI 10.1007/s00122-004-1747-0; Jaccard P., 1908, B SOC VAUD SCI N, V44, P223; Karp A., 1997, IPGRI TECHNICAL B, V2; Kole C, 2011, WILD CROP RELATIVES: GENOMIC AND BREEDING RESOURCES: MILLETS AND GRASSES, P1, DOI 10.1007/978-3-642-14255-0; Kolliker R, 1999, EUPHYTICA, V106, P261, DOI 10.1023/A:1003598705582; Lamia K, 2010, SCI HORTIC-AMSTERDAM, V127, P54, DOI 10.1016/j.scienta.2010.09.012; Last L, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-102; Li Dayu, 2007, Journal of Genetics and Genomics, V34, P984, DOI 10.1016/S1673-8527(07)60111-8; Lidner R, 1997, GRASS FORAGE SCI, V52, P291; Madensis P, 2014, GEN MOL RES, V13, P426; Manners V, 2013, GENE, V519, P91, DOI 10.1016/j.gene.2013.01.037; MANTEL N, 1967, CANCER RES, V27, P209; Mao LH, 2014, BIOCHEM SYST ECOL, V55, P107, DOI 10.1016/j.bse.2014.02.021; McGregor CE, 2000, EUPHYTICA, V113, P135, DOI 10.1023/A:1003925620546; MCLEAN A, 1980, J RANGE MANAGE, V33, P213, DOI 10.2307/3898288; Meudt HM, 2007, TRENDS PLANT SCI, V12, P106, DOI 10.1016/j.tplants.2007.02.001; Mika V, 2002, ROST VYROBA, V48, P243; Mousset C, 1982, JOURN ASF, P105; Muthusamy S, 2008, ELECTRON J BIOTECHN, V11, DOI 10.2225/vol11-issue3-fulltext-8; NEI M, 1978, GENETICS, V89, P583; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Pejic I, 1998, THEOR APPL GENET, V97, P1248, DOI 10.1007/s001220051017; Peng Y, 2008, HEREDITAS, V145, P174, DOI 10.1111/j.0018-0661.2008.02038.x; Posselt U. K., 2006, Czech Journal of Genetics and Plant Breeding, V42, P87; Reeves G, 1998, ANN BOT, V45, P1; Ricardo F, 2002, GRASSLAND SCI EUROPE, V7, P468; Rohlf FJ, 1997, NTSYS PC VERSION 2 0; Savelkoul PHM, 1999, J CLIN MICROBIOL, V37, P3083, DOI 10.1128/JCM.37.10.3083-3091.1999; Sen S, 2010, MOL BIOTECHNOL, V46, P72, DOI 10.1007/s12033-010-9281-6; THORMANN CE, 1994, THEOR APPL GENET, V88, P973, DOI 10.1007/BF00220804; Tuna M, 2004, EUPHYTICA, V135, P39, DOI 10.1023/B:EUPH.0000009537.08697.4e; Volaire F., 1991, Agricoltura Mediterranea, V121, P263; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Yeh F. C., 1997, MICROSOFT WINDOW BAS; Zeng Bing, 2006, Yichuan, V28, P1093, DOI 10.1360/yc-006-1093; ZIETKIEWICZ E, 1994, GENOMICS, V20, P176, DOI 10.1006/geno.1994.1151	44	50	57	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0152972	10.1371/journal.pone.0152972	http://dx.doi.org/10.1371/journal.pone.0152972			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27070939	Green Submitted, gold, Green Published			2022-12-27	WOS:000373900700024
J	Martinez, EJ; Gil, MV; Fernandez, C; Rosas, JG; Gomez, X				Martinez, E. J.; Gil, M. V.; Fernandez, C.; Rosas, J. G.; Gomez, X.			Anaerobic Codigestion of Sludge: Addition of Butcher's Fat Waste as a Cosubstrate for Increasing Biogas Production	PLOS ONE			English	Article							GREASE TRAP SLUDGE; CO-DIGESTION; SEWAGE-SLUDGE; ACTIVATED-SLUDGE; ORGANIC-MATTER; ACIDS; FTIR; SPECTROSCOPY; INHIBITION; ENHANCEMENT	Fat waste discarded from butcheries was used as a cosubstrate in the anaerobic codigestion of sewage sludge (SS). The process was evaluated under mesophilic and thermophilic conditions. The codigestion was successfully attained despite some inhibitory stages initially present that had their origin in the accumulation of volatile fatty acids (VFA) and adsorption of long-chain fatty acids (LCFA). The addition of a fat waste improved digestion stability and increased biogas yields thanks to the higher organic loading rate (OLR) applied to the reactors. However, thermophilic digestion was characterized by an effluent of poor quality and high VFA content. Results from spectroscopic analysis suggested the adsorption of lipid components onto the anaerobic biomass, thus disturbing the complete degradation of substrate during the treatment. The formation of fatty aggregates in the thermophilic reactor prevented process failure by avoiding the exposure of biomass to the toxic effect of high LCFA concentrations.	[Martinez, E. J.; Fernandez, C.; Rosas, J. G.; Gomez, X.] Univ Leon, Chem & Environm Bioprocess Engn Grp, Nat Resources Inst IRENA, E-24071 Leon, Spain; [Gil, M. V.] INCAR CSIC, Inst Nacl Carbon, Oviedo, Asturias, Spain	Universidad de Leon; Consejo Superior de Investigaciones Cientificas (CSIC); Instituto de Ciencia Tecnologia del Carbono INCAR-CSIC	Gomez, X (corresponding author), Univ Leon, Chem & Environm Bioprocess Engn Grp, Nat Resources Inst IRENA, E-24071 Leon, Spain.	xagomb@unileon.es	Rosas Mayoral, Jose Guillermo/ABE-8287-2021; TORRES, E. JUDITH MARTINEZ/P-4308-2019; GIL, MARÍA V/A-2774-2017; ELIA JUDITH Martinez, E. J. MARTINEZ TORRES/M-8654-2013; Fernandez, Camino/P-6170-2017; Gomez, Xiomar/C-9031-2014	Rosas Mayoral, Jose Guillermo/0000-0002-3235-8555; TORRES, E. JUDITH MARTINEZ/0000-0002-4426-4353; GIL, MARÍA V/0000-0002-2258-3011; ELIA JUDITH Martinez, E. J. MARTINEZ TORRES/0000-0002-4426-4353; Gomez, Xiomar/0000-0001-9595-8825	Ministerio de Economia y Competitividad [CTQ2015-68925-R]	Ministerio de Economia y Competitividad(Spanish Government)	This work was financially supported by the Ministerio de Economia y Competitividad through the project CTQ2015-68925-R (http://www.mineco.gob.es/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGELIDAKI I, 1992, APPL MICROBIOL BIOT, V37, P808, DOI 10.1007/BF00174850; [Anonymous], 2008, AGR SYST, V98, P126, DOI [10.1016/j.agsy.2008.05.003, DOI 10.1016/J.AGSY.2008.05.003]; [Anonymous], 2006, LIVESTOCKS LONG SHAD, V3, P1, DOI [10.1007/s10666-008-9149-3, DOI 10.1007/S10666-008-9149-3]; APHA, 2005, STANDARD METHODS EXA, V21st; Bolzonella D, 2012, WASTE MANAGE, V32, P1196, DOI 10.1016/j.wasman.2012.01.006; Borowski S, 2015, WASTE MANAGE, V40, P119, DOI 10.1016/j.wasman.2015.03.021; Carballo T, 2008, BIODEGRADATION, V19, P815, DOI 10.1007/s10532-008-9184-4; Cavaleiro AJ, 2008, BIORESOURCE TECHNOL, V99, P4086, DOI 10.1016/j.biortech.2007.09.005; Davidsson A, 2008, WASTE MANAGE, V28, P986, DOI 10.1016/j.wasman.2007.03.024; De Oliveira Silva J, 2012, THERMOCHIM ACTA, V528, P72, DOI [DOI 10.1016/J.TCA.2011.11.010, 10.1016/j.tca.2011.11.010]; Drewnowski A, 1997, J AM DIET ASSOC, V97, pS58, DOI 10.1016/S0002-8223(97)00732-3; Fernandez C, 2015, BIOMASS BIOENERG, V81, P55, DOI 10.1016/j.biombioe.2015.05.024; Francioso O, 2010, J HAZARD MATER, V175, P740, DOI 10.1016/j.jhazmat.2009.10.071; Guillen MD, 1997, J AM OIL CHEM SOC, V74, P1281, DOI 10.1007/s11746-997-0058-4; HANAKI K, 1981, BIOTECHNOL BIOENG, V23, P1591, DOI 10.1002/bit.260230717; Hernandez-Martinez M, 2013, LWT-FOOD SCI TECHNOL, V52, P12, DOI 10.1016/j.lwt.2013.01.001; Hidalgo D, 2015, INT J ENVIRON SCI TE, V12, P1727, DOI 10.1007/s13762-014-0560-9; Cuetos MJ, 2010, BIODEGRADATION, V21, P543, DOI 10.1007/s10532-009-9322-7; Jouraiphy A, 2008, BIORESOURCE TECHNOL, V99, P1066, DOI 10.1016/j.biortech.2007.02.031; Kim M, 2002, WATER RES, V36, P4369, DOI 10.1016/S0043-1354(02)00147-1; Kim SH, 2004, J CHEM TECHNOL BIOT, V79, P63, DOI 10.1002/jctb.939; Lalman JA, 2001, WATER RES, V35, P2975, DOI 10.1016/S0043-1354(00)00593-5; Luostarinen S, 2009, BIORESOURCE TECHNOL, V100, P79, DOI 10.1016/j.biortech.2008.06.029; Martinez EJ, 2012, INT BIODETER BIODEGR, V75, P1, DOI 10.1016/j.ibiod.2012.07.015; Mata-Alvarez J, 2000, BIORESOURCE TECHNOL, V74, P3, DOI 10.1016/S0960-8524(00)00023-7; Meissl K, 2007, TALANTA, V72, P791, DOI 10.1016/j.talanta.2006.12.005; Naumann A, 2010, FIELD CROP RES, V119, P78, DOI 10.1016/j.fcr.2010.06.017; Pereira MA, 2005, BIOTECHNOL BIOENG, V92, P15, DOI 10.1002/bit.20548; Pereira MA, 2004, BIOTECHNOL BIOENG, V88, P502, DOI 10.1002/bit.20278; Provenzano MR, 2014, WASTE MANAGE, V34, P653, DOI 10.1016/j.wasman.2013.12.001; Rasit N, 2015, RENEW SUST ENERG REV, V45, P351, DOI 10.1016/j.rser.2015.01.066; Sage M, 2008, J DAIRY SCI, V91, P4062, DOI 10.3168/jds.2007-0931; Silvestre G, 2014, APPL ENERG, V117, P87, DOI 10.1016/j.apenergy.2013.11.075; Socrates G., 2004, INFRARED RAMAN CHARA; Tandon P, 2000, J MOL STRUCT, V524, P201, DOI 10.1016/S0022-2860(00)00378-1; Walkley A, 1934, SOIL SCI, V37, P29, DOI 10.1097/00010694-193401000-00003; Wu LJ, 2015, INT BIODETER BIODEGR, V104, P315, DOI 10.1016/j.ibiod.2015.06.020; Yirong C, 2015, WASTE BIOMASS VALORI, V6, P1, DOI 10.1007/s12649-014-9327-2; Zhang T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066845; Zonta Z, 2013, WATER RES, V47, P1369, DOI 10.1016/j.watres.2012.12.007	40	34	34	3	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0153139	10.1371/journal.pone.0153139	http://dx.doi.org/10.1371/journal.pone.0153139			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27071074	gold, Green Published			2022-12-27	WOS:000373900700034
J	Grassi, P; Doucet, L; Giglione, P; Grunwald, V; Melichar, B; Galli, L; De Giorgi, U; Sabbatini, R; Ortega, C; Santoni, M; Bamias, A; Verzoni, E; Derosa, L; Studentova, H; Pacifici, M; Coppa, J; Mazzaferro, V; de Braud, F; Porta, C; Escudier, B; Procopio, G				Grassi, Paolo; Doucet, Ludovic; Giglione, Palma; Gruenwald, Viktor; Melichar, Bohuslav; Galli, Luca; De Giorgi, Ugo; Sabbatini, Roberto; Ortega, Cinzia; Santoni, Matteo; Bamias, Aristotelis; Verzoni, Elena; Derosa, Lisa; Studentova, Hana; Pacifici, Monica; Coppa, Jorgelina; Mazzaferro, Vincenzo; de Braud, Filippo; Porta, Camillo; Escudier, Bernard; Procopio, Giuseppe			Clinical Impact of Pancreatic Metastases from Renal Cell Carcinoma: A Multicenter Retrospective Analysis	PLOS ONE			English	Article							INTERFERON-ALPHA; DOUBLE-BLIND; BONE; RESECTION	Pancreatic metastases from renal cell carcinoma are uncommon and their prognostic significance is not well defined. In this analysis we evaluated the outcome of patients with pancreatic metastases treated with either targeted therapies or local treatment to the pancreas. Patients with pancreatic metastases from renal cell carcinoma treated between 1993 and 2014 were identified from 11 European centers. Clinical records were retrospectively reviewed. Kaplan-Meier method and log-rank test were used to evaluate progression-free survival and overall survival. Cox's proportional hazard models were used for survival analysis. In total, 276 PM patients were evaluated, including 77 (28%) patients treated by either surgery or radiotherapy to the pancreas, and 256 (93%) who received systemic therapy. Median time from nephrectomy to diagnosis of pancreatic metastases was 91 months (IQR 54-142). Disease control rate after first-line TTs was 84%, with a median progression-free survival of 12 months (95% CI 10-14). Median overall survival was 73 months (95% CI 61-86) with a 5-year OS of 58%. Median OS of patients treated with local treatment was 106 months (95% CI 78-204) with a 5-year overall survival of 75%. On multivariable analysis, nephrectomy (HR 5.31; 95% CI 2.36-11.92; p<0.0001), Memorial Sloan Kettering/International Metastatic RCC Database Consortium prognostic score (HR 1.45, 95% CI 0.94-2.23 for intermediate vs good vs risk; HR 2.76 95%, CI 1.43-5.35 for poor vs good risk p = 0.0099) and pancreatic local treatment (HR 0.48; 95% CI 0.30-0.78 p = 0.0029) were associated with overall survival. Difference in median OS between patients with PM and that reported in a matched-control group of mRCC patients with extrapancreatic metastases was statistically significant (p < .0001). Pancreatic metastases from renal cell carcinoma usually occur years after nephrectomy, are associated with an indolent behavior and a prolonged survival. Targeted therapies and locoregional approaches are active and achieve high disease control rate.	[Grassi, Paolo; Verzoni, Elena; de Braud, Filippo; Procopio, Giuseppe] Fdn IRCCS Ist Nazl Tumori, Med Oncol 1, Via G Venezian 1, I-20133 Milan, Italy; [Doucet, Ludovic; Escudier, Bernard] Gustave Roussy, 114 Rue Edouard Vaillant, F-94805 Villejuif, France; [Giglione, Palma; Porta, Camillo] IRCCS San Matteo Univ Hosp Fdn, Med Oncol, Viale Camillo Golgi 19, I-27100 Pavia, Italy; [Gruenwald, Viktor] Hannover Med Sch, Clin Haematol Hemostasis Oncol & Stemcelltranspla, Carl Neuberg Str 1, D-30625 Hannover, Germany; [Melichar, Bohuslav] Palacky Univ, Sch Med, Dept Oncol, IP Pavlova 6, Olomouc 77520, Czech Republic; [Melichar, Bohuslav] Teaching Hosp, IP Pavlova 6, Olomouc 77520, Czech Republic; [Galli, Luca] AOUP, Med Oncol 2, Ist Toscano Tumori, Via Roma 67, I-56126 Pisa, Italy; [De Giorgi, Ugo] Ist Sci Romagnolo Studio & Cura Tumori IRST IRCCS, Dept Med Oncol, Via P Maroncelli 40, I-47014 Meldola, Italy; [Sabbatini, Roberto] Univ Hosp, Dept Oncol & Haematol & Resp Dis, Via Pozzo 71, I-41124 Modena, Italy; [Ortega, Cinzia] IRCCS, Med Oncol 1, Candiolo Canc Inst FPO, Str Prov,142 Km 3,95, I-10060 Candiolo, Italy; [Santoni, Matteo] Univ Politecn Marche, Med Oncol, AOU Osped Riuniti, Via Conca 71, I-60126 Ancona, Italy; [Bamias, Aristotelis] Alexandra Gen Hosp, Dept Clin Therapeut, V Sofias & Lourou 1, Athens 11528, Greece; [Pacifici, Monica] Fdn IRCCS Ist Nazl Tumori, Med Stat, Trial Ctr, Via G Venezian 1, I-20133 Milan, Italy; [Coppa, Jorgelina; Mazzaferro, Vincenzo] Fdn IRCCS Ist Nazl Tumori, Gastrointestinal Surg & Liver Transplantat Unit, Via G Venezian 1, I-20133 Milan, Italy	Fondazione IRCCS Istituto Nazionale Tumori Milan; UNICANCER; Gustave Roussy; IRCCS Fondazione San Matteo; Hannover Medical School; Palacky University Olomouc; University Hospital Olomouc; ISPRO Istituto per lo studio, la prevenzione e la rete oncologica; University of Pisa; Azienda Ospedaliero Universitaria Pisana; IRCCS Meldola (IRST); Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia Hospital; IRCCS Fondazione del Piemonte per l'Oncologia; Marche Polytechnic University; Alexandra Hospital; Fondazione IRCCS Istituto Nazionale Tumori Milan; Fondazione IRCCS Istituto Nazionale Tumori Milan	Procopio, G (corresponding author), Fdn IRCCS Ist Nazl Tumori, Med Oncol 1, Via G Venezian 1, I-20133 Milan, Italy.	giuseppe.procopio@istitutotumori.mi.it	Grassi, Paolo/L-9808-2017; Porta, Camillo/AAB-9482-2020; Sabbatini, Roberto/AAC-5739-2022; Mazzaferro, Vincenzo/C-2726-2017; Sabbatini, Roberto/AAC-5398-2022; Bamias, Aristotelis/AAD-5332-2019; de Braud, Filippo/B-9997-2017; Procopio, Giuseppe/K-2072-2016; DEROSA, LISA/E-6814-2015; Mazzaferro, Vincenzo/AAL-4707-2020; Verzoni, Elena/K-6025-2016; Coppa, Jorgelina/C-3093-2017; studentova, Hana/E-6589-2017	Grassi, Paolo/0000-0002-5691-2768; Mazzaferro, Vincenzo/0000-0002-4013-8085; Sabbatini, Roberto/0000-0002-8943-7545; Bamias, Aristotelis/0000-0002-5996-7262; de Braud, Filippo/0000-0003-0103-730X; Procopio, Giuseppe/0000-0002-2498-402X; Verzoni, Elena/0000-0001-9756-6112; Coppa, Jorgelina/0000-0003-2466-0524; studentova, Hana/0000-0003-2105-9258; Galli, Luca/0000-0001-6008-0266; Santoni, Matteo/0000-0001-7340-6173; Derosa, Lisa/0000-0003-0527-2964				Albiges L, 2015, EUR UROL, V67, P100, DOI 10.1016/j.eururo.2014.04.006; Ballarin R, 2011, WORLD J GASTROENTERO, V17, P4747, DOI 10.3748/wjg.v17.i43.4747; Bassi C, 2003, BRIT J SURG, V90, P555, DOI 10.1002/bjs.4072; Beuselinck B, 2011, ANN ONCOL, V22, P794, DOI 10.1093/annonc/mdq554; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Escudier B, 2007, LANCET, V370, P2103, DOI 10.1016/S0140-6736(07)61904-7; Escudier B, 2007, NEW ENGL J MED, V356, P125, DOI 10.1056/NEJMoa060655; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Ghavamian R, 2000, MAYO CLIN PROC, V75, P581, DOI 10.4065/75.6.581; Grassi P, 2014, FUTURE ONCOL, V10, P1361, DOI [10.2217/FON.14.69, 10.2217/fon.14.69]; Grassi P, 2013, CLIN GENITOURIN CANC, V11, P484, DOI 10.1016/j.clgc.2013.04.022; Heng DYC, 2009, J CLIN ONCOL, V27, P5794, DOI 10.1200/JCO.2008.21.4809; Hudes G, 2007, NEW ENGL J MED, V356, P2271, DOI 10.1056/NEJMoa066838; Kalra S, 2016, BJU INT, V117, P761, DOI 10.1111/bju.13185; Law CHL, 2003, ANN SURG ONCOL, V10, P922, DOI 10.1245/ASO.2003.02.003; Mckay RR, 2014, EUR UROL, V65, P577, DOI 10.1016/j.eururo.2013.08.012; Motzer RJ, 1996, NEW ENGL J MED, V335, P865, DOI 10.1056/NEJM199609193351207; Motzer RJ, 1999, J CLIN ONCOL, V17, P2530, DOI 10.1200/JCO.1999.17.8.2530; Motzer RJ, 2008, LANCET, V372, P449, DOI 10.1016/S0140-6736(08)61039-9; Motzer RJ, 2007, NEW ENGL J MED, V356, P115, DOI 10.1056/NEJMoa065044; Rini BI, 2011, LANCET, V378, P1931, DOI 10.1016/S0140-6736(11)61613-9; Santoni M, 2015, ANN SURG ONCOL, V22, P2094, DOI 10.1245/s10434-014-4256-7; Santoni M, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0122-0; Sellner F, 2006, ANN SURG ONCOL, V13, P75, DOI 10.1245/ASO.2006.03.064; Sohn TA, 2001, J GASTROINTEST SURG, V5, P346, DOI 10.1016/S1091-255X(01)80060-3; Sternberg CN, 2010, J CLIN ONCOL, V28, P1061, DOI 10.1200/JCO.2009.23.9764; Tanis PJ, 2009, BRIT J SURG, V96, P579, DOI 10.1002/bjs.6606; Thompson LDR, 2000, CANCER, V89, P1076, DOI 10.1002/1097-0142(20000901)89:5<1076::AID-CNCR17>3.0.CO;2-M; Wente MN, 2005, PANCREAS, V30, P218, DOI 10.1097/01.mpa.0000153337.58105.47; Zerbi A, 2008, ANN SURG ONCOL, V15, P1161, DOI 10.1245/s10434-007-9782-0	30	42	45	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2016	11	4							e0151662	10.1371/journal.pone.0151662	http://dx.doi.org/10.1371/journal.pone.0151662			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0KH	27064898	Green Published, Green Submitted, gold			2022-12-27	WOS:000373891000007
J	Tang, YL; Ge, JJ; Liu, FT; Wu, P; Guo, SS; Liu, ZY; Wang, YX; Wang, Y; Ding, ZT; Wu, JJ; Zuo, CT; Wang, J				Tang, Yilin; Ge, Jingjie; Liu, Fengtao; Wu, Ping; Guo, Sisi; Liu, Zhenyang; Wang, Yixuan; Wang, Ying; Ding, Zhengtong; Wu, Jianjun; Zuo, Chuantao; Wang, Jian			Cerebral Metabolic Differences Associated with Cognitive Impairment in Parkinson's Disease	PLOS ONE			English	Article							ORAL WORD-ASSOCIATION; GLUCOSE-METABOLISM; CHOLINERGIC FUNCTION; DIAGNOSTIC-CRITERIA; STROOP TEST; DEMENTIA; DISORDER; BRAIN; HYPOMETABOLISM; DOPAMINE	Purpose To characterize cerebral glucose metabolism associated with different cognitive states in Parkinson's disease (PD) using F-18-fluorodeoxyglucose (FDG) and Positron Emission Tomography (PET). Methods Three groups of patients were recruited in this study including PD patients with dementia (PDD; n = 10), with mild cognitive impairment (PD-MCI; n = 20), and with no cognitive impairment (PD-NC; n = 30). The groups were matched for age, sex, education, disease duration, motor disability, levodopa equivalent dose and Geriatric Depression Rating Scale (GDS) score. All subjects underwent a FDG-PET study. Maps of regional metabolism in the three groups were compared using statistical parametric mapping (SPM5). Results PD-MCI patients exhibited limited areas of hypometabolism in the frontal, temporal and parahippocampal gyrus compared with the PD-NC patients (p < 0.01). PDD patients had bilateral areas of hypometabolism in the frontal and posterior parietal-occipital lobes compared with PD-MCI patients (p < 0.01), and exhibited greater metabolic reductions in comparison with PD-NC patients (p < 0.01). Conclusions Compared with PD-NC patients, hypometabolism was much higher in the PDD patients than in PD-MCI patients, mainly in the posterior cortical areas. The result might suggest an association between posterior cortical hypometabolismand more severe cognitive impairment. PD-MCI might be important for early targeted therapeutic intervention and disease modification.	[Tang, Yilin; Liu, Fengtao; Guo, Sisi; Liu, Zhenyang; Wang, Yixuan; Wang, Ying; Ding, Zhengtong; Wu, Jianjun; Wang, Jian] Fudan Univ, Huashan Hosp, Dept Neurol, 12 Wulumuqi Zhong Rd, Shanghai 200040, Peoples R China; [Ge, Jingjie; Wu, Ping; Zuo, Chuantao] Fudan Univ, Huashan Hosp, PET Ctr, 518 East Wuzhong Rd, Shanghai 200235, Peoples R China	Fudan University; Fudan University	Wang, J (corresponding author), Fudan Univ, Huashan Hosp, Dept Neurol, 12 Wulumuqi Zhong Rd, Shanghai 200040, Peoples R China.; Zuo, CT (corresponding author), Fudan Univ, Huashan Hosp, PET Ctr, 518 East Wuzhong Rd, Shanghai 200235, Peoples R China.	zuoct_cn2000@126.com; wangjian_hs@fudan.edu.cn	wang, yixuan/GXW-2866-2022; Wang, Yixuan/GZK-6559-2022; Zuo, Chuantao/AAD-9940-2022; Wu, Jian/AAU-5221-2020; Wu, Jian/AAU-5221-2020	Wu, Jian/0000-0001-9933-7364; Wu, Ping/0000-0002-2758-1218; Wu, Jian/0000-0002-3394-1507	National Natural Science Foundation of China [81071018, 81171189, 81371413, 81401135]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was financially supported by Grants (Nos. 81071018, 81171189, 81371413 and 81401135) from the National Natural Science Foundation of China.	Bohnen NI, 2003, ARCH NEUROL-CHICAGO, V60, P1745, DOI 10.1001/archneur.60.12.1745; Bohnen NI, 2011, J NUCL MED, V52, P848, DOI 10.2967/jnumed.111.089946; Broeders M, 2013, NEUROLOGY, V81, P346, DOI 10.1212/WNL.0b013e31829c5c86; Caffarra P, 2002, NEUROL SCI, V22, P443, DOI 10.1007/s100720200003; Caviness JN, 2007, MOVEMENT DISORD, V22, P1272, DOI 10.1002/mds.21453; Dubois B, 2007, MOVEMENT DISORD, V22, P2314, DOI 10.1002/mds.21844; Emre M, 2003, LANCET NEUROL, V2, P229, DOI 10.1016/S1474-4422(03)00351-X; Emre M, 2007, MOVEMENT DISORD, V22, P1689, DOI 10.1002/mds.21507; Garcia-Garcia D, 2012, EUR J NUCL MED MOL I, V39, P1767, DOI 10.1007/s00259-012-2198-5; Gonzalez-Redondo R, 2014, BRAIN, V137, P2356, DOI 10.1093/brain/awu159; Guo QH, 2009, ALZ DIS ASSOC DIS, V23, P253, DOI 10.1097/WAD.0b013e3181999e92; [郭起浩 GUO Qihao], 2008, [中华神经科杂志, Chinese Journal of Neurology], V41, P234; Hely MA, 2008, MOVEMENT DISORD, V23, P837, DOI 10.1002/mds.21956; Hilker R, 2005, NEUROLOGY, V65, P1716, DOI 10.1212/01.wnl.0000191154.78131.f6; Hosokai Y, 2009, MOVEMENT DISORD, V24, P854, DOI 10.1002/mds.22444; Huang C, 2008, NEUROLOGY, V70, P1470, DOI 10.1212/01.wnl.0000304050.05332.9c; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; KATZMAN R, 1988, J CLIN EPIDEMIOL, V41, P971, DOI 10.1016/0895-4356(88)90034-0; Kehagia AA, 2010, LANCET NEUROL, V9, P1200, DOI 10.1016/S1474-4422(10)70212-X; KUHL DE, 1985, J NUCL MED, V26, pP69; Litvan I, 2012, MOVEMENT DISORD, V27, P349, DOI 10.1002/mds.24893; Lucas JA, 2005, CLIN NEUROPSYCHOL, V19, P243, DOI 10.1080/13854040590945337; Lyoo CH, 2010, EUR NEUROL, V64, P65, DOI 10.1159/000315036; Narayanan NS, 2013, REV NEUROSCIENCE, V24, P267, DOI 10.1515/revneuro-2013-0004; Narayanan NS, 2012, P NATL ACAD SCI USA, V109, P20726, DOI 10.1073/pnas.1211258109; Nobili F, 2009, MOVEMENT DISORD, V24, P414, DOI 10.1002/mds.22381; Pappata S, 2011, NEUROLOGY, V77, P1357, DOI 10.1212/WNL.0b013e3182315259; Pedersen KF, 2013, JAMA NEUROL, V70, P580, DOI 10.1001/jamaneurol.2013.2110; PEPPARD RF, 1992, ARCH NEUROL-CHICAGO, V49, P1262, DOI 10.1001/archneur.1992.00530360060019; PERRY RH, 1983, LANCET, V2, P789; SCATTON B, 1983, BRAIN RES, V275, P321, DOI 10.1016/0006-8993(83)90993-9; Sheridan LK, 2006, ARCH CLIN NEUROPSYCH, V21, P23, DOI 10.1016/j.acn.2005.07.003; Shinotoh H, 2001, ADV NEUROL, V86, P249; Steinberg BA, 2005, CLIN NEUROPSYCHOL, V19, P329, DOI 10.1080/13854040590945210; Tard C, 2015, J PARKINSON DIS, V5, P569, DOI 10.3233/JPD-150583; VanderBorght T, 1997, J NUCL MED, V38, P797; Williams-Gray CH, 2009, BRAIN, V132, P2958, DOI 10.1093/brain/awp245; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4; Zhao QH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0057333, 10.1371/journal.pone.0061140]; Zuo CT, 2013, J CEREBR BLOOD F MET, V33, P880, DOI 10.1038/jcbfm.2013.23	40	25	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2016	11	4							e0152716	10.1371/journal.pone.0152716	http://dx.doi.org/10.1371/journal.pone.0152716			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0KH	27064684	Green Submitted, gold, Green Published			2022-12-27	WOS:000373891000017
J	Hou, DH; Chen, X; Zhang, LK				Hou, Dianhai; Chen, Xi; Zhang, Lei-Ke			Proteomic Analysis of Mamestra Brassicae Nucleopolyhedrovirus Progeny Virions from Two Different Hosts	PLOS ONE			English	Article							OCCLUSION-DERIVED VIRUS; SINGLE-NUCLEOCAPSID NUCLEOPOLYHEDROVIRUS; NUCLEAR POLYHEDROSIS-VIRUS; OS INFECTIVITY FACTOR; BUDDED-VIRUS; PROTEIN-COMPOSITION; VIRAL REPLICATION; GENE; IDENTIFICATION; BACULOVIRUSES	Mamestra brassicae nucleopolyhedrovirus (MabrNPV) has a wide host range replication in more than one insect species. In this study, a sequenced MabrNPV strain, MabrNPV-CTa, was used to perform proteomic analysis of both BVs and ODVs derived from two infected hosts: Helicoverpa armigera and Spodoptera exigua. A total of 82 and 39 viral proteins were identified in ODVs and BVs, respectively. And totally, 23 and 76 host proteins were identified as virion-associated with ODVs and BVs, respectively. The host proteins incorporated into the virus particles were mainly involved in cytoskeleton, signaling, vesicle trafficking, chaperone and metabolic systems. Some host proteins, such as actin, cyclophilin A and heat shock protein 70 would be important for viral replication. Several host proteins involved in immune response were also identified in BV, and a C-type lectin protein was firstly found to be associated with BV and its family members have been demonstrated to be involved in entry process of other viruses. This study facilitated the annotation of baculovirus genome, and would help us to understand baculovirus virion structure. Furthermore, the identification of host proteins associated with virions produced in vivo would facilitate investigations on the involvement of intriguing host proteins in virus replication.	[Hou, Dianhai; Zhang, Lei-Ke] Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan 430071, Peoples R China; [Chen, Xi] Wuhan Inst Biotechnol, Wuhan, Peoples R China	Chinese Academy of Sciences; Wuhan Institute of Virology, CAS	Zhang, LK (corresponding author), Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan 430071, Peoples R China.	zhangleike@wh.iov.cn			National Science Foundation of China [31400142, 31500144]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by grants from the National Science Foundation of China 31400142 (DH Hou) and 31500144 (LK Zhang).	Adang MJ, 2013, HANDBOOK OF PROTEOLYTIC ENZYMES, VOLS 1 AND 2, 3RD EDITION, P405, DOI 10.1016/B978-0-12-382219-2.00081-8; Bartenschlager R, 2007, VIRUS RES, V127, P195, DOI 10.1016/j.virusres.2007.02.022; Braconi CT, 2014, J GEN VIROL, V95, P980, DOI 10.1099/vir.0.061127-0; BRAUNAGEL SC, 1994, VIROLOGY, V202, P315, DOI 10.1006/viro.1994.1348; Braunagel SC, 2003, P NATL ACAD SCI USA, V100, P9797, DOI 10.1073/pnas.1733972100; Braunagel SC, 1999, J VIROL, V73, P8559, DOI 10.1128/JVI.73.10.8559-8570.1999; Brudner M, 2013, LECTIN DEPENDENT ENH; Budatha M, 2007, BIOCHEM J, V405, P287, DOI 10.1042/BJ20070054; Caballero P., 1992, Biocontrol Science and Technology, V2, P35, DOI 10.1080/09583159209355215; Chen L, 2013, VIRUS RES, V173, P404, DOI 10.1016/j.virusres.2012.12.016; Chen L, 2012, ARCH VIROL, V157, P617, DOI 10.1007/s00705-011-1211-9; Choi JB, 2013, VIRUS GENES, V47, P133, DOI 10.1007/s11262-013-0922-2; Deng F, 2007, J VIROL, V81, P9377, DOI 10.1128/JVI.00632-07; DOYLE CJ, 1990, APPL ENVIRON MICROB, V56, P2704, DOI 10.1128/AEM.56.9.2704-2710.1990; Fang MG, 2009, J VIROL, V83, P12569, DOI 10.1128/JVI.01141-09; Gandhi KM, 2012, J GEN VIROL, V93, P1795, DOI 10.1099/vir.0.041848-0; Gohla A, 2002, CURR BIOL, V12, P1704, DOI 10.1016/S0960-9822(02)01184-3; HARRISON RL, 1995, J GEN VIROL, V76, P1451, DOI 10.1099/0022-1317-76-6-1451; Hawtin RE, 1997, VIROLOGY, V238, P243, DOI 10.1006/viro.1997.8816; Hou DH, 2013, J VIROL, V87, P829, DOI 10.1128/JVI.02329-12; Jehle JA, 2006, ARCH VIROL, V151, P1257, DOI 10.1007/s00705-006-0763-6; Jehle JA, 2006, VIROLOGY, V346, P180, DOI 10.1016/j.virol.2005.10.032; Li LL, 2006, VIRUS RES, V121, P42, DOI 10.1016/j.virusres.2006.03.014; Li LL, 2002, VIROLOGY, V297, P226, DOI 10.1006/viro.2002.1411; Li ZF, 2006, GENE, V372, P33, DOI 10.1016/j.gene.2005.11.029; Lin GY, 2002, J VIROL, V76, P5503, DOI 10.1128/JVI.76.11.5503-5514.2002; Liu XY, 2008, INTERVIROLOGY, V51, P369, DOI 10.1159/000193462; Makela AR, 2006, ADV VIRUS RES, V68, P91, DOI 10.1016/S0065-3527(06)68003-2; Marek M, 2011, J VIROL, V85, P5350, DOI 10.1128/JVI.00035-11; Masler EP, 1997, COMP BIOCHEM PHYS B, V116, P11, DOI 10.1016/S0305-0491(96)00194-0; Matsuno K, 2010, DIFFERENT POTENTIAL; McCarthy CB, 2008, VIROLOGY, V375, P277, DOI 10.1016/j.virol.2008.01.039; Monsma SA, 1996, J VIROL, V70, P4607, DOI 10.1128/JVI.70.7.4607-4616.1996; Ningshen TJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079468; Ohkawa T, 2010, J CELL BIOL, V190, P187, DOI 10.1083/jcb.201001162; Ono C, 2012, VIRUS RES, V165, P197, DOI 10.1016/j.virusres.2012.02.016; PEARSON MN, 1988, VIROLOGY, V167, P407, DOI 10.1016/0042-6822(88)90102-X; Peng K, 2012, J VIROL, V86, P4981, DOI 10.1128/JVI.06801-11; Perera O, 2007, J VIROL, V81, P4585, DOI 10.1128/JVI.02391-06; Radhakrishnan A, 2010, MOL CELL PROTEOMICS, V9, P1829, DOI 10.1074/mcp.M110.001651; Saksena S, 2006, NAT STRUCT MOL BIOL, V13, P500, DOI 10.1038/nsmb1098; Shen HX, 2009, CURR MICROBIOL, V59, P65, DOI 10.1007/s00284-009-9399-6; Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200; Simon O, 2012, J INVERTEBR PATHOL, V109, P117, DOI 10.1016/j.jip.2011.10.010; Slack J, 2007, ADV VIRUS RES, V69, P99, DOI 10.1016/S0065-3527(06)69003-9; Sugiura N, 2011, J BIOL CHEM, V286, P29026, DOI 10.1074/jbc.M111.251157; Tang P, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-168; Tang Q, 2013, J INVERTEBR PATHOL, V113, P70, DOI 10.1016/j.jip.2013.01.006; TWEETEN KA, 1980, J VIROL, V33, P866, DOI 10.1128/JVI.33.2.866-876.1980; Wang LH, 2009, J GEN VIROL, V90, P1641, DOI 10.1099/vir.0.010397-0; Wang Q, 2008, J VIROL, V82, P4072, DOI 10.1128/JVI.02319-07; Wang RR, 2010, J VIROL, V84, P7233, DOI 10.1128/JVI.00040-10; Wang XF, 2011, J PROTEOME RES, V10, P2817, DOI 10.1021/pr2000804; Wu D, 2005, J GEN VIROL, V86, P2439, DOI 10.1099/vir.0.81110-0; Xi QY, 2007, VIRUS GENES, V34, P223, DOI 10.1007/s11262-006-0045-0; Xu F, 2011, VIRUS RES, V158, P1, DOI 10.1016/j.virusres.2011.02.014; Xu HJ, 2006, J BIOCHEM MOL BIOL, V39, P263; Yang M, 2014, J VIROL, V88, P12586, DOI 10.1128/JVI.01313-14; Yao Q, 2011, J BIOL CHEM, V286, P27342, DOI 10.1074/jbc.M111.220848; Zheng FL, 2011, VIRUS RES, V155, P203, DOI 10.1016/j.virusres.2010.10.006; Zhou Z, 2013, ACTA BIOCH BIOPH SIN, V45, P465, DOI 10.1093/abbs/gmt027	61	8	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2016	11	4							e0153365	10.1371/journal.pone.0153365	http://dx.doi.org/10.1371/journal.pone.0153365			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6JK	27058368	gold, Green Published, Green Submitted			2022-12-27	WOS:000373604800030
J	Kim, JH; Jeong, HS; Kim, KM; Lee, YJ; Jung, MH; Park, JJ; Kim, JP; Woo, SH				Kim, Jin Hyun; Jeong, Han-Sin; Kim, Kyung Mi; Lee, Ye Jin; Jung, Myeong Hee; Park, Jung Je; Kim, Jin Pyeong; Woo, Seung Hoon			Extra-Esophageal Pepsin from Stomach Refluxate Promoted Tonsil Hypertrophy	PLOS ONE			English	Article							RECURRENT TONSILLITIS; EPITHELIAL-CELLS; OTITIS-MEDIA; LARYNGOPHARYNGEAL REFLUX; GASTRIC PEPSIN; CHILDREN; INHIBITION; PREVALENCE; DISEASE; EAR	Background Gastroesophageal reflux is associated with numerous pathologic conditions of the upper aero-digestive tract. Gastric pepsin within reflux contributes to immunologic reactions in the tonsil. In this study, we aimed to find the relationships between pepsin and tonsillar hypertrophy. Methods and finding We explored the notion whether tonsillar hypertrophy was due to pepsin-mediated gastric reflux in tonsil hypertrophy. Fifty-four children with tonsil hypertrophy and 30 adults with tonsillitis were recruited before surgical treatment. Blood and tonsil tissues from each patient were harvested for analysis of changes in lymphocyte and macrophage numbers coupled with histological and biochemical analysis. Pepsin was expressed at different levels in tonsil tissues from each tonsillar hypertrophy. Pepsin-positive cells were found in the crypt epithelium, surrounding the lymphoid follicle with developing fibrosis, and also surrounding the lymphoid follicle that faced the crypt. And also, pepsin staining was well correlated with damaged tonsillar squamous epithelium and TGF-beta 1 and iNOS expression in the tonsil section. In addition, pepsin and TGF-beta 1-positive cells were co-localized with CD68-positive cells in the crypt and surrounding germinal centers. In comparison of macrophage responsiveness to pepsin, peripheral blood mononuclear cells (PBMNCs) were noticeably larger in the presence of activated pepsin in the child group. Furthermore, CD11c and CD163-positive cells were significantly increased by activated pepsin. However, this was not seen for the culture of PBMNCs from the adult group. Conclusions The lymphocytes and monocytes are in a highly proliferative state in the tonsillar hypertrophy and associated with increased expression of pro-inflammatory factors as a result of exposure to stomach reflux pepsin.	[Kim, Jin Hyun; Kim, Kyung Mi; Lee, Ye Jin; Jung, Myeong Hee] Gyeongsang Natl Univ Hosp, Biomed Res Inst, Jinju, Gyeongsangnamdo, South Korea; [Jeong, Han-Sin] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea; [Park, Jung Je; Kim, Jin Pyeong; Woo, Seung Hoon] Gyeongsang Natl Univ Hosp, Dept Otolaryngol, Jinju, Gyeongsangnamdo, South Korea; [Woo, Seung Hoon] Gyeongsang Natl Univ Hosp, Inst Hlth Sci, Jinju, Gyeongsangnamdo, South Korea	Gyeongsang National University; Gyeongsang National University Hospital; Sungkyunkwan University (SKKU); Samsung Medical Center; Gyeongsang National University; Gyeongsang National University Hospital; Gyeongsang National University; Gyeongsang National University Hospital	Woo, SH (corresponding author), Gyeongsang Natl Univ Hosp, Dept Otolaryngol, Jinju, Gyeongsangnamdo, South Korea.; Woo, SH (corresponding author), Gyeongsang Natl Univ Hosp, Inst Hlth Sci, Jinju, Gyeongsangnamdo, South Korea.	lesaby@hanmail.net	Jeong, Han-Sin/C-4884-2011; Jeong, Han Sin/F-4597-2014	Jeong, Han-Sin/0000-0003-4652-0573; 	Basic Science Research Program, through the National Research Foundation of Korea (NRF); Ministry of Science, ICT, and Future Planning [2013R1A1A1012542]; Leading Foreign Research Institute Recruitment Program, through the National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology (MEST) [2012K1A4A3053142]; biomedcal research institute fund from the Gyeongsang National University Hospital [GNUHBIF-2014-0009]	Basic Science Research Program, through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Science, ICT, and Future Planning(Ministry of Science, ICT & Future Planning, Republic of Korea); Leading Foreign Research Institute Recruitment Program, through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology (MEST)(Ministry of Education, Science & Technology (MEST), Republic of Korea); biomedcal research institute fund from the Gyeongsang National University Hospital	This study was supported by the Basic Science Research Program, through the National Research Foundation of Korea (NRF), funded by the Ministry of Science, ICT, and Future Planning (2013R1A1A1012542). This study was further supported by the Leading Foreign Research Institute Recruitment Program, through the National Research Foundation of Korea (NRF), funded by the Ministry of Education, Science and Technology (MEST) (2012K1A4A3053142)). This work was supported by biomedcal research institute fund (GNUHBIF-2014-0009) from the Gyeongsang National University Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-aziz MM, 2013, INT J PEDIATR OTORHI, V77, P1765, DOI 10.1016/j.ijporl.2013.08.014; AGREN K, 1995, ACTA OTO-LARYNGOL, V115, P689, DOI 10.3109/00016489509139388; Alatas N, 2008, ARCH OTOLARYNGOL, V134, P477, DOI 10.1001/archotol.134.5.477; Ameli F, 2014, ALLERGY RHINOL, V5, pE137, DOI 10.2500/ar.2014.5.0095; BIELUCH VM, 1989, ANN OTO RHINOL LARYN, V98, P332, DOI 10.1177/000348948909800503; Bothwell MR, 1999, OTOLARYNG HEAD NECK, V121, P255, DOI 10.1016/S0194-5998(99)70181-6; He ZP, 2008, CURR ALLERGY ASTHM R, V8, P513, DOI 10.1007/s11882-008-0094-7; HOLNESS CL, 1993, BLOOD, V81, P1607; Jiang Q, 2011, MOL CELL ENDOCRINOL, V331, P34, DOI 10.1016/j.mce.2010.07.023; Jiang T, 2014, KIDNEY INT, V85, P333, DOI 10.1038/ki.2013.343; Johnston N, 2004, LARYNGOSCOPE, V114, P2129, DOI 10.1097/01.mlg.0000149445.07146.03; Johnston N, 2012, LARYNGOSCOPE, V122, P1317, DOI 10.1002/lary.23307; Kaditis AG, 2004, PEDIATR PULM, V37, P499, DOI 10.1002/ppul.20002; Kelly EA, 2014, OTOLARYNG HEAD NECK, V150, P618, DOI 10.1177/0194599813517862; KOCH RJ, 1995, LARYNGOSCOPE, V105, P42, DOI 10.1288/00005537-199501000-00011; Kraus J, 2014, ACTA OTO-LARYNGOL, V134, P88, DOI 10.3109/00016489.2013.840924; Mai JT, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-61; Markiewski MM, 2007, AM J PATHOL, V171, P715, DOI 10.2353/ajpath.2007.070166; O'Reilly RC, 2015, JAMA OTOLARYNGOL, V141, P350, DOI 10.1001/jamaoto.2014.3581; Onal M, 2015, INT J PEDIATR OTORHI, V79, P191, DOI 10.1016/j.ijporl.2014.12.005; Roberts AL, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-3; Samuels TL, 2013, ANN OTO RHINOL LARYN, V122, P632, DOI 10.1177/000348941312201006; Southwood JE, 2015, ANN OTO RHINOL LARYN, V124, P957, DOI 10.1177/0003489415593556; Stapleton A, 2008, INT J PEDIATR OTORHI, V72, P409, DOI 10.1016/j.ijporl.2007.11.003; SUGIYAMA M, 1982, INT J PEDIATR OTORHI, V4, P193, DOI 10.1016/0165-5876(82)90001-5; Tasker A, 2002, LANCET, V359, P493, DOI 10.1016/S0140-6736(02)07665-1; Todorovic MM, 2013, BOSNIAN J BASIC MED, V13, P230; Xue XC, 2014, J MED VIROL, V86, P963, DOI 10.1002/jmv.23894; Zhang PC, 2003, CLIN OTOLARYNGOL, V28, P235, DOI 10.1046/j.1365-2273.2003.00697.x; Zhao WX, 2014, INT J MOL MED, V33, P687, DOI 10.3892/ijmm.2013.1613	30	8	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2016	11	4							e0152336	10.1371/journal.pone.0152336	http://dx.doi.org/10.1371/journal.pone.0152336			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6JK	27058240	gold, Green Published, Green Submitted			2022-12-27	WOS:000373604800005
J	Chen, L; Yang, L; Yao, M; Cui, XJ; Xue, CC; Wang, YJ; Shu, B				Chen, Lin; Yang, Long; Yao, Min; Cui, Xue-Jun; Xue, Chun-Chun; Wang, Yong-Jun; Shu, Bing			Biomechanical Characteristics of Osteoporotic Fracture Healing in Ovariectomized Rats: A Systematic Review	PLOS ONE			English	Review							BONE TURNOVER; TIME-COURSE; REPAIR; MODEL; DEFECT; AGE; ASSESSMENTS; EXPRESSION; OSTEOPENIA; TISSUE	Biomechanical tests are widely used in animal studies on osteoporotic fracture healing. However, the biomechanical recovery process is still unknown, leading to difficulty in choosing time points for biomechanical tests and in correctly assessing osteoporotic fracture healing. To determine the biomechanical recovery process during osteoporotic fracture healing, studies on osteoporotic femur fracture healing with biomechanical tests in ovariectomized rat (OVX) models were collected from PUBMED, EMBASE, and Chinese databases. Quadratic curves of fracture healing time and maximum load were fitted with data from the analyzed studies. In the fitted curve for normal fractures, the predicted maximum load was 145.56 N, and the fracture healing time was 88.0 d. In the fitted curve for osteoporotic fractures, the predicted maximum load was 122.30 N, and the fracture healing time was 95.2 d. The maximum load of fractured femurs in OVX rats was also lower than that in sham rats at day 84 post-fracture (D84 PF). The fracture healing time was prolonged and maximum load at D84 PF decreased in OVX rats with closed fractures. The maximum load of Wister rats was higher than that of Sprague-Dawley (SD) rats, but the fracture healing time of SD and Wister rats was similar. Osteoporotic fracture healing was delayed in rats that were < = 12 weeks old when ovariectomized, and at D84 PF, the maximum load of rats < = 12 weeks old at ovariectomy was lower than that of rats >12 weeks old at ovariectomy. There was no significant difference in maximum load at D84 PF between rats with an osteoporosis modeling time <12 weeks and > = 12 weeks. In conclusion, fracture healing was delayed and biomechanical property decreased by osteoporosis. Time points around D95.2 PF should be considered for biomechanical tests of osteoporotic femur fracture healing in OVX rat models. Osteoporotic fracture healing in OVX rats was affected by the fracture type but not by the strain of the rat.	[Chen, Lin; Yang, Long; Yao, Min; Cui, Xue-Jun; Xue, Chun-Chun; Wang, Yong-Jun; Shu, Bing] Shanghai Univ Tradit Chinese Med, Longhua Hosp, Shanghai, Peoples R China; [Chen, Lin; Yang, Long; Yao, Min; Cui, Xue-Jun; Xue, Chun-Chun; Wang, Yong-Jun; Shu, Bing] Shanghai Univ Tradit Chinese Med, Spine Res Inst, Shanghai, Peoples R China	Shanghai University of Traditional Chinese Medicine; Shanghai University of Traditional Chinese Medicine	Shu, B (corresponding author), Shanghai Univ Tradit Chinese Med, Longhua Hosp, Shanghai, Peoples R China.; Shu, B (corresponding author), Shanghai Univ Tradit Chinese Med, Spine Res Inst, Shanghai, Peoples R China.	shubing523@hotmail.com		Shu, Bing/0000-0002-6009-5377	National Natural Foundation of China [81403239]; Ministry of Education of People's Republic of China [IRT1270]	National Natural Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of People's Republic of China(Ministry of Education, China)	The work was supported by National Natural Foundation of China (81403239 to BS, http://www.nsfc.gov.cn/) and Ministry of Education of People's Republic of China (IRT1270 to YJW, http://www.moe.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alt V, 2013, ACTA BIOMATER, V9, P7035, DOI 10.1016/j.actbio.2013.02.002; Augat P, 1998, J ORTHOPAED RES, V16, P475, DOI 10.1002/jor.1100160413; Augat P, 2005, OSTEOPOROSIS INT, V16, pS36, DOI 10.1007/s00198-004-1728-9; Blokhuis TJ, 2012, J ORTHOP RES, V30, P720, DOI 10.1002/jor.22013; Bossini PS, 2012, EXP GERONTOL, V47, P136, DOI 10.1016/j.exger.2011.11.005; Cao GL, 2014, TIANJIN MED J, V42, P238; Chen LW, 2013, ORTHOPEDICS, V36, pE687, DOI 10.3928/01477447-20130523-10; Cheung WH, 2012, J ORTHOP RES, V30, P129, DOI 10.1002/jor.21487; Chow SK, 2014, ARCH ORTHOP TRAUM SU, V134, P1405, DOI 10.1007/s00402-014-2070-0; Cook Gillian E, 2015, J Orthop Trauma, V29 Suppl 12, pS57, DOI 10.1097/BOT.0000000000000470; Dai GC, 2013, CHINESE J COAL IND M, V16, P890; Diwan AD, 2013, INDIAN J ORTHOP, V47, P540, DOI 10.4103/0019-5413.121569; Estai MA, 2011, CLINICS, V66, P2113, DOI 10.1590/S1807-59322011001200018; Fangel R, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3598847; Feinklestein SP, 1999, STROKE, V30, P2752, DOI 10.1161/01.STR.30.12.2752; Fisher M, 2009, STROKE, V40, P2244, DOI 10.1161/STROKEAHA.108.541128; Francisco JI, 2011, J ORTHOP RES, V29, P189, DOI 10.1002/jor.21217; Fu LJ, 2009, BONE, V44, P893, DOI 10.1016/j.bone.2009.01.378; Habermann B, 2010, CALCIFIED TISSUE INT, V86, P82, DOI 10.1007/s00223-009-9317-8; Hao Y, 2001, Chin J Traumatol, V4, P102; Hao YJ, 2007, BONE, V41, P631, DOI 10.1016/j.bone.2007.06.006; Hao YQ, 2005, CHINESE J OSTEOPOROS, P273; Huang XH., 2012, THESIS SHANXI MED U; Ibrahim NI, 2013, CURR DRUG TARGETS, V14, P1642, DOI 10.2174/1389450114666131216224003; [金文杰 Jin Wenjie], 2013, [中国骨质疏松杂志, Chinese Journal of Osteoporosis], V19, P494; KALU DN, 1991, BONE MINER, V15, P175, DOI 10.1016/0169-6009(91)90124-I; Kubo T, 1999, J STEROID BIOCHEM, V68, P197, DOI 10.1016/S0960-0760(99)00032-1; Kuo YJ, 2014, J HISTOCHEM CYTOCHEM, V62, P565, DOI 10.1369/0022155414538264; Leitner MM, 2009, LAB ANIM-UK, V43, P266, DOI 10.1258/la.2008.008045; Li M, 1997, BONE, V20, P55, DOI 10.1016/S8756-3282(96)00317-1; Li ZQ, 2009, THESIS TIANJIN MED U; Lill CA, 2003, J ORTHOPAED RES, V21, P836, DOI 10.1016/S0736-0266(02)00266-8; Liu RJ, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-288; McCann RM, 2008, J ORTHOP RES, V26, P384, DOI 10.1002/jor.20505; Mohamad S, 2012, CLINICS, V67, P1077, DOI 10.6061/clinics/2012(09)16; Namkung-Matthai H, 2001, BONE, V28, P80, DOI 10.1016/S8756-3282(00)00414-2; PANKOVICH AM, 1981, CLIN ORTHOP RELAT R, P185; Qiao Lin, 2005, Sichuan Da Xue Xue Bao Yi Xue Ban, V36, P108; Qiu ZJ, 2010, THESIS SOOCHOW U; [荣建民 Rong Jianmin], 2012, [中国组织工程研究, Chinese Journal of Tissue Engineering Research], V16, P7809; Schindeler A, 2009, DIFFERENTIATION, V77, P12, DOI 10.1016/j.diff.2008.09.007; Sengupta S, 2005, J STEROID BIOCHEM, V94, P421, DOI 10.1016/j.jsbmb.2004.12.039; Sha M, 2009, ACTA ORTHOP, V80, P135, DOI 10.1080/17453670902807490; Shi HF, 2010, BONE, V46, P1299, DOI 10.1016/j.bone.2009.11.028; Sun DX, 2014, THESIS NANJING U TRA; Thormann U, 2014, INJURY, V45, P487, DOI 10.1016/j.injury.2013.10.033; Turner CH, 2001, J BONE MINER RES, V16, P1532, DOI 10.1359/jbmr.2001.16.8.1532; Wang AY, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/958908; [王广斌 Wang Guangbin], 2012, [中国骨质疏松杂志, Chinese Journal of Osteoporosis], V18, P507; Wang Jian-wei, 2005, Chin J Traumatol, V8, P111; [王磊 Wang Lei], 2005, [医用生物力学, Journal of medical biomechanics], V20, P235; Wang XF, 2010, THESIS SOOCHOW U; Wang XP, 2014, J MED RES, V43, P45; Watanabe Y, 2001, J ORTHOP RES, V19, P548, DOI 10.1016/S0736-0266(00)00042-5; Wei JS, 2014, ASIAN PAC J TROP MED, V7, P801, DOI 10.1016/S1995-7645(14)60140-1; WRONSKI TJ, 1989, BONE, V10, P295, DOI 10.1016/8756-3282(89)90067-7; WRONSKI TJ, 1988, CALCIFIED TISSUE INT, V43, P179, DOI 10.1007/BF02571317; Xiao DM, 2007, CHINESE J ORTHOPAEDI, V9, P448; Xu Shao-wen, 2003, Chin J Traumatol, V6, P160; Xue JY, 2014, THESIS SHANXI MED U; YAMAZAKI I, 1989, J BONE MINER RES, V4, P13; [尹宏 Yin Hong], 2012, [中国组织工程研究, Chinese Journal of Tissue Engineering Research], V16, P5389; [袁绍辉 Yuan Shaohui], 2011, [中国组织工程研究与临床康复, Journal of Clinical Rehabilitative Tissue Engineering Research], V15, P208; Zhang C., 2008, THESIS SHANGHAI JIAO; [张超 ZHANG Chao], 2009, [药学服务与研究, Pharmaceutical Care and Research], V9, P61; Zhang G, 2014, THESIS CHONGQING MED	66	15	15	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153120	10.1371/journal.pone.0153120	http://dx.doi.org/10.1371/journal.pone.0153120			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27055104	Green Published, gold, Green Submitted			2022-12-27	WOS:000373608000080
J	Nikolayevskyy, V; Hillemann, D; Richter, E; Ahmed, N; van der Werf, MJ; Kodmon, C; Drobniewski, F; Ruesch-Gerdes, S				Nikolayevskyy, Vladyslav; Hillemann, Doris; Richter, Elvira; Ahmed, Nada; van der Werf, Marieke J.; Kodmon, Csaba; Drobniewski, Francis; Ruesch-Gerdes, Sabine		ERLTB-Net Network	External Quality Assessment for Tuberculosis Diagnosis and Drug Resistance in the European Union: A Five Year Multicentre Implementation Study	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; WORLDWIDE PROFICIENCY; VARIABLE-NUMBER; COUNTRIES; COMPLEX; ROUNDS	Background External quality assurance (EQA) systems are essential to ensure accurate diagnosis of TB and drug-resistant TB. The implementation of EQA through organising regular EQA rounds and identification of training needs is one of the key activities of the European TB reference laboratory network (ERLTB-Net). The aim of this study was to analyse the results of the EQA rounds in a systematic manner and to identify potential benefits as well as common problems encountered by the participants. Methods The ERLTB-Net developed seven EQA modules to test laboratories' proficiency for TB detection and drug susceptibility testing using both conventional and rapid molecular tools. All National TB Reference laboratories in the European Union and European Economic Area (EU/EEA) Member States were invited to participate in the EQA scheme. Results A total of 32 National TB Reference laboratories participated in six EQA rounds conducted in 2010-2014. The participation rate ranged from 52.9%-94.1% over different modules and rounds. Overall, laboratories demonstrated very good proficiency proving their ability to diagnose TB and drug-resistant TB with high accuracy in a timely manner. A small number of laboratories encountered problems with identification of specific Non-tuberculous Mycobacteria (NTMs) (N = 5) and drug susceptibility testing to Pyrazinamide, Amikacin, Capreomycin, and Ethambutol (N = 4). Conclusions The European TB Reference laboratories showed a steady and high level of performance in the six EQA rounds. A network such as ERLTB-Net can be instrumental in developing and implementing EQA and in establishing collaboration between laboratories to improve the diagnosis of TB in the EU/EEA.	[Nikolayevskyy, Vladyslav; Ahmed, Nada; Drobniewski, Francis] PHE Natl Mycobacterium Reference Lab, London, England; [Hillemann, Doris; Richter, Elvira; Ruesch-Gerdes, Sabine] Forschungszentrum Borstel, Natl Reference Lab Mycobacteria, Borstel, Germany; [van der Werf, Marieke J.; Kodmon, Csaba] European Ctr Dis Prevent & Control, Stockholm, Sweden; [Nikolayevskyy, Vladyslav; Drobniewski, Francis] Univ London Imperial Coll Sci Technol & Med, London, England	Forschungszentrum Borstel; European Centre for Disease Prevention & Control; Imperial College London	Nikolayevskyy, V (corresponding author), PHE Natl Mycobacterium Reference Lab, London, England.; Nikolayevskyy, V (corresponding author), Univ London Imperial Coll Sci Technol & Med, London, England.	vlad.nikolayevskyy@phe.gov.uk	Nikolayevskyy, Vladyslav/HFZ-7738-2022; Fitzgibbon, Margaret M/AAK-3043-2021; Ködmön, Csaba/AAP-8247-2021; Fattorini, Lanfranco/C-1032-2016; Kranzer, Katharina/O-8845-2014	Nikolayevskyy, Vladyslav/0000-0002-9502-0332; Fitzgibbon, Margaret M/0000-0001-8822-214X; Ködmön, Csaba/0000-0001-8040-6753; Fattorini, Lanfranco/0000-0003-1673-1804; Thomsen, Vibeke Ostergaard/0000-0002-1653-6294; Kranzer, Katharina/0000-0001-5691-7270	European Centre for Disease Control (ECDC) [2009/004, 2014/001]	European Centre for Disease Control (ECDC)	This study has received funding from the European Centre for Disease Control (ECDC) under the grants 2009/004 and 2014/001 (www.ecdc.europa.eu). The funders contributed to the data analysis.	Brown TJ, 2006, J MICROBIOL METH, V65, P294, DOI 10.1016/j.mimet.2005.08.002; de Beer JL, 2014, INT J TUBERC LUNG D, V18, P594, DOI 10.5588/ijtld.13.0531; de Beer JL, 2012, J CLIN MICROBIOL, V50, P662, DOI 10.1128/JCM.00607-11; Drobniewski F, 2012, INT J TUBERC LUNG D, V16, P860, DOI 10.5588/ijtld.12.0180; Drobniewski F, 2013, BMC MED IN PRESS; Drobniewski FA, 1999, J CLIN PATHOL, V52, P334, DOI 10.1136/jcp.52.5.334; Drobniewski FA, 2006, EUR RESP J; Drobniewski FA, 2008, EURO SURVEILL, V13, P8076; European Centre for Disease Prevention and Control, 2008, FRAM ACT PLAN FIGHT; Fattorini L, 2008, INT J TUBERC LUNG D, V12, P214; Hillemann D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076765; International Standards Organization, 2012, 151892012 ISO; Johansen IS, 2003, INT J TUBERC LUNG D, V7, P899; Kato-Maeda M, 2011, FUTURE MICROBIOL, V6, P203, DOI 10.2217/FMB.10.165; Laszlo A, 2002, INT J TUBERC LUNG D, V6, P748; Lonnroth K, 2015, EUR RESPIR J, V45, P928, DOI 10.1183/09031936.00214014; Niemann S, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a021188; Shulgina MV, 2009, INT J TUBERC LUNG D, V13, P1294; Walton C, 2005, CLIN MICROBIOL INFEC, V11, P1016, DOI 10.1111/j.1469-0691.2005.01261.x; World Health Organization, 2015, TUB SURV MON EUR 201	20	22	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0152926	10.1371/journal.pone.0152926	http://dx.doi.org/10.1371/journal.pone.0152926			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27055064	Green Published, Green Submitted, gold			2022-12-27	WOS:000373608000055
J	Siegling, AB; Petrides, KV				Siegling, Alex B.; Petrides, K. V.			Zeroing In on Mindfulness Facets: Similarities, Validity, and Dimensionality across Three Independent Measures	PLOS ONE			English	Article							PSYCHOMETRIC PROPERTIES; SELF-REPORT; INCREMENTAL VALIDITY; KENTUCKY INVENTORY; QUESTIONNAIRE; VALIDATION; VERSION	The field of mindfulness has seen a proliferation of psychometric measures, characterised by differences in operationalisation and conceptualisation. To illuminate the scope of, and offer insights into, the diversity apparent in the burgeoning literature, two distinct samples were used to examine the similarities, validity, and dimensionality of mindfulness facets and subscales across three independent measures: the Five Facet Mindfulness Questionnaire (FFMQ), Philadelphia Mindfulness Scale (PHLMS), and Toronto Mindfulness Scale (TMS). Results revealed problematic associations of FFMQ Observe with the other FFMQ facets and supported a four-factor structure (omitting this facet), while disputing the originally envisaged five-factor model; thus, solidifying a pattern in the literature. Results also confirmed the bidimensional nature of the PHLMS and TMS subscales, respectively. A joint Confirmatory Factor Analysis showed that PHLMS Acceptance could be assimilated within the FFMQ's four-factor model (as a distinct factor). The study offers a way of understanding interrelationships between the available mindfulness scales, so as to help practitioners and researchers make a more informed choice when conceptualising and operationalising mindfulness.	[Siegling, Alex B.; Petrides, K. V.] UCL, London Psychometr Lab, London, England	University of London; University College London	Siegling, AB (corresponding author), UCL, London Psychometr Lab, London, England.	a.siegling@ucl.ac.uk	Siegling, Alex/O-2327-2019	Siegling, Alex/0000-0003-2411-9826				Aguado J, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00404; Baer RA, 2006, ASSESSMENT, V13, P27, DOI 10.1177/1073191105283504; Baer RA, 2004, ASSESSMENT, V11, P191, DOI 10.1177/1073191104268029; Barnes S, 2007, J MARITAL FAM THER, V33, P482, DOI 10.1111/j.1752-0606.2007.00033.x; BENTLER PM, 1987, SOCIOL METHOD RES, V16, P78, DOI 10.1177/0049124187016001004; Bergomi C, 2013, MINDFULNESS, V4, P18, DOI 10.1007/s12671-012-0102-9; Bodner T.E., 2001, 13 ANN AM PSYCHOL SO; Bohlmeijer E, 2011, ASSESSMENT, V18, P308, DOI 10.1177/1073191111408231; Brown KW, 2007, PSYCHOL INQ, V18, P272, DOI 10.1080/10478400701703344; Brown KW, 2003, J PERS SOC PSYCHOL, V84, P822, DOI 10.1037/0022-3514.84.4.822; Cardaciotto L, 2008, ASSESSMENT, V15, P204, DOI 10.1177/1073191107311467; Cash M., 2010, MINDFULNESS, V1, P177, DOI [https://doi.org/10.1007/s12671-010-0023-4, DOI 10.1007/S12671-010-0023-4, 10.1007/s12671-010-0023-4]; Cebolla A, 2012, EUR J PSYCHIAT, V26, P118, DOI 10.4321/S0213-61632012000200005; Chadwick P, 2008, BRIT J CLIN PSYCHOL, V47, P451, DOI 10.1348/014466508X314891; Christopher MS, 2012, MINDFULNESS, V3, P124, DOI 10.1007/s12671-011-0086-x; Christopher MS, 2010, CURR PSYCHOL, V29, P10, DOI 10.1007/s12144-009-9067-9; Christopher MS, 2009, J CLIN PSYCHOL, V65, P590, DOI 10.1002/jclp.20580; Consedine NS, 2014, PSYCHOL HEALTH MED, V19, P392, DOI 10.1080/13548506.2013.824596; COSTA PT, 1995, J PERS ASSESS, V64, P21, DOI 10.1207/s15327752jpa6401_2; Curtiss J, 2014, J PSYCHOPATHOL BEHAV, V36, P683, DOI 10.1007/s10862-014-9429-y; Davis KM, 2009, J COGN PSYCHOTHER, V23, P185, DOI 10.1891/0889-8391.23.3.185; Erisman SM, 2012, MINDFULNESS, V3, P30, DOI 10.1007/s12671-011-0078-x; Feldman G, 2007, J PSYCHOPATHOL BEHAV, V29, P177, DOI 10.1007/s10862-006-9035-8; Fink S, 2009, BODY IMAGE, V6, P326, DOI 10.1016/j.bodyim.2009.07.003; Ghorbani N, 2009, CURR PSYCHOL, V28, P211, DOI 10.1007/s12144-009-9060-3; Hart R, 2013, REV GEN PSYCHOL, V17, P453, DOI 10.1037/a0035212; Heidenreich T, 2006, VERHALTENSTHERAPIE, V16, P33, DOI 10.1159/000091521; Hofling V, 2011, J CLIN PSYCHOL, V67, P639, DOI 10.1002/jclp.20778; Hooper D., 2008, EJBRM, V6, P53, DOI [DOI 10.1037/1082[HYPHEN]989X.12.1.58, 10.21427/D79B73]; Kabat-Zinn J., 1994, WHEREVER YOU GO THER; Lau MA, 2006, J CLIN PSYCHOL, V62, P1445, DOI 10.1002/jclp.20326; Neale-Lorello D, 2015, MINDFULNESS, V6, P1286, DOI 10.1007/s12671-015-0396-5; Ong JC, 2009, EXPLORE-NY, V5, P30, DOI 10.1016/j.explore.2008.10.004; Park T, 2013, QUAL LIFE RES, V22, P2639, DOI 10.1007/s11136-013-0395-8; Pirson M., 2012, DEV VALIDATION LANGE, DOI [10.2139/ssrn.2158921, DOI 10.2139/SSRN.2158921]; Sauer S, 2013, MINDFULNESS, V4, P3, DOI 10.1007/s12671-012-0122-5; Segal Z. V., 2002, MINDFULNESS BASED CO; Siegling AB, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01164; Smith GT, 2009, PSYCHOL ASSESSMENT, V21, P272, DOI 10.1037/a0016699; Smith GT, 2003, PSYCHOL ASSESSMENT, V15, P467, DOI 10.1037/1040-3590.15.4.467; Smith GT, 2009, OXFORD HDB PERSONALI, P81; Tran US, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110192; Tran US, 2013, J CLIN PSYCHOL, V69, P951, DOI 10.1002/jclp.21996; Vidrine JI, 2009, SUBST ABUS, V30, P318, DOI 10.1080/08897070903252973; Vujanovic Anka A., 2010, Cognitive Behaviour Therapy, V39, P203, DOI 10.1080/16506070903441630; Walach H, 2006, PERS INDIV DIFFER, V40, P1543, DOI 10.1016/j.paid.2005.11.025; Williams MJ, 2014, PSYCHOL ASSESSMENT, V26, P407, DOI 10.1037/a0035566	47	32	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153073	10.1371/journal.pone.0153073	http://dx.doi.org/10.1371/journal.pone.0153073			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DI6KO	27055017	Green Published, gold, Green Submitted			2022-12-27	WOS:000373608000071
J	Hall, CM; Adams, NA; Bradley, JS; Bryant, KA; Davis, AA; Dickman, CR; Fujita, T; Kobayashi, S; Lepczyk, CA; McBride, EA; Pollock, KH; Styles, IM; van Heezik, Y; Wang, F; Calver, MC				Hall, Catherine M.; Adams, Nigel A.; Bradley, J. Stuart; Bryant, Kate A.; Davis, Alisa A.; Dickman, Christopher R.; Fujita, Tsumugi; Kobayashi, Shinichi; Lepczyk, Christopher A.; McBride, E. Anne; Pollock, Kenneth H.; Styles, Irene M.; van Heezik, Yolanda; Wang, Ferian; Calver, Michael C.			Community Attitudes and Practices of Urban Residents Regarding Predation by Pet Cats on Wildlife: An International Comparison	PLOS ONE			English	Article							DOMESTIC CATS; FELIS-SILVESTRIS; TOXOPLASMA-GONDII; COMPANION ANIMALS; NEW-ZEALAND; POPULATION; BIRDS; CONSERVATION; DIVERSITY; AUSTRALIA	International differences in practices and attitudes regarding pet cats' interactions with wildlife were assessed by surveying citizens from at least two cities in Australia, New Zealand, the UK, the USA, China and Japan. Predictions tested were: (i) cat owners would agree less than non-cat owners that cats might threaten wildlife, (ii) cat owners value wildlife less than non-cat owners, (iii) cat owners are less accepting of cat legislation/restrictions than non-owners, and (iv) respondents from regions with high endemic biodiversity (Australia, New Zealand, China and the USA state of Hawaii) would be most concerned about pet cats threatening wildlife. Everywhere non-owners were more likely than owners to agree that pet cats killing wildlife were a problem in cities, towns and rural areas. Agreement amongst non-owners was highest in Australia (95%) and New Zealand (78%) and lowest in the UK (38%). Irrespective of ownership, over 85% of respondents from all countries except China (65%) valued wildlife in cities, towns and rural areas. Non-owners advocated cat legislation more strongly than owners except in Japan. Australian non-owners were the most supportive (88%), followed by Chinese non-owners (80%) and Japanese owners (79.5%). The UK was least supportive (non-owners 43%, owners 25%). Many Australian (62%), New Zealand (51%) and Chinese owners (42%) agreed that pet cats killing wildlife in cities, towns and rural areas was a problem, while Hawaiian owners were similar to the mainland USA (20%). Thus high endemic biodiversity might contribute to attitudes in some, but not all, countries. Husbandry practices varied internationally, with predation highest where fewer cats were confined. Although the risk of wildlife population declines caused by pet cats justifies precautionary action, campaigns based on wildlife protection are unlikely to succeed outside Australia or New Zealand. Restrictions on roaming protect wildlife and benefit cat welfare, so welfare is a better rationale.	[Hall, Catherine M.; Bradley, J. Stuart; Bryant, Kate A.; Calver, Michael C.] Murdoch Univ, Sch Vet & Life Sci, Murdoch, WA 6150, Australia; [Adams, Nigel A.] Unitec Inst Technol, Fac Social & Hlth Sci, Dept Nat Sci, Auckland, New Zealand; [Davis, Alisa A.] Univ Hawaii Manoa, Dept Nat Resources & Environm Management, Honolulu, HI 96822 USA; [Dickman, Christopher R.] Univ Sydney, Sch Life & Environm Sci, Sydney, NSW 2006, Australia; [Fujita, Tsumugi; Kobayashi, Shinichi; Wang, Ferian] Nihon Univ, Coll Bioresource Sci, Fujisawa, Kanagawa, Japan; [Lepczyk, Christopher A.] Auburn Univ, Sch Forestry & Wildlife Sci, Auburn, AL 36849 USA; [McBride, E. Anne] Univ Southampton, Sch Psychol, Southampton, Hants, England; [Pollock, Kenneth H.] N Carolina State Univ, Dept Appl Ecol, Raleigh, NC 27695 USA; [Styles, Irene M.] Univ Western Australia, Grad Sch Educ, Perth, WA 6009, Australia; [van Heezik, Yolanda] Univ Otago, Dept Zool, POB 54, Dunedin, New Zealand	Murdoch University; Unitec NZ; University of Hawaii System; University of Hawaii Manoa; University of Sydney; Nihon University; Auburn University System; Auburn University; University of Southampton; University of North Carolina; North Carolina State University; University of Western Australia; University of Otago	Calver, MC (corresponding author), Murdoch Univ, Sch Vet & Life Sci, Murdoch, WA 6150, Australia.	m.calver@murdoch.edu.au	van Heezik, Yolanda/I-2744-2019; Dickman, Christopher/Q-4662-2019	van Heezik, Yolanda/0000-0003-0494-5311; Dickman, Christopher/0000-0002-1067-3730; Bryant, Kate/0000-0002-5264-5260	Australian Research Council; Murdoch University Research Studentship	Australian Research Council(Australian Research Council); Murdoch University Research Studentship	Funding was provided by the Australian Research Council (http://www.arc.gov.au), and this is a general acknowledgement of a theme in grant funding rather than an acknowledgement of a specific grant, and a Murdoch University Research Studentship (http://www.murdoch.edu.au). No specific project number is available for this award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACAC, 2010, CONTR PET CAR IND AU; Aguilar GD, 2013, APPL GEOGR, V37, P160, DOI 10.1016/j.apgeog.2012.11.009; ALBERT A, 1988, J MARRIAGE FAM, V50, P543, DOI 10.2307/352019; American Association of Feline Practitioners, 2007, CONF OWN IND CATS 20; American Bird Conservancy, 2011, HUMAN ATTITUDES AND; Andrich D., 2013, INTERPRETING RUMM203; ARMSTRONG JS, 1977, J MARKETING RES, V14, P396, DOI 10.2307/3150783; AVMA-American Veterinary Medical Association, 2012, US PET OWN STAT 2012; Baker PJ, 2005, MAMMAL REV, V35, P302, DOI 10.1111/j.1365-2907.2005.00071.x; Baldock FC, 2003, AUST VET J, V81, P289, DOI 10.1111/j.1751-0813.2003.tb12577.x; Balogh AL, 2011, J ORNITHOL, V152, P717, DOI 10.1007/s10336-011-0648-7; Barratt DG, 1998, WILDLIFE RES, V25, P475, DOI 10.1071/WR97026; Beaumont M, 2001, MOL ECOL, V10, P319, DOI 10.1046/j.1365-294x.2001.01196.x; Beckerman AP, 2007, ANIM CONSERV, V10, P320, DOI 10.1111/j.1469-1795.2007.00115.x; Bender DJ, 1998, ECOLOGY, V79, P517, DOI 10.2307/176950; Biro Z, 2005, J ZOOL, V266, P187, DOI 10.1017/S0952836905006771; Bond TG., 2020, APPL RASCH MODEL FUN; Bonnington C, 2013, J APPL ECOL, V50, P15, DOI 10.1111/1365-2664.12025; Boone WJ, 2014, RASCH ANAL HUMAN SCI; Bradshaw J, 2013, VET REC, V173, P554, DOI 10.1136/vr.f7278; BRICKEL CM, 1979, GERONTOLOGIST, V19, P368, DOI 10.1093/geront/19.4.368; Burbidge A.A., 2014, P15; Calver MC, 2013, ANIM WELFARE, V22, P95, DOI 10.7120/09627286.22.1.095; Calver M. C., 2011, Pacific Conservation Biology, V16, P244; Calver M, 2007, BIOL CONSERV, V137, P341, DOI 10.1016/j.biocon.2007.02.015; Calver MC, 2011, BIOL CONSERV, V144, P1895, DOI 10.1016/j.biocon.2011.04.015; Chaseling S, 2001, 10 URBAN ANIMAL MANA; Cheng M, 2015, NURS EDUC TODAY, V35, P843, DOI 10.1016/j.nedt.2015.03.001; Chu K, 2009, JAVMA-J AM VET MED A, V234, P1023, DOI 10.2460/javma.234.8.1023; CHURCHER PB, 1987, J ZOOL, V212, P439, DOI 10.1111/j.1469-7998.1987.tb02915.x; Crew G., 2008, CAT ON THE ISLAND; Dabritz HA, 2006, JAVMA-J AM VET MED A, V229, P74, DOI 10.2460/javma.229.1.74; De Vaus D., 2002, SURVEYS SOCIAL RES; Dickman C. R., 2014, CARNIVORES AUSTR PRE, P173; Dickman CR, 2015, APPL ANIM BEHAV SCI, V173, P76, DOI 10.1016/j.applanim.2014.09.021; DUFTY AC, 1994, WILDLIFE RES, V21, P445, DOI 10.1071/WR9940445; Egenvall A, 2009, J VET INTERN MED, V23, P1175, DOI 10.1111/j.1939-1676.2009.0396.x; Erickson Wallace P., 2005, U S Forest Service General Technical Report PSW, V191, P1029; Euromonitor International, 2004, CHIN CHANG ATT PET O; Farnworth MJ, 2011, J APPL ANIM WELF SCI, V14, P59, DOI 10.1080/10888705.2011.527604; Flux JEC, 2007, NEW ZEAL J ZOOL, V34, P289, DOI 10.1080/03014220709510087; Foster-Bey John., 2008, RACE ETHNICITY CITIZ; Gaston KJ, 2005, BIODIVERS CONSERV, V14, P3327, DOI 10.1007/s10531-004-9513-9; Gordon JK, 2010, WILDLIFE RES, V37, P372, DOI 10.1071/WR09127; Goyder J., 2002, J OFF STAT, V18, P1, DOI DOI https://doi.org/1266793999?accountid=16531; Grayson J, 2002, AUST VET J, V80, P536, DOI 10.1111/j.1751-0813.2002.tb11030.x; Grayson Jacky, 2004, P169; Grayson Jacky, 2007, P195; Hall CM, APPL ANIM B IN PRESS; Harris RB, 1996, ENVIRON VALUE, V5, P303, DOI 10.3197/096327196776679249; Harzing AW, 2012, MANAGE INT REV, V52, P341, DOI 10.1007/s11575-011-0111-2; Hill D, 2002, CLIN MICROBIOL INFEC, V8, P634, DOI 10.1046/j.1469-0691.2002.00485.x; Hunter Louise, 2012, Nurse Res, V20, P11; Johnson J, 2014, AUST VET J, V92, P226, DOI 10.1111/avj.12182; Jongman EC, 2007, J VET BEHAV, V2, P193, DOI 10.1016/j.jveb.2007.09.003; Kinnear JE, 2002, BIOL CONSERV, V108, P335, DOI 10.1016/S0006-3207(02)00116-7; Lampila P, 2005, CONSERV BIOL, V19, P1537, DOI 10.1111/j.1523-1739.2005.00201.x; Lecis R, 2006, MOL ECOL, V15, P119, DOI 10.1111/j.1365-294X.2005.02812.x; Lepczyk CA, 2004, BIOL CONSERV, V115, P191, DOI 10.1016/S0006-3207(03)00107-1; Lepczyk CA, 2010, CONSERV BIOL, V24, P627, DOI 10.1111/j.1523-1739.2009.01426.x; Liberg O, 2000, DOMESTIC CAT BIOL IT, P120; Lilith M, 2006, AUSTRAL ECOL, V31, P176, DOI 10.1111/j.1442-9993.2006.01582.x; Lilith Maggie, 2010, Pacific Conservation Biology, V16, P162; Lohr CA, 2014, HUM-WILDL INTERACT, V8, P56; Lohr CA, 2014, CONSERV BIOL, V28, P392, DOI 10.1111/cobi.12201; Loss SR, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2380; Loss SR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101565; Loss SR, 2014, J WILDLIFE MANAGE, V78, P763, DOI 10.1002/jwmg.721; Loss SR, 2013, BIOL CONSERV, V168, P201, DOI 10.1016/j.biocon.2013.10.007; Loss SR, 2012, FRONT ECOL ENVIRON, V10, P357, DOI 10.1890/110251; Macdonald EA, 2015, GLOB ECOL CONSERV, V3, P851, DOI 10.1016/j.gecco.2015.04.006; Machado JC, 2014, AUST VET J, V92, P492, DOI 10.1111/avj.12253; Matsui S, 2012, IBIS, V154, P621, DOI 10.1111/j.1474-919X.2012.01225.x; McBeath Jerry, 2006, Journal of International Wildlife Law and Policy, V9, P293, DOI 10.1080/13880290601039238; McDonald JL, 2015, ECOL EVOL, V5, P2745, DOI 10.1002/ece3.1553; Melson GF, 2003, AM BEHAV SCI, V47, P31, DOI 10.1177/0002764203255210; Mesago Messe Frankfurt Corp, 2014, INT 2014 INT FAIR BE; Miller PS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113553; Murray JK, 2010, VET REC, V166, P163, DOI 10.1136/vr.b4712; Nattress R, 1992, P 1 NAT C URB AN MAN; Nelson SH, 2005, APPL ANIM BEHAV SCI, V94, P273, DOI 10.1016/j.applanim.2005.04.003; O'Haire M, 2010, J VET BEHAV, V5, P226, DOI 10.1016/j.jveb.2010.02.002; O'Haire ME, 2013, J AUTISM DEV DISORD, V43, P1606, DOI 10.1007/s10803-012-1707-5; Osborne W, 1991, P WORKSH IMP CATS NA, P14; Paton D.C., 1991, P WORKSH IMP CATS NA, P64; PATON DC, 1990, BIRD OBSERV, V696, P34; Patronek GJ, 1997, J AM VET MED ASSOC, V210, P637; Peterson MN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044616; Plourde L, 2014, JPN STUD, V34, P115, DOI 10.1080/10371397.2014.928183; REARK, 1994, SURV POP CHAR HUNT B; REARK, 1994, CAT SUB SURV SYDN ME; Risbey DA, 2000, WILDLIFE RES, V27, P223, DOI 10.1071/WR98092; Rochlitz I, 2005, APPL ANIM BEHAV SCI, V93, P97, DOI 10.1016/j.applanim.2005.01.002; Rochlitz I, 2004, J SMALL ANIM PRACT, V45, P390, DOI 10.1111/j.1748-5827.2004.tb00253.x; Rochlitz I., 2001, JSAP, V42, P376; RSPB, 2014, AR CATS CA BIRD DECL; Ruxton GD, 2002, J ZOOL, V256, P81, DOI 10.1017/S0952836902000109; Sakurai R, 2010, SOCIOL THEOR METHOD, V25, P267; SCOTT WJ, 1979, POLITICAL BEHAV, V0001; SELBY LA, 1981, J SMALL ANIM PRACT, V22, P129, DOI 10.1111/j.1748-5827.1981.tb00592.x; SIEGEL JM, 1990, J PERS SOC PSYCHOL, V58, P1081, DOI 10.1037/0022-3514.58.6.1081; Sims V, 2008, DIVERS DISTRIB, V14, P387, DOI 10.1111/j.1472-4642.2007.00444.x; Slater MR, 2008, PREV VET MED, V85, P267, DOI 10.1016/j.prevetmed.2008.02.001; Statsoft Inc, STATISTICA DAT ANAL; Stieger S, 2007, J AM SOC INF SCI TEC, V58, P1653, DOI 10.1002/asi.20651; STRAEDE CM, 1993, ANTHROZOOS, V6, P30, DOI 10.2752/089279393787002385; Tabachnick B. G., 2001, USING MULTIVARIATE S; Tenter AM, 2009, MEM I OSWALDO CRUZ, V104, P364, DOI 10.1590/S0074-02762009000200033; Thomas RL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049369; Tokyo International Communication Committee, 2006, COMPR LIV GUID FOR R; Torrey EF, 2007, SCHIZOPHRENIA BULL, V33, P729, DOI 10.1093/schbul/sbl050; Toukhsati SR, 2012, ANTHROZOOS, V25, P61, DOI 10.2752/175303712X13240472427195; Uetake K, 2014, J APPL ANIM WELF SCI, V17, P172, DOI 10.1080/10888705.2013.798558; van Heezik Y, 2008, LANDSCAPE URBAN PLAN, V87, P223, DOI 10.1016/j.landurbplan.2008.06.004; van Heezik Y, 2013, ECOSYSTEMS, V16, P1442, DOI 10.1007/s10021-013-9694-8; van Heezik Y, 2010, BIOL CONSERV, V143, P121, DOI 10.1016/j.biocon.2009.09.013; Wandesforde-Smith G., 2014, SOC SCI ELECT PUBL, V17, P1476, DOI [10.1080/13880292.2014.953371, DOI 10.1080/13880292.2014.953371]; Wei XL, 2014, NICOTINE TOB RES, V16, P390, DOI 10.1093/ntr/ntt162; White G., 2013, CATS; White JG, 2005, LANDSCAPE URBAN PLAN, V71, P123, DOI 10.1016/j.landurbplan.2004.02.006; Wildlife Society, 2006, FIN POS STAT FER FRE; Willson SK, 2015, GLOB ECOL CONSERV, V3, P359, DOI 10.1016/j.gecco.2015.01.004; Wood LJ, 2007, SOC ANIM, V15, P43, DOI 10.1163/156853007X169333; Woods M, 2003, MAMMAL REV, V33, P174, DOI 10.1046/j.1365-2907.2003.00017.x; Yeh ET, 2013, J PEASANT STUD, V40, P1165, DOI 10.1080/03066150.2013.859575; Zar JH., 2010, BIOSTAT ANAL, V5th	126	65	71	3	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0151962	10.1371/journal.pone.0151962	http://dx.doi.org/10.1371/journal.pone.0151962			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DI6IX	27050447	Green Published, Green Accepted, gold			2022-12-27	WOS:000373603500019
J	Hedley, RW				Hedley, Richard W.			Complexity, Predictability and Time Homogeneity of Syntax in the Songs of Cassin's Vireo (Vireo cassinii)	PLOS ONE			English	Article							SINGING PATTERNS; BIRD SONG; SEQUENCES; ORGANIZATION; CLASSIFICATION; PHYLOGENY; EVOLUTION; CONTEXT; WREN	Many species of animals deliver vocalizations in sequences presumed to be governed by internal rules, though the nature and complexity of these syntactical rules have been investigated in relatively few species. Here I present an investigation into the song syntax of fourteen male Cassin's Vireos (Vireo cassinii), a species whose song sequences are highly temporally structured. I compare their song sequences to three candidate models of varying levels of complexity-zero-order, first-order and second-order Markov models-and employ novel methods to interpolate between these three models. A variety of analyses, including sequence simulations, Fisher's exact tests, and model likelihood analyses, showed that the songs of this species are too complex to be described by a zero-order or first-order Markov model. The model that best fit the data was intermediate in complexity between a first-and second-order model, though I also present evidence that some transition probabilities are conditioned on up to three preceding phrases. In addition, sequences were shown to be predictable with more than 54% accuracy overall, and predictability was positively correlated with the rate of song delivery. An assessment of the time homogeneity of syntax showed that transition probabilities between phrase types are largely stable over time, but that there was some evidence for modest changes in syntax within and between breeding seasons, a finding that I interpret to represent changes in breeding stage and social context rather than irreversible, secular shifts in syntax over time. These findings constitute a valuable addition to our understanding of bird song syntax in free-living birds, and will contribute to future attempts to understand the evolutionary importance of bird song syntax in avian communication.	[Hedley, Richard W.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA USA	University of California System; University of California Los Angeles	Hedley, RW (corresponding author), Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA USA.	rhedley@ucla.edu			National Science Foundation [1125423]; Audubon society branch in Pasadena; Audubon society branch in Los Angeles; Audubon society branch in Santa Monica Bay; Div Of Information & Intelligent Systems [1125423] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Audubon society branch in Pasadena; Audubon society branch in Los Angeles; Audubon society branch in Santa Monica Bay; Div Of Information & Intelligent Systems(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This research was funded by National Science Foundation Award Number 1125423 (http://www.nsf.gov/) and was supplemented by three small grants from the Audubon society branches in Pasadena (http://www.pasadenaaudubon.org), Los Angeles (http://www.losangelesaudubon.org), and Santa Monica Bay (https://smbasblog.wordpress.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, R LANG ENV STAT COMP; Arriaga JG, 2016, NEUROCOMPUTING, V175, P966, DOI 10.1016/j.neucom.2015.05.129; Arriaga JG, 2014, LECT NOTES COMPUT SC, V8495, P291, DOI 10.1007/978-3-319-07491-7_30; Barker FK, 2004, P NATL ACAD SCI USA, V101, P11040, DOI 10.1073/pnas.0401892101; Beecher MD, 2000, ANIM BEHAV, V59, P21, DOI 10.1006/anbe.1999.1276; Berwick RC, 2011, TRENDS COGN SCI, V15, P113, DOI 10.1016/j.tics.2011.01.002; Bolhuis JJ, 2013, BIRDSONG, SPEECH, AND LANGUAGE: EXPLORING THE EVOLUTION OF MIND AND BRAIN, P1; BORROR DJ, 1981, CONDOR, V83, P217, DOI 10.2307/1367311; Byers BE, 2009, ANIM BEHAV, V77, P13, DOI 10.1016/j.anbehav.2008.10.003; CHATFIELD C, 1970, J THEOR BIOL, V29, P427, DOI 10.1016/0022-5193(70)90107-4; DESTAVOLA BL, 1988, J R STAT SOC C-APPL, V37, P242; DOBSON CW, 1977, BEHAVIOUR, V62, P277, DOI 10.1163/156853977X00144; DOBSON CW, 1979, BEHAVIOUR, V68, P86, DOI 10.1163/156853979X00250; FALLS JB, 1975, CAN J ZOOL, V53, P1165, DOI 10.1139/z75-135; Gentner TQ, 1998, ANIM BEHAV, V56, P579, DOI 10.1006/anbe.1998.0810; Gil D, 2000, BEHAVIOUR, V137, P759, DOI 10.1163/156853900502330; Hauser MD, 2002, SCIENCE, V298, P1569, DOI 10.1126/science.298.5598.1569; Hedley RW, 2016, J ORNITHOL, V157, P13, DOI 10.1007/s10336-015-1238-x; HOWESJONES D, 1985, CAN J ZOOL, V63, P2756, DOI 10.1139/z85-411; James G, 2013, SPRINGER TEXTS STAT, V103, P1, DOI 10.1007/978-1-4614-7138-7_1; James LS, 2014, J NEUROPHYSIOL, V112, P2040, DOI 10.1152/jn.00217.2014; Jin DZ, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001108; Jin DZ, 2013, PROGR COGNITIVE SCI; Jurafsky D., 2009, SPEECH LANGUAGE PROC; Katahira K, 2007, BIOL CYBERN, V97, P441, DOI 10.1007/s00422-007-0184-y; Katahira K, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0842; Katahira K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024516; Kershenbaum A, 2015, METHODS ECOL EVOL, V6, P1452, DOI 10.1111/2041-210X.12433; Kershenbaum A, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1370; KROODSMA DE, 1975, CONDOR, V77, P294, DOI 10.2307/1366225; LANGMORE NE, 1992, ETHOLOGY, V90, P143; LEMON RE, 1973, ANIM BEHAV, V21, P28, DOI 10.1016/S0003-3472(73)80037-5; LEMON RE, 1993, ETHOLOGY, V93, P198; LEMON RE, 1971, ANIM BEHAV, V19, P1, DOI 10.1016/S0003-3472(71)80129-X; Li M, 1993, AN INTRODUCTION TO K; Margoliash D, 2002, J COMP PHYSIOL A, V188, P851, DOI 10.1007/s00359-002-0351-5; Markowitz JE, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003052; MARTIN DJ, 1990, WILSON BULL, V102, P655; Podos J, 2007, ADV STUD BEHAV, V37, P403, DOI 10.1016/S0065-3454(07)37009-5; Prum RO, 2015, NATURE, V526, P569, DOI 10.1038/nature15697; Sakata JT, 2009, J NEUROPHYSIOL, V102, P2485, DOI 10.1152/jn.00340.2009; Sasahara K, 2006, CIC 2006: 15TH INTERNATIONAL CONFERENCE ON COMPUTING, PROCEEDINGS, P80; SLATER PJB, 1983, ANIM BEHAV, V31, P272, DOI 10.1016/S0003-3472(83)80197-3; SMITH WJ, 1978, ANIM BEHAV, V26, P862, DOI 10.1016/0003-3472(78)90153-7; Soma M, 2011, BEHAV ECOL, V22, P363, DOI 10.1093/beheco/arq219; STODDARD PK, 1992, CAN J ZOOL, V70, P1440, DOI 10.1139/z92-200; Tan B, 2002, EUR J OPER RES, V137, P524, DOI 10.1016/S0377-2217(01)00081-9; Tan LN, 2015, J ACOUST SOC AM, V137, P1069, DOI 10.1121/1.4906168; Tan LN, 2013, INT CONF ACOUST SPEE, P763, DOI 10.1109/ICASSP.2013.6637751; ten Cate C, 2012, PHILOS T R SOC B, V367, P1984, DOI 10.1098/rstb.2012.0055; Vehrencamp SL, 2007, BEHAV ECOL, V18, P849, DOI 10.1093/beheco/arm054; VERNER J, 1975, Living Bird, V14, P263; Warren TL, 2012, J NEUROSCI, V32, P15414, DOI 10.1523/JNEUROSCI.1254-12.2012; WITTEN IH, 1991, IEEE T INFORM THEORY, V37, P1085, DOI 10.1109/18.87000; Wolfram S., 2002, NEW KIND SCI	56	16	16	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0150822	10.1371/journal.pone.0150822	http://dx.doi.org/10.1371/journal.pone.0150822			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050537	Green Submitted, Green Published, gold			2022-12-27	WOS:000373603500002
J	Barmchi, MP; Samarasekera, G; Gilbert, M; Auld, VJ; Zhang, B				Barmchi, Mojgan Padash; Samarasekera, Gayathri; Gilbert, Mary; Auld, Vanessa J.; Zhang, Bing			Magi Is Associated with the Par Complex and Functions Antagonistically with Bazooka to Regulate the Apical Polarity Complex	PLOS ONE			English	Article							TIGHT JUNCTION PROTEIN; DROSOPHILA EPITHELIAL-CELLS; SCAFFOLDING PROTEIN; PDZ-PROTEIN; KINASE-C; SYNAPTIC LOCALIZATION; GUANYLATE KINASE; CHOLERA-TOXIN; APKC; NEUROBLASTS	The mammalian MAGI proteins play important roles in the maintenance of adherens and tight junctions. The MAGI family of proteins contains modular domains such as WW and PDZ domains necessary for scaffolding of membrane receptors and intracellular signaling components. Loss of MAGI leads to reduced junction stability while overexpression of MAGI can lead to increased adhesion and stabilization of epithelial morphology. However, how Magi regulates junction assembly in epithelia is largely unknown. We investigated the single Drosophila homologue of Magi to study the in vivo role of Magi in epithelial development. Magi is localized at the adherens junction and forms a complex with the polarity proteins, Par3/Bazooka and aPKC. We generated a Magi null mutant and found that Magi null mutants were viable with no detectable morphological defects even though the Magi protein is highly conserved with vertebrate Magi homologues. However, overexpression of Magi resulted in the displacement of Baz/Par3 and aPKC and lead to an increase in the level of PIP3. Interestingly, we found that Magi and Baz functioned in an antagonistic manner to regulate the localization of the apical polarity complex. Maintaining the balance between the level of Magi and Baz is an important determinant of the levels and localization of apical polarity complex.	[Barmchi, Mojgan Padash; Samarasekera, Gayathri; Gilbert, Mary; Auld, Vanessa J.] Univ British Columbia, Dept Zool, Vancouver, BC, Canada; [Barmchi, Mojgan Padash; Zhang, Bing] Univ Oklahoma, Dept Biol, Norman, OK 73019 USA; [Barmchi, Mojgan Padash; Zhang, Bing] Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA	University of British Columbia; University of Oklahoma System; University of Oklahoma - Norman; University of Missouri System; University of Missouri Columbia	Auld, VJ (corresponding author), Univ British Columbia, Dept Zool, Vancouver, BC, Canada.; Zhang, B (corresponding author), Univ Oklahoma, Dept Biol, Norman, OK 73019 USA.; Zhang, B (corresponding author), Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA.	auld@zoology.ubc.ca; zhangbing@missouri.edu		Padash Barmchi, Mojgan/0000-0003-1505-8953; Auld, Vanessa/0000-0003-3976-9186	Canadian Institute of Health Research [MOP-82862]; National Institute of Neurological Disorders and Stroke [RO1-NS060878]; University of Missouri; National Institutes of Health/National Institute of Neurological Disorders and Stroke [RO1-NS060878]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084947] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060878] Funding Source: NIH RePORTER	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); University of Missouri; National Institutes of Health/National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding provided by Canadian Institute of Health Research, http://www.cihr-irsc.gc.ca/e/193.html, grant number: MOP-82862 to VA, National Institute of Neurological Disorders and Stroke, http://www.ninds.nih.gov/, grant number: RO1-NS060878 to BZ and University of Missouri, http://missouri.edu/ to BZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Drs. Dave Bilder, Chris Doe, Denise Montell, Gregory Longmore, Vivian Budnik, Herbert Jackle and Andreas Wordarz for generously providing reagents, the Bloomington Drosophila Stock Center, and Dr. Jody Summers for the generous permission to use her Olympus FV1000 confocal microscope. We thank Kate O'Connor-Giles and Scott Gratz for advice on CRISPR/Cas9 and for providing their U6-3 vector. We thank the TRiP at Harvard Medical School (NIH/NIGMS R01-GM084947) for providing stocks and the Developmental Studies Hybridoma Bank (University of Iowa, Department of Biology, Iowa City) for antibodies. This research was supported by grants from the Canadian Institute of Health Research (MOP-82862 to VJA) and in part from the National Institutes of Health/National Institute of Neurological Disorders and Stroke (RO1-NS060878 to BZ) and by an internal fund from the University of Missouri (to BZ).	Bassett AR, 2013, CELL REP, V4, P220, DOI 10.1016/j.celrep.2013.06.020; Beller M, 2002, MECH DEVELOP, V119, pS253, DOI 10.1016/S0925-4773(03)00125-4; Berger S, 2007, GENETICS, V176, P2189, DOI 10.1534/genetics.107.071449; Bilder D, 2003, NAT CELL BIOL, V5, P53, DOI 10.1038/ncb897; Blank N, 2007, IMMUNOL CELL BIOL, V85, P378, DOI 10.1038/sj.icb.7100045; Blow NS, 2005, PLOS PATHOG, V1, P92, DOI 10.1371/journal.ppat.0010008; Brodsky MH, 2004, MOL CELL BIOL, V24, P1219, DOI 10.1128/MCB.24.3.1219-1231.2004; Brodsky MH, 2000, CELL, V101, P103, DOI 10.1016/S0092-8674(00)80627-3; Claret S, 2014, CURR BIOL, V24, P1071, DOI 10.1016/j.cub.2014.03.056; Danielson E, 2012, J NEUROSCI, V32, P6967, DOI 10.1523/JNEUROSCI.0025-12.2012; de Haan L, 2004, MOL MEMBR BIOL, V21, P77, DOI 10.1080/09687680410001663267; Dobrosotskaya I, 1997, J BIOL CHEM, V272, P31589, DOI 10.1074/jbc.272.50.31589; Dobrosotskaya IY, 2000, BIOCHEM BIOPH RES CO, V270, P903, DOI 10.1006/bbrc.2000.2471; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Emtage L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004613; Georgiou M, 2008, CURR BIOL, V18, P1631, DOI 10.1016/j.cub.2008.09.029; Gervais L, 2008, DEVELOPMENT, V135, P3829, DOI 10.1242/dev.029009; Glaunsinger BA, 2000, ONCOGENE, V19, P5270, DOI 10.1038/sj.onc.1203906; Gratz SJ, 2013, FLY, V7, P249, DOI 10.4161/fly.26566; Gray A, 1999, BIOCHEM J, V344, P929, DOI 10.1042/0264-6021:3440929; Gregorc U, 2007, APOPTOSIS, V12, P343, DOI 10.1007/s10495-006-0579-6; Harder T, 1998, J CELL BIOL, V141, P929, DOI 10.1083/jcb.141.4.929; HAY BA, 1994, DEVELOPMENT, V120, P2121; Hebbar S, 2008, J LIPID RES, V49, P1077, DOI 10.1194/jlr.M700543-JLR200; Hirabayashi S, 2003, MOL CELL BIOL, V23, P4267, DOI 10.1128/MCB.23.12.4267-4282.2003; Hirao K, 1998, J BIOL CHEM, V273, P21105, DOI 10.1074/jbc.273.33.21105; Hirose T, 2002, J CELL SCI, V115, P2485; Hutterer A, 2004, DEV CELL, V6, P845, DOI 10.1016/j.devcel.2004.05.003; Ide N, 1999, ONCOGENE, V18, P7810, DOI 10.1038/sj.onc.1203153; Izumi Y, 1998, J CELL BIOL, V143, P95, DOI 10.1083/jcb.143.1.95; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; Johnson K, 2002, CURR BIOL, V12, P1675, DOI 10.1016/S0960-9822(02)01180-6; Jokhi V, 2013, CELL REP, V3, P988, DOI 10.1016/j.celrep.2013.03.015; Koh YH, 1999, CELL, V98, P353, DOI 10.1016/S0092-8674(00)81964-9; Kotelevets L, 2004, FASEB J, V18, P115, DOI 10.1096/fj.04-1942fje; Krahn MP, 2010, CURR BIOL, V20, P636, DOI 10.1016/j.cub.2010.01.065; Kranjec C, 2014, J VIROL, V88, P7155, DOI 10.1128/JVI.03247-13; Kranjec C, 2011, J VIROL, V85, P1757, DOI 10.1128/JVI.01756-10; Langton PF, 2007, DEV CELL, V13, P773, DOI 10.1016/j.devcel.2007.11.005; Langton PF, 2009, CURR BIOL, V19, P1969, DOI 10.1016/j.cub.2009.10.027; Latorre IJ, 2005, J CELL SCI, V118, P4283, DOI 10.1242/jcs.02560; Laura RP, 2002, EXP CELL RES, V275, P155, DOI 10.1006/excr.2002.5475; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lehtonen S, 2005, P NATL ACAD SCI USA, V102, P9814, DOI 10.1073/pnas.0504166102; Leibfried A, 2008, CURR BIOL, V18, P1639, DOI 10.1016/j.cub.2008.09.063; Lida J, 2004, MOL CELL NEUROSCI, V27, P497, DOI 10.1016/j.mcn.2004.08.006; Lin D, 2000, NAT CELL BIOL, V2, P540, DOI 10.1038/35019582; Lynch AM, 2012, CURR BIOL, V22, P1891, DOI 10.1016/j.cub.2012.08.024; Muller HAJ, 1996, J CELL BIOL, V134, P149, DOI 10.1083/jcb.134.1.149; Nagashima S, 2015, J BIOCHEM, V157, P177, DOI 10.1093/jb/mvv009; Patrie KM, 2002, J BIOL CHEM, V277, P30183, DOI 10.1074/jbc.M203072200; Petronczki M, 2001, NAT CELL BIOL, V3, P43, DOI 10.1038/35050550; Pinal N, 2006, CURR BIOL, V16, P140, DOI 10.1016/j.cub.2005.11.068; Pinheiro EM, 2004, DEVELOPMENT, V131, P5243, DOI 10.1242/dev.01412; Ramachandran P, 2009, DEV NEUROBIOL, V69, P583, DOI 10.1002/dneu.20728; Ren XJ, 2013, P NATL ACAD SCI USA, V110, P19012, DOI 10.1073/pnas.1318481110; Rolls MM, 2003, J CELL BIOL, V163, P1089, DOI 10.1083/jcb.200306079; Sakurai A, 2006, MOL BIOL CELL, V17, P966, DOI 10.1091/mbc.E05-07-0647; Shewan A, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004796; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Stetak A, 2011, DEV BIOL, V350, P24, DOI 10.1016/j.ydbio.2010.10.026; Subauste MC, 2005, J BIOL CHEM, V280, P5676, DOI 10.1074/jbc.M405561200; Suzuki A, 2001, J CELL BIOL, V152, P1183, DOI 10.1083/jcb.152.6.1183; Tanemoto M, 2008, J BIOL CHEM, V283, P12241, DOI 10.1074/jbc.M707738200; Tanentzapf G, 2003, NAT CELL BIOL, V5, P46, DOI 10.1038/ncb896; TEPASS U, 1990, CELL, V61, P787, DOI 10.1016/0092-8674(90)90189-L; Thomas M, 2002, ONCOGENE, V21, P5088, DOI 10.1038/sj.onc.1205668; Tian AG, 2008, DEVELOPMENT, V135, P463, DOI 10.1242/dev.016253; Vidal M, 2006, CURR OPIN GENET DEV, V16, P10, DOI 10.1016/j.gde.2005.12.004; von Stein W, 2005, DEVELOPMENT, V132, P1675, DOI 10.1242/dev.01720; Warner SJ, 2010, CURR BIOL, V20, P677, DOI 10.1016/j.cub.2010.03.025; Wasserscheid I, 2007, DEV DYNAM, V236, P1064, DOI 10.1002/dvdy.21089; Wichmann A, 2010, DEV BIOL, V346, P80, DOI 10.1016/j.ydbio.2010.07.023; WIEGANDT H, 1992, BIOCHIM BIOPHYS ACTA, V1123, P117, DOI 10.1016/0005-2760(92)90101-Z; Wodarz A, 2000, J CELL BIOL, V150, P1361, DOI 10.1083/jcb.150.6.1361; Wodarz A, 1999, NATURE, V402, P544, DOI 10.1038/990128; Xu ZG, 2008, J NEUROSCI, V28, P11269, DOI 10.1523/JNEUROSCI.3833-08.2008; Yamada Y, 2008, DEVELOPMENT, V135, P207, DOI 10.1242/dev.010389; Yamagata M, 2010, J NEUROSCI, V30, P3579, DOI 10.1523/JNEUROSCI.6319-09.2010; Yu ZS, 2013, GENETICS, V195, P289, DOI 10.1534/genetics.113.153825; Zaessinger S, 2015, DEVELOPMENT, V142, P1102, DOI 10.1242/dev.116277; Zaric J, 2012, ONCOGENE, V31, P48, DOI 10.1038/onc.2011.218	82	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153259	10.1371/journal.pone.0153259	http://dx.doi.org/10.1371/journal.pone.0153259			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27074039	gold, Green Submitted, Green Published			2022-12-27	WOS:000374131200067
J	Doocy, S; Lyles, E; Akhu-Zaheya, L; Oweis, A; Al Ward, N; Burton, A				Doocy, Shannon; Lyles, Emily; Akhu-Zaheya, Laila; Oweis, Arwa; Al Ward, Nada; Burton, Ann			Health Service Utilization among Syrian Refugees with Chronic Health Conditions in Jordan	PLOS ONE			English	Article								Introduction The influx of Syrian refugees into Jordan presents an immense burden to the Jordanian health system, particularly in treating chronic health conditions. This study was undertaken to assess utilization of health services for chronic health conditions among Syrian refugees in non-camp settings. Methods A survey of Syrian refugees in Jordan was undertaken in June 2014 to characterize health seeking behaviors and issues related to accessing care for hypertension, diabetes, cardiovascular diseases, chronic respiratory diseases, and arthritis. A cluster design with probability proportional to size sampling was used to attain a nationally representative sample of 1550 non-camp Syrian refugee households. Results Of 1363 cases with a chronic health condition diagnosis, 84.7% had received care in Jordan. Public facilities faced a heavy burden serving over half (53.9%) of care-seekers; the remainder received care in the private (29.6%) and NGO/charity (16.6%) sectors. Individuals with non-communicable diseases (NCDs) in the central region of Jordan and with arthritis had the lowest rates of care-seeking when compared to other regions and conditions. Overall, 31.6% of care-seekers had an out-of-pocket payment for the most recent care-seeking event which averaged 18.8 USD (median = 0 USD), excluding cost of medications. Discussion Forced displacement presents major challenges to those with NCDs, which have the potential to seriously impact both the quality of life and life expectancy amongst refugees. NCD patterns among Syrian refugees indicate the importance of continuing support to public sector services in Jordan to adequately meet expanding needs and ensure appropriate prevention and control of priority NCDs.	[Doocy, Shannon; Lyles, Emily] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Akhu-Zaheya, Laila; Oweis, Arwa] Jordan Univ Sci & Technol, Irbid, Jordan; [Al Ward, Nada] World Hlth Org, Amman, Jordan; [Burton, Ann] United Nations High Commissioner Refugees, Amman, Jordan	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Jordan University of Science & Technology; World Health Organization	Doocy, S (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA.	doocy1@jhu.edu			World Health Organization	World Health Organization(World Health Organization)	World Health Organization funded this project. They provided technical support for the study's design and data collection.	Assessment Capacities Project (ACAPS), 2014, REG AN SYR 2; Demaio A., 2013, PLOS CURR, V5, DOI [10.1371/currents.dis.53e08b951d59ff913ab8b9bb51c4d0de, DOI 10.1371/CURRENTS.DIS.53E08B951D59FF913AB8B9BB51C4D0DE]; HelpAge International and Handicap International, 2014, HIDD VICT SYR CRIS D; Integrated Regional Information Networks (IRIN), 2010, SYR NEW LAW CURB SMO; International Labour Organization, 2021, ASS INF VULN DIS GRO; International Medical Corps (IMC), 2013, POP BAS HLTH ASS SYR; Lorig KR, 2001, MED CARE, V39, P1217, DOI 10.1097/00005650-200111000-00008; Spiegel P, 2010, FORCED MIG REV, P34; The Hashemite Kingdom of Jordan . Ministry of Planning and International Cooperation , 2014, JORD RESP PLAN 2015; The World Bank, OFF EXCH RAT LCU PER; UNHCR, 2015, WORLD WAR UNHCR GLOB; United Nations High Commissioner for Refugees (UNCHR), 2014, GLOB STRAT PUBL HLTH; United Nations High Commissioner for Refugees (UNHCR), 2013, GUID INHCR SUPP HLTH; United Nations High Commissioner for Refugees (UNHCR), 2015, EXT STAT REP ACT REG; United Nations High Commissioner for Refugees (UNHCR), 2015, SYR REG RESP; World Bank, 2002, SMOK PREV SYR AR REP; World Health Organization, 2014, NONC DIS NCD COUNTR	17	41	41	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0150088	10.1371/journal.pone.0150088	http://dx.doi.org/10.1371/journal.pone.0150088			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073930	Green Published, gold, Green Submitted			2022-12-27	WOS:000374131200003
J	Veulemans, V; Zeus, T; Kleinebrecht, L; Balzer, J; Hellhammer, K; Polzin, A; Horn, P; Blehm, A; Minol, JP; Kropil, P; Westenfeld, R; Rassaf, T; Lichtenberg, A; Kelm, M				Veulemans, Verena; Zeus, Tobias; Kleinebrecht, Laura; Balzer, Jan; Hellhammer, Katharina; Polzin, Amin; Horn, Patrick; Blehm, Alexander; Minol, Jan-Philipp; Kroepil, Patric; Westenfeld, Ralf; Rassaf, Tienush; Lichtenberg, Artur; Kelm, Malte			Comparison of Manual and Automated Preprocedural Segmentation Tools to Predict the Annulus Plane Angulation and C-Arm Positioning for Transcatheter Aortic Valve Replacement	PLOS ONE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; ACUTE KIDNEY INJURY; COMPUTED-TOMOGRAPHY; IMPLANTATION; SOFTWARE; ROOT; PROSTHESIS; PROJECTION; SELECTION; STENOSIS	Background Preprocedural manual multi-slice-CT-segmentation tools (MSCT-ST) define the gold standard for planning transcatheter aortic valve replacement (TAVR). They are able to predict the perpendicular line of the aortic annulus (PPL) and to indicate the corresponding C-arm angulation (CAA). Fully automated planning-tools and their clinical relevance have not been systematically evaluated in a real world setting so far. Methods and Results The study population consists of an all-comers cohort of 160 consecutive TAVR patients with a drop out of 35 patients for technical and anatomical reasons. 125 TAVR patients underwent preprocedural analysis by manual (M-MSCT) and fully automated MSCT-ST (A-MSCT). Method-comparison was performed for 105 patients (Cohort A). In Cohort A, CAA was defined for each patient, and accordance within 10 degrees between M-MSCT and A-MSCT was considered adequate for concept-proof (95% in LAO/RAO; 94% in CRAN/CAUD). Intraprocedural CAA was defined by repetitive angiograms without utilizing the preprocedural measurements. In Cohort B, intraprocedural CAA was established with the use of AMSCT (20 patients). Using preprocedural A-MSCT to indicate the corresponding CAA, the levels of contrast medium (ml) and radiation exposure (cine runs) were reduced in Cohort B compared to Cohort A significantly (23.3 +/- 10.3 vs. 35.3 +/- 21.1 ml, p = 0.02; 1.6 +/- 0.7 vs. 2.4 +/- 1.4 cine runs; p = 0.02) and trends towards more safety in valve-positioning could be demonstrated. Conclusions A-MSCT-analysis provides precise preprocedural information on CAA for optimal visualization of the aortic annulus compared to the M-MSCT gold standard. Intraprocedural application of this information during TAVR significantly reduces the levels of contrast and radiation exposure.	[Veulemans, Verena; Zeus, Tobias; Kleinebrecht, Laura; Balzer, Jan; Hellhammer, Katharina; Polzin, Amin; Horn, Patrick; Westenfeld, Ralf; Rassaf, Tienush; Kelm, Malte] Univ Hosp Dusseldorf, Dept Med, Pulm Dis, Div Cardiol, Dusseldorf, Germany; [Blehm, Alexander; Minol, Jan-Philipp; Lichtenberg, Artur] Univ Hosp Dusseldorf, Clin Cardiovasc Surg, Fac Med, Dusseldorf, Germany; [Kroepil, Patric] Univ Hosp Dusseldorf, Inst Radiol, Dusseldorf, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital	Veulemans, V (corresponding author), Univ Hosp Dusseldorf, Dept Med, Pulm Dis, Div Cardiol, Dusseldorf, Germany.	Verena.Veulemanns@med.uni-duesseldorf.de		Kelm, Malte/0000-0003-0060-1052	federal state government of North-Rhine-Westphalia; European Union (EFRE-Program "Med in NRW", Germany) [005-GW01-235A]; German Research Foundation (DFG; Germany) [RA 969/7-2]	federal state government of North-Rhine-Westphalia; European Union (EFRE-Program "Med in NRW", Germany); German Research Foundation (DFG; Germany)(German Research Foundation (DFG))	The study was supported with a restricted grant from the federal state government of North-Rhine-Westphalia and European Union (EFRE-Program "Med in NRW", support code 005-GW01-235A, Germany); T.R. is a Heisenberg professor, funded by the German Research Foundation (DFG; RA 969/7-2, Germany).	Achenbach S, 2012, J CARDIOVASC COMPUT, V6, P366, DOI 10.1016/j.jcct.2012.11.002; Ando G, 2014, CIRC-CARDIOVASC INTE, V7, P465, DOI 10.1161/CIRCINTERVENTIONS.114.001545; Arnold M, 2012, J CARDIOVASC COMPUT, V6, P422, DOI 10.1016/j.jcct.2012.10.008; Binder RK, 2012, CIRC-CARDIOVASC INTE, V5, P247, DOI 10.1161/CIRCINTERVENTIONS.111.966531; Celik O, 2015, ANGIOLOGY, V66, P519, DOI 10.1177/0003319714542277; Cribier A, 2004, J AM COLL CARDIOL, V43, P698, DOI 10.1016/j.jacc.2003.11.026; del Valle-Fernandez R, 2010, EUR HEART J, V31, P2170, DOI 10.1093/eurheartj/ehq093; Delgado Victoria, 2010, Expert Rev Cardiovasc Ther, V8, P113, DOI 10.1586/erc.09.135; Dvir D, 2010, CATHETER CARDIO INTE, V76, P450, DOI 10.1002/ccd.22362; Kasel AM, 2013, JACC-CARDIOVASC IMAG, V6, P249, DOI 10.1016/j.jcmg.2012.12.005; Kurra V, 2010, JACC-CARDIOVASC INTE, V3, P105, DOI 10.1016/j.jcin.2009.10.014; Leon MB, 2011, EUR HEART J, V32, P205, DOI 10.1093/eurheartj/ehq406; Leon MB, 2010, NEW ENGL J MED, V363, P1597, DOI 10.1056/NEJMoa1008232; Lou J, 2015, J CARDIOVASC COMPUT, V9, P42, DOI 10.1016/j.jcct.2014.11.003; Nishimura RA, 2014, J THORAC CARDIOV SUR, V148, pE1, DOI 10.1016/j.jtcvs.2014.05.014; Rosset A, 2004, J DIGIT IMAGING, V17, P205, DOI 10.1007/s10278-004-1014-6; Samim M, 2013, JACC-CARDIOVASC IMAG, V6, P238, DOI 10.1016/j.jcmg.2012.12.004; Schultz C, 2010, EUROINTERVENTION, V6, P505, DOI 10.4244/EIJ30V6I4A84; Smith CR, 2011, NEW ENGL J MED, V364, P2187, DOI 10.1056/NEJMoa1103510; Tuzcu EM, 2008, CATHETER CARDIO INTE, V72, P579, DOI 10.1002/ccd.21788; Tzikas A, 2010, CATHETER CARDIO INTE, V76, P602, DOI 10.1002/ccd.22641; Vaitkus PT, 2014, J INVASIVE CARDIOL, V26, P328	22	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0151918	10.1371/journal.pone.0151918	http://dx.doi.org/10.1371/journal.pone.0151918			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073910	gold, Green Published			2022-12-27	WOS:000374131200011
J	Fox, L; Walsh, JC; Morrison, TG; O' Gorman, D; Ruane, N; Mitchell, C; Carey, JJ; Coughlan, R; McGuire, BE				Fox, Lisa; Walsh, Jane C.; Morrison, Todd G.; O' Gorman, David; Ruane, Nancy; Mitchell, Caroline; Carey, John J.; Coughlan, Robert; McGuire, Brian E.			Cognitive Coping Style and the Effectiveness of Distraction or Sensation-Focused Instructions in Chronic Pain Patients	PLOS ONE			English	Article							SELF-EFFICACY BELIEFS; CHRONIC BACK-PAIN; FEAR-AVOIDANCE; TRAIT ANXIETY; META-ANALYSIS; ATTENTION; QUESTIONNAIRE; EXPECTANCIES; PERCEPTION; STRATEGIES	Aim This study set out to investigate whether cognitive coping strategies that match participants' preferred coping style effectively reduce pain intensity and situational anxiety in a population of people with chronic pain. Method Chronic pain patients (N = 43) completed questionnaires on coping style, pain intensity, self-efficacy, and situational/trait anxiety. Participants were classified as Monitors (n = 16) or Blunters (n = 19) based on their Miller Behavioural Style Scale score. Participants were then provided with an audiotaped intervention in which they were instructed to focus on pain sensations or to engage in a distraction task and then to rate the pain intensity and their anxiety during and after the attentional focus and distraction conditions. The two interventions were each completed by all participants, having been presented in counterbalanced order. Results Findings revealed that Monitors' level of anxiety decreased following a congruent (i.e., sensation-focused) intervention. No effects were obtained in terms of perceived pain. For blunters, however, their perceived levels of anxiety and pain did not attenuate following a congruent, distraction-focused intervention. Conclusion Among persons experiencing chronic pain, tailoring coping strategies to match an individual's preferred coping style-in particular, those with a high level of monitoring-may enhance the benefit of psychological approaches to management of anxiety.	[Fox, Lisa; Walsh, Jane C.; McGuire, Brian E.] Natl Univ Ireland, Sch Psychol, Galway, Ireland; [Morrison, Todd G.] Univ Saskatchewan, Dept Psychol, Saskatoon, SK S7N 0W0, Canada; [O' Gorman, David; Ruane, Nancy; Mitchell, Caroline; McGuire, Brian E.] Natl Univ Ireland, Ctr Pain Res, Galway, Ireland; [O' Gorman, David; Ruane, Nancy; Mitchell, Caroline] Galway Univ Hosp, Div Pain Med, Galway, Ireland; [Carey, John J.; Coughlan, Robert] Galway Univ Hosp, Dept Rheumatol, Galway, Ireland; [Carey, John J.; Coughlan, Robert] Natl Univ Ireland, Sch Med, Galway, Ireland	Ollscoil na Gaillimhe-University of Galway; University of Saskatchewan; Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway	McGuire, BE (corresponding author), Natl Univ Ireland, Sch Psychol, Galway, Ireland.; McGuire, BE (corresponding author), Natl Univ Ireland, Ctr Pain Res, Galway, Ireland.	brian.mcguire@nuigalway.ie	Carey, John/AAF-5461-2019; Walsh, Jane/AAP-6870-2021	Walsh, Jane/0000-0001-5476-1348; Carey, John/0000-0001-7292-2328; Morrison, Todd/0000-0001-8033-3822				Antony MM, 2001, BEHAV RES THER, V39, P1137; ARNTZ A, 1994, PAIN, V56, P307, DOI 10.1016/0304-3959(94)90169-4; Asghari A, 2001, PAIN, V94, P85, DOI 10.1016/S0304-3959(01)00344-X; Barnes LLB, 2002, EDUC PSYCHOL MEAS, V62, P603, DOI 10.1177/0013164402062004005; BIEDERMAN JJ, 1994, BEHAV MODIF, V18, P89; BROWN GK, 1987, PAIN, V31, P53, DOI 10.1016/0304-3959(87)90006-6; Claes N, 2015, PAIN, V156, P1449, DOI 10.1097/j.pain.0000000000000116; CORNWALL A, 1988, PAIN, V35, P105, DOI 10.1016/0304-3959(88)90282-5; COUNCIL JR, 1988, PAIN, V33, P323, DOI 10.1016/0304-3959(88)90291-6; DOLCE JJ, 1986, PAIN, V24, P365, DOI 10.1016/0304-3959(86)90122-3; ECCLESTON C, 1995, BEHAV RES THER, V33, P391, DOI 10.1016/0005-7967(94)00057-Q; Forys KL, 2007, HEALTH PSYCHOL, V26, P22, DOI 10.1037/0278-6133.26.1.22; Gatchel R., 2002, PSYCHOL APPROACHES P; Gibson L, 1996, J OCCUP REHABIL, V6, P159, DOI 10.1007/BF02110753; Harvey AG, 2000, BEHAV RES THER, V38, P1117, DOI 10.1016/S0005-7967(99)00150-3; Hilzenrat N, 2006, CAN J GASTROENTEROL, V20, P597, DOI 10.1155/2006/610489; James JE, 2002, BRIT J HEALTH PSYCH, V7, P149, DOI 10.1348/135910702169411; JENSEN MP, 1991, PAIN, V44, P263, DOI 10.1016/0304-3959(91)90095-F; Kabat-Zinn J, 1984, REVISIONS, V7, P66; Keogh E, 2002, PAIN, V97, P195, DOI 10.1016/S0304-3959(01)00427-4; Kerns RD, 2014, HEALTH PSYCHOL, V33, P938, DOI 10.1037/a0034406; Legrain V, 2009, PAIN, V144, P230, DOI 10.1016/j.pain.2009.03.020; LETHEM J, 1983, BEHAV RES THER, V21, P401, DOI 10.1016/0005-7967(83)90009-8; MARTELLI MF, 1987, J CONSULT CLIN PSYCH, V55, P201, DOI 10.1037/0022-006X.55.2.201; MCCAUL KD, 1984, PSYCHOL BULL, V95, P516, DOI 10.1037/0033-2909.95.3.516; MELZACK R, 1965, SCIENCE, V150, P971, DOI 10.1126/science.150.3699.971; MILLER SM, 1987, J PERS SOC PSYCHOL, V52, P345, DOI 10.1037/0022-3514.52.2.345; Moriarty O, 2011, PROG NEUROBIOL, V93, P385, DOI 10.1016/j.pneurobio.2011.01.002; MULLEN B, 1982, J PSYCHOSOM RES, V26, P43, DOI 10.1016/0022-3999(82)90061-7; Nicholas MK, 2007, EUR J PAIN, V11, P153, DOI 10.1016/j.ejpain.2005.12.008; Nicholas MK, 1989, ANN C BRIT PSYCH SOC; Nordin K, 2002, J MED GENET, V39, P689, DOI 10.1136/jmg.39.9.689; Price DD, 2001, HDB PAIN ASSESSMENT, P53; Sarda J, 2007, STRESS HEALTH, V23, P185, DOI 10.1002/smi.1135; Spielberger C. D., 1973, MANUAL STATE TRAIT I; SULS J, 1985, HEALTH PSYCHOL, V4, P249, DOI 10.1037/0278-6133.4.3.249; Turk DC, 1987, PAIN BEHAV MED COGNI; Van Damme S, 2010, NEUROSCI BIOBEHAV R, V34, P204, DOI 10.1016/j.neubiorev.2009.01.005; Verhoeven K, 2010, PAIN, V149, P229, DOI 10.1016/j.pain.2010.01.019; Vlaeyen JWS, 2000, PAIN, V85, P317, DOI 10.1016/S0304-3959(99)00242-0; Williamson A, 2005, J CLIN NURS, V14, P798, DOI 10.1111/j.1365-2702.2005.01121.x; Wright DB, 2003, BRIT J EDUC PSYCHOL, V73, P123, DOI 10.1348/000709903762869950	42	6	8	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0142285	10.1371/journal.pone.0142285	http://dx.doi.org/10.1371/journal.pone.0142285			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ0NI	27071028	Green Published, gold, Green Submitted			2022-12-27	WOS:000373900700001
J	Otto, S; Pappalardo, SE; Cardinali, A; Masin, R; Zanin, G; Borin, M				Otto, Stefan; Pappalardo, Salvatore E.; Cardinali, Alessandra; Masin, Roberta; Zanin, Giuseppe; Borin, Maurizio			Vegetated Ditches for the Mitigation of Pesticides Runoff in the Po Valley	PLOS ONE			English	Article							AGRICULTURAL DRAINAGE DITCHES; LAMBDA-CYHALOTHRIN; MISSISSIPPI DELTA; HERBICIDE RUNOFF; FUGACITY MODEL; SURFACE WATERS; LANDSCAPES; MESOTRIONE; FATE; SULCOTRIONE	In intensive agricultural systems runoff is one of the major potential diffuse pollution pathways for pesticides and poses a risk to surface water. Ditches are common in the Po Valley and can potentially provide runoff mitigation for the protection of watercourses. The effectiveness depends on ditch characteristics, so there is an urgent need for site-specific field trials. The use of a fugacity model (multimedia model) can allows recognition of the mitigation main processes. A field experiment was conducted in order to evaluate the mitigation capacity of a typical vegetated ditch, and results were compared with predictions by a fugacity model. To evaluate herbicide mitigation after an extreme runoff, the ditch was flooded with water containing mesotrione, S-metolachlor and terbuthylazine. Two other subsequent floods with uncontaminated water were applied 27 and 82 days later to evaluate herbicides release. Results show that the ditch can immediately reduce runoff concentration of herbicides by at least 50% even in extreme flooding conditions. The half-distances were about 250 m. As a general rule, a runoff of 1 mm from 5 ha is mitigated by 99% in 100 m of vegetated ditch. Herbicides retention in the vegetated ditch was reversible, and the second flood mobilized 0.03-0.2% of the previous one, with a concentration below the drinking water limit of 0.1 mu g L-1. No herbicide was detected in the third flood, because the residual amount in the ditch was too low. Fugacity model results show that specific physical-chemical parameters may be used and a specific soil-sediment-plant compartment included for modelling herbicides behaviour in a vegetated ditch, and confirm that accumulation is low or negligible for herbicides with a half-life of 40 days or less. Shallow vegetated ditches can thus be included in a general agri-environment scheme for the mitigation of pesticides runoff together with wetlands and linear buffer strips. These structures are present in the landscape, and their environmental role can be exploited by proper management.	[Otto, Stefan] CNR, Inst Agroenvironm & Forest Biol, Viale Univ 16, Legnaro, PD, Italy; [Pappalardo, Salvatore E.; Cardinali, Alessandra; Masin, Roberta; Zanin, Giuseppe; Borin, Maurizio] Univ Padua, Dept Agron Food Nat Resources Anim & Environm, Viale Univ 16, Legnaro, PD, Italy	Consiglio Nazionale delle Ricerche (CNR); University of Padua	Otto, S (corresponding author), CNR, Inst Agroenvironm & Forest Biol, Viale Univ 16, Legnaro, PD, Italy.	stefan.otto@ibaf.cnr.it	borin, maurizio/AAY-1399-2021	Otto, Stefan/0000-0002-4341-8517; borin, maurizio/0000-0002-4074-2098	GRIMiCID project, within the Plan for the Rural Development (Piano per lo Sviluppo Rurale, PSR Misura 124) of the Veneto Region	GRIMiCID project, within the Plan for the Rural Development (Piano per lo Sviluppo Rurale, PSR Misura 124) of the Veneto Region	This research was conducted with financial support of GRIMiCID project 2013-2015, within the Plan for the Rural Development (Piano per lo Sviluppo Rurale, PSR Misura 124) of the Veneto Region.; This research was conducted with financial support of GRIMiCID project 2013-2015, within the Plan for the Rural Development (Piano per lo Sviluppo Rurale, PSR Misura 124) of the Veneto Region.	Aslam S, 2013, CHEMOSPHERE, V91, P1447, DOI 10.1016/j.chemosphere.2012.12.005; Barchanska H, 2012, ENVIRON MONIT ASSESS, V184, P321, DOI 10.1007/s10661-011-1970-5; Bennett ER, 2005, ENVIRON TOXICOL CHEM, V24, P2121, DOI 10.1897/04-357R.1; Bereswill R, 2012, AGR ECOSYST ENVIRON, V146, P81, DOI 10.1016/j.agee.2011.10.010; Boithias L, 2014, CHEMOSPHERE, V99, P134, DOI 10.1016/j.chemosphere.2013.10.050; Bouldin JL, 2004, ENVIRON POLLUT, V132, P403, DOI 10.1016/j.envpol.2004.05.026; CALAMARI D, 1987, CHEMOSPHERE, V16, P2359, DOI 10.1016/0045-6535(87)90293-1; Caracciolo A. Barra, 2005, Environmental Pollution, V134, P525; Cardinali A, 2013, INT J ENVIRON AN CH, V93, P1628, DOI 10.1080/03067319.2013.841151; Chaabane H, 2008, PEST MANAG SCI, V64, P86, DOI 10.1002/ps.1456; Cooper CM, 2004, WATER SCI TECHNOL, V49, P117, DOI 10.2166/wst.2004.0176; DI GUARDO A, 1994, CHEMOSPHERE, V28, P511, DOI 10.1016/0045-6535(94)90295-X; Fava L, 2007, MICROCHEM J, V86, P204, DOI 10.1016/j.microc.2007.03.003; Freitas LG, 2004, J CHROMATOGR A, V1028, P277, DOI 10.1016/j.chroma.2003.11.094; Ghirardello D, 2014, ENVIRON POLLUT, V184, P502, DOI 10.1016/j.envpol.2013.10.002; Gregoire C, 2009, ENVIRON CHEM LETT, V7, P205, DOI 10.1007/s10311-008-0167-9; Hackett M, MULTIFUNCTIONAL ROLE; Hand LH, 2001, ENVIRON TOXICOL CHEM, V20, P1740, DOI [10.1897/1551-5028(2001)020&lt;1740:IOAPOT&gt;2.0.CO;2, 10.1002/etc.5620200817]; Herzon I, 2008, BIOL CONSERV, V141, P1171, DOI 10.1016/j.biocon.2008.03.005; Laabs V, 2000, CHEMOSPHERE, V41, P1441, DOI 10.1016/S0045-6535(99)00546-9; Macbean C., 2012, ENDOSULFAN PESTICIDE, V16th, P414; MACKAY D, 1982, ENVIRON SCI TECHNOL, V16, pA654, DOI 10.1021/es00106a724; MacLeod M, 2010, ENVIRON SCI TECHNOL, V44, P8360, DOI [10.1021/es100968w, 10.1021/es103297w]; Mahabali S, 2014, WATER AIR SOIL POLL, V225, DOI 10.1007/s11270-013-1771-2; Merlin G, 2002, ENVIRON TOXICOL CHEM, V21, P1236, DOI [10.1897/1551-5028(2002)021<1236:FABOII>2.0.CO;2, 10.1897/1551-5028(2002)021&lt;1236:FABOII&gt;2.0.CO;2]; Moore MT, 2008, J ENVIRON QUAL, V37, P486, DOI 10.2134/jeq2007.0172; Moore MT, 2001, AGR ECOSYST ENVIRON, V87, P309, DOI 10.1016/S0167-8809(01)00148-7; Morselli M, 2015, SCI TOTAL ENVIRON, V526, P338, DOI 10.1016/j.scitotenv.2015.04.072; Otto S, 2008, CHEMOSPHERE, V71, P74, DOI 10.1016/j.chemosphere.2007.10.029; Otto S, 2015, J ENVIRON MANAGE, V162, P290, DOI 10.1016/j.jenvman.2015.07.060; Otto S, 2012, CHEMOSPHERE, V88, P113, DOI 10.1016/j.chemosphere.2012.02.081; Pappalardo SE, 2016, HYDROBIOLOGIA, V774, P193, DOI 10.1007/s10750-015-2375-1; Tomlin C.D.S., 2006, PESTICIDE MANUAL; Tournebize J, 2013, ECOL ENG, V56, P52, DOI 10.1016/j.ecoleng.2012.06.001; Vymazal J, 2015, ENVIRON INT, V75, P11, DOI 10.1016/j.envint.2014.10.026; Zhang XY, 2011, SCI TOTAL ENVIRON, V409, P1949, DOI 10.1016/j.scitotenv.2011.02.012; Zollo LA, 2015, INT J CLIMA IN PRESS	37	18	18	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0153287	10.1371/journal.pone.0153287	http://dx.doi.org/10.1371/journal.pone.0153287			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27070781	Green Published, Green Submitted, gold			2022-12-27	WOS:000373900700047
J	Pan, YS; Wang, YJ; Li, H; Gaisano, HY; Wang, YL; He, Y				Pan, Yuesong; Wang, Yongjun; Li, Hao; Gaisano, Herbert Y.; Wang, Yilong; He, Yan			Association of Diabetes and Prognosis of Minor Stroke and Its Subtypes: A Prospective Observational Study	PLOS ONE			English	Article							ISCHEMIC-STROKE; RISK-FACTORS; SECONDARY PREVENTION; ARTERIAL STIFFNESS; CLOPIDOGREL; RECURRENCE; INSIGHTS; TIA	Background The association between diabetes mellitus (DM) and prognosis of minor stroke is unclear. The aim of this study is to investigate whether DM contributes to the prognosis of minor stroke or its specific subtype. Methods All minor ischemic stroke patients were derived from the China National Stroke Registry and classified into 5 subtypes according to the TOAST (Trial of Org 10172 in Acute Stroke Treatment) criteria. DM was defined as either self-reported physician diagnosis of diabetes or use of hypoglycemic medications during hospitalization or at discharge. Patients were followed up for 1 year for clinical outcomes of recurrent stroke, death and functional outcome. Poor functional outcomes were defined as a score of 2-6 for modified Rankin Score. Associations between DM and prognosis of minor stroke and its subtypes were analyzed by univariable and multivariable logistic regression. Results Of 4,548 patients with minor stroke, 1,230(27.0%) patients had DM, 1,038(22.8%) had poor outcomes and 570(13.0%) of 4,401 patients had recurrent stroke at 1 year. In multivariable analyses, DM were significantly associated with 1-year stroke recurrence (Odds Ratio [OR], 1.31; 95% confidence interval [CI]: 1.08-1.59) and poor outcome (OR, 1.51; 95% CI: 1.28-1.77). Among the subtypes of minor stroke, DM was only significantly associated with 1-year stroke recurrence (OR, 1.63; 95% CI: 1.07-2.50) and poor outcome (OR, 1.73; 95% CI: 1.22-2.45) in the small-artery occlusion subtype. Conclusions DM significantly increased the risk of stroke recurrence and poor outcome in the small-artery occlusion subtype, but not in other subtypes of minor stroke.	[Pan, Yuesong; He, Yan] Capital Med Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Beijing, Peoples R China; [Pan, Yuesong; He, Yan] Beijing Municipal Key Lab Clin Epidemiol, Beijing, Peoples R China; [Wang, Yongjun; Li, Hao; Wang, Yilong] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Beijing, Peoples R China; [Wang, Yongjun; Li, Hao; Wang, Yilong] China Natl Clin Res Ctr Neurol Dis, Beijing, Peoples R China; [Wang, Yongjun; Li, Hao; Wang, Yilong] Beijing Inst Brain Disorders, Ctr Stroke, Beijing, Peoples R China; [Wang, Yongjun; Li, Hao; Wang, Yilong] Beijing Key Lab Translat Med Cerebrovasc Dis, Beijing, Peoples R China; [Gaisano, Herbert Y.] Univ Toronto, Dept Physiol, Toronto, ON, Canada	Capital Medical University; Capital Medical University; University of Toronto	He, Y (corresponding author), Capital Med Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Beijing, Peoples R China.; He, Y (corresponding author), Beijing Municipal Key Lab Clin Epidemiol, Beijing, Peoples R China.; Wang, YL (corresponding author), Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Beijing, Peoples R China.; Wang, YL (corresponding author), China Natl Clin Res Ctr Neurol Dis, Beijing, Peoples R China.; Wang, YL (corresponding author), Beijing Inst Brain Disorders, Ctr Stroke, Beijing, Peoples R China.; Wang, YL (corresponding author), Beijing Key Lab Translat Med Cerebrovasc Dis, Beijing, Peoples R China.	yilong528@gmail.com; yanhe118@sina.com	Pan, Yuesong/AAI-6303-2020; Li, Hao/GPS-9834-2022	Pan, Yuesong/0000-0003-3082-6789; 	Ministry of Science and Technology of the People's Republic of China [2006BAI01A11, 2011BAI08B01, 2011BAI08B02, 2012ZX09303-005-001, 2013BAI09B03, 2015BAI09B01]; Beijing Biobank of Cerebral Vascular Disease [D131100005313003]; Beijing Institute for Brain Disorders [BIBD-PXM2013_014226_07_000084]	Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); Beijing Biobank of Cerebral Vascular Disease; Beijing Institute for Brain Disorders	This study is supported by grants from the Ministry of Science and Technology of the People's Republic of China (2006BAI01A11, 2011BAI08B01, 2011BAI08B02, 2012ZX09303-005-001, 2013BAI09B03 and 2015BAI09B01), a grant from the Beijing Biobank of Cerebral Vascular Disease (D131100005313003), and a grant from Beijing Institute for Brain Disorders (BIBD-PXM2013_014226_07_000084).	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; [Anonymous], 1989, STROKE, V20, P1407; Aquil N, 2011, JCPSP-J COLL PHYSICI, V21, P280, DOI 05.2011/JCPSP.280283; Bejot Y, 2008, J NEUROL NEUROSUR PS, V79, P1344, DOI 10.1136/jnnp.2008.150318; Chandratheva A, 2011, STROKE, V42, P632, DOI 10.1161/STROKEAHA.110.593301; Diener HC, 2005, EXPERT OPIN PHARMACO, V6, P755, DOI 10.1517/14656566.6.5.755; Dong Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131487; Ferrari J, 2010, NEUROLOGY, V74, P136, DOI 10.1212/WNL.0b013e3181c9188b; Gunarathne A, 2009, STROKE, V40, P2298, DOI 10.1161/STROKEAHA.109.548388; Hankey GJ, 2013, J NEUROL NEUROSUR PS, V84, P281, DOI 10.1136/jnnp-2012-303365; Jia Q, 2011, STROKE, V42, P2758, DOI 10.1161/STROKEAHA.111.621649; Johnston SC, 2007, LANCET, V369, P283, DOI 10.1016/S0140-6736(07)60150-0; Laurencin C, 2015, CEREBROVASC DIS, V40, P3, DOI 10.1159/000381866; Liou CW, 2008, EUR J NEUROL, V15, P802, DOI 10.1111/j.1468-1331.2008.02181.x; Merwick A, 2010, LANCET NEUROL, V9, P1060, DOI 10.1016/S1474-4422(10)70240-4; Palacio S, 2014, STROKE, V45, P2689, DOI 10.1161/STROKEAHA.114.005018; Saad MI, 2015, ENDOCRINE, V50, P537, DOI 10.1007/s12020-015-0709-4; Saeed M, 2004, STROKE, V35, P824, DOI 10.1161/01.STROKE.0000121646.23955.0f; Sato S, 2014, NEUROLOGY, V83, P174, DOI 10.1212/WNL.0000000000000572; Shou J, 2015, J STROKE CEREBROVASC, V24, P1961, DOI 10.1016/j.jstrokecerebrovasdis.2015.04.004; Tsai CF, 2015, INT J STROKE, V10, P485, DOI 10.1111/ijs.12508; Tuttolomondo A, 2012, ATHEROSCLEROSIS, V225, P216, DOI 10.1016/j.atherosclerosis.2012.08.027; Wang XW, 2015, NEUROLOGY, V85, P573, DOI 10.1212/WNL.0000000000001844; Wang YL, 2013, STROKE, V44, P1232, DOI 10.1161/STROKEAHA.111.000302; Wang YJ, 2011, INT J STROKE, V6, P355, DOI 10.1111/j.1747-4949.2011.00584.x; Wu LY, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0505-z; Xu Y, 2013, JAMA-J AM MED ASSOC, V310, P948, DOI 10.1001/jama.2013.168118; Zhang CQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120105	28	15	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0153178	10.1371/journal.pone.0153178	http://dx.doi.org/10.1371/journal.pone.0153178			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27070309	Green Published, gold			2022-12-27	WOS:000373900700036
J	Weissman, A; Ngak, S; Srean, C; Sansothy, N; Mills, S; Ferradini, L				Weissman, Amy; Ngak, Song; Srean, Chhim; Sansothy, Neth; Mills, Stephen; Ferradini, Laurent			HIV Prevalence and Risks Associated with HIV Infection among Transgender Individuals in Cambodia	PLOS ONE			English	Article							SUBSTANCE USE; SEXUAL RISK; WOMEN; BEHAVIORS; POWER; INTERVENTIONS; GENDER; LIFE	Introduction Recognizing transgender individuals have a high risk of HIV acquisition, and to inform policies and programming, we conducted an HIV prevalence and risk behaviors survey among transgender individuals in Cambodia. Methods Cross-sectional survey using a respondent driven sampling method with self-administered audio-computer assisted interviews. HIV testing was performed prior to the questionnaire with results available immediately after. Eligible participants were >= 18 years, identified as male at birth and self-identified/expressed as a different gender, and reported having sex with at least one male partner in past year. From six major urban centers of Cambodia, 891 transgender individuals were recruited. Results The majority of the 891 participants self-identified as third gender or female (94.5%), were young (median age 23, IQR [20-27]), had secondary education or higher (80.5%), not married (89.7%), and employed (90.2%). The majority had first sex before 18 years (66.8%), with a male (79.9%), 37.9% having been paid or paying for this first sex. The rate of HIV positivity among participants was found to be 4.15%. Consistent condom use with male and female partners was low with all partner types, but particularly low with male partners when paying for sex (20.3%). The majority of participants reported having experienced discrimination in their lifetime (54.8%) and 30.3% had been assaulted. Multivariate analysis revealed that older age (adjusted OR = 14.73 [4.20, 51.67] for age 35-44 and adjusted OR = 7.63 [2.55, 22.81] for age 30-34), only having a primary school education or no schooling at all (adjusted OR = 2.62 [1.18, 5.80], being a resident of Siem Reap (adjusted OR = 7.44 [2.37,23.29], receiving payment at first sex (adjusted OR = 2.26 [1.00, 5.11], having sex during/after using drugs (adjusted OR = 2.90 [1.09,7.73]), inconsistent condom use during last anal sex (adjusted OR = 3.84 [1.58, 9.33]), and reporting low self-esteem (adjusted OR = 3.25 [1.35,7.85]) were independently associated with HIV infection. Conclusions This study confirms transgender individuals as one of the highest-risk groups for HIV infection in Cambodia. It suggests the need for programmatic strategies that mitigate identified associated risks and facilitate access to HIV care for this population.	[Weissman, Amy; Ngak, Song; Srean, Chhim; Ferradini, Laurent] FHI 360, Phnom Penh, Cambodia; [Mills, Stephen] FHI 360, Bangkok, Thailand; [Sansothy, Neth] Natl Ctr HIV AIDS Dermatol & Sexually Transmitted, Phnom Penh, Cambodia; [Sansothy, Neth] Univ Hlth Sci, Phnom Penh, Cambodia; [Weissman, Amy] Save Children, Viangchan, Laos; [Mills, Stephen] WHO, Phnom Penh, Cambodia	Save the Children; World Health Organization	Weissman, A (corresponding author), FHI 360, Phnom Penh, Cambodia.; Weissman, A (corresponding author), Save Children, Viangchan, Laos.	aweissman@savechildren.org	; Chhim, Srean/E-8829-2016	Weissman, Amy/0000-0003-2510-3500; Chhim, Srean/0000-0003-1558-1875	President's Emergency Plan for AIDS Relief (PEPFAR) through the United States Agency for International Development (USAID) [GHS-1-00-07-00007-00, FHI 360]; USAID LINKAGES Project [AID-OAA-14-00045]	President's Emergency Plan for AIDS Relief (PEPFAR) through the United States Agency for International Development (USAID)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); USAID LINKAGES Project(United States Agency for International Development (USAID))	This research was supported by the President's Emergency Plan for AIDS Relief (PEPFAR) through the United States Agency for International Development (USAID) in Cambodia Contract No. GHS-1-00-07-00007-00 with FHI 360. Further support was provided by the USAID LINKAGES Project Cooperative Agreement No. AID-OAA-14-00045 to FHI 360. The content of this article does not necessarily reflect the views of USAID, the United States Government, nor FHI 360. The study was conducted by FHI 360 in collaboration with NCHADS under the PRASIT project.	Baral SD, 2013, LANCET INFECT DIS, V13, P214, DOI 10.1016/S1473-3099(12)70315-8; Chhorvann C, 2007, BEHAV SURVEILLANCE S; FELMLEE DH, 1994, SEX ROLES, V31, P275, DOI 10.1007/BF01544589; FHI 360, 2000, BEH SURV SURV BSS GU; Girault P, 2004, AIDS EDUC PREV, V16, P31, DOI 10.1521/aeap.16.1.31.27727; Harvey SM, 2002, WOMEN HEALTH, V36, P69, DOI 10.1300/J013v36n04_06; Heckathorn DD, 1997, SOC PROBL, V44, P174, DOI 10.1525/sp.1997.44.2.03x0221m; Herbst JH, 2008, AIDS BEHAV, V12, P1, DOI 10.1007/s10461-007-9299-3; Hotton AL, 2013, AIDS EDUC PREV, V25, P62, DOI 10.1521/aeap.2013.25.1.62; IPPF, 2008, PEOPL LIV HIV STIGM; Joint United Nations Programme on HIV/AIDS, 2011, UNAIDS TERM GUID; Keuroghlian AS, 2015, DRUG ALCOHOL DEPEN, V152, P139, DOI 10.1016/j.drugalcdep.2015.04.008; Liu K, 2010, BROS KHMER BEHAV RIS, P360; Lombardi EL, 2001, J HOMOSEXUAL, V42, P89, DOI 10.1300/J082v42n01_05; Melendez RM, 2007, CULT HEALTH SEX, V9, P233, DOI 10.1080/13691050601065909; National Center for HIV/AIDS Dermatology & STIs (NCHADS), 2013, BOOST CONT PREV CAR; National Center for HIV/AIDS Dermatology & STIs (NCHADS), 2013, BIOL BEH SURV STUD B; NCHADS, 2006, SER ASS HUM IMM VIR; Opeiario D, 2008, JAIDS-J ACQ IMM DEF, V48, P97, DOI 10.1097/QAI.0b013e31816e3971; Operario D, 2011, AIDS BEHAV, V15, P674, DOI 10.1007/s10461-010-9795-8; Pettifor AE, 2004, EMERG INFECT DIS, V10, P1996, DOI 10.3201/eid1011.040252; Poteat T, 2015, LANCET, V385, P274, DOI 10.1016/S0140-6736(14)60833-3; Pulerwitz J, 2002, AIDS CARE, V14, P789, DOI 10.1080/0954012021000031868; Reback CJ, 2014, AIDS BEHAV, V18, P1359, DOI 10.1007/s10461-013-0657-z; Schenk K., 2005, ETHICAL APPROACHES G; Sevelius JM, 2009, AIDS EDUC PREV, V21, P113, DOI 10.1521/aeap.2009.21.2.113; SOPHEAB H, 2005, CAMBODIA STI PREVALE; UNDP, 2018, MAN MIN SUST DEV SOU; World Health Organization, 2011, PREVENTION TREATMENT; World Health Organization, 2014, POL BRIEF CONS GUID	30	26	26	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0152906	10.1371/journal.pone.0152906	http://dx.doi.org/10.1371/journal.pone.0152906			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ0NI	27070152	Green Published, gold, Green Submitted			2022-12-27	WOS:000373900700019
J	Jacob, SP; Lakshmikanth, CL; Chaithra, VH; Kumari, TRS; Chen, CH; McIntyre, TM; Marathe, GK				Jacob, Shancy Petsel; Lakshmikanth, Chikkamenahalli Lakshminarayana; Chaithra, Vyala Hanumanthareddy; Kumari, Titus Ruth Shantha; Chen, Chu-Huang; McIntyre, Thomas M.; Marathe, Gopal Kedihitlu			Lipopolysaccharide Cross-Tolerance Delays Platelet-Activating Factor-Induced Sudden Death in Swiss Albino Mice: Involvement of Cyclooxygenase in Cross-Tolerance	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; PHOSPHOLIPID OXIDATION-PRODUCTS; TOLL-LIKE RECEPTORS; NF-KAPPA-B; FACTOR-ACETYLHYDROLASE; LUNG INJURY; FACTOR PAF; SEPTIC SHOCK; ENDOTOXIN TOLERANCE; INDUCED HYPOTENSION	Lipopolysaccharide (LPS) signaling through Toll-like receptor-4 (TLR-4) has been implicated in the pathogenesis of many infectious diseases. Some believe that TLR-mediated pathogenicity is due, in part, to the lipid pro-inflammatory mediator platelet-activating factor (PAF), but this has been questioned. To test the direct contribution of PAF in endotoxemia in murine models, we injected PAF intraperitoneally into Swiss albino mice in the presence and absence of LPS. PAF alone (5 mu g/mouse) caused death within 15-20 min, but this could be prevented by pretreating mice with PAF-receptor (PAF-R) antagonists or PAF-acetylhydrolase (PAF-AH). A low dose of LPS (5 mg/kg body wt) did not impair PAF-induced death, whereas higher doses (10 or 20 mg/kg body wt) delayed death, probably via LPS cross-tolerance. Cross-tolerance occurred only when PAF was injected simultaneously with LPS or within 30 min of LPS injection. Tolerance does not appear to be due to an abundant soluble mediator. Histologic examination of lungs and liver and measurement of circulating TNF-alpha and IL-10 levels suggested that the inflammatory response is not diminished during cross-tolerance. Interestingly, aspirin, a non-specific cyclooxygenase (COX) inhibitor, partially blocked PAF-induced sudden death, whereas NS-398, a specific COX-2 inhibitor, completely protected mice from the lethal effects of PAF. Both COX inhibitors (at 20 mg/kg body wt) independently amplified the cross-tolerance exerted by higher dose of LPS, suggesting that COX-derived eicosanoids may be involved in these events. Thus, PAF does not seem to have a protective role in endotoxemia, but its effects are delayed by LPS in a COX-sensitive way. These findings are likely to shed light on basic aspects of the endotoxin cross-tolerance occurring in many disease conditions and may offer new opportunities for clinical intervention.	[Jacob, Shancy Petsel; Lakshmikanth, Chikkamenahalli Lakshminarayana; Chaithra, Vyala Hanumanthareddy; Marathe, Gopal Kedihitlu] Univ Mysore, Dept Studies Biochem, Mysuru 570006, Karnataka, India; [Kumari, Titus Ruth Shantha] St Philomenas Coll, Dept Zool, Mysuru 570015, Karnataka, India; [Chen, Chu-Huang] St Lukes Episcopal Hosp, Texas Heart Inst, Vasc & Med Res, Houston, TX 77225 USA; [McIntyre, Thomas M.] Cleveland Clin, Lerner Res Inst, Dept Cellular & Mol Med NC10, 9500 Euclid Ave, Cleveland, OH 44195 USA	University of Mysore; Saint Lukes Episcopal Hospital; Texas Heart Institute; Cleveland Clinic Foundation	Marathe, GK (corresponding author), Univ Mysore, Dept Studies Biochem, Mysuru 570006, Karnataka, India.	marathe1962@gmail.com	Jacob, Shancy Petsel/J-6265-2019	Marathe, Gopal/0000-0002-0025-6677	University Grants Commission (UGC), India	University Grants Commission (UGC), India(University Grants Commission, India)	The authors thank the University Grants Commission (UGC), India (for Non NET fellowship, Basic Science Research fellowship, Major Research Project and Special Assistance Program) and the Vision Group of Science & Technology (VGST), Government of Karnataka, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham E, 2000, AM J PHYSIOL-LUNG C, V279, pL1137, DOI 10.1152/ajplung.2000.279.6.L1137; Angus DC, 2001, AM J RESP CRIT CARE, V164, P1154, DOI 10.1164/ajrccm.164.7.2012126; Barnes PJ, TRENDS IN PHARMACOLO, V8, P285; Beishuizen A, 1999, ADV CLIN CHEM, V33, P55; Bento AF, 2011, J IMMUNOL, V187, P1957, DOI 10.4049/jimmunol.1101305; BENVENISTE J, 1977, NATURE, V269, P170, DOI 10.1038/269170a0; BENVENISTE J, 1972, J EXP MED, V136, P1356, DOI 10.1084/jem.136.6.1356; Biswas SK, 2009, TRENDS IMMUNOL, V30, P475, DOI 10.1016/j.it.2009.07.009; Bochkov VN, 2002, NATURE, V419, P77, DOI 10.1038/nature01023; BRADLEY PP, 1982, J INVEST DERMATOL, V78, P206, DOI 10.1111/1523-1747.ep12506462; Cain BS, 2000, CRIT CARE MED, V28, P2164, DOI 10.1097/00003246-200006000-00100; CANNON JG, 1990, J INFECT DIS, V161, P79, DOI 10.1093/infdis/161.1.79; CARSWELL EA, 1975, P NATL ACAD SCI USA, V72, P3666, DOI 10.1073/pnas.72.9.3666; CASALSSTENZEL J, 1987, EUR J PHARMACOL, V135, P117, DOI 10.1016/0014-2999(87)90602-9; Cavaillon J-M., 1994, J ENDOTOXIN RES, V1, P21, DOI 10.1177/096805199400100105; CHANG SW, 1987, J CLIN INVEST, V79, P1498, DOI 10.1172/JCI112980; Chen JW, 2007, J LIPID RES, V48, P2365, DOI 10.1194/jlr.M700325-JLR200; Chosay JG, 1997, AM J PHYSIOL-GASTR L, V272, pG1195, DOI 10.1152/ajpgi.1997.272.5.G1195; Czermak BJ, 1999, AM J PATHOL, V154, P1057, DOI 10.1016/S0002-9440(10)65358-8; DEMOPOULOS CA, 1979, J BIOL CHEM, V254, P9355; DOEBBER TW, 1985, BIOCHEM BIOPH RES CO, V127, P799, DOI 10.1016/S0006-291X(85)80014-0; Elliott GT, 1998, J MOL CELL CARDIOL, V30, P3, DOI 10.1006/jmcc.1997.0586; Endo Y, 1999, BRIT J PHARMACOL, V128, P5, DOI 10.1038/sj.bjp.0702747; Erridge C, 2008, J BIOL CHEM, V283, P24748, DOI 10.1074/jbc.M800352200; Ferlito M, 2001, J LEUKOCYTE BIOL, V70, P821; Flach R, 1997, J ENDOTOXIN RES, V4, P241, DOI 10.1177/096805199700400401; Fukuda Y, 2000, EUR J PHARMACOL, V390, P203, DOI 10.1016/S0014-2999(99)00920-6; FUTAKI N, 1994, PROSTAGLANDINS, V47, P55, DOI 10.1016/0090-6980(94)90074-4; Giral M, 1996, BRIT J PHARMACOL, V118, P1223, DOI 10.1111/j.1476-5381.1996.tb15527.x; Gomes RN, 2006, SHOCK, V26, P41, DOI 10.1097/01.shk.0000209562.00070.1a; Goodman RB, 2003, CYTOKINE GROWTH F R, V14, P523, DOI 10.1016/S1359-6101(03)00059-5; GRAHAM RM, 1994, CRIT CARE MED, V22, P204, DOI 10.1097/00003246-199402000-00009; Guo RF, 2007, ANTIOXID REDOX SIGN, V9, P1991, DOI 10.1089/ars.2007.1785; HANAHAN DJ, 1987, PROG LIPID RES, V26, P1, DOI 10.1016/0163-7827(87)90006-3; HANAHAN DJ, 1986, ANNU REV BIOCHEM, V55, P483, DOI 10.1146/annurev.bi.55.070186.002411; HANDLEY DA, 1986, IMMUNOPHARMACOLOGY, V12, P11, DOI 10.1016/0162-3109(86)90046-9; HASLETT C, 1987, AM REV RESPIR DIS, V136, P9, DOI 10.1164/ajrccm/136.1.9; Henderson WR, 2000, J IMMUNOL, V164, P3360, DOI 10.4049/jimmunol.164.6.3360; Hiki N, 2003, J TRAUMA, V54, P584, DOI 10.1097/01.TA.0000060180.29719.57; HONDA Z, 1991, NATURE, V349, P342, DOI 10.1038/349342a0; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; INARREA P, 1985, IMMUNOPHARMACOLOGY, V9, P45, DOI 10.1016/0162-3109(85)90046-3; Ishii S, 1998, J EXP MED, V187, P1779, DOI 10.1084/jem.187.11.1779; Ishii S, 1997, EMBO J, V16, P133, DOI 10.1093/emboj/16.1.133; JAESCHKE H, 1991, AM J PHYSIOL, V261, pG1051, DOI 10.1152/ajpgi.1991.261.6.G1051; Jeong YI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006503; Knapp S, 2007, J IMMUNOL, V178, P993, DOI 10.4049/jimmunol.178.2.993; KOLTAI M, 1993, J LIPID MEDIATOR, V6, P183; KOPP E, 1994, SCIENCE, V265, P956, DOI 10.1126/science.8052854; Kupfner JG, 2001, J IMMUNOL, V167, P7044, DOI 10.4049/jimmunol.167.12.7044; Kuzkov VV, 2006, CRIT CARE MED, V34, P1647, DOI 10.1097/01.CCM.0000218817.24208.2E; Lehner MD, 2001, J IMMUNOL, V166, P5161, DOI 10.4049/jimmunol.166.8.5161; Leitinger N, 1997, ADV EXP MED BIOL, V433, P379; Lopez-Bojorquez L, 2004, ARCH MED RES, V35, P465, DOI 10.1016/j.arcmed.2004.07.006; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Marathe GK, 2000, FREE RADICAL BIO MED, V28, P1762, DOI 10.1016/S0891-5849(00)00234-3; Marathe GK, 2014, J LIPID RES, V55, P1847, DOI 10.1194/jlr.R045492; Marshall JC, 2014, TRENDS MOL MED, V20, P195, DOI 10.1016/j.molmed.2014.01.007; Mathiak G, 1997, SHOCK, V7, P391, DOI 10.1097/00024382-199706000-00001; Matute-Bello G, 2001, AM J RESP CRIT CARE, V163, P234, DOI 10.1164/ajrccm.163.1.9909034; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Miotla JM, 1998, AM J RESP CELL MOL, V18, P197, DOI 10.1165/ajrcmb.18.2.2846; Moreno SE, 2006, J IMMUNOL, V177, P1264, DOI 10.4049/jimmunol.177.2.1264; MOZES T, 1991, J LIPID MEDIATOR, V4, P309; Murakami K, 1996, THROMB HAEMOSTASIS, V75, P965; Nagase T, 1999, J CLIN INVEST, V104, P1071, DOI 10.1172/JCI7727; Nakos G, 1998, INTENS CARE MED, V24, P296, DOI 10.1007/s001340050571; PAGE CP, 1987, INT J TISSUE REACT, V9, P27; Park SH, 2011, NAT IMMUNOL, V12, P607, DOI 10.1038/ni.2043; PRESCOTT SM, 1990, J BIOL CHEM, V265, P17381; Prescott SM, 2000, ANNU REV BIOCHEM, V69, P419, DOI 10.1146/annurev.biochem.69.1.419; Qiu QM, 2011, WORLD J EMERG MED, V2, P302, DOI 10.5847/wjem.j.1920-8642.2011.04.011; RANDOW F, 1995, J EXP MED, V181, P1887, DOI 10.1084/jem.181.5.1887; Saturnino SF, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-240; Schwarz NT, 2002, GASTROENTEROLOGY, V123, P586, DOI 10.1053/gast.2002.34777; Serhan CN, 2002, J EXP MED, V196, P1025, DOI 10.1084/jem.20020760; Shindou H, 2007, J BIOL CHEM, V282, P6532, DOI 10.1074/jbc.M609641200; Shinohara H, 1999, J BIOL CHEM, V274, P12263, DOI 10.1074/jbc.274.18.12263; SMITH WL, 1990, ADV PROSTAG THROMB L, V20, P14; Song W, 1996, BRIT J PHARMACOL, V118, P2157, DOI 10.1111/j.1476-5381.1996.tb15657.x; STAFFORINI DM, 1987, J BIOL CHEM, V262, P4223; Subbanagounder G, 1999, CIRC RES, V85, P311, DOI 10.1161/01.RES.85.4.311; Teixeira-da-Cunha MGA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074567; Tjoelker LW, 2000, BBA-MOL CELL BIOL L, V1488, P102, DOI 10.1016/S1388-1981(00)00114-1; TJOELKER LW, 1995, NATURE, V374, P549, DOI 10.1038/374549a0; TJOELKER LW, 1995, J BIOL CHEM, V270, P25481, DOI 10.1074/jbc.270.43.25481; Tsoupras AB, 2011, J INFLAMM-LOND, V8, DOI 10.1186/1476-9255-8-17; Uhlig S, 2005, PHARMACOL REP, V57, P206; Vadas P, 2008, NEW ENGL J MED, V358, P28, DOI 10.1056/NEJMoa070030; van der Poll T, 2008, LANCET INFECT DIS, V8, P32, DOI 10.1016/S1473-3099(07)70265-7; Varisco BM, 2011, ADV PHARMACOL SCI, V2011, DOI 10.1155/2011/254619; Walton KA, 2003, ARTERIOSCL THROM VAS, V23, P1197, DOI 10.1161/01.ATV.0000079340.80744.B8; Wang H, 1997, PEDIATR RES, V42, P597, DOI 10.1203/00006450-199711000-00008; Watanabe JJ, 2003, J BIOL CHEM, V278, P33161, DOI 10.1074/jbc.M305321200; Yost CC, 2010, BIOCHIMIE, V92, P692, DOI 10.1016/j.biochi.2010.02.011; Zheng GH, 2012, INFLAMMATION, V35, P1419, DOI 10.1007/s10753-012-9455-4	96	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2016	11	4							e0153282	10.1371/journal.pone.0153282	http://dx.doi.org/10.1371/journal.pone.0153282			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0KH	27064683	Green Submitted, Green Published, gold			2022-12-27	WOS:000373891000041
J	Jo, P; Konig, A; Schirmer, M; Kitz, J; Conradi, LC; Azizian, A; Bernhardt, M; Wolff, HA; Grade, M; Ghadimi, M; Strobel, P; Schildhaus, HU; Gaedcke, J				Jo, Peter; Koenig, Alexander; Schirmer, Markus; Kitz, Julia; Conradi, Lena-Christin; Azizian, Azadeh; Bernhardt, Markus; Wolff, Hendrik A.; Grade, Marian; Ghadimi, Michael; Stroebel, Philipp; Schildhaus, Hans-Ulrich; Gaedcke, Jochen			Heterogeneity of KRAS Mutation Status in Rectal Cancer	PLOS ONE			English	Article							METASTATIC COLORECTAL-CANCER; BRAF; CETUXIMAB; THERAPY; SPECIMENS; CHEMORADIOTHERAPY; CHEMOTHERAPY; EVOLUTION; IMPACT; SITES	Introduction Anti-EGFR targeted therapy is of increasing importance in advanced colorectal cancer and prior KRAS mutation testing is mandatory for therapy. However, at which occasions this should be performed is still under debate. We aimed to assess in patients with locally advanced rectal cancer whether there is intra-specimen KRAS heterogeneity prior to and upon preoperative chemoradiotherapy (CRT), and if there are any changes in KRAS mutation status due to this intervention. Materials and Methods KRAS mutation status analyses were performed in 199 tumor samples from 47 patients with rectal cancer. To evaluate the heterogeneity between different tumor areas within the same tumor prior to preoperative CRT, 114 biopsies from 34 patients (mean 3 biopsies per patient) were analyzed (pre-therapeutic intratumoral heterogeneity). For the assessment of heterogeneity after CRT residual tumor tissue (85 samples) from 12 patients (mean 4.2 tissue samples per patient) were analyzed (post-therapeutic intratumoral heterogeneity) and assessment of heterogeneity before and after CRT was evaluated in corresponding patient samples (interventional heterogeneity). Primer extension method (SNaPshot (TM)) was used for initial KRAS mutation status testing for Codon 12, 13, 61, and 146. Discordant results by this method were reevaluated by using the FDA-approved KRAS Pyro Kit 24, V1 and the RAS Extension Pyro Kit 24, V1 Kit (therascreen (R) KRAS test). Results For 20 (43%) out of the 47 patients, a KRAS mutation was detected. With 12 out of 20, the majority of these mutations affected codon 35. We did not obtained evidence that CRT results in changes of the KRAS mutation pattern. In addition, no intratumoral heterogeneity in the KRAS mutational status could be proven. This was true for both the biopsies prior to CRT and the resection specimens thereafter. The discrepancy observed in some samples when using the SNaPshot (TM) assay was due to insufficient sensitivity of this technique upon massive tumor regression by CRT as application of the therascreen (R) KRAS test revealed concordant results. Conclusion Our results indicate that the KRAS mutation status at the primary tumor site of rectal cancer is homogenous. Its assessment for therapeutic decisions is feasible in pre-therapeutic biopsies as well as in post-therapeutic resected specimens. The amount of viable tumor cells seems to be an important determinant for assay sensitivity and should thus be considered for selection of the analytical method.	[Jo, Peter; Conradi, Lena-Christin; Azizian, Azadeh; Bernhardt, Markus; Grade, Marian; Ghadimi, Michael; Gaedcke, Jochen] Univ Med Ctr Goettingen, Dept Gen Visceral & Pediat Surg, Gottingen, Germany; [Koenig, Alexander] Univ Med Ctr Goettingen, Dept Gastroenterol & Gastrointestinal Oncol, Gottingen, Germany; [Schirmer, Markus] Univ Med Ctr Goettingen, Dept Clin Pharmacol, Gottingen, Germany; [Kitz, Julia; Stroebel, Philipp; Schildhaus, Hans-Ulrich] Univ Med Ctr Goettingen, Dept Pathol, Gottingen, Germany; [Wolff, Hendrik A.] Radiotherapy & Radiol Munich, Munich, Germany	University of Gottingen; University of Gottingen; University of Gottingen; University of Gottingen	Gaedcke, J (corresponding author), Univ Med Ctr Goettingen, Dept Gen Visceral & Pediat Surg, Gottingen, Germany.	jochen.gaedcke@med.uni-goettingen.de			Deutsche Forschungsgemeinschaft (DFG)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	The work is part of the Clinical Research Unit (KFO 179) and was supported by the Deutsche Forschungsgemeinschaft (DFG).	Artale S, 2008, J CLIN ONCOL, V26, P4217, DOI 10.1200/JCO.2008.18.7286; Boissiere-Michot F, 2012, MODERN PATHOL, V25, P731, DOI 10.1038/modpathol.2011.210; de Castro DG, 2012, BRIT J CANCER, V107, P345, DOI 10.1038/bjc.2012.259; Demes M, 2013, J GASTROINTEST ONCOL, V4, P182, DOI 10.3978/j.issn.2078-6891.2013.012; Dutta PR, 2007, CANCER LETT, V254, P165, DOI 10.1016/j.canlet.2007.02.006; Dworak O, 1997, INT J COLORECTAL DIS, V12, P19, DOI 10.1007/s003840050072; Fisher R, 2013, BRIT J CANCER, V108, P479, DOI 10.1038/bjc.2012.581; Gaedcke J, 2010, RADIOTHER ONCOL, V94, P76, DOI 10.1016/j.radonc.2009.10.001; Gaiser T, 2013, INT J CANCER, V132, P1800, DOI 10.1002/ijc.27869; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Han CB, 2012, CANCER INVEST, V30, P741, DOI 10.3109/07357907.2012.732159; Hunt JL, 2004, ARCH PATHOL LAB MED, V128, P1372; Hurst Carolyn D, 2009, BMC Res Notes, V2, P66, DOI 10.1186/1756-0500-2-66; Imamura Y, 2012, CLIN CANCER RES, V18, P4753, DOI 10.1158/1078-0432.CCR-11-3210; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Lamy A, 2011, MODERN PATHOL, V24, P1090, DOI 10.1038/modpathol.2011.60; Lievre A, 2006, CANCER RES, V66, P3992, DOI 10.1158/0008-5472.CAN-06-0191; Lievre A, 2008, J CLIN ONCOL, V26, P374, DOI 10.1200/JCO.2007.12.5906; Marjanovic ND, 2013, CLIN CHEM, V59, P168, DOI 10.1373/clinchem.2012.184655; Normanno N, 2015, ANN ONCOL, V26, P1710, DOI 10.1093/annonc/mdv176; Norton N, 2002, HUM GENET, V110, P471, DOI 10.1007/s00439-002-0706-6; Oliveira C, 2007, ONCOGENE, V26, P158, DOI 10.1038/sj.onc.1209758; Ondrejka SL, 2011, AM J SURG PATHOL, V35, P1327, DOI 10.1097/PAS.0b013e3182253800; Queiros P, 2015, VIRCHOWS ARCH, V467, P383, DOI 10.1007/s00428-015-1823-7; Richman SD, 2011, ANAL CELL PATHOL, V34, P61, DOI [10.1155/2011/393521, 10.3233/ACP-2011-0005]; Rodel C, 2012, LANCET ONCOL, V13, P679, DOI 10.1016/S1470-2045(12)70187-0; Sauer R, 2004, NEW ENGL J MED, V351, P1731, DOI 10.1056/NEJMoa040694; Sherwood J, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0207-9; Van Cutsem E, 2009, NEW ENGL J MED, V360, P1408, DOI 10.1056/NEJMoa0805019	29	11	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2016	11	4							e0153278	10.1371/journal.pone.0153278	http://dx.doi.org/10.1371/journal.pone.0153278			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0KH	27064574	Green Published, gold, Green Submitted			2022-12-27	WOS:000373891000040
J	Lee, DH; Lee, DW; Han, BS				Lee, Dong-Hoon; Lee, Do-Wan; Han, Bong-Soo			Possibility Study of Scale Invariant Feature Transform (SIFT) Algorithm Application to Spine Magnetic Resonance Imaging	PLOS ONE			English	Article							CORD	The purpose of this study is an application of scale invariant feature transform (SIFT) algorithm to stitch the cervical-thoracic-lumbar (C-T-L) spine magnetic resonance (MR) images to provide a view of the entire spine in a single image. All MR images were acquired with fast spin echo (FSE) pulse sequence using two MR scanners (1.5 T and 3.0 T). The stitching procedures for each part of spine MR image were performed and implemented on a graphic user interface (GUI) configuration. Moreover, the stitching process is performed in two categories; manual point-to-point (mPTP) selection that performed by user specified corresponding matching points, and automated point-to-point (aPTP) selection that performed by SIFT algorithm. The stitched images using SIFT algorithm showed fine registered results and quantitatively acquired values also indicated little errors compared with commercially mounted stitching algorithm in MRI systems. Our study presented a preliminary validation of the SIFT algorithm application to MRI spine images, and the results indicated that the proposed approach can be performed well for the improvement of diagnosis. We believe that our approach can be helpful for the clinical application and extension of other medical imaging modalities for image stitching.	[Lee, Dong-Hoon; Lee, Do-Wan] Johns Hopkins Univ, Sch Med, Dept Radiol, Div MR Res, Baltimore, MD 21205 USA; [Han, Bong-Soo] Yonsei Univ, Coll Hlth Sci, Dept Radiol Sci, Wonju, South Korea	Johns Hopkins University; Yonsei University	Han, BS (corresponding author), Yonsei Univ, Coll Hlth Sci, Dept Radiol Sci, Wonju, South Korea.	bshan@yonsei.ac.kr	Han, Bong Soo/AAL-6704-2020; Lee, Dong-Hoon/G-4959-2016	Lee, Dong-Hoon/0000-0002-5013-4440	"Leaders in INdustry-university Cooperation (LINC)" Project - Ministry of Education, Science and Technology (MEST) [2012-8-5299]	"Leaders in INdustry-university Cooperation (LINC)" Project - Ministry of Education, Science and Technology (MEST)	This research was supported by the "Leaders in INdustry-university Cooperation (LINC)" Project funded by the Ministry of Education, Science and Technology (MEST) (2012-8-5299). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbar H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103561; Baheti B., 2015, IEEE C PER COM, P1; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Brown M, 2002, BRIT MACH VIS C, DOI DOI 10.5244/C.16.23; Chen Jian, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P1437; Cheung W, 2009, IEEE T IMAGE PROCESS, V18, P2012, DOI 10.1109/TIP.2009.2024578; Daguang J, 2013, ADV INFORM SCI SERVI, V5, P164; Daliri MR, 2012, J MED SYST, V36, P995, DOI 10.1007/s10916-011-9738-6; Dzyubachyk O, 2013, MAGN RESON MED, V69, P1777, DOI 10.1002/mrm.24404; Filippi CG, 2010, EUR RADIOL, V20, P2194, DOI 10.1007/s00330-010-1797-4; FISCHLER MA, 1981, COMMUN ACM, V24, P381, DOI 10.1145/358669.358692; Harris C., 1988, P ALV VIS C MANCH UK, V15, P147, DOI [10.5244/C.2.23, DOI 10.5244/C.2.23]; Lowe D. G., 1999, Proceedings of the Seventh IEEE International Conference on Computer Vision, P1150, DOI 10.1109/ICCV.1999.790410; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Nair G, 2010, NEUROIMAGE, V53, P576, DOI 10.1016/j.neuroimage.2010.06.060; Paganelli C, 2012, IEEE ENG MED BIO, P6543, DOI 10.1109/EMBC.2012.6347493; Paganelli C, 2013, MED PHYS, V40, DOI 10.1118/1.4822486; Paganelli C, 2013, PHYS MED BIOL, V58, P287, DOI 10.1088/0031-9155/58/2/287; SHI JB, 1994, 1994 IEEE COMPUTER SOCIETY CONFERENCE ON COMPUTER VISION AND PATTERN RECOGNITION, PROCEEDINGS, P593, DOI 10.1109/CVPR.1994.323794; Wang DF, 2012, J NEUROSCI METH, V209, P371, DOI 10.1016/j.jneumeth.2012.06.026; Zhang XH, 2014, BIO-MED MATER ENG, V24, P2847, DOI 10.3233/BME-141103; Zhu J, 2014, COMPUT MATH METHOD M, V2014, DOI 10.1155/2014/926312	22	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2016	11	4							e0153043	10.1371/journal.pone.0153043	http://dx.doi.org/10.1371/journal.pone.0153043			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0KH	27064404	gold, Green Published, Green Submitted			2022-12-27	WOS:000373891000026
J	Reddy, BL; Saier, MH				Reddy, Bhaskara L.; Saier, Milton H., Jr.			Properties and Phylogeny of 76 Families of Bacterial and Eukaryotic Organellar Outer Membrane Pore-Forming Proteins	PLOS ONE			English	Article							TRANSPORTER CLASSIFICATION DATABASE; RAFFINOSE PLASMID PRSD2; BETA-BARREL PROTEINS; WEB-BASED PROGRAM; CELL-WALL; FUNCTIONAL-CHARACTERIZATION; EVOLUTIONARY RELATIONSHIPS; CRYSTAL-STRUCTURE; X-RAY; CHANNEL	We here report statistical analyses of 76 families of integral outer membrane pore-forming proteins (OMPPs) found in bacteria and eukaryotic organelles. 47 of these families fall into one superfamily (SFI) which segregate into fifteen phylogenetic clusters. Families with members of the same protein size, topology and substrate specificities often cluster together. Virtually all OMPP families include only proteins that form transmembrane pores. Nine such families, all of which cluster together in the SFI phylogenetic tree, contain both alpha- and beta-structures, are multi domain, multi subunit systems, and transport macromolecules. Most other SFI OMPPs transport small molecules. SFII and SFV homologues derive from Actinobacteria while SFIII and SFIV proteins derive from chloroplasts. Three families of actinobacterial OMPPs and two families of eukaryotic OMPPs apparently consist primarily of alpha-helices (alpha-TMSs). Of the 71 families of (putative) beta-barrel OMPPs, only twenty could not be assigned to a superfamily, and these derived primarily from Actinobacteria (1), chloroplasts (1), spirochaetes (8), and proteobacteria (10). Proteins were identified in which two or three full length OMPPs are fused together. Family characteristic are described and evidence agrees with a previous proposal suggesting that many arose by adjacent beta-hairpin structural unit duplications.	[Reddy, Bhaskara L.; Saier, Milton H., Jr.] Univ Calif San Diego, Dept Mol Biol, Div Biol Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Saier, MH (corresponding author), Univ Calif San Diego, Dept Mol Biol, Div Biol Sci, La Jolla, CA 92093 USA.	msaier@ucsd.edu		Saier, Milton/0000-0001-5530-0017	NIH [GM077402, GM109895]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM109895, R01GM077402] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by NIH (grant #GM077402 and GM109895). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aistleitner K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055010; Albrecht R, 2006, ACTA CRYSTALLOGR F, V62, P415, DOI 10.1107/S1744309106010190; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Altschul SF, 2009, NUCLEIC ACIDS RES, V37, P815, DOI 10.1093/nar/gkn981; Andersen C, 1998, EUR J BIOCHEM, V254, P679, DOI 10.1046/j.1432-1327.1998.2540679.x; Arnold T, 2007, J MOL BIOL, V366, P1174, DOI 10.1016/j.jmb.2006.12.029; Bagos PG, 2004, NUCLEIC ACIDS RES, V32, pW400, DOI 10.1093/nar/gkh417; Barth E, 2010, J BACTERIOL, V192, P786, DOI 10.1128/JB.01142-09; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Beckwith CR, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00332; BENZ R, 1993, BIOCHIM BIOPHYS ACTA, V1149, P224, DOI 10.1016/0005-2736(93)90205-E; Biegert A, 2008, BIOINFORMATICS, V24, P807, DOI 10.1093/bioinformatics/btn039; Bolla JM, 2004, ACTA CRYSTALLOGR D, V60, P2349, DOI 10.1107/S0907444904024795; Braun V, 2007, BIOMETALS, V20, P219, DOI 10.1007/s10534-006-9072-5; Buljan M, 2009, BIOCHEM SOC T, V37, P751, DOI 10.1042/BST0370751; Bushell SR, 2013, STRUCTURE, V21, P844, DOI 10.1016/j.str.2013.03.010; Chen JS, 2011, J MOL MICROB BIOTECH, V21, P83, DOI 10.1159/000334611; Chen SC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118893; Chiang Z, 2015, BRIEF BIOINFORM, V16, P865, DOI 10.1093/bib/bbu053; Clantin B, 2007, SCIENCE, V317, P957, DOI 10.1126/science.1143860; Collins RF, 2007, TRENDS MICROBIOL, V15, P96, DOI 10.1016/j.tim.2007.01.002; Condemine G, 2005, J BACTERIOL, V187, P1959, DOI 10.1128/JB.187.6.1959-1965.2005; Confer AW, 2013, VET MICROBIOL, V163, P207, DOI 10.1016/j.vetmic.2012.08.019; Costa-Riu N, 2003, MOL MICROBIOL, V50, P1295, DOI 10.1046/j.1365-2958.2003.03754.x; Cox K, 2008, EUR BIOPHYS J BIOPHY, V37, P131, DOI 10.1007/s00249-007-0185-8; Crook MB, 2013, J BACTERIOL, V195, P3663, DOI 10.1128/JB.00480-13; DAYHOFF MO, 1983, METHOD ENZYMOL, V91, P524; Dong CJ, 2006, NATURE, V444, P226, DOI 10.1038/nature05267; Eren E, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001242; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Gentle IE, 2005, MOL MICROBIOL, V58, P1216, DOI 10.1111/j.1365-2958.2005.04906.x; Giacani L, 2015, INFECT IMMUN, V83, P2275, DOI 10.1128/IAI.00360-15; Goetze TA, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0445-1; Gomolplitinant KM, 2011, J MEMBRANE BIOL, V240, P89, DOI 10.1007/s00232-011-9347-9; Granoff DM, 2010, CLIN INFECT DIS, V50, pS54, DOI 10.1086/648966; Grundy WN, 1996, COMPUT APPL BIOSCI, V12, P303; Hansel A, 1998, CURR MICROBIOL, V36, P321, DOI 10.1007/s002849900316; Hohle TH, 2011, P NATL ACAD SCI USA, V108, P15390, DOI 10.1073/pnas.1110137108; Huang HB, 2007, J BACTERIOL, V189, P1998, DOI 10.1128/JB.01548-06; Huang YH, 2009, P NATL ACAD SCI USA, V106, P7403, DOI 10.1073/pnas.0902789106; Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003; Hunten P, 2005, MICROBIOL-SGM, V151, P2429, DOI 10.1099/mic.0.27903-0; Hutter CAJ, 2014, ACTA CRYSTALLOGR D, V70, P1770, DOI 10.1107/S1399004714007147; Itoh Y, 2008, J BACTERIOL, V190, P3670, DOI 10.1128/JB.01920-07; Kalmokoff ML, 2009, ANAEROBE, V15, P74, DOI 10.1016/j.anaerobe.2009.01.001; Kattner C, 2015, APPL BIOCHEM BIOTECH, V175, P2907, DOI 10.1007/s12010-014-1473-2; Khemiri A, 2008, FEMS MICROBIOL LETT, V278, P171, DOI 10.1111/j.1574-6968.2007.00985.x; Kim JS, 2015, MOL CELLS, V38, P180, DOI 10.14348/molcells.2015.2277; Korhonen TK, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00035; Korkmaz F, 2015, ARCH BIOCHEM BIOPHYS, V576, P73, DOI 10.1016/j.abb.2015.04.010; Kozjak V, 2003, J BIOL CHEM, V278, P48520, DOI 10.1074/jbc.C300442200; KUAN J, 1993, CRIT REV BIOCHEM MOL, V28, P209, DOI 10.3109/10409239309086795; Lam VH, 2011, BIOL CHEM, V392, P5, DOI 10.1515/BC.2011.018; Lee A, 2014, MICROBIOL-SGM, V160, P1679, DOI 10.1099/mic.0.077776-0; Liang BY, 2007, P NATL ACAD SCI USA, V104, P16140, DOI 10.1073/pnas.0705466104; Lieberman JA, 2015, MBIO, V6, DOI 10.1128/mBio.00322-15; Lukatsky DB, 2007, J MOL BIOL, V365, P1596, DOI 10.1016/j.jmb.2006.11.020; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Mazar J, 2007, TRENDS MICROBIOL, V15, P508, DOI 10.1016/j.tim.2007.10.005; Meli AC, 2006, J BIOL CHEM, V281, P158, DOI 10.1074/jbc.M508524200; Mertins B, 2014, BIOL CHEM, V395, P1435, DOI 10.1515/hsz-2014-0203; Modi N, 2013, BIOCHEMISTRY-US, V52, P5522, DOI 10.1021/bi400522b; Niederweis M, 1999, MOL MICROBIOL, V33, P933, DOI 10.1046/j.1365-2958.1999.01472.x; Niederweis M, 2003, MOL MICROBIOL, V49, P1167, DOI 10.1046/j.1365-2958.2003.03662.x; Niederweis M, 2008, MICROBIOL-SGM, V154, P679, DOI 10.1099/mic.0.2007/012872-0; NIKAIDO H, 1994, J BIOL CHEM, V269, P3905; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Noinaj N, 2015, CURR OPIN STRUC BIOL, V31, P35, DOI 10.1016/j.sbi.2015.02.012; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; Paquet JY, 2001, J BACTERIOL, V183, P4839, DOI 10.1128/JB.183.16.4839-4847.2001; Park JH, 1996, J MEMBRANE BIOL, V153, P171, DOI 10.1007/s002329900120; Paulsen IT, 1997, FEMS MICROBIOL LETT, V156, P1, DOI 10.1111/j.1574-6968.1997.tb12697.x; Pavlenok M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038726; Pei XY, 2011, P NATL ACAD SCI USA, V108, P2112, DOI 10.1073/pnas.1012588108; Puntervoll P, 2002, MICROBIOL-SGM, V148, P3395, DOI 10.1099/00221287-148-11-3395; Ranquin A, 2004, RES MICROBIOL, V155, P611, DOI 10.1016/j.resmic.2004.05.007; Reddy A, 2014, J MOL MICROB BIOTECH, V24, P161, DOI 10.1159/000363506; Reddy BL, 2013, BBA-BIOMEMBRANES, V1828, P2654, DOI 10.1016/j.bbamem.2013.07.004; Reddy VS, 2012, FEBS J, V279, P2036, DOI 10.1111/j.1742-4658.2012.08590.x; Reddy VS, 2012, FEBS J, V279, P2022, DOI 10.1111/j.1742-4658.2012.08588.x; Rehman ZU, 2013, APPL ENVIRON MICROB, V79, P2002, DOI 10.1128/AEM.03960-12; Remaut H, 2008, CELL, V133, P640, DOI 10.1016/j.cell.2008.03.033; Remmert M, 2010, MOL BIOL EVOL, V27, P1348, DOI 10.1093/molbev/msq017; Remmert M, 2009, NUCLEIC ACIDS RES, V37, pW446, DOI 10.1093/nar/gkp325; Saier MH, 2003, MOL MICROBIOL, V48, P1145, DOI 10.1046/j.1365-2958.2003.03499.x; Saier MH, 2000, MICROBIOL MOL BIOL R, V64, P354, DOI 10.1128/MMBR.64.2.354-411.2000; Saier MH, 2008, MICROBE, P323; Saier MH, 2008, ADV APPL MICROBIOL, V65, P141, DOI 10.1016/S0065-2164(08)00606-0; Saier MH, 2006, NUCLEIC ACIDS RES, V34, pD181, DOI 10.1093/nar/gkj001; Saier MH, 2016, NUCLEIC ACIDS RES, V44, pD372, DOI 10.1093/nar/gkv1103; Saier MH, 2014, NUCLEIC ACIDS RES, V42, pD251, DOI 10.1093/nar/gkt1097; Saier MH, 2009, NUCLEIC ACIDS RES, V37, pD274, DOI 10.1093/nar/gkn862; SCHIRMER T, 1995, SCIENCE, V267, P512, DOI 10.1126/science.7824948; Simmerman RF, 2014, INT REV CEL MOL BIO, V308, P1, DOI 10.1016/B978-0-12-800097-7.00001-4; Soding J, 2003, BIOESSAYS, V25, P837, DOI 10.1002/bies.10321; Soding J, 2006, NUCLEIC ACIDS RES, V34, pW374, DOI 10.1093/nar/gkl195; Soding J, 2006, NUCLEIC ACIDS RES, V34, pW137, DOI 10.1093/nar/gkl130; Speer A, 2015, MOL MICROBIOL, V97, P881, DOI 10.1111/mmi.13073; Sun G, 2007, J BACTERIOL, V189, P6222, DOI 10.1128/JB.00552-07; Tamber S, 2007, J BACTERIOL, V189, P929, DOI 10.1128/JB.01296-06; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tsirigos KD, 2011, NUCLEIC ACIDS RES, V39, pD324, DOI 10.1093/nar/gkq863; Tsu BV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137184; Tusnady GE, 2010, CURR PROTEIN PEPT SC, V11, P550; Ulmke C, 1997, J BACTERIOL, V179, P5783, DOI 10.1128/jb.179.18.5783-5788.1997; Ulrich T, 2015, INT J MED MICROBIOL, V305, P259, DOI 10.1016/j.ijmm.2014.12.009; van den Berg B, 2005, CURR OPIN STRUC BIOL, V15, P401, DOI 10.1016/j.sbi.2005.06.003; VANROSMALEN M, 1993, RES MICROBIOL, V144, P507, DOI 10.1016/0923-2508(93)90001-I; Viklund H, 2008, BIOINFORMATICS, V24, P2928, DOI 10.1093/bioinformatics/btn550; Vrljic M., 1999, Journal of Molecular Microbiology and Biotechnology, V1, P327; WALLIN E, 1993, COMPUT APPL BIOSCI, V9, P117; Walther DM, 2009, P NATL ACAD SCI USA, V106, P2531, DOI 10.1073/pnas.0807830106; Wang B, 2009, J MEMBRANE BIOL, V231, P1, DOI 10.1007/s00232-009-9200-6; Wang HG, 2016, MICROBIOL RES, V182, P109, DOI 10.1016/j.micres.2015.10.004; Wee SK, 2014, FEMS MICROBIOL LETT, V350, P90, DOI 10.1111/1574-6968.12304; WEISS MS, 1990, FEBS LETT, V267, P268, DOI 10.1016/0014-5793(90)80942-C; Wetzler LM, 2010, FUTURE MICROBIOL, V5, P749, DOI 10.2217/FMB.10.41; Wirth C, 2009, J MOL BIOL, V394, P718, DOI 10.1016/j.jmb.2009.09.054; Wong FH, 2012, J MOL MICROB BIOTECH, V22, P105, DOI 10.1159/000338542; Xiao Anthony Y, 2010, Int J Microbiol, V2010, P589391, DOI 10.1155/2010/589391; Ye JQ, 2004, EMBO J, V23, P3187, DOI 10.1038/sj.emboj.7600330; Yee DC, 2013, FEBS J, V280, P5780, DOI 10.1111/febs.12499; Yen MR, 2010, METHODS MOL BIOL, V637, P47, DOI 10.1007/978-1-60761-700-6_3; Yen MR, 2009, J MOL MICROB BIOTECH, V17, P163, DOI 10.1159/000239667; Yen MR, 2002, BBA-BIOMEMBRANES, V1562, P6, DOI 10.1016/S0005-2736(02)00359-0; Young GB, 1999, BBA-BIOMEMBRANES, V1415, P306, DOI 10.1016/S0005-2736(98)00196-5; Zhai YF, 2002, J MOL MICROB BIOTECH, V4, P69; Zhai YF, 2001, J MOL MICROB BIOTECH, V3, P501; Zhai YF, 2001, J MOL MICROB BIOTECH, V3, P285; Zheng WH, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-98; Ziegler K, 2008, J MOL BIOL, V379, P482, DOI 10.1016/j.jmb.2008.04.017	131	15	15	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2016	11	4							e0152733	10.1371/journal.pone.0152733	http://dx.doi.org/10.1371/journal.pone.0152733			38	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0KH	27064789	Green Published, Green Submitted, gold			2022-12-27	WOS:000373891000018
J	Yokrattanasak, J; De Gaetano, A; Panunzi, S; Satiracoo, P; Lawton, WM; Lenbury, Y				Yokrattanasak, Jiraphat; De Gaetano, Andrea; Panunzi, Simona; Satiracoo, Pairote; Lawton, Wayne M.; Lenbury, Yongwimon			A Simple, Realistic Stochastic Model of Gastric Emptying	PLOS ONE			English	Article							DIFFERENTIAL-EQUATIONS; PARAMETER-ESTIMATION; KINETICS; VARIABILITY; ABSORPTION; INGESTION; MECHANISM; DYNAMICS; TRANSIT; HUMANS	Several models of Gastric Emptying (GE) have been employed in the past to represent the rate of delivery of stomach contents to the duodenum and jejunum. These models have all used a deterministic form (algebraic equations or ordinary differential equations), considering GE as a continuous, smooth process in time. However, GE is known to occur as a sequence of spurts, irregular both in size and in timing. Hence, we formulate a simple stochastic process model, able to represent the irregular decrements of gastric contents after a meal. The model is calibrated on existing literature data and provides consistent predictions of the observed variability in the emptying trajectories. This approach may be useful in metabolic modeling, since it describes well and explains the apparently heterogeneous GE experimental results in situations where common gastric mechanics across subjects would be expected.	[Yokrattanasak, Jiraphat; Satiracoo, Pairote; Lenbury, Yongwimon] Mahidol Univ, Dept Math, Bangkok 10400, Thailand; [Yokrattanasak, Jiraphat; Satiracoo, Pairote; Lenbury, Yongwimon] Ctr Excellence Math, Bangkok 10400, Thailand; [De Gaetano, Andrea; Panunzi, Simona] CNR, Inst Syst Anal & Informat IASI A Ruberti, Rome, Italy; [Lawton, Wayne M.] Univ Western Australia, Sch Math & Stat, Perth, WA 6009, Australia	Mahidol University; Consiglio Nazionale delle Ricerche (CNR); Istituto di Analisi dei Sistemi ed Informatica "Antonio Ruberti" (IASI-CNR); University of Western Australia	Yokrattanasak, J (corresponding author), Mahidol Univ, Dept Math, Bangkok 10400, Thailand.; Yokrattanasak, J (corresponding author), Ctr Excellence Math, Bangkok 10400, Thailand.; Yokrattanasak, J (corresponding author), CNR, Inst Syst Anal & Informat IASI A Ruberti, Rome, Italy.	jibeau17@gmail.com	Panunzi, Simona/AAK-9337-2020; De Gaetano, Andrea/AAC-4805-2021	De Gaetano, Andrea/0000-0001-7712-056X; Panunzi, Simona/0000-0003-0956-8578; Lenbury, Yongwimon/0000-0002-8270-1980	Strategic Scholarships Fellowships Frontier Research Networks, the Office of the Commission on Higher Education, Thailand; Commission on Higher Education under the program Strategic Scholarships Fellowships Frontier Research Networks, Mahidol University; Centre of Excellence in Mathematics, Thailand	Strategic Scholarships Fellowships Frontier Research Networks, the Office of the Commission on Higher Education, Thailand; Commission on Higher Education under the program Strategic Scholarships Fellowships Frontier Research Networks, Mahidol University; Centre of Excellence in Mathematics, Thailand	JY received the funding from Strategic Scholarships Fellowships Frontier Research Networks, the Office of the Commission on Higher Education, Thailand (http://www.research.mua.go.th/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Appreciation is extended toward the Commission on Higher Education under the program Strategic Scholarships Fellowships Frontier Research Networks, Mahidol University, and the Centre of Excellence in Mathematics, Thailand, for financial support.	Abell TL, 2008, AM J GASTROENTEROL, V103, P753, DOI 10.1111/j.1572-0241.2007.01636.x; Bachar M, 2013, LECT NOTES MATH, V2058, P1, DOI 10.1007/978-3-642-32157-3; Berne RM, 2004, PHYSIOLOGY, P554; BROPHY CM, 1986, DIGEST DIS SCI, V31, P799, DOI 10.1007/BF01296046; Cuenod CA, 2011, MATH BIOSCI, V233, P68, DOI 10.1016/j.mbs.2011.06.006; Dalla Man C, 2006, IEEE T BIO-MED ENG, V53, P2472, DOI 10.1109/TBME.2006.883792; De Gaetano A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070875; Ditlevsen S, 2005, MATH BIOSCI, V194, P49, DOI 10.1016/j.mbs.2004.12.007; Ditlevsen S, 2005, B MATH BIOL, V67, P547, DOI 10.1016/j.bulm.2004.09.005; Ditlevsen S., 2005, REVSTAT, V3, P137; Donnet S, 2013, ADV DRUG DELIVER REV, V65, P929, DOI 10.1016/j.addr.2013.03.005; Ferrante L, 2005, BIOMETRICAL J, V47, P309, DOI 10.1002/bimj.200410125; FRASER AG, 1995, BRIT J CLIN PHARMACO, V40, P387, DOI 10.1111/j.1365-2125.1995.tb04561.x; Gebraeel NZ, 2005, IIE TRANS, V37, P543, DOI 10.1080/07408170590929018; Goetze O, 2007, AM J PHYSIOL-GASTR L, V292, pG11, DOI 10.1152/ajpgi.00498.2005; Hiren MR, 2011, INT RES J PHARM, V2, P106; JOBLING M, 1986, ENVIRON BIOL FISH, V16, P35, DOI 10.1007/BF00005158; Kim I, 2010, STAT MED, V29, P1839, DOI 10.1002/sim.3956; Lamberton D., 1996, INTRO STOCHASTIC CAL; Locatelli I, 2009, PHARM RES-DORDR, V26, P1607, DOI 10.1007/s11095-009-9869-3; Mettetal JT, 2006, P NATL ACAD SCI USA, V103, P7304, DOI 10.1073/pnas.0509874103; Michael J, 2010, FUNDAMENTALS MED PHY, P430; MOCH KJ, 1993, Z ERNAHRUNGSWISS, V32, P2, DOI 10.1007/BF01610081; Modchang C, 2010, PHYS BIOL, V7, DOI 10.1088/1478-3975/7/2/026008; Neisy A, 2011, WORLD APPL SCI J, V13, P2288; Ogungbenro K, 2012, EUR J PHARM SCI, V45, P302, DOI 10.1016/j.ejps.2011.11.020; Patton KT, 2009, ANATOMY PHYSL, P882; Pedersen JF, 2003, ACTA RADIOL, V44, P340, DOI 10.1034/j.1600-0455.2003.00055.x; Perri F, 2005, Eur Rev Med Pharmacol Sci, V9, P3; Picchini U, 2008, MATH MED BIOL, V25, P141, DOI 10.1093/imammb/dqn011; Picchini U, 2006, J MATH BIOL, V53, P771, DOI 10.1007/s00285-006-0032-z; Ramanathan M, 1999, PHARMACEUT RES, V16, P584, DOI 10.1023/A:1011910800110; ROSE EF, 1979, J FORENSIC SCI, V24, P200; Salinari S, 2011, AM J PHYSIOL-ENDOC M, V300, pE955, DOI 10.1152/ajpendo.00451.2010; Schirra J, 1996, J CLIN INVEST, V97, P92, DOI 10.1172/JCI118411; Sherwood L, 2010, HUMAN PHYSL CELLS SY, P591; Si XS, 2013, MECH SYST SIGNAL PR, V35, P219, DOI 10.1016/j.ymssp.2012.08.016; Si XS, 2011, EUR J OPER RES, V213, P1, DOI 10.1016/j.ejor.2010.11.018; SIEGEL JA, 1988, GUT, V29, P85, DOI 10.1136/gut.29.1.85; Srivastava R, 2002, J THEOR BIOL, V218, P309, DOI 10.1006/jtbi.2002.3078; Stamatakis M, 2009, BIOPHYS J, V96, P887, DOI 10.1016/j.bpj.2008.10.028; STUBBS DF, 1977, GUT, V18, P202, DOI 10.1136/gut.18.3.202; Tvrdonova M, 2009, BASIC CLIN PHARMACOL, V104, P35, DOI 10.1111/j.1742-7843.2008.00304.x; Vinik A, 2008, DIABETES CARE, V31, P2410, DOI 10.2337/dc08-1694; Yu LX, 1999, INT J PHARMACEUT, V186, P119, DOI 10.1016/S0378-5173(99)00147-7	45	17	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2016	11	4							e0153297	10.1371/journal.pone.0153297	http://dx.doi.org/10.1371/journal.pone.0153297			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6JK	27057750	Green Submitted, Green Published, gold			2022-12-27	WOS:000373604800027
J	Cardnell, RJ; Feng, Y; Mukherjee, S; Diao, LX; Tong, P; Stewart, CA; Masrorpour, F; Fan, YH; Nilsson, M; Shen, YQ; Heymach, JV; Wang, J; Byers, LA				Cardnell, Robert J.; Feng, Ying; Mukherjee, Seema; Diao, Lixia; Tong, Pan; Stewart, C. Allison; Masrorpour, Fatemeh; Fan, YouHong; Nilsson, Monique; Shen, Yuqiao; Heymach, John V.; Wang, Jing; Byers, Lauren A.			Activation of the PI3K/mTOR Pathway following PARP Inhibition in Small Cell Lung Cancer	PLOS ONE			English	Article							DRUG-DRUG INTERACTIONS; BREAST-CANCER; PI3K INHIBITOR; DNA-REPAIR; POLY(ADP-RIBOSE) POLYMERASE; THERAPEUTIC TARGETS; IN-VITRO; TUMORS; CARCINOMA; RESISTANCE	Small cell lung cancer (SCLC) is an aggressive malignancy with limited treatment options. We previously found that PARP is overexpressed in SCLC and that targeting PARP reduces cell line and tumor growth in preclinical models. However, SCLC cell lines with PI3K/mTOR pathway activation were relatively less sensitive to PARP inhibition. In this study, we investigated the proteomic changes in PI3K/mTOR and other pathways that occur following PAPR inhibition and/or knockdown in vitro and in vivo. Using reverse-phase protein array, we found the proteins most significantly upregulated following treatment with the PARP inhibitors olaparib and rucaparib were in the PI3K/mTOR pathway (p-mTOR, p-AKT, and pS6) (p <= 0.02). Furthermore, amongst the most significantly down-regulated proteins were LKB1 and its targets AMPK and TSC, which negatively regulate the PI3K pathway (p <= 0.042). Following PARP knockdown in cell lines, phosphorylated mTOR, AKT and S6 were elevated and LKB1 signaling was diminished. Global ATP concentrations increased following PARP inhibition (p <= 0.02) leading us to hypothesize that the observed increased PI3K/mTOR pathway activation following PARP inhibition results from decreased ATP usage and a subsequent decrease in stress response signaling via LKB1. Based on these results, we then investigated whether co-targeting with a PARP and PI3K inhibitor (BKM-120) would work better than either single agent alone. A majority of SCLC cell lines were sensitive to BKM-120 at clinically achievable doses, and cMYC expression was the strongest biomarker of response. At clinically achievable doses of talazoparib (the most potent PARP inhibitor in SCLC clinical testing) and BKM-120, an additive effect was observed in vitro. When tested in two SCLC animal models, a greater than additive interaction was seen (p <= 0.008). The data presented here suggest that combining PARP and PI3K inhibitors enhances the effect of either agent alone in preclinical models of SCLC, warranting further investigation of such combinations in SCLC patients.	[Cardnell, Robert J.; Mukherjee, Seema; Stewart, C. Allison; Masrorpour, Fatemeh; Fan, YouHong; Nilsson, Monique; Heymach, John V.; Byers, Lauren A.] Univ Texas MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX 77030 USA; [Feng, Ying] Biomarin Pharmaceut Inc, Novato, CA USA; [Diao, Lixia; Tong, Pan; Shen, Yuqiao; Wang, Jing] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; BioMarin Pharmaceutical Inc.; University of Texas System; UTMD Anderson Cancer Center	Byers, LA (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX 77030 USA.	lbyers@mdanderson.org	Heymach, John/AAG-2361-2019	Heymach, John/0000-0001-9068-8942	MD Anderson Cancer Center Support Grant [NIH P30 CA016672]; University of Texas-Southwestern and MD Anderson Cancer Center Lung SPORE [5 P50 CA070907]; NIH [1R01 CA168484-01]; Rexanna's Foundation for Fighting Lung Cancer; MD Anderson Cancer Center Physician Scientist Award; Lee Clark Fellowship of The University of Texas MD Anderson Cancer Center - Jeane F. Shelby Scholarship Fund; NCI Cancer Clinical Investigator Team Leadership Award [P30 CA016672]; Sheikh Khalifa Bin Zayed Al Nahyan Institute for the Personalized Cancer Therapy's (IPCT's) Center for Professional Education and Training; National Lung Cancer Research Partnership; Lung Cancer Research Foundation; LUNGevity Foundation; Sidney Kimmel Foundation for Cancer Research; NATIONAL CANCER INSTITUTE [P50CA070907, R01CA168484, P30CA016672] Funding Source: NIH RePORTER	MD Anderson Cancer Center Support Grant; University of Texas-Southwestern and MD Anderson Cancer Center Lung SPORE; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rexanna's Foundation for Fighting Lung Cancer; MD Anderson Cancer Center Physician Scientist Award; Lee Clark Fellowship of The University of Texas MD Anderson Cancer Center - Jeane F. Shelby Scholarship Fund; NCI Cancer Clinical Investigator Team Leadership Award; Sheikh Khalifa Bin Zayed Al Nahyan Institute for the Personalized Cancer Therapy's (IPCT's) Center for Professional Education and Training; National Lung Cancer Research Partnership; Lung Cancer Research Foundation; LUNGevity Foundation; Sidney Kimmel Foundation for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by MD Anderson Cancer Center Support Grant (NIH P30 CA016672); University of Texas-Southwestern and MD Anderson Cancer Center Lung SPORE (5 P50 CA070907); through generous philanthropic contributions to The University of Texas MD Anderson Lung Cancer Moon Shot Program; NIH 1R01 CA168484-01 (JVH); David Bruton, Jr., Endowed Chair (JVH); the Rexanna's Foundation for Fighting Lung Cancer (http://www.rexannasfoundation.org/) (JVH); MD Anderson Cancer Center Physician Scientist Award (LAB); Lee Clark Fellowship of The University of Texas MD Anderson Cancer Center, supported by the Jeane F. Shelby Scholarship Fund (LAB); an NCI Cancer Clinical Investigator Team Leadership Award (P30 CA016672) (LAB); The Sheikh Khalifa Bin Zayed Al Nahyan Institute for the Personalized Cancer Therapy's (IPCT's) Center for Professional Education and Training (LAB); the National Lung Cancer Research Partnership, made possible by the North Carolina Lung Cancer Partnership (http://www.freetobreathe.org/) (LAB); the Lung Cancer Research Foundation (http://www.lungcancerresearchfoundation.org/) (LAB); LUNGevity Foundation (http://www.lungevity.org/) (LAB); and The Sidney Kimmel Foundation for Cancer Research (http://kimmel.org/) (LAB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addie M, 2013, J MED CHEM, V56, P2059, DOI 10.1021/jm301762v; Bendell JC, 2012, J CLIN ONCOL, V30, P282, DOI 10.1200/JCO.2011.36.1360; Bliss CI, 1939, ANN APPL BIOL, V26, P585, DOI 10.1111/j.1744-7348.1939.tb06990.x; Bouwman P, 2014, CLIN CANCER RES, V20, P540, DOI 10.1158/1078-0432.CCR-13-0225; Britten CD, 2013, CANCER CHEMOTH PHARM, V71, P1395, DOI 10.1007/s00280-013-2121-1; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Burger MT, 2011, ACS MED CHEM LETT, V2, P774, DOI 10.1021/ml200156t; Byers LA, 2015, CANCER-AM CANCER SOC, V121, P664, DOI 10.1002/cncr.29098; Byers LA, 2013, CLIN CANCER RES, V19, P279, DOI 10.1158/1078-0432.CCR-12-1558; Byers LA, 2012, CANCER DISCOV, V2, P798, DOI 10.1158/2159-8290.CD-12-0112; Cardnell RJ, 2013, CLIN CANCER RES, V19, P6322, DOI 10.1158/1078-0432.CCR-13-1975; Cardnell RJG, 2015, CLIN CANCER RES, V21, P3480, DOI 10.1158/1078-0432.CCR-14-3286; Cascone T, 2011, J CLIN INVEST, V121, P1313, DOI 10.1172/JCI42405; Chen ZT, 2015, MOL MED REP, V12, P1868, DOI 10.3892/mmr.2015.3604; Dejan J., 2012, AACR 103 ANN M; Ebi H, 2013, P NATL ACAD SCI USA, V110, P21124, DOI 10.1073/pnas.1314124110; Ethier C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047978; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; George J, 2015, NATURE, V524, P47, DOI 10.1038/nature14664; Govindan R, 2006, J CLIN ONCOL, V24, P4539, DOI 10.1200/JCO.2005.04.4859; Hardie DG, 2014, ANNU REV NUTR, V34, P31, DOI 10.1146/annurev-nutr-071812-161148; Hu J, 2007, BIOINFORMATICS, V23, P1986, DOI 10.1093/bioinformatics/btm283; Ibrahim YH, 2012, CANCER DISCOV, V2, P1036, DOI 10.1158/2159-8290.CD-11-0348; Ilic N, 2011, P NATL ACAD SCI USA, V108, pE699, DOI 10.1073/pnas.1108237108; Juvekar A, 2012, CANCER DISCOV, V2, P1048, DOI 10.1158/2159-8290.CD-11-0336; Kim MY, 2005, GENE DEV, V19, P1951, DOI 10.1101/gad.1331805; Kong DX, 2014, INVEST NEW DRUG, V32, P1134, DOI 10.1007/s10637-014-0152-z; Korsse SE, 2013, BBA-REV CANCER, V1835, P194, DOI 10.1016/j.bbcan.2012.12.006; Matulonis U, AACR ANN M 2015 PHIL; Matulonis U, 2014, J CLIN ONCOL, V32, p5s; Mazumdar T, 2014, MOL CANCER THER, V13, P2738, DOI 10.1158/1535-7163.MCT-13-1090; Neeley ES, 2012, CANCER INFORM, V11, P77, DOI 10.4137/CIN.S9055; Owonikoko TK, 2015, LUNG CANCER, V89, P66, DOI 10.1016/j.lungcan.2015.04.015; Peifer M, 2012, NAT GENET, V44, P1104, DOI 10.1038/ng.2396; PRICHARD MN, 1990, ANTIVIR RES, V14, P181, DOI 10.1016/0166-3542(90)90001-N; Schaffer BE, 2010, CANCER RES, V70, P3877, DOI 10.1158/0008-5472.CAN-09-4228; Serra V, 2011, ONCOGENE, V30, P2547, DOI 10.1038/onc.2010.626; Shen YQ, 2015, J PHARMACOL EXP THER, V353, P446, DOI 10.1124/jpet.114.222448; Sos ML, 2009, P NATL ACAD SCI USA, V106, P18351, DOI 10.1073/pnas.0907325106; Tong P, 2015, BIOINFORMATICS, V31, P1692, DOI 10.1093/bioinformatics/btv028; U.S. Cancer Statistics Working Group, 2014, US CANC STAT 1999 20; Umemura S, 2014, J THORAC ONCOL, V9, P1324, DOI 10.1097/JTO.0000000000000250; Wainberg Z, 2014, J CLIN ONCOL S, V32, p5s; Walls M, 2014, CLIN CANCER RES, V20, P631, DOI 10.1158/1078-0432.CCR-13-1663; Wang LF, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2565; Wang T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013662; Wojtalla A, 2013, CLIN CANCER RES, V19, P96, DOI 10.1158/1078-0432.CCR-12-1138; Zhou J, 2013, FEBS LETT, V587, P170, DOI 10.1016/j.febslet.2012.11.018	48	61	62	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0152584	10.1371/journal.pone.0152584	http://dx.doi.org/10.1371/journal.pone.0152584			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27055253	Green Submitted, gold, Green Published			2022-12-27	WOS:000373608000025
J	Hart, TA; Stratton, N; Coleman, TA; Wilson, HA; Simpson, SH; Julien, RE; Hoe, D; Leahy, B; Maxwell, J; Adam, BD				Hart, Trevor A.; Stratton, Natalie; Coleman, Todd A.; Wilson, Holly A.; Simpson, Scott H.; Julien, Rick E.; Hoe, David; Leahy, Bob; Maxwell, John; Adam, Barry D.			A Pilot Trial of a Sexual Health Counseling Intervention for HIV-Positive Gay and Bisexual MenWho Report Anal Sex without Condoms	PLOS ONE			English	Article							RISK BEHAVIOR; SENSATION SEEKING; COMPULSIVITY; LONELINESS; RELIABILITY; PREVENTION; DIAGNOSIS; VALIDITY; SAMPLE; CITY	Background Even in the presence of promising biomedical treatment as prevention, HIV incidence among men who have sex with men has not always decreased. Counseling interventions, therefore, continue to play an important role in reducing HIV sexual transmission behaviors among gay and bisexual men and other men who have sex with men. The present study evaluated effects of a small-group counseling intervention on psychosocial outcomes and HIV sexual risk behavior. Method HIV-positive (HIV+) peer counselors administered seven 2-hour counseling sessions to groups of 5 to 8 HIV+ gay and bisexual men. The intervention employed information provision, motivational interviewing, and behavioral skills building to reduce sexual transmission risk behaviors. Results There was a significant reduction in condomless anal sex (CAS) with HIV-negative and unknown HIV-status partners, from 50.0% at baseline to 28.9% of the sample at 3-month follow-up. Findings were robust even when controlling for whether the participant had an undetectable viral load at baseline. Significant reductions were also found in the two secondary psychosocial outcomes, loneliness and sexual compulsivity. Conclusions The findings provide preliminary evidence that this intervention may offer an efficient way of concurrently reducing CAS and mental health problems, such as sexual compulsivity and loneliness, for HIV+ gay and bisexual men.	[Hart, Trevor A.; Stratton, Natalie; Coleman, Todd A.; Wilson, Holly A.] Ryerson Univ, Dept Psychol, Toronto, ON, Canada; [Hart, Trevor A.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Simpson, Scott H.; Julien, Rick E.; Maxwell, John] AIDS Comm Toronto, Toronto, ON, Canada; [Hoe, David; Leahy, Bob] Gay Mens Sexual Hlth Alliance, Poz Prevent Working Grp, Toronto, ON, Canada; [Adam, Barry D.] Univ Windsor, Dept Sociol Anthropol & Criminol, Windsor, ON N9B 3P4, Canada; [Adam, Barry D.] Ontario HIV Treatment Network, Toronto, ON, Canada	Toronto Metropolitan University; University of Toronto; University of Windsor	Hart, TA (corresponding author), Ryerson Univ, Dept Psychol, Toronto, ON, Canada.; Hart, TA (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada.	trevor.hart@ryerson.ca		Adam, Barry/0000-0002-8836-4153; Hart, Trevor/0000-0001-5107-7452	Canadian Institutes of Health Research Community-Based Research Operating Grant [194233]; Ontario HIV Treatment Network START Development Grants in Prevention Research START 100; Ontario HIV Treatment Network Career Scientist Award [650]; Canadian Institutes of Health Research New Investigator Salary Award	Canadian Institutes of Health Research Community-Based Research Operating Grant(Canadian Institutes of Health Research (CIHR)); Ontario HIV Treatment Network START Development Grants in Prevention Research START 100; Ontario HIV Treatment Network Career Scientist Award; Canadian Institutes of Health Research New Investigator Salary Award(Canadian Institutes of Health Research (CIHR))	The study was funded by the Canadian Institutes of Health Research Community-Based Research Operating Grant #194233 and Ontario HIV Treatment Network START Development Grants in Prevention Research START 100. During the study, TAH was supported by Ontario HIV Treatment Network Career Scientist Award #650 and a Canadian Institutes of Health Research New Investigator Salary Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam BD, 2007, RISK MANAGEMENT CIRC; [Anonymous], 2014, HIV GAY BIS MEN FACT; Baggaley RF, 2010, AIDS, V24, P2418, DOI 10.1097/QAD.0b013e32833dbdfd; Bancroft J, 2003, ARCH SEX BEHAV, V32, P555, DOI 10.1023/A:1026041628364; Bing EG, 2001, ARCH GEN PSYCHIAT, V58, P721, DOI 10.1001/archpsyc.58.8.721; Bruun T, 2014, C RETR OPP INF 2014; Chen SY, 2003, JAIDS-J ACQ IMM DEF, V33, P166, DOI 10.1097/00126334-200306010-00008; Cox J, 2006, M TRACK HIV SURV SYS; Curry M, 2003, HIV MED, V4, P271; Davis M, 2004, SEX TRANSM INFECT, V80, P451; DiClemente C.C., 2002, MOTIVATIONAL INTERVI, V2nd ed., P201; Dodds JP, 2006, INT AIDS C 2006 AUG, P13; Dodge B, 2008, SEX TRANSM INFECT, V84, P324, DOI 10.1136/sti.2007.028696; Fisher J, 2004, J ACQ IMMUN DEF SYND, V7, pS78; Fisher J, 1998, INT AIDS C 1998 JUN, P3; Fisher JD, 2002, HEALTH PSYCHOL, V21, P177, DOI 10.1037//0278-6133.21.2.177; Frankis JS, 2006, AIDS CARE, V18, P54, DOI 10.1080/09540120500159482; Golin CE, 2012, AIDS BEHAV, V16, P1182, DOI 10.1007/s10461-011-0025-9; Grov C, 2010, AIDS CARE, V22, P630, DOI 10.1080/09540120903280901; Grov C, 2010, ARCH SEX BEHAV, V39, P788, DOI 10.1007/s10508-008-9439-5; Grulich AE, 1998, AIDS, V12, P2508; Halkitis PN, 2008, J GAY LESBIAN SOC SE, V20, P288, DOI 10.1080/10538720802310709; Halkitis PN, 2005, AIDS, V19, pS27, DOI 10.1097/01.aids.0000167349.23374.a3; Hart TA, 2015, COG BEHAV P IN PRESS; Hart TA, 2010, J ASSOC NURSE AIDS C, V21, P439, DOI 10.1016/j.jana.2010.06.001; Herbst JH, 2007, AM J PREV MED, V32, pS38, DOI 10.1016/j.amepre.2006.12.006; Hoots BE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132962; Hospers HJ, 2005, AIDS, V19, P1097, DOI 10.1097/01.aids.0000174457.08992.62; Hubach RD, 2015, AIDS EDUC PREV, V27, P72, DOI 10.1521/aeap.2015.27.1.72; Hull MW, 2013, J FOOD DRUG ANAL, V21, pS95, DOI 10.1016/j.jfda.2013.09.043; Johnson WD, 2005, AIDS EDUC PREV, V17, P568, DOI 10.1521/aeap.2005.17.6.568; Johnson WD, 2008, COCHRANE LIB, V3, P1; KALICHMAN SC, 1994, J PERS ASSESS, V62, P385, DOI 10.1207/s15327752jpa6203_1; KALICHMAN SC, 1995, J PERS ASSESS, V65, P586, DOI 10.1207/s15327752jpa6503_16; Kirby T, 2014, LANCET, V383, P399, DOI 10.1016/S0140-6736(14)60137-9; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Ling DI, 2015, SEX TRANSM DIS, V42, P153, DOI 10.1097/OLQ.0000000000000250; Mansergh G, 2002, AIDS, V16, P653, DOI 10.1097/00002030-200203080-00018; Marcus U, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-014-0738-2; Martin JI, 1997, PSYCHOL REP, V81, P815, DOI 10.2466/pr0.1997.81.3.815; Mimiaga MJ, 2012, AIDS PATIENT CARE ST, V26, P681, DOI 10.1089/apc.2012.0216; Montero-Marin J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087071; Morin SF, 2005, JAIDS-J ACQ IMM DEF, V40, P226, DOI 10.1097/01.qai.0000166375.16222.eb; Moser E. B., 2004, P 29 ANN SAS US GROU; Moskowitz DA, 2007, SEX ADDICT COMPULS, V14, P21, DOI 10.1080/10720160601150121; Myers T, 2004, ADDICT RES THEORY, V12, P213, DOI 10.1080/16066350310001640161; Parsons JT, 2012, AM J PUBLIC HEALTH, V102, P156, DOI 10.2105/AJPH.2011.300284; Parsons JT, 2003, AIDS EDUC PREV, V15, P383, DOI 10.1521/aeap.15.6.383.24043; Parsons JT, 2015, AIDS BEHAV, P1; Pathela P, 2011, JAIDS-J ACQ IMM DEF, V58, P408, DOI 10.1097/QAI.0b013e318230e1ca; Pererson JL, 2006, J COMMUNITY PSYCHOL, V34, P37, DOI 10.1002/jcop.20082; Philp A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077200; Public Health Agency of Canada, 2013, HIV AIDS CAN SURV RE; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rollnick S., 2008, MOTIVATIONAL INTERVI; Rompa D, 2001, AM J PREV MED, V21, P84; Russell DW, 1996, J PERS ASSESS, V66, P20, DOI 10.1207/s15327752jpa6601_2; Safren SA, 2010, JAIDS J ACQ IMMUN S1, V55, P74; Safren SA, 2011, AIDS BEHAV, V15, pS30, DOI 10.1007/s10461-011-9898-x; Sanchez Travis Howard, 2015, JMIR Public Health Surveill, V1, pe3, DOI 10.2196/publichealth.4314; Sim MG, 2009, AUST FAM PHYSICIAN, V38, P986; Stall R, 2003, AM J PUBLIC HEALTH, V93, P939, DOI 10.2105/AJPH.93.6.939; Tulloch TG, 2015, ARCH SEX BEHAV; Wejnert C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076878; Whittier DK, 2005, ARCH SEX BEHAV, V34, P95, DOI 10.1007/s10508-005-1003-y; Wolitski RJ, 2011, AIDS BEHAV, V15, pS9, DOI 10.1007/s10461-011-9901-6	66	17	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0152762	10.1371/journal.pone.0152762	http://dx.doi.org/10.1371/journal.pone.0152762			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DI6KO	27054341	Green Published, Green Submitted, gold			2022-12-27	WOS:000373608000043
J	Murata, A; Saito, H; Schug, J; Ogawa, K; Kameda, T				Murata, Aiko; Saito, Hisamichi; Schug, Joanna; Ogawa, Kenji; Kameda, Tatsuya			Spontaneous Facial Mimicry Is Enhanced by the Goal of Inferring Emotional States: Evidence for Moderation of "Automatic" Mimicry by Higher Cognitive Processes	PLOS ONE			English	Article							GENDER-DIFFERENCES; SOCIAL-CONTEXT; EXPRESSIONS; IMITATION; CONTAGION; RESPONSES; FAIRNESS; DISPLAY; EMPATHY; IMPACT	A number of studies have shown that individuals often spontaneously mimic the facial expressions of others, a tendency known as facial mimicry. This tendency has generally been considered a reflex-like "automatic" response, but several recent studies have shown that the degree of mimicry may be moderated by contextual information. However, the cognitive and motivational factors underlying the contextual moderation of facial mimicry require further empirical investigation. In this study, we present evidence that the degree to which participants spontaneously mimic a target's facial expressions depends on whether participants are motivated to infer the target's emotional state. In the first study we show that facial mimicry, assessed by facial electromyography, occurs more frequently when participants are specifically instructed to infer a target's emotional state than when given no instruction. In the second study, we replicate this effect using the Facial Action Coding System to show that participants are more likely to mimic facial expressions of emotion when they are asked to infer the target's emotional state, rather than make inferences about a physical trait unrelated to emotion. These results provide convergent evidence that the explicit goal of understanding a target's emotional state affects the degree of facial mimicry shown by the perceiver, suggesting moderation of reflex-like motor activities by higher cognitive processes.	[Murata, Aiko; Saito, Hisamichi] Hokkaido Univ, Dept Behav Sci, Sapporo, Hokkaido, Japan; [Murata, Aiko] Japan Soc Promot Sci, Tokyo, Japan; [Schug, Joanna] Coll William & Mary, Dept Psychol, Williamsburg, VA 23185 USA; [Ogawa, Kenji] Hokkaido Univ, Dept Psychol, Sapporo, Hokkaido, Japan; [Kameda, Tatsuya] Univ Tokyo, Dept Social Psychol, Tokyo, Japan	Hokkaido University; Japan Society for the Promotion of Science; William & Mary; Hokkaido University; University of Tokyo	Kameda, T (corresponding author), Univ Tokyo, Dept Social Psychol, Tokyo, Japan.	tkameda@l.u-tokyo.ac.jp		Schug, Joanna/0000-0003-1925-9496; Ogawa, Kenji/0000-0003-3556-1038	Japan Society for the Promotion of Science [25118004]; Japan Society for the Promotion of Science, Topic-Setting Program to Advance Cutting-Edge Humanities and Social Sciences Research; Grants-in-Aid for Scientific Research [16H06324] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Society for the Promotion of Science, Topic-Setting Program to Advance Cutting-Edge Humanities and Social Sciences Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The study design, data collection and analysis were supported by Japan Society for the Promotion of Science, Grant-in-aid for Scientific Research on Innovative Areas (#25118004, PI: Tatsuya Kameda). Preparation of the manuscript was supported by Japan Society for the Promotion of Science, Topic-Setting Program to Advance Cutting-Edge Humanities and Social Sciences Research (PI: Tatsuya Kameda).	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Bailey PE, 2009, PSYCHOL AGING, V24, P995, DOI 10.1037/a0015789; Bourgeois P, 2008, BIOL PSYCHOL, V77, P343, DOI 10.1016/j.biopsycho.2007.11.008; BREHM SS, 1984, SEX ROLES, V10, P405, DOI 10.1007/BF00287557; Cannon PR, 2009, COGNITION EMOTION, V23, P918, DOI 10.1080/02699930802234864; Davila-Ross M, 2011, EMOTION, V11, P1013, DOI 10.1037/a0022594; Dimberg U, 2000, PSYCHOL SCI, V11, P86, DOI 10.1111/1467-9280.00221; Dimberg U, 2000, PSYCHOPHYSIOLOGY, V37, P693, DOI 10.1111/1469-8986.3750693; DIMBERG U, 1990, BIOL PSYCHOL, V30, P151, DOI 10.1016/0301-0511(90)90024-Q; Ekman P, 2002, FACS MANUAL; Fischer AH, 2012, FRONT PSYCHOL, V3, P268; FRIDLUND AJ, 1986, PSYCHOPHYSIOLOGY, V23, P567, DOI 10.1111/j.1469-8986.1986.tb00676.x; Gallese V., 2005, PHENOMENOLOGY COGNIT, V4, P23, DOI [10.1007/s11097-005-4737-z, DOI 10.1007/S11097-005-4737-Z]; Gunes H, 2013, IMAGE VISION COMPUT, V31, P120, DOI 10.1016/j.imavis.2012.06.016; Hawrysh B. M., 1991, ASIA PAC J MARKET LO, V3, P40, DOI [DOI 10.1108/EB010222, 10.1108/eb010222]; Hess U, 2001, INT J PSYCHOPHYSIOL, V40, P129, DOI 10.1016/S0167-8760(00)00161-6; Hess U, 2013, PERS SOC PSYCHOL REV, V17, P142, DOI 10.1177/1088868312472607; Hofman D, 2012, P ROY SOC B-BIOL SCI, V279, P3535, DOI 10.1098/rspb.2012.0694; Humphrey N., 1984, NEW SCI; Iacoboni M, 2006, NAT REV NEUROSCI, V7, P942, DOI 10.1038/nrn2024; Ickes W, 2000, PERS RELATIONSHIP, V7, P95, DOI 10.1111/j.1475-6811.2000.tb00006.x; Kameda T, 2005, CURR DIR PSYCHOL SCI, V14, P331, DOI 10.1111/j.0963-7214.2005.00392.x; Kameda T, 2015, EVOL PSYCHOL-SER, P243, DOI 10.1007/978-3-319-12697-5_19; Kameda T, 2012, PERS SOC PSYCHOL B, V38, P997, DOI 10.1177/0146167212442229; Konvalinka I, 2011, P NATL ACAD SCI USA, V108, P8514, DOI 10.1073/pnas.1016955108; Kret ME, 2015, PSYCHOL SCI, V26, P1401, DOI 10.1177/0956797615588306; Kret ME, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104886; Lamm C, 2011, NEUROIMAGE, V54, P2492, DOI 10.1016/j.neuroimage.2010.10.014; LUNDQVIST LO, 1995, SCAND J PSYCHOL, V36, P130, DOI 10.1111/j.1467-9450.1995.tb00974.x; Mancini G, 2013, SCI REP-UK, V3, DOI 10.1038/srep01527; McCarthy A, 2008, J CROSS CULT PSYCHOL, V39, P716, DOI 10.1177/0022022108323807; McCarthy A, 2006, J CROSS CULT PSYCHOL, V37, P717, DOI 10.1177/0022022106292079; MELTZOFF AN, 1977, SCIENCE, V198, P75, DOI 10.1126/science.198.4312.75; Mitchell JP, 2009, PHILOS T R SOC B, V364, P1309, DOI 10.1098/rstb.2008.0318; Myowa-Yamakoshi M, 2004, DEVELOPMENTAL SCI, V7, P437, DOI 10.1111/j.1467-7687.2004.00364.x; Oberman LM, 2007, SOC NEUROSCI-UK, V2, P167, DOI 10.1080/17470910701391943; Palagi E, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150505; Rizzolatti G, 2001, NAT REV NEUROSCI, V2, P661, DOI 10.1038/35090060; Ross MD, 2008, BIOL LETTERS, V4, P27, DOI 10.1098/rsbl.2007.0535; Rychlowska M, 2015, P NATL ACAD SCI USA, V112, pE2429, DOI 10.1073/pnas.1413661112; Sato W, 2007, COGNITION, V104, P1, DOI 10.1016/j.cognition.2006.05.001; Schutz-Bosbach S, 2007, TRENDS COGN SCI, V11, P349, DOI 10.1016/j.tics.2007.06.005; Seibt B, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01122; Singer T, 2006, NATURE, V439, P466, DOI 10.1038/nature04271; Tamura Ryo, 2006, Shinrigaku Kenkyu, V77, P377; Vrana SR, 2004, BIOL PSYCHOL, V66, P63, DOI 10.1016/j.biopsycho.2003.07.004; Zaki J, 2012, NAT NEUROSCI, V15, P675, DOI 10.1038/nn.3085	47	27	27	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153128	10.1371/journal.pone.0153128	http://dx.doi.org/10.1371/journal.pone.0153128			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DI6KO	27055206	gold, Green Published			2022-12-27	WOS:000373608000081
J	Tobias, J; Von Mentzer, A; Frykberg, PL; Aslett, M; Page, AJ; Sjoling, A; Svennerholm, AM				Tobias, Joshua; Von Mentzer, Astrid; Frykberg, Patricia Loayza; Aslett, Martin; Page, Andrew J.; Sjoling, Asa; Svennerholm, Ann-Mari			Stability of the Encoding Plasmids and Surface Expression of CS6 Differs in Enterotoxigenic Escherichia coli (ETEC) Encoding Different Heat-Stable (ST) Enterotoxins (STh and STp)	PLOS ONE			English	Article							COLONIZATION FACTOR CS6; FACTOR-ANTIGEN-I; STRAINS; BINDING; CHILDREN; PROTEIN; ISOLATE; TOXINS	Enterotoxigenic Escherichia coli (ETEC), one of the most common reasons of diarrhea among infants and children in developing countries, causes disease by expression of either or both of the enterotoxins heat-labile (LT) and heat-stable (ST; divided into human-type [STh] and porcine-type [STp] variants), and colonization factors (CFs) among which CS6 is one of the most prevalent ETEC CFs. In this study we show that ETEC isolates expressing CS6+STh have higher copy numbers of the cssABCD operon encoding CS6 than those expressing CS6+STp. Long term cultivation of up to ten over-night passages of ETEC iso-lates harboring CS6+STh (n = 10) or CS6+STp (n = 15) showed instability of phenotypic expression of CS6 in a majority of the CS6+STp isolates, whereas most of the CS6+STh isolates retained CS6 expression. The observed instability was a correlated with loss of genes cssA and cssD as examined by PCR. Mobilization of the CS6 plasmid from an unstable CS6+STp isolate into a laboratory E. coli strain resulted in loss of the plasmid after a single over-night passage whereas the plasmid from an CS6+STh strain was retained in the laboratory strain during 10 passages. A sequence comparison between the CS6 plasmids from a stable and an unstable ETEC isolate revealed that genes necessary for plasmid stabilization, for example pemI, pemK, stbA, stbB and parM, were not present in the unstable ETEC isolate. Our results indicate that stable retention of CS6 may in part be affected by the stability of the plasmid on which both CS6 and STp or STh are located.	[Tobias, Joshua; Von Mentzer, Astrid; Frykberg, Patricia Loayza; Sjoling, Asa; Svennerholm, Ann-Mari] Univ Gothenburg, Inst Biomed, Dept Microbiol & Immunol, S-40530 Gothenburg, Sweden; [Aslett, Martin; Page, Andrew J.] Wellcome Trust Sanger Inst, Pathogen Genom, Cambridge CB10 1SA, England; [Sjoling, Asa] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, S-17177 Stockholm, Sweden	University of Gothenburg; Wellcome Trust Sanger Institute; Karolinska Institutet	Tobias, J (corresponding author), Univ Gothenburg, Inst Biomed, Dept Microbiol & Immunol, S-40530 Gothenburg, Sweden.	joshua.tobias@meduniwien.ac.at	von Mentzer, Astrid/I-5449-2018	von Mentzer, Astrid/0000-0002-2167-1394; Page, Andrew/0000-0001-6919-6062; Sjoling, Asa/0000-0003-1529-1720	Swedish Research Council; Swedish Foundation for Strategic Research [SB12-0072]; Wellcome Trust [WT 098051]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by grants from the Swedish Research Council, the Swedish Foundation for Strategic Research (grant no SB12-0072) and the Wellcome Trust (grant WT 098051).	Chin CS, 2013, NAT METHODS, V10, P563, DOI [10.1038/NMETH.2474, 10.1038/nmeth.2474]; Debnath A, 2015, MICROBIOL-SGM, V161, P865, DOI 10.1099/mic.0.000038; ECHEVERRIA P, 1986, INFECT IMMUN, V51, P626, DOI 10.1128/IAI.51.2.626-630.1986; EVANS DG, 1979, INFECT IMMUN, V25, P738, DOI 10.1128/IAI.25.2.738-748.1979; Gaastra W, 1996, TRENDS MICROBIOL, V4, P444, DOI 10.1016/0966-842X(96)10068-8; Helander A, 1997, J CLIN MICROBIOL, V35, P867, DOI 10.1128/JCM.35.4.867-872.1997; Hunt Martin, 2015, Genome Biol, V16, P294, DOI 10.1186/s13059-015-0849-0; Jansson L, 2006, INFECT IMMUN, V74, P3488, DOI 10.1128/IAI.02006-05; Jansson L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004487; Munson GP, 2000, MOL MICROBIOL, V36, P1391, DOI 10.1046/j.1365-2958.2000.01957.x; MURRAY BE, 1983, J BACTERIOL, V153, P566, DOI 10.1128/JB.153.1.566-570.1983; Nagy B, 1999, VET RES, V30, P259; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; Nicklasson M, 2008, MICROB PATHOGENESIS, V44, P246, DOI 10.1016/j.micpath.2007.06.009; Qadri F, 2005, CLIN MICROBIOL REV, V18, P465, DOI 10.1128/CMR.18.3.465-483.2005; Rodas C, 2009, J CLIN MICROBIOL, V47, P1218, DOI 10.1128/JCM.00316-09; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Shaheen HI, 2009, J CLIN MICROBIOL, V47, P189, DOI 10.1128/JCM.01282-08; SOMMERFELT H, 1989, APMIS, V97, P436, DOI 10.1111/j.1699-0463.1989.tb00812.x; THOMAS LV, 1987, INFECT IMMUN, V55, P1929, DOI 10.1128/IAI.55.8.1929-1931.1987; Tobias J, 2008, VACCINE, V26, P5373, DOI 10.1016/j.vaccine.2008.07.091; Tobias J, 2011, VACCINE, V29, P8863, DOI 10.1016/j.vaccine.2011.09.096; Tobias J, 2010, VACCINE, V28, P6977, DOI 10.1016/j.vaccine.2010.08.047; Torres OR, 2015, EPIDEMIOL INFECT, V143, P1662, DOI 10.1017/S0950268814002295; von Mentzer A, 2014, NAT GENET, V46, P1321, DOI 10.1038/ng.3145; Wajima T, 2013, PLASMID, V70, P343, DOI 10.1016/j.plasmid.2013.07.006; Wajima T, 2011, MICROB PATHOGENESIS, V51, P243, DOI 10.1016/j.micpath.2011.06.004; Wolf MK, 1997, FEMS MICROBIOL LETT, V148, P35, DOI 10.1016/S0378-1097(97)00009-8	28	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0152899	10.1371/journal.pone.0152899	http://dx.doi.org/10.1371/journal.pone.0152899			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27054573	Green Submitted, Green Published, gold			2022-12-27	WOS:000373608000052
J	Huan, HB; Wen, XD; Chen, XJ; Wu, LL; Liu, WH; Habib, NA; Bie, P; Xia, F				Huan, Hongbo; Wen, Xudong; Chen, Xuejiao; Wu, Lili; Liu, Weihui; Habib, Nagy A.; Bie, Ping; Xia, Feng			C/EBP alpha Short-Activating RNA Suppresses Metastasis of Hepatocellular Carcinoma through Inhibiting EGFR/beta-Catenin Signaling Mediated EMT	PLOS ONE			English	Article							BINDING-PROTEIN-ALPHA; EPITHELIAL-MESENCHYMAL TRANSITION; PANCREATIC-CANCER; DOWN-REGULATION; BETA-CATENIN; EXPRESSION; GROWTH; MECHANISMS; PHENOTYPE; DIAGNOSIS	Hepatocellular carcinoma is associated with high mortality, and tumor metastasis is an important reason for poor prognosis. However, metastasis has not been effectively prevented in clinical therapy and the mechanisms underlying metastasis have not been fully characterized. CCAAT/enhancer-binding protein-alpha (C/EBP alpha) is a transcriptional regulator with an essential role in tumor metastasis. We used short-activating RNAs (saRNA) to enhance expression of C/EBP alpha. Intravenous injection of C/EBP alpha-saRNA in a nude mouse liver orthotopic xenograft tumor model inhibited intrahepatic and distant metastasis. C/EBP alpha-saRNA-treated mice showed increased serum levels of albumin and decreased alanine aminotransferase (ALT), glutamic-oxalacetic transaminase (AST), indicating a role of C/EBP alpha in improving liver function. Migration and invasion were inhibited in hepatoma cell lines transfected with C/EBP alpha-saRNA. We also observed an inhibition of epithelial-mesenchymal transition (EMT) and suppression of epidermal growth factor receptor (EGFR), EGFR phosphorylation, and beta-catenin in C/EBPa-saRNA-transfected cells. Our results suggested that C/EBP alpha-saRNA successfully inhibited HCC metastasis by inhibiting EGFR/beta-catenin signaling pathway mediated EMT in vitro and in vivo.	[Huan, Hongbo; Wen, Xudong; Wu, Lili; Bie, Ping; Xia, Feng] Third Mil Med Univ, Inst Hepatobiliary Surg, Southwest Hosp, Chongqing, Peoples R China; [Chen, Xuejiao] Third Mil Med Univ, Inst Pathol, Southwest Hosp, Lab Biotherapy Canc, Chongqing, Peoples R China; [Chen, Xuejiao] Third Mil Med Univ, Southwest Canc Ctr, Southwest Hosp, Chongqing, Peoples R China; [Liu, Weihui] Chengdu Mil Gen Hosp, Gen Surg Ctr, Chengdu, Sichuan Provinc, Peoples R China; [Habib, Nagy A.] Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Surg & Canc, London, England	Army Medical University; Army Medical University; Army Medical University; Imperial College London	Xia, F (corresponding author), Third Mil Med Univ, Inst Hepatobiliary Surg, Southwest Hosp, Chongqing, Peoples R China.	txzzxf@163.com			National Natural Sciences Foundation of China [81272224]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Sciences Foundation of China (No. 81272224), which was won by FX. F X conceived and designed the experiments, and decided to submit the manuscript. http://www.nsfc.gov.cn	Banerjee P, 2016, STEM CELLS, V34, P334, DOI 10.1002/stem.2245; Bennett KL, 2007, CANCER RES, V67, P4657, DOI 10.1158/0008-5472.CAN-06-4793; Chen WQ, 2016, CA-CANCER J CLIN, V66, P115, DOI 10.3322/caac.21338; Cheung CT, 2015, CARCINOGENESIS, V36, P914, DOI 10.1093/carcin/bgv069; Cicchini C, 2015, LIVER INT, V35, P302, DOI 10.1111/liv.12577; Claperon A, 2014, J HEPATOL, V61, P325, DOI 10.1016/j.jhep.2014.03.033; Das S, 2015, CURR PHARM DESIGN, V21, P1249, DOI 10.2174/1381612821666141211115234; Fan FT, 2014, ASIAN PAC J CANCER P, V15, P1961, DOI 10.7314/APJCP.2014.15.5.1961; Forner A, 2012, LANCET ONCOL, V13, P750, DOI 10.1016/S1470-2045(12)70271-1; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Gao YZ, 2015, TUMOR BIOL, V36, P7409, DOI 10.1007/s13277-015-3408-0; Gunasinghe NPAD, 2012, CANCER METAST REV, V31, P469, DOI 10.1007/s10555-012-9377-5; Hahn S, 2013, EMBO J, V32, P3079, DOI 10.1038/emboj.2013.236; Higashikawa K, 2007, CANCER RES, V67, P9207, DOI 10.1158/0008-5472.CAN-07-0932; Huang LH, 2015, ACTA PHARM SIN B, V5, P390, DOI 10.1016/j.apsb.2015.07.001; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Li Y, 2008, J BIOL CHEM, V283, P12686, DOI 10.1074/jbc.C700185200; Lindsey S, 2015, INT REV CEL MOL BIO, V314, P1, DOI 10.1016/bs.ircmb.2014.10.001; Liu WH, 2015, J CANCER RES CLIN, V141, P1767, DOI 10.1007/s00432-015-1943-0; Liu WS, 2015, ONCOTARGET, V6, P35522, DOI 10.18632/oncotarget.5849; Liu YN, 2004, ONCOGENE, V23, P278, DOI 10.1038/sj.onc.1207022; Lu GD, 2015, HEPATOLOGY, V61, P965, DOI 10.1002/hep.27593; Ming J, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20150167; Muller C, 2010, EMBO J, V29, P897, DOI 10.1038/emboj.2009.404; Nakao K, 2014, J GASTROENTEROL, V49, P589, DOI 10.1007/s00535-014-0932-4; Parkin DM, 2001, INT J CANCER, V94, P153, DOI 10.1002/ijc.1440; Qi JJ, 2016, GUT, V65, P1690, DOI 10.1136/gutjnl-2014-307900; Reebye V, 2014, HEPATOLOGY, V59, P216, DOI 10.1002/hep.26669; Reebye V, 2013, MOL THER-NUCL ACIDS, V2, DOI 10.1038/mtna.2013.23; Rhee KJ, 2015, INT J MOL SCI, V16, P30015, DOI 10.3390/ijms161226215; Shi DB, 2015, CANCER LETT, V369, P376, DOI 10.1016/j.canlet.2015.08.029; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Voutila J, 2012, MOL THER-NUCL ACIDS, V1, DOI 10.1038/mtna.2012.20; Xue M, 2015, MOL MED REP, V12, P2121, DOI 10.3892/mmr.2015.3563; Yamamoto K, 2014, CARCINOGENESIS, V35, P2404, DOI 10.1093/carcin/bgu136; Yanaka Y, 2015, CARCINOGENESIS, V36, P1363, DOI 10.1093/carcin/bgv106; Ye LY, 2016, CANCER RES, V76, P818, DOI 10.1158/0008-5472.CAN-15-0977; Zeng CJ, 2015, STEM CELLS DEV, V24, P2467, DOI 10.1089/scd.2015.0202; Zhou JN, 2015, HEPATOLOGY, V62, P801, DOI 10.1002/hep.27887	39	32	36	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0153117	10.1371/journal.pone.0153117	http://dx.doi.org/10.1371/journal.pone.0153117			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050434	gold, Green Published			2022-12-27	WOS:000373603500103
J	Yamamuro, K; Kimoto, S; Iida, J; Kishimoto, N; Nakanishi, Y; Tanaka, S; Ota, T; Makinodan, M; Kishimoto, T				Yamamuro, Kazuhiko; Kimoto, Sohei; Iida, Junzo; Kishimoto, Naoko; Nakanishi, Yoko; Tanaka, Shohei; Ota, Toyosaku; Makinodan, Manabu; Kishimoto, Toshifumi			Reduced Prefrontal Cortex Hemodynamic Response in Adults with Methamphetamine Induced Psychosis: Relevance for Impulsivity	PLOS ONE			English	Article							NEAR-INFRARED SPECTROSCOPY; OBSESSIVE-COMPULSIVE DISORDER; INHIBITORY CONTROL; BRAIN ACTIVATION; DEPENDENT INDIVIDUALS; STROOP COLOR; WORD TEST; STIMULANT PSYCHOSIS; YOUNG-CHILDREN; SCHIZOPHRENIA	Patients with methamphetamine abuse/dependence often exhibit high levels of impulsivity, which may be associated with the structural abnormalities and functional hypoactivities observed in the frontal cortex of these subjects. Although near-infrared spectroscopy (NIRS) is a simple and non-invasive method for characterizing the clinical features of various psychiatric illnesses, few studies have used NIRS to directly investigate the association between prefrontal cortical activity and inhibitory control in patients with methamphetamine-induced psychosis (MAP). Using a 24-channel NIRS system, we compared hemodynamic responses during the Stroop color-word task in 14 patients with MAP and 21 healthy controls matched for age, sex and premorbid IQ. In addition, we used the Barrett Impulsivity Scale-11 (BIS-11) to assess impulsivity between subject groups. The MAP group exhibited significantly less activation in the anterior and frontopolar prefrontal cortex accompanied by lower Stroop color-word task performance, compared with controls. Moreover, BIS-11 scores were significantly higher in the MAP group, and were negatively correlated with the hemodynamic responses in prefrontal cortex. Our data suggest that reduced hemodynamic responses in the prefrontal cortex might reflect higher levels of impulsivity in patients with MAP, providing new insights into disrupted inhibitory control observed in MAP.	[Yamamuro, Kazuhiko; Kimoto, Sohei; Kishimoto, Naoko; Nakanishi, Yoko; Tanaka, Shohei; Ota, Toyosaku; Makinodan, Manabu; Kishimoto, Toshifumi] Nara Med Univ, Sch Med, Dept Psychiat, Kashihara, Nara 634, Japan; [Iida, Junzo] Nara Med Univ, Sch Med, Fac Nursing, Kashihara, Nara 634, Japan	Nara Medical University; Nara Medical University	Kimoto, S (corresponding author), Nara Med Univ, Sch Med, Dept Psychiat, Kashihara, Nara 634, Japan.	sohei@naramed-u.ac.jp		Kimoto, Sohei/0000-0002-3148-690X				Akiyama K, 2006, ANN NY ACAD SCI, V1074, P125, DOI 10.1196/annals.1369.012; Asahi S, 2004, EUR ARCH PSY CLIN N, V254, P245, DOI 10.1007/s00406-004-0488-z; Batki SL, 2004, AM J ADDICTION, V13, P461, DOI 10.1080/10550490490512834; Bilder RM, 2002, AM J PSYCHIAT, V159, P1018, DOI 10.1176/appi.ajp.159.6.1018; Chen CK, 2003, PSYCHOL MED, V33, P1407, DOI 10.1017/S0033291703008353; Chmielewski WX, 2015, NEUROIMAGE, V112, P96, DOI 10.1016/j.neuroimage.2015.02.060; Crockett MJ, 2013, NEURON, V79, P391, DOI 10.1016/j.neuron.2013.05.028; Curran C, 2004, BRIT J PSYCHIAT, V185, P196, DOI 10.1192/bjp.185.3.196; Deng Xianhua, 2012, Shanghai Arch Psychiatry, V24, P271, DOI 10.3969/j.issn.1002-0829.2012.05.004; Ehlis AC, 2005, BIOL PSYCHOL, V69, P315, DOI 10.1016/j.biopsycho.2004.09.003; Fekete T, 2014, NEUROIMAGE, V85, P345, DOI 10.1016/j.neuroimage.2013.07.022; Goldberg TE, 1996, J CLIN PSYCHIAT, V57, P62; GOLDEN CJ, 1975, J PERS ASSESS, V39, P386, DOI 10.1207/s15327752jpa3904_10; GOLDEN CJ, 1976, J CLIN PSYCHOL, V32, P654, DOI 10.1002/1097-4679(197607)32:3<654::AID-JCLP2270320336>3.0.CO;2-Z; Greenwald MK, 2013, ADDICT BIOL, V18, P836, DOI 10.1111/j.1369-1600.2011.00431.x; Hege MA, 2015, INT J OBESITY, V39, P353, DOI 10.1038/ijo.2014.99; Herz MI, 1997, AM J PSYCHIAT, V154, P1; Hoshi Y, 2001, J APPL PHYSIOL, V90, P1657, DOI 10.1152/jappl.2001.90.5.1657; Hwang K, 2014, J NEUROSCI, V34, P9551, DOI 10.1523/JNEUROSCI.4889-13.2014; Inagaki A., 2006, JAPANESE J CLIN PSYC, V9, P1443; IWANAMI A, 1994, ACTA PSYCHIAT SCAND, V89, P428, DOI 10.1111/j.1600-0447.1994.tb01541.x; JENSEN AR, 1966, ACTA PSYCHOL, V25, P36, DOI 10.1016/0001-6918(66)90004-7; Kameyama M, 2006, NEUROIMAGE, V29, P172, DOI 10.1016/j.neuroimage.2005.07.025; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Kishimoto M, 2008, BIOL PSYCHIAT, V63, P191, DOI 10.1016/j.biopsych.2007.03.019; Kleinschmidt A, 1996, J CEREBR BLOOD F MET, V16, P817, DOI 10.1097/00004647-199609000-00006; Lee B, 2009, J NEUROSCI, V29, P14734, DOI 10.1523/JNEUROSCI.3765-09.2009; Leland DS, 2008, BIOL PSYCHIAT, V63, P184, DOI 10.1016/j.biopsych.2007.04.031; Liu X, 2004, NEUROIMAGE, V22, P1097, DOI 10.1016/j.neuroimage.2004.02.033; Logan GD, 1997, PSYCHOL SCI, V8, P60, DOI 10.1111/j.1467-9280.1997.tb00545.x; Matsuoka K, 2006, PSYCHIAT CLIN NEUROS, V60, P332, DOI 10.1111/j.1440-1819.2006.01510.x; Matsuzawa D, 2007, AM J PSYCHIAT, V164, P1105, DOI 10.1176/appi.ajp.164.7.1105; Mayer K, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0683-4; Moll J, 2006, P NATL ACAD SCI USA, V103, P15623, DOI 10.1073/pnas.0604475103; Monterosso JR, 2005, DRUG ALCOHOL DEPEN, V79, P273, DOI 10.1016/j.drugalcdep.2005.02.002; Naruse Nobuya, 2015, Nihon Rinsho, V73, P1481; Navailles S, 2015, CEREB CORTEX, V25, P3167, DOI 10.1093/cercor/bhu112; Negoro H, 2010, CHILD PSYCHIAT HUM D, V41, P193, DOI 10.1007/s10578-009-0160-y; Nestor LJ, 2011, PSYCHIAT RES-NEUROIM, V194, P287, DOI 10.1016/j.pscychresns.2011.04.010; Ohmae E, 2006, NEUROIMAGE, V29, P697, DOI 10.1016/j.neuroimage.2005.08.008; Okada K, 2013, PROG NEURO-PSYCHOPH, V43, P7, DOI 10.1016/j.pnpbp.2012.11.013; Okada N, 2016, ADDICT BIOL, V21, P489, DOI 10.1111/adb.12224; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Ota T, 2013, CHILD PSYCHIAT HUM D, V44, P265, DOI 10.1007/s10578-012-0323-0; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Paulus MP, 2003, BIOL PSYCHIAT, V53, P65, DOI 10.1016/S0006-3223(02)01442-7; Paulus MP, 2002, NEUROPSYCHOPHARMACOL, V26, P53, DOI 10.1016/S0893-133X(01)00334-7; Payer DE, 2011, ARCH GEN PSYCHIAT, V68, P271, DOI 10.1001/archgenpsychiatry.2010.154; Prevor MB, 2005, COGNITIVE DEV, V20, P256, DOI 10.1016/j.cogdev.2005.04.001; Roberts W, 2011, ACTA PSYCHOL, V138, P419, DOI 10.1016/j.actpsy.2011.09.002; Roehr B, 2005, BRIT MED J, V331, P476, DOI 10.1136/bmj.331.7515.476; Salo R, 2002, PSYCHIAT RES, V111, P65, DOI 10.1016/S0165-1781(02)00111-7; Salo R, 2009, BIOL PSYCHIAT, V65, P706, DOI 10.1016/j.biopsych.2008.11.026; Schiffer B, 2010, BRAIN, V133, P3093, DOI 10.1093/brain/awq153; Schiller B, 2014, CEREB CORTEX, V24, P2430, DOI 10.1093/cercor/bht095; Schroeter ML, 2002, HUM BRAIN MAPP, V17, P61, DOI 10.1002/hbm.10052; Schweitzer JB, 2000, AM J PSYCHIAT, V157, P278, DOI 10.1176/appi.ajp.157.2.278; Shinba T, 2004, BIOL PSYCHIAT, V55, P154, DOI 10.1016/S0006-3223(03)00547-X; Simon SL, 2002, J ADDICT DIS, V21, P61; Simon SL, 2000, AM J ADDICTION, V9, P222; Singh AK, 2006, NEUROIMAGE, V33, P542, DOI 10.1016/j.neuroimage.2006.06.047; Song YN, 2015, BEHAV BRAIN RES, V290, P187, DOI 10.1016/j.bbr.2015.04.047; Stanford MS, 2009, PERS INDIV DIFFER, V47, P385, DOI 10.1016/j.paid.2009.04.008; Stoeckel LE, 2013, BRAIN IMAGING BEHAV, V7, P116, DOI 10.1007/s11682-012-9201-4; Suto T, 2004, BIOL PSYCHIAT, V55, P501, DOI 10.1016/j.biopsych.2003.09.008; Tam A, 2015, BRAIN IMAGING BEHAV, V9, P609, DOI 10.1007/s11682-014-9323-y; Taniguchi K, 2012, J MED INVESTIG, V59, P45, DOI 10.2152/jmi.59.45; Toronov V, 2001, MED PHYS, V28, P521, DOI 10.1118/1.1354627; TREISMAN A, 1969, NATURE, V222, P437, DOI 10.1038/222437a0; TREMBLAY RE, 1994, ARCH GEN PSYCHIAT, V51, P732; Tsujimoto S, 2011, TRENDS COGN SCI, V15, P169, DOI 10.1016/j.tics.2011.02.001; Tsuzuki D, 2007, NEUROIMAGE, V34, P1506, DOI 10.1016/j.neuroimage.2006.10.043; Ujike H, 2004, ANN NY ACAD SCI, V1025, P279, DOI 10.1196/annals.1316.035; Valdes IH, 2006, PSYCHIAT RES-NEUROIM, V147, P239, DOI 10.1016/j.pscychresns.2006.01.014; Villringer K, 1997, ADV EXP MED BIOL, V413, P149; Yamamuro K, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0472-3; Yang Y, 2009, MOL PSYCHIATR, V14, P561, DOI 10.1038/mp.2009.12; Zhang L, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.5.057012	78	11	12	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0152373	10.1371/journal.pone.0152373	http://dx.doi.org/10.1371/journal.pone.0152373			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050450	Green Published, Green Submitted, gold			2022-12-27	WOS:000373603500035
J	Zakeri, B; Carr, PA; Lu, TK				Zakeri, Bijan; Carr, Peter A.; Lu, Timothy K.			Multiplexed Sequence Encoding: A Framework for DNA Communication	PLOS ONE			English	Article							DIGITAL INFORMATION; STORAGE; PROTEIN; BOND	Synthetic DNA has great propensity for efficiently and stably storing non-biological information. With DNA writing and reading technologies rapidly advancing, new applications for synthetic DNA are emerging in data storage and communication. Traditionally, DNA communication has focused on the encoding and transfer of complete sets of information. Here, we explore the use of DNA for the communication of short messages that are fragmented across multiple distinct DNA molecules. We identified three pivotal points in a communication-data encoding, data transfer & data extraction-and developed novel tools to enable communication via molecules of DNA. To address data encoding, we designed DNA-based individualized keyboards (iKeys) to convert plaintext into DNA, while reducing the occurrence of DNA homopolymers to improve synthesis and sequencing processes. To address data transfer, we implemented a secret-sharing system-Multiplexed Sequence Encoding (MuSE)-that conceals messages between multiple distinct DNA molecules, requiring a combination key to reveal messages. To address data extraction, we achieved the first instance of chromatogram patterning through multiplexed sequencing, thereby enabling a new method for data extraction. We envision these approaches will enable more widespread communication of information via DNA.	[Zakeri, Bijan; Lu, Timothy K.] MIT, Dept Elect Engn & Comp Sci, Dept Biol Engn, Elect Res Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Zakeri, Bijan; Carr, Peter A.; Lu, Timothy K.] MIT, Synthet Biol Ctr, 500 Technol Sq, Cambridge, MA 02139 USA; [Carr, Peter A.] MIT, Lincoln Lab, 244 Wood St, Lexington, MA 02420 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Lincoln Laboratory; Massachusetts Institute of Technology (MIT)	Zakeri, B (corresponding author), MIT, Dept Elect Engn & Comp Sci, Dept Biol Engn, Elect Res Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Zakeri, B; Carr, PA (corresponding author), MIT, Synthet Biol Ctr, 500 Technol Sq, Cambridge, MA 02139 USA.; Carr, PA (corresponding author), MIT, Lincoln Lab, 244 Wood St, Lexington, MA 02420 USA.	bijan.zakeri@oxfordalumni.org; carr@ll.mit.edu			Defense Advanced Research Projects Agency under Air Force Contract [FA8721-05-C-0002]; NIH [1R01EB017755, 1DP2OD008435, 1P50GM098792]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB017755] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [F31ES027304, F32ES027306] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM098792] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD008435] Funding Source: NIH RePORTER	Defense Advanced Research Projects Agency under Air Force Contract; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work is sponsored by the Defense Advanced Research Projects Agency under Air Force Contract #FA8721-05-C-0002, and NIH grants 1R01EB017755, 1DP2OD008435, and 1P50GM098792.	Bancroft C, 2001, SCIENCE, V293, P1763; Blazej RG, 2006, P NATL ACAD SCI USA, V103, P7240, DOI 10.1073/pnas.0602476103; Carr PA, 2009, NAT BIOTECHNOL, V27, P1151, DOI 10.1038/nbt.1590; Church GM, 2012, SCIENCE, V337, P1628, DOI 10.1126/science.1226355; Clarke J, 2009, NAT NANOTECHNOL, V4, P265, DOI [10.1038/NNANO.2009.12, 10.1038/nnano.2009.12]; Clelland CT, 1999, NATURE, V399, P533, DOI 10.1038/21092; Cox JPL, 2001, TRENDS BIOTECHNOL, V19, P247, DOI 10.1016/S0167-7799(01)01671-7; Ferguson N, 2010, CRYPTOGRAPHY ENG DES; Goldman N, 2013, NATURE, V494, P77, DOI 10.1038/nature11875; Grass RN, 2015, ANGEW CHEM INT EDIT, V54, P2552, DOI 10.1002/anie.201411378; Haughton D, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-121; Heider D, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-176; Kawano Tomonori, 2013, Commun Integr Biol, V6, pe23478, DOI 10.4161/cib.23478; Liss M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042465; San Millan AS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6208; Sennels Lau, 2012, Artif DNA PNA XNA, V3, P109, DOI 10.4161/adna.22671; Stoddart D, 2009, P NATL ACAD SCI USA, V106, P7702, DOI 10.1073/pnas.0901054106; Tulpan D, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/634832; Veggiani G, 2014, TRENDS BIOTECHNOL, V32, P506, DOI 10.1016/j.tibtech.2014.08.001; Voelkerding KV, 2009, CLIN CHEM, V55, P641, DOI 10.1373/clinchem.2008.112789; Zakeri B, 2015, CURR OPIN CHEM BIOL, V28, P9, DOI 10.1016/j.cbpa.2015.05.020; Zakeri B, 2015, CHEMBIOCHEM, V16, P2277, DOI 10.1002/cbic.201500372; Zakeri B, 2012, P NATL ACAD SCI USA, V109, pE690, DOI 10.1073/pnas.1115485109; Zakeri B, 2010, J AM CHEM SOC, V132, P4526, DOI 10.1021/ja910795a	24	4	4	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0152774	10.1371/journal.pone.0152774	http://dx.doi.org/10.1371/journal.pone.0152774			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050646	Green Published, gold			2022-12-27	WOS:000373603500055
J	Montalbano, M; Curcuru, G; Shirafkan, A; Vento, R; Rastellini, C; Cicalese, L				Montalbano, Mauro; Curcuru, Giuseppe; Shirafkan, Ali; Vento, Renza; Rastellini, Cristiana; Cicalese, Luca			Modeling of Hepatocytes Proliferation Isolated from Proximal and Distal Zones from Human Hepatocellular Carcinoma Lesion	PLOS ONE			English	Article							CELL; TOXICITY; CULTURE	Isolation of hepatocytes from cirrhotic human livers and subsequent primary culture are important new tools for laboratory research and cell-based therapeutics in the study of hepatocellular carcinoma (HCC). Using such techniques, we have previously identified different subpopulations of human hepatocytes and among them one is showing a progressive transformation of hepatocytes in HCC-like cells. We have hypothesized that increasing the distance from the neoplastic lesion might affect hepatocyte function and transformation capacity. However, limited information is available in comparing the growth and proliferation of human hepatocytes obtained from different areas of the same cirrhotic liver in relation to their distance from the HCC lesion. In this study, hepatocytes from 10 patients with cirrhosis and HCC undergoing surgical resections from specimens obtained at a proximal (CP) and distal (CD) distance from the HCC lesion were isolated and placed in primary culture. CP hepatocytes (CP-Hep) were isolated between 1 to 3 cm (leaving at least 1cm margin to avoid cancer cells and/or satellite lesions), while CD hepatocytes (CD-Hep) were isolated from more than 5 cm or from the contralateral-lobe. A statistical model was built to analyze the proliferation rates of these cells and we evaluated expression of HCC markers (Glypican-3 (GPC3), alpha Smooth Muscle Actin (alpha-SMA) and PCNA). We observed a significant difference in proliferation and in-vitro growth showing that CP-Hep had a proliferation pattern and rate significantly different than CD-Hep. Based on these data, this model can provide information to predict growth of human hepatocytes in primary culture in relation to their precancerous state with significant differences in the HCC markers expression. This model provides an important innovative tool for in-vitro analysis of HCC.	[Montalbano, Mauro; Shirafkan, Ali; Rastellini, Cristiana; Cicalese, Luca] Univ Texas Med Branch, Dept Surg, Galveston, TX 77555 USA; [Montalbano, Mauro] Univ Palermo, Dept Expt Biomed & Clin Neurosci, Via Vespro 129, I-90127 Palermo, Italy; [Curcuru, Giuseppe] Univ Palermo, Dept Chem Management Informat & Mech Engn, Palermo, Italy; [Vento, Renza] Univ Palermo, Dept Biol Chem & Pharmaceut Sci & Technol, Biochem Lab, Palermo, Italy; [Vento, Renza] Temple Univ, Inst Canc Res & Mol Med, Philadelphia, PA 19122 USA; [Vento, Renza] Temple Univ, Ctr Biotechnol, Coll Sci & Biotechnol, Philadelphia, PA 19122 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Palermo; University of Palermo; University of Palermo; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Cicalese, L (corresponding author), Univ Texas Med Branch, Dept Surg, Galveston, TX 77555 USA.	lucicale@utmb.edu	Montalbano, Mauro/AAA-6833-2021	Montalbano, Mauro/0000-0002-0456-452X				Bhogal RH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018222; Corlu A, 2015, METHODS MOL BIOL, V1250, P27, DOI 10.1007/978-1-4939-2074-7_3; De Bruyn T, 2013, EXPERT OPIN DRUG MET, V9, P589, DOI 10.1517/17425255.2013.773973; Gomez-Lechon MJ, 2003, CURR DRUG METAB, V4, P292, DOI 10.2174/1389200033489424; Haruyama Y, 2016, WORLD J GASTROENTERO, V22, P275, DOI 10.3748/wjg.v22.i1.275; Hughes RD, 2006, LIVER TRANSPLANT, V12, P713, DOI 10.1002/lt.20732; Kawahara T, 2010, LIVER TRANSPLANT, V16, P974, DOI 10.1002/lt.22099; Levy G, 2015, NAT BIOTECHNOL, V33, P1264, DOI 10.1038/nbt.3377; Ma S, 2015, TUMOR BIOL, DOI [10.1007/s13277-015-4582, DOI 10.1007/S13277-015-4582-]; Montalbano M, 2015, INT J ONCOL, DOI [10.3892/ijo.2015.3312, DOI 10.3892/IJ0.2015.3312]; Portolani N, 2006, ANN SURG, V243, P229, DOI 10.1097/01.sla.0000197706.21803.a1; Ramboer E, 2014, J HEPATOL, V61, P925, DOI 10.1016/j.jhep.2014.05.046; RATANASAVANH D, 1988, XENOBIOTICA, V18, P765, DOI 10.3109/00498258809041715; Wilkening S, 2003, DRUG METAB DISPOS, V31, P1035, DOI 10.1124/dmd.31.8.1035; Xu YP, 2016, ONCOTARGET, V7, P8866, DOI 10.18632/oncotarget.6839; Yoshizato Katsutoshi, 2012, Curr Drug Discov Technol, V9, P63; Zhang XL, 2015, ANTI-CANCER AGENT ME, V15, P755, DOI 10.2174/1871520615666150202111721	17	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153613	10.1371/journal.pone.0153613	http://dx.doi.org/10.1371/journal.pone.0153613			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27074018	gold, Green Published, Green Submitted			2022-12-27	WOS:000374131200112
J	Mueller, S; Martin, S; Schwarz, M; Grunwald, M				Mueller, Stephanie; Martin, Sven; Schwarz, Michael; Grunwald, Martin			Temporal Modulations of Contact Force during Haptic Surface Exploration	PLOS ONE			English	Article							ANOREXIA-NERVOSA; FINGERTIP FORCES; THETA-POWER; GRIP FORCE; LOAD FORCE; PERCEPTION; ROUGHNESS; DISCRIMINATION; MOVEMENTS	Individuals constantly modulate their exploratory movements and adapt their internal hypotheses to incoming sensory information to achieve a thorough and realistic percept. Perception depends on the exploratory movements as well as influencing them. While this seems to be common sense, scientifically we know very little about the temporal dynamics during haptic exploration. To address this, we investigated the exploratory force modulations of two groups of healthy young adults during the exploration of grated surfaces with differing detection difficulty during successive (n = 20) and random stimulus presentation (n = 20). Results showed that exploratory force depended on stimulus properties and increased with increasing detection difficulty. Both experiments yielded the same direction of results with slightly smaller effects in the random stimulus presentation group. Across exploration time average fingertip force also increased. The biggest increase occurred systematically at the beginning (within the first 40 percent) of exploration time per stimulus indicating that most critical information is received during the initial contact phase and is directly transformed into the exploration procedure and force application. Furthermore, video-analyses and comparisons to our high temporal resolution data revealed strong dynamic changes in pressure application during test stimulus exploration with differences in the force dynamics and exploration strategies of simple and difficult stimuli.	[Mueller, Stephanie; Martin, Sven; Schwarz, Michael; Grunwald, Martin] Univ Leipzig, Hapt Res Lab, Paul Flechsig Inst Brain Res, Fac Med, D-04109 Leipzig, Germany	Leipzig University	Grunwald, M (corresponding author), Univ Leipzig, Hapt Res Lab, Paul Flechsig Inst Brain Res, Fac Med, D-04109 Leipzig, Germany.	mgrun@medizin.uni-leipzig.de	Mueller, Stephanie/A-6742-2017		DFE. e.V.; Haptic Forschungszentrum GmbH, Leipzig; German Research Foundation (DFG); Universitaet Leipzig	DFE. e.V.; Haptic Forschungszentrum GmbH, Leipzig; German Research Foundation (DFG)(German Research Foundation (DFG)); Universitaet Leipzig	This research project was funded in part by DFE. e.V.; Haptic Forschungszentrum GmbH, Leipzig. Publication was supported by German Research Foundation (DFG) and Universitaet Leipzig within the program of Open Access Publishing.	[Anonymous], 2009, EUROHAPTICS C 2009 S; BELL J, 1994, PROG NEUROBIOL, V42, P79, DOI 10.1016/0301-0082(94)90022-1; Chen J, 1998, HUMAN HAPTIC INTERAC; COLE KJ, 1988, J NEUROPHYSIOL, V60, P1513, DOI 10.1152/jn.1988.60.4.1513; Cole KJ, 1999, J NEUROSCI, V19, P3238; FLANAGAN JR, 1993, NEUROSCI LETT, V152, P53, DOI 10.1016/0304-3940(93)90481-Y; Frings S, 2012, PHYSIOLOGIE, P624; Gregory RL, 1973, EYE BRAIN; Grunwald M, 2002, ARCH CLIN NEUROPSYCH, V17, P485, DOI 10.1016/S0887-6177(01)00131-7; Grunwald M, 2001, J CLIN EXP NEUROPSYC, V23, P520, DOI 10.1076/jcen.23.4.520.1229; Grunwald M, 2001, INT J EAT DISORDER, V29, P417, DOI 10.1002/eat.1038; Grunwald M, 2001, COGNITIVE BRAIN RES, V11, P33, DOI 10.1016/S0926-6410(00)00061-6; Grunwald M, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00292; Halata Zdenek, 2008, P85, DOI 10.1007/978-3-7643-7612-3_6; JOHANSSON RS, 1984, EXP BRAIN RES, V56, P550; JOHANSSON RS, 1992, CURR OPIN NEUROBIOL, V2, P815, DOI 10.1016/0959-4388(92)90139-C; Kaim LR, 2009, WORLD HAPTICS 2009: THIRD JOINT EUROHAPTICS CONFERENCE AND SYMPOSIUM ON HAPTIC INTERFACES FOR VIRTUAL ENVIRONMENT AND TELEOPERATOR SYSTEMS, PROCEEDINGS, P565, DOI 10.1109/WHC.2009.4810830; Katz D, 1969, AUFBAU TASTWELT REPR; Keenan KG, 2009, J NEUROSCI, V29, P8784, DOI 10.1523/JNEUROSCI.0853-09.2009; Klatzky RL, 1999, ATTENTION PERFORM, V17, P165; LEDERMAN SJ, 1981, B PSYCHONOMIC SOC, V18, P253; LEDERMAN SJ, 1974, PERCEPT PSYCHOPHYS, V16, P385, DOI 10.3758/BF03203958; LEDERMAN SJ, 1972, PERCEPT PSYCHOPHYS, V12, P401, DOI 10.3758/BF03205850; Matsui K, 2014, ADV ROBOTICS, V28, P883, DOI 10.1080/01691864.2014.894939; Mueller S, 2014, EXP BRAIN RES, V232, P1905, DOI 10.1007/s00221-014-3882-4; Mueller S, 2014, INT NEUROPSYCHIATRIC, V2, P141, DOI DOI 10.9734/INDJ/2014/8102; Mueller S, 2014, PT Z PHYSIOTHERAPEUT, V66, P91; Mueller S, 2013, EXP BRAIN RES, V231, P415, DOI 10.1007/s00221-013-3706-y; Nefs HT, 2002, PERCEPT PSYCHOPHYS, V64, P969, DOI 10.3758/BF03196800; Osterberg G., 1935, ACTA OPHTHALMOL, V13, P6; Parikh PJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124137; RADWIN RG, 1992, ERGONOMICS, V35, P275, DOI 10.1080/00140139208967813; Ross H. E., 2008, HUMAN HAPTIC PERCEPT, DOI [10.1007/978-3-7643-7612-3_22, DOI 10.1007/978-3-7643-7612-3_22]; Smith AM, 2002, EXP BRAIN RES, V147, P209, DOI 10.1007/s00221-002-1240-4; Smith AM, 1996, J NEUROPHYSIOL, V75, P1957, DOI 10.1152/jn.1996.75.5.1957; Smith SE, 2008, MYCORRHIZAL SYMBIOSIS, 3RD EDITION, pVII; Tanaka Yoshihiro, 2012, Haptics: Perception, Devices, Mobility, and Communication. Proceedings International Conference (EuroHaptics 2012), P163, DOI 10.1007/978-3-642-31404-9_28; Tanaka Y, 2014, PLOS ONE, V9; Westling G., 1981, SOC NEUR ABSTR, V247	39	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0152897	10.1371/journal.pone.0152897	http://dx.doi.org/10.1371/journal.pone.0152897			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ3UC	27073843	gold, Green Published, Green Submitted			2022-12-27	WOS:000374131200043
J	Shearstone, JR; Golonzhka, O; Chonkar, A; Tamang, D; van Duzer, JH; Jones, SS; Jarpe, MB				Shearstone, Jeffrey R.; Golonzhka, Olga; Chonkar, Apurva; Tamang, David; van Duzer, John H.; Jones, Simon S.; Jarpe, Matthew B.			Chemical Inhibition of Histone Deacetylases 1 and 2 Induces Fetal Hemoglobin through Activation of GATA2	PLOS ONE			English	Article							SICKLE-CELL-DISEASE; GLOBIN GENE-EXPRESSION; ACUTE MYELOID-LEUKEMIA; GAMMA-GLOBIN; TRANSCRIPTIONAL REPRESSION; BETA-THALASSEMIA; BCL11A; ERYTHROPOIESIS; HYDROXYUREA; POTENT	Therapeutic intervention aimed at reactivation of fetal hemoglobin protein (HbF) is a promising approach for ameliorating sickle cell disease (SCD) and beta-thalassemia. Previous studies showed genetic knockdown of histone deacetylase (HDAC) 1 or 2 is sufficient to induce HbF. Here we show that ACY-957, a selective chemical inhibitor of HDAC1 and 2 (HDAC1/2), elicits a dose and time dependent induction of.-globin mRNA (HBG) and HbF in cultured primary cells derived from healthy individuals and sickle cell patients. Gene expression profiling of erythroid progenitors treated with ACY-957 identified global changes in gene expression that were significantly enriched in genes previously shown to be affected by HDAC1 or 2 knockdown. These genes included GATA2, which was induced greater than 3-fold. Lentiviral overexpression of GATA2 in primary erythroid progenitors increased HBG, and reduced adult beta-globin mRNA (HBB). Furthermore, knockdown of GATA2 attenuated HBG induction by ACY-957. Chromatin immunoprecipitation and sequencing (ChIP-Seq) of primary erythroid progenitors demonstrated that HDAC1 and 2 occupancy was highly correlated throughout the GATA2 locus and that HDAC1/2 inhibition led to elevated histone acetylation at well-known GATA2 autoregulatory regions. The GATA2 protein itself also showed increased binding at these regions in response to ACY-957 treatment. These data show that chemical inhibition of HDAC1/2 induces HBG and suggest that this effect is mediated, at least in part, by histone acetylation-induced activation of the GATA2 gene.	[Shearstone, Jeffrey R.; Golonzhka, Olga; Chonkar, Apurva; Tamang, David; van Duzer, John H.; Jones, Simon S.; Jarpe, Matthew B.] Acetylon Pharmaceut Inc, Boston, MA USA		Shearstone, JR (corresponding author), Acetylon Pharmaceut Inc, Boston, MA USA.	jshearstone@acetylon.com		Shearstone, Jeffrey/0000-0002-6875-1826	National Heart, Lung, and Blood Institute of the National Institutes of Health [1R41HL118917-01]; Acetylon Pharmaceuticals; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R41HL118917] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Acetylon Pharmaceuticals; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by the National Heart, Lung, and Blood Institute of the National Institutes of Health under Award Number 1R41HL118917-01 (http://www.nhlbi.nih.gov). The funder provided support in the form of research materials and salaries for authors JRS and MBJ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funding was also provided by Acetylon Pharmaceuticals (http://www.acetylon.com). The funder provided support in the form of research materials and salaries for JRS, OG, AC, DT, JHD, SSJ, and MBJ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are listed in the 'Author Contributions' section.	BANK A, 1980, SCIENCE, V207, P486, DOI 10.1126/science.7352255; Bauer DE, 2011, CURR OPIN PEDIATR, V23, P1, DOI 10.1097/MOP.0b013e3283420fd0; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Bradner JE, 2010, P NATL ACAD SCI USA, V107, P12617, DOI 10.1073/pnas.1006774107; Bradner JE, 2010, NAT CHEM BIOL, V6, P238, DOI 10.1038/NCHEMBIO.313; Bresnick EH, 2010, J BIOL CHEM, V285, P31087, DOI 10.1074/jbc.R110.159079; Bunn HF, 1997, NEW ENGL J MED, V337, P762, DOI 10.1056/NEJM199709113371107; Cao H, 2006, AM J HEMATOL, V81, P981, DOI 10.1002/ajh.20676; CHARACHE S, 1995, NEW ENGL J MED, V332, P1317, DOI 10.1056/NEJM199505183322001; DESIMONE J, 1982, P NATL ACAD SCI-BIOL, V79, P4428, DOI 10.1073/pnas.79.14.4428; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Ernst J, 2010, NAT BIOTECHNOL, V28, P817, DOI 10.1038/nbt.1662; Esrick EB, 2015, AM J HEMATOL; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Forget BG, 1998, ANN NY ACAD SCI, V850, P38, DOI 10.1111/j.1749-6632.1998.tb10460.x; Grass JA, 2003, P NATL ACAD SCI USA, V100, P8811, DOI 10.1073/pnas.1432147100; Grass JA, 2006, MOL CELL BIOL, V26, P7056, DOI 10.1128/MCB.01033-06; Gregory GD, 2010, BLOOD, V115, P2156, DOI 10.1182/blood-2009-10-251280; Guha M, 2015, NAT REV DRUG DISCOV, V14, P226, DOI 10.1038/nrd4583; Hahn CN, 2011, NAT GENET, V43, P1012, DOI 10.1038/ng.913; Heideman MR, 2014, HAEMATOLOGICA, V99, P1292, DOI 10.3324/haematol.2013.092643; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hong W, 2005, EMBO J, V24, P2367, DOI 10.1038/sj.emboj.7600703; Hu JP, 2013, BLOOD, V121, P3246, DOI 10.1182/blood-2013-01-476390; Ikonomi P, 2000, GENE, V261, P277, DOI 10.1016/S0378-1119(00)00510-2; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jamison DT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1; Jiang J, 2006, BLOOD, V108, P1077, DOI 10.1182/blood-2006-01-008912; Kiefer CM, 2011, BLOOD, V118, P6200, DOI 10.1182/blood-2011-06-363101; Krivega I, 2015, BLOOD, V126, P665, DOI 10.1182/blood-2015-02-629972; Kupcho KR, 2014, CANCER RES, V74, DOI 10.1158/1538-7445.AM2014-4784; Kupcho KR, 2014, SELECTIVE BIOLUMINOG; Kuroyanagi Y, 2006, BIOCHEM BIOPH RES CO, V344, P1038, DOI 10.1016/j.bbrc.2006.03.203; Lauffer BEL, 2013, J BIOL CHEM, V288, P26926, DOI 10.1074/jbc.M113.490706; LEONARD M, 1993, BLOOD, V82, P1071; Liberati C, 2001, J BIOL CHEM, V276, P41700, DOI 10.1074/jbc.M102987200; LOKEN MR, 1987, BLOOD, V69, P255; Martowicz ML, 2005, J BIOL CHEM, V280, P1724, DOI 10.1074/jbc.M406038200; Methot JL, 2008, BIOORG MED CHEM LETT, V18, P973, DOI 10.1016/j.bmcl.2007.12.031; Miccio A, 2010, EMBO J, V29, P442, DOI 10.1038/emboj.2009.336; Moriguchi T, 2014, INT J HEMATOL, V100, P417, DOI 10.1007/s12185-014-1568-0; Musallam KM, 2012, BLOOD, V119, P364, DOI 10.1182/blood-2011-09-382408; Pal S, 2004, P NATL ACAD SCI USA, V101, P980, DOI 10.1073/pnas.0307612100; Petzer AL, 1996, J EXP MED, V183, P2551, DOI 10.1084/jem.183.6.2551; Renneville A, 2015, BLOOD, V126, P1930, DOI 10.1182/blood-2015-06-649087; Rivers A, 2015, EXP HEMATOL, V43, P546, DOI 10.1016/j.exphem.2015.04.005; Ronzoni L, 2014, BRIT J HAEMATOL, V165, P714, DOI 10.1111/bjh.12814; Rund D, 2005, NEW ENGL J MED, V353, P1135, DOI 10.1056/NEJMra050436; Rupon JW, 2006, P NATL ACAD SCI USA, V103, P6617, DOI 10.1073/pnas.0509322103; Sanalkumar R, 2014, P NATL ACAD SCI USA, V111, pE1091, DOI 10.1073/pnas.1400065111; Sankaran VG, 2011, NEW ENGL J MED, V365, P807, DOI 10.1056/NEJMoa1103070; Sankaran VG, 2008, SCIENCE, V322, P1839, DOI 10.1126/science.1165409; Shearstone JR., 2012, BLOOD, V120, P3259; Shi LH, 2013, NAT MED, V19, P291, DOI 10.1038/nm.3101; Shih AH, 2015, CANCER CELL, V27, P502, DOI 10.1016/j.ccell.2015.03.009; Simon R, 2007, CANCER INFORM, V3, P11; Skarpidi E, 2003, EXP HEMATOL, V31, P197, DOI 10.1016/S0301-472X(02)01030-5; Spinner MA, 2014, BLOOD, V123, P809, DOI 10.1182/blood-2013-07-515528; Sripichai O, 2009, BLOOD, V114, P2299, DOI 10.1182/blood-2009-05-219386; Steinberg MH, 2003, JAMA-J AM MED ASSOC, V289, P1645, DOI 10.1001/jama.289.13.1645; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Subramanian S, 2010, PHARMACEUTICALS, V3, P2751, DOI 10.3390/ph3092751; Suzuki T, 1999, J MED CHEM, V42, P3001, DOI 10.1021/jm980565u; Tallack MR, 2013, CURR OPIN HEMATOL, V20, P193, DOI 10.1097/MOH.0b013e32835f59ba; Tanabe O, 2007, EMBO J, V26, P2295, DOI 10.1038/sj.emboj.7601676; TSAI FY, 1994, NATURE, V371, P221, DOI 10.1038/371221a0; Wang M, 2002, BRIT J HAEMATOL, V119, P1098, DOI 10.1046/j.1365-2141.2002.03958.x; Witt O, 2003, BLOOD, V101, P2001, DOI 10.1182/blood-2002-08-2617; Witter DJ, 2008, BIOORG MED CHEM LETT, V18, P726, DOI 10.1016/j.bmcl.2007.11.047; Xu J, 2013, P NATL ACAD SCI USA, V110, P6518, DOI 10.1073/pnas.1303976110; Xu J, 2010, GENE DEV, V24, P783, DOI 10.1101/gad.1897310; Yamamura K, 2006, BRIT J HAEMATOL, V135, P242, DOI 10.1111/j.1365-2141.2006.06275.x; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao Q, 2009, NAT STRUCT MOL BIOL, V16, P304, DOI 10.1038/nsmb.1568; Zhou DW, 2010, NAT GENET, V42, P742, DOI 10.1038/ng.637	75	19	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153767	10.1371/journal.pone.0153767	http://dx.doi.org/10.1371/journal.pone.0153767			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073918	Green Submitted, Green Published, gold			2022-12-27	WOS:000374131200119
J	Lei, XY; Xiao, LM; Liu, YN; Li, YM				Lei, Xian-Yang; Xiao, La-Mei; Liu, Ya-Nan; Li, Ya-Min			Prevalence of Depression among Chinese University Students: A Meta-Analysis	PLOS ONE			English	Article							COLLEGE-STUDENTS; MENTAL-HEALTH; SYMPTOMS; ANXIETY; AMERICAN	Background Depression is a major mental health issue worldwide, and university students with heavy burdens of study are at a high risk for depression. While a number of studies have been conducted regarding depression among university students in China, there is a lack of information regarding the national prevalence of depression among Chinese university students. Therefore, we performed a meta-analysis to statistically pool the prevalence of depression among Chinese university students. Methods A systematic search of scientific databases was conducted, including Chinese Web of Knowledge, Embase, PubMed, Wanfang (a Chinese database) and Weipu (a Chinese database) to find relevant publications published between 1995 and December 2015. This was supplemented by a secondary review of the reference lists of all retrieved papers to find additional relevant citations. Studies published in either English or Chinese that provided prevalence estimates of depression in Chinese university students were considered. Prevalence estimates of each eligible study were extracted and pooled in our meta-analysis using a random-effects model. Results A total of 39 studies conducted between 1997 and 2015 including 32,694 university students were analyzed. Our results indicate that the overall prevalence of depression among Chinese university students is 23.8% (95% CI: 19.9%-28.5%). Substantial heterogeneity in prevalence estimates was noted. Subgroup analysis revealed that the prevalence of depression among medical students is higher than among other students. Conclusions Overall, the prevalence of depression among Chinese university students is exceedingly high. This suggests that it is imperative that more attention be given to the development of appropriate mental healthcare strategies for university students in China.	[Lei, Xian-Yang; Xiao, La-Mei; Li, Ya-Min] Cent S Univ, Xiangya Hosp 2, Changsha, Hunan, Peoples R China; [Lei, Xian-Yang] Cent S Univ, Off President, Changsha, Hunan, Peoples R China; [Liu, Ya-Nan] Cent S Univ, Xiangya Nursing Sch, Changsha, Hunan, Peoples R China	Central South University; Central South University; Central South University	Li, YM (corresponding author), Cent S Univ, Xiangya Hosp 2, Changsha, Hunan, Peoples R China.	li_yamin3@163.com	Li, Yamin/AAM-5819-2020					Adams TB, 2008, J AM COLL HEALTH, V56, P657, DOI 10.3200/JACH.56.6.657-664; Amarasuriya SD, 2015, ASIAN J PSYCHIATR, V15, P32, DOI 10.1016/j.ajp.2015.04.012; Bagby, 1994, Assessment, V1, P59, DOI 10.1177/1073191194001001009; Bayram N, 2008, SOC PSYCH PSYCH EPID, V43, P667, DOI 10.1007/s00127-008-0345-x; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Bostanci M, 2005, CROAT MED J, V46, P96; Brown GW., 2012, SOCIAL ORIGINS DEPRE; Buckner JD, 2007, ADDICT BEHAV, V32, P1957, DOI 10.1016/j.addbeh.2006.12.019; Chen L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058379; Deeks JJ, 2001, SYSTEMATIC REV HLTH, P285, DOI DOI 10.1002/9780470693926.CH15; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Eller T, 2006, DEPRESS ANXIETY, V23, P250, DOI 10.1002/da.20166; Faries D, 2000, J PSYCHIATR RES, V34, P3, DOI 10.1016/S0022-3956(99)00037-0; Feng Q, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0100914, 10.1371/journal.pone.0104348]; Franko DL, 2005, J ADOLESCENT HEALTH, V37, P526, DOI 10.1016/j.jadohealth.2004.08.028; Garlow SJ, 2008, DEPRESS ANXIETY, V25, P482, DOI 10.1002/da.20321; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hu Teh-wei, 2004, Australas Psychiatry, V12 Suppl, pS11; Hysenbegasi A, 2005, J MENT HEALTH POLICY, V8, P145; Ibrahim AK, 2013, J PSYCHIATR RES, V47, P391, DOI 10.1016/j.jpsychires.2012.11.015; Ibrahim MB, 2015, ALEX J MED, V51, P167, DOI 10.1016/j.ajme.2014.06.002; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Kisch J, 2005, SUICIDE LIFE-THREAT, V35, P3, DOI 10.1521/suli.35.1.3.59263; Li ZZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104368; Lowe B, 2004, J AFFECT DISORDERS, V81, P61, DOI 10.1016/S0165-0327(03)00198-8; Lu W, 2015, J HUAZHONG U SCI-MED, V35, P815, DOI 10.1007/s11596-015-1512-4; Luo MY, 2010, CHINA YOUTH STUDY, V11, P32; Mikolajczyk RT, 2008, SOC PSYCH PSYCH EPID, V43, P105, DOI 10.1007/s00127-007-0282-0; Mushquash AR, 2013, ADDICT BEHAV, V38, P2180, DOI 10.1016/j.addbeh.2012.11.008; Nguyen M, 2011, AUSTR MED STUDENT J, V2, P65; Ovuga E, 2006, WORLD PSYCHIATRY, V5, P51; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Sobocki P, 2007, EUR PSYCHIAT, V22, P146, DOI 10.1016/j.eurpsy.2006.10.006; Steptoe A, 2007, INT J BEHAV MED, V14, P97, DOI 10.1007/BF03004175; STUART A, 1994, KENDALLS ADV THEORY, VI; Voelker R, 2003, JAMA-J AM MED ASSOC, V289, P2055, DOI 10.1001/jama.289.16.2055; Wu Jiao, 2012, Zhonghua Liu Xing Bing Xue Za Zhi, V33, P1111; Yao SQ, 2009, DEPRESS ANXIETY, V26, P930, DOI 10.1002/da.20465; Yen S, 2000, J CONSULT CLIN PSYCH, V68, P993, DOI 10.1037/0022-006X.68.6.993; Zhang YL, 2013, ASIA-PAC PSYCHIAT, V5, P268, DOI 10.1111/appy.12103; Zong JG, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-66; Zung W.W.K., 1986, ASSESSMENT DEPRESSIO, P221, DOI 10.1007/978-3-642-70486-4n_21; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V12, P63, DOI 10.1001/archpsyc.1965.01720310065008	45	127	138	10	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0153454	10.1371/journal.pone.0153454	http://dx.doi.org/10.1371/journal.pone.0153454			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ0NI	27070790	Green Submitted, gold, Green Published			2022-12-27	WOS:000373900700071
J	Deng, AY; Chauvet, C; Menard, A				Deng, Alan Y.; Chauvet, Cristina; Menard, Annie			Alterations in Fibronectin Type III Domain Containing 1 Protein Gene Are Associated with Hypertension	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCUS; G-BETA-GAMMA; BLOOD-PRESSURE; CRITICAL PERSPECTIVE; DAHL RATS; KNOCKOUT; RAT-CHROMOSOME-1; IDENTIFICATION; DISSECTION; CONNEXIN43	Multiple quantitative trait loci (QTLs) for blood pressure (BP) have been detected in rat models of human polygenic hypertension. Great challenges confronting us include molecular identifications of individual QTLs. We first defined the chromosome region harboring C1QTL1 to a segment of 1.9 megabases that carries 9 genes. Among them, we identified the gene encoding the fibronectin type III domain containing 1 protein (Fndc1)/activator of G protein signaling 8 (Ags8) to be the strongest candidate for C1QTL1, since numerous non-synonymous mutations are found. Moreover, the 5' Fndc1/Ags8 putative promoter contains numerous mutations that can account for its differential expression in kidneys and the heart, prominent organs in modulating BP, although the Fndc1/Ags8 protein was not detectable in these organs under our experimental conditions. This work has provided the premier evidence that Fndc1/Ags8 is a novel and strongest candidate gene for C1QTL1 without completely excluding other 8 genes in the C1QTL1-residing interval. If proven true by future in vivo function studies such as single-gene Fndc1/Ags8 congenics, transgenesis or targeted-gene modifications, it might represent a part of the BP genetic architecture that operates in the upstream position distant from the end-phase physiology of BP control, since it activates a Gbetagamma component in a signaling pathway. Its functional role could validate the concept that a QTL in itself can influence BP 'indirectly' by regulating other genes downstream in a pathway. The elucidation of the mechanisms initiated by Fndc/Ags8 variations will reveal novel insights into the BP modulation via a regulatory hierarchy.	[Deng, Alan Y.; Chauvet, Cristina; Menard, Annie] Univ Montreal, Dept Med, CRCHUM Ctr Hosp Univ Montreal, Res Ctr, Montreal, PQ H3C 3J7, Canada	Universite de Montreal	Deng, AY (corresponding author), Univ Montreal, Dept Med, CRCHUM Ctr Hosp Univ Montreal, Res Ctr, Montreal, PQ H3C 3J7, Canada.	alan.deng@umontreal.ca			Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada)	AYD received funding from Canadian Institutes of Health Research for the conduct of the experiments. CC is supported by a doctoral fellowship from the Heart and Stroke Foundation of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Atanur SS, 2013, CELL, V154, P691, DOI 10.1016/j.cell.2013.06.040; BORK P, 1992, P NATL ACAD SCI USA, V89, P8990, DOI 10.1073/pnas.89.19.8990; Caro C. G., 2012, MECH CIRCULATION, VSecond; Chauvet C, 2013, HUM MOL GENET, V22, P4451, DOI 10.1093/hmg/ddt294; Chauvet C, 2011, J HYPERTENS, V29, P1320, DOI 10.1097/HJH.0b013e32834705e4; Clemitson JR, 2007, CIRC RES, V100, P992, DOI 10.1161/01.RES.0000261961.41889.9c; Cowley AW, 2008, HYPERTENSION, V52, P777, DOI 10.1161/HYPERTENSIONAHA.107.092858; Cowley AW, 2006, NAT REV GENET, V7, P829, DOI 10.1038/nrg1967; Deng AY, 2007, HUM MOL GENET, V16, pR195, DOI 10.1093/hmg/ddm126; Deng AY, 2007, HYPERTENSION, V49, P740, DOI 10.1161/01.HYP.0000259105.09235.56; Deng AY, 2015, J HYPERTENS, V33, P669, DOI 10.1097/HJH.0000000000000479; Deng AY, 2013, PHYSIOL GENOMICS, V45, P1196, DOI 10.1152/physiolgenomics.00165.2013; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; Haefliger JA, 1999, ARTERIOSCL THROM VAS, V19, P1615, DOI 10.1161/01.ATV.19.7.1615; Haefliger JA, 2006, J CLIN INVEST, V116, P405, DOI 10.1172/JCI23327; Joe B, 2003, J HYPERTENS, V21, P2077, DOI 10.1097/00004872-200311000-00017; Jones MB, 2004, MOL INTERV, V4, P200, DOI 10.1124/mi.4.4.4; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Liao Y, 2001, P NATL ACAD SCI USA, V98, P9989, DOI 10.1073/pnas.171305298; Saez JC, 2003, PHYSIOL REV, V83, P1359, DOI 10.1152/physrev.00007.2003; Sato M, 2006, P NATL ACAD SCI USA, V103, P797, DOI 10.1073/pnas.0507467103; Sato M, 2009, J BIOL CHEM, V284, P31431, DOI 10.1074/jbc.M109.014068; Siffert W, 1998, NAT GENET, V18, P45, DOI 10.1038/ng0198-45; Solan JL, 2009, BIOCHEM J, V419, P261, DOI 10.1042/BJ20082319; White JK, 2013, CELL, V154, P452, DOI 10.1016/j.cell.2013.06.022; Yagil C, 2005, CIRC RES, V96, P617, DOI 10.1161/01.RES.0000160556.52369.61	28	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2016	11	4							e0151399	10.1371/journal.pone.0151399	http://dx.doi.org/10.1371/journal.pone.0151399			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0KH	27064407	Green Published, Green Submitted, gold			2022-12-27	WOS:000373891000002
J	Kroll, AJ; Jones, JE; Stringer, AB; Meekins, DJ				Kroll, Andrew J.; Jones, Jay E.; Stringer, Angela B.; Meekins, Douglas J.			Multistate Models Reveal Long-Term Trends of Northern Spotted Owls in the Absence of a Novel Competitor	PLOS ONE			English	Article							SITE OCCUPANCY DYNAMICS; BARRED OWLS; MULTIPLE STATES; HABITAT; POPULATIONS; CLIMATE; OREGON; WASHINGTON; CALIFORNIA; RANGE	Quantifying spatial and temporal variability in population trends is a critical aspect of successful management of imperiled species. We evaluated territory occupancy dynamics of northern spotted owls (Strix occidentalis caurina), California, USA, 1990-2014. The study area possessed two unique aspects. First, timber management has occurred for over 100 years, resulting in dramatically different forest successional and structural conditions compared to other areas. Second, the barred owl (Strix varia), an exotic congener known to exert significant negative effects on spotted owls, has not colonized the study area. We used a Bayesian dynamic multistate model to evaluate if territory occupancy of reproductive spotted owls has declined as in other study areas. The state-space approach for dynamic multistate modeling imputes the number of territories for each nesting state and allows for the estimation of longer-term trends in occupied or reproductive territories from longitudinal studies. The multistate approach accounts for different detection probabilities by nesting state (to account for either inherent differences in detection or for the use of different survey methods for different occupancy states) and reduces bias in state assignment. Estimated linear trends in the number of reproductive territories suggested an average loss of approximately one half territory per year (-0.55, 90% CRI: -0.76, -0.33), in one management block and a loss of 0.15 per year (-0.15, 90% CRI: -0.24, -0.07), in another management block during the 25 year observation period. Estimated trends in the third management block were also negative, but substantial uncertainty existed in the estimate (-0.09, 90% CRI: -0.35, 0.17). Our results indicate that the number of territories occupied by northern spotted owl pairs remained relatively constant over a 25 year period (-0.07, 90% CRI: -0.20, 0.05; -0.01, 90% CRI: -0.19, 0.16; -0.16, 90% CRI: -0.40, 0.06). However, we cannot exclude small-to-moderate declines or increases in paired territory numbers due to uncertainty in our estimates. Collectively, we conclude spotted owl pair populations on this landscape managed for commercial timber production appear to be more stable and do not show sharp year-over-year declines seen in both managed and unmanaged landscapes with substantial barred owl colonization and persistence. Continued monitoring of reproductive territories can determine whether recent declines continue or whether trends reverse as they have on four previous occasions. Experimental investigations to evaluate changes to spotted owl occupancy dynamics when barred owl populations are reduced or removed entirely can confirm the generality of this conclusion.	[Kroll, Andrew J.; Jones, Jay E.] Weyerhaeuser, Fed Way, Washington, DC USA; [Stringer, Angela B.] Fire Mt Consulting LLC, Vancouver, WA USA; [Meekins, Douglas J.] Campbell Global LLC, Cathlamet, WA USA		Kroll, AJ (corresponding author), Weyerhaeuser, Fed Way, Washington, DC USA.	aj.kroll@weyerhaeuser.com	Kroll, Andrew/ABB-3724-2020	Kroll, Andrew/0000-0001-7747-830X	Hawthorne Timber Company; Usal Redwood Forest Company; Weyerhaeuser	Hawthorne Timber Company; Usal Redwood Forest Company; Weyerhaeuser	Surveys were funded by Hawthorne Timber Company and Usal Redwood Forest Company. Data compilation and analysis were unfunded. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funders provided support in the form of salaries for authors (AS, DM), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Weyerhaeuser provided support in the form of salaries for authors (AK, JJ). The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], 2010, R LANG ENV STAT COMP; Anthony R. G., 2006, WILDLIFE MONOGRAPHS, V163; Bailey LL, 2009, BIOL CONSERV, V142, P2983, DOI 10.1016/j.biocon.2009.07.028; CAREY AB, 1992, ECOL MONOGR, V62, P223, DOI 10.2307/2937094; Dugger KM, 2016, CONDOR, V118, P57, DOI 10.1650/CONDOR-15-24.1; Dugger KM, 2011, ECOL APPL, V21, P2459, DOI 10.1890/10-2142.1; Farber SL, 2012, J WILDLIFE MANAGE, V76, P1145, DOI 10.1002/jwmg.368; Fish U.S., 2012, EXPT REM BARR OWLS B; Forsman E.D., 1983, PNWGTR162 USDA FOR S; Forsman E.D., 1984, WILDLIFE MONOGR, V87, P64; Franklin AB, 2000, ECOL MONOGR, V70, P539, DOI 10.1890/0012-9615(2000)070[0539:CHQAFI]2.0.CO;2; Franklin J. F., 1973, NATURAL VEGETATION O; Gelman A., 2004, BAYESIAN DATA ANAL; Glenn EM, 2011, J WILDLIFE MANAGE, V75, P1279, DOI 10.1002/jwmg.177; Herter DR, 2000, J RAPTOR RES, V34, P279; Kelly EG, 2003, CONDOR, V105, P45, DOI 10.1650/0010-5422(2003)105[45:ABODSO]2.0.CO;2; Kroll AJ, 2010, J WILDLIFE MANAGE, V74, P1264, DOI 10.2193/2009-429; Kuehl R. O., 1999, DESIGN EXPT STAT PRI, V2nd; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; Mackenzie DI, 2009, ECOLOGY, V90, P823, DOI 10.1890/08-0141.1; MacKenzie DI, 2003, ECOLOGY, V84, P2200, DOI 10.1890/02-3090; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Mayer K.E., 1988, GUIDE WILDLIFE HABIT; Nichols JD, 2007, ECOLOGY, V88, P1395, DOI 10.1890/06-1474; Olson GS, 2005, J WILDLIFE MANAGE, V69, P918, DOI 10.2193/0022-541X(2005)069[0918:MOSODF]2.0.CO;2; Olson GS, 2004, J WILDLIFE MANAGE, V68, P1039, DOI 10.2193/0022-541X(2004)068[1039:MDPONS]2.0.CO;2; Pavlacky DC, 2012, J WILDLIFE MANAGE, V76, P154, DOI 10.1002/jwmg.245; Plummer M., 2003, PROC 3 INT WORK DIST, P1; Rosenberg DK, 2003, CAN J ZOOL, V81, P1715, DOI 10.1139/Z03-167; Sawyer J. O., 2000, REDWOOD FOREST, P39; Su Y-S, R2JAGS PACKAGE RUNNI; TAYLOR AL, 1976, CONDOR, V78, P560, DOI 10.2307/1367110; Thomas JW, 1990, CONSERVATION STRATEG; U.S. Fish and Wildlife Service, 2004, NO SPOTT OWL 5 YEAR; United States Department of Agriculture, 1988, SPOTT OWLS INV MON H; United States Fish and Wildlife Service, 1992, PROT SURV PROP MAN A, V17; United States Fish and Wildlife Service, 2011, PROT SURV PROP MAN A; US Fish and Wildlife Service, 1990, FED REGISTER, V55, P26114; Western Regional Climate Center, FORT BRAGG 5 N; Yackulic CB, 2014, ECOLOGY, V95, P265, DOI 10.1890/13-0012.1	40	8	8	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2016	11	4							e0152888	10.1371/journal.pone.0152888	http://dx.doi.org/10.1371/journal.pone.0152888			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0KH	27065016	Green Published, gold, Green Submitted			2022-12-27	WOS:000373891000022
J	Said, EA; Al-Reesi, I; Al-Riyami, M; Al-Naamani, K; Al-Sinawi, S; Al-Balushi, MS; Koh, CY; Al-Busaidi, JZ; Idris, MA; Al-Jabri, AA				Said, Elias A.; Al-Reesi, Iman; Al-Riyami, Marwa; Al-Naamani, Khalid; Al-Sinawi, Shadia; Al-Balushi, Mohammed S.; Koh, Crystal Y.; Al-Busaidi, Juma Z.; Idris, Mohamed A.; Al-Jabri, Ali A.			A Potential Inhibitory Profile of Liver CD68(+) Cells during HCV Infection as Observed by an Increased CD80 and PD-L1 but Not CD86 Expression	PLOS ONE			English	Article							CD8(+) T-CELLS; CHRONIC HEPATITIS; MACROPHAGE APOPTOSIS; DUCTULAR REACTION; KUPFFER CELLS; CTLA-4; RESPONSES; MICROPARTICLES; INDUCTION; CYTOKINES	Aim The lack of potent innate immune responses during HCV infection might lead to a delay in initiating adaptive immune responses. Kupffer cells (KCs) and liver-infiltrating monocytes/ macrophages (CD68(+) cells) are essential to establish effective anti-HCV responses. They express co-stimulatory molecules, CD80 and CD86. CD86 upregulation induces activator responses that are then potentially regulated by CD80. The relative levels of expression of CD80, CD86 and the inhibitory molecule, PD-L1, on CD68(+) cells modulate T cell activation. A few studies have explored CD80 and PD-L1 expression on KCs and infiltrating monocytes/ macrophages in HCV-infected livers, and none investigated CD86 expression in these cells. These studies have identified these cells based on morphology only. We investigated the stimulatory/ inhibitory profile of CD68(+) cells in HCV-infected livers based on the balance of CD80, CD86 and PD-L1 expression. Methods CD80, CD86 and PD-L1 expression by CD68(+) cells in the lobular and portal areas of the liver of chronic HCV-infected (n = 16) and control (n = 14) individuals was investigated using double staining immunohistochemistry. Results The count of CD68(+) KCs in the lobular areas of the HCV-infected livers was lower than that in the control (p = 0.041). The frequencies of CD68(+)CD80(+) cells and CD68(+)PD-L1(+) cells in both lobular and total areas of the liver were higher in HCV-infected patients compared with those in the control group (p = 0.001, 0.031 and 0.007 respectively). Moreover, in the lobular areas of the HCV-infected livers, the frequency of CD68(+)CD80(+) cells was higher than that of CD68(+)CD86(+) and CD68(+)PD-L1(+) cells. In addition, the frequencies of CD68(+)CD80(+) and CD68(+)CD86(+) cells were higher in the lobular areas than the portal areas. Conclusions Our results show that CD68(+) cells have an inhibitory profile in the HCV-infected livers. This might help explain the delayed T cell response and viral persistence during HCV infection.	[Said, Elias A.; Al-Reesi, Iman; Al-Balushi, Mohammed S.; Koh, Crystal Y.; Al-Busaidi, Juma Z.; Idris, Mohamed A.; Al-Jabri, Ali A.] Sultan Qaboos Univ, Coll Med & Hlth Sci, Dept Microbiol & Immunol, POB 35,Code 123, Muscat, Oman; [Al-Riyami, Marwa; Al-Sinawi, Shadia] Sultan Qaboos Univ, Coll Med & Hlth Sci, Dept Pathol, POB 35,Code 123, Muscat, Oman; [Al-Naamani, Khalid] Armed Forces Hosp, Dept Med, Muscat, Oman	Sultan Qaboos University; Sultan Qaboos University	Said, EA (corresponding author), Sultan Qaboos Univ, Coll Med & Hlth Sci, Dept Microbiol & Immunol, POB 35,Code 123, Muscat, Oman.	elias.said@gmail.com	Said, Elias/AAY-5557-2020					Boing AN, 2008, PLATELETS, V19, P96, DOI 10.1080/09537100701777295; Boltjes A, 2014, J HEPATOL, V61, P660, DOI 10.1016/j.jhep.2014.04.026; Burgio VL, 1998, HEPATOLOGY, V27, P1600, DOI 10.1002/hep.510270620; Carter LL, 2002, EUR J IMMUNOL, V32, P634, DOI 10.1002/1521-4141(200203)32:3<634::AID-IMMU634>3.0.CO;2-9; Distler JHW, 2005, APOPTOSIS, V10, P731, DOI 10.1007/s10495-005-2941-5; Flynn JK, 2011, J VIRAL HEPATITIS, V18, P549, DOI 10.1111/j.1365-2893.2010.01335.x; Gadd VL, 2014, HEPATOLOGY, V59, P1393, DOI 10.1002/hep.26937; Gadd VL, 2013, LIVER INT, V33, P569, DOI 10.1111/liv.12050; Horner SM, 2013, NAT MED, V19, P879, DOI 10.1038/nm.3253; Huber LC, 2007, APOPTOSIS, V12, P363, DOI 10.1007/s10495-006-0622-7; Jeffery LE, 2014, IMMUNOLOGY, V143, P142; Kassel R, 2009, HEPATOLOGY, V50, P1625, DOI 10.1002/hep.23173; Kong LQ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059771, 10.1371/journal.pone.0078275]; Larrea E, 2007, J VIROL, V81, P3662, DOI 10.1128/JVI.02248-06; Lim EJ, 2014, J GEN VIROL, V95, P2204, DOI 10.1099/vir.0.065862-0; Liu BS, 2011, J LEUKOCYTE BIOL, V89, P981, DOI 10.1189/jlb.1210680; Manzotti CN, 2006, EUR J IMMUNOL, V36, P1413, DOI 10.1002/eji.200535170; McGuinness PH, 2000, GUT, V46, P260, DOI 10.1136/gut.46.2.260; Messina JP, 2015, HEPATOLOGY, V61, P77, DOI 10.1002/hep.27259; Mochizuki K, 1997, HEPATOLOGY, V25, P713, DOI 10.1002/hep.510250337; Munteanu F, 2014, 2014 INTERNATIONAL CONFERENCE ON OPTIMIZATION OF ELECTRICAL AND ELECTRONIC EQUIPMENT (OPTIM), P756, DOI 10.1109/OPTIM.2014.6850917; Qureshi OS, 2011, SCIENCE, V332, P600, DOI 10.1126/science.1202947; Reiser M, 1997, J HEPATOL, V26, P471, DOI 10.1016/S0168-8278(97)80409-6; Riezu-Boj JI, 2011, J HEPATOL, V54, P422, DOI 10.1016/j.jhep.2010.07.014; Romo-Tena J, 2013, AUTOIMMUN REV, V12, P1171, DOI 10.1016/j.autrev.2013.07.002; Said EA, 2010, NAT MED, V16, P452, DOI 10.1038/nm.2106; Sandler NG, 2011, GASTROENTEROLOGY, V141, P1220, DOI 10.1053/j.gastro.2011.06.063; Sangro B, 2013, J HEPATOL, V59, P81, DOI 10.1016/j.jhep.2013.02.022; Sansom DM, 2000, IMMUNOLOGY, V101, P169, DOI 10.1046/j.1365-2567.2000.00121.x; Shin EC, 2011, GASTROENTEROLOGY, V141, P686, DOI 10.1053/j.gastro.2011.05.006; Thimme R, 2012, FEMS MICROBIOL REV, V36, P663, DOI 10.1111/j.1574-6976.2011.00319.x; Wang ZQ, 2001, IMMUNOLOGY, V102, P331, DOI 10.1046/j.1365-2567.2001.01171.x; Xaus J, 2000, BLOOD, V95, P3823; Yadav D, 2007, MOL IMMUNOL, V44, P2616, DOI 10.1016/j.molimm.2006.12.008; Zhang Q, 2014, J IMMUNOL, V192, P2913, DOI 10.4049/jimmunol.1302951	35	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2016	11	4							e0153191	10.1371/journal.pone.0153191	http://dx.doi.org/10.1371/journal.pone.0153191			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0KH	27065104	Green Published, Green Submitted, gold			2022-12-27	WOS:000373891000035
J	Fuchsl, AM; Reber, SO				Fuechsl, Andrea M.; Reber, Stefan O.			Chronic Psychosocial Stress and Negative Feedback Inhibition: Enhanced Hippocampal Glucocorticoid Signaling despite Lower Cytoplasmic GR Expression	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; TRANSCRIPTIONAL ACTIVITY; GENE-EXPRESSION; RAT-BRAIN; MALE-MICE; HPA AXIS; CORTICOSTERONE; RECEPTOR; PITUITARY; PROTEIN	Chronic subordinate colony housing (CSC), a pre-clinically validated mouse model for chronic psychosocial stress, results in increased basal and acute stress-induced plasma adrenocorticotropic hormone (ACTH) levels. We assessed CSC effects on hippocampal glucocorticoid (GC) receptor (GR), mineralocorticoid receptor (MR), and FK506 binding protein (FKBP51) expression, acute heterotypic stressor-induced GR translocation, as well as GC effects on gene expression and cell viability in isolated hippocampal cells. CSC mice showed decreased GR mRNA and cytoplasmic protein levels compared with single-housed control (SHC) mice. Basal and acute stress-induced nuclear GR protein expression were comparable between CSC and SHC mice, as were MR and FKBP51 mRNA and/or cytoplasmic protein levels. In vitro the effect of corticosterone (CORT) on hippocampal cell viability and gene transcription was more pronounced in CSC versus SHC mice. In summary, CSC mice show an, if at all, increased hippocampal GC signaling capacity despite lower cytoplasmic GR protein expression, making negative feedback deficits in the hippocampus unlikely to contribute to the increased ACTH drive following CSC.	[Fuechsl, Andrea M.; Reber, Stefan O.] Univ Regensburg, Dept Behav & Mol Neurobiol, D-93053 Regensburg, Germany; [Fuechsl, Andrea M.; Reber, Stefan O.] Univ Ulm, Clin Psychosomat Med & Psychotherapy, Lab Mol Psychosomat, D-89081 Ulm, Germany	University of Regensburg; Ulm University	Reber, SO (corresponding author), Univ Ulm, Clin Psychosomat Med & Psychotherapy, Lab Mol Psychosomat, D-89081 Ulm, Germany.	stefan.reber@uniklinik-ulm.de			Deutsche Forschungsgemeinschaft/German Research Foundation [DFG-RE 2911/5-1]; German Research Foundation [DFG-RE 2911/5-1]	Deutsche Forschungsgemeinschaft/German Research Foundation(German Research Foundation (DFG)); German Research Foundation(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft/German Research Foundation to SOR, DFG-RE 2911/5-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful to N. Grunwald, N. Uschold-Schmidt, D. Langgartner, S. Peters, C. Stangl and V. Kufner for excellent technical and experimental assistance. Furthermore, the authors are grateful to the German Research Foundation for funding (DFG-RE 2911/5-1).	Adzic M, 2009, J ENDOCRINOL, V202, P87, DOI 10.1677/JOE-08-0509; Bartolomucci A, 2003, BRAIN RES BULL, V62, P173, DOI 10.1016/j.brainresbull.2003.09.009; Binder EB, 2009, PSYCHONEUROENDOCRINO, V34, P99, DOI 10.1016/j.psyneuen.2009.05.021; CHROUSOS GP, 1992, JAMA-J AM MED ASSOC, V267, P1244, DOI 10.1001/jama.267.9.1244; Conway-Campbell BL, 2010, J NEUROENDOCRINOL, V22, P1093, DOI 10.1111/j.1365-2826.2010.02051.x; Datson NA, 2008, EUR J PHARMACOL, V583, P272, DOI 10.1016/j.ejphar.2007.11.070; De Kloet ER, 1998, ENDOCR REV, V19, P269, DOI 10.1210/er.19.3.269; deLeon MJ, 1997, J CLIN ENDOCR METAB, V82, P3251, DOI 10.1210/jc.82.10.3251; DRAGUNOW M, 1985, EPILEPSIA, V26, P480, DOI 10.1111/j.1528-1157.1985.tb05684.x; Droste SK, 2008, ENDOCRINOLOGY, V149, P3244, DOI 10.1210/en.2008-0103; ELLIOTT EM, 1992, J NEUROCHEM, V59, P1033, DOI 10.1111/j.1471-4159.1992.tb08345.x; ELLIOTT EM, 1993, BRAIN RES, V602, P84, DOI 10.1016/0006-8993(93)90245-I; Forray MI, 2004, BRAIN RES REV, V47, P145, DOI 10.1016/j.brainresrev.2004.07.011; Fuchsl AM, 2014, ENDOCRINOLOGY, V155, P117, DOI 10.1210/en.2013-1742; Fuchsl AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084161; Fuchsl AM, 2013, STRESS, V16, P461, DOI 10.3109/10253890.2013.793303; Guo YF, 2008, ACTA BIOCH BIOPH SIN, V40, P426, DOI 10.1111/j.1745-7270.2008.00418.x; Herman JP, 2006, BEHAV BRAIN RES, V174, P215, DOI 10.1016/j.bbr.2006.05.035; Hill MN, 2011, J NEUROSCI, V31, P10506, DOI 10.1523/JNEUROSCI.0496-11.2011; HUTCHISON KA, 1993, ANN NY ACAD SCI, V684, P35, DOI 10.1111/j.1749-6632.1993.tb32269.x; HUXTABLE RJ, 1989, PROG NEUROBIOL, V32, P471, DOI 10.1016/0301-0082(89)90019-1; JOELS M, 1992, TRENDS NEUROSCI, V15, P25, DOI 10.1016/0166-2236(92)90345-9; Joels M, 2006, TRENDS PHARMACOL SCI, V27, P244, DOI 10.1016/j.tips.2006.03.007; Karatsoreos IN, 2011, TRENDS COGN SCI, V15, P576, DOI 10.1016/j.tics.2011.10.005; Karst H, 2005, J NEUROPHYSIOL, V94, P3479, DOI 10.1152/jn.00143.2005; Kellendonk C, 2002, BRAIN RES BULL, V57, P73, DOI 10.1016/S0361-9230(01)00638-4; Kitraki E, 1999, NEUROENDOCRINOLOGY, V69, P331, DOI 10.1159/000054435; KOVACS KJ, 1988, BRAIN RES, V474, P205, DOI 10.1016/0006-8993(88)90435-0; Kudielka BM, 2006, BIOL PSYCHOL, V72, P147, DOI 10.1016/j.biopsycho.2005.09.001; Kumar R, 2008, BIOL-TARGETS THER, V2, P845; LANDFIELD PW, 1992, J NEUROBIOL, V23, P1247, DOI 10.1002/neu.480230914; Langgartner D, 2015, FRONT PSYCHIATRY, V6, DOI 10.3389/fpsyt.2015.00018; Lee T, 2009, NEUROREPORT, V20, P1554, DOI 10.1097/WNR.0b013e328332bb09; Martinez-Claros M, 2013, J CHEM NEUROANAT, V48-49, P23, DOI 10.1016/j.jchemneu.2013.01.001; McEwen BS, 1999, ANNU REV NEUROSCI, V22, P105, DOI 10.1146/annurev.neuro.22.1.105; MILLER AH, 1992, BIOL PSYCHIAT, V32, P850, DOI 10.1016/0006-3223(92)90175-Y; MOGUILEWSKY M, 1980, J STEROID BIOCHEM, V12, P309, DOI 10.1016/0022-4731(80)90285-X; Moosavi M, 2008, NEUROENDOCRINOLOGY, V88, P293, DOI 10.1159/000150441; Pariante CM, 2008, TRENDS NEUROSCI, V31, P464, DOI 10.1016/j.tins.2008.06.006; Peters S, 2012, STRESS, V15, P403, DOI 10.3109/10253890.2011.631232; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; Raison CL, 2003, AM J PSYCHIAT, V160, P1554, DOI 10.1176/appi.ajp.160.9.1554; Reber SO, 2007, ENDOCRINOLOGY, V148, P670, DOI 10.1210/en.2006-0983; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Retana-Marquez S, 2003, PSYCHONEUROENDOCRINO, V28, P207, DOI 10.1016/S0306-4530(02)00017-3; REUL JMHM, 1985, ENDOCRINOLOGY, V117, P2505, DOI 10.1210/endo-117-6-2505; SAPOLSKY RM, 1988, BRAIN RES, V453, P367, DOI 10.1016/0006-8993(88)90180-1; SAPOLSKY RM, 1984, ENDOCRINOLOGY, V114, P287, DOI 10.1210/endo-114-1-287; Schmidt D, 2010, BRAIN BEHAV IMMUN, V24, P1097, DOI 10.1016/j.bbi.2010.04.014; Schmidt MV, 2007, PSYCHONEUROENDOCRINO, V32, P417, DOI 10.1016/j.psyneuen.2007.02.011; Singewald GM, 2009, STRESS, V12, P58, DOI 10.1080/10253890802042082; SPENCER RL, 1991, BRAIN RES, V549, P236, DOI 10.1016/0006-8993(91)90463-6; SPENCER RL, 1990, NEUROENDOCRINOLOGY, V52, P481, DOI 10.1159/000125632; Spiga F, 2011, J PSYCHOPHARMACOL, V25, P211, DOI 10.1177/0269881109348175; Tasker JG, 2006, ENDOCRINOLOGY, V147, P5549, DOI 10.1210/en.2006-0981; Torner L, 2009, J NEUROSCI, V29, P1826, DOI 10.1523/JNEUROSCI.3178-08.2009; Tritos N, 1999, NEUROENDOCRINOLOGY, V69, P324, DOI 10.1159/000054434; Uschold-Schmidt N, 2012, PSYCHONEUROENDOCRINO; Uschold-Schmidt N, 2013, J ENDOCRINOL, V218, P193, DOI 10.1530/JOE-13-0027; Vallone D, 1997, EMBO J, V16, P5310, DOI 10.1093/emboj/16.17.5310; Wagner KV, 2012, NEUROPSYCHOPHARMACOL; WATANABE Y, 1992, BRAIN RES, V588, P341, DOI 10.1016/0006-8993(92)91597-8; Weigel NL, 2007, MOL ENDOCRINOL, V21, P2311, DOI 10.1210/me.2007-0101; Weiser MJ, 2011, J NEUROENDOCRINOL, V23, P1231, DOI 10.1111/j.1365-2826.2011.02217.x; Yamamoto T, 2005, J BIOL CHEM, V280, P42036, DOI 10.1074/jbc.M509600200	65	10	10	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2016	11	4							e0153164	10.1371/journal.pone.0153164	http://dx.doi.org/10.1371/journal.pone.0153164			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6JK	27057751	gold, Green Published, Green Submitted			2022-12-27	WOS:000373604800019
J	Bernardi, A; Nikolaou, A; Meneghesso, A; Morosinotto, T; Chachuat, B; Bezzo, F				Bernardi, Andrea; Nikolaou, Andreas; Meneghesso, Andrea; Morosinotto, Tomas; Chachuat, BenoOt; Bezzo, Fabrizio			High-Fidelity Modelling Methodology of Light-Limited Photosynthetic Production in Microalgae	PLOS ONE			English	Article							CHLOROPHYLL FLUORESCENCE; ALGAL PHOTOSYNTHESIS; MECHANISTIC MODEL; FLUID-DYNAMICS; GROWTH; PHOTOINHIBITION; IDENTIFIABILITY; DESIGN; PHYTOPLANKTON; OPTIMIZATION	Reliable quantitative description of light-limited growth in microalgae is key to improving the design and operation of industrial production systems. This article shows how the capability to predict photosynthetic processes can benefit from a synergy between mathematical modelling and lab-scale experiments using systematic design of experiment techniques. A model of chlorophyll fluorescence developed by the authors [Nikolaou et al., J Biotechnol 194: 91-99, 2015] is used as starting point, whereby the representation of non-photochemical-quenching (NPQ) process is refined for biological consistency. This model spans multiple time scales ranging from milliseconds to hours, thus calling for a combination of various experimental techniques in order to arrive at a sufficiently rich data set and determine statistically meaningful estimates for the model parameters. The methodology is demonstrated for the microalga Nannochloropsis gaditana by combining pulse amplitude modulation (PAM) fluorescence, photosynthesis rate and antenna size measurements. The results show that the calibrated model is capable of accurate quantitative predictions under a wide range of transient light conditions. Moreover, this work provides an experimental validation of the link between fluorescence and photosynthesis-irradiance (PI) curves which had been theoricized.	[Bernardi, Andrea; Bezzo, Fabrizio] Univ Padua, Dept Ind Engn, CAPE Lab, Padua, Italy; [Bernardi, Andrea; Bezzo, Fabrizio] Univ Padua, Dept Ind Engn, PAR Lab, Padua, Italy; [Nikolaou, Andreas; Chachuat, BenoOt] Univ London Imperial Coll Sci Technol & Med, Dept Chem Engn, Ctr Proc Syst Engn, London SW7 2AZ, England; [Meneghesso, Andrea; Morosinotto, Tomas] Univ Padua, Dept Biol, PAR Lab, Padua, Italy	University of Padua; University of Padua; Imperial College London; University of Padua	Bezzo, F (corresponding author), Univ Padua, Dept Ind Engn, CAPE Lab, Padua, Italy.; Bezzo, F (corresponding author), Univ Padua, Dept Ind Engn, PAR Lab, Padua, Italy.	fabrizio.bezzo@unipd.it	Chachuat, Benoit/AAT-7654-2021; Chachuat, Benoit/J-6899-2012; Morosinotto, Tomas/AAC-3188-2019	Chachuat, Benoit/0000-0003-4780-9686; Chachuat, Benoit/0000-0003-4780-9686; Morosinotto, Tomas/0000-0002-0803-7591; Bezzo, Fabrizio/0000-0003-1561-0584; Bernardi, Andrea/0000-0002-8102-2759; Meneghesso, Andrea/0000-0002-8970-8739	European Research Council (BIOLEAP) [309485]; University of Padova [CPDR147230]; Ministero dell'Istruzione, dell'Universita e della Ricerca project PRIN [2012XSAWYM]; European Research Council (DOP-ECOS) [PCIG09-GA-2011-293953]; PRIN "Improving biofuels and high added value molecules production from unicellular algae" [2012XSAWYM]	European Research Council (BIOLEAP); University of Padova; Ministero dell'Istruzione, dell'Universita e della Ricerca project PRIN; European Research Council (DOP-ECOS); PRIN "Improving biofuels and high added value molecules production from unicellular algae"	TM gratefully acknowledges financial support by the European Research Council (https://erc.europa.eu) starting grant 309485 (BIOLEAP). AB and FB gratefully acknowledge the University of Padova for financial support under project prot. CPDR147230. FB and TM gratefully acknowledge Ministero dell'Istruzione, dell'Universita e della Ricerca (http://www.istruzione.it) for financial support by project PRIN 2012 prot. 2012XSAWYM. AN and BC gratefully acknowledge financial support by the European Research Council (https://erc.europa.eu) career integration grant PCIG09-GA-2011-293953 (DOP-ECOS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; TM gratefully acknowledges financial support by ERC starting grant 309485 (BIOLEAP). AB and FB gratefully acknowledge the University of Padova for financial support under project "A model-based approach to enhance light use efficiency in the industrial production of microalgae" (prot. CPDR147230). FB and TM gratefully acknowledge financial support by project PRIN 2012 "Improving biofuels and high added value molecules production from unicellular algae" (prot. 2012XSAWYM). AN and BC gratefully acknowledge financial support by ERC career integration grant PCIG09-GA-2011-293953 (DOP-ECOS).	Adesanya VO, 2014, BIORESOURCE TECHNOL, V157, P293, DOI 10.1016/j.biortech.2014.01.032; Baker NR, 2008, ANNU REV PLANT BIOL, V59, P89, DOI 10.1146/annurev.arplant.59.032607.092759; Bellu G, 2007, COMPUT METH PROG BIO, V88, P52, DOI 10.1016/j.cmpb.2007.07.002; Bernard O, 2016, ADV BIOCHEM ENG BIOT, V153, P59, DOI 10.1007/10_2014_287; Bernard O, 2012, BIORESOURCE TECHNOL, V123, P520, DOI 10.1016/j.biortech.2012.07.022; Bernard O, 2011, J PROCESS CONTR, V21, P1378, DOI 10.1016/j.jprocont.2011.07.012; Bernardi A, 2014, IND ENG CHEM RES, V53, P6738, DOI 10.1021/ie500523z; Bernardi A, 2015, COMPUT-AIDED CHEM EN, V37, P2483; Bonente G, 2012, J BIOL CHEM, V287, P5833, DOI 10.1074/jbc.M111.304279; Chakrabarty A, 2013, WIRES SYST BIOL MED, V5, P181, DOI 10.1002/wsbm.1204; EILERS PHC, 1988, ECOL MODEL, V42, P199, DOI 10.1016/0304-3800(88)90057-9; Falkowski P. G., 1997, AQUATIC PHOTOSYNTHES, V256; Franceschini G, 2008, CHEM ENG SCI, V63, P4846, DOI 10.1016/j.ces.2007.11.034; Galvanin F, 2013, J PHARMACOKINET PHAR, V40, P451, DOI 10.1007/s10928-013-9321-5; Garcia-Camacho F, 2012, J THEOR BIOL, V304, P1, DOI 10.1016/j.jtbi.2012.03.021; Han BP, 2000, J PLANKTON RES, V22, P865, DOI 10.1093/plankt/22.5.865; Hartmann P., 2014, 19 WORLD C INT FED A; Huot Y, 2010, DEVEL APPL PHYCOL, V4, P31, DOI 10.1007/978-90-481-9268-7_3; Joliot P, 2006, BBA-BIOENERGETICS, V1757, P362, DOI 10.1016/j.bbabio.2006.02.018; KIEFER J, 1959, J ROY STAT SOC B, V21, P272; KOK B, 1956, BIOCHIM BIOPHYS ACTA, V21, P234, DOI 10.1016/0006-3002(56)90003-8; Kramer DM, 2004, PHOTOSYNTH RES, V79, P209, DOI 10.1023/B:PRES.0000015391.99477.0d; Mata TM, 2010, RENEW SUST ENERG REV, V14, P217, DOI 10.1016/j.rser.2009.07.020; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; Miao HY, 2011, SIAM REV, V53, P3, DOI 10.1137/090757009; Nauha EK, 2013, CHEM ENG J, V229, P559, DOI 10.1016/j.cej.2013.06.065; Nikolaou A, J THEOR BIO IN PRESS; Nikolaou A, 2015, J BIOTECHNOL, V194, P91, DOI 10.1016/j.jbiotec.2014.12.001; Peers G, 2009, NATURE, V462, P518, DOI 10.1038/nature08587; Pinnola A, 2013, PLANT CELL, V25, P3519, DOI 10.1105/tpc.113.114538; Quinn J, 2011, BIORESOURCE TECHNOL, V102, P5083, DOI 10.1016/j.biortech.2011.01.019; Rubio FC, 2003, BIOTECHNOL BIOENG, V81, P459, DOI 10.1002/bit.10492; Simionato D, 2013, BIOPHYS CHEM, V182, P71, DOI 10.1016/j.bpc.2013.06.017; Simionato D, 2013, EUKARYOT CELL, V12, P665, DOI 10.1128/EC.00363-12; Suggett DJ, 2003, EUR J PHYCOL, V38, P371, DOI 10.1080/09670260310001612655; Walter E, 1997, COMMUN CONTR ENG, V8; Wu XX, 2001, CHEM ENG SCI, V56, P3527, DOI 10.1016/S0009-2509(01)00048-3	37	11	11	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0152387	10.1371/journal.pone.0152387	http://dx.doi.org/10.1371/journal.pone.0152387			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27055271	Green Published, gold			2022-12-27	WOS:000373608000018
J	Kuo, KL; Su, YF; Wu, CH; Tsai, CY; Chang, CH; Lin, CL; Tsai, TH				Kuo, Keng-Liang; Su, Yu-Feng; Wu, Chieh-Hsin; Tsai, Cheng-Yu; Chang, Chih-Hui; Lin, Chih-Lung; Tsai, Tai-Hsin			Assessing the Intraoperative Accuracy of Pedicle Screw Placement by Using a Bone-Mounted Miniature Robot System through Secondary Registration	PLOS ONE			English	Article							LUMBAR SPINE; FIXATION; GUIDANCE	Introduction Pedicle screws are commonly employed to restore spinal stability and correct deformities. The Renaissance robotic system was developed to improve the accuracy of pedicle screw placement. Purpose In this study, we developed an intraoperative classification system for evaluating the accuracy of pedicle screw placements through secondary registration. Furthermore, we evaluated the benefits of using the Renaissance robotic system in pedicle screw placement and postoperative evaluations. Finally, we examined the factors affecting the accuracy of pedicle screw implantation. Results Through use of the Renaissance robotic system, the accuracy of Kirschner-wire (K-wire) placements deviating <3 mm from the planned trajectory was determined to be 98.74%. According to our classification system, the robot-guided pedicle screw implantation attained an accuracy of 94.00% before repositioning and 98.74% after repositioning. However, the malposition rate before repositioning was 5.99%; among these placements, 4.73% were immediately repositioned using the robot system and 1.26% were manually repositioned after a failed robot repositioning attempt. Most K-wire entry points deviated caudally and laterally. Conclusion The Renaissance robotic system offers high accuracy in pedicle screw placement. Secondary registration improves the accuracy through increasing the precision of the positioning; moreover, intraoperative evaluation enables immediate repositioning. Furthermore, the K-wire tends to deviate caudally and laterally from the entry point because of skiving, which is characteristic of robot-assisted pedicle screw placement.	[Su, Yu-Feng; Tsai, Cheng-Yu; Chang, Chih-Hui; Lin, Chih-Lung] Kaohsiung Med Univ, Coll Med, Grad Inst Clin Med, Kaohsiung, Taiwan; [Kuo, Keng-Liang; Wu, Chieh-Hsin; Lin, Chih-Lung; Tsai, Tai-Hsin] Kaohsiung Med Univ, Grad Inst Med, Coll Med, Kaohsiung, Taiwan; [Kuo, Keng-Liang; Su, Yu-Feng; Wu, Chieh-Hsin; Tsai, Cheng-Yu; Chang, Chih-Hui; Lin, Chih-Lung; Tsai, Tai-Hsin] Kaohsiung Med Univ Hosp, Dept Neurosurg, Kaohsiung, Taiwan; [Lin, Chih-Lung; Tsai, Tai-Hsin] Kaohsiung Med Univ, Dept Neurosurg, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University	Lin, CL (corresponding author), Kaohsiung Med Univ, Coll Med, Grad Inst Clin Med, Kaohsiung, Taiwan.; Lin, CL; Tsai, TH (corresponding author), Kaohsiung Med Univ, Dept Neurosurg, Kaohsiung, Taiwan.	chihlung1@yahoo.com; geet810224@yahoo.com.tw		Kuo, Keng-Liang/0000-0001-7353-0967; Su, Yu-feng/0000-0003-0355-3981				Boos N, 1997, Eur Spine J, V6, P2, DOI 10.1007/BF01676569; Devito DP, 2010, SPINE, V35, P2109, DOI 10.1097/BRS.0b013e3181d323ab; DICK WT, 1988, CLIN ORTHOP RELAT R, P70; Hamill CL, 1996, SPINE, V21, P1241, DOI 10.1097/00007632-199605150-00020; Hu XB, 2013, EUR SPINE J, V22, P661, DOI 10.1007/s00586-012-2499-1; Kantelhardt S, 2011, EUR SPINE J, V20, P860, DOI 10.1007/s00586-011-1729-2; Kim YJ, 2004, SPINE, V29, P333, DOI 10.1097/01.BRS.0000109983.12113.9B; Kosmopoulos V, 2007, SPINE, V32, pE111, DOI 10.1097/01.brs.0000254048.79024.8b; Lee GW, 2015, SPINE J, V15, P1519, DOI 10.1016/j.spinee.2015.02.038; Lieberman IH, 2006, NEUROSURGERY, V59, P641, DOI 10.1227/01.NEU.0000229055.00829.5B; Lieberman IH, 2012, J SPINAL DISORD TECH, V25, P241, DOI 10.1097/BSD.0b013e318218a5ef; Lonstein JE, 1999, J BONE JOINT SURG AM, V81A, P1519, DOI 10.2106/00004623-199911000-00003; Pechlivanis I, 2009, SPINE, V34, P392, DOI 10.1097/BRS.0b013e318191ed32; Ringel F, 2012, SPINE, V37, pE496, DOI 10.1097/BRS.0b013e31824b7767; Roser F, 2013, NEUROSURGERY, V72, pA12, DOI 10.1227/NEU.0b013e318270d02c; Schizas C, 2012, ACTA ORTHOP BELG, V78, P240; SUK SI, 1995, SPINE, V20, P1399, DOI 10.1097/00007632-199506000-00012; Togawa D, 2007, NEUROSURGERY, V60, P129, DOI 10.1227/01.NEU.0000249257.16912.AA; YAHIRO MA, 1994, SPINE, V19, pS2297	19	41	47	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153235	10.1371/journal.pone.0153235	http://dx.doi.org/10.1371/journal.pone.0153235			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27054360	Green Submitted, Green Published, gold			2022-12-27	WOS:000373608000107
J	Rana, SB; Zadlock, FJ; Zhang, ZP; Murphy, WR; Bentivegna, CS				Rana, Satshil B.; Zadlock, Frank J.; Zhang, Ziping; Murphy, Wyatt R.; Bentivegna, Carolyn S.			Comparison of De Novo Transcriptome Assemblers and k-mer Strategies Using the Killifish, Fundulus heteroclitus	PLOS ONE			English	Article							RNA-SEQ DATA; MODEL; OPTIMIZATION; ANNOTATION; EXPRESSION; DISCOVERY	Background De novo assembly of non-model organism's transcriptomes has recently been on the rise in concert with the number of de novo transcriptome assembly software programs. There is a knowledge gap as to what assembler software or k-mer strategy is best for construction of an optimal de novo assembly. Additionally, there is a lack of consensus on which evaluation metrics should be used to assess the quality of de novo transcriptome assemblies. Result Six different assembly strategies were evaluated from four different assemblers. The Trinity assembly was used in its default 25 single k-mer value while Bridger, Oases, and SOAP de-novo- Trans were performed with multiple k-mer strategies. Bridger, Oases, and SOAPdenovo- Trans used a small multiple k-mer (SMK) strategy consisting of the k-mer lengths of 21, 25, 27, 29, 31, and 33. Additionally, Oases and SOAPdenovo-Trans were performed using a large multiple k-mer (LMK) strategy consisting of k-mer lengths of 25, 35, 45, 55, 65, 75, and 85. Eleven metrics were used to evaluate each assembly strategy including three genome related evaluation metrics (contig number, N50 length, Contigs >1 kb, reads) and eight transcriptome evaluation metrics (mapped back to transcripts (RMBT), number of full length transcripts, number of open reading frames, Detonate RSEM-EVAL score, and percent alignment to the southern platyfish, Amazon molly, BUSCO and CEGMA databases). The assembly strategy that performed the best, that is it was within the top three of each evaluation metric, was the Bridger assembly (10 of 11) followed by the Oases SMK assembly (8 of 11), the Oases LMK assembly (6 of 11), the Trinity assembly (4 of 11), the SOAP LMK assembly (4 of 11), and the SOAP SMK assembly (3 of 11). Conclusion This study provides an in-depth multi k-mer strategy investigation concluding that the assembler itself had a greater impact than k-mer size regardless of the strategy employed. Additionally, the comprehensive performance transcriptome evaluation metrics utilized in this study identified the need for choosing metrics centered on user defined research goals. Based on the evaluation metrics performed, the Bridger assembly was able to construct the best assembly of the testis transcriptome in Fundulus heteroclitus.	[Rana, Satshil B.; Zadlock, Frank J.; Bentivegna, Carolyn S.] Seton Hall Univ, Dept Biol Sci, S Orange, NJ 07079 USA; [Zhang, Ziping] SUNY Cobleskill, Dept Nat Sci & Math, Cobleskill, NY USA; [Murphy, Wyatt R.] Seton Hall Univ, Dept Chem & Biochem, S Orange, NJ 07079 USA	Seton Hall University; State University of New York (SUNY) System; SUNY Cobleskill; Seton Hall University	Zadlock, FJ (corresponding author), Seton Hall Univ, Dept Biol Sci, S Orange, NJ 07079 USA.	Frank.Zadlock@student.shu.edu	Zhang, Ziping/AAH-2392-2021	Zhang, Ziping/0000-0003-2802-1586; Rana, Satshil/0000-0001-9670-1810	Louisiana Department of Wildlife and Fisheries (LDWF)-LSU [69670]	Louisiana Department of Wildlife and Fisheries (LDWF)-LSU	This project is sponsored by funding provided by the Louisiana Department of Wildlife and Fisheries (LDWF)-LSU Contract #69670.	Andrews S., 2010, FASTQC QUALITY CONTR; Ashrafi H, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-571; Baker M, 2012, NAT METHODS, V9, P333, DOI 10.1038/nmeth.1935; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Burnett KG, 2007, COMP BIOCHEM PHYS D, V2, P257, DOI 10.1016/j.cbd.2007.09.001; Chang Z, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0596-2; Chopra R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115055; Duan JL, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-392; Fan HK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059997; Gao J, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-585; Garg R, 2011, DNA RES, V18, P53, DOI 10.1093/dnares/dsq028; Gordo SMC, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-168; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Haznedaroglu BZ, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-170; He B, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-014-1192-7; Huth TJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-805; Ji PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035152; Kumar A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086012; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Li B, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0553-5; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Moreton J, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00190; Nakasugi K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091776; Nandety RS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081681; O'Neil ST, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-465; Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071; Robertson G, 2010, NAT METHODS, V7, P909, DOI 10.1038/nmeth.1517; Salisbury JP, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1354-2; Salzberg SL, 2012, GENOME RES, V22, P557, DOI 10.1101/gr.131383.111; Schliesky S, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00220; Schmieder R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017288; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Sharma N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097497; Simao FA, 2015, BIOINFORMATICS, V31, P3210, DOI 10.1093/bioinformatics/btv351; Surget-Groba Y, 2010, GENOME RES, V20, P1432, DOI 10.1101/gr.103846.109; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Xie YL, 2014, BIOINFORMATICS, V30, P1660, DOI 10.1093/bioinformatics/btu077; Zeng V, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-581; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhao QY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S14-S2	41	27	29	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153104	10.1371/journal.pone.0153104	http://dx.doi.org/10.1371/journal.pone.0153104			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27054874	gold, Green Published, Green Submitted			2022-12-27	WOS:000373608000078
J	Wang, ZK; Wang, J; Liu, J; Ying, SH; Peng, XJ; Feng, MG				Wang, Zhi-Kang; Wang, Jie; Liu, Jing; Ying, Sheng-Hua; Peng, Xiao-Jun; Feng, Ming-Guang			Proteomic and Phosphoproteomic Insights into a Signaling Hub Role for Cdc14 in Asexual Development and Multiple Stress Responses in Beauveria bassiana	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; MITOTIC EXIT; ASPERGILLUS-NIDULANS; TRICHODERMA-REESEI; SECRETOME ANALYSIS; PHOSPHATASE CDC14; ITRAQ; PHOSPHORYLATION; QUANTITATION; ENZYMES	Cdc14 is a dual-specificity phosphatase that regulates nuclear behavior by dephosphorylating phosphotyrosine and phosphoserine/phosphothreonine in fungi. Previously, Cdc14 was shown to act as a positive regulator of cytokinesis, asexual development and multiple stress responses in Beauveria bassiana, a fungal insect pathogen. This study seeks to gain deep insight into a pivotal role of Cdc14 in the signaling network of B. bassiana by analyzing the Cdc14-specific proteome and phosphoproteome generated by the 8-plex iTRAQ labeling and MS/MS analysis of peptides and phosphopeptides. Under normal conditions, 154 proteins and 86 phosphorylation sites in 67 phosphoproteins were upregulated in Delta cdc14 versus wild-type, whereas 117 proteins and 85 phosphorylation sites in 58 phosphoproteins were significantly downregulated. Co-cultivation of.cdc14 with NaCl (1 M), H2O2 (3 mM) and Congo red (0.15 mg/ml) resulted in the upregulation /downregulation of 23/63, 41/39 and 79/79 proteins and of 127/112, 52/47 and 105/226 phosphorylation sites in 85/92, 45/36 and 79/146 phosphoproteins, respectively. Bioinformatic analyses revealed that Cdc14 could participate in many biological and cellular processes, such as carbohydrate metabolism, glycerophospholipid metabolism, the MAP Kinase signaling pathway, and DNA conformation, by regulating protein expression and key kinase phosphorylation in response to different environmental cues. These indicate that in B. bassiana, Cdc14 is a vital regulator of not only protein expression but also many phosphorylation events involved in developmental and stress-responsive pathways. Fourteen conserved and novel motifs were identified in the fungal phosphorylation events.	[Wang, Zhi-Kang; Wang, Jie; Liu, Jing; Ying, Sheng-Hua; Feng, Ming-Guang] Zhejiang Univ, Coll Life Sci, Inst Microbiol, Hangzhou 310058, Zhejiang, Peoples R China; [Peng, Xiao-Jun] Jingjie PTM Biolabs Hangzhou Co Ltd, Hangzhou 310018, Zhejiang, Peoples R China	Zhejiang University	Feng, MG (corresponding author), Zhejiang Univ, Coll Life Sci, Inst Microbiol, Hangzhou 310058, Zhejiang, Peoples R China.	mgfeng@zju.edu.cn			National Natural Science foundation of China [31572054, 31270537, 31321063]; Jingjie PTM Biolabs (Hangzhou) Co., Ltd.	National Natural Science foundation of China(National Natural Science Foundation of China (NSFC)); Jingjie PTM Biolabs (Hangzhou) Co., Ltd.	The study was financially supported by the National Natural Science foundation of China (Grant Nos.: 31572054, 31270537 and 31321063) at http://www.nsfc.gov.cn/. The funder played no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript, but Jingjie PTM Biolabs (Hangzhou) Co., Ltd. provided support in the form of salaries for a co-author (XJP) who carried out the iTRAQ labeling and MS/MS analysis only upon a service contract without any other interest.	Adav SS, 2015, J PROTEOMICS, V119, P154, DOI 10.1016/j.jprot.2015.02.007; Adav SS, 2013, J PROTEOMICS, V83, P180, DOI 10.1016/j.jprot.2013.03.023; Adav SS, 2010, J PROTEOME RES, V9, P3932, DOI 10.1021/pr100148j; Bardin AJ, 2001, NAT REV MOL CELL BIO, V2, P815, DOI 10.1038/35099020; Beausoleil SA, 2004, P NATL ACAD SCI USA, V101, P12130, DOI 10.1073/pnas.0404720101; Beltrao P, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000134; Breitkreutz A, 2010, SCIENCE, V328, P1043, DOI 10.1126/science.1176495; Cagas SE, 2011, ANTIMICROB AGENTS CH, V55, P146, DOI 10.1128/AAC.00884-10; Chen Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087948; Choe L, 2007, PROTEOMICS, V7, P3651, DOI 10.1002/pmic.200700316; Clemente-Blanco A, 2006, J CELL SCI, V119, P1130, DOI 10.1242/jcs.02820; Cueille N, 2001, J CELL SCI, V114, P2649; Dumitrescu TP, 2002, CELL CYCLE, V1, P304, DOI 10.4161/cc.1.5.147; FENG MG, 1994, BIOCONTROL SCI TECHN, V4, P3, DOI 10.1080/09583159409355309; Fong AMVA, 2003, MOL MICROBIOL, V50, P487, DOI 10.1046/j.1365-2958.2003.03735.x; Gan CS, 2007, J PROTEOME RES, V6, P821, DOI 10.1021/pr060474i; Geymonat M, 2002, CURR BIOL, V12, pR482, DOI 10.1016/S0960-9822(02)00963-6; Gouw JW, 2010, MOL CELL PROTEOMICS, V9, P11, DOI 10.1074/mcp.R900001-MCP200; Hall MC, 2008, J BIOL CHEM, V283, P10396, DOI 10.1074/jbc.M710011200; Hynes MJ, 2010, EUKARYOT CELL, V9, P1039, DOI 10.1128/EC.00080-10; Jaspersen SL, 1999, CURR BIOL, V9, P227, DOI 10.1016/S0960-9822(99)80111-0; Manavalan A, 2011, J PROTEOMICS, V75, P642, DOI 10.1016/j.jprot.2011.09.001; McCollum D, 2001, TRENDS CELL BIOL, V11, P89, DOI 10.1016/S0962-8924(00)01901-2; Mocciaro A, 2010, J CELL SCI, V123, P2867, DOI 10.1242/jcs.074815; Parrou JL, 1999, YEAST, V15, P191, DOI 10.1002/(SICI)1097-0061(199902)15:3<191::AID-YEA358>3.0.CO;2-O; Pierce A, 2008, MOL CELL PROTEOMICS, V7, P853, DOI 10.1074/mcp.M700251-MCP200; Pottiez G, 2012, J PROTEOME RES, V11, P3774, DOI 10.1021/pr300414z; Ramsubramaniam N, 2014, PROTEOMICS, V14, P2454, DOI 10.1002/pmic.201400063; Rispail N, 2009, FUNGAL GENET BIOL, V46, P287, DOI 10.1016/j.fgb.2009.01.002; Roberts DW, 2004, ADV APPL MICROBIOL, V54, P1, DOI 10.1016/S0065-2164(04)54001-7; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; Schwartz D, 2005, NAT BIOTECHNOL, V23, P1391, DOI 10.1038/nbt1146; Schwartz D, 2009, MOL CELL PROTEOMICS, V8, P365, DOI 10.1074/mcp.M800332-MCP200; Smits HP, 2000, YEAST, V16, P1325, DOI 10.1002/1097-0061(200010)16:14<1325::AID-YEA627>3.0.CO;2-E; Solar T, 2008, APPL MICROBIOL BIOT, V78, P613, DOI 10.1007/s00253-007-1339-4; Taylor RD, 2008, PROTEOMICS, V8, P2256, DOI 10.1002/pmic.200700610; Trautmann S, 2005, CURR BIOL, V15, P1384, DOI 10.1016/j.cub.2005.06.039; Valadi A, 2004, J BIOL CHEM, V279, P39677, DOI 10.1074/jbc.M403310200; Villen J, 2007, P NATL ACAD SCI USA, V104, P1488, DOI 10.1073/pnas.0609836104; Visintin R, 1998, MOL CELL, V2, P709, DOI 10.1016/S1097-2765(00)80286-5; Wang J, 2016, ENVIRON MICROBIOL, V18, P1037, DOI 10.1111/1462-2920.13197; Wang J, 2013, SCI REP-UK, V3, DOI 10.1038/srep03086; Wang ZL, 2013, ENVIRON MICROBIOL, V15, P409, DOI 10.1111/j.1462-2920.2012.02848.x; Wiese S, 2007, PROTEOMICS, V7, P340, DOI 10.1002/pmic.200600422; Xiao GH, 2012, SCI REP-UK, V2, DOI 10.1038/srep00483; Xie XQ, 2013, ENVIRON MICROBIOL, V15, P447, DOI 10.1111/j.1462-2920.2012.02871.x; Xie XQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030298; Xiong Y, 2014, FUNGAL GENET BIOL, V72, P21, DOI 10.1016/j.fgb.2014.05.005; Yuste-Rojas M, 2000, MOL GEN GENET, V263, P60, DOI 10.1007/PL00008676; Zakrzewska A, 2003, APPL ENVIRON MICROB, V69, P4383, DOI 10.1128/AEM.69.8.4383-4389.2003; Zhang SZ, 2011, APPL ENVIRON MICROB, V77, P2676, DOI 10.1128/AEM.02747-10	51	17	17	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153007	10.1371/journal.pone.0153007	http://dx.doi.org/10.1371/journal.pone.0153007			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27055109	gold, Green Published			2022-12-27	WOS:000373608000064
J	Hardison, DR; Holland, WC; McCall, JR; Bourdelais, AJ; Baden, DG; Darius, HT; Chinain, M; Tester, PA; Shea, D; Quintana, HAF; Morris, JA; Litaker, RW				Hardison, D. Ransom; Holland, William C.; McCall, Jennifer R.; Bourdelais, Andrea J.; Baden, Daniel G.; Darius, H. Taiana; Chinain, Mireille; Tester, Patricia A.; Shea, Damian; Quintana, Harold A. Flores; Morris, James A., Jr.; Litaker, R. Wayne			Fluorescent Receptor Binding Assay for Detecting Ciguatoxins in Fish	PLOS ONE			English	Article							SENSITIVE SODIUM-CHANNELS; SITE 5; CIGUATERA; BREVETOXINS; TOXICITY; TOXINS	Ciguatera fish poisoning is an illness suffered by > 50,000 people yearly after consumption of fish containing ciguatoxins (CTXs). One of the current methodologies to detect ciguatoxins in fish is a radiolabeled receptor binding assay (RBA((R))). However, the license requirements and regulations pertaining to radioisotope utilization can limit the applicability of the RBA((R)) in certain labs. A fluorescence based receptor binding assay (RBA((F))) was developed to provide an alternative method of screening fish samples for CTXs in facilities not certified to use radioisotopes. The new assay is based on competition binding between CTXs and fluorescently labeled brevetoxin-2 (BODIPY (R)-PbTx-2) for voltage-gated sodium channel receptors at site 5 instead of a radiolabeled brevetoxin. Responses were linear in fish tissues spiked from 0.1 to 1.0 ppb with Pacific ciguatoxin-3C (P-CTX-3C) with a detection limit of 0.075 ppb. Carribean ciguatoxins were confirmed in Caribbean fish by LC-MS/MS analysis of the regional biomarker (C-CTX-1). Fish (N = 61) of six different species were screened using the RBA((F)). Results for corresponding samples analyzed using the neuroblastoma cell-based assay (CBA-N2a) correlated well (R-2 = 0.71) with those of the RBA((F)), given the low levels of CTX present in positive fish. Data analyses also showed the resulting toxicity levels of P-CTX-3C equivalents determined by CBA-N2a were consistently lower than the RBA((F)) affinities expressed as% binding equivalents, indicating that a given amount of toxin bound to the site 5 receptors translates into corresponding lower cytotoxicity. Consequently, the RBA((F)), which takes approximately two hours to perform, provides a generous estimate relative to the widely used CBA-N2a which requires 2.5 days to complete. Other RBA((F)) advantages include the long-term(> 5 years) stability of the BODIPY (R)-PbTx-2 and having similar results as the commonly used RBA((R)). The RBA((F)) is cost-effective, allows high sample throughput, and is well-suited for routine CTX monitoring programs.	[Hardison, D. Ransom; Holland, William C.; Tester, Patricia A.; Morris, James A., Jr.; Litaker, R. Wayne] NOAA, Ctr Coastal Fisheries & Habitat Res, Beaufort, NC USA; [McCall, Jennifer R.; Bourdelais, Andrea J.; Baden, Daniel G.] Univ N Carolina, MARBIONC CREST Res Pk, Wilmington, NC 28401 USA; [McCall, Jennifer R.] SeaTox Res Inc, UNCW CREST Res Pk, Wilmington, NC USA; [Darius, H. Taiana; Chinain, Mireille] ILM, UMR EIO 241, Lab Tox Microalgae, Papeete, Tahiti, France; [Tester, Patricia A.] JHT Inc, Orlando, FL USA; [Shea, Damian] N Carolina State Univ, Environm Chem & Toxicol Lab, Raleigh, NC 27695 USA; [Quintana, Harold A. Flores] US FDA, Div Seafood Sci & Technol, Gulf Coast Seafood Lab, Dauphin Isl, AL USA	National Oceanic Atmospheric Admin (NOAA) - USA; University of North Carolina; University of North Carolina Wilmington; Ifremer; University of North Carolina; North Carolina State University; US Food & Drug Administration (FDA)	Hardison, DR (corresponding author), NOAA, Ctr Coastal Fisheries & Habitat Res, Beaufort, NC USA.	rance.hardison@noaa.gov	Shea, Damian/K-1360-2014; CHINAIN, Mireille/G-7055-2017; DARIUS, Hélène Taiana/J-6163-2015; Litaker, Richard Wayne/AAH-2036-2021	Shea, Damian/0000-0003-1348-6639; CHINAIN, Mireille/0000-0001-6560-1278; DARIUS, Hélène Taiana/0000-0002-1184-7034; Litaker, Richard Wayne/0000-0001-6293-8000	National Oceanic and Atmospheric Administration's Ecology and Oceanography of Harmful Algae Blooms contribution [843]; National Oceanic and Atmospheric Administration; National Ocean Service; Centers for Coastal Ocean Science; Center for Coastal Fisheries and Habitat Research; Cooperative Institute for Ocean Exploration, Research, and Technology CIOERT [NA14OAR4320260]; NOAA; DOC	National Oceanic and Atmospheric Administration's Ecology and Oceanography of Harmful Algae Blooms contribution; National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA); National Ocean Service; Centers for Coastal Ocean Science; Center for Coastal Fisheries and Habitat Research; Cooperative Institute for Ocean Exploration, Research, and Technology CIOERT; NOAA(National Oceanic Atmospheric Admin (NOAA) - USA); DOC	Funding was provided by the National Oceanic and Atmospheric Administration's Ecology and Oceanography of Harmful Algae Blooms contribution #843 - http://coastalscience.noaa.gov/research/habs/ecohab RWL PAT DRH WCH DS. Program funds were provided by the National Oceanic and Atmospheric Administration, National Ocean Service, Centers for Coastal Ocean Science, Center for Coastal Fisheries and Habitat Research-DRH WCH RWL PAT JAM. The UNCW partnership is in part funded through the Cooperative Institute for Ocean Exploration, Research, and Technology CIOERT, award number NA14OAR4320260, NOAA, DOC. Authors associated with this are DGB, AJB, and JRM. NOAA National Marine Fisheries, Office of International Affairs-United States Department of State-JAM. The commercial partner SeaTox Research Inc. was not responsible the design or execution of the project, nor did they provide salary support to any of the collaborators. Their role was limited to providing reagents and running the radioactive receptor binding assay using extracts prepared by DRH and WCH. JHT provided support in the form of salary for PT, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham A, 2012, FOOD CHEM, V131, P192, DOI 10.1016/j.foodchem.2011.08.059; [Anonymous], 2011, FISH FISH PROD HAZ C; BAGNIS R, 1979, AM J TROP MED HYG, V28, P1067, DOI 10.4269/ajtmh.1979.28.1067; Caillaud A, 2012, FOOD ADDIT CONTAM A, V29, P1000, DOI 10.1080/19440049.2012.660707; Caillaud A, 2010, MAR DRUGS, V8, P1838, DOI 10.3390/md8061838; Darius HT, 2007, TOXICON, V50, P612, DOI 10.1016/j.toxicon.2007.05.007; Dechraoui MYB, 2007, TOXICON, V49, P100, DOI 10.1016/j.toxicon.2006.10.002; Dechraoui MYB, 2005, TOXICON, V46, P261, DOI 10.1016/j.toxicon.2005.04.006; Dickey Robert W., 2008, P479; Dickey RW, 2010, TOXICON, V56, P123, DOI 10.1016/j.toxicon.2009.09.008; Ledreux A, 2014, HARMFUL ALGAE, V39, P165, DOI 10.1016/j.hal.2014.07.009; Lewis RJ, 2000, THER DRUG MONIT, V22, P61, DOI 10.1097/00007691-200002000-00013; LOMBET A, 1987, FEBS LETT, V219, P355, DOI 10.1016/0014-5793(87)80252-1; MANGER RL, 1993, ANAL BIOCHEM, V214, P190, DOI 10.1006/abio.1993.1476; Mattei C, 1999, J NEUROSCI RES, V55, P666, DOI 10.1002/(SICI)1097-4547(19990315)55:6<666::AID-JNR2>3.3.CO;2-8; McCall JR, 2014, J AOAC INT, V97, P307, DOI 10.5740/jaoacint.SGEMcCall; McCall JR, 2012, HARMFUL ALGAE, V19, P85, DOI 10.1016/j.hal.2012.06.003; Pawlowiez R, 2013, FOOD ADDIT CONTAM A, V30, P567, DOI 10.1080/19440049.2012.755644; POLI MA, 1986, MOL PHARMACOL, V30, P129; Solino L, 2015, TOXICON, V102, P62, DOI 10.1016/j.toxicon.2015.05.015; Van Dolah F. M., 1994, Natural Toxins, V2, P189, DOI 10.1002/nt.2620020407; Van Dolah FM, 2001, J AOAC INT, V84, P1617; Vetter I., 2014, SEAFOOD FRESHWATER T, P925; Wilcox CL, 2015, ENVIRON BIOL FISH, V98, P961, DOI 10.1007/s10641-014-0313-0	24	50	50	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153348	10.1371/journal.pone.0153348	http://dx.doi.org/10.1371/journal.pone.0153348			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073998	Green Published, Green Submitted, gold			2022-12-27	WOS:000374131200077
J	Huang, HM; Hsiao, IT				Huang, Hsuan-Ming; Hsiao, Ing-Tsung			Accelerating an Ordered-Subset Low-Dose X-Ray Cone Beam Computed Tomography Image Reconstruction with a Power Factor and Total Variation Minimization	PLOS ONE			English	Article							WEIGHTED LEAST-SQUARES; DEDICATED BREAST CT; ITERATIVE RECONSTRUCTION; ALGORITHMS; REDUCTION; QUALITY	In recent years, there has been increased interest in low-dose X-ray cone beam computed tomography (CBCT) in many fields, including dentistry, guided radiotherapy and small animal imaging. Despite reducing the radiation dose, low-dose CBCT has not gained widespread acceptance in routine clinical practice. In addition to performing more evaluation studies, developing a fast and high-quality reconstruction algorithm is required. In this work, we propose an iterative reconstruction method that accelerates ordered-subsets (OS) reconstruction using a power factor. Furthermore, we combine it with the total-variation (TV) minimization method. Both simulation and phantom studies were conducted to evaluate the performance of the proposed method. Results show that the proposed method can accelerate conventional OS methods, greatly increase the convergence speed in early iterations. Moreover, applying the TV minimization to the power acceleration scheme can further improve the image quality while preserving the fast convergence rate.	[Huang, Hsuan-Ming; Hsiao, Ing-Tsung] Chang Gung Univ, Inst Radiol Res, Med Phys Res Ctr, Taoyuan, Taiwan; [Huang, Hsuan-Ming; Hsiao, Ing-Tsung] Chang Gung Mem Hosp, Taoyuan, Taiwan; [Huang, Hsuan-Ming; Hsiao, Ing-Tsung] Chang Gung Mem Hosp, Dept Nucl Med, Taoyuan, Taiwan; [Huang, Hsuan-Ming; Hsiao, Ing-Tsung] Chang Gung Mem Hosp, Neurosci Res Ctr, Taoyuan, Taiwan; [Hsiao, Ing-Tsung] Chang Gung Univ, Coll Med, Dept Med Imaging & Radiol Sci, Taoyuan, Taiwan; [Hsiao, Ing-Tsung] Chang Gung Univ, Coll Med, Hlth Aging Res Ctr, Taoyuan, Taiwan	Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University	Hsiao, IT (corresponding author), Chang Gung Univ, Inst Radiol Res, Med Phys Res Ctr, Taoyuan, Taiwan.; Hsiao, IT (corresponding author), Chang Gung Mem Hosp, Taoyuan, Taiwan.; Hsiao, IT (corresponding author), Chang Gung Mem Hosp, Dept Nucl Med, Taoyuan, Taiwan.; Hsiao, IT (corresponding author), Chang Gung Mem Hosp, Neurosci Res Ctr, Taoyuan, Taiwan.; Hsiao, IT (corresponding author), Chang Gung Univ, Coll Med, Dept Med Imaging & Radiol Sci, Taoyuan, Taiwan.; Hsiao, IT (corresponding author), Chang Gung Univ, Coll Med, Hlth Aging Res Ctr, Taoyuan, Taiwan.	ihsiao@mail.cgu.edu.tw		Hsiao, Ing-Tsung/0000-0002-5255-7498; Huang, Hsuan-Ming/0000-0002-1376-6262	Ministry of Science Technology, Taiwan [MOST 104-2218-E-182-002, MOST 1032314-B-182-010-MY3]; Chang Gung Memorial Hospital, Taiwan [CMRPD1E0301, CIRPD3E0121, CMRPD1C0642, CMRPD1C0672]	Ministry of Science Technology, Taiwan; Chang Gung Memorial Hospital, Taiwan(Chang Gung Memorial Hospital)	Funded by Ministry of Science Technology, Taiwan: MOST 104-2218-E-182-002 and MOST 1032314-B-182-010-MY3 (https://www.most.gov.tw/) Chang Gung Memorial Hospital, Taiwan: CMRPD1E0301, CIRPD3E0121, CMRPD1C0642 and CMRPD1C0672 (https://www.cgmh.org.tw/index.htm).	Ahn S, 2006, IEEE T MED IMAGING, V25, P283, DOI 10.1109/TMI.2005.862740; Anderson JMM, 2005, IEEE T MED IMAGING, V24, P337, DOI 10.1109/TMI.2004.842453; Beekman FJ, 2001, PHYS MED BIOL, V46, P1835, DOI 10.1088/0031-9155/46/7/307; Boone JM, 2001, RADIOLOGY, V221, P657, DOI 10.1148/radiol.2213010334; Boone John M, 2004, Mol Imaging, V3, P149, DOI 10.1162/1535350042380326; Chen ZQ, 2013, PHYS MED BIOL, V58, P2119, DOI 10.1088/0031-9155/58/7/2119; Erdogan H, 1999, PHYS MED BIOL, V44, P2835, DOI 10.1088/0031-9155/44/11/311; Erdogan H, 1999, IEEE T MED IMAGING, V18, P801, DOI 10.1109/42.802758; Fahimian BP, 2010, PHYS MED BIOL, V55, P5383, DOI 10.1088/0031-9155/55/18/008; Fessler JA, 1997, IEEE T MED IMAGING, V16, P166, DOI 10.1109/42.563662; Gao Y, 2014, OPT EXPRESS, V22, P15190, DOI 10.1364/OE.22.015190; Gayou O, 2007, MED PHYS, V34, P499, DOI 10.1118/1.2428407; Hagen CK, 2014, MED PHYS, V41, DOI 10.1118/1.4884297; Hsiao IT, 2010, PHYS MED BIOL, V55, P599, DOI 10.1088/0031-9155/55/3/003; HUDSON HM, 1994, IEEE T MED IMAGING, V13, P601, DOI 10.1109/42.363108; Hwang D, 2006, PHYS MED BIOL, V51, P237, DOI 10.1088/0031-9155/51/2/004; Jia X, 2011, PHYS MED BIOL, V56, P3787, DOI 10.1088/0031-9155/56/13/004; Jia X, 2011, J X-RAY SCI TECHNOL, V19, P139, DOI 10.3233/XST-2011-0283; Kim D, 2015, IEEE T MED IMAGING, V34, P167, DOI 10.1109/TMI.2014.2350962; Kim D, 2013, IEEE T MED IMAGING, V32, P1965, DOI 10.1109/TMI.2013.2266898; LANGE K, 1995, IEEE T IMAGE PROCESS, V4, P1430, DOI 10.1109/83.465107; Lindfors KK, 2008, RADIOLOGY, V246, P725, DOI 10.1148/radiol.2463070410; Matenine D, 2015, MED PHYS, V42, P1505, DOI 10.1118/1.4914143; McCollough CH, 2006, RADIOGRAPHICS, V26, P503, DOI 10.1148/rg.262055138; McCollough CH, 2009, RADIOL CLIN N AM, V47, P27, DOI 10.1016/j.rcl.2008.10.006; Nesterov Y, 2005, MATH PROGRAM, V103, P127, DOI 10.1007/s10107-004-0552-5; Pauwels R, 2012, EUR J RADIOL, V81, P267, DOI 10.1016/j.ejrad.2010.11.028; Pouliot J, 2005, INT J RADIAT ONCOL, V61, P552, DOI 10.1016/j.ijrobp.2004.10.011; Quan E, 2009, PHYS MED BIOL, V54, P1061, DOI 10.1088/0031-9155/54/4/016; Rit S, 2014, J PHYS CONF SER, V489, DOI 10.1088/1742-6596/489/1/012079; Ritman EL, 2011, ANNU REV BIOMED ENG, V13, P531, DOI 10.1146/annurev-bioeng-071910-124717; Ritschl L, 2011, PHYS MED BIOL, V56, P1545, DOI 10.1088/0031-9155/56/6/003; Roberts JA, 2009, BRIT J RADIOL, V82, P35, DOI 10.1259/bjr/31419627; Sidky EY, 2006, J X-RAY SCI TECHNOL, V14, P119; Sidky EY, 2009, MED PHYS, V36, P4920, DOI 10.1118/1.3232211; TANAKA E, 1987, IEEE T MED IMAGING, V6, P98, DOI 10.1109/TMI.1987.4307809; Wang AS, 2015, MED PHYS, V42, P2699, DOI 10.1118/1.4914378; Wang G, 2004, J X-RAY SCI TECHNOL, V12, P169; Wang J, 2006, IEEE T MED IMAGING, V25, P1272, DOI 10.1109/TMI.2006.882141; Yang XL, 2015, OPT EXPRESS, V23, P5368, DOI 10.1364/OE.23.005368; Yu HY, 2014, IEEE ACCESS, V2, P602, DOI 10.1109/ACCESS.2014.2326165; Yu HY, 2009, PHYS MED BIOL, V54, P2791, DOI 10.1088/0031-9155/54/9/014	42	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153421	10.1371/journal.pone.0153421	http://dx.doi.org/10.1371/journal.pone.0153421			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073853	gold, Green Published			2022-12-27	WOS:000374131200089
J	Lee, JS; Lee, DC; Ha, DH; Kim, SW; Cho, DW				Lee, Jung-Seob; Lee, Dong Chang; Ha, Dong-Heon; Kim, Sung Won; Cho, Dong-Woo			Redefining the Septal L-Strut to Prevent Collapse	PLOS ONE			English	Article							BIOMECHANICAL PROPERTIES; CARTILAGE; EAR	During septorhinoplasty, septal cartilage is frequently resected for various purposes but the L-strut is preserved. Numerous materials are inserted into the nasal dorsum during dorsal augmenation rhinoplasty without considering nasal structural safety. This study used a finite element method (FEM) to redefine the septal L-strut, to prevent collapse as pressure moved from the rhinion to the supratip breakpoint on the nasal dorsum and as the contact percentage between the caudal L-strut and the maxillary crest changed. We designed a 1cm- wide L-strut model based on computed tomography data. At least 45% of the width of the L-strut in the inferior portion of the caudal strut must be preserved during septoplasty to stabilize the septum. In augmentation rhinoplasty, the caudal L-strut must either be preserved perfectly or reinforced to prevent collapse or distortion of the L-strut. The dorsal augmentation material must be fixed in an augmentation pocket to prevent movement of graft material toward the supratip breakpoint, which can disrupt the L-strut. We conducted a numerical analysis using a FEM to predict tissue/organ behavior and to help clinicians understand the reasons for target tissue/organ collapse and deformation.	[Lee, Jung-Seob; Ha, Dong-Heon; Cho, Dong-Woo] POSTECH, Dept Mech Engn, Pohang, South Korea; [Lee, Dong Chang; Kim, Sung Won] Catholic Univ Korea, Dept Otolaryngol Head & Neck Surg, Coll Med, Seoul, South Korea	Pohang University of Science & Technology (POSTECH); Catholic University of Korea	Cho, DW (corresponding author), POSTECH, Dept Mech Engn, Pohang, South Korea.; Kim, SW (corresponding author), Catholic Univ Korea, Dept Otolaryngol Head & Neck Surg, Coll Med, Seoul, South Korea.	kswent@catholic.ac.kr; dwcho@postech.ac.kr			National Research Foundation of Korea (NRF) grant - Ministry of Science, ICT and Future Planning [2010-0018294, 2014R1A2A2A01004325]; Korea Health Industry Development Institute - Ministry of Health and Welfare [HI14C3228]	National Research Foundation of Korea (NRF) grant - Ministry of Science, ICT and Future Planning; Korea Health Industry Development Institute - Ministry of Health and Welfare	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Ministry of Science, ICT and Future Planning (No. 2010-0018294, No. 2014R1A2A2A01004325) and the Korea Health Industry Development Institute funded by the Ministry of Health and Welfare (HI14C3228).	Gan RZ, 2004, ANN BIOMED ENG, V32, P847, DOI 10.1023/B:ABME.0000030260.22737.53; GLASGOLD MJ, 1988, OTOLARYNG HEAD NECK, V99, P374, DOI 10.1177/019459988809900404; Jang YJ, 2014, FACIAL PLAST SURG CL, V22, P357, DOI 10.1016/j.fsc.2014.04.001; Jin HR, 2011, AURIS NASUS LARYNX, V38, P157, DOI 10.1016/j.anl.2010.05.014; Jung JW, 2014, INT J PRECIS ENG MAN, V15, P2611, DOI 10.1007/s12541-014-0634-0; Jung JW, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4024570; Killlan G., 1905, ANN OTO RHINOL LARYN, V14, P363; Kim David W, 2006, Facial Plast Surg, V22, P9, DOI 10.1055/s-2006-939948; Kim JS, 2010, ANN PLAS SURG, V65, P519, DOI 10.1097/SAP.0b013e3181d59f95; Koike T, 2002, J ACOUST SOC AM, V111, P1306, DOI 10.1121/1.1451073; Kundu J, 2015, J TISSUE ENG REGEN M, V9, P1286, DOI 10.1002/term.1682; Lee JS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119996; Lee SJ, 2010, LARYNGOSCOPE, V120, P1931, DOI 10.1002/lary.21072; Lee SJ, 2010, LARYNGOSCOPE, V120, P1508, DOI 10.1002/lary.20976; Liong Kyrin, 2013, J Med Eng, V2013, P250274, DOI 10.1155/2013/250274; Manuel CT, 2014, LARYNGOSCOPE, V124, P649, DOI 10.1002/lary.24321; Mau T, 2007, LARYNGOSCOPE, V117, P1902, DOI 10.1097/MLG.0b013e3181255ec4; Planas J, 1977, Clin Plast Surg, V4, P55; Richmon JD, 2005, AM J RHINOL, V19, P617, DOI 10.1177/194589240501900616; Richmon JD, 2006, AM J RHINOL, V20, P496, DOI 10.2500/ajr.2006.20.2932; Shamouelian D, 2015, LARYNGOSCOPE, V125, P326, DOI 10.1002/lary.24845; Toriumi DM, 2010, CLIN PLAST SURG, V37, P335, DOI 10.1016/j.cps.2009.12.008; Toriumi Dean M, 2007, Facial Plast Surg Clin North Am, V15, P293, DOI 10.1016/j.fsc.2007.04.003; Vampola T, 2011, J ACOUST SOC AM, V129, P310, DOI 10.1121/1.3506347	24	34	36	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153056	10.1371/journal.pone.0153056	http://dx.doi.org/10.1371/journal.pone.0153056			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073993	Green Published, Green Submitted, gold			2022-12-27	WOS:000374131200048
J	Li, CT; Chen, FM; Qi, FG; Liu, M; Li, Z; Liang, FL; Jing, XJ; Lu, GH; Wang, JQ				Li, Chuantao; Chen, Fuming; Qi, Fugui; Liu, Miao; Li, Zhao; Liang, Fulai; Jing, Xijing; Lu, Guohua; Wang, Jianqi			Searching for Survivors through Random Human-Body Movement Outdoors by Continuous-Wave Radar Array	PLOS ONE			English	Article							VITAL SIGN DETECTION; LIFE DETECTION; CANCELLATION; SYSTEM; SUPPRESSION; RADIATION; NOISE	It is a major challenge to search for survivors after chemical or nuclear leakage or explosions. At present, biological radar can be used to achieve this goal by detecting the survivor's respiration signal. However, owing to the random posture of an injured person at a rescue site, the radar wave may directly irradiate the person's head or feet, in which it is difficult to detect the respiration signal. This paper describes a multichannel-based antenna array technology, which forms an omnidirectional detection system via 24-GHz Doppler biological radar, to address the random positioning relative to the antenna of an object to be detected. Furthermore, since the survivors often have random body movement such as struggling and twitching, the slight movements of the body caused by breathing are obscured by these movements. Therefore, a method is proposed to identify random human-body movement by utilizing multichannel information to calculate the background variance of the environment in combination with a constant-false-alarm-rate detector. The conducted outdoor experiments indicate that the system can realize the omnidirectional detection of random human-body movement and distinguish body movement from environmental interference such as movement of leaves and grass. The methods proposed in this paper will be a promising way to search for survivors outdoors.	[Li, Chuantao; Chen, Fuming; Qi, Fugui; Liu, Miao; Li, Zhao; Liang, Fulai; Jing, Xijing; Lu, Guohua; Wang, Jianqi] Fourth Mil Med Univ, Dept Biomed Engn, Xian 710032, Peoples R China; [Wang, Jianqi] Shaanxi Univ Technol, Hanzhong, Peoples R China	Air Force Military Medical University; Shaanxi University of Technology	Lu, GH; Wang, JQ (corresponding author), Fourth Mil Med Univ, Dept Biomed Engn, Xian 710032, Peoples R China.; Wang, JQ (corresponding author), Shaanxi Univ Technol, Hanzhong, Peoples R China.	lugh1976@fmmu.edu.cn; wangjq@fmmu.edu.cn			National Natural Science Foundation of China [61327805, 61271102]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work is supported by the National Natural Science Foundation of China (No. 61327805, No. 61271102). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chioukh L, 2014, IEEE T MICROW THEORY, V62, P1847, DOI 10.1109/TMTT.2014.2343934; Diebold S, 2012, J INFRARED MILLIM TE, V33, P1250, DOI 10.1007/s10762-012-9941-7; Gu CZ, 2013, IEEE T MICROW THEORY, V61, P4678, DOI 10.1109/TMTT.2013.2288226; Kazemi S, 2014, BIOMED SIGNAL PROCES, V13, P79, DOI 10.1016/j.bspc.2014.03.012; Lazaro A, 2014, SENSORS-BASEL, V14, P2595, DOI 10.3390/s140202595; Li CZ, 2008, IEEE T MICROW THEORY, V56, P3143, DOI 10.1109/TMTT.2008.2007139; Li CT, 2015, SENSORS-BASEL, V15, P14830, DOI 10.3390/s150714830; Li Z, 2013, IEEE T MICROW THEORY, V61, P2086, DOI 10.1109/TMTT.2013.2247054; Lin JC, 2006, IEEE ANTENN PROPAG M, V48, P157, DOI 10.1109/MAP.2006.1645601; Mikhelson IV, 2011, IEEE T BIO-MED ENG, V58, P1671, DOI 10.1109/TBME.2011.2111371; Nicholls B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006246; Rohling H, 1983, AEROSPACE ELECT SYST, P608; Sachs J, 2014, AD HOC NETW, V13, P42, DOI 10.1016/j.adhoc.2012.07.002; Wang FK, 2011, IEEE T MICROW THEORY, V59, P3577, DOI 10.1109/TMTT.2011.2171712; Wiesner S, 2007, ENG MED BIOL SOC 200; Yu X, 2011, MICR S MTT 2011 IEEE; Zhang Y, 2015, IEEE GEOSCI REMOTE S, V12, P482, DOI 10.1109/LGRS.2014.2347294	17	9	9	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0152201	10.1371/journal.pone.0152201	http://dx.doi.org/10.1371/journal.pone.0152201			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073860	Green Published, gold			2022-12-27	WOS:000374131200017
J	Nillius, D; von Muller, L; Wagenpfeil, S; Klein, R; Herrmann, M				Nillius, Dorothea; von Mueller, Lutz; Wagenpfeil, Stefan; Klein, Renate; Herrmann, Mathias			Methicillin-Resistant Staphylococcus aureus in Saarland, Germany: The Long-Term Care Facility Study	PLOS ONE			English	Article							NURSING-HOMES; MRSA INFECTION; RISK-FACTORS; METICILLIN-RESISTANT; MOLECULAR EPIDEMIOLOGY; NOSOCOMIAL INFECTION; HOSPITAL ADMISSION; GERIATRIC UNIT; COLONIZATION; PREVALENCE	Background Multiresistant organisms pose a threat for patients and care recipients. Control interventions need to be tailored to region, the type of institution considered, and risk factors. The German state of Saarland is ideally suited to study colonisation epidemiology throughout its various health and care institutions. After conclusion of a large admission prevalence study in acute care hospitals, we now performed a methicillin-resistant Staphylococcus aureus (MRSA) point prevalence study in Saarland long term care facilities (LTCF), allowing for a direct comparison with respect of MRSA prevalence and associated risk factors between these two institutional types located within a confined region. Methodology and Principal Findings Of all LTCF of the region, 65/136 participated in the study performed between 09/2013 and 07/2014. Overall, complete microbiological specimen and questionnaires of 2,858 of 4,275 (66.8%) LTCF residents were obtained. 136/2,858 (4.8%) screened residents revealed MRSA carrier status. Multivariate risk factor analysis yielded ulcer/deep soft tissue infection, urinary tract catheter, and MRSA history with multiple MRSA decolonisation cycles to be independently associated with MRSA carrier status. Conclusion As already known from previous studies, colonisation with MRSA is common in LTCF residents even in an area with relatively low MRSA prevalence. This found prevalence can now be related to the acute care admission prevalence (2.2%) as well as to the admission prevalence in acute care geriatric departments (7.6%). The common clonal attribution (spa type) of MRSA isolates prevalent in the LTCF population as well as in the acute care admission population points towards a close relationship between both types of institutions. However, the ostensible absence of risk factors such as "previous hospitalisation" in conjunction with newly identified factors such as "multiple decolonisation cycles" refers to MRSA colonisation risks independent of contact with acute care facilities. Overall, this large LTCF point prevalence study allows data-based, region-tailored decisions on MRSA screening policies and provides a basis for additional preventative measures.	[Nillius, Dorothea; von Mueller, Lutz; Herrmann, Mathias] Univ Saarland, Inst & State Lab Med Microbiol & Hyg, Homburg, Germany; [Nillius, Dorothea; von Mueller, Lutz; Herrmann, Mathias] Univ Saarland, Med Ctr, Homburg, Germany; [Wagenpfeil, Stefan] Univ Saarland, Inst Med Biometry Epidemiol & Med Informat, Homburg, Germany; [Klein, Renate] Saarland Minist Social Affairs Hlth Women & Famil, Saarbrucken, Germany; [von Mueller, Lutz] Christophorus Kliniken GmbH, Inst Lab Med Microbiol & Hyg LMH, Coesfeld, Germany	Saarland University; Saarland University; Saarland University	Nillius, D (corresponding author), Univ Saarland, Inst & State Lab Med Microbiol & Hyg, Homburg, Germany.; Nillius, D (corresponding author), Univ Saarland, Med Ctr, Homburg, Germany.	dorothea.nillius@gmx.de	Herrmann, Mathias/B-6475-2013	Herrmann, Mathias/0000-0003-2638-2257; von Muller, Lutz/0000-0001-9013-4245	State of Saarland; German Minister of Health [IIA5-2512FSB101]	State of Saarland; German Minister of Health	This study was supported by a fund of the State of Saarland, and a grant of the German Minister of Health, grant IIA5-2512FSB101. Neither funding body had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The acknowledgment of one of the coauthors (RK) is solely for the purpose of declaring her employment by the State of Saarland Ministry of Social Affairs, Health, Women and Families (part of the State of Saarland Government); it does not impede the above statement.	Andersson H, 2012, SCAND J INFECT DIS, V44, P641, DOI 10.3109/00365548.2012.671956; [Anonymous], 2005, Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz, V48, P1061; Barr B, 2007, INFECT CONT HOSP EP, V28, P853, DOI 10.1086/516795; Becker K, 2016, J CLIN MICROBIOL, V54, P180, DOI 10.1128/JCM.02081-15; Bellini C, 2015, INFECT CONT HOSP EP, V36, P401, DOI 10.1017/ice.2014.74; Bourbeau PP, 2009, J CLIN MICROBIOL, V47, P1101, DOI 10.1128/JCM.01963-08; Bradley SF, 1997, DRUG AGING, V10, P185, DOI 10.2165/00002512-199710030-00003; Cassone M, 2015, CURR GERIATR REP, V4, P87, DOI 10.1007/s13670-015-0120-2; Cheng VCC, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-205; Cosgrove SE, 2003, CLIN INFECT DIS, V36, P53, DOI 10.1086/345476; Couderc C, 2014, CLIN INFECT DIS, V59, P206, DOI 10.1093/cid/ciu236; Datta R, 2008, CLIN INFECT DIS, V47, P176, DOI 10.1086/589241; Davis KA, 2004, CLIN INFECT DIS, V39, P776, DOI 10.1086/422997; de Kraker MEA, 2011, ANTIMICROB AGENTS CH, V55, P1598, DOI 10.1128/AAC.01157-10; Eveillard M, 2008, AGE AGEING, V37, P294, DOI 10.1093/ageing/afn021; Fallon EO, 2009, J GERONTOL A-BIOL, V64, P138, DOI 10.1093/gerona/gln020; Grabe C, 2010, EPIDEMIOL B, V18, P163; Greenland K, 2011, J AM GERIATR SOC, V59, P768, DOI 10.1111/j.1532-5415.2011.03325.x; Greub G, 2011, CLIN MICROBIOL INFEC, V17, P655, DOI 10.1111/j.1469-0691.2011.03513.x; Gruber I, 2013, INT J MED MICROBIOL, V303, P405, DOI 10.1016/j.ijmm.2013.05.002; Hamed M, 2015, INFECT GENET EVOL, V36, P475, DOI 10.1016/j.meegid.2015.08.020; Harbarth S, 2008, JAMA-J AM MED ASSOC, V299, P1149, DOI 10.1001/jama.299.10.1149; Herrmann M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073876; Hetem DJ, 2013, EMERG INFECT DIS, V19, P1797, DOI 10.3201/eid1911.121085; Heudorf U, 2014, BUNDESGESUNDHEITSBLA, V57, P414, DOI 10.1007/s00103-013-1927-7; Ho KM, 2009, ANAESTH INTENS CARE, V37, P457, DOI 10.1177/0310057X0903700320; Hogardt M, 2015, EURO SURVEILL, V20; Huang SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024340; Jans B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064908; Kock R, 2009, J HOSP INFECT, V71, P320, DOI 10.1016/j.jhin.2008.12.001; Kommission fur Krankenhaushygiene und Infektionspravention (KRINKO) beim Robert Koch-Institut, 2014, BUNDESGESUNDHEITSBLA, V57, P696; KRINKO, 1999, BUNDESGESUNDHEITSBLA, V42, P954; Manzur A, 2008, CLIN MICROBIOL INFEC, V14, P867, DOI 10.1111/j.1469-0691.2008.02060.x; March A, 2010, CLIN MICROBIOL INFEC, V16, P934, DOI 10.1111/j.1469-0691.2009.03024.x; Mehraj J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107937; Mellmann A, 2006, PLOS MED, V3, P348, DOI 10.1371/journal.pmed.0030033; Meyer E, 2014, DTSCH ARZTEBL INT, V111, P331, DOI 10.3238/arztebl.2014.0331; Morgan M, 2008, J ANTIMICROB CHEMOTH, V62, P1181, DOI 10.1093/jac/dkn405; Mossong J, 2013, EPIDEMIOL INFECT, V141, P1199, DOI 10.1017/S0950268812001999; Neuhaus B, 2002, BUNDESGESUNDHEITSBLA, V45, P894; Pfingsten-Wurzburg S, 2011, J HOSP INFECT, V78, P108, DOI 10.1016/j.jhin.2011.02.011; Pujol M, 1996, AM J MED, V100, P509, DOI 10.1016/S0002-9343(96)00014-9; Rabinowitz RP, 2012, PM&R, V4, P18, DOI 10.1016/j.pmrj.2011.09.011; Reynolds C, 2011, INFECT CONT HOSP EP, V32, P91, DOI 10.1086/657637; Robinson JO, 2014, CLIN MICROBIOL INFEC, V20, P530, DOI 10.1111/1469-0691.12388; Schaumburg F, 2012, J CLIN MICROBIOL, V50, P3186, DOI 10.1128/JCM.01174-12; Schoevaerdts D, 2012, J INFECTION, V65, P109, DOI 10.1016/j.jinf.2012.02.004; STAMM AM, 1993, AM J INFECT CONTROL, V21, P70, DOI 10.1016/0196-6553(93)90227-U; Stenehjem E, 2013, AM J INFECT CONTROL, V41, P405, DOI 10.1016/j.ajic.2012.07.017; Trick WE, 2001, J AM GERIATR SOC, V49, P270, DOI 10.1046/j.1532-5415.2001.4930270.x; von Baum H, 2002, INFECT CONT HOSP EP, V23, P511, DOI 10.1086/502098; Warnke P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111627; Warnke P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089667; Whitby M, 2003, CLIN INFECT DIS, V37, P459, DOI 10.1086/375846; Whitby M, 2001, MED J AUSTRALIA, V175, P264, DOI 10.5694/j.1326-5377.2001.tb143562.x; Woltering R, 2008, DEUT MED WOCHENSCHR, V133, P999, DOI 10.1055/s-2008-1075683; Yaw LK, 2014, LANCET INFECT DIS, V14, P967, DOI 10.1016/S1473-3099(14)70876-X; Yoshida Junichi, 2013, Infect Drug Resist, V6, P59, DOI 10.2147/IDR.S45843	58	18	18	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153030	10.1371/journal.pone.0153030	http://dx.doi.org/10.1371/journal.pone.0153030			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073899	Green Submitted, Green Published, gold			2022-12-27	WOS:000374131200046
J	Xerxa, E; Barbisin, M; Chieppa, MN; Krmac, H; Vallino Costassa, E; Vatta, P; Simmons, M; Caramelli, M; Casalone, C; Corona, C; Legname, G				Xerxa, Elena; Barbisin, Maura; Chieppa, Maria Novella; Krmac, Helena; Vallino Costassa, Elena; Vatta, Paolo; Simmons, Marion; Caramelli, Maria; Casalone, Cristina; Corona, Cristiano; Legname, Giuseppe			Whole Blood Gene Expression Profiling in Preclinical and Clinical Cattle Infected with Atypical Bovine Spongiform Encephalopathy	PLOS ONE			English	Article							LONG NONCODING RNAS; MICROARRAY ANALYSIS; X-CHROMOSOME; PRION; IDENTIFICATION; PROTEIN; BSE; TRANSMISSION; SCRAPIE; DISEASE	Prion diseases, such as bovine spongiform encephalopathies (BSE), are transmissible neurodegenerative disorders affecting humans and a wide variety of mammals. Variant Creutzfeldt-Jakob disease (vCJD), a prion disease in humans, has been linked to exposure to BSE prions. This classical BSE (cBSE) is now rapidly disappearing as a result of appropriate measures to control animal feeding. Besides cBSE, two atypical forms (named Hand L-type BSE) have recently been described in Europe, Japan, and North America. Here we describe the first wide-spectrum microarray analysis in whole blood of atypical BSE-infected cattle. Transcriptome changes in infected animals were analyzed prior to and after the onset of clinical signs. The microarray analysis revealed gene expression changes in blood prior to the appearance of the clinical signs and during the progression of the disease. A set of 32 differentially expressed genes was found to be in common between clinical and preclinical stages and showed a very similar expression pattern in the two phases. A 22-gene signature showed an oscillating pattern of expression, being differentially expressed in the preclinical stage and then going back to control levels in the symptomatic phase. One gene, SEL1L3, was downregulated during the progression of the disease. Most of the studies performed up to date utilized various tissues, which are not suitable for a rapid analysis of infected animals and patients. Our findings suggest the intriguing possibility to take advantage of whole blood RNA transcriptional profiling for the preclinical identification of prion infection. Further, this study highlighted several pathways, such as immune response and metabolism that may play an important role in peripheral prion pathogenesis. Finally, the gene expression changes identified in the present study may be further investigated as a fingerprint for monitoring the progression of disease and for developing targeted therapeutic interventions.	[Xerxa, Elena; Barbisin, Maura; Krmac, Helena; Vatta, Paolo; Legname, Giuseppe] SISSA, Funct & Struct Genom Sect, Trieste, Italy; [Chieppa, Maria Novella; Vallino Costassa, Elena; Caramelli, Maria; Casalone, Cristina; Corona, Cristiano] Ist Zooprofilatt Sperimentale Piemonte Liguria &, Turin, Italy; [Simmons, Marion] Anim & Plant Hlth Agcy Weybridge, Dept Pathol, Addlestone, Surrey, England	International School for Advanced Studies (SISSA); IZS Piemonte Liguria e Valle D'aosta; Animal & Plant Health Agency UK	Legname, G (corresponding author), SISSA, Funct & Struct Genom Sect, Trieste, Italy.	legname@sissa.it	Legname, Giuseppe/C-1723-2012; Casalone, Cristina/J-6763-2018; Costassa, Elena Vallino/N-7639-2019; Vallino Costassa, Elena/J-4026-2018	Legname, Giuseppe/0000-0003-0716-4393; Casalone, Cristina/0000-0001-5271-832X; Costassa, Elena Vallino/0000-0001-8582-1294; Vallino Costassa, Elena/0000-0001-8582-1294	European Regional Development Fund; Cross-Border Cooperation Italy-Slovenia, Programme; Strategic Project TRANS2CARE; Italian Ministry of University and Research under the FIRB program [RBAP11FRE9, IZSPLV 24/07RC, RF-2009-1474758, IZSPLV 05/11RC]	European Regional Development Fund(European Commission); Cross-Border Cooperation Italy-Slovenia, Programme; Strategic Project TRANS2CARE; Italian Ministry of University and Research under the FIRB program	Funded by European Regional Development Fund, Cross-Border Cooperation Italy-Slovenia, Programme 2007-2013, Strategic Project TRANS2CARE and by the Italian Ministry of University and Research under the FIRB program RBAP11FRE9 to G. Legname as well as IZSPLV 24/07RC to MC, RF-2009-1474758 to C. Casalone, and IZSPLV 05/11RC to C. Corona. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi A, 2000, CELL DEATH DIFFER, V7, P889, DOI 10.1038/sj.cdd.4400737; Almeida LM, 2011, GENET MOL RES, V10, P3948, DOI 10.4238/2011.October.25.5; Balkema-Buschmann A, 2011, PREV VET MED, V102, P112, DOI 10.1016/j.prevetmed.2011.04.006; Barbisin M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-434; Baron TGM, 2006, EMERG INFECT DIS, V12, P1125; Basu U, 2012, CURR GENOMICS, V13, P369, DOI 10.2174/138920212801619223; Basu U, 2012, PRION, V6, P282, DOI 10.4161/pri.19915; Beringue V, 2007, J NEUROSCI, V27, P6965, DOI 10.1523/JNEUROSCI.0693-07.2007; Biacabe AG, 2004, EMBO REP, V5, P110, DOI 10.1038/sj.embor.7400054; Biagioli M, 2009, P NATL ACAD SCI USA, V106, P15454, DOI 10.1073/pnas.0813216106; BLOMSTROM DC, 1986, J BIOL CHEM, V261, P8811; Booth S, 2004, J GEN VIROL, V85, P3459, DOI 10.1099/vir.0.80110-0; Borovecki F, 2005, P NATL ACAD SCI USA, V102, P11023, DOI 10.1073/pnas.0504921102; Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; Buschmann A, 2006, VET MICROBIOL, V117, P103, DOI 10.1016/j.vetmic.2006.06.016; Calingasan NY, 2002, NEUROBIOL AGING, V23, P31, DOI 10.1016/S0197-4580(01)00246-9; Capobianco R, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030031; Casalone C, 2004, P NATL ACAD SCI USA, V101, P3065, DOI 10.1073/pnas.0305777101; Colby DW, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a006833; Dudas S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010638; Filali H, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-59; Filali H, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-14; Filali H, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-399; Gardner RG, 2000, J CELL BIOL, V151, P69, DOI 10.1083/jcb.151.1.69; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Harris RA, 2002, ADV ENZYME REGUL, V42, P249, DOI 10.1016/S0065-2571(01)00061-9; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Henderson ST, 2008, NEUROTHERAPEUTICS, V5, P470, DOI 10.1016/j.nurt.2008.05.004; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jacobs JG, 2007, J CLIN MICROBIOL, V45, P1821, DOI 10.1128/JCM.00160-07; Johnson R, 2012, NEUROBIOL DIS, V46, P245, DOI 10.1016/j.nbd.2011.12.006; Kabanova S, 2009, INT J MED SCI, V6, P156; Khaniya B, 2009, J TOXICOL ENV HEAL A, V72, P1008, DOI 10.1080/15287390903084199; Kim Hyeon O, 2008, Adv Appl Bioinform Chem, V1, P29; Kong QZ, 2008, J VIROL, V82, P3697, DOI 10.1128/JVI.02561-07; Konold T, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-22; Lloyd S, 2011, TOP CURR CHEM, V305, P1, DOI 10.1007/128_2011_157; Loeuillet C, 2010, J INFECT DIS, V202, P648, DOI 10.1086/654818; Lombardi G, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000075; Lyahyai J, 2010, ANIM BIOTECHNOL, V21, P1, DOI 10.1080/10495390903323851; Masujin K, 2008, PRION, V2, P123, DOI 10.4161/pri.2.3.7437; MCKINLEY MP, 1983, CELL, V35, P57, DOI 10.1016/0092-8674(83)90207-6; Ness SA, 2007, MOL BIOTECHNOL, V36, P205, DOI 10.1007/s12033-007-0012-6; Nguyen DK, 2006, NAT GENET, V38, P47, DOI 10.1038/ng1705; Okada H, 2012, VET PATHOL, V49, P819, DOI 10.1177/0300985811427150; Panelli S, 2011, J TOXICOL ENV HEAL A, V74, P96, DOI 10.1080/15287394.2011.529059; Penny GD, 1996, NATURE, V379, P131, DOI 10.1038/379131a0; Polak MP, 2012, VET J, V191, P128, DOI 10.1016/j.tvjl.2010.12.019; Priemer G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067599; Prusiner SB, 2001, NEW ENGL J MED, V344, P1516, DOI 10.1056/NEJM200105173442006; Reger MA, 2004, NEUROBIOL AGING, V25, P311, DOI 10.1016/S0197-4580(03)00087-3; Richt JA, 2007, J VET DIAGN INVEST, V19, P142, DOI 10.1177/104063870701900202; Sanges R, 2007, BIOINFORMATICS, V23, P3406, DOI 10.1093/bioinformatics/btm469; Sawiris GP, 2007, J GEN VIROL, V88, P1356, DOI 10.1099/vir.0.82387-0; Seipelt M, 1999, J NEUROL NEUROSUR PS, V66, P172, DOI 10.1136/jnnp.66.2.172; Shephard F, 2014, MITOCHONDRION, V14, P64, DOI 10.1016/j.mito.2013.12.001; Simmons MM, 2011, VET PATHOL, V48, P948, DOI 10.1177/0300985810387072; Skinner PJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-114; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Straub AC, 2012, NATURE, V491, P473, DOI 10.1038/nature11626; Sun YZ, 2013, MED HYPOTHESES, V81, P319, DOI 10.1016/j.mehy.2013.04.010; Szutowicz A, 2013, NEUROCHEM RES, V38, P1523, DOI 10.1007/s11064-013-1060-x; Tan J, 1999, SCIENCE, V286, P2352, DOI 10.1126/science.286.5448.2352; Tang Y, 2009, J VIROL, V83, P9464, DOI 10.1128/JVI.00352-09; Team C, 2013, R LANG ENV STAT COMP; Tester S, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-64; Torres JM, 2011, EMERG INFECT DIS, V17, P1636, DOI 10.3201/eid1709.101403; Tortosa R, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-109; Tylee DS, 2013, AM J MED GENET B, V162, P595, DOI 10.1002/ajmg.b.32150; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang Ren-Gang, 2012, Shengli Xuebao, V64, P577; Wang RG, 2011, GLIA, V59, P946, DOI 10.1002/glia.21167; Warnes Gregory R., 2014, GPLOTS VARIOUS RPROG; WELLS GAH, 1987, VET REC, V121, P419, DOI 10.1136/vr.121.18.419; Will RG, 1996, LANCET, V347, P921, DOI 10.1016/S0140-6736(96)91412-9; Wilson R, 2013, J GEN VIROL, V94, P2819, DOI 10.1099/vir.0.052738-0; Yamakawa Y, 2003, JPN J INFECT DIS, V56, P221; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Zhang S, 2014, NUTR METAB, V11, DOI 10.1186/1743-7075-11-10	80	8	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153425	10.1371/journal.pone.0153425	http://dx.doi.org/10.1371/journal.pone.0153425			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073865	Green Published, gold, Green Submitted			2022-12-27	WOS:000374131200090
J	Yan, HM; Behun, MA; Cook, MD; Ranadive, SM; Lane-Cordova, AD; Kappus, RM; Woods, JA; Wilund, KR; Baynard, T; Halliwill, JR; Fernhall, B				Yan, Huimin; Behun, Michael A.; Cook, Marc D.; Ranadive, Sushant M.; Lane-Cordova, Abbi D.; Kappus, Rebecca M.; Woods, Jeffrey A.; Wilund, Kenneth R.; Baynard, Tracy; Halliwill, John R.; Fernhall, Bo			Differential Post-Exercise Blood Pressure Responses between Blacks and Caucasians	PLOS ONE			English	Article							EXERCISE HYPOTENSION; RACIAL-DIFFERENCES; MEDIATED VASODILATATION; DYNAMIC EXERCISE; NITRIC-OXIDE; HYPERTENSION; REDUCTION; HISTAMINE; DISEASE; YOUNG	Post-exercise hypotension (PEH) is widely observed in Caucasians (CA) and is associated with histamine receptors 1- and 2-(H1R and H2R) mediated post-exercise vasodilation. However, it appears that blacks (BL) may not exhibit PEH following aerobic exercise. Hence, this study sought to determine the extent to which BL develop PEH, and the contribution of histamine receptors to PEH (or lack thereof) in this population. Forty-nine (22 BL, 27 CA) young and healthy subjects completed the study. Subjects were randomly assigned to take either a combined H1R and H2R antagonist (fexofenadine and ranitidine) or a control placebo. Supine blood pressure (BP), cardiac output and peripheral vascular resistance measurements were obtained at baseline, as well as at 30 min, 60 min and 90 min after 45 min of treadmill exercise at 70% heart rate reserve. Exercise increased diastolic BP in young BL but not in CA. Post-exercise diastolic BP was also elevated in BL after exercise with histamine receptor blockade. Moreover, H1R and H2R blockade elicited differential responses in stroke volume between BL and CA at rest, and the difference remained following exercise. Our findings show differential BP responses following exercise in BL and CA, and a potential role of histamine receptors in mediating basal and post-exercise stroke volume in BL. The heightened BP and vascular responses to exercise stimulus is consistent with the greater CVD risk in BL.	[Yan, Huimin; Behun, Michael A.; Ranadive, Sushant M.; Woods, Jeffrey A.; Wilund, Kenneth R.] Univ Illinois, Dept Kinesiol & Community Hlth, Champaign, IL USA; [Yan, Huimin] E Carolina Univ, Dept Kinesiol, Greenville, NC USA; [Cook, Marc D.; Lane-Cordova, Abbi D.; Kappus, Rebecca M.; Baynard, Tracy; Fernhall, Bo] Univ Illinois, Dept Kinesiol & Nutr, Chicago, IL USA; [Halliwill, John R.] Univ Oregon, Dept Human Physiol, Eugene, OR 97403 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of North Carolina; East Carolina University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Oregon	Yan, HM (corresponding author), Univ Illinois, Dept Kinesiol & Community Hlth, Champaign, IL USA.	yanh14@ecu.edu	Ranadive, Sushant/AAN-4098-2021; Baynard, Tracy/AAN-8711-2021	Ranadive, Sushant/0000-0003-1674-4285; Halliwill, John/0000-0003-3001-1715; Yan, Huimin/0000-0003-0907-1246; Baynard, Tracy/0000-0002-5150-4095	American Heart Association pre-doctoral fellowship [12PRE9610007]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL115027] Funding Source: NIH RePORTER	American Heart Association pre-doctoral fellowship(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funded by American Heart Association pre-doctoral fellowship #12PRE9610007 to Huimin Yan.	AKHRAS F, 1985, BRIT HEART J, V53, P598; Bond Vernon Jr., 1999, Ethnicity and Disease, V9, P104; Brito LC, 2014, BRAZ J MED BIOL RES, V47, P626, DOI 10.1590/1414-431X20143832; Brown MD, 2013, EXERC SPORT SCI REV, V41, P44, DOI 10.1097/JES.0b013e318279cbbd; Campia U, 2002, J AM COLL CARDIOL, V40, P754, DOI 10.1016/S0735-1097(02)02015-6; Enweze L, 2007, ETHNIC DIS, V17, P664; Ergul S, 1996, HYPERTENSION, V28, P652, DOI 10.1161/01.HYP.28.4.652; Fahs CA, 2010, APPL PHYSIOL NUTR ME, V35, P294, DOI 10.1139/H10-020; Feairheller DL, 2011, CTS-CLIN TRANSL SCI, V4, P32, DOI 10.1111/j.1752-8062.2011.00264.x; FLORAS JS, 1989, HYPERTENSION, V14, P28, DOI 10.1161/01.HYP.14.1.28; FLORAS JS, 1991, CAN J CARDIOL, V7, P253; FLORAS JS, 1992, J HUM HYPERTENS, V6, P265; Forjaz CLM, 2000, BLOOD PRESS MONIT, V5, P255, DOI 10.1097/00126097-200010000-00002; FROHLICH ED, 1990, HYPERTENSION, V15, P675, DOI 10.1161/01.HYP.15.6.675; GARG DC, 1985, J CLIN PHARMACOL, V25, P437, DOI 10.1002/j.1552-4604.1985.tb02873.x; GROSS PM, 1981, J CEREBR BLOOD F MET, V1, P441, DOI 10.1038/jcbfm.1981.49; Halliwill JR, 2013, EXP PHYSIOL, V98, P7, DOI 10.1113/expphysiol.2011.058065; Headley Samuel A., 1998, Ethnicity and Disease, V8, P312; Hecksteden A, 2013, CLIN J SPORT MED, V23, P58, DOI 10.1097/JSM.0b013e31825b6974; Heffernan KS, 2008, AM J PHYSIOL-HEART C, V295, pH2380, DOI 10.1152/ajpheart.00902.2008; Jones H, 2008, EUR J APPL PHYSIOL, V104, P481, DOI 10.1007/s00421-008-0797-4; Jones H, 2009, CHRONOBIOL INT, V26, P293, DOI 10.1080/07420520902739717; Jones H, 2008, CHRONOBIOL INT, V25, P987, DOI 10.1080/07420520802548044; Kahn DF, 2002, HYPERTENSION, V40, P195, DOI 10.1161/01.HYP.0000024571.69634.ED; KALINER M, 1981, J ALLERGY CLIN IMMUN, V68, P365, DOI 10.1016/0091-6749(81)90134-2; KENNEY MJ, 1993, HYPERTENSION, V22, P653, DOI 10.1161/01.HYP.22.5.653; LANG CC, 1995, NEW ENGL J MED, V333, P155, DOI 10.1056/NEJM199507203330304; Liu S, 2013, EUR J PREV CARDIOL, V20, P956, DOI 10.1177/2047487312454759; Liu S, 2012, MED SCI SPORT EXER, V44, P1644, DOI 10.1249/MSS.0b013e31825408fb; Lizardo JHF, 2008, CLIN EXP PHARMACOL P, V35, P782, DOI 10.1111/j.1440-1681.2008.04950.x; Lockwood JM, 2005, J PHYSIOL-LONDON, V563, P633, DOI 10.1113/jphysiol.2004.080325; Lockwood JM, 2005, J APPL PHYSIOL, V98, P447, DOI 10.1152/japplphysiol.00787.2004; McCord JL, 2006, J APPL PHYSIOL, V101, P1693, DOI 10.1152/japplphysiol.00441.2006; McCord JL, 2006, J APPL PHYSIOL, V100, P67, DOI 10.1152/japplphysiol.00959.2005; Melenovsky V, 2007, J AM COLL CARDIOL, V49, P198, DOI 10.1016/j.jacc.2006.08.050; Myers GL, 2006, CLIN CHEM, V52, P5, DOI 10.1373/clinchem.2005.0525144; Pescatello LS, 2004, J HYPERTENS, V22, P1881, DOI 10.1097/00004872-200410000-00009; Pescatello LS, 2003, AM HEART J, V145, P364, DOI 10.1067/mhj.2003.107; Pescatello LS, 2001, MED SCI SPORT EXER, V33, P1855, DOI 10.1097/00005768-200111000-00009; Preston RA, 2000, ARCH INTERN MED, V160, P1449, DOI 10.1001/archinte.160.10.1449; Quyyumi Arshed A., 1998, American Journal of Medicine, V105, p32S, DOI 10.1016/S0002-9343(98)00209-5; Rockstroh JK, 1997, AM J HYPERTENS, V10, P971, DOI 10.1016/S0895-7061(97)00165-9; Rossow L, 2010, AM J HYPERTENS, V23, P358, DOI 10.1038/ajh.2009.269; Rueckert PA, 1996, MED SCI SPORT EXER, V28, P24, DOI 10.1097/00005768-199601000-00010; Russell T, 1998, CLIN PHARMACOL THER, V64, P612, DOI 10.1016/S0009-9236(98)90052-2; Senitko AN, 2002, J APPL PHYSIOL, V92, P2368, DOI 10.1152/japplphysiol.00020.2002; Stein CM, 1997, CLIN PHARMACOL THER, V62, P436, DOI 10.1016/S0009-9236(97)90122-3; Stein CM, 2000, HYPERTENSION, V36, P945, DOI 10.1161/01.HYP.36.6.945; TURNER JR, 1994, INT J PSYCHOPHYSIOL, V17, P159, DOI 10.1016/0167-8760(94)90031-0; Vita JA, 2003, J CARD FAIL, V9, pS199, DOI 10.1054/S1071-9164(03)00588-8; Wallace JP, 1997, AM J HYPERTENS, V10, P728, DOI 10.1016/S0895-7061(97)00070-8; WATKINS J, 1982, BRIT HEART J, V47, P539; Yan H, 2014, AM J PHYSIOL-HEART C, V306, pH60, DOI 10.1152/ajpheart.00710.2013	53	6	6	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153445	10.1371/journal.pone.0153445	http://dx.doi.org/10.1371/journal.pone.0153445			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27074034	Green Submitted, Green Published, gold			2022-12-27	WOS:000374131200095
J	Dewa, CS; Trojanowski, L; Tamminga, SJ; Ringash, J; McQuestion, M; Hoch, JS				Dewa, Carolyn S.; Trojanowski, Lucy; Tamminga, Sietske J.; Ringash, Jolie; McQuestion, Maurene; Hoch, Jeffrey S.			Advice about Work-Related Issues to Peers and Employers from Head and Neck Cancer Survivors	PLOS ONE			English	Article							META-SYNTHESIS; RETURN; EXPERIENCES; DISABILITY; INTERVIEWS	Purpose The purpose of this exploratory and descriptive study is to contribute to the sparse return-towork literature on head and neck cancer (HNC) survivors. Interview participants were asked to reflect upon their work-related experience with cancer by answering two specific questions: (1) What advice would you give someone who has been newly diagnosed with head and neck cancer? (2) What advice would you give to employers of these people? Methods Data were gathered through 10 individual semi-structured in-depth interviews with HNC clinic patients at a regional cancer center's head and neck clinic in Ontario, Canada. A constant comparative method of theme development was used. Codes identified in and derived from the data were discussed by research team members until consensus was reached. Codes with similar characteristics were grouped together and used to develop overarching themes. Results Work-related advice for peers focused on personal self-care and interactions within workplaces. Work-related advice to employers focused on demonstrating basic human values as well as the importance of communication. Discussion The study results suggest HNC clinic patients should be proactive with employers and help to set reasonable expectations and provide a realistic plan for work to be successfully completed. HNC clinic patients should develop communication skills to effectively disclose their cancer and treatment to employers. Conclusions In this exploratory study, HNC clinic patients' advice was solution-focused underscoring the importance of self-care and pro-active communication and planning with employers. Employers were advised to demonstrate core human values throughout all phases of the work disability episode beginning at diagnosis.	[Dewa, Carolyn S.; Trojanowski, Lucy] Ctr Addict & Mental Hlth, Ctr Res Employment & Workpl Hlth, Toronto, ON, Canada; [Dewa, Carolyn S.] Univ Calif Davis, Dept Psychiat & Behav Sci, Sacramento, CA 95817 USA; [Dewa, Carolyn S.; Hoch, Jeffrey S.] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Tamminga, Sietske J.] Univ Amsterdam, Acad Med Ctr, Coronel Inst Occupat Hlth, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Ringash, Jolie; McQuestion, Maurene] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada; [Hoch, Jeffrey S.] Univ Calif Davis, Dept Publ Hlth Sci, Davis, CA 95616 USA	University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of California System; University of California Davis; University of Toronto; University of Amsterdam; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of California System; University of California Davis	Dewa, CS (corresponding author), Ctr Addict & Mental Hlth, Ctr Res Employment & Workpl Hlth, Toronto, ON, Canada.; Dewa, CS (corresponding author), Univ Calif Davis, Dept Psychiat & Behav Sci, Sacramento, CA 95817 USA.; Dewa, CS (corresponding author), Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada.	csdewa@ucdavis.ca	Hoch, Jeffrey/O-3406-2017	Hoch, Jeffrey/0000-0002-4880-4281; Ringash, Jolie/0000-0002-7337-0411; Dewa, Carolyn/0000-0001-5647-3905; Tamminga, Sietske/0000-0002-2228-1187	Canadian Centre for Applied Research in Cancer Control [19789]; Dr. Dewa's Canadian Institutes of Health Research/Public Health Agency of Canada Applied Public Health Chair [86895]	Canadian Centre for Applied Research in Cancer Control; Dr. Dewa's Canadian Institutes of Health Research/Public Health Agency of Canada Applied Public Health Chair	This study was funded by Canadian Centre for Applied Research in Cancer Control (Grant #19789) and Dr. Dewa's Canadian Institutes of Health Research/Public Health Agency of Canada Applied Public Health Chair (Grant # 86895). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Canadian Partnership Against Cancer, 2012, RES REL WORKPL SUPP; Creswell J. W., 2014, RES DESIGN QUALITATI, V4th; Dewa CS, 2016, CAN J PSYCHIAT, V61, P176, DOI 10.1177/0706743716632515; DiCicco-Bloom B, 2006, MED EDUC, V40, P314, DOI 10.1111/j.1365-2929.2006.02418.x; Feuerstein M, 2005, J OCCUP REHABIL, V15, P1, DOI 10.1007/s10926-005-0868-x; Forte T, 2012, CANCER CAUSE CONTROL, V23, P1343, DOI 10.1007/s10552-012-0013-z; Garnaes E, 2015, INT J CANCER, V136, P2196, DOI 10.1002/ijc.29254; GLASER BG, 1965, SOC PROBL, V12, P436, DOI 10.1525/sp.1965.12.4.03a00070; Government of Canada, 2014, SICK LEAV WORK REL I; Grunfeld EA, 2010, OCCUP MED-OXFORD, V60, P611, DOI 10.1093/occmed/kqq143; Grunfeld EA, 2008, J OCCUP REHABIL, V18, P381, DOI 10.1007/s10926-008-9152-1; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Harry B., 2005, ED RES, V34, P3, DOI [10.3102/0013189X034002003, DOI 10.3102/0013189X034002003]; Huang SH, 2015, J CLIN ONCOL, V33, P836, DOI 10.1200/JCO.2014.58.6412; Isaksson J, 2016, SUPPORT CARE CANCER, V24, P205, DOI 10.1007/s00520-015-2769-7; Johnson-Obaseki S, 2012, OTOLARYNG HEAD NECK, V147, P74, DOI 10.1177/0194599812437332; Kennedy F, 2007, EUR J CANCER CARE, V16, P17, DOI 10.1111/j.1365-2354.2007.00729.x; Loisel P, 2005, J OCCUP REHABIL, V15, P507, DOI 10.1007/s10926-005-8031-2; McDonald JT, 2014, J OTOLARYNGOL-HEAD N, V43, DOI 10.1186/1916-0216-43-2; McKay G, 2013, J OCCUP REHABIL, V23, P93, DOI 10.1007/s10926-012-9386-9; Mehnert A, 2011, CRIT REV ONCOL HEMAT, V77, P109, DOI 10.1016/j.critrevonc.2010.01.004; National Cancer Institute, 2004, NAT ACT PLAN CANC SU; Nilsson M, 2011, EUR J ONCOL NURS, V15, P267, DOI 10.1016/j.ejon.2011.03.005; Patton M. Q., 1990, QUALITATIVE EVALUATI; Pryce J, 2007, J OCCUP REHABIL, V17, P83, DOI 10.1007/s10926-006-9040-5; Richardson A, 2011, BRIT J CANCER, V105, pS82, DOI 10.1038/bjc.2011.425; Saldana J., 2021, CODING MANUAL QUALIT, P1; Service Canada, 2014, GEN INF EMPL INS PRE; Spelten ER, 2002, PSYCHO-ONCOL, V11, P124, DOI 10.1002/pon.585; Stergiou-Kita M, 2014, J CANCER SURVIV, V8, P657, DOI 10.1007/s11764-014-0377-z; Tamminga SJ, 2012, SCAND J WORK ENV HEA, V38, P144, DOI 10.5271/sjweh.3199; Tiedtke C, 2014, J OCCUP REHABIL, V24, P399, DOI 10.1007/s10926-013-9465-6; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Verdonck-de Leeuw IM, 2010, ORAL ONCOL, V46, P56, DOI 10.1016/j.oraloncology.2009.11.001; Wells M, 2013, PSYCHO-ONCOLOGY, V22, P1208, DOI 10.1002/pon.3148	35	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0152944	10.1371/journal.pone.0152944	http://dx.doi.org/10.1371/journal.pone.0152944			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ0NI	27070654	Green Published, gold			2022-12-27	WOS:000373900700022
J	Sharpe, RM; Koepke, T; Harper, A; Grimes, J; Galli, M; Satoh-Cruz, M; Kalyanaraman, A; Evans, K; Kramer, D; Dhingra, A				Sharpe, Richard M.; Koepke, Tyson; Harper, Artemus; Grimes, John; Galli, Marco; Satoh-Cruz, Mio; Kalyanaraman, Ananth; Evans, Katherine; Kramer, David; Dhingra, Amit			CisSERS: Customizable In Silico Sequence Evaluation for Restriction Sites	PLOS ONE			English	Article							MARKER DEVELOPMENT; SNP DISCOVERY; TOOL; DESIGN; PROGRAM; DNA; PCR	High-throughput sequencing continues to produce an immense volume of information that is processed and assembled into mature sequence data. Data analysis tools are urgently needed that leverage the embedded DNA sequence polymorphisms and consequent changes to restriction sites or sequence motifs in a high-throughput manner to enable biological experimentation. CisSERS was developed as a standalone open source tool to analyze sequence datasets and provide biologists with individual or comparative genome organization information in terms of presence and frequency of patterns or motifs such as restriction enzymes. Predicted agarose gel visualization of the custom analyses results was also integrated to enhance the usefulness of the software. CisSERS offers several novel functionalities, such as handling of large and multiple datasets in parallel, multiple restriction enzyme site detection and custom motif detection features, which are seamlessly integrated with real time agarose gel visualization. Using a simple fasta-formatted file as input, CisSERS utilizes the REBASE enzyme database. Results from CisSERS enable the user to make decisions for designing genotyping by sequencing experiments, reduced representation sequencing, 3'UTR sequencing, and cleaved amplified polymorphic sequence (CAPS) molecular markers for large sample sets. CisSERS is a java based graphical user interface built around a perl backbone. Several of the applications of CisSERS including CAPS molecular marker development were successfully validated using wet-lab experimentation. Here, we present the tool CisSERS and results from in-silico and corresponding wet-lab analyses demonstrating that CisSERS is a technology platform solution that facilitates efficient data utilization in genomics and genetics studies.	[Sharpe, Richard M.; Koepke, Tyson; Dhingra, Amit] Washington State Univ, Mol Plant Sci Grad Program, Pullman, WA 99164 USA; [Koepke, Tyson; Harper, Artemus; Galli, Marco; Evans, Katherine; Dhingra, Amit] Washington State Univ, Dept Hort, Pullman, WA 99164 USA; [Sharpe, Richard M.] Washington State Univ, Sch Biol Sci, Pullman, WA 99164 USA; [Grimes, John; Kalyanaraman, Ananth] Washington State Univ, Elect Engn & Comp Sci, Pullman, WA 99164 USA; [Satoh-Cruz, Mio; Kramer, David] Michigan State Univ, MSU DOE Plant Res Lab, E Lansing, MI 48824 USA	Washington State University; Washington State University; Washington State University; Washington State University; Michigan State University; United States Department of Energy (DOE)	Dhingra, A (corresponding author), Washington State Univ, Mol Plant Sci Grad Program, Pullman, WA 99164 USA.; Dhingra, A (corresponding author), Washington State Univ, Dept Hort, Pullman, WA 99164 USA.	adhingra@wsu.edu	Dhingra, Amit/E-7369-2010; Dhingra, Amit/AAX-9566-2020; Kramer, David/B-9588-2016	Dhingra, Amit/0000-0002-4464-2502; Kramer, David/0000-0003-2181-6888; Sharpe, Richard/0000-0002-8513-4862; EVANS, KATE/0000-0002-2184-7433	WSU Agriculture Research Center Hatch funds; Department of Agriculture National Research Initiative (USDA-NRI) [2008 -35300-04676]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008336] Funding Source: NIH RePORTER	WSU Agriculture Research Center Hatch funds; Department of Agriculture National Research Initiative (USDA-NRI); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by WSU Agriculture Research Center Hatch funds to AD and KE. US Department of Agriculture National Research Initiative (USDA-NRI) grant 2008 -35300-04676 to AD and AK supported AH and JG. TAK acknowledges the National Institutes of Health Protein Biotechnology Training Grant T32GM008336 and ARCS Fellowship Program. RMS's work was supported by the National Science Foundation under Grants IOS 0641232 and MCB 1146928 and by Civilian Research and Development Foundation Grant RUB1-2982-ST-10 to Gerald E. Edwards, WSU. Work related to characterization of the cfq mutant was supported by US Department of Energy, Office of Science, Basic Energy Sciences Program DE-FG02-04ERl5559 to DMK.	Agarwal M, 2008, PLANT CELL REP, V27, P617, DOI 10.1007/s00299-008-0507-z; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Chang HW, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-173; Chang HW, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-30; Chutimanitsakun Y, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-4; Eveland AL, 2008, PLANT PHYSIOL, V146, P32, DOI 10.1104/pp.107.108597; Gaudet M, 2007, PLANT MOL BIOL REP, V25, P1, DOI 10.1007/s11105-007-0003-6; Ilic K, 2004, TRENDS GENET, V20, P280, DOI 10.1016/j.tig.2004.04.012; Koepke T, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-18; Krishnan V, 2009, COMPUTATIONAL APPROA; Neff MM, 2002, TRENDS GENET, V18, P613, DOI 10.1016/S0168-9525(02)02820-2; Sanchez CC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-559; Shu YJ, 2011, MOL BIOL REP, V38, P1841, DOI 10.1007/s11033-010-0300-2; Taylor J, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-27; Thiel T, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh006; Van Tassell CP, 2008, NAT METHODS, V5, P247, DOI 10.1038/NMETH.1185; Velasco R, 2010, NAT GENET, V42, P833, DOI 10.1038/ng.654; Vincze T, 2003, NUCLEIC ACIDS RES, V31, P3688, DOI 10.1093/nar/gkg526; Williams G, EMBOSS TRIMEST; Zhang RF, 2005, NUCLEIC ACIDS RES, V33, pW489, DOI 10.1093/nar/gki358	20	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0152404	10.1371/journal.pone.0152404	http://dx.doi.org/10.1371/journal.pone.0152404			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27071032	Green Published, Green Submitted, gold			2022-12-27	WOS:000373900700009
J	Stevens, JP; Baker, K; Howell, MD; Banzett, RB				Stevens, Jennifer P.; Baker, Kathy; Howell, Michael D.; Banzett, Robert B.			Prevalence and Predictive Value of Dyspnea Ratings in Hospitalized Patients: Pilot Studies	PLOS ONE			English	Article							SURVIVAL; MORTALITY; PAIN; CANCER; MANAGEMENT; SYMPTOMS; TEAM; COPD; ILL	Background Dyspnea (breathing discomfort) can be as powerfully aversive as pain, yet is not routinely assessed and documented in the clinical environment. Routine identification and documentation of dyspnea is the first step to improved symptom management and it may also identify patients at risk of negative clinical outcomes. Objective To estimate the prevalence of dyspnea and of dyspnea-associated risk among hospitalized patients. Design Two pilot prospective cohort studies. Setting Single academic medical center. Patients Consecutive patients admitted to four inpatient units: cardiology, hematology/oncology, medicine, and bariatric surgery. Measurements In Study 1, nurses documented current and recent patient-reported dyspnea at the time of the Initial Patient Assessment in 581 inpatients. In Study 2, nurses documented current dyspnea at least once every nursing shift in 367 patients. We describe the prevalence of burdensome dyspnea, and compare it to pain. We also compared dyspnea ratings with a composite of adverse outcomes: 1) receipt of care from the hospital's rapid response system, 2) transfer to the intensive care unit, or 3) death in hospital. We defined burdensome dyspnea as a rating of 4 or more on a 10-point scale. Results Prevalence of burdensome current dyspnea upon admission (Study 1) was 13% (77 of 581, 95% CI 11%-16%). Prevalence of burdensome dyspnea at some time during the hospitalization (Study 2) was 16% (57 of 367, 95% CI 12%-20%). Dyspnea was associated with higher odds of a negative outcome. Conclusions In two pilot studies, we identified a significant symptom burden of dyspnea in hospitalized patients. Patients reporting dyspnea may benefit from a more careful focus on symptom management and may represent a population at greater risk for negative outcomes.	[Stevens, Jennifer P.] Beth Israel Deaconess Med Ctr, Ctr Healthcare Delivery Sci, Boston, MA 02215 USA; [Stevens, Jennifer P.; Banzett, Robert B.] Beth Israel Deaconess Med Ctr, Dept Med, Div Pulm Crit Care & Sleep Med, Boston, MA 02215 USA; [Stevens, Jennifer P.; Banzett, Robert B.] Harvard Univ, Sch Med, Boston, MA USA; [Baker, Kathy] Beth Israel Deaconess Med Ctr, Dept Nursing, Boston, MA 02215 USA; [Howell, Michael D.] Univ Chicago, Dept Med, Sect Pulm & Crit Care, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Howell, Michael D.] Univ Chicago, Ctr Healthcare Delivery Sci & Innovat, Chicago, IL 60637 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; University of Chicago; University of Chicago	Stevens, JP (corresponding author), Beth Israel Deaconess Med Ctr, Ctr Healthcare Delivery Sci, Boston, MA 02215 USA.; Stevens, JP (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Div Pulm Crit Care & Sleep Med, Boston, MA 02215 USA.; Stevens, JP (corresponding author), Harvard Univ, Sch Med, Boston, MA USA.	jpsteven@bidmc.harvard.edu			National Institute for Health's National Institute of Nursing Research [NR10006]; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR010006] Funding Source: NIH RePORTER	National Institute for Health's National Institute of Nursing Research; NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	This work was funded by the National Institute for Health's National Institute of Nursing Research, NR10006 (https://www.ninr.nih.gov/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abidov A, 2005, NEW ENGL J MED, V353, P1889, DOI 10.1056/NEJMoa042741; [Anonymous], 1960, BMJ-BRIT MED J, V2, P1665; Baker K, 2013, AM J NURSING PENDING; Baker K, 2013, AM J NURS, V113, P42, DOI 10.1097/01.NAJ.0000437112.43059.a0; Bellomo R, 2004, CRIT CARE MED, V32, P916, DOI 10.1097/01.CCM.0000119428.02968.9E; Dalton J A, 2001, Pain Manag Nurs, V2, P54, DOI 10.1053/jpmn.2001.23918; de Rond M, 1999, J ADV NURS, V29, P436, DOI 10.1046/j.1365-2648.1999.00903.x; Desbiens NA, 1997, PAIN, V71, P149, DOI 10.1016/S0304-3959(97)03353-8; Djarv T, 2010, J CLIN ONCOL, V28, P1666, DOI 10.1200/JCO.2009.23.5143; Dorman S, 2007, PALLIATIVE MED; DOWNIE WW, 1978, ANN RHEUM DIS, V37, P378, DOI 10.1136/ard.37.4.378; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Escalante CP, 1996, CANCER, V78, P1314, DOI 10.1002/(SICI)1097-0142(19960915)78:6<1314::AID-CNCR21>3.0.CO;2-2; Escobar GJ, 2008, MED CARE, V46, P232, DOI 10.1097/MLR.0b013e3181589bb6; HARDY JR, 1994, EUR J CANCER, V30A, P284, DOI 10.1016/0959-8049(94)90242-9; Healy LA, 2008, DIS ESOPHAGUS, V21, P522, DOI 10.1111/j.1442-2050.2008.00814.x; Heyse-Moore LH, 1991, PALLIATIVE MED, V5, P20, DOI DOI 10.1177/026921639100500105; Howell MD, 2012, CRIT CARE MED, V40, P2562, DOI 10.1097/CCM.0b013e318259007b; Johnson SR, 2004, THORAX, V59, P800, DOI 10.1136/thx.2004.023283; MALTONI M, 1995, CANCER-AM CANCER SOC, V75, P2613, DOI 10.1002/1097-0142(19950515)75:10<2613::AID-CNCR2820751032>3.0.CO;2-1; Meek PM, 2003, HEART LUNG, V32, P335, DOI 10.1016/S0147-9563(03)00100-6; Meek PM, 2001, EUR RESPIR J, V18, P474, DOI 10.1183/09031936.01.00083501; Nishimura K, 2002, CHEST, V121, P1434, DOI 10.1378/chest.121.5.1434; Nishiyama O, 2010, EUR RESPIR J, V36, P1067, DOI 10.1183/09031936.00152609; O'Driscoll M, 1999, EUR J CANCER CARE, V8, P37; Parshall MB, 2012, AM J RESP CRIT CARE, V185, P435, DOI 10.1164/rccm.201111-2042ST; Parshall MB, 2012, HEART LUNG, V41, P44, DOI 10.1016/j.hrtlng.2011.05.003; Onen ZP, 2007, RESP MED, V101, P1390, DOI 10.1016/j.rmed.2007.02.002; Schmidt M, 2014, INTENS CARE MED, V40, P1, DOI 10.1007/s00134-013-3117-3; Sha MC, 2005, AM J MED, V118, P301, DOI 10.1016/j.amjmed.2004.12.015; Shih FJ, 1999, HEART LUNG, V28, P41, DOI 10.1016/S0147-9563(99)70042-7; Thomas JR, 2002, LANCET ONCOL, V3, P223, DOI 10.1016/S1470-2045(02)00713-1; Twaddle ML, 2007, J PALLIAT MED, V10, P86, DOI 10.1089/jpm.2006.0048; Zhu LM, 2012, PAIN RES MANAG, V17, P173, DOI 10.1155/2012/586589	34	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0152601	10.1371/journal.pone.0152601	http://dx.doi.org/10.1371/journal.pone.0152601			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27070144	Green Published, Green Submitted, gold			2022-12-27	WOS:000373900700011
J	Tomaschek, F; Higgins, PG; Stefanik, D; Wisplinghoff, H; Seifert, H				Tomaschek, Franziska; Higgins, Paul G.; Stefanik, Danuta; Wisplinghoff, Hilmar; Seifert, Harald			Head-to-Head Comparison of Two Multi-Locus Sequence Typing (MLST) Schemes for Characterization of Acinetobacter baumannii Outbreak and Sporadic Isolates	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; PREVALENT OXA CARBAPENEMASES; MOLECULAR EPIDEMIOLOGY; INTERLABORATORY REPRODUCIBILITY; MULTIPLEX PCR; REP-PCR; EMERGENCE; DIFFERENTIATE; CALCOACETICUS; INFECTIONS	To compare the two Acinetobacter baumannii multi-locus sequence typing (MLST) schemes and to assess their suitability to aid in outbreak analysis we investigated the molecular epidemiology of 99 Acinetobacter baumannii isolates representing outbreak-related and sporadic isolates from 24 hospitals in four different countries (Germany, Poland, Sweden, and Turkey). Pulsed-field gel electrophoresis (PFGE) was used as the reference method to determine the epidemiologic relatedness of isolates and compared to MLST using both the Oxford and Pasteur scheme. Rep-PCR was used to define international clonal lineages (IC). We identified 26 unique outbreak strains and 21 sporadic strains. The majority of outbreaks were associated with carbapenem-resistant A. baumannii harbouring oxacillinase OXA-23-like and corresponding to IC 2. Sequence types (STs) obtained from the Oxford scheme correlate well with PFGE patterns, while the STs of the Pasteur scheme are more in accordance with rep-PCR grouping, but neither one is mirroring completely the results of the comparator. On two occasions the Oxford scheme identified two different STs within a single outbreak where PFGE patterns had only one band difference. The CCs of both MLST schemes were able to define clonal clusters that were concordant with the ICs determined by rep-PCR. IC4 corresponds to the previously described CC15 Pasteur (= CC103 Oxford). It can be concluded that both MLST schemes are valuable tools for population-based studies. In addition, the higher discriminatory power of the Oxford scheme that compares with the resolution obtained with PFGE can often aid in outbreak analysis.	[Tomaschek, Franziska; Higgins, Paul G.; Stefanik, Danuta; Wisplinghoff, Hilmar; Seifert, Harald] Univ Cologne, Inst Med Microbiol Immunol & Hyg, D-50931 Cologne, Germany; [Higgins, Paul G.; Seifert, Harald] German Ctr Infect Res DZIF, Partner Site Cologne Bonn, Cologne, Germany	University of Cologne; German Center for Infection Research; University of Cologne	Seifert, H (corresponding author), Univ Cologne, Inst Med Microbiol Immunol & Hyg, D-50931 Cologne, Germany.; Seifert, H (corresponding author), German Ctr Infect Res DZIF, Partner Site Cologne Bonn, Cologne, Germany.	harald.seifert@uni-koeln.de	Higgins, Paul/B-6708-2011	Higgins, Paul/0000-0001-8677-9454				Adams-Haduch JM, 2011, J CLIN MICROBIOL, V49, P3849, DOI 10.1128/JCM.00619-11; Bartual SG, 2005, J CLIN MICROBIOL, V43, P4382, DOI 10.1128/JCM.43.9.4382-4390.2005; Climaco EC, 2013, INFECT GENET EVOL, V19, P127, DOI 10.1016/j.meegid.2013.06.024; Diancourt L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010034; Dijkshoorn L, 1996, J CLIN MICROBIOL, V34, P1519, DOI 10.1128/JCM.34.6.1519-1525.1996; Dijkshoorn L, 2007, NAT REV MICROBIOL, V5, P939, DOI 10.1038/nrmicro1789; Endo S, 2012, J ANTIMICROB CHEMOTH, V67, P1623, DOI 10.1093/jac/dks094; Fishbain J, 2010, CLIN INFECT DIS, V51, P79, DOI 10.1086/653120; Garnacho-Montero J, 2015, INTENS CARE MED, V41, P2057, DOI 10.1007/s00134-015-4079-4; Hamouda A, 2010, J CLIN MICROBIOL, V48, P2476, DOI 10.1128/JCM.02431-09; Higgins PG, 2007, CLIN MICROBIOL INFEC, V13, P1199, DOI 10.1111/j.1469-0691.2007.01819.x; Higgins PG, 2012, J CLIN MICROBIOL, V50, P3493, DOI 10.1128/JCM.01759-12; Higgins PG, 2012, J MED MICROBIOL, V61, P137, DOI 10.1099/jmm.0.036046-0; Higgins PG, 2010, J CLIN MICROBIOL, V48, P4592, DOI 10.1128/JCM.01765-10; Higgins PG, 2010, J ANTIMICROB CHEMOTH, V65, P233, DOI 10.1093/jac/dkp428; Higgins PG, 2010, INT J ANTIMICROB AG, V35, P305, DOI 10.1016/j.ijantimicag.2009.10.014; Karah N, 2012, DRUG RESIST UPDATE, V15, P237, DOI 10.1016/j.drup.2012.06.001; Nemec A, 2008, J ANTIMICROB CHEMOTH, V62, P484, DOI 10.1093/jac/dkn205; Nemec A, 2015, INT J SYST EVOL MICR, V65, P934, DOI 10.1099/ijs.0.000043; Park YK, 2009, DIAGN MICR INFEC DIS, V64, P43, DOI 10.1016/j.diagmicrobio.2009.01.012; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; Seifert H, 2005, J CLIN MICROBIOL, V43, P4328, DOI 10.1128/JCM.43.9.4328-4335.2005; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Urwin R, 2003, TRENDS MICROBIOL, V11, P479, DOI 10.1016/j.tim.2003.08.006; van Dessel H, 2004, RES MICROBIOL, V155, P105, DOI 10.1016/j.resmic.2003.10.003; Villalon P, 2011, J CLIN MICROBIOL, V49, P875, DOI 10.1128/JCM.01026-10; Wisplinghoff H, 2012, J INFECTION, V64, P282, DOI 10.1016/j.jinf.2011.12.008; Woo PCY, 2011, DIAGN MICR INFEC DIS, V70, P316, DOI 10.1016/j.diagmicrobio.2011.03.006; Woodford N, 2006, INT J ANTIMICROB AG, V27, P351, DOI 10.1016/j.ijantimicag.2006.01.004	29	54	54	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0153014	10.1371/journal.pone.0153014	http://dx.doi.org/10.1371/journal.pone.0153014			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27071077	Green Submitted, gold, Green Published			2022-12-27	WOS:000373900700026
J	Oliveira, AS; Gizzi, L; Ketabi, S; Farina, D; Kersting, UG				Oliveira, Anderson Souza; Gizzi, Leonardo; Ketabi, Shahin; Farina, Dario; Kersting, Uwe Gustav			Modular Control of Treadmill vs Overground Running	PLOS ONE			English	Article							MUSCLE SYNERGIES; MOTOR MODULES; HUMAN LOCOMOTION; WALKING; ACTIVATION; PATTERNS; KINEMATICS; BIOMECHANICS; ORGANIZATION; VARIABILITY	Motorized treadmills have been widely used in locomotion studies, although a debate remains concerning the extrapolation of results obtained from treadmill experiments to overground locomotion. Slight differences between treadmill (TRD) and overground running (OVG) kinematics and muscle activity have previously been reported. However, little is known about differences in the modular control of muscle activation in these two conditions. Therefore, we aimed at investigating differences between motor modules extracted from TRD and OVG by factorization of multi-muscle electromyographic (EMG) signals. Twelve healthy men ran on a treadmill and overground at their preferred speed while we recorded tibial acceleration and surface EMG from 11 ipsilateral lower limb muscles. We extracted motor modules representing relative weightings of synergistic muscle activations by non-negative matrix factorization from 20 consecutive gait cycles. Four motor modules were sufficient to accurately reconstruct the EMG signals in both TRD and OVG (average reconstruction quality = 92 +/- 3%). Furthermore, a good reconstruction quality (80 +/- 7%) was obtained also when muscle weightings of one condition (either OVG or TRD) were used to reconstruct the EMG data from the other condition. The peak amplitudes of activation signals showed a similar timing (pattern) across conditions. The magnitude of peak activation for the module related to initial contact was significantly greater for OVG, whereas peak activation for modules related to leg swing and preparation to landing were greater for TRD. We conclude that TRD and OVG share similar muscle weightings throughout motion. In addition, modular control for TRD and OVG is achieved with minimal temporal adjustments, which were dependent on the phase of the running cycle.	[Oliveira, Anderson Souza] Aalborg Univ, Dept Mech & Mfg Engn, Aalborg, Denmark; [Gizzi, Leonardo; Farina, Dario] Univ Gottingen, Bernstein Ctr Computat Neurosci, Bernstein Focus Neurotechnol Gottingen, Inst Neurorehabil Syst,Univ Med Ctr Gottingen, D-37073 Gottingen, Germany; [Ketabi, Shahin; Kersting, Uwe Gustav] Aalborg Univ, Dept Hlth Sci & Technol, Aalborg, Denmark	Aalborg University; University of Gottingen; Aalborg University	Oliveira, AS (corresponding author), Aalborg Univ, Dept Mech & Mfg Engn, Aalborg, Denmark.	oliveira@m-tech.aau.dk	Gizzi, Leonardo/B-5691-2013; Kersting, Uwe/AAS-6693-2021; Farina, Dario/AAB-2648-2019; Oliveira, Anderson/AAJ-1068-2020; Ketabi, Shahin/AAY-5124-2020	Gizzi, Leonardo/0000-0003-3009-6261; Oliveira, Anderson/0000-0003-2186-8100; Ketabi, Shahin/0000-0002-6818-151X; Kersting, Uwe G/0000-0001-9373-2080	Center for Sensory-Motor Interaction (Aalborg University); European Commission 7th Framework Program as part of the project, H2R [600698]	Center for Sensory-Motor Interaction (Aalborg University); European Commission 7th Framework Program as part of the project, H2R	This study was supported by the Center for Sensory-Motor Interaction (Aalborg University) and the European Commission 7th Framework Program as part of the project, H2R (No. 600698). Dario Farina received the grant.; This study was supported by the Center for Sensory-Motor Interaction (Aalborg University) and the European Commission 7th Framework Program as part of the project, H2R (No. 600698).	Anunciacao O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076300; Barbero M, 2012, ATLAS OF MUSCLE INNE; BASSETT DR, 1985, MED SCI SPORT EXER, V17, P477, DOI 10.1249/00005768-198508000-00013; Baur H, 2007, ISOKINET EXERC SCI, V15, P165, DOI 10.3233/IES-2007-0262; Cappellini G, 2006, J NEUROPHYSIOL, V95, P3426, DOI 10.1152/jn.00081.2006; Oliveira ASC, 2012, J NEUROPHYSIOL, V108, P1895, DOI 10.1152/jn.00217.2012; Cheung VCK, 2005, J NEUROSCI, V25, P6419, DOI 10.1523/JNEUROSCI.4904-04.2005; Chvatal SA, 2012, J NEUROSCI, V32, P12237, DOI 10.1523/JNEUROSCI.6344-11.2012; Clark DJ, 2010, J NEUROPHYSIOL, V103, P844, DOI 10.1152/jn.00825.2009; d'Avella A, 2005, P NATL ACAD SCI USA, V102, P3076, DOI 10.1073/pnas.0500199102; d'Avella A, 2003, NAT NEUROSCI, V6, P300, DOI 10.1038/nn1010; Dominici N, 2011, SCIENCE, V334, P997, DOI 10.1126/science.1210617; Fetz EE, 2011, VOLITIONAL CONTROL N, V3, P571, DOI [10.1113/jphysiol.2006.127142, DOI 10.1113/JPHYSIOL.2006.127142]; Frere J, 2012, FRONT COMPUT NEUROSC, V6, DOI 10.3389/fncom.2012.00099; Garcia-Perez JA, 2013, GAIT POSTURE, V38, P929, DOI 10.1016/j.gaitpost.2013.04.026; Gizzi L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137844; Gizzi L, 2011, J NEUROPHYSIOL, V106, P202, DOI 10.1152/jn.00727.2010; Grillner S, 2011, SCIENCE, V334, P912, DOI 10.1126/science.1214778; Gwin JT, 2011, NEUROIMAGE, V54, P1289, DOI 10.1016/j.neuroimage.2010.08.066; Hart CB, 2010, J NEUROSCI, V30, P1322, DOI 10.1523/JNEUROSCI.5894-08.2010; Hug F, 2010, J APPL PHYSIOL, V108, P1727, DOI 10.1152/japplphysiol.01305.2009; Ivanenko YP, 2006, J NEUROPHYSIOL, V95, P602, DOI 10.1152/jn.00767.2005; Jordan K, 2007, GAIT POSTURE, V26, P128, DOI 10.1016/j.gaitpost.2006.08.010; Kong PW, 2012, GAIT POSTURE, V36, P46, DOI 10.1016/j.gaitpost.2012.01.001; Kutch JJ, 2008, J NEUROPHYSIOL, V100, P2455, DOI 10.1152/jn.90274.2008; Lacquaniti F, 2012, CURR OPIN NEUROBIOL, V22, P822, DOI 10.1016/j.conb.2012.03.012; Lacquaniti F, 2012, J PHYSIOL-LONDON, V590, P2189, DOI 10.1113/jphysiol.2011.215137; LAFORTUNE MA, 1995, J BIOMECH, V28, P989, DOI 10.1016/0021-9290(94)00150-3; Lavcanska V, 2005, HUM MOVEMENT SCI, V24, P544, DOI 10.1016/j.humov.2005.08.001; Lee DD, 2001, ADV NEUR IN, V13, P556; Lee SJ, 2008, J APPL PHYSIOL, V104, P747, DOI 10.1152/japplphysiol.01380.2006; Martino G, 2015, J NEUROPHYSIOL, V114, P2867, DOI 10.1152/jn.00029.2015; Muceli S, 2010, J NEUROPHYSIOL, V103, P1532, DOI 10.1152/jn.00559.2009; NELSON RC, 1972, MED SCI SPORT EXER, V4, P233, DOI 10.1249/00005768-197200440-00029; NIGG BM, 1995, MED SCI SPORT EXER, V27, P98; Oliveira AS, 2013, NEUROSCIENCE, V228, P283, DOI 10.1016/j.neuroscience.2012.10.027; Oliveira AS, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00335; Petersen TH, 2012, J PHYSIOL-LONDON, V590, P2443, DOI 10.1113/jphysiol.2012.227397; Riley PO, 2008, MED SCI SPORT EXER, V40, P1093, DOI 10.1249/MSS.0b013e3181677530; Schache AG, 2001, CLIN BIOMECH, V16, P667, DOI 10.1016/S0268-0033(01)00061-4; Selles RW, 2005, IEEE T NEUR SYS REH, V13, P81, DOI 10.1109/TNSRE.2004.843176; Sinclair J, 2013, SPORT BIOMECH, V12, P272, DOI 10.1080/14763141.2012.759614; Sipp AR, 2013, J NEUROPHYSIOL, V110, P2050, DOI 10.1152/jn.00744.2012; Steele KM, 2015, J NEUROPHYSIOL, V113, P2102, DOI 10.1152/jn.00769.2013; Turpin NA, 2011, J ELECTROMYOGR KINES, V21, P1030, DOI 10.1016/j.jelekin.2011.07.013; Wank V, 1998, INT J SPORTS MED, V19, P455, DOI 10.1055/s-2007-971944; White SC, 2002, J APPL BIOMECH, V18, P74, DOI 10.1123/jab.18.1.74	47	31	32	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2016	11	4							e0153307	10.1371/journal.pone.0153307	http://dx.doi.org/10.1371/journal.pone.0153307			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0KH	27064978	Green Published, Green Submitted, gold			2022-12-27	WOS:000373891000044
J	Tada, H; Matsuyama, T; Nishioka, T; Hagiwara, M; Kiyoura, Y; Shimauchi, H; Matsushita, K				Tada, Hiroyuki; Matsuyama, Takashi; Nishioka, Takashi; Hagiwara, Makoto; Kiyoura, Yusuke; Shimauchi, Hidetoshi; Matsushita, Kenji			Porphyromonas gingivalis Gingipain-Dependently Enhances IL-33 Production in Human Gingival Epithelial Cells	PLOS ONE			English	Article							PROTEINASE-ACTIVATED RECEPTOR-2; INNATE LYMPHOID-CELLS; THYMIC STROMAL LYMPHOPOIETIN; NECROSIS-FACTOR-ALPHA; IMMUNE-RESPONSES; PERIODONTAL-DISEASE; CREVICULAR FLUID; TYPE-2 IMMUNITY; ADAPTIVE IMMUNITY; CYTOKINE IL-33	The cytokine IL-33 is constitutively expressed in epithelial cells and it augments Th2 cytokine-mediated inflammatory responses by regulating innate immune cells. We aimed to determine the role of the periodontal pathogen, Porphyromonas gingivalis, in the enhanced expression of IL-33 in human gingival epithelial cells. We detected IL-33 in inflamed gingival epithelium from patients with chronic periodontitis, and found that P. gingivalis increased IL-33 expression in the cytoplasm of human gingival epithelial cells in vitro. In contrast, lipopolysaccharide, lipopeptide, and fimbriae derived from P. gingivalis did not increase IL-33 expression. Specific inhibitors of P. gingivalis proteases (gingipains) suppressed IL-33 mRNA induction by P. gingivalis and the P. gingivalis gingipain-null mutant KDP136 did not induce IL-33 expression. A small interfering RNA for protease-activated receptor-2 (PAR-2) as well as inhibitors of phospholipase C, p38 and NF-.B inhibited the expression of IL-33 induced by P. gingivalis. These results indicate that the PAR-2/IL-33 axis is promoted by P. gingivalis infection in human gingival epithelial cells through a gingipain-dependent mechanism.	[Tada, Hiroyuki; Hagiwara, Makoto; Matsushita, Kenji] Natl Ctr Geriatr & Gerontol, Dept Oral Dis Res, Obu, Aichi, Japan; [Tada, Hiroyuki] Tohoku Univ, Grad Sch Dent, Div Oral Microbiol, Sendai, Miyagi 980, Japan; [Nishioka, Takashi] Tohoku Univ, Grad Sch Dent, Div Oral Diag, Sendai, Miyagi 980, Japan; [Shimauchi, Hidetoshi] Tohoku Univ, Grad Sch Dent, Div Periodontol & Endodontol, Sendai, Miyagi 980, Japan; [Matsuyama, Takashi] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Periodontol, Kagoshima 890, Japan; [Kiyoura, Yusuke] Ohu Univ, Sch Dent, Dept Oral Med Sci, Koriyama, Fukushima, Japan	National Center for Geriatrics & Gerontology; Tohoku University; Tohoku University; Tohoku University; Kagoshima University	Tada, H (corresponding author), Natl Ctr Geriatr & Gerontol, Dept Oral Dis Res, Obu, Aichi, Japan.; Tada, H (corresponding author), Tohoku Univ, Grad Sch Dent, Div Oral Microbiol, Sendai, Miyagi 980, Japan.	htada@dent.tohoku.ac.jp			Japan Society for the Promotion of Science [25463225, 22390354]; Takeda Science Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported by Grand-in-Aids for Scientific Research (25463225 to HT, 22390354 to KM) from the Japan Society for the Promotion of Science; and the Takeda Science Foundation (HT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S, 2011, J IMMUNOL, V187, P1609, DOI 10.4049/jimmunol.1003080; Allakhverdi Z, 2007, J IMMUNOL, V179, P2051, DOI 10.4049/jimmunol.179.4.2051; Amano A, 2004, J PERIODONTAL RES, V39, P136, DOI 10.1111/j.1600-0765.2004.00719.x; Bartemes KR, 2012, J IMMUNOL, V188, P1503, DOI 10.4049/jimmunol.1102832; Beklen A, 2014, BIOTECH HISTOCHEM, V89, P209, DOI 10.3109/10520295.2013.832800; Belham CL, 1996, BIOCHEM J, V320, P939, DOI 10.1042/bj3200939; Bohm SK, 1996, J BIOL CHEM, V271, P22003; Bohm SK, 1996, BIOCHEM J, V314, P1009; Boisvert H, 2008, CELL MICROBIOL, V10, P2538, DOI 10.1111/j.1462-5822.2008.01228.x; Buduneli N, 2012, J PERIODONTOL, V83, P362, DOI 10.1902/jop.2011.110239; Byers DE, 2013, J CLIN INVEST, V123, P3967, DOI 10.1172/JCI65570; Calkins CC, 1998, J BIOL CHEM, V273, P6611, DOI 10.1074/jbc.273.12.6611; Cayrol C, 2014, CURR OPIN IMMUNOL, V31, P31, DOI 10.1016/j.coi.2014.09.004; Cayrol C, 2009, P NATL ACAD SCI USA, V106, P9021, DOI 10.1073/pnas.0812690106; Chang YJ, 2011, NAT IMMUNOL, V12, P631, DOI 10.1038/ni.2045; Darveau RP, 2004, INFECT IMMUN, V72, P5041, DOI 10.1128/IAI.72.9.5041-5051.2004; DeFea KA, 2000, J CELL BIOL, V148, P1267, DOI 10.1083/jcb.148.6.1267; Delima AJ, 2003, PERIODONTOL 2000, V31, P55, DOI 10.1034/j.1600-0757.2003.03105.x; Dommisch H, 2007, INFECT IMMUN, V75, P4326, DOI 10.1128/IAI.00455-07; Dommisch H, 2010, INNATE IMMUN-LONDON, V16, P226, DOI 10.1177/1753425909339237; Enoksson M, 2011, J IMMUNOL, V186, P2523, DOI 10.4049/jimmunol.1003383; Alves VTE, 2013, INFECT IMMUN, V81, P4399, DOI 10.1128/IAI.01107-13; Fagundes JAG, 2011, J PERIODONTOL, V82, P1596, DOI 10.1902/jop.2011.110073; Giacaman RA, 2009, MICROBIOL-SGM, V155, P3238, DOI 10.1099/mic.0.029132-0; Haenuki Y, 2012, J ALLERGY CLIN IMMUN, V130, P184, DOI 10.1016/j.jaci.2012.02.013; Hashimoto M, 2004, INT IMMUNOL, V16, P1431, DOI 10.1093/intimm/dxh146; Holzhausen M, 2010, J DENT RES, V89, P948, DOI 10.1177/0022034510373765; Hudson CA, 2008, J LEUKOCYTE BIOL, V84, P631, DOI 10.1189/jlb.1207830; Jagels MA, 1996, INFECT IMMUN, V64, P1984, DOI 10.1128/IAI.64.6.1984-1991.1996; Jones LA, 2010, EUR J IMMUNOL, V40, P426, DOI 10.1002/eji.200939705; Kakkar R, 2012, J BIOL CHEM, V287, P6941, DOI 10.1074/jbc.M111.298703; Kato T, 2007, FEMS MICROBIOL LETT, V273, P96, DOI 10.1111/j.1574-6968.2007.00779.x; Kim HY, 2012, J ALLERGY CLIN IMMUN, V129, P216, DOI 10.1016/j.jaci.2011.10.036; Kouzaki H, 2013, AM J RESP CELL MOL, V49, P741, DOI 10.1165/rcmb.2012-0304OC; Kouzaki H, 2011, J IMMUNOL, V186, P4375, DOI 10.4049/jimmunol.1003020; Kouzaki H, 2009, J IMMUNOL, V183, P1427, DOI 10.4049/jimmunol.0900904; LAMONT RJ, 1995, INFECT IMMUN, V63, P3878, DOI 10.1128/IAI.63.10.3878-3885.1995; Le H, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00104; Lourbakos A, 2001, INFECT IMMUN, V69, P5121, DOI 10.1128/IAI.69.8.5121-5130.2001; Luthi AU, 2009, IMMUNITY, V31, P84, DOI 10.1016/j.immuni.2009.05.007; Macfarlane SR, 2005, BRIT J PHARMACOL, V145, P535, DOI 10.1038/sj.bjp.0706204; Makimura Y, 2006, CLIN EXP IMMUNOL, V146, P159, DOI 10.1111/j.1365-2249.2006.03182.x; Malcolm J, 2015, J DENT RES, V94, P968, DOI 10.1177/0022034515577815; Meephansan J, 2012, J INVEST DERMATOL, V132, P2593, DOI 10.1038/jid.2012.185; Mikolajczyk-Pawlinska J, 1998, FEBS LETT, V440, P282, DOI 10.1016/S0014-5793(98)01461-6; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Moussion C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003331; Nakayama K, 1996, J BACTERIOL, V178, P2818, DOI 10.1128/jb.178.10.2818-2824.1996; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Nile CJ, 2010, IMMUNOLOGY, V130, P172, DOI 10.1111/j.1365-2567.2009.03221.x; Oboki Keisuke, 2010, Allergology International, V59, P143, DOI 10.2332/allergolint.10-RAI-0186; OGAWA T, 1989, INFECT IMMUN, V57, P3466, DOI 10.1128/IAI.57.11.3466-3471.1989; Ogawa T, 2002, EUR J IMMUNOL, V32, P2543, DOI 10.1002/1521-4141(200209)32:9<2543::AID-IMMU2543>3.0.CO;2-2; Papathanasiou E, 2014, J PERIODONTAL RES, V49, P55, DOI 10.1111/jre.12078; Pathirana RD, 2010, PERIODONTOL 2000, V52, P218, DOI 10.1111/j.1600-0757.2009.00330.x; Paul WE, 2010, NAT REV IMMUNOL, V10, P225, DOI 10.1038/nri2735; Peyret-Lacombe A, 2009, CYTOKINE, V46, P201, DOI 10.1016/j.cyto.2009.01.006; Pike RN, 1996, J BACTERIOL, V178, P2876, DOI 10.1128/jb.178.10.2876-2882.1996; Potempa J, 2003, CURR PROTEIN PEPT SC, V4, P397, DOI 10.2174/1389203033487036; Prefontaine D, 2009, J IMMUNOL, V183, P5094, DOI 10.4049/jimmunol.0802387; Price AE, 2010, P NATL ACAD SCI USA, V107, P11489, DOI 10.1073/pnas.1003988107; Ricks TK, 2009, J BIOL CHEM, V284, P34444, DOI 10.1074/jbc.M109.048942; Rothmeier AS, 2012, SEMIN IMMUNOPATHOL, V34, P133, DOI 10.1007/s00281-011-0289-1; Saenz SA, 2008, IMMUNOL REV, V226, P172, DOI 10.1111/j.1600-065X.2008.00713.x; Schiering C, 2014, NATURE, V513, P564, DOI 10.1038/nature13577; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Seatter MJ, 2004, CELL SIGNAL, V16, P21, DOI 10.1016/S0898-6568(03)00095-0; Shi Y, 1999, J BIOL CHEM, V274, P17955, DOI 10.1074/jbc.274.25.17955; Shimosato T, 2010, BIOCHEM BIOPH RES CO, V394, P81, DOI 10.1016/j.bbrc.2010.02.110; Snelgrove RJ, 2014, J ALLERGY CLIN IMMUN, V134, P583, DOI 10.1016/j.jaci.2014.02.002; Stathopoulou PG, 2009, ORAL MICROBIOL IMMUN, V24, P11, DOI 10.1111/j.1399-302X.2008.00467.x; Tada H, 2015, INTERFACE ORAL HEALT, P293; Watanabe K, 2001, INFECT IMMUN, V69, P6731, DOI 10.1128/IAI.69.11.6731-6737.2001; Yasuda K, 2012, P NATL ACAD SCI USA, V109, P3451, DOI 10.1073/pnas.1201042109; Yilmaz O, 2006, INFECT IMMUN, V74, P703, DOI 10.1128/IAI.74.1.703-710.2006	75	24	26	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2016	11	4							e0152794	10.1371/journal.pone.0152794	http://dx.doi.org/10.1371/journal.pone.0152794			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6JK	27058037	Green Submitted, gold, Green Published			2022-12-27	WOS:000373604800012
J	Niu, C; Chauhan, U; Gargus, M; Shaker, A				Niu, Chao; Chauhan, Uday; Gargus, Matthew; Shaker, Anisa			Generation and Characterization of an Immortalized Human Esophageal Myofibroblast Line	PLOS ONE			English	Article							CELLS; TELOMERASE	Stromal cells with a myofibroblast phenotype present in the normal human esophagus are increased in individuals with gastro-esophageal reflux disease (GERD). We have previously demonstrated that myofibroblasts stimulated with acid and TLR4 agonists increase IL-6 and IL-8 secretion using primary cultures of myofibroblasts established from normal human esophagus. While primary cultures have the advantage of reflecting the in vivo environment, a short life span and unavoidable heterogeneity limits the usefulness of this model in larger scale in vitro cellular signaling studies. The major aim of this paper therefore was to generate a human esophageal myofibroblast line with an extended lifespan. In the work presented here we have generated and characterized an immortalized human esophageal myofibroblast line by transfection with a commercially available GFP-hTERT lentivirus. Immortalized human esophageal myofibroblasts demonstrate phenotypic, genotypic and functional similarity to primary cultures of esophageal myofibroblasts we have previously described. We found that immortalized esophageal myofibroblasts retain myofibroblast spindle-shaped morphology at low and high confluence beyond passage 80, and express alpha-SMA, vimentin, and CD90 myofibroblast markers. Immortalized human esophageal myofibroblasts also express the putative acid receptor TRPV1 and TLR4 and retain the functional capacity to respond to stimuli encountered in GERD with secretion of IL-6. Finally, immortalized human esophageal myofibroblasts also support the stratified growth of squamous esophageal epithelial cells in 3D organotypic cultures. This newly characterized immortalized human esophageal myofibroblast cell line can be used in future cellular signaling and co-culture studies.	[Niu, Chao; Chauhan, Uday; Gargus, Matthew; Shaker, Anisa] USC, Keck Sch Med, Dept Med, Div Gastroenterol & Hepatol, Los Angeles, CA USA	University of Southern California; University of Southern California Keck Hospital	Shaker, A (corresponding author), USC, Keck Sch Med, Dept Med, Div Gastroenterol & Hepatol, Los Angeles, CA USA.	ashaker@usc.edu			National Cancer Institute [KO8CA153036, R03CA198692]; USC Research Center for Liver Diseases (NIH grant) [P30 DK048522]; NATIONAL CANCER INSTITUTE [R03CA198692, K08CA153036] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK048522] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); USC Research Center for Liver Diseases (NIH grant)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by National Cancer Institute KO8CA153036 (AS), National Cancer Institute R03CA198692 (AS); histology services were provided by the Liver Histology Core and RT-PCT, ELISA were performed at the Analytical-Metabolic-Instrumentation Core, both of the USC Research Center for Liver Diseases (NIH grant No. P30 DK048522).	Gargus M, 2015, AM J PHYSIOL-GASTR L, V308, pG904, DOI 10.1152/ajpgi.00333.2014; Kalabis J, 2012, NAT PROTOC, V7, P235, DOI 10.1038/nprot.2011.437; Karst AM, 2011, P NATL ACAD SCI USA, V108, P7547, DOI 10.1073/pnas.1017300108; Morales CP, 1999, NAT GENET, V21, P115, DOI 10.1038/5063; Nisato RE, 2004, AM J PATHOL, V165, P11, DOI 10.1016/S0002-9440(10)63271-3; Orlando Roy C., 2000, American Journal of Medicine, V108, p104S; Powell DW, 1999, AM J PHYSIOL-CELL PH, V277, pC183, DOI 10.1152/ajpcell.1999.277.2.C183; Powell DW, 1999, AM J PHYSIOL-CELL PH, V277, pC1, DOI 10.1152/ajpcell.1999.277.1.C1; Shaker A, 2013, AM J PHYSIOL-GASTR L, V304, pG662, DOI 10.1152/ajpgi.00225.2012; Yang LY, 2009, GASTROENTEROLOGY, V137, P588, DOI 10.1053/j.gastro.2009.04.046	10	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153185	10.1371/journal.pone.0153185	http://dx.doi.org/10.1371/journal.pone.0153185			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27055018	Green Published, gold			2022-12-27	WOS:000373608000095
J	Ricotti, V; Spinty, S; Roper, H; Hughes, I; Tejura, B; Robinson, N; Layton, G; Davies, K; Muntoni, F; Tinsley, J				Ricotti, Valeria; Spinty, Stefan; Roper, Helen; Hughes, Imelda; Tejura, Bina; Robinson, Neil; Layton, Gary; Davies, Kay; Muntoni, Francesco; Tinsley, Jonathon			Safety, Tolerability, and Pharmacokinetics of SMT C1100, a 2-Arylbenzoxazole Utrophin Modulator, following Single-and Multiple-Dose Administration to Pediatric Patients with Duchenne Muscular Dystrophy	PLOS ONE			English	Article							MDX MICE; EXPRESSION	Purpose SMT C1100 is a utrophin modulator being evaluated as a treatment for Duchenne muscular dystrophy (DMD). This study, the first in pediatric DMD patients, reports the safety, tolerability and PK parameters of single and multiple doses of SMT C1100, as well as analyze potential biomarkers of muscle damage. Methods This multicenter, Phase 1 study enrolled 12 patients, divided equally into three groups (A-C). Group A were given 50 mg/kg on Days 1 and 11, and 50 mg/kg bid on Days 2 to 10. Group B and C received 100 mg/kg on Days 1 and 11; Group B and Group C were given 100 mg/kg bid and 100 mg/kg tid, respectively, on Days 2 to 10. A safety review was performed on all patients following the single dose and there was at least 2 weeks between each dose escalation, for safety and PK review. Adverse events (AEs) were monitored throughout the study. Results Most patients experienced mild AEs and there were no serious AEs. Two patients required analgesia for pain (headache, ear pain and toothache). One patient experienced moderate psychiatric AEs (abnormal behaviour and mood swings). Plasma concentrations of SMT C1100 at Days 1 and 11 indicated a high degree of patient variability regardless of dose. Unexpectedly the SMT C1100 levels were significantly lower than similar doses administered to healthy volunteers in an earlier clinical study. In general, individual baseline changes of creatine phosphokinase, alanine aminotransferase, aspartate aminotransferase levels fell with SMT C1100 dosing. Conclusions SMT C1100 was well tolerated in pediatric DMD patients.	[Ricotti, Valeria; Muntoni, Francesco] UCL Inst Child Hlth, Dubowitz Neuromuscular Ctr, London, England; [Spinty, Stefan] Alder Hey Childrens NHS Fdn Trust, Liverpool, Merseyside, England; [Roper, Helen] Heart England NHS Fdn Trust, Birmingham Heartlands Hosp, Birmingham B9 5ST, W Midlands, England; [Hughes, Imelda] Cent Manchester Univ Hosp NHS Fdn Trust, Royal Manchester Childrens Hosp, Manchester, Lancs, England; [Tejura, Bina; Tinsley, Jonathon] Summit Therapeut, Abingdon, Oxon, England; [Robinson, Neil] SHB Enterprises Ltd, Beaconsfield, England; [Layton, Gary] ParamStat Ltd, Ash, England; [Davies, Kay] Univ Oxford, Dept Physiol Anat & Genet, MRC Funct Genom Unit, Oxford OX1 2JD, England	University of London; University College London; Alder Hey Children's NHS Foundation Trust; Heart of England NHS Foundation Trust; University of Birmingham; Royal Manchester Children's Hospital; University of Manchester; University of Oxford	Tinsley, J (corresponding author), Summit Therapeut, Abingdon, Oxon, England.	jon.tinsley@summitplc.com			Summit Therapeutics; SHB Enterprises Limited; ParamStat Limited; MRC Centre Grant; Muscular Dystrophy Campaign Centre Grant; Great Ormond Street Hospital Biomedical Research Centre; MRC [MR/N010698/1, MC_UU_12021/2, G0801763] Funding Source: UKRI; Medical Research Council [G0801763, MC_UU_12021/2, MR/N010698/1] Funding Source: researchfish	Summit Therapeutics; SHB Enterprises Limited; ParamStat Limited; MRC Centre Grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Muscular Dystrophy Campaign Centre Grant(Muscular Dystrophy Association); Great Ormond Street Hospital Biomedical Research Centre; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was funded by Summit Therapeutics. Authors Bina Tejura and Jonathon Tinsley are employed by Summit Therapeutics. The funder, Summit Therapeutics provided support in the form of salaries for authors BTand JT, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Author Neil Robinson is employed by SHB Enterprises Limited. Author Gary Layton is employed by ParamStat Limited. SHB Enterprises Limited and ParamStat Limited provided support in the form of salaries for authors NR and GL respectively, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; FM wishes to thank the support of the MRC Centre Grant and of the Muscular Dystrophy Campaign Centre Grant. The support of the Great Ormond Street Hospital Biomedical Research Centre is also gratefully acknowledged. We thank Medscimedia Ltd for editorial support.	Chakkalakal JV, 2003, P NATL ACAD SCI USA, V100, P7791, DOI 10.1073/pnas.0932671100; Chancellor DR, 2011, J MED CHEM, V54, P3241, DOI 10.1021/jm200135z; Dennis CL, 1996, NUCLEIC ACIDS RES, V24, P1646, DOI 10.1093/nar/24.9.1646; Emery A E, 1991, Neuromuscul Disord, V1, P19, DOI 10.1016/0960-8966(91)90039-U; Finkel RS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081302; Rasic MV, 2014, BALK J MED GENET, V17, P25, DOI 10.2478/bjmg-2014-0071; Ricotti V, 2016, DEV MED CHILD NEUROL, V58, P77, DOI 10.1111/dmcn.12922; Squire S, 2002, HUM MOL GENET, V11, P3333, DOI 10.1093/hmg/11.26.3333; TANAKA K, 1983, BRAIN DEV-JPN, V5, P511, DOI 10.1016/S0387-7604(83)80085-0; Tinsley J, 1998, NAT MED, V4, P1441, DOI 10.1038/4033; Tinsley J, 2015, J CLIN PHARMACOL, V55, P698, DOI 10.1002/jcph.468; Tinsley JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019189; van Deutekom JCT, 2003, NAT REV GENET, V4, P774, DOI 10.1038/nrg1180; Voit T, 2014, LANCET NEUROL, V13, P987, DOI 10.1016/S1474-4422(14)70195-4	14	37	40	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0152840	10.1371/journal.pone.0152840	http://dx.doi.org/10.1371/journal.pone.0152840			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27055247	Green Published, Green Submitted, gold			2022-12-27	WOS:000373608000049
J	Valenciano, A; Baskin, JA; Abella, J; Perez-Ramos, A; Alvarez-Sierra, MA; Morales, J; Hartstone-Rose, A				Valenciano, Alberto; Baskin, Jon A.; Abella, Juan; Perez-Ramos, Alejandro; Angeles Alvarez-Sierra, M.; Morales, Jorge; Hartstone-Rose, Adam			Megalictis, the Bone-Crushing Giant Mustelid (Carnivora, Mustelidae, Oligobuninae) from the Early Miocene of North America	PLOS ONE			English	Article							BIOGEOGRAPHIC HISTORY; MAMMALIA; EVOLUTION; RECONSTRUCTION; PHYLOGENY; RADIATION; PLIOCENE; ORIGIN	We describe cranial and mandibular remains of three undescribed individuals of the giant mustelid Megalictis ferox Matthew, 1907 from the latest Arikareean (Ar4), Early Miocene mammal fauna of Nebraska, and Wyoming (USA) housed at the American Museum of Natural History (New York, USA). Our phylogenetic hypothesis indicates that Ar4 specimens assigned to M. ferox constitute a monophyletic group. We assign three additional species previously referred to Paroligobunis to Megalictis: M. simplicidens, M. frazieri, and "M." petersoni. The node containing these four species of Megalictis and Oligobunis forms the Oligobuninae. We test the hypothesis that Oligobuninae (Megalictis and Oligobunis) is a stem mustelid taxon. Our results indicate that the Oligobuninae form the sister clade to the crown extant mustelids. Based on the cranium, M. ferox is a jaguar-size mustelid and the largest terrestrial mustelid known to have existed. This new material also sheds light on a new ecomorphological interpretation of M. ferox as a bone-crushing durophage (similar to hyenas), rather than a cat-like hypercarnivore, as had been previously described. The relative large size of M. ferox, together with a stout rostrum and mandible made it one of the more powerful predators of the Early Miocene of the Great Plains of North America.	[Valenciano, Alberto; Angeles Alvarez-Sierra, M.] UCM, CSIC, Inst Geociencias, Dept Geol Sedimentaria & Cambio Medioambiental, Madrid, Spain; [Valenciano, Alberto; Angeles Alvarez-Sierra, M.] UCM, Fac Ciencias Geol, Dept Paleontol, Madrid, Spain; [Baskin, Jon A.] Texas A&M Univ, Dept Biol & Hlth Sci, Kingsville, TX USA; [Abella, Juan] Univ Estatal Peninsula Santa Elena, La Libertad, Santa Elena, Ecuador; [Abella, Juan] Univ Autonoma Barcelona, Inst Catala Paleontol Miquel Crusafont, Edif ICP,Campus UAB, E-08193 Barcelona, Spain; [Perez-Ramos, Alejandro] Univ Malaga, Fac Ciencias, Dept Ecol & Geol, E-29071 Malaga, Spain; [Morales, Jorge] CSIC, Museo Nacl Ciencias Nat, Dept Paleobiol, E-28006 Madrid, Spain; [Hartstone-Rose, Adam] Univ S Carolina, Sch Med, Dept Cell Biol & Anat, Columbia, SC USA; [Hartstone-Rose, Adam] Univ S Carolina, Dept Anthropol, Columbia, SC 29208 USA	Complutense University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UCM - Instituto de Geociencias (IGEO); Complutense University of Madrid; Texas A&M University System; Texas A&M University Kingsville; Autonomous University of Barcelona; Institut Catala de Paleontologia Miquel Crusafont (ICP); Universidad de Malaga; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Hartstone-Rose, A (corresponding author), Univ S Carolina, Sch Med, Dept Cell Biol & Anat, Columbia, SC USA.; Hartstone-Rose, A (corresponding author), Univ S Carolina, Dept Anthropol, Columbia, SC 29208 USA.	AdamHR@sc.edu	Vaquero, Alberto Valenciano/N-8757-2019; Morales, Jorge/L-1476-2014; Hartstone-Rose, Adam/AAU-3332-2020; Abella, Juan/AAB-1040-2020; Hartstone-Rose, Adam/I-3503-2016	Vaquero, Alberto Valenciano/0000-0003-1633-2248; Morales, Jorge/0000-0001-5170-5754; Abella, Juan/0000-0002-3433-6093; Hartstone-Rose, Adam/0000-0001-5307-5573; ALVAREZ SIERRA, MARIA DE LOS ANGELES/0000-0002-2649-5887; Perez-Ramos, Alejandro/0000-0003-1417-4338	European Union's Seventh Framework Programme (SYNTHESYS) [226506, SE-TAF-3637]; USC School of Medicine (Columbia, South Carolina, USA); AMNH (Collection Study Grant Program); International Travel Grant 2015 from Vertebrate Paleontology department of FLMNH from UF; CSIC program (CSIC program "Junta para la ampliacion de estudios") [JAE-PRE_CP2011]; European Social Fund; FPI fellowship [BES-2013-065469, CGL2012-37866]; Spanish Ministerio de Economia y Competitividad [CGL2015-68333, CGL2011-28877, CGL2011-28681]; University of South Carolina School of Medicine (Columbia, South Carolina, USA);  [BSCH-UCM 910607]	European Union's Seventh Framework Programme (SYNTHESYS); USC School of Medicine (Columbia, South Carolina, USA); AMNH (Collection Study Grant Program); International Travel Grant 2015 from Vertebrate Paleontology department of FLMNH from UF; CSIC program (CSIC program "Junta para la ampliacion de estudios"); European Social Fund(European Social Fund (ESF)); FPI fellowship(Spanish Government); Spanish Ministerio de Economia y Competitividad(Spanish Government); University of South Carolina School of Medicine (Columbia, South Carolina, USA); 	A.V. has received funding from the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement no 226506 (SYNTHESYS; SE-TAF-3637), the USC School of Medicine (Columbia, South Carolina, USA), the AMNH (Collection Study Grant Program 2014) and the International Travel Grant 2015 from the Vertebrate Paleontology department of FLMNH from UF. A.V. is researcher in formation in the CSIC program JAE-PRE_CP2011 (CSIC program "Junta para la ampliacion de estudios"), co-funded by the European Social Fund. A.P.R. is a pre-doctoral FPI fellowship (BES-2013-065469) of the project CGL2012-37866. This study was also supported by the Spanish Ministerio de Economia y Competitividad (research project CGL2015-68333, CGL2011-28877 and CGL2011-28681), the research group BSCH-UCM 910607 and University of South Carolina School of Medicine (Columbia, South Carolina, USA).; We are indebted to J. Flynn, J. Meng and R. O'leary (AMNH) for access to the unpublished material of Megalictis ferox housed in the department of Vertebrate Paleontology at the AMNH. A.V. wants thank to the Collection Study Grant Program 2014 of AMNH and the International Travel Grant Vertebrate Paleontology Program 2015 FLMNH of UF that gave him the opportunity to study its extant and extinct carnivoran collections. We would also like to thank E. Westwig, J. Meng, R. O'Leary, J. Galkin, and the late R. Tedford of the AMNH, D. Kalthoff of the NRM, D. Lunde of the USNM, R. Hulbert Jr of the FLMNH and E. Lopez Errasquin and P. Perez Dios of the MNCN for access to comparative material under their care. We are grateful to L. Werdelin (NRM) for kindly allowing us to study the cast of the skull and mandibles of Ekorus ekakeran; G. Koufos (LGPUT) for providing us the measurements of Plesiogulo crassa from Perivolaki; K. Wellspring (ACM) and the Beneski Museum of Natural History at Amherst College, R. Hulbert JR (FLMNH) and the Florida Museum of Natural History, A.C. Henrici (CM) and the Carnegie Museum of Natural History for graciously sending us photographs of "Megalictis" petersoni, Megalictis frazieri and Megalictis simplicidens and the genotype of Aelurocyon brevifacies respectively. We thanks D. DeMiguel (ICP) his recommendations on the manuscript. A.V. is researcher in formation in the CSIC program JAE-PRE_CP2011 (CSIC program " Junta para la ampliacion de estudios"), co-funded by the European Social Fund. A.P.R. is a pre-doctoral FPI fellowship (BES-2013-065469) of the project CGL2012-37866. J.A. thanks the "Proyecto Prometeo" of the "Secretaria de Educacion Superior, Ciencia Tecnologia e Innovacion", Republic of Ecuador. We thank the editor Brian Lee Beatty and the reviewers Mieczyslaw Wolsan and two anonymous reviewers for their useful comments and suggestions, which greatly improved the original manuscript.	Albright LB, 2008, J GEOL, V116, P211, DOI 10.1086/587650; [Anonymous], 1981, SMITHSON CONTRIB PAL; [Anonymous], 1821, ANAL NATURAL CLASSIF; Barone R., 2000, ANATOMIE COMP MAMMIF, V2; Barone R., 1999, ANATOMIE COMP MAMMIF, V1; Baskin Jon A., 1998, P152, DOI 10.1017/CBO9780511529924.011; Cope ED, 1890, AM NAT, V24, P950; Cope ED, 1879, P ACAD NAT SCI PHILA, V31, P168; Elbroch M., 2006, ANIMAL SKULLS GUIDE; Evans H.E., 2010, MILLERS GUIDE DISSEC, VFourth; Evans H.E., 2013, MILLERS ANATOMY DOG; Ewer R.F., 1998, CARNIVORES; Finarelli JA, 2006, SYST BIOL, V55, P301, DOI 10.1080/10635150500541698; Finarelli J, 2008, J MAMM EVOL, V15, P231, DOI 10.1007/s10914-008-9074-x; Fisher G., 1817, MEM SOC IMP NATURALI, V5, P368; Frailey D, 1978, OCCASIONAL PAPERS MU, V75, P1; Geoffroy Saint-Hilaire ûÙ., 1833, REV ENCY, V59, P76; Geraads D, 2011, J VERTEBR PALEONTOL, V31, P447, DOI 10.1080/02724634.2011.550356; Ginsburg Leonard, 1999, P109; Hartstone-Rose A, 2011, J ZOOL, V285, P119, DOI 10.1111/j.1469-7998.2011.00821.x; Hartstone-Rose A, 2012, ANAT REC, V295, P1336, DOI 10.1002/ar.22518; Hartstone-Rose A, 2008, CR PALEVOL, V7, P629, DOI 10.1016/j.crpv.2008.09.015; HENDEY Q B, 1978, Annals of the South African Museum, V76, P329; Holliday JA, 2004, PALEOBIOLOGY, V30, P108, DOI 10.1666/0094-8373(2004)030<0108:EOHTEO>2.0.CO;2; Hunt Jr RM, 1996, U WYOMING CONTRIB GE, V31, P35; Hunt RM, 2002, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2002)385<0001:NACMDF>2.0.CO;2; Kirpichnikov AA, 1955, VOPROSY GEOLOGII AZI, V2, P810; Koepfli KP, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-10; Koufos GD, 2006, PALAEONTOGR ABT A, V276, P39; Kretzoi M., 1943, FOLDTANY KOZLONY, V52, P10; Lariviere S, 2009, HDB MAMMALS WORLD, V1, P564; Li B, 2014, MOL PHYLOGENET EVOL, V80, P156, DOI 10.1016/j.ympev.2014.08.002; Loomis FB, 1932, AM J SCI, V24, P316; Martin JE, 2011, P S DAK ACAD SCI, V90, P37; Matthew WD, 1907, B AM MUS NAT HIST, V23, P169; Orlov YU, 1948, ACTA ZOOLOGICA, V29, P63; Orlov YU, 1933, T PALEONT I AKAD NAU, V2, P165; Ozansoy F, 1965, MEMOIRES SOC GEOLOGI, V44, P1; Peigne S, 2006, J VERTEBR PALEONTOL, V26, P788, DOI 10.1671/0272-4634(2006)26[788:ANMOTM]2.0.CO;2; Peterson O.A., 1907, ANN CARNEGIE MUS, V4, P21; Peterson O A, 1909, MEM CARNEGIE MUS, V4, P41; Peterson OA, 1910, ANN CARNEGIE MUS, V4, P205; Pomel A., 1846, B SOC GEOLOGIQUE FRA, V3, P353; RADINSKY LB, 1982, PALEOBIOLOGY, V8, P177, DOI 10.1017/S0094837300006928; Riggs ES, 1945, PUBL FIELD MUS NAT H, V9, P69; Riggs ES, 1942, FIELD MUS NAT HIST G, V7, P59; Rybczynski N, 2009, NATURE, V458, P1021, DOI 10.1038/nature07985; Sato JJ, 2012, MOL PHYLOGENET EVOL, V63, P745, DOI 10.1016/j.ympev.2012.02.025; Sato JJ, 2009, MOL PHYLOGENET EVOL, V53, P907, DOI 10.1016/j.ympev.2009.08.019; SAVAGE R. J. G., 1957, PROC ZOOL SOC LONDON, V129, P151; Scapino RP, 1968, THESIS U ILLINOIS; Schultz CB, 1938, AM J SCI, V35, P441; Smith JB, 2003, J VERTEBR PALEONTOL, V23, P1, DOI 10.1671/0272-4634(2003)23[1:APFAST]2.0.CO;2; Swofford DL, 2002, PAUP PHYLOGENETIC AN; TEDFORD RH, 1976, SYST ZOOL, V25, P363, DOI 10.2307/2412511; Tedford Richard H., 2004, P169; Teilhard de Chardin P., 1945, I GEOBIOL PEKING, V12, P1; TURNBULL WD, 1970, FIELDIANA GEOLOGY, V18, P149; Valenciano A, 2015, J VERTEBR PALEONTOL, V35, DOI 10.1080/02724634.2014.934570; Van Valkenburgh B, 2007, INTEGR COMP BIOL, V47, P147, DOI 10.1093/icb/icm016; Viret J., 1939, Travaux du Laboratoire de Geologie Lyon, V37, P1; Waibl H., 2005, NOMINA ANATOMICA VET; Wang X, 2008, DOG FAMILY CANIDAE T; Wang XM, 2005, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2005)483[0001:AAAACF]2.0.CO;2; WERDELIN L, 1996, CARNIVORE BEHAV ECOL, V2, P582; Werdelin Lars, 2003, P261; Willemsen GF, 1992, SCRIPTA GEOL, V101, P1; Wolsan M, 2005, PLEN S 9 INT MAMM C, P372; Wolsan M, 2013, ZOOL J LINN SOC-LOND, V167, P208, DOI 10.1111/j.1096-3642.2012.00868.x; Wolsan M, 2010, CLADISTICS, V26, P168, DOI 10.1111/j.1096-0031.2009.00281.x	70	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0152430	10.1371/journal.pone.0152430	http://dx.doi.org/10.1371/journal.pone.0152430			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27054570	Green Published, gold, Green Accepted			2022-12-27	WOS:000373608000020
J	Caron, MMJ; Emans, PJ; Sanen, K; Surtel, DAM; Cremers, A; Ophelders, D; van Rhijn, LW; Welting, TJM				Caron, Marjolein M. J.; Emans, Pieter J.; Sanen, Kathleen; Surtel, Don A. M.; Cremers, Andy; Ophelders, Daan; van Rhijn, Lodewijk W.; Welting, Tim J. M.			The Role of Prostaglandins and COX-Enzymes in Chondrogenic Differentiation of ATDC5 Progenitor Cells	PLOS ONE			English	Article							HUMAN ARTICULAR CHONDROCYTES; IN-VITRO; CARTILAGE; LINE; E-2; PHOSPHORYLATION; CYCLOOXYGENASES; INHIBITION; RECEPTORS; PROTEINS	Objectives NSAIDs are used to relieve pain and decrease inflammation by inhibition of cyclooxygenase (COX)-catalyzed prostaglandin (PG) synthesis. PGs are fatty acid mediators involved in cartilage homeostasis, however the action of their synthesizing COX-enzymes in cartilage differentiation is not well understood. In this study we hypothesized that COX-1 and COX-2 have differential roles in chondrogenic differentiation. Methods ATDC5 cells were differentiated in the presence of COX-1 (SC-560, Mofezolac) or COX-2 (NS398, Celecoxib) specific inhibitors. Specificity of the NSAIDs and inhibition of specific prostaglandin levels were determined by EIA. Prostaglandins were added during the differentiation process. Chondrogenic outcome was determined by gene-and protein expression analyses. Results Inhibition of COX-1 prevented Col2a1 and Col10a1 expression. Inhibition of COX-2 resulted in decreased Col10a1 expression, while Col2a1 remained unaffected. To explain this difference expression patterns of both COX-enzymes as well as specific prostaglandin concentrations were determined. Both COX-enzymes are upregulated during late chondrogenic differentiation, whereas only COX-2 is briefly expressed also early in differentiation. PGD2 and PGE2 followed the COX-2 expression pattern, whereas PGF2a and TXA2 levels remained low. Furthermore, COX inhibition resulted in decreased levels of all tested PGs, except for PGD2 and PGF2a in the COX-1 inhibited condition. Addition of PGE2 and PGF2a resulted in increased expression of chondrogenic markers, whereas TXA2 increased expression of hypertrophic markers. Conclusions Our findings point towards a differential role for COX-enzymes and PG-production in chondrogenic differentiation of ATDC5 cells. Ongoing research is focusing on further elucidating the functional partition of cyclooxygenases and specific prostaglandin production.	[Caron, Marjolein M. J.; Emans, Pieter J.; Sanen, Kathleen; Surtel, Don A. M.; Cremers, Andy; Ophelders, Daan; van Rhijn, Lodewijk W.; Welting, Tim J. M.] Maastricht Univ, Med Ctr, Caphri Sch Publ Hlth & Primary Care, Dept Orthopaed Surg, NL-6200 MD Maastricht, Netherlands	Maastricht University	Caron, MMJ (corresponding author), Maastricht Univ, Med Ctr, Caphri Sch Publ Hlth & Primary Care, Dept Orthopaed Surg, NL-6200 MD Maastricht, Netherlands.	marjolein.caron@maastrichtuniversity.nl		Ophelders, Daan/0000-0001-7410-5102	Dutch Arthritis Association [LLP14]; Dutch Stichting Annafonds\NOREF [07/07, 08/42]; ReumaFonds [LLP-14] Funding Source: researchfish	Dutch Arthritis Association; Dutch Stichting Annafonds\NOREF; ReumaFonds	This work was financially supported by the Dutch Arthritis Association (grant LLP14) and the Dutch Stichting Annafonds vertical bar NOREF (grants 07/07 and 08/42). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATSUMI T, 1990, CELL DIFFER DEV, V30, P109, DOI 10.1016/0922-3371(90)90079-C; Brochhausen C, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1948; Caron MMJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033467; Chandrasekharan NV, 2002, P NATL ACAD SCI USA, V99, P13926, DOI 10.1073/pnas.162468699; Chen L, 2005, DIFFERENTIATION, V73, P350, DOI 10.1111/j.1432-0436.2005.00038.x; Clark CA, 2009, J ORTHOP RES, V27, P785, DOI 10.1002/jor.20805; de Crombrugghe B, 2001, CURR OPIN CELL BIOL, V13, P721, DOI 10.1016/S0955-0674(00)00276-3; DiBattista JA, 1996, MOL CELL ENDOCRINOL, V123, P27, DOI 10.1016/0303-7207(96)03887-7; Goldring Mary B., 1996, Am J Ther, V3, P9, DOI 10.1097/00045391-199601000-00003; Gualde N, 2004, IMMUNOL CELL BIOL, V82, P353, DOI 10.1111/j.0818-9641.2004.01251.x; Itoh S, 2012, J BIOL CHEM, V287, P29227, DOI 10.1074/jbc.M112.372086; Jakob M, 2004, RHEUMATOLOGY, V43, P852, DOI 10.1093/rheumatology/keh197; Kis B, 2006, INFLAMM RES, V55, P274, DOI 10.1007/s00011-006-0083-z; Lefebvre Veronique, 2005, Birth Defects Research, V75, P200, DOI 10.1002/bdrc.20048; Lowe GN, 1996, ENDOCRINOLOGY, V137, P2208, DOI 10.1210/en.137.6.2208; Malki S, 2005, EMBO J, V24, P1798, DOI 10.1038/sj.emboj.7600660; Mastbergen SC, 2008, ANN RHEUM DIS, V67, P52, DOI 10.1136/ard.2006.065946; Mastbergen SC, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1846; Miyamoto M, 2003, OSTEOARTHR CARTILAGE, V11, P644, DOI 10.1016/S1063-4584(03)00118-3; MOHAMEDALI H, 1995, RHEUMATOL INT, V14, P191, DOI 10.1007/BF00262297; Morita I, 2002, PROSTAG OTH LIPID M, V68-9, P165, DOI 10.1016/S0090-6980(02)00029-1; NEEDLEMAN P, 1986, ANNU REV BIOCHEM, V55, P69, DOI 10.1146/annurev.biochem.55.1.69; SAMUELSSON B, 1978, ANNU REV BIOCHEM, V47, P997, DOI 10.1146/annurev.bi.47.070178.005025; Schwartz Z, 1998, ENDOCRINOLOGY, V139, P1825, DOI 10.1210/en.139.4.1825; Simmons DL, 2004, PHARMACOL REV, V56, P387, DOI 10.1124/pr.56.3.3; Tsatsanis C, 2006, INT J BIOCHEM CELL B, V38, P1654, DOI 10.1016/j.biocel.2006.03.021; VANDEROUDERAA FJ, 1977, BIOCHIM BIOPHYS ACTA, V487, P315, DOI 10.1016/0005-2760(77)90008-X; Vane JR, 1998, ANNU REV PHARMACOL, V38, P97, DOI 10.1146/annurev.pharmtox.38.1.97; Warner TD, 2002, P NATL ACAD SCI USA, V99, P13371, DOI 10.1073/pnas.222543099; Welting T J M, 2011, Eur Cell Mater, V22, P420; Yao YC, 2013, J CELL BIOCHEM, V114, P1223, DOI 10.1002/jcb.24467	31	13	14	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0153162	10.1371/journal.pone.0153162	http://dx.doi.org/10.1371/journal.pone.0153162			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050768	Green Submitted, gold, Green Published			2022-12-27	WOS:000373603500107
J	den Haan, MC; van Zuylen, VL; Pluijmert, NJ; Schutte, CI; Fibbe, WE; Schalij, MJ; Roelofs, H; Atsma, DE				den Haan, Melina C.; van Zuylen, Vanessa-Leigh; Pluijmert, Niek J.; Schutte, Cindy I.; Fibbe, Willem E.; Schalij, Martin J.; Roelofs, Helene; Atsma, Douwe E.			Discrepant Results of Experimental Human Mesenchymal Stromal Cell Therapy after Myocardial Infarction: Are Animal Models Robust Enough?	PLOS ONE			English	Article							STEM-CELLS; IN-VIVO; ISCHEMIC-HEART; TRANSPLANTATION; DIFFERENTIATION; EXPRESSION; INJECTION; DISEASE; REPAIR	Background Human mesenchymal stromal cells (MSCs) have been reported to preserve cardiac function in myocardial infarction (MI) models. Previously, we found a beneficial effect of intra-myocardial injection of unstimulated human MSCs (uMSCs) on cardiac function after permanent coronary artery ligation. In the present study we aimed to extend this research by investigating the effect of intramyocardial injection of human MSCs pre-stimulated with the pro-inflammatory cytokine interferon-gamma (iMSCs), since pro-inflammatory priming has shown additional salutary effects in multiple experimental disease models. Methods MI was induced in NOD/Scid mice by permanent ligation of the left anterior descending coronary artery. Animals received intramyocardial injection of uMSCs, iMSCs or PBS. Sham-operated animals were used to determine baseline characteristics. Cardiac performance was assessed after 2 and 14 days using 7-Tesla magnetic resonance imaging and pressure-volume loop measurements. Histology and q-PCR were used to confirm MSC engraftment in the heart. Results Both uMSC and iMSC therapy had no significant beneficial effect on cardiac function or remodelling in contrast to our previous studies. Conclusions Animal models for cardiac MSC therapy appear less robust than initially envisioned.	[den Haan, Melina C.; van Zuylen, Vanessa-Leigh; Pluijmert, Niek J.; Schutte, Cindy I.; Schalij, Martin J.; Atsma, Douwe E.] Leiden Univ, Med Ctr, Dept Cardiol, Leiden, Netherlands; [van Zuylen, Vanessa-Leigh; Fibbe, Willem E.; Roelofs, Helene] Leiden Univ, Dept Immunohematol & Blood Transfus, Med Ctr, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Atsma, DE (corresponding author), Leiden Univ, Med Ctr, Dept Cardiol, Leiden, Netherlands.	D.E.Atsma@lumc.nl	Pluijmert, Niek/ABE-5760-2020	Pluijmert, Niek/0000-0002-7251-5244	SmartCare project of the research program of the BioMedical Materials Program; Dutch Ministry of Economic Affairs; TeRM SmartMix Program of the Netherlands Ministry of Economic Affairs; Netherlands Ministry of Education, Culture and Science	SmartCare project of the research program of the BioMedical Materials Program; Dutch Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands); TeRM SmartMix Program of the Netherlands Ministry of Economic Affairs; Netherlands Ministry of Education, Culture and Science	This work was supported by the SmartCare project of the research program of the BioMedical Materials Program, co-funded by the Dutch Ministry of Economic Affairs. The authors gratefully acknowledge the support of the TeRM SmartMix Program of the Netherlands Ministry of Economic Affairs and the Netherlands Ministry of Education, Culture and Science.	Arminan A, 2010, J AM COLL CARDIOL, V55, P2244, DOI 10.1016/j.jacc.2009.08.092; Behfar A, 2010, J AM COLL CARDIOL, V56, P721, DOI 10.1016/j.jacc.2010.03.066; Bollache E, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-63; Carr CA, 2008, AM J PHYSIOL-HEART C, V295, pH533, DOI 10.1152/ajpheart.00094.2008; Croitoru-Lamoury J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014698; Danilouchkine MG, 2005, J CARDIOVASC MAGN R, V7, P447, DOI 10.1081/JCMR-200053578; DelaRosa O, 2009, TISSUE ENG PT A, V15, P2795, DOI [10.1089/ten.tea.2008.0630, 10.1089/ten.TEA.2008.0630]; den Haan MC, 2012, J CELL MOL MED, V16, P1508, DOI 10.1111/j.1582-4934.2011.01468.x; Deuse T, 2009, CIRCULATION, V120, pS247, DOI 10.1161/CIRCULATIONAHA.108.843680; Dixon JA, 2009, CIRCULATION, V120, pS220, DOI 10.1161/CIRCULATIONAHA.108.842302; Duijvestein M, 2011, STEM CELLS, V29, P1549, DOI 10.1002/stem.698; Flynn A, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt127; Francois M, 2012, J CELL PHYSIOL, V227, P3535, DOI 10.1002/jcp.24081; Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826; Grauss RW, 2008, STEM CELLS, V26, P1083, DOI 10.1634/stemcells.2007-0523; Grauss RW, 2007, AM J PHYSIOL-HEART C, V293, pH2438, DOI 10.1152/ajpheart.00365.2007; Hassan F, 2012, J PHARMACOL EXP THER, V343, P62, DOI 10.1124/jpet.112.196915; Hemeda H, 2010, STEM CELLS DEV, V19, P693, DOI 10.1089/scd.2009.0365; Huang XP, 2010, CIRCULATION, V122, P2419, DOI 10.1161/CIRCULATIONAHA.110.955971; Kinnaird T, 2004, CIRC RES, V94, P678, DOI 10.1161/01.RES.0000118601.37875.AC; Krause K, 2009, HEART, V95, P1145, DOI 10.1136/hrt.2008.155077; Leor J, 2007, HEART, V93, P1278, DOI 10.1136/hrt.2006.093161; Loffredo FS, 2011, CELL STEM CELL, V8, P389, DOI 10.1016/j.stem.2011.02.002; McBride C, 2003, CYTOTHERAPY, V5, P7, DOI 10.1080/14653240310000038; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Nelson TJ, 2009, CIRCULATION, V120, P408, DOI 10.1161/CIRCULATIONAHA.109.865154; Nygren JM, 2004, NAT MED, V10, P494, DOI 10.1038/nm1040; Polchert D, 2008, EUR J IMMUNOL, V38, P1745, DOI 10.1002/eji.200738129; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Schuleri KH, 2009, EUR HEART J, V30, P2722, DOI 10.1093/eurheartj/ehp265; Shake JG, 2002, ANN THORAC SURG, V73, P1919, DOI 10.1016/S0003-4975(02)03517-8; Silva GV, 2005, CIRCULATION, V111, P150, DOI 10.1161/01.CIR.0000151812.86142.45; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Taylor DA, 1998, NAT MED, V4, P929, DOI 10.1038/nm0898-929; Uemura R, 2006, CIRC RES, V98, P1414, DOI 10.1161/01.RES.0000225952.61196.39; van der Bogt KEA, 2008, CIRCULATION, V118, pS121, DOI 10.1161/CIRCULATIONAHA.107.759480; van der Bogt KEA, 2009, TRANSPLANTATION, V87, P642, DOI 10.1097/TP.0b013e31819609d9; van Ramshorst J, 2009, JAMA-J AM MED ASSOC, V301, P1997, DOI 10.1001/jama.2009.685; van Zuylen VL, 2015, CARDIOVASC DRUG THER, V29, P59, DOI 10.1007/s10557-014-6568-z; Williams AR, 2011, CIRC RES, V109, P923, DOI 10.1161/CIRCRESAHA.111.243147; Zuo S, 2012, STEM CELLS DEV, V21, P598, DOI 10.1089/scd.2011.0071	41	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0152938	10.1371/journal.pone.0152938	http://dx.doi.org/10.1371/journal.pone.0152938			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050443	Green Submitted, gold, Green Published			2022-12-27	WOS:000373603500070
J	Heidebrecht, CL; Podewils, LJ; Pym, A; Mthiyane, T; Cohen, T				Heidebrecht, Christine L.; Podewils, Laura J.; Pym, Alexander; Mthiyane, Thuli; Cohen, Ted			Assessing Local Risk of Rifampicin-Resistant Tuberculosis in KwaZulu-Natal, South Africa Using Lot Quality Assurance Sampling	PLOS ONE			English	Article							RAPID ASSESSMENT; APPLICABILITY; PREVALENCE	Background KwaZulu-Natal (KZN) has the highest burden of notified multidrug-resistant tuberculosis (MDR TB) and extensively drug-resistant (XDR) TB cases in South Africa. A better understanding of spatial heterogeneity in the risk of drug-resistancemay help to prioritize local responses. Methods Between July 2012 and June 2013, we conducted a two-way Lot Quality Assurance Sampling (LQAS) study to classify the burden of rifampicin (RIF)-resistant TB among incident TB cases notified within the catchment areas of seven laboratories in two northern and one southern district of KZN. Decision rules for classification of areas as having either a high-or low-risk of RIF resistant TB (based on proportion of RIF resistance among all TB cases) were based on consultation with local policy makers. Results We classified five areas as high-risk and two as low-risk. High-risk areas were identified in both Southern and Northern districts, with the greatest proportion of RIF resistance observed in the northernmost area, the Manguzi community situated on the Mozambique border. Conclusion Our study revealed heterogeneity in the risk of RIF resistant disease among incident TB cases in KZN. This study demonstrates the potential for LQAS to detect geographic heterogeneity in areas where access to drug susceptibility testing is limited.	[Heidebrecht, Christine L.] MRC, Clin & Biomed TB Res Unit, Durban, South Africa; [Podewils, Laura J.] Ctr Dis Control & Prevent, Div TB Eliminat, Atlanta, GA USA; [Pym, Alexander] KwaZulu Natal Res Inst TB & HIV, Durban, South Africa; [Mthiyane, Thuli] Univ KwaZulu Natal, Sch Lab Med & Med Sci, Durban, South Africa; [Cohen, Ted] Yale Univ, Sch Publ Hlth, Epidemiol Microbial Dis, New Haven, CT USA	Centers for Disease Control & Prevention - USA; University of Kwazulu Natal; Yale University	Cohen, T (corresponding author), Yale Univ, Sch Publ Hlth, Epidemiol Microbial Dis, New Haven, CT USA.	theodore.cohen@yale.edu		Pym, Alexander/0000-0002-6260-8180; Mthiyane, Thuli/0000-0002-1782-5485; Cohen, Ted/0000-0002-8091-7198	Centers for Disease Control and Prevention [5 U51 PS000729-05, PA PS07-006]; South African Medical Research Council [5 U51 PS000729-05, PA PS07-006]; National Institute of General Medical Sciences [NIH U54GM088558]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088558] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This evaluation was supported by a cooperative agreement between the Centers for Disease Control and Prevention and the South African Medical Research Council (Cooperative Agreement 5 U51 PS000729-05, PA PS07-006). TC was supported by NIH U54GM088558 from the National Institute of General Medical Sciences.	Biedron C, 2010, INT J EPIDEMIOL, V39, P72, DOI 10.1093/ije/dyp363; Brooker S, 2005, TROP MED INT HEALTH, V10, P647, DOI 10.1111/j.1365-3156.2005.01446.x; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Gandhi NR, 2013, J INFECT DIS, V207, P9, DOI 10.1093/infdis/jis631; Hedt BL, 2012, EPIDEMIOLOGY, V23, P293, DOI 10.1097/EDE.0b013e3182459455; Mushtaq MU, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-60; Myatt M, 2003, B WORLD HEALTH ORGAN, V81, P877; Olives C, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001806; Pezzoli L, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-415; Stevens W., 2012, 4 GLOB LAB IN PARTN; Vella V, 2011, INT J TUBERC LUNG D, V15, P1170, DOI 10.5588/ijtld.10.0781; Wallengren K, 2011, EMERG INFECT DIS, V17, P1913, DOI 10.3201/eid1710.100952; World Health Organization, 2015, WHOHTMTB201522; Zignol M, 2011, CLIN INFECT DIS, V52, P901, DOI 10.1093/cid/cir081	14	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0153143	10.1371/journal.pone.0153143	http://dx.doi.org/10.1371/journal.pone.0153143			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050561	Green Published, gold			2022-12-27	WOS:000373603500105
J	Barenholz, U; Keren, L; Segal, E; Milo, R				Barenholz, Uri; Keren, Leeat; Segal, Eran; Milo, Ron			A Minimalistic Resource Allocation Model to Explain Ubiquitous Increase in Protein Expression with Growth Rate	PLOS ONE			English	Article							ESCHERICHIA-COLI; GENE-EXPRESSION; BACTERIAL-GROWTH; YEAST; COORDINATION; TRANSLATION; CULTURE; LAWS	Most proteins show changes in level across growth conditions. Many of these changes seem to be coordinated with the specific growth rate rather than the growth environment or the protein function. Although cellular growth rates, gene expression levels and gene regulation have been at the center of biological research for decades, there are only a few models giving a base line prediction of the dependence of the proteome fraction occupied by a gene with the specific growth rate. We present a simple model that predicts a widely coordinated increase in the fraction of many proteins out of the proteome, proportionally with the growth rate. The model reveals how passive redistribution of resources, due to active regulation of only a few proteins, can have proteome wide effects that are quantitatively predictable. Our model provides a potential explanation for why and how such a coordinated response of a large fraction of the proteome to the specific growth rate arises under different environmental conditions. The simplicity of our model can also be useful by serving as a baseline null hypothesis in the search for active regulation. We exemplify the usage of the model by analyzing the relationship between growth rate and proteome composition for the model microorganism E. coli as reflected in recent proteomics data sets spanning various growth conditions. We find that the fraction out of the proteome of a large number of proteins, and from different cellular processes, increases proportionally with the growth rate. Notably, ribosomal proteins, which have been previously reported to increase in fraction with growth rate, are only a small part of this group of proteins. We suggest that, although the fractions of many proteins change with the growth rate, such changes may be partially driven by a global effect, not necessarily requiring specific cellular control mechanisms.	[Barenholz, Uri; Milo, Ron] Weizmann Inst Sci, Dept Plant & Environm Sci, IL-76100 Rehovot, Israel; [Keren, Leeat; Segal, Eran] Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science	Milo, R (corresponding author), Weizmann Inst Sci, Dept Plant & Environm Sci, IL-76100 Rehovot, Israel.	ron.milo@weizmann.ac.il	Segal, Eran/AAF-4855-2019	Keren, Leeat/0000-0002-6799-6303; Barenholz, Uri/0000-0002-3097-9681; Milo, Ron/0000-0003-1641-2299; Segal, Eran/0000-0002-6859-1164	European Research Council - NOVCARBFIX [646827]; Alternative sustainable Energy Research Initiative; Alternative Sustainable Energy Research PhD fellowships program	European Research Council - NOVCARBFIX; Alternative sustainable Energy Research Initiative; Alternative Sustainable Energy Research PhD fellowships program	This work was supported by European Research Council, 646827 - NOVCARBFIX, (https://erc.europa.eu/, RM) and Alternative sustainable Energy Research Initiative, Alternative Sustainable Energy Research PhD fellowships program (http://www.weizmann.ac.il/AERI/, UB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berthoumieux S, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2012.70; Bosdriesz E, 2015, FEBS J, V282, P2029, DOI 10.1111/febs.13258; Brauer MJ, 2008, MOL BIOL CELL, V19, P352, DOI 10.1091/mbc.E07-08-0779; Bremer H, 1996, ESCHERICHIA COLI SAL; Castrillo Juan I, 2007, J Biol, V6, P4, DOI 10.1186/jbiol54; Chatterji D, 2001, CURR OPIN MICROBIOL, V4, P160, DOI 10.1016/S1369-5274(00)00182-X; Christiano R, 2014, CELL REP, V9, P1959, DOI 10.1016/j.celrep.2014.10.065; Dennis PP, 2004, MICROBIOL MOL BIOL R, V68, P639, DOI 10.1128/MMBR.68.4.639-668.2004; European Council, 2011, OFFICIAL J EUROPEAN, VL 054, P0001; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gerosa L, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.14; Hui S, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20145697; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Ingraham J. L., 1983, GROWTH BACTERIAL CEL; Kaneko K, 2014, UNIVERSAL RELATIONSH, P7; Keren L, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.59; Klumpp S, 2014, CURR OPIN BIOTECH, V28, P96, DOI 10.1016/j.copbio.2014.01.001; Klumpp S, 2009, CELL, V139, P1366, DOI 10.1016/j.cell.2009.12.001; Klumpp S, 2008, P NATL ACAD SCI USA, V105, P20245, DOI 10.1073/pnas.0804953105; Li ZP, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-45; Maaloe O, 1969, DEVELOP BIOL       S, V3, P33; McKinney W., 2011, PYTHON HIGH PERFORMA, P1; Molenaar D, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.82; Murray HD, 2003, MOL CELL, V12, P125, DOI 10.1016/S1097-2765(03)00266-1; Neidhardt FC, 1999, J BACTERIOL, V181, P7405, DOI 10.1128/JB.181.24.7405-7408.1999; NOMURA M, 1984, ANNU REV BIOCHEM, V53, P75, DOI 10.1146/annurev.bi.53.070184.000451; Oliphant TE, 2007, COMPUT SCI ENG, V9, P10, DOI 10.1109/MCSE.2007.58; Paalme T, 1995, J MICROBIOL METH, V24, P145, DOI 10.1016/0167-7012(95)00064-X; PEDERSEN S, 1978, CELL, V14, P179, DOI 10.1016/0092-8674(78)90312-4; Peebo K, 2015, MOL BIOSYST, V11, P1184, DOI 10.1039/c4mb00721b; Regenberg B, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-11-r107; Saldanha AJ, 2004, MOL BIOL CELL, V15, P4089, DOI 10.1091/mbc.e04-04-0306; Salgado H, 2013, NUCLEIC ACIDS RES, V41, pD203, DOI 10.1093/nar/gks1201; SCHAECHTER M, 1958, J GEN MICROBIOL, V19, P592, DOI 10.1099/00221287-19-3-592; Schmidt A, 2016, NAT BIOTECHNOL, V34, P104, DOI 10.1038/nbt.3418; Scott M, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145379; Scott M, 2011, CURR OPIN BIOTECH, V22, P559, DOI 10.1016/j.copbio.2011.04.014; Scott M, 2010, SCIENCE, V330, P1099, DOI 10.1126/science.1192588; Srivatsan A, 2008, CURR OPIN MICROBIOL, V11, P100, DOI 10.1016/j.mib.2008.02.001; Tao H, 1999, J BACTERIOL, V181, P6425, DOI 10.1128/JB.181.20.6425-6440.1999; Valgepea K, 2013, MOL BIOSYST, V9, P2344, DOI 10.1039/c3mb70119k; Weisse AY, 2015, P NATL ACAD SCI USA, V112, pE1038, DOI 10.1073/pnas.1416533112; You CH, 2013, NATURE, V500, P301, DOI 10.1038/nature12446; Zaslaver A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000545	44	13	13	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153344	10.1371/journal.pone.0153344	http://dx.doi.org/10.1371/journal.pone.0153344			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073913	Green Published, Green Submitted, gold			2022-12-27	WOS:000374131200076
J	De Pasquale, I; Di Cagno, R; Buchin, S; De Angelis, M; Gobbetti, M				De Pasquale, Ilaria; Di Cagno, Raffaella; Buchin, Solange; De Angelis, Maria; Gobbetti, Marco			Spatial Distribution of the Metabolically Active Microbiota within Italian PDO Ewes' Milk Cheeses	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; STARTER CULTURES; ECOLOGY DYNAMICS; PUGLIESE CHEESE; RAW-MILK; SURFACE; SYSTEMS	Italian PDO (Protected Designation of Origin) Fiore Sardo (FS), Pecorino Siciliano (PS) and Pecorino Toscano (PT) ewes' milk cheeses were chosen as hard cheese model systems to investigate the spatial distribution of the metabolically active microbiota and the related effects on proteolysis and synthesis of volatile components (VOC). Cheese slices were divided in nine sub-blocks, each one separately subjected to analysis and compared to whole cheese slice (control). Gradients for moisture, and concentrations of salt, fat and protein distinguished sub-blocks, while the cell density of the main microbial groups did not differ. Secondary proteolysis differed between sub-blocks of each cheese, especially when the number and area of hydrophilic and hydrophobic peptide peaks were assessed. The concentration of free amino acids (FAA) agreed with these data. As determined through Purge and Trap (PT) coupled with Gas Chromatography-Mass Spectrometry (PT-GC/MS), and regardless of the cheese variety, the profile with the lowest level of VOC was restricted to the region identified by the letter E defined as core. As shown through pyrosequencing of the 16S rRNA targeting RNA, the spatial distribution of the metabolically active microbiota agreed with the VOC distribution. Differences were highlighted between core and the rest of the cheese. Top and bottom under rind sub-blocks of all three cheeses harbored the widest biodiversity. The cheese sub-block analysis revealed the presence of a microbiota statistically correlated with secondary proteolysis events and/or synthesis of VOC.	[De Pasquale, Ilaria; Di Cagno, Raffaella; De Angelis, Maria; Gobbetti, Marco] Univ Bari Aldo Moro, Dept Soil Plant & Food Sci, Bari, Italy; [Buchin, Solange] INRA, UR 342, Technol & Anal Laitieres, Poligny, France	Universita degli Studi di Bari Aldo Moro; INRAE	Di Cagno, R (corresponding author), Univ Bari Aldo Moro, Dept Soil Plant & Food Sci, Bari, Italy.	raffaella.dicagno@uniba.it	De Pasquale, Ilaria/ABD-1371-2021; De Angelis, Maria/AAA-9909-2019	De Pasquale, Ilaria/0000-0003-2582-4367; 				Albenzio M, 2001, INT J FOOD MICROBIOL, V67, P35, DOI 10.1016/S0168-1605(00)00533-X; ANDREWS AT, 1983, J DAIRY RES, V50, P45, DOI 10.1017/S0022029900032519; Arfi K, 2003, J BIOTECHNOL, V105, P245, DOI 10.1016/j.jbiotec.2003.07.003; Bockelmann W, 2002, INT DAIRY J, V12, P123, DOI 10.1016/S0958-6946(01)00152-2; Bockelmann W., 1997, 5th Cheese Symposium, 11-13th March 1997., P121; Bonnarme P, 2001, J DAIRY RES, V68, P663, DOI 10.1017/S002202990100509X; Buccioni A, 2010, INT DAIRY J, V20, P190, DOI 10.1016/j.idairyj.2009.10.001; Callon C, 2011, FOOD CONTROL, V22, P1911, DOI 10.1016/j.foodcont.2011.05.003; Callon C, 2011, INT J FOOD MICROBIOL, V145, P379, DOI 10.1016/j.ijfoodmicro.2010.12.019; Charlet M, 2009, INT J FOOD MICROBIOL, V131, P10, DOI 10.1016/j.ijfoodmicro.2008.08.022; Coda R, 2006, J DAIRY SCI, V89, P4126, DOI 10.3168/jds.S0022-0302(06)72458-4; Corsetti A, 2001, INT J FOOD MICROBIOL, V69, P1, DOI 10.1016/S0168-1605(01)00567-0; CROW VL, 1990, APPL ENVIRON MICROB, V56, P1656, DOI 10.1128/AEM.56.6.1656-1665.1990; De Filippis F, 2013, PLOS ONE, V9; De Filippis F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070222; De Pasquale I, 2014, APPL ENVIRON MICROB, V80, P6243, DOI 10.1128/AEM.02097-14; De Pasquale I, 2014, APPL ENVIRON MICROB, V80, P4085, DOI 10.1128/AEM.00757-14; Di Cagno R, 2007, J DAIRY SCI, V90, P2689, DOI 10.3168/jds.2006-654; Di Cagno R, 2006, INT DAIRY J, V16, P119, DOI 10.1016/j.idairyj.2005.01.012; Dolci P, 2014, INT J FOOD MICROBIOL, V185, P127, DOI 10.1016/j.ijfoodmicro.2014.05.021; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Ercolini D, 2000, APPL ENVIRON MICROB, V69, P3540; Ercolini D, 2013, APPL ENVIRON MICROB, V79, P3148, DOI 10.1128/AEM.00256-13; Fitzsimons NA, 2001, J APPL MICROBIOL, V90, P600, DOI 10.1046/j.1365-2672.2001.01285.x; Fleurot I, 2014, APPL ENVIRON MICROB, V80, P5106, DOI 10.1128/AEM.01042-14; FOX PF, 1963, J DAIRY SCI, V46, P744, DOI 10.3168/jds.S0022-0302(63)89134-1; Fox PF, 2000, FUNDAMENTALS CHEESES; Fuka MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080734; Gobbetti M, 2007, WOODHEAD PUBL FOOD S, P121, DOI 10.1533/9781845693053.1.121; Gobbetti M, 1997, INT DAIRY J, V7, P519, DOI 10.1016/S0958-6946(97)00047-2; Gobbetti M, 2002, INT DAIRY J, V12, P511, DOI 10.1016/S0958-6946(02)00042-0; GOBBETTI M, 2004, CHEESE CHEM PHYS MIC, V2, P51; Gobbetti M, 2015, TRENDS FOOD SCI TECH, V45, P167, DOI 10.1016/j.tifs.2015.07.016; Hayaloglu AA, 2007, INT J FOOD SCI TECH, V42, P930, DOI 10.1111/j.1365-2621.2006.01312.x; Institute for Industrial Research and Standards, 1955, 69 I IND RES STAND; International Dairy Federation, 1964, 25 INT DAIR FED; International Dairy Federation, 1982, 4A IDF; Irlinger F, 2009, CURR OPIN BIOTECH, V20, P142, DOI 10.1016/j.copbio.2009.02.016; Jeanson S, 2011, APPL ENVIRON MICROB, V77, P1493, DOI 10.1128/AEM.02233-10; Lessard MH, 2012, APPL ENVIRON MICROB, V78, P1813, DOI 10.1128/AEM.06645-11; Mangia NP, 2008, FOOD MICROBIOL, V25, P366, DOI 10.1016/j.fm.2007.09.009; McSweeney PLH, 2000, LAIT, V80, P293, DOI 10.1051/lait:2000127; Minervini F, 2012, APPL ENVIRON MICROB, V78, P1251, DOI 10.1128/AEM.07721-11; Monfredini L, 2012, SYST APPL MICROBIOL, V35, P54, DOI 10.1016/j.syapm.2011.07.002; Montel MC, 2014, INT J FOOD MICROBIOL, V177, P136, DOI 10.1016/j.ijfoodmicro.2014.02.019; Mounier J, 2009, INT J FOOD MICROBIOL, V133, P31, DOI 10.1016/j.ijfoodmicro.2009.04.020; O'Sullivan DJ, 2015, APPL ENVIRON MICROB, V81, P2525, DOI 10.1128/AEM.04054-14; Ogier JC, 2004, APPL ENVIRON MICROB, V70, P5628, DOI 10.1128/AEM.70.9.5628-5643.2004; Ottogalli G, 2001, ATLANTE DEI FORMAGGI, P72; Pelaez C, 2005, INT DAIRY J, V15, P831, DOI 10.1016/j.idairyj.2004.12.001; Quigley L, 2013, FEMS MICROBIOL REV, V37, P664, DOI 10.1111/1574-6976.12030; Reeder J, 2010, NAT METHODS, V7, P668, DOI 10.1038/nmeth0910-668b; Savijoki K, 2006, APPL MICROBIOL BIOT, V71, P394, DOI 10.1007/s00253-006-0427-1; Sheehan A, 2009, INT DAIRY J, V19, P321, DOI 10.1016/j.idairyj.2008.11.008; Smit G, 2005, FEMS MICROBIOL REV, V29, P591, DOI 10.1016/j.femsre.2005.04.002; Wolfe BE, 2014, CELL, V158, P422, DOI 10.1016/j.cell.2014.05.041; Wouters JTM, 2002, INT DAIRY J, V12, P91, DOI 10.1016/S0958-6946(01)00151-0	58	24	24	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153213	10.1371/journal.pone.0153213	http://dx.doi.org/10.1371/journal.pone.0153213			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073835	Green Submitted, Green Published, gold			2022-12-27	WOS:000374131200061
J	El-Badawy, A; El-Badri, N				El-Badawy, Ahmed; El-Badri, Nagwa			Clinical Efficacy of Stem Cell Therapy for Diabetes Mellitus: A Meta-Analysis	PLOS ONE			English	Article							CORD BLOOD-TRANSFUSION; UMBILICAL-CORD; ISLET TRANSPLANTATION; C-PEPTIDE; YOUNG-CHILDREN; NEW-ONSET; INSULIN; INFUSION; KETOACIDOSIS; TRIAL	Background Stem cell therapy is a promising therapeutic modality for advanced diabetes mellitus (DM). This study presents a meta-analysis of relevant clinical trials to determine the efficacy of stem cell therapy in DM. We aim to critically evaluate and synthesize clinical evidence on the safety and efficiency of different types of stem cell therapy for both T1DM and T2DM. Methods and Findings We pooled participant-level data from twenty-two eligible clinical trials that satisfied our inclusion criteria, with a total of 524 patients. There were significant differences in the outcome based on the type and source of the infused cells. Out of all T1DM patients who received CD34(+) hematopoietic stem cell (HSC) infusion, 58.9% became insulin independent for a mean period of 16 months, whereas the results were uniformly negative in patients who received umbilical cord blood (UCB). Infusion of umbilical cord mesenchymal stem cells (UC-MSCs) provided significantly beneficial outcome in T1DM, when compared to bone-marrow mesenchymal stem cells (BM-MSCs) (P<0.0001 and P = 0.1557). Administration of stem cell therapy early after DM diagnosis was more effective than intervention at later stages (relative risk = 2.0, P = 0.0008). Adverse effects were observed in only 21.72% of both T1DM and T2DM stem cell recipients with no reported mortality. Out of all poor responders, 79.5% were diagnosed with diabetic ketoacidosis. Conclusions Stem cell transplantation can represent a safe and effective treatment for selected patients with DM. In this cohort of trials, the best therapeutic outcome was achieved with CD34(+) HSC therapy for T1DM, while the poorest outcome was observed with HUCB for T1DM. Diabetic ketoacidosis impedes therapeutic efficacy.	[El-Badawy, Ahmed; El-Badri, Nagwa] Zewail City Sci & Technol, Ctr Excellence Stem Cells & Regenerat Med CESC, 6th Of October City, Egypt	Egyptian Knowledge Bank (EKB); Zewail City of Science & Technology	El-Badri, N (corresponding author), Zewail City Sci & Technol, Ctr Excellence Stem Cells & Regenerat Med CESC, 6th Of October City, Egypt.	nelbadri@zewailcity.edu.eg	El-Badawy, Ahmed/U-4911-2017	El-Badawy, Ahmed/0000-0002-2707-5796	Science and Technology Development Fund (STDF), Egypt [5300]	Science and Technology Development Fund (STDF), Egypt(Science and Technology Development Fund (STDF))	This work is supported by grant #5300, funded by the Science and Technology Development Fund (STDF), Egypt.	[Anonymous], 2012, J VASC INTERV RADIOL; BAILAR JC, 1988, ANN INTERN MED, V108, P266, DOI 10.7326/0003-4819-108-2-266; Barton FB, 2012, DIABETES CARE, V35, P1436, DOI 10.2337/dc12-0063; Bassi R, 2011, CURR DIABETES REP, V11, P355, DOI 10.1007/s11892-011-0211-1; Bell GI, 2012, DIABETOLOGIA, V55, P1755, DOI 10.1007/s00125-012-2520-6; Bhansali A, 2014, CELL TRANSPLANT, V23, P1075, DOI 10.3727/096368913X665576; Bhansali A, 2009, STEM CELLS DEV, V18, P1407, DOI 10.1089/scd.2009.0164; Carlsson PO, 2015, DIABETES, V64, P587, DOI 10.2337/db14-0656; Couri CEB, 2009, JAMA-J AM MED ASSOC, V301, P1573, DOI 10.1001/jama.2009.470; D'Addio A, 2011, BONE MARROW TRANSPL, V46, P356, DOI 10.1038/bmt.2010.128; D'Addio F, 2014, DIABETES, V63, P3041, DOI 10.2337/db14-0295; D'Addio F, 2014, DIABETES CARE, V37, P267, DOI 10.2337/dc13-1663; DerSimonian R, 1996, STAT MED, V15, P1237, DOI 10.1002/(SICI)1097-0258(19960630)15:12<1237::AID-SIM301>3.0.CO;2-N; El-Badawy A, 2015, STEM CELLS CLONING, V8, P67, DOI 10.2147/SCCAA.S80157; El-Badri N, 2013, J NUCLEIC ACIDS, V2013, DOI 10.1155/2013/194858; Everly Matthew J, 2009, Clin Transpl, P75; Fadini GP, 2013, DIABETES CARE, V36, P943, DOI 10.2337/dc12-1084; Fiorina P, 2008, AM J TRANSPLANT, V8, P1990, DOI 10.1111/j.1600-6143.2008.02353.x; Fiorina P, 2011, J IMMUNOL, V186, P121, DOI 10.4049/jimmunol.1000799; Gaba RC, 2012, J VASC INTERV RADIOL, V23, P583, DOI 10.1016/j.jvir.2012.01.057; Gao JZ, 2001, CELLS TISSUES ORGANS, V169, P12, DOI 10.1159/000047856; Giannopoulou EZ, 2014, PEDIATR DIABETES, V15, P100, DOI 10.1111/pedi.12072; Green S, 2005, INTERN MED J, V35, P4; Greene RE, 2008, BRIT J DERMATOL, V158, P1380, DOI 10.1111/j.1365-2133.2008.08552.x; Gu WQ, 2012, DIABETES CARE, V35, P1413, DOI 10.2337/dc11-2161; Haller MJ, 2013, BIOL BLOOD MARROW TR, V19, P1126, DOI 10.1016/j.bbmt.2013.04.011; Haller MJ, 2011, DIABETES CARE, V34, P2567, DOI 10.2337/dc11-1406; Haller MJ, 2009, DIABETES CARE, V32, P2041, DOI 10.2337/dc09-0967; Hauge AW, 2014, TRANSFUSION, V54, P1055, DOI 10.1111/trf.12383; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Hilling DE, 2014, CELL TRANSPLANT, V23, P921, DOI 10.3727/096368913X666412; Hirshberg Boaz, 2007, Curr Diab Rep, V7, P301, DOI 10.1007/s11892-007-0048-9; Hu JX, 2013, ENDOCR J, V60, P347; Hu JX, 2012, ENDOCR J, V59, P1031, DOI 10.1507/endocrj.EJ12-0092; Jiang Ranhua, 2011, Front Med, V5, P94, DOI 10.1007/s11684-011-0116-z; Komulainen J, 1996, ARCH DIS CHILD, V75, P410, DOI 10.1136/adc.75.5.410; Li LR, 2012, J CLIN ENDOCR METAB, V97, P1729, DOI 10.1210/jc.2011-2188; Lin YN, 2012, EUR J RADIOL, V81, P461, DOI 10.1016/j.ejrad.2010.12.077; Liu XB, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt446; McCall M, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007823; McDonald GB, 2003, BLOOD, V101, P2043, DOI 10.1182/blood-2002-06-1860; Mesples Alejandro, 2013, Med Sci Monit, V19, P852, DOI 10.12659/MSM.889525; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; Okahara M, 2010, ABDOM IMAGING, V35, P134, DOI 10.1007/s00261-009-9581-0; Pileggi A, 2012, DIABETES, V61, P1355, DOI 10.2337/db12-0355; Rose KL, 2007, PEDIATR RES, V61, P301, DOI 10.1203/pdr.0b013e318030d193; Scully Tony, 2012, Nature, V485, pS2; Secchi A, 1998, LANCET, V352, P65, DOI 10.1016/S0140-6736(05)79546-5; Shapiro AMJ, 2006, NEW ENGL J MED, V355, P1318, DOI 10.1056/NEJMoa061267; Sherry N, 2011, LANCET, V378, P487, DOI 10.1016/S0140-6736(11)60931-8; Snarski E, 2011, BONE MARROW TRANSPL, V46, P562, DOI 10.1038/bmt.2010.147; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Thakkar UG, 2015, CYTOTHERAPY, V17, P940, DOI 10.1016/j.jcyt.2015.03.608; Tong Q, 2013, J CLIN ENDOCR METAB, V98, pE1501, DOI 10.1210/jc.2013-1451; Trivedi HL, 2008, TRANSPL P, V40, P1135, DOI 10.1016/j.transproceed.2008.03.113; Vanikar AV, 2010, STEM CELLS INT, V2010, DOI 10.4061/2010/582382; Wu ZX, 2014, CYTOTHERAPY, V16, P258, DOI 10.1016/j.jcyt.2013.10.004; Zhang XF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031887; Zhao Y, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-3	60	71	71	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0151938	10.1371/journal.pone.0151938	http://dx.doi.org/10.1371/journal.pone.0151938			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073927	Green Submitted, Green Published, gold			2022-12-27	WOS:000374131200012
J	Walper, E; Weiste, C; Mueller, MJ; Hamberg, M; Droge-Laser, W				Walper, Elisabeth; Weiste, Christoph; Mueller, Martin J.; Hamberg, Mats; Droge-Laser, Wolfgang			Screen Identifying Arabidopsis Transcription Factors Involved in the Response to 9-Lipoxygenase-Derived Oxylipins	PLOS ONE			English	Article							AMINO-ACID-METABOLISM; OXIDATIVE STRESS; LIPID-PEROXIDATION; DEFENSE RESPONSES; SIGNALING PATHWAY; GENE-EXPRESSION; PLANT DEFENSE; JASMONATE; ACTIVATION; RESISTANCE	13-Lipoxygenase-derived oxylipins, such as jasmonates act as potent signaling molecules in plants. Although experimental evidence supports the impact of oxylipins generated by the 9-Lipoxygenase (9-LOX) pathway in root development and pathogen defense, their signaling function in plants remains largely elusive. Based on the root growth inhibiting properties of the 9-LOX-oxylipin 9-HOT (9-hydroxy-10,12,15-octadecatrienoic acid), we established a screening approach aiming at identifying transcription factors (TFs) involved in signaling and/or metabolism of this oxylipin. Making use of the AtTORF-Ex (Arabidopsis thaliana Transcription Factor Open Reading Frame Expression) collection of plant lines overexpressing TF genes, we screened for those TFs which restore root growth on 9-HOT. Out of 6,000 lines, eight TFs were recovered at least three times and were therefore selected for detailed analysis. Overexpression of the basic leucine Zipper (bZIP) TF TGA5 and its target, the monoxygenase CYP81D11 reduced the effect of added 9-HOT, presumably due to activation of a detoxification pathway. The highly related ETHYLENE RESPONSE FACTORs ERF106 and ERF107 induce a broad detoxification response towards 9-LOX-oxylipins and xenobiotic compounds. From a set of 18 related group S-bZIP factors isolated in the screen, bZIP11 is known to participate in auxin-mediated root growth and may connect oxylipins to root meristem function. The TF candidates isolated in this screen provide starting points for further attempts to dissect putative signaling pathways involving 9-LOX-derived oxylipins.	[Walper, Elisabeth; Weiste, Christoph; Mueller, Martin J.; Droge-Laser, Wolfgang] Univ Wurzburg, Julius von Sachs Inst, Julius von Sachs Pl 2, D-97082 Wurzburg, Germany; [Hamberg, Mats] Karolinska Inst, Div Physiol Chem 2, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden	University of Wurzburg; Karolinska Institutet	Droge-Laser, W (corresponding author), Univ Wurzburg, Julius von Sachs Inst, Julius von Sachs Pl 2, D-97082 Wurzburg, Germany.	wolfgang.droege-laser@uni-wuerzburg.de	mueller, martin j/C-7616-2019	Hamberg, Mats/0000-0002-8910-7810	Graduate School "Lipid Signaling" (Deutsche Forschungsgemeinschaft) [GK1342]; DFG; University of Wuerzburg	Graduate School "Lipid Signaling" (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); University of Wuerzburg	The project was funded by the Graduate School "Lipid Signaling" (Deutsche Forschungsgemeinschaft, GK1342) (http://www.dfg.de/en/). Recipient: EW. Project leaders: MJM, WDL. This publication was funded by DFG and the University of Wuerzburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Christiane Gatz (University of Gottingen, Germany) for sharing seeds and Sarah Frosch for technical assistance. The project was funded by the Graduate School "Lipid Signaling" (Deutsche Forschungsgemeinschaft, GK1342) (http://www.dfg.de/en/). Recipient: EW. Project leaders: MJM, WDL. This publication was funded by DFG and the University of Wuerzburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird L, 2013, P NATL ACAD SCI USA, V110, P15259, DOI 10.1073/pnas.1305687110; Bannenberg G, 2009, LIPIDS, V44, P85, DOI 10.1007/s11745-008-3245-7; Bethke G, 2009, P NATL ACAD SCI USA, V106, DOI 10.1073/pnas.0810206106; Blee E, 2014, PLANT PHYSIOL, V166, P109, DOI 10.1104/pp.114.245316; Blee E, 2012, FEBS J, V279, P3981, DOI 10.1111/j.1742-4658.2012.08757.x; Browse J, 2009, ANNU REV PLANT BIOL, V60, P183, DOI 10.1146/annurev.arplant.043008.092007; Bruce TJA, 2008, P NATL ACAD SCI USA, V105, P4553, DOI 10.1073/pnas.0710305105; Catinot J, 2015, PLANT CELL ENVIRON, V38, P2721, DOI 10.1111/pce.12583; Christensen SA, 2015, P NATL ACAD SCI USA, V112, P11407, DOI 10.1073/pnas.1511131112; Cookson SJ, 2015, PLANT CELL IN PRESS; Cutcliffe JW, 2011, J EXP BOT, V62, P4995, DOI 10.1093/jxb/err199; Dietrich K, 2011, PLANT CELL, V23, P381, DOI 10.1105/tpc.110.075390; Dubois M, 2013, PLANT PHYSIOL, V162, P319, DOI 10.1104/pp.113.216341; Farmer EE, 2007, CURR OPIN PLANT BIOL, V10, P380, DOI 10.1016/j.pbi.2007.04.019; Farmer EE, 2013, ANNU REV PLANT BIOL, V64, P429, DOI 10.1146/annurev-arplant-050312-120132; Fischer BB, 2012, P NATL ACAD SCI USA, V109, pE1302, DOI 10.1073/pnas.1116843109; Fode B, 2008, PLANT CELL, V20, P3122, DOI 10.1105/tpc.108.058974; Hamberg M, 2003, J BIOL CHEM, V278, P51796, DOI 10.1074/jbc.M310514200; Hanson J, 2008, PLANT J, V53, P935, DOI 10.1111/j.1365-313X.2007.03385.x; Jakoby M, 2002, TRENDS PLANT SCI, V7, P106, DOI 10.1016/S1360-1385(01)02223-3; Koster J, 2012, PLANT PHYSIOL, V159, P391, DOI 10.1104/pp.112.194274; Lauxmann M, 2015, PLANT CELL IN PRESS; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Llorca CM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139884; Lopez MA, 2011, PLANT J, V67, P447, DOI 10.1111/j.1365-313X.2011.04608.x; Ma JK, 2011, NEW PHYTOL, V191, P733, DOI 10.1111/j.1469-8137.2011.03735.x; Ma Q, 2008, CHEM RES TOXICOL, V21, P1651, DOI 10.1021/tx800156s; Mair A, 2015, ELIFE, V4, DOI 10.7554/eLife.05828; Marcos R, 2015, PLANT PHYSIOL, V169, P2324, DOI 10.1104/pp.15.00992; Meng XZ, 2013, PLANT CELL, V25, P1126, DOI 10.1105/tpc.112.109074; Mosblech A, 2009, PLANT PHYSIOL BIOCH, V47, P511, DOI 10.1016/j.plaphy.2008.12.011; Mueller S, 2008, PLANT CELL, V20, P768, DOI 10.1105/tpc.107.054809; Muller B, 2008, NATURE, V453, P1094, DOI 10.1038/nature06943; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nakano T, 2006, PLANT PHYSIOL, V140, P411, DOI 10.1104/pp.105.073783; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Pauwels L, 2011, PLANT CELL, V23, P3089, DOI 10.1105/tpc.111.089300; Ramel F, 2012, J EXP BOT, V63, P3999, DOI 10.1093/jxb/ers102; Rashotte AM, 2006, P NATL ACAD SCI USA, V103, P11081, DOI 10.1073/pnas.0602038103; Stotz HU, 2013, J EXP BOT, V64, P963, DOI 10.1093/jxb/ers389; Vellosillo T, 2007, PLANT CELL, V19, P831, DOI 10.1105/tpc.106.046052; Vellosillo T, 2010, PLANT PHYSIOL, V154, P444, DOI 10.1104/pp.110.161273; Vicente J, 2012, MOL PLANT, V5, P914, DOI 10.1093/mp/ssr105; Vollenweider S, 2000, PLANT J, V24, P467, DOI 10.1046/j.1365-313x.2000.00897.x; Wehner N, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00068; Weigel R., 2002, ARABIDOPSIS LAB MANU; Weiste C, 2007, PLANT J, V52, P382, DOI 10.1111/j.1365-313X.2007.03229.x; Weiste C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4883; Zander M, 2010, PLANT J, V61, P200, DOI 10.1111/j.1365-313X.2009.04044.x; Zhang YL, 2003, PLANT CELL, V15, P2647, DOI 10.1105/tpc.014894; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367; Zuo JR, 2000, PLANT J, V24, P265, DOI 10.1046/j.1365-313x.2000.00868.x	52	8	8	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153216	10.1371/journal.pone.0153216	http://dx.doi.org/10.1371/journal.pone.0153216			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073862	Green Submitted, Green Published, gold			2022-12-27	WOS:000374131200062
J	Elebro, J; Heby, M; Warfvinge, CF; Nodin, B; Eberhard, J; Jirstrom, K				Elebro, Jacob; Heby, Margareta; Warfvinge, Carl Fredrik; Nodin, Bjorn; Eberhard, Jakob; Jirstrom, Karin			Expression and Prognostic Significance of Human Epidermal Growth Factor Receptors 1, 2 and 3 in Periampullary Adenocarcinoma	PLOS ONE			English	Article							COLORECTAL-CANCER; AMPULLARY CARCINOMA; PROTEIN EXPRESSION; PANCREATIC-CANCER; PREDICTIVE SIGNIFICANCE; HER3 OVEREXPRESSION; TISSUE MICROARRAY; INTESTINAL-TYPE; SOLID TUMORS; COPY NUMBER	Periampullary adenocarcinoma, including pancreatic cancer, is a heterogeneous group of tumours with dismal prognosis, for which there is an urgent need to identify novel treatment strategies. The human epithelial growth factor receptors EGFR, HER2 and HER3 have been studied in several tumour types, and HER-targeting drugs have a beneficial effect on survival in selected types of cancer. However, these effects have not been evident in pancreatic cancer, and remain unexplored in other types of periampullary cancer. The prognostic impact of HER-expression in these cancers also remains unclear. The aim of this study was therefore to examine the expression and prognostic value of EGFR, HER2 and HER3 in periampullary cancer, with particular reference to histological subtype. To this end, protein expression of EGFR, HER2 and HER3, and HER2 gene amplification was assessed by immunohistochemistry and silver in situ hybridization, respectively, on tissue microarrays with tumours from 175 periampullary adenocarcinomas, with follow-up data on recurrence-free survival (RFS) and overall survival (OS) for up to 5 years. EGFR expression was similar in pancreatobiliary (PB) and intestinal (I) type tumours, but high HER2 and HER3 expression was significantly more common in I-type tumours. In PB-type cases receiving adjuvant gemcitabine, but not in untreated cases, high EGFR expression was significantly associated with a shorter OS and RFS, with a significant treatment interaction in relation to OS (p(interaction) = 0.042). In I-type cases, high EGFR expression was associated with a shorter OS and RFS in univariable, but not in multivariable, analysis. High HER3 expression was associated with a prolonged RFS in univariable, but not in multivariable, analysis. Neither HER2 protein expression nor gene amplification was prognostic. The finding of a potential interaction between the expression of EGFR and response to adjuvant chemotherapy in PB-type tumours needs validation, and merits further study.	[Elebro, Jacob; Heby, Margareta; Warfvinge, Carl Fredrik; Nodin, Bjorn; Eberhard, Jakob; Jirstrom, Karin] Lund Univ, Dept Clin Sci, Div Oncol & Pathol, Skane Univ Hosp, S-22185 Lund, Sweden	Lund University; Skane University Hospital	Elebro, J (corresponding author), Lund Univ, Dept Clin Sci, Div Oncol & Pathol, Skane Univ Hosp, S-22185 Lund, Sweden.	jacob.elebro@med.lu.se		Elebro, Jacob/0000-0002-9550-8012	Swedish Research Council; Swedish Cancer Society; Gunnar Nilsson Cancer Foundation; Mrs Berta Kamprad Foundation; Swedish Government Grant for Clinical Research; Lund University Faculty of Medicine; University Hospital Research Grants	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Gunnar Nilsson Cancer Foundation; Mrs Berta Kamprad Foundation; Swedish Government Grant for Clinical Research; Lund University Faculty of Medicine; University Hospital Research Grants	This study was supported by grants from the Swedish Research Council, the Swedish Cancer Society, the Gunnar Nilsson Cancer Foundation, the Mrs Berta Kamprad Foundation, the Swedish Government Grant for Clinical Research, Lund University Faculty of Medicine and University Hospital Research Grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloysius MM, 2009, HISTOPATHOLOGY, V55, P236, DOI 10.1111/j.1365-2559.2009.03351.x; Ata A, 2015, PATHOL ONCOL RES, V21, P831, DOI 10.1007/s12253-014-9847-x; Baiocchi G, 2009, INT J COLORECTAL DIS, V24, P1059, DOI 10.1007/s00384-009-0702-6; Baumhoer D, 2008, VIRCHOWS ARCH, V453, P579, DOI 10.1007/s00428-008-0669-7; Begnami MD, 2011, J CLIN ONCOL, V29, P3030, DOI 10.1200/JCO.2010.33.6313; Beji A, 2012, CLIN CANCER RES, V18, P956, DOI 10.1158/1078-0432.CCR-11-1186; Bloomston M, 2006, DIGEST SURG, V23, P74, DOI 10.1159/000093497; Bronsert P, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-428; Cappuzzo F, 2008, ANN ONCOL, V19, P717, DOI 10.1093/annonc/mdm492; Carpelan-Holmstrom M, 2005, GUT, V54, P385, DOI 10.1136/gut.2004.047191; Chang F, 2003, LEUKEMIA, V17, P590, DOI 10.1038/sj.leu.2402824; Chou A, 2013, GENOME MED, V5, DOI 10.1186/gm482; Chung KY, 2005, J CLIN ONCOL, V23, P1803, DOI 10.1200/JCO.2005.08.037; Day JD, 1996, HUM PATHOL, V27, P119, DOI 10.1016/S0046-8177(96)90364-0; Ekblad L, 2012, ANTICANCER RES, V32, P783; Elebro J, 2015, ACTA ONCOL, P1; Elebro J, 2014, J TRANSL MED, V12, DOI 10.1186/s12967-014-0289-8; Elebro J, 2014, DIAGN PATHOL, V9, DOI 10.1186/1746-1596-9-80; Engholm GFJ, 2015, NORDCAN CANC INCIDEN; Fristedt R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112728; Garrett JT, 2011, P NATL ACAD SCI USA, V108, P5021, DOI 10.1073/pnas.1016140108; Hayashi M, 2008, CLIN CANCER RES, V14, P7843, DOI 10.1158/1078-0432.CCR-08-1064; Heby M, 2015, BMC CLIN PATHOL, V15, DOI 10.1186/s12907-015-0009-1; Hechtman JF, 2015, MODERN PATHOL, V28, P1123, DOI 10.1038/modpathol.2015.57; Hedner C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148101; HICKEY K, 1994, CANCER, V74, P1693, DOI 10.1002/1097-0142(19940915)74:6<1693::AID-CNCR2820740609>3.0.CO;2-#; Hirakawa T, 2011, ONCOLOGY-BASEL, V81, P192, DOI 10.1159/000333825; Jarde T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138336; Kawamoto T, 2015, J GASTROENTEROL, V50, P467, DOI 10.1007/s00535-014-0984-5; Koeppen HKW, 2001, HISTOPATHOLOGY, V38, P96, DOI 10.1046/j.1365-2559.2001.01084.x; Koka V, 2002, ANTICANCER RES, V22, P1593; Komoto M, 2009, CANCER SCI, V100, P1243, DOI 10.1111/j.1349-7006.2009.01176.x; Lazrek Y, 2013, NEOPLASIA, V15, P335, DOI 10.1593/neo.121960; Lievre A, 2006, CANCER RES, V66, P3992, DOI 10.1158/0008-5472.CAN-06-0191; Linderoth J, 2007, EUR J HAEMATOL, V79, P146, DOI 10.1111/j.1600-0609.2007.00892.x; LoRusso P, 2013, CLIN CANCER RES, V19, P3078, DOI 10.1158/1078-0432.CCR-12-3051; Luo GP, 2011, PANCREATOLOGY, V11, P595, DOI 10.1159/000334465; Mikhitarian K, 2014, MODERN PATHOL, V27, P665, DOI 10.1038/modpathol.2013.185; Moore MJ, 2007, J CLIN ONCOL, V25, P1960, DOI 10.1200/JCO.2006.07.9525; Moroni M, 2005, LANCET ONCOL, V6, P279, DOI 10.1016/S1470-2045(05)70102-9; Nishio M, 2015, LUNG CANCER, V88, P275, DOI 10.1016/j.lungcan.2015.03.010; O'Hayer K, 2015, J PANCREATIC CANCER, V1, P7, DOI 10.1089/crpc.2015.29004.koh; Ocana A, 2013, JNCI-J NATL CANCER I, V105, P266, DOI 10.1093/jnci/djs501; Potti A, 2003, ANTICANCER RES, V23, P2671; QUINN CM, 1994, HISTOPATHOLOGY, V25, P247, DOI 10.1111/j.1365-2559.1994.tb01324.x; Roskoski R, 2014, PHARMACOL RES, V79, P34, DOI 10.1016/j.phrs.2013.11.002; Ruschoff J, 2012, MODERN PATHOL, V25, P637, DOI 10.1038/modpathol.2011.198; Safran H, 2004, CANCER INVEST, V22, P706, DOI 10.1081/CNV-200032974; Safran H, 2001, AM J CLIN ONCOL-CANC, V24, P496, DOI 10.1097/00000421-200110000-00016; Seo AN, 2015, VIRCHOWS ARCH, V466, P645, DOI 10.1007/s00428-015-1747-2; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; SOLTOFF SP, 1994, MOL CELL BIOL, V14, P3550, DOI 10.1128/MCB.14.6.3550; Stoecklein NH, 2004, J CLIN ONCOL, V22, P4737, DOI 10.1200/JCO.2004.05.142; Swain SM, 2015, NEW ENGL J MED, V372, P724, DOI 10.1056/NEJMoa1413513; Tobita K, 2003, INT J MOL MED, V11, P305; Torhorst J, 2001, AM J PATHOL, V159, P2249, DOI 10.1016/S0002-9440(10)63075-1; Uegaki K, 1997, ANTICANCER RES, V17, P3841; Westgaard A, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-5; Westgaard A, 2013, ANN SURG ONCOL, V20, P430, DOI 10.1245/s10434-012-2603-0; Xia M, 2015, HUM PATHOL, V46, P1315, DOI 10.1016/j.humpath.2015.05.012	60	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0153533	10.1371/journal.pone.0153533	http://dx.doi.org/10.1371/journal.pone.0153533			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27070783	gold, Green Submitted, Green Published			2022-12-27	WOS:000373900700079
J	Gaisl, T; Wons, AM; Rossi, V; Bratton, DJ; Schlatzer, C; Schwarz, EI; Camen, G; Kohler, M				Gaisl, Thomas; Wons, Annette M.; Rossi, Valentina; Bratton, Daniel J.; Schlatzer, Christian; Schwarz, Esther I.; Camen, Giovanni; Kohler, Malcolm			Simulated Obstructive Sleep Apnea Increases P-Wave Duration and P-Wave Dispersion	PLOS ONE			English	Article							PRESSURE; ASSOCIATION; ARRHYTHMIAS; ACTIVATION; HYPOPNEA; TIMES; DELAY	Background A high P-wave duration and dispersion (Pd) have been reported to be a prognostic factor for the occurrence of paroxysmal atrial fibrillation (PAF), a condition linked to obstructive sleep apnea (OSA). We tested the hypothesis of whether a short-term increase of P-wave duration and Pd can be induced by respiratory manoeuvres simulating OSA in healthy subjects and in patients with PAF. Methods 12-lead-electrocardiography (ECG) was recorded continuously in 24 healthy subjects and 33 patients with PAF, while simulating obstructive apnea (Mueller manoeuvre, MM), obstructive hypopnea (inspiration through a threshold load, ITH), central apnea (AP), and during normal breathing (BL) in randomized order. The P-wave duration and Pd was calculated by using dedicated software for ECG-analysis. Results P-wave duration and Pd significantly increased during MM and ITH compared to BL in all subjects (+13.1ms and +13.8ms during MM; +11.7ms and +12.9ms during ITH; p<0.001 for all comparisons). In MM, the increase was larger in healthy subjects when compared to patients with PAF (p<0.05). Conclusion Intrathoracic pressure swings through simulated obstructive sleep apnea increase P-wave duration and Pd in healthy subjects and in patients with PAF. Our findings imply that intrathoracic pressure swings prolong the intra-atrial and inter-atrial conduction time and therefore may represent an independent trigger factor for the development for PAF.	[Gaisl, Thomas; Wons, Annette M.; Rossi, Valentina; Bratton, Daniel J.; Schlatzer, Christian; Schwarz, Esther I.; Camen, Giovanni; Kohler, Malcolm] Univ Zurich Hosp, Dept Pulmonol, CH-8091 Zurich, Switzerland; [Gaisl, Thomas] Spital Zollikerberg, Zollikerberg, Switzerland; [Kohler, Malcolm] Univ Zurich, Ctr Integrat Human Physiol, Zurich, Switzerland; [Kohler, Malcolm] Univ Zurich, Ctr Interdisciplinary Sleep Res, Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); University of Zurich	Kohler, M (corresponding author), Univ Zurich Hosp, Dept Pulmonol, CH-8091 Zurich, Switzerland.; Kohler, M (corresponding author), Univ Zurich, Ctr Integrat Human Physiol, Zurich, Switzerland.; Kohler, M (corresponding author), Univ Zurich, Ctr Interdisciplinary Sleep Res, Zurich, Switzerland.	Malcolm.Kohler@usz.ch	Gaisl, Thomas/I-7762-2019; Schwarz, Esther/AAA-2325-2021	Gaisl, Thomas/0000-0002-9017-6143; Schwarz, Esther Irene/0000-0001-8840-981X; Bratton, Daniel/0000-0002-6135-0894	Clinical Research Priority Program Sleep and Health of the University of Zurich, Switzerland	Clinical Research Priority Program Sleep and Health of the University of Zurich, Switzerland	This work was supported by the Clinical Research Priority Program Sleep and Health of the University of Zurich, Switzerland.	Bayir PT, 2014, ANN NONINVAS ELECTRO, V19, P226, DOI 10.1111/anec.12106; Brown DA, 2010, CARDIOVASC RES, V88, P241, DOI 10.1093/cvr/cvq231; Cagirci G, 2011, J ELECTROCARDIOL, V44, P478, DOI 10.1016/j.jelectrocard.2011.03.009; Camen G, 2013, EUR J APPL PHYSIOL, V113, P489, DOI 10.1007/s00421-012-2457-y; Cicek D, 2012, AM J MED SCI, V344, P180, DOI 10.1097/MAJ.0b013e318239a67f; Clarenbach CF, 2013, J APPL PHYSIOL, V115, P613, DOI 10.1152/japplphysiol.00439.2013; Gaisl T, 2015, EUR RESP J; Gupta S, 2012, J CLIN SLEEP MED, V8, P649, DOI 10.5664/jcsm.2256; Jazi MH, 2014, SLEEP BREATH, V18, P549, DOI 10.1007/s11325-013-0917-1; Kohler M, 2010, NAT REV CARDIOL, V7, P677, DOI 10.1038/nrcardio.2010.145; LEIER CV, 1979, AM J CARDIOL, V44, P442, DOI 10.1016/0002-9149(79)90394-1; Li Li, 2014, Europace, V16, P1309, DOI 10.1093/europace/euu066; Linz D, 2011, HEART RHYTHM, V8, P1436, DOI 10.1016/j.hrthm.2011.03.053; Maeno K, 2013, HEART VESSELS, V28, P639, DOI 10.1007/s00380-012-0288-8; Maeno K, 2013, CIRC-ARRHYTHMIA ELEC, V6, P287, DOI 10.1161/CIRCEP.113.000266; Magnani JW, 2009, CIRC-ARRHYTHMIA ELEC, V2, P72, DOI 10.1161/CIRCEP.108.806828; Mehra R, 2006, AM J RESP CRIT CARE, V173, P910, DOI 10.1164/rccm.200509-1442OC; Narkiewicz K, 1999, CIRCULATION, V100, P2332, DOI 10.1161/01.CIR.100.23.2332; Oliveira W, 2008, J AM SOC ECHOCARDIOG, V21, P1355, DOI 10.1016/j.echo.2008.09.007; Rossi VA, 2013, EUR RESPIR J, V41, P1439, DOI 10.1183/09031936.00128412; Schlatzer C, 2015, EUROPACE; Stowhas AC, 2011, CHEST, V140, P675, DOI 10.1378/chest.10-2799; Suzuki Masaaki, 2005, Sleep Breath, V9, P64, DOI 10.1007/s11325-005-0015-0; VIROLAINEN J, 1995, J APPL PHYSIOL, V79, P455, DOI 10.1152/jappl.1995.79.2.455	24	7	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0152994	10.1371/journal.pone.0152994	http://dx.doi.org/10.1371/journal.pone.0152994			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27071039	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000373900700025
J	Niu, JK; Miao, JR; Tang, Y; Nan, Q; Liu, Y; Yang, G; Dong, XQ; Huang, Q; Xia, SX; Wang, KH; Miao, YL				Niu, Junkun; Miao, Jiarong; Tang, Yuan; Nan, Qiong; Liu, Yan; Yang, Gang; Dong, Xiangqian; Huang, Qi; Xia, Shuxian; Wang, Kunhua; Miao, Yinglei			Identification of Environmental Factors Associated with Inflammatory Bowel Disease in a Southwestern Highland Region of China: A Nested Case-Control Study	PLOS ONE			English	Article							ULCERATIVE-COLITIS; RISK-FACTORS; HYGIENE HYPOTHESIS; CROHNS-DISEASE; APPENDECTOMY; POPULATION; LIFE; IBD; METAANALYSIS; ANTIBIOTICS	Background The aim of this study was to examine environmental factors associated with inflammatory bowel disease (IBD) in Yunnan Province, a southwestern highland region of China. Methods In this nested case-control study, newly diagnosed ulcerative colitis (UC) cases in 2 cities in Yunnan Province and Crohn's disease (CD) cases in 16 cities in Yunnan Province were recruited between 2008 and 2013. Controls were matched by geography, sex and age at a ratio of 1:4. Data were collected using the designed questionnaire. Conditional logistic regression models were used to estimate adjusted odds ratios (ORs). Results A total of 678 UC and 102 CD cases were recruited. For UC, various factors were associated with an increased risk of developing UC: dietary habits, including frequent irregular meal times; consumption of fried foods, salty foods and frozen dinners; childhood factors, including intestinal infectious diseases and frequent use of antibiotics; and other factors, such as mental labor, high work stress, use of non-aspirin non-steroidal anti-inflammatory drugs and allergies (OR > 1, p < 0.05). Other factors showed a protective effect: such as consumption of fruits, current smoking, physical activity, and drinking tea (OR < 1, p < 0.05). For CD, appendectomy and irregular meal times increased the disease risk (OR > 1, p < 0.05), whereas physical activity may have reduced this risk (OR < 1, p < 0.05). Conclusions This study is the first nested case-control study to analyze the association between environmental factors and IBD onset in a southwestern highland region of China. Certain dietary habits, lifestyles, allergies and childhood factors may play important roles in IBD, particularly UC.	[Niu, Junkun; Miao, Jiarong; Nan, Qiong; Liu, Yan; Yang, Gang; Dong, Xiangqian; Huang, Qi; Xia, Shuxian; Miao, Yinglei] Kunming Med Univ, Yunnan Inst Digest Dis, Affiliated Hosp 1, Dept Gastroenterol, Kunming, Yunnan Province, Peoples R China; [Tang, Yuan] First Peoples Hosp Qujing, Dept Gastroenterol, Qujing, Yunnan Province, Peoples R China; [Wang, Kunhua] Kunming Med Univ, Affiliated Hosp 1, Dept Gen Surg, Yunnan Inst Digest Dis, Kunming, Yunnan Province, Peoples R China	Kunming Medical University; Kunming Medical University	Miao, YL (corresponding author), Kunming Med Univ, Yunnan Inst Digest Dis, Affiliated Hosp 1, Dept Gastroenterol, Kunming, Yunnan Province, Peoples R China.; Wang, KH (corresponding author), Kunming Med Univ, Affiliated Hosp 1, Dept Gen Surg, Yunnan Inst Digest Dis, Kunming, Yunnan Province, Peoples R China.	wangkunhua1@medmail.com.cn; myldu@sina.com		Niu, Junkun/0000-0001-9458-0138	National Natural Science Foundation of China [81260074, 81160055]; Yunnan Institute of digestive disease [2014NS123]; Medical academic leader of Yunnan Provincial Bureau of Health [D-201215]; Social development of science and technology projects of Yunnan Province [2013CA021]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Yunnan Institute of digestive disease; Medical academic leader of Yunnan Provincial Bureau of Health; Social development of science and technology projects of Yunnan Province	This work was supported by National Natural Science Foundation of China (81260074, 81160055), Yunnan Institute of digestive disease (2014NS123), Medical academic leader of Yunnan Provincial Bureau of Health (D-201215), and Social development of science and technology projects of Yunnan Province (2013CA021).	Alberto L, 2006, GASTROENTEROLOGY, V130, P1588, DOI 10.1053/j.gastro.2006.02.004; Ananthakrishnan AN, 2012, ANN INTERN MED, V156, P350, DOI 10.7326/0003-4819-156-5-201203060-00007; Beaugerie L, 2010, INFLAMM BOWEL DIS, V16, P356, DOI 10.1002/ibd.21064; Bernstein CN, 2008, GUT, V57, P1185, DOI 10.1136/gut.2007.122143; Bernstein CN, 2006, AM J GASTROENTEROL, V101, P993, DOI 10.1111/j.1572-0241.2006.00381.x; Burisch J, 2013, CURR OPIN GASTROEN, V29, P357, DOI 10.1097/MOG.0b013e32836229fb; Danese S, 2006, WORLD J GASTROENTERO, V12, P4807; De Vroey B, 2010, AM J GASTROENTEROL, V105, P2693, DOI 10.1038/ajg.2010.396; Dixon LJ, 2015, INFLAMM BOWEL DIS, V21, P912, DOI 10.1097/MIB.0000000000000289; Farzaei MH, 2015, CURR PHARM BIOTECHNO, V16, P196, DOI 10.2174/1389201016666150118131704; Gearry RB, 2010, J GASTROEN HEPATOL, V25, P325, DOI 10.1111/j.1440-1746.2009.06140.x; Gismera CS, 2008, WORLD J GASTROENTERO, V14, P5491, DOI 10.3748/wjg.14.5491; Guldan G S, 1995, J Hum Lact, V11, P11, DOI 10.1177/089033449501100116; Hou JK, 2011, AM J GASTROENTEROL, V106, P563, DOI 10.1038/ajg.2011.44; Kaplan GG, 2008, AM J GASTROENTEROL, V103, P2925, DOI 10.1111/j.1572-0241.2008.02118.x; Khalili H, 2013, GUT, V62, P1153, DOI 10.1136/gutjnl-2012-302362; Koloski NA, 2008, WORLD J GASTROENTERO, V14, P165, DOI 10.3748/wjg.14.165; LENNARDJONES JE, 1989, SCAND J GASTROENTERO, V24, P2, DOI 10.3109/00365528909091339; Lerebours E, 2007, AM J GASTROENTEROL, V102, P122, DOI 10.1111/j.1572-0241.2006.00931.x; Li JK, 2013, EUR J CONTRACEP REPR, V18, P148, DOI 10.3109/13625187.2013.776673; Lopez-Serrano P, 2010, SCAND J GASTROENTERO, V45, P1464, DOI 10.3109/00365521.2010.510575; Luo CH, 2011, COLORECTAL DIS, V13, P166, DOI 10.1111/j.1463-1318.2009.02094.x; Mahid SS, 2006, MAYO CLIN PROC, V81, P1462, DOI 10.4065/81.11.1462; Mosher William D, 2010, Vital Health Stat 23, P1; Naganuma M, 2001, AM J GASTROENTEROL, V96, P1123; Ng SC, 2014, GUT               S1, V146; Ng SC, 2015, J GASTROEN HEPATOL, V30, P440, DOI 10.1111/jgh.12859; Ng SC, 2013, GUT, V62, P630, DOI 10.1136/gutjnl-2012-303661; Radford-Smith GL, 2002, GUT, V51, P808, DOI 10.1136/gut.51.6.808; Roblin X, 2012, GUT, V61, P635, DOI 10.1136/gutjnl-2011-300576; Sakamoto N, 2005, INFLAMM BOWEL DIS, V11, P154, DOI 10.1097/00054725-200502000-00009; Satsangi J, 2006, GUT, V55, P749, DOI 10.1136/gut.2005.082909; Shaw SY, 2010, AM J GASTROENTEROL, V105, P2687, DOI 10.1038/ajg.2010.398	33	27	29	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0153524	10.1371/journal.pone.0153524	http://dx.doi.org/10.1371/journal.pone.0153524			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27070313	Green Published, Green Submitted, gold			2022-12-27	WOS:000373900700076
J	Ghoddousi, A; Soofi, M; Hamidi, AK; Lumetsberger, T; Egli, L; Khorozyan, I; Kiabi, BH; Waltert, M				Ghoddousi, Arash; Soofi, Mahmood; Hamidi, Amirhossein Kh.; Lumetsberger, Tanja; Egli, Lukas; Khorozyan, Igor; Kiabi, Bahram H.; Waltert, Matthias			Assessing the Role of Livestock in Big Cat Prey Choice Using Spatiotemporal Availability Patterns	PLOS ONE			English	Article							LEOPARDS PANTHERA-PARDUS; NATIONAL-PARK; CAMERA TRAPS; PERSIAN LEOPARD; PREDATION; SELECTION; WILD; HABITAT; KILL; IDENTIFICATION	Livestock is represented in big cat diets throughout the world. Husbandry approaches aim to reduce depredation, which may influence patterns of prey choice, but whether felids have a preference for livestock or not often remains unclear as most studies ignore livestock availability. We assessed prey choice of the endangered Persian leopard (Panthera pardus saxicolor) in Golestan National Park, Iran, where conflict over livestock depredation occurs. We analyzed leopard diet (77 scats) and assessed wild and domestic prey abundance by line transect sampling (186 km), camera-trapping (2777 camera days), double-observer point-counts (64 scans) and questionnaire surveys (136 respondents). Based on interviews with 18 shepherds, we estimated monthly grazing time outside six villages with 96 conflict cases to obtain a small livestock (domestic sheep and goat) availability coefficient. Using this coefficient, which ranged between 0.40 and 0.63 for different villages, we estimated the numbers of sheep and goats available to leopard depredation. Leopard diet consisted mainly of wild boar (Sus scrofa) (50.2% biomass consumed), but bezoar goat (Capra aegagrus) was the most preferred prey species (I-j = 0.73), whereas sheep and goats were avoided (Ij = -0.54). When absolute sheep and goat numbers (similar to 11250) were used instead of the corrected ones (similar to 6392), avoidance of small livestock appeared to be even stronger (Ij = -0.71). We suggest that future assessments of livestock choice by felids should incorporate such case-specific corrections for spatiotemporal patterns of availability, which may vary with husbandry methods. Such an approach increases our understanding of human-felid conflict dynamics and the role of livestock in felid diets.	[Ghoddousi, Arash; Soofi, Mahmood; Lumetsberger, Tanja; Egli, Lukas; Khorozyan, Igor; Waltert, Matthias] Univ Gottingen, JF Blumenbach Inst Zool & Anthropol, Workgrp Endangered Species, D-37073 Gottingen, Germany; [Soofi, Mahmood; Hamidi, Amirhossein Kh.] Persian Wildlife Heritage Fdn, Tehran, Iran; [Kiabi, Bahram H.] Shahid Beheshti Univ, Fac Biol Sci, GC, Tehran, Iran	University of Gottingen; Shahid Beheshti University	Ghoddousi, A (corresponding author), Univ Gottingen, JF Blumenbach Inst Zool & Anthropol, Workgrp Endangered Species, D-37073 Gottingen, Germany.	arash.ghoddousi@stud.uni-goettingen.de	Waltert, Matthias/E-9134-2010; Soofi, Mahmood/AAL-5283-2021; Khorozyan, Igor/A-2510-2019; Ghoddousi, Arash/B-3914-2015	Waltert, Matthias/0000-0001-7053-0291; Soofi, Mahmood/0000-0002-6167-2527; Khorozyan, Igor/0000-0002-0657-7500; Ghoddousi, Arash/0000-0001-9605-3091	German Academic Exchange Service (DAAD) [91540556]; Panthera Kaplan Graduate Awards; Erasmus Mundus/SALAM from Alexander von Humboldt Foundation [2013-2437-001-001-EMA2, 1151598]; Mohammed bin Zayed Species Conservation Fund [12255025]; Open Access Grant Program of the German Research Foundation (DFG); Open Access Publication Fund of the University of Gottingen	German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Panthera Kaplan Graduate Awards; Erasmus Mundus/SALAM from Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Mohammed bin Zayed Species Conservation Fund; Open Access Grant Program of the German Research Foundation (DFG)(German Research Foundation (DFG)); Open Access Publication Fund of the University of Gottingen	AG was supported by German Academic Exchange Service (DAAD; https://www.daad.de, project No. 91540556) and Panthera Kaplan Graduate Awards (http://www.panthera.org/). Erasmus Mundus/SALAM (http://portal.uw.edu.pl/en/web/salam/, project No. 2013-2437-001-001-EMA2) supports MS and IK receives funding from Alexander von Humboldt Foundation (http://www.humboldtfoundation.de/, project No. 1151598). Mohammed bin Zayed Species Conservation Fund supported IK & MS in collection of conflict data from study villages (http://www.speciesconservation.org/, project No. 12255025). This publication was supported financially by the Open Access Grant Program of the German Research Foundation (DFG) and the Open Access Publication Fund of the University of Gottingen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhani H., 2005, ILLUSTRATED FLORA GO, V1; Athreya V, 2016, ORYX, V50, P156, DOI 10.1017/S0030605314000106; Balme G, 2007, ANIM BEHAV, V74, P589, DOI 10.1016/j.anbehav.2006.12.014; Buckland S.T., 2001, pi; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Clements HS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101054; Colwell RK, 2013, ESTIMATES STAT ESTIM; Cusack JJ, 2015, J WILDLIFE MANAGE, V79, P1014, DOI 10.1002/jwmg.902; De Marinis AM, 2006, WILDLIFE BIOL, V12, P305, DOI 10.2981/0909-6396(2006)12[305:HIKOWA]2.0.CO;2; Firouz E., 2005, COMPLETE FAUNA IRAN; Gervasi V, 2014, J ZOOL, V292, P175, DOI 10.1111/jzo.12088; Ghoddousi A, 2016, ANIM CONSERV, V19, P273, DOI 10.1111/acv.12240; Ghoddousi A, 2010, ORYX, V44, P551, DOI 10.1017/S0030605310000827; Goshtasb H., 2001, THESIS ISLAMIC AZAD; Hamidi Amirhossein Kh., 2014, Cat News, V60, P12; Hayward MW, 2006, J ZOOL, V270, P298, DOI 10.1111/j.1469-7998.2006.00139.x; Hayward MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023607; Inskip C, 2009, ORYX, V43, P18, DOI 10.1017/S003060530899030X; Johansson O, 2015, BIOL CONSERV, V184, P251, DOI 10.1016/j.biocon.2015.02.003; KARANTH KU, 1995, J ANIM ECOL, V64, P439, DOI 10.2307/5647; Khorozyan I, 2015, BIOL CONSERV, V192, P268, DOI 10.1016/j.biocon.2015.09.031; Khorozyan I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129221; Kiabi B.H., 1978, THESIS MICHIGAN STAT; Klare U, 2011, MAMMAL REV, V41, P294, DOI 10.1111/j.1365-2907.2011.00183.x; Kuiper TR, 2015, BIOL CONSERV, V191, P546, DOI 10.1016/j.biocon.2015.08.012; Linnell JDC, 1999, WILDLIFE SOC B, V27, P698; Loveridge Andrew J., 2010, P161; Lumetsberger T., 2014, THESIS GEORG AUGUST; Miller JRB, 2015, BIODIVERS CONSERV, V24, P2887, DOI 10.1007/s10531-015-0993-6; Minnie L, 2015, AFR J WILDL RES, V45, P204, DOI 10.3957/056.045.0204; Moa PF, 2006, WILDLIFE BIOL, V12, P63, DOI 10.2981/0909-6396(2006)12[63:DTSDOL]2.0.CO;2; Mondal K, 2011, MAMMALIA, V75, P201, DOI 10.1515/MAMM.2011.011; Mukherjee S, 2013, BIOL REV, V88, P550, DOI 10.1111/brv.12014; Nichols JD, 2000, AUK, V117, P393, DOI 10.1642/0004-8038(2000)117[0393:ADOAFE]2.0.CO;2; Odden J, 2008, J WILDLIFE MANAGE, V72, P276, DOI 10.2193/2005-537; OLI MK, 1993, J ZOOL, V231, P71, DOI 10.1111/j.1469-7998.1993.tb05354.x; Pitman RT, 2014, J ZOOL, V292, P18, DOI 10.1111/jzo.12078; Pitman RT, 2013, S AFR J WILDL RES, V43, P167, DOI 10.3957/056.043.0204; Podgorski T, 2013, J MAMMAL, V94, P109, DOI 10.1644/12-MAMM-A-038.1; Rowcliffe JM, 2008, J APPL ECOL, V45, P1228, DOI 10.1111/j.1365-2664.2008.01473.x; Rowcliffe JM, 2011, METHODS ECOL EVOL, V2, P464, DOI 10.1111/j.2041-210X.2011.00094.x; Sangay T, 2008, BIOL CONSERV, V141, P1272, DOI 10.1016/j.biocon.2008.02.027; Sappington JM, 2007, J WILDLIFE MANAGE, V71, P1419, DOI 10.2193/2005-723; Shams B, 2010, EUR J WILDLIFE RES, V56, P883; Sharbafi E, 2011, THESIS ISLAMIC AZAD; Shehzad W, 2015, ORYX, V49, P248, DOI 10.1017/S0030605313001026; Speicher J, 2013, THESIS GEORG AUGUST; Stephens D.W., 1986, pi; Suryawanshi KR, 2012, OECOLOGIA, V169, P581, DOI 10.1007/s00442-011-2237-0; Thomas L, 2010, J APPL ECOL, V47, P5, DOI 10.1111/j.1365-2664.2009.01737.x; Tortato FR, 2015, ANIM CONSERV, V18, P539, DOI 10.1111/acv.12207; Wachter B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038066; Wang SW, 2006, BIOL CONSERV, V129, P558, DOI 10.1016/j.biocon.2005.11.024; Woodroffe R, 2007, BIODIVERS CONSERV, V16, P1245, DOI 10.1007/s10531-006-9124-8	54	36	36	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2016	11	4							e0153439	10.1371/journal.pone.0153439	http://dx.doi.org/10.1371/journal.pone.0153439			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0KH	27064680	Green Published, gold, Green Submitted			2022-12-27	WOS:000373891000053
J	Berlanga, M; Llorens, C; Comas, J; Guerrero, R				Berlanga, Mercedes; Llorens, Carlos; Comas, Jaume; Guerrero, Ricardo			Gut Bacterial Community of the Xylophagous Cockroaches Cryptocercus punctulatus and Parasphaeria boleiriana	PLOS ONE			English	Article							WOOD-FEEDING COCKROACHES; H-2 PLUS CO2; TERMITE-GUT; MICROBIAL COMMUNITY; DIVERSITY; DICTYOPTERA; PHYLOGENY; HINDGUT; PROTISTS; 16S	Cryptocercus punctulatus and Parasphaeria boleiriana are two distantly related xylophagous and subsocial cockroaches. Cryptocercus is related to termites. Xylophagous cockroaches and termites are excellent model organisms for studying the symbiotic relationship between the insect and their microbiota. In this study, high-throughput 454 pyrosequencing of 16S rRNA was used to investigate the diversity of metagenomic gut communities of C. punctulatus and P. boleiriana, and thereby to identify possible shifts in symbiont allegiances during cockroaches evolution. Our results revealed that the hindgut prokaryotic communities of both xylophagous cockroaches are dominated by members of four Bacteria phyla: Bacteroidetes, Firmicutes, Proteobacteria, and Actinobacteria. Other identified phyla were Spirochaetes, Planctomycetes, candidatus Saccharibacteria (formerly TM7), and Acidobacteria, each of which represented 1-2% of the total population detected. Community similarity based on phylogenetic relatedness by unweighted UniFrac analyses indicated that the composition of the bacterial community in the two species was significantly different (P < 0.05). Phylogenetic analysis based on the characterized clusters of Bacteroidetes, Spirochaetes, and Deltaproteobacteria showed that many OTUs present in both cockroach species clustered with sequences previously described in termites and other cockroaches, but not with those from other animals or environments. These results suggest that, during their evolution, those cockroaches conserved several bacterial communities from the microbiota of a common ancestor. The ecological stability of those microbial communities may imply the important functional role for the survival of the host of providing nutrients in appropriate quantities and balance.	[Berlanga, Mercedes] Univ Barcelona, Fac Pharm, Dept Microbiol & Parasitol, Barcelona, Spain; [Llorens, Carlos; Comas, Jaume] Univ Barcelona CCiTUB, Unity Genom, Sci Ctr, Barcelona, Spain; [Llorens, Carlos; Comas, Jaume] Univ Barcelona CCiTUB, Unity Genom, Technol Ctr, Barcelona, Spain; [Llorens, Carlos] Biotechvana, Valencia, Spain; [Guerrero, Ricardo] Univ Barcelona, Fac Med, Lab Mol Microbiol & Antimicrobials, Dept Pathol & Expt Therapeut,IDIBELL, Barcelona 7, Spain; [Guerrero, Ricardo] Acad Europaea, Barcelona Knowledge Hub, Barcelona, Spain	University of Barcelona; University of Barcelona; University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona	Berlanga, M (corresponding author), Univ Barcelona, Fac Pharm, Dept Microbiol & Parasitol, Barcelona, Spain.	mberlanga@ub.edu	Berlanga, Mercedes/I-4287-2016	Berlanga, Mercedes/0000-0002-7305-7046; Guerrero, Ricardo/0000-0001-5019-9933	Spanish Ministry of Science and Technology [CGL2009-08922]; Biotechvana	Spanish Ministry of Science and Technology(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Biotechvana	This study was funded by CGL2009-08922 (Spanish Ministry of Science and Technology) to Ricardo Guerrero. Author Carlos Llorens is employed by Biotechvana during the study. Biotechvana provided support in the form of salary for author CL, but did not provide specific funding for this study and did not have any additional role in the study design, data collection, decision to publish, or preparation of the manuscript. This specific role of this author is articulated in the 'author contributions' section.	Bauer E, 2015, FEMS MICROBIOL ECOL, V91, DOI 10.1093/femsec/fiu028; Berlanga M, 2007, INT MICROBIOL, V10, P133, DOI 10.2436/20.1501.01.19; Berlanga M, 2011, INT MICROBIOL, V14, P83, DOI 10.2436/20.1501.01.138; Berlanga M, 2009, INT MICROBIOL, V12, P227, DOI 10.2436/20.1501.01.102; Bertino-Grimaldi D, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-609; Boucias DG, 2013, MOL ECOL, V22, P1836, DOI 10.1111/mec.12230; Brune A, 2015, ANNU REV MICROBIOL, V69, P145, DOI 10.1146/annurev-micro-092412-155715; Brune A, 2014, NAT REV MICROBIOL, V12, P168, DOI 10.1038/nrmicro3182; Carrasco P, 2014, INT MICROBIOL, V17, P99, DOI 10.2436/20.1501.01.212; Desai MS, 2012, ISME J, V6, P1302, DOI 10.1038/ismej.2011.194; Dietrich C, 2014, APPL ENVIRON MICROB, V80, P2261, DOI 10.1128/AEM.04206-13; Diouf M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140014; Droge S, 2005, J GEN APPL MICROBIOL, V51, P57, DOI 10.2323/jgam.51.57; Engel P, 2013, FEMS MICROBIOL REV, V37, P699, DOI 10.1111/1574-6976.12025; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Futami R., 2011, BIOTECHVANA BIOINFOR; GIJZEN HJ, 1994, APPL ENVIRON MICROB, V60, P1822, DOI 10.1128/AEM.60.6.1822-1826.1994; Grandcolas P, 2002, T AM ENTOMOL SOC, V128, P23; Guerrero R, 2013, INT MICROBIOL, V16, P133, DOI 10.2436/20.1501.01.188; Hongoh Y, 2011, CELL MOL LIFE SCI, V68, P1311, DOI 10.1007/s00018-011-0648-z; Iida T, 2000, FEMS MICROBIOL ECOL, V34, P17, DOI 10.1111/j.1574-6941.2000.tb00750.x; Ikeda-Ohtsubo W, 2010, ENV MICROBIOL REP, V2, P554, DOI 10.1111/j.1758-2229.2009.00124.x; Inward D, 2007, BIOL LETTERS, V3, P331, DOI 10.1098/rsbl.2007.0102; Jones RT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061218; Kambhampati S, 2007, BIOL J LINN SOC, V90, P457, DOI 10.1111/j.1095-8312.2006.00734.x; Klass KD, 2008, MOL PHYLOGENET EVOL, V46, P809, DOI 10.1016/j.ympev.2007.11.028; Kohler T, 2012, APPL ENVIRON MICROB, V78, P4691, DOI 10.1128/AEM.00683-12; Leadbetter JR, 1999, SCIENCE, V283, P686, DOI 10.1126/science.283.5402.686; Lilburn TG, 1999, ENVIRON MICROBIOL, V1, P331; Lo N, 2003, MOL BIOL EVOL, V20, P907, DOI 10.1093/molbev/msg097; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Lynn DH, 2013, J EUKARYOT MICROBIOL, V60, P335, DOI 10.1111/jeu.12037; Makonde HM, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1262-6; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Middelbos IS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009768; Minard G, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00059; Moya A, 2008, NAT REV GENET, V9, P218, DOI 10.1038/nrg2319; NALEPA CA, 1990, ANN ENTOMOL SOC AM, V83, P786, DOI 10.1093/aesa/83.4.786; Nalepa CA, 2015, ECOL ENTOMOL, V40, P323, DOI 10.1111/een.12197; Nawrocki EP, 2009, BIOINFORMATICS, V25, P1335, DOI 10.1093/bioinformatics/btp157; Nicholas K.B., 1997, EMBNEW NEWS, V4, P14; Noda S, 2006, ENVIRON MICROBIOL, V8, P11, DOI 10.1111/j.1462-2920.2005.00860.x; Noda S, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-158; Ohkuma M, 2009, P ROY SOC B-BIOL SCI, V276, P239, DOI 10.1098/rspb.2008.1094; Ohkuma M, 2008, TRENDS MICROBIOL, V16, P345, DOI 10.1016/j.tim.2008.04.004; Ohkuma M, 2015, P NATL ACAD SCI USA, V112, P10224, DOI 10.1073/pnas.1423979112; Otani S, 2014, MOL ECOL, V23, P4631, DOI 10.1111/mec.12874; Pellens R, 2002, CAN J ZOOL, V80, P350, DOI 10.1139/Z01-230; Pellens R, 2007, MOL PHYLOGENET EVOL, V43, P616, DOI 10.1016/j.ympev.2006.12.017; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Rahman NA, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0067-8; Rosengaus RB, 2011, APPL ENVIRON MICROB, V77, P4303, DOI 10.1128/AEM.01886-10; Rosenthal AZ, 2011, ISME J, V5, P1133, DOI 10.1038/ISMEJ.2011.3; Schauer C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085861; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Scully ED, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1096; Shinzato N, 2007, BIOSCI BIOTECH BIOCH, V71, P906, DOI 10.1271/bbb.60540; Sudakaran S, 2012, MOL ECOL, V21, P6134, DOI 10.1111/mec.12027; Sun YJ, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp285; Tai V, 2015, APPL ENVIRON MICROB, V81, P1059, DOI 10.1128/AEM.02945-14; Trautwein MD, 2012, ANNU REV ENTOMOL, V57, P449, DOI 10.1146/annurev-ento-120710-100538; Wada-Katsumata A, 2015, P NATL ACAD SCI USA, V112, P15678, DOI 10.1073/pnas.1504031112; Yarza P, 2010, SYST APPL MICROBIOL, V33, P291, DOI 10.1016/j.syapm.2010.08.001; Yuki M, 2015, ENVIRON MICROBIOL, V17, P4942, DOI 10.1111/1462-2920.12945; Yun JH, 2014, APPL ENVIRON MICROB, V80, P5254, DOI 10.1128/AEM.01226-14	66	23	23	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0152400	10.1371/journal.pone.0152400	http://dx.doi.org/10.1371/journal.pone.0152400			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27054320	Green Published, gold, Green Submitted			2022-12-27	WOS:000373608000019
J	Qu, HY; Xing, WX; Wu, FF; Wang, YZ				Qu, Haiyong; Xing, Wenxi; Wu, Fenfen; Wang, Yongzhang			Rapid and Inexpensive Method of Loading Fluorescent Dye into Pollen Tubes and Root Hairs	PLOS ONE			English	Article							CALCIUM-CHANNELS; PYRUS-PYRIFOLIA; CA2+; CELLS; GROWTH; ARABIDOPSIS; GERMINATION; DYNAMICS; GRADIENT; CAMELEON	The most direct technique for studying calcium, which is an essential element for pollen tube growth, is Ca2+ imaging. Because membranes are relatively impermeable, the loading of fluorescent Ca2+ probes into plant cells is a challenging task. Thus, we have developed a new method of loading fluo-4 acetoxymethyl ester into cells that uses a cell lysis solution to improve the introduction of this fluorescent dye into pollen tubes. Using this method, the loading times were reduced to 15 min. Furthermore, loading did not have to be performed at low (4 degrees C) temperatures and was successful at room temperature, and pluronic F-127 was not required, which would theoretically allow for the loading of an unlimited number of cells. Moreover, the method can also be used to fluorescently stain root hairs.	[Qu, Haiyong] Qingdao Agr Univ, Coll Hort, 700 Changcheng Rd, Qingdao, Shandong Provin, Peoples R China; [Xing, Wenxi; Wu, Fenfen; Wang, Yongzhang] Qingdao Agr Univ, Dept Hort, Qingdao, Peoples R China	Qingdao Agricultural University; Qingdao Agricultural University	Qu, HY (corresponding author), Qingdao Agr Univ, Coll Hort, 700 Changcheng Rd, Qingdao, Shandong Provin, Peoples R China.	haiyongqu@126.com	Qu, Haiyong/AAG-6678-2020	Qu, Haiyong/0000-0002-5786-450X	Shandong province natural fund	Shandong province natural fund	The work was supported by Shandong province natural fund.	Bothwell JHF, 2006, PLANT J, V46, P327, DOI 10.1111/j.1365-313X.2006.02687.x; Brack KE, 2010, EXP PHYSIOL, V95, P80, DOI 10.1113/expphysiol.2009.048215; BREWBAKE JL, 1963, AM J BOT, V50, P859, DOI 10.2307/2439772; Cui YN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145661; Fan JL, 2011, J PLANT PHYSIOL, V168, P1157, DOI 10.1016/j.jplph.2011.01.031; Froschauer EM, 2004, FEMS MICROBIOL LETT, V237, P49, DOI 10.1016/j.femsle.2004.06.013; Gee KR, 2000, CELL CALCIUM, V27, P97, DOI 10.1054/ceca.1999.0095; GELLI A, 1993, PLANT PHYSIOL, V102, P1139, DOI 10.1104/pp.102.4.1139; Hill AE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036585; HINKLE PM, 1992, J BIOL CHEM, V267, P25553; Iwano M, 2004, PLANT PHYSIOL, V136, P3562, DOI 10.1104/pp.104.046961; Kanchiswamy CN, 2014, INT J MOL SCI, V15, P3842, DOI 10.3390/ijms15033842; Kroeger JH, 2008, J THEOR BIOL, V253, P363, DOI 10.1016/j.jtbi.2008.02.042; KWAN CY, 1990, AM J PHYSIOL, V258, pC1006, DOI 10.1152/ajpcell.1990.258.6.C1006; Ling Y, 2013, PLANTA, V238, P831, DOI 10.1007/s00425-013-1938-5; MARUYAMA I, 1989, Journal of Toxicological Sciences, V14, P153; MCAINSH MR, 1995, PLANT CELL, V7, P1207, DOI 10.1105/tpc.7.8.1207; Michard E, 2008, SEX PLANT REPROD, V21, P169, DOI 10.1007/s00497-008-0076-x; Putney JW, 2014, CELL CALCIUM, V55, P290, DOI 10.1016/j.ceca.2014.01.001; Qu HY, 2007, NEW PHYTOL, V174, P524, DOI 10.1111/j.1469-8137.2007.02069.x; Sutachan JJ, 2006, BRAIN RES, V1068, P131, DOI 10.1016/j.brainres.2005.11.003; Takahashi A, 1999, PHYSIOL REV, V79, P1089, DOI 10.1152/physrev.1999.79.4.1089; Wang QL, 2005, PLANT PHYSIOL, V139, P1692, DOI 10.1104/pp.105.069765; Watahiki MK, 2004, SEX PLANT REPROD, V17, P125, DOI 10.1007/s00497-004-0224-x; Wu JY, 2012, ACTA PHYSIOL PLANT, V34, P969, DOI 10.1007/s11738-011-0893-7; Zhang WH, 1998, PLANT J, V15, P147, DOI 10.1046/j.1365-313X.1998.00188.x	26	15	16	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0152320	10.1371/journal.pone.0152320	http://dx.doi.org/10.1371/journal.pone.0152320			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27055240	Green Published, gold			2022-12-27	WOS:000373608000017
J	Templeman, NM; Mehran, AE; Johnson, JD				Templeman, Nicole M.; Mehran, Arya E.; Johnson, James D.			Hyper-Variability in Circulating Insulin, High Fat Feeding Outcomes, and Effects of Reducing Ins2 Dosage in Male Ins1-Null Mice in a Specific Pathogen-Free Facility	PLOS ONE			English	Article							DIET-INDUCED OBESITY; CHRONIC SOCIAL STRESS; GUT MICROBIOTA; GENE; RAT; HYPERINSULINEMIA; SECRETION; EXPOSURE; RELEASE; C57BL/6	Insulin is an essential hormone with key roles in energy homeostasis and body composition. Mice and rats, unlike other mammals, have two insulin genes: the rodent-specific Ins1 gene and the ancestral Ins2 gene. The relationships between insulin gene dosage and obesity has previously been explored in male and female Ins2(-/-) mice with full or reduced Ins1 dosage, as well as in female Ins1(-/-) mice with full or partial Ins2 dosage. We report herein unexpected hyper-variability in Ins1-null male mice, with respect to their circulating insulin levels and to the physiological effects of modulating Ins2 gene dosage. Two large cohorts of Ins1(-/-):Ins2(+/-) mice and their Ins1(-/-):Ins2(+/+) littermates were fed chow diet or high fat diet (HFD) from weaning, and housed in specific pathogen-free conditions. Cohort A and cohort B were studied one year apart. Contrary to female mice from the same litters, inactivating one Ins2 allele on the complete Ins1-null background did not consistently cause a reduction of circulating insulin in male mice, on either diet. In cohort A, all HFD-fed males showed an equivalent degree of insulin hypersecretion and weight gain, regardless of Ins2 dosage. In cohort B the effects of HFD appeared generally diminished, and cohort B Ins1(-/-):Ins2(+/-) males showed decreased insulin levels and body mass compared to Ins1(-/-):Ins2(+/+) littermates, on both diets. Although experimental conditions were consistent between cohorts, we found that HFD-fed Ins1(-/-):Ins2(+/-) mice with lower insulin levels had increased corticosterone. Collectively, these observations highlight the phenotypic characteristics that change in association with differences in circulating insulin and Ins2 gene dosage, particularly in male mice.	[Templeman, Nicole M.; Mehran, Arya E.; Johnson, James D.] Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V5Z 1M9, Canada	University of British Columbia	Johnson, JD (corresponding author), Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V5Z 1M9, Canada.	james.d.johnson@ubc.ca		Templeman, Nicole/0000-0003-2839-231X	Canadian Institutes of Health Research; Novo-Nordisk; Natural Science and Engineering Council of Canada Canadian Graduate Scholarship; University of British Columbia	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Novo-Nordisk(Novo Nordisk); Natural Science and Engineering Council of Canada Canadian Graduate Scholarship; University of British Columbia	Financial support was provided by an operating grant from Canadian Institutes of Health Research and from an unrestricted investigator-initiated grant from Novo-Nordisk to JDJ. NMT was supported by Natural Science and Engineering Council of Canada Canadian Graduate Scholarship, and by a Four-Year Fellowship from the University of British Columbia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Magdalena P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002069; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Berglund ED, 2008, DIABETES, V57, P1790, DOI 10.2337/db07-1615; Bruce-Keller AJ, 2015, BIOL PSYCHIAT, V77, P607, DOI 10.1016/j.biopsych.2014.07.012; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; DAVIES PO, 1994, GENOMICS, V21, P665, DOI 10.1006/geno.1994.1334; Delaunay F, 1997, J CLIN INVEST, V100, P2094, DOI 10.1172/JCI119743; DELTOUR L, 1993, P NATL ACAD SCI USA, V90, P527, DOI 10.1073/pnas.90.2.527; DELTOUR L, 1995, DEV BIOL, V168, P686, DOI 10.1006/dbio.1995.1114; Dror V, 2007, DIABETOLOGIA, V50, P2504, DOI 10.1007/s00125-007-0835-5; Duvillie B, 1997, P NATL ACAD SCI USA, V94, P5137, DOI 10.1073/pnas.94.10.5137; Duvillie B, 1998, GENOMICS, V47, P52, DOI 10.1006/geno.1997.5070; EBBESEN P, 1992, ANN NY ACAD SCI, V673, P46, DOI 10.1111/j.1749-6632.1992.tb27435.x; Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014; Fernandez-Twinn DS, 2006, PHYSIOL BEHAV, V88, P234, DOI 10.1016/j.physbeh.2006.05.039; Finger BC, 2011, NEUROSCIENCE, V192, P351, DOI 10.1016/j.neuroscience.2011.06.072; Fu Z, 2013, CURR DIABETES REV, V9, P25, DOI 10.2174/157339913804143225; GIDDINGS SJ, 1994, NAT GENET, V6, P310, DOI 10.1038/ng0394-310; Goodman PA, 1996, MOL CELL ENDOCRINOL, V120, P139, DOI 10.1016/0303-7207(96)03830-0; Goren HJ, 2004, ENDOCRINOLOGY, V145, P3307, DOI 10.1210/en.2003-1400; Hay CW, 2006, DIABETES, V55, P3201, DOI 10.2337/db06-0788; Jeong IK, 2001, DIABETES RES CLIN PR, V51, P163, DOI 10.1016/S0168-8227(00)00229-1; Jhaveri KA, 2007, BRAIN BEHAV IMMUN, V21, P975, DOI 10.1016/j.bbi.2007.03.007; KHAN A, 1992, AM J PHYSIOL, V263, pE663, DOI 10.1152/ajpendo.1992.263.4.E663; Lambillotte C, 1997, J CLIN INVEST, V99, P414, DOI 10.1172/JCI119175; Lee KTY, 2011, ENDOCRINOLOGY, V152, P3005, DOI 10.1210/en.2011-0060; Leroux L, 2001, DIABETES, V50, pS150, DOI 10.2337/diabetes.50.2007.S150; Li CY, 2006, DIABETES CARE, V29, P2396, DOI 10.2337/dc06-0289; LINDE S, 1989, J CHROMATOGR, V462, P243, DOI 10.1016/S0021-9673(00)91351-7; Maniam J, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00073; Mayer EJ, 1996, AM J EPIDEMIOL, V143, P323; McAuley KA, 2001, DIABETES CARE, V24, P460, DOI 10.2337/diacare.24.3.460; Mehran A, 2015, PREPRINT; Mehran AE, 2012, CELL METAB, V16, P723, DOI 10.1016/j.cmet.2012.10.019; Mekada K, 2009, EXP ANIM TOKYO, V58, P141, DOI 10.1538/expanim.58.141; Meur G, 2011, J BIOL CHEM, V286, P13647, DOI 10.1074/jbc.M110.204248; Morimoto S, 2001, ENDOCRINOLOGY, V142, P1442, DOI 10.1210/en.142.4.1442; Mott R, 2014, CELL, V156, P332, DOI 10.1016/j.cell.2013.11.043; Murgatroyd C, 2009, NAT NEUROSCI, V12, P1559, DOI 10.1038/nn.2436; O'Regan D, 2004, AM J PHYSIOL-ENDOC M, V287, pE863, DOI 10.1152/ajpendo.00137.2004; Pascuan CG, 2014, J IMMUNOTOXICOL, V11, P78, DOI 10.3109/1547691X.2013.800171; Peters J, 2014, NAT REV GENET, V15, P517, DOI 10.1038/nrg3766; Phillips TJ, 1999, PSYCHOPHARMACOLOGY, V147, P5, DOI 10.1007/s002130051128; Rasmussen S, 2009, J AM ASSOC LAB ANIM, V48, P363; Salvalaggio PRO, 2002, TRANSPLANTATION, V74, P877, DOI 10.1097/00007890-200209270-00023; SCHUMACHER MC, 1992, DIABETES, V41, P416, DOI 10.2337/diabetes.41.4.416; Shiao MS, 2008, GENETICS, V178, P1683, DOI 10.1534/genetics.108.087023; SOARES MB, 1985, MOL CELL BIOL, V5, P2090, DOI 10.1128/MCB.5.8.2090; Sorge RE, 2014, NAT METHODS, V11, P629, DOI [10.1038/nmeth.2935, 10.1038/NMETH.2935]; Sterlemann V, 2008, HORM BEHAV, V53, P386, DOI 10.1016/j.yhbeh.2007.11.001; Templeman NM, 2015, DIABETOLOGIA, V58, P2392, DOI 10.1007/s00125-015-3676-7; THURLBY PL, 1979, BRIT J NUTR, V42, P377, DOI 10.1079/BJN19790127; WENTWORTH BM, 1992, MOL CELL ENDOCRINOL, V86, P177, DOI 10.1016/0303-7207(92)90142-S; WENTWORTH BM, 1986, J MOL EVOL, V23, P305, DOI 10.1007/BF02100639; Wolfer DP, 2002, TRENDS NEUROSCI, V25, P336, DOI 10.1016/S0166-2236(02)02192-6; Wong WPS, 2010, P NATL ACAD SCI USA, V107, P13057, DOI 10.1073/pnas.0914501107; Zardooz H, 2006, LIFE SCI, V79, P57, DOI 10.1016/j.lfs.2005.12.032	57	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153280	10.1371/journal.pone.0153280	http://dx.doi.org/10.1371/journal.pone.0153280			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27055260	Green Published, gold, Green Submitted			2022-12-27	WOS:000373608000114
J	Zicari, AM; Occasi, F; Di Mauro, F; Lollobrigida, V; Di Fraia, M; Savastano, V; Loffredo, L; Nicita, F; Spalice, A; Duse, M				Zicari, Anna Maria; Occasi, Francesca; Di Mauro, Federica; Lollobrigida, Valeria; Di Fraia, Marco; Savastano, Vincenzo; Loffredo, Lorenzo; Nicita, Francesco; Spalice, Alberto; Duse, Marzia			Mean Platelet Volume, Vitamin D and C Reactive Protein Levels in Normal Weight Children with Primary Snoring and Obstructive Sleep Apnea Syndrome	PLOS ONE			English	Article							DYSFUNCTION; RISK	Introduction Studies on Mean Platelet Volume (MPV) in children with Sleep Disordered Breathing (SDB) report conflicting results and the hypothesis of an intermittent hypoxemia leading to a systemic inflammation is reaching consensus. Vitamin D exerts anti-inflammatory properties and its deficiency has been supposed to play a role in sleep disorders. Emerging interest is rising about Primary Snoring (PS) since it is reasonable that also undetectable alteration of hypoxia might predispose to an increased production of inflammatory mediators. In this perspective, in a group of children affected by SDB, our aim was to investigate MPV, vitamin D and C Reactive Protein (CRP) levels, which had been previously evaluated separately in different studies focused only on Obstructive Sleep Apnea Syndrome (OSAS). Materials and Methods We enrolled 137 children: 70 healthy controls (HC), 67 affected by SDB undergoing a polysomnographic evaluation, 22 with a diagnosis of PS and 45 with a diagnosis of OSAS. All patients underwent routine biochemical evaluations including blood cell counts, CRP and vitamin D. Results Children affected by SDB had a mean age of 8.49 +/- 2.19 and were prevalently males (23 females, 34%; 44 males, 66%). MPV levels were higher in OSAS and PS when compared to HC; platelet count (PLT) and CRP levels were higher while Vitamin D levels were lower in children with SDB when compared to HC. MPV levels were correlated with PLT (r = -0.54; p<0.001), vitamin D (r = -0.39; p<0.001) and CRP (r = 0.21; p<0.01). A multiple regression was run to predict MPV levels from vitamin D, CRP and PLT and these variables significantly predicted MPV (F = 17.42, p<0.0001; adjusted R2 = 0.37). Only platelet count and vitamin D added statistically significantly to the prediction (p<0.05). Conclusion The present study provides evidence of higher MPV and lower vitamin D levels in children with PS as well as in children with OSAS, and supports the underlying inflammation, hence, highlighting the importance of an early diagnosis of this previously considered benign form of SDB.	[Zicari, Anna Maria; Occasi, Francesca; Di Mauro, Federica; Lollobrigida, Valeria; Di Fraia, Marco; Savastano, Vincenzo; Nicita, Francesco; Spalice, Alberto; Duse, Marzia] Univ Roma La Sapienza, Dept Pediat, Piazzale Aldo Moro 5, I-00185 Rome, Italy; [Loffredo, Lorenzo] Univ Roma La Sapienza, Dept Internal Med & Med Specialties, Piazzale Aldo Moro 5, I-00185 Rome, Italy	Sapienza University Rome; Sapienza University Rome	Occasi, F (corresponding author), Univ Roma La Sapienza, Dept Pediat, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	occasi.f@gmail.com	Loffredo, Lorenzo/K-4873-2016; ZICARI, Anna Maria/K-7921-2018; Nicita, Francesco/F-8529-2018	Loffredo, Lorenzo/0000-0002-6542-6235; Spalice, Alberto/0000-0002-8455-796X; Di Fraia, Marco/0000-0002-9679-8859; ZICARI, Anna Maria/0000-0002-2476-1790; Nicita, Francesco/0000-0002-5612-821X				Au CT, 2009, PEDIATR CLIN N AM, V56, P243, DOI 10.1016/j.pcl.2008.10.012; Autier P, 2014, LANCET DIABETES ENDO, V2, P76, DOI 10.1016/S2213-8587(13)70165-7; Biggs SN, 2014, SLEEP MED REV, V18, P463, DOI 10.1016/j.smrv.2014.06.009; BRODSKY L, 1987, INT J PEDIATR OTORHI, V13, P149, DOI 10.1016/0165-5876(87)90091-7; BROUILETTE R, 1984, J PEDIATR-US, V105, P10, DOI 10.1016/S0022-3476(84)80348-0; Cannell JJ, 2014, DERM-ENDOCRINOL, V6, DOI 10.4161/19381980.2014.983401; Carlander B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020433; Carra MC, 2012, J OROFAC PAIN, V26, P267; CARROLL JL, 1995, CHEST, V108, P610, DOI 10.1378/chest.108.3.610; Cassano P, 2003, INT J PEDIATR OTORHI, V67, P1303, DOI 10.1016/j.ijporl.2003.07.018; Cengiz C, 2013, PAK J MED SCI, V29, P569, DOI 10.12669/pjms.292.2715; Chu SG, 2010, J THROMB HAEMOST, V8, P148, DOI 10.1111/j.1538-7836.2009.03584.x; Cook DG, 2000, ATHEROSCLEROSIS, V149, P139, DOI 10.1016/S0021-9150(99)00312-3; Cure MC, 2014, ANN LAB MED, V34, P98, DOI 10.3343/alm.2014.34.2.98; Di Rosa M, 2012, CELL IMMUNOL, V280, P36, DOI 10.1016/j.cellimm.2012.10.009; Gasparyan AY, 2011, CURR PHARM DESIGN, V17, P47; Gozal D, 2007, AM J RESP CRIT CARE, V176, P188, DOI 10.1164/rccm.200610-1519OC; Kapsoritakis AN, 2001, AM J GASTROENTEROL, V96, P776; Khalyfa A, 2011, SLEEP, V34, P153, DOI 10.1093/sleep/34.2.153; Kheirandish-Gozal L, 2010, SLEEP MED, V11, P714, DOI 10.1016/j.sleep.2009.12.013; Koyama T, 1998, SEMIN THROMB HEMOST, V24, P217, DOI 10.1055/s-2007-995845; Li AM, 2013, INT J CARDIOL, V167, P2092, DOI 10.1016/j.ijcard.2012.05.108; Li AM, 2009, J PEDIATR-US, V155, P362, DOI 10.1016/j.jpeds.2009.03.041; Liefaard MC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131740; Loffredo L, 2015, ATHEROSCLEROSIS, V240, P222, DOI 10.1016/j.atherosclerosis.2015.03.024; Marcus CL, 2012, PEDIATRICS, V130, pE714, DOI 10.1542/peds.2012-1672; Mete T, 2013, J ENDOCRINOL INVEST, V36, P681, DOI 10.3275/8923; Onder S, 2014, INT J PEDIATR OTORHI, V78, P1449, DOI 10.1016/j.ijporl.2014.06.001; Peterson CA, 2008, J INFLAMM-LOND, V5, DOI 10.1186/1476-9255-5-10; Reid D, 2011, INT J PEDIATR OTORHI, V75, P261, DOI 10.1016/j.ijporl.2010.11.012; Sagit M, 2012, J CRANIOFAC SURG, V23, P974, DOI 10.1097/SCS.0b013e31824e2c08; Sokucu SN, 2014, PULM MED, V2014, DOI 10.1155/2014/754839; Soyalic Harun, 2015, Kulak Burun Bogaz Ihtis Derg, V25, P16, DOI 10.5606/kbbihtisas.2015.28863; Tauman R, 2004, SLEEP, V27, P502, DOI 10.1093/sleep/27.3.502; Tauman R, 2004, PEDIATRICS, V113, pE564, DOI 10.1542/peds.113.6.e564; Varol E, 2015, PLATELETS, V26, P274, DOI 10.3109/09537104.2013.867939; Varol E, 2010, SCAND J CLIN LAB INV, V70, P497, DOI 10.3109/00365513.2010.520733; Gonzalez EV, 2010, ACTA OTORRINOLAR ESP, V61, P14, DOI 10.1016/S0001-6519(10)71240-1; Vlahandonis A, 2013, SLEEP MED REV, V17, P75, DOI 10.1016/j.smrv.2012.04.004; Wang TJ, 2008, CIRCULATION, V117, P503, DOI 10.1161/CIRCULATIONAHA.107.706127; Zicari AM, 2014, INT J IMMUNOPATH PH, V27, P449, DOI 10.1177/039463201402700317	41	22	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0152497	10.1371/journal.pone.0152497	http://dx.doi.org/10.1371/journal.pone.0152497			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27054959	Green Submitted, Green Published, gold			2022-12-27	WOS:000373608000022
J	Morgan, AJL; San Jose, LH; Jamieson, WD; Wymant, JM; Song, B; Stephens, P; Barrow, DA; Castell, OK				Morgan, Alex J. L.; San Jose, Lorena Hidalgo; Jamieson, William D.; Wymant, Jennifer M.; Song, Bing; Stephens, Phil; Barrow, David A.; Castell, Oliver K.			Simple and Versatile 3D Printed Microfluidics Using Fused Filament Fabrication	PLOS ONE			English	Article							DNA ANALYSIS; STEM-CELLS; DEVICES; CHIP; ENCAPSULATION; TECHNOLOGIES; GENERATION; ELECTRODES; SEPARATION; THERAPY	The uptake of microfluidics by the wider scientific community has been limited by the fabrication barrier created by the skills and equipment required for the production of traditional microfluidic devices. Here we present simple 3D printed microfluidic devices using an inexpensive and readily accessible printer with commercially available printer materials. We demonstrate that previously reported limitations of transparency and fidelity have been overcome, whilst devices capable of operating at pressures in excess of 2000 kPa illustrate that leakage issues have also been resolved. The utility of the 3D printed microfluidic devices is illustrated by encapsulating dental pulp stem cells within alginate droplets; cell viability assays show the vast majority of cells remain live, and device transparency is sufficient for single cell imaging. The accessibility of these devices is further enhanced through fabrication of integrated ports and by the introduction of a Lego (R)-like modular system facilitating rapid prototyping whilst offering the potential for novices to build microfluidic systems from a database of microfluidic components.	[Morgan, Alex J. L.; San Jose, Lorena Hidalgo; Barrow, David A.] Cardiff Univ, Cardiff Sch Engn, Queens Bldg, Cardiff CF24 3AA, S Glam, Wales; [Jamieson, William D.; Wymant, Jennifer M.; Castell, Oliver K.] Cardiff Univ, Sch Pharm & Pharmaceut Sci, Redwood Bldg,King Edward VII Ave, Cardiff CF10 3NB, S Glam, Wales; [San Jose, Lorena Hidalgo; Song, Bing; Stephens, Phil] Cardiff Univ, Sch Dent, Cardiff Inst Tissue Engn & Repair, Oral & Biomed Sci, Heath Pk, Cardiff CF14 4XY, S Glam, Wales	Cardiff University; Cardiff University; Cardiff University	Morgan, AJL (corresponding author), Cardiff Univ, Cardiff Sch Engn, Queens Bldg, Cardiff CF24 3AA, S Glam, Wales.	morganaj3@cardiff.ac.uk	Morgan, Alex/AAQ-1119-2020; Song, Bing/AAB-4755-2021; Castell, Oliver/N-9340-2014; Jamieson, William/F-9534-2016	Song, Bing/0000-0001-9356-2333; Castell, Oliver/0000-0002-6059-8062; Jamieson, William/0000-0001-8260-5211	synbiCITE through the Cardiff University Synthetic Biology Initiative; European Research Council, StG [243261]; Cancer Research Wales; EPSRC [EP/H045848/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/H045848/1] Funding Source: researchfish	synbiCITE through the Cardiff University Synthetic Biology Initiative; European Research Council, StG(European Research Council (ERC)); Cancer Research Wales; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This study was funded by synbiCITE (synbicite.com) through the Cardiff University Synthetic Biology Initiative, AJLM, and European Research Council, StG grant 243261, LHSJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Cell stains were gratefully received from Professor Arwyn Jones, School of Pharmacy and Pharmaceutical Sciences, Cardiff University. J. Wymant is supported by Cancer Research Wales. Oliver K Castell is a Cardiff University SBP Research Fellow.	Agresti JJ, 2010, P NATL ACAD SCI USA, V107, P4004, DOI 10.1073/pnas.0910781107; Au AK, 2014, LAB CHIP, V14, P1294, DOI 10.1039/c3lc51360b; Autebert J, 2012, METHODS, V57, P297, DOI 10.1016/j.ymeth.2012.07.002; Baret JC, 2009, LAB CHIP, V9, P1850, DOI 10.1039/b902504a; Barrow DA, 2011, J CHROMATOGR A, V1218, P1983, DOI 10.1016/j.chroma.2010.11.086; Berthier E, 2012, LAB CHIP, V12, P1224, DOI 10.1039/c2lc20982a; Bhargava KC, 2014, P NATL ACAD SCI USA, V111, P15013, DOI 10.1073/pnas.1414764111; Bhattacharya S, 2005, J MICROELECTROMECH S, V14, P590, DOI 10.1109/JMEMS.2005.844746; Bishop GW, 2015, ANAL CHEM, V87, P5437, DOI 10.1021/acs.analchem.5b00903; Capel AJ, 2013, LAB CHIP, V13, P4583, DOI 10.1039/c3lc50844g; Caplan AI, 2005, TISSUE ENG, V11, P1198, DOI 10.1089/ten.2005.11.1198; Choi S, 2007, LAB CHIP, V7, P1532, DOI 10.1039/b705203k; Crevensten G, 2004, ANN BIOMED ENG, V32, P430, DOI 10.1023/B:ABME.0000017545.84833.7c; Erkal JL, 2014, LAB CHIP, V14, P2023, DOI 10.1039/c4lc00171k; Gillies JM, 2006, APPL RADIAT ISOTOPES, V64, P333, DOI 10.1016/j.apradiso.2005.08.009; Gunther A, 2006, LAB CHIP, V6, P1487, DOI 10.1039/b609851g; Guo MT, 2012, LAB CHIP, V12, P2146, DOI 10.1039/c2lc21147e; Ho CMB, 2015, 3D PRINTED MICROFLUI; Hosokawa K, 2004, LAB CHIP, V4, P181, DOI 10.1039/b403930k; Hutchings MJ, 2013, MICROREACTORS IN ORGANIC CHEMISTRY AND CATALYSIS, 2ND EDITION, P197; Khandurina J, 2000, ANAL CHEM, V72, P2995, DOI 10.1021/ac991471a; Kim P, 2008, SOFT LITHOGRAPHY FOR; Kitson PJ, 2012, LAB CHIP, V12, P3267, DOI 10.1039/c2lc40761b; Koster S, 2008, LAB CHIP, V8, P1110, DOI 10.1039/b802941e; Langelier SM, 2011, LAB CHIP, V11, P1679, DOI 10.1039/c0lc00517g; Lee J, 2008, TISSUE ENG PART B-RE, V14, P61, DOI 10.1089/teb.2007.0150; Lee W, 2014, ANAL CHEM, V86, P6683, DOI 10.1021/ac501436d; Lion N, 2003, ELECTROPHORESIS, V24, P3533, DOI 10.1002/elps.200305629; Machluf M, 2000, WORLD J UROL, V18, P80, DOI 10.1007/s003450050014; Mao XL, 2012, LAB CHIP, V12, P1412, DOI 10.1039/c2lc90022j; Martino C, 2014, LAB CHIP, V14, P4178, DOI 10.1039/c4lc00992d; Mathieson JS, 2013, BEILSTEIN J NANOTECH, V4, P285, DOI 10.3762/bjnano.4.31; Rhee M, 2008, LAB CHIP, V8, P1365, DOI 10.1039/b805137b; Sackmann EK, 2014, NATURE, V507, P181, DOI 10.1038/nature13118; Shallan AI, 2014, ANAL CHEM, V86, P3124, DOI 10.1021/ac4041857; Tabar V, 2014, NAT REV GENET, V15, P82, DOI 10.1038/nrg3563; Therriault D, 2003, NAT MATER, V2, P265, DOI 10.1038/nmat863; Tseng Peter, 2014, Lab Chip, V14, P1491, DOI 10.1039/c4lc90023e; Waldbaur A, 2011, ANAL METHODS-UK, V3, P2681, DOI 10.1039/c1ay05253e; Weigl BH, 2003, ADV DRUG DELIVER REV, V55, P349, DOI 10.1016/S0169-409X(02)00223-5; Wells WA, 1998, CHEM BIOL, V5, pR115, DOI 10.1016/S1074-5521(98)90623-8; Wu LD, 2012, ANAL CHEM, V84, P9324, DOI 10.1021/ac302085y; Yager P, 2006, NATURE, V442, P412, DOI 10.1038/nature05064; Yobas L, 2006, LAB CHIP, V6, P1073, DOI 10.1039/b602240e; Yuen PK, 2008, LAB CHIP, V8, P1374, DOI 10.1039/b805086d	45	104	107	8	125	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0152023	10.1371/journal.pone.0152023	http://dx.doi.org/10.1371/journal.pone.0152023			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050661	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000373603500021
J	Nakahashi, S; Yamada, T; Ogura, T; Nakajima, K; Suzuki, K; Imai, H				Nakahashi, Susumu; Yamada, Tomomi; Ogura, Toru; Nakajima, Ken; Suzuki, Kei; Imai, Hiroshi			Association of Patient Care with Ventilator-Associated Conditions in Critically Ill Patients: Risk Factor Analysis	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; ACUTE LUNG INJURY; EVENTS; PNEUMONIA; SURVEILLANCE; PREVENTION; PREVENTABILITY; IMPLEMENTATION; DEFINITION; GUIDELINE	Background Ventilator-associated conditions (VACs), for which new surveillance definitions and methods were issued by the Center for Disease Control and Prevention (CDC), are respiratory complications occurring in conjunction with the use of invasive mechanical ventilation and are related to adverse outcomes in critically ill patients. However, to date, risk factors for VACs have not been adequately established, leading to a need for developing a better understanding of the risks. The objective of this study was to explore care-related risk factors as a process indicator and provide valuable information pertaining to VAC preventive measures. Methods This retrospective, single-center, cohort study was conducted in the intensive-care unit (ICU) of a university hospital in Japan. Patient data were automatically sampled using a computerized medical records system and retrospectively analyzed. Management and care-related, but not host-related, factors were exhaustively analyzed using multivariate analysis for risks of VACs. VAC correlation to mortality was also investigated. Results Of the 3122 patients admitted in the ICU, 303 ventilated patients meeting CDC-specified eligibility criteria were included in the analysis. Thirty-seven VACs (12.2%) were found with a corresponding rate of 12.1 per 1000 ventilator days. Multivariate analysis revealed four variables related to patient care as risk factors for VACs: absence of intensivist participation in management of ventilated patients [adjusted HR (AHR): 7.325, P < 0.001)], using relatively higher driving pressure (AHR: 1.216, P < 0.001), development of edema (AHR: 2.145, P = 0.037), and a larger body weight increase (AHR: 0.058, P = 0.005). Furthermore, this research confirmed mortality differences in patients with VACs and statistically derived risks compared with those without VACs (HR: 2.623, P = 0.008). Conclusion Four risk factors related to patient care were clearly identified to be the key factors for VAC preventive measures.	[Nakahashi, Susumu; Suzuki, Kei; Imai, Hiroshi] Mie Univ Hosp, Dept Emergency, Tsu, Mie, Japan; [Nakahashi, Susumu; Suzuki, Kei; Imai, Hiroshi] Mie Univ Hosp, Crit Care Ctr, Tsu, Mie, Japan; [Yamada, Tomomi] Osaka Univ, Grad Sch Med, Dept Clin Epidemiol & Biostat, Suita, Osaka, Japan; [Ogura, Toru] Mie Univ Hosp, Clin Res Support Ctr, Tsu, Mie, Japan; [Nakajima, Ken] Mie Univ, Sch Med, Dept Radiol, Tsu, Mie 514, Japan	Mie University; Mie University; Osaka University; Mie University; Mie University	Nakahashi, S (corresponding author), Mie Univ Hosp, Dept Emergency, Tsu, Mie, Japan.; Nakahashi, S (corresponding author), Mie Univ Hosp, Crit Care Ctr, Tsu, Mie, Japan.	n14w4@s3.dion.ne.jp						Abbott CA, 2006, WORLDV EVID-BASED NU, V3, P139, DOI 10.1111/j.1741-6787.2006.00066.x; Al-Tawfiq JA, 2010, AM J INFECT CONTROL, V38, P552, DOI 10.1016/j.ajic.2010.01.008; Amato MBP, 2015, NEW ENGL J MED, V372, P747, DOI 10.1056/NEJMsa1410639; Boyer AF, 2015, CHEST, V147, P68, DOI 10.1378/chest.14-0544; Caserta RA, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-234; Chittawatanarat K, 2015, THER CLIN RISK MANAG, V11, P1097, DOI 10.2147/TCRM.S86409; Dessap AM, 2014, CHEST, V146, P58, DOI 10.1378/chest.13-2564; Gattinoni L, 2006, NEW ENGL J MED, V354, P1775, DOI 10.1056/NEJMoa052052; Graf J, 2008, CURR OPIN CRIT CARE, V14, P44, DOI 10.1097/MCC.0b013e3282f2f4cb; Hawe CS, 2009, INTENS CARE MED, V35, P1180, DOI 10.1007/s00134-009-1461-0; Hayashi Y, 2013, CLIN INFECT DIS, V56, P471, DOI 10.1093/cid/cis926; Klompas M, 2007, JAMA-J AM MED ASSOC, V297, P1583, DOI 10.1001/jama.297.14.1583; Klompas M, 2015, AM J RESP CRIT CARE, V191, P292, DOI 10.1164/rccm.201407-1394OC; Klompas M, 2014, INFECT CONT HOSP EP, V35, P502, DOI 10.1086/675834; Klompas M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018062; Klouwenberg PMCK, 2014, AM J RESP CRIT CARE, V189, P947, DOI 10.1164/rccm.201307-1376OC; Lewis SC, 2014, CRIT CARE MED, V42, P1839, DOI 10.1097/CCM.0000000000000338; Lilly CM, 2014, CRIT CARE MED, V42, P2019, DOI 10.1097/CCM.0000000000000396; Marini JJ, 2008, CRIT CARE MED, V36, P3252, DOI 10.1097/CCM.0b013e31818f0e68; Muscedere J, 2013, CHEST, V144, P1453, DOI 10.1378/chest.13-0853; (NHSN) CfDCaPNHSN, SURV VENT ASS EV; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Raoof S, 2014, AM J CRIT CARE, V23, P7, DOI 10.4037/ajcc2014469; Resar R, 2005, JT COMM J QUAL PATIE, V31, P243, DOI 10.1016/S1553-7250(05)31031-2; Sakr Y, 2005, CHEST, V128, P3098, DOI 10.1378/chest.128.5.3098; Shime N, 2012, CHEST, V141, P281, DOI 10.1378/chest.11-2387; Slutsky AS, 2013, NEW ENGL J MED, V369, P2126, DOI 10.1056/NEJMra1208707; Stevens JP, 2014, CHEST, V146, P1612, DOI 10.1378/chest.13-2255; Sundararajan V, 2004, J CLIN EPIDEMIOL, V57, P1288, DOI 10.1016/j.jclinepi.2004.03.012; Wiedemann HP, 2006, NEW ENGL J MED, V354, P2564	30	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0153060	10.1371/journal.pone.0153060	http://dx.doi.org/10.1371/journal.pone.0153060			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050836	Green Submitted, Green Published, gold			2022-12-27	WOS:000373603500091
J	Badura, P; Sigmund, E; Geckova, AM; Sigmundova, D; Sirucek, J; van Dijk, JP; Reijneveld, SA				Badura, Petr; Sigmund, Erik; Geckova, Andrea Madarasova; Sigmundova, Dagmar; Sirucek, Jan; van Dijk, Jitse P.; Reijneveld, Sijmen A.			Is Participation in Organized Leisure-Time Activities Associated with School Performance in Adolescence?	PLOS ONE			English	Article							YOUTH ACTIVITY INVOLVEMENT; FAMILY AFFLUENCE SCALE; AGED CHILDREN HBSC; EXTRACURRICULAR ACTIVITIES; ACADEMIC-ACHIEVEMENT; HEALTH BEHAVIOR; DEVELOPMENTAL EXPERIENCES; PHYSICAL-ACTIVITY; AFRICAN-AMERICAN; ADULT SUPPORT	Background Organized leisure-time activities (OLTA) have been identified as a context suitable for improvement of school performance. This study aimed to assess the associations between participation in OLTA and school engagement, school-related stress, academic achievement and whether these associations differ by specific pattern of OLTA participation, gender and age. Furthermore, it assessed whether OLTA participants are more likely to acquire support for schoolwork from outside the family. Methods The sample concerned 10,483 adolescents (49.2% boys) aged 11, 13 and 15 from the Health Behaviour in School-aged Children data collection in 2014 in the Czech Republic. Logistic regressions adjusted for gender and age were used to analyse the associations between participation in OLTA and four education-related outcomes. Results Participation in OLTA was associated with higher school engagement, lower levels of school-related stress and better academic achievement regardless of gender and age. The strongest associations were observed for adolescents involved in various types of OLTA concurrently, with odds ratios ranging from 1.34 (95% confidence interval (CI) 1.17-1.54) for lower school-related stress to 1.97 (95% CI 1.73-2.25) for above-average academic achievement. OLTA participants were also more likely to have a non-familial person to help them with schoolwork, though this association was weaker in 15-year-olds. Conclusion Youth involvement in OLTA is linked to general better school performance and attachment to school. Adolescents participating in more activities at the same time have the best school performance.	[Badura, Petr; Sigmund, Erik; Geckova, Andrea Madarasova; Sigmundova, Dagmar] Palacky Univ, Inst Act Lifestyle, Fac Phys Culture, CR-77147 Olomouc, Czech Republic; [Geckova, Andrea Madarasova; van Dijk, Jitse P.] Palacky Univ, Olomouc Univ Soc & Hlth Inst, CR-77147 Olomouc, Czech Republic; [Geckova, Andrea Madarasova] Safarik Univ, Dept Hlth Psychol, Fac Med, Kosice, Slovakia; [Geckova, Andrea Madarasova; van Dijk, Jitse P.] Safarik Univ, Grad Sch, Kosice Inst Soc & Hlth, Kosice, Slovakia; [Sirucek, Jan] Masaryk Univ, Inst Res Children Youth & Family, Fac Social Studies, Brno, Czech Republic; [van Dijk, Jitse P.; Reijneveld, Sijmen A.] Univ Groningen, Univ Med Ctr Groningen, Dept Community & Occupat Med, Groningen, Netherlands	Palacky University Olomouc; Palacky University Olomouc; University of Pavol Jozef Safarik Kosice; University of Pavol Jozef Safarik Kosice; Masaryk University Brno; University of Groningen	Badura, P (corresponding author), Palacky Univ, Inst Act Lifestyle, Fac Phys Culture, CR-77147 Olomouc, Czech Republic.	petr.badura@upol.cz	Sigmund, Erik/A-1173-2013; Geckova, Andrea Madarasova/C-4082-2012; Geckova, Andrea Madarasova/AAF-2993-2019; Badura, Petr/M-5081-2016; Sigmundová, Dagmar/G-6413-2016; Sirucek, Jan/T-9154-2019	Sigmund, Erik/0000-0002-5643-5586; Geckova, Andrea Madarasova/0000-0003-2993-3798; Geckova, Andrea Madarasova/0000-0003-2993-3798; Badura, Petr/0000-0003-0261-018X; Sigmundová, Dagmar/0000-0002-2603-8117; Sirucek, Jan/0000-0001-9939-9864; Reijneveld, Sijmen/0000-0002-1206-7523	Slovak Research and Development Agency [APVV-0032-11]; Czech Science Foundation [GA14-02804S]; Ministry of Education, Youth and Sports (MEYS) of Czech Republic [LG 14043]	Slovak Research and Development Agency(Slovak Research and Development Agency); Czech Science Foundation(Grant Agency of the Czech Republic); Ministry of Education, Youth and Sports (MEYS) of Czech Republic	This work was supported by the Slovak Research and Development Agency under contract No. APVV-0032-11, by a research grant from the Czech Science Foundation under reg. No. GA14-02804S and by the Ministry of Education, Youth and Sports (MEYS) of the Czech Republic under Contract No. LG 14043.	Appleton JJ, 2008, PSYCHOL SCHOOLS, V45, P369, DOI 10.1002/pits.20303; Badura P, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2427-5; Bohnert A, 2010, REV EDUC RES, V80, P576, DOI 10.3102/0034654310364533; Bosakova L, 2015, INT J PUBLIC HEALTH, P1, DOI [10.1007/s00038-0150-0749-9, DOI 10.1007/S00038-0150-0749-9]; Boyce W, 2006, SOC INDIC RES, V78, P473, DOI 10.1007/s11205-005-1607-6; Covay E, 2010, SOCIOL EDUC, V83, P20, DOI 10.1177/0038040709356565; Crean HF, 2012, J APPL DEV PSYCHOL, V33, P175, DOI 10.1016/j.appdev.2012.04.003; Currie C, 2014, HEALTH BEHAVIOUR IN; Currie C, 2008, SOC SCI MED, V66, P1429, DOI 10.1016/j.socscimed.2007.11.024; Currie C, 2009, INT J PUBLIC HEALTH, V54, P131, DOI 10.1007/s00038-009-5404-x; Darling N, 2005, J YOUTH ADOLESCENCE, V34, P493, DOI 10.1007/s10964-005-7266-8; Domazet SL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146319; Dotterer AM, 2007, J YOUTH ADOLESCENCE, V36, P391, DOI 10.1007/s10964-006-9161-3; Dworkin JB, 2003, J YOUTH ADOLESCENCE, V32, P17, DOI 10.1023/A:1021076222321; Eccles JS, 2011, J RES ADOLESCENCE, V21, P225, DOI 10.1111/j.1532-7795.2010.00725.x; Eccles JS, 2003, J SOC ISSUES, V59, P865, DOI 10.1046/j.0022-4537.2003.00095.x; Elgar FJ, 2015, LANCET, V385, P2088, DOI 10.1016/S0140-6736(14)61460-4; Esteban-Cornejo I, 2015, MED SCI SPORT EXER, V47, P2552, DOI 10.1249/MSS.0000000000000706; Felder-Puig R, 2012, J SCHOOL HEALTH, V82, P404, DOI 10.1111/j.1746-1561.2012.00715.x; Fischer N, 2014, DEV PSYCHOL, V50, P1788, DOI 10.1037/a0036705; Fredricks JA, 2006, DEV PSYCHOL, V42, P698, DOI 10.1037/0012-1649.42.4.698; Fredricks JA, 2012, J YOUTH ADOLESCENCE, V41, P295, DOI 10.1007/s10964-011-9704-0; Fredricks JA, 2010, J RES ADOLESCENCE, V20, P307, DOI 10.1111/j.1532-7795.2009.00627.x; Gibbs BG, 2015, SOC SCI RES, V50, P367, DOI 10.1016/j.ssresearch.2014.08.013; Guevremont A, 2014, J SCHOOL HEALTH, V84, P317, DOI 10.1111/josh.12154; Haapasalo I, 2010, SCAND J EDUC RES, V54, P133, DOI 10.1080/00313831003637915; Hansen DM, 2010, J APPL DEV PSYCHOL, V31, P413, DOI 10.1016/j.appdev.2010.07.001; Hansen DM, 2003, J RES ADOLESCENCE, V13, P25, DOI 10.1111/1532-7795.1301006; Himelfarb I, 2014, EDUC STUD-UK, V40, P81, DOI 10.1080/03055698.2013.821941; Knifsend CA, 2012, J YOUTH ADOLESCENCE, V41, P379, DOI 10.1007/s10964-011-9737-4; Larson RW, 2006, DEV PSYCHOL, V42, P849, DOI 10.1037/0012-1649.42.5.849; Larson RW, 2000, AM PSYCHOL, V55, P170, DOI 10.1037/0003-066X.55.1.170; Lerner R. M., 2005, WORKSH SCI AD HLTH D; Lerner Richard M, 2012, New Dir Youth Dev, V2012, P119, DOI 10.1002/yd.20034; Mahoney JL, 1997, DEV PSYCHOL, V33, P241, DOI 10.1037/0012-1649.33.2.241; Metsapelto RL, 2012, SCAND J EDUC RES, V56, P167, DOI 10.1080/00313831.2011.581681; Metzger A, 2009, J EARLY ADOLESCENCE, V29, P426, DOI 10.1177/0272431608322949; Morris DS, 2015, YOUTH SOC, V47, P267, DOI 10.1177/0044118X12461159; Mueller MK, 2011, J ADOLESCENCE, V34, P1115, DOI 10.1016/j.adolescence.2011.07.010; Newland LA, 2015, CHILD INDIC RES, V8, P177, DOI 10.1007/s12187-014-9287-x; Ottova V, 2012, J EARLY ADOLESCENCE, V32, P126, DOI 10.1177/0272431611419510; Pickett W, 2006, INJURY PREV, V12, P87, DOI 10.1136/ip.2005.011106; Pitel L, 2012, J EPIDEMIOL COMMUN H, V66, P1122, DOI 10.1136/jech-2011-200914; Ravens-Sieberer U, 2004, YOUNG PEOPLES HEALTH; Rose-Krasnor L, 2006, J YOUTH ADOLESCENCE, V35, P385, DOI 10.1007/s10964-006-9037-6; Schaefer DR, 2011, DEV PSYCHOL, V47, P1141, DOI 10.1037/a0024091; Sharp EH, 2015, J YOUTH ADOLESCENCE, V44, P62, DOI 10.1007/s10964-014-0153-4; Sigmundova D, 2014, INT J ENV RES PUB HE, V11, P7163, DOI 10.3390/ijerph110707163; Strenze T, 2007, INTELLIGENCE, V35, P401, DOI 10.1016/j.intell.2006.09.004; Suhrcke M, 2011, THE IMPACT OF HEALTH; Torsheim T, 2001, SOC SCI MED, V53, P603, DOI 10.1016/S0277-9536(00)00370-1; Vereecken C, 2001, ARCH PUBLIC HEALTH, V59, P43	52	23	23	3	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153276	10.1371/journal.pone.0153276	http://dx.doi.org/10.1371/journal.pone.0153276			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ3UC	27073841	Green Published, Green Submitted, gold			2022-12-27	WOS:000374131200070
J	Freitas, AC; Wylezinska, M; Birch, MJ; Petersen, SE; Miquel, ME				Freitas, Andreia C.; Wylezinska, Marzena; Birch, Malcolm J.; Petersen, Steffen E.; Miquel, Marc E.			Comparison of Cartesian and Non-Cartesian Real-Time MRI Sequences at 1.5T to Assess Velar Motion and Velopharyngeal Closure during Speech	PLOS ONE			English	Article							VOCAL-TRACT; 3 T; VIDEOFLUOROSCOPY; RECONSTRUCTION; FLASH	Dynamic imaging of the vocal tract using real-time MRI has been an active and growing area of research, having demonstrated great potential to become routinely performed in the clinical evaluation of speech and swallowing disorders. Although many technical advances have been made in regards to acquisition and reconstruction methodologies, there is still no consensus in best practice protocols. This study aims to compare Cartesian and non-Cartesian real-time MRI sequences, regarding image quality and temporal resolution trade-off, for dynamic speech imaging. Five subjects were imaged at 1.5T, while performing normal phonation, in order to assess velar motion and velopharyngeal closure. Data was acquired using both Cartesian and non-Cartesian (spiral and radial) real-time sequences at five different spatial-temporal resolution sets, between 10 fps (1.7x1.7x10 mm(3)) and 25 fps (1.5x1.5x10 mm(3)). Only standard scanning resources provided by the MRI scanner manufacturer were used to ensure easy applicability to clinical evaluation and reproducibility. Data sets were evaluated by comparing measurements of the velar structure, dynamic contrast-to-noise ratio and image quality visual scoring. Results showed that for all proposed sequences, FLASH spiral acquisitions provided higher contrast-to-noise ratio, up to a 170.34% increase at 20 fps, than equivalent bSSFP Cartesian acquisitions for the same spatial-temporal resolution. At higher frame rates (22 and 25 fps), spiral protocols were optimal and provided higher CNR and visual scoring than equivalent radial protocols. Comparison of dynamic imaging at 10 and 22 fps for radial and spiral acquisitions revealed no significant difference in CNR performance, thus indicating that temporal resolution can be doubled without compromising spatial resolution (1.9x1.9 mm(2)) or CNR. In summary, this study suggests that the use of FLASH spiral protocols should be preferred over bSSFP Cartesian for the dynamic imaging of velopharyngeal closure, as it allows for an improvement in CNR and overall image quality without compromising spatial-temporal resolution.	[Freitas, Andreia C.; Wylezinska, Marzena; Petersen, Steffen E.; Miquel, Marc E.] Queen Mary Univ London, NIHR Cardiovasc Biomed Res Unit Barts, William Harvey Res Inst, London, England; [Freitas, Andreia C.; Birch, Malcolm J.; Miquel, Marc E.] Barts Hlth NHS Trust, Clin Phys, London, England; [Wylezinska, Marzena] UCL Inst Neurol, Neuroradiol Acad Unit, Dept Brain Repair & Rehabil, London, England	University of London; Queen Mary University London; Barts Health NHS Trust; University of London; University College London	Freitas, AC (corresponding author), Queen Mary Univ London, NIHR Cardiovasc Biomed Res Unit Barts, William Harvey Res Inst, London, England.; Freitas, AC (corresponding author), Barts Hlth NHS Trust, Clin Phys, London, England.	a.freitas@qmul.ac.uk	Petersen, Steffen E/A-8389-2011; Freitas, Andreia/AAK-3194-2020	Petersen, Steffen E/0000-0003-4622-5160; Freitas, Andreia/0000-0001-5340-1471	CLEFT [CLEFT-2013-1]; Institute of Physics and Engineering in Medicine (IPEM) Innovation and Research Award; National Institute for Health Research Cardiovascular Biomedical Research Unit at Barts	CLEFT; Institute of Physics and Engineering in Medicine (IPEM) Innovation and Research Award; National Institute for Health Research Cardiovascular Biomedical Research Unit at Barts	This project is funded by CLEFT (CLEFT-2013-1) and an Institute of Physics and Engineering in Medicine (IPEM) Innovation and Research Award for computer equipment. MEM is partly (20%) funded by the National Institute for Health Research Cardiovascular Biomedical Research Unit at Barts. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bae Y, 2011, CLEFT PALATE-CRAN J, V48, P695, DOI 10.1597/09-158; Beer AJ, 2004, J MAGN RESON IMAGING, V20, P791, DOI 10.1002/jmri.20197; Breyer T, 2009, MAGN RESON IMAGING, V27, P48, DOI 10.1016/j.mri.2008.05.018; Burdumy M, 2015, J MAGN RESON IMAGING, V42, P925, DOI 10.1002/jmri.24857; Delattre BMA, 2010, MAGN RESON IMAGING, V28, P862, DOI 10.1016/j.mri.2010.03.036; Demolin D, 2002, CR BIOL, V325, P547, DOI 10.1016/S1631-0691(02)01458-0; Drissi C, 2011, EUR RADIOL, V21, P1462, DOI 10.1007/s00330-011-2069-7; Echternach M, 2008, LOGOP PHONIATR VOCO, V33, P67, DOI 10.1080/14015430701875653; Echternach M, 2010, J VOICE, V24, P133, DOI 10.1016/j.jvoice.2008.06.004; Freitas AC, 2015, P ISMRM 23 SCI SESS, P655; Fu MJ, 2015, IEEE ENG MED BIO, P1568, DOI 10.1109/EMBC.2015.7318672; Griswold MA, 2002, MAGN RESON MED, V47, P1202, DOI 10.1002/mrm.10171; Havstam C, 2005, BRIT J PLAST SURG, V58, P922, DOI 10.1016/j.bjps.2005.02.012; HENNINGSSON G, 1991, CLEFT PALATE-CRAN J, V28, P413, DOI 10.1597/1545-1569(1991)028<0413:CBMVAN>2.3.CO;2; HOLSINGER AE, 1990, MAGNET RESON MED, V14, P547, DOI 10.1002/mrm.1910140312; KUEHN DP, 1976, CLEFT PALATE J, V13, P88; Kulinna-Cosentini C, 2015, EUR RADIOL; Lingala SG, 2016, J MAGN RESON IMAGING, V43, P28, DOI 10.1002/jmri.24997; Lingala SG, 2016, MAGN RESON MED; Martins P., 2012, P IBERSPEECH 7 JORN, P231; Miquel ME, 2014, PEDIATR RADIOL, V73, P1820; Narayanan S, 2004, J ACOUST SOC AM, V115, P1771, DOI 10.1121/1.1652588; Niebergall A, 2013, MAGN RESON MED, V69, P477, DOI 10.1002/mrm.24276; Perry JL, 2011, CLEFT PALATE-CRAN J, V48, P123, DOI 10.1597/09-256; Proctor M, 2013, J ACOUST SOC AM, V133, P1043, DOI 10.1121/1.4773865; Pruessmann KP, 1999, MAGNET RESON MED, V42, P952, DOI 10.1002/(SICI)1522-2594(199911)42:5<952::AID-MRM16>3.0.CO;2-S; Ramanarayanan V, 2013, J ACOUST SOC AM, V134, P510, DOI 10.1121/1.4807639; Sagar P, 2015, PEDIATR RADIOL, V45, P217, DOI 10.1007/s00247-014-3141-7; Scott AD, 2012, BRIT J RADIOL, V85, pE1083, DOI 10.1259/bjr/32938996; Scott AD, 2014, PHYS MEDICA, V30, P604, DOI 10.1016/j.ejmp.2014.05.001; Sell D, 2011, CLEFT PALATE SPEECH: ASSESSMENT AND INTERVENTION, P145; Silver AL, 2011, ARCH OTOLARYNGOL, V137, P258, DOI 10.1001/archoto.2011.11; Sutton BP, 2010, J MAGN RESON IMAGING, V32, P1228, DOI 10.1002/jmri.22369; Uecker M, 2008, MAGN RESON MED, V60, P674, DOI 10.1002/mrm.21691; Wylezinska M, 2015, P ISMRM 23 SCI SESS, P2302	35	10	10	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153322	10.1371/journal.pone.0153322	http://dx.doi.org/10.1371/journal.pone.0153322			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073905	gold, Green Published, Green Submitted			2022-12-27	WOS:000374131200074
J	Park, CH; Han, DS; Jeong, JY; Eun, CS; Yoo, KS; Jeon, YC; Sohn, JH				Park, Chan Hyuk; Han, Dong Soo; Jeong, Jae Yoon; Eun, Chang Soo; Yoo, Kyo-Sang; Jeon, Yong Cheol; Sohn, Joo Hyun			The Optimal Cut-Off Value of Neutrophil-to-Lymphocyte Ratio for Predicting Prognosis in Adult Patients with Henoch-Schonlein Purpura	PLOS ONE			English	Article								Background The development of gastrointestinal (GI) bleeding and end-stage renal disease (ESRD) can be a concern in the management of Henoch-Schonlein purpura (HSP). We aimed to evaluate whether the neutrophil-to-lymphocyte ratio (NLR) is associated with the prognosis of adult patients with HSP. Methods Clinical data including the NLR of adult patients with HSP were retrospectively analyzed. Patients were classified into three groups as follows: (a) simple recovery, (b) wax & wane without GI bleeding, and (c) development of GI bleeding. The optimal cut-off value was determined using a receiver operating characteristics curve and the Youden index. Results A total of 66 adult patients were enrolled. The NLR was higher in the GI bleeding group than in the simple recovery or wax & wane group (simple recovery vs. wax & wane vs. GI bleeding; median [IQR], 2.32 [1.61-3.11] vs. 3.18 [2.16-3.71] vs. 7.52 [4.91-10.23], P < 0.001). For the purpose of predicting simple recovery, the optimal cut-off value of NLR was 3.18, and the sensitivity and specificity were 74.1% and 75.0%,respectively. For predicting development of GI bleeding, the optimal cut-off value was 3.90 and the sensitivity and specificity were 87.5% and 88.6%, respectively. Conclusions The NLR is useful for predicting development of GI bleeding as well as simple recovery without symptom relapse. Two different cut-off values of NLR, 3.18 for predicting an easy HSPrecovery without symptom relapse and 3.90 for predicting GI bleeding can be used in adult patients with HSP.	[Park, Chan Hyuk; Han, Dong Soo; Jeong, Jae Yoon; Eun, Chang Soo; Yoo, Kyo-Sang; Jeon, Yong Cheol; Sohn, Joo Hyun] Hanyang Univ, Guri Hosp, Dept Internal Med, Coll Med, Guri, South Korea	Hanyang University	Han, DS (corresponding author), Hanyang Univ, Guri Hosp, Dept Internal Med, Coll Med, Guri, South Korea.	hands@hanyang.ac.kr	Park, Chan Hyuk/I-1794-2016; Han, Dong Soo/P-1753-2015; Han, Dong Soo/AHD-6285-2022	Park, Chan Hyuk/0000-0003-3824-3481; Han, Dong Soo/0000-0001-7103-3318; Jeong, Jae Yoon/0000-0002-3624-3261	Basic Science Research Program through National Research Foundation of Korea - Ministry of Education [NRF-2011-0010841]; Grant of Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [A120176]	Basic Science Research Program through National Research Foundation of Korea - Ministry of Education; Grant of Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea	This study was supported by Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education (NRF-2011-0010841) and a Grant of the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (A120176) (DSH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education (NRF-2011-0010841) and a Grant of the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (A120176) (DSH).	Balta S, 2013, BRIT J CANCER, V109, P3125, DOI 10.1038/bjc.2013.598; Blanco R, 1997, ARTHRITIS RHEUM, V40, P859, DOI 10.1002/art.1780400513; Hong J, 2015, PEDIATR GASTROENTERO, V18, P39, DOI 10.5223/pghn.2015.18.1.39; Jauhola O, 2012, PEDIATR NEPHROL, V27, P933, DOI 10.1007/s00467-012-2106-z; JENNETTE JC, 1994, ARTHRITIS RHEUM-US, V37, P187, DOI 10.1002/art.1780370206; Kellerman PS, 2006, AM J KIDNEY DIS, V48, P1009, DOI 10.1053/j.ajkd.2006.08.031; Kwon JH, 2015, BMC GASTROENTEROL, V15, DOI 10.1186/s12876-015-0378-z; Lin Syh-Jae, 1998, Acta Paediatrica Sinica, V39, P94; Makay B, 2014, RHEUMATOL INT, V34, P1323, DOI 10.1007/s00296-014-2986-2; MARTINEZFRONTANILLA LA, 1984, J PEDIATR SURG, V19, P434, DOI 10.1016/S0022-3468(84)80269-9; MICHEL BA, 1992, J RHEUMATOL, V19, P721; MILLS JA, 1990, ARTHRITIS RHEUM, V33, P1114; Nam EJ, 2014, ENDOSCOPY, V46, P981, DOI 10.1055/s-0034-1377757; Pillebout E, 2002, J AM SOC NEPHROL, V13, P1271, DOI 10.1097/01.ASN.0000013883.99976.22; Proctor MJ, 2012, BRIT J CANCER, V107, P695, DOI 10.1038/bjc.2012.292; Rieu P, 1999, ANN MED INTERNE, V150, P151; Ronkainen J, 2006, J PEDIATR-US, V149, P241, DOI 10.1016/j.jpeds.2006.03.024; SAULSBURY FT, 1983, CLIN PEDIATR, V22, P185, DOI 10.1177/000992288302200305; TancredeBohin E, 1997, ARCH DERMATOL, V133, P438, DOI 10.1001/archderm.133.4.438; Turkmen K, 2012, RENAL FAILURE, V34, P155, DOI 10.3109/0886022X.2011.641514; Uppal SS, 2006, CLIN EXP RHEUMATOL, V24, pS26; Weiss PF, 2010, PEDIATRICS, V126, P674, DOI 10.1542/peds.2009-3348	22	22	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153238	10.1371/journal.pone.0153238	http://dx.doi.org/10.1371/journal.pone.0153238			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073884	gold, Green Published, Green Submitted			2022-12-27	WOS:000374131200064
J	Polanczyk, A; Podyma, M; Trebinski, L; Chrzastek, J; Zbicinski, I; Stefanczyk, L				Polanczyk, Andrzej; Podyma, Marek; Trebinski, Lukasz; Chrzastek, Jaroslaw; Zbicinski, Ireneusz; Stefanczyk, Ludomir			A Novel Attempt to Standardize Results of CFD Simulations Basing on Spatial Configuration of Aortic Stent-Grafts	PLOS ONE			English	Article							ENDOVASCULAR REPAIR; ANEURYSM REPAIR; BLOOD-FLOW; MODEL; FIXATION; ENDOLEAKS; MIGRATION; DEVICE; AAA	Currently, studies connected with Computational Fluid Dynamic (CFD) techniques focus on assessing hemodynamic of blood flow in vessels in different conditions e.g. after stent-graft's placement. The paper propose a novel method of standardization of results obtained from calculations of stent-grafts' "pushing forces" (cumulative WSS-Wall Shear Stress), and describes its usefulness in diagnostic process. AngioCT data from 27 patients were used to reconstruct 3D geometries of stent-grafts which next were used to create respective reference cylinders. We made an assumption that both the side surface and the height of a stent-graft and a reference cylinder were equal. The proposed algorithm in conjunction with a stent-graft "pushing forces" on an implant wall, allowed us to determine which spatial configuration of a stent-graft predispose to the higher risk of its migration. For stent-grafts close to cylindrical shape (shape factor phi close to 1) WSS value was about 267Pa, while for stent-grafts different from cylindrical shape (f close to 2) WSS value was about 635Pa. It was also noticed that deformation in the stent-graft's bifurcation part impaired blood flow hemodynamic. Concluding the proposed algorithm of standardization proved its usefulness in estimating the WSS values that may be useful in diagnostic process. Angular bends or tortuosity in bifurcations of an aortic implant should be considered in further studies of estimation of the risk of implantation failure.	[Polanczyk, Andrzej; Podyma, Marek; Zbicinski, Ireneusz] Lodz Univ Technol, Dept Heat & Mass Transfer, Fac Proc & Environm Engn, Lodz, Poland; [Trebinski, Lukasz; Chrzastek, Jaroslaw; Stefanczyk, Ludomir] Med Univ Lodz, Dept Radiol & Diagnost Imaging, Lodz, Poland	Lodz University of Technology; Medical University Lodz	Polanczyk, A (corresponding author), Lodz Univ Technol, Dept Heat & Mass Transfer, Fac Proc & Environm Engn, Lodz, Poland.	andrzej.polanczyk@gmail.com	Zbicinski, Ireneusz/R-2160-2019; Polanczyk, Andrzej/P-5705-2019; Polanczyk, Andrzej/X-7303-2018; Polanczyk, Andrzej/K-9853-2019	Zbicinski, Ireneusz/0000-0002-4285-8350; Polanczyk, Andrzej/0000-0001-8894-752X; Polanczyk, Andrzej/0000-0001-8894-752X; 	National Science Centre of Poland [2011/01/B/ST8/06689]; Polish National Centre for Research and Development [501/10-34-19-605]	National Science Centre of Poland(National Science Centre, Poland); Polish National Centre for Research and Development	This work was supported by the National Science Centre of Poland (grant number 2011/01/B/ST8/06689 to IZ) and the Polish National Centre for Research and Development (501/10-34-19-605 to AP).	Albertini JN, 2006, J CARDIOVASC SURG, V47, P245; Amblard A, 2009, MED ENG PHYS, V31, P27, DOI 10.1016/j.medengphy.2008.03.005; Avgerinos ED, 2011, J ENDOVASC THER, V18, P462, DOI 10.1583/11-3411.1; Bartoli MA, 2012, ANN VASC SURG, V26, P166, DOI 10.1016/j.avsg.2011.02.047; Baum RA, 2003, J VASC INTERV RADIOL, V14, P1111, DOI 10.1097/01.RVI.0000085773.71254.86; Carroccio A, 2002, J VASC SURG, V36, P679, DOI 10.1067/mva.2002.128309; Chong CK, 2004, J BIOMECH, V37, P89, DOI 10.1016/S0021-9290(03)00236-7; Cieri E, 2013, EUR J VASC ENDOVASC, V46, P192, DOI 10.1016/j.ejvs.2013.05.012; Fung GSK, 2008, COMPUT BIOL MED, V38, P484, DOI 10.1016/j.compbiomed.2008.01.012; Grabenwoger M, 2003, EUR J CARDIO-THORAC, V23, P788, DOI 10.1016/S1010-7940(03)00075-7; Gundert TJ, 2012, J BIOMECH ENG-T ASME, V134, DOI 10.1115/1.4005542; HINGHOFERSZALKAY H, 1987, J APPL PHYSIOL, V63, P1003, DOI 10.1152/jappl.1987.63.3.1003; Howell BA, 2007, J ENDOVASC THER, V14, P138, DOI 10.1583/1545-1550(2007)14[138:CFDWBA]2.0.CO;2; Ito H, 2013, ANN VASC DIS, V6, P189, DOI [10.3400/avd.oa.12-00101, DOI 10.3400/AVD.OA.12-00101]; Johnston BM, 2006, J BIOMECH, V39, P1116, DOI 10.1016/j.jbiomech.2005.01.034; Lee J, 2012, ANN BIOMED ENG, V40, P2399, DOI 10.1007/s10439-012-0583-7; Litwinski RA, 2006, J VASC SURG, V44, P1176, DOI 10.1016/j.jvs.2006.08.028; Molony DS, 2010, EUR J VASC ENDOVASC, V40, P332, DOI 10.1016/j.ejvs.2010.06.001; Morris L, 2004, J BIOMECH, V37, P1087, DOI 10.1016/j.jbiomech.2003.11.014; Parodi J C, 1991, Ann Vasc Surg, V5, P491, DOI 10.1007/BF02015271; Pietura R, 2001, Wiad Lek, V54, P583; Pintoux D, 2011, ANN VASC SURG, V25, P1012, DOI 10.1016/j.avsg.2010.08.013; Polanczyk A, 2015, J BIOMECH, V48, P425, DOI 10.1016/j.jbiomech.2014.12.033; Polanczyk A, 2012, CHEM PROCESS ENG-INZ, V33, P53, DOI 10.2478/v10176-012-0005-2; Poon EKW, 2014, J BIOMECH, V47, P2843, DOI 10.1016/j.jbiomech.2014.07.030; Prinssen M, 2004, EUR J VASC ENDOVASC, V27, P121, DOI 10.1016/j.ejvs.2003.11.006; Raben JS, 2015, J APPL BIOMATER FUNC, V13, pE116, DOI 10.5301/jabfm.5000217; Simon HA, 2010, ANN BIOMED ENG, V38, P3295, DOI 10.1007/s10439-010-0086-3; Stefanczyk L, 2008, POL J RADIOL, V73, P22; Stiehm M., 2013, Biomedical Engineering-Biomedizinische Technik, V58, DOI 10.1515/bmt-2013-4351; Szmidt Jacek, 2007, Interact Cardiovasc Thorac Surg, V6, P490, DOI 10.1510/icvts.2007.152447; Valencia A, 2011, ADV APPL FLUID MECH, V9, P105; Valencia A, 2012, ADV APPL FLUID MECH, V12, P49; VOLODOS NL, 1986, VESTN KHIR IM GREKOV, V137, P123; Xenos M, 2010, IEEE ENG MED BIO, P5173, DOI 10.1109/IEMBS.2010.5626138; Xenos M, 2010, ANN BIOMED ENG, V38, P3323, DOI 10.1007/s10439-010-0094-3; Yu CH, 2014, BIO-MED MATER ENG, V24, P2417, DOI 10.3233/BME-141055	37	29	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153332	10.1371/journal.pone.0153332	http://dx.doi.org/10.1371/journal.pone.0153332			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073907	gold, Green Published, Green Submitted			2022-12-27	WOS:000374131200075
J	Reid, N; Daly, RM; Winkler, EAH; Gardiner, PA; Eakin, EG; Owen, N; Dunstan, DW; Healy, GN				Reid, Natasha; Daly, Robin M.; Winkler, Elisabeth A. H.; Gardiner, Paul A.; Eakin, Elizabeth G.; Owen, Neville; Dunstan, David W.; Healy, Genevieve N.			Associations of Monitor-Assessed Activity with Performance-Based Physical Function	PLOS ONE			English	Article							MEASURED SEDENTARY TIME; MUSCLE STRENGTH; BODY-COMPOSITION; ELDERLY-WOMEN; LIFE-STYLE; FITNESS; RELIABILITY; VALIDITY; BEHAVIOR; HEALTH	The purpose of this study was to investigate the cross-sectional associations of monitorderived measures of sedentary time and physical activity with performance-based physical function in healthy Australian adults. Data from 602 participants (mean age 58.1 +/- 10.0 years; 58% female) from the 2011/12 wave of the Australian Diabetes, Obesity and Lifestyle (AusDiab3) study were analyzed. The thigh-worn activPAL3 T monitor (7-days continuous wear) was used to derive time during waking hours spent: sitting/reclining; standing; and, stepping (overall, and separately as light [<3 METs] and moderate-to-vigorous physical activity [ MVPA; >= 3 METs]), and number of sit-stand transitions. Associations of these (in hours/day, or 15 transitions/ day) with physical function measures (8ft Timed Up and Go [ TUG-8; log-transformed seconds] and Knee Extensor Strength [ KES; kg]) were tested via linear regression, adjusting for confounders. Interactions by sex and age-category (< 45; 45-54; 55-64; >= 65 years) were tested. In all participants, KES was significantly (p<0.05) associated with stepping and MVPA stepping only; none of the activity measures were associated with TUG-8. However, subgroup analysis revealed that in older adults (>= 65 years), TUG-8 was associated with stepping and MVPA stepping (both p<0.05). All associations with sitting time, standing, sit-stand transition and sex interactions were not statistically significant. In summary, sitting time was not significantly associated with impaired muscle strength or gait/mobility in Australian adults aged 36-80 years, but light-to moderate activity (stepping) was positively associated with muscle strength, and gait/mobility in older adults aged >= 65 years. The direction of causation is not known and remains important to investigate considering the high prevalence of both poor function and limited activity in older age.	[Reid, Natasha; Winkler, Elisabeth A. H.; Gardiner, Paul A.; Eakin, Elizabeth G.; Owen, Neville; Dunstan, David W.; Healy, Genevieve N.] Univ Queensland, Sch Publ Hlth, Brisbane, Qld, Australia; [Daly, Robin M.; Dunstan, David W.] Deakin Univ, Ctr Phys Act & Nutr Res, Melbourne, Vic, Australia; [Gardiner, Paul A.] Univ Queensland, Mater Res Inst, South Brisbane, Australia; [Owen, Neville; Dunstan, David W.; Healy, Genevieve N.] Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia; [Owen, Neville] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Melbourne, Vic, Australia; [Owen, Neville; Dunstan, David W.] Monash Univ, Alfred Hosp, Dept Med, Melbourne, Vic 3181, Australia; [Dunstan, David W.] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic 3181, Australia; [Dunstan, David W.] Univ Western Australia, Sch Sport Sci Exercise & Hlth, Perth, WA 6009, Australia; [Healy, Genevieve N.] Australian Catholic Univ, Mary MacKillop Inst Hlth Res, Melbourne, Vic, Australia; [Healy, Genevieve N.] Curtin Univ, Sch Physiotherapy, Perth, WA 6845, Australia; [Gardiner, Paul A.] Univ Queensland, Sch Med, Ctr Res Geriatr Med, Brisbane, Qld, Australia	University of Queensland; Deakin University; Mater Research; University of Queensland; Baker Heart and Diabetes Institute; University of Melbourne; Florey Institute of Neuroscience & Mental Health; Monash University; Monash University; University of Western Australia; Australian Catholic University; Curtin University; University of Queensland	Reid, N (corresponding author), Univ Queensland, Sch Publ Hlth, Brisbane, Qld, Australia.	n.reid@uq.edu.au	Reid, Natasha/I-2092-2019; Gardiner, Paul A/F-2751-2010; Winkler, Elisabeth/AAD-7153-2022; Dunstan, David Wayne/E-8473-2010; Daly, Robin/AAN-2353-2020; Healy, Genevieve/A-7408-2008; Eakin, Elizabeth G/F-7918-2010	Reid, Natasha/0000-0002-8528-9741; Gardiner, Paul A/0000-0002-8072-2673; Winkler, Elisabeth/0000-0003-1452-6102; Dunstan, David Wayne/0000-0003-2629-9568; Daly, Robin/0000-0002-9897-1598; Healy, Genevieve/0000-0001-7093-7892; Eakin, Elizabeth G/0000-0002-8835-9995	National Health and Medical Research Council of Australia (NHMRC Program) [APP566940]; Centre of Research Excellence grant [APP1057608, APP1000986]; Senior Principal Research Fellowship [1003960]; Dementia Research Development Fellowship [1103311]; Australian Research Council Research Fellowship [FT100100918]; Heart Foundation Postdoctoral Fellowship [PH 12B 7054]; Victorian Government's OIS Program; Australian Federal Government (Australian Postgraduate Award Scholarship); Victorian Government's OIS Programme; National Health and Medical Research Council (NHMRC) [233200]; Australian Government Department of Health and Ageing; Abbott Australasia Pty Ltd; Alphapharm Pty Ltd; AstraZeneca, Bristol-Myers Squibb; City Health Centre-Diabetes Service-Canberra; Department of Health and Community Services-Northern Territory; Department of Health and Human ServicesTasmania; Department of Health-New South Wales; Department of Health-Western Australia; Department of Health-South Australia; Department of Human Services-Victoria; Diabetes Australia; Diabetes Australia Northern Territory; Eli Lilly Australia; Estate of the Late Edward Wilson; GlaxoSmithKline; Jack Brockhoff Foundation; Janssen-Cilag; Kidney Health Australia; Marian FH Flack Trust; Menzies Research Institute; Merck Sharp Dohme; Novartis Pharmaceuticals; Novo Nordisk Pharmaceuticals; Pfizer Pty Ltd; Pratt Foundation; Queensland Health; Roche Diagnostics Australia; Royal Prince Alfred Hospital, Sydney; Sanofi Aventis; Sanofi Synthelabo	National Health and Medical Research Council of Australia (NHMRC Program)(National Health and Medical Research Council (NHMRC) of Australia); Centre of Research Excellence grant; Senior Principal Research Fellowship; Dementia Research Development Fellowship; Australian Research Council Research Fellowship(Australian Research Council); Heart Foundation Postdoctoral Fellowship; Victorian Government's OIS Program; Australian Federal Government (Australian Postgraduate Award Scholarship); Victorian Government's OIS Programme; National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Government Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing); Abbott Australasia Pty Ltd(Abbott Laboratories); Alphapharm Pty Ltd; AstraZeneca, Bristol-Myers Squibb(Bristol-Myers SquibbAstraZeneca); City Health Centre-Diabetes Service-Canberra; Department of Health and Community Services-Northern Territory; Department of Health and Human ServicesTasmania; Department of Health-New South Wales; Department of Health-Western Australia; Department of Health-South Australia; Department of Human Services-Victoria; Diabetes Australia; Diabetes Australia Northern Territory; Eli Lilly Australia(Eli Lilly); Estate of the Late Edward Wilson; GlaxoSmithKline(GlaxoSmithKline); Jack Brockhoff Foundation; Janssen-Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Kidney Health Australia; Marian FH Flack Trust; Menzies Research Institute; Merck Sharp Dohme(Merck & Company); Novartis Pharmaceuticals(Novartis); Novo Nordisk Pharmaceuticals(Novo Nordisk); Pfizer Pty Ltd(Pfizer); Pratt Foundation; Queensland Health; Roche Diagnostics Australia; Royal Prince Alfred Hospital, Sydney(University of Sydney); Sanofi Aventis(Sanofi-Aventis); Sanofi Synthelabo	This work was supported by: National Health and Medical Research Council of Australia (NHMRC Program Grant #APP566940 to NO; Centre of Research Excellence grant #APP1057608 to GNH, NO, DWD, EGE with funding support provided to EAHW; Senior Principal Research Fellowship #1003960 to NO; funding support to PAG from Centre of Research Excellence grant #APP1000986; Dementia Research Development Fellowship #1103311 to PG); Australian Research Council Research Fellowship (#FT100100918 to DWD); Heart Foundation Postdoctoral Fellowship (#PH 12B 7054 to GNH); the Victorian Government's OIS Program (to NO and DWD); and by the Australian Federal Government (Australian Postgraduate Award Scholarship to NR). The Australian Diabetes, Obesity and Lifestyle study (AusDiab), co-coordinated by the Baker IDI Heart and Diabetes Institute, was supported in part by the Victorian Government's OIS Programme, and gratefully acknowledges the generous support given by National Health and Medical Research Council (NHMRC grant 233200), Australian Government Department of Health and Ageing. Abbott Australasia Pty Ltd, Alphapharm Pty Ltd, AstraZeneca, Bristol-Myers Squibb, City Health Centre-Diabetes Service-Canberra, Department of Health and Community Services-Northern Territory, Department of Health and Human ServicesTasmania, Department of Health-New South Wales, Department of Health-Western Australia, Department of Health-South Australia, Department of Human Services-Victoria, Diabetes Australia, Diabetes Australia Northern Territory, Eli Lilly Australia, Estate of the Late Edward Wilson, GlaxoSmithKline, Jack Brockhoff Foundation, Janssen-Cilag, Kidney Health Australia, Marian & FH Flack Trust, Menzies Research Institute, Merck Sharp & Dohme, Novartis Pharmaceuticals, Novo Nordisk Pharmaceuticals, Pfizer Pty Ltd, Pratt Foundation, Queensland Health, Roche Diagnostics Australia, Royal Prince Alfred Hospital, Sydney, Sanofi Aventis and Sanofi Synthelabo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDRESEN EM, 1994, AM J PREV MED, V10, P77, DOI 10.1016/S0749-3797(18)30622-6; [Anonymous], 2014, AUSTR PHYS ACT SED B; Aoyagi Y, 2009, GERONTOLOGY, V55, P523, DOI 10.1159/000236326; Barnes J, 2012, APPL PHYSIOL NUTR ME, V37, P540, DOI [10.1139/H2012-024, 10.1139/h2012-024]; Bohannon RW, 2001, AM J PHYS MED REHAB, V80, P13, DOI 10.1097/00002060-200101000-00004; Buman MP, 2010, AM J EPIDEMIOL, V172, P1155, DOI 10.1093/aje/kwq249; Chastin SFM, 2012, AGE AGEING, V41, P111, DOI 10.1093/ageing/afr075; Cohen J.E., 1988, STAT POWER ANAL BEHA; Daly RM, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-71; Dunstan DW, 2002, DIABETES RES CLIN PR, V57, P119, DOI 10.1016/S0168-8227(02)00025-6; Edwardson CL, 2016, J SPORT HLTH SCI; Ervin RB, 2006, PREVALENCE FUNCTIONA; Gianoudis J, 2015, OSTEOPOROSIS INT, V26, P571, DOI 10.1007/s00198-014-2895-y; Granat MH, 2012, PHYSIOL MEAS, V33, P1785, DOI 10.1088/0967-3334/33/11/1785; Grant PM, 2006, BRIT J SPORT MED, V40, P992, DOI 10.1136/bjsm.2006.030262; Grant PM, 2008, J AGING PHYS ACTIV, V16, P201, DOI 10.1123/japa.16.2.201; Healy GN, 2008, DIABETES CARE, V31, P369, DOI 10.2337/dc07-1795; Ikezoe T, 2013, ARCH GERONTOL GERIAT, V57, P221, DOI 10.1016/j.archger.2013.04.004; Ireland P, 1994, Asia Pac J Clin Nutr, V3, P19; JENKINSON C, 1994, QUAL LIFE RES, V3, P7, DOI 10.1007/BF00647843; Kozey-Keadle S, 2011, MED SCI SPORT EXER, V43, P1561, DOI 10.1249/MSS.0b013e31820ce174; Lyden K, 2015, MED SCI SPORTS EXERC; Lyden K, 2012, MED SCI SPORT EXER, V44, P2243, DOI 10.1249/MSS.0b013e318260c477; Paterson DH, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-38; Pijnappels M, 2008, EUR J APPL PHYSIOL, V102, P585, DOI 10.1007/s00421-007-0613-6; Pillay JD, 2014, J PHYS ACT HEALTH, V11, P10, DOI 10.1123/jpah.2011-0288; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rikli RE, 1999, J AGING PHYS ACTIV, V7, P162, DOI 10.1123/japa.7.2.162; Rikli RE, 1999, J AGING PHYS ACTIV, V7, P129, DOI 10.1123/japa.7.2.129; Ruiz JR, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a439; Ryan CG, 2006, BRIT J SPORT MED, V40, P779, DOI 10.1136/bjsm.2006.027276; Santos DA, 2012, EXP GERONTOL, V47, P908, DOI 10.1016/j.exger.2012.07.011; Sardinha LB, 2015, J GERONTOL A-BIOL, V70, P119, DOI 10.1093/gerona/glu193; Sole G, 2007, ARCH PHYS MED REHAB, V88, P626, DOI 10.1016/j.apmr.2007.02.006; Spittaels H, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-149; Stevens Judy A., 2000, Morbidity and Mortality Weekly Report, V49, P3; Tanamas SK., 2013, AUSDIAB 2012 AUSTR D; Tikkanen O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052228; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Vallance JK, 2014, CANCER-AM CANCER SOC, V120, P2919, DOI 10.1002/cncr.28779; Visser M, 2005, J GERONTOL A-BIOL, V60, P324, DOI 10.1093/gerona/60.3.324; Willett WC, 1997, AM J CLIN NUTR, V65, P1220, DOI 10.1093/ajcn/65.4.1220S; Yoshida D, 2010, J PHYSIOL ANTHROPOL, V29, P211, DOI 10.2114/jpa2.29.211	43	25	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153398	10.1371/journal.pone.0153398	http://dx.doi.org/10.1371/journal.pone.0153398			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ3UC	27073888	Green Published, gold			2022-12-27	WOS:000374131200082
J	Tape, KD; Gustine, DD; Ruess, RW; Adams, LG; Clark, JA				Tape, Ken D.; Gustine, David D.; Ruess, Roger W.; Adams, Layne G.; Clark, Jason A.			Range Expansion of Moose in Arctic Alaska Linked to Warming and Increased Shrub Habitat	PLOS ONE			English	Article							PERMAFROST DEGRADATION; NORTHERN ALASKA; CLIMATE; VEGETATION; TEMPERATURE; STRATEGIES; FOREST; HETEROGENEITY; EXTINCTION; MEGAFAUNA	Twentieth century warming has increased vegetation productivity and shrub cover across northern tundra and treeline regions, but effects on terrestrial wildlife have not been demonstrated on a comparable scale. During this period, Alaskan moose (Alces alces gigas) extended their range from the boreal forest into tundra riparian shrub habitat; similar extensions have been observed in Canada (A. a. andersoni) and Eurasia (A. a. alces). Northern moose distribution is thought to be limited by forage availability above the snow in late winter, so the observed increase in shrub habitat could be causing the northward moose establishment, but a previous hypothesis suggested that hunting cessation triggered moose establishment. Here, we use recent changes in shrub cover and empirical relationships between shrub height and growing season temperature to estimate available moose habitat in Arctic Alaska c. 1860. We estimate that riparian shrubs were approximately 1.1 m tall c. 1860, greatly reducing the available forage above the snowpack, compared to 2 m tall in 2009. We believe that increases in riparian shrub habitat after 1860 allowed moose to colonize tundra regions of Alaska hundreds of kilometers north and west of previous distribution limits. The northern shift in the distribution of moose, like that of snowshoe hares, has been in response to the spread of their shrub habitat in the Arctic, but at the same time, herbivores have likely had pronounced impacts on the structure and function of these shrub communities. These northward range shifts are a bellwether for other boreal species and their associated predators.	[Tape, Ken D.; Clark, Jason A.] Univ Alaska, Inst Northern Engn, Fairbanks, AK 99701 USA; [Gustine, David D.; Adams, Layne G.] US Geol Survey, Alaska Sci Ctr, Anchorage, AK USA; [Ruess, Roger W.] Univ Alaska, Inst Arctic Biol, Fairbanks, AK 99775 USA	University of Alaska System; University of Alaska Fairbanks; United States Department of the Interior; United States Geological Survey; University of Alaska System; University of Alaska Fairbanks	Tape, KD (corresponding author), Univ Alaska, Inst Northern Engn, Fairbanks, AK 99701 USA.	kdtape@alaska.edu		Clark, Jason/0000-0002-4810-5261	EPSCoR NSF award [OIA-1208927]; U.S. Geological Survey's Changing Arctic Ecosystem Initiative within the Wildlife Program of the Ecosystem Mission Area; Division Of Environmental Biology [1026415] Funding Source: National Science Foundation	EPSCoR NSF award; U.S. Geological Survey's Changing Arctic Ecosystem Initiative within the Wildlife Program of the Ecosystem Mission Area; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	KDT was supported by EPSCoR NSF award #OIA-1208927. DDG and LGA received support from U.S. Geological Survey's Changing Arctic Ecosystem Initiative within the Wildlife Program of the Ecosystem Mission Area. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anchukaitis KJ, 2013, J CLIMATE, V26, P3001, DOI 10.1175/JCLI-D-11-00139.1; Beck PSA, 2011, ARCT ANTARCT ALP RES, V43, P355, DOI 10.1657/1938-4246-43.3.355; Bieniek PA, 2014, J CLIMATE, V27, P2800, DOI 10.1175/JCLI-D-13-00342.1; Boer AH, 2007, ECOLOGY MANAGEMENT N, P337; Boertje RD, 1996, J WILDLIFE MANAGE, V60, P474, DOI 10.2307/3802065; Bowyer RT, 1999, J MAMMAL, V80, P1070, DOI 10.2307/1383161; Brower CD, 1942, FIFTY YEARS BELOW ZE; Brown R, 2010, JOURNAL OF GEOPHYSIC, P115; BRYANT JP, 1985, ECOLOGY, V66, P1564, DOI 10.2307/1938018; Burch ES, 2012, CARIBOU HERDS OF NORTHWEST ALASKA, 1850-2000, P1; Carroll G, 2011, UNIT 26A MOOSE MANAG, P643; Christie KS, 2015, BIOSCIENCE, V65, P1123, DOI 10.1093/biosci/biv137; COADY JW, 1980, CAN FIELD NAT, V94, P61; Cook JA, 2009, RECENT MAMMALS OF AL; Cooper A, 2015, SCIENCE, V349, P602, DOI 10.1126/science.aac4315; den Herder M, 2008, BASIC APPL ECOL, V9, P324, DOI 10.1016/j.baae.2007.03.005; Frost GV, 2014, GLOBAL CHANGE BIOL, V20, P1264, DOI 10.1111/gcb.12406; Glaser FS, 1950, PREDATOR AND GAME SU; Gorn T, 2010, UNIT 22 MOOSE MANAGE, P522; Guthrie RD, 2006, NATURE, V441, P207, DOI 10.1038/nature04604; Hall ER, 1956, MAMMALS OF NORTHERN; HALL ES, 1973, J MAMMAL, V54, P294, DOI 10.2307/1378902; Hollingsworth TN, 2010, CAN J FOREST RES, V40, P1273, DOI 10.1139/X10-094; Jorgenson MT, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/3/035017; Jorgenson MT, 2001, CLIMATIC CHANGE, V48, P551, DOI 10.1023/A:1005667424292; Kantner S, 2015, SWALLOWED BY THE GRE; Karns Patrick D., 1998, P125; Kaufman DS, 2009, SCIENCE, V325, P1236, DOI 10.1126/science.1173983; Kay CE, 1997, ALCES N AM, V33, P141; KELSALL J P, 1974, Naturaliste Canadien (Quebec), V101, P117; Kielland K., 2006, ALASKAS CHANGING BOR, P211; Kitti H, 2009, POLAR BIOL, V32, P253, DOI 10.1007/s00300-008-0526-9; Lachenbruch A.H, 1959, US GEOL SURV B C, P73; Leffingwell EdK, 1919, THE CANNING RIVER RE; LeResche R.E., 1974, Naturaliste Canadien, V101, P143; Lowry TS, 2013, RECONSTRUCTION OF A, P1; Makarova Olga A., 2009, Alces, V45, P13; Mann DH, 2015, P NATL ACAD SCI USA, V112, P14301, DOI 10.1073/pnas.1516573112; Mann DH, 2013, QUATERNARY SCI REV, V70, P91, DOI 10.1016/j.quascirev.2013.03.015; Mech LD, 1966, THE WOLVES OF ISLE R; Moskvitina NS, 2011, CONTEMP PROBL ECOL+, V4, P444, DOI 10.1134/S1995425511040163; Mould E, 1977, P N AM MOOS C WORKSH, V13, P144; Murray DL, 2006, WILDLIFE MONOGR, P1, DOI 10.2193/0084-0173(2006)166[1:PNDACI]2.0.CO;2; Myers-Smith IH, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/4/045509; Naito AT, 2015, ECOL EVOL, V5, P87, DOI 10.1002/ece3.1341; Naito AT, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/4/045506; Nelson RK, 1982, TRACKS IN THE WILDLA; Nossov DR, 2011, J ECOL, V99, P621, DOI 10.1111/j.1365-2745.2010.01792.x; Pajunen A, 2008, POLAR BIOL, V31, P1233, DOI 10.1007/s00300-008-0462-8; Pomeroy JW, 2006, HYDROL PROCESS, V20, P923, DOI 10.1002/hyp.6124; Rausch R., 1951, Arctic Montreal, V4, P146; Rearden J, 1998, ALASKAS WOLF MAN THE; Rearden J, 1993, SHADOWS ON THE KOYUK; Rearden J, 2006, WHITE ALASKAN TALES; Ruess RW, 2013, ECOL MONOGR, V83, P177, DOI 10.1890/12-0782.1; Sable EG, 1961, ARCTIC, V14, P176; Schickhoff U, 2002, PHYTOCOENOLOGIA, V32, P145, DOI 10.1127/0340-269X/2002/0032-0145; SNAP, 2015, SCENARIOS NETWORK FO; STEPHENS PW, 1984, HOLARCTIC ECOL, V7, P239; Sturm M, 2001, NATURE, V411, P546, DOI 10.1038/35079180; Sturm M, 2004, ANN GLACIOL-SER, V38, P253, DOI 10.3189/172756404781815112; Swanson DK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138387; Tape K, 2006, GLOBAL CHANGE BIOL, V12, P686, DOI 10.1111/j.1365-2486.2006.01128.x; Tape KD, 2010, THE CHANGING ARCTIC; Tape KD, 2016, GLOBAL CHANGE BIOL, V22, P208, DOI 10.1111/gcb.13058; Tape KD, 2012, ECOSYSTEMS, V15, P711, DOI 10.1007/s10021-012-9540-4; Telfer E.S., 1984, P145; Turetsky MR, 2006, GEOPHYSICAL RESEARCH, V33; WALKER DA, 1987, CAN J BOT, V65, P988, DOI 10.1139/b87-136; Walker DA, 1985, VEGETATION AND ENVIR; Walsh JE, 2008, J CLIMATE, V21, P6156, DOI 10.1175/2008JCLI2163.1; White KS, 2001, CAN J ZOOL, V79, P2055, DOI 10.1139/cjz-79-11-2055; Xu L, 2013, NAT CLIM CHANGE, V3, P581, DOI [10.1038/nclimate1836, 10.1038/NCLIMATE1836]; YESNER DR, 1989, ARCTIC, V42, P97	74	64	71	0	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0152636	10.1371/journal.pone.0152636	http://dx.doi.org/10.1371/journal.pone.0152636			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27074023	gold, Green Published			2022-12-27	WOS:000374131200031
J	Weiderhold, KN; Fadri-Moskwik, M; Pan, J; Nishino, M; Chuang, C; Deeraksa, A; Lin, SH; Yu-Lee, LY				Weiderhold, Kimberly N.; Fadri-Moskwik, Maria; Pan, Jing; Nishino, Michiya; Chuang, Carol; Deeraksa, Arpaporn; Lin, Sue-Hwa; Yu-Lee, Li-Yuan			Dynamic Phosphorylation of NudC by Aurora B in Cytokinesis	PLOS ONE			English	Article							CHROMOSOMAL PASSENGER COMPLEX; NUCLEAR-MOVEMENT PROTEIN; MEDIATED ABSCISSION CHECKPOINT; SPINDLE MIDZONE FORMATION; MIGRATION GENE NUDC; CELL-DIVISION; ASPERGILLUS-NIDULANS; NEURONAL MIGRATION; CHAPERONE ACTIVITY; MOLECULAR-CLONING	Nuclear distribution protein C (NudC) is a mitotic regulator that plays a role in cytokinesis. However, how NudC is regulated during cytokinesis remains unclear. Here, we show that NudC is phosphorylated by Aurora B, a kinase critical for cell abscission. NudC is co-localized with Aurora B at the midbody and co-immunoprecipitated with Aurora B in mitosis. Inhibition of Aurora B by ZM447439 reduced NudC phosphorylation, suggesting that NudC is an Aurora B substrate in vivo. We identified T40 on NudC as an Aurora B phosphorylation site. NudC depletion resulted in cytokinesis failure with a dramatic elongation of the intercellular bridge between daughter cells, sustained Aurora B activity at the midbody, and reduced cell abscission. These cytokinetic defects can be rescued by the ectopic expression of wild-type NudC. Reconstitution with T40A phospho-defective NudC was found to rescue the cytokinesis defect. In contrast, reconstitution with the T40D phospho-mimetic NudC was inefficient in supporting the completion of cytokinesis. These results suggest that that dynamic phosphorylation of NudC by Aurora B regulates cytokinesis.	[Weiderhold, Kimberly N.; Nishino, Michiya; Yu-Lee, Li-Yuan] Baylor Coll Med, Program Integrat Mol & Biomed Sci, Houston, TX 77030 USA; [Fadri-Moskwik, Maria; Pan, Jing; Deeraksa, Arpaporn; Yu-Lee, Li-Yuan] Baylor Coll Med, Dept Med, Sect Allergy Immunol & Rheumatol, Houston, TX 77030 USA; [Chuang, Carol; Yu-Lee, Li-Yuan] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Lin, Sue-Hwa] Univ Texas MD Anderson Canc Ctr, Dept Translat Mol Pathol, Houston, TX 77030 USA; [Nishino, Michiya; Yu-Lee, Li-Yuan] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Pathol, Boston, MA 02215 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Yu-Lee, LY (corresponding author), Baylor Coll Med, Program Integrat Mol & Biomed Sci, Houston, TX 77030 USA.; Yu-Lee, LY (corresponding author), Baylor Coll Med, Dept Med, Sect Allergy Immunol & Rheumatol, Houston, TX 77030 USA.; Yu-Lee, LY (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.; Yu-Lee, LY (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Pathol, Boston, MA 02215 USA.	yulee@bcm.edu		Nishino, Michiya/0000-0003-4692-4981	NIH [NRSA F31-GM084695, IRACDA K12-GM084897, T32-AI07495, T32-DK07696, P50-CA140388, RO1-CA174798, RO1-DK53176, U19-AI071130]; Cancer Prevention and Research Institute of Texas [CPRIT RP110327, CPRIT RP150282, CPRIT RP150179]; Dan L. Duncan Cancer Center; Alkek Award in Experimental Therapeutics; Biology of Inflammation Award; NATIONAL CANCER INSTITUTE [R01CA174798, P50CA140388] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI071130, T32AI007495] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053176, T32DK007696] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM084897, F31GM084695] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas; Dan L. Duncan Cancer Center; Alkek Award in Experimental Therapeutics; Biology of Inflammation Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH fellowships (NRSA F31-GM084695 to K.N.W.; IRACDA K12-GM084897 to M.F.-M.), NIH training grants (T32-AI07495 for M.F.-M. and A.D.; T32-DK07696 for A.D. and C.C.), and grants from the NIH (P50-CA140388, RO1-CA174798 to S.-H.L.; RO1-DK53176, U19-AI071130 to L.-Y.Y.-L.), Cancer Prevention and Research Institute of Texas (CPRIT RP110327, CPRIT RP150282 to S.-H.L.; CPRIT RP150179 to S.-H.L. and L.-Y.Y.-L.), Dan L. Duncan Cancer Center (L.-Y.Y.-L. and S.-H.L.), Alkek Award in Experimental Therapeutics (L.-Y.Y.-L. and S.-H.L.) and Biology of Inflammation Award (L.-Y.Y.-L.).	Aumais JP, 2003, J CELL SCI, V116, P1991, DOI 10.1242/jcs.00412; Aumais JP, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-24-j0002.2001; Bastos RN, 2013, J CELL BIOL, V202, P605, DOI 10.1083/jcb.201301094; Bieling P, 2010, CELL, V142, P420, DOI 10.1016/j.cell.2010.06.033; BRENNER S, 1981, J CELL BIOL, V91, P95, DOI 10.1083/jcb.91.1.95; Cappello S, 2011, DEV BIOL, V357, P326, DOI 10.1016/j.ydbio.2011.07.001; Carlton JG, 2012, SCIENCE, V336, P220, DOI 10.1126/science.1217180; Carmena M, 2012, NAT REV MOL CELL BIO, V13, P789, DOI 10.1038/nrm3474; Cheeseman LM, 2002, CELL, V111, P163, DOI 10.1016/S0092-8674(02)00973-X; Chuang C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073841; Clute P, 1999, NAT CELL BIOL, V1, P82, DOI 10.1038/10049; Cunniff J, 1997, MECH DEVELOP, V66, P55, DOI 10.1016/S0925-4773(97)00085-3; D'Avino PP, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00221; Dawe AL, 2001, DEV GENES EVOL, V211, P434, DOI 10.1007/s004270100176; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; Fadri-Moskwik M, 2012, FASEB J, V26, P4057, DOI 10.1096/fj.12-206656; Faircloth LM, 2009, CELL STRESS CHAPERON, V14, P95, DOI 10.1007/s12192-008-0061-1; Fededa JP, 2012, NAT CELL BIOL, V14, P440, DOI 10.1038/ncb2482; Fuller BG, 2008, NATURE, V453, P1132, DOI 10.1038/nature06923; Garcia-Ranea JA, 2002, FEBS LETT, V529, P162, DOI 10.1016/S0014-5793(02)03321-5; Glotzer M, 2009, NAT REV MOL CELL BIO, V10, P9, DOI 10.1038/nrm2609; Gocke CD, 2000, HISTOCHEM CELL BIOL, V114, P293; Gromley A, 2005, CELL, V123, P75, DOI 10.1016/j.cell.2005.07.027; Gruneberg U, 2004, J CELL BIOL, V166, P167, DOI 10.1083/jcb.200403084; Guizetti J, 2012, TRENDS CELL BIOL, V22, P133, DOI 10.1016/j.tcb.2011.11.007; Guse A, 2005, CURR BIOL, V15, P778, DOI 10.1016/j.cub.2005.03.041; Hoffman DB, 2001, MOL BIOL CELL, V12, P1995, DOI 10.1091/mbc.12.7.1995; Hu CK, 2012, MOL BIOL CELL, V23, P1024, DOI 10.1091/mbc.E11-08-0721; Hu CK, 2011, CURR BIOL, V21, P815, DOI 10.1016/j.cub.2011.04.019; Kitagawa M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064826; Kitzen JJEM, 2010, CRIT REV ONCOL HEMAT, V73, P99, DOI 10.1016/j.critrevonc.2009.03.009; Knowlton AL, 2006, CURR BIOL, V16, P1705, DOI 10.1016/j.cub.2006.07.057; Kurasawa Y, 2004, EMBO J, V23, P3237, DOI 10.1038/sj.emboj.7600347; Kurasawa Y, 2010, MOL BIOL CELL, V21, P1188, DOI 10.1091/mbc.E09-11-0950; Lampson MA, 2011, TRENDS CELL BIOL, V21, P133, DOI 10.1016/j.tcb.2010.10.007; Lee SH, 2015, FRONT CELL DEV BIOL, V3, P1; Lewellyn L, 2011, J CELL BIOL, V193, P155, DOI 10.1083/jcb.201008138; Li XY, 2004, J BIOL CHEM, V279, P47201, DOI 10.1074/jbc.M403029200; Lin SH, 2004, ONCOGENE, V23, P2499, DOI 10.1038/sj.onc.1207343; Liu D, 2009, SCIENCE, V323, P1350, DOI 10.1126/science.1167000; MASTRONARDE DN, 1993, J CELL BIOL, V123, P1475, DOI 10.1083/jcb.123.6.1475; Matsumoto N, 1999, HUM GENET, V104, P498, DOI 10.1007/s004390050994; Matuliene J, 2004, MOL BIOL CELL, V15, P3083, DOI 10.1091/mbc.E03-12-0888; McCleland ML, 2004, CURR BIOL, V14, P131, DOI 10.1016/j.cub.2003.12.058; Mendoza M, 2009, NAT CELL BIOL, V11, P477, DOI 10.1038/ncb1855; Mierzwa B, 2014, DEV CELL, V31, P525, DOI 10.1016/j.devcel.2014.11.006; Miller BA, 1999, EXP HEMATOL, V27, P742, DOI 10.1016/S0301-472X(98)00074-5; Moreau N, 2001, INT J DEV BIOL, V45, P839; Morris NR, 2000, J CELL BIOL, V148, P1097, DOI 10.1083/jcb.148.6.1097; Morris SM, 1998, EXP CELL RES, V238, P23, DOI 10.1006/excr.1997.3822; Morris SM, 1997, MOL ENDOCRINOL, V11, P229, DOI 10.1210/me.11.2.229; Morris SM, 1998, CURR BIOL, V8, P603, DOI 10.1016/S0960-9822(98)70232-5; Morrow CJ, 2005, J CELL SCI, V118, P3639, DOI 10.1242/jcs.02487; MULLINS JM, 1982, J CELL BIOL, V94, P654, DOI 10.1083/jcb.94.3.654; Nakajima Y, 2011, J CELL BIOL, V194, P137, DOI 10.1083/jcb.201009137; Neef R, 2006, CURR BIOL, V16, P301, DOI 10.1016/j.cub.2005.12.030; Neto H, 2011, J CELL SCI, V124, P3199, DOI 10.1242/jcs.083949; Nishino M, 2006, CURR BIOL, V16, P1414, DOI 10.1016/j.cub.2006.05.052; Ohashi S, 2006, ONCOGENE, V25, P7691, DOI 10.1038/sj.onc.1209754; OSMANI AH, 1990, J CELL BIOL, V111, P543, DOI 10.1083/jcb.111.2.543; Ozlu N, 2010, MOL CELL PROTEOMICS, V9, P336, DOI 10.1074/mcp.M900308-MCP200; Rosasco-Nitcher SE, 2008, SCIENCE, V319, P469, DOI 10.1126/science.1148980; Rozelle DK, 2011, J CELL BIOL, V193, P285, DOI 10.1083/jcb.201011002; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Salimian KJ, 2011, CURR BIOL, V21, P1158, DOI 10.1016/j.cub.2011.06.015; Schiel JA, 2013, CURR OPIN CELL BIOL, V25, P92, DOI 10.1016/j.ceb.2012.10.012; Sessa F, 2005, MOL CELL, V18, P379, DOI 10.1016/j.molcel.2005.03.031; Skop AR, 2004, SCIENCE, V305, P61, DOI 10.1126/science.1097931; Slattery SD, 2008, CELL CYCLE, V7, P787, DOI 10.4161/cc.7.6.5563; Steigemann P, 2009, TRENDS CELL BIOL, V19, P606, DOI 10.1016/j.tcb.2009.07.008; Steigemann P, 2009, CELL, V136, P473, DOI 10.1016/j.cell.2008.12.020; Suzuki SO, 2007, ACTA NEUROPATHOL, V113, P591, DOI 10.1007/s00401-006-0180-7; Taipale M, 2014, CELL, V158, P434, DOI 10.1016/j.cell.2014.05.039; Tan L, 2011, P NATL ACAD SCI USA, V108, P16675, DOI 10.1073/pnas.1106748108; Toba S, 2012, NEUROPATHOLOGY, V32, P432, DOI 10.1111/j.1440-1789.2012.01301.x; Uehara R, 2013, J CELL BIOL, V202, P623, DOI 10.1083/jcb.201302123; van der Waal MS, 2012, EXP CELL RES, V318, P1407, DOI 10.1016/j.yexcr.2012.03.015; Wang EX, 2011, J CELL BIOL, V194, P538, DOI 10.1083/jcb.201103044; Wei MX, 2006, J CELL BIOCHEM, V98, P429, DOI 10.1002/jcb.20803; Yamada M, 2010, EMBO J, V29, P517, DOI 10.1038/emboj.2009.378; Yasui Y, 2004, J BIOL CHEM, V279, P12997, DOI 10.1074/jbc.M311128200; Zheng MY, 2011, J MOL BIOL, V409, P722, DOI 10.1016/j.jmb.2011.04.018; Zhou T, 2003, DEV CELL, V5, P127, DOI 10.1016/S1534-5807(03)00186-2; Zhou TH, 2006, P NATL ACAD SCI USA, V103, P9039, DOI 10.1073/pnas.0602916103; Zhu CJ, 2005, P NATL ACAD SCI USA, V102, P343, DOI 10.1073/pnas.0408438102; Zhu CJ, 2006, P NATL ACAD SCI USA, V103, P6196, DOI 10.1073/pnas.0506926103; Zhu XJ, 2010, J BIOL CHEM, V285, P29903, DOI 10.1074/jbc.M110.105494	87	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153455	10.1371/journal.pone.0153455	http://dx.doi.org/10.1371/journal.pone.0153455			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27074040	Green Submitted, gold, Green Published			2022-12-27	WOS:000374131200096
J	Han, YM; Ripley, B; Serada, S; Naka, T; Fujimoto, M				Han, Yongmei; Ripley, Barry; Serada, Satoshi; Naka, Tetsuji; Fujimoto, Minoru			Interleukin-6 Deficiency Does Not Affect Motor Neuron Disease Caused by Superoxide Dismutase 1 Mutation	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; INFLAMMATORY TH17 RESPONSES; COLLAGEN-INDUCED ARTHRITIS; AMELIORATES JOINT DISEASE; NECROSIS-FACTOR-ALPHA; MOUSE MODEL; FAMILIAL ALS; RECEPTOR; CELLS; BLOCKADE	Background & Aim Amyotrophic Lateral Sclerosis (ALS) is an adult-onset, progressive, motor neuron degenerative disease. Recent evidence indicates that inflammation is associated with many neuro-degenerative diseases including ALS. Previously, abnormal levels of inflammatory cytokines including IL-1 beta, IL-6 and TNF-alpha were described in ALS patients and/or in mouse ALS models. In addition, one study showed that blocking IL-1 beta could slow down progression of ALS-like symptoms in mice. In this study, we examined a role for IL-6 in ALS, using an animal model for familial ALS. Methods Mice with mutant SOD1 (G93A) transgene, a model for familial ALS, were used in this study. The expression of the major inflammatory cytokines, IL-6, IL-1 beta and TNF-alpha, in spinal cords of these SOD1 transgenic (TG) mice were assessed by real time PCR. Mice were then crossed with IL-6(-/-) mice to generate SOD1TG/IL-6(-/-) mice. SOD1 TG/IL-6(-/-) mice (n = 17) were compared with SOD1 TG/IL-6(+/-) mice (n = 18), SOD1 TG/IL-6(+/+) mice (n = 11), WT mice (n = 15), IL-6(+/-) mice (n = 5) and IL-6(-/-) mice (n = 8), with respect to neurological disease severity score, body weight and the survival. We also histologically compared the motor neuron loss in lumber spinal cords and the atrophy of hamstring muscles between these mouse groups. Results Levels of IL-6, IL-1 beta and TNF-alpha in spinal cords of SOD1 TG mice was increased compared to WT mice. However, SOD1 TG/IL-6(-/-) mice exhibited weight loss, deterioration in motor function and shortened lifespan (167.55 +/- 11.52 days), similarly to SOD1 TG/IL-6(+/+) mice (164.31 +/- 12.16 days). Motor neuron numbers and IL-1 beta and TNF-alpha levels in spinal cords were not significantly different in SOD1 TG/IL-6(-/-) mice and SOD1 TG/IL-6 (+/+) mice. Conclusion These results provide compelling preclinical evidence indicating that IL-6 does not directly contribute to motor neuron disease caused by SOD1 mutations.	[Han, Yongmei] Osaka Univ, Grad Sch Frontier Biosci, 1-3 Yamadaoka, Suita, Osaka 5650871, Japan; [Han, Yongmei; Serada, Satoshi; Naka, Tetsuji; Fujimoto, Minoru] Natl Inst Biomed Innovat Hlth & Nutr, Lab Immune Signal, Osaka, Japan; [Ripley, Barry] Osaka Univ, Lab Immune Regulat, IFReC Res Bldg,3-1 Yamadaoka, Suita, Osaka 5650871, Japan	Osaka University; Osaka University	Fujimoto, M (corresponding author), Natl Inst Biomed Innovat Hlth & Nutr, Lab Immune Signal, Osaka, Japan.	mfujimoto@nibiohn.go.jp		Serada, Satoshi/0000-0001-6948-9009; Naka, Tetsuji/0000-0002-1269-3997; FUJIMOTO, MINORU/0000-0002-6390-8863				Appel SH, 2010, TRENDS IMMUNOL, V31, P7, DOI 10.1016/j.it.2009.09.003; Audet JN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034932; Beers DR, 2008, P NATL ACAD SCI USA, V105, P15558, DOI 10.1073/pnas.0807419105; Bendotti C, 2004, TRENDS MOL MED, V10, P393, DOI 10.1016/j.molmed.2004.06.009; Chiu IM, 2008, P NATL ACAD SCI USA, V105, P17913, DOI 10.1073/pnas.0804610105; Evans MC, 2013, MOL CELL NEUROSCI, V53, P34, DOI 10.1016/j.mcn.2012.10.008; Fiala Milan, 2013, Am J Neurodegener Dis, V2, P129; Fujimoto M, 2008, ARTHRITIS RHEUM-US, V58, P3710, DOI 10.1002/art.24126; Gabay C, 2001, ARTHRITIS RHEUM-US, V44, P451, DOI 10.1002/1529-0131(200102)44:2<451::AID-ANR64>3.3.CO;2-8; Gill A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006489; Goldbach-Mansky R, 2009, J ALLERGY CLIN IMMUN, V124, P1141, DOI 10.1016/j.jaci.2009.11.016; Gowing G, 2006, J NEUROSCI, V26, P11397, DOI 10.1523/JNEUROSCI.0602-06.2006; Hensley K, 2003, NEUROBIOL DIS, V14, P74, DOI 10.1016/S0969-9961(03)00087-1; Hohki S, 2010, EXP EYE RES, V91, P162, DOI 10.1016/j.exer.2010.04.009; Ilieva H, 2009, J CELL BIOL, V187, P761, DOI 10.1083/jcb.200908164; Jeyachandran A, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00462; Kishimoto T, 2005, ANNU REV IMMUNOL, V23, P1, DOI 10.1146/annurev.immunol.23.021704.115806; Kunis G, 2015, J NEUROSCI, V35, P6381, DOI 10.1523/JNEUROSCI.3644-14.2015; Lincecum JM, 2010, NAT GENET, V42, P392, DOI 10.1038/ng.557; Masters SL, 2009, ANNU REV IMMUNOL, V27, P621, DOI 10.1146/annurev.immunol.25.022106.141627; Meissner F, 2010, P NATL ACAD SCI USA, V107, P13046, DOI 10.1073/pnas.1002396107; Mizwicki Mathew T, 2012, Am J Neurodegener Dis, V1, P305; Murdock BJ, 2015, NEUROBIOL DIS, V77, P1, DOI 10.1016/j.nbd.2015.02.017; Nishimoto N, 2006, NAT CLIN PRACT RHEUM, V2, P619, DOI 10.1038/ncprheum0338; Papadimitriou D, 2010, NEUROBIOL DIS, V37, P493, DOI 10.1016/j.nbd.2009.10.005; Pasinelli P, 2006, NAT REV NEUROSCI, V7, P710, DOI 10.1038/nrn1971; Pfohl Stephen R, 2015, J Neuromuscul Dis, V2, P137; PIGUET PF, 1992, IMMUNOLOGY, V77, P510; Rizzo F, 2014, CELL MOL LIFE SCI, V71, P999, DOI 10.1007/s00018-013-1480-4; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Rothstein JD, 2009, ANN NEUROL, V65, pS3, DOI 10.1002/ana.21543; Rutherford NJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000193; Schwartz M, 2014, J AUTOIMMUN, V54, P8, DOI 10.1016/j.jaut.2014.08.002; Sekizawa T, 1998, J NEUROL SCI, V154, P194, DOI 10.1016/S0022-510X(97)00228-1; Serada S, 2008, P NATL ACAD SCI USA, V105, P9041, DOI 10.1073/pnas.0802218105; Spooren A, 2011, BRAIN RES REV, V67, P157, DOI 10.1016/j.brainresrev.2011.01.002; Tada S, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-19; Takagi N, 1998, ARTHRITIS RHEUM, V41, P2117, DOI 10.1002/1529-0131(199812)41:12<2117::AID-ART6>3.3.CO;2-G; Tanaka T, 2012, ANNU REV PHARMACOL, V52, P199, DOI 10.1146/annurev-pharmtox-010611-134715; Terabe F, 2011, INFLAMM BOWEL DIS, V17, P491, DOI 10.1002/ibd.21384; THORBECKE GJ, 1992, P NATL ACAD SCI USA, V89, P7375, DOI 10.1073/pnas.89.16.7375; Vucic S, 2014, TRENDS NEUROSCI, V37, P433, DOI 10.1016/j.tins.2014.05.006; WILLIAMS RO, 1992, P NATL ACAD SCI USA, V89, P9784, DOI 10.1073/pnas.89.20.9784; Zhou C, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-52	44	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0153399	10.1371/journal.pone.0153399	http://dx.doi.org/10.1371/journal.pone.0153399			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27070121	Green Published, gold, Green Submitted			2022-12-27	WOS:000373900700059
J	Beaudreau, AH; Whitney, EJ				Beaudreau, Anne H.; Whitney, Emily J.			Historical Patterns and Drivers of Spatial Changes in Recreational Fishing Activity in Puget Sound, Washington	PLOS ONE			English	Article							GULF-OF-CALIFORNIA; LOCAL KNOWLEDGE; FISHERIES; MANAGEMENT; CONSERVATION; IMPACTS; SPOTS	Small-scale fisheries are the primary users of many coastal fish stocks; yet, spatial and temporal patterns of recreational and subsistence fishing in coastal marine ecosystems are poorly documented. Knowledge about the spatial distribution of fishing activities can inform place-based management that balances species conservation with opportunities for recreation and subsistence. We used a participatory mapping approach to document changes in spatial fishing patterns of 80 boat-based recreational anglers from 1950 to 2010 in Puget Sound, Washington, USA. Hand-drawn fishing areas for salmon, rockfishes, flatfishes, and crabs were digitized and analyzed in a Geographic Information System. We found that recreational fishing has spanned the majority of Puget Sound since the 1950s, with the heaviest use limited to small areas of central and northern Puget Sound. People are still fishing in the same places they were decades ago, with relatively little change in specific locations despite widespread declines in salmon and bottomfish populations during the second half of the 20th century. While the location of core fishing areas remained consistent, the size of those areas and intensity of use changed over time. The size of fishing areas increased through the 2000s for salmon but declined after the 1970s and 1980s for rockfishes, flatfishes, and crabs. Our results suggest that the spatial extent of recreational bottomfishing increased after the 1960s, when the availability of motorized vessels and advanced fish-finding technologies allowed anglers to expand their scope beyond localized angling from piers and boathouses. Respondents offered a wide range of reasons for shifts in fishing areas over time, reflecting substantial individual variation in motivations and behaviors. Changes in fishing areas were most commonly attributed to changes in residence and declines in target species and least tied to fishery regulations, despite the implementation of at least 25 marine preserves since 1970.	[Beaudreau, Anne H.; Whitney, Emily J.] Univ Alaska Fairbanks, Sch Fisheries & Ocean Sci, 17101 Point Lena Loop Rd, Juneau, AK 99801 USA	University of Alaska System; University of Alaska Fairbanks	Beaudreau, AH (corresponding author), Univ Alaska Fairbanks, Sch Fisheries & Ocean Sci, 17101 Point Lena Loop Rd, Juneau, AK 99801 USA.	abeaudreau@alaska.edu			U.S. Environmental Protection Agency [DW13923277]; Fidalgo Chapter of the Puget Sound Anglers Association; University of Alaska Fairbanks School of Fisheries and Ocean Sciences	U.S. Environmental Protection Agency(United States Environmental Protection Agency); Fidalgo Chapter of the Puget Sound Anglers Association; University of Alaska Fairbanks School of Fisheries and Ocean Sciences	This research was supported by the U.S. Environmental Protection Agency (http://www.epa.gov/, grant # DW13923277; AHB), the Fidalgo Chapter of the Puget Sound Anglers Association (http://www.psafidalgo.org/; AHB), and the University of Alaska Fairbanks School of Fisheries and Ocean Sciences (http://www.uaf.edu/sfos/; AHB, EJW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arlinghaus R, 2006, ENVIRON CONSERV, V33, P46, DOI 10.1017/S0376892906002700; Beaudreau AH, 2014, ECOL APPL, V24, P244, DOI 10.1890/13-0817.1; Beaudreau AH, 2011, CONSERV LETT, V4, P451, DOI 10.1111/j.1755-263X.2011.00199.x; Begossi A, 2001, REG ENVIRON CHANGE, V2, P1, DOI 10.1007/s101130100022; Begossi A, 2006, ECOL SOC, V11; Bergmann M, 2004, FISH RES, V66, P373, DOI 10.1016/j.fishres.2003.07.007; Berkeley SA, 2004, FISHERIES, V29, P23, DOI 10.1577/1548-8446(2004)29[23:FSVPOA]2.0.CO;2; Bernard H. R., 2017, RES METHODS ANTHR; Bertrand S, 2008, PROG OCEANOGR, V79, P379, DOI 10.1016/j.pocean.2008.10.009; Blanchard JL, 2005, CAN J FISH AQUAT SCI, V62, P2001, DOI 10.1139/F05-109; Chambers JM., 1992, STAT MODELS S; Close CH, 2006, J ENVIRON MANAGE, V78, P341, DOI 10.1016/j.jenvman.2005.04.027; Coleman FC, 2004, SCIENCE, V305, P1958, DOI 10.1126/science.1100397; Coll M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085670; Collie JS, 2000, J ANIM ECOL, V69, P785, DOI 10.1046/j.1365-2656.2000.00434.x; Cooke SJ, 2004, BIOSCIENCE, V54, P857, DOI 10.1641/0006-3568(2004)054[0857:TRORFI]2.0.CO;2; Davis A, 2003, HUM ECOL, V31, P463, DOI 10.1023/A:1025075923297; Daw TM, 2008, FISH RES, V90, P17, DOI 10.1016/j.fishres.2007.09.027; Erisman BE, 2011, CAN J FISH AQUAT SCI, V68, P1705, DOI 10.1139/F2011-090; Hall GB, 2007, FISH RES, V83, P11, DOI 10.1016/j.fishres.2006.08.015; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; HILBORN R, 1985, CAN J FISH AQUAT SCI, V42, P2, DOI 10.1139/f85-001; HILBORN R, 1992; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jennings S, 2012, ICES J MAR SCI, V69, P1053, DOI 10.1093/icesjms/fss050; Klein CJ, 2008, CONSERV BIOL, V22, P691, DOI 10.1111/j.1523-1739.2008.00896.x; Kraig E, 2014, WASHINGTON STATE SPO; Laver PN, 2008, J WILDLIFE MANAGE, V72, P290, DOI 10.2193/2005-589; Leopold M, 2014, ICES J MAR SCI, V71, P1781, DOI 10.1093/icesjms/fst204; Lewin WC, 2006, REV FISH SCI, V14, P305, DOI 10.1080/10641260600886455; Love M. S., 2002, ROCKFISHES NE PACIFI; Miller B. S., 1980, GEOGRAPHICAL DISTRIB, V1-3; Moreno-Baez M, 2012, OCEAN COAST MANAGE, V55, P111, DOI 10.1016/j.ocecoaman.2011.10.001; Moreno-Baez M, 2010, B MAR SCI, V86, P339; National Oceanic and Atmospheric Administration (NOAA), RECR FISH STAT; NEHLSEN W, 1991, FISHERIES, V16, P4, DOI 10.1577/1548-8446(1991)016&lt;0004:PSATCS&gt;2.0.CO;2; Neis B, 1999, CAN J FISH AQUAT SCI, V56, P1949, DOI 10.1139/cjfas-56-10-1949; Office of Financial Management (OFM), POPULATION; Pacunski R.E., 2008, MARINE HABITAT MAPPI, P109, DOI [10.4027/mhmta.2008.08, DOI 10.4027/MHMTA.2008.08]; Pacunski RE, 2013, PUBLICATION FPT; Palsson WA., 2009, BIOL ASSESSMENT ROCK; R Core Team, 2012, R LANG ENV STAT COMP; Sawchuk JH, 2015, MAR POLICY, V54, P98, DOI 10.1016/j.marpol.2014.12.014; Scholz A, 2004, MAR POLICY, V28, P335, DOI 10.1016/j.marpol.2003.09.003; St Martin K, 2001, ANN ASSOC AM GEOGR, V91, P122, DOI 10.1111/0004-5608.00236; U.S. Commission of Fish and Fisheries, 1892, REP COMM 16; WAND MP, 1994, COMPUTATION STAT, V9, P97; Washington Department of Natural Resources, 1972, N INL WAT, V1; Washington Department of Natural Resources, 1972, S INL WAT, V2; Weisberg S., 1985, APPL LINEAR REGRESSI; Williams GD, 2010, MAR POLICY, V34, P1010, DOI 10.1016/j.marpol.2010.02.008; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423; Yates KL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068424	53	10	10	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0152190	10.1371/journal.pone.0152190	http://dx.doi.org/10.1371/journal.pone.0152190			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DI6KO	27054890	Green Submitted, Green Published, gold			2022-12-27	WOS:000373608000014
J	McDonald, KA; Stearne, SM; Alderson, JA; North, I; Pires, NJ; Rubenson, J				McDonald, Kirsty A.; Stearne, Sarah M.; Alderson, Jacqueline A.; North, Ian; Pires, Neville J.; Rubenson, Jonas			The Role of Arch Compression and Metatarsophalangeal Joint Dynamics in Modulating Plantar Fascia Strain in Running	PLOS ONE			English	Article							FOOT POSTURE INDEX; LONGITUDINAL ARCH; ACHILLES-TENDON; BIOMECHANICAL EVALUATION; MECHANICAL-PROPERTIES; WINDLASS MECHANISM; STANCE PHASE; WALK-RUN; APONEUROSIS; SUPPORT	Elastic energy returned from passive-elastic structures of the lower limb is fundamental in lowering the mechanical demand on muscles during running. The purpose of this study was to investigate the two length-modulating mechanisms of the plantar fascia, namely medial longitudinal arch compression and metatarsophalangeal joint (MPJ) excursion, and to determine how these mechanisms modulate strain, and thus elastic energy storage/return of the plantar fascia during running. Eighteen runners (9 forefoot and 9 rearfoot strike) performed three treadmill running trials; unrestricted shod, shod with restricted arch compression (via an orthotic-style insert), and barefoot. Three-dimensional motion capture and ground reaction force data were used to calculate lower limb kinematics and kinetics including MPJ angles, moments, powers and work. Estimates of plantar fascia strain due to arch compression and MPJ excursion were derived using a geometric model of the arch and a subject-specific musculoskeletal model of the plantar fascia, respectively. The plantar fascia exhibited a typical elastic stretch-shortening cycle with the majority of strain generated via arch compression. This strategy was similar in fore-and rear-foot strike runners. Restricting arch compression, and hence the elastic-spring function of the arch, was not compensated for by an increase in MPJ-derived strain. In the second half of stance the plantar fascia was found to transfer energy between the MPJ (energy absorption) and the arch (energy production during recoil). This previously unreported energy transfer mechanism reduces the strain required by the plantar fascia in generating useful positive mechanical work at the arch during running.	[McDonald, Kirsty A.; Stearne, Sarah M.; Alderson, Jacqueline A.; Pires, Neville J.; Rubenson, Jonas] Univ Western Australia, Sch Sport Sci Exercise & Hlth, Perth, WA 6009, Australia; [North, Ian] Willetton Podiatry, Perth, WA, Australia; [Rubenson, Jonas] Penn State Univ, Dept Kinesiol, Biomech Lab, State Coll, PA USA	University of Western Australia; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University	Rubenson, J (corresponding author), Univ Western Australia, Sch Sport Sci Exercise & Hlth, Perth, WA 6009, Australia.; Rubenson, J (corresponding author), Penn State Univ, Dept Kinesiol, Biomech Lab, State Coll, PA USA.	jonas@psu.edu	Alderson, Jacqueline/V-3491-2019; Stearne, Sarah/F-9865-2013	Alderson, Jacqueline/0000-0002-8866-0913; Rubenson, Jonas/0000-0003-2854-1776; Stearne, Sarah/0000-0001-5278-2532	Willetton Podiatry (Perth, Australia); Orthotech Laboratories (Melbourne, Australia); Frank Pyke Memorial Scholarship (The University of Western Australia)	Willetton Podiatry (Perth, Australia); Orthotech Laboratories (Melbourne, Australia); Frank Pyke Memorial Scholarship (The University of Western Australia)	Willetton Podiatry (Perth, Australia) provided support in the form of salaries for author I. N., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section. Orthotech Laboratories (Melbourne, Australia) provided a substantial financial discount for the production of the orthotic inserts which were used in the current study but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. During the course of this research K. A.M. was awarded personal financial support in the form of the Frank Pyke Memorial Scholarship (The University of Western Australia).	Arangio GA, 1998, FOOT ANKLE INT, V19, P705, DOI 10.1177/107110079801901010; BASMAJIAN JV, 1963, J BONE JOINT SURG AM, V45, P1189, DOI 10.2106/00004623-196345060-00006; Besier TF, 2003, J BIOMECH, V36, P1159, DOI 10.1016/S0021-9290(03)00087-3; BOBBERT MF, 1988, J BIOMECH, V21, P249, DOI 10.1016/0021-9290(88)90175-3; BOJSENMOLLER F, 1979, J ANAT, V129, P165; Caravaggi P, 2009, J EXP BIOL, V212, P2491, DOI 10.1242/jeb.025767; Carson MC, 2001, J BIOMECH, V34, P1299, DOI 10.1016/S0021-9290(01)00101-4; CAVAGNA GA, 1977, AM J PHYSIOL, V233, pR243, DOI 10.1152/ajpregu.1977.233.5.R243; CAVAGNA GA, 1964, J APPL PHYSIOL, V19, P249, DOI 10.1152/jappl.1964.19.2.249; CAVANAGH PR, 1980, J BIOMECH, V13, P397, DOI 10.1016/0021-9290(80)90033-0; Cheng HYK, 2008, J BIOMECH, V41, P1937, DOI 10.1016/j.jbiomech.2008.03.028; Denton JD, 2003, RUNNING TIMES, P80; DIEDRICH FJ, 1995, J EXP PSYCHOL HUMAN, V21, P183, DOI 10.1037/0096-1523.21.1.183; Endo K, 2009, INTELLIGENT ROBOTS S; Evans AM, 2003, J AM PODIAT MED ASSN, V93, P203, DOI 10.7547/87507315-93-3-203; Flanigan RM, 2007, FOOT ANKLE INT, V28, P815, DOI 10.3113/FAI.2007.0815; Gefen A, 2003, FOOT ANKLE INT, V24, P238, DOI 10.1177/107110070302400307; Hageman ER, 2011, FOOT ANKLE INT, V32, P623, DOI 10.3113/FAI.2011.0623; HICKS JH, 1954, J ANAT, V88, P25; HUANG CK, 1993, FOOT ANKLE, V14, P353, DOI 10.1177/107110079301400609; Kelly LA, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.1188; Kelly LA, 2012, CLIN BIOMECH, V27, P46, DOI 10.1016/j.clinbiomech.2011.07.013; KER RF, 1987, NATURE, V325, P147, DOI 10.1038/325147a0; KITAOKA HB, 1994, FOOT ANKLE INT, V15, P557, DOI 10.1177/107110079401501007; Kogler GF, 2001, FOOT ANKLE INT, V22, P433, DOI 10.1177/107110070102200513; Kogler GF, 1996, CLIN BIOMECH, V11, P243, DOI 10.1016/0268-0033(96)00019-8; Kristianslund E, 2012, J BIOMECH, V45, P666, DOI 10.1016/j.jbiomech.2011.12.011; Lee SJ, 2008, J APPL PHYSIOL, V104, P747, DOI 10.1152/japplphysiol.01380.2006; Natali AN, 2010, CONNECT TISSUE RES, V51, P337, DOI 10.3109/03008200903389127; PANDY MG, 1991, J BIOMECH, V24, P1, DOI 10.1016/0021-9290(91)90321-D; Pavan PG, 2011, SURG RADIOL ANAT, V33, P905, DOI 10.1007/s00276-011-0873-z; Perl DP, 2012, MED SCI SPORT EXER, V44, P1335, DOI 10.1249/MSS.0b013e318247989e; Prilutsky BI, 2001, J EXP BIOL, V204, P2277; PRILUTSKY BI, 1994, J BIOMECH, V27, P25, DOI 10.1016/0021-9290(94)90029-9; Redmond AC, 2006, CLIN BIOMECH, V21, P89, DOI 10.1016/j.clinbiomech.2005.08.002; Riley PO, 2008, MED SCI SPORT EXER, V40, P1093, DOI 10.1249/MSS.0b013e3181677530; Salzler MJ, 2012, FOOT ANKLE INT, V33, P262, DOI 10.3113/FAI.2012.0262; Sasaki K, 2006, GAIT POSTURE, V23, P383, DOI 10.1016/j.gaitpost.2005.05.002; Sinclair J, 2014, FAOJ, V7, P7; SNOW SW, 1995, FOOT ANKLE INT, V16, P418, DOI 10.1177/107110079501600707; Stearne SM, 2016, SCI REP-UK, V6, DOI 10.1038/srep19403; Stearne SM, 2014, MED SCI SPORT EXER, V46, P1578, DOI 10.1249/MSS.0000000000000254; Stecco C, 2013, J ANAT, V223, P665, DOI 10.1111/joa.12111; Stefanyshyn DJ, 1997, J BIOMECH, V30, P1081, DOI 10.1016/S0021-9290(97)00081-X; THORDARSON DB, 1995, CLIN ORTHOP RELAT R, P165; WINTER DA, 1980, J BIOMECH, V13, P923, DOI 10.1016/0021-9290(80)90162-1	46	50	50	3	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0152602	10.1371/journal.pone.0152602	http://dx.doi.org/10.1371/journal.pone.0152602			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27054319	Green Published, Green Submitted, gold			2022-12-27	WOS:000373608000027
J	Sonomoto, K; Yamaoka, K; Kaneko, H; Yamagata, K; Sakata, K; Zhang, XM; Kondo, M; Zenke, Y; Sabanai, K; Nakayamada, S; Sakai, A; Tanaka, Y				Sonomoto, Koshiro; Yamaoka, Kunihiro; Kaneko, Hiroaki; Yamagata, Kaoru; Sakata, Kei; Zhang, Xiangmei; Kondo, Masahiro; Zenke, Yukichi; Sabanai, Ken; Nakayamada, Shingo; Sakai, Akinori; Tanaka, Yoshiya			Spontaneous Differentiation of Human Mesenchymal Stem Cells on Poly-Lactic-Co-Glycolic Acid Nano-Fiber Scaffold	PLOS ONE			English	Article							VERSUS-HOST-DISEASE; CLASSIFICATION; CARTILAGE; CRITERIA; REPAIR	Introduction Mesenchymal stem cells (MSCs) have immunosuppressive activity and can differentiate into bone and cartilage; and thus seem ideal for treatment of rheumatoid arthritis (RA). Here, we investigated the osteogenesis and chondrogenesis potentials of MSCs seeded onto nano-fiber scaffolds (NFs) in vitro and possible use for the repair of RA-affected joints. Methods MSCs derived from healthy donors and patients with RA or osteoarthritis (OA) were seeded on poly-lactic-glycolic acid (PLGA) electrospun NFs and cultured in vitro. Results Healthy donor-derived MSCs seeded onto NFs stained positive with von Kossa at Day 14 post-stimulation for osteoblast differentiation. Similarly, MSCs stained positive with Safranin O at Day 14 post-stimulation for chondrocyte differentiation. Surprisingly, even cultured without any stimulation, MSCs expressed RUNX2 and SOX9 (master regulators of bone and cartilage differentiation) at Day 7. Moreover, MSCs stained positive for osteocalcin, a bone marker, and simultaneously also with Safranin O at Day 14. On Day 28, the cell morphology changed from a spindle-like to an osteocyte-like appearance with processes, along with the expression of dentin matrix protein-1 (DMP-1) and matrix extracellular phosphoglycoprotein (MEPE), suggesting possible differentiation of MSCs into osteocytes. Calcification was observed on Day 56. Expression of osteoblast and chondrocyte differentiation markers was also noted in MSCs derived from RA or OA patients seeded on NFs. Lactic acid present in NFs potentially induced MSC differentiation into osteoblasts. Conclusions Our PLGA scaffold NFs induced MSC differentiation into bone and cartilage. NFs induction process resembled the procedure of endochondral ossification. This finding indicates that the combination of MSCs and NFs is a promising therapeutic technique for the repair of RA or OA joints affected by bone and cartilage destruction.	[Sonomoto, Koshiro; Yamaoka, Kunihiro; Yamagata, Kaoru; Sakata, Kei; Zhang, Xiangmei; Kondo, Masahiro; Nakayamada, Shingo; Tanaka, Yoshiya] Univ Occupat & Environm Hlth, Sch Med, Dept Internal Med 1, Kitakyushu, Fukuoka 807, Japan; [Kaneko, Hiroaki] Teijin Ltd, Integrat Technol Res Inst, Hino, Tokyo, Japan; [Zenke, Yukichi; Sabanai, Ken; Sakai, Akinori] Univ Occupat & Environm Hlth, Sch Med, Dept Orthoped, Kitakyushu, Fukuoka 807, Japan; [Sonomoto, Koshiro] Natl Hosp Org, Beppu Med Ctr, Rheumatol, Beppu, Oita, Japan; [Yamaoka, Kunihiro] Keio Univ, Div Rheumatol, Internal Med, Shinjuku Ku, Tokyo, Japan; [Sakata, Kei; Kondo, Masahiro] Mitsubishi Tanabe Pharma Corp, Div Res, Res Unit B, Yokohama, Kanagawa, Japan	University of Occupational & Environmental Health - Japan; Teijin Limited; University of Occupational & Environmental Health - Japan; Keio University; Mitsubishi Tanabe Pharma Corporation	Tanaka, Y (corresponding author), Univ Occupat & Environm Hlth, Sch Med, Dept Internal Med 1, Kitakyushu, Fukuoka 807, Japan.	tanaka@med.uoeh-u.ac.jp			Japan Society for the Promotion of Science KAKENHI [25860821]; Mitsubishi Tanabe pharma corporation; Teijin limited; Grants-in-Aid for Scientific Research [25860821] Funding Source: KAKEN	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Mitsubishi Tanabe pharma corporation; Teijin limited; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The Japan Society for the Promotion of Science KAKENHI [grant number 25860821], granted to KSonomoto for this research project. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Mitsubishi Tanabe pharma corporation provided support in the form of salaries for K. Sakata and MK but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Teijin limited provided support in the form of salaries for HK but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aletaha D, 2010, ANN RHEUM DIS, V69, P1580, DOI [10.1136/ard.2010.138461, 10.1002/art.27584]; ALTMAN R, 1986, ARTHRITIS RHEUM, V29, P1039, DOI 10.1002/art.1780290816; Bentzon JF, 2005, BIOCHEM BIOPH RES CO, V330, P633, DOI 10.1016/j.bbrc.2005.03.072; Bhat S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027475; Curran JM, 2013, BIOMATERIALS, V34, P9352, DOI 10.1016/j.biomaterials.2013.08.044; Eames BF, 2004, DEV BIOL, V274, P188, DOI 10.1016/j.ydbio.2004.07.006; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Hare JM, 2009, J AM COLL CARDIOL, V54, P2277, DOI 10.1016/j.jacc.2009.06.055; Hermida-Gomez T, 2011, J RHEUMATOL, V38, P339, DOI 10.3899/jrheum.100614; HOPF H, 1992, MUSCULOSKELETAL INFE, P329; Horwitz EM, 2002, P NATL ACAD SCI USA, V99, P8932, DOI 10.1073/pnas.132252399; HUNT TK, 1990, J TRAUMA, V30, pS122; HUNT TK, 1972, SURG GYNECOL OBSTETR, V135, P561; Kondo M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079463; Le Blanc K, 2004, LANCET, V363, P1439, DOI 10.1016/S0140-6736(04)16104-7; Le Blanc K, 2012, NAT REV IMMUNOL, V12, P383, DOI 10.1038/nri3209; LeBlanc K, 2008, LANCET, V371, P1579, DOI 10.1016/S0140-6736(08)60690-X; Morille M, 2013, J CONTROL RELEASE, V170, P99, DOI 10.1016/j.jconrel.2013.04.017; Olivares-Navarrete R, 2010, BIOMATERIALS, V31, P2728, DOI 10.1016/j.biomaterials.2009.12.029; Oshita K, 2011, ARTHRITIS RHEUM-US, V63, P1658, DOI 10.1002/art.30309; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Sola-Penna M, 2008, IUBMB LIFE, V60, P605, DOI 10.1002/iub.97; Sonomoto K, 2012, ARTHRITIS RHEUM-US, V64, P3355, DOI 10.1002/art.34555; Toyokawa N, 2010, ARTHROSCOPY, V26, P375, DOI 10.1016/j.arthro.2009.08.006; Valenti MT, 2008, BONE, V43, P1084, DOI 10.1016/j.bone.2008.07.252; Wang CJ, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/579141; Yu Y, 2015, ARTHRITIS RHEUMATOL, V67, P1274, DOI 10.1002/art.39049; Zhang XJ, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0085007, 10.1186/1748-717X-9-64]	28	39	41	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153231	10.1371/journal.pone.0153231	http://dx.doi.org/10.1371/journal.pone.0153231			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27055270	Green Submitted, Green Published, gold			2022-12-27	WOS:000373608000106
J	Tsirogiannis, C; Sandel, B				Tsirogiannis, Constantinos; Sandel, Brody			Fast Computations for Measures of Phylogenetic Beta Diversity	PLOS ONE			English	Article							COMMUNITY STRUCTURE	For many applications in ecology, it is important to examine the phylogenetic relations between two communities of species. More formally, let T be a phylogenetic tree and let A and B be two samples of its tips, representing the examined communities. We want to compute a value that expresses the phylogenetic diversity between A and B in T. There exist several measures that can do this; these are the so-called phylogenetic beta diversity (beta-diversity) measures. Two popular measures of this kind are the Community Distance (CD) and the Common Branch Length (CBL). In most applications, it is not sufficient to compute the value of a beta diversity measure for two communities A and B; we also want to know if this value is relatively large or small compared to all possible pairs of communities in T that have the same size. To decide this, the ideal approach is to compute a standardised index that involves the mean and the standard deviation of this measure among all pairs of species samples that have the same number of elements as A and B. However, no method exists for computing exactly and efficiently this index for CD and CBL. We present analytical expressions for computing the expectation and the standard deviation of CD and CBL. Based on these expressions, we describe efficient algorithms for computing the standardised indices of the two measures. Using standard algorithmic analysis, we provide guarantees on the theoretical efficiency of our algorithms. We implemented our algorithms and measured their efficiency in practice. Our implementations compute the standardised indices of CD and CBL in less than twenty seconds for a hundred pairs of samples on trees with 7 . 10(4) tips. Our implementations are available through the R package PhyloMeasures.	[Tsirogiannis, Constantinos] Aarhus Univ, MADALGO, Aarhus, Denmark; Aarhus Univ, Dept Bios, Aarhus, Denmark	Aarhus University; Aarhus University	Tsirogiannis, C (corresponding author), Aarhus Univ, MADALGO, Aarhus, Denmark.	constant@madalgo.au.dk			Massive Data Algorithmics (MADALGO); Ecoinformatics and Biodiversity	Massive Data Algorithmics (MADALGO); Ecoinformatics and Biodiversity	This work was supported by Massive Data Algorithmics (MADALGO) (http://madalgo.au.dk/) and Ecoinformatics and Biodiversity (http://bios.au.dk/en/about-bioscience/organisation/ecoinformatics-andbiodiversity/ecoinformatics-researchprofile/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; Chao A, 2015, METHODS ECOL EVOL, V6, P380, DOI 10.1111/2041-210X.12247; Cody M.L., 1975, P214; Eiserhardt WL, 2013, BOT J LINN SOC, V171, P244, DOI 10.1111/j.1095-8339.2012.01276.x; Feng G, 2015, SCI REP-UK, V5, DOI 10.1038/srep09337; Goloboff PA, 2009, CLADISTICS, V25, P211, DOI 10.1111/j.1096-0031.2009.00255.x; Graham CH, 2008, ECOL LETT, V11, P1265, DOI 10.1111/j.1461-0248.2008.01256.x; Graham CH, 2009, P NATL ACAD SCI USA, V106, P19673, DOI 10.1073/pnas.0901649106; Holt B, 2013, SCIENCE, V339, P74, DOI 10.1126/science.1228282; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Leprieur F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042760; Meynard CN, 2011, GLOBAL ECOL BIOGEOGR, V20, P893, DOI 10.1111/j.1466-8238.2010.00647.x; Nipperess DA, 2013, METHODS ECOL EVOL, V4, P566, DOI 10.1111/2041-210X.12042; O'Dwyer JP, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002832; Peixoto FP, 2014, J BIOGEOGR, V41, P762, DOI 10.1111/jbi.12241; Pellissier L, 2013, ECOL LETT, V16, P600, DOI 10.1111/ele.12083; Qian H, 2013, GLOBAL ECOL BIOGEOGR, V22, P1152, DOI 10.1111/geb.12076; Ricotta C, 2015, J PLANT ECOL, V8, P12, DOI 10.1093/jpe/rtu008; Steel M, 2007, SYST ASSOC SPEC VOL, V72, P97; Swenson NG, 2012, ECOLOGY, V93, pS112, DOI 10.1890/11-0402.1; Swenson NG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021264; Tsirogiannis Constantinos, 2012, Algorithms in Bioinformatics. Proceedings of the12th International Workshop, WABI 2012, P30, DOI 10.1007/978-3-642-33122-0_3; Tsirogiannis C, 2016, ECOGRAPHY, V39, P709, DOI 10.1111/ecog.01814; Tsirogiannis C, 2014, LECT N BIOINFORMAT, V8701, P187, DOI 10.1007/978-3-662-44753-6_15; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; WHITTAKER ROBERT H., 1960, ECOL MONOGR, V30, P279, DOI 10.2307/1943563	26	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0151167	10.1371/journal.pone.0151167	http://dx.doi.org/10.1371/journal.pone.0151167			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27054697	Green Published, gold, Green Submitted			2022-12-27	WOS:000373608000005
J	Aubert, AH; Breuer, L				Aubert, Alice H.; Breuer, Lutz			New Seasonal Shift in In-Stream Diurnal Nitrate Cycles Identified by Mining High-Frequency Data	PLOS ONE			English	Article							WATER-QUALITY; DESERT STREAM; DYNAMICS; RIVER; SITU; VARIABILITY; CATCHMENTS; TRANSPORT; INSIGHTS; SYSTEMS	The recent development of in-situ monitoring devices, such as UV-spectrometers, makes the study of short-term stream chemistry variation relevant, especially the study of diurnal cycles, which are not yet fully understood. Our study is based on high-frequency data from an agricultural catchment (Studienlandschaft Schwingbachtal, Germany). We propose a novel approach, i.e. the combination of cluster analysis and Linear Discriminant Analysis, to mine from these data nitrate behavior patterns. As a result, we observe a seasonality of nitrate diurnal cycles, that differs from the most common cycle seasonality described in the literature, i.e. pre-dawn peaks in spring. Our cycles appear in summer and the maximum and minimum shift to a later time in late summer/autumn. This is observed both for water-and energy-limited years, thus potentially stressing the role of evapotranspiration. This concluding hypothesis on the role of evapotranspiration on nitrate stream concentration, which was obtained through data mining, broadens the perspective on the diurnal cycling of stream nitrate concentrations.	[Aubert, Alice H.; Breuer, Lutz] Univ Giessen, Inst Landscape Ecol & Resources Management ILR, Res Ctr BioSyst Land Use & Nutr IFZ, Heinrich Buff Ring 26, Giessen, Germany; [Aubert, Alice H.] Eawag, ESS, Uberlandstr 133, Dubendorf, Switzerland	Justus Liebig University Giessen; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG)	Aubert, AH (corresponding author), Univ Giessen, Inst Landscape Ecol & Resources Management ILR, Res Ctr BioSyst Land Use & Nutr IFZ, Heinrich Buff Ring 26, Giessen, Germany.; Aubert, AH (corresponding author), Eawag, ESS, Uberlandstr 133, Dubendorf, Switzerland.	alice.aubert@eawag.ch	Aubert, Alice/AAN-3797-2020; Aubert, Alice/Q-2753-2016; Aubert, Alice/AAX-8878-2021; Breuer, Lutz/C-6652-2013	Aubert, Alice/0000-0001-6613-5942; Aubert, Alice/0000-0001-6613-5942; Aubert, Alice/0000-0001-6613-5942; Breuer, Lutz/0000-0001-9720-1076				ABROL YP, 1983, PLANT CELL ENVIRON, V6, P595; Aubert AH, 2013, HYDROL EARTH SYST SC, V17, P1379, DOI 10.5194/hess-17-1379-2013; Aubert AH, 2014, ENVIRON SCI TECHNOL, V48, P930, DOI 10.1021/es403723r; Babovic V, 2005, HYDROL PROCESS, V19, P1511, DOI 10.1002/hyp.5862; Bende-Michl U, 2013, ENVIRON MONIT ASSESS, V185, P9191, DOI 10.1007/s10661-013-3246-8; Borken W, 2009, GLOBAL CHANGE BIOL, V15, P808, DOI 10.1111/j.1365-2486.2008.01681.x; Campbell JM, 2015, HYDROL EARTH SYST SC, V19, P453, DOI 10.5194/hess-19-453-2015; Cohen MJ, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2011JG001715; Fovet O, 2014, CAHIER TECHNIQUE INR, V82, P1; Godsey SE, 2014, HYDROL PROCESS, V28, P5791, DOI 10.1002/hyp.10310; Graham CB, 2013, HYDROL PROCESS, V27, P2541, DOI 10.1002/hyp.9334; Gribovszki Z, 2010, J HYDROL, V385, P371, DOI 10.1016/j.jhydrol.2010.02.001; GRIMM NB, 1987, ECOLOGY, V68, P1157, DOI 10.2307/1939200; Halliday SJ, 2013, BIOGEOSCIENCES, V10, P8013, DOI 10.5194/bg-10-8013-2013; Halliday SJ, 2014, WATER-SUI, V6, P150, DOI 10.3390/w6010150; Heffernan JB, 2010, LIMNOL OCEANOGR, V55, P677, DOI 10.4319/lo.2009.55.2.0677; Jeong JJ, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2012JG001999; Kessler AJ, 2015, J GEOPHYS RES-BIOGEO, V120, P538, DOI 10.1002/2014JG002852; Kirchner JW, 2004, HYDROL PROCESS, V18, P1353, DOI 10.1002/hyp.5537; Krause S, 2015, ECOHYDROLOGY, V8, P529, DOI 10.1002/eco.1646; Lauer F, 2013, WATER RESOUR RES, V49, P400, DOI 10.1029/2012WR012537; MANNY B A, 1973, Freshwater Biology, V3, P31, DOI 10.1111/j.1365-2427.1973.tb00060.x; Nimick DA, 2011, CHEM GEOL, V283, P3, DOI 10.1016/j.chemgeo.2010.08.017; Nippgen F, 2015, WATER RESOUR RES, V51, P4550, DOI 10.1002/2014WR016719; Orlowski N, 2014, WATER-SUI, V6, P3085, DOI 10.3390/w6103085; Pellerin BA, 2012, BIOGEOCHEMISTRY, V108, P183, DOI 10.1007/s10533-011-9589-8; Pellerin BA, 2009, FRESHWATER BIOL, V54, P376, DOI 10.1111/j.1365-2427.2008.02111.x; Pinay G, 2015, ECOSYSTEMS, V18, P1101, DOI 10.1007/s10021-015-9878-5; Roberts BJ, 2007, J GEOPHYS RES-BIOGEO, V112, DOI 10.1029/2007JG000422; Rusjan S, 2010, BIOGEOCHEMISTRY, V97, P123, DOI 10.1007/s10533-009-9361-5; Sandford RC, 2007, ENVIRON SCI TECHNOL, V41, P8420, DOI 10.1021/es071447b; Skeffington RA, 2015, HYDROL EARTH SYST SC, V19, P2491, DOI 10.5194/hess-19-2491-2015; Trauth N, 2014, J GEOPHYS RES-BIOGEO, V119, P910, DOI 10.1002/2013JG002586; TriOS, 2011, USERAND INSTALLATION; VALETT HM, 1993, HYDROBIOLOGIA, V259, P133, DOI 10.1007/BF00006593; Wade AJ, 2012, HYDROL EARTH SYST SC, V16, P4323, DOI 10.5194/hess-16-4323-2012; WARWICK JJ, 1986, WATER RES, V20, P1325, DOI 10.1016/0043-1354(86)90165-X; Worrall F, 2015, J HYDROL, V523, P830, DOI 10.1016/j.jhydrol.2015.01.075	38	24	24	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153138	10.1371/journal.pone.0153138	http://dx.doi.org/10.1371/journal.pone.0153138			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073838	gold, Green Published			2022-12-27	WOS:000374131200052
J	Fu, J; Liu, ZZ; Wang, JZ				Fu, Jian; Liu, Zhenzhong; Wang, Jingzheng			Multi-Mounted X-Ray Computed Tomography	PLOS ONE			English	Article							CT; RECONSTRUCTION; SCAN	Most existing X-ray computed tomography (CT) techniques work in single-mounted mode and need to scan the inspected objects one by one. It is time-consuming and not acceptable for the inspection in a large scale. In this paper, we report a multi-mounted CT method and its first engineering implementation. It consists of a multi-mounted scanning geometry and the corresponding algebraic iterative reconstruction algorithm. This approach permits the CT rotation scanning of multiple objects simultaneously without the increase of penetration thickness and the signal crosstalk. Compared with the conventional single-mounted methods, it has the potential to improve the imaging efficiency and suppress the artifacts from the beam hardening and the scatter. This work comprises a numerical study of the method and its experimental verification using a dataset measured with a developed multi-mounted X-ray CT prototype system. We believe that this technique is of particular interest for pushing the engineering applications of X-ray CT.	[Fu, Jian; Liu, Zhenzhong; Wang, Jingzheng] Beijing Univ Aeronaut & Astronaut, Res Ctr Digital Radiat Imaging, Beijing 100083, Peoples R China	Beihang University	Fu, J (corresponding author), Beijing Univ Aeronaut & Astronaut, Res Ctr Digital Radiat Imaging, Beijing 100083, Peoples R China.	fujian706@buaa.edu.cn			National Natural Science Foundation of China [11574023]; Chinese Academy of Science [U1432101, 11179009]; Beijing Natural Science Foundation [7152088]; Program for New Century Excellent Talents in University from Ministry of Education of P.R. China [NCET-13-0022]; China Scholarship Council [201306025021]; Beijing NOVA program [2009A09]; National Natural Science Foundation of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Science(Chinese Academy of Sciences); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Program for New Century Excellent Talents in University from Ministry of Education of P.R. China; China Scholarship Council(China Scholarship Council); Beijing NOVA program(Beijing Municipal Science & Technology Commission); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors acknowledge financial support from National Natural Science Foundation of China (11574023), the large scale science facilities joint fund by National Natural Science Foundation of China and Chinese Academy of Science (U1432101, 11179009), Beijing Natural Science Foundation (7152088), Program for New Century Excellent Talents in University (NCET-13-0022) from Ministry of Education of P.R. China, China Scholarship Council (201306025021) and Beijing NOVA program (2009A09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beckmann EC, 2005, PHYS TODAY, V58, P84, DOI 10.1063/1.1897571; Braz D, 2011, NDT&E INT, V44, P195, DOI 10.1016/j.ndteint.2010.11.005; Chen JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092414; Cierniak R, 2011, X-RAY COMPUTED TOMOGRAPHY IN BIOMEDICAL ENGINEERING, P1, DOI 10.1007/978-0-85729-027-4; Dierolf M, 2010, NATURE, V467, P436, DOI 10.1038/nature09419; FELDKAMP LA, 1984, J OPT SOC AM A, V1, P612, DOI 10.1364/JOSAA.1.000612; Fingerle AA, 2014, RADIOLOGY, V272, P739, DOI 10.1148/radiol.14130876; Flohr TG, 2006, EUR RADIOL, V16, P256, DOI 10.1007/s00330-005-2919-2; Flores L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143202; Fratzl P, 2015, NATURE, V527, P308, DOI 10.1038/527308a; Fu J, 2014, EPL-EUROPHYS LETT, V106, DOI 10.1209/0295-5075/106/68002; Fu J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141682; Fu J, 2015, ANAL BIOANAL CHEM, V407, P7647, DOI 10.1007/s00216-015-8922-9; Fu J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117502; Fu J, 2014, ANAL BIOANAL CHEM, V406, P897, DOI 10.1007/s00216-013-7482-0; Fu J, 2012, OPT EXPRESS, V20, P21512, DOI 10.1364/OE.20.021512; Fu J, 2012, NUCL INSTRUM METH A, V688, P1, DOI 10.1016/j.nima.2012.05.093; Fu JA, 2010, IEEE T NUCL SCI, V57, P1071, DOI 10.1109/TNS.2010.2044662; Gao HW, 2007, NUCL INSTRUM METH A, V579, P395, DOI 10.1016/j.nima.2007.04.084; GULLBERG GT, 1990, MED PHYS, V17, P264, DOI 10.1118/1.596505; Herman GT, 2009, ADV PATTERN RECOGNIT, P1, DOI 10.1007/978-1-84628-723-7; Hsieh J., 2003, COMPUTED TOMOGRAPHY; Hsieh SS, 2013, MED PHYS, V40, DOI 10.1118/1.4789918; Hsieh SS, 2012, PROC SPIE, V8313, DOI 10.1117/12.912490; Hsieh SS, 2011, PROC SPIE, V7961, DOI 10.1117/12.878801; Hu H, 1999, MED PHYS, V26, P5, DOI 10.1118/1.598470; Kak A.V., 1988, PRINCIPLES COMPUTERI, DOI DOI 10.1137/1.9780898719277.CH7; Klingenbeck-Regn K, 1999, EUR J RADIOL, V31, P110, DOI 10.1016/S0720-048X(99)00086-8; Ning PG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092568; Parikh S, 2016, HEART FAIL CLIN, V12, P97, DOI 10.1016/j.hfc.2015.08.008; Peeters F, 1979, Ned Tijdschr Geneeskd, V123, P2192; Sandoghchi SR, 2014, OPT EXPRESS, V22, P26181, DOI 10.1364/OE.22.026181; Sawall S, 2012, MED PHYS, V39, P5384, DOI 10.1118/1.4739506; Schuetz P, 2014, NDT&E INT, V64, P59, DOI 10.1016/j.ndteint.2014.03.002; Vaid S, 2015, NEUROIMAG CLIN N AM, V25, P527, DOI 10.1016/j.nic.2015.07.002; Wetter OE, 2013, J FORENSIC RADIOL IM, V1, P152, DOI 10.1016/j.jofri.2013.07.002; Yu W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130793; Yu W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109345	38	1	1	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153406	10.1371/journal.pone.0153406	http://dx.doi.org/10.1371/journal.pone.0153406			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073911	Green Published, Green Submitted, gold			2022-12-27	WOS:000374131200085
J	Guo, W; Guan, X; Pan, XD; Sun, XS; Wang, FJ; Ji, Y; Huang, P; Deng, YF; Zhang, Q; Han, Q; Yi, P; Namaka, M; Liu, Y; Deng, YC; Li, XH				Guo, Wei; Guan, Xiao; Pan, Xiaodong; Sun, Xiongshan; Wang, Fangjie; Ji, Yan; Huang, Pei; Deng, Yafei; Zhang, Qi; Han, Qi; Yi, Ping; Namaka, Michael; Liu, Ya; Deng, Youcai; Li, Xiaohui			Post-Natal Inhibition of NF-kappa B Activation Prevents Renal Damage Caused by Prenatal LPS Exposure	PLOS ONE			English	Article							SMOOTH MUSCLE ACTIN; ANGIOTENSIN-II; KIDNEY-DISEASE; RISK-FACTORS; RATS; EXPRESSION; LIPOPOLYSACCHARIDE; FIBROSIS; INJURY; CELLS	Prenatal exposure to an inflammatory stimulus has been shown to cause renal damage in offspring. Our present study explored the role of intra-renal NF-kappa B activation in the development of progressive renal fibrosis in offspring that underwent prenatal exposure to an inflammatory stimulus. Time-dated pregnant rats were treated with saline (control group) or 0.79 mg/kg lipopolysaccharide (LPS) through intra-peritoneal injection on gestational day 8, 10 and 12. At the age of 7 weeks, offspring from control or LPS group were treated with either tap water (Con+Ve or LPS+Ve group) or pyrollidine dithiocarbamate (PDTC, 120mg/L), a NF-kappa B inhibitor, via drinking water starting (Con+PDTC or LPS+PDTC group), respectively, till the age of 20 or 68 weeks. The gross structure of kidney was assessed by hematoxylin-eosin, periodic acid-Schiff staining and Sirius red staining. The expression levels of TNF-alpha, IL-6, alpha-smooth muscle actin (alpha-SMA) and renin-angiotensin system (RAS) genes were determined by real time polymerase chain reaction and/or immunohistochemical staining. Our data showed that post-natal persistent PDTC administration efficiently repressed intra-renal NF-kappa B activation, TNF-alpha and IL-6 expression. Post-natal PDTC also prevented intra-renal glycogen deposition and collagenous fiber generation as evident by the reduced expression of collagen III and interstitial alpha-SMA in offspring of prenatal LPS exposure. Furthermore, post-natal PDTC administration reversed the intra-renal reninangiotensin system (RAS) over-activity in offspring of prenatal LPS exposure. In conclusion, prenatal inflammatory exposure results in offspring's intra-renal NF-kappa B activation along with inflammation which cross-talked with excessive RAS activation that caused exacerbation of renal fibrosis and dysfunction in the offspring. Thus, early life prevention of NF-kappa B activation may be a potential preventive strategy for chronic renal inflammation and progressive renal damage.	[Guo, Wei; Guan, Xiao; Pan, Xiaodong; Sun, Xiongshan; Wang, Fangjie; Ji, Yan; Huang, Pei; Deng, Yafei; Zhang, Qi; Han, Qi; Liu, Ya; Deng, Youcai; Li, Xiaohui] Third Mil Med Univ, Inst Mat Med, Coll Pharm, Chongqing 400038, Peoples R China; [Guo, Wei] Third Mil Med Univ, Southwest Hosp, Dept Pharm, Chongqing 400038, Peoples R China; [Guan, Xiao; Pan, Xiaodong; Sun, Xiongshan; Wang, Fangjie; Ji, Yan; Huang, Pei; Deng, Yafei; Zhang, Qi; Han, Qi; Liu, Ya; Deng, Youcai; Li, Xiaohui] Third Mil Med Univ, Coll Pharm, Ctr Translat Med, Chongqing 400038, Peoples R China; [Yi, Ping] Third Mil Med Univ, Daping Hosp, Dept Obstet & Gynecol, Chongqing 400038, Peoples R China; [Namaka, Michael] Univ Manitoba, Apotex Ctr 750, Coll Pharm, McDermot Ave, Winnipeg, MB R3E 0T5, Canada; [Namaka, Michael] Univ Manitoba, Apotex Ctr 750, Coll Med, McDermot Ave, Winnipeg, MB R3E 0T5, Canada; [Namaka, Michael] Shantou Univ Med Coll & Coll Med Univ Manitoba, Joint Lab Biol Psychiat, Shantou 515063, Peoples R China	Army Medical University; Army Medical University; Army Medical University; Army Medical University; University of Manitoba; University of Manitoba	Liu, Y; Deng, YC; Li, XH (corresponding author), Third Mil Med Univ, Inst Mat Med, Coll Pharm, Chongqing 400038, Peoples R China.; Liu, Y; Deng, YC; Li, XH (corresponding author), Third Mil Med Univ, Coll Pharm, Ctr Translat Med, Chongqing 400038, Peoples R China.	liuya1979@hotmail.com; dengyc125@hotmail.com; lpsh008@aliyun.com	Deng, Youcai/GZK-9548-2022	Deng, Youcai/0000-0001-5488-8576; Xiongshan, Sun/0000-0002-7958-0620; Guo, Wei/0000-0002-6938-9005	Natural Science Foundation of China [81520108029, 81273507, 81473210, 81503083, 81170580]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Natural Science Foundation of China [81520108029, 81273507, 81473210, 81503083, 81170580]; http://www.nsfc.gov.cn/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arends NJT, 2005, CLIN ENDOCRINOL, V62, P44, DOI 10.1111/j.1365-2265.2004.02171.x; Bagshaw SM, 2008, CRIT CARE MED, V36, pS172, DOI 10.1097/CCM.0b013e318168c92f; Benigni A, 2010, EMBO MOL MED, V2, P247, DOI 10.1002/emmm.201000080; Blank U, 2007, IMMUNOL REV, V217, P79, DOI 10.1111/j.1600-065X.2007.00503.x; Boor P, 2010, NAT REV NEPHROL, V6, P643, DOI 10.1038/nrneph.2010.120; Boukhalfa G, 1996, EXP NEPHROL, V4, P241; Chow CK, 2013, JAMA-J AM MED ASSOC, V310, P959, DOI 10.1001/jama.2013.184182; Cuzzocrea S, 2003, INTENS CARE MED, V29, P2016, DOI 10.1007/s00134-003-1887-8; de Steenwinkel FDO, 2013, ANN RHEUM DIS, V72, P1995, DOI 10.1136/annrheumdis-2012-202539; Deng YC, 2016, SCI REP-UK, V6, DOI 10.1038/srep21692; Deng YC, 2015, IMMUNITY, V42, P457, DOI 10.1016/j.immuni.2015.02.006; Deng YC, 2014, J IMMUNOL, V193, P2994, DOI 10.4049/jimmunol.1302600; Elbe H, 2015, HUM EXP TOXICOL, V34, P100, DOI 10.1177/0960327114531995; Elks CM, 2009, AM J PHYSIOL-RENAL, V296, pF298, DOI 10.1152/ajprenal.90628.2008; Gorgas DL, 2008, EMERG MED CLIN N AM, V26, P345, DOI 10.1016/j.emc.2008.01.007; Hao XQ, 2013, EXP TOXICOL PATHOL, V65, P433, DOI 10.1016/j.etp.2012.01.001; Hao XQ, 2010, HYPERTENS RES, V33, P76, DOI 10.1038/hr.2009.185; HAY PE, 1994, BRIT MED J, V308, P295, DOI 10.1136/bmj.308.6924.295; Kawasaki Y, 2008, PEDIATR NEPHROL, V23, P913, DOI 10.1007/s00467-008-0749-6; Kim J, 2014, AM J PHYSIOL-RENAL, V307, pF971, DOI 10.1152/ajprenal.00256.2014; Klahr S, 2000, KIDNEY INT, V57, pS7, DOI 10.1046/j.1523-1755.2000.07509.x; Koeners MP, 2011, J HYPERTENS, V29, P1160, DOI 10.1097/HJH.0b013e3283468344; Kurts C, 2013, NAT REV IMMUNOL, V13, P738, DOI 10.1038/nri3523; LAZARIDES E, 1975, CELL, V6, P289, DOI 10.1016/0092-8674(75)90180-4; Lien E, 2000, J CLIN INVEST, V105, P497, DOI 10.1172/JCI8541; Lin TH, 2014, ACTA BIOMATER, V10, P1, DOI 10.1016/j.actbio.2013.09.034; Liu SF, 1999, CIRCULATION, V100, P1330, DOI 10.1161/01.CIR.100.12.1330; Liu YH, 2006, KIDNEY INT, V69, P213, DOI 10.1038/sj.ki.5000054; Liu YH, 2011, NAT REV NEPHROL, V7, P684, DOI 10.1038/nrneph.2011.149; Mezzano SA, 2001, HYPERTENSION, V38, P635, DOI 10.1161/hy09t1.094234; Muller DN, 2000, HYPERTENSION, V35, P193, DOI 10.1161/01.HYP.35.1.193; Nilsson C, 2001, ENDOCRINOLOGY, V142, P2622, DOI 10.1210/en.142.6.2622; Noronha IL, 2002, NEPHROL DIAL TRANSPL, V17, P363, DOI 10.1093/ndt/17.3.363; ORNOY A, 1976, AM J OBSTET GYNECOL, V124, P196, DOI 10.1016/S0002-9378(16)33298-7; Palinski W, 2014, CIRCULATION, V129, P2066, DOI 10.1161/CIRCULATIONAHA.113.001805; RAIJ L, 1984, KIDNEY INT, V26, P137, DOI 10.1038/ki.1984.147; Rangan GK, 1999, KIDNEY INT, V56, P118, DOI 10.1046/j.1523-1755.1999.00529.x; Rosenbaugh EG, 2013, AM J PHYSIOL-REG I, V304, pR917, DOI 10.1152/ajpregu.00395.2012; Roson MI, 2006, KIDNEY INT, V70, P1439, DOI 10.1038/sj.ki.5001831; Ruiz-Ortega M, 2006, NEPHROL DIAL TRANSPL, V21, P16, DOI 10.1093/ndt/gfi265; Safir A, 2010, LIVER INT, V30, P765, DOI 10.1111/j.1478-3231.2010.02218.x; SCHRECK R, 1992, J EXP MED, V175, P1181, DOI 10.1084/jem.175.5.1181; Tamada S, 2003, KIDNEY INT, V63, P306, DOI 10.1046/j.1523-1755.2003.00714.x; Wang XQ, 2014, FREE RADICAL BIO MED, V76, P242, DOI 10.1016/j.freeradbiomed.2014.08.010; Wang ZC, 2014, AM J PHYSIOL-RENAL, V306, pF1236, DOI 10.1152/ajprenal.00673.2013; Wei YL, 2007, ACTA PHARMACOL SIN, V28, P651, DOI 10.1111/j.1745-7254.2007.00593.x; Zhao SY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102273; Zhou JZ, 2013, MOL MED REP, V8, P95, DOI 10.3892/mmr.2013.1498	48	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153434	10.1371/journal.pone.0153434	http://dx.doi.org/10.1371/journal.pone.0153434			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073902	Green Published, Green Submitted, gold			2022-12-27	WOS:000374131200092
J	Niessen, ASM; Meijer, RR; Tendeiro, JN				Niessen, A. Susan M.; Meijer, Rob R.; Tendeiro, Jorge N.			Predicting Performance in Higher Education Using Proximal Predictors	PLOS ONE			English	Article							GRADUATE STUDENT SELECTION; COMPREHENSIVE METAANALYSIS; VALIDITY; ADMISSION; SCHOOL; TESTS	We studied the validity of two methods for predicting academic performance and student-program fit that were proximal to important study criteria. Applicants to an undergraduate psychology program participated in a selection procedure containing a trial-studying test based on a work sample approach, and specific skills tests in English and math. Test scores were used to predict academic achievement and progress after the first year, achievement in specific course types, enrollment, and dropout after the first year. All tests showed positive significant correlations with the criteria. The trial-studying test was consistently the best predictor in the admission procedure. We found no significant differences between the predictive validity of the trial-studying test and prior educational performance, and substantial shared explained variance between the two predictors. Only applicants with lower trial-studying scores were significantly less likely to enroll in the program. In conclusion, the trial-studying test yielded predictive validities similar to that of prior educational performance and possibly enabled self-selection. In admissions aimed at student-program fit, or in admissions in which past educational performance is difficult to use, a trial-studying test is a good instrument to predict academic performance.	[Niessen, A. Susan M.; Meijer, Rob R.; Tendeiro, Jorge N.] Univ Groningen, Dept Psychometr & Stat, Groningen, Netherlands	University of Groningen	Niessen, ASM (corresponding author), Univ Groningen, Dept Psychometr & Stat, Groningen, Netherlands.	a.s.m.niessen@rug.nl	Tendeiro, Jorge/AAE-2167-2021	Niessen, Susan/0000-0001-8249-9295; Tendeiro, Jorge/0000-0003-1660-3642				Anderson N, 2010, INT J SELECT ASSESS, V18, P291, DOI 10.1111/j.1468-2389.2010.00512.x; [Anonymous], 2006, STAFFING ORG CONT PR; ASHER JJ, 1974, PERS PSYCHOL, V27, P519, DOI 10.1111/j.1744-6570.1974.tb01173.x; Atkinson RC, 2009, EDUC RESEARCHER, V38, P665, DOI 10.3102/0013189X09351981; Bacon DR, 2006, J MARKET EDUC, V28, P35, DOI 10.1177/0273475305284638; Breaugh JA, 2008, HUM RESOUR MANAGE R, V18, P103, DOI 10.1016/j.hrmr.2008.07.003; Callinan M, 2000, INT J SELECT ASSESS, V8, P248, DOI 10.1111/1468-2389.00154; Cohen J.E., 1988, STAT POWER ANAL BEHA; DeRaad B, 1996, EUR J PERSONALITY, V10, P303, DOI 10.1002/(SICI)1099-0984(199612)10:5<303::AID-PER262>3.0.CO;2-2; DOWNS S, 1978, J OCCUP PSYCHOL, V51, P271, DOI 10.1111/j.2044-8325.1978.tb00423.x; Eva KW, 2009, MED EDUC, V43, P767, DOI 10.1111/j.1365-2923.2009.03407.x; Eva KW, 2004, ACAD MED, V79, pS40, DOI 10.1097/00001888-200410001-00012; Eva KW, 2003, MED EDUC, V37, P587, DOI 10.1046/j.1365-2923.2003.01563.x; Hakkinen I., 2004, THESIS UPPSALA U UPP; Hox J.J, 2010, MULTILEVEL ANAL TECH, V2nd ed., DOI [10.4324/9780203852279, DOI 10.4324/9780203852279]; Kuncel NR, 2007, SCIENCE, V315, P1080, DOI 10.1126/science.1136618; Kuncel NR, 2001, PSYCHOL BULL, V127, P162, DOI 10.1037/0033-2909.127.1.162; Lievens F, 2002, INT J SELECT ASSESS, V10, P245, DOI 10.1111/1468-2389.00215; Lievens F, 2013, MED EDUC, V47, P182, DOI 10.1111/medu.12089; Meijer RR, 2016, CLIN MED IN PRESS; PEERS IS, 1994, BRIT J EDUC PSYCHOL, V64, P1, DOI 10.1111/j.2044-8279.1994.tb01081.x; Reiter HI, 2007, MED EDUC, V41, P378, DOI 10.1111/j.1365-2929.2007.02709.x; Schmidt FL, 1998, PSYCHOL BULL, V124, P262, DOI 10.1037/0033-2909.124.2.262; Schmitt N, 2012, EDUC PSYCHOL-US, V47, P18, DOI 10.1080/00461520.2011.610680; Schripsema NR, 2014, MED EDUC, V48, P1201, DOI 10.1111/medu.12537; Schwager ITL, 2015, INT J SELECT ASSESS, V23, P71, DOI 10.1111/ijsa.12096; Shultz MM, 2012, EDUC PSYCHOL-US, V47, P51, DOI 10.1080/00461520.2011.610679; STEIGER JH, 1980, PSYCHOL BULL, V87, P245, DOI 10.1037/0033-2909.87.2.245; Thornton G, 2013, APA HDB TESTING ASSE, V1, P533, DOI DOI 10.1037/14047-029; University of Groningen, 2015, ETH COMM PSYCH; Urlings-Strop LC, 2013, MED TEACH, V35, P497, DOI 10.3109/0142159X.2013.774333; Visser K., 2012, TIJDSCHRIFT HOGER ON, V30, P161; Vorst HCM, 1997, RES REPORT; WERNIMONT PF, 1968, J APPL PSYCHOL, V52, P372, DOI 10.1037/h0026244	35	25	26	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153663	10.1371/journal.pone.0153663	http://dx.doi.org/10.1371/journal.pone.0153663			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ3UC	27073859	Green Published, gold			2022-12-27	WOS:000374131200116
J	Sawada, R; Sato, W; Uono, S; Kochiyama, T; Kubota, Y; Yoshimura, S; Toichi, M				Sawada, Reiko; Sato, Wataru; Uono, Shota; Kochiyama, Takanori; Kubota, Yasutaka; Yoshimura, Sayaka; Toichi, Motomi			Neuroticism Delays Detection of Facial Expressions	PLOS ONE			English	Article							VISUAL-SEARCH; ANTI-EXPRESSIONS; PERSONALITY; DEPRESSION; FACES; EXTRAVERSION; EMOTION; ANXIETY; PEOPLE; ME	The rapid detection of emotional signals from facial expressions is fundamental for human social interaction. The personality factor of neuroticism modulates the processing of various types of emotional facial expressions; however, its effect on the detection of emotional facial expressions remains unclear. In this study, participants with high- and low-neuroticism scores performed a visual search task to detect normal expressions of anger and happiness, and their anti-expressions within a crowd of neutral expressions. Anti-expressions contained an amount of visual changes equivalent to those found in normal expressions compared to neutral expressions, but they were usually recognized as neutral expressions. Subjective emotional ratings in response to each facial expression stimulus were also obtained. Participants with high-neuroticism showed an overall delay in the detection of target facial expressions compared to participants with low-neuroticism. Additionally, the high-neuroticism group showed higher levels of arousal to facial expressions compared to the low-neuroticism group. These data suggest that neuroticism modulates the detection of emotional facial expressions in healthy participants; high levels of neuroticism delay overall detection of facial expressions and enhance emotional arousal in response to facial expressions.	[Sawada, Reiko; Sato, Wataru] Kyoto Univ, Primate Res Inst, Inuyama, Aichi 484, Japan; [Uono, Shota; Yoshimura, Sayaka; Toichi, Motomi] Kyoto Univ, Grad Sch Med, Kyoto, Japan; [Kochiyama, Takanori] Adv Telecommun Res Inst Int, Brain Act Imaging Ctr, Seika, Kyoto, Japan; [Kubota, Yasutaka] Shiga Univ, Hlth & Med Serv Ctr, Otsu, Shiga, Japan; [Sawada, Reiko; Sato, Wataru] Kyoto Univ, Grad Sch Med, Kyoto, Japan	Kyoto University; Kyoto University; Advanced Telecommunications Research Institute International; Shiga University; Kyoto University	Sato, W (corresponding author), Kyoto Univ, Primate Res Inst, Inuyama, Aichi 484, Japan.; Sato, W (corresponding author), Kyoto Univ, Grad Sch Med, Kyoto, Japan.	sato.wataru.4v@kyoto-u.ac.jp	Sato, Wataru/E-7503-2017; Yoshimura, Sayaka/GQY-9131-2022	Sato, Wataru/0000-0002-5335-1272; Yoshimura, Sayaka/0000-0003-4273-8575; Uono, Shota/0000-0003-0547-0522; Kochiyama, Takanori/0000-0002-4023-0674	Japan Society for the Promotion of Science Funding Program for Next Generation World-Leading Researchers [LZ008]	Japan Society for the Promotion of Science Funding Program for Next Generation World-Leading Researchers	This study was supported by funds from the Japan Society for the Promotion of Science Funding Program for Next Generation World-Leading Researchers (LZ008). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andric S, 2016, EARLY INTERV PSYCHIA, V10, P160, DOI 10.1111/eip.12212; Canli T, 2000, J NEUROSCI, V20; Cave KR, 2006, VIS COGN, V14, P629, DOI 10.1080/13506280500193107; COSTA PT, 1980, J PERS SOC PSYCHOL, V38, P668, DOI 10.1037/0022-3514.38.4.668; Costa PT, 2007, REVISED NEO PERSONAL; DeYoung CG, 2007, J PERS SOC PSYCHOL, V93, P880, DOI 10.1037/0022-3514.93.5.880; Di Simplicio M, 2014, NEUROPSYCHOPHARMACOL, V39, P3059, DOI 10.1038/npp.2014.159; Doty TJ, 2013, EMOTION, V13, P183, DOI 10.1037/a0031373; EKMAN P, 1994, PSYCHOL BULL, V115, P268, DOI 10.1037/0033-2909.115.2.268; Ekman P., 1997, INNOVATIONS SOCIAL S, V10, P333, DOI [DOI 10.1080/13511610.1997.9968538, 10.1080/13511610.1997.9968538]; Ekman P., 1976, PICTURES FACIAL AFFE; Elfenbein HA, 2003, J PERS SOC PSYCHOL, V85, P276, DOI 10.1037/0022-3514.85.2.276; Haas BW, 2008, NEUROIMAGE, V42, P385, DOI 10.1016/j.neuroimage.2008.04.027; Hadwin JA, 2003, J CHILD PSYCHOL PSYC, V44, P432, DOI 10.1111/1469-7610.00133; HANSEN CH, 1988, J PERS SOC PSYCHOL, V54, P917, DOI 10.1037/0022-3514.54.6.917; Kendler KS, 2006, ARCH GEN PSYCHIAT, V63, P1113, DOI 10.1001/archpsyc.63.10.1113; Kirk R., 2014, EXPT DESIGN PROCEDUR, DOI [10.4135/9781483384733, DOI 10.4135/9781483384733]; Lang PJ, 1998, J CLIN NEUROPHYSIOL, V15, P397, DOI 10.1097/00004691-199809000-00004; LARSEN RJ, 1989, PERS INDIV DIFFER, V10, P1221, DOI 10.1016/0191-8869(89)90233-X; MCCRAE RR, 1987, J PERS SOC PSYCHOL, V52, P81, DOI 10.1037/0022-3514.52.1.81; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Perlman SB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005952; Saito Takako, 2005, Shinrigaku Kenkyu, V75, P517; Sato W, 2010, VIS COGN, V18, P369, DOI 10.1080/13506280902767763; Sato W, 2009, SOC BEHAV PERSONAL, V37, P491, DOI 10.2224/sbp.2009.37.4.491; Sawada R, 2015, SCI REP-UK, V5, DOI 10.1038/srep14042; Sawada R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094747; Sawada R, 2014, BRAIN RES, V1560, P60, DOI 10.1016/j.brainres.2014.02.046; Seidel EM, 2010, PSYCHIAT RES, V177, P124, DOI 10.1016/j.psychres.2010.02.001; Shimonaka Y., 1999, REVISED NEO PERSONAL; Tong F, 1999, J EXP PSYCHOL HUMAN, V25, P1016, DOI 10.1037/0096-1523.25.4.1016; Williams MA, 2005, VIS COGN, V12, P29, DOI 10.1080/13506280444000193	32	9	9	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153400	10.1371/journal.pone.0153400	http://dx.doi.org/10.1371/journal.pone.0153400			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ3UC	27073904	Green Published, gold, Green Submitted			2022-12-27	WOS:000374131200083
J	Tsao, PC; Shiau, YS; Chiang, SH; Ho, HC; Liu, YL; Chung, YF; Lin, LJ; Chen, MR; Chang, JK; Soong, WJ; Lin, HL; Hwang, B; Hsiao, KJ				Tsao, Pei-Chen; Shiau, Yu-Shih; Chiang, Szu-Hui; Ho, Hui-Chen; Liu, Yu-Ling; Chung, Yuan-Fang; Lin, Li-Ju; Chen, Ming-Ren; Chang, Jia-Kan; Soong, Wen-Jue; Lin, Hsiu-Lian; Hwang, Betau; Hsiao, Kwang-Jen			Development of a Newborn Screening Program for Critical Congenital Heart Disease (CCHD) in Taipei	PLOS ONE			English	Article							PULSE OXIMETRY; DEFECTS; PREVALENCE; IMPACT	Background Early detection of critical congenital heart disease (CCHD) can significantly reduce morbidity and mortality among newborns. We investigate the feasibility of implementing a community-based newborn CCHD screening program in Taipei. Methods Twelve birthing facilities in Taipei participated in a trial screening program between October 1, 2013, and March 31, 2014. Newborns underwent pulse oximetry at 24-36 h old, with probes attached to the right hand and one lower limb. Any screening saturation >= 95% in either extremity, with an absolute difference of <= 3% between the right hand and foot, was accepted as a screening pass. A screening result was considered as a fail if the oxygen saturation was <95% at either probe site, on 3 separate occasions, each separated by 30 min or the first result was <95% at either probe site, and any subsequent oxygen saturation measurement was <90%. Public health nurses would follow up all missed or refused cases. Results Of the 6,387 live births, 6,296 newborns (coverage rate: 6,296/6,387 = 98.6%) underwent appropriate pulse oximetry screening. Sixteen newborns (0.25%) were reported to have a failed screening result. Five of these screen positive newborns were confirmed with CCHD; two of them were diagnosed solely attributed to the failed screening results. The false-positive rate was 0.18%. Implementing a 6-month screening program for CCHD produced good case detection rate, while using efficient screening and referral systems. Conclusion This program was successful in integrating screening, referral and public health tracking systems. The protocol outlined in this report could provide a community-based model for worldwide implementation.	[Tsao, Pei-Chen; Soong, Wen-Jue] Taipei Vet Gen Hosp, Dept Pediat, Div Gen Pediat, Taipei, Taiwan; [Tsao, Pei-Chen; Soong, Wen-Jue; Hwang, Betau] Natl Yang Ming Univ, Sch Med, Dept Pediat, Taipei 112, Taiwan; [Tsao, Pei-Chen] Natl Yang Ming Univ, Inst Physiol, Sch Med, Taipei 112, Taiwan; [Tsao, Pei-Chen] Natl Yang Ming Univ, Sch Med, Inst Emergency & Crit Care Med, Taipei 112, Taiwan; [Shiau, Yu-Shih; Chiang, Szu-Hui; Hsiao, Kwang-Jen] Prevent Med Fdn, Taipei, Taiwan; [Ho, Hui-Chen] Taipei Inst Pathol, Taipei, Taiwan; [Liu, Yu-Ling; Chung, Yuan-Fang; Lin, Li-Ju; Lin, Hsiu-Lian] Taipei City Govt, Dept Hlth, Taipei, Taiwan; [Chen, Ming-Ren] MacKay Childrens Hosp, Taipei, Taiwan; [Chang, Jia-Kan] Cheng Hsin Gen Hosp, Dept Pediat, Taipei, Taiwan; [Hwang, Betau] Taipei City Hosp, Zhongxiao Branch, Taipei, Taiwan; [Hwang, Betau] Tungs Taichung Metroharbor Hosp, Cardiac Med Ctr, Taichung, Taiwan; [Hsiao, Kwang-Jen] Taipei City Hosp, Dept Educ & Res, Taipei, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Cheng Hsin General Hospital; Taipei City Hospital; Tungs' Taichung MetroHarbor Hospital; Taipei City Hospital	Hwang, B (corresponding author), Natl Yang Ming Univ, Sch Med, Dept Pediat, Taipei 112, Taiwan.; Hsiao, KJ (corresponding author), Prevent Med Fdn, Taipei, Taiwan.; Hwang, B (corresponding author), Taipei City Hosp, Zhongxiao Branch, Taipei, Taiwan.; Hwang, B (corresponding author), Tungs Taichung Metroharbor Hosp, Cardiac Med Ctr, Taichung, Taiwan.; Hsiao, KJ (corresponding author), Taipei City Hosp, Dept Educ & Res, Taipei, Taiwan.	bthwang@vghtpe.gov.tw; hsiao@pmf.tw			United Way of Taiwan	United Way of Taiwan	This project was partially funded by the United Way of Taiwan.; We thank the entire staff of the 12 birthing facilities involved in collecting the screening data throughout the project, including Taipei City hospital Zhongxing Branch, Renai Branch, Heping Fuyou Branch, Zhongxiao Branch, Yang-Ming Branch; Taipei Veterans General Hospital; MacKay Memorial Hospital; Tri-Service General Hospital; Cheng Hsin General Hospital; West Garden Hospital; Taipei Union Hospital for Women and Children; and Dr. Hsu Obs-Gyn Clinic. We thank the data manager of Taipei Institute of Pathology, who didn't involve in the research, anonymized all the patient's record and information. This project was partially funded by the United Way of Taiwan. We thank Professor Yu-Ru Kou (Institute of Physiology, School of Medicine, National Yang-Ming University) for his advice; and the public health nurses who worked hard with case follow-up.	Botto LD, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.3.e32; Brown KL, 2006, HEART, V92, P1298, DOI 10.1136/hrt.2005.078097; Daubeney PEF, 1996, ARCH PEDIAT ADOL MED, V150, P109; de-Wahl Granelli Anne, 2009, BMJ, V338, pa3037, DOI 10.1136/bmj.a3037; Ewer AK, 2013, CURR OPIN CARDIOL, V28, P92, DOI 10.1097/HCO.0b013e32835d7e42; Garg LF, 2013, PEDIATRICS, V132, pE314, DOI 10.1542/peds.2013-0269; Granelli AD, 2014, ACTA PAEDIATR, V103, P1136, DOI 10.1111/apa.12758; Huang HM, 2013, INT J PEDIATR OTORHI, V77, P1734, DOI 10.1016/j.ijporl.2013.08.004; Kemper AR, 2011, PEDIATRICS, V128, pE1259, DOI 10.1542/peds.2011-1317; Mahle WT, 2009, CIRCULATION, V120, P447, DOI 10.1161/CIRCULATIONAHA.109.192576; Mellander M, 2006, ACTA PAEDIATR, V95, P407, DOI 10.1080/08035250500541910; Niu DM, 2010, J INHERIT METAB DIS, V33, pS295, DOI 10.1007/s10545-010-9129-z; Peterson C, 2014, JAMA PEDIATR, V168, P361, DOI 10.1001/jamapediatrics.2013.4779; Reller MD, 2008, J PEDIATR-US, V153, P807, DOI 10.1016/j.jpeds.2008.05.059; Richmond S, 2002, ARCH DIS CHILD-FETAL, V87, pF83, DOI 10.1136/fn.87.2.F83; Riede FT, 2010, EUR J PEDIATR, V169, P975, DOI 10.1007/s00431-010-1160-4; Silberbach M, 2007, PEDIATR REV, V28, P123, DOI 10.1542/pir.28-4-123; Singh A, 2014, ARCH DIS CHILD-FETAL, V99, pF297, DOI [10.1136/archdischild-2013-303968, 10.1136/archdischild-2013-305657]; Thangaratinam S, 2007, ARCH DIS CHILD-FETAL, V92, pF176, DOI 10.1136/adc.2006.107656; Thangaratinam S, 2012, LANCET, V379, P2459, DOI 10.1016/S0140-6736(12)60107-X; Woodward GA, 1996, PEDIATR EMERG CARE, V12, P317, DOI 10.1097/00006565-199608000-00021; Wu MH, 2010, J PEDIATR-US, V156, P782, DOI 10.1016/j.jpeds.2009.11.062; Yeh SJ, 2013, PEDIATR NEONATOL, V54, P113, DOI 10.1016/j.pedneo.2012.11.010; Yilmazer MM, 2010, INDIAN J PEDIATR, V77, P813, DOI 10.1007/s12098-010-0105-2; Zhao QM, 2014, LANCET, V384, P747, DOI 10.1016/S0140-6736(14)60198-7	25	6	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153407	10.1371/journal.pone.0153407	http://dx.doi.org/10.1371/journal.pone.0153407			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073996	Green Submitted, Green Published, gold			2022-12-27	WOS:000374131200086
J	Araye, A; Goudet, A; Barbier, J; Pichard, S; Baron, B; England, P; Perez, J; Zinn-Justin, S; Chenal, A; Gillet, D				Araye, Anne; Goudet, Amelie; Barbier, Julien; Pichard, Sylvain; Baron, Bruno; England, Patrick; Perez, Javier; Zinn-Justin, Sophie; Chenal, Alexandre; Gillet, Daniel			The Translocation Domain of Botulinum Neurotoxin A Moderates the Propensity of the Catalytic Domain to Interact with Membranes at Acidic pH	PLOS ONE			English	Article							TOXIN T-DOMAIN; LIGHT-CHAIN PROTEASE; DIPHTHERIA-TOXIN; SPECTROSCOPIC ANALYSIS; TETANUS; CHANNEL; IDENTIFICATION; INHIBITION; PROTEINS; BEHAVIOR	Botulinum neurotoxin A (BoNT/A) is composed of three domains: a catalytic domain (LC), a translocation domain (H-N) and a receptor-binding domain (H-C). Like most bacterial toxins BoNT/A is an amphitropic protein, produced in a soluble form that is able to interact, penetrate and/or cross a membrane to achieve its toxic function. During intoxication BoNT/A is internalized by the cell by receptor-mediated endocytosis. Then, LC crosses the membrane of the endocytic compartment and reaches the cytosol. This translocation is initiated by the low pH found in this compartment. It has been suggested that LC passes in an unfolded state through a transmembrane passage formed by H-N. We report here that acidification induces no major conformational change in either secondary or tertiary structures of LC and H-N of BoNT/A in solution. GdnHCl-induced denaturation experiments showed that the stability of LC and H-N increases as pH drops, and that H-N further stabilizes LC. Unexpectedly we found that LC has a high propensity to interact with and permeabilize anionic lipid bilayers upon acidification without the help of H-N. This property is downplayed when LC is linked to H-N. H-N thus acts as a chaperone for LC by enhancing its stability but also as a moderator of the membrane interaction of LC.	[Araye, Anne; Goudet, Amelie; Barbier, Julien; Pichard, Sylvain; Gillet, Daniel] Paris Saclay Univ, LabEx LERMIT, CEA Saclay, CEA,iBiTec S SIMOPRO, F-91191 Gif Sur Yvette, France; [Baron, Bruno; England, Patrick] Inst Pasteur, Proteopole, Plateforme Biophys Macromol & Leurs Interact PFBM, F-75724 Paris 15, France; [Perez, Javier] Synchrotron Soleil, F-91192 Gif Sur Yvette, France; [Zinn-Justin, Sophie] CEA Saclay, CEA, iBiTec S LBSR, F-91191 Gif Sur Yvette, France; [Chenal, Alexandre] Inst Pasteur, Unite Biochim Interact Macromol, UMR 3528, F-75724 Paris 15, France	CEA; UDICE-French Research Universities; Universite Paris Saclay; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; SOLEIL Synchrotron; CEA; UDICE-French Research Universities; Universite Paris Saclay; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Gillet, D (corresponding author), Paris Saclay Univ, LabEx LERMIT, CEA Saclay, CEA,iBiTec S SIMOPRO, F-91191 Gif Sur Yvette, France.	daniel.gillet@cea.fr		Chenal, Alexandre/0000-0002-4959-1003; barbier, julien/0000-0003-2187-4973; ENGLAND, Patrick/0000-0001-6410-5918	joint ministerial program of R&D against CBRNE threats; Agence Nationale de la Recherche [ANR-10-LABX-33]; DGA; CEA	joint ministerial program of R&D against CBRNE threats; Agence Nationale de la Recherche(French National Research Agency (ANR)); DGA; CEA(French Atomic Energy Commission)	This work was funded by the joint ministerial program of R&D against CBRNE threats. SIMOPRO is a member of the Laboratory of Excellence LERMIT supported by a grant from the Agence Nationale de la Recherche (ANR-10-LABX-33). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Nicolas Durafourc and Maite Paternostre for help with LUV preparation. For help with protein production and purification we thank Cassandra Porebski. For help with AUC experiments we thank Bertrand Raynal. AA was supported by DGA and CEA. This work was funded by the joint ministerial program of R&D against CBRNE threats. SIMOPRO is a member of the Laboratory of Excellence LERMIT supported by a grant from the Agence Nationale de la Recherche (ANR-10-LABX-33). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnon SS, 2001, JAMA-J AM MED ASSOC, V285, P1059, DOI 10.1001/jama.285.8.1059; Baldwin MR, 2004, PROTEIN EXPRES PURIF, V37, P187, DOI 10.1016/j.pep.2004.05.009; Binz T, 2009, J NEUROCHEM, V109, P1584, DOI 10.1111/j.1471-4159.2009.06093.x; Cai SW, 2006, PROTEIN J, V25, P455, DOI 10.1007/s10930-006-9028-1; Chassaing A, 2011, FEBS J, V278, P4516, DOI 10.1111/j.1742-4658.2011.08053.x; Chenal A, 2002, J BIOL CHEM, V277, P43425, DOI 10.1074/jbc.M204148200; Chenal A, 2010, BIOPHYS J, V99, P3744, DOI 10.1016/j.bpj.2010.10.016; Eswaramoorthy S, 2004, BIOCHEMISTRY-US, V43, P2209, DOI 10.1021/bi035844k; Falguieres T, 2006, BIOL CELL, V98, P125, DOI 10.1042/BC20050001; Feld GK, 2012, PROTEIN SCI, V21, P606, DOI 10.1002/pro.2052; Fischer A, 2007, P NATL ACAD SCI USA, V104, P10447, DOI 10.1073/pnas.0700046104; Fu FN, 2002, BIOPHYS CHEM, V99, P17, DOI 10.1016/S0301-4622(02)00135-7; Fu ZJ, 2006, BIOCHEMISTRY-US, V45, P8903, DOI 10.1021/bi060786z; Galloux M, 2008, J BIOL CHEM, V283, P27668, DOI 10.1074/jbc.M802557200; Geny B, 2006, BIOL CELL, V98, P667, DOI 10.1042/BC20050082; Hammond K, 2002, BIOCHEMISTRY-US, V41, P3243, DOI 10.1021/bi011163i; Harper CB, 2011, J BIOL CHEM, V286, P35966, DOI 10.1074/jbc.M111.283879; HOCH DH, 1985, P NATL ACAD SCI USA, V82, P1692, DOI 10.1073/pnas.82.6.1692; Humeau Y, 2000, BIOCHIMIE, V82, P427, DOI 10.1016/S0300-9084(00)00216-9; Jiang JS, 2015, NATURE, V521, P545, DOI 10.1038/nature14247; Koriazova LK, 2003, NAT STRUCT BIOL, V10, P13, DOI 10.1038/nsb879; Kumaran D, 2009, J MOL BIOL, V386, P233, DOI 10.1016/j.jmb.2008.12.027; Lacy DB, 1998, NAT STRUCT BIOL, V5, P898, DOI 10.1038/2338; Lai B, 2010, J MEMBRANE BIOL, V236, P191, DOI 10.1007/s00232-010-9292-z; Li L, 2000, BIOCHEMISTRY-US, V39, P6466, DOI 10.1021/bi992729u; Montagner C, 2007, BIOCHEMISTRY-US, V46, P1878, DOI 10.1021/bi602381z; Montal M, 2010, ANNU REV BIOCHEM, V79, P591, DOI 10.1146/annurev.biochem.051908.125345; Montal M, 2009, TOXICON, V54, P565, DOI 10.1016/j.toxicon.2008.11.018; MONTECUCCO C, 1986, TRENDS BIOCHEM SCI, V11, P314, DOI 10.1016/0968-0004(86)90282-3; MONTECUCCO C, 1988, BIOCHEM J, V251, P379, DOI 10.1042/bj2510379; MONTECUCCO C, 1989, BIOCHEM J, V259, P47, DOI 10.1042/bj2590047; Nozaki Y, 1972, Methods Enzymol, V26, P43; Poulain B, 2008, BOTULINUM J, V1, P14, DOI DOI 10.1504/TBJ.2008.018951; Ren JH, 1999, SCIENCE, V284, P955, DOI 10.1126/science.284.5416.955; Rossetto Ornella, 2008, V184, P129; Rummel A, 2007, P NATL ACAD SCI USA, V104, P359, DOI 10.1073/pnas.0609713104; Rummel A, 2013, CURR TOP MICROBIOL, V364, P61, DOI 10.1007/978-3-642-33570-9_4; Schiavo G, 2000, PHYSIOL REV, V80, P717, DOI 10.1152/physrev.2000.80.2.717; SCHMID MF, 1993, NATURE, V364, P827, DOI 10.1038/364827a0; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Spooner RA, 2012, CURR TOP MICROBIOL, V357, P19, DOI 10.1007/82_2011_154; Stura EA, 2012, J BIOL CHEM, V287, P33607, DOI 10.1074/jbc.M112.396697; Sun SH, 2012, BIOCHEMISTRY-US, V51, P5655, DOI 10.1021/bi3004928; Swaminathan S, 2000, NAT STRUCT BIOL, V7, P693, DOI 10.1038/78005; Wang Y, 1997, J BIOL CHEM, V272, P25091, DOI 10.1074/jbc.272.40.25091	45	8	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0153401	10.1371/journal.pone.0153401	http://dx.doi.org/10.1371/journal.pone.0153401			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27070312	Green Published, Green Submitted, gold			2022-12-27	WOS:000373900700060
J	Roksandic, M; Alarie, K; Suarez, RR; Huebner, E; Roksandic, I				Roksandic, Mirjana; Alarie, Kaitlynn; Rodriguez Suarez, Roberto; Huebner, Erwin; Roksandic, Ivan			Not of African Descent: Dental Modification among Indigenous Caribbean People from Canimar Abajo, Cuba	PLOS ONE			English	Article							TOOTH MUTILATION; SKELETAL REMAINS; CONSUMPTION; TEETH	Dental modifications in the Caribbean are considered to be an African practice introduced to the Caribbean archipelago by the influx of enslaved Africans during colonial times. Skeletal remains which exhibited dental modifications are by default considered to be Africans, African descendants, or post-contact indigenous people influenced by an African practice. Individual E-105 from the site of Canmar Abajo (Cuba), with a direct C-14 AMS date of 990800 cal BC, provides the first unequivocal evidence of dental modifications in the Antilles prior to contact with Europeans in AD 1492. Central incisors showing evidence of significant crown reduction (loss of crown volume regardless of its etiology) were examined macroscopically and with a scanning electron microscope (SEM) to determine if the observed alterations were due to deliberate modification or other (unintentional) factors considered: postmortem breakage, violent accidental breakage, non-dietary use of teeth, and wear caused by habitual or repeated actions. The pattern of crown reduction is consistent with deliberate dental modification of the type commonly encountered among African and African descendent communities in post-contact Caribbean archaeological assemblages. Six additional individuals show similar pattern of crown reduction of maxillary incisors with no analogous wear in corresponding mandibular dentition.	[Roksandic, Mirjana; Roksandic, Ivan] Univ Winnipeg, Dept Anthropol, 515 Portage Ave, Winnipeg, MB R3B 2E9, Canada; [Roksandic, Mirjana; Alarie, Kaitlynn] Univ Manitoba, Dept Anthropol, 66 Chancellors Circle, Winnipeg, MB R3T 2N2, Canada; [Rodriguez Suarez, Roberto] Univ La Habana, Museo Antropol Montane, Calle 25 455 Vedado, Havana 10400, Cuba; [Huebner, Erwin] Univ Manitoba, Dept Biol, 66 Chancellors Circle, Winnipeg, MB R3T 2N2, Canada	University of Winnipeg; University of Manitoba; Universidad de la Habana; University of Manitoba	Roksandic, M (corresponding author), Univ Winnipeg, Dept Anthropol, 515 Portage Ave, Winnipeg, MB R3B 2E9, Canada.; Roksandic, M (corresponding author), Univ Manitoba, Dept Anthropol, 66 Chancellors Circle, Winnipeg, MB R3T 2N2, Canada.	m.roksandic@uwinnipeg.ca	Roksandic, Mirjana/B-1812-2019	Roksandic, Mirjana/0000-0003-0291-6357	SSHRC Standard Research Grant SSHRC [410-2011-1179]	SSHRC Standard Research Grant SSHRC	The research was funded under SSHRC Standard Research Grant SSHRC - 410-2011-1179 to MR and IR (http://www.sshrc-crsh.gc.ca/homeaccueil-eng.aspx).	Alt KW, 1998, DENTAL ANTHROPOLOGY, P387; Andrefsky W., 2005, CAMB MAN ARCHAEOL, DOI DOI 10.1017/CBO9780511810244; [Anonymous], 1997, BONES MAYA STUDIES A; [Anonymous], 2003, ESTUD ANTHR BIOL, V11, P951; Bonfiglioli B, 2004, INT J OSTEOARCHAEOL, V14, P448, DOI 10.1002/oa.726; Buikstra J. E., 1994, RES SERIES ARKANSAS, V44; Buxton LHD, 1938, MAN, V38, P49, DOI 10.2307/2791870; de Armas YC, 2015, J ARCHAEOL SCI, V58, P121, DOI 10.1016/j.jas.2015.03.003; Constantino PJ, 2010, BIOL LETTERS, V6, P826, DOI 10.1098/rsbl.2010.0304; Constenla Umana A., 2012, INDIGENOUS LANGUAGES, P391, DOI 10.1515/9783110258035.391; de la Borbolla DFR, 1940, AM J PHYS ANTHROPOL, V26, P349, DOI 10.1002/ajpa.1330260136; Farabee WC, 1918, AM J PHYS ANTHROPOL, V1, P427, DOI 10.1002/ajpa.1330010403; Giusti Juan B., 1992, REV SALUS CULT, V4, P95; Goose, 1963, MAN, V63, P91; HANDLER JS, 1982, J HUM EVOL, V11, P297, DOI 10.1016/S0047-2484(82)80021-3; HANDLER JS, 1994, HIST ARCHAEOL, V28, P113, DOI 10.1007/BF03374193; Herrmann N.P., 1999, DENT ANTHR, V13, P9; IRISH JD, 1987, AM J PHYS ANTHROPOL, V73, P209, DOI 10.1002/ajpa.1330730207; Irish JD, 1997, AM J PHYS ANTHROPOL, V102, P141; Klein Herbert S., 2010, ATLANTIC SLAVE TRADE, V2nd; Lee JJW, 2011, BIOL REV, V86, P959, DOI 10.1111/j.1469-185X.2011.00181.x; MILNER GR, 1991, ADVANCES IN DENTAL ANTHROPOLOGY, P357; Molnar P, 2011, CLIN ORAL INVEST, V15, P681, DOI 10.1007/s00784-010-0447-1; ORTNER DJ, 1966, AM J PHYS ANTHROPOL, V25, P177, DOI 10.1002/ajpa.1330250212; Pagan-Jimenez JR, 2015, QUATERNARY SCI REV, V123, P231, DOI 10.1016/j.quascirev.2015.07.005; Price TD, 2006, AM J PHYS ANTHROPOL, V130, P485, DOI 10.1002/ajpa.20390; Rodriguez Ramos R., 2013, OXFORD HDB CARIBBEAN, P155, DOI 10.1093/OXFORDHB/9780195392302.013.0058; Roksandic I, 2015, P C INT ASS CAR ARCH; Roksandic M., 2002, ADV FORENSIC TAPHONO, P99; Roksandic M, 2015, RADIOCARBON, V57, P755, DOI 10.2458/azu_rc.57.18313; Roksandic M, 2011, AM J PHYS ANTHROPOL, V145, P337, DOI 10.1002/ajpa.21508; Romero Molina J., 1970, HDB MIDDLE AM INDIAN, V9, P50; Saul Julie Mather, 1997, BONES MAYA STUDIES A, P28; Sawyer D R, 1992, Ann Dent, V51, P24; Schroeder H, 2014, INT J OSTEOARCHAEOL, V24, P688, DOI 10.1002/oa.2253; Schroeder H, 2006, SAFA P; Schroeder H, 2015, P NATL ACAD SCI USA, V112, P3669, DOI 10.1073/pnas.1421784112; Scott GR, 2011, INT J OSTEOARCHAEOL, V21, P723, DOI 10.1002/oa.1184; Singer R, 1953, S AFR J SCI, V50, P116; Stewart TD, 1939, MAN, V39, P49, DOI 10.2307/2793034; Stewart TD, 1942, AM ANTHROPOL, V44, P328, DOI 10.1525/aa.1942.44.2.02a00260; STEWART TD, 1968, AM J PHYS ANTHROPOL, V28, P31, DOI 10.1002/ajpa.1330280112; Tiesler V, 2001, HOMO, V52, P277; TURNER CG, 1983, AM J PHYS ANTHROPOL, V61, P125, DOI 10.1002/ajpa.1330610113; van Duijvenbode Anne, 2011, COMMUNITIES CONTACT, P225; Van Reenen J.F., 1986, VARIATION CULTURE EV, P159; Wasterlain SN, 2016, INT J OSTEOARCHAEOL, V26, P621, DOI 10.1002/oa.2453	47	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0153536	10.1371/journal.pone.0153536	http://dx.doi.org/10.1371/journal.pone.0153536			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ0NI	27071012	Green Published, gold, Green Submitted			2022-12-27	WOS:000373900700081
J	Lee, KM; Song, JM; Cho, JH; Hwang, HS				Lee, Kyung-Min; Song, Jin-Myoung; Cho, Jin-Hyoung; Hwang, Hyeon-Shik			Influence of Head Motion on the Accuracy of 3D Reconstruction with Cone-Beam CT: Landmark Identification Errors in Maxillofacial Surface Model	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; ARTIFACTS; CBCT; REDUCTION; SPACE	Purpose The purpose of this study was to investigate the influence of head motion on the accuracy of three-dimensional (3D) reconstruction with cone-beam computed tomography (CBCT) scan. Materials and Methods Fifteen dry skulls were incorporated into a motion controller which simulated four types of head motion during CBCT scan: 2 horizontal rotations (to the right/to the left) and 2 vertical rotations (upward/downward). Each movement was triggered to occur at the start of the scan for 1 second by remote control. Four maxillofacial surface models with head motion and one control surface model without motion were obtained for each skull. Nine landmarks were identified on the five maxillofacial surface models for each skull, and landmark identification errors were compared between the control model and each of the models with head motion. Results Rendered surface models with head motion were similar to the control model in appearance; however, the landmark identification errors showed larger values in models with head motion than in the control. In particular, the Porion in the horizontal rotation models presented statistically significant differences (P < .05). Statistically significant difference in the errors between the right and left side landmark was present in the left side rotation which was opposite direction to the scanner rotation (P < .05). Conclusions Patient movement during CBCT scan might cause landmark identification errors on the 3D surface model in relation to the direction of the scanner rotation. Clinicians should take this into consideration to prevent patient movement during CBCT scan, particularly horizontal movement.	[Lee, Kyung-Min; Song, Jin-Myoung; Cho, Jin-Hyoung] Chonnam Natl Univ, Dent Res Inst 4D, Sch Dent, Dept Orthodont, Gwangju, South Korea; [Hwang, Hyeon-Shik] Chonnam Natl Univ, Dent Sci Res Inst, Sch Dent, Dept Orthodont, Gwangju, South Korea	Chonnam National University; Chonnam National University	Hwang, HS (corresponding author), Chonnam Natl Univ, Dent Sci Res Inst, Sch Dent, Dept Orthodont, Gwangju, South Korea.	hhwang@chonnam.ac.kr			Chonnam National University [2012-0821]	Chonnam National University	This study was financially supported by Chonnam National University, 2012 (Grant number 2012-0821, URL: www.chonnam.ac.kr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboudara C, 2009, AM J ORTHOD DENTOFAC, V135, P468, DOI 10.1016/j.ajodo.2007.04.043; Alamri Hadi Mohammed, 2012, General Dentistry, V60, P390; Angelopoulos Christos, 2012, Atlas Oral Maxillofac Surg Clin North Am, V20, P1, DOI 10.1016/j.cxom.2011.12.008; Barghan Sevin, 2010, J Calif Dent Assoc, V38, P33; Barrett JF, 2004, RADIOGRAPHICS, V24, P1679, DOI 10.1148/rg.246045065; Baumgaertel S, 2009, AM J ORTHOD DENTOFAC, V136, P19, DOI 10.1016/j.ajodo.2007.09.016; Bontempi M, 2008, INT J COMPUT ASS RAD, V3, P249, DOI 10.1007/s11548-008-0157-1; Cevidanes LHS, 2007, AM J ORTHOD DENTOFAC, V131, P44, DOI 10.1016/j.ajodo.2005.03.029; De Man B, 2004, PHYS MED BIOL, V49, P2463, DOI 10.1088/0031-9155/49/11/024; Dey J, 2010, MED PHYS, V37, P6453, DOI 10.1118/1.3517836; Donaldson K, 2013, DENTOMAXILLOFAC RAD, V42, DOI 10.1259/dmfr/91866873; Dudic A, 2009, AM J ORTHOD DENTOFAC, V135, P434, DOI 10.1016/j.ajodo.2008.10.014; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Hanzelka T, 2013, OR SURG OR MED OR PA, V116, P769, DOI 10.1016/j.oooo.2013.08.010; Herzog H, 2005, J NUCL MED, V46, P1059; Honey OB, 2007, AM J ORTHOD DENTOFAC, V132, P429, DOI 10.1016/j.ajodo.2005.10.032; Lagravere MO, 2010, AM J ORTHOD DENTOFAC, V137, P598, DOI 10.1016/j.ajodo.2008.07.018; Lee CC, 1998, MAGN RESON MED, V39, P234, DOI 10.1002/mrm.1910390210; Li L, 2011, IEEE NUCL SCI CONF R, P2895, DOI 10.1109/NSSMIC.2011.6152513; Lo J, 2010, J ORAL MAXIL SURG, V68, P1444, DOI 10.1016/j.joms.2009.11.008; Lu W, 2005, MED PHYS, V32, P3295, DOI 10.1118/1.2074187; Mueller K, 1999, IEEE T MED IMAGING, V18, P519, DOI 10.1109/42.781017; Rodet T, 2004, MED PHYS, V31, P1972, DOI 10.1118/1.1759828; Schulze R, 2011, DENTOMAXILLOFAC RAD, V40, P265, DOI 10.1259/dmfr/30642039; Sun Y, 2013, J CRANIO MAXILL SURG, V41, P522, DOI 10.1016/j.jcms.2012.11.017; Wagner A, 2003, INVEST RADIOL, V38, P733, DOI 10.1097/01.rli.0000084889.92250.b0; Walker L, 2005, AM J ORTHOD DENTOFAC, V128, P418, DOI 10.1016/j.ajodo.2004.04.033	27	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2016	11	4							e0153210	10.1371/journal.pone.0153210	http://dx.doi.org/10.1371/journal.pone.0153210			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0KH	27065238	gold, Green Published, Green Submitted			2022-12-27	WOS:000373891000036
J	Wang, KC; Huang, CH; Huang, CJ; Fang, SB				Wang, Ke-Chuan; Huang, Chih-Hung; Huang, Ching-Jou; Fang, Shiuh-Bin			Impacts of Salmonella enterica Serovar Typhimurium and Its speG Gene on the Transcriptomes of In Vitro M Cells and Caco-2 Cells	PLOS ONE			English	Article							INTESTINAL M-CELL; PATCH M-CELLS; FOLLICLE-ASSOCIATED EPITHELIUM; FACTOR SPI-B; STEM-CELLS; EXPRESSION; DIFFERENTIATION; ACTIVATION; INFECTION; TRANSPORT	Microfold or membranous (M) cells are specialized intestinal epithelial cells responsible for host immunity. The speG mutant of Salmonella Typhimurium (S. Typhimurium) is a nonreplicating strain within human cells to be a candidate vaccine vector for interacting with M cells. We conducted this study to identify the genes are differently expressed between in vitro M cells and Caco-2 cells, and to determine whether S. Typhimurium and speG affect the transcriptomes of both cell types. In vitro M cells and Caco-2 cells were infected with wild-type (WT) S. Typhimurium, its Delta speG mutant, or none for 1 h for RNA microarrays; the transcriptomes among the 6 pools were pairwisely compared. Genetic loci encoding scaffold (e.g., HSCHR7_CTG4_4, HSCHR9_CTG9_35), long noncoding RNA, membrane-associated protein (PITPNB), neuron-related proteins (OR8D1, OR10G9, and NTNG2), and transporter proteins (MICU2 and SLC28A1) were significantly upregulated in uninfected M cells compared with uninfected Caco-2 cells; and their encoding proteins are promising M-cell markers. Significantly upregulated HSCHR7_CTG4_4 of uninfected in vitro M cells were speG-independently downregulated by S. Typhimurium infection that is a remarkable change representing an important but unreported characteristic of M cells. The immune responses of in vitro M cells and Caco-2 cells can differ and reply on speG or not, with speG-dependent regulation of KYL4, SCTR, IL6, TNF, and CELF4 in Caco-2 cells, JUN, KLF6, and KCTD11 in M cells, or speG-independent modulation of ZFP36 in both cells. This study facilitates understanding of the immune responses of in vitro M cells after administering the S. Typhimurium Delta speG mutant as a future vaccine vector.	[Wang, Ke-Chuan; Huang, Ching-Jou; Fang, Shiuh-Bin] Taipei Med Univ, Shuang Ho Hosp, Dept Pediat, Div Pediat Gastroenterol & Hepatol, Taipei, Taiwan; [Wang, Ke-Chuan; Huang, Ching-Jou; Fang, Shiuh-Bin] Taipei Med Univ, Coll Med, Sch Med, Dept Pediat, Taipei, Taiwan; [Huang, Chih-Hung] Natl Taipei Univ Technol, Grad Inst Biochem & Biomed Engn, Taipei 106, Taiwan	Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; National Taipei University of Technology	Fang, SB (corresponding author), Taipei Med Univ, Shuang Ho Hosp, Dept Pediat, Div Pediat Gastroenterol & Hepatol, Taipei, Taiwan.; Fang, SB (corresponding author), Taipei Med Univ, Coll Med, Sch Med, Dept Pediat, Taipei, Taiwan.	sbfang@tmu.edu.tw	Fang, Shiuh-Bin/J-4645-2014	Fang, Shiuh-Bin/0000-0003-2742-8886	Ministry of Science and Technology [102-2320-B-038-009-]; National Taipei University of Technology-Taipei Medical University Joint Research Program [NTUT-TMU-101-18, NTUT-TMU-102-09]; Career Development Grant, National Health Research Institutes, Taiwan [NHRI-EX103-10234SC]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Taipei University of Technology-Taipei Medical University Joint Research Program; Career Development Grant, National Health Research Institutes, Taiwan	The work was supported by the following: Ministry of Science and Technology, formerly the National Science Council (NSC 102-2320-B-038-009-), https://www.most.gov.tw/en/public; National Taipei University of Technology-Taipei Medical University Joint Research Program (NTUT-TMU-101-18, NTUT-TMU-102-09), http://www-en.ntut.edu.tw/bin/home.php, http://www.tmu.edu.tw/english/main.php; and Career Development Grant, National Health Research Institutes, Taiwan (NHRI-EX103-10234SC), http://english.nhri.org.tw/NHRI_WEB/nhriw001Action.do. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avraham R, 2015, CELL, V162, P1309, DOI 10.1016/j.cell.2015.08.027; Barbagallo M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027226; Bayeva M, 2012, CELL METAB, V16, P645, DOI 10.1016/j.cmet.2012.10.001; Bhat R, 2010, P NATL ACAD SCI USA, V107, P2580, DOI 10.1073/pnas.0915139107; Bolos V, 2003, J CELL SCI, V116, P499, DOI 10.1242/jcs.00224; Cosker KE, 2008, J CELL SCI, V121, P796, DOI 10.1242/jcs.019166; Couper KN, 2008, J IMMUNOL, V180, P5771, DOI 10.4049/jimmunol.180.9.5771; Das Abhijit, 2011, Neural Syst Circuits, V1, P4, DOI 10.1186/2042-1001-1-4; de Lau W, 2012, MOL CELL BIOL, V32, P3639, DOI 10.1128/MCB.00434-12; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; ELDRIDGE JH, 1987, J IMMUNOL, V139, P2255; Fang SB, 2011, THESIS UCL; Fiermonte G, 2009, J BIOL CHEM, V284, P18152, DOI 10.1074/jbc.M109.014118; Figueiredo JF, 2009, MICROBES INFECT, V11, P302, DOI 10.1016/j.micinf.2008.12.005; Gewirtz AT, 2000, J CLIN INVEST, V105, P79, DOI 10.1172/JCI8066; Giannasca PJ, 1999, INFECT IMMUN, V67, P946, DOI 10.1128/IAI.67.2.946-953.1999; Gullberg E, 2000, BIOCHEM BIOPH RES CO, V279, P808, DOI 10.1006/bbrc.2000.4038; Gust B, 2003, P NATL ACAD SCI USA, V100, P1541, DOI 10.1073/pnas.0337542100; HAMMOND MEW, 1995, J IMMUNOL, V155, P1428; Haraga A, 2008, NAT REV MICROBIOL, V6, P53, DOI 10.1038/nrmicro1788; Hase K, 2005, DNA RES, V12, P127, DOI 10.1093/dnares/12.2.127; Hondo T, 2011, AM J PHYSIOL-GASTR L, V300, pG442, DOI 10.1152/ajpgi.00345.2010; Huang FC, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/103890; Imamura K, 2014, MOL CELL, V53, P393, DOI 10.1016/j.molcel.2014.01.009; Jang MH, 2004, P NATL ACAD SCI USA, V101, P6110, DOI 10.1073/pnas.0400969101; Jelsbak L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036149; JEPSON MA, 1992, HISTOCHEM J, V24, P33, DOI 10.1007/BF01043285; JONES BD, 1994, J EXP MED, V180, P15, DOI 10.1084/jem.180.1.15; Jones MA, 2007, AVIAN PATHOL, V36, P199, DOI 10.1080/03079450701264118; Kanaya T, 2012, NAT IMMUNOL, V13, P729, DOI 10.1038/ni.2352; Kerneis S, 1997, SCIENCE, V277, P949, DOI 10.1126/science.277.5328.949; Kroger C, 2013, CELL HOST MICROBE, V14, P683, DOI 10.1016/j.chom.2013.11.010; Kroger C, 2012, P NATL ACAD SCI USA, V109, pE1277, DOI 10.1073/pnas.1201061109; Lapthorne S, 2012, IMMUNOLOGY, V136, P312, DOI 10.1111/j.1365-2567.2012.03581.x; Li ZH, 2014, P NATL ACAD SCI USA, V111, P1002, DOI 10.1073/pnas.1313768111; Ma AD, 1998, MOL CELL BIOL, V18, P4744, DOI 10.1128/MCB.18.8.4744; Ma BY, 2012, J BIOL CHEM, V287, P19008, DOI 10.1074/jbc.M111.281873; Mabbott NA, 2013, MUCOSAL IMMUNOL, V6, P666, DOI 10.1038/mi.2013.30; Mallilankaraman K, 2012, CELL, V151, P630, DOI 10.1016/j.cell.2012.10.011; Mandal S, 2011, STEM CELLS, V29, P486, DOI 10.1002/stem.590; Martinez-Argudo I, 2008, MICROBIOL-SGM, V154, P3887, DOI 10.1099/mic.0.2008/021162-0; Mitsuyama K, 2006, CYTOKINE GROWTH F R, V17, P451, DOI 10.1016/j.cytogfr.2006.09.003; Okkenhaug K, 2003, NAT REV IMMUNOL, V3, P317, DOI 10.1038/nri1056; Peferoen L, 2014, IMMUNOLOGY, V141, P302, DOI 10.1111/imm.12163; Peterson LW, 2014, NAT REV IMMUNOL, V14, P141, DOI 10.1038/nri3608; Pielage JF, 2007, INT J BIOCHEM CELL B, V39, P1886, DOI 10.1016/j.biocel.2007.05.009; Rajasekaran SA, 2008, BBA-BIOMEMBRANES, V1778, P757, DOI 10.1016/j.bbamem.2007.11.007; Sato S, 2013, MUCOSAL IMMUNOL, V6, P838, DOI 10.1038/mi.2012.122; Schaljo B, 2009, J IMMUNOL, V183, P1197, DOI 10.4049/jimmunol.0803883; Sigel E, 2012, J BIOL CHEM, V287, P40224, DOI 10.1074/jbc.R112.386664; Srikumar S, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005262; Suzuki T, 2011, J BIOL CHEM, V286, P31263, DOI 10.1074/jbc.M111.238147; Tahoun A, 2012, CELL HOST MICROBE, V12, P645, DOI 10.1016/j.chom.2012.10.009; Takeda K, 1998, J IMMUNOL, V161, P4652; Terahara K, 2008, J IMMUNOL, V180, P7840, DOI 10.4049/jimmunol.180.12.7840; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; Venable CL, 2000, J BIOL CHEM, V275, P18318, DOI 10.1074/jbc.M908392199; Verbrugghe P, 2006, J PATHOL, V209, P240, DOI 10.1002/path.1970; Yamamoto M, 2012, CURR TOP MICROBIOL, V354, P39, DOI 10.1007/82_2011_134	59	7	7	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2016	11	4							e0153444	10.1371/journal.pone.0153444	http://dx.doi.org/10.1371/journal.pone.0153444			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0KH	27064787	Green Published, gold			2022-12-27	WOS:000373891000054
J	Zaganjor, I; Sekkarie, A; Tsang, BL; Williams, J; Razzaghi, H; Mulinare, J; Sniezek, JE; Cannon, MJ; Rosenthal, J				Zaganjor, Ibrahim; Sekkarie, Ahlia; Tsang, Becky L.; Williams, Jennifer; Razzaghi, Hilda; Mulinare, Joseph; Sniezek, Joseph E.; Cannon, Michael J.; Rosenthal, Jorge			Describing the Prevalence of Neural Tube Defects Worldwide: A Systematic Literature Review	PLOS ONE			English	Review							FOLIC-ACID FORTIFICATION; MAJOR CONGENITAL-MALFORMATIONS; POPULATION-BASED SURVEY; BIRTH-DEFECTS; FLOUR FORTIFICATION; NATIONAL REGISTRY; SPINA-BIFIDA; RISK-FACTORS; ANOMALIES; REGION	Background Folate-sensitive neural tube defects (NTDs) are an important, preventable cause of morbidity and mortality worldwide. There is a need to describe the current global burden of NTDs and identify gaps in available NTD data. Methods and Findings We conducted a systematic review and searched multiple databases for NTD prevalence estimates and abstracted data from peer-reviewed literature, birth defects surveillance registries, and reports published between January 1990 and July 2014 that had greater than 5,000 births and were not solely based on mortality data. We classified countries according to World Health Organization (WHO) regions and World Bank income classifications. The initial search yielded 11,614 results; after systematic review we identified 160 full text manuscripts and reports that met the inclusion criteria. Data came from 75 countries. Coverage by WHO region varied in completeness (i.e., % of countries reporting) as follows: African (17%), Eastern Mediterranean (57%), European (49%), Americas (43%), South-East Asian (36%), and Western Pacific (33%). The reported NTD prevalence ranges and medians for each region were: African (5.2-75.4; 11.7 per 10,000 births), Eastern Mediterranean (2.1-124.1; 21.9 per 10,000 births), European (1.3-35.9; 9.0 per 10,000 births), Americas (3.3-27.9; 11.5 per 10,000 births), South-East Asian (1.9-66.2; 15.8 per 10,000 births), and Western Pacific (0.3-199.4; 6.9 per 10,000 births). The presence of a registry or surveillance system for NTDs increased with country income level: low income (0%), lower-middle income (25%), upper-middle income (70%), and high income (91%). Conclusions Many WHO member states (120/194) did not have any data on NTD prevalence. Where data are collected, prevalence estimates vary widely. These findings highlight the need for greater NTD surveillance efforts, especially in lower-income countries. NTDs are an important public health problem that can be prevented with folic acid supplementation and fortification of staple foods.	[Zaganjor, Ibrahim; Sekkarie, Ahlia; Tsang, Becky L.; Williams, Jennifer; Razzaghi, Hilda; Mulinare, Joseph; Sniezek, Joseph E.; Cannon, Michael J.; Rosenthal, Jorge] Ctr Dis Control & Prevent, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA USA; [Razzaghi, Hilda; Mulinare, Joseph] Carter Consulting Inc, Atlanta, GA USA	Centers for Disease Control & Prevention - USA	Zaganjor, I (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA USA.	wwa3@cdc.gov	Razzaghi, Hilda/AFQ-9027-2022	Razzaghi, Hilda/0000-0002-8053-9748	Carter Consulting Inc.	Carter Consulting Inc.	AS, IZ, and BLT were supported in part by an appointment to the Research Participation Program at the CDC administered by the Oak Ridge Institute for Science and Education (ORISE). The commercial company, Carter Consulting Inc., provided support in the form of salaries for authors [HR, JM]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollahi Z, 2011, ANN NUTR METAB, V58, P188, DOI 10.1159/000329726; Acevedo CR, 2004, THESIS U SAN CARLOS; Afshar M, 2006, NEUROSCIENCES, V11, P289; Ahuka O L, 2006, East Afr Med J, V83, P95; AIREDE KI, 1992, J TROP PEDIATRICS, V38, P27, DOI 10.1093/tropej/38.1.27; Al Hosani H., 2005, Eastern Mediterranean Health Journal, V11, P690; Al-Ani ZR, 2012, SAUDI MED J, V33, P979; Al-Jama F, 2001, J Obstet Gynaecol, V21, P595, DOI 10.1080/01443610120085546; Al-Sadoon I, 1999, MED J BASRAH U, V17, P27; Alasfoor D, 2013, HDB FOOD FORTIFICATI, P321; Alfaro N, 2004, INVESTIGACION SALUD, V6, P180; Amarin ZO, 2010, PAEDIATR PERINAT EP, V24, P349, DOI 10.1111/j.1365-3016.2010.01123.x; ANYEBUNO M, 1993, E AFR MED J, V70, P572; Aqrabawi H. E., 2005, Eastern Mediterranean Health Journal, V11, P819; Asindi A, 2001, ANN SAUDI MED, V21, P26, DOI 10.5144/0256-4947.2001.26; Behrooz Ahmad, 2007, Sultan Qaboos Univ Med J, V7, P31; Bener A, 2012, J PEDIATR NEUROL, V10, P193, DOI 10.3233/JPN-2012-0567; Berry RJ, 1999, NEW ENGL J MED, V341, P1485, DOI 10.1056/NEJM199911113412001; Berry RJ, 2010, FOOD NUTR BULL, V31, pS22, DOI 10.1177/15648265100311S103; Bhide P, 2013, BIRTH DEFECTS RES A, V97, P437, DOI 10.1002/bdra.23153; Blencowe H, 2010, INT J EPIDEMIOL, V39, P110, DOI 10.1093/ije/dyq028; Boo NY, 2013, J TROP PEDIATRICS, V59, P338, DOI 10.1093/tropej/fmt026; BORMAN B, 1990, TERATOLOGY, V42, P405, DOI 10.1002/tera.1420420409; BOWER C, 1989, MED J AUSTRALIA, V150, P613, DOI 10.5694/j.1326-5377.1989.tb136723.x; Canfield MA, 2014, AM J PUBLIC HEALTH, pe1; Castilla EE, 2003, AM J MED GENET A, V123A, P123, DOI 10.1002/ajmg.a.20230; Centers for Disease Control Prevention (CDC), 1992, MMWR-MORBID MORTAL W, V41, P1; Chen BY, 2009, J FORMOS MED ASSOC, V108, P460, DOI 10.1016/S0929-6646(09)60093-0; Chen G, 2009, BIOMED ENVIRON SCI, V22, P340, DOI 10.1016/S0895-3988(09)60065-9; Cheng N, 2003, ANN TROP PAEDIATR, V23, P25, DOI 10.1179/000349803125002823; Christianson A., 2006, GLOBAL REPORT BIRTH; Cordero A., 2010, Morbidity and Mortality Weekly Report, V59, P980; Crider KS, 2011, NUTRIENTS, V3, P370, DOI 10.3390/nu3030370; Dai L, 2011, WORLD J PEDIATR, V7, P302, DOI 10.1007/s12519-011-0326-0; Daoud AS, 1996, SAUDI MED J, V17, P78; Barboza-Arguello MD, 2015, MATERN CHILD HLTH J, V19, P583, DOI 10.1007/s10995-014-1542-8; De Wals P, 2007, NEW ENGL J MED, V357, P135, DOI 10.1056/NEJMoa067103; Delshad S, 2009, TROP DOCT, V39, P156, DOI 10.1258/td.2008.070434; Dey AC, 2010, J HEALTH POPUL NUTR, V28, P343; Dryden R, 1997, P N G Med J, V40, P4; Dudin A, 1997, ANN TROP PAEDIATR, V17, P217, DOI 10.1080/02724936.1997.11747889; Duttachoudhury A, 1997, J Indian Med Assoc, V95, P141; Ebrahimi S, 2013, SHIRAZ E MED J, V14, P1; Ekanem Theresa B., 2008, Congenital Anomalies, V48, P167, DOI 10.1111/j.1741-4520.2008.00204.x; Elsheikh GEA, 2009, KHATOUM MED J, V2, P185; European Surveillance of Congenital Anomalies (EUROCAT), 2012, PREV TABL; Fan LC, 2013, BIRTH DEFECTS RES A, V97, P750, DOI 10.1002/bdra.23148; Farhud D. D., 2000, Iranian Journal of Public Health, V29, P83; Flood L, 2013, WEST PAC SURVEILL RE, V4, DOI [10.5365/wpsar.2012.3.3.006, 10.5365/WPSAR.2012.3.3.006]; Gonzalez-Andrade F, 2010, APPL CLIN GENET, V3, P29; Groisman B, 2013, ARCH ARGENT PEDIATR, V111, P484, DOI [10.5546/aap.2013.484, 10.5546/aap.2013.eng.484]; Grover Neelam, 2000, Indian Journal of Pediatrics, V67, P249, DOI 10.1007/BF02758158; Hakami WS, 2011, SAUDI MED J, V32, P1137; Hernandez R, 2001, REV MED POST INAH, V6, P148; Hernandez-Herrera Ricardo Jorge, 2008, Rev Med Inst Mex Seguro Soc, V46, P201; Himmetoglu O, 1996, INT J GYNECOL OBSTET, V55, P117, DOI 10.1016/S0020-7292(96)02743-9; Houcher B., 2012, NEURAL TUBE DEFECTS; IMAIZUMI Y, 1991, JPN J HUM GENET, V36, P275, DOI 10.1007/BF01910546; International Clearinghouse for Birth Defects Surveillance and Research, 2011, ANN REP 2011 DAT 200; Jaruratanasirikul S, 2014, CHILD NERV SYST, V30, P1269, DOI 10.1007/s00381-014-2410-y; Jooma R, 2004, J Pak Med Assoc, V54, P540; Khattak ST, 2009, J AYUB MED COLL ABBO, V22, P61; Kim MA, 2012, J KOREAN MED SCI, V27, P1233, DOI 10.3346/jkms.2012.27.10.1233; Kinasha ADA, 2002, EUR J PEDIATR SURG, V12, pS38; Kitisomprayoonkul Nutjira, 2001, Journal of the Medical Association of Thailand, V84, P483; Klusmann A, 2005, ACTA PAEDIATR, V94, P1538, DOI 10.1080/08035250500340396; Kovacheva K, 2009, BALK J MED GENET, V12, P37; Li XH, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-161; Li Ying, 2009, Beijing Da Xue Xue Bao Yi Xue Ban, V41, P414; Liu J, 2007, CHILD NERV SYST, V23, P1119, DOI 10.1007/s00381-007-0344-3; Lo A, 2014, J GLOB HEALTH, V4, DOI 10.7189/jogh.04.010402; Lopez-Camelo JS, 2010, AM J MED GENET A, V152A, P2444, DOI 10.1002/ajmg.a.33479; Luquetti Daniela Varela, 2010, J Registry Manag, V37, P112; Macaldowie A, 2011, NEURAL TUBE DEFECTS; Madi S. A., 2005, Eastern Mediterranean Health Journal, V11, P700; Mahadevan B., 2005, Indian Journal of Pediatrics, V72, P557, DOI 10.1007/BF02724177; Malla B K, 2007, Kathmandu Univ Med J (KUMJ), V5, P557; Mandiracioglu A, 2004, TURKISH J PEDIATR, V46, P214; Masri AT, 2006, J PEDIATR NEUROL, V4, P245; McDonnell R, 2014, J PUBLIC HLTH, P1; Mohammed YA., 2011, EGYPTIAN J MED HUMAN, V12, P79, DOI [10.1016/j.ejmhg.2011.02.003, DOI 10.1016/j.ejmhg.2011.02.003]; Moher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1136/bmj.i4086, 10.1136/bmj.b2535, 10.1186/2046-4053-4-1]; Msamati B C, 2000, Cent Afr J Med, V46, P292; Murshid WR, 2000, PEDIATR NEUROSURG, V32, P10, DOI 10.1159/000028890; Najmi RS., 1998, JCPSP-J COLL PHYSICI, V8, P265; Hernandez EN, 2013, B MED HOSP INFANT M, V70, P499; Nazer J, 2013, REV MED CHILE, V141, P751, DOI 10.4067/S0034-98872013000600009; Njamnshi AK, 2008, J NEUROL SCI, V270, P13, DOI 10.1016/j.jns.2008.01.010; Onrat ST, 2009, GENET MOL RES, V8, P154, DOI 10.4238/vol8-1gmr552; Orioli IM, 2011, BIRTH DEFECTS RES A, V91, P831, DOI 10.1002/bdra.20830; Ostos H., 2000, Biomedica, V20, P18; Pachajoa Harry, 2011, Rev. salud pública, V13, P152; Pasternak B, 2013, JAMA-J AM MED ASSOC, V310, P1601, DOI 10.1001/jama.2013.278343; Perveen F, 2007, JCPSP-J COLL PHYSICI, V17, P340; Petrova JG, 2009, ACTA OBSTET GYN SCAN, V88, P667, DOI 10.1080/00016340902898008; Ponne S., 2006, Indian Journal of Nutrition and Dietetics, V43, P272; Poretti A, 2008, SWISS MED WKLY, V138, P608, DOI 2008/41/smw-12352; Qazi Gulrukh, 2010, J Ayub Med Coll Abbottabad, V22, P41; Rad IA, 2008, IRAN J CHILD NEUROL, V2, P19; Rosenthal J, 2014, PUBLIC HEALTH NUTR, V17, P537, DOI 10.1017/S1368980013000256; Rudan I, 2010, LANCET, V375, P1083, DOI 10.1016/S0140-6736(10)60060-8; Safdar OY, 2007, SAUDI MED J, V28, P1227; Sanabria Rojas Hernán A., 2013, An. Fac. med., V74, P175; Sarkar S, 2013, J CLIN NEONATOL, V2, P131, DOI 10.4103/2249-4847.119998; Sayed AR, 2008, BIRTH DEFECTS RES A, V82, P211, DOI 10.1002/bdra.20442; Seto Toshio, 2003, Congenit Anom (Kyoto), V43, P286; SHARMA AK, 1994, INDIAN J MED RES, V99, P223; Shi LM, 2002, OCCUP MED-OXFORD, V52, P325, DOI 10.1093/occmed/52.6.325; Singh R, 2000, East Mediterr Health J, V6, P65; Sixty-Third World Health Assembly, 2010, AG IT 11 7 BIRTH DEF; SOOD M, 1991, Indian Journal of Pediatrics, V58, P363, DOI 10.1007/BF02754968; Stoll C, 2011, AM J MED GENET A, V155A, P565, DOI 10.1002/ajmg.a.33886; Taksande Amar, 2010, Indian J Hum Genet, V16, P159, DOI 10.4103/0971-6866.73412; Hoang T, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-67; Tuncbilek E, 1999, TURKISH J PEDIATR, V41, P299; U.S. Centers for Disease Control and Prevention, 2014, FOL AC BIRTH DEF COU; VENTER PA, 1995, S AFR MED J, V85, P15; VILJOEN DL, 1995, S AFR MED J, V85, P630; Wasant Pornswan, 2005, J Med Assoc Thai, V88 Suppl 8, pS92; WHO, 2015, WHO REG OFF; WHO, 2020, BIRTH DEF SURV MAN P, V2nd; *WHO, 2015, GLOB HLTH EST GHE CA; World Health Organization, 2015, COUNTR; Yan LF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041689; Yang M, 2015, J MATERN-FETAL NEO M, V28, P799, DOI 10.3109/14767058.2014.932767; Youngblood ME, 2013, BIRTH DEFECTS RES A, V97, P658, DOI 10.1002/bdra.23166; Zarante I, 2010, BIOMEDICA, V30, P65, DOI 10.7705/biomedica.v30i1.154; Zhang XH, 2011, BIRTH DEFECTS RES A, V91, P34, DOI 10.1002/bdra.20725; Zhang XG, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-125; Zlotogora J, 2006, ISRAEL MED ASSOC J, V8, P601	130	217	225	3	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2016	11	4							e0151586	10.1371/journal.pone.0151586	http://dx.doi.org/10.1371/journal.pone.0151586			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0KH	27064786	Green Submitted, gold, Green Published			2022-12-27	WOS:000373891000006
J	Kim, YJ; Kim, DN				Kim, Young-Joo; Kim, Do-Nyun			Structural Basis for Elastic Mechanical Properties of the DNA Double Helix	PLOS ONE			English	Article							MAGNETIC TWEEZERS; SINGLE-MOLECULE; NUCLEIC-ACIDS; ROD MODEL; B-DNA; DEPENDENCE; STIFFNESS; TWIST; CONTINUUM; TENSION	In this article, we investigate the principal structural features of the DNA double helix and their effects on its elastic mechanical properties. We develop, in the pursuit of this purpose, a helical continuum model consisting of a soft helical core and two stiff ribbons wrapping around it. The proposed model can reproduce the negative twist-stretch coupling of the helix successfully as well as its global stretching, bending, and torsional rigidities measured experimentally. Our parametric study of the model using the finite element method further reveals that the stiffness of phosphate backbones is a crucial factor for the counterintuitive overwinding behavior of the duplex and its extraordinarily high torsional rigidity, the major-minor grooves augment the twist-stretch coupling, and the change of the helicity might be responsible for the transition from a negative to a positive twist-stretching coupling when a tensile force is applied to the duplex.	[Kim, Young-Joo; Kim, Do-Nyun] Seoul Natl Univ, Dept Mech & Aerosp Engn, Gwanak Ro 1, Seoul 08826, South Korea; [Kim, Do-Nyun] Seoul Natl Univ, Inst Adv Machines & Design, Gwanak Ro 1, Seoul 08826, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Kim, DN (corresponding author), Seoul Natl Univ, Dept Mech & Aerosp Engn, Gwanak Ro 1, Seoul 08826, South Korea.; Kim, DN (corresponding author), Seoul Natl Univ, Inst Adv Machines & Design, Gwanak Ro 1, Seoul 08826, South Korea.	dnkim@snu.ac.kr			National Research Foundation of Korea [2013R1A1A1010626]; Ministry of Science, ICT and Future Planning [CAMM-2014M3A6B3063711]	National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Science, ICT and Future Planning(Ministry of Science, ICT & Future Planning, Republic of Korea)	National Research Foundation of Korea (No. 2013R1A1A1010626, http://www.nrf.re.kr) supported DK and YK; and Ministry of Science, ICT and Future Planning (No. CAMM-2014M3A6B3063711, http://english.msip.go.kr) supported DK and YK.	Bai XC, 2012, P NATL ACAD SCI USA, V109, P20012, DOI 10.1073/pnas.1215713109; Balaeff A, 1999, PHYS REV LETT, V83, P4900, DOI 10.1103/PhysRevLett.83.4900; Balaeff A, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.031919; Balaeff A, 2004, PHILOS T R SOC A, V362, P1355, DOI 10.1098/rsta.2004.1384; Baumann CG, 1997, P NATL ACAD SCI USA, V94, P6185, DOI 10.1073/pnas.94.12.6185; Bryant Z, 2003, NATURE, V424, P338, DOI 10.1038/nature01810; Bryant Z, 2012, CURR OPIN STRUC BIOL, V22, P304, DOI 10.1016/j.sbi.2012.04.007; Bustamante C, 2003, NATURE, V421, P423, DOI 10.1038/nature01405; Bustamante C, 2000, CURR OPIN STRUC BIOL, V10, P279, DOI 10.1016/S0959-440X(00)00085-3; Chiang KN, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2163267; CRICK FHC, 1975, NATURE, V255, P530, DOI 10.1038/255530a0; Douglas SM, 2009, NATURE, V459, P414, DOI 10.1038/nature08016; Forth S, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.148301; Geggier S, 2010, P NATL ACAD SCI USA, V107, P15421, DOI 10.1073/pnas.1004809107; Gore J, 2006, NATURE, V442, P836, DOI 10.1038/nature04974; Gross P, 2011, NAT PHYS, V7, P731, DOI [10.1038/nphys2002, 10.1038/NPHYS2002]; Herrero-Galan E, 2013, J AM CHEM SOC, V135, P122, DOI 10.1021/ja3054755; HOGAN ME, 1987, NATURE, V329, P263, DOI 10.1038/329263a0; Lionnet T, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.178102; Lipfert J, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1450; Lipfert J, 2010, NAT METHODS, V7, P977, DOI [10.1038/nmeth.1520, 10.1038/NMETH.1520]; Lipfert J, 2010, NUCLEIC ACIDS RES, V38, P7122, DOI 10.1093/nar/gkq598; Ma L, 2009, BIOPHYS J, V96, P3543, DOI 10.1016/j.bpj.2009.01.047; Manning RS, 1996, J CHEM PHYS, V105, P5626, DOI 10.1063/1.472373; MARINI JC, 1982, P NATL ACAD SCI-BIOL, V79, P7664, DOI 10.1073/pnas.79.24.7664; Moroz JD, 1997, P NATL ACAD SCI USA, V94, P14418, DOI 10.1073/pnas.94.26.14418; Munteanu MG, 1998, TRENDS BIOCHEM SCI, V23, P341, DOI 10.1016/S0968-0004(98)01265-1; Peters JP, 2013, NUCLEIC ACIDS RES, V41, P10593, DOI 10.1093/nar/gkt808; RHODES D, 1980, NATURE, V286, P573, DOI 10.1038/286573a0; Roychoudhury M, 2000, P NATL ACAD SCI USA, V97, P13608, DOI 10.1073/pnas.250476297; Salerno D, 2010, NUCLEIC ACIDS RES, V38, P7089, DOI 10.1093/nar/gkq597; Sanghani SR, 1996, NUCLEIC ACIDS RES, V24, P1632, DOI 10.1093/nar/24.9.1632; SCHLICK T, 1995, CURR OPIN STRUC BIOL, V5, P245, DOI 10.1016/0959-440X(95)80083-2; Smith SB, 1996, SCIENCE, V271, P795, DOI 10.1126/science.271.5250.795; WANG JC, 1979, P NATL ACAD SCI USA, V76, P200, DOI 10.1073/pnas.76.1.200; Wang MD, 1997, BIOPHYS J, V72, P1335, DOI 10.1016/S0006-3495(97)78780-0; WATSON JD, 1953, NATURE, V171, P737, DOI 10.1038/171737a0; Wenner JR, 2002, BIOPHYS J, V82, P3160, DOI 10.1016/S0006-3495(02)75658-0; WING R, 1980, NATURE, V287, P755, DOI 10.1038/287755a0; WU HM, 1981, P NATL ACAD SCI-BIOL, V78, P6808, DOI 10.1073/pnas.78.11.6808	40	16	16	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153228	10.1371/journal.pone.0153228	http://dx.doi.org/10.1371/journal.pone.0153228			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27055239	gold, Green Published, Green Submitted			2022-12-27	WOS:000373608000105
J	Kim, YJ; Lee, JH; Harn, CH; Kim, CG				Kim, Young-Joong; Lee, Joon-Ho; Harn, Chee Hark; Kim, Chang-Gi			Transgenic Cabbage Expressing Cry1Ac1 Does Not Affect the Survival and Growth of the Wolf Spider, Pardosa astrigera L. Koch (Araneae: Lycosidae)	PLOS ONE			English	Article							BT COTTON; CROPS; RICE; THERIDIIDAE; ARTHROPODS; RESISTANT; PROTEINS; ECOLOGY; FIELDS	Both herbivores that consume transgenic crops and their predators can be exposed to insecticidal proteins expressed in those crops. We conducted a tritrophic bioassay to evaluate the ecotoxicological impacts that Bt cabbage (Brassica oleracea var. capitata) expressing Cry1Ac1 protein might have on the wolf spider (Pardosa astrigera), a non-target generalist predator. Enzyme-Linked Immunosorbent Assays indicated that protein levels were 4.61 ng g(-1) dry weight in fruit flies (Drosophila melanogaster) fed with the transgenic cabbage and 1.86 ng g(-1) dry weight in the wolf spiders that preyed upon them. We also compared the life history traits of spiders collected from Bt versus non-Bt cabbage and found no significant differences in their growth, survival, and developmental rates. Because Bt cabbage did not affect the growth of fruit flies, we conclude that any indirect effects that this crop had on the wolf spider were probably not mediated by prey quality. Therefore, exposure to Cry1Ac1 protein when feeding upon prey containing that substance from transgenic cabbage has only a negligible influence on those non-target predatory spiders.	[Kim, Young-Joong; Kim, Chang-Gi] Korea Res Inst Biosci & Biotechnol, Bioevaluat Ctr, Cheongju 28116, South Korea; [Kim, Young-Joong; Lee, Joon-Ho] Seoul Natl Univ, Dept Agr Biotechnol, Entomol Program, Seoul 08826, South Korea; [Lee, Joon-Ho] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul 08826, South Korea; [Harn, Chee Hark] Nongwoo Bio Co, R&D Headquarters, Yeoju 12648, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Seoul National University (SNU); Seoul National University (SNU)	Kim, CG (corresponding author), Korea Res Inst Biosci & Biotechnol, Bioevaluat Ctr, Cheongju 28116, South Korea.	cgkim@kribb.re.kr	Kim, Chang-Gi/M-2984-2013	Kim, Chang-Gi/0000-0002-2588-8259	KRIBB Research Initiative Program; Export Promotion Technology Development Program, Ministry of Agriculture, Food and Rural Affairs; National Research Foundation of Korea (NRF) - MEST [20110028162]	KRIBB Research Initiative Program; Export Promotion Technology Development Program, Ministry of Agriculture, Food and Rural Affairs; National Research Foundation of Korea (NRF) - MEST(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of Korea)	This research was financially supported by the KRIBB Research Initiative Program and the Export Promotion Technology Development Program, Ministry of Agriculture, Food and Rural Affairs, and the National Research Foundation of Korea (NRF) funded by MEST (No. 20110028162).	Capinera JL., 2001, HDB VEGETABLE PESTS; Carpenter Janet E, 2011, GM Crops, V2, P7, DOI 10.4161/gmcr.2.1.15086; Chen M, 2009, ECOTOXICOLOGY, V18, P230, DOI 10.1007/s10646-008-0276-z; Clark BW, 2005, J AGR FOOD CHEM, V53, P4643, DOI 10.1021/jf040442k; Devos Y, 2012, TRANSGENIC RES, V21, P1, DOI 10.1007/s11248-011-9515-9; HAGSTRUM DW, 1971, ANN ENTOMOL SOC AM, V64, P757, DOI 10.1093/aesa/64.4.757; Han P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102980; Jespersen LB, 2003, FUNCT ECOL, V17, P737, DOI 10.1111/j.1365-2435.2003.00788.x; Jung MP, 2012, ENVIRON MONIT ASSESS, V184, P1773, DOI 10.1007/s10661-011-2077-8; Kim BM, 2014, THESIS; Kim YJ, 2015, J ASIA-PAC ENTOMOL, V18, P657, DOI 10.1016/j.aspen.2015.07.015; Lee SY, 2014, ENVIRON ENTOMOL, V43, P819, DOI 10.1603/EN12259; Liu Zhi-Cheng, 2003, Acta Entomologica Sinica, V46, P454; Lu YH, 2012, NATURE, V487, P362, DOI 10.1038/nature11153; Ludy C, 2006, BIOL CONTROL, V38, P314, DOI 10.1016/j.biocontrol.2006.05.010; Ludy C, 2006, ENTOMOL EXP APPL, V118, P145, DOI 10.1111/j.1570-7458.2006.00375.x; Markow TA, 2008, FUNCT ECOL, V22, P747, DOI 10.1111/j.1365-2435.2008.01457.x; Mayntz D, 2001, OECOLOGIA, V127, P207, DOI 10.1007/s004420000591; Meissle M, 2012, ENVIRON ENTOMOL, V41, P1037, DOI 10.1603/EN11321; Meissle M, 2009, PLANT BIOTECHNOL J, V7, P645, DOI 10.1111/j.1467-7652.2009.00431.x; Miyashita K., 1968, APPL ENTOMOL ZOOL, V3, P81, DOI [10.1303/aez.3.81, DOI 10.1303/AEZ.3.81]; Naranjo S.E., 2009, CAB REV, V4, DOI DOI 10.1079/PAVSNNR20094011; Naranjo SE, 2005, ENVIRON ENTOMOL, V34, P1193, DOI 10.1603/0046-225X(2005)034[1193:LAOTEO]2.0.CO;2; NYFFELER M, 1987, J APPL ENTOMOL, V103, P321, DOI 10.1111/j.1439-0418.1987.tb00992.x; Peng Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083663; Peterson JA, 2011, J ARACHNOL, V39, P1, DOI 10.1636/M10-98.1; Pickavance JR, 2001, J ARACHNOL, V29, P367, DOI 10.1636/0161-8202(2001)029[0367:LCOFSO]2.0.CO;2; Quan XY, 2011, B INSECTOL, V64, P223; Romeis J, 2006, NAT BIOTECHNOL, V24, P63, DOI 10.1038/nbt1180; Romeis J, 2008, NAT BIOTECHNOL, V26, P203, DOI 10.1038/nbt1381; ROOT RB, 1973, ECOL MONOGR, V43, P95, DOI 10.2307/1942161; Shelton AM, 2002, ANNU REV ENTOMOL, V47, P845, DOI 10.1146/annurev.ento.47.091201.145309; TALEKAR NS, 1993, ANNU REV ENTOMOL, V38, P275, DOI 10.1146/annurev.en.38.010193.001423; Tian JC, 2010, ENVIRON ENTOMOL, V39, P1369, DOI 10.1603/EN10003; Tian JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035164; Torres JB, 2005, ENVIRON ENTOMOL, V34, P1242, DOI 10.1603/0046-225X(2005)034[1242:CAGPAI]2.0.CO;2; Torres JB, 2008, TRANSGENIC RES, V17, P345, DOI 10.1007/s11248-007-9109-8; Wei W, 2008, J APPL ENTOMOL, V132, P1, DOI 10.1111/j.1439-0418.2007.01242.x; Zhou Jingyu, 2014, ScientificWorldJournal, V2014, P530942, DOI 10.1155/2014/530942	39	4	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153395	10.1371/journal.pone.0153395	http://dx.doi.org/10.1371/journal.pone.0153395			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27055120	Green Published, Green Submitted, gold			2022-12-27	WOS:000373608000128
J	Melin, M; Hagerman, I; Gonon, A; Gustafsson, T; Rullman, E				Melin, Michael; Hagerman, Inger; Gonon, Adrian; Gustafsson, Thomas; Rullman, Eric			Variability in Physical Activity Assessed with Accelerometer Is an Independent Predictor of Mortality in CHF Patients	PLOS ONE			English	Article							CHRONIC HEART-FAILURE; TRIAL INVESTIGATING OUTCOMES; EXERCISE OXYGEN-CONSUMPTION; CARDIAC TRANSPLANTATION; AMBULATORY PATIENTS; SURVIVAL SCORE; PARAMETERS; MODEL; ASSOCIATION; VALIDATION	Aims Patients with heart failure often display a distinct pattern of walking characterized by short step-length and frequent short pauses. In the current study we sought to explore if qualitative aspects of movement have any additive value to established factors to predict all-cause mortality in patients with advanced heart failure. Methods and results 60 patients with advanced heart failure (NYHA III, peak VO2 <20 ml/kg and LVEF <35%) underwent symptom-limited CPX, echocardiography and routine chemistry. Physical activity was assessed using an accelerometer worn attached to the waist during waking hours for 7 consecutive days. The heart-failure survival score (HFSS) was calculated for each patient. All accelerometer-derived variables were analyzed with regard to all-cause mortality and added to a baseline model utilizing HFSS scores. HFSS score was significantly associated with the incidence of death (P < 0.001; c-index 0.71; CI, 0.67-0.73). The addition of peak skewness to the HFSS model significantly improved the predictive ability with an increase in c-index to 0.74 (CI, 0.69-0.78), likelihood ratio P < 0.02, establishing skewness as a predictor of increased event rates when accounting for baseline risk. Conclusion The feature skewness, a measure of asymmetry in the intensity level of periods of high physical activity, was identified to be predictive of all-cause mortality independent of the established prognostic model-HFSS and peak VO2. The findings from the present study emphasize the use of accelerometer analysis in clinical practice to make more accurate prognoses in addition to extract features of physical activity relevant to functional classification.	[Melin, Michael; Hagerman, Inger; Rullman, Eric] Karolinska Inst, Karolinska Univ Hosp, Dept Cardiol, Stockholm, Sweden; [Melin, Michael; Gonon, Adrian; Gustafsson, Thomas; Rullman, Eric] Karolinska Inst, Karolinska Univ Hosp, Dept Lab Med, Div Clin Physiol, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital	Rullman, E (corresponding author), Karolinska Inst, Karolinska Univ Hosp, Dept Cardiol, Stockholm, Sweden.; Rullman, E (corresponding author), Karolinska Inst, Karolinska Univ Hosp, Dept Lab Med, Div Clin Physiol, Stockholm, Sweden.	eric.rullman@ki.se	Gustafsson, Thomas/AAH-1056-2019	Rullman, Eric/0000-0003-2854-7262; Gustafsson, Thomas/0000-0002-1559-4206	Swedish Heart and Lung Foundation; Swedish County Council (ALF); Swedish Research Council; Knut and Alice Wallenberg Foundation; Swedish Society for Medical Research (SSMF)	Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Swedish County Council (ALF); Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Society for Medical Research (SSMF)	The study was funded by grants from the Swedish Heart and Lung Foundation, the Swedish County Council (ALF), Swedish Research Council, Knut and Alice Wallenberg Foundation and Swedish Society for Medical Research (SSMF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaronson KD, 1997, CIRCULATION, V95, P2660, DOI 10.1161/01.CIR.95.12.2660; Abete P, 2013, HEART FAIL REV, V18, P529, DOI 10.1007/s10741-012-9363-6; Bensimhon DR, 2008, AM J CARDIOL, V102, P712, DOI 10.1016/j.amjcard.2008.04.047; Cahalin LP, 2013, HEART FAIL REV, V18, P79, DOI 10.1007/s10741-012-9332-0; Chyu J, 2014, CIRC-HEART FAIL, V7, P88, DOI 10.1161/CIRCHEARTFAILURE.113.000404; Conraads VM, 2014, CIRC-HEART FAIL, V7, P279, DOI 10.1161/CIRCHEARTFAILURE.113.000883; Corra U, 2014, EUR J HEART FAIL, V16, P929, DOI 10.1002/ejhf.156; da Silva VZM, 2013, J CARD FAIL, V19, P635, DOI 10.1016/j.cardfail.2013.08.002; DAVIES SW, 1992, BRIT HEART J, V68, P469; DePasquale EC, 2014, J HEART LUNG TRANSPL, V33, P775, DOI 10.1016/j.healun.2014.04.019; Gass AL, 2015, CARDIOL REV, V23, P182, DOI 10.1097/CRD.0000000000000066; Goda A, 2011, J HEART LUNG TRANSPL, V30, P1236, DOI 10.1016/j.healun.2011.05.012; Hagstromer M, 2007, MED SCI SPORT EXER, V39, P1502, DOI 10.1249/mss.0b013e3180a76de5; Hlatky Mark A, 2009, Circulation, V119, P2408, DOI 10.1161/CIRCULATIONAHA.109.192278; Hsieh FY, 2000, CONTROL CLIN TRIALS, V21, P552, DOI 10.1016/S0197-2456(00)00104-5; Jehn M, 2013, INT J CARDIOL, V168, P4723, DOI 10.1016/j.ijcard.2013.07.171; Jessup M, 2003, NEW ENGL J MED, V348, P2007, DOI 10.1056/NEJMra021498; Komajda M, 2009, EUR HEART J, V30, P478, DOI 10.1093/eurheartj/ehn539; Koster A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037696; Lund LH, 2005, AM J CARDIOL, V95, P734, DOI 10.1016/j.amjcard.2004.11.024; MANCINI DM, 1991, CIRCULATION, V83, P778, DOI 10.1161/01.CIR.83.3.778; Mentz RJ, 2013, AM HEART J, V166, P488, DOI 10.1016/j.ahj.2013.06.002; Neyt M, 2014, ANN CARDIOTHORAC SUR, V3, P439, DOI 10.3978/j.issn.2225-319X.2014.09.02; O'Connor CM, 2009, JAMA-J AM MED ASSOC, V301, P1439, DOI 10.1001/jama.2009.454; Pardaens S, 2013, ACTA CARDIOL, V68, P495, DOI 10.1080/AC.68.5.2994473; Patel CB, 2014, J HEART LUNG TRANSPL, V33, P667, DOI 10.1016/j.healun.2014.02.014; Prince SA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137759; Ritt LE, 2012, J CARDIOPULM REHABIL, V32, P141, DOI 10.1097/HCR.0b013e31824f9ddf; Santos R, 2014, BRIT J SPORT MED, V48, P1508, DOI 10.1136/bjsports-2012-091610; Swank AM, 2012, CIRC-HEART FAIL, V5, P579, DOI 10.1161/CIRCHEARTFAILURE.111.965186; Tudor-Locke C, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.110332	31	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153036	10.1371/journal.pone.0153036	http://dx.doi.org/10.1371/journal.pone.0153036			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27054323	gold, Green Published, Green Submitted			2022-12-27	WOS:000373608000067
J	Zou, Y; Xie, JR; Wang, BH				Zou, You; Xie, Jiarong; Wang, Binghong			Evacuation of Pedestrians with Two Motion Modes for Panic System	PLOS ONE			English	Article							EMERGENCY EVACUATION; JAMMING TRANSITION; DYNAMICS; SIMULATION; FLOW; DERIVATION; NETWORKS; ESCAPE	In this paper, we have captured an underlying mechanism of emergence of collective panic in pedestrian evacuations by using a modification of the lattice-gas model. We classify the motion of pedestrians into two modes according to their moods. One is gentle (mode I), the other is flustered (mode II). First, to research the cause for crowd, we fix the motion modes of pedestrians and increase the proportion of pedestrians with motion mode II (rho(II)). The simulation results show that the pedestrians with motion mode II are lack of evacuation efficiency and cause more casualties. Further, we use the SIS (susceptible-infective-susceptible) model to describe the spreading of the panic mood. The system can be in the high-mix state when the infection probability lambda is greater than a fuzzy threshold. In addition, the distances S from wounded people to the exit are researched, the number of wounded people gets maximum at the internal S = 5 similar to 10, which is independent of rho(II) and lambda. This research can help us to understand and prevent the emergence of collective panic and reduce wounds in the real evacuation.	[Zou, You; Xie, Jiarong; Wang, Binghong] Univ Sci & Technol China, Dept Modern Phys, Hefei 230026, Anhui, Peoples R China; [Wang, Binghong] Wenzhou Univ, Coll Phys & Elect Informat Engn, Wenzhou 325035, Zhejiang, Peoples R China; [Wang, Binghong] Southwest Univ Sci & Technol, Sch Sci, Mianyang 621010, Sichuan, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Wenzhou University; Southwest University of Science & Technology - China	Wang, BH (corresponding author), Univ Sci & Technol China, Dept Modern Phys, Hefei 230026, Anhui, Peoples R China.; Wang, BH (corresponding author), Wenzhou Univ, Coll Phys & Elect Informat Engn, Wenzhou 325035, Zhejiang, Peoples R China.; Wang, BH (corresponding author), Southwest Univ Sci & Technol, Sch Sci, Mianyang 621010, Sichuan, Peoples R China.	bhwang@ustc.edu.cn			National Natural Science Foundation of China [11275186, 91024026, FOM2014OF001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by The National Natural Science Foundation of China (Grant Nos. 11275186, 91024026, FOM2014OF001). The funders had an important role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Burstedde C, 2001, PHYSICA A, V295, P507, DOI 10.1016/S0378-4371(01)00141-8; DALEY DJ, 1964, NATURE, V204, P1118, DOI 10.1038/2041118a0; GRANOVETTER MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; Helbing D, 2000, NATURE, V407, P487, DOI 10.1038/35035023; Helbing D, 1996, PHYSICA A, V233, P253, DOI 10.1016/S0378-4371(96)00228-2; HELBING D, 1995, PHYS REV E, V51, P4282, DOI 10.1103/PhysRevE.51.4282; Helbing D, 2000, PHYS REV LETT, V84, P1240, DOI 10.1103/PhysRevLett.84.1240; Helbing D, 2001, REV MOD PHYS, V73, P1067, DOI 10.1103/RevModPhys.73.1067; Helbing D, 1996, PHYS REV E, V53, P2366, DOI 10.1103/PhysRevE.53.2366; HENDERSON LF, 1971, NATURE, V229, P381, DOI 10.1038/229381a0; Hoogendoorn S, 2003, OPTIM CONTR APPL MET, V24, P153, DOI 10.1002/oca.727; Huang HJ, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.021131; Lachapelle A, 2011, TRANSPORT RES B-METH, V45, P1572, DOI 10.1016/j.trb.2011.07.011; Ma PJ, 2013, PHYSICA A, V392, P215, DOI 10.1016/j.physa.2012.07.053; Miguel AF, 2009, PHYS LETT A, V373, P1734, DOI 10.1016/j.physleta.2009.03.020; Muramatsu H, 2000, PHYSICA A, V275, P281, DOI 10.1016/S0378-4371(99)00447-1; Muramatsu M, 1999, PHYSICA A, V267, P487, DOI 10.1016/S0378-4371(99)00018-7; Muramatsu M, 2000, PHYSICA A, V286, P377, DOI 10.1016/S0378-4371(00)00336-8; Nakayama A, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.016105; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; Santos FC, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.056128; Shi DM, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.022802; Tajima Y, 2001, PHYSICA A, V292, P545, DOI 10.1016/S0378-4371(00)00630-0; Tanimoto J, 2010, PHYSICA A, V389, P5611, DOI 10.1016/j.physa.2010.08.032; Yamamoto K, 2007, PHYSICA A, V379, P654, DOI 10.1016/j.physa.2007.02.040; Yu W, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.046105; Yu WJ, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.026112; Zheng XP, 2011, COMPUT MATH APPL, V62, P4627, DOI 10.1016/j.camwa.2011.10.048; Zheng XP, 2011, PHYSICA A, V390, P1042, DOI 10.1016/j.physa.2010.12.007	30	8	9	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153388	10.1371/journal.pone.0153388	http://dx.doi.org/10.1371/journal.pone.0153388			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27055024	Green Published, gold, Green Submitted			2022-12-27	WOS:000373608000127
J	Biedron, R; Perun, A; Jozefowski, S				Biedron, Rafal; Perun, Angelika; Jozefowski, Szczepan			CD36 Differently Regulates Macrophage Responses to Smooth and Rough Lipopolysaccharide	PLOS ONE			English	Article							PATTERN-RECOGNITION RECEPTOR; LOW-DENSITY-LIPOPROTEIN; SCAVENGER RECEPTOR; ESCHERICHIA-COLI; STAPHYLOCOCCUS-AUREUS; ANCHORED PROTEINS; SR-A; LPS; CD14; ENDOCYTOSIS	Lipopolysaccharide (LPS) is the major pathogen-associated molecular pattern of Gram-negative bacterial infections, and includes smooth (S-LPS) and rough (R-LPS) chemotypes. Upon activation by LPS through CD14, TLR4/MD-2 heterodimers sequentially induce two waves of intracellular signaling for macrophage activation: the MyD88-dependent pathway from the plasma membrane and, following internalization, the TRIF-dependent pathway from endosomes. We sought to better define the role of scavenger receptors CD36 and CD204/SR-A as accessory LPS receptors that can contribute to pro-inflammatory and microbicidal activation of macrophages. We have found that CD36 differently regulates activation of mouse macrophages by S-LPS versus R-LPS. The ability of CD36 to substitute for CD14 in loading R-LPS, but not S-LPS onto TLR4/MD-2 allows CD14-independent macrophage responses to R-LPS. Conversely, S-LPS, but not R-LPS effectively stimulates CD14 binding to CD36, which favors S-LPS transfer from CD14 onto TLR4/MD-2 under conditions of low CD14 occupancy with S-LPS in serum-free medium. In contrast, in the presence of serum, CD36 reduces S-LPS binding to TLR4/MD-2 and the subsequent MyD88-dependent signaling, by mediating internalization of S-LPS/CD14 complexes. Additionally, CD36 positively regulates activation of TRIF-dependent signaling by both S-LPS and R-LPS, by promoting TLR4/MD-2 endocytosis. In contrast, we have found that SR-A does not function as a S-LPS receptor. Thus, by co-operating with CD14 in both R-and S-LPS loading onto TLR4/MD-2, CD36 can enhance the sensitivity of tissue-resident macrophages in detecting infections by Gram-negative bacteria. However, in later phases, following influx of serum to the infection site, the CD36-mediated negative regulation of MyD88-dependent branch of S-LPS-induced TLR4 signaling might constitute a mechanism to prevent an excessive inflammatory response, while preserving the adjuvant effect of S-LPS for adaptive immunity.	[Biedron, Rafal; Perun, Angelika; Jozefowski, Szczepan] Jagiellonian Univ, Coll Med, Dept Immunol, Krakow, Poland	Jagiellonian University; Collegium Medicum Jagiellonian University	Jozefowski, S (corresponding author), Jagiellonian Univ, Coll Med, Dept Immunol, Krakow, Poland.	szczepan.jozefowski@uj.edu.pl	Biedron, Rafal/AAN-9034-2020		National Science Centre, Poland [2012/05/B/NZ6/00813]; Jagiellonian University Medical College [K/ZDS/004602]; Leading National Research Centre (KNOW)	National Science Centre, Poland(National Science Centre, Poland); Jagiellonian University Medical College; Leading National Research Centre (KNOW)	This study was supported by grants from the National Science Centre, Poland (grant no. 2012/05/B/NZ6/00813) and from the Jagiellonian University Medical College (grant no. K/ZDS/004602). The publication fee was covered by the Leading National Research Centre (KNOW) 2012-2017. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi S, 2003, J EXP MED, V198, P1035, DOI 10.1084/jem.20031076; Aksoy E, 2012, NAT IMMUNOL, V13, P1045, DOI 10.1038/ni.2426; ASHKENAS J, 1993, J LIPID RES, V34, P983; Baranova IN, 2008, J IMMUNOL, V181, P7147, DOI 10.4049/jimmunol.181.10.7147; Biedron R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123293; Bjorkbacka H, 2004, PHYSIOL GENOMICS, V19, P319, DOI 10.1152/physiolgenomics.00128.2004; Chadda R, 2007, TRAFFIC, V8, P702, DOI 10.1111/j.1600-0854.2007.00565.x; Chiang CY, 2012, J BIOL CHEM, V287, P3704, DOI 10.1074/jbc.C111.328559; Collins RF, 2009, J BIOL CHEM, V284, P30288, DOI 10.1074/jbc.M109.045104; Cotena A, 2004, J IMMUNOL, V173, P6427, DOI 10.4049/jimmunol.173.10.6427; Czerkies M, 2013, IMMUNOBIOLOGY, V218, P1217, DOI 10.1016/j.imbio.2013.04.005; Drummond R, 2013, INNATE IMMUN-LONDON, V19, P30, DOI 10.1177/1753425912449548; Durrbach A, 1996, J CELL SCI, V109, P457; Fujimoto LM, 2000, TRAFFIC, V1, P161, DOI 10.1034/j.1600-0854.2000.010208.x; Gandhapudi SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056855; Gangloff SC, 2005, J IMMUNOL, V175, P3940, DOI 10.4049/jimmunol.175.6.3940; Gauthier NC, 2007, J CELL BIOL, V177, P343, DOI 10.1083/jcb.200609061; GOLDMAN RC, 1982, J BACTERIOL, V151, P1210, DOI 10.1128/JB.151.3.1210-1221.1982; HAILMAN E, 1994, J EXP MED, V179, P269, DOI 10.1084/jem.179.1.269; HAMPTON RY, 1991, NATURE, V352, P342, DOI 10.1038/352342a0; Heit B, 2013, DEV CELL, V24, P372, DOI 10.1016/j.devcel.2013.01.007; Hoebe K, 2005, NATURE, V433, P523, DOI 10.1038/nature03253; Huber M, 2006, EUR J IMMUNOL, V36, P701, DOI 10.1002/eji.200535593; Husebye H, 2006, EMBO J, V25, P683, DOI 10.1038/sj.emboj.7600991; Husebye H, 2010, IMMUNITY, V33, P583, DOI 10.1016/j.immuni.2010.09.010; Jaqaman K, 2011, CELL, V146, P593, DOI 10.1016/j.cell.2011.06.049; Jiang ZF, 2005, NAT IMMUNOL, V6, P565, DOI 10.1038/ni1207; Jozefowski S, 2014, INNATE IMMUN-LONDON, V20, P826, DOI 10.1177/1753425913510960; Jozefowski S, 2011, ANAL BIOCHEM, V413, P185, DOI 10.1016/j.ab.2011.02.031; Jozefowski S, 2010, INFLAMM RES, V59, P277, DOI 10.1007/s00011-009-0096-5; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Kim JI, 2005, J BIOL CHEM, V280, P11347, DOI 10.1074/jbc.M414607200; Kunjathoor VV, 2002, J BIOL CHEM, V277, P49982, DOI 10.1074/jbc.M209649200; Layoun A, 2012, AM J PATHOL, V180, P2340, DOI 10.1016/j.ajpath.2012.01.046; Luk JM, 1995, ANAL BIOCHEM, V232, P217, DOI 10.1006/abio.1995.0010; Lukacova M, 2008, CLIN MICROBIOL INFEC, V14, P200, DOI 10.1111/j.1469-0691.2007.01876.x; Maldonado-Baez L, 2013, EXP CELL RES, V319, P2759, DOI 10.1016/j.yexcr.2013.08.008; Muller-Loennies S, 2003, J BIOL CHEM, V278, P34090, DOI 10.1074/jbc.M303985200; Ono K, 2006, J IMMUNOL, V177, P5517, DOI 10.4049/jimmunol.177.8.5517; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Patel SN, 2007, J IMMUNOL, V178, P3954, DOI 10.4049/jimmunol.178.6.3954; Peiser L, 2002, INFECT IMMUN, V70, P5346, DOI 10.1128/IAI.70.10.5346-5354.2002; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Poussin C, 1998, J BIOL CHEM, V273, P20285, DOI 10.1074/jbc.273.32.20285; PUGIN J, 1994, IMMUNITY, V1, P509, DOI 10.1016/1074-7613(94)90093-0; Pupo E, 2013, FEBS J, V280, P1095, DOI 10.1111/febs.12104; Refaei M, 2011, TRAFFIC, V12, P1012, DOI 10.1111/j.1600-0854.2011.01206.x; Sabharanjak S, 2002, DEV CELL, V2, P411, DOI 10.1016/S1534-5807(02)00145-4; SCHMIDT G, 1973, Journal of General Microbiology, V77, P151; Seimon TA, 2006, P NATL ACAD SCI USA, V103, P19794, DOI 10.1073/pnas.0609671104; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Stuart LM, 2005, J CELL BIOL, V170, P477, DOI 10.1083/jcb.200501113; Tanimura N, 2008, BIOCHEM BIOPH RES CO, V368, P94, DOI 10.1016/j.bbrc.2008.01.061; Vasselon T, 1999, J EXP MED, V190, P509, DOI 10.1084/jem.190.4.509; Watanabe S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060078; Xiang Q, 2009, J INT MED RES, V37, P491, DOI 10.1177/147323000903700225; Xu WY, 2007, MOL IMMUNOL, V44, P2315, DOI 10.1016/j.molimm.2006.11.013; Yu HH, 2012, BBA-MOL CELL RES, V1823, P1192, DOI 10.1016/j.bbamcr.2012.05.004; Zanoni I, 2011, CELL, V147, P868, DOI 10.1016/j.cell.2011.09.051; Zeng YC, 2003, J BIOL CHEM, V278, P45931, DOI 10.1074/jbc.M307722200	61	10	11	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153558	10.1371/journal.pone.0153558	http://dx.doi.org/10.1371/journal.pone.0153558			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073833	Green Published, gold			2022-12-27	WOS:000374131200106
J	Larsen, ME; Nicholas, J; Christensen, H				Larsen, Mark Erik; Nicholas, Jennifer; Christensen, Helen			A Systematic Assessment of Smartphone Tools for Suicide Prevention	PLOS ONE			English	Article							DEPRESSION; INTERNET; SCALE; RISK	Background Suicide is a leading cause of death globally, and there has been a rapid growth in the use of new technologies such as mobile health applications (apps) to help identify and support those at risk. However, it is not known whether these apps are evidence-based, or indeed contain potentially harmful content. This review examines the concordance of features in publicly available apps with current scientific evidence of effective suicide prevention strategies. Methods Apps referring to suicide or deliberate self-harm (DSH) were identified on the Android and iOS app stores. Systematic review methodology was employed to screen and review app content. App features were labelled using a coding scheme that reflected the broad range of evidence-based medical and population-based suicide prevention interventions. Best-practice for suicide prevention was based upon a World Health Organization report and supplemented by other reviews of the literature. Results One hundred and twenty-three apps referring to suicide were identified and downloaded for full review, 49 of which were found to contain at least one interactive suicide prevention feature. Most apps focused on obtaining support from friends and family (n = 27) and safety planning (n = 14). Of the different suicide prevention strategies contained within the apps, the strongest evidence in the literature was found for facilitating access to crisis support (n = 13). All reviewed apps contained at least one strategy that was broadly consistent with the evidence base or best-practice guidelines. Apps tended to focus on a single suicide prevention strategy (mean = 1.1), although safety plan apps provided the opportunity to provide a greater number of techniques (mean = 3.9). Potentially harmful content, such as listing lethal access to means or encouraging risky behaviour in a crisis, was also identified. Discussion Many suicide prevention apps are available, some of which provide elements of best practice, but none that provide comprehensive evidence-based support. Apps with potentially harmful content were also identified. Despite the number of apps available, and their varied purposes, there is a clear need to develop useful, pragmatic, and multifaceted mobile resources for this population. Clinicians should be wary in recommending apps, especially as potentially harmful content can be presented as helpful. Currently safety plan apps are the most comprehensive and evidence-informed, for example, "Safety Net" and "Mood-Tools-Depression Aid".	[Larsen, Mark Erik; Nicholas, Jennifer; Christensen, Helen] Univ New S Wales, Black Dog Inst, Sydney, NSW, Australia; [Nicholas, Jennifer] Univ New S Wales, Sch Psychiat, Fac Med, Sydney, NSW, Australia	Black Dog Institute; University of New South Wales Sydney; University of New South Wales Sydney	Larsen, ME (corresponding author), Univ New S Wales, Black Dog Inst, Sydney, NSW, Australia.	mark.larsen@blackdog.org.au	Christensen, Helen/F-5053-2012; Nicholas, Jennifer/I-1538-2019	Christensen, Helen/0000-0003-0435-2065; Nicholas, Jennifer/0000-0003-1889-1107	National Health and Medical Research Council Centre for Research Excellence in Suicide Prevention [1042580]; National Health and Medical Research Council [1056964]	National Health and Medical Research Council Centre for Research Excellence in Suicide Prevention; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This review was supported by the National Health and Medical Research Council Centre for Research Excellence in Suicide Prevention 1042580, and National Health and Medical Research Council John Cade Fellowship 1056964. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre RTP, 2013, J TECHNOL HUMAN SERV, V31, P269, DOI 10.1080/15228835.2013.814750; Apple, IOS APPR GUID; Biddle L, 2008, BRIT MED J, V336, P800, DOI 10.1136/bmj.39525.442674.AD; Bush NE, 2015, SUICIDE LIFE-THREAT, V45, P1, DOI 10.1111/sltb.12103; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; Czyz EK, 2013, J AM COLL HEALTH, V61, P398, DOI 10.1080/07448481.2013.820731; De Jaegere E, 2014, ETHICAL GUIDELINES T; Donker T, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2791; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Huckvale K, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-144; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Larsen JLS, 2016, CRISIS, V37, P236, DOI 10.1027/0227-5910/a000371; Leitner M., 2008, EFFECTIVENESS INTERV; Luxton DD, 2011, TELEMED E-HEALTH, V17, P50, DOI 10.1089/tmj.2010.0091; Mann JJ, 2005, JAMA-J AM MED ASSOC, V294, P2064, DOI 10.1001/jama.294.16.2064; Mrazek P., 1994, REDUCING RISKS MENTA; Nicholas J, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.4581; Pew Research Centre, 2015, SMARTPH DIFF 2015; Scott A., 2012, WHICH STRATEGIES SUI; Shand FL, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-396; Shekelle P., 2009, STRATEGIES SUICIDE P; Shen N, 2015, JMIR MHEALTH UHEALTH, V3, DOI 10.2196/mhealth.3713; Suicide Prevention Resource Center, ADHERENCE TO STANDAR; Tam J, 2007, EUR J INTERN MED, V18, P453, DOI 10.1016/j.ejim.2007.04.009; Torous J, 2014, JMIR MHEALTH UHEALTH, V2, DOI 10.2196/mhealth.2994; Westerlund M, 2012, J MED INTERNET RES, V14, DOI 10.2196/jmir.1979; World Health Organization, 2000, DIS INJ REG MORT EST	27	139	141	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0152285	10.1371/journal.pone.0152285	http://dx.doi.org/10.1371/journal.pone.0152285			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073900	gold, Green Published			2022-12-27	WOS:000374131200019
J	Waniewski, J; Debowska, M; Wojcik-Zaluska, A; Ksiazek, A; Zaluska, W				Waniewski, Jacek; Debowska, Malgorzata; Wojcik-Zaluska, Alicja; Ksiazek, Andrzej; Zaluska, Wojciech			Quantification of Dialytic Removal and Extracellular Calcium Mass Balance during a Weekly Cycle of Hemodialysis	PLOS ONE			English	Article							DIALYSIS ADEQUACY INDEXES; CHRONIC KIDNEY-DISEASE; PERITONEAL-DIALYSIS; PARATHYROID-HORMONE; MATHEMATICAL-MODEL; KINETIC-MODEL; SERUM-CALCIUM; HOMEOSTASIS; PHOSPHATE; OUTCOMES	Objectives The removal of calcium during hemodialysis with low calcium concentration in dialysis fluid is generally slow, and the net absorption of calcium from dialysis fluid is often reported. The details of the calcium transport process during dialysis and calcium mass balance in the extracellular fluid, however, have not been fully studied. Methods Weekly cycle of three dialysis sessions with interdialytic breaks of 2-2-3 days was monitored in 25 stable patients on maintenance hemodialysis with calcium concentration in dialysis fluid of 1.35 mmol/L. Total and ionic calcium were frequently measured in blood and dialysate. The volume of fluid compartments was measured by bioimpedance. Results Weekly dialytic removal of 12.79 +/- 8.71 mmol calcium was found in 17 patients, whereas 9.48 +/- 8.07 mmol calcium was absorbed per week from dialysis fluid in 8 patients. Ionic calcium was generally absorbed from dialysis fluid, whereas complexed calcium (the difference of total and ionic calcium in dialysis fluid) was removed from the body. The concentration of total calcium in plasma increased slightly during dialysis. The mass of total and ionic calcium in extracellular fluid decreased during dialysis in patients with the dialytic removal of calcium from the body and did not change in patients with the absorption of calcium from dialysis fluid. Conclusions We conclude that about one third of patients on dialysis with calcium 1.35 mmol/L in dialysis fluid may absorb calcium from dialysis fluid and therefore individual prescriptions of calcium concentration in dialysis fluid should be considered for such patients.	[Waniewski, Jacek; Debowska, Malgorzata] Polish Acad Sci, Inst Biocybernet & Biomed Engn, Dept Math Modelling Physiol Proc, Warsaw, Poland; [Wojcik-Zaluska, Alicja] Med Univ Lublin, Dept Phys Therapy & Rehabil, Lublin, Poland; [Ksiazek, Andrzej; Zaluska, Wojciech] Med Univ Lublin, Dept Nephrol, Lublin, Poland	Polish Academy of Sciences; Nalecz Institute of Biocybernetics & Biomedical Engineering of the Polish Academy of Sciences; Medical University of Lublin; Medical University of Lublin	Debowska, M (corresponding author), Polish Acad Sci, Inst Biocybernet & Biomed Engn, Dept Math Modelling Physiol Proc, Warsaw, Poland.	mdebowska@ibib.waw.pl	Debowska, Malgorzata/F-3035-2015	Debowska, Malgorzata/0000-0001-8741-7930	National Science Centre (Poland) [N N518 289840]	National Science Centre (Poland)	This study was supported by the National Science Centre (Poland), grant no N N518 289840. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agar BU, 2011, CLIN J AM SOC NEPHRO, V6, P2854, DOI 10.2215/CJN.03860411; Basile C, 2011, INT J NEPHROL, V2011, DOI 10.4061/2011/540592; Basile C, 2012, AM J KIDNEY DIS, V59, P92, DOI 10.1053/j.ajkd.2011.08.033; Basile C, 2010, NEPHROL DIAL TRANSPL, V25, P1356, DOI 10.1093/ndt/gfp700; Casino FG, 1996, NEPHROL DIAL TRANSPL, V11, P1574; Casino FG, 2004, NEPHROL DIAL TRANSPL, V19, P1454, DOI 10.1093/ndt/gfh218; Debowska M., 2011, PROGR HEMODIALYSIS F, P3; Debowska M, 2007, ASAIO J, V53, P566, DOI 10.1097/MAT.0b013e31810c06d2; Debowska M, 2007, ARTIF ORGANS, V31, P61, DOI 10.1111/j.1525-1594.2007.00341.x; Debowska M, 2015, ARTIF ORGANS, V39, P1005, DOI 10.1111/aor.12489; Debowska M, 2015, NEPHROL DIAL TRANSPL, V30, P129, DOI 10.1093/ndt/gfu266; Debowska M, 2010, ARTIF ORGANS, V34, P412, DOI 10.1111/j.1525-1594.2009.00873.x; Drueke TB, 2009, NEPHROL DIAL TRANSPL, V24, P2990, DOI 10.1093/ndt/gfp365; Goldsmith DJA, 2010, NEPHROL DIAL TRANSPL, V25, P3823, DOI 10.1093/ndt/gfq513; Gonzalez-Parra E, 2014, BLOOD PURIFICAT, V38, P224, DOI 10.1159/000366126; Gotch F, 2007, BLOOD PURIFICAT, V25, P139, DOI 10.1159/000096891; Gotch F, 2010, BLOOD PURIFICAT, V29, P163, DOI 10.1159/000245924; Gotch FA, 2010, KIDNEY INT, V78, P343, DOI 10.1038/ki.2010.157; Gotch FA, 2009, NEPHROL DIAL TRANSPL, V24, P2994, DOI 10.1093/ndt/gfp360; Guyton A.C., 2006, TXB MED PHYSL; Jean G, 2013, NEPHROL DIAL TRANSPL, V28, P176, DOI 10.1093/ndt/gfs119; Karohl C, 2010, NEPHROL DIAL TRANSPL, V25, P1244, DOI 10.1093/ndt/gfp597; Leypoldt JK, 2003, NEPHROL DIAL TRANSPL, V18, P769, DOI 10.1093/ndt/gfg019; Malberti F, 2003, NEPHROL DIAL TRANSPL, V18, P37, DOI 10.1093/ndt/gfg1077; Messa P, 2009, BLOOD PURIFICAT, V27, P360, DOI 10.1159/000209249; Nikolov IG, 2009, BLOOD PURIFICAT, V27, P350, DOI 10.1159/000209248; NORDIN BEC, 1990, CLIN BIOCHEM, V23, P3, DOI 10.1016/0009-9120(90)90309-I; Peterson MC, 2010, BONE, V46, P49, DOI 10.1016/j.bone.2009.08.053; Pun PH, 2016, HEMODIAL INT, V20, P421, DOI 10.1111/hdi.12382; Raposo JF, 2002, J CLIN ENDOCR METAB, V87, P4330, DOI 10.1210/jc.2002-011870; Ross Morton A, 1997, NUTR MANAGMENT RENAL, P341; Tentori F, 2008, AM J KIDNEY DIS, V52, P519, DOI 10.1053/j.ajkd.2008.03.020; Toussaint Nigel, 2006, Hemodial Int, V10, P326, DOI 10.1111/j.1542-4758.2006.00125.x; WANIEWSKI J, 1992, NEPHROL DIAL TRANSPL, V7, P50; Waniewski J, 2006, BLOOD PURIFICAT, V24, P355, DOI 10.1159/000093199; Waniewski J, 2014, ASAIO J, V60, P90, DOI 10.1097/MAT.0000000000000017; Waniewski J, 2010, BLOOD PURIFICAT, V30, P257, DOI 10.1159/000320764	37	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153285	10.1371/journal.pone.0153285	http://dx.doi.org/10.1371/journal.pone.0153285			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073861	Green Published, gold, Green Submitted			2022-12-27	WOS:000374131200071
J	Maifeld, SV; Ro, B; Mok, H; Chu, M; Yu, L; Yamagata, R; Leonardson, T; Chio, V; Parhy, B; Park, S; Carlson, M; Machhi, S; Ulbrandt, N; Falsey, AR; Walsh, EE; Wang, CK; Esser, MT; Zuo, FR				Maifeld, Sarah V.; Ro, Bodrey; Mok, Hoyin; Chu, Marla; Yu, Li; Yamagata, Ryan; Leonardson, Tansy; Chio, Vera; Parhy, Bandita; Park, Samuel; Carlson, Marcia; Machhi, Shushil; Ulbrandt, Nancy; Falsey, Ann R.; Walsh, Edward E.; Wang, C. Kathy; Esser, Mark T.; Zuo, Fengrong			Development of Electrochemiluminescent Serology Assays to Measure the Humoral Response to Antigens of Respiratory Syncytial Virus	PLOS ONE			English	Article							SERUM ANTIBODY-RESPONSES; SUBGROUP-B; G-PROTEIN; SEQUENCE CONSERVATION; N-PROTEINS; F-PROTEIN; INFECTION; RSV; VACCINE; ATTACHMENT	Sensitive and precise serology assays are needed to measure the humoral response to antigens of respiratory syncytial virus (RSV) following natural infection or vaccination. We developed and evaluated a collection of electrochemiluminescent (ECL) serology assays using four RSV antigens (F, N, Ga and Gb). To assess the merits of ECL technology, the four ECL serology assays were evaluated using a well-characterized "gold standard" panel of acute and convalescent serum samples from fifty-nine RSV-positive and thirty RSV-negative elderly subjects (>= 65 years old). The combined results from the four ECL assays demonstrated good concordance to the "gold standard" diagnosis, reaching 95% diagnostic sensitivity and 100% diagnostic specificity. Additionally, a combination of ECL assays provided higher diagnostic sensitivity than a commercially available diagnostic ELISA or cell-based microneutralization assay. In summary, these data demonstrate the advantages of using ECL-based serology assays and highlight their use as a sensitive diagnostic approach to detect recent RSV infection in an elderly population.	[Maifeld, Sarah V.; Ro, Bodrey; Mok, Hoyin; Chu, Marla; Parhy, Bandita; Wang, C. Kathy; Zuo, Fengrong] MedImmune, Appl Immunol & Microbiol, Mountain View, CA USA; [Yu, Li; Yamagata, Ryan] Medimmune Inc, Nonclin Biostat, Gaithersburg, MD 20878 USA; [Leonardson, Tansy; Chio, Vera; Park, Samuel] MedImmune, Vaccine & Analyt Sci, Mountain View, CA USA; [Carlson, Marcia] Medimmune Inc, Purificat Proc Sci, Gaithersburg, MD 20878 USA; [Machhi, Shushil] Medimmune Inc, Cell Culture & Fermentat Sci, Gaithersburg, MD 20878 USA; [Ulbrandt, Nancy] Dept Infect Dis & Vaccines, Gaithersburg, MD USA; [Falsey, Ann R.; Walsh, Edward E.] Univ Rochester, Sch Med, Dept Med, Rochester, NY USA; [Falsey, Ann R.; Walsh, Edward E.] Rochester Gen Hosp, Dept Med, Rochester, NY 14621 USA; [Esser, Mark T.] Medimmune Inc, Translat Med, Gaithersburg, MD 20878 USA; Genentech Inc, Bioanalyt Business & Operat, San Francisco, CA 94080 USA; [Parhy, Bandita] Gilead Sci Inc, Clin Viroloy, 353 Lakeside Dr, Foster City, CA 94404 USA; [Park, Samuel] Genentech Inc, Global Biol QC Adventitious Agents & Crit Reagent, San Francisco, CA 94080 USA; [Zuo, Fengrong] Medivation, Pharmaceut Operat, San Francisco, CA USA	AstraZeneca; Medimmune; AstraZeneca; Medimmune; AstraZeneca; Medimmune; AstraZeneca; Medimmune; AstraZeneca; Medimmune; University of Rochester; Rochester General Hospital; AstraZeneca; Medimmune; Roche Holding; Genentech; Gilead Sciences; Roche Holding; Genentech	Maifeld, SV (corresponding author), MedImmune, Appl Immunol & Microbiol, Mountain View, CA USA.	maifelds@medimmune.com			National Institutes of Health [R01-AI-45969]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045969] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	ARF and EEW received a funding grant (R01-AI-45969) from the National Institutes of Health (http://www.nih.gov/) for the surveillance study. The National Institutes of Health had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. SVM, BR, HM, M. Chu, LY, RY, TL, VC, BP, SP, M. Carlson, SM, NU, CKW, MTE and FZ are current or past employees of MedImmune. Because of these authors' status as current or past employees of the study sponsor, the sponsor participated in study design, data collection and analysis, decision to publish, and preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Anderson LJ, 2013, VACCINE, V31, pB209, DOI 10.1016/j.vaccine.2012.11.106; Anderson LJ, 2013, SEMIN IMMUNOL, V25, P160, DOI 10.1016/j.smim.2013.04.011; ANDERSON LJ, 1985, J INFECT DIS, V151, P626, DOI 10.1093/infdis/151.4.626; Brandenburg AH, 1997, J MED VIROL, V52, P97, DOI 10.1002/(SICI)1096-9071(199705)52:1&lt;97::AID-JMV16&gt;3.0.CO;2-Y; Buraphacheep W, 1997, J CLIN MICROBIOL, V35, P354, DOI 10.1128/JCM.35.2.354-357.1997; Burton DR, 2002, NAT REV IMMUNOL, V2, P706, DOI 10.1038/nri891; Cane PA, 1996, J MED VIROL, V48, P253, DOI 10.1002/(SICI)1096-9071(199603)48:3<253::AID-JMV7>3.0.CO;2-7; Chu HY, 2014, J INFECT DIS, V210, P1582, DOI 10.1093/infdis/jiu316; CONNORS M, 1991, J VIROL, V65, P1634, DOI 10.1128/JVI.65.3.1634-1637.1991; DEAVER DR, 1995, NATURE, V377, P758, DOI 10.1038/377758a0; Englund JA, 1996, J CLIN MICROBIOL, V34, P1649, DOI 10.1128/JCM.34.7.1649-1653.1996; Falsey AR, 2008, J INFECT DIS, V198, P1317, DOI 10.1086/592168; Falsey AR, 2014, J INFECT DIS, V209, P1873, DOI 10.1093/infdis/jit839; Falsey AR, 1998, J INFECT DIS, V177, P463, DOI 10.1086/517376; Falsey AR, 2005, NEW ENGL J MED, V352, P1749, DOI 10.1056/NEJMoa043951; Falsey AR, 2002, J CLIN MICROBIOL, V40, P817, DOI 10.1128/JCM.40.3.817-820.2002; Glenn GM, 2013, VACCINE, V31, P524, DOI 10.1016/j.vaccine.2012.11.009; Guvenel AK, 2014, EXPERT REV VACCINES, V13, P333, DOI 10.1586/14760584.2014.878653; Hall CB, 2001, CLIN INFECT DIS, V33, P792, DOI 10.1086/322657; Hangartner L, 2006, NAT REV IMMUNOL, V6, P231, DOI 10.1038/nri1783; HENDERSON FW, 1979, NEW ENGL J MED, V300, P530, DOI 10.1056/NEJM197903083001004; HENDRY RM, 1988, J INFECT DIS, V157, P640, DOI 10.1093/infdis/157.4.640; Jiang J, 2007, SPRINGER SER STAT, P1, DOI 10.1007/978-0-387-47946-0; JOHNSON PR, 1988, J GEN VIROL, V69, P2623, DOI 10.1099/0022-1317-69-10-2623; JOHNSON PR, 1987, P NATL ACAD SCI USA, V84, P5625, DOI 10.1073/pnas.84.16.5625; JOHNSON PR, 1989, J GEN VIROL, V70, P1539, DOI 10.1099/0022-1317-70-6-1539; Kumari S, 2014, CLIN VACCINE IMMUNOL, V21, P383, DOI 10.1128/CVI.00594-13; Kurzweil V, 2013, EXPERT REV VACCINES, V12, P1047, DOI 10.1586/14760584.2013.824706; Langedijk JPM, 1997, J CLIN MICROBIOL, V35, P1656, DOI 10.1128/JCM.35.7.1656-1660.1997; Malkin E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077104; Melero JA, 1997, J GEN VIROL, V78, P2411, DOI 10.1099/0022-1317-78-10-2411; MUELENAER PM, 1991, J INFECT DIS, V164, P15, DOI 10.1093/infdis/164.1.15; MUFSON MA, 1985, J GEN VIROL, V66, P2111, DOI 10.1099/0022-1317-66-10-2111; Murata Y, 2010, VACCINE, V28, P6242, DOI 10.1016/j.vaccine.2010.07.011; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Null D, 1998, PEDIATRICS, V102, P531, DOI 10.1542/peds.102.3.531; Ochola R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008088; RICHARDSON LS, 1978, INFECT IMMUN, V20, P660, DOI 10.1128/IAI.20.3.660-664.1978; Rudraraju R, 2013, VIRUSES-BASEL, V5, P577, DOI 10.3390/v5020577; Saah AJ, 1997, ANN INTERN MED, V126, P91, DOI 10.7326/0003-4819-126-1-199701010-00026; Sastre P, 2010, J VIROL METHODS, V168, P170, DOI 10.1016/j.jviromet.2010.05.011; Sebaugh JL, 2003, PHARM STAT, V2, P167, DOI 10.1002/pst.62; Sullender WM, 2000, CLIN MICROBIOL REV, V13, P1, DOI 10.1128/CMR.13.1.1-15.2000; Tang RS, 2004, J VIROL, V78, P11198, DOI 10.1128/JVI.78.20.11198-11207.2004; Walsh EE, 2013, J INFECT DIS, V207, P1424, DOI 10.1093/infdis/jit038; Walsh EE, 2004, J INFECT DIS, V190, P373, DOI 10.1086/421524; Wu H, 2007, J MOL BIOL, V368, P652, DOI 10.1016/j.jmb.2007.02.024	47	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0153019	10.1371/journal.pone.0153019	http://dx.doi.org/10.1371/journal.pone.0153019			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27070145	Green Published, Green Submitted, gold			2022-12-27	WOS:000373900700027
J	Yaya, I; Landoh, DE; Saka, B; Vignikin, K; Aboubakari, AS; N'dri, KM; Gbetoglo, KD; Edorh, AM; Ahlegnan, K; Yenkey, HC; Toudeka, AS; Pitche, P				Yaya, Issifou; Landoh, Dadja Essoya; Saka, Bayaki; Vignikin, Kokou; Aboubakari, Abdoul-Samadou; N'dri, Kouame Mathias; Gbetoglo, Kodjo Dodji; Edorh, Atavi-Mensah; Ahlegnan, Komla; Yenkey, Holali Comlan; Toudeka, Ayawavi Sitsope; Pitche, Palokinam			Consistent Condom Use during Casual Sex among Long-Truck Drivers in Togo	PLOS ONE			English	Article							HIV-INFECTION; TRANSMISSION; PREVENTION; BEHAVIOR; WORKERS	Background In 2008, the proportion of truck drivers who were not systematically protected during sex was 63% with casual partners and 60% with sex workers. Despite the high level of knowledge on HIV/AIDS and the growing awareness of the existence of the risk of HIV infection, condom use always encounters resistance among truck drivers in Togo. We sought to document the factors associated with condom use during casual sex among trucks' drivers in Togo. Methods This was an analytical cross-sectional study conducted in 2010 and targeted truckers at truck station on the two main roads of Togo, Lome-Cinkasse and Kodjoviakope-Sanvee Condji. Results In this study, 1,782 trucks' drivers and their helpers were interviewed. All were men, and their mean age was 28.8 +/- 8.8 years. Trucks' drivers were doing an average of 3 stops on their journeys and 1,229 (69%) of them had at least two years of experience in the work. Of the 1,782 trucks' drivers, only 620 (34.8%) had consistently used condoms during casual sex in the last three months. In multivariate analysis, predictors were: education level (primary schooling: OR = 1.54; p = 0.002; Secondary schooling and higher OR = 1.38; p = 0.036), good knowledge of ways of HIV transmission (OR = 1.53; p = 0.000), tested for HIV (OR = 1.67, p = 0.000), duration in the profession (2-5 years: OR = 1.43, p = 0.008; more than 5 years: OR = 1.38, p = 0.027), and HIV risk's perception (OR = 1.44, p = 0.000). Conclusion These results highlight factors associated with consistent condom use during casual sex by truck drivers in Togo. This is a key population group at high risk of HIV transmission toward which the national HIV/AIDS control program should strengthen the HIV prevention strategies.	[Yaya, Issifou; N'dri, Kouame Mathias] Aix Marseille Univ, Fac Med, Lab Sante Publ, EA 3279, Campus Timone, Marseille, France; [Yaya, Issifou; Vignikin, Kokou; Gbetoglo, Kodjo Dodji; Edorh, Atavi-Mensah; Ahlegnan, Komla; Yenkey, Holali Comlan; Toudeka, Ayawavi Sitsope] Univ Lome, URD, Lome, Togo; [Landoh, Dadja Essoya] Minist Sante Togo, Div Epidemiol, Lome, Togo; [Saka, Bayaki; Pitche, Palokinam] Univ Lome, CHU Sylvanus Olympio, Serv Dermatol & IST, Lome, Togo; [Aboubakari, Abdoul-Samadou] Ctr Hosp Univ Kara, Serv Gynecoobstet, Kara, Togo; [Pitche, Palokinam] Conseil Natl Lutte IST VIH Sida, Lome, Togo	UDICE-French Research Universities; Aix-Marseille Universite	Saka, B (corresponding author), Univ Lome, CHU Sylvanus Olympio, Serv Dermatol & IST, Lome, Togo.	barthelemysaka@yahoo.fr	YAYA, Issifou/J-3662-2017	YAYA, Issifou/0000-0002-2554-6515; N'DRI, KOUAME MATHIAS/0000-0001-8620-0457				Arulogun OS, 2011, J BASIC APPL SCI RES, V1, P1380; Atilola Glory O, 2010, J Infect Public Health, V3, P166, DOI 10.1016/j.jiph.2010.08.002; Coalition Interagence sida et developpement, 2004, MIGR INT VIH SID; Dude A, 2009, J GLOB INFECT DIS, V1, P21, DOI 10.4103/0974-777X.52977; Ekanem E E, 2005, Afr J Reprod Health, V9, P78; Febon A., 2006, ETUDE IMPACT COMPAGN; Gibney L, 2003, SOC SCI MED, V56, P1411, DOI 10.1016/S0277-9536(02)00138-7; Kiderlen TR, 2015, J INFECT PUBLIC HEAL, V8, P346, DOI 10.1016/j.jiph.2015.02.001; Lau J T F, 2012, Hong Kong Med J, V18 Suppl 3, P39; Laukamm-Josten U, 2000, AIDS CARE, V12, P27, DOI 10.1080/09540120047440; Matovu JKB, 2012, INT J STD AIDS, V23, P267, DOI 10.1258/ijsa.2011.011313; Morris CN, 2006, SEX TRANSM INFECT, V82, P368, DOI 10.1136/sti.2006.020933; Ntozi James P M, 2003, Afr Health Sci, V3, P107; Ramjee G, 2002, SEX TRANSM DIS, V29, P44, DOI 10.1097/00007435-200201000-00008; Sawal N, 2016, QJM-INT J MED, V109, P467, DOI 10.1093/qjmed/hcv205; Unite de Recherche Demogaphique (URD), 2008, AN COMP CONN ATT PRA	16	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0153264	10.1371/journal.pone.0153264	http://dx.doi.org/10.1371/journal.pone.0153264			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27071059	Green Published, gold			2022-12-27	WOS:000373900700042
J	Xiu, FM; Anipindi, VC; Nguyen, PV; Boudreau, J; Liang, H; Wan, YH; Snider, DP; Kaushic, C				Xiu, Fangming; Anipindi, Varun C.; Nguyen, Philip V.; Boudreau, Jeanette; Liang, Hong; Wan, Yonghong; Snider, Denis P.; Kaushic, Charu			High Physiological Concentrations of Progesterone Reverse Estradiol-Mediated Changes in Differentiation and Functions of Bone Marrow Derived Dendritic Cells	PLOS ONE			English	Article							AUTOIMMUNE-DISEASE; HUMAN-PREGNANCY; SEX-DIFFERENCES; GM-CSF; RECEPTOR; MOUSE; IMMUNITY; HORMONES; ESTRIOL; MACROPHAGES	Female sex steroids, estradiol (E2) and progesterone (P4), play a key role in regulating immune responses in women, including dendritic cell (DC) development, and functions. Although the two hormones co-occur in the body of women throughout the reproductive years, no studies have explored their complex combinatorial effects on DCs, given their ability to regulate each other's actions. We examined murine bone marrow derived dendritic cells (BMDC) differentiation and functions, in the presence of a wide range of physiological concentrations of each hormone, as well as the combination of the two hormones. E2 (10(-12) to 10(-8)M) enhanced the differentiation of CD11b(+)CD11c(+)DCs from BM precursor cells, and promoted the expression of CD40 and MHC Class-II, in a dose-dependent manner. In contrast, P4 (10(-9) to 10(-5)M) inhibited DC differentiation, but only at the highest concentrations. These effects on BMDCs were observed both in the presence or absence of LPS. When both hormones were combined, higher concentrations of P4, at levels seen in pregnancy (10(-6)M) reversed the E2 effects, regardless of the concentration of E2, especially in the absence of LPS. Functionally, antigen uptake was decreased and pro-inflammatory cytokines, IL-12, IL-1 and IL-6 production by CD11b(+)CD11c(+)DCs, was increased in the presence of E2 and these effects were reversed by high concentrations of P4. Our results demonstrate the distinct effects of E2 and P4 on differentiation and functions of bone marrow myeloid DCs. The dominating effect of higher physiological concentrations of P4 provides insight into how DC functions could be modulated during pregnancy.	[Xiu, Fangming; Anipindi, Varun C.; Nguyen, Philip V.; Boudreau, Jeanette; Liang, Hong; Wan, Yonghong; Snider, Denis P.; Kaushic, Charu] McMaster Univ, McMaster Immunol Res Ctr, Dept Pathol & Mol Med, Michael G DeGroote Ctr Learning & Discovery, Hamilton, ON L8N 3Z5, Canada	McMaster University	Kaushic, C (corresponding author), McMaster Univ, McMaster Immunol Res Ctr, Dept Pathol & Mol Med, Michael G DeGroote Ctr Learning & Discovery, Hamilton, ON L8N 3Z5, Canada.	kaushic@mcmaster.ca		Kaushic, Charu/0000-0002-7088-2569; Boudreau, Jeanette/0000-0003-0203-2180	Canadian Institutes of Health Research; Ontario HIV Treatment Network	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario HIV Treatment Network	The work was supported by the following: Canadian Institutes of Health Research, http://www.cihr-irsc.gc.ca/e/193. html; and Ontario HIV Treatment Network, http://www.ohtn.on.ca/. Grants were awarded to CK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Blois SM, 2004, BIOL REPROD, V70, P1018, DOI 10.1095/biolreprod.103.022640; Boudreau Jeanette, 2008, J Vis Exp, DOI 10.3791/769; Butts CL, 2010, MUCOSAL IMMUNOL, V3, P496, DOI 10.1038/mi.2010.28; Butts CL, 2007, INT IMMUNOL, V19, P287, DOI 10.1093/intimm/dxl145; Carreras E, 2008, J IMMUNOL, V180, P727, DOI 10.4049/jimmunol.180.2.727; Escribese MM, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-118; Feinshtein V, 2010, ARCH GYNECOL OBSTET, V281, P387, DOI 10.1007/s00404-009-1125-x; Gillgrass AE, 2005, J VIROL, V79, P3117, DOI 10.1128/JVI.79.5.3117-3126.2005; Gillgrass AE, 2005, J VIROL, V79, P3107, DOI 10.1128/JVI.79.5.3107-3116.2005; Helft J, 2015, IMMUNITY, V42, P1197, DOI 10.1016/j.immuni.2015.05.018; Hughes GC, 2007, AUTOIMMUNITY, V40, P470, DOI 10.1080/08916930701464764; Hughes GC, 2012, AUTOIMMUN REV, V11, pA502, DOI 10.1016/j.autrev.2011.12.003; Iwasaki A, 2007, ANNU REV IMMUNOL, V25, P381, DOI 10.1146/annurev.immunol.25.022106.141634; KATZENELLENBOGEN BS, 1984, J STEROID BIOCHEM, V20, P1033, DOI 10.1016/0022-4731(84)90015-3; KAUSHIC C, 1995, ENDOCRINOLOGY, V136, P2836, DOI 10.1210/en.136.7.2836; Kaushic C, 2011, J REPROD IMMUNOL; Keenihan SNH, 2004, BIOL REPROD, V70, P1562, DOI 10.1095/biolreprod.103.024794; Kovats S, 2012, HORM BEHAV, V62, P254, DOI 10.1016/j.yhbeh.2012.04.011; Lanzavecchia A, 2001, CURR OPIN IMMUNOL, V13, P291, DOI 10.1016/S0952-7915(00)00218-1; Liang J, 2006, INT IMMUNOPHARMACOL, V6, P830, DOI 10.1016/j.intimp.2005.12.002; LORIAUX DL, 1972, J CLIN ENDOCR METAB, V35, P887, DOI 10.1210/jcem-35-6-887; Lutz MB, 1996, EUR J IMMUNOL, V26, P586, DOI 10.1002/eji.1830260313; Masiano S, 2001, ENDOCRINOLOGY PARTUR, P86; MAUVAISJARVIS P, 1986, ANN NY ACAD SCI, V464, P152, DOI 10.1111/j.1749-6632.1986.tb16002.x; Meier A, 2009, NAT MED, V15, P955, DOI 10.1038/nm.2004; Miner JN, 2003, MOL ENDOCRINOL, V17, P117, DOI 10.1210/me.2002-0010; Nguyen P, 2014, CELLULAR MO IN PRESS; Paharkova-Vatchkova V, 2004, J IMMUNOL, V172, P1426, DOI 10.4049/jimmunol.172.3.1426; SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389; Segerer SE, 2009, AM J REPROD IMMUNOL, V62, P165, DOI 10.1111/j.1600-0897.2009.00726.x; TULCHINSKY D, 1972, AM J OBSTET GYNECOL, V112, P1095, DOI 10.1016/0002-9378(72)90185-8; Turley SJ, 2010, NAT REV IMMUNOL, V10, P813, DOI 10.1038/nri2886; VIRGO BB, 1974, ENDOCRINOLOGY, V95, P1486, DOI 10.1210/endo-95-5-1486; WEISS G, 1975, OBSTET GYNECOL, V46, P557; Whitacre CC, 2001, NAT IMMUNOL, V2, P777, DOI 10.1038/ni0901-777; WIRA CR, 1977, NATURE, V268, P534, DOI 10.1038/268534a0; Wood GA, 2007, REPRODUCTION, V133, P1035, DOI 10.1530/REP-06-0302; Xu YP, 2011, J REPROD IMMUNOL, V91, P17, DOI 10.1016/j.jri.2011.06.101	39	21	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2016	11	4							e0153304	10.1371/journal.pone.0153304	http://dx.doi.org/10.1371/journal.pone.0153304			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0KH	27064901	Green Submitted, Green Published, gold			2022-12-27	WOS:000373891000043
J	Ishizuka, K; Kimura, H; Wang, CY; Xing, JR; Kushima, I; Arioka, Y; Oya-Ito, T; Uno, Y; Okada, T; Mori, D; Aleksic, B; Ozaki, N				Ishizuka, Kanako; Kimura, Hiroki; Wang, Chenyao; Xing, Jingrui; Kushima, Itaru; Arioka, Yuko; Oya-Ito, Tomoko; Uno, Yota; Okada, Takashi; Mori, Daisuke; Aleksic, Branko; Ozaki, Norio			Investigation of Rare Single-Nucleotide PCDH15 Variants in Schizophrenia and Autism Spectrum Disorders	PLOS ONE			English	Article							BIPOLAR DISORDER; INNER-EAR; MUTATIONS; DISEASE; GENES; IDENTIFICATION; CHILDREN; RISK	Both schizophrenia (SCZ) and autism spectrum disorders (ASD) are neuropsychiatric disorders with overlapping genetic etiology. Protocadherin 15 (PCDH15), which encodes a member of the cadherin super family that contributes to neural development and function, has been cited as a risk gene for neuropsychiatric disorders. Recently, rare variants of large effect have been paid attention to understand the etiopathology of these complex disorders. Thus, we evaluated the impacts of rare, single-nucleotide variants (SNVs) in PCDH15 on SCZ or ASD. First, we conducted coding exon-targeted resequencing of PCDH15 with next-generation sequencing technology in 562 Japanese patients (370 SCZ and 192 ASD) and detected 16 heterozygous SNVs. We then performed association analyses on 2,096 cases (1,714 SCZ and 382 ASD) and 1,917 controls with six novel variants of these 16 SNVs. Of these six variants, four (p. R219K, p. T281A, p. D642N, c. 3010-1G> C) were ultra-rare variants (minor allele frequency < 0.0005) that may increase disease susceptibility. Finally, no statistically significant association between any of these rare, heterozygous PCDH15 point variants and SCZ or ASD was found. Our results suggest that a larger sample size of resequencing subjects is necessary to detect associations between rare PCDH15 variants and neuropsychiatric disorders.	[Ishizuka, Kanako; Kimura, Hiroki; Wang, Chenyao; Xing, Jingrui; Kushima, Itaru; Arioka, Yuko; Oya-Ito, Tomoko; Uno, Yota; Okada, Takashi; Mori, Daisuke; Aleksic, Branko; Ozaki, Norio] Nagoya Univ, Grad Sch Med, Dept Psychiat, Nagoya, Aichi 4648601, Japan	Nagoya University	Aleksic, B (corresponding author), Nagoya Univ, Grad Sch Med, Dept Psychiat, Nagoya, Aichi 4648601, Japan.	branko@med.nagoya-u.ac.jp	Mori, Daisuke/M-4952-2014; Aleksic, Branko/L-7851-2019; Aleksic, Branko/G-1540-2011; Ozaki, Norio/M-8908-2014; OKADA, Takashi/M-8902-2014	Mori, Daisuke/0000-0002-9072-2546; Aleksic, Branko/0000-0001-8982-4580; Aleksic, Branko/0000-0001-8982-4580; Ozaki, Norio/0000-0002-7360-4898; OKADA, Takashi/0000-0001-5580-9913; Kushima, Itaru/0000-0002-0018-5178; Arioka, Yuko/0000-0002-1792-8812	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Ministry of Health, Labour, and Welfare of Japan; Japan Agency for Medical Research and Development (AMED); Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS) project of AMED; Innovative Areas "Comprehensive Brain Science Network"	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS) project of AMED; Innovative Areas "Comprehensive Brain Science Network"	The current research was supported by research grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; the Ministry of Health, Labour, and Welfare of Japan; "Integrated research on neuropsychiatric disorders" carried out under the Strategic Research Program for Brain Sciences from the Japan Agency for Medical Research and Development (AMED); the Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS) project of AMED; Grant-in-Aid for Scientific Research on Innovative Areas "Glial assembly: a new regulatory machinery of brain function and disorders"; and Innovative Areas "Comprehensive Brain Science Network."	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Ahmed ZM, 2001, AM J HUM GENET, V69, P25, DOI 10.1086/321277; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Bourgeron T, 2015, NAT REV NEUROSCI, V16, P551, DOI 10.1038/nrn3992; Brandwein AB, 2015, J AUTISM DEV DISORD, V45, P230, DOI 10.1007/s10803-014-2212-9; Craddock N, 2010, BRIT J PSYCHIAT, V196, P92, DOI 10.1192/bjp.bp.109.073429; Dammeyer J, 2012, BEHAV BRAIN FUNCT, V8, DOI 10.1186/1744-9081-8-16; De Rubeis S, 2014, NATURE, V515, P209, DOI 10.1038/nature13772; Fromer M, 2014, NATURE, V506, P179, DOI 10.1038/nature12929; Gibson G, 2012, NAT REV GENET, V13, P135, DOI 10.1038/nrg3118; Girard M, 2011, CLIN J PAIN, V27, P790, DOI 10.1097/AJP.0b013e31821d904c; Hirano S, 2012, PHYSIOL REV, V92, P597, DOI 10.1152/physrev.00014.2011; Hoischen A, 2014, NAT NEUROSCI, V17, P764, DOI 10.1038/nn.3703; Hommer RE, 2015, SCHIZOPHRENIA BULL, V41, P313, DOI 10.1093/schbul/sbu188; Hu X, 2014, MOL PSYCHIATR, V19, P857, DOI 10.1038/mp.2013.131; Iossifov I, 2014, NATURE, V515, P216, DOI 10.1038/nature13908; Irimia M, 2014, CELL, V159, P1511, DOI 10.1016/j.cell.2014.11.035; Kenny EM, 2014, MOL PSYCHIATR, V19, P872, DOI 10.1038/mp.2013.127; Kimura H, 2015, SCHIZOPHRENIA BULL, V41, P744, DOI 10.1093/schbul/sbu147; Krumm N, 2015, NAT GENET, V47, P582, DOI 10.1038/ng.3303; Kryukov GV, 2007, AM J HUM GENET, V80, P727, DOI 10.1086/513473; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Kushima I, 2012, SCHIZOPHRENIA BULL, V38, P552, DOI 10.1093/schbul/sbq118; Landrum MJ, 2014, NUCLEIC ACIDS RES, V42, pD980, DOI 10.1093/nar/gkt1113; Lee SH, 2013, NAT GENET, V45, P984, DOI 10.1038/ng.2711; Lee S, 2014, AM J HUM GENET, V95, P5, DOI 10.1016/j.ajhg.2014.06.009; Malhotra D, 2012, CELL, V148, P1223, DOI 10.1016/j.cell.2012.02.039; Matsuya A, 2008, NUCLEIC ACIDS RES, V36, pD787, DOI 10.1093/nar/gkm878; McClellan J, 2010, CELL, V141, P210, DOI 10.1016/j.cell.2010.03.032; Moens LN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023450; Mowry BJ, 2013, MOL PSYCHIATR, V18, P38, DOI 10.1038/mp.2012.34; Murcia CL, 2001, MECH DEVELOP, V105, P163, DOI 10.1016/S0925-4773(01)00388-4; Nakashima M, 2014, J HUM GENET, V59, P471, DOI 10.1038/jhg.2014.51; Noor A, 2014, AM J MED GENET B, V165, P303, DOI 10.1002/ajmg.b.32232; Oikkonen J, 2015, MOL PSYCHIATR, V20, P275, DOI 10.1038/mp.2014.8; Pettersson E, 2016, MOL PSYCHIATR, V21, P717, DOI 10.1038/mp.2015.116; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Purcell SM, 2014, NATURE, V506, P185, DOI 10.1038/nature12975; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Rapoport J, 2009, J AM ACAD CHILD PSY, V48, P10, DOI 10.1097/CHI.0b013e31818b1c63; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Selten JP, 2015, JAMA PSYCHIAT, V72, P483, DOI 10.1001/jamapsychiatry.2014.3059; Shergill SS, 2005, AM J PSYCHIAT, V162, P2384, DOI 10.1176/appi.ajp.162.12.2384; Smoller JW, 2013, LANCET, V381, P1371, DOI 10.1016/S0140-6736(12)62129-1; Song WJ, 2008, BIOCHEM BIOPH RES CO, V367, P700, DOI 10.1016/j.bbrc.2007.12.117; Sorte HS, 2013, PSYCHIAT GENET, V23, P61, DOI 10.1097/YPG.0b013e32835d718b; Sotomayor M, 2012, NATURE, V492, P128, DOI 10.1038/nature11590; Stein JL, 2013, NEURON, V77, P209, DOI 10.1016/j.neuron.2013.01.010; Sullivan PF, 2012, ARCH GEN PSYCHIAT, V69, P1099, DOI 10.1001/archgenpsychiatry.2012.730; Sullivan PF, 2012, NAT REV GENET, V13, P537, DOI 10.1038/nrg3240; Xiong HY, 2015, SCIENCE, V347, DOI 10.1126/science.1254806; Ye R, 2014, GENES BRAIN BEHAV, V13, P261, DOI 10.1111/gbb.12119; Zuk O, 2014, P NATL ACAD SCI USA, V111, pE455, DOI 10.1073/pnas.1322563111	53	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2016	11	4							e0153224	10.1371/journal.pone.0153224	http://dx.doi.org/10.1371/journal.pone.0153224			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DI6JK	27058588	Green Submitted, Green Published, gold			2022-12-27	WOS:000373604800023
J	Iimura, Y; Sugano, H; Nakajima, M; Higo, T; Suzuki, H; Nakanishi, H; Arai, H				Iimura, Yasushi; Sugano, Hidenori; Nakajima, Madoka; Higo, Takuma; Suzuki, Hiroharu; Nakanishi, Hajime; Arai, Hajime			Analysis of Epileptic Discharges from Implanted Subdural Electrodes in Patients with Sturge-Weber Syndrome	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; REFRACTORY EPILEPSY; STROKE; CHILDREN; SEIZURES; MRI; ONSET; ELECTROENCEPHALOGRAPHY; DIAGNOSIS; PATTERNS	Objective Almost two-thirds of patients with Sturge-Weber syndrome (SWS) have epilepsy, and half of them require surgery for it. However, it is well known that scalp electroencephalography (EEG) does not demonstrate unequivocal epileptic discharges in patients with SWS. Therefore, we analyzed interictal and ictal discharges from intracranial subdural EEG recordings in patients treated surgically for SWS to elucidate epileptogenicity in this disorder. Methods Five intractable epileptic patients with SWS who were implanted with subdural electrodes for presurgical evaluation were enrolled in this study. We examined the following seizure parameters: seizure onset zone (SOZ), propagation speed of seizure discharges, and seizure duration by visual inspection. Additionally, power spectrogram analysis on some frequency bands at SOZ was performed from 60 s before the visually detected seizure onset using the EEG Complex Demodulation Method (CDM). Results We obtained 21 seizures from five patients for evaluation, and all seizures initiated from the cortex under the leptomeningeal angioma. Most of the patients presented with motionless staring and respiratory distress as seizure symptoms. The average seizure propagation speed and duration were 3.1 +/- 3.6 cm/min and 19.4 +/- 33.6 min, respectively. Significant power spectrogram changes at the SOZ were detected at 10-30 Hz from 15 s before seizure onset, and at 30-80 Hz from 5 s before seizure onset. Significance In patients with SWS, seizures initiate from the cortex under the leptomeningeal angioma, and seizure propagation is slow and persists for a longer period. CDM indicated beta to low gamma-ranged seizure discharges starting from shortly before the visually detected seizure onset. Our ECoG findings indicate that ischemia is a principal mechanism underlying ictogenesis and epileptogenesis in SWS.	[Iimura, Yasushi; Sugano, Hidenori; Nakajima, Madoka; Higo, Takuma; Suzuki, Hiroharu; Nakanishi, Hajime; Arai, Hajime] Juntendo Univ, Epilepsy Ctr, Dept Neurosurg, Tokyo, Japan	Juntendo University	Iimura, Y (corresponding author), Juntendo Univ, Epilepsy Ctr, Dept Neurosurg, Tokyo, Japan.	yiimura@juntendo.ac.jp	Nakajima, Madoka/AAU-6505-2021	Iimura, Yasushi/0000-0003-4263-5920				ARZIMANOGLOU A, 1992, ACTA NEUROL SCAND, V86, P18, DOI 10.1111/j.1600-0404.1992.tb04465.x; Aye SMM, 2013, LUPUS, V22, P510, DOI 10.1177/0961203312474705; Bauman JA, 2008, NEUROSURGERY, V62, P489, DOI [10.1227/01.neu.0000316252.47028.2d, 10.1227/01.NEU.0000148908.71296.FA]; BERK RA, 1979, J ABNORM CHILD PSYCH, V7, P113, DOI 10.1007/BF00924515; BODE H, 1992, EUR J PEDIATR, V151, P706, DOI 10.1007/BF01957579; BRENNER RP, 1976, NEUROLOGY, V26, P629, DOI 10.1212/WNL.26.7.629; CHIRON C, 1989, J NEUROL NEUROSUR PS, V52, P1402, DOI 10.1136/jnnp.52.12.1402; Coley SC, 1998, CHILD NERV SYST, V14, P693, DOI 10.1007/s003810050299; Comi AM, 2003, J CHILD NEUROL, V18, P509, DOI 10.1177/08830738030180080701; CURE JK, 1995, AM J NEURORADIOL, V16, P1539; Delalande O, 2007, NEUROSURGERY, V60, P19, DOI 10.1227/01.NEU.0000249246.48299.12; Di Rocco C, 2006, CHILD NERV SYST, V22, P909, DOI 10.1007/s00381-006-0143-2; Garcia-Morales I, 2002, J CLIN NEUROPHYSIOL, V19, P172, DOI 10.1097/00004691-200203000-00009; Ghatan S, 2014, J NEUROSURG-PEDIATR, V14, P58, DOI 10.3171/2014.3.PEDS13440; Griffiths PD, 1997, NEURORADIOLOGY, V39, P219, DOI 10.1007/s002340050398; Hata D, 1998, SEIZURE-EUR J EPILEP, V7, P505, DOI 10.1016/S1059-1311(98)80011-3; Hidenori S, 2009, CHILD NERV SYST, V25, P143, DOI [10.1007/s00381-008-0696-3, DOI 10.1007/S00381-008-0696-3]; Jansen FE, 2002, CLIN NEUROPHYSIOL, V113, P1025, DOI 10.1016/S1388-2457(02)00105-0; Maton B, 2010, EPILEPSIA, V51, P257, DOI 10.1111/j.1528-1167.2009.02304.x; Ohno K, 2014, BRAIN DEV, V26, P288; Okudaira Y, 1997, CHILD NERV SYST, V13, P214, DOI 10.1007/s003810050070; PASCUALCASTROVIEJO I, 1993, PEDIATR NEUROL, V9, P283, DOI 10.1016/0887-8994(93)90064-J; Perucca P, 2014, BRAIN, V137, P183, DOI 10.1093/brain/awt299; Pinton F, 1997, J NEUROL NEUROSUR PS, V63, P616, DOI 10.1136/jnnp.63.5.616; PROBST FP, 1980, NEURORADIOLOGY, V20, P73, DOI 10.1007/BF00339549; Rafay MF, 2009, STROKE, V40, P2402, DOI 10.1161/STROKEAHA.109.547281; Rando T, 2000, NEUROPEDIATRICS, V31, P202, DOI 10.1055/s-2000-7454; Srejic LR, 2013, J NEUROSURG, V118, P1098, DOI 10.3171/2013.1.JNS121059; Sugano H, 2014, EPILEPSIA, V55, P683, DOI 10.1111/epi.12547; SUJANSKY E, 1995, J CHILD NEUROL, V10, P49, DOI 10.1177/088307389501000113; Tay SKH, 2006, EPILEPSIA, V47, P1504, DOI 10.1111/j.1528-1167.2006.00623.x; Van Gompel JJ, 2008, NEUROSURGERY, V63, P498, DOI 10.1227/01.NEU.0000324996.37228.F8; van Mierlo P, 2013, EPILEPSIA, V54, P1409, DOI 10.1111/epi.12206; Walsh BH, 2011, DEV MED CHILD NEUROL, V53, P89, DOI 10.1111/j.1469-8749.2010.03837.x; Wu JL, 2011, J MAGN RESON IMAGING, V34, P791, DOI 10.1002/jmri.22687; Yu TW, 2007, EUR J PAEDIATR NEURO, V11, P96, DOI 10.1016/j.ejpn.2006.11.008	36	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0152992	10.1371/journal.pone.0152992	http://dx.doi.org/10.1371/journal.pone.0152992			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27054715	Green Submitted, Green Published, gold			2022-12-27	WOS:000373608000061
J	Tagge, I; O'Connor, A; Chaudhary, P; Pollaro, J; Berlow, Y; Chalupsky, M; Bourdette, D; Woltjer, R; Johnson, M; Rooney, W				Tagge, Ian; O'Connor, Audrey; Chaudhary, Priya; Pollaro, Jim; Berlow, Yosef; Chalupsky, Megan; Bourdette, Dennis; Woltjer, Randy; Johnson, Mac; Rooney, William			Spatio-Temporal Patterns of Demyelination and Remyelination in the Cuprizone Mouse Model	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; CORPUS-CALLOSUM; MAGNETIZATION-TRANSFER; SUBVENTRICULAR ZONE; MULTIPLE-SCLEROSIS; WHITE-MATTER; IN-VIVO; REGIONAL HETEROGENEITY; BRAIN; MRI	Cuprizone administration in mice provides a reproducible model of demyelination and spontaneous remyelination, and has been useful in understanding important aspects of human disease, including multiple sclerosis. In this study, we apply high spatial resolution quantitative MRI techniques to establish the spatio-temporal patterns of acute demyelination in C57BL/6 mice after 6 weeks of cuprizone administration, and subsequent remyelination after 6 weeks of post-cuprizone recovery. MRI measurements were complemented with Black Gold II stain for myelin and immunohistochemical stains for associated tissue changes. Gene expression was evaluated using the Allen Gene Expression Atlas. Twenty-five C57BL/6 male mice were split into control and cuprizone groups; MRI data were obtained at baseline, after 6 weeks of cuprizone, and 6 weeks post-cuprizone. High-resolution (100 mu m isotropic) whole-brain coverage magnetization transfer ratio (MTR) parametric maps demonstrated concurrent caudal-to-rostral and medial-to-lateral gradients of MTR decrease within corpus callosum (CC) that correlated well with demyelination assessed histologically. Our results show that demyelination was not limited to the midsagittal line of the corpus callosum, and also that opposing gradients of demyelination occur in the lateral and medial CC. T-2-weighted MRI gray/white matter contrast was strong at baseline, weak after 6 weeks of cuprizone treatment, and returned to a limited extent after recovery. MTR decreases during demyelination were observed throughout the brain, most clearly in callosal white matter. Myelin damage and repair appear to be influenced by proximity to oligodendrocyte progenitor cell populations and exhibit an inverse correlation with myelin basic protein gene expression. These findings suggest that susceptibility to injury and ability to repair vary across the brain, and whole-brain analysis is necessary to accurately characterize this model. Whole-brain parametric mapping across time is essential for gaining a real understanding of disease processes in-vivo. MTR increases in healthy mice throughout adolescence and adulthood were observed, illustrating the need for appropriate age-matched controls. Elucidating the unique and site-specific demyelination in the cuprizone model may offer new insights into in mechanisms of both damage and repair in human demyelinating diseases.	[Tagge, Ian; O'Connor, Audrey; Pollaro, Jim; Berlow, Yosef; Rooney, William] Oregon Hlth & Sci Univ, Adv Imaging Res Ctr, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA; [Tagge, Ian; Rooney, William] Oregon Hlth & Sci Univ, Biomed Engn, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA; [Chaudhary, Priya; Bourdette, Dennis; Rooney, William] Oregon Hlth & Sci Univ, Neurol, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA; [Chalupsky, Megan; Woltjer, Randy] Oregon Hlth & Sci Univ, Pathol, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA; [Bourdette, Dennis] Portland VA Med Ctr, 3710 SW US Vet Hosp Rd, Portland, OR 97239 USA; [Johnson, Mac] Vertex Pharmaceut Inc, 50 Northern Ave, Boston, MA 02210 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Portland VA Medical Center; Vertex Pharmaceuticals	Tagge, I; Rooney, W (corresponding author), Oregon Hlth & Sci Univ, Adv Imaging Res Ctr, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	taggei@ohsu.edu; rooneyw@ohsu.edu		Tagge, Ian/0000-0002-5260-7117; Chaudhary, Priya/0000-0001-6404-6049	Vertex Pharmaceuticals, Inc.; NIA [P30 AG008017]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS061800] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG008017] Funding Source: NIH RePORTER	Vertex Pharmaceuticals, Inc.(Vertex Pharmaceuticals); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The primary funder, Vertex Pharmaceuticals, Inc., provided a grant to investigate MRI biomarkers of myelination which supported experimental costs and partial salary support for authors AO'C, JP, IT, and WR, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. MJ, on behalf of Vertex Pharmaceuticals, Inc., contributed to study design insofar as suggesting the use of cuprizone in mice to validate MRI biomarkers of myelin content in-vivo. The funders had no role in data acquisition, processing, or analysis. MJ reviewed the paper prior to submission and offered comments on presentation, but otherwise did not have a role in the decision to publish.; Evan Calkins, Danielle Galipeau, and David Clark provided excellent technical support in histological processing. We would like to express our thanks to the Advanced Light Microscopy Core (P30 NS061800) Facility at the Oregon Health & Science University. Immunohistochemical studies were performed in the laboratory of the Oregon Brain Bank and the Oregon Alzheimer's Disease Center (supported by NIA P30 AG008017).	Aboitiz F, 2003, BRAZ J MED BIOL RES, V36, P409, DOI 10.1590/S0100-879X2003000400002; ABOITIZ F, 1992, BRAIN RES, V598, P143, DOI 10.1016/0006-8993(92)90178-C; Acs Peter, 2012, Methods Mol Biol, V900, P403, DOI 10.1007/978-1-60761-720-4_20; Allen Institute for Brain Science, 2015, ALL MOUS BRAIN ATL; Back S. A, 2014, PATHOPHYSIOLOGY GLIA; Baloch S, 2009, CEREB CORTEX, V19, P675, DOI 10.1093/cercor/bhn112; Beatrice B, 2015, BIOL OPEN, P1; Benetti F, 2010, NEUROTOXICOLOGY, V31, P509, DOI 10.1016/j.neuro.2010.05.008; Boretius S, 2012, NEUROIMAGE, V59, P2678, DOI 10.1016/j.neuroimage.2011.08.051; CARLTON WILLIAM W., 1967, LIFE SCI, V6, P11, DOI 10.1016/0024-3205(67)90356-6; CARLTON WW, 1966, TOXICOL APPL PHARM, V8, P512, DOI 10.1016/0041-008X(66)90062-7; Cate HS, 2010, J NEUROCHEM, V115, P11, DOI 10.1111/j.1471-4159.2010.06660.x; Donega M, 2013, NEURAL STEM CELLS NE, DOI 10.5772/55426; Falangola MF, 2014, NMR BIOMED, V27, P948, DOI 10.1002/nbm.3140; Fjaer S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084162; Goldberg J, 2015, J MOL NEUROSCI; Goldberg J, 2013, CELL MOL NEUROBIOL, V33, P1087, DOI 10.1007/s10571-013-9975-y; Gudi V, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00073; Gudi V, 2009, BRAIN RES, V1283, P127, DOI 10.1016/j.brainres.2009.06.005; Guglielmetti C, 2016, NEUROIMAGE, V125, P363, DOI 10.1016/j.neuroimage.2015.10.052; Guglielmetti C, 2014, NEUROIMAGE, V86, P99, DOI 10.1016/j.neuroimage.2013.07.080; Hiremath MM, 1998, J NEUROIMMUNOL, V92, P38, DOI 10.1016/S0165-5728(98)00168-4; Jarjour AA, 2004, NEUROSCIENTIST, V10, P99, DOI 10.1177/1073858403260751; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Kaneko N, 2011, GENES-BASEL, V2, P107, DOI 10.3390/genes2010107; Kipp M, 2009, ACTA NEUROPATHOL, V118, P723, DOI 10.1007/s00401-009-0591-3; Larvaron P, 2007, NMR BIOMED, V20, P413, DOI 10.1002/nbm.1082; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lucchinetti C, 2000, ANN NEUROL, V47, P707, DOI 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q; Mason JL, 2000, J NEUROSCI RES, V61, P251, DOI 10.1002/1097-4547(20000801)61:3<251::AID-JNR3>3.0.CO;2-W; Mason JL, 2001, NEUROPATH APPL NEURO, V27, P50, DOI 10.1046/j.0305-1846.2001.00301.x; Merkler D, 2005, NMR BIOMED, V18, P395, DOI 10.1002/nbm.972; Mottershead JP, 2003, J NEUROL, V250, P1293, DOI 10.1007/s00415-003-0192-3; Pasquini LA, 2007, NEUROCHEM RES, V32, P279, DOI 10.1007/s11064-006-9165-0; Petratos S, 2004, GLIA, V48, P64, DOI 10.1002/glia.20056; Portnoy S, 2007, MAGN RESON MED, V58, P144, DOI 10.1002/mrm.21244; Prineas JW, 2012, ANN NEUROL, V72, P18, DOI 10.1002/ana.23634; Sawamoto K, 2006, SCIENCE, V311, P629, DOI 10.1126/science.1119133; Schmidt T, 2013, J MOL NEUROSCI, V49, P80, DOI 10.1007/s12031-012-9896-0; Schregel K, 2012, P NATL ACAD SCI USA, V109, P6650, DOI 10.1073/pnas.1200151109; Silvestroff L, 2010, J COMP NEUROL, V518, P2261, DOI 10.1002/cne.22330; Skripuletz T, 2010, BRAIN PATHOL, V20, P301, DOI 10.1111/j.1750-3639.2009.00271.x; Sled JG, 2001, MAGNET RESON MED, V46, P923, DOI 10.1002/mrm.1278; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Stanisz GJ, 2005, MAGNET RESON MED, V54, P507, DOI 10.1002/mrm.20605; Steelman AJ, 2012, NEUROSCI RES, V72, P32, DOI 10.1016/j.neures.2011.10.002; Stidworthy MF, 2003, BRAIN PATHOL, V13, P329; STURROCK RR, 1980, NEUROPATH APPL NEURO, V6, P415, DOI 10.1111/j.1365-2990.1980.tb00219.x; Tardif CL, 2012, MULT SCLER INT, V2012, DOI 10.1155/2012/742018; Thiessen JD, 2013, NMR BIOMED, V26, P1562, DOI 10.1002/nbm.2992; Tobin JE, 2011, J NEUROPATH EXP NEUR, V70, P157, DOI 10.1097/NEN.0b013e31820937e4; Van Rossum G., 2007, USENIX ANN TECHN C; Vavasour IM, 2011, J MAGN RESON IMAGING, V33, P713, DOI 10.1002/jmri.22441; Wergeland S, 2012, APMIS, V120, P648, DOI 10.1111/j.1600-0463.2012.02882.x; Wu QZ, 2008, J MAGN RESON IMAGING, V27, P446, DOI 10.1002/jmri.21111; Xie M, 2010, J NEUROPATHOL EXP NE, V69, P704; Yang HJ, 2009, BRAIN RES, V1270, P121, DOI 10.1016/j.brainres.2009.03.011; Yarnykh VL, 2012, MAGN RESON MED, V68, P166, DOI 10.1002/mrm.23224; Zaaraoui W, 2008, MAGN RESON MATER PHY, V21, P357, DOI 10.1007/s10334-008-0141-3; Zatta P, 2005, CELL MOL LIFE SCI, V62, P1502, DOI 10.1007/s00018-005-5073-8	60	36	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0152480	10.1371/journal.pone.0152480	http://dx.doi.org/10.1371/journal.pone.0152480			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27054832	Green Published, gold, Green Submitted			2022-12-27	WOS:000373608000021
J	Alsaweed, M; Lai, CT; Hartmann, PE; Geddes, DT; Kakulas, F				Alsaweed, Mohammed; Lai, Ching Tat; Hartmann, Peter E.; Geddes, Donna T.; Kakulas, Foteini			Human Milk Cells and Lipids Conserve Numerous Known and Novel miRNAs, Some of Which Are Differentially Expressed during Lactation	PLOS ONE			English	Article							BREAST-MILK; MAMMARY-GLAND; MICRORNA BIOGENESIS; GENE-EXPRESSION; STEM-CELLS; INFANT; RNA; IDENTIFICATION; PATHWAYS; ENDOCYTOSIS	Human milk (HM) is rich in miRNAs, which are thought to contribute to infant protection and development. We used deep sequencing to profile miRNAs in the cell and lipid fractions of HM obtained post-feeding from 10 lactating women in months 2, 4, and 6 postpartum. In both HM fractions, 1,195 mature known miRNAs were identified, which were positively associated with the cell (p = 0.048) and lipid (p = 0.010) content of HM. An additional 5,167 novel miRNA species were predicted, of which 235 were high-confidence miRNAs. HM cells contained more known miRNAs than HM lipids (1,136 and 835 respectively, p<0.001). Although the profile of the novel miRNAs was very different between cells and lipids, with the majority conserved in the cell fraction and being mother-specific, 2/3 of the known miRNAs common between cells and lipids were similarly expressed (p>0.05). Great similarities between the two HM fractions were also found in the profile of the top 20 known miRNAs. These were largely similar also between the three lactation stages examined, as were the total miRNA concentration, and the number and expression of the known miRNAs common between cells and lipids (p>0.05). Yet, approximately a third of all known miRNAs were differentially expressed during the first 6 months of lactation (p<0.05), with more pronounced miRNA upregulation seen in month 4. These findings indicate that although the total miRNA concentration of HM cells and lipids provided to the infant does not change in first 6 months of lactation, the miRNA composition is altered, particularly in month 4 compared to months 2 and 6. This may reflect the remodeling of the gland in response to infant feeding patterns, which usually change after exclusive breastfeeding, suggesting adaptation to the infant's needs.	[Alsaweed, Mohammed; Lai, Ching Tat; Hartmann, Peter E.; Geddes, Donna T.; Kakulas, Foteini] Univ Western Australia, Sch Chem & Biochem, Crawley, WA, Australia; [Alsaweed, Mohammed] Majmaah Univ, Coll Appl Med Sci, Riyadh, Saudi Arabia	University of Western Australia; Majmaah University	Kakulas, F (corresponding author), Univ Western Australia, Sch Chem & Biochem, Crawley, WA, Australia.	foteini.kakulas@uwa.edu.au	Lai, ching tat/M-2452-2018; Geddes, Donna/H-9254-2014	Lai, ching tat/0000-0002-9025-4922; Geddes, Donna/0000-0002-0431-7078; Hartmann, Peter/0000-0002-7709-0740	Medela AG (Switzerland); Majmaah University, Riyadh, Saudi Arabia	Medela AG (Switzerland); Majmaah University, Riyadh, Saudi Arabia	FK, CTL, PEH and DTG received an unrestricted research grant from Medela AG (Switzerland). The company had no input in designing or conducting the study or the decision to publish the manuscript. MA received a PhD scholarship from Majmaah University, Riyadh, Saudi Arabia.	Abbott AL, 2005, DEV CELL, V9, P403, DOI 10.1016/j.devcel.2005.07.009; Adam J, 2015, EUR PHYS J C, V75, DOI 10.1140/epjc/s10052-015-3422-9; Alsaweed M, 2015, DEV BIOL IN PRESS; Alsaweed M, 2015, SCI REPORTS IN PRESS; Alsaweed M, 2015, INT J ENV RES PUB HE, V12, P13981, DOI 10.3390/ijerph121113981; Alsaweed M, 2015, J CELL BIOCHEM, V116, P2397, DOI 10.1002/jcb.25207; Arntz OJ, 2015, MOL NUTR FOOD RES, V59, P1701, DOI 10.1002/mnfr.201500222; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baier SR, 2014, J NUTR, V144, P1495, DOI 10.3945/jn.114.196436; Ballard O, 2013, PEDIATR CLIN N AM, V60, P49, DOI 10.1016/j.pcl.2012.10.002; Bode L, 2014, ADV NUTR, V5, P571, DOI 10.3945/an.114.006643; Bussing I, 2008, TRENDS MOL MED, V14, P400, DOI 10.1016/j.molmed.2008.07.001; CATASSI C, 1995, J PEDIATR GASTR NUTR, V21, P383, DOI 10.1097/00005176-199511000-00003; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chen T, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-100; Chen X, 2010, CELL RES, V20, P1128, DOI 10.1038/cr.2010.80; Fallingborg J, 1999, DAN MED BULL, V46, P183; Gailhouste L, 2013, HEPATOLOGY, V58, P1153, DOI 10.1002/hep.26422; Gu YR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043691; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Hassiotou F, 2014, BI ANN C INT SOC RES; Hassiotou F, 2015, FASEB J S, V29; Hassiotou F, 2015, ADV NUTR, V6, P267, DOI 10.3945/an.114.007377; Hassiotou F, 2014, ADV NUTR, V5, P770, DOI 10.3945/an.114.006924; Hassiotou F, 2013, CLIN TRANSL IMMUNOL, V2, DOI 10.1038/cti.2013.1; Hassiotou F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078232; Hassiotou F, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00079; Hassiotou F, 2013, J HUM LACT, V29, P171, DOI 10.1177/0890334413477242; Hassiotou F, 2013, CLIN ANAT, V26, P29, DOI 10.1002/ca.22165; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; JAIN L, 1989, ARCH DIS CHILD-FETAL, V64, P930, DOI 10.1136/adc.64.7_Spec_No.930; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Kapsimali M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r173; KernSmooth S, 2015, PACKAGE LATTICE LATT; Kloosterman WP, 2007, PLOS BIOL, V5, P1738, DOI 10.1371/journal.pbio.0050203; Kosaka Nobuyoshi, 2010, Silence, V1, P7, DOI 10.1186/1758-907X-1-7; Kramer MS, 2010, EARLY HUM DEV, V86, P729, DOI 10.1016/j.earlhumdev.2010.08.005; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Lemay DG, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-872; Liu HJ, 2014, BMC GENOMICS, V15, DOI [10.1186/1471-2164-15-433, 10.1186/1471-2164-15-25]; Melnik BC, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-43; Mitoulas LR, 2003, BRIT J NUTR, V90, P979, DOI 10.1079/BJN2003979; Mitoulas LR, 2002, BRIT J NUTR, V88, P29, DOI [10.1079/BJN2002579, 10.1079/BJNBJN2002579]; Modepalli V, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1012; Moore SE, 2009, ACTA PAEDIATR, V98, P1168, DOI 10.1111/j.1651-2227.2009.01292.x; Munch EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0050564; Neilson JR, 2007, GENE DEV, V21, P578, DOI 10.1101/gad.1522907; Pieters BCH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121123; Pinheiro J., 2019, NLME LINEAR NONLINEA; PRENTICE A, 1987, ACTA PAEDIATR SCAND, V76, P592, DOI 10.1111/j.1651-2227.1987.tb10526.x; Rai D, 2014, CRIT REV FOOD SCI, V54, P1539, DOI 10.1080/10408398.2011.642422; Rstudio Team, 2015, RSTUDIO INT DEV R; Stevens EE, 2009, J PERINAT EDUC, V18, P32, DOI 10.1624/105812409X426314; Tanaka T, 2009, DIFFERENTIATION, V77, P181, DOI 10.1016/j.diff.2008.10.001; Tian T, 2014, J BIOL CHEM, V289, P22258, DOI 10.1074/jbc.M114.588046; Tordonato C, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00072; Twigger AJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep12933; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Weber JA, 2010, CLIN CHEM, V56, P1733, DOI 10.1373/clinchem.2010.147405; WEILER IJ, 1983, AM J REPROD IMMUNOL, V4, P95, DOI 10.1111/j.1600-0897.1983.tb00261.x; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Wolf T, 2015, J NUTR, V145, P2201, DOI 10.3945/jn.115.218586; Yang J, 2015, CELL RES, V25, P517, DOI 10.1038/cr.2015.26; Yi SK, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-754; Zhang CL, 2014, J NUTR, V144, P1142, DOI 10.3945/jn.114.192575; Zhang L, 2012, CELL RES, V22, P107, DOI 10.1038/cr.2011.158; Zhou L, 2000, IMMUNOLOGY, V101, P570, DOI 10.1046/j.1365-2567.2000.00144.x; Zhou Q, 2012, INT J BIOL SCI, V8, P118, DOI 10.7150/ijbs.8.118; Zhou XY, 2008, J EXP MED, V205, P1983, DOI 10.1084/jem.20080707	70	41	41	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0152610	10.1371/journal.pone.0152610	http://dx.doi.org/10.1371/journal.pone.0152610			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27074017	Green Published, Green Submitted, gold			2022-12-27	WOS:000374131200030
J	Benoit, RM; Ostermeier, C; Geiser, M; Li, JSZ; Widmer, H; Auer, M				Benoit, Roger M.; Ostermeier, Christian; Geiser, Martin; Li, Julia Su Zhou; Widmer, Hans; Auer, Manfred			Seamless Insert-Plasmid Assembly at High Efficiency and Low Cost	PLOS ONE			English	Article							LIGATION-INDEPENDENT CLONING; INCOMPLETE PRIMER EXTENSION; ESCHERICHIA-COLI; PCR PRODUCTS; IN-VITRO; RAPID METHOD; ENZYME-FREE; DNA; RECOMBINATION; MUTAGENESIS	Seamless cloning methods, such as co-transformation cloning, sequence-and ligation-independent cloning (SLIC) or the Gibson assembly, are essential tools for the precise construction of plasmids. The efficiency of co-transformation cloning is however low and the Gibson assembly reagents are expensive. With the aim to improve the robustness of seamless cloning experiments while keeping costs low, we examined the importance of complementary single-stranded DNA ends for co-transformation cloning and the influence of single-stranded gaps in circular plasmids on SLIC cloning efficiency. Most importantly, our data show that single-stranded gaps in double-stranded plasmids, which occur in typical SLIC protocols, can drastically decrease the efficiency at which the DNA transforms competent E. coli bacteria. Accordingly, filling-in of single-stranded gaps using DNA polymerase resulted in increased transformation efficiency. Ligation of the remaining nicks did not lead to a further increase in transformation efficiency. These findings demonstrate that highly efficient insert-plasmid assembly can be achieved by using only T5 exonuclease and Phusion DNA polymerase, without Taq DNA ligase from the original Gibson protocol, which significantly reduces the cost of the reactions. We successfully used this modified Gibson assembly protocol with two short insert-plasmid overlap regions, each counting only 15 nucleotides.	[Benoit, Roger M.] Paul Scherrer Inst, Lab Biomol Res, Villigen, Switzerland; [Ostermeier, Christian] Novartis Pharma AG, Basel, Switzerland; [Geiser, Martin; Widmer, Hans] Novartis Inst BioMed Res, Basel, Switzerland; [Li, Julia Su Zhou] Scripps Res Inst, Kellog Sch Sci & Technol, La Jolla, CA 92037 USA; [Auer, Manfred] Univ Edinburgh, Sch Biol Sci CSE, Edinburgh, Midlothian, Scotland; [Auer, Manfred] Univ Edinburgh, Sch Biomed Sci CMVM, Edinburgh, Midlothian, Scotland	Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Novartis; Novartis; Scripps Research Institute; University of Edinburgh; University of Edinburgh	Benoit, RM (corresponding author), Paul Scherrer Inst, Lab Biomol Res, Villigen, Switzerland.; Auer, M (corresponding author), Univ Edinburgh, Sch Biol Sci CSE, Edinburgh, Midlothian, Scotland.; Auer, M (corresponding author), Univ Edinburgh, Sch Biomed Sci CMVM, Edinburgh, Midlothian, Scotland.	roger.benoit@psi.ch; manfred.auer@ed.ac.uk		Auer, Manfred/0000-0001-8920-3522; Benoit, Roger/0000-0001-9420-7739	Novartis Institutes for BioMedical Research; Paul Scherrer Institute; Scottish Universities Life Sciences Alliance (SULSA); Medical Research Council (MRC) [J54359]; European Community's 7th Framework Program "PRIMES" [278568]; Biotechnology and Biological Sciences Research Council [998839] Funding Source: researchfish	Novartis Institutes for BioMedical Research; Paul Scherrer Institute; Scottish Universities Life Sciences Alliance (SULSA); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Community's 7th Framework Program "PRIMES"; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Novartis Institutes for BioMedical Research, Paul Scherrer Institute, the Scottish Universities Life Sciences Alliance (SULSA- http://www.sulsa.ac.uk), the Medical Research Council (MRC- www.mrc.ac.uk, J54359), and by the European Community's 7th Framework Program (FP7/2007-2013, www.primesfp7.eu) under grant agreement no 278568 "PRIMES". The funders provided support in the form of salaries for authors [RMB, CO, MG, HW, MA], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; ASLANIDIS C, 1994, PCR METH APPL, V4, P172; Benoit RM, 2006, PROTEIN EXPRES PURIF, V45, P66, DOI 10.1016/j.pep.2005.09.022; Bieniossek Christoph, 2009, Journal of Structural and Functional Genomics, V10, P37, DOI 10.1007/s10969-008-9047-6; Blanusa M, 2010, ANAL BIOCHEM, V406, P141, DOI 10.1016/j.ab.2010.07.011; BUBECK P, 1993, NUCLEIC ACIDS RES, V21, P3601, DOI 10.1093/nar/21.15.3601; Casali Nicola, 2003, Methods Mol Biol, V235, P27; Chen GJ, 2002, BIOTECHNIQUES, V32, P516, DOI 10.2144/02323st02; Donahue WF, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf094; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Howorka S, 1998, BIOTECHNIQUES, V25, P764, DOI 10.2144/98255bm03; Howorka Stefan, 2002, Methods Mol Biol, V182, P139; INOUE H, 1990, GENE, V96, P23, DOI 10.1016/0378-1119(90)90336-P; JONES DH, 1991, BIOTECHNIQUES, V10, P62; JONES DH, 1990, NATURE, V344, P793, DOI 10.1038/344793a0; KARU AE, 1973, J BIOL CHEM, V248, P4874; Klock HE, 2008, PROTEINS, V71, P982, DOI 10.1002/prot.21786; Kuzminov A, 1997, J BACTERIOL, V179, P880, DOI 10.1128/jb.179.3.880-888.1997; Li CA, 1997, NUCLEIC ACIDS RES, V25, P4165, DOI 10.1093/nar/25.20.4165; Li MZ, 2007, NAT METHODS, V4, P251, DOI 10.1038/NMETH1010; Li Mamie Z, 2012, Methods Mol Biol, V852, P51, DOI 10.1007/978-1-61779-564-0_5; Lu Q, 2005, TRENDS BIOTECHNOL, V23, P199, DOI 10.1016/j.tibtech.2005.02.008; Olieric N, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-56; OLINER JD, 1993, NUCLEIC ACIDS RES, V21, P5192, DOI 10.1093/nar/21.22.5192; OLSEN DB, 1989, NUCLEIC ACIDS RES, V17, P9613, DOI 10.1093/nar/17.23.9613; SCHILDKRAUT C, 1965, BIOPOLYMERS, V3, P195, DOI 10.1002/bip.360030207; Tillett D, 1999, NUCLEIC ACIDS RES, V27, DOI 10.1093/nar/27.19.e26; ULLMANN A, 1967, J MOL BIOL, V24, P339, DOI 10.1016/0022-2836(67)90341-5; Xia YZ, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1189; Zhu DW, 2010, ANAL BIOCHEM, V397, P162, DOI 10.1016/j.ab.2009.10.018	31	23	30	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153158	10.1371/journal.pone.0153158	http://dx.doi.org/10.1371/journal.pone.0153158			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073895	Green Published, Green Submitted, gold			2022-12-27	WOS:000374131200055
J	Deng, YT; Ye, JQ; Luo, Q; Huang, ZK; Peng, YP; Xiong, GL; Guo, Y; Jiang, H; Li, JM				Deng, Yating; Ye, Jianqing; Luo, Qing; Huang, Zhikun; Peng, Yiping; Xiong, Guoliang; Guo, Yang; Jiang, Hong; Li, Junming			Low-Density Granulocytes Are Elevated in Mycobacterial Infection and Associated with the Severity of Tuberculosis	PLOS ONE			English	Article							NEUTROPHILS; PATHOGENESIS; INFLAMMATION; IMMUNITY	Tuberculosis remains a global health problem caused by infection with Mycobacterium tuberculosis. Numerous studies have established a close correlation between the development of tuberculosis and the roles of neutrophils. Recently, a distinct population of CD15(+) granulocytes was found to be present in the peripheral blood mononuclear cell (PBMC) fraction in humans. This population of granulocytes, termed low-density granulocytes (LDGs), was reported to be elevated and associated with disease activity or severity in a number of different conditions including SLE, asthma and HIV infection. However, both the frequency and clinical significance of LDGs associated with tuberculosis are unclear. Here we determined LDG levels and made comparisons between subjects with active pulmonary tuberculosis (PTB) and healthy controls, between PTB patients with mild-to-moderate disease and patients with advanced disease, and among PTB patients following anti-tuberculous therapy of varying durations. The direct correlation between M. tuberculosis infection and LDG levels was confirmed by in vitro infection of whole peripheral blood and isolated granulocytes with mycobacteria. Our results demonstrated that PBMCs in PTB patients contained significantly elevated percentages of LDGs compared with control subjects. LDGs in tuberculosis expressed higher levels of activation markers compared to normal-density granulocytes (NDGs). M. tuberculosis induced the generation of LDGs in both whole blood and isolated NDGs from control subjects, which suggests that LDGs associated with M. tuberculosis infection are likely to originate from in situ activation. Furthermore, our results revealed that the frequency of LDGs is associated with the severity of tuberculosis.	[Deng, Yating; Ye, Jianqing; Luo, Qing; Huang, Zhikun; Guo, Yang; Jiang, Hong; Li, Junming] Nanchang Univ, Dept Clin Lab, Affiliated Hosp 1, Nanchang, Jiangxi, Peoples R China; [Peng, Yiping] Jiangxi Chest Hosp, Dept TB, Nanchang, Jiangxi, Peoples R China; [Xiong, Guoliang] Jiangxi Chest Hosp, Dept Clin Lab, Nanchang, Jiangxi, Peoples R China	Nanchang University	Li, JM (corresponding author), Nanchang Univ, Dept Clin Lab, Affiliated Hosp 1, Nanchang, Jiangxi, Peoples R China.	lisir361@163.com		Li, Junming/0000-0003-1409-3634	National Natural Science Foundation of China [81060001, 81170006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (grant numbers: 81060001 and 81170006 to L.J.-M.). URL of NSFC: http://www.nsfc.gov.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleman M, 2002, AM J RESP CELL MOL, V27, P583, DOI 10.1165/rcmb.2002-0038OC; Beisiegel M, 2009, J INFECT DIS, V199, P1222, DOI 10.1086/597421; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Carmona-Rivera C, 2013, SEMIN IMMUNOPATHOL, V35, P455, DOI 10.1007/s00281-013-0375-7; Chinese Medical Association, 2005, GUID CLIN DIAGN TREA; Cloke T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048939; Cloke T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072034; Corleis B, 2012, CELL MICROBIOL, V14, P1109, DOI 10.1111/j.1462-5822.2012.01783.x; Denny MR, 2010, J IMMUNOL, V184, P3284, DOI 10.4049/jimmunol.0902199; Dey B, 2014, SEMIN IMMUNOL, V26, P486, DOI 10.1016/j.smim.2014.09.002; Elghetany MT, 2002, BLOOD CELL MOL DIS, V28, P260, DOI 10.1006/bcmd.2002.0513; Eruslanov EB, 2005, INFECT IMMUN, V73, P1744, DOI 10.1128/IAI.73.3.1744-1753.2005; Eum SY, 2010, CHEST, V137, P122, DOI 10.1378/chest.09-0903; Fu J, 2014, ANN ALLERG ASTHMA IM, V113, P635, DOI 10.1016/j.anai.2014.08.024; Grayson PC, 2015, ARTHRITIS RHEUMATOL, V67, P1922, DOI 10.1002/art.39153; Kaplan MJ, 2011, NAT REV RHEUMATOL, V7, P691, DOI 10.1038/nrrheum.2011.132; Korbel DS, 2008, MICROBES INFECT, V10, P995, DOI 10.1016/j.micinf.2008.07.039; Peiper S. C., 1997, LEUCOCYTE TYPING, P972; Philips JA, 2012, ANNU REV PATHOL-MECH, V7, P353, DOI 10.1146/annurev-pathol-011811-132458; Ralph AP, 2010, THORAX, V65, P863, DOI 10.1136/thx.2010.136242; Seiler P, 2000, J INFECT DIS, V181, P671, DOI 10.1086/315278; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Ssemaganda A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085696	23	51	54	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153567	10.1371/journal.pone.0153567	http://dx.doi.org/10.1371/journal.pone.0153567			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073889	Green Published, gold			2022-12-27	WOS:000374131200107
J	Enerly, E; Bonde, J; Schee, K; Pedersen, H; Lonnberg, S; Nygard, M				Enerly, Espen; Bonde, Jesper; Schee, Kristina; Pedersen, Helle; Lonnberg, Stefan; Nygard, Mari			Self-Sampling for Human Papillomavirus Testing among Non-Attenders Increases Attendance to the Norwegian Cervical Cancer Screening Programme	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; GENOTYPE SPECIFICITY; WOMEN; METAANALYSIS; PARTICIPATION; REASONS; SWEDEN; AUDIT	Increasing attendance to screening offers the best potential for improving the effectiveness of well-established cervical cancer screening programs. Self-sampling at home for human papillomavirus (HPV) testing as an alternative to a clinical sampling can be a useful policy to increase attendance. To determine whether self-sampling improves screening attendance for women who do not regularly attend the Norwegian Cervical Cancer Screening Programme (NCCSP), 800 women aged 25-69 years in the Oslo area who were due to receive a 2nd reminder to attend regular screening were randomly selected and invited to be part of the intervention group. Women in this group received one of two self-sampling devices, Evalyn Brush or Delphi Screener. To attend screening, women in the intervention group had the option of using the self-sampling device (self-sampling subgroup) or visiting their physician for a cervical smear. Self-sampled specimens were split and analyzed for the presence of high-risk (hr) HPV by the CLART (R) HPV2 test and the digene (R) Hybrid Capture (HC)2 test. The control group consisted of 2593 women who received a 2nd reminder letter according to the current guidelines of the NCCSP. The attendance rates were 33.4% in the intervention group and 23.2% in the control group, with similar attendance rates for both self-sampling devices. Women in the self-sampling subgroup responded favorably to both self-sampling devices and cited not remembering receiving a call for screening as the most dominant reason for previous non-attendance. Thirty-two of 34 (94.1%) hrHPV-positive women in the self-sampling subgroup attended follow-up. In conclusion, self-sampling increased attendance rates and was feasible and well received. This study lends further support to the proposal that self-sampling may be a valuable alternative for increasing cervical cancer screening coverage in Norway.	[Enerly, Espen; Schee, Kristina; Nygard, Mari] Oslo Univ Hosp, Canc Registry Norway, Dept Res, Oslo, Norway; [Bonde, Jesper; Pedersen, Helle] Copenhagen Univ Hosp Hvidovre, Dept Pathol, Hvidovre, Denmark; [Bonde, Jesper; Pedersen, Helle] Copenhagen Univ Hosp Hvidovre, Clin Res Ctr, Hvidovre, Denmark; [Lonnberg, Stefan] Oslo Univ Hosp, Cerv Canc Screening Programme, Canc Registry Norway, Oslo, Norway	University of Oslo; University of Copenhagen; University of Copenhagen; University of Oslo	Enerly, E (corresponding author), Oslo Univ Hosp, Canc Registry Norway, Dept Res, Oslo, Norway.	espen.enerly@kreftregisteret.no	Enerly, Espen/P-4666-2019; Bonde, Jesper/AAN-5930-2020	Enerly, Espen/0000-0002-2974-2273; Lonnberg, Stefan/0000-0002-5561-9041; Bonde, Jesper/0000-0003-4853-6747; Nygard, Mari/0000-0002-4100-4855	Norwegian Cancer Society [63499]	Norwegian Cancer Society(Norwegian Cancer Society)	This study was funded by Norwegian Cancer Society (Grant# 63499) (https://kreftforeningen.no/en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrae B, 2008, JNCI-J NATL CANCER I, V100, P622, DOI 10.1093/jnci/djn099; Andreassen Trude, 2014, Tidsskr Nor Laegeforen, V134, P1122, DOI 10.4045/tidsskr.14.0240; Arbyn M, 2014, J PATHOL, V234, P431, DOI 10.1002/path.4424; Arbyn M, 2014, LANCET ONCOL, V15, P172, DOI 10.1016/S1470-2045(13)70570-9; Arbyn M, 2009, EUR J CANCER, V45, P2640, DOI 10.1016/j.ejca.2009.07.018; Bosgraaf RP, 2014, PREV MED, V64, P108, DOI 10.1016/j.ypmed.2014.04.011; Broberg G, 2014, INT J CANCER, V134, P2223, DOI 10.1002/ijc.28545; Bruni L, 2010, J INFECT DIS, V202, P1789, DOI 10.1086/657321; Cancer Registry of Norway, 2012, CANC NORW 2010 CANC; Castle PE, 2008, J CLIN MICROBIOL, V46, P2595, DOI 10.1128/JCM.00824-08; Eaker S, 2001, PREV MED, V32, P482, DOI 10.1006/pmed.2001.0844; Hansen BT, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-264; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Biological agents, 2012, IARC MON EV CARC RIS, V100; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lonnberg S, 2013, INT J CANCER, V132, P2134, DOI 10.1002/ijc.27844; Nygard JF, 2005, CANCER CAUSE CONTROL, V16, P463, DOI 10.1007/s10552-004-6295-z; Nygard JF, 2002, J MED SCREEN, V9, P86, DOI 10.1136/jms.9.2.86; Poljak M, 2009, J CLIN MICROBIOL, V47, P2611, DOI 10.1128/JCM.00278-09; Racey CS, 2013, CAN J PUBLIC HEALTH, V104, pE159, DOI 10.1007/BF03405681; Rebolj M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086835; Rebolj M, 2013, CURR PHARM DESIGN, V19, P1439; Ronco G, 2014, LANCET, V383, P524, DOI 10.1016/S0140-6736(13)62218-7; Rossi PG, 2015, BRIT J CANCER, V112, P667, DOI 10.1038/bjc.2015.11; Rossi PG, 2011, BRIT J CANCER, V104, P248, DOI 10.1038/sj.bjc.6606040; Sasieni P, 2009, BRIT MED J, V339, pb2968, DOI DOI 10.1136/BMJ.B2968; Skare GB, 2014, MASSEUNDERSOKELSEN M; Szarewski A, 2011, BRIT J CANCER, V104, P915, DOI 10.1038/bjc.2011.48; Verdoodt F, 2015, EUR J CANCER, V51, P2375, DOI 10.1016/j.ejca.2015.07.006	28	55	55	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0151978	10.1371/journal.pone.0151978	http://dx.doi.org/10.1371/journal.pone.0151978			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073929	Green Published, Green Submitted, gold			2022-12-27	WOS:000374131200013
J	Bai, L; Li, MQ; Sun, JL; Yang, XG; Lu, YQ; Lu, SS; Lu, KH				Bai, Lin; Li, Mengqi; Sun, Junli; Yang, Xiaogan; Lu, Yangqing; Lu, Shengsheng; Lu, Kehuan			RNA-Seq Profiling of Intact and Enucleated Oocyte SCNT Embryos Reveals the Role of Pig Oocyte Nucleus in Somatic Reprogramming	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; DEVELOPMENTAL COMPETENCE; MICE; FIBROBLASTS; TOOL	The specific molecular mechanisms involved in somatic reprogramming remain unidentified. Removal of the oocyte genome is one of the primary causes of developmental failure in cloned embryos, whereas intact oocyte shows stronger reprogramming capability than enucleated oocyte. To identify the reason for the low efficiency of cloning and elucidate the mechanisms involved in somatic reprogramming by the oocyte nucleus, we injected pig cumulus cells into 539 intact MII oocytes and 461 enucleated MII oocytes. Following activation, 260 polyploidy embryos developed to the blastocyst stage whereas only 93 traditionally cloned embryos (48.2% vs. 20.2%, P < 0.01) reached blastocyst stage. Blastocysts generated from intact oocytes also had more cells than those generated from enucleated oocytes (60.70 vs. 46.65, P < 0.01). To identify the genes that contribute to this phenomenon, two early embryos in 2-cell and 4-cell stages were collected for single-cell RNA sequencing. The two kinds of embryos were found to have dramatically different transcriptome profiles. Intact oocyte nuclear transfer embryos showed 1,738 transcripts that were up-regulated relative to enucleated cloned embryos at the 2-cell stage and 728 transcripts that were down-regulated (vertical bar log2Ratio vertical bar >= 5). They showed 2,941 transcripts that were upregulated during the 4-cell stage and 1,682 that were down-regulated (vertical bar log2Ratio vertical bar >= 5). The most significantly enriched gene ontology categories were those involved in the regulation of binding, catalytic activity, and molecular transducer activity. Other genes that were notably up-regulated and expressed in intact oocyte nuclear transfer embryos were metabolic process. This study provides a comprehensive profile of the differences in gene expression between intact oocyte nuclear transfer embryos and traditional nuclear transfer embryos. This work thus paves the way for further research on the mechanisms underlying somatic reprogramming by oocytes.	[Bai, Lin; Li, Mengqi; Sun, Junli; Yang, Xiaogan; Lu, Yangqing; Lu, Shengsheng; Lu, Kehuan] Guangxi Univ, State Key Lab Conservat & Utilizat Subtrop Agrobi, 100 Daxue Rd, Nanning 530004, Guangxi Zhuang, Peoples R China; [Bai, Lin; Li, Mengqi; Sun, Junli; Yang, Xiaogan; Lu, Yangqing; Lu, Shengsheng; Lu, Kehuan] Guangxi Univ, Guangxi High Educ Lab Anim Reprod & Biotechnol, 100 Daxue Rd, Nanning 530004, Guangxi Zhuang, Peoples R China	Guangxi University; Guangxi University	Lu, SS; Lu, KH (corresponding author), Guangxi Univ, State Key Lab Conservat & Utilizat Subtrop Agrobi, 100 Daxue Rd, Nanning 530004, Guangxi Zhuang, Peoples R China.; Lu, SS; Lu, KH (corresponding author), Guangxi Univ, Guangxi High Educ Lab Anim Reprod & Biotechnol, 100 Daxue Rd, Nanning 530004, Guangxi Zhuang, Peoples R China.	sslu@gxu.edu.cn; khlu@gxu.edu.cn			National Natural Science Foundation of China [31260553]; Guangxi High Education Innovative Research Group and Eminent Scholar Project [2014-7]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangxi High Education Innovative Research Group and Eminent Scholar Project	This work was supported by the National Natural Science Foundation of China (Award Number: 31260553; Recipient: Kehuan Lu; URL: http://www.nsfc.gov.cn/); Guangxi High Education Innovative Research Group and Eminent Scholar Project (Award Number: 2014-7 Recipient: Yangqing Lu URL: http://www.gxedu.gov.cn/).	cells Cloned pigs produced by nuclear transfer from adult somatic, 2000, NATURE, V407, P86; Chesne P, 2002, NAT BIOTECHNOL, V20, P366, DOI 10.1038/nbt0402-366; Chung Y, 2009, CLONING STEM CELLS, V11, P213, DOI 10.1089/clo.2009.0004; Cibelli JB, 1998, SCIENCE, V280, P1256, DOI 10.1126/science.280.5367.1256; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Do JT, 2004, STEM CELLS, V22, P941, DOI 10.1634/stemcells.22-6-941; Dolcet X, 2005, VIRCHOWS ARCH, V446, P475, DOI 10.1007/s00428-005-1264-9; Hall VJ, 2007, HUM REPROD, V22, P52, DOI 10.1093/humrep/del345; Heindryckx B, 2007, HUM REPROD, V22, P1982, DOI 10.1093/humrep/dem106; Hooper SD, 2005, BIOINFORMATICS, V21, P4432, DOI 10.1093/bioinformatics/bti696; Humpherys D, 2001, SCIENCE, V293, P95, DOI 10.1126/science.1061402; Hunter RB, 2004, J CLIN INVEST, V114, P1504, DOI 10.1172/JCI200421696; Inoue A, 2008, HUM REPROD, V23, P1377, DOI 10.1093/humrep/den096; Jaenisch Rudolf, 2002, Cloning and Stem Cells, V4, P389, DOI 10.1089/153623002321025069; Jouneau A, 2003, CURR OPIN GENET DEV, V13, P486, DOI 10.1016/j.gde.2003.08.007; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kubota C, 2000, P NATL ACAD SCI USA, V97, P990, DOI 10.1073/pnas.97.3.990; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Ling L, 2001, CLONING, V3, P51; Ma H, 2014, NATURE, V511, P177, DOI 10.1038/nature13551; Maeda I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2780; Noggle S, 2011, NATURE, V478, P70, DOI 10.1038/nature10397; Ogushi S, 2008, SCIENCE, V319, P613, DOI 10.1126/science.1151276; Onishi A, 2000, SCIENCE, V289, P1188, DOI 10.1126/science.289.5482.1188; Pereira L, 2006, MOL CELL BIOL, V26, P7479, DOI 10.1128/MCB.00368-06; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Shin T, 2002, NATURE, V415, P859, DOI 10.1038/nature723; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Vassena R, 2007, DEV BIOL, V304, P75, DOI 10.1016/j.ydbio.2006.12.015; Wakayama S, 2007, CURR BIOL, V17, pR120, DOI 10.1016/j.cub.2006.12.020; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Wakayama T, 1999, P NATL ACAD SCI USA, V96, P14984, DOI 10.1073/pnas.96.26.14984; Wrenzycki C, 2006, GENE EXPRESSION METH, P285; Yang H, 2010, CELL RES, V20, P1034, DOI 10.1038/cr.2010.97; Zhou WP, 2013, CELL REPROGRAM, V15, P92, DOI 10.1089/cell.2012.0043	37	5	5	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0153093	10.1371/journal.pone.0153093	http://dx.doi.org/10.1371/journal.pone.0153093			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27070804	gold, Green Submitted, Green Published			2022-12-27	WOS:000373900700031
J	Li, YL; Zhang, JL; Min, D; Zhou, HY; Lin, N; Li, QS				Li, Yun-lan; Zhang, Jiali; Min, Dong; Zhou Hongyan; Lin, Niu; Li, Qing-shan			Anticancer Effects of 1,3-Dihydroxy-2-Methylanthraquinone and the Ethyl Acetate Fraction of Hedyotis Diffusa Willd against HepG2 Carcinoma Cells Mediated via Apoptosis	PLOS ONE			English	Article							BCL-2 FAMILY-MEMBERS; CYTOCHROME-C; CANCER; ANTHRAQUINONES; RUBIADIN; PATHWAY; ARREST; P53	Hedyotis Diffusa Willd, used in Traditional Chinese Medicine, is a treatment for various diseases including cancer, owing to its mild effectiveness and low toxicity. The aim of this study was to identify the main anticancer components in Hedyotis Diffusa Willd, and explore mechanisms underlying their activity. Hedyotis Diffusa Willd was extracted and fractionated using ethyl acetate to obtain the H-Ethyl acetate fraction, which showed higher anticancer activity than the other fractions obtained against HepG2 cells with sulforhodamine B assays. The active component of the H-Ethyl acetate fraction was identified to be 1,3-dihydroxy-2-methy-lanthraquinone (DMQ) with much high inhibitory rate up to 48.9 +/- 3.3% and selectivity rate up to 9.4 +/- 4.5 folds (p<0.01) at 125 mu mol/L. HepG2 cells treated with the fraction and DMQ visualized morphologically using light and fluorescence microscopy. Annexin V-fluorescein isothiocyanate / propidium iodide staining flow cytometry, DNA ladder and cell cycle distribution assays. Mechanistic studies showed up-regulation of caspase-3, -8, and -9 proteases activities (p<0.001), indicating involvement of mitochondrial apoptotic and death receptor pathways. Further studies revealed that reactive oxygen species in DMQ and the fraction treated HepG2 cells increased (p<0.01) while mitochondrial membrane potential reduced significantly (p<0.001) compared to the control by flow cytometry assays. Western blot analysis showed that Bax, p53, Fas, FasL, p21 and cytoplasmic cytochrome C were up-regulated (p<0.01), while Bcl-2, mitochondrial cytochrome C, cyclin E and CDK 2 were down-regulated dose-dependently (p<0.01). The reverse transcriptase-polymerase chain reaction showed that mRNA expressions of p53 and Bax increased (p<0.001) while that of Bcl-2 decreased (p<0.001). Pre-treatment with caspase-8 inhibitor Z-IETD-FMK, or caspase-9 inhibitor Z-LEHD-FMK, attenuated the growth-inhibitory and apoptosis-inducing effects of DMQ and the fraction on HepG2 cells. These results suggested that DMQ and the H-Ethyl acetate fraction of Hedyotis Diffusa Willd showed potential anticancer effects. Furthermore, the mechanisms of action may involve mitochondrial apoptotic and death receptor pathways.	[Li, Yun-lan; Zhang, Jiali; Min, Dong; Zhou Hongyan; Lin, Niu; Li, Qing-shan] Shanxi Med Univ, Sch Pharmaceut Sci, Taiyuan 030001, Peoples R China	Shanxi Medical University	Li, YL; Li, QS (corresponding author), Shanxi Med Univ, Sch Pharmaceut Sci, Taiyuan 030001, Peoples R China.	liyunlanrr@163.com; sxlqs2012@163.com			Natural Science Foundation of Shanxi Province [2014011027-1]; Program for Science and Technology of Shanxi Province [20130313021-9]; Top Science and Technology Innovation Teams of Higher Learning Institutions of Shanxi Province; Program for the Top Young and Middle-aged Innovative Talents of Higher Learning Institutions of Shanxi Province; Foundation of Young Academic Leader in Shanxi Province; Shanxi Province Returnees Preferred Project; Education Reform and Research Project of the colleges and universities of Shanxi Province; Program for the Natural Science Foundation of Shanxi Province [2014011027-1]	Natural Science Foundation of Shanxi Province(Natural Science Foundation of Shanxi Province); Program for Science and Technology of Shanxi Province; Top Science and Technology Innovation Teams of Higher Learning Institutions of Shanxi Province; Program for the Top Young and Middle-aged Innovative Talents of Higher Learning Institutions of Shanxi Province; Foundation of Young Academic Leader in Shanxi Province; Shanxi Province Returnees Preferred Project; Education Reform and Research Project of the colleges and universities of Shanxi Province; Program for the Natural Science Foundation of Shanxi Province	This research was supported by the Natural Science Foundation of Shanxi Province (No. 2014011027-1), Program for Science and Technology of Shanxi Province (No. 20130313021-9), the Top Science and Technology Innovation Teams of Higher Learning Institutions of Shanxi Province, the Program for the Top Young and Middle-aged Innovative Talents of Higher Learning Institutions of Shanxi Province (2015), Foundation of Young Academic Leader in Shanxi Province, Shanxi Province Returnees Preferred Project in 2012, Education Reform and Research Project of the colleges and universities of Shanxi Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Financial supports form Program for the Natural Science Foundation of Shanxi Province (No. 2014011027-1), Program for Science and Technology of Shanxi Province (No. 20130313021-9), the Top Science and Technology Innovation Teams of Higher Learning Institutions of Shanxi Province, the Program for the Top Young and Middle-aged Innovative Talents of Higher Learning Institutions of Shanxi Province (2015), Foundation of Young Academic Leader in Shanxi Province, Shanxi Province Returnees Preferred Project in 2012, Education Reform and Research Project of the colleges and universities of Shanxi Province are gratefully acknowledged.	Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; BERGH J, 1995, NAT MED, V1, P1029, DOI 10.1038/nm1095-1029; Bouillet P, 2002, J CELL SCI, V115, P1567; Cillessen SAGM, 2010, J PATHOL, V220, P509, DOI 10.1002/path.2670; Comini LR, 2011, PHYTOMEDICINE, V18, P1093, DOI 10.1016/j.phymed.2011.05.008; Ekert PG, 2005, CURR OPIN CELL BIOL, V17, P626, DOI 10.1016/j.ceb.2005.09.001; Gupta S, 2003, ARCH BIOCHEM BIOPHYS, V410, P177, DOI 10.1016/S0003-9861(02)00668-9; Harry A Rogoff, 2004, CELL CYCLE, V3, P845; Huang Wei-Hua, 2008, Zhongguo Zhong Yao Za Zhi, V33, P524; Jiang XJ, 2004, ANNU REV BIOCHEM, V73, P87, DOI 10.1146/annurev.biochem.73.011303.073706; Ju SM, 2015, PHARM BIOL, V53, P1002, DOI 10.3109/13880209.2014.952834; Kanokmedhakul K, 2005, J ETHNOPHARMACOL, V100, P284, DOI 10.1016/j.jep.2005.03.018; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kuo YJ, 2015, IN VIVO, V29, P453; Ledgerwood EC, 2009, CLIN CANCER RES, V15, P420, DOI 10.1158/1078-0432.CCR-08-1172; Newton HB, 2005, EXPERT REV ANTICANC, V5, P355, DOI 10.1586/14737140.5.2.355; Niu Y, 2013, J ASIAN NAT PROD RES, V15, P550, DOI 10.1080/10286020.2013.781589; Ow YLP, 2008, NAT REV MOL CELL BIO, V9, P532, DOI 10.1038/nrm2434; Rao GMM, 2006, J ETHNOPHARMACOL, V103, P484, DOI 10.1016/j.jep.2005.08.073; Ribble D, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-12; Vittar NBR, 2014, PHOTODIAGN PHOTODYN, V11, P182, DOI 10.1016/j.pdpdt.2014.02.002; Sayers TJ, 2011, CANCER IMMUNOL IMMUN, V60, P1173, DOI 10.1007/s00262-011-1008-4; Soini Y, 1998, AM J PATHOL, V153, P1041, DOI 10.1016/S0002-9440(10)65649-0; Tripathi YB, 1997, INDIAN J BIOCHEM BIO, V34, P302; Trivedi R, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.429; Weyhenmeyer B., 2012, Experimental Oncology, V34, P192; Zhao J, 2012, CANCER LETT, V314, P8, DOI 10.1016/j.canlet.2011.09.040; Zheng L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118276	28	28	28	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2016	11	4							e0151502	10.1371/journal.pone.0151502	http://dx.doi.org/10.1371/journal.pone.0151502			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0KH	27064569	Green Published, gold, Green Submitted			2022-12-27	WOS:000373891000004
J	Min, JJ; Kim, G; Lee, JH; Hong, KY; Kim, WS; Lee, YT				Min, Jeong Jin; Kim, Gahyun; Lee, Jong-Hwan; Hong, Kwan Young; Kim, Wook Sung; Lee, Young-Tak			Does the Type of Anesthetic Technique Affect In-Hospital and One-Year Outcomes after Off-Pump Coronary Arterial Bypass Surgery?	PLOS ONE			English	Article							PRESERVES MYOCARDIAL-FUNCTION; VOLATILE ANESTHETICS; ATRIAL-FIBRILLATION; PROPOFOL ANESTHESIA; CARDIAC-SURGERY; SEVOFLURANE; DESFLURANE; ISOFLURANE; PROTECTION; INJURY	Despite numerous previous studies, there is little data on the effects of anesthetics on clinical outcome after off-pump coronary arterial bypass grafting (OPCAB). Therefore, we retrospectively compared the effects of anesthetic choice on in-hospital major adverse events (MAEs) and one-year major adverse cardiovascular and cerebral events (MACCEs) in patients undergoing OPCAB. Electronic medical records were reviewed in 192 patients who received propofol-remifenanil total intravenous anesthesia (TIVA) and propensity score-matched 662 patients who received isoflurane anesthesia. The primary endpoints were in-hospital MAEs and one-year MACCEs. The components of in-hospital MAEs were in-hospital death, myocardial infarction (MI), coronary revascularization, stroke, renal failure, prolonged mechanical ventilation longer than 72 h, and postoperative new cardiac arrhythmia requiring treatment. One-year MACCEs was defined as a composite of all-cause mortality, MI, coronary revascularization, and stroke. There was no significant difference in risk of in-hospital MAEs (OR = 1.29, 95% CI = 0.88-1.88, P = 0.20) or one-year MACCEs (OR = 0.81; 95% CI = 0.46-1.42, P = 0.46) between the groups. The risk of postoperative new arrhythmia including new atrial fibrillation significantly increased in the TIVA group compared to the isoflurane anesthesia group (OR = 1.72, 95% CI = 1.12-2.63, P = 0.01). In conclusion, the choice between propofol-remifentanil TIVA and isoflurane anesthesia did not show differences in incidence of in-hospital MAEs or one-year MACCEs in patients undergoing OPCAB. However, further studies on the effects of anesthetics on development of in-hospital new arrhythmia will be needed.	[Min, Jeong Jin; Kim, Gahyun; Lee, Jong-Hwan; Hong, Kwan Young] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Anesthesiol & Pain Med, Seoul, South Korea; [Kim, Wook Sung; Lee, Young-Tak] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Thorac & Cardiovasc Surg, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Lee, JH (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Anesthesiol & Pain Med, Seoul, South Korea.	jonghwanlee75@gmail.com		Hong, Kwan Young/0000-0001-6213-1848				Almassi GH, 2012, J THORAC CARDIOV SUR, V143, P93, DOI 10.1016/j.jtcvs.2011.10.003; Baki ED, 2013, INFLAMMATION, V36, P1327, DOI 10.1007/s10753-013-9671-6; Bein B, 2005, ANESTH ANALG, V100, P610, DOI 10.1213/01.ANE.0000145012.27484.A7; Bignami E, 2013, J CARDIOTHOR VASC AN, V27, P50, DOI 10.1053/j.jvca.2012.06.007; Conzen PF, 2003, ANESTHESIOLOGY, V99, P826, DOI 10.1097/00000542-200310000-00013; Cope DK, 1997, ANESTHESIOLOGY, V86, P699, DOI 10.1097/00000542-199703000-00023; De Hert S, 2009, ANAESTHESIA, V64, P953, DOI 10.1111/j.1365-2044.2009.06008.x; De Hert SG, 2004, ANESTHESIOLOGY, V101, P299, DOI 10.1097/00000542-200408000-00009; De Hert SG, 2003, ANESTHESIOLOGY, V99, P314, DOI 10.1097/00000542-200308000-00013; De Hert SG, 2002, ANESTHESIOLOGY, V97, P42, DOI 10.1097/00000542-200207000-00007; Guarracino F, 2006, J CARDIOTHOR VASC AN, V20, P477, DOI 10.1053/j.jvca.2006.05.012; Orriach JLG, 2013, J CRIT CARE, V28, DOI 10.1016/j.jcrc.2013.06.004; Helgadottir S, 2012, J CARDIOTHORAC SURG, V7, DOI 10.1186/1749-8090-7-87; Kato R, 2002, CAN J ANAESTH, V49, P777, DOI 10.1007/BF03017409; Kehl F, 2002, ANESTHESIOLOGY, V96, P183, DOI 10.1097/00000542-200201000-00032; Landoni G, 2014, BRIT J ANAESTH, V113, P955, DOI 10.1093/bja/aeu290; Landoni G, 2013, BRIT J ANAESTH, V111, P886, DOI 10.1093/bja/aet231; Law-Koune JD, 2006, J CARDIOTHOR VASC AN, V20, P484, DOI 10.1053/j.jvca.2005.08.001; Moussa ID, 2013, J AM COLL CARDIOL, V62, P1563, DOI 10.1016/j.jacc.2013.08.720; Mrozinski P, 2014, ANAESTH INTENSIVE TH, V46, P4, DOI [10.5603/AIT.2014.002, 10.5603/AIT.2014.0002]; Rassen JA, 2012, PHARMACOEPIDEM DR S, V21, P69, DOI 10.1002/pds.3263; Riess ML, 2004, AM J PHYSIOL-HEART C, V286, pH1603, DOI 10.1152/ajpheart.00963.2003; Sanchez-Conde P, 2008, ANESTH ANALG, V106, P371, DOI 10.1213/ane.0b013e318160580b; Sirvinskas E, 2015, PERFUSION; Subramaniam B, 2014, ANESTH ANALG, V118, P277, DOI 10.1213/ANE.0000000000000100; Symons JA, 2006, BRIT J ANAESTH, V97, P127, DOI 10.1093/bja/ael149; Tanaka K, 2002, AM J PHYSIOL-HEART C, V282, pH2018, DOI 10.1152/ajpheart.01130.2001; Tempe DK, 2011, J CARDIOTHOR VASC AN, V25, P59, DOI 10.1053/j.jvca.2010.03.002; Yoo YC, 2014, KIDNEY INT, V86, P414, DOI 10.1038/ki.2013.532; Zaman AG, 2000, CIRCULATION, V101, P1403, DOI 10.1161/01.CIR.101.12.1403	30	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0152060	10.1371/journal.pone.0152060	http://dx.doi.org/10.1371/journal.pone.0152060			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27054364	gold, Green Published			2022-12-27	WOS:000373608000011
J	Preuss, A; Schaafs, LA; Werncke, T; Steffen, IG; Hamm, B; Elgeti, T				Preuss, Alexandra; Schaafs, Lars-Arne; Werncke, Thomas; Steffen, Ingo G.; Hamm, Bernd; Elgeti, Thomas			Run-Off Computed Tomography Angiography (CTA) for Discriminating the Underlying Causes of Intermittent Claudication	PLOS ONE			English	Article							PERIPHERAL ARTERIAL-DISEASE; EXTRAVASCULAR INCIDENTAL FINDINGS; MULTIDETECTOR CT; ABDOMINAL-AORTA; LUMBAR SPINE; DIAGNOSIS; PREVALENCE; MANAGEMENT; SCANS	Aim To evaluate run-off computed tomography angiography (CTA) of abdominal aorta and lower extremities for detecting musculoskeletal pathologies and clinically relevant extravascular incidental findings in patients with intermittent claudication (IC) and suspected peripheral arterial disease (PAD). Does run-off CTA allow image-based therapeutic decision making by discriminating the causes of intermittent claudication in patients with suspected peripheral arterial disease PAD? Material and Methods Retrospective re-evaluation of CTAs performed in patients with acute or chronic intermittent claudication (i.e., Fontaine stages I to IIB) between January 2005 and October 2013. Allocation to one of three categories of underlying causes of IC symptoms: vascular, musculoskeletal (MSK) or both. Clinically relevant extravascular incidental findings were evaluated. Medical records were reviewed to verify specific therapies as well as main and incidental findings. Results While focused on vascular imaging, CTA image quality was sufficient for evaluation of the MSK system in all cases. The underlying cause of IC was diagnosed in run-off CTA as vascular, MSK and a combination in n = 138 (65%), n = 10 (4%), and n = 66 (31%) cases, respectively. Specific vascular or MSK therapy was recorded in n = 123 and n = 9 cases. In n = 82, no follow-up was possible. Clinically relevant extravascular incidental findings were detected in n = 65 patients (30%) with neoplasia, ascites and pleural effusion being the most common findings. Discussion Run-off CTA allows identification of vascular, MSK, and combined causes of IC in patients with suspected PAD and can guide specific therapy. CTA also allowed confident detection of crEVIF although detection did not necessarily trigger workup or treatment.	[Preuss, Alexandra; Schaafs, Lars-Arne; Steffen, Ingo G.; Hamm, Bernd; Elgeti, Thomas] Charite, Dept Radiol, D-13353 Berlin, Germany; [Werncke, Thomas] Hannover Med Sch, Inst Radiol, D-30623 Hannover, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Hannover Medical School	Schaafs, LA (corresponding author), Charite, Dept Radiol, D-13353 Berlin, Germany.	lars-arne.schaafs@charite.de	Werncke, Thomas/AFV-2471-2022; Schaafs, Lars-Arne/ABC-5936-2021	Schaafs, Lars-Arne/0000-0002-2250-5419	Abbott; Actelion Pharmaceuticals; Bayer Schering Pharma; Bayer Vital; BRACCO Group; Bristol-Myers Squibb; Charite research organisation GmbH; Deutsche Krebshilfe; Dt. Stiftung fur Herzforschung; Essex Pharma; EU Programmes; Fibrex Medical Inc.; Focused Ultrasound Surgery Foundation; Fraunhofer Gesellschaft; Guerbet; INC Research; InSightec Ud.; IPSEN Pharma; Kendlel MorphoSys AG; Lilly GmbH; Lundbeck GmbH; MeVis Medical Solutions AG; Nexus Oncology; Novartis; Parexel Clinical Research Organisation Service; Perceptive; Pfizer GmbH; Philipps; Sanofis-Aventis S.A; Siemens; Spectranetics GmbH; Terumo Medical Corporation; TNS Healthcare GMbH; Toshiba; UCB Pharma; Wyeth Pharma; Zukunftsfond Berlin (TSB); Amgen; AO Foundation; BARD; BBraun; Boehring Ingelheimer; Brainsgate; PPD (Clinical Research Organisation); CELLACT Pharma; Celgene; CeloNova BioSciences; Covance; DC Deviees, Ine. USA; Ganymed; Gilead Sciences; Glaxo Smith Kline; ICON (Clinical Research Organisation); Jansen; LUX Bioseienees; MedPass; Merek; Mologen; Nuvisan; Pluristem; Quintiles; Roehe; Sehumaeher GmbH; Seattle Geneties; Symphogen; TauRx Therapeuties Ud.; Accovion; AIO: Arbeitsgemeinschaft Internistische Onkologie; ASR Advanced sleep research; Astellas; Theradex; Galena Biopharma; Chiltern; PRAint; Inspiremd; Medronic; Respicardia; Silena Therapeutics; Spectrum Pharmaceuticals; St. Jude	Abbott(Abbott Laboratories); Actelion Pharmaceuticals; Bayer Schering Pharma(Bayer AG); Bayer Vital(Bayer AG); BRACCO Group; Bristol-Myers Squibb(Bristol-Myers Squibb); Charite research organisation GmbH; Deutsche Krebshilfe(Deutsche Krebshilfe); Dt. Stiftung fur Herzforschung; Essex Pharma; EU Programmes; Fibrex Medical Inc.; Focused Ultrasound Surgery Foundation; Fraunhofer Gesellschaft; Guerbet; INC Research; InSightec Ud.; IPSEN Pharma(Ipsen); Kendlel MorphoSys AG; Lilly GmbH; Lundbeck GmbH(Lundbeck Corporation); MeVis Medical Solutions AG; Nexus Oncology; Novartis(Novartis); Parexel Clinical Research Organisation Service; Perceptive; Pfizer GmbH; Philipps; Sanofis-Aventis S.A; Siemens(Siemens AG); Spectranetics GmbH; Terumo Medical Corporation; TNS Healthcare GMbH; Toshiba; UCB Pharma(UCB Pharma SA); Wyeth Pharma(Wyeth); Zukunftsfond Berlin (TSB); Amgen(Amgen); AO Foundation; BARD(US-Israel Binational Science Foundation); BBraun; Boehring Ingelheimer; Brainsgate; PPD (Clinical Research Organisation); CELLACT Pharma(Dexcel Pharma); Celgene(Bristol-Myers SquibbCelgene Corporation); CeloNova BioSciences; Covance; DC Deviees, Ine. USA; Ganymed; Gilead Sciences(Gilead Sciences); Glaxo Smith Kline(GlaxoSmithKline); ICON (Clinical Research Organisation); Jansen; LUX Bioseienees; MedPass; Merek; Mologen; Nuvisan; Pluristem; Quintiles; Roehe; Sehumaeher GmbH; Seattle Geneties; Symphogen; TauRx Therapeuties Ud.; Accovion; AIO: Arbeitsgemeinschaft Internistische Onkologie; ASR Advanced sleep research; Astellas(Astellas Pharmaceuticals); Theradex; Galena Biopharma; Chiltern; PRAint; Inspiremd; Medronic; Respicardia; Silena Therapeutics; Spectrum Pharmaceuticals; St. Jude(St. Jude Medical)	BH has received research grants for the Department of Radiology, Charite - Universitatsmedizin Berlin from the following companies: 1. Abbott, 2. Actelion Pharmaceuticals, 3. Bayer Schering Pharma, 4. Bayer Vital, 5. BRACCO Group, 6. Bristol-Myers Squibb, 7. Charite research organisation GmbH, 8. Deutsche Krebshilfe, 9. Dt. Stiftung fur Herzforschung, 10. Essex Pharma, 11. EU Programmes, 12. Fibrex Medical Inc., 13. Focused Ultrasound Surgery Foundation, 14. Fraunhofer Gesellschaft, 15. Guerbet, 16. INC Research, 17. InSightec Ud., 18. IPSEN Pharma, 19. Kendlel MorphoSys AG, 20. Lilly GmbH, 21. Lundbeck GmbH, 22. MeVis Medical Solutions AG, 23. Nexus Oncology, 24. Novartis, 25. Parexel Clinical Research Organisation Service, 26. Perceptive, 27. Pfizer GmbH, 28. Philipps, 29. Sanofis-Aventis S.A, 30. Siemens, 31. Spectranetics GmbH, 32. Terumo Medical Corporation, 33. TNS Healthcare GMbH, 34. Toshiba, 35. UCB Pharma, 36. Wyeth Pharma, 37. Zukunftsfond Berlin (TSB), 38. Amgen, 39. AO Foundation, 40. BARD, 41. BBraun (Sponsoring eines Workshops), 42. Boehring Ingelheimer, 43. Brainsgate, 44. PPD (Clinical Research Organisation), 45. CELLACT Pharma, 46. Celgene, 47. CeloNova BioSciences, 48. Covance, 49. DC Deviees, Ine. USA, 50. Ganymed, 51. Gilead Sciences, 52. Glaxo Smith Kline, 53. ICON (Clinical Research Organisation), 54. Jansen, 55. LUX Bioseienees, 56. MedPass, 57. Merek, 58. Mologen, 59. Nuvisan, 60. Pluristem, 61. Quintiles, 62. Roehe, 63. Sehumaeher GmbH (Sponsoring eines Workshops), 64. Seattle Geneties, 65. Symphogen, 66. TauRx Therapeuties Ud., 67. Accovion, 68. AIO: Arbeitsgemeinschaft Internistische Onkologie, 69. ASR Advanced sleep research, 70. Astellas, 71. Theradex, 72. Galena Biopharma, 73. Chiltern, 74. PRAint, 75. Inspiremd, 76. Medronic, 77. Respicardia, 78. Silena Therapeutics, 79. Spectrum Pharmaceuticals, 80. St. Jude. The remaining authors have no conflicts of interest. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apfaltrer P, 2012, AM J ROENTGENOL, V198, P939, DOI 10.2214/AJR.11.7231; Bendix K, 2011, EUR J RADIOL, V80, P109, DOI 10.1016/j.ejrad.2010.05.024; Berland LL, 2010, J AM COLL RADIOL, V7, P754, DOI 10.1016/j.jacr.2010.06.013; BODEN SD, 1990, J BONE JOINT SURG AM, V72A, P403, DOI 10.2106/00004623-199072030-00013; Crockett MT, 2015, EUR J RADIOL, V84, P1569, DOI 10.1016/j.ejrad.2015.05.014; Duan YH, 2013, AM J ROENTGENOL, V201, pW906, DOI 10.2214/AJR.12.10209; Eun SS, 2012, J NEURORADIOLOGY, V39, P104, DOI 10.1016/j.neurad.2011.02.008; Fung HB, 2010, AM J GERIATR PHARMAC, V8, P47, DOI 10.1016/j.amjopharm.2010.01.003; Han SH, 2013, PAIN PHYSICIAN, V16, P513; HAWKES CH, 1978, J NEUROL SCI, V38, P337, DOI 10.1016/0022-510X(78)90140-5; Iezzi R, 2007, ABDOM IMAGING, V32, P489, DOI 10.1007/s00261-006-9136-6; Jeon CH, 2012, EUR SPINE J, V21, P1165, DOI 10.1007/s00586-011-2072-3; Kayhan A, 2012, EUR J RADIOL, V81, P542, DOI 10.1016/j.ejrad.2011.01.100; Kinder A, 2012, EUR J RADIOL, V81, pE561, DOI 10.1016/j.ejrad.2011.06.027; Levin David C, 2007, J Am Coll Radiol, V4, P457, DOI 10.1016/j.jacr.2007.02.011; Mamisch N, 2012, RADIOLOGY, V264, P174, DOI 10.1148/radiol.12111930; Met R, 2009, JAMA-J AM MED ASSOC, V301, P415, DOI 10.1001/jama.301.4.415; Nadeau M, 2013, CAN J SURG, V56, P372, DOI 10.1503/cjs.016512; Naidu SG, 2010, AM J ROENTGENOL, V194, P1630, DOI 10.2214/AJR.09.3538; Norgren L, 2007, EUR J VASC ENDOVASC, V33, pS5, DOI 10.1016/j.ejvs.2006.09.024; Ouwendijk R, 2005, RADIOLOGY, V236, P1094, DOI 10.1148/radiol.2363041140; Preuss A, 2015, CLIN RADIOL, V70, P622, DOI 10.1016/j.crad.2015.02.014; Schernthaner R, 2008, EUR RADIOL, V18, P665, DOI 10.1007/s00330-007-0822-8; Schernthaner R, 2007, AM J ROENTGENOL, V189, P1215, DOI 10.2214/AJR.07.2054; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; STANTON PE, 1987, AM SURGEON, V53, P71; Steurer J, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-175; Suri P, 2010, JAMA-J AM MED ASSOC, V304, P2628, DOI 10.1001/jama.2010.1833; Uesugi K, 2012, J ORTHOP SCI, V17, P673, DOI 10.1007/s00776-012-0311-z; Werncke T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119900; WIESEL SW, 1984, SPINE, V9, P549, DOI 10.1097/00007632-198409000-00003	31	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0152780	10.1371/journal.pone.0152780	http://dx.doi.org/10.1371/journal.pone.0152780			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27054846	Green Published, gold			2022-12-27	WOS:000373608000046
J	Wehbe, M; Anantha, M; Backstrom, I; Leung, A; Chen, K; Malhotra, A; Edwards, K; Bally, MB				Wehbe, Mohamed; Anantha, Malathi; Backstrom, Ian; Leung, Ada; Chen, Kent; Malhotra, Armaan; Edwards, Katarina; Bally, Marcel B.			Nanoscale Reaction Vessels Designed for Synthesis of Copper-Drug Complexes Suitable for Preclinical Development	PLOS ONE			English	Article							LARGE UNILAMELLAR VESICLES; REACTIVATES LATENT HIV-1; BREAST-CANCER CELLS; RNA-POLYMERASE I; SODIUM DIETHYLDITHIOCARBAMATE; LIPOSOMAL SYSTEMS; ANTICANCER AGENTS; PH GRADIENTS; DISULFIRAM; INHIBITION	The development of copper-drug complexes (CDCs) is hindered due to their very poor aqueous solubility. Diethyldithiocarbamate (DDC) is the primary metabolite of disulfiram, an approved drug for alcoholism that is being repurposed for cancer. The anticancer activity of DDC is dependent on complexation with copper to form copper bis-diethyldithiocarbamate (Cu(DDC)(2)), a highly insoluble complex that has not been possible to develop for indications requiring parenteral administration. We have resolved this issue by synthesizing Cu(DDC)(2) inside liposomes. DDC crosses the liposomal lipid bilayer, reacting with the entrapped copper; a reaction that can be observed through a colour change as the solution goes from a light blue to dark brown. This method is successfully applied to other CDCs including the anti-parasitic drug clioquinol, the natural product quercetin and the novel targeted agent CX-5461. Our method provides a simple, transformative solution enabling, for the first time, the development of CDCs as viable candidate anticancer drugs; drugs that would represent a brand new class of therapeutics for cancer patients.	[Wehbe, Mohamed; Anantha, Malathi; Backstrom, Ian; Leung, Ada; Chen, Kent; Malhotra, Armaan; Bally, Marcel B.] British Columbia Canc Res Ctr, Expt Therapeut, Vancouver, BC V5Z 1L3, Canada; [Wehbe, Mohamed; Bally, Marcel B.] Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC, Canada; [Leung, Ada; Bally, Marcel B.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada; [Edwards, Katarina] Uppsala Univ, Dept Chem, 3 Husargatan B7, Uppsala, Sweden; [Bally, Marcel B.] Ctr Drug Res & Dev, Vancouver, BC, Canada	British Columbia Cancer Agency; University of British Columbia; University of British Columbia; Uppsala University	Wehbe, M (corresponding author), British Columbia Canc Res Ctr, Expt Therapeut, Vancouver, BC V5Z 1L3, Canada.; Wehbe, M (corresponding author), Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC, Canada.	Mwehbe@bccrc.ca	Edwards, Katarina/AAR-7679-2021; Edwards, Katarina/A-1159-2012; Bracewell, Daniel/B-1988-2008	Edwards, Katarina/0000-0003-0674-2219; Edwards, Katarina/0000-0003-0674-2219; Bracewell, Daniel/0000-0003-3866-3304; Leung, Ada/0000-0002-8018-1248; Backstrom, Ian/0000-0003-2203-540X	Canadian Institutes of Health Research [MOP102611]; Canadian Cancer Society Research Institute [702491]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS))	The research described in this original paper was supported by grant funding from the Canadian Institutes of Health Research (MOP102611) http://www.cihr-irsc.gc.ca/e/193.html and the Canadian Cancer Society Research Institute (Award #702491) http://www.cancer.ca/en/research/grants-and-awards/current-funding-opportunities/innovationgrants/. Both grants were received by MB.	Abraham SA, 2005, METHOD ENZYMOL, V391, P71, DOI 10.1016/S0076-6879(05)91004-5; Abraham SA, 2004, J CONTROL RELEASE, V96, P449, DOI 10.1016/j.jconrel.2004.02.017; Allen C, 2002, BIOSCIENCE REP, V22, P225, DOI 10.1023/A:1020186505848; Bacher F, 2015, DALTON T, V44, P9071, DOI 10.1039/c5dt01076d; Bywater MJ, 2012, CANCER CELL, V22, P51, DOI 10.1016/j.ccr.2012.05.019; Ceh B, 1997, J COLLOID INTERF SCI, V185, P9, DOI 10.1006/jcis.1996.4555; Chen D, 2007, CANCER RES, V67, P1636, DOI 10.1158/0008-5472.CAN-06-3546; Chen D, 2006, CANCER RES, V66, P10425, DOI 10.1158/0008-5472.CAN-06-2126; Chityala VK, 2014, BIOINORG CHEM APPL, V2014, DOI 10.1155/2014/691260; Creaven BS, 2010, INORG CHIM ACTA, V363, P4048, DOI 10.1016/j.ica.2010.08.009; CULLIS PR, 1991, TRENDS BIOTECHNOL, V9, P268, DOI 10.1016/0167-7799(91)90088-Y; Cvek B, 2008, J MED CHEM, V51, P6256, DOI 10.1021/jm8007807; Dicko A, 2007, INT J PHARMACEUT, V337, P219, DOI 10.1016/j.ijpharm.2007.01.004; Ding WQ, 2009, IUBMB LIFE, V61, P1013, DOI 10.1002/iub.253; Dos Santos N, 2004, BBA-BIOMEMBRANES, V1661, P47, DOI 10.1016/j.bbamem.2003.11.016; Doyon G, 2013, AIDS, V27, pF7, DOI 10.1097/QAD.0b013e3283570620; Drygin D, 2011, CANCER RES, V71, P1418, DOI 10.1158/0008-5472.CAN-10-1728; Frezza M, 2010, CURR PHARM DESIGN, V16, P1813, DOI 10.2174/138161210791209009; Gou Y, 2015, J INORG BIOCHEM, V144, P47, DOI 10.1016/j.jinorgbio.2014.12.012; Haddach M, 2012, ACS MED CHEM LETT, V3, P602, DOI 10.1021/ml300110s; HARAN G, 1993, BIOCHIM BIOPHYS ACTA, V1151, P201, DOI 10.1016/0005-2736(93)90105-9; Hein N, 2013, CANCER RES, V73, DOI 10.1158/1538-7445.FBCR13-B16; HOPE MJ, 1985, BIOCHIM BIOPHYS ACTA, V812, P55, DOI 10.1016/0005-2736(85)90521-8; JOHANSSON B, 1992, ACTA PSYCHIAT SCAND, V86, P15, DOI 10.1111/j.1600-0447.1992.tb03310.x; Kanchi S, 2014, ARAB J CHEM, V7, P11, DOI 10.1016/j.arabjc.2013.04.026; LAKOMAA EL, 1982, TOXICOL APPL PHARM, V65, P286, DOI 10.1016/0041-008X(82)90011-4; Liu P, 2012, BRIT J CANCER, V107, P1488, DOI 10.1038/bjc.2012.442; MADDEN TD, 1990, CHEM PHYS LIPIDS, V53, P37, DOI 10.1016/0009-3084(90)90131-A; Marzano C, 2009, ANTI-CANCER AGENT ME, V9, P185, DOI 10.2174/187152009787313837; MAYER LD, 1990, BIOCHIM BIOPHYS ACTA, V1025, P143, DOI 10.1016/0005-2736(90)90091-2; Moseley H W, 1934, Science, V79, P507, DOI 10.1126/science.79.2057.507-a; Palanimuthu D, 2013, J MED CHEM, V56, P722, DOI 10.1021/jm300938r; Rae C, 2013, J NUCL MED, V54, P953, DOI 10.2967/jnumed.112.113324; SANANDRES MP, 1994, TALANTA, V41, P179, DOI 10.1016/0039-9140(94)80105-3; Santini C, 2014, CHEM REV, V114, P815, DOI 10.1021/cr400135x; Schimmer AD, 2011, CURR CANCER DRUG TAR, V11, P325; Tripathy DR, 2011, FEBS LETT, V585, P3270, DOI 10.1016/j.febslet.2011.09.005; WILLMOTT PL, 1950, ANALYST, V75, P24, DOI 10.1039/an9507500024; Xing SF, 2011, J VIROL, V85, P6060, DOI 10.1128/JVI.02033-10; Zhang HJ, 2010, CANCER RES, V70, P3996, DOI 10.1158/0008-5472.CAN-09-3752	40	34	34	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153416	10.1371/journal.pone.0153416	http://dx.doi.org/10.1371/journal.pone.0153416			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27055237	Green Published, Green Submitted, gold			2022-12-27	WOS:000373608000129
J	Collin, A; Le Marec, F; Vandenhende, MA; Lazaro, E; Duffau, P; Cazanave, C; Gerard, Y; Dabis, F; Bruyand, M; Bonnet, F				Collin, Amandine; Le Marec, Fabien; Vandenhende, Marie-Anne; Lazaro, Estibaliz; Duffau, Pierre; Cazanave, Charles; Gerard, Yann; Dabis, Francois; Bruyand, Mathias; Bonnet, Fabrice		ANRS CO3 Aquitaine Cohort Study Gr	Incidence and Risk Factors for Severe Bacterial Infections in People Living with HIV. ANRS CO3 Aquitaine Cohort, 2000-2012	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; MICROBIAL TRANSLOCATION; PNEUMONIA; MORTALITY; VIRUS; MORBIDITY; DISEASE; TRENDS; ERA	Severe non-AIDS bacterial infections (SBI) are the leading cause of hospital admissions among people living with HIV (PLHIV) in industrialized countries. We aimed to estimate the incidence of SBI and their risk factors in a large prospective cohort of PLHIV patients over a 13-year period in France. Patients followed up in the ANRS CO3 Aquitaine cohort between 2000 and 2012 were eligible; SBI was defined as a clinical diagnosis associated with hospitalization of >= 48 hours or death. Survival analysis was conducted to identify risk factors for SBI. Total follow-up duration was 39,256 person-years [PY] (31,370 PY on antiretroviral treatment [ART]). The incidence of SBI decreased from 26.7/1000 PY [95% CI: 22.9-30.5] over the period 2000-2002 to 11.9/1000 PY [10.1-13.8] in 2009-2012 (p <0.0001). Factors independently associated to increased risk of SBI were: plasma HIVRNA>50 copies/mL (Hazard Ratio [HR] = 5.1, 95% Confidence Interval: 4.2-6.2), CD4 count <500 cells/mm(3) and CD4/CD8 ratio <0.8 (with a dose-response relationship for both markers), history of cancer (HR = 1.4 [1.0-1.9]), AIDS stage (HR = 1.7 [1.3-2.1]) and HCV coinfection (HR = 1.4, [1.1-1.6]). HIV-positive patients with diabetes were more prone to SBI (HR = 1.6 [0.92.6]). Incidence of SBI decreased over a 13-year period due to the improvement in the virological and immune status of PLHIV on ART. Risk factors for SBI include low CD4 count and detectable HIV RNA, but also CD4/CD8 ratio, HCV coinfection, history of cancer and diabetes, comorbid conditions that have been frequent among PLHIV in recent years.	[Collin, Amandine; Vandenhende, Marie-Anne; Lazaro, Estibaliz; Duffau, Pierre; Cazanave, Charles; Gerard, Yann; Dabis, Francois; Bruyand, Mathias; Bonnet, Fabrice] Ctr Hosp Univ CHU Bordeaux, Coordinat Reg Lutte Infect VIH COREVIH, Bordeaux, France; [Collin, Amandine; Vandenhende, Marie-Anne; Duffau, Pierre; Bonnet, Fabrice] CHU Bordeaux, Serv Med Interne, Bordeaux, France; [Collin, Amandine; Vandenhende, Marie-Anne; Duffau, Pierre; Bonnet, Fabrice] CHU Bordeaux, Serv Malad Infect, Bordeaux, France; [Le Marec, Fabien; Vandenhende, Marie-Anne; Dabis, Francois; Bruyand, Mathias; Bonnet, Fabrice] Univ Bordeaux, ISPED, Ctr INSERM Epidemiol Biostat U897, Rue Leo Saignat, Bordeaux, France; [Le Marec, Fabien; Vandenhende, Marie-Anne; Dabis, Francois; Bruyand, Mathias; Bonnet, Fabrice] Univ Bordeaux, INSERM, U897, Ctr Inserm Epidemiol & Biostat, Rue Leo Saignat, Bordeaux, France; [Lazaro, Estibaliz] CHU Bordeaux, Serv Med Interne & Malad Infect, Pessac, France; [Cazanave, Charles] CHU Bordeaux, Federat Malad Infect & Trop, Pessac, France; [Gerard, Yann] CH Dax, Serv Malad Infect, Dax, France	CHU Bordeaux; CHU Bordeaux; CHU Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; CHU Bordeaux; CHU Bordeaux	Bonnet, F (corresponding author), Ctr Hosp Univ CHU Bordeaux, Coordinat Reg Lutte Infect VIH COREVIH, Bordeaux, France.; Bonnet, F (corresponding author), CHU Bordeaux, Serv Med Interne, Bordeaux, France.; Bonnet, F (corresponding author), CHU Bordeaux, Serv Malad Infect, Bordeaux, France.; Bonnet, F (corresponding author), Univ Bordeaux, ISPED, Ctr INSERM Epidemiol Biostat U897, Rue Leo Saignat, Bordeaux, France.; Bonnet, F (corresponding author), Univ Bordeaux, INSERM, U897, Ctr Inserm Epidemiol & Biostat, Rue Leo Saignat, Bordeaux, France.	fabrice.bonnet@chu-bordeaux.fr	Bonnet, Fabrice/T-3254-2019; Vandenhende, Marie-Anne/T-6625-2019; DABIS, FRANCOIS/S-9298-2019; Bruyand, Mathias/AAP-6177-2020; Cazanave, Charles/AHE-5492-2022	DABIS, FRANCOIS/0000-0002-1614-8857; 	France Recherche Nord&Sud Sida-HIV Hepatites (ANRS) [7 (AC7)]; Bordeaux University Hospital through the COREVIH Aquitaine [Inserm (U897)]; Bordeaux School of Public Health (ISPED)	France Recherche Nord&Sud Sida-HIV Hepatites (ANRS); Bordeaux University Hospital through the COREVIH Aquitaine; Bordeaux School of Public Health (ISPED)	This work is supported by a grant of France Recherche Nord&Sud Sida-HIV Hepatites (ANRS) within the Coordinated Action no. 7 (AC7). Other sources of support include the Bordeaux University Hospital through the COREVIH Aquitaine, Inserm (U897) and the Bordeaux School of Public Health (ISPED). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida D, 2001, Braz J Infect Dis, V5, P136; [Anonymous], 2014, ALINEA PLUS; Benard A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008896; Bertoni AG, 2001, DIABETES CARE, V24, P1044, DOI 10.2337/diacare.24.6.1044; Bonnet F, 2007, HIV MED, V8, P547, DOI 10.1111/j.1468-1293.2007.00508.x; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Christou L, 2007, AM J GASTROENTEROL, V102, P1510, DOI 10.1111/j.1572-0241.2007.01286.x; Deeks SG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3172; Domingo P, 2009, JAIDS-J ACQ IMM DEF, V51, P582, DOI 10.1097/QAI.0b013e3181adcb01; Ferry T, 2009, JAIDS-J ACQ IMM DEF, V51, P407, DOI 10.1097/QAI.0b013e3181acb65f; Ford N, 2015, LANCET; Grau I, 2005, ARCH INTERN MED, V165, P1533, DOI 10.1001/archinte.165.13.1533; Hessamfar M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102671; Hodgson K, 2015, IMMUNOLOGY, V144, P171, DOI 10.1111/imm.12394; Hoen B, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.19034; Holland T, 2014, CLIN INFECT DIS, V59, pS331, DOI 10.1093/cid/ciu598; Huson MAM, 2015, LANCET INFECT DIS, V15, P95, DOI 10.1016/S1473-3099(14)70917-X; Huson MAM, 2014, CLIN INFECT DIS, V58, P79, DOI 10.1093/cid/cit596; Kohli R, 2006, CLIN INFECT DIS, V43, P90, DOI 10.1086/504871; Kosmidis CI, 2012, LEUKEMIA LYMPHOMA, V53, P8, DOI 10.3109/10428194.2011.602770; Landau DA, 2010, J RHEUMATOL, V37, P615, DOI 10.3899/jrheum.090790; Ledergerber B, 1999, JAMA-J AM MED ASSOC, V282, P2220, DOI 10.1001/jama.282.23.2220; Marchetti G, 2013, CLIN MICROBIOL REV, V26, P2, DOI 10.1128/CMR.00050-12; Morlat P, 2014, AIDS, V28, P1181, DOI 10.1097/QAD.0000000000000222; Nitzan O, 2015, DIABET METAB SYND OB, V8, P129, DOI 10.2147/DMSO.S51792; Pedersen RH, 2011, HIV MED, V12, P323, DOI 10.1111/j.1468-1293.2010.00892.x; Serrano-Villar S, 2014, PLOS ONE, V1; Serrano-Villar S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004078; Shah BR, 2003, DIABETES CARE, V26, P510, DOI 10.2337/diacare.26.2.510; Smith CJ, 2014, LANCET, V384, P241, DOI 10.1016/S0140-6736(14)60604-8; Sogaard OS, 2013, J INFECTION, V66, P439, DOI 10.1016/j.jinf.2012.12.012; Sogaard OS, 2008, CLIN INFECT DIS, V47, P1345, DOI 10.1086/592692; Terrier B, 2011, ARTHRITIS RHEUM-US, V63, P1748, DOI 10.1002/art.30319; Thyrault M, 1997, INTENS CARE MED, V23, P1018, DOI 10.1007/s001340050451	34	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0152970	10.1371/journal.pone.0152970	http://dx.doi.org/10.1371/journal.pone.0152970			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050752	Green Published, Green Submitted, gold			2022-12-27	WOS:000373603500073
J	Feng, YM; Zhao, D; Zhang, N; Yu, CG; Zhang, Q; Thijs, L; Staessen, JA				Feng, Ying-Mei; Zhao, Dong; Zhang, Ning; Yu, Cai-Guo; Zhang, Qiang; Thijs, Lutgarde; Staessen, Jan A.			Insulin Resistance in Relation to Lipids and Inflammation in Type-2 Diabetic Patients and Non-Diabetic People	PLOS ONE			English	Article							BLOOD-CELL COUNT; ADIPOSE-TISSUE; OBESITY; DYSLIPIDEMIA; ASSOCIATIONS; MACROPHAGES; DYSFUNCTION; CYTOKINES	Background We demonstrated in experimental studies that hypercholesterolaemia enhances the proliferation of haematopoietic stem cells and the subsequent differentiation to neutrophils, whereas HDL-cholesterol inhibits these processes. To translate our experimental findings to clinical practice, we investigated in Chinese type-2 diabetic patients and in Flemish nondiabetic people the independent and joint associations of insulin resistance with markers of dyslipidaemia and inflammation, while looking for consistency between ethnicities and across the spectrum of insulin resistance. Methods We studied 798 Chinese patients with type-2 diabetes (53.6% women; mean age, 60.6 years) admitted to a tertiary referral centre and 1060 white Flemish (50.5%; 51.1 years) randomly recruited in Northern Belgium. Fasting insulin resistance (HOMA-IR) was derived from C-peptide in Chinese and from insulin in Flemish using the Homeostasis Model of Assessment algorithm. In multivariable-adjusted analyses, HOMA-IR was regressed on triglycerides, HDL-cholesterol and neutrophil count. Results In Chinese patients, the percentage changes in HOMA-IR associated with triglycerides, HDL-cholesterol and neutrophils (per 1-SD increment) amounted to 8.1 (95% confidence interval, 3.0 to 13.4; p = 0.0015), -8.7 (-13.0 to -4.2; p = 0.0002) and 5.6 (1.0 to 10.4; p = 0.017). In non-diabetic Flemish, the corresponding estimates were 11.7 (8.3 to 15.1; p<0.0001), -1.7 (-4.6 to 1.4; p = 0.28) and 3.3% (0.5 to 6.3; p = 0.022), respectively. None of the interaction terms between the three explanatory variables reached significance in Chinese or Flemish (p >= 0.10).	[Feng, Ying-Mei; Zhao, Dong; Zhang, Ning; Yu, Cai-Guo; Zhang, Qiang] Capital Med Univ, Lu He Hosp, Dept Endocrinol, Beijing, Peoples R China; [Feng, Ying-Mei; Zhao, Dong; Zhang, Ning; Yu, Cai-Guo; Zhang, Qiang] Capital Med Univ, Beijing Key Lab Diabet Prevent & Res, Beijing, Peoples R China; [Thijs, Lutgarde; Staessen, Jan A.] Univ Leuven, Studies Coordinating Ctr, Res Unit Hypertens & Cardiovasc Epidemiol, KU Leuven Dept Cardiovasc Dis, Leuven, Belgium; [Staessen, Jan A.] Maastricht Univ, R&D Grp VitaK, NL-6200 MD Maastricht, Netherlands	Capital Medical University; Capital Medical University; KU Leuven; Maastricht University	Feng, YM (corresponding author), Capital Med Univ, Lu He Hosp, Dept Endocrinol, Beijing, Peoples R China.; Feng, YM (corresponding author), Capital Med Univ, Beijing Key Lab Diabet Prevent & Res, Beijing, Peoples R China.	yingmeif13@sina.com	Staessen, Jan A/A-1065-2011	Staessen, Jan A/0000-0002-3026-1637; Thijs, Lutgarde/0000-0002-8108-2356	National Science Funding in China [81470566]; Beijing Municipal Science & Technology Commission [Z131100006813018]; Health and Research Bureau of Tongzhou District; European Union [HEALTH-2011.2.4.2-2-EU-MASCARA, HEALTH-F7-305507 HOMAGE]; European Union (European Re-search Council Advanced Researcher) [2011-294713-EPLORE]; Fonds voor Wetenschappelijk Onderzoek Vlaanderen; Ministry of the Flemish Community, Brussels, Belgium [G.0881.13, G.088013]	National Science Funding in China; Beijing Municipal Science & Technology Commission(Beijing Municipal Science & Technology Commission); Health and Research Bureau of Tongzhou District; European Union(European Commission); European Union (European Re-search Council Advanced Researcher); Fonds voor Wetenschappelijk Onderzoek Vlaanderen(FWO); Ministry of the Flemish Community, Brussels, Belgium	The study in Chinese patients received support from the National Science Funding in China (81470566), the Beijing Municipal Science & Technology Commission (Z131100006813018), and the Health and Research Bureau of Tongzhou District (R5). The European Union (HEALTH-2011.2.4.2-2-EU-MASCARA, HEALTH-F7-305507 HOMAGE and the European Re-search Council Advanced Researcher Grant-2011-294713-EPLORE) and the Fonds voor Wetenschappelijk Onderzoek Vlaanderen, Ministry of the Flemish Community, Brussels, Belgium (G.0881.13 and G.088013) currently support the Studies Coordinating Centre in Leuven.	Andrade VL, 2012, CLIN BIOCHEM, V45, P412, DOI 10.1016/j.clinbiochem.2012.01.008; Barter PJ, 2004, CIRC RES, V95, P764, DOI 10.1161/01.RES.0000146094.59640.13; Dalmas E, 2014, DIABETES, V63, P1966, DOI 10.2337/db13-1511; de Vries MA, 2015, METABOLISM, V64, P213, DOI 10.1016/j.metabol.2014.10.011; Feng YM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047286; Gower BA, 2015, J NUTR, V145, P177, DOI 10.3945/jn.114.195065; Hong EG, 2009, DIABETES, V58, P2525, DOI 10.2337/db08-1261; Hu M, 2015, DIS MARKERS, V2015, DOI 10.1155/2015/154014; Johnson R, 1997, CLIN CHEM, V43, P2183; Kontush A, 2014, CARDIOVASC RES, V103, P341, DOI 10.1093/cvr/cvu147; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Lastra G, 2013, HORM MOL BIOL CLIN I, V15, P49, DOI 10.1515/hmbci-2013-0025; Lee CTC, 2014, CLIN ENDOCRINOL, V81, P536, DOI 10.1111/cen.12390; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Li Y, 2007, HYPERTENSION, V49, P1291, DOI 10.1161/HYPERTENSIONAHA.106.085498; Liu LF, 2015, DIABETOLOGIA, V58, P1579, DOI 10.1007/s00125-015-3603-y; Mancia G, 2013, EUR HEART J, V34, P2159, DOI 10.1093/eurheartj/eht151; Mansuy-Aubert V, 2013, CELL METAB, V17, P534, DOI 10.1016/j.cmet.2013.03.005; McCann JC, 2015, FASEB J, V29, P3287, DOI 10.1096/fj.15-271833; Mooradian AD, 2009, NAT CLIN PRACT ENDOC, V5, P150, DOI 10.1038/ncpendmet1066; Perry RJ, 2015, CELL, V160, P745, DOI 10.1016/j.cell.2015.01.012; Sattar N, 2010, LANCET, V375, P735, DOI 10.1016/S0140-6736(09)61965-6; Shim WS, 2006, DIABETES RES CLIN PR, V73, P284, DOI 10.1016/j.diabres.2006.02.001; Siebel AL, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00258; Sloan-Lancaster J, 2013, DIABETES CARE, V36, P2239, DOI 10.2337/dc12-1835; Talukdar S, 2012, NAT MED, V18, P1407, DOI 10.1038/nm.2885; Taskinen MR, 2015, ATHEROSCLEROSIS, V239, P483, DOI 10.1016/j.atherosclerosis.2015.01.039; Tian JY, 2008, DIABETES RES CLIN PR, V82, P132, DOI 10.1016/j.diabres.2008.05.014; Tong PC, 2004, DIABETES CARE, V27, P216, DOI 10.2337/diacare.27.1.216; Van Gassen N, 2015, STEM CELL TRANSL MED, V4, P555, DOI 10.5966/sctm.2014-0272; Vella CA, 2013, DIABETES CARE, V36, P1377, DOI 10.2337/dc12-1550; Wang QL, 2014, DIABETES, V63, P4172, DOI 10.2337/db14-0026; Yudkin JS, 1999, ARTERIOSCL THROM VAS, V19, P972, DOI 10.1161/01.ATV.19.4.972	33	25	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153171	10.1371/journal.pone.0153171	http://dx.doi.org/10.1371/journal.pone.0153171			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073920	Green Published, Green Submitted, gold			2022-12-27	WOS:000374131200056
J	Karuga, RN; Njenga, SN; Mulwa, R; Kilonzo, N; Bahati, P; O'reilley, K; Gelmon, L; Mbaabu, S; Wachihi, C; Githuka, G; Kiragu, M				Karuga, Robinson Njoroge; Njenga, Serah Nduta; Mulwa, Rueben; Kilonzo, Nduku; Bahati, Prince; O'reilley, Kevin; Gelmon, Lawrence; Mbaabu, Stephen; Wachihi, Charles; Githuka, George; Kiragu, Michael			"How I Wish This Thing Was Initiated 100 Years Ago!" Willingness to Take Daily Oral Pre-Exposure Prophylaxis among Men Who Have Sex with Men in Kenya	PLOS ONE			English	Article							HIV-INFECTION; AFRICAN WOMEN; RISK; PREVENTION; WORKERS; CHALLENGES; BEHAVIOR; BOTSWANA; MOMBASA; MSM	Background The MSM population in Kenya contributes to 15% of HIV incidence. This calls for innovative HIV prevention interventions. Pre-exposure prophylaxis (PrEP) has been efficacious in preventing HIV among MSM in trials. There is limited data on the willingness to take daily oral PrEP in sub-Sahara Africa. PrEP has not been approved for routine use in most countries globally. This study aimed to document the willingness to take PrEP and barriers to uptake and adherence to PrEP in Kenya. The findings will inform the design of a PrEP delivery program as part of the routine HIV combination prevention. Methods Eighty MSM were recruited in 2 Counties in December 2013. Quantitative data on sexual behaviour and willingness to take PrEP were collected using semi-structured interviews and analysed using SPSS. Qualitative data on knowledge of PrEP, motivators and barriers to uptake and adherence to PrEP were collected using in-depth interviews and FGDs and analysed using Nvivo. Analysis of data in willingness to take PrEP was conducted on the HIV negative participants (n = 55). Results 83% of MSM were willing to take daily oral HIV PrEP. Willingness to take PrEP was higher among the bi-sexual and younger men. Motivators for taking PrEP were the need to stay HIV negative and to protect their partners. History of poor medication adherence, fear of side effects and HIV stigma were identified as potential barriers to adherence. Participants were willing to buy PrEP at a subsidized price. Conclusions There is willingness to take PrEP among MSM in Kenya and there is need to invest in targeted education and messaging on PrEP to enhance adherence, proper use and reduce stigma in the general population and among policy makers.	[Karuga, Robinson Njoroge; Njenga, Serah Nduta; Mulwa, Rueben; Mbaabu, Stephen; Kiragu, Michael] LVCT Hlth, Nairobi, Kenya; [Kilonzo, Nduku] Natl AIDS Control Council NACC, Nairobi, Kenya; [Gelmon, Lawrence; Wachihi, Charles] Univ Nairobi, Univ Manitoba, SWOP Clin, Nairobi, Kenya; [Githuka, George] Natl AIDS & STIs Control Program NASCOP, Nairobi, Kenya; [Bahati, Prince] Int AIDS Vaccine Initiat, Nairobi, Kenya; [O'reilley, Kevin] World Hlth Org, Geneva, Switzerland	University of Nairobi; International AIDS Vaccine Initiative; World Health Organization	Karuga, RN (corresponding author), LVCT Hlth, Nairobi, Kenya.	rkaruga@lvcthealth.org		Karuga, Robinson/0000-0003-3249-5047	Bill & Melinda Gates Foundation through the Georgetown University [OPP1032254]; London School of Hygiene and Tropical Medicine	Bill & Melinda Gates Foundation through the Georgetown University; London School of Hygiene and Tropical Medicine	This study was funded through a research grant from Bill & Melinda Gates Foundation (grant ID: OPP1032254) through the Georgetown University and London School of Hygiene and Tropical Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Baral S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004997; Beyrer C, 2012, LANCET, V380, P367, DOI 10.1016/S0140-6736(12)60821-6; Beyrer C, 2010, SEX TRANSM INFECT, V86, P323, DOI 10.1136/sti.2009.040162; Choopanya K, 2013, LANCET, V381, P2083, DOI 10.1016/S0140-6736(13)61127-7; Eisingerich AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028238; Geibel S, 2012, FACTS VIEWS VIS OBGY, V4, P285; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Hoff CC, 2012, AIDS PATIENT CARE ST, V26, P738, DOI 10.1089/apc.2012.0198; [IAVI JHU- CPHHR UNDP amfAR], 2011, BEST PRACT GUID COND; Joint United Nations Programme on HIV/AIDS, 2014, FAST TRACK ENDING AI; Larmarange J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013189; Marrazzo JM, 2015, NEW ENGL J MED, V372, P509, DOI 10.1056/NEJMoa1402269; McKinnon LR, 2014, SEX TRANSM INFECT, V90, P237, DOI 10.1136/sextrans-2013-051310; Ministry of Health, 2014, KEN HIV EST; Ministry of Health, 2014, KEN AIDS STRAT FRAM; Mutua G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033103; NACC, 2009, KEN AN HIV PREV RESP; NACC, 2014, KEN AIDS RESP PROGR; [NASCOP National AIDS and STI Control Program], 2010, INT BIOB SURV; [National AIDS and STI Control Program National AIDS Control Council], 2014, KEN PREV REV ROADM; National AIDS and STI Control Programme (NASCOP), 2014, KEN AIDS IND SURV 20; Okal J, 2009, CULT HEALTH SEX, V11, P811, DOI 10.1080/13691050902906488; Okanlawon K, 2013, CULT HEALTH SEX, V15, P22, DOI 10.1080/13691058.2012.754053; Sanders EJ, 2007, AIDS, V21, P2513, DOI 10.1097/QAD.0b013e3282f2704a; Sullivan PS, 2012, LANCET, V380, P388, DOI 10.1016/S0140-6736(12)60955-6; [Technology NCfSa Government of Kenya], 2004, GUID ETH COND BIOM R; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; Van Damme L, 2012, NEW ENGL J MED, V367, P411, DOI 10.1056/NEJMoa1202614; Van der Elst EM, 2013, AIDS BEHAV, V17, P2162, DOI 10.1007/s10461-012-0317-8	30	37	38	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0151716	10.1371/journal.pone.0151716	http://dx.doi.org/10.1371/journal.pone.0151716			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ3UC	27073896	Green Submitted, Green Published, gold			2022-12-27	WOS:000374131200010
J	Yet, I; Menni, C; Shin, SY; Mangino, M; Soranzo, N; Adamski, J; Suhre, K; Spector, TD; Kastenmuller, G; Bell, JT				Yet, Idil; Menni, Cristina; Shin, So-Youn; Mangino, Massimo; Soranzo, Nicole; Adamski, Jerzy; Suhre, Karsten; Spector, Tim D.; Kastenmueller, Gabi; Bell, Jordana T.			Genetic Influences on Metabolite Levels: A Comparison across Metabolomic Platforms	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; PHENOTYPES; PROFILES; TWINSUK; DISEASE; KORA	Metabolomic profiling is a powerful approach to characterize human metabolism and help understand common disease risk. Although multiple high-throughput technologies have been developed to assay the human metabolome, no technique is capable of capturing the entire human metabolism. Large-scale metabolomics data are being generated in multiple cohorts, but the datasets are typically profiled using different metabolomics platforms. Here, we compared analyses across two of the most frequently used metabolomic platforms, Biocrates and Metabolon, with the aim of assessing how complimentary metabolite profiles are across platforms. We profiled serum samples from 1,001 twins using both targeted (Biocrates, n = 160 metabolites) and non-targeted (Metabolon, n = 488 metabolites) mass spectrometry platforms. We compared metabolite distributions and performed genome-wide association analyses to identify shared genetic influences on metabolites across platforms. Comparison of 43 metabolites named for the same compound on both platforms indicated strong positive correlations, with few exceptions. Genome-wide association scans with high-throughput metabolic profiles were performed for each dataset and identified genetic variants at 7 loci associated with 16 unique metabolites on both platforms. The 16 metabolites showed consistent genetic associations and appear to be robustly measured across platforms. These included both metabolites named for the same compound across platforms as well as unique metabolites, of which 2 (nonanoylcarnitine (C9) [Biocrates]/Unknown metabolite X-13431 [Metabolon] and PC aa C28: 1 [Biocrates]/1-stearoylglycerol [Metabolon]) are likely to represent the same or related biochemical entities. The results demonstrate the complementary nature of both platforms, and can be informative for future studies of comparative and integrative metabolomics analyses in samples profiled on different platforms.	[Yet, Idil; Menni, Cristina; Mangino, Massimo; Spector, Tim D.; Kastenmueller, Gabi; Bell, Jordana T.] Kings Coll London, Dept Twin Res & Genet Epidemiol, London WC2R 2LS, England; [Shin, So-Youn; Soranzo, Nicole] Wellcome Trust Sanger Inst, Dept Human Genet, Hinxton, England; [Shin, So-Youn] Univ Bristol, Sch Social & Community Med, Integrat Epidemiol Unit, MRC, Bristol, Avon, England; [Adamski, Jerzy; Kastenmueller, Gabi] Helmholtz Zentrum Munchen, Inst Bioinformat & Syst Biol, Neuherberg, Germany; [Suhre, Karsten] Weill Cornell Med Coll Qatar, Doha, Qatar	University of London; King's College London; Wellcome Trust Sanger Institute; University of Bristol; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Qatar Foundation (QF); Weill Cornell Medical College Qatar	Kastenmuller, G; Bell, JT (corresponding author), Kings Coll London, Dept Twin Res & Genet Epidemiol, London WC2R 2LS, England.; Kastenmuller, G (corresponding author), Helmholtz Zentrum Munchen, Inst Bioinformat & Syst Biol, Neuherberg, Germany.	g.kastenmueller@helmholtz-muenchen.de; jordana.bell@kcl.ac.uk	Bell, Jordana/AAH-7312-2019; yet, idil/H-8848-2017; Suhre, Karsten/AAF-1778-2020; Kastenmüller, Gabi/ABF-5987-2020; Mangino, Massimo/F-5134-2011	yet, idil/0000-0002-1227-0716; Suhre, Karsten/0000-0001-9638-3912; Mangino, Massimo/0000-0002-2167-7470; Adamski, Jerzy/0000-0001-9259-0199; Kastenmuller, Gabi/0000-0002-2368-7322; Bell, Jordana/0000-0002-3858-5986; Menni, Cristina/0000-0001-9790-0571; Soranzo, Nicole/0000-0003-1095-3852	Wellcome Trust; European Community's Seventh Framework Programme; National Institute for Health Research (NIHR); King's College London; ERC; Medical Research Council [MC_UU_12013/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0514-10027] Funding Source: researchfish; MRC [MC_UU_12013/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); European Community's Seventh Framework Programme(European Commission); National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); King's College London(General Electric); ERC(European Research Council (ERC)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study was funded in part by the Wellcome Trust and the European Community's Seventh Framework Programme (FP7/2007-2013). TwinsUK also received support from the Wellcome Trust, the National Institute for Health Research (NIHR)-funded BioResource, Clinical Research Facility and Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust in partnership with King's College London. TS is an NIHR senior Investigator and is holder of an ERC Advanced Principal Investigator award. SNP Genotyping was performed by The Wellcome Trust Sanger Institute and National Eye Institute via NIH/CIDR.	Adamski J, 2013, CURR OPIN BIOTECH, V24, P39, DOI 10.1016/j.copbio.2012.10.003; Assfalg M, 2008, P NATL ACAD SCI USA, V105, P1420, DOI 10.1073/pnas.0705685105; Boker S, 2011, PSYCHOMETRIKA, V76, P306, DOI 10.1007/s11336-010-9200-6; Boomsma DI, 2006, TWIN RES HUM GENET, V9, P849, DOI 10.1375/183242706779462426; Buscher JM, 2009, ANAL CHEM, V81, P2135, DOI 10.1021/ac8022857; DeHaven CD, 2010, J CHEMINFORMATICS, V2, DOI 10.1186/1758-2946-2-9; Draisma HHM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8208; Dumas ME, 2007, NAT GENET, V39, P666, DOI 10.1038/ng2026; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Gieger C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000282; Holle R, 2005, GESUNDHEITSWESEN, V67, pS19, DOI 10.1055/s-2005-858235; Homuth G, 2012, J ENDOCRINOL, V215, P17, DOI 10.1530/JOE-12-0144; Illig T, 2010, NAT GENET, V42, P137, DOI 10.1038/ng.507; Kastenmuller G, 2015, HUM MOL GENET; Kettunen J, 2012, NAT GENET, V44, P269, DOI 10.1038/ng.1073; Krumsiek J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003005; Mandal R, 2012, GENOME MED, V4, DOI 10.1186/gm337; Menni C, 2013, METABOLOMICS, V9, P506, DOI 10.1007/s11306-012-0469-6; Mittelstrass K, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002215; Moayyeri A, 2013, INT J EPIDEMIOL, V42, P76, DOI 10.1093/ije/dyr207; Moayyeri A, 2013, TWIN RES HUM GENET, V16, P144, DOI 10.1017/thg.2012.89; Nicholson G, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002270; Psychogios N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016957; Raffler J, 2013, GENOME MED, V5, DOI 10.1186/gm417; Riboli E, 1997, INT J EPIDEMIOL, V26, pS6, DOI 10.1093/ije/26.suppl_1.S6; Romisch-Margl W, 2012, METABOLOMICS, V8, P133, DOI 10.1007/s11306-011-0293-4; Rueedi R, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004132; Shin SY, 2014, NAT GENET, V46, P543, DOI 10.1038/ng.2982; Silander K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003615; Suhre K, 2011, NATURE, V477, P54, DOI 10.1038/nature10354; Suhre K, 2011, NAT GENET, V43, P565, DOI 10.1038/ng.837; Suhre K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013953; Vinayavekhin N, 2010, ACS CHEM BIOL, V5, P91, DOI 10.1021/cb900271r; Watson AD, 2006, J LIPID RES, V47, P2101, DOI 10.1194/jlr.R600022-JLR200; Wichmann HE, 2005, GESUNDHEITSWESEN, V67, pS26, DOI 10.1055/s-2005-858226; Yousri NA, 2014, METABOLOMICS, V10, P1005, DOI 10.1007/s11306-014-0629-y; Zhou X, 2012, NAT GENET, V44, P821, DOI 10.1038/ng.2310	37	50	50	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153672	10.1371/journal.pone.0153672	http://dx.doi.org/10.1371/journal.pone.0153672			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073872	Green Published, Green Submitted, gold			2022-12-27	WOS:000374131200117
J	Banko, AV; Lazarevic, IB; Folic, MM; Djukic, VB; Cirkovic, AM; Karalic, DZ; Cupic, MD; Jovanovic, TP				Banko, Ana V.; Lazarevic, Ivana B.; Folic, Miljan M.; Djukic, Vojko B.; Cirkovic, Andja M.; Karalic, Danijela Z.; Cupic, Maja D.; Jovanovic, Tanja P.			Characterization of the Variability of Epstein-Barr Virus Genes in Nasopharyngeal Biopsies: Potential Predictors for Carcinoma Progression	PLOS ONE			English	Article							LATENT MEMBRANE PROTEIN-1; 30-BP DELETION; SEQUENCE VARIATION; HIGH-FREQUENCY; LMP1; POLYMORPHISM; DISEASE; TUMORS; EPIDEMIOLOGY; PATHOGENESIS	Epstein-Barr virus (EBV) infection is a significant factor in the pathogenesis of nasopharyngeal carcinoma, especially in the undifferentiated carcinoma of nasopharyngeal type (UCNT, World Health Organization type III), which is the dominant histopathological type in high-risk areas. The major EBV oncogene is latent membrane protein 1 (LMP1). LMP1 gene shows variability with different tumorigenic and immunogenic potentials. EBV nuclear antigen 1 (EBNA1) regulates progression of EBV-related tumors; however, the influence of EBNA1 sequence variability on tumor pathogenesis is controversial. The aims of this study were to characterize polymorphisms of EBV genes in non-endemic nasopharyngeal carcinoma biopsies and to investigate potential sequence patterns that correlate with the clinical presentation of nasopharyngeal carcinoma. In total, 116 tumor biopsies of undifferentiated carcinoma of nasopharyngeal type (UCNT), collected from 2008 to 2014, were evaluated in this study. The genes EBNA2, LMP1, and EBNA1 were amplified using nested-PCR. EBNA2 genotyping was performed by visualization of PCR products using gel electrophoresis. Investigation of LMP1 and EBNA1 included sequence, phylogenetic, and statistical analyses. The presence of EBV DNA was significantly distributed between TNM stages. LMP1 variability showed six variants, with the detection of the first China1 and North Carolina variants in European nasopharyngeal carcinoma biopsies. Newly discovered variants Srb1 and Srb2 were UCNT-specific LMP1 polymorphisms. The B95-8 and North Carolina variants are possible predictors for favorable TNM stages. In contrast, deletions in LMP1 are possible risk factors for the most disfavorable TNM stage, independent of EBNA2 or EBNA1 variability. A newly discovered EBNA1 subvariant, P-thr-sv-5, could be a potential diagnostic marker, as it represented a UCNT-specific EBNA1 subvariant. A particular combination of EBNA2, LMP1, and EBNA1 polymorphisms, type 1/Med/P-thr was identified as a possible risk factor for TNM stage IVB or progression to the N3 stage.	[Banko, Ana V.; Lazarevic, Ivana B.; Karalic, Danijela Z.; Cupic, Maja D.; Jovanovic, Tanja P.] Univ Belgrade, Inst Microbiol & Immunol, Fac Med, Belgrade, Serbia; [Folic, Miljan M.; Djukic, Vojko B.] Univ Belgrade, Clin Ctr Serbia, Fac Med, Clin Otorhinolaryngol & Maxillofacial Surg, Belgrade, Serbia; [Cirkovic, Andja M.] Univ Belgrade, Inst Med Stat & Informat, Fac Med, Belgrade, Serbia	University of Belgrade; Clinical Centre of Serbia; University of Belgrade; University of Belgrade	Banko, AV (corresponding author), Univ Belgrade, Inst Microbiol & Immunol, Fac Med, Belgrade, Serbia.	ana.banko@mfub.bg.ac.rs	Banko, Ana/GQQ-2011-2022	Cirkovic, Andja/0000-0002-7542-5690; Lazarevic, Ivana/0000-0001-6795-1378; Banko, Ana/0000-0002-6829-096X; Miljanovic, Danijela/0000-0001-9446-8701; Cupic, Maja/0000-0003-4482-9251	Ministry of Education, Science and Technological Development, Republic of Serbia [175073]	Ministry of Education, Science and Technological Development, Republic of Serbia	The study was supported by the Ministry of Education, Science and Technological Development, Republic of Serbia, Grant No. 175073 (http://www.mpn.gov.rs/).	Aga M, 2014, ONCOGENE, V33, P4613, DOI 10.1038/onc.2014.66; Ai Junhong, 2012, Virol J, V9, P13, DOI 10.1186/1743-422X-9-13; Lorenzetti MA, 2010, J MED VIROL, V82, P1730, DOI 10.1002/jmv.21871; Banko A, 2012, J MED VIROL, V84, P632, DOI 10.1002/jmv.23217; Bhatia K, 1996, ONCOGENE, V13, P177; Busson P, 2004, TRENDS MICROBIOL, V12, P356, DOI 10.1016/j.tim.2004.06.005; Chang CM, 2009, VIRUS RES, V143, P209, DOI 10.1016/j.virusres.2009.07.005; Chang ET, 2006, CANCER EPIDEM BIOMAR, V15, P1765, DOI 10.1158/1055-9965.EPI-06-0353; Chen JP, 2012, NANOSCALE RES LETT, V7, P1, DOI 10.1186/1556-276X-7-170; Dardari R, 2006, INT J CANCER, V118, P1977, DOI 10.1002/ijc.21595; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Dawson CW, 2012, SEMIN CANCER BIOL, V22, P144, DOI 10.1016/j.semcancer.2012.01.004; Edwards RH, 2004, J VIROL, V78, P868, DOI 10.1128/JVI.78.2.868-881.2004; Edwards RH, 1999, VIROLOGY, V261, P79, DOI 10.1006/viro.1999.9855; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Ikegaya H, 2008, J VIROL METHODS, V147, P78, DOI 10.1016/j.jviromet.2007.08.010; Jia WH, 2012, SEMIN CANCER BIOL, V22, P117, DOI 10.1016/j.semcancer.2012.01.009; Kennedy G, 2003, P NATL ACAD SCI USA, V100, P14269, DOI 10.1073/pnas.2336099100; KNECHT H, 1993, BLOOD, V82, P2937; Kulwichit W, 1998, P NATL ACAD SCI USA, V95, P11963, DOI 10.1073/pnas.95.20.11963; Li DJ, 2009, J MED VIROL, V81, P1253, DOI 10.1002/jmv.21503; Longnecker R, 2013, FIELDS VIROLOGY, V2, P1898; Lyons SF, 1998, SEMIN ONCOL, V25, P461; Mendes TM, 2008, BRAZ J INFECT DIS, V12, P186, DOI 10.1590/S1413-86702008000300005; MILLER WE, 1994, J GEN VIROL, V75, P2729, DOI 10.1099/0022-1317-75-10-2729; MOORTHY RK, 1993, J VIROL, V67, P1638, DOI 10.1128/JVI.67.3.1638-1646.1993; Morris MA, 2016, SCI REP-UK, V6, DOI 10.1038/srep19533; PATHMANATHAN R, 1995, NEW ENGL J MED, V333, P693, DOI 10.1056/NEJM199509143331103; Perez-Ordonez B, 2007, HEAD NECK PATHOL, V1, P141, DOI 10.1007/s12105-007-0020-7; Puchhammer-Stockl E, 2006, J CLIN VIROL, V36, P239, DOI 10.1016/j.jcv.2006.03.004; Rambaut A., 2007, FIGTREE V1; Rosales-Perez S, 2014, ARCH MED RES, V45, P229, DOI 10.1016/j.arcmed.2014.02.002; ROWE M, 1994, J VIROL, V68, P5602, DOI 10.1128/JVI.68.9.5602-5612.1994; SAMPLE J, 1990, J VIROL, V64, P4084, DOI 10.1128/JVI.64.9.4084-4092.1990; SANDVEJ K, 1994, BLOOD, V84, P4053, DOI 10.1182/blood.V84.12.4053.bloodjournal84124053; Sandvej K, 2000, J PATHOL, V191, P127, DOI 10.1002/(SICI)1096-9896(200006)191:2<127::AID-PATH614>3.0.CO;2-E; Senyuta N, 2014, J MED VIROL, V86, P290, DOI 10.1002/jmv.23729; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tan EL, 2003, J MED VIROL, V69, P251, DOI 10.1002/jmv.10282; Tiwawech D, 2008, J CLIN VIROL, V42, P1, DOI 10.1016/j.jcv.2007.11.011; Vallat-Decouvelaere AV, 2002, NEUROPATH APPL NEURO, V28, P471, DOI 10.1046/j.1365-2990.2002.t01-1-00418.x; WANG D, 1985, CELL, V43, P831, DOI 10.1016/0092-8674(85)90256-9; Wang JT, 2003, J MED VIROL, V69, P417, DOI 10.1002/jmv.10305; Xu J, 2013, NANOSCALE RES LETT, V8, P1, DOI 10.1186/1556-276X-8-54; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452; Zeng YX, 2002, SEMIN CANCER BIOL, V12, P443, DOI 10.1016/S1044579X02000871	47	21	21	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0153498	10.1371/journal.pone.0153498	http://dx.doi.org/10.1371/journal.pone.0153498			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27071030	Green Submitted, gold, Green Published			2022-12-27	WOS:000373900700073
J	Collings, S; Thompson, O; Hirst, E; Goossens, L; George, A; Weinkove, R				Collings, Shaun; Thompson, Oliver; Hirst, Evan; Goossens, Louise; George, Anup; Weinkove, Robert			Non-Invasive Detection of Anaemia Using Digital Photographs of the Conjunctiva	PLOS ONE			English	Article							IMAGE-ANALYSIS; DIAGNOSTIC-ACCURACY; ERYTHEMA; PALLOR; QUANTIFICATION; HEMOGLOBIN; CAMERAS; CARE	Background and Aims Anaemia is a major health burden worldwide. Although the finding of conjunctival pallor on clinical examination is associated with anaemia, inter-observer variability is high, and definitive diagnosis of anaemia requires a blood sample. We aimed to detect anaemia by quantifying conjunctival pallor using digital photographs taken with a consumer camera and a popular smartphone. Our goal was to develop a non-invasive screening test for anaemia. Patients and Methods The conjunctivae of haemato-oncology in-and outpatients were photographed in ambient lighting using a digital camera (Panasonic DMC-LX5), and the internal rear-facing camera of a smartphone (Apple iPhone 5S) alongside an in-frame calibration card. Following image calibration, conjunctival erythema index (EI) was calculated and correlated with laboratory-measured haemoglobin concentration. Three clinicians independently evaluated each image for conjunctival pallor. Results Conjunctival EI was reproducible between images (average coefficient of variation 2.96%). EI of the palpebral conjunctiva correlated more strongly with haemoglobin concentration than that of the forniceal conjunctiva. Using the compact camera, palpebral conjunctival EI had a sensitivity of 93% and 57% and specificity of 78% and 83% for detection of anaemia (haemoglobin < 110 g/L) in training and internal validation sets, respectively. Similar results were found using the iPhone camera, though the EI cut-off value differed. Conjunctival EI analysis compared favourably with clinician assessment, with a higher positive likelihood ratio for prediction of anaemia. Conclusions Erythema index of the palpebral conjunctiva calculated from images taken with a compact camera or mobile phone correlates with haemoglobin and compares favourably to clinician assessment for prediction of anaemia. If confirmed in further series, this technique may be useful for the non-invasive screening for anaemia.	[Collings, Shaun] Univ Otago, Wellington Sch Med, Wellington, New Zealand; [Collings, Shaun; Weinkove, Robert] Malaghan Inst Med Res, Wellington, New Zealand; [Thompson, Oliver; Hirst, Evan] Callaghan Innovat, Sensing & Automat Grp, Lower Hutt, New Zealand; [Goossens, Louise] Capital & Coast Dist Hlth Board, Photog Dept, Wellington, New Zealand; [George, Anup; Weinkove, Robert] Capital & Coast Dist Hlth Board, Wellington Blood & Canc Ctr, Wellington, New Zealand; [Weinkove, Robert] Univ Otago Wellington, Dept Pathol & Mol Med, Wellington, New Zealand	University of Otago; Malaghan Institute; Victoria University Wellington; Callaghan Innovation; University of Otago	Weinkove, R (corresponding author), Malaghan Inst Med Res, Wellington, New Zealand.; Weinkove, R (corresponding author), Capital & Coast Dist Hlth Board, Wellington Blood & Canc Ctr, Wellington, New Zealand.; Weinkove, R (corresponding author), Univ Otago Wellington, Dept Pathol & Mol Med, Wellington, New Zealand.	rweinkove@malaghan.org.nz	Weinkove, Robert/I-6991-2012; Hirst, Evan/B-4003-2008; Weinkove, Robert/S-4457-2019	Weinkove, Robert/0000-0003-3645-7988; Weinkove, Robert/0000-0003-3645-7988; Collings, Sunny/0000-0002-5486-1194	Leukaemia & Blood Cancer New Zealand	Leukaemia & Blood Cancer New Zealand	This study was funded as a summer student research project for Shaun Collings by the Leukaemia & Blood Cancer New Zealand (http://www.leukaemia.org.nz/). There is no grant number associated with this, however a grant confirmation letter can be supplied upon request. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apple, 2013, APPL EV SPEC EV SEPT; Butt Z, 2010, J PAK MED ASSOC, V60, P762; Chalco Juan P, 2005, BMC Pediatr, V5, P46, DOI 10.1186/1471-2431-5-46; Chowdhury MEEK, 2002, TROP MED INT HEALTH, V7, P133, DOI 10.1046/j.1365-3156.2002.00837.x; Coffin D, IJ PLUGINS DCRAW; Hickner J, 2008, QUAL SAF HEALTH CARE, V17, P194, DOI 10.1136/qshc.2006.021915; Kalantri A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008545; Klasnja P, 2012, J BIOMED INFORM, V45, P184, DOI 10.1016/j.jbi.2011.08.017; Sanchis-Gomar F, 2013, JALA-J LAB AUTOM, V18, P198, DOI 10.1177/2211068212457560; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Setaro M, 2002, SKIN RES TECHNOL, V8, P84, DOI 10.1034/j.1600-0846.2002.00328.x; Suner S, 2007, J EMERG MED, V33, P105, DOI 10.1016/j.jemermed.2007.02.011; Van Poucke Sven, 2010, BMC Med Imaging, V10, P7, DOI 10.1186/1471-2342-10-7; Vander Haeghen Y, 2006, ARCH DERMATOL, V142, P42, DOI 10.1001/archderm.142.1.42; World Health Organisation, 2005, WHO REP, V51; World Health Organisation, 1968, WHO TECH REP SER, V503, P1; Yamamoto T, 2008, SKIN RES TECHNOL, V14, P26, DOI 10.1111/j.1600-0846.2007.00256.x; Zhao Y, 2013, PHOTODIAGN PHOTODYN, V10, P96, DOI 10.1016/j.pdpdt.2012.10.001	18	43	43	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0153286	10.1371/journal.pone.0153286	http://dx.doi.org/10.1371/journal.pone.0153286			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27070544	Green Published, Green Submitted, gold			2022-12-27	WOS:000373900700046
J	Pinket, AS; Van Lippevelde, W; De Bourdeaudhuij, I; Deforche, B; Cardon, G; Androutsos, O; Koletzko, B; Moreno, LA; Socha, P; Iotova, V; Manios, Y; De Craemer, M				Pinket, An-Sofie; Van Lippevelde, Wendy; De Bourdeaudhuij, Ilse; Deforche, Benedicte; Cardon, Greet; Androutsos, Odysseas; Koletzko, Berthold; Moreno, Luis A.; Socha, Piotr; Iotova, Violeta; Manios, Yannis; De Craemer, Marieke		ToyBox-study Grp	Effect and Process Evaluation of a Cluster Randomized Control Trial on Water Intake and Beverage Consumption in Preschoolers from Six European Countries: The ToyBox-Study	PLOS ONE			English	Article							FAMILY-INVOLVED INTERVENTION; SUGAR-SWEETENED BEVERAGES; PHYSICAL-ACTIVITY; PREVENT OBESITY; SOCIOECONOMIC-STATUS; CHILDHOOD OBESITY; HYDRATION STATUS; SEDENTARY TIME; ENERGY-PROJECT; FLUID INTAKE	Background Within the ToyBox-study, a kindergarten-based, family-involved intervention was developed to prevent overweight and obesity in European preschoolers, targeting four key behaviours related to early childhood obesity, including water consumption. The present study aimed to examine the effect of the ToyBox-intervention (cluster randomized controlled trial) on water intake and beverage consumption in European preschoolers and to investigate if the intervention effects differed by implementation score of kindergartens and parents/caregivers. Method A sample of 4964 preschoolers (4.7 +/- 0.4 years; 51.5% boys) from six European countries (Belgium, Bulgaria, Germany, Greece, Poland, Spain) was included in the data analyses. A standardized protocol was used and parents/caregivers filled in socio-demographic data and a food-frequency questionnaire. To assess intervention effects, multilevel repeated measures analyses were conducted for the total sample and for the six country-specific samples. Based on the process evaluation questionnaire of teachers and parents/caregivers, an implementation score was constructed. To assess differences in water intake and beverage consumption by implementation score in the total sample, multilevel repeated measures analyses were performed. Results Limited intervention effects on water intake from beverages and overall beverage consumption were found. However, important results were found on prepacked fruit juice consumption, with a larger decrease in the intervention group compared to the control group. However, also a decline in plain milk consumption was found. Implementation scores were rather low in both kindergartens and parents/caregivers. Nevertheless, more favorable effects on beverage choices were found in preschoolers whose parents/caregivers and kindergarten teachers had higher implementation scores compared to those with lower implementation scores. Conclusion The ToyBox-intervention can provide the basis for the development of more tailor-made interventions. However, new strategies to improve implementation of interventions should be created.	[Pinket, An-Sofie; Van Lippevelde, Wendy; Deforche, Benedicte] Univ Ghent, Dept Publ Hlth, B-9000 Ghent, Belgium; [Van Lippevelde, Wendy; Cardon, Greet; De Craemer, Marieke] Univ Ghent, Dept Movement & Sport Sci, B-9000 Ghent, Belgium; [Deforche, Benedicte] Vrije Univ Brussel, Dept Human Biometry & Biomech, Brussels, Belgium; [Androutsos, Odysseas; Manios, Yannis] Harokopio Univ, Dept Nutr & Dietet, Sch Hlth Sci & Educ, Athens, Greece; [Koletzko, Berthold] Univ Munich, Dr von Hauner Childrens Hosp, Munich, Germany; [Moreno, Luis A.] Univ Zaragoza, GENUD Growth Exercise NUtr & Dev Res Grp, Zaragoza, Spain; [Socha, Piotr] Childrens Mem Hlth Inst, Warsaw, Poland; [Iotova, Violeta] Med Univ Varna, Dept Pediat & Med Genet, Varna, Bulgaria	Ghent University; Ghent University; Vrije Universiteit Brussel; Harokopio University Athens; University of Munich; University of Zaragoza; Children's Memorial Health Institute; Medical University Varna	Pinket, AS (corresponding author), Univ Ghent, Dept Publ Hlth, B-9000 Ghent, Belgium.	ansofie.pinket@ugent.be	De+Bourdeaudhuij, Ilse/AAC-5528-2019; De Craemer, Marieke/Z-3050-2019; Paw, Mai Chin A/N-1665-2019; Iotova, Violeta/AAO-2387-2021; Moreno, Luis/S-1780-2019; Radkova, Zhaneta/AAM-1538-2020; Androutsos, Odysseas/ABF-8670-2021; Manios, Yannis/AAM-8953-2021; Summerbell, Carolyn D/O-3759-2015; Van Lippevelde, Wendy/AAM-6490-2021; De Craemer, Marieke/P-6072-2016; De Miguel-Etayo, Pilar/B-5258-2014	De+Bourdeaudhuij, Ilse/0000-0001-9969-7597; De Craemer, Marieke/0000-0002-5220-7850; Paw, Mai Chin A/0000-0001-6259-2441; Moreno, Luis/0000-0003-0454-653X; Radkova, Zhaneta/0000-0003-2007-8019; Manios, Yannis/0000-0001-6486-114X; Summerbell, Carolyn D/0000-0003-1910-9383; De Miguel-Etayo, Pilar/0000-0001-6173-5850; te Velde, Saskia/0000-0002-4674-8052; Kulaga, Zbigniew/0000-0003-0509-1004; Iotova, Violeta/0000-0003-4160-1200; Pinket, An-Sofie/0000-0003-2744-5686; Moore, Helen J/0000-0002-0165-7552; Socha, Piotr/0000-0002-1621-464X; Cardon, Greet/0000-0003-4983-6557; Van Lippevelde, Wendy/0000-0002-8535-0215	European Commission [245200]; Medical Research Council [MR/K02325X/1] Funding Source: researchfish	European Commission(European CommissionEuropean Commission Joint Research Centre); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The ToyBox-study is funded by the Seventh Framework Programme (CORDIS FP7) of the European Commission under grant agreement no 245200. The sponsor had no role in the design or conduct of the study, the collection, management, analysis or interpretation of the data, or the preparation, review and approval of the manuscript.	Androutsos O, 2014, OBES REV, V15, P74, DOI 10.1111/obr.12185; Androutsos O, 2014, OBES REV, V15, P48, DOI 10.1111/obr.12182; Bar-David Y, 2005, ACTA PAEDIATR, V94, P1667, DOI 10.1080/08035250500254670; Bellisle F, 2010, EUR J CLIN NUTR, V64, P350, DOI 10.1038/ejcn.2010.4; Benton D, 2011, NUTRIENTS, V3, P555, DOI 10.3390/nu3050555; Bornhorst C, 2014, INT J OBESITY, V38, pS115, DOI 10.1038/ijo.2014.142; Briefel RR, 2013, J ACAD NUTR DIET, V113, P269, DOI 10.1016/j.jand.2012.10.016; Brug J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034742; Centis E, 2012, PEDIATR OBES, V7, P436, DOI 10.1111/j.2047-6310.2012.00079.x; CUNNINGHAM CE, 1993, J CONSULT CLIN PSYCH, V61, P871, DOI 10.1037/0022-006X.61.5.871; D'Anci KE, 2006, NUTR REV, V64, P457, DOI [10.1301/nr.2006.oct.457-464, 10.1111/j.1753-4887.2006.tb00176.x]; De Coen V, 2012, APPETITE, V59, P76, DOI 10.1016/j.appet.2012.03.024; De Craemer M, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-278; de Ruyter JC, 2012, NEW ENGL J MED, V367, P1397, DOI 10.1056/NEJMoa1203034; DeBoer MD, 2013, PEDIATRICS, V132, P413, DOI 10.1542/peds.2013-0570; Drewnowski A, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-85; Durlak JA, 2008, AM J COMMUN PSYCHOL, V41, P327, DOI 10.1007/s10464-008-9165-0; Feferbaum R, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1005; Gonzalez-Suarez C, 2009, AM J PREV MED, V37, P418, DOI 10.1016/j.amepre.2009.07.012; Hingle MD, 2010, PREV MED, V51, P103, DOI 10.1016/j.ypmed.2010.04.014; Hulscher MEJL, 2003, QUAL SAF HEALTH CARE, V12, P40, DOI 10.1136/qhc.12.1.40; Huybrechts I, 2009, INT J ENV RES PUB HE, V6, P382, DOI 10.3390/ijerph6010382; Jequier E, 2010, EUR J CLIN NUTR, V64, P115, DOI 10.1038/ejcn.2009.111; Kleiner SM, 1999, J AM DIET ASSOC, V99, P200, DOI 10.1016/S0002-8223(99)00048-6; Kunin-Batson AS, 2015, J NUTR EDUC BEHAV, V47, P206, DOI 10.1016/j.jneb.2015.01.002; LaRowe TL, 2007, J AM DIET ASSOC, V107, P1124, DOI 10.1016/j.jada.2007.04.013; Manios Y, 2014, OBES REV, V15, P5, DOI 10.1111/obr.12175; Manios Y, 2012, OBES REV, V13, P3, DOI 10.1111/j.1467-789X.2011.00974.x; Masento NA, 2014, BRIT J NUTR, V111, P1841, DOI 10.1017/S0007114513004455; Moreno LA, 2008, INT J OBESITY, V32, P5, DOI DOI 10.1038/IJO.2008.28; Mouratidou T, 2014, OBES REV, V15, P53, DOI 10.1111/obr.12183; Nethe A, 2012, OBES REV, V13, P118, DOI 10.1111/j.1467-789X.2011.00963.x; Nixon CA, 2012, OBES REV, V13, P106, DOI 10.1111/j.1467-789X.2011.00962.x; Panel on Dietary Reference Intakes for Electrolytes and Water, 2005, DIET REF INT WAT POT; Payr A, 2014, OBES REV, V15, P40, DOI 10.1111/obr.12177; Pinket A, PUBLIC HLTH IN PRESS; Popkin BM, 2010, NUTR REV, V68, P439, DOI 10.1111/j.1753-4887.2010.00304.x; Rader RK, 2014, CLIN PEDIATR, V53, P1047, DOI 10.1177/0009922814540989; Resnicow K, 1998, HEALTH EDUC RES, V13, P239, DOI 10.1093/her/13.2.239; Saunders RP, 2005, HEALTH PROMOT PRACT, V6, P134, DOI 10.1177/1524839904273387; Shirreffs SM, 2004, BRIT J NUTR, V91, P951, DOI 10.1079/BJN20041149; van Stralen MM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-65; Vanhauwaert E, 2012, DEACTIEVE VOEDINGSDR, P37; Ventura AK, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-15; Verloigne M, 2015, OBES REV, V16, P89, DOI 10.1111/obr.12353; Verloigne M, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-805; Weaver C., 2013, Milk and dairy products in human nutrition, P103; WINKLEBY MA, 1992, AM J PUBLIC HEALTH, V82, P816, DOI 10.2105/AJPH.82.6.816	48	22	22	4	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2016	11	4							e0152928	10.1371/journal.pone.0152928	http://dx.doi.org/10.1371/journal.pone.0152928			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ0KH	27064274	Green Published, gold, Green Submitted			2022-12-27	WOS:000373891000025
J	Barbosa, A; Balague, V; Valera, F; Martinez, A; Benzal, J; Motas, M; Diaz, JI; Mira, A; Pedros-Alio, C				Barbosa, Andres; Balague, Vanessa; Valera, Francisco; Martinez, Ana; Benzal, Jesus; Motas, Miguel; Diaz, Julia I.; Mira, Alex; Pedros-Alio, Carlos			Age-Related Differences in the Gastrointestinal Microbiota of Chinstrap Penguins (Pygoscelis antarctica)	PLOS ONE			English	Article							INTERSPECIFIC VARIATIONS; INTESTINAL MICROBIOTA; BACTERIAL PATHOGENS; CLOACAL BACTERIA; COMMUNITY; GROWTH; EVOLUTION; BIRDS	The gastrointestinal tract microbiota is known to play very important roles in the well being of animals. It is a complex community composed by hundreds of microbial species interacting closely among them and with their host, that is, a microbial ecosystem. The development of high throughput sequencing techniques allows studying the diversity of such communities in a realistic way and considerable work has been carried out in mammals and some birds such as chickens. Wild birds have received less attention and in particular, in the case of penguins, only a few individuals of five species have been examined with molecular techniques. We collected cloacal samples from Chinstrap penguins in the Vapour Col rookery in Deception Island, Antarctica, and carried out pyrosequencing of the V1-V3 region of the 16S rDNA in samples from 53 individuals, 27 adults and 26 chicks. This provided the first description of the Chinstrap penguin gastrointestinal tract microbiota and the most extensive in any penguin species. Firmicutes, Bacteoridetes, Proteobacteria, Fusobacteria, Actinobacteria, and Tenericutes were the main components. There were large differences between chicks and adults. The former had more Firmicutes and the latter more Bacteroidetes and Proteobacteria. In addition, adults had richer and more diverse bacterial communities than chicks. These differences were also observed between parents and their offspring. On the other hand, nests explained differences in bacterial communities only among chicks. We suggest that environmental factors have a higher importance than genetic factors in the microbiota composition of chicks. The results also showed surprisingly large differences in community composition with other Antarctic penguins including the congeneric Adelie and Gentoo penguins.	[Barbosa, Andres] CSIC, Museo Nacl Ciencias Nat, Dept Ecol Evolut, E-28006 Madrid, Spain; [Balague, Vanessa; Pedros-Alio, Carlos] CSIC, Inst Ciencies Mar, Dept Biol Marina & Oceanog, Barcelona, Spain; [Valera, Francisco; Benzal, Jesus] CSIC, Estn Expt Zonas Aridas, Dept Ecol Func & Evolut, Almeria, Spain; [Martinez, Ana] Univ Nacl Autonoma Mexico, Inst Invest Mat, Mexico City 04510, DF, Mexico; [Motas, Miguel] Univ Murcia, Fac Vet, Murcia, Spain; [Diaz, Julia I.] CCT La Plata CONICET UNLP, Ctr Estudios Parasitol & Vectores, La Plata, Buenos Aires, Argentina; [Mira, Alex] FISABIO Fdn, Ctr Adv Res Publ Hlth, Dept Genom & Hlth, Valencia, Spain; [Pedros-Alio, Carlos] CSIC, Ctr Nacl Biotecnol, Syst & Synthet Biol Program, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental de Zonas Aridas (EEZA); Universidad Nacional Autonoma de Mexico; University of Murcia; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Pedros-Alio, C (corresponding author), CSIC, Ctr Nacl Biotecnol, Syst & Synthet Biol Program, Madrid, Spain.	cpedros@cnb.csic.es	Motas, Miguel/L-3061-2014; Benzal, Jesús/T-4555-2017; Barbosa, Andrés/C-3208-2008; Valera, Francisco/R-3437-2019; Valera, Francisco/J-5951-2014; Pedrós-Alió, Carlos/H-1222-2011; Mira, Alex/A-7244-2010	Motas, Miguel/0000-0002-2229-7779; Barbosa, Andrés/0000-0001-8434-3649; Valera, Francisco/0000-0003-2266-8899; Valera, Francisco/0000-0003-2266-8899; Pedrós-Alió, Carlos/0000-0003-1009-4277; Martinez, Ana/0000-0002-0515-1946; Mira, Alex/0000-0002-9127-3877	Ministerio de Economia y Competitividad (Espana) [CGL2007-60369, CTM2011-24427]; "Marine Gems" Ministerio de Economia y Competitividad (Espana) [CTM2010-20361]; "EcoBGM" Ministerio de Economia y Competitividad (Espana) [CTM2013-48292-C3-1-R]	Ministerio de Economia y Competitividad (Espana)(Spanish Government); "Marine Gems" Ministerio de Economia y Competitividad (Espana); "EcoBGM" Ministerio de Economia y Competitividad (Espana)	CGL2007-60369 Ministerio de Economia y Competitividad (Espana, http://www.mineco.gob.es/) AB, CTM2011-24427 Ministerio de Economia y Competitividad (Espana, http://www.mineco.gob.es/) AB, CTM2010-20361 "Marine Gems" Ministerio de Economia y Competitividad (Espana, http://www.mineco.gob.es) CPA, CTM2013-48292-C3-1-R "EcoBGM" Ministerio de Economia y Competitividad (Espana, http://ww.mineco.gob.es/) CPA.	Banks JC, 2009, ENVIRON MICROBIOL, V11, P577, DOI 10.1111/j.1462-2920.2008.01816.x; Barbosa A, 2009, POLAR BIOL, V32, P1095, DOI 10.1007/s00300-009-0640-3; Beier S, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00149; Benskin CMH, 2009, BIOL REV, V84, P349, DOI 10.1111/j.1469-185X.2008.00076.x; Berger S, 2003, J ORNITHOL, V144, P317, DOI 10.1007/BF02465631; Bonnedahl J, 2005, AMBIO, V34, P430, DOI 10.1639/0044-7447(2005)034[0430:ISOHBP]2.0.CO;2; BRITTINGHAM MC, 1988, J WILDLIFE DIS, V24, P299, DOI 10.7589/0090-3558-24.2.299; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Crespo BG, 2015, BIORXIV; Dewar ML, 2014, FEMS MICROBIOL ECOL, V89, P47, DOI 10.1111/1574-6941.12332; Dewar ML, 2013, MICROBIOLOGYOPEN, V2, P195, DOI 10.1002/mbo3.66; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Gonzalez-Braojos S, 2014, INTERACCIONES ECOLOG; Gonzalez-Braojos S, 2015, J ORNITHOL, V156, P327, DOI 10.1007/s10336-014-1100-6; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Human Microbiome Project Consortium, 2012, Nature, V486, P207, DOI 10.1038/nature11234; Kohl KD, 2012, J COMP PHYSIOL B, V182, P591, DOI 10.1007/s00360-012-0645-z; Kyle PD, 1993, J WILDL REHABIL, V8; Lan Y, 2005, WORLD POULTRY SCI J, V61, P95, DOI 10.1079/WPS200445; Lefebvre KA, 2002, TOXICON, V40, P971, DOI 10.1016/S0041-0101(02)00093-4; Ley RE, 2008, NAT REV MICROBIOL, V6, P776, DOI 10.1038/nrmicro1978; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Li XB, 2004, P NATL ACAD SCI USA, V101, P627, DOI 10.1073/pnas.0307645100; Lombardo MP, 1996, CONDOR, V98, P167, DOI 10.2307/1369521; Lucas FS, 2005, J AVIAN BIOL, V36, P510, DOI 10.1111/j.0908-8857.2005.03479.x; Meade GC, 1997, GASTROINTESTINAL MIC; Mills TK, 1999, AUK, V116, P947; Morales SE, 2009, APPL ENVIRON MICROB, V75, P668, DOI 10.1128/AEM.01757-08; Moreno J, 2003, AUK, V120, P784, DOI 10.1642/0004-8038(2003)120[0784:BEOCBO]2.0.CO;2; Nuttall Patricia A., 1997, P271; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Potti J, 2002, ECOL LETT, V5, P709, DOI 10.1046/j.1461-0248.2002.00375.x; R Core Team, 2021, R LANGUAGE ENV STAT; Reeder J, 2010, NAT METHODS, V7, P668, DOI 10.1038/nmeth0910-668b; Ruiz-Rodriguez M, 2009, BIOL J LINN SOC, V96, P406, DOI 10.1111/j.1095-8312.2008.01127.x; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Salazar G, 2016, ISME J, V10, P596, DOI 10.1038/ismej.2015.137; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Scupham AJ, 2007, FEMS MICROBIOL ECOL, V60, P136, DOI 10.1111/j.1574-6941.2006.00245.x; SIEBURTH JM, 1959, J BACTERIOL, V77, P521, DOI 10.1128/JB.77.5.521-531.1959; SOUCEK Z, 1970, APPL MICROBIOL, V20, P561, DOI 10.1128/AEM.20.4.561-566.1970; Stanley D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084290; Tanikawa T, 2011, POULTRY SCI, V90, P1004, DOI 10.3382/ps.2010-01153; Valles Y, 2012, CLIN MICROBIOL INFEC, V18, P21, DOI 10.1111/j.1469-0691.2012.03876.x; van Dongen WFD, 2013, BMC ECOL, V13, DOI 10.1186/1472-6785-13-11; Vik U, 2013, SCI REP-UK, V3, DOI 10.1038/srep03471; Waite DW, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00223; Williams TD, 1995, PENGUINS SPHENISCIDA; Yoshitomi B, 2012, CHEMOSPHERE, V86, P891, DOI 10.1016/j.chemosphere.2011.10.042; Zoetendal EG, 2004, J NUTR, V134, P465, DOI 10.1093/jn/134.2.465	51	50	51	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153215	10.1371/journal.pone.0153215	http://dx.doi.org/10.1371/journal.pone.0153215			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27055030	Green Published, Green Submitted, gold			2022-12-27	WOS:000373608000103
J	Azevedo, CTD; do Brasil, PEAA; Guida, L; Moreira, MEL				de Oliveira Azevedo, Christianne Terra; do Brasil, Pedro Emmanuel A. A.; Guida, Leticia; Lopes Moreira, Maria Elizabeth			Performance of Polymerase Chain Reaction Analysis of the Amniotic Fluid of Pregnant Women for Diagnosis of Congenital Toxoplasmosis: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							PRENATAL-DIAGNOSIS; MOLECULAR DIAGNOSIS; GONDII; INFECTION; PCR; TRANSMISSION; TIME; AGE; MULTICENTER; PROGRAMS	Introduction Congenital infection caused by Toxoplasma gondii can cause serious damage that can be diagnosed in utero or at birth, although most infants are asymptomatic at birth. Prenatal diagnosis of congenital toxoplasmosis considerably improves the prognosis and outcome for infected infants. For this reason, an assay for the quick, sensitive, and safe diagnosis of fetal toxoplasmosis is desirable. Goal To systematically review the performance of polymerase chain reaction (PCR) analysis of the amniotic fluid of pregnant women with recent serological toxoplasmosis diagnoses for the diagnosis of fetal toxoplasmosis. Method A systematic literature review was conducted via a search of electronic databases; the literature included primary studies of the diagnostic accuracy of PCR analysis of amniotic fluid from pregnant women who seroconverted during pregnancy. The PCR test was compared to a gold standard for diagnosis. Results A total of 1.269 summaries were obtained from the electronic database and reviewed, and 20 studies, comprising 4.171 samples, met the established inclusion criteria and were included in the review. The following results were obtained: studies about PCR assays for fetal toxoplasmosis are generally susceptible to bias; reports of the tests' use lack critical information; the protocols varied among studies; the heterogeneity among studies was concentrated in the tests' sensitivity; there was evidence that the sensitivity of the tests increases with time, as represented by the trimester; and there was more heterogeneity among studies in which there was more time between maternal diagnosis and fetal testing. The sensitivity of the method, if performed up to five weeks after maternal diagnosis, was 87% and specificity was 99%. Conclusion The global sensitivity heterogeneity of the PCR test in this review was 66.5%(I-2). The tests show low evidence of heterogeneity with a sensitivity of 87% and specificity of 99% when performed up to five weeks after maternal diagnosis. The test has a known performance and could be recommended for use up to five weeks after maternal diagnosis, when there is suspicion of fetal toxoplasmosis.	[de Oliveira Azevedo, Christianne Terra; Guida, Leticia; Lopes Moreira, Maria Elizabeth] Fiocruz MS, IFF, Inst Nacl Saude Mulher Crianca & Adolescente Fern, Recife, PE, Brazil; [do Brasil, Pedro Emmanuel A. A.] Fiocruz MS, Ipec, Inst Nacl Infectol Evandro Chagas, Recife, PE, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	Moreira, MEL (corresponding author), Fiocruz MS, IFF, Inst Nacl Saude Mulher Crianca & Adolescente Fern, Recife, PE, Brazil.	bebethiff@gmail.com	Brasil, Pedro E A A/B-4357-2008; Guida, Leticia/AAZ-2357-2021; Moreira, Maria Elisabeth Lopes/AAA-3775-2020	Brasil, Pedro E A A/0000-0002-6700-2268; Moreira, Maria Elisabeth Lopes/0000-0002-2034-0294				Andrade GMQ, 2001, REV MED MINAS GERAIS, V11, P202; Antsaklis A, 2002, PRENATAL DIAG, V22, P1107, DOI 10.1002/pd.476; Avelino MM, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-33; Avelino Mariza Martins, 2004, Braz J Infect Dis, V8, P164, DOI 10.1590/S1413-86702004000200007; Baquero-Artigao F, 2013, AN PEDIATR, V79, P116, DOI 10.1016/j.anpedi.2012.12.001; Bastien P, 2008, J CLIN MICROBIOL, V46, P1897, DOI 10.1128/JCM.02258-07; Bastien Patrick, 2002, Trans R Soc Trop Med Hyg, V96 Suppl 1, pS205, DOI 10.1016/S0035-9203(02)90078-7; Bessieres M, 2002, IMMUNO-ANAL BIOL SPE, V17, P358; Bessieres MH, 2009, MEM I OSWALDO CRUZ, V104, P389, DOI 10.1590/S0074-02762009000200038; Bossuyt PM, 2003, ANN INTERN MED, V138, P40, DOI 10.7326/0003-4819-138-1-200301070-00010; BURG JL, 1989, J CLIN MICROBIOL, V27, P1787, DOI 10.1128/JCM.27.8.1787-1792.1989; Cao Y, 1999, Zhonghua Fu Chan Ke Za Zhi, V34, P517; Castro FC, 2001, REV BRAS GINECOL OBS, V23, P277; CAZENAVE J, 1992, PRENATAL DIAG, V12, P119, DOI 10.1002/pd.1970120207; Cermakova Z, 2003, ACTA MED HRADEC KRAL, V47, P71; Czuba B, 2000, WIAD PARAZYTOL, V47, P91; Dupouy-Camet J, 1991, COMP VALUE POLYM CHA, P315; Eida Omima M., 2009, Journal of the Egyptian Society of Parasitology, V39, P541; Favero A, 1997, DIAGN LAB 2 LIVELLO, V12, P459; Figueiro EA, 2005, REV BRAS GINECOL OBS, V27, P442, DOI 10.1590/S0100-72032005000800002; Foulon W, 1999, AM J OBSTET GYNECOL, V181, P843, DOI 10.1016/S0002-9378(99)70311-X; Foulon W, 1999, AM J OBSTET GYNECOL, V180, P410, DOI 10.1016/S0002-9378(99)70224-3; Geerts I, 2008, TIJDSCHR GENEESKD, V64, P920; Gola J, 2000, Ginekol Pol, V71, P954; Golab E., 1996, Medycyna Doswiadczalna i Mikrobiologia, V48, P189; Golab E, 2001, WIAD PARAZYTOL, V48, P311; Hill D, 2002, CLIN MICROBIOL INFEC, V8, P634, DOI 10.1046/j.1469-0691.2002.00485.x; Jenum PA, 1998, APMIS, V106, P680, DOI 10.1111/j.1699-0463.1998.tb00211.x; Kieffer F, 2008, PEDIATR INFECT DIS J, V27, P27, DOI 10.1097/INF.0b013e318134286d; Kieffer F, 2013, HAND CLINIC, V112, P1099, DOI 10.1016/B978-0-444-52910-7.00028-3; KNERER B, 1995, WIEN KLIN WOCHENSCHR, V107, P137; Kompalic-Cristo A, 2004, T ROY SOC TROP MED H, V98, P92, DOI 10.1016/S0035-9203(03)00012-9; Li S, 1995, Zhonghua Fu Chan Ke Za Zhi, V30, P200; Ma Yu-yan, 2003, Zhonghua Fu Chan Ke Za Zhi, V38, P8; McLeod R, 2009, MEM I OSWALDO CRUZ, V104, P320, DOI 10.1590/S0074-02762009000200029; Nagaty Ibraheim M., 2009, JOURNAL OF THE EGYPTIAN SOCIETY OF PARASITOLOGY, V39, P625; Nagy B, 2005, MAGY NOORV L, V68, P95; Ordinaire I, 2004, REAL TIME QUANTITATI, P67; Paquet C, 2013, J OBSTET GYNAECOL CA, V35, P78, DOI 10.1016/S1701-2163(15)31053-7; Perez P, 2006, PERFORMANCES TESTS I; Prasil P, 2010, CZECH SLOVAK PEDIAT, V65, P432; Prusa AR, 2015, CLIN MICROBIOL INFEC, V21, DOI 10.1016/j.cmi.2014.09.018; Rabilloud M, 2010, PEDIATR INFECT DIS J, V29, P421, DOI 10.1097/INF.0b013e3181c80493; Robert-Gangneux F, 1999, J CLIN MICROBIOL, V37, P2893, DOI 10.1128/JCM.37.9.2893-2898.1999; Romand S, 2001, OBSTET GYNECOL, V97, P296, DOI 10.1016/S0029-7844(00)01118-2; Lopes-Mori FMR, 2011, REV ASSOC MED BRAS, V57, P594, DOI 10.1590/S0104-42302011000500021; Slawska H, 2000, WIAD PARAZYTOL, V47, P99; Slawska Helena, 2005, Ginekol Pol, V76, P536; Sterkers Y, 2010, CLIN MICROBIOL INFEC, V16, P1594, DOI [10.1111/j.1469-0691.2009.03101.x, 10.1111/j.1469-0691.2010.03101.x]; Sterkers Y, 2012, J CLIN MICROBIOL, V50, P3944, DOI 10.1128/JCM.00918-12; Szenborn L, 2009, PRZEGL LEK, V67, P54; Teixeira LE, 2013, REV SOC BRAS MED TRO, V46, P584, DOI 10.1590/0037-8682-0095-2013; Thalib L, 2005, BJOG-INT J OBSTET GY, V112, P567, DOI 10.1111/j.1471-0528.2005.00486.x; Thiebaut R, 2007, LANCET, V369, P115, DOI 10.1016/S0140-6736(07)60072-5; Tomasoni LR, 2014, NEW MICROBIOL, V37, P347; Tuma W, 1994, LAB MED, V18, P512; Vidigal Paula Vieira Teixeira, 2002, Rev. Soc. Bras. Med. Trop., V35, P1, DOI 10.1590/S0037-86822002000100001; Wallon M, 2013, CLIN INFECT DIS, V56, P1223, DOI 10.1093/cid/cit032; Wallon M, 2010, OBSTET GYNECOL, V115, P727, DOI 10.1097/AOG.0b013e3181d57b09; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; Xia A, 1991, ZHONGGUO JI SHENG CH, V10, P171	61	21	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0149938	10.1371/journal.pone.0149938	http://dx.doi.org/10.1371/journal.pone.0149938			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27055272	Green Submitted, Green Published, gold			2022-12-27	WOS:000373608000002
J	Engvall, G; Angstrom-Brannstrom, C; Mullaney, T; Nilsson, K; Wickart-Johansson, G; Svard, AM; Nyholm, T; Lindh, J; Lindh, V				Engvall, Gunn; Angstrom-Brannstrom, Charlotte; Mullaney, Tara; Nilsson, Kristina; Wickart-Johansson, Gun; Svard, Anna-Maja; Nyholm, Tufve; Lindh, Jack; Lindh, Viveca			It Is Tough and Tiring but It Works-Children's Experiences of Undergoing Radiotherapy	PLOS ONE			English	Article							CHILDHOOD	Approximately 300 children ages 0 to 18 are diagnosed with cancer in Sweden every year, and 80 to 90 of them undergo radiotherapy treatment. The aim was to describe children's experiences of preparing for and undergoing radiotherapy, and furthermore to describe children's suggestions for improvement. Thirteen children between the ages of 5 and 15 with various cancer diagnoses were interviewed. Data was analyzed using qualitative content analysis. The findings revealed five categories: positive and negative experiences with hospital stays and practical arrangements; age-appropriate information, communication, and guidance to various degrees; struggle with emotions; use of distraction and other suitable coping strategies; and children's suggestions for improvement during radiotherapy. An overarching theme emerged: "It is tough and tiring but it works". Some key areas were: explanatory visits, the need for information and communication, being afraid, discomfort and suffering, the need for media distraction, dealing with emotions, and the need for support. A systematic, family-centered preparation program could possible help families prepare and individualized distraction during radiotherapy could contribute to reducing distress. Further studies with interventions could clarify successful programs.	[Engvall, Gunn] Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden; [Engvall, Gunn] Uppsala Univ, Dept Publ Hlth & Caring Sci, Uppsala, Sweden; [Angstrom-Brannstrom, Charlotte; Lindh, Viveca] Umea Univ, Dept Nursing, Umea, Sweden; [Mullaney, Tara] Umea Univ, Umea Inst Design, Umea, Sweden; [Nilsson, Kristina] Univ Uppsala Hosp, Dept Oncol Radiol & Clin Immunol, Sect Oncol, Uppsala, Sweden; [Wickart-Johansson, Gun] Karolinska Univ Hosp, Radiumhemmet, Dept Oncol, Stockholm, Sweden; [Svard, Anna-Maja; Nyholm, Tufve; Lindh, Jack] Umea Univ, Dept Radiat Sci, Umea, Sweden	Uppsala University; Uppsala University; Umea University; Umea University; Uppsala University; Uppsala University Hospital; Karolinska Institutet; Karolinska University Hospital; Umea University	Engvall, G (corresponding author), Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden.; Engvall, G (corresponding author), Uppsala Univ, Dept Publ Hlth & Caring Sci, Uppsala, Sweden.	gunn.engvall@kbh.uu.se	Nyholm, Tufve/I-1402-2019	Nyholm, Tufve/0000-0002-8971-9788; Engvall, Gunn/0000-0002-5225-9650	Swedish Childhood Cancer Foundation [PR 2013-0025]	Swedish Childhood Cancer Foundation(European Commission)	Funding provided by grant number PR 2013-0025, The Swedish Childhood Cancer Foundation, URL: http://www.barncancerfonden.se. TN received the funding.	Angstroem-Braennstroem, 2014, J PEDIATR ONCOL NURS, V31, P135, DOI 10.1177/1043454214521693; Aringstrom-Brannstrom C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141086; Bjork Maria, 2006, J Pediatr Oncol Nurs, V23, P210, DOI 10.1177/1043454206289737; Bucholtz J D, 1994, Oncol Nurs Forum, V21, P987; Carter B, 2013, RES NURS HEALTH, V36, P95, DOI 10.1002/nur.21517; Compas BE, 2009, NEW DIR CHILD ADOLES, V124, P87, DOI 10.1002/cd.245; Filin A, 2009, J PEDIATR ONCOL NURS, V26, P81, DOI 10.1177/1043454208328766; Fortier MA, 2011, BRIT J ANAESTH, V106, P713, DOI 10.1093/bja/aer010; Goske MJ, 2013, RADIOGRAPHY, V19, P283, DOI 10.1016/j.radi.2013.04.003; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Gustafsson G, CHILDHOOD CANC INCID; Harrison TM, 2010, J PEDIATR NURS, V25, P335, DOI 10.1016/j.pedn.2009.01.006; Harvey-Lloyd JM, 2013, RADIOGRAPHY, V19, P285, DOI 10.1016/j.radi.2013.07.010; Hildenbrand AK, 2011, J PEDIATR ONCOL NURS, V28, P344, DOI 10.1177/1043454211430823; McGovern SL, 2012, CURR ONCOL REP, V14, P320, DOI 10.1007/s11912-012-0235-y; Patton M. Q., 2002, QUALITATIVE RES EVAL, V3rd; Pimm P, 1997, RADIOGRAPHY, V3, P27, DOI [10.1016/S1078-8174(97)80022-3, DOI 10.1016/S1078-8174(97)80022-3]; Scott Linda, 2002, Eur J Oncol Nurs, V6, P15, DOI 10.1054/ejon.2001.0162; Shrimpton BJM, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-001666; Soanes L, 2009, EUR J ONCOL NURS, V13, P255, DOI 10.1016/j.ejon.2009.03.009; Stackhouse C, 2013, RADIOGRAPHY, V19, P302, DOI 10.1016/j.radi.2013.08.004; Tornqvist E, 2015, J CHILD HEALTH CARE, V19, P359, DOI 10.1177/1367493513518374; Trier-Bieniek A, 2012, QUAL RES, V12, P630, DOI 10.1177/1468794112439005; Woodman H, 2013, RADIOGRAPHY, V19, P311, DOI 10.1016/j.radi.2013.08.006	24	11	11	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153029	10.1371/journal.pone.0153029	http://dx.doi.org/10.1371/journal.pone.0153029			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27055258	gold, Green Published, Green Submitted			2022-12-27	WOS:000373608000066
J	Flahault, A; Trystram, D; Fouchard, M; Knebelmann, B; Nataf, F; Joly, D				Flahault, Adrien; Trystram, Denis; Fouchard, Marie; Knebelmann, Bertrand; Nataf, Francois; Joly, Dominique			Screening for Unruptured Intracranial Aneurysms in Autosomal Dominant Polycystic Kidney Disease: A Survey of 420 Nephrologists	PLOS ONE			English	Article							PHYSICIAN PRACTICE; PREVALENCE; MANAGEMENT; HEMORRHAGE; SURVIVAL; ADPKD; GENE	Background Despite a high prevalence of intracranial aneurysm (ICA) in autosomal dominant polycystic kidney disease (ADPKD), rupture events are rare. The current recommendations for ICA screening are based on expert opinions and studies with low levels of evidence. Objectives The aim of our study was to describe the attitudes of practicing nephrologists in Europe towards screening for ICA using magnetic resonance angiography (MRA). Methods We conducted a web-based survey among 1315 European French-speaking nephrologists and nephrology residents. An anonymous, electronic questionnaire including 24 independent questions related to ICA screening modalities, indications and participant profiles was sent by email between September and December 2014. Four hundred and twenty nephrologists (mostly from France) participated, including 31 nephrology residents; the response rate was 32%. Results Systematic screening for ICA was advocated by 28% of the nephrologists. A family history of ICA rupture, sudden death, stroke and migraine were consensual indications for screening (> 90% of the panel). In other clinical situations largely not covered by the recommendations (pregnancy, nephrectomy, kidney transplantation, cardiac or hepatic surgery, uncontrolled hypertension, lack of familial ADPKD history, at-risk activity, tobacco use), the attitudes towards screening were highly divergent. ICA screening was influenced by nephrologists experience with ADPKD and by their practice setting. The majority of participants (57%) would not repeat a normal ICA screening. Only a few participants (22%) knew that non-contrast MRA was the reference diagnostic tool for ICA screening, whereas most participants thought that contrast enhancement was necessary to screen for ICA. The results from the nephrology residents were analyzed separately and yielded similar results. Conclusion This practice survey revealed that most nephrologists follow the current recommendations for the initial screening of ICAs. However, more than a quarter of the panel was in favor of systematic ICA screening, most nephrologists did not know that contrast medium was not necessary to screen for ICA using MRA, and many areas of uncertainty remain.	[Flahault, Adrien; Fouchard, Marie; Knebelmann, Bertrand; Joly, Dominique] Univ Paris 05, Hop Necker Enfants Malad, AP HP, Fac Med,Serv Nephrol, Paris, France; [Trystram, Denis] Univ Paris 05, Ctr Hosp St Anne, INSERM UMR 894, Serv Neuroradiol, Paris, France; [Nataf, Francois] Univ Paris 05, Ctr Hosp St Anne, INSERM UMR 894, Serv Neurochirurg, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; GHU PARIS Psychiatrie Neurosciences; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; GHU PARIS Psychiatrie Neurosciences; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Joly, D (corresponding author), Univ Paris 05, Hop Necker Enfants Malad, AP HP, Fac Med,Serv Nephrol, Paris, France.	dominique.joly@aphp.fr	Flahault, Adrien/Q-4576-2017	Flahault, Adrien/0000-0003-4632-6332; Trystram, Denis/0000-0003-1496-222X				Belz MM, 2001, AM J KIDNEY DIS, V38, P770, DOI 10.1053/ajkd.2001.27694; Brown RD, 2014, LANCET NEUROL, V13, P393, DOI 10.1016/S1474-4422(14)70015-8; Chapman AB, 2015, KIDNEY INT, V88, P17, DOI 10.1038/ki.2015.59; CHAUVEAU D, 1994, KIDNEY INT, V45, P1140, DOI 10.1038/ki.1994.151; Cornec-Le Gall E, 2013, J AM SOC NEPHROL, V24, P1006, DOI 10.1681/ASN.2012070650; Gibbs GF, 2005, J MAGN RESON IMAGING, V21, P97, DOI 10.1002/jmri.20247; Irazabal MV, 2011, CLIN J AM SOC NEPHRO, V6, P1274, DOI 10.2215/CJN.09731110; Kanaan N, 2014, NAT REV NEPHROL, V10, P455, DOI 10.1038/nrneph.2014.104; Levy M, 2000, KIDNEY INT, V58, P925, DOI 10.1046/j.1523-1755.2000.00250.x; Peabody JW, 2004, ANN INTERN MED, V141, P771, DOI 10.7326/0003-4819-141-10-200411160-00008; Perrone RD, 2001, AM J KIDNEY DIS, V38, P777, DOI 10.1053/ajkd.2001.27720; Pirson Y, 2002, J AM SOC NEPHROL, V13, P269, DOI 10.1681/ASN.V131269; Rossetti S, 2003, LANCET, V361, P2196, DOI 10.1016/S0140-6736(03)13773-7; Rozenfeld MN, 2014, AM J NEURORADIOL, V35, P3, DOI 10.3174/ajnr.A3437; SCHIEVINK WI, 1992, J AM SOC NEPHROL, V3, P88; Schrier RW, 2004, J AM SOC NEPHROL, V15, P1023, DOI 10.1097/01.ASN.0000118527.74850.66; Shiue I, 2012, J NEUROL SCI, V313, P92, DOI 10.1016/j.jns.2011.09.017; Spithoven EM, 2014, NEPHROL DIAL TRANSPL, V29, P15, DOI 10.1093/ndt/gfu017; Torres VE, 2007, LANCET, V369, P1287, DOI 10.1016/S0140-6736(07)60601-1; United States Renal Data System, 2015, 2015 USRDS ANNUAL DA; Veloski J, 2005, AM J MED QUAL, V20, P151, DOI 10.1177/1062860605274520; Vernooij MW, 2007, NEW ENGL J MED, V357, P1821, DOI 10.1056/NEJMoa070972; Vlak MHM, 2011, LANCET NEUROL, V10, P626, DOI 10.1016/S1474-4422(11)70109-0; Xu HW, 2011, STROKE, V42, P204, DOI 10.1161/STROKEAHA.110.578740; Yoo DJ, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-39	25	13	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153176	10.1371/journal.pone.0153176	http://dx.doi.org/10.1371/journal.pone.0153176			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27054719	Green Published, Green Submitted, gold			2022-12-27	WOS:000373608000093
J	Fonseca, F; Meneghel, J; Cenard, S; Passot, S; Morris, GJ				Fonseca, Fernanda; Meneghel, Julie; Cenard, Stephanie; Passot, Stephanie; Morris, G. John			Determination of Intracellular Vitrification Temperatures for Unicellular Micro Organisms under Conditions Relevant for Cryopreservation	PLOS ONE			English	Article							DELBRUECKII SUBSP BULGARICUS; GLASS-TRANSITION; ESCHERICHIA-COLI; FREEZING-INJURY; OSMOTIC-STRESS; CELL; CRYOTOLERANCE; SUSPENSIONS; BEHAVIOR; STORAGE	During cryopreservation ice nucleation and crystal growth may occur within cells or the intracellular compartment may vitrify. Whilst previous literature describes intracellular vitrification in a qualitative manner, here we measure the intracellular vitrification temperature of bacteria and yeasts under conditions relevant to cryopreservation, including the addition of high levels of permeating and nonpermeating additives and the application of rapid rates of cooling. The effects of growth conditions that are known to modify cellular freezing resistance on the intracellular vitrification temperature are also examined. For bacteria a plot of the activity on thawing against intracellular glass transition of the maximally freeze-concentrated matrix (Tg') shows that cells with the lowest value of intracellular Tg' survive the freezing process better than cells with a higher intracellular Tg'. This paper demonstrates the role of the physical state of the intracellular environment in determining the response of microbial cells to preservation and could be a powerful tool to be manipulated to allow the optimization of methods for the preservation of microorganisms.	[Fonseca, Fernanda; Meneghel, Julie; Cenard, Stephanie; Passot, Stephanie] Univ Paris Saclay, INRA, AgroParisTech, UMR GMPA, Thiverval Grignon, France; [Morris, G. John] Asymptote Ltd, St Johns Innovat Ctr, Cambridge CB4 0WS, England	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; St Johns Innovation Centre - UK	Fonseca, F (corresponding author), Univ Paris Saclay, INRA, AgroParisTech, UMR GMPA, Thiverval Grignon, France.	fonseca@grignon.inra.fr	Fonseca, Fernanda/AAR-9094-2020; FONSECA, FERNANDA/HDN-9451-2022	Fonseca, Fernanda/0000-0003-3394-182X; FONSECA, FERNANDA/0000-0002-0315-6479	National Institute of Agronomic Research (Paris, France)	National Institute of Agronomic Research (Paris, France)	This study was supported by the National Institute of Agronomic Research (Paris, France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABLETT S, 1992, J CHEM SOC FARADAY T, V88, P789, DOI 10.1039/ft9928800789; BANK H, 1973, J CELL BIOL, V57, P729, DOI 10.1083/jcb.57.3.729; CHANG BS, 1992, CRYOBIOLOGY, V29, P632, DOI 10.1016/0011-2240(92)90067-C; Clarke A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066207; Colandene JD, 2007, J PHARM SCI-US, V96, P1598, DOI 10.1002/jps.20812; van de Guchte M, 2006, P NATL ACAD SCI USA, V103, P9274, DOI 10.1073/pnas.0603024103; Fonseca F, 2006, APPL ENVIRON MICROB, V72, P6474, DOI 10.1128/AEM.00998-06; Gao C, 2005, THERMOCHIM ACTA, V435, P38, DOI 10.1016/j.tca.2005.03.024; Gautier J, 2013, J DAIRY SCI, V96, P5591, DOI 10.3168/jds.2013-6802; Kilbride P, 2014, CRYOBIOLOGY, V69, P367, DOI 10.1016/j.cryobiol.2014.09.003; Mazur P, 2004, LIFE IN THE FROZEN STATE, P3, DOI 10.1201/9780203647073.ch1; Mazur P, 2011, CRYOBIOLOGY, V62, P1, DOI 10.1016/j.cryobiol.2010.10.159; Meister E, 2009, J PHARM SCI-US, V98, P3072, DOI 10.1002/jps.21586; Miermont A, 2013, P NATL ACAD SCI USA, V110, P5725, DOI 10.1073/pnas.1215367110; Mika JT, 2011, CURR OPIN BIOTECH, V22, P117, DOI 10.1016/j.copbio.2010.09.009; Mika JT, 2010, MOL MICROBIOL, V77, P200, DOI 10.1111/j.1365-2958.2010.07201.x; Morris GJ, 2012, CRYOBIOLOGY, V64, P71, DOI 10.1016/j.cryobiol.2011.12.002; MORRIS GJ, 1988, CRYOBIOLOGY, V25, P471, DOI 10.1016/0011-2240(88)90055-7; Morris GJ, 2004, CRYOLETTERS, V25, P265; Mourao MA, 2014, BIOPHYS J, V107, P2761, DOI 10.1016/j.bpj.2014.10.051; Passot S, 2005, EUR J PHARM BIOPHARM, V60, P335, DOI 10.1016/j.ejpb.2005.02.013; Rapatz G, 1963, ELECT MICROSCOPY STU; Rapatz GL, 1966, CRYOBIOLOGY, P149; Seki S, 2009, CRYOBIOLOGY, V58, P157, DOI 10.1016/j.cryobiol.2008.11.011; SHALAEV EY, 1995, J CHEM SOC FARADAY T, V91, P1511, DOI 10.1039/ft9959101511; Slade L., 1989, PROTEIN QUALITY EFFE, P9; Sochacki KA, 2011, BIOPHYS J, V100, P22, DOI 10.1016/j.bpj.2010.11.044; SPINNLER HE, 1989, J DAIRY RES, V56, P755, DOI 10.1017/S0022029900029332; Streit F, 2007, J BIOTECHNOL, V128, P659, DOI 10.1016/j.jbiotec.2006.11.012; Sun WQ, 1997, COMP BIOCHEM PHYS A, V117, P327, DOI 10.1016/S0300-9629(96)00271-X; To BCS, 1997, J FOOD SCI, V62, P576, DOI 10.1111/j.1365-2621.1997.tb04434.x; To CSB, 1997, J FOOD SCI, V62, P585; Zhou EH, 2009, P NATL ACAD SCI USA, V106, P10632, DOI 10.1073/pnas.0901462106	33	27	28	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0152939	10.1371/journal.pone.0152939	http://dx.doi.org/10.1371/journal.pone.0152939			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27055246	gold, Green Published			2022-12-27	WOS:000373608000057
J	Lee, YK; Hwang, SY; Shin, TG; Jo, IJ; Suh, GY; Jeon, K				Lee, Young Kun; Hwang, Sung Yeon; Shin, Tae Gun; Jo, Ik Joon; Suh, Gee Young; Jeon, Kyeongman			Prognostic Value of Lactate and Central Venous Oxygen Saturation after Early Resuscitation in Sepsis Patients	PLOS ONE			English	Article							GOAL-DIRECTED RESUSCITATION; SEPTIC SHOCK; CRITICALLY-ILL; MANAGEMENT; CLEARANCE; THERAPY; BUNDLE	The objective of this study was to evaluate the prognostic value of static and dynamic variables of central venous oxygen saturation (ScvO(2)) and lactate in patients with severe sepsis or septic shock who underwent early quantitative resuscitation. We also investigated whether ScvO(2) measured after initial resuscitation could provide additive prognostic value to that of lactate. We analyzed the sepsis registry for patients presenting to the emergency department and included patients with simultaneous measurements of lactate and ScvO(2) at the time of presentation (H0) and 6 hours (H6) after resuscitation. The primary outcome was 28-day mortality and multivariable logistic analysis was used to adjust for confounders. A total of 363 patients were included, and the overall 28-day mortality was 18%. The area under the receiver operator characteristic curve for predicting 28-day mortality was as follows: lactate (H6), 0.81; lactate (H0), 0.73; relative lactate change, 0.67; ScvO(2) (H6), 0.65; relative ScvO(2) change 0.59; ScvO(2) (H0), 0.58. Patients with lactate normalization showed significantly lower 28-day mortality compared to patients without lactate normalization (3% vs. 28%, P<0.01). However, in those who achieved ScvO(2) (H6) >= 70%, there was a significant difference in 28-mortality only in patients without lactate normalization (21% vs. 39%, P<0.01) but no difference in those with lactate normalization (4% vs. 3%, P = 0.71). Inmultivariable analysis, lactate normalization was significantly associated with 28-daymortality (adjusted odds ratio [OR] for 28-day mortality, 0.20; 95% confidence interval [CI], 0.07-0.54; P <0.01), but ScvO(2) (H6) >= 70% showed only a marginal association (the adjusted OR for 28-day mortality, 0.51; 95% CI, 0.26-1.01; P = 0.05). ScvO(2) (H6) >= 70% was associated with 28-day mortality only in cases without lactate normalization in subgroup analysis (adjusted OR 0.37, 95% CI, 0.18-0.79; P = 0.01). Six-hour lactate was the strongest predictor of 28-day mortality in patients with severe sepsis or septic shock. Six-hour ScvO(2) provided additional prognostic value only in cases where lactate values were not normalized after resuscitation.	[Lee, Young Kun; Suh, Gee Young; Jeon, Kyeongman] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Crit Care Med, Seoul, South Korea; [Lee, Young Kun; Hwang, Sung Yeon; Shin, Tae Gun; Jo, Ik Joon] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Emergency Med, Seoul, South Korea; [Suh, Gee Young; Jeon, Kyeongman] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Pulm & Crit Care Med,Dept Med, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Jeon, K (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Crit Care Med, Seoul, South Korea.; Jeon, K (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Pulm & Crit Care Med,Dept Med, Seoul, South Korea.	kjeon@skku.edu	Shin, Tae Gun/GSD-5866-2022; Suh, Gee Young/O-3676-2019; Jeon, Kyeongman/F-5963-2019	Suh, Gee Young/0000-0001-5473-1712; Jeon, Kyeongman/0000-0002-4822-1772	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI14C0743]; Samsung Medical Center	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea; Samsung Medical Center(Samsung)	This study was supported by a grant of the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (HI14C0743). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. In addition, Samsung Medical Center provided support in the form of salaries for all of authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Annane D, 2003, AM J RESP CRIT CARE, V168, P165, DOI 10.1164/rccm.2201087; [Anonymous], 2014, NEW ENGL J MED, DOI DOI 10.1056/NEJMoa1401602; [Anonymous], IMPACT TIMELY ANTIBI; Arnold RC, 2009, SHOCK, V32, P35, DOI 10.1097/SHK.0b013e3181971d47; Dellinger RP, 2013, CRIT CARE MED, V41, P580, DOI 10.1097/CCM.0b013e31827e83af; Hernandez G, 2012, CURR OPIN CRIT CARE, V18, P280, DOI 10.1097/MCC.0b013e3283532c08; Hernandez G, 2011, J CRIT CARE, V26, DOI 10.1016/j.jcrc.2010.09.007; Hwang SY, 2014, SHOCK, V42, P205, DOI 10.1097/SHK.0000000000000205; Jeon K, 2012, SHOCK, V37, P463, DOI 10.1097/SHK.0b013e31824c31d1; Jones AE, 2010, JAMA-J AM MED ASSOC, V303, P739, DOI 10.1001/jama.2010.158; Joshi R, 2014, J EMERG MED, V47, P493, DOI 10.1016/j.jemermed.2014.06.016; Kang MJ, 2012, SHOCK, V38, P474, DOI 10.1097/SHK.0b013e31826eea2b; Kaukonen KM, 2014, JAMA-J AM MED ASSOC, V311, P1308, DOI 10.1001/jama.2014.2637; Levraut J, 2003, CRIT CARE MED, V31, P705, DOI 10.1097/01.CCM.0000045561.85810.45; Levy MM, 2001, INTENS CARE MED, V29, P530, DOI DOI 10.1007/S00134-003-1662-X; Mouncey PR, 2015, NEW ENGL J MED, V372, P1301, DOI 10.1056/NEJMoa1500896; Nguyen HB, 2004, CRIT CARE MED, V32, P1637, DOI 10.1097/01.CCM.0000132904.35713.A7; Park HY, 2012, CRIT CARE, V16, DOI 10.1186/cc10601; Park JH, 2014, LUNG, V192, P435, DOI 10.1007/s00408-014-9564-y; Peake SL, 2014, NEW ENGL J MED, V371, P1496, DOI 10.1056/NEJMoa1404380; Puskarich MA, 2013, CHEST, V143, P1548, DOI 10.1378/chest.12-0878; Puskarich MA, 2012, ACAD EMERG MED, V19, P252, DOI 10.1111/j.1553-2712.2012.01292.x; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Rivers EP, 2011, CHEST, V140, P1408, DOI 10.1378/chest.11-2563; Shin TG, 2013, CRIT CARE, V17, DOI 10.1186/cc13047; Song YH, 2012, SHOCK, V38, P249, DOI 10.1097/SHK.0b013e3182613e33; Suetrong B, 2016, CHEST, V149, P252, DOI 10.1378/chest.15-1703; Vincent JL, 2014, CLIN EXP EMERG MED, V1, P3, DOI 10.15441/ceem.14.005; Vincent JL, 2013, NEW ENGL J MED, V369, P1726, DOI 10.1056/NEJMra1208943	29	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153305	10.1371/journal.pone.0153305	http://dx.doi.org/10.1371/journal.pone.0153305			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27054713	Green Published, gold			2022-12-27	WOS:000373608000117
J	Leisching, G; Pietersen, RD; Mpongoshe, V; van Heerden, C; van Helden, P; Wiid, I; Baker, B				Leisching, Gina; Pietersen, Ray-Dean; Mpongoshe, Vuyiseka; van Heerden, Carel; van Helden, Paul; Wiid, Ian; Baker, Bienyameen			The Host Response to a Clinical MDR Mycobacterial Strain Cultured in a Detergent-Free Environment: A Global Transcriptomics Approach	PLOS ONE			English	Article							CORD FACTOR; IMMUNE-RESPONSE; GENE-EXPRESSION; WESTERN CAPE; IFN-ALPHA; CELL-WALL; IN-VIVO; TUBERCULOSIS; GROWTH; RESISTANCE	During Mycobacterium tuberculosis (M.tb) infection, the initial interactions between the pathogen and the host cell determines internalization and innate immune response events. It is established that detergents such as Tween alter the mycobacterial cell wall and solubilize various lipids and proteins. The implication of this is significant since induced changes on the cell wall affect macrophage uptake and the immune response to M.tb. Importantly, during transmission between hosts, aerosolized M.tb enters the host in its native form, i.e. in a detergent-free environment, thus in vitro and in vivo studies should mimic this as closely as possible. To this end, we have optimized a procedure for growing and processing detergent-free M.tb and assessed the response of murine macrophages (BMDM) infected with multi drug-resistant M.tb (R179 Beijing 220 clinical isolate) using RNAseq. We compared the effects of the host response to M.tb cultured under standard laboratory conditions (Tween 80 containing medium -R179T), or in detergent-free medium (R179NT). RNAseq comparisons reveal 2651 differentially expressed genes in BMDMs infected with R179T M.tb vs. BMDMs infected with R179NT M.tb. A range of differentially expressed genes involved in BMDM receptor interaction with M.tb (Mrc1, Ifngr1, Tlr9, Fpr1 and Itgax) and pro-inflammatory cytokines/chemokines (Il6, Il1b, Tnf, Ccl5 and Cxcl14) were selected for analysis through qPCR. BMDMs infected with R179NT stimulate a robust inflammatory response. Interestingly, R179NT M.tb induce transcription of Fpr1, a receptor which detects bacterial formyl peptides and initiates a myriad of immune responses. Additionally we show that the host components Cxcl14, with an unknown role in M.tb infection, and Tlr9, an emerging role player, are only stimulated by infection with R179NT M.tb. Taken together, our results suggest that the host response differs significantly in response to Tween 80 cultured M.tb and should therefore not be used in infection experiments.	[Leisching, Gina; Pietersen, Ray-Dean; Mpongoshe, Vuyiseka; van Helden, Paul; Wiid, Ian; Baker, Bienyameen] Univ Stellenbosch, Fac Med & Hlth Sci, Div Mol Biol & Human Genet, DST NRF Ctr Excellence Biomed TB Res,SA MRC Ctr T, ZA-7600 Stellenbosch, South Africa; [van Heerden, Carel] Univ Stellenbosch, DNA Sequencing Unit, CAF, ZA-7600 Stellenbosch, South Africa	National Research Foundation - South Africa; Stellenbosch University; Stellenbosch University	Leisching, G (corresponding author), Univ Stellenbosch, Fac Med & Hlth Sci, Div Mol Biol & Human Genet, DST NRF Ctr Excellence Biomed TB Res,SA MRC Ctr T, ZA-7600 Stellenbosch, South Africa.	ginal@sun.ac.za	Leisching, Gina/O-9447-2019; Baker, Bienyameen/F-9150-2015	Leisching, Gina/0000-0002-4764-4781; Baker, Bienyameen/0000-0002-2158-6763; Pietersen, Ray-Dean/0000-0002-3794-8503; van Heerden, Carel/0000-0003-1786-7527				ARMSTRONG JA, 1975, J EXP MED, V142, P1, DOI 10.1084/jem.142.1.1; Arts RJW, 2011, EUR CYTOKINE NETW, V22, P11, DOI 10.1684/ecn.2011.0274; Bafica A, 2005, J EXP MED, V202, P1715, DOI 10.1084/jem.20051782; BARROW WW, 1982, J BACTERIOL, V150, P381, DOI 10.1128/JB.150.1.381-384.1982; Behar SM, 2010, NAT REV MICROBIOL, V8, P668, DOI 10.1038/nrmicro2387; Brennan MJ, 2001, INFECT IMMUN, V69, P7326, DOI 10.1128/IAI.69.12.7326-7333.2001; Carvalho NB, 2011, INFECT IMMUN, V79, P1638, DOI 10.1128/IAI.01030-10; Chun T, 2001, J EXP MED, V193, P1213, DOI 10.1084/jem.193.10.1213; CUTLER RR, 1987, TUBERCLE, V68, P209, DOI 10.1016/0041-3879(87)90057-2; Cywes C, 1997, INFECT IMMUN, V65, P4258, DOI 10.1128/IAI.65.10.4258-4266.1997; Dai C, 2015, J IMMUNOL; DECHASTELLIER C, 1995, EUR J CELL BIOL, V68, P167; Dhanasekaran S, 2014, GENES IMMUN, V15, P265, DOI 10.1038/gene.2014.13; DUBOS RJ, 1946, J EXP MED, V83, P409, DOI 10.1084/jem.83.5.409; Ernst S, 2004, J IMMUNOL, V172, P7669, DOI 10.4049/jimmunol.172.12.7669; FALKOW S, 1992, ANNU REV CELL BIOL, V8, P333, DOI 10.1146/annurev.cb.08.110192.002001; Finlay BB, 1997, SCIENCE, V276, P718, DOI 10.1126/science.276.5313.718; Frick IM, 2011, J IMMUNOL, V187, P4300, DOI 10.4049/jimmunol.1004179; Geisel RE, 2005, J IMMUNOL, V174, P5007, DOI 10.4049/jimmunol.174.8.5007; Gopalakrishnan A, 2014, J IMMUNOL S, V192; Gray ES, 2012, FASEB J, V26; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Hunter RL, 2006, ANN CLIN LAB SCI, V36, P371; Hussain S, 1999, J IMMUNOL, V163, P2041; Ioerger TR, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-670; Jacobsen M, 2007, J MOL MED, V85, P613, DOI 10.1007/s00109-007-0157-6; Johnson R, 2010, INT J TUBERC LUNG D, V14, P119; JOINER KA, 1990, SCIENCE, V249, P641, DOI 10.1126/science.2200126; Joosten SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073230; KIERSZENBAUM F, 1995, PARASITE IMMUNOL, V17, P207, DOI 10.1111/j.1365-3024.1995.tb00890.x; MADONNA GS, 1989, INFECT IMMUN, V57, P2495, DOI 10.1128/IAI.57.8.2495-2501.1989; Maerki C, 2009, J IMMUNOL, V182, P507, DOI 10.4049/jimmunol.182.1.507; Marshall JD, 2007, J LEUKOCYTE BIOL, V82, P497, DOI 10.1189/jlb.0906575; MASAKI S, 1990, MICROBIOL IMMUNOL, V34, P653, DOI 10.1111/j.1348-0421.1990.tb01041.x; Matikainen S, 2001, EUR J IMMUNOL, V31, P2236, DOI 10.1002/1521-4141(200107)31:7<2236::AID-IMMU2236>3.0.CO;2-G; MCDONOUGH KA, 1995, INFECT IMMUN, V63, P4802, DOI 10.1128/IAI.63.12.4802-4811.1995; Menozzi FD, 1996, J EXP MED, V184, P993, DOI 10.1084/jem.184.3.993; Nalpas NC, 2015, SCI REP-UK, V5, DOI 10.1038/srep13629; Oshiumi H, 2003, NAT IMMUNOL, V4, P161, DOI 10.1038/ni886; Ozawa S, 2006, BIOCHEM BIOPH RES CO, V348, P406, DOI 10.1016/j.bbrc.2006.07.070; Ray M, 2000, J INFECT DIS, V181, P1121, DOI 10.1086/315330; RETZINGER GS, 1981, J BIOL CHEM, V256, P8208; SAITO R, 1976, INFECT IMMUN, V13, P776, DOI 10.1128/IAI.13.3.776-781.1976; SAITO R, 1977, INFECT IMMUN, V16, P725, DOI 10.1128/IAI.16.3.725-729.1977; Sani M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000794; Schwarze SR, 2005, PROSTATE, V64, P67, DOI 10.1002/pros.20215; Shurin GV, 2005, J IMMUNOL, V174, P5490, DOI 10.4049/jimmunol.174.9.5490; SIDDIQI SH, 1988, CURR MICROBIOL, V17, P105, DOI 10.1007/BF01568794; Singhal A, 2007, INFECT IMMUN, V75, P2500, DOI 10.1128/IAI.01743-06; STINSON MW, 1971, AM REV RESPIR DIS, V104, P717; Stokes RW, 2004, INFECT IMMUN, V72, P5676, DOI 10.1128/IAI.72.10.5676-5686.2004; Sutherland JS, 2014, CLIN MICROBIOL INFEC, V20, pO230, DOI 10.1111/1469-0691.12383; ValentinWeigand P, 1996, INFECT IMMUN, V64, P2467, DOI 10.1128/IAI.64.7.2467-2473.1996; VANBOXTEL RM, 1990, APMIS, V98, P901; Wang C, 2011, J LIPIDS, V2011, DOI 10.1155/2011/676535; YAMANE I, 1954, CR SOC BIOL, V148, P769; YARKONI E, 1976, INFECT IMMUN, V14, P1125, DOI 10.1128/IAI.14.5.1125-1129.1976; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780	58	23	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153079	10.1371/journal.pone.0153079	http://dx.doi.org/10.1371/journal.pone.0153079			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27055235	gold, Green Published			2022-12-27	WOS:000373608000073
J	Tada, T; Miyoshi-Akiyama, T; Shimada, K; Shiroma, A; Nakano, K; Teruya, K; Satou, K; Hirano, T; Shimojima, M; Kirikae, T				Tada, Tatsuya; Miyoshi-Akiyama, Tohru; Shimada, Kayo; Shiroma, Akino; Nakano, Kazuma; Teruya, Kuniko; Satou, Kazuhito; Hirano, Takashi; Shimojima, Masahiro; Kirikae, Teruo			A Carbapenem-Resistant Pseudomonas aeruginosa Isolate Harboring Two Copies of bla(IMP-34) Encoding a Metallo-beta-Lactamase	PLOS ONE			English	Article							II TOPOISOMERASE MUTATIONS; GENE; STRAINS	A carbapenem-resistant strain of Pseudomonas aeruginosa, NCGM1984, was isolated in 2012 from a hospitalized patient in Japan. Immunochromatographic assay showed that the isolate was positive for IMP-type metallo-beta-lactamase. Complete genome sequencing revealed that NCGM1984 harbored two copies of bla(IMP-34), located at different sites on the chromosome. Each blaIMP-34 was present in the same structures of the class 1 integrons, tnpA(ISPa7)-intI1-qacG-bla(IMP-34)-aac(6')-Ib-qacEdelta1-sul1-orf5-tniBdelta-tniA. The isolate belonged to multilocus sequence typing ST235, one of the international high-risk clones. IMP-34, with an amino acid substitution (Glu126Gly) compared with IMP-1, hydrolyzed all beta-lactamases tested except aztreonam, and its catalytic activities were similar to IMP-1. This is the first report of a clinical isolate of an IMP-34-producing P. aeruginosa harboring two copies of blaI(MP-34) on its chromosome.	[Tada, Tatsuya; Miyoshi-Akiyama, Tohru; Shimada, Kayo; Kirikae, Teruo] Natl Ctr Global Hlth & Med, Res Inst, Dept Infect Dis, Shinjuku Ku, 1-21-1 Toyama, Tokyo, Japan; [Miyoshi-Akiyama, Tohru] Natl Ctr Global Hlth & Med, Res Inst, Pathogen Microbe Lab, Shinjuku Ku, 1-21-1 Toyama, Tokyo, Japan; [Shiroma, Akino; Nakano, Kazuma; Teruya, Kuniko; Satou, Kazuhito; Hirano, Takashi] Okinawa Inst Adv Sci, Div Res & Dev, Okinawa, Japan; [Shimojima, Masahiro] BML Inc, Dept Accuracy Management, Kawagoe, Saitama, Japan	National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan; BML, Inc.	Kirikae, T (corresponding author), Natl Ctr Global Hlth & Med, Res Inst, Dept Infect Dis, Shinjuku Ku, 1-21-1 Toyama, Tokyo, Japan.	tkirikae@ri.ncgm.go.jp		Nakano, Kazuma/0000-0001-9908-6526	International Health Cooperation Research [27-S-1102, 26-A-103]; Research Program on Emerging and Re-emerging Infectious Diseases from Japan Agency for Medical Research and Development, AMED	International Health Cooperation Research; Research Program on Emerging and Re-emerging Infectious Diseases from Japan Agency for Medical Research and Development, AMED(Japan Agency for Medical Research and Development (AMED))	The study was supported by grants from International Health Cooperation Research (27-S-1102 and 26-A-103) and Research Program on Emerging and Re-emerging Infectious Diseases from the Japan Agency for Medical Research and Development, AMED. BML Inc. provided support in the form of salaries for the author [MS], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the author are articulated in the 'author contributions' section.	Akasaka T, 2001, ANTIMICROB AGENTS CH, V45, P2263, DOI 10.1128/AAC.45.8.2263-2268.2001; [Anonymous], 2015, M100S25 CLSI; Boschi L, 2000, ANTIMICROB AGENTS CH, V44, P1538, DOI 10.1128/AAC.44.6.1538-1543.2000; Bush K, 2001, CLIN INFECT DIS, V32, P1085, DOI 10.1086/319610; Bush K, 2010, ANTIMICROB AGENTS CH, V54, P969, DOI 10.1128/AAC.01009-09; COLLIS CM, 1995, ANTIMICROB AGENTS CH, V39, P155, DOI 10.1128/AAC.39.1.155; Crowder MW, 1998, ANTIMICROB AGENTS CH, V42, P921, DOI 10.1128/AAC.42.4.921; Jacoby GA, 2005, NEW ENGL J MED, V352, P380, DOI 10.1056/NEJMra041359; Jovcic B, 2014, ANTON LEEUW INT J G, V105, P613, DOI 10.1007/s10482-013-0094-z; Jovcic B, 2013, ANTIMICROB AGENTS CH, V57, P3405, DOI 10.1128/AAC.02312-12; Jove T, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000793; Kitao T, 2011, J MICROBIOL METH, V87, P330, DOI 10.1016/j.mimet.2011.09.011; Kitao T, 2010, J ANTIMICROB CHEMOTH, V65, P1382, DOI 10.1093/jac/dkq148; Mano Y, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0378-8; Mouneimne H, 1999, ANTIMICROB AGENTS CH, V43, P62, DOI 10.1128/AAC.43.1.62; NORMARK S, 1977, J BACTERIOL, V132, P912, DOI 10.1128/JB.132.3.912-922.1977; Notake S, 2013, J CLIN MICROBIOL, V51, P1762, DOI 10.1128/JCM.00234-13; Oliver A, 2015, DRUG RESIST UPDATE, V21-22, P41, DOI 10.1016/j.drup.2015.08.002; Papagiannitsis CC, 2009, ANTIMICROB AGENTS CH, V53, P277, DOI 10.1128/AAC.00912-08; Partridge SR, 2001, ANTIMICROB AGENTS CH, V45, P1263, DOI 10.1128/AAC.45.4.1263-1270.2001; Queenan AM, 2010, ANTIMICROB AGENTS CH, V54, P565, DOI 10.1128/AAC.01004-09; Shigemoto N, 2013, DIAGN MICR INFEC DIS, V76, P119, DOI 10.1016/j.diagmicrobio.2013.02.030; Tada T, 2012, J MICROBIOL METH; Tada T, 2015, ANTIMICROB AGENTS CH, V59, P7090, DOI 10.1128/AAC.01611-15; Tada T, 2013, ANTIMICROB AGENTS CH, V57, P4427, DOI 10.1128/AAC.00716-13; Tojo M, 2014, J INFECT CHEMOTHER, V20, P586, DOI 10.1016/j.jiac.2014.04.014; Walsh TR, 2005, CLIN MICROBIOL REV, V18, P306, DOI 10.1128/CMR.18.2.306-325.2005; Yamaguchi Y, 2005, J BIOL CHEM, V280, P20824, DOI 10.1074/jbc.M414314200	28	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0149385	10.1371/journal.pone.0149385	http://dx.doi.org/10.1371/journal.pone.0149385			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27055243	gold, Green Published			2022-12-27	WOS:000373608000001
J	Adeloye, D; David, RA; Aderemi, AV; Iseolorunkanmi, A; Oyedokun, A; Iweala, EEJ; Omoregbe, N; Ayo, CK				Adeloye, Davies; David, Rotimi Adedeji; Aderemi, Adewale Victor; Iseolorunkanmi, Alexander; Oyedokun, Ayo; Iweala, Emeka E. J.; Omoregbe, Nicholas; Ayo, Charles K.			An Estimate of the Incidence of Prostate Cancer in Africa: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							TARGETED THERAPY; PALLIATIVE CARE; EASTERN LIBYA; SOUTH-AFRICA; POPULATION; MORTALITY; BURDEN; REGISTRY; TRENDS; EPIDEMIOLOGY	Background Prostate cancer (PCa) is rated the second most common cancer and sixth leading cause of cancer deaths among men globally. Reports show that African men suffer disproportionately from PCa compared to men from other parts of the world. It is still quite difficult to accurately describe the burden of PCa in Africa due to poor cancer registration systems. We systematically reviewed the literature on prostate cancer in Africa and provided a continent-wide incidence rate of PCa based on available data in the region. Methods A systematic literature search of Medline, EMBASE and Global Health from January 1980 to June 2015 was conducted, with additional search of Google Scholar, International Association of Cancer Registries (IACR), International Agency for Research on Cancer (IARC), and WHO African region websites, for studies that estimated incidence rate of PCa in any African location. Having assessed quality and consistency across selected studies, we extracted incidence rates of PCa and conducted a random effects meta-analysis. Results Our search returned 9766 records, with 40 studies spreading across 16 African countries meeting our selection criteria. We estimated a pooled PCa incidence rate of 22.0 (95% CI: 19.93-23.97) per 100,000 population, and also reported a median incidence rate of 19.5 per 100,000 population. We observed an increasing trend in PCa incidence with advancing age, and over the main years covered. Conclusion Effective cancer registration and extensive research are vital to appropriately quantifying PCa burden in Africa. We hope our findings may further assist at identifying relevant gaps, and contribute to improving knowledge, research, and interventions targeted at prostate cancer in Africa.	[Adeloye, Davies] Covenant Univ, Demog & Social Stat, PMB 1023, Ota, Ogun State, Nigeria; [Adeloye, Davies; Omoregbe, Nicholas; Ayo, Charles K.] Covenant Univ, E Hlth Res Cluster, PMB 1023, Ota, Ogun State, Nigeria; [Adeloye, Davies] Univ Edinburgh, Ctr Global Hlth Res, Edinburgh, Midlothian, Scotland; [Adeloye, Davies] Univ Edinburgh, World Hlth Org Collaborating Ctr Populat Hlth Res, Usher Inst, Edinburgh, Midlothian, Scotland; [David, Rotimi Adedeji] Obafemi Awolowo Univ, Dept Surg, Teaching Hosp Complex, Ife, Nigeria; [Aderemi, Adewale Victor] Osun State Univ, Dept Biochem, Coll Hlth Sci, Osogbo, Nigeria; [Iseolorunkanmi, Alexander] Covenant Univ, Univ Hlth Ctr, Ota, Nigeria; [Oyedokun, Ayo] St Nicholas Hosp, Lagos, Nigeria; [Iweala, Emeka E. J.] Covenant Univ, Dept Biol Sci, PMB 1023, Ota, Ogun State, Nigeria; [Omoregbe, Nicholas; Ayo, Charles K.] Covenant Univ, Dept Comp & Informat Sci, PMB 1023, Ota, Ogun State, Nigeria	Covenant University; Covenant University; University of Edinburgh; University of Edinburgh; World Health Organization; Obafemi Awolowo University; Covenant University; Covenant University; Covenant University	Adeloye, D (corresponding author), Covenant Univ, Demog & Social Stat, PMB 1023, Ota, Ogun State, Nigeria.; Adeloye, D (corresponding author), Covenant Univ, E Hlth Res Cluster, PMB 1023, Ota, Ogun State, Nigeria.; Adeloye, D (corresponding author), Univ Edinburgh, Ctr Global Hlth Res, Edinburgh, Midlothian, Scotland.; Adeloye, D (corresponding author), Univ Edinburgh, World Hlth Org Collaborating Ctr Populat Hlth Res, Usher Inst, Edinburgh, Midlothian, Scotland.	Davies.Adeloye@covenantuniversity.edu.ng	David, Rotimi/ABD-7245-2020; Adeloye, Davies/AAB-6302-2022; Iweala, Emeka/C-6406-2014	David, Rotimi/0000-0003-1823-4625; Iweala, Emeka/0000-0002-1393-1416; Adeloye, Davies/0000-0003-1316-8139; Omoregbe, Nicholas/0000-0001-7274-6512				Abdel-Wahab M, 2013, LANCET ONCOL, V14, pE168, DOI 10.1016/S1470-2045(12)70532-6; Adebamowo C A, 2009, Afr J Med Med Sci, V38 Suppl 2, P5; Adeloye D, 2015, RES J HLTH SCI, V3, P139; Adeloye D, 2014, GOOD DATA AFRICA WIL; Afolayan E A O, 2004, Niger Postgrad Med J, V11, P225; Ahmed A, 2014, J CELL PHYSIOL, V229, P271, DOI 10.1002/jcp.24456; Aikins AD, 2010, GLOBALIZATION HEALTH, V6, DOI 10.1186/1744-8603-6-5; Akaiso lOE, 2013, NIGERIAN JOURNAL OF, V19, P88; Andriole GL, 2012, J NATL CANCER I, V104, P125, DOI 10.1093/jnci/djr500; Angwafo F F, 1994, Bull Cancer Radiother, V81, P155; [Anonymous], 2013, LANCET, V386; Arbyn M, 2011, ANN ONCOL, V22, P2675, DOI 10.1093/annonc/mdr015; Awadelkarim KD, 2012, SCI TOTAL ENVIRON, V423, P214, DOI 10.1016/j.scitotenv.2010.09.010; Baade PD, 2009, MOL NUTR FOOD RES, V53, P171, DOI 10.1002/mnfr.200700511; Babb C, 2014, PROSTATE CANCER, V2014, DOI 10.1155/2014/419801; Badmus TA, 2010, UROLOGY, V76, P412, DOI 10.1016/j.urology.2010.03.020; Bah E, 2001, BRIT J CANCER, V84, P1207, DOI 10.1054/bjoc.2001.1730; Banda LT, 2001, TROP MED INT HEALTH, V6, P296, DOI 10.1046/j.1365-3156.2001.00707.x; Barry MJ, 2001, NEW ENGL J MED, V344, P1373, DOI 10.1056/NEJM200105033441806; BASSETT MT, 1995, INT J CANCER, V63, P29, DOI 10.1002/ijc.2910630107; BAYO S, 1990, INT J CANCER, V45, P679, DOI 10.1002/ijc.2910450418; Beaglehole R, 2011, LANCET, V378, P449, DOI 10.1016/S0140-6736(11)60879-9; Bowa K, 2009, AFR J UROL, V15, P84, DOI 10.1007/s12301-009-0025-4; Boyle P, 2008, ANN ONCOL, V19, P1519, DOI 10.1093/annonc/mdn426; Bray F, 2012, LANCET ONCOL, V13, P790, DOI 10.1016/S1470-2045(12)70211-5; [Cancer in Africa: Bridging Science and Humanity African Organization for Research and Training in Cancer], 2013, AORTIC 2013; Cazap E, 2012, CANC RES C 103 AN S1, V72; Center MM, 2012, EUR UROL, V61, P1079, DOI 10.1016/j.eururo.2012.02.054; Cereda V, 2014, EXPERT OPIN INV DRUG, V23, P469, DOI 10.1517/13543784.2014.885950; Chokunonga E, 2000, INT J CANCER, V85, P54, DOI 10.1002/(SICI)1097-0215(20000101)85:1&lt;54::AID-IJC10&gt;3.0.CO;2-D; Chu LW, 2011, PROSTATE CANCER, V2011, DOI 10.1155/2011/947870; Dassie JP, 2014, MOL THER, V22, P1910, DOI 10.1038/mt.2014.117; Derleth CL, 2013, ONCOLOGY-NY, V27, P620; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Echimane AK, 2000, CANCER, V89, P653, DOI 10.1002/1097-0142(20000801)89:3&lt;653::AID-CNCR22&gt;3.0.CO;2-Z; Ekwere PD, 2002, J NATL MED ASSOC, V94, P619; El Mistiri M, 2010, ANN ONCOL, V21, P1924, DOI 10.1093/annonc/mdq334; El Mistiri M, 2007, INT J CANCER, V120, P392, DOI 10.1002/ijc.22273; Enow OGE, 2012, GASTROENTEROL HEPTOL, V1, P58, DOI [DOI 10.4103/2348-3113.133639, 10.5530/ogh.2012.1.14]; Farmer P, 2010, LANCET, V376, P1186, DOI 10.1016/S0140-6736(10)61152-X; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Grant Liz, 2011, BMJ Support Palliat Care, V1, P118, DOI 10.1136/bmjspcare-2011-000057; Haas GP, 2008, CAN J UROL, V15, P3866; Harding R, 2013, LANCET ONCOL, V14, pE183, DOI 10.1016/S1470-2045(12)70396-0; Hsing AW, 2014, J UROLOGY, V192, P730, DOI 10.1016/j.juro.2014.04.017; IARC, 1987, INT CLASS DIS ONC MO; Ifere Godwin O, 2012, Clin Epidemiol, V4, P19, DOI 10.2147/CLEP.S23536; Ikuerowo SO, 2013, PAN AFR MED J, V15, DOI 10.11604/pamj.2013.15.129.2489; Jedy-Agba E, 2012, CANCER EPIDEMIOL, V36, pE271, DOI 10.1016/j.canep.2012.04.007; Jemal A, 2012, CANCER-AM CANCER SOC, V118, P4372, DOI 10.1002/cncr.27410; Kingham TP, 2013, LANCET ONCOL, V14, pE158, DOI 10.1016/S1470-2045(12)70472-2; Koulibaly M, 1997, INT J CANCER, V70, P39, DOI 10.1002/(SICI)1097-0215(19970106)70:1&lt;39::AID-IJC6&gt;3.0.CO;2-7; Kyei Mathew Yamoah, 2013, ISRN Urol, V2013, P832496, DOI 10.1155/2013/832496; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Missaoui N, 2010, INT J CANCER, V127, P2669, DOI 10.1002/ijc.25490; Mohammed A Z, 2003, Niger Postgrad Med J, V10, P1; Mohammed A Z, 2008, Niger J Med, V17, P280; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Morris K, 2003, LANCET ONCOL, V4, P5, DOI 10.1016/S1470-2045(03)00969-0; Mqoqi N, 2004, CANCER IN SOUTH AFRI; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Newton R, 1996, INT J CANCER, V66, P75, DOI 10.1002/(SICI)1097-0215(19960328)66:1<75::AID-IJC14>3.3.CO;2-4; O'Brien M, 2013, LANCET ONCOL, V14, pE176, DOI 10.1016/S1470-2045(12)70343-1; Obiorah CC, 2011, NIGER J CLIN PRACT, V14, P363, DOI 10.4103/1119-3077.86785; Odedina Folakemi T, 2009, Infect Agent Cancer, V4 Suppl 1, pS2, DOI 10.1186/1750-9378-4-S1-S2; Ogunbiyi JO, 1999, J NATL MED ASSOC, V91, P159; Oluwole OP, 2015, AFR J UROL, V21, P15, DOI 10.1016/j.afju.2014.09.004; Oranusi CK, 2004, NIGER J CLIN PRACT, V7, P2; Osegbe DN, 1997, J UROLOGY, V157, P1340, DOI 10.1016/S0022-5347(01)64966-8; Parkin DM, 2008, LANCET ONCOL, V9, P683, DOI 10.1016/S1470-2045(08)70175-X; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Parkin DM, 2001, EUR J CANCER, V37, pS4, DOI 10.1016/S0959-8049(01)00267-2; Parkin DM, 2001, LANCET ONCOL, V2, P533, DOI 10.1016/S1470-2045(01)00486-7; Parkin DM, 2003, IARC SCI PUBLICATION, V153; Parkin DM, 2006, NAT REV CANCER, V6, P603, DOI 10.1038/nrc1948; Parkin DM, 2010, INT J CANCER, V126, P1187, DOI 10.1002/ijc.24838; Percy C., 1990, INT CLASSIFICATION D; Pisani P, 1999, INT J CANCER, V83, P18, DOI 10.1002/(SICI)1097-0215(19990924)83:1&lt;18::AID-IJC5&gt;3.0.CO;2-M; Popoola AO, 2013, J DENT MED SCI, V6, P68; Rebbeck TR, 2013, PROSTATE CANCER, V2013, DOI 10.1155/2013/560857; Rudan I, 2015, J GLOB HEALTH, V5, P2, DOI 10.7189/jogh.05.010101; Ruenes A, 2008, CAN J UROL, V15, P3886; Salako Ayo Abdulkadir, 2009, Cases J, V2, P144, DOI 10.1186/1757-1626-2-144; Sapira MK, 2002, NIGERIAN J SURG RES, V4, P1; Sighoko D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018415; Soliman AS, 1999, CANCER CAUSE CONTROL, V10, P349, DOI 10.1023/A:1008968701313; Somdyala NIM, 2010, INT J CANCER, V127, P2420, DOI 10.1002/ijc.25246; Somdyala NIM, 2015, INT J CANCER, V136, pE470, DOI 10.1002/ijc.29224; Valsecchi MG, 2008, LANCET ONCOL, V9, P159, DOI 10.1016/S1470-2045(08)70028-7; Wabinga HR, 2000, BRIT J CANCER, V82, P1585, DOI 10.1054/bjoc.1999.1071; Whelan S L, 1992, IARC Sci Publ, P178; WHO, 1976, INT CLASSIFICATION D; World Bank, 2013, WORLD BANK LIST EC; World Health Organization, 2013, CANC FACT SHEET; Wright M, 2008, J PAIN SYMPTOM MANAG, V35, P469, DOI 10.1016/j.jpainsymman.2007.06.006; Yawe K T, 2006, West Afr J Med, V25, P298	98	73	75	0	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153496	10.1371/journal.pone.0153496	http://dx.doi.org/10.1371/journal.pone.0153496			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073921	Green Submitted, Green Published, gold			2022-12-27	WOS:000374131200101
J	Charles, MK; Lindegren, ML; Wester, CW; Blevins, M; Sterling, TR; Dung, NT; Dusingize, JC; Avit-Edi, D; Durier, N; Castelnuovo, B; Nakigozi, G; Cortes, CP; Ballif, M; Fenner, L				Charles, M. Katherine; Lindegren, Mary Lou; Wester, C. William; Blevins, Meridith; Sterling, Timothy R.; Nguyen Thi Dung; Dusingize, Jean Claude; Avit-Edi, Divine; Durier, Nicolas; Castelnuovo, Barbara; Nakigozi, Gertrude; Cortes, Claudia P.; Ballif, Marie; Fenner, Lukas		Int Epidemiology Databases	Implementation of Tuberculosis Intensive Case Finding, Isoniazid Preventive Therapy, and Infection Control ("Three I's") and HIV-Tuberculosis Service Integration in Lower Income Countries	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; SOUTH-AFRICA; CARE; RISK; CHALLENGES; EXPERIENCE; OUTCOMES; LESSONS	Setting World Health Organization advocates for integration of HIV-tuberculosis (TB) services and recommends intensive case finding (ICF), isoniazid preventive therapy (IPT), and infection control ("Three I's") for TB prevention and control among persons living with HIV. Objective To assess the implementation of the "Three I's" of TB-control at HIV treatment sites in lower income countries. Design Survey conducted between March-July, 2012 at 47 sites in 26 countries: 6 (13%) Asia Pacific, 7 (15%), Caribbean, Central and South America, 5 (10%) Central Africa, 8 (17%) East Africa, 14 (30%) Southern Africa, and 7 (15%) West Africa.	[Charles, M. Katherine; Lindegren, Mary Lou; Wester, C. William; Blevins, Meridith; Sterling, Timothy R.] Vanderbilt Univ, Sch Med, VIGH, Nashville, TN USA; [Nguyen Thi Dung] Natl Hosp Trop Dis, Hanoi, Vietnam; [Dusingize, Jean Claude] Womens Equ Access Care & Treatment, Kigali, Rwanda; [Avit-Edi, Divine] MTCTPlus, Abidjan, Cote Ivoire; [Durier, Nicolas] AmfAR, TREAT Asia, Bangkok, Thailand; [Castelnuovo, Barbara] Infect Dis Inst, Kampala, Uganda; [Nakigozi, Gertrude] Rakai Hlth Sci Program, Kalisizo, Uganda; [Cortes, Claudia P.] Univ Chile, Sch Med, Santiago, Chile; [Ballif, Marie; Fenner, Lukas] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland; [Fenner, Lukas] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Fenner, Lukas] Univ Basel, Basel, Switzerland	Vanderbilt University; National Hospital of Tropical Diseases; Rakai Health Sciences Program; Universidad de Chile; University of Bern; University of Basel; Swiss Tropical & Public Health Institute; University of Basel	Charles, MK (corresponding author), Vanderbilt Univ, Sch Med, VIGH, Nashville, TN USA.	katie.charles@vanderbilt.edu	Ostergaard, Lars/AAA-3020-2020; Rabie, Helena/ABH-1437-2020; Prozesky, Hans Walter/ABE-6956-2020; Adebamowo, Clement/C-8778-2011; Cortes, Claudia P/AAF-7326-2020; Wejse, Christian/C-8468-2014; Wehbe, Firas/Q-6176-2019; Yotebieng, Marcel/L-2083-2013; Boulle, Andrew/C-1413-2008	Ostergaard, Lars/0000-0003-2459-0511; Rabie, Helena/0000-0001-6336-2963; Prozesky, Hans Walter/0000-0001-9715-3449; Adebamowo, Clement/0000-0002-6571-2880; Cortes, Claudia P/0000-0001-9101-9783; Wejse, Christian/0000-0002-2534-2942; Wehbe, Firas/0000-0002-3984-9584; Egger, Matthias/0000-0001-7462-5132; Fomsgaard, Anders/0000-0003-4304-0603; Gottlieb, Geoffrey/0000-0002-5749-481X; Erikstrup, Christian/0000-0001-6551-6647; Yunihastuti, Evy/0000-0001-6650-0559; Boettiger, David/0000-0002-5951-4503; Chaiwarith, Romanee/0000-0002-1241-5954; Yotebieng, Marcel/0000-0003-2110-2631; Fenner, Lukas/0000-0003-3309-4835; Dusingize, Jean Claude/0000-0001-5721-100X; Technau, Karl-Gunter/0000-0001-7367-7512; Ruxrungtham, Kiat/0000-0001-7348-2352; Ostergaard, Lars/0000-0002-7619-605X; Eugen-Olsen, Jesper/0000-0002-4630-4275; Aaby, Peter/0000-0001-8331-1389; Boulle, Andrew/0000-0002-7713-8062; Law, Matthew/0000-0002-3540-8837; MASKEW, MHAIRI/0000-0003-4238-0200; Egger, Matthias/0000-0002-1791-1842; HEMA, Arsene/0000-0002-5279-643X; Mofenson, Lynne/0000-0002-2818-9808; Cornell, Morna/0000-0001-7149-8799; Anglaret, Xavier/0000-0003-3319-8423	National Institute of Allergy and Infectious Diseases (NIAID) of National Institutes of Health (NIH) [U01AI069924, U01AI069907, U01A096299, U01AI069911, U01AI069923, U01AI069919]; IeDEA Network Coordinating Center (INCC) at Vanderbilt University [U01AI096186]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069919, UM1AI069476, U01AI069924, U01AI069907, U01AI069923, U01AI069911, UM1AI069421, U01AI096186] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID) of National Institutes of Health (NIH); IeDEA Network Coordinating Center (INCC) at Vanderbilt University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Research reported in this publication was supported by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) under the following grant award numbers: Southern Africa (U01AI069924), Asia-Pacific (U01AI069907), Central Africa (U01A096299), East Africa (U01AI069911), the Caribbean, Central and South America (U01AI069923), West Africa (U01AI069919) and the IeDEA Network Coordinating Center (INCC) at Vanderbilt University (U01AI096186). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balcells ME, 2006, EMERG INFECT DIS, V12, P744; Corbett EL, 2006, LANCET, V367, P926, DOI 10.1016/S0140-6736(06)68383-9; Durovni B, 2010, AIDS, V24, pS49, DOI 10.1097/01.aids.0000391022.95412.a6; Fenner L, 2011, INT J TUBERC LUNG D, V15, P620, DOI 10.5588/ijtld.10.0249; Fenner L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077697; Friedland G, 2007, J INFECT DIS, V196, pS114, DOI 10.1086/518664; Gandhi NR, 2009, JAIDS-J ACQ IMM DEF, V50, P37, DOI 10.1097/QAI.0b013e31818ce6c4; Getahun H, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000391; Golub JE, 2013, INT J TUBERC LUNG D, V17, P856, DOI 10.5588/ijtld.13.0059; Golub JE, 2009, AIDS, V23, P631, DOI 10.1097/QAD.0b013e328327964f; Harris JB, 2008, INT J TUBERC LUNG D, V12, P773; Hermans SM, 2012, JAIDS-J ACQ IMM DEF, V60, pE29, DOI 10.1097/QAI.0b013e318251aeb4; Howard AA, 2010, CLIN INFECT DIS, V50, pS238, DOI 10.1086/651497; Lawn SD, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-258; Njozing BN, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-328; Organization WH, 2012, WHO POL COLL TB HIV; Phiri S, 2011, TROP MED INT HEALTH, V16, P1397, DOI 10.1111/j.1365-3156.2011.02848.x; Reid MJA, 2012, INT J TUBERC LUNG D, V16, P1605, DOI 10.5588/ijtld.12.0033; Saito S, 2012, JAIDS-J ACQ IMM DEF, V61, P216, DOI 10.1097/QAI.0b013e3182638ec7; van Halsema CL, 2010, AIDS, V24, P1051, DOI 10.1097/QAD.0b013e32833849df; WHO, 2009, WHO POL INF CONTR HL; WHO, 2008, EPI SEM 2008; World Health Organization, 2012, GUID INT TUB CAS FIN	23	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153243	10.1371/journal.pone.0153243	http://dx.doi.org/10.1371/journal.pone.0153243			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073928	Green Published, Green Accepted, gold			2022-12-27	WOS:000374131200066
J	Danto, M; Witzmann, F; Frobisch, NB				Danto, Marylene; Witzmann, Florian; Froebisch, Nadia B.			Vertebral Development in Paleozoic and Mesozoic Tetrapods Revealed by Paleohistological Data	PLOS ONE			English	Article							METOPOSAURUS-DIAGNOSTICUS TEMNOSPONDYLI; PLAGIOSAURID GERROTHORAX PULCHERRIMUS; BONE-HISTOLOGY; POSTCRANIAL SKELETON; TRIASSIC TEMNOSPONDYL; CRANIAL MORPHOLOGY; EXTANT AMPHIBIANS; EVOLUTION; GERMANY; KRASIEJOW	Basal tetrapods display a wide spectrum of vertebral centrum morphologies that can be used to distinguish different tetrapod groups. The vertebral types range from multipartite centra in stem-tetrapods, temnospondyls, and seymouriamorphs up to monospondylous centra in lepospondyls and have been drawn upon for reconstructing major evolutionary trends in tetrapods that are now considered textbook knowledge. Two modes of vertebral formation have been postulated: the multipartite vertebrae formed first as cartilaginous elements with subsequent ossification. The monospondylous centrum, in contrast, was formed by direct ossification without a cartilaginous precursor. This study describes centrum morphogenesis in basal tetrapods for the first time, based on bone histology. Our results show that the intercentra of the investigated stem-tetrapods consist of a small band of periosteal bone and a dense network of endochondral bone. In stereospondyl temnospondyls, high amounts of calcified cartilage are preserved in the endochondral trabeculae. Notably, the periosteal region is thickened and highly vascularized in the plagiosaurid stereospondyls. Among "microsaur" lepospondyls, the thickened periosteal region is composed of compact bone and the notochordal canal is surrounded by large cell lacunae. In nectridean lepospondyls, the periosteal region has a spongy structure with large intertrabecular spaces, whereas the endochondral region has a highly cancellous structure. Our observations indicate that regardless of whether multipartite or monospondylous, the centra of basal tetrapods display first endochondral and subsequently periosteal ossification. A high interspecific variability is observed in growth rate, organization, and initiation of periosteal ossification. Moreover, vertebral development and structure reflect different lifestyles. The bottom-dwelling Plagiosauridae increase their skeletal mass by hyperplasy of the periosteal region. In nectrideans, the skeletal mass decreases, as the microstructure is spongy and lightly built. Additionally, we observed that vertebral structure is influenced by miniaturization in some groups. The phylogenetic information that can be drawn from vertebral development, however, is limited.	[Danto, Marylene; Witzmann, Florian; Froebisch, Nadia B.] Leibniz Inst Evolut & Biodiversitatsforsch, Museum Nat Kunde, Invalidenstr 43, D-10115 Berlin, Germany; [Witzmann, Florian] Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA	Leibniz Institut fur Evolutions und Biodiversitatsforschung; Brown University	Danto, M (corresponding author), Leibniz Inst Evolut & Biodiversitatsforsch, Museum Nat Kunde, Invalidenstr 43, D-10115 Berlin, Germany.	marylene.danto@mfn-berlin.de			Leibniz Association	Leibniz Association	MD was founded by the Deutsche Forschungsgemeinschaft (DFG WI 3144/3-1). The publication of this article was funded by the Open Access fund of the Leibniz Association.	Amprino R, 1947, ARCH BIOL, V58, P317; Anderson JS, 2001, SYST BIOL, V50, P170; ANDREWS SM, 1991, T ROY SOC EDIN-EARTH, V82, P239, DOI 10.1017/S0263593300005332; [Anonymous], 1966, VERTEBRATE PALEONTOL; Boisvert CA, 2009, J EXP ZOOL PART B, V312B, P1, DOI 10.1002/jez.b.21238; BOLT JR, 1969, SCIENCE, V166, P888, DOI 10.1126/science.166.3907.888; Bolt JR, 1968, THESIS U CHICAGO; Borkhvardt V. G., 1969, PALEONTOL ZH, V3, P146; Bossy Kathleen A., 1998, P73; CARROLL R, 1998, ENCY PALEOHERPETOL 1, P1; Carroll R.L., 1978, Memoirs of the American Philosophical Society, V126, P1; Carroll R.L., 1989, Historical Biology, V3, P1; Carroll RL, 1999, EVOL DEV, V1, P36; CARROLL RL, 1995, J VERTEBR PALEONTOL, V15, P37, DOI 10.1080/02724634.1995.10011206; CARROLL RL, 1968, CAN J ZOOLOG, V46, P1175, DOI 10.1139/z68-168; Carroll RL, 2007, ZOOL J LINN SOC-LOND, V150, P1, DOI 10.1111/j.1096-3642.2007.00246.x; Carroll Robert L., 2000, Amphibian Biology, V4, P1198; Carroll Robert L., 2000, Amphibian Biology, V4, P973; Castanet J., 2003, Amphibian Biology, V5, P1598; Clack J.A., 2012, GAINING GROUND, VSecond; Clack JA, 2009, SPEC PAP PALAEONTOL, P15, DOI 10.1111/j.1475-4983.2009.00867.x; CRUICKSHANK ARI, 1980, PROC R SOC SER B-BIO, V209, P513, DOI 10.1098/rspb.1980.0110; de Ricqles A., 1981, Annales de Paleontologie Vertebres, V67, P141; de Ricqles Armand, 2001, P289; DERICQLES A, 1979, CR ACAD SCI D NAT, V288, P1147; Enlow D. H., 1956, Texas Journal of Science, V8, P405; Francillon-Vieillot H., 1990, P471; Frobisch NB, 2009, SYST BIOL, V58, P312, DOI 10.1093/sysbio/syp029; GARDINER BG, 1983, ZOOL J LINN SOC-LOND, V79, P1, DOI 10.1111/j.1096-3642.1983.tb01160.x; GODFREY SJ, 1989, PHILOS T ROY SOC B, V323, P75, DOI 10.1098/rstb.1989.0002; Golubev V. K., 1998, PALEONTOL J, V32, P278; Hall B.K., 2015, BONES CARTILAGE DEV; Hellrung Hanna, 2003, Stuttgarter Beitraege zur Naturkunde Serie B (Geologie und Palaeontologie), V330, P1; HOLMES R, 1984, PHILOS T ROY SOC B, V306, P431, DOI 10.1098/rstb.1984.0103; Holmes R., 1989, Historical Biology, V2, P111; Houssaye A, 2009, INTEGR ZOOL, V4, P325, DOI 10.1111/j.1749-4877.2009.00146.x; Jarvik E., 1980, BASIC STRUCTURE EVOL, V1; Kirschbaum F., 1988, Monographs in Developmental Biology, V21, P112; Klembara J, 2000, T ROY SOC EDIN-EARTH, V90, P287; Konietzko-Meier D, 2013, NETH J GEOSCI, V92, P97, DOI 10.1017/S0016774600000020; Konietzko-Meier D, 2012, EARTH ENV SCI T R SO, V103, P237, DOI 10.1017/S1755691013000273; Konietzko-Meier D, 2014, BIOL J LINN SOC, V112, P747, DOI 10.1111/bij.12301; Konietzko-Meier D, 2013, J VERTEBR PALEONTOL, V33, P1003, DOI 10.1080/02724634.2013.765886; Konietzko-Meier D, 2013, PALAEOGEOGR PALAEOCL, V370, P145, DOI 10.1016/j.palaeo.2012.12.003; Laurin M, 1998, ANN SCI NAT ZOOL, V19, P1, DOI 10.1016/S0003-4339(98)80132-9; Laurin Michel, 2000, Amphibian Biology, V4, P1064; LAWSON R, 1966, J MORPHOL, V118, P137, DOI 10.1002/jmor.1051180109; LOMBARD RE, 1995, PALAEONTOLOGY, V38, P471; Marjanovic D, 2008, ACTA PALAEONTOL POL, V53, P413, DOI 10.4202/app.2008.0305; Marjanovic D, 2013, GEODIVERSITAS, V35, P207, DOI 10.5252/g2013n1a8; Marjanovic D, 2008, CONTRIB ZOOL, V77, P149, DOI 10.1163/18759866-07703002; Miall L. C., 1875, M BRIT ASS ADV SCI, V44, P149; Milner A.R., 1990, Systematics Association Special Volume Series, P321; Milner A.R., 2000, HDB PALAOHERPETOLO B, V3B, P1; Mukherjee D, 2010, J VERTEBR PALEONTOL, V30, P78, DOI 10.1080/02724630903409121; Novikov I.V., 2000, PALEONTOL J+, V34, P165; Novikov Igor V., 2000, P60; Olori JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128333; Panchen A. L., 1977, PROBLEMS VERTEBRATE, P289; Pawley Kat, 2004, Palaeontologia Africana, V40, P1; Pyron RA, 2011, SYST BIOL, V60, P466, DOI 10.1093/sysbio/syr047; Reisz RR, 2009, NATURWISSENSCHAFTEN, V96, P789, DOI 10.1007/s00114-009-0533-x; Romer A, 1956, OSTEOLOGY REPTILES; ROMER A. S., 1947, BULL MUS COMP ZOOL HARVARD UNIV, V99, P1; ROMER ALFRED S., 1964, BULL MUS COMP ZOOL [HARVARD UNIV], V131, P87; Ruta M, 2003, BIOL REV, V78, P251, DOI 10.1017/S1464793102006103; Ruta M, 2007, J SYST PALAEONTOL, V5, P69, DOI 10.1017/S1477201906002008; Ruta M, 2006, T ROY SOC EDIN-EARTH, V97, P31, DOI 10.1017/S0263593300001395; Sanchez S, 2013, EVOL BIOL, V40, P627, DOI 10.1007/s11692-013-9238-3; Sanchez S, 2010, J EVOLUTION BIOL, V23, P2076, DOI 10.1111/j.1420-9101.2010.02081.x; Sanchez S, 2008, BIOL LETTERS, V4, P411, DOI 10.1098/rsbl.2008.0159; Sanchez S, 2010, EVOL DEV, V12, P315, DOI 10.1111/j.1525-142X.2010.00417.x; Schultze H-P., 1970, Am. Mus. Novit., VNo. 2408, P1; Schoch RR, 2014, PALAEONTOLOGY, V57, P1045, DOI 10.1111/pala.12101; Schoch RR, 2013, J SYST PALAEONTOL, V11, P673, DOI 10.1080/14772019.2012.699006; Schoch RR, 2012, LETHAIA, V45, P371, DOI 10.1111/j.1502-3931.2011.00290.x; Schoch RR, 2010, ZOOL J LINN SOC-LOND, V160, P515, DOI 10.1111/j.1096-3642.2009.00613.x; Schoch Rainer R., 1999, Stuttgarter Beitraege zur Naturkunde Serie B (Geologie und Palaeontologie), V278, P1; Schoch RR, 2009, ANNU REV EARTH PL SC, V37, P135, DOI 10.1146/annurev.earth.031208.100113; Schoch RR, 2014, HDB PALAOHERPETOLOGI, V3A2, P1; SCHULTZE HP, 1986, J MORPHOL, V190, P215, DOI 10.1002/jmor.1051900206; Sigurdsen T, 2011, ZOOL J LINN SOC-LOND, V162, P457, DOI 10.1111/j.1096-3642.2010.00683.x; Sigurdsen T, 2010, J VERTEBR PALEONTOL, V30, P1360, DOI 10.1080/02724634.2010.501445; Sigurdsen T, 2009, J MORPHOL, V270, P1443, DOI 10.1002/jmor.10769; Smithson Tim, 2000, Amphibian Biology, V4, P1053; Steen MC, 1938, P ZOOL SOC LOND B-SY, V108, P205, DOI 10.1111/j.1096-3642.1938.tb00027.x; Sulej Tomasz, 2007, Palaeontologia Polonica, V64, P29; Vallin G, 2004, J VERTEBR PALEONTOL, V24, P56, DOI 10.1671/5.1; Vorobyeva E., 1991, P68; WAKE DB, 1973, J MORPHOL, V139, P251, DOI 10.1002/jmor.1051390302; WARREN A, 1991, ALCHERINGA, V15, P43, DOI 10.1080/03115519108619009; Warren Anne, 1997, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V247, P1; Watson DMS, 1920, PHILOS T R SOC LON B, V209, P1, DOI 10.1098/rstb.1920.0001; White T. E., 1939, Bulletin of the Museum of Comparative Zoology, V85, P325; WILLIAMS EE, 1959, Q REV BIOL, V34, P1; Witzmann F, 2006, J VERTEBR PALEONTOL, V26, P7, DOI 10.1671/0272-4634(2006)26[7:DPAOSI]2.0.CO;2; Witzmann F, 2008, NATURWISSENSCHAFTEN, V95, P67, DOI 10.1007/s00114-007-0291-6; Witzmann F, 2012, PALAEONTOLOGY, V55, P31, DOI 10.1111/j.1475-4983.2011.01116.x; Witzmann Florian, 2009, Palaeodiversity, P233; Witzmann F, 2010, ACTA ZOOL-STOCKHOLM, V91, P96, DOI 10.1111/j.1463-6395.2008.00385.x; Woodward HN, 2013, BONE HISTOLOGY OF FOSSIL TETRAPODS: ADVANCING METHODS, ANALYSIS, AND INTERPRETATION, P195; ZHANG FK, 1984, VERTEBRAT PALASIATIC, V22, P294	102	21	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0152586	10.1371/journal.pone.0152586	http://dx.doi.org/10.1371/journal.pone.0152586			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27074015	Green Published, gold			2022-12-27	WOS:000374131200029
J	Regier, T; Carstensen, A; Kemp, C				Regier, Terry; Carstensen, Alexandra; Kemp, Charles			Languages Support Efficient Communication about the Environment: Words for Snow Revisited	PLOS ONE			English	Article							REDUNDANCY; CLIMATE	The claim that Eskimo languages have words for different types of snow is well-known among the public, but has been greatly exaggerated through popularization and is therefore viewed with skepticism by many scholars of language. Despite the prominence of this claim, to our knowledge the line of reasoning behind it has not been tested broadly across languages. Here, we note that this reasoning is a special case of the more general view that language is shaped by the need for efficient communication, and we empirically test a variant of it against multiple sources of data, including library reference works, Twitter, and large digital collections of linguistic and meteorological data. Consistent with the hypothesis of efficient communication, we find that languages that use the same linguistic form for snow and ice tend to be spoken in warmer climates, and that this association appears to be mediated by lower communicative need to talk about snow and ice. Our results confirm that variation in semantic categories across languages may be traceable in part to local communicative needs. They suggest moreover that despite its awkward history, the topic of "words for snow" may play a useful role as an accessible instance of the principle that language supports efficient communication.	[Regier, Terry] Univ Calif Berkeley, Dept Linguist, Cognit Sci Program, Berkeley, CA 94720 USA; [Carstensen, Alexandra] Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA; [Kemp, Charles] Carnegie Mellon Univ, Dept Psychol, Pittsburgh, PA 15213 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Carnegie Mellon University	Regier, T (corresponding author), Univ Calif Berkeley, Dept Linguist, Cognit Sci Program, Berkeley, CA 94720 USA.	terry.regier@berkeley.edu		Kemp, Charles/0000-0001-9683-8737; Carstensen, Alexandra/0000-0003-0582-9152	National Science Foundation [SBE-1041707, DGE-1106400]; Berkeley Research Impact Initiative (BRII) - UC Berkeley Library	National Science Foundation(National Science Foundation (NSF)); Berkeley Research Impact Initiative (BRII) - UC Berkeley Library	This research was supported by the National Science Foundation (www.nsf.gov) under grants SBE-1041707 (TR) and DGE-1106400 (AC). Publication was made possible in part by support from the Berkeley Research Impact Initiative (BRII) sponsored by the UC Berkeley Library.	[Anonymous], 2013, APPROACHES MEASURING, DOI DOI 10.1515/9783110305258.285; Baddeley R, 2009, PSYCHOL SCI, V20, P1100, DOI 10.1111/j.1467-9280.2009.02412.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boas Franz, 1911, HDB AM INDIAN LANGUA, V1, P1; Bybee JoanL., 1994, EVOLUTION GRAMMAR TE; Cancho RFI, 2003, P NATL ACAD SCI USA, V100, P788, DOI 10.1073/pnas.0335980100; Dediu D., 2015, LANGUAGE FAMILY CLAS; Eisenstein J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113114; EMBER M, 1978, AM ANTHROPOL, V80, P364, DOI 10.1525/aa.1978.80.2.02a00100; Everett C, 2015, P NATL ACAD SCI USA, V112, P1322, DOI 10.1073/pnas.1417413112; Fedzechkina M, 2012, P NATL ACAD SCI USA, V109, P17897, DOI 10.1073/pnas.1215776109; Greenberg JH, 2005, LANGUAGE UNIVERSALS: WITH SPECIAL REFERENCE TO FEATURE HIERARCHIES, P72; Hammarstrom H, 2015, GLOTTOLOG 2 4; Haspelmath M., 2009, WORLD LOANWORD DATAB; Hawkins J, 2003, EFFICIENCY COMPLEXIT; Jaeger TF, 2010, COGNITIVE PSYCHOL, V61, P23, DOI 10.1016/j.cogpsych.2010.02.002; Kemp C, 2012, SCIENCE, V336, P1049, DOI 10.1126/science.1218811; Kirby S, 2015, COGNITION, V141, P87, DOI 10.1016/j.cognition.2015.03.016; Krupnik I, 2010, SIKU: KNOWING OUR ICE: DOCUMENTING INUIT SEA-ICE KNOWLEDGE AND USE, P377, DOI 10.1007/978-90-481-8587-0_16; Levy R, 2008, COGNITION, V106, P1126, DOI 10.1016/j.cognition.2007.05.006; LIST J, 2013, P 10 INT C COMP SEM; Maddieson I, 2015, 170 M AC SOC AM; MARTIN L, 1986, AM ANTHROPOL, V88, P418, DOI 10.1525/aa.1986.88.2.02a00080; Nichols Johanna, 2013, AUTOTYP GENEALOGY GE; Piantadosi ST, 2011, P NATL ACAD SCI USA, V108, P3526, DOI 10.1073/pnas.1012551108; Pullum G., 1991, GREAT ESKIMO VOCABUL, P159; Regier T, 2015, BLACKW HBK LINGUIST, P237; Roberts S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070902; Sapir E, 1912, AM ANTHROPOL, V14, P226, DOI 10.1525/aa.1912.14.2.02a00020; Saxton D., 1969, DICT PAPAGO PIMA ENG; Voegelin CharlesFrederick., 1977, CLASSIFICATION INDEX; Whorf Benjamin., 1956, LANGUAGE THOUGHT REA; WITKOWSKI SR, 1978, ANNU REV ANTHROPOL, V7, P427, DOI 10.1146/annurev.an.07.100178.002235; WITKOWSKI SR, 1985, ETHNOLOGY, V24, P197, DOI 10.2307/3773610; Youn H, 2016, P NATL ACAD SCI USA, V113, P1766, DOI 10.1073/pnas.1520752113; Zipf G. K., 1949, HUMAN BEHAV PRINCIPL	37	39	39	4	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0151138	10.1371/journal.pone.0151138	http://dx.doi.org/10.1371/journal.pone.0151138			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ3UC	27073981	Green Published, gold			2022-12-27	WOS:000374131200006
J	Ruggeri, P; Splendiani, A; Occhipinti, G; Fioravanti, T; Santojanni, A; Leonori, I; De Felice, A; Arneri, E; Procaccini, G; Catanese, G; Ticina, V; Bonanno, A; Cerioni, PN; Giovannotti, M; Grant, WS; Barucchi, VC				Ruggeri, Paolo; Splendiani, Andrea; Occhipinti, Giulia; Fioravanti, Tatiana; Santojanni, Alberto; Leonori, Iole; De Felice, Andrea; Arneri, Enrico; Procaccini, Gabriele; Catanese, Gaetano; Ticina, Vjekoslav; Bonanno, Angelo; Cerioni, Paola Nisi; Giovannotti, Massimo; Grant, William Stewart; Barucchi, Vincenzo Caputo			Biocomplexity in Populations of European Anchovy in the Adriatic Sea	PLOS ONE			English	Article							POLYMORPHIC MICROSATELLITE LOCI; ENGRAULIS-ENCRASICOLUS; GENETIC DIFFERENTIATION; SEASCAPE GENETICS; GENERAL-CIRCULATION; MAXIMUM-LIKELIHOOD; MITOCHONDRIAL-DNA; MARINE FISH; SELECTION; SOFTWARE	The sustained exploitation of marine populations requires an understanding of a species' adaptive seascape so that populations can track environmental changes from short-and long-term climate cycles and from human development. The analysis of the distributions of genetic markers among populations, together with correlates of life-history and environmental variability, can provide insights into the extent of adaptive variation. Here, we examined genetic variability among populations of mature European anchovies (n = 531) in the Adriatic (13 samples) and Tyrrhenian seas (2 samples) with neutral and putative non-neutral microsatellite loci. These genetic markers failed to confirm the occurrence of two anchovy species in the Adriatic Sea, as previously postulated. However, we found fine-scale population structure in the Adriatic, especially in northern areas, that was associated with four of the 13 environmental variables tested. Geographic gradients in sea temperature, salinity and dissolved oxygen appear to drive adaptive differences in spawning time and early larval development among populations. Resolving adaptive seascapes in Adriatic anchovies provides a means to understand mechanisms underpinning local adaptation and a basis for optimizing exploitation strategies for sustainable harvests.	[Ruggeri, Paolo; Splendiani, Andrea; Occhipinti, Giulia; Fioravanti, Tatiana; Cerioni, Paola Nisi; Giovannotti, Massimo; Barucchi, Vincenzo Caputo] Univ Politecn Marche, Dipartimento Sci Vita & Ambiente, Via Brecce Bianche, I-60131 Ancona, Italy; [Santojanni, Alberto; Leonori, Iole; De Felice, Andrea] CNR, Ist Sci Marine, Sez Pesca Marittima, I-60125 Ancona, Italy; [Arneri, Enrico] FAO FIRF, Dept Fisheries & Aquaculture, AdriaMed Project, Viale Terme di Caracalla, I-00153 Rome, Italy; [Procaccini, Gabriele; Catanese, Gaetano] Anton Dohrn, Stn Zool, I-80121 Naples, Italy; [Ticina, Vjekoslav] Inst Oceanog & Fisheries, Lab Fisheries Sci & Management Pelag & Demersal R, Setaliste I Mestrovica 63, Split 21000, Croatia; [Bonanno, Angelo] CNR, IAMC, Detached Unit Capo Granitola TP, Via Mare 3, I-91021 Torretta Granitola Fraz, TP, Italy; [Grant, William Stewart] Alaska Dept Fish & Game, Commercial Fishery Div, Commercial Fisheries Div, Anchorage, AK 99518 USA	Marche Polytechnic University; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze Marine (ISMAR-CNR); Stazione Zoologica Anton Dohrn di Napoli; Croatian Institute of Oceanography & Fisheries (IZOR); Consiglio Nazionale delle Ricerche (CNR); L'Istituto per l'Ambiente Marino Costiero (IAMC-CNR); Alaska Department of Fish & Game	Barucchi, VC (corresponding author), Univ Politecn Marche, Dipartimento Sci Vita & Ambiente, Via Brecce Bianche, I-60131 Ancona, Italy.	v.caputo@univpm.it	De+Felice, Andrea/AHA-1500-2022; CATANESE, GAETANO/A-7510-2009; Procaccini, Gabriele/A-6618-2010; Leonori, Iole/AAF-6681-2020; De Felice, Andrea/L-9465-2014; Bonanno, Angelo/H-9025-2013; Leonori, Iole/AAD-7901-2020; Giovannotti, Massimo/AAZ-3563-2020; Procaccini, Gabriele/AAA-7040-2019	De+Felice, Andrea/0000-0002-0051-2052; CATANESE, GAETANO/0000-0001-6219-4494; Procaccini, Gabriele/0000-0002-6179-468X; Leonori, Iole/0000-0001-7673-1684; De Felice, Andrea/0000-0002-0051-2052; Bonanno, Angelo/0000-0002-3868-751X; Leonori, Iole/0000-0001-7673-1684; Procaccini, Gabriele/0000-0002-6179-468X; SANTOJANNI, ALBERTO/0000-0003-4947-3004; NISI CERIONI, Paola/0000-0001-5074-9843; Ruggeri, Paolo/0000-0002-5433-508X; Giovannotti, Massimo/0000-0001-7622-3583	RITMARE National Flagship Project (Italian Ministry for University and Research) [SP2_WP1_AZ4_UO02]; Universita Politecnica delle Marche (Ancona, Italy)	RITMARE National Flagship Project (Italian Ministry for University and Research); Universita Politecnica delle Marche (Ancona, Italy)	This work was supported by RITMARE National Flagship Project (Italian Ministry for University and Research), SP2_WP1_AZ4_UO02; and annual funds provided by Universita Politecnica delle Marche (Ancona, Italy) to Vincenzo Caputo Barucchi.	Antao T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-323; Artegiani A, 1997, J PHYS OCEANOGR, V27, P1492, DOI 10.1175/1520-0485(1997)027<1492:TASGCP>2.0.CO;2; Artegiani A, 1997, J PHYS OCEANOGR, V27, P1515, DOI 10.1175/1520-0485(1997)027<1515:TASGCP>2.0.CO;2; BASSAM BJ, 1991, ANAL BIOCHEM, V196, P80, DOI 10.1016/0003-2697(91)90120-I; Beaumont MA, 1996, P ROY SOC B-BIOL SCI, V263, P1619, DOI 10.1098/rspb.1996.0237; Beerli P, 2006, BIOINFORMATICS, V22, P341, DOI 10.1093/bioinformatics/bti803; Bembo DG, 1996, MAR BIOL, V126, P529, DOI 10.1007/BF00354635; Biktashev VN, 2003, J PLANKTON RES, V25, P21, DOI 10.1093/plankt/25.1.21; Bird CE, 2011, CRUSTACEAN ISS, V19, P31; Borrell YJ, 2012, ICES J MAR SCI, V69, P1357, DOI 10.1093/icesjms/fss129; Borsa P, 2004, CR BIOL, V327, P1113, DOI 10.1016/j.crvi.2004.09.003; Borsa P, 2002, BIOL J LINN SOC, V75, P261, DOI 10.1111/j.1095-8312.2002.tb01426.x; Brookfield JFY, 1996, MOL ECOL, V5, P453, DOI 10.1046/j.1365-294X.1996.00098.x; BULJAN M., 1976, OCEANOGR MAR BIOL AN, V14, P11; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Charlesworth B, 2009, NAT REV GENET, V10, P195, DOI 10.1038/nrg2526; Chistiakov DA, 2006, AQUACULTURE, V255, P1, DOI 10.1016/j.aquaculture.2005.11.031; Chiu TS, 2002, MOL ECOL NOTES, V2, P49, DOI 10.1046/j.1471-8286.2002.00142.x; Cognetti G., 2000, SEAS MILLENN ENV EVA, V1, P267; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Ellegren H, 2004, NAT REV GENET, V5, P435, DOI 10.1038/nrg1348; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2009, HEREDITY, V103, P285, DOI 10.1038/hdy.2009.74; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Falush D, 2003, GENETICS, V164, P1567; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; Gaggiotti OE, 2009, EVOLUTION, V63, P2939, DOI 10.1111/j.1558-5646.2009.00779.x; Giani M, 2012, ESTUAR COAST SHELF S, V115, P1, DOI 10.1016/j.ecss.2012.08.023; Giannoulaki M, 2013, FISH OCEANOGR, V22, P69, DOI 10.1111/fog.12005; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hedgecock D, 2011, B MAR SCI, V87, P971, DOI 10.5343/bms.2010.1051; Hedrick PW, 2005, EVOLUTION, V59, P1633, DOI 10.1111/j.0014-3820.2005.tb01814.x; Hilborn R, 2003, P NATL ACAD SCI USA, V100, P6564, DOI 10.1073/pnas.1037274100; ILES TD, 1982, SCIENCE, V215, P627, DOI 10.1126/science.215.4533.627; Irigoien X, 2009, J PLANKTON RES, V31, P1, DOI 10.1093/plankt/fbn096; Jombart T, 2010, BMC GENET, V11, DOI [DOI 10.1186/1471-2156-11-94, 10.1186/1471-2156-11-94]; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Kauer MO, 2003, GENETICS, V165, P1137; Kelly RP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008594; Kopelman NM, 2015, MOL ECOL RESOUR, V15, P1179, DOI 10.1111/1755-0998.12387; Lamichhaney S, 2012, P NATL ACAD SCI USA, V109, P19345, DOI 10.1073/pnas.1216128109; Landi M, 2005, MOL ECOL NOTES, V5, P266, DOI 10.1111/j.1471-8286.2005.00892.x; Lin L, 2011, GENET MOL RES, V10, P764, DOI 10.4238/vol10-2gmr1085; Manel S, 2013, TRENDS ECOL EVOL, V28, P614, DOI 10.1016/j.tree.2013.05.012; Manni F, 2004, HUM BIOL, V76, P173, DOI 10.1353/hub.2004.0034; Meier K, 2011, HEREDITY, V106, P488, DOI 10.1038/hdy.2010.164; Milano I, 2014, MOL ECOL, V23, P118, DOI 10.1111/mec.12568; Morello EB, 2009, OCEANOGR MAR BIOL, V47, P209; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Olsen EM, 2008, EVOL APPL, V1, P524, DOI 10.1111/j.1752-4571.2008.00024.x; Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x; Pakaki V, 2009, MOL ECOL RESOUR, V9, P1406, DOI 10.1111/j.1755-0998.2009.02681.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Pritchard JK, 2000, GENETICS, V155, P945; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; Riccioni G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080105; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Riginos C, 2013, GEOGR COMPASS, V7, P197, DOI 10.1111/gec3.12032; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Ruggeri P, PLOS ONE, V11, DOI [10.1371/journal.pone.0151507, DOI 10.1371/J0URNAL.P0NE.0151507]; Russello MA, 2012, EVOL APPL, V5, P39, DOI 10.1111/j.1752-4571.2011.00206.x; Ruzzante DE, 2006, P ROY SOC B-BIOL SCI, V273, P1459, DOI 10.1098/rspb.2005.3463; Santojanni A, 2006, CLIM RES, V31, P181, DOI 10.3354/cr031181; Schlotterer C, 2000, CHROMOSOMA, V109, P365, DOI 10.1007/s004120000089; Selkoe KA, 2011, MAR ECOL PROG SER, V436, P291, DOI 10.3354/meps09238; Selkoe KA, 2008, FISH FISH, V9, P363, DOI 10.1111/j.1467-2979.2008.00300.x; Selkoe KA, 2010, MOL ECOL, V19, P3708, DOI 10.1111/j.1365-294X.2010.04658.x; Silva G, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1093; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; TAGGART JB, 1992, J FISH BIOL, V40, P963, DOI 10.1111/j.1095-8649.1992.tb02641.x; ter Braak C.J.F., 2002, CANOCO REFERENCE MAN, P500; Tortonese E., 1970, FAUNA D ITALIA 1, VX; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vasemagi A, 2005, MOL BIOL EVOL, V22, P1067, DOI 10.1093/molbev/msi093; Vucetic T., 1964, Acta Adriatica, V11, P277; Waples RS, 1998, J HERED, V89, P438, DOI 10.1093/jhered/89.5.438; Warner RR, 2002, B MAR SCI, V70, P245; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; White C, 2010, P ROY SOC B-BIOL SCI, V277, P1685, DOI 10.1098/rspb.2009.2214; Zarraonaindia I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042201; Zarraonaindia I, 2009, ICES J MAR SCI, V66, P2176, DOI 10.1093/icesjms/fsp187; Zorica B, 2013, FISH OCEANOGR, V22, P32, DOI 10.1111/fog.12002	86	11	11	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153061	10.1371/journal.pone.0153061	http://dx.doi.org/10.1371/journal.pone.0153061			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27074008	Green Submitted, gold, Green Published			2022-12-27	WOS:000374131200050
J	Tomizawa, M; Shinozaki, F; Motoyoshi, Y; Sugiyama, T; Yamamoto, S; Ishige, N				Tomizawa, Minoru; Shinozaki, Fuminobu; Motoyoshi, Yasufumi; Sugiyama, Takao; Yamamoto, Shigenori; Ishige, Naoki			Improved Survival and Initiation of Differentiation of Human Induced Pluripotent Stem Cells to Hepatocyte-Like Cells upon Culture in William's E Medium followed by Hepatocyte Differentiation Inducer Treatment	PLOS ONE			English	Article							EFFICIENT GENERATION; HUMAN LIVER; AMINO-ACID; GROWTH; PCR; FIBROBLASTS; ARGININE	Background Hepatocyte differentiation inducer (HDI) lacks both glucose and arginine, but is supplemented with galactose and ornithine, and is added together with other reagents such as apoptosis inhibitor and oncostatin M. Although human induced pluripotent stem (iPS) cells initiate hepatocyte differentiation, most die within 7 days. In this study, we investigated both HDI and conventional media for their potential to improve cell survival. Materials and Methods 201B7 iPS cells were cultured in conventional media. This consisted of three cycles of 5-day culture in William's E (WE) medium, followed by a 2-day culture in HDI. Results Expression levels of a-feto protein (AFP) were higher in cells cultured in WE and in Dulbecco's Modified Eagle's Medium/Nutrient F-12 Ham (DF12). 201B7 cells expressed the highest AFP and albumin (ALB) when cultured in HDI for 2 days following 7-day culture in WE. After three cycles of 5-day culture in WE followed by 2 days in HDI, 201B7 cells expressed AFP and ALB 54 +/- 2.3 (average +/- standard deviation) and 73 +/- 15.1 times higher, respectively, than those cultured in ReproFF (feeder-free condition). Conclusion 201B7 cells survived culture in WE for 7 days followed HDI for 2 days. After three cycles of culture under these conditions, hepatocyte differentiation was enhanced, as evidenced by increased AFP and ALB expression.	[Tomizawa, Minoru] Shimoshizu Hosp, Natl Hosp Org, Dept Gastroenterol, 934-5 Shikawatashi, Yotsukaido, Chiba 2840003, Japan; [Shinozaki, Fuminobu] Shimoshizu Hosp, Natl Hosp Org, Dept Radiol, 934-5 Shikawatashi, Yotsukaido, Chiba 2840003, Japan; [Motoyoshi, Yasufumi] Shimoshizu Hosp, Natl Hosp Org, Dept Neurol, 934-5 Shikawatashi, Yotsukaido, Chiba 2840003, Japan; [Sugiyama, Takao] Shimoshizu Hosp, Natl Hosp Org, Dept Rheumatol, 934-5 Shikawatashi, Yotsukaido, Chiba 2840003, Japan; [Yamamoto, Shigenori] Shimoshizu Hosp, Natl Hosp Org, Dept Pediat, 934-5 Shikawatashi, Yotsukaido, Chiba 2840003, Japan; [Ishige, Naoki] Shimoshizu Hosp, Natl Hosp Org, Dept Neurosurg, 934-5 Shikawatashi, Yotsukaido, Chiba 2840003, Japan		Tomizawa, M (corresponding author), Shimoshizu Hosp, Natl Hosp Org, Dept Gastroenterol, 934-5 Shikawatashi, Yotsukaido, Chiba 2840003, Japan.	nihminor-cib@umin.ac.jp						AI YJ, 1995, GENOME RES, V5, P53, DOI 10.1101/gr.5.1.53; Chang HM, 2012, INT J MOL SCI, V13, P3598, DOI 10.3390/ijms13033598; Dabos KJ, 2004, CELL TRANSPLANT, V13, P213, DOI 10.3727/000000004783984007; DAVIES B, 1995, GENOMICS, V25, P372, DOI 10.1016/0888-7543(95)80036-L; DeLaForest A, 2011, DEVELOPMENT, V138, P4143, DOI 10.1242/dev.062547; Farghali H, 2002, PHARMACOL RES, V46, P511, DOI 10.1016/S1043661802002347; Gallagher RC, 2014, J PEDIATR-US, V164, P720, DOI 10.1016/j.jpeds.2013.12.024; Ghodsizadeh A, 2014, BIOTECHNOL LETT, V36, P1095, DOI 10.1007/s10529-014-1454-0; Hirschi KK, 2014, ANNU REV BIOMED ENG, V16, P277, DOI 10.1146/annurev-bioeng-071813-105108; Husson A, 2003, EUR J BIOCHEM, V270, P1887, DOI 10.1046/j.1432-1033.2003.03559.x; Inamura M, 2011, MOL THER, V19, P400, DOI 10.1038/mt.2010.241; Kondo Y, 2014, DRUG METAB PHARMACOK, V29, P407, DOI 10.2133/dmpk.DMPK-14-RG-022; MITAKA T, 1991, HEPATOLOGY, V13, P21, DOI 10.1016/0270-9139(91)90211-D; MITAKA T, 1991, J CELL PHYSIOL, V147, P495, DOI 10.1002/jcp.1041470316; NAKAMURA T, 1984, BIOCHEM BIOPH RES CO, V122, P884, DOI 10.1016/0006-291X(84)91173-2; Nava S, 2005, DIFFERENTIATION, V73, P249, DOI 10.1111/j.1432-0436.2005.00019.x; Ohira RH, 2005, BIOCHEM BIOPH RES CO, V331, P239, DOI 10.1016/j.bbrc.2005.03.143; Raggi CC, 2005, CLIN CHEM LAB MED, V43, P542, DOI 10.1515/CCLM.2005.094; Shan J, 2013, NAT CHEM BIOL, V9, P514, DOI 10.1038/nchembio.1270; Si-Tayeb K, 2010, HEPATOLOGY, V51, P297, DOI 10.1002/hep.23354; Song ZH, 2009, CELL RES, V19, P1233, DOI 10.1038/cr.2009.107; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takayama K, 2012, MOL THER, V20, P127, DOI 10.1038/mt.2011.234; Takeba Y, 2011, J PHARMACOL SCI, V115, P516, DOI 10.1254/jphs.10215FP; Takebe T, 2013, NATURE, V499, P481, DOI 10.1038/nature12271; Tam S, 2009, J VIROL METHODS, V161, P183, DOI 10.1016/j.jviromet.2009.04.033; Tellinghuisen J, 2015, ANAL CHEM, V87, P8925, DOI 10.1021/acs.analchem.5b02057; Tomizawa M, 1998, BIOCHEM BIOPH RES CO, V249, P1, DOI 10.1006/bbrc.1998.8999; Tomizawa M, 2008, CELL TISSUE RES, V333, P17, DOI 10.1007/s00441-008-0618-4; Tomizawa M, 2013, BIOMED REP, V1, P18, DOI 10.3892/br.2012.2; Tomizawa M, 2015, J CELL BIOCHEM, V116, P1479, DOI 10.1002/jcb.25139; Tomizawa M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071897; Vasanthan KS, 2015, ANAL CHIM ACTA, V890, P83, DOI 10.1016/j.aca.2015.06.057; Wheatley DN, 2000, CELL PHYSIOL BIOCHEM, V10, P37, DOI 10.1159/000016333; Wu DF, 1997, MOL CELL BIOCHEM, V173, P103, DOI 10.1023/A:1006831811622; Zaret KS, 2008, COLD SH Q B, V73, P119, DOI 10.1101/sqb.2008.73.040; Zimmermann B, 2005, CLIN CHEM, V51, P1598, DOI 10.1373/clinchem.2005.051235	37	3	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153435	10.1371/journal.pone.0153435	http://dx.doi.org/10.1371/journal.pone.0153435			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073925	gold, Green Published, Green Submitted			2022-12-27	WOS:000374131200093
J	Hertz, U; Kelly, M; Rutledge, RB; Winston, J; Wright, N; Dolan, RJ; Bahrami, B				Hertz, Uri; Kelly, Maria; Rutledge, Robb B.; Winston, Joel; Wright, Nicholas; Dolan, Raymond J.; Bahrami, Bahador			Oxytocin Effect on Collective Decision Making: A Randomized Placebo Controlled Study	PLOS ONE			English	Article							NEURAL MECHANISMS; IN-GROUP; BRAIN; NEUROPEPTIDES; VASOPRESSIN; INCREASES; FACES; NEUROSCIENCE; AFFILIATION; GUIDELINES	Collective decision making often benefits both the individuals and the group in a variety of contexts. However, for the group to be successful, individuals should be able to strike a balance between their level of competence and their influence on the collective decisions. The hormone oxytocin has been shown to promote trust, conformism and attention to social cues. We wondered if this hormone may increase participants' (unwarranted) reliance on their partners' opinion, resulting in a reduction in collective benefit by disturbing the balance between influence and competence. To test this hypothesis we employed a randomized double-blind placebo-controlled design in which male dyads self-administered intranasal oxytocin or placebo and then performed a visual search task together. Compared to placebo, collective benefit did not decrease under oxytocin. Using an exploratory time dependent analysis, we observed increase in collective benefit over time under oxytocin. Moreover, trial-by-trial analysis showed that under oxytocin the more competent member of each dyad was less likely to change his mind during disagreements, while the less competent member showed a greater willingness to change his mind and conform to the opinion of his more reliable partner. This role-dependent effect may be mediated by enhanced monitoring of own and other's performance level under oxytocin. Such enhanced social learning could improve the balance between influence and competence and lead to efficient and beneficial collaboration.	[Hertz, Uri; Wright, Nicholas; Bahrami, Bahador] UCL, Inst Cognit Neurosci, London WC1N 3AR, England; [Kelly, Maria] Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England; [Rutledge, Robb B.; Winston, Joel; Dolan, Raymond J.] UCL, Inst Neurol, Wellcome Trust Ctr Neuroimaging, London WC1N 3BG, England; [Rutledge, Robb B.; Dolan, Raymond J.] Max Planck Univ Coll London, Ctr Computat Psychiat & Ageing Res, London WC1B 5EH, England; [Wright, Nicholas] Univ Birmingham, Sch Govt & Soc, Inst Conflict Cooperat & Secur, Birmingham B15 2TT, W Midlands, England; [Wright, Nicholas] Carnegie Endowment Int Peace, Washington, DC 20037 USA	University of London; University College London; University of Oxford; University of London; University College London; University of Birmingham	Hertz, U (corresponding author), UCL, Inst Cognit Neurosci, 17 Queen Sq, London WC1N 3AR, England.	u.hertz@ucl.ac.uk	Winston, Joel/F-6180-2010; Wright, Nicholas/HHY-7227-2022; Hertz, Uri/AAA-4799-2020	Winston, Joel/0000-0002-3957-0612; Hertz, Uri/0000-0003-4852-3516; Rutledge, Robb/0000-0001-7337-5039	European Research Council [NeuroCoDec] [309865]; Wellcome Trust [098362, 095939, 091593]	European Research Council [NeuroCoDec]; Wellcome Trust(Wellcome TrustEuropean Commission)	The European Research Council supported BB and UH,[NeuroCoDec 309865]. The Wellcome Trust supported RJD [098362] and JW [095939]. The Wellcome Trust Centre for Neuroimaging is supported by core funding from the Wellcome Trust [091593]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki Y, 2015, MOL PSYCHIATR, V20, P447, DOI 10.1038/mp.2014.74; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Bahrami B, 2012, PHILOS T R SOC B, V367, P1350, DOI 10.1098/rstb.2011.0420; Bahrami B, 2010, SCIENCE, V329, P1081, DOI 10.1126/science.1185718; Bartz JA, 2006, HORM BEHAV, V50, P518, DOI 10.1016/j.yhbeh.2006.06.018; Bartz JA, 2011, TRENDS COGN SCI, V15, P301, DOI 10.1016/j.tics.2011.05.002; Behrens TEJ, 2008, NATURE, V456, P245, DOI 10.1038/nature07538; Behrens TEJ, 2009, SCIENCE, V324, P1160, DOI 10.1126/science.1169694; Bethlehem RAI, 2013, PSYCHONEUROENDOCRINO, V38, P962, DOI 10.1016/j.psyneuen.2012.10.011; Boorman ED, 2013, NEURON, V80, P1558, DOI 10.1016/j.neuron.2013.10.024; Born J, 2002, NAT NEUROSCI, V5, P514, DOI 10.1038/nn849; Campbell A, 2008, BIOL PSYCHOL, V77, P1, DOI 10.1016/j.biopsycho.2007.09.001; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; COHEN J, 1973, EDUC PSYCHOL MEAS, V33, P107, DOI 10.1177/001316447303300111; Cushing BS, 2000, HORM BEHAV, V37, P49, DOI 10.1006/hbeh.1999.1558; Dal Monte O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103677; de Bruijn ERA, 2009, J NEUROSCI, V29, P12183, DOI 10.1523/JNEUROSCI.1751-09.2009; De Dreu CKW, 2011, P NATL ACAD SCI USA, V108, P1262, DOI 10.1073/pnas.1015316108; De Dreu CKW, 2010, EUR J SOC PSYCHOL, V40, P1110, DOI 10.1002/ejsp.763; De Dreu CKW, 2010, SCIENCE, V328, P1408, DOI 10.1126/science.1189047; Declerck CH, 2010, HORM BEHAV, V57, P368, DOI 10.1016/j.yhbeh.2010.01.006; Ditzen B, 2009, BIOL PSYCHIAT, V65, P728, DOI 10.1016/j.biopsych.2008.10.011; Domes G, 2007, BIOL PSYCHIAT, V61, P731, DOI 10.1016/j.biopsych.2006.07.015; Dugatkin LA, 1997, BIOSCIENCE, V47, P355, DOI 10.2307/1313150; Evans SL, 2014, BRAIN RES, V1580, P69, DOI 10.1016/j.brainres.2013.11.008; Frith CD, 2012, ANNU REV PSYCHOL, V63, P287, DOI 10.1146/annurev-psych-120710-100449; Fusaroli R, 2012, PSYCHOL SCI, V23, P931, DOI 10.1177/0956797612436816; Green DM, 1966, SIGNAL DETECTION THE; GRIFFIN D, 1992, COGNITIVE PSYCHOL, V24, P411, DOI 10.1016/0010-0285(92)90013-R; Guastella AJ, 2008, BIOL PSYCHIAT, V63, P3, DOI 10.1016/j.biopsych.2007.06.026; Guastella AJ, 2013, PSYCHONEUROENDOCRINO, V38, P612, DOI 10.1016/j.psyneuen.2012.11.019; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Heinrichs M, 2003, BIOL PSYCHIAT, V54, P1389, DOI 10.1016/S0006-3223(03)00465-7; Heinrichs M, 2008, PROG BRAIN RES, V170, P337, DOI 10.1016/S0079-6123(08)00428-7; Huang Y, 2015, PSYCHONEUROENDOCRINO, V60, P114, DOI 10.1016/j.psyneuen.2015.06.003; Insel TR, 2010, NEURON, V65, P768, DOI 10.1016/j.neuron.2010.03.005; Israel S, 2012, PSYCHONEUROENDOCRINO, V37, P1341, DOI 10.1016/j.psyneuen.2012.02.001; Kirsch P, 2005, J NEUROSCI, V25, P11489, DOI 10.1523/JNEUROSCI.3984-05.2005; Kollock P, 1998, ANNU REV SOCIOL, V24, P183, DOI 10.1146/annurev.soc.24.1.183; Kosfeld M, 2005, NATURE, V435, P673, DOI 10.1038/nature03701; Kruger J, 1999, J PERS SOC PSYCHOL, V77, P1121, DOI 10.1037/0022-3514.77.6.1121; Labuschagne I, 2012, INT J NEUROPSYCHOPH, V15, P883, DOI 10.1017/S1461145711001489; Landman R, 2014, P NATL ACAD SCI USA, V111, P18037, DOI 10.1073/pnas.1420167111; LATANE B, 1979, J PERS SOC PSYCHOL, V37, P822, DOI 10.1037//0022-3514.37.6.822; Mahmoodi A, 2015, P NATL ACAD SCI USA, V112, P3835, DOI 10.1073/pnas.1421692112; Meyer-Lindenberg A, 2011, NAT REV NEUROSCI, V12, P524, DOI 10.1038/nrn3044; Mikolajczak M, 2010, PSYCHOL SCI, V21, P1072, DOI 10.1177/0956797610377343; Moher D, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c869; Neumann ID, 2008, J NEUROENDOCRINOL, V20, P858, DOI 10.1111/j.1365-2826.2008.01726.x; Neumann ID, 2013, PSYCHONEUROENDOCRINO, V38, P1985, DOI 10.1016/j.psyneuen.2013.03.003; Noonan MP, 2011, J NEUROSCI, V31, P14399, DOI 10.1523/JNEUROSCI.6456-10.2011; Paloyelis Y, 2016, BIOL PSYCHIAT, V79, P693, DOI 10.1016/j.biopsych.2014.10.005; Petrovic P, 2008, J NEUROSCI, V28, P6607, DOI 10.1523/JNEUROSCI.4572-07.2008; Santos FC, 2008, NATURE, V454, P213, DOI 10.1038/nature06940; Saxe R, 2006, CURR OPIN NEUROBIOL, V16, P235, DOI 10.1016/j.conb.2006.03.001; Shamay-Tsoory SG, 2009, BIOL PSYCHIAT, V66, P864, DOI 10.1016/j.biopsych.2009.06.009; Singer T, 2008, EMOTION, V8, P781, DOI 10.1037/a0014195; Sripada CS, 2013, INT J NEUROPSYCHOPH, V16, P255, DOI 10.1017/S1461145712000533; Stallen M, 2012, PSYCHOL SCI, V23, P1288, DOI 10.1177/0956797612446026; Steyer, 1997, MEHRDIMENSIONALE BEF; Striepens N, 2013, SCI REP-UK, V3, DOI 10.1038/srep03440; Vickers A J, 2001, BMC Med Res Methodol, V1, P6, DOI 10.1186/1471-2288-1-6; Williams EF, 2013, J PERS SOC PSYCHOL, V104, P976, DOI 10.1037/a0032416; Wright ND, 2012, P ROY SOC B-BIOL SCI, V279, P2275, DOI 10.1098/rspb.2011.2523; Yaniv I, 2000, ORGAN BEHAV HUM DEC, V83, P260, DOI 10.1006/obhd.2000.2909; Yoshida W, 2010, J NEUROSCI, V30, P10744, DOI 10.1523/JNEUROSCI.5895-09.2010	66	9	9	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0153352	10.1371/journal.pone.0153352	http://dx.doi.org/10.1371/journal.pone.0153352			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ0NI	27070542	Green Published, gold, Green Submitted			2022-12-27	WOS:000373900700054
J	Ding, XT; Jiang, YP; Hao, T; Jin, HJ; Zhang, HM; He, LZ; Zhou, Q; Huang, DF; Hui, DF; Yu, JZ				Ding, Xiaotao; Jiang, Yuping; Hao, Ting; Jin, Haijun; Zhang, Hongmei; He, Lizhong; Zhou, Qiang; Huang, Danfeng; Hui, Dafeng; Yu, Jizhu			Effects of Heat Shock on Photosynthetic Properties, Antioxidant Enzyme Activity, and Downy Mildew of Cucumber (Cucumis sativus L.)	PLOS ONE			English	Article							OXIDATIVE STRESS; PSEUDOPERONOSPORA-CUBENSIS; CHLOROPHYLL FLUORESCENCE; MOLECULAR-MECHANISMS; HYDROGEN-PEROXIDE; SUPEROXIDE-DISMUTASE; ELECTRON-TRANSPORT; CO2 ASSIMILATION; PHOTOSYSTEM-II; ABIOTIC STRESS	Heat shock is considered an abiotic stress for plant growth, but the effects of heat shock on physiological responses of cucumber plant leaves with and without downy mildew disease are still not clear. In this study, cucumber seedlings were exposed to heat shock in greenhouses, and the responses of photosynthetic properties, carbohydrate metabolism, antioxidant enzyme activity, osmolytes, and disease severity index of leaves with or without the downy mildew disease were measured. Results showed that heat shock significantly decreased the net photosynthetic rate, actual photochemical efficiency, photochemical quenching coefficient, and starch content. Heat shock caused an increase in the stomatal conductance, transpiration rate, antioxidant enzyme activities, total soluble sugar content, sucrose content, soluble protein content and proline content for both healthy leaves and downy mildew infected leaves. These results demonstrate that heat shock activated the transpiration pathway to protect the photosystem from damage due to excess energy in cucumber leaves. Potential resistance mechanisms of plants exposed to heat stress may involve higher osmotic regulation capacity related to an increase of total accumulations of soluble sugar, proline and soluble protein, as well as higher antioxidant enzymes activity in stressed leaves. Heat shock reduced downy mildew disease severity index by more than 50%, and clearly alleviated downy mildew development in the greenhouses. These findings indicate that cucumber may have a complex physiological change to resist short-term heat shock, and suppress the development of the downy mildew disease.	[Ding, Xiaotao; Jiang, Yuping; Hao, Ting; Jin, Haijun; Zhang, Hongmei; He, Lizhong; Zhou, Qiang; Yu, Jizhu] Shanghai Acad Agr Sci, Inst Hort Res, Shanghai Key Lab Protected Hort Technol, Shanghai 201106, Peoples R China; [Ding, Xiaotao; Huang, Danfeng] Shanghai Jiao Tong Univ, Sch Agr & Biol, Shanghai 202400, Peoples R China; [Hui, Dafeng] Tennessee State Univ, Dept Biol Sci, Nashville, TN 37209 USA	Shanghai Academy of Agricultural Sciences; Shanghai Jiao Tong University; Tennessee State University	Yu, JZ (corresponding author), Shanghai Acad Agr Sci, Inst Hort Res, Shanghai Key Lab Protected Hort Technol, Shanghai 201106, Peoples R China.; Hui, DF (corresponding author), Tennessee State Univ, Dept Biol Sci, Nashville, TN 37209 USA.	dhui@tnstate.edu; woloveorange2011@163.com		Hui, Dafeng/0000-0002-5284-2897	National Natural Science Foundation of China [31301818]; Developmental Plan of the Shanghai Agriculture Commission [1-10, 1-42]; National Key Technology Support Program [2014BAD08B01]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Developmental Plan of the Shanghai Agriculture Commission; National Key Technology Support Program(National Key Technology R&D Program)	This work was supported by the National Natural Science Foundation of China (31301818), the Developmental Plan of the Shanghai Agriculture Commission (1-10, 2014; 1-42, 2015), and National Key Technology Support Program (2014BAD08B01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeselmani M, 2006, PLANT SCI, V171, P382, DOI 10.1016/j.plantsci.2006.04.009; Ashraf M, 2007, ENVIRON EXP BOT, V59, P206, DOI 10.1016/j.envexpbot.2005.12.006; Bagi FF, 2014, CROP PROT, V61, P74, DOI 10.1016/j.cropro.2014.03.012; Baker NR, 2008, ANNU REV PLANT BIOL, V59, P89, DOI 10.1146/annurev.arplant.59.032607.092759; Baker NR, 2004, J EXP BOT, V55, P1607, DOI 10.1093/jxb/erh196; Bitton S, 2014, PLANT PROTECTION MAN; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BUYSSE J, 1993, J EXP BOT, V44, P1627, DOI 10.1093/jxb/44.10.1627; CAKMAK I, 1992, PLANT PHYSIOL, V98, P1222, DOI 10.1104/pp.98.4.1222; Carmo-Silva AE, 2012, PLANTA, V236, P1433, DOI 10.1007/s00425-012-1691-1; Cohen Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140015; Cohen Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126103; Coruzzi G, 2001, PLANT PHYSIOL, V125, P61, DOI 10.1104/pp.125.1.61; Cui XH, 2008, J INSECT SCI, V8; Dai AH, 2012, ENVIRON EXP BOT, V79, P1, DOI 10.1016/j.envexpbot.2012.01.003; Ding XT, 2013, ACTA PHYSIOL PLANT, V35, P1427, DOI 10.1007/s11738-012-1182-9; Durner J, 1996, J BIOL CHEM, V271, P28492, DOI 10.1074/jbc.271.45.28492; Elad Y, 2014, ACTA HORTIC, V1015, P89; Fadzillah NM, 1996, PLANTA, V199, P552, DOI 10.1007/BF00195186; Faralli M, 2015, BIOL PLANTARUM, V59, P537, DOI 10.1007/s10535-015-0518-x; Gao Y, 2010, SCI HORTIC-AMSTERDAM, V126, P20, DOI 10.1016/j.scienta.2010.06.006; GIANNOPOLITIS CN, 1977, PLANT PHYSIOL, V59, P309, DOI 10.1104/pp.59.2.309; Granke LL, 2014, PLANT DIS, V98, P674, DOI 10.1094/PDIS-05-13-0567-RE; Hasanuzzaman M, 2013, INT J MOL SCI, V14, P9643, DOI 10.3390/ijms14059643; Jha UC, 2014, PLANT BREEDING, V133, P679, DOI 10.1111/pbr.12217; Jung SY, 2000, PLANT SCI, V153, P145, DOI 10.1016/S0168-9452(99)00259-9; Kishor PBK, 2005, CURR SCI INDIA, V88, P424; Koca H, 2007, ENVIRON EXP BOT, V60, P344, DOI 10.1016/j.envexpbot.2006.12.005; Lawlor DW, 2009, ANN BOT-LONDON, V103, P561, DOI [10.1093/aob/mcn244, 10.1093/aob/mcn256]; Lebeda A, 2007, ACTA HORTIC, P327, DOI 10.17660/ActaHortic.2007.731.44; Lebeda A, 2011, EUR J PLANT PATHOL, V129, P157, DOI 10.1007/s10658-010-9658-1; Lesk C, 2016, NATURE, V529, P84, DOI 10.1038/nature16467; Li H, 2013, PLANT PHYSIOL BIOCH, V71, P1, DOI 10.1016/j.plaphy.2013.06.018; Lu CM, 2003, J EXP BOT, V54, P851, DOI 10.1093/jxb/erg080; Mathur S, 2014, J PHOTOCH PHOTOBIO B, V137, P116, DOI 10.1016/j.jphotobiol.2014.01.010; Matysik J, 2002, CURR SCI INDIA, V82, P525; Mittler R, 2006, TRENDS PLANT SCI, V11, P15, DOI 10.1016/j.tplants.2005.11.002; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; Neufeld KN, 2012, PLANT DIS, V96, P345, DOI 10.1094/PDIS-07-11-0560; Nostar O, 2013, PHYSIOL MOL PLANT P, V83, P84, DOI 10.1016/j.pmpp.2013.05.004; Qu AL, 2013, BIOCHEM BIOPH RES CO, V432, P203, DOI 10.1016/j.bbrc.2013.01.104; Rizhsky L, 2004, PLANT PHYSIOL, V134, P1683, DOI 10.1104/pp.103.033431; Rolland F, 2002, PLANT CELL, V14, pS185, DOI 10.1105/tpc.010455; Ruelland E, 2010, ENVIRON EXP BOT, V69, P225, DOI 10.1016/j.envexpbot.2010.05.011; Sato T, 2002, ACTA HORTIC, P165, DOI 10.17660/ActaHortic.2002.588.25; Scafaro AP, 2010, J EXP BOT, V61, P191, DOI 10.1093/jxb/erp294; Shao L, 2007, J INTEGR PLANT BIOL, V49, P1341, DOI 10.1111/j.1744-7909.2007.00527.x; SLOOTEN L, 1995, PLANT PHYSIOL, V107, P737, DOI 10.1104/pp.107.3.737; Srivastava A, 1997, BBA-BIOENERGETICS, V1320, P95, DOI 10.1016/S0005-2728(97)00017-0; Wahid A, 2007, ENVIRON EXP BOT, V61, P199, DOI 10.1016/j.envexpbot.2007.05.011; Wahid A, 2007, BIOL PLANTARUM, V51, P104, DOI 10.1007/s10535-007-0021-0; Widiastuti A, 2013, PHYSIOL MOL PLANT P, V84, P86, DOI 10.1016/j.pmpp.2013.08.003; Yamasaki H, 1996, ARCH BIOCHEM BIOPHYS, V332, P183, DOI 10.1006/abbi.1996.0331; Yang XT, 2007, NEW ZEAL J AGR RES, V50, P1261, DOI 10.1080/00288230709510411; Yuan YH, 2014, J PLANT GROWTH REGUL, V33, P798, DOI 10.1007/s00344-014-9427-z; Zhang J, 2012, BIOL PLANTARUM, V56, P780, DOI 10.1007/s10535-012-0136-9; Zhang R, 2009, PHOTOSYNTH RES, V100, P29, DOI 10.1007/s11120-009-9420-8; Zhou YH, 2004, PLANT CELL ENVIRON, V27, P1503, DOI 10.1111/j.1365-3040.2004.01255.x; Zushi K, 2012, SCI HORTIC-AMSTERDAM, V148, P39, DOI 10.1016/j.scienta.2012.09.022	60	36	38	3	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2016	11	4							e0152429	10.1371/journal.pone.0152429	http://dx.doi.org/10.1371/journal.pone.0152429			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0KH	27065102	gold, Green Published, Green Submitted			2022-12-27	WOS:000373891000011
J	Avila-Flores, IJ; Hernandez-Diaz, JC; Gonzalez-Elizondo, MS; Prieto-Ruiz, JA; Wehenkel, C				Jaime Avila-Flores, Israel; Ciro Hernandez-Diaz, Jose; Socorro Gonzalez-Elizondo, Maria; Angel Prieto-Ruiz, Jose; Wehenkel, Christian			Degree of Hybridization in Seed Stands of Pinus engelmannii Carr. In the Sierra Madre Occidental, Durango, Mexico	PLOS ONE			English	Article							FRAGMENT-LENGTH POLYMORPHISMS; AFLP MARKERS; NATURAL HYBRIDIZATION; RETICULATE EVOLUTION; QUERCUS-CRASSIFOLIA; MOLECULAR EVIDENCE; HYBRID SPECIATION; GENETIC DIVERSITY; SIZE HOMOPLASY; ZONE	Hybridization is an important evolutionary force, because interspecific gene transfer can introduce more new genetic material than is directly generated by mutations. Pinus engel-mannii Carr. is one of the nine most common pine species in the pine-oak forest ecoregion in the state of Durango, Mexico. This species is widely harvested for lumber and is also used in reforestation programmes. Interspecific hybrids between P. engelmannii and Pinus arizonica Engelm. have been detected by morphological analysis. The presence of hybrids in P. engelmannii seed stands may affect seed quality and reforestation success. Therefore, the goals of this research were to identify introgressive hybridization between P. engelmannii and other pine species in eight seed stands of this species in Durango, Mexico, and to examine how hybrid proportion is related to mean genetic dissimilarity between trees in these stands, using Amplified Fragment Length Polymorphism (AFLP) markers and morphological traits. Differences in the average current annual increment of putative hybrids and pure trees were also tested for statistical significance. Morphological and genetic analyses of 280 adult trees were carried out. Putative hybrids were found in all the seed stands studied. The hybrids did not differ from the pure trees in vigour or robustness. All stands with putative P. engelmannii hybrids detected by both AFLPs and morphological traits showed the highest average values of the Tanimoto distance, which indicates: i) more heterogeneous genetic material, ii) higher genetic variation and therefore iii) the higher evolutionary potential of these stands, and iv) that the morphological differentiation (hybrid/not hybrid) is strongly associated with the Tanimoto distance per stand. We conclude that natural pairwise hybrids are very common in the studied stands. Both morphological and molecular approaches are necessary to confirm the genetic identity of forest reproductive material.	[Jaime Avila-Flores, Israel] Univ Juarez Estado Durango, Doctorado Inst Ciencias Agr & Forestales, Apdo Postal 741, Durango 34000, Durango, Mexico; [Ciro Hernandez-Diaz, Jose; Wehenkel, Christian] Univ Juarez Estado Durango, Inst Silvicultura & Ind Madera, Apdo Postal 741, Durango 34000, Durango, Mexico; [Socorro Gonzalez-Elizondo, Maria] Inst Politecn Nacl, CIIDIR Unidad Durango, Sigma 119 Fracc,20 Noviembre 2, Durango 34220, Durango, Mexico; [Angel Prieto-Ruiz, Jose] Univ Juarez Estado Durango, Fac Ciencias Forestales, Blvd Durango & Ave,Papaloapan S-N,Col Valle Sur, Durango 34120, Durango, Mexico	Universidad Juarez del Estado de Durango; Universidad Juarez del Estado de Durango; Instituto Politecnico Nacional - Mexico; Universidad Juarez del Estado de Durango	Wehenkel, C (corresponding author), Univ Juarez Estado Durango, Inst Silvicultura & Ind Madera, Apdo Postal 741, Durango 34000, Durango, Mexico.	wehenkel@ujed.mx	Gonzalez-Elizondo, M. Socorro/H-9143-2017	Gonzalez-Elizondo, M. Socorro/0000-0002-4047-154X				Allendorf FW, 2001, TRENDS ECOL EVOL, V16, P613, DOI 10.1016/S0169-5347(01)02290-X; Althoff DM, 2007, SYST BIOL, V56, P477, DOI 10.1080/10635150701427077; Anderson E., 1949, INTROGRESSIVE HYBRID; ARNOLD ML, 1995, TRENDS ECOL EVOL, V10, P67, DOI 10.1016/S0169-5347(00)88979-X; ARNOLD ML, 1997, OXFORD SERIES ECOLOG; BARTON AM, 1993, AM J BOT, V80, P15, DOI 10.2307/2445115; BARTON NH, 1985, ANNU REV ECOL SYST, V16, P113, DOI 10.1146/annurev.es.16.110185.000553; Caballero A, 2008, GENETICS, V179, P539, DOI 10.1534/genetics.107.083246; Chunco AJ, 2014, ECOL EVOL, V4, P2019, DOI 10.1002/ece3.1052; CONKLE MT, 1988, PONDEROSA PINE SPECI, V27, P43; Critchfield W. B., 1984, Madrono, V31, P144; CRITCHFIELD WILLIAM B., 1967, SILVAE GENET, V16, P89; Debreczy Z, 2011, CONIFERS WORLD, V1-2; DEICHSEL G, 1985, CLUSTERANALYSE DISKR; Delgado P, 2007, INT J PLANT SCI, V168, P861, DOI 10.1086/518260; EdwardsBurke MA, 1997, AM J BOT, V84, P879, DOI 10.2307/2446277; EHRENBERG C, 1955, HEREDITAS, V41, P291; Epperson BK, 2009, AM J BOT, V96, P707, DOI 10.3732/ajb.0800005; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Fogelqvist J, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0461-7; Futuyma D. J., 1998, EVOLUTIONARY BIOL; Garcia AA, 2003, PINACEAS DE DURANGO; Garrett Peter W, 1979, SPECIES HYBRIDIZATIO; Gernandt DS, 2009, SYST BOT, V34, P481, DOI 10.1600/036364409789271290; Gernandt DS, 2005, TAXON, V54, P29, DOI 10.2307/25065300; Gomez JM, 2015, BIODIVERS CONSERV, V24, P1843, DOI 10.1007/s10531-015-0909-5; Gompert Z, 2006, SCIENCE, V314, P1923, DOI 10.1126/science.1135875; Gort G, 2012, EUPHYTICA, V183, P389, DOI 10.1007/s10681-011-0368-3; Gregorius HR, 2007, SILVAE GENET, V56, P190, DOI 10.1515/sg-2007-0029; Guo YP, 2005, NEW PHYTOL, V166, P273, DOI 10.1111/j.1469-8137.2005.01315.x; HARRISON RG, 1993, HYBRID ZONES AND THE EVOLUTIONARY PROCESS, P3; HAVEY MJ, 1989, THEOR APPL GENET, V77, P395, DOI 10.1007/BF00305835; Hernandez LS, 2013, PLOS ONE, V8; Kaplan Z, 2007, ANN BOT-LONDON, V99, P1213, DOI 10.1093/aob/mcm072; Koerber GR, 2013, AUST SYST BOT, V26, P156, DOI 10.1071/SB12034; Krauss SL, 2000, MOL ECOL, V9, P1241, DOI 10.1046/j.1365-294x.2000.01001.x; Kuchma O, 2011, MUTAT RES-GEN TOX EN, V725, P29, DOI 10.1016/j.mrgentox.2011.07.003; Simental-Rodriguez SL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111623; Linder CR, 1998, THEOR APPL GENET, V96, P339, DOI 10.1007/s001220050746; Little EL, 1965, BOT DESCRIPTIONS FOR; Liu ZJ, 2003, GENETICS, V165, P687; Mallet J, 2007, NATURE, V446, P279, DOI 10.1038/nature05706; Manly BFJ, 1997, RANDOMIZATION BOOTST; Penaloza-Ramirez JM, 2010, ANN BOT-LONDON, V105, P389, DOI 10.1093/aob/mcp301; MICHELMORE RW, 1987, ANNU REV PHYTOPATHOL, V25, P383, DOI 10.1146/annurev.py.25.090187.002123; Muhlfeld CC, 2014, NAT CLIM CHANGE, V4, P620, DOI [10.1038/NCLIMATE2252, 10.1038/nclimate2252]; O'Hanlon PC, 2000, MOL ECOL, V9, P815, DOI 10.1046/j.1365-294x.2000.00924.x; PELOQUIN RL, 1984, SOUTHWEST NAT, V29, P115, DOI 10.2307/3670776; Peloquin RL, 1971, THESIS U CALIF, P196; Pritchard JK, 2000, GENETICS, V155, P945; Quijada A, 1997, MOL ECOL, V6, P995, DOI 10.1046/j.1365-294X.1997.t01-1-00273.x; REHFELDT GE, 1993, AM J BOT, V80, P330, DOI 10.2307/2445357; Rieseberg LH, 1998, NEW PHYTOL, V140, P599, DOI 10.1046/j.1469-8137.1998.00315.x; Rieseberg LH, 1997, ANNU REV ECOL SYST, V28, P359, DOI 10.1146/annurev.ecolsys.28.1.359; Roe AD, 2014, ECOL EVOL, V4, P1629, DOI 10.1002/ece3.1029; SanCristobal M, 2006, ANIM GENET, V37, P232, DOI 10.1111/j.1365-2052.2006.01440.x; Shasany AK, 2005, J HERED, V96, P542, DOI 10.1093/jhered/esi091; Silva-Flores R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105034; Skrede I, 2012, FUNGAL BIOL-UK, V116, P778, DOI 10.1016/j.funbio.2012.04.009; Gonzalez-Elizondo MS, 2012, ACTA BOT MEX, V101, P49; Gonzalez-Elizondo MS, 2012, ACTA BOT MEX, V100, P351, DOI 10.21829/abm100.2012.40; Gonzalez-Elizondo MS, 2012, ACTA BOT MEX, V99, P55, DOI 10.21829/abm99.2012.19; Stuber C.W., 1992, PLANT BREED REV, V9, P37; Styles B. T., 1993, Biological diversity of Mexico: origins and distribution., P397; Tovar-Sanchez E, 2006, OECOLOGIA, V147, P702, DOI 10.1007/s00442-005-0328-5; Tovar-Sanchez E, 2004, AM J BOT, V91, P1352, DOI 10.3732/ajb.91.9.1352; Ungerer MC, 1998, P NATL ACAD SCI USA, V95, P11757, DOI 10.1073/pnas.95.20.11757; Vargas-Mendoza CF, 2011, PHYLOGENETIC ANAL ME; Vekemans X, 2004, MOL ECOL, V13, P921, DOI 10.1046/j.1365-294X.2004.02076.x; Villa-Salas AB, 1980, IUFRO MAB C RES MULT, P20; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Vuylsteke M, 1999, THEOR APPL GENET, V99, P921, DOI 10.1007/s001220051399; Wehenkel C., 2015, Forstarchiv, V86, P194; WENDEL JF, 1991, EVOLUTION, V45, P694, DOI 10.1111/j.1558-5646.1991.tb04339.x; Willyard A, 2009, MOL PHYLOGENET EVOL, V52, P498, DOI 10.1016/j.ympev.2009.02.011; Xu SQ, 2008, TREE GENET GENOMES, V4, P849, DOI 10.1007/s11295-008-0157-x; Zhou RC, 2005, MOL PHYLOGENET EVOL, V35, P595, DOI 10.1016/j.ympev.2005.03.012	77	17	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2016	11	4							e0152651	10.1371/journal.pone.0152651	http://dx.doi.org/10.1371/journal.pone.0152651			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0KH	27064490	Green Published, gold, Green Submitted			2022-12-27	WOS:000373891000015
J	Sung, HY; Choi, BO; Jeong, JH; Kong, KA; Hwang, J; Ahn, JH				Sung, Hye Youn; Choi, Byung-Ok; Jeong, Jee Hyang; Kong, Kyoung Ae; Hwang, Jinha; Ahn, Jung-Hyuck			Amyloid Beta-Mediated Hypomethylation of Heme Oxygenase 1 Correlates with Cognitive Impairment in Alzheimer's Disease	PLOS ONE			English	Article							DNA METHYLATION STATUS; PRECURSOR PROTEIN; GENE-EXPRESSION; CSF BIOMARKERS; DIAGNOSIS; BRAIN; ASTROGLIA; CANCER; TIME; TOOL	To identify epigenetically regulated genes involved in the pathogenesis of Alzheimer's disease (AD) we analyzed global mRNA expression and methylation profiles in amyloid precursor protein (APP)-Swedish mutant-expressing AD model cells, H4-sw and selected heme oxygenase-1 (HMOX1), which is associated with pathological features of AD such as neurofibrillary tangles and senile plaques. We examined the epigenetic regulatory mechanism of HMOX1 and its application as a diagnostic and prognostic biomarker for AD. Our results show that HMOX1 mRNA and protein expression was approximately 12.2-fold and 7.9-fold increased in H4-sw cells, respectively. Increased HMOX1 expression was also detected in the brain, particularly the hippocampus, of AD model transgenic mice. However, the methylation of specific CpG sites within its promoter, particularly at CpG located -374 was significantly decreased in H4-sw cells. Treatment of neuroglioma cells with the demethylating agent 5-aza-20-deoxycytidine resulted in reduced methylation of HMOX1 promoter accompanied by enhanced HMOX1 expression strongly supporting DNA methylation-dependent transcriptional regulation of HMOX1. Toxic A beta-induced aberrant hypomethylation of HMOX1 at -374 promoter CpG site was correlated with increased HMOX1 expression. In addition to neuroglioma cells, we also found A beta-induced epigenetic regulation of HMOX1 in human T lymphocyte Jurkat cells. We evaluated DNA methylation status of HMOX1 at -374 promoter CpG site in blood samples from AD patients, patients with mild cognitive impairment (MCI), and control individuals using quantitative methylation-specific polymerase chain reaction. We observed lower methylation of HMOX1 at the -374 promoter CpG site in AD patients compared to MCI and control individuals, and a correlation between Mini-Mental State Examination score and demethylation level. Receiver operating characteristics analysis revealed good discrimination of AD patients from MCI patients and control individuals. Our findings suggest that the methylation status of HMOX1 at a specific promoter CpG site is related to AD progression.	[Sung, Hye Youn; Ahn, Jung-Hyuck] Ewha Womans Univ, Sch Med, Dept Biochem, Seoul, South Korea; [Choi, Byung-Ok] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurol, Seoul, South Korea; [Jeong, Jee Hyang] Ewha Womans Univ, Mokdong Hosp, Dept Neurol, Seoul, South Korea; [Kong, Kyoung Ae] Ewha Womans Univ, Med Ctr, Clin Trial Ctr, Seoul, South Korea; [Hwang, Jinha] Seoul Natl Univ, Grad Sch, Dept Biomed Sci, Seoul, South Korea; [Ahn, Jung-Hyuck] Ewha Womans Univ, Sch Med, Tissue Injury Def Res Ctr, Dept Biochem, Seoul, South Korea	Ewha Womans University; Sungkyunkwan University (SKKU); Samsung Medical Center; Ewha Womans University; Ewha Womans University; Seoul National University (SNU); Ewha Womans University	Ahn, JH (corresponding author), Ewha Womans Univ, Sch Med, Dept Biochem, Seoul, South Korea.; Ahn, JH (corresponding author), Ewha Womans Univ, Sch Med, Tissue Injury Def Res Ctr, Dept Biochem, Seoul, South Korea.	ahnj@ewha.ac.kr		Ahn, Jung-Hyuck/0000-0001-9589-3881	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [NRF-2013R1A1A2060213, NRF-2012R1A1A2004214, NRF-2015R1A2A2A01003997]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [2010-0027945]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (NRF-2013R1A1A2060213, NRF-2012R1A1A2004214 and NRF-2015R1A2A2A01003997), and this research was also supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (2010-0027945). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn HJ, 2010, J KOREAN MED SCI, V25, P1071, DOI 10.3346/jkms.2010.25.7.1071; Barone E, 2014, NEUROBIOL DIS, V62, P144, DOI 10.1016/j.nbd.2013.09.018; Bock C, 2009, EPIGENOMICS-UK, V1, P99, DOI 10.2217/EPI.09.6; Calabrese V, 2007, NEUROCHEM RES, V32, P757, DOI 10.1007/s11064-006-9203-y; Chae SS, 2010, J NEUROSCI RES, V88, P1926, DOI 10.1002/jnr.22356; Chen K, 2000, J NEUROCHEM, V75, P304, DOI 10.1046/j.1471-4159.2000.0750304.x; Chen UL, 2009, BIOCHEM BIOPH RES CO, V378, P57, DOI 10.1016/j.bbrc.2008.10.173; Chopra K, 2011, EXPERT OPIN THER TAR, V15, P535, DOI 10.1517/14728222.2011.557363; Chouliaras L, 2010, PROG NEUROBIOL, V90, P498, DOI 10.1016/j.pneurobio.2010.01.002; Frankel D, 2000, J CELL PHYSIOL, V185, P80, DOI 10.1002/1097-4652(200010)185:1<80::AID-JCP7>3.0.CO;2-W; Fuso A, 2005, MOL CELL NEUROSCI, V28, P195, DOI 10.1016/j.mcn.2004.09.007; Hansson O, 2006, LANCET NEUROL, V5, P228, DOI 10.1016/S1474-4422(06)70355-6; Humpel C, 2011, TRENDS BIOTECHNOL, V29, P26, DOI 10.1016/j.tibtech.2010.09.007; Irizarry Michael C, 2004, NeuroRx, V1, P226; Jack CR, 2008, J MAGN RESON IMAGING, V27, P685, DOI 10.1002/jmri.21049; Kang Y., 1997, J KOREAN NEUROL ASS, V15, P300; Kennedy BP, 2004, J NEURAL TRANSM, V111, P547, DOI 10.1007/s00702-003-0096-5; Le W, 1999, J NEUROSCI RES, V56, P652; Lee J, 2010, BMB REP, V43, P649, DOI 10.5483/BMBRep.2010.43.10.649; Lopez OL, 2013, J ALZHEIMERS DIS, V33, pS427, DOI 10.3233/JAD-2012-129015; Mattsson N, 2009, JAMA-J AM MED ASSOC, V302, P385, DOI 10.1001/jama.2009.1064; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Mulero-Navarro S, 2008, CRIT REV ONCOL HEMAT, V68, P1, DOI 10.1016/j.critrevonc.2008.03.001; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Ray S, 2007, NAT MED, V13, P1359, DOI 10.1038/nm1653; Ryter SW, 2000, FREE RADICAL BIO MED, V28, P289, DOI 10.1016/S0891-5849(99)00223-3; Schipper HM, 2006, NEUROBIOL AGING, V27, P252, DOI 10.1016/j.neurobiolaging.2005.01.016; SCHIPPER HM, 1995, ANN NEUROL, V37, P758, DOI 10.1002/ana.410370609; Schipper HM, 2009, J NEUROCHEM, V110, P469, DOI 10.1111/j.1471-4159.2009.06160.x; Shaw LM, 2009, ANN NEUROL, V65, P403, DOI 10.1002/ana.21610; Shin J-Y, BMB REP, V43, P704; Shin J, 2010, BMB REP, V43, P704, DOI [10.3858/BMBRep.2010.43.10.704, 10.5483/BMBRep.2010.43.10.704]; SMITH MA, 1994, AM J PATHOL, V145, P42; Song W, 2006, J CELL PHYSIOL, V206, P655, DOI 10.1002/jcp.20509; Sung HY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099047; Sung HY, 2011, BIOCHEM BIOPH RES CO, V414, P700, DOI 10.1016/j.bbrc.2011.09.136; TANAKA J, 1989, ACTA NEUROL SCAND, V80, P554, DOI 10.1111/j.1600-0404.1989.tb03926.x; Tsai HC, 2011, CELL RES, V21, P502, DOI 10.1038/cr.2011.24; Wang DY, 2015, J ALZHEIMERS DIS, V43, P519, DOI 10.3233/JAD-140567; West RL, 1995, J MOL NEUROSCI, V6, P141, DOI 10.1007/BF02736773; Yu UY, 2014, KOREAN J PHYSIOL PHA, V18, P155, DOI 10.4196/kjpp.2014.18.2.155; Yun SM, 2013, NEUROBIOL AGING, V34, P650, DOI 10.1016/j.neurobiolaging.2012.08.005; Zhou L, 2012, BIOCHEM BIOPH RES CO, V423, P697, DOI 10.1016/j.bbrc.2012.06.017; Zukor H, 2009, J NEUROCHEM, V109, P776, DOI 10.1111/j.1471-4159.2009.06007.x	44	16	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2016	11	4							e0153156	10.1371/journal.pone.0153156	http://dx.doi.org/10.1371/journal.pone.0153156			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6JK	27058954	Green Published, Green Submitted, gold			2022-12-27	WOS:000373604800018
J	DiSilvestro, DJ; Melgar-Bermudez, E; Yasmeen, R; Fadda, P; Lee, LJ; Kalyanasundaram, A; Gilor, CL; Ziouzenkova, O				DiSilvestro, David J.; Melgar-Bermudez, Emiliano; Yasmeen, Rumana; Fadda, Paolo; Lee, L. James; Kalyanasundaram, Anuradha; Gilor, Chen L.; Ziouzenkova, Ouliana			Leptin Production by Encapsulated Adipocytes Increases Brown Fat, Decreases Resistin, and Improves Glucose Intolerance in Obese Mice	PLOS ONE			English	Article							VENTROMEDIAL HYPOTHALAMUS; PERIPHERAL-TISSUES; 3T3-L1 ADIPOCYTES; GENE-PRODUCT; BODY-WEIGHT; OB/OB MICE; OB RNA; INSULIN; SECRETION; THERAPY	The neuroendocrine effects of leptin on metabolism hold promise to be translated into a complementary therapy to traditional insulin therapy for diabetes and obesity. However, injections of leptin can provoke inflammation. We tested the effects of leptin, produced in the physiological adipocyte location, on metabolism in mouse models of genetic and dietary obesity. We generated 3T3-L1 adipocytes constitutively secreting leptin and encapsulated them in a poly-L-lysine membrane, which protects the cells from immune rejection. Ob/ob mice (OB) were injected with capsules containing no cells (empty, OB[Emp]), adipocytes (OB[3T3]), or adipocytes overexpressing leptin (OB[Lep]) into both visceral fat depots. Leptin was found in the plasma of OB[Lep], but not OB[Emp] and OB[3T3] mice at the end of treatment (72 days). The OB[Lep] and OB[3T3] mice have transiently suppressed appetite and weight loss compared to OB[Emp]. Only OB[Lep] mice have greater brown fat mass, metabolic rate, and reduced resistin plasma levels compared to OB[Emp]. Glucose tolerance was markedly better in OB[Lep] vs. OB[Emp] and OB[3T3] mice as well as in wild type mice with high-fat diet-induced obesity and insulin resistance treated with encapsulated leptin-producing adipocytes. Our proof-of-principle study provides evidence of long-term improvement of glucose tolerance with encapsulated adipocytes producing leptin.	[DiSilvestro, David J.; Melgar-Bermudez, Emiliano; Yasmeen, Rumana; Ziouzenkova, Ouliana] Ohio State Univ, Dept Human Sci, Columbus, OH 43210 USA; [Fadda, Paolo] Ohio State Univ, Ctr Comprehens Canc, Genom Shared Resource, Columbus, OH 43210 USA; [Lee, L. James] Ohio State Univ, NSF Nanoscale Sci & Engn Ctr Affordable Nanoengn, Columbus, OH 43210 USA; [Kalyanasundaram, Anuradha] Ohio State Univ, Davis Heart & Lung Res Inst, Dept Physiol & Cell Biol, Columbus, OH 43210 USA; [Gilor, Chen L.] Ohio State Univ, Vet Clin Sci, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; National Science Foundation (NSF); University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Ziouzenkova, O (corresponding author), Ohio State Univ, Dept Human Sci, Columbus, OH 43210 USA.	ziouzenkova.1@osu.edu	Ziouzenkova, Ouliana/B-3690-2012; Ziouzenkova, Ouliana/AAM-1971-2020	Ziouzenkova, Ouliana/0000-0003-2449-2591; 	American Egg Board [20020728]; Novo Nordisk Pharmaceuticals [10040042]; Food Innovation Center; National Center for Research Resources [R21OD017244, UL1TR001070, UL1RR025755, NCI P30CA16058]; Office of the Director (OD), National Institutes of Health; NIH Roadmap for Medical Research; National Center For Advancing Translational Sciences [UL1TR001070]; NATIONAL CANCER INSTITUTE [P30CA016058] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001070] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025755] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R21OD017244] Funding Source: NIH RePORTER	American Egg Board; Novo Nordisk Pharmaceuticals(Novo Nordisk); Food Innovation Center; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Office of the Director (OD), National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center For Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by Award Number 20020728 from American Egg Board and Award Number 10040042 from Novo Nordisk Pharmaceuticals as well as by the Food Innovation Center. The project described was supported by Award Number R21OD017244 (O.Z.), UL1TR001070 (CCTS), UL1RR025755 and NCI P30CA16058 (OSUCCC) from the National Center for Research Resources, funded by the Office of the Director (OD), National Institutes of Health and supported by the NIH Roadmap for Medical Research. The project described was also supported by Award Number Grant UL1TR001070 from the National Center For Advancing Translational Sciences. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center for Research Resources or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldo BA, 2014, DRUG SAFETY, V37, P921, DOI 10.1007/s40264-014-0226-z; BATCHELOR BR, 1975, METABOLISM, V24, P77, DOI 10.1016/0026-0495(75)90009-8; Bence KK, 2006, NAT MED, V12, P917, DOI 10.1038/nm1435; Bernotiene E, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2004; Costa A, 1997, NEUROREPORT, V8, P1131, DOI 10.1097/00001756-199703240-00014; Dodd GT, 2015, CELL, V160, P88, DOI 10.1016/j.cell.2014.12.022; Elliott RB, 2007, XENOTRANSPLANTATION, V14, P157, DOI 10.1111/j.1399-3089.2007.00384.x; Fantuzzi G, 2000, J LEUKOCYTE BIOL, V68, P437; Farooqi IS, 2002, J CLIN INVEST, V110, P1093, DOI 10.1172/JCI200215693; Fujikawa T, 2013, CELL METAB, V18, P431, DOI 10.1016/j.cmet.2013.08.004; Gibson WT, 2004, J CLIN ENDOCR METAB, V89, P4821, DOI 10.1210/jc.2004-0376; Ginter E, 2013, ADV EXP MED BIOL, V771, P42; Glaum SR, 1996, MOL PHARMACOL, V50, P230; Gonzalez M, 2013, ATHEROSCLEROSIS, V228, P485, DOI 10.1016/j.atherosclerosis.2013.03.018; Haque MS, 1999, DIABETES, V48, P1706, DOI 10.2337/diabetes.48.9.1706; Harris RBS, 1998, ENDOCRINOLOGY, V139, P8, DOI 10.1210/en.139.1.8; Herrero L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122570; INGALLS AM, 1950, J HERED, V41, P317, DOI 10.1093/oxfordjournals.jhered.a106073; Khan A, 2001, INT J OBESITY, V25, P816, DOI 10.1038/sj.ijo.0801628; Klebanov S, 2005, J ENDOCRINOL, V186, P203, DOI 10.1677/joe.1.06150; Kshatriya S, 2010, CURR OPIN NEPHROL HY, V19, P72, DOI 10.1097/MNH.0b013e328332fb49; Liu XM, 2015, ENDOCRINOLOGY, V156, P2461, DOI 10.1210/en.2014-1598; MAFFEI M, 1995, P NATL ACAD SCI USA, V92, P6957, DOI 10.1073/pnas.92.15.6957; MAFFEI M, 1995, NAT MED, V1, P1155, DOI 10.1038/nm1195-1155; Minokoshi Y, 1999, DIABETES, V48, P287, DOI 10.2337/diabetes.48.2.287; Mistry AM, 1997, J NUTR, V127, P2065; Morsy MA, 1998, GENE THER, V5, P8, DOI 10.1038/sj.gt.3300565; Muzzin P, 1996, P NATL ACAD SCI USA, V93, P14804, DOI 10.1073/pnas.93.25.14804; Norman D, 2003, MOL CELL ENDOCRINOL, V200, P99, DOI 10.1016/S0303-7207(02)00410-0; Ogden CL, 2012, NCHS DATA BRIEF; Oosman SN, 2008, MOL THER, V16, P1138, DOI 10.1038/mt.2008.62; Oral EA, 2002, NEW ENGL J MED, V346, P570, DOI 10.1056/NEJMoa012437; Orchard TJ, 2003, DIABETES CARE, V26, P1374, DOI 10.2337/diacare.26.5.1374; Pollock KE, 2015, ENDOCRINOLOGY, V156, P3777, DOI 10.1210/en.2015-1247; Qi Y, 2006, DIABETES, V55, P3083, DOI 10.2337/db05-0615; Satoh N, 1999, DIABETES, V48, P1787, DOI 10.2337/diabetes.48.9.1787; Soedling H, 2015, MOL METAB, V4, P619, DOI 10.1016/j.molmet.2015.06.007; STEPHENS TW, 1995, NATURE, V377, P530, DOI 10.1038/377530a0; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; SURWIT RS, 1985, PSYCHOSOM MED, V47, P565, DOI 10.1097/00006842-198511000-00006; Turner RT, 2015, J ENDOCRINOL, V227, P129, DOI 10.1530/JOE-15-0280; Unger RH, 2015, CELL METAB, V21, P15, DOI 10.1016/j.cmet.2014.10.011; Wang YH, 2006, J NUTR, V136, P2953, DOI 10.1093/jn/136.12.2953; Woods AJ, 1996, NATURE, V381, P745, DOI 10.1038/381745a0; Xu L, 2015, JOVE-J VIS EXP, DOI 10.3791/52806; Yang FP, 2012, BIOMATERIALS, V33, P5638, DOI 10.1016/j.biomaterials.2012.04.035; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Yasmeen R, 2013, DIABETES, V62, P124, DOI 10.2337/db11-1779; Ye F, 2010, J ENDOCRINOL, V206, P27, DOI 10.1677/JOE-10-0090; Yu X, 2008, P NATL ACAD SCI USA, V105, P14070, DOI 10.1073/pnas.0806993105; Zeigerer A, 2008, EXP CELL RES, V314, P2249, DOI 10.1016/j.yexcr.2008.04.003; Zeng WW, 2015, CELL, V163, P84, DOI 10.1016/j.cell.2015.08.055; Zhang XL, 2008, BIOMATERIALS, V29, P4253, DOI 10.1016/j.biomaterials.2008.07.032	53	13	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153198	10.1371/journal.pone.0153198	http://dx.doi.org/10.1371/journal.pone.0153198			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27055280	gold, Green Published, Green Submitted			2022-12-27	WOS:000373608000098
J	Atukunda, EC; Mugyenyi, GR; Obua, C; Atuhumuza, EB; Musinguzi, N; Tornes, YF; Agaba, AG; Siedner, MJ				Atukunda, Esther Cathyln; Mugyenyi, Godfrey Rwambuka; Obua, Celestino; Atuhumuza, Elly Bronney; Musinguzi, Nicholas; Tornes, Yarine Fajardo; Agaba, Amon Ganaafa; Siedner, Mark Jacob			Measuring Post-Partum Haemorrhage in Low-Resource Settings: The Diagnostic Validity of Weighed Blood Loss versus Quantitative Changes in Hemoglobin	PLOS ONE			English	Article							SUBLINGUAL MISOPROSTOL; VISUAL ESTIMATION; TRIAL; DELIVERY	Background Accurate estimation of blood loss is central to prompt diagnosis and management of postpartum hemorrhage (PPH), which remains a leading cause of maternal mortality in low-resource countries. In such settings, blood loss is often estimated visually and subjectively by attending health workers, due to inconsistent availability of laboratory infrastructure. We evaluated the diagnostic accuracy of weighed blood loss (WBL) versus changes in peri-partum hemoglobin to detect PPH. Methods Data from this analysis were collected as part of a randomized controlled trial comparing oxytocin with misoprostol for PPH (NCT01866241). Blood samples for complete blood count were drawn on admission and again prior to hospital discharge or before blood transfusion. During delivery, women were placed on drapes and had pre-weighed sanitary towels placed around their perineum. Blood was then drained into a calibrated container and the sanitary towels were added to estimate WBL, where each gram of blood was estimated as a milliliter. Sensitivity, specificity, negative and positive predictive values (PPVs) were calculated at various blood volume loss and time combinations, and we fit receiver-operator curves using blood loss at 1, 2, and 24 hours compared to a reference standard of haemoglobin decrease of >10%. Results A total of 1,140 women were enrolled in the study, of whom 258 (22.6%) developed PPH, defined as a haemoglobin drop >10%, and 262 (23.0%) had WBL >= 500mL. WBL generally had a poor sensitivity for detection of PPH (<75% for most volume-time combinations). In contrast, the specificity of WBL was high with blood loss >= 500mL at 1h and >= 750mL at any time points excluding PPH in over 97% of women. As such, WBL has a high PPV (>85%) in high prevalence settings when WBL exceeds 750mL. Conclusion WBL has poor sensitivity but high specificity compared to laboratory-based methods of PPH diagnosis. These characteristics correspond to a high PPV in areas with high PPH prevalence. Although WBL is not useful for excluding PPH, this low-cost, simple and reproducible method is promising as a reasonable method to identify significant PPH in such settings where quantifiable red cell indices are unavailable.	[Atukunda, Esther Cathyln; Mugyenyi, Godfrey Rwambuka; Obua, Celestino; Atuhumuza, Elly Bronney; Musinguzi, Nicholas; Tornes, Yarine Fajardo; Agaba, Amon Ganaafa] Mbarara Univ Sci & Technol, Mbarara, Uganda; [Siedner, Mark Jacob] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Siedner, Mark Jacob] Massachusetts Gen Hosp, Ctr Global Hlth, Boston, MA 02114 USA; [Siedner, Mark Jacob] Harvard Univ, Sch Med, Boston, MA USA	Mbarara University of Science & Technology; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Atukunda, EC (corresponding author), Mbarara Univ Sci & Technol, Mbarara, Uganda.	estheratukunda@gmail.com		Obua, Celestino/0000-0001-6949-3059	Father Bash Foundation; Divine Mercy Hospital scholarship [FBF PS1981]; National Institutes of Health [MH K23099916]; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH099916] Funding Source: NIH RePORTER	Father Bash Foundation; Divine Mercy Hospital scholarship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was funded by the Father Bash Foundation and Divine Mercy Hospital scholarship awards to ECA (FBF PS1981). MJS receives support from the National Institutes of Health (MH K23099916). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Kadri HMF, 2011, ARCH GYNECOL OBSTET, V283, P1207, DOI 10.1007/s00404-010-1522-1; Ambardekar S, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-276; Atukunda EC, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001752; Bellad MB, 2012, BJOG-INT J OBSTET GY, V119, P975, DOI 10.1111/j.1471-0528.2012.03341.x; Bellad MB., 2009, J SAFOG, V1, P29; Chua S, 1998, GYNECOL OBSTET INVES, V46, P31, DOI 10.1159/000009992; Comeau P J, 1983, AANA J, V51, P81; Crowe S, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-4; DUTHIE SJ, 1991, EUR J OBSTET GYN R B, V38, P119, DOI 10.1016/0028-2243(91)90188-Q; Flordal PA, 1997, EUR J ANAESTH, V14, P35, DOI 10.1097/00003643-199703001-00007; Gulmezoglu AM, 2001, LANCET, V358, P689, DOI 10.1016/S0140-6736(01)05835-4; Hoj L, 2005, BMJ-BRIT MED J, V331, P723, DOI 10.1136/bmj.331.7519.723; JOHAR RS, 1993, J GYNECOL SURG, V9, P151, DOI 10.1089/gyn.1993.9.151; Lee MH, 2006, VET SURG, V35, P388, DOI 10.1111/j.1532-950X.2006.00162.x; Lynch CB, 2006, TXB POSTPARTUM HEMOR; Maslovitz S, 2008, ACTA OBSTET GYN SCAN, V87, P929, DOI 10.1080/00016340802317794; NELSON GH, 1981, SOUTHERN MED J, V74, P550, DOI 10.1097/00007611-198105000-00011; Patel A, 2006, INT J GYNECOL OBSTET, V93, P220, DOI 10.1016/j.ijgo.2006.02.014; PATH, 2013, BLOOD LOSS MEAS; Schorn MN, 2010, J MIDWIFERY WOM HEAL, V55, P20, DOI 10.1016/j.jmwh.2009.02.014; Stewart CL, 2014, J TRAUMA ACUTE CARE, V77, P892, DOI 10.1097/TA.0000000000000423; Tourne G, 2004, J Gynecol Obstet Biol Reprod (Paris), V33, P229; World Health Organization WHO, 2012, RECOMMENDATIONS PREV	23	13	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0152408	10.1371/journal.pone.0152408	http://dx.doi.org/10.1371/journal.pone.0152408			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050823	Green Published, gold			2022-12-27	WOS:000373603500039
J	Cronlein, T; Langguth, B; Eichhammer, P; Busch, V				Croenlein, Tatjana; Langguth, Berthold; Eichhammer, Peter; Busch, Volker			Impaired Recognition of Facially Expressed Emotions in Different Groups of Patients with Sleep Disorders	PLOS ONE			English	Article							PSYCHIATRIC-DISORDERS; DEPRESSIVE SYMPTOMS; GENERAL-POPULATION; DAYTIME SLEEPINESS; APNEA; DEPRIVATION; INSOMNIA; STIMULI; DISTURBANCES; THERAPY	Introduction Recently it has been shown that acute sleep loss has a direct impact on emotional processing in healthy individuals. Here we studied the effect of chronically disturbed sleep on emotional processing by investigating two samples of patients with sleep disorders. Methods 25 patients with psychophysiologic insomnia (23 women and 2 men, mean age: 51.6 SD; 10.9 years), 19 patients with sleep apnea syndrome (4 women and 15 men, mean age: 51.9; SD 11.1) and a control sample of 24 subjects with normal sleep (15 women and 9 men, mean age 45.3; SD 8.8) completed a Facial Expressed Emotion Labelling (FEEL) task, requiring participants to categorize and rate the intensity of six emotional expression categories: anger, anxiety, fear, happiness, disgust and sadness. Differences in FEEL score and its subscales among the three samples were analysed using ANOVA with gender as a covariate. Results Both patients with psychophysiologic insomnia and patients with sleep apnea showed significantly lower performance in the FEEL test as compared to the control group. Differences were seen in the scales happiness and sadness. Patient groups did not differ from each other. Conclusion By demonstrating that previously known effects of acute sleep deprivation on emotional processing can be extended to persons experiencing chronically disturbed sleep, our data contribute to a deeper understanding of the relationship between sleep loss and emotions.	[Croenlein, Tatjana; Langguth, Berthold; Eichhammer, Peter] Univ Regensburg, Dept Psychiat & Psychotherapy, D-93053 Regensburg, Germany	University of Regensburg	Cronlein, T (corresponding author), Univ Regensburg, Dept Psychiat & Psychotherapy, D-93053 Regensburg, Germany.	tatjana.croenlein@medbo.de	Langguth, Berthold/AAP-2638-2021					American Academy of Sleep Medicine, 2005, DIAGN COD MAN ICSD 2, V2nd ed.; Anderson C, 2011, BEHAV BRAIN RES, V217, P463, DOI 10.1016/j.bbr.2010.09.020; Baglioni C, 2014, SLEEP, V37, P1907, DOI 10.5665/sleep.4240; Baglioni C, 2010, SLEEP MED REV, V14, P227, DOI 10.1016/j.smrv.2009.10.007; Beattie L, 2015, SLEEP MED REV, V24, P83, DOI 10.1016/j.smrv.2014.12.005; Buysse Daniel J, 2011, Drug Discov Today Dis Models, V8, P129; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Cronlein T, 2014, PSYCHOTHER PSYCHOSOM, V83, P255, DOI 10.1159/000360706; Dahl R E, 1996, Semin Pediatr Neurol, V3, P44, DOI 10.1016/S1071-9091(96)80028-3; Di Giannantonio M, 2012, EUR NEUROPSYCHOPHARM, V22, pS505, DOI 10.1016/j.euroneuro.2012.07.004; FORD DE, 1989, JAMA-J AM MED ASSOC, V262, P1479, DOI 10.1001/jama.262.11.1479; Franzen PL, 2009, BIOL PSYCHOL, V80, P300, DOI 10.1016/j.biopsycho.2008.10.010; Genzel L, 2015, NEUROBIOL LEARN MEM, V122, P110, DOI 10.1016/j.nlm.2015.01.008; Goel N, 2009, SEMIN NEUROL, V29, P320, DOI 10.1055/s-0029-1237117; Habukawa M, 2010, SLEEP MED, V11, P552, DOI 10.1016/j.sleep.2010.02.007; Sanchez AI, 2009, SLEEP MED REV, V13, P223, DOI 10.1016/j.smrv.2008.07.002; Ishman SL, 2010, LARYNGOSCOPE, V120, P2331, DOI 10.1002/lary.21111; Kessler H, 2006, INT J EAT DISORDER, V39, P245, DOI 10.1002/eat.20228; Kessler H, 2002, VERHALTENSTHERAPIE V, V23, P297; Kret ME, 2015, NEUROSCI BIOBEHAV R, V52, P153, DOI 10.1016/j.neubiorev.2015.02.011; Kyle SD, 2014, SLEEP, V37, P775, DOI 10.5665/sleep.3588; Ma N, 2015, SLEEP, V38, P233, DOI 10.5665/sleep.4404; Martinotti G, 2012, J CLIN PSYCHOPHARM, V32, P487, DOI 10.1097/JCP.0b013e31825d6c25; Nofzinger EA, 2004, AM J PSYCHIAT, V161, P2126, DOI 10.1176/appi.ajp.161.11.2126; Ohayon MM, 2010, J PSYCHOSOM RES, V69, P565, DOI 10.1016/j.jpsychores.2010.03.010; Ohayon MM, 2003, J CLIN PSYCHIAT, V64, P1195, DOI 10.4088/JCP.v64n1009; Palagini L, 2013, SLEEP MED REV, V17, P377, DOI 10.1016/j.smrv.2012.11.001; Pallesen S, 2004, PERCEPT MOTOR SKILL, V98, P1305, DOI 10.2466/PMS.98.3.1305-1314; Riemann D, 2009, DRUGS, V69, P43, DOI 10.2165/11531130-000000000-00000; Rosales-Lagarde A, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00025; Schwartz DJ, 2005, J CLIN SLEEP MED, V1, P35; Sharafkhaneh A, 2005, SLEEP, V28, P1405, DOI 10.1093/sleep/28.11.1405; Tempesta D, 2010, BRAIN RES BULL, V82, P104, DOI 10.1016/j.brainresbull.2010.01.014; van der Helm E, 2011, CURR BIOL, V21, P2029, DOI 10.1016/j.cub.2011.10.052; van der Helm E, 2010, SLEEP, V33, P335, DOI 10.1093/sleep/33.3.335; Walker MP, 2009, PSYCHOL BULL, V135, P731, DOI 10.1037/a0016570; Yoo SS, 2007, CURR BIOL, V17, pR877, DOI 10.1016/j.cub.2007.08.007; Zohar D, 2005, SLEEP, V28, P47, DOI 10.1093/sleep/28.1.47	38	19	20	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0152754	10.1371/journal.pone.0152754	http://dx.doi.org/10.1371/journal.pone.0152754			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ3UC	27073852	Green Published, Green Submitted, gold			2022-12-27	WOS:000374131200035
J	Li, Z; Liu, Y; Wei, QQ; Liu, YJ; Liu, WW; Zhang, XL; Yu, YD				Li, Zhao; Liu, Yong; Wei, Qingquan; Liu, Yuanjie; Liu, Wenwen; Zhang, Xuelian; Yu, Yude			Picoliter Well Array Chip-Based Digital Recombinase Polymerase Amplification for Absolute Quantification of Nucleic Acids	PLOS ONE			English	Article							MEDIATED ISOTHERMAL AMPLIFICATION; REAL-TIME; DNA AMPLIFICATION; DROPLET FORMATION; CHAIN-REACTION; PCR; EMULSIFICATION; DEVICES; PLASMA	Absolute, precise quantification methods expand the scope of nucleic acids research and have many practical applications. Digital polymerase chain reaction (dPCR) is a powerful method for nucleic acid detection and absolute quantification. However, it requires thermal cycling and accurate temperature control, which are difficult in resource-limited conditions. Accordingly, isothermal methods, such as recombinase polymerase amplification (RPA), are more attractive. We developed a picoliter well array (PWA) chip with 27,000 consistently sized picoliter reactions (314 pL) for isothermal DNA quantification using digital RPA (dRPA) at 39 degrees C. Sample loading using a scraping liquid blade was simple, fast, and required small reagent volumes (i.e., < 20 mu L). Passivating the chip surface using a methoxy-PEG-silane agent effectively eliminated cross-contamination during dRPA. Our creative optical design enabled wide-field fluorescence imaging in situ and both end-point and real-time analyses of picoliter wells in a 6-cm(2) area. It was not necessary to use scan shooting and stitch serial small images together. Using this method, we quantified serial dilutions of a Listeria monocytogenes gDNA stock solution from 9 x 10(-1) to 4 x 10(-3) copies per well with an average error of less than 11% (N = 15). Overall dRPA-on-chip processing required less than 30 min, which was a 4-fold decrease compared to dPCR, requiring approximately 2 h. dRPA on the PWA chip provides a simple and highly sensitive method to quantify nucleic acids without thermal cycling or precise micropump/microvalve control. It has applications in fast field analysis and critical clinical diagnostics under resource-limited settings.	[Li, Zhao; Liu, Yong; Wei, Qingquan; Liu, Yuanjie; Liu, Wenwen; Zhang, Xuelian; Yu, Yude] Chinese Acad Sci, State Key Lab Integrated Optoelect, Inst Semicond, POB 912, Beijing 100083, Peoples R China; [Yu, Yude] Chinese Acad Sci, Joint Lab Bioinformat Acquisit & Sensing Technol, Inst Semicond, Beijing Inst Genom, POB 912, Beijing 100083, Peoples R China	Chinese Academy of Sciences; Institute of Semiconductors, CAS; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Institute of Semiconductors, CAS	Yu, YD (corresponding author), Chinese Acad Sci, State Key Lab Integrated Optoelect, Inst Semicond, POB 912, Beijing 100083, Peoples R China.; Yu, YD (corresponding author), Chinese Acad Sci, Joint Lab Bioinformat Acquisit & Sensing Technol, Inst Semicond, Beijing Inst Genom, POB 912, Beijing 100083, Peoples R China.	yudeyu@semi.ac.cn	Liu, Yuanjie/AFO-5688-2022	Liu, Yuanjie/0000-0002-3041-893X	Instrument Developing Project of the Chinese Academy of Sciences [YZ201301]; State Key Program of National Natural Science of China [61334008]	Instrument Developing Project of the Chinese Academy of Sciences; State Key Program of National Natural Science of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Instrument Developing Project of the Chinese Academy of Sciences (Grant No. YZ201301) and the State Key Program of National Natural Science of China (Grant No. 61334008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants from the Instrument Developing Project of the Chinese Academy of Sciences (Grant No. YZ201301) and the State Key Program of National Natural Science of China (Grant No. 61334008). We are grateful to Fengying Miao and Yuchen Feng for their technical assistance in the development of PWA chip-based dRPA. We furthermore want to thank Liwen Luo from TwistDx China for helpful discussion and providing the sequences of the RPA oligos.	Abd El Wahed A, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0071642, 10.1371/currents.outbreaks.62df1c7c75ffc96cd59034531e2e8364]; Abyzov A, 2012, NATURE, V492, P438, DOI 10.1038/nature11629; Baker M, 2012, NAT METHODS, V9, P541, DOI 10.1038/nmeth.2027; Barrett AN, 2012, CLIN CHEM, V58, P1026, DOI 10.1373/clinchem.2011.178939; Beaver JA, 2014, CLIN CANCER RES, V20, P2643, DOI 10.1158/1078-0432.CCR-13-2933; Beck J, 2013, CLIN CHEM, V59, P1732, DOI 10.1373/clinchem.2013.210328; Beer NR, 2007, ANAL CHEM, V79, P8471, DOI 10.1021/ac701809w; Belgrader P, 2013, CLIN CHEM, V59, P991, DOI 10.1373/clinchem.2012.197855; Blainey PC, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1074; Boyle DS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103091; Burns MJ, 2010, EUR FOOD RES TECHNOL, V231, P353, DOI 10.1007/s00217-010-1277-8; COMPTON J, 1991, NATURE, V350, P91, DOI 10.1038/350091a0; Crannell ZA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112146; Crannell ZA, 2014, ANAL CHEM, V86, P5615, DOI 10.1021/ac5011298; Dean FB, 2002, P NATL ACAD SCI USA, V99, P5261, DOI 10.1073/pnas.082089499; Diehl F, 2006, NAT METHODS, V3, P551, DOI 10.1038/NMETH898; Dressman D, 2003, P NATL ACAD SCI USA, V100, P8817, DOI 10.1073/pnas.1133470100; Englade-Franklin LE, 2013, INTERFACE FOCUS, V3, DOI 10.1098/rsfs.2012.0102; Fu TT, 2012, CHEM ENG SCI, V84, P207, DOI 10.1016/j.ces.2012.08.039; Giuffrida MC, 2015, ANAL BIOANAL CHEM, V407, P1533, DOI 10.1007/s00216-014-8405-4; Hatch AC, 2011, LAB CHIP, V11, P3838, DOI 10.1039/c1lc20561g; Herold KC, 2015, J CLIN INVEST, V125, P1163, DOI 10.1172/JCI78142; Heyries KA, 2011, NAT METHODS, V8, P649, DOI [10.1038/NMETH.1640, 10.1038/nmeth.1640]; HILL C, 1995, CLIN CHEM, V41, pS107; Hindson CM, 2013, NAT METHODS, V10, P1003, DOI 10.1038/nmeth.2633; Hori M, 2007, BIOCHEM BIOPH RES CO, V352, P323, DOI 10.1016/j.bbrc.2006.11.037; Jarvius J, 2006, NAT METHODS, V3, P725, DOI 10.1038/NMETH916; Kalisky T, 2011, NAT METHODS, V8, P311, DOI 10.1038/nmeth0411-311; Kang LF, 2010, J BIOMED MATER RES A, V93A, P547, DOI 10.1002/jbm.a.32557; Kumaresan P, 2008, ANAL CHEM, V80, P3522, DOI 10.1021/ac800327d; Li M, 2006, NAT METHODS, V3, P95, DOI 10.1038/NMETH850; Li N., 2008, J ASS LAB AUTOM, V13, P237; Lillis L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108189; Lizardi PM, 1998, NAT GENET, V19, P225, DOI 10.1038/898; Lo YMD, 2007, P NATL ACAD SCI USA, V104, P13116, DOI 10.1073/pnas.0705765104; Malsch D, 2010, MICROFLUID NANOFLUID, V8, P497, DOI 10.1007/s10404-009-0479-5; Mazutis L, 2009, ANAL CHEM, V81, P4813, DOI 10.1021/ac900403z; McDermott GP, 2013, ANAL CHEM, V85, P11619, DOI 10.1021/ac403061n; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Morrison T, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl639; Nie ZH, 2008, MICROFLUID NANOFLUID, V5, P585, DOI 10.1007/s10404-008-0271-y; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; Ottesen EA, 2006, SCIENCE, V314, P1464, DOI 10.1126/science.1131370; Piepenburg O, 2006, PLOS BIOL, V4, P1115, DOI 10.1371/journal.pbio.0040204; Rane TD, 2015, LAB CHIP, V15, P776, DOI 10.1039/c4lc01158a; Rohrman BA, 2012, LAB CHIP, V12, P3082, DOI 10.1039/c2lc40423k; Rosser A, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1055-3; Sanchez-Freire V, 2012, NAT PROTOC, V7, P829, DOI 10.1038/nprot.2012.021; Schuler F, 2015, LAB CHIP, V15, P2759, DOI 10.1039/c5lc00291e; Shen F, 2011, ANAL CHEM, V83, P3533, DOI 10.1021/ac200247e; Shen F, 2010, LAB CHIP, V10, P2666, DOI 10.1039/c004521g; Shen F, 2010, ANAL CHEM, V82, P4606, DOI 10.1021/ac1007249; Shoffner MA, 1996, NUCLEIC ACIDS RES, V24, P375, DOI 10.1093/nar/24.2.375; Strain MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055943; Sun YN, 2014, LAB CHIP, V14, P3603, DOI 10.1039/c4lc00598h; Sundberg SO, 2010, ANAL CHEM, V82, P1546, DOI 10.1021/ac902398c; Tadmor AD, 2011, SCIENCE, V333, P58, DOI 10.1126/science.1200758; Tewhey R, 2009, NAT BIOTECHNOL, V27, P1025, DOI 10.1038/nbt.1583; Tsaloglou MN, 2015, ANALYST, V140, P258, DOI [10.1039/C4AN01683A, 10.1039/c4an01683a]; Vincent M, 2004, EMBO REP, V5, P795, DOI 10.1038/sj.embor.7400200; Vogelstein B, 1999, P NATL ACAD SCI USA, V96, P9236, DOI 10.1073/pnas.96.16.9236; WALKER GT, 1992, NUCLEIC ACIDS RES, V20, P1691, DOI 10.1093/nar/20.7.1691; Ward T, 2005, ELECTROPHORESIS, V26, P3716, DOI 10.1002/elps.200500173; Warren L, 2006, P NATL ACAD SCI USA, V103, P17807, DOI 10.1073/pnas.0608512103; Weaver S, 2010, METHODS, V50, P271, DOI 10.1016/j.ymeth.2010.01.003; White RA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-116; Williams R, 2006, NAT METHODS, V3, P545, DOI 10.1038/NMETH896; Xu JH, 2008, MICROFLUID NANOFLUID, V5, P711, DOI 10.1007/s10404-008-0306-4; Yan L, 2014, MOL BIOSYST, V10, P970, DOI 10.1039/c3mb70304e; Zanoli LM, 2013, BIOSENSORS-BASEL, V3, P18, DOI 10.3390/bios3010018; Zhu QY, 2014, LAB CHIP, V14, P1176, DOI 10.1039/c3lc51327k; Zhu QY, 2012, LAB CHIP, V12, P4755, DOI 10.1039/c2lc40774d; Zimmermann B, 2002, CLIN CHEM, V48, P362; Zou ZQ, 2005, J MICROMECH MICROENG, V15, P1476, DOI 10.1088/0960-1317/15/8/014	74	28	28	9	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153359	10.1371/journal.pone.0153359	http://dx.doi.org/10.1371/journal.pone.0153359			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27074005	gold, Green Published, Green Submitted			2022-12-27	WOS:000374131200078
J	Nowrouzi, S; Andersen, AN; Macfadyen, S; Staunton, KM; VanDerWal, J; Robson, SKA				Nowrouzi, Somayeh; Andersen, Alan N.; Macfadyen, Sarina; Staunton, Kyran M.; VanDerWal, Jeremy; Robson, Simon K. A.			Ant Diversity and Distribution along Elevation Gradients in the Australian Wet Tropics: The Importance of Seasonal Moisture Stability	PLOS ONE			English	Article							RAIN-FOREST BIRDS; SPECIES-RICHNESS; CLIMATE-CHANGE; LATITUDINAL GRADIENTS; COMMUNITY STRUCTURE; FUNCTIONAL-GROUPS; WATER-BALANCE; HUMID TROPICS; RANGE SHIFTS; BIODIVERSITY	The threat of anthropogenic climate change has seen a renewed focus on understanding contemporary patterns of species distribution. This is especially the case for the biota of tropical mountains, because tropical species often have particularly narrow elevational ranges and there are high levels of short-range endemism. Here we describe geographic patterns of ant diversity and distribution in the World Heritage-listed rainforests of the Australian Wet Tropics (AWT), revealing seasonal moisture stability to be an important environmental correlate of elevational patterns of species composition. We sampled ants in leaf litter, on the litter surface and on tree trunks at 26 sites from six subregions spanning five degrees of latitude and elevation ranges from 100-1,300 m. A total of 296 species from 63 genera were recorded. Species richness showed a slight peak at mid elevations, and did not vary significantly with latitude. Species composition varied substantially between subregions, and many species have highly localised distributions. There was very marked species turnover with elevation, with a particularly striking compositional disjunction between 600 m and 800 m at each subregion. This disjunction coincides with a strong environmental threshold of seasonal stability in moisture associated with cloud 'stripping'. Our study therefore provides further support for climatic stability as a potential mechanism underlying patterns of diversity. The average height of orographic cloud layers is predicted to rise under global warming, and associated shifts in seasonal moisture stability may exacerbate biotic change caused by rising temperature alone.	[Nowrouzi, Somayeh; Staunton, Kyran M.; VanDerWal, Jeremy; Robson, Simon K. A.] James Cook Univ, Coll Marine & Ecosyst Sci, Ctr Trop Biodivers & Climate Change, Townsville, Qld 4811, Australia; [Andersen, Alan N.] CSIRO Land & Water Flagship, Darwin, NT 0822, Australia; [Nowrouzi, Somayeh; Macfadyen, Sarina] CSIRO Land & Water Flagship, Canberra, ACT 2601, Australia; [VanDerWal, Jeremy] James Cook Univ, Div Res & Innovat, ERes Ctr, Townsville, Qld 4811, Australia	James Cook University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO); James Cook University	Nowrouzi, S (corresponding author), James Cook Univ, Coll Marine & Ecosyst Sci, Ctr Trop Biodivers & Climate Change, Townsville, Qld 4811, Australia.; Nowrouzi, S (corresponding author), CSIRO Land & Water Flagship, Canberra, ACT 2601, Australia.	sarah.nowrouzi@csiro.au	Robson, Simon KA/D-1168-2011; Staunton, Kyran/W-2263-2019; Andersen, Alan N/F-8763-2010; Macfadyen, Sarina/C-1511-2008	Robson, Simon KA/0000-0001-8870-1933; Staunton, Kyran/0000-0001-6812-3320; Andersen, Alan N/0000-0003-1487-3323; Macfadyen, Sarina/0000-0003-3553-4910	National Environmental Research Program of Australian Government	National Environmental Research Program of Australian Government	SN was supported by a PhD scholarship from the National Environmental Research Program of Australian Government (https://www.environment.gov.au/science/nerp). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Stephen Williams played a key role in establishing the project. Jodie Hayward, Magen Pettit, Celenie Christophe, Maxence Plouviez, Antoine Esnouf, Clemence Roldan, Carina Svensson and Arnaud Gourret provided valuable field and laboratory assistance, and Nick Nicholls gave valuable advice on R software. We thank them all. SN was supported by a PhD scholarship from the National Environmental Research Program of Australian Government.	Agosti D, 2000, BIOL DIVERSITY HDB S; Andersen AN, 2012, INSECT SOC, V59, P433, DOI 10.1007/s00040-012-0238-6; Andersen A.N., 1991, P333; Andersen AN, 2015, J BIOGEOGR, V42, P2313, DOI 10.1111/jbi.12599; ANDERSEN AN, 1995, J BIOGEOGR, V22, P15, DOI 10.2307/2846070; Andersen AN, 2000, ANTS NO AUSTR GUIDE; Anderson AS, 2012, GLOBAL CHANGE BIOL, V18, P2126, DOI 10.1111/j.1365-2486.2012.02683.x; Anderson MJ, 2005, PERMANOVA FORTRAN CO; Aristophanous M., 2014, UNDERSTANDING PATTER; Aristophanous M, 2010, ZOOKEYS, P1, DOI 10.3897/zookeys.34.215; Barron EJ, 1995, STUDIES GEOPHYSICS, P108; Bellard C, 2012, ECOL LETT, V15, P365, DOI 10.1111/j.1461-0248.2011.01736.x; Benzing D.H., 1998, POTENTIAL IMPACTS CL, P379; Bharti H, 2013, ASIAN MYRMECOL, V5, P79; Bolton B, 2007, TAXONOMY DOLICHODERI; Botes A, 2006, J BIOGEOGR, V33, P71, DOI 10.1111/j.1365-2699.2005.01336.x; Botkin DB, 2007, BIOSCIENCE, V57, P227, DOI 10.1641/B570306; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Brown KS, 1997, J INSECT CONSERV, V1, P25, DOI 10.1023/A:1018422807610; Bruhl CA, 1998, J TROP ECOL, V14, P285, DOI 10.1017/S0266467498000224; Bruhl CA, 1999, J TROP ECOL, V15, P265, DOI 10.1017/S0266467499000802; Bruijnzeel L. A, 1990, HYDROLOGY MOIST TROP; Burwell Chris J., 2011, Memoirs of the Queensland Museum, V55, P391; Bush MB, 2002, GLOBAL ECOL BIOGEOGR, V11, P463, DOI 10.1046/j.1466-822X.2002.00305.x; Carnaval AC, 2009, SCIENCE, V323, P785, DOI 10.1126/science.1166955; Chao AN, 2013, METHODS ECOL EVOL, V4, P1091, DOI 10.1111/2041-210X.12108; Chao A, 2012, ECOLOGY, V93, P2533, DOI 10.1890/11-1952.1; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Colwell RK, 2004, AM NAT, V163, pE1, DOI 10.1086/382056; CUSHMAN JH, 1993, OECOLOGIA, V95, P30, DOI 10.1007/BF00649503; Dale A, 2007, PRELIMINARY ASSESSME; Davidson DW, 2003, SCIENCE, V300, P969, DOI 10.1126/science.1082074; Del Toro I, 2015, DIVERS DISTRIB, V21, P781, DOI 10.1111/ddi.12331; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; Diamond SE, 2012, GLOBAL CHANGE BIOL, V18, P448, DOI 10.1111/j.1365-2486.2011.02542.x; Dunn RR, 2009, ECOL LETT, V12, P324, DOI 10.1111/j.1461-0248.2009.01291.x; Fisher BL, 1999, FIELD ZOOL, P129; Gibson-Reinemer DK, 2015, ECOL EVOL, V5, P2340, DOI 10.1002/ece3.1518; Goosem S, 2002, UPDATE ORIGINAL WET; Graham CH, 2014, ECOGRAPHY, V37, P711, DOI 10.1111/ecog.00578; Graham CH, 2010, ECOGRAPHY, V33, P1062, DOI 10.1111/j.1600-0587.2010.06430.x; Graham CH, 2006, P NATL ACAD SCI USA, V103, P632, DOI 10.1073/pnas.0505754103; Grimbacher PS, 2009, BIOTROPICA, V41, P328, DOI 10.1111/j.1744-7429.2008.00477.x; Grytnes J.-A., 2010, ELEVATIONAL GRADIENT; Heterick BE, 2001, INVERTEBR TAXON, V15, P353, DOI 10.1071/IT00003; Hickling R, 2006, GLOBAL CHANGE BIOL, V12, P450, DOI 10.1111/j.1365-2486.2006.01116.x; Hilbert D. W., 2008, LIVING DYNAMIC TROPI, P107; Hilbert DW, 2001, AUSTRAL ECOL, V26, P590, DOI 10.1046/j.1442-9993.2001.01137.x; Holldobler B., 1990, pi; Hutley LB, 1997, AUST J BOT, V45, P311, DOI 10.1071/BT96014; JANZEN DH, 1967, AM NAT, V101, P233, DOI 10.1086/282487; Jenkins CN, 2011, DIVERS DISTRIB, V17, P652, DOI 10.1111/j.1472-4642.2011.00770.x; Kanowski J, 2001, AUSTRAL ECOL, V26, P165, DOI 10.1046/j.1442-9993.2001.01103.x; Kaspari M, 2004, OECOLOGIA, V140, P407, DOI 10.1007/s00442-004-1607-2; Kaufmann E, 2006, NATURWISSENSCHAFTEN, V93, P216, DOI 10.1007/s00114-005-0081-y; KERSHAW AP, 1994, PALAEOGEOGR PALAEOCL, V109, P399, DOI 10.1016/0031-0182(94)90188-0; Laurance WF, 2011, BIOL CONSERV, V144, P548, DOI 10.1016/j.biocon.2010.10.010; Longino JT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104030; Longino JT, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00200.1; Longino JT, 2002, ECOLOGY, V83, P689, DOI 10.1890/0012-9658(2002)083[0689:TAFOAT]2.0.CO;2; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; McDonald TE, 2000, SECURING WET TROPICS; McJannet D, 2008, LIVING DYNAMIC TROPI; McJannet D, 2007, HYDROL PROCESS, V21, P1703, DOI 10.1002/hyp.6346; Menendez R, 2014, GLOBAL ECOL BIOGEOGR, V23, P646, DOI 10.1111/geb.12142; Meteorology ABo, 2015, SEV TROP CYCL YAS 20; MONTEITH G. B, 2008, LIVING DYNAMIC TROPI, P178, DOI DOI 10.1002/9781444300321.CH13; Munyai TC, 2012, J INSECT CONSERV, V16, P677, DOI 10.1007/s10841-011-9449-9; New M, 2002, CLIMATE RES, V21, P1, DOI 10.3354/cr021001; OLSON DM, 1994, J TROP ECOL, V10, P129, DOI 10.1017/S0266467400007793; Parsons SA, 2008, J TROP ECOL, V24, P317, DOI 10.1017/S0266467408004963; Patrick M, 2012, BIOTROPICA, V44, P472, DOI 10.1111/j.1744-7429.2012.00855.x; Pereira HM, 2010, SCIENCE, V330, P1496, DOI 10.1126/science.1196624; PIANKA ER, 1966, AM NAT, V100, P33, DOI 10.1086/282398; Pounds JA, 1999, NATURE, V398, P611, DOI 10.1038/19297; Prather CM, 2013, BIOL REV, V88, P327, DOI 10.1111/brv.12002; R Development Core Team, R LANG ENV STAT COMP; Rahbek C, 2005, ECOL LETT, V8, P224, DOI 10.1111/j.1461-0248.2004.00701.x; Rapp JM, 2014, F1000RESEARCH, P3; Reichel H, 1996, AUST J ZOOL, V44, P81, DOI 10.1071/ZO9960081; Robertson HG, 2002, BIODIVERS CONSERV, V11, P1637, DOI 10.1023/A:1016883901065; ROSENBERG DM, 1986, ENVIRON MANAGE, V10, P773, DOI 10.1007/BF01867730; Sanders NJ, 2002, ECOGRAPHY, V25, P25, DOI 10.1034/j.1600-0587.2002.250104.x; Shattuck SO, 2013, ZOOTAXA, V3669, P287, DOI 10.11646/zootaxa.3669.3.5; Shattuck S, 2009, ZOOTAXA, P1; Shattuck SO, 2012, ZOOTAXA, P1; Sheldon KS, 2014, ECOLOGY, V95, P2134, DOI 10.1890/13-1703.1; Shoo LP, 2005, BIOL CONSERV, V125, P335, DOI 10.1016/j.biocon.2005.04.003; Smith DJ, 2009, ZOOTAXA, P57, DOI 10.11646/zootaxa.2142.1.5; Smith MA, 2014, ECOGRAPHY, V37, P720, DOI 10.1111/j.1600-0587.2013.00631.x; Staunton KM, 2013, VULNERABILITY FLIGTL; Staunton KM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088635; Taylor R.W., 1985, Zoological Catalogue of Australia, V2, P1; TAYLOR RW, 1977, AUST J ZOOL, V25, P581, DOI 10.1071/ZO9770581; Taylor RW, 1972, BIOGEOGRAPHY INSECTS; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Tracey J, 1994, RAINFORESTS NO AUSTR, P87; Turton SM, 2012, GEOGR RES-AUST, V50, P15, DOI 10.1111/j.1745-5871.2011.00724.x; van Ingen LT, 2008, J TROP ECOL, V24, P445, DOI 10.1017/S0266467408005166; Wallace J, 2012, J HYDROL, V475, P84, DOI 10.1016/j.jhydrol.2012.09.032; Wang Minsheng, 2003, Bulletin of the Museum of Comparative Zoology, V157, P383; Welbergen J, 2015, CLIMATE CHANGE IMPAC; Williams SE, 2009, P NATL ACAD SCI USA, V106, P19737, DOI 10.1073/pnas.0901640106; Williams SE, 2008, DIVERS DISTRIB, V14, P69, DOI 10.1111/j.1472-4642.2007.00418.x; Williams SE, 2010, AUSTRAL ECOL, V35, P650, DOI 10.1111/j.1442-9993.2009.02073.x; Williams YM, 2006, BIOL LETT-UK, V2, P532, DOI 10.1098/rsbl.2006.0541; Willig MR, 2003, ANNU REV ECOL EVOL S, V34, P273, DOI 10.1146/annurev.ecolsys.34.012103.144032; Wilson, 1988, BIODIVERSITY, P170; WTMA, 2013, ANN REP STAT WET TRO; Yek SH, 2009, J INSECT SCI, V9, DOI 10.1673/031.009.1201	111	25	25	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153420	10.1371/journal.pone.0153420	http://dx.doi.org/10.1371/journal.pone.0153420			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073848	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000374131200088
J	Silbiger, NJ; Guadayol, O; Thomas, FIM; Donahue, MJ				Silbiger, Nyssa J.; Guadayol, Oscar; Thomas, Florence I. M.; Donahue, Megan J.			A Novel mu CT Analysis Reveals Different Responses of Bioerosion and Secondary Accretion to Environmental Variability	PLOS ONE			English	Article							GREAT-BARRIER-REEF; REUNION INDIAN-OCEAN; CORAL-REEFS; INTERNAL BIOEROSION; CONTINENTAL-SHELF; CLIMATE-CHANGE; RATES; ACIDIFICATION; PACIFIC; DISSOLUTION	Corals build reefs through accretion of calcium carbonate (CaCO3) skeletons, but net reef growth also depends on bioerosion by grazers and borers and on secondary calcification by crustose coralline algae and other calcifying invertebrates. However, traditional field methods for quantifying secondary accretion and bioerosion confound both processes, do not measure them on the same time-scale, or are restricted to 2D methods. In a prior study, we compared multiple environmental drivers of net erosion using pre- and post-deployment micro-computed tomography scans (mu CT; calculated as the % change in volume of experimental CaCO3 blocks) and found a shift from net accretion to net erosion with increasing ocean acidity. Here, we present a novel mu CT method and detail a procedure that aligns and digitally subtracts pre- and post-deployment mu CT scans and measures the simultaneous response of secondary accretion and bioerosion on blocks exposed to the same environmental variation over the same time-scale. We tested our method on a dataset from a prior study and show that it can be used to uncover information previously unattainable using traditional methods. We demonstrated that secondary accretion and bioerosion are driven by different environmental parameters, bioerosion is more sensitive to ocean acidity than secondary accretion, and net erosion is driven more by changes in bioerosion than secondary accretion.	[Silbiger, Nyssa J.] Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92717 USA; [Silbiger, Nyssa J.; Thomas, Florence I. M.; Donahue, Megan J.] Univ Hawaii Manoa, Hawaii Inst Marine Biol, Kaneohe, HI USA; [Guadayol, Oscar] Lincoln Univ, Sch Life Sci, Joseph Banks Labs, Lincoln, NE USA	University of California System; University of California Irvine; University of Hawaii System; University of Hawaii Manoa	Silbiger, NJ (corresponding author), Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92717 USA.; Silbiger, NJ (corresponding author), Univ Hawaii Manoa, Hawaii Inst Marine Biol, Kaneohe, HI USA.	nyssa.silbiger@uci.edu	Guadayol, Òscar/N-2940-2013; Donahue, Megan/Q-3528-2017	Guadayol, Òscar/0000-0001-9552-1041; Silbiger, Nyssa/0000-0003-4916-3217; Donahue, Megan/0000-0002-7529-001X; Thomas, Florence/0000-0003-4347-6474	NOAA Office of National Marine Sanctuaries-HIMB partnership (MOA) [2009-039/7932]; National Science Foundation EPSCoR Hawai'i; NOAA Dr. Nancy Foster Scholarship; Sigma-Xi GIAR; Hawai'i Sea [1889, 1847]; National Oceanic and Atmospheric Administration [R/IR-18]; University of Hawai'i Sea Grant College Program, School of Ocean and Earth Science and Technology, Office of Sea Grant, Department of Commerce [NA09OAR4170060]	NOAA Office of National Marine Sanctuaries-HIMB partnership (MOA); National Science Foundation EPSCoR Hawai'i; NOAA Dr. Nancy Foster Scholarship; Sigma-Xi GIAR; Hawai'i Sea; National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA); University of Hawai'i Sea Grant College Program, School of Ocean and Earth Science and Technology, Office of Sea Grant, Department of Commerce	Funding for this project came from NOAA Office of National Marine Sanctuaries-HIMB partnership (MOA #2009-039/7932), National Science Foundation EPSCoR Hawai'i, NOAA Dr. Nancy Foster Scholarship to N.J.S., Sigma-Xi GIAR to N.J.S., and by Hawai'i Sea Grants #1889 to F.I.M.T and #1847 to M.J.D. and F.I.M.T. This paper is funded in part by a grant/cooperative agreement from the National Oceanic and Atmospheric Administration, Project No. R/IR-18, which is sponsored by the University of Hawai'i Sea Grant College Program, School of Ocean and Earth Science and Technology, under Institutional Grant No. NA09OAR4170060 Office of Sea Grant, Department of Commerce. The views expressed herein are those of the authors and do not necessarily reflect the views of NOAA or any of its subagencies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelson A, 1997, ANNU REV ECOL SYST, V28, P317, DOI 10.1146/annurev.ecolsys.28.1.317; Alwany MA, 2009, J EXP MAR BIOL ECOL, V371, P170, DOI 10.1016/j.jembe.2009.01.019; Anderson D. R., 2008, MODEL BASED INFERENC; Andersson AJ, 2013, ANNU REV MAR SCI, V5, P321, DOI 10.1146/annurev-marine-121211-172241; Barkley HC, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500328; Becker L, 1996, P 8 INT COR S SPRING, V2, P1819; BELLWOOD DR, 1995, MAR BIOL, V121, P419, DOI 10.1007/BF00349451; Beuck L, 2007, FACIES, V53, P157, DOI 10.1007/s10347-006-0094-9; Marquez JC, 2012, MAR ECOL-EVOL PERSP, V33, P417, DOI 10.1111/j.1439-0485.2011.00506.x; Carreiro-Silva M, 2005, CORAL REEFS, V24, P214, DOI 10.1007/s00338-004-0445-3; Carreiro-Silva M, 2009, MAR ECOL PROG SER, V392, P1, DOI 10.3354/meps08251; Castillo KD, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1856; CHAZOTTES V, 1995, PALAEOGEOGR PALAEOCL, V113, P189, DOI 10.1016/0031-0182(95)00043-L; Chazottes V, 2002, CORAL REEFS, V21, P375, DOI 10.1007/s00338-002-0259-0; Comeau S, 2013, LIMNOL OCEANOGR, V58, P388, DOI 10.4319/lo.2013.58.1.0388; Crook ED, 2013, P NATL ACAD SCI USA, V110, P11044, DOI 10.1073/pnas.1301589110; Davidson TM, 2013, J EXP MAR BIOL ECOL, V446, P115, DOI 10.1016/j.jembe.2013.05.008; DeCarlo TM, 2014, GEOLOGY; Drupp P, 2011, AQUAT GEOCHEM, V17, P473, DOI 10.1007/s10498-010-9115-y; Duarte CM, 2013, ESTUAR COAST, V36, P221, DOI 10.1007/s12237-013-9594-3; Dumont CP, 2013, J EXP MAR BIOL ECOL, V441, P71, DOI 10.1016/j.jembe.2013.01.018; Edinger EN, 1996, LETHAIA, V29, P275, DOI 10.1111/j.1502-3931.1996.tb01660.x; Edinger EN, 2000, MAR POLLUT BULL, V40, P404, DOI 10.1016/S0025-326X(99)00237-4; Erez J, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P151, DOI 10.1007/978-94-007-0114-4_10; Fabricius KE, 2005, MAR POLLUT BULL, V50, P125, DOI 10.1016/j.marpolbul.2004.11.028; Fang JKH, 2013, GLOBAL CHANGE BIOL, V19, P3581, DOI 10.1111/gcb.12334; FRECHETTE M, 1989, LIMNOL OCEANOGR, V34, P19, DOI 10.4319/lo.1989.34.1.0019; Godinot C, 2012, BIOGEOSCIENCES, V9, P2377, DOI 10.5194/bg-9-2377-2012; GOLUBIC S, 1970, LETHAIA, V3, P203, DOI 10.1111/j.1502-3931.1970.tb01858.x; Grange JS, 2015, ENVIRON SCI POLLUT R, V22, P13625, DOI 10.1007/s11356-014-4069-z; Guadayol O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085213; Harney JN, 2003, J SEDIMENT RES, V73, P856, DOI 10.1306/051503730856; Hassan M., 1997, P1813; HEIN FJ, 1975, B MAR SCI, V25, P133; Hernandez-Ballesteros LM, 2013, J EXP MAR BIOL ECOL, V441, P23, DOI 10.1016/j.jembe.2013.01.016; HIGHSMITH RC, 1981, INT REV GES HYDROBIO, V66, P335, DOI 10.1002/iroh.19810660307; HIGHSMITH RC, 1981, AM NAT, V117, P193, DOI 10.1086/283698; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hofmann GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028983; Holmes KE, 2000, MAR POLLUT BULL, V40, P606, DOI 10.1016/S0025-326X(00)00067-9; Hutchings P, 2005, MAR POLLUT BULL, V51, P438, DOI 10.1016/j.marpolbul.2004.10.044; Hutchings P., 1995, OCEANOGRAPHIC LIT RE, V9, P781; HUTCHINGS PA, 1986, CORAL REEFS, V4, P239, DOI 10.1007/BF00298083; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; KIENE WE, 1994, CORAL REEFS, V13, P91, DOI 10.1007/BF00300767; Kuffner IB, 2008, NAT GEOSCI, V1, P114, DOI 10.1038/ngeo100; Le Grand HM, 2011, CORAL REEFS, V30, P97, DOI 10.1007/s00338-010-0670-x; Legland David, 2007, Image Analysis & Stereology, V26, P83, DOI 10.5566/ias.v26.p83-92; Londono-Cruz E, 2003, MAR ECOL PROG SER, V265, P289, DOI 10.3354/meps265289; MacGeachy J. K., 1977, Proceedings int Coral Reef Symp, V3, P477; Manzello DP, 2008, P NATL ACAD SCI USA, V105, P10450, DOI 10.1073/pnas.0712167105; Massaro RFS, 2012, AQUAT GEOCHEM, V18, P357, DOI 10.1007/s10498-012-9170-7; Mattes D, 2001, PROC SPIE, V4322, P1609, DOI 10.1117/12.431046; MORAN DP, 1988, MAR ECOL PROG SER, V44, P249, DOI 10.3354/meps044249; Nava H, 2008, J EXP BIOL, V211, P2827, DOI 10.1242/jeb.019216; NOWELL ARM, 1984, ANNU REV ECOL SYST, V15, P303, DOI 10.1146/annurev.es.15.110184.001511; Ong L, 2010, MAR BIOL, V157, P1313, DOI 10.1007/s00227-010-1411-y; Pandolfi JM, 2011, SCIENCE, V333, P418, DOI 10.1126/science.1204794; Pari N, 2002, J EXP MAR BIOL ECOL, V276, P109, DOI 10.1016/S0022-0981(02)00243-5; Perry CT, 1998, CORAL REEFS, V17, P277, DOI 10.1007/s003380050129; Peyrot-Clausade M, 1999, B GEOL SOC DENMARK, V45, P151; Przeslawski R, 2008, GLOBAL CHANGE BIOL, V14, P2773, DOI 10.1111/j.1365-2486.2008.01693.x; ReakaKudla ML, 1996, CORAL REEFS, V15, P101; Reyes-Nivia C, 2013, GLOBAL CHANGE BIOL, V19, P1919, DOI 10.1111/gcb.12158; RISK MJ, 1995, CORAL REEFS, V14, P79, DOI 10.1007/BF00303427; Rivest EB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121742; Rodolfo-Metalpa R, 2011, NAT CLIM CHANGE, V1, P308, DOI 10.1038/NCLIMATE1200; ROSE CS, 1985, PSZNI MAR ECOL, V6, P345, DOI 10.1111/j.1439-0485.1985.tb00142.x; RUTZLER K, 1975, OECOLOGIA, V19, P203, DOI 10.1007/BF00345306; SAMMARCO PW, 1990, MAR ECOL PROG SER, V59, P145, DOI 10.3354/meps059145; SAMMARCO PW, 1987, J EXP MAR BIOL ECOL, V112, P185, DOI 10.1016/0022-0981(87)90116-X; Schonberg CHL, 2008, CURRENT DEVELOPMENTS IN BIOEROSION, P147, DOI 10.1007/978-3-540-77598-0_8; Schonberg CHL, 2002, MAR ECOL-P S Z N I, V23, P313, DOI 10.1046/j.1439-0485.2002.02811.x; SCOTT PJB, 1988, CORAL REEFS, V7, P145, DOI 10.1007/BF00300974; Shamberger KEF, 2014, GEOPHYS RES LETT, V41, P499, DOI 10.1002/2013GL058489; Silbiger NJ, 2015, BIOGEOSCIENCES, V12, P567, DOI 10.5194/bg-12-567-2015; Silbiger NJ, 2014, MAR ECOL PROG SER, V515, P33, DOI 10.3354/meps10999; Silverman J, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036282; Smith JE, 2013, MAR BIOL, V160, P2437, DOI 10.1007/s00227-013-2239-z; SMITH SV, 1984, LIMNOL OCEANOGR, V29, P1149, DOI 10.4319/lo.1984.29.6.1149; Styner M, 2000, IEEE T MED IMAGING, V19, P153, DOI 10.1109/42.845174; Tribollet A, 2006, J PHYCOL, V42, P292, DOI 10.1111/j.1529-8817.2006.00198.x; Tribollet A, 2005, CORAL REEFS, V24, P422, DOI 10.1007/s00338-005-0003-7; Tribollet A, 2002, CORAL REEFS, V21, P424, DOI 10.1007/s00338-002-0267-0; Tribollet A, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003286; Tribollet A, 2008, CURRENT DEVELOPMENTS IN BIOEROSION, P67, DOI 10.1007/978-3-540-77598-0_4; Vogel N, 2016, CORAL REEFS, P1; Wisshak M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045124; Yates KK, 2007, MAR CHEM, V104, P110, DOI 10.1016/j.marchem.2006.12.008; Zubia M, 2001, OCEANOL ACTA, V24, P251, DOI 10.1016/S0399-1784(01)01144-6	90	21	22	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153058	10.1371/journal.pone.0153058	http://dx.doi.org/10.1371/journal.pone.0153058			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27074001	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000374131200049
J	Wills, PJ; Anjana, M; Nitin, M; Varun, R; Sachidanandan, P; Jacob, TM; Lilly, M; Thampan, RV; Varma, KK				Wills, Pallara Janardhanan; Anjana, Mohan; Nitin, Mohan; Varun, Raghuveeran; Sachidanandan, Parayil; Jacob, Tharaniyil Mani; Lilly, Madhavan; Thampan, Raghava Varman; Varma, Koyikkal Karthikeya			Population Explosions of Tiger Moth Lead to Lepidopterism Mimicking Infectious Fever Outbreaks	PLOS ONE			English	Article							MAST-CELLS; LONOMIA CATERPILLAR; HISTAMINE-RELEASE; IMMUNE-RESPONSES; CHIKUNGUNYA; DEFENSES; LATITUDE; DISEASE; SYSTEM	Lepidopterism is a disease caused by the urticating scales and toxic fluids of adult moths, butterflies or its caterpillars. The resulting cutaneous eruptions and systemic problems progress to clinical complications sometimes leading to death. High incidence of fever epidemics were associated with massive outbreaks of tiger moth Asota caricae adult populations during monsoon in Kerala, India. A significant number of monsoon related fever characteristic to lepidopterism was erroneously treated as infectious fevers due to lookalike symptoms. To diagnose tiger moth lepidopterism, we conducted immunoblots for tiger moth specific IgE in fever patients' sera. We selected a cohort of patients (n = 155) with hallmark symptoms of infectious fevers but were tested negative to infectious fevers. In these cases, the total IgE was elevated and was detected positive (78.6%) for tiger moth specific IgE allergens. Chemical characterization of caterpillar and adult moth fluids was performed by HPLC and GC-MS analysis and structural identification of moth scales was performed by SEM analysis. The body fluids and chitinous scales were found to be highly toxic and inflammatory in nature. To replicate the disease in experimental model, wistar rats were exposed to live tiger moths in a dose dependant manner and observed similar clinico-pathological complications reported during the fever epidemics. Further, to link larval abundance and fever epidemics we conducted cointegration test for the period 2009 to 2012 and physical presence of the tiger moths were found to be cointegrated with fever epidemics. In conclusion, our experiments demonstrate that inhalation of aerosols containing tiger moth fluids, scales and hairs cause systemic reactions that can be fatal to human. All these evidences points to the possible involvement of tiger moth disease as a major cause to the massive and fatal fever epidemics observed in Kerala.	[Wills, Pallara Janardhanan; Anjana, Mohan; Varun, Raghuveeran; Lilly, Madhavan; Thampan, Raghava Varman; Varma, Koyikkal Karthikeya] Malabar Inst Med Sci Aster MIMS, MIMS Res Fdn, Kozhikode, Kerala, India; [Nitin, Mohan] ICFO Inst Ciencies Foton, Barcelona, Spain; [Sachidanandan, Parayil] State Forens Sci Lab, Thiruvananthapuram, Kerala, India; [Jacob, Tharaniyil Mani] Nirmala Coll, Dept Stat, Muvattupuzha, Kerala, India	Barcelona Institute of Science & Technology; Universitat Politecnica de Catalunya; Institut de Ciencies Fotoniques (ICFO)	Wills, PJ (corresponding author), Malabar Inst Med Sci Aster MIMS, MIMS Res Fdn, Kozhikode, Kerala, India.	willsmimsrf@gmail.com	Mohan, Nitin/ABB-9787-2020	Mohan, Nitin/0000-0002-5168-1462	MIMS Research Foundation	MIMS Research Foundation	The study was funded by MIMS Research Foundation.	[Anonymous], IM; Basset Yves, 1997, P341; Battisti A, 2011, ANNU REV ENTOMOL, V56, P203, DOI 10.1146/annurev-ento-120709-144844; Binder M, 2001, J IMMUNOL, V167, P5470, DOI 10.4049/jimmunol.167.9.5470; Binstadt BA, 2006, NAT IMMUNOL, V7, P284, DOI 10.1038/ni1306; Bischoff SC, 2007, NAT REV IMMUNOL, V7, P93, DOI 10.1038/nri2018; Blaszczyk EB, 2010, BIOMEDICAL ASPECTS H, P247; Carrijo-Carvalho LC, 2007, TOXICON, V49, P741, DOI 10.1016/j.toxicon.2006.11.033; Cawdell-Smith AJ, 2012, EQUINE VET J, V44, P282, DOI 10.1111/j.2042-3306.2011.00424.x; Craft KJ, 2010, P NATL ACAD SCI USA, V107, P5041, DOI 10.1073/pnas.0913084107; Da Silva CA, 2009, J IMMUNOL, V182, P3573, DOI 10.4049/jimmunol.0802113; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; Diaz JH, 2005, AM J TROP MED HYG, V72, P347, DOI 10.4269/ajtmh.2005.72.347; DICKEY DA, 1979, J AM STAT ASSOC, V74, P427, DOI 10.2307/2286348; Directorate of Health Services, PUBLIC HLTH; Enserink M, 2007, SCIENCE, V318, P1860, DOI 10.1126/science.318.5858.1860; Fortoul TI, 2008, HISTOL HISTOPATHOL, V23, P1321, DOI 10.14670/HH-23.1321; Fujii T, 2002, BIOL PHARM BULL, V25, P1524, DOI 10.1248/bpb.25.1524; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Hanski I, 1998, NATURE, V396, P41, DOI 10.1038/23876; Hess A, 2011, P NATL ACAD SCI USA, V108, P3731, DOI 10.1073/pnas.1011774108; Holloway JD, 1988, MOTHS BORNEO FAMILY, P85; Hossler EW, 2009, DERMATOL THER, V22, P353, DOI 10.1111/j.1529-8019.2009.01247.x; HUANG DZ, 1991, J TROP MED HYG, V94, P79; Hui X, 2004, ANN BOT-LONDON, V94, P377, DOI 10.1093/aob/mch153; JOHANSEN S, 1990, OXFORD B ECON STAT, V52, P169, DOI 10.1111/j.1468-0084.1990.mp52002003.x; Joosten LAB, 2006, P NATL ACAD SCI USA, V103, P3298, DOI 10.1073/pnas.0511233103; Jourdain F, 2012, PARASITE, V19, P117, DOI 10.1051/parasite/2012192117; Kannan M, 2009, INDIAN J MED RES, V129, P311; Kaufmann P, 2002, J GEOPHYS RES-SPACE, V107, DOI 10.1029/2001JA000292; Khan MM, 2010, BIOMEDICAL ASPECTS OF HISTAMINE: CURRENT PERSPECTIVES, P151, DOI 10.1007/978-90-481-9349-3_7; Lee CG, 2008, CURR OPIN IMMUNOL, V20, P684, DOI 10.1016/j.coi.2008.10.002; Li YP, 2009, INT J BIOL SCI, V5, P451; Malaque CMS, 2006, AM J TROP MED HYG, V74, P807, DOI 10.4269/ajtmh.2006.74.807; Mokry J, 2007, J PHYSIOL PHARMACOL, V58, P409; Moon Ji-Ae, 2005, Korean Journal of Microbiology and Biotechnology, V33, P255; Nair KSS, 2007, TROPICAL FOREST INSECT PESTS: ECOLOGY, IMPACT, AND MANAGEMENT, P119, DOI 10.1017/CBO9780511542695.009; Nair PMC, 2008, INDIAN PEDIATR, V45, P605; Nelson WA, 2013, SCIENCE, V341, P796, DOI 10.1126/science.1238477; Nishida R, 2002, ANNU REV ENTOMOL, V47, P57, DOI 10.1146/annurev.ento.47.091201.145121; Pan TL, 2014, FOOD CHEM TOXICOL, V65, P105, DOI 10.1016/j.fct.2013.12.033; Raffa KF, 2013, P NATL ACAD SCI USA, V110, P2193, DOI 10.1073/pnas.1216666110; Rudmann DG, 2012, TOXICOL SCI, V125, P586, DOI 10.1093/toxsci/kfr318; Santos-Magadan S, 2009, CONTACT DERMATITIS, V60, P109, DOI 10.1111/j.1600-0536.2008.01464.x; Scoble MJ, 1992, LEPIDOPTERA FORM FUN, P63; Song QS, 2001, J CHEM ECOL, V27, P1929, DOI 10.1023/A:1012226400586; Sudeep AB, 2008, J BIOSCIENCES, V33, P443, DOI 10.1007/s12038-008-0063-2; Sunday JM, 2014, P NATL ACAD SCI USA, V111, P5610, DOI 10.1073/pnas.1316145111; TASAKA K, 1986, AGENTS ACTIONS, V18, P49, DOI 10.1007/BF01987980; TASAKA K, 1990, AGENTS ACTIONS, V30, P114, DOI 10.1007/BF01969013; US National Library of Medicine 1-Octanol, HUM HLTH EFF; Varshney V, 2008, DOWN EARTH, V17, P38; Villas-Boas IM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071938; Villas-Boas IM, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001531; Webb BA, 2004, J INSECT PHYSIOL, V50, P185, DOI 10.1016/j.jinsphys.2003.11.008; Weller SJ, 1999, BIOL J LINN SOC, V68, P557, DOI 10.1111/j.1095-8312.1999.tb01188.x; WILLMER PG, 1982, ADV INSECT PHYSIOL, V16, P1, DOI 10.1016/S0065-2806(08)60151-4; World Health Organization, CHIK IN IND	58	5	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0152787	10.1371/journal.pone.0152787	http://dx.doi.org/10.1371/journal.pone.0152787			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073878	Green Published, Green Submitted, gold			2022-12-27	WOS:000374131200037
J	Ziegenhorn, MA				Ziegenhorn, Morgan A.			Best Dressed Test: A Study of the Covering Behavior of the Collector Urchin Tripneustes gratilla	PLOS ONE			English	Article							SEA-URCHIN; PREDATION	Many sea urchin genera exhibit cryptic covering behaviors. One such behavior has been documented in the sea urchin Tripneustes gratilla, and previous studies have theorized that this behavior serves as protection from UV radiation. However, other hypotheses have been presented such as protection from predators or added weight to help T. gratilla resist strong currents. A field study was conducted in October-November 2015 in Moorea, French Polynesia to assess urchin covering behavior in natural habitats. The study found that urchins partially underneath rocks covered more, and with more algae, than urchins totally underneath rocks. To test if this behavior was driven by light intensity, a series of 30-minute experimental trials were run on 10 individuals in bright and dim conditions. Individuals were given red and clear plastic, and percent cover of each was recorded. These tests were repeated once fifty percent of spines had been removed from the urchin, in order to determine whether spine loss affects T. gratilla covering behavior. The study found that urchins had a distinct preference for cover that best protects them from UV radiation. Spine loss did not significantly affect urchin ability to cover, and urchins with removed spines still preferred opaque cover. Additionally, covering behavior was mapped onto a phylogeny of echinoderms to determine how it might have evolved. Understanding urchin covering behavior more fully is a step towards an understanding of the evolution of cryptic behavior across species.	[Ziegenhorn, Morgan A.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Ziegenhorn, MA (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA.	maziggy@berkeley.edu						Adams NL, 2001, MAR ECOL PROG SER, V213, P87, DOI 10.3354/meps213087; Agatsuma Y, 2001, FISHERIES SCI, V67, P1181, DOI 10.1046/j.1444-2906.2001.00379.x; Amato KR, 2008, B MAR SCI, V82, P255; Ambrose HW, 2002, HDB BIOL INVESTIGATI; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Belleza Dominic Franco C., 2012, Philippine Scientist, V49, P34; Crook AC, 1999, J MAR BIOL ASSOC UK, V79, P1117, DOI 10.1017/S002531549900137X; Cruz C, 1994, BIOL GEOMORPHOLOGY T, V4, P22; DAYTON PK, 1977, MAR BIOL, V39, P361, DOI 10.1007/BF00391939; DIX TG, 1970, PAC SCI, V24, P187; Dubois P, 2001, MICROSC RES TECHNIQ, V55, P427, DOI 10.1002/jemt.1188; Dumont CP, 2007, ANIM BEHAV, V73, P979, DOI 10.1016/j.anbehav.2006.11.008; FORSTER GR, 1959, J MAR BIOL ASSOC UK, V38, P361, DOI 10.1017/S0025315400006147; James DW, 2000, MAR BIOL, V137, P913, DOI 10.1007/s002270000423; Kehas AJ, 2005, MAR BIOL, V146, P1111, DOI 10.1007/s00227-004-1514-4; LEWIS JOHN B., 1958, CANADIAN JOUR ZOOL, V36, P607; LITTLEWOOD DTJ, 1995, PHILOS T R SOC B, V347, P213, DOI 10.1098/rstb.1995.0023; Maddison W.P., MESQUITE MODULAR SYS; Milligan HN, 1915, ZOOLOGIST, V894, P441; MILLOTT N, 1975, ADV MAR BIOL, V13, P1, DOI 10.1016/S0065-2881(08)60279-5; MILLOTT N, 1956, J EXP BIOL, V33, P508; Moore HB, 1966, ECOLOGY ECHINOIDS PH, P73; OGDEN NB, 1989, B MAR SCI, V45, P539; Pawson DL, 2013, DEEP-SEA RES PT II, V92, P207, DOI 10.1016/j.dsr2.2013.01.023; Pederson HG, 2006, J EXP MAR BIOL ECOL, V336, P120, DOI 10.1016/j.jembe.2006.04.010; Portmann A, 1959, ANIMAL CAMOUFLAGE; R Core Team, 2021, R LANGUAGE ENV STAT; SMITH AB, 1988, MOL BIOL EVOL, V5, P345; Stevens M, 2009, PHILOS T R SOC B, V364, P423, DOI 10.1098/rstb.2008.0217; Thet MM, 2004, ZOOL SCI, V21, P265, DOI 10.2108/zsj.21.265; Unger B, 1993, P 8 INT ECH C DIJ FR, P913; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; YANAGISAWA Y, 1972, Publications of the Seto Marine Biological Laboratory, V19, P431; Yoshida M., 1966, P435; Zhao CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093709; Zhao C, 2014, MAR FRESHW BEHAV PHY, V47, P11, DOI 10.1080/10236244.2013.868075	36	8	8	5	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153581	10.1371/journal.pone.0153581	http://dx.doi.org/10.1371/journal.pone.0153581			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073915	Green Published, gold, Green Submitted			2022-12-27	WOS:000374131200108
J	Chen, JF; Zhang, LY; Liu, ST; Li, ZM; Huang, RR; Li, YM; Cheng, HL; Li, XT; Zhou, B; Wu, SW; Chen, W; Wu, JY; Ding, JQ				Chen, Jiafa; Zhang, Luyan; Liu, Songtao; Li, Zhimin; Huang, Rongrong; Li, Yongming; Cheng, Hongliang; Li, Xiantang; Zhou, Bo; Wu, Suowei; Chen, Wei; Wu, Jianyu; Ding, Junqiang			The Genetic Basis of Natural Variation in Kernel Size and Related Traits Using a Four-Way Cross Population in Maize	PLOS ONE			English	Article							GENERATION INTER-CROSS; GRAIN-SIZE; YIELD COMPONENTS; MAGIC POPULATIONS; QTL DETECTION; TRADE-OFF; SEED SIZE; MAJOR QTL; RICE; ENCODES	Kernel size is an important component of grain yield in maize breeding programs. To extend the understanding on the genetic basis of kernel size traits (i.e., kernel length, kernel width and kernel thickness), we developed a set of four-way cross mapping population derived from four maize inbred lines with varied kernel sizes. In the present study, we investigated the genetic basis of natural variation in seed size and other components of maize yield (e.g., hundred kernel weight, number of rows per ear, number of kernels per row). In total, ten QTL affecting kernel size were identified, three of which (two for kernel length and one for kernel width) had stable expression in other components of maize yield. The possible genetic mechanism behind the trade-off of kernel size and yield components was discussed.	[Chen, Jiafa; Li, Zhimin; Huang, Rongrong; Li, Yongming; Cheng, Hongliang; Li, Xiantang; Zhou, Bo; Wu, Suowei; Chen, Wei; Wu, Jianyu; Ding, Junqiang] Henan Agr Univ, Coll Agron, Synerget Innovat Ctr Henan Grain Crops, Zhengzhou 450002, Peoples R China; [Chen, Jiafa; Li, Zhimin; Huang, Rongrong; Li, Yongming; Cheng, Hongliang; Li, Xiantang; Zhou, Bo; Wu, Suowei; Chen, Wei; Wu, Jianyu] Henan Agr Univ, Natl Key Lab Wheat & Maize Crop Sci, Zhengzhou 450002, Peoples R China; [Zhang, Luyan] Chinese Acad Agr Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Inst Crop Sci, Beijing 100081, Peoples R China; [Zhang, Luyan] Chinese Acad Agr Sci, CIMMYT China Off, Beijing 100081, Peoples R China; [Liu, Songtao] Henan Vocat Coll Agr, Zhengzhou 450002, Peoples R China	Henan Agricultural University; Henan Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Chinese Academy of Agricultural Sciences	Wu, JY; Ding, JQ (corresponding author), Henan Agr Univ, Coll Agron, Synerget Innovat Ctr Henan Grain Crops, Zhengzhou 450002, Peoples R China.; Wu, JY (corresponding author), Henan Agr Univ, Natl Key Lab Wheat & Maize Crop Sci, Zhengzhou 450002, Peoples R China.	henau1302@126.com; dingjunqiang1203@163.com	Wu, Suowei/AAW-4748-2021; li, yong/HDN-3885-2022	Wu, Jianyu/0000-0002-9090-2512; chen, jiafa/0000-0002-5684-6692	Henan Basic Research Program of China [142102110051]	Henan Basic Research Program of China	This work was supported by Henan Basic Research Program of China (142102110051).	Andrade FH, 2005, J CROP IMPROV, V14, P51, DOI 10.1300/J411v14n01_05; Austin DF, 1996, THEOR APPL GENET, V92, P817, DOI 10.1007/BF00221893; Bandillo N, 2013, RICE, V6, DOI 10.1186/1939-8433-6-11; BHAVE MR, 1990, PLANT CELL, V2, P581, DOI 10.1105/tpc.2.6.581; Cavanagh C, 2008, CURR OPIN PLANT BIOL, V11, P215, DOI 10.1016/j.pbi.2008.01.002; Chen JF, 2012, MOL BREEDING, V30, P1649, DOI 10.1007/s11032-012-9748-1; Cheng WH, 1996, PLANT CELL, V8, P971, DOI 10.1105/tpc.8.6.971; Chou HH, 2011, SCIENCE, V332, P1190, DOI 10.1126/science.1203799; Dell'Acqua M, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0716-z; Ding JQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141619; Fan CH, 2006, THEOR APPL GENET, V112, P1164, DOI 10.1007/s00122-006-0218-1; Flint-Garcia SA, 2003, ANNU REV PLANT BIOL, V54, P357, DOI 10.1146/annurev.arplant.54.031902.134907; Gnan S, 2014, GENETICS, V198, P1751, DOI 10.1534/genetics.114.170746; Gupta PK, 2006, GENOME, V49, P565, DOI 10.1139/G06-063; Huang BE, 2015, THEOR APPL GENET, V128, P999, DOI 10.1007/s00122-015-2506-0; Huang BE, 2012, PLANT BIOTECHNOL J, V10, P826, DOI 10.1111/j.1467-7652.2012.00702.x; Huang X, 2011, NAT GENET, P1; JIANG CJ, 1995, GENETICS, V140, P1111; KNAPP SJ, 1985, CROP SCI, V25, P192, DOI 10.2135/cropsci1985.0011183X002500010046x; Kover PX, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000551; Li CH, 2013, EUPHYTICA, V193, P303, DOI 10.1007/s10681-013-0901-7; Li Q, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-143; Li YL, 2009, EUPHYTICA, V169, P273, DOI 10.1007/s10681-009-9966-8; Li YB, 2011, NAT GENET, V43, P1266, DOI 10.1038/ng.977; Li YongXiang, 2009, Scientia Agricultura Sinica, V42, P408; Liu Y, 2014, THEOR APPL GENET, V127, P1019, DOI 10.1007/s00122-014-2276-0; Martin A, 2006, PLANT CELL, V18, P3252, DOI 10.1105/tpc.106.042689; Neuffer MG, 1997, MUTANTS MAIZE; Pascual L, 2015, PLANT BIOTECHNOL J, V13, P565, DOI 10.1111/pbi.12282; Peng B, 2011, THEOR APPL GENET, V122, P1305, DOI 10.1007/s00122-011-1532-9; Ram R, 2014, GENETICS, V198, P75, DOI 10.1534/genetics.114.163014; Rebetzke GJ, 2014, PLANT BIOTECHNOL J, V12, P219, DOI 10.1111/pbi.12130; Sadras VO, 2007, FIELD CROP RES, V100, P125, DOI 10.1016/j.fcr.2006.07.004; Sannemann W, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0284-7; *SAS I, 1999, SAS US GUID STAT; SCHMIDT RJ, 1992, PLANT CELL, V4, P689, DOI 10.1105/tpc.4.6.689; Shomura A, 2008, NAT GENET, V40, P1023, DOI 10.1038/ng.169; Song XJ, 2007, NAT GENET, V39, P623, DOI 10.1038/ng2014; Svenson KL, 2012, GENETICS, V190, P437, DOI 10.1534/genetics.111.132597; Takano-Kai N, 2009, GENETICS, V182, P1323, DOI 10.1534/genetics.109.103002; Tester M, 2010, SCIENCE, V327, P818, DOI 10.1126/science.1183700; VELDBOOM LR, 1994, THEOR APPL GENET, V89, P451, DOI 10.1007/BF00225380; Veldboom LR, 1996, CROP SCI, V36, P1310, DOI 10.2135/cropsci1996.0011183X003600050040x; VENABLE DL, 1992, AM NAT, V140, P287, DOI 10.1086/285413; Verbyla AP, 2014, THEOR APPL GENET, V127, P1753, DOI 10.1007/s00122-014-2337-4; Wang GF, 2012, PLANT CELL, V24, P3447, DOI 10.1105/tpc.112.101360; Wang SK, 2015, NAT GENET, V47, P949, DOI 10.1038/ng.3352; Wang SK, 2012, NAT GENET, V44, P950, DOI 10.1038/ng.2327; Wang YX, 2015, NAT GENET, V47, P944, DOI 10.1038/ng.3346; Zhang L, 2015, J INTEGR PLANT BIOL; Zhang LY, 2015, G3-GENES GENOM GENET, V5, P427, DOI 10.1534/g3.114.016022; Zhang XJ, 2012, P NATL ACAD SCI USA, V109, P21534, DOI 10.1073/pnas.1219776110	52	30	35	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0153428	10.1371/journal.pone.0153428	http://dx.doi.org/10.1371/journal.pone.0153428			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27070143	Green Published, Green Submitted, gold			2022-12-27	WOS:000373900700067
J	Ji, J; Wang, H; Li, Y; Zheng, L; Yin, YP; Zou, ZZ; Zhou, FG; Zhou, WP; Shen, F; Gao, CF				Ji, Jun; Wang, Hao; Li, Yan; Zheng, Lei; Yin, Yuepeng; Zou, Zhenzhen; Zhou, Feiguo; Zhou, Weiping; Shen, Feng; Gao, Chunfang			Diagnostic Evaluation of Des-Gamma-Carboxy Prothrombin versus alpha-Fetoprotein for Hepatitis B Virus-Related Hepatocellular Carcinoma in China: A Large-Scale, Multicentre Study	PLOS ONE			English	Article							CHRONIC LIVER-DISEASE; PIVKA-II; TUMOR-MARKER; CARBOXYPROTHROMBIN; BIOMARKERS; SURVIVAL; CIRRHOSIS; HBV	An efficient serum marker for hepatocellular carcinoma (HCC) is currently lacking and requires intensive exploration. We aimed to evaluate the performance of des-gamma-carboxy prothrombin (DCP) for identifying hepatitis B virus-related HCC in a large, multicentre study in China. A total of 1034 subjects in three cohorts (A, B, and C) including HCC and various non-HCC controls were enrolled from 4 academic medical centers in China from January 2011 to February 2014. Blind parallel detections were conducted for DCP and AFP. The area under the receiver operating characteristic curve (AUC) was used to evaluate the diagnostic efficacies. In cohort A, which comprised 521 subjects, including patients with HCC, liver metastasis, liver cirrhosis (LC), and liver hemangiomas as well as healthy controls (HCs), the accuracy of DCP for distinguishing HCC from various controls was 6.2-9.7% higher than that of AFP. In cohort B, which comprised 447 subjects, including patients with HCC, LC, and chronic hepatitis B as well as HC, the accuracy of DCP was further elevated (12.3-20.67% higher than that of AFP). The superiority of DCP to AFP was more profound in the surveillance of early HCC [AUC 0.837 (95% CI: 0.771-0.903) vs. 0.650 (0.555-0.745)] and AFP-negative HCC [AUC: 0.856 (0.798-0.914)] and in discriminating HCC from LC (accuracy: 92.9% vs. 64.71%). Higher DCP levels were associated with worse clinical behaviors and shorter disease-free survival. DCP not only is complementary to AFP in identifying AFP-negative HCC and in excluding AFP-positive non-HCC (liver cirrhosis), but also demonstrates improved performance in HCC surveillance, early diagnosis, treatment response and recurrence monitoring in the HBV-related population.	[Ji, Jun; Yin, Yuepeng; Zou, Zhenzhen; Gao, Chunfang] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Dept Lab Med, Shanghai, Peoples R China; [Wang, Hao] Second Mil Med Univ, Changzheng Hosp, Dept Lab Med, Shanghai, Peoples R China; [Li, Yan] Wuhan Univ, Renmin Hosp, Dept Lab Med, Wuhan, Hubei, Peoples R China; [Zheng, Lei] Southern Med Univ, Nanfang Hosp, Dept Lab Med, Guangdong, Peoples R China; [Zhou, Feiguo; Zhou, Weiping; Shen, Feng] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Dept Liver Surg, Shanghai, Peoples R China	Naval Medical University; Naval Medical University; Wuhan University; Southern Medical University - China; Naval Medical University	Gao, CF (corresponding author), Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Dept Lab Med, Shanghai, Peoples R China.	gaocf1115@163.com	Shen, Feng/GSD-2508-2022		National Natural Science Foundation [81271925, 81301516]; State Key Project on Infectious Diseases [2012ZX10002-016]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); State Key Project on Infectious Diseases	This work was supported by the National Natural Science Foundation 81271925 (G.C.), 81301516 (J.J.) and the State Key Project on Infectious Diseases 2012ZX10002-016 (S.F., G.C.).	Anzola M, 2004, J VIRAL HEPATITIS, V11, P383, DOI 10.1111/j.1365-2893.2004.00521.x; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Cantarini MC, 2006, AM J GASTROENTEROL, V101, P91, DOI 10.1111/j.1572-0241.2006.00364.x; Dohmen K, 2003, HEPATO-GASTROENTEROL, V50, P2072; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; Farinati F, 2006, AM J GASTROENTEROL, V101, P524, DOI 10.1111/j.1572-0241.2006.00443.x; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Fujikawa T, 2007, J BIOL CHEM, V282, P8741, DOI 10.1074/jbc.M609358200; Fujikawa T, 2009, ACTA MED OKAYAMA, V63, P299; Hann H. W., 2014, Journal of Medical Microbiology and Diagnosis, V3, P130; Johnson P J, 2001, Clin Liver Dis, V5, P145, DOI 10.1016/S1089-3261(05)70158-6; Johnson PJ, 1999, J GASTROEN HEPATOL, V14, pS32, DOI 10.1046/j.1440-1746.1999.01873.x; Kaibori M, 2004, WORLD J SURG, V28, P702, DOI 10.1007/s00268-004-7205-y; Kim DY, 2007, ONCOLOGY-BASEL, V72, P52, DOI 10.1159/000111707; Li CZ, 2014, HEPATOL RES, V44, pE11, DOI 10.1111/hepr.12201; LIEBMAN HA, 1984, NEW ENGL J MED, V310, P1427, DOI 10.1056/NEJM198405313102204; Llovet JM, 2008, JNCI-J NATL CANCER I, V100, P698, DOI 10.1093/jnci/djn134; Lok ASF, 2009, HEPATOLOGY, V50, P661, DOI 10.1002/hep.23190; Marrero JA, 2003, HEPATOLOGY, V37, P1114, DOI 10.1053/jhep.2003.50195; Marrero JA, 2009, GASTROENTEROLOGY, V137, P110, DOI 10.1053/j.gastro.2009.04.005; Mukozu T, 2013, ANTICANCER RES, V33, P1013; Nagaoka S, 2003, CANCER, V98, P2671, DOI 10.1002/cncr.11839; Nakamura S, 2006, AM J GASTROENTEROL, V101, P2038, DOI 10.1111/j.1572-0241.2006.00681.x; Nanashima A, 2013, ANTICANCER RES, V33, P2689; Park H, 2014, LIVER INT, V34, P313, DOI 10.1111/liv.12274; Parkin DM, 2001, LANCET ONCOL, V2, P533, DOI 10.1016/S1470-2045(01)00486-7; Qin LX, 2004, J CANCER RES CLIN, V130, P497, DOI 10.1007/s00432-004-0572-9; Sobin, 2009, UICC TNM CLASSIFICAT; Song PP, 2013, BIOSCI TRENDS, V7, P1, DOI 10.5582/bst.2013.v7.1.1; Sterling RK, 2012, AM J GASTROENTEROL, V107, P64, DOI 10.1038/ajg.2011.312; TAKETA K, 1990, HEPATOLOGY, V12, P1420, DOI 10.1002/hep.1840120625; Tanabe G, 1999, HEPATO-GASTROENTEROL, V46, P2442; Tang W, 2005, ONCOL REP, V13, P25; Wands JR, 2004, NEW ENGL J MED, V351, P1567, DOI 10.1056/NEJMe048237; Wang SB, 2009, CLIN EXP METASTAS, V26, P469, DOI 10.1007/s10585-009-9246-y	35	47	56	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0153227	10.1371/journal.pone.0153227	http://dx.doi.org/10.1371/journal.pone.0153227			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27070780	gold, Green Published, Green Submitted			2022-12-27	WOS:000373900700039
J	Kim, EB; Jin, GD; Lee, JY; Choi, YJ				Kim, Eun Bae; Jin, Gwi-Deuk; Lee, Jun-Yeong; Choi, Yun-Jaie			Genomic Features and Niche-Adaptation of Enterococcus faecium Strains from Korean Soybean-Fermented Foods	PLOS ONE			English	Article							DEGRADATION; PHYLOGENIES; ALIGNMENT; DOENJANG	Certain strains of Enterococcus faecium contribute beneficially to human health and food fermentation. However, other E. faecium strains are opportunistic pathogens due to the acquisition of virulence factors and antibiotic resistance determinants. To characterize E. faecium from soybean fermentation, we sequenced the genomes of 10 E. faecium strains from Korean soybean-fermented foods and analyzed their genomes by comparing them with 51 clinical and 52 non-clinical strains of different origins. Hierarchical clustering based on 13,820 orthologous genes from all E. faecium genomes showed that the 10 strains are distinguished from most of the clinical strains. Like non-clinical strains, their genomes are significantly smaller than clinical strains due to fewer accessory genes associated with antibiotic resistance, virulence, and mobile genetic elements. Moreover, we identified niche-associated gene gain and loss from the soybean strains. Thus, we conclude that soybean E. faecium strains might have evolved to have distinctive genomic features that may contribute to its ability to thrive during soybean fermentation.	[Kim, Eun Bae; Jin, Gwi-Deuk] Kangwon Natl Univ, Coll Anim Life Sci, Dept Anim Life Sci, Chunchon, Kangwon Do, South Korea; [Kim, Eun Bae] Kangwon Natl Univ, Coll Anim Life Sci, Div Appl Anim Sci, Chunchon, Kangwon Do, South Korea; [Lee, Jun-Yeong; Choi, Yun-Jaie] Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea; [Choi, Yun-Jaie] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul, South Korea	Kangwon National University; Kangwon National University; Seoul National University (SNU); Seoul National University (SNU)	Kim, EB (corresponding author), Kangwon Natl Univ, Coll Anim Life Sci, Dept Anim Life Sci, Chunchon, Kangwon Do, South Korea.; Kim, EB (corresponding author), Kangwon Natl Univ, Coll Anim Life Sci, Div Appl Anim Sci, Chunchon, Kangwon Do, South Korea.	itanimal@kangwon.ac.kr		Lee, Jun-Yeong/0000-0002-4342-1863	Strategic Initiative for Microbiomes in Agriculture and Food, Ministry of Agriculture, Food and Rural Affairs, Republic of Korea, multi-ministerial Genome Technology to Business Translation Program [914005-04]	Strategic Initiative for Microbiomes in Agriculture and Food, Ministry of Agriculture, Food and Rural Affairs, Republic of Korea, multi-ministerial Genome Technology to Business Translation Program	This study was supported by a grant from the Strategic Initiative for Microbiomes in Agriculture and Food, Ministry of Agriculture, Food and Rural Affairs, Republic of Korea as part of the multi-ministerial Genome Technology to Business Translation Program (Grant ID: 914005-04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by a grant from the Strategic Initiative for Microbiomes in Agriculture and Food, Ministry of Agriculture, Food and Rural Affairs, Republic of Korea as part of the multi-ministerial Genome Technology to Business Translation Program (Grant ID: 914005-04). We appreciate KACC (Korean Agricultural Culture Collection) for donation of E. faecium strains for this study.	Arias CA, 2012, NAT REV MICROBIOL, V10, P266, DOI 10.1038/nrmicro2761; Authority EFS, 2012, EFSA J, V10, P10; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Barbosa J, 2014, INT J FOOD MICROBIOL, V191, P144, DOI 10.1016/j.ijfoodmicro.2014.09.009; Boisvert S, 2010, J COMPUT BIOL, V17, P1519, DOI 10.1089/cmb.2009.0238; 김용상, 2011, [Korean Journal of Microbiology, 미생물학회지], V47, P275; Caryl JA, 2012, ANTIMICROB AGENTS CH, V56, P3378, DOI 10.1128/AAC.05957-11; Castillo-Rojas G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059491; de Regt MJA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030319; Diaz M, 2003, APPL ENVIRON MICROB, V69, P1229, DOI 10.1128/AEM.69.2.1229-1236.2003; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Hammami R, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-22; Hill C, 2012, J BACTERIOL, V194, P5725, DOI 10.1128/JB.00980-12; Jeong DW, 2014, J MICROBIOL BIOTECHN, V24, P648, DOI 10.4014/jmb.1401.01009; Jo YJ, 2011, J FOOD SCI, V76, pC368, DOI 10.1111/j.1750-3841.2011.02068.x; Kim EB, 2014, APPL ENVIRON MICROB, V80, P154, DOI 10.1128/AEM.03108-13; Kim MH, 2012, FOOD SCI BIOTECHNOL, V21, P9, DOI 10.1007/s10068-012-0002-8; Kopit LM, 2014, APPL ENVIRON MICROB, V80, P1899, DOI 10.1128/AEM.03859-13; Lam MMC, 2012, J BACTERIOL, V194, P2334, DOI 10.1128/JB.00259-12; Lebreton F, 2013, MBIO, V4, DOI 10.1128/mBio.00534-13; Leong D, 2014, FRONT MICROBIOL, V5, DOI [10.3389/fmicb.2014.00683, 10.3389/fmicb.2014.00436, 10.3389/fmicb.2014.00241]; Liu B, 2009, NUCLEIC ACIDS RES, V37, pD443, DOI 10.1093/nar/gkn656; Martinez-Villaluenga C, 2012, J AGR FOOD CHEM, V60, P10235, DOI 10.1021/jf302751m; Masood MI, 2011, CRIT REV MICROBIOL, V37, P91, DOI 10.3109/1040841X.2010.536522; Ochiai A, 2007, APPL ENVIRON MICROB, V73, P3803, DOI 10.1128/AEM.00147-07; Palmer KL, 2012, MBIO, V3, DOI 10.1128/mBio.00318-11; 이영덕, 2012, [The Korean Journal of Food and Nutrition, 한국식품영양학회지], V25, P188; Rizk G, 2010, BIOINFORMATICS, V26, P2534, DOI 10.1093/bioinformatics/btq485; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Shukla S, 2010, FOOD CHEM TOXICOL, V48, P2005, DOI 10.1016/j.fct.2010.04.034; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; van Heel AJ, 2013, NUCLEIC ACIDS RES, V41, pW448, DOI 10.1093/nar/gkt391; Willems RJL, 2009, FUTURE MICROBIOL, V4, P1125, DOI [10.2217/fmb.09.82, 10.2217/FMB.09.82]	36	9	9	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0153279	10.1371/journal.pone.0153279	http://dx.doi.org/10.1371/journal.pone.0153279			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27070419	gold, Green Published, Green Submitted			2022-12-27	WOS:000373900700045
J	Li, TS; Zhao, J; Yang, JY; Ma, X; Dai, QY; Huang, H; Wang, LN; Liu, P				Li, Taishun; Zhao, Jun; Yang, Jiaying; Ma, Xu; Dai, Qiaoyun; Huang, Hao; Wang, Lina; Liu, Pei			A Meta-Analysis of the Association between ESR1 Genetic Variants and the Risk of Breast Cancer	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; DIAGNOSTIC-ACCURACY; GERMAN POPULATIONS; CHINESE WOMEN; ESTROGEN; POLYMORPHISMS; SUSCEPTIBILITY; ALPHA; STATISTICS; PATHWAY	Background Single nucleotide polymorphisms (SNPs) in the estrogen receptor gene (ESR1) play critical roles in breast cancer (BC) susceptibility. Genome-wide association studies have reported that SNPs in ESR1 are associated with BC susceptibility; however, the results of recent studies have been inconsistent. Therefore, we performed this meta-analysis to obtain more accurate and credible results. Methods We pooled published literature from PubMed, EMBASE, and Web of Science and calculated odds ratios (ORs) with 95% confidence intervals (CIs) to assess the strength of associations using fixed effects models and random effects models. Twenty relevant case-control and cohort studies of the 3 related SNPs were identified. Results Three SNPs of the ESR1 gene, rs2077647: T>C, rs2228480: G>A and rs3798577: T>C, were not associated with increased BC risk in our overall meta-analysis. Stratified analysis by ethnicity showed that in Caucasians, the rs2228480 AA genotype was associated with a 26% decreased risk of BC compared with the GG genotype (OR = 0.740, 95% CI: 0.5550.987). The C allele of the rs3798577: T>C variant was associated with decreased BC risk in Asians (OR = 0.828, 95% CI: 0.730-0.939), while Caucasians with this allele were found to experience significantly increased BC risk (OR = 1.551, 95% CI: 1.037-2.321). A non-significant association between rs2077647 and BC risk was identified in all of the evaluated ethnic populations. Conclusion Rs3798577 was associated with an increased risk of BC in Caucasian populations but a decreased risk in Asians. Rs2228480 had a large protective effect in Caucasians, while rs2077647 was not associated with BC risk.	[Li, Taishun; Yang, Jiaying; Huang, Hao; Wang, Lina] Southeast Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China; [Zhao, Jun; Ma, Xu; Dai, Qiaoyun; Liu, Pei] Natl Res Inst Family Planning, Beijing, Peoples R China	Southeast University - China; National Research Institute for Family Planning - China	Liu, P (corresponding author), Natl Res Inst Family Planning, Beijing, Peoples R China.	liupeiseu@126.com			Program of National Scientific Data Sharing Platform for Population and Health	Program of National Scientific Data Sharing Platform for Population and Health	This work was supported by the Program of National Scientific Data Sharing Platform for Population and Health. Xu Ma received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anghel A, 2010, PATHOL ONCOL RES, V16, P485, DOI 10.1007/s12253-010-9263-9; Barrdahl M, 2014, HUM MOL GENET, V23, P5260, DOI 10.1093/hmg/ddu223; Barzan D, 2013, EUR J HUM GENET, V21, P1286, DOI 10.1038/ejhg.2013.38; Boone S, 2013, TGF B SIGNALING PATH; Bosviel R, 2012, CANCER EPIDEMIOL, V36, pE177, DOI 10.1016/j.canep.2012.02.001; Diergaarde B, 2008, CANCER EPIDEM BIOMAR, V17, P1751, DOI 10.1158/1055-9965.EPI-08-0168; Fernandez LP, 2006, INT J CANCER, V119, P467, DOI 10.1002/ijc.21847; Gallicchio L, 2006, BMC CANCER, V6, P1, DOI 10.1186/1471-2407-6-173; Gjerdevik M, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-109; Gold B, 2004, CANCER RES, V64, P8891, DOI 10.1158/0008-5472.CAN-04-1256; Guo H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052445; He BS, 2015, TUMOR BIOL, V36, P4575, DOI 10.1007/s13277-015-3102-2; Hein R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042380; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hsiao WC, 2004, BREAST CANCER RES, V6, pR180, DOI 10.1186/bcr770; Jeon S, 2010, BREAST CANCER RES TR, V121, P737, DOI 10.1007/s10549-009-0640-6; Kallel I, 2009, BIOMED RESEARCH INTE, V2009, DOI [10.1155/2009/753683, DOI 10.1155/2009/753683]; Kim HC, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3158; Ladd AM Gonzalez-Zuloeta, 2008, BREAST CANC RES TREA, V107, P415, DOI [10.1007/s10549-007-9562-3, DOI 10.1007/S10549-007-9562-3]; Li LW, 2012, ASIAN PAC J CANCER P, V13, P5105, DOI 10.7314/APJCP.2012.13.10.5105; Li N, 2010, BREAST CANCER RES TR, V121, P177, DOI 10.1007/s10549-009-0532-9; Lipphardt MF, 2013, INT J CLIN EXP MED, V6, P282; Long JR, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002532; Mahdi KM, 2013, ASIAN PAC J CANCER P, V14, P3403, DOI 10.7314/APJCP.2013.14.6.3403; Nyante SJ, 2015, CANCER CAUSE CONTROL, V26, P121, DOI 10.1007/s10552-014-0491-2; O'Brien KM, 2014, CANCER EPIDEM BIOMAR, V23, P84, DOI 10.1158/1055-9965.EPI-13-0463; Rinella ES, 2013, HUM GENET, V132, P523, DOI 10.1007/s00439-013-1269-4; Sasaki M, 2003, EUR J CLIN PHARMACOL, V59, P389, DOI 10.1007/s00228-003-0609-z; Schacht DV, 2014, AM J ROENTGENOL, V202, P289, DOI 10.2214/AJR.13.11553; Scholz C, 2015, BREAST CANCER RES TR, V151, P569, DOI 10.1007/s10549-015-3422-3; Siddig A, 2008, ANN NY ACAD SCI, V1138, P95, DOI 10.1196/annals.1414.015; Son BH, 2015, J CANCER RES CLIN, V141, P633, DOI 10.1007/s00432-014-1849-2; Song FJ, 2002, INT J EPIDEMIOL, V31, P88, DOI 10.1093/ije/31.1.88; Soysal SD, 2015, BREAST CANCER RES TR, V151, P709, DOI 10.1007/s10549-015-3427-y; Sprague BL, 2015, AM J EPIDEMIOL, V181, P956, DOI 10.1093/aje/kwu474; Tapper W, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2213; Thakkinstian A, 2005, STAT MED, V24, P1291, DOI 10.1002/sim.2010; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Tse YE, 2006, ESTROGEN RECEPTOR GE, DOI [10.5353/th_b3870946, DOI 10.5353/TH_B3870946]; Turnbull C, 2010, NAT GENET, V42, P504, DOI 10.1038/ng.586; Wang J, 2013, CHINESE J SHIP RES, V8, P7, DOI DOI 10.1371/J0URNAL.P0NE.0068798; Wang Y, 2014, INTERNATIONAL CONFERENCE ON REMOTE SENSING AND WIRELESS COMMUNICATIONS (RSWC 2014), P6; [徐迎春 Xu Yingchun], 2004, [吉林大学学报. 医学版, Journal of Jilin Univeristy. Medicine edition], V30, P904; Yu JC, 2006, J BIOMED SCI, V13, P419, DOI 10.1007/s11373-006-9069-7; Yu JC, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2821; Zhang LN, 2009, BREAST CANCER RES TR, V114, P327, DOI 10.1007/s10549-008-9998-0; Zhang LN, 2008, ASS GENETIC POLYM ER; Zheng SL, 2003, CANCER RES, V63, P7624; Zhou Y, 2014, STAT MED, V33, P2701, DOI 10.1002/sim.6115	49	15	15	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0153314	10.1371/journal.pone.0153314	http://dx.doi.org/10.1371/journal.pone.0153314			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27070141	gold, Green Published			2022-12-27	WOS:000373900700051
J	Stiegel, MA; Pleil, JD; Sobus, JR; Madden, MC				Stiegel, Matthew A.; Pleil, Joachim D.; Sobus, Jon R.; Madden, Michael C.			Inflammatory Cytokines and White Blood Cell Counts Response to Environmental Levels of Diesel Exhaust and Ozone Inhalation Exposures	PLOS ONE			English	Article							AIR-POLLUTION; PARTICULATE MATTER; BREATH CONDENSATE; NO2 EMISSIONS; LUNG-FUNCTION; BIOMARKERS; DISEASE; DYSFUNCTION; VOLUNTEERS; PARTICLES	Epidemiological observations of urban inhalation exposures to diesel exhaust (DE) and ozone (O-3) have shown pre-clinical cardiopulmonary responses in humans. Identifying the key biological mechanisms that initiate these health bioindicators is difficult due to variability in environmental exposure in time and from person to person. Previously, environmentally controlled human exposure chambers have been used to study DE and O-3 dose-response patterns separately, but investigation of co-exposures has not been performed under controlled conditions. Because a mixture is a more realistic exposure scenario for the general public, in this study we investigate the relationships of urban levels of urban-level DE exposure (300 mu g/m(3)), O-3 (0.3 ppm), DE + O-3 co-exposure, and innate immune system responses. Fifteen healthy human volunteers were studied for changes in ten inflammatory cytokines (interleukins 1 beta, 2, 4, 5, 8, 10, 12p70 and 13, IFN-gamma, and TNF-alpha) and counts of three white blood cell types (lymphocytes, monocytes, and neutrophils) following controlled exposures to DE, O3, and DE+O-3. The results show subtle cytokines responses to the diesel-only and ozone-only exposures, and that a more complex (possibly synergistic) relationship exists in the combination of these two exposures with suppression of IL-5, IL-12p70, IFN-gamma, and TNF-alpha that persists up to 22-hours for IFN-gamma and TNF-alpha. The white blood cell differential counts showed significant monocyte and lymphocyte decreases and neutrophil increases following the DE + O3 exposure; lymphocytes and neutrophils changes also persist for at least 22-hours. Because human studies must be conducted under strict safety protocols at environmental levels, these effects are subtle and are generally only seen with detailed statistical analysis. This study indicates that the observed associations between environmental exposures and cardiopulmonary effects are possibly mediated by inflammatory response mechanisms.	[Stiegel, Matthew A.] Duke Univ, Med Ctr, Dept Occupat & Environm Safety, Div Occupat Hyg & Safety, Durham, NC USA; [Pleil, Joachim D.; Sobus, Jon R.] US EPA, Natl Exposure Res Lab, Human Exposure & Atmospher Sci Div, Res Triangle Pk, NC 27711 USA; [Madden, Michael C.] US EPA, Natl Hlth & Environm Effects Res Lab, Environm Publ Hlth Div, Chapel Hill, NC USA	Duke University; United States Environmental Protection Agency; United States Environmental Protection Agency	Pleil, JD (corresponding author), US EPA, Natl Exposure Res Lab, Human Exposure & Atmospher Sci Div, Res Triangle Pk, NC 27711 USA.	pleil.joachim@epa.gov		Sobus, Jon/0000-0003-0740-6604	US Government	US Government	The authors JDP, JRS, MCM and the study were fully funded by the US Government as part of their employment.	Alexis NE, 2010, INHAL TOXICOL, V22, P593, DOI 10.3109/08958371003596587; Alexis NE, 2009, J ALLERGY CLIN IMMUN, V124, P1222, DOI 10.1016/j.jaci.2009.07.036; Amann A, 2014, J BREATH RES, V8, DOI 10.1088/1752-7155/8/3/034001; Angrish MM, 2016, J TOXICOL ENV HLT 25, V25, P1; [Anonymous], 1998, GENDER DIFFERENCES S; Bao AH, 2013, FRONT BIOSCI-LANDMRK, V18, P838, DOI 10.2741/4147; Bar-Ilan A, 2010, J AIR WASTE MANAGE, V60, P977, DOI 10.3155/1047-3289.60.8.977; Bean HD, 2015, BIOMARKERS, V20, P1, DOI 10.3109/1354750X.2014.985254; Bosson J, 2008, EUR RESPIR J, V31, P1234, DOI 10.1183/09031936.00078407; Bosson J, 2009, INHAL TOXICOL, V21, P913, DOI 10.1080/08958370802657389; Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1; Brunekreef B, 2002, LANCET, V360, P1233, DOI 10.1016/S0140-6736(02)11274-8; Buzzard NA, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-13; Chuang KJ, 2007, AM J RESP CRIT CARE, V176, P370, DOI 10.1164/rccm.200611-1627OC; Chung KF, 1999, THORAX, V54, P825, DOI 10.1136/thx.54.9.825; Cousins DJ, 2002, J IMMUNOL, V169, P2498, DOI 10.4049/jimmunol.169.5.2498; Devlin RB, 2012, CIRCULATION, V126, P104, DOI 10.1161/CIRCULATIONAHA.112.094359; Dix DJ, 2007, TOXICOL SCI, V95, P5, DOI 10.1093/toxsci/kfl103; EPA U.S, 2002, HLTH ASS DOC DIES EN; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Faustini A, 2013, EUR RESPIR J, V42, P304, DOI 10.1183/09031936.00128712; Gilliland FD, 2002, AM J RESP CRIT CARE, V166, P457, DOI 10.1164/rccm.2112064; Gold DR, 2000, CIRCULATION, V101, P1267, DOI 10.1161/01.CIR.101.11.1267; HATCH GE, 1994, AM J RESP CRIT CARE, V150, P676, DOI 10.1164/ajrccm.150.3.8087337; Holgate Stephen T, 2003, Res Rep Health Eff Inst, P1; Huang YCT, 2012, INHAL TOXICOL, V24, P790, DOI 10.3109/08958378.2012.718809; Jerrett M, 2009, NEW ENGL J MED, V360, P1085, DOI 10.1056/NEJMoa0803894; Kampa M, 2008, ENVIRON POLLUT, V151, P362, DOI 10.1016/j.envpol.2007.06.012; Kim CS, 2011, AM J RESP CRIT CARE, V183, P1215, DOI 10.1164/rccm.201011-1813OC; Knudsen Thomas, 2013, Methods Mol Biol, V947, P343, DOI 10.1007/978-1-62703-131-8_26; Kodavanti UP, 2011, ENVIRON HEALTH PERSP, V119, P312, DOI 10.1289/ehp.1002386; Kurtenbach Ralf, 2012, Environmental Sciences Europe, V24, P21, DOI 10.1186/2190-4715-24-21; Laskin Debra L, 2010, Res Rep Health Eff Inst, P3; Madden MC, 2014, PART FIBRE TOXICOL, V11, DOI 10.1186/s12989-014-0037-5; Meso Scale Discovery, 2012, MSD BIOM ASS HUM TH1; Nordenhall C, 2000, EUR RESPIR J, V15, P1046, DOI 10.1034/j.1399-3003.2000.01512.x; Oakes JL, 2013, AM J RESP CELL MOL, V48, P27, DOI 10.1165/rcmb.2012-0187OC; Pleil JD, 2015, J BREATH RES, V9, DOI 10.1088/1752-7155/9/4/047108; Pleil JD, 2014, J BREATH RES, V8, DOI 10.1088/1752-7155/8/2/029001; Pleil JD, 2013, ANAL CHEM, V85, P9984, DOI 10.1021/ac402306f; Pleil JD, 2012, J TOXICOL ENV HEAL B, V15, P264, DOI 10.1080/10937404.2012.672148; Pleil JD, 2011, BIOMARKERS, V16, P99, DOI 10.3109/1354750X.2010.541565; Pope CA, 2006, J AIR WASTE MANAGE, V56, P709, DOI 10.1080/10473289.2006.10464485; Psychogios N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016957; Rappaport SM, 2010, SCIENCE, V330, P460, DOI 10.1126/science.1192603; Romagnani S, 2000, ANN ALLERG ASTHMA IM, V85, P9, DOI 10.1016/S1081-1206(10)62426-X; Saito Y, 2002, EXP LUNG RES, V28, P201, DOI 10.1080/019021402753570509; Sawyer K, 2010, J TOXICOL ENV HEAL A, V73, P41, DOI 10.1080/15287390903248901; SCHELEGLE ES, 1991, AM REV RESPIR DIS, V143, P1353, DOI 10.1164/ajrccm/143.6.1353; Stevens T, 2008, TOXICOL SCI, V102, P359, DOI 10.1093/toxsci/kfn006; Stevens T, 2009, TOXICOL SCI, V107, P522, DOI 10.1093/toxsci/kfn248; Stiegel MA, 2015, BIOMARKERS, V20, P35, DOI 10.3109/1354750X.2014.988646; Sydbom A, 2001, EUR RESPIR J, V17, P733, DOI 10.1183/09031936.01.17407330; Tornqvist H, 2007, AM J RESP CRIT CARE, V176, P395, DOI 10.1164/rccm.200606-872OC; Wild CP, 2005, CANCER EPIDEM BIOMAR, V14, P1847, DOI 10.1158/1055-9965.EPI-05-0456; WRIGHT SP, 1992, BIOMETRICS, V48, P1005, DOI 10.2307/2532694; Xu YY, 2013, PART FIBRE TOXICOL, V10, DOI 10.1186/1743-8977-10-60; Yang HM, 2001, ENVIRON HEALTH PERSP, V109, P515, DOI 10.2307/3454711	58	37	37	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2016	11	4							e0152458	10.1371/journal.pone.0152458	http://dx.doi.org/10.1371/journal.pone.0152458			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6JK	27058360	Green Published, gold, Green Submitted			2022-12-27	WOS:000373604800006
J	Janssens, PLHR; Penders, J; Hursel, R; Budding, AE; Savelkoul, PHM; Westerterp-Plantenga, MS				Janssens, Pilou L. H. R.; Penders, John; Hursel, Rick; Budding, Andries E.; Savelkoul, Paul H. M.; Westerterp-Plantenga, Margriet S.			Long-Term Green Tea Supplementation Does Not Change the Human Gut Microbiota	PLOS ONE			English	Article							ENERGY-EXPENDITURE; FAT OXIDATION; INTESTINAL MICROBIOTA; COFFEE CONSUMPTION; BODY-COMPOSITION; POLYPHENOLS; METABOLISM; MICROFLORA; EXTRACT; OBESITY	Background Green tea catechins may play a role in body weight regulation through interactions with the gut microbiota. Aim We examined whether green tea supplementation for 12 weeks induces changes in composition of the human gut microbiota. Methods 58 Caucasian men and women were included in a randomized, placebo-controlled design. For 12 weeks, subjects consumed either green tea (>0.56 g/d epigallocatechin-gallate + 0.28 similar to 0.45 g/d caffeine) or placebo capsules. Fecal samples were collected twice (baseline, vs. week 12) for analyses of total bacterial profiles by means of IS-profiling, a 16S-23S interspacer region-based profiling method. Results No significant changes between baseline and week 12 in subjects receiving green tea or placebo capsules, and no significant interactions between treatment (green tea or placebo) and time (baseline and week 12) were observed for body composition. Analysis of the fecal samples in subjects receiving green tea and placebo showed similar bacterial diversity and community structures, indicating there were no significant changes in bacterial diversity between baseline and week 12 in subjects receiving green tea capsules or in subjects receiving placebo capsules. No significant interactions were observed between treatment (green tea or placebo) and time (baseline and week 12) for the gut microbial diversity. Although, there were no significant differences between normal weight and overweight subjects in response to green tea, we did observe a reduced bacterial alpha diversity in overweight as compared to normal weight subjects (p = 0.002). Conclusion Green tea supplementation for 12 weeks did not have a significant effect on composition of the gut microbiota.	[Janssens, Pilou L. H. R.; Hursel, Rick; Westerterp-Plantenga, Margriet S.] Maastricht Univ, Dept Human Biol, Sch Nutr & Translat Res Metab NUTRIM, NL-6200 MD Maastricht, Netherlands; [Penders, John; Savelkoul, Paul H. M.] Maastricht Univ, Med Ctr, Dept Med Microbiol, Sch Nutr & Translat Res Metab NUTRIM, NL-6200 MD Maastricht, Netherlands; [Budding, Andries E.; Savelkoul, Paul H. M.] Vrije Univ Amsterdam, Med Ctr, Dept Med Microbiol & Infect Control, Amsterdam, Netherlands	Maastricht University; Maastricht University; Vrije Universiteit Amsterdam	Janssens, PLHR (corresponding author), Maastricht Univ, Dept Human Biol, Sch Nutr & Translat Res Metab NUTRIM, NL-6200 MD Maastricht, Netherlands.	plhr.janssens@maastrichtuniversity.nl	Penders, John/A-1280-2011	Penders, John/0000-0001-9146-5919; Budding, Andries/0000-0001-5128-5411				[Anonymous], 2001, J OLEO SCI, DOI DOI 10.5650/JOS.50.599; Aura AM, 2005, EUR J NUTR, V44, P133, DOI 10.1007/s00394-004-0502-2; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Berube-Parent S, 2005, BRIT J NUTR, V94, P432, DOI 10.1079/BJN20051502; BRAY J. ROGER, 1957, ECOL MONOGR, V27, P325, DOI 10.2307/1942268; Budding AE, 2010, FASEB J, V24, P4556, DOI 10.1096/fj.10-156190; Cowan TE, 2014, J NUTR BIOCHEM, V25, P489, DOI 10.1016/j.jnutbio.2013.12.009; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040; Flint HJ, 2012, NAT REV GASTRO HEPAT, V9, P577, DOI 10.1038/nrgastro.2012.156; Graham C, 2015, NUTR REV, P1; Harada U, 2005, J HEALTH SCI, V51, P248, DOI 10.1248/jhs.51.248; Hsu TF, 2006, EUR J CLIN NUTR, V60, P1330, DOI 10.1038/sj.ejcn.1602464; Hursel R, 2011, NUTRIENTS, V3, P725, DOI 10.3390/nu3080725; Janssens PLHR, 2015, J NUTR, V145, P864, DOI 10.3945/jn.114.207829; Janssens PL, 2015, J NUTR; Jaquet M, 2009, INT J FOOD MICROBIOL, V130, P117, DOI 10.1016/j.ijfoodmicro.2009.01.011; Jin JS, 2012, MICROBIOL IMMUNOL, V56, P729, DOI 10.1111/j.1348-0421.2012.00502.x; Kozuma K, 2005, HYPERTENS RES, V28, P711, DOI 10.1291/hypres.28.711; Lee HC, 2006, RES MICROBIOL, V157, P876, DOI 10.1016/j.resmic.2006.07.004; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Matsuyama T, 2008, OBESITY, V16, P1338, DOI 10.1038/oby.2008.60; Most J, 2014, INT J OBESITY, V38, P698, DOI 10.1038/ijo.2013.231; Nagao T., 2001, Journal of Oleo Science, V50, P717; Nagao T, 2007, OBESITY, V15, P1473, DOI 10.1038/oby.2007.176; Oksanen J., **DATA OBJECT**; OKUBO T, 1992, BIOSCI BIOTECH BIOCH, V56, P588, DOI 10.1271/bbb.56.588; Parkar SG, 2008, INT J FOOD MICROBIOL, V124, P295, DOI 10.1016/j.ijfoodmicro.2008.03.017; Plasqui G, 2011, INT J OBESITY, V35, P1124, DOI 10.1038/ijo.2010.250; R Core Team, 2013, R LANG ENV STAT COMP; Rastmanesh R, 2011, CHEM-BIOL INTERACT, V189, P1, DOI 10.1016/j.cbi.2010.10.002; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Rudelle S, 2007, OBESITY, V15, P349, DOI 10.1038/oby.2007.529; Scalbert A, 2002, BIOMED PHARMACOTHER, V56, P276, DOI 10.1016/S0753-3322(02)00205-6; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Tzounis X, 2008, BRIT J NUTR, V99, P782, DOI 10.1017/S0007114507853384; Van Citters Gregg W, 2005, Curr Gastroenterol Rep, V7, P317; Wang H, OBESITY SILVER SPRIN, V18, P773; Wang HQ, 2010, OBESITY, V18, P773, DOI 10.1038/oby.2009.256; Westerterp-Plantenga MS, 2005, OBES RES, V13, P1195, DOI 10.1038/oby.2005.142; Williamson G, 2010, BRIT J NUTR, V104, pS48, DOI 10.1017/S0007114510003946; Zoetendal EG, 1998, APPL ENVIRON MICROB, V64, P3854	46	48	52	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153134	10.1371/journal.pone.0153134	http://dx.doi.org/10.1371/journal.pone.0153134			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27054321	Green Submitted, Green Published, gold			2022-12-27	WOS:000373608000083
J	Lee, JE; Kim, Y; Kim, KH; Lee, DY; Lee, Y				Lee, Jung-Eun; Kim, Yunjung; Kim, Kyoung Heon; Lee, Do Yup; Lee, Youngseok			Contribution of Drosophila TRPA1 to Metabolism	PLOS ONE			English	Article							EXTENDS LIFE-SPAN; CLUSTER-ANALYSIS; FATTY-ACIDS; METHIONINE; MELANOGASTER; RESTRICTION; HEAT; SUPPLEMENTATION; TOLERANCE; INCREASES	Transient receptor potential (TRP) cation channels are highly conserved in humans and insects. Some of these channels are expressed in internal organs and their functions remain incompletely understood. By direct knock-in of the GAL4 gene into the trpA1 locus in Drosophila, we identified the expression of this gene in the subesophageal ganglion (SOGs) region. In addition, the neurites present in the dorsal posterior region as well as the drosophila insulin-like peptide 2 (dILP2)-positive neurons send signals to the SOGs. The signal is sent to the crop, which is an enlarged organ of the esophagus and functions as a storage place for food in the digestive system. To systematically investigate the role of TRPA1 in metabolism, we applied non-targeted metabolite profiling analysis together with gas-chromatography/ time-of-flight mass spectrometry, with an aim to identify a wide range of primary metabolites. We effectively captured distinctive metabolomic phenotypes and identified specific metabolic dysregulation triggered by TRPA1 mutation based on reconstructed metabolic network analysis. Primarily, the network analysis pinpointed the simultaneous down-regulation of intermediates in the methionine salvation pathway, in contrast to the synchronized up-regulation of a range of free fatty acids. The gene dosage-dependent dynamics of metabolite levels among wild-type, hetero-and homozygous mutants, and their coordinated metabolic modulation under multiple gene settings across five different genotypes confirmed the direct linkages of TRPA1 to metabolism.	[Lee, Jung-Eun; Kim, Yunjung; Lee, Do Yup; Lee, Youngseok] Kookmin Univ, PLUS Project BK21, Dept Bio & Fermentat Convergence Technol, Seoul 02707, South Korea; [Kim, Kyoung Heon] Korea Univ, Grad Sch, Dept Biotechnol, Seoul, South Korea	Kookmin University; Korea University	Lee, DY; Lee, Y (corresponding author), Kookmin Univ, PLUS Project BK21, Dept Bio & Fermentat Convergence Technol, Seoul 02707, South Korea.	rome73@kookmin.ac.kr; ylee@kookmin.ac.kr	Kim, Kyoung Heon/F-1059-2013	Kim, Kyoung Heon/0000-0003-4600-8668; Lee, Youngseok/0000-0003-0459-1138	National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [2012M3A9B2052525]; Basic Science Research Program of the NRF of Korea - Ministry of Education [2014R1A1A2058094]; Bio & Medical Technology Development Program of the National Research Foundation (NRF) [NRF-2014M3A9B6069345, NRF 2013M3A9B6046519]	National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning; Basic Science Research Program of the NRF of Korea - Ministry of Education; Bio & Medical Technology Development Program of the National Research Foundation (NRF)	This work was supported by a grant to Y.L. from the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (2012M3A9B2052525), and the Basic Science Research Program of the NRF of Korea funded by the Ministry of Education (2014R1A1A2058094), and a grant to D.Y.L. from the Bio & Medical Technology Development Program of the National Research Foundation (NRF) (grant numbers: NRF-2014M3A9B6069345 and NRF 2013M3A9B6046519). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers E, 2009, IUBMB LIFE, V61, P1132, DOI 10.1002/iub.278; Billker O, 1998, NATURE, V392, P289, DOI 10.1038/32667; Chen Z, 2013, J ANIM PLANT SCI-PAK, V23, P1634; Conrad T, 2012, SCIENCE, V337, P742, DOI 10.1126/science.1221428; Dhaunsi GS, 2005, CELL BIOCHEM FUNCT, V23, P65, DOI 10.1002/cbf.1173; Donner TW, 2010, NUTR RES, V30, P801, DOI 10.1016/j.nutres.2010.09.007; Du EJ, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005773; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Elshorbagy AK, 2011, J LIPID RES, V52, P104, DOI 10.1194/jlr.M010215; Fiehn O, 2000, NAT BIOTECHNOL, V18, P1157, DOI 10.1038/81137; Fiehn O, SETUP ANNOTATION MET; Fiehn O, 2011, J BIOL CHEM, V286, P23637, DOI 10.1074/jbc.R110.173617; Flatt T, 2009, NATURE, V462, P989, DOI 10.1038/462989a; Fowler MA, 2013, LIFE SCI, V92, P394, DOI 10.1016/j.lfs.2012.07.029; Gerich JE, 1999, DIABETES OBES METAB, V1, P257, DOI 10.1046/j.1463-1326.1999.00027.x; Goto SG, 2010, BIOCHEM BIOPH RES CO, V391, P1251, DOI 10.1016/j.bbrc.2009.12.053; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; Holzer P, 2011, PHARMACOL THERAPEUT, V131, P142, DOI 10.1016/j.pharmthera.2011.03.006; HOTTIGER T, 1987, FEBS LETT, V220, P113, DOI 10.1016/0014-5793(87)80886-4; Huck JHJ, 2003, CLIN CHEM, V49, P1375, DOI 10.1373/49.8.1375; Islam R, 2013, J NEUROSCI, V33, P12306, DOI 10.1523/JNEUROSCI.5220-12.2013; Kang K, 2010, NATURE, V464, P597, DOI 10.1038/nature08848; Kim SH, 2010, P NATL ACAD SCI USA, V107, P8440, DOI 10.1073/pnas.1001425107; Kupers R, 2009, PAIN, V142, P89, DOI 10.1016/j.pain.2008.12.008; Kwon Y, 2010, CURR BIOL, V20, P1672, DOI 10.1016/j.cub.2010.08.016; Lee BC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4592; Lee DY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068831; Lee DY, 2012, MOL CELL PROTEOMICS, V11, P973, DOI 10.1074/mcp.M111.016733; Lee YM, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/210604; Lee Y, 2013, J NEUROSCI, V33, P6716, DOI 10.1523/JNEUROSCI.4237-12.2013; Lee Y, 2009, P NATL ACAD SCI USA, V106, P4495, DOI 10.1073/pnas.0811744106; Liedtke WB., 2006, TRP ION CHANNEL FUNC; Mary C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052877; Mashima R, 2003, ANAL BIOCHEM, V313, P28, DOI 10.1016/S0003-2697(02)00537-7; Miller RA, 2005, AGING CELL, V4, P119, DOI 10.1111/j.1474-9726.2005.00152.x; Min KJ, 2006, MECH AGEING DEV, V127, P643, DOI 10.1016/j.mad.2006.02.005; Pavlidis P, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-10-research0042; Russell P, 2014, BIOL DYNAMIC SCI; Sabri A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074656; Schauer R, 1997, N COMP BIOC B, V29, P243; Scholz M, SETUPX A PUBLIC STUD; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Troen AM, 2007, AGE, V29, P29, DOI 10.1007/s11357-006-9018-4; Vesala L, 2012, J EXP BIOL, V215, P2891, DOI 10.1242/jeb.069948; Virtanen JK, 2006, NUTR METAB CARDIOVAS, V16, P113, DOI 10.1016/j.numecd.2005.05.005	45	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0152935	10.1371/journal.pone.0152935	http://dx.doi.org/10.1371/journal.pone.0152935			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27055172	Green Published, gold, Green Submitted			2022-12-27	WOS:000373608000056
J	Xu, Q; Li, X; Wang, S; Wang, C; Huang, FF; Gao, Q; Wu, LJ; Tao, LX; Guo, J; Wang, W; Guo, XH				Xu, Qin; Li, Xia; Wang, Shuo; Wang, Chao; Huang, Fangfang; Gao, Qi; Wu, Lijuan; Tao, Lixin; Guo, Jin; Wang, Wei; Guo, Xiuhua			Fine Particulate Air Pollution and Hospital Emergency Room Visits for Respiratory Disease in Urban Areas in Beijing, China, in 2013	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; CASE-CROSSOVER; TIME-SERIES; GASEOUS-POLLUTANTS; COARSE PARTICLES; DAILY MORTALITY; INCREASED RISK; AMBIENT PM2.5; ADMISSIONS; MATTER	Background Heavy fine particulate matter (PM2.5) air pollution occurs frequently in China. However, epidemiological research on the association between short-term exposure to PM2.5 pollution and respiratory disease morbidity is still limited. This study aimed to explore the association between PM2.5 pollution and hospital emergency room visits (ERV) for total and cause-specific respiratory diseases in urban areas in Beijing. Methods Daily counts of respiratory ERV from Jan 1 to Dec 31, 2013, were obtained from ten general hospitals located in urban areas in Beijing. Concurrently, data on PM2.5 were collected from the Beijing Environmental Protection Bureau, including 17 ambient air quality monitoring stations. A generalized-additive model was used to explore the respiratory effects of PM2.5, after controlling for confounding variables. Subgroup analyses were also conducted by age and gender. Results A total of 92,464 respiratory emergency visits were recorded during the study period. The mean daily PM2.5 concentration was 102.1 +/- 73.6 mu g/m(3). Every 10 mu g/m(3) increase in PM2.5 concentration at lag(0) was associated with an increase in ERV, as follows: 0.23% for total respiratory disease (95% confidence interval [CI]: 0.11%-0.34%), 0.19% for upper respiratory tract infection (URTI) (95% CI: 0.04%-0.35%), 0.34% for lower respiratory tract infection (LRTI) (95% CI: 0.14%-0.53%) and 1.46% for acute exacerbation of chronic obstructive pulmonary disease (AECOPD) (95% CI: 0.13%-2.79%). The strongest association wasidentified between AECOPD and PM2.5 concentration at lag(0-3) (3.15%, 95% CI: 1.39%-4.91%). The estimated effects were robust after adjusting for SO2, O-3, CO and NO2. Females and people 60 years of age and older demonstrated a higher risk of respiratory disease after PM2.5 exposure. Conclusion PM2.5 was significantly associated with respiratory ERV, particularly for URTI, LRTI and AECOPD in Beijing. The susceptibility to PM2.5 pollution varied by gender and age.	[Xu, Qin; Li, Xia; Wang, Chao; Huang, Fangfang; Gao, Qi; Wu, Lijuan; Tao, Lixin; Guo, Jin; Wang, Wei; Guo, Xiuhua] Capital Med Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Beijing, Peoples R China; [Xu, Qin; Li, Xia; Wang, Chao; Huang, Fangfang; Gao, Qi; Wu, Lijuan; Tao, Lixin; Guo, Jin; Wang, Wei; Guo, Xiuhua] Beijing Municipal Key Lab Clin Epidemiol, Beijing, Peoples R China; [Li, Xia] Univ Limerick, Grad Entry Med Sch, Limerick, Ireland; [Wang, Shuo] Capital Med Univ, Beijing Chaoyang Hosp, Beijing, Peoples R China; [Wang, Wei] Edith Cowan Univ, Sch Med Sci, Perth, WA, Australia	Capital Medical University; University of Limerick; Capital Medical University; Edith Cowan University	Wang, W; Guo, XH (corresponding author), Capital Med Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Beijing, Peoples R China.; Wang, W; Guo, XH (corresponding author), Beijing Municipal Key Lab Clin Epidemiol, Beijing, Peoples R China.; Wang, W (corresponding author), Edith Cowan Univ, Sch Med Sci, Perth, WA, Australia.	wei.wang@ecu.edu.au; statguo@ccmu.edu.cn	TAO, Li/HIR-4254-2022; Gao, Qi/N-8721-2019	Gao, Qi/0000-0002-5370-5536	National Natural Science Foundation of China [81530087, 81373099, 81302516]; National Science and Technology Major Project [2012ZX10005009-003]; Importation and Development of High-Calibre Talents Project of Beijing Municipal Institutions [IDHT20130213]; MOE (Ministry of Education of the People's Republic of China) Project of Humanities, Social Sciences [7131002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Project; Importation and Development of High-Calibre Talents Project of Beijing Municipal Institutions; MOE (Ministry of Education of the People's Republic of China) Project of Humanities, Social Sciences	XG is supported by National Natural Science Foundation of China (grant number: 81530087 and 81373099, http://www.nsfc.gov.cn/), National Science and Technology Major Project (grant number: 2012ZX10005009-003, http://www.nmp.gov.cn/). WW is supported by the Importation and Development of High-Calibre Talents Project of Beijing Municipal Institutions (grant number: IDHT20130213, http://www.beijing.gov.cn/). XL is supported by National Natural Science Foundation of China (grant number: 81302516, http://www.nsfc.gov.cn/), MOE (Ministry of Education of the People's Republic of China) Project of Humanities, Social Sciences (grant number: 7131002, http://www.moe.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman DG, 2003, BMJ-BRIT MED J, V326, P219, DOI 10.1136/bmj.326.7382.219; Beelen R, 2014, LANCET, V383, P785, DOI 10.1016/S0140-6736(13)62158-3; Bell ML, 2015, EPIDEMIOLOGY, V26, P575, DOI 10.1097/EDE.0000000000000310; Belleudi V, 2010, EPIDEMIOLOGY, V21, P414, DOI 10.1097/EDE.0b013e3181d5c021; Cakmak S, 2006, J OCCUP ENVIRON MED, V48, P89, DOI 10.1097/01.jom.0000184878.11956.4b; Chen Y, 2005, INHAL TOXICOL, V17, P649, DOI 10.1080/08958370500189420; Cheng MH, 2014, J TOXICOL ENV HEAL A, V77, P1075, DOI 10.1080/15287394.2014.922387; Dai LZ, 2014, ENVIRON HEALTH PERSP, V122, P837, DOI 10.1289/ehp.1307568; Dominici F, 2006, JAMA-J AM MED ASSOC, V295, P1127, DOI 10.1001/jama.295.10.1127; Dominici F, 2012, JAMA-J AM MED ASSOC, V307, P2100, DOI 10.1001/jama.2012.4601; Goldman GT, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-61; Guo YM, 2014, SCI REP-UK, V4, DOI 10.1038/srep05509; Guo YM, 2010, SCI TOTAL ENVIRON, V409, P300, DOI 10.1016/j.scitotenv.2010.10.013; Halonen JI, 2008, THORAX, V63, P635, DOI 10.1136/thx.2007.091371; Halonen JI, 2009, EPIDEMIOLOGY, V20, P143, DOI 10.1097/EDE.0b013e31818c7237; Happo MS, 2010, INHAL TOXICOL, V22, P402, DOI 10.3109/08958370903527908; Host S, 2008, OCCUP ENVIRON MED, V65, P544, DOI 10.1136/oem.2007.036194; Ito K, 2007, J EXPO SCI ENV EPID, V17, pS45, DOI 10.1038/sj.jes.7500627; Kan HD, 2008, ENVIRON HEALTH PERSP, V116, P1183, DOI 10.1289/ehp.10851; Li L, 2014, INT J ENV RES PUB HE, V11, P8909, DOI 10.3390/ijerph110908909; Li MN, 2014, ENVIRON POLLUT, V189, P85, DOI 10.1016/j.envpol.2014.02.024; Li P, 2013, ENVIRON SCI POLLUT R, V20, P6433, DOI 10.1007/s11356-013-1688-8; Li Y, 2015, INT J BIOMETEOROL, V59, P1761, DOI 10.1007/s00484-015-0984-z; Lu F, 2015, ENVIRON RES, V136, P196, DOI 10.1016/j.envres.2014.06.029; Lv J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124586; Ma WJ, 2014, ENVIRON RES, V134, P127, DOI 10.1016/j.envres.2014.07.007; Qian ZM, 2010, J AIR WASTE MANAGE, V60, P481, DOI 10.3155/1047-3289.60.4.481; Qiu H, 2014, THORAX, V69, P1027, DOI 10.1136/thoraxjnl-2014-205429; Qiu H, 2013, INT J CARDIOL, V168, P500, DOI 10.1016/j.ijcard.2012.09.199; Samoli E, 2005, ENVIRON HEALTH PERSP, V113, P88, DOI 10.1289/ehp.7387; Samoli E, 2014, ENVIRON INT, V67, P54, DOI 10.1016/j.envint.2014.02.013; Schwartz J, 2002, ENVIRON HEALTH PERSP, V110, P1025, DOI 10.1289/ehp.021101025; Sunyer J, 2000, AM J EPIDEMIOL, V151, P50, DOI 10.1093/oxfordjournals.aje.a010121; Tian LW, 2014, AM J EPIDEMIOL, V180, P1159, DOI 10.1093/aje/kwu248; Tsai SS, 2014, J TOXICOL ENV HEAL A, V77, P1091, DOI 10.1080/15287394.2014.922388; Tsai SS, 2013, INT J ENV RES PUB HE, V10, P6015, DOI 10.3390/ijerph10116015; Wang YG, 2014, ENVIRON INT, V73, P413, DOI 10.1016/j.envint.2014.08.016; Winquist A, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-68; Wong CM, 2001, ENVIRON HEALTH PERSP, V109, P335, DOI 10.2307/3454891; Xie WX, 2015, HEART, V101, P257, DOI 10.1136/heartjnl-2014-306165; Xiong QL, 2015, INT J ENV RES PUB HE, V12, P11880, DOI 10.3390/ijerph120911880; Xu MM, 2014, ENVIRON HEALTH-GLOB, V13, DOI 10.1186/1476-069X-13-109; Yang CX, 2012, INT ARCH OCC ENV HEA, V85, P579, DOI 10.1007/s00420-011-0707-7; Zhao H, 2014, TOXICOLOGY, V325, P180, DOI 10.1016/j.tox.2014.09.006; Zheng S, 2013, INT J ENV RES PUB HE, V10, P462, DOI 10.3390/ijerph10020462; Zhou MG, 2015, ENVIRON RES, V136, P396, DOI 10.1016/j.envres.2014.09.038	46	124	137	1	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153099	10.1371/journal.pone.0153099	http://dx.doi.org/10.1371/journal.pone.0153099			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27054582	Green Published, gold, Green Submitted			2022-12-27	WOS:000373608000076
J	Han, D; Hartaigh, BO; Lee, JH; Cho, IJ; Shim, CY; Chang, HJ; Hong, GR; Ha, JW; Chung, N				Han, Donghee; Hartaigh, Briain O.; Lee, Ji Hyun; Cho, In-Jeong; Shim, Chi Young; Chang, Hyuk-Jae; Hong, Geu-Ru; Ha, Jong-Won; Chung, Namsik			Impact of D-Dimer for Prediction of Incident Occult Cancer in Patients with Unprovoked Venous Thromboembolism	PLOS ONE			English	Article							DEEP-VEIN THROMBOSIS; PULMONARY-EMBOLISM; POOR-PROGNOSIS; RISK; MANAGEMENT; DIAGNOSIS	Background Unprovoked venous thromboembolism (VTE) is related to a higher incidence of occult cancer. D-dimer is clinically used for screening VTE, and has often been shown to be present in patients with malignancy. We explored the predictive value of D-dimer for detecting occult cancer in patients with unprovoked VTE. Methods We retrospectively examined data from 824 patients diagnosed with deep vein thrombosis or pulmonary thromboembolism. Of these, 169 (20.5%) patients diagnosed with unprovoked VTE were selected to participate in this study. D-dimer was categorized into three groups as: <2,000, 2,000-4,000, and >4,000 ng/ml. Cox regression analysis was employed to estimate the odds of occult cancer and metastatic state of cancer according to D-dimer categories. Results During a median 5.3 (interquartile range: 3.4-6.7) years of follow-up, 24 (14%) patients with unprovoked VTE were diagnosed with cancer. Of these patients, 16 (67%) were identified as having been diagnosed with metastatic cancer. Log transformed D-dimer levels were significantly higher in those with occult cancer as compared with patients without diagnosis of occult cancer (3.5 +/- 0.5 vs. 3.2 +/- 0.5, P-value = 0.009, respectively). D-dimer levels >4,000 ng/ml was independently associated with occult cancer (HR: 4.12, 95% CI: 1.54-11.04, P-value = 0.005) when compared with D-dimer levels <2,000 ng/ml, even after adjusting for age, gender, and type of VTE (e.g., deep vein thrombosis or pulmonary thromboembolism). D-dimer levels >4000 ng/ml were also associated with a higher likelihood of metastatic cancer (HR: 9.55, 95% CI: 2.46-37.17, P-value <0.001). Conclusion Elevated D-dimer concentrations >4000 ng/ml are independently associated with the likelihood of occult cancer among patients with unprovoked VTE.	[Han, Donghee; Lee, Ji Hyun; Cho, In-Jeong; Shim, Chi Young; Chang, Hyuk-Jae; Hong, Geu-Ru; Ha, Jong-Won; Chung, Namsik] Yonsei Univ, Coll Med, Severance Hosp, Dept Internal Med,Div Cardiol, Seoul, South Korea; [Hartaigh, Briain O.] New York Presbyterian Hosp, Dalio Inst Cardiovasc Imaging, New York, NY USA; [Hartaigh, Briain O.] Weill Cornell Med Ctr, New York, NY USA	Yonsei University; Yonsei University Health System; NewYork-Presbyterian Hospital; Cornell University	Hong, GR (corresponding author), Yonsei Univ, Coll Med, Severance Hosp, Dept Internal Med,Div Cardiol, Seoul, South Korea.	grhong@yuhs.ac	Shim, Chi Young/AAK-1057-2021	Shim, Chi Young/0000-0002-6136-0136; Chang, Hyuk-Jae/0000-0002-6139-7545; Hong, Geu-Ru/0000-0003-4981-3304; Ha, Jong-Won/0000-0002-8260-2958				Ay C, 2012, HAEMATOL-HEMATOL J, V97, P1158, DOI 10.3324/haematol.2011.054718; Carrier M, 2008, ANN INTERN MED, V149, P323, DOI 10.7326/0003-4819-149-5-200809020-00007; Carrier M, 2015, NEW ENGL J MED, V373, P697, DOI 10.1056/NEJMoa1506623; Carrier M, 2009, THROMB HAEMOSTASIS, V101, P886, DOI 10.1160/TH-08-10-0689; Cushman M, 2003, BLOOD, V101, P1243, DOI 10.1182/blood-2002-05-1416; Douketis JD, 2009, J THROMB HAEMOST, V7, P546, DOI 10.1111/j.1538-7836.2008.03268.x; Heit JA, 2002, ARCH INTERN MED, V162, P1245, DOI 10.1001/archinte.162.11.1245; Konstantinides SV, 2014, EUR HEART J, V35, P3033, DOI 10.1093/eurheartj/ehu283; Palareti G, 2006, NEW ENGL J MED, V355, P1780, DOI 10.1056/NEJMoa054444; Palumbo JS, 2000, BLOOD, V96, P3302, DOI 10.1182/blood.V96.10.3302; Piccioli A, 2004, J THROMB HAEMOST, V2, P884, DOI 10.1111/j.1538-7836.2004.00720.x; Rege KR, 2004, THROMB HAEMOSTASIS, V91, P1219, DOI 10.1160/TH03-11-0699; Rothman KJ., 2008, MODERN EPIDEMIOLOGY; Sakurai M, 2015, INT J GYNECOL CANCER, V25, P593, DOI 10.1097/IGC.0000000000000415; Schutgens REG, 2005, HAEMATOLOGICA, V90, P214; Sorensen HT, 1998, NEW ENGL J MED, V338, P1169, DOI 10.1056/NEJM199804233381701; Timp JF, 2013, BLOOD, V122, P1712, DOI 10.1182/blood-2013-04-460121; van Doormaal FF, 2011, J THROMB HAEMOST, V9, P79, DOI 10.1111/j.1538-7836.2010.04101.x	18	24	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153514	10.1371/journal.pone.0153514	http://dx.doi.org/10.1371/journal.pone.0153514			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073982	Green Published, gold, Green Submitted			2022-12-27	WOS:000374131200102
J	Plessow, R; Arora, NK; Brunner, B; Wieser, S				Plessow, Rafael; Arora, Narendra Kumar; Brunner, Beatrice; Wieser, Simon			Cost-Effectiveness of Price Subsidies on Fortified Packaged Infant Cereals in Reducing Iron Deficiency Anemia in 6-23-Month-Old-Children in Urban India	PLOS ONE			English	Article							WILLINGNESS-TO-PAY; EXPERIMENTAL AUCTIONS; BIAS	Introduction Iron deficiency anaemia (IDA) is a major public health problem in India and especially harmful in early childhood due to its impact on cognitive development and increased all-cause mortality. We estimate the cost-effectiveness of price subsidies on fortified packaged infant cereals (F-PICs) in reducing IDA in 6-23-monthold children in urban India. Materials and Methods Cost-effectiveness is estimated by comparing the net social cost of price subsidies with the disability-adjusted life-years (DALYs) averted with price subsidies. The net social costs correspond to the cost of the subsidy minus the monetary costs saved by reducing IDA. The estimation proceeds in three steps: 1) the current lifetime costs of IDA are assessed with a health economic model combining the prevalence of anemia, derived from a large population survey, with information on the health consequences of IDA and their costs in terms of mortality, morbidity, and DALYs. 2) The effects of price subsidies on the demand for F-PICs are assessed with a market survey among 4801 households in 12 large Indian cities. 3) The cost-effectiveness is calculated by combining the findings of the first two steps with the results of a systematic review on the effectiveness of F-PICs in reducing IDA. We compare the cost-effectiveness of interventions that differ in the level of the subsidy and in the socioeconomic strata (SES) eligible for the subsidy. Results The lifetime social costs of IDA in 6-23-month-old children in large Indian cities amount to production losses of 3222 USD and to 726,000 DALYs. Poor households incur the highest costs, yet even wealthier households suffer substantial losses. The market survey reveals that few households currently buy F-PICs, with the share ranging from 14% to 36%. Wealthier households are generally more likely to buy FPICs. The costs of the subsidies per DALY averted range from 909 to 3649 USD. Interventions targeted at poorer households are most effective. Almost all interventions are cost saving from a societal perspective when taking into account the reduction of future production losses. Return per DALY averted ranges between gains of 1655 USD to a cost of 411 USD. Conclusion Price subsidies on F-PICs are a cost-effective way to reduce the social costs of IDA in 6-23-month-old children in large Indian cities. Interventions targeting poorer households are especially cost-effective.	[Plessow, Rafael; Brunner, Beatrice; Wieser, Simon] Zurich Univ Appl Sci, Winterthur Inst Hlth Econ, Winterthur, Switzerland; [Arora, Narendra Kumar] INCLEN, Int Clin Epidemiol Network, New Delhi, India	Zurich University of Applied Sciences	Wieser, S (corresponding author), Zurich Univ Appl Sci, Winterthur Inst Hlth Econ, Winterthur, Switzerland.	simon.wieser@zhaw.ch	Wieser, Simon/AAC-1589-2022; Wieser, Simon/AAH-6581-2020	Wieser, Simon/0000-0003-1821-2944	Nestle Research Center (Switzerland)	Nestle Research Center (Switzerland)	The study was partially funded by the Nestle Research Center (Switzerland) and speaker honorarium and conference travel grants were provided to SW. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. NKA has received no funding for this study.	Agarwal R, 2013, NEONATOLOGY, V103, P54, DOI 10.1159/000342227; Alvarez-Uria G, 2014, ANEMIA, V2014, DOI 10.1155/2014/176182; Anand T, 2014, NUTRITION, V30, P764, DOI 10.1016/j.nut.2013.11.022; [Anonymous], 2015, WORLD EC OUTLOOK DAT; Ashraf N, 2010, AM ECON REV, V100, P2383, DOI 10.1257/aer.100.5.2383; Blumenschein K, 2008, ECON J, V118, P114; Cohen J, 2010, Q J ECON, V125, P1, DOI 10.1162/qjec.2010.125.1.1; Corrigan JR, 2009, AM J AGR ECON, V91, P837, DOI 10.1111/j.1467-8276.2009.01267.x; De Groote H, 2011, AGR ECON-BLACKWELL, V42, P1, DOI 10.1111/j.1574-0862.2010.00466.x; Dewey KG, 2013, J NUTR, V143, P2050, DOI 10.3945/jn.113.182527; Dewey KG., 2013, STRATEGIES ENSURING; Eichler K, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-506; Fiszbein A, 2009, CONDITIONAL CASH TRA; Global Alliance for Improved Nutrition (GAIN), 2015, GAIN IYCN WORK PAP S; Government of India, 2014, CENS OF IND 2011; Institute for Health Metrics and Evaluation (IHME), 2013, GBD PROF; International Institute for Population Sciences (IIPS) and Macro International, 2007, NAT FAM HLTH SURV NF; Jha R, 2011, J ASIAN ECON, V22, P189, DOI 10.1016/j.asieco.2010.11.004; Kotecha Prakash V, 2011, Indian J Community Med, V36, P8, DOI 10.4103/0970-0218.80786; Lozoff B, 2006, ARCH PEDIAT ADOL MED, V160, P1108, DOI 10.1001/archpedi.160.11.1108; Lutter Chessa K., 2003, Food and Nutrition Bulletin, V24, P83; Morwitz VG, 2007, INT J FORECASTING, V23, P347, DOI 10.1016/j.ijforecast.2007.05.015; Nestle India, 2013, CHART ETH RESP BEH S; Pasricha SR, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-617; Plessow R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136581; Poverty Action Lab, 2011, PRIC IS WRONG J PAL; Ram, 2009, EC POLITICAL WEEKLY, VXLIV; Rutstein S. O., 2004, DHS WEALTH INDEX; Sachdev HPS, 2013, EUR J CLIN NUTR, V67, P475, DOI 10.1038/ejcn.2012.212; Sridhar T, 2014, INT J SOCIOL SOC POL, V34, P107; Stekhoven D.J, 2013, MISSFOREST NONPARAME; Stekhoven DJ, 2012, BIOINFORMATICS, V28, P112, DOI 10.1093/bioinformatics/btr597; Webb J.R., 2002, UNDERSTANDING DESIGN; Whitehead JC, 2007, RESOUR ENERGY ECON, V29, P247, DOI 10.1016/j.reseneeco.2006.10.001; World Bank, WORLD BANK DAT 2015; World Health Organization, 2002, COST EFF STRAT PLANN; World Health Organization, 2003, UN GLOB STRAT INF YO; World Health Organization, 2008, INT COD MARK BREAST; Yip R, 2002, J NUTR, V132, p859S, DOI 10.1093/jn/132.4.859S	39	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0152800	10.1371/journal.pone.0152800	http://dx.doi.org/10.1371/journal.pone.0152800			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ3UC	27073892	Green Published, Green Submitted, gold			2022-12-27	WOS:000374131200038
J	Tang, CZ; Zhao, ZY; Chen, C; Zheng, XH; Sun, FF; Zhang, XL; Tian, J; Fan, MX; Wu, Y; Jia, J				Tang, Chaozheng; Zhao, Zhiyong; Chen, Chuang; Zheng, Xiaohui; Sun, Fenfen; Zhang, Xiaoli; Tian, Jing; Fan, Mingxia; Wu, Yi; Jia, Jie			Decreased Functional Connectivity of Homotopic Brain Regions in Chronic Stroke Patients: A Resting State fMRI Study	PLOS ONE			English	Article							UPPER-EXTREMITY FUNCTION; HUMAN CEREBELLUM; MOTOR RECOVERY; REORGANIZATION; TOPOGRAPHY; PREDICTION; DOMAINS; SYSTEMS; TASKS	The recovery of motor functions is accompanied by brain reorganization, and identifying the inter-hemispheric interaction post stroke will conduce to more targeted treatments. However, the alterations of bi-hemispheric coordination pattern between homologous areas in the whole brain for chronic stroke patients were still unclear. The present study focuses on the functional connectivity (FC) of mirror regions of the whole brain to investigate the inter-hemispheric interaction using a new fMRI method named voxel-mirrored homotopic connectivity (VMHC). Thirty left subcortical chronic stroke patients with pure motor deficits and 37 well-matched healthy controls (HCs) underwent resting-state fMRI scans. We employed a VMHC analysis to determine the brain areas showed significant differences between groups in FC between homologous regions, and we explored the relationships between the mean VMHC of each survived area and clinical tests within patient group using Pearson correlation. In addition, the brain areas showed significant correlations between the mean VMHC and clinical tests were defined as the seed regions for whole brain FC analysis. Relative to HCs, patients group displayed lower VMHC in the precentral gyrus, postcentral gyrus, inferior frontal gyrus, middle temporal gyrus, calcarine gyrus, thalamus, cerebellum anterior lobe, and cerebellum posterior lobe (CPL). Moreover, the VMHC of CPL was positively correlated with the Fugl-Meyer Score of hand (FMA-H), while a negative correlation between illness duration and the VMHC of this region was also detected. Furthermore, we found that when compared with HCs, the right CPL exhibited reduced FC with the left precentral gyrus, inferior frontal gyrus, inferior parietal lobule, middle temporal gyrus, thalamus and hippocampus. Our results suggest that the functional coordination across hemispheres is impaired in chronic stroke patients, and increased VMHC of the CPL is significantly associated with higher FMA-H scores. These findings may be helpful in understanding the mechanism of hand deficit after stroke, and the CPL may serve as a target region for hand rehabilitation following stroke.	[Tang, Chaozheng; Zhang, Xiaoli; Tian, Jing; Wu, Yi; Jia, Jie] Fudan Univ, Dept Rehabil Med, Huashan Hosp, Shanghai 200433, Peoples R China; [Zhao, Zhiyong; Zheng, Xiaohui; Fan, Mingxia] E China Normal Univ, Shanghai Key Lab Magnet Resonance, Shanghai 200062, Peoples R China; [Chen, Chuang] Fujian Univ Tradit Chinese Med, Coll Rehabil Med, Fuzhou, Peoples R China; [Sun, Fenfen] E China Normal Univ, Sch Psychol & Cognit Sci, Shanghai 200062, Peoples R China; [Jia, Jie] Jingan Dist Ctr Hosp, Dept Rehabil Med, Shanghai, Peoples R China	Fudan University; East China Normal University; Fujian University of Traditional Chinese Medicine; East China Normal University	Jia, J (corresponding author), Fudan Univ, Dept Rehabil Med, Huashan Hosp, Shanghai 200433, Peoples R China.; Jia, J (corresponding author), Jingan Dist Ctr Hosp, Dept Rehabil Med, Shanghai, Peoples R China.	shannonjj@126.com		Tang, Chaozheng/0000-0002-2021-9988	12th Five-Year Supporting Project of Ministry of Science and Technology of the People's Republic of China [2013BAI10B03]; Research Plan of National Natural Science Foundation of China (NSFC) Awarded Project [31450110072]; Development Program of China (863 program) [SS2015AA020501]	12th Five-Year Supporting Project of Ministry of Science and Technology of the People's Republic of China; Research Plan of National Natural Science Foundation of China (NSFC) Awarded Project(National Natural Science Foundation of China (NSFC)); Development Program of China (863 program)(National High Technology Research and Development Program of China)	This work was granted by the 12th Five-Year Supporting Project of Ministry of Science and Technology of the People's Republic of China (2013BAI10B03), the Research Plan of National Natural Science Foundation of China (NSFC) Awarded Project (31450110072) and the Development Program of China (863 program, SS2015AA020501). JJ received the funding. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson J. S., 2010, CEREB CORTEX; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Avenanti A, 2012, NEUROLOGY, V78, P256, DOI 10.1212/WNL.0b013e3182436558; Beebe JA, 2009, STROKE, V40, P1772, DOI 10.1161/STROKEAHA.108.536763; Carter AR, 2010, ANN NEUROL, V67, P365, DOI 10.1002/ana.21905; Dacosta-Aguayo R, 2014, HUM BRAIN MAPP, V35, P3819, DOI 10.1002/hbm.22439; Elsner B, 2013, COCHRANE LIB; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Guo WB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071368; Hoptman MJ, 2012, SCHIZOPHR RES, V141, P1, DOI 10.1016/j.schres.2012.07.027; Hu XF, 2015, J NEUROL, V262, P760, DOI 10.1007/s00415-014-7627-x; Inman CS, 2012, NEUROIMAGE, V59, P227, DOI 10.1016/j.neuroimage.2011.07.083; Kelly C, 2011, BIOL PSYCHIAT, V69, P684, DOI 10.1016/j.biopsych.2010.11.022; Krienen FM, 2009, CEREB CORTEX, V19, P2485, DOI 10.1093/cercor/bhp135; Liang BS, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00645; Loubinoux I, 2003, NEUROIMAGE, V20, P2166, DOI 10.1016/j.neuroimage.2003.08.017; Loubinoux I, 2007, CEREB CORTEX, V17, P2980, DOI 10.1093/cercor/bhm023; MacIntosh BJ, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00060; Milenkovic S, 2013, LATERALITY, V18, P340, DOI 10.1080/1357650X.2012.683196; Nudo RJ, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00887; O'Reilly JX, 2010, CEREB CORTEX, V20, P953, DOI 10.1093/cercor/bhp157; Park CH, 2011, STROKE, V42, P1357, DOI 10.1161/STROKEAHA.110.596155; Puh U, 2007, INT J PSYCHOPHYSIOL, V63, P173, DOI 10.1016/j.ijpsycho.2006.03.011; Salvador R, 2005, CEREB CORTEX, V15, P1332, DOI 10.1093/cercor/bhi016; Schlaug G, 2013, FRONT NEUROL, V4, DOI [10.3389/fneur.2013.00004, DOI 10.3389/FNEUR.2013.00004]; Schmahmann JD, 2009, NEUROSCIENCE, V162, P852, DOI 10.1016/j.neuroscience.2009.06.023; Schoch B, 2006, NEUROIMAGE, V30, P36, DOI 10.1016/j.neuroimage.2005.09.018; Stinear C, 2010, LANCET NEUROL, V9, P1228, DOI 10.1016/S1474-4422(10)70247-7; Stinear CM, 2012, BRAIN, V135, P2527, DOI 10.1093/brain/aws146; Stoodley CJ, 2012, NEUROIMAGE, V59, P1560, DOI 10.1016/j.neuroimage.2011.08.065; Stoodley CJ, 2010, CORTEX, V46, P831, DOI 10.1016/j.cortex.2009.11.008; Stoodley CJ, 2009, NEUROIMAGE, V44, P489, DOI 10.1016/j.neuroimage.2008.08.039; Sun HX, 2013, J STROKE, V15, P109, DOI 10.5853/jos.2013.15.2.109; Thiel A, 2015, STROKE, V46, P296, DOI 10.1161/STROKEAHA.114.006307; Urbin MA, 2014, NEUROREHAB NEURAL RE, V28, P761, DOI 10.1177/1545968314522349; Veerbeek JM, 2011, STROKE, V42, P1482, DOI 10.1161/STROKEAHA.110.604090; Wang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060191; Ward NS, 2004, ARCH NEUROL-CHICAGO, V61, P1844, DOI 10.1001/archneur.61.12.1844; Ward NS, 2003, BRAIN, V126, P1430, DOI 10.1093/brain/awg145; Xu HJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084729; Yin D, 2013, AM J NEURORADIOL, V34, P1341, DOI 10.3174/ajnr.A3410; Yin DZ, 2013, NEURORADIOLOGY, V55, P761, DOI 10.1007/s00234-013-1146-9; Zuo XN, 2014, NEUROSCI BIOBEHAV R, V45, P100, DOI 10.1016/j.neubiorev.2014.05.009; Zuo XN, 2010, J NEUROSCI, V30, P15034, DOI 10.1523/JNEUROSCI.2612-10.2010	44	41	48	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0152875	10.1371/journal.pone.0152875	http://dx.doi.org/10.1371/journal.pone.0152875			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27074031	Green Submitted, Green Published, gold			2022-12-27	WOS:000374131200041
J	Asante, A; Price, J; Hayen, A; Jan, S; Wiseman, V				Asante, Augustine; Price, Jennifer; Hayen, Andrew; Jan, Stephen; Wiseman, Virginia			Equity in Health Care Financing in Low- and Middle-Income Countries: A Systematic Review of Evidence from Studies Using Benefit and Financing Incidence Analyses	PLOS ONE			English	Article							USER FEES; POOR; PROGRESSIVITY; AFRICA; INSURANCE; SERVICES; COVERAGE; ACCESS; REFORM; PAYS	Introduction Health financing reforms in low-and middle-income countries (LMICs) over the past decades have focused on achieving equity in financing of health care delivery through universal health coverage. Benefit and financing incidence analyses are two analytical methods for comprehensively evaluating how well health systems perform on these objectives. This systematic review assesses progress towards equity in health care financing in LMICs through the use of BIA and FIA. Methods and Findings Key electronic databases including Medline, Embase, Scopus, Global Health, CinAHL, EconLit and Business Source Premier were searched. We also searched the grey literature, specifically websites of leading organizations supporting health care in LMICs. Only studies using benefit incidence analysis (BIA) and/or financing incidence analysis (FIA) as explicit methodology were included. A total of 512 records were obtained from the various sources. The full texts of 87 references were assessed against the selection criteria and 24 were judged appropriate for inclusion. Twelve of the 24 studies originated from sub-Saharan Africa, nine from the Asia-Pacific region, two from Latin America and one from the Middle East. The evidence points to a pro-rich distribution of total health care benefits and progressive financing in both sub-Saharan Africa and Asia-Pacific. In the majority of cases, the distribution of benefits at the primary health care level favoured the poor while hospital level services benefit the better-off. A few Asian countries, namely Thailand, Malaysia and Sri Lanka, maintained a pro-poor distribution of health care benefits and progressive financing. Conclusion Studies evaluated in this systematic review indicate that health care financing in LMICs benefits the rich more than the poor but the burden of financing also falls more on the rich. There is some evidence that primary health care is pro-poor suggesting a greater investment in such services and removal of barriers to care can enhance equity. The results overall suggest that there are impediments to making health care more accessible to the poor and this must be addressed if universal health coverage is to be a reality.	[Asante, Augustine; Price, Jennifer; Hayen, Andrew; Wiseman, Virginia] Univ New S Wales, Sch Publ Hlth & Community Med, Sydney, NSW, Australia; [Jan, Stephen] George Inst Global Hlth, Sydney, NSW 2000, Australia; [Jan, Stephen] Univ Sydney, Sydney, NSW 2006, Australia; [Wiseman, Virginia] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London WC1, England	University of New South Wales Sydney; George Institute for Global Health; University of Sydney; University of Sydney; University of London; London School of Hygiene & Tropical Medicine	Asante, A (corresponding author), Univ New S Wales, Sch Publ Hlth & Community Med, Sydney, NSW, Australia.	a.asante@unsw.edu.au	Wiseman, Virginia/AAH-5011-2021; Jan, Stephen/AAG-3333-2021	Jan, Stephen/0000-0003-2839-1405; Hayen, Andrew/0000-0003-4046-8030; Wiseman, Virginia/0000-0002-7911-0741	Australian Government; Department of Foreign Affairs and Trade (DFAT)	Australian Government(Australian GovernmentCGIAR); Department of Foreign Affairs and Trade (DFAT)	This research was funded through a grant from the Australian Government under the Australian Development Research Awards Scheme (ADRAS). This document is an output from research funded by the Department of Foreign Affairs and Trade (DFAT). The views and opinions expressed in this document are those of the authors and do not necessarily reflect the views of DFAT or the Australian Government. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADB, 2012, IMP OUT OF POCK EXP; Akazili J, 2012, HEALTH POLICY PLANN, V27, pi13, DOI 10.1093/heapol/czs004; Angeles G, 2007, INT J PUBLIC POLICY, V2, P186; Anselmi L, 2015, HEALTH POLICY PLANN, V30, P528, DOI 10.1093/heapol/czu034; Asante AD, 2014, BMJ OPEN, P4; Castano RA, 2002, HEALTH POLICY PLANN, V17, P5, DOI 10.1093/heapol/17.suppl_1.5; Castro-Leal F, 2000, B WORLD HEALTH ORGAN, V78, P66; Chakraborty LS, 2013, ANAL PUBLIC EXPENDIT; Chen MS, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-466; Chopra M, 2012, LANCET, V380, P1331, DOI 10.1016/S0140-6736(12)61423-8; Chuma J, 2012, BMC PUBLIC HEALTH, V12, DOI [10.1186/1472-6963-12-413, 10.1186/1471-2458-12-20]; Uga MAD, 2007, HEALTH AFFAIR, V26, P1017, DOI 10.1377/hlthaff.26.4.1017; *GHAN STAT SERV, 2004, GHAN DEM HLTH SURV 2; Ghana Statistical Service Ghana Health Service and ICF International, 2015, GHAN DEM HLTH SURV 2; Gilson L, 1997, HEALTH POLICY PLANN, V12, P273, DOI 10.1093/oxfordjournals.heapol.a018882; Gilson L, 2005, BMJ-BRIT MED J, V331, P762, DOI 10.1136/bmj.331.7519.762; Halasa Y., 2010, Eastern Mediterranean Health Journal, V16, P467; ILO, 2008, SOC HLTH PROT ILO ST; Ir P, 2009, LANCET, V374, P608, DOI 10.1016/S0140-6736(09)61515-4; John EU, 2013, AM J PUBLIC HLTH RES, V1, P196, DOI [DOI 10.12691/ajphr-1-8-1, 10.12691/ajphr-1-8-1]; KAKWANI NC, 1977, ECON J, V87, P71, DOI 10.2307/2231833; Kenya National Bureau of Statistics, 2004, KEN DEM HLTH SURV 20; Kenya National Bureau of Statistics Ministry of Health National AIDS Control Council Kenya Medical Research Institute, 2015, KEN DEM HLTH SURV 20; Kruk ME, 2010, SOC SCI MED, V70, P904, DOI 10.1016/j.socscimed.2009.11.025; Kwon S., 2012, DIRECT HOUSEHOLD PAY; Limwattananon S, 2011, EQUITY IMPACT UNIVER; Mangham L., 2006, Malawi Medical Journal, V18, P60; McIntyre D, 2006, SOC SCI MED, V62, P858, DOI 10.1016/j.socscimed.2005.07.001; McIntyre D, 2011, HEALTH POLICY PLANN, V26, P174, DOI 10.1093/heapol/czq031; Mejía Mejía Aurelio, 2013, Lect. Econ., P229; Mills A, 2012, LANCET, V380, P126, DOI 10.1016/S0140-6736(12)60357-2; Mtei G, 2012, HEALTH POLICY PLANN, V27, pi23, DOI 10.1093/heapol/czs018; Murphy B, 2014, MED J AUSTRALIA, V200, P615, DOI 10.5694/mja14.00632; Nigeria National Population Commission ICF International, 2014, NIG DEM HLTH SURV 20; Noirhomme M, 2007, HEALTH POLICY PLANN, V22, P246, DOI 10.1093/heapol/czm015; Nyonator F, 1999, HEALTH POLICY PLANN, V14, P329, DOI 10.1093/heapol/14.4.329; O'Donnell O, 2008, J HEALTH ECON, V27, P460, DOI 10.1016/j.jhealeco.2007.08.005; O'Donnell O, 2007, CAD SAUDE PUBLICA, V23, P2820, DOI 10.1590/S0102-311X2007001200003; O'Donnell O, 2007, WORLD BANK ECON REV, V21, P93, DOI 10.1093/wber/lhl009; Oduro A.D., 2010, FORMAL INFORMAL SOCI; Onwujekwe O, 2012, INT J EQUITY HEALTH, V11, DOI 10.1186/1475-9276-11-70; Popay J., 2006, GUIDANCE CONDUCT NAR; Saleh K, 2013, DIR DEV, P1, DOI 10.1596/978-0-8213-9599-8; Shafie AA, 2013, SOC SCI MED, V96, P272, DOI 10.1016/j.socscimed.2013.02.045; Sparrow R, 2013, SOC SCI MED, V96, P264, DOI 10.1016/j.socscimed.2012.09.043; Starfield B, 2005, MILBANK Q, V83, P457, DOI 10.1111/j.1468-0009.2005.00409.x; Tangcharoensathien V, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0342-3; Tangcharoensathien V, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001726; Tangcharoensathien V, 2011, LANCET, V377, P863, DOI 10.1016/S0140-6736(10)61890-9; Wagstaff A, 2002, HEALTH ECON, V11, P103, DOI 10.1002/hec.685; Wagstaff A, 2012, HEALTH ECON, V21, P351, DOI 10.1002/hec.1727; WHO, 2013, WORLD MALARIA REPORT 2013, P1; WHO, 2010, WORLD MALARIA REPORT 2010, P1; Wiseman V, 2015, HEALTH POLICY PLANN, V30, P1053, DOI 10.1093/heapol/czu108; World Bank, 2012, HLTH EQ FIN PROT REP; World Bank, 2014, WORLD DEV IND 2014; Yu CP, 2006, INT J HEALTH PLAN M, V21, P193, DOI 10.1002/hpm.845; Yu CP, 2008, INT J EQUITY HEALTH, V7, DOI 10.1186/1475-9276-7-15	58	85	89	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2016	11	4							e0152866	10.1371/journal.pone.0152866	http://dx.doi.org/10.1371/journal.pone.0152866			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ0KH	27064991	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000373891000021
J	Ulloa, R; Kacperski, C; Sancho, F				Ulloa, Roberto; Kacperski, Celina; Sancho, Fernando			Institutions and Cultural Diversity: Effects of Democratic and Propaganda Processes on Local Convergence and Global Diversity	PLOS ONE			English	Article							INFORMATION FEEDBACK; SOCIAL-INFLUENCE; GLOBALIZATION; PERSONALITY; STRATEGIES	In a connected world where people influence each other, what can cause a globalized monoculture, and which measures help to preserve the coexistence of cultures? Previous research has shown that factors such as homophily, population size, geography, mass media, and type of social influence play important roles. In the present paper, we investigate for the first time the impact that institutions have on cultural diversity. In our first three studies, we extend existing agent-based models and explore the effects of institutional influence and agent loyalty. We find that higher institutional influence increases cultural diversity, while individuals' loyalty to their institutions has a small, preserving effect. In three further studies, we test how bottom-up and top-down processes of institutional influence impact our model. We find that bottom-up democratic practices, such as referenda, tend to produce convergence towards homogeneity, while top-down information dissemination practices, such as propaganda, further increase diversity. In our last model-an integration of bottom-up and topdown processes into a feedback loop of information-we find that when democratic processes are rare, the effects of propaganda are amplified, i.e., more diversity emerges; however, when democratic processes are common, they are able to neutralize or reverse this propaganda effect. Importantly, our models allow for control over the full spectrum of diversity, so that a manipulation of our parameters can result in preferred levels of diversity, which will be useful for the study of other factors in the future. We discuss possible mechanisms behind our results, applications, and implications for political and social sciences.	[Ulloa, Roberto] Univ Western Ontario, Dept Modern Languages & Literatures, London, ON, Canada; [Kacperski, Celina] Univ Western Ontario, Sport & Exercise Psychol Lab, London, ON, Canada; [Sancho, Fernando] Univ Seville, Dept Ciencias Computac & Inteligencia Artificial, Seville, Spain	Western University (University of Western Ontario); Western University (University of Western Ontario); University of Sevilla	Ulloa, R (corresponding author), Univ Western Ontario, Dept Modern Languages & Literatures, London, ON, Canada.	roberto.ur@protonmail.com		Kacperski, Celina/0000-0002-8844-5164				Abelson R.P., 1964, MATH MODELS DISTRIBU, P142; Alesina A, 2013, FAMILY TIES; Alesina AF, 2002, 319762 ID SOC SCI RE; [Anonymous], 2015, 23 POSLANCEV BOJU PR; [Anonymous], 2015, IRISH TIMES; AXELROD R, 1985, WORLD POLIT, V38, P226, DOI 10.2307/2010357; Axelrod R, 1997, J CONFLICT RESOLUT, V41, P203, DOI 10.1177/0022002797041002001; Berger P. L., 1966, SOCIAL CONSTRUCTION; Bourdieu P., 1977, OUTLINE THEORY OFPRA; Boyd R., 1985, CULTURE EVOLUTIONARY; Brandstatter H, 1997, SMALL GR RES, V28, P146, DOI 10.1177/1046496497281006; Caldwell DF, 1997, PERS SOC PSYCHOL B, V23, P1003, DOI 10.1177/01461672972310001; D'Angelo M, 2000, EUROPE C CULTURAL PO; DEUTSCH MORTON, 1955, JOUR ABNORMAL AND SOCIAL PSYCHOL, V51-31, P629, DOI 10.1037/h0046408; Durkheim E., 1951, SUICIDE STUDY SOCIOL, DOI 10.2307/2088294; Durkheim E, 1895, RULES SOCIOLOGICAL M, V8th ed.; Epstein J.M., 1996, GROWING ARTIFICIAL S; Ermisch J, 2010, J ECON BEHAV ORGAN, V75, P365, DOI 10.1016/j.jebo.2010.05.007; Festinger L., 1950, SOCIAL PRESSURES INF; Fisher M, 2021, NEW YORK TIMES; Flache A, 2011, J CONFLICT RESOLUT, V55, P970, DOI 10.1177/0022002711414371; Follmer H., 1974, J MATH ECON, V1, P51, DOI [10.1016/0304-4068(74)90035-4, DOI 10.1016/0304-4068(74)90035-4]; Freeman L., 1991, RES METHODS SOCIAL N; FREEMAN LC, 1993, SOCIOL METHODOL, V23, P127, DOI 10.2307/271008; FRENCH JRP, 1956, PSYCHOL REV, V63, P181, DOI 10.1037/h0046123; Gonzalez-Avella JC, 2007, JASSS-J ARTIF SOC S, V10; Goren E, 2013, REPORT NO ID 2255492; Greig JM, 2002, J CONFLICT RESOLUT, V46, P225, DOI 10.1177/0022002702046002003; Harary F, 1959, STUDIES SOCIAL POWER, P168; Hegselmann R, 2002, JASSS-J ARTIF SOC S, V5; Jacobs D, 2012, FORBES; James P., 2006, GLOBALISM NATIONALIS; JOWETT G., 2014, PROPAGANDA PERSUASIO; Klemm K, 2005, J ECON DYN CONTROL, V29, P321, DOI 10.1016/j.jedc.2003.08.005; Klemm K, 2003, PHYS REV E, V67, DOI 10.1063/1.1571335; Kollman K, 1998, 75548 ID SOC SCI RES; Lazarsfeld P. F., 1954, FREEDOM CONTROL MOD, V18, P18, DOI DOI 10.1111/J.1467-8705.2012.02056_3.X; Macy MW, 2003, DYNAMIC SOCIAL NETWORK MODELING AND ANALYSIS, P162; Mas M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000959; Makowsky MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080380; Manzo G, 2015, SOCIOL METHOD RES, V44, P329, DOI 10.1177/0049124114544225; McGuigan J., 2004, RETHINKING CULTURAL; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; Montiel CJ., 1997, PEACE CONFLICT J PEA, V3, P115, DOI [DOI 10.1207/S15327949PAC0302_1, 10.1207/s15327949pac0302_1]; North DC, 1991, J EC PERSPEC; Parisi D, 2003, J CONFLICT RESOLUT, V47, P163, DOI 10.1177/0022002702251025; Quattrociocchi W, 2014, SCI REP-UK, V4, DOI 10.1038/srep04938; Reynolds R. G., 1994, Third Annual Conference on Evolutionary Programming, P131; Rupar T, 2014, WASHINGTON POST; SCHELLING TC, 1969, AM ECON REV, V59, P488; SCHELLING TC, 1971, J MATH SOCIOL, V1, P143, DOI 10.1080/0022250X.1971.9989794; Serdult Uwe, 2012, TAIWAN J DEMOCRACY, V8, P69; Shibanai Y, 2001, J CONFLICT RESOLUT, V45, P80, DOI 10.1177/0022002701045001004; SNIDAL D, 1985, INT ORGAN, V39, P579, DOI 10.1017/S002081830002703X; Suarez J-L, 2010, JASSS, V14, P19, DOI DOI 10.18564/JASSS.1855; The Propaganda Society, 2011, PROM CULT POL GLOB C; WAGNER RH, 1983, AM POLIT SCI REV, V77, P330, DOI 10.2307/1958919; WOLFRAM S, 1983, REV MOD PHYS, V55, P601, DOI 10.1103/RevModPhys.55.601	59	3	3	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2016	11	4							e0153334	10.1371/journal.pone.0153334	http://dx.doi.org/10.1371/journal.pone.0153334			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DI6JK	27058247	Green Published, Green Submitted, gold			2022-12-27	WOS:000373604800029
J	Best, PB; Photopoulou, T				Best, Peter B.; Photopoulou, Theoni			Identifying the "demon whale-biter": Patterns of scarring on large whales attributed to a cookie-cutter shark Isistius sp	PLOS ONE			English	Article							SQUALOID SHARK; KILLER WHALES; SOUTH-AFRICA; BRASILIENSIS; MOVEMENTS; CETACEANS; TRANSPORT; FISHES; WOUNDS; HAWAII	The presence of crater-like wounds on cetaceans and other large marine vertebrates and invertebrates has been attributed to various organisms. We review the evidence for the identity of the biting agent responsible for crater wounds on large whales, using data collected from sei (Balaenoptera borealis), fin (B. physalus), inshore and offshore Bryde's (B. brydeii sp) and sperm whales (Physeter macrocephalus) examined at the Donkergat whaling station, Saldanha Bay, South Africa between March and October 1963. We then analyse the intensity and trends in its predation on large whales. Despite the scarcity of local records, we conclude that a cookie-cutter shark Isistius sp is the most likely candidate. We make inferences about the trends in (1) total counts of unhealed bitemarks, and (2) the proportion of unhealed bitemarks that were recent. We use day of the year; reproductive class, social grouping or sex; depth interval and body length as candidate covariates. The models with highest support for total counts of unhealed bitemarks involve the day of the year in all species. Depth was an important predictor in all species except offshore Bryde's whales. Models for the proportion of recent bites were only informative for sei and fin whales. We conclude that temporal scarring patterns support what is currently hypothesized about the distribution and movements of these whale species, given that Isistius does not occur in the Antarctic and has an oceanic habitat. The incidence of fresh bites confirms the presence of Isistius in the region. The lower numbers of unhealed bites on medium-sized sperm whales suggests that this group spends more time outside the area in which bites are incurred, providing a clue to one of the biggest gaps in our understanding of the movements of mature and maturing sperm males.	[Best, Peter B.] Univ Pretoria, Dept Zool & Entomol, Mammal Res Inst, ZA-0002 Pretoria, South Africa; [Photopoulou, Theoni] Univ Cape Town, Dept Stat Sci, Ctr Stat Ecol Environm & Conservat, ZA-7700 Rondebosch, South Africa	University of Pretoria; University of Cape Town	Photopoulou, T (corresponding author), Univ Cape Town, Dept Stat Sci, Ctr Stat Ecol Environm & Conservat, ZA-7700 Rondebosch, South Africa.	theoni.photopoulou@gmail.com	Photopoulou, Theoni/E-3994-2012	Photopoulou, Theoni/0000-0001-9616-9940				Barton K., 2013, MUMIN MULTIMODEL INF; Bass AJ, 1976, SHARKS E COAST SO AF; Berzin A, 1972, ISR PROGR SCI TRANSL; Best P, 2007, WHALES DOLPHINS SO A; Best P.B., 1979, Behavior of Marine Animals, V3, P227; Best PB, 2001, MAR ECOL PROG SER, V220, P277, DOI 10.3354/meps220277; Best PB, 1999, S AFR J MARINE SCI, V21, P393; BEST PB, 1977, REPORTS INT WHALING, V1, P10; Best Peter B., 1996, Report of the International Whaling Commission, V46, P315; Best Peter B., 2001, Journal of Cetacean Research and Management Special Issue, V2, P161; CLARKE MR, 1972, J MAR BIOL ASSOC UK, V52, P599, DOI 10.1017/S0025315400021603; Collett R, 1886, P ZOOL SOC LOND, V18, P243; Dwyer SL, 2011, AQUAT MAMM, V37, P111, DOI 10.1578/AM.37.2.2011.111; Fristrup KM, 2002, MAR MAMMAL SCI, V18, P42, DOI 10.1111/j.1748-7692.2002.tb01017.x; Goodall Thomas B., 1913, Zoologist London, V17; Hoyos-Padilla M, 2013, PAC SCI, V67, P129, DOI 10.2984/67.1.10; International Whaling Commission, 1946, SCHED INT CONV REG W; ISOUCHI T, 1970, Japanese Journal of Ichthyology, V17, P124; Ivashin M, 1978, REP INT WHAL COMM, V199; JAHN AE, 1988, BIOL OCEANOGR, V5, P297, DOI DOI 10.1080/01965581.1987.10749519; JONES EC, 1971, FISH BULL NATL OC AT, V69, P791; Krefft G., 1953, Zoologischer Anzeiger, V150, P275; Mackintosh N. A., 1929, Discovery Reports Cambridge, V1, P257; Mate BR, 2011, MAR MAMMAL SCI, V27, P455, DOI 10.1111/j.1748-7692.2010.00412.x; MATTHEWS L. HARRISON, 1938, DISCOVERY REPTS [GOVT DEPENDENCIES FALKLAND ISLANDS], V17, P183; MATTHEWS L. HARRISON, 1938, DISCOVERY REPTS [GOVT DEPENDENCIES FALKLAND ISLANDS], V17, P93; McSweeney DJ, 2007, MAR MAMMAL SCI, V23, P666, DOI 10.1111/j.1748-7692.2007.00135.x; Moore Michael, 2003, Aquatic Mammals, V29, P383, DOI 10.1578/01675420360736569; North American Cartographic Information Society, 2013, NAT EARTH DAT; Olsen O, 1913, P ZOOL SOC LOND, V1913, P1073; Papastamatiou YP, 2010, ENVIRON BIOL FISH, V88, P361, DOI 10.1007/s10641-010-9649-2; Penry G, 2010, BIOL S AFRICAN BRYDE; PIKE G. C., 1951, JOUR FISH RES BD CANADA, V8, P275; de la Gala-Hernandez SR, 2008, CAN J ZOOL, V86, P307, DOI 10.1139/Z07-141; Sherchenko V., 1970, PRIRODA, V6, P72; SHEVCHENKO V. I., 1971, T ALANTNIRO, V39, P67; Shevchenko VI, 1977, REP INT WHAL COMM REP INT WHAL COMM, P130; Souto Luciano Raimundo Alardo, 2007, Biotemas, V20, P19; Wagenmakers EJ, 2004, PSYCHON B REV, V11, P192, DOI 10.3758/BF03206482; Whitehead H., 2003, SPERM WHALES SOCIAL; Widder EA, 1998, ENVIRON BIOL FISH, V53, P267, DOI 10.1023/A:1007498915860; Williams R, 2009, MAR MAMMAL SCI, V25, P327, DOI 10.1111/j.1748-7692.2008.00255.x; Wiseman N., 2008, GENETIC IDENTITY ECO; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x	44	16	18	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0152643	10.1371/journal.pone.0152643	http://dx.doi.org/10.1371/journal.pone.0152643			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27055057	gold, Green Published			2022-12-27	WOS:000373608000031
J	Quan, V; Verani, JR; Cohen, C; von Gottberg, A; Meiring, S; Cutland, CL; Schrag, SJ; Madhi, SA				Quan, Vanessa; Verani, Jennifer R.; Cohen, Cheryl; von Gottberg, Anne; Meiring, Susan; Cutland, Clare L.; Schrag, Stephanie J.; Madhi, Shabir A.			Invasive Group B Streptococcal Disease in South Africa: Importance of Surveillance Methodology	PLOS ONE			English	Article							YOUNG-INFANTS; PREVENTION; INFECTION; SEPSIS; BURDEN; SOWETO; TRIAL; RISK; HIV	Data on neonatal group B streptococcal (GBS) invasive disease burden are needed to refine prevention policies. Differences in surveillance methods and investigating for cases can lead to varying disease burden estimates. We compared the findings of laboratory-based passive surveillance for GBS disease across South Africa, and for one of the provinces compared this to a real-time, systematic, clinical surveillance in a population-defined region in Johannesburg, Soweto. Passive surveillance identified a total of 799 early-onset disease (EOD, <7 days age) and 818 LOD (late onset disease, 7-89 days age) cases nationwide. The passive surveillance provincial incidence varied for EOD (range 0.00 to 1.23/1000 live births), and was 0.03 to 1.04/1000 live births for LOD. The passive surveillance rates for Soweto, were not significantly different compared to those from the systematic surveillance (EOD 1.23 [95% CI 1.06-1.43] vs. 1.50 [95% CI 1.30-1.71], respectively, rate ratio 0.82 [95% CI 0.67-1.01]; LOD 1.04 [95% CI 0.90-1.23] vs. 1.22 [95% CI 1.05-1.42], rate ratio 0.85 [95% CI 0.68-1.07]). A review of the few cases missed in the passive system in Soweto, suggested that missing key identifiers, such as date of birth, resulted in their omission during the electronic data extraction process. Our analysis suggests that passive surveillance provides a modestly lower estimate of invasive GBS rates compared to real time sentinel-site systematic surveillance, however, this is unlikely to be the reason for the provincial variability in incidence of invasive GBS disease in South Africa. This, possibly reflects that invasive GBS disease goes undiagnosed due to issues related to access to healthcare, poor laboratory capacity and varying diagnostic procedures or empiric antibiotic treatment of neonates with suspected sepsis in the absence of attempting to making a microbiological diagnosis. An efficacious GBS vaccine for pregnant women, when available, could be used as a probe to better quantify the burden of invasive GBS disease in low- middle resourced settings such as ours. From our study passive systems are important to monitor trends over time as long as they are interpreted with caution; active systems give better detailed information and will have greater representivity when expanded to other surveillance sites.	[Quan, Vanessa; Cohen, Cheryl; von Gottberg, Anne; Meiring, Susan; Madhi, Shabir A.] Natl Hlth Lab Serv, Natl Inst Communicable Dis, Johannesburg, South Africa; [Verani, Jennifer R.; Schrag, Stephanie J.] Ctr Dis Control & Prevent, Atlanta, GA USA; [Cohen, Cheryl; von Gottberg, Anne] Univ Witwatersrand, Fac Hlth Sci, Johannesburg, South Africa; [Cutland, Clare L.; Madhi, Shabir A.] Univ Witwatersrand, Fac Hlth Sci, Resp & Meningeal Pathogens Res Unit, MRC, Johannesburg, South Africa; [Madhi, Shabir A.] Natl Res Fdn, Vaccine Preventable Dis, Dept Sci & Technol, Gauteng, South Africa	National Health Laboratory Service; National Institute for Communicable Diseases (NICD); Centers for Disease Control & Prevention - USA; University of Witwatersrand; University of Witwatersrand; National Research Foundation - South Africa	Quan, V (corresponding author), Natl Hlth Lab Serv, Natl Inst Communicable Dis, Johannesburg, South Africa.; Quan, V (corresponding author), Natl Inst Communicable Dis, Div Publ Hlth Surveillance & Response, Private Bag X4, ZA-2131 Johannesburg, Gauteng, South Africa.	vanessaq@nicd.ac.za	Cutland, Clare L./GXE-9967-2022; Meiring, Susan/M-1463-2019	Cutland, Clare L./0000-0001-8250-8307; Meiring, Susan/0000-0003-4508-5469; Cohen, Cheryl/0000-0003-0376-2302	NICD/NHLS; Novartis	NICD/NHLS; Novartis(Novartis)	The funding of this study was through NICD/NHLS, but SAM and CLC as well as the Institution received grant support from Novartis. SAM and CLC have been clinical trialists on Novartis- funded GBS vaccine studies. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. This study was not related to the Novartis funding.	Actuarial Society of South Africa, 2011, ASSA 2008 MOD 2011; [Anonymous], 2014, MILLENIUM DEV GOALS; Cutland CL, 2015, EMERG INFECT DIS, V21, P638, DOI 10.3201/eid2104.141562; Cutland CL, 2012, PEDIATRICS, V130, pE581, DOI 10.1542/peds.2011-1548; Cutland CL, 2009, LANCET, V374, P1909, DOI 10.1016/S0140-6736(09)61339-8; Dagnew AF, 2012, CLIN INFECT DIS, V55, P91, DOI 10.1093/cid/cis395; Edmond KM, 2012, LANCET, V379, P547, DOI 10.1016/S0140-6736(11)61651-6; Feikin DR, 2014, LANCET, V383, P1762, DOI 10.1016/S0140-6736(13)61682-7; Frigati L, 2014, SOUTH AFR J INFECT D, V29, P33, DOI 10.1080/23120053.2014.11441564; Gray KJ, 2007, EMERG INFECT DIS, V13, P223, DOI 10.3201/eid1302.060680; Heyderman RS, 2015, LANCET INFE IN PRESS; Kwatra G, 2013, 8 WORLD C WORLD SOC; Madhi SA, 2003, ANN TROP PAEDIATR, V23, P15, DOI 10.1179/000349803125002814; Madhi SA, 2013, VACCINE, V31, pD52, DOI 10.1016/j.vaccine.2013.02.029; Schrag SJ, 2012, PEDIATR INFECT DIS J, V31, P821, DOI 10.1097/INF.0b013e31825c4b5a; Schrag SJ, 2011, LANCET, V378, P11, DOI 10.1016/S0140-6736(10)61932-0; Schuchat A, 1998, CLIN MICROBIOL REV, V11, P497, DOI 10.1128/CMR.11.3.497; Verani Jennifer R., 2010, Morbidity and Mortality Weekly Report, V59, P1; von Gottberg A, 2014, NEW ENGL J MED, V371, P1889, DOI 10.1056/NEJMoa1401914	19	12	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0152524	10.1371/journal.pone.0152524	http://dx.doi.org/10.1371/journal.pone.0152524			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27055184	gold, Green Published, Green Submitted			2022-12-27	WOS:000373608000024
J	Yu, TH; Chung, KP; Wei, CJ; Chien, KL; Hou, YC				Yu, Tsung-Hsien; Chung, Kuo-Piao; Wei, Chung-Jen; Chien, Kuo-Liong; Hou, Yu-Chang			Do the Preferences of Healthcare Provider Selection Vary among Rural and Urban Patients with Different Income and Cause Different Outcome?	PLOS ONE			English	Article							ELIMINATING DISPARITIES; HOSPITAL VOLUME; QUALITY; INSURANCE; TAIWAN; FRAMEWORK; SURGERY; ACCESS	Background Equal access to healthcare facilities and high-level quality of care are important strategies to eliminate the disparity in outcome of care. However, the existing literature regarding how urban or rural dwelling patients with different income level select healthcare providers is insufficient. The purposes of this study were to examine whether differences of healthcare provider selection exist among urban and rural coronary artery bypass surgery (CABG) patients with different income level. If so, we further investigated the associated impact on mortality. Methods A retrospective, multilevel study design was conducted using claims data from 2007-2011 Taiwan's Universal Health Insurance Scheme. Healthcare providers' performance and patients' travelling distance to hospitals were used to define the patterns of healthcare provider selection. Baron and Kenny's procedures for mediation effect were conducted. Results There were 10,108 CABG surgeries included in this study. The results showed that urban dwelling and higher income patients were prone to receive care from better-performance providers. The travelling distances of urban dwelling patients was 15 KM shorter, especially when they received better-performance provider's care. The results also showed that the difference of healthcare provider selection and mortality rate existed between rural and urban dwelling patients with different income levels. After the procedure of mediation effect testing, the results showed that the healthcare provider selection partially mediated the relationships between patients' residential areas with different income levels and 30-day mortality. Conclusion Preferences of healthcare provider selection vary among rural and urban patients with different income, and such differences partially mediated the outcome of care. Health authorities should pay attention to this issue, and propose appropriate solutions to eliminate the disparity in outcome of CABG care.	[Yu, Tsung-Hsien; Chung, Kuo-Piao; Hou, Yu-Chang] Natl Taiwan Univ, Inst Hlth Policy & Management, Taipei 10764, Taiwan; [Wei, Chung-Jen] Fu Jen Catholic Univ, Dept Publ Hlth, Taipei, Taiwan; [Chien, Kuo-Liong] Natl Taiwan Univ, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan; [Hou, Yu-Chang] Minist Hlth & Welf, Tao Yuan Gen Hosp, Dept Chinese Med, Taoyuan, Taiwan; [Hou, Yu-Chang] Chuan Yuan Christian Univ, Dept Biosci Technol, Taoyuan, Taiwan	National Taiwan University; Fu Jen Catholic University; National Taiwan University	Hou, YC (corresponding author), Natl Taiwan Univ, Inst Hlth Policy & Management, Taipei 10764, Taiwan.; Hou, YC (corresponding author), Minist Hlth & Welf, Tao Yuan Gen Hosp, Dept Chinese Med, Taoyuan, Taiwan.; Hou, YC (corresponding author), Chuan Yuan Christian Univ, Dept Biosci Technol, Taoyuan, Taiwan.	houyc0115@mail2000.com.tw		Yu, Tsung-Hsien/0000-0002-6874-989X; WEI, CHUNG-JEN/0000-0002-9225-6606; CHUNG, KUO-PIAO/0000-0001-9482-7065; CHIEN, KUO-LIONG/0000-0003-4979-8351	Taiwan Ministry of Science and Technology [MOST-104-2410-H-002-191]	Taiwan Ministry of Science and Technology	Taiwan Ministry of Science and Technology provided the financial support (MOST-104-2410-H-002-191).	BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Beal AC, 2011, HEALTH AFFAIR, V30, P1868, DOI 10.1377/hlthaff.2011.0976; Chang HY, 2015, ASIA-PAC J PUBLIC HE, V27, pNP958, DOI 10.1177/1010539512471073; Cheng TM, 2015, HEALTH AFFAIR, V34, P502, DOI 10.1377/hlthaff.2014.1332; Chowdhury MM, 2007, BRIT J SURG, V94, P145, DOI 10.1002/bjs.5714; Finks JF, 2011, NEW ENGL J MED, V364, P2128, DOI 10.1056/NEJMsa1010705; Halm EA, 2002, ANN INTERN MED, V137, P511, DOI 10.7326/0003-4819-137-6-200209170-00012; Hsiao YY, 2013, INT J QUAL HEALTH C, V25, P232, DOI 10.1093/intqhc/mzt029; Hsu CC, 2012, DIABETES CARE, V35, P2286, DOI 10.2337/dc11-2052; Kiguli J, 2009, PATIENT PREFER ADHER, V3, P77; Lien HM, 2008, J HEALTH ECON, V27, P1208, DOI 10.1016/j.jhealeco.2008.03.002; Lin YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062492; Lin YH, 2013, BMC INT HEALTH HUM R, V13, DOI 10.1186/1472-698X-13-15; Lu JFR, 2003, HEALTH AFFAIR, V22, P77, DOI 10.1377/hlthaff.22.3.77; LUFT HS, 1979, NEW ENGL J MED, V301, P1364, DOI 10.1056/NEJM197912203012503; Mangram AJ, 1999, INFECT CONT HOSP EP, V20, P250, DOI 10.1086/501620; Masuda JR, 2012, SOC SCI MED, V75, P1244, DOI 10.1016/j.socscimed.2012.04.034; Mathieu JE, 2007, J ORGAN BEHAV, V28, P141, DOI 10.1002/job.436; McInnes D Keith, 2010, Inform Prim Care, V18, P59; Mensah GA, 2005, CIRCULATION, V111, P1233, DOI 10.1161/01.CIR.0000158136.76824.04; Phipps MS, 2014, J RURAL HEALTH, V30, P1, DOI 10.1111/jrh.12029; Rumball-Smith J, 2013, INT J QUAL HEALTH C, V25, P248, DOI 10.1093/intqhc/mzt012; Scott KW, 2014, NEW ENGL J MED, V371, P3, DOI 10.1056/NEJMp1402157; Shadmi E, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-609; Singh JM, 2009, CRIT CARE, V13, DOI 10.1186/cc7883; Tung YC, 2014, MED CARE, V52, P519, DOI 10.1097/MLR.0000000000000132; Wen CP, 2008, ANN INTERN MED, V148, P258, DOI 10.7326/0003-4819-148-4-200802190-00004; Wu XD, 2008, KNOWL INF SYST, V14, P1, DOI 10.1007/s10115-007-0114-2; Yu TH, 2015, INT J QUALITY HLTH C; Yu TH, 2014, INT J EQUITY HEALTH, V13, DOI 10.1186/s12939-014-0064-8; Zhang W, 2007, INT J QUAL HEALTH C, V19, P11, DOI 10.1093/intqhc/mzl047; Zhang Z, 2009, ORGAN RES METHODS, V12, P695, DOI 10.1177/1094428108327450	32	3	3	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0152776	10.1371/journal.pone.0152776	http://dx.doi.org/10.1371/journal.pone.0152776			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DI6KO	27054711	gold, Green Published, Green Submitted			2022-12-27	WOS:000373608000045
J	Emsens, WJ; Aggenbach, CJS; Schoutens, K; Smolders, AJP; Zak, D; van Diggelen, R				Emsens, Willem-Jan; Aggenbach, Camiel J. S.; Schoutens, Ken; Smolders, Alfons J. P.; Zak, Dominik; van Diggelen, Rudy			Soil Iron Content as a Predictor of Carbon and Nutrient Mobilization in Rewetted Fens	PLOS ONE			English	Article							ORGANIC-MATTER DECOMPOSITION; WATER-TABLE FLUCTUATIONS; PHOSPHORUS MOBILIZATION; PHOSPHATE SORPTION; FERRIC IRON; RICH FENS; REDUCTION; AMMONIUM; PEAT; SEDIMENT	Rewetted, previously drained fens often remain sources rather than sinks for carbon and nutrients. To date, it is poorly understood which soil characteristics stimulate carbon and nutrient mobilization upon rewetting. Here, we assess the hypothesis that a large pool of iron in the soil negatively affects fen restoration success, as flooding-induced iron reduction (Fe3+ to Fe2+) causes a disproportionate breakdown of organic matter that is coupled with a release of inorganic compounds. We collected intact soil cores in two iron-poor and two iron-rich drained fens, half of which were subjected to a rewetting treatment while the other half was kept drained. Prolonged drainage led to the mobilization of nitrate (NO3-, > 1 mmol L-1) in all cores, regardless of soil iron content. In the rewetted iron-rich cores, a sharp increase in pore water iron (Fe) concentrations correlated with concentrations of inorganic carbon (TIC, > 13 mmol L-1) and dissolved organic carbon (DOC, > 16 mmol L-1). Additionally, ammonium (NH4+) accumulated up to phytotoxic concentrations of 1 mmol L-1 in the pore water of the rewetted iron-rich cores. Disproportionate mobilization of Fe, TIC, DOC and NH4+ was absent in the rewetted iron-poor cores, indicating a strong interaction between waterlogging and iron-mediated breakdown of organic matter. Concentrations of dissolved phosphorus (P) rose slightly in all cores upon rewetting, but remained low throughout the experiment. Our results suggest that large pools of iron in the top soil of drained fens can hamper the restoration of the fen's sink-service for ammonium and carbon upon rewetting. We argue that negative effects of iron should be most apparent in fens with fluctuating water levels, as temporary oxygenation allows frequent regeneration of Fe3+. We conclude that rewetting of iron-poor fens may be more feasible for restoration.	[Emsens, Willem-Jan; Aggenbach, Camiel J. S.; Schoutens, Ken; van Diggelen, Rudy] Univ Antwerp, Dept Biol, Ecosyst Management Res Grp, Univ Pl 1C, B-2610 Antwerp, Belgium; [Aggenbach, Camiel J. S.] KWR Watercycle Res Inst, POB 1072, NL-3430 BB Nieuwegein, Netherlands; [Smolders, Alfons J. P.] Radboud Univ Nijmegen, Inst Wetland & Water Res, Dept Aquat Ecol & Environm Biol, Heyendaalseweg 135 1, NL-6525 ED Nijmegen, Netherlands; [Smolders, Alfons J. P.] B WARE Res Ctr, Toernooiveld 1, NL-6525 ED Nijmegen, Netherlands; [Zak, Dominik] Leibniz Inst Freshwater Ecol & Inland Fisheries, Chem Analyt & Biogeochem, Muggelseedamm 301, D-12587 Berlin, Germany; [Zak, Dominik] Aarhus Univ, Dept Biosci, DK-8600 Vejlsovej, Silkeborg, Denmark	University of Antwerp; KWR Watercycle Research Institute; Radboud University Nijmegen; Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB); Aarhus University	Emsens, WJ (corresponding author), Univ Antwerp, Dept Biol, Ecosyst Management Res Grp, Univ Pl 1C, B-2610 Antwerp, Belgium.	willem-jan.emsens@uantwerpen.be	Smolders, Alfons J.P./H-2583-2012; Aggenbach, Camiel/AAE-3298-2021; Zak, Dominik Henrik/GFL-5719-2022; Emsens, Willem-Jan/AAW-1162-2020; Schoutens, Ken/AEQ-1606-2022	Zak, Dominik Henrik/0000-0002-1229-5294; Emsens, Willem-Jan/0000-0002-2667-237X; van Diggelen, Rudy/0000-0001-8053-945X; Aggenbach, Camiel/0000-0002-2617-3909	FWO Fonds Wetenschappelijk Onderzoek [11M0414N]; OBN Research Program [OBN178-BE]	FWO Fonds Wetenschappelijk Onderzoek(FWO); OBN Research Program	This work was supported by FWO Fonds Wetenschappelijk Onderzoek (11M0414N to WJE); www.fwo.be, OBN Research Program (OBN178-BE to university of Antwerp); www.natuurkennis.nl. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHTNICH C, 1995, BIOL FERT SOILS, V19, P65, DOI 10.1007/BF00336349; Aggenbach CJS, 2013, PRESLIA, V85, P405; Burgin AJ, 2007, FRONT ECOL ENVIRON, V5, P89, DOI 10.1890/1540-9295(2007)5[89:HWOTRO]2.0.CO;2; Clement JC, 2005, SOIL BIOL BIOCHEM, V37, P2323, DOI 10.1016/j.soilbio.2005.03.027; Estop-Aragones C, 2012, SOIL BIOL BIOCHEM, V47, P1, DOI 10.1016/j.soilbio.2011.12.008; Evans MG, 1999, J HYDROL, V221, P141, DOI 10.1016/S0022-1694(99)00085-2; Fenner N, 2011, HYDROBIOLOGIA, V674, P51, DOI 10.1007/s10750-011-0733-1; Freeman C, 2004, NATURE, V430, P195, DOI 10.1038/nature02707; Geurts JJM, 2008, FRESHWATER BIOL, V53, P2101, DOI 10.1111/j.1365-2427.2008.02038.x; Geurts JJM, 2009, ENVIRON POLLUT, V157, P2072, DOI 10.1016/j.envpol.2009.02.024; Grootjans AP, 2006, APPL VEG SCI, V9, P175, DOI 10.1658/1402-2001(2006)9[175:HLSOBF]2.0.CO;2; Hansen HCB, 1996, ENVIRON SCI TECHNOL, V30, P2053, DOI 10.1021/es950844w; Heiberg L, 2012, J ENVIRON QUAL, V41, P938, DOI 10.2134/jeq2011.0067; Heiberg L, 2010, J ENVIRON QUAL, V39, P734, DOI 10.2134/jeq2009.0222; Holden J, 2005, PHILOS T R SOC A, V363, P2891, DOI 10.1098/rsta.2005.1671; Hughes S, 1998, SOIL USE MANAGE, V14, P248, DOI 10.1111/j.1475-2743.1998.tb00161.x; Kalbitz K, 2000, SOIL SCI, V165, P277, DOI 10.1097/00010694-200004000-00001; Kasimir-Klemedtsson A, 1997, SOIL USE MANAGE, V13, P245, DOI 10.1111/j.1475-2743.1997.tb00595.x; Kusel K, 2008, BIOGEOSCIENCES, V5, P1537; Lal R., 1997, SOIL PROCESSES CARBO, VVolume 11; Lamers L.P.M., 2014, BIOL REV; Li YC, 2012, J SOIL SEDIMENT, V12, P683, DOI 10.1007/s11368-012-0507-z; LOVLEY DR, 1991, MICROBIOL REV, V55, P259, DOI 10.1128/MMBR.55.2.259-287.1991; LOVLEY DR, 1986, APPL ENVIRON MICROB, V51, P683, DOI 10.1128/AEM.51.4.683-689.1986; Lucassen ECHET, 2005, PLANT SOIL, V269, P109, DOI 10.1007/s11104-004-0554-3; Lucassen ECHET, 2006, J VEG SCI, V17, P425, DOI 10.1111/j.1654-1103.2006.tb02463.x; Lucassen ECHET, 2009, FRESHWATER BIOL, V54, P2300, DOI 10.1111/j.1365-2427.2009.02264.x; Murphy Tom, 2001, Limnology, V2, P119, DOI 10.1007/s102010170007; Parkhurst D.L., 1999, 994259 US GEOL SURV, VVolume 312, P99; Pastor J, 2003, OIKOS, V100, P380, DOI 10.1034/j.1600-0706.2003.11774.x; PATRICK WH, 1974, SCIENCE, V186, P53, DOI 10.1126/science.186.4158.53; Preston MD, 2011, SCI TOTAL ENVIRON, V409, P1235, DOI 10.1016/j.scitotenv.2010.12.027; Richert M, 2000, RESTOR ECOL, V8, P186, DOI 10.1046/j.1526-100x.2000.80026.x; Riedel T, 2013, P NATL ACAD SCI USA, V110, P10101, DOI 10.1073/pnas.1221487110; Russow R, 2013, ISOT ENVIRON HEALT S, V49, P438, DOI 10.1080/10256016.2013.831089; Sakadevan K, 1998, WATER RES, V32, P393, DOI 10.1016/S0043-1354(97)00271-6; Schlotzhauer SM, 1999, WATER RESOUR RES, V35, P3675, DOI 10.1029/1999WR900126; Smolders AJP, 2006, CHEM ECOL, V22, P93, DOI 10.1080/02757540600579730; Smolders AJP, 1995, FRESHWATER BIOL, V34, P559, DOI 10.1111/j.1365-2427.1995.tb00913.x; Van Bodegom PM, 2005, BIOGEOCHEMISTRY, V76, P69, DOI 10.1007/s10533-005-2053-x; van de Riet BP, 2013, WATER AIR SOIL POLL, V224, DOI 10.1007/s11270-013-1440-5; Van Dijk J, 2004, BIOGEOCHEMISTRY, V71, P317, DOI 10.1007/s10533-004-0079-0; Venterink HO, 2002, PLANT SOIL, V243, P119, DOI 10.1023/A:1019993510737; Walpersdorf E, 2013, GEODERMA, V193, P189, DOI 10.1016/j.geoderma.2012.10.003; Zak D, 2008, EUR J SOIL SCI, V59, P1191, DOI 10.1111/j.1365-2389.2008.01081.x; Zak D, 2007, BIOGEOCHEMISTRY, V85, P141, DOI 10.1007/s10533-007-9122-2; Zak D, 2010, ECOL APPL, V20, P1336, DOI 10.1890/08-2053.1	47	21	21	7	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0153166	10.1371/journal.pone.0153166	http://dx.doi.org/10.1371/journal.pone.0153166			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050837	Green Published, gold			2022-12-27	WOS:000373603500108
J	Zhang, ZQ; Wang, GS; Kang, KF; Wu, GB; Wang, P				Zhang, Zhiqiao; Wang, Gongsui; Kang, Kaifu; Wu, Guobiao; Wang, Peng			The Diagnostic Accuracy and Clinical Utility of Three Noninvasive Models for Predicting Liver Fibrosis in Patients with HBV Infection	PLOS ONE			English	Article							CHRONIC HEPATITIS-B; PLATELET RATIO INDEX; ASPARTATE-AMINOTRANSFERASE; FIB-4; CIRRHOSIS; HISTOLOGY; MARKERS; BIOPSY; AREAS; TESTS	Aim To evaluate the diagnostic accuracy and clinical utility of the fibrosis index based on the four factors (FIB-4), aspartate aminotransferase-to-platelet ratio index (APRI), and aspartate aminotransferase-alanine aminotransferase ratio index (AAR) for predicting liver fibrosis in patients with HBV infection. Methods From January 2006 to December 2010, a total of 1543 consecutive chronic hepatitis B (CHB) patients who underwent liver biopsies were enrolled. FIB-4, APRI, and AAR were calculated. The areas under the receiver-operating characteristic curves (AUROCs) were calculated to assess the diagnostic accuracy of these models. The AUROCs of these models were compared by DeLong's test. For further comparisons in different studies, the AUROCs were adjusted to conduct Adjusted AUROCs(ADjAUROCs) according to the prevalence of fibrosis stages using the difference between advanced and nonadvanced fibrosis (DANA). Results For prediction of significant fibrosis, severe fibrosis, and cirrhosis, the AUROCs of FIB-4 were 0.646(ADjAUROC 0.717), 0.670(ADjAUROC 0.741), and 0.715(ADjAUROC 0.786) respectively; whereas it were 0.656(ADjAUROC 0.727), 0.653(ADjAUROC 0.724) and 0.639 (ADjAUROC 0.710) for APRI, 0.498(ADjAUROC 0.569), 0.548(ADjAUROC 0.619) and 0.573(ADjAUROC 0.644) for AAR. The further comparisons demonstrated that there were no significant differences of AUROCs between FIB-4 and APRI in predicting significant and severe fibrosis(P > 0.05), while FIB-4 was superior to APRI in predicting cirrhosis(P < 0.001). Further subgroup analysis demonstrated that the diagnostic accuracy of FIB-4 and APRI in patients with normal alanine aminotransferase(ALT) were higher than that in patients with elevated ALT. Conclusions The results demonstrated that FIB-4 and APRI are useful for diagnosis of fibrosis. FIB-4 and APRI have similar diagnostic accuracy in predicting significant and severe fibrosis, while FIB-4 is superior to APRI in predicting cirrhosis. The clinical utility of FIB-4 and APRI for fibrosis need further external validation in a large population before it was used for prediction of fibrosis in patients with HBV infection.	[Zhang, Zhiqiao; Wang, Gongsui; Wang, Peng] Shunde First Peoples Hosp, Dept Infect Dis, Shunde, Guangdong, Peoples R China; [Kang, Kaifu; Wu, Guobiao] Shunde First Peoples Hosp, Dept Pathol, Shunde, Guangdong, Peoples R China		Wang, P (corresponding author), Shunde First Peoples Hosp, Dept Infect Dis, Shunde, Guangdong, Peoples R China.	sdgrxjbk@163.com			Guangdong Provincial Health Department [A2013695]; Finance Department of Guangdong Province	Guangdong Provincial Health Department; Finance Department of Guangdong Province	This study was funded by Guangdong Provincial Health Department (No: A2013695). The funding account was RMB 10000. The funding was given by Finance Department of Guangdong Province. Peng Wang received the funding. The funders had no role in study design, data collection and analysis, decision to publish, preparation, or writing of the manuscript. The URL of Guangdong Provincial Health Department is http://www.gdwst.gov.cn/.	Alberti A, 2002, ANN INTERN MED, V137, P961, DOI 10.7326/0003-4819-137-12-200212170-00009; Basar O, 2013, CLIN RES HEPATOL GAS, V37, P152, DOI 10.1016/j.clinre.2012.07.003; Blackstone EH, 2001, J THORAC CARDIOV SUR, V122, P430, DOI 10.1067/mtc.2001.117536; Bonnard P, 2010, AM J TROP MED HYG, V82, P454, DOI 10.4269/ajtmh.2010.09-0088; Carlo F, 2006, CLIN BIOCHEM, V39, P339, DOI 10.1016/j.clinbiochem.2006.01.011; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Emanuel E, 2008, HEPATOLOGY, V48, P2086, DOI 10.1002/hep.22622; Grunkemeier GL, 2004, ANN THORAC SURG, V77, P1142, DOI 10.1016/j.athoracsur.2004.01.005; Kim BK, 2010, LIVER INT, V30, P546, DOI 10.1111/j.1478-3231.2009.02192.x; Lee WM, 1997, NEW ENGL J MED, V337, P1733, DOI 10.1056/NEJM199712113372406; Li YY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105728; Lieber CS, 2006, AM J GASTROENTEROL, V101, P1500, DOI 10.1111/j.1572-0241.2006.00610.x; Liu CH, 2006, LIVER INT, V26, P1087, DOI 10.1111/j.1478-3231.2006.01355.x; Ma J, 2013, EUR J GASTROEN HEPAT, V25, P428, DOI 10.1097/MEG.0b013e32835cb5dd; Mallet V, 2009, ALIMENT PHARM THER, V29, P409, DOI 10.1111/j.1365-2036.2008.03895.x; Marcellin P, 2009, J HEPATOL, V50, P227, DOI 10.1016/j.jhep.2008.10.001; Poynard T, 2006, HEPATOLOGY, V43, P374, DOI 10.1002/hep.21086; Poynard T, 2007, CLIN CHEM, V53, P1615, DOI 10.1373/clinchem.2007.085795; Sebastian G, 2008, J VIRAL HEPATITIS, V15, P212, DOI 10.1111/j.1365-2893.2007.00932.x; Sebastiani G, 2011, ALIMENT PHARM THER, V34, P1202, DOI 10.1111/j.1365-2036.2011.04861.x; Shackel NA, 2006, INTERN MED J, V36, P689, DOI 10.1111/j.1445-5994.2006.01210.x; Sterling RK, 2006, HEPATOLOGY, V43, P1317, DOI 10.1002/hep.21178; Teshale E, 2014, J VIRAL HEPAT; Ucar F, 2013, EUR J GASTROEN HEPAT, V25, P1076, DOI 10.1097/MEG.0b013e32835fd699; Vallet-Pichard A, 2007, HEPATOLOGY, V46, P32, DOI 10.1002/hep.21669; Wai CT, 2006, LIVER INT, V26, P666, DOI 10.1111/j.1478-3231.2006.01287.x; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346; Wang H, 2013, J VIRAL HEPATITIS, V20, pe3, DOI 10.1111/jvh.12010; WILLIAMS ALB, 1988, GASTROENTEROLOGY, V95, P734, DOI 10.1016/S0016-5085(88)80022-2; Xiao GQ, 2015, HEPATOLOGY, V61, P292, DOI 10.1002/hep.27382; Xu XY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100182	31	21	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0152757	10.1371/journal.pone.0152757	http://dx.doi.org/10.1371/journal.pone.0152757			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050531	Green Published, Green Submitted, gold			2022-12-27	WOS:000373603500054
J	Veerman, JL; Sacks, G; Antonopoulos, N; Martin, J				Veerman, J. Lennert; Sacks, Gary; Antonopoulos, Nicole; Martin, Jane			The Impact of a Tax on Sugar-Sweetened Beverages on Health and Health Care Costs: A Modelling Study	PLOS ONE			English	Article							OBESITY; OVERWEIGHT; RISK	This paper aims to estimate the consequences of an additional 20% tax on sugar-sweetened beverages (SSBs) on health and health care expenditure. Participants were adult (aged > = 20) Australians alive in 2010, who were modelled over their remaining lifetime. We used lifetable-based epidemiological modelling to examine the potential impact of a 20% valoric tax on SSBs on total lifetime disability-adjusted life years (DALYs), incidence, prevalence, and mortality of obesity-related disease, and health care expenditure. Over the lifetime of adult Australian alive in 2010, seemingly modest estimated changes in average bodymass as a result of the SSB tax translated to gains of 112,000 health-adjusted life years for men (95% uncertainty interval [UI]: 73,000-155,000) and 56,000 (95% UI: 36,000-76,000) for women, and a reduction in overall health care expenditure of AUD609 million (95% UI: 368 million-870 million). The tax is estimated to reduce the number of new type 2 diabetes cases by approximately 800 per year. Twenty-five years after the introduction of the tax, there would be 4,400 fewer prevalent cases of heart disease and 1,100 fewer persons living with the consequences of stroke, and an estimated 1606 extra people would be alive as a result of the tax. The tax would generate an estimated AUD400 million in revenue each year. Governments should consider increasing the tax on sugared drinks. This would improve population health, reduce health care costs, as well as bring in direct revenue.	[Veerman, J. Lennert] Univ Queensland, Sch Publ Hlth, Brisbane, Qld, Australia; [Sacks, Gary] Deakin Univ, WHO Collaborating Ctr Obes Prevent, Melbourne, Vic, Australia; [Antonopoulos, Nicole; Martin, Jane] Canc Council Victoria, Obes Policy Coalit, Melbourne, Vic, Australia	University of Queensland; Deakin University; World Health Organization; Cancer Council Victoria	Veerman, JL (corresponding author), Univ Queensland, Sch Publ Hlth, Brisbane, Qld, Australia.	l.veerman@uq.edu.au	Sacks, Gary/I-5731-2014; Veerman, Lennert/A-9973-2011	Sacks, Gary/0000-0001-9736-1539; Martin, Jane/0000-0002-9132-0928; Veerman, Lennert/0000-0002-3206-8232	Obesity Policy Coalition; NHMRC [APP1041020]; Australian Research Council [DE160100307]	Obesity Policy Coalition; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	This work was supported by the Obesity Policy Coalition and by NHMRC funding for the Centre for Research Excellence in Obesity Policy and Food Systems (APP1041020). GS is the recipient of an Australian Research Council Discovery Early Career Researcher Award (project number DE160100307). Two of the authors (JM, NA) are employed by the Obesity Policy Coalition. The NHMRC was not involved in the study or the reporting.	[Anonymous], 2013, GLOB BURD DIS COUNTR; Colchero MA, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.h6704; Australian Bureau of Statistics, 2012, AUSTR HLTH SURV 2011; Australian Bureau of Statistics, 2011, HOUSEHOLD EXPENDITUR; Briggs ADM, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6189; Chisholm D, 2004, J STUD ALCOHOL, V65, P782, DOI 10.15288/jsa.2004.65.782; Crammond B, 2013, OBES REV, V14, P213, DOI 10.1111/obr.12004; Escobar MAC, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1072; Forster M, 2011, INT J OBESITY, V35, P1071, DOI 10.1038/ijo.2010.246; Frisvold D, 2015, INCIDENCE TAXES SUGA; Hall KD, 2011, LANCET, V378, P826, DOI 10.1016/S0140-6736(11)60812-X; Long MW, 2015, AM J PREV MED, V49, P112, DOI 10.1016/j.amepre.2015.03.004; Malik VS, 2010, CIRCULATION, V121, P1356, DOI 10.1161/CIRCULATIONAHA.109.876185; Mytton OT, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2931; NUTTAB, 2010, NUTR TABL US AUSTR 2; Preventative Health Taskforce, 2009, 1 PREV HLTH TASKF CO; Sacks G, 2011, INT J OBESITY, V35, P1001, DOI 10.1038/ijo.2010.228; Sharma A, 2014, HEALTH ECON, V23, P1159, DOI 10.1002/hec.3070; Stewart RAH, 2008, NEW ZEAL MED J, V121, P11; Thow AM, 2014, NUTR REV, V72, P551, DOI 10.1111/nure.12123; van Baal PHM, 2008, PLOS MED, V5, P242, DOI 10.1371/journal.pmed.0050029; Veerman JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026051; Veerman L., 2010, ASSESSING COST EFFEC; Villanueva T, 2011, CAN MED ASSOC J, V183, pE1229, DOI 10.1503/cmaj.109-4031; WHO Regional Office for Europe, 2015, US PRIC POL PROM HLT; World Health Organization, 2008, 2008 2013 ACT PLAN G	26	88	89	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0151460	10.1371/journal.pone.0151460	http://dx.doi.org/10.1371/journal.pone.0151460			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073855	gold, Green Published, Green Submitted			2022-12-27	WOS:000374131200008
J	Wagner, DR; Cain, DL; Clark, NW				Wagner, Dale R.; Cain, Dustin L.; Clark, Nicolas W.			Validity and Reliability of A-Mode Ultrasound for Body Composition Assessment of NCAA Division I Athletes	PLOS ONE			English	Article							GENERALIZED EQUATIONS; FAT MEASUREMENT; VALIDATION; DENSITY; TISSUE; SYSTEM	This study evaluated the validity and reliability of the BodyMetrix (TM) BX2000 A-mode ultrasound for estimating percent body fat (%BF) in athletes by comparing it to skinfolds and the BOD POD. Forty-five (22 males, 23 females) National Collegiate Athletic Association (NCAA) Division-I athletes volunteered for this study. Subjects were measured once in the BOD POD then twice by two technicians for skinfolds and ultrasound. A one-way repeated-measures ANOVA revealed significant differences between body composition methods (F = 13.24, p < 0.01, eta(2) = 0.24). This difference was further explained by a sex-specific effect such that the mean difference between ultrasound and BOD POD was large for females (similar to 5% BF) but small for males (similar to 1.5% BF). Linear regression using the % BF estimate from ultrasound to predict % BF from BOD POD resulted in an R-2 = 0.849, SEE = 2.6% BF and a TE = 4.4% BF. The inter-rater intraclass correlation (ICC) for skinfold was 0.966 with a large 95% confidence interval (CI) of 0.328 to 0.991. The inter-rater ICC for ultrasound was 0.987 with a much smaller 95% CI of 0.976 to 0.993. Both skinfolds and ultrasound had test-retest ICCs >= 0.996. The BX2000 ultrasound device had excellent test-retest reliability, and its inter-rater reliability was superior to the skinfold method. The validity of this method is questionable, particularly for female athletes. However, due to its excellent reliability, coaches and trainers should consider this portable and easy to use A-mode ultrasound to assess body composition changes in athletes.	[Wagner, Dale R.; Cain, Dustin L.; Clark, Nicolas W.] Utah State Univ, Human Movement Sci Program, Logan, UT 84322 USA	Utah System of Higher Education; Utah State University	Wagner, DR (corresponding author), Utah State Univ, Human Movement Sci Program, Logan, UT 84322 USA.	dale.wagner@usu.edu	Wagner, Dale/D-9821-2012; Clark, Nicolas/AAW-7347-2020	Clark, Nicolas/0000-0002-0019-2896				Aandstad A, 2014, MIL MED, V179, P208, DOI 10.7205/MILMED-D-12-00545; Ballard TP, 2004, MED SCI SPORT EXER, V36, P731, DOI 10.1249/01.MSS.0000121943.02489.2B; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Heyward V.H., 2004, APPL BODY COMPOSITIO, V2nd ed.; JACKSON AS, 1978, BRIT J NUTR, V40, P497, DOI 10.1079/BJN19780152; JACKSON AS, 1980, MED SCI SPORT EXER, V12, P175; Johnson Kelly E, 2012, Int J Exerc Sci, V5, P205; KISPERT CP, 1987, PHYS THER, V67, P917, DOI 10.1093/ptj/67.6.917; Loenneke JP, 2014, CLIN PHYSIOL FUNCT I, V34, P159, DOI 10.1111/cpf.12077; LOHMAN TG, 1984, MED SCI SPORT EXER, V16, P92; Lohman TG, 1992, CAD SAUDE PUBLICA, pS116; Moon JR, 2009, EUR J APPL PHYSIOL, V105, P119, DOI 10.1007/s00421-008-0881-9; Muller W, 2013, BRIT J SPORT MED, V47, P1001, DOI 10.1136/bjsports-2013-092882; Muller W, 2013, BRIT J SPORT MED, V47, P1028, DOI 10.1136/bjsports-2013-092232; Pineau JC, 2007, ANN NUTR METAB, V51, P421, DOI 10.1159/000111161; Pineau JC, 2009, J ATHL TRAINING, V44, P142, DOI 10.4085/1062-6050-44.2.142; Siri W., 1961, TECHNIQUES MEASURING, P223; Smith-Ryan AE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091750; Sundgot-Borgen J, 2013, BRIT J SPORT MED, V47, P1012, DOI 10.1136/bjsports-2013-092966; Ulbricht L, 2012, IEEE ENG MED BIO, P1952, DOI 10.1109/EMBC.2012.6346337; Utter AC, 2008, MED SCI SPORT EXER, V40, P943, DOI 10.1249/MSS.0b013e318163f29e; Wagner DR, 2015, APPL PHYSIOL NUTR ME, V40, P1075, DOI 10.1139/apnm-2015-0126; Wagner DR, 1999, RES Q EXERCISE SPORT, V70, P135, DOI 10.1080/02701367.1999.10608031; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1; [No title captured], DOI DOI 10.1155/2013/280713	25	31	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153146	10.1371/journal.pone.0153146	http://dx.doi.org/10.1371/journal.pone.0153146			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073854	Green Published, Green Submitted, gold			2022-12-27	WOS:000374131200053
J	Yu, HY; Yu, J; Ren, YJ; Yang, Y; Xiao, X				Yu, Haiying; Yu, Jian; Ren, Yanjun; Yang, Yun; Xiao, Xing			Serum CEACAM1 Level Is Associated with Diagnosis and Prognosis in Patients with Osteosarcoma	PLOS ONE			English	Article							CANCER; EXPRESSION; EXPERIENCE; BIOMARKER; MARKER; DOMAIN; TUMOR; INHIBITION	Carcinoembryonic antigen related cell adhesion molecule 1 (CEACAM1) is a trans-membrane multifunctional cell adhesion molecule associated with tumor cell proliferation, apoptosis, angiogenesis, invasion, and migration during tumor development. In the present study, we evaluated serum CEACAM1 level in osteosarcoma patients to explore its diagnostic and prognostic value for this particular malignancy. Sera from 113 patients with primary osteosarcoma, 98 patients with benign bone tumors and 126 healthy controls were obtained. Serum CEACAM1 level was measured with ELISA and correlation with clinicopathological characteristics was further analyzed. Receiver operating curves (ROC), Kaplan-Meier curves, and log-rank analyses as well as Cox proportional hazard models were used to evaluate diagnostic and prognostic significance. The results revealed that serum CEACAM1 level was significantly higher in osteosarcoma patients compared to benign bone tumors and healthy controls (455.2 +/- 179.9 vs 287.4 +/- 103.2, 260.8 +/- 109.7 pg/ml, respectively). Osteosarcoma patients with larger tumors, later-tumor stages, low tumor grades, and distant metastases had much higher CEACAM1 compared to those with smaller tumors, earlier tumor stages, high tumor grades and non-distant metastases (P < 0.05 for all). Multivariate logistic regression analysis confirmed that high serum CEACAM1 level was an independent risk factor for distant metastases (OR = 3.02, 95% CI 1.65-4.17). To distinguish osteosarcoma patients from those with benign bone tumor and healthy controls, ROC/AUC analysis indicated an AUC of 0.81 (sensitivity 0.61; specificity 0.89) and an AUC of 0.77 (sensitivity 0.57; specificity 0.92), respectively. Osteosarcoma patients with higher CEACAM1 had relatively lower survival compared to those with low CEACAM1 (P < 0.01), and multivariate analyses for overall survival revealed that high serum CEACAM1 level was an independent prognostic factor for osteosarcoma (HR = 1.56, 95% CI 1.23-3.28). The present study suggested that elevated serum CEACAM1 level might be a novel diagnostic and prognostic biomarker for osteosarcoma patients.	[Yu, Haiying] Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Dept Radiol, Jinan, Shandong, Peoples R China; [Yu, Jian] Caoxian Peoples Hosp, Dept Orthoped, Jinan, Shandong, Peoples R China; [Ren, Yanjun; Yang, Yun; Xiao, Xing] Shandong Prov Qianfoshan Hosp, Dept Orthoped, Jinan, Shandong, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan; Shandong First Medical University & Shandong Academy of Medical Sciences	Xiao, X (corresponding author), Shandong Prov Qianfoshan Hosp, Dept Orthoped, Jinan, Shandong, Peoples R China.	xiaoxbone@163.com						Bacci G, 2003, CANCER, V97, P3068, DOI 10.1002/cncr.11456; Beauchemin N, 2013, CANCER METAST REV, V32, P643, DOI 10.1007/s10555-013-9444-6; Cai HK, 2015, J SURG RES, V194, P505, DOI 10.1016/j.jss.2014.11.025; Clark JCM, 2008, J CANCER RES CLIN, V134, P281, DOI 10.1007/s00432-007-0330-x; Draberova L, 2000, IMMUNOLOGY, V101, P279, DOI 10.1046/j.1365-2567.2000.00113.x; Esmailiejah AA, 2015, TUMOUR BIOL; Fan JY, 2015, TUMOR BIOL, V11; Farlow EC, 2010, CLIN CANCER RES, V16, P3452, DOI 10.1158/1078-0432.CCR-09-3192; Fiori V, 2012, ANN I SUPER SANITA, V48, P161, DOI [10.4415/ANN_12_02.09, 10.4415/ANN_12_02_09]; Gazitt Y, 2009, INT J ONCOL, V34, P551, DOI 10.3892/ijo_00000181; Gray-Owen SD, 2006, NAT REV IMMUNOL, V6, P433, DOI 10.1038/nri1864; Isakoff MS, 2015, J CLIN ONCOL, V33, P3029, DOI 10.1200/JCO.2014.59.4895; Jaffe N, 2009, CANCER TREAT RES, V152, P239, DOI 10.1007/978-1-4419-0284-9_12; Kager L, 2006, J CLIN ONCOL, V24, P1535, DOI 10.1200/JCO.2005.04.2978; Kuespert K, 2006, CURR OPIN CELL BIOL, V18, P565, DOI 10.1016/j.ceb.2006.08.008; Leary SES, 2013, CANCER-AM CANCER SOC, V119, P2645, DOI 10.1002/cncr.28111; Li CX, 2009, EXP CELL RES, V315, P1225, DOI 10.1016/j.yexcr.2008.12.015; Lian F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121499; Luo W, 2015, AM J TRANSL RES, V7, P1236; Ottaviani G, 2009, CANCER TREAT RES, V152, P3, DOI 10.1007/978-1-4419-0284-9_1; Shen QJ, 2012, LANCET ONCOL, V13, P817, DOI 10.1016/S1470-2045(12)70233-4; Simeone DM, 2007, PANCREAS, V34, P436, DOI 10.1097/MPA.0b013e3180333ae3; Sivan S, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/290536; Tilki D, 2010, EUR UROL, V57, P648, DOI 10.1016/j.eururo.2009.05.040; Trieb K, 2001, INT J BIOCHEM CELL B, V33, P11, DOI 10.1016/S1357-2725(00)00066-2; Yang CC, 2015, CLIN CHIM ACTA, V450, P277, DOI 10.1016/j.cca.2015.09.005; Yang Z, 2015, BIOMED PHARMACOTHER, V75, P153, DOI 10.1016/j.biopha.2015.07.018; Zhang C, 2014, INT J CLIN EXP PATHO, V7, P4194; Zhang J, 2015, CLIN CHIM ACTA, V444, P182, DOI 10.1016/j.cca.2014.12.041; Zhou MQ, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-359	30	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153601	10.1371/journal.pone.0153601	http://dx.doi.org/10.1371/journal.pone.0153601			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27074014	gold, Green Published, Green Submitted			2022-12-27	WOS:000374131200110
J	Doss, JF; Jonassaint, JC; Garrett, ME; Ashley-Koch, AE; Telen, MJ; Chi, JT				Doss, Jennifer F.; Jonassaint, Jude C.; Garrett, Melanie E.; Ashley-Koch, Allison E.; Telen, Marilyn J.; Chi, Jen-Tsan			Phase 1 Study of a Sulforaphane-Containing Broccoli Sprout Homogenate for Sickle Cell Disease	PLOS ONE			English	Article							FETAL-HEMOGLOBIN; BARDOXOLONE METHYL; PULMONARY-HYPERTENSION; ERYTHROID-CELLS; GENE-EXPRESSION; KIDNEY-FUNCTION; ANEMIA; HYDROXYUREA; ACTIVATION; MORBIDITY	Sickle cell disease (SCD) is the most common inherited hemoglobinopathy worldwide. Our previous results indicate that the reduced oxidative stress capacity of sickle erythrocytes may be caused by decreased expression of NRF2 (Nuclear factor (erythroid-derived 2)-like 2), an oxidative stress regulator. We found that activation of NRF2 with sulforaphane (SFN) in erythroid progenitors significantly increased the expression of NRF2 targets HMOX1, NQO1, and HBG1 (subunit of fetal hemoglobin) in a dose-dependent manner. Therefore, we hypothesized that NRF2 activation with SFN may offer therapeutic benefits for SCD patients by restoring oxidative capacity and increasing fetal hemoglobin concentration. To test this hypothesis, we performed a Phase 1, open-label, dose-escalation study of SFN, contained in a broccoli sprout homogenate (BSH) that naturally contains SFN, in adults with SCD. The primary and secondary study endpoints were safety and physiological response to NRF2 activation, respectively. We found that BSH was well tolerated, and the few adverse events that occurred during the trial were not likely related to BSH consumption. We observed an increase in the mean relative whole blood mRNA levels for the NRF2 target HMOX1 (p = 0.02) on the last day of BSH treatment, compared to pre-treatment. We also observed a trend toward increased mean relative mRNA levels of the NRF2 target HBG1 (p = 0.10) from baseline to end of treatment, but without significant changes in HbF protein. We conclude that BSH, in the provided doses, is safe in stable SCD patients and may induce changes in gene expression levels. We therefore propose investigation of more potent NRF2 inducers, which may elicit more robust physiological changes and offer clinical benefits to SCD patients.	[Doss, Jennifer F.; Chi, Jen-Tsan] Duke Univ, Dept Mol Genet & Microbiol, Durham, NC USA; [Doss, Jennifer F.; Chi, Jen-Tsan] Duke Univ, Ctr Genom & Computat Biol, Durham, NC USA; [Jonassaint, Jude C.; Telen, Marilyn J.] Duke Univ, Dept Med, Div Hematol, Durham, NC USA; [Jonassaint, Jude C.; Telen, Marilyn J.] Duke Univ, Duke Comprehens Sickle Cell Ctr, Durham, NC USA; [Garrett, Melanie E.; Ashley-Koch, Allison E.] Duke Univ, Ctr Human Dis Modeling, Durham, NC USA	Duke University; Duke University; Duke University; Duke University; Duke University	Chi, JT (corresponding author), Duke Univ, Dept Mol Genet & Microbiol, Durham, NC USA.; Chi, JT (corresponding author), Duke Univ, Ctr Genom & Computat Biol, Durham, NC USA.; Telen, MJ (corresponding author), Duke Univ, Dept Med, Div Hematol, Durham, NC USA.; Telen, MJ (corresponding author), Duke Univ, Duke Comprehens Sickle Cell Ctr, Durham, NC USA.	marilyn.telen@dm.duke.edu; jentsan.chi@duke.edu		Ashley-Koch, Allison/0000-0001-5409-9155; Chi, Jen-Tsan/0000-0003-3433-903X; Telen, Marilyn/0000-0003-3809-1780	Doris Duke Charitable Foundation [2011098]	Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF))	This study was funded by the Doris Duke Charitable Foundation, grant number 2011098. MT and JC received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinsheye I, 2011, BLOOD, V118, P19, DOI 10.1182/blood-2011-03-325258; Atwell LL, 2015, MOL NUTR FOOD RES, V59, P424, DOI 10.1002/mnfr.201400674; Charache S, 1996, MEDICINE, V75, P300, DOI 10.1097/00005792-199611000-00002; Cipolla BG, 2015, CANCER PREV RES, V8, P712, DOI 10.1158/1940-6207.CAPR-14-0459; Clarke JD, 2011, PHARMACOL RES, V64, P456, DOI 10.1016/j.phrs.2011.07.005; de Zeeuw D, 2013, NEW ENGL J MED, V369, P2492, DOI 10.1056/NEJMoa1306033; Elmariah H, 2014, AM J HEMATOL, V89, P530, DOI 10.1002/ajh.23683; Gao B, 2014, CLIN PHARMACOL-ADV A, V6, P19, DOI 10.2147/CPAA.S35078; Gibbs A, 2009, P NATL ACAD SCI USA, V106, P16663, DOI 10.1073/pnas.0908908106; Goldman DC, 2015, RADIAT RES, V183, P338, DOI 10.1667/RR13900.1; HEBBEL RP, 1982, J CLIN INVEST, V70, P1253, DOI 10.1172/JCI110724; Jaiswal AK, 2004, FREE RADICAL BIO MED, V36, P1199, DOI 10.1016/j.freeradbiomed.2004.02.074; Kato GJ, 2006, BLOOD, V107, P2279, DOI 10.1182/blood-2005-06-2373; Kaul DK, 2000, BLOOD, V95, P368, DOI 10.1182/blood.V95.2.368; Lee JM, 2004, P NATL ACAD SCI USA, V101, P9751, DOI 10.1073/pnas.0403620101; Macari ER, 2013, BLOOD, V121, P830, DOI 10.1182/blood-2012-07-443986; Macari ER, 2011, BLOOD, V117, P5987, DOI 10.1182/blood-2010-10-314096; Meyer M, 2013, RESP MED, V107, P472, DOI 10.1016/j.rmed.2012.11.006; Morris CR, 2008, BLOOD, V111, P402, DOI 10.1182/blood-2007-04-081703; Nath KA, 2015, NAT REV NEPHROL, V11, P161, DOI 10.1038/nrneph.2015.8; Noah TL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098671; Nur E, 2011, AM J HEMATOL, V86, P484, DOI 10.1002/ajh.22012; Okpala H, 2004, BLOOD REV, V18, P65, DOI 10.1016/S0268-960X(03)00037-7; PAULING L, 1949, SCIENCE, V109, P443; Pergola PE, 2011, NEW ENGL J MED, V365, P327, DOI 10.1056/NEJMoa1105351; Pergola PE, 2011, AM J NEPHROL, V33, P469, DOI 10.1159/000327599; Prevention CfDCa, 2011, SICKL CELL DIS DAT S; Probst BL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122942; Promsote W, 2014, INVEST OPHTH VIS SCI, V55, P5382, DOI 10.1167/iovs.14-14179; Rees DC, 2010, LANCET, V376, P2018, DOI 10.1016/S0140-6736(10)61029-X; Riedl MA, 2009, CLIN IMMUNOL, V130, P244, DOI 10.1016/j.clim.2008.10.007; Sangokoya C, 2010, BLOOD, V116, P4338, DOI 10.1182/blood-2009-04-214817; SCHACTER L, 1988, FASEB J, V2, P237, DOI 10.1096/fasebj.2.3.3350236; Schaer DJ, 2013, BLOOD, V121, P1276, DOI 10.1182/blood-2012-11-451229; Shapiro TA, 2001, CANCER EPIDEM BIOMAR, V10, P501; Singh K, 2014, P NATL ACAD SCI USA, V111, P15550, DOI 10.1073/pnas.1416940111; Steinberg MH, 2003, JAMA-J AM MED ASSOC, V289, P1645, DOI 10.1001/jama.289.13.1645; Venugopal R, 1996, P NATL ACAD SCI USA, V93, P14960, DOI 10.1073/pnas.93.25.14960; Voskaridou E, 2010, BLOOD, V115, P2354, DOI 10.1182/blood-2009-05-221333; Wong CP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086787; Zennadi R, 2007, BLOOD, V110, P2708, DOI 10.1182/blood-2006-11-056101; ZHANG YS, 1992, P NATL ACAD SCI USA, V89, P2399, DOI 10.1073/pnas.89.6.2399	42	41	41	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0152895	10.1371/journal.pone.0152895	http://dx.doi.org/10.1371/journal.pone.0152895			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27071063	gold, Green Published, Green Submitted			2022-12-27	WOS:000373900700018
J	Katt, ME; Xu, ZS; Gerecht, S; Searson, PC				Katt, Moriah E.; Xu, Zinnia S.; Gerecht, Sharon; Searson, Peter C.			Human Brain Microvascular Endothelial Cells Derived from the BC1 iPS Cell Line Exhibit a Blood-Brain Barrier Phenotype	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; ADVANCE TRANSLATIONAL RESEARCH; TIGHT JUNCTION; DRUG DISCOVERY; MODEL; PERMEABILITY; TRANSPORTERS; EXPRESSION; DERIVATION; CLAUDIN	The endothelial cells that form capillaries in the brain are highly specialized, with tight junctions that minimize paracellular transport and an array of broad-spectrum efflux pumps that make drug delivery to the brain extremely challenging. One of the major limitations in blood-brain barrier research and the development of drugs to treat central nervous system diseases is the lack of appropriate cell lines. Recent reports indicate that the derivation of human brain microvascular endothelial cells (hBMECs) from human induced pluripotent stem cells (iPSCs) may provide a solution to this problem. Here we demonstrate the derivation of hBMECs extended to two new human iPSC lines: BC1 and GFP-labeled BC1. These hBMECs highly express adherens and tight junction proteins VE-cadherin, ZO-1, occludin, and claudin-5. The addition of retinoic acid upregulates VE-cadherin expression, and results in a significant increase in transendothelial electrical resistance to physiological values. The permeabilities of tacrine, rhodamine 123, and Lucifer yellow are similar to values obtained for MDCK cells. The efflux ratio for rhodamine 123 across hBMECs is in the range 2-4 indicating polarization of efflux transporters. Using the rod assay to assess cell organization in small vessels and capillaries, we show that hBMECs resist elongation with decreasing diameter but show progressive axial alignment. The derivation of hBMECs with a blood-brain barrier phenotype from the BC1 cell line highlights that the protocol is robust. The expression of GFP in hBMECs derived from the BC1-GFP cell line provides an important new resource for BBB research.	[Katt, Moriah E.; Gerecht, Sharon; Searson, Peter C.] Johns Hopkins Univ, Dept Mat Sci & Engn, 3400 North Charles St, Baltimore, MD 21218 USA; [Katt, Moriah E.; Xu, Zinnia S.; Gerecht, Sharon; Searson, Peter C.] Johns Hopkins Univ, Inst Nanobiotechnol, 100 Croft Hall,3400 North Charles St, Baltimore, MD 21218 USA; [Xu, Zinnia S.] Johns Hopkins Univ, Dept Biomed Engn, 720 Rutland Ave, Baltimore, MD 21205 USA; [Gerecht, Sharon; Searson, Peter C.] Johns Hopkins Univ, Dept Chem & Biomol Engn, 3400 North Charles St, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Searson, PC (corresponding author), Johns Hopkins Univ, Dept Mat Sci & Engn, 3400 North Charles St, Baltimore, MD 21218 USA.; Searson, PC (corresponding author), Johns Hopkins Univ, Inst Nanobiotechnol, 100 Croft Hall,3400 North Charles St, Baltimore, MD 21218 USA.; Searson, PC (corresponding author), Johns Hopkins Univ, Dept Chem & Biomol Engn, 3400 North Charles St, Baltimore, MD 21218 USA.	searson@jhu.edu	Gerecht, Sharon/HCH-8629-2022	Gerecht, Sharon/0000-0002-8542-4835; Searson, Peter/0000-0002-5417-0828	NIH [R01CA170629]; DTRA [HDTRA1-15-1-0046]; NATIONAL CANCER INSTITUTE [R01CA170629] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DTRA(United States Department of DefenseDefense Threat Reduction Agency); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH (R01CA170629) and DTRA (HDTRA1-15-1-0046). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; BUTT AM, 1990, J PHYSIOL-LONDON, V429, P47, DOI 10.1113/jphysiol.1990.sp018243; CASTRO DJ, 1992, LARYNGOSCOPE, V102, P868, DOI 10.1288/00005537-199208000-00005; Cecchelli R, 2007, NAT REV DRUG DISCOV, V6, P650, DOI 10.1038/nrd2368; Cecchelli R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099733; Chiba H, 2008, BBA-BIOMEMBRANES, V1778, P588, DOI 10.1016/j.bbamem.2007.08.017; Chou BK, 2011, CELL RES, V21, P518, DOI 10.1038/cr.2011.12; de Boer AG, 2003, ANNU REV PHARMACOL, V43, P629, DOI 10.1146/annurev.pharmtox.43.100901.140204; Dejana E, 2008, J CELL SCI, V121, P2115, DOI 10.1242/jcs.017897; Eigenmann DE, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-33; Giacomini KM, 2010, NAT REV DRUG DISCOV, V9, P215, DOI 10.1038/nrd3028; Gunzel D, 2013, PHYSIOL REV, V93, P525, DOI 10.1152/physrev.00019.2012; Hewitt KJ, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-186; Irvine JD, 1999, J PHARM SCI, V88, P28, DOI 10.1021/js9803205; Keep RF, 2011, J NEUROCHEM, V119, P417, DOI 10.1111/j.1471-4159.2011.07425.x; Krause G, 2009, ANN NY ACAD SCI, V1165, P34, DOI 10.1111/j.1749-6632.2009.04057.x; Lelong-Rebel IH, 2005, ANTICANCER RES, V25, P3925; Lippmann ES, 2014, SCI REP-UK, V4, DOI 10.1038/srep04160; Lippmann ES, 2012, NAT BIOTECHNOL, V30, P783, DOI 10.1038/nbt.2247; Lundquist S, 2002, PHARMACEUT RES, V19, P976, DOI 10.1023/A:1016462205267; Matsuo H, 2000, NEUROREPORT, V11, P3507, DOI 10.1097/00001756-200011090-00021; Mizee MR, 2013, J NEUROSCI, V33, P1660, DOI 10.1523/JNEUROSCI.1338-12.2013; Morita K, 1999, J CELL BIOL, V147, P185, DOI 10.1083/jcb.147.1.185; Neuwelt E, 2008, LANCET NEUROL, V7, P84, DOI 10.1016/S1474-4422(07)70326-5; Neuwelt EA, 2011, NAT REV NEUROSCI, V12, P169, DOI 10.1038/nrn2995; Nitta T, 2003, J CELL BIOL, V161, P653, DOI 10.1083/jcb.200302070; Ohtsuki S, 2007, PHARM RES-DORDR, V24, P1745, DOI 10.1007/s11095-007-9374-5; Piontek J, 2008, FASEB J, V22, P146, DOI 10.1096/fj.07-8319com; Reichel Andreas, 2003, Methods Mol Med, V89, P307; Seetharaman S, 1998, J NEUROCHEM, V70, P1151, DOI 10.1046/j.1471-4159.1998.70031151.x; Staudt T, 2007, MICROSC RES TECHNIQ, V70, P1, DOI 10.1002/jemt.20396; Steiner O, 2011, J CEREBR BLOOD F MET, V31, P315, DOI 10.1038/jcbfm.2010.96; Summerfield SG, 2007, J PHARMACOL EXP THER, V322, P205, DOI 10.1124/jpet.107.121525; Summers WK, 2006, ALZHEIMER'S DISEASE: A CENTURY OF SCIENTIFIC AND CLINICAL RESEARCH, P439; Sung JH, 2005, DRUG METAB DISPOS, V33, P440, DOI 10.1124/dmd.104.002220; Swenson ES, 2007, STEM CELLS, V25, P2593, DOI 10.1634/stemcells.2007-0241; Urich E, 2013, SCI REP-UK, V3, DOI 10.1038/srep01500; Vetkin DO, 2004, BIOL BULL+, V31, P121, DOI 10.1023/B:BIBU.0000022465.09009.9a; Wang Q, 2005, INT J PHARMACEUT, V288, P349, DOI 10.1016/j.ijpharm.2004.10.007; Weksler B, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-16; Wilson HK, 2015, FLUIDS BARRIERS CNS, V12, DOI 10.1186/s12987-015-0007-9; Wong Andrew D, 2013, Front Neuroeng, V6, P7, DOI 10.3389/fneng.2013.00007; Ye M, 2014, SCI REP-UK, V4, DOI 10.1038/srep04681; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zou CL, 2012, STEM CELLS DEV, V21, P2298, DOI 10.1089/scd.2011.0688	46	79	80	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0152105	10.1371/journal.pone.0152105	http://dx.doi.org/10.1371/journal.pone.0152105			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27070801	Green Published, gold, Green Submitted			2022-12-27	WOS:000373900700007
J	Kim, YE; Kim, DH; Roh, YK; Ju, SY; Yoon, YJ; Nam, GE; Nam, HY; Choi, JS; Lee, JE; Sang, JE; Han, K; Park, YG				Kim, Young-Eun; Kim, Do-Hoon; Roh, Yong-Kyun; Ju, Sang-Yhun; Yoon, Yeo-Joon; Nam, Ga-Eun; Nam, Hyo-Yun; Choi, Jun-Seok; Lee, Jong-Eun; Sang, Jung-Eun; Han, Kyungdo; Park, Yong-Gyu			Relationship between Serum Ferritin Levels and Dyslipidemia in Korean Adolescents	PLOS ONE			English	Article							NUTRITION EXAMINATION SURVEY; CARDIOVASCULAR RISK-FACTORS; EXAMINATION SURVEY KNHANES; METABOLIC SYNDROME; NATIONAL-HEALTH; INSULIN-RESISTANCE; DIABETES-MELLITUS; FREE-RADICALS; ASSOCIATION; MEN	Background Ferritin is associated with various cardiometabolic risk factors such as dyslipidemia, hypertension, obesity, and insulin resistance in adults. We aimed to study the association between serum ferritin levels and dyslipidemia in adolescents, because dyslipidemia is considered an important modifiable cardiovascular risk factor in the young. Methods We analyzed 1,879 subjects (1,026 boys and 853 girls) from the 2009-2010 Korean National Health and Nutrition Examination Survey IV. Subjects were categorized into quartiles according to their lipid parameters, which were classified according to age and gender. Those in the highest quartile groups for total cholesterol, low-density lipoprotein cholesterol (LDL-C), and triglyceride concentrations were diagnosed as having dyslipidemia. Those in the lowest quartile for high-density lipoprotein cholesterol (HDL-C) values were diagnosed with abnormal levels. Results In boys, total cholesterol, LDL-C, and triglyceride concentrations were significantly correlated with serum ferritin levels. In both boys and girls, serum ferritin levels were negatively associated with HDL-C values, even after adjusting for all covariates. Furthermore, there was no significant correlation between serum ferritin levels and total cholesterol, LDL, and triglyceride concentrations in girls. Conclusion Serum ferritin levels were significantly associated with major dyslipidemia parameters, more prominently in boys than in girls, and this association represents a cardiometabolic risk factor.	[Kim, Young-Eun; Kim, Do-Hoon; Yoon, Yeo-Joon; Nam, Ga-Eun; Nam, Hyo-Yun; Choi, Jun-Seok; Lee, Jong-Eun; Sang, Jung-Eun] Korea Univ, Coll Med, Dept Family Med, Seoul 136705, South Korea; [Roh, Yong-Kyun] Hallym Univ, Coll Med, Dept Family Med, Chunchon, South Korea; [Ju, Sang-Yhun] Catholic Univ, Dept Family Med, Coll Med, Seoul, South Korea; [Han, Kyungdo; Park, Yong-Gyu] Catholic Univ, Coll Med, Dept Biostat, Seoul, South Korea	Korea University; Korea University Medicine (KU Medicine); Hallym University; Catholic University of Korea; Catholic University of Korea	Kim, DH (corresponding author), Korea Univ, Coll Med, Dept Family Med, Seoul 136705, South Korea.; Park, YG (corresponding author), Catholic Univ, Coll Med, Dept Biostat, Seoul, South Korea.	kmcfm@hanmail.net; ygpark@catholic.ac.kr	Nam, Ga Eun/AAU-6055-2020; Ju, Sang Yhun/Q-2946-2019; Nam, Ga Eun/AAA-1577-2021	Ju, Sang Yhun/0000-0002-0553-7128; Nam, Ga Eun/0000-0002-6739-9904; Kim, Do Hoon/0000-0001-7421-4501; Park, Yong Gyu/0000-0002-8721-3230; Kim, Young-Eun/0000-0003-0694-6844				Andrews NC, 1999, NEW ENGL J MED, V341, P1986, DOI 10.1056/NEJM199912233412607; Chang JS, 2013, ASIA PAC J CLIN NUTR, V22, P400, DOI 10.6133/apjcn.2013.22.3.07; Children NCEPEPoBCLi, 1991, HIGHL REP EXP PAN BL; Chun MY, 2012, KOREAN J FAM MED, V33, P144, DOI 10.4082/kjfm.2012.33.3.144; Daniels SR, 2008, PEDIATRICS, V122, P198, DOI 10.1542/peds.2008-1349; Ferrannini E, 2000, LANCET, V355, P2181, DOI 10.1016/S0140-6736(00)02397-7; Ford ES, 1999, DIABETES CARE, V22, P1978, DOI 10.2337/diacare.22.12.1978; Gillum RF, 2001, INT J OBESITY, V25, P639, DOI 10.1038/sj.ijo.0801561; Han LL, 2014, MOL NUTR FOOD RES, V58, P2189, DOI 10.1002/mnfr.201400088; Iwasaki T, 2005, DIABETES CARE, V28, P2486, DOI 10.2337/diacare.28.10.2486; Jehn M, 2004, DIABETES CARE, V27, P2422, DOI 10.2337/diacare.27.10.2422; Jeon Yeon Jin, 2013, Ann Pediatr Endocrinol Metab, V18, P141, DOI 10.6065/apem.2013.18.3.141; Kalantar-Zadeh K, 2006, CLIN J AM SOC NEPHRO, V1, pS9, DOI 10.2215/CJN.01390406; Kang HT, 2012, CLIN CHIM ACTA, V413, P636, DOI 10.1016/j.cca.2011.12.011; Kavey REW, 2003, CIRCULATION, V107, P1562, DOI 10.1161/01.CIR.0000061521.15730.6E; Kim CW, 2012, METABOLISM, V61, P1182, DOI 10.1016/j.metabol.2012.01.007; Kim CH, 2011, METABOLISM, V60, P414, DOI 10.1016/j.metabol.2010.03.007; Kim DW, 2015, PUBLIC HEALTH NUTR, V18, P1369, DOI 10.1017/S1368980014001712; Kim HM, 2006, AM J EPIDEMIOL, V164, P787, DOI 10.1093/aje/kwj251; Kouda K, 2004, J EPIDEMIOL, V14, P78, DOI 10.2188/jea.14.78; LAUER RM, 1992, PEDIATRICS, V89, P495; Lee BK, 2011, METABOLISM, V60, P1416, DOI 10.1016/j.metabol.2011.02.008; Lee Hye-Ja, 2014, Osong Public Health Res Perspect, V5, P204, DOI 10.1016/j.phrp.2014.06.005; Li J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074168; Liao Y, 2008, ACTA PAEDIATR, V97, P1449, DOI 10.1111/j.1651-2227.2008.00946.x; McGill HC, 2000, ARTERIOSCL THROM VAS, V20, P1998, DOI 10.1161/01.ATV.20.8.1998; McGill HC, 2001, CIRCULATION, V103, P1546; Mittendorfer B, 2005, CURR OPIN CLIN NUTR, V8, P367, DOI 10.1097/01.mco.0000172574.64019.98; Moran A, 2002, J CLIN ENDOCR METAB, V87, P4817, DOI 10.1210/jc.2002-020517; Moriarty-Kelsey M, 2010, J PEDIATR ENDOCR MET, V23, P1281, DOI 10.1515/jpem.2010.202; Pham NM, 2013, METABOLISM, V62, P561, DOI 10.1016/j.metabol.2012.07.025; Nishizawa H, 2002, DIABETES, V51, P2734, DOI 10.2337/diabetes.51.9.2734; Park SK, 2012, DIABETES CARE, V35, P2521, DOI 10.2337/dc12-0543; Piperno A, 2002, J HYPERTENS, V20, P1513, DOI 10.1097/00004872-200208000-00013; Tsimihodimos Vasilis, 2006, Metabolic Syndrome and Related Disorders, V4, P196, DOI 10.1089/met.2006.4.196; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Wang W, 2010, BBA-GEN SUBJECTS, V1800, P760, DOI 10.1016/j.bbagen.2010.03.011; Williams MJA, 2002, ATHEROSCLEROSIS, V165, P179, DOI 10.1016/S0021-9150(02)00233-2; Wilson JG, 2003, AM J MED SCI, V325, P332, DOI 10.1097/00000441-200306000-00004; WOLFF SP, 1993, BRIT MED BULL, V49, P642, DOI 10.1093/oxfordjournals.bmb.a072637; Yalta K, 2011, INT J CARDIOL, V153, P225, DOI 10.1016/j.ijcard.2011.09.057; Yao DC, 2005, FREE RADICAL BIO MED, V39, P1385, DOI 10.1016/j.freeradbiomed.2005.07.015; Yoo KD, 2012, CLIN ENDOCRINOL, V77, P233, DOI 10.1111/j.1365-2265.2011.04248.x; Zandman-Goddard G, 2007, AUTOIMMUN REV, V6, P457, DOI 10.1016/j.autrev.2007.01.016; Zelber-Sagi S, 2007, J HEPATOL, V46, P700, DOI 10.1016/j.jhep.2006.09.018	45	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0153167	10.1371/journal.pone.0153167	http://dx.doi.org/10.1371/journal.pone.0153167			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27070153	Green Published, Green Submitted, gold			2022-12-27	WOS:000373900700035
J	Klein, K; Hennig, S; Paul, SK				Klein, Kerenaftali; Hennig, Stefanie; Paul, Sanjoy Ketan			A Bayesian Modelling Approach with Balancing Informative Prior for Analysing Imbalanced Data	PLOS ONE			English	Article							RUN LENGTH CONTROL; AMINOGLYCOSIDE THERAPY; TOBRAMYCIN	When a dataset is imbalanced, the prediction of the scarcely-sampled subpopulation can be over-influenced by the population contributing to the majority of the data. The aim of this study was to develop a Bayesian modelling approach with balancing informative prior so that the influence of imbalance to the overall prediction could be minimised. The new approach was developed in order to weigh the data in favour of the smaller subset(s). The method was assessed in terms of bias and precision in predicting model parameter estimates of simulated datasets. Moreover, the method was evaluated in predicting optimal dose levels of tobramycin for various age groups in a motivating example. The bias estimates using the balancing informative prior approach were smaller than those generated using the conventional approach which was without the consideration for the imbalance in the datasets. The precision estimates were also superior. The method was further evaluated in a motivating example of optimal dosage prediction of tobramycin. The resulting predictions also agreed well with what had been reported in the literature. The proposed Bayesian balancing informative prior approach has shown a real potential to adequately weigh the data in favour of smaller subset(s) of data to generate robust prediction models.	[Klein, Kerenaftali; Paul, Sanjoy Ketan] QIMR Berghofer Med Res Inst, Clin Trials & Biostat Unit, 300 Herston Rd, Brisbane, Qld, Australia; [Hennig, Stefanie] Univ Queensland, Sch Pharm, 20 Cornwall St, Brisbane, Qld, Australia	QIMR Berghofer Medical Research Institute; University of Queensland	Klein, K (corresponding author), QIMR Berghofer Med Res Inst, Clin Trials & Biostat Unit, 300 Herston Rd, Brisbane, Qld, Australia.	kerenaftali.klein@qimrberghofer.edu.au	Hennig, Stefanie/E-4426-2011; Paul, Sanjoy K/F-8199-2010	Hennig, Stefanie/0000-0001-5972-3711; Paul, Sanjoy K/0000-0003-0848-7194				Anderson BJ, 2011, PEDIATR ANESTH, V21, P222, DOI 10.1111/j.1460-9592.2011.03536.x; Burkhardt O, 2006, J ANTIMICROB CHEMOTH, V58, P822, DOI 10.1093/jac/dkl328; Chawla NV, 2005, DATA MINING AND KNOWLEDGE DISCOVERY HANDBOOK, P853, DOI 10.1007/0-387-25465-X_40; CLEVELAND WS, 1981, AM STAT, V35, P54, DOI 10.2307/2683591; European Committee on Antimicrobial Susceptibility Testing, 2013, ANT WILD TYP DISTR M; Gabrielsson J., 2007, PHARMACOKINETIC PHAR, V4th; Geweke J, 1991, BAYESIAN STAT, V4; Gilks WR, 1996, MARKOV CHAIN MONTE C; Haibo He, 2009, IEEE Transactions on Knowledge and Data Engineering, V21, P1263, DOI 10.1109/TKDE.2008.239; HEIDELBERGER P, 1983, OPER RES, V31, P1109, DOI 10.1287/opre.31.6.1109; HEIDELBERGER P, 1981, COMMUN ACM, V24, P233, DOI 10.1145/358598.358630; Hennig S, 2013, CLIN PHARMACOKINET, V52, P289, DOI 10.1007/s40262-013-0036-y; HSU MC, 1984, PEDIATR INFECT DIS J, V3, P526, DOI 10.1097/00006454-198411000-00009; Kashuba ADM, 1999, ANTIMICROB AGENTS CH, V43, P623, DOI 10.1128/AAC.43.3.623; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Massie J, 2006, J PAEDIATR CHILD H, V42, P601, DOI 10.1111/j.1440-1754.2006.00944.x; MOORE RD, 1987, J INFECT DIS, V155, P93, DOI 10.1093/infdis/155.1.93; Murry KR, 1999, PHARMACOTHERAPY, V19, P1252, DOI 10.1592/phco.19.16.1252.30876; R Development Core Team, 2012, R LANG ENV STAT COMP; Rahman M. Mostafizur, 2013, International Journal of Machine Learning and Computing, V3, P59, DOI 10.7763/IJMLC.2013.V3.307; Standing JS, 2008, PREDICTING PAEDIAT T; Yap BW, 2014, P 1 INT C ADV DAT IN, P13, DOI DOI 10.1007/978-981-4585-18-7_2	22	4	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0152700	10.1371/journal.pone.0152700	http://dx.doi.org/10.1371/journal.pone.0152700			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27070549	gold, Green Published			2022-12-27	WOS:000373900700014
J	Worstell, NC; Krishnan, P; Weatherston, JD; Wu, HJ				Worstell, Nolan C.; Krishnan, Pratik; Weatherston, Joshua D.; Wu, Hung-Jen			Binding Cooperativity Matters: A GM(1)-Like Ganglioside-Cholera Toxin B Subunit Binding Study Using a Nanocube-Based Lipid Bilayer Array	PLOS ONE			English	Article							SURFACE-PLASMON RESONANCE; CELL-SURFACE; GM1; MICROARRAY; AFFINITY; MEMBRANES; RECEPTOR; SPECIFICITY; DERIVATIVES; EXPRESSION	Protein-glycan recognition is often mediated by multivalent binding. These multivalent bindings can be further complicated by cooperative interactions between glycans and individual glycan binding subunits. Here we have demonstrated a nanocube-based lipid bilayer array capable of quantitatively elucidating binding dissociation constants, maximum binding capacity, and binding cooperativity in a high-throughput format. Taking cholera toxin B subunit (CTB) as a model cooperativity system, we studied both GM(1) and GM(1)-like gangliosides binding to CTB. We confirmed the previously observed CTB-GM(1) positive cooperativity. Surprisingly, we demonstrated fucosyl-GM(1) has approximately 7 times higher CTB binding capacity than GM(1). In order to explain this phenomenon, we hypothesized that the reduced binding cooperativity of fucosyl-GM(1) caused the increased binding capacity. This was unintuitive, as GM(1) exhibited higher binding avidity (16 times lower dissociation constant). We confirmed the hypothesis using a theoretical stepwise binding model of CTB. Moreover, by taking a mixture of fucosyl-GM(1) and GM(2), we observed the mild binding avidity fucosyl-GM(1) activated GM(2) receptors enhancing the binding capacity of the lipid bilayer surface. This was unexpected as GM(2) receptors have negligible binding avidity in pure GM(2) bilayers. These unexpected discoveries demonstrate the importance of binding cooperativity in multivalent binding mechanisms. Thus, quantitative analysis of multivalent protein-glycan interactions in heterogeneous glycan systems is of critical importance. Our user-friendly, robust, and high-throughput nanocube-based lipid bilayer array offers an attractive method for dissecting these complex mechanisms.	[Worstell, Nolan C.; Krishnan, Pratik; Weatherston, Joshua D.; Wu, Hung-Jen] Texas A&M Univ, Dept Chem Engn, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Wu, HJ (corresponding author), Texas A&M Univ, Dept Chem Engn, College Stn, TX 77843 USA.	hjwu@tamu.edu	; Wu, Hung-Jen/H-3769-2016	Weatherston, Joshua/0000-0002-7946-1218; Wu, Hung-Jen/0000-0003-3082-7431	National Science Foundation [DBI-0116835]	National Science Foundation(National Science Foundation (NSF))	We would like to acknowledge the Microscopy & Imaging Center at Texas A&M University for use of their FEI Technai G2 F20 FE-TEM, FEI Vitrobot, and FEI Quanta 600 FE-SEM. The FE-SEM acquisition was supported in part by the National Science Foundation under Grant No. DBI-0116835.	Arnaud J, 2013, CHEM SOC REV, V42, P4798, DOI 10.1039/c2cs35435g; Castellana ET, 2007, BIOINTERPHASES, V2, P57, DOI 10.1116/1.2732312; Cecioni S, 2015, CHEM REV, V115, P525, DOI 10.1021/cr500303t; Dawson G, 2015, BBA-MOL CELL BIOL L, V1851, P1026, DOI 10.1016/j.bbalip.2015.02.007; Gallegos KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030368; Giuliani A, 1995, MOL CELL BIOCHEM, V152, P103, DOI 10.1007/BF01076072; Hu S, 2009, PROTEOM CLIN APPL, V3, P148, DOI 10.1002/prca.200800153; Iwabuchi K, 2012, BIOFACTORS, V38, P275, DOI 10.1002/biof.1017; Jung H, 2009, J STRUCT BIOL, V168, P90, DOI 10.1016/j.jsb.2009.05.010; Kim CS, 2012, ANAL CHEM, V84, P6884, DOI 10.1021/ac301511t; Kuziemko GM, 1996, BIOCHEMISTRY-US, V35, P6375, DOI 10.1021/bi952314i; Lauer S, 2002, BIOCHEMISTRY-US, V41, P1742, DOI 10.1021/bi0112816; Leney AC, 2014, ANAL CHEM, V86, P5271, DOI 10.1021/ac4041179; Lin H, 2014, J AM SOC MASS SPECTR, V25, P104, DOI 10.1007/s13361-013-0751-5; Ma Y, 2012, ANAL BIOANAL CHEM, V404, P51, DOI 10.1007/s00216-012-6096-2; MacKenzie CR, 1997, J BIOL CHEM, V272, P5533, DOI 10.1074/jbc.272.9.5533; MASSERINI M, 1992, BIOCHEMISTRY-US, V31, P2422, DOI 10.1021/bi00123a030; Mikhalyov I, 2011, BBA-BIOMEMBRANES, V1808, P1930, DOI 10.1016/j.bbamem.2011.04.002; Molander-Melin M, 2005, J NEUROCHEM, V92, P171, DOI 10.1111/j.1471-4159.2004.02849.x; Mornet S, 2005, NANO LETT, V5, P281, DOI 10.1021/nl048153y; Niitsoo O, 2011, J COLLOID INTERF SCI, V354, P887, DOI 10.1016/j.jcis.2010.11.013; Palma AS, 2014, CURR OPIN CHEM BIOL, V18, P87, DOI 10.1016/j.cbpa.2014.01.007; Park S, 2013, CHEM SOC REV, V42, P4310, DOI 10.1039/c2cs35401b; Pukin AV, 2007, CHEMBIOCHEM, V8, P1500, DOI 10.1002/cbic.200700266; Rinaldi S, 2009, GLYCOBIOLOGY, V19, P789, DOI 10.1093/glycob/cwp049; SCHENGRUND CL, 1989, J BIOL CHEM, V264, P13233; SCHON A, 1989, BIOCHEMISTRY-US, V28, P5019, DOI 10.1021/bi00438a017; Schwarz A, 1997, J HISTOCHEM CYTOCHEM, V45, P611, DOI 10.1177/002215549704500413; Sheikh KA, 1999, BRAIN, V122, P449, DOI 10.1093/brain/122.3.449; Shi JJ, 2007, J AM CHEM SOC, V129, P5954, DOI 10.1021/ja069375w; Sly KL, 2014, ANAL CHEM, V86, P11045, DOI 10.1021/ac500094v; Sun YG, 2003, NANO LETT, V3, P955, DOI 10.1021/nl034312m; Tanaka M, 2005, NATURE, V437, P656, DOI 10.1038/nature04164; Tao A, 2006, ANGEW CHEM INT EDIT, V45, P4597, DOI 10.1002/anie.200601277; Tao SC, 2008, GLYCOBIOLOGY, V18, P761, DOI 10.1093/glycob/cwn063; Terrell J, 2008, J LIPOSOME RES, V18, P21, DOI [10.1080/08982100801893929, 10.1080/08982100801893929 ]; Tuosto L, 2001, EUR J IMMUNOL, V31, P345, DOI 10.1002/1521-4141(200102)31:2<345::AID-IMMU345>3.3.CO;2-C; Turnbull WB, 2004, J AM CHEM SOC, V126, P1047, DOI 10.1021/ja0378207; Varki A., 2009, ESSENTIALS GLYCOBIOL; Wang LL, 2014, GLYCOBIOLOGY, V24, P507, DOI 10.1093/glycob/cwu019; Wang R, 2011, J DISPER SCI TECHNOL, V32, P532, DOI 10.1080/01932691003757082; Willison HJ, 2002, BRAIN, V125, P2591, DOI 10.1093/brain/awf272; Winter EM, 2006, ANAL CHEM, V78, P174, DOI 10.1021/ac0514927; Wu HJ, 2012, NAT METHODS, V9, P1189, DOI [10.1038/NMETH.2211, 10.1038/nmeth.2211]; Yamazaki V, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-18; Yanagisawa M, 2007, GLYCOBIOLOGY, V17, p57R, DOI 10.1093/glycob/cwm018; Yanagisawa M, 2006, GLYCOBIOLOGY, V16, p19G, DOI 10.1093/glycob/cwl003; Zhu XY, 2009, J AM CHEM SOC, V131, P13646, DOI 10.1021/ja902783n	48	26	26	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0153265	10.1371/journal.pone.0153265	http://dx.doi.org/10.1371/journal.pone.0153265			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27070150	Green Published, gold, Green Submitted			2022-12-27	WOS:000373900700043
J	Coronado-Montoya, S; Levis, AW; Kwakkenbos, L; Steele, RJ; Turner, EH; Thombs, BD				Coronado-Montoya, Stephanie; Levis, Alexander W.; Kwakkenbos, Linda; Steele, Russell J.; Turner, Erick H.; Thombs, Brett D.			Reporting of Positive Results in Randomized Controlled Trials of Mindfulness-Based Mental Health Interventions	PLOS ONE			English	Article							QUALITY-OF-LIFE; COGNITIVE THERAPY; STRESS REDUCTION; PUBLICATION BIAS; EXCESS SIGNIFICANCE; PRIMARY OUTCOMES; METAANALYSIS; DEPRESSION; ANXIETY; PREVENTION	Background A large proportion of mindfulness-based therapy trials report statistically significant results, even in the context of very low statistical power. The objective of the present study was to characterize the reporting of "positive" results in randomized controlled trials of mindfulness-based therapy. We also assessed mindfulness-based therapy trial registrations for indications of possible reporting bias and reviewed recent systematic reviews and meta-analyses to determine whether reporting biases were identified. Methods CINAHL, Cochrane CENTRAL, EMBASE, ISI, MEDLINE, PsycInfo, and SCOPUS databases were searched for randomized controlled trials of mindfulness-based therapy. The number of positive trials was described and compared to the number that might be expected if mindfulness-based therapy were similarly effective compared to individual therapy for depression. Trial registries were searched for mindfulness-based therapy registrations. CINAHL, Cochrane CENTRAL, EMBASE, ISI, MEDLINE, PsycInfo, and SCOPUS were also searched for mindfulness-based therapy systematic reviews and meta-analyses. Results 108 (87%) of 124 published trials reported >= 1 positive outcome in the abstract, and 109 (88%) concluded that mindfulness-based therapy was effective, 1.6 times greater than the expected number of positive trials based on effect size d = 0.55 (expected number positive trials = 65.7). Of 21 trial registrations, 13 (62%) remained unpublished 30 months post-trial completion. No trial registrations adequately specified a single primary outcome measure with time of assessment. None of 36 systematic reviews and meta-analyses concluded that effect estimates were overestimated due to reporting biases. Conclusions The proportion of mindfulnessbased therapy trials with statistically significant results may overstate what would occur in practice.	[Coronado-Montoya, Stephanie; Levis, Alexander W.; Kwakkenbos, Linda; Steele, Russell J.; Thombs, Brett D.] McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada; [Coronado-Montoya, Stephanie; Kwakkenbos, Linda; Thombs, Brett D.] McGill Univ, Dept Psychiat, Montreal, PQ, Canada; [Steele, Russell J.; Thombs, Brett D.] McGill Univ, Dept Math & Stat, Montreal, PQ, Canada; [Turner, Erick H.] Oregon Hlth & Sci Univ, Dept Psychiat, Portland, OR 97201 USA; [Turner, Erick H.] Portland VA Med Ctr, Dept Psychiat, Portland, OR USA; [Thombs, Brett D.] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Thombs, Brett D.] McGill Univ, Dept Med, Montreal, PQ, Canada; [Thombs, Brett D.] McGill Univ, Dept Educ & Counselling Psychol, Montreal, PQ, Canada; [Thombs, Brett D.] McGill Univ, Dept Psychol, Montreal, PQ, Canada; [Thombs, Brett D.] McGill Univ, Sch Nursing, Montreal, PQ, Canada	Lady Davis Institute; McGill University; McGill University; McGill University; Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Portland VA Medical Center; McGill University; McGill University; McGill University; McGill University; McGill University	Thombs, BD (corresponding author), McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada.; Thombs, BD (corresponding author), McGill Univ, Dept Psychiat, Montreal, PQ, Canada.; Thombs, BD (corresponding author), McGill Univ, Dept Math & Stat, Montreal, PQ, Canada.; Thombs, BD (corresponding author), McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada.; Thombs, BD (corresponding author), McGill Univ, Dept Med, Montreal, PQ, Canada.; Thombs, BD (corresponding author), McGill Univ, Dept Educ & Counselling Psychol, Montreal, PQ, Canada.; Thombs, BD (corresponding author), McGill Univ, Dept Psychol, Montreal, PQ, Canada.; Thombs, BD (corresponding author), McGill Univ, Sch Nursing, Montreal, PQ, Canada.	brett.thombs@mcgill.ca	Turner, Erick/A-4848-2008; Steele, Russell J/G-6926-2017; Kwakkenbos, Linda/GXH-2756-2022	Turner, Erick/0000-0002-3522-3357; Kwakkenbos, Linda/0000-0002-1573-4504; Coronado-Montoya, Stephanie/0000-0003-2491-5689				Abbott RA, 2014, J PSYCHOSOM RES, V76, P341, DOI 10.1016/j.jpsychores.2014.02.012; [Anonymous], 2015, MBCT CLIN PRACT; Azar M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142894; Bawa FLM, 2015, BRIT J GEN PRACT, V65, pE387, DOI 10.3399/bjgp15X685297; Bohlmeijer E, 2010, J PSYCHOSOM RES, V68, P539, DOI 10.1016/j.jpsychores.2009.10.005; Boutron I, 2010, JAMA-J AM MED ASSOC, V303, P2058, DOI 10.1001/jama.2010.651; Bower P, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f540; Brewer JA, 2009, SUBST ABUS, V30, P306, DOI 10.1080/08897070903250241; Center for Mindfulness in Medicine, 2014, STRESS RED PROGR; Chen KW, 2012, DEPRESS ANXIETY, V29, P545, DOI 10.1002/da.21964; Chiesa A, 2011, PSYCHIAT RES, V187, P441, DOI 10.1016/j.psychres.2010.08.011; Cramer H, 2012, CURR ONCOL, V19, pE343, DOI 10.3747/co.19.1016; Cuijpers P, 2010, PSYCHOL MED, V40, P211, DOI 10.1017/S0033291709006114; Cuijpers P, 2008, PSYCHOTHER RES, V18, P225, DOI 10.1080/10503300701442027; de Vibe M., 2012, CAMPBELL SYSTEMATIC, V3, P1, DOI [DOI 10.4073/CSR.2012.3, 10.4073/csr.2012.3]; Driessen E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137864; Driessen E, 2010, J CONSULT CLIN PSYCH, V78, P668, DOI 10.1037/a0020570; Dwan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003081; EASTERBROOK PJ, 1991, LANCET, V337, P867, DOI 10.1016/0140-6736(91)90201-Y; Fanelli D, 2013, P NATL ACAD SCI USA, V110, P15031, DOI 10.1073/pnas.1302997110; Fanelli D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010068; Ferguson CJ, 2012, PSYCHOL METHODS, V17, P120, DOI 10.1037/a0024445; Fjorback LO, 2011, ACTA PSYCHIAT SCAND, V124, P102, DOI 10.1111/j.1600-0447.2011.01704.x; Flint J, 2015, PSYCHOL MED, V45, P439, DOI 10.1017/S0033291714001421; Galante J, 2013, J RES NURS, V18, P133, DOI 10.1177/1744987112466087; Goyal M, 2014, JAMA INTERN MED, V174, P357, DOI 10.1001/jamainternmed.2013.13018; Hoffman CJ, 2012, J CLIN ONCOL, V30, P1335, DOI 10.1200/JCO.2010.34.0331; Hofmann SG, 2010, J CONSULT CLIN PSYCH, V78, P169, DOI 10.1037/a0018555; Hughes JW, 2013, PSYCHOSOM MED, V75, P721, DOI 10.1097/PSY.0b013e3182a3e4e5; Ioannidis JPA, 2008, J EVAL CLIN PRACT, V14, P951, DOI 10.1111/j.1365-2753.2008.00986.x; Ioannidis JPA, 2007, CLIN TRIALS, V4, P245, DOI 10.1177/1740774507079441; Ioannidis JPA, 2007, CAN MED ASSOC J, V176, P1091, DOI 10.1503/cmaj.060410; Ioannidis JPA, 2013, J MATH PSYCHOL, V57, P184, DOI 10.1016/j.jmp.2013.03.002; Ioannidis JPA, 2011, ARCH GEN PSYCHIAT, V68, P773, DOI 10.1001/archgenpsychiatry.2011.28; Jazaieri H, 2012, J CLIN PSYCHOL, V68, P715, DOI 10.1002/jclp.21863; Johansson B, 2012, BRAIN INJURY, V26, P1621, DOI 10.3109/02699052.2012.700082; Kabat-Zinn J., 1990, FULL CATASTROPHE LIV; KABATZINN J, 1982, GEN HOSP PSYCHIAT, V4, P33, DOI 10.1016/0163-8343(82)90026-3; Kaviani H, 2012, ARCH PSYCHIATR PSYCH, V14, P21; Kim YW, 2009, DEPRESS ANXIETY, V26, P601, DOI 10.1002/da.20552; King AP, 2013, DEPRESS ANXIETY, V30, P638, DOI 10.1002/da.22104; Klainin-Yobas P, 2012, INT J NURS STUD, V49, P109, DOI 10.1016/j.ijnurstu.2011.08.014; Kyzas PA, 2007, EUR J CANCER, V43, P2559, DOI 10.1016/j.ejca.2007.08.030; Lakhan SE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071834; Lau J, 2006, BMJ-BRIT MED J, V333, P597, DOI 10.1136/bmj.333.7568.597; Leykin Y, 2009, CLIN PSYCHOL-SCI PR, V16, P54, DOI 10.1111/j.1468-2850.2009.01143.x; Lillis J, 2009, ANN BEHAV MED, V37, P58, DOI 10.1007/s12160-009-9083-x; Masuda A, 2013, NEUROPSYCHIATRY-LOND, V3, P433, DOI 10.2217/npy.13.36; Mathieu S, 2009, JAMA-J AM MED ASSOC, V302, P977, DOI 10.1001/jama.2009.1242; Mavridis D, 2014, EVID-BASED MENT HEAL, V17, P11, DOI 10.1136/eb-2013-101700; Milette K, 2011, J PSYCHOSOM RES, V70, P205, DOI 10.1016/j.jpsychores.2010.09.015; National Collaborating Centre for Mental Health, 2011, COMMON MENTAL HEALTH; Parswani Manish J, 2013, Int J Yoga, V6, P111, DOI 10.4103/0973-6131.113405; Piet J, 2012, J CONSULT CLIN PSYCH, V80, P1007, DOI 10.1037/a0028329; Piet J, 2011, CLIN PSYCHOL REV, V31, P1032, DOI 10.1016/j.cpr.2011.05.002; Pradhan EK, 2007, ARTHRIT RHEUM-ARTHR, V57, P1134, DOI 10.1002/art.23010; R Development Core Team, R LANG ENV STAT COMP; Riehm KE, 2015, J PSYCHOSOM RES, V79, P1, DOI 10.1016/j.jpsychores.2015.04.010; Rodgers M, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16280; Ross JS, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7292; Rothstein HR, 2005, PUBLICATION BIAS IN META-ANALYSIS: PREVENTION, ASSESSMENT AND ADJUSTMENTS, P1, DOI 10.1002/0470870168; Schneider S, 2010, J BEHAV MED, V33, P1, DOI 10.1007/s10865-009-9227-2; Sterne JAC, 2011, COCHRANE HDB SYSTEMA; Strauss C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096110; Teasdale JD, 2000, J CONSULT CLIN PSYCH, V68, P615, DOI 10.1037//0022-006X.68.4.615; Turner EH, 2008, NEW ENGL J MED, V358, P252, DOI 10.1056/NEJMsa065779; Tzoulaki I, 2013, JAMA INTERN MED, V173, P664, DOI 10.1001/jamainternmed.2013.3018; van Son J, 2013, DIABETES CARE, V36, P823, DOI 10.2337/dc12-1477; Vedula SS, 2009, NEW ENGL J MED, V361, P1963, DOI 10.1056/NEJMsa0906126; Whiteford HA, 2013, LANCET, V382, P1575, DOI 10.1016/S0140-6736(13)61611-6; Williams JMG, 2007, THE MINDFUL WAY THRO	71	72	73	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2016	11	4							e0153220	10.1371/journal.pone.0153220	http://dx.doi.org/10.1371/journal.pone.0153220			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DI6JK	27058355	Green Published, Green Submitted, gold			2022-12-27	WOS:000373604800022
J	Xie, BK; Qin, ZX; Liu, S; Nong, SQ; Ma, QY; Chen, BJ; Liu, MJ; Pan, TB; Liao, DJ				Xie, Bingkun; Qin, Zhaoxian; Liu, Shuai; Nong, Suqun; Ma, Qingyan; Chen, Baojian; Liu, Mingjun; Pan, Tianbiao; Liao, D. Joshua			Cloning of Porcine Pituitary Tumor Transforming Gene 1 and Its Expression in Porcine Oocytes and Embryos	PLOS ONE			English	Article							TRANSCRIPTIONAL ACTIVATION FUNCTION; SOMATIC-CELL CLONING; MATERNAL EFFECT GENE; PROTEIN-SYNTHESIS; TRANSCOMPLEMENTARY ACTIVATION; CHROMATID SEPARATION; CLONED EMBRYOS; BINDING-FACTOR; MOUSE EMBRYO; IN-VITRO	Thematernal-to-embryonic transition (MET) is a complex process that occurs during early mammalian embryogenesis and is characterized by activation of the zygotic genome, initiation of embryonic transcription, and replacement of maternal mRNA with embryonic mRNA. The objective of this study was to reveal the temporal expression and localization patterns of PTTG1 during early porcine embryonic development and to establish a relationship between PTTG1 and the MET. To achieve this goal, reverse transcription-polymerase chain reaction (RT-PCR) was performed to clone porcine PTTG1. Subsequently, germinal vesicle (GV)- and metaphase II (MII)-stage oocytes, zygotes, 2-, 4-, and 8-cell-stage embryos, morulas, and blastocysts were produced in vitro and their gene expression was analyzed. The results revealed that the coding sequence of porcine PTTG1 is 609-bp in length and that it encodes a 202-aa polypeptide. Using qRT-PCR, PTTG1 mRNA expression was observed to be maintained at high levels in GV-and MII-stage oocytes. The transcript levels in oocytes were also significantly higher than those in embryos from the zygote to blastocyst stages. Immunohistochemical analyses revealed that porcine PTTG1 was primarily localized to the cytoplasm and partially localized to the nucleus. Further more, the PTTG1 protein levels in MII-stage oocytes and zygotes were significantly higher than those in embryos from the 2-cell to blastocyst stage. After fertilization, the level of this protein began to decrease gradually until the blastocyst stage. The results of our study suggest that porcine PTTG1 is a new candidate maternal effect gene (MEG) that may participate in the processes of oocyte maturation and zygotic genome activation during porcine embryogenesis.	[Xie, Bingkun; Qin, Zhaoxian; Nong, Suqun; Ma, Qingyan; Chen, Baojian; Liu, Mingjun; Pan, Tianbiao] Guangxi Inst Anim Sci, Guangxi Key Lab Livestock Genet Improvement, Nanning, Guangxi, Peoples R China; [Liu, Shuai] Hebei Res Inst Family Planning, Shijiazhuang, Hebei, Peoples R China; [Liao, D. Joshua] Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA	University of Minnesota System	Xie, BK (corresponding author), Guangxi Inst Anim Sci, Guangxi Key Lab Livestock Genet Improvement, Nanning, Guangxi, Peoples R China.	bkxie@163.com			National Natural Science Foundation of China [31360544]; Guangxi Natural Science Foundation [2013GXNSFBA019117, 2011GXNSFA018109]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangxi Natural Science Foundation(National Natural Science Foundation of Guangxi Province)	This work was supported by the National Natural Science Foundation of China (Grant No. 31360544) and Guangxi Natural Science Foundation (2013GXNSFBA019117, 2011GXNSFA018109). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernal JA, 2008, CELL DEATH DIFFER, V15, P202, DOI 10.1038/sj.cdd.4402254; BOUNIOL C, 1995, EXP CELL RES, V218, P57, DOI 10.1006/excr.1995.1130; Bradshaw C, 2007, HISTOL HISTOPATHOL, V22, P219, DOI 10.14670/HH-22.219; BRAUDE P, 1988, NATURE, V332, P459, DOI 10.1038/332459a0; BrawTal R, 1997, J REPROD FERTIL, V109, P165, DOI 10.1530/jrf.0.1090165; Burns KH, 2003, SCIENCE, V300, P633, DOI 10.1126/science.1081813; Chien WW, 2000, J BIOL CHEM, V275, P19422, DOI 10.1074/jbc.M910105199; CROSBY IM, 1988, J REPROD FERTIL, V82, P769, DOI 10.1530/jrf.0.0820769; Dankert D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108907; Davis D L, 1985, J Reprod Fertil Suppl, V33, P115; Dominguez A, 1998, ONCOGENE, V17, P2187, DOI 10.1038/sj.onc.1202140; El-Sayed A, 2006, PHYSIOL GENOMICS, V28, P84, DOI 10.1152/physiolgenomics.00111.2006; Evsikov AV, 2009, MOL REPROD DEV, V76, P805, DOI 10.1002/mrd.21038; Fair T, 1997, ANAT EMBRYOL, V195, P327, DOI 10.1007/s004290050052; FREI RE, 1989, J REPROD FERTIL, V86, P637, DOI 10.1530/jrf.0.0860637; Ghanem N, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-90; Kim Kyeoung-Hwa, 2014, Clin Exp Reprod Med, V41, P47, DOI 10.5653/cerm.2014.41.2.47; LATHAM KE, 1991, DEVELOPMENT, V112, P921; Li L, 2013, MOL ASPECTS MED, V34, P919, DOI 10.1016/j.mam.2013.01.003; Li L, 2010, DEVELOPMENT, V137, P859, DOI 10.1242/dev.039487; Li ZC, 2013, CELL REPROGRAM, V15, P459, DOI 10.1089/cell.2013.0010; McCabe CJ, 1999, J ENDOCRINOL, V162, P163, DOI 10.1677/joe.0.1620163; Narducci MG, 2002, P NATL ACAD SCI USA, V99, P11712, DOI 10.1073/pnas.182412399; Pei L, 1997, MOL ENDOCRINOL, V11, P433, DOI 10.1210/me.11.4.433; Pei L, 2001, J BIOL CHEM, V276, P8484, DOI 10.1074/jbc.M009654200; Pei L, 2000, J BIOL CHEM, V275, P31191, DOI 10.1074/jbc.M002451200; Pierconti F, 2015, ANDROLOGIA, V47, P427, DOI 10.1111/and.12283; RAM PT, 1993, DEV BIOL, V156, P552, DOI 10.1006/dbio.1993.1101; Ramos-Morales F, 2000, ONCOGENE, V19, P403, DOI 10.1038/sj.onc.1203320; Samiec M, 2012, THERIOGENOLOGY, V78, P1855, DOI 10.1016/j.theriogenology.2012.06.029; Samiec M, 2012, POL J VET SCI, V15, P509, DOI 10.2478/v10181-012-0078-3; Samiec M, 2011, POL J VET SCI, V14, P317, DOI 10.2478/v10181-011-0050-7; Samiec M, 2011, POL J VET SCI, V14, P329, DOI 10.2478/v10181-011-0051-6; Samiec M, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/814686; Samiec M, 2014, REPROD BIOL, V14, P128, DOI 10.1016/j.repbio.2013.12.006; Samiec M, 2012, ANIM SCI PAP REP, V30, P383; Sangalli JR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101022; Sirard MA, 2001, THERIOGENOLOGY, V55, P1241, DOI 10.1016/S0093-691X(01)00480-0; Smith VE, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001699; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; Su JM, 2015, J PINEAL RES, V59, P455, DOI 10.1111/jpi.12275; Tong Y, 2007, ONCOGENE, V26, P5596, DOI 10.1038/sj.onc.1210339; Tong ZB, 2000, NAT GENET, V26, P267, DOI 10.1038/81547; Wang ZY, 2000, J BIOL CHEM, V275, P7459, DOI 10.1074/jbc.275.11.7459; Yao YQ, 2003, BIOCHEM BIOPH RES CO, V304, P60, DOI 10.1016/S0006-291X(03)00537-0; Zhang X, 1999, MOL ENDOCRINOL, V13, P156, DOI 10.1210/me.13.1.156; Zheng P, 2009, P NATL ACAD SCI USA, V106, P7473, DOI 10.1073/pnas.0900519106; Zou H, 1999, SCIENCE, V285, P418, DOI 10.1126/science.285.5426.418; Zur A, 2001, EMBO J, V20, P792, DOI 10.1093/emboj/20.4.792	49	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2016	11	4							e0153189	10.1371/journal.pone.0153189	http://dx.doi.org/10.1371/journal.pone.0153189			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6JK	27058238	gold, Green Published			2022-12-27	WOS:000373604800021
J	Aslam, SK; Zaheer, S; Qureshi, MS; Aslam, SN; Shafique, K				Aslam, Syeda Kanwal; Zaheer, Sidra; Qureshi, Muhammad Sameer; Aslam, Syeda Nisma; Shafique, Kashif			Socio-Economic Disparities in Use of Family Planning Methods among Pakistani Women: Findings from Pakistan Demographic and Health Surveys	PLOS ONE			English	Article							CONTRACEPTION; INEQUALITIES; MULTILEVEL; PREVALENCE; TRENDS; WAR	Background Several developing countries like Pakistan step into Sustainable Development Goals period with crucial maternal and child health needs that need to be addressed for improving health outcomes among people. We aim to explore existent socio-economic disparities in use of family planning methods (FPM) among Pakistani women, and compare any such inequalities between the years 2006 and 2013. Setting Pakistan Demographic and Health Surveys (PDHS) 2006-7 (n = 9177) and the most recent 2012-13(n = 13558) data were used to conduct secondary analysis. Participants were ever married women aged between 15 and 49 years. Socio-economic status was assessed by the education level and wealth index. Inequalities were measured through Odds Ratio (OR), Relative Index of inequality (RII), and Slope index of inequality (SII) on non-use of FPM. Results Although the prevalence of FPM use has increased over time (28% in 2006 versus 54% in 2013), the socio-economic inequalities persistently exist. Comparing results of PDHS 2006 with PDHS 2013, education related absolute inequalities among urban dwellers increased from -0.41 (95% CI -0.67, -0.13, p-value < 0.01) to -0.83 (95% CI -1.02, -0.63, p-value < 0.01); and increased from -0.93 (95% CI -1.21, -0.64, p-value < 0.01) to -0.98 (95% CI -1.20, -0.76, p-value < 0.01) among rural dwellers. Similarly wealth related absolute inequalities are also existent. Conclusions Although the FPM use has increased over time, but it is important to note that socio-economic gap in use of FPM persists. Such differences have disadvantaged the poor and the illiterate. Family planning programs may target the disadvantaged subgroups for ensuring well-being of women and children in Pakistan.	[Aslam, Syeda Kanwal; Zaheer, Sidra; Shafique, Kashif] Dow Univ Hlth Sci, Sch Publ Hlth, Karachi, Pakistan; [Qureshi, Muhammad Sameer] Dow Univ Hlth Sci, Dept Biochem, Karachi, Pakistan; [Aslam, Syeda Nisma] Dow Univ Hlth Sci, Dr Ishrat Ul Ibad Inst Oral Hlth Sci, Karachi, Pakistan; [Shafique, Kashif] Univ Glasgow, Inst Hlth & Wellbeing, Publ Hlth, 1 Lilybank Gardens, Glasgow G12 8RZ, Lanark, Scotland	Dow University of Health Sciences; Dow University of Health Sciences; Dow University of Health Sciences; University of Glasgow	Shafique, K (corresponding author), Dow Univ Hlth Sci, Sch Publ Hlth, Karachi, Pakistan.; Shafique, K (corresponding author), Univ Glasgow, Inst Hlth & Wellbeing, Publ Hlth, 1 Lilybank Gardens, Glasgow G12 8RZ, Lanark, Scotland.	syeda.kanwal@duhs.edu.pk		Shafique, Kashif/0000-0001-7151-5122; Aslam, Syeda Kanwal/0000-0001-6048-9993				Alkema L, 2013, LANCET, V381, P1642, DOI 10.1016/S0140-6736(12)62204-1; [Anonymous], 2013, PAK DEM HLTH SURV 20; [Anonymous], 2008, PAKISTAN DEMOGRAPHIC; Aslam SK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129790; Bentley R, 2009, J FAM PLAN REPROD H, V35, P221, DOI 10.1783/147118909789587277; Blaikie P, 2014, RISK 2 NATURAL HAZAR; Calverton M. MEASURE DHS, 1994, MEASURE DHS DEMOGRAP; Campbell M, 2006, STUD FAMILY PLANN, V37, P87, DOI 10.1111/j.1728-4465.2006.00088.x; Chandhick N, 2003, Indian J Med Sci, V57, P303; Christiaensen L, 2014, WORLD DEV, V63, P43, DOI 10.1016/j.worlddev.2013.10.002; Cleland J, 2006, LANCET, V368, P1810, DOI 10.1016/S0140-6736(06)69480-4; Darroch JE, 2013, CONTRACEPTION, V87, P259, DOI 10.1016/j.contraception.2012.08.029; Deng, 2012, MASSES FLIGHT GLOBAL; Denton EH, 2014, GLOBAL POPULATION RE, P199; Garcia -Moreno Claudia, 2001, PUTTING WOMEN 1 ETHI; Hamid S, 2006, INT FAM PLAN PERSPEC, V32, P71, DOI 10.1363/3207106; Haslegrave M, 2014, REPROD HEALTH MATTER, V22, P102, DOI 10.1016/S0968-8080(14)44812-2; Joshi P. C., 1974, Journal of Peasant Studies, V1, P164, DOI 10.1080/03066157408437882; Khan MS, 2015, EMERG THEMES EPIDEMI, V12, DOI 10.1186/s12982-015-0023-x; Kirby JB, 2008, SOC FORCES, V87, P325, DOI 10.1353/sof.0.0062; Lightbourne RE, 1980, URBAN RURAL DIFFEREN; Norheim OF, 2015, LANCET, V385, P239, DOI 10.1016/S0140-6736(14)61591-9; Ortayli N, 2010, STUD FAMILY PLANN, V41, P101, DOI 10.1111/j.1728-4465.2010.00230.x; Rauf A, 2011, EUR J PUBLIC HEALTH, V21, P638, DOI 10.1093/eurpub/ckq084; Rogers P, 2014, ROUT CRIT TERROR, P25; Ruiz-Munoz D, 2012, HEALTH PLACE, V18, P408, DOI 10.1016/j.healthplace.2011.12.007; Rutstein S.O., 2004, DHS WEALTH INDEX ORC; Somani R., 2013, CHILD CARE PRACT, V19, P267, DOI [DOI 10.1080/13575279.2013.785936, 10.1080/13575279.2013.785936]; Stringhini S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049443; WAGSTAFF A, 1991, SOC SCI MED, V33, P545, DOI 10.1016/0277-9536(91)90212-U; Zafar S, 2014, INT J HEALTH POLICY, V3, P393, DOI 10.15171/ijhpm.2014.119	31	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153313	10.1371/journal.pone.0153313	http://dx.doi.org/10.1371/journal.pone.0153313			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DI6KO	27055164	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000373608000120
J	Eliseev, P; Balantcev, G; Nikishova, E; Gaida, A; Bogdanova, E; Enarson, D; Ornstein, T; Detjen, A; Dacombe, R; Gospodarevskaya, E; Phillips, PPJ; Mann, G; Squire, SB; Mariandyshev, A				Eliseev, Platon; Balantcev, Grigory; Nikishova, Elena; Gaida, Anastasia; Bogdanova, Elena; Enarson, Donald; Ornstein, Tara; Detjen, Anne; Dacombe, Russell; Gospodarevskaya, Elena; Phillips, Patrick P. J.; Mann, Gillian; Squire, Stephen Bertel; Mariandyshev, Andrei			The Impact of a Line Probe Assay Based Diagnostic Algorithm on Time to Treatment Initiation and Treatment Outcomes for Multidrug Resistant TB Patients in Arkhangelsk Region, Russia	PLOS ONE			English	Article							MDR-TB; TUBERCULOSIS; IMPLEMENTATION	Background In the Arkhangelsk region of Northern Russia, multidrug-resistant (MDR) tuberculosis (TB) rates in new cases are amongst the highest in the world. In 2014, MDR-TB rates reached 31.7% among new cases and 56.9% among retreatment cases. The development of new diagnostic tools allows for faster detection of both TB and MDR-TB and should lead to reduced transmission by earlier initiation of anti-TB therapy. Study Aim The PROVE-IT (Policy Relevant Outcomes from Validating Evidence on Impact) Russia study aimed to assess the impact of the implementation of line probe assay (LPA) as part of an LPA-based diagnostic algorithm for patients with presumptive MDR-TB focusing on time to treatment initiation with time from first-care seeking visit to the initiation of MDR-TB treatment rather than diagnostic accuracy as the primary outcome, and to assess treatment outcomes. We hypothesized that the implementation of LPA would result in faster time to treatment initiation and better treatment outcomes. Methods A culture-based diagnostic algorithm used prior to LPA implementation was compared to an LPA-based algorithm that replaced BacTAlert and Lowenstein Jensen (LJ) for drug sensitivity testing. A total of 295 MDR-TB patients were included in the study, 163 diagnosed with the culture-based algorithm, 132 with the LPA-based algorithm. Results Among smear positive patients, the implementation of the LPA-based algorithm was associated with a median decrease in time to MDR-TB treatment initiation of 50 and 66 days compared to the culture-based algorithm (BacTAlert and LJ respectively, p<0.001). In smear negative patients, the LPA-based algorithm was associated with a median decrease in time to MDR-TB treatment initiation of 78 days when compared to the culture-based algorithm (LJ, p<0.001). However, several weeks were still needed for treatment initiation in LPA-based algorithm, 24 days in smear positive, and 62 days in smear negative patients. Overall treatment outcomes were better in LPA-based algorithm compared to culture-based algorithm (p = 0.003). Treatment success rates at 20 months of treatment were higher in patients diagnosed with the LPA-based algorithm (65.2%) as compared to those diagnosed with the culture-based algorithm (44.8%). Mortality was also lower in the LPA-based algorithm group (7.6%) compared to the culture-based algorithm group (15.9%). There was no statistically significant difference in smear and culture conversion rates between the two algorithms. Conclusion The results of the study suggest that the introduction of LPA leads to faster time to MDR diagnosis and earlier treatment initiation as well as better treatment outcomes for patients with MDR-TB. These findings also highlight the need for further improvements within the health system to reduce both patient and diagnostic delays to truly optimize the impact of new, rapid diagnostics.	[Eliseev, Platon; Mariandyshev, Andrei] Northern State Med Univ, Arkhangelsk, Russia; [Balantcev, Grigory; Bogdanova, Elena] Northern Arctic Fed Univ, Arkhangelsk, Russia; [Nikishova, Elena; Gaida, Anastasia] Arkhangelsk Clin AntiTB Dispensary, Arkhangelsk, Russia; [Enarson, Donald; Ornstein, Tara; Detjen, Anne] Int Union TB & Lung Dis, Paris, France; [Dacombe, Russell; Gospodarevskaya, Elena; Mann, Gillian; Squire, Stephen Bertel] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Phillips, Patrick P. J.] UCL, MRC Clin Trials Unit, London, England	Northern State Medical University; Northern Arctic Federal University; Liverpool School of Tropical Medicine; University of Liverpool; Medical Research Council Clinical Trials Unit; University of London; University College London	Eliseev, P (corresponding author), Northern State Med Univ, Arkhangelsk, Russia.	pediatrics@yandex.ru	Bogdanova, Elena/AAC-7516-2019; Nikishova, Elena/AAE-9181-2019; Eliseev, Platon I/I-2944-2018; Gaida, Anastasia/GWD-0656-2022; Mariandyshev, Andrei/D-1744-2018; Phillips, Patrick/B-6347-2008	Eliseev, Platon I/0000-0001-9039-4557; Mariandyshev, Andrei/0000-0002-8485-5625; Nikishova, Elena/0000-0002-1542-6958; Phillips, Patrick/0000-0002-6336-7024; Bogdanova, Elena/0000-0001-9610-4709; Squire, Stephen/0000-0001-7173-9038	United States Agency for International Development (USAID) Cooperative Agreement (TREAT TB) [GHN-A-00-08-00004-00]; MRC [MC_UU_12023/27] Funding Source: UKRI; Medical Research Council [MC_UU_12023/27] Funding Source: researchfish	United States Agency for International Development (USAID) Cooperative Agreement (TREAT TB)(United States Agency for International Development (USAID)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The research was supported by a United States Agency for International Development (USAID) Cooperative Agreement (TREAT TB - Agreement No. GHN-A-00-08-00004-00). The contents are the responsibility of the authors and do not necessarily reflect the views of USAID.	[Anonymous], 2010, BACT AL US MAN; [Anonymous], 2010, MULTIDRUG EXTENSIVEL; Arentz M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076533; Baral SC, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-46; CANETTI G, 1963, B WORLD HEALTH ORGAN, V29, P565; Debieu M, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0061075, 10.1371/journal.pone.0082943]; Eliseev PI, 2013, INT J MYCOBACT, V2, P103, DOI 10.1016/j.ijmyco.2013.04.002; European Centre for Disease Prevention and Control, TUB SURV MON EUR 201; FIND, 2008, ANN REPORT; Jacobson KR, 2013, CLIN INFECT DIS, V56, P503, DOI 10.1093/cid/cis920; Keshavjee S, 2008, LANCET, V372, P1403, DOI 10.1016/S0140-6736(08)61204-0; Ling DI, 2008, EUR RESPIR J, V32, P1165, DOI 10.1183/09031936.00061808; Mann G, 2010, INT J TUBERC LUNG D, V14, P1518; Marais E, 2014, INFECTION, V42, P405, DOI 10.1007/s15010-013-0572-2; Naidoo P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103328; Narasimooloo R, 2012, SAMJ S AFR MED J, V102, P360, DOI 10.7196/SAMJ.5361; NSMU, 2016, TUB ARKH REG NEW MON; Perelman MI, 2000, INT J TUBERC LUNG D, V4, P1097; Punga VV, 2009, INT J TUBERC LUNG D, V13, P1309; Salman H, 2006, MGIT PROCEDURE MANUA; Singla N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102989; WHO, 2010, GLOB TUB REP 2010; World Health Organization, 2020, GLOBAL TUBERCULOSIS; World Health Organization, 2013, DEFINITIONS REPORTIN; Yagui M, 2006, INT J TUBERC LUNG D, V10, P838	25	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0152761	10.1371/journal.pone.0152761	http://dx.doi.org/10.1371/journal.pone.0152761			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27055269	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000373608000042
J	Li, L; Meng, FL; Hu, XY; Qiao, L; Sun, CQ; Tian, HW; Zheng, WT				Li, Lei; Meng, Fanling; Hu, Xiaoying; Qiao, Liang; Sun, Chang Q.; Tian, Hongwei; Zheng, Weitao			TiO2 Band Restructuring by B and P Dopants	PLOS ONE			English	Article							PHOTOCATALYTIC ACTIVITY; VISIBLE-LIGHT; DOPED TIO2; OPTICAL-PROPERTIES; ELECTRONIC-STRUCTURES; TITANIUM-DIOXIDE; BORON; GAP; DEGRADATION; DEFECTS	An examination of the effect of B- and P-doping and codoping on the electronic structure of anatase TiO2 by performing density functional theory calculations revealed the following: (i) B-or P-doping effects are similar to atomic undercoordination effects on local bond relaxation and core electron entrapment; (ii) the locally entrapped charge adds impurity levels within the band gap that could enhance the utilization of TiO2 to absorb visible light and prolong the carrier lifetime; (iii) the core electron entrapment polarizes nonbonding electrons in the upper edges of the valence and conduction bands, which reduces not only the work function but also the band gap; and (iv) work function reduction enhances the reactivity of the carriers and band gap reduction promotes visible-light absorption. These observations may shed light on effective catalyst design and synthesis.	[Li, Lei; Meng, Fanling; Tian, Hongwei; Zheng, Weitao] Jilin Univ, MOE, Dept Mat Sci, Changchun 130023, Peoples R China; [Li, Lei; Meng, Fanling; Tian, Hongwei; Zheng, Weitao] Jilin Univ, MOE, Key Lab Automobile Mat, Changchun 130023, Peoples R China; [Li, Lei; Meng, Fanling; Tian, Hongwei; Zheng, Weitao] Jilin Univ, State Key Lab Superhard Mat, Changchun 130023, Peoples R China; [Hu, Xiaoying; Qiao, Liang] Changchun Univ, Coll Sci, Changchun, Peoples R China; [Sun, Chang Q.] Nanyang Technol Univ, Sch Elect & Elect Engn, Singapore 639798, Singapore	Jilin University; Jilin University; Jilin University; Changchun University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Tian, HW; Zheng, WT (corresponding author), Jilin Univ, MOE, Dept Mat Sci, Changchun 130023, Peoples R China.; Tian, HW; Zheng, WT (corresponding author), Jilin Univ, MOE, Key Lab Automobile Mat, Changchun 130023, Peoples R China.; Tian, HW; Zheng, WT (corresponding author), Jilin Univ, State Key Lab Superhard Mat, Changchun 130023, Peoples R China.	tianhw@jlu.edu.cn; wtzheng@jlu.edu.cn	SUN, CHANG/GXM-3680-2022; Hu, Xiaoying/E-2530-2017; Tian, Hongwei/D-4592-2011; Changqing, Sun/B-8698-2008; zheng, weitao/HCH-5112-2022	Hu, Xiaoying/0000-0002-1754-6697; Tian, Hongwei/0000-0002-4111-1087; Changqing, Sun/0000-0003-2076-1133; zheng, weitao/0000-0002-9028-278X	National Natural Science Foundation of China [51472106, 51202017, 51372095]; Natural Science Foundation of Jilin Province [20140101107JC, 20140101092JC]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jilin Province	H.T. was supported by National Natural Science Foundation of China (Grant Nos. 51472106, 51202017 and 51372095, URLs: http://www.nsfc.gov.cn/) and Natural Science Foundation of Jilin Province (Grant Nos. 20140101107JC and 20140101092JC, URLs: http://kjt.jl.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JP, 2014, PHYS CHEM CHEM PHYS, V16, P21016, DOI 10.1039/c4cp01083c; Andrei C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109836; Asahi R, 2001, SCIENCE, V293, P269, DOI 10.1126/science.1061051; Asahi R, 2000, PHYS REV B, V61, P7459, DOI 10.1103/PhysRevB.61.7459; BURDETT JK, 1987, J AM CHEM SOC, V109, P3639, DOI 10.1021/ja00246a021; Chen D, 2006, IND ENG CHEM RES, V45, P4110, DOI 10.1021/ie0600902; Feng ND, 2011, J PHYS CHEM C, V115, P2709, DOI 10.1021/jp108008a; Finazzi E, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2996362; Fittipaldi M, 2008, INORG CHIM ACTA, V361, P3980, DOI 10.1016/j.ica.2008.03.052; Gai YQ, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.036402; Geng H, 2006, J PHYS-CONDENS MAT, V18, P87, DOI 10.1088/0953-8984/18/1/006; Giannakas AE, 2013, APPL CATAL B-ENVIRON, V132, P460, DOI 10.1016/j.apcatb.2012.12.017; Grabowska E, 2009, PROCEDIA CHEM, V1, P1553, DOI 10.1016/j.proche.2009.11.003; Hou QY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122620; Hu ZP, 2011, J PHYS CHEM C, V115, P5841, DOI 10.1021/jp111350u; Huang J, 2012, ANGEW CHEM INT EDIT, V51, P12711, DOI 10.1002/anie.201204341; Li C, 2014, PHYS CHEM CHEM PHYS, V16, P21446, DOI 10.1039/c4cp03587a; Li L, 2015, PHYS CHEM CHEM PHYS, V17, P9867, DOI 10.1039/c4cp05985a; Li L, 2014, APPL SURF SCI, V317, P568, DOI 10.1016/j.apsusc.2014.08.078; Lin L, 2007, APPL CATAL B-ENVIRON, V76, P196, DOI 10.1016/j.apcatb.2007.05.023; Lin YM, 2013, J MATER CHEM A, V1, P4516, DOI 10.1039/c3ta01298k; Liu G, 2008, ANGEW CHEM INT EDIT, V47, P5277, DOI 10.1002/anie.200705633; Liu Y, 2015, J PHYS CHEM C; Patel N, 2015, J PHYS CHEM C, V119, P18581, DOI 10.1021/acs.jpcc.5b05290; Perdew J, CHAPTER UNIFIED THEO; Schrauben JN, 2012, SCIENCE, V336, P1298, DOI 10.1126/science.1220234; Segall MD, 2002, J PHYS-CONDENS MAT, V14, P2717, DOI 10.1088/0953-8984/14/11/301; Sun C. Q., 2014, RELAXATION CHEM BOND; Sun C.Q., 2010, USA patent: publication: US, Patent No. [20130090865, US20130090865]; Wang P, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.193103; Weiher N, 2007, J AM CHEM SOC; Wendt S, 2008, SCIENCE, V320, P1755, DOI 10.1126/science.1159846; Wu YM, 2010, APPL CATAL B-ENVIRON, V97, P182, DOI 10.1016/j.apcatb.2010.03.038; Yang DL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024788; Yang KS, 2007, J PHYS CHEM C, V111, P18985, DOI 10.1021/jp0756350; Yu DD, 2015, PHYS LETT A, V379, P1666, DOI 10.1016/j.physleta.2015.04.044; Zaleska A, 2009, APPL CATAL B-ENVIRON, V89, P469, DOI 10.1016/j.apcatb.2009.01.005; Zhao W, 2004, J AM CHEM SOC, V126, P4782, DOI 10.1021/ja0396753; Zhu HX, 2014, PHYS LETT A, V378, P2719, DOI 10.1016/j.physleta.2014.07.029	39	8	8	1	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0152726	10.1371/journal.pone.0152726	http://dx.doi.org/10.1371/journal.pone.0152726			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27054763	Green Published, gold			2022-12-27	WOS:000373608000037
J	Nair, M; Kurinczuk, JJ; Knight, M				Nair, Manisha; Kurinczuk, Jennnifer J.; Knight, Marian			Establishing a National Maternal Morbidity Outcome Indicator in England: A Population-Based Study Using Routine Hospital Data	PLOS ONE			English	Article							RISK-FACTORS; PERIPARTUM HYSTERECTOMY; POSTPARTUM HEMORRHAGE; CESAREAN DELIVERY; HEALTH FACILITIES; PREGNANCY; CHILDBIRTH; MANAGEMENT; UK; COMPLICATIONS	Introduction As maternal deaths become rarer, monitoring near-miss or severe maternal morbidity becomes important as a tool to measure changes in care quality. Many calls have been made to use routinely available hospital administration data to monitor the quality of maternity care. We investigated 1) the feasibility of developing an English Maternal Morbidity Outcome Indicator (EMMOI) by reproducing an Australian indicator using routinely available hospital data, 2) the impact of modifications to the indicator to address potential data quality issues, 3) the reliability of the indicator. Methods We used data from 6,389,066 women giving birth in England from April 2003 to March 2013 available in the Hospital Episode Statistics (HES) database of the Health and Social care Information centre (HSCIC). A composite indicator, EMMOI, was generated from the diagnoses and procedure codes. Rates of individual morbid events included in the EMMOI were compared with the rates in the UK reported by population-based studies. Results EMMOI included 26 morbid events (17 diagnosis and 9 procedures). Selection of the individual morbid events was guided by the Australian indicator and published literature for conditions associated with maternal morbidity and mortality in the UK, but was mainly driven by the quality of the routine hospital data. Comparing the rates of individual morbid events of the indicator with figures from population-based studies showed that the possibility of false positive and false negative cases cannot be ruled out. Conclusion While routine English hospital data can be used to generate a composite indicator to monitor trends in maternal morbidity during childbirth, the quality and reliability of this monitoring indicator depends on the quality of the hospital data, which is currently inadequate.	[Nair, Manisha; Kurinczuk, Jennnifer J.; Knight, Marian] Univ Oxford, Nuffield Dept Populat Hlth, Natl Perinatal Epidemiol Unit, Oxford, England	University of Oxford	Nair, M (corresponding author), Univ Oxford, Nuffield Dept Populat Hlth, Natl Perinatal Epidemiol Unit, Oxford, England.	manisha.nair@npeu.ox.ac.uk	Knight, Marian/B-6225-2009	Knight, Marian/0000-0002-1984-4575; Nair, Manisha/0000-0003-0660-5054	National Institute for Health Research (NIHR) Research Professorship [NIHR-RP-011-032]; National Institute for Health Research [RP-PG-0608-10038] Funding Source: researchfish	National Institute for Health Research (NIHR) Research Professorship; National Institute for Health Research(National Institute for Health Research (NIHR))	Knight is funded by a National Institute for Health Research (NIHR) Research Professorship (NIHR-RP-011-032). The views expressed in this publication are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta CD, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001672; Audit Commission, 2002, DAT REM IMPR QUAL PA; Bose P, 2006, BJOG-INT J OBSTET GY, V113, P919, DOI 10.1111/j.1471-0528.2006.01018.x; Bush N, 2013, EUR J PREV CARDIOL, V20, P12, DOI 10.1177/1741826711432117; Chappell LC, 2013, BMJ-BRIT MED J, P346; Chu SY, 2008, AM J OBSTET GYNECOL, V199, pE18, DOI [10.1016/j.ajog.2008.02.038, 10.1016/j.ajog.2007.12.020]; Collins K, 2015, BEST PRACT RES CLIN; Das J., 2014, ARE I BIRTHS I DEATH; Fitzpatrick KE, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001184; Fitzpatrick KE, 2015, BJOG INT J OBSTET GY; Gupta S, 2015, J OBSTET GYN INDIA, V65, P23, DOI 10.1007/s13224-014-0558-8; Halder A, 2014, J TURK-GER GYNECOL A, V15, P222, DOI 10.5152/jtgga.2014.14076; Health & Social Care Information Centre, HOSP EP STAT; Hollowel J, 2011, 4 NIHR SERV DEL ORG; Hospital Episode Statistics, 2010, DAT DICT INP; Johanson R, 2002, BRIT MED J, V324, P892, DOI 10.1136/bmj.324.7342.892; Kayem G, 2011, BJOG-INT J OBSTET GY, V118, P856, DOI 10.1111/j.1471-0528.2011.02921.x; Knight M, 2007, BJOG-INT J OBSTET GY, V114, P1072, DOI 10.1111/j.1471-0528.2007.01423.x; Knight M, 2008, BJOG-INT J OBSTET GY, V115, P453, DOI 10.1111/j.1471-0528.2007.01622.x; Knight M, 2007, BJOG-INT J OBSTET GY, V114, P1380, DOI 10.1111/j.1471-0528.2007.01507.x; Knight M, 2014, SAVING LIVES IMPROVI, P2014; Kurinczuk Jennifer J., 2015, SAVING LIVES IMPROVI; Lim SS, 2010, LANCET, V375, P2009, DOI 10.1016/S0140-6736(10)60744-1; Lumbiganon P, 2010, LANCET, V375, P490, DOI 10.1016/S0140-6736(09)61870-5; Morris S, 2003, BRIT MED J, V327, P1277, DOI 10.1136/bmj.327.7426.1277; Mpembeni Rose Nm, 2007, BMC Pregnancy Childbirth, V7, P29, DOI 10.1186/1471-2393-7-29; O'Dowd A, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h5785; Oteng-Ntim E, 2015, BRIT J HAEMATOL, V169, P129, DOI 10.1111/bjh.13270; Paul BK, 2002, SOC SCI MED, V54, P1755, DOI 10.1016/S0277-9536(01)00148-4; Quality Information Committee, 2013, 1 NAT DAT QUAL REP H; Quinn AC, 2012, BRIT J ANAESTHESIA; Rajasekar D, 1997, BRIT J OBSTET GYNAEC, V104, P731, DOI 10.1111/j.1471-0528.1997.tb11986.x; Randive B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067452; Roberts CL, 2008, MED CARE, V46, P786, DOI 10.1097/MLR.0b013e318178eae4; Roberts CL, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-7; Royal College of Obstetricians and Gynaecologists, 2013, PATT MAT CAR ENGL NH; Scott CA, 2012, OBSTET GYNECOL, V120, P318, DOI 10.1097/AOG.0b013e31825f287c; SCOTT DB, 1990, BRIT J ANAESTH, V64, P537, DOI 10.1093/bja/64.5.537; Selo-Ojeme Dan O., 2005, Archives of Gynecology and Obstetrics, V271, P154, DOI 10.1007/s00404-004-0715-x; Simpson EL, 2001, BRIT J OBSTET GYNAEC, V108, P56, DOI 10.1111/j.1471-0528.2001.00004.x; Smith J, 2007, J OBSTET GYNAECOL, V27, P44, DOI 10.1080/01443610601016925; Souza JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044129; Spencer SA, 2011, HOSP EPISODE STAT HE; Statistics E, 2014, ANN REPORT; Villar J, 2006, LANCET, V367, P1819, DOI 10.1016/S0140-6736(06)68704-7; Wen SW, 2005, CAN MED ASSOC J, V173, P759, DOI 10.1503/cmaj.045156; Wyber R, 2015, B WORLD HEALTH ORGAN, V93, P203, DOI 10.2471/BLT.14.139022; Zelop C, 2004, CLIN OBSTET GYNECOL, V47, P386, DOI 10.1097/00003081-200406000-00012	48	29	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153370	10.1371/journal.pone.0153370	http://dx.doi.org/10.1371/journal.pone.0153370			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27054761	Green Published, gold			2022-12-27	WOS:000373608000125
J	Alexandrou, AJ; Brown, AR; Chapman, ML; Estacion, M; Turner, J; Mis, MA; Wilbrey, A; Payne, EC; Gutteridge, A; Cox, PJ; Doyle, R; Printzenhoff, D; Lin, ZX; Marron, BE; West, C; Swain, NA; Storer, RI; Stupple, PA; Castle, NA; Hounshell, JA; Rivara, M; Randall, A; Dib-Hajj, SD; Krafte, D; Waxman, SG; Patel, MK; Butt, RP; Stevens, EB				Alexandrou, Aristos J.; Brown, Adam R.; Chapman, Mark L.; Estacion, Mark; Turner, Jamie; Mis, Malgorzata A.; Wilbrey, Anna; Payne, Elizabeth C.; Gutteridge, Alex; Cox, Peter J.; Doyle, Rachel; Printzenhoff, David; Lin, Zhixin; Marron, Brian E.; West, Christopher; Swain, Nigel A.; Storer, R. Ian; Stupple, Paul A.; Castle, Neil A.; Hounshell, James A.; Rivara, Mirko; Randall, Andrew; Dib-Hajj, Sulayman D.; Krafte, Douglas; Waxman, Stephen G.; Patel, Manoj K.; Butt, Richard P.; Stevens, Edward B.			Subtype-Selective Small Molecule Inhibitors Reveal a Fundamental Role for Nav1.7 in Nociceptor Electrogenesis, Axonal Conduction and Presynaptic Release	PLOS ONE			English	Article							NA(V)1.7 SODIUM-CHANNELS; ACTION-POTENTIAL PROPAGATION; CLOSED-STATE INACTIVATION; ALPHA-SUBUNIT; MEMBRANE-PROPERTIES; VOLTAGE SENSOR; DORSAL-HORN; PAIN; EXPRESSION; NEURONS	Human genetic studies show that the voltage gated sodium channel 1.7 (Na(v)1.7) is a key molecular determinant of pain sensation. However, defining the Na(v)1.7 contribution to nociceptive signalling has been hampered by a lack of selective inhibitors. Here we report two potent and selective arylsulfonamide Na(v)1.7 inhibitors; PF-05198007 and PF-05089771, which we have used to directly interrogate Na(v)1.7's role in nociceptor physiology. We report that Na(v)1.7 is the predominant functional TTX-sensitive Na-v in mouse and human nociceptors and contributes to the initiation and the upstroke phase of the nociceptor action potential. Moreover, we confirm a role for Na(v)1.7 in influencing synaptic transmission in the dorsal horn of the spinal cord as well as peripheral neuropeptide release in the skin. These findings demonstrate multiple contributions of Na(v)1.7 to nociceptor signalling and shed new light on the relative functional contribution of this channel to peripheral and central noxious signal transmission.	[Alexandrou, Aristos J.; Brown, Adam R.; Turner, Jamie; Mis, Malgorzata A.; Wilbrey, Anna; Payne, Elizabeth C.; Gutteridge, Alex; Cox, Peter J.; Butt, Richard P.; Stevens, Edward B.] Pfizer Neusentis, Portway Buiding,Granta Pk, Cambridge CB21 6GS, England; [Chapman, Mark L.; Printzenhoff, David; Lin, Zhixin; Marron, Brian E.; West, Christopher; Castle, Neil A.; Krafte, Douglas] Pfizer Neusentis, 4222 Emperor Blvd, Durham, NC 27703 USA; [Hounshell, James A.; Rivara, Mirko; Patel, Manoj K.] Univ Virginia Hlth Syst, Dept Anesthesiol, Charlottesville, VA 22911 USA; [Swain, Nigel A.; Storer, R. Ian; Stupple, Paul A.] Pfizer Neusentis, Worldwide Med Chem, Portway Bldg,Granta Pk, Cambridge CB21 6GS, England; [Doyle, Rachel] Pfizer Global R&D, Ramsgate Rd, Sandwich CT13 9NJ, Kent, England; [Estacion, Mark; Dib-Hajj, Sulayman D.; Waxman, Stephen G.] Yale Univ, Sch Med, Ctr Neurosci & Regenerat Res, West Haven, CT 06516 USA; [Estacion, Mark; Dib-Hajj, Sulayman D.; Waxman, Stephen G.] Vet Affairs Hosp, West Haven, CT 06516 USA; [Randall, Andrew] Univ Exeter, Sch Med, Hatherly Bldg,Prince Wales Rd, Exeter EX4 4PS, Devon, England; [Chapman, Mark L.; Printzenhoff, David; Lin, Zhixin; Marron, Brian E.; West, Christopher; Castle, Neil A.; Krafte, Douglas] Icagen, 4222 Emperor Blvd, Durham, NC 27703 USA; [Rivara, Mirko] Univ Parma, Dipartimento Farm, I-43100 Parma, Italy; [Doyle, Rachel] Tetrad Discovery Ltd Innovat House Discovery Pk, Ramsgate Rd, Sandwich CT13 9ND, Kent, England; [Mis, Malgorzata A.] Univ Bristol, Sch Physiol Pharmacol & Neurosci, Biomed Sci Bldg, Bristol BS8 1TD, Avon, England; [Stupple, Paul A.] Monash Univ, Monash Inst Pharmaceut Sci, Parkville Campus,381 Royal Parade, Parkville, Vic 3052, Australia	Pfizer; Pfizer; University of Virginia; Pfizer; Pfizer; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; University of Exeter; University of Parma; Pfizer; University of Bristol; Monash University	Butt, RP; Stevens, EB (corresponding author), Pfizer Neusentis, Portway Buiding,Granta Pk, Cambridge CB21 6GS, England.	Richard.Butt@pfizer.com; Edward.Stevens@pfizer.com	Rivara, Mirko/P-6855-2019; Waxman, Stephen/Z-2507-2019; Estacion, Mark/H-2444-2011; Rivara, Mirko/R-3505-2017	Waxman, Stephen/0000-0001-5718-7177; Estacion, Mark/0000-0002-7271-1165; Rivara, Mirko/0000-0001-6809-0020; Gutteridge, Alex/0000-0001-7515-634X; Randall, Andrew/0000-0001-8852-3671	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS075157] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [1099809] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Ahuja S, 2015, SCIENCE, V350, DOI 10.1126/science.aac5464; Bagal SK, 2014, BIOORG MED CHEM LETT, V24, P3690, DOI 10.1016/j.bmcl.2014.06.038; Bennett DLH, 2014, LANCET NEUROL, V13, P587, DOI 10.1016/S1474-4422(14)70024-9; Black JA, 1996, MOL BRAIN RES, V43, P117, DOI 10.1016/S0169-328X(96)00163-5; Black JA, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-82; Blair NT, 2002, J NEUROSCI, V22, P10277; Castle N, 2009, COMB CHEM HIGH T SCR, V12, P107, DOI 10.2174/138620709787047993; Cavanaugh DJ, 2011, J NEUROSCI, V31, P10119, DOI 10.1523/JNEUROSCI.1299-11.2011; Cox JJ, 2006, NATURE, V444, P894, DOI 10.1038/nature05413; Cummins TR, 1998, J NEUROSCI, V18, P9607; Cummins TR, 2004, J NEUROSCI, V24, P8232, DOI 10.1523/JNEUROSCI.2695-04.2004; Davidson S, 2014, PAIN, V155, P1861, DOI 10.1016/j.pain.2014.06.017; Dib-Hajj SD, 2005, BRAIN, V128, P1847, DOI 10.1093/brain/awh514; Dib-Hajj SD, 2015, NAT REV NEUROSCI, V16, P511, DOI 10.1038/nrn3977; Dib-Hajj SD, 2013, NAT REV NEUROSCI, V14, P49, DOI 10.1038/nrn3404; Dib-Hajj SD, 2010, ANNU REV NEUROSCI, V33, P325, DOI 10.1146/annurev-neuro-060909-153234; Djouhri L, 2003, J PHYSIOL-LONDON, V550, P739, DOI 10.1113/jphysiol.2003.042127; Drenth JPH, 2007, J CLIN INVEST, V117, P3603, DOI 10.1172/JCI33297; Engel D, 2005, NEURON, V45, P405, DOI 10.1016/j.neuron.2004.12.048; Fertleman CR, 2006, NEURON, V52, P767, DOI 10.1016/j.neuron.2006.10.006; Fukuoka T, 2008, J COMP NEUROL, V510, P188, DOI 10.1002/cne.21786; Fukuoka T, 2011, NEUROSCI RES, V70, P164, DOI 10.1016/j.neures.2011.01.020; Herzog RI, 2003, J PHYSIOL-LONDON, V551, P741, DOI 10.1113/jphysiol.2003.047357; Ho C, 2011, MOL CELL NEUROSCI, V46, P159, DOI 10.1016/j.mcn.2010.08.017; JACKSON MB, 1995, J PHYSIOL-LONDON, V483, P597, DOI 10.1113/jphysiol.1995.sp020609; Jarvis MF, 2007, P NATL ACAD SCI USA, V104, P8520, DOI 10.1073/pnas.0611364104; Klede M, 2003, J NEUROPHYSIOL, V90, P353, DOI 10.1152/jn.01136.2002; Lawson JJ, 2008, J PAIN, V9, P298, DOI 10.1016/j.jpain.2007.12.001; Lee JH, 2014, CELL, V157, P1393, DOI 10.1016/j.cell.2014.03.064; McCormack K, 2013, P NATL ACAD SCI USA, V110, pE2724, DOI 10.1073/pnas.1220844110; Minett MS, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1795; Muroi Y, 2011, J PHYSIOL-LONDON, V589, P5663, DOI 10.1113/jphysiol.2011.215384; NAGY JI, 1983, J COMP NEUROL, V218, P145, DOI 10.1002/cne.902180203; Passmore Gayle M., 2005, Journal of Pharmacological and Toxicological Methods, V51, P201, DOI 10.1016/j.vascn.2004.08.007; PEARCE RJ, 1994, NEUROSCIENCE, V63, P1041, DOI 10.1016/0306-4522(94)90571-1; Ragsdale DS, 1996, P NATL ACAD SCI USA, V93, P9270, DOI 10.1073/pnas.93.17.9270; Raymond CK, 2004, J BIOL CHEM, V279, P46234, DOI 10.1074/jbc.M406387200; RIBEIRODASILVA A, 1989, J COMP NEUROL, V281, P497, DOI 10.1002/cne.902810402; Rush AM, 2007, J PHYSIOL-LONDON, V579, P1, DOI 10.1113/jphysiol.2006.121483; Schmalhofer WA, 2008, MOL PHARMACOL, V74, P1476, DOI 10.1124/mol.108.047670; Usoskin D, 2015, NAT NEUROSCI, V18, P145, DOI 10.1038/nn.3881; Vasylyev DV, 2014, J NEUROPHYSIOL, V111, P1429, DOI 10.1152/jn.00763.2013; Wilson MJ, 2011, P NATL ACAD SCI USA, V108, P10302, DOI 10.1073/pnas.1107027108; Yang Y, 2004, J MED GENET, V41, P171, DOI 10.1136/jmg.2003.012153	44	114	114	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0152405	10.1371/journal.pone.0152405	http://dx.doi.org/10.1371/journal.pone.0152405			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050761	Green Published, gold			2022-12-27	WOS:000373603500038
J	Chiner, E; Llombart, M; Valls, J; Pastor, E; Sancho-Chust, JN; Andreu, AL; Sanchez-de-la-Torre, M; Barbe, F				Chiner, Eusebi; Llombart, Monica; Valls, Joan; Pastor, Esther; Sancho-Chust, Jose N.; Luz Andreu, Ada; Sanchez-de-La-Torre, Manuel; Barbe, Ferran			Association between Obstructive Sleep Apnea and Community-Acquired Pneumonia	PLOS ONE			English	Article							POSITIVE AIRWAY PRESSURE; GASTROESOPHAGEAL-REFLUX; QUANTITATIVE ASPIRATION; RISK; INFLAMMATION; POPULATION; PREVALENCE; HYPOPNEA; OUTCOMES; MODEL	Background We hypothesized that obstructive sleep apnea (OSA) can predispose individuals to lower airway infections and community-acquired pneumonia (CAP) due to upper airway microaspiration. This study evaluated the association between OSA and CAP. Methods We performed a case-control study that included 82 patients with CAP and 41 patients with other infections (control group). The controls were matched according to age, sex and body mass index (BMI). A respiratory polygraph (RP) was performed upon admission for patients in both groups. The severity of pneumonia was assessed according to the Pneumonia Severity Index (PSI). The associations between CAP and the Epworth Sleepiness Scale (ESS), OSA, OSA severity and other sleep-related variables were evaluated using logistic regression models. The associations between OSA, OSA severity with CAP severity were evaluated with linear regression models and non-parametric tests. Findings No significant differences were found between CAP and control patients regarding anthropometric variables, toxic habits and risk factors for CAP. Patients with OSA, defined as individuals with an Apnea-Hypopnea Index (AHI) >= 10, showed an increased risk of CAP (OR = 2.86, 95% CI 1.29-6.44, p = 0.01). Patients with severe OSA (AHI >= 30) also had a higher risk of CAP (OR = 3.18, 95% CI 1.11-11.56, p = 0.047). In addition, OSA severity, defined according to the AHI quartile, was also significantly associated with CAP (p = 0.007). Furthermore, OSA was significantly associated with CAP severity (p = 0.0002), and OSA severity was also associated with CAP severity (p = 0.0006). Conclusions OSA and OSA severity are associated with CAP when compared to patients admitted to the hospital for non-respiratory infections. In addition, OSA and OSA severity are associated with CAP severity. These results support the potential role of OSA in the pathogenesis of CAP and could have clinical implications. This link between OSA and infection risk should be explored to investigate the relationships among gastroesophageal reflux, silent aspiration, laryngeal sensory dysfunction and CAP.	[Chiner, Eusebi; Llombart, Monica; Pastor, Esther; Sancho-Chust, Jose N.; Luz Andreu, Ada] Hosp Univ St Joan dAlacant, Resp Dept, Alacant, Spain; [Valls, Joan] IRB Lleida, Biostat & Epidemiol Unit, Catalonia, Spain; [Sanchez-de-La-Torre, Manuel; Barbe, Ferran] Univ Lleida, IRB Lleida, Resp Dept, Hosp Univ Arnau de Vilanova & Santa Maria, Catalonia, Spain; [Sanchez-de-La-Torre, Manuel; Barbe, Ferran] Ctr Invest Biomed Red Enfermedades Resp CIBERES, Madrid, Spain	Institut de Recerca Biomedica - IRB Lleida; Institut de Recerca Biomedica - IRB Lleida; Universitat de Lleida; CIBER - Centro de Investigacion Biomedica en Red; CIBERES	Chiner, E (corresponding author), Hosp Univ St Joan dAlacant, Resp Dept, Alacant, Spain.; Barbe, F (corresponding author), Univ Lleida, IRB Lleida, Resp Dept, Hosp Univ Arnau de Vilanova & Santa Maria, Catalonia, Spain.; Barbe, F (corresponding author), Ctr Invest Biomed Red Enfermedades Resp CIBERES, Madrid, Spain.	echinervives@gmail.com; febarbe.lleida.ics@gencat.cat	Barbé, Ferran/A-5988-2010; de la Torre, Manuel Sanchez/B-5578-2009; Sánchez-de-la-Torre, Manuel/AAC-9514-2022; Sancho-Chust, Jose N./ABH-5025-2020; Chiner, Eusebi/AAM-5120-2020; Sanchez-de-la-Torre, Manuel/AAP-2663-2020; Valls, Joan/GXM-6532-2022	Barbé, Ferran/0000-0002-2340-8928; de la Torre, Manuel Sanchez/0000-0002-5695-348X; Sanchez-de-la-Torre, Manuel/0000-0002-5695-348X; Valls, Joan/0000-0002-4806-7568; Sancho-Chust, Jose N./0000-0002-3028-0715				Barbe F, 2012, JAMA-J AM MED ASSOC, V307, P2161, DOI 10.1001/jama.2012.4366; Beal M, 2004, LARYNGOSCOPE, V114, P965, DOI 10.1097/00005537-200406000-00002; Campos-Rodriguez F, 2013, AM J RESP CRIT CARE, V187, P99, DOI 10.1164/rccm.201209-1671OC; Chiner E, 1999, Arch Bronconeumol, V35, P422; Chiner E, 2003, AM J RESP CRIT CARE, V167, pA403; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; Friedman M, 2007, ANN OTO RHINOL LARYN, V116, P805, DOI 10.1177/000348940711601103; Gleeson K, 1997, CHEST, V111, P1266, DOI 10.1378/chest.111.5.1266; Goldbart AD, 2012, CHEST, V141, P1210, DOI 10.1378/chest.11-1998; Heinzer R, 2015, LANCET RESP MED, V3, P310, DOI 10.1016/S2213-2600(15)00043-0; Jean RE, 2015, J CRIT CARE, V30, P778, DOI 10.1016/j.jcrc.2015.03.016; Konermann M, 2002, AM J OTOLARYNG, V23, P20, DOI 10.1053/ajot.2002.28775; Lindam A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129836; Lindenauer PK, 2014, CHEST, V145, P1032, DOI 10.1378/chest.13-1544; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Marin JM, 2005, LANCET, V365, P1046, DOI 10.1016/S0140-6736(05)71141-7; MARTIN RJ, 1982, AM REV RESPIR DIS, V125, P175; Menendez R, 2010, ARCH BRONCONEUMOL, V46, P543, DOI 10.1016/j.arbres.2010.06.014; Moreno-Indias I, 2015, EUR RESPIR J, V45, P1055, DOI 10.1183/09031936.00184314; Nacher M, 2007, RESP PHYSIOL NEUROBI, V155, P93, DOI 10.1016/j.resp.2006.06.004; Payne RJ, 2006, OTOLARYNG HEAD NECK, V134, P836, DOI 10.1016/j.otohns.2006.01.012; Ramsey D, 2005, DYSPHAGIA, V20, P218, DOI 10.1007/s00455-005-0018-9; Ravelli AM, 2006, CHEST, V130, P1520, DOI 10.1378/chest.130.5.1520; Sanchez-de-la-Torre M, 2013, LANCET RESP MED, V1, P61, DOI 10.1016/S2213-2600(12)70051-6; Santos-Silva R, 2009, SLEEP, V32, P629, DOI 10.1093/sleep/32.5.629; Schindler A, 2014, DYSPHAGIA, V29, P44, DOI 10.1007/s00455-013-9474-9; Su VYF, 2014, CAN MED ASSOC J, V186, P415, DOI 10.1503/cmaj.131547; SULLIVAN CE, 1979, J APPL PHYSIOL, V47, P17, DOI 10.1152/jappl.1979.47.1.17; Suurna MV, 2008, OTOLARYNG HEAD NECK, V139, P286, DOI 10.1016/j.otohns.2008.03.012; Valbuza JS, 2011, SLEEP BREATH, V15, P209, DOI 10.1007/s11325-010-0474-9; Wang HD, 1998, CHEST, V114, P1496, DOI 10.1378/chest.114.5.1496-a	31	30	30	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0152749	10.1371/journal.pone.0152749	http://dx.doi.org/10.1371/journal.pone.0152749			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050437	Green Submitted, Green Published, gold			2022-12-27	WOS:000373603500053
J	Zabeen, B; Craig, ME; Virk, SA; Pryke, A; Chan, AKF; Cho, YH; Benitez-Aguirre, PZ; Hing, S; Donaghue, KC				Zabeen, Bedowra; Craig, Maria E.; Virk, Sohaib A.; Pryke, Alison; Chan, Albert K. F.; Cho, Yoon Hi; Benitez-Aguirre, Paul Z.; Hing, Stephen; Donaghue, Kim C.			Insulin Pump Therapy Is Associated with Lower Rates of Retinopathy and Peripheral Nerve Abnormality	PLOS ONE			English	Article							GLYCEMIC VARIABILITY; DIABETES-MELLITUS; ADVERSE EVENTS; ADOLESCENTS; INFUSION; COMPLICATIONS; CHILDREN; INJECTIONS; SAFETY	Objective To compare rates of microvascular complications in adolescents with type 1 diabetes treated with continuous subcutaneous insulin infusion (CSII) versus multiple daily injections (MDI). Research Design and Methods Prospective cohort of 989 patients (aged 12-20 years; diabetes duration >5 years) treated with CSII or MDI for >12 months. Microvascular complications were assessed from 200014: early retinopathy (seven-field fundal photography), peripheral nerve function (thermal and vibration threshold testing), autonomic nerve abnormality (heart rate variability analysis of electrocardiogram recordings) and albuminuria (albumin creatinine ratio/timed overnight albumin excretion). Generalized estimating equations (GEE) were used to examine the relationship between treatment and complications rates, adjusting for socio-economic status (SES) and known risk factors including HbA(1)c and diabetes duration. Results Comparing CSII with MDI: HbA1C was 8.6% [70mmol/mol] vs. 8.7% [72 mmol/mol]) (p = 0.7), retinopathy 17% vs. 22% (p = 0.06); microalbuminuria 1% vs. 4% (p = 0.07), peripheral nerve abnormality 27% vs. 33% (p = 0.108) and autonomic nerve abnormality 24% vs. 28% (p = 0.401). In multivariable GEE, CSII use was associated with lower rates of retinopathy (OR 0.66, 95% CI 0.45-0.95, p = 0.029) and peripheral nerve abnormality (OR 0.63, 95% CI 0.42-0.95, p = 0.026), but not albuminuria (OR 0.46, 95% CI 0.10-2.17, p = 0.33). SES was not associated with any of the complication outcomes. Conclusions In adolescents, CSII use is associated with lower rates of retinopathy and peripheral nerve abnormality, suggesting an apparent benefit of CSII over MDI independent of glycemic control or SES.	[Zabeen, Bedowra; Craig, Maria E.; Virk, Sohaib A.; Pryke, Alison; Chan, Albert K. F.; Cho, Yoon Hi; Benitez-Aguirre, Paul Z.; Donaghue, Kim C.] Childrens Hosp Westmead, Inst Endocrinol & Diabet, Sydney, NSW, Australia; [Zabeen, Bedowra] Bangladesh Inst Res & Rehabil Diabet Endocrine &, Dept Paediat, Dhaka, Bangladesh; [Zabeen, Bedowra] Bangladesh Inst Res & Rehabil Diabet Endocrine &, Changing Diabet Children Program, Dhaka, Bangladesh; [Craig, Maria E.; Virk, Sohaib A.] Univ New S Wales, Sch Womens & Childrens Hlth, Sydney, NSW, Australia; [Craig, Maria E.; Cho, Yoon Hi; Benitez-Aguirre, Paul Z.; Donaghue, Kim C.] Univ Sydney, Discipline Paediat & Child Hlth, Sydney, NSW 2006, Australia; [Hing, Stephen] Childrens Hosp Westmead, Dept Ophthalmol, Sydney, NSW, Australia	University of Sydney; University of New South Wales Sydney; University of Sydney; University of Sydney	Donaghue, KC (corresponding author), Childrens Hosp Westmead, Inst Endocrinol & Diabet, Sydney, NSW, Australia.; Donaghue, KC (corresponding author), Univ Sydney, Discipline Paediat & Child Hlth, Sydney, NSW 2006, Australia.	kim.donaghue@health.nsw.gov.au	Cho, Yoon Hi/AFQ-6512-2022	Craig, Maria E/0000-0001-6004-576X; Cho, Yoon Hi/0000-0001-6568-8991				[Anonymous], 1995, DIABETES, V44, P968; [Anonymous], 1987, PEDIATRICS, V79, P1; Australian Bureau of Statistic, 2006, SEIFA SOC IND AR; Bragd J, 2008, DIABETES METAB, V34, P612, DOI 10.1016/j.diabet.2008.04.005; Ceriello A, 2003, DIABETOLOGIA, V46, pM9, DOI 10.1007/s00125-002-0931-5; Ceriello A, 2010, DIABETIC MED, V27, P862, DOI 10.1111/j.1464-5491.2010.02967.x; Cho YH, 2015, DIABETES CARE, V38, P676, DOI 10.2337/dc14-1848; Cho YH, 2014, CLIN ENDOCRINOL, V80, P818, DOI 10.1111/cen.12238; DAVIES AG, 1988, ARCH DIS CHILD, V63, P329, DOI 10.1136/adc.63.3.329; Downie E, 2011, DIABETES CARE, V34, P2368, DOI 10.2337/dc11-0102; Hirsch IB, 2015, DIABETES CARE, V38, P1610, DOI 10.2337/dc14-2898; Hoogma RPLM, 2006, DIABETIC MED, V23, P141, DOI 10.1111/j.1464-5491.2005.01738.x; Jeitler K, 2008, DIABETOLOGIA, V51, P941, DOI 10.1007/s00125-008-0974-3; Johnson SR, 2013, DIABETOLOGIA, V56, P2392, DOI 10.1007/s00125-013-3007-9; KLEIN R, 1990, AUST NZ J OPHTHALMOL, V18, P19, DOI 10.1111/j.1442-9071.1990.tb00579.x; Kuczmarski RJ, 2000, VITAL HLTH STAT, V11, P1; Lenhard MJ, 2001, ARCH INTERN MED, V161, P2293, DOI 10.1001/archinte.161.19.2293; MECKLENBURG RS, 1982, NEW ENGL J MED, V307, P513, DOI 10.1056/NEJM198208263070901; Mohsin F, 2005, DIABETES CARE, V28, P1974, DOI 10.2337/diacare.28.8.1974; Monami M, 2010, ACTA DIABETOL, V47, pS77, DOI 10.1007/s00592-009-0132-5; Plotnick LP, 2003, DIABETES CARE, V26, P1142, DOI 10.2337/diacare.26.4.1142; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Steineck I, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h3234; Weissberg-Benchell J, 2003, DIABETES CARE, V26, P1079, DOI 10.2337/diacare.26.4.1079; Wheeler BJ, 2014, DIABETES TECHNOL THE, V16, P558, DOI 10.1089/dia.2013.0388; Wheeler BJ, 2014, DIABETES TECHNOL THE, V16, P204, DOI 10.1089/dia.2013.0315; Yeh HC, 2012, ANN INTERN MED, V157, P336, DOI 10.7326/0003-4819-157-5-201209040-00508	27	55	56	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0153033	10.1371/journal.pone.0153033	http://dx.doi.org/10.1371/journal.pone.0153033			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050468	Green Published, Green Submitted, gold			2022-12-27	WOS:000373603500087
J	Galvan-Quesada, S; Doadrio, I; Alda, F; Perdices, A; Reina, RG; Varela, MG; Hernandez, N; Mendoza, AC; Bermingham, E; Dominguez-Dominguez, O				Galvan-Quesada, Sesangari; Doadrio, Ignacio; Alda, Fernando; Perdices, Anabel; Gisela Reina, Ruth; Garcia Varela, Martin; Hernandez, Natividad; Campos Mendoza, Antonio; Bermingham, Eldredge; Dominguez-Dominguez, Omar			Molecular Phylogeny and Biogeography of the Amphidromous Fish Genus Dormitator Gill 1861 (Teleostei: Eleotridae)	PLOS ONE			English	Article							FRESH-WATER FISHES; EVOLUTIONARY HISTORY; POPULATION-STRUCTURE; OCEAN CURRENTS; LIFE-HISTORY; FAT SLEEPER; ATLANTIC; PHYLOGEOGRAPHY; DIVERGENCE; ISTHMUS	Species of the genus Dormitator, also known as sleepers, are representatives of the amphidromous freshwater fish fauna that inhabit the tropical and subtropical coastal environments of the Americas and Western Africa. Because of the distribution of this genus, it could be hypothesized that the evolutionary patterns in this genus, including a pair of geminate species across the Central American Isthmus, could be explained by vicariance following the break-up of Gondwana. However, the evolutionary history of this group has not been evaluated. We constructed a time-scaled molecular phylogeny of Dormitator using mitochondrial (Cytochrome b) and nuclear (Rhodopsin and beta-actin) DNA sequence data to infer and date the cladogenetic events that drove the diversification of the genus and to relate them to the biogeographical history of Central America. Two divergent lineages of Dormitator were recovered: one that included all of the Pacific samples and another that included all of the eastern and western Atlantic samples. In contrast to the Pacific lineage, which showed no phylogeographic structure, the Atlantic lineage was geographically structured into four clades: Cameroon, Gulf of Mexico, West Cuba and Caribbean, showing evidence of potential cryptic species. The separation of the Pacific and Atlantic lineages was estimated to have occurred similar to 1 million years ago (Mya), whereas the four Atlantic clades showed mean times of divergence between 0.2 and 0.4 Mya. The splitting times of Dormitator between ocean basins are similar to those estimated for other geminate species pairs with shoreline estuarine preferences, which may indicate that the common evolutionary histories of the different clades are the result of isolation events associated with the closure of the Central American Isthmus and the subsequent climatic and oceanographic changes.	[Galvan-Quesada, Sesangari] Univ Michoacana, Programa Inst Doctorado Ciencias Biol, Morelia, Michoacan, Mexico; [Galvan-Quesada, Sesangari; Campos Mendoza, Antonio; Dominguez-Dominguez, Omar] Univ Michoacana, Fac Biol, Lab Biol Acuat, Morelia, Michoacan, Mexico; [Doadrio, Ignacio; Perdices, Anabel] CSIC, Museo Nacl Ciencias Nat, Dept Biodiversidad & Biol Evolut, E-28006 Madrid, Spain; [Alda, Fernando; Perdices, Anabel; Gisela Reina, Ruth; Bermingham, Eldredge] Smithsonian Trop Res Inst, Apartado 2072, Balboa, Panama; [Garcia Varela, Martin] Univ Nacl Autonoma Mexico, Inst Biol, Mexico City 04510, DF, Mexico; [Hernandez, Natividad] Inst Med Trop Pedro Kouri, Apartado 601, Havana, Cuba; [Alda, Fernando] Louisiana State Univ, Dept Biol Sci, Museum Nat Sci, Baton Rouge, LA 70803 USA; [Bermingham, Eldredge] Patricia & Phillip Frost Museum Sci, Miami, FL USA	Universidad Michoacana de San Nicolas de Hidalgo; Universidad Michoacana de San Nicolas de Hidalgo; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); Smithsonian Institution; Smithsonian Tropical Research Institute; Universidad Nacional Autonoma de Mexico; Louisiana State University System; Louisiana State University	Galvan-Quesada, S (corresponding author), Univ Michoacana, Programa Inst Doctorado Ciencias Biol, Morelia, Michoacan, Mexico.; Galvan-Quesada, S; Dominguez-Dominguez, O (corresponding author), Univ Michoacana, Fac Biol, Lab Biol Acuat, Morelia, Michoacan, Mexico.	galygq@hotmail.com; goodeido@yahoo.com.mx	Doadrio, Ignacio/F-8448-2016; Alda, Fernando/C-5646-2011	Doadrio, Ignacio/0000-0003-4863-9711; Alda, Fernando/0000-0002-6858-9566	CIC-UMSNH; PIFI-UMSNH program (Mexico); PAPIIT-UNAM [IN207213]; CONACyT [179048, 216640]; Museo Nacional de Ciencias Naturales-CSIC; Spanish Ministry of Economy and Competitiveness (Spain) [CGL2013-41375-P]; Smithsonian Tropical Research Institute (Panama)	CIC-UMSNH; PIFI-UMSNH program (Mexico); PAPIIT-UNAM(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Museo Nacional de Ciencias Naturales-CSIC; Spanish Ministry of Economy and Competitiveness (Spain)(Spanish Government); Smithsonian Tropical Research Institute (Panama)(Smithsonian InstitutionSmithsonian Tropical Research Institute)	The authors are grateful for the following financial support for this research: CIC-UMSNH (2010, 2011) and PIFI-UMSNH program (Mexico) to ODD; PAPIIT-UNAM No. IN207213 and CONACyT No. 179048 (Mexico) to MGV; Museo Nacional de Ciencias Naturales-CSIC and Spanish Ministry of Economy and Competitiveness No. CGL2013-41375-P (Spain) to ID; Smithsonian Tropical Research Institute (Panama) to EB; CONACyT PhD scholarship No. 216640 granted to SGQ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agorreta A, 2013, MOL PHYLOGENET EVOL, V69, P619, DOI 10.1016/j.ympev.2013.07.017; Akihito, 2000, GENE, V259, P5, DOI 10.1016/S0378-1119(00)00488-1; Alonso R, 2012, J BIOGEOGR, V39, P434, DOI 10.1111/j.1365-2699.2011.02594.x; [Anonymous], 2014, TRACER V1 6; [Anonymous], 2020, CATALOG FISHES; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; AVISE JC, 1992, OIKOS, V63, P62, DOI 10.2307/3545516; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Bacon CD, 2015, P NATL ACAD SCI USA, V112, P6110, DOI 10.1073/pnas.1423853112; Beguer M, 2007, ECOL FRESHW FISH, V16, P221, DOI 10.1111/j.1600-0633.2006.00214.x; Bermingham E, 1998, MOL ECOL, V7, P499, DOI 10.1046/j.1365-294x.1998.00358.x; Bermingham Eldredge, 1997, P113, DOI 10.1016/B978-012417540-2/50009-9; Bloom DD, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2081; BOWEN BW, 1990, MAR BIOL, V107, P371, DOI 10.1007/BF01313418; Carlin JL, 2003, MAR BIOL, V143, P1057, DOI 10.1007/s00227-003-1151-3; Castro-Aguirre J. L., 1999, ICTIOFAUNA ESTUARINO; Ceron-Souza I, 2015, ECOL EVOL, V5, P3486, DOI 10.1002/ece3.1569; Chen WJ, 2003, MOL PHYLOGENET EVOL, V26, P262, DOI 10.1016/S1055-7903(02)00371-8; Chubb AL, 1998, J HERED, V89, P8, DOI 10.1093/jhered/89.1.8; Coates AG, 2005, CARIBB J SCI, V41, P374; Coats DA, 1992, PHYS OCEANOGRAPHY US; Cook BD, 2009, J N AM BENTHOL SOC, V28, P709, DOI 10.1899/09-008.1; Craig MT, 2004, J BIOGEOGR, V31, P1085, DOI 10.1111/j.1365-2699.2004.01035.x; Cronin Thomas M., 1996, P76; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Darwin C., 1872, P458; Doadrio I, 2009, MOL PHYLOGENET EVOL, V50, P16, DOI 10.1016/j.ympev.2008.09.014; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Edwards SV, 2000, EVOLUTION, V54, P1839; Floeter SR, 2008, J BIOGEOGR, V35, P22, DOI 10.1111/j.1365-2699.2007.01790.x; FOLLETT WI, 1960, SYST ZOOL, V9, P212, DOI 10.2307/2411968; Froese R., 2015, FISHBASE; Ginsburg I., 1953, Journal of the Washington Academy of Sciences, V43, P18; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Harrison J, 1992, FAUNE DES POISONS DE, V2; Haug GH, 1998, NATURE, V393, P673, DOI 10.1038/31447; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Iturralde-Vinent MA, 1999, B AM MUS NAT HIST, P1; Johns GC, 1998, MOL BIOL EVOL, V15, P1481, DOI 10.1093/oxfordjournals.molbev.a025875; Jordan DS, 1908, AM NAT, V42, P73, DOI 10.1086/278905; Knowlton N, 1998, P ROY SOC B-BIOL SCI, V265, P2257, DOI 10.1098/rspb.1998.0568; Kullander S. O., 2003, CHECK LIST FRESHWATE, P657; Landa A, 1977, FAO INF PESCA, V2, P106; Lara A, 2010, MOL ECOL RESOUR, V10, P421, DOI 10.1111/j.1755-0998.2009.02785.x; Leathwick JR, 2008, J BIOGEOGR, V35, P1481, DOI 10.1111/j.1365-2699.2008.01887.x; Lessios HA, 2008, ANNU REV ECOL EVOL S, V39, P63, DOI 10.1146/annurev.ecolsys.38.091206.095815; MASSAY S, 1992, J FISH BIOL, V40, P815, DOI 10.1111/j.1095-8649.1992.tb02627.x; McDowall RM, 2001, FISH FISH, V2, P278, DOI 10.1046/j.1467-2960.2001.00050.x; McDowall R.M., 1988, DIADROMY FISHES; McDowall RM, 1999, MOL ECOL, V8, P527, DOI 10.1046/j.1365-294x.1999.00560.x; McMahan CD, 2013, J BIOGEOGR, V40, P894, DOI 10.1111/jbi.12036; Miller M.A., 2010, P GAT COMP ENV WORKS; Miura O, 2010, MOL PHYLOGENET EVOL, V56, P40, DOI 10.1016/j.ympev.2010.04.012; Muss A, 2001, EVOLUTION, V55, P561, DOI 10.1554/0014-3820(2001)055[0561:POOTRO]2.0.CO;2; MYERS GS, 1949, COPEIA, P89; Nelson DJ, 1994, FISHES WORLD; NORDLIE FG, 1993, J FISH BIOL, V43, P433, DOI 10.1006/jfbi.1993.1145; NORRIS S. M., 2005, FRESHWATER FISHES ME; Ornelas-Garcia Claudia Patricia, 2008, BMC Evol Biol, V8, P340, DOI 10.1186/1471-2148-8-340; PALUMBI SR, 1994, ANNU REV ECOL SYST, V25, P547, DOI 10.1146/annurev.es.25.110194.002555; Palumbi Stephen R., 1996, P205; Parrish JT, 1993, AFRICA S AM CONNECTI, P8; Paz A, 2015, MOL ECOL, V24, P3723, DOI 10.1111/mec.13275; Perdices A, 2005, MOL PHYLOGENET EVOL, V37, P460, DOI 10.1016/j.ympev.2005.01.020; Perdices A, 2002, MOL PHYLOGENET EVOL, V25, P172, DOI 10.1016/S1055-7903(02)00224-5; Picq S, 2014, J BIOGEOGR, V41, P1520, DOI 10.1111/jbi.12309; RAUCHENBERGER M, 1988, SYST ZOOL, V37, P356, DOI 10.2307/2992198; Reeves RG, 2006, BIOL J LINN SOC, V88, P235, DOI 10.1111/j.1095-8312.2006.00619.x; Renner S, 2004, INT J PLANT SCI, V165, pS23, DOI 10.1086/383334; RICHARDSON PL, 1986, J GEOPHYS RES-OCEANS, V91, P537, DOI 10.1029/JC091iC09p10537; Robalo JI, 2006, MOL PHYLOGENET EVOL, V39, P276, DOI 10.1016/j.ympev.2005.08.009; ROSEN DE, 1985, ANN MO BOT GARD, V72, P636, DOI 10.2307/2399218; Robertson DR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102918; Sambrook J., 1989, MOLECULAR CLONING A; Schmidt DN, 2007, DEEP-TIME PERSPECTIVES ON CLIMATE CHANGE: MARRYING THE SIGNAL FROM COMPUTER MODELS AND BIOLOGICAL PROXIES, P427; SHULMAN MJ, 1995, EVOLUTION, V49, P897, DOI 10.1111/j.1558-5646.1995.tb02325.x; Smith SA, 2005, J BIOGEOGR, V32, P1835, DOI 10.1111/j.1365-2699.2005.01317.x; Soltis DE, 2006, MOL ECOL, V15, P4261, DOI 10.1111/j.1365-294X.2006.03061.x; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stramma L, 1999, DEEP-SEA RES PT II, V46, P279, DOI 10.1016/S0967-0645(98)00109-X; Taillebois L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075465; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Taylor MS, 2003, SCIENCE, V299, P107, DOI 10.1126/science.1079365; Thacker CE, 2005, MOL PHYLOGENET EVOL, V37, P858, DOI 10.1016/j.ympev.2005.05.004; Tringali MD, 1999, MOL PHYLOGENET EVOL, V13, P193, DOI 10.1006/mpev.1999.0624; VERGARA RR, 1992, PRINCIPALES CARACTER; Victor BC, 2010, ZOOL STUD, V49, P865; Violante-Gonzalez J, 2008, REV BIOL TROP, V56, P1419; Yang ZH, 2006, MOL BIOL EVOL, V23, P212, DOI 10.1093/molbev/msj024	90	21	22	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153538	10.1371/journal.pone.0153538	http://dx.doi.org/10.1371/journal.pone.0153538			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27074006	gold, Green Submitted, Green Published			2022-12-27	WOS:000374131200105
J	Gergely, A; Compton, AB; Newberry, RC; Miklosi, A				Gergely, Anna; Compton, Anna B.; Newberry, Ruth C.; Miklosi, Adam			Social Interaction with an "Unidentified Moving Object" Elicits A-Not-B Error in Domestic Dogs	PLOS ONE			English	Article							CANIS-FAMILIARIS; PERSEVERATIVE SEARCH; CALLITHRIX-JACCHUS; SPATIAL MEMORY; BEHAVIOR; PERMANENCE; CONTEXT; TASK	Mechanical "unidentified moving objects" (UMO's) are useful for controlled investigations into features of social interaction that generate cooperativeness and positive social affiliation in domestic dogs (Canis familiaris). We hypothesized that, if a UMO interacted socially with a dog, the UMO would become associated with certain social cues and would subsequently affect dog behaviour. We assigned dogs to a Human, Social UMO or Non-Social UMO partner. In the Human and Social UMO conditions, the partner interacted with the dog cooperatively whereas the Non-Social UMO partner was unresponsive to the dog's actions. We then tested dogs with their partner in a Piagetian A-not-B error paradigm, predicting that the Human and Social UMO partners would be more likely to elicit A-not-B errors in dogs than the Non-Social UMO partner. Five trials were conducted in which the dog watched its partner hide a ball behind one of two screens (A or B). As predicted, dogs in the Human and Social UMO conditions were more likely to search for the ball behind the A screen during B trials than dogs in the Non-Social UMO condition. These results reveal that the unfamiliar partner's social responsiveness leads rapidly to accepting information communicated by the partner. This study has generated a better understanding of crucial features of agents that promote dog social behaviour, which will facilitate the programming of robots for various cooperative tasks.	[Gergely, Anna] Hungarian Acad Sci, Inst Cognit Neurosci & Psychol, Budapest, Hungary; [Compton, Anna B.; Newberry, Ruth C.] Norwegian Univ Life Sci, Dept Anim Husb & Aquaculture, As, Norway; [Miklosi, Adam] Eotvos Lorand Univ, Dept Ethol, Budapest, Hungary; [Miklosi, Adam] MTA ELTE Comparat Ethol Res Grp, Budapest, Hungary	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; Norwegian University of Life Sciences; Eotvos Lorand University; MTA-ELTE Comparative Ethology Research Group	Gergely, A (corresponding author), Hungarian Acad Sci, Inst Cognit Neurosci & Psychol, Budapest, Hungary.	anna.gergely66@gmail.com	Newberry, Ruth C/L-5054-2013; Miklosi, Adam/N-5147-2017	Newberry, Ruth C/0000-0002-5238-6959; Miklosi, Adam/0000-0003-4831-8985	Swiss National Science Foundation (SNSF) [CRSI22 133059]; Hungarian Science Foundation (OTKA) [K-100695]	Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); Hungarian Science Foundation (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	This research was supported by the Swiss National Science Foundation (SNSF) Sinergia project SWARMIX (project number CRSI22 133059) and the Hungarian Science Foundation (OTKA grant K-100695). The Erasmus program (http://www.esn.org) supported travel between Norway and Hungary. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Gergely A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072727; Csibra G, 2009, TRENDS COGN SCI, V13, P148, DOI 10.1016/j.tics.2009.01.005; Flushing E. F., 2012, P 2 WORKSH ROB SENS; Gergely A, 2015, ANIM BEHAV, V108, P137, DOI 10.1016/j.anbehav.2015.07.024; Hofstadter M, 1996, CHILD DEV, V67, P646, DOI 10.1111/j.1467-8624.1996.tb01757.x; Kis A, 2012, ANIM COGN, V15, P97, DOI 10.1007/s10071-011-0436-z; Krause J, 2011, TRENDS ECOL EVOL, V26, P369, DOI 10.1016/j.tree.2011.03.015; Kubinyi E, 2004, BEHAV PROCESS, V65, P231, DOI 10.1016/j.beproc.2003.10.003; Lakatos G, 2014, ANIM COGN, V17, P387, DOI 10.1007/s10071-013-0670-7; Lakatos G, 2009, ANIM COGN, V12, P621, DOI 10.1007/s10071-009-0221-4; Leaver SDA, 2008, BEHAVIOUR, V145, P377, DOI 10.1163/156853908783402894; MACDONALD SE, 1994, J COMP PSYCHOL, V108, P328, DOI 10.1037/0735-7036.108.4.328; Macpherson K, 2010, J COMP PSYCHOL, V124, P47, DOI 10.1037/a0018084; Mataric MJ, 1998, TRENDS COGN SCI, V2, P82, DOI 10.1016/S1364-6613(98)01141-3; Mendes N, 2004, J COMP PSYCHOL, V118, P103, DOI 10.1037/0735-7036.118.1.103; Miklosi A, 1998, Anim Cogn, V1, P113, DOI 10.1007/s100710050016; Olton D.S., 1981, P333; Peter A, 2015, Q J EXP PSYCHOL, V68, P940, DOI 10.1080/17470218.2014.970206; Piaget J., 1954, CONSTRUCTION REALITY; Smith LB, 1999, PSYCHOL REV, V106, P235, DOI 10.1037/0033-295X.106.2.235; Sumegi Z, 2014, J COMP PSYCHOL, V128, P21, DOI 10.1037/a0033084; Szetei V, 2003, APPL ANIM BEHAV SCI, V83, P141, DOI 10.1016/S0168-1591(03)00114-X; Topal J, 2008, SCIENCE, V321, P1831, DOI 10.1126/science.1161437; Topal J, 2009, SCIENCE, V325, P1269, DOI 10.1126/science.1176960	24	11	11	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0151600	10.1371/journal.pone.0151600	http://dx.doi.org/10.1371/journal.pone.0151600			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ3UC	27073867	Green Published, gold, Green Submitted			2022-12-27	WOS:000374131200009
J	Mills, D; Gomberawalla, A; Gordon, EJ; Tondre, J; Nejad, M; Nguyen, T; Pogoda, JM; Rao, JY; Chatterton, R; Henning, S; Love, SM				Mills, Dixie; Gomberawalla, Ameer; Gordon, Eva J.; Tondre, Julie; Nejad, Mitra; Nguyen, Tinh; Pogoda, Janice M.; Rao, Jianyu; Chatterton, Robert; Henning, Susanne; Love, Susan M.			Examination of Duct Physiology in the Human Mammary Gland	PLOS ONE			English	Article							NIPPLE ASPIRATE FLUID; BREAST-CANCER RISK; INTRADUCTAL THERAPY; WOMEN; ANATOMY; LAVAGE; EPITHELIUM; PRECURSORS; ESTROGEN	Background The human breast comprise several ductal systems, or lobes, which contain a small amount of fluid containing cells, hormones, proteins and metabolites. The complex physiology of these ducts is likely a contributing factor to the development of breast cancer, especially given that the vast majority of breast cancers begin in a single lobular unit. Methods We examined the levels of total protein, progesterone, estradiol, estrone sulfate, dehydroepiandrosterone sulfate, and macrophages in ductal fluid samples obtained from 3 ducts each in 78 women, sampled twice over a 6 month period. Samples were processed for both cytological and molecular analysis. Intraclass correlation coefficients and mixed models were utilized to identify significant data. Results We found that the levels of these ductal fluid components were generally uncorrelated among ducts within a single breast and over time, suggesting that each lobe within the breast has a distinct physiology. However, we also found that estradiol was more correlated in women who were nulliparous or produced nipple aspirate fluid. Conclusions Our results provide evidence that the microenvironment of any given lobular unit is unique to that individual unit, findings that may provide clues about the initiation and development of ductal carcinomas.	[Mills, Dixie; Gomberawalla, Ameer; Gordon, Eva J.; Tondre, Julie; Nejad, Mitra; Nguyen, Tinh; Love, Susan M.] Dr Susan Love Res Fdn, 2811 Wilshire Blvd,Suite 500, Santa Monica, CA 90403 USA; [Pogoda, Janice M.] Univ So Calif, Dept Prevent Med, Keck Sch Med, Los Angeles, CA 90089 USA; [Rao, Jianyu] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Chatterton, Robert] Northwestern Univ, Dept Obstet & Gynecol, Feinberg Sch Med, 710 North Fairbanks Court, Chicago, IL 60611 USA; [Henning, Susanne] Univ Calif Los Angeles, David Geffen Sch Med, Ctr Human Nutr, Los Angeles, CA 90095 USA; [Gomberawalla, Ameer] Columbia Univ, Dept Breast Surg, Med Ctr, New York, NY USA	University of Southern California; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Northwestern University; Feinberg School of Medicine; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Columbia University	Gomberawalla, A (corresponding author), Dr Susan Love Res Fdn, 2811 Wilshire Blvd,Suite 500, Santa Monica, CA 90403 USA.	ameergombera@gmail.com			Avon Foundation [CA2005]; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER	Avon Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	SL received grant CA2005 from the Avon Foundation, www.avonfoundation.org. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baltzell KA, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-75; Bhandare D, 2005, CANCER EPIDEM BIOMAR, V14, P2620, DOI 10.1158/1055-9965.EPI-05-0302; Chatterton Robert Treat Jr., 2010, Hormones & Cancer, V1, P197, DOI 10.1007/s12672-010-0021-y; Chatterton RT, 2004, CANCER EPIDEM BIOMAR, V13, P928; Cooper A, 1845, ANATOMY DIS BREAST P; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; de Souza Ana Paula Duarte, 2012, Front Biosci (Elite Ed), V4, P2354; Diallo R, 2001, J PATHOL, V193, P27, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH747>3.0.CO;2-H; Dooley WC, 2001, J NATL CANCER I, V93, P1624, DOI 10.1093/jnci/93.21.1624; Dooley WC, 2009, BREAST J, V15, pS90, DOI 10.1111/j.1524-4741.2009.00799.x; Field CA, 2007, J R STAT SOC B, V69, P369, DOI 10.1111/j.1467-9868.2007.00593.x; Finkelstein MM, 2001, AIHAJ, V62, P195, DOI 10.1080/15298660108984622; Flanagan M, 2010, CURR BREAST CANCER R, V2, P75, DOI 10.1007/s12609-010-0015-3; Gann PH, 2006, CANCER EPIDEM BIOMAR, V15, P39, DOI 10.1158/1055-9965.EPI-05-0470; Going JJ, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1527; Going JJ, 2004, J PATHOL, V203, P538, DOI 10.1002/path.1556; Goldstein NS, 2011, INT J RADIAT ONCOL, V79, P818, DOI 10.1016/j.ijrobp.2009.11.016; Greene H., 2003, ECONOMETRIC ANAL; HOLLAND R, 1994, SEMIN DIAGN PATHOL, V11, P181; Jacobs L, 2010, CURR OPIN INVEST DR, V11, P646; Khan SA, 2009, CANCER PREV RES, V2, P265, DOI 10.1158/1940-6207.CAPR-08-0119; Kopans D.B., 2006, BREAST IMAGING; Love SM, 2004, CANCER-AM CANCER SOC, V101, P1947, DOI 10.1002/cncr.20559; Lubin JH, 2004, ENVIRON HEALTH PERSP, V112, P1691, DOI 10.1289/ehp.7199; NOGUCHI S, 1994, CANCER, V74, P872, DOI 10.1002/1097-0142(19940801)74:3<872::AID-CNCR2820740313>3.0.CO;2-P; Patil DB, 2008, BREAST CANCER RES TR, V112, P327, DOI 10.1007/s10549-007-9861-8; PETRAKIS NL, 1986, BREAST CANCER RES TR, V8, P7, DOI 10.1007/BF01805919; Ramsay DT, 2005, J ANAT, V206, P525, DOI 10.1111/j.1469-7580.2005.00417.x; Rubin DB, 2004, MULTIPLE IMPUTATION; SAS Institute, 2009, SAS STAT 9 2 US GUID; TEBOUL M, 1995, ATLAS ULTRASOUND DUC; Tondre J, 2008, ANN SURG ONCOL, V15, P2734, DOI 10.1245/s10434-008-0060-6; Tot T, 2005, VIRCHOWS ARCH, V447, P1, DOI 10.1007/s00428-005-1274-7; Tsai YC, 1996, CANCER RES, V56, P402; WELLINGS SR, 1980, PATHOL RES PRACT, V166, P515, DOI 10.1016/S0344-0338(80)80248-2; Wrensch MR, 2001, JNCI-J NATL CANCER I, V93, P1791, DOI 10.1093/jnci/93.23.1791	36	6	6	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0150653	10.1371/journal.pone.0150653	http://dx.doi.org/10.1371/journal.pone.0150653			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073976	gold, Green Published, Green Submitted			2022-12-27	WOS:000374131200005
J	Murunga, AN; Miruka, DO; Driver, C; Nkomo, FS; Cobongela, SZZ; Owira, PMO				Murunga, Alfred N.; Miruka, David O.; Driver, Christine; Nkomo, Fezile S.; Cobongela, Snazo Z. Z.; Owira, Peter M. O.			Grapefruit Derived Flavonoid Naringin Improves Ketoacidosis and Lipid Peroxidation in Type 1 Diabetes Rat Model	PLOS ONE			English	Article							OXIDATIVE STRESS; METABOLIC SYNDROME; CITRUS FLAVONOIDS; HYPERGLYCEMIA; DYSLIPIDEMIA; HESPERIDIN; DIAGNOSIS; MELLITUS	Background Hypoglycemic effects of grapefruit juice are well known but the effects of naringin, its main flavonoid on glucose intolerance and metabolic complications in type 1 diabetes are not known. Objectives To investigate the effects of naringin on glucose intolerance, oxidative stress and ketonemia in type 1 diabetic rats. Methods Sprague-Dawley rats divided into 5 groups (n = 7) were orally treated daily with 3.0 ml/kg body weight (BW)/day of distilled water (group 1) or 50 mg/kg BW of naringin (groups 2 and 4, respectively). Groups 3, 4 and 5 were given a single intra-peritoneal injection of 60 mg/kg BW of streptozotocin to induce diabetes. Group 3 was further treated with subcutaneous insulin (4.0 IU/kg BW) twice daily, respectively. Results Stretozotocin (STZ) only-treated groups exhibited hyperglycemia, polydipsia, polyuria, weight loss, glucose intolerance, low fasting plasma insulin and reduced hepatic glycogen content compared to the control group. Furthermore they had significantly elevated Malondialdehyde (MDA), acetoacetate, beta-hydroxybutyrate, anion gap and significantly reduced blood pH and plasma bicarbonate compared to the control group. Naringin treatment significantly improved Fasting Plasma Insulin (FPI), hepatic glycogen content, malondialdehyde, beta-hydroxybutyrate, acetoacetate, bicarbonate, blood pH and anion gap but not Fasting Blood Glucose (FBG) compared to the STZ only-treated group. Conclusions Naringin is not hypoglycemic but ameliorates ketoacidosis and oxidative stress. Naringin supplements could therefore mitigate complications of diabetic ketoacidosis.	[Murunga, Alfred N.; Miruka, David O.; Driver, Christine; Nkomo, Fezile S.; Cobongela, Snazo Z. Z.; Owira, Peter M. O.] Univ KwaZulu Natal, Mol & Clin Pharmacol Res Lab, Dept Pharmacol, Discipline Pharmaceut Sci,Sch Hlth Sci, POB X5401, Durban, South Africa	University of Kwazulu Natal	Owira, PMO (corresponding author), Univ KwaZulu Natal, Mol & Clin Pharmacol Res Lab, Dept Pharmacol, Discipline Pharmaceut Sci,Sch Hlth Sci, POB X5401, Durban, South Africa.	owirap@ukzn.ac.za		Cobongela, Sinazo/0000-0001-9057-3096	Career Development Award by South African Medical Research Council	Career Development Award by South African Medical Research Council	The study was funded by Career Development Award by the South African Medical Research Council to the corresponding author.	Adebiyi AO, 2016, J CARDIOVASC PHARM, V67, P136, DOI 10.1097/FJC.0000000000000325; Adebiyi OO, 2015, NUTRIENTS, V7, P10352, DOI 10.3390/nu7125540; Alam MA, 2014, ADV NUTR, V5, P404, DOI 10.3945/an.113.005603; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Ali MM, 2004, Z NATURFORSCH C, V59, P726; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Arai S, 2013, AM J CRIT CARE, V22, P328, DOI 10.4037/ajcc2013533; Babu PVA, 2006, CLIN EXP PHARMACOL P, V33, P1184, DOI 10.1111/j.1440-1681.2006.04509.x; Casteels K, 2003, REV ENDOCR METAB DIS, V4, P159, DOI 10.1023/A:1022942120000; Chiasson JL, 2003, CAN MED ASSOC J, V168, P859; Fiorentino TV, 2013, CURR PHARM DESIGN, V19, P5695, DOI 10.2174/1381612811319320005; Hayanga JA, 2016, EUR J NUTR, V55, P631, DOI 10.1007/s00394-015-0883-4; Jung UJ, 2004, J NUTR, V134, P2499, DOI 10.1093/jn/134.10.2499; Jung UJ, 2006, INT J BIOCHEM CELL B, V38, P1134, DOI 10.1016/j.biocel.2005.12.002; Kraut JA, 2007, CLIN J AM SOC NEPHRO, V2, P162, DOI 10.2215/CJN.03020906; Li PB, 2014, FOOD CHEM TOXICOL, V66, P65, DOI 10.1016/j.fct.2014.01.023; Mahmoud AM, 2012, J DIABETES COMPLICAT, V26, P483, DOI 10.1016/j.jdiacomp.2012.06.001; McPherson PAC, 2012, J PHYSIOL BIOCHEM, V68, P141, DOI 10.1007/s13105-011-0112-4; Murunga AN, 2013, TROP MED INT HEALTH, V18, P1357, DOI 10.1111/tmi.12195; Niki E, 2008, BIOFACTORS, V34, P171, DOI 10.1002/biof.5520340208; Parmar HS, 2012, DIABETES RES CLIN PR, V97, P105, DOI 10.1016/j.diabres.2012.02.011; Phulukdaree A, 2010, S AFR J SCI, V106, P54, DOI 10.4102/sajs.v106i1/2.10; Pu P, 2012, ARCH BIOCHEM BIOPHYS, V518, P61, DOI 10.1016/j.abb.2011.11.026; Punithavathi VR, 2008, J APPL TOXICOL, V28, P806, DOI 10.1002/jat.1343; Rewers A, 2012, CURR DIABETES REP, V12, P524, DOI 10.1007/s11892-012-0307-2; SEIFTER S, 1950, ARCH BIOCHEM, V25, P191; SHULMAN RG, 1995, P NATL ACAD SCI USA, V92, P8535, DOI 10.1073/pnas.92.19.8535; Stojanovic V, 2011, CAN VET J, V52, P426; Usher-Smith JA, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4092; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Wolfsdorf J, 2009, PEDIATR DIABETES, V10, P118, DOI 10.1111/j.1399-5448.2009.00569.x; Xulu S, 2012, J CARDIOVASC PHARM, V59, P133, DOI 10.1097/FJC.0b013e31823827a4; Zygmunt K, 2010, BIOCHEM BIOPH RES CO, V398, P178, DOI 10.1016/j.bbrc.2010.06.048	33	25	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153241	10.1371/journal.pone.0153241	http://dx.doi.org/10.1371/journal.pone.0153241			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073901	Green Published, Green Submitted, gold			2022-12-27	WOS:000374131200065
J	Alemu, YM; Andargie, G; Gebeye, E				Alemu, Yihun Mulugeta; Andargie, Gashaw; Gebeye, Ejigu			High Incidence of Tuberculosis in the Absence of Isoniazid and Cotrimoxazole Preventive Therapy in Children Living with HIV in Northern Ethiopia: A Retrospective Follow-Up Study	PLOS ONE			English	Article							VIRUS-INFECTED CHILDREN; ANTIRETROVIRAL THERAPY; CHILDHOOD TUBERCULOSIS; COHORT; PREVALENCE; MORTALITY; ANEMIA; HEALTH; IMPACT; HAART	Objective To identify the incidence of and predictors for tuberculosis in children living with HIV in Northern Ethiopia. Design Observational, retrospective follow-up study. Methods A total of 645 HIV-infected children were observed between September 2009 and September 2014. Cox regression analysis was used to identify predictors for developing TB. Results The incidence rate of tuberculosis was 4.2 per 100 child-years. Incidence of tuberculosis was higher for subjects who were not on cotrimoxazole preventive therapy, were not on isoniazid preventive therapy, had delayed motor development, had a CD4 cell count below the threshold, had hemoglobin level less than 10 mg/dl and were assessed as World Health Organization (WHO) clinical stage III or IV. Conclusion Incidence of TB in children living with HIV was high. This study reaffirmed that isoniazid preventive therapy is one of the best strategy to reduce incidence of TB in children living with HIV. All children living with HIV should be screened for TB but for children with delayed motor development, advanced WHO clinical stage, anemia or immune suppression, intensified screening is highly recommended.	[Alemu, Yihun Mulugeta] Bahir Dar Univ, Coll Med & Hlth Sci, Sch Publ Hlth, Bahir Dar, Ethiopia; [Andargie, Gashaw; Gebeye, Ejigu] Univ Gondar, Coll Med & Hlth Sci, Inst Publ Hlth, Gondar, Ethiopia	Bahir Dar University; University of Gondar	Alemu, YM (corresponding author), Bahir Dar Univ, Coll Med & Hlth Sci, Sch Publ Hlth, Bahir Dar, Ethiopia.	yihun.mulugeta@yahoo.com						Abuogi LL, 2013, INT J TUBERC LUNG D, V17, P1291, DOI 10.5588/ijtld.12.0740; Assebe LF, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1719-0; Auld AF, 2014, INT J TUBERC LUNG D, V18, P381, DOI 10.5588/ijtld.13.0395; Ayele HT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1089-3; Ayieko J, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-91; Bain B J, 1999, Curr Opin Hematol, V6, P89, DOI 10.1097/00062752-199903000-00006; Batista Jd, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0063916, DOI 10.1371/JOURNAL.PONE.0063916]; Braitstein P, 2009, PEDIATR INFECT DIS J, V28, P626, DOI 10.1097/INF.0b013e31819665c5; Buonomo E, 2015, EPIDEMIOL PREV, V39, P108; Calis JCJ, 2008, NEW ENGL J MED, V358, P888, DOI 10.1056/NEJMoa072727; Central Statistical Agency, 2014, HIV AIDS EST PROJ ET; Creemers-Schild D, 2015, TREATMENT PNEUMOCYST; Cruz AT, 2014, LANCET GLOB HEALTH, V2, pE432, DOI 10.1016/S2214-109X(14)70269-4; Day CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094949; Dodd PJ, 2014, LANCET GLOB HEALTH, V2, pE453, DOI 10.1016/S2214-109X(14)70245-1; Edathodu J, 2009, INT J INFECT DIS, V13, P243, DOI 10.1016/j.ijid.2007.12.017; Edmonds A, 2009, INT J EPIDEMIOL, V38, P1612, DOI 10.1093/ije/dyp208; Espinal RA, 2000, LANCET, V355, P275, DOI 10.1016/S0140-6736(99)04402-5; Ezeamama AE, 2015, INT J INFECT DIS, V35, P73, DOI 10.1016/j.ijid.2015.04.008; Federal HIV/AIDS Prevention and Control Office Ministry of Health, 2007, FEDERAL HIV AIDS PRE; Federal Ministry of Health Ethiopia, 2013, GUID LIN CLIN PROGR; Fisk DT, 2003, CLIN INFECT DIS, V36, P70, DOI 10.1086/344951; Getahun H, 2010, CLIN INFECT DIS, V50, pS201, DOI 10.1086/651492; Horacio RE, 2015, J ACQUIR IMMUNE DEFI; Hussain T, 2007, TUBERCULOSIS, V87, P7, DOI 10.1016/j.tube.2006.01.001; Kassa E, 1999, AIDS, V13, P381, DOI 10.1097/00002030-199902250-00011; Kerkhoff AD, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0320-9; Li N, 2013, AIDS, V27, P1273, DOI 10.1097/QAD.0b013e32835ecb24; Martinson NA, 2009, INT J TUBERC LUNG D, V13, P862; Mocroft A, 1999, AIDS, V13, P943, DOI 10.1097/00002030-199905280-00010; Moreno S, 2008, INT J TUBERC LUNG D, V12, P1393; Moses A, 1998, BLOOD, V91, P1479, DOI 10.1182/blood.V91.5.1479.1479_1479_1495; Mu WW, 2014, AIDS CARE, V26, P1127, DOI 10.1080/09540121.2014.882492; Pawlowski A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002464; Santiago-Rodriguez Eduardo J, 2014, BMC Res Notes, V7, P439, DOI 10.1186/1756-0500-7-439; Seddon JA, 2014, INFECT DRUG RESIST, V7, P153, DOI 10.2147/IDR.S45090; Suthar AB, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001270; Teck R, 2005, INT J TUBERC LUNG D, V9, P258; Thomas P, 2000, PEDIATR INFECT DIS J, V19, P700, DOI 10.1097/00006454-200008000-00006; United States Agency for International Development, 2013, REP GLOB AIDS EP; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; WHO Multicentre Growth Reference, 2006, MOT DEV WIND ACH 6 G; WILKINSON D, 2000, COCHRANE DATABASE SY, V4; World Health Organisation, 2006, GUID NAT TUB PROGR M; World Health Organization, 2021, 10 THREATS GLOB HLTH; World Health Organization, 2014, GLOB TUB REP; World Health Organization and United Nations Children's Fund, 2009, WHO CHILD GROWTH STA; Yirdaw KD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104557; Zachariah R, 2007, LANCET INFECT DIS, V7, P686, DOI 10.1016/S1473-3099(07)70239-6; Zammarchi L, 2014, MEDITERR J HEMATOL I, V6, DOI 10.4084/MJHID.2014.043; Zar HJ, 2007, BRIT MED J, V334, P136, DOI 10.1136/bmj.39000.486400.55	51	13	13	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0152941	10.1371/journal.pone.0152941	http://dx.doi.org/10.1371/journal.pone.0152941			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27070435	Green Published, gold, Green Submitted			2022-12-27	WOS:000373900700021
J	Chang, CW; Petrie, T; Clark, A; Lin, X; Sondergaard, CS; Griffiths, LG				Chang, Chia Wei; Petrie, Tye; Clark, Alycia; Lin, Xin; Sondergaard, Claus S.; Griffiths, Leigh G.			Mesenchymal Stem Cell Seeding of Porcine Small Intestinal Submucosal Extracellular Matrix for Cardiovascular Applications	PLOS ONE			English	Article							PRELIMINARY EXPERIENCE; MYOCARDIAL-INFARCTION; PARACRINE MECHANISMS; REPAIR; TRANSPLANTATION; RECONSTRUCTION; REGENERATION; GRAFTS; TISSUE; SURGERY	In this study, we investigate the translational potential of a novel combined construct using an FDA-approved decellularized porcine small intestinal submucosa extracellular matrix (SIS-ECM) seeded with human or porcine mesenchymal stem cells (MSCs) for cardiovascular indications. With the emerging success of individual component in various clinical applications, the combination of SIS-ECM with MSCs could provide additional therapeutic potential compared to individual components alone for cardiovascular repair. We tested the in vitro effects of MSC-seeding on SIS-ECM on resultant construct structure/function properties and MSC phenotypes. Additionally, we evaluated the ability of porcine MSCs to modulate recipient graft-specific response towards SIS-ECM in a porcine cardiac patch in vivo model. Specifically, we determined: 1) in vitro loading-capacity of human MSCs on SIS-ECM, 2) effect of cell seeding on SIS-ECM structure, compositions and mechanical properties, 3) effect of SIS-ECM seeding on human MSC phenotypes and differentiation potential, and 4) optimal orientation and dose of porcine MSCs seeded SIS-ECM for an in vivo cardiac application. In this study, histological structure, biochemical compositions and mechanical properties of the FDA-approved SIS-ECM biomaterial were retained following MSCs re-population in vitro. Similarly, the cellular phenotypes and differentiation potential of MSCs were preserved following seeding on SIS-ECM. In a porcine in vivo patch study, the presence of porcine MSCs on SIS-ECM significantly reduced adaptive T cell response regardless of cell dose and orientation compared to SIS-ECM alone. These findings substantiate the clinical translational potential of combined SIS-ECM seeded with MSCs as a promising therapeutic candidate for cardiac applications.	[Chang, Chia Wei; Clark, Alycia; Griffiths, Leigh G.] Univ Calif Davis, Sch Vet Med, Dept Med & Epidemiol, Davis, CA 95616 USA; [Petrie, Tye; Lin, Xin; Sondergaard, Claus S.] Univ Calif Davis, Sch Med, Dept Surg, Sacramento, CA 95817 USA	University of California System; University of California Davis; University of California System; University of California Davis	Griffiths, LG (corresponding author), Univ Calif Davis, Sch Vet Med, Dept Med & Epidemiol, Davis, CA 95616 USA.	lggriffiths@ucdavis.edu		Griffiths, Leigh/0000-0001-6147-5972	California Institute for Regenerative Medicine (CIRM) [TR3-05626, TG2-01163]	California Institute for Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine)	This work was supported by funding from California Institute for Regenerative Medicine (CIRM): TR3-05626 (LGG and CSS) and TG2-01163 (CWC).	Allman AJ, 2001, TRANSPLANTATION, V71, P1631, DOI 10.1097/00007890-200106150-00024; Bank RA, 1997, J CHROMATOGR B, V703, P37, DOI 10.1016/S0378-4347(97)00391-5; Boyd WD, 2010, HEART SURG FORUM, V13, pE311, DOI 10.1532/HSF98.20091184; Caione P, 2006, PEDIATR SURG INT, V22, P593, DOI 10.1007/s00383-006-1705-9; Caione P, 2012, PEDIATR SURG INT, V28, P421, DOI 10.1007/s00383-012-3063-0; Chalajour F, 2012, ANN THORAC SURG, V93, P1311, DOI 10.1016/j.athoracsur.2011.08.055; Du XF, 2012, INT J PEDIATR OTORHI, V76, P345, DOI 10.1016/j.ijporl.2011.12.005; Engelmayr GC, 2006, BIOMATERIALS, V27, P6083, DOI 10.1016/j.biomaterials.2006.07.045; Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826; Hodde J P, 2005, J Wound Care, V14, P23; Hodde JP, 2001, ENDOTHELIUM-NEW YORK, V8, P11, DOI 10.3109/10623320109063154; Hodonsky C, 2015, ANN THORAC SURG, V99, P605, DOI 10.1016/j.athoracsur.2014.08.071; Janis AD, 2012, J BIOMATER APPL, V26, P1013, DOI 10.1177/0885328210391688; Katritsis DG, 2005, CATHETER CARDIO INTE, V65, P321, DOI 10.1002/ccd.20406; Kini S, 2001, OBES SURG, V11, P469, DOI 10.1381/096089201321209350; Lam MT, 2013, TISSUE ENG PT A, V19, P738, DOI [10.1089/ten.tea.2012.0480, 10.1089/ten.TEA.2012.0480]; Li AH, 2014, CIRC RES, V114, P916, DOI 10.1161/CIRCRESAHA.114.302819; Lin HK, 2014, TISSUE ENG PART B-RE, V20, P73, DOI 10.1089/ten.TEB.2013.0126; Lin X, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0165-3; Lopes MF, 2006, DIS ESOPHAGUS, V19, P254, DOI 10.1111/j.1442-2050.2006.00574.x; Lopes MF, 2006, J INVEST SURG, V19, P105, DOI 10.1080/08941930600569621; Makris EA, 2013, OSTEOARTHR CARTILAGE, V21, P634, DOI 10.1016/j.joca.2013.01.007; McCready RA, 2005, J VASC SURG, V41, P782, DOI 10.1016/j.jvs.2005.02.035; Mirotsou M, 2011, J MOL CELL CARDIOL, V50, P280, DOI 10.1016/j.yjmcc.2010.08.005; Mostow EN, 2005, J VASC SURG, V41, P837, DOI 10.1016/j.jvs.2005.01.042; Murphy KD, 2008, J HAND SURG-AM, V33A, P1168, DOI 10.1016/j.jhsa.2008.02.003; *NAT RES COUNC, 1996, GUID CAR US LAB AN; Niezgoda Jeffrey A, 2005, Adv Skin Wound Care, V18, P258, DOI 10.1097/00129334-200506000-00012; Nihsen Edith S, 2008, Adv Skin Wound Care, V21, P479, DOI 10.1097/01.ASW.0000323561.14144.19; Nihsen Edith S, 2007, Adv Skin Wound Care, V20, P541, DOI 10.1097/01.ASW.0000294756.97425.c9; Palmer EM, 2002, TISSUE ENG, V8, P893, DOI 10.1089/10763270260424259; Perin EC, 2003, CIRCULATION, V107, P2294, DOI 10.1161/01.CIR.0000070596.30552.8B; PREVEL CD, 1995, ANN PLAS SURG, V35, P381, DOI 10.1097/00000637-199510000-00009; Quarti A, 2011, INTERACT CARDIOV TH, V13, P569, DOI 10.1510/icvts.2011.280016; Ramaswamy S, 2010, BIOMATERIALS, V31, P1114, DOI 10.1016/j.biomaterials.2009.10.019; Ranganath SH, 2012, CELL STEM CELL, V10, P244, DOI 10.1016/j.stem.2012.02.005; Rossetto VJV, 2013, ACTA VET SCAND, V55, DOI 10.1186/1751-0147-55-39; Scholl FG, 2010, WORLD J PEDIATR CONG, V1, P132, DOI 10.1177/2150135110362092; Sharma AK, 2011, STEM CELLS, V29, P241, DOI 10.1002/stem.568; Slachman FN, 2014, ANN THORAC SURG, V97, pE129, DOI 10.1016/j.athoracsur.2013.10.103; Strauer BE, 2002, CIRCULATION, V106, P1913, DOI 10.1161/01.CIR.0000034046.87607.1C; Taljaard M, 2010, AM HEART J, V159, P354, DOI 10.1016/j.ahj.2009.12.021; Tang YL, 2005, ANN THORAC SURG, V80, P229, DOI 10.1016/j.athoracsur.2005.02.072; Williams AR, 2011, CIRC RES, V108, P792, DOI 10.1161/CIRCRESAHA.111.242610; Witt RG, 2013, EUR J CARDIO-THORAC, V44, P72, DOI 10.1093/ejcts/ezs638; Wollert KC, 2004, LANCET, V364, P141, DOI 10.1016/S0140-6736(04)16626-9; Wong ML, 2011, BIOMATERIALS, V32, P8129, DOI 10.1016/j.biomaterials.2011.07.030; Yanagawa B, 2013, INNOVATIONS, V8, P348, DOI 10.1097/IMI.0000000000000014	48	37	38	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0153412	10.1371/journal.pone.0153412	http://dx.doi.org/10.1371/journal.pone.0153412			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27070546	Green Submitted, gold, Green Published			2022-12-27	WOS:000373900700062
J	Dai, RJ; Lu, R; Ahmed, SA				Dai, Rujuan; Lu, Ran; Ahmed, S. Ansar			The Upregulation of Genomic Imprinted DLK1-Dio3 miRNAs in Murine Lupus Is Associated with Global DNA Hypomethylation	PLOS ONE			English	Article							CD4(+) T-CELLS; AUTOIMMUNE-DISEASES; MICRORNA CLUSTER; INTERFERON-GAMMA; NITRIC-OXIDE; METHYLATION; ERYTHEMATOSUS; DOMAIN; EXPRESSION; CANCER	Epigenetic factors such as DNA methylation and microRNAs (miRNAs) are now increasingly recognized as vital contributors to lupus etiology. In this study, we investigated the potential interaction of these two epigenetic factors in lupus-prone MRL-lpr mice. We recently reported dysregulated expression of miRNAs in splenocytes of MRL-lpr mice. Here, we report that a majority of the upregulated miRNAs in MRL-lpr mice is located at the genomic imprinted DLK1-Dio3 domain. Further, we show a differential magnitude of upregulation of DLK1-Dio3 miRNA cluster in purified splenic CD4(+) T, CD19(+) B, and splenic CD4(-)CD19(-) cells from MRL-lpr lupus mice when compared to control MRL mice. MRL-lpr splenocytes (especially CD19(+) and CD4(-)CD19(-) subsets) were hypomethylated compared to cells from control, MRL mice. We further show that deliberate demethylation of splenocytes from control MRL mice, but not from MRL-lpr lupus mice, with specific DNA methylation inhibitor 5-Aza-2'-deoxycytidine significantly augmented DLK1-Dio3 miRNAs expression. These findings strongly indicate that the upregulation of DLK1-Dio3 miRNAs in lupus splenic cell subsets is associated with reduced global DNA methylation levels in lupus cells. There was a differential upregulation of DLK-Dio3 miRNAs among various demethylated splenic cell subsets, which implies varied sensitivity of DLK1-Dio3 miRNA cluster in these cell subsets to DNA hypomethylation. Finally, inhibition of select DLK1-Dio3 miRNA such as miR-154, miR-379 and miR-300 with specific antagomirs significantly reduced the production of lupus-relevant IFN gamma, IL-1 beta, IL-6, and IL-10 in lipopolysaccharide (LPS) activated splenocytes from MRL-lpr mice. Our study is the first to show that DNA methylation regulates genomic imprinted DLK1-Dio3 miRNAs in autoimmune lupus, which suggests a connection of DNA methylation, miRNA and genomic imprinting in lupus pathogenesis.	[Dai, Rujuan; Lu, Ran; Ahmed, S. Ansar] Virginia Tech, Infect Dis Res Facil IDRF, Dept Biomed Sci & Pathobiol, Virginia Maryland Coll Vet Med VMCVM, Blacksburg, VA USA	Virginia Polytechnic Institute & State University	Dai, RJ; Ahmed, SA (corresponding author), Virginia Tech, Infect Dis Res Facil IDRF, Dept Biomed Sci & Pathobiol, Virginia Maryland Coll Vet Med VMCVM, Blacksburg, VA USA.	rdai05@vt.edu; ansrahms@vt.edu	lu, ran/HHC-8613-2022		Virginia-Maryland College of Veterinary Medicine (VMCVM); Intramural Research Competition Grant [IRC 175185]; Alliance for Lupus Research (ALR) [219631]	Virginia-Maryland College of Veterinary Medicine (VMCVM); Intramural Research Competition Grant; Alliance for Lupus Research (ALR)	This work was supported by Virginia-Maryland College of Veterinary Medicine (VMCVM, http://www.vetmed.vt.edu/) Intramural Research Competition Grant (IRC 175185) and Alliance for Lupus Research (ALR, http://www.lupusresearch.org/; Award ID: 219631). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Absher DM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003678; Balada E, 2007, ANN NY ACAD SCI, V1108, P127, DOI 10.1196/annals.1422.015; Beebe AM, 2002, CYTOKINE GROWTH F R, V13, P403, DOI 10.1016/S1359-6101(02)00025-4; Benetatos L, 2013, CELL MOL LIFE SCI, V70, P795, DOI 10.1007/s00018-012-1080-8; Carr MS, 2007, GENOMICS, V89, P280, DOI 10.1016/j.ygeno.2006.10.005; Ceribelli A, 2011, ARTHRITIS RHEUM-US, V63, P1177, DOI 10.1002/art.30192; Chafin CB, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/430239; Chong MMW, 2008, J EXP MED, V205, P2449, DOI [10.1084/jem.20071219090508c, 10.1084/jem.20081219]; Cobb BS, 2005, J EXP MED, V201, P1367, DOI 10.1084/jem.20050572; Coit P, 2013, J AUTOIMMUN, V43, P78, DOI 10.1016/j.jaut.2013.04.003; Crispin JC, 2010, TRENDS MOL MED, V16, P47, DOI 10.1016/j.molmed.2009.12.005; Da Rocha ST, 2008, TRENDS GENET, V24, P306, DOI 10.1016/j.tig.2008.03.011; Dai R, 2007, J IMMUNOL, V179, P1776, DOI 10.4049/jimmunol.179.3.1776; Dai RJ, 2013, BIOL SEX DIFFER, V4, DOI 10.1186/2042-6410-4-19; Dai RJ, 2014, THER CLIN RISK MANAG, V10, P151, DOI 10.2147/TCRM.S33517; Dai R, 2011, TRANSL RES, V157, P163, DOI 10.1016/j.trsl.2011.01.007; Dai RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014302; Dai RJ, 2008, BLOOD, V112, P4591, DOI 10.1182/blood-2008-04-152488; Hedrich CM, 2011, TRENDS MOL MED, V17, P714, DOI 10.1016/j.molmed.2011.07.005; Hewagama A, 2013, J AUTOIMMUN, V41, P60, DOI 10.1016/j.jaut.2012.12.006; Hewagama A, 2009, J AUTOIMMUN, V33, P3, DOI 10.1016/j.jaut.2009.03.007; Javierre BM, 2010, GENOME RES, V20, P170, DOI 10.1101/gr.100289.109; Kameswaran V, 2014, CELL METAB, V19, P135, DOI 10.1016/j.cmet.2013.11.016; Karpuzoglu E, 2006, ENDOCRINOLOGY, V147, P662, DOI 10.1210/en.2005-0829; Khan S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068753; Kono DH, 2006, SPRINGER SEMIN IMMUN, V28, P83, DOI 10.1007/s00281-006-0030-7; Koralov SB, 2008, CELL, V132, P860, DOI 10.1016/j.cell.2008.02.020; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Lin SP, 2003, NAT GENET, V35, P97, DOI 10.1038/ng1233; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Manodoro F, 2014, BLOOD, V123, P2066, DOI 10.1182/blood-2012-12-469833; Muljo SA, 2005, J EXP MED, V202, P261, DOI 10.1084/jem.20050678; Ohl K, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/432595; Pan W, 2010, J IMMUNOL, V184, P6773, DOI 10.4049/jimmunol.0904060; Patel DR, 2010, CURR OPIN RHEUMATOL, V22, P478, DOI 10.1097/BOR.0b013e32833ae915; QUDDUS J, 1993, J CLIN INVEST, V92, P38, DOI 10.1172/JCI116576; Richardson Bruce, 2012, Methods Mol Biol, V900, P169, DOI 10.1007/978-1-60761-720-4_8; Richardson BC, 2014, NAT REV RHEUMATOL, V10, P72, DOI 10.1038/nrrheum.2013.211; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Saito Y, 2006, CANCER CELL, V9, P435, DOI 10.1016/j.ccr.2006.04.020; Sawalha AH, 2007, EUR J IMMUNOL, V37, P1407, DOI 10.1002/eji.200636872; Seitz H, 2004, GENOME RES, V14, P1741, DOI 10.1101/gr.2743304; Shen N, 2012, NAT REV RHEUMATOL, V8, P701, DOI 10.1038/nrrheum.2012.142; Steshina EY, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-44; Stittrich AB, 2010, NAT IMMUNOL, V11, P1057, DOI 10.1038/ni.1945; Takada S, 2002, HUM MOL GENET, V11, P77, DOI 10.1093/hmg/11.1.77; Vinuesa CG, 2009, INT REV IMMUNOL, V28, P112, DOI 10.1080/08830180902934909; Wolffe AP, 1999, SCIENCE, V286, P481, DOI 10.1126/science.286.5439.481; Xin CG, 2014, MOL CELL BIOCHEM, V387, P271, DOI 10.1007/s11010-013-1892-3; Yan Sheng, 2014, Immune Netw, V14, P138, DOI 10.4110/in.2014.14.3.138; Yu JS, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-121; Zehavi L, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-44; Zeng TB, 2014, FEBS LETT, V588, P4665, DOI 10.1016/j.febslet.2014.10.038; Zhang L, 2008, P NATL ACAD SCI USA, V105, P7004, DOI 10.1073/pnas.0801615105; Zhao S, 2011, ARTHRITIS RHEUM-US, V63, P1376, DOI 10.1002/art.30196	55	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0153509	10.1371/journal.pone.0153509	http://dx.doi.org/10.1371/journal.pone.0153509			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27070142	gold, Green Published, Green Submitted			2022-12-27	WOS:000373900700075
J	Leong, KH; Looi, CY; Loong, XM; Cheah, FK; Supratman, U; Litaudon, M; Mustafa, MR; Awang, K				Leong, Kok Hoong; Looi, Chung Yeng; Loong, Xe-Min; Cheah, Foo Kit; Supratman, Unang; Litaudon, Marc; Mustafa, Mohd Rais; Awang, Khalijah			Cycloart-24-ene-26-ol-3-one, a New Cycloartane Isolated from Leaves of Aglaia exima Triggers Tumour Necrosis Factor-Receptor 1-Mediated Caspase-Dependent Apoptosis in Colon Cancer Cell Line	PLOS ONE			English	Article							P53; PROLIFERATION; ACTIVATION; EXPRESSION; COMPLEXES; MECHANISM; PRB	Plants in the Meliaceae family are known to possess interesting biological activities, such as antimalaral, antihypertensive and antitumour activities. Previously, our group reported the plant-derived compound cycloart-24-ene-26-ol-3-one isolated from the hexane extracts of Aglaia exima leaves, which shows cytotoxicity towards various cancer cell lines, in particular, colon cancer cell lines. In this report, we further demonstrate that cycloart-24-ene-26-ol-3-one, from here forth known as cycloartane, reduces the viability of the colon cancer cell lines HT-29 and CaCO-2 in a dose-and time-dependent manner. Further elucidation of the compound's mechanism showed that it binds to tumour necrosis factor-receptor 1 (TNF-R1) leading to the initiation of caspase-8 and, through the activation of Bid, in the activation of caspase-9. This activity causes a reduction in mitochondrial membrane potential (MMP) and the release of cytochrome-C. The activation of caspase-8 and -9 both act to commit the cancer cells to apoptosis through downstream caspase-3/7 activation, PARP cleavage and the lack of NFkB translocation into the nucleus. A molecular docking study showed that the cycloartane binds to the receptor through a hydrophobic interaction with cysteine-96 and hydrogen bonds with lysine-75 and - 132. The results show that further development of the cycloartane as an anti-cancer drug is worthwhile.	[Leong, Kok Hoong; Cheah, Foo Kit] Univ Malaya, Fac Med, Dept Pharm, Kuala Lumpur, Malaysia; [Leong, Kok Hoong; Mustafa, Mohd Rais; Awang, Khalijah] Univ Malaya, Dept Chem, Fac Sci, Ctr Nat Prod & Drug Discovery CENAR, Kuala Lumpur 59100, Malaysia; [Looi, Chung Yeng; Mustafa, Mohd Rais] Univ Malaya, Fac Med, Dept Pharmacol, Kuala Lumpur 50603, Malaysia; [Loong, Xe-Min; Awang, Khalijah] Univ Malaya, Dept Chem, Fac Sci, Kuala Lumpur 59100, Malaysia; [Supratman, Unang] Padjadjaran State Univ, Fac Math & Nat Sci, Dept Chem, Jatinangor, Indonesia; [Litaudon, Marc] CNRS 1, Ctr Rech Gif, Inst Chim Subst Nat, Ave Terrasse, Gif Sur Yvette, France	Universiti Malaya; Universiti Malaya; Universiti Malaya; Universiti Malaya; Universitas Padjadjaran; Centre National de la Recherche Scientifique (CNRS)	Awang, K (corresponding author), Univ Malaya, Dept Chem, Fac Sci, Ctr Nat Prod & Drug Discovery CENAR, Kuala Lumpur 59100, Malaysia.; Awang, K (corresponding author), Univ Malaya, Dept Chem, Fac Sci, Kuala Lumpur 59100, Malaysia.	khalijah@um.edu.my	Leong, Kok Hoong/J-1956-2015; Leong, Kok Hoong/D-9505-2012; Mustafa, Mohamed R/B-1647-2009; AWANG, KHALIJAH/B-8781-2010; Supratman, Unang/P-2028-2018	Leong, Kok Hoong/0000-0002-7317-6117; Leong, Kok Hoong/0000-0002-7317-6117; Mustafa, Mohamed R/0000-0002-7864-5189; AWANG, KHALIJAH/0000-0001-5971-6570; Supratman, Unang/0000-0003-1104-2321	University of Malaya [RP001/2012A, RP001A-13BIO]; University Malaya High Impact Research [H-20001-E00002]; Ministry of Higher Education of Malaysia [FP006-2011A]	University of Malaya(Universiti Malaya); University Malaya High Impact Research; Ministry of Higher Education of Malaysia(Ministry of Education, Malaysia)	This work was supported by the University of Malaya [grants RP001/2012A, RP001A-13BIO]; University Malaya High Impact Research [grant H-20001-E00002]; and the Ministry of Higher Education of Malaysia [grant FP006-2011A]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awang K, 2012, FITOTERAPIA, V83, P1391, DOI 10.1016/j.fitote.2012.10.004; Balkwill F, 2009, NAT REV CANCER, V9, P361, DOI 10.1038/nrc2628; Baron DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114158; Breidenbach M, 2003, ANTI-CANCER DRUG, V14, P341, DOI 10.1097/00001813-200306000-00003; Cabal-Hierro L, 2012, CELL SIGNAL, V24, P1297, DOI 10.1016/j.cellsig.2012.02.006; Chau H, 2011, EXP CELL RES, V317, P1841, DOI 10.1016/j.yexcr.2011.05.015; Davis CD, 2010, SEMIN ONCOL, V37, P243, DOI 10.1053/j.seminoncol.2010.05.001; DeSantis CE, 2014, CA-CANCER J CLIN, V64, P252, DOI 10.3322/caac.21235; Farzaneh V, 2015, IND CROP PROD, V65, P247, DOI 10.1016/j.indcrop.2014.10.057; Gannon PO, 2013, EUR J CANCER, V49, P2441, DOI 10.1016/j.ejca.2013.02.026; Ioachim E, 2008, INT J CLIN PRACT, V62, P1736, DOI 10.1111/j.1742-1241.2006.01105.x; Ioachim EE, 1999, ANTICANCER RES, V19, P2147; Iwatsuki M, 2010, INT J CANCER, V126, P1828, DOI 10.1002/ijc.24879; Khazir J, 2014, PHYTOCHEM LETT, V7, P173, DOI 10.1016/j.phytol.2013.11.010; Laszczyk MN, 2009, PLANTA MED, V75, P1549, DOI 10.1055/s-0029-1186102; Lavrik I, 2005, J CELL SCI, V118, P265, DOI 10.1242/jcs.01610; Liew SY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087286; Liu SF, 2006, AM J PHYSIOL-LUNG C, V290, pL622, DOI 10.1152/ajplung.00477.2005; Liu XH, 2010, BIOORG MED CHEM LETT, V20, P5705, DOI 10.1016/j.bmcl.2010.08.017; Looi CY, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-166; MAJNO G, 1995, AM J PATHOL, V146, P3; Milner AE, 2009, CELL DEATH DIFFER, V9, P287; Pan L, 2013, J NAT PROD, V76, P394, DOI 10.1021/np3007588; Pan Li, 2012, Front Biosci (Schol Ed), V4, P142; Paydar M, 2014, DRUG DES DEV THER, V8, P719, DOI 10.2147/DDDT.S58178; Pereira DM, 2012, CURR PHARM BIOTECHNO, V13, P632, DOI 10.2174/138920112799857530; Reed JC, 2003, CANCER CELL, V3, P17, DOI 10.1016/S1535-6108(02)00241-6; Sawyers C, 2004, NATURE, V432, P294, DOI 10.1038/nature03095; Schneider-Brachert W, 2004, IMMUNITY, V21, P415, DOI 10.1016/j.immuni.2004.08.017; Sheikh MS, 2003, CELL CYCLE, V2, P550, DOI 10.4161/cc.2.6.566; Shi J, 2008, BIOCHEM PHARMACOL, V75, P1729, DOI 10.1016/j.bcp.2008.01.021; Wajant H, 2001, CELL SIGNAL, V13, P389, DOI 10.1016/S0898-6568(01)00160-7; Wu Y, 2010, BRIT J CANCER, V102, P639, DOI 10.1038/sj.bjc.6605530	33	18	19	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0152652	10.1371/journal.pone.0152652	http://dx.doi.org/10.1371/journal.pone.0152652			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27070314	Green Published, gold			2022-12-27	WOS:000373900700012
J	Qian, YQ; He, FP; Wang, W				Qian, Yu-Qi; He, Feng-Peng; Wang, Wei			Seasonality, Rather than Nutrient Addition or Vegetation Types, Influenced Short-Term Temperature Sensitivity of Soil Organic Carbon Decomposition	PLOS ONE			English	Article							MICROBIAL COMMUNITY COMPOSITION; CLIMATE-CHANGE; PHOSPHORUS LIMITATION; NITROGEN LIMITATION; ROOT RESPIRATION; N FERTILIZATION; TROPICAL FOREST; ELEVATED CO2; MATTER; DYNAMICS	The response of microbial respiration from soil organic carbon (SOC) decomposition to environmental changes plays a key role in predicting future trends of atmospheric CO2 concentration. However, it remains uncertain whether there is a universal trend in the response of microbial respiration to increased temperature and nutrient addition among different vegetation types. In this study, soils were sampled in spring, summer, autumn and winter from five dominant vegetation types, including pine, larch and birch forest, shrubland, and grassland, in the Saihanba area of northern China. Soil samples from each season were incubated at 1, 10, and 20 degrees C for 5 to 7 days. Nitrogen (N; 0.035 mM as NH4NO3) and phosphorus (P; 0.03 mM as P2O5) were added to soil samples, and the responses of soil microbial respiration to increased temperature and nutrient addition were determined. We found a universal trend that soil microbial respiration increased with increased temperature regardless of sampling season or vegetation type. The temperature sensitivity (indicated by Q10, the increase in respiration rate with a 10 degrees C increase in temperature) of microbial respiration was higher in spring and autumn than in summer and winter, irrespective of vegetation type. The Q10 was significantly positively correlated with microbial biomass and the fungal: bacterial ratio. Microbial respiration (or Q10) did not significantly respond to N or P addition. Our results suggest that short-term nutrient input might not change the SOC decomposition rate or its temperature sensitivity, whereas increased temperature might significantly enhance SOC decomposition in spring and autumn, compared with winter and summer.	[Qian, Yu-Qi; Wang, Wei] Peking Univ, Coll Urban & Environm Sci, Dept Ecol, Beijing 100871, Peoples R China; [Qian, Yu-Qi; Wang, Wei] Peking Univ, Minist Educ, Key Lab Earth Surface Proc, Beijing 100871, Peoples R China; [He, Feng-Peng] Peking Univ, Shenzhen Grad Sch, Shenzhen 518055, Peoples R China	Peking University; Peking University; Peking University; University Town of Shenzhen	Wang, W (corresponding author), Peking Univ, Coll Urban & Environm Sci, Dept Ecol, Beijing 100871, Peoples R China.; Wang, W (corresponding author), Peking Univ, Minist Educ, Key Lab Earth Surface Proc, Beijing 100871, Peoples R China.	wangw@urban.pku.edu.cn	He, Feng/HHS-6457-2022	He, Feng/0000-0002-1996-0744	Projects of the National Natural Science Foundation of China [31222011, 31270363, 31321061]; National Basic Research Program of China [2013CB956303]; University Construction Projects from Central Authorities in Beijing and Research Fund of State Key Laboratory of Soil and Sustainable Agriculture, Nanjing Institute of Soil Science, Chinese Academy of Science [Y412201439]	Projects of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); University Construction Projects from Central Authorities in Beijing and Research Fund of State Key Laboratory of Soil and Sustainable Agriculture, Nanjing Institute of Soil Science, Chinese Academy of Science	This work was supported by Projects of the National Natural Science Foundation of China (No. 31222011, 31270363, and 31321061) http://www.nsfc.gov.cn/; National Basic Research Program of China (No. 2013CB956303) http://www.most.gov.cn/eng/programmes1/200610/t20061009_36223.htm; University Construction Projects from Central Authorities in Beijing and Research Fund of State Key Laboratory of Soil and Sustainable Agriculture, Nanjing Institute of Soil Science, Chinese Academy of Science (Y412201439) http://english.issas.cas.cn/au/bi/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison SD, 2010, NAT GEOSCI, V3, P336, DOI 10.1038/NGEO846; Baath E, 2003, GLOBAL CHANGE BIOL, V9, P1788, DOI 10.1046/j.1365-2486.2003.00692.x; Balser TC, 2009, GLOBAL CHANGE BIOL, V15, P2935, DOI 10.1111/j.1365-2486.2009.01946.x; Billings SA, 2008, LANDSCAPE ECOL, V23, P581, DOI 10.1007/s10980-008-9218-7; Bond-Lamberty B, 2010, NATURE, V464, P579, DOI 10.1038/nature08930; Bowden RD, 2004, FOREST ECOL MANAG, V196, P43, DOI 10.1016/j.foreco.2004.03.011; Bradford MA, 2008, ECOL LETT, V11, P1316, DOI 10.1111/j.1461-0248.2008.01251.x; Brzostek ER, 2011, ECOLOGY, V92, P892, DOI 10.1890/10-1803.1; Buckeridge KM, 2008, APPL SOIL ECOL, V39, P210, DOI 10.1016/j.apsoil.2007.12.010; Cleveland CC, 2002, ECOSYSTEMS, V5, P680, DOI 10.1007/s10021-002-0202-9; Cleveland CC, 2007, BIOGEOCHEMISTRY, V85, P235, DOI 10.1007/s10533-007-9132-0; Conant RT, 2008, ECOLOGY, V89, P2384, DOI 10.1890/08-0137.1; Cox PM, 2000, NATURE, V408, P184, DOI 10.1038/35041539; Craine JM, 2007, ECOLOGY, V88, P2105, DOI 10.1890/06-1847.1; Dalias P, 2001, GLOBAL CHANGE BIOL, V7, P181, DOI 10.1046/j.1365-2486.2001.00386.x; Ding F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095348; Ding WX, 2010, GEODERMA, V155, P381, DOI 10.1016/j.geoderma.2009.12.023; Drake JE, 2013, ECOSPHERE, V4, DOI 10.1890/ES13-00020.1; Fierer N, 2003, SOIL BIOL BIOCHEM, V35, P167, DOI 10.1016/S0038-0717(02)00251-1; Fontaine S, 2005, ECOL LETT, V8, P1075, DOI 10.1111/j.1461-0248.2005.00813.x; Gallo M, 2004, MICROB ECOL, V48, P218, DOI 10.1007/s00248-003-9001-x; Gnankambary Z, 2008, SOIL BIOL BIOCHEM, V40, P350, DOI 10.1016/j.soilbio.2007.08.015; Gutknecht JLM, 2012, GLOBAL CHANGE BIOL, V18, P2256, DOI 10.1111/j.1365-2486.2012.02686.x; Hartley IP, 2008, SOIL BIOL BIOCHEM, V40, P1567, DOI 10.1016/j.soilbio.2008.01.007; Iyamuremye F, 1996, ADV IN AGRON USA; Janssens IA, 2003, GLOBAL CHANGE BIOL, V9, P911, DOI 10.1046/j.1365-2486.2003.00636.x; Jia SX, 2010, PLANT SOIL, V333, P325, DOI 10.1007/s11104-010-0348-8; Jones C, 2005, GLOBAL CHANGE BIOL, V11, P154, DOI 10.1111/j.1365-2486.2004.00885.x; Keiblinger KM, 2010, FEMS MICROBIOL ECOL, V73, P430, DOI 10.1111/j.1574-6941.2010.00912.x; Kirita H, 1971, JAPANESE J ECOL; Kirschbaum MUF, 2006, SOIL BIOL BIOCHEM, V38, P2510, DOI 10.1016/j.soilbio.2006.01.030; Kuzyakov Y, 2010, SOIL BIOL BIOCHEM, V42, P1363, DOI 10.1016/j.soilbio.2010.04.003; Lavoie M, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001629; Leifeld J, 2005, BIOGEOCHEMISTRY, V75, P433, DOI 10.1007/s10533-005-2237-4; Lemke P, 2007, CLIM CHANG, V2007, P337; Lipson DA, 2002, MICROB ECOL, V43, P307, DOI 10.1007/s00248-001-1057-x; Lipson DA, 2009, BIOGEOCHEMISTRY, V95, P23, DOI 10.1007/s10533-008-9252-1; Liptzin D, 2009, SOIL BIOL BIOCHEM, V41, P1696, DOI 10.1016/j.soilbio.2009.05.013; Luo YQ, 2001, NATURE, V413, P622, DOI 10.1038/35098065; Mahecha MD, 2010, SCIENCE, V329, P838, DOI 10.1126/science.1189587; Malcolm GM, 2009, GLOBAL CHANGE BIOL, V15, P2485, DOI 10.1111/j.1365-2486.2008.01839.x; Malik MA, 2012, SOIL BIOL BIOCHEM, V49, P106, DOI 10.1016/j.soilbio.2012.02.013; McMahon SK, 2009, ENV MICROBIOL REP, V1, P162, DOI 10.1111/j.1758-2229.2009.00025.x; Mikan CJ, 2002, SOIL BIOL BIOCHEM, V34, P1785, DOI 10.1016/S0038-0717(02)00168-2; Mo W, 2005, AGR FOREST METEOROL, V134, P81, DOI 10.1016/j.agrformet.2005.08.015; Monson RK, 2006, NATURE, V439, P711, DOI 10.1038/nature04555; Moore-Kucera J, 2008, SOIL BIOL BIOCHEM, V40, P2485, DOI 10.1016/j.soilbio.2008.06.002; Nziguheba G, 1998, PLANT SOIL, V198, P159, DOI 10.1023/A:1004389704235; Olsson P, 2005, GLOBAL CHANGE BIOL, V11, P1745, DOI 10.1111/j.1365-2486.2005.001033.x; Paterson E, 2009, SOIL BIOL BIOCHEM, V41, P1352, DOI 10.1016/j.soilbio.2009.02.012; Pendall E, 2007, SOIL BIOL BIOCHEM, V39, P2628, DOI 10.1016/j.soilbio.2007.05.016; Phillips RP, 2007, NEW PHYTOL, V176, P655, DOI 10.1111/j.1469-8137.2007.02204.x; Reichstein M, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2003GB002035; Schadt CW, 2003, SCIENCE, V301, P1359, DOI 10.1126/science.1086940; Schadel C, 2013, OECOLOGIA, V171, P721, DOI 10.1007/s00442-012-2577-4; Schimel JP, 2003, SOIL BIOL BIOCHEM, V35, P549, DOI 10.1016/S0038-0717(03)00015-4; [石丽丽 SHI LIli], 2008, [安徽农业科学, Journal of Anhui Agricultural Sciences], V36, P4185; Singh BK, 2010, NAT REV MICROBIOL, V8, P779, DOI 10.1038/nrmicro2439; SINGH JS, 1989, NATURE, V338, P499, DOI 10.1038/338499a0; Sinsabaugh RL, 2002, BIOGEOCHEMISTRY, V60, P1, DOI 10.1023/A:1016541114786; Six J, 2006, SOIL SCI SOC AM J, V70, P555, DOI 10.2136/sssaj2004.0347; Suseela V, 2012, GLOBAL CHANGE BIOL, V18, P336, DOI 10.1111/j.1365-2486.2011.02516.x; Tarnocai C, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003327; Trumbore S, 2000, ECOL APPL, V10, P399, DOI 10.1890/1051-0761(2000)010[0399:AOSOMA]2.0.CO;2; Vanhala P, 2011, GLOBAL CHANGE BIOL, V17, P538, DOI 10.1111/j.1365-2486.2009.02154.x; VOSE JM, 1995, CAN J FOREST RES, V25, P1243, DOI 10.1139/x95-137; Waldrop MP, 2000, SOIL BIOL BIOCHEM, V32, P1837, DOI 10.1016/S0038-0717(00)00157-7; Wallenstein MD, 2007, FEMS MICROBIOL ECOL, V59, P428, DOI 10.1111/j.1574-6941.2006.00260.x; Wang W, 2010, PLANT SOIL, V333, P391, DOI 10.1007/s11104-010-0354-x; Wang W, 2010, SOIL BIOL BIOCHEM, V42, P451, DOI 10.1016/j.soilbio.2009.11.028; Wang WJ, 2004, SOIL BIOL BIOCHEM, V36, P2045, DOI 10.1016/j.soilbio.2004.05.023; Zak DR, 2007, ECOLOGY, V88, P2630, DOI 10.1890/06-1819.1; Zelles L, 1997, CHEMOSPHERE, V35, P275, DOI 10.1016/S0045-6535(97)00155-0; Zhang XY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092985; Zhou LY, 2014, GLOBAL CHANGE BIOL, V20, P2332, DOI 10.1111/gcb.12490	75	6	7	6	109	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0153415	10.1371/journal.pone.0153415	http://dx.doi.org/10.1371/journal.pone.0153415			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27070782	Green Submitted, Green Published, gold			2022-12-27	WOS:000373900700063
J	Rahal, AK; Badgett, RG; Hoffman, RM				Rahal, Ahmad K.; Badgett, Robert G.; Hoffman, Richard M.			Screening Coverage Needed to Reduce Mortality from Prostate Cancer: A Living Systematic Review	PLOS ONE			English	Review							HYPERTONIC SALINE; AMERICAN-COLLEGE; STRATEGIES; BENEFITS; TRIAL	Introduction Screening for prostate cancer remains controversial because of conflicting results from the two major trials: The Prostate, Lung, Colorectal and Ovarian Cancer (PLCO) screening trial and the European Randomized Study of Screening for Prostate Cancer (ERSPC). Objective Meta-analyze and meta-regress the available PSA screening trials. Methods We performed a living systematic review and meta-regression of the reduction in prostate cancer mortality as a function of the duration of screening provided in each trial. We searched PubMed, Web of Science, the Cochrane Registry, and references lists from previous meta-analyses to identify randomized trials of PSA screening. We followed PRISMA guidelines and qualified strength of evidence with a GRADE Profile. Results We found 6 trials, but excluded one that also screened with trans-rectal ultrasound. We considered each ERSPC center as a separate trial. When pooling together all 11 trials we found no significant benefit from screening; however, the heterogeneity was 28.2% (95% CI: 0% to 65%). Heterogeneity was explained by variations in the duration of serial screening (I-2 0%; 95% CI: 0% to 52%). When we analyzed the subgroup of trials that added more than 3 years of screening (range 3.2 to 3.8) we found a significant benefit for screening with risk ratio 0.78 (95% CI 0.65-0.94; I-2 = 0%; 95% CI: 0% to 69%) and a number needed to invite for screening of 1000. We downgraded the quality of evidence to moderate due to our retrospective identification of subgroups and limited data on control group screening. Conclusions Adequate duration of screening reduces mortality from prostate cancer. The benefit, while small, compares favorably with screening for other cancers. Our projections are limited by the moderate quality of evidence.	[Rahal, Ahmad K.; Badgett, Robert G.] Univ Kansas, Sch Med, Dept Internal Med, Wichita, KS 67214 USA; [Hoffman, Richard M.] Univ Iowa, Dept Internal Med, Div Gen Internal Med, Carver Coll Med, Iowa City, IA 52242 USA	University of Kansas; University of Kansas Medical Center; University of Iowa	Rahal, AK (corresponding author), Univ Kansas, Sch Med, Dept Internal Med, Wichita, KS 67214 USA.	arahal@kumc.edu	Badgett, Robert/AAD-3429-2021	Badgett, Robert/0000-0003-2888-3303; Hoffman, Richard/0000-0002-4714-7726	NATIONAL CANCER INSTITUTE [P30CA086862] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Andriole GL, 2009, NEW ENGL J MED, V360, P1310, DOI 10.1056/NEJMoa0810696; Badgett RG, 2015, JAMA PEDIATR, V169, P788, DOI 10.1001/jamapediatrics.2015.0681; Bell N, 2014, CAN MED ASSOC J, V186, P1225, DOI 10.1503/cmaj.140703; Chou R, 2011, ANN INTERN MED, V155, P762, DOI 10.7326/0003-4819-155-11-201112060-00375; Cornell JE, 2014, ANN INTERN MED, V160, P267, DOI 10.7326/M13-2886; Elliott JH, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001603; Elmunzer BJ, 2015, GASTROINTEST ENDOSC, V81, P700, DOI 10.1016/j.gie.2014.10.033; Etzioni R, 1999, J UROLOGY, V162, P741, DOI 10.1097/00005392-199909010-00032; Grade Working Group, METH; Grewal S, 2014, JAMA PEDIATR, V168, P607, DOI 10.1001/jamapediatrics.2014.423; Gulati R, 2013, ANN INTERN MED, V158, P145, DOI 10.7326/0003-4819-158-3-201302050-00003; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1311, DOI [10.1016/j.jclinepi.2011.03.017, 10.1016/j.jclinepi.2011.06.004]; Heidenreich A, 2013, EUR UROL, V64, P347, DOI 10.1016/j.eururo.2013.06.051; Heijnsdijk EAM, 2012, NEW ENGL J MED, V367, P595, DOI 10.1056/NEJMoa1201637; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Hugosson J, 2010, LANCET ONCOL, V11, P725, DOI 10.1016/S1470-2045(10)70146-7; Ilic Dragan, 2013, Cochrane Database Syst Rev, pCD004720, DOI 10.1002/14651858.CD004720.pub3; Kiellman A, 2009, J UROLOGY, V181, P1615, DOI 10.1016/j.juro.2008.11.115; Labrie F, 2004, PROSTATE, V59, P311, DOI 10.1002/pros.20017; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Moyer VA, 2012, ANN INTERN MED, V157, P120, DOI 10.7326/0003-4819-157-2-201207170-00459; Nelson HD, 2009, ANN INTERN MED, V151, P727, DOI 10.7326/0003-4819-151-10-200911170-00009; Open MetaAnalysis Contributors, PROSTATE CANCER SCRE; Pinsky PF, 2010, CLIN TRIALS, V7, P303, DOI 10.1177/1740774510374091; Qaseem A, 2013, ANN INTERN MED, V158, P761, DOI 10.7326/0003-4819-158-10-201305210-00633; R Core Team, 2014, R A LANGUAGE AND ENV; Riaz IB, 2016, ANN INTERN MED, V164, P634, DOI [10.7326/L15-0567, 10.7326/L15-0565]; Roobol MJ, 2009, EUR UROL, V56, P584, DOI 10.1016/j.eururo.2009.07.018; Ross KS, 2000, JAMA-J AM MED ASSOC, V284, P1399, DOI 10.1001/jama.284.11.1399; Sandblom G, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1539; Schroder FH, 2012, NEW ENGL J MED, V366, P981, DOI 10.1056/NEJMoa1113135; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084; Schwartz LM, 2009, ANN INTERN MED, V150, P516, DOI 10.7326/0003-4819-150-8-200904210-00106; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Turner EL, 2014, BRIT J CANCER, V110, P2829, DOI 10.1038/bjc.2014.242; Wilt TJ, 2015, ANN INTERN MED, V162, P718, DOI 10.7326/M14-2326; Wu GHM, 2012, EUR UROL, V61, P1011, DOI 10.1016/j.eururo.2012.01.008	37	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0153417	10.1371/journal.pone.0153417	http://dx.doi.org/10.1371/journal.pone.0153417			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27070904	gold, Green Submitted, Green Published			2022-12-27	WOS:000373900700064
J	Xi, XJ; Zhu, YG; Tong, YP; Yang, XL; Tang, NN; Ma, SM; Li, S; Cheng, Z				Xi, Xiu-Jie; Zhu, Yun-Guo; Tong, Ying-Peng; Yang, Xiao-Ling; Tang, Nan-Nan; Ma, Shu-Min; Li, Shan; Cheng, Zhou			Assessment of the Genetic Diversity of Different Job's Tears (Coix lacryma-jobi L.) Accessions and the Active Composition and Anticancer Effect of Its Seed Oil	PLOS ONE			English	Article							MA-YUEN-STAPF; BREAST-CANCER CELLS; FATTY-ACID-COMPOSITION; LACHRYMA-JOBI; LINOLEIC-ACID; ISSR MARKERS; ADLAY SEED; IN-VITRO; PRENEOPLASTIC LESIONS; ETHANOLIC EXTRACT	Job's tears (Coix lachryma-jobi L.) is an important crop used as food and herbal medicine in Asian countries. A drug made of Job's tears seed oil has been clinically applied to treat multiple cancers. In this study, the genetic diversity of Job's tears accessions and the fatty acid composition, triglyceride composition, and anti-proliferative effect of Job's tears seed oil were analyzed using morphological characteristics and ISSR markers, GC-MS, HPLC-ELSD, and the MTT method. ISSR analysis demonstrated low genetic diversity of Job's tears at the species level (h = 0.21, l = 0.33) and the accession level (h = 0.07, l = 0.10), and strong genetic differentiation (G(ST) = 0.6702) among all accessions. It also clustered the 11 accessions into three cultivated clades corresponding with geographical locations and two evidently divergent wild clades. The grouping patterns based on morphological characteristics and chemical profiles were in accordance with those clustered by ISSR analysis. Significant differences in morphological characteristics, fatty acid composition, triglyceride composition, and inhibition rates of seed oil were detected among different accessions, which showed a highly significant positive correlation with genetic variation. These results suggest that the seed morphological characteristics, fatty acid composition, and triglyceride composition may be mainly attributed to genetic factors. The proportion of palmitic acid and linoleic acid to oleic acid displayed a highly significant positive correlation with the inhibition rates of Job's tears seed oil for T24 cells, and thus can be an important indicator for quality control for Job's tears.	[Xi, Xiu-Jie; Zhu, Yun-Guo; Yang, Xiao-Ling; Tang, Nan-Nan; Ma, Shu-Min; Li, Shan; Cheng, Zhou] Tongji Univ, Sch Life Sci & Technol, Shanghai 200092, Peoples R China; [Tong, Ying-Peng] Zhejiang Univ Technol, Coll Pharm, Hangzhou, Zhejiang, Peoples R China	Tongji University; Zhejiang University of Technology	Cheng, Z (corresponding author), Tongji Univ, Sch Life Sci & Technol, Shanghai 200092, Peoples R China.	lishanbio@tongji.edu.cn; chengzhou@tongji.edu.cn		CHENG, Zhou/0000-0001-5866-748X	Natural Science Foundation of Shanghai [12ZR1432900]	Natural Science Foundation of Shanghai(Natural Science Foundation of Shanghai)	This work was sponsored by Natural Science Foundation of Shanghai (12ZR1432900) (http://www.stcsm.gov.cn/gk/ywgz/bgxz/kyjh/ghxfasb/292351.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal M, 2008, PLANT CELL REP, V27, P617, DOI 10.1007/s00299-008-0507-z; Agostini G, 2008, PLANT SYST EVOL, V274, P135, DOI 10.1007/s00606-008-0037-8; [Anonymous], 1997, MOL BIOL BIOTECHNOLO; ARORA RK, 1977, ECON BOT, V31, P358, DOI 10.1007/BF02866887; Beeharry N, 2003, MUTAT RES-FUND MOL M, V530, P27, DOI 10.1016/S0027-5107(03)00134-9; Beyer H, 2015, J APPL BOT FOOD QUAL, V88, P192, DOI 10.5073/JABFQ.2015.088.027; Bruschi P, 2003, ANN BOT-LONDON, V91, P707, DOI 10.1093/aob/mcg075; Casiva PV, 2002, AM J BOT, V89, P843, DOI 10.3732/ajb.89.5.843; CHAJES V, 1995, BREAST CANCER RES TR, V34, P199, DOI 10.1007/BF00689711; Chang HC, 2003, J AGR FOOD CHEM, V51, P3656, DOI 10.1021/jf021142a; Chavez-Pesqueira M, 2014, AM J BOT, V101, P1092, DOI 10.3732/ajb.1400051; Chen ChengBin, 2008, Southwest China Journal of Agricultural Sciences, V21, P792; Chen HJ, 2012, FOOD CHEM TOXICOL, V50, P3808, DOI 10.1016/j.fct.2012.07.011; Chen HJ, 2011, FOOD CHEM, V126, P1741, DOI 10.1016/j.foodchem.2010.12.074; [陈勇 CHEN Yong], 2005, [中国现代应用药学, Chinese Journal of Modern Applied Pharmacy], V22, P246; Chung CP, 2011, J AGR FOOD CHEM, V59, P6025, DOI 10.1021/jf2009556; Chung CP, 2010, J AGR FOOD CHEM, V58, P7616, DOI 10.1021/jf101084e; [丁怡 Ding Yi], 2004, [药物分析杂志, Chinese Journal of Pharmaceutical Analysis], V24, P249; Doyle J. J., 1987, PHYTOCHEM B, P11; Egesel CO, 2011, ACTA SCI-AGRON, V33, P613, DOI 10.4025/actasciagron.v33i4.11031; EXCOFFIER L, 1992, GENETICS, V131, P479; FALCONER JS, 1994, BRIT J CANCER, V69, P826, DOI 10.1038/bjc.1994.161; Figueiredo AC, 2008, FLAVOUR FRAG J, V23, P213, DOI 10.1002/ffj.1875; [高微微 GAO Weiwei], 2006, [中草药, Chinese Traditional and Herbal Drugs], V37, P293; George S, 2009, AM J BOT, V96, P2022, DOI 10.3732/ajb.0800368; Goddard MA, 2010, TRENDS ECOL EVOL, V25, P90, DOI 10.1016/j.tree.2009.07.016; Hamrick JL, 1996, PHILOS T ROY SOC B, V351, P1291, DOI 10.1098/rstb.1996.0112; Hardy S, 2000, CANCER RES, V60, P6353; Hardy S, 2003, J BIOL CHEM, V278, P31861, DOI 10.1074/jbc.M300190200; Hawkins RA, 1998, J PATHOL, V185, P61; Hoisington D, 1999, P NATL ACAD SCI USA, V96, P5937, DOI 10.1073/pnas.96.11.5937; Hsu HY, 2003, J AGR FOOD CHEM, V51, P3763, DOI 10.1021/jf021154w; [华海清(综述) Hua Haiqing], 2012, [中国肿瘤临床, Chinese Journal of Clinical Oncology], V39, P1143; Huang BW, 2005, PHYTOMEDICINE, V12, P433, DOI 10.1016/j.phymed.2004.02.010; Huang DW, 2009, J AGR FOOD CHEM, V57, P10651, DOI 10.1021/jf9028514; Huang DW, 2009, J AGR FOOD CHEM, V57, P2259, DOI 10.1021/jf803255p; HUANG H, 1995, CROP GERMPLASM, V4, P4; Hung WC, 2003, J AGR FOOD CHEM, V51, P7333, DOI 10.1021/jf0340512; Javidfar F, 2006, PLANT BREEDING, V125, P65, DOI 10.1111/j.1439-0523.2006.01187.x; Karron JD, 1987, EVOL ECOL, V1, P47, DOI 10.1007/BF02067268; Kuo CC, 2001, J AGR FOOD CHEM, V49, P1564, DOI 10.1021/jf001215v; Leimu R, 2006, J ECOL, V94, P942, DOI 10.1111/j.1365-2745.2006.01150.x; Li A, 2001, ANN BOT-LONDON, V87, P585, DOI 10.1006/anbo.2001.1390; [李春花 LI Chunhua], 2015, [植物遗传资源学报, Journal of Plant Genetic Resources], V16, P277; Li Da-Peng, 2007, Zhongguo Xinyao yu Linchuang Zazhi, V26, P778; Li DP, 1999, TRADITIONAL CHINESE, V10, P99, DOI [10.3321/j.issn:1003-9783.1999.02.012, DOI 10.3321/J.ISSN:1003-9783.1999.02.012]; [李峻岭(综述) Li Junling], 2012, [中国肿瘤临床, Chinese Journal of Clinical Oncology], V39, P1139; Li SC, 2011, J SCI FOOD AGR, V91, P547, DOI 10.1002/jsfa.4219; Li XH, 2001, GENET RESOUR CROP EV, V48, P189, DOI 10.1023/A:1011282109563; [李玉升 Li Yusheng], 2012, [中国肿瘤临床, Chinese Journal of Clinical Oncology], V39, P1158; Li Z., 2012, ELECT J DIFFERENTIAL, V2012, P1, DOI DOI 10.3969/J.ISSN.1674-1161.2012.01.028; Liang Y, 2006, GUANGXI AGR SCI, V37, P341, DOI [10.3969/j.issn.2095-1191.2006.04.001, DOI 10.3969/J.ISSN.2095-1191.2006.04.001]; Lim TK, 2012, EDIBLE MED NONMEDICA, V5, P243, DOI [10.1007/978-94-007-5653-3_14, DOI 10.1007/978-94-007-5653-3_14]; Lu XF, 2010, J ZHEJIANG UNIV-SC B, V11, P923, DOI 10.1631/jzus.B1000125; Lu XF, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-106; Ma KH, 2010, BIOL PLANTARUM, V54, P272, DOI 10.1007/s10535-010-0047-6; Ma X, 2008, BIOCHEM SYST ECOL, V36, P514, DOI 10.1016/j.bse.2008.03.003; MANTEL N, 1967, CANCER RES, V27, P209; MELLO LV, 1995, EUPHYTICA, V81, P217, DOI 10.1007/BF00025436; Normile D, 2003, SCIENCE, V299, P188, DOI 10.1126/science.299.5604.188; NUMATA M, 1994, PLANTA MED, V60, P356, DOI 10.1055/s-2006-959500; Nybom H, 2004, MOL ECOL, V13, P1143, DOI 10.1111/j.1365-294X.2004.02141.x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Rao PN, 2010, NUCLEUS CALCUTTA, V53, P13, DOI 10.1007/s13237-010-0013-x; Rodrigues L, 2013, BIOCHEM SYST ECOL, V50, P51, DOI 10.1016/j.bse.2013.03.007; Saidi M, 2013, MOL BIOL REP, V40, P6501, DOI 10.1007/s11033-013-2768-z; Sato K, 2010, FOOD SCI TECHNOL RES, V16, P613, DOI 10.3136/fstr.16.613; SCHAAFFHAUSEN REIMAR v., 1952, ECON BOT, V6, P216, DOI 10.1007/BF02985062; Sood A, 2015, PLANT PHYSIOL BIOCH, V94, P253, DOI 10.1016/j.plaphy.2015.06.015; Su H., 2012, FUJIAN NONGYE XUEBAO, V27, P695, DOI 10.3969/j.issn.1008-0384.2012.07.007; Tian B, 2012, GENET RESOUR CROP EV, V59, P901, DOI 10.1007/s10722-011-9732-3; Wang LF, 2012, MOLECULES, V17, P8886, DOI 10.3390/molecules17088886; [王硕 Wang Shuo], 2015, [中草药, Chinese Traditional and Herbal Drugs], V46, P112; Wang Shuo, 2013, Journal of Yunnan Agricultural University, V28, P157; [王筱菁 WANG Xiaojing], 2007, [中国骨质疏松杂志, Chinese Journal of Osteoporosis], V13, P542; Wright S, 1931, GENETICS, V16, P0097; Xiang Zhi-Min, 2005, Zhongguo Zhong Yao Za Zhi, V30, P1436; Yeh PH, 2006, INT J VITAM NUTR RES, V76, P299, DOI 10.1024/0300-9831.76.5.299; Yue W, 2008, LISHIZHEN MED MAT ME, V19, P314, DOI [10.3969/j.issn.1008-0805.2008.02.028, DOI 10.3969/J.ISSN.1008-0805.2008.02.028]; Zhang QX, 2013, BIOCHEM SYST ECOL, V48, P248, DOI 10.1016/j.bse.2012.12.024; Zhou LL, 2010, PLANT MOL BIOL, V74, P631, DOI 10.1007/s11103-010-9705-5	81	33	42	7	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0153269	10.1371/journal.pone.0153269	http://dx.doi.org/10.1371/journal.pone.0153269			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27070310	Green Published, gold			2022-12-27	WOS:000373900700044
J	Marquez-Ibarra, A; Huerta, M; Villalpando-Hernandez, S; Rios-Silva, M; Diaz-Reval, MI; Cruzblanca, H; Mancilla, E; Trujillo, X				Marquez-Ibarra, Adriana; Huerta, Miguel; Villalpando-Hernandez, Salvador; Rios-Silva, Monica; Diaz-Reval, Maria I.; Cruzblanca, Humberto; Mancilla, Evelyn; Trujillo, Xochitl			The Effects of Dietary Iron and Capsaicin on Hemoglobin, Blood Glucose, Insulin Tolerance, Cholesterol, and Triglycerides, in Healthy and Diabetic Wistar Rats	PLOS ONE			English	Article							OXIDATIVE STRESS; OVERLOAD; ANEMIA; STORES; MODEL; METABOLISM; INCREASES; RECEPTOR; LIPIDS; LIVER	Objective Our aim was to assess the effects of dietary iron, and the compound capsaicin, on hemoglobin as well as metabolic indicators including blood glucose, cholesterol, triglycerides, insulin, and glucose tolerance. Materials and Methods Our animal model was the Wistar rat, fed a chow diet, with or without experimentally induced diabetes. Diabetic males were fed control, low, or high-iron diets, the latter, with or without capsaicin. Healthy rats were fed identical diets, but without the capsaicin supplement. We then measured the parameters listed above, using the Student t-test and ANOVA, to compare groups. Results Healthy rats fed a low-iron diet exhibited significantly reduced total cholesterol and triglyceride levels, compared with rats fed a control diet. Significantly reduced blood lipid was also provoked by low dietary iron in diabetic rats, compared with those fed a control diet. Insulin, and glucose tolerance was only improved in healthy rats fed the low-iron diet. Significant increases in total cholesterol were found in diabetic rats fed a high-iron diet, compared with healthy rats fed the same diet, although no statistical differences were found for triglycerides. Hemoglobin levels, which were not statistically different in diabetic versus healthy rats fed the high-iron diet, fell when capsaicin was added. Capsaicin also provoked a fall in the level of cholesterol and triglycerides in diabetic animals, versus diabetics fed with the high iron diet alone. In conclusion, low levels of dietary iron reduced levels of serum triglycerides, hemoglobin, and cholesterol, and significantly improved insulin, and glucose tolerance in healthy rats. In contrast, a high-iron diet increased cholesterol significantly, with no significant changes to triglyceride concentrations. The addition of capsaicin to the high-iron diet (for diabetic rats) further reduced levels of hemoglobin, cholesterol, and triglycerides. These results suggest that capsaicin, may be suitable for the treatment of elevated hemoglobin, in patients.	[Marquez-Ibarra, Adriana; Huerta, Miguel; Rios-Silva, Monica; Diaz-Reval, Maria I.; Cruzblanca, Humberto; Mancilla, Evelyn; Trujillo, Xochitl] Univ Colima, Ctr Univ Invest Biomed, Unidad Invest Dr Enrico Stefani, Colima, Colima, Mexico; [Villalpando-Hernandez, Salvador] Inst Nacl Salud Publ, Ctr Invest Nutr & Salud, Univ 655 Colonia Santa Maria Ahuacatitlan, Cuernavaca, Morelos, Mexico	Universidad de Colima; Instituto Nacional de Salud Publica	Trujillo, X (corresponding author), Univ Colima, Ctr Univ Invest Biomed, Unidad Invest Dr Enrico Stefani, Colima, Colima, Mexico.	rosio@ucol.mx	Villalpando, Salvador/AAS-3874-2021; Trujillo, Xóchitl/AHC-2100-2022; Huerta, Miguel/AEP-0820-2022; Trujillo, Xochitl/P-7020-2017	Villalpando, Salvador/0000-0001-6429-3816; Trujillo, Xóchitl/0000-0001-8146-5667; Huerta, Miguel/0000-0001-8515-0777; Trujillo, Xochitl/0000-0001-7506-1674	FRABA-Universidad de Colima-Mexico; CONACyT-Mexico	FRABA-Universidad de Colima-Mexico; CONACyT-Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	FRABA-Universidad de Colima-Mexico to XT and MH, provided partial sponsorship of this research. Part of these results were part of AMI's PhD Thesis at Faculty of Medicine, Universidad de Colima, Mexico. AMI received a fellowship for PhD studies from CONACyT-Mexico.	Abd Allah Eman S H, 2014, Pathophysiology, V21, P293, DOI 10.1016/j.pathophys.2014.06.002; Alexandrakis MG, 2012, ISRN HEMATOL, DOI [10.5402/2012/246915, DOI 10.5402/2012/246915]; BOREL MJ, 1993, AM J PHYSIOL, V264, pE380, DOI 10.1152/ajpendo.1993.264.3.E380; Brunet S, 1999, HEPATOLOGY, V29, P1809, DOI 10.1002/hep.510290612; Cherng JY, 2005, LIFE SCI, V76, P3001, DOI 10.1016/j.lfs.2004.10.055; Cooksey RC, 2010, AM J PHYSIOL-ENDOC M, V298, pE1236, DOI 10.1152/ajpendo.00022.2010; de Almeida MM, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-200; Dongiovanni P, 2013, AM J PATHOL, V182, P2254, DOI 10.1016/j.ajpath.2013.02.019; Fernandez-Real JM, 2002, DIABETES, V51, P2348, DOI 10.2337/diabetes.51.8.2348; Ganz T, 2012, BBA-MOL CELL RES, V1823, P1434, DOI 10.1016/j.bbamcr.2012.01.014; Graham RM, 2010, HEPATOLOGY, V52, P462, DOI 10.1002/hep.23712; Huang JY, 2011, DIABETES, V60, P80, DOI 10.2337/db10-0593; Ikeda Y, 2013, AM J PHYSIOL-RENAL, V304, pF1028, DOI 10.1152/ajprenal.00473.2012; Jiang R, 2004, JAMA-J AM MED ASSOC, V291, P711, DOI 10.1001/jama.291.6.711; Kamei A, 2010, PHYSIOL GENOMICS, V42, P149, DOI 10.1152/physiolgenomics.00150.2009; Kempaiah RK, 2005, MOL CELL BIOCHEM, V275, P7, DOI 10.1007/s11010-005-7643-3; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kundu D, 2013, NIGER J CLIN PRACT, V16, P100, DOI 10.4103/1119-3077.106776; Lee CG, 2011, DIABETES CARE, V34, P2381, DOI 10.2337/dc11-1032; Lee CYJ, 2003, PHYTOTHER RES, V17, P454, DOI 10.1002/ptr.1172; Maaroufi K, 2009, NEUROBIOL LEARN MEM, V92, P345, DOI 10.1016/j.nlm.2009.04.002; Mehdad A, 2015, J NUTR HEALTH AGING, V19, P846, DOI 10.1007/s12603-015-0541-9; Merono T, 2011, MEDICINA-BUENOS AIRE, V71, P566; Minamiyama Y, 2010, AM J PHYSIOL-ENDOC M, V298, pE1140, DOI 10.1152/ajpendo.00620.2009; Miron VR, 2007, MOL CELL BIOCHEM, V298, P101, DOI 10.1007/s11010-006-9357-6; Panjeta Mirsad, 2015, Mater Sociomed, V27, P144, DOI 10.5455/msm.2015.27.144-148; Prakash UNS, 2013, J TRACE ELEM MED BIO, V27, P184, DOI 10.1016/j.jtemb.2012.11.003; Rajpathak SN, 2009, BBA-GEN SUBJECTS, V1790, P671, DOI 10.1016/j.bbagen.2008.04.005; Rios-Silva M, 2014, INT J MED SCI, V11, P448, DOI 10.7150/ijms.8034; Salonen JT, 1998, BRIT MED J, V317, P727, DOI 10.1136/bmj.317.7160.727; Smotra S, 2008, JK SCI, V10, P170; SRINIVASAN MR, 1992, INDIAN J MED RES-B, V96, P133; TAI MM, 1994, DIABETES CARE, V17, P152, DOI 10.2337/diacare.17.2.152; Tang N, 2014, FOOD FUNCT, V5, P390, DOI 10.1039/c3fo60292c; Thomas MC, 2003, DIABETES CARE, V26, P1164, DOI 10.2337/diacare.26.4.1164; Thompson K, 2006, TOXICOL APPL PHARM, V210, P17, DOI 10.1016/j.taap.2005.05.014; Uchida K, 2011, ENDOCR J, V58, P1021, DOI 10.1507/endocrj.EJ11-0130; Whittaker P, 2001, BRIT J NUTR, V86, P587, DOI 10.1079/BJN2001439; Zhang SY, 2014, OBES SURG, V24, P405, DOI 10.1007/s11695-013-1103-z; Zhao ZX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041641; ZHOU XF, 1990, BRIT J PHARMACOL, V100, P523, DOI 10.1111/j.1476-5381.1990.tb15840.x; Zolghadri Y, 2014, INT J MOL CELL MED, V3, P255	42	21	21	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2016	11	4							e0152625	10.1371/journal.pone.0152625	http://dx.doi.org/10.1371/journal.pone.0152625			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0KH	27064411	gold, Green Published, Green Submitted			2022-12-27	WOS:000373891000014
J	Baiden, F; Bruce, J; Webster, J; Tivura, M; Delmini, R; Amengo-Etego, S; Owusu-Agyei, S; Chandramohan, D				Baiden, Frank; Bruce, Jane; Webster, Jayne; Tivura, Mathilda; Delmini, Rupert; Amengo-Etego, Seeba; Owusu-Agyei, Seth; Chandramohan, Daniel			Effect of Test-Based versus Presumptive Treatment of Malaria in Under-Five Children in Rural Ghana - A Cluster-Randomised Trial	PLOS ONE			English	Article							RAPID DIAGNOSTIC-TESTS; ASYMPTOMATIC PARASITEMIA; INFANTS; SAFETY; COHORT; TIME; AREA	Background Malaria-endemic countries in sub-Saharan Africa are shifting from the presumptive approach that is based on clinical judgement (CJ) to the test-based approach that is based on confirmation through test with rapid diagnostic tests (RDT). It has been suggested that the loss of the prophylactic effect of presumptive-administered ACT in children who do not have malaria will result in increase in their risk of malaria and anaemia. Methods and Findings We undertook a cluster-randomized controlled trial to compare the effects of the presumptive approach using clinical judgment (CJ-arm) and the test-based approach using RDTs (RDT-arm in a high-transmission setting in Ghana. A total of 3046 eligible children (1527 in the RDT arm and 1519 in the CJ-arm) living around 32 health centres were enrolled. Nearly half were female (48.7%) and 47.8% were below the age of 12 months as at enrolment. Over 24-months, the incidence of all episodes of malaria following the first febrile illness was 0.64 (95% CI 0.49-0.82) and 0.76 (0.63-0.93) per child per year in the RDT and CJ arms respectively (adjusted rate ratio 1.13 (0.82-1.55). After the first episode of febrile illness, the incidence of severe anaemia was the same in both arms (0.11 per child per year) and that of moderate anaemia was 0.16 (0.13-0.21) vs. 0.17 (0.14-0.21) per child year respectively. The incidence of severe febrile illness was 0.15 (0.09, 0.24) in the RDT arm compared to 0.17 (0.11, 0.28) per child per year respectively. The proportion of fever cases receiving ACT was lower in the RDT arm (72% vs 81%; p = 0.02). Conclusion The test-based approach to the management of malaria did not increase the incidence of malaria or anaemia among under-five children in this setting.	[Baiden, Frank] Ensign Coll Publ Hlth, Epidemiol Unit, Kpong, Eastern Region, Ghana; [Bruce, Jane; Webster, Jayne; Owusu-Agyei, Seth; Chandramohan, Daniel] Univ London London Sch Hyg & Trop Med, Dept Dis Control, Keppel St, London WC1E 7HT, England; [Tivura, Mathilda; Delmini, Rupert; Amengo-Etego, Seeba; Owusu-Agyei, Seth] ACT Trial Team, Kintampo Hlth Res Ctr, Kintampo, Brong Ahafo Reg, Ghana	University of London; London School of Hygiene & Tropical Medicine; Kintampo Health Research Centre	Baiden, F (corresponding author), Ensign Coll Publ Hlth, Epidemiol Unit, Kpong, Eastern Region, Ghana.	baidenf@gmail.com	Baiden, Frank/AAF-7309-2020; Baiden, Frank/Q-2018-2019	Baiden, Frank/0000-0003-0141-6561; Owusu-Agyei, Seth/0000-0002-0807-1781; Webster, Jayne/0000-0002-0498-8883	ACT Consortium through a grant from the Bill and Melinda Gates Foundation; Robert S. McNamara Fellowship Program at the World Bank	ACT Consortium through a grant from the Bill and Melinda Gates Foundation; Robert S. McNamara Fellowship Program at the World Bank	This research was funded by the ACT Consortium (www.actconsortium.org) through a grant from the Bill and Melinda Gates Foundation to the London School of Hygiene and Tropical Medicine. Frank Baiden is supported by a grant from the Robert S. McNamara Fellowship Program at the World Bank. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], NAT REV MICROB S SEP; [Anonymous], NAT REV MICROB S SEP; [Anonymous], LANCET; Aponte JJ, 2009, LANCET, V374, P1533, DOI 10.1016/S0140-6736(09)61258-7; Baiden F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045556; Baiden F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034073; Bell D, 2008, T ROY SOC TROP MED H, V102, P1064, DOI 10.1016/j.trstmh.2008.05.007; Bisoffi Z, 2009, TROP MED INT HEALTH, V14, P491, DOI 10.1111/j.1365-3156.2009.02246.x; Chandramohan D, 2005, BMJ-BRIT MED J, V331, P727, DOI 10.1136/bmj.331.7519.727; d'Acremont V, 2010, CLIN INFECT DIS, V51, P506, DOI 10.1086/655688; D'Acremont V, 2009, PLOS MED, V6, P4, DOI 10.1371/journal.pmed.0050252; Gosling RD, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-132; Ishengoma DS, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-176; Lubell Y, 2007, AM J TROP MED HYG, V77, P128, DOI 10.4269/ajtmh.2007.77.128; Maude RJ, 2010, INT HEALTH, V2, P239, DOI 10.1016/j.inhe.2010.09.005; Msellem MI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000070; Mtove G, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-290; Njama-Meya D, 2004, TROP MED INT HEALTH, V9, P862, DOI 10.1111/j.1365-3156.2004.01277.x; Njama-Meya D, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-7; Olliaro P, 2008, TROP MED INT HEALTH, V13, P83, DOI 10.1111/j.1365-3156.2007.01977.x; Owusu-Agyei S, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-220; Peeling RW, 2010, CLIN MICROBIOL INFEC, V16, P1062, DOI 10.1111/j.1469-0691.2010.03279.x; Schellenberg D, 2001, LANCET, V357, P1471, DOI 10.1016/S0140-6736(00)04643-2; WHO, 2012, WORLD MALARIA REPORT 2012, P1; WHO, 2010, GUID TREATM MAL, V2nd; Wongsrichanalai C, 2008, EMERG INFECT DIS, V14, P716, DOI 10.3201/eid1405.071601; World Health Organization Department of Child Adolescent Health World Health Organization and UNICEF, 2005, HDB IMCI INT MAN CHI	27	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0152960	10.1371/journal.pone.0152960	http://dx.doi.org/10.1371/journal.pone.0152960			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27055275	Green Accepted, gold, Green Published			2022-12-27	WOS:000373608000058
J	Blattmann, P; Heusel, M; Aebersold, R				Blattmann, Peter; Heusel, Moritz; Aebersold, Ruedi			SWATH2stats: An R/Bioconductor Package to Process and Convert Quantitative SWATH-MS Proteomics Data for Downstream Analysis Tools	PLOS ONE			English	Article							MASS-SPECTROMETRY; STATISTICAL-ANALYSIS; R-PACKAGE	SWATH-MS is an acquisition and analysis technique of targeted proteomics that enables measuring several thousand proteins with high reproducibility and accuracy across many samples. OpenSWATH is popular open-source software for peptide identification and quantification from SWATH-MS data. For downstream statistical and quantitative analysis there exist different tools such as MSstats, mapDIA and aLFQ. However, the transfer of data from OpenSWATH to the downstream statistical tools is currently technically challenging. Here we introduce the R/Bioconductor package SWATH2stats, which allows convenient processing of the data into a format directly readable by the downstream analysis tools. In addition, SWATH2stats allows annotation, analyzing the variation and the reproducibility of the measurements, FDR estimation, and advanced filtering before submitting the processed data to downstream tools. These functionalities are important to quickly analyze the quality of the SWATH-MS data. Hence, SWATH2stats is a new open-source tool that summarizes several practical functionalities for analyzing, processing, and converting SWATH-MS data and thus facilitates the efficient analysis of large-scale SWATH/DIA datasets.	[Blattmann, Peter; Heusel, Moritz; Aebersold, Ruedi] ETH, Inst Mol Syst Biol, Dept Biol, CH-8093 Zurich, Switzerland; [Heusel, Moritz] ETH, Competence Ctr Personalized Med UZH ETH, PhD Program Mol & Translat Biomed, CH-8044 Zurich, Switzerland; [Heusel, Moritz] ETH, Life Sci Zurich Grad Sch, CH-8044 Zurich, Switzerland; [Heusel, Moritz] Univ Zurich, CH-8044 Zurich, Switzerland; [Aebersold, Ruedi] Univ Zurich, Fac Sci, CH-8057 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University of Zurich	Blattmann, P (corresponding author), ETH, Inst Mol Syst Biol, Dept Biol, CH-8093 Zurich, Switzerland.	blattmann@imsb.biol.ethz.ch	Blattmann, Peter/D-2880-2012	Blattmann, Peter/0000-0001-9105-6381	Swiss SystemsX.ch initiative; European research council [233226-PROTEOMICS v3.0]; Institut Merieux; Swiss National Science Foundation [3100A0-130530]; Advanced ERC grant [670821]; ETH Zurich; SystemsX.ch	Swiss SystemsX.ch initiative; European research council(European Research Council (ERC)European Commission); Institut Merieux; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Advanced ERC grant; ETH Zurich(ETH Zurich); SystemsX.ch	This work was supported by the Swiss SystemsX.ch initiative, evaluated by the Swiss National Science Foundation, to PB. MH was supported by grants from the European research council [233226-PROTEOMICS v3.0] and the Institut Merieux to RA. The RA group is supported by the Swiss National Science Foundation [3100A0-130530], Advanced ERC grant [#670821], ETH Zurich and SystemsX.ch. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Choi H, 2008, J PROTEOME RES, V7, P47, DOI 10.1021/pr700747q; Choi M, 2014, BIOINFORMATICS, V30, P2524, DOI 10.1093/bioinformatics/btu305; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gillet LC, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.O111.016717; Lam H, 2010, J PROTEOME RES, V9, P605, DOI 10.1021/pr900947u; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Picotti P, 2012, NAT METHODS, V9, P555, DOI [10.1038/NMETH.2015, 10.1038/nmeth.2015]; Reiter L, 2011, NAT METHODS, V8, P430, DOI [10.1038/NMETH.1584, 10.1038/nmeth.1584]; Reiter L, 2009, MOL CELL PROTEOMICS, V8, P2405, DOI 10.1074/mcp.M900317-MCP200; Rost HL, 2014, NAT BIOTECHNOL, V32, P219, DOI 10.1038/nbt.2841; Rosenberger G, 2014, BIOINFORMATICS, V30, P2511, DOI 10.1093/bioinformatics/btu200; Serang O, 2015, J PROTEOME RES, V14, P4099, DOI 10.1021/acs.jproteome.5b00568; Teleman J, 2015, BIOINFORMATICS, V31, P555, DOI 10.1093/bioinformatics/btu686; Teo GS, 2015, J PROTEOMICS, V129, P108, DOI 10.1016/j.jprot.2015.09.013; Tsou CC, 2015, NAT METHODS, V12, P258, DOI [10.1038/NMETH.3255, 10.1038/nmeth.3255]; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wickham H, 2007, J STAT SOFTW, V21, P1	18	29	29	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153160	10.1371/journal.pone.0153160	http://dx.doi.org/10.1371/journal.pone.0153160			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27054327	Green Submitted, Green Published, gold			2022-12-27	WOS:000373608000091
J	Vera, F; Rivera, R; Romero-Maltrana, D; Villanueva, J				Vera, Francisco; Rivera, Rodrigo; Romero-Maltrana, Diego; Villanueva, Jaime			Negative Pressures and the First Water Siphon Taller than 10.33 Meters	PLOS ONE			English	Article							SURFACE-TENSION; PATTERNS; SAP	A siphon is a device that is used to drain a container, with water rising inside a hose in the form of an inverted U and then going down towards a discharge point placed below the initial water level. The siphon is the first of a number of inventions of the ancients documented about 2.000 years ago by Hero of Alexandria in his treatise Pneumatics, and although the explanation given by Hero was essentially correct, there is nowadays a controversy about the underlying mechanism that explains the working of this device. Discussions concerning the physics of a siphon usually refer to concepts like absolute negative pressures, the strength of liquid's cohesion and the possibility of a siphon working in vacuum or in the presence of bubbles. Torricelli understood the working principle of the barometer and the impossibility of pumping water out of wells deeper than 10.33 m. Following Torricelli's ideas it would also not be possible to build a siphon that drives pure water to ascend higher than 10.33 m. In this work, we report the first siphon that drives water (with surfactant) to ascend higher than the Torricellian limit. Motivated by the rising of sap in trees, we built a 15.4 m siphon that shows that absolute negative pressures are not prohibited, that cohesion plays an important role in transmitting forces through a fluid, and that surfactants can help to the transport of water in a metastable regime of negative pressures.	[Vera, Francisco; Rivera, Rodrigo; Romero-Maltrana, Diego; Villanueva, Jaime] Pontificia Univ Catolica Valparaiso, Inst Fis, Valparaiso, Chile	Pontificia Universidad Catolica de Valparaiso	Vera, F (corresponding author), Pontificia Univ Catolica Valparaiso, Inst Fis, Valparaiso, Chile.	francisco.vera.ucv@gmail.com		Maltrana, Diego/0000-0003-2550-5243; Vera, Francisco/0000-0002-6272-7390	FONDECYT [1151257, 1151169]; DGIP-PUCV	FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); DGIP-PUCV	The authors would like to acknowledge financial support from FONDECYT Projects 1151257 and 1151169, and DGIP-PUCV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boatwright AL, 2011, J CHEM EDUC, V88, P1547, DOI 10.1021/ed2001818; Brodersen CR, 2010, PLANT PHYSIOL, V154, P1088, DOI 10.1104/pp.110.162396; Brown HR, 2013, PHYS PERSPECT, V15, P320, DOI 10.1007/s00016-013-0117-1; Caupin F, 2006, CR PHYS, V7, P1000, DOI 10.1016/j.crhy.2006.10.015; Christensen-Dalsgaard KK, 2011, TREE PHYSIOL, V31, P361, DOI 10.1093/treephys/tpr018; Dikici B, 2014, J THERM ANAL CALORIM, V116, P1387, DOI 10.1007/s10973-013-3634-x; Domec JC, 2011, TREE PHYSIOL, V31, P359, DOI 10.1093/treephys/tpr039; Duane W, 1902, SCIENCE, V15, P152, DOI 10.1126/science.15.369.152; HAYWARD ATJ, 1971, AM SCI, V59, P434; HAYWARD ATJ, 1970, NATURE, V225, P376, DOI 10.1038/225376b0; Hetsroni G, 2001, INT J HEAT MASS TRAN, V44, P485, DOI 10.1016/S0017-9310(00)00099-5; Holbrook NM, 2008, PHYS TODAY, V76; Hughes Stephen W., 2010, Physics Education, V45, P162, DOI 10.1088/0031-9120/45/2/006; Hughes S, 2014, SCI REP-UK, V4, DOI 10.1038/srep04741; KELL GS, 1983, AM J PHYS, V51, P1038, DOI 10.1119/1.13353; Liger-Belair G, 2005, J PHYS CHEM B, V109, P14573, DOI 10.1021/jp051650y; Minor R. S, 1914, SCH SCI MATH, V12, P152, DOI [10.1111/j.1949-8594.1914.tb16014.x, DOI 10.1111/J.1949-8594.1914.TB16014.X]; Planinsic Gorazd, 2010, Physics Education, V45, P356, DOI 10.1088/0031-9120/45/4/005; Polidori G, 2009, AM SCI, V97, P294, DOI 10.1511/2009.79.294; Potter A., 1971, Physics Education, V6, P362, DOI 10.1088/0031-9120/6/5/005; Ramette Joshua J., 2011, Physics Education, V46, P412, DOI 10.1088/0031-9120/46/4/006; Richert Alex, 2011, Physics Teacher, V49, P78, DOI 10.1119/1.3543576; Tyree M. T., 2002, SPR S WOOD; Tyree MT, 2003, NATURE, V423, P923, DOI 10.1038/423923a; Woodcroft B., 1851, PNEUMATICS HERO ALEX, P11; Wright K, 2003, DISCOVERY MAGAZI MAR; Zwieniecki MA, 2009, TRENDS PLANT SCI, V14, P530, DOI 10.1016/j.tplants.2009.07.002	27	10	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153055	10.1371/journal.pone.0153055	http://dx.doi.org/10.1371/journal.pone.0153055			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27054847	Green Published, gold			2022-12-27	WOS:000373608000070
J	Wen, Y; Alshikho, MJ; Herbert, MR				Wen, Ya; Alshikho, Mohamad J.; Herbert, Martha R.			Pathway Network Analyses for Autism Reveal Multisystem Involvement, Major Overlaps with Other Diseases and Convergence upon MAPK and Calcium Signaling	PLOS ONE			English	Article							PROTEIN-KINASE-C; SET ENRICHMENT ANALYSIS; SPECTRUM DISORDERS; SFARI GENE; RISK; DYSFUNCTION; ACTIVATION; PREVALENCE; METABOLISM; MUTATIONS	We used established databases in standard ways to systematically characterize gene ontologies, pathways and functional linkages in the large set of genes now associated with autism spectrum disorders (ASDs). These conditions are particularly challenging-they lack clear pathognomonic biological markers, they involve great heterogeneity across multiple levels (genes, systemic biological and brain characteristics, and nuances of behavioral manifestations)-and yet everyone with this diagnosis meets the same defining behavioral criteria. Using the human gene list from Simons Foundation Autism Research Initiative (SFARI) we performed gene set enrichment analysis with the Kyoto Encyclopedia of Genes and Genomes (KEGG) Pathway Database, and then derived a pathway network from pathway-pathway functional interactions again in reference to KEGG. Through identifying the GO (Gene Ontology) groups in which SFARI genes were enriched, mapping the coherence between pathways and GO groups, and ranking the relative strengths of representation of pathway network components, we 1) identified 10 disease-associated and 30 function-associated pathways 2) revealed calcium signaling pathway and neuroactive ligand-receptor interaction as themost enriched, statistically significant pathways from the enrichment analysis, 3) showed calcium signaling pathways and MAPK signaling pathway to be interactive hubs with other pathways and also to be involved with pervasively present biological processes, 4) found convergent indications that the process "calcium-PRC (protein kinase C)-Ras-Raf-MAPK/ERK" is likely a major contributor to ASD pathophysiology, and 5) noted that perturbations associated with KEGG's category of environmental information processing were common. These findings support the idea that ASD-associated genes may contribute not only to core features of ASD themselves but also to vulnerability to other chronic and systemic problems potentially including cancer, metabolic conditions and heart diseases. ASDsmay thus arise, or emerge, from underlying vulnerabilities related to pleiotropic genes associated with pervasively important molecular mechanisms, vulnerability to environmental input andmultiple systemic co-morbidities.	[Wen, Ya; Alshikho, Mohamad J.; Herbert, Martha R.] Massachusetts Gen Hosp, Dept Neurol, TRANSCEND Res, Charlestown, MA USA; [Wen, Ya; Alshikho, Mohamad J.; Herbert, Martha R.] Harvard Univ, Sch Med, Boston, MA USA; [Wen, Ya; Herbert, Martha R.] Higher Synth Fdn, Cambridge, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Wen, Y; Herbert, MR (corresponding author), Massachusetts Gen Hosp, Dept Neurol, TRANSCEND Res, Charlestown, MA USA.; Wen, Y; Herbert, MR (corresponding author), Harvard Univ, Sch Med, Boston, MA USA.; Wen, Y; Herbert, MR (corresponding author), Higher Synth Fdn, Cambridge, MA USA.	ywen3@mgh.harvard.edu; martha.herbert@mgh.harvard.edu	Wen, Ya/M-6341-2016	Wen, Ya/0000-0003-0134-8853; /0000-0002-5420-4223				Abrahams BS, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-36; Adviento B, 2014, J MED GENET, V51, P10, DOI 10.1136/jmedgenet-2013-101951; Araki SI, 2003, J AM SOC NEPHROL, V14, P2015, DOI 10.1097/01.ASN.0000077347.27669.5C; Banerjee-Basu S, 2010, DIS MODEL MECH, V3, P133, DOI 10.1242/dmm.005439; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Bilder DA, 2013, PEDIATRICS, V132, pE1276, DOI 10.1542/peds.2013-1188; Cartwright EJ, 2011, BIOFACTORS, V37, P175, DOI 10.1002/biof.149; Catterall WA, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003947; Chibber R, 2003, DIABETES, V52, P1519, DOI 10.2337/diabetes.52.6.1519; Corrales MA, 2011, AUTISM ENV GENOMICS; Cristino AS, 2014, MOL PSYCHIATR, V19, P294, DOI 10.1038/mp.2013.16; Darling N.J., 2014, SCI REP-UK, V1843, P2150, DOI DOI 10.1016/J.BBAMCR.2014.01.009; De Rubeis S, 2014, NATURE, V515, P209, DOI 10.1038/nature13772; DeBerardinis RJ, 2008, GENET MED, V10, P267, DOI 10.1097/GIM.0b013e31818b0d9b; Dhandapany PS, 2014, NAT GENET, V46, P635, DOI 10.1038/ng.2963; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Ebert DH, 2013, NATURE, V493, P327, DOI 10.1038/nature11860; Egan AM, 2013, CHILD OBES, V9, P125, DOI 10.1089/chi.2012.0028; Faridar A, 2014, MOL AUTISM, V5, DOI 10.1186/2040-2392-5-57; Gardener H, 2009, BRIT J PSYCHIAT, V195, P7, DOI 10.1192/bjp.bp.108.051672; Gehart H, 2010, EMBO REP, V11, P834, DOI 10.1038/embor.2010.160; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Hertz-Picciotto I, 2009, EPIDEMIOLOGY, V20, P84, DOI 10.1097/EDE.0b013e3181902d15; Hoischen A, 2014, NAT NEUROSCI, V17, P764, DOI 10.1038/nn.3703; Idris I, 2001, DIABETOLOGIA, V44, P659, DOI 10.1007/s001250051675; Kalkman HO, 2012, NEUROSCI BIOBEHAV R, V36, P2206, DOI 10.1016/j.neubiorev.2012.07.008; King M, 2009, INT J EPIDEMIOL, V38, P1224, DOI 10.1093/ije/dyp261; Kohane IS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033224; Krakowiak P, 2012, PEDIATRICS, V129, pE1121, DOI 10.1542/peds.2011-2583; Kranias E. G., 2007, V45, P523; Lam KSL, 2006, RES DEV DISABIL, V27, P254, DOI 10.1016/j.ridd.2005.03.003; Li L, 2013, EVID-BASED COMPL ALT, V2013, P1, DOI DOI 10.1155/2013/467245; Liebmann C, 2001, CELL SIGNAL, V13, P777, DOI 10.1016/S0898-6568(01)00192-9; Lu ATH, 2012, MOL AUTISM, V3, DOI 10.1186/2040-2392-3-18; Mascia F, 2012, J INVEST DERMATOL, V132, P811, DOI 10.1038/jid.2011.406; McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001; Ming X, 2005, BRAIN DEV-JPN, V27, P509, DOI 10.1016/j.braindev.2005.01.003; Ouwenga RL, 2015, MOL AUTISM, V6, DOI 10.1186/s13229-015-0008-1; Pao GM, 2014, P NATL ACAD SCI USA, V111, pE1240, DOI 10.1073/pnas.1400783111; Parikshak NN, 2013, CELL, V155, P1008, DOI 10.1016/j.cell.2013.10.031; Pucilowska J, 2015, J NEUROSCI, V35, P3190, DOI 10.1523/JNEUROSCI.4864-13.2015; Razzaque MA, 2007, NAT GENET, V39, P1013, DOI 10.1038/ng2078; Ronan JL, 2013, NAT REV GENET, V14, P440, DOI 10.1038/nrg3508; Rossignol DA, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.4; Sakai Y, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002166; Sandin S, 2014, JAMA-J AM MED ASSOC, V311, P1770, DOI 10.1001/jama.2014.4144; Shao B, 2013, DIABETES OBES METAB, V15, P993, DOI 10.1111/dom.12120; Skafidas E, 2014, MOL PSYCHIATR, V19, P504, DOI 10.1038/mp.2012.126; Splawski I, 2004, CELL, V119, P19, DOI 10.1016/j.cell.2004.09.011; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tyler CV, 2011, AJIDD-AM J INTELLECT, V116, P371, DOI 10.1352/1944-7558-116.5.371; Vivar JC, 2013, OMICS, V17, P414, DOI 10.1089/omi.2012.0083; Wallace JA, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00087; Wittkowski KM, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2013.124	54	80	83	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153329	10.1371/journal.pone.0153329	http://dx.doi.org/10.1371/journal.pone.0153329			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DI6KO	27055244	Green Published, gold			2022-12-27	WOS:000373608000121
J	Imamura, Y; Haruta, M; Tomita, Y; Matsumura, K; Ikeda, T; Yuno, A; Hirayama, M; Nakayama, H; Mizuta, H; Nishimura, Y; Senju, S				Imamura, Yuya; Haruta, Miwa; Tomita, Yusuke; Matsumura, Keiko; Ikeda, Tokunori; Yuno, Akira; Hirayama, Masatoshi; Nakayama, Hideki; Mizuta, Hiroshi; Nishimura, Yasuharu; Senju, Satoru			Generation of Large Numbers of Antigen-Expressing Human Dendritic Cells Using CD14-ML Technology	PLOS ONE			English	Article							CANCER PATIENTS; PEPTIDE VACCINE; IDENTIFICATION; EPITOPES; MATURATION; RESPONSES; MELANOMA; TRIAL; LUNG; CTL	We previously reported a method to expand human monocytes through lentivirus-mediated introduction of cMYC and BMI1, and we named the monocyte-derived proliferating cells, CD14-ML. CD14-ML differentiated into functional DC (CD14-ML-DC) upon addition of IL-4, resulting in the generation of a large number of DC. One drawback of this method was the extensive donor-dependent variation in proliferation efficiency. In the current study, we found that introduction of BCL2 or LYL1 along with cMYC and BMI1 was beneficial. Using the improved method, we obtained CD14-ML from all samples, regardless of whether the donors were healthy individuals or cancer patients. In vitro stimulation of peripheral blood T cells with CD14-ML-DC that were loaded with cancer antigen-derived peptides led to the establishment of CD4(+) and CD8(+) T cell lines that recognized the peptides. Since CD14-ML was propagated for more than 1 month, we could readily conduct genetic modification experiments. To generate CD14-ML-DC that expressed antigenic proteins, we introduced lentiviral antigen-expression vectors and subjected the cells to 2 weeks of culture for drug-selection and expansion. The resulting antigen-expressing CD14-ML-DC successfully induced CD8+ T cell lines that were reactive to CMVpp65 or MART1/MelanA, suggesting an application in vaccination therapy. Thus, this improved method enables the generation of a sufficient number of DC for vaccination therapy from a small amount of peripheral blood from cancer patients. Information on T cell epitopes is not necessary in vaccination with cancer antigen-expressing CD14-ML-DC; therefore, all patients, irrespective of HLA type, will benefit from anti-cancer therapy based on this technology.	[Imamura, Yuya; Haruta, Miwa; Tomita, Yusuke; Matsumura, Keiko; Ikeda, Tokunori; Yuno, Akira; Hirayama, Masatoshi; Nishimura, Yasuharu; Senju, Satoru] Kumamoto Univ, Grad Sch Med Sci, Dept Immunogenet, Kumamoto, Japan; [Imamura, Yuya; Mizuta, Hiroshi] Kumamoto Univ, Fac Life Sci, Dept Orthopaed Surg, Kumamoto, Japan; [Tomita, Yusuke] Kumamoto Univ, Fac Life Sci, Dept Resp Med, Kumamoto, Japan; [Ikeda, Tokunori] Kumamoto Univ, Fac Life Sci, Dept Neurol, Kumamoto, Japan; [Yuno, Akira; Hirayama, Masatoshi; Nakayama, Hideki] Kumamoto Univ, Fac Life Sci, Dept Oral & Maxillofacal Surg, Kumamoto, Japan	Kumamoto University; Kumamoto University; Kumamoto University; Kumamoto University; Kumamoto University	Senju, S (corresponding author), Kumamoto Univ, Grad Sch Med Sci, Dept Immunogenet, Kumamoto, Japan.	senjusat@gpo.kumamoto-u.ac.jp	Ikeda, Tokunori/S-6043-2019		Japan Society for the Promotion of Science [24300334, 26290057, 15H04311, 23650609, 25640091]; Grants-in-Aid for Scientific Research [25640091, 16H06498] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Grants-in-Aid for Scientific Research from Japan Society for the Promotion of Science (24300334, 26290057, 15H04311) and Grant-in-Aid for the Challenging Exploratory Research from Japan Society for the Promotion of Science (23650609, 25640091). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	FREUDENTHAL PS, 1990, P NATL ACAD SCI USA, V87, P7698, DOI 10.1073/pnas.87.19.7698; Harao M, 2008, INT J CANCER, V123, P2616, DOI 10.1002/ijc.23823; Hardy MY, 2009, IMMUNOL CELL BIOL, V87, P606, DOI 10.1038/icb.2009.44; Haruta M, 2013, HUM IMMUNOL, V74, P1400, DOI 10.1016/j.humimm.2013.05.017; Imai K, 2011, BRIT J CANCER, V104, P300, DOI 10.1038/sj.bjc.6606052; Itoh T, 2003, CANCER IMMUNOL IMMUN, V52, P207, DOI 10.1007/s00262-002-0337-8; KAWAKAMI Y, 1994, J EXP MED, V180, P347, DOI 10.1084/jem.180.1.347; Kotsakis A, 2014, LUNG CANCER, V86, P59, DOI 10.1016/j.lungcan.2014.07.018; Kuroki H, 2003, CANCER IMMUNOL IMMUN, V52, P561, DOI 10.1007/s00262-003-0394-7; Kuzushima K, 2001, BLOOD, V98, P1872, DOI 10.1182/blood.V98.6.1872; Kyte JA, 2006, CANCER GENE THER, V13, P905, DOI 10.1038/sj.cgt.7700961; Miyoshi H, 1998, J VIROL, V72, P8150, DOI 10.1128/JVI.72.10.8150-8157.1998; Nakahara S, 2003, CANCER RES, V63, P4112; Orsini G, 2013, INT J MOL SCI, V14, P22022, DOI 10.3390/ijms141122022; Osawa R, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/848042; Schwartzentruber DJ, 2011, NEW ENGL J MED, V364, P2119, DOI 10.1056/NEJMoa1012863; Senju S, 2011, GENE THER, V18, P874, DOI 10.1038/gt.2011.22; Staff C, 2011, VACCINE, V29, P6817, DOI 10.1016/j.vaccine.2010.12.063; Su Z, 2003, CANCER RES, V63, P2127; Suda T, 2007, CANCER SCI, V98, P1803, DOI 10.1111/j.1349-7006.2007.00603.x; Sundarasetty BS, 2015, GENE THER, V22, P707, DOI 10.1038/gt.2015.43; Tabata H, 1998, HUM IMMUNOL, V59, P549, DOI 10.1016/S0198-8859(98)00050-0; Tomita Y, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/onci.28100; Tomita Y, 2014, INT J CANCER, V134, P352, DOI 10.1002/ijc.28376; Tomita Y, 2013, CLIN CANCER RES, V19, P4508, DOI 10.1158/1078-0432.CCR-13-0197; Tomita Y, 2011, CANCER SCI, V102, P71, DOI 10.1111/j.1349-7006.2010.01780.x; Triozzi PL, 2005, J IMMUNOTHER, V28, P382, DOI 10.1097/01.cji.0000162779.88687.4c; Uemura Y, 2003, J IMMUNOL, V170, P947, DOI 10.4049/jimmunol.170.2.947; VANVOORHIS WC, 1982, J EXP MED, V155, P1172, DOI 10.1084/jem.155.4.1172; Yoshikawa T, 2011, CANCER SCI, V102, P918, DOI 10.1111/j.1349-7006.2011.01896.x; Yoshitake Y, 2015, CLIN CANCER RES, V21, P312, DOI 10.1158/1078-0432.CCR-14-0202	31	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0152384	10.1371/journal.pone.0152384	http://dx.doi.org/10.1371/journal.pone.0152384			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050553	Green Submitted, Green Published, gold			2022-12-27	WOS:000373603500036
J	Kodumudi, KN; Siegel, J; Weber, AM; Scott, E; Sarnaik, AA; Pilon-Thomas, S				Kodumudi, Krithika N.; Siegel, Jessica; Weber, Amy M.; Scott, Ellen; Sarnaik, Amod A.; Pilon-Thomas, Shari			Immune Checkpoint Blockade to Improve Tumor Infiltrating Lymphocytes for Adoptive Cell Therapy	PLOS ONE			English	Article							T-LYMPHOCYTES; LAG-3; LIVER	Tumor-infiltrating lymphocytes (TIL) has been associated with improved survival in cancer patients. Within the tumor microenvironment, regulatory cells and expression of co-inhibitory immune checkpoint molecules can lead to the inactivation of TIL. Hence, there is a need to develop strategies that disrupt these negative regulators to achieve robust antitumor immune responses. We evaluated the blockade of immune checkpoints and their effect on T cell infiltration and function. We examined the ability of TIL to induce tumor-specific immune responses in vitro and in vivo. TIL isolated from tumor bearing mice were tumor-specific and expressed co-inhibitory immune checkpoint molecules. Administration of monoclonal antibodies against immune checkpoints led to a significant delay in tumor growth. However, anti-PD-L1 antibody treated mice had a significant increase in T cell infiltration and IFN-gamma production compared to other groups. Adoptive transfer of in vitro expanded TIL from tumors of anti-PD-L1 antibody treated mice led to a significant delay in tumor growth. Blockade of co-inhibitory immune checkpoints could be an effective strategy to improve TIL infiltration and function.	[Kodumudi, Krithika N.; Siegel, Jessica; Weber, Amy M.; Scott, Ellen; Sarnaik, Amod A.; Pilon-Thomas, Shari] H Lee Moffitt Canc Ctr & Res Inst, Dept Immunol, 12902 Magnolia Dr,SRB 3,Room 24314, Tampa, FL 33612 USA	H Lee Moffitt Cancer Center & Research Institute	Pilon-Thomas, S (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Dept Immunol, 12902 Magnolia Dr,SRB 3,Room 24314, Tampa, FL 33612 USA.	Shari.Pilon-Thomas@moffitt.org	Sarnaik, Amod/W-5536-2019	Scott, Ellen/0000-0003-1933-9779	Phi Beta Psi sorority award; Flow Cytometry Core Facility at the H. Lee Moffitt Cancer Center & Research Institute; an NCI designated Comprehensive Cancer Center [P30-CA076292]; NCI-K23 award [K23 CA178083-01]; Miles for Moffitt award; NATIONAL CANCER INSTITUTE [P30CA076292, K23CA178083] Funding Source: NIH RePORTER	Phi Beta Psi sorority award; Flow Cytometry Core Facility at the H. Lee Moffitt Cancer Center & Research Institute; an NCI designated Comprehensive Cancer Center; NCI-K23 award; Miles for Moffitt award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the research grant to Krithika Kodumudi by a Phi Beta Psi sorority award and in part by the Flow Cytometry Core Facility at the H. Lee Moffitt Cancer Center & Research Institute; an NCI designated Comprehensive Cancer Center (P30-CA076292). This work was also supported, in part, by a NCI-K23 award (Amod Sarnaik, K23 CA178083-01) and Miles for Moffitt award to Shari Pilon-Thomas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abiko K, 2013, CLIN CANCER RES, V19, P1363, DOI 10.1158/1078-0432.CCR-12-2199; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Brahmer JR, 2010, J CLIN ONCOL, V28, P3167, DOI 10.1200/JCO.2009.26.7609; Camisaschi C, 2014, J INVEST DERMATOL, V134, P1893, DOI 10.1038/jid.2014.29; Camisaschi C, 2010, J IMMUNOL, V184, P6545, DOI 10.4049/jimmunol.0903879; Chacon JA, ONCOIMMUNOLOGY, V2; Curran MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019499; Demeure CE, 2001, EUR J CANCER, V37, P1709, DOI 10.1016/S0959-8049(01)00184-8; Dudley ME, 2008, J CLIN ONCOL, V26, P5233, DOI 10.1200/JCO.2008.16.5449; Dudley ME, 2003, J IMMUNOTHER, V26, P332, DOI 10.1097/00002371-200307000-00005; Duraiswamy J, 2013, CANCER RES, V73, P3591, DOI 10.1158/0008-5472.CAN-12-4100; Gros A, 2014, J CLIN INVEST, V124, P2246, DOI [10.1172/JC173639, 10.1172/JCI73639]; Grosso JF, 2007, J CLIN INVEST, V117, P3383, DOI 10.1172/JCI31184; Huang CT, 2004, IMMUNITY, V21, P503, DOI 10.1016/j.immuni.2004.08.010; Katz SC, 2009, ANN SURG ONCOL, V16, P2524, DOI 10.1245/s10434-009-0585-3; Kocak E, 2006, CANCER RES, V66, P7276, DOI 10.1158/0008-5472.CAN-05-2128; Lipson EJ, 2013, CLIN CANCER RES, V19, P462, DOI 10.1158/1078-0432.CCR-12-2625; Maier H, 2007, J IMMUNOL, V178, P2714, DOI 10.4049/jimmunol.178.5.2714; Mocellin S, 1836, BIOCHIM BIOPHYS ACTA, P187; Pilon-Thomas S, J IMMUNOTHER, V35, P615; Pilon-Thomas S, 2010, J IMMUNOL, V184, P3442, DOI 10.4049/jimmunol.0904114; Sakuishi K, 2010, J EXP MED, V207, P2187, DOI 10.1084/jem.20100643; Serriari NE, 2010, J IMMUNOL, V185, P3140, DOI 10.4049/jimmunol.0902487; Son CH, J IMMUNOTHER, V37, P1; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Triebel F, 2003, TRENDS IMMUNOL, V24, P619, DOI 10.1016/j.it.2003.10.001; Turcotte S, 2014, CLIN CANCER RES, V20, P331, DOI 10.1158/1078-0432.CCR-13-1736; Turcotte S, 2013, J IMMUNOL, V191, P2217, DOI 10.4049/jimmunol.1300538; Watanabe N, 2003, NAT IMMUNOL, V4, P670, DOI 10.1038/ni944; Weber J, CANC IMMUN, V13, P7; Woo SR, 2012, CANCER RES, V72, P917, DOI 10.1158/0008-5472.CAN-11-1620; Wu X, 2014, BRIT J CANCER, V111, P1391, DOI 10.1038/bjc.2014.416; Yu P, 2010, CLIN CANCER RES, V16, P6019, DOI 10.1158/1078-0432.CCR-10-1966	33	40	42	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0153053	10.1371/journal.pone.0153053	http://dx.doi.org/10.1371/journal.pone.0153053			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050669	Green Published, gold, Green Submitted			2022-12-27	WOS:000373603500089
J	Cheek, NN				Cheek, Nathan N.			Face-ism and Objectification in Mainstream and LGBT Magazines	PLOS ONE			English	Article							FACIAL PROMINENCE; PRIME-TIME; TELEVISION COMMERCIALS; MALE POLITICIANS; MEDIA IMAGES; GENDER; RACE; REPRESENTATIONS; PERCEPTIONS; PICTURE	In visual media, men are often shown with more facial prominence than women, a manifestation of sexism that has been labeled face-ism. The present research extended the study of facial prominence and gender representation in media to include magazines aimed at lesbian, gay, bisexual, and transgender (LGBT) audiences for the first time, and also examined whether overall gender differences in facial prominence can still be found in mainstream magazines. Face-ism emerged in Newsweek, but not in Time, The Advocate, or Out. Although there were no overall differences in facial prominence between mainstream and LGBT magazines, there were differences in the facial prominence of men and women among the four magazines included in the present study. These results suggest that face-ism is still a problem, but that it may be restricted to certain magazines. Furthermore, future research may benefit from considering individual magazine titles rather than broader categories of magazines, given that the present study found few similarities between different magazines in the same media category-indeed, Out and Time were more similar to each other than they were to the other magazine in their respective categories.	[Cheek, Nathan N.] Swarthmore Coll, Dept Psychol, Swarthmore, PA 19081 USA	Swarthmore College	Cheek, NN (corresponding author), Swarthmore Coll, Dept Psychol, Swarthmore, PA 19081 USA.	nathan.n.cheek@gmail.com		Cheek, Nathan/0000-0003-3515-4141				ARCHER D, 1983, J PERS SOC PSYCHOL, V45, P725, DOI 10.1037/0022-3514.45.4.725; Aubrey JS, 2004, MEDIA PSYCHOL, V6, P111, DOI 10.1207/s1532785xmep0602_1; Coltrane S, 2000, SEX ROLES, V42, P363, DOI 10.1023/A:1007046204478; COPELAND GA, 1989, J BROADCAST ELECTRON, V33, P209; Eaton AW, 2008, PHILOS COMPASS, V3, P873, DOI 10.1111/j.1747-9991.2008.00154.x; Fredrickson BL, 1997, PSYCHOL WOMEN QUART, V21, P173, DOI 10.1111/j.1471-6402.1997.tb00108.x; Glascock J, 2004, SEX ROLES, V51, P423, DOI 10.1023/B:SERS.0000049231.67432.a9; Goffman E., 1976, GENDER ADVERTISEMENT, P1; Gonsoulin ME, 2010, J HOMOSEXUAL, V57, P1158, DOI 10.1080/00918369.2010.508327; Greenwood DN, 2010, HANDBOOK OF GENDER RESEARCH IN PSYCHOLOGY, VOL 2, P643, DOI 10.1007/978-1-4419-1467-5_27; Groesz LM, 2002, INT J EAT DISORDER, V31, P1, DOI 10.1002/eat.10005; HALL CCI, 1994, SEX ROLES, V31, P329; Kapidzic S, 2015, J BROADCAST ELECTRON, V59, P278, DOI 10.1080/08838151.2015.1029127; Kenix L.J., 2011, ALTERNATIVE MAINSTRE; KITE ME, 1987, PSYCHOL WOMEN QUART, V11, P83, DOI 10.1111/j.1471-6402.1987.tb00776.x; Konrath S, 2012, PSYCHOL WOMEN QUART, V36, P476, DOI 10.1177/0361684312455317; Konrath SH, 2007, MEDIA PSYCHOL, V10, P436, DOI 10.1080/15213260701533219; Lanzieri N, 2013, BODY IMAGE, V10, P251, DOI 10.1016/j.bodyim.2012.12.003; Levesque MJ, 1999, SEX ROLES, V41, P241, DOI 10.1023/A:1018806329197; Loughnan S, 2010, EUR J SOC PSYCHOL, V40, P709, DOI 10.1002/ejsp.755; Mastro DE, 2003, J BROADCAST ELECTRON, V47, P638, DOI 10.1207/s15506878jobem4704_9; Matthews JL, 2007, SEX ROLES, V57, P515, DOI 10.1007/s11199-007-9276-3; MCARTHUR LZ, 1975, J SOC PSYCHOL, V97, P209, DOI 10.1080/00224545.1975.9923340; Melkote K., 2010, INTERRELATIONSHIP BU, P213; Milillo D, 2008, J LESBIAN STUD, V12, P381, DOI 10.1080/10894160802278267; Mulvey Laura, 2006, MEDIA CULTURAL STUDI, P342; Plous S, 1997, PSYCHOL WOMEN QUART, V21, P627, DOI 10.1111/j.1471-6402.1997.tb00135.x; Saucier JA, 2008, J HOMOSEXUAL, V55, P504, DOI 10.1080/00918360802345297; SCHWARZ N, 1989, EUR J SOC PSYCHOL, V19, P311, DOI 10.1002/ejsp.2420190405; Signorielli N, 2004, J BROADCAST ELECTRON, V48, P279, DOI 10.1207/s15506878jobem4802_7; Smith L.R., 2012, J INTERCULTURAL COMM, V41, P279, DOI DOI 10.1080/17475759.2012.728771; Smith LR, 2016, COMMUN SPORT, V4, P62, DOI 10.1177/2167479514522793; Szillis U, 2007, INT J INTERNET SCI, V2, P3; ZUCKERMAN M, 1986, J NONVERBAL BEHAV, V10, P215, DOI 10.1007/BF00987481; ZUCKERMAN M, 1994, J PERS SOC PSYCHOL, V66, P86, DOI 10.1037/0022-3514.66.1.86	35	3	3	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153592	10.1371/journal.pone.0153592	http://dx.doi.org/10.1371/journal.pone.0153592			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ3UC	27074012	gold, Green Published			2022-12-27	WOS:000374131200109
J	Walsh, P; Behrens, N; Chaigneau, FRC; McEligot, H; Agrawal, K; Newman, JW; Anderson, M; Gershwin, LJ				Walsh, Paul; Behrens, Nicole; Chaigneau, Francisco R. Carvallo; McEligot, Heather; Agrawal, Karan; Newman, John W.; Anderson, Mark; Gershwin, Laurel J.			A Randomized Placebo Controlled Trial of Ibuprofen for Respiratory Syncytial Virus Infection in a Bovine Model	PLOS ONE			English	Article							PUBLIC-HEALTH-SERVICE; 20-CARBON FATTY-ACIDS; ANTIBACTERIAL TREATMENT; CLINICAL-EFFICACY; CYCLOOXYGENASE 2; REYES-SYNDROME; RSV INFECTION; PULMONARY; DISEASE; DEXAMETHASONE	Background Respiratory syncytial virus (RSV) is the most common cause of bronchiolitis and hospital admission in infants. An analogous disease occurs in cattle and costs US agriculture a billion dollars a year. RSV causes much of its morbidity indirectly via adverse effects of the host response to the virus. RSV is accompanied by elevated prostaglandin E-2 (PGE(2)) which is followed by neutrophil led inflammation in the lung. Ibuprofen is a prototypical nonsteroidal anti-inflammatory drug that decreases PGE2 levels by inhibiting cyclooxygenase. Hypotheses We hypothesized that treatment of RSV with ibuprofen would decrease PGE2 levels, modulate the immune response, decrease clinical illness, and decrease the histopathological lung changes in a bovine model of RSV. We further hypothesized that viral replication would be unaffected. Methods We performed a randomized placebo controlled trial of ibuprofen in 16 outbred Holstein calves that we infected with RSV. We measured clinical scores, cyclooxygenase, lipoxygenase and endocannabinoid products in plasma and mediastinal lymph nodes and interleukin (Il)-4, II-13, II-17 and interferon-gamma in mediastinal lymph nodes. RSV shedding was measured daily and nasal II-6, II-8 and II-17 every other day. The calves were necropsied on Day 10 post inoculation and histology performed. Results One calf in the ibuprofen group required euthanasia on Day 8 of infection for respiratory distress. Clinical scores (p<0.01) and weight gain (p = 0.08) seemed better in the ibuprofen group. Ibuprofen decreased cyclooxygenase, lipoxygenase, and cytochrome P450 products, and increased monoacylglycerols in lung lymph nodes. Ibuprofen modulated the immune response as measured by narrowed range of observed II-13, II-17 and IFN-gamma gene expression in mediastinal lymph nodes. Lung histology was not different between groups, and viral shedding was increased in calves randomized to ibuprofen. Conclusions Ibuprofen decreased PGE(2), modulated the immune response, and improved clinical outcomes. However lung histopathology was not affected and viral shedding was increased.	[Walsh, Paul] Sutter Med Ctr Sacramento, Dept Emergency Med, Div Pediat Emergency Med, Sacramento, CA USA; [Behrens, Nicole; McEligot, Heather; Gershwin, Laurel J.] Univ Calif Davis, Dept Pathol Microbiol & Immunol, Sch Vet Med, 1 Shields Ave, Davis, CA 95616 USA; [Chaigneau, Francisco R. Carvallo] Calif Anim Hlth & Food Safety Lab, San Bernardino Branch, 105 W Cent Ave, San Bernardino, CA USA; [Newman, John W.] ARS, Obes & Metab Res Unit, USDA, Western Human Nutr Res Ctr, Davis, CA USA; [Agrawal, Karan; Newman, John W.] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA; [Agrawal, Karan; Newman, John W.] Univ Calif Davis, NIH West Coast Metabol Ctr, Davis, CA 95616 USA; [Anderson, Mark] Calif Anim Hlth & Food Safety Lab, 620 W Hlth Sci Dr, Davis, CA USA	University of California System; University of California Davis; United States Department of Agriculture (USDA); University of California System; University of California Davis; University of California System; University of California Davis	Walsh, P (corresponding author), Sutter Med Ctr Sacramento, Dept Emergency Med, Div Pediat Emergency Med, Sacramento, CA USA.	yousentwhohome@gmail.com		Newman, John/0000-0001-9632-6571; Agrawal, Karan/0000-0002-9536-9489	National Heart, Lung, and Blood Institute at the National Institutes of Health (NIH) [5K12HL108964-02]; Pediatric Emergency Medicine Research Foundation, Long Beach, California; USDA [5306-51530-019-00D, 2032-5130-022-00D]; West Coast Metabolomics Center Grant [NIH U24 DK097154]; ARS [ARS-0426826] Funding Source: Federal RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K12HL108964] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute at the National Institutes of Health (NIH); Pediatric Emergency Medicine Research Foundation, Long Beach, California; USDA(United States Department of Agriculture (USDA)); West Coast Metabolomics Center Grant; ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was funded by Award 5K12HL108964-02 from the National Heart, Lung, and Blood Institute at the National Institutes of Health (NIH) and by the Pediatric Emergency Medicine Research Foundation, Long Beach, California. Additional support was provided by the USDA Intramural Projects 5306-51530-019-00D and 2032-5130-022-00D, and the West Coast Metabolomics Center Grant NIH U24 DK097154. The USDA is an equal opportunity provider and employer.	Aso H, 2012, AM J PHYSIOL-LUNG C, V302, pL266, DOI 10.1152/ajplung.00248.2011; Bancos S, 2009, CELL IMMUNOL, V258, P18, DOI 10.1016/j.cellimm.2009.03.007; Blanken MO, 2013, NEW ENGL J MED, V368, P1791, DOI 10.1056/NEJMoa1211917; Buckingham SC, 2002, J INFECT DIS, V185, P1222, DOI 10.1086/340024; Bystrom J, 2013, VIRUSES-BASEL, V5, P777, DOI 10.3390/v5030777; Campbell EL, 2011, J IMMUNOL, V187, P3475, DOI 10.4049/jimmunol.1100150; COLLIE DDS, 1992, BRIT VET J, V148, P33, DOI 10.1016/0007-1935(92)90064-8; Corneli HM, 2007, NEW ENGL J MED, V357, P331, DOI 10.1056/NEJMoa071255; Daniel TO, 1999, CANCER RES, V59, P4574; DeVincenzo JP, 2005, J INFECT DIS, V191, P1861, DOI 10.1086/430008; Duttweiler L, 2004, ARCH DIS CHILD, V89, P1155, DOI 10.1136/adc.2004.049551; El Saleeby CM, 2004, CLIN INFECT DIS, V39, pE17, DOI 10.1086/421779; Eron NB, 2011, HEALTH PROMOT PRACT, V12, P370, DOI 10.1177/1524839909341033; Evans A. M., 2001, Clinical Rheumatology, V20, pS9; Friton GM, 2004, BERL MUNCH TIERARZTL, V117, P304; Gadomski AM, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001266.pub4; Gershwin LJ, 2011, AM J VET RES, V72, P134, DOI 10.2460/ajvr.72.1.134; Gershwin LJ, 1998, VACCINE, V16, P1225, DOI 10.1016/S0264-410X(98)80123-0; Gershwin LJ, 2000, AM J VET RES, V61, P291, DOI 10.2460/ajvr.2000.61.291; Gilroy DW, 1998, EUR J PHARMACOL, V355, P211, DOI 10.1016/S0014-2999(98)00508-1; GRAHAM BS, 1991, J CLIN INVEST, V88, P1026, DOI 10.1172/JCI115362; GRAHAM NMH, 1990, J INFECT DIS, V162, P1277, DOI 10.1093/infdis/162.6.1277; Grapov D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048852; Grapov D, 2012, BIOINFORMATICS, V28, P2288, DOI 10.1093/bioinformatics/bts439; Guindon J, 2006, PAIN, V121, P85, DOI 10.1016/j.pain.2005.12.007; Holgate ST, 2011, AM J RESP CRIT CARE, V183, P147, DOI 10.1164/rccm.201007-1135ED; HURWITZ ES, 1985, NEW ENGL J MED, V313, P849, DOI 10.1056/NEJM198510033131403; HURWITZ ES, 1987, JAMA-J AM MED ASSOC, V257, P1905, DOI 10.1001/jama.257.14.1905; Karlsson J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103589; Lesko SM, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e20; Liu F, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010636.pub2; Liu JY, 2010, BIOCHEM PHARMACOL, V79, P880, DOI 10.1016/j.bcp.2009.10.025; Liu TS, 2005, VIROLOGY, V343, P12, DOI 10.1016/j.virol.2005.08.012; Lockwood PW, 2003, VET REC, V152, P392, DOI 10.1136/vr.152.13.392; Marcinkiewicz Janusz, 1997, Archivum Immunologiae et Therapiae Experimentalis, V45, P163; Markworth JF, AM J REGULATORY INTE, pR1281; Miles EA, 2003, CLIN EXP ALLERGY, V33, P624, DOI 10.1046/j.1365-2222.2003.01637.x; Miles EA, 2002, CYTOKINE, V20, P215, DOI 10.1006/cyto.2002.2007; Newcomb DC, 2013, AM J RESP CELL MOL, V48, P711, DOI 10.1165/rcmb.2013-0017OC; PALUMBO GJ, 1993, P NATL ACAD SCI USA, V90, P2020, DOI 10.1073/pnas.90.5.2020; Pandey R, 2009, PHARMACOL RES, V60, P85, DOI 10.1016/j.phrs.2009.03.019; PARKS WM, 1981, J PHARMACOL EXP THER, V219, P415; Prymula R, 2009, LANCET, V374, P1339, DOI 10.1016/S0140-6736(09)61208-3; Reddy ST, 1997, J BIOL CHEM, V272, P3231, DOI 10.1074/jbc.272.6.3231; Reynaud D, 1997, PROSTAG LEUKOTR ESS, V56, P9, DOI 10.1016/S0952-3278(97)90518-4; Richardson JY, 2005, J IMMUNOL, V174, P4356, DOI 10.4049/jimmunol.174.7.4356; Rouzer CA, 2011, CHEM REV, V111, P5899, DOI 10.1021/cr2002799; Roy B, 2002, J LEUKOCYTE BIOL, V72, P580; Salichs M, 2013, J ANIM SCI, V91, P4469, DOI 10.2527/jas.2012-6165; Somers CC, 2009, PEDIAT ALLERG IMM-UK, V20, P477, DOI 10.1111/j.1399-3038.2009.00852.x; Sznajer Y, 2004, J PEDIATR-US, V145, P115, DOI 10.1016/j.jpeds.2004.03.049; Thorburn K, 2006, THORAX, V61, P611, DOI 10.1136/thx.2005.048397; Tilley SL, J CLIN INVESTIGATIO, P15; Van Hecken A, 2000, J CLIN PHARMACOL, V40, P1109; VANDERHOEK JY, 1984, J BIOL CHEM, V259, P6752; VILLANUEVA M, 1993, BRIT J CLIN PHARMACO, V35, P235, DOI 10.1111/j.1365-2125.1993.tb05690.x; von Moltke J, 2012, NATURE, V490, P107, DOI 10.1038/nature11351; Walsh P, 2016, J VET PHARMACOL THER, V39, P518, DOI 10.1111/jvp.12295; Walsh P, 2008, ACAD EMERG MED, V15, P305, DOI 10.1111/j.1553-2712.2008.00064.x; Weinberger DM, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001776; Woolums AR, 1999, AM J VET RES, V60, P473; Yao CC, 2009, NAT MED, V15, P633, DOI 10.1038/nm.1968; Zidar N, 2009, J CELL MOL MED, V13, P3753, DOI 10.1111/j.1582-4934.2008.00430.x	63	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0152913	10.1371/journal.pone.0152913	http://dx.doi.org/10.1371/journal.pone.0152913			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073858	Green Published, Green Submitted, gold			2022-12-27	WOS:000374131200044
J	Hamilton, J; Stevens, G; Girdler, S				Hamilton, Josette; Stevens, Gillian; Girdler, Sonya			Becoming a Mentor: The Impact of Training and the Experience of Mentoring University Students on the Autism Spectrum	PLOS ONE			English	Article							SUPPORT; CHALLENGES; DISORDERS; BENEFITS; ADULTS	While it is widely recognised that the number of young adults diagnosed with Autism Spectrum Disoders (ASD) is increasing, there is currently limited understanding of effective support for the transition to adulthood. One approach gaining increasing attention in the university sector is specialised peer mentoring. The aim of this inductive study was to understand the impact of peer mentor training on seven student mentors working with university students with an ASD. Kirkpatrick's model framed a mixed methods evaluation of the mentors' training and description of their experience. Overall, the training was well received by the mentors, who reported on average a 29% increase in their ASD knowledge following the training. Results from the semi-structured interviews conducted three months after the training, found that mentors felt that the general ASD knowledge they gained as part of their training had been essential to their role. The mentors described how their overall experience had been positive and reported that the training and support provided to them was pivotal to their ability to succeed in as peer mentors to students with ASD. This study provides feedback in support of specialist peer-mentoring programs for university students and can inform recommendations for future programs and research.	[Hamilton, Josette; Stevens, Gillian] Curtin Univ, Sch Psychol & Speech Pathol, Perth, WA 6845, Australia; [Hamilton, Josette; Stevens, Gillian; Girdler, Sonya] Cooperat Res Ctr Living Autism Spectrum Disorders, Brisbane, Qld, Australia; [Girdler, Sonya] Curtin Univ, Sch Occupat Therapy & Social Work, Perth, WA 6845, Australia	Curtin University; Curtin University	Girdler, S (corresponding author), Cooperat Res Ctr Living Autism Spectrum Disorders, Brisbane, Qld, Australia.; Girdler, S (corresponding author), Curtin Univ, Sch Occupat Therapy & Social Work, Perth, WA 6845, Australia.	sonya.girdler@curtin.edu.au	Girdler, Sonya/ABC-9629-2021	Girdler, Sonya/0000-0001-7992-0800	Cooperative Research Centre for Living with Autism Spectrum Disorders (Autism CRC) under the Australian Government's Cooperative Research Centres Program [3.032RS]	Cooperative Research Centre for Living with Autism Spectrum Disorders (Autism CRC) under the Australian Government's Cooperative Research Centres Program(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	This work was supported by the Cooperative Research Centre for Living with Autism Spectrum Disorders (Autism CRC) [project number 3.032RS], established and supported under the Australian Government's Cooperative Research Centres Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Autism Spectrum Australia, 2012, WE BEL INV EXP ASP N; Baranik LE, 2010, J VOCAT BEHAV, V76, P366, DOI 10.1016/j.jvb.2009.07.004; Baron-Cohen S, 2009, BRIT J PSYCHIAT, V194, P500, DOI 10.1192/bjp.bp.108.059345; Bebko JM, 2011, MENTORING PROGRAM ST; Bolte S, 2014, AUTISM, V18, P67, DOI 10.1177/1362361313517367; Brugha TS, 2011, ARCH GEN PSYCHIAT, V68, P459, DOI 10.1001/archgenpsychiatry.2011.38; Chakrabarti S, 2005, AM J PSYCHIAT, V162, P1133, DOI 10.1176/appi.ajp.162.6.1133; Cresswell J. W., 2011, DESIGNING CONDUCTING; Crisp G, 2009, RES HIGH EDUC, V50, P525, DOI 10.1007/s11162-009-9130-2; Crotty M, 1996, PHENOMENOLOGY NURSIN; Ensher EA, 2011, J VOCAT BEHAV, V79, P253, DOI 10.1016/j.jvb.2010.11.008; Grbich C.F., 1999, QUALITATIVE RES HLTH; Hastwell J, 2013, BARON COHEN S ASPERG; Howlin P, 2012, CAN J PSYCHIAT, V57, P275, DOI 10.1177/070674371205700502; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; JACOBI M, 1991, REV EDUC RES, V61, P505, DOI 10.3102/00346543061004505; Kirkpatrick D, 1996, TRAINING DEV, V50, P54; Kirkpatrick J., 2007, T+D-BETTER PERFORM W, V61, P34; Larose S, 2013, MENTOR TUTOR, V21, P150, DOI 10.1080/13611267.2013.813728; Lincoln Y.S., 1985, NATURALISTIC ENQUIRY; Martin N, 2008, J INCLUSIVE PRACTICE, V1, P3; Martin SM, 2012, CHILD YOUTH SERV REV, V34, P940, DOI 10.1016/j.childyouth.2012.01.025; Mavropoulou S, 2012, EUR J SPEC NEEDS EDU, V27, P337, DOI 10.1080/08856257.2012.691230; Morton Sarah, 2013, Community Pract, V86, P32; Ness BM, 2013, MENTOR TUTOR, V21, P356, DOI 10.1080/13611267.2013.855865; O'Shea S, 2013, MENTOR TUTOR, V21, P392, DOI 10.1080/13611267.2013.855863; Parise MR, 2008, J VOCAT BEHAV, V72, P225, DOI 10.1016/j.jvb.2007.10.011; Perrew? P.L., 2000, HUMAN RESOURCE MANAG, V10, P177, DOI [DOI 10.1016/S1053-4822(99)00045-5, 10.1016/S1053-4822(99)00045-5]; Rajuan M, 2011, NEW ED, V7, P172, DOI DOI 10.1080/1547688X.2011.574592; Roberts A., 2000, MENTOR TUTOR, V8, P145, DOI [10.1080/713685524, DOI 10.1080/713685524]; Strauss A., 1990, BASICS QUALITATIVE R; Tavassoli T, 2013, AUTISM, P1362; Van Hees V, 2015, J AUTISM DEV DISORD, V45, P1673, DOI 10.1007/s10803-014-2324-2; Winfrey EC, 1999, ENCY ED TECHNOLOGY	34	25	25	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0153204	10.1371/journal.pone.0153204	http://dx.doi.org/10.1371/journal.pone.0153204			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ0NI	27070418	gold, Green Published, Green Submitted			2022-12-27	WOS:000373900700037
J	Yang, EJ; Ahn, S; Lee, K; Mahmood, U; Kim, HS				Yang, Eun-Jeong; Ahn, Sangzin; Lee, Kihwan; Mahmood, Usman; Kim, Hye-Sun			Early Behavioral Abnormalities and Perinatal Alterations of PTEN/AKT Pathway in Valproic Acid Autism Model Mice	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT; PRENATAL EXPOSURE; ANIMAL-MODEL; SYNAPTIC-TRANSMISSION; SPECTRUM DISORDERS; MOUSE MODELS; BRAIN VOLUME; RAT MODEL; CHILDREN; FMR1	Exposure to valproic acid (VPA) during pregnancy has been linked with increased incidence of autism, and has repeatedly been demonstrated as a useful autism mouse model. We examined the early behavioral and anatomical changes as well as molecular changes in mice prenatally exposed to VPA (VPA mice). In this study, we first showed that VPA mice showed developmental delays as assessed with self-righting, eye opening tests and impaired social recognition. In addition, we provide the first evidence that primary cultured neurons from VPA-treated embryos present an increase in dendritic spines, compared with those from control mice. Mutations in phosphatase and tensin homolog (PTEN) gene are also known to be associated with autism, and mice with PTEN knockout show autistic characteristics. Protein expression of PTEN was decreased and the ratio of p-AKT/AKT was increased in the cerebral cortex and the hippocampus, and a distinctive anatomical change in the CA1 region of the hippocampus was observed. Taken together, our study suggests that prenatal exposure to VPA induces developmental delays and neuroanatomical changes via the reduction of PTEN level and these changes were detectable in the early days of life.	[Yang, Eun-Jeong; Ahn, Sangzin; Lee, Kihwan; Kim, Hye-Sun] Seoul Natl Univ, Coll Med, Dept Pharmacol & Biomed Sci, Seoul, South Korea; [Ahn, Sangzin] Inje Univ, Coll Med, Dept Pharmacol, Busan, South Korea; [Mahmood, Usman; Kim, Hye-Sun] Seoul Natl Univ, Interdisciplinary Program Brain Sci, Coll Nat Sci, Seoul, South Korea; [Kim, Hye-Sun] Seoul Natl Univ, Coll Med, Bundang Hosp, Sungnam, South Korea	Seoul National University (SNU); Inje University; Seoul National University (SNU); Seoul National University (SNU)	Kim, HS (corresponding author), Seoul Natl Univ, Interdisciplinary Program Brain Sci, Coll Nat Sci, Seoul, South Korea.	usman.mahmood85@outlook.com; hyisun@snu.ac.kr	Ahn, Sangzin/E-8807-2016	Ahn, Sangzin/0000-0003-2749-0014; Mahmood, Usman/0000-0001-5883-5009	Korea Healthcare Technology R&D Project of Ministry for Health, Welfare and Family Affairs of the Republic of Korea [HI3C1451]; National Research Foundation of Korea (NRF) through the Ministry of Education, Science and Technology [NRF-2011-0021866]	Korea Healthcare Technology R&D Project of Ministry for Health, Welfare and Family Affairs of the Republic of Korea; National Research Foundation of Korea (NRF) through the Ministry of Education, Science and Technology(National Research Foundation of Korea)	This study was financially supported by grants from the Korea Healthcare Technology R&D Project (HI3C1451) of Ministry for Health, Welfare and Family Affairs of the Republic of Korea, by the National Research Foundation of Korea (NRF) through the Ministry of Education, Science and Technology (NRF-2011-0021866). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali IU, 1999, JNCI-J NATL CANCER I, V91, P1922, DOI 10.1093/jnci/91.22.1922; Arakawa H, 2008, BEHAV BRAIN RES, V190, P97, DOI 10.1016/j.bbr.2008.02.009; ARDINGER HH, 1988, AM J MED GENET, V29, P171, DOI 10.1002/ajmg.1320290123; Bescoby-Chambers N, 2001, DEV MED CHILD NEUROL, V43, P847, DOI 10.1017/S0012162201211542; Boukhris T, 2016, JAMA PEDIATR, V170, P117, DOI 10.1001/jamapediatrics.2015.3356; Buxbaum JD, 2007, AM J MED GENET B, V144B, P484, DOI 10.1002/ajmg.b.30493; Campbell DJ, 2014, J AM ACAD CHILD PSY, V53, P1063, DOI 10.1016/j.jaac.2014.07.008; Chen C, 2017, BRAIN IMAGING BEHAV, V11, P38, DOI 10.1007/s11682-015-9504-3; CHRISTIANSON AL, 1994, DEV MED CHILD NEUROL, V36, P361; Clipperton-Allen AE, 2014, HUM MOL GENET, V23, P3490, DOI 10.1093/hmg/ddu057; Courchesne E, 2001, NEUROLOGY, V57, P245, DOI 10.1212/WNL.57.2.245; Courchesne E, 2011, JAMA-J AM MED ASSOC, V306, P2001, DOI 10.1001/jama.2011.1638; Cullen KE, 2012, TRENDS NEUROSCI, V35, P185, DOI 10.1016/j.tins.2011.12.001; DELONG GR, 1992, NEUROSCI BIOBEHAV R, V16, P63, DOI 10.1016/S0149-7634(05)80052-1; Devlin B, 2012, CURR OPIN GENET DEV, V22, P229, DOI 10.1016/j.gde.2012.03.002; Dudova I, 2014, NEUROPSYCH DIS TREAT, V10, P277, DOI 10.2147/NDT.S57057; Dufour-Rainfray D, 2011, NEUROSCI BIOBEHAV R, V35, P1254, DOI 10.1016/j.neubiorev.2010.12.013; Elsabbagh M, 2012, AUTISM RES, V5, P160, DOI 10.1002/aur.239; Favre MR, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00088; Felix-Ortiz AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037313; Gandal MJ, 2010, BIOL PSYCHIAT, V68, P1100, DOI 10.1016/j.biopsych.2010.09.031; Goffin A, 2001, AM J MED GENET, V105, P521, DOI 10.1002/ajmg.1477; Gogolla N, 2009, J NEURODEV DISORD, V1, P172, DOI 10.1007/s11689-009-9023-x; Goldani AAS, 2014, FRONT PSYCHIATRY, V5, DOI 10.3389/fpsyt.2014.00100; Grossman AW, 2006, BRAIN RES, V1084, P158, DOI 10.1016/j.brainres.2006.02.044; Grossman AW, 2010, BRAIN RES, V1355, P221, DOI 10.1016/j.brainres.2010.07.090; HACK M, 1995, FUTURE CHILD, V5, P176, DOI 10.2307/1602514; Hamilton SM, 2014, BEHAV NEUROSCI, V128, P103, DOI 10.1037/a0035988; Hara Y, 2012, J PHARMACOL SCI, V118, P543, DOI 10.1254/jphs.12025SC; Hardan AY, 2001, J CHILD NEUROL, V16, P421, DOI 10.2310/7010.2001.7113; Hoeft F, 2008, ARCH GEN PSYCHIAT, V65, P1087, DOI 10.1001/archpsyc.65.9.1087; Holmes GL, 2007, NEUROLOGY, V69, pS28, DOI 10.1212/01.wnl.0000302369.24230.c6; Holmes GL, 2007, EPILEPSY BEHAV, V11, P270, DOI 10.1016/j.yebeh.2007.08.022; Howlin P, 2000, J CHILD PSYCHOL PSYC, V41, P561, DOI 10.1017/S0021963099005806; Ingram JL, 2000, NEUROTOXICOL TERATOL, V22, P319, DOI 10.1016/S0892-0362(99)00083-5; Isshiki M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5742; Kane MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048975; Kataoka S, 2013, INT J NEUROPSYCHOPH, V16, P91, DOI 10.1017/S1461145711001714; Kim HJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088924; Kim KC, 2011, TOXICOL LETT, V201, P137, DOI 10.1016/j.toxlet.2010.12.018; Kolozsi E, 2009, NEUROSCIENCE, V163, P1201, DOI 10.1016/j.neuroscience.2009.07.021; Kwon CH, 2006, NEURON, V50, P377, DOI 10.1016/j.neuron.2006.03.023; Lee K, 2012, J NEUROSCI, V32, P5678, DOI 10.1523/JNEUROSCI.6471-11.2012; Lugo JN, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00027; Martin HGS, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00023; Matelski L, 2016, J AUTOIMMUN, V67, P1, DOI 10.1016/j.jaut.2015.11.003; McFarlane L, 2013, SEX DEV, V7, P207, DOI 10.1159/000348677; Meador KJ, 2013, LANCET NEUROL, V12, P244, DOI 10.1016/S1474-4422(12)70323-X; Mehta MV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026077; Miles JH, 2011, GENET MED, V13, P278, DOI 10.1097/GIM.0b013e3181ff67ba; Mittal VA, 2011, PSYCHIAT RES, V189, P158, DOI 10.1016/j.psychres.2011.06.006; Mohapatra S, 2012, EXP BRAIN RES, V217, P197, DOI 10.1007/s00221-011-2986-3; Monk CS, 2009, NEUROIMAGE, V47, P764, DOI 10.1016/j.neuroimage.2009.04.069; Moretti P, 2006, J NEUROSCI, V26, P319, DOI 10.1523/JNEUROSCI.2623-05.2006; Moy SS, 2004, GENES BRAIN BEHAV, V3, P287, DOI 10.1111/j.1601-1848.2004.00076.x; Nelson PG, 2006, INT J DEV NEUROSCI, V24, P73, DOI 10.1016/j.ijdevneu.2005.10.003; O'Roak BJ, 2012, SCIENCE, V338, P1619, DOI 10.1126/science.1227764; Orrico A, 2009, CLIN GENET, V75, P195, DOI 10.1111/j.1399-0004.2008.01074.x; Ozonoff S, 2010, J AM ACAD CHILD PSY, V49, P256, DOI 10.1016/j.jaac.2009.11.009; Pyhala R, 2014, PEDIATRICS, V134, P1075, DOI 10.1542/peds.2014-1097; Riedel A, 2014, PSYCHIAT RES-NEUROIM, V223, P67, DOI 10.1016/j.pscychresns.2014.05.013; Roberts L, 2003, BRAIN RES, V991, P271, DOI 10.1016/j.brainres.2003.08.022; Rodier PM, 1996, J COMP NEUROL, V370, P247, DOI 10.1002/(SICI)1096-9861(19960624)370:2<247::AID-CNE8>3.0.CO;2-2; Ronald A, 2011, AM J MED GENET B, V156B, P255, DOI 10.1002/ajmg.b.31159; Roullet FI, 2010, NEUROSCIENCE, V170, P514, DOI 10.1016/j.neuroscience.2010.06.069; Roullet FI, 2013, NEUROTOXICOL TERATOL, V36, P47, DOI 10.1016/j.ntt.2013.01.004; Saitoh O, 2001, BRAIN, V124, P1317, DOI 10.1093/brain/124.7.1317; Sandhya T, 2012, NEUROCHEM RES, V37, P1121, DOI 10.1007/s11064-012-0717-1; Schneider T, 2005, NEUROPSYCHOPHARMACOL, V30, P80, DOI 10.1038/sj.npp.1300518; Schneider T, 2008, PSYCHONEUROENDOCRINO, V33, P728, DOI 10.1016/j.psyneuen.2008.02.011; Seltzer MM, 2004, MENT RETARD DEV D R, V10, P234, DOI 10.1002/mrdd.20038; Speed HE, 2015, J NEUROSCI, V35, P9648, DOI 10.1523/JNEUROSCI.3125-14.2015; Spencer CM, 2005, GENES BRAIN BEHAV, V4, P420, DOI 10.1111/j.1601-183X.2005.00123.x; Stoner R, 2014, NEW ENGL J MED, V370, P1209, DOI 10.1056/NEJMoa1307491; Sulis ML, 2003, TRENDS CELL BIOL, V13, P478, DOI 10.1016/S0962-8924(03)00175-2; Tang GM, 2014, NEURON, V83, P1131, DOI 10.1016/j.neuron.2014.07.040; Teitelbaum P, 1998, P NATL ACAD SCI USA, V95, P13982, DOI 10.1073/pnas.95.23.13982; Tsai NP, 2012, CELL, V151, P1581, DOI 10.1016/j.cell.2012.11.040; Varga EA, 2009, GENET MED, V11, P111, DOI 10.1097/GIM.0b013e31818fd762; Veenstra-VanderWeele J, 2012, P NATL ACAD SCI USA, V109, P5469, DOI 10.1073/pnas.1112345109; Wagner GC, 2006, J AUTISM DEV DISORD, V36, P779, DOI 10.1007/s10803-006-0117-y; Yu IT, 2009, NEUROPHARMACOLOGY, V56, P473, DOI 10.1016/j.neuropharm.2008.09.019; Zaki SA, 2010, ANN SAUDI MED, V30, P233, DOI 10.4103/0256-4947.62839; Zwaigenbaum L, 2005, INT J DEV NEUROSCI, V23, P143, DOI 10.1016/j.ijdevneu.2004.05.001	84	22	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0153298	10.1371/journal.pone.0153298	http://dx.doi.org/10.1371/journal.pone.0153298			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27071011	Green Submitted, Green Published, gold			2022-12-27	WOS:000373900700049
J	Dashtsoodol, N; Shigeura, T; Ozawa, R; Harada, M; Kojo, S; Watanabe, T; Koseki, H; Nakayama, M; Ohara, O; Taniguchi, M				Dashtsoodol, Nyambayar; Shigeura, Tomokuni; Ozawa, Ritsuko; Harada, Michishige; Kojo, Satoshi; Watanabe, Takashi; Koseki, Haruhiko; Nakayama, Manabu; Ohara, Osamu; Taniguchi, Masaru			Generation of Novel Traj18-Deficient Mice Lacking V alpha 14 Natural Killer T Cells with an Undisturbed T Cell Receptor alpha-Chain Repertoire	PLOS ONE			English	Article							NKT CELLS; INNATE; MOUSE; IDENTIFICATION; DIVERSITY	Invariant V alpha 14 natural killer T (NKT) cells, characterized by the expression of a single invariant T cell receptor (TCR) a chain encoded by rearranged Trav11 (V alpha 14)-Traj18 (J alpha 18) gene segments in mice, and TRAV10 (V alpha 24)-TRAJ18 (J alpha 18) in humans, mediate adjuvant effects to activate various effector cell types in both innate and adaptive immune systems that facilitates the potent antitumor effects. It was recently reported that the J alpha 18-deficient mouse described by our group in 1997 harbors perturbed TCRa repertoire, which raised concerns regarding the validity of some of the experimental conclusions that have been made using this mouse line. To resolve this concern, we generated a novel Traj18-deficient mouse line by specifically targeting the Traj18 gene segment using Cre-Lox approach. Here we showed the newly generated Traj18-deficient mouse has, apart from the absence of Traj18, an undisturbed TCR alpha chain repertoire by using next generation sequencing and by detecting normal generation of V alpha 19J alpha 33 expressing mucosal associated invariant T cells, whose development was abrogated in the originally described J alpha 18-KO mice. We also demonstrated here the definitive requirement for NKT cells in the protection against tumors and their potent adjuvant effects on antigen-specific CD8 T cells.	[Dashtsoodol, Nyambayar; Shigeura, Tomokuni; Ozawa, Ritsuko; Harada, Michishige; Kojo, Satoshi; Taniguchi, Masaru] RIKEN, Ctr Integrat Med Sci IMS, Lab Immune Regulat, Yokohama, Kanagawa 2300045, Japan; [Watanabe, Takashi; Ohara, Osamu] RIKEN, Ctr Integrat Med Sci IMS, Lab Integrat Genom, Yokohama, Kanagawa 2300045, Japan; [Koseki, Haruhiko] RIKEN, Ctr Integrat Med Sci IMS, Lab Dev Genet, Yokohama, Kanagawa 2300045, Japan; [Nakayama, Manabu] Kazusa DNA Res Inst, Dept Human Genome Res, Kisarazu, Chiba 2920818, Japan; [Dashtsoodol, Nyambayar] Mongolian Natl Univ Med Sci MNUMS, Core Res Lab, Ulaanbaatar 14210, Mongolia	RIKEN; RIKEN; RIKEN; Kazusa DNA Research Institute; Mongolian National University of Medical Sciences	Taniguchi, M (corresponding author), RIKEN, Ctr Integrat Med Sci IMS, Lab Immune Regulat, Yokohama, Kanagawa 2300045, Japan.	masaru.taniguchi@riken.jp	Kojo, Satoshi/N-7135-2018; Ohara, Osamu/G-5448-2015	Kojo, Satoshi/0000-0002-9263-8831; Ohara, Osamu/0000-0002-3328-9571; Dashtsoodol, Nyambayar/0000-0003-4890-9267	JSPS KAKENHI Grants [24790490, 15K08291, 23229005]; Grants-in-Aid for Scientific Research [23229005] Funding Source: KAKEN	JSPS KAKENHI Grants; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by JSPS KAKENHI Grants 24790490 to ND; 15K08291 to SK; and 23229005 to MT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedel R, 2012, NAT IMMUNOL, V13, P705, DOI 10.1038/ni.2347; Chandra S, 2015, NAT IMMUNOL, V16, P799, DOI 10.1038/ni.3203; Chen YH, 1997, IMMUNITY, V6, P459, DOI 10.1016/S1074-7613(00)80289-7; Cui JQ, 1997, SCIENCE, V278, P1623, DOI 10.1126/science.278.5343.1623; Dashtsoodol N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003688; Fujii S, 2010, SEMIN IMMUNOL, V22, P97, DOI 10.1016/j.smim.2009.10.002; Li S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3333; Moro K, 2015, NAT PROTOC, V10, P792, DOI 10.1038/nprot.2015.047; Rahimpour A, 2015, J EXP MED, V212, P1095, DOI 10.1084/jem.20142110; Reantragoon R, 2013, J EXP MED, V210, P2305, DOI 10.1084/jem.20130958; Taniguchi M, 2003, ANNU REV IMMUNOL, V21, P483, DOI 10.1146/annurev.immunol.21.120601.141057; Taniguchi M, 2010, INT IMMUNOL, V22, P1, DOI 10.1093/intimm/dxp104; Toura I, 1999, J IMMUNOL, V163, P2387; Watarai H, 2008, NAT PROTOC, V3, P70, DOI 10.1038/nprot.2007.515; Watarai H, 2010, BLOOD, V115, P230, DOI 10.1182/blood-2009-04-217729	15	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2016	11	4							e0153347	10.1371/journal.pone.0153347	http://dx.doi.org/10.1371/journal.pone.0153347			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0KH	27064277	Green Published, Green Submitted, gold			2022-12-27	WOS:000373891000049
J	Sreedhar, R; Tiku, PK				Sreedhar, Roopesh; Tiku, Purnima Kaul			Cupincin: A Unique Protease Purified from Rice (Oryza sativa L.) Bran Is a New Member of the Cupin Superfamily	PLOS ONE			English	Article							SOYBEAN BETA-CONGLYCININ; SEED STORAGE PROTEINS; SECONDARY STRUCTURE; SWISS-MODEL; ASPARTIC PROTEINASE; EVOLUTION; MOBILIZATION; ACIDIFICATION; CONSERVATION; DEGRADATION	Cupin superfamily is one of the most diverse super families. This study reports the purification and characterization of a novel cupin domain containing protease from rice bran for the first time. Hypothetical protein OsI_13867 was identified and named as cupincin. Cupincin was purified to 4.4 folds with a recovery of 4.9%. Cupincin had an optimum pH and temperature of pH 4.0 and 60 degrees C respectively. Cupincin was found to be a homotrimer, consisting of three distinct subunits with apparent molecular masses of 33.45 kDa, 22.35 kDa and 16.67 kDa as determined by MALDI-TOF, whereas it eluted as a single unit with an apparent molecular mass of 135.33 +/- 3.52 kDa in analytical gel filtration and migrated as a single band in native page, suggesting its homogeneity. Sequence identity of cupincin was deduced by determining the amino-terminal sequence of the polypeptide chains and by and de novo sequencing. For understanding the hydrolysing mechanism of cupincin, its three-dimensional model was developed. Structural analysis indicated that cupincin contains His313, His326 and Glu318 with zinc ion as the putative active site residues, inhibition of enzyme activity by 1,10-phenanthroline and atomic absorption spectroscopy confirmed the presence of zinc ion. The cleavage specificity of cupincin towards oxidized B-chain of insulin was highly specific; cleaving at the Leu(15)-Tyr(16) position, the specificity was also determined using neurotensin as a substrate, where it cleaved only at the Glu(1)-Tyr(2) position. Limited proteolysis of the protease suggests a specific function for cupincin. These results demonstrated cupincin as a completely new protease.	[Sreedhar, Roopesh; Tiku, Purnima Kaul] CSIR Cent Food Technol Res Inst, Dept Prot Chem & Technol, Mysuru, Karnataka, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Food Technological Research Institute (CFTRI)	Tiku, PK (corresponding author), CSIR Cent Food Technol Res Inst, Dept Prot Chem & Technol, Mysuru, Karnataka, India.	purnima@cftri.res.in	Tiku, Purnima Kaul/I-7930-2019		Council of Scientific and Industrial Research (CSIR), INDIA [BSC0202]; Indian Council of Medical Research, New Delhi	Council of Scientific and Industrial Research (CSIR), INDIA(Council of Scientific & Industrial Research (CSIR) - India); Indian Council of Medical Research, New Delhi(Indian Council of Medical Research (ICMR))	This work was financially supported by Council of Scientific and Industrial Research (CSIR), INDIA through 12th Five year plan project WELFO (BSC0202). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Director, CSIR-Central Food Technological Research Institute (CFTRI), Mysuru for his support and encouragement. The authors wish to thank Dr. V. Prakash, former Director, CSIR-CFTRI and Dr. Lalitha R Gowda, former scientist CSIR-CFTRI for their valuable support and suggestions during the initial part of this work. Authors thank Dr. Asha Martin for technical help in Amino-terminal sequencing and Gerd Vegarud, Professor, Norwegian University of Life Sciences for MS/MS analysis. We thank Dr. Sridevi A. Singh for help in CD analysis and team Schrodinger for providing the free trial version of the software. Roopesh S acknowledges the Senior Research Fellowship award from Indian Council of Medical Research, New Delhi.	Adachi M, 2001, J MOL BIOL, V305, P291, DOI 10.1006/jmbi.2000.4310; Anand R, 2002, BIOCHEMISTRY-US, V41, P7659, DOI 10.1021/bi0200965; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; ASAKURA T, 1995, EUR J BIOCHEM, V232, P77, DOI 10.1111/j.1432-1033.1995.tb20783.x; ASAKURA T, 1995, BIOSCI BIOTECH BIOCH, V59, P1793, DOI 10.1271/bbb.59.1793; Asakura T, 1997, J AGR FOOD CHEM, V45, P1070, DOI 10.1021/jf960582x; Barrett A J, 2000, NATURE ENCY LIFE SCI, DOI [10.1038/npg.els.0000670, DOI 10.1038/NPG.ELS.0000670]; Baumlein H, 1995, J MOL EVOL, V41, P1070, DOI 10.1007/BF00173188; Bleukx W, 2000, J CEREAL SCI, V32, P31, DOI 10.1006/jcrs.2000.0300; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen JJ, 2008, P NATL ACAD SCI USA, V105, P11436, DOI 10.1073/pnas.0804761105; Chen JJ, 2009, GENE, V442, P108, DOI 10.1016/j.gene.2009.04.021; Copley SD, 2012, J BIOL CHEM, V287, P3, DOI 10.1074/jbc.R111.254714; Devaraj KB, 2008, PHYTOCHEMISTRY, V69, P647, DOI 10.1016/j.phytochem.2007.09.003; Dominguez F, 1999, PLANT PHYSIOL, V119, P81, DOI 10.1104/pp.119.1.81; Dunwell JM, 2004, PHYTOCHEMISTRY, V65, P7, DOI 10.1016/j.phytochem.2003.08.016; Dunwell JM, 2001, TRENDS BIOCHEM SCI, V26, P740, DOI 10.1016/S0968-0004(01)01981-8; Dunwell JM, 2000, MICROBIOL MOL BIOL R, V64, P153, DOI 10.1128/MMBR.64.1.153-179.2000; Felicioli R, 1997, ANAL BIOCHEM, V244, P176, DOI 10.1006/abio.1996.9917; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Fontana A, 1997, J MOL BIOL, V266, P223, DOI 10.1006/jmbi.1996.0787; FOX JW, 1991, ACS SYM SER, V460, P62; Garcia-Lorenzo M, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-30; Geer LY, 2010, NUCLEIC ACIDS RES, V38, pD492, DOI 10.1093/nar/gkp858; Gerlt JA, 2012, J BIOL CHEM, V287, P29, DOI 10.1074/jbc.R111.240945; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; He FL, 2007, J EXP BOT, V58, P1059, DOI 10.1093/jxb/erl267; Huang JY, 2013, J EXP BOT, V64, P3351, DOI 10.1093/jxb/ert173; Igarashi Y, 2009, NUCLEIC ACIDS RES, V37, pD611, DOI 10.1093/nar/gkn683; Ivanisenko VA, 2004, NUCLEIC ACIDS RES, V32, pW549, DOI 10.1093/nar/gkh439; Kazanov MD, 2011, J PROTEOME RES, V10, P3642, DOI 10.1021/pr200271w; Ko TP, 2000, ACTA CRYSTALLOGR D, V56, P411, DOI 10.1107/S0907444900002237; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LAWRENCE MC, 1994, J MOL BIOL, V238, P748, DOI 10.1006/jmbi.1994.1333; Lees JG, 2006, BIOINFORMATICS, V22, P1955, DOI 10.1093/bioinformatics/btl327; Lobley A, 2002, BIOINFORMATICS, V18, P211, DOI 10.1093/bioinformatics/18.1.211; Martinez-Camacho JL, 2004, J PLANT PHYSIOL, V161, P1289, DOI 10.1016/j.jplph.2004.05.010; Maruyama N, 2003, BBA-PROTEINS PROTEOM, V1648, P99, DOI 10.1016/S1570-9639(03)00113-4; Maruyama N, 2001, EUR J BIOCHEM, V268, P3595, DOI 10.1046/j.1432-1327.2001.02268.x; Maruyama Y, 2004, ACTA CRYSTALLOGR D, V60, P289, DOI 10.1107/S0907444903027367; Meng EC, 2011, CURR OPIN STRUC BIOL, V21, P391, DOI 10.1016/j.sbi.2011.03.007; Muntz K, 1996, J EXP BOT, V47, P605, DOI 10.1093/jxb/47.5.605; Natarajan S, 2007, J PLANT PHYSIOL, V164, P756, DOI 10.1016/j.jplph.2006.05.014; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Poldermans B., 1990, PROTEOLYTIC ENZYMES; QI XQ, 1992, PLANT PHYSIOL, V99, P725, DOI 10.1104/pp.99.2.725; Qureshi TM, 2012, DAIRY SCI TECHNOL, V92, P613, DOI 10.1007/s13594-012-0078-1; Rao MB, 1998, MICROBIOL MOL BIOL R, V62, P597, DOI 10.1128/MMBR.62.3.597-635.1998; SATAKE M, 1963, J BIOCHEM-TOKYO, V53, P438, DOI 10.1093/oxfordjournals.jbchem.a127720; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Shutov AD, 2003, J EXP BOT, V54, P1645, DOI 10.1093/jxb/erg165; SHUTOV AD, 1987, PHYTOCHEMISTRY, V26, P1557, DOI 10.1016/S0031-9422(00)82245-1; Shutov A, 2012, J PLANT PHYSIOL, V169, P1227, DOI 10.1016/j.jplph.2012.06.004; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Straganz GD, 2006, CHEMBIOCHEM, V7, P1536, DOI 10.1002/cbic.200600152; Tan-Wilson AL, 2012, PHYSIOL PLANTARUM, V145, P140, DOI 10.1111/j.1399-3054.2011.01535.x; Tandang-Silvas MRG, 2010, BBA-PROTEINS PROTEOM, V1804, P1432, DOI 10.1016/j.bbapap.2010.02.016; Turk B, 2012, EMBO J, V31, P1630, DOI 10.1038/emboj.2012.42; Uhlig H, 1998, INDUSTRIAL ENZYMES T; Woo EJ, 2000, NAT STRUCT BIOL, V7, P1036	61	8	10	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2016	11	4							e0152819	10.1371/journal.pone.0152819	http://dx.doi.org/10.1371/journal.pone.0152819			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0KH	27064905	gold, Green Published, Green Submitted			2022-12-27	WOS:000373891000019
J	Hajizadeh, S; Tehrani, FR; Simbar, M; Farzadfar, F				Hajizadeh, Shayesteh; Tehrani, Fahimeh Ramezani; Simbar, Masoumeh; Farzadfar, Farshad			Effects of Recruiting Midwives into a Family Physician Program on Women's Awareness and Preference for Mode of Delivery and Caesarean Section Rates in Rural Areas of Kurdistan	PLOS ONE			English	Article							PRIMARY-CARE; HUMAN-RESOURCES; HEALTH; IRAN; OUTCOMES; BIRTH; FEAR; DETERMINANTS; PROVIDERS; REQUEST	Background The accepted rate rate of caesarean section is 15%. It is expected that an increase in the density of midwives in the family physician program lead to a decrease in this indicator. This study aimed to compare the rates of caesarean section and women's awareness and preference for mode of delivery before and after the implementation of the family physician program in health centres with and without an increase in midwives density. Methods In this cross-sectional study, using multistage cluster sampling method a total of 668 mothers with two-month-old children were selected from among all mothers with two-month-old children who were living in rural areas of Kurdistan province. Using the difference-in-differences model and Matchit statistical model, the factors associated with caesarean section rates and women's awareness and preference for mode of delivery were compared in centres with and without an increase in midwives density after the implementation of the family physician program. To compare the changes before and after the program, we used the data collected from the same number of women in 2005 as the baseline. Results After adjusting for baseline data collected in 2005, the resutls showed no significant change in caesarean section rates and women's awareness and preference for mode of delivery in the centres with and without an increase in midwives density after the implementation of the family physician program. The Matchit model showed a significant mean increase 14%(0.03-0.25) in women's awareness of the benefits of natural childbirth between 2005 and 2013 in health centres where the density of midwives increased compared with health centres where it did not. The difference-in-differences model showed that the odds ratio of women's preference for caesarean section decreased by 41% among participants who were aware of the benefits of natural childbirth, (OR = 0.59, 95% CI: (0.22-0.85); P>0.001). Conclusions The results of this study showed that an increase in the density of midwives in the family physician program led to an increase in women's awareness of the benefits of natural childbirth. An increase in women's awareness of the benefits of natural childbirth was associated with a decreased preference for caesarean section, however this reduction did not have a significant impact on caesarean section rates; possibly, this finding might be attributed to the complexity of this problem that needs a mixed strategy involving various stockholders.	[Hajizadeh, Shayesteh; Simbar, Masoumeh] Shahid Beheshti Univ Med Sci, Fac Nursing & Midwifery, Midwifery & Reprod Hlth Dept, Tehran, Iran; [Tehrani, Fahimeh Ramezani] Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Reprod Endocrinol Res Ctr, Tehran, Iran; [Farzadfar, Farshad] Univ Tehran Med Sci, Endocrinol & Metab Populat Sci Inst, Noncommunicable Dis Res Ctr, Tehran, Iran	Shahid Beheshti University Medical Sciences; Shahid Beheshti University Medical Sciences; Tehran University of Medical Sciences	Tehrani, FR (corresponding author), Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Reprod Endocrinol Res Ctr, Tehran, Iran.	ramezani@endocrine.ac.ir	Simbar, Masoumeh/AAB-4352-2019; Tehrani, Fahimeh Ramezani/H-6133-2017	Simbar, Masoumeh/0000-0003-2843-3150; Tehrani, Fahimeh Ramezani/0000-0002-4609-065X; Farzadfar, Farshad/0000-0001-8288-4046	Ministry of Health and Medical Education, Research deputy of Shahid Beheshti University of Medical Sciences, Health deputy of Kurdistan University of Medical sciences	Ministry of Health and Medical Education, Research deputy of Shahid Beheshti University of Medical Sciences, Health deputy of Kurdistan University of Medical sciences	This article has been part of PhD thesis on the women of Kurdistan, Iran. The total budget for this research allocated by Shahid Beheshti University of Medical Science in Iran was nearly $1500.; The authors would like to thank the Ministry of Health and Medical Education, Research deputy of Shahid Beheshti University of Medical Sciences, Health deputy of Kurdistan University of Medical sciences for their supports. It is worth mentioning that this study was part of a PhD thesis on Reproductive Health which was conducted by Shayesteh Hajizadeh I (PhD student of Reproductive Health, School of Nursing and Midwifery, Shahid Beheshti University of Medical Sciences).	Ahmad-Nia S, 2009, East Mediterr Health J, V15, P1389; Aiken LH, 2002, JAMA-J AM MED ASSOC, V288, P1987, DOI 10.1001/jama.288.16.1987; Anand S, 2004, LANCET, V364, P1603, DOI 10.1016/S0140-6736(04)17313-3; [Anonymous], 1985, LANCET, V2, P436; Atout MM, 2012, CANADIAN J SCI IND R, V3, P179; Badakhsh MH, 2012, ARCH IRAN MED, V15, P4, DOI 012151/AIM.004; Behague DP, 2002, BMJ-BRIT MED J, V324, P942, DOI 10.1136/bmj.324.7343.942; BELIZAN JM, 1991, LANCET, V338, P1462, DOI 10.1016/0140-6736(91)92763-R; Belizan JM, 1999, BMJ-BRIT MED J, V319, P1397, DOI 10.1136/bmj.319.7222.1397; BHATIA JC, 1995, INT J GYNECOL OBSTET, V50, pS153, DOI 10.1016/0020-7292(95)02504-6; Busato A, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-8; Campbell RJ, 2003, FAM MED, V35, P60; Chalmers B, 2010, BIRTH-ISS PERINAT C, V37, P44, DOI 10.1111/j.1523-536X.2009.00377.x; Chen L, 2004, LANCET, V364, P1984, DOI 10.1016/S0140-6736(04)17482-5; Deng W, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-285; Dodd JM, 2004, PLANNED EFFECTIVE RE; Dorsi E, 2006, ARTIGO ARTICLE, V22, P2067, DOI [10.1186/s12978-015- 0114-8, DOI 10.1186/S12978-015-0114-8, DOI 10.1590/S0102-311X2006001000012]; Farzadfar F, 2012, LANCET, V379, P47, DOI 10.1016/S0140-6736(11)61349-4; Ferrante JM, 2000, J AM BOARD FAM PRACT, V13, P408, DOI DOI 10.3122/15572625-13-6-408; Frankenberg E, 1995, Health Transit Rev, V5, P143; Frankenberg E, 2001, DEMOGRAPHY, V38, P253, DOI 10.1353/dem.2001.0014; Gagnon AJ, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002869.pub2; Gamble JA, 2000, BIRTH-ISS PERINAT C, V27, P256, DOI 10.1046/j.1523-536x.2000.00256.x; GonzalezPerez GJ, 1996, J EPIDEMIOL COMMUN H, V50, P225, DOI 10.1136/jech.50.2.225; Gulliford MC, 2002, J PUBLIC HEALTH MED, V24, P252, DOI 10.1093/pubmed/24.4.252; Harder VS, 2010, PSYCHOL METHODS, V15, P234, DOI 10.1037/a0019623; Hemminki E, 2009, ACTA OBSTET GYN SCAN, V88, P1138, DOI 10.1080/00016340903214957; Hopkins K, 2000, SOC SCI MED, V51, P725, DOI 10.1016/S0277-9536(99)00480-3; Horey D, 2004, INFORM PREGNANT WOME; Jiang M, 2011, MATERN CHILD HLTH J, V15, P1296, DOI 10.1007/s10995-010-0677-5; Keshtkar AA, 2008, ANAL TRENDS MATERNAL; Lauer J. A., 2010, DETERMINANTS CAESARE; Lotfi R, 2014, INT J PREVENTIVE MED, V5, P1552; Lumbiganon P, 2010, LANCET, V375, P490, DOI 10.1016/S0140-6736(09)61870-5; McCourt C, 2007, BIRTH-ISS PERINAT C, V34, P65, DOI 10.1111/j.1523-536X.2006.00147.x; Ministry of Health and Medical Education, 2012, OP GUID FAM PHYS PRO; Ministry of Health and Medical Education, 2008, REP SURV MON EV REPR; Needleman J, 2002, NEW ENGL J MED, V346, P1715, DOI 10.1056/NEJMsa012247; Nerum H, 2006, BIRTH-ISS PERINAT C, V33, P221, DOI 10.1111/j.1523-536X.2006.00107.x; O'Connor AM, 2009, DECISION AIDS PEOPLE; Pierard E., 2009, THE EFFECT OF PHYSIC; Potter JE, 2001, BRIT MED J, V323, P1155, DOI 10.1136/bmj.323.7322.1155; Saisto T, 2001, OBSTET GYNECOL, V98, P820, DOI 10.1016/S0029-7844(01)01552-6; Sans-Corrales M, 2006, FAM PRACT, V23, P308, DOI 10.1093/fampra/cmi112; Shi LY, 2000, INT J HEALTH SERV, V30, P541, DOI 10.2190/N4M8-303M-72UA-P1K1; Stapleton H, 2002, BMJ-BRIT MED J, V324, P639, DOI 10.1136/bmj.324.7338.639; Takian A, 2013, FAM PRACT, V30, P551, DOI 10.1093/fampra/cmt025; Tang SL, 2006, AM J OBSTET GYNECOL, V195, P1527, DOI 10.1016/j.ajog.2006.03.044; Thomas J., 2001, NATL SENTINEL CAESAR; Villar J, 2007, BRIT MED J, V335, P1025, DOI 10.1136/bmj.39363.706956.55; Villar J, 2006, LANCET, V367, P1819, DOI 10.1016/S0140-6736(06)68704-7; Yazdizadeh B, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-159	52	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2016	11	4							e0151268	10.1371/journal.pone.0151268	http://dx.doi.org/10.1371/journal.pone.0151268			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DI6JK	27058952	Green Published, gold, Green Submitted			2022-12-27	WOS:000373604800002
J	Llopis-Torregrosa, V; Husekova, B; Sychrova, H				Llopis-Torregrosa, Vicent; Husekova, Barbora; Sychrova, Hana			Potassium Uptake Mediated by Trk1 Is Crucial for Candida glabrata Growth and Fitness	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; CATION HOMEOSTASIS; INTRACELLULAR PH; AFFINITY POTASSIUM; NA+/H+ ANTIPORTER; GENE DISRUPTION; YEAST; TRANSPORT; SODIUM; TOLERANCE	The maintenance of potassium homeostasis is crucial for all types of cells, including Candida glabrata. Three types of plasma-membrane systems mediating potassium influx with different transport mechanisms have been described in yeasts: the Trk1 uniporter, the Hak cation-proton symporter and the Acu ATPase. The C. glabrata genome contains only one gene encoding putative system for potassium uptake, the Trk1 uniporter. Therefore, its importance in maintaining adequate levels of intracellular potassium appears to be critical for C. glabrata cells. In this study, we first confirmed the potassium-uptake activity of the identified gene's product by heterologous expression in a suitable S. cerevisiae mutant, further we generated a corresponding deletion mutant in C. glabrata and analysed its phenotype in detail. The obtained results show a pleiotropic effect on the cell physiology when CgTRK1 is deleted, affecting not only the ability of trk1 Delta to grow at low potassium concentrations, but also the tolerance to toxic alkali-metal cations and cationic drugs, as well as the membrane potential and intracellular pH. Taken together, our results find the sole potassium uptake system in C. glabrata cells to be a promising target in the search for its specific inhibitors and in developing new antifungal drugs.	[Llopis-Torregrosa, Vicent; Husekova, Barbora; Sychrova, Hana] Acad Sci Czech Republ, Inst Physiol, Dept Membrane Transport, Prague, Czech Republic	Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences	Llopis-Torregrosa, V (corresponding author), Acad Sci Czech Republ, Inst Physiol, Dept Membrane Transport, Prague, Czech Republic.	Vicent.LlopisTorregrosa@fgu.cas.cz	Llopis, Vicent/AAW-2467-2021; Sychrova, Hana/B-1350-2012	Llopis, Vicent/0000-0003-1041-9676; Sychrova, Hana/0000-0001-5967-5019	Czech National Science Foundation [GA CR 302/12/1151, 16-03398S]; European Commission [MC-ITN-2013-606786 ImResFun]	Czech National Science Foundation(Grant Agency of the Czech Republic); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the Czech National Science Foundation (GA CR 302/12/1151 and 16-03398S) and the European Commission Framework 7 Programme (MC-ITN-2013-606786 ImResFun). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arino J, 2014, ADV MICROB PHYSIOL, V64, P1, DOI 10.1016/B978-0-12-800143-1.00001-4; Arino J, 2010, MICROBIOL MOL BIOL R, V74, P95, DOI 10.1128/MMBR.00042-09; Baev D, 2004, J BIOL CHEM, V279, P55060, DOI 10.1074/jbc.M411031200; Banuelos MA, 1998, MICROBIOL-UK, V144, P2749, DOI 10.1099/00221287-144-10-2749; Barreto L, 2011, EUKARYOT CELL, V10, P1241, DOI 10.1128/EC.05029-11; Benito B, 2004, EUKARYOT CELL, V3, P359, DOI 10.1128/EC.3.2.359-368.2004; Bertl A, 2003, MOL MICROBIOL, V47, P767, DOI 10.1046/j.1365-2958.2003.03335.x; Bihler H, 2002, BBA-BIOMEMBRANES, V1558, P109, DOI 10.1016/S0005-2736(01)00414-X; Bolotin-Fukuhara M, 2014, YEAST, V31, P279, DOI 10.1002/yea.3019; Borst A, 2005, ANTIMICROB AGENTS CH, V49, P783, DOI 10.1128/AAC.49.2.783-787.2005; CAMACHO M, 1981, CURR MICROBIOL, V6, P295, DOI 10.1007/BF01566880; Cyert MS, 2013, GENETICS, V193, P677, DOI 10.1534/genetics.112.147207; Dujon B, 2004, NATURE, V430, P35, DOI 10.1038/nature02579; Elicharova H, 2014, MICROBIOL-SGM, V160, P1705, DOI 10.1099/mic.0.078600-0; Enjalbert B, 2009, MOL MICROBIOL, V72, P216, DOI 10.1111/j.1365-2958.2009.06640.x; Gabaldon T, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-623; Gaskova D, 1998, YEAST, V14, P1189, DOI 10.1002/(SICI)1097-0061(19980930)14:13<1189::AID-YEA320>3.3.CO;2-B; Gelis S, 2015, MICROBIOL-SGM, V161, P1260, DOI 10.1099/mic.0.000078; Gomez MJ, 1996, FEMS MICROBIOL LETT, V135, P157, DOI 10.1016/0378-1097(95)00441-6; Hendrych T, 2009, BBA-BIOMEMBRANES, V1788, P717, DOI 10.1016/j.bbamem.2008.12.001; Herrera R, 2014, BBA-BIOMEMBRANES, V1838, P127, DOI 10.1016/j.bbamem.2013.08.022; HILL JE, 1986, YEAST, V2, P163, DOI 10.1002/yea.320020304; Ho HL, 2015, FEMS YEAST RES, V15, DOI 10.1093/femsyr/fov066; Husekova B, 2016, CAN J MICROBIOL, V62, P394, DOI 10.1139/cjm-2015-0766; JUST G, 1989, MYCOSES, V32, P47; Kahm M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002548; Kinclova O, 2001, MOL MICROBIOL, V40, P656, DOI 10.1046/j.1365-2958.2001.02412.x; Kinclova O, 2001, FEBS LETT, V504, P11, DOI 10.1016/S0014-5793(01)02755-7; Kodedova M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139306; Krauke Y, 2011, FEMS YEAST RES, V11, P29, DOI 10.1111/j.1567-1364.2010.00686.x; Krauke Y, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-80; Kurtzman CP, 1998, ANTON LEEUW INT J G, V73, P331, DOI 10.1023/A:1001761008817; Maresova L, 2010, YEAST, V27, P317, DOI 10.1002/yea.1755; Martinez JL, 2011, FUNGAL GENET BIOL, V48, P177, DOI 10.1016/j.fgb.2010.06.013; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Miranda M, 2009, FEMS YEAST RES, V9, P278, DOI 10.1111/j.1567-1364.2008.00471.x; MYERS AM, 1986, GENE, V45, P299, DOI 10.1016/0378-1119(86)90028-4; Navarrete C, 2010, FEMS YEAST RES, V10, P508, DOI 10.1111/j.1567-1364.2010.00630.x; Orij R, 2009, MICROBIOL-SGM, V155, P268, DOI 10.1099/mic.0.022038-0; Perlroth J, 2007, MED MYCOL, V45, P321, DOI 10.1080/13693780701218689; Petrezselyova S, 2011, FOLIA MICROBIOL, V56, P23, DOI 10.1007/s12223-011-0009-1; Pohl Hana R, 2013, Met Ions Life Sci, V13, P29, DOI 10.1007/978-94-007-7500-8_2; Ramos J, 2011, FEMS MICROBIOL LETT, V317, P1, DOI 10.1111/j.1574-6968.2011.02214.x; Reuss O, 2004, GENE, V341, P119, DOI 10.1016/j.gene.2004.06.021; Roetzer A, 2011, FEMS MICROBIOL LETT, V314, P1, DOI 10.1111/j.1574-6968.2010.02102.x; Stribny J, 2012, CURR GENET, V58, P255, DOI 10.1007/s00294-012-0381-7; Szczerba MW, 2009, J PLANT PHYSIOL, V166, P447, DOI 10.1016/j.jplph.2008.12.009; Ullah A, 2013, MICROBIOL-SGM, V159, P803, DOI 10.1099/mic.0.063610-0; Vale-Silva LA, 2015, FEMS YEAST RES, V15, DOI 10.1093/femsyr/fov025; Vermitsky JP, 2006, MOL MICROBIOL, V61, P704, DOI 10.1111/j.1365-2958.2006.05235.x; Yenush L, 2005, MOL CELL BIOL, V25, P8683, DOI 10.1128/MCB.25.19.8683-8692.2005; Zimmermannova O, 2015, FEMS YEAST RES, V15, DOI 10.1093/femsyr/fov029	52	12	13	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2016	11	4							e0153374	10.1371/journal.pone.0153374	http://dx.doi.org/10.1371/journal.pone.0153374			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6JK	27058598	Green Published, gold, Green Submitted			2022-12-27	WOS:000373604800031
J	Issop, L; Ostuni, MA; Lee, S; Laforge, M; Peranzi, G; Rustin, P; Benoist, JF; Estaquier, J; Papadopoulos, V; Lacapere, JJ				Issop, Leeyah; Ostuni, Mariano A.; Lee, Sunghoon; Laforge, Mireille; Peranzi, Gabriel; Rustin, Pierre; Benoist, Jean-Francois; Estaquier, Jerome; Papadopoulos, Vassilios; Lacapere, Jean-Jacques			Translocator Protein-Mediated Stabilization of Mitochondrial Architecture during Inflammation Stress in Colonic Cells	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; PERIPHERAL BENZODIAZEPINE-RECEPTOR; MANGANESE SUPEROXIDE-DISMUTASE; COLORECTAL-CANCER; BOWEL-DISEASE; 18 KDA; ANTISENSE KNOCKOUT; QUALITY-CONTROL; BINDING-SITES; IN-VITRO	Chronic inflammation of the gastrointestinal tract increasing the risk of cancer has been described to be linked to the high expression of the mitochondrial translocator protein (18 kDa; TSPO). Accordingly, TSPO drug ligands have been shown to regulate cytokine production and to improve tissue reconstruction. We used HT-29 human colon carcinoma cells to evaluate the role of TSPO and its drug ligands in tumor necrosis factor (TNF)-induced inflammation. TNF-induced interleukin (IL)-8 expression, coupled to reactive oxygen species (ROS) production, was followed by TSPO overexpression. TNF also destabilized mitochondrial ultrastructure, inducing cell death by apoptosis. Treatment with the TSPO drug ligand PK 11195 maintained the mitochondrial ultrastructure, reducing IL-8 and ROS production and cell death. TSPO silencing and overexpression studies demonstrated that the presence of TSPO is essential to control IL-8 and ROS production, so as to maintain mitochondrial ultrastructure and to prevent cell death. Taken together, our data indicate that inflammation results in the disruption of mitochondrial complexes containing TSPO, leading to cell death and epithelia disruption. Significance: This work implicates TSPO in the maintenance of mitochondrial membrane integrity and in the control of mitochondrial ROS production, ultimately favoring tissue regeneration.	[Issop, Leeyah; Peranzi, Gabriel; Lacapere, Jean-Jacques] Univ Paris 06, Ecole Normale Super, PSL Res Univ, Sorbonne Univ,Dept Chim,CNRS,UMR 7203,LBM, 4 Pl Jussieu, F-75005 Paris, France; [Issop, Leeyah; Lee, Sunghoon; Papadopoulos, Vassilios] McGill Univ, Ctr Hlth, Res Inst, Montreal, PQ H4A 3J1, Canada; [Issop, Leeyah; Lee, Sunghoon; Papadopoulos, Vassilios] McGill Univ, Dept Med, Montreal, PQ H4A 3J1, Canada; [Ostuni, Mariano A.] Univ Paris 07, Inst Natl Transfus Sanguine, INSERM, UMRS 1134, 6 Rue Alexandre Cabanel, F-75015 Paris, France; [Laforge, Mireille; Estaquier, Jerome] Univ Paris 05, CNRS FR 3636, Paris, France; [Rustin, Pierre; Benoist, Jean-Francois] Hop Robert Debre, INSERM, UMR 1141, F-75019 Paris, France; [Rustin, Pierre; Benoist, Jean-Francois] Univ Paris 07, F-75019 Paris, France; [Estaquier, Jerome] Univ Laval, Fac Med, Dept Microbiol Infectiol & Immunol, Quebec City, PQ G1V 06A, Canada	Arts et Metiers Institute of Technology; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Sorbonne Universite; Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); McGill University; McGill University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Laval University	Lacapere, JJ (corresponding author), Univ Paris 06, Ecole Normale Super, PSL Res Univ, Sorbonne Univ,Dept Chim,CNRS,UMR 7203,LBM, 4 Pl Jussieu, F-75005 Paris, France.	jean-jacqueslacapere@upmc.fr	Papadopoulos, Vassilios/AAI-2613-2019; , ESTAQUIER/AAR-7799-2020; OSTUNI, Mariano/J-2930-2015	Papadopoulos, Vassilios/0000-0002-1183-8568; , ESTAQUIER/0000-0002-9432-8044; OSTUNI, Mariano/0000-0001-6769-3786; benoist, jean-francois/0000-0002-5389-8585; ISSOP, LEEYAH/0000-0002-2359-7722	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (INSERM); Universities (UPMC, Paris Diderot); Agence Nationale de la Recherche [ANR BLAN-0190-01]; Ministere de la Recherche; Association contre les Maladies Mitochondriales (AMMi); Canadian Institutes of Health Research [MOP-125983]; Canada Research Chair in Biochemical Pharmacology	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Universities (UPMC, Paris Diderot); Agence Nationale de la Recherche(French National Research Agency (ANR)); Ministere de la Recherche(Ministry of Science and Innovation, Spain (MICINN)Ministry of Research, France); Association contre les Maladies Mitochondriales (AMMi); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chair in Biochemical Pharmacology	The authors are supported by the Centre National de la Recherche Scientifique (CNRS), the Institut National de la Sante et de la Recherche Medicale (INSERM), the Universities (UPMC, Paris Diderot), and grants from the Agence Nationale de la Recherche (ANR BLAN-0190-01 to JJL); the Ministere de la Recherche (fellowship to LI); Association contre les Maladies Mitochondriales (AMMi) to PR; and the Canadian Institutes of Health Research (MOP-125983) and the Canada Research Chair in Biochemical Pharmacology to VP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABREUMARTIN MT, 1995, J IMMUNOL, V155, P4147; Adli M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009428; Arnoult D, 2005, J BIOL CHEM, V280, P35742, DOI 10.1074/jbc.M505970200; AUGERON C, 1984, CANCER RES, V44, P3961; Bae KR, 2014, J NEUROIMMUNE PHARM, V9, P424, DOI 10.1007/s11481-014-9540-6; Batarseh A, 2010, BIOCHEMISTRY-US, V49, P4766, DOI 10.1021/bi100020e; Bribes E, 2004, J HISTOCHEM CYTOCHEM, V52, P19, DOI 10.1177/002215540405200103; Bruno MEC, 2005, J IMMUNOL, V174, P7278, DOI 10.4049/jimmunol.174.11.7278; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Cogliati S, 2013, CELL, V155, P160, DOI 10.1016/j.cell.2013.08.032; Da Cruz S, 2008, BBA-MOL CELL RES, V1783, P904, DOI 10.1016/j.bbamcr.2008.02.006; Delavoie F, 2003, BIOCHEMISTRY-US, V42, P4506, DOI 10.1021/bi0267487; Estaquier J, 2012, ADV EXP MED BIOL, V942, P157, DOI 10.1007/978-94-007-2869-1_7; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Garg AK, 2002, MOL IMMUNOL, V39, P509, DOI 10.1016/S0161-5890(02)00207-9; Gatenby RA, 2007, INT J BIOCHEM CELL B, V39, P1358, DOI 10.1016/j.biocel.2007.03.021; Gatliff J, 2014, AUTOPHAGY, V10, P2279, DOI 10.4161/15548627.2014.991665; GOOSSENS V, 1995, P NATL ACAD SCI USA, V92, P8115, DOI 10.1073/pnas.92.18.8115; Guillery O, 2008, BIOL CELL, V100, P315, DOI 10.1042/BC20070110; HACKENBROCK CR, 1971, J CELL BIOL, V51, P123, DOI 10.1083/jcb.51.1.123; Han ZQ, 2003, J RECEPT SIG TRANSD, V23, P225, DOI 10.1081/RRS-120025210; Hanna AN, 2001, MOL BIOL CELL, V12, P3618, DOI 10.1091/mbc.12.11.3618; Ho-Pun-Cheung A, 2008, ANN BIOL CLIN-PARIS, V66, P121, DOI 10.1684/abc.2008.0204; Jaremko L, 2014, SCIENCE, V343, P1363, DOI 10.1126/science.1248725; Jawad N, 2011, RECENT RESULTS CANC, V185, P99, DOI 10.1007/978-3-642-03503-6_6; JUNG HC, 1995, J CLIN INVEST, V95, P55, DOI 10.1172/JCI117676; KATZ Y, 1988, EUR J PHARMACOL, V148, P483, DOI 10.1016/0014-2999(88)90135-5; KATZ Y, 1990, ONCOLOGY, V47, P139; Kelly-Hershkovitz E, 1998, J BIOL CHEM, V273, P5478, DOI 10.1074/jbc.273.10.5478; Konigsrainer I, 2007, EUR SURG RES, V39, P359, DOI 10.1159/000106380; Koopman WJH, 2005, AM J PHYSIOL-CELL PH, V288, pC1440, DOI 10.1152/ajpcell.00607.2004; Kraus S, 2009, CURR OPIN PHARMACOL, V9, P405, DOI 10.1016/j.coph.2009.06.006; Levin E, 2005, BIOCHEMISTRY-US, V44, P9924, DOI 10.1021/bi050150s; Li W, 2007, BIOCHEM PHARMACOL, V73, P491, DOI 10.1016/j.bcp.2006.10.025; Lukas M, 2010, DIGEST DIS, V28, P619, DOI 10.1159/000320276; Maaser K, 2002, CLIN CANCER RES, V8, P3205; Manna SK, 1998, J BIOL CHEM, V273, P13245, DOI 10.1074/jbc.273.21.13245; Mills E, 2014, TRENDS CELL BIOL, V24, P313, DOI 10.1016/j.tcb.2013.11.008; Morales A, 1997, J BIOL CHEM, V272, P30371, DOI 10.1074/jbc.272.48.30371; Murail S, 2008, BIOCHIM BIOPHYS ACTA, V1778, P375; O'Neill LAJ, 2014, NATURE, V515, P350, DOI 10.1038/nature13941; Ostuni MA, 2007, BIOL CELL, V99, P639, DOI 10.1042/BC20070048; Ostuni MA, 2010, INFLAMM BOWEL DIS, V16, P1476, DOI 10.1002/ibd.21250; Papadopoulos V, 2006, TRENDS PHARMACOL SCI, V27, P402, DOI 10.1016/j.tips.2006.06.005; Peranzi G, 2010, METHODS MOL BIOL, V654, P221, DOI 10.1007/978-1-60761-762-4_12; Porporato PE, 2014, CELL REP, V8, P754, DOI 10.1016/j.celrep.2014.06.043; Rahman I, 2006, NAT PROTOC, V1, P3159, DOI 10.1038/nprot.2006.378; Ramonaite R, 2014, WORLD J GASTROENTERO, V20, P12533, DOI 10.3748/wjg.v20.i35.12533; Reisinger V, 2008, J PROTEOMICS, V71, P277, DOI 10.1016/j.jprot.2008.05.004; ROUSSET M, 1986, BIOCHIMIE, V68, P1035, DOI 10.1016/S0300-9084(86)80177-8; RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8; Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777; SCHULZEOSTHOFF K, 1992, J BIOL CHEM, V267, P5317; Shoukrun R, 2008, PHARMACOGENET GENOM, V18, P977, DOI 10.1097/FPC.0b013e3283117d52; Taylor EB, 2011, BIOCHEM SOC T, V39, P1509, DOI 10.1042/BST0391509; Tondera D, 2009, EMBO J, V28, P1589, DOI 10.1038/emboj.2009.89; Vallette G, 1997, BRIT J PHARMACOL, V121, P187, DOI 10.1038/sj.bjp.0701118; VISNER GA, 1990, J BIOL CHEM, V265, P2856; Weisinger G, 2004, BIOCHEMISTRY-US, V43, P12315, DOI 10.1021/bi030251v; WONG GHW, 1988, SCIENCE, V242, P941, DOI 10.1126/science.3263703; ZENTELLA A, 1993, CYTOKINE, V5, P436, DOI 10.1016/1043-4666(93)90033-2; Zisman TL, 2008, WORLD J GASTROENTERO, V14, P2662, DOI 10.3748/wjg.14.2662	62	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0152919	10.1371/journal.pone.0152919	http://dx.doi.org/10.1371/journal.pone.0152919			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27054921	Green Published, gold, Green Submitted			2022-12-27	WOS:000373608000054
J	Kim, Y; Aw, TG; Rose, JB				Kim, Yiseul; Aw, Tiong Gim; Rose, Joan B.			Transporting Ocean Viromes: Invasion of the Aquatic Biosphere	PLOS ONE			English	Article							VIRAL COMMUNITIES; BALLAST WATER; VIRUSES; PHYTOPLANKTON; DIVERSITY; SHIPS	Studies of marine viromes (viral metagenomes) have revealed that DNA viruses are highly diverse and exhibit biogeographic patterns. However, little is known about the diversity of RNA viruses, which are mostly composed of eukaryotic viruses, and their biogeographic patterns in the oceans. A growth in global commerce and maritime traffic may accelerate spread of diverse and non-cosmopolitan DNA viruses and potentially RNA viruses from one part of the world to another. Here, we demonstrated through metagenomic analyses that failure to comply with mid-ocean ballast water exchange regulation could result in movement of viromes including both DNA viruses and RNA viruses (including potential viral pathogens) unique to geographic and environmental niches. Furthermore, our results showed that virus richness (known and unknown viruses) in ballast water is associated with distance between ballast water exchange location and its nearest shoreline as well as length of water storage time in ballast tanks (voyage duration). However, richness of only known viruses is governed by local environmental conditions and different viral groups have different responses to environmental variation. Overall, these results identified ballast water as a factor contributing to ocean virome transport and potentially increased exposure of the aquatic bioshpere to viral invasion.	[Kim, Yiseul; Rose, Joan B.] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA; [Aw, Tiong Gim; Rose, Joan B.] Michigan State Univ, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA	Michigan State University; Michigan State University	Kim, Y (corresponding author), Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA.	kimyise2@msu.edu			National Science Foundation, Partnerships for International Research and Education [OISE-0530174]	National Science Foundation, Partnerships for International Research and Education(National Science Foundation (NSF)NSF - Office of the Director (OD))	This study was supported by the National Science Foundation, Partnerships for International Research and Education (OISE-0530174).	de Carcer DA, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400127; Amalfitano S, 2015, HYDROBIOLOGIA, V746, P13, DOI 10.1007/s10750-014-2002-6; Angly FE, 2006, PLOS BIOL, V4, P2121, DOI 10.1371/journal.pbio.0040368; Balique F, 2015, VIRUSES-BASEL, V7, P2074, DOI 10.3390/v7042074; BOEHME J, 1993, MAR ECOL PROG SER, V97, P1, DOI 10.3354/meps097001; Breitbart M, 2002, P NATL ACAD SCI USA, V99, P14250, DOI 10.1073/pnas.202488399; Brum JR, 2015, SCIENCE, V348, DOI 10.1126/science.1261498; Bunge J, 2012, BIOINFORMATICS, V28, P1045, DOI 10.1093/bioinformatics/bts075; COCHLAN WP, 1993, MAR ECOL PROG SER, V92, P77, DOI 10.3354/meps092077; Culley AI, 2002, LIMNOL OCEANOGR, V47, P1508, DOI 10.4319/lo.2002.47.5.1508; Danovaro R, 2011, FEMS MICROBIOL REV, V35, P993, DOI 10.1111/j.1574-6976.2010.00258.x; David M, 2015, SPRINGER SERIES INVA, V8, P59; Dinsdale EA, 2008, NATURE, V452, P629, DOI 10.1038/nature06810; Djikeng A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007264; Drake LA, 2007, MAR POLLUT BULL, V55, P333, DOI 10.1016/j.marpolbul.2006.11.007; Fancello L, 2013, ISME J, V7, P359, DOI 10.1038/ismej.2012.101; Garigliany MM, 2014, SCI REP-UK, V4, DOI 10.1038/srep07552; GEF-UNDP-IMO GloBallast Partnerships IOI, 2009, GLOBALLAST MONOGRAPH, V17; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hurwitz BL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057355; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; International Maritime Organization, 2004, INT CONV CONTR MAN S; Ito T, 2013, J GEN VIROL, V94, P2094, DOI 10.1099/vir.0.052902-0; Jaykus LA, 1996, APPL ENVIRON MICROB, V62, P2074, DOI 10.1128/AEM.62.6.2074-2080.1996; Kim Y, 2015, ENVIRON SCI TECHNOL, V49, P8396, DOI 10.1021/acs.est.5b01633; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Leichsenring J, 2011, MAR POLLUT BULL, V62, P1103, DOI 10.1016/j.marpolbul.2011.01.034; Litchman E, 2010, ECOL LETT, V13, P1560, DOI 10.1111/j.1461-0248.2010.01544.x; Lopez-Bueno A, 2009, SCIENCE, V326, P858, DOI 10.1126/science.1179287; Martinez JM, 2014, ISME J, V8, P1079, DOI 10.1038/ismej.2013.214; Peng Y, 2012, BIOINFORMATICS, V28, P1420, DOI 10.1093/bioinformatics/bts174; R Development Core Team, 2010, R A LANGUAGE AND ENV; Roux S, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-76; Roux S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033641; Ruiz GM, 2000, NATURE, V408, P49, DOI 10.1038/35040695; Smits SL, 2013, EMERG INFECT DIS, V19, P1511, DOI 10.3201/eid1909.130404; Tseng CH, 2013, ISME J, V7, P2374, DOI 10.1038/ismej.2013.118; Van Tan L, 2014, SCI REP-UK, V4, DOI 10.1038/srep03967; Walker PJ, 2010, VET RES, V41, DOI 10.1051/vetres/2010022; Wang D, 2002, P NATL ACAD SCI USA, V99, P15687, DOI 10.1073/pnas.242579699; Williamson SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042047; Winter C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100600; Wommack KE, 2015, J MICROBIOL, V53, P181, DOI 10.1007/s12275-015-5068-6	43	17	19	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0152671	10.1371/journal.pone.0152671	http://dx.doi.org/10.1371/journal.pone.0152671			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27055282	gold, Green Published, Green Submitted			2022-12-27	WOS:000373608000034
J	Liew, KL; Jee, JM; Yap, I; Yong, PVC				Liew, Kah Leong; Jee, Jap Meng; Yap, Ivan; Yong, Phelim Voon Chen			In Vitro Analysis of Metabolites Secreted during Infection of Lung Epithelial Cells by Cryptococcus neoformans	PLOS ONE			English	Article							O-ACETYLATION; VIRULENCE; PATHWAY; BIOSYNTHESIS; METABOLOMICS; ADAPTATION; ANTIBODY; REVEALS; ACID	Cryptococcus neoformans is an encapsulated basidiomycetous yeast commonly associated with pigeon droppings and soil. The opportunistic pathogen infects humans through the respiratory system and the metabolic implications of C. neoformans infection have yet to be explored. Studying the metabolic profile associated with the infection could lead to the identification of important metabolites associated with pulmonary infection. Therefore, the aim of the study was to simulate cryptococcal infection at the primary site of infection, the lungs, and to identify the metabolic profile and important metabolites associated with the infection at low and high multiplicity of infections (MOI). The culture supernatant of lung epithelial cells infected with C. neoformans at MOI of 10 and 100 over a period of 18 hours were analysed using gas chromatography mass spectrometry. The metabolic profiles obtained were further analysed using multivariate analysis and the pathway analysis tool, MetaboAnalyst 2.0. Based on the results from the multivariate analyses, ten metabolites were selected as the discriminatory metabolites that were important in both the infection conditions. The pathways affected during early C. neoformans infection of lung epithelial cells were mainly the central carbon metabolism and biosynthesis of amino acids. Infection at a higher MOI led to a perturbance in the beta-alanine metabolism and an increase in the secretion of pantothenic acid into the growth media. Pantothenic acid production during yeast infection has not been documented and the beta-alanine metabolism as well as the pantothenate and CoA biosynthesis pathways may represent underlying metabolic pathways associated with disease progression. Our study suggested that a-alanine metabolism and the pantothenate and CoA biosynthesis pathways might be the important pathways associated with cryptococcal infection.	[Liew, Kah Leong; Jee, Jap Meng; Yong, Phelim Voon Chen] Taylors Univ, Sch Biosci, Subang Jaya, Selangor Darul, Malaysia; [Yap, Ivan] Int Med Univ, Dept Life Sci, Kuala Lumpur 57000, Malaysia	Taylor's University; International Medical University Malaysia	Yong, PVC (corresponding author), Taylors Univ, Sch Biosci, Subang Jaya, Selangor Darul, Malaysia.	phelimvoonchen.yong@taylors.edu.my	Yap, Ivan Kok Seng/ABD-4843-2020; Yong, Phelim VC/M-5961-2015	Yap, Ivan Kok Seng/0000-0002-7523-5352; Yong, Phelim VC/0000-0002-5817-7381	Exploratory Research Grant Scheme [ERGS/1/2012/STG03/TAYLOR/03/1]; Taylor's University Postgraduate Research Scholarship Programme	Exploratory Research Grant Scheme; Taylor's University Postgraduate Research Scholarship Programme	This work was supported by grants from Exploratory Research Grant Scheme (ERGS/1/2012/STG03/TAYLOR/03/1) to PVCY and Taylor's University Postgraduate Research Scholarship Programme to KLL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albuquerque P, 2014, MBIO, V5, DOI 10.1128/mBio.00986-13; Aliferis KA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111930; Arora S, 2006, INFECT IMMUN, V74, P4339, DOI 10.1128/IAI.01989-05; Bai YN, 2014, CLIN CHIM ACTA, V436, P207, DOI 10.1016/j.cca.2014.05.022; Beste DJV, 2013, CHEM BIOL, V20, P1012, DOI 10.1016/j.chembiol.2013.06.012; Bien CM, 2009, MOL MICROBIOL, V74, P672, DOI 10.1111/j.1365-2958.2009.06895.x; Birungi G, 2010, J PROTEOME RES, V9, P6523, DOI 10.1021/pr100727m; Bogdanov M, 2008, BRAIN, V131, P389, DOI 10.1093/brain/awm304; Choi JN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041654; Choo KhiKhi, 2015, British Microbiology Research Journal, V7, P100, DOI 10.9734/BMRJ/2015/16464; COGLIATI M, 2013, SCIENTIFICA, DOI DOI 10.1155/2013/675213; David J, 2015, FRONT CELL INFECT MI, V5, DOI 10.3389/fcimb.2015.00080; Flores CL, 2000, FEMS MICROBIOL REV, V24, P507, DOI 10.1111/j.1574-6976.2000.tb00553.x; Gostincar C, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00390; Griffiths EJ, 2012, MOL MICROBIOL, V86, P1404, DOI 10.1111/mmi.12065; Guimaraes AJ, 2010, CELL MICROBIOL, V12, P740, DOI 10.1111/j.1462-5822.2010.01430.x; Hu GG, 2008, MOL MICROBIOL, V69, P1456, DOI 10.1111/j.1365-2958.2008.06374.x; Janbon G, 2001, MOL MICROBIOL, V42, P453, DOI 10.1046/j.1365-2958.2001.02651.x; Kentner D, 2014, P NATL ACAD SCI USA, V111, P9929, DOI 10.1073/pnas.1406694111; Kouskoumvekaki I, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/525497; Kozel TR, 2003, INFECT IMMUN, V71, P2868, DOI 10.1128/IAI.71.5.2868-2875.2003; Kretschmer M, 2012, EUKARYOT CELL, V11, P1042, DOI 10.1128/EC.00128-12; Kronstad J, 2012, EUKARYOT CELL, V11, P109, DOI 10.1128/EC.05273-11; Lebeer S, 2007, J BACTERIOL, V189, P860, DOI 10.1128/JB.01394-06; Li Shu Shun, 2010, Proc Am Thorac Soc, V7, P186, DOI 10.1513/pats.200907-063AL; Liew KahLeong, 2012, African Journal of Biotechnology, V11, P10469; Liu OW, 2008, CELL, V135, P174, DOI 10.1016/j.cell.2008.07.046; Mapelli V, 2008, TRENDS BIOTECHNOL, V26, P490, DOI 10.1016/j.tibtech.2008.05.008; Mayer FL, 2013, VIRULENCE, V4, P119, DOI 10.4161/viru.22913; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Patel D, 2013, MBIO, V4, DOI 10.1128/mBio.00400-13; Robertson EJ, 2009, APPL ENVIRON MICROB, V75, P2528, DOI 10.1128/AEM.02846-08; Rude TH, 2002, INFECT IMMUN, V70, P5684, DOI 10.1128/IAI.70.10.5684-5694.2002; Saha DC, 2008, INDIAN J MED RES, V127, P483; Spry C, 2008, FEMS MICROBIOL REV, V32, P56, DOI 10.1111/j.1574-6976.2007.00093.x; Tay ST, 2010, MYCOSES, V53, P509, DOI 10.1111/j.1439-0507.2009.01750.x; White WH, 2001, J BIOL CHEM, V276, P10794, DOI 10.1074/jbc.M009804200; Zhang AH, 2013, CLIN CHIM ACTA, V418, P86, DOI 10.1016/j.cca.2012.12.024	38	20	21	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153356	10.1371/journal.pone.0153356	http://dx.doi.org/10.1371/journal.pone.0153356			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27054608	Green Submitted, gold, Green Published			2022-12-27	WOS:000373608000124
J	Wen, XY; Zhang, HW				Wen, Xinyu; Zhang, Huawei			Photoelectrochemical Properties of CuS-GeO2-TiO2 Composite Coating Electrode	PLOS ONE			English	Article							PHOTOCATALYTIC DECOMPOSITION; TITANIUM-DIOXIDE; TIO2; FILMS; DEGRADATION; NANOPARTICLES; DEPOSITION	The ITO (indium tin oxide) conductive glass-matrix CuS-GeO2-TiO2 composite coating was generated via EPD (electrophoretic deposition) and followed by a sintering treatment at 450 degrees C for 40 minutes. Characterizations of the CuS-GeO2-TiO2 composite coating were taken by SEM (scanning electron microscope), XRD (X-ray diffraction), EDX (energy dispersive X-ray), UV-Vis DRS (ultraviolet-visible diffuse reflection spectrum), and FT-IR (Fourier transform infrared spectroscopy). Results showed that CuS and GeO2 had dispersed in this CuS-GeO2-TiO2 composite coating (mass percentages for CuS and GeO2 were 1.23% and 2.79%, respectively). The electrochemical studies (cyclic voltammetry (CV), electrochemical impedance spectroscopy (EIS) and Tafel polarization) of this CuS-GeO2-TiO2 composite coating electrode were performed in pH = 9.51 Na2CO3-NaHCO3 buffer solution containing 0.50 mol/L CH3OH under the conditions of visible light, ultraviolet light (lambda = 365 nm), and dark (without light irradiation as control), respectively. Electrochemical studies indicated that this CuS-GeO2-TiO2 composite coating electrode had better photoelectrocatalytic activity than the pure TiO2 electrode in the electrocatalysis of methanol under visible light.	[Wen, Xinyu; Zhang, Huawei] Yunnan Normal Univ, Sch Tourism & Geog Sci, Kunming 650500, Peoples R China; [Wen, Xinyu] Fujian Normal Univ, Coll Chem & Chem Engn, Fuzhou 350117, Peoples R China	Yunnan Normal University; Fujian Normal University	Zhang, HW (corresponding author), Yunnan Normal Univ, Sch Tourism & Geog Sci, Kunming 650500, Peoples R China.	hwzhang@ynnu.edu.cn	Zhang, Huawei/H-1924-2016	Zhang, Huawei/0000-0002-8701-4266	College of Chemistry and Chemical Engineering	College of Chemistry and Chemical Engineering	The authors thank the College of Chemistry and Chemical Engineering for the support of this work. The authors also thank Guangchao Liang for his suggestion and comments of this contribution.	Bessekhouad Y, 2004, J PHOTOCH PHOTOBIO A, V163, P569, DOI 10.1016/j.jphotochem.2004.02.006; Butterfield IM, 1997, J APPL ELECTROCHEM, V27, P385, DOI 10.1023/A:1018453402332; Devi LG, 2009, CATAL COMMUN, V10, P794, DOI 10.1016/j.catcom.2008.11.041; Erokhina S, 2003, LANGMUIR, V19, P766, DOI 10.1021/la026433s; Feng JM, 2009, PROG ORG COAT, V64, P268, DOI 10.1016/j.porgcoat.2008.08.022; FUJISHIMA A, 1972, NATURE, V238, P37, DOI 10.1038/238037a0; Grzechulska J, 2000, WATER RES, V34, P1638, DOI 10.1016/S0043-1354(99)00275-4; Hu C, 2001, APPL CATAL B-ENVIRON, V30, P277; Kamat PV, 2002, CURR OPIN COLLOID IN, V7, P282, DOI 10.1016/S1359-0294(02)00069-9; Kang MG, 1999, J PHOTOCH PHOTOBIO A, V125, P119, DOI 10.1016/S1010-6030(99)00092-1; LINSEBIGLER AL, 1995, CHEM REV, V95, P735, DOI 10.1021/cr00035a013; Liu SX, 2007, J HAZARD MATER, V143, P257, DOI 10.1016/j.jhazmat.2006.09.026; Liu YH, 2008, J MATER SCI, V43, P5005, DOI 10.1007/s10853-008-2740-9; Lo SC, 2004, J HAZARD MATER, V114, P183, DOI 10.1016/j.jhazmat.2004.08.007; Molinari R, 2002, CATAL TODAY, V75, P77, DOI 10.1016/S0920-5861(02)00047-0; Moskalewicz T, 2002, SURF COAT TECH, V201, P7467; Murugan AV, 2006, MATER LETT, V60, P479, DOI 10.1016/j.matlet.2005.09.017; Peng F, 2003, CHINESE J CATAL+, V24, P243; Subasri R, 2003, ELECTROCHEM COMMUN, V5, P897, DOI 10.1016/j.elecom.2003.08.016; SUN SG, 1987, J ELECTROANAL CHEM, V236, P95, DOI 10.1016/0022-0728(87)88021-X; Takeuchi M, 2000, CATAL LETT, V67, P135, DOI 10.1023/A:1019065521567; Tang FQ, 2004, MATER RES BULL, V39, P2155, DOI 10.1016/j.materresbull.2004.08.012; Wang YQ, 1999, ACTA PHYS-CHIM SIN, V15, P222, DOI 10.3866/PKU.WHXB19990306; Wu Peng-fei, 2005, Corrosion Science and Protection Technology, V17, P104; Xu B., 2010, GUANGZHOU HUAGONG, V38, P147; Yamashita H, 2002, J PHOTOCH PHOTOBIO A, V148, P257, DOI 10.1016/S1010-6030(02)00051-5; Zacharias M, 1997, APPL PHYS LETT, V71, P380, DOI 10.1063/1.119543; Zhang ZX, 2000, J WUHAN U NAT SCI ED, V46, P84; Zhong LS, 2007, CHEM MATER, V19, P4557, DOI 10.1021/cm0714032	29	9	9	2	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0152862	10.1371/journal.pone.0152862	http://dx.doi.org/10.1371/journal.pone.0152862			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27055277	Green Published, Green Submitted, gold			2022-12-27	WOS:000373608000050
J	Weidner, C; Rousseau, M; Plauth, A; Wowro, SJ; Fischer, C; Abdel-Aziz, H; Sauer, S				Weidner, Christopher; Rousseau, Morten; Plauth, Annabell; Wowro, Sylvia J.; Fischer, Cornelius; Abdel-Aziz, Heba; Sauer, Sascha			Iberis amara Extract Induces Intracellular Formation of Reactive Oxygen Species and Inhibits Colon Cancer	PLOS ONE			English	Article							ANTIINFLAMMATORY PROPERTIES; STW-5 IBEROGAST(R); PLANT POLYPHENOLS; ANTIOXIDANTS; THERAPY; HEALTH; CELLS; PROLIFERATION; CHEMOTHERAPY; ANTICANCER	Massively increasing global incidences of colorectal cancer require efficient treatment and prevention strategies. Here, we report unexpected anticancerogenic effects of hydroethanolic Iberis amara extract (IAE), which is known as a widely used phytomedical product for treating gastrointestinal complaints. IAE significantly inhibited the proliferation of HT-29 and T84 colon carcinoma cells with an inhibitory concentration (IC50) of 6 and 9 mu g/ml, respectively, and further generated inhibitory effects in PC-3 prostate and MCF7 breast cancer cells. Inhibition of proliferation in HT-29 cells was associated with a G2/M phase cell cycle arrest including reduced expression of various regulatory marker proteins. Notably, in HT-29 cells IAE further induced apoptosis by intracellular formation of reactive oxygen species (ROS). Consistent with predictions derived from our in vitro experiments, bidaily oral gavage of 50 mg/kg of IAE over 4 weeks resulted in significant inhibition of tumor growth in a mouse HT-29 tumor xenograft model. Taken together, Iberis amara extracts could become useful alternatives for preventing and treating the progression of colon cancer.	[Weidner, Christopher; Rousseau, Morten; Plauth, Annabell; Wowro, Sylvia J.; Fischer, Cornelius; Sauer, Sascha] Max Planck Inst Mol Genet, Otto Warburg Lab, Ihnestr 73, D-14195 Berlin, Germany; [Abdel-Aziz, Heba] Steigerwald Arzneimittelwerk GmbH, Dept Sci, Darmstadt, Germany; [Sauer, Sascha] Univ Wurzburg, CU Syst Med, D-97070 Wurzburg, Germany	Max Planck Society; Bayer AG; Steigerwald Pharmaceutical Factory GmbH; University of Wurzburg	Sauer, S (corresponding author), Max Planck Inst Mol Genet, Otto Warburg Lab, Ihnestr 73, D-14195 Berlin, Germany.; Sauer, S (corresponding author), Univ Wurzburg, CU Syst Med, D-97070 Wurzburg, Germany.	sauer@molgen.mpg.de		Wowro, Sylvia/0000-0003-1728-9210; Plauth, Annabell/0000-0002-4521-1368	German Ministry for Education and Research (BMBF) [0315082, 01EA1303]; Steigerwald Arzneimittelwerk GmbH	German Ministry for Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Steigerwald Arzneimittelwerk GmbH	This work was supported by the German Ministry for Education and Research (BMBF, grant numbers 0315082, 01EA1303). Author HAA was supported by Steigerwald Arzneimittelwerk GmbH in the form of salary. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammon HPT, 2006, PHYTOMEDICINE, V13, P67, DOI 10.1016/j.phymed.2006.08.004; Bonaterra GA, 2013, PHYTOMEDICINE, V20, P691, DOI 10.1016/j.phymed.2013.02.011; Bouayed J, 2010, OXID MED CELL LONGEV, V3, P228, DOI 10.4161/oxim.3.4.12858; Braun Michael S, 2011, Ther Adv Med Oncol, V3, P43, DOI 10.1177/1758834010388342; Brenner H, 2014, LANCET, V383, P1490, DOI 10.1016/S0140-6736(13)61649-9; Dinkova-Kostova AT, 2012, TRENDS MOL MED, V18, P337, DOI 10.1016/j.molmed.2012.04.003; Fadok VA, 1998, CELL DEATH DIFFER, V5, P551, DOI 10.1038/sj.cdd.4400404; Forester SC, 2011, MOL NUTR FOOD RES, V55, P844, DOI 10.1002/mnfr.201000641; Fuhr L, 2015, J NAT PROD, V78, P1160, DOI 10.1021/np500747y; Germann I, 2006, PHYTOMEDICINE, V13, P45, DOI 10.1016/j.phymed.2006.03.018; Halliwell B, 2008, ARCH BIOCHEM BIOPHYS, V476, P107, DOI 10.1016/j.abb.2008.01.028; HARTWELL LH, 1994, SCIENCE, V266, P1821, DOI 10.1126/science.7997877; Hayes JD, 2008, EUR J NUTR, V47, P73, DOI 10.1007/s00394-008-2009-8; Hoensch Harald P, 2005, Int J Gastrointest Cancer, V35, P187, DOI 10.1385/IJGC:35:3:187; Khan HY, 2012, CURR DRUG TARGETS, V13, P1738; Ko JSK, 2013, CURR PHARM DESIGN, V19, P48, DOI 10.2174/13816128130109; Kong YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103760; Kroll U, 2006, PHYTOMEDICINE, V13, P12, DOI 10.1016/j.phymed.2006.03.016; Mitchison TJ, 2012, MOL BIOL CELL, V23, P1, DOI 10.1091/mbc.E10-04-0335; Quideau S, 2011, ANGEW CHEM INT EDIT, V50, P586, DOI 10.1002/anie.201000044; Ristow M, 2009, P NATL ACAD SCI USA, V106, P8665, DOI 10.1073/pnas.0903485106; Schempp H, 2006, PHYTOMEDICINE, V13, P36, DOI 10.1016/j.phymed.2006.03.017; Shekhar MPV, 2011, CURR CANCER DRUG TAR, V11, P613; Wagner H, 2009, PHYTOMEDICINE, V16, P97, DOI 10.1016/j.phymed.2008.12.018; Weidner C, 2015, PHYTOMEDICINE, V22, P262, DOI 10.1016/j.phymed.2014.12.008; Weidner C, 2014, MOL NUTR FOOD RES, V58, P903, DOI 10.1002/mnfr.201300477; Weidner C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080335; Yang Y, 2013, CURR MED CHEM, V20, P3677, DOI 10.2174/0929867311320999165	28	17	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0152398	10.1371/journal.pone.0152398	http://dx.doi.org/10.1371/journal.pone.0152398			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050665	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000373603500037
J	Choi, SH; Kim, SH; Shim, KW; Han, JW; Choi, J; Kim, DS; Lyu, CJ; Kim, JW; Suh, CO; Cho, J				Choi, Seo Hee; Kim, Se Hoon; Shim, Kyu-Won; Han, Jung Woo; Choi, Junjeong; Kim, Dong-Seok; Lyu, Chuhl Joo; Kim, Jun Won; Suh, Chang-Ok; Cho, Jaeho			Treatment Outcome and Prognostic Molecular Markers of Supratentorial Primitive Neuroectodermal Tumors	PLOS ONE			English	Article							CELL LUNG-CANCER; YOUNG-CHILDREN; BRAIN-TUMORS; INTENSIVE CHEMOTHERAPY; BREAST-CANCER; RAD51; EXPRESSION; SURVIVAL; RADIOTHERAPY; RADIATION	Background To identify prognostic factors and define the optimal management of patients with supratentorial primitive neuroectodermal tumors (sPNETs), we investigated treatment outcomes and explored the prognostic value of specific molecular markers. Methods A total of 47 consecutive patients with pathologically confirmed sPNETs between May 1985 and June 2012 were included. Immunohistochemical analysis of LIN28, OLIG2, and Rad51 expression was performed and correlated with clinical outcome. Results With a median follow-up of 70 months, 5-year overall survival (OS) and progression-free survival (PFS) was 55.5% and 40%, respectively, for all patients. Age, surgical extent, and radiotherapy were significant prognostic factors for OS and PFS. Patients who received initially planned multimodal treatment without interruption (i.e., radiotherapy and surgery (>= subtotal resection), with or without chemotherapy) showed significantly higher 5-year OS (71.2%) and PFS (63.1%). In 29 patients with available tumor specimens, tumors with high expression of either LIN28 or OLIG2 or elevated level of Rad51 were significantly associated with poorer prognosis. Conclusions We found that multimodal treatment improved outcomes for sPNET patients, especially when radiotherapy and >= subtotal resection were part of the treatment regimen.	[Choi, Seo Hee; Suh, Chang-Ok; Cho, Jaeho] Yonsei Univ, Coll Med, Dept Radiat Oncol, Seoul, South Korea; [Kim, Se Hoon] Yonsei Univ, Coll Med, Dept Pathol, Seoul, South Korea; [Shim, Kyu-Won; Kim, Dong-Seok] Yonsei Univ, Coll Med, Dept Neurosurg, Seoul, South Korea; [Han, Jung Woo; Lyu, Chuhl Joo] Yonsei Univ, Coll Med, Dept Pediat, Seoul, South Korea; [Choi, Junjeong] Yonsei Univ, Coll Med, Coll Pharm, Dept Pharm, Seoul, South Korea; [Kim, Jun Won] Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Radiat Oncol, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Cho, J (corresponding author), Yonsei Univ, Coll Med, Dept Radiat Oncol, Seoul, South Korea.	jjhmd@yuhs.ac	Choi, Seo-hee/AFL-9783-2022; Choi, Seo-hee/AAH-1969-2022	Kim, Se Hoon/0000-0001-7516-7372; Kim, Jun Won/0000-0003-1358-364X; Han, Jung Woo/0000-0001-8936-1205; Shim, Kyuwon/0000-0002-9441-7354; Cho, Jaeho/0000-0001-9966-5157; Lyu, Chuhl Joo/0000-0001-7124-7818; Choi, Seo Hee/0000-0002-4083-6414				Burnett ME, 1997, CANCER GENET CYTOGEN, V97, P25, DOI 10.1016/S0165-4608(96)00319-6; COHEN BH, 1995, J CLIN ONCOL, V13, P1687, DOI 10.1200/JCO.1995.13.7.1687; Dirks PB, 1996, J NEURO-ONCOL, V29, P75, DOI 10.1007/BF00165520; Fangusaro J, 2008, PEDIATR BLOOD CANCER, V50, P312, DOI [10.1002/pbc.21307, 10.1002/pbc.21555]; Gandhi R, 2013, J NEURO-ONCOL, V114, P141, DOI 10.1007/s11060-013-1163-x; Hansen LT, 2003, INT J CANCER, V105, P472, DOI 10.1002/ijc.11106; Jakacki RI, 1999, CHILD NERV SYST, V15, P586, DOI 10.1007/s003810050547; Johnston DL, 2008, J NEURO-ONCOL, V86, P101, DOI 10.1007/s11060-007-9440-1; Kim DG, 2002, J NEURO-ONCOL, V60, P43, DOI 10.1023/A:1020207902659; Korshunov A, 2010, ACTA NEUROPATHOL, V120, P253, DOI 10.1007/s00401-010-0688-8; Le Scodan R, 2010, INT J RADIAT ONCOL, V78, P328, DOI 10.1016/j.ijrobp.2009.07.1735; Li MH, 2009, CANCER CELL, V16, P533, DOI 10.1016/j.ccr.2009.10.025; Li Y, 2011, J SURG ONCOL, V104, P617, DOI 10.1002/jso.22018; Mason WP, 1998, J CLIN ONCOL, V16, P210, DOI 10.1200/JCO.1998.16.1.210; McBride SM, 2008, INT J RADIAT ONCOL, V72, P1319, DOI 10.1016/j.ijrobp.2008.03.033; Ohnishi T, 1998, BIOCHEM BIOPH RES CO, V245, P319, DOI 10.1006/bbrc.1998.8440; Paulino AC, 2004, INT J RADIAT ONCOL, V58, P1171, DOI 10.1016/j.ijrobp.2003.08.022; Picard D, 2012, LANCET ONCOL, V13, P838, DOI 10.1016/S1470-2045(12)70257-7; Pizer BL, 2006, EUR J CANCER, V42, P1120, DOI 10.1016/j.ejca.2006.01.039; Qiao GB, 2005, BRIT J CANCER, V93, P137, DOI 10.1038/sj.bjc.6602665; Reddy AT, 2000, CANCER, V88, P2189, DOI 10.1002/(SICI)1097-0142(20000501)88:9<2189::AID-CNCR27>3.0.CO;2-G; Richardson C, 2005, CANCER LETT, V218, P127, DOI 10.1016/j.canlet.2004.08.009; Russo C, 1999, CANCER, V86, P331, DOI 10.1002/(SICI)1097-0142(19990715)86:2<331::AID-CNCR18>3.0.CO;2-#; Soderlund K, 2007, RADIOTHER ONCOL, V84, P242, DOI 10.1016/j.radonc.2007.06.012; Tennstedt P, 2013, INT J CANCER, V132, P2118, DOI 10.1002/ijc.27907; Timmermann B, 2006, J CLIN ONCOL, V24, P1554, DOI 10.1200/JCO.2005.04.8074; Timmermann B, 2002, J CLIN ONCOL, V20, P842, DOI 10.1200/JCO.20.3.842; Vispe S, 1998, NUCLEIC ACIDS RES, V26, P2859, DOI 10.1093/nar/26.12.2859; von Bueren AO, 2012, LANCET ONCOL, V13, P753, DOI 10.1016/S1470-2045(12)70260-7; Welsh JW, 2009, INT J RADIAT ONCOL, V74, P1251, DOI 10.1016/j.ijrobp.2009.03.018	30	14	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153443	10.1371/journal.pone.0153443	http://dx.doi.org/10.1371/journal.pone.0153443			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27074032	Green Submitted, Green Published, gold			2022-12-27	WOS:000374131200094
J	Kalinowski, M; Gradzki, Z; Jarosz, L; Kato, K; Hieda, Y; Kakuda, T; Takai, S				Kalinowski, Marcin; Gradzki, Zbigniew; Jarosz, Lukasz; Kato, Kiyoko; Hieda, Yu; Kakuda, Tsutomu; Takai, Shinji			Plasmid Profiles of Virulent Rhodococcus equi Strains Isolated from Infected Foals in Poland	PLOS ONE			English	Article							FRAGMENT-LENGTH-POLYMORPHISMS; HORSE-BREEDING FARMS; 87-KB TYPE-I; CLINICAL-MANIFESTATIONS; MOLECULAR EPIDEMIOLOGY; SOIL; PREVALENCE; PATHOGENESIS; ENVIRONMENT; DIAGNOSIS	Rhodococcus equi is an important bacterial pathogen in foals up to 6 months old, widespread in horse farms all over the world. It was found that only virulent R. equi strains expressing 15-17 kDa virulence-associated protein (VapA) and having large virulence plasmid of 85-90 kb containing vapA gene are pathogenic for horses. To date, 12 plasmid types have been reported in VapA positive strains from horses. There are no data concerning plasmid types of Polish field R. equi strains isolated from horses and horse farm environment. The aim of the study is to determine plasmid profiles of virulent R. equi strains isolated in Poland from dead foals as well as from soil samples taken from horse breeding farms. Plasmid profiles of 10 clinical strains derived from 8 farms and 11 environmental strains from 3 farms, confirmed as virulent by PCR, were compared with 12 reference strains containing the known plasmid size and type. Plasmid DNAs were analysed by digestion with the restriction endonucleases BamHI, EcoRI, EcoT22I, and HindIII for detailed comparison and estimation of plasmid sizes. The results of RFLP analysis revealed that all except one isolates used in the study are classified as VapA 85 kb type I plasmid. One strain harboured VapA 87 kb type I plasmid. This is the first report of plasmid types of Polish field R. equi strains. The results of our preliminary investigations on horse farms located in central and eastern Poland indicate that the virulent R. equi strains thus far isolated from diseased foals and horse farms environment represent a highly uniform plasmid pattern.	[Kalinowski, Marcin; Gradzki, Zbigniew; Jarosz, Lukasz] Univ Life Sci Lublin, Dept Epizootiol, Fac Vet Med, Lublin, Poland; [Kalinowski, Marcin; Gradzki, Zbigniew; Jarosz, Lukasz] Univ Life Sci Lublin, Clin Infect Dis, Fac Vet Med, Lublin, Poland; [Kato, Kiyoko; Hieda, Yu; Kakuda, Tsutomu; Takai, Shinji] Kitasato Univ, Sch Vet Med & Anim Sci, Towada, Aomori 034, Japan	University of Life Sciences in Lublin; University of Life Sciences in Lublin; Kitasato University	Kalinowski, M (corresponding author), Univ Life Sci Lublin, Dept Epizootiol, Fac Vet Med, Lublin, Poland.; Kalinowski, M (corresponding author), Univ Life Sci Lublin, Clin Infect Dis, Fac Vet Med, Lublin, Poland.	marcin.kalinowski@up.lublin.pl	Grądzki, Zbigniew/R-6589-2018; Kalinowski, Marcin/AAQ-3950-2020	Grądzki, Zbigniew/0000-0002-5390-3225; Kakuda, Tsutomu/0000-0002-0951-2884; Jarosz, Lukasz/0000-0002-4914-1758; Kalinowski, Marcin/0000-0003-4769-5471				Bell KS, 1996, LETT APPL MICROBIOL, V23, P72, DOI 10.1111/j.1472-765X.1996.tb00033.x; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; Cohen ND, 2014, VET CLIN N AM-EQUINE, V30, P609, DOI 10.1016/j.cveq.2014.08.010; Duquesne F, 2010, FEMS MICROBIOL LETT, V311, P76, DOI 10.1111/j.1574-6968.2010.02070.x; Giguere S, 1997, VET MICROBIOL, V56, P313, DOI 10.1016/S0378-1135(97)00099-0; Giguere S, 2011, J VET INTERN MED, V25, P1221, DOI 10.1111/j.1939-1676.2011.00804.x; Gradzki Z, 2006, MED WETER, V62, P1310; Hondalus MK, 1997, VET MICROBIOL, V56, P257, DOI 10.1016/S0378-1135(97)00094-1; Makrai L, 2002, VET MICROBIOL, V88, P377, DOI 10.1016/S0378-1135(02)00157-8; Makrai L, 2008, VET MICROBIOL, V131, P318, DOI 10.1016/j.vetmic.2008.04.009; Meijer WG, 2004, VET RES, V35, P383, DOI 10.1051/vetres:2004024; Muscatello G, 2007, EQUINE VET J, V39, P470, DOI 10.2746/042516407X209217; Muscatello G, 2012, VET J, V192, P20, DOI 10.1016/j.tvjl.2011.08.014; Nicholson VM, 1997, J CLIN MICROBIOL, V35, P738, DOI 10.1128/JCM.35.3.738-740.1997; Reuss SM, 2015, VET CLIN N AM-EQUINE, V31, P121, DOI 10.1016/j.cveq.2014.11.004; Ribeiro MG, 2005, COMP IMMUNOL MICROB, V28, P53, DOI 10.1016/j.cimid.2004.07.001; Sellon DC, 1997, AM J VET RES, V58, P1232; Son WG, 2006, J VET MED SCI, V68, P249, DOI 10.1292/jvms.68.249; Takai S, 1999, J CLIN MICROBIOL, V37, P3417, DOI 10.1128/JCM.37.10.3417-3420.1999; TAKAI S, 1991, J CLIN MICROBIOL, V29, P2887, DOI 10.1128/JCM.29.12.2887-2889.1991; TAKAI S, 1993, J CLIN MICROBIOL, V31, P1726, DOI 10.1128/JCM.31.7.1726-1729.1993; TAKAI S, 1991, INFECT IMMUN, V59, P4056, DOI 10.1128/IAI.59.11.4056-4060.1991; Takai S, 1997, VET MICROBIOL, V56, P167, DOI 10.1016/S0378-1135(97)00085-0; Takai S, 2005, J VET MED SCI, V67, P611, DOI 10.1292/jvms.67.611; Takai S, 2003, J INFECT DIS, V188, P1717, DOI 10.1086/379739; Takai S, 2003, J VET MED SCI, V65, P1313, DOI 10.1292/jvms.65.1313; Takai S, 2001, J VET DIAGN INVEST, V13, P489, DOI 10.1177/104063870101300606; Topino S, 2010, AIDS PATIENT CARE ST, V24, P211, DOI 10.1089/apc.2009.0248; Vazquez-Boland JA, 2013, VET MICROBIOL, V167, P9, DOI 10.1016/j.vetmic.2013.06.016; Venner M, 2007, RES VET SCI, V83, P311, DOI 10.1016/j.rvsc.2007.01.009; WOOLCOCK JB, 1979, J CLIN MICROBIOL, V9, P640; Zietek-Barszcz A, 2009, B VET I PULAWY, V53, P345	32	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0152887	10.1371/journal.pone.0152887	http://dx.doi.org/10.1371/journal.pone.0152887			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27074033	Green Published, Green Submitted, gold			2022-12-27	WOS:000374131200042
J	Kurita, T; Kikuchi, M; Yoshimura, Y; Hiraishi, H; Hasegawa, C; Takahashi, T; Hirosawa, T; Furutani, N; Higashida, H; Ikeda, T; Mutou, K; Asada, M; Minabe, Y				Kurita, Toshiharu; Kikuchi, Mitsuru; Yoshimura, Yuko; Hiraishi, Hirotoshi; Hasegawa, Chiaki; Takahashi, Tetsuya; Hirosawa, Tetsu; Furutani, Naoki; Higashida, Haruhiro; Ikeda, Takashi; Mutou, Kouhei; Asada, Minoru; Minabe, Yoshio			Atypical Bilateral Brain Synchronization in the Early Stage of Human Voice Auditory Processing in Young Children with Autism	PLOS ONE			English	Article							2-TO 5-YEAR-OLD CHILDREN; CORPUS-CALLOSUM; SPECTRUM DISORDERS; FUNCTIONAL CONNECTIVITY; STEM RESPONSES; WHITE-MATTER; DEVELOPMENTAL-CHANGES; LANGUAGE PERFORMANCE; EVOKED-RESPONSES; SPEECH SOUNDS	Autism spectrum disorder (ASD) has been postulated to involve impaired neuronal cooperation in large-scale neural networks, including cortico-cortical interhemispheric circuitry. In the context of ASD, alterations in both peripheral and central auditory processes have also attracted a great deal of interest because these changes appear to represent pathophysiological processes; therefore, many prior studies have focused on atypical auditory responses in ASD. The auditory evoked field (AEF), recorded by magnetoencephalography, and the synchronization of these processes between right and left hemispheres was recently suggested to reflect various cognitive abilities in children. However, to date, no previous study has focused on AEF synchronization in ASD subjects. To assess global coordination across spatially distributed brain regions, the analysis of Omega complexity from multichannel neurophysiological data was proposed. Using Omega complexity analysis, we investigated the global coordination of AEFs in 3-8-year-old typically developing (TD) children (n = 50) and children with ASD (n = 50) in 50-ms time-windows. Children with ASD displayed significantly higher Omega complexities compared with TD children in the time-window of 0-50 ms, suggesting lower whole brain synchronization in the early stage of the P1m component. When we analyzed the left and right hemispheres separately, no significant differences in any time-windows were observed. These results suggest lower right-left hemispheric synchronization in children with ASD compared with TD children. Our study provides new evidence of aberrant neural synchronization in young children with ASD by investigating auditory evoked neural responses to the human voice.	[Kurita, Toshiharu; Kikuchi, Mitsuru; Hirosawa, Tetsu; Furutani, Naoki; Higashida, Haruhiro; Mutou, Kouhei; Minabe, Yoshio] Kanazawa Univ, Dept Psychiat & Neurobiol, Grad Sch Med Sci, Kanazawa, Ishikawa 9208640, Japan; [Kikuchi, Mitsuru; Yoshimura, Yuko; Hiraishi, Hirotoshi; Hasegawa, Chiaki; Takahashi, Tetsuya] Kanazawa Univ, Res Ctr Child Mental Dev, Kanazawa, Ishikawa 9208640, Japan; [Ikeda, Takashi; Asada, Minoru] Osaka Univ, Dept Adapt Machine Syst, Grad Sch Engn, Suita, Osaka 5650871, Japan	Kanazawa University; Kanazawa University; Osaka University	Kikuchi, M (corresponding author), Kanazawa Univ, Dept Psychiat & Neurobiol, Grad Sch Med Sci, Kanazawa, Ishikawa 9208640, Japan.; Kikuchi, M (corresponding author), Kanazawa Univ, Res Ctr Child Mental Dev, Kanazawa, Ishikawa 9208640, Japan.	mitsuruk@med.kanazawa-u.ac.jp	Hasegawa, Chiaki/HHS-2658-2022; higashida, haruhiro/L-3773-2015	Hasegawa, Chiaki/0000-0001-8730-8769; Furutani, Naoki/0000-0001-5953-2114; higashida, haruhiro/0000-0002-1779-0606	MEXT [24000012]; Center of Innovation Program from Japan Science and Technology Agency, JST, Japan; Grants-in-Aid for Scientific Research [25461755, 26670537] Funding Source: KAKEN	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Center of Innovation Program from Japan Science and Technology Agency, JST, Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	MA is supported by a Grant-in-Aid for Specially Promoted Research from MEXT (Research Number 24000012, http://www.jsps.go.jp/english/e-grants/). YM is supported by the Center of Innovation Program from the Japan Science and Technology Agency, JST, Japan (http://www.mext.go.jp/a_menu/kagaku/coi/index.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander AL, 2007, NEUROIMAGE, V34, P61, DOI 10.1016/j.neuroimage.2006.08.032; American Psychiatric Association, 1994, DIAGNOSTIC AND STATI; Anderson JS, 2011, CEREB CORTEX, V21, P1134, DOI 10.1093/cercor/bhq190; Anderson V., 2007, JPN KOREAN LINGUIST, V15, P43; Bailey T, 2012, APPL NEUROPSYCH-CHIL, V1, P112, DOI 10.1080/21622965.2012.703890; Brito AR, 2009, J NEUROIMAGING, V19, P337, DOI 10.1111/j.1552-6569.2009.00366.x; Brock J, 2013, J AUTISM DEV DISORD, V43, P2726, DOI 10.1007/s10803-013-1805-z; Cacace AT, 1998, J SPEECH LANG HEAR R, V41, P355, DOI 10.1044/jslhr.4102.355; Cardy JEO, 2005, NEUROREPORT, V16, P521, DOI 10.1097/00001756-200504040-00021; Cardy JEO, 2005, NEUROREPORT, V16, P329, DOI 10.1097/00001756-200503150-00005; Cardy JEO, 2004, NEUROREPORT, V15, P1867, DOI 10.1097/00001756-200408260-00006; Cherkassky VL, 2006, NEUROREPORT, V17, P1687, DOI 10.1097/01.wnr.0000239956.45448.4c; Cook HM, 1990, THE SENTENCE FINAL P; Demopoulos C, 2016, AUTISM RES, V9, P107, DOI 10.1002/aur.1495; Dinstein I, 2011, NEURON, V70, P1218, DOI 10.1016/j.neuron.2011.04.018; Edgar JC, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00417; Flagg EJ, 2005, NEUROSCI LETT, V386, P82, DOI 10.1016/j.neulet.2005.05.037; Gage NM, 2003, NEUROREPORT, V14, P2047, DOI 10.1097/00001756-200311140-00008; Gage NM, 2003, DEV BRAIN RES, V144, P201, DOI 10.1016/S0165-3806(03)00172-X; Ghanbari Y, 2012, LECT NOTES COMPUT SC, V7512, P231, DOI 10.1007/978-3-642-33454-2_29; Gilley PM, 2005, CLIN NEUROPHYSIOL, V116, P648, DOI 10.1016/j.clinph.2004.09.009; Hardan AY, 2000, NEUROLOGY, V55, P1033, DOI 10.1212/WNL.55.7.1033; Hiraishi H, 2015, PSYCHIAT CLIN NEUROS, V69, P153, DOI 10.1111/pcn.12261; Hitoglou M, 2010, PEDIATR NEUROL, V42, P309, DOI 10.1016/j.pediatrneurol.2009.10.009; Johnson BW, 2010, CLIN NEUROPHYSIOL, V121, P340, DOI 10.1016/j.clinph.2009.10.017; Kajikawa S, 2004, J CHILD LANG, V31, P215, DOI 10.1017/S0305000903005968; Kaufman A. S, 2004, KAUFMAN BRIEF INTELL; Keary CJ, 2009, J AUTISM DEV DISORD, V39, P834, DOI 10.1007/s10803-009-0689-4; Keller TA, 2007, NEUROREPORT, V18, P23, DOI 10.1097/01.wnr.0000239965.21685.99; Kennedy DP, 2008, NEUROIMAGE, V39, P1877, DOI 10.1016/j.neuroimage.2007.10.052; Khalfa S, 2001, EUR J NEUROSCI, V13, P628, DOI 10.1046/j.1460-9568.2001.01423.x; Kikuchi M, 2015, SOC COGN AFFECT NEUR, V10, P248, DOI 10.1093/scan/nsu049; Kikuchi M, 2013, NEUROIMAGE-CLIN, V2, P394, DOI 10.1016/j.nicl.2013.03.003; Kikuchi M, 2013, SCI REP-UK, V3, DOI 10.1038/srep01139; Kikuchi M, 2011, J NEUROSCI, V31, P14984, DOI 10.1523/JNEUROSCI.2785-11.2011; KLIN A, 1993, J AUTISM DEV DISORD, V23, P15, DOI 10.1007/BF01066416; Lord C., 1999, DIAGNOSTIC OBSERVATI; Manes F, 1999, J NEUROPSYCH CLIN N, V11, P470, DOI 10.1176/jnp.11.4.470; Matsuzaki J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102599; Matsuzaki J, 2012, NEUROREPORT, V23, P113, DOI 10.1097/WNR.0b013e32834ebf44; Monk CS, 2009, NEUROIMAGE, V47, P764, DOI 10.1016/j.neuroimage.2009.04.069; Orekhova EV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039906; Patterson RD, 2008, PHILOS T R SOC B, V363, P1023, DOI 10.1098/rstb.2007.2157; Ponton C, 2002, CLIN NEUROPHYSIOL, V113, P407, DOI 10.1016/S1388-2457(01)00733-7; Remijn GB, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00170; Roberts T. P, 2011, BIOL PSYCHIAT; Roberts TPL, 2013, BRAIN RES, V1537, P79, DOI 10.1016/j.brainres.2013.09.011; Roberts TPL, 2010, AUTISM RES, V3, P8, DOI 10.1002/aur.111; Rosenhall U, 2003, EAR HEARING, V24, P206, DOI 10.1097/01.AUD.0000069326.11466.7E; Roth DAE, 2012, DEV MED CHILD NEUROL, V54, P23, DOI 10.1111/j.1469-8749.2011.04149.x; Schadow J, 2009, NEUROIMAGE, V47, P651, DOI 10.1016/j.neuroimage.2009.04.074; Scheich H, 2011, HEARING RES, V271, P3, DOI 10.1016/j.heares.2010.10.006; Schmidt GL, 2009, NEUROREPORT, V20, P1037, DOI 10.1097/WNR.0b013e32832e0ca7; Seither-Preisler A, 2014, J NEUROSCI, V34, P10937, DOI 10.1523/JNEUROSCI.5315-13.2014; Sharma A, 1997, EVOKED POTENTIAL, V104, P540, DOI 10.1016/S0168-5597(97)00050-6; SKOFF BF, 1980, PSYCHIAT RES, V2, P157, DOI 10.1016/0165-1781(80)90072-4; Squires T., 2009, PRAGMATICS, V4, P1; Stanfield AC, 2008, EUR PSYCHIAT, V23, P289, DOI 10.1016/j.eurpsy.2007.05.006; TANGUAY PE, 1982, ARCH GEN PSYCHIAT, V39, P174; Vidal CN, 2006, BIOL PSYCHIAT, V60, P218, DOI 10.1016/j.biopsych.2005.11.011; Wackermann J, 1996, ACTA NEUROBIOL EXP, V56, P197; Wackermann J, 1999, INT J PSYCHOPHYSIOL, V34, P65, DOI 10.1016/S0167-8760(99)00038-0; Wilson TW, 2007, BIOL PSYCHIAT, V62, P192, DOI 10.1016/j.biopsych.2006.07.002; Wing L, 2002, J CHILD PSYCHOL PSYC, V43, P307, DOI 10.1111/1469-7610.00023; Wolff JJ, 2012, AM J PSYCHIAT, V169, P589, DOI 10.1176/appi.ajp.2011.11091447; Yoshimura Y, 2014, NEUROIMAGE, V101, P440, DOI 10.1016/j.neuroimage.2014.07.034; Yoshimura Y, 2012, EUR J NEUROSCI, V35, P644, DOI 10.1111/j.1460-9568.2012.07998.x	67	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153077	10.1371/journal.pone.0153077	http://dx.doi.org/10.1371/journal.pone.0153077			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ3UC	27074011	Green Published, Green Submitted, gold			2022-12-27	WOS:000374131200051
J	Little, A; Elliott, B; Conneller, C; Pomstra, D; Evans, AA; Fitton, LC; Holland, A; Davis, R; Kershaw, R; O'Connor, S; O'Connor, T; Sparrow, T; Wilson, AS; Jordan, P; Collins, MJ; Colonese, AC; Craig, OE; Knight, R; Lucquin, AJA; Taylor, B; Milner, N				Little, Aimee; Elliott, Benjamin; Conneller, Chantal; Pomstra, Diederik; Evans, Adrian A.; Fitton, Laura C.; Holland, Andrew; Davis, Robert; Kershaw, Rachel; O'Connor, Sonia; O'Connor, Terry; Sparrow, Thomas; Wilson, Andrew S.; Jordan, Peter; Collins, Matthew J.; Colonese, Andre Carlo; Craig, Oliver E.; Knight, Rebecca; Lucquin, Alexandre J. A.; Taylor, Barry; Milner, Nicky			Technological Analysis of the World's Earliest Shamanic Costume: A Multi-Scalar, Experimental Study of a Red Deer Headdress from the Early Holocene Site of Star Carr, North Yorkshire, UK	PLOS ONE			English	Article							PRODUCTS; POTTERY; BURIAL	Shamanic belief systems represent the first form of religious practice visible within the global archaeological record. Here we report on the earliest known evidence of shamanic costume: modified red deer crania headdresses from the Early Holocene site of Star Carr (c. 11 kya). More than 90% of the examples from prehistoric Europe come from this one site, establishing it as a place of outstanding shamanistic/cosmological significance. Our work, involving a programme of experimental replication, analysis of macroscopic traces, organic residue analysis and 3D image acquisition, metrology and visualisation, represents the first attempt to understand the manufacturing processes used to create these artefacts. The results produced were unexpected-rather than being carefully crafted objects, elements of their production can only be described as expedient.	[Little, Aimee; Elliott, Benjamin; Fitton, Laura C.; Davis, Robert; O'Connor, Terry; Collins, Matthew J.; Colonese, Andre Carlo; Craig, Oliver E.; Knight, Rebecca; Lucquin, Alexandre J. A.] Univ York, Dept Archaeol, BioArCh, York YO10 5DD, N Yorkshire, England; [Conneller, Chantal] Univ Manchester, Sch Arts Languages & Cultures, Manchester, Lancs, England; [Pomstra, Diederik] Leiden Univ, Fac Archaeol, Leiden, Netherlands; [Evans, Adrian A.; Holland, Andrew; Kershaw, Rachel; O'Connor, Sonia; Sparrow, Thomas; Wilson, Andrew S.] Univ Bradford, Sch Archaeol Sci, Bradford BD7 1DP, W Yorkshire, England; [Jordan, Peter] Univ Groningen, Arctic Ctr, Groningen, Netherlands; [Taylor, Barry] Dept Hist & Archaeol, Chester, Cheshire, England; [Fitton, Laura C.] Hull York Med Sch, York, N Yorkshire, England	University of York - UK; University of Manchester; Leiden University; Leiden University - Excl LUMC; University of Bradford; University of Groningen; University of Hull; University of York - UK	Little, A (corresponding author), Univ York, Dept Archaeol, BioArCh, York YO10 5DD, N Yorkshire, England.	aimee.little@york.ac.uk	Colonese, Andre Carlo/AAA-9266-2020; Jordan, Peter/HDO-4721-2022; Evans, Adrian/ABE-2632-2020; Lucquin, Alexandre/K-9045-2017	Colonese, Andre Carlo/0000-0002-0279-6634; Jordan, Peter/0000-0002-2837-3920; Evans, Adrian/0000-0003-3612-7372; wilson, andrew/0000-0003-1346-937X; Holland, Andrew/0000-0003-0554-822X; Elliott, Benjamin/0000-0002-2456-1983; Lucquin, Alexandre/0000-0003-4892-6323	European Research Council [283938]; English Heritage [6793, 6796]; Arts and Humanities Research Council [AH/L00688X/1]; Vale of Pickering Research Trust; AHRC [AH/K006169/1, AH/J007935/1, AH/L00688X/1] Funding Source: UKRI; Arts and Humanities Research Council [AH/K006169/1, AH/J007935/1] Funding Source: researchfish	European Research Council(European Research Council (ERC)European Commission); English Heritage; Arts and Humanities Research Council(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC)); Vale of Pickering Research Trust; AHRC(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC)); Arts and Humanities Research Council(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC))	European Research Council funded the POSTGLACIAL Project, No. 283938. NM received the funding. English Heritage funded part of this research, grant numbers 6793 and 6796. NM received the funding. The funders supported the excavation of the site of Star Carr which led to the discovery of the headdress, its analysis, and the preparation of this manuscript. The Arts and Humanities Research Council funded the 'Fragmented Heritage' Research Project (AH/L00688X/1), under which aspects of the acquisition and metrology of 3D data presented by this research took place. ASW and AAE received this funding.; We thank the landowners, English Heritage and Natural England for allowing excavations on the site and the support from the Vale of Pickering Research Trust. Further thanks to the British Deer Society for providing the deer skull. This manuscript benefited from the anonymous reviewers' comments, to who we are grateful.	Bevan L, 2003, PEOPLING MESOLITHIC, V1157, P35; Chatterton R., 2003, PEOPLING MESOLITHIC, P69; Clark G., 1954, EXCAVATIONS STAR CAR; Conneller, 2011, ARCHAEOLOGY MAT SUBS; Conneller C., 2004, ARCHAEOL DIALOG, V11, P37, DOI DOI 10.1017/S1380203804001357; Conneller C, 2003, P PREHIST SOC, V65, P85; Craig OE, 2007, ARCHAEOMETRY, V49, P135, DOI 10.1111/j.1475-4754.2007.00292.x; Craig OE, 2012, RAPID COMMUN MASS SP, V26, P2359, DOI 10.1002/rcm.6349; Driscoll-Engelstad B, 2005, ARCTIC ANTHROPOL, V42, P33, DOI 10.1353/arc.2011.0010; Du Bois C., 1936, AM ARCHAEOLOGY ETHNO, V36, P1; Elliott B., 2010, P PREHIST SOC, V76, P75, DOI DOI 10.1017/S0079497X00000451; Gifford E., 1936, AM ARCHAEOLOGY ETHNO, V36, P247; Grant J., 2008, ARCHAEOLOGY COURSEBO; Grosman L, 2008, P NATL ACAD SCI USA, V105, P17665, DOI 10.1073/pnas.0806030105; Hansel FA, 2004, TETRAHEDRON LETT, V45, P2999, DOI 10.1016/j.tetlet.2004.01.111; Heyne FG, 1999, ASIAN FOLKLORE STUD, V58, P377, DOI 10.2307/1179101; Jordan P., 2003, MAT CULTURE SACRED L; Lane P, 2004, HUNTER GATHERERS HIS; Lawson John, 1967, NEW VOYAGE CAROLINA; Milo RG, 1998, J ARCHAEOL SCI, V25, P99, DOI 10.1006/jasc.1997.0233; Moyne de Morgues L., 1875, NARRATIVE LE MOYNE A; Oliva M., 2005, PALAEOLITHIC MESOLIT, P11; PENTIKAINEN Juha, 1996, SHAMANISM NO ECOLOGY; Pernet H., 2006, RITUAL MASKS DECEPTI; Porr M, 2006, INT J OSTEOARCHAEOL, V16, P395, DOI 10.1002/oa.839; Regert M, 2003, MEAS SCI TECHNOL, V14, P1620, DOI 10.1088/0957-0233/14/9/313; Schmidt Robert, 2000, ARCHAEOLOGIES SEXUAL, P220; Smart Ninian, 1989, WORLDS RELIG OLD TRA; Strachey W., 1953, HIST TRAVEL VIRINGIA; Vitebsky P., 2006, REINDEER PEOPLE LIVI; Vitebsky Piers, 2005, REINDEER PEOPLE LIVI; Wetmore R., 1975, 1 LAND N CAROLINA IN; Zvelebil M., 1993, ARCHAEOLOGICAL REV C, V12, P51	33	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0152136	10.1371/journal.pone.0152136	http://dx.doi.org/10.1371/journal.pone.0152136			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	DJ3UC	27073850	Green Published, Green Accepted, gold			2022-12-27	WOS:000374131200016
J	Nielsen, NO; Bjerregaard, P; Ronn, PF; Friis, H; Andersen, S; Melbye, M; Lundqvist, M; Cohen, AS; Hougaard, DM; Jorgensen, ME				Nielsen, Nina O.; Bjerregaard, Peter; Ronn, Pernille F.; Friis, Henrik; Andersen, Stig; Melbye, Mads; Lundqvist, Marika; Cohen, Arieh S.; Hougaard, David M.; Jorgensen, Marit E.			Associations between Vitamin D Status and Type 2 Diabetes Measures among Inuit in Greenland May Be Affected by Other Factors	PLOS ONE			English	Article							CIRCULATING 25-HYDROXYVITAMIN D; SERUM 25-HYDROXYVITAMIN-D; 1,25-DIHYDROXYVITAMIN D-3; RECEPTOR EXPRESSION; INSULIN-RESISTANCE; RISK; GLUCOSE; METAANALYSIS; POPULATION; CALCIUM	Objective Epidemiological studies have provided evidence of an association between vitamin D insufficiency and type 2 diabetes. Vitamin D levels have decreased among Inuit in Greenland, and type 2 diabetes is increasing. We hypothesized that the decline in vitamin D could have contributed to the increase in type 2 diabetes, and therefore investigated associations between serum 25(OH)D3 as a measure of vitamin D status and glucose homeostasis and glucose intolerance in an adult Inuit population. Methods 2877 Inuit (>= 18 years) randomly selected for participation in the Inuit Health in Transition study were included. Fasting-and 2 hour plasma glucose and insulin, C-peptide and HbA(1c) were measured, and associations with serum 25(OH)D3 were analysed using linear and logistic regression. A subsample of 330 individuals who also donated a blood sample in 1987, were furthermore included. Results After adjustment, increasing serum 25(OH)D3 (per 10 nmol/L) was associated with higher fasting plasma glucose (0.02 mmol/L, p = 0.004), 2hour plasma glucose (0.05 nmol/L, p = 0.002) and HbA(1 c) (0.39%, p<0.001), and with lower beta-cell function (-1.00 mmol/L, p<0.001). Serum 25(OH) D3 was positively associated with impaired fasting glycaemia (OR: 1.08, p = 0.001), but not with IGT or type 2 diabetes. Conclusions Our results did not support an association between low vitamin D levels and risk of type 2 diabetes. Instead, we found weak positive associations between vitamin D levels and fasting- and 2 hour plasma glucose levels, HbA(1c) and impaired fasting glycaemia, and a negative association with beta-cell function, underlining the need for determination of the causal relationship.	[Nielsen, Nina O.; Bjerregaard, Peter; Jorgensen, Marit E.] Univ Southern Denmark, Natl Inst Publ Hlth, Copenhagen, Denmark; [Bjerregaard, Peter] Univ Greenland, Greeenland Ctr Hlth Res, Nuuk, Greenland; [Ronn, Pernille F.; Jorgensen, Marit E.] Steno Diabet Ctr, DK-2820 Gentofte, Denmark; [Ronn, Pernille F.] Aarhus Univ, Dept Publ Hlth, Aarhus, Denmark; [Friis, Henrik] Univ Copenhagen, Dept Nutr Exercise & Sports, Copenhagen, Denmark; [Andersen, Stig] Aalborg Univ Hosp, Aalborg, Denmark; [Melbye, Mads] Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark; [Lundqvist, Marika; Cohen, Arieh S.; Hougaard, David M.] Statens Serum Inst, Dept Congenital Disorders, DK-2300 Copenhagen, Denmark	University of Southern Denmark; Steno Diabetes Center; Aarhus University; University of Copenhagen; Aalborg University; Aalborg University Hospital; Statens Serum Institut; Statens Serum Institut	Nielsen, NO (corresponding author), Univ Southern Denmark, Natl Inst Publ Hlth, Copenhagen, Denmark.	noni@niph.dk	Bjerregaard, Peter/ABD-8894-2020; Friis, Henrik/N-2047-2014; Rønn, Pernille Falberg/AAT-3523-2021; Hougaard, David/AAD-6368-2019; Andersen, Stig/J-2636-2015; Friis, Henrik/P-2891-2019	Bjerregaard, Peter/0000-0001-7153-8447; Friis, Henrik/0000-0002-2848-2940; Rønn, Pernille Falberg/0000-0001-6338-6615; Friis, Henrik/0000-0002-2848-2940; Andersen, Stig/0000-0003-3632-5213; Nielsen, Nina Odgaard/0000-0001-6127-5970; Jorgensen, Marit Eika/0000-0001-8356-5565; melbye, mads/0000-0001-8264-6785	Government of Greenland's health department [2011-047012/2012-074239]; Aase and Ejnar Danielsen's Foundation [10-000444]; Dagmar Marshalls Foundation	Government of Greenland's health department; Aase and Ejnar Danielsen's Foundation; Dagmar Marshalls Foundation	The study was supported by the Government of Greenland's health department (2011-047012/2012-074239), Aase and Ejnar Danielsen's Foundation (10-000444), and Dagmar Marshalls Foundation. All grants were received by NON. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afzal S, 2013, CLIN CHEM, V59, P381, DOI 10.1373/clinchem.2012.193003; Agborsangaya C, 2010, NUTR CANCER, V62, P51, DOI 10.1080/01635580903191460; Andersen S, 2013, BRIT J NUTR, V110, P50, DOI 10.1017/S0007114512004709; Andersen S, 2013, BRIT J NUTR, V109, P928, DOI 10.1017/S0007114512002097; Bell DSH, 2011, SOUTH MED J, V104, P335, DOI 10.1097/01.SMJ.0000397893.94525.0e; Bjerregaard P, 2010, SIF WRITINGS GREENLA, V19; Dahl-Petersen IK, 2013, DIABETES RES CLIN PR, V102, P242, DOI 10.1016/j.diabres.2013.10.004; Dahl-Petersen IK, 2013, MED SCI SPORT EXER, V45, P728, DOI 10.1249/MSS.0b013e31827a6b40; de Boer IH, 2008, DIABETES CARE, V31, P701, DOI 10.2337/dc07-1829; Durup D, 2015, J CLIN ENDOCR METAB, V100, P2339, DOI 10.1210/jc.2014-4551; Elder PA, 2008, CLIN CHEM, V54, P1993; Forouhi NG, 2012, DIABETOLOGIA, V55, P2173, DOI 10.1007/s00125-012-2544-y; Fukumoto Seiji, 2014, Bonekey Rep, V3, P497, DOI 10.1038/bonekey.2013.231; Gutt M, 2000, DIABETES RES CLIN PR, V47, P177, DOI 10.1016/S0168-8227(99)00116-3; Heaney RP, 2008, NUTR REV, V66, pS178, DOI 10.1111/j.1753-4887.2008.00102.x; HELDENBERG D, 1992, AM J CLIN NUTR, V56, P533, DOI 10.1093/ajcn/56.3.533; Husemoen LLN, 2012, EUR J CLIN NUTR, V66, P1309, DOI 10.1038/ejcn.2012.134; Husemoen LLN, 2012, DIABETES CARE, V35, P1695, DOI 10.2337/dc11-1309; Jeppesen C, 2015, ENVIRON RES, V143, P192, DOI 10.1016/j.envres.2015.10.013; Jorgensen ME, 2012, DIABETIC MED, V29, P755, DOI 10.1111/j.1464-5491.2011.03527.x; Jorgensen ME, 2010, J CLIN ENDOCR METAB, V95, pE333, DOI 10.1210/jc.2010-0710; Jorgensen ME, 2002, DIABETES CARE, V25, P1766, DOI 10.2337/diacare.25.10.1766; Kirii K, 2009, DIABETOLOGIA, V52, P2542, DOI 10.1007/s00125-009-1554-x; Knekt P, 2008, EPIDEMIOLOGY, V19, P666, DOI 10.1097/EDE.0b013e318176b8ad; Maestro B, 2002, CELL BIOCHEM FUNCT, V20, P227, DOI 10.1002/cbf.951; Maestro B, 2000, ENDOCR J, V47, P383, DOI 10.1507/endocrj.47.383; Miller GJ, 1995, CLIN CANCER RES, V1, P997; Misfeldt J, 1988, Arctic Med Res, V47, P173; Moltke I, 2014, NATURE, V512, P190, DOI 10.1038/nature13425; Nielsen NO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112949; Nielsen NO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080686; Nielsen NO, 2010, BRIT J NUTR, V104, P1487, DOI 10.1017/S0007114510002333; Pittas AG, 2006, DIABETES CARE, V29, P650, DOI 10.2337/diacare.29.03.06.dc05-1961; Pittas AG, 2007, J CLIN ENDOCR METAB, V92, P2017, DOI 10.1210/jc.2007-0298; Pittas AG, 2012, DIABETES CARE, V35, P565, DOI 10.2337/dc11-1795; Robinson JG, 2011, DIABETES CARE, V34, P628, DOI 10.2337/dc10-1632; Scragg R, 2004, DIABETES CARE, V27, P2813, DOI 10.2337/diacare.27.12.2813; Stadlmayr A, 2015, ACTA DIABETOL, V52, P39, DOI 10.1007/s00592-014-0596-9; Tuohimaa P, 2004, INT J CANCER, V108, P104, DOI 10.1002/ijc.11375; Webb AR, 2006, PROG BIOPHYS MOL BIO, V92, P17, DOI 10.1016/j.pbiomolbio.2006.02.004; WHO, 2006, DEFINITION AND DIAGN; Ye Z, 2015, LANCET DIABETES ENDO, V3, P35, DOI 10.1016/S2213-8587(14)70184-6; Yoon Jung Won, 2012, Korean J Pediatr, V55, P206, DOI 10.3345/kjp.2012.55.6.206	43	19	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0152763	10.1371/journal.pone.0152763	http://dx.doi.org/10.1371/journal.pone.0152763			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073876	gold, Green Published, Green Submitted			2022-12-27	WOS:000374131200036
J	Shrubovych, J; Bartel, D; Szucsich, NU; Resch, MC; Pass, G				Shrubovych, Julia; Bartel, Daniela; Szucsich, Nikolaus Urban; Resch, Monika Carol; Pass, Guenther			Morphological and Genetic Analysis of the Acerentomon doderoi Group (Protura: Acerentomidae) with Description of A. christiani sp nov	PLOS ONE			English	Article								Acerentomon christiani sp. nov. is described from Vienna, Austria. The new species is a member of the "doderoi" group, characterized by the presence of seta x on tergite VII. It is most similar to A. gallicum, A. brevisetosum and A. tenuisetosum, but differs from these species in the length of foretarsal sensillum c and certain other chaetotaxic measurements and indices. In addition to the morphological description, the DNA barcoding region of the mitochondrial cytochrome c oxidase subunit 1 gene (COI) and the 28S ribosomal RNA of the new species are provided. The morphological characters and the barcode of the new species are discussed in comparison to those of other Acerentomon species. An identification key to all known Acerentomon spp. of the "doderoi" group is given.	[Shrubovych, Julia] Polish Acad Sci, Inst Systemat & Evolut Anim, Krakow, Poland; [Bartel, Daniela; Szucsich, Nikolaus Urban; Resch, Monika Carol; Pass, Guenther] Univ Vienna, Dept Integrat Zool, Vienna, Austria; [Szucsich, Nikolaus Urban] Museum Nat Hist Vienna, Dept Zool 3, Vienna, Austria	Polish Academy of Sciences; Institute of Systematics & Evolution of Animals of the Polish Academy of Sciences; University of Vienna	Pass, G (corresponding author), Univ Vienna, Dept Integrat Zool, Vienna, Austria.	guenther.pass@univie.ac.at	Szucsich, Nikolaus/O-1776-2017; Shrubovych, Julia/F-9767-2014	Szucsich, Nikolaus/0000-0002-8945-5153; Shrubovych, Julia/0000-0002-8880-0007	ABOL, the Austrian Barcode of Life; FWF [P 20497-B17, P 23251-B17]; Austrian Science Fund (FWF) [P 23251] Funding Source: researchfish	ABOL, the Austrian Barcode of Life; FWF(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	NUS is financed by ABOL, the Austrian Barcode of Life. DB and GP are supported by grant number P 23251-B17 of the FWF, and MCR by grant number P 20497-B17 of the FWF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boehm Alexander, 2011, Soil Organisms, V83, P335; Christian Erhard, 2011, P1; Francois Jean, 2006, Bulletin de la Societe Entomologique de France, V111, P5; Galli L, 2015, ITAL J ZOOL, P1; Nosek J, 1973, EUROPEAN PROTURA THE; Nosek J, 1965, ANNOTATIONES ZOOL BO, V14, P1; Pass Guenther, 2011, Soil Organisms, V83, P309; Resch MC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090653; RUSEK JOSEF, 1965, VESTNIK CESK SPOLECNOSTI ZOOL, V29, P223; Rusek J, 2012, ZOOTAXA, P54, DOI 10.11646/zootaxa.3262.1.5; Shrubovych J, 2014, ZOOTAXA, V 3755, P136, DOI 10.11646/zootaxa.3755.2.2; Shrubovych Julia, 2009, Acta Zoologica Cracoviensia Ser. B - Invertebrata, V52B, P9, DOI 10.3409/azc.52b_1-2.09-15; SZEPTYCKI A, 1980, Polskie Pismo Entomologiczne, V50, P311; SZEPTYCKI A, 1988, Acta Zoologica Cracoviensia, V31, P297; Szeptycki A., 2008, Zoologiya Bespozvonochnykh, V5, P65; Szeptycki Andrzej, 2007, Acta Zoologica Cracoviensia Ser B-Invertebrata, V50B; Szeptycki Andrzej, 1993, Acta Zoologica Cracoviensia, V36, P29; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tuxen SL, 1964, PROTURA REVISION SPE	19	7	7	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0148033	10.1371/journal.pone.0148033	http://dx.doi.org/10.1371/journal.pone.0148033			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073924	Green Published, gold			2022-12-27	WOS:000374131200002
J	Vianna, CA; Horta, BL; Gigante, DP; De Barros, FCLF				Vianna, Carolina Avila; Horta, Bernardo Lessa; Gigante, Denise Petrucci; Lopes Fernandes de Barros, Fernando Celso			Pulse Wave Velocity at Early Adulthood: Breastfeeding and Nutrition during Pregnancy and Childhood	PLOS ONE			English	Article							BODY-MASS INDEX; ARTERIAL STIFFNESS; BLOOD-PRESSURE; BIRTH COHORT; YOUNG-ADULTS; WEIGHT-GAIN; FETAL ORIGINS; HEART-DISEASE; LATER LIFE; INFANCY	Background Pulse wave velocity (PWV) is an early marker of arterial stiffness. Low birthweight, infant feeding and childhood nutrition have been associated with cardiovascular disease in adulthood. In this study, we evaluated the association of PWV at 30 years of age with birth condition and childhood nutrition, among participants of the 1982 Pelotas birth cohort. Methods In 1982, the hospital births in Pelotas, southern Brazil, were identified just after delivery. Those liveborn infants whose family lived in the urban area of the city were examined and have been prospectively followed. At 30 years of age, we tried to follow the whole cohort and PWV was assessed in 1576 participants. Results Relative weight gain from 2 to 4 years was positively associated with PWV. Regarding nutritional status in childhood, PWV was higher among those whose weight-for-age z-score at 4 years was >1 standard deviation above the mean. On the other hand, height gain, birthweight and duration of breastfeeding were not associated with PWV. Conclusion Relative weight gain after 2 years of age is associated with increased PWV, while birthweight and growth in the first two years of life were not associated. These results suggest that the relative increase of weight later in childhood is associated with higher cardiovascular risk.	[Vianna, Carolina Avila; Horta, Bernardo Lessa; Gigante, Denise Petrucci; Lopes Fernandes de Barros, Fernando Celso] Univ Fed Pelotas, Dept Social Med, Pelotas, RS, Brazil; [Lopes Fernandes de Barros, Fernando Celso] Univ Catolica Pelotas, Postgrad Program Hlth & Behav, Pelotas, RS, Brazil	Universidade Federal de Pelotas; Universidade Catolica de Pelotas; Universidade Federal de Pelotas	Vianna, CA (corresponding author), Univ Fed Pelotas, Dept Social Med, Pelotas, RS, Brazil.	caruvianna@hotmail.com	Vianna, Carolina Avila/V-5088-2019; Horta, Bernardo/A-7604-2008	Vianna, Carolina Avila/0000-0002-1501-0784; Horta, Bernardo/0000-0001-9843-412X; Barros, Fernando/0000-0001-5973-1746				Adair LS, 2009, AM J CLIN NUTR, V89, P1383, DOI 10.3945/ajcn.2008.27139; Alwan A, 2011, GLOBAL STATUS REPORT ON NONCOMMUNICABLE DISEASES 2010, P1; BARKER DJP, 1989, LANCET, V2, P577; BARKER DJP, 1995, BRIT MED J, V311, P171, DOI 10.1136/bmj.311.6998.171; Barros FC, 2008, REV SAUDE PUBL, V42, P7, DOI 10.1590/S0034-89102008000900003; Boutouyrie P, 2002, HYPERTENSION, V39, P10, DOI 10.1161/hy0102.099031; BRAUNWALD E, 2005, BRAUNWALDS HEART DIS; Brion MJA, 2011, INT J EPIDEMIOL, V40, P670, DOI 10.1093/ije/dyr020; de Jonge LL, 2013, J NUTR, V143, P1959, DOI 10.3945/jn.113.174326; De Onis M, 2006, WHO CHILD GROWTH STA; FARRAR DJ, 1991, CIRCULATION, V83, P1754, DOI 10.1161/01.CIR.83.5.1754; Horta BL, 2015, ACTA PAEDIATR, V104, P30, DOI 10.1111/apa.13133; Horta BL, 2015, INT J EPIDEMIOL, V44, P441, DOI 10.1093/ije/dyv017; Jarvisalo MJ, 2009, EUR J CLIN NUTR, V63, P640, DOI 10.1038/ejcn.2008.17; Kelishadi R, 2014, PAEDIATRICS AND INTE, V18; Kramer MS, 2001, JAMA-J AM MED ASSOC, V285, P413, DOI 10.1001/jama.285.4.413; Lacolley P, 2009, CARDIOVASC RES, V81, P637, DOI 10.1093/cvr/cvn353; Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254; Leeson CPM, 2001, BRIT MED J, V322, P643, DOI 10.1136/bmj.322.7287.643; LONDON GM, 1993, KIDNEY INT, V43, pS42; Lucas A, 1999, BRIT MED J, V319, P245, DOI 10.1136/bmj.319.7204.245; Maldonado J, 2011, J HYPERTENS, V29, P669, DOI 10.1097/HJH.0b013e3283432063; Martin RM, 2005, AM J EPIDEMIOL, V161, P15, DOI 10.1093/aje/kwh338; MARTYN CN, 1995, BRIT HEART J, V73, P116; Mendis S, 2005, GLOB HEART, V1, P3, DOI DOI 10.1016/j.precon.2005.02.010; Menezes AMB, 2012, J EPIDEMIOL COMMUN H, V66, P149, DOI 10.1136/jech.2010.124842; Mitchell GF, 2010, CIRCULATION, V121, P505, DOI 10.1161/CIRCULATIONAHA.109.886655; Montgomery AA, 2000, LANCET, V355, P2136, DOI 10.1016/S0140-6736(00)02385-0; Murray LJ, 2001, J EPIDEMIOL COMMUN H, V55, P665, DOI 10.1136/jech.55.9.665; Mzayek F, 2009, J EPIDEMIOL COMMUN H, V63, P729, DOI 10.1136/jech.2008.084475; NEWMAN WP, 1991, ANN NY ACAD SCI, V623, P16, DOI 10.1111/j.1749-6632.1991.tb43715.x; O'Rourke MF, 2005, HYPERTENSION, V46, P200, DOI 10.1161/01.HYP.0000168052.00426.65; OHTSUKA S, 1994, J AM COLL CARDIOL, V24, P1406, DOI 10.1016/0735-1097(94)90127-9; Ong KK, 2006, ACTA PAEDIATR, V95, P904, DOI 10.1080/08035250600719754; Owen CG, 2003, BMJ-BRIT MED J, V327, P1189, DOI 10.1136/bmj.327.7425.1189; Risnes KR, 2011, INT J EPIDEMIOL, V40, P647, DOI 10.1093/ije/dyq267; Sachdev HS, 2005, AM J CLIN NUTR, V82, P456, DOI 10.1093/ajcn/82.2.456; Salvi P, 2012, J ADOLESCENT HEALTH, V51, P373, DOI 10.1016/j.jadohealth.2012.01.009; Schack-Nielsen L, 2005, BRIT J NUTR, V94, P1004, DOI 10.1079/BJN20051518; Singhal A, 2004, LANCET, V363, P1642, DOI 10.1016/S0140-6736(04)16210-7; Stettler N, 2003, AM J CLIN NUTR, V77, P1374, DOI 10.1093/ajcn/77.6.1374; Tauzin L, 2014, J DEV ORIG HLTH DIS, V5, P448, DOI 10.1017/S2040174414000385; Tennant IA, 2014, HYPERTENSION, V64, P664, DOI 10.1161/HYPERTENSIONAHA.114.03230; Tomlinson LA, 2012, CURR OPIN NEPHROL HY, V21, P655, DOI 10.1097/MNH.0b013e32835856e3; Toschke AM, 2007, AM J CLIN NUTR, V85, P1578, DOI 10.1093/ajcn/85.6.1578; TRACY RE, 1995, ATHEROSCLEROSIS, V116, P163, DOI 10.1016/0021-9150(95)05525-2; WILLIAMS RL, 1982, OBSTET GYNECOL, V59, P624; Zieman SJ, 2005, ARTERIOSCL THROM VAS, V25, P932, DOI 10.1161/01.ATV.0000160548.78317.29	48	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0152501	10.1371/journal.pone.0152501	http://dx.doi.org/10.1371/journal.pone.0152501			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073916	gold, Green Submitted, Green Published			2022-12-27	WOS:000374131200027
J	Zhang, XQ; Bilic, I; Marek, A; Glosmann, M; Hess, M				Zhang, Xinquan; Bilic, Ivana; Marek, Ana; Gloesmann, Martin; Hess, Michael			C-Terminal Amino Acids 471-507 of Avian Hepatitis E Virus Capsid Protein Are Crucial for Binding to Avian and Human Cells	PLOS ONE			English	Article							COMPLETE GENOMIC SEQUENCE; CROSS-SPECIES INFECTION; UNITED-STATES; GENETIC IDENTIFICATION; CHICKEN STRAIN; CDNA-CLONE; HEV; CONSTRUCTION; SEROPREVALENCE; PATHOGENICITY	The infection of chickens with avian Hepatitis E virus (avian HEV) can be asymptomatic or induces clinical signs characterized by increased mortality and decreased egg production in adult birds. Due to the lack of an efficient cell culture system for avian HEV, the interaction between virus and host cells is still barely understood. In this study, four truncated avian HEV capsid proteins (ORF2-1 - ORF2-4) with an identical 338aa deletion at the N-terminus and gradual deletions from 0, 42, 99 and 136aa at the C-terminus, respectively, were expressed and used to map the possible binding site within avian HEV capsid protein. Results from the binding assay showed that three truncated capsid proteins attached to avian LMH cells, but did not penetrate into cells. However, the shortest construct, ORF2-4, lost the capability of binding to cells suggesting that the presence of amino acids 471 to 507 of the capsid protein is crucial for the attachment. The construct ORF2-3 (aa339-507) was used to study the potential binding of avian HEV capsid protein to human and other avian species. It could be demonstrated that ORF2-3 was capable of binding to QT-35 cells from Japanese quail and human HepG2 cells but failed to bind to P815 cells. Additionally, chicken serum raised against ORF2-3 successfully blocked the binding to LMH cells. Treatment with heparin sodium salt or sodium chlorate significantly reduced binding of ORF2-3 to LMH cells. However, heparinase II treatment of LMH cells had no effect on binding of the ORF2-3 construct, suggesting a possible distinct attachment mechanism of avian as compared to human HEV. For the first time, interactions between avian HEV capsid protein and host cells were investigated demonstrating that aa471 to 507 of the capsid protein are needed to facilitate interaction with different kind of cells from different species.	[Zhang, Xinquan; Bilic, Ivana; Marek, Ana; Hess, Michael] Univ Vet Med, Dept Farm Anim & Vet Publ Hlth, Clin Poultry & Fish Med, Vienna, Austria; [Gloesmann, Martin] Univ Vet Med, VetCore Facil Res, Vienna, Austria	University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna	Hess, M (corresponding author), Univ Vet Med, Dept Farm Anim & Vet Publ Hlth, Clin Poultry & Fish Med, Vienna, Austria.	Michael.Hess@vetmeduni.ac.at	Glösmann, Martin/F-9349-2019	Glösmann, Martin/0000-0002-2094-3247; Bilic, Ivana/0000-0003-3296-5117; Hess, Michael/0000-0002-6991-0120				Ahmad I, 2011, VIRUS RES, V161, P47, DOI 10.1016/j.virusres.2011.02.011; Bilic L, 2009, J GEN VIROL, V90, P863, DOI 10.1099/vir.0.007179-0; Billam P, 2008, J CLIN MICROBIOL, V46, P2630, DOI 10.1128/JCM.00536-08; Billam P, 2007, J GEN VIROL, V88, P1538, DOI 10.1099/vir.0.82754-0; Cong Wei, 2014, ScientificWorldJournal, V2014, P296285, DOI 10.1155/2014/296285; Guo H, 2006, J GEN VIROL, V87, P217, DOI 10.1099/vir.0.81393-0; Haqshenas G, 2001, J GEN VIROL, V82, P2449, DOI 10.1099/0022-1317-82-10-2449; He SZ, 2008, J GEN VIROL, V89, P245, DOI 10.1099/vir.0.83308-0; Huang FF, 2005, J GEN VIROL, V86, P2585, DOI 10.1099/vir.0.81070-0; Huang FF, 2004, J GEN VIROL, V85, P1609, DOI 10.1099/vir.0.79841-0; Huang FF, 2002, J CLIN MICROBIOL, V40, P4197, DOI 10.1128/JCM.40.11.4197-4202.2002; Huang YW, 2007, J VIROL, V81, P3018, DOI 10.1128/JVI.02259-06; Johne R, 2014, INFECT GENET EVOL, V27, P212, DOI 10.1016/j.meegid.2014.06.024; Kalia M, 2009, J VIROL, V83, P12714, DOI 10.1128/JVI.00717-09; Kapur N, 2012, J VIRAL HEPATITIS, V19, P436, DOI 10.1111/j.1365-2893.2011.01559.x; Kwon HM, 2012, VIRUS GENES, V45, P237, DOI 10.1007/s11262-012-0761-6; Kwon HM, 2011, VET MICROBIOL, V147, P310, DOI 10.1016/j.vetmic.2010.07.016; Li SW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000537; Marek A, 2010, VET MICROBIOL, V145, P54, DOI 10.1016/j.vetmic.2010.03.014; Meng X. J., 2013, DIS POULTRY, P494; Morrow CJ, 2008, AVIAN PATHOL, V37, P527, DOI 10.1080/03079450802356946; MOSCOVICI C, 1977, CELL, V11, P95, DOI 10.1016/0092-8674(77)90320-8; Okamoto H, 2013, J GASTROENTEROL, V48, P147, DOI 10.1007/s00535-012-0682-0; Park SJ, 2015, J GEN VIROL, V96, P1015, DOI 10.1099/vir.0.000045; Payne CJ, 1999, VET MICROBIOL, V68, P119, DOI 10.1016/S0378-1135(99)00067-X; Peralta B, 2009, VET MICROBIOL, V137, P31, DOI 10.1016/j.vetmic.2008.12.010; RALPH P, 1976, J EXP MED, V143, P1528, DOI 10.1084/jem.143.6.1528; Schneider-Schaulies J, 2000, J GEN VIROL, V81, P1413, DOI 10.1099/0022-1317-81-6-1413; Sun XM, 2013, CELL REP, V3, P769, DOI 10.1016/j.celrep.2013.01.025; Sun ZF, 2004, J CLIN MICROBIOL, V42, P2658, DOI 10.1128/JCM.42.6.2658-2662.2004; Trowbridge JM, 2002, GLYCOBIOLOGY, V12, p117R, DOI 10.1093/glycob/cwf066; Troxler S, 2014, AVIAN PATHOL, V43, P310, DOI 10.1080/03079457.2014.924616; Yamashita T, 2009, P NATL ACAD SCI USA, V106, P12986, DOI 10.1073/pnas.0903699106; Zhang W, 2008, EPIDEMIOL INFECT, V136, P1020, DOI 10.1017/S095026880700965X; Zhang XX, 2014, PAK VET J, V34, P130; Zhao Q, 2013, J VIROL METHODS, V187, P32, DOI 10.1016/j.jviromet.2012.08.026	36	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153723	10.1371/journal.pone.0153723	http://dx.doi.org/10.1371/journal.pone.0153723			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073893	gold, Green Published, Green Submitted			2022-12-27	WOS:000374131200118
J	Castillo, D; Christiansen, RH; Dalsgaard, I; Madsen, L; Espejo, R; Middelboe, M				Castillo, Daniel; Christiansen, Roi Hammershaimb; Dalsgaard, Inger; Madsen, Lone; Espejo, Romilio; Middelboe, Mathias			Comparative Genome Analysis Provides Insights into the Pathogenicity of Flavobacterium psychrophilum	PLOS ONE			English	Article							RAINBOW-TROUT; POPULATION-STRUCTURE; ONCORHYNCHUS-MYKISS; VIRULENCE FACTORS; GLIDING MOTILITY; SEQUENCE; SYSTEM; GENES; IDENTIFICATION; DIVERSITY	Flavobacterium psychrophilum is a fish pathogen in salmonid aquaculture worldwide that causes cold water disease (CWD) and rainbow trout fry syndrome (RTFS). Comparative genome analyses of 11 F. psychrophilum isolates representing temporally and geographically distant populations were used to describe the F. psychrophilum pan-genome and to examine virulence factors, prophages, CRISPR arrays, and genomic islands present in the genomes. Analysis of the genomic DNA sequences were complemented with selected phenotypic characteristics of the strains. The pan genome analysis showed that F. psychrophilum could hold at least 3373 genes, while the core genome contained 1743 genes. On average, 67 new genes were detected for every new genome added to the analysis, indicating that F. psychrophilum possesses an open pan genome. The putative virulence factors were equally distributed among isolates, independent of geographic location, year of isolation and source of isolates. Only one prophage-related sequence was found which corresponded to the previously described prophage 6H, and appeared in 5 out of 11 isolates. CRISPR array analysis revealed two different loci with dissimilar spacer content, which only matched one sequence in the database, the temperate bacteriophage 6H. Genomic Islands (GIs) were identified in F. psychrophilum isolates 950106-1/1 and CSF 259-93, associated with toxins and antibiotic resistance. Finally, phenotypic characterization revealed a high degree of similarity among the strains with respect to biofilm formation and secretion of extracellular enzymes. Global scale dispersion of virulence factors in the genomes and the abilities for biofilm formation, hemolytic activity and secretion of extracellular enzymes among the strains suggested that F. psychrophilum isolates have a similar mode of action on adhesion, colonization and destruction of fish tissues across large spatial and temporal scales of occurrence. Overall, the genomic characterization and phenotypic properties may provide new insights to the mechanisms of pathogenicity in F. psychrophilum.	[Castillo, Daniel; Christiansen, Roi Hammershaimb; Middelboe, Mathias] Univ Copenhagen, Marine Biol Sect, Helsingor, Denmark; [Christiansen, Roi Hammershaimb; Dalsgaard, Inger; Madsen, Lone] Tech Univ Denmark, Natl Vet Inst, Frederiksberg, Denmark; [Espejo, Romilio] Univ Chile, Ctr Nacl Genom & Bioinformat, Santiago, Chile; [Espejo, Romilio] Univ Chile, Inst Nutr & Tecnol Alimentos, Santiago, Chile	University of Copenhagen; Technical University of Denmark; Universidad de Chile; Universidad de Chile	Middelboe, M (corresponding author), Univ Copenhagen, Marine Biol Sect, Helsingor, Denmark.	mmiddelboe@bio.ku.dk	Middelboe, Mathias/B-9995-2009	Middelboe, Mathias/0000-0002-9587-9171; Castillo, Daniel/0000-0002-1612-5401; Dalsgaard, Inger/0000-0003-2066-1060; Madsen, Lone/0000-0001-8435-9827	Danish Directorate for Food, Fisheries and Agri Business [3414-09-02613]; Danish Strategic Research Council (ProAqua) [09-072829]; EU-IRSES (AQUAPHAGE) [69175]; EU-IRSES	Danish Directorate for Food, Fisheries and Agri Business; Danish Strategic Research Council (ProAqua); EU-IRSES (AQUAPHAGE); EU-IRSES	This work was supported by The Danish Directorate for Food, Fisheries and Agri Business, grant # 3414-09-02613; The Danish Strategic Research Council (ProAqua, grant # 09-072829); and EU-IRSES (AQUAPHAGE, grant # 69175). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by a grant from The Danish Directorate for Food, Fisheries and Agri Business, The Danish Strategic Research Council (ProAqua, project # 09-072829) and by the EU-IRSES-funded project AQUAPHAGE.	Arai H, 2007, J FISH DIS, V30, P345, DOI 10.1111/j.1365-2761.2007.00809.x; Avendano-Herrera R, 2014, VET MICROBIOL, V170, P298, DOI 10.1016/j.vetmic.2014.02.009; Bernardet JF, 2002, INT J SYST EVOL MICR, V52, P1049, DOI 10.1099/00207713-52-3-1049; BERNARDET JF, 1989, APPL ENVIRON MICROB, V55, P1796, DOI 10.1128/AEM.55.7.1796-1800.1989; Bertolini J. M., 1994, Journal of Aquatic Animal Health, V6, P224, DOI 10.1577/1548-8667(1994)006&lt;0224:EDOPFS&gt;2.3.CO;2; Blom J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-154; Bloomfield GA, 1997, MICROBIOL-UK, V143, P553, DOI 10.1099/00221287-143-2-553; Bruno D. W., 1992, Bulletin of the European Association of Fish Pathologists, V12, P215; Bruun MS, 2000, AQUACULTURE, V187, P201, DOI 10.1016/S0044-8486(00)00310-0; Bustos P. A., 1995, Bulletin of the European Association of Fish Pathologists, V15, P162; Castillo D, 2012, J FISH DIS, V35, P193, DOI 10.1111/j.1365-2761.2011.01336.x; Castillo D, 2015, APPL ENVIRON MICROB, V81, P1157, DOI 10.1128/AEM.03699-14; Castillo D, 2014, MICROB ECOL, V67, P748, DOI 10.1007/s00248-014-0375-8; Castillo D, 2014, FEMS MICROBIOL LETT, V351, P51, DOI 10.1111/1574-6968.12342; Chen F, 2006, NUCLEIC ACIDS RES, V34, pD363, DOI 10.1093/nar/gkj123; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Drummond AJBA, 2010, GENEIOUS V7 1 4; Duchaud E, 2007, NAT BIOTECHNOL, V25, P763, DOI 10.1038/nbt1313; Engel P, 2012, NATURE, V482, P107, DOI 10.1038/nature10729; Fouts DE, 2006, NUCLEIC ACIDS RES, V34, P5839, DOI 10.1093/nar/gkl732; Fredriksen BN, 2013, VACCINE, V31, P1994, DOI 10.1016/j.vaccine.2013.01.016; Fujiwara-Nagata E, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-34; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hesami S, 2011, APPL ENVIRON MICROB, V77, P1593, DOI 10.1128/AEM.01717-10; Hogfors-Ronnholm E, 2010, MICROB PATHOGENESIS, V49, P369, DOI 10.1016/j.micpath.2010.08.002; HORIUCHI M, 1991, FISH PATHOL, V26, P211; Ikegami A, 2004, INFECT IMMUN, V72, P4619, DOI 10.1128/IAI.72.8.4619-4627.2004; Joensen KG, 2014, J CLIN MICROBIOL, V52, P1501, DOI 10.1128/JCM.03617-13; Keim P, 2009, MOL ASPECTS MED, V30, P397, DOI 10.1016/j.mam.2009.08.005; Kondo M, 2002, MICROBES INFECT, V4, P279, DOI 10.1016/S1286-4579(02)01539-3; Kuck P, 2010, MOL PHYLOGENET EVOL, V56, P1115, DOI 10.1016/j.ympev.2010.04.024; Laanto E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053157; Land M, 2015, FUNCT INTEGR GENOMIC, V15, P141, DOI 10.1007/s10142-015-0433-4; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lindsay JA, 1998, MOL MICROBIOL, V29, P527, DOI 10.1046/j.1365-2958.1998.00947.x; Lorenzen E., 1991, Bulletin of the European Association of Fish Pathologists, V11, P77; Madsen L, 2000, J FISH DIS, V23, P211, DOI 10.1046/j.1365-2761.2000.00240.x; Maione D, 2005, SCIENCE, V309, P148, DOI 10.1126/science.1109869; Mann RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055644; McBride MJ, 2013, J BACTERIOL, V195, P270, DOI 10.1128/JB.01962-12; Nematollahi A, 2003, J FISH DIS, V26, P563, DOI 10.1046/j.1365-2761.2003.00488.x; Nicolas P, 2008, APPL ENVIRON MICROB, V74, P3702, DOI 10.1128/AEM.00244-08; Nilsen H, 2014, APPL ENVIRON MICROB, V80, P2728, DOI 10.1128/AEM.04233-13; Ostland VE, 2000, J FISH DIS, V23, P329, DOI 10.1046/j.1365-2761.2000.00251.x; Rasko DA, 2008, J BACTERIOL, V190, P6881, DOI 10.1128/JB.00619-08; Sampson TR, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00037; Sato K, 2010, P NATL ACAD SCI USA, V107, P276, DOI 10.1073/pnas.0912010107; Soares SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030848; Soule M, 2005, DIS AQUAT ORGAN, V65, P209, DOI 10.3354/dao065209; Stenholm AR, 2008, APPL ENVIRON MICROB, V74, P4070, DOI 10.1128/AEM.00428-08; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Syvanen M, 2012, ANNU REV GENET, V46, P341, DOI 10.1146/annurev-genet-110711-155529; Tatusova T., 2013, PROKARYOTIC GENOME A; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Tettelin H, 2008, CURR OPIN MICROBIOL, V11, P472, DOI 10.1016/j.mib.2008.09.006; Tomida S, 2013, MBIO, V4, DOI 10.1128/mBio.00003-13; Toranzo A.E., 1993, Bulletin of the European Association of Fish Pathologists, V13, P30; Touchon M, 2011, APPL ENVIRON MICROB, V77, P7656, DOI 10.1128/AEM.05625-11; Vos M, 2009, ISME J, V3, P199, DOI 10.1038/ismej.2008.93; Whittle G, 2002, CELL MOL LIFE SCI, V59, P2044, DOI 10.1007/s000180200004; Wiens GD, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00889-14; Wiklund T., 1994, Bulletin of the European Association of Fish Pathologists, V14, P44; Wu AKK, 2015, STAND GENOMIC SCI, V10, DOI 10.1186/1944-3277-10-3; Wu HJ, 2008, CURR OPIN CHEM BIOL, V12, P93, DOI 10.1016/j.cbpa.2008.01.023; Yoon SH, 2015, NUCLEIC ACIDS RES, V43, pD624, DOI 10.1093/nar/gku985; Zegans ME, 2009, J BACTERIOL, V191, P210, DOI 10.1128/JB.00797-08; Zhou CE, 2007, NUCLEIC ACIDS RES, V35, pD391, DOI 10.1093/nar/gkl791; Zhou Y, 2011, NUCLEIC ACIDS RES, V39, pW347, DOI 10.1093/nar/gkr485	69	30	30	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0152515	10.1371/journal.pone.0152515	http://dx.doi.org/10.1371/journal.pone.0152515			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27071075	Green Published, Green Submitted, gold			2022-12-27	WOS:000373900700010
J	Pla, A; Pascual, M; Guerri, C				Pla, Antoni; Pascual, Maria; Guerri, Consuelo			Autophagy Constitutes a Protective Mechanism against Ethanol Toxicity in Mouse Astrocytes and Neurons	PLOS ONE			English	Article							UBIQUITIN-PROTEASOME; CELL-DEATH; RECEPTOR 4; INHIBITION; TLR4; MTOR; CLEARANCE; SYSTEM	Ethanol induces brain damage and neurodegeneration by triggering inflammatory processes in glial cells through activation of Toll-like receptor 4 (TLR4) signaling. Recent evidence indicates the role of protein degradation pathways in neurodegeneration and alcoholic liver disease, but how these processes affect the brain remains elusive. We have demonstrated that chronic ethanol consumption impairs proteolytic pathways in mouse brain, and the immune response mediated by TLR4 receptors participates in these dysfunctions. We evaluate the in vitro effects of an acute ethanol dose on the autophagy-lysosome pathway (ALP) on WT and TLR4(-/-) mouse astrocytes and neurons in primary culture, and how these changes affect cell survival. Our results show that ethanol induces overexpression of several autophagy markers (ATG12, LC3-II, CTSB), and increases the number of lysosomes in WT astrocytes, effects accompanied by a basification of lysosomal pH and by lowered phosphorylation levels of autophagy inhibitor mTOR, along with activation of complexes beclin-1 and ULK1. Notably, we found only minor changes between control and ethanol- treated TLR4(-/-) mouse astroglial cells. Ethanol also triggers the expression of the inflammatory mediators iNOS and COX-2, but induces astroglial death only slightly. Blocking autophagy by using specific inhibitors increases both inflammation and cell death. Conversely, in neurons, ethanol down-regulates the autophagy pathway and triggers cell death, which is partially recovered by using autophagy enhancers. These results support the protective role of the ALP against ethanol-induced astroglial cell damage in a TLR4-dependent manner, and provide new insight into the mechanisms that underlie ethanol-induced brain damage and are neuronal sensitive to the ethanol effects.	[Pla, Antoni; Pascual, Maria; Guerri, Consuelo] Ctr Invest Principe Felipe, Dept Cellular Pathol, C Eduardo Primo Yufera 3, Valencia 46012, Spain	Prince Felipe Research Center	Guerri, C (corresponding author), Ctr Invest Principe Felipe, Dept Cellular Pathol, C Eduardo Primo Yufera 3, Valencia 46012, Spain.	cguerri@cipf.es	Guerri, Consuelo/B-5181-2014; Guerri, Consuelo/R-1171-2019; Pascual, Maria/H-5181-2015	Guerri, Consuelo/0000-0001-9485-6202; Pascual, Maria/0000-0003-1420-631X	Spanish Ministry of Economics and Competitiveness [SAF2012-33747]; FEDER funds [RD12-0028-007]; PNSD [20101037]; GV-Conselleria d'Educacio: PROMETEO [II/2014-063]; Generalitat Valenciana-Conselleria d'Educacio [ACIF/2011/30]; Spanish Ministry of Health: The Institute Carlos III	Spanish Ministry of Economics and Competitiveness(Spanish Government); FEDER funds(European Commission); PNSD; GV-Conselleria d'Educacio: PROMETEO; Generalitat Valenciana-Conselleria d'Educacio(Center for Forestry Research & Experimentation (CIEF)); Spanish Ministry of Health: The Institute Carlos III	This work has been supported by grants from the Spanish Ministry of Economics and Competitiveness (SAF2012-33747), the Spanish Ministry of Health: The Institute Carlos III and FEDER funds (RTA-Network RD12-0028-007), and PNSD (Ex. 20101037), GV-Conselleria d'Educacio: PROMETEO II/2014-063. A. Pla has been supported by a pre-doctoral fellowship from the Generalitat Valenciana-Conselleria d'Educacio (Ex. ACIF/2011/30).	Alfonso-Loeches S, 2012, GLIA, V60, P948, DOI 10.1002/glia.22327; Alfonso-Loeches S, 2010, J NEUROSCI, V30, P8285, DOI 10.1523/JNEUROSCI.0976-10.2010; Barres BA, 2000, CURR OPIN NEUROBIOL, V10, P642, DOI 10.1016/S0959-4388(00)00134-3; Blanco AM, 2005, J IMMUNOL, V175, P6893, DOI 10.4049/jimmunol.175.10.6893; Buchanan MM, 2010, J NEUROCHEM, V114, P13, DOI 10.1111/j.1471-4159.2010.06736.x; Chen G, 2012, AUTOPHAGY, V8, P1577, DOI 10.4161/auto.21376; Delgado MA, 2008, EMBO J, V27, P1110, DOI 10.1038/emboj.2008.31; Ding WX, 2011, AUTOPHAGY, V7, P248, DOI 10.4161/auto.7.2.14347; Ding WX, 2010, GASTROENTEROLOGY, V139, P1740, DOI 10.1053/j.gastro.2010.07.041; Donohue TM, 2009, WORLD J GASTROENTERO, V15, P1178, DOI 10.3748/wjg.15.1178; Dooley HC, 2014, MOL CELL, V55, P238, DOI 10.1016/j.molcel.2014.05.021; Eid N, 2015, WORLD J HEPATOL, V7, P1154, DOI 10.4254/wjh.v7.i9.1154; Eskelinen EL, 2005, AUTOPHAGY, V1, P1, DOI 10.4161/auto.1.1.1270; Fernandez-Lizarbe S, 2009, J IMMUNOL, V183, P4733, DOI 10.4049/jimmunol.0803590; Frake RA, 2015, J CLIN INVEST, V125, P65, DOI 10.1172/JCI73944; Galluzzi L, 2008, CURR MOL MED, V8, P78; Giordano S, 2014, REDOX BIOL, V2, P82, DOI 10.1016/j.redox.2013.12.013; Hayes DM, 2013, ALCOHOL CLIN EXP RES, V37, P425, DOI 10.1111/j.1530-0277.2012.01955.x; Janen SB, 2010, GLIA, V58, P1766, DOI 10.1002/glia.21047; Kaur J, 2015, NAT REV MOL CELL BIO, V16, P461, DOI 10.1038/nrm4024; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Kramer S, 2008, AM J PHYSIOL-RENAL, V294, pF440, DOI 10.1152/ajprenal.00379.2007; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Lindqvist LM, 2014, AUTOPHAGY, V10, P1474, DOI 10.4161/auto.29639; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Luo J, 2014, AUTOPHAGY, V10, P2099, DOI 10.4161/15548627.2014.981916; Vidal-Donet JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055526; Mazan-Mamczarz K, 2015, CELL COMMUN SIGNAL, V13, DOI 10.1186/s12964-015-0091-0; Menzies FM, 2015, CELL DEATH DIFFER, V22, P433, DOI 10.1038/cdd.2014.151; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Nikoletopoulou V, 2015, CELL DEATH DIFFER, V22, P398, DOI 10.1038/cdd.2014.204; Okun E, 2011, TRENDS NEUROSCI, V34, P269, DOI 10.1016/j.tins.2011.02.005; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pascual-Lucas M, 2014, J NEUROCHEM, V129, P448, DOI 10.1111/jnc.12639; Pattingre S, 2008, BIOCHIMIE, V90, P313, DOI 10.1016/j.biochi.2007.08.014; Pla A, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.46; Ramachandran N, 2009, CELL, V137, P235, DOI 10.1016/j.cell.2009.01.054; Rautou PE, 2010, J HEPATOL, V53, P1123, DOI 10.1016/j.jhep.2010.07.006; Rivera JF, 2014, J CLIN INVEST, V124, P3489, DOI 10.1172/JCI71981; Shi CS, 2010, AUTOPHAGY, V6, P986, DOI 10.4161/auto.6.7.13288; Tydlacka S, 2008, J NEUROSCI, V28, P13285, DOI 10.1523/JNEUROSCI.4393-08.2008; von Haefen C, 2011, ALCOHOL CLIN EXP RES, V35, P1381, DOI 10.1111/j.1530-0277.2011.01473.x; Wang XK, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00012; Wu DF, 2012, FREE RADICAL BIO MED, V53, P1346, DOI 10.1016/j.freeradbiomed.2012.07.005; Xilouri M, 2010, CNS NEUROL DISORD-DR, V9, P701, DOI 10.2174/187152710793237421; Xu Y, 2007, IMMUNITY, V27, P135, DOI 10.1016/j.immuni.2007.05.022; Zhang JB, 2013, NEUROTOX RES, V24, P478, DOI 10.1007/s12640-013-9392-5	48	47	47	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0153097	10.1371/journal.pone.0153097	http://dx.doi.org/10.1371/journal.pone.0153097			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27070930	Green Submitted, Green Published, gold			2022-12-27	WOS:000373900700032
J	Stone, BC; Kas, A; Billman, ZP; Fuller, DH; Fuller, JT; Shendure, J; Murphy, SC				Stone, Brad C.; Kas, Arnold; Billman, Zachary P.; Fuller, Deborah H.; Fuller, James T.; Shendure, Jay; Murphy, Sean C.			Complex Minigene Library Vaccination for Discovery of Pre-Erythrocytic Plasmodium T Cell Antigens	PLOS ONE			English	Article							MHC CLASS-I; CIRCUMSPOROZOITE PROTEIN; PROTECTIVE IMMUNITY; ANTIBODY-RESPONSES; DNA IMMUNIZATION; MALARIA; FALCIPARUM; SPOROZOITE; MICE; SURFACE	Development of a subunit vaccine targeting liver-stage Plasmodium parasites requires the identification of antigens capable of inducing protective T cell responses. However, traditional methods of antigen identification are incapable of evaluating T cell responses against large numbers of proteins expressed by these parasites. This bottleneck has limited development of subunit vaccines against Plasmodium and other complex intracellular pathogens. To address this bottleneck, we are developing a synthetic minigene technology for multi-antigen DNA vaccines. In an initial test of this approach, pools of long (150 bp) antigen-encoding oligonucleotides were synthesized and recombined into vectors by ligation-independent cloning to produce two DNA minigene library vaccines. Each vaccine encoded peptides derived from 36 (vaccine 1) and 53 (vaccine 2) secreted or transmembrane pre-erythrocytic P. yoelii proteins. BALB/cj mice were vaccinated three times with a single vaccine by biolistic particle delivery (gene gun) and screened for interferon-.-producing T cell responses by ELISPOT. Library vaccination induced responses against four novel antigens. Naive mice exposed to radiation-attenuated sporozoites mounted a response against only one of the four novel targets (PyMDH, malate dehydrogenase). The response to PyMDH could not be recalled by additional homologous sporozoite immunizations but could be partially recalled by heterologous cross-species sporozoite exposure. Vaccination against the dominant PyMDH epitope by DNA priming and recombinant Listeria boosting did not protect against sporozoite challenge. Improvements in library design and delivery, combined with methods promoting an increase in screening sensitivity, may enable complex minigene screening to serve as a high-throughput system for discovery of novel T cell antigens.	[Stone, Brad C.; Kas, Arnold; Billman, Zachary P.; Murphy, Sean C.] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [Stone, Brad C.; Kas, Arnold; Billman, Zachary P.; Murphy, Sean C.] Univ Washington, Ctr Emerging & Re Emerging Infect Dis, Seattle, WA 98195 USA; [Fuller, Deborah H.; Fuller, James T.; Murphy, Sean C.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Shendure, Jay] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Murphy, Sean C.] Fred Hutchinson Canc Res Ctr, Seattle Malaria Clin Trials Ctr, 1124 Columbia St, Seattle, WA 98104 USA; [Murphy, Sean C.] Ctr Infect Dis Res, Human Challenge Ctr, Seattle, WA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Center for Infectious Disease Research; Walter Reed Army Institute of Research (WRAIR)	Stone, BC; Murphy, SC (corresponding author), Univ Washington, Dept Lab Med, Seattle, WA 98195 USA.; Stone, BC; Murphy, SC (corresponding author), Univ Washington, Ctr Emerging & Re Emerging Infect Dis, Seattle, WA 98195 USA.; Murphy, SC (corresponding author), Univ Washington, Dept Microbiol, Seattle, WA 98195 USA.; Murphy, SC (corresponding author), Fred Hutchinson Canc Res Ctr, Seattle Malaria Clin Trials Ctr, 1124 Columbia St, Seattle, WA 98104 USA.; Murphy, SC (corresponding author), Ctr Infect Dis Res, Human Challenge Ctr, Seattle, WA USA.	stoneb4@uw.edu; murphysc@uw.edu	Billman, Zachary/AAE-4245-2019; Shendure, Jay/AAU-3684-2021; Murphy, Sean C./AAC-7531-2019	Murphy, Sean C./0000-0002-2048-0131; Fuller, Deborah/0000-0001-7315-2441	NIH [1K08AI097238]; Bill and Melinda Gates Foundation [OPP1069993]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI097238] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was partially funded by the NIH (1K08AI097238 to S.C.M., https://www.niaid.nih.gov) and the Bill and Melinda Gates Foundation (OPP1069993 to B.C.S. and S.C.M., http://www.gatesfoundation.org). The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.	Aguiar Joao C, 2015, PLoS One, V10, pe0136109, DOI 10.1371/journal.pone.0136109; Arrington J, 2002, J VIROL, V76, P4536, DOI 10.1128/JVI.76.9.4536-4546.2002; Barth S, 2010, J PATHOL, V221, P117, DOI 10.1002/path.2694; Bergmann-Leitner ES, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012294; CLYDE DF, 1973, AM J MED SCI, V266, P169, DOI 10.1097/00000441-197309000-00002; Dobano C, 2007, IMMUNOL LETT, V111, P92, DOI 10.1016/j.imlet.2007.05.007; Doll K, 2014, J IMMUNOL, V192; Doolan DL, 2000, J IMMUNOL, V165, P1453, DOI 10.4049/jimmunol.165.3.1453; Doolan DL, 2003, P NATL ACAD SCI USA, V100, P9952, DOI 10.1073/pnas.1633254100; Doolan DL, 1996, J EXP MED, V183, P1739, DOI 10.1084/jem.183.4.1739; Duffy PE, 2012, EXPERT REV VACCINES, V11, P1261, DOI [10.1586/ERV.12.92, 10.1586/erv.12.92]; Epstein JE, 2011, SCIENCE, V334, P475, DOI 10.1126/science.1211548; Ferraro B, 2013, INFECT IMMUN, V81, P3709, DOI 10.1128/IAI.00180-13; FIDOCK DA, 1994, MOL BIOCHEM PARASIT, V64, P219, DOI 10.1016/0166-6851(94)00012-3; Frevert U, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00482; Fu TM, 1998, VACCINE, V16, P1711, DOI 10.1016/S0264-410X(98)00134-0; Fuller DH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033715; Goldwich A, 2008, J IMMUNOL, V180, P372, DOI 10.4049/jimmunol.180.1.372; GUERINMARCHAND C, 1987, NATURE, V329, P164, DOI 10.1038/329164a0; Guo HL, 2008, VIRAL IMMUNOL, V21, P61, DOI 10.1089/vim.2007.0082; Hassan IA, 2014, PARASITE IMMUNOL, V36, P674, DOI 10.1111/pim.12146; Hiller NL, 2004, SCIENCE, V306, P1934, DOI 10.1126/science.1102737; Hoffman SL, 2015, VACCINE, V33, pD13, DOI 10.1016/j.vaccine.2015.07.091; Hoffman SL, 2015, AM J PREV MED, V49, pS319, DOI 10.1016/j.amepre.2015.09.011; Hooper JW, 2003, VIROLOGY, V306, P181, DOI 10.1016/S0042-6822(02)00038-7; Hooper JW, 2000, VIROLOGY, V266, P329, DOI 10.1006/viro.1999.0096; Hospers GAP, 2009, VACCINE, V28, P386, DOI 10.1016/j.vaccine.2009.10.036; Imai T, 2008, BIOCHEM BIOPH RES CO, V365, P758, DOI 10.1016/j.bbrc.2007.11.034; Kariu T, 2006, MOL MICROBIOL, V59, P1369, DOI 10.1111/j.1365-2958.2005.05024.x; Keitany GJ, 2014, INFECT IMMUN, V82, P5143, DOI 10.1128/IAI.02320-14; KHUSMITH S, 1991, SCIENCE, V252, P715, DOI 10.1126/science.1827210; KUMAR S, 1988, NATURE, V334, P258, DOI 10.1038/334258a0; La Motte RN, 1998, J IMMUNOL, V161, P6552; Lundegaard C, 2008, NUCLEIC ACIDS RES, V36, pW509, DOI 10.1093/nar/gkn202; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; Mishra S, 2011, VACCINE, V29, P7335, DOI 10.1016/j.vaccine.2011.07.081; MOELANS IIMD, 1991, MOL BIOCHEM PARASIT, V45, P193, DOI 10.1016/0166-6851(91)90086-L; Mueller AK, 2005, NATURE, V433, P164, DOI 10.1038/nature03188; Mullbacher A, 1999, SCAND J IMMUNOL, V49, P563; Murphy SC, 2013, P NATL ACAD SCI USA, V110, P6055, DOI 10.1073/pnas.1303834110; Novotny LA, 2003, J IMMUNOL, V171, P1978, DOI 10.4049/jimmunol.171.4.1978; NUSSENZWEIG RS, 1967, NATURE, V216, P160, DOI 10.1038/216160a0; PERTMER TM, 1995, VACCINE, V13, P1427, DOI 10.1016/0264-410X(95)00069-D; Putrianti ED, 2009, J INFECT DIS, V199, P899, DOI 10.1086/597121; Reguzova A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116412; Reyes-Sandoval A, 2009, CURR OPIN MOL THER, V11, P72; ROBSON KJH, 1988, NATURE, V335, P79, DOI 10.1038/335079a0; Roestenberg M, 2009, NEW ENGL J MED, V361, P468, DOI 10.1056/NEJMoa0805832; SANCHEZ GI, 1994, EXP PARASITOL, V79, P59, DOI 10.1006/expr.1994.1060; Schwartz JJ, 2012, NAT METHODS, V9, P913, DOI 10.1038/nmeth.2137; Sedegah M, 2004, GENES IMMUN, V5, P553, DOI 10.1038/sj.gene.6364125; SEDEGAH M, 1994, P NATL ACAD SCI USA, V91, P9866, DOI 10.1073/pnas.91.21.9866; Sedegah M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106241; Seder RA, 2013, SCIENCE, V341, P1359, DOI 10.1126/science.1241800; Spring M, 2013, VACCINE, V31, P4975, DOI 10.1016/j.vaccine.2013.08.007; Stoute JA, 1997, NEW ENGL J MED, V336, P86, DOI 10.1056/NEJM199701093360202; Van Braeckel-Budimir N, 2015, J IMMUNOL S, V194; Van Braeckel-Budimir N, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00272; Vaughan AM, 2009, CELL MICROBIOL, V11, P506, DOI 10.1111/j.1462-5822.2008.01270.x; von Seidlein L, 2013, ARCH DIS CHILD, V98, P981, DOI 10.1136/archdischild-2013-304173; Wang RB, 2005, EUR J IMMUNOL, V35, P1859, DOI 10.1002/eji.200425807; Wang RB, 2005, INFECT IMMUN, V73, P2863, DOI 10.1128/IAI.73.5.2863-2872.2005; Wang RB, 1998, INFECT IMMUN, V66, P4193; Wang RB, 1998, SCIENCE, V282, P476, DOI 10.1126/science.282.5388.476; Weiss WR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031247; WEISS WR, 1990, J EXP MED, V171, P763, DOI 10.1084/jem.171.3.763; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Zhang YW, 2014, METHODS MOL BIOL, V1116, P235, DOI 10.1007/978-1-62703-764-8_16; ZHU JD, 1991, MOL BIOCHEM PARASIT, V48, P223, DOI 10.1016/0166-6851(91)90117-O	69	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0153449	10.1371/journal.pone.0153449	http://dx.doi.org/10.1371/journal.pone.0153449			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27070430	Green Published, gold, Green Submitted			2022-12-27	WOS:000373900700069
J	Herout, S; Mandorfer, M; Breitenecker, F; Reiberger, T; Grabmeier-Pfistershammer, K; Rieger, A; Aichelburg, MC				Herout, Sandra; Mandorfer, Mattias; Breitenecker, Florian; Reiberger, Thomas; Grabmeier-Pfistershammer, Katharina; Rieger, Armin; Aichelburg, Maximilian C.			Impact of Early Initiation of Antiretroviral Therapy in Patients with Acute HIV Infection in Vienna, Austria	PLOS ONE			English	Article							TRANSMISSION; DNA	Background It is unclear whether antiretroviral therapy (ART) should be initiated during acute HIV infection. Most recent data provides evidence of benefits of early ART. Methods We retrospectively compared the clinical and immunological course of individuals with acute HIV infection, who received ART within 3 months (group A) or not (group B) after diagnosis. Results Among the 84 individuals with acute HIV infection, 57 (68%) received ART within 3 months (A) whereas 27 (32%) did not receive ART within 3 months (B), respectively. Clinical progression to CDC stadium B or C within 5 years after the diagnosis of HIV was less common in (A) when compared to (B) (P = 0.002). After twelve months, both the mean increase in CD4+ T cell count and the mean decrease in viral load was more pronounced in (A), when compared to (B) (225 vs. 87 cells/mu l; P = 0.002 and -4.19 vs. -1.14 log10 copies/mL; P<0.001). Twenty-four months after diagnosis the mean increase from baseline of CD4+ T cells was still higher in group A compared to group B (251 vs. 67 cells/mu l, P = 0.004). Conclusions Initiation of ART during acute HIV infection is associated with a lower probability of clinical progression to more advanced CDC stages and significant immunological benefits.	[Herout, Sandra; Breitenecker, Florian; Grabmeier-Pfistershammer, Katharina; Rieger, Armin; Aichelburg, Maximilian C.] Med Univ Vienna, Dept Dermatol, Div Immunol Allergy & Infect Dis DIAID, Vienna, Austria; [Mandorfer, Mattias; Reiberger, Thomas] Med Univ Vienna, Vienna HIV & Liver Study Grp, Div Gastroenterol & Hepatol, Dept Internal Med 3, Vienna, Austria	Medical University of Vienna; Medical University of Vienna	Aichelburg, MC (corresponding author), Med Univ Vienna, Dept Dermatol, Div Immunol Allergy & Infect Dis DIAID, Vienna, Austria.	maximilian.aichelburg@meduniwien.ac.at	Reiberger, Thomas/H-7613-2019; Mandorfer, Mattias/H-7603-2019	Reiberger, Thomas/0000-0002-4590-3583; Mandorfer, Mattias/0000-0003-2330-0017; Osorio, Sandra/0000-0002-6651-3197; Grabmeier-Pfistershammer, Katharina/0000-0003-0665-5414				[Anonymous], 2015, GUID CLIN MAN TREATM, P7; Austrian HIV Cohort Study (AHIVCOS), 2014, 26 AHIVCOS STUDIA UN; Braun DL, 2015, CLIN INFECT DIS, V61, P1013, DOI 10.1093/cid/civ398; Brenner BG, 2007, J INFECT DIS, V195, P951, DOI 10.1086/512088; Cain LE, 2011, ANN INTERN MED, V154, P509, DOI 10.7326/0003-4819-154-8-201104190-00001; Casari S, 2012, J Prev Med Hyg, V53, P190; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Danel C, 2015, NEW ENGL J MED, V373, P808, DOI 10.1056/NEJMoa1507198; de Luna J.R.G., 2014, J AIDS HIV RES, V5, P285; Delwart E, 2002, AIDS, V16, P189, DOI 10.1097/00002030-200201250-00007; Fidler S, 2013, NEW ENGL J MED, V368, P207, DOI 10.1056/NEJMoa1110039; Gianella S, 2011, ANTIVIR THER, V16, P535, DOI 10.3851/IMP1776; Grijsen ML, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001196; Hogan CM, 2012, J INFECT DIS, V205, P87, DOI 10.1093/infdis/jir699; Jain V, 2013, J INFECT DIS, V208, P1202, DOI 10.1093/infdis/jit311; Le T, 2013, NEW ENGL J MED, V368, P218, DOI 10.1056/NEJMoa1110187; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; Malhotra U, 2000, J INFECT DIS, V181, P121, DOI 10.1086/315202; Mocroft A, 2000, J ACQ IMMUN DEF SYND, V24, P475, DOI 10.1097/00126334-200008150-00013; Ngo-Giang-Huong N, 2001, AIDS, V15, P665, DOI 10.1097/00002030-200104130-00001; Pilcher CD, 2004, J INFECT DIS, V189, P1785, DOI 10.1086/386333; Pilcher CD, 2004, J CLIN INVEST, V113, P937, DOI [10.1172/JCI200421540, 10.1172/JCI21540]; Saez-Cirion A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003211; Sterne JAC, 2009, LANCET, V373, P1352, DOI 10.1016/S0140-6736(09)60612-7; Strain MC, 2005, J INFECT DIS, V191, P1410, DOI 10.1086/428777; von Wyl V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027463; Yerly S, 2000, AIDS, V14, P243, DOI 10.1097/00002030-200002180-00006	27	25	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2016	11	4							e0152910	10.1371/journal.pone.0152910	http://dx.doi.org/10.1371/journal.pone.0152910			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0KH	27065239	gold, Green Published, Green Submitted			2022-12-27	WOS:000373891000024
J	Candela, S; Dito, R; Casolla, B; Silvestri, E; Sette, G; Filippi, F; Taurino, M; Brancadoro, D; Orzi, F				Candela, Serena; Dito, Raffaele; Casolla, Barbara; Silvestri, Emanuele; Sette, Giuliano; Filippi, Federico; Taurino, Maurizio; Brancadoro, Domitilla; Orzi, Francesco			Hypothermia during Carotid Endarterectomy: A Safety Study	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; MILD HYPOTHERMIA; BRAIN; STENOSIS; NEUROPROTECTION; OUTCOMES; RISK; RAT	Background CEA is associated with peri-operative risk of brain ischemia, due both to emboli production caused by manipulation of the plaque and to potentially noxious reduction of cerebral blood flow by carotid clamping. Mild hypothermia (34-35 degrees C) is probably the most effective approach to protect brain from ischemic insult. It is therefore a substantial hypothesis that hypothermia lowers the risk of ischemic brain damage potentially associated with CEA. Purpose of the study is to test whether systemic endovascular cooling to a target of 34.5-35 degrees C, initiated before and maintained during CEA, is feasible and safe. Methods The study was carried out in 7 consecutive patients referred to the Vascular Surgery Unit and judged eligible for CEA. Cooling was initiated 60-90 min before CEA, by endovascular approach (Zoll system). The target temperature was maintained during CEA, followed by passive, controlled rewarming (0.4 degrees C/h). The whole procedure was carried out under anesthesia. Results All the patients enrolled had no adverse events. Two patients exhibited a transient bradycardia (heart rate 30 beats/min). There were no significant differences in the clinical status, laboratory and physiological data measured before and after CEA. Conclusions Systemic cooling to 34.5-35.0 degrees C, initiated before and maintained during carotid clamping, is feasible and safe.	[Candela, Serena; Casolla, Barbara; Sette, Giuliano; Orzi, Francesco] Univ Roma La Sapienza, Sch Med & Psychol, St Andrea Hosp, NESMOS Neurosci Mental Hlth & Sensory Organs Dept, Piazzale Aldo Moro 5, I-00185 Rome, Italy; [Dito, Raffaele; Filippi, Federico; Taurino, Maurizio] Univ Roma La Sapienza, Sch Med & Psychol, St Andrea Hosp, Cardiothorac Vasc Sci Dept, Piazzale Aldo Moro 5, I-00185 Rome, Italy; [Silvestri, Emanuele; Brancadoro, Domitilla] Univ Roma La Sapienza, Sch Med & Psychol, St Andrea Hosp, Surg Anesthet Sci Dept, Piazzale Aldo Moro 5, I-00185 Rome, Italy	Sapienza University Rome; Azienda Ospedaliera Sant'Andrea; Sapienza University Rome; Azienda Ospedaliera Sant'Andrea; Sapienza University Rome; Azienda Ospedaliera Sant'Andrea	Candela, S (corresponding author), Univ Roma La Sapienza, Sch Med & Psychol, St Andrea Hosp, NESMOS Neurosci Mental Hlth & Sensory Organs Dept, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	serena.candela@uniroma1.it	Casolla, Barbara/ABD-1372-2020	TAURINO, Maurizio/0000-0001-5853-9410; Sette, Giuliano/0000-0002-8324-4371	Movi Spa	Movi Spa	The Movi Spa (www.movigroup.com) was the source of support for the study, providing the equipment and paying for the patient's health insurance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnett HJM, 1998, NEW ENGL J MED, V339, P1415, DOI 10.1056/NEJM199811123392002; BUSTO R, 1989, STROKE, V20, P904, DOI 10.1161/01.STR.20.7.904; Erecinska M, 2003, J CEREBR BLOOD F MET, V23, P513, DOI 10.1097/01.WCB.0000066287.21705.21; Go C, 2015, ANN VASC SURG, V29, P1265, DOI 10.1016/j.avsg.2015.03.031; Grotta JC, 2013, NEW ENGL J MED, V369, P1143, DOI 10.1056/NEJMcp1214999; Gupta PK, 2013, J VASC SURG, V57, P318, DOI 10.1016/j.jvs.2012.08.116; KAMME F, 1995, EUR J NEUROSCI, V7, P2007, DOI 10.1111/j.1460-9568.1995.tb00623.x; Kang JW, 2014, J VASC SURG, V59, P944, DOI [10.1016/j.jvs.2013.10.059, 10.1016/j.jvs.2014.02.014]; Kil HY, 1996, J CEREBR BLOOD F MET, V16, P100, DOI 10.1097/00004647-199601000-00012; Lee JH, 2014, ANN SURG TREAT RES, V86, P39, DOI 10.4174/astr.2014.86.1.39; Li J, 2011, J NEUROTRAUM, V28, P1281, DOI 10.1089/neu.2011.1751; Lotocki G, 2009, J NEUROTRAUM, V26, P1123, DOI 10.1089/neu.2008.0802; STEEN PA, 1983, ANESTHESIOLOGY, V58, P527, DOI 10.1097/00000542-198306000-00009; TAYLOR DW, 1991, NEW ENGL J MED, V325, P445; van der Worp HB, 2010, J CEREBR BLOOD F MET, V30, P1079, DOI 10.1038/jcbfm.2010.44; WALKER MD, 1995, JAMA-J AM MED ASSOC, V273, P1421, DOI 10.1001/jama.1995.03520420037035; Wu TC, 2013, LANCET NEUROL, V12, P275, DOI 10.1016/S1474-4422(13)70013-9; Xu LJ, 2002, J CEREBR BLOOD F MET, V22, P21, DOI 10.1097/00004647-200201000-00003; Yenari M, 2008, STROKE, V39, P2910, DOI 10.1161/STROKEAHA.108.514471; Yenari MA, 2012, NAT REV NEUROSCI, V13, P267, DOI 10.1038/nrn3174	20	4	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2016	11	4							e0152658	10.1371/journal.pone.0152658	http://dx.doi.org/10.1371/journal.pone.0152658			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6JK	27058874	gold, Green Published			2022-12-27	WOS:000373604800009
J	Chen, JJ; Zheng, ZY; Chen, Y; Li, JQ; Qian, SH; Shi, YF; Sun, L; Han, YX; Zhang, SH; Yu, K				Chen, Jingjing; Zheng, Zhouyi; Chen, Yi; Li, Jiaqi; Qian, Shanhu; Shi, Yifen; Sun, Lan; Han, Yixiang; Zhang, Shenghui; Yu, Kang			Histone Deacetylase Inhibitors Trichostatin A and MCP30 Relieve Benzene-Induced Hematotoxicity via Restoring Topoisomerase II alpha	PLOS ONE			English	Article							HEMATOPOIETIC STEM; TRANSCRIPTIONAL ACTIVATION; DEPENDENT REGULATION; GENE-EXPRESSION; DNA METHYLATION; CELL; CANCER; MICE; APOPTOSIS; HYDROQUINONE	Dysfunction of histone acetylation inhibits topoisomerase II alpha (Topo II alpha), which is implicated in benzene-induced hematotoxicity in patients with chronic benzene exposure. Whether histone deacetylase (HDAC) inhibitors can relieve benzene-induced hematotoxicity remains unclear. Here we showed that hydroquinone, a main metabolite of benzene, increased the HDAC activity, decreased the Topo II alpha expression and induced apoptosis in human bone marrow mononuclear cells in vitro, and treatment with two HDAC inhibitors, namely trichostatin A (TSA) or a mixture of ribosome-inactivating proteins MCP30, almost completely reversed these effects. We further established a benzene poisoning murine model by inhaling benzene vapor in a container and found that benzene poisoning decreased the expression and activity of Topo II alpha, and impaired acetylation of histone H4 and H3. The analysis of regulatory factors of Topo II alpha promoter found that benzene poisoning decreased the mRNA levels of SP1 and C-MYB, and increased the mRNA level of SP3. Both TSA and MCP30 significantly enhanced the acetylation of histone H3 and H4 in Topo II alpha promoter and increased the expression and activity of Topo II alpha in benzene poisoning mice, which contributed to relieve the symptoms of hematotoxicity. Thus, treatment with HDAC inhibitors represents an attractive approach to reduce benzene-induced hematotoxicity.	[Chen, Jingjing; Zheng, Zhouyi; Chen, Yi; Li, Jiaqi; Qian, Shanhu; Shi, Yifen; Sun, Lan; Zhang, Shenghui; Yu, Kang] Wenzhou Med Univ, Dept Hematol, Affiliated Hosp 1, Wenzhou 325015, Peoples R China; [Han, Yixiang] Wenzhou Med Univ, Lab Internal Med, Affiliated Hosp 1, Wenzhou 325015, Peoples R China	Wenzhou Medical University; Wenzhou Medical University	Zhang, SH; Yu, K (corresponding author), Wenzhou Med Univ, Dept Hematol, Affiliated Hosp 1, Wenzhou 325015, Peoples R China.	shenghuizhang1@126.com; yukang62@126.com	Zhang, Shenghui/AAI-7388-2021; chen, JJ/HGB-6029-2022		National Natural Science Foundation of China [81100355, 81172613, 81300430]; Zhejiang Provincial Natural Science Foundation of China [LQ12H08002, Y2111000, LY16H080007]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	This work was supported by National Natural Science Foundation of China (No.81100355, 81172613, 81300430), and Zhejiang Provincial Natural Science Foundation of China (No. LQ12H08002, Y2111000, LY16H080007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKSOY M, 1989, ENVIRON HEALTH PERSP, V82, P193, DOI 10.2307/3430775; Avila AM, 2007, J CLIN INVEST, V117, P659, DOI 10.1172/JCI29562; Baccarelli A, 2009, CURR OPIN PEDIATR, V21, P243, DOI 10.1097/MOP.0b013e32832925cc; Backs J, 2006, CIRC RES, V98, P15, DOI 10.1161/01.RES.0000197782.21444.8f; Baker RK, 2001, BLOOD, V98, P830, DOI 10.1182/blood.V98.3.830; Beerman I, 2014, EXP CELL RES, V329, P192, DOI 10.1016/j.yexcr.2014.09.013; Bibikova M, 2006, GENOME RES, V16, P1075, DOI 10.1101/gr.5319906; Brandt TL, 1997, J BIOL CHEM, V272, P6278, DOI 10.1074/jbc.272.10.6278; Chow PW, 2015, TOXICOL APPL PHARM, V284, P8, DOI 10.1016/j.taap.2015.01.016; Esteller M, 2002, J PATHOL, V196, P1, DOI 10.1002/path.1024; Faiola B, 2004, STEM CELLS, V22, P750, DOI 10.1634/stemcells.22-5-750; FORNI AM, 1971, ARCH ENVIRON HEALTH, V23, P385, DOI 10.1080/00039896.1971.10666024; Fung J, 2004, J APPL TOXICOL, V24, P183, DOI 10.1002/jat.960; Gao A, 2011, CELL BIOL INT, V35, P391, DOI 10.1042/CBI20100256; Gieseler F, 1999, LEUKEMIA, V13, P1859, DOI 10.1038/sj.leu.2401570; HAGEN G, 1994, EMBO J, V13, P3843, DOI 10.1002/j.1460-2075.1994.tb06695.x; Han YX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136484; Hirabayashi Yoko, 2004, Toxicol Pathol, V32 Suppl 2, P12, DOI 10.1080/01926230490451725; Hopfner R, 2002, ANTICANCER RES, V22, P3165; Ji Z, 2010, LEUKEMIA, V24, P986, DOI 10.1038/leu.2010.43; Kumar P, 2014, J BIOL CHEM, V289, P6991, DOI 10.1074/jbc.M113.511444; Lezama RV, 2001, TOXICOLOGY, V162, P179, DOI 10.1016/S0300-483X(01)00371-7; Linet MS, 2015, INT J CANCER, V137, P2184, DOI 10.1002/ijc.29591; Louis M, 2004, INT J ONCOL, V25, P1701; Mahal K, 2015, EXP CELL RES, V336, P263, DOI 10.1016/j.yexcr.2015.06.008; Pogorelnik B, 2013, CURR PHARM DESIGN, V19, P2474, DOI 10.2174/1381612811319130016; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Shames DS, 2007, CURR MOL MED, V7, P85, DOI 10.2174/156652407779940413; SNYDER R, 1993, ENVIRON HEALTH PERSP, V100, P293, DOI 10.2307/3431535; Son MY, 2002, CANCER LETT, V184, P81, DOI 10.1016/S0304-3835(02)00160-X; Sonnemann J, 2012, BRIT J HAEMATOL, V158, P664, DOI 10.1111/j.1365-2141.2012.09187.x; Urnov FD, 2001, ONCOGENE, V20, P2991, DOI 10.1038/sj.onc.1204323; Wang LP, 2012, CHEM RES TOXICOL, V25, P1303, DOI 10.1021/tx3001169; WARD CO, 1985, AM J IND MED, V7, P457, DOI 10.1002/ajim.4700070510; Williams KE, 2002, MOL CELL PROTEOMICS, V1, P885, DOI 10.1074/mcp.M200067-MCP200; Xiong SD, 2009, INT J CANCER, V125, P774, DOI 10.1002/ijc.24325; Yoon JH, 1999, BIOCHEM J, V344, P367, DOI 10.1042/0264-6021:3440367; Yu K, 2007, INT J TOXICOL, V26, P315, DOI 10.1080/10915810701489697; Yu K, 2011, TOXICOL LETT, V203, P111, DOI 10.1016/j.toxlet.2011.02.020; Zhang SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046853	40	8	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2016	11	4							e0153330	10.1371/journal.pone.0153330	http://dx.doi.org/10.1371/journal.pone.0153330			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6JK	27058040	gold, Green Published, Green Submitted			2022-12-27	WOS:000373604800028
J	Grogan, SM; Brown-Guedira, G; Haley, SD; McMaster, GS; Reid, SD; Smith, J; Byrne, PF				Grogan, Sarah M.; Brown-Guedira, Gina; Haley, Scott D.; McMaster, Gregory S.; Reid, Scott D.; Smith, Jared; Byrne, Patrick F.			Allelic Variation in Developmental Genes and Effects on Winter Wheat Heading Date in the US Great Plains	PLOS ONE			English	Article							VERNALIZATION RESPONSE; RHT-1 LOCI; REGISTRATION; PHOTOPERIOD; PPD-D1; TOLERANCE; CULTIVARS; VRN-A1; GROWTH; TIME	Heading date in wheat (Triticum aestivum L.) and other small grain cereals is affected by the vernalization and photoperiod pathways. The reduced-height loci also have an effect on growth and development. Heading date, which occurs just prior to anthesis, was evaluated in a population of 299 hard winter wheat entries representative of the U.S. Great Plains region, grown in nine environments during 2011-2012 and 2012-2013. The germplasm was evaluated for candidate genes at vernalization (Vrn-A1, Vrn-B1, and Vrn-D1), photoperiod (Ppd-A1, Ppd-B1 and Ppd-D1), and reduced-height (Rht-B1 and Rht-D1) loci using polymerase chain reaction (PCR) and Kompetitive Allele Specific PCR (KASP) assays. Our objectives were to determine allelic variants known to affect flowering time, assess the effect of allelic variants on heading date, and investigate changes in the geographic and temporal distribution of alleles and haplotypes. Our analyses enhanced understanding of the roles developmental genes have on the timing of heading date in wheat under varying environmental conditions, which could be used by breeding programs to improve breeding strategies under current and future climate scenarios. The significant main effects and two-way interactions between the candidate genes explained an average of 44% of variability in heading date at each environment. Among the loci we evaluated, most of the variation in heading date was explained by Ppd-D1, Ppd-B1, and their interaction. The prevalence of the photoperiod sensitive alleles Ppd-A1b, Ppd-B1b, and Ppd-D1b has gradually decreased in U.S. Great Plains germplasm over the past century. There is also geographic variation for photoperiod sensitive and reduced-height alleles, with germplasm from breeding programs in the northern Great Plains having greater incidences of the photoperiod sensitive alleles and lower incidence of the semi-dwarf alleles than germplasm from breeding programs in the central or southern plains.	[Grogan, Sarah M.; Haley, Scott D.; Reid, Scott D.; Byrne, Patrick F.] Colorado State Univ, Soil & Crop Sci, Ft Collins, CO 80523 USA; [Brown-Guedira, Gina; Smith, Jared] USDA ARS, Reg Small Grains Genotyping Lab, Raleigh, NC 27695 USA; [McMaster, Gregory S.] USDA ARS, Agr Syst Res Unit, Raleigh, NC 27695 USA	Colorado State University; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Byrne, PF (corresponding author), Colorado State Univ, Soil & Crop Sci, Ft Collins, CO 80523 USA.	Patrick.Byrne@colostate.edu	Byrne, Patrick/AFP-4228-2022; Haley, Scott/C-1228-2013	Haley, Scott/0000-0002-1996-9570; Bratschun, Sarah/0000-0001-5918-8480	USDA National Institute of Food and Agriculture AFRI grant [2011-68002-30029]	USDA National Institute of Food and Agriculture AFRI grant	Funding was provided by the USDA National Institute of Food and Agriculture AFRI grant to the Triticeae-CAP project (2011-68002-30029, http://www.triticeaecap.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baenziger PS, 2011, J PLANT REGIST, V5, P75, DOI 10.3198/jpr2010.02.0084crc; Barton K., 2015, MUMIN MULTIMODEL INF; Beales J, 2007, THEOR APPL GENET, V115, P721, DOI 10.1007/s00122-007-0603-4; Beaujean AA, 2012, BAYLOREDPSYCH R PACK; Beniston M, 2007, CLIMATIC CHANGE, V81, P71, DOI 10.1007/s10584-006-9226-z; Boden SA, 2015, NAT PLANTS, V1, P1, DOI [10.1038/NPLANTS.2014.16, 10.1038/nplants.2014.16]; Brown HE, 2013, ANN BOT-LONDON, V112, P1683, DOI 10.1093/aob/mct224; BUSH MG, 1988, FIELD CROP RES, V18, P243, DOI 10.1016/0378-4290(88)90018-4; Cane K, 2013, CROP PASTURE SCI, V64, P100, DOI 10.1071/CP13086; Cavanagh CR, 2013, P NATL ACAD SCI USA, V110, P8057, DOI 10.1073/pnas.1217133110; Chen YH, 2009, THEOR APPL GENET, V118, P881, DOI 10.1007/s00122-008-0946-5; Cockram J, 2007, J EXP BOT, V58, P1231, DOI 10.1093/jxb/erm042; Diaz A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033234; Distelfeld A, 2009, CURR OPIN PLANT BIOL, V12, P178, DOI 10.1016/j.pbi.2008.12.010; Dubcovsky J, 1998, THEOR APPL GENET, V97, P968, DOI 10.1007/s001220050978; Eagles HA, 2010, CROP PASTURE SCI, V61, P721, DOI 10.1071/CP10121; Eagles HA, 2011, PLANT BREEDING, V130, P413, DOI 10.1111/j.1439-0523.2011.01856.x; Ellis MH, 2002, THEOR APPL GENET, V105, P1038, DOI 10.1007/s00122-002-1048-4; Fox J., 2019, R COMPANION APPL REG, V.; Fu DL, 2005, MOL GENET GENOMICS, V273, P54, DOI 10.1007/s00438-004-1095-4; Griffiths S, 2009, THEOR APPL GENET, V119, P383, DOI 10.1007/s00122-009-1046-x; Grogan S, 2015, THESIS COLORADO STAT; Guedira M, 2010, CROP SCI, V50, P1811, DOI 10.2135/cropsci2009.10.0626; Guedira M, 2014, CROP SCI, V54, P1960, DOI 10.2135/cropsci2013.12.0833; Guo ZA, 2010, NEW PHYTOL, V185, P841, DOI 10.1111/j.1469-8137.2009.03099.x; Guttieri MJ, 2015, CROP SCI, V55, P1035, DOI 10.2135/cropsci2014.07.0506; Haley SD, 2009, J PLANT REGIST, V3, P181, DOI 10.3198/jpr2008.12.0727crc; Haley SD, 2005, CROP SCI, V45, P2654, DOI 10.2135/cropsci2005.0030; Johnson JW, 2002, CROP SCI, V42, P661, DOI 10.2135/cropsci2002.0661; Kamran A, 2014, PLANT BREEDING, V133, P321, DOI 10.1111/pbr.12149; Kamran A, 2014, EUPHYTICA, V197, P1, DOI 10.1007/s10681-014-1075-7; Kiss T, 2014, MOL BREEDING, V34, P297, DOI 10.1007/s11032-014-0034-2; LAW CN, 1976, HEREDITY, V36, P49, DOI 10.1038/hdy.1976.5; Lenth RV, 2016, J STAT SOFTW, V69, P1, DOI 10.18637/jss.v069.i01; Li AX, 2013, J INTEGR PLANT BIOL, V55, P1026, DOI 10.1111/jipb.12103; Littell RC, 2006, SAS MIXED MODELS, P437; Lobell DB, 2011, SCIENCE, V333, P616, DOI [10.1126/science.1204531, 10.1126/science.1206376]; Marshall D, 1999, CROP SCI, V39, P1532, DOI 10.2135/cropsci1999.3951507x; Marshall DS, 1998, CROP SCI, V38; McMaster GS, 1997, ADV AGRON, V59, P63, DOI 10.1016/S0065-2113(08)60053-X; Merker A., 1982, Cereal Research Communications, V10, P105; Milec Z, 2012, MOL BREEDING, V30, P317, DOI 10.1007/s11032-011-9621-7; Miralles DJ, 2000, AUST J PLANT PHYSIOL, V27, P931, DOI 10.1071/PP00021; Murphy JP, 2004, CROP SCI, V44, P1479, DOI 10.2135/cropsci2004.1479; Nishida H, 2013, MOL BREEDING, V31, P27, DOI 10.1007/s11032-012-9765-0; Pearce S, 2011, PLANT PHYSIOL, V157, P1820, DOI 10.1104/pp.111.183657; Peng JR, 1999, NATURE, V400, P256, DOI 10.1038/22307; R Core Team, 2013, R LANG ENV STAT COMP; Riede CR, 1996, CROP SCI, V36, P905, DOI 10.2135/cropsci1996.0011183X0036000400015x; Roussel V, 2005, THEOR APPL GENET, V111, P162, DOI 10.1007/s00122-005-2014-8; Rudd JC, 2012, J PLANT REGIST, V6, P60, DOI 10.3198/jpr2011.01.0045crc; Santra DK, 2009, PLANT BREEDING, V128, P576, DOI 10.1111/j.1439-0523.2009.01681.x; Schmitz C, 2014, AGR ECON-BLACKWELL, V45, P69, DOI 10.1111/agec.12090; Sears RG, 1997, CROP SCI, V37, P1010, DOI 10.2135/cropsci1997.0011183X003700030062x; Shcherban AB, 2014, PLANT BREEDING, P1; Slafer G., 2012, APPL PHYSL WHEAT BRE, P109; SMITH EL, 1985, CROP SCI, V25, P367, DOI 10.2135/cropsci1985.0011183X002500020052x; Tanio M, 2007, BREEDING SCI, V57, P65, DOI 10.1270/jsbbs.57.65; Trevaskis B, 2007, TRENDS PLANT SCI, V12, P352, DOI 10.1016/j.tplants.2007.06.010; Trevaskis B, 2010, FUNCT PLANT BIOL, V37, P479, DOI 10.1071/FP10056; Wilhelm EP, 2013, THEOR APPL GENET, V126, P2233, DOI 10.1007/s00122-013-2130-9; Wilhelm EP, 2013, THEOR APPL GENET, V126, P1733, DOI 10.1007/s00122-013-2088-7; Wilhelm EP, 2013, THEOR APPL GENET, V126, P1321, DOI 10.1007/s00122-013-2055-3; Wilhelm EP, 2009, THEOR APPL GENET, V118, P285, DOI 10.1007/s00122-008-0898-9; Worland AJ, 1998, EUPHYTICA, V100, P385, DOI 10.1023/A:1018327700985; Worland T., 2001, WORLD WHEAT BOOK HIS, P59; Yan L, 2004, THEOR APPL GENET, V109, P1677, DOI 10.1007/s00122-004-1796-4; Yan LL, 2004, SCIENCE, V303, P1640, DOI 10.1126/science.1094305; ZADOKS JC, 1974, WEED RES, V14, P415, DOI 10.1111/j.1365-3180.1974.tb01084.x; Zhu J, 2014, THEOR APPL GENET, V127, P1183, DOI 10.1007/s00122-014-2290-2; Zhu XK, 2011, MOL BREEDING, V27, P501, DOI 10.1007/s11032-010-9447-8	71	46	49	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2016	11	4							e0152852	10.1371/journal.pone.0152852	http://dx.doi.org/10.1371/journal.pone.0152852			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6JK	27058239	Green Published, Green Submitted, gold			2022-12-27	WOS:000373604800013
J	Harrison, N; Harrison, RJ; Kidner, CA				Harrison, Nicola; Harrison, Richard J.; Kidner, Catherine A.			Comparative Analysis of Begonia Plastid Genomes and Their Utility for Species-Level Phylogenetics	PLOS ONE			English	Article							CHLOROPLAST GENOME; ASIAN BEGONIA; SEQUENCE; DNA; EVOLUTION; GENUS; ORGANIZATION; RARE; BIOGEOGRAPHY; FLOW	Recent, rapid radiations make species-level phylogenetics difficult to resolve. We used a multiplexed, high-throughput sequencing approach to identify informative genomic regions to resolve phylogenetic relationships at low taxonomic levels in Begonia from a survey of sixteen species. A long-range PCR method was used to generate draft plastid genomes to provide a strong phylogenetic backbone, identify fast evolving regions and provide informative molecular markers for species-level phylogenetic studies in Begonia.	[Harrison, Nicola; Harrison, Richard J.] NIAB EMR, East Malling, Kent, England; [Harrison, Nicola; Harrison, Richard J.] Univ Reading, Reading, Berks, England; [Kidner, Catherine A.] Royal Bot Gardens Edinburgh, Edinburgh, Midlothian, Scotland; [Kidner, Catherine A.] Univ Edinburgh, Darwin Bldg,Kings Bldg, Edinburgh, Midlothian, Scotland	University of Reading; Royal Botanic Gardens, Kew; University of Edinburgh	Kidner, CA (corresponding author), Royal Bot Gardens Edinburgh, Edinburgh, Midlothian, Scotland.; Kidner, CA (corresponding author), Univ Edinburgh, Darwin Bldg,Kings Bldg, Edinburgh, Midlothian, Scotland.	C.Kidner@rbge.ac.uk	Harrison, Richard/E-3169-2015	Harrison, Richard/0000-0002-3307-3519; Kidner, Catherine/0000-0001-6426-3000	BBSRC DTP PhD studentship; RBGE Small Project Fund - Friends of RBGE; MRC [G0701786]; BBSRC [BB/E019447/1]; Biotechnology and Biological Sciences Research Council [BB/E019447/1] Funding Source: researchfish; Medical Research Council [G0701786] Funding Source: researchfish	BBSRC DTP PhD studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); RBGE Small Project Fund - Friends of RBGE; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funding was provided by a BBSRC DTP PhD studentship to NH and from the RBGE Small Project Fund supported by Friends of RBGE. RJH was funded by MRC grant G0701786. CK was supported by funding from BBSRC grant BB/E019447/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brouard JS, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-290; Chumley TW, 2006, MOL BIOL EVOL, V23, P2175, DOI 10.1093/molbev/msl089; Chung SM, 2007, GENOME, V50, P215, DOI 10.1139/G07-003; Clement WL, 2004, AM J BOT, V91, P905, DOI 10.3732/ajb.91.6.905; Cronn R, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn502; DOORENBOS J, 1998, SECTIONS BEGONIA INC; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Forrest LL, 2005, SYST BOT, V30, P671, DOI 10.1600/0363644054782297; Forrest LL, 2003, PLANT SYST EVOL, V241, P193, DOI 10.1007/s00606-002-0033-y; Fuller D., 2014, THESIS U EDINBURG; Goodall-Copestake WP, 2010, BIOL J LINN SOC, V101, P243, DOI 10.1111/j.1095-8312.2010.01489.x; Goodall-Copestake WP, 2009, BOT J LINN SOC, V159, P363, DOI 10.1111/j.1095-8339.2009.00948.x; Goulding SE, 1996, MOL GEN GENET, V252, P195, DOI 10.1007/BF02173220; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Howe CJ, 2003, PHILOS T ROY SOC B, V358, P99, DOI 10.1098/rstb.2002.1176; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hughes M, 2008, MOL ECOL, V17, P2643, DOI 10.1111/j.1365-294X.2008.03788.x; Hughes M, 2003, BIOL CONSERV, V113, P277, DOI 10.1016/S0006-3207(02)00375-0; Jiao QJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027646; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Khan A, 2010, AFR J BIOTECHNOL, V9, P3494; Matolweni LO, 2000, AM J BOT, V87, P431, DOI 10.2307/2656639; Millen RS, 2001, PLANT CELL, V13, P645, DOI 10.1105/tpc.13.3.645; Moonlight PW, 2015, J BIOGEOGR, V42, P1137, DOI 10.1111/jbi.12496; Neale S, 2006, FLORICULTURE ORNAMEN; Nylander JAA., 2004, BIOINFORMATICS; PALMER JD, 1985, ANNU REV GENET, V19, P325, DOI 10.1146/annurev.ge.19.120185.001545; Plana V, 2004, MOL PHYLOGENET EVOL, V31, P449, DOI 10.1016/j.ympev.2003.08.023; Plana V, 2003, SYST BOT, V28, P693; Plana V, 2002, THESIS U GLASGOW; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rajbhandary S., 2011, Gardens' Bulletin (Singapore), V63, P277; Rambaut A, 2010, FIGTREE V131; Schaefer H, 2011, TAXON, V60, P122, DOI 10.1002/tax.601011; SHINOZAKI K, 1986, EMBO J, V5, P2043, DOI 10.1002/j.1460-2075.1986.tb04464.x; STRAUSS SH, 1988, P NATL ACAD SCI USA, V85, P3898, DOI 10.1073/pnas.85.11.3898; Swofford D., 2002, PAUP 4 0 B10 PHYLOGE; Tebbitt MC., 2005, BEGONIAS CULTIVATION; Thomas DC, 2011, MOL PHYLOGENET EVOL, V60, P428, DOI 10.1016/j.ympev.2011.05.006; Thomas DC, 2010, THESIS U GLASGOW; Twyford AD, 2013, BOT J LINN SOC, V171, P260, DOI 10.1111/j.1095-8339.2012.01265.x; USA The Angiosperm Phylogeny Group, 2003, Botanical Journal of the Linnean Society, V141, P399, DOI 10.1046/j.1095-8339.2003.t01-1-00158.x; Whittall JB, 2010, MOL ECOL, V19, P100, DOI 10.1111/j.1365-294X.2009.04474.x; Wicke S, 2011, PLANT MOL BIOL, V76, P273, DOI 10.1007/s11103-011-9762-4; Wojciechowski M.F., 2000, ADV LEGUME SYST, V9, P277; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Yukawa M, 2006, MOL GENET GENOMICS, V275, P367, DOI 10.1007/s00438-005-0092-6; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	49	10	11	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2016	11	4							e0153248	10.1371/journal.pone.0153248	http://dx.doi.org/10.1371/journal.pone.0153248			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6JK	27058864	Green Published, Green Submitted, gold			2022-12-27	WOS:000373604800025
J	Asbrand, J; Svaldi, J; Kramer, M; Breuninger, C; Tuschen-Caffier, B				Asbrand, Julia; Svaldi, Jennifer; Kraemer, Martina; Breuninger, Christoph; Tuschen-Caffier, Brunna			Familial Accumulation of Social Anxiety Symptoms and Maladaptive Emotion Regulation	PLOS ONE			English	Article							SELF-REGULATION; DISORDERS; CHILDHOOD; CHILDREN; PHOBIA; LIFE; PSYCHOPATHOLOGY; SOCIALIZATION; MODEL; SCALE	Background Social anxiety is thought to be strongly related to maladaptive emotion regulation (ER). As social anxiety symptoms accumulate in families, we hypothesize that maladaptive ER is also more prevalent in families with anxious children. Thus, we analyze differences in emotion regulation of both child and mother in relation to social anxiety, as well as both their ER strategies in dealing with anxiety. Further, a positive relation between child and maternal ER strategies is assumed. Method Children (aged 9 to 13 years) with social, anxiety disorder (SAD; n = 25) and healthy controls (HC, n = 26) as well as their mothers completed several measures of social anxiety and trait ER strategies towards anxiety. As ER of children is still in development, age is considered as covariate. Results SAD children and their mothers reported more maladaptive ER strategies than HC dyads. Maternal maladaptive ER was related negatively to child adaptive ER which was further moderated by the child's age. Discussion Maladaptive ER strategies seem to contribute to the exacerbation of social anxiety in both mother and child. Mothers reporting maladaptive ER may have difficulties supporting their child in coping with social anxiety while simultaneously also experiencing heightened levels of anxiety. Deeper understanding of interactional processes between mothers and children during development can assist the comprehension of factors maintaining SAD. Implications for future research and possible consequences for interventions are discussed.	[Asbrand, Julia; Kraemer, Martina; Breuninger, Christoph; Tuschen-Caffier, Brunna] Univ Freiburg, Inst Psychol, Dept Clin Psychol & Psychotherapy, Hugstetter Str 55, D-79106 Freiburg, Germany; [Svaldi, Jennifer] Univ Tubingen, Dept Clin Psychol, Inst Psychol, Tubingen, Germany	University of Freiburg; Eberhard Karls University of Tubingen	Asbrand, J (corresponding author), Univ Freiburg, Inst Psychol, Dept Clin Psychol & Psychotherapy, Hugstetter Str 55, D-79106 Freiburg, Germany.	julia.asbrand@psychologie.uni-freiburg.de	Asbrand, Julia/GLV-6447-2022	Asbrand, Julia/0000-0003-2740-6070; Breuninger, Christoph/0000-0002-1956-9753	German National Merit Foundation; DFG [TU 78/5-2]; Albert Ludwigs University Freiburg	German National Merit Foundation; DFG(German Research Foundation (DFG)); Albert Ludwigs University Freiburg	This research was supported by a stipend from the German National Merit Foundation granted to the first author. Compensation for participants was provided by the Scientific Community Freiburg/Breisgau. The diagnostic procedure was subsidised by a grant from the DFG (Grant Number: TU 78/5-2) to the last author. The article processing charge was funded by the Albert Ludwigs University Freiburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection	Aiken L. S., 1991, MULTIPLE REGRESSION; Aldao A, 2010, CLIN PSYCHOL REV, V30, P217, DOI 10.1016/j.cpr.2009.11.004; Amstadter A, 2008, J ANXIETY DISORD, V22, P211, DOI 10.1016/j.janxdis.2007.02.004; [Anonymous], 2001, EARLY EDUC DEV, DOI DOI 10.1207/S15566935EED1201_6; Bariola E, 2012, J CHILD FAM STUD, V21, P443, DOI 10.1007/s10826-011-9497-5; Bariola E, 2011, CLIN CHILD FAM PSYCH, V14, P198, DOI 10.1007/s10567-011-0092-5; Barrett PM, 1994, J CONSULT CLIN PSYCH, V64, P333; Beauchaine TP, 2013, DEV PSYCHOPATHOL, V25, P1505, DOI 10.1017/S0954579413000746; Beidel DC, 1999, J AM ACAD CHILD PSY, V38, P643, DOI 10.1097/00004583-199906000-00010; Bogels SM, 2001, BEHAV RES THER, V39, P273, DOI 10.1016/S0005-7967(00)00005-X; Butler EA, 2003, EMOTION, V3, P48, DOI 10.1037/1528-3542.3.1.48; Calkins S D, 1994, Monogr Soc Res Child Dev, V59, P53, DOI 10.2307/1166138; Chavira DA, 2004, DEPRESS ANXIETY, V20, P155, DOI 10.1002/da.20039; Cisler JM, 2010, J PSYCHOPATHOL BEHAV, V32, P68, DOI 10.1007/s10862-009-9161-1; Clark D. M., 1995, SOCIALPHOBIA DIAGNOS, P69, DOI DOI 10.1017/S1352465808004487; Cole PM, 2004, CHILD DEV, V75, P317, DOI 10.1111/j.1467-8624.2004.00673.x; Connor KM, 2001, DEPRESS ANXIETY, V14, P137, DOI 10.1002/da.1055; Derogatis L. R., 1999, USE PSYCHOL TESTING, P679, DOI DOI 10.1037/T07502-000; Diamond LM, 2003, MOTIV EMOTION, V27, P125, DOI 10.1023/A:1024521920068; Eisenberg N, 1998, PSYCHOL INQ, V9, P317, DOI 10.1207/s15327965pli0904_1; Eisenberg N, 1997, CHILD DEV, V68, P642, DOI 10.2307/1132116; Eisenberg N, 2010, ANNU REV CLIN PSYCHO, V6, P495, DOI 10.1146/annurev.clinpsy.121208.131208; Fosco GM, 2013, J FAM ISSUES, V34, P557, DOI 10.1177/0192513X12445889; Garnefski N, 2001, PERS INDIV DIFFER, V30, P1311, DOI 10.1016/S0191-8869(00)00113-6; GINSBURG GS, 1995, CLIN PSYCHOL REV, V15, P457, DOI 10.1016/0272-7358(95)00026-L; Ginsburg GS, 1998, J ABNORM CHILD PSYCH, V26, P175, DOI 10.1023/A:1022668101048; Goldin PR, 2009, ARCH GEN PSYCHIAT, V66, P170, DOI 10.1001/archgenpsychiatry.2008.525; Gottman JM, 1997, METAEMOTION; Grob A., 2005, FRAGEBOGEN ERHEBUNG; Gross JJ, 2003, J PERS SOC PSYCHOL, V85, P348, DOI 10.1037/0022-3514.85.2.348; Gunzenhauser C, 2014, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00992; Hunt M, 2003, J PERS ASSESS, V80, P26, DOI 10.1207/S15327752JPA8001_10; In-Albon T, 2007, PSYCHOTHER PSYCHOSOM, V76, P15, DOI 10.1159/000096361; Kashdan TB, 2001, CLIN CHILD FAM PSYCH, V4, P37, DOI 10.1023/A:1009576610507; Katz LF, 1996, J FAM PSYCHOL, V10, P284, DOI 10.1037/0893-3200.10.3.284; Kiel EJ, 2015, CURR OPIN PSYCHOL, V3, P11, DOI 10.1016/j.copsyc.2015.01.006; Klaghofer R, 2001, Z KLIN PSYCHOL PSYCH, V49, P115; Koole SL, 2011, COGNITION EMOTION, V25, P389, DOI 10.1080/02699931.2010.550505; LAGRECA AM, 1988, J CLIN CHILD PSYCHOL, V17, P84, DOI 10.1207/s15374424jccp1701_11; LAGRECA AM, 1993, J CLIN CHILD PSYCHOL, V22, P17, DOI 10.1207/s15374424jccp2201_2; Lieb R, 2000, ARCH GEN PSYCHIAT, V57, P859, DOI 10.1001/archpsyc.57.9.859; Mauss IB, 2007, SOC PERSONAL PSYCHOL, V1, P146, DOI 10.1111/j.1751-9004.2007.00005.x; Mendlowitz SL, 1999, J AM ACAD CHILD PSY, V38, P1223, DOI 10.1097/00004583-199910000-00010; Onwuegbuzie A.J., 2004, UNDERSTANDING STAT, V3, P201, DOI DOI 10.1207/S15328031US0304_1; Rapee RM, 1997, BEHAV RES THER, V35, P741, DOI 10.1016/S0005-7967(97)00022-3; Schneider S., 2009, KINDER DIPS DIAGNOST, V2nd; Schreier S-S, 2008, KLIN DIAGNOSTIK EVAL, P430; Morris AS, 2007, SOC DEV, V16, P361, DOI 10.1111/j.1467-9507.2007.00389.x; Silk JS, 2011, J APPL DEV PSYCHOL, V32, P127, DOI 10.1016/j.appdev.2011.02.001; SILVERMAN WK, 1988, J AM ACAD CHILD PSY, V27, P772, DOI 10.1097/00004583-198811000-00019; Southam-Gerow MA, 2000, J CLIN CHILD PSYCHOL, V29, P319, DOI 10.1207/S15374424JCCP2903_3; Spence SH, 2000, J CHILD PSYCHOL PSYC, V41, P713, DOI 10.1017/S0021963099005934; Suveg C, 2004, J CLIN CHILD ADOLESC, V33, P750, DOI 10.1207/s15374424jccp3304_10; Suveg C, 2011, CHILD PSYCHIAT HUM D, V42, P507, DOI 10.1007/s10578-011-0223-8; Thompson R A, 1994, Monogr Soc Res Child Dev, V59, P25, DOI 10.2307/1166137; Turk CL, 2005, COGNITIVE THER RES, V29, P89, DOI 10.1007/s10608-005-1651-1; Velting ON, 2001, J CHILD PSYCHOL PSYC, V42, P127, DOI 10.1111/1469-7610.00705; Wittchen HU, 1999, PSYCHOL MED, V29, P309, DOI 10.1017/S0033291798008174	58	6	6	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153153	10.1371/journal.pone.0153153	http://dx.doi.org/10.1371/journal.pone.0153153			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DI6KO	27055278	Green Published, Green Submitted, gold			2022-12-27	WOS:000373608000088
J	Chae, YK; Gagliato, DD; Pai, SG; Carneiro, B; Mohindra, N; Giles, FJ; Ramakrishnan-Geethakumari, P; Sohn, J; Liu, SY; Chen, HQ; Ueno, N; Hortobagyi, G; Gonzalez-Angulo, AM				Chae, Young Kwang; Gagliato, Debora de Melo; Pai, Sachin Gopalkrishna; Carneiro, Benedito; Mohindra, Nisha; Giles, Francis Joseph; Ramakrishnan-Geethakumari, Praveen; Sohn, Joohyuk; Liu, Shuying; Chen, Huiqin; Ueno, Naoto; Hortobagyi, Gabriel; Gonzalez-Angulo, Ana Maria			The Association between EGFR and cMET Expression and Phosphorylation and Its Prognostic Implication in Patients with Breast Cancer	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; RANDOMIZED PHASE-II; C-MET; LUNG-CANCER; CELLS; THERAPY; AMPLIFICATION; COMBINATION; RESISTANCE; CETUXIMAB	EGFR and cMET cross-talk is involved in breast cancer (BC) progression and resistance to different targeted therapies, however little is known about the co-expression patterns of EGFR and cMET or its prognostic significance in BC. Protein levels of EGFR, cMET and their phosphorylated proteins were measured in 825 BC samples using reverse phase protein array (RPPA). Given unimodal distribution of proteins, the median was selected as a cut-off after sensitivity analyses. Kaplan-Meier survival curves were used to estimate relapse-free (RFS) and overall survival (OS). Cox-proportional hazards models were utilized to determine associations between EGFR and cMET with outcomes. Mean age was 58 years with 457 (55%) hormone receptor (HR) positive, 211 (26%) triple-negative (TN) and 148 (18%) HER2 positive tumors (HER2+). HER2+ was associated with higher EGFR expression and phosphorylation, compared to HR and TN (p<0.05). High EGFR expression was associated with higher phosphorylated-cMET (p-cMET) but not cMET (ANOVA p-cMET p<0.001; cMET p = 0.34). The same association was found with high phosphorylated-EGFR (p-EGFR) group at Tyr992 and Tyr1068 (both p<0.001). High expressions in either of two p-EGFRs were linked with higher cMET as well (all p<0.001). For the TN subtype, high expression in EGFR and p-EGFR at Tyr992 but not at Tyr1068 was associated with higher p-cMET (p<0.00, p = 0.012, p = 0.4 respectively). Only high expression in pEGFR at Tyr992 was linked with higher expression of cMET (p = 0.02). In contrast, among HER2 subtype, high expression in p-EGFR at Tyr1068 but not at Tyr992 was associated with higher cMET and p-cMET (cMET p = 0.023; p-cMET p<0.001). Four subgroups of patients defined by dichotomized EGFR/ p-EGFR and cMET/p-cMET level demonstrated no significant differences in survival. In multivariate analyses, neither cMET nor EGFR expression/activation was found to be an independent prognostic factor in survival outcome.	[Chae, Young Kwang; Gagliato, Debora de Melo; Ramakrishnan-Geethakumari, Praveen; Sohn, Joohyuk; Liu, Shuying; Chen, Huiqin; Ueno, Naoto; Hortobagyi, Gabriel; Gonzalez-Angulo, Ana Maria] Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA; [Chae, Young Kwang; Pai, Sachin Gopalkrishna; Carneiro, Benedito; Giles, Francis Joseph] Northwestern Univ, Northwestern Med Dev Therapeut Inst, Chicago, IL 60611 USA; [Chae, Young Kwang; Pai, Sachin Gopalkrishna; Carneiro, Benedito; Mohindra, Nisha; Giles, Francis Joseph] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [Chae, Young Kwang; Pai, Sachin Gopalkrishna; Carneiro, Benedito; Mohindra, Nisha; Giles, Francis Joseph] Northwestern Univ, Div Hematol & Oncol, Feinberg Sch Med, Chicago, IL 60611 USA; [Gagliato, Debora de Melo] Hosp Sirio Libanes, Dept Clin Oncol, Sao Paulo, SP, Brazil; [Gagliato, Debora de Melo] ICESP, Sao Paulo, SP, Brazil	University of Texas System; UTMD Anderson Cancer Center; Northwestern University; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; Northwestern University; Feinberg School of Medicine; Hospital Sirio Libanes	Chae, YK (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA.; Chae, YK (corresponding author), Northwestern Univ, Northwestern Med Dev Therapeut Inst, Chicago, IL 60611 USA.; Chae, YK (corresponding author), Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA.; Chae, YK (corresponding author), Northwestern Univ, Div Hematol & Oncol, Feinberg Sch Med, Chicago, IL 60611 USA.	young.chae@northwestern.edu	Pai, Sachin/K-7689-2019	Pai, Sachin/0000-0002-6755-3895	NCI NIH HHS [P30 CA016672, P30 CA060553] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA016672, P30CA060553] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Baselga J, 2013, J CLIN ONCOL, V31, P2586, DOI 10.1200/JCO.2012.46.2408; Bergstrom JD, 2000, EXP CELL RES, V259, P293, DOI 10.1006/excr.2000.4967; Beviglia L, 1997, INT J CANCER, V74, P301, DOI 10.1002/(SICI)1097-0215(19970620)74:3<301::AID-IJC12>3.0.CO;2-E; Blumenschein GR, 2012, J CLIN ONCOL, V30, P3287, DOI 10.1200/JCO.2011.40.3774; Boccaccio C, 2006, NAT REV CANCER, V6, P637, DOI 10.1038/nrc1912; BOTTARO DP, 1991, SCIENCE, V251, P802, DOI 10.1126/science.1846706; Carey LA, 2012, J CLIN ONCOL, V30, P2615, DOI 10.1200/JCO.2010.34.5579; Chia SK, 2007, CANCER, V110, P973, DOI 10.1002/cncr.22867; DeSantis C, 2014, CA-CANCER J CLIN, V64, P52, DOI 10.3322/caac.21203; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Gagliato DD, 2014, CLIN BREAST CANCER, V14, P468, DOI 10.1016/j.clbc.2014.06.001; Garnett J, 2013, NEOPLASIA, V15, P73, DOI 10.1593/neo.121536; Garofalo M, 2012, NAT MED, V18, P74, DOI 10.1038/nm.2577; Gherardi E, 2012, NAT REV CANCER, V12, P89, DOI 10.1038/nrc3205; Graveel CR, 2009, P NATL ACAD SCI USA, V106, P12909, DOI 10.1073/pnas.0810403106; Guo A, 2008, P NATL ACAD SCI USA, V105, P692, DOI 10.1073/pnas.0707270105; Hammond ME, 2011, J CLIN ONCOL, V29, pE458, DOI 10.1200/JCO.2011.35.2245; Hennessy Bryan T, 2010, Clin Proteomics, V6, P129, DOI 10.1007/s12014-010-9055-y; Hochgrafe F, 2010, CANCER RES, V70, P9391, DOI 10.1158/0008-5472.CAN-10-0911; Jo MJ, 2000, J BIOL CHEM, V275, P8806, DOI 10.1074/jbc.275.12.8806; Kim YJ, 2014, INT J CANCER, V134, P2424, DOI 10.1002/ijc.28566; Lengyel E, 2005, INT J CANCER, V113, P678, DOI 10.1002/ijc.20598; Liska D, 2011, CLIN CANCER RES, V17, P472, DOI 10.1158/1078-0432.CCR-10-0568; Martin TA, 2010, ANTI-CANCER AGENT ME, V10, P2, DOI 10.2174/1871520611009010002; Masuda H, 2012, BREAST CANCER RES TR, V136, P331, DOI 10.1007/s10549-012-2289-9; Moerkens M, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-283; NICHOLSON RI, 1994, BREAST CANCER RES TR, V29, P117, DOI 10.1007/BF00666187; NICHOLSON RI, 1993, EUR J CANCER, V29A, P1018, DOI 10.1016/S0959-8049(05)80215-1; Nicholson RI, 2001, EUR J CANCER, V37, pS9, DOI 10.1016/s0959-8049(01)00231-3; Park HS, 2014, MODERN PATHOL, V27, P1212, DOI 10.1038/modpathol.2013.251; Paulson AK, 2013, MOL CANCER RES, V11, P1112, DOI 10.1158/1541-7786.MCR-13-0042; Raghav KP, 2012, CLIN CANCER RES, V18, P2269, DOI 10.1158/1078-0432.CCR-11-2830; Tengs T, 2006, CANCER LETT, V239, P227, DOI 10.1016/j.canlet.2005.08.007; Tredan O, 2015, CLIN BREAST CANCER, V15, P8, DOI 10.1016/j.clbc.2014.07.007; Xu AM, 2010, CANCER RES, V70, P3857, DOI 10.1158/0008-5472.CAN-10-0163; Yan SC, 2015, DIAGN PATHOL, V10, DOI 10.1186/s13000-015-0296-y; Zeng ZS, 2008, CANCER LETT, V265, P258, DOI 10.1016/j.canlet.2008.02.049	37	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0152585	10.1371/journal.pone.0152585	http://dx.doi.org/10.1371/journal.pone.0152585			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27055285	Green Published, gold			2022-12-27	WOS:000373608000026
J	Lindmark, A; van Rompaye, B; Goetghebeur, E; Glader, EL; Eriksson, M				Lindmark, Anita; van Rompaye, Bart; Goetghebeur, Els; Glader, Eva-Lotta; Eriksson, Marie			The Importance of Integrating Clinical Relevance and Statistical Significance in the Assessment of Quality of Care-Illustrated Using the Swedish Stroke Register	PLOS ONE			English	Article							PROFILING HOSPITAL PERFORMANCE; INSTITUTIONAL PERFORMANCE; RISK-ADJUSTMENT; ISCHEMIC-STROKE; FUNNEL PLOTS; OUTCOMES; ISSUES; MODELS	Background When profiling hospital performance, quality inicators are commonly evaluated through hospital-specific adjusted means with confidence intervals. When identifying deviations from a norm, large hospitals can have statistically significant results even for clinically irrelevant deviations while important deviations in small hospitals can remain undiscovered. We have used data from the Swedish Stroke Register (Riksstroke) to illustrate the properties of a benchmarking method that integrates considerations of both clinical relevance and level of statistical significance. Methods The performance measure used was case-mix adjusted risk of death or dependency in activities of daily living within 3 months after stroke. A hospital was labeled as having outlying performance if its case-mix adjusted risk exceeded a benchmark value with a specified statistical confidence level. The benchmark was expressed relative to the population risk and should reflect the clinically relevant deviation that is to be detected. A simulation study based on Riksstroke patient data from 2008-2009 was performed to investigate the effect of the choice of the statistical confidence level and benchmark value on the diagnostic properties of the method. Results Simulations were based on 18,309 patients in 76 hospitals. The widely used setting, comparing 95% confidence intervals to the national average, resulted in low sensitivity (0.252) and high specificity (0.991). There were large variations in sensitivity and specificity for different requirements of statistical confidence. Lowering statistical confidence improved sensitivity with a relatively smaller loss of specificity. Variations due to different benchmark values were smaller, especially for sensitivity. This allows the choice of a clinically relevant benchmark to be driven by clinical factors without major concerns about sufficiently reliable evidence. Conclusions The study emphasizes the importance of combining clinical relevance and level of statistical confidence when profiling hospital performance. To guide the decision process a web-based tool that gives ROC-curves for different scenarios is provided.	[Lindmark, Anita; van Rompaye, Bart; Eriksson, Marie] Umea Univ, Dept Stat, Umea Sch Business & Econ, S-90187 Umea, Sweden; [van Rompaye, Bart; Goetghebeur, Els] Univ Ghent, Dept Appl Math Comp Sci & Stat, B-9000 Ghent, Belgium; [Glader, Eva-Lotta] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden	Umea University; Ghent University; Umea University	Lindmark, A (corresponding author), Umea Univ, Dept Stat, Umea Sch Business & Econ, S-90187 Umea, Sweden.	anita.lindmark@umu.se	Eriksson, Marie/H-2452-2012; Glader, Eva-Lotta/AGR-3015-2022; Eriksson, Marie/AAB-6215-2019; Goetghebeur, Els J/H-7939-2016	Eriksson, Marie/0000-0003-3298-1555; Eriksson, Marie/0000-0003-3298-1555; Lindmark, Anita/0000-0002-4600-0060	Swedish Research Council [2012-5934]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	The study was funded by the Swedish Research Council (http://www.vr.se/), grant no. 2012-5934. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asplund K, 2011, INT J STROKE, V6, P99, DOI 10.1111/j.1747-4949.2010.00557.x; Austin PC, 2003, MED DECIS MAKING, V23, P526, DOI 10.1177/0272989X03258443; Austin PC, 2001, J EVAL CLIN PRACT, V7, P35, DOI 10.1046/j.1365-2753.2001.00261.x; Centers for Medicare & Medicaid Services, 2014, HOSP COMP; DeLong ER, 1997, STAT MED, V16, P2645, DOI 10.1002/(SICI)1097-0258(19971215)16:23<2645::AID-SIM696>3.0.CO;2-D; Fonarow GC, 2012, JAMA-J AM MED ASSOC, V308, P257, DOI 10.1001/jama.2012.7870; Goldstein H, 1996, J ROY STAT SOC A STA, V159, P385, DOI 10.2307/2983325; Hubbard RA, 2015, STAT MED, V34, P93, DOI 10.1002/sim.6318; Katzan IL, 2014, STROKE, V45, P918, DOI 10.1161/01.str.0000441948.35804.77; Kolfschoten NE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088737; Kunadian B, 2009, CATHETER CARDIO INTE, V73, P589, DOI 10.1002/ccd.21893; NHS Improving Quality, NAT PEER REV PROGR 2; Normand SLT, 1997, J AM STAT ASSOC, V92, P803, DOI 10.2307/2965545; Paddock SM, 2014, HEALTH SERV RES, V49, P1056, DOI 10.1111/1475-6773.12149; Riksstroke, 2013, RISKS STROK ARSR 201; Schulman J, 2008, J PERINATOL, V28, P588, DOI 10.1038/jp.2008.67; Shahian DM, 2008, CIRCULATION, V117, P1955, DOI 10.1161/CIRCULATIONAHA.107.747873; Shahian DM, 2015, BMJ QUAL SAF, V24, P95, DOI 10.1136/bmjqs-2015-003934; Spiegelhalter DJ, 2005, STAT MED, V24, P1185, DOI 10.1002/sim.1970; STARMARK JE, 1988, ACTA NEUROCHIR, V91, P12, DOI 10.1007/BF01400521; Sweden The National Board of Health and Welfare & Swedish Association of Local Authorities and Regions, 2013, OPPNA JAMFORELSER 20; The Swedish Association of Local Authorities and Regions, 2015, MOT 61 PERS VARD K N; van Dishoeck AM, 2011, BMJ QUAL SAF, V20, P651, DOI 10.1136/bmjqs.2009.035881; Varewyck M, 2016, STAT MED, V35, P227, DOI 10.1002/sim.6634; Varewyck M, 2014, BIOSTATISTICS, V15, P651, DOI 10.1093/biostatistics/kxu019; World Health Organization (WHO). Division of Country Health Systems, PERF ASS TOOL QUAL I	26	0	0	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153082	10.1371/journal.pone.0153082	http://dx.doi.org/10.1371/journal.pone.0153082			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27054326	Green Published, gold, Green Submitted			2022-12-27	WOS:000373608000075
J	Mobascher, A; Diaz-Lacava, A; Wagner, M; Gallinat, J; Wienker, TF; Drichel, D; Becker, T; Steffens, M; Dahmen, N; Grunder, G; Thurauf, N; Kiefer, F; Kornhuber, J; Toliat, MR; Thiele, H; Nurnberg, P; Steinlein, O; Winterer, G				Mobascher, A.; Diaz-Lacava, A.; Wagner, M.; Gallinat, J.; Wienker, T. F.; Drichel, D.; Becker, T.; Steffens, M.; Dahmen, N.; Gruender, G.; Thuerauf, N.; Kiefer, F.; Kornhuber, J.; Toliat, M. R.; Thiele, H.; Nuernberg, P.; Steinlein, O.; Winterer, G.			Association of Common Polymorphisms in the Nicotinic Acetylcholine Receptor Alpha4 Subunit Gene with an Electrophysiological Endophenotype in a Large Population-Based Sample	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; INTRACEREBRAL POTENTIALS; WORKING-MEMORY; VISUAL-STIMULI; RARE TARGET; ELECTROMAGNETIC TOMOGRAPHY; VISUOSPATIAL ATTENTION; RESPONSE SPEED; CHRNA4 GENE; SCHIZOPHRENIA	Variation in genes coding for nicotinic acetylcholine receptor (nAChR) subunits affect cognitive processes and may contribute to the genetic architecture of neuropsychiatric disorders. Single nucleotide polymorphisms (SNPs) in the CHRNA4 gene that codes for the alpha4 subunit of alpha4/beta2-containing receptors have previously been implicated in aspects of (mostly visual) attention and smoking-related behavioral measures. Here we investigated the effects of six synonymous but functional CHRNA4 exon 5 SNPs on the N100 event-related potential (ERP), an electrophysiological endophenotype elicited by a standard auditory odd-ball. A total of N = 1,705 subjects randomly selected from the general population were studied with electroencephalography (EEG) as part of the German Multicenter Study on nicotine addiction. Two of the six variants, rs1044396 and neighboring rs1044397, were significantly associated with N100 amplitude. This effect was pronounced in females where we also observed an effect on reaction time. Sequencing of the complete exon 5 region in the population sample excluded the existence of additional/functional variants thatmay be responsible for the observed effects. This is the first large-scale population-based study investigation the effects of CHRNA4 SNPs on brain activitymeasures related to stimulus processing and attention. Our results provide further evidence that common synonymous CHRNA4 exon 5 SNPs affect cognitive processes and suggest that they also play a role in the auditory system. As N100 amplitude reduction is considered a schizophrenia-related endophenotype the SNPs studied here may also be associated with schizophrenia outcome measures.	[Mobascher, A.; Dahmen, N.] Mainz Univ Hosp, Dept Psychiat, Mainz, Germany; [Diaz-Lacava, A.; Toliat, M. R.; Thiele, H.; Nuernberg, P.] Univ Cologne, Cologne Ctr Genom, D-50931 Cologne, Germany; [Wagner, M.] Bonn Univ Hosp, Dept Psychiat, Bonn, Germany; [Gallinat, J.] Univ Med Ctr Hamburg Eppendorf UKE, Dept Psychiat & Psychotherapy, Hamburg, Germany; [Wienker, T. F.] Max Planck Inst Mol Genet, Ihnestr 73, D-14195 Berlin, Germany; [Drichel, D.; Becker, T.] Ernst Moritz Arndt Univ Greifswald, Greifswald, Germany; [Steffens, M.] Fed Inst Drugs & Med Devices BfArM, Div Res, Bonn, Germany; [Gruender, G.] Rhein Westfal TH Aachen, Univ Hosp, Dept Psychiat, D-52062 Aachen, Germany; [Thuerauf, N.; Kornhuber, J.] Univ Erlangen Nurnberg, Univ Hosp, Dept Psychiat, D-91054 Erlangen, Germany; [Kiefer, F.] Cent Inst Mental Hlth, Dept Addict Behav & Addict Med, Mannheim, Germany; [Steinlein, O.] Univ Munich, Dept Human Genet, Munich, Germany; [Winterer, G.] Charite, ECRC, D-13353 Berlin, Germany	University Hospital Mainz; University of Cologne; University of Bonn; University of Hamburg; University Medical Center Hamburg-Eppendorf; Max Planck Society; Ernst Moritz Arndt Universitat Greifswald; RWTH Aachen University; RWTH Aachen University Hospital; University of Erlangen Nuremberg; Central Institute of Mental Health; University of Munich; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Mobascher, A (corresponding author), Mainz Univ Hosp, Dept Psychiat, Mainz, Germany.	amobascher@ihr-gesundheitszentrum.de	Thiele, Holger/ABE-6792-2020; Wagner, Michael/E-2325-2011; Kornhuber, Johannes/B-9613-2014	Thiele, Holger/0000-0002-0169-998X; Wagner, Michael/0000-0003-2589-6440; Kornhuber, Johannes/0000-0002-8096-3987; Drichel, Dmitriy/0000-0001-5978-3458	German Research Foundation (Deutsche Forschungsgemeinschaft, DFG)	German Research Foundation (Deutsche Forschungsgemeinschaft, DFG)(German Research Foundation (DFG))	The study 'Genetics of Nicotine Dependence and Neurobiological Phenotypes' (Wi1316/9-1-Principle Investigator: GW) was funded by the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG) as part of the Priority Program (Schwerpunktprogramm) SPP1226: 'Nicotine-Molecular and Physiological Effects in CNS' (Coordinator: G. Winterer). http://www.nicotine-research.com.	Ahrens S, 2015, PSYCHOPHARMACOLOGY, V232, P2323, DOI 10.1007/s00213-015-3869-2; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BAUDENA P, 1995, ELECTROEN CLIN NEURO, V94, P251, DOI 10.1016/0013-4694(95)98476-O; Breckel TPK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126460; Breitling LP, 2009, PHARMACOGENOMICS J, V9, P219, DOI 10.1038/tpj.2009.6; Dineley KT, 2015, TRENDS PHARMACOL SCI, V36, P96, DOI 10.1016/j.tips.2014.12.002; Eggert M, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0204-1; Espeseth T, 2007, NEUROSCIENCE, V147, P974, DOI 10.1016/j.neuroscience.2007.04.027; First M.B., 2016, STRUCTURED CLIN INTE; Gallinat J, 2002, NEUROIMAGE, V17, P110, DOI 10.1006/nimg.2002.1213; Giessing C, 2012, NEUROIMAGE, V59, P831, DOI 10.1016/j.neuroimage.2011.07.061; Gotti C, 2006, TRENDS PHARMACOL SCI, V27, P482, DOI 10.1016/j.tips.2006.07.004; Greenwood PM, 2012, NEUROSCI BIOBEHAV R, V36, P1331, DOI 10.1016/j.neubiorev.2012.02.010; Greenwood PM, 2009, P NATL ACAD SCI USA, V106, P3633, DOI 10.1073/pnas.0807891106; Greenwood PM, 2005, J COGNITIVE NEUROSCI, V17, P1611, DOI 10.1162/089892905774597281; HALGREN E, 1995, ELECTROEN CLIN NEURO, V94, P229, DOI 10.1016/0013-4694(95)98475-N; Halgren E, ELECTROENCEPHALOGR C, V94, P191; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Henrich J, 2010, BEHAV BRAIN SCI, V33, P61, DOI 10.1017/S0140525X0999152X; Holmes AP, 1996, J CEREBR BLOOD F MET, V16, P7, DOI 10.1097/00004647-199601000-00002; Hutchison KE, 2007, ARCH GEN PSYCHIAT, V64, P1078, DOI 10.1001/archpsyc.64.9.1078; Lao O, 2008, CURR BIOL, V18, P1241, DOI 10.1016/j.cub.2008.07.049; Lee S, 2012, AM J HUM GENET, V91, P224, DOI 10.1016/j.ajhg.2012.06.007; Lehrl S., 2005, MANUAL ZUM MWT B MEH; Li MD, 2005, HUM MOL GENET, V14, P1211, DOI 10.1093/hmg/ddi132; Lindenberg A, 2011, ADDICT BIOL, V16, P638, DOI 10.1111/j.1369-1600.2011.00322.x; Markett S, 2011, EUR NEUROPSYCHOPHARM, V21, P216, DOI 10.1016/j.euroneuro.2010.10.011; Markett SA, 2010, J COGNITIVE NEUROSCI, V22, P1944, DOI 10.1162/jocn.2009.21354; Mobascher A, 2008, PHARMACOPSYCHIATRY, V41, pS51, DOI 10.1055/s-2008-1081463; Mulert C, 2003, INT J PSYCHOPHYSIOL, V47, P175, DOI 10.1016/S0167-8760(02)00125-3; Mulert C, 2001, NEUROIMAGE, V13, P589, DOI 10.1006/nimg.2000.0727; Nees F, 2015, NEUROPHARMACOLOGY, V96, P289, DOI 10.1016/j.neuropharm.2014.10.021; Onitsuka T, 2013, PSYCHIAT CLIN NEUROS, V67, P461, DOI 10.1111/pcn.12090; Parasuraman R, 2005, PSYCHOL SCI, V16, P200, DOI 10.1111/j.0956-7976.2005.00804.x; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; PASCUALMARQUI RD, 1994, INT J PSYCHOPHYSIOL, V18, P49, DOI 10.1016/0167-8760(84)90014-X; Polich J, 2006, INT J PSYCHOPHYSIOL, V60, P172, DOI 10.1016/j.ijpsycho.2005.12.012; Quednow BB, 2012, P NATL ACAD SCI USA, V109, P6271, DOI 10.1073/pnas.1118051109; Rahman S, 2015, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00426; Reinvang I, 2009, NEUROSCI LETT, V453, P131, DOI 10.1016/j.neulet.2009.02.029; Rosburg T, 2008, PSYCHIAT RES, V161, P259, DOI 10.1016/j.psychres.2008.03.017; Schneider KK, 2015, NEUROREPORT, V26, P186, DOI 10.1097/WNR.0000000000000313; Schneider KK, 2015, BEHAV BRAIN RES, V284, P11, DOI 10.1016/j.bbr.2015.01.041; Turetsky BI, 2008, BIOL PSYCHIAT, V64, P1051, DOI 10.1016/j.biopsych.2008.06.018; Winterer G, 2007, HUM MOL GENET, V16, P2165, DOI 10.1093/hmg/ddm168; Zoli M, 2015, NEUROPHARMACOLOGY, V96, P302, DOI 10.1016/j.neuropharm.2014.11.003	46	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0152984	10.1371/journal.pone.0152984	http://dx.doi.org/10.1371/journal.pone.0152984			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27054571	Green Accepted, Green Published, gold			2022-12-27	WOS:000373608000060
J	Moen, ST; Hatcher, CL; Singh, AK				Moen, Scott T.; Hatcher, Christopher L.; Singh, Anup K.			A Centrifugal Microfluidic Platform That Separates Whole Blood Samples into Multiple Removable Fractions Due to Several Discrete but Continuous Density Gradient Sections	PLOS ONE			English	Article							MONONUCLEAR-CELLS; SEDIMENTATION; MONOCYTES; VOLUME	We present a miniaturized centrifugal platform that uses density centrifugation for separation and analysis of biological components in small volume samples (similar to 5 mu L). We demonstrate the ability to enrich leukocytes for on-disk visualization via microscopy, as well as recovery of viable cells from each of the gradient partitions. In addition, we simplified the traditional Modified Wright-Giemsa staining by decreasing the time, volume, and expertise involved in the procedure. From a whole blood sample, we were able to extract 95.15% of leukocytes while excluding 99.8% of red blood cells. This platform has great potential in both medical diagnostics and research applications as it offers a simpler, automated, and inexpensive method for biological sample separation, analysis, and downstream culturing.	[Moen, Scott T.; Singh, Anup K.] Sandia Natl Labs, Livermore, CA USA; [Moen, Scott T.; Hatcher, Christopher L.; Singh, Anup K.] Univ Texas Med Branch, Galveston, TX 77555 USA	United States Department of Energy (DOE); Sandia National Laboratories; University of Texas System; University of Texas Medical Branch Galveston	Moen, ST (corresponding author), Sandia Natl Labs, Livermore, CA USA.; Moen, ST (corresponding author), Univ Texas Med Branch, Galveston, TX 77555 USA.	stmoen@utmb.edu			National Institute of Allergy and Infectious Diseases [R01AI0988530]; U.S. Department of Energy's National Nuclear Security Administration [DE-AC04-94AL85000]; NIH-NIAID [R01AI0988530]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI098853] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); U.S. Department of Energy's National Nuclear Security Administration(National Nuclear Security Administration); NIH-NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was funded by National Institute of Allergy and Infectious Diseases (Grant R01AI0988530). Sandia National Laboratories is a multi-program laboratory managed and operated by Sandia Corporation, a wholly owned subsidiary of Lockheed Martin Corporation, for the U.S. Department of Energy's National Nuclear Security Administration under contract DE-AC04-94AL85000 (STM).; This research was funded by NIH-NIAID grant number R01AI0988530. Sandia National Laboratories is a multi-program laboratory managed and operated by Sandia Corporation, a wholly owned subsidiary of Lockheed Martin Corporation, for the U.S. Department of Energy's National Nuclear Security Administration under contract DE-AC04-94AL85000. We would also like to thank Greg Berry and Mardelle Susman for their editing services.	Andre MC, 2012, J LEUKOCYTE BIOL, V91, P977, DOI 10.1189/jlb.0911474; BERTHOLD F, 1981, BLUT, V43, P367, DOI 10.1007/BF00320315; Boyum A, 1968, Scand J Clin Lab Invest Suppl, V97, P7; BOYUM A, 1991, SCAND J IMMUNOL, V34, P697, DOI 10.1111/j.1365-3083.1991.tb01594.x; Cho H, 2007, J COLLOID INTERF SCI, V306, P379, DOI 10.1016/j.jcis.2006.10.077; Cho Y-K, 2007, TRANSDUCERS 2007 200, P387, DOI [10.1109/SENSOR.2007.4300149, DOI 10.1109/SENSOR.2007.4300149]; COLOTTA F, 1994, AM J PATHOL, V144, P975; De Boer BA, 1998, CLIN EXP IMMUNOL, V114, P252; Fogeda M, 1999, J VIROL, V73, P4052, DOI 10.1128/JVI.73.5.4052-4061.1999; Hoeboer SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065564; Kinahan DJ, 2014, SENSOR ACTUAT A-PHYS, V215, P71, DOI 10.1016/j.sna.2013.11.010; Klinken SP, 2002, INT J BIOCHEM CELL B, V34, P1513, DOI 10.1016/S1357-2725(02)00087-0; Leidinger P, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-474; Meyer HS, 2001, JAMA-J AM MED ASSOC, P95; Park JM, 2014, ANAL CHEM, V86, P3735, DOI 10.1021/ac403456t; Park JM, 2012, ANAL CHEM, V84, P7400, DOI 10.1021/ac3011704; Pitts KL, 2013, J MECH BEHAV BIOMED, V17, P333, DOI 10.1016/j.jmbbm.2012.07.007; POPPE LJ, 1988, COMPUT GEOSCI, V14, P541, DOI 10.1016/0098-3004(88)90034-9; Pritchard CC, 2012, CANCER PREV RES, V5, P492, DOI 10.1158/1940-6207.CAPR-11-0370; RAGHUPRASAD PK, 1982, J IMMUNOL, V129, P2128; Ratner BD, 2004, CHEM ENG; Rosina J, 2007, PHYSIOL RES, V56, pS93, DOI 10.33549/physiolres.931306; Traves SL, 2004, J LEUKOCYTE BIOL, V76, P441, DOI 10.1189/jlb.1003495; ZIPURSKY A, 1976, BLOOD, V48, P361	24	15	16	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153137	10.1371/journal.pone.0153137	http://dx.doi.org/10.1371/journal.pone.0153137			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27054764	Green Published, gold, Green Submitted			2022-12-27	WOS:000373608000085
J	Yang, SN; Li, FJ; Chen, JM; Zhang, G; Liao, YH; Huang, TC				Yang, Shih-Neng; Li, Fang-Jing; Chen, Jun-Ming; Zhang, Geoffrey; Liao, Yen-Hsiu; Huang, Tzung-Chi			Kinetic Curve Type Assessment for Classification of Breast Lesions Using Dynamic Contrast-Enhanced MR Imaging	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; CANCER; MODEL; IMAGES; QUANTIFICATION; PERMEABILITY; FEASIBILITY; DIAGNOSIS; FEATURES; VALUES	Objective The aim of this study was to employ a kinetic model with dynamic contrast enhancement-magnetic resonance imaging to develop an approach that can efficiently distinguish malignant from benign lesions. Materials and Methods A total of 43 patients with 46 lesions who underwent breast dynamic contrast enhancement-magnetic resonance imaging were included in this retrospective study. The distribution of malignant to benign lesions was 31/15 based on histological results. This study integrated a single-compartment kinetic model and dynamic contrast enhancement-magnetic resonance imaging to generate a kinetic modeling curve for improving the accuracy of diagnosis of breast lesions. Kinetic modeling curves of all different lesions were analyzed by three experienced radiologists and classified into one of three given types. Receiver operating characteristic and Kappa statistics were used for the qualitative method. The findings of the three radiologists based on the time-signal intensity curve and the kinetic curve were compared. Results An average sensitivity of 82%, a specificity of 65%, an area under the receiver operating characteristic curve of 0.76, and a positive predictive value of 82% and negative predictive value of 63% was shown with the kinetic model (p = 0.017, 0.052, 0.068), as compared to an average sensitivity of 80%, a specificity of 55%, an area under the receiver operating characteristic of 0.69, and a positive predictive value of 79% and negative predictive value of 57% with the time-signal intensity curve method (p = 0.003, 0.004, 0.008). The diagnostic consistency of the three radiologists was shown by the.-value, 0.857 (p<0.001) with the method based on the time-signal intensity curve and 0.826 (p<0.001) with the method of the kinetic model. Conclusions According to the statistic results based on the 46 lesions, the kinetic modeling curve method showed higher sensitivity, specificity, positive and negative predictive values as compared with the time-signal intensity curve method in lesion classification.	[Yang, Shih-Neng; Huang, Tzung-Chi] China Med Univ, Dept Biomed Imaging & Radiol Sci, Taichung, Taiwan; [Yang, Shih-Neng] China Med Univ Hosp, Dept Radiat Oncol, Taichung, Taiwan; [Li, Fang-Jing; Liao, Yen-Hsiu] Triserv Gen Hosp, Dept Radiat Oncol, Taipei, Taiwan; [Chen, Jun-Ming] China Med Univ Hosp, Dept Radiol, Taichung, Taiwan; [Zhang, Geoffrey] Univ S Florida, H Lee Moffitt Canc Ctr, Dept Radiat Oncol, Tampa, FL 33682 USA; [Huang, Tzung-Chi] Asia Univ, Dept Bioinformat & Med Engn, Taichung, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Tri-Service General Hospital; China Medical University Taiwan; China Medical University Hospital - Taiwan; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Asia University Taiwan	Huang, TC (corresponding author), China Med Univ, Dept Biomed Imaging & Radiol Sci, Taichung, Taiwan.; Huang, TC (corresponding author), Asia Univ, Dept Bioinformat & Med Engn, Taichung, Taiwan.	tzungchi.huang@mail.cmu.edu.tw						Agliozzo S, MED PHYS, V39, P1704; Baltzer PAT, 2010, AM J ROENTGENOL, V194, P1658, DOI 10.2214/AJR.09.3486; Baum F, 2002, EUR RADIOL, V12, P1087, DOI 10.1007/s00330-001-1213-1; Bluemke DA, 2004, JAMA-J AM MED ASSOC, V292, P2735, DOI 10.1001/jama.292.22.2735; Boetes C, 2005, Cancer Imaging, V5 Spec No A, pS10, DOI 10.1102/1470-7330.2005.0040; Brix G, 2004, MAGNET RESON MED, V52, P420, DOI 10.1002/mrm.20161; Delille JP, 2002, RADIOLOGY, V223, P558, DOI 10.1148/radiol.2232010428; DeMartini Wendy, 2008, Top Magn Reson Imaging, V19, P143, DOI 10.1097/RMR.0b013e31818a40a5; El Khouli RH, 2009, AM J ROENTGENOL, V193, pW295, DOI 10.2214/AJR.09.2483; Fick A, 1885, ANN PHYS-LEIPZIG, V94, P59; Gilbert FJ, 2016, CLIN RADIOL, V71, P141, DOI 10.1016/j.crad.2015.11.008; Henderson E, 2000, J MAGN RESON IMAGING, V12, P991, DOI 10.1002/1522-2586(200012)12:6<991::AID-JMRI26>3.0.CO;2-1; Ingrisch M, 2013, J PHARMACOKINET PHAR, V40, P281, DOI 10.1007/s10928-013-9315-3; KETY SS, 1948, J CLIN INVEST, V27, P476, DOI 10.1172/JCI101994; Kinkel K, 2000, AM J ROENTGENOL, V175, P35, DOI 10.2214/ajr.175.1.1750035; Kriege M, 2004, NEW ENGL J MED, V351, P427, DOI 10.1056/NEJMoa031759; Kuhl C, 2007, RADIOLOGY, V244, P356, DOI 10.1148/radiol.2442051620; Kuhl CK, 1999, RADIOLOGY, V211, P101, DOI 10.1148/radiology.211.1.r99ap38101; Liu T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103576; Lorthois S, 2014, J THEOR BIOL, V353, P157, DOI 10.1016/j.jtbi.2014.03.004; Macura KJ, 2006, RADIOGRAPHICS, V26, P1719, DOI 10.1148/rg.266065025; Martin DR, 2008, RADIOLOGY, V246, P241, DOI 10.1148/radiol.2461062129; Moadel RM, 2011, SEMIN NUCL MED, V41, P229, DOI 10.1053/j.semnuclmed.2010.12.005; Nye JA, 2014, NUCL MED BIOL, V41, P217, DOI 10.1016/j.nucmedbio.2013.12.013; Orel SG, 2001, RADIOLOGY, V220, P13, DOI 10.1148/radiology.220.1.r01jl3113; Roberts C, 2008, RADIOLOGY, V246, P845, DOI 10.1148/radiol.2463070298; Schnall MD, 2006, RADIOLOGY, V238, P42, DOI 10.1148/radiol.2381042117; Schnall MD, 2001, ACAD RADIOL, V8, P591, DOI 10.1016/S1076-6332(03)80683-9; Schulz-Wendtland R, 2009, EUR J RADIOL, V72, P258, DOI 10.1016/j.ejrad.2009.05.052; Sheiman RG, 2008, RADIOLOGY, V249, P878, DOI 10.1148/radiol.2492080026; Sitek A, 2005, RADIOLOGY, V237, P670, DOI 10.1148/radiol.2372041403; Wang LC, 2009, AM J ROENTGENOL, V193, P826, DOI 10.2214/AJR.08.1335	32	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0152827	10.1371/journal.pone.0152827	http://dx.doi.org/10.1371/journal.pone.0152827			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27055113	Green Published, Green Submitted, gold			2022-12-27	WOS:000373608000048
J	Infante, J; Rosalen, PL; Lazarini, JG; Franchin, M; de Alencar, SM				Infante, Juliana; Rosalen, Pedro Luiz; Lazarini, Josy Goldoni; Franchin, Marcelo; de Alencar, Severino Matias			Antioxidant and Anti-Inflammatory Activities of Unexplored Brazilian Native Fruits	PLOS ONE			English	Article							NEUTROPHILS; CAPACITIES	Brazilian native fruits are unmatched in their variety, but a poorly explored resource for the development of food and pharmaceutical products. The aim of this study was to evaluate the phenolic composition as well as the antioxidant and anti-inflammatory activities of the extracts of leaves, seeds, and pulp of four Brazilian native fruits (Eugenia leitonii, Eugenia involucrata, Eugenia brasiliensis, and Eugenia myrcianthes). GC-MS analyses of the ethanolic extracts showed the presence of epicatechin and gallic acid as the major compounds in these fruits. Antioxidant activity was measured using synthetic DPPH free-radical scavenging, beta-carotene bleaching assay, and reactive oxygen species (ROO center dot, O-2 center dot(-), and HOCl). The fruit extracts also exhibited antioxidant effect against biologically relevant radicals such as peroxyl, superoxide, and hypochlorous acid. In general, the pulps were the fruit fractions that exhibited the lowest antioxidant activities, whereas the leaves showed the highest ones. The anti-inflammatory activity was assessed in an in vivo model using the carrageenan-induced neutrophil migration assay, which evaluates the inflammatory response in the acute phase. The pulp, seeds, and leaves of these fruits reduced the neutrophil influx by 40% to 64%. Based on these results, we suggest that the anti-inflammatory activity of these native fruits is related to the modulation of neutrophil migration, through the inhibition of cytokines, chemokines, and adhesion molecules, as well as to the antioxidant action of their ethanolic extracts in scavenging the free-radicals released by neutrophils. Therefore, these native fruits can be useful to produce food additives and functional foods.	[Infante, Juliana; de Alencar, Severino Matias] Univ Sao Paulo, Dept Agrifood Ind Food & Nutr, Luiz de Queiroz Coll Agr, Padua Dias Ave,POB 9, BR-13418900 Piracicaba, SP, Brazil; [Rosalen, Pedro Luiz; Lazarini, Josy Goldoni; Franchin, Marcelo] Univ Estadual Campinas, Dept Physiol Sci, Piracicaba Dent Sch, 901 Limeira Ave, BR-13414903 Piracicaba, SP, Brazil	Universidade de Sao Paulo; Universidade Estadual de Campinas	de Alencar, SM (corresponding author), Univ Sao Paulo, Dept Agrifood Ind Food & Nutr, Luiz de Queiroz Coll Agr, Padua Dias Ave,POB 9, BR-13418900 Piracicaba, SP, Brazil.	smalencar@usp.br	Lazarini, Josy Goldoni/L-3477-2016; Rosalen, Pedro Luiz/I-3718-2012; Franchin, Marcelo/M-7636-2017; Alencar, Severino Matias/B-7743-2012	Lazarini, Josy Goldoni/0000-0002-3498-8243; Rosalen, Pedro Luiz/0000-0003-0812-4027; Franchin, Marcelo/0000-0001-5613-2756; Alencar, Severino Matias/0000-0002-6637-7973	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2013/13190-2, 2014/50235-7]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Grant number: 2013/13190-2 - Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - JI; and Grant number: 2014/50235-7 - Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - SMA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argyropoulou A, 2013, NAT PROD REP, V30, P1412, DOI 10.1039/c3np70031c; Delfanian M, 2015, FOOD SCI NUTR, V3, P613, DOI [10.1002/fsn3.201, 10.1002/fsn3.320]; Denny C, 2014, J FUNCT FOODS, V8, P292, DOI 10.1016/j.jff.2014.03.016; Edreva A, 2005, AGR ECOSYST ENVIRON, V106, P119, DOI 10.1016/j.agee.2004.10.022; Emmons CL, 1999, J AGR FOOD CHEM, V47, P4894, DOI 10.1021/jf990530i; Folmer F, 2014, PHYTOCHEM REV, V13, P295, DOI 10.1007/s11101-013-9319-z; Food and Agriculture Organization of the United Nations, 2009, FEED WORLD 2050 HIGH; Fraga CG, 2011, FREE RADICAL BIO MED, V51, P813, DOI 10.1016/j.freeradbiomed.2011.06.002; Rodriguez-Roque MJ, 2016, FOOD FUNCT, V7, P380, DOI [10.1039/c5fo01060h, 10.1039/C5FO01060H]; JOLY C.A., 2011, REV USP, V89, P114; Locatelli C, 2013, EUR J MED CHEM, V60, P233, DOI 10.1016/j.ejmech.2012.10.056; Ma MM, 2015, INFLAMMATION, V38, P1669, DOI 10.1007/s10753-015-0144-y; Marinovic MP, 2015, TOXICOL IN VITRO, V29, P1766, DOI 10.1016/j.tiv.2015.07.014; Massarioli AP, 2013, J FOOD AGRIC ENVIRON, V11, P288; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Melo PS, 2015, FOOD CHEM, V181, P160, DOI 10.1016/j.foodchem.2015.02.087; Nemeth T, 2012, IMMUNOL LETT, V143, P9, DOI 10.1016/j.imlet.2012.01.013; Oldoni TLC, 2011, SEP PURIF TECHNOL, V77, P208, DOI 10.1016/j.seppur.2010.12.007; Patthamakanokporn O, 2008, J FOOD COMPOS ANAL, V21, P241, DOI 10.1016/j.jfca.2007.10.002; Sadik CD, 2012, J LEUKOCYTE BIOL, V91, P207, DOI 10.1189/jlb.0811402; Singleton VL, 1999, METHOD ENZYMOL, V299, P152; Tiveron AP, 2012, INT J MOL SCI, V13, P8943, DOI 10.3390/ijms13078943; Wang SY, 2011, INT J FOOD SCI TECH, V46, P2482, DOI 10.1111/j.1365-2621.2011.02771.x; Wang SY, 2000, J AGR FOOD CHEM, V48, P140, DOI 10.1021/jf9908345; Wong SH, 2004, ARCH IMMUNOL THER EX, V52, P379; Wu XL, 2004, J AGR FOOD CHEM, V52, P4026, DOI 10.1021/jf049696w	26	52	54	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0152974	10.1371/journal.pone.0152974	http://dx.doi.org/10.1371/journal.pone.0152974			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050817	Green Submitted, Green Published, gold			2022-12-27	WOS:000373603500074
J	Tabuchi, T; Colwell, B				Tabuchi, Takahiro; Colwell, Brian			Disparity and Trends in Secondhand Smoke Exposure among Japanese Employees, Particularly Smokers vs. Non-Smokers	PLOS ONE			English	Article							ENVIRONMENTAL TOBACCO-SMOKE; AREAS	Background Monitoring disparities in secondhand smoke (SHS) exposure is important for tailoring smoke-free policies to the needs of different groups. We examined disparity and trends in SHS exposure among both nonsmokers and smokers at Japanese workplaces between 2002 and 2012. Methods A total of 32,940 employees in nationally representative, population-based, repeated cross-sectional surveys in 2002, 2007 and 2012 in Japan was analyzed. Adjusted rate ratios for workplace SHS exposure from other people ("everyday" and "everyday or sometimes") were calculated according to covariates, using log-binomial regression models with survey weights. In this survey, employees who do not smoke at workplace are defined as workplace-nonsmokers; and those smoke at workplace are used as workplace-smokers. SHS exposure for smokers does not involve their own SHS. Results While everyday SHS exposure prevalence in workplace-nonsmokers decreased markedly (33.2% to 11.4%), that in workplace-smokers decreased only slightly (63.3% to 55.6%). Workplace-smokers were significantly more likely to report everyday SHS exposure than workplace-nonsmokers, and the degree of association increased over time: compared with the nonsmokers (reference), covariates-adjusted rate ratio (95% confidence interval) for the smokers increased from 1.70 (1.62-1.77) in 2002 to 4.16 (3.79-4.56) in 2012. Similar results were observed for everyday or sometimes SHS exposure. Compared with complete workplace smoking bans, partial and no bans were consistently and significantly associated with high SHS exposure among both nonsmokers and smokers. We also observed disparities in SHS exposure by employee characteristics, such as age group and worksite scale. Conclusions Although overall SHS exposure decreased among Japanese employees between 2002 and 2012, the SHS exposure disparity between nonsmokers and smokers widened. Because smokers reported more frequent SHS exposure than nonsmokers, subsequent mortality due to SHS exposure may be higher in smokers than in nonsmokers. This information may be useful for advocating workplace smoke-free policies.	[Tabuchi, Takahiro] Osaka Med Ctr Canc & Cardiovasc Dis, Ctr Canc Control & Stat, Osaka, Japan; [Colwell, Brian] Texas A&M Sch Publ Hlth, Dept Hlth Promot & Community Hlth Sci, College Stn, TX USA	Osaka Medical Center for Cancer & Cardiovascular Diseases; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Tabuchi, T (corresponding author), Osaka Med Ctr Canc & Cardiovasc Dis, Ctr Canc Control & Stat, Osaka, Japan.	tabuchitak@gmail.com	Colwell, Gregory Brian/E-2713-2018; Colwell, Brian/AAT-7009-2021; Matsuo, Keitaro/H-6758-2019	Colwell, Gregory Brian/0000-0002-9338-2778; Colwell, Brian/0000-0002-9338-2778; Matsuo, Keitaro/0000-0003-1761-6314; Tabuchi, Takahiro/0000-0002-1050-3125	Japan Agency for Medical Research and Development [27310201]; Ministry of Health, Labour and Welfare: Comprehensive Research on Life-Style Related Diseases including Cardiovascular Diseases and Diabetes Mellitus [H25-010]	Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Ministry of Health, Labour and Welfare: Comprehensive Research on Life-Style Related Diseases including Cardiovascular Diseases and Diabetes Mellitus	This work was supported by the Japan Agency for Medical Research and Development (Grant number; 27310201) and the Ministry of Health, Labour and Welfare: Comprehensive Research on Life-Style Related Diseases including Cardiovascular Diseases and Diabetes Mellitus (Grant number; H25-010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brookhart MA, 2013, CIRC-CARDIOVASC QUAL, V6, P604, DOI 10.1161/CIRCOUTCOMES.113.000359; Cains T, 2004, TOB CONTROL, V13, P17, DOI 10.1136/tc.2003.005488; Callinan JE, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005992.pub2; Chapman S, 2007, PUBLIC HEALTH ADVOCACY AND TOBACCO CONTROL: MAKING SMOKING HISTORY, P1, DOI 10.1002/9780470692479; Drope J, 2004, TOB CONTROL, V13, P41, DOI 10.1136/tc.2003.004101; Eriksen M, 2012, TOBACCO ATLAS; Eriksen M, 2015, THE TOBACCO ATLAS; Fichtenberg CM, 2002, BMJ-BRIT MED J, V325, P188, DOI 10.1136/bmj.325.7357.188; International Agency for Research on Cancer, 2009, IARC HDB CANC PREV T, V13; Johansson A, 2005, ANN EPIDEMIOL, V15, P453, DOI 10.1016/j.annepidem.2004.09.012; Joossens L, 2014, TOBACCO CONTROL SCAL; Katanoda K, 2014, TOB CONTROL, V23, P359, DOI 10.1136/tobaccocontrol-2012-050852; Kungskulniti N, 2015, TOB CONTROL, V24, P532, DOI 10.1136/tobaccocontrol-2013-051313; Lai HK, 2009, PEDIATRICS, V124, P1306, DOI 10.1542/peds.2009-0669; Lam TH, 2005, TOB CONTROL, V14, P307, DOI 10.1136/tc.2005.011775; Lonergan BJ, 2014, NICOTINE TOB RES, V16, P1121, DOI 10.1093/ntr/ntu046; McNabola A, 2012, ENVIRON INT, V44, P68, DOI 10.1016/j.envint.2012.01.012; Murata Y, 2012, ENVIRONMENTAL RESEAR; Oberg M, 2011, LANCET, V377, P139, DOI 10.1016/S0140-6736(10)61388-8; Piccardo MT, 2010, ENVIRON HEALTH-GLOB, V9, DOI 10.1186/1476-069X-9-5; Pion M, 2004, TOB CONTROL, V13, P37, DOI 10.1136/tc.2003.005447; Reis MF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102421; Spiegelman D, 2005, AM J EPIDEMIOL, V162, P199, DOI 10.1093/aje/kwi188; Tabuchi T, 2015, NICOTINE TOB RES; Tabuchi T, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/303917; U. S. Department of Health and Human Services, 2006, HLTH CONS INV EXP TO; Wang MJ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0064860, 10.1371/journal.pone.0072082, 10.1371/journal.pone.0073741]; World Health Organization, 2015, MPOWER; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	29	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0152096	10.1371/journal.pone.0152096	http://dx.doi.org/10.1371/journal.pone.0152096			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050819	Green Published, gold, Green Submitted			2022-12-27	WOS:000373603500023
J	Barber, ALA; Randi, D; Muller, CA; Huber, L				Barber, Anjuli L. A.; Randi, Dania; Mueller, Corsin A.; Huber, Ludwig			The Processing of Human Emotional Faces by Pet and Lab Dogs: Evidence for Lateralization and Experience Effects	PLOS ONE			English	Article							HUMAN COMMUNICATIVE SIGNALS; CANIS-FAMILIARIS; FACIAL EXPRESSIONS; PAN-TROGLODYTES; CHIMERIC FACES; RHESUS-MONKEYS; RECOGNITION; PERCEPTION; CHIMPANZEES; DISCRIMINATION	From all non-human animals dogs are very likely the best decoders of human behavior. In addition to a high sensitivity to human attentive status and to ostensive cues, they are able to distinguish between individual human faces and even between human facial expressions. However, so far little is known about how they process human faces and to what extent this is influenced by experience. Here we present an eye-tracking study with dogs emanating from two different living environments and varying experience with humans: pet and lab dogs. The dogs were shown pictures of familiar and unfamiliar human faces expressing four different emotions. The results, extracted from several different eye-tracking measurements, revealed pronounced differences in the face processing of pet and lab dogs, thus indicating an influence of the amount of exposure to humans. In addition, there was some evidence for the influences of both, the familiarity and the emotional expression of the face, and strong evidence for a left gaze bias. These findings, together with recent evidence for the dog's ability to discriminate human facial expressions, indicate that dogs are sensitive to some emotions expressed in human faces.	[Barber, Anjuli L. A.] Med Univ Vienna, Univ Vet Med Vienna, Messerli Res Inst, Comparat Cognit, Vienna, Austria; Univ Vienna, Vienna, Austria	Medical University of Vienna; University of Veterinary Medicine Vienna; University of Vienna	Barber, ALA (corresponding author), Med Univ Vienna, Univ Vet Med Vienna, Messerli Res Inst, Comparat Cognit, Vienna, Austria.	anjuli.barber@vetmeduni.ac.at		Barber, Anjuli/0000-0002-6826-960X; Huber, Ludwig/0000-0002-0217-136X	Vienna Science and Technology Funds (WWTF) [CS11-005]	Vienna Science and Technology Funds (WWTF)	The research presented here was funded by the Vienna Science and Technology Funds (WWTF), No. CS11-005; http://www.wwtf.at/) to LH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi I, 2007, ANIM COGN, V10, P17, DOI 10.1007/s10071-006-0025-8; Adolphs R, 2001, NEUROPSYCHOLOGY, V15, P516, DOI 10.1037//0894-4105.15.4.516; Althoff RR, 1999, J EXP PSYCHOL LEARN, V25, P997, DOI 10.1037/0278-7393.25.4.997; Alves Nelson Torro, 2008, Psychol. Neurosci., V1, P63, DOI 10.1590/S1983-32882008000100010; Barton JJS, 2006, PERCEPTION, V35, P1089, DOI 10.1068/p5547; Bates D, 2014, JOURNAL OF STATISTIC, pxx; Borod JC, 1983, COGNITIVE PROCESSING; Bourne VJ, 2008, LATERALITY, V13, P92, DOI 10.1080/13576500701754315; Bradshaw J., 2014, DOG SENSE NEW SCI DO; Brauer J, 2014, THE SOCIAL DOG, DOI [10.1016/B978-0-12-407818-5.00010-3, DOI 10.1016/B978-0-12-407818-5.00010-3]; Bruce V., 1998, EYE BEHOLDER SCI FAC; Butler S, 2005, NEUROPSYCHOLOGIA, V43, P52, DOI 10.1016/j.neuropsychologia.2004.06.005; de Wit TCJ, 2008, RES AUTISM SPECT DIS, V2, P651, DOI 10.1016/j.rasd.2008.01.004; DEKOSKY ST, 1980, BRAIN LANG, V9, P206, DOI 10.1016/0093-934X(80)90141-8; DIAMOND R, 1986, J EXP PSYCHOL GEN, V115, P107, DOI 10.1037/0096-3445.115.2.107; Dilks DD, 2015, PEERJ, V3, DOI 10.7717/peerj.1115; Dufour V, 2006, BEHAV PROCESS, V73, P107, DOI 10.1016/j.beproc.2006.04.006; Ehrlichman H., 1987, DUALITY UNITY BRAIN, P194, DOI DOI 10.1007/978-1-4613-1949-8_13; Ekman P, 1972, EMOTION HUMAN FACE, DOI [10.1016/B978-0-08-016643-8.50001-X, DOI 10.1016/B978-0-08-016643-8.50001-X]; Fournier DA, 2012, OPTIM METHOD SOFTW, V27, P233, DOI 10.1080/10556788.2011.597854; Fried I, 1997, NEURON, V18, P753, DOI 10.1016/S0896-6273(00)80315-3; Friesen WV, 1975, J PERSONALITY; Gacsi M, 2005, DEV PSYCHOBIOL, V47, P111, DOI 10.1002/dev.20082; Gacsi M, 2004, ANIM COGN, V7, P144, DOI 10.1007/s10071-003-0205-8; Gliga T, 2007, PROG BRAIN RES, V164, P323, DOI 10.1016/S0079-6123(07)64018-7; Gothard KM, 2009, ANIM COGN, V12, P155, DOI 10.1007/s10071-008-0179-7; Guo K, 2009, ANIM COGN, V12, P409, DOI 10.1007/s10071-008-0199-3; Holmqvist K., 2011, EYE TRACKING COMPREH; Horowitz A, 2014, SCI STUDY CANIS FAMI; Huber L., 2010, ENCY ANIMAL BEHAV, P261, DOI DOI 10.1016/B978-0-08-045337-8.00096-6; Huber L, 2014, J VET BEHAV, V9, pe7, DOI [10.1016/j.jveb.2014.09.026, DOI 10.1016/J.JVEB.2014.09.026]; Hunnius S, 2011, COGNITION EMOTION, V25, P193, DOI 10.1080/15298861003771189; Kalin NH, 1998, BEHAV NEUROSCI, V112, P286, DOI 10.1037/0735-7044.112.2.286; Kaminski J., 2014, SOCIAL DOG BEHAV COG; Kanazawa S, 1996, PRIMATES, V37, P25, DOI 10.1007/BF02382917; Kano F, 2010, ANIM BEHAV, V79, P227, DOI 10.1016/j.anbehav.2009.11.003; Kanwisher N, 2006, PHILOS T R SOC B, V361, P2109, DOI 10.1098/rstb.2006.1934; Kendrick KM, 1996, BEHAV PROCESS, V38, P19, DOI 10.1016/0376-6357(96)00006-X; Kendrick KM, 2006, CORTEX, V42, P96, DOI 10.1016/S0010-9452(08)70328-9; Kirchhofer KC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030913; Le Grand R, 2001, NATURE, V410, P890, DOI 10.1038/35073749; Lee E, 2008, PSYCHIAT RES, V157, P77, DOI 10.1016/j.psychres.2007.02.005; Lee WY, 2011, ANIM COGN, V14, P817, DOI 10.1007/s10071-011-0415-4; Leopold DA, 2010, J COMP PSYCHOL, V124, P233, DOI 10.1037/a0019460; Liversedge S., 2011, OXFORD HDB EYE MOVEM; Marechal L, 2010, ANIM BEHAV, V79, P1157, DOI 10.1016/j.anbehav.2010.02.022; Miklosi A, 2003, CURR BIOL, V13, P763, DOI 10.1016/S0960-9822(03)00263-X; Miklosi A., 2014, DOG BEHAV EVOLUTION; Mondloch CJ, 2003, DEVELOPMENT OF FACE PROCESSING IN INFACY AND EARLY CHILDHOOD: CURRENT PERSPECTIVES, P99; Muller CA, 2015, CURR BIOL, V25, P601, DOI 10.1016/j.cub.2014.12.055; Nagasawa M, 2011, ANIM COGN, V14, P525, DOI 10.1007/s10071-011-0386-5; Nitzschner M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046880; Parr L., 1999, ANIM COGN, V2, P123, DOI [10.1007/s100710050032, DOI 10.1007/S100710050032]; Parr LA, 1999, NATURE, V399, P647, DOI 10.1038/21345; Parr LA, 2000, PHYSIOL BEHAV, V71, P363, DOI 10.1016/S0031-9384(00)00349-8; Parr LA, 2000, J COMP PSYCHOL, V114, P47, DOI 10.1037//0735-7036.114.1.47; Parr LA, 1998, J COGNITIVE NEUROSCI, V10, P615, DOI 10.1162/089892998563013; Pascalis O, 2002, SCIENCE, V296, P1321, DOI 10.1126/science.1070223; Peterson M. A., 2006, PERCEPTION FACES OBJ, DOI [10.1093/acprof:Oso/9780195313659.001.0001, DOI 10.1093/ACPROF:OSO/9780195313659.001.0001]; Peterson MF, 2012, P NATL ACAD SCI USA, V109, pE3314, DOI 10.1073/pnas.1214269109; Phillips ML, 1997, BRAIN COGNITION, V35, P225, DOI 10.1006/brcg.1997.0939; Proops L, 2009, P NATL ACAD SCI USA, V106, P947, DOI 10.1073/pnas.0809127105; Quaranta A, 2007, CURR BIOL, V17, pR199, DOI 10.1016/j.cub.2007.02.008; R Development Core Team, 2014, R LANG ENV STAT COMP, P409; Racca A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036076; Racca A, 2010, ANIM COGN, V13, P525, DOI 10.1007/s10071-009-0303-3; RYAN CME, 1994, BEHAV PROCESS, V33, P155, DOI 10.1016/0376-6357(94)90064-7; Salva OR, 2015, NEUROSCI BIOBEHAV R, V50, P150, DOI 10.1016/j.neubiorev.2014.12.015; Salva OR, 2012, COMP COGN BEHAV REV, V7, P110, DOI 10.3819/ccbr.2012.70006; Salva OR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018802; Siniscalchi M, 2010, BEHAV BRAIN RES, V208, P516, DOI 10.1016/j.bbr.2009.12.042; Siniscalchi M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003349; Somppi S, 2014, ANIM COGN, V17, P793, DOI 10.1007/s10071-013-0713-0; Somppi S, 2012, ANIM COGN, V15, P163, DOI 10.1007/s10071-011-0442-1; Stephan C, 2012, AVIAN BIOL RES, V5, P75, DOI 10.3184/175815512X13350970204867; SUBERI M, 1977, NEUROPSYCHOLOGIA, V15, P757, DOI 10.1016/0028-3932(77)90006-9; Tate AJ, 2006, PHILOS T R SOC B, V361, P2155, DOI 10.1098/rstb.2006.1937; Teglas E, 2012, CURR BIOL, V22, P209, DOI 10.1016/j.cub.2011.12.018; Thieltges H, 2011, ANIM COGN, V14, P303, DOI 10.1007/s10071-010-0354-5; TOMKINS SS, 1964, PERCEPT MOTOR SKILL, V18, P119, DOI 10.2466/pms.1964.18.1.119; Topal J, 2014, THE SOCIAL DOG, P1; Tsao DY, 2008, ANNU REV NEUROSCI, V31, P411, DOI 10.1146/annurev.neuro.30.051606.094238; Udell MAR, 2011, LEARN BEHAV, V39, P318, DOI 10.3758/s13420-011-0043-5; Viranyi Z, 2008, ANIM COGN, V11, P373, DOI 10.1007/s10071-007-0127-y; Watling D, 2012, LATERALITY, V17, P389, DOI 10.1080/1357650X.2012.682160; Wobber V, 2009, INTERACT STUD, V10, P206, DOI 10.1075/is.10.2.06wob	86	36	36	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0152393	10.1371/journal.pone.0152393	http://dx.doi.org/10.1371/journal.pone.0152393			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ3UC	27074009	Green Published, gold, Green Submitted			2022-12-27	WOS:000374131200023
J	Mohan, V; Pandey, A; Sreelakshmi, Y; Sharma, R				Mohan, Vijee; Pandey, Arun; Sreelakshmi, Yellamaraju; Sharma, Rameshwar			Neofunctionalization of Chromoplast Specific Lycopene Beta Cyclase Gene (CYC-B) in Tomato Clade	PLOS ONE			English	Article							PROVIDES INSIGHTS; GENOME SEQUENCE; FRUIT; CHLOROPLAST; EVOLUTION; PATTERNS; ELEMENTS; ORGAN; COLOR; RIN	The ancestor of tomato underwent whole genome triplication ca. 71 Myr ago followed by widespread gene loss. However, few of the triplicated genes are retained in modern day tomato including lycopene beta cyclase that mediates conversion of lycopene to beta-carotene. The fruit specific beta-carotene formation is mediated by a chromoplast-specific paralog of lycopene beta cyclase (CYC-B) gene. Presently limited information is available about how the variations in CYC-B gene contributed to its neofunctionalization. CYC-B gene in tomato clade contained several SNPs and In-Dels in the coding sequence (33 haplotypes) and promoter region (44 haplotypes). The CYC-B gene coding sequence in tomato appeared to undergo purifying selection. The transit peptide sequence of CYC-B protein was predicted to have a stronger plastid targeting signal than its chloroplast specific paralog indicating a possible neofunctionalization. In promoter of two B-og (Beta old gold) mutants, a NUPT (nuclear plastid) DNA fragment of 256 bp, likely derived from a S. chilense accession, was present. In transient expression assay, this promoter was more efficient than the "Beta type" promoter. CARGATCONSENSUS box sequences are required for the binding of the MADS-box regulatory protein RIPENING INHIBITOR (RIN). The loss of CARGATCONSENSUS box sequence from CYC-B promoter in tomato may be related to attenuation of its efficiency to promote higher accumulation of beta-carotene than lycopene during fruit ripening.	[Mohan, Vijee; Pandey, Arun; Sreelakshmi, Yellamaraju; Sharma, Rameshwar] Univ Hyderabad, Dept Plant Sci, Repository Tomato Genom Resources, Hyderabad 500134, Andhra Pradesh, India	University of Hyderabad	Sharma, R (corresponding author), Univ Hyderabad, Dept Plant Sci, Repository Tomato Genom Resources, Hyderabad 500134, Andhra Pradesh, India.	rameshwar.sharma@gmail.com	Mohan, Vijee/AAQ-4436-2021	Mohan, Vijee/0000-0001-6472-0187	Department of Biotechnology, India [BT/PR/5275/AGR/16/465/2004]; International Atomic Energy Agency, Vienna; Council of Scientific and Industrial Research, India (research fellowship)	Department of Biotechnology, India(Department of Biotechnology (DBT) India); International Atomic Energy Agency, Vienna(International Atomic Energy Agency); Council of Scientific and Industrial Research, India (research fellowship)	This work was supported by the Department of Biotechnology, India (grant no. BT/PR/5275/AGR/16/465/2004;) to RS and YS, International Atomic Energy Agency, Vienna to YS and Council of Scientific and Industrial Research, India (research fellowship to VM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aflitos S, 2014, PLANT J, V80, P136, DOI 10.1111/tpj.12616; Alba R, 2005, PLANT CELL, V17, P2954, DOI 10.1105/tpc.105.036053; Anderson LK, 2010, CYTOGENET GENOME RES, V129, P24, DOI 10.1159/000313850; Azari R, 2010, BIOTECHNOL ADV, V28, P108, DOI 10.1016/j.biotechadv.2009.10.003; Bouvier F, 2000, EUR J BIOCHEM, V267, P6346, DOI 10.1046/j.1432-1327.2000.01722.x; Busch BL, 2011, PLANT CELL, V23, P3595, DOI 10.1105/tpc.111.087981; Chang WC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-561; Colbert T, 2001, PLANT PHYSIOL, V126, P480, DOI 10.1104/pp.126.2.480; Egea I, 2011, ANN BOT-LONDON, V108, P291, DOI 10.1093/aob/mcr140; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Enfissi EMA, 2010, PLANT CELL, V22, P1190, DOI 10.1105/tpc.110.073866; FINER JJ, 1992, PLANT CELL REP, V11, P323, DOI 10.1007/BF00233358; Garcia-Closas R, 2004, BRIT J NUTR, V91, P1005, DOI 10.1079/BJN20041130; Hellens RP, 2005, PLANT METHODS, V1, DOI 10.1186/1746-4811-1-13; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Ito Y, 2008, PLANT J, V55, P212, DOI 10.1111/j.1365-313X.2008.03491.x; Kim Seungill, 2014, Nat Genet, V46, P270, DOI 10.1038/ng.2877; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Klee HJ, 2011, ANNU REV GENET, V45, P41, DOI 10.1146/annurev-genet-110410-132507; Knapp S., 2009, SYST BOT, V84, P1; Liu SL, 2011, GENOME BIOL EVOL, V3, P1419, DOI 10.1093/gbe/evr114; Marques AC, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r54; Matsuo M, 2005, PLANT CELL, V17, P665, DOI 10.1105/tpc.104.027706; Mialoundama AS, 2010, PLANT PHYSIOL, V153, P970, DOI 10.1104/pp.110.155440; Moore RC, 2005, CURR OPIN PLANT BIOL, V8, P122, DOI 10.1016/j.pbi.2004.12.001; Ng PC, 2006, ANNU REV GENOM HUM G, V7, P61, DOI 10.1146/annurev.genom.7.080505.115630; Peters SA, 2012, PLANT J, V71, P602, DOI 10.1111/j.1365-313X.2012.05012.x; RICK CM, 1953, AM NAT, V87, P359, DOI 10.1086/281796; Rick CM, 1961, REPORT TOMATO GENETI, V11, P21; Ronen G, 2000, P NATL ACAD SCI USA, V97, P11102, DOI 10.1073/pnas.190177497; Rozas J, 2009, METHODS MOL BIOL, V537, P337, DOI 10.1007/978-1-59745-251-9_17; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Silletti MF, 2013, MOL BREEDING, V31, P665, DOI 10.1007/s11032-012-9824-6; Sneath Peter H.A, 1973, NUMERICAL TAXONOMY; Sreelakshmi Y, 2010, PLANT METHODS, V6, DOI 10.1186/1746-4811-6-3; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Taylor NE, 2003, NUCLEIC ACIDS RES, V31, P3808, DOI 10.1093/nar/gkg574; Thorup TA, 2000, P NATL ACAD SCI USA, V97, P11192, DOI 10.1073/pnas.97.21.11192; Till BJ, 2006, NAT PROTOC, V1, P2465, DOI 10.1038/nprot.2006.329; Vrebalov J, 2002, SCIENCE, V296, P343, DOI 10.1126/science.1068181; WILLSON MF, 1990, AM NAT, V136, P790, DOI 10.1086/285132; Woischnik M, 2002, GENOME RES, V12, P885, DOI 10.1101/gr.227202; Woodhouse MR, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000409; Yoshida T, 2014, DNA RES, V21, P127, DOI 10.1093/dnares/dst045; Yuan Q, 2002, MOL GENET GENOMICS, V267, P713, DOI 10.1007/s00438-002-0706-1; Zhong SL, 2013, NAT BIOTECHNOL, V31, P154, DOI 10.1038/nbt.2462	46	12	13	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0153333	10.1371/journal.pone.0153333	http://dx.doi.org/10.1371/journal.pone.0153333			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27070417	Green Published, gold, Green Submitted			2022-12-27	WOS:000373900700053
J	Ranaware, PB; Mishra, A; Vijayakumar, P; Gandhale, PN; Kumar, H; Kulkarni, DD; Raut, AA				Ranaware, Pradip B.; Mishra, Anamika; Vijayakumar, Periyasamy; Gandhale, Pradeep N.; Kumar, Himanshu; Kulkarni, Diwakar D.; Raut, Ashwin Ashok			Genome Wide Host Gene Expression Analysis in Chicken Lungs Infected with Avian Influenza Viruses	PLOS ONE			English	Article							INNATE IMMUNE-RESPONSE; CYTOKINE RESPONSES; RIG-I; ANTIVIRAL RESPONSES; A-VIRUS; EPITHELIAL-CELLS; H5N1 INFECTION; PATHOGENESIS; DUCKS; PATHOGENICITY	The molecular pathogenesis of avian influenza infection varies greatly with individual bird species and virus strain. The molecular pathogenesis of the highly pathogenic avian influenza virus (HPAIV) or the low pathogenic avian influenza virus (LPAIV) infection in avian species remains poorly understood. Thus, global immune response of chickens infected with HPAI H5N1 (A/duck/India/02CA10/2011) and LPAI H9N2 (A/duck/India/249800/2010) viruses was studied using microarray to identify crucial host genetic components responsive to these infection. HPAI H5N1 virus induced excessive expression of type I IFNs (IFNA and IFNG), cytokines (IL1B, IL18, IL22, IL13, and IL12B), chemokines (CCL4, CCL19, CCL10, and CX3CL1) and IFN stimulated genes (OASL, MX1, RSAD2, IFITM5, IFIT5, GBP 1, and EIF2AK) in lung tissues. This dysregulation of host innate immune genes may be the critical determinant of the severity and the outcome of the influenza infection in chickens. In contrast, the expression levels of most of these genes was not induced in the lungs of LPAI H9N2 virus infected chickens. This study indicated the relationship between host immune genes and their roles in pathogenesis of HPAIV infection in chickens.	[Ranaware, Pradip B.; Mishra, Anamika; Vijayakumar, Periyasamy; Gandhale, Pradeep N.; Kulkarni, Diwakar D.; Raut, Ashwin Ashok] ICAR Natl Inst High Secur Anim Dis, Pathogen Lab, OIE Reference Lab Avian Influenza, Bhopal, Madhya Pradesh, India; [Kumar, Himanshu] Indian Inst Sci Educ & Res Bhopal, Dept Biol Sci, Immunol Lab, Bhopal 462066, Madhya Pradesh, India	Indian Council of Agricultural Research (ICAR); ICAR - National Institute of High Security Animal Diseases; Indian Institute of Science Education & Research (IISER) - Bhopal	Raut, AA (corresponding author), ICAR Natl Inst High Secur Anim Dis, Pathogen Lab, OIE Reference Lab Avian Influenza, Bhopal, Madhya Pradesh, India.	ashwin.hsadl@gmail.com	Vijayakumar, Periyasamy/GLU-1992-2022; Gandhale, Pradeep/AAE-6383-2020; Kumar, Himanshu/J-4494-2012	Vijayakumar, Periyasamy/0000-0003-1170-8955; Gandhale, Pradeep/0000-0002-0807-5571; Raut, Ashwin/0000-0002-4978-901X; Kumar, Himanshu/0000-0001-5246-2694	Department of Biotechnology [BT/IN/Indo-UK/FADH/48/AM/2013]; ICAR-National Institute of High Security Animal Disease; BBSRC [BB/L004666/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/L004666/1] Funding Source: researchfish	Department of Biotechnology; ICAR-National Institute of High Security Animal Disease; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the Department of Biotechnology (grant number: BT/IN/Indo-UK/FADH/48/AM/2013) and ICAR-National Institute of High Security Animal Disease (Institute funded research project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DJ, 2000, VET MICROBIOL, V74, P3, DOI 10.1016/S0378-1135(00)00160-7; Arankalle VA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013099; Balachandran S, 2000, IMMUNITY, V13, P129, DOI 10.1016/S1074-7613(00)00014-5; Barber MRW, 2013, MOL IMMUNOL, V54, P89, DOI 10.1016/j.molimm.2012.10.038; Barber MRW, 2010, P NATL ACAD SCI USA, V107, P5913, DOI 10.1073/pnas.1001755107; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; Burggraaf S, 2014, VIRUS RES, V185, P23, DOI 10.1016/j.virusres.2014.03.012; Cameron CM, 2008, J VIROL, V82, P11308, DOI 10.1128/JVI.00691-08; Chan MCW, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-135; Cilloniz C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000604; Cornelissen JBWJ, 2013, AVIAN PATHOL, V42, P347, DOI 10.1080/03079457.2013.807325; Cornelissen JBWJ, 2012, AVIAN PATHOL, V41, P519, DOI 10.1080/03079457.2012.732691; Dallas PB, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-59; Dauber B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000473; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Gingras S, 2004, J BIOL CHEM, V279, P54702, DOI 10.1074/jbc.M411043200; GRANT CE, 1995, NUCLEIC ACIDS RES, V23, P2137, DOI 10.1093/nar/23.12.2137; Guo Y, 1999, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V13, P105; Hale BG, 2010, FUTURE MICROBIOL, V5, P23, DOI [10.2217/fmb.09.108, 10.2217/FMB.09.108]; Honda K, 2005, NATURE, V434, P1035, DOI 10.1038/nature03547; Huang YH, 2013, NAT GENET, V45, P776, DOI 10.1038/ng.2657; Iwasaki A, 2014, NAT REV IMMUNOL, V14, P315, DOI 10.1038/nri3665; Karpala AJ, 2011, J IMMUNOL, V186, P5397, DOI 10.4049/jimmunol.1003712; Karpala AJ, 2011, J INTERF CYTOK RES, V31, P393, DOI 10.1089/jir.2010.0069; Kobasa D, 2007, NATURE, V445, P319, DOI 10.1038/nature05495; Kozak W, 1997, AM J PHYSIOL-REG I, V272, pR621, DOI 10.1152/ajpregu.1997.272.2.R621; Kuribayashi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068375; La Gruta NL, 2007, IMMUNOL CELL BIOL, V85, P85, DOI 10.1038/sj.icb.7100026; Le Goffic R, 2007, J IMMUNOL, V178, P3368, DOI 10.4049/jimmunol.178.6.3368; Lee SMY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008072; Li YP, 2007, ARCH VIROL, V152, P463, DOI 10.1007/s00705-006-0878-9; Liniger M, 2012, J VIROL, V86, P705, DOI 10.1128/JVI.00742-11; Lipatov AS, 2005, J GEN VIROL, V86, P1121, DOI 10.1099/vir.0.80663-0; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Mansell A, 2006, NAT IMMUNOL, V7, P148, DOI 10.1038/ni1299; Maughan MN, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-94; Moulin HR, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-6; Nang NT, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-64; OIE, 2009, AV INFL TERR AN HLTH, P1; Pantin-Jackwood MJ, 2009, REV SCI TECH OIE, V28, P113, DOI 10.20506/rst.28.1.1869; Pauli EK, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000196; Peiris M, 1999, LANCET, V354, P916, DOI 10.1016/S0140-6736(99)03311-5; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Pichlmair A, 2011, NAT IMMUNOL, V12, P624, DOI 10.1038/ni.2048; Post J, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-61; Pothlichet J, 2008, J IMMUNOL, V180, P2034, DOI 10.4049/jimmunol.180.4.2034; Pothlichet J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003256; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; Rebel JMJ, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-10; Reemers SS, 2009, J GEN VIROL, V90, P2134, DOI 10.1099/vir.0.012401-0; Sasai M, 2010, SCIENCE, V329, P1530, DOI 10.1126/science.1187029; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Silverman RH, 2007, J VIROL, V81, P12720, DOI 10.1128/JVI.01471-07; Smith J, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1778-8; STAEHELI P, 1986, CELL, V44, P147, DOI 10.1016/0092-8674(86)90493-9; Steinhauer DA, 1999, VIROLOGY, V258, P1, DOI 10.1006/viro.1999.9716; Sutejo R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033732; Suzuki K, 2009, J VIROL, V83, P7475, DOI 10.1128/JVI.01434-08; Szretter KJ, 2007, J VIROL, V81, P2736, DOI 10.1128/JVI.02336-06; Turan K, 2004, NUCLEIC ACIDS RES, V32, P643, DOI 10.1093/nar/gkh192; Vervelde L, 2013, DEV COMP IMMUNOL, V39, P198, DOI 10.1016/j.dci.2012.10.011; Vijayakumar P, 2015, GENE, V559, P77, DOI 10.1016/j.gene.2015.01.016; Watanabe T, 2010, CELL HOST MICROBE, V7, P427, DOI 10.1016/j.chom.2010.05.008; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Xing Z, 2008, J GEN VIROL, V89, P1288, DOI 10.1099/vir.0.83362-0; Yuen T, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e48	67	52	53	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0153671	10.1371/journal.pone.0153671	http://dx.doi.org/10.1371/journal.pone.0153671			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27071061	gold, Green Published, Green Submitted			2022-12-27	WOS:000373900700082
J	Stec, DE; John, K; Trabbic, CJ; Luniwal, A; Hankins, MW; Baum, J; Hinds, TD				Stec, David E.; John, Kezia; Trabbic, Christopher J.; Luniwal, Amarjit; Hankins, Michael W.; Baum, Justin; Hinds, Terry D., Jr.			Bilirubin Binding to PPAR alpha Inhibits Lipid Accumulation	PLOS ONE			English	Article							ACTIVATED RECEPTOR-ALPHA; IMPROVES INSULIN SENSITIVITY; INTERVAL TRAINING INCREASES; CORONARY-ARTERY-DISEASE; SERUM BILIRUBIN; GLUCOCORTICOID-RECEPTOR; METABOLIC SYNDROME; ADIPONECTIN LEVELS; HEPATIC STEATOSIS; ADIPOSE-TISSUE	Numerous clinical and population studies have demonstrated that increased serum bilirubin levels protect against cardiovascular and metabolic diseases such as obesity and diabetes. Bilirubin is a potent antioxidant, and the beneficial actions of moderate increases in plasma bilirubin have been thought to be due to the antioxidant effects of this bile pigment. In the present study, we found that bilirubin has a new function as a ligand for PPAR alpha. We show that bilirubin can bind directly to PPAR alpha and increase transcriptional activity. When we compared biliverdin, the precursor to bilirubin, on PPAR alpha transcriptional activation to known PPAR alpha ligands, WY 14,643 and fenofibrate, it showed that fenofibrate and biliverdin have similar activation properties. Treatment of 3T3-L1 adipocytes with biliverdin suppressed lipid accumulation and upregulated PPAR alpha target genes. We treated wild-type and PPAR alpha KO mice on a high fat diet with fenofibrate or bilirubin for seven days and found that both signal through PPAR alpha dependent mechanisms. Furthermore, the effect of bilirubin on lowering glucose and reducing body fat percentage was blunted in PPAR alpha KO mice. These data demonstrate a new function for bilirubin as an agonist of PPAR alpha, which mediates the protection from adiposity afforded by moderate increases in bilirubin.	[John, Kezia; Baum, Justin; Hinds, Terry D., Jr.] Univ Toledo, Coll Med, Dept Physiol & Pharmacol, Ctr Hypertens & Personalized Med, Toledo, OH 43614 USA; [Trabbic, Christopher J.; Luniwal, Amarjit] Univ Toledo, Coll Pharm & Pharmaceut Sci, Ctr Drug Design & Dev, Toledo, OH 43614 USA; [Hankins, Michael W.] Univ Mississippi, Med Ctr, Dept Physiol & Biophys, Cardiovasc Renal Res Ctr, 2500 North State St, Jackson, MS 39216 USA; [Luniwal, Amarjit] North Amer Sci Associates Inc NAMSA, 6750 Wales Rd, Northwood, OH 43619 USA	University System of Ohio; University of Toledo; University System of Ohio; University of Toledo; University of Mississippi; University of Mississippi Medical Center	Hinds, TD (corresponding author), Univ Toledo, Coll Med, Dept Physiol & Pharmacol, Ctr Hypertens & Personalized Med, Toledo, OH 43614 USA.	Terry.Hinds@utoledo.edu	Hinds, Terry/B-8495-2015	Hinds, Terry/0000-0002-7599-1529	National Institutes of Health [L32MD009154]; National Heart, Lung and Blood Institute [K01HL-125445, PO1HL-051971, HL088421]; National Institute of General Medical Sciences [P20GM-104357]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL051971, K01HL125445, R01HL088421] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM104357] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health L32MD009154 (T.D.H.), the National Heart, Lung and Blood Institute [K01HL-125445] (T.D.H.) and (PO1HL-051971), [HL088421] (D.E.S.), and the National Institute of General Medical Sciences (P20GM-104357) (D.E.S.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Andersson C, 2009, METABOLISM, V58, P1109, DOI 10.1016/j.metabol.2009.04.003; Arner P, 2008, FEBS LETT, V582, P1725, DOI 10.1016/j.febslet.2008.04.038; Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Berglund ED, 2009, ENDOCRINOLOGY, V150, P4084, DOI 10.1210/en.2009-0221; Burgomaster KA, 2005, J APPL PHYSIOL, V98, P1985, DOI 10.1152/japplphysiol.01095.2004; Chau MDL, 2010, P NATL ACAD SCI USA, V107, P12553, DOI 10.1073/pnas.1006962107; Chen WC, 2014, MED SCI SPORT EXER, V46, P1517, DOI 10.1249/MSS.0000000000000272; Chen YH, 2008, DIABETES CARE, V31, P1615, DOI 10.2337/dc07-2126; Cheriyath Pramil, 2010, J Clin Med Res, V2, P201, DOI 10.4021/jocmr425w; Choi SH, 2013, NUTR METAB CARDIOVAS, V23, P31, DOI 10.1016/j.numecd.2011.03.001; Cure E, 2013, ANATOL J CARDIOL, V13, P791, DOI 10.5152/akd.2013.266; Ghem C, 2010, INT HEART J, V51, P86, DOI 10.1536/ihj.51.86; Gonzalez Mdel C, 2012, PPAR RES, V2012, DOI [10.1155/2012/483536, DOI 10.1155/2012/483536]; Goto T, 2011, J LIPID RES, V52, P873, DOI 10.1194/jlr.M011320; Harano Y, 2006, LIVER INT, V26, P613, DOI 10.1111/j.1478-3231.2006.01265.x; Hinds TD, 2014, OBESITY, V22, P705, DOI 10.1002/oby.20559; Hinds TD, 2011, J BIOL CHEM, V286, P42911, DOI 10.1074/jbc.M111.311662; Hinds TD, 2010, MOL ENDOCRINOL, V24, P1715, DOI 10.1210/me.2009-0411; Hopkins TA, 2007, CARDIOVASC RES, V74, P11, DOI 10.1016/j.cardiores.2006.10.009; Hosick PA, 2014, INT J OBESITY, V38, P132, DOI 10.1038/ijo.2013.61; Jang BK, 2012, CLIN MOL HEPATOL, V18, P357, DOI 10.3350/cmh.2012.18.4.357; John K, 2016, AM J PHYSIOL-ENDOC M, V310, pE249, DOI 10.1152/ajpendo.00478.2015; Kim DH, 2008, J PHARMACOL EXP THER, V325, P833, DOI 10.1124/jpet.107.135285; Kobashi C, 2005, CIRC RES, V97, P1245, DOI 10.1161/01.RES.0000194328.57164.36; Kwak MS, 2012, CLIN MOL HEPATOL, V18, P383, DOI 10.3350/cmh.2012.18.4.383; Lankisch TO, 2006, HEPATOLOGY, V44, P1324, DOI 10.1002/hep.21361; Larter CZ, 2012, J GASTROEN HEPATOL, V27, P341, DOI 10.1111/j.1440-1746.2011.06939.x; Li M, 2008, DIABETES, V57, P1526, DOI 10.2337/db07-1764; Lundasen T, 2007, BIOCHEM BIOPH RES CO, V360, P437, DOI 10.1016/j.bbrc.2007.06.068; O'Brien L, 2015, TRENDS ENDOCRIN MET, V26, P212, DOI 10.1016/j.tem.2015.02.001; Potthoff MJ, 2009, P NATL ACAD SCI USA, V106, P10853, DOI 10.1073/pnas.0904187106; Pozzi A, 2010, J BIOL CHEM, V285, P12840, DOI 10.1074/jbc.M109.081554; Ren HZ, 2010, PPAR RES, V2010, DOI 10.1155/2010/727194; Seo YS, 2008, J GASTROEN HEPATOL, V23, P102, DOI 10.1111/j.1440-1746.2006.04819.x; Sierra ML, 2007, J MED CHEM, V50, P685, DOI 10.1021/jm058056x; Stechschulte LA, 2014, MOL ENDOCRINOL, V28, P1254, DOI 10.1210/me.2014-1023; Stechschulte LA, 2014, MOL ENDOCRINOL, V28, P1265, DOI 10.1210/me.2014-1022; STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864; Talanian JL, 2007, J APPL PHYSIOL, V102, P1439, DOI 10.1152/japplphysiol.01098.2006; Torgerson JS, 1997, OBES RES, V5, P105, DOI 10.1002/j.1550-8528.1997.tb00650.x; Tsuchida A, 2005, DIABETES, V54, P3358, DOI 10.2337/diabetes.54.12.3358; Vitek L, 2002, ATHEROSCLEROSIS, V160, P449, DOI 10.1016/S0021-9150(01)00601-3; Wang MY, 1999, J BIOL CHEM, V274, P17541, DOI 10.1074/jbc.274.25.17541; Wray J, 2008, EXP PHYSIOL, V93, P148, DOI 10.1113/expphysiol.2007.038612; Wray JA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007421; Wu YH, 2011, J DIABETES, V3, P217, DOI 10.1111/j.1753-0407.2011.00138.x; Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392; Yang XF, 2009, INTERNAL MED, V48, P1595, DOI 10.2169/internalmedicine.48.2286; Zhou YT, 1999, P NATL ACAD SCI USA, V96, P2391, DOI 10.1073/pnas.96.5.2391; Zucker SD, 1999, J BIOL CHEM, V274, P10852, DOI 10.1074/jbc.274.16.10852	50	106	108	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0153427	10.1371/journal.pone.0153427	http://dx.doi.org/10.1371/journal.pone.0153427			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27071062	Green Published, gold, Green Submitted			2022-12-27	WOS:000373900700066
J	Lacerda, ALF; Kersanach, R; Cortinhas, MCS; Prata, PFS; Dumont, LFC; Proietti, MC; Maggioni, R; D'Incao, F				Figueiredo Lacerda, Ana Luzia; Kersanach, Ralf; Silva Cortinhas, Maria Cristina; Sanmartin Prata, Pedro Fernandes; Cestari Dumont, Luiz Felipe; Proietti, Maira Carneiro; Maggioni, Rodrigo; D'Incao, Fernando			High Connectivity among Blue Crab (Callinectes sapidus) Populations in the Western South Atlantic	PLOS ONE			English	Article							MAXIMUM-LIKELIHOOD-ESTIMATION; CHINESE MITTEN CRAB; MICROSATELLITE MARKERS; GENETIC DIFFERENTIATION; COALESCENT APPROACH; ERIOCHEIR-SINENSIS; CHESAPEAKE BAY; 1896 DECAPODA; BRAZIL; PORTUNIDAE	Population connectivity in the blue crab Callinectes sapidus was evaluated along 740 km of the Western South Atlantic coast. Blue crabs are the most exploited portunid in Brazil. Despite their economic importance, few studies report their ecology or population structure. Here we sampled four estuarine areas in southern Brazil during winter 2013 and summer 2014 in order to evaluate diversity, gene flow and structure of these populations. Nine microsatellite markers were evaluated for 213 adult crabs, with identification of seven polymorphic loci and 183 alleles. Pairwise FST values indicated low population structure ranging from -0.00023 to 0.01755. A Mantel test revealed that the geographic distance does not influence genetic (r = -0.48), and structure/migration rates confirmed this, showing that even the populations located at the opposite extremities of our covered region presented low FST and exchanged migrants. These findings show that there is a significant amount of gene flow between blue crab populations in South Brazil, likely influenced by local current dynamics that allow the transport of a high number of larvae between estuaries. Considering the elevated gene flow, the populations can be considered a single genetic stock. However, further information on population size and dynamics, as well as fishery demands and impacts at different regions, are necessary for harvest management purposes.	[Figueiredo Lacerda, Ana Luzia; Silva Cortinhas, Maria Cristina; Sanmartin Prata, Pedro Fernandes; Cestari Dumont, Luiz Felipe; Proietti, Maira Carneiro; D'Incao, Fernando] Univ Fed Rio Grande, Inst Oceanog, Rio Grande Do Sul, RS, Brazil; [Kersanach, Ralf] Univ Fed Rio Grande, Inst Ciencias Biol, Rio Grande Do Sul, RS, Brazil; [Maggioni, Rodrigo] Univ Fed Ceara, Inst Ciencias Mar, Fortaleza, Ceara, Brazil	Universidade Federal do Rio Grande; Universidade Federal do Rio Grande; Universidade Federal do Ceara	Lacerda, ALF (corresponding author), Univ Fed Rio Grande, Inst Oceanog, Rio Grande Do Sul, RS, Brazil.	analuzialacerda@gmail.com	Maggioni, Rodrigo/E-5948-2011; Dumont, Luiz/D-4870-2014	Maggioni, Rodrigo/0000-0002-1119-1020; Dumont, Luiz/0000-0001-8575-4167; Proietti, Maira/0000-0002-5504-5770; Lacerda, Ana Luzia/0000-0001-6654-5597	Universidade Federal do Rio Grande-FURG; Coordenacao de Aperfeicoamento Pessoal de Nivel Superior-CAPES	Universidade Federal do Rio Grande-FURG; Coordenacao de Aperfeicoamento Pessoal de Nivel Superior-CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This research was supported by grants from Universidade Federal do Rio Grande-FURG (http://www.furg.br) and Coordenacao de Aperfeicoamento Pessoal de Nivel Superior-CAPES (http://www.capes.gov.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboim MA, 2003, MOL ECOL NOTES, V3, P18, DOI 10.1046/j.1471-8286.2003.00337.x; Aguilar R, 2005, J EXP MAR BIOL ECOL, V319, P117, DOI 10.1016/j.jembe.2004.08.030; Azuma N, 2008, MAR BIOTECHNOL, V10, P39, DOI 10.1007/s10126-007-9033-1; Beacham TD, 2008, J SHELLFISH RES, V27, P901, DOI 10.2983/0730-8000(2008)27[901:PSODCC]2.0.CO;2; Beerli P, 1999, GENETICS, V152, P763; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; Boutin-Ganache I, 2001, BIOTECHNIQUES, V31, P24, DOI 10.2144/01311bm02; Brooker AL, 2000, MAR BIOL, V136, P149, DOI 10.1007/s002270050017; Chang YM, 2008, J GENET GENOMICS, V35, P171, DOI 10.1016/S1673-8527(08)60023-5; Chiessi CM, 2014, PALAEOGEOGR PALAEOCL, V415, P28, DOI 10.1016/j.palaeo.2013.12.005; COSTLOW JD, 1967, HELGOLAND WISS MEER, V15, P84, DOI 10.1007/BF01618611; COSTLOW JD, 1959, BIOL BULL, V116, P373, DOI 10.2307/1538947; Cowen RK, 2009, ANNU REV MAR SCI, V1, P443, DOI 10.1146/annurev.marine.010908.163757; D'Incao F., 1991, ATLANTICA, V13, P159; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Forward RB, 2003, MAR BIOL, V142, P747, DOI 10.1007/s00227-002-0966-7; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Herborg LM, 2007, MOL ECOL, V16, P231, DOI 10.1111/j.1365-294X.2006.03133.x; HINES AH, 1987, MAR ECOL PROG SER, V36, P55, DOI 10.3354/meps036055; Hines AH, 2003, B MAR SCI, V72, P287; Hines AH, 2010, BIOL MANAGEMENT EXPL, DOI [10.4027/bmecpcc.2010.22, DOI 10.4027/BMECPCC.2010.22]; Kennedy VS, BLUE CRAB CALLINECTE; KORDOS LM, 1993, MAR BIOL, V117, P227, DOI 10.1007/BF00345667; Ma HY, 2012, J EXP BIOL, V215, P3120, DOI 10.1242/jeb.071654; Marques WC, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2010JC006190; Matano RP, 2010, OCEAN SCI, V6, P983, DOI 10.5194/os-6-983-2010; Matano RP, 1993, J PHYS OCEANOGRAPGHY, V23, P79; MCMILLENJACKSON AL, 1994, MAR BIOL, V118, P53, DOI 10.1007/BF00699219; Mendonca JT, 2010, BRAZ J BIOL, V70, P37, DOI 10.1590/S1519-69842010000100007; NOAA. National Oceanographic and Atmospheric Administration National Marine Fisheries Service Office of Science and Technology Commercial Fisheries, 2014, COMM FISH ANN COMM L; Pascoal S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007268; Peliz A, 2007, J MARINE SYST, V68, P215, DOI 10.1016/j.jmarsys.2006.11.007; Piola AR, 2010, OCEAN SCI, V6, P345, DOI 10.5194/os-6-345-2010; Pritchard JK, 2000, GENETICS, V155, P945; Rodrigues MA, 2008, IHERINGIA SER ZOOL, V98, P372, DOI 10.1590/S0073-47212008000300012; Rodrigues Marcos Alaniz, 2011, Atlantica, V33, P141; Rousset F, 1997, GENETICS, V145, P1219; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Sambrook KJ, 1989, MOL CLONING LAB MANU; Seeliger U, 1998, ECOSSISTEMAS COSTEIR; Severino-Rodrigues E, 2013, REV BIOL TROP, V61, P595; Silveira I.C.A., 2000, REV BRAS OCEANOGR, V48, P171, DOI [10.1590/S1413-77392000000200008, DOI 10.1590/S1413-77392000000200008]; Steven CR, 2005, J EXP MAR BIOL ECOL, V319, P3, DOI 10.1016/j.jembe.2004.04.020; STRAMMA L, 1991, J MAR RES, V49, P281, DOI 10.1357/002224091784995864; Thorrold SR, 2002, B MAR SCI, V70, P291; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Weber LI, 2000, HYDROBIOLOGIA, V420, P203, DOI 10.1023/A:1003992630229; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Yednock BK, 2014, MAR BIOL, V161, P871, DOI 10.1007/s00227-013-2387-1; Zavialov PO, 1998, J PHYS OCEANOGR, V28, P545, DOI 10.1175/1520-0485(1998)028<0545:AIMFSC>2.0.CO;2	52	16	16	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2016	11	4							e0153124	10.1371/journal.pone.0153124	http://dx.doi.org/10.1371/journal.pone.0153124			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0KH	27064977	gold, Green Published, Green Submitted			2022-12-27	WOS:000373891000032
J	Liao, TL; Lin, CH; Chen, YM; Chang, CL; Chen, HH; Chen, DY				Liao, Tsai-Ling; Lin, Ching-Heng; Chen, Yi-Ming; Chang, Chia-Li; Chen, Hsin-Hua; Chen, Der-Yuan			Different Risk of Tuberculosis and Efficacy of Isoniazid Prophylaxis in Rheumatoid Arthritis Patients with Biologic Therapy: A Nationwide Retrospective Cohort Study in Taiwan	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; FACTOR ANTAGONISTS; INFECTION; MYCOBACTERIAL; RITUXIMAB; REACTIVATION; MULTICENTER; COMORBIDITY; INHIBITORS; DISEASES	Increasing evidence indicates an increased risk of tuberculosis (TB) for rheumatoid arthritis (RA) patients receiving biologic therapy, and the effectiveness of isoniazid prophylaxis (INHP) in TB prevention. We aimed to examine 1) the incidence rate (IR) and risk factors for TB among RA patients receiving different therapies; 2) INHP effectiveness for TB prevention; 3) mortality rates after TB diagnosis in patients receiving different therapies. This retrospective study was conducted using a nationwide database: 168,720 non-RA subjects and a total of 42,180 RA patients including 36,162 csDMARDs-exposed, 3,577 etanercept-exposed, 1,678 adalimumab-exposed and 763 rituximab-exposed patients. TB risk was 2.7-fold higher in RA cohort compared with non-RA group, with an adjusted hazard ratio (aHR) of 2.58. Advanced age, male, the use of corticosteroids >= 5mg/day, and the presence of diabetes mellitus (DM), chronic obstructive pulmonary disease and chronic kidney disease were risk factors for developing TB. Using csDMARDs-exposed group as reference, aHR of TB was the highest with adalimumab treatment (1.52), followed by etanercept (1.16), and the lowest with rituximab (0.08). INHP could effectively reduce TB risk in biologics-exposed patients. Mortality rates after TB diagnosis were higher in RA patients, particularly the elderly and those with DM, with lower rates in adalimumab-exposed patients compared with csDMARDs-exposed patients. In conclusion, TB risk was increased in patients receiving TNF-alpha inhibitors, but the risk associated with rituximab therapy was relatively low. With the effectiveness of INHP shown in the prevention of biologics-associated TB, stricter implementation of INHP should be beneficial. The mortality from biologics-associated TB may be efficiently reduced through increased awareness.	[Liao, Tsai-Ling; Lin, Ching-Heng; Chen, Yi-Ming; Chang, Chia-Li; Chen, Hsin-Hua; Chen, Der-Yuan] Taichung Vet Gen Hosp, Dept Med Educ & Res, Taichung, Taiwan; [Liao, Tsai-Ling; Chen, Yi-Ming; Chen, Der-Yuan] Natl Chung Hsing Univ, Inst Biomed Sci, Taichung 40227, Taiwan; [Liao, Tsai-Ling; Chen, Yi-Ming; Chen, Der-Yuan] Natl Chung Hsing Univ, Rong Hsing Res Ctr Translat Med, Taichung 40227, Taiwan; [Lin, Ching-Heng] Natl Taipei Univ Nursing & Hlth Sci, Dept Hlth Care Management, Taipei, Taiwan; [Chen, Yi-Ming; Chen, Hsin-Hua; Chen, Der-Yuan] Taichung Vet Gen Hosp, Div Allergy Immunol & Rheumatol, Taipei, Taiwan; [Chen, Yi-Ming; Chen, Hsin-Hua; Chen, Der-Yuan] Natl Yang Ming Univ, Fac Med, Taipei 112, Taiwan; [Chen, Der-Yuan] Chung Shan Med Univ, Inst Microbiol & Immunol, Taichung, Taiwan	Taichung Veterans General Hospital; National Chung Hsing University; National Chung Hsing University; National Taipei University of Nursing & Health Science (NTUNHS); Taichung Veterans General Hospital; National Yang Ming Chiao Tung University; Chung Shan Medical University	Chen, DY (corresponding author), Taichung Vet Gen Hosp, Dept Med Educ & Res, Taichung, Taiwan.; Chen, DY (corresponding author), Natl Chung Hsing Univ, Inst Biomed Sci, Taichung 40227, Taiwan.; Chen, DY (corresponding author), Natl Chung Hsing Univ, Rong Hsing Res Ctr Translat Med, Taichung 40227, Taiwan.; Chen, DY (corresponding author), Taichung Vet Gen Hosp, Div Allergy Immunol & Rheumatol, Taipei, Taiwan.; Chen, DY (corresponding author), Natl Yang Ming Univ, Fac Med, Taipei 112, Taiwan.; Chen, DY (corresponding author), Chung Shan Med Univ, Inst Microbiol & Immunol, Taichung, Taiwan.	dychen@vghtc.gov.tw	Chen, Yi-Ming/AAV-3806-2021	Chen, Yi-Ming/0000-0001-7593-3065	Taichung Veterans General Hospital, Taiwan [TCVGH-NHRI10307]	Taichung Veterans General Hospital, Taiwan	This study was supported in part by grants from Taichung Veterans General Hospital, Taiwan (TCVGH-NHRI10307) [http://www.vghtc.gov.tw]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arkema EV, 2015, ANN RHEUM DIS, V74, P1212, DOI 10.1136/annrheumdis-2013-204960; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Askling J, 2005, ARTHRITIS RHEUM-US, V52, P1986, DOI 10.1002/art.21137; Brassard P, 2009, ARTHRIT RHEUM-ARTHR, V61, P300, DOI 10.1002/art.24476; Brode SK, 2014, CHEST, V146, P563, DOI 10.1378/chest.13-2058; Carmona L, 2005, ARTHRITIS RHEUM-US, V52, P1766, DOI 10.1002/art.21043; Centers for Disease Control R. O. C. (Taiwan), 2013, TAIW TUB CONTR REP 2; Chen DY, 2012, ANN RHEUM DIS, V71, P231, DOI 10.1136/annrheumdis-2011-200489; Chen YM, 2013, RHEUMATOLOGY, V52, P697, DOI 10.1093/rheumatology/kes365; Cohen SB, 2006, ARTHRITIS RHEUM-US, V54, P2793, DOI 10.1002/art.22025; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Doran MF, 2002, ARTHRITIS RHEUM, V46, P2294, DOI 10.1002/art.10529; Doran MF, 2002, ARTHRITIS RHEUM, V46, P2287, DOI 10.1002/art.10524; Dougados M, 2014, ANN RHEUM DIS, V73, P62, DOI 10.1136/annrheumdis-2013-204223; Dunlap NE, 2000, AM J RESP CRIT CARE, V161, P1376, DOI 10.1164/ajrccm.161.4.16141; Edwards JCW, 2004, NEW ENGL J MED, V350, P2572, DOI 10.1056/NEJMoa032534; Gardam MA, 2003, LANCET INFECT DIS, V3, P148, DOI 10.1016/S1473-3099(03)00545-0; Gomez-Reino JJ, 2003, ARTHRITIS RHEUM-US, V48, P2122, DOI 10.1002/art.11137; Gomez-Reino JJ, 2007, ARTHRIT RHEUM-ARTHR, V57, P756, DOI 10.1002/art.22768; Gupta A, 2012, IMMUNOBIOLOGY, V217, P363, DOI 10.1016/j.imbio.2011.07.008; Jick SS, 2006, ARTHRIT RHEUM-ARTHR, V55, P19, DOI 10.1002/art.21705; Jou RW, 2009, EMERG INFECT DIS, V15, P1525, DOI 10.3201/eid1509.081336; Kourbeti IS, 2014, CLIN INFECT DIS, V58, P1649, DOI 10.1093/cid/ciu185; Ledingham J, 2005, RHEUMATOLOGY, V44, P157, DOI 10.1093/rheumatology/keh464; Lee CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037978; Lee H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119260; Lee JH, 2014, KOREAN J INTERN MED, V29, P76, DOI 10.3904/kjim.2014.29.1.76; Liao TL, 2015, EMERG INFECT DIS, V21, P1387, DOI 10.3201/eid2108.141846; Lin CH, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-5; Lobue P, 2010, RESPIROLOGY, V15, P603, DOI 10.1111/j.1440-1843.2010.01751.x; Maglione PJ, 2007, J IMMUNOL, V178, P7222, DOI 10.4049/jimmunol.178.11.7222; Marais BJ, 2013, LANCET INFECT DIS, V13, P436, DOI 10.1016/S1473-3099(13)70015-X; Navarra SV, 2014, INT J RHEUM DIS, V17, P291, DOI 10.1111/1756-185X.12188; Reed GW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058044; Schluger NW, 2002, CHEST, V121, P1733, DOI 10.1378/chest.121.6.1733; Tubach F, 2009, ARTHRITIS RHEUM-US, V60, P1884, DOI 10.1002/art.24632; van Vollenhoven RF, 2013, ANN RHEUM DIS, V72, P1496, DOI 10.1136/annrheumdis-2012-201956; WHO, 2009, GLOBAL TUBERCULOSIS; WHO, 2014, GLOB TUB REP 2014; Winthrop KL, 2013, ANN RHEUM DIS, V72, P37, DOI 10.1136/annrheumdis-2011-200690; Winthrop KL, 2008, CLIN INFECT DIS, V46, P1738, DOI 10.1086/587989; Winthrop KL, 2013, NAT REV RHEUMATOL, V9, P524, DOI 10.1038/nrrheum.2013.82; Yamada T, 2006, ANN RHEUM DIS, V65, P1661, DOI 10.1136/ard.2005.047274; Yeh JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110922; Zellweger JP, 2015, AM J RESP CRIT CARE	45	29	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2016	11	4							e0153217	10.1371/journal.pone.0153217	http://dx.doi.org/10.1371/journal.pone.0153217			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0KH	27064275	gold, Green Submitted, Green Published			2022-12-27	WOS:000373891000037
J	Deng, WB; Allahverdyan, AE				Deng, Weibing; Allahverdyan, Armen E.			Stochastic Model for Phonemes Uncovers an Author-Dependency of Their Usage	PLOS ONE			English	Article							LEXICAL ACCESS; CHINESE; REALITY; WORD	We study rank-frequency relations for phonemes, the minimal units that still relate to linguistic meaning. We show that these relations can be described by the Dirichlet distribution, a direct analogue of the ideal-gas model in statistical mechanics. This description allows us to demonstrate that the rank-frequency relations for phonemes of a text do depend on its author. The author-dependency effect is not caused by the author's vocabulary (common words used in different texts), and is confirmed by several alternative means. This suggests that it can be directly related to phonemes. These features contrast to rank-frequency relations for words, which are both author and text independent and are governed by the Zipf's law.	[Deng, Weibing] Cent China Normal Univ, Complex Sci Ctr, Wuhan 430079, Peoples R China; [Deng, Weibing] Cent China Normal Univ, Inst Particle Phys, Wuhan 430079, Peoples R China; [Allahverdyan, Armen E.] Yerevan Phys Inst, Alikhanian Bros St 2, Yerevan 375036, Armenia	Central China Normal University; Central China Normal University; Yerevan Physics Institute	Allahverdyan, AE (corresponding author), Yerevan Phys Inst, Alikhanian Bros St 2, Yerevan 375036, Armenia.	armen.allahverdyan@gmail.com			National Natural Science Foundation of China [11505071]; Programme of Introducing Talents of Discipline to Universities [B08033]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Programme of Introducing Talents of Discipline to Universities(Ministry of Education, China - 111 Project)	This work was supported by National Natural Science Foundation of China (Grant No. 11505071), the Programme of Introducing Talents of Discipline to Universities under Grant NO. B08033.	ABLER WL, 1989, J SOC BIOL STRUCT, V12, P1, DOI 10.1016/0140-1750(89)90015-8; Allahverdyan AE, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.062804; Baayen Harald, 2001, WORD FREQUENCY DISTR; Balian R., 1992, MICROPHYSICS MACROPH, VI; Chen QH, 2012, J QUANT LINGUIST, V19, P232, DOI 10.1080/09296174.2012.685305; DARROCH JN, 1971, J AM STAT ASSOC, V66, P641, DOI 10.2307/2283547; David HA, 1970, ORDER STAT; Deng WB, 2014, EUR PHYS J B, V87, DOI 10.1140/epjb/e2014-40805-2; Dover Y, 2004, PHYSICA A, V334, P591, DOI 10.1016/j.physa.2003.09.029; FOSS DJ, 1973, J VERB LEARN VERB BE, V12, P246, DOI 10.1016/S0022-5371(73)80069-6; Frigyik B. A., UWEETR20100006; Gibbs AL, 2002, INT STAT REV, V70, P419, DOI 10.2307/1403865; Good I. J., 1969, ENCY LINGUISTICS INF, P567; Gusein-Zade S. M., 1988, Problems of Information Transmission, V24, P338; HOLMES DI, 1994, COMPUT HUMANITIES, V28, P87, DOI 10.1007/BF01830689; Ivanov V. V., 1978, EVEN ODD ASYMMETRY B; JAYNES ET, 1968, IEEE T SYST SCI CYB, VSSC4, P227, DOI 10.1109/TSSC.1968.300117; Kessler B, 1997, J MEM LANG, V37, P295, DOI 10.1006/jmla.1997.2522; Koppel M, 2009, J AM SOC INF SCI TEC, V60, P9, DOI 10.1002/asi.20961; Kukushkina O. V., 2001, Problems of Information Transmission, V37, P172, DOI 10.1023/A:1010478226705; Levelt WJM, 1999, BEHAV BRAIN SCI, V22, P1; Levelt WJM, 2000, EUR J COGN PSYCHOL, V12, P433, DOI 10.1080/095414400750050178; Lysenko VG, 2014, VOP FILOS, P9; Martindale C., 1996, J QUANT LINGUIST, V3, P106, DOI [DOI 10.1080/09296179608599620, 10.1080/09296179608599620]; MOYNIHAN M, 1970, J THEOR BIOL, V29, P85, DOI 10.1016/0022-5193(70)90120-7; Nathan G., OXFORD HDB COGNITIVE; Pande H., 2013, INT J MATH SCI COMPU, V3, P19; Port R, 2007, NEW IDEAS PSYCHOL, V25, P143, DOI 10.1016/j.newideapsych.2007.02.001; SAMPSON G, 1994, LINGUISTICS, V32, P117, DOI 10.1515/ling.1994.32.1.117; Sapir E., 1949, SELECTED WRITINGS E, P46; SAVIN HB, 1970, J VERB LEARN VERB BE, V9, P295, DOI 10.1016/S0022-5371(70)80064-0; Schafer JL, 1997, ANAL INCOMPLETE MULT, V1st, DOI 10.1201/9781439821862; Scherba L. V., 1910, MEMOIRES SOC LINGUIS, V16, P1; Shrejder Yu. A., 1967, PROBL PEREDACHI INF, V3, P57; SHTRIKMAN S, 1994, J INFORM SCI, V20, P142, DOI 10.1177/016555159402000208; SIGURD B, 1968, PHONETICA, V18, P1, DOI 10.1159/000258595; SKOYLES JR, 1990, J SOC BIOL STRUCT, V13, P321, DOI 10.1016/0140-1750(90)90502-W; Staal F, 2006, J INDIAN PHILOS, V34, P89, DOI 10.1007/s10781-005-8189-0; Stamatatos E, 2009, J AM SOC INF SCI TEC, V60, P538, DOI 10.1002/asi.21001; Tambovtsev Y., 2007, SKASE J THEORETICAL, V4, P1; Twaddell WF, 1936, LANGUAGE, V12, P53, DOI 10.2307/409020; Ule L., 1982, ALLC Bulletin, V10, P73; Vakarin EV, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.036120; Valimaa-Blum R., 2009, COGNITEXTES REV ASS, P2; WITTEN IH, 1990, INT J MAN MACH STUD, V32, P545, DOI 10.1016/S0020-7373(05)80033-1; Wyllis L. E., 1981, LIB TRENDS, V30, P53; ZHAO KH, 1990, AM J PHYS, V58, P449, DOI 10.1119/1.16476; Zwick M., 1978, APPL GEN SYSTEMS RES, V1, P521	48	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2016	11	4							e0152561	10.1371/journal.pone.0152561	http://dx.doi.org/10.1371/journal.pone.0152561			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	DI6JK	27058596	gold, Green Submitted, Green Published			2022-12-27	WOS:000373604800007
J	Zhang, LH; Li, J; Li, X; Nasir, K; Zhang, HB; Wu, YJ; Hu, S; Wang, Q; Downing, NS; Desai, NR; Masoudi, FA; Spertus, JA; Krumholz, HM; Jiang, LX				Zhang, Lihua; Li, Jing; Li, Xi; Nasir, Khurram; Zhang, Haibo; Wu, Yongjian; Hu, Shuang; Wang, Qing; Downing, Nicholas S.; Desai, Nihar R.; Masoudi, Frederick A.; Spertus, John A.; Krumholz, Harlan M.; Jiang, Lixin		China PEACE Collaborative Grp	National Assessment of Statin Therapy in Patients Hospitalized with Acute Myocardial Infarction: Insight from China PEACE-Retrospective AMI Study, 2001, 2006, 2011	PLOS ONE			English	Article							ACUTE CORONARY SYNDROMES; ASSOCIATION TASK-FORCE; ST-ELEVATION; WRITING COMMITTEE; AMERICAN-COLLEGE; CARDIOVASCULAR ANGIOGRAPHY; PULMONARY REHABILITATION; EMERGENCY PHYSICIANS; GENDER-DIFFERENCES; PATTERNS	Background Statin therapy is among the most effective treatments to improve short-and long-term mortality after acute myocardial infarction. The use of statin, and the intensity of their use, has not been described in acute myocardial infarction patients in China, a country with a rapidly growing burden of cardiovascular disease. Methods and Results Using a nationally representative sample of patients with acute myocardial infarction admitted to 162 Chinese hospitals in 2001, 2006 and 2011, we identified 14,958 patients eligible for statin therapy to determine rates of statin use and the intensity of statin therapy, defined as those statin regimens with expected low-density lipoprotein cholesterol lowering of at least 40%, to identify factors associated with the use of statin therapy. Statin use among hospitalized patients with acute myocardial infarction increased from 27.9% in 2001 to 72.5% in 2006, and 88.8% in 2011 (P<0.001 for trend). Regional variation in statin use correspondingly decreased over time. Among treated patients, those receiving intensive statin therapy increased from 1.0% in 2001 to 24.2% in 2006 to 57.2% in 2011(P<0.001 for trend). Patients without low-density lipoprotein cholesterol measured were less likely to be treated with statin or to receive intensive therapy. Conclusions The use of statin therapy has dramatically increased over the past decade in Chinese patients with acute myocardial infarction. However, half of patients still did not receive intensive statin therapy in 2011. Given that guidelines strongly endorse intensive statin therapy for acute myocardial infarction patients, initiatives promoting the use of statin therapy, with attention to treatment intensity, would support further improvements in practice.	[Zhang, Lihua; Li, Jing; Li, Xi; Zhang, Haibo; Wu, Yongjian; Hu, Shuang; Wang, Qing; Jiang, Lixin] Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, Natl Clin Res Ctr Cardiovasc Dis, State Key Lab Cardiovasc Dis,Fuwai Hosp, Beijing 100730, Peoples R China; [Zhang, Lihua; Li, Jing; Li, Xi; Zhang, Haibo; Wu, Yongjian; Hu, Shuang; Wang, Qing; Jiang, Lixin] Peking Union Med Coll, Beijing 100021, Peoples R China; [Nasir, Khurram] Baptist Hlth South Florida, Ctr Healthcare Adv & Outcomes, Miami, FL USA; [Nasir, Khurram; Krumholz, Harlan M.] Baptist Hlth South Florida, Miami Cardiac & Vasc Inst, Miami, FL USA; [Downing, Nicholas S.; Desai, Nihar R.] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, 20 York St, New Haven, CT 06504 USA; [Masoudi, Frederick A.] Univ Colorado, Div Cardiol, Anschutz Med Campus, Aurora, CO USA; [Spertus, John A.] Univ Missouri, St Lukes Mid Amer Heart Inst, Kansas City, MO 64110 USA; [Krumholz, Harlan M.] Yale Univ, Sch Med, Dept Internal Med, Sect Cardiovasc Med, New Haven, CT 06510 USA; [Krumholz, Harlan M.] Yale Univ, Sch Med, Dept Internal Med, Robert Wood Johnson Clin Scholars Program, New Haven, CT 06510 USA; [Krumholz, Harlan M.] Yale Univ, Sch Publ Hlth, Dept Hlth Policy & Management, New Haven, CT USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Baptist Cardiac & Vascular Institute; University of Colorado System; University of Colorado Anschutz Medical Campus; Saint Luke's Mid America Heart Institute; University of Missouri System; University of Missouri Kansas City; Yale University; Yale University; Yale University	Jiang, LX (corresponding author), Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, Natl Clin Res Ctr Cardiovasc Dis, State Key Lab Cardiovasc Dis,Fuwai Hosp, Beijing 100730, Peoples R China.; Jiang, LX (corresponding author), Peking Union Med Coll, Beijing 100021, Peoples R China.	jiangl@fwoxford.org	Spertus, John/ABD-3075-2021; Masoudi, Frederick/Q-7467-2019; , Harlan/AAI-2875-2020	Li, Xi/0000-0003-2249-688X; Wu, Yongjian/0000-0002-5590-8396	Research Special Fund for Public Welfare Industry of Health from National Health and Family Planning Commission of China [201202025]; National Heart, Lung, and Blood Institute [U01 HL105270-03]; Chinese government; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL105270] Funding Source: NIH RePORTER	Research Special Fund for Public Welfare Industry of Health from National Health and Family Planning Commission of China; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Chinese government; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This project was partly supported by the Research Special Fund for Public Welfare Industry of Health (201202025) from National Health and Family Planning Commission of China. Dr. Krumholz are supported by grant U01 HL105270-03 (Center for Cardiovascular Outcomes Research at Yale University) from the National Heart, Lung, and Blood Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We appreciate the multiple contributions made by study teams at the China Oxford Centre for International Health Research and the Yale-New Haven Hospital Center for Outcomes Research and Evaluation in the realms of study design and operations, particularly the data collection by the China PEACE Collaborative Group of Yi Pi, Jiamin Liu, Wuhanbilige Hundei, Xue Du, Wenchi Guan, Xin Zheng, and Yuanlin Guo. We are grateful for the support provided by the Chinese government.	Anderson JL, 2007, CIRCULATION, V116, pE148, DOI 10.1161/CIRCULATIONAHA.107.181940; Anonymous, 2007, Zhonghua Xinxueguanbing Zazhi, V35, P295; Anonymous, 2007, Zhonghua Xinxueguanbing Zazhi, V35, P390; Armitage J, 2010, LANCET, V376, P1658, DOI 10.1016/S0140-6736(10)60310-8; Arnold SV, 2014, CIRCULATION, V129, P1303, DOI 10.1161/CIRCULATIONAHA.113.003589; Bassand JP, 2007, EUR HEART J, V28, P1598, DOI 10.1093/eurheartj/ehm161; Buettner C, 2008, J GEN INTERN MED, V23, P1182, DOI 10.1007/s11606-008-0636-7; Cannon CP, 2013, J AM COLL CARDIOL, V61, P992, DOI 10.1016/j.jacc.2012.10.005; Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583; Cao Q, 2012, INT J HEALTH SERV, V42, P177, DOI 10.2190/HS.42.2.b; China Society of Cardiology of Chinese Medical Association, 2010, Zhonghua Xin Xue Guan Bing Za Zhi, V38, P675; Chong PH, 2002, ANN PHARMACOTHER, V36, P1907, DOI 10.1345/aph.1C116; Dallongevillle J, 2010, HEART, V96, P1744, DOI 10.1136/hrt.2010.196170; Dharmarajan K, 2013, CIRC-CARDIOVASC QUAL, V6, P732, DOI 10.1161/CIRCOUTCOMES.113.000441; Elbarouni B, 2012, AM J CARDIOL, V109, P1418, DOI 10.1016/j.amjcard.2012.01.352; Ferrieres J, 2009, ATHEROSCLEROSIS, V204, P491, DOI 10.1016/j.atherosclerosis.2008.09.031; Guan F, 2010, CHINESE MED J-PEKING, V123, P884, DOI 10.3760/cma.j.issn.0366-6999.2010.07.022; Haynes R, 2013, EUR HEART J, V34, P1279, DOI 10.1093/eurheartj/eht055; Hulten E, 2006, ARCH INTERN MED, V166, P1814, DOI 10.1001/archinte.166.17.1814; Jacobs AK, 2007, CIRCULATION, V116, P217, DOI 10.1161/CIRCULATIONAHA.107.184043; Ko DT, 2005, AM HEART J, V150, P419, DOI 10.1016/j.ahj.2004.09.057; Krumholz HM, 2008, J AM COLL CARDIOL, V52, P2046, DOI 10.1016/j.jacc.2008.10.012; Larsen AI, 2014, AM J CARDIOL, V113, P1273, DOI 10.1016/j.amjcard.2014.01.401; Lee KH, 2011, J AM COLL CARDIOL, V58, P1664, DOI 10.1016/j.jacc.2011.05.057; Lenderink T, 2006, EUR HEART J, V27, P1799, DOI 10.1093/eurheartj/ehl125; Li J, 2015, LANCET, V385, P441, DOI 10.1016/S0140-6736(14)60921-1; Li X, 2012, CHINESE MED J-PEKING, V125, P1703, DOI 10.3760/cma.j.issn.0366-6999.2012.10.005; Liao JK, 2007, AM J CARDIOL, V99, P410, DOI 10.1016/j.amjcard.2006.08.051; Liu M, 2007, LANCET NEUROL, V6, P456, DOI 10.1016/S1474-4422(07)70004-2; Ministry of Labour and Social Security, 2004, ESS DRUG CAT NAT BAS; Schwartz GG, 2001, JAMA-J AM MED ASSOC, V285, P1711, DOI 10.1001/jama.285.13.1711; Shiu JR, 2012, AM J CARDIOL, V109, P1, DOI 10.1016/j.amjcard.2011.07.064; Stone NJ, 2014, J AM COLL CARDIOL, V63, P2889, DOI 10.1016/j.jacc.2013.11.002; The World Bank, HLTH HARM LIF CHIN S; Vale N, 2011, COCHRANE DB SYST REV, V6; Victor BM, 2014, AM J CARDIOL, V113, P1611, DOI 10.1016/j.amjcard.2014.02.018; Wang C, 2013, CHEST, V143, P524, DOI 10.1378/chest.12-1839	37	49	53	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2016	11	4							e0150806	10.1371/journal.pone.0150806	http://dx.doi.org/10.1371/journal.pone.0150806			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6JK	27058862	Green Submitted, Green Published, gold			2022-12-27	WOS:000373604800001
J	Fridrich, S; Hahn, SA; Linzmaier, M; Felten, M; Zwarg, J; Lennerz, V; Tuettenberg, A; Stocker, W				Fridrich, Sven; Hahn, Susanne A.; Linzmaier, Marion; Felten, Matthias; Zwarg, Jenny; Lennerz, Volker; Tuettenberg, Andrea; Stoecker, Walter			How Soluble GARP Enhances TGF beta Activation	PLOS ONE			English	Article							REGULATORY T-CELLS; GROWTH-FACTOR-BETA; TRANSFORMING GROWTH-FACTOR-BETA-1; LATENT COMPLEX; EXPRESSION; PROTEINS; SURFACE; TGF-BETA-1; GENES; TREG	GARP (glycoprotein A repetitions predominant) is a cell surface receptor on regulatory Tlymphocytes, platelets, hepatic stellate cells and certain cancer cells. Its described function is the binding and accommodation of latent TGF beta (transforming growth factor), before the activation and release of the mature cytokine. For regulatory T cells it was shown that a knockdown of GARP or a treatment with blocking antibodies dramatically decreases their immune suppressive capacity. This confirms a fundamental role of GARP in the basic function of regulatory T cells. Prerequisites postulated for physiological GARP function include membrane anchorage of GARP, disulfide bridges between the propeptide of TGF beta and GARP and connection of this propeptide to alpha(v)beta(6) or alpha(v)beta(8) integrins of target cells during mechanical TGF beta release. Other studies indicate the existence of soluble GARP complexes and a functionality of soluble GARP alone. In order to clarify the underlying molecular mechanism, we expressed and purified recombinant TGF beta and a soluble variant of GARP. Surprisingly, soluble GARP and TGF beta formed stable non-covalent complexes in addition to disulfide-coupled complexes, depending on the redox conditions of the microenvironment. We also show that soluble GARP alone and the two variants of complexes mediate different levels of TGF beta activity. TGF beta activation is enhanced by the non-covalent GARP-TGF beta complex already at low (nanomolar) concentrations, at which GARP alone does not show any effect. This supports the idea of soluble GARP acting as immune modulator in vivo.	[Fridrich, Sven; Linzmaier, Marion; Felten, Matthias; Stoecker, Walter] JGU Mainz, Inst Zool, Cell & Matrix Biol, Mainz, Germany; [Hahn, Susanne A.; Tuettenberg, Andrea] Univ Hosp Mainz, Dermatol, Mainz, Germany; [Zwarg, Jenny; Lennerz, Volker] Univ Hosp Mainz, Med Ctr 3, Mainz, Germany	Johannes Gutenberg University of Mainz; University Hospital Mainz; University Hospital Mainz	Stocker, W (corresponding author), JGU Mainz, Inst Zool, Cell & Matrix Biol, Mainz, Germany.	stoecker@uni-mainz.de	Stöcker, Walter/AAB-9704-2019	Stöcker, Walter/0000-0002-1515-6994	Deutsche Forschungsgemeinschaft (DFG) [GRK1043]; Research Center for Immunotherapy at the University Hospital Mainz; Wilhelm-Sander-Stiftung	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Research Center for Immunotherapy at the University Hospital Mainz; Wilhelm-Sander-Stiftung	The authors acknowledge support by the Deutsche Forschungsgemeinschaft (DFG, GRK1043), by the Research Center for Immunotherapy at the University Hospital Mainz to WS and by the Wilhelm-Sander-Stiftung to AT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABSHER M, 1991, J IMMUNOL METHODS, V138, P301, DOI 10.1016/0022-1759(91)90179-J; Becker C, 2003, BIOL CHEM, V384, P825, DOI 10.1515/BC.2003.092; Buscemi L, 2011, CURR BIOL, V21, P2046, DOI 10.1016/j.cub.2011.11.037; Card CM, 2009, J INFECT DIS, V199, P1318, DOI 10.1086/597801; D'Alise AM, 2011, P NATL ACAD SCI USA, V108, P8737, DOI 10.1073/pnas.1105364108; Gauthy E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076186; Hahn SA, 2013, BLOOD, V122, P1182, DOI 10.1182/blood-2012-12-474478; Kalathil S, 2013, CANCER RES, V73, P2435, DOI 10.1158/0008-5472.CAN-12-3381; KANZAKI T, 1990, CELL, V61, P1051, DOI 10.1016/0092-8674(90)90069-Q; Kehrl BYJH, 1986, J EXP MED, V163, P1037; KOBE B, 1995, CURR OPIN STRUC BIOL, V5, P409, DOI 10.1016/0959-440X(95)80105-7; KULKARNI AB, 1993, P NATL ACAD SCI USA, V90, P770, DOI 10.1073/pnas.90.2.770; Lennerz V, 2005, P NATL ACAD SCI USA, V102, P16013, DOI 10.1073/pnas.0500090102; Li YH, 2015, 3RD INTERNATIONAL CONFERENCE ON COMPUTER SCIENCE AND INFORMATION ENGINEERING (CSIE 2015), P1; Macaulay IC, 2007, BLOOD, V109, P3260, DOI 10.1182/blood-2006-07-036269; Massague J, 2012, FEBS LETT, V586, P1953, DOI 10.1016/j.febslet.2012.03.023; McMahon GA, 1996, BIOCHEM J, V313, P343, DOI 10.1042/bj3130343; Miller MM, 2013, AIDS RES HUM RETROV, V29, P641, DOI 10.1089/aid.2012.0322; Oida T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018365; OLLENDORFF V, 1994, CELL GROWTH DIFFER, V5, P213; Probst-Kepper M, 2009, J CELL MOL MED, V13, P3343, DOI 10.1111/j.1582-4934.2009.00782.x; Probst-Kepper M, 2009, TRANSFUS MED HEMOTH, V36, P302, DOI 10.1159/000235929; Robertson IB, 2013, CYTOKINE GROWTH F R, V24, P355, DOI 10.1016/j.cytogfr.2013.06.003; Stockis J, 2009, EUR J IMMUNOL, V39, P3315, DOI 10.1002/eji.200939684; Suarez-Pinzon WL, 2002, CELL TRANSPLANT, V11, P519; Tran DQ, 2009, P NATL ACAD SCI USA, V106, P13445, DOI 10.1073/pnas.0901944106; Wang R, 2012, MOL BIOL CELL, V23, P1129, DOI 10.1091/mbc.E11-12-1018; Wang R, 2009, P NATL ACAD SCI USA, V106, P13439, DOI 10.1073/pnas.0901965106; Wang R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002705; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; Wu F, 1996, AM J PHYSIOL, pL879	31	17	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153290	10.1371/journal.pone.0153290	http://dx.doi.org/10.1371/journal.pone.0153290			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27054568	Green Published, Green Submitted, gold			2022-12-27	WOS:000373608000116
J	Hoffmann, H; Zhao, G; Asseng, S; Bindi, M; Biernath, C; Constantin, J; Coucheney, E; Dechow, R; Doro, L; Eckersten, H; Gaiser, T; Grosz, B; Heinlein, F; Kassie, BT; Kersebaum, KC; Klein, C; Kuhnert, M; Lewan, E; Moriondo, M; Nendel, C; Priesack, E; Raynal, H; Roggero, PP; Rotter, RP; Siebert, S; Specka, X; Tao, FL; Teixeira, E; Trombi, G; Wallach, D; Weihermuller, L; Yeluripati, J; Ewert, F				Hoffmann, Holger; Zhao, Gang; Asseng, Senthold; Bindi, Marco; Biernath, Christian; Constantin, Julie; Coucheney, Elsa; Dechow, Rene; Doro, Luca; Eckersten, Henrik; Gaiser, Thomas; Grosz, Balazs; Heinlein, Florian; Kassie, Belay T.; Kersebaum, Kurt-Christian; Klein, Christian; Kuhnert, Matthias; Lewan, Elisabet; Moriondo, Marco; Nendel, Claas; Priesack, Eckart; Raynal, Helene; Roggero, Pier P.; Rotter, Reimund P.; Siebert, Stefan; Specka, Xenia; Tao, Fulu; Teixeira, Edmar; Trombi, Giacomo; Wallach, Daniel; Weihermueller, Lutz; Yeluripati, Jagadeesh; Ewert, Frank			Impact of Spatial Soil and Climate Input Data Aggregation on Regional Yield Simulations	PLOS ONE			English	Article							SYSTEMS SIMULATION; NITROGEN DYNAMICS; WINTER-WHEAT; CROP MODELS; DATA RESOLUTION; SCALE; WATER; VARIABILITY; CALIBRATION; WEATHER	We show the error in water-limited yields simulated by crop models which is associated with spatially aggregated soil and climate input data. Crop simulations at large scales (regional, national, continental) frequently use input data of low resolution. Therefore, climate and soil data are often generated via averaging and sampling by area majority. This may bias simulated yields at large scales, varying largely across models. Thus, we evaluated the error associated with spatially aggregated soil and climate data for 14 crop models. Yields of winter wheat and silage maize were simulated under water-limited production conditions. We calculated this error from crop yields simulated at spatial resolutions from 1 to 100 km for the state of North Rhine-Westphalia, Germany. Most models showed yields biased by <15% when aggregating only soil data. The relative mean absolute error (rMAE) of most models using aggregated soil data was in the range or larger than the inter-annual or inter-model variability in yields. This error increased further when both climate and soil data were aggregated. Distinct error patterns indicate that the rMAE may be estimated from few soil variables. Illustrating the range of these aggregation effects across models, this study is a first step towards an ex-ante assessment of aggregation errors in large-scale simulations.	[Hoffmann, Holger; Zhao, Gang; Gaiser, Thomas; Siebert, Stefan; Ewert, Frank] Univ Bonn, INRES, Crop Sci Grp, Bonn, Germany; [Asseng, Senthold; Kassie, Belay T.] Univ Florida, Agr & Biol Engn Dept, Gainesville, FL USA; [Bindi, Marco; Trombi, Giacomo] Univ Florence, Dept Agrifood Prod & Environm Sci, Florence, Italy; [Biernath, Christian; Heinlein, Florian; Klein, Christian; Priesack, Eckart] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Biochem Plant Pathol, Neuherberg, Germany; [Constantin, Julie; Raynal, Helene; Wallach, Daniel] INRA, Auzeville, France; [Coucheney, Elsa; Lewan, Elisabet] Swedish Univ Agr Sci, Dept Soil & Environm, Uppsala, Sweden; [Dechow, Rene; Grosz, Balazs] Thunen Inst Climate Smart Agr, Braunschweig, Germany; [Doro, Luca; Roggero, Pier P.] Univ Sassari, Desertificat Res Grp, I-07100 Sassari, Italy; [Eckersten, Henrik] Swedish Univ Agr Sci, Dept Crop Prod Ecol, Uppsala, Sweden; [Kersebaum, Kurt-Christian; Nendel, Claas; Specka, Xenia] Leibniz Ctr Agr Landscape Res, Inst Landscape Syst Anal, Muncheberg, Germany; [Kuhnert, Matthias] Univ Aberdeen, Sch Biol Sci, Inst Biol & Environm Sci, Aberdeen, Scotland; [Moriondo, Marco] CNR, Ibimet, Florence, Italy; [Rotter, Reimund P.; Tao, Fulu] Nat Resources Inst Finland Luke, Environm Impacts Grp, Vantaa, Finland; [Teixeira, Edmar] New Zealand Inst Plant & Food Res Ltd, Canterbury Agr & Sci Ctr, Syst Modelling Team, Sustainable Prod Grp, Lincoln, New Zealand; [Weihermueller, Lutz] Forschungszentrum Julich, Agrosphere Inst IBG 3, D-52425 Julich, Germany; [Yeluripati, Jagadeesh] Craigiebuckler, James Hutton Inst, Aberdeen, Scotland	University of Bonn; State University System of Florida; University of Florida; University of Florence; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; INRAE; Swedish University of Agricultural Sciences; Johann Heinrich von Thunen Institute; University of Sassari; Swedish University of Agricultural Sciences; Leibniz Zentrum fur Agrarlandschaftsforschung (ZALF); University of Aberdeen; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biometeorologia (IBIMET-CNR); Natural Resources Institute Finland (Luke); New Zealand Institute for Plant & Food Research Ltd; Helmholtz Association; Research Center Julich; James Hutton Institute	Hoffmann, H (corresponding author), Univ Bonn, INRES, Crop Sci Grp, Bonn, Germany.	hhoffmann@uni-bonn.de	Specka, Xenia/U-8770-2019; Kersebaum, Kurt Christian/A-7558-2010; bindi, marco/M-6415-2014; Teixeira, Edmar/K-1238-2016; Priesack, Eckart/M-7341-2014; Wallach, Daniel/A-1194-2012; Grosz, Balazs/AFT-1500-2022; Gaiser, Thomas/AAD-6326-2021; Nendel, Claas/C-8844-2013; Doro, Luca/AAA-5596-2021; Asseng, Senthold/Y-6014-2019; Moriondo, Marco/H-5279-2019; Rötter, Reimund/Y-9579-2019; Roggero, Pier Paolo/D-2580-2012; Yeluripati, Jagadeesh/AAF-3283-2020; Siebert, Stefan/B-8621-2009; Hoffmann, Holger/A-8169-2013	Specka, Xenia/0000-0002-1890-0192; Kersebaum, Kurt Christian/0000-0002-3679-8427; bindi, marco/0000-0002-8968-954X; Teixeira, Edmar/0000-0002-4835-0590; Wallach, Daniel/0000-0003-3500-8179; Gaiser, Thomas/0000-0002-5820-2364; Nendel, Claas/0000-0001-7608-9097; Asseng, Senthold/0000-0002-7583-3811; Moriondo, Marco/0000-0002-8356-7517; Rötter, Reimund/0000-0002-3804-9964; Roggero, Pier Paolo/0000-0002-7269-4334; Yeluripati, Jagadeesh/0000-0003-3107-2595; Siebert, Stefan/0000-0002-9998-0672; Hoffmann, Holger/0000-0001-9811-5065; Trombi, Giacomo/0000-0002-3775-272X; Tao, F/0000-0001-8574-0080; coucheney, elsa/0000-0001-5988-2085; Kuhnert, Matthias/0000-0003-3284-2133; DORO, Luca/0000-0003-1404-2255; Ewert, Frank/0000-0002-4392-8154; Weihermuller, Lutz/0000-0003-1991-7735; Priesack, Eckart/0000-0002-5088-9528; Constantin, Julie/0000-0001-9647-5374	German Federal Ministry of Food and Agriculture (BMEL) through Federal Office for Agriculture and Food (BLE) [2851ERA01J]; FACCE MACSUR through Finnish Ministry of Agriculture and Forestry (MMM) [3200009600]; Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning [220-2007-1218]; faculty of Natural Resources and Agricultural Sciences (Swedish University of Agricultural Sciences); INRA ACCAF metaprogram; UR MIAT INRA; Helmholtz project "REKLIM - Regional Climate Change"; HGF Alliance "Remote Sensing and Earth System Dynamics" (EDA); German Research Foundation (Deutsche Forschungsgemeinschaft, DFG) [FOR1695]; German Science Foundation [EW 119/5-1]; BBSRC [BB/K009265/1, BB/N004922/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/K009265/1, BB/N004922/1] Funding Source: researchfish	German Federal Ministry of Food and Agriculture (BMEL) through Federal Office for Agriculture and Food (BLE); FACCE MACSUR through Finnish Ministry of Agriculture and Forestry (MMM); Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning(Swedish Research Council Formas); faculty of Natural Resources and Agricultural Sciences (Swedish University of Agricultural Sciences); INRA ACCAF metaprogram; UR MIAT INRA; Helmholtz project "REKLIM - Regional Climate Change"; HGF Alliance "Remote Sensing and Earth System Dynamics" (EDA); German Research Foundation (Deutsche Forschungsgemeinschaft, DFG)(German Research Foundation (DFG)); German Science Foundation(German Research Foundation (DFG)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was financially supported by the German Federal Ministry of Food and Agriculture (BMEL) through the Federal Office for Agriculture and Food (BLE), (2851ERA01J). FT and RPR were supported by FACCE MACSUR (3200009600) through the Finnish Ministry of Agriculture and Forestry (MMM). EC, HE, and EL were supported by The Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (220-2007-1218) and by the strategic funding 'Soil-Water-Landscape' from the faculty of Natural Resources and Agricultural Sciences (Swedish University of Agricultural Sciences) and thank professor P-E Jansson (Royal Institute of Technology, Stockholm) for support. JC, HR, and DW thank the INRA ACCAF metaprogram for funding and Eric Casellas from UR MIAT INRA for support. CB was funded by the Helmholtz project "REKLIM - Regional Climate Change". CK was funded by the HGF Alliance "Remote Sensing and Earth System Dynamics" (EDA). FH was funded by the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG) under the Grant FOR1695. FE and SS acknowledge support by the German Science Foundation (project EW 119/5-1). HH, GZ, SS, TG, and FE thank Andreas Enders and Gunther Krauss (INRES, University of Bonn) for support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AG-Boden, 2005, AD HOC ARB BOD BOD K; Angulo C, 2014, EUR J AGRON, V61, P35, DOI 10.1016/j.eja.2014.07.005; Angulo C, 2013, EUR J AGRON, V49, P104, DOI 10.1016/j.eja.2013.04.003; Asseng S, 2004, FIELD CROP RES, V85, P85, DOI 10.1016/S0378-4290(03)00154-0; Asseng S, 1998, FIELD CROP RES, V57, P163, DOI 10.1016/S0378-4290(97)00117-2; Baranowski P, 2015, CLIM RES, V65, P39, DOI 10.3354/cr01321; Baron C, 2005, PHILOS T R SOC B, V360, P2095, DOI 10.1098/rstb.2005.1741; Bergez JE, 2013, ENVIRON MODELL SOFTW, V39, P39, DOI 10.1016/j.envsoft.2012.03.011; Brisson N, 1998, AGRONOMIE, V18, P311, DOI 10.1051/agro:19980501; Brisson N., 2009, FORMALISATIONS PARAM; CALE WG, 1983, J THEOR BIOL, V100, P539, DOI 10.1016/0022-5193(83)90446-0; Cologne District Council (Bezirksregierung Koln), 2013, NORDRH WESTF ZAHL GE; Conrad Y, 2009, PHYS CHEM EARTH, V34, P530, DOI 10.1016/j.pce.2008.08.003; de Wit AJW, 2005, AGR FOREST METEOROL, V135, P156, DOI 10.1016/j.agrformet.2005.11.012; Del Grosso SJ, 2006, J ENVIRON QUAL, V35, P1451, DOI 10.2134/jeq2005.0160; Del Grosso SJ, 2001, MODELING CARBON AND NITROGEN DYNAMICS FOR SOIL MANAGEMENT, P303; Easterling WE, 1998, AGR FOREST METEOROL, V90, P51, DOI 10.1016/S0168-1923(97)00091-9; Ershadi A, 2013, REMOTE SENS ENVIRON, V131, P51, DOI 10.1016/j.rse.2012.12.007; Evans LT, 1999, CROP SCI, V39, P1544, DOI 10.2135/cropsci1999.3961544x; Ewert F, 2015, HDB CLIMATE CHANGE A, P262; Ewert F, 2011, AGR ECOSYST ENVIRON, V142, P6, DOI 10.1016/j.agee.2011.05.016; FAO, 2015, FAO WORLD SOIL RES R; Folberth C, 2012, ECOL MODEL, V235, P8, DOI 10.1016/j.ecolmodel.2012.03.035; Hansen JW, 2006, CLIM RES, V33, P27, DOI 10.3354/cr033027; Hansen JW, 2000, AGR SYST, V65, P43, DOI 10.1016/S0308-521X(00)00025-1; Herbst M, 2008, ECOL MODEL, V214, P271, DOI 10.1016/j.ecolmodel.2008.02.007; Hoffmann H, 2015, CLIM RES, V65, P53, DOI 10.3354/cr01326; Hoffmann H, 2016, CLIMATE SOIL INPUT D; Hoffmann H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075033; Holzworth DP, 2014, ENVIRON MODELL SOFTW, V62, P327, DOI 10.1016/j.envsoft.2014.07.009; Janssen S, 2009, ENVIRON SCI POLICY, V12, P573, DOI 10.1016/j.envsci.2009.01.007; Jansson PE, 2012, T ASABE, V55, P1335; Jansson P.E., 2004, COUPLED HEAT MASS TR; Keating BA, 2003, EUR J AGRON, V18, P267, DOI 10.1016/S1161-0301(02)00108-9; Kersebaum KC, 2011, ADV AGR SYST MODEL, V2, P65, DOI 10.2134/advagricsystmodel2.c2; Kersebaum KC, 1998, NUTR CYCL AGROECOSYS, V50, P313, DOI 10.1023/A:1009721218584; Kersebaum KC, 2007, NUTR CYCL AGROECOSYS, V77, P39, DOI 10.1007/s10705-006-9044-8; Krzywinski M, 2014, NAT METHODS, V11, P119, DOI 10.1038/nmeth.2813; Lugato E, 2006, GEODERMA, V135, P315, DOI 10.1016/j.geoderma.2006.01.012; Meentemeyer V, 1989, LANDSCAPE ECOL, V3, P163, DOI 10.1007/BF00131535; Nendel C, 2013, FIELD CROP RES, V145, P67, DOI 10.1016/j.fcr.2013.02.014; Nendel C, 2011, ECOL MODEL, V222, P1614, DOI 10.1016/j.ecolmodel.2011.02.018; Olesen JE, 2000, AGR ECOSYST ENVIRON, V82, P213, DOI 10.1016/S0167-8809(00)00227-9; Parton WJ, 2001, J GEOPHYS RES-ATMOS, V106, P17403, DOI 10.1029/2001JD900101; Parton WJ, 1992, CENTURY USERS MANUAL; PIERCE LL, 1995, LANDSCAPE ECOL, V10, P239, DOI 10.1007/BF00129258; POESEN J, 1994, CATENA, V23, P1, DOI 10.1016/0341-8162(94)90050-7; Priesack E, 2006, NUTR CYCL AGROECOSYS, V75, P1, DOI 10.1007/s10705-006-9006-1; RASTETTER EB, 1992, ECOL APPL, V2, P55, DOI 10.2307/1941889; Rezaei EE, 2015, EUR J AGRON, V65, P69, DOI 10.1016/j.eja.2015.02.003; Rosenzweig C, 2014, P NATL ACAD SCI USA, V111, P3268, DOI 10.1073/pnas.1222463110; Shibu ME, 2010, EUR J AGRON, V32, P255, DOI 10.1016/j.eja.2010.01.003; Specka X, 2015, EUR J AGRON, V71, P73, DOI 10.1016/j.eja.2015.08.004; Stockle CO, 2003, EUR J AGRON, V18, P289, DOI 10.1016/S1161-0301(02)00109-0; Tao F, 2009, AGR FOREST METEOROL, V149, P831, DOI 10.1016/j.agrformet.2008.11.004; Taylor KE, 2001, J GEOPHYS RES-ATMOS, V106, P7183, DOI 10.1029/2000JD900719; Therond O, 2011, AGR ECOSYST ENVIRON, V142, P85, DOI 10.1016/j.agee.2010.05.007; TORRI D, 1994, CATENA, V23, P65, DOI 10.1016/0341-8162(94)90053-1; van Bussel LGJ, 2011, AGR ECOSYST ENVIRON, V142, P75, DOI 10.1016/j.agee.2010.03.019; van Ittersum MK, 2003, EUR J AGRON, V18, P201, DOI 10.1016/S1161-0301(02)00106-5; vanIttersum MK, 1997, FIELD CROP RES, V52, P197, DOI 10.1016/S0378-4290(97)00037-3; Wang EL, 2000, ENVIRON MODELL SOFTW, V15, P179, DOI 10.1016/S1364-8152(99)00033-X; Wassenaar T, 1999, CLIMATE RES, V11, P209, DOI 10.3354/cr011209; Webber H, 2015, EUR J AGRON, V71, P123, DOI 10.1016/j.eja.2015.09.002; WENDLING U, 1995, WASSERWIRTSCHAFT, V85, P602; Williams J. R., 1995, Computer models of watershed hydrology., P909; Wold S, 2001, CHEMOMETR INTELL LAB, V58, P109, DOI 10.1016/S0169-7439(01)00155-1; Yeluripati JB, 2009, SOIL BIOL BIOCHEM, V41, P2579, DOI 10.1016/j.soilbio.2009.08.021; Zhao G, 2015, CLIM RES, V65, P141, DOI 10.3354/cr01301; Zhao G, 2015, AGR FOREST METEOROL, V200, P156, DOI 10.1016/j.agrformet.2014.09.026; Zhao G, 2013, GLOBAL CHANGE BIOL, V19, P1585, DOI 10.1111/gcb.12145; [No title captured], DOI DOI 10.1016/J.AGRFORMET.2011.10.003	72	65	72	1	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0151782	10.1371/journal.pone.0151782	http://dx.doi.org/10.1371/journal.pone.0151782			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27055028	Green Published, Green Accepted, gold			2022-12-27	WOS:000373608000007
J	Lizandra, J; Devis-Devis, J; Perez-Gimeno, E; Valencia-Peris, A; Peiro-Velert, C				Lizandra, Jorge; Devis-Devis, Jose; Perez-Gimeno, Esther; Valencia-Peris, Alexandra; Peiro-Velert, Carmen			Does Sedentary Behavior Predict Academic Performance in Adolescents or the Other Way Round? A Longitudinal Path Analysis	PLOS ONE			English	Article							ELECTRONIC MEDIA USE; PHYSICAL-ACTIVITY; PROSOCIAL BEHAVIOR; PROSPECTIVE COHORT; ACHIEVEMENT; HEALTH; SCHOOL; TELEVISION; CHILDREN; YOUTH	This study examined whether adolescents' time spent on sedentary behaviors (academic, technological-based and social-based activities) was a better predictor of academic performance than the reverse. A cohort of 755 adolescents participated in a three-year period study. Structural Equation Modeling techniques were used to test plausible causal hypotheses. Four competing models were analyzed to determine which model best fitted the data. The Best Model was separately tested by gender. The Best Model showed that academic performance was a better predictor of sedentary behaviors than the other way round. It also indicated that students who obtained excellent academic results were more likely to succeed academically three years later. Moreover, adolescents who spent more time in the three different types of sedentary behaviors were more likely to engage longer in those sedentary behaviors after the three-year period. The better the adolescents performed academically, the less time they devoted to social-based activities and more to academic activities. An inverse relationship emerged between time dedicated to technological-based activities and academic sedentary activities. A moderating auto-regressive effect by gender indicated that boys were more likely to spend more time on technological-based activities three years later than girls. To conclude, previous academic performance predicts better sedentary behaviors three years later than the reverse. The positive longitudinal auto-regressive effects on the four variables under study reinforce the 'success breeds success' hypothesis, with academic performance and social-based activities emerging as the strongest ones. Technological-based activities showed a moderating effect by gender and a negative longitudinal association with academic activities that supports a displacement hypothesis. Other longitudinal and covariate effects reflect the complex relationships among sedentary behaviors and academic performance and the need to explore these relationships in depth. Theoretical and practical implications for school health are outlined.	[Lizandra, Jorge; Devis-Devis, Jose] Univ Valencia, Dept Educ Fis & Esport, Valencia, Spain; [Perez-Gimeno, Esther; Valencia-Peris, Alexandra; Peiro-Velert, Carmen] Univ Valencia, Dept Didact Expressio Mus Plast & Corporal, Valencia, Spain	University of Valencia; University of Valencia	Devis-Devis, J (corresponding author), Univ Valencia, Dept Educ Fis & Esport, Valencia, Spain.	jose.devis@uv.es	Valencia-Peris, Alexandra/ABE-5860-2020; Devis-Devis, Jose/G-8758-2015; Lizandra, Jorge/O-6916-2015; Valencia-Peris, Alexandra/L-2260-2014; Peiró-Velert, Carmen/N-6056-2015	Valencia-Peris, Alexandra/0000-0002-2031-9743; Devis-Devis, Jose/0000-0003-4599-3782; Lizandra, Jorge/0000-0001-5599-133X; Peiró-Velert, Carmen/0000-0003-4794-6541	Ministry of Science and Innovation [EDU2009-13664]; Generalitat Valenciana (Spain) [ACIF/2013/214]	Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat Valenciana (Spain)(Center for Forestry Research & Experimentation (CIEF))	The Ministry of Science and Innovation partially funded this paper (research project EDU2009-13664 to CPV). The Generalitat Valenciana (Spain) supported the VALi+d predoctoral contract to Jorge Lizandra (ACIF/2013/214). There was no additional external funding received for this study. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1987, PSYCHOMETRIKA, V52, P317, DOI 10.1007/BF02294359; Biddle SJH, 2009, INT J BEHAV MED, V16, P278, DOI 10.1007/s12529-008-9028-y; Bryant AL, 2003, J RES ADOLESCENCE, V13, P361, DOI 10.1111/1532-7795.1303005; CDC (Centers for Disease Control and Prevention), 2010, ASS SCH BAS PHYS ACT; Costigan SA, 2013, J ADOLESCENT HEALTH, V52, P382, DOI 10.1016/j.jadohealth.2012.07.018; Crespo CJ, 2001, ARCH PEDIAT ADOL MED, V155, P360, DOI 10.1001/archpedi.155.3.360; Flaig G., 1994, EMPIR ECON, V19, P55, DOI [DOI 10.1007/BF01205728, 10.1007/BF01205728]; Garcia-Continente X, 2014, EUR J PUBLIC HEALTH, V24, P5, DOI 10.1093/eurpub/ckt013; Gonzalez LM, 2011, HAEMOPHILIA, V17, P676, DOI 10.1111/j.1365-2516.2010.02469.x; Greenberg MT, 2010, J CONSULT CLIN PSYCH, V78, P156, DOI 10.1037/a0018607; Hardy LL, 2007, PREV MED, V45, P71, DOI 10.1016/j.ypmed.2007.03.014; Hardy LL, 2006, AUST NZ J PUBL HEAL, V30, P534, DOI 10.1111/j.1467-842X.2006.tb00782.x; Hardy LL, 2007, J ADOLESCENT HEALTH, V40, P158, DOI 10.1016/j.jadohealth.2006.09.009; Hardy LL, 2010, ARCH PEDIAT ADOL MED, V164, P643, DOI 10.1001/archpediatrics.2010.88; Hardy LL, 2009, AM J PREV MED, V36, P120, DOI 10.1016/j.amepre.2008.09.034; Henry KL, 2007, HEALTH EDUC RES, V22, P372, DOI 10.1093/her/cyl083; Hinkley T, 2014, JAMA PEDIATR, V168, P485, DOI 10.1001/jamapediatrics.2014.94; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Iannotti RJ, 2009, INT J PUBLIC HEALTH, V54, P191, DOI 10.1007/s00038-009-5410-z; Ingles CJ, 2009, AN PSICOL-SPAIN, V25, P93; Jackson LA, 2011, COMPUT HUM BEHAV, V27, P228, DOI 10.1016/j.chb.2010.08.001; Johnson JG, 2007, ARCH PEDIAT ADOL MED, V161, P480, DOI 10.1001/archpedi.161.5.480; Kam Chi-Ming, 2003, Prev Sci, V4, P55, DOI 10.1023/A:1021786811186; Lassen SR, 2006, PSYCHOL SCHOOLS, V43, P701, DOI 10.1002/pits.20177; Le-Scherban F, 2014, ANN EPIDEMIOL, V24, P344, DOI 10.1016/j.annepidem.2014.02.008; Levine LE, 2007, CYBERPSYCHOL BEHAV, V10, P560, DOI 10.1089/cpb.2007.9990; Little TD, 1997, MULTIVAR BEHAV RES, V32, P53, DOI 10.1207/s15327906mbr3201_3; Lubans DR, 2011, OBES REV, V12, P781, DOI 10.1111/j.1467-789X.2011.00896.x; Majem LS, 2003, MED CLIN-BARCELONA, V121, P725, DOI 10.1016/S0025-7753(03)74077-9; Mathers M, 2009, ACAD PEDIATR, V9, P307, DOI 10.1016/j.acap.2009.04.003; Morley BC, 2012, MED J AUSTRALIA, V196, P189, DOI 10.5694/mja11.11184; Nelson MC, 2006, PEDIATRICS, V117, P1281, DOI 10.1542/peds.2005-1692; Norris T.L., 2010, THESIS; Peiro-Velert C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099478; Prot S, 2014, PSYCHOL SCI, V25, P358, DOI 10.1177/0956797613503854; Rideout V. J., 2010, MEDIA LIVES 8 18 YEA; Romer D, 2013, J ADOLESCENT HEALTH, V52, P613, DOI 10.1016/j.jadohealth.2012.11.012; Ross CE, 2000, SOCIOL EDUC, V73, P270, DOI 10.2307/2673234; Ruiz JR, 2010, J PEDIATR-US, V157, P917, DOI 10.1016/j.jpeds.2010.06.026; Salanova M, 2010, ANXIETY STRESS COPIN, V23, P53, DOI 10.1080/10615800802609965; Santoro M. D., 2000, J HIGH TECHNOLOGY MA, V11, P255, DOI DOI 10.1016/S1047-8310(00)00032-8; Serrano-Sanchez JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024453; Sharif I, 2010, J ADOLESCENT HEALTH, V46, P52, DOI 10.1016/j.jadohealth.2009.05.012; Shin N, 2004, J GENET PSYCHOL, V165, P367, DOI 10.3200/GNTP.165.4.367-382; Solana AA, 2015, RES Q EXERCISE SPORT, V86, P233, DOI 10.1080/02701367.2015.1039891; Subrahmanyam K, 2001, J APPL DEV PSYCHOL, V22, P7, DOI 10.1016/S0193-3973(00)00063-0; Swing EL, 2010, PEDIATRICS, V126, P214, DOI 10.1542/peds.2009-1508; Valencia-Peris A, CULT ED IN PRESS; Walsh JL, 2013, EMERG ADULTHOOD, V1, P219, DOI 10.1177/2167696813479780; Westerlund H, 2013, J EPIDEMIOL COMMUN H, V67, P508, DOI 10.1136/jech-2012-202052	51	9	9	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153272	10.1371/journal.pone.0153272	http://dx.doi.org/10.1371/journal.pone.0153272			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DI6KO	27055121	Green Published, gold			2022-12-27	WOS:000373608000112
J	Bessa-Silva, AR; Vallinoto, M; Sodre, D; da Cunha, DB; Hadad, D; Asp, NE; Sampaio, I; Schneider, H; Sequeira, F				Bessa-Silva, Adam Rick; Vallinoto, Marcelo; Sodre, Davidson; da Cunha, Divino Bruno; Hadad, Dante; Asp, Nils Edvin; Sampaio, Iracilda; Schneider, Horacio; Sequeira, Fernando			Patterns of Genetic Variability in Island Populations of the Cane Toad (Rhinella marina) from the Mouth of the Amazon	PLOS ONE			English	Article							HOLOCENE MANGROVE DYNAMICS; SEA-LEVEL CHANGES; EVOLUTIONARY HISTORY; NORTHEASTERN PARA; NORTHERN BRAZIL; BUFO-MARINUS; FROG; BUFONIDAE; MIGRATION; INFERENCE	The Amazonian coast has several unique geological characteristics resulting from the interaction between drainage pattern of the Amazon River and the Atlantic Ocean. It is one of the most extensive and sedimentologically dynamic regions of the world, with a large number of continental islands mostly formed less than 10,000 years ago. The natural distribution of the cane toad (Rhinella marina), one of the world's most successful invasive species, in this complex Amazonian system provides an intriguing model for the investigation of the effects of isolation or the combined effects of isolation and habitat dynamic changes on patterns of genetic variability and population differentiation. We used nine fast-evolving microsatellite loci to contrast patterns of genetic variability in six coastal (three mainlands and three islands) populations of the cane toad near the mouth of the Amazon River. Results from Bayesian multilocus clustering approach and Discriminant Analyses of Principal Component were congruent in showing that each island population was genetically differentiated from the mainland populations. All FST values obtained from all pairwise comparisons were significant, ranging from 0.048 to 0.186. Estimates of both recent and historical gene flow were not significantly different from zero across all population pairs, except the two mainland populations inhabiting continuous habitats. Patterns of population differentiation, with a high level of population substructure and absence/restricted gene flow, suggested that island populations of R. marina are likely isolated since the Holocene sea-level rise. However, considering the similar levels of genetic variability found in both island and mainland populations, it is reliable to assume that they were also isolated for longer periods. Given the genetic uniqueness of each cane toad population, together with the high natural vulnerability of the coastal regions and intense human pressures, we suggest that these populations should be treated as discrete units for conservation management purposes.	[Bessa-Silva, Adam Rick; Vallinoto, Marcelo; Sodre, Davidson; da Cunha, Divino Bruno; Hadad, Dante] Fed Univ Para, Inst Estudos Costeiros IECOS, Lab Evolucao LEVO, Campus Braganca, BR-66059 Belem, Para, Brazil; [Vallinoto, Marcelo; Sodre, Davidson; da Cunha, Divino Bruno; Sequeira, Fernando] Univ Porto, CIBIO InBIO, Lab Associado, Ctr Invest Biodiversidade & Recursos Genet, Campus Agr Vairao, Vairao, Portugal; [Asp, Nils Edvin] Fed Univ Para, Lab Geol Costeira LAGECO, Inst Estudos Costeiros IECOS, Campus Braganca, BR-66059 Belem, Para, Brazil; [Sampaio, Iracilda; Schneider, Horacio] Fed Univ Para, Lab Filogenom & Bioinformat, Inst Estudos Costeiros IECOS, Campus Braganca, BR-66059 Belem, Para, Brazil	Universidade Federal do Para; Universidade do Porto; Universidade Federal do Para; Universidade Federal do Para	Vallinoto, M (corresponding author), Fed Univ Para, Inst Estudos Costeiros IECOS, Lab Evolucao LEVO, Campus Braganca, BR-66059 Belem, Para, Brazil.; Vallinoto, M (corresponding author), Univ Porto, CIBIO InBIO, Lab Associado, Ctr Invest Biodiversidade & Recursos Genet, Campus Agr Vairao, Vairao, Portugal.	mvallino@ufpa.br	Vallinoto, Marcelo/ABF-9834-2021; Asp, Nils/J-6226-2012; Vallinoto, Marcelo/J-3086-2012; Cunha, Divino Bruno da/AHD-0839-2022; SAMPAIO, IRACILDA/J-6514-2012; Sodré, Davidson/GNP-8094-2022; Sequeira, Fernando/C-3119-2012; Schneider, Horacio/J-7131-2012	Vallinoto, Marcelo/0000-0002-3465-3830; Asp, Nils/0000-0002-6468-6158; Vallinoto, Marcelo/0000-0002-3465-3830; SAMPAIO, IRACILDA/0000-0002-2137-4656; Sodré, Davidson/0000-0002-7223-3204; Sequeira, Fernando/0000-0003-0740-7981; Schneider, Horacio/0000-0002-5987-6395; Silva, Adam Bessa/0000-0002-6093-6180	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Fundacao para a Ciencia e a Tecnologia (FCT) [PTDC/BIA-BEC/105093/2008]; FCT [SFRH/BPD/87721/2012]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; MCT/CNPq; CNPq	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); MCT/CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Funding was provided by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior through scholarships to ABS, DBC and DS; Fundacao para a Ciencia e a Tecnologia (FCT) through project PTDC/BIA-BEC/105093/2008 and FCT postdoctoral fellowships SFRH/BPD/87721/2012 to FS; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico through scholarships to DBC and DS (Ciencia Sem Fronteiras), research project and research fellowship (MCT/CNPq 14 - 2010, MCT/CNPq - 2009, Universal 14-2013, PQ 10/2012) and through a post-doctoral fellowship to MV (232916/2013-6, CNPq).	Allentoft Morten E., 2010, Diversity, V2, P47; [Anonymous], 2020, BIOL AMPHIBIANS, V28, P32; Asp NE, 2004, LONG TO SHORT TERM M; Bacon Jamie P., 2006, Applied Herpetology, V3, P39, DOI 10.1163/157075406775247049; Bacon JP, 2013, J EXP ZOOL PART B, V320B, P218, DOI 10.1002/jez.b.22496; Barbara VF, 2005, C ESQ EMS EXT I FED; Beerli P, 2006, BIOINFORMATICS, V22, P341, DOI 10.1093/bioinformatics/bti803; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; Behling H, 2004, VEG HIST ARCHAEOBOT, V13, P73, DOI 10.1007/s00334-004-0031-1; Behling H, 2001, PALAEOGEOGR PALAEOCL, V167, P225, DOI 10.1016/S0031-0182(00)00239-X; Bell RC, 2012, J BIOGEOGR, V39, P1733, DOI 10.1111/j.1365-2699.2012.02708.x; Bessa-Silva AR, 2015, CONSERV GENET RESOUR, V7, P247, DOI 10.1007/s12686-014-0349-7; Blaustein AR, 2003, FRONT ECOL ENVIRON, V1, P87, DOI 10.1890/1540-9295(2003)001[0087:TCODA]2.0.CO;2; Branner J C, 1884, Science, V4, P488, DOI 10.1126/science.ns-4.95.488; Brown GP, 2007, P NATL ACAD SCI USA, V104, P17698, DOI 10.1073/pnas.0705057104; Nery JRC, 2011, J ENVIRON RADIOACTIV, V102, P348, DOI 10.1016/j.jenvrad.2011.01.008; CHARLESWORTH D, 1987, ANNU REV ECOL SYST, V18, P237, DOI 10.1146/annurev.es.18.110187.001321; Chen S-F, 2012, PLOS ONE, V7; Cohen Marcelo C. L., 2005, Wetlands Ecology and Management, V13, P433, DOI 10.1007/s11273-004-0413-2; Cohen MM, 2001, AM J MED GENET, V104, P101, DOI 10.1002/ajmg.10002; Cristescu R, 2010, CONSERV GENET, V11, P1043, DOI 10.1007/s10592-009-9949-2; Duryea MC, 2015, HEREDITY, V115, P225, DOI 10.1038/hdy.2015.31; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Emel SL, 2012, CONSERV GENET, V13, P1685, DOI 10.1007/s10592-012-0407-1; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Guimaraes JTF, 2013, HOLOCENE, V23, P528, DOI 10.1177/0959683612463097; Fernandes RD, 2007, NAVIGATION AMAZON RI; Fort Douglas J., 2006, Applied Herpetology, V3, P143, DOI 10.1163/157075406776984239; Fostier AH, 2000, SCI TOTAL ENVIRON, V260, P201, DOI 10.1016/S0048-9697(00)00564-7; Fouquet A, 2015, J TROP ECOL, V31, P361, DOI 10.1017/S0266467415000206; FRANKHAM R, 1995, CONSERV BIOL, V9, P792, DOI 10.1046/j.1523-1739.1995.09040792.x; Frankham R., 2004, PRIMER CONSERVATION, DOI [10.1017/CBO9780511817359, DOI 10.1017/CBO9780511817359]; Frankham R, 2014, BIOL CONSERV, V170, P56, DOI 10.1016/j.biocon.2013.12.036; Frost D. R., 2015, AMPHIBIAN SPECIES WO; Garcia-Munoz Enrique, 2010, Herpetology Notes, V3, P267; Gascon C, 1998, BIOTROPICA, V30, P104, DOI 10.1111/j.1744-7429.1998.tb00373.x; Grammer TC, 2005, MECH DEVELOP, V122, P263, DOI 10.1016/j.mod.2004.11.003; Grazziotin FG, 2006, MOL ECOL, V15, P3969, DOI 10.1111/j.1365-294X.2006.03057.x; Haanes H, 2013, ECOL EVOL, V3, P4230, DOI 10.1002/ece3.819; Hedges SB, 1996, HERPETOLOGICA, V52, P466; Irion G., 2011, AMAZONIAN FLOODPLAIN, VXVIII, P27; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Kjerfve B., 1993, MANGROVES BRAZIL MAN, P245, DOI [10.1016/j.ocecoaman.2016.03.011, DOI 10.1016/J.OCECOAMAN.2016.03.011]; Lampert KP, 2003, MOL ECOL, V12, P3325, DOI 10.1046/j.1365-294X.2003.02016.x; LEARY RF, 1984, AM NAT, V124, P540, DOI 10.1086/284293; Li JW, 2010, MOL ECOL, V19, P494, DOI 10.1111/j.1365-294X.2009.04494.x; Li R, 2009, J ZOOL, V277, P309, DOI 10.1111/j.1469-7998.2008.00543.x; Lougheed SC, 1999, P ROY SOC B-BIOL SCI, V266, P1829, DOI 10.1098/rspb.1999.0853; Martinez-Solano I, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-38; Maslin M, 2006, QUATERNARY SCI REV, V25, P3338, DOI 10.1016/j.quascirev.2006.10.012; Meirmans PG, 2004, MOL ECOL NOTES, V4, P792, DOI 10.1111/j.1471-8286.2004.00770.x; Mochiutti S, 2000, WORKSHOP ECOLAB, P57; Mol JH, 2004, CONSERV BIOL, V18, P201, DOI 10.1111/j.1523-1739.2004.00080.x; Mol JH, 2001, ENVIRON RES, V86, P183, DOI 10.1006/enrs.2001.4256; Moller AP, 1997, AM NAT, V149, P916, DOI 10.1086/286030; Mortimer E, 2011, P ROY SOC B-BIOL SCI, V278, P1247, DOI 10.1098/rspb.2010.1779; Patel Yogi A., 2012, BIOS, V83, P75; Phillips BL, 2007, AUSTRAL ECOL, V32, P169, DOI 10.1111/j.1442-9993.2007.01664.x; Phillips BL, 2004, P NATL ACAD SCI USA, V101, P17150, DOI 10.1073/pnas.0406440101; PIMM SL, 1988, AM NAT, V132, P757, DOI 10.1086/284889; Pritchard JK, 2000, GENETICS, V155, P945; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rollins LA, 2015, MOL ECOL, V24, P2264, DOI 10.1111/mec.13184; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rossetti DD, 2001, J S AM EARTH SCI, V14, P77; Santana LO, 2005, AN 12 S BRAS SENS RE, P673; Sequeira F, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-264; Silva MV, 2011, AN 15 S BRAS SENS RE, P8614; Souza PWM, 2009, LECT NOTES EARTH SCI, V107, P347; Tingley R, 2014, P NATL ACAD SCI USA, V111, P10233, DOI 10.1073/pnas.1405766111; Tolledo J, 2014, HERPETOL J, V24, P237; Vallinoto M, 2010, ZOOL SCR, V39, P128, DOI 10.1111/j.1463-6409.2009.00415.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vasquez D, 2013, ZOOL STUD, V52, DOI 10.1186/1810-522X-52-35; Vedel V, 2006, VEG HIST ARCHAEOBOT, V15, P115, DOI 10.1007/s00334-005-0023-9; Velo-Anton G, 2012, MOL PHYLOGENET EVOL, V65, P965, DOI 10.1016/j.ympev.2012.08.016; Velo-Anton G, 2012, HEREDITY, V108, P410, DOI 10.1038/hdy.2011.91; Viana AP, 2012, MAR POLLUT BULL, V64, P489, DOI 10.1016/j.marpolbul.2012.01.006; Vital H, 2000, CHEM GEOL, V168, P151, DOI 10.1016/S0009-2541(00)00191-1; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wells JT, 1995, DEV SEDIMENTOL, V53, P179, DOI DOI 10.1016/S0070-4571(05)80026-3; Williams RN, 2008, BIOL LETTERS, V4, P549, DOI 10.1098/rsbl.2008.0233; Williams SE, 2008, PLOS BIOL, V6, P2621, DOI 10.1371/journal.pbio.0060325; Wilson GA, 2003, GENETICS, V163, P1177; Wright AN, 2002, J HERPETOL, V36, P129, DOI 10.2307/1565818; Zhai SN, 2012, J BIOGEOGR, V39, P1347, DOI 10.1111/j.1365-2699.2012.02685.x; Zug P.B, 1979, MARINE TOAD BUFO MAR, DOI DOI 10.5479/SI.00810282.284	90	10	11	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0152492	10.1371/journal.pone.0152492	http://dx.doi.org/10.1371/journal.pone.0152492			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073849	Green Published, gold			2022-12-27	WOS:000374131200025
J	Guo, HP; Hong, CT; Chen, XM; Xu, YX; Liu, Y; Jiang, DA; Zheng, BS				Guo, Haipeng; Hong, Chuntao; Chen, Xiaomin; Xu, Yanxia; Liu, Yan; Jiang, Dean; Zheng, Bingsong			Different Growth and Physiological Responses to Cadmium of the Three Miscanthus Species	PLOS ONE			English	Article							BRASSICA-JUNCEA L.; ZEA-MAYS L.; C-4 PHOTOSYNTHESIS; OXIDATIVE STRESS; STOMATAL CONDUCTANCE; MALATE-DEHYDROGENASE; PLANT-GROWTH; X GIGANTEUS; TOLERANCE; SEEDLINGS	Miscanthus has been proposed as a promising crop for phytoremediation due to its high biomass yield and remarkable adaptability to different environments. However, little is known about the resistance of Miscanthus spp. to cadmium (Cd). To determine any differences in resistance of Miscanthus to Cd, we examined plant growth, net photosynthetic rate (Pn), activities of anti-oxidant and C4 photosynthetic enzymes, concentrations of Cd in leaves and roots, and observed the chloroplast structure in three Miscanthus species treated with 0, 10, 50, 100 or 200 mu M Cd in solutions. Miscanthus sinensis showed more sensitivity to Cd, including sharp decreases in growth, Pn, PEPC activity and damage to chloroplast structure, and the highest H2O2 and Cd concentrations in leaves and roots after Cd treatments. Miscanthus sacchariflorus showed higher resistance to Cd and better growth, had the highest Pn and phosphoenolpyruvate carboxylase (PEPC) activities and integrative chloroplast structure and the lowest hydrogen peroxide (H2O2) and leaf and root Cd concentrations. The results could play an important role in understanding the mechanisms of Cd tolerance in plants and in application of phytoremediation.	[Guo, Haipeng; Xu, Yanxia; Liu, Yan; Jiang, Dean] Zhejiang Univ, Coll Life Sci, State Key Lab Plant Physiol & Biochem, Hangzhou 310003, Zhejiang, Peoples R China; [Hong, Chuntao] Acad Agr Sci Ningbo City, Ningbo, Zhejiang, Peoples R China; [Chen, Xiaomin; Zheng, Bingsong] Zhejiang A&F Univ, Nurturing Stn, State Key Lab Subtrop Silviculture, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang A&F University	Jiang, DA (corresponding author), Zhejiang Univ, Coll Life Sci, State Key Lab Plant Physiol & Biochem, Hangzhou 310003, Zhejiang, Peoples R China.; Zheng, BS (corresponding author), Zhejiang A&F Univ, Nurturing Stn, State Key Lab Subtrop Silviculture, Hangzhou, Zhejiang, Peoples R China.	dajiang@zju.edu.cn; bszheng@zafu.edu.cn	chen, xia/GYR-3948-2022; X, Yanxia/AAB-8236-2022; chen, xia/GXM-5435-2022; chen, xi/GXH-3653-2022		National Science and Technology Support Plan of China [2012BAC09B01]; National Natural Science Foundation of China [31371591, 31470683]	National Science and Technology Support Plan of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The present research was financially supported by the National Science and Technology Support Plan of China (2012BAC09B01, DAJ) and the National Natural Science Foundation of China (31371591, DAJ and 31470683, BSZ).	Andosch A, 2012, J PLANT PHYSIOL, V169, P1489, DOI 10.1016/j.jplph.2012.06.002; Arduini I, 2004, ENVIRON EXP BOT, V52, P89, DOI 10.1016/j.envexpbot.2004.01.001; Bauddh K, 2012, INT J PHYTOREMEDIAT, V14, P772, DOI 10.1080/15226514.2011.619238; Beyel V, 2005, PHYSIOL PLANTARUM, V124, P249, DOI 10.1111/j.1399-3054.2005.00508.x; Bianconi D, 2013, E3S WEB CONF, V1, DOI 10.1051/e3sconf/20130113002; Cha-um S, 2009, AGR SCI CHINA, V8, P51, DOI 10.1016/S1671-2927(09)60008-0; Chaney RL, 1997, CURR OPIN BIOTECH, V8, P279, DOI 10.1016/S0958-1669(97)80004-3; Chen ZJ, 2015, PLANT PHYSIOL, V167, P176, DOI 10.1104/pp.114.251017; Cho UH, 2005, PLANT SCI, V168, P113, DOI 10.1016/j.plantsci.2004.07.021; Cui WT, 2013, J HAZARD MATER, V260, P715, DOI 10.1016/j.jhazmat.2013.06.032; Daud MK, 2015, CHEMOSPHERE, V120, P309, DOI 10.1016/j.chemosphere.2014.07.060; Deniau AX, 2006, THEOR APPL GENET, V113, P907, DOI 10.1007/s00122-006-0350-y; Dias MC, 2013, ACTA PHYSIOL PLANT, V35, P1281, DOI 10.1007/s11738-012-1167-8; Doubnerova V, 2011, PLANT SCI, V180, P575, DOI 10.1016/j.plantsci.2010.12.005; Dudka S, 1997, J ENVIRON QUAL, V26, P590, DOI 10.2134/jeq1997.00472425002600030003x; EDWARDS GE, 1985, ANNU REV PLANT PHYS, V36, P255, DOI 10.1146/annurev.pp.36.060185.001351; Efthimiadou A, 2009, NOT BOT HORTI AGROBO, V37, P104; FARQUHAR GD, 1982, ANNU REV PLANT PHYS, V33, P317, DOI 10.1146/annurev.pp.33.060182.001533; Feng XP, 2014, CROP SCI, V54, P1645, DOI 10.2135/cropsci2013.02.0091; Feng XP, 2012, PHOTOSYNTHETICA, V50, P577, DOI 10.1007/s11099-012-0061-3; Fernandez R, 2013, J HAZARD MATER, V244, P555, DOI 10.1016/j.jhazmat.2012.10.044; Foyer CH, 2011, PLANT PHYSIOL, V155, P2, DOI 10.1104/pp.110.167569; Ghannoum O, 2009, ANN BOT-LONDON, V103, P635, DOI 10.1093/aob/mcn093; Gill SS, 2012, PLANT SCI, V182, P112, DOI 10.1016/j.plantsci.2011.04.018; Gill SS, 2011, PLANT SIGNAL BEHAV, V6, P293, DOI 10.4161/psb.6.2.15049; Grigorova B, 2012, J PLANT INTERACT, V7, P204, DOI 10.1080/17429145.2011.654134; Hassan Z, 2011, ENVIRON EXP BOT, V72, P53, DOI 10.1016/j.envexpbot.2010.04.003; He Y, 2014, PLANT PHYSIOL BIOCH, V74, P118, DOI 10.1016/j.plaphy.2013.11.008; Hodkinson TR, 2002, J PLANT RES, V115, P381, DOI 10.1007/s10265-002-0049-3; Hong C.T., 2014, ADV MATER RES-KR, V1051, P333, DOI [10.4028/www.scientific.net/AMR.1051.333, DOI 10.4028/WWW.SCIENTIFIC.NET/AMR.1051.333]; Hou WH, 2007, PLANT PHYSIOL BIOCH, V45, P62, DOI 10.1016/j.plaphy.2006.12.005; JACQUOT JPP, 1981, PLANT PHYSIOL, V68, P300, DOI 10.1104/pp.68.2.300; Ji PH, 2011, ENVIRON POLLUT, V159, P762, DOI 10.1016/j.envpol.2010.11.029; Jorgensen U, 2011, CURR OPIN ENV SUST, V3, P24, DOI 10.1016/j.cosust.2010.12.003; Kayama M, 2001, INT J PLANT SCI, V162, P1025, DOI 10.1086/322890; Khan AL, 2014, BIOL FERT SOILS, V50, P75, DOI 10.1007/s00374-013-0833-3; Lichtenthaler HK., 2001, CURRENT PROTOCOLS FO, P431, DOI DOI 10.1002/0471142913.FAF0403S01; Lin RZ, 2007, CHEMOSPHERE, V69, P89, DOI 10.1016/j.chemosphere.2007.04.041; Liu HJ, 2015, J HAZARD MATER, V286, P440, DOI 10.1016/j.jhazmat.2015.01.008; Liu J, 2010, PHOTOSYNTHETICA, V48, P127, DOI 10.1007/s11099-010-0017-4; Liu WX, 2015, ENVIRON TOXICOL CHEM, V34, P92, DOI 10.1002/etc.2760; Markelz RJC, 2011, J EXP BOT, V62, P3235, DOI 10.1093/jxb/err056; Misra V, 2005, ENVIRON INT, V31, P417, DOI 10.1016/j.envint.2004.08.005; Pavel PB, 2014, SCI TOTAL ENVIRON, V479, P125, DOI 10.1016/j.scitotenv.2014.01.097; Ray T. B., 1979, PHOTOSYNTHESIS 2, V6, P77; Sekmen AH, 2012, ENVIRON EXP BOT, V77, P63, DOI 10.1016/j.envexpbot.2011.10.012; Shao QS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085996; Srivastava RK, 2014, PROTOPLASMA, V251, P1047, DOI 10.1007/s00709-014-0614-3; Stewart JR, 2009, GCB BIOENERGY, V1, P126, DOI 10.1111/j.1757-1707.2009.01010.x; VOJTECHOVA M, 1991, BIOL PLANTARUM, V33, P386, DOI 10.1007/BF02897690; Wang H, 2009, PHOTOSYNTHETICA, V47, P277, DOI 10.1007/s11099-009-0043-2; Xue ZC, 2013, BIOL PLANTARUM, V57, P587, DOI 10.1007/s10535-013-0318-0; Ye ZP, 2007, PHOTOSYNTHETICA, V45, P637, DOI 10.1007/s11099-007-0110-5; Zarcinas BA, 2004, ENVIRON GEOCHEM HLTH, V26, P343, DOI 10.1007/s10653-005-4669-0; Zhuang XL, 2007, ENVIRON INT, V33, P406, DOI 10.1016/j.envint.2006.12.005	55	66	67	6	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0153475	10.1371/journal.pone.0153475	http://dx.doi.org/10.1371/journal.pone.0153475			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27070918	Green Published, gold, Green Submitted			2022-12-27	WOS:000373900700072
J	Nguyen, HT; Dawal, SZM; Nukman, Y; Rifai, AP; Aoyama, H				Huu-Tho Nguyen; Dawal, Siti Zawiah Md; Nukman, Yusoff; Rifai, Achmad P.; Aoyama, Hideki			An Integrated MCDM Model for Conveyor Equipment Evaluation and Selection in an FMC Based on a Fuzzy AHP and Fuzzy ARAS in the Presence of Vagueness	PLOS ONE			English	Article							MULTIPLE CRITERIA ASSESSMENT; MATERIAL HANDLING EQUIPMENT; ANALYTIC HIERARCHY PROCESS; DECISION-SUPPORT-SYSTEM; MACHINE-TOOL SELECTION; NETWORK PROCESS; MAKING MODEL; ALTERNATIVES; DESIGN; PRESERVATION	The conveyor system plays a vital role in improving the performance of flexible manufacturing cells (FMCs). The conveyor selection problem involves the evaluation of a set of potential alternatives based on qualitative and quantitative criteria. This paper presents an integrated multi-criteria decision making (MCDM) model of a fuzzy AHP (analytic hierarchy process) and fuzzy ARAS (additive ratio assessment) for conveyor evaluation and selection. In this model, linguistic terms represented as triangular fuzzy numbers are used to quantify experts' uncertain assessments of alternatives with respect to the criteria. The fuzzy set is then integrated into the AHP to determine the weights of the criteria. Finally, a fuzzy ARAS is used to calculate the weights of the alternatives. To demonstrate the effectiveness of the proposed model, a case study is performed of a practical example, and the results obtained demonstrate practical potential for the implementation of FMCs.	[Huu-Tho Nguyen; Dawal, Siti Zawiah Md; Nukman, Yusoff; Rifai, Achmad P.] Univ Malaya, Fac Engn, Dept Mech Engn, Kuala Lumpur, Malaysia; [Aoyama, Hideki] Keio Univ, Sch Integrated Design Engn, Tokyo, Japan	Universiti Malaya; Keio University	Nguyen, HT (corresponding author), Univ Malaya, Fac Engn, Dept Mech Engn, Kuala Lumpur, Malaysia.	nguyenhuutho@siswa.um.edu.my	DAWAL, SITI ZAWIAH MD/B-9816-2010; Bin Yusoff, Nukman/B-5302-2010	DAWAL, SITI ZAWIAH MD/0000-0003-0496-5128; Bin Yusoff, Nukman/0000-0002-7389-2164; Rifai, Achmad Pratama/0000-0003-4890-8344; NGUYEN, Huu-Tho/0000-0001-8558-5906	High Impact Research MOHE Grant from the Ministry of Education Malaysia [UM.C/625/1/HIR/MOHE/ENG/35 (D000035-16001)]	High Impact Research MOHE Grant from the Ministry of Education Malaysia	This research is supported by High Impact Research MOHE Grant UM.C/625/1/HIR/MOHE/ENG/35 (D000035-16001) from the Ministry of Education Malaysia. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghdaie MH, 2013, INZ EKON, V24, P5, DOI 10.5755/j01.ee.24.1.2822; Anand G, 2011, J ADV MANAG RES, V8, P123, DOI 10.1108/09727981111129336; [Anonymous], [No title captured]; [Anonymous], 2013, TOPSIS METHOD MULTIP; Avikal S, 2014, INT J PROD RES, V52, P1306, DOI 10.1080/00207543.2013.831999; Balezentiene L, 2012, SCI WORLD J, DOI 10.1100/2012/908384; Bazzazi AA, 2011, EXPERT SYST APPL, V38, P2550, DOI 10.1016/j.eswa.2010.08.043; Bose G., 2013, INT J IND ENG COMP, V4, P535, DOI [10.5267/j.ijiec.2013.06.002, DOI 10.5267/J.IJIEC.2013.06.002]; Bulut E, 2015, APPL MATH MODEL, V39, P913, DOI 10.1016/j.apm.2014.07.018; Candan G, 2015, INT J PROD RES, V53, P897, DOI 10.1080/00207543.2014.939244; Chan FTS, 2001, J MATER PROCESS TECH, V116, P137, DOI 10.1016/S0924-0136(01)01038-X; Chang D.Y., 1992, OPTIM TECH APPL, V1, P352; Chang DY, 1996, EUR J OPER RES, V95, P649, DOI 10.1016/0377-2217(95)00300-2; Chatterjee P., 2013, INT J MAT SCI ENG, V1, P104, DOI DOI 10.12720/IJMSE.1.2.104-111; Chen CT, 2000, FUZZY SET SYST, V114, P1, DOI 10.1016/S0165-0114(97)00377-1; Chen JF, 2015, APPL SOFT COMPUT, V28, P100, DOI 10.1016/j.asoc.2014.11.050; CHU HK, 1995, INT J PROD RES, V33, P3311, DOI 10.1080/00207549508904876; Dadelo S, 2012, ECON COMPUT ECON CYB, V46, P65; Demirel T, 2008, SPRINGER SER OPTIM A, V16, P53; Deng XY, 2014, EXPERT SYST APPL, V41, P156, DOI 10.1016/j.eswa.2013.07.018; Deng Y., 2012, J INF COMPUT SCI, V9, P2421; Fonseca DJ, 2004, EXPERT SYST APPL, V26, P615, DOI 10.1016/j.eswa.2003.12.011; Ghadikolaei A. S., 2014, B SOC PARANAENSE MAT, V32, P163; Hadi-Vencheh A, 2015, INT J COMPUT INTEG M, V28, P534, DOI 10.1080/0951192X.2014.880948; Hassan MMD, 2010, J MANUF TECHNOL MANA, V21, P246, DOI 10.1108/17410381011014396; Hosny O, 2013, ENG CONSTR ARCHIT MA, V20, P381, DOI 10.1108/ECAM-09-2011-0088; Hung YH, 2011, DECIS SUPPORT SYST, V51, P270, DOI 10.1016/j.dss.2010.11.021; Nguyen HT, 2014, EXPERT SYST APPL, V41, P3078, DOI 10.1016/j.eswa.2013.10.039; Kersuliene V, 2014, PROCD SOC BEHV, V110, P897, DOI 10.1016/j.sbspro.2013.12.935; Kersuliene V, 2014, J BUS ECON MANAG, V15, P232, DOI 10.3846/16111699.2014.903201; Kulak O, 2005, EXPERT SYST APPL, V29, P310, DOI 10.1016/j.eswa.2005.04.004; Kutut V, 2014, ARCH CIV MECH ENG, V14, P287, DOI 10.1016/j.acme.2013.10.007; Kutut V, 2013, PROCEDIA ENGINEER, V57, P657, DOI 10.1016/j.proeng.2013.04.083; Lashgari A, 2012, INZ EKON, V23, P125, DOI 10.5755/j01.ee.23.2.1544; Mardani A, 2015, EXPERT SYST APPL, V42, P4126, DOI 10.1016/j.eswa.2015.01.003; Maruthur NM, 2015, PLOS ONE, V10; Mavi Reza Kiani, 2015, International Journal of Services and Operations Management, V22, P165; Mousavi SM, 2014, INT J COMPUT INTEG M, V27, P547, DOI 10.1080/0951192X.2013.834460; Nguyen HT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133599; Onut S, 2009, INT J ADV MANUF TECH, V44, P818, DOI 10.1007/s00170-008-1897-3; Opricovic S, 2004, EUR J OPER RES, V156, P445, DOI 10.1016/s0377-2217(03)00020-1; Prakash C, 2015, J MANUFACTURING SYST; Punnakitikashem P, 2010, INT J QUAL RELIAB MA, V27, P1021, DOI 10.1108/02656711011084819; Rao RV, 2007, SPRINGER SER ADV MAN, P1, DOI 10.1007/978-1-84628-819-7; Rossi D, 2013, INT J IND ERGONOM, V43, P314, DOI 10.1016/j.ergon.2013.04.009; Saaty TL., 2008, INT J SERV SCI, V1, P2008, DOI [DOI 10.1504/IJSSCI.2008.017590, 10.1504/IJSSCI.2008.017590]; Safaei Ghadikolaei A, 2014, TECHNOL ECON DEV ECO, V20, P274, DOI 10.3846/20294913.2014.913274; Saghafian S, 2005, COMPUTATIONAL INTELL; Saputro TE, 2015, INT J PROD RES, P1; Shariati S, 2014, INZ EKON, V25, P410; Sliogeriene J, 2013, ENRGY PROCED, V32, P11, DOI 10.1016/j.egypro.2013.05.003; Su XY, 2015, RISK ANAL, V35, P1296, DOI 10.1111/risa.12347; Taylan O, 2014, APPL SOFT COMPUT, V17, P105, DOI 10.1016/j.asoc.2014.01.003; Tompkins J. A., 2010, FACILITIES PLANNING, V4th; Tupenaite L, 2010, J CIV ENG MANAG, V16, P257, DOI 10.3846/jcem.2010.30; Turskis Z, 2013, INT J INF TECH DECIS, V12, P45, DOI 10.1142/S021962201350003X; Turskis Z, 2012, J ENVIRON ENG LANDSC, V20, P110, DOI 10.3846/16486897.2011.645827; Turskis Z, 2010, INFORMATICA-LITHUAN, V21, P597; Turskis Z, 2010, TRANSPORT-VILNIUS, V25, P423, DOI 10.3846/transport.2010.52; Tuzkaya G, 2010, EXPERT SYST APPL, V37, P2853, DOI 10.1016/j.eswa.2009.09.004; Udhayakumar P, 2010, INT J ADV MANUF TECH, V50, P1075, DOI 10.1007/s00170-010-2583-9; Wang YM, 2011, INT J APPROX REASON, V52, P541, DOI 10.1016/j.ijar.2010.12.004; Wu Q, 2012, MANAG PROD ENG REV, V3, P62, DOI 10.2478/v10270-012-0007-z; Yazdani-Chamzini A, 2014, J CIV ENG MANAG, V20, P660, DOI 10.3846/13923730.2013.802714; Yi XB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069498; Yong D, 2006, INT J ADV MANUF TECH, V28, P839, DOI 10.1007/s00170-004-2436-5; Yusuff RM, 2001, ROBOT CIM-INT MANUF, V17, P421, DOI 10.1016/S0736-5845(01)00016-3; ZADEH LA, 1965, INFORM CONTROL, V8, P338, DOI 10.1016/S0019-9958(65)90241-X; Zamani M, 2014, J BUS ECON MANAG, V15, P403, DOI 10.3846/16111699.2014.923929; Zavadskas EK, 2010, ARCH CIV MECH ENG, V10, P123, DOI 10.1016/S1644-9665(12)60141-1; Zavadskas EK, 2015, APPL SOFT COMPUT, V26, P180, DOI 10.1016/j.asoc.2014.09.019; Zavadskas EK, 2012, J CIV ENG MANAG, V18, P834, DOI 10.3846/13923730.2012.744537; Zavadskas EK, 2012, INT J INF TECH DECIS, V11, P501, DOI 10.1142/S0219622012400135; Zavadskas EK, 2010, TECHNOL ECON DEV ECO, V16, P159, DOI 10.3846/tede.2010.10; Zhang XG, 2015, APPL INTELL, V43, P760, DOI 10.1007/s10489-015-0664-z	75	40	40	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0153222	10.1371/journal.pone.0153222	http://dx.doi.org/10.1371/journal.pone.0153222			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27070543	Green Published, gold			2022-12-27	WOS:000373900700038
J	Al-Khanbashi, M; Caramuta, S; Alajmi, AM; Al-Haddabi, I; Al-Riyami, M; Lui, WO; Al-Moundhri, MS				Al-Khanbashi, Manal; Caramuta, Stefano; Alajmi, Adil M.; Al-Haddabi, Ibrahim; Al-Riyami, Marwa; Lui, Weng-Onn; Al-Moundhri, Mansour S.			Tissue and Serum miRNA Profile in Locally Advanced Breast Cancer (LABC) in Response to Neo-Adjuvant Chemotherapy (NAC) Treatment	PLOS ONE			English	Article							LYMPH-NODE METASTASIS; GENE-EXPRESSION; DOWN-REGULATION; POTENTIAL ROLE; TUMOR RELAPSE; MICRORNA; SURVIVAL; MIR-21; IDENTIFICATION; BIOMARKERS	Introduction MicroRNAs (miRNAs) are small non-coding RNA that plays a vital role in cancer progression. Neo-adjuvant chemotherapy (NAC) has become the standard of care for locally advanced breast cancer. The aim of this study was to evaluate miRNA alterations during NAC using multiple samples of tissue and serum to correlate miRNA expression with clinico-pathological features and patient outcomes. Methods Tissue and serum samples were collected from patients with locally advanced breast cancer undergoing NAC at four time points: time of diagnosis, after the first and fourth cycle of doxorubicin/cyclophosphamide treatment, and after the fourth cycle of docetaxel administration. First, we evaluated the miRNA expression profiles in tissue and correlated expression with clinico-pathological features. Then, a panel of four miRNAs (miR-451, miR-3200, miR-21, and miR-205) in serum samples was further validated using quantitative reverse-transcription polymerase chain reaction (RT-qPCR). The alterations in serum levels of miRNA, associations with clinical and pathological responses, correlation with clinico-pathological features, and survival outcomes were studied using Friedman, Mann-Whitney U, and Spearman, Wilcoxon signed-ranks tests. P <= 0.05 was considered statistically significant. Results We analyzed 72 tissue samples and 108 serum samples from 9 patients and 27 patients, respectively. MicroRNA expression profiling of tumor versus normal tissue revealed more than 100 differentially expressed miRNAs. Serum miR-451 levels were significantly decreased during treatment, and higher serum levels were associated with improved clinical and pathological responses and disease-free survival. This is one of the early reports on miR-3200 in response to treatment in breast cancer, as serum levels of miR-3200 found to decline during NAC, and higher serum levels were associated with lower residual breast cancer burden and relapse rates at time of diagnosis. Conclusion Variations in serum miRNA levels during NAC treatment may be therapeutically significant for predicting response and survival outcomes.	[Al-Khanbashi, Manal; Al-Moundhri, Mansour S.] Sultan Qaboos Univ, Dept Med, Coll Med & Hlth Sci, Med Oncol Unit, Muscat, Oman; [Caramuta, Stefano; Lui, Weng-Onn] Karolinska Inst, Karolinska Univ Hosp Solna, Dept Oncol Pathol, Canc Ctr Karolinska, Stockholm, Sweden; [Alajmi, Adil M.] Sultan Qaboos Univ, Dept Surg, Coll Med & Hlth Sci, Muscat, Oman; [Al-Haddabi, Ibrahim; Al-Riyami, Marwa] Sultan Qaboos Univ, Dept Pathol, Coll Med, Muscat, Oman	Sultan Qaboos University; Karolinska Institutet; Karolinska University Hospital; Sultan Qaboos University; Sultan Qaboos University	Al-Moundhri, MS (corresponding author), Sultan Qaboos Univ, Dept Med, Coll Med & Hlth Sci, Med Oncol Unit, Muscat, Oman.	mansours@squ.edu.om	Lui, Weng-Onn/X-5957-2019; Lui, Weng-Onn/G-6703-2013	Lui, Weng-Onn/0000-0003-4717-4473; Lui, Weng-Onn/0000-0003-4717-4473; Al-Moundhri, Mansour/0000-0003-3963-1232	Oman research council; Research Council, Sultanate of Oman [RC/MED/MEDI/11/01]	Oman research council(Ministry of Higher Education, Research & Innovation, OmanThe Research Council Oman); Research Council, Sultanate of Oman(Ministry of Higher Education, Research & Innovation, OmanThe Research Council Oman)	The study is funded by Oman research council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to acknowledge Dr. Amal Gadalla for her guidance in some of the statistical analyses and Dr. Andreas Montelius and Mr. Jonathan Mustonen for their assistance in depositing microarray data. We also would like to thank the core facility at Novum, BEA, Bioinformatics and Expression Analysis, which is supported by the board of research at the Karolinska Institute and the research committee at the Karolinska hospital. We also thank our colleagues in Medical Oncology Unit at Sultan Qaboos University Hospital for their support. This work was funded and supported by the Research Council, Sultanate of Oman (RC/MED/MEDI/11/01).	Asaga S, 2011, CLIN CHEM, V57, P84, DOI 10.1373/clinchem.2010.151845; Ashish B A, 2005, J CANCER RES THER, V1, P21; Bisso A, 2013, CELL CYCLE, V12, P1679, DOI 10.4161/cc.24757; Burgos KL, 2013, RNA, V19, P712, DOI 10.1261/rna.036863.112; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Cance WG, 2002, ANN SURG, V236, P295, DOI 10.1097/00000658-200209000-00006; D'Ippolito E, 2013, INT J MOL SCI, V14, P22202, DOI 10.3390/ijms141122202; de Planell-Saguer M, 2013, CLIN BIOCHEM, V46, P869, DOI 10.1016/j.clinbiochem.2013.02.017; Edge SB, 2010, AJCC CANC STAGING MA; Fabbri M, 2008, CANCER J, V14, P1, DOI 10.1097/PPO.0b013e318164145e; Freres R, 2014, EUR J CANCER, V50, P53; Hamfjord J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034150; Heneghan HM, 2010, ANN SURG, V251, P499, DOI 10.1097/SLA.0b013e3181cc939f; Hu ZB, 2012, CARCINOGENESIS, V33, P828, DOI 10.1093/carcin/bgs030; Hutchinson L, 2010, NAT REV CLIN ONCOL, V7, P669, DOI 10.1038/nrclinonc.2010.192; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Kalniete D, 2013, ACTA CHIRURG LATVIE, V13, P7; Kang WK, 2015, BMC GASTROENTEROL, V15, DOI 10.1186/s12876-015-0227-0; Khokher S, 2012, ASIAN PAC J CANCER P, V13, P3213, DOI 10.7314/APJCP.2012.13.7.3213; Kjersem JB, 2014, MOL ONCOL, V8, P59, DOI 10.1016/j.molonc.2013.09.001; Kovalchuk O, 2008, MOL CANCER THER, V7, P2152, DOI 10.1158/1535-7163.MCT-08-0021; Lee DY, 2007, P NATL ACAD SCI USA, V104, P20350, DOI 10.1073/pnas.0706901104; Lee MC, 2007, SURG CLIN N AM, V87, P379, DOI 10.1016/j.suc.2007.01.012; Majid S, 2010, CANCER RES, V70, P2809, DOI 10.1158/0008-5472.CAN-09-4176; Mattie MD, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-24; Molnar V, 2008, SEMIN CANCER BIOL, V18, P111, DOI 10.1016/j.semcancer.2008.01.001; Nahleh Z, 2008, CURR ONCOL, V15, P271; Ng EKO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053141; Pan X, 2013, MOL CANCER THER, V12, P1153, DOI 10.1158/1535-7163.MCT-12-0802; Peltier HJ, 2008, RNA, V14, P844, DOI 10.1261/rna.939908; Sahlberg KK, 2015, CLIN CANCER RES, V21, P1207, DOI 10.1158/1078-0432.CCR-14-2011; Scarpati GDV, 2014, BIOMED RES INT, V2014, P8; To KKW, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-99; Vageli D., 2013, EUR RESPIR J, V42, P4639; Van der Auwera I, 2010, BRIT J CANCER, V103, P532, DOI 10.1038/sj.bjc.6605787; van Schooneveld E, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0526-y; Wang B, 2014, IUBMB LIFE, V66, P371, DOI 10.1002/iub.1273; Wang FJ, 2010, GYNECOL ONCOL, V119, P586, DOI 10.1016/j.ygyno.2010.07.021; Wang GN, 2015, ANN LAB MED, V35, P226, DOI 10.3343/alm.2015.35.2.226; Wickramasinghe NS, 2009, NUCLEIC ACIDS RES, V37, P2584, DOI 10.1093/nar/gkp117; Xiong YZ, 2013, CLIN VACCINE IMMUNOL, V20, P1089, DOI 10.1128/CVI.00044-13; Xu HD, 2014, CELL BIOCHEM BIOPHYS, V69, P163, DOI 10.1007/s12013-013-9783-5; Yan LX, 2008, RNA, V14, P2348, DOI 10.1261/rna.1034808; Yang XW, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-909; Zhu Weizhu, 2009, BMC Res Notes, V2, P89, DOI 10.1186/1756-0500-2-89	46	38	40	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2016	11	4							e0152032	10.1371/journal.pone.0152032	http://dx.doi.org/10.1371/journal.pone.0152032			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0KH	27064979	Green Published, gold			2022-12-27	WOS:000373891000008
J	Bizzarri, M; Giudici, P; Cassanelli, S; Solieri, L				Bizzarri, Melissa; Giudici, Paolo; Cassanelli, Stefano; Solieri, Lisa			Chimeric Sex-Determining Chromosomal Regions and Dysregulation of Cell-Type Identity in a Sterile Zygosaccharomyces Allodiploid Yeast	PLOS ONE			English	Article							HETEROTHALLIC HAPLOID YEAST; MATING-TYPE GENES; COMPARATIVE GENOMICS; POPULATION GENOMICS; HYBRID STERILITY; LIFE-CYCLE; HO GENE; EVOLUTION; PROTEIN; ROUXII	Allodiploidization is a fundamental yet evolutionarily poorly characterized event, which impacts genome evolution and heredity, controlling organismal development and polyploid cell-types. In this study, we investigated the sex determination system in the allodiploid and sterile ATCC 42981 yeast, a member of the Zygosaccharomyces rouxii species complex, and used it to study how a chimeric mating-type gene repertoire contributes to hybrid reproductive isolation. We found that ATCC 42981 has 7 MAT-like (MTL) loci, 3 of which encode alpha-idiomorph and 4 encode a-idiomorph. Two phylogenetically divergent MAT expression loci were identified on different chromosomes, accounting for a hybrid a/alpha genotype. Furthermore, extra a-idimorph-encoding loci (termed MTLa copies 1 to 3) were recognized, which shared the same MATa1 ORFs but diverged for MATa2 genes. Each MAT expression locus was linked to a HML silent cassette, while the corresponding HMR loci were located on another chromosome. Two putative parental sex chromosome pairs contributed to this unusual genomic architecture: one came from an as-yet-undescribed taxon, which has the NCYC 3042 strain as a unique representative, while the other did not match any MAT-HML and HMR organizations previously described in Z. rouxii species. This chimeric rearrangement produces two copies of the HO gene, which encode for putatively functional endonucleases essential for mating-type switching. Although both a and a coding sequences, which are required to obtain a functional cell-type a1-alpha 2 regulator, were present in the allodiploid ATCC 42981 genome, the transcriptional circuit, which regulates entry into meiosis in response to meiosis-inducing salt stress, appeared to be turned off. Furthermore, haploid and a-specific genes, such as MAT alpha 1 and HO, were observed to be actively transcribed and up-regulated under hypersaline stress. Overall, these evidences demonstrate that ATCC 42981 is unable to repress haploid a-specific genes and to activate meiosis in response to stress. We argue that sequence divergence within the chimeric a1-alpha 2 heterodimer could be involved in the generation of negative epistasis, contributing to the allodiploid sterility and the dysregulation of cell identity.	[Bizzarri, Melissa; Giudici, Paolo; Cassanelli, Stefano; Solieri, Lisa] Univ Modena & Reggio Emilia, Dept Life Sci, Via Amendola 2, I-42122 Reggio Emilia, Italy	Universita di Modena e Reggio Emilia	Solieri, L (corresponding author), Univ Modena & Reggio Emilia, Dept Life Sci, Via Amendola 2, I-42122 Reggio Emilia, Italy.	lisa.solieri@unimore.it	Solieri, Lisa/I-4352-2012	Solieri, Lisa/0000-0003-3546-6903				Alipaz JA, 2005, AM NAT, V165, P429, DOI 10.1086/428407; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anderson JS, 2000, BIOCHEMISTRY-US, V39, P10045, DOI 10.1021/bi000677z; Baker CR, 2012, CELL, V151, P80, DOI 10.1016/j.cell.2012.08.018; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bayes JJ, 2009, SCIENCE, V326, P1538, DOI 10.1126/science.1181756; Belfort M, 1997, NUCLEIC ACIDS RES, V25, P3379, DOI 10.1093/nar/25.17.3379; Brideau NJ, 2006, SCIENCE, V314, P1292, DOI 10.1126/science.1133953; Butler G, 2004, P NATL ACAD SCI USA, V101, P1632, DOI 10.1073/pnas.0304170101; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; COVITZ PA, 1991, GENE DEV, V5, P1982, DOI 10.1101/gad.5.11.1982; Coyne J.A., 2004, SPECIATION; Dettman JR, 2007, NATURE, V447, P585, DOI 10.1038/nature05856; Dunn B, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003366; Fabre E, 2005, MOL BIOL EVOL, V22, P856, DOI 10.1093/molbev/msi070; Friedrich A, 2015, MOL BIOL EVOL, V32, P184, DOI 10.1093/molbev/msu295; Gelfand B, 2011, MOL CELL BIOL, V31, P1701, DOI 10.1128/MCB.01071-10; Goossens KVY, 2015, MBIO, V6, DOI 10.1128/mBio.00427-15; Gordon JL, 2008, YEAST, V25, P449, DOI 10.1002/yea.1598; Gordon JL, 2011, P NATL ACAD SCI USA, V108, P20024, DOI 10.1073/pnas.1112808108; GOUTTE C, 1988, CELL, V52, P875, DOI 10.1016/0092-8674(88)90429-1; Granek JA, 2011, CURR OPIN MICROBIOL, V14, P676, DOI 10.1016/j.mib.2011.09.004; Haber JE, 2012, GENETICS, V191, P33, DOI 10.1534/genetics.111.134577; Hafez M, 2012, GENOME, V55, P553, DOI [10.1139/G2012-049, 10.1139/g2012-049]; HARASHIMA S, 1989, MOL CELL BIOL, V9, P4523, DOI 10.1128/MCB.9.10.4523; Heitman J, 2009, NATURE, V460, P807, DOI 10.1038/460807a; HERSKOWITZ I, 1988, MICROBIOL REV, V52, P536, DOI 10.1128/MMBR.52.4.536-553.1988; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; Hongay CF, 2006, CELL, V127, P735, DOI 10.1016/j.cell.2006.09.038; Hunter N, 1996, EMBO J, V15, P1726, DOI 10.1002/j.1460-2075.1996.tb00518.x; James SA, 2005, FEMS YEAST RES, V5, P747, DOI 10.1016/j.femsyr.2005.02.004; Johnson NA, 2010, TRENDS GENET, V26, P317, DOI 10.1016/j.tig.2010.04.005; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Kinclova O, 2001, J BIOTECHNOL, V88, P151, DOI 10.1016/S0168-1656(01)00274-7; Knop M, 2006, BIOESSAYS, V28, P696, DOI 10.1002/bies.20435; KUES U, 1992, MYCOL RES, V96, P993; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leandro MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068165; Lee HY, 2008, CELL, V135, P1065, DOI 10.1016/j.cell.2008.10.047; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mallona I, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-404; Marcet-Houben M, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002220; Martin T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015199; Mathias JR, 2004, NUCLEIC ACIDS RES, V32, P6469, DOI 10.1093/nar/gkh985; MITCHELL AP, 1986, NATURE, V319, P738, DOI 10.1038/319738a0; MORI H, 1967, APPL MICROBIOL, V15, P928, DOI 10.1128/AEM.15.4.928-934.1967; MORI H, 1973, J FERMENT TECHNOL, V51, P379; Nolte AW, 2010, TRENDS GENET, V26, P54, DOI 10.1016/j.tig.2009.12.001; Orr HA, 2001, EVOLUTION, V55, P1085; Otto SP, 2008, CURR BIOL, V18, pR1121, DOI 10.1016/j.cub.2008.09.039; Piatkowska EM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003836; Pribylova L, 2007, YEAST, V24, P171, DOI 10.1002/yea.1470; Rajaei N, 2014, P NATL ACAD SCI USA, V111, P15491, DOI 10.1073/pnas.1406027111; Rieseberg LH, 2003, SCIENCE, V301, P1211, DOI 10.1126/science.1086949; Ruderfer DM, 2006, NAT GENET, V38, P1077, DOI 10.1038/ng1859; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Scannell DR, 2007, YEAST, V24, P929, DOI 10.1002/yea.1515; SHAH JC, 1992, MOL CELL BIOL, V12, P1078, DOI 10.1128/MCB.12.3.1078; SILICIANO PG, 1984, CELL, V37, P969, DOI 10.1016/0092-8674(84)90431-8; Solieri L, 2014, G3-GENES GENOM GENET, V4, P1011, DOI 10.1534/g3.114.010405; Solieri L, 2014, FEMS YEAST RES, V14, P586, DOI 10.1111/1567-1364.12146; Solieri L, 2013, FEMS YEAST RES, V13, P245, DOI 10.1111/1567-1364.12027; Solieri L, 2013, INT J SYST EVOL MICR, V63, P364, DOI 10.1099/ijs.0.043323-0; Solieri L, 2008, FUNGAL GENET BIOL, V45, P1582, DOI 10.1016/j.fgb.2008.10.001; Souciet JL, 2009, GENOME RES, V19, P1696, DOI 10.1101/gr.091546.109; Steensels J, 2014, FEMS MICROBIOL REV, V38, P947, DOI 10.1111/1574-6976.12073; STERNBERG PW, 1987, CELL, V48, P567, DOI 10.1016/0092-8674(87)90235-2; Stoddard BL, 2005, Q REV BIOPHYS, V38, P49, DOI 10.1017/S0033583505004063; STRATHERN J, 1988, GENETICS, V120, P75; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tsai IJ, 2008, P NATL ACAD SCI USA, V105, P4957, DOI 10.1073/pnas.0707314105; Tuch BB, 2008, PLOS BIOL, V6, P352, DOI 10.1371/journal.pbio.0060038; Van de Peer Y, 2009, NAT REV GENET, V10, P725, DOI 10.1038/nrg2600; van Dyk D, 2003, GENETICS, V165, P1045; Watanabe J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062121; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; WOLBERGER C, 1991, CELL, V67, P517, DOI 10.1016/0092-8674(91)90526-5; Wolfe KH, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002221; Wolfe KH, 2001, NAT REV GENET, V2, P333, DOI 10.1038/35072009; Zhao S, 2005, J COMPUT BIOL, V12, P1047, DOI 10.1089/cmb.2005.12.1047; Zorgo E, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003388	81	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2016	11	4							e0152558	10.1371/journal.pone.0152558	http://dx.doi.org/10.1371/journal.pone.0152558			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0KH	27065237	Green Published, Green Submitted, gold			2022-12-27	WOS:000373891000012
J	Zhang, HQ; Liu, ZK; Chen, H; Tang, M				Zhang, Haoqiang; Liu, Zhenkun; Chen, Hui; Tang, Ming			Symbiosis of Arbuscular Mycorrhizal Fungi and Robinia pseudoacacia L. Improves Root Tensile Strength and Soil Aggregate Stability	PLOS ONE			English	Article							BLACK LOCUST; LOESS PLATEAU; FUNCTIONAL DIVERSITY; SLOPE STABILITY; PLANT-GROWTH; GLOMALIN; NITROGEN; PROTEIN; PHOSPHORUS; DROUGHT	Robinia pseudoacacia L. (black locust) is a widely planted tree species on Loess Plateau for revegetation. Due to its symbiosis forming capability with arbuscular mycorrhizal (AM) fungi, we explored the influence of arbuscular mycorrhizal fungi on plant biomass, root morphology, root tensile strength and soil aggregate stability in a pot experiment. We inoculated R. pseudoacacia with/without AM fungus (Rhizophagus irregularis or Glomus versiforme), and measured root colonization, plant growth, root morphological characters, root tensile force and tensile strength, and parameters for soil aggregate stability at twelve weeks after inoculation. AM fungi colonized more than 70% plant root, significantly improved plant growth. Meanwhile, AM fungi elevated root morphological parameters, root tensile force, root tensile strength, Glomalin-related soil protein (GRSP) content in soil, and parameters for soil aggregate stability such as water stable aggregate (WSA), mean weight diameter (MWD) and geometric mean diameter (GMD). Root length was highly correlated with WSA, MWD and GMD, while hyphae length was highly correlated with GRSP content. The improved R. pseudoacacia growth, root tensile strength and soil aggregate stability indicated that AM fungi could accelerate soil fixation and stabilization with R. pseudoacacia, and its function in revegetation on Loess Plateau deserves more attention.	[Zhang, Haoqiang; Liu, Zhenkun; Chen, Hui; Tang, Ming] Northwest A&F Univ, Coll Forestry, Yangling 712100, Shaanxi, Peoples R China	Northwest A&F University - China	Tang, M (corresponding author), Northwest A&F Univ, Coll Forestry, Yangling 712100, Shaanxi, Peoples R China.	tangm@nwsuaf.edu.cn		Tang, Ming/0000-0002-8158-6300	Special Fund for Forest Scientific Research in the Public Welfare [201404217]; National Natural Science Foundation of China [31270639, 31170567]; Program for Changjiang Scholars and Innovative Research Team in University of China [IRT1035]; Northwest A & F University doctoral research start-up fund [Z109021503]	Special Fund for Forest Scientific Research in the Public Welfare; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in University of China(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Northwest A & F University doctoral research start-up fund	This research was supported by Special Fund for Forest Scientific Research in the Public Welfare (201404217), the National Natural Science Foundation of China (31270639 and 31170567), the Program for Changjiang Scholars and Innovative Research Team in University of China (IRT1035), and Northwest A & F University doctoral research start-up fund (Z109021503). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT LK, 1984, NEW PHYTOL, V97, P437, DOI 10.1111/j.1469-8137.1984.tb03609.x; An SS, 2010, CATENA, V81, P226, DOI 10.1016/j.catena.2010.04.002; Auge RM, 2004, CAN J SOIL SCI, V84, P373, DOI 10.4141/S04-002; Auge RM, 2001, MYCORRHIZA, V11, P3, DOI 10.1007/s005720100097; Auge RM, 2001, PLANT SOIL, V230, P87, DOI 10.1023/A:1004891210871; Avio L, 2006, NEW PHYTOL, V172, P347, DOI 10.1111/j.1469-8137.2006.01839.x; Balat M, 2010, ENERG EXPLOR EXPLOIT, V28, P173, DOI 10.1260/0144-5987.28.3.173; Bedini S, 2009, SOIL BIOL BIOCHEM, V41, P1491, DOI 10.1016/j.soilbio.2009.04.005; BONFANTEFASOLO P, 1990, PLANTA, V180, P537, DOI 10.1007/BF02411452; Brown LK, 2013, PLANT SOIL, V372, P195, DOI 10.1007/s11104-013-1718-9; Bucking H, 2005, NEW PHYTOL, V165, P899, DOI 10.1111/j.1469-8137.2004.01274.x; Cierjacks A, 2013, J ECOL, V101, P1623, DOI 10.1111/1365-2745.12162; Dalby R, 2004, AM BEE J, V144, P382; De Baets S, 2008, PLANT SOIL, V305, P207, DOI 10.1007/s11104-008-9553-0; Driver JD, 2005, SOIL BIOL BIOCHEM, V37, P101, DOI 10.1016/j.soilbio.2004.06.011; Duiker SW, 2001, CATENA, V45, P103, DOI 10.1016/S0341-8162(01)00145-X; Fokom R, 2012, SOIL TILL RES, V120, P69, DOI 10.1016/j.still.2011.11.004; Gao J., 2006, EXPT GUIDANCE PLANT; Genet M, 2005, PLANT SOIL, V278, P1, DOI 10.1007/s11104-005-8768-6; GEORGE E, 1995, CRIT REV BIOTECHNOL, V15, P257, DOI 10.3109/07388559509147412; GILLESPIE AR, 1990, SOIL SCI SOC AM J, V54, P538, DOI 10.2136/sssaj1990.03615995005400020042x; GIOVANNETTI M, 1980, NEW PHYTOL, V84, P489, DOI 10.1111/j.1469-8137.1980.tb04556.x; Gong MG, 2012, ANN MICROBIOL, V62, P1579, DOI 10.1007/s13213-011-0413-4; Gonzalez-Garcia S, 2011, INT J LIFE CYCLE ASS, V16, P465, DOI 10.1007/s11367-011-0272-z; Gray DH, 1996, BIOTECHNICAL SOIL BI; Grunewald H, 2009, BIOENERG RES, V2, P123, DOI 10.1007/s12155-009-9038-x; Guo XiaoPing, 2005, Forestry Studies in China, V7, P57, DOI 10.1007/s11632-005-0023-y; Hallett PD, 2009, PLANT SOIL, V314, P183, DOI 10.1007/s11104-008-9717-y; HOAGLAND D. R., 1950, Circular. California Agricultural Experiment Station, V347; Hohnjec N, 2005, PLANT PHYSIOL, V137, P1; Li T, 2014, MYCORRHIZA, V24, P595, DOI 10.1007/s00572-014-0578-3; MARSCHNER H, 1994, PLANT SOIL, V159, P89, DOI 10.1007/BF00000098; MILLER RM, 1990, SOIL BIOL BIOCHEM, V22, P579, DOI 10.1016/0038-0717(90)90001-G; Olesniewicz KS, 1999, NEW PHYTOL, V142, P133, DOI 10.1046/j.1469-8137.1999.00372.x; Operstein V., 2000, PROC INST CIV ENG-GR, V4, P81, DOI DOI 10.1680/GRIM.2000.4.2.81; PHILLIPS JM, 1970, T BRIT MYCOL SOC, V55, P158, DOI 10.1016/S0007-1536(70)80110-3; Pregitzer KS, 2002, ECOL MONOGR, V72, P293, DOI 10.1890/0012-9615(2002)072[0293:FRAONN]2.0.CO;2; Purin S, 2007, PEDOBIOLOGIA, V51, P123, DOI 10.1016/j.pedobi.2007.03.002; Qiu LP, 2010, PLANT SOIL, V332, P207, DOI 10.1007/s11104-010-0286-5; Reubens B, 2007, TREES-STRUCT FUNCT, V21, P385, DOI 10.1007/s00468-007-0132-4; Rice SK, 2004, PLANT ECOL, V174, P97, DOI 10.1023/B:VEGE.0000046049.21900.5a; Rillig MC, 2006, NEW PHYTOL, V171, P41, DOI 10.1111/j.1469-8137.2006.01750.x; Rillig MC, 2004, CAN J SOIL SCI, V84, P355, DOI 10.4141/S04-003; Rillig MC, 2002, PLANT SOIL, V238, P325, DOI 10.1023/A:1014483303813; Schroeder MS, 2005, MYCORRHIZA, V15, P203, DOI 10.1007/s00572-004-0324-3; Schussler A., 2010, GLOMEROMYCOTA SPECIE; SCHWEIGER PF, 1995, NEW PHYTOL, V131, P247, DOI 10.1111/j.1469-8137.1995.tb05726.x; Sheng M, 2009, CAN J MICROBIOL, V55, P879, DOI [10.1139/W09-031, 10.1139/w09-031]; Six J, 2004, SOIL TILL RES, V79, P7, DOI 10.1016/j.still.2004.03.008; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Smith SE, 2004, NEW PHYTOL, V162, P511, DOI 10.1111/j.1469-8137.2004.01039.x; Staddon PL, 2003, SCIENCE, V300, P1138, DOI 10.1126/science.1084269; Tateno R, 2007, FOREST ECOL MANAG, V241, P84, DOI 10.1016/j.foreco.2006.12.026; Tosi M, 2007, GEOMORPHOLOGY, V87, P268, DOI 10.1016/j.geomorph.2006.09.019; Ussiri DAN, 2006, SOIL SCI SOC AM J, V70, P1797, DOI 10.2136/sssaj2005.0352; Wang B, 2012, ENVIRON EARTH SCI, V65, P597, DOI 10.1007/s12665-011-1107-8; Wang S, 2014, SCI HORTIC-AMSTERDAM, V170, P137, DOI 10.1016/j.scienta.2014.03.003; Wright SF, 1998, SOIL BIOL BIOCHEM, V30, P1853, DOI 10.1016/S0038-0717(98)00047-9; Wright SF, 1996, SOIL SCI, V161, P575, DOI 10.1097/00010694-199609000-00003; Wu QS, 2012, SOIL BIOL BIOCHEM, V45, P181, DOI 10.1016/j.soilbio.2011.10.002; Wu QS, 2008, EUR J SOIL BIOL, V44, P122, DOI 10.1016/j.ejsobi.2007.10.001; Yang YR, 2014, J PLANT GROWTH REGUL, V33, P612, DOI 10.1007/s00344-013-9410-0; Zhang HQ, 2014, MYCORRHIZA, V24, P419, DOI 10.1007/s00572-013-0553-4	63	26	30	13	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2016	11	4							e0153378	10.1371/journal.pone.0153378	http://dx.doi.org/10.1371/journal.pone.0153378			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0KH	27064570	gold, Green Published, Green Submitted			2022-12-27	WOS:000373891000052
J	Arellano-Orden, E; Calero-Acuna, C; Moreno-Mata, N; Gomez-Izquierdo, L; Sanchez-Lopez, V; Lopez-Ramirez, C; Tobar, D; Lopez-Villalobos, JL; Gutierrez, C; Blanco-Orozco, A; Lopez-Campos, JL				Arellano-Orden, Elena; Calero-Acuna, Carmen; Moreno-Mata, Nicolas; Gomez-Izquierdo, Lourdes; Sanchez-Lopez, Veronica; Lopez-Ramirez, Cecilia; Tobar, Daniela; Luis Lopez-Villalobos, Jose; Gutierrez, Cesar; Blanco-Orozco, Ana; Luis Lopez-Campos, Jose			Cigarette Smoke Decreases the Maturation of Lung Myeloid Dendritic Cells	PLOS ONE			English	Article							SMALL AIRWAYS; ACCUMULATION; DIFFERENTIATION; LINEAGES; SUBSETS; IMPACT; COPD	Background Conflicting data exist on the role of pulmonary dendritic cells (DCs) and their maturation in patients with chronic obstructive pulmonary disease (COPD). Herein, we investigated whether disease severity and smoking status could affect the distribution and maturation of DCs in lung tissues of patients undergoing elective pneumectomy or lobectomy for suspected primary lung cancer. Materials and Methods A total of 75 consecutive patients were included. Spirometry testing was used to identify COPD. Lung parenchyma sections anatomically distant from the primary lesion were examined. We used flow cytometry to identify different DCs subtypes-including BDCA1-positive myeloid DCs (mDCs), BDCA3-positive mDCs, and plasmacytoid DCs (pDCs)-and determine their maturation markers (CD40, CD80, CD83, and CD86) in all participants. We also identified follicular DCs (fDCs), Langerhans DCs (LDCs), and pDCs in 42 patients by immunohistochemistry. Results COPD was diagnosed in 43 patients (16 current smokers and 27 former smokers), whereas the remaining 32 subjects were classified as non-COPD (11 current smokers, 13 former smokers, and 8 never smokers). The number and maturation of DCs did not differ significantly between COPD and non-COPD patients. However, the results of flow cytometry indicated that maturation markers CD40 and CD83 of BDCA1-positive mDCs were significantly decreased in smokers than in non-smokers (P = 0.023 and 0.013, respectively). Immunohistochemistry also revealed a lower number of LDCs in COPD patients than in non-COPD subjects. Conclusions Cigarette smoke, rather than airflow limitation, is the main determinant of impaired DCs maturation in the lung.	[Arellano-Orden, Elena; Calero-Acuna, Carmen; Moreno-Mata, Nicolas; Gomez-Izquierdo, Lourdes; Sanchez-Lopez, Veronica; Lopez-Ramirez, Cecilia; Tobar, Daniela; Luis Lopez-Villalobos, Jose; Gutierrez, Cesar; Blanco-Orozco, Ana; Luis Lopez-Campos, Jose] Univ Seville, Hosp Univ Virgen del Rocio, Inst Biomed Sevilla IBiS, Unidad Med Quirurg Enfermedades Resp, Seville, Spain; [Moreno-Mata, Nicolas; Luis Lopez-Villalobos, Jose; Luis Lopez-Campos, Jose] Inst Salud Carlos III, CIBER Enfermedades Resp CIBERES, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III	Arellano-Orden, E (corresponding author), Univ Seville, Hosp Univ Virgen del Rocio, Inst Biomed Sevilla IBiS, Unidad Med Quirurg Enfermedades Resp, Seville, Spain.	marellano-ibis@us.es	Bodineau, José Luis López-Campos/AAG-5203-2019	Bodineau, José Luis López-Campos/0000-0003-1703-1367; Moreno Mata, Nicolas/0000-0002-1230-068X; Gomez-Izquierdo, Lourdes/0000-0001-5918-2134; Sanchez Lopez, Veronica/0000-0001-7326-6158	Instituto de Salud Carlos III, Ministerio de Economia y Competitividad, Fondo de Investigacion Sanitaria [PS09/00826]	Instituto de Salud Carlos III, Ministerio de Economia y Competitividad, Fondo de Investigacion Sanitaria	This study was supported by a grant from the Instituto de Salud Carlos III, Ministerio de Economia y Competitividad, Fondo de Investigacion Sanitaria (project PS09/00826).	Abe M, 2006, CLIN IMMUNOL, V118, P300, DOI 10.1016/j.clim.2005.09.019; [Anonymous], 1996, Am J Respir Crit Care Med, V153, P861; Barnes PJ, 2014, CLIN CHEST MED, V35, P71, DOI 10.1016/j.ccm.2013.10.004; Barnes PJ, 2003, ANNU REV MED, V54, P113, DOI 10.1146/annurev.med.54.101601.152209; Bosma BM, 2007, CLIN EXP IMMUNOL, V149, P525, DOI 10.1111/j.1365-2249.2007.03449.x; D'hulst AI, 2005, EUR RESPIR J, V26, P204, DOI 10.1183/09031936.05.00095204; Demedts IK, 2005, AM J RESP CELL MOL, V32, P177, DOI 10.1165/rcmb.2004-0279OC; Demedts IK, 2007, AM J RESP CRIT CARE, V175, P998, DOI 10.1164/rccm.200608-1113OC; Demedts IK, 2006, AM J RESP CELL MOL, V35, P387, DOI 10.1165/rcmb.2005-0382OC; Freeman CM, 2009, AM J RESP CRIT CARE, V180, P1179, DOI 10.1164/rccm.200904-0552OC; Givi ME, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0291-6; Kheradmand F, 2009, AM J RESP CRIT CARE, V180, P1166, DOI 10.1164/rccm.200909-1391ED; Liao SX, 2015, MOL MED REP, V11, P219, DOI 10.3892/mmr.2014.2759; Liu YJ, 2001, CELL, V106, P259, DOI 10.1016/S0092-8674(01)00456-1; Lommatzsch M, 2010, EUR RESPIR J, V35, P1130, DOI 10.1183/09031936.00090109; Lommatzsch M, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-114; Masten BJ, 2006, J IMMUNOL, V177, P7784, DOI 10.4049/jimmunol.177.11.7784; Robinson SP, 1999, EUR J IMMUNOL, V29, P2769, DOI 10.1002/(SICI)1521-4141(199909)29:09<2769::AID-IMMU2769>3.0.CO;2-2; Rogers AV, 2008, THORAX, V63, P108, DOI 10.1136/thx.2007.078253; Rozkova D, 2006, CLIN IMMUNOL, V120, P260, DOI 10.1016/j.clim.2006.04.567; Shah RN, 2001, HUM PATHOL, V32, P745, DOI 10.1053/hupa.2001.25595; Shodell M, 2003, LUPUS, V12, P222, DOI 10.1191/0961203303lu362xx; Stoll P, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0174-x; Stoll P, 2014, RESP RES, V15, DOI 10.1186/1465-9921-15-48; Tsoumakidou M, 2009, INT ARCH ALLERGY IMM, V150, P389, DOI 10.1159/000226240; Tsoumakidou M, 2009, CHEST, V136, P726, DOI 10.1378/chest.08-2824; Van Pottelberge GR, 2010, EUR RESPIR J, V36, P781, DOI 10.1183/09031936.00140409; Van Pottelberge GR, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-35; Vassallo R, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-45	29	14	14	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2016	11	4							e0152737	10.1371/journal.pone.0152737	http://dx.doi.org/10.1371/journal.pone.0152737			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6JK	27058955	Green Published, gold, Green Submitted			2022-12-27	WOS:000373604800010
J	Betik, AC; Aguila, J; McConell, GK; McAinch, AJ; Mathai, ML				Betik, Andrew C.; Aguila, Jay; McConell, Glenn K.; McAinch, Andrew J.; Mathai, Michael L.			Tocotrienols and Whey Protein Isolates Substantially Increase Exercise Endurance Capacity in Diet -Induced Obese Male Sprague-Dawley Rats	PLOS ONE			English	Article							RICH FRACTION SUPPLEMENTATION; SKELETAL-MUSCLE; INSULIN SENSITIVITY; MITOCHONDRIAL BIOGENESIS; ENZYME-ACTIVITY; FAT; RESISTANCE; METABOLISM; MORTALITY; OXIDATION	Background and Aims Obesity and impairments in metabolic health are associated with reductions in exercise capacity. Both whey protein isolates (WPIs) and vitamin E tocotrienols (TCTs) exert favorable effects on obesity-related metabolic parameters. This research sought to determine whether these supplements improved exercise capacity and increased glucose tolerance in diet-induced obese rats. Methods Six week old male rats (n = 35) weighing 187 +/- 32g were allocated to either: Control (n = 9), TCT (n = 9), WPI (n = 8) or TCT + WPI (n = 9) and placed on a high-fat diet (40% of energy from fat) for 10 weeks. Animals received 50mg/kg body weight and 8% of total energy intake per day of TCTs and/or WPIs respectively. Food intake, body composition, glucose tolerance, insulin sensitivity, exercise capacity, skeletal muscle glycogen content and oxidative enzyme activity were determined. Results Both TCT and WPI groups ran >50% longer (2271 +/- 185m and 2195 +/- 265m respectively) than the Control group (1428 +/- 139m) during the run to exhaustion test (P<0.05), TCT + WPI did not further improve exercise endurance (2068 +/- 104m). WPIs increased the maximum in vitro activity of beta-hydroxyacyl-CoA in the soleus muscle (P<0.05 vs. Control) but not in the plantaris. Citrate synthase activity was not different between groups. Neither supplement had any effect on weight gain, adiposity, glucose tolerance or insulin sensitivity. Conclusion Ten weeks of both TCTs and WPIs increased exercise endurance by 50% in sedentary, diet-induced obese rats. These positive effects of TCTs and WPIs were independent of body weight, adiposity or glucose tolerance.	[Betik, Andrew C.; Aguila, Jay; McConell, Glenn K.; McAinch, Andrew J.; Mathai, Michael L.] Victoria Univ, Coll Hlth & Biomed, Ctr Chron Dis, Melbourne, Vic 8001, Australia; [Betik, Andrew C.; McConell, Glenn K.; McAinch, Andrew J.] Victoria Univ, ISEAL, Melbourne, Vic 8001, Australia	Victoria University; Victoria University	Betik, AC (corresponding author), Victoria Univ, Coll Hlth & Biomed, Ctr Chron Dis, Melbourne, Vic 8001, Australia.; Betik, AC (corresponding author), Victoria Univ, ISEAL, Melbourne, Vic 8001, Australia.	Andrew.Betik@vu.edu.au		McConell, Glenn/0000-0002-8572-9065; Betik, Andrew/0000-0001-8294-9719; McAinch, Andrew/0000-0002-8762-4865	Australian Government's Collaborative Research Networks (CRN) program	Australian Government's Collaborative Research Networks (CRN) program(Australian Government)	This research was supported through the Australian Government's Collaborative Research Networks (CRN) program (AJM).	ARMSTRONG RB, 1984, AM J ANAT, V171, P259, DOI 10.1002/aja.1001710303; Baliarsingh S, 2005, ATHEROSCLEROSIS, V182, P367, DOI 10.1016/j.atherosclerosis.2005.02.020; Bergmeyer HU, 1974, METHODS ENZYMATIC AN; Betik AC, 2008, EXP PHYSIOL, V93, P863, DOI 10.1113/expphysiol.2008.042069; Betik AC, 2009, AM J PHYSIOL-REG I, V297, pR744, DOI 10.1152/ajpregu.90959.2008; Bishop DJ, 2010, AM J PHYSIOL-ENDOC M, V299, pE225, DOI 10.1152/ajpendo.00738.2009; Britton SL, 2005, IUBMB LIFE, V57, P631, DOI 10.1080/15216540500251684; Bruckbauer A, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-91; Budin SB, 2009, CLINICS, V64, P235, DOI 10.1590/S1807-59322009000300015; Chen WC, 2014, MED SCI SPORT EXER, V46, P1517, DOI 10.1249/MSS.0000000000000272; Chin SF, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-42; Coen PM, 2013, OBESITY, V21, P2362, DOI 10.1002/oby.20381; Cornall LM, 2013, MOL CELL ENDOCRINOL, V365, P108, DOI 10.1016/j.mce.2012.10.003; Fang F, 2010, MOL NUTR FOOD RES, V54, P345, DOI 10.1002/mnfr.200900119; Fock KM, 2013, J GASTROEN HEPATOL, V28, P59, DOI 10.1111/jgh.12407; Fogelholm M, 2010, OBES REV, V11, P202, DOI 10.1111/j.1467-789X.2009.00653.x; Furnes MW, 2009, OBES SURG, V19, P1430, DOI 10.1007/s11695-009-9863-1; Hall LML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014197; Haram PM, 2009, CARDIOVASC RES, V81, P723, DOI 10.1093/cvr/cvn332; Hayes A, 2008, CURR OPIN CLIN NUTR, V11, P40, DOI 10.1097/MCO.0b013e3282f2a57d; Henderson KK, 2002, J APPL PHYSIOL, V93, P1265, DOI 10.1152/japplphysiol.00809.2001; Hill KM, 2013, J INT SOC SPORT NUTR, V10, DOI 10.1186/1550-2783-10-8; HOLLOSZY JO, 1967, J BIOL CHEM, V242, P2278; Jenkin KA, 2016, BRIT J PHARMACOL, V173, P1128, DOI 10.1111/bph.13056; Kavanagh T, 2002, CIRCULATION, V106, P666, DOI 10.1161/01.CIR.0000024413.15949.ED; Kim JY, 2000, AM J PHYSIOL-ENDOC M, V279, pE1039, DOI 10.1152/ajpendo.2000.279.5.E1039; Kokkinos P, 2008, CIRCULATION, V117, P614, DOI 10.1161/CIRCULATIONAHA.107.734764; Contarteze RVL, 2008, COMP BIOCHEM PHYS A, V151, P415, DOI 10.1016/j.cbpa.2007.03.005; Lee JS, 2001, EXP PHYSIOL, V86, P499, DOI 10.1113/eph8602158; Lee SP, 2009, EUR J APPL PHYSIOL, V107, P587, DOI 10.1007/s00421-009-1159-6; Lessard SJ, 2011, AM J PHYSIOL-REG I, V300, pR175, DOI 10.1152/ajpregu.00338.2010; Morifuji M, 2005, BRIT J NUTR, V93, P439, DOI 10.1079/BJN20051373; Morino K, 2006, DIABETES, V55, pS9, DOI 10.2337/db06-S002; Myers J, 2002, NEW ENGL J MED, V346, P793, DOI 10.1056/NEJMoa011858; NAHORSKI SR, 1972, ANAL BIOCHEM, V49, P492, DOI 10.1016/0003-2697(72)90453-8; Nowak G, 2012, J PHARMACOL EXP THER, V340, P330, DOI 10.1124/jpet.111.186882; Oberbach A, 2006, DIABETES CARE, V29, P895, DOI 10.2337/diacare.29.04.06.dc05-1854; Pal S, 2013, OBES REV, V14, P324, DOI 10.1111/obr.12005; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Premilovac D, 2013, CARDIOVASC RES, V98, P28, DOI 10.1093/cvr/cvt015; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Rivas DA, 2011, AM J PHYSIOL-REG I, V300, pR835, DOI 10.1152/ajpregu.00659.2010; Robinson MJ, 2013, APPL PHYSIOL NUTR ME, V38, P120, DOI 10.1139/apnm-2012-0092; Schloesser A, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/789710; Shen YQ, 2015, OBESITY, V23, P1000, DOI 10.1002/oby.21056; Sousa GTD, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-67; Srere PA., 1969, METHODS ENZYMOLOGY, P3, DOI DOI 10.1016/0076-6879(69)13005-0; Srinivasan K, 2005, PHARMACOL RES, V52, P313, DOI 10.1016/j.phrs.2005.05.004; St-Pierre P, 2012, DIABETES OBES METAB, V14, P753, DOI 10.1111/j.1463-1326.2012.01598.x; St-Pierre P, 2010, DIABETES OBES METAB, V12, P798, DOI 10.1111/j.1463-1326.2010.01235.x; Sun XC, 2007, LIPIDS, V42, P297, DOI 10.1007/s11745-007-3029-5; Sun XC, 2009, NUTR METAB, V6, DOI 10.1186/1743-7075-6-26; Tanaka S, 2007, METABOLISM, V56, P1719, DOI 10.1016/j.metabol.2007.07.017; Theriault A, 1999, CLIN BIOCHEM, V32, P309, DOI 10.1016/S0009-9120(99)00027-2; Wei M, 1999, JAMA-J AM MED ASSOC, V282, P1547, DOI 10.1001/jama.282.16.1547; Wong WY, 2012, NUTRIENTS, V4, P1527, DOI 10.3390/nu4101527; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Zhou J, 2011, OBESITY, V19, P1568, DOI 10.1038/oby.2011.14	58	5	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2016	11	4							e0152562	10.1371/journal.pone.0152562	http://dx.doi.org/10.1371/journal.pone.0152562			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6JK	27058737	gold, Green Accepted, Green Published			2022-12-27	WOS:000373604800008
J	Beutler, E; Beltrami, FG; Boutellier, U; Spengler, CM				Beutler, Eveline; Beltrami, Fernando G.; Boutellier, Urs; Spengler, Christina M.			Effect of Regular Yoga Practice on Respiratory Regulation and Exercise Performance	PLOS ONE			English	Article							VENTILATORY RESPONSE; CHEMOREFLEX RESPONSE; TRAINED MALES; BAROREFLEX; PRESSURES; CAPACITY; HYPOXIA; VALUES; SLOPE; CYCLE	Yoga alters spontaneous respiratory regulation and reduces hypoxic and hypercapnic ventilatory responses. Since a lower ventilatory response is associated with an improved endurance capacity during whole-body exercise, we tested whether yogic subjects (YOGA) show an increased endurance capacity compared to matched non-yogic individuals (CON) with similar physical activity levels. Resting ventilation, the ventilatory response to hypercapnia, passive leg movement and exercise, as well as endurance performance were assessed. YOGA (n = 9), compared to CONTROL (n = 6), had a higher tidal volume at rest (0.7 +/- 0.2 vs. 0.5 +/- 0.1 l, p = 0.034) and a reduced ventilatory response to hypercapnia (33 +/- 15 vs. 47 +/- 15 l.min(-1), p = 0.048). A YOGA subgroup (n = 6) with maximal performance similar to CONTROL showed a blunted ventilatory response to passive cycling (11 +/- 2 vs. 14 +/- 2 l.min(-1), p = 0.039) and a tendency towards lower exercise ventilation (33 +/- 2 vs. 36 +/- 3 l.min(-1), p = 0.094) while cycling endurance (YOGA: 17.3 +/- 3.3; CON: 19.6 +/- 8.5 min, p = 0.276) did not differ. Thus, yoga practice was not associated with improved exercise capacity nor with significant changes in exercise ventilation despite a significantly different respiratory regulation at rest and in response to hypercapnia and passive leg movement.	[Beutler, Eveline; Beltrami, Fernando G.; Boutellier, Urs; Spengler, Christina M.] ETH, Inst Human Movement Sci, Exercise Physiol Lab, Winterthurerstr 190, CH-8057 Zurich, Switzerland; [Boutellier, Urs; Spengler, Christina M.] Univ Zurich, Zurich Ctr Integrat Human Physiol ZIHP, Winterthurerstr 190, CH-8057 Zurich, Switzerland	ETH Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP)	Spengler, CM (corresponding author), ETH, Inst Human Movement Sci, Exercise Physiol Lab, Winterthurerstr 190, CH-8057 Zurich, Switzerland.; Spengler, CM (corresponding author), Univ Zurich, Zurich Ctr Integrat Human Physiol ZIHP, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	christina.spengler@hest.ethz.ch	Spengler, Christina M./E-9776-2012	Spengler, Christina M./0000-0002-4598-3595				Aldrich TK, 2002, AM J RESP CRIT CARE, V166, P548, DOI 10.1164/rccm.166.4.518; BALASUBRAMANIAN B, 1991, Indian Journal of Physiology and Pharmacology, V35, P281; Bernardi L, 1998, LANCET, V351, P1308, DOI 10.1016/S0140-6736(97)10341-5; Bernardi L, 2001, J HYPERTENS, V19, P2221, DOI 10.1097/00004872-200112000-00016; Bernardi L, 2007, EUR J APPL PHYSIOL, V99, P511, DOI 10.1007/s00421-006-0373-8; Birkel DA, 2000, ALTERN THER HEALTH M, V6, P55; Bowman AJ, 1997, EUR J CLIN INVEST, V27, P443, DOI 10.1046/j.1365-2362.1997.1340681.x; BYRNEQUINN E, 1971, J APPL PHYSIOL, V30, P91, DOI 10.1152/jappl.1971.30.1.91; Calbet JAL, 2006, RESP PHYSIOL NEUROBI, V151, P132, DOI 10.1016/j.resp.2006.01.014; Clark AL, 1997, HEART, V77, P138, DOI 10.1136/hrt.77.2.138; Evans JA, 2009, RESP CARE, V54, P1348; FLUME PA, 1994, RESP PHYSIOL, V95, P53, DOI 10.1016/0034-5687(94)90047-7; Flume PA, 1996, RESP PHYSIOL, V103, P221, DOI 10.1016/0034-5687(95)00094-1; FOWLER WS, 1954, J APPL PHYSIOL, V6, P539, DOI 10.1152/jappl.1954.6.9.539; GOPAL K S, 1973, Indian Journal of Physiology and Pharmacology, V17, P273; Guenette JA, 2006, APPL PHYSIOL NUTR ME, V31, P159, DOI 10.1139/H05-016; Hagins Marshall, 2007, BMC Complement Altern Med, V7, P40, DOI 10.1186/1472-6882-7-40; Harms CA, 2008, MED SCI SPORT EXER, V40, P664, DOI 10.1249/MSS.0b013e3181621325; Harver A, 2000, CHEST, V118, P679, DOI 10.1378/chest.118.3.679; Ingle L, 2007, INT J CARDIOL, V118, P350, DOI 10.1016/j.ijcard.2006.07.105; JOSHI L N, 1992, Indian Journal of Physiology and Pharmacology, V36, P105; Joshi M, 2009, J ALTERN COMPLEM MED, V15, P281, DOI 10.1089/acm.2008.0250; Lansing RW, 2000, AM J RESP CRIT CARE, V162, P1690, DOI 10.1164/ajrccm.162.5.9907096; LEVINE BD, 1992, MED SCI SPORT EXER, V24, P769; LORINC Z, 1991, AM J PHYSIOL, V261, pR747, DOI 10.1152/ajpregu.1991.261.3.R747; MAKWANA K, 1988, Indian Journal of Physiology and Pharmacology, V32, P202; MCCONNELL AK, 1992, J GERONTOL, V47, pB137, DOI 10.1093/geronj/47.4.B137; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Miyamura M, 2002, JPN J PHYSIOL, V52, P313, DOI 10.2464/jilm.52.313; Ohtake PJ, 1998, MED SCI SPORT EXER, V30, P17, DOI 10.1097/00005768-199801000-00004; Oosthuyse T, 2010, SPORTS MED, V40, P207, DOI 10.2165/11317090-000000000-00000; Ozkaplan A, 2005, EUR J APPL PHYSIOL, V95, P52, DOI 10.1007/s00421-005-1399-z; Pomidori L, 2009, J CARDIOPULM REHABIL, V29, P133, DOI 10.1097/HCR.0b013e31819a0227; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; Raju P S, 1986, Indian J Physiol Pharmacol, V30, P121; Raju P S, 1997, J Altern Complement Med, V3, P291, DOI 10.1089/acm.1997.3.291; RAJU PS, 1994, INDIAN J MED RES, V100, P81; Ray U. S., 2001, Indian Journal of Physiology and Pharmacology, V45, P37; Ray US, 2001, INDIAN J MED RES, V114, P215; READ DJC, 1967, AUSTRALAS ANN MED, V16, P20; Sarang PS, 2006, APPL PSYCHOPHYS BIOF, V31, P143, DOI 10.1007/s10484-006-9012-8; Spengler CM, 2000, J PHYSIOL-LONDON, V526, P683, DOI 10.1111/j.1469-7793.2000.00683.x; Spicuzza L, 2000, LANCET, V356, P1495, DOI 10.1016/S0140-6736(00)02881-6; STANESCU DC, 1981, J APPL PHYSIOL, V51, P1625, DOI 10.1152/jappl.1981.51.6.1625; Tatsumi K, 1997, J APPL PHYSIOL, V83, P1706, DOI 10.1152/jappl.1997.83.5.1706; Telles S, 1993, Indian J Med Sci, V47, P235; Tran M D, 2001, Prev Cardiol, V4, P165, DOI 10.1111/j.1520-037X.2001.00542.x; ULDRY C, 1995, THORAX, V50, P371, DOI 10.1136/thx.50.4.371; Verges S, 2008, RESP PHYSIOL NEUROBI, V161, P16, DOI 10.1016/j.resp.2007.11.004; Villien F, 2005, RESP PHYSIOL NEUROBI, V146, P85, DOI 10.1016/j.resp.2004.11.010; WHITE DP, 1983, J APPL PHYSIOL, V54, P874, DOI 10.1152/jappl.1983.54.4.874; WHITE DP, 1985, J APPL PHYSIOL, V59, P1452, DOI 10.1152/jappl.1985.59.5.1452; Wilkie SS, 2015, J APPL PHYSIOL, V118, P255, DOI 10.1152/japplphysiol.00400.2014; WILSON SH, 1984, THORAX, V39, P535, DOI 10.1136/thx.39.7.535; Yadav Raj Kumar, 2001, Indian Journal of Physiology and Pharmacology, V45, P493	55	10	10	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153159	10.1371/journal.pone.0153159	http://dx.doi.org/10.1371/journal.pone.0153159			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27055287	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000373608000090
J	Breckenridge, CB; Berry, C; Chang, ET; Sielken, RL; Mandel, JS				Breckenridge, Charles B.; Berry, Colin; Chang, Ellen T.; Sielken, Robert L., Jr.; Mandel, Jack S.			Association between Parkinson's Disease and Cigarette Smoking, Rural Living, Well-Water Consumption, Farming and Pesticide Use: Systematic Review and Meta-Analysis	PLOS ONE			English	Review							ENVIRONMENTAL RISK-FACTORS; OCCUPATIONAL-EXPOSURE; COFFEE CONSUMPTION; ALPHA-SYNUCLEIN; YOUNG-ONSET; EPIDEMIOLOGIC EVIDENCE; DOPAMINERGIC-NEURONS; AGRICULTURAL WORK; SUBSTANTIA-NIGRA; CAUSAL INFERENCE	Objective Bradford Hill's viewpoints were used to conduct a weight-of-the-evidence assessment of the association between Parkinson's disease (PD) and rural living, farming and pesticide use. The results were compared with an assessment based upon meta-analysis. For comparison, we also evaluated the association between PD and cigarette smoking as a "positive control" because a strong inverse association has been described consistently in the literature. Methods PubMed was searched systematically to identify all published epidemiological studies that evaluated associations between Parkinson's disease (PD) and cigarette smoking, rural living, well-water consumption, farming and the use of pesticides, herbicides, insecticides, fungicides or paraquat. Studies were categorized into two study quality groups (Tier 1 or Tier 2); data were abstracted and a forest plot of relative risks (RRs) was developed for each risk factor. In addition, when available, RRs were tabulated for more highly exposed individuals compared with the unexposed. Summary RRs for each risk factor were calculated by meta-analysis of Tier 1, Tier 2 and all studies combined, with sensitivity analyses stratified by other study characteristics. Indices of between-study heterogeneity and evidence of reporting bias were assessed. Bradford Hill's viewpoints were used to determine if a causal relationship between PD and each risk factor was supported by the weight of the evidence. Findings There was a consistent inverse (negative) association between current cigarette smoking and PD risk. In contrast, associations between PD and rural living, well-water consumption, farming and the use of pesticides, herbicides, insecticides, fungicides or paraquat were less consistent when assessed quantitatively or qualitatively. Conclusion The weight of the evidence and meta-analysis support the conclusion that there is a causal relationship between PD risk and cigarette smoking, or some unknown factor correlated with cigarette smoking. There may be risk factors associated with rural living, farming, pesticide use or well-water consumption that are causally related to PD, but the studies to date have not identified such factors. To overcome the limitations of research in this area, future studies will have to better characterize the onset of PD and its relationship to rural living, farming and exposure to pesticides.	[Breckenridge, Charles B.] Syngenta Crop Protect LLC, Greensboro, NC 27419 USA; [Berry, Colin] Univ London, London E1 4NS, England; [Chang, Ellen T.; Mandel, Jack S.] Exponent Inc, Menlo Pk, CA 94025 USA; [Sielken, Robert L., Jr.] Sielken & Associates Consulting Inc, College Stn, TX 77845 USA	Syngenta; University of London; Exponent	Mandel, JS (corresponding author), Exponent Inc, Menlo Pk, CA 94025 USA.	jckmandel@yahoo.com	Berry, Colin/AAF-5268-2020		Syngenta Crop Protection, LLC; Syngenta; Exponent, Inc.; Sielken & Associates Consulting, Inc.	Syngenta Crop Protection, LLC(Syngenta); Syngenta(Syngenta); Exponent, Inc.; Sielken & Associates Consulting, Inc.	This project was supported by a grant from Syngenta Crop Protection, LLC. Syngenta paid hourly fees for the time spent by the following co-authors of the study: Drs. Jack S. Mandel (JSM), Sir Colin Berry (CB), Ellen T. Chang (ETC), and Robert L. Sielken, Jr. (RLS). Dr. Charles B. Breckenridge (CBB), who is an employee of Syngenta, received annual compensation in the form of salary and company benefits, however Syngenta did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Exponent, Inc. and Sielken & Associates Consulting, Inc. provided support in the form of salaries for authors ETC, JSM, and RLS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adami HO, 2011, TOXICOL SCI, V122, P223, DOI 10.1093/toxsci/kfr113; Allam MF, 2004, MOVEMENT DISORD, V19, P614, DOI 10.1002/mds.20029; Allen MT, 2013, CRIT REV TOXICOL, V43, P515, DOI 10.3109/10408444.2013.798719; Ascherio A, 2004, AM J EPIDEMIOL, V160, P977, DOI 10.1093/aje/kwh312; Ascherio A, 2006, ANN NEUROL, V60, P197, DOI 10.1002/ana.20904; Baldereschi M, 2003, ACTA NEUROL SCAND, V108, P239, DOI 10.1034/j.1600-0404.2003.00128.x; Baldi I, 2003, NEUROEPIDEMIOLOGY, V22, P305, DOI 10.1159/000071194; Baldi I, 2003, AM J EPIDEMIOL, V157, P409, DOI 10.1093/aje/kwf216; Barbeau A, 1987, Adv Neurol, V45, P299; Barbeau A, 1986, ADV NEUROL, V45, P299; Beaman B. L., 1992, Vulnerable brain and environmental risks. Volume 2: Toxins in food., P147; Beaman BL, 2000, MED MICROBIOL IMMUN, V188, P161, DOI 10.1007/s004309900030; Behari M, 2001, J NEUROL SCI, V190, P49, DOI 10.1016/S0022-510X(01)00578-0; Benedetti MD, 2000, NEUROLOGY, V55, P1350, DOI 10.1212/WNL.55.9.1350; Berry C, 2013, RE PATHS PESTICIDES; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Boffetta P, 2008, JNCI-J NATL CANCER I, V100, P988, DOI 10.1093/jnci/djn191; Boffetta P, 2009, INT J EPIDEMIOL, V38, P678, DOI 10.1093/ije/dyn362; Bonifati V., 2010, MOVEMENT DISORD, V4, P83; Borenstein Michael, 2007, METAANALYSIS FIXED E; Braak H, 2004, CELL TISSUE RES, V318, P121, DOI 10.1007/s00441-004-0956-9; Breckenridge CB, 2013, NEUROTOXICOLOGY, V37, P1, DOI 10.1016/j.neuro.2013.03.005; Brighina L, 2008, NEUROLOGY, V70, P1461, DOI 10.1212/01.wnl.0000304049.31377.f2; Brown TP, 2006, ENVIRON HEALTH PERSP, V114, P156, DOI 10.1289/ehp.8095; BURN DJ, 1994, J NEUROL NEUROSUR PS, V57, P278, DOI 10.1136/jnnp.57.3.278; BUTTERFIELD PG, 1993, NEUROLOGY, V43, P1150, DOI 10.1212/WNL.43.6.1150; Chan DKY, 1998, J NEUROL NEUROSUR PS, V65, P781, DOI 10.1136/jnnp.65.5.781; CHATURVEDI S, 1995, CAN J NEUROL SCI, V22, P232, DOI 10.1017/S0317167100039901; Checkoway H, 2002, AM J EPIDEMIOL, V155, P732, DOI 10.1093/aje/155.8.732; Chen H, 2010, NEUROLOGY, V74, P878, DOI 10.1212/WNL.0b013e3181d55f38; Cole P., 1997, J MARKETING RES, V27, P10279; Cookson MR, 2005, ANNU REV BIOCHEM, V74, P29, DOI 10.1146/annurev.biochem.74.082803.133400; Costello S, 2009, AM J EPIDEMIOL, V169, P919, DOI 10.1093/aje/kwp006; Cuervo AM, 2010, TRENDS ENDOCRIN MET, V21, P142, DOI 10.1016/j.tem.2009.10.003; Das K, 2011, NEURODEGENER DIS, V8, P345, DOI 10.1159/000323797; De Palma G, 1998, LANCET, V352, P1986; DeMichele G, 1996, MOVEMENT DISORD, V11, P17, DOI 10.1002/mds.870110105; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dhillon Amanpreet S, 2008, J Agromedicine, V13, P37, DOI 10.1080/10599240801986215; Dick FD, 2007, OCCUP ENVIRON MED, V64, P666, DOI 10.1136/oem.2006.027003; Dick S, 2007, OCCUP MED-OXFORD, V57, P50, DOI 10.1093/occmed/kql109; Dong JQ, 2003, BIOMED ENVIRON SCI, V16, P173; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Duzcan F, 2003, MOVEMENT DISORD, V18, P799, DOI 10.1002/mds.10440; Egger M, 1997, BMJ-BRIT MED J, V315, P1533, DOI 10.1136/bmj.315.7121.1533; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Elbaz A, 2004, ANN NEUROL, V55, P430, DOI 10.1002/ana.20051; Elbaz A, 2009, ANN NEUROL, V66, P494, DOI 10.1002/ana.21717; Engel LS, 2001, OCCUP ENVIRON MED, V58, P582, DOI 10.1136/oem.58.9.582; Evans AH, 2006, J NEUROL NEUROSUR PS, V77, P317, DOI 10.1136/jnnp.2005.065417; Fall PA, 1999, MOVEMENT DISORD, V14, P28, DOI 10.1002/1531-8257(199901)14:1&lt;28::AID-MDS1007&gt;3.0.CO;2-O; Farrer M, 2001, ANN NEUROL, V50, P293, DOI 10.1002/ana.1132; Farrer MJ, 2010, MOVEMENT DISORD, P102; Feldman AL, 2011, PARKINSONISM RELAT D, V17, P677, DOI 10.1016/j.parkreldis.2011.06.009; Firestone JA, 2005, ARCH NEUROL-CHICAGO, V62, P91, DOI 10.1001/archneur.62.1.91; Firestone JA, 2010, AM J IND MED, V53, P217, DOI 10.1002/ajim.20788; Fitzmaurice AG, 2014, NEUROLOGY, V82, P419, DOI 10.1212/WNL.0000000000000083; Fitzmaurice AG, 2013, P NATL ACAD SCI USA, V110, P636, DOI 10.1073/pnas.1220399110; Fong CS, 2007, CLIN CHIM ACTA, V378, P136, DOI 10.1016/j.cca.2006.11.006; Fowler JS, 1996, NATURE, V379, P733, DOI 10.1038/379733a0; Freire C, 2012, NEUROTOXICOLOGY, V33, P947, DOI 10.1016/j.neuro.2012.05.011; Frigerio R, 2005, NEUROLOGY, V65, P1575, DOI 10.1212/01.wnl.0000184520.21744.a2; Frigerio R, 2006, MOVEMENT DISORD, V21, P1688, DOI 10.1002/mds.21009; Galanaud JP, 2005, MOVEMENT DISORD, V20, P181, DOI 10.1002/mds.20307; Gasser T, 2010, PROG BRAIN RES, V183, P3, DOI 10.1016/S0079-6123(10)83001-8; Gatto NM, 2009, ENVIRON HEALTH PERSP, V117, P1912, DOI 10.1289/ehp.0900852; Goldman SM, 2012, MOVEMENT DISORD, V27, P1652, DOI 10.1002/mds.25216; Goldman SM, 2005, NEUROLOGY, V65, P1430, DOI 10.1212/01.wnl.0000180361.74060.70; Goodman M, 2014, BIRTH DEFECTS RES B, V101, P215, DOI 10.1002/bdrb.21101; Gorell JM, 1998, NEUROLOGY, V50, P1346, DOI 10.1212/WNL.50.5.1346; Gorell JM, 2004, J NEUROL SCI, V217, P169, DOI 10.1016/j.jns.2003.09.014; Gorell JM, 1999, NEUROLOGY, V52, P115, DOI 10.1212/WNL.52.1.115; GRANDINETTI A, 1994, AM J EPIDEMIOL, V139, P1129, DOI 10.1093/oxfordjournals.aje.a116960; GREENLAND S, 1994, AM J EPIDEMIOL, V140, P783, DOI 10.1093/oxfordjournals.aje.a117326; Hancock DB, 2008, BMC NEUROL, V8, DOI 10.1186/1471-2377-8-6; Hancock DB, 2007, ARCH NEUROL-CHICAGO, V64, P576, DOI 10.1001/archneur.64.4.576; Harris MA, 2012, J OCCUP ENVIRON HYG, V9, P371, DOI 10.1080/15459624.2012.679853; Hatcher JM, 2008, TRENDS PHARMACOL SCI, V29, P322, DOI 10.1016/j.tips.2008.03.007; Hattori N, 2010, MOVEMENT DISORD, V4, P54; Hellenbrand W, 1997, INT J EPIDEMIOL, V26, P328, DOI 10.1093/ije/26.2.328; Hernan MA, 2001, ANN NEUROL, V50, P780, DOI 10.1002/ana.10028; Hernan MA, 2002, ANN NEUROL, V52, P276, DOI 10.1002/ana.10277; HERTZMAN C, 1994, MOVEMENT DISORD, V9, P69, DOI 10.1002/mds.870090111; HERTZMAN C, 1990, AM J IND MED, V17, P349, DOI 10.1002/ajim.4700170307; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; HO SC, 1989, NEUROLOGY, V39, P1314, DOI 10.1212/WNL.39.10.1314; Hristina VD, 2010, INT J NEUROSCI, V120, P361, DOI 10.3109/00207451003668374; HUBBLE JP, 1993, NEUROLOGY, V43, P1693, DOI 10.1212/WNL.43.9.1693; HUBBLE JP, 1995, J CLIN MICROBIOL, V33, P2768, DOI 10.1128/JCM.33.10.2768-2769.1995; Ioannidis JPA, 2008, EPIDEMIOLOGY, V19, P640, DOI 10.1097/EDE.0b013e31818131e7; Ioannidis JPA, 2011, EPIDEMIOLOGY, V22, P450, DOI 10.1097/EDE.0b013e31821b506e; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Jackson-Lewis Vernice, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS183, DOI 10.1016/S1353-8020(11)70057-8; JIMENEZJIMENEZ FJ, 1992, MOVEMENT DISORD, V7, P149, DOI 10.1002/mds.870070209; Kamel F, 2007, AM J EPIDEMIOL, V165, P364, DOI 10.1093/aje/kwk024; Kamel F, 2013, SCIENCE, V341, P722, DOI 10.1126/science.1243619; Kirkey KL, 2001, AM J IND MED, V39, P564, DOI 10.1002/ajim.1055; Kivimaki M, 2013, INT J EPIDEMIOL, V42, P367, DOI 10.1093/ije/dyt036; Kiyohara C, 2010, PARKINSONISM RELAT D, V16, P447, DOI 10.1016/j.parkreldis.2010.04.009; Kiyohara Chikako, 2011, Fukuoka Acta Medica, V102, P254; Klein C., 2010, MOVEMENT DISORD, V4, P15; KOLLER W, 1990, NEUROLOGY, V40, P1218, DOI 10.1212/WNL.40.8.1218; Kuopio AM, 1999, MOVEMENT DISORD, V14, P928, DOI 10.1002/1531-8257(199911)14:6<928::AID-MDS1004>3.0.CO;2-Z; Kyrozis A, 2013, EUR J EPIDEMIOL, V28, P67, DOI 10.1007/s10654-012-9760-0; Le WD, 2014, NEUROTHERAPEUTICS, V11, P92, DOI 10.1007/s13311-013-0234-1; Lee E, 2002, AM J IND MED, V42, P410, DOI 10.1002/ajim.10131; Lee PC, 2012, NEUROLOGY, V79, P2061, DOI 10.1212/WNL.0b013e3182749f28; Li AA, 2005, J OCCUP ENVIRON MED, V47, P1059, DOI 10.1097/01.jom.0000174294.58575.3e; Liou HH, 1997, NEUROLOGY, V48, P1583, DOI 10.1212/WNL.48.6.1583; Litvan I, 2003, MOVEMENT DISORD, V18, P467, DOI 10.1002/mds.10459; Liu R, 2012, AM J EPIDEMIOL, V175, P1200, DOI 10.1093/aje/kwr451; Ma L, 2006, ACTA NEUROL SCAND, V113, P278, DOI 10.1111/j.1600-0404.2005.00571.x; Mandel JS, 2012, REGUL TOXICOL PHARM, V62, P385, DOI 10.1016/j.yrtph.2011.10.004; Marder K, 1998, NEUROLOGY, V50, P279, DOI 10.1212/WNL.50.1.279; Martin I, 2010, PROG BRAIN RES, V183, P21, DOI 10.1016/S0079-6123(10)83002-X; Martinez-Vicente M, 2011, WILEY SERIES PROTEIN, P101; MARTYN CN, 1995, J NEUROL SCI, V132, P201, DOI 10.1016/0022-510X(95)00148-U; MAYEUX R, 1994, MOVEMENT DISORD, V9, P207, DOI 10.1002/mds.870090215; McCann SJ, 1998, NEUROEPIDEMIOLOGY, V17, P310, DOI 10.1159/000026185; McCormack AL, 2005, J NEUROCHEM, V93, P1030, DOI 10.1111/j.1471-4159.2005.03088.x; McCormack AL, 2002, NEUROBIOL DIS, V10, P119, DOI 10.1006/nbdi.2002.0507; Minnema DJ, 2014, REGUL TOXICOL PHARM, V68, P250, DOI 10.1016/j.yrtph.2013.12.010; MORANO A, 1994, ACTA NEUROL SCAND, V89, P164; Moretto A, 2013, TOXICOLOGY, V307, P24, DOI 10.1016/j.tox.2012.11.021; Nicoletti A, 2010, NEUROL SCI, V31, P47, DOI 10.1007/s10072-009-0182-z; Noyce AJ, 2012, ANN NEUROL, V72, P893, DOI 10.1002/ana.23687; Ntzani EE, 2013, EFSA SUPPORTING PUBL, VEN-497, P159, DOI DOI 10.2903/SP.EFSA.2013.EN-497; Olsen J, 2003, J EPIDEMIOL COMMUN H, V57, P86, DOI 10.1136/jech.57.2.86; Paganini-Hill A, 2001, NEUROEPIDEMIOLOGY, V20, P118, DOI 10.1159/000054770; Pals P, 2003, EUR J EPIDEMIOL, V18, P1133, DOI 10.1023/B:EJEP.0000006639.05690.92; Park J, 2005, NEUROTOXICOLOGY, V26, P99, DOI 10.1016/j.neuro.2004.07.001; Park J, 2004, IND HEALTH, V42, P352, DOI 10.2486/indhealth.42.352; Park RM, 2005, AM J IND MED, V48, P63, DOI 10.1002/ajim.20178; Parkinson J, 2002, J NEUROPSYCH CLIN N, V14, P223, DOI 10.1176/appi.neuropsych.14.2.223; Petersen MS, 2008, NEUROTOXICOLOGY, V29, P584, DOI 10.1016/j.neuro.2008.03.001; Pezzoli G, 2013, NEUROLOGY, V80, P2035, DOI 10.1212/WNL.0b013e318294b3c8; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Powers KM, 2008, MOVEMENT DISORD, V23, P88, DOI 10.1002/mds.21782; Preux PM, 2000, NEUROEPIDEMIOLOGY, V19, P333, DOI 10.1159/000026273; Priyadarshi A, 2001, ENVIRON RES, V86, P122, DOI 10.1006/enrs.2001.4264; Priyadarshi A, 2000, NEUROTOXICOLOGY, V21, P435; Quik M, 2004, TRENDS NEUROSCI, V27, P561, DOI 10.1016/j.tins.2004.06.008; Ragonese P, 2003, NEUROEPIDEMIOLOGY, V22, P297, DOI 10.1159/000071193; Ravina BM, 2003, NEUROLOGY, V60, P1234, DOI 10.1212/01.WNL.0000058760.13152.1A; Ray NJ, 2013, J NEURAL TRANSM, V120, P659, DOI 10.1007/s00702-012-0933-5; Ritz B, 2007, ARCH NEUROL-CHICAGO, V64, P990, DOI 10.1001/archneur.64.7.990; Ritz B, 2014, NEUROLOGY, V83, P1396, DOI 10.1212/WNL.0000000000000879; Ritz BR, 2009, ENVIRON HEALTH PERSP, V117, P964, DOI 10.1289/ehp.0800277; Rocca WA, 1996, MOVEMENT DISORD, V11, P201, DOI 10.1002/mds.870110214; Rothman KJ, 2005, AM J PUBLIC HEALTH, V95, pS144, DOI 10.2105/AJPH.2004.059204; Rothman KJ., 2008, MODERN EPIDEMIOLOGY; Rugbjerg K, 2011, SCAND J WORK ENV HEA, V37, P427, DOI 10.5271/sjweh.3142; Saaksjarvi K, 2008, EUR J CLIN NUTR, V62, P908, DOI 10.1038/sj.ejcn.1602788; Sanyal J, 2010, CAN J NEUROL SCI, V37, P637, DOI 10.1017/S0317167100010829; Sasco A J, 1990, Epidemiology, V1, P460, DOI 10.1097/00001648-199011000-00008; Scott WK, 2005, NEUROLOGY, V64, P442, DOI 10.1212/01.WNL.0000150905.93241.B2; Seidler A, 1996, NEUROLOGY, V46, P1275, DOI 10.1212/WNL.46.5.1275; SEMCHUK KM, 1992, NEUROLOGY, V42, P1328, DOI 10.1212/WNL.42.7.1328; SHAPIRO S, 1994, AM J EPIDEMIOL, V140, P771, DOI 10.1093/oxfordjournals.aje.a117324; Sharma V, 2012, INT J PHARM PHARM SC, V4, P55; Shino MY, 2010, MOVEMENT DISORD, V25, P2587, DOI 10.1002/mds.23361; Skeie GO, 2010, MOVEMENT DISORD, V25, P1847, DOI 10.1002/mds.23178; Smargiassi A, 1998, NEUROTOXICOLOGY, V19, P709; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; STERN M, 1991, ARCH NEUROL-CHICAGO, V48, P903, DOI 10.1001/archneur.1991.00530210029018; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Stevens JT, 2014, HAYES' PRINCIPLES AND METHODS OF TOXICOLOGY, 6TH EDITION, P711; Tan EK, 2003, J NEUROL SCI, V216, P163, DOI 10.1016/j.jns.2003.07.006; Tan LC, 2008, AM J EPIDEMIOL, V167, P553, DOI 10.1093/aje/kwm338; Tanaka K, 2010, ACTA NEUROL SCAND, V122, P377, DOI 10.1111/j.1600-0404.2010.01327.x; Tanaka K, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-83; Tanner CM, 2011, ENVIRON HEALTH PERSP, V119, P866, DOI 10.1289/ehp.1002839; Tanner CM, 2009, ARCH NEUROL-CHICAGO, V66, P1106, DOI 10.1001/archneurol.2009.195; TANNER CM, 1989, NEUROLOGY, V39, P660, DOI 10.1212/WNL.39.5.660; TANNER CM, 1990, NEUROLOGY, V40, P17; Taylor CA, 1999, AM J MED GENET, V88, P742, DOI 10.1002/(SICI)1096-8628(19991215)88:6<742::AID-AJMG29>3.0.CO;2-#; Thacker EL, 2007, NEUROLOGY, V68, P764, DOI 10.1212/01.wnl.0000256374.50227.4b; Thenganatt MA, 2014, JAMA NEUROL, V71, P499, DOI 10.1001/jamaneurol.2013.6233; Tomenson JA, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000283; Torta DME, 2008, PSYCHIAT CLIN NEUROS, V62, P203, DOI 10.1111/j.1440-1819.2008.01756.x; Tsai CH, 2002, CLIN NEUROL NEUROSUR, V104, P328, DOI 10.1016/S0303-8467(02)00027-6; Tsui JKC, 1999, CAN J PUBLIC HEALTH, V90, P334, DOI 10.1007/BF03404523; Tuchsen F, 2000, SCAND J WORK ENV HEA, V26, P359; Tzourio C, 1997, NEUROLOGY, V49, P1267, DOI 10.1212/WNL.49.5.1267; Uversky V, 2011, WILEY SERIES PROTEIN, P1; Valente EM, 2010, MOVEMENT DISORD, V4, P66; van der Mark Marianne, 2012, Environ Health Perspect, V120, P340, DOI 10.1289/ehp.1103881; Van Maele-Fabry G, 2012, ENVIRON INT, V46, P30, DOI 10.1016/j.envint.2012.05.004; Vanacore N, 2000, NEUROLOGY, V54, P114, DOI 10.1212/WNL.54.1.114; Viswanathan M, 2011, DEV RTI ITEM BANK RI; von Elm E, 2007, PLOS MED, V4, P1623, DOI [10.1371/journal.pmed.0040296, 10.1371/journal.pmed.0040297]; Wang A, 2011, EUR J EPIDEMIOL, V26, P547, DOI 10.1007/s10654-011-9574-5; WANG WZ, 1993, NEUROEPIDEMIOLOGY, V12, P209, DOI 10.1159/000110319; Weed DL, 2005, RISK ANAL, V25, P1545, DOI 10.1111/j.1539-6924.2005.00699.x; Weed DL, 2010, ANN EPIDEMIOL, V20, P347, DOI 10.1016/j.annepidem.2010.02.001; Wells G SB, 2013, NEWCASTLE OTTAWA SCA; Werneck ALD, 1999, ARQ NEURO-PSIQUIAT, V57, P347, DOI 10.1590/S0004-282X1999000300001; Whitton PS, 2007, BRIT J PHARMACOL, V150, P963, DOI 10.1038/sj.bjp.0707167; Williamson PR, 2005, STAT METHODS MED RES, V14, P515, DOI 10.1191/0962280205sm415oa; Willis AW, 2010, NEUROEPIDEMIOLOGY, V34, P143, DOI 10.1159/000275491; Wirdefeldt K, 2005, ANN NEUROL, V57, P27, DOI 10.1002/ana.20307; Wirdefeldt K, 2011, EUR J EPIDEMIOL, V26, pS1, DOI 10.1007/s10654-011-9581-6; Wright JM, 2005, ARCH ENVIRON HEALTH, V60, P32, DOI 10.3200/AEOH.60.1.32-38; Zorzon M, 2002, ACTA NEUROL SCAND, V105, P77, DOI 10.1034/j.1600-0404.2002.1o040.x	206	90	95	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0151841	10.1371/journal.pone.0151841	http://dx.doi.org/10.1371/journal.pone.0151841			42	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DI6KO	27055126	Green Published, Green Submitted, gold			2022-12-27	WOS:000373608000008
J	Butler, AA; Lord, SR; Fitzpatrick, RC				Butler, Annie A.; Lord, Stephen R.; Fitzpatrick, Richard C.			Perceptions of Speed and Risk: Experimental Studies of Road Crossing by Older People	PLOS ONE			English	Article							VISUAL CONTROL; GAP SELECTION; SELF-MOTION; AGE; TIME; PEDESTRIANS; FALLS; DECISIONS; MODEL; YOUNG	Crossing a road safely is a complex task requiring good sensorimotor function and integration of information about traffic speed, distances and one's own speed. Poor judgement through age-related sensorimotor or cognitive impairment or a predisposition to take risks could lead to errors with serious consequences. On a simulated road, 85 participants (age >= 70 years) were asked to cross in front of an approaching car with a clearance as small as considered safe in two conditions; (1) with nothing else to attend to (free crossing) and (2) with an additional ball-gathering task while waiting to cross (task crossing). Participants were categorised according to their crossing outcome (failed to cross, 'hit', exact, safe, cautious). Participants also performed two sub-studies; (1) the perception of the time-to-arrival of moving objects and (2) the perception of own gait speed. Physical and cognitive function and everyday risk-taking behaviour were also assessed. In free crossing, clearances varied but no participants were "hit" by the car. In task crossing, participants allowed smaller clearances and 10% of participants would have been hit while 13% missed the opportunity to cross altogether. Across a wide range of physical and cognitive measures, including perceived and actual gait speed, a consistent pattern was observed in the task crossing condition. The exact group performed best, the 'hit', safe and cautious groups performed less well while those who missed the opportunity (fail) performed worst. The exact group reported taking the greatest risks in everyday life whereas the remaining groups reported being cautious. In conclusion, we found older people with poorer perceptual, physical and cognitive function made inappropriate and risky decisions in a divided attention road-crossing task despite self-reports of cautious behaviour in everyday life.	[Butler, Annie A.; Lord, Stephen R.; Fitzpatrick, Richard C.] Neurosci Res Australia, Sydney, NSW, Australia; [Butler, Annie A.; Lord, Stephen R.; Fitzpatrick, Richard C.] Univ New S Wales, Sydney, NSW, Australia	Neuroscience Research Australia; University of New South Wales Sydney	Lord, SR (corresponding author), Neurosci Res Australia, Sydney, NSW, Australia.; Lord, SR (corresponding author), Univ New S Wales, Sydney, NSW, Australia.	s.lord@neura.edu.au		Lord, Stephen R/0000-0002-7111-8802	National Health and Medical Research Council [400941]; Neuroscience Research Australia; Albert Chua PhD Scholarship	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Neuroscience Research Australia; Albert Chua PhD Scholarship	This work was funded by the National Health and Medical Research Council, Grant No. 400941 (www.nhmrc.gov.au) (SL and RF), and Prince of Wales Medical Research Institute (now Neuroscience Research Australia, www.neura.edu.au), Albert Chua PhD Scholarship (AB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATSB, 2002, OLD PED; ATSB, 2003, AUSTR TR SAF BUR COM, V14; Bernhoft IM, 2008, TRANSPORT RES F-TRAF, V11, P83, DOI 10.1016/j.trf.2007.08.004; BERTHOZ A, 1975, EXP BRAIN RES, V23, P471; Butler AA, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-31; Butler AA, 2015, J GERONTOL A-BIOL, V70, P628, DOI 10.1093/gerona/glu201; Butler AA, 2011, J GERONTOL A-BIOL, V66, P896, DOI 10.1093/gerona/glr071; Carthy T., 1995, RISK SAFETY ROADS OL; Centre for Road Safety Transport for NSW, 2012, ROAD TRAFF CRASH NEW; DeLucia PR, 2003, TRANSP RES F, V6, P63, DOI DOI 10.1016/S1369-8478(02)00047-5; Dimitrakopoulos G, 2010, IEEE VEH TECHNOL MAG, V5, P77, DOI 10.1109/MVT.2009.935537; Dommes A, 2015, ACCIDENT ANAL PREV, V85, P229, DOI 10.1016/j.aap.2015.09.022; Dommes A, 2014, J SAFETY RES, V50, P27, DOI 10.1016/j.jsr.2014.03.008; Dommes A, 2013, ACCIDENT ANAL PREV, V59, P135, DOI 10.1016/j.aap.2013.05.017; Dommes A, 2011, OPHTHAL PHYSL OPT, V31, P292, DOI 10.1111/j.1475-1313.2011.00835.x; Elliott D, 1995, FEDERAL OFFICE ROAD, VCR 163; Fitzpatrick RC, 1999, J PHYSIOL-LONDON, V517, P931, DOI 10.1111/j.1469-7793.1999.0931s.x; Fitzpatrick RC, 2006, CURR BIOL, V16, P1509, DOI 10.1016/j.cub.2006.05.063; Gandhi T, 2007, IEEE T INTELL TRANSP, V8, P413, DOI 10.1109/TITS.2007.903444; Gibson JJ, 1950, PERCEPTION VISUAL WO; Gorrie CA, 2006, DEMENT GERIATR COGN, V22, P20, DOI 10.1159/000093066; Hancock PA, 1997, ECOL PSYCHOL, V9, P265, DOI 10.1207/s15326969eco0904_2; Hatfield J, 2007, ACCIDENT ANAL PREV, V39, P197, DOI 10.1016/j.aap.2006.07.001; HOLLAND CA, 1992, APPL COGNITIVE PSYCH, V6, P217, DOI 10.1002/acp.2350060304; Holland C, 2007, ACCIDENT ANAL PREV, V39, P224, DOI 10.1016/j.aap.2006.07.003; Holland C, 2010, ACCIDENT ANAL PREV, V42, P1097, DOI 10.1016/j.aap.2009.12.023; JAFFE GJ, 1986, ARCH OPHTHALMOL-CHIC, V104, P1021; Jonsson R, 1998, SCAND AUDIOL, V27, P81, DOI 10.1080/010503998420324; Lappe M, 1999, TRENDS COGN SCI, V3, P329, DOI 10.1016/S1364-6613(99)01364-9; LEE DN, 1976, PERCEPTION, V5, P437, DOI 10.1068/p050437; LEE DN, 1977, SCAND J PSYCHOL, V18, P224, DOI 10.1111/j.1467-9450.1977.tb00281.x; LEE DN, 1984, ERGONOMICS, V27, P1271, DOI 10.1080/00140138408963608; Liu YC, 2014, SAFETY SCI, V63, P77, DOI 10.1016/j.ssci.2013.11.002; Lobjois R, 2007, ACCIDENT ANAL PREV, V39, P934, DOI 10.1016/j.aap.2006.12.013; Lobjois R, 2009, ACCIDENT ANAL PREV, V41, P259, DOI 10.1016/j.aap.2008.12.001; LORD SR, 1991, AGE AGEING, V20, P175, DOI 10.1093/ageing/20.3.175; Lord SR, 1996, ARCH PHYS MED REHAB, V77, P232, DOI 10.1016/S0003-9993(96)90103-3; Lord SR, 2001, J GERONTOL A-BIOL, V56, pM627, DOI 10.1093/gerona/56.10.M627; LundinOlsson L, 1997, LANCET, V349, P617, DOI 10.1016/S0140-6736(97)24009-2; Marottoli RA, 1998, ACCIDENT ANAL PREV, V30, P331, DOI 10.1016/S0001-4575(97)00100-0; O'Hern S, 2015, TRAFFIC INJ PREV, V16, pS161, DOI 10.1080/15389588.2015.1061662; Oudejans RRD, 1996, ECOL PSYCHOL, V8, P259, DOI 10.1207/s15326969eco0803_4; Oxley J, 1997, ACCIDENT ANAL PREV, V29, P839, DOI 10.1016/S0001-4575(97)00053-5; Oxley JA, 2005, ACCIDENT ANAL PREV, V37, P962, DOI 10.1016/j.aap.2005.04.017; Petzoldt T, 2014, ACCIDENT ANAL PREV, V72, P127, DOI 10.1016/j.aap.2014.06.019; POWELL LE, 1995, J GERONTOL A-BIOL, V50, pM28, DOI 10.1093/gerona/50A.1.M28; Rauch SD, 2001, ANN NY ACAD SCI, V942, P220; Sachdev PS, 2010, INT PSYCHOGERIATR, V22, P1248, DOI 10.1017/S1041610210001067; SCHIFF W, 1992, PSYCHOL AGING, V7, P518, DOI 10.1037/0882-7974.7.4.518; Scialfa CT, 1987, P HUM FACT ERG SOC A, V5, P558; Tang TQ, 2011, INT J MOD PHYS B, V25, P4471, DOI 10.1142/S0217979211059462; Tang TQ, 2015, PHYSICA A, V440, P49, DOI 10.1016/j.physa.2015.08.002; Tang TQ, 2012, TRANSPORT RES C-EMER, V22, P1, DOI 10.1016/j.trc.2011.11.005; Tang TQ, 2010, INT J MOD PHYS C, V21, P159, DOI 10.1142/S0129183110015038; Weber KD, 1998, EXP BRAIN RES, V120, P377, DOI 10.1007/s002210050411; Woollacott M, 2002, GAIT POSTURE, V16, P1, DOI 10.1016/S0966-6362(01)00156-4; Yanik A, 1991, J TRAFFIC MED, V10, P87; Yardley L, 2005, AGE AGEING, V34, P614, DOI 10.1093/ageing/afi196; Zuckerman M, 2000, J PERS, V68, P999, DOI 10.1111/1467-6494.00124; Zuckerman M, 2007, SENSATION SEEKING RI	60	19	19	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0152617	10.1371/journal.pone.0152617	http://dx.doi.org/10.1371/journal.pone.0152617			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DI6KO	27054918	Green Published, Green Submitted, gold			2022-12-27	WOS:000373608000030
J	Kahlert, S; Junnikkala, S; Renner, L; Hynonen, U; Hartig, R; Nossol, C; Barta-Boszormenyi, A; Danicke, S; Souffrant, WB; Palva, A; Rothkotter, HJ; Kluess, J				Kahlert, Stefan; Junnikkala, Sami; Renner, Lydia; Hynonen, Ulla; Hartig, Roland; Nossol, Constanze; Barta-Boszormenyi, Aniko; Daenicke, Sven; Souffrant, Wolfgang-Bernhard; Palva, Airi; Rothkoetter, Hermann-Josef; Kluess, Jeannette			Physiological Concentration of Exogenous Lactate Reduces Antimycin A Triggered Oxidative Stress in Intestinal Epithelial Cell Line IPEC-1 and IPEC-J2 In Vitro	PLOS ONE			English	Article							MONOCARBOXYLATE TRANSPORTERS MCT1; MITOCHONDRIAL-FUNCTION; HYDROGEN-PEROXIDE; SUPEROXIDE ANION; WEANED PIGLETS; PIG; PATHOGENESIS; MODULATION; EXPRESSION; AR-C155858	Weaning triggers an adaptation of the gut function including luminal lactate generation by lactobacilli, depending on gastrointestinal site. We hypothesized that both lactobacilli and lactate influence porcine intestinal epithelial cells. In vivo experiments showed that concentration of lactate was significantly higher in gastric, duodenal and jejunal chyme of suckling piglets compared to their weaned counterparts. In an in vitro study we investigated the impact of physiological lactate concentration as derived from the in vivo study on the porcine intestinal epithelial cells IPEC-1 and IPEC-J2. We detected direct adherence of lactobacilli on the apical epithelial surface and a modulated F-actin structure. Application of lactobacilli culture supernatant alone or lactate (25 mM) at low pH (pH 4) changed the F-actin structure in a similar manner. Treatment of IPEC cultures with lactate at near neutral pH resulted in a significantly reduced superoxide-generation in Antimycin A-challenged cells. This protective effect was nearly completely reversed by inhibition of cellular lactate uptake via monocarboxylate transporter. Lactate treatment enhanced NADH autofluorescence ratio (F-cytosol/F-nucleus) in non-challenged cells, indicating an increased availability of reduced nucleotides, but did not change the overall ATP content of the cells. Lactobacilli-derived physiological lactate concentration in intestine is relevant for alleviation of redox stress in intestinal epithelial cells.	[Kahlert, Stefan; Renner, Lydia; Nossol, Constanze; Barta-Boszormenyi, Aniko; Rothkoetter, Hermann-Josef] Univ Magdeburg, Inst Anat, D-39106 Magdeburg, Germany; [Daenicke, Sven; Kluess, Jeannette] Fed Res Inst Anim Hlth, Inst Anim Nutr, Friedrich Loeffler Inst, Braunschweig, Germany; [Hartig, Roland] Univ Magdeburg, Inst Mol & Clin Immunol, D-39106 Magdeburg, Germany; [Junnikkala, Sami; Hynonen, Ulla; Palva, Airi] Univ Helsinki, Dept Vet Biosci, Helsinki, Finland; [Souffrant, Wolfgang-Bernhard] Leibniz Inst Farm Anim Biol, Res Unit Nutr Physiol Oskar Kellner, Dummerstorf, Germany	Otto von Guericke University; Friedrich Loeffler Institute; Otto von Guericke University; University of Helsinki; Forschungsinstitut fur Nutztierbiologie (FBN)	Kahlert, S (corresponding author), Univ Magdeburg, Inst Anat, D-39106 Magdeburg, Germany.	stefan.kahlert@med.ovgu.de		Hartig, Roland/0000-0002-3706-7458; Hynonen, Ulla/0000-0002-2002-7804	EU 5th frame-work program "HealthyPigut" [QLK5-CT-2000-00522]; EU 7th frame-work program INTERPLAY [227549]	EU 5th frame-work program "HealthyPigut"; EU 7th frame-work program INTERPLAY	Funded by EU 5th frame-work program "HealthyPigut" (contract-no.: QLK5-CT-2000-00522) and EU 7th frame-work program INTERPLAY (grant agreement no.: 227549).	Arpaia N, 2014, IMMUNOL CELL BIOL, V92, P561, DOI 10.1038/icb.2014.40; Bhattacharyya A, 2014, PHYSIOL REV, V94, P329, DOI 10.1152/physrev.00040.2012; CARTER WO, 1994, J LEUKOCYTE BIOL, V55, P253; Castilho RF, 1999, J NEUROCHEM, V72, P1394, DOI 10.1046/j.1471-4159.1999.721394.x; CRANWELL PD, 1976, BRIT J NUTR, V36, P71, DOI 10.1079/BJN19760059; Degroote J, 2012, J ANIM SCI, V90, P359, DOI 10.2527/jas.53809; Diesing AK, 2011, TOXICOL LETT, V200, P8, DOI 10.1016/j.toxlet.2010.10.006; HAACKER K, 1983, ARCH TIERERNAHR, V33, P505, DOI 10.1080/17450398309425704; Halestrap AP, 1999, BIOCHEM J, V343, P281, DOI 10.1042/0264-6021:3430281; Halestrap AP, 2004, PFLUG ARCH EUR J PHY, V447, P619, DOI 10.1007/s00424-003-1067-2; Handy DE, 2012, ANTIOXID REDOX SIGN, V16, P1323, DOI 10.1089/ars.2011.4123; Hinoi E, 2006, MOL PHARMACOL, V70, P925, DOI 10.1124/mol.106.024398; Hou YQ, 2011, BRIT J NUTR, V106, P357, DOI 10.1017/S0007114511000249; Hynonen U, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-199; Ishiguro K, 2014, IMMUNOL CELL BIOL, V92, P624, DOI 10.1038/icb.2014.31; Kahlert S, 2008, J NEUROSCI METH, V171, P87, DOI 10.1016/j.jneumeth.2008.02.015; Kaur T, 2003, MOL CELL BIOCHEM, V253, P15, DOI 10.1023/A:1026088915240; Kluess J, 2003, ARCH ANIMAL BREEDING, V36, P101; Konstantinov SR, 2006, ENVIRON MICROBIOL, V8, P1191, DOI 10.1111/j.1462-2920.2006.01009.x; Latham T, 2012, NUCLEIC ACIDS RES, V40, P4794, DOI 10.1093/nar/gks066; Marti R, 2010, APPL ENVIRON MICROB, V76, P1456, DOI 10.1128/AEM.01895-09; Mayevsky A, 2013, J CLIN MONIT COMPUT, V27, P1, DOI 10.1007/s10877-012-9414-5; Muller FL, 2004, J BIOL CHEM, V279, P49064, DOI 10.1074/jbc.M407715200; Ovens MJ, 2010, BIOCHEM J, V431, P217, DOI 10.1042/BJ20100890; Ovens MJ, 2010, BIOCHEM J, V425, P523, DOI 10.1042/BJ20091515; Piechota-Polanczyk A, 2014, N-S ARCH PHARMACOL, V387, P605, DOI 10.1007/s00210-014-0985-1; Pritchard KA, 2001, J BIOL CHEM, V276, P17621, DOI 10.1074/jbc.C100084200; Robert F., 2009, Journees de la Recherche Porcine en France, V41, P173; Schnackenberg CG, 2002, CURR OPIN PHARMACOL, V2, P121, DOI 10.1016/S1471-4892(02)00133-9; Sepponen K, 2007, VET J, V174, P122, DOI 10.1016/j.tvjl.2006.05.015; Seth A, 2008, AM J PHYSIOL-GASTR L, V294, pG1060, DOI 10.1152/ajpgi.00202.2007; Shieh JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030240; Stanley A, 2014, ANTIOXID REDOX SIGN, V20, P2026, DOI 10.1089/ars.2013.5713; Steube KG, 2012, CYTOTECHNOLOGY, V64, P373, DOI 10.1007/s10616-011-9420-3; Tang YA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012417; Tuohy KM, 2003, DRUG DISCOV TODAY, V8, P692, DOI 10.1016/S1359-6446(03)02746-6; Turroni F, 2014, CELL MOL LIFE SCI, V71, P183, DOI 10.1007/s00018-013-1318-0; Vandenbroucke V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023871; Wentworth CC, 2011, J BIOL CHEM, V286, P38448, DOI 10.1074/jbc.M111.268938; Wu MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100591; Xu JX, 2014, NUTRITION, V30, P584, DOI 10.1016/j.nut.2013.10.018; Ying WH, 2008, ANTIOXID REDOX SIGN, V10, P179, DOI 10.1089/ars.2007.1672	42	16	16	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153135	10.1371/journal.pone.0153135	http://dx.doi.org/10.1371/journal.pone.0153135			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27054581	Green Published, gold, Green Submitted			2022-12-27	WOS:000373608000084
J	Liu, WL; Shih, HC; Weng, IS; Ko, YZ; Tsai, CC; Chou, CH; Chiang, YC				Liu, Wen-Lin; Shih, Huei-Chuan; Weng, I-Szu; Ko, Ya-Zhu; Tsai, Chi-Chu; Chou, Chang-Hung; Chiang, Yu-Chung			Characterization of Genomic Inheritance of Intergeneric Hybrids between Ascocenda and Phalaenopsis Cultivars by GISH, PCR-RFLP and RFLP	PLOS ONE			English	Article							INTERSPECIFIC HYBRIDS; RIBOSOMAL DNA; CHLOROPLAST DNA; PATERNAL INHERITANCE; MATERNAL INHERITANCE; CONCERTED EVOLUTION; LINKAGE MAP; RDNA; SEQUENCES; DISCRIMINATION	Background The intergeneric hybrids between Ascocenda John De Biase ` Blue' and Phalaenopsis Chih Shang's Stripes have been generated to introduce the blue color into the Phalaenopsis germplasm in prior study. In order to confirm the inheritance in hybrid progenies, genomic in situ hybridization (GISH) and restriction fragment length polymorphism (RFLP) analysis were conducted to confirm the intergeneric hybridization status. Methods/Results GISH analysis showed the presence of both maternal and paternal chromosomes in the cells of the putative hybrids indicating that the putative hybrid seedlings were intergeneric hybrids of the two parents. Furthermore, twenty-seven putative hybrids were randomly selected for DNA analysis, and the external transcribed spacer (ETS) regions of nrDNA were analyzed using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) and RFLP analyses to identify the putative hybrids. RFLP analysis showed that the examined seedlings were intergeneric hybrids of the two parents. However, PCRRFLP analysis showed bias to maternal genotype. Conclusions Both GISH and RFLP analyses are effective detection technology to identify the intergeneric hybridization status of putative hybrids. Furthermore, the use of PCR-RFLP analysis to identify the inheritance of putative hybrids should be carefully evaluated.	[Liu, Wen-Lin; Weng, I-Szu; Tsai, Chi-Chu] Kaohsiung Dist Agr Res & Extens Stn, Pingtung 900, Taiwan; [Shih, Huei-Chuan] Meiho Univ, Dept Nursing, Pingtung 912, Taiwan; [Ko, Ya-Zhu; Chiang, Yu-Chung] Natl Sun Yat Sen Univ, Dept Biol Sci, Kaohsiung 804, Taiwan; [Tsai, Chi-Chu] Natl Pingtung Univ Sci & Technol, Pingtung 912, Taiwan; [Chou, Chang-Hung] China Med Univ, Res Ctr Biodivers, Taichung 404, Taiwan; [Chiang, Yu-Chung] Kaohsiung Med Univ, Dept Biomed Sci & Environm Biol, Kaohsiung 807, Taiwan	National Sun Yat Sen University; National Pingtung University Science & Technology; China Medical University Taiwan; Kaohsiung Medical University	Tsai, CC (corresponding author), Kaohsiung Dist Agr Res & Extens Stn, Pingtung 900, Taiwan.; Chiang, YC (corresponding author), Natl Sun Yat Sen Univ, Dept Biol Sci, Kaohsiung 804, Taiwan.; Tsai, CC (corresponding author), Natl Pingtung Univ Sci & Technol, Pingtung 912, Taiwan.; Chou, CH (corresponding author), China Med Univ, Res Ctr Biodivers, Taichung 404, Taiwan.; Chiang, YC (corresponding author), Kaohsiung Med Univ, Dept Biomed Sci & Environm Biol, Kaohsiung 807, Taiwan.	tsaicc@mail.kdais.gov.tw; choumasa@mail.cmu.edu.tw; yuchung@mail.nsysu.edu.tw	Chiang, Yu-Chung/E-9143-2011	Ko, Ya-Zhu/0000-0002-5810-6487	Ministry of Science and Technology, Taiwan [MOST 103-2321-B-067E-001]; China Medical University, Taichung, Taiwan;  [MOST 103-2621-B-110 -001]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); China Medical University, Taichung, Taiwan(China Medical University); 	This research was supported by funding from the Ministry of Science and Technology, Taiwan, MOST 103-2321-B-067E-001 to CCT, partial from MOST 103-2621-B-110 -001 to YCC, and from the China Medical University, Taichung, Taiwan to CHC.	ANAMTHAWATJONSSON K, 1990, THEOR APPL GENET, V79, P721, DOI 10.1007/BF00224236; Asker S. E., 1992, APOMIXIS PLANTS; Baldwin BG, 1998, MOL PHYLOGENET EVOL, V10, P449, DOI 10.1006/mpev.1998.0545; BALDWIN BG, 1995, ANN MO BOT GARD, V82, P247, DOI 10.2307/2399880; BELLAMY A, 1995, THEOR APPL GENET, V91, P505, DOI 10.1007/BF00222980; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; BRANDHAM PE, 1982, GENETICA, V59, P29, DOI 10.1007/BF00130812; CHANG C, 1988, P NATL ACAD SCI USA, V85, P6856, DOI 10.1073/pnas.85.18.6856; Chang SB, 2000, BOT BULL ACAD SINICA, V41, P219; Christenson E.A., 2001, PHALAENOPSIS MONOGRA; CIPRIANI G, 1995, MOL GEN GENET, V247, P693, DOI 10.1007/BF00290400; DEJONG JH, 1993, GENOME, V36, P1032, DOI 10.1139/g93-138; Devos N, 2006, MOL PHYLOGENET EVOL, V38, P767, DOI 10.1016/j.ympev.2005.11.013; DEWIND N, 1995, CELL, V82, P321, DOI 10.1016/0092-8674(95)90319-4; Diaz RS, 1998, BRAZ J MED BIOL RES, V31, P1239, DOI 10.1590/S0100-879X1998001000001; Doyle J. J., 1987, PHYTOCHEM B, P11; Dressler RL, 1993, PHYLOGENY CLASSIFICA; ELLERSTROM S, 1977, HEREDITAS, V87, P107; Fagerlind F, 1940, SV BOT TIDSK, V34, P335; Franzke A, 1999, THEOR APPL GENET, V98, P831, DOI 10.1007/s001220051140; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; HILLIS DM, 1991, SCIENCE, V251, P308, DOI 10.1126/science.1987647; Holderegger R, 2005, TREES-STRUCT FUNCT, V19, P742, DOI 10.1007/s00468-005-0006-6; Holttum RE, 1952, ORCHID J, V1, P58; Housley DJE, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-253; Hu ZanMin, 1996, Acta Botanica Sinica, V38, P253; Huang YJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133722; Jian Li, 2013, Journal of Plant Breeding and Crop Science, V5, P158; JONES D L, 1989, Lindleyana, V4, P139; KAMEMOTO H., 1964, BOT GAZ, V125, P132, DOI 10.1086/336259; Kao YY, 2001, ANN BOT-LONDON, V87, P387, DOI 10.1006/anbo.2000.1348; Kelch DG, 2003, MOL ECOL, V12, P141, DOI 10.1046/j.1365-294X.2003.01710.x; Khrustaleva LI, 2005, GENETICS, V169, P1673, DOI 10.1534/genetics.104.038687; KIM KJ, 1994, PLANT SYST EVOL, V190, P157, DOI 10.1007/BF00986191; Kovarik A, 1996, THEOR APPL GENET, V92, P1108, DOI 10.1007/BF00224057; KUROIWA T, 1991, INT REV CYTOL, V128, P1; Li DW, 2013, MOL GENET GENOMICS, V288, P101, DOI 10.1007/s00438-012-0732-6; Liao PC, 2010, BOT STUD, V51, P413; Lim KB, 2003, THEOR APPL GENET, V106, P568, DOI 10.1007/s00122-002-1070-6; Lin CC, 2005, BOT BULL ACAD SINICA, V46, P339; Logacheva MD, 2010, MOL PHYLOGENET EVOL, V57, P471, DOI 10.1016/j.ympev.2010.06.001; MANHART JR, 1992, J PHYCOL, V28, P730, DOI 10.1111/j.0022-3646.1992.00730.x; McKinnon GE, 2001, GENOME, V44, P831, DOI 10.1139/gen-44-5-831; Moir WWG, 1995, AN ORCHID DATABASE; Nwakanma DC, 2003, THEOR APPL GENET, V108, P154, DOI 10.1007/s00122-003-1402-1; OCHMAN H, 1988, GENETICS, V120, P621; Piperidis N, 2014, METHODS MOL BIOL, V1115, P325, DOI 10.1007/978-1-62703-767-9_16; Poczai P, 2010, MOL BIOL REP, V37, P1897, DOI 10.1007/s11033-009-9630-3; Raina S. N., 2001, Methods in Cell Science, V23, P83, DOI 10.1023/A:1013197705523; Ruano G, 1992, PCR Methods Appl, V2, P112; Sang T, 1995, THESIS OHIO STATE U; SCHLOTTERER C, 1994, CURR BIOL, V4, P777, DOI 10.1016/S0960-9822(00)00175-5; SCHWARZACHER T, 1989, ANN BOT-LONDON, V64, P315, DOI 10.1093/oxfordjournals.aob.a087847; SHINDO K, 1963, CYTOLOGIA, V28, P390, DOI 10.1508/cytologia.28.390; Shore JS, 1998, AM J BOT, V85, P328, DOI 10.2307/2446324; Skalick a K, 2003, AM J BOT, V90, P988, DOI [10.3732/ajb.90.7.988, DOI 10.3732/AJB.90.7.988]; SOLIMAN KM, 1993, THEOR APPL GENET, V85, P913, DOI 10.1007/BF00225038; STINE M, 1989, THEOR APPL GENET, V78, P768, DOI 10.1007/BF00266656; Tsai CC, 2006, J HORTIC SCI BIOTECH, V81, P691, DOI 10.1080/14620316.2006.11512125; Tsai CC, 2009, ACTA HORTIC, V829, P413; Tsai CC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141761; Tsai CC, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0560-z; Tsai CC, 2012, SCI HORTIC-AMSTERDAM, V142, P84, DOI 10.1016/j.scienta.2012.05.004; Volkov RA, 1999, MOL BIOL EVOL, V16, P311, DOI 10.1093/oxfordjournals.molbev.a026112; Wan DS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089769; WENDEL JF, 1995, MOL PHYLOGENET EVOL, V4, P298, DOI 10.1006/mpev.1995.1027; WENDEL JF, 1995, P NATL ACAD SCI USA, V92, P280, DOI 10.1073/pnas.92.1.280; Yang TW, 2000, AM J BOT, V87, P1452, DOI 10.2307/2656871	68	3	5	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153512	10.1371/journal.pone.0153512	http://dx.doi.org/10.1371/journal.pone.0153512			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27055268	gold, Green Published, Green Submitted			2022-12-27	WOS:000373608000130
J	Rahman, A; Sahrin, M; Afrin, S; Earley, K; Ahmed, S; Rahman, SMM; Banu, S				Rahman, Arfatur; Sahrin, Mahfuza; Afrin, Sadia; Earley, Keith; Ahmed, Shahriar; Rahman, S. M. Mazidur; Banu, Sayera			Comparison of Xpert MTB/RIF Assay and GenoType MTBDRplus DNA Probes for Detection of Mutations Associated with Rifampicin Resistance in Mycobacterium tuberculosis	PLOS ONE			English	Article							RPOB GENE; ISONIAZID RESISTANCE; MOLECULAR-DETECTION; RAPID DETECTION; STRAINS; BEACONS; CHINA	Background GeneXpert MTB/RIF (Xpert) and Genotype MTBDRplus (DRplus) are two World Health Organization (WHO) endorsed probe based molecular drug susceptibility testing (DST) methods for rapid diagnosis of drug resistant tuberculosis. Both methods target the same 81 bp Rifampicin Resistance Determining Region (RRDR) of bacterial RNA polymerase beta subunit (rpoB) for detection of Rifampicin (RIF) resistance associated mutations using DNA probes. So there is a correspondence of the probes of each other and expected similarity of probe binding. Methods We analyzed 92 sputum specimens by Xpert, DRplus and LJ proportion method (LJ-DST). We compared molecular DSTs with gold standard LJ-DST. We wanted to see the agreement level of two molecular methods for detection of RIF resistance associated mutations. The 81bp RRDR region of rpoB gene of discrepant cases between the two molecular methods was sequenced by Sanger sequencing. Results The agreement of Xpert and DRplus with LJ-DST for detection of RIF susceptibility was found to be 93.5% and 92.4%, respectively. We also found 92.4% overall agreement of two molecular methods for the detection of RIF susceptibility. A total of 84 out of 92 samples (91.3%) had agreement on the molecular locus of RRDR mutation by DRplus and Xpert. Sanger sequencing of 81bp RRDR revealed that Xpert probes detected seven of eight discrepant cases correctly and DRplus was erroneous in all the eight cases. Conclusion Although the overall concordance with LJ-DST was similar for both Xpert and DRplus assay, Xpert demonstrated more accuracy in the detection of RIF susceptibility for discrepant isolates compared with DRplus. This observation would be helpful for the improvement of probe based detection of drug resistance associated mutations especially rpoB mutation in M. tuberculosis.	[Rahman, Arfatur; Sahrin, Mahfuza; Afrin, Sadia; Ahmed, Shahriar; Rahman, S. M. Mazidur; Banu, Sayera] Int Ctr Diarrheal Dis Res, Dhaka, Bangladesh; [Earley, Keith] Oregon Hlth & Sci Univ, Portland, OR 97201 USA	International Centre for Diarrhoeal Disease Research (ICDDR); Oregon Health & Science University	Banu, S (corresponding author), Int Ctr Diarrheal Dis Res, Dhaka, Bangladesh.	sbanu@icddrb.org	Rahman, Arfatur/AAC-1482-2022; Afrin, Sadia/AAQ-5030-2020; AHMED, SHAHRIAR/N-8532-2019; Ahmed, Shahriar/A-3109-2019; Afrin, Sadia/AAQ-5363-2020	Rahman, Arfatur/0000-0001-8749-0337; AHMED, SHAHRIAR/0000-0002-8833-4130; Ahmed, Shahriar/0000-0002-8833-4130; Rahman, Syed Mohammad Mazidur/0000-0003-2887-6250; Banu, Sayera/0000-0002-5121-1962; Afrin, Sadia/0000-0001-5063-9900	USAID through CDC; Government of Bangladesh; Government of Sweden; Government of the UK	USAID through CDC(United States Agency for International Development (USAID)); Government of Bangladesh; Government of Sweden; Government of the UK	This research protocol was funded by USAID through CDC. icddr,b acknowledges with gratitude the commitment of USAID and CDC to their research efforts. icddr, b is thankful to the Governments of Bangladesh, Sweden, and the UK for providing core/unrestricted support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banu S, 2014, J CLIN MICROBIOL, V52, P156, DOI 10.1128/JCM.02378-13; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Campbell PJ, 2011, ANTIMICROB AGENTS CH, V55, P2032, DOI 10.1128/AAC.01550-10; Cavusoglu C, 2002, J CLIN MICROBIOL, V40, P4435, DOI 10.1128/JCM.40.12.4435-4438.2002; Chen L, 2010, J ANTIMICROB CHEMOTH, V65, P1299, DOI 10.1093/jac/dkq102; Drobniewski F., 2013, ERLN TB EXPERT OPINI; El-Hajj HH, 2001, J CLIN MICROBIOL, V39, P4131, DOI 10.1128/JCM.39.11.4131-4137.2001; Fang RD, 2008, TUBERCULOSIS, V88, P469, DOI 10.1016/j.tube.2008.02.002; Farooqi JQ, 2012, J PAK MED ASSOC, V62, P767; Helb D, 2010, J CLIN MICROBIOL, V48, P229, DOI 10.1128/JCM.01463-09; Heysell SK, 2012, FUTURE MOL DIAGNOSTI; Hillemann D, 2005, J CLIN MICROBIOL, V43, P3699, DOI 10.1128/JCM.43.8.3699-3703.2005; Hofmann-Thiel S, 2009, EUR RESPIR J, V33, P368, DOI 10.1183/09031936.00089808; Ioannidis P, 2011, J CLIN MICROBIOL, V49, P3068, DOI 10.1128/JCM.00718-11; Kent PT, 1985, GUIDE LEVEL 3 LAB; Kim BJ, 1997, J CLIN MICROBIOL, V35, P492, DOI 10.1128/JCM.35.2.492-494.1997; Lawn SD, 2011, FUTURE MICROBIOL, V6, P1067, DOI [10.2217/FMB.11.84, 10.2217/fmb.11.84]; Lee ASG, 2005, J CLIN MICROBIOL, V43, P2026, DOI 10.1128/JCM.43.4.2026-2027.2005; Mani C, 2001, J CLIN MICROBIOL, V39, P2987, DOI 10.1128/JCM.39.8.2987-2990.2001; Miotto P, 2006, J CLIN MICROBIOL, V44, P2485, DOI 10.1128/JCM.00083-06; Ocheretina O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090569; Organization W. H, 2015, GLOB TUB REP 2015; Organization WH, 2014, GLOB TUB REP 2014; Organization WH, 2010, GLOB PLAN STOP TB 20; Piatek AS, 1998, NAT BIOTECHNOL, V16, P359, DOI 10.1038/nbt0498-359; Pozzi G, 1999, J CLIN MICROBIOL, V37, P1197, DOI 10.1128/JCM.37.4.1197-1199.1999; Racheal S. D. M., 2015, British Journal of Medicine and Medical Research, V5, P1044, DOI 10.9734/BJMMR/2015/13979; Rufai SB, 2014, J CLIN MICROBIOL, V52, P1846, DOI 10.1128/JCM.03005-13; Science HL, GENOTYPE MTBDRPLUS V; TELENTI A, 1993, LANCET, V341, P647, DOI 10.1016/0140-6736(93)90417-F; Tyagi S, 1996, NAT BIOTECHNOL, V14, P303, DOI 10.1038/nbt0396-303; Williamson DA, 2012, DIAGN MICR INFEC DIS, V74, P207, DOI 10.1016/j.diagmicrobio.2012.06.013; WorldHealthOrganization, 2013, AUT REAL TIM NUCL AM; Yuan X, 2012, J CLIN MICROBIOLOGY	34	40	46	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0152694	10.1371/journal.pone.0152694	http://dx.doi.org/10.1371/journal.pone.0152694			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27054344	gold, Green Published, Green Submitted			2022-12-27	WOS:000373608000035
J	Rosier, BT; Lazova, MD				Rosier, Bob T.; Lazova, Milena D.			Dose-Response Analysis of Chemotactic Signaling Response in Salmonella typhimurium LT2 upon Exposure to Cysteine/Cystine Redox Pair	PLOS ONE			English	Article							INTESTINAL MUCUS BARRIER; ESCHERICHIA-COLI; REPELLENT TAXIS; BACTERIAL; CHEMORECEPTORS; CYSTINE; RECEPTOR; COOPERATIVITY; SENSITIVITY; PATHWAY	The chemotaxis system enables motile bacteria to search for an optimum level of environmental factors. Salmonella typhimurium senses the amino acid cysteine as an attractant and its oxidized dimeric form, cystine, as a repellent. We investigated the dose-response dependence of changes in chemotactic signaling activity upon exposure to cysteine and cystine of S. typhimurium LT2 using in vivo fluorescence resonance energy transfer (FRET) measurements. The dose-response curve of the attractant response to cysteine had a sigmoidal shape, typical for receptor-ligand interactions. However, in a knockout strain of the chemoreceptor genes tsr and tar, we detected a repellent response to cysteine solutions, scaling linearly with the logarithm of the cysteine concentration. Interestingly, the magnitude of the repellent response to cystine also showed linear dependence to the logarithm of the cystine concentration. This linear dependence was observed over more than four orders of magnitude, where detection started at nanomolar concentrations. Notably, low concentrations of another oxidized compound, benzoquinone, triggered similar responses. In contrast to S. typhimurium 14028, where no response to cystine was observed in a knockout strain of chemoreceptor genes mcpB and mcpC, here we showed that McpB/McpC-independent responses to cystine existed in the strain S. typhimurium LT2 even at nanomolar concentrations. Additionally, knocking out mcpB and mcpC did not affect the linear dose-response dependence, whereas enhanced responses were only observed to solutions that where not pH neutral (>100 mu M cystine) in the case of McpC overexpression. We discuss that the linear dependence of the response on the logarithm of cystine concentrations could be a result of a McpB/C-independent redox-sensing pathway that exists in S. typhimurium LT2. We supported this hypothesis with experiments with defined cysteine/cystine mixed solutions, where a transition from repellent to attractant response occurred depending on the estimated redox potential.	[Rosier, Bob T.; Lazova, Milena D.] FOM Inst Atom & Mol Phys AMOLF, Amsterdam, Netherlands; [Rosier, Bob T.] Max Planck Inst MPI Terr Microbiol Marburg, Hessen, Germany; [Lazova, Milena D.] MIT, Dept Biol, Cambridge, MA USA	AMOLF; Massachusetts Institute of Technology (MIT)	Lazova, MD (corresponding author), FOM Inst Atom & Mol Phys AMOLF, Amsterdam, Netherlands.; Lazova, MD (corresponding author), MIT, Dept Biol, Cambridge, MA USA.	lazova@mit.edu		Rosier, Bob T./0000-0002-3267-6561	Netherlands Organization for Scientific Research / Foundation for Fundamental Research on Matter	Netherlands Organization for Scientific Research / Foundation for Fundamental Research on Matter(FOM (The Netherlands)Netherlands Organization for Scientific Research (NWO))	This work was supported by The Netherlands Organization for Scientific Research / Foundation for Fundamental Research on Matter.	ADLER J, 1973, J BACTERIOL, V115, P824, DOI 10.1128/JB.115.3.824-847.1973; ADLER J, 1966, SCIENCE, V153, P708, DOI 10.1126/science.153.3737.708; ADLER J, 1969, SCIENCE, V166, P1588, DOI 10.1126/science.166.3913.1588; BERG HC, 1984, J GEN MICROBIOL, V130, P2915; Berg HC, 2000, PHYS TODAY, V53, P24, DOI 10.1063/1.882934; Bespalov VA, 1996, P NATL ACAD SCI USA, V93, P10084, DOI 10.1073/pnas.93.19.10084; Bibikov SI, 1997, J BACTERIOL, V179, P4075, DOI 10.1128/jb.179.12.4075-4079.1997; Briegel A, 2012, P NATL ACAD SCI USA, V109, P3766, DOI 10.1073/pnas.1115719109; BRIGHAM MP, 1960, J CLIN INVEST, V39, P1633, DOI 10.1172/JCI104186; Burne R A, 2012, Adv Dent Res, V24, P77, DOI 10.1177/0022034512449462; Corazziari ES, 2009, J PEDIATR GASTR NUTR, V48, pS54, DOI 10.1097/MPG.0b013e3181a117ea; Corfield AP, 2000, GUT, V47, P589, DOI 10.1136/gut.47.4.589; CRAWHALL JC, 1967, BIOCHEM J, V105, P891, DOI 10.1042/bj1050891; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DEWEY DL, 1965, NATURE, V206, P1369, DOI 10.1038/2061369a0; Edwards JC, 2006, MOL MICROBIOL, V62, P823, DOI 10.1111/j.1365-2958.2006.05411.x; Englert DL, 2010, J BACTERIOL, V192, P2633, DOI 10.1128/JB.00854-09; Falke JJ, 2002, P NATL ACAD SCI USA, V99, P6530, DOI 10.1073/pnas.112214199; Garcia-Quintanilla M, 2011, PLASMID, V65, P169, DOI 10.1016/j.plasmid.2010.12.001; Hazelbauer GL, 2008, TRENDS BIOCHEM SCI, V33, P9, DOI 10.1016/j.tibs.2007.09.014; Hazelbauer GL, 1971, NAT NEW BIO, V230; HEDBLOM ML, 1983, J BACTERIOL, V155, P1463, DOI 10.1128/JB.155.3.1463-1466.1983; Ishii T, 1999, FREE RADICAL RES, V31, P351, DOI 10.1080/10715769900300921; Jarvik T, 2010, J BACTERIOL, V192, P560, DOI 10.1128/JB.01233-09; KELLN RA, 1990, MOL GEN GENET, V222, P438, DOI 10.1007/BF00633852; KIHARA M, 1981, J BACTERIOL, V145, P1209, DOI 10.1128/JB.145.3.1209-1221.1981; Kim Young S, 2010, Curr Gastroenterol Rep, V12, P319, DOI 10.1007/s11894-010-0131-2; KONDOH H, 1979, P NATL ACAD SCI USA, V76, P260, DOI 10.1073/pnas.76.1.260; Lane MC, 2006, J BACTERIOL, V188, P5618, DOI 10.1128/JB.00449-06; Lazova MD, 2012, MOL MICROBIOL, V84, P697, DOI 10.1111/j.1365-2958.2012.08051.x; Lazova MD, 2011, P NATL ACAD SCI USA, V108, P13870, DOI 10.1073/pnas.1108608108; Lengeler JW, 1996, HDB BIOL PHYS, V2; Linden SK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003952; Lux R, 1999, MOL BIOL CELL, V10, P1133, DOI 10.1091/mbc.10.4.1133; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; McGhie EJ, 2009, CURR OPIN MICROBIOL, V12, P117, DOI 10.1016/j.mib.2008.12.001; MOWBRAY SL, 1987, CELL, V50, P171, DOI 10.1016/0092-8674(87)90213-3; Neidhardt FCeic, 1996, ESCHERICHIA COLI SAL; Neumann S, 2014, PLOS ONE, V9; Prinz Heino, 2010, J Chem Biol, V3, P37, DOI 10.1007/s12154-009-0029-3; Rebbapragada A, 1997, P NATL ACAD SCI USA, V94, P10541, DOI 10.1073/pnas.94.20.10541; Rosner JL, 1997, CURR TOP CELL REGUL, V35, P163, DOI 10.1016/S0070-2137(97)80007-6; Salman H, 2007, NAT CELL BIOL, V9, P1098, DOI 10.1038/ncb1632; Shimizu TS, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.37; Sourjik V, 2004, NATURE, V428, P437, DOI 10.1038/nature02406; Sourjik V, 2002, P NATL ACAD SCI USA, V99, P123, DOI 10.1073/pnas.011589998; Sourjik V, 2007, METHOD ENZYMOL, V423, P365, DOI 10.1016/S0076-6879(07)23017-4; Sourjik V, 2012, CURR OPIN CELL BIOL, V24, P262, DOI 10.1016/j.ceb.2011.11.008; Stock J, 1999, TRENDS MICROBIOL, V7, P1, DOI 10.1016/S0966-842X(98)01429-2; Swidsinski A, 2007, GUT, V56, P343, DOI 10.1136/gut.2006.098160; TREVORS JT, 1980, B ENVIRON CONTAM TOX, V25, P672, DOI 10.1007/BF01985590; Wadhams GH, 2004, NAT REV MOL CELL BIO, V5, P1024, DOI 10.1038/nrm1524; Winfield MD, 2003, APPL ENVIRON MICROB, V69, P3687, DOI 10.1128/AEM.69.7.3687-3694.2003; Yang Y, 2012, MOL MICROBIOL, V62, P823; Yang YL, 2015, MOL MICROBIOL, V96, P1272, DOI 10.1111/mmi.13006; Yuan JH, 2008, P NATL ACAD SCI USA, V105, P1182, DOI 10.1073/pnas.0711539105	56	2	2	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0152815	10.1371/journal.pone.0152815	http://dx.doi.org/10.1371/journal.pone.0152815			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27054963	Green Submitted, Green Published, gold			2022-12-27	WOS:000373608000047
J	Braczkowski, AR; Balme, GA; Dickman, A; Fattebert, J; Johnson, P; Dickerson, T; Macdonald, DW; Hunter, L				Braczkowski, Alexander Richard; Balme, Guy Andrew; Dickman, Amy; Fattebert, Julien; Johnson, Paul; Dickerson, Tristan; Macdonald, David Whyte; Hunter, Luke			Scent Lure Effect on Camera-Trap Based Leopard Density Estimates	PLOS ONE			English	Article							CAPTURE-RECAPTURE MODELS; PANTHERA-PARDUS; SOUTH-AFRICA; MARK-RECAPTURE; POPULATIONS; INFERENCE; CARNIVORES; JAGUAR; CONSERVATION; INFORMATION	Density estimates for large carnivores derived from camera surveys often have wide confidence intervals due to low detection rates. Such estimates are of limited value to authorities, which require precise population estimates to inform conservation strategies. Using lures can potentially increase detection, improving the precision of estimates. However, by altering the spatio-temporal patterning of individuals across the camera array, lures may violate closure, a fundamental assumption of capture-recapture. Here, we test the effect of scent lures on the precision and veracity of density estimates derived from camera-trap surveys of a protected African leopard population. We undertook two surveys (a 'control' and 'treatment' survey) on Phinda Game Reserve, South Africa. Survey design remained consistent except a scent lure was applied at camera-trap stations during the treatment survey. Lures did not affect the maximum movement distances (p = 0.96) or temporal activity of female (p = 0.12) or male leopards (p = 0.79), and the assumption of geographic closure was met for both surveys (p >0.05). The numbers of photographic captures were also similar for control and treatment surveys (p = 0.90). Accordingly, density estimates were comparable between surveys (although estimates derived using non-spatial methods (7.28-9.28 leopards/100km(2)) were considerably higher than estimates from spatially-explicit methods (3.40-3.65 leopards/100km(2)). The precision of estimates from the control and treatment surveys, were also comparable and this applied to both non-spatial and spatial methods of estimation. Our findings suggest that at least in the context of leopard research in productive habitats, the use of lures is not warranted.	[Braczkowski, Alexander Richard; Dickman, Amy; Johnson, Paul; Macdonald, David Whyte] Univ Oxford, Recanati Kaplan Ctr, Dept Zool, Wildlife Conservat Res Unit, Tubney House, Tubney, Oxon, England; [Balme, Guy Andrew; Fattebert, Julien; Dickerson, Tristan; Hunter, Luke] Panthera, 8 West 40th St,18th Floor, New York, NY USA; [Balme, Guy Andrew] Univ Cape Town, Dept Biol Sci, ZA-7700 Rondebosch, South Africa; [Dickman, Amy] Ruaha Carnivore Project, Iringa, Tanzania; [Fattebert, Julien] Univ Kwazulu Natal, Sch Life Sci, Westville Campus, Durban, South Africa	University of Oxford; University of Cape Town; University of Kwazulu Natal	Braczkowski, AR (corresponding author), Univ Oxford, Recanati Kaplan Ctr, Dept Zool, Wildlife Conservat Res Unit, Tubney House, Tubney, Oxon, England.	alexander.braczkowski@gmail.com	Hunter, Luke T.B./H-3324-2019; Fattebert, Julien/I-8126-2019	Hunter, Luke T.B./0000-0001-9653-6544; Fattebert, Julien/0000-0001-5510-6804; Braczkowski, Alexander/0000-0002-0099-7803	Panthera New York; Timbo-Stichting Foundation; Albert and Didy Hartog; Robertson Foundation; Recanati-Kaplan Foundation	Panthera New York; Timbo-Stichting Foundation; Albert and Didy Hartog; Robertson Foundation; Recanati-Kaplan Foundation	Panthera New York provided vehicles, camera-traps and funding for fieldwork. Albert and Didy Hartog and the Timbo-Stichting Foundation also provided funding for fieldwork. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Albert and Didy Hartog, the Timbo-Stichting Foundation and Panthera for funding the study and the provision of materials to perform this research. & Beyond is thanked for access to research sites. DWM thanks the Robertson Foundation and the Recanati-Kaplan Foundation for support. The authors have no conflicts of interest to declare.	Ariefiandy A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058800; Athreya V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057872; Bailey, 1993, AFRICAN LEOPARD ECOL; Balme G, 2014, BIOL CONSERV, V179, P144, DOI 10.1016/j.biocon.2014.09.021; Balme GA, 2010, ANIM CONSERV, V13, P315, DOI 10.1111/j.1469-1795.2009.00342.x; Balme G, 2007, ANIM BEHAV, V74, P589, DOI 10.1016/j.anbehav.2006.12.014; Balme GA, 2014, CONSERV LETT, V7, P3, DOI 10.1111/conl.12028; Balme GA, 2009, BIOL CONSERV, V142, P2681, DOI 10.1016/j.biocon.2009.06.020; Balme GA, 2009, J WILDLIFE MANAGE, V73, P433, DOI 10.2193/2007-368; Balme GA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035209; Borchers D, 2014, METHODS ECOL EVOL, V5, P656, DOI 10.1111/2041-210X.12196; Bothma J.d.P., 1999, LARGER CARNIVORES AF, P22, DOI [10.1007/978-3-662-03766-9_2/COVER, DOI 10.1007/978-3-662-03766-9_2/COVER]; Braczkowski AR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123100; Braczkowski Alexander, 2013, Cat News, V58, P13; Chandler RB, 2011, ECOLOGY, V92, P1429, DOI 10.1890/10-2433.1; Di Minin E, 2013, ANIM CONSERV, V16, P249, DOI 10.1111/j.1469-1795.2012.00595.x; du Preez BD, 2014, BIOL CONSERV, V176, P153, DOI 10.1016/j.biocon.2014.05.021; Gray TNE, 2012, J WILDLIFE MANAGE, V76, P163, DOI 10.1002/jwmg.230; Efford M., 2015, PACKAGE SECR VERSION; Efford M. G., 2004, Animal Biodiversity and Conservation, V27, P217; Fattebert J, 2013, THESIS U KWAZULU NAT; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Gerber BD, 2012, POPUL ECOL, V54, P43, DOI 10.1007/s10144-011-0276-3; Gopalaswamy AM, 2012, METHODS ECOL EVOL, V3, P1067, DOI 10.1111/j.2041-210X.2012.00241.x; Gopalaswamy AM, 2012, ECOLOGY, V93, P1741, DOI 10.1890/11-2110.1; Grant TL, 2012, THESIS RHODES U GRAH; Grey JNC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082832; Hijmans RJ., 2013, RASTER PACKAGE R VER; Janecka JE, 2011, J MAMMAL, V92, P771, DOI 10.1644/10-MAMM-A-036.1; Karanth KU, 1998, ECOLOGY, V79, P2852; Keitt T., 2013, RGDAL PACKAGE R VERS; Lindsey PA, 2006, ANIM CONSERV, V9, P283, DOI 10.1111/j.1469-1795.2006.00034.x; Maputla NW, 2013, AFR J ECOL, V51, P422, DOI 10.1111/aje.12047; Marnewick K, 2008, S AFR J WILDL RES, V38, P59, DOI 10.3957/0379-4369-38.1.59; Martins Q, 2013, AFR J ECOL, V51, P571, DOI 10.1111/aje.12068; Mazerolle MJ, 2006, AMPHIBIA-REPTILIA, V27, P169, DOI 10.1163/156853806777239922; MITHTHAPALA S, 1989, J ZOOL, V218, P527, DOI 10.1111/j.1469-7998.1989.tb04996.x; Noss AJ, 2012, ANIM CONSERV, V15, P527, DOI 10.1111/j.1469-1795.2012.00545.x; O'Connell A, 2011, CAMERA TRAPS IN ANIMAL ECOLOGY: METHODS AND ANALYSES, pV; Obbard ME, 2010, J APPL ECOL, V47, P76, DOI 10.1111/j.1365-2664.2009.01758.x; OTIS DL, 1978, WILDLIFE MONOGR, P1; Pesenti E, 2013, J MAMMAL, V94, P73, DOI 10.1644/11-MAMM-A-322.1; Pradel R, 1996, BIOMETRICS, V52, P703, DOI 10.2307/2532908; R Core Team, 2018, R LANG ENV STAT COMP; Ray J.C., 2005, 24 WILDL CONS SOC; Royle JA, 2009, ECOLOGY, V90, P3233, DOI 10.1890/08-1481.1; Royle JA, 2014, SPATIAL CAPTURE-RECAPTURE, P1; Sollmann R, 2013, BIOL CONSERV, V167, P242, DOI 10.1016/j.biocon.2013.08.003; Sollmann R, 2011, BIOL CONSERV, V144, P1017, DOI 10.1016/j.biocon.2010.12.011; Stanley TR, 1999, ENVIRON ECOL STAT, V6, P197, DOI 10.1023/A:1009674322348; Sunquist ME, 2002, WILD CATS WORLD; Thomas P., 2005, ANIM KEEPERSFORUM, V32, P342; Thorn M, 2009, S AFR J WILDL RES, V39, P1, DOI 10.3957/056.039.0101; Tobler MW, 2013, BIOL CONSERV, V159, P375, DOI 10.1016/j.biocon.2012.12.012; Williams B. K., 2002, ANAL MANAGEMENT ANIM; Zar JH, 1999, BIOSTATISTICAL ANAL	56	56	56	2	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0151033	10.1371/journal.pone.0151033	http://dx.doi.org/10.1371/journal.pone.0151033			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050816	gold, Green Published			2022-12-27	WOS:000373603500005
J	Jenkins, A; Croitoru, A; Crooks, AT; Stefanidis, A				Jenkins, Andrew; Croitoru, Arie; Crooks, Andrew T.; Stefanidis, Anthony			Crowdsourcing a Collective Sense of Place	PLOS ONE			English	Article							TWITTER; INFORMATION; SPACE; MEDIA; SIZE	Place can be generally defined as a location that has been assigned meaning through human experience, and as such it is of multidisciplinary scientific interest. Up to this point place has been studied primarily within the context of social sciences as a theoretical construct. The availability of large amounts of user-generated content, e.g. in the form of social media feeds or Wikipedia contributions, allows us for the first time to computationally analyze and quantify the shared meaning of place. By aggregating references to human activities within urban spaces we can observe the emergence of unique themes that characterize different locations, thus identifying places through their discernible sociocultural signatures. In this paper we present results from a novel quantitative approach to derive such sociocultural signatures from Twitter contributions and also from corresponding Wikipedia entries. By contrasting the two we show how particular thematic characteristics of places ( referred to herein as platial themes) are emerging from such crowd-contributed content, allowing us to observe the meaning that the general public, either individually or collectively, is assigning to specific locations. Our approach leverages probabilistic topic modelling, semantic association, and spatial clustering to find locations are conveying a collective sense of place. Deriving and quantifying such meaning allows us to observe how people transform a location to a place and shape its characteristics.	[Jenkins, Andrew; Croitoru, Arie; Stefanidis, Anthony] George Mason Univ, Dept Geog & GeoInformat Sci, Fairfax, VA 22030 USA; [Croitoru, Arie; Stefanidis, Anthony] George Mason Univ, Ctr Geospatial Intelligence, Fairfax, VA 22030 USA; [Crooks, Andrew T.] George Mason Univ, Dept Computat & Data Sci, Fairfax, VA 22030 USA	George Mason University; George Mason University; George Mason University	Jenkins, A (corresponding author), George Mason Univ, Dept Geog & GeoInformat Sci, Fairfax, VA 22030 USA.	ajenki11@gmu.edu	Crooks, Andrew T/L-2018-2017	Crooks, Andrew T/0000-0002-5034-6654	George Mason University	George Mason University	Publication of this article was funded in part by the George Mason University Libraries Open Access Publishing Fund and a Provost Award. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams B, 2015, INT J GEOGR INF SYST, P1; Arun R., 2010, ADV KNOWLEDGE DISCOV, V6118, DOI [10.1007/978-3-642-13657-3_43, DOI 10.1007/978-3-642-13657-3_43]; Auer Soren, 2007, DBPEDIA NUCL WEB OPE; Batty M., 1999, Computers, Environment and Urban Systems, V23, P205, DOI 10.1016/S0198-9715(99)00015-0; Batty M., 2007, CITIES COMPLEXITY UN; Batty M., 2013, NEW SCI CITIES; Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; BRANDENBURG AM, 1995, SOC NATUR RESOUR, V8, P381, DOI 10.1080/08941929509380931; Bruns A., 2012, PRODUSING THEORY DIG, P15; Burton SH, 2012, J MED INTERNET RES, V14, P366, DOI 10.2196/jmir.2121; CLARK PJ, 1954, ECOLOGY, V35, P445, DOI 10.2307/1931034; Croitoru A., 2014, BIG DATA TECHNIQUES, P207; Crooks A, 2014, INT J GEOGR INF SYST, V29, P1; de Mattos B, 2006, HERPETOL J, V23, P29; DevineWright P, 1997, J ENVIRON PSYCHOL, V17, P33, DOI 10.1006/jevp.1996.0037; Dilrukshi I, 2013, PROCEEDINGS OF THE 2013 8TH INTERNATIONAL CONFERENCE ON COMPUTER SCIENCE & EDUCATION (ICCSE 2013), P287; Sagar Paul, 1992, Notornis, V39, P1, DOI 10.1145/143103.143108; GETIS A, 1992, GEOGR ANAL, V24, P189, DOI 10.1111/j.1538-4632.1992.tb00261.x; Gieryn TF, 2000, ANNU REV SOCIOL, V26, P463, DOI 10.1146/annurev.soc.26.1.463; Goodchild MF, 2012, SPAT STAT-NETH, V1, P110, DOI 10.1016/j.spasta.2012.03.002; Goode L, 2009, NEW MEDIA SOC   1124; Graham S., 1999, EUR PLAN STUD, V7, P623, DOI [10.1080/09654319908720542, DOI 10.1080/09654319908720542]; Gustafson P, 2001, J ENVIRON PSYCHOL, V21, P5, DOI 10.1006/jevp.2000.0185; Hargittai E, 2011, NEW MEDIA SOC, V13, P824, DOI 10.1177/1461444811405805; Healey P, 2004, INT J URBAN REGIONAL, V28, P45, DOI 10.1111/j.0309-1317.2004.00502.x; Hidalgo MC, 2001, J ENVIRON PSYCHOL, V21, P273, DOI 10.1006/jevp.2001.0221; Iosif E, 2010, IEEE T KNOWL DATA EN, V22, P1637, DOI 10.1109/TKDE.2009.193; Janac M, 2013, RIVER RES APPL, V29, P90, DOI 10.1002/rra.1582; Kaplan AM, 2010, BUS HORIZONS, V53, P59, DOI 10.1016/j.bushor.2009.09.003; KEARNS RA, 1993, SOC SCI MED, V37, P711, DOI 10.1016/0277-9536(93)90364-A; KENKEL NC, 1986, ECOLOGY, V67, P919, DOI 10.2307/1939814; Kittur A, 2009, CHI2009: PROCEEDINGS OF THE 27TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1-4, P1509; KULLBACK S, 1951, ANN MATH STAT, V22, P79, DOI 10.1214/aoms/1177729694; Law J, 2004, ECON SOC, V33, P390, DOI 10.1080/0308514042000225716; Lee KH, 2011, ACTA HORTIC, V900, P251, DOI 10.1109/ICDMW.2011.171; Lewicka M, 2010, J ENVIRON PSYCHOL, V30, P35, DOI 10.1016/j.jenvp.2009.05.004; Liu Y, 2015, ANN ASSOC AM GEOGR, V105, P512, DOI 10.1080/00045608.2015.1018773; Louail T, 2014, SCI REP-UK, V4, DOI 10.1038/srep05276; Mathioudakis M., 2010, P 2010 ACM SIGMOD IN, P1155, DOI DOI 10.1145/1807167.1807306; Matsuo Y., 2006, P 2006 C EMPIRICAL M, P542, DOI [10.3115/1610075.1610150, DOI 10.3115/1610075.1610150]; Paez A., 2004, GEOJOURNAL, V61, P53, DOI [10.1007/s10708-005-0877-5, DOI 10.1007/S10708-005-0877-5]; Pak A., 2010, COMPUTER, P1320, DOI DOI 10.1371/JOURNAL.PONE.0026624; Popescu A, 2010, P JCDL 10 NY ACM, P129; Recchia G, 2009, BEHAV RES METHODS, V41, P647, DOI 10.3758/BRM.41.3.647; Relph E., 1976, PLACE PLACELESSNESS; Renkonen O., THESIS; Roche S, 2015, PROGR HUMAN GEOGRAPH; Salesses P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068400; Shao GS, 2009, INTERNET RES, V19, P7, DOI 10.1108/10662240910927795; Steiger E, 2016, INT J GEOGR INF SCI, V30, P1694, DOI 10.1080/13658816.2015.1099658; Tuan Y.-F., 1977, SPACE PLACE PERSPECT; Wagner C, 2013, 2013 ASE/IEEE INTERNATIONAL CONFERENCE ON SOCIAL COMPUTING (SOCIALCOM), P303, DOI 10.1109/SocialCom.2013.49; Wang XR, 2007, IEEE DATA MINING, P697, DOI 10.1109/ICDM.2007.86; Williams DR, 1998, J FOREST, V96, P18; WOLDA H, 1981, OECOLOGIA, V50, P296, DOI 10.1007/BF00344966; Zhao WNX, 2011, LECT NOTES COMPUT SC, V6611, P338, DOI 10.1007/978-3-642-20161-5_34	57	53	53	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0152932	10.1371/journal.pone.0152932	http://dx.doi.org/10.1371/journal.pone.0152932			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DI6IX	27050432	Green Published, Green Submitted, gold			2022-12-27	WOS:000373603500069
J	Johnson, C; Giles, JT; Bathon, J; Lederer, D; Hoffman, EA; Barr, RG; Danoff, SK				Johnson, Cheilonda; Giles, Jon T.; Bathon, Joan; Lederer, David; Hoffman, Eric A.; Barr, R. Graham; Danoff, Sonye K.			Smoking and Subclinical ILD in RA versus the Multi-Ethnic Study of Atherosclerosis	PLOS ONE			English	Article							INTERSTITIAL LUNG-DISEASE; RHEUMATOID-ARTHRITIS; CIGARETTE-SMOKING; CARDIAC CT; HLA-DRB1; MESA; GENE	A population-based cohort showed an association between cigarette smoking and subclinical parenchymal lung disease defined as regions of increased computed tomography (CT) lung densitometry. This technique has not been applied to the rheumatoid arthritis (RA) population where associated ILD is highly prevalent. The association between cumulative cigarette smoking and volume of areas of high attenuation (HAA: >-600 and <-250 Hounsfield Units) on full inspiratory CT was compared in 172 RA participants and 3,969 controls in a general population sample. Multivariable regression models were used to adjust for demography, anthropometrics, percent emphysema, and CT parameters. The mean cumulative cigarette smoking exposure was 25 (IQR 10-42) and 15(IQR 5-31) pack-years for the RA and non-RA cohorts, respectively. Mean HAA was 153(+/- 57) cm(3) and 129(+/- 50) cm(3) in the RA and non-RA cohorts, respectively. Each 10 cigarette pack-year increment was associated with a higher HAA by 0.03% (95% CI, 0.007-0.05%) in RA patients and by 0.008% (95% CI, 0.003-0.01%) in those without RA (interaction p = 0.001). Cigarette smoking was associated with higher lung attenuation; with a magnitude of association more pronounced in those with RA than in the general population. These data suggest that cigarette smoking may be a more potent ILD risk factor for RA patients than in the general population.	[Johnson, Cheilonda; Danoff, Sonye K.] Johns Hopkins Univ, Sch Med, Dept Med, Div Pulm & Crit Care Med, Baltimore, MD 21205 USA; [Giles, Jon T.; Bathon, Joan] Columbia Univ, Dept Med, Coll Phys & Surg, Div Rheumatol, New York, NY USA; [Lederer, David; Barr, R. Graham] Columbia Univ, Dept Med, Coll Phys & Surg, Div Pulm Allergy & Crit Care Med, New York, NY USA; [Hoffman, Eric A.] Univ Iowa, Dept Radiol, Carver Coll Med, Iowa City, IA 52242 USA; [Barr, R. Graham] Columbia Univ, Dept Med, Coll Phys & Surg, Div Gen Med, New York, NY USA; [Barr, R. Graham] Columbia Univ, Dept Epidemiol, Coll Phys & Surg, New York, NY USA	Johns Hopkins University; Columbia University; Columbia University; University of Iowa; Columbia University; Columbia University	Danoff, SK (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Div Pulm & Crit Care Med, Baltimore, MD 21205 USA.	sdanoff@jhmi.edu	Lederer, David/W-7957-2018; Johnson, Cheilonda/AAB-4555-2020	Lederer, David/0000-0001-5258-0228; Johnson, Cheilonda/0000-0003-3040-4981; Hoffman, Eric/0000-0001-8456-9437; Danoff, Sonye K./0000-0001-9172-8977	Arthritis Foundation [6127]; American College of Rheumatology Within Our Reach; National Institutes of Health [R01-H077162, RC1-100543, R01-093081, R01-HL103676]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077612, R01HL112986, R01HL103676] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005605] Funding Source: NIH RePORTER	Arthritis Foundation; American College of Rheumatology Within Our Reach; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was funded by the Arthritis Foundation 6127, American College of Rheumatology Within Our Reach, and National Institutes of Health R01-H077162, RC1-100543, R01-093081, and R01-HL103676.	American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias, 2002, AM J RESP CRIT CARE, V165, P277, DOI [DOI 10.1164/AJRCCM.165.2.ATS01, 10.1164/ajrccm.165.2.ats01]; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Baka Z, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2751; Best AC, 2003, RADIOLOGY, V228, P407, DOI 10.1148/radiol.2282020274; Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113; Bongartz T, 2007, RHEUMATOLOGY, V46, P70, DOI 10.1093/rheumatology/kel202; Carr JJ, 2005, RADIOLOGY, V234, P35, DOI 10.1148/radiol.2341040439; Cavagna L, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/759760; Demoruelle MK, 2012, ARTHRITIS RHEUM-US, V64, P1756, DOI 10.1002/art.34344; ELLMAN P, 1948, BMJ-BRIT MED J, V2, P816, DOI 10.1136/bmj.2.4583.816; Furukawa H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033133; Giles JT, 2014, ANN RHEUM DIS, V73, P1487, DOI 10.1136/annrheumdis-2012-203160; Giles JT, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2641; Gochuico BR, 2008, ARCH INTERN MED, V168, P159, DOI 10.1001/archinternmed.2007.59; Habib HM, 2011, CLIN RHEUMATOL, V30, P217, DOI 10.1007/s10067-010-1492-5; Harlow L, 2013, ARTHRITIS RHEUM-US, V65, P869, DOI 10.1002/art.37881; Hoffman Eric A, 2014, Ann Am Thorac Soc, V11, P898, DOI 10.1513/AnnalsATS.201310-364OC; Hoffman EA, 2009, ACAD RADIOL, V16, P689, DOI 10.1016/j.acra.2008.12.024; Hutchinson D, 2001, ANN RHEUM DIS, V60, P223, DOI 10.1136/ard.60.3.223; Kallberg H, 2007, AM J HUM GENET, V80, P867, DOI 10.1086/516736; Klareskog L, 2006, ARTHRITIS RHEUM-US, V54, P38, DOI 10.1002/art.21575; Klareskog L, 2011, SEMIN IMMUNOL, V23, P92, DOI 10.1016/j.smim.2011.01.014; Lederer DJ, 2009, AM J RESP CRIT CARE, V180, P407, DOI 10.1164/rccm.200812-1966OC; Linn-Rasker SP, 2006, ANN RHEUM DIS, V65, P366, DOI 10.1136/ard.2005.041079; LUUKKAINEN R, 1995, SCAND J RHEUMATOL, V24, P119, DOI 10.3109/03009749509099296; Mikuls TR, 2010, ARTHRITIS RHEUM-US, V62, P3560, DOI 10.1002/art.27716; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Mori S, 2012, RESP MED, V106, P1591, DOI 10.1016/j.rmed.2012.07.006; Olson AL, 2011, AM J RESP CRIT CARE, V183, P372, DOI 10.1164/rccm.201004-0622OC; Pappas DA, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3037; Pedersen M, 2007, ARTHRITIS RHEUM-US, V56, P1446, DOI 10.1002/art.22597; Reynisdottir G, 2016, ANN RHEUM DIS, V75, P1722, DOI 10.1136/annrheumdis-2015-208216; Reynisdottir G, 2014, ARTHRITIS RHEUMATOL, V66, P31, DOI 10.1002/art.38201; Saag KG, 1996, ARTHRITIS RHEUM-US, V39, P1711, DOI 10.1002/art.1780391014; Thorley Andrew J, 2007, Int J Chron Obstruct Pulmon Dis, V2, P409; Tsuchiya Y, 2011, EUR RESPIR J, V37, P1411, DOI 10.1183/09031936.00019210; Vassallo R, 2012, CLIN CHEST MED, V33, P165, DOI 10.1016/j.ccm.2011.11.004; Westedt ML, 1998, RHEUMATOL INT, V18, P1, DOI 10.1007/s002960050045; Willis VC, 2013, ARTHRITIS RHEUM-US, V65, P2545, DOI 10.1002/art.38066; Wolfe F, 2000, J RHEUMATOL, V27, P630; Yahya A, 2012, MOD RHEUMATOL, V22, P524, DOI 10.1007/s10165-011-0544-2	41	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0153024	10.1371/journal.pone.0153024	http://dx.doi.org/10.1371/journal.pone.0153024			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050433	Green Submitted, Green Published, gold			2022-12-27	WOS:000373603500086
J	Ren, C; Tong, TJ; Hong, Y; Yang, QE				Ren, Chen; Tong, Tian-Jing; Hong, Yu; Yang, Qin-Er			Senecio changii (Asteraceae: Senecioneae), a New Species from Sichuan, China	PLOS ONE			English	Article							EXTERNAL TRANSCRIBED SPACER; DELIMITATION; CONFIDENCE; POSITION; RDNA; ETS	Senecio changii (Asteraceae: Senecioneae), a new species from Muli, Sichuan, southwestern China, is described. It is distinguished in Chinese Senecio s.s. by having lyrate-pinnatisect to pinnatisect leaves and a single terminal large discoid capitulum which is somewhat nodding. Evidence from floral micromorphology, karyology and molecular phylogenetic analyses based on the nuclear ITS/ETS sequence data all support its membership within Senecio s.s.	[Ren, Chen; Tong, Tian-Jing; Hong, Yu; Yang, Qin-Er] Chinese Acad Sci, South China Bot Garden, Key Lab Plant Resources Conservat & Sustainable U, Guangzhou 510650, Guangdong, Peoples R China; [Yang, Qin-Er] Jishou Univ, Key Lab Plant Resources Conservat & Utilizat Huna, Jishou 416000, Peoples R China; [Tong, Tian-Jing; Hong, Yu] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; South China Botanical Garden, CAS; Jishou University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Ren, C (corresponding author), Chinese Acad Sci, South China Bot Garden, Key Lab Plant Resources Conservat & Sustainable U, Guangzhou 510650, Guangdong, Peoples R China.	chenren@scbg.ac.cn			National Natural Science Foundation of China [31300169, 31370232]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (www.nsfc.gov.cn/; grant nos. 31300169 to Chen Ren and 31370232 to Qin-Er Yang). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Baldwin BG, 1998, MOL PHYLOGENET EVOL, V10, P449, DOI 10.1006/mpev.1998.0545; Chen Y. L., 2011, FLORA CHINA, V20-21, P371; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Farris JS, 1995, SYST BIOL, V44, P570, DOI 10.2307/2413663; Farris JS, 1995, CLADISTICS, V10, P315, DOI [DOI 10.1111/J.1096-0031.1994.TB00181.X, DOI 10.1111/J.1096-0031.1996.TB00196.X]; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; Huelsenbeck JP, 2004, MOL BIOL EVOL, V21, P1123, DOI 10.1093/molbev/msh123; IUCN, 2012, IUCN RED LIST CATEGO, VSecond edition; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LEVAN A, 1964, HEREDITAS-GENETISK A, V52, P201, DOI 10.1111/j.1601-5223.1964.tb01953.x; Markos S, 2001, SYST BOT, V26, P168; Mittermeier R.A., 2004, HOTSPOTS REVISITED; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nordenstam B, 1977, BIOL CHEM COMPOSITAE, P799; Nordenstam B, 2006, COMPOSITAE NEWSLETT, V44, P12; Nordenstam B, 1978, OPERA BOT, V44, P1; Nordenstam B., 2009, SYSTEMATICS EVOLUTIO, P503; Pelser P.B., 2006, COMPOSITAE NEWSLETTE, V44, P1; Pelser PB, 2002, AM J BOT, V89, P929, DOI 10.3732/ajb.89.6.929; Pelser PB, 2007, TAXON, V56, P1077, DOI 10.2307/25065905; Pelser PB, 2010, AM J BOT, V97, P856, DOI 10.3732/ajb.0900287; Rambaut A., 2014, TRACER V1 6; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Swofford DL., 2003, PAUP PHYLOGENETIC AN; Tang Ming, 2013, Journal of Tropical and Subtropical Botany, V21, P220; WETTER MA, 1983, BRITTONIA, V35, P1, DOI 10.2307/2806039; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315	31	2	2	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0151423	10.1371/journal.pone.0151423	http://dx.doi.org/10.1371/journal.pone.0151423			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050905	Green Published, Green Submitted, gold			2022-12-27	WOS:000373603500006
J	Beller, E; Klopp, D; Gottler, J; Kaesmacher, J; Zimmer, C; Kirschke, JS; Prothmann, S				Beller, Ebba; Klopp, David; Goettler, Jens; Kaesmacher, Johannes; Zimmer, Claus; Kirschke, Jan S.; Prothmann, Sascha			Closed-Cell Stent-Assisted Coiling of Intracranial Aneurysms: Evaluation of Changes in Vascular Geometry Using Digital Subtraction Angiography	PLOS ONE			English	Article							WALL SHEAR-STRESS; BIFURCATION ANEURYSMS; UNRUPTURED ANEURYSMS; CEREBRAL ANEURYSM; ARTERY ANEURYSMS; HEMODYNAMICS; FLOW; EMBOLIZATION; DEPLOYMENT; SIZE	Background Stent-assisted coil embolization (SACE) plays an important role in the treatment of intracranial aneurysms. The purpose of this study was to investigate geometrical changes caused by closed-cell design stents in bifurcation and sidewall aneurysms. Methods 31 patients with 34 aneurysms underwent SACE with closed-cell design stents. Inflow angle alpha, determined by aneurysm neck and afferent vessel, and angle between afferent and efferent vessel close to (delta(1)), respectively, more remote from the aneurysm neck (delta(2)) were graphically determined in 2D angiography projections. Results Stent assisted coiling resulted in a significant increase of all three angles from a mean value (+/- SEM) of alpha = 119 degrees (+/- 6.5 degrees) pretreatment to 130 degrees (+/- 6.6 degrees) posttreatment (P <= .001), delta(1) = 129 degrees (+/- 6.4 degrees) to 139 degrees (+/- 6.1 degrees), (P <= .001) and delta(2) = 115 degrees (+/- 8.4 degrees) to 126 degrees (+/- 7.5 degrees), (P <= .01). Angular change of d1 in AcomA aneurysms was significant greater compared to sidewall aneurysms (26 degrees +/- 4.9 degrees versus 8 degrees +/- 2.3 degrees, P <= .05). The initial angle of delta(1) and delta(2) revealed a significantly inverse relationship to the angle increase (delta(1): r = -0.41, P <= .05 and delta(2): r = -0.47, P <= .01). Moreover, angle delta(1) was significantly higher in unruptured compared to ruptured aneurysms (135 degrees +/- 7.1 degrees versus 103 degrees +/- 10.8 degrees, P <= .05). Conclusion Stent deployment modulates the geometry of the aneurysm-vessel complex, which may lead to favorable hemodynamic changes more similar to unruptured than to ruptured aneurysms. Our findings also suggest that the more acute-angled aneurysm-vessel anatomy, the larger the angular change. Further studies are needed to investigate whether these changes improve the clinical outcome.	[Beller, Ebba; Goettler, Jens; Kaesmacher, Johannes; Zimmer, Claus; Kirschke, Jan S.; Prothmann, Sascha] Tech Univ Munich, Klinikum Rechts Isar, Abt Diagnost & Intervent Neuroradiol, D-80290 Munich, Germany; [Klopp, David] Acandis GmbH & Co KG, Pforzheim, Germany	Technical University of Munich	Beller, E (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Abt Diagnost & Intervent Neuroradiol, D-80290 Munich, Germany.	Beller@tum.de	Kaesmacher, Johannes/I-6136-2019; Kirschke, Jan/E-2550-2012	Kaesmacher, Johannes/0000-0002-9177-2289; Kirschke, Jan/0000-0002-7557-0003; Beller, Ebba/0000-0002-5268-151X				[Anonymous], 2006, SURG NEUROL; Backes D, 2014, STROKE, V45, P1299, DOI 10.1161/STROKEAHA.113.004421; Baharoglu MI, 2012, J NEUROSURG, V116, P871, DOI 10.3171/2011.11.JNS11311; Balasso A, 2014, BIORHEOLOGY, V51, P341, DOI 10.3233/BIR-14019; Beck J, 2006, SURG NEUROL, V65, P18, DOI 10.1016/j.surneu.2005.05.019; Bendok BR, 2007, NEUROSURGERY, V61, P835, DOI 10.1227/01.NEU.0000298913.24625.26; Biondi A, 2007, NEUROSURGERY, V61, P460, DOI 10.1227/01.NEU.0000290890.62201.A9; Boussel L, 2008, STROKE, V39, P2997, DOI 10.1161/STROKEAHA.108.521617; Carter BS, 2006, NEUROSURGERY, V58, P217, DOI 10.1227/01.NEU.0000194639.37803.F8; Cebral JR, 2005, IEEE T MED IMAGING, V24, P457, DOI 10.1109/TMI.2005.844159; Cho WS, 2014, CLIN RADIOL, V69, pE63, DOI 10.1016/j.crad.2013.08.021; De Bock S, 2012, J BIOMECH, V45, P1353, DOI 10.1016/j.jbiomech.2012.03.012; de Rooij NK, 2009, J NEUROL, V256, P45, DOI 10.1007/s00415-009-0028-x; Gao B, 2012, AM J NEURORADIOL, V33, P649, DOI 10.3174/ajnr.A2841; Gao BL, 2013, NEUROSURGERY, V72, P739, DOI 10.1227/NEU.0b013e318286fab3; Gao BL, 2013, NEUROSURGERY, V72, P617, DOI 10.1227/NEU.0b013e3182846d9f; Hetts SW, 2014, AM J NEURORADIOL, V35, P698, DOI 10.3174/ajnr.A3755; Huang QH, 2011, AM J NEURORADIOL, V32, P1721, DOI 10.3174/ajnr.A2597; Jou LD, 2005, AM J NEURORADIOL, V26, P2357; Kono K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108033; Lauric A, 2012, NEUROSURGERY, V71, P38, DOI 10.1227/NEU.0b013e3182503bf9; Lin N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079635; Lopes D, 2005, NEUROSURGERY, V56, P416, DOI 10.1227/01.NEU.0000145867.25167.CF; Malek AM, 1999, JAMA-J AM MED ASSOC, V282, P2035, DOI 10.1001/jama.282.21.2035; Pierot L, 2011, RADIOLOGY, V258, P546, DOI 10.1148/radiol.10100894; Piotin M, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00041; Piotin M, 2010, STROKE, V41, P110, DOI 10.1161/STROKEAHA.109.558114; Rayz VL, 2010, ANN BIOMED ENG, V38, P3058, DOI 10.1007/s10439-010-0065-8; Saglam M, 2015, DIAGN INTERV RADIOL; Seshadhri S, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4004410; Shojima M, 2004, STROKE, V35, P2500, DOI 10.1161/01.STR.0000144648.89172.0f; Spiotta AM, 2011, NEUROSURGERY, V69, P421, DOI 10.1227/NEU.0b013e318214abbd; Tremmel M, 2009, NEUROSURGERY, V64, P622, DOI 10.1227/01.NEU.0000341529.11231.69; Xiang JP, 2011, STROKE, V42, P144, DOI 10.1161/STROKEAHA.110.592923; Xu JY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138648; Yoo E, 2009, AM J NEURORADIOL, V30, P1028, DOI 10.3174/ajnr.A1482; Zenteno MA, 2005, NEUROSURGERY, V57, P208, DOI 10.1227/01.NEU.0000163683.64511.24; Zenteno Marco, 2010, J Med Case Rep, V4, P64, DOI 10.1186/1752-1947-4-64; Zenteno MA, 2008, J NEUROSURG, V108, P1104, DOI 10.3171/JNS/2008/108/6/1104	39	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153403	10.1371/journal.pone.0153403	http://dx.doi.org/10.1371/journal.pone.0153403			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073908	Green Published, gold			2022-12-27	WOS:000374131200084
J	Esteves-Pereira, AP; Deneux-Tharaux, C; Nakamura-Pereira, M; Saucedo, M; Bouvier-Colle, MH; Leal, MD				Esteves-Pereira, Ana Paula; Deneux-Tharaux, Catherine; Nakamura-Pereira, Marcos; Saucedo, Monica; Bouvier-Colle, Marie-Helene; Leal, Maria do Carmo			Caesarean Delivery and Postpartum Maternal Mortality: A Population-Based Case Control Study in Brazil	PLOS ONE			English	Article							PREGNANCY OUTCOMES; PERINATAL HEALTH; VAGINAL DELIVERY; GLOBAL SURVEY; RISKS; BIRTH; RATES; HEMORRHAGE; MORBIDITY; MODE	Background Cesarean delivery rates continue to increase worldwide and reached 57% in Brazil in 2014. Although the safety of this surgery has improved in the last decades, this trend is a concern because it carries potential risks to women's health and may be a modifiable risk factor of maternal mortality. This paper aims to investigate the risk of postpartum maternal death directly associated with cesarean delivery in comparison to vaginal delivery in Brazil. Methods This was a population-based case-control study performed in eight Brazilian states. To control for indication bias, deaths due to antenatal morbidity were excluded. We included 73 cases of postpartum maternal deaths from 2009-2012. Controls were selected from the Birth in Brazil Study, a 2011 nationwide survey including 9,221 postpartum women. We examined the association of cesarean section and postpartum maternal death by multivariate logistic regression, adjusting for confounders. Results After controlling for indication bias and confounders, the risk of postpartum maternal death was almost three-fold higher with cesarean than vaginal delivery ( OR 2.87, 95% CI 1.635.06), mainly due to deaths from postpartum hemorrhage and complications of anesthesia. Conclusion Cesarean delivery is an independent risk factor of postpartum maternal death. Clinicians and patients should consider this fact in balancing the benefits and risks of the procedure.	[Esteves-Pereira, Ana Paula; Deneux-Tharaux, Catherine; Saucedo, Monica; Bouvier-Colle, Marie-Helene] Paris Descartes Univ, DHU Risks Pregnancy,Epope, Ctr Epidemiol & Stat Sorbonne Paris Cite CRESS, Inserm UMR 1153,Obstet Perinatal & Pediat Epidemi, Paris, France; [Esteves-Pereira, Ana Paula; Nakamura-Pereira, Marcos; Leal, Maria do Carmo] Fundacao Oswaldo Cruz, Sergio Arouca Natl Sch Publ Hlth, Dept Epidemiol & Quantitat Methods Hlth, Rio De Janeiro, RJ, Brazil; [Nakamura-Pereira, Marcos] Fundacao Oswaldo Cruz, Natl Inst Women Children & Adolescents Hlth Ferna, Rio De Janeiro, RJ, Brazil	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	Esteves-Pereira, AP (corresponding author), Paris Descartes Univ, DHU Risks Pregnancy,Epope, Ctr Epidemiol & Stat Sorbonne Paris Cite CRESS, Inserm UMR 1153,Obstet Perinatal & Pediat Epidemi, Paris, France.; Esteves-Pereira, AP (corresponding author), Fundacao Oswaldo Cruz, Sergio Arouca Natl Sch Publ Hlth, Dept Epidemiol & Quantitat Methods Hlth, Rio De Janeiro, RJ, Brazil.	ana.pep@gmail.com	Nakamura-Pereira, Marcos/O-4496-2014; Nakamura-Pereira, Marcos/X-1107-2019; deneux-tharaux, catherine/R-1111-2016	Nakamura-Pereira, Marcos/0000-0002-4231-0205; Nakamura-Pereira, Marcos/0000-0002-4231-0205; deneux-tharaux, catherine/0000-0002-6561-3321	National Council for Scientific and Technological Development (CNPq); Sergio Arouca National School of Public Health; Oswaldo Cruz Foundation (INOVA Project); Foundation for supporting Research; State of Rio de Janeiro (FAPERJ); Ministry of Health, Brazil; Maternal Mortality Enquiry Committees	National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Sergio Arouca National School of Public Health; Oswaldo Cruz Foundation (INOVA Project); Foundation for supporting Research; State of Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Ministry of Health, Brazil; Maternal Mortality Enquiry Committees	The Birth in Brazil Study was funded by the National Council for Scientific and Technological Development (CNPq); Sergio Arouca National School of Public Health, Oswaldo Cruz Foundation (INOVA Project); and Foundation for supporting Research in the State of Rio de Janeiro (FAPERJ). The Ministry of Health, Brazil, funded the Maternal Mortality Enquiry Committees. APE received a post-doc scholarship from CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azevedo Bittencourt SD, 2014, CAD SAUDE PUBLICA S1, V30, pS1; Dias MAB, 2014, CAD SAUDE PUBLICA, V30, DOI 10.1590/0102-311X00154213; Brasil. Ministerio da Saude, 2009, GUIA VIG EP OB MAT G; Brasil. Ministerio da saude, 2014, NASC RES MAE AN TIP; Camargo K R Jr, 2000, Cad Saude Publica, V16, P439; Chongsuvivatwong V, 2010, J OBSTET GYNAECOL RE, V36, P45, DOI 10.1111/j.1447-0756.2009.01100.x; de Frias PG, 2014, CAD SAUDE PUBLICA, V30, P2068, DOI 10.1590/0102-311X00196113; de Frias PG, 2010, CAD SAUDE PUBLICA, V26, P671, DOI 10.1590/S0102-311X2010000400010; Deneux-Tharaux C, 2006, OBSTET GYNECOL, V108, P541, DOI 10.1097/01.AOG.0000233154.62729.24; Fawole AO, 2012, AFR HEALTH SCI, V12, P32; Gabriel Guilherme Paiva, 2014, Rev. paul. pediatr., V32, P183, DOI 10.1590/0103-0582201432306; Kamilya G, 2010, J OBSTET GYNAECOL RE, V36, P248, DOI 10.1111/j.1447-0756.2009.01125.x; Leal MD, 2012, REPROD HEALTH, V9, DOI 10.1186/1742-4755-9-15; de Vasconcellos MTL, 2014, CAD SAUDE PUBLICA, V30, DOI 10.1590/0102-311X00176013; LILFORD RJ, 1990, BRIT J OBSTET GYNAEC, V97, P883, DOI 10.1111/j.1471-0528.1990.tb02442.x; Liu SL, 2007, CAN MED ASSOC J, V176, P455, DOI 10.1503/cmaj.060870; Lumbiganon P, 2010, LANCET, V375, P490, DOI 10.1016/S0140-6736(09)61870-5; Macfarlane A., 2015, BJOG; Morse ML, 2011, CAD SAUDE PUBLICA, V27, P623, DOI 10.1590/S0102-311X2011000400002; Nakamura-Pereira M, 2016, REPROD HLTH IN PRESS; Ophir E, 2008, ARCH GYNECOL OBSTET, V277, P401, DOI 10.1007/s00404-007-0476-4; Pacagnella RC, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-159; Pfitscher LC, 2016, TROP MED INT HEALTH, V21, P183, DOI 10.1111/tmi.12633; de Jesus GR, 2015, BJOG-INT J OBSTET GY, V122, P606, DOI 10.1111/1471-0528.13119; Rocha EA, 2015, INT J GYNECOL OBSTET, V128, P131, DOI 10.1016/j.ijgo.2014.08.023; Say L, 2009, BEST PRACT RES CL OB, V23, P287, DOI 10.1016/j.bpobgyn.2009.01.007; Schantz-Dunn Julianna, 2011, Rev Obstet Gynecol, V4, P86; Sheldon WR, 2014, BJOG-INT J OBSTET GY, V121, P5, DOI 10.1111/1471-0528.12636; Domingues RMSM, 2014, CAD SAUDE PUBLICA, V30, DOI 10.1590/0102-311X00105113; Souza JP, 2014, BJOG-INT J OBSTET GY, V121, P1, DOI 10.1111/1471-0528.12735; Szwarcwald CL, 2014, CAD SAUDE PUBLICA, V30, DOI 10.1590/0102-311X00125313; Vadnais M, 2006, SEMIN PERINATOL, V30, P242, DOI 10.1053/j.semperi.2006.07.014; Villar J, 2007, BRIT MED J, V335, P1025, DOI 10.1136/bmj.39363.706956.55; Villar J, 2006, LANCET, V367, P1819, DOI 10.1016/S0140-6736(06)68704-7; Vogel JP, 2015, LANCET GLOB HEALTH, V3, pE260, DOI 10.1016/S2214-109X(15)70094-X; Ye JF, 2014, BIRTH-ISS PERINAT C, V41, P237, DOI 10.1111/birt.12104	36	57	62	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153396	10.1371/journal.pone.0153396	http://dx.doi.org/10.1371/journal.pone.0153396			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073870	Green Published, Green Submitted, gold			2022-12-27	WOS:000374131200081
J	Bagavathiannan, MV; Norsworthy, JK				Bagavathiannan, Muthukumar V.; Norsworthy, Jason K.			Multiple-Herbicide Resistance Is Widespread in Roadside Palmer Amaranth Populations	PLOS ONE			English	Article							GLYPHOSATE; CONFIRMATION; CORRIDORS; HABITATS; ARKANSAS; GEORGIA	Herbicide-resistant Palmer amaranth is a widespread issue in row-crop production in the Midsouthern US. Palmer amaranth is commonly found on roadside habitats in this region, but little is known on the degree of herbicide resistance in these populations. Herbicide resistance in roadside Palmer amaranth populations can represent the spread of an adaptive trait across a selective landscape. A large-scale survey was carried out in the Mississippi Delta region of eastern Arkansas to document the level of resistance in roadside Palmer amaranth populations to pyrithiobac and glyphosate, two important herbicides with broad history of use in the region. A total of 215 Palmer amaranth populations collected across 500 random survey sites were used in the evaluations. About 89 and 73% of the surveyed populations showed >90% survival to pyrithiobac and glyphosate, respectively. Further, only 3% of the populations were completely susceptible to glyphosate, while none of the populations was completely controlled by pyrithiobac. Among the 215 populations evaluated, 209 populations showed multiple resistance to both pyrithiobac and glyphosate at varying degrees. Dose-response assays confirmed the presence of high levels of herbicide resistance in the five selected populations (>= 25-fold compared to a susceptible standard). Results demonstrate the prevalence of multiple-herbicide resistance in roadside Palmer amaranth populations in this region. Growers should be vigilant of Palmer amaranth infestation in roadsides adjacent to their fields and implement appropriate control measures to prevent likely spread of herbicide resistance into their fields.	[Bagavathiannan, Muthukumar V.] Texas A&M Univ, Dept Soil & Crop Sci, College Stn, TX 77843 USA; [Norsworthy, Jason K.] Univ Arkansas, Dept Crop Soil & Environm Sci, Fayetteville, AR 72701 USA	Texas A&M University System; Texas A&M University College Station; University of Arkansas System; University of Arkansas Fayetteville	Bagavathiannan, MV (corresponding author), Texas A&M Univ, Dept Soil & Crop Sci, College Stn, TX 77843 USA.	muthu@tamu.edu	Norsworthy, Jason/GXZ-5733-2022	Norsworthy, Jason/0000-0002-7379-6201	Cotton Incorporated; Arkansas Soybean Promotion Board	Cotton Incorporated(Cotton R&D Corp); Arkansas Soybean Promotion Board	Funding was provided by Cotton Incorporated and Arkansas Soybean Promotion Board. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional funding sources for this study.; Funding for this research was provided by Cotton Incorporated and Arkansas Soybean Promotion Board. No additional funding sources for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansong M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080275; Bagavathiannan MV, SPREAD HERBICIDE RES; Burgos NR, 2001, PEST MANAG SCI, V57, P449, DOI 10.1002/ps.308; Culpepper AS, 2006, WEED SCI, V54, P620, DOI 10.1614/WS-06-001R.1; Gelbard JL, 2003, CONSERV BIOL, V17, P420, DOI 10.1046/j.1523-1739.2003.01408.x; Heap I, INT SURVEY HERBICIDE; HORAK MJ, 1995, WEED TECHNOL, V9, P192, DOI 10.1017/S0890037X00023174; Jhala AJ, 2014, WEED TECHNOL, V28, P28, DOI 10.1614/WT-D-13-00090.1; Jodoin Y, 2008, J APPL ECOL, V45, P459, DOI 10.1111/j.1365-2664.2007.01362.x; Korres NE, 2015, WEED TECHNOL, V29, P587, DOI 10.1614/WT-D-14-00130.1; Meunier G, 2012, INVAS PLANT SCI MANA, V5, P92, DOI 10.1614/IPSM-D-11-00049.1; Norsworthy JK, 2008, WEED TECHNOL, V22, P108, DOI 10.1614/WT-07-128.1; Riar DS, 2013, WEED TECHNOL, V27, P612, DOI 10.1614/WT-D-12-00167.1; Rios SI, 2014, P BELTW COTT C NEW O; SAUER J, 1957, EVOLUTION, V11, P11, DOI 10.2307/2405808; Sosnoskie LM, WEED SCI, V60, P366; Sosnoskie LM, 2011, WEED SCI, V59, P321, DOI 10.1614/WS-D-10-00132.1; Sprague C, GLYPHOSATE RESISTANT; Ward SM, 2013, WEED TECHNOL, V27, P12, DOI 10.1614/WT-D-12-00113.1; Webster TM, 2012, WEED SCI, V60, P145, DOI 10.1614/WS-D-11-00092.1	20	24	25	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0148748	10.1371/journal.pone.0148748	http://dx.doi.org/10.1371/journal.pone.0148748			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27071064	Green Published, Green Submitted, gold			2022-12-27	WOS:000373900700002
J	Dimov, LF; Franciosi, AC; Campos, ACP; Brunoni, AR; Pagano, RL				Dimov, Luiz Fabio; Franciosi, Adriano Cardozo; Pinheiro Campos, Ana Carolina; Brunoni, Andre Russowsky; Pagano, Rosana Lima			Top-Down Effect of Direct Current Stimulation on the Nociceptive Response of Rats	PLOS ONE			English	Article							MOTOR CORTEX STIMULATION; C-FOS EXPRESSION; MIDBRAIN PERIAQUEDUCTAL GRAY; TRANSCRANIAL DC-STIMULATION; CENTRAL-NERVOUS-SYSTEM; IMMEDIATE-EARLY GENES; SPINAL-CORD-INJURY; DORSAL-HORN; NEUROPATHIC PAIN; HIGH-DEFINITION	Transcranial direct current stimulation (tDCS) is an emerging, noninvasive technique of neurostimulation for treating pain. However, the mechanisms and pathways involved in its analgesic effects are poorly understood. Therefore, we investigated the effects of direct current stimulation (DCS) on thermal and mechanical nociceptive thresholds and on the activation of the midbrain periaqueductal gray (PAG) and the dorsal horn of the spinal cord (DHSC) in rats; these central nervous system areas are associated with pain processing. Male Wistar rats underwent cathodal DCS of the motor cortex and, while still under stimulation, were evaluated using tail-flick and paw pressure nociceptive tests. Sham stimulation and naive rats were used as controls. We used a randomized design; the assays were not blinded to the experimenter. Immunoreactivity of the early growth response gene 1 (Egr-1), which is a marker of neuronal activation, was evaluated in the PAG and DHSC, and enkephalin immunoreactivity was evaluated in the DHSC. DCS did not change the thermal nociceptive threshold; however, it increased the mechanical nociceptive threshold of both hind paws compared with that of controls, characterizing a topographical effect. DCS decreased the Egr-1 labeling in the PAG and DHSC as well as the immunoreactivity of spinal enkephalin. Altogether, the data suggest that DCS disinhibits the midbrain descending analgesic pathway, consequently inhibiting spinal nociceptive neurons and causing an increase in the nociceptive threshold. This study reinforces the idea that the motor cortex participates in the neurocircuitry that is involved in analgesia and further clarifies the mechanisms of action of tDCS in pain treatment.	[Dimov, Luiz Fabio; Franciosi, Adriano Cardozo; Pinheiro Campos, Ana Carolina; Pagano, Rosana Lima] Hosp Sirio Libanes, Lab Neuromodulat & Expt Pain, Rua Prof Daher Cutait 69, BR-01308060 Sao Paulo, SP, Brazil; [Brunoni, Andre Russowsky] Univ Sao Paulo, Fac Med, SIN, Dept & Inst Psychiat,Lab Neurosci LIM27, Rua Doutor Ovidio Pires Campos 785, BR-05403000 Sao Paulo, SP, Brazil; [Brunoni, Andre Russowsky] Univ Sao Paulo, Ctr Clin & Epidemiol Res, Univ Hosp, Ave Prof Lineu Prestes 2565,Ext 3, BR-05508000 Sao Paulo, SP, Brazil; [Brunoni, Andre Russowsky] Univ Sao Paulo, Interdisciplinary Ctr Appl Neuromodulat CINA, Univ Hosp, Ave Prof Lineu Prestes 2565,Ext 3, BR-05508000 Sao Paulo, SP, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Pagano, RL (corresponding author), Hosp Sirio Libanes, Lab Neuromodulat & Expt Pain, Rua Prof Daher Cutait 69, BR-01308060 Sao Paulo, SP, Brazil.	rosana.lpagano@hsl.org.br	Franciosi, Adriano C/R-3102-2016; Campos, Ana Carolina Pinheiro/AAD-7760-2019; , Ap/AAB-2985-2019; Dimov, Luiz Fabio/AAS-2616-2020; Pagano, Rosana Lima/I-1088-2013; Brunoni, Andre R./H-8394-2012	Franciosi, Adriano C/0000-0001-7172-539X; Campos, Ana Carolina Pinheiro/0000-0003-2901-5823; , Ap/0000-0002-5351-6575; Brunoni, Andre R./0000-0002-6310-3571; Dimov, Luiz Fabio/0000-0002-7264-3000	Hospital Sirio Libanes; Sao Paulo State Foundation (FAPESP); FAPESP [11/21631-3, 09/50772-4, 12/20911-5]; NARSAD Young Investigator from the Brain & Behavior Research Foundation [20493]; Brazilian National Council for Scientific and Technological Development (CNPq) [303197, 470904]	Hospital Sirio Libanes; Sao Paulo State Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); NARSAD Young Investigator from the Brain & Behavior Research Foundation(NARSAD); Brazilian National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This research was supported by the Hospital Sirio Libanes and Sao Paulo State Foundation (FAPESP). LFD, RLP and ARB were funded by FAPESP (11/21631-3, 09/50772-4 and 12/20911-5, respectively). ARB is supported by NARSAD Young Investigator from the Brain & Behavior Research Foundation (Grant Number 20493) and Brazilian National Council for Scientific and Technological Development (CNPq, Grant Numbers 303197 and 470904). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachmann CG, 2010, CLIN NEUROPHYSIOL, V121, P2083, DOI 10.1016/j.clinph.2010.05.005; BANDLER R, 1994, TRENDS NEUROSCI, V17, P379, DOI 10.1016/0166-2236(94)90047-7; BASBAUM AI, 1984, ANNU REV NEUROSCI, V7, P309, DOI 10.1146/annurev.ne.07.030184.001521; BASBAUM AI, 1991, NEW ENGL J MED, V325, P1168, DOI 10.1056/NEJM199110173251610; BASBAUM AI, 1978, ANN NEUROL, V4, P451, DOI 10.1002/ana.410040511; Beaudry H, 2011, J NEUROSCI, V31, P13068, DOI 10.1523/JNEUROSCI.1817-11.2011; Beckmann AM, 1997, NEUROCHEM INT, V31, P477, DOI 10.1016/S0197-0186(96)00136-2; BEHBEHANI MM, 1995, PROG NEUROBIOL, V46, P575, DOI 10.1016/0301-0082(95)00009-K; Benarroch EE, 2012, NEUROLOGY, V78, P210, DOI 10.1212/WNL.0b013e31823fcdee; BENNETT GJ, 1982, BRAIN RES, V240, P162, DOI 10.1016/0006-8993(82)90656-4; Benninger DH, 2010, J NEUROL NEUROSUR PS, V81, P1105, DOI 10.1136/jnnp.2009.202556; Boggio PS, 2008, EUR J NEUROL, V15, P1124, DOI 10.1111/j.1468-1331.2008.02270.x; Bolognini N, 2015, J PAIN, V16, P657, DOI 10.1016/j.jpain.2015.03.013; Bowman BR, 2015, AUTON NEUROSCI-BASIC, V193, P84, DOI 10.1016/j.autneu.2015.08.006; Brunoni AR, 2014, EXPERT REV MED DEVIC, V11, P383, DOI 10.1586/17434440.2014.911082; Brunoni AR, 2011, REV NEUROSCIENCE, V22, P471, DOI 10.1515/RNS.2011.042; BURITOVA J, 1995, BRAIN RES, V674, P211, DOI 10.1016/0006-8993(95)00009-F; Buritova J, 2003, EUR J PAIN, V7, P241, DOI 10.1016/S1090-3801(02)00122-2; CANAVERO S, 1995, J NEUROSURG, V83, P1117; Castillo-Saavedra L, 2016, J PAIN, V17, P14, DOI 10.1016/j.jpain.2015.09.009; Chapman V, 1996, J NEUROPHYSIOL, V76, P1817, DOI 10.1152/jn.1996.76.3.1817; Chen WL, 2008, NEUROPHARMACOLOGY, V54, P944, DOI 10.1016/j.neuropharm.2008.02.002; Cioato SG, 2015, BRAIN STIMUL; D'amour FE, 1941, J PHARMACOL EXP THER, V72, P74; DaSilva AF, 2015, FRONT NEUROANAT, V9, DOI 10.3389/fnana.2015.00089; DaSilva AF, 2012, HEADACHE, V52, P1283, DOI 10.1111/j.1526-4610.2012.02141.x; de Andrade DC, 2011, PAIN, V152, P320, DOI 10.1016/j.pain.2010.10.032; Di Lazzaro V, 2008, BRAIN STIMUL, V1, P345, DOI 10.1016/j.brs.2008.07.004; DICKENSON AH, 1983, EXP BRAIN RES, V49, P174, DOI 10.1007/BF00238577; DosSantos MF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102350; DosSantos Marcos Fabio, 2012, Front Psychiatry, V3, P93, DOI 10.3389/fpsyt.2012.00093; Fagerlund AJ, 2015, PAIN, V156, P62, DOI 10.1016/j.pain.0000000000000006; Ferrucci R, 2014, NEUROREHABILITATION, V34, P121, DOI 10.3233/NRE-131019; Foerster BR, 2015, ARTHRITIS RHEUMATOL, V67, P576, DOI 10.1002/art.38945; Fonoff ET, 2009, BEHAV BRAIN RES, V202, P138, DOI 10.1016/j.bbr.2009.03.018; Fonoff ET, 2009, BEHAV BRAIN RES, V196, P63, DOI 10.1016/j.bbr.2008.07.027; Franca NRM, 2013, BEHAV BRAIN RES, V250, P211, DOI 10.1016/j.bbr.2013.05.019; Fregni F, 2006, ARTHRITIS RHEUM-US, V54, P3988, DOI 10.1002/art.22195; Fregni F, 2007, LANCET NEUROL, V6, P188, DOI 10.1016/S1474-4422(07)70032-7; Fregni F, 2006, PAIN, V122, P197, DOI 10.1016/j.pain.2006.02.023; George A, 2000, PAIN, V88, P267, DOI 10.1016/S0304-3959(00)00333-X; Giuliani A, 2004, INT J TISSUE REACT, V26, P29; GOGAS KR, 1991, NEUROSCIENCE, V42, P617, DOI 10.1016/0306-4522(91)90031-I; Harris JA, 1998, BRAIN RES BULL, V45, P1, DOI 10.1016/S0361-9230(97)00277-3; Heinricher MM, 2009, BRAIN RES REV, V60, P214, DOI 10.1016/j.brainresrev.2008.12.009; HERDEGEN T, 1991, J COMP NEUROL, V313, P178, DOI 10.1002/cne.903130113; Herdegen T, 1998, BRAIN RES REV, V28, P370, DOI 10.1016/S0165-0173(98)00018-6; HERDEGEN T, 1990, NEUROSCI LETT, V120, P21, DOI 10.1016/0304-3940(90)90158-6; Herrera DG, 1996, PROG NEUROBIOL, V50, P83, DOI 10.1016/S0301-0082(96)00021-4; Hiscock JJ, 2001, J NEUROSCI RES, V66, P1094, DOI 10.1002/jnr.1252.abs; HOKFELT T, 1977, NEUROSCI LETT, V5, P25, DOI 10.1016/0304-3940(77)90160-4; HOKFELT T, 1979, NEUROSCI LETT, V14, P55, DOI 10.1016/0304-3940(79)95343-6; Holsheimer J, 2007, ACTA NEUROCHIR SUPPL, V97, P57; HUNT SP, 1987, NATURE, V328, P632, DOI 10.1038/328632a0; Keay KA, 2002, EXP PHYSIOL, V87, P275, DOI 10.1113/eph8702355; Kuo MF, 2007, J NEUROSCI, V27, P14442, DOI 10.1523/JNEUROSCI.4104-07.2007; Lang N, 2005, EUR J NEUROSCI, V22, P495, DOI 10.1111/j.1460-9568.2005.04233.x; LANTERIMINET M, 1993, NEUROSCIENCE, V55, P737, DOI 10.1016/0306-4522(93)90439-M; Laste G, 2012, EXP BRAIN RES, V221, P75, DOI 10.1007/s00221-012-3149-x; LEBARS D, 1979, PAIN, V6, P283, DOI 10.1016/0304-3959(79)90049-6; Liebetanz D, 2002, BRAIN, V125, P2238, DOI 10.1093/brain/awf238; Liebetanz D, 2006, EPILEPSIA, V47, P1216, DOI 10.1111/j.1528-1167.2006.00539.x; Lima MC, 2008, NEUROLOGY, V2329, P37; Liu RJ, 1999, BRAIN RES, V830, P183, DOI 10.1016/S0006-8993(99)01293-7; Ma JY, 2001, LIFE SCI, V69, P969, DOI 10.1016/S0024-3205(01)01191-2; Maarrawi J, 2007, PAIN, V127, P183, DOI 10.1016/j.pain.2006.10.013; Maarrawi J, 2013, PAIN, V154, P2563, DOI 10.1016/j.pain.2013.07.042; Marques PR, 2016, PROG NEURO-PSYCHOPH, V64, P44, DOI 10.1016/j.pnpbp.2015.06.016; Mehta S, 2015, SPINAL CORD, V53, P780, DOI 10.1038/sc.2015.118; Mielke D, 2013, NEUROL RES, V35, P1029, DOI 10.1179/1743132813Y.0000000248; Millan MJ, 2002, PROG NEUROBIOL, V66, P355, DOI 10.1016/S0301-0082(02)00009-6; MOLANDER C, 1984, J COMP NEUROL, V230, P133, DOI 10.1002/cne.902300112; MORGAN JI, 1989, TRENDS NEUROSCI, V12, P459, DOI 10.1016/0166-2236(89)90096-9; Nekhendzy V, 2004, ANESTH ANALG, V98, P730, DOI 10.1213/01.ANE.0000096007.12845.70; Nguyen JP, 1999, PAIN, V82, P245, DOI 10.1016/S0304-3959(99)00062-7; Nitsche MA, 2004, CEREB CORTEX, V14, P1240, DOI 10.1093/cercor/bhh085; Nitsche MA, 2004, NEUROPSYCHOPHARMACOL, V29, P1573, DOI 10.1038/sj.npp.1300517; Nitsche MA, 2004, EUR J NEUROSCI, V19, P2720, DOI 10.1111/j.0953-816X.2004.03398.x; Nitsche MA, 2001, NEUROLOGY, V57, P1899, DOI 10.1212/WNL.57.10.1899; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Nitsche MA, 2003, J PHYSIOL-LONDON, V553, P293, DOI 10.1113/jphysiol.2003.049916; Nitsche MA, 2005, J PHYSIOL-LONDON, V568, P291, DOI 10.1113/jphysiol.2005.092429; Nitsche MA, 2008, BRAIN STIMUL, V1, P206, DOI 10.1016/j.brs.2008.06.004; Pagano RL, 2012, PAIN, V153, P2359, DOI 10.1016/j.pain.2012.08.002; Pagano RL, 2011, EUR J PAIN, V15, DOI 10.1016/j.ejpain.2010.08.003; Paxinos G., RAT BRAIN STEREOTAXI, VSeventh; POHL M, 1994, J NEUROCHEM, V63, P1226; RANDALL LO, 1957, ARCH INT PHARMACOD T, V111, P409; RAYNOR K, 1994, MOL PHARMACOL, V45, P330; Reidler JS, 2012, J PAIN, V13, P450, DOI 10.1016/j.jpain.2012.01.005; RUDA MA, 1982, SCIENCE, V215, P1523, DOI 10.1126/science.6121374; RUDA MA, 1986, PROG BRAIN RES, V66, P219, DOI 10.1016/S0079-6123(08)64606-3; SENBA E, 1982, J COMP NEUROL, V208, P54, DOI 10.1002/cne.902080105; SHENG M, 1990, NEURON, V4, P477, DOI 10.1016/0896-6273(90)90106-P; Shiozawa P, 2014, INT J NEUROPSYCHOPH, V17, P1539, DOI 10.1017/S1461145714000807; Sohn MK, 2013, ANN REHABIL MED-ARM, V37, P759, DOI 10.5535/arm.2013.37.6.759; Song BB, 2007, BRAIN RES, V1158, P57, DOI 10.1016/j.brainres.2007.05.006; Soyguder Z, 2005, BRAIN RES, V1033, P202, DOI 10.1016/j.brainres.2004.11.044; Adachi LNS, 2015, EXP BRAIN RES, V233, P1377, DOI 10.1007/s00221-015-4212-1; Adachi LNS, 2012, BRAIN RES, V1489, P17, DOI 10.1016/j.brainres.2012.10.009; Szakacs R, 2003, BRAIN RES BULL, V59, P485, DOI 10.1016/S0361-9230(02)00965-6; Tao YX, 1997, NEUROSCI LETT, V221, P105, DOI 10.1016/S0304-3940(96)13300-0; Terney D, 2008, J PAIN SYMPTOM MANAG, V36, P79, DOI 10.1016/j.jpainsymman.2007.08.014; Vaseghi B, 2015, EUR J NEUROSCI, V42, P2426, DOI 10.1111/ejn.13043; Vaseghi B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123873; Villamar MF, 2013, J PAIN, V14, P371, DOI 10.1016/j.jpain.2012.12.007; Wachter D, 2011, EXP NEUROL, V227, P322, DOI 10.1016/j.expneurol.2010.12.005; Wassermann EM, 2005, TRENDS COGN SCI, V9, P503, DOI 10.1016/j.tics.2005.09.001; Zaghi Soroush, 2009, J Pain Manag, V2, P339; Zhang Y, 2015, J CLIN INVEST, V125, P3782, DOI 10.1172/JCI81156; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	111	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0153506	10.1371/journal.pone.0153506	http://dx.doi.org/10.1371/journal.pone.0153506			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27071073	gold, Green Published, Green Submitted			2022-12-27	WOS:000373900700074
J	Laemmle, A; Gallagher, RC; Keogh, A; Stricker, T; Gautschi, M; Nuoffer, JM; Baumgartner, MR; Haberle, J				Laemmle, Alexander; Gallagher, Renata C.; Keogh, Adrian; Stricker, Tamar; Gautschi, Matthias; Nuoffer, Jean-Marc; Baumgartner, Matthias R.; Haeberle, Johannes			Frequency and Pathophysiology of Acute Liver Failure in Ornithine Transcarbamylase Deficiency (OTCD)	PLOS ONE			English	Article							UREA CYCLE DISORDERS; MUTATIONS; COAGULATION; MOUSE; COAGULOPATHY; HEPATOCYTES; SPECTRUM; DISEASE	Background Acute liver failure (ALF) has been reported in ornithine transcarbamylase deficiency (OTCD) and other urea cycle disorders (UCD). The frequency of ALF in OTCD is not well-defined and the pathogenesis is not known. Aim To evaluate the prevalence of ALF in OTCD, we analyzed the Swiss patient cohort. Laboratory data from 37 individuals, 27 females and 10 males, diagnosed between 12/1991 and 03/2015, were reviewed for evidence of ALF. In parallel, we performed cell culture studies using human primary hepatocytes from a single patient treated with ammonium chloride in order to investigate the inhibitory potential of ammonia on hepatic protein synthesis. Results More than 50% of Swiss patients with OTCD had liver involvement with ALF at least once in the course of disease. Elevated levels of ammonia often correlated with (laboratory) coagulopathy as reflected by increased values for international normalized ratio (INR) and low levels of hepatic coagulation factors which did not respond to vitamin K. In contrast, liver transaminases remained normal in several cases despite massive hyperammonemia and liver involvement as assessed by pathological INR values. In our in vitro studies, treatment of human primary hepatocytes with ammonium chloride for 48 hours resulted in a reduction of albumin synthesis and secretion by approximately 40%. Conclusion In conclusion, ALF is a common complication of OTCD, which may not always lead to severe symptoms and may therefore be underdiagnosed. Cell culture experiments suggest an ammonia-induced inhibition of hepatic protein synthesis, thus providing a possible pathophysiological explanation for hyperammonemia-associated ALF.	[Laemmle, Alexander; Stricker, Tamar; Baumgartner, Matthias R.; Haeberle, Johannes] Univ Childrens Hosp, Div Metab, Zurich, Switzerland; [Laemmle, Alexander; Stricker, Tamar; Baumgartner, Matthias R.; Haeberle, Johannes] Univ Childrens Hosp, Childrens Res Ctr CRC, Zurich, Switzerland; [Laemmle, Alexander; Baumgartner, Matthias R.] Univ Zurich, Radiz Rare Dis Initiat Zurich, Clin Res Prior Program Rare Dis, Zurich, Switzerland; [Gallagher, Renata C.] Univ Calif San Francisco, Dept Pediat, Med Genet, San Francisco, CA USA; [Keogh, Adrian] Univ Hosp Bern, Dept Clin Res, CH-3010 Bern, Switzerland; [Keogh, Adrian] Univ Hosp Bern, Clin Visceral Surg & Med, CH-3010 Bern, Switzerland; [Gautschi, Matthias; Nuoffer, Jean-Marc] Univ Childrens Hosp, Dept Pediat, Bern, Switzerland; [Gautschi, Matthias; Nuoffer, Jean-Marc] Univ Bern, Univ Inst Clin Chem, Bern, Switzerland; [Baumgartner, Matthias R.; Haeberle, Johannes] Univ Zurich, Zurich Ctr Integrat Human Physiol, Zurich, Switzerland	University Children's Hospital Zurich; University Children's Hospital Zurich; University of Zurich; University of California System; University of California San Francisco; University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP)	Laemmle, A (corresponding author), Univ Childrens Hosp, Div Metab, Zurich, Switzerland.; Laemmle, A (corresponding author), Univ Childrens Hosp, Childrens Res Ctr CRC, Zurich, Switzerland.; Laemmle, A (corresponding author), Univ Zurich, Radiz Rare Dis Initiat Zurich, Clin Res Prior Program Rare Dis, Zurich, Switzerland.	a_laemmle@hotmail.com	Laemmle, Alexander/ADK-5108-2022; Baumgartner, Matthias/Q-2855-2017; Gautschi, Matthias/J-3353-2014; Nuoffer, Jean-Marc/C-8936-2009	Laemmle, Alexander/0000-0001-9191-1886; Baumgartner, Matthias/0000-0002-9270-0826; Gautschi, Matthias/0000-0003-1358-1759; Haberle, Johannes/0000-0003-0635-091X; Nuoffer, Jean-Marc/0000-0003-3650-6153	EMDO Stiftung Zurich [851]; Forschungszentrum Kind (FZK) - University Children's Hospital Zurich [10511]; Swiss National Science Foundation [310030_153196]; Rare Disease Initiative Zurich (radiz), a clinical research priority program for rare diseases of the University of Zurich, Switzerland; Office of Rare Diseases Research (ORDR) [U54HD061221]; National Center for Advancing Translational Science (NCATS) [U54HD061221]; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) [U54HD061221]; O'Malley Foundation; Rotenberg Family Fund; Dietmar-Hopp Foundation; Kettering Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD061221] Funding Source: NIH RePORTER	EMDO Stiftung Zurich; Forschungszentrum Kind (FZK) - University Children's Hospital Zurich; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Rare Disease Initiative Zurich (radiz), a clinical research priority program for rare diseases of the University of Zurich, Switzerland; Office of Rare Diseases Research (ORDR); National Center for Advancing Translational Science (NCATS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); O'Malley Foundation; Rotenberg Family Fund; Dietmar-Hopp Foundation; Kettering Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the "EMDO Stiftung Zurich" (grant 851 to JH and AL), by the "Forschungszentrum Kind (FZK) - University Children's Hospital Zurich" (grant 10511 to AL), and by the Swiss National Science Foundation (grant 310030_153196 to JH). AL and MRB are supported by the Rare Disease Initiative Zurich (radiz), a clinical research priority program for rare diseases of the University of Zurich, Switzerland. The Urea Cycle Disorders Consortium (UCDC; U54HD061221) is a part of the National Institutes of Health (NIH) Rare Disease Clinical Research Network (RDCRN), supported through collaboration between the Office of Rare Diseases Research (ORDR), the National Center for Advancing Translational Science (NCATS and the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). The Urea Cycle Disorders Consortium is also supported by the O'Malley Foundation, the Rotenberg Family Fund, the Dietmar-Hopp Foundation, and the Kettering Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batshaw ML, 2014, MOL GENET METAB, V113, P127, DOI 10.1016/j.ymgme.2014.08.001; Biron-Andreani C, 2010, METHODS MOL BIOL, V640, P431, DOI 10.1007/978-1-60761-688-7_23; Braissant O, 2013, J INHERIT METAB DIS, V36, P595, DOI 10.1007/s10545-012-9546-2; Brassier A, 2013, MOL GENET METAB, V109, P28, DOI 10.1016/j.ymgme.2013.01.017; Brusilow S., 2001, METABOLIC MOL BASES, V8th, P1909; de Groot MJ, 2010, J INHERIT METAB DIS, V33, pS413, DOI 10.1007/s10545-010-9207-2; Faghfoury H, 2011, MOL GENET METAB, V102, P413, DOI 10.1016/j.ymgme.2010.12.007; Gallagher RC, 2014, J PEDIATR-US, V164, P720, DOI 10.1016/j.jpeds.2013.12.024; GROMPE M, 1991, AM J HUM GENET, V48, P212; Haberle J, 2013, ARCH BIOCHEM BIOPHYS, V536, P101, DOI 10.1016/j.abb.2013.04.009; Haberle J, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-32; HATA A, 1989, AM J HUM GENET, V45, P123; HENTZEN D, 1991, HUM GENET, V88, P153; HODGES PE, 1989, P NATL ACAD SCI USA, V86, P4142, DOI 10.1073/pnas.86.11.4142; Ihara K, 2013, PEDIATRICS, V131, pE327, DOI 10.1542/peds.2012-0030; Kolker S, 2015, J INHERIT METAB DIS, V38, P1041, DOI 10.1007/s10545-015-9839-3; LEIBUNDGUT EO, 1995, HUM GENET, V95, P191; Li JJ, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/1471-230X-14-151; MADDALENA A, 1988, J CLIN INVEST, V82, P1353, DOI 10.1172/JCI113738; Malato Y, 2011, J CLIN INVEST, V121, P4850, DOI 10.1172/JCI59261; MATSUURA T, 1994, HUM MUTAT, V3, P402, DOI 10.1002/humu.1380030415; McCullough BA, 2000, AM J MED GENET, V93, P313, DOI 10.1002/1096-8628(20000814)93:4<313::AID-AJMG11>3.0.CO;2-M; Mhanni AA, 2008, J PEDIATR GASTR NUTR, V46, P312, DOI 10.1097/MPG.0b013e318145a8e5; Mustafa A, 2006, J INHERIT METAB DIS, V29, P586, DOI 10.1007/s10545-006-0303-2; Narkewicz MR, 2009, J PEDIATR-US, V155, P801, DOI 10.1016/j.jpeds.2009.06.005; Ng VL, 2009, CLIN LAB MED, V29, P265, DOI 10.1016/j.cll.2009.05.001; Northup PG, 2013, CLIN GASTROENTEROL H, V11, P1064, DOI 10.1016/j.cgh.2013.02.026; Perito ER, 2014, LIVER TRANSPLANT, V20, P89, DOI 10.1002/lt.23765; Rencurel F, 2006, MOL PHARMACOL, V70, P1925, DOI 10.1124/mol.106.029421; Rivera-Barahona A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122966; Salek J, 2010, LIVER TRANSPLANT, V16, P1049, DOI 10.1002/lt.22118; Samuel N, 2013, ISR MED ASSOC J, V15, P777; Sinclair M, 2014, OBSTET GYNECOL, V123, P480, DOI 10.1097/AOG.000000000000005; Squires RH, 2006, J PEDIATR-US, V148, P652, DOI 10.1016/j.jpeds.2005.12.051; Teufel U, 2011, PEDIATR TRANSPLANT, V15, pE110, DOI 10.1111/j.1399-3046.2009.01171.x; TUCHMAN M, 1993, HUM MUTAT, V2, P174, DOI 10.1002/humu.1380020304; Tuchman M, 1997, J INHERIT METAB DIS, V20, P525, DOI 10.1023/A:1005301513465; TUCHMAN M, 1994, HUM MUTAT, V4, P57, DOI 10.1002/humu.1380040109; Tuchman M, 2008, MOL GENET METAB, V94, P397, DOI 10.1016/j.ymgme.2008.05.004; Wang QY, 2014, ARCH BIOCHEM BIOPHYS, V555, P16, DOI 10.1016/j.abb.2014.05.019; Yaplito-Lee J, 2013, MOL GENET METAB, V108, P161, DOI 10.1016/j.ymgme.2013.01.006	41	35	39	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0153358	10.1371/journal.pone.0153358	http://dx.doi.org/10.1371/journal.pone.0153358			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27070778	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000373900700055
J	Rabelo, LA; Todiras, M; Nunes-Souza, V; Qadri, F; Szijarto, IA; Gollasch, M; Penninger, JM; Bader, M; Santos, RA; Alenina, N				Rabelo, Luiza A.; Todiras, Mihail; Nunes-Souza, Valeria; Qadri, Fatimunnisa; Szijarto, Istvan Andras; Gollasch, Maik; Penninger, Josef M.; Bader, Michael; Santos, Robson A.; Alenina, Natalia			Genetic Deletion of ACE2 Induces Vascular Dysfunction in C57BL/6 Mice: Role of Nitric Oxide Imbalance and Oxidative Stress	PLOS ONE			English	Article							ANGIOTENSIN-CONVERTING ENZYME-2; IMPROVES ENDOTHELIAL FUNCTION; BLOOD-PRESSURE; SUPEROXIDE GENERATION; DEFICIENT MICE; KNOCKOUT MICE; NADPH OXIDASE; FREE-RADICALS; RECEPTOR MAS; SYNTHASE	Accumulating evidence indicates that angiotensin-converting enzyme 2 (ACE2) plays a critical role in cardiovascular homeostasis, and its altered expression is associated with major cardiac and vascular disorders. The aim of this study was to evaluate the regulation of vascular function and assess the vascular redox balance in ACE2-deficient (ACE2(-/y)) animals. Experiments were performed in 20-22 week-old C57BL/6 and ACE2(-/y) male mice. Evaluation of endothelium-dependent and -independent relaxation revealed an impairment of in vitro and in vivo vascular function in ACE2(-/y) mice. Drastic reduction in eNOS expression at both protein and mRNA levels, and a decrease in (NO)-N-center dot concentrations were observed in aortas of ACE2(-/y) mice in comparison to controls. Consistently, these mice presented a lower plasma and urine nitrite concentration, confirming reduced (NO)-N-center dot availability in ACE2-deficient animals. Lipid peroxidation was significantly increased and superoxide dismutase activity was decreased in aorta homogenates of ACE2(-/y) mice, indicating impaired antioxidant capacity. Taken together, our data indicate, that ACE2 regulates vascular function by modulating nitric oxide release and oxidative stress. In conclusion, we elucidate mechanisms by which ACE2 is involved in the maintenance of vascular homeostasis. Furthermore, these findings provide insights into the role of the renin-angiotensin system in both vascular and systemic redox balance.	[Rabelo, Luiza A.; Todiras, Mihail; Nunes-Souza, Valeria; Qadri, Fatimunnisa; Bader, Michael; Alenina, Natalia] Max Delbruck Ctr Mol Med, Berlin, Germany; [Rabelo, Luiza A.; Nunes-Souza, Valeria] Univ Fed Alagoas, Lab Reatividade Cardiovasc, Maceio, Alagoas, Brazil; [Rabelo, Luiza A.; Todiras, Mihail; Nunes-Souza, Valeria; Bader, Michael; Santos, Robson A.; Alenina, Natalia] Inst Nacl Ciencia & Tecnol NanoBiofarmaceut NanoB, Sao Paulo, Brazil; [Qadri, Fatimunnisa; Bader, Michael] Charite, D-13353 Berlin, Germany; [Szijarto, Istvan Andras; Gollasch, Maik] Charite Campus Virchow Klinikum, ECRC, Nephrol Intens Care, Berlin, Germany; [Penninger, Josef M.] Austrian Acad Sci, Inst Mol Biotechnol, A-1010 Vienna, Austria; [Bader, Michael; Santos, Robson A.; Alenina, Natalia] Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Universidade Federal de Alagoas; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); Universidade Federal de Minas Gerais	Alenina, N (corresponding author), Max Delbruck Ctr Mol Med, Berlin, Germany.; Alenina, N (corresponding author), Inst Nacl Ciencia & Tecnol NanoBiofarmaceut NanoB, Sao Paulo, Brazil.; Alenina, N (corresponding author), Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil.	alenina@mdc-berlin.de	Bader, Michael/K-2124-2013; Santos, Robson A S/C-9336-2011; Penninger, Josef M/I-6860-2013; Rabêlo, Luiza A./S-4050-2019; Todiras, Mihail/AAT-4426-2020	Santos, Robson A S/0000-0001-8738-5852; Penninger, Josef M/0000-0002-8194-3777; Todiras, Mihail/0000-0002-9373-4753; Bader, Michael/0000-0003-4780-4164; Szijarto, Istvan/0000-0002-0796-9450	Deutsche Forschungsgemeinschaft (DFG); Deutsche Akademische Austauschdienst (DAAD); Brazilian fellowship [BJT 407352/2013-9]; CNPq-Brazil [202139/2010-7]; Fellowship DAAD/CNPq/CAPES - Brazil [246794/2012-7]; DAAD/CNPq program PROBRAL	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Deutsche Akademische Austauschdienst (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Brazilian fellowship; CNPq-Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fellowship DAAD/CNPq/CAPES - Brazil; DAAD/CNPq program PROBRAL	The Deutsche Forschungsgemeinschaft (DFG) and Deutsche Akademische Austauschdienst (DAAD) to MG, the Brazilian fellowship BJT 407352/2013-9 to NA, the Postdoctoral Fellowship from CNPq-Brazil (Grant 202139/2010-7) to LAR, the Fellowship DAAD/CNPq/CAPES - Brazil (Grant 246794/2012-7) to VNS, and the DAAD/CNPq program PROBRAL to NA and RAS supportred this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alghamri MS, 2013, J CARDIOVASC PHARM T, V18, P138, DOI 10.1177/1074248412460124; Bandeira SD, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/819310; Bauer UE, 2014, LANCET, V384, P45, DOI 10.1016/S0140-6736(14)60648-6; Berka V, 2004, J BIOL CHEM, V279, P32243, DOI 10.1074/jbc.M404044200; Bodiga S, 2011, CARDIOVASC RES, V91, P151, DOI 10.1093/cvr/cvr036; Botelho-Santos Giancarla Aparecida, 2012, Ther Adv Cardiovasc Dis, V6, P201, DOI 10.1177/1753944712461164; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brandes RP, 2000, HYPERTENSION, V35, P231, DOI 10.1161/01.HYP.35.1.231; Briones AM, 2009, HYPERTENSION, V54, P142, DOI 10.1161/HYPERTENSIONAHA.109.133710; Chen CA, 2008, J BIOL CHEM, V283, P27038, DOI 10.1074/jbc.M802269200; Cosentino F, 2001, ARTERIOSCL THROM VAS, V21, P496, DOI 10.1161/01.ATV.21.4.496; Crackower MA, 2002, NATURE, V417, P822, DOI 10.1038/nature00786; DEISSEROTH A, 1970, PHYSIOL REV, V50, P319, DOI 10.1152/physrev.1970.50.3.319; Dumitrescu C, 2007, P NATL ACAD SCI USA, V104, P15081, DOI 10.1073/pnas.0702986104; Fesus G, 2007, CARDIOVASC RES, V75, P719, DOI 10.1016/j.cardiores.2007.05.025; Fraga-Silva RA, 2013, HYPERTENSION, V61, P1233, DOI 10.1161/HYPERTENSIONAHA.111.00627; Gurley SB, 2008, EXP PHYSIOL, V93, P538, DOI 10.1113/expphysiol.2007.040014; Gurley SB, 2006, J CLIN INVEST, V116, P2218, DOI 10.1172/JCI16980; Higashi Y, 2002, NEW ENGL J MED, V346, P1954, DOI 10.1056/NEJMoa013591; Jin HY, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0042432, 10.1371/journal.pone.0038502]; Kleinbongard P, 2006, FREE RADICAL BIO MED, V40, P295, DOI 10.1016/j.freeradbiomed.2005.08.025; Lei XG, 2007, ANNU REV NUTR, V27, P41, DOI 10.1146/annurev.nutr.27.061406.093716; Lovren F, 2008, AM J PHYSIOL-HEART C, V295, pH1377, DOI 10.1152/ajpheart.00331.2008; Miller FJ, 1998, CIRC RES, V82, P1298, DOI 10.1161/01.RES.82.12.1298; Mueller CFH, 2005, ARTERIOSCL THROM VAS, V25, P274, DOI 10.1161/01.ATV.0000149143.04821.eb; MUGGE A, 1991, CIRC RES, V69, P1293, DOI 10.1161/01.RES.69.5.1293; Nakaoka H, 2013, J AM SOC HYPERTENS, V7, P259, DOI 10.1016/j.jash.2013.03.002; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Oudit GY, 2009, EUR J CLIN INVEST, V39, P618, DOI 10.1111/j.1365-2362.2009.02153.x; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Patel SK, 2012, AM J HYPERTENS, V25, P216, DOI 10.1038/ajh.2011.188; Patel VB, 2014, HYPERTENSION, V64, P157, DOI 10.1161/HYPERTENSIONAHA.114.03388; Pena-Silva RA, 2012, STROKE, V43, P3358, DOI 10.1161/STROKEAHA.112.667063; Peshavariya HM, 2007, FREE RADICAL RES, V41, P699, DOI 10.1080/10715760701297354; Rabelo LA, 2011, HYPERTENS RES, V34, P154, DOI 10.1038/hr.2010.235; Rabelo LA, 2008, J AM SOC HYPERTENS, V2, P418, DOI 10.1016/j.jash.2008.05.003; Rafikov R, 2011, J ENDOCRINOL, V210, P271, DOI 10.1530/JOE-11-0083; Rentzsch B, 2008, HYPERTENSION, V52, P967, DOI 10.1161/HYPERTENSIONAHA.108.114322; Santos RAS, 2003, P NATL ACAD SCI USA, V100, P8258, DOI 10.1073/pnas.1432869100; Saraswathi R, 2011, CLIN EXP HYPERTENS, V33, P437, DOI 10.3109/10641963.2010.549259; Shi Y, 2007, BRIT J PHARMACOL, V152, P1033, DOI 10.1038/sj.bjp.0707439; Shi Y, 2009, J DIABETES, V1, P151, DOI 10.1111/j.1753-0407.2009.00030.x; Shiota A, 2010, HYPERTENS RES, V33, P298, DOI 10.1038/hr.2009.231; Thatcher SE, 2011, ARTERIOSCL THROM VAS, V31, P758, DOI 10.1161/ATVBAHA.110.221614; Thomas MC, 2010, CIRC RES, V107, P888, DOI 10.1161/CIRCRESAHA.110.219279; Tian XY, 2012, CIRC RES, V110, P1211, DOI [10.1161/CIRCRESAHA.111.262170, 10.1161/circresaha.111.262170]; Touyz RM, 2011, HYPERTENS RES, V34, P5, DOI 10.1038/hr.2010.201; Vasquez-Vivar J, 1998, P NATL ACAD SCI USA, V95, P9220, DOI 10.1073/pnas.95.16.9220; Vinh A, 2008, CARDIOVASC RES, V77, P178, DOI 10.1093/cvr/cvm021; White AR, 2006, HYPERTENSION, V47, P245, DOI 10.1161/01.HYP.0000198543.34502.d7; Wilkinson IB, 2002, BRIT J CLIN PHARMACO, V53, P189, DOI 10.1046/j.1365-2125.2002.1528adoc.x; Wong DW, 2007, AM J PATHOL, V171, P438, DOI 10.2353/ajpath.2007.060977; Xu P, 2008, HYPERTENSION, V51, P574, DOI 10.1161/HYPERTENSIONAHA.107.102764; Yamamoto K, 2006, HYPERTENSION, V47, P718, DOI 10.1161/01.HYP.0000205833.89478.5b; Zhang Y, 2015, ANTIOXID REDOX SIGN, V23, P880, DOI 10.1089/ars.2014.6070	55	46	47	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0150255	10.1371/journal.pone.0150255	http://dx.doi.org/10.1371/journal.pone.0150255			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27070147	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000373900700003
J	Deryugina, T; Shurchkov, O				Deryugina, Tatyana; Shurchkov, Olga			The Effect of Information Provision on Public Consensus about Climate Change	PLOS ONE			English	Article							SUPPORT; SCIENCE; PERCEPTIONS	Despite over 20 years of research and scientific consensus on the topic, climate change continues to be a politically polarizing issue. We conducted a survey experiment to test whether providing the public with information on the exact extent of scientific agreement about the occurrence and causes of climate change affects respondents' own beliefs and bridges the divide between conservatives and liberals. First, we show that the public significantly underestimated the extent of the scientific consensus. We then find that those given concrete information about scientists' views were more likely to report believing that climate change was already underway and that it was caused by humans. However, their beliefs about the necessity of making policy decisions and their willingness to donate money to combat climate change were not affected. Information provision affected liberals, moderates, and conservatives similarly, implying that the gap in beliefs between liberals and conservatives is not likely to be bridged by information treatments similar to the one we study. Finally, we conducted a 6-month follow-up with respondents to see if the treatment effect persisted; the results were statistically inconclusive.	[Deryugina, Tatyana] Univ Illinois, Dept Finance, Urbana, IL 61801 USA; [Shurchkov, Olga] Wellesley Coll, Dept Econ, Wellesley, MA 02181 USA	University of Illinois System; University of Illinois Urbana-Champaign; Wellesley College	Deryugina, T (corresponding author), Univ Illinois, Dept Finance, Urbana, IL 61801 USA.	deryugin@illinois.edu		Shurchkov, Olga/0000-0003-1962-7551	University of Illinois, Urbana-Champaign (UIUC) Campus Research Board [13013]	University of Illinois, Urbana-Champaign (UIUC) Campus Research Board	Research support was received from the University of Illinois, Urbana-Champaign (UIUC) Campus Research Board ID# 13013 https://crb.research.illinois.edu/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aklin M, 2014, ENVIRON SCI POLICY, V38, P173, DOI 10.1016/j.envsci.2013.10.006; Andreoni J, 2014, 20649 NBER; Angrist JD, 2009, MOSTLY HARMLESS ECONOMETRICS: AN EMPIRICISTS COMPANION, P1; Bauer MW, 2007, PUBLIC UNDERST SCI, V16, P79, DOI 10.1177/0963662506071287; Bollinger B, 2011, AM ECON J-ECON POLIC, V3, P91, DOI 10.1257/pol.3.1.91; Bolsen T, 2014, AM POLIT RES, V42, P65, DOI 10.1177/1532673X13484173; Cameron TA, 2005, J RISK UNCERTAINTY, V30, P63, DOI 10.1007/s11166-005-5833-8; Census Bureau of the United States, 2016, QUICK FACTS; Corbett JB, 2004, SCI COMMUN, V26, P129, DOI 10.1177/1075547004270234; Dunlap RE, 2008, ENVIRONMENT; Edenhofer O., 2014, CONTRIBUTION WORKING; FESTINGER L, 1962, SCI AM, V207, P93, DOI 10.1038/scientificamerican1062-93; Gentzkow M, 2011, Q J ECON, V126, P1799, DOI 10.1093/qje/qjr044; Kellstedt PM, 2008, RISK ANAL, V28, P113, DOI 10.1111/j.1539-6924.2008.01010.x; Kiesel K, 2013, INT J IND ORGAN, V31, P153, DOI 10.1016/j.ijindorg.2010.11.002; Kuziemko I, 2015, AM ECON REV, V105, P1478, DOI 10.1257/aer.20130360; Lewandowsky S, 2013, NAT CLIM CHANGE, V3, P399, DOI [10.1038/nclimate1720, 10.1038/NCLIMATE1720]; McCright AM, 2013, CLIMATIC CHANGE, V119, P511, DOI 10.1007/s10584-013-0704-9; Nyhan B, 2014, PEDIATRICS, V133, pE835, DOI 10.1542/peds.2013-2365; Pew Research Center, 2015, PUBL SCIENT VIEWS SC; Ramirez MD, 2014, POLIT PSYCHOL, V35, P401, DOI 10.1111/pops.12064; Rosenberg S, 2010, CLIM CHANG, V101, P3; Schwartzstein J, 2014, J EUR ECON ASSOC, V12, P1423, DOI 10.1111/jeea.12104; Sturgis P, 2004, PUBLIC UNDERST SCI, V13, P55, DOI 10.1177/0963662504042690; van der Linden SL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118489; van der Linden SL, 2014, CLIMATIC CHANGE, V126, P255, DOI 10.1007/s10584-014-1190-4	27	54	54	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2016	11	4							e0151469	10.1371/journal.pone.0151469	http://dx.doi.org/10.1371/journal.pone.0151469			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ0KH	27064486	Green Published, Green Submitted, gold			2022-12-27	WOS:000373891000003
J	Li, BL; Shi, J; Gutman, BA; Baxter, LC; Thompson, PM; Caselli, RJ; Wang, YL				Li, Bolun; Shi, Jie; Gutman, Boris A.; Baxter, Leslie C.; Thompson, Paul M.; Caselli, Richard J.; Wang, Yalin		Alzheimer's Dis Neuroimaging	Influence of APOE Genotype on Hippocampal Atrophy over Time - An N=1925 Surface-Based ADNI Study	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; TENSOR-BASED MORPHOMETRY; APOLIPOPROTEIN-E GENOTYPE; ONSET ALZHEIMER-DISEASE; E EPSILON 4; BRAIN ATROPHY; GENETIC RISK; CONFORMAL PARAMETERIZATION; AUTOMATED SEGMENTATION; SUBCORTICAL STRUCTURES	The apolipoprotein E (APOE) e4 genotype is a powerful risk factor for late-onset Alzheimer's disease (AD). In the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort, we previously reported significant baseline structural differences in APOE e4 carriers relative to non-carriers, involving the left hippocampus more than the right-a difference more pronounced in e4 homozygotes than heterozygotes. We now examine the longitudinal effects of APOE genotype on hippocampal morphometry at 6-, 12- and 24-months, in the ADNI cohort. We employed a new automated surface registration system based on conformal geometry and tensor-based morphometry. Among different hippocampal surfaces, we computed high-order correspondences, using a novel inverse-consistent surface-based fluid registration method and multivariate statistics consisting of multivariate tensor-based morphometry (mTBM) and radial distance. At each time point, using Hotelling's T-2 test, we found significant morphological deformation in APOE e4 carriers relative to non-carriers in the full cohort as well as in the non-demented (pooled MCI and control) subjects at each follow-up interval. In the complete ADNI cohort, we found greater atrophy of the left hippocampus than the right, and this asymmetry was more pronounced in e4 homozygotes than heterozygotes. These findings, combined with our earlier investigations, demonstrate an e4 dose effect on accelerated hippocampal atrophy, and support the enrichment of prevention trial cohorts with e4 carriers.	[Li, Bolun; Shi, Jie; Wang, Yalin] Arizona State Univ, Sch Comp Informat & Decis Syst Engn, Tempe, AZ USA; [Gutman, Boris A.; Thompson, Paul M.] Univ So Calif, Inst Neuroimaging & Informat, Imaging Genet Ctr, Marina Del Rey, CA USA; [Baxter, Leslie C.] Barrow Neurol Inst, Human Brain Imaging Lab, Phoenix, AZ 85013 USA; [Caselli, Richard J.] Mayo Clin Arizona, Dept Neurol, Scottsdale, AZ USA	Arizona State University; Arizona State University-Tempe; University of Southern California; Barrow Neurological Institute; Mayo Clinic; Mayo Clinic Phoenix	Wang, YL (corresponding author), Arizona State Univ, Sch Comp Informat & Decis Syst Engn, Tempe, AZ USA.	ylwang@asu.edu	Thompson, Paul M/C-4194-2018; Shi, Jie/D-1147-2017	Thompson, Paul M/0000-0002-4720-8867; Wang, Yalin/0000-0002-6241-735X; Baxter, Leslie/0000-0002-3971-863X; Shi, Jie/0000-0002-9095-0557	National Institute on Aging [R21AG043760, R21AG049216, R01AG031581, P30AG19610]; National Science Foundation [DMS-1413417, IIS-1421165]; Arizona Alzheimer's Consortium [ADHS14-052688]; NIH ENIGMA Center - Big Data to Knowledge (BD2K) Centers of Excellence program [U54EB020403]; Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health) [U01 AG024904]; DOD ADNI (Department of Defense) [W81XWH-12-2-0012]; National Institute on Aging; National Institute of Biomedical Imaging and Bioengineering; Canadian Institutes of Health Research; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [U54EB005149, U54EB020403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U01AG024904, R01AG031581, R21AG049216, P30AG019610, R21AG043760] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Science Foundation(National Science Foundation (NSF)); Arizona Alzheimer's Consortium; NIH ENIGMA Center - Big Data to Knowledge (BD2K) Centers of Excellence program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); DOD ADNI (Department of Defense); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was funded by the National Institute on Aging (R21AG043760 to BL, JS, LCB, RJC and YW, R21AG049216 to JS, PMT and YW, R01AG031581 and P30AG19610 to RJC), the National Science Foundation (DMS-1413417, IIS-1421165 to YW), and the Arizona Alzheimer's Consortium (ADHS14-052688 to BL, JS and YW). BAG, PMT and YW are also supported, in part, by the NIH ENIGMA Center grant U54EB020403, which is supported by the Big Data to Knowledge (BD2K) Centers of Excellence program. Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904) and DOD ADNI (Department of Defense award number W81XWH-12-2-0012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904) and DOD ADNI (Department of Defense award number W81XWH-12-2-0012). ADNI-PI is Michael W. Weiner, MD(email: Michael.Weiner@ucsf.edu). A complete listing of ADNI investigators can be found at https://adni.loni.usc.edu/wp-content/uploads/how_to_apply/ADNI_Acknowledgement_List.pdf. Data used in preparation of this article were obtained from the ADNI (adni.loni.usc.edu). As such, the investigators within the ADNI contributed to the design and implementation of ADNI and/or provided data but did not participate in analysis or writing of this report. ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; Biogen Idec Inc.; Bristol-Myers Squibb Company; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; EuroImmun; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; Fujirebio; GE Healthcare;; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Medpace, Inc.; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Synarc Inc.; and Takeda Pharmaceutical Company. The Canadian Institutes of Rev December 5, 2013 Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California, San Diego. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of Southern California.	Apostolova LG, 2010, NEUROIMAGE, V51, P488, DOI 10.1016/j.neuroimage.2009.12.125; Arsigny V, 2006, MAGN RESON MED, V56, P411, DOI 10.1002/mrm.20965; Baltes C, 2011, METHODS MOL BIOL, V711, P511, DOI 10.1007/978-1-61737-992-5_26; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bennett DA, 2009, NEUROLOGY, V72, P1495, DOI 10.1212/WNL.0b013e3181a2e87d; BERG L, 1988, PSYCHOPHARMACOL BULL, V24, P637; Blacker D, 2007, ARCH NEUROL-CHICAGO, V64, P862, DOI 10.1001/archneur.64.6.862; BRECHBUHLER C, 1995, COMPUT VIS IMAGE UND, V61, P154, DOI 10.1006/cviu.1995.1013; BroNielsen M, 1996, LECT NOTES COMPUT SC, V1131, P267; Cao J, 1999, ANN STAT, V27, P925; Cardenas VA, 2011, NEUROBIOL AGING, V32, P572, DOI 10.1016/j.neurobiolaging.2009.04.011; Caselli RJ, 2011, NEUROLOGY, V76, P1078, DOI 10.1212/WNL.0b013e318211c3ae; Caselli RJ, 2013, J ALZHEIMERS DIS, V33, pS405, DOI 10.3233/JAD-2012-129026; Caselli RJ, 2010, NEUROSCI LETT, V473, P168, DOI 10.1016/j.neulet.2010.02.016; Caselli RJ, 2009, NEW ENGL J MED, V361, P255, DOI 10.1056/NEJMoa0809437; Chen KW, 2007, AM J PSYCHIAT, V164, P916, DOI 10.1176/appi.ajp.164.6.916; Cho Y, 2011, NEUROIMAGE, V57, P1376, DOI 10.1016/j.neuroimage.2011.05.066; Cohen RM, 2001, NEUROLOGY, V57, P2223, DOI 10.1212/WNL.57.12.2223; CORDER EH, 1994, NAT GENET, V7, P180, DOI 10.1038/ng0694-180; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Crivello F, 2010, NEUROIMAGE, V53, P1064, DOI 10.1016/j.neuroimage.2009.12.116; Csernansky JG, 2000, NEUROLOGY, V55, P1636, DOI 10.1212/WNL.55.11.1636; D'Agostino E, 2003, MED IMAGE ANAL, V7, P565, DOI 10.1016/S1361-8415(03)00039-2; de Flores R, 2015, HUM BRAIN MAPP, V36, P463, DOI 10.1002/hbm.22640; Dean DC, 2014, JAMA NEUROL, V71, P11, DOI 10.1001/jamaneurol.2013.4544; DELEON MJ, 1989, LANCET, V2, P672; den Heijer T, 2010, BRAIN, V133, P1163, DOI 10.1093/brain/awq048; DICKSON DW, 1992, NEUROBIOL AGING, V13, P179, DOI 10.1016/0197-4580(92)90027-U; Erten-Lyons D, 2013, JAMA NEUROL, V70, P616, DOI 10.1001/jamaneurol.2013.1957; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.1997.03550160069041; Filippini N, 2009, P NATL ACAD SCI USA, V106, P7209, DOI 10.1073/pnas.0811879106; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fox NC, 1999, NEUROLOGY, V52, P1687, DOI 10.1212/WNL.52.8.1687; Frey BJ, 2003, ALZHEIMERS DIS; Gouras GK, 1997, ANN NEUROL, V41, P402, DOI 10.1002/ana.410410317; Gu XF, 2004, IEEE T MED IMAGING, V23, P949, DOI 10.1109/TMI.2004.831226; Gutman B, 2009, HIPPOCAMPUS, V19, P572, DOI 10.1002/hipo.20627; Haller JW, 1996, RADIOLOGY, V199, P787, DOI 10.1148/radiology.199.3.8638006; Hao YF, 2014, HUM BRAIN MAPP, V35, P2674, DOI 10.1002/hbm.22359; Holmes AP, 1996, J CEREBR BLOOD F MET, V16, P7, DOI 10.1097/00004647-199601000-00002; Hotelling H, 1931, ANN MATH STAT, V2, P360, DOI 10.1214/aoms/1177732979; Hua X, 2010, NEUROIMAGE, V51, P63, DOI 10.1016/j.neuroimage.2010.01.104; Jack CR, 2008, J MAGN RESON IMAGING, V27, P685, DOI 10.1002/jmri.21049; Jack CR, 2003, NEUROLOGY, V60, P253, DOI 10.1212/01.WNL.0000042480.86872.03; Jack CR, 2004, NEUROLOGY, V62, P591, DOI 10.1212/01.WNL.0000110315.26026.EF; Joshi SC, 2000, IEEE T IMAGE PROCESS, V9, P1357, DOI 10.1109/83.855431; Joshi SH, 2016, BIOL PSYCHIAT, V79, P282, DOI 10.1016/j.biopsych.2015.02.029; Kim S, 2012, PROC CVPR IEEE, P25, DOI [10.1109/MMBIA.2012.6164736, 10.1109/CVPR.2012.6247654]; Kim W. H., 2012, ADV NEURAL INFORM PR; Knickmeyer RC, 2014, CEREB CORTEX, V24, P1230, DOI 10.1093/cercor/bhs401; Kok E, 2009, ANN NEUROL, V65, P650, DOI 10.1002/ana.21696; Langbaum JB, 2013, NAT REV NEUROL, V9, P371, DOI 10.1038/nrneurol.2013.107; Lao Y, 2016, BRAIN STRUCT FUNCT, V221, P487, DOI 10.1007/s00429-014-0921-7; Lemaitre H, 2005, NEUROIMAGE, V24, P1205, DOI 10.1016/j.neuroimage.2004.10.016; Leow A, 2005, LECT NOTES COMPUT SC, V3565, P493; Lepore N, 2008, IEEE T MED IMAGING, V27, P129, DOI 10.1109/TMI.2007.906091; Li B, 2015, CORR APOE4 GEN HIPP; Lorensen W.E., 1987, ACM SIGGRAPH COMPUTE, V21, P163, DOI [DOI 10.1145/37402.37422, 10.1145/37401.37422]; Lyall DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080513; Morra JH, 2009, HUM BRAIN MAPP, V30, P2766, DOI 10.1002/hbm.20708; Morra JH, 2009, NEUROIMAGE, V45, pS3, DOI 10.1016/j.neuroimage.2008.10.043; Morris JC, 2010, ANN NEUROL, V67, P122, DOI 10.1002/ana.21843; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; O'Dwyer L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048895; Patenaude B, 2011, NEUROIMAGE, V56, P907, DOI 10.1016/j.neuroimage.2011.02.046; Pievani M, 2011, NEUROIMAGE, V55, P909, DOI 10.1016/j.neuroimage.2010.12.081; Pizer SM, 1999, IEEE T MED IMAGING, V18, P851, DOI 10.1109/42.811263; Protas HD, 2013, JAMA NEUROL, V70, P320, DOI 10.1001/2013.jamaneurol.286; Qiu AQ, 2009, NEUROIMAGE, V44, P620, DOI 10.1016/j.neuroimage.2008.10.010; Reiman EM, 2005, P NATL ACAD SCI USA, V102, P8299, DOI 10.1073/pnas.0500579102; Reiman EM, 1998, ANN NEUROL, V44, P288, DOI 10.1002/ana.410440226; Reiman EM, 1996, NEW ENGL J MED, V334, P752, DOI 10.1056/NEJM199603213341202; Reiman EM, 2012, NEUROIMAGE, V61, P505, DOI 10.1016/j.neuroimage.2011.11.075; Reiman EM, 2009, P NATL ACAD SCI USA, V106, P6820, DOI 10.1073/pnas.0900345106; Rey D, 2002, MED IMAGE ANAL, V6, P163, DOI 10.1016/S1361-8415(02)00056-7; Roussotte FF, 2014, J NEUROSCI, V34, P6537, DOI 10.1523/JNEUROSCI.5236-13.2014; Roussotte FF, 2014, NEUROBIOL AGING, V35, P1309, DOI 10.1016/j.neurobiolaging.2013.11.030; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Shen L, 2009, HIPPOCAMPUS, V19, P588, DOI 10.1002/hipo.20613; Shi J, 2015, NEUROIMAGE, V104, P1, DOI 10.1016/j.neuroimage.2014.09.062; Shi J, 2014, HUM BRAIN MAPP, V35, P3903, DOI 10.1002/hbm.22447; Shi J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066736; Shi J, 2013, NEUROIMAGE, V78, P111, DOI 10.1016/j.neuroimage.2013.04.018; SOININEN H, 1995, NEUROLOGY, V45, P391, DOI 10.1212/WNL.45.2.391; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Stonnington CM, 2010, NEUROIMAGE, V51, P1405, DOI 10.1016/j.neuroimage.2010.03.051; Styner M, 2004, MED IMAGE ANAL, V8, P197, DOI 10.1016/j.media.2004.06.004; Thirion JP, 2000, MED IMAGE ANAL, V4, P111, DOI 10.1016/S1361-8415(00)00012-8; Thompson PM, 2004, NEUROIMAGE, V22, P1754, DOI 10.1016/j.neuroimage.2004.03.040; Van Leemput K, 2009, HIPPOCAMPUS, V19, P549, DOI 10.1002/hipo.20615; Villemagne VL, 2009, ARCH NEUROL-CHICAGO, V66, P1537, DOI 10.1001/archneurol.2009.285; Wachinger C, 2015, NEUROIMAGE, V109, P232, DOI 10.1016/j.neuroimage.2015.01.032; Wang G, 2015, MED IMAGE ANAL, V22, P1, DOI 10.1016/j.media.2015.01.005; Wang L, 2006, NEUROIMAGE, V30, P52, DOI 10.1016/j.neuroimage.2005.09.017; Wang L, 2003, NEUROIMAGE, V20, P667, DOI 10.1016/S1053-8119(03)00361-6; Wang L, 2007, IEEE T MED IMAGING, V26, P462, DOI 10.1109/TMI.2006.887380; Wang YL, 2007, IEEE T MED IMAGING, V26, P853, DOI 10.1109/TMI.2007.895464; Wang YL, 2013, NEUROIMAGE, V74, P209, DOI 10.1016/j.neuroimage.2013.02.011; Wang YL, 2012, IEEE T MED IMAGING, V31, P251, DOI 10.1109/TMI.2011.2168233; Wang YL, 2011, NEUROIMAGE, V56, P1993, DOI 10.1016/j.neuroimage.2011.03.040; Wang YL, 2010, NEUROIMAGE, V49, P2141, DOI 10.1016/j.neuroimage.2009.10.086; Wechsler D, 1987, WMS R WECHSLER MEMOR; Wolz R, 2010, NEUROIMAGE, V52, P109, DOI 10.1016/j.neuroimage.2010.04.006; Yang XF, 2013, HUM BRAIN MAPP, V34, P3075, DOI 10.1002/hbm.22125; Yassa MA, 2010, NEUROIMAGE, V51, P1242, DOI 10.1016/j.neuroimage.2010.03.040; Younes L, 2014, HUM BRAIN MAPP, V35, P792, DOI 10.1002/hbm.22214; Yushkevich PA, 2015, NEUROIMAGE, V111, P526, DOI 10.1016/j.neuroimage.2015.01.004; Yushkevich PA, 2015, HUM BRAIN MAPP, V36, P258, DOI 10.1002/hbm.22627; ZANNIS VI, 1982, MOL CELL BIOCHEM, V42, P3; ZANNIS VI, 1982, J LIPID RES, V23, P911; Zhang W, 2015, AR ALZH CONS ANN SCI	111	36	36	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2016	11	4							e0152901	10.1371/journal.pone.0152901	http://dx.doi.org/10.1371/journal.pone.0152901			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0KH	27065111	gold, Green Published, Green Submitted			2022-12-27	WOS:000373891000023
J	Rambli, A; Abuzaid, AHM; Bin Mohamed, I; Hussin, AG				Rambli, Adzhar; Abuzaid, Ali H. M.; Bin Mohamed, Ibrahim; Hussin, Abdul Ghapor			Procedure for Detecting Outliers in a Circular Regression Model	PLOS ONE			English	Article								A number of circular regression models have been proposed in the literature. In recent years, there is a strong interest shown on the subject of outlier detection in circular regression. An outlier detection procedure can be developed by defining a new statistic in terms of the circular residuals. In this paper, we propose a new measure which transforms the circular residuals into linear measures using a trigonometric function. We then employ the row deletion approach to identify observations that affect the measure the most, a candidate of outlier. The corresponding cut-off points and the performance of the detection procedure when applied on Down and Mardia's model are studied via simulations. For illustration, we apply the procedure on circadian data.	[Rambli, Adzhar; Bin Mohamed, Ibrahim] Univ Malaya, Inst Math Sci, Kuala Lumpur, Malaysia; [Abuzaid, Ali H. M.] Al Azhar Univ Gaza, Fac Sci, Dept Math, Gaza, Israel; [Hussin, Abdul Ghapor] Natl Def Univ Malaysia, Ctr Def Fdn Studies, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Pertahanan Nasional Malaysia	Rambli, A (corresponding author), Univ Malaya, Inst Math Sci, Kuala Lumpur, Malaysia.	adzfranc@gmail.com	BIN MOHAMED, IBRAHIM/B-8643-2010; RAMBLI, ADZHAR/ABD-1232-2020	BIN MOHAMED, IBRAHIM/0000-0001-5518-4132; Abuzaid, Ali/0000-0002-6680-7371; Rambli, Adzhar/0000-0001-9947-1176	University of Malaya Research Grant Scheme [RP009C-13AFR, RP014C-15SUS]	University of Malaya Research Grant Scheme	University of Malaya Research Grant Scheme (no. RP009C-13AFR) - website: http://umresearch.um.edu.my. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are most grateful to the Associate Editor and referees for their through reading and valuable suggestions, which led to a substantial improvement of the article. This research is financially supported by the University of Malaya Research Grant Scheme (no. RP014C-15SUS).	Abuzaid AH, 2013, J STAT COMPUT SIM, V83, P269, DOI 10.1080/00949655.2011.602679; Abuzaid A, 2011, CHIANG MAI J SCI, V38, P321; Barnett V., 1984, OUTLIERS STAT DATA; Downs TD, 2002, BIOMETRIKA, V89, P683, DOI 10.1093/biomet/89.3.683; FISHER NI, 1992, BIOMETRICS, V48, P665, DOI 10.2307/2532334; GOULD AL, 1969, BIOMETRICS, V25, P683, DOI 10.2307/2528567; Hayakawa T, 1993, STAT SCI DATA ANAL, P109; Hussin A.G., 2004, J APPL SCI TECHNOL, V9, P1; Ibrahim S, 2013, COMMUN STAT-SIMUL C, V42, P2272, DOI 10.1080/03610918.2012.697239; JOHNSON RA, 1978, J AM STAT ASSOC, V73, P602, DOI 10.2307/2286608; LAYCOCK PJ, 1975, BIOMETRIKA, V62, P305, DOI 10.1093/biomet/62.2.305; Rao JS., 2001, TOPICS CIRCULAR STAT; Rivest LP, 1997, BIOMETRIKA, V84, P717, DOI 10.1093/biomet/84.3.717; Welsch R, 1980, REGRESSION DIAGNOSTI	14	5	5	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2016	11	4							e0153074	10.1371/journal.pone.0153074	http://dx.doi.org/10.1371/journal.pone.0153074			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0KH	27064566	Green Published, gold, Green Submitted			2022-12-27	WOS:000373891000028
J	Rosenlund, S; Holsgaard-Larsen, A; Overgaard, S; Jensen, C				Rosenlund, Signe; Holsgaard-Larsen, Anders; Overgaard, Soren; Jensen, Carsten			The Gait Deviation Index Is Associated with Hip Muscle Strength and Patient-Reported Outcome in Patients with Severe Hip Osteoarthritis-A Cross-Sectional Study	PLOS ONE			English	Article							QUALITY-OF-LIFE; LATERAL APPROACH; CEREBRAL-PALSY; WALKING SPEED; ARTHROPLASTY; KNEE; CHILDREN; PAIN; VALIDITY; INDIVIDUALS	Background The Gait Deviation Index summarizes overall gait 'quality', based on kinematic data from a 3-dimensional gait analysis. However, it is unknown which clinical outcomes may affect the Gait Deviation Index in patients with primary hip osteoarthritis. The aim of this study was to investigate associations between Gait Deviation Index as a measure of gait 'quality' and hip muscle strength and between Gait Deviation Index and patient-reported outcomes in patients with primary hip osteoarthritis. Method Forty-seven patients (34 males), aged 61.1 +/- 6.7 years, with BMI 27.3 +/- 3.4 (kg/m(2)) and with severe primary hip osteoarthritis underwent 3-dimensional gait analysis. Mean Gait Deviation Index, pain after walking and maximal isometric hip muscle strength (flexor, extensor, and abductor) were recorded. All patients completed the 'Physical Function Short-form of the Hip disability and Osteoarthritis Outcome Score (HOOS-Physical Function) and the Hip disability and Osteoarthritis Outcome Score subscales for pain (HOOS-Pain) and quality-of-life (HOOS-QOL). Results Mean Gait Deviation Index was positively associated with hip abduction strength (p<0.01, r = 0.40), hip flexion strength (p = 0.01, r = 0.37), HOOS-Physical Function (p<0.01, r = 0.41) HOOS-QOL (p<0.01, r = 0.41), and negatively associated with HOOS-Pain after walking (p<0.01, r = -0.45). Adjusting the analysis for walking speed did not affect the association. Conclusion Patients with the strongest hip abductor and hip flexor muscles had the best gait 'quality'. Furthermore, patients with higher physical function, quality of life scores and lower pain levels demonstrated better gait 'quality'. These findings indicate that interventions aimed at improving hip muscle strength and pain management may to a moderate degree improve the overall gait 'quality' in patients with primary hip OA.	[Rosenlund, Signe; Holsgaard-Larsen, Anders; Overgaard, Soren; Jensen, Carsten] Univ Southern Denmark, Dept Orthopaed Surg & Traumatol, Odense Univ Hosp, Inst Clin Res, Odense C, Denmark; [Rosenlund, Signe] Koge Hosp, Dept Orthopaed Surg & Traumatol, Koge, Denmark	University of Southern Denmark; Odense University Hospital	Rosenlund, S (corresponding author), Univ Southern Denmark, Dept Orthopaed Surg & Traumatol, Odense Univ Hosp, Inst Clin Res, Odense C, Denmark.; Rosenlund, S (corresponding author), Koge Hosp, Dept Orthopaed Surg & Traumatol, Koge, Denmark.	signe.rosenlund@gmail.com	Holsgaard-Larsen, Anders/F-1033-2013; Jensen, C./H-9034-2019; Overgaard, Søren/AAX-9407-2020	Holsgaard-Larsen, Anders/0000-0003-4106-6930; Jensen, C./0000-0002-8074-1583; Overgaard, Soren/0000-0001-6829-4787	Danish Rheumatism Association [R102-A2116, R108-A2436]; Region of Zealand [1641013, 12-000095/64]; Region of Southern Denmark [11/28589]; Bevica Foundation; Bjarne Jensen Foundation; Odense University Hospital	Danish Rheumatism Association; Region of Zealand; Region of Southern Denmark; Bevica Foundation; Bjarne Jensen Foundation; Odense University Hospital	This work was supported by the Danish Rheumatism Association (R102-A2116 and R108-A2436), (https://www.gigtforeningen.dk) (SR), the Region of Zealand (Brevid: 1641013 and Sagsnummer: 12-000095/64), (http://www.regionsjaelland.dk/Sundhed/forskning/forskningsfinansiering/Sider/oekonomi.aspx) (SR), the Region of Southern Denmark (j.nr. 11/28589), (http://www.regionsyddanmark.dk/wm325002) (SR), the Bevica Foundation (no grant number), (http://www.bevica.dk/bevica-fonden/formalansogning) (SR), the Bjarne Jensen Foundation (no grant number), (http://www.bjarnejensensfond.dk) (SR), and Odense University Hospital (no grant number), (http://www.ouh.dk/default.asp?id=402241) (SO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amlie E, 2014, ACTA ORTHOP, V85, P463, DOI 10.3109/17453674.2014.934183; Arokoski MH, 2002, J RHEUMATOL, V29, P2185; Behery OA, 2014, CLIN ORTHOP RELAT R, V472, P3452, DOI 10.1007/s11999-014-3886-1; Bejek Z, 2006, KNEE SURG SPORT TR A, V14, P612, DOI 10.1007/s00167-005-0005-6; Bellamy N, 1997, J RHEUMATOL, V24, P799; Bennell KL, 2010, OSTEOARTHR CARTILAGE, V18, P621, DOI 10.1016/j.joca.2010.01.010; Bergh I, 2000, AGING CLIN EXP RES, V12, P380, DOI 10.1007/BF03339864; Beyer NT, 2008, TRANSLATION CROSS CU; Bhave A, 2005, J BONE JOINT SURG AM, V87A, P9, DOI 10.2106/JBJS.E.00628; Brostrom EW, 2013, SCAND J RHEUMATOL, V42, P356, DOI 10.3109/03009742.2013.776102; Cimolin V, 2014, GAIT POSTURE, V39, P1005, DOI 10.1016/j.gaitpost.2014.02.001; Cimolin V, 2011, RES DEV DISABIL, V32, P377, DOI 10.1016/j.ridd.2010.10.017; Constantinou M, 2014, J ORTHOP SPORT PHYS, V44, P291, DOI 10.2519/jospt.2014.4634; Davis AM, 2009, OSTEOARTHR CARTILAGE, V17, P843, DOI 10.1016/j.joca.2009.01.005; DAVIS RB, 1991, HUM MOVEMENT SCI, V10, P575, DOI 10.1016/0167-9457(91)90046-Z; Esbjornsson AC, 2014, SCAND J RHEUMATOL, V43, P124, DOI 10.3109/03009742.2013.822095; Foucher KC, 2007, J BIOMECH, V40, P3432, DOI 10.1016/j.jbiomech.2007.05.020; Galli M, 2012, J MOTOR BEHAV, V44, P161, DOI 10.1080/00222895.2012.664180; Hassan BS, 2002, ANN RHEUM DIS, V61, P422, DOI 10.1136/ard.61.5.422; Holnapy G, 2013, J ELECTROMYOGR KINES, V23, P966, DOI 10.1016/j.jelekin.2013.04.005; Horstmann T, 2013, AM J PHYS MED REHAB, V92, P1060, DOI 10.1097/PHM.0b013e3182970fc4; Hurwitz DE, 1997, J ORTHOP RES, V15, P629, DOI 10.1002/jor.1100150421; Jensen C, 2011, OSTEOARTHR CARTILAGE, V19, P1108, DOI 10.1016/j.joca.2011.06.011; Jensen C, 2015, J ARTHROPLASTY, V30, P2343, DOI 10.1016/j.arth.2015.06.049; Jensen C, 2015, GAIT POSTURE, V42, P36, DOI 10.1016/j.gaitpost.2015.02.009; Jones CA, 2012, CLIN GERIATR MED, V28, P395, DOI 10.1016/j.cger.2012.06.001; KADABA MP, 1990, J ORTHOP RES, V8, P383, DOI 10.1002/jor.1100080310; Kean CO, 2015, CLIN BIOMECH, V30, P226, DOI 10.1016/j.clinbiomech.2015.01.008; Kiss RM, 2012, HUM MOVEMENT SCI, V31, P1302, DOI 10.1016/j.humov.2012.02.004; Landry SC, 2007, J BIOMECH, V40, P1754, DOI 10.1016/j.jbiomech.2006.08.010; Laroche D, 2011, OSTEOARTHR CARTILAGE, V19, P194, DOI 10.1016/j.joca.2010.10.024; Lindemann U, 2006, CLIN REHABIL, V20, P413, DOI 10.1191/0269215506cr958oa; LONG WT, 1993, CLIN ORTHOP RELAT R, P73; Maanum G, 2012, J REHABIL MED, V44, P272, DOI 10.2340/16501977-0930; Massaad A, 2014, GAIT POSTURE, V39, P354, DOI 10.1016/j.gaitpost.2013.08.001; Molloy M, 2010, GAIT POSTURE, V31, P479, DOI 10.1016/j.gaitpost.2010.01.025; Rasmussen HM, 2015, GAIT POSTURE, V42, P133, DOI 10.1016/j.gaitpost.2015.04.019; Reidy J, 2011, STAT MATHS PSYCHOL; Rosenlund S, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-354; Rozumalski A, 2012, GAIT POSTURE, V36, pS51, DOI DOI 10.1016/J.GAITPOST.2011.10.267; Samuel D, 2012, AGE AGEING, V41, P224, DOI 10.1093/ageing/afr156; Schwartz MH, 2008, GAIT POSTURE, V28, P351, DOI 10.1016/j.gaitpost.2008.05.001; SHIH CH, 1994, CLIN ORTHOP RELAT R, P115; Sicard-Rosenbaum L, 2002, J GERONTOL A-BIOL, V57, pM47, DOI 10.1093/gerona/57.1.M47; Steinhilber B, 2013, J GERIATR PHYS THER, V37, P99, DOI [10.1097/JPT.0000000000000008, DOI 10.1097/JPT.0000000000000008]; Thorborg K, 2010, BRIT J SPORT MED, V44, P1186, DOI 10.1136/bjsm.2009.060889; van der Krogt MM, 2012, GAIT POSTURE, V36, P113, DOI 10.1016/j.gaitpost.2012.01.017; Vicon&REG, 2010, PLUG IN GAIT PROD GU; WHO, 2014, GLOB HLTH EST 2014; WHO, 2002, WHOEIPGPECAS013; Widler KS, 2009, J BONE JOINT SURG AM, V91A, P2666, DOI 10.2106/JBJS.H.01119; Wilson JLA, 2012, CLIN BIOMECH, V27, P210, DOI 10.1016/j.clinbiomech.2011.09.009; Wren TAL, 2013, GAIT POSTURE, V38, P236, DOI 10.1016/j.gaitpost.2012.11.018; Zeni J, 2015, J ORTHOP RES, V33, P382, DOI 10.1002/jor.22772; Zeni J, 2014, ARTHRIT CARE RES, V66, P1506, DOI 10.1002/acr.22329	55	19	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2016	11	4							e0153177	10.1371/journal.pone.0153177	http://dx.doi.org/10.1371/journal.pone.0153177			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ0KH	27065007	Green Published, Green Submitted, gold			2022-12-27	WOS:000373891000034
J	Shen, YQ; Ng, LF; Low, NPW; Hagen, T; Gruber, J; Inoue, T				Shen, Yanqing; Ng, Li Fang; Low, Natarie Pei Wen; Hagen, Thilo; Gruber, Jan; Inoue, Takao			C. elegans miro-1 Mutation Reduces the Amount of Mitochondria and Extends Life Span	PLOS ONE			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; UNFOLDED PROTEIN RESPONSE; SYSTEMATIC RNAI SCREEN; ELECTRON-TRANSPORT; HYDROGEN-PEROXIDE; OXIDATIVE STRESS; GENE-EXPRESSION; LONGEVITY; GTPASE; MIRO	Mitochondria play a critical role in aging, however, the underlying mechanism is not well understood. We found that a mutation disrupting the C. elegans homolog of Miro GTPase (miro-1) extends life span. This phenotype requires simultaneous loss of miro-1 from multiple tissues including muscles and neurons, and is dependent on daf-16/FOXO. Notably, the amount of mitochondria in the miro-1 mutant is reduced to approximately 50% of the wildtype. Despite this reduction, oxygen consumption is only weakly reduced, suggesting that mitochondria of miro-1 mutants are more active than wild-type mitochondria. The ROS damage is slightly reduced and the mitochondrial unfolded protein response pathway is weakly activated in miro-1 mutants. Unlike previously described long-lived mitochondrial electron transport chain mutants, miro-1 mutants have normal growth rate. These results suggest that the reduction in the amount of mitochondria can affect the life span of an organism through activation of stress pathways.	[Shen, Yanqing; Low, Natarie Pei Wen; Hagen, Thilo; Gruber, Jan; Inoue, Takao] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore; [Ng, Li Fang; Gruber, Jan] Yale NUS Coll, Div Sci, Singapore, Singapore	National University of Singapore; Yale NUS College	Inoue, T (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore.	bchti@nus.edu.sg			Singapore Ministry of Education Academic Research Fund [T1-2012-Bridging-04, MOE2015-T2-1-106, MOE2014-T2-2-120]; NIH Office of Research Infrastructure Programs [P40 OD010440]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	Singapore Ministry of Education Academic Research Fund(Ministry of Education, Singapore); NIH Office of Research Infrastructure Programs(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by Singapore Ministry of Education Academic Research Fund: T1-2012-Bridging-04; Singapore Ministry of Education Academic Research Fund: MOE2015-T2-1-106; and Singapore Ministry of Education Academic Research Fund: MOE2014-T2-2-120. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Goh Kah Yee for help with the manuscript. We thank the Mitani Laboratory at the Tokyo Women's Medical University School of Medicine for providing the miro-1(tm1966) mutant. Some strains were provided by the CGC, which is funded by NIH Office of Research Infrastructure Programs (P40 OD010440).	Ailion M, 1999, P NATL ACAD SCI USA, V96, P7394, DOI 10.1073/pnas.96.13.7394; Benedetti C, 2006, GENETICS, V174, P229, DOI 10.1534/genetics.106.061580; Bennett CF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4483; BOVERIS A, 1973, BIOCHEM J, V134, P707, DOI 10.1042/bj1340707; BRENNER S, 1974, GENETICS, V77, P71; Calixto A, 2010, NAT METHODS, V7, P554, DOI [10.1038/NMETH.1463, 10.1038/nmeth.1463]; Dancy BM, 2014, EXP GERONTOL, V56, P245, DOI 10.1016/j.exger.2014.03.028; Durieux J, 2011, CELL, V144, P79, DOI 10.1016/j.cell.2010.12.016; Felkai S, 1999, EMBO J, V18, P1783, DOI 10.1093/emboj/18.7.1783; Feng JL, 2001, DEV CELL, V1, P633, DOI 10.1016/S1534-5807(01)00071-5; Fransson A, 2006, BIOCHEM BIOPH RES CO, V344, P500, DOI 10.1016/j.bbrc.2006.03.163; Fransson A, 2003, J BIOL CHEM, V278, P6495, DOI 10.1074/jbc.M208609200; FRIEDMAN DB, 1988, J GERONTOL, V43, pB102, DOI 10.1093/geronj/43.4.B102; Golden TR, 2007, AGING CELL, V6, P179, DOI 10.1111/j.1474-9726.2007.00273.x; Gruber J, 2015, ANTIOXIDANTS REDOX S; Gruber J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019444; Guo XF, 2005, NEURON, V47, P379, DOI 10.1016/j.neuron.2005.06.027; Hamilton B, 2005, GENE DEV, V19, P1544, DOI 10.1101/gad.1308205; HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Honda Y, 1999, FASEB J, V13, P1385, DOI 10.1096/fasebj.13.11.1385; Houtkooper RH, 2013, NATURE, V497, P451, DOI 10.1038/nature12188; JENSEN PK, 1966, BIOCHIM BIOPHYS ACTA, V122, P157, DOI 10.1016/0926-6593(66)90057-9; Jornayvaz FR, 2010, ESSAYS BIOCHEM, V47, P69, DOI [10.1042/BSE0470069, 10.1042/bse0470069]; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Koshiba T, 2011, J BIOL CHEM, V286, P354, DOI 10.1074/jbc.M110.180034; Lee SS, 2003, NAT GENET, V33, P40, DOI 10.1038/ng1056; MacAskill AF, 2009, NEURON, V61, P541, DOI 10.1016/j.neuron.2009.01.030; MADURO M, 1995, GENETICS, V141, P977; Mahoney TR, 2006, NAT PROTOC, V1, P1772, DOI 10.1038/nprot.2006.281; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Nguyen TT, 2014, P NATL ACAD SCI USA, V111, pE3631, DOI 10.1073/pnas.1402449111; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Palikaras K, 2015, NATURE, V521, P525, DOI 10.1038/nature14300; Ranjan M, 2013, FREE RADICAL BIO MED, V63, P381, DOI 10.1016/j.freeradbiomed.2013.05.025; Rual JF, 2004, GENOME RES, V14, P2162, DOI 10.1101/gr.2505604; Rube DA, 2004, MOL CELL BIOCHEM, V256, P331, DOI 10.1023/B:MCBI.0000009879.01256.f6; Saotome M, 2008, P NATL ACAD SCI USA, V105, P20728, DOI 10.1073/pnas.0808953105; Schaffer S, 2011, BIOGERONTOLOGY, V12, P195, DOI 10.1007/s10522-010-9310-7; Schulz TJ, 2007, CELL METAB, V6, P280, DOI 10.1016/j.cmet.2007.08.011; Sieburth D, 2005, NATURE, V436, P510, DOI 10.1038/nature03809; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; Tavernarakis N, 2008, AUTOPHAGY, V4, P870, DOI 10.4161/auto.6730; Toth ML, 2008, AUTOPHAGY, V4, P330, DOI 10.4161/auto.5618; Tsang WY, 2002, BIOCHEM BIOPH RES CO, V291, P8, DOI 10.1006/bbrc.2002.6394; Van Raamsdonk JM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000361; van Spronsen M, 2013, NEURON, V77, P485, DOI 10.1016/j.neuron.2012.11.027; Wang XN, 2011, CELL, V147, P893, DOI 10.1016/j.cell.2011.10.018; Yamamoto H, 2011, CELL, V147, P827, DOI 10.1016/j.cell.2011.10.017; Yamaoka S, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00350; Yang CC, 2011, AGING CELL, V10, P724, DOI 10.1111/j.1474-9726.2011.00711.x; Yang W, 2007, GENETICS, V177, P2063, DOI 10.1534/genetics.107.080788	53	16	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2016	11	4							e0153233	10.1371/journal.pone.0153233	http://dx.doi.org/10.1371/journal.pone.0153233			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0KH	27064409	gold, Green Submitted, Green Published			2022-12-27	WOS:000373891000038
J	Silva, LMG; da Silva, CAA; da Silva, A; Vieira, RP; Mesquita-Ferrari, RA; Cogo, JC; Zamuner, SR				Goncalves Silva, Luciana Miato; Alves da Silva, Camila Aparecida; da Silva, Aline; Vieira, Rodolfo Paula; Mesquita-Ferrari, Raquel Agnelli; Cogo, Jose Carlos; Zamuner, Stella Regina			Photobiomodulation Protects and Promotes Differentiation of C2C12 Myoblast Cells Exposed to Snake Venom	PLOS ONE			English	Article							LEVEL LASER THERAPY; MUSCLE HEALING-PROCESS; SKELETAL-MUSCLE; PHOSPHOLIPASES A(2); SAO-PAULO; IRRADIATION; INFLAMMATION; ANTIVENOMS; MECHANISM; PROTEINS	Background Snakebites is a neglected disease and in Brazil is considered a serious health problem, with the majority of the snakebites caused by the genus Bothrops. Antivenom therapy and other first-aid treatments do not reverse local myonecrose which is the main sequel caused by the envenomation. Several studies have shown the effectiveness of low level laser (LLL) therapy in reducing local myonecrosis induced by Bothropic venoms, however the mechanism involved in this effect is unknown. In this in vitro study, we aimed to analyze the effect of LLL irradiation against cytotoxicity induced by Bothrops jararacussu venom on myoblast C2C12 cells. Methodology C2C12 were utilized as a model target and were incubated with B. jararacussu venom (12.5 mu g/mL) and immediately irradiated with LLL at wavelength of red 685 nm or infrared 830 nm with energy density of 2.0, 4.6 and 7.0 J/cm(2). Effects of LLL on cellular responses of venom-induced cytotoxicity were examined, including cell viability, measurement of cell damage and intra and extracellular ATP levels, expression of myogenic regulatory factors, as well as cellular differentiation. Results In non-irradiated cells, the venom caused a decrease in cell viability and a massive release of LDH and CK levels indicating myonecrosis. Infrared and red laser at all energy densities were able to considerably decrease venom-induced cytotoxicity. Laser irradiation induced myoblasts to differentiate into myotubes and this effect was accompanied by up regulation of MyoD and specially myogenin. Moreover, LLL was able to reduce the extracellular while increased the intracellular ATP content after venom exposure. In addition, no difference in the intensity of cytotoxicity was shown by non-irradiated and irradiated venom. Conclusion LLL irradiation caused a protective effect on C2C12 cells against the cytotoxicity caused by B. jararacussu venom and promotes differentiation of these cells by up regulation of myogenic factors. A modulatory effect of ATP synthesis may be suggested as a possible mechanism mediating cytoprotection observed under laser irradiation.	[Goncalves Silva, Luciana Miato; Alves da Silva, Camila Aparecida; da Silva, Aline; Vieira, Rodolfo Paula; Zamuner, Stella Regina] Univ Nove de Julho UNINOVE, Posgrad Program Med, Sao Paulo, SP, Brazil; [Mesquita-Ferrari, Raquel Agnelli] Univ Nove de Julho UNINOVE, Posgrad Program Biophoton, Sao Paulo, SP, Brazil; [Cogo, Jose Carlos] Univ Vale Paraiba, UNIVAP, Inst Res & Dev, Sao Jose Dos Campos, SP, Brazil	Universidade Nove de Julho; Universidade Nove de Julho; Universidade do Vale do Paraiba	Zamuner, SR (corresponding author), Univ Nove de Julho UNINOVE, Posgrad Program Med, Sao Paulo, SP, Brazil.	stella.rz@uninove.br	Fernandes, Kristianne Porta Santos/I-4417-2016; Ferrari, Raquel/I-4419-2016; de Paula Vieira, Rodolfo/E-9315-2011; Zamuner, Stella R/C-3132-2012; Zamuner, Stella Regina/AAA-8106-2019	Fernandes, Kristianne Porta Santos/0000-0001-7156-9286; Ferrari, Raquel/0000-0001-5142-9526; de Paula Vieira, Rodolfo/0000-0001-6379-1143; Zamuner, Stella R/0000-0002-4694-7617; 	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2011/04660-0, 2011/14376-6]; FAPESP [2011/04660-0, 2011/14376-6, 2012/15165-2]; CNPq-PQ [449948/2014-0]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq-PQ(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The authors acknowledge the financial support from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), 2011/04660-0 and 2011/14376-6. CMS is recipient of FAPESP M.Sc. fellowship (Grant no 2011/04660-0), RPV is recipient of FAPESP grant process: 2012/15165-2 and SRZ is recipient of CNPq-PQ grant Process: 449948/2014-0 and FAPESP 2011/14376-6. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avci P, 2013, SEMIN CUTAN MED SURG, V32, P41; Barbosa AM, 2010, J VENOM ANIM TOXINS, V16, P470, DOI 10.1590/S1678-91992010000300014; Barbosa AM, 2008, TOXICON, V51, P1236, DOI 10.1016/j.toxicon.2008.02.007; Barbosa AM, 2009, PHOTOMED LASER SURG, V27, P591, DOI 10.1089/pho.2008.2296; Barretto SR, 2013, J PHOTOCH PHOTOBIO B, V129, P135, DOI 10.1016/j.jphotobiol.2013.10.002; Blais A, 2005, GENE DEV, V19, P553, DOI 10.1101/gad.1281105; Brunelli RM, 2014, LASER MED SCI, V29, P91, DOI 10.1007/s10103-013-1277-6; Burattini S, 2004, EUR J HISTOCHEM, V48, P223; Bustillo S, 2012, TOXICON, V59, P338, DOI 10.1016/j.toxicon.2011.11.007; Cao Y, 2006, EMBO J, V25, P502, DOI 10.1038/sj.emboj.7600958; CARDOSO JLC, 1993, Q J MED, V86, P315; Cintra-Francischinelli M, 2010, P NATL ACAD SCI USA, V107, P14140, DOI 10.1073/pnas.1009128107; da Silva CJ, 2003, TOXICON, V41, P251, DOI 10.1016/S0041-0101(02)00287-8; de Araujo CEN, 2007, J PHOTOCH PHOTOBIO B, V86, P87, DOI 10.1016/j.jphotobiol.2006.08.006; de Sousa EA, 2013, PHOTOCH PHOTOBIO SCI, V12, P1895, DOI 10.1039/c3pp50036e; Doin-Silva R, 2009, PHOTOCHEM PHOTOBIOL, V85, P63, DOI 10.1111/j.1751-1097.2008.00397.x; dos Santos JI, 2011, PROTEINS, V79, P61, DOI 10.1002/prot.22858; Dourado DM, 2003, LASER SURG MED, V33, P352, DOI 10.1002/lsm.10237; Dourado DM, 2011, PHOTOCHEM PHOTOBIOL, V87, P418, DOI 10.1111/j.1751-1097.2010.00878.x; Fernandes CAH, 2014, BBA-PROTEINS PROTEOM, V1844, P2265, DOI 10.1016/j.bbapap.2014.09.015; Ferraz MC, 2014, MOLECULES, V19, P5790, DOI 10.3390/molecules19055790; Gutierrez JM, 2003, TOXICON, V42, P915, DOI 10.1016/j.toxicon.2003.11.005; Hawkins D, 2005, ANN NY ACAD SCI, V1056, P486, DOI 10.1196/annals.1352.040; Huang YY, 2009, DOSE-RESPONSE, V7, P358, DOI 10.2203/dose-response.09-027.Hamblin; Idzko M, 2013, ALLERGY, V68, P472, DOI 10.1111/all.12119; KARU T, 1995, J PHOTOCH PHOTOBIO B, V27, P219, DOI 10.1016/1011-1344(94)07078-3; Lomonte B, 1999, TOXICON, V37, P145, DOI 10.1016/S0041-0101(98)00171-8; Milani R, 1997, QJM-MON J ASSOC PHYS, V90, P323, DOI 10.1093/qjmed/90.5.323; Mora-Obando D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109846; Nadur-Andrade N, 2014, PHOTOCH PHOTOBIO SCI, V13, P1561, DOI 10.1039/c4pp00111g; Nadur-Andrade N, 2014, PHOTOCHEM PHOTOBIOL, V90, P207, DOI 10.1111/php.12189; Nadur-Andrade N, 2012, LASER MED SCI, V27, P65, DOI 10.1007/s10103-011-0914-1; Nakano J, 2009, EXP PHYSIOL, V94, P1005, DOI 10.1113/expphysiol.2009.047738; Neto HS, 2004, TOXICON, V44, P847, DOI 10.1016/j.toxicon.2004.08.007; Peplow PV, 2010, PHOTOMED LASER SURG, V28, pS3, DOI 10.1089/pho.2010.2771; Rangel J, 2011, CELL BIOCHEM FUNCT, V29, P365, DOI 10.1002/cbf.1758; Rodrigues NC, 2013, J REHABIL RES DEV, V50, P985, DOI 10.1682/JRRD.2012.08.0147; Segura A, 2010, TOXICON, V56, P980, DOI 10.1016/j.toxicon.2010.07.001; Shefer G, 2003, BBA-MOL CELL RES, V1593, P131, DOI 10.1016/S0167-4889(02)00350-6; Silva CAA, 2012, CLIN EXP MED LETT, V53, P7; Souza L.G., 2011, CLIN EXP MED LETT, V52, P97; Vomero VU, 2009, TOXICON, V54, P361, DOI 10.1016/j.toxicon.2009.04.006; Yen YP, 2010, ENVIRON HEALTH PERSP, V118, P949, DOI 10.1289/ehp.0901525; Yin H, 2013, PHYSIOL REV, V93, P23, DOI 10.1152/physrev.00043.2011; Zamuner SR, 2004, TOXICON, V44, P259, DOI 10.1016/j.toxicon.2004.05.029	45	20	20	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2016	11	4							e0152890	10.1371/journal.pone.0152890	http://dx.doi.org/10.1371/journal.pone.0152890			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6JK	27058357	Green Published, Green Submitted, gold			2022-12-27	WOS:000373604800014
J	Changsom, D; Lerdsamran, H; Wiriyarat, W; Chakritbudsabong, W; Siridechadilok, B; Prasertsopon, J; Noisumdaeng, P; Masamae, W; Puthavathana, P				Changsom, Don; Lerdsamran, Hatairat; Wiriyarat, Witthawat; Chakritbudsabong, Warunya; Siridechadilok, Bunpote; Prasertsopon, Jarunee; Noisumdaeng, Pirom; Masamae, Wanibtisam; Puthavathana, Pilaipan			Influenza Neuraminidase Subtype N1: Immunobiological Properties and Functional Assays for Specific Antibody Response	PLOS ONE			English	Article							A VIRUS; LETHAL INFLUENZA; ANTINEURAMINIDASE ANTIBODY; CROSS-PROTECTION; PANDEMIC H1N1; RECOMBINANT; HEMAGGLUTININ; INFECTION; IMMUNITY; IMMUNIZATION	Influenza neuraminidase (NA) proteins expressed in TK- cells infected with recombinant vaccinia virus carrying NA gene of highly pathogenic avian influenza H5N1 virus or 2009 pandemic H1N1 (H1N1pdm) virus were characterized for their biological properties, i.e., cell localization, molecular weight (MW), glycosylation and sialidase activity. Immune sera collected from BALB/c mice immunized with these recombinant viruses were assayed for binding and functional activities of anti-NA antibodies. Recombinant NA proteins were found localized in cytoplasm and cytoplasmic membrane of the infected cells. H1N1pdm NA protein had MW at about 75 kDa while it was 55 kDa for H5N1 NA protein. Hyperglycosylation was more pronounced in H1N1pdm NA compared to H5N1 NA according to N-glycosidase F treatment. Three dimensional structures also predicted that H1N1 NA globular head contained 4 and that of H5N1 contained 2 potential glycosylation sites. H5N1 NA protein had higher sialidase activity than H1N1pdm NA protein as measured by both MUNANA-based assay and fetuin-based enzyme-linked lectin assay (ELLA). Plaque reduction assay demonstrated that anti-NA antibody could reduce number of plaques and plaque size through inhibiting virus release, not virus entry. Assay for neuraminidase-inhibition (NI) antibody by ELLA showed specific and cross reactivity between H5N1 NA and H1N1pdm NA protein derived from reverse genetic viruses or wild type viruses. In contrast, replication-inhibition assay in MDCK cells showed that anti-H1N1 NA antibody moderately inhibited viruses with homologous NA gene only, while anti-H5N1 NA antibody modestly inhibited the replication of viruses containing homologous NA gene and NA gene derived from H1N1pdm virus. Anti-H1N1 NA antibody showed higher titers of inhibiting virus replication than anti-H5N1 NA antibody, which are consistent with the results on reduction in plaque numbers and sizes as well as in inhibiting NA enzymatic activity. No assay showed cross reactivity with reassorted PR8 (H1N1) virus and H3N2 wild type viruses.	[Changsom, Don; Masamae, Wanibtisam; Puthavathana, Pilaipan] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Microbiol, Bangkok 10700, Thailand; [Lerdsamran, Hatairat; Prasertsopon, Jarunee; Puthavathana, Pilaipan] Mahidol Univ, Fac Med Technol, Ctr Res & Innovat, Nakhon Pathom, Thailand; [Wiriyarat, Witthawat; Chakritbudsabong, Warunya] Mahidol Univ, Dept Preclin & Appl Anim Sci, Fac Vet Sci, Nakhon Pathom, Thailand; [Siridechadilok, Bunpote] Natl Sci & Technol Dev Agcy, Natl Ctr Genet Engn & Biotechnol BIOTEC, Pathum Thani, Thailand; [Noisumdaeng, Pirom] Thammasat Univ, Fac Publ Hlth, Pathum Thani, Thailand; [Puthavathana, Pilaipan] Mahidol Univ, Ctr Emerging & Neglected Infect Dis, Nakhon Pathom, Thailand	Mahidol University; Mahidol University; Mahidol University; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); Thammasat University; Mahidol University	Puthavathana, P (corresponding author), Mahidol Univ, Siriraj Hosp, Fac Med, Dept Microbiol, Bangkok 10700, Thailand.; Puthavathana, P (corresponding author), Mahidol Univ, Fac Med Technol, Ctr Res & Innovat, Nakhon Pathom, Thailand.; Puthavathana, P (corresponding author), Mahidol Univ, Ctr Emerging & Neglected Infect Dis, Nakhon Pathom, Thailand.	pilaipan.put@mahidol.ac.th			Office of the Higher Education Commission; Faculty of Medicine Siriraj Hospital (Mahidol University); Mahidol University under the National Research Universities Initiative	Office of the Higher Education Commission; Faculty of Medicine Siriraj Hospital (Mahidol University); Mahidol University under the National Research Universities Initiative	The Office of the Higher Education Commission, Siriraj Thesis Scholarship from the Faculty of Medicine Siriraj Hospital (Mahidol University), and Mahidol University under the National Research Universities Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAUSE E, 1983, BIOCHEM J, V209, P331, DOI 10.1042/bj2090331; Bosch BJ, 2010, J VIROL, V84, P10366, DOI 10.1128/JVI.01035-10; Bright RA, 2009, VACCINE, V27, P6366, DOI 10.1016/j.vaccine.2009.02.084; Cate TR, 2010, VACCINE, V28, P2076, DOI 10.1016/j.vaccine.2009.12.041; CHAKRABARTI S, 1985, MOL CELL BIOL, V5, P3403, DOI 10.1128/MCB.5.12.3403; Chen Z, 1999, VACCINE, V17, P653, DOI 10.1016/S0264-410X(98)00247-3; Chen Z, 2000, VACCINE, V18, P3214, DOI 10.1016/S0264-410X(00)00149-3; Chen ZY, 2012, VACCINE, V30, P2516, DOI 10.1016/j.vaccine.2012.01.090; Cohen M, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-321; Couch RB, 2012, VACCINE, V31, P190, DOI 10.1016/j.vaccine.2012.10.065; Couzens L, 2014, J VIROL METHODS, V210, P7, DOI 10.1016/j.jviromet.2014.09.003; Deroo T, 1996, VACCINE, V14, P561, DOI 10.1016/0264-410X(95)00157-V; Easterbrook JD, 2012, VIROLOGY, V432, P39, DOI 10.1016/j.virol.2012.06.003; Eichelberger M, 2008, VACCINE, V26, P4299, DOI 10.1016/j.vaccine.2008.06.012; EPSTEIN SL, 1993, J IMMUNOL, V150, P5484; Halbherr SJ, 2015, J VIROL, V89, P1550, DOI 10.1128/JVI.02949-14; Hessel A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012217; Hoffmann E, 2000, P NATL ACAD SCI USA, V97, P6108, DOI 10.1073/pnas.100133697; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; JAHIEL RI, 1966, J BACTERIOL, V92, P1521, DOI 10.1128/JB.92.5.1521-1534.1966; JAKEMAN KJ, 1989, J GEN VIROL, V70, P1523, DOI 10.1099/0022-1317-70-6-1523; JOHANSSON BE, 1987, P NATL ACAD SCI USA, V84, P6869, DOI 10.1073/pnas.84.19.6869; JOHANSSON BE, 1995, VACCINE, V13, P841, DOI 10.1016/0264-410X(94)00071-T; JOHANSSON BE, 1989, J VIROL, V63, P1239, DOI 10.1128/JVI.63.3.1239-1246.1989; Johansson BE, 1999, VACCINE, V17, P2073, DOI 10.1016/S0264-410X(98)00413-7; Kilbourne ED, 2004, J INFECT DIS, V189, P459, DOI 10.1086/381123; KILBOURNE ED, 1968, J VIROL, V2, P281, DOI 10.1128/JVI.2.4.281-288.1968; Knossow M, 2002, VIROLOGY, V302, P294, DOI 10.1006/viro.2002.1625; Lerdsamran H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016164; Li YF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095539; Marcelin G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026335; Martinet W, 1997, EUR J BIOCHEM, V247, P332, DOI 10.1111/j.1432-1033.1997.00332.x; Matrosovich MN, 2004, J VIROL, V78, P12665, DOI 10.1128/JVI.78.22.12665-12667.2004; MONTO AS, 1973, LANCET, V1, P623, DOI 10.1016/S0140-6736(73)92196-X; Noisumdaeng P, 2014, VIROLOGY, V454, P254, DOI 10.1016/j.virol.2014.02.024; Ohuchi M, 2006, MICROBES INFECT, V8, P1287, DOI 10.1016/j.micinf.2005.12.008; PALESE P, 1974, VIROLOGY, V61, P397, DOI 10.1016/0042-6822(74)90276-1; Panaampon J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036318; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Quan FS, 2012, VIROLOGY, V430, P127, DOI 10.1016/j.virol.2012.05.006; Rockman S, 2013, J VIROL, V87, P3053, DOI 10.1128/JVI.02434-12; Sandbulte MR, 2007, PLOS MED, V4, P265, DOI 10.1371/journal.pmed.0040059; Sandbulte MR, 2009, INFLUENZA OTHER RESP, V3, P233, DOI 10.1111/j.1750-2659.2009.00094.x; SCHULMAN JL, 1969, B WORLD HEALTH ORGAN, V41, P647; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; SMITH GL, 1987, VIROLOGY, V160, P336, DOI 10.1016/0042-6822(87)90004-3; Sylte MJ, 2007, VACCINE, V25, P3763, DOI 10.1016/j.vaccine.2007.02.011; Tanimoto T, 2005, VACCINE, V23, P4598, DOI 10.1016/j.vaccine.2005.04.042; Wan HQ, 2013, J VIROL, V87, P9290, DOI 10.1128/JVI.01203-13; WEBSTER RG, 1988, VIROLOGY, V164, P230, DOI 10.1016/0042-6822(88)90640-X; WILSON IA, 1990, ANNU REV IMMUNOL, V8, P737, DOI 10.1146/annurev.iy.08.040190.003513; Wohlbold TJ, 2015, MBIO, V6, DOI 10.1128/mBio.02556-14; Wu CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042363; Yang YL, 2012, MOL BIOL REP, V39, P857, DOI 10.1007/s11033-011-0809-z; Yongkiettrakul S, 2009, J VIROL METHODS, V156, P44, DOI 10.1016/j.jviromet.2008.10.025	55	6	6	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153183	10.1371/journal.pone.0153183	http://dx.doi.org/10.1371/journal.pone.0153183			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27054879	gold, Green Published, Green Submitted			2022-12-27	WOS:000373608000094
J	Estrela, HFG; Damasio, ES; Fonseca, EKUN; Bergamaschi, CT; Campos, RR				Estrela, Heder F. G.; Damasio, Elaine S.; Fonseca, Eduardo K. U. N.; Bergamaschi, Cassia T.; Campos, Ruy R.			Differential Sympathetic Vasomotor Activation Induced by Liver Cirrhosis in Rats	PLOS ONE			English	Article							HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; NERVOUS-SYSTEM REGULATION; ARTERIAL-BLOOD-PRESSURE; DUCT-LIGATED RATS; PORTAL-HYPERTENSION; BAROREFLEX SENSITIVITY; VENTROLATERAL MEDULLA; ALCOHOLIC CIRRHOSIS; SPLANCHNIC VASODILATION; AUTONOMIC DYSFUNCTION	We tested the hypothesis that there is a topographical sympathetic activation in rats submitted to experimental cirrhosis. Baseline renal (rSNA) and splanchnic (sSNA) sympathetic nerve activities were evaluated in anesthetized rats. In addition, we evaluated main arterial pressure (MAP), heart rate (HR), and baroreceptor reflex sensitivity (BRS). Cirrhotic Wistar rats were obtained by bile duct ligation (BDL). MAP and HR were measured in conscious rats, and cardiac BRS was assessed by changes in blood pressure induced by increasing doses of phenylephrine or sodium nitroprusside. The BRS and baseline for the control of sSNA and rSNA were also evaluated in urethane-anesthetized rats. Cirrhotic rats had increased baseline sSNA (BDL, 102 vs control, 58 spikes/s; p<0.05), but no baseline changes in the rSNA compared to controls. These data were accompanied by increased splanchnic BRS (p<0.05) and decreased cardiac (p<0.05) and renal BRS (p<0.05). Furthermore, BDL rats had reduced basal MAP (BDL, 93 vs control, 101 mmHg; p<0.05) accompanied by increased HR (BDL, 378 vs control, 356; p<0.05). Our data have shown topographical sympathetic activation in rats submitted to experimental cirrhosis. The BDL group had increased baseline sSNA, independent of dysfunction in the BRS and no changes in baseline rSNA. However, an impairment of rSNA and HR control by arterial baroreceptor was noted. We suggest that arterial baroreceptor impairment of rSNA and HR is an early marker of cardiovascular dysfunction related to liver cirrhosis and probably a major mechanism leading to sympathoexcitation in decompensated phase.	[Estrela, Heder F. G.; Damasio, Elaine S.; Fonseca, Eduardo K. U. N.; Bergamaschi, Cassia T.; Campos, Ruy R.] Univ Fed Sao Paulo, Dept Physiol, Escola Paulista Med, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP)	Campos, RR (corresponding author), Univ Fed Sao Paulo, Dept Physiol, Escola Paulista Med, Sao Paulo, Brazil.	ruy.camposjr@unifesp.br	Fonseca, Eduardo Kaiser U./M-7298-2019; Campos, Ruy R/H-8339-2017; Campos, Ruy R R/I-3691-2015; Bergamaschi, Cassia/AAZ-9441-2020	Campos, Ruy R/0000-0002-9404-0817; Campos, Ruy R R/0000-0002-9404-0817; Kaiser Ururahy Nunes Fonseca, Eduardo/0000-0002-0233-0041; Bergamaschi, Cassia/0000-0002-5741-6993	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2013/22522-9]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [472613/2013-8, 301840/2013-0]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was supported by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) 2013/22522-9 and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) 472613/2013-8 and 301840/2013-0. Heder F. G. Estrela was supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aller MA, 2010, EUR J GASTROEN HEPAT, V22, P651, DOI 10.1097/MEG.0b013e32832e0a2f; ANDRESEN MC, 1994, ANNU REV PHYSIOL, V56, P93, DOI 10.1146/annurev.physiol.56.1.93; ARRANZ CT, 1995, ARCH PHYSIOL BIOCHEM, V103, P422, DOI 10.3109/13813459509047132; BIOULACSAGE P, 1990, J HEPATOL, V10, P105, DOI 10.1016/0168-8278(90)90080-B; Bomzon A, 1998, J PHARMACOL TOXICOL, V39, P75, DOI 10.1016/S1056-8719(98)00005-7; CARRIVE P, 1989, BRAIN RES, V493, P385, DOI 10.1016/0006-8993(89)91176-1; Coll M, 2008, J HEPATOL, V49, P43, DOI 10.1016/j.jhep.2008.03.015; Coll M, 2010, LIVER INT, V30, P593, DOI 10.1111/j.1478-3231.2009.02176.x; Coote JH, 2005, EXP PHYSIOL, V90, P169, DOI 10.1113/expphysiol.2004.029041; Coote JH, 1998, CLIN EXP PHARMACOL P, V25, P461, DOI 10.1111/j.1440-1681.1998.tb02235.x; DEAN C, 1986, BRAIN RES, V377, P271, DOI 10.1016/0006-8993(86)90868-1; DEAN C, 1992, J AUTONOM NERV SYST, V37, P1, DOI 10.1016/0165-1838(92)90139-8; DIBONA GF, 1991, AM J PHYSIOL, V260, pR298, DOI 10.1152/ajpregu.1991.260.2.R298; DiBona GF, 1996, AM J PHYSIOL-REG I, V271, pR295, DOI 10.1152/ajpregu.1996.271.1.R295; Dietrich P, 2013, J HEPATOL, V58, P254, DOI 10.1016/j.jhep.2012.09.027; Dillon JF, 1997, J HEPATOL, V26, P331, DOI 10.1016/S0168-8278(97)80049-9; Ezkurdia N, 2012, LIVER INT, V32, P1295, DOI 10.1111/j.1478-3231.2012.02762.x; Farah VMA, 1999, BRAZ J MED BIOL RES, V32, P361, DOI 10.1590/S0100-879X1999000300018; Fink GD, 2009, HYPERTENSION, V53, P307, DOI 10.1161/HYPERTENSIONAHA.108.119990; GAUDIN C, 1989, LIFE SCI, V45, P1333, DOI 10.1016/0024-3205(89)90019-2; GAUDIN C, 1992, GASTROEN CLIN BIOL, V16, P498; Guyenet PG, 2006, NAT REV NEUROSCI, V7, P335, DOI 10.1038/nrn1902; HAYES K, 1990, J PHYSIOL-LONDON, V428, P371, DOI 10.1113/jphysiol.1990.sp018217; HENDRICKSE MT, 1992, LANCET, V339, P1462, DOI 10.1016/0140-6736(92)92042-E; HENRIKSEN JH, 1987, GUT, V28, P1637, DOI 10.1136/gut.28.12.1637; HENRIKSEN JH, 1991, CLIN PHYSIOL, V11, P293, DOI 10.1111/j.1475-097X.1991.tb00658.x; HENRIKSEN JH, 1989, CIRC RES, V65, P388, DOI 10.1161/01.RES.65.2.388; Iwakiri Y, 2006, HEPATOLOGY, V43, pS121, DOI 10.1002/hep.20993; Jensen KJ, 2013, COMPR PHYSIOL, V3, P655, DOI 10.1002/cphy.c120018; KOUNTOURAS J, 1984, BRIT J EXP PATHOL, V65, P305; La Villa G, 2002, HEPATOLOGY, V35, P1441, DOI 10.1053/jhep.2002.33334; Laffi G, 1996, HEPATOLOGY, V24, P1063; Lanfranchi A, 1998, Blood Press Suppl, V3, P40; Larsen PD, 2001, AM J PHYSIOL-REG I, V280, pR1704, DOI 10.1152/ajpregu.2001.280.6.R1704; LEE SS, 1986, AM J PHYSIOL, V251, pG176, DOI 10.1152/ajpgi.1986.251.2.G176; LLACH J, 1988, GASTROENTEROLOGY, V94, P482, DOI 10.1016/0016-5085(88)90441-6; LOVICK TA, 1987, J PHYSIOL-LONDON, V389, P23, DOI 10.1113/jphysiol.1987.sp016644; LOVICK TA, 1985, BRAIN RES, V331, P353, DOI 10.1016/0006-8993(85)91562-8; MACGILCHRIST AJ, 1991, HEPATOLOGY, V13, P689, DOI 10.1016/0270-9139(91)92565-P; Malhi H, 2008, GASTROENTEROLOGY, V134, P1641, DOI 10.1053/j.gastro.2008.03.002; MCALLEN RM, 1995, CLIN EXP HYPERTENS, V17, P209, DOI 10.3109/10641969509087066; McAllen RM, 1997, CLIN EXP HYPERTENS, V19, P607, DOI 10.3109/10641969709083173; Milovanovic B, 2009, GEN PHYSIOL BIOPHYS, V28, P251; Moller S, 2008, GUT, V57, P268, DOI 10.1136/gut.2006.112177; MOLLER S, 1995, HEPATOLOGY, V22, P88, DOI 10.1016/0270-9139(95)90357-7; Moller S, 2007, AM J PHYSIOL-HEART C, V292, pH2966, DOI 10.1152/ajpheart.01227.2006; Morrison SF, 2001, AM J PHYSIOL-REG I, V281, pR683, DOI 10.1152/ajpregu.2001.281.3.R683; Mueller PJ, 2011, AM J PHYSIOL-REG I, V300, pR1230, DOI 10.1152/ajpregu.00713.2010; MURRAY BM, 1985, CIRC RES, V57, P424, DOI 10.1161/01.RES.57.3.424; NICHOLLS KM, 1985, CIRC RES, V56, P457, DOI 10.1161/01.RES.56.3.457; Oben JA, 2004, ANAT REC PART A, V280A, P874, DOI 10.1002/ar.a.20081; Osborn JW, 2011, CURR HYPERTENS REP, V13, P221, DOI 10.1007/s11906-011-0188-9; Peinado MA, 2002, AUTON NEUROSCI-BASIC, V99, P67, DOI 10.1016/S1566-0702(02)00135-2; Pereira RM, 2008, WORLD J GASTROENTERO, V14, P4505, DOI 10.3748/wjg.14.4505; Pozzi M, 2001, HEPATOLOGY, V34, P1113, DOI 10.1053/jhep.2001.29198; RODRIGUEZMARTINEZ M, 1995, AM J PHYSIOL-REG I, V268, pR117, DOI 10.1152/ajpregu.1995.268.1.R117; Scislo TJ, 2005, NEUROL RES, V27, P182, DOI 10.1179/016164105X21959; SHALDON C, 1961, LANCET, V1, P957; Stocker SD, 2004, AM J PHYSIOL-REG I, V286, pR719, DOI 10.1152/ajpregu.00494.2003; Struthers AD, 2004, HEART, V90, P1229, DOI 10.1136/hrt.2003.025312; Tank J, 2003, HYPERTENSION, V41, P1234, DOI 10.1161/01.HYP.0000070957.08219.C9; Thiesson HC, 2007, AM J PHYSIOL-REG I, V292, pR625, DOI 10.1152/ajpregu.00418.2005; Van de Casteele M, 2001, PHARMACOL THERAPEUT, V90, P35, DOI 10.1016/S0163-7258(01)00123-1; Veelken R, 2005, AM J PHYSIOL-RENAL, V288, pF1267, DOI 10.1152/ajprenal.00069.2003; Veglio F, 1998, LIVER, V18, P420; Wong F, 1998, GASTROENTEROLOGY, V115, P397, DOI 10.1016/S0016-5085(98)70206-9; Yang YY, 2002, J HEPATOL, V36, P600, DOI 10.1016/S0168-8278(02)00037-5; Yang Z, 2006, EXP PHYSIOL, V91, P791, DOI 10.1113/expphysiol.2006.034082; Zollner G, 2009, BRIT J PHARMACOL, V156, P7, DOI 10.1111/j.1476-5381.2008.00030.x	69	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0152512	10.1371/journal.pone.0152512	http://dx.doi.org/10.1371/journal.pone.0152512			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27055088	Green Submitted, gold, Green Published			2022-12-27	WOS:000373608000023
J	Hegner, B; Schaub, T; Catar, R; Kusch, A; Wagner, P; Essin, K; Lange, C; Riemekasten, G; Dragun, D				Hegner, Bjoern; Schaub, Theres; Catar, Rusan; Kusch, Angelika; Wagner, Philine; Essin, Kirill; Lange, Claudia; Riemekasten, Gabriela; Dragun, Duska			Intrinsic Deregulation of Vascular Smooth Muscle and Myofibroblast Differentiation in Mesenchymal Stromal Cells from Patients with Systemic Sclerosis	PLOS ONE			English	Article							STEM-CELLS; ANGIOGENESIS; MECHANISMS; EXPRESSION; PERICYTES; COLLAGEN; MARKERS; TISSUE; PDGF	Introduction Obliterative vasculopathy and fibrosis are hallmarks of systemic sclerosis (SSc), a severe systemic autoimmune disease. Bone marrow-derived mesenchymal stromal cells (MSCs) from SSc patients may harbor disease-specific abnormalities. We hypothesized disturbed vascular smooth muscle cell (VSMC) differentiation with increased propensity towards myofibroblast differentiation in response to SSc-microenvironment defining growth factors and determined responsible mechanisms. Methods We studied responses of multipotent MSCs from SSc-patients (SSc-MSCs) and healthy controls (H-MSCs) to long-term exposure to CTGF, b-FGF, PDGF-BB or TGF-beta 1. Differentiation towards VSMC and myofibroblast lineages was analyzed on phenotypic, biochemical, and functional levels. Intracellular signaling studies included analysis of TGF-beta receptor regulation, SMAD, AKT, ERK1/2 and autocrine loops. Results VSMC differentiation towards both, contractile and synthetic VSMC phenotypes in response to CTGF and b-FGF was disturbed in SSc-MSCs. H-MSCs and SSc-MSCs responded equally to PDGF-BB with prototypic fibroblastic differentiation. TGF-beta 1 initiated myofibroblast differentiation in both cell types, yet with striking phenotypic and functional differences: In relation to H-MSC-derived myofibroblasts induced by TGF-beta 1, those obtained from SSc-MSCs expressed more contractile proteins, migrated towards TGF-beta 1, had low proliferative capacity, and secreted higher amounts of collagen paralleled by reduced MMP expression. Higher levels of TGF-beta receptor 1 and enhanced canonical and noncanonical TGF-beta signaling in SSc-MSCs accompanied aberrant differentiation response of SSc-MSCs in comparison to H-MSCs. Conclusions Deregulated VSMC differentiation with a shift towards myofibroblast differentiation expands the concept of disturbed endogenous regenerative capacity of MSCs from SSc patients. Disease related intrinsic hyperresponsiveness to TGF-beta 1 with increased collagen production may represent one responsible mechanism. Better understanding of repair barriers and harnessing beneficial differentiation processes in MSCs could widen options of autologous MSC application in SSc patients.	[Hegner, Bjoern; Schaub, Theres; Catar, Rusan; Kusch, Angelika; Wagner, Philine; Dragun, Duska] Charite, Clin Nephrol & Intens Care Med, Berlin, Germany; [Hegner, Bjoern; Schaub, Theres; Dragun, Duska] Berlin Brandenburg Sch Regenerat Therapies BSRT, Berlin, Germany; [Hegner, Bjoern; Schaub, Theres; Catar, Rusan; Kusch, Angelika; Dragun, Duska] Charite, CCR, Berlin, Germany; [Schaub, Theres] Free Univ Berlin, Inst Chem & Biochem, Berlin, Germany; [Essin, Kirill] Fac Med Charite, Expt & Clin Res Ctr, Berlin, Germany; [Essin, Kirill] Max Delbruck Ctr Mol Med, Berlin, Germany; [Lange, Claudia] Univ Med Ctr Hamburg Eppendorf, Dept Cell & Gene Therapy, Clin Stem Cell Transplantat, Hamburg, Germany; [Riemekasten, Gabriela] Charite, Clin Rheumatol & Clin Immunol, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Hamburg; University Medical Center Hamburg-Eppendorf; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Hegner, B (corresponding author), Charite, Clin Nephrol & Intens Care Med, Berlin, Germany.; Hegner, B (corresponding author), Berlin Brandenburg Sch Regenerat Therapies BSRT, Berlin, Germany.; Hegner, B (corresponding author), Charite, CCR, Berlin, Germany.	bjoern.hegner@charite.de	Catar, Rusan Ali/I-3948-2019; Riemekasten, Gabriela/B-5019-2017	Catar, Rusan Ali/0000-0002-7000-7860; Hegner, Bjorn/0000-0003-3524-1165; Dragun, Duska/0000-0002-0310-9269	European Union; Berlin [HEALTH-F2-2009-241544]; German Scleroderma Foundation (Berlin)	European Union; Berlin; German Scleroderma Foundation (Berlin)	The European Union Framework Programme 7 as part of the SysKid project (HEALTH-F2-2009-241544; Berlin; B.H., T.S. and D.D.) and the German Scleroderma Foundation (Berlin; B.H., G.R. and D.D.) supported the research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bautch VL, 2011, NAT MED, V17, P1437, DOI 10.1038/nm.2539; Bianco P, 2013, NAT MED, V19, P35, DOI 10.1038/nm.3028; Caplan AI, 2011, J ORTHOP RES, V29, P1795, DOI 10.1002/jor.21462; Cipriani P, 2007, ARTHRITIS RHEUM-US, V56, P1994, DOI 10.1002/art.22698; Collett GDM, 2005, CIRC RES, V96, P930, DOI 10.1161/01.RES.0000163634.51301.0d; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Crisan M, 2011, ORGANOGENESIS, V7, P101, DOI 10.4161/org.7.2.16150; Davidoff MS, 2004, J CELL BIOL, V167, P935, DOI 10.1083/jcb.200409107; Del Papa N, 2006, ARTHRITIS RHEUM-US, V54, P2605, DOI 10.1002/art.22035; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Eyden B, 2008, J CELL MOL MED, V12, P22, DOI 10.1111/j.1582-4934.2007.00213.x; Gabrielli A, 2009, NEW ENGL J MED, V360, P1989, DOI 10.1056/NEJMra0806188; Guiducci S, 2007, AUTOIMMUN REV, V6, P520, DOI 10.1016/j.autrev.2006.12.006; Guiducci S, 2011, ANN RHEUM DIS, V70, P2011, DOI 10.1136/ard.2011.150607; Hegner B, 2005, J HYPERTENS, V23, P1191, DOI 10.1097/01.hjh.0000170382.31085.5d; Hegner B, 2009, ARTERIOSCL THROM VAS, V29, P232, DOI 10.1161/ATVBAHA.108.179457; Humphreys BD, 2010, AM J PATHOL, V176, P85, DOI 10.2353/ajpath.2010.090517; Jimenez SA, 2001, J CLIN INVEST, V108, P1395, DOI 10.1172/JCI200112347; Jinnin M, 2010, J DERMATOL, V37, P11, DOI 10.1111/j.1346-8138.2009.00738.x; KIRK TZ, 1995, J BIOL CHEM, V270, P3423, DOI 10.1074/jbc.270.7.3423; Lange C, 2007, J CELL PHYSIOL, V213, P18, DOI 10.1002/jcp.21081; Larghero J, 2008, ANN RHEUM DIS, V67, P443, DOI 10.1136/ard.2007.071233; Mendoza FA, 2016, ARTHRITIS RHEUMATOL, V68, P210, DOI 10.1002/art.39421; Olson LE, 2011, DEV CELL, V20, P815, DOI 10.1016/j.devcel.2011.04.019; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Pattanaik D, 2011, J INFLAMM RES, V4, P105, DOI 10.2147/JIR.S18145; Raines EW, 2004, CYTOKINE GROWTH F R, V15, P237, DOI 10.1016/j.cytogfr.2004.03.004; Rajkumar VS, 2005, ARTHRITIS RES THER, V7, pR1113, DOI 10.1186/ar1790; Trojanowska M, 2010, NAT REV RHEUMATOL, V6, P453, DOI 10.1038/nrrheum.2010.102; Vanneaux V, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-001890; Varga J, 2007, J CLIN INVEST, V117, P557, DOI 10.1172/JCI31139; Zeisberg EM, 2010, CIRC RES, V107, P1304, DOI 10.1161/CIRCRESAHA.110.231910	32	24	25	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153101	10.1371/journal.pone.0153101	http://dx.doi.org/10.1371/journal.pone.0153101			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27054717	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000373608000077
J	Larson, LR; Jennings, V; Cloutier, SA				Larson, Lincoln R.; Jennings, Viniece; Cloutier, Scott A.			Public Parks and Wellbeing in Urban Areas of the United States	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; GREEN SPACE; ECOSYSTEM SERVICES; ENVIRONMENTAL-HEALTH; NATURE EXPERIENCE; LOCAL PARKS; LOS-ANGELES; NEIGHBORHOOD; COMMUNITY; HAPPINESS	Sustainable development efforts in urban areas often focus on understanding and managing factors that influence all aspects of health and wellbeing. Research has shown that public parks and green space provide a variety of physical, psychological, and social benefits to urban residents, but few studies have examined the influence of parks on comprehensive measures of subjective wellbeing at the city level. Using 2014 data from 44 U.S. cities, we evaluated the relationship between urban park quantity, quality, and accessibility and aggregate self-reported scores on the Gallup-Healthways Wellbeing Index (WBI), which considers five different domains of wellbeing (e.g., physical, community, social, financial, and purpose). In addition to park-related variables, our best-fitting OLS regression models selected using an information theory approach controlled for a variety of other typical geographic and socio-demographic correlates of wellbeing. Park quantity (measured as the percentage of city area covered by public parks) was among the strongest predictors of overall wellbeing, and the strength of this relationship appeared to be driven by parks' contributions to physical and community wellbeing. Park quality (measured as per capita spending on parks) and accessibility (measured as the overall percentage of a city's population within 1/2 mile of parks) were also positively associated with wellbeing, though these relationships were not significant. Results suggest that expansive park networks are linked to multiple aspects of health and wellbeing in cities and positively impact urban quality of life.	[Larson, Lincoln R.] Clemson Univ, Dept Pk Recreat & Tourism Management, Clemson, SC USA; [Jennings, Viniece] US Forest Serv, USDA, Southern Res Stn, Integrating Human & Nat Syst, Athens, GA USA; [Cloutier, Scott A.] Arizona State Univ, Julie Ann Wrigley Global Inst Sustainabil, Tempe, AZ USA	Clemson University; United States Department of Agriculture (USDA); United States Forest Service; Arizona State University; Arizona State University-Tempe	Larson, LR (corresponding author), Clemson Univ, Dept Pk Recreat & Tourism Management, Clemson, SC USA.	LRL@clemson.edu		Larson, Lincoln/0000-0001-9591-1269	U.S.D.A. joint venture Forest Service [14-JV-11330144-060]	U.S.D.A. joint venture Forest Service	U.S.D.A. joint venture Forest Service agreement #14-JV-11330144-060; U.S. Forest Service employee VJ was involved with the study design, data collection and analysis, and preparation of the manuscript. Any opinions, findings, conclusions, or recommendations expressed in this publication are those of the authors and do not necessarily reflect the view of the Forest Service or USDA.	Alcock I, 2014, ENVIRON SCI TECHNOL, V48, P1247, DOI 10.1021/es403688w; Anderson DR, 2001, J WILDLIFE MANAGE, V65, P373, DOI 10.2307/3803088; Arnberger A, 2012, URBAN FOR URBAN GREE, V11, P41, DOI 10.1016/j.ufug.2011.11.003; Asah ST, 2012, ENVIRON BEHAV, V44, P545, DOI 10.1177/0013916510397757; Bancroft C, 2015, SOC SCI MED, V138, P22, DOI 10.1016/j.socscimed.2015.05.034; Bartolini S, 2013, SOC INDIC RES, V110, P1033, DOI 10.1007/s11205-011-9971-x; Baur JWR, 2014, J PARK RECREAT ADM, V32, P19; Bedimo-Rung AL, 2005, AM J PREV MED, V28, P159, DOI 10.1016/j.amepre.2004.10.024; Bell SL, 2014, HEALTH PLACE, V30, P287, DOI 10.1016/j.healthplace.2014.10.005; Blanchflower DG, 2004, SCAND J ECON, V106, P393, DOI 10.1111/j.0347-0520.2004.00369.x; Boillot A, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0052708, 10.1371/journal.pone.0064417]; Bratman GN, 2015, P NATL ACAD SCI USA, V112, P8567, DOI 10.1073/pnas.1510459112; Bratman GN, 2012, ANN NY ACAD SCI, V1249, P118, DOI 10.1111/j.1749-6632.2011.06400.x; Brereton F, 2008, ECOL ECON, V65, P386, DOI 10.1016/j.ecolecon.2007.07.008; Brown G, 2014, LANDSCAPE URBAN PLAN, V121, P34, DOI 10.1016/j.landurbplan.2013.09.006; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cattell V, 2008, HEALTH PLACE, V14, P544, DOI 10.1016/j.healthplace.2007.10.007; Centers for Disease Control and Prevention (CDC), 2012, NAT ENV PUBL HLTH TR; Chiesura A, 2004, LANDSCAPE URBAN PLAN, V68, P129, DOI 10.1016/j.landurbplan.2003.08.003; Cho SH, 2008, ECOL ECON, V66, P403, DOI 10.1016/j.ecolecon.2007.10.012; Cloutier Scott, 2014, Environment Development and Sustainability, V16, P633, DOI 10.1007/s10668-013-9499-0; Cloutier S, 2014, ECOL INDIC, V40, P147, DOI 10.1016/j.ecolind.2014.01.012; Cohen DA, 2007, AM J PUBLIC HEALTH, V97, P509, DOI 10.2105/AJPH.2005.072447; Comstock N, 2010, J ENVIRON PSYCHOL, V30, P435, DOI 10.1016/j.jenvp.2010.05.001; Dadvand P, 2015, P NATL ACAD SCI USA, V112, P7937, DOI 10.1073/pnas.1503402112; Dai D, 2011, LANDSCAPE URBAN PLAN, V102, P234, DOI 10.1016/j.landurbplan.2011.05.002; Diener E, 1999, PSYCHOL BULL, V125, P276, DOI 10.1037//0033-2909.125.2.276; Diener E., 2008, HAPPINESS UNLOCKING; Diener E., 2005, J HAPPINESS STUD, V7, P397, DOI DOI 10.1007/S10902-006-9000-Y; Diener E, 2008, APPL PSYCHOL-INT REV, V57, P37, DOI 10.1111/j.1464-0597.2008.00353.x; Duncan G, 2010, J HAPPINESS STUD, V11, P163, DOI 10.1007/s10902-008-9129-y; Easterlin RA, 2003, P NATL ACAD SCI USA, V100, P11176, DOI 10.1073/pnas.1633144100; Elmqvist T, 2015, CURR OPIN ENV SUST, V14, P101, DOI 10.1016/j.cosust.2015.05.001; Fan YL, 2011, HEALTH PLACE, V17, P1202, DOI 10.1016/j.healthplace.2011.08.008; Florida R, 2014, SINGLES NOW MAKE MOR; Florida R, 2013, REG STUD, V47, P613, DOI 10.1080/00343404.2011.589830; Galea S, 2005, ANNU REV PUBL HEALTH, V26, P341, DOI 10.1146/annurev.publhealth.26.021304.144708; Gallup Inc, 2009, GALL HEALTH WELL BEI; Godbey G, 2010, BENEFITS PHYS ACTIVI; Gomez-Baggethun E, 2013, ECOL ECON, V86, P235, DOI 10.1016/j.ecolecon.2012.08.019; Graham Carol, 2009, HAPPINESS WORLD PARA; Han B, 2014, PREV MED, V69, pS106, DOI 10.1016/j.ypmed.2014.08.033; Hartig T, 2014, ANNU REV PUBL HEALTH, V35, P207, DOI 10.1146/annurev-publhealth-032013-182443; Hur M, 2010, J ENVIRON PSYCHOL, V30, P52, DOI 10.1016/j.jenvp.2009.05.005; Jennings V, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13020196; Jennings V, 2015, INT J ENV RES PUB HE, V12, P1952, DOI 10.3390/ijerph120201952; Jennings VL, 2016, AM J PREV MED, V50, P642, DOI 10.1016/j.amepre.2015.11.001; Jesdale BM, 2013, ENVIRON HEALTH PERSP, V121, P811, DOI 10.1289/ehp.1205919; Joassart-Marcelli P, 2010, ENVIRON PLANN A, V42, P1174, DOI 10.1068/a42198; Kabisch N, 2015, ENVIRON IMPACT ASSES, V50, P25, DOI 10.1016/j.eiar.2014.08.007; Kabisch N, 2014, LANDSCAPE URBAN PLAN, V122, P129, DOI 10.1016/j.landurbplan.2013.11.016; Kaczynski AT, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/s12966-014-0146-4; Kaczynski AT, 2009, LEISURE SCI, V31, P174, DOI 10.1080/01490400802686045; Kahneman D, 2004, AM ECON REV, V94, P429, DOI 10.1257/0002828041301713; Kahneman D, 2010, P NATL ACAD SCI USA, V107, P16489, DOI 10.1073/pnas.1011492107; Kazmierczak A, 2013, LANDSCAPE URBAN PLAN, V109, P31, DOI 10.1016/j.landurbplan.2012.05.007; Keniger LE, 2013, INT J ENV RES PUB HE, V10, P913, DOI 10.3390/ijerph10030913; Kuo FE, 1998, AM J COMMUN PSYCHOL, V26, P823, DOI 10.1023/A:1022294028903; Kuo M, 2015, FRONT PSYCHOL, V6, DOI [10.3389/fpsyg.2015.01093, 10.3389/fpg.2015.01093]; Lachowycz K, 2013, LANDSCAPE URBAN PLAN, V118, P62, DOI 10.1016/j.landurbplan.2012.10.012; Lawless NM, 2011, SOC INDIC RES, V101, P341, DOI 10.1007/s11205-010-9667-7; Lederbogen F, 2011, NATURE, V474, P498, DOI 10.1038/nature10190; Lee ACK, 2011, J PUBLIC HEALTH-UK, V33, P212, DOI 10.1093/pubmed/fdq068; Leung A., 2013, SEARCHING HAPPINESS, P247; Leyden KM, 2011, URBAN AFF REV, V47, P861, DOI 10.1177/1078087411403120; Litt JS, 2011, AM J PUBLIC HEALTH, V101, P1466, DOI 10.2105/AJPH.2010.300111; Low S, 2013, ASHGATE RESEARCH COMPANION TO PLANNING AND CULTURE, P295; Maas J, 2006, J EPIDEMIOL COMMUN H, V60, P587, DOI 10.1136/jech.2005.043125; McGranahan D, 2012, NATURAL AMENITIES SC; Miles R, 2012, J URBAN HEALTH, V89, P1, DOI 10.1007/s11524-011-9621-2; Mitchell R, 2008, LANCET, V372, P1655, DOI 10.1016/S0140-6736(08)61689-X; Nahlik A.M, 2013, EPA600R13ORD004914; Newman P., 2008, CITIES SUSTAINABLE E; O'Brien C, 2008, CAN PSYCHOL, V49, P289, DOI 10.1037/a0013235; Pennock M, 2011, ENVIRON IMPACT ASSES, V31, P61, DOI 10.1016/j.eiar.2010.04.003; Pfeiffer D, J AM PLANNI IN PRESS; Rath T., 2010, WELLBEING 5 ESSENTIA; Rehdanz K, 2005, ECOL ECON, V52, P111, DOI 10.1016/j.ecolecon.2004.06.015; Rentfrow PJ, 2009, J RES PERS, V43, P1073, DOI 10.1016/j.jrp.2009.08.005; Richardson EA, 2012, J EPIDEMIOL COMMUN H, V66, P160, DOI 10.1136/jech.2011.137240; Royall R., 1997, STAT EVIDENCE LIKELI; Russell R, 2013, ANNU REV ENV RESOUR, V38, P473, DOI 10.1146/annurev-environ-012312-110838; Sears LE, 2014, POPUL HEALTH MANAG, V17, P357, DOI 10.1089/pop.2013.0119; Seltenrich N, 2015, ENVIRON HEALTH PERSP, V123, pA254, DOI 10.1289/ehp.123-A254; Shafer CS, 2000, LANDSCAPE URBAN PLAN, V49, P163, DOI 10.1016/S0169-2046(00)00057-8; Shanahan DF, 2015, BIOSCIENCE, V65, P476, DOI 10.1093/biosci/biv032; Shanahan Danielle F, 2015, Am J Public Health, V105, P470, DOI 10.2105/AJPH.2014.302324; Smith LM, 2013, ECOL INDIC, V28, P79, DOI 10.1016/j.ecolind.2012.02.032; Stiglitz E., 2009, REPORT COMMISSION ME; Tabachnick B. G., 2019, USING MULTIVARIATE S, V5; Talen E, 1999, URBAN STUD, V36, P1361, DOI 10.1080/0042098993033; Thin N, 2012, SOCIAL HAPPINESS RES; Thompson CW, 2012, LANDSCAPE URBAN PLAN, V105, P221, DOI 10.1016/j.landurbplan.2011.12.015; Trust for Public Land, 2014, 2014 CIT PARK FACTS; Tzoulas K, 2007, LANDSCAPE URBAN PLAN, V81, P167, DOI 10.1016/j.landurbplan.2007.02.001; U. S. Census Bureau, 2014, STAT COUNT QUICKFACT; van den Berg AE, 2010, SOC SCI MED, V70, P1203, DOI 10.1016/j.socscimed.2010.01.002; Voicu I, 2008, REAL ESTATE ECON, V36, P241, DOI 10.1111/j.1540-6229.2008.00213.x; Wakefield S, 2007, HEALTH PROMOT INT, V22, P92, DOI 10.1093/heapro/dam001; Wakefield SEL, 2001, HEALTH PLACE, V7, P163, DOI 10.1016/S1353-8292(01)00006-5; Weiss CC, 2011, J URBAN HEALTH, V88, P297, DOI 10.1007/s11524-011-9551-z; West ST, 2012, J PUBLIC HEALTH MAN, V18, P423, DOI 10.1097/PHH.0b013e318238ea27; White MP, 2013, PSYCHOL SCI, V24, P920, DOI 10.1177/0956797612464659; Wolch J, 2011, HEALTH PLACE, V17, P207, DOI 10.1016/j.healthplace.2010.10.001; Wolf KL, 2015, ENVIRON HEALTH PERSP, V123, P390, DOI 10.1289/ehp.1408216; World Health Organization, 2014, URB POP GROWTH; Wu CD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108548; Zelenski JM, 2015, J ENVIRON PSYCHOL, V42, P24, DOI 10.1016/j.jenvp.2015.01.005; Zidansek EH, 2009, ENERGY, V32, P891	109	149	154	19	234	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153211	10.1371/journal.pone.0153211	http://dx.doi.org/10.1371/journal.pone.0153211			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DI6KO	27054887	Green Published, gold			2022-12-27	WOS:000373608000102
J	Sung, SY; Chang, JL; Chen, KC; Yeh, SD; Liu, YR; Su, YH; Hsueh, CY; Chung, LWK; Hsieh, CL				Sung, Shian-Ying; Chang, Junn-Liang; Chen, Kuan-Chou; Yeh, Shauh-Der; Liu, Yun-Ru; Su, Yen-Hao; Hsueh, Chia-Yen; Chung, Leland W. K.; Hsieh, Chia-Ling			Co-Targeting Prostate Cancer Epithelium and Bone Stroma by Human Osteonectin-Promoter-Mediated Suicide Gene Therapy Effectively Inhibits Androgen-Independent Prostate Cancer Growth	PLOS ONE			English	Article							RENAL-CELL CARCINOMA; COTARGETING TUMOR; METASTASIS; EXPRESSION; SEQUENCE; REPLICATION; FIBROBLASTS; MODALITY; PROTEIN; MODEL	Stromal-epithelial interaction has been shown to promote local tumor growth and distant metastasis. We sought to create a promising gene therapy approach that co-targets cancer and its supporting stromal cells for combating castration-resistant prostate tumors. Herein, we demonstrated that human osteonectin is overexpressed in the prostate cancer epithelium and tumor stroma in comparison with their normal counterpart. We designed a novel human osteonectin promoter (hON-522E) containing positive transcriptional regulatory elements identified in both the promoter and exon 1 region of the human osteonectin gene. In vitro reporter assays revealed that the hON-522E promoter is highly active in androgen receptor negative and metastatic prostate cancer and bone stromal cells compared to androgen receptor-positive prostate cancer cells. Moreover, in vivo prostate-tumor-promoting activity of the hON-522E promoter was confirmed by intravenous administration of an adenoviral vector containing the hON-522E promoter-driven luciferase gene (Ad-522E-Luc) into mice bearing orthotopic human prostate tumor xenografts. In addition, an adenoviral vector with the hON-522E-promoter-driven herpes simplex virus thymidine kinase gene (Ad-522E-TK) was highly effective against the growth of androgen-independent human prostate cancer PC3M and bone stromal cell line in vitro and in pre-established PC3M tumors in vivo upon addition of the prodrug ganciclovir. Because of the heterogeneity of human prostate tumors, hON-522E promoter-mediated gene therapy has the potential for the treatment of hormone refractory and bone metastatic prostate cancers.	[Sung, Shian-Ying; Hsueh, Chia-Yen; Hsieh, Chia-Ling] Taipei Med Univ, Coll Med Sci & Technol, PhD Program Translat Med, Taipei, Taiwan; [Chang, Junn-Liang] Taoyuan Armed Forces Gen Hosp, Dept Pathol & Lab Med, Taoyuan, Taiwan; [Chang, Junn-Liang] Ming Chuan Univ, Dept Biomed Engn, Taoyuan, Taiwan; [Chen, Kuan-Chou] Taipei Med Univ, Grad Inst Clin Med, Taipei, Taiwan; [Chen, Kuan-Chou] Minist Hlth & Welf, TMU Shuang Ho Hosp, Div Urol, New Taipei, Taiwan; [Yeh, Shauh-Der] Taipei Med Univ Hosp, Div Urol, Taipei, Taiwan; [Liu, Yun-Ru] Taipei Med Univ, Off Human Res, Joint Biobank, Taipei, Taiwan; [Su, Yen-Hao] Minist Hlth & Welf, TMU Shuang Ho Hosp, Dept Surg, Div Gen Surg, New Taipei, Taiwan; [Chung, Leland W. K.] Cedars Sinai Med Ctr, Dept Med, Los Angeles, CA 90048 USA	Taipei Medical University; Ming Chuan University; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Cedars Sinai Medical Center	Hsieh, CL (corresponding author), Taipei Med Univ, Coll Med Sci & Technol, PhD Program Translat Med, Taipei, Taiwan.	chsieh2@tmu.edu.tw			Ministry of Science and Technology [MOST 103-2320-B-038-040-MY3, 103-2320-B-038-039-MY3]; Ministry of Health and Welfare [MOHW105-TDU-B-212-134001]; Taipei Medical University, Taiwan [TMUTOP103003-6, TMUTOP103003-3, 104TMU-SHH-01-3]; NATIONAL CANCER INSTITUTE [P01CA098912] Funding Source: NIH RePORTER	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Ministry of Health and Welfare(Ministry of Health, Labour and Welfare, Japan); Taipei Medical University, Taiwan; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by Grant MOST 103-2320-B-038-040-MY3 (CLH) and 103-2320-B-038-039-MY3 (SYS) from the Ministry of Science and Technology, MOHW105-TDU-B-212-134001 (SYS) from the Ministry of Health and Welfare, and TMUTOP103003-6 (CLH), TMUTOP103003-3 (SYS) and 104TMU-SHH-01-3 (YHS) from Taipei Medical University, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allred DC, 1998, MODERN PATHOL, V11, P155; Bisanz K, 2005, MOL THER, V12, P634, DOI 10.1016/j.ymthe.2005.05.012; Bradshaw AD, 2001, J CLIN INVEST, V107, P1049, DOI 10.1172/JCI12939; Brekken Rolf A., 2001, Matrix Biology, V19, P816; Brower V, 2008, J NATL CANCER I, V100, P1276, DOI 10.1093/jnci/djn335; Chen NY, 2007, CANCER RES, V67, P6544, DOI 10.1158/0008-5472.CAN-07-1330; Cheville JC, 2002, CANCER-AM CANCER SOC, V95, P1028, DOI 10.1002/cncr.10788; Chlenski A, 2010, SEMIN CELL DEV BIOL, V21, P55, DOI 10.1016/j.semcdb.2009.11.018; Choudhury KR, 2010, J HISTOCHEM CYTOCHEM, V58, P95, DOI 10.1369/jhc.2009.953554; CHUNG LWK, 1991, CANCER METAST REV, V10, P263, DOI 10.1007/BF00050797; De S, 2003, J BIOL CHEM, V278, P39044, DOI 10.1074/jbc.M304494200; DeRosa CA, 2012, PROSTATE CANCER P D, V15, P150, DOI 10.1038/pcan.2011.61; GLEAVE ME, 1992, J UROLOGY, V147, P1151, DOI 10.1016/S0022-5347(17)37506-7; GRAHAM FL, 1995, MOL BIOTECHNOL, V3, P207, DOI 10.1007/BF02789331; Hafner M, 1995, MATRIX BIOL, V14, P733, DOI 10.1016/S0945-053X(05)80016-2; Hsiao WC, 2012, MOL PHARMACEUT, V9, P1396, DOI 10.1021/mp200649g; Hsieh CL, 2004, CANCER GENE THER, V11, P148, DOI 10.1038/sj.cgt.7700665; Hsieh CL, 2002, CANCER RES, V62, P3084; Hsieh CL, 2003, CANC GENE THER; Jacob K, 1999, CANCER RES, V59, P4453; Jin FS, 2005, CANCER GENE THER, V12, P257, DOI 10.1038/sj.cgt.7700790; Johnson NA, 2010, J GENE MED, V12, P892, DOI 10.1002/jgm.1516; Josson S, 2010, SEMIN CELL DEV BIOL, V21, P26, DOI 10.1016/j.semcdb.2009.11.016; Karlou M, 2010, NAT REV UROL, V7, P494, DOI 10.1038/nrurol.2010.134; Ko SC, 1996, CANCER RES, V56, P4614; Koeneman KS, 1999, PROSTATE, V39, P246; Lecrone V, 2000, CELL CALCIUM, V27, P35, DOI 10.1054/ceca.1999.0083; Matsubara S, 2001, CANCER RES, V61, P6012; NOMURA S, 1990, ANN NY ACAD SCI, V580, P252, DOI 10.1111/j.1749-6632.1990.tb17934.x; NOMURA S, 1989, J BIOL CHEM, V264, P12201; Omlin A, 2014, THER ADV UROL, V6, P3, DOI 10.1177/1756287213509677; Ribeiro N, 2014, J CELL BIOCHEM, V115, P17, DOI 10.1002/jcb.24649; Sato N, 2003, ONCOGENE, V22, P5021, DOI 10.1038/sj.onc.1206807; Seruga B, 2011, NAT REV CLIN ONCOL, V8, P12, DOI 10.1038/nrclinonc.2010.136; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Sung SY, 2008, CANCER RES, V68, P9996, DOI 10.1158/0008-5472.CAN-08-2492; TERMINE JD, 1981, CELL, V26, P99, DOI 10.1016/0092-8674(81)90037-4; Thomas R, 2000, CLIN CANCER RES, V6, P1140; Wong YC, 2000, INT REV CYTOL, V199, P65, DOI 10.1016/S0074-7696(00)99002-8; YOUNG MF, 1989, J BIOL CHEM, V264, P450	40	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153350	10.1371/journal.pone.0153350	http://dx.doi.org/10.1371/journal.pone.0153350			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27054343	Green Submitted, Green Published, gold			2022-12-27	WOS:000373608000123
J	Jones, AG; Lonergan, M; Henley, WE; Pearson, ER; Hattersley, AT; Shields, BM				Jones, Angus G.; Lonergan, Mike; Henley, William E.; Pearson, Ewan R.; Hattersley, Andrew T.; Shields, Beverley M.			Should Studies of Diabetes Treatment Stratification Correct for Baseline HbA1c?	PLOS ONE			English	Article							REGRESSION; INSULIN; SULFONYLUREAS; METAANALYSIS; ASSOCIATION; ADJUSTMENT; EFFICACY; TARGET	Aims Baseline HbA1c is a major predictor of response to glucose lowering therapy and therefore a potential confounder in studies aiming to identify other predictors. However, baseline adjustment may introduce error if the association between baseline HbA1c and response is substantially due to measurement error and regression to the mean. We aimed to determine whether studies of predictors of response should adjust for baseline HbA1c. Methods We assessed the relationship between baseline HbA1c and glycaemic response in 257 participants treated with GLP-1R agonists and assessed whether it reflected measurement error and regression to the mean using duplicate 'pre-baseline' HbA1c measurements not included in the response variable. In this cohort and an additional 2659 participants treated with sulfonylureas we assessed the relationship between covariates associated with baseline HbA1c and treatment response with and without baseline adjustment, and with a bias correction using pre-baseline HbA1c to adjust for the effects of error in baseline HbA1c. Results Baseline HbA1c was a major predictor of response (R-2 = 0.19, beta = -0.44, p<0.001). The association between pre-baseline and response was similar suggesting the greater response at higher baseline HbA1cs is not mainly due to measurement error and subsequent regression to the mean. In unadjusted analysis in both cohorts, factors associated with baseline HbA1c were associated with response, however these associations were weak or absent after adjustment for baseline HbA1c. Bias correction did not substantially alter associations. Conclusions Adjustment for the baseline HbA1c measurement is a simple and effective way to reduce bias in studies of predictors of response to glucose lowering therapy.	[Jones, Angus G.; Hattersley, Andrew T.; Shields, Beverley M.] Univ Exeter, Sch Med, NIHR Exeter Clin Res Facil, Exeter, Devon, England; [Lonergan, Mike; Pearson, Ewan R.] Univ Dundee, Med Res Inst, Dundee, Scotland; [Henley, William E.] Univ Exeter, Sch Med, Inst Hlth Serv Res, Exeter, Devon, England	University of Exeter; University of Dundee; University of Exeter	Jones, AG (corresponding author), Univ Exeter, Sch Med, NIHR Exeter Clin Res Facil, Exeter, Devon, England.	angus.jones@exeter.ac.uk		Hattersley, Andrew/0000-0001-5620-473X; Jones, Angus/0000-0002-0883-7599; Pearson, Ewan/0000-0001-9237-8585	National Institute of Health Research (NIHR) (UK); NIHR Clinical Research Network; Wellcome trust; Diabetes UK; MRC/ABPI MASTERMIND project; National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care (CLAHRC) for the South West Peninsula; MRC [MR/N00633X/1, MR/K005707/1] Funding Source: UKRI; Medical Research Council [MR/N00633X/1, MR/K005707/1] Funding Source: researchfish; National Institute for Health Research [DRF-2010-03-72, NF-SI-0611-10219, CL-2014-23-001, CS-2015-15-018] Funding Source: researchfish	National Institute of Health Research (NIHR) (UK)(National Institute for Health Research (NIHR)); NIHR Clinical Research Network; Wellcome trust(Wellcome TrustEuropean Commission); Diabetes UK(Diabetes UK); MRC/ABPI MASTERMIND project(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care (CLAHRC) for the South West Peninsula; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	The Predicting Response to Incretin Based Agents (PRIBA) study was funded by the National Institute of Health Research (NIHR) (UK) and supported by the NIHR Clinical Research Network. The GoDARTS study was funded by the Wellcome trust and is supported by Diabetes UK. ATH, ERP, BMS, WEH and ML are funded for this analysis as part of the MRC/ABPI MASTERMIND project. AGJ is an NIHR Clinician Scientist. ATH is an NIHR Senior Investigator and a Wellcome Trust Senior Investigator. ERP is a Wellcome Trust New Investigator. ATH and BMS are core staff members of the NIHR Exeter Clinical Research Facility. WEH is partially supported by the National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care (CLAHRC) for the South West Peninsula. The views given in this paper do not necessarily represent those of NIHR, the NHS or the Department of Health.	[Anonymous], 2013, DIABETOLOGIA S1, V56; Barnett AG, 2005, INT J EPIDEMIOL, V34, P215, DOI 10.1093/ije/dyh299; Bloomgarden ZT, 2006, DIABETES CARE, V29, P2137, DOI 10.2337/dc06-1120; Deenen MJ, 2011, ONCOLOGIST, V16, P811, DOI 10.1634/theoncologist.2010-0258; DeFronzo RA, 2010, DIABETIC MED, V27, P309, DOI 10.1111/j.1464-5491.2010.02941.x; Diamant M, 2010, LANCET, V375, P2234, DOI 10.1016/S0140-6736(10)60406-0; Donnan PT, 2002, DIABETIC MED, V19, P279, DOI 10.1046/j.1464-5491.2002.00689.x; Donnelly LA, 2006, DIABETIC MED, V23, P128, DOI 10.1111/j.1464-5491.2005.01755.x; Gale Edwin A M, 2007, Diabetes Care, V30, P2989, DOI 10.2337/dc07-0155; Giugliano D, 2011, INT J CLIN PRACT, V65, P602, DOI 10.1111/j.1742-1241.2010.02619.x; Glymour MM, 2005, AM J EPIDEMIOL, V162, P267, DOI 10.1093/aje/kwi187; Harrison L, 2009, STAT MED, V28, P3260, DOI 10.1002/sim.3725; Hopewell JC, 2013, EUR HEART J, V34, P982, DOI 10.1093/eurheartj/ehs344; Jones AG, 2016, DIABETES CARE, V39, P250, DOI 10.2337/dc15-0258; Kraha A, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00044; McArdle PF, 2009, HUM HERED, V67, P176, DOI 10.1159/000181156; Pearson ER, 2003, LANCET, V362, P1275, DOI 10.1016/S0140-6736(03)14571-0; Pearson ER, 2006, NEW ENGL J MED, V355, P467, DOI 10.1056/NEJMoa061759; Senn S., 2007, STAT ISSUES DRUG DEV; Senn S, 2006, STAT MED, V25, P4334, DOI 10.1002/sim.2682; 't Hart LM, 2013, DIABETES, V62, P3275, DOI 10.2337/db13-0227; Thong KY, 2014, DIABETIC MED, V31, P403, DOI 10.1111/dme.12367; Trusheim MR, 2007, NAT REV DRUG DISCOV, V6, P287, DOI 10.1038/nrd2251; Yanez ND, 2002, ANN EPIDEMIOL, V12, P34, DOI 10.1016/S1047-2797(01)00280-0; Yanez ND, 1998, STAT MED, V17, P2597, DOI 10.1002/(SICI)1097-0258(19981130)17:22<2597::AID-SIM940>3.0.CO;2-G	25	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0152428	10.1371/journal.pone.0152428	http://dx.doi.org/10.1371/journal.pone.0152428			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050911	Green Published, Green Submitted, gold			2022-12-27	WOS:000373603500040
J	Luo, LQ; Li, DF; Zhang, W; Tu, SK; Zhu, XP; Tian, G				Luo, Longqiang; Li, Dingfang; Zhang, Wen; Tu, Shikui; Zhu, Xiaopeng; Tian, Gang			Accurate Prediction of Transposon-Derived piRNAs by Integrating Various Sequential and Physicochemical Features	PLOS ONE			English	Article							LONG NONCODING RNA; PIWI; DNA; IDENTIFICATION; BIOGENESIS; GENES; MODES	Background Piwi-interacting RNA (piRNA) is the largest class of small non-coding RNA molecules. The transposon-derived piRNA prediction can enrich the research contents of small ncRNAs as well as help to further understand generation mechanism of gamete. Methods In this paper, we attempt to differentiate transposon-derived piRNAs from non-piRNAs based on their sequential and physicochemical features by using machine learning methods. We explore six sequence-derived features, i.e. spectrum profile, mismatch profile, subsequence profile, position-specific scoring matrix, pseudo dinucleotide composition and local structure-sequence triplet elements, and systematically evaluate their performances for transposonderived piRNA prediction. Finally, we consider two approaches: direct combination and ensemble learning to integrate useful features and achieve high-accuracy prediction models. Results We construct three datasets, covering three species: Human, Mouse and Drosophila, and evaluate the performances of prediction models by 10-fold cross validation. In the computational experiments, direct combination models achieve AUC of 0.917, 0.922 and 0.992 on Human, Mouse and Drosophila, respectively; ensemble learning models achieve AUC of 0.922, 0.926 and 0.994 on the three datasets. Conclusions Compared with other state-of-the-art methods, our methods can lead to better performances. In conclusion, the proposed methods are promising for the transposon-derived piRNA prediction. The source codes and datasets are available in S1 File.	[Luo, Longqiang; Li, Dingfang] Wuhan Univ, Sch Math & Stat, Wuhan 430072, Peoples R China; [Zhang, Wen; Tian, Gang] Wuhan Univ, Sch Comp, Wuhan 430072, Peoples R China; [Zhang, Wen] Wuhan Univ, Res Inst Shenzhen, Shenzhen 518057, Peoples R China; [Tu, Shikui; Zhu, Xiaopeng] Univ Massachusetts, Sch Med, Program Bioinformat & Integrat Biol, 368 Plantat St, Worcester, MA 01605 USA	Wuhan University; Wuhan University; Wuhan University; University of Massachusetts System; University of Massachusetts Worcester	Zhang, W (corresponding author), Wuhan Univ, Sch Comp, Wuhan 430072, Peoples R China.; Zhang, W (corresponding author), Wuhan Univ, Res Inst Shenzhen, Shenzhen 518057, Peoples R China.	zhangwen@whu.edu.cn	xiaopeng, zhu/A-6755-2011; Zhang, Wen/W-7471-2019	xiaopeng, zhu/0000-0003-2007-9820; Zhang, Wen/0000-0001-5221-2628	National Natural Science Foundation of China [61271337, 61103126, 61572368]; Shenzhen Development Foundation [JCYJ20130401160028781]; China Scholarship Council [201406275015]; Natural Science Foundation of Hubei Province, China [ZRY2014000901]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenzhen Development Foundation; China Scholarship Council(China Scholarship Council); Natural Science Foundation of Hubei Province, China(Natural Science Foundation of Hubei Province)	This work is supported by the National Natural Science Foundation of China (61271337, 61103126, 61572368), Shenzhen Development Foundation (JCYJ20130401160028781), China Scholarship Council (201406275015) and the Natural Science Foundation of Hubei Province, China (ZRY2014000901). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeel T, 2009, BIOINFORMATICS, V25, pI313, DOI 10.1093/bioinformatics/btp191; Alexei A, 2006, NATURE, V442, P203; Betel D, 2007, PLOS COMPUT BIOL, V3, P2219, DOI 10.1371/journal.pcbi.0030222; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Bu DC, 2012, NUCLEIC ACIDS RES, V40, pD210, DOI 10.1093/nar/gkr1175; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Claverie JM, 2005, SCIENCE, V309, P1529, DOI 10.1126/science.1116800; Cox DN, 1998, GENE DEV, V12, P3715, DOI 10.1101/gad.12.23.3715; Cucchiara A., 2012, TECHNOMETRICS, V34, P358, DOI DOI 10.2307/1270048; Das PP, 2008, MOL CELL, V31, P79, DOI 10.1016/j.molcel.2008.06.003; El-Manzalawy Yasser, 2008, Comput Syst Bioinformatics Conf, V7, P121, DOI 10.1142/9781848162648_0011; Grivna ST, 2006, GENE DEV, V20, P1709, DOI 10.1101/gad.1434406; Houwing S, 2007, CELL, V129, P69, DOI 10.1016/j.cell.2007.03.026; Huang Y, 2012, J PHYSIOL BIOCHEM, V68, P611, DOI 10.1007/s13105-012-0166-y; Jiang H, 2008, BIOINFORMATICS, V24, P2395, DOI 10.1093/bioinformatics/btn429; Karolchik D, 2014, NUCLEIC ACIDS RES, V42, pD590; Klattenhoff C, 2008, DEVELOPMENT, V135, P3, DOI 10.1242/dev.006486; Lau NC, 2006, SCIENCE, V313, P363, DOI 10.1126/science.1130164; LESLIE C, 2002, P PSB, V7, P566; Leslie CS, 2004, BIOINFORMATICS, V20, P467, DOI 10.1093/bioinformatics/btg431; Liu B, 2015, NUCLEIC ACIDS RES, V43, pW65, DOI 10.1093/nar/gkv458; Liu B, 2015, BIOINFORMATICS, V31, P1307, DOI 10.1093/bioinformatics/btu820; Lodhi H, 2002, J MACH LEARN RES, V2, P419, DOI 10.1162/153244302760200687; Mattick JS, 2005, SCIENCE, V309, P1527, DOI 10.1126/science.1117806; Meenakshisundaram K, 2009, J BIOINFORMATICS SEQ, V1, P31; Robine N, 2009, CURR BIOL, V19, P2066, DOI 10.1016/j.cub.2009.11.064; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Seto AG, 2007, MOL CELL, V26, P603, DOI 10.1016/j.molcel.2007.05.021; Sinha S, 2006, BIOINFORMATICS, V22, pE454, DOI 10.1093/bioinformatics/btl227; Song L, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-298; Stormo GD, 2000, BIOINFORMATICS, V16, P16, DOI 10.1093/bioinformatics/16.1.16; Thomson T, 2009, ANNU REV CELL DEV BI, V25, P355, DOI 10.1146/annurev.cellbio.24.110707.175327; Wang K, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/s12859-014-0419-6; Wei LY, 2014, IEEE ACM T COMPUT BI, V11, P192, DOI 10.1109/TCBB.2013.146; Wen Zhang, 2013, 2013 IEEE International Conference on Bioinformatics and Biomedicine (BIBM), P4, DOI 10.1109/BIBM.2013.6732451; Xia XH, 2012, SCIENTIFICA, V2012, DOI 10.6064/2012/917540; Xie CY, 2014, NUCLEIC ACIDS RES, V42, pD98, DOI 10.1093/nar/gkt1222; Xue CH, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-310; Yin H, 2007, NATURE, V450, P304, DOI 10.1038/nature06263; Zhang W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128194; Zhang W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043575; Zhang Y, 2011, BIOINFORMATICS, V27, P771, DOI 10.1093/bioinformatics/btr016; Zou Q, 2015, MOLECULAR INFORMATIC, V2003, P2992	44	45	45	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153268	10.1371/journal.pone.0153268	http://dx.doi.org/10.1371/journal.pone.0153268			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27074043	Green Submitted, Green Published, gold			2022-12-27	WOS:000374131200069
J	Mahmood, ASMA; Wu, TJ; Mazumder, R; Vijay-Shanker, K				Mahmood, A. S. M. Ashique; Wu, Tsung-Jung; Mazumder, Raja; Vijay-Shanker, K.			DiMeX: A Text Mining System for Mutation-Disease Association Extraction	PLOS ONE			English	Article							SEQUENCE VARIANTS; DATABASE; CANCER; GENES	The number of published articles describing associations between mutations and diseases is increasing at a fast pace. There is a pressing need to gather such mutation-disease associations into public knowledge bases, but manual curation slows down the growth of such databases. We have addressed this problem by developing a text-mining system (DiMeX) to extract mutation to disease associations from publication abstracts. DiMeX consists of a series of natural language processing modules that preprocess input text and apply syntactic and semantic patterns to extract mutation-disease associations. DiMeX achieves high precision and recall with F-scores of 0.88, 0.91 and 0.89 when evaluated on three different datasets for mutation-disease associations. DiMeX includes a separate component that extracts mutation mentions in text and associates them with genes. This component has been also evaluated on different datasets and shown to achieve state-of-the-art performance. The results indicate that our system outperforms the existing mutation-disease association tools, addressing the low precision problems suffered by most approaches. DiMeX was applied on a large set of abstracts from Medline to extract mutation-disease associations, as well as other relevant information including patient/cohort size and population data. The results are stored in a database that can be queried and downloaded at http://biotm.cis.udel.edu/dimex/. We conclude that this high-throughput text-mining approach has the potential to significantly assist researchers and curators to enrich mutation databases.	[Mahmood, A. S. M. Ashique; Vijay-Shanker, K.] Univ Delaware, Dept Comp & Informat Sci, Newark, DE 19716 USA; [Wu, Tsung-Jung; Mazumder, Raja] George Washington Univ, Dept Biochem & Mol Med, Washington, DC USA; [Mazumder, Raja] George Washington Univ, McCormick Genom & Prote Ctr, Washington, DC USA	University of Delaware; George Washington University; George Washington University	Mahmood, ASMA (corresponding author), Univ Delaware, Dept Comp & Informat Sci, Newark, DE 19716 USA.	ashique@udel.edu		Mazumder, Raja/0000-0001-8823-9945	National Institute of Food and Agriculture (NIFA) [2011-67015-21639]	National Institute of Food and Agriculture (NIFA)	This work was supported by National Institute of Food and Agriculture (NIFA) Award Number: 2011-67015-21639.	Amberger J, 2009, NUCLEIC ACIDS RES, V37, pD793, DOI 10.1093/nar/gkn665; Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; Beroud C, 2005, HUM MUTAT, V26, P184, DOI 10.1002/humu.20210; Burger JD, 2014, DATABASE-OXFORD, DOI 10.1093/database/bau094; Caporaso JG, 2007, BIOINFORMATICS, V23, P1862, DOI 10.1093/bioinformatics/btm235; Capriotti E, 2012, BRIEF BIOINFORM, V13, P495, DOI 10.1093/bib/bbr070; Cheng D, 2008, NUCLEIC ACIDS RES, V36, pW399, DOI 10.1093/nar/gkn296; Doughty E, 2011, BIOINFORMATICS, V27, P408, DOI 10.1093/bioinformatics/btq667; Erdogmus Muge, 2007, J Bioinform Comput Biol, V5, P1261, DOI 10.1142/S021972000700317X; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Furlong LI, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-84; Hirohata K, 2008, P 3 INT JOINT C NAT, VI, P381; Horn F, 2004, BIOINFORMATICS, V20, P557, DOI 10.1093/bioinformatics/btg449; Jimeno Y. A., 2014, F1000RESEARCH, V3, P18; Kim SN, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S2-S5; Landrum MJ, 2014, NUCLEIC ACIDS RES, V42, pD980, DOI 10.1093/nar/gkt1113; Lee LC, 2007, PLOS COMPUT BIOL, V3, P184, DOI 10.1371/journal.pcbi.0030016; Liakata M, 2012, BIOINFORMATICS, V28, P991, DOI 10.1093/bioinformatics/bts071; McDonald RT, 2004, BIOINFORMATICS, V20, P3249, DOI 10.1093/bioinformatics/bth350; McKnight Larry, 2003, AMIA Annu Symp Proc, P440; Miwa M, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-108; Naderi N, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S4-S10; Narayanaswamy Meenakshi, 2003, Pac Symp Biocomput, P427; Plazzer JP, 2013, FAM CANCER, V12, P175, DOI 10.1007/s10689-013-9616-0; Rebholz-Schuhmann D, 2004, NUCLEIC ACIDS RES, V32, P135, DOI 10.1093/nar/gkh162; Saunders RE, 2008, HUM MUTAT, V29, P333, DOI 10.1002/humu.20629; Schenck M, 2013, REC HEALTH CARE INF, V04; Schwartz Ariel S, 2003, Pac Symp Biocomput, P451; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Singh A, 2008, NUCLEIC ACIDS RES, V36, pD815, DOI 10.1093/nar/gkm659; Stenson PD, 2009, GENOME MED, V1, DOI 10.1186/gm13; Thomas P., 2014, SETH SNP EXTRACTION; Thomas PE, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S4-S4; Thompson P, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-393; Thorisson GA, 2009, NUCLEIC ACIDS RES, V37, pD797, DOI 10.1093/nar/gkn748; Verspoor K, 2013, DATABASE-OXFORD, DOI 10.1093/database/bat019; Wei CH, 2013, NUCLEIC ACIDS RES, V41, pW518, DOI 10.1093/nar/gkt441; Wei CH, 2013, BIOINFORMATICS, V29, P1433, DOI 10.1093/bioinformatics/btt156; Whirl-Carrillo M, 2012, CLIN PHARMACOL THER, V92, P414, DOI 10.1038/clpt.2012.96; Winnenburg R, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S8-S3; Wu TJ, 2014, DATABASE-OXFORD, DOI 10.1093/database/bau022; Yeniterzi S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S8-S2; Yip Yum Lina, 2007, J Bioinform Comput Biol, V5, P1215, DOI 10.1142/S021972000700320X; Zhang J, 2011, J GENET GENOMICS, V38, P95, DOI 10.1016/j.jgg.2011.02.003	44	34	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0152725	10.1371/journal.pone.0152725	http://dx.doi.org/10.1371/journal.pone.0152725			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073839	Green Submitted, gold, Green Published			2022-12-27	WOS:000374131200034
J	Marx, S; Hammerle, M; Klonner, C; Hofle, B				Marx, Sabrina; Haemmerle, Martin; Klonner, Carolin; Hoefle, Bernhard			3D Participatory Sensing with Low-Cost Mobile Devices for Crop Height Assessment A Comparison with Terrestrial Laser Scanning Data	PLOS ONE			English	Article							GEOGRAPHIC INFORMATION; ASSISTED GPS; TECHNOLOGY; SMARTPHONES; ACCURACY; DENSITY; MODELS; APP	The integration of local agricultural knowledge deepens the understanding of complex phenomena such as the association between climate variability, crop yields and undernutrition. Participatory Sensing (PS) is a concept which enables laymen to easily gather geodata with standard low-cost mobile devices, offering new and efficient opportunities for agricultural monitoring. This study presents a methodological approach for crop height assessment based on PS. In-field crop height variations of a maize field in Heidelberg, Germany, are gathered with smartphones and handheld GPS devices by 19 participants. The comparison of crop height values measured by the participants to reference data based on terrestrial laser scanning (TLS) results in R-2 = 0.63 for the handheld GPS devices and R-2 = 0.24 for the smartphone-based approach. RMSE for the comparison between crop height models (CHM) derived from PS and TLS data is 10.45 cm (GPS devices) and 14.69 cm (smartphones). Furthermore, the results indicate that incorporating participants' cognitive abilities in the data collection process potentially improves the quality data captured with the PS approach. The proposed PS methods serve as a fundament to collect agricultural parameters on field-level by incorporating local people. Combined with other methods such as remote sensing, PS opens new perspectives to support agricultural development.	[Marx, Sabrina; Haemmerle, Martin; Klonner, Carolin; Hoefle, Bernhard] Heidelberg Univ, Inst Geog, GISci, Heidelberg, Germany; [Hoefle, Bernhard] Heidelberg Univ, HCE, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Marx, S (corresponding author), Heidelberg Univ, Inst Geog, GISci, Heidelberg, Germany.	marx@uni-heidelberg.de	Höfle, Bernhard/A-4702-2010	Höfle, Bernhard/0000-0001-5849-1461; Hammerle, Martin/0000-0001-7527-8515; Klonner, Carolin/0000-0003-1981-2204	Heidelberg Center for the Environment (HCE) of the Heidelberg University; Deutsche Forschungsgemeinschaft; Heidelberg University	Heidelberg Center for the Environment (HCE) of the Heidelberg University; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Heidelberg University	This research was funded by the Heidelberg Center for the Environment (HCE) of the Heidelberg University, www.hce.uni-heidelberg.de. Furthermore, the authors would like to acknowledge financial support by Deutsche Forschungsgemeinschaft and Heidelberg University within the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aanensen DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006968; Anokwa Y, 2009, COMPUTER, V42, P97, DOI 10.1109/MC.2009.328; Galindo PA, 2012, PRECIS AGRIC, V13, P594, DOI 10.1007/s11119-012-9267-4; Batchelor S, 2014, 2 INT C ICT SUST; Bauer C., 2013, P MOMM; Benavent X, 2012, MATH PROBL ENG, V2012, DOI 10.1155/2012/678326; Boulos MNK, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-24; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brovelli MA, OSGEO J, V13, P29; Brunette W, OPEN DATA KIT 2 0 EX; Confalonieri R, 2013, COMPUT ELECTRON AGR, V96, P67, DOI 10.1016/j.compag.2013.04.019; Confalonieri R, 2011, EUR J AGRON, V34, P20, DOI 10.1016/j.eja.2010.09.003; Corburn J, 2004, AM J PUBLIC HEALTH, V94, P541, DOI 10.2105/AJPH.94.4.541; Craig WJ, 2001, COMMUNITY PARTICIPAT; Dandois JP, 2013, REMOTE SENS ENVIRON, V136, P259, DOI 10.1016/j.rse.2013.04.005; Degrossi LC, 2014, 26 INT C SOFTW ENG K; Delgado JA, 2013, COMPUT ELECTRON AGR, V91, P121, DOI 10.1016/j.compag.2012.12.008; Dorn H, 2015, ISPRS INT J GEO-INF, V4, P1657, DOI 10.3390/ijgi4031657; Ehlert D, 2013, COMPUT ELECTRON AGR, V93, P10, DOI 10.1016/j.compag.2013.01.002; Enenkel M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142030; Eskenazi B, 2014, ENVIRON INT, V68, P219, DOI 10.1016/j.envint.2014.03.003; ESRI, 2013, ARCGIS HELP; FAO WFP IFAD, 2012, STAT FOOD INS WORLD; Ferster CJ, 2013, COMPUT GEOSCI-UK, V51, P339, DOI 10.1016/j.cageo.2012.09.009; Frommberger L, 2013, PROCEEDINGS OF THE 3RD ACM SYMPOSIUM ON COMPUTING FOR DEVELOPMENT (ACM DEV 2013); Garmin Ltd, 2009, OREGON SER OWN MAN; Goma HC, 2001, AGR ECOSYST ENVIRON, V87, P179, DOI 10.1016/S0167-8809(01)00277-8; Goodchild MF, 2007, GEOJOURNAL, V69, P211, DOI 10.1007/s10708-007-9111-y; Hammerle M, 2014, SENSORS-BASEL, V14, P24212, DOI 10.3390/s141224212; Haklay M, 2013, CROWDSOURCING GEOGRA, P105, DOI [10.1007/978-94-007-4587-2_7, DOI 10.1007/978-94-007-4587-2_7]; Hartung C., 2010, OPEN DATA KIT TOOLS; Hedgecock W, 2013, HIGH ACCURACY DIFFER; Heipke C, 2010, ISPRS J PHOTOGRAMM, V65, P550, DOI 10.1016/j.isprsjprs.2010.06.005; de Frutos SH, 2014, TRANSPORT RES C-EMER, V38, P136, DOI 10.1016/j.trc.2013.11.012; Hillen F, 2015, INT J APPL EARTH OBS, V40, P29, DOI 10.1016/j.jag.2015.03.012; Hofle B, 2014, IEEE GEOSCI REMOTE S, V11, P94, DOI 10.1109/LGRS.2013.2247022; Hwang Soyoung, 2012, INT J SMART HOME, V6, P1; Isaaks EH, 1989, APPL GEOSTATISTICS; Jackson SP, 2013, ISPRS INT GEO-INF, V2, P507, DOI 10.3390/ijgi2020507; Kamel Boulos Maged N, 2011, Int J Health Geogr, V10, P67, DOI 10.1186/1476-072x-10-67; Kim J, 2013, ISPRS J PHOTOGRAMM, V79, P1, DOI 10.1016/j.isprsjprs.2013.02.001; Klonner C, 2015, INT J DIGIT EARTH, V8, P153, DOI 10.1080/17538947.2014.881427; Kotovirta V, 2012, 6 INT C INN MOB INT; Kotovirta V, 2011, ENVIOBSERVER PARTICI; Krivoruchko Konstantin, 2012, EMPIRICAL BAYESIAN K; Luo JB, 2011, MULTIMED TOOLS APPL, V51, P187, DOI 10.1007/s11042-010-0623-y; Lwin KK., 2011, J GEOGRAPHIC INFORM, V3, P382, DOI DOI 10.4236/JGIS.2011.34037; Marx S, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1189; Mendez D, 2013, PERVASIVE MOB COMPUT, V9, P132, DOI 10.1016/j.pmcj.2012.11.001; Micheletti N, 2014, EARTH SURF PROCESSES, V14; Phalkey RK, 2015, P NATL ACAD SCI USA, V112, pE4522, DOI 10.1073/pnas.1409769112; Pilz J, 2008, STOCH ENV RES RISK A, V22, P621, DOI 10.1007/s00477-007-0165-7; Rafoss T, 2010, COMPUT ELECTRON AGR, V74, P336, DOI 10.1016/j.compag.2010.08.006; Rajput ZA, 2012, J AM MED INFORM ASSN, V19, P655, DOI 10.1136/amiajnl-2011-000476; Ramesh MV, 2012, 21 ANN WIR OPT COMM; Reddy S, 2007, IMAGE BROWSING PROCE; Riano D, 2003, REMOTE SENS ENVIRON, V86, P177, DOI 10.1016/S0034-4257(03)00098-1; RIEGL, 2014, RISCAN PRO; Saeys W, 2009, BIOSYST ENG, V102, P22, DOI 10.1016/j.biosystemseng.2008.10.003; Schlatter BE, 2005, J PHYS EDUC RECREAT, V76, P28, DOI 10.1080/07303084.2005.10609309; Schmid F, NEW MICROMAPPING MET; Sinn P, 2013, LANDSCHAFT GESCH HEI; Sommer C, 2011, I S BIOMED IMAGING, P230, DOI 10.1109/ISBI.2011.5872394; Sritarapipat T, 2014, SENSORS-BASEL, V14, P900, DOI 10.3390/s140100900; Sui D., 2013, CROWDSOURCING GEOGRA, P1; Sun C, 2006, DYNAMIC MOBILE GIS, V1-23; Tilly N, 2015, AGRICULTURE-BASEL, V5, P538, DOI 10.3390/agriculture5030538; Tilly N, 2014, J APPL REMOTE SENS, V8, DOI 10.1117/1.JRS.8.083671; USAID, 2013, CROWDS APPL AGR DEV, P1; Vijayanarasimhan S, 2014, INT J COMPUT VISION, V108, P97, DOI 10.1007/s11263-014-0721-9; Weber TC, 2009, FOREST ECOL MANAG, V258, P2068, DOI 10.1016/j.foreco.2009.08.001; Wehr A, 1999, ISPRS J PHOTOGRAMM, V54, P68, DOI 10.1016/S0924-2716(99)00011-8; Wien TU, 2014, OPALS OR PROC AIRB L; World Bank, 2013, ICT DAT COLL MON EV; World Bank, REACH RUR POOR REN S; Zacharias P, 2012, GEOINFORMATIK 2012, P2012; Zandbergen PA, 2011, J NAVIGATION, V64, P381, DOI 10.1017/S0373463311000051; Zandbergen PA, 2009, T GIS, V13, P5, DOI 10.1111/j.1467-9671.2009.01152.x; Zarco-Tejada PJ, 2014, EUR J AGRON, V55, P89, DOI 10.1016/j.eja.2014.01.004	80	4	4	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0152839	10.1371/journal.pone.0152839	http://dx.doi.org/10.1371/journal.pone.0152839			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073917	gold, Green Published, Green Submitted			2022-12-27	WOS:000374131200039
J	Niranjani, G; Murugan, R				Niranjani, Gnanapragasam; Murugan, Rajamanickam			Theory on the Mechanism of DNA Renaturation: Stochastic Nucleation and Zipping	PLOS ONE			English	Article							HELIX-COIL TRANSITION; HYBRIDIZATION KINETICS; SECONDARY STRUCTURE; NUCLEIC-ACIDS; THERMODYNAMICS; DISPLACEMENT; DEPENDENCE; MODEL	Renaturation of the complementary single strands of DNA is one of the important processes that requires better understanding in the view of molecular biology and biological physics. Here we develop a stochastic dynamical model on the DNA renaturation. According to our model there are at least three steps in the renaturation process viz. nonspecific-contact formation, correct-contact formation and nucleation, and zipping. Most of the earlier two-state models combined nucleation with nonspecific-contact formation step. In our model we suggest that it is considerably meaningful when we combine the nucleation with the zipping since nucleation is the initial step of zipping and nucleated and zipping molecules are indistinguishable. Nonspecific contact formation step is a pure three-dimensional diffusion controlled collision process. Whereas nucleation involves several rounds of one-dimensional slithering and internal displacement dynamics of one single strand of DNA on the other complementary strand in the process of searching for the correct-contact and then initiate nucleation. Upon nucleation, the stochastic zipping follows to generate a fully renatured double stranded DNA. It seems that the square-root dependency of the overall renaturation rate constant on the length of reacting single strands originates mainly from the geometric constraints in the diffusion controlled nonspecific-contact formation step. Further the inverse scaling of the renaturation rate on the viscosity of reaction medium also originates from nonspecific contact formation step. On the other hand the inverse scaling of the renaturation rate with the sequence complexity originates from the stochastic zipping which involves several rounds of crossing over the free-energy barrier at microscopic levels. When the sequence of renaturing single strands of DNA is repetitive with less complexity then the cooperative effects will not be noticeable since the parallel zipping will be a dominant enhancing factor. However for DNA strands with high sequence complexity and length one needs to consider the underlying cooperative effects both at microscopic and macroscopic levels to explain various scaling behaviours of the overall renaturation rate.	[Niranjani, Gnanapragasam; Murugan, Rajamanickam] Indian Inst Technol Madras, Dept Biotechnol, Madras, Tamil Nadu, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras	Murugan, R (corresponding author), Indian Inst Technol Madras, Dept Biotechnol, Madras, Tamil Nadu, India.	rmurugan@gmail.com	Murugan, Rajamanickam/A-9700-2008	Murugan, Rajamanickam/0000-0002-5454-3540				Anderson MLM, 1999, NUCLEIC ACID HYBRIDI; Araque JC, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3568145; Bath J, 2007, NAT NANOTECHNOL, V2, P275, DOI 10.1038/nnano.2007.104; Benjamin L, 2000, GENES VII; Bloomfield VA, 1974, PHYSICAL CHEMISTRY O; Cantor C. R., 1980, BIOPHYSICAL CHEMISTR; Chen CL, 2007, NUCLEIC ACIDS RES, V35, P2875, DOI 10.1093/nar/gkm177; CRAIG ME, 1971, J MOL BIOL, V62, P383, DOI 10.1016/0022-2836(71)90434-7; DAVIDSON EH, 1975, CELL, V4, P217, DOI 10.1016/0092-8674(75)90170-1; de Gennes PG, 1979, SCALING CONCEPTS IN; Debye P., 1942, TRANS ELECTROCHEM SO, P265; DEGENNES PG, 1976, J PHYS-PARIS, V37, P1445, DOI 10.1051/jphys:0197600370120144500; Dirks RM, 2007, SIAM REV, V49, P65, DOI 10.1137/060651100; Gao Y, 2006, NUCLEIC ACIDS RES, V34, P3370, DOI 10.1093/nar/gkl422; Gardiner CW, 2002, HANDBOOK OF STOCHAST; Goldar A, 2004, EUR PHYS J E, V14, P211, DOI 10.1140/epje/i2004-10011-7; Lukacs GL, 2000, J BIOL CHEM, V275, P1625, DOI 10.1074/jbc.275.3.1625; MANNING GS, 1976, BIOPOLYMERS, V15, P1333, DOI 10.1002/bip.1976.360150709; MANNING GS, 1978, Q REV BIOPHYS, V11, P179, DOI 10.1017/S0033583500002031; MONTROLL EW, 1946, J CHEM PHYS, V14, P202, DOI 10.1063/1.1724118; MORRISON LE, 1993, BIOCHEMISTRY-US, V32, P3095, DOI 10.1021/bi00063a022; Murugan R, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.011901; Murugan R, 2003, BIOPHYS CHEM, V104, P535, DOI 10.1016/S0301-4622(03)00043-7; Murugan R, 2010, BIOPHYS J, V99, P353, DOI 10.1016/j.bpj.2010.04.026; Murugan R, 2002, BIOCHEM BIOPH RES CO, V293, P870, DOI 10.1016/S0006-291X(02)00305-4; Niu L, 2015, CHEM COMMUN, V51, P7717, DOI 10.1039/c5cc00783f; Ouldridge TE, 2013, NUCLEIC ACIDS RES, V41, P8886, DOI 10.1093/nar/gkt687; Pinheiro AV, 2011, NAT NANOTECHNOL, V6, P763, DOI [10.1038/nnano.2011.187, 10.1038/NNANO.2011.187]; PORSCHKE D, 1973, BIOPOLYMERS, V12, P1313, DOI 10.1002/bip.1973.360120609; PORSCHKE D, 1971, J MOL BIOL, V62, P361, DOI 10.1016/0022-2836(71)90433-5; Qian L, 2011, SCIENCE, V332, P1196, DOI 10.1126/science.1200520; RAU DC, 1975, J CHEM PHYS, V62, P2354, DOI 10.1063/1.430761; Risken H., 1996, FOKKER PLANK EQUATIO; Robertson RM, 2006, P NATL ACAD SCI USA, V103, P7310, DOI 10.1073/pnas.0601903103; Sambriski EJ, 2009, P NATL ACAD SCI USA, V106, P18125, DOI 10.1073/pnas.0904721106; Sambriski EJ, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/3/034105; Sambriski EJ, 2009, BIOPHYS J, V96, P1675, DOI 10.1016/j.bpj.2008.09.061; SantaLucia J, 2004, ANNU REV BIOPH BIOM, V33, P415, DOI 10.1146/annurev.biophys.32.110601.141800; Sikorav JL, 2009, J PHYS CHEM B, V113, P3715, DOI 10.1021/jp807096z; STUDIER FW, 1969, J MOL BIOL, V41, P199, DOI 10.1016/0022-2836(69)90385-4; Van Kampen N. G., 1994, STOCHASTIC PROCESSES; WATSON JD, 1953, NATURE, V171, P737, DOI 10.1038/171737a0; WETMUR JG, 1968, J MOL BIOL, V31, P349, DOI 10.1016/0022-2836(68)90414-2; Woodside MT, 2006, SCIENCE, V314, P1001, DOI 10.1126/science.1133601; Zhang DY, 2009, J AM CHEM SOC, V131, P17303, DOI 10.1021/ja906987s	45	5	5	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153172	10.1371/journal.pone.0153172	http://dx.doi.org/10.1371/journal.pone.0153172			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27074030	gold, Green Published, Green Submitted			2022-12-27	WOS:000374131200057
J	Rivera-Sylva, HE; Hedrick, BP; Dodson, P				Rivera-Sylva, Hector E.; Hedrick, Brandon P.; Dodson, Peter			A Centrosaurine (Dinosauria: Ceratopsia) from the Aguja Formation (Late Campanian) of Northern Coahuila, Mexico	PLOS ONE			English	Article							TRANS-PECOS TEXAS; WEST TEXAS; HADROSAURID DINOSAURIA; PHYLOGENETIC ANALYSIS; SOUTHERN COAHUILA; VERTEBRATE FAUNA; HORNED DINOSAURS; PARRAS BASIN; BIG-BEND; AGE	While centrosaurines and ceratopsids in general are abundant in the Late Campanian of northern Laramidia, they are much less commonly found in southern Laramidia. This has supported hypotheses of dinosaur provinciality and endemism in the Late Cretaceous with the delineation of at least two separate faunal zones, north and south Laramidia. There have been 12 genera of centrosaurines recognized from northern Laramidia while two genera, Diabloceratops and Nasutoceratops, have been named from southern Laramidia. We present an osteological description and taphonomic outline for a new centrosaurine ceratopsid from the Aguja Formation of northern Coahuila, Mexico that is not currently diagnosable to the generic level, but likely represents a new taxon. Further, we have included three-dimensional surface scans of all material attributed to this animal. Considering the large number of centrosaurines from northern Laramidia, it is likely that cladistic analyses are biased towards this faunal zone. New findings of southern centrosaurines are needed to correct this bias. This discovery expands the range of centrosaurines south to Coahuila, Mexico and adds new information to better characterize the morphology and taxonomy of centrosaurines from southern Laramidia and their evolution in comparison to their northern counterparts.	[Rivera-Sylva, Hector E.] Museo Desierto Carlos Abedrop Davila, Dept Paleontol, 3745 Parque Las Maravillas Saltillo, Saltillo 25022, Coahuila, Mexico; [Hedrick, Brandon P.; Dodson, Peter] Univ Penn, Dept Earth & Environm Sci, Philadelphia, PA 19104 USA; [Dodson, Peter] Univ Penn, Sch Vet Med, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Hedrick, BP (corresponding author), Univ Penn, Dept Earth & Environm Sci, Philadelphia, PA 19104 USA.	bphedrick1@gmail.com			University of Pennsylvania Paleobiology Stipend; Greg and Susan Walker Foundation; Consejo Estatal de Ciencia y Tecnologia (COECyT); Museo del Desierto	University of Pennsylvania Paleobiology Stipend; Greg and Susan Walker Foundation; Consejo Estatal de Ciencia y Tecnologia (COECyT); Museo del Desierto	The authors received funding support from Dr. Narayan Avadhani, the University of Pennsylvania Paleobiology Stipend, and the Greg and Susan Walker Foundation for collection and preparation of fossil material. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r We would like to thank Jorge A. Ortiz Mendieta, Ruben Guzman Gutierrez, and Homero Hernandez for help collecting material and Lorena Ahedo Percastegui, Yesica Rodriguez Salinas, and Abraham I. Oyervidez Salazar for preparing the material. We also thank the Consejo Estatal de Ciencia y Tecnologia (COECyT) and the Museo del Desierto for supporting this investigation with special thanks to the authorities of Ocampo for their kind assistance and support to the Coahuila Desert Dinosaur Project. This research would not be possible without helpful discussions with Sam Cordero (University of Pennsylvania), Andrew McDonald, Eric Morschhauser (Drexel University), Michael Ryan (Cleveland Museum of Natural History), and Phil Manning (University of Manchester). We thank the Willi Hennig Society for access to TNT. We thank Eric Lund for providing photos of comparative material. We also especially thank Jorge A. Ortiz Mendieta for contributing drawings for Fig 1. Finally, we thanks reviewers Michael Ryan and Mark Loewen and editor Andy Farke for their valuable reviews and comments.	Befus KS, 2008, J VOLCANOL GEOTH RES, V173, P245, DOI 10.1016/j.jvolgeores.2008.01.021; Breyer JA, 2007, J GEOL, V115, P243, DOI 10.1086/510640; Brinkman Donald, 2002, Journal of Vertebrate Paleontology, V22, p38A; Brochu CA, 1996, J VERTEBR PALEONTOL, V16, P49, DOI 10.1080/02724634.1996.10011283; Brown B, 1937, AM MUS NOVIT, V955, P1; DODSON P, 1993, AM J SCI, V293A, P200, DOI 10.2475/ajs.293.A.200; Dodson P., 1996, THE HORNED DINOSAURS; Dodson P, 2004, DINOSAURIA, 2ND EDITION, P494; Eberth DA, 2004, REV MEX CIENC GEOL, V21, P335; Eberth D, 2003, J VERTEBR PALEONTOL, V23, p47A; Edmund G., 1985, ROYAL ONTARIO MUSEUM, V1985, P35; Evans DC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130007; Farke AA, 2011, ACTA PALAEONTOL POL, V56, P691, DOI 10.4202/app.2010.0121; Gates TA, 2007, J VERTEBR PALEONTOL, V27, P917, DOI 10.1671/0272-4634(2007)27[917:VCANLH]2.0.CO;2; GIFFIN EB, 1990, PALEOBIOLOGY, V16, P448, DOI 10.1017/S0094837300010186; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Gonzales-Leon CM, 1995, SONORA GEOLOGIA DEL, V1, P20; Hatcher JB, 1907, MONOGRAPHS US GEOLOG, V49, P3; Heckert AB, 2003, NEUES JAHRB GEOL P-A, V227, P343; Hedrick B. P., 2014, GSA ABSTRACTS GRAMS, V46, P2; Kirkland J., 2000, SOC VERT PAL ANN M F, V3, P133; Kirkland James I., 2010, P117; Kirkland James I., 2006, BULLETIN OF THE NEW MEXICO MUSEUM OF NATURAL HISTORY AND SCIENCE, P299; Lambe LM., 1915, CANADA GEOLOGICAL SU, V12, P1; LANGSTON W, 1975, CAN J EARTH SCI, V12, P1576, DOI 10.1139/e75-142; Lehman T.M., 1982, THESIS; Lehman Thomas M., 2001, P310; Lehman TM, 2006, J VERTEBR PALEONTOL, V26, P922, DOI 10.1671/0272-4634(2006)26[922:FIUAFT]2.0.CO;2; Lehman Thomas M., 1997, P223; Loewen Mark A., 2013, P488; Loewen Mark A., 2010, P99; Longrich NR, 2010, CRETACEOUS RES, V31, P274, DOI 10.1016/j.cretres.2009.12.002; Maiorino L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081608; Maiorino L, 2013, J VERTEBR PALEONTOL, V33, P1385, DOI 10.1080/02724634.2013.779922; Marsh O.C., 1890, AM J SCI, V39, P418, DOI DOI 10.2475/AJS.S3-39.233.418; Marsh OC., 1888, AM J SCI, V36, P477, DOI [10.2475/ajs.s3-36.216.477, DOI 10.2475/AJS.S3-36.216.477.]; McDonald AT, 2010, NEW PERSPECTIVES ON, P156; McDonald AT, 2013, JOURNAL OF VERTE BRA, P174; MURRAY GE, 1960, J PALEONTOL, V34, P368; Owen R., 1842, REPORT BRIT ASS ADV, V9, P60; Penkalski P, 1999, J VERTEBR PALEONTOL, V19, P692, DOI 10.1080/02724634.1999.10011182; Prieto-Marquez A, 2012, HIST BIOL, V24, P607, DOI 10.1080/08912963.2012.671311; Rivera-Sylva HE, 2006, SOCIEDAD MEXICANA DE, V10, P129; Rivera-Sylva HE, 2012, B SOC GEOL MEX, V64, P155, DOI 10.18268/BSGM2012v64n1a11; Rivera-Sylva HE, 2011, REV MEX CIENC GEOL, V28, P267; Rivera-Sylva Héctor E., 2009, Bol. Soc. Geol. Mex, V61, P239; Roberts Eric M., 2013, P85; Rodriguez-de la Rosa Ruben A., 2004, Ichnos, V11, P27, DOI 10.1080/10420940490428841; Rowe T., 1992, Journal of Vertebrate Paleontology, V12, P472; Russell AP, CANADIAN J EARTH SCI, V42, P1369; Ryan MJ, 2007, J VERTEBR PALEONTOL, V27, P944, DOI 10.1671/0272-4634(2007)27[944:AROTLC]2.0.CO;2; Ryan MJ, 2007, J PALEONTOL, V81, P376, DOI 10.1666/0022-3360(2007)81[376:ANBCCF]2.0.CO;2; Ryan MJ, 2014, NATURWISSENSCHAFTEN, V101, P505, DOI 10.1007/s00114-014-1183-1; Ryan MJ, 2012, CAN J EARTH SCI, V49, P1251, DOI 10.1139/e2012-056; Sampson SD, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1186; Sampson Scott D., 2010, P405; Sampson SD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012292; Sampson SD, 1995, J VERTEBR PALEONTOL, V15, P743, DOI 10.1080/02724634.1995.10011259; Sankey JT, 2001, J PALEONTOL, V75, P208, DOI 10.1666/0022-3360(2001)075<0208:LCSDAF>2.0.CO;2; Seeley H.G., 1887, P R SOC LONDON, V43, P165, DOI [10.1098/rspl.1887.0117, DOI 10.1098/RSPL.1887.0117]; SERENO PC, 1986, NATL GEOGR RES, V2, P234; Silva-Barcenas A., 1969, PALEONTOLOGIA MEXICA, V28, P1; Sullivan Robert M., 2010, P169; Sullivan Robert M., 2006, Bulletin of the New Mexico Museum of Natural History and Science, P7; The MathWorks Inc, 2012, MATLAB STAT TOOLB RE; Wagner JR, 2009, J VERTEBR PALEONTOL, V29, P605, DOI 10.1671/039.029.0208; Weidie A. E, 1972, GULF COAST ASS GEOLO, V22, P323; Wick SL, 2013, NATURWISSENSCHAFTEN, V100, P667, DOI 10.1007/s00114-013-1063-0; Williamson T.E., 1997, NEW MEXICO MUSEUM NA, V11, P51	69	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0150529	10.1371/journal.pone.0150529	http://dx.doi.org/10.1371/journal.pone.0150529			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073969	Green Published, gold, Green Submitted			2022-12-27	WOS:000374131200004
J	Bizhang, M; Riemer, K; Arnold, WH; Domin, J; Zimmer, S				Bizhang, Mozhgan; Riemer, Katharina; Arnold, Wolfgang H.; Domin, Julia; Zimmer, Stefan			Influence of Bristle Stiffness of Manual Toothbrushes on Eroded and Sound Human Dentin - An In Vitro Study	PLOS ONE			English	Article							ELECTRIC TOOTHBRUSHES; DIFFERENT ABRASIVITY; FILAMENT DIAMETER; PLAQUE REMOVAL; HUMAN ENAMEL; TOOTH WEAR; FORCE; HYPERSENSITIVITY; DENTIFRICE; EFFICACY	Aim The aim of this study was to determine the influence of manual toothbrushes with different bristle stiffness on the abrasivity on eroded and sound human dentin. Materials and Methods Dentin specimens were made from impacted third molars and attributed to three groups: erosion-abrasion (EA), abrasion (A) and erosion (E). The specimens from EA and E were treated with 1% citric acid (pH 2.3) for 1 min rinsed, and neutralized with artificial saliva for 15 min. This cycle was repeated five times. Thereafter, specimens from EA and A were treated with three toothbrushes types with different bristle stiffness (soft, medium, and hard) in a custom-made toothbrushing machine. The brushing was performed at a load of 3 N with a toothpaste slurry for 630 s. This procedure was repeated five times, in group EA after each erosion cycle. EA and A groups passed through five cycles with a total of 6300 strokes. The abrasivity was analyzed by contact-free profilometry. Kruskal-Wallis and Mann-Whitney U tests were performed for statistical analysis. Results With respect to bristle stiffness there was no statistically significant difference in dentin loss within the EA group. In group A, a statistically significantly higher dentin loss was found for the soft in comparison to the hard bristles. No statistically significant differences were measured between soft/medium and medium/hard toothbrushes. The amount of dentin loss from specimens in the EA group was significantly higher than in the A group. Conclusions Within the limitations of this study, the dentin loss in the Abrasion group was higher with soft bristles than with hard ones. This result might have an influence on the toothbrush recommendations for patients with non-carious cervical lesions.	[Bizhang, Mozhgan; Riemer, Katharina; Domin, Julia; Zimmer, Stefan] Univ Witten Herdecke, Dept Operat & Prevent Dent, Witten, Germany; [Arnold, Wolfgang H.] Univ Witten Herdecke, Dept Biol & Mat Sci Dent, Witten, Germany	Witten Herdecke University; Witten Herdecke University	Bizhang, M (corresponding author), Univ Witten Herdecke, Dept Operat & Prevent Dent, Witten, Germany.	mozhgan.bizhang@uni-wh.de						ABSI EG, 1995, J ORAL REHABIL, V22, P175, DOI 10.1111/j.1365-2842.1995.tb01561.x; Addy M, 2005, INT DENT J, V55, P261; Boyd RL, 1997, J CLIN DENT, V8, P72; Creeth Jonathan E, 2009, J Dent Hyg, V83, P111; Dyer D, 2000, J CLIN PERIODONTOL, V27, P99, DOI 10.1034/j.1600-051x.2000.027002099.x; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; FRALEIGH CM, 1967, J DENT RES, V46, P209, DOI 10.1177/00220345670460011201; Ganss C, 2000, ARCH ORAL BIOL, V45, P897, DOI 10.1016/S0003-9969(00)00041-8; Ganss C, 2009, CLIN ORAL INVEST, V13, P203, DOI 10.1007/s00784-008-0230-8; Ganss C, 2009, EUR J ORAL SCI, V117, P255, DOI 10.1111/j.1600-0722.2009.00617.x; Grippo JO, 2004, J AM DENT ASSOC, V135, P1109, DOI 10.14219/jada.archive.2004.0369; Hara AT, 2009, J DENT, V37, P781, DOI 10.1016/j.jdent.2009.06.006; HARRINGTON JH, 1964, J AM DENT ASSOC, V68, P343, DOI 10.14219/jada.archive.1964.0099; Hayasaki H, 2014, JPN DENT SCI REV, V50, P69, DOI 10.1016/j.jdsr.2014.04.001; Hooper S, 2003, J CLIN PERIODONTOL, V30, P802, DOI 10.1034/j.1600-051X.2003.00367.x; Hooper SM, 2007, J DENT, V35, P476, DOI 10.1016/j.jdent.2007.01.003; Hunter M.L., 2000, TOOTH WEAR SENSITIVI, P161; Joiner A, 2008, J DENT, V36, pS32, DOI 10.1016/j.jdent.2008.02.003; KLIMEK J, 1982, DEUT ZAHNAERZTL Z, V37, P836; MANLY RS, 1966, J DENT RES, V45, P1822, DOI 10.1177/00220345660450064601; MIERAU HD, 1984, DEUT ZAHNAERZTL Z, V39, P634; Milosevic A, 2002, BR DENT J, V192, P514; Moore C, 2005, J CLIN PERIODONTOL, V32, P1242, DOI 10.1111/j.1600-051X.2005.00857.x; ROBERTSO.NA, 1972, J PERIODONTAL RES, V7, P346, DOI 10.1111/j.1600-0765.1972.tb01725.x; Sabrah AHA, 2013, WEAR, V306, P73, DOI 10.1016/j.wear.2013.07.001; Sancakli HS, 2015, AUST DENT J, V60, P38, DOI 10.1111/adj.12271; Turssi CP, 2008, J MATER SCI-MATER M, V19, P47, DOI 10.1007/s10856-007-3140-4; Turssi CP, 2005, AM J DENT, V18, P251; Turssi CP, 2004, CARIES RES, V38, P473, DOI 10.1159/000079629; van der Weijden GA, 1998, J CLIN PERIODONTOL, V25, P413; Van't Spijker A, 2009, INT J PROSTHODONT, V22, P35; VanderWeijden FA, 1996, AM J DENT, V9, pS31; vanderWeijden GA, 1996, J CLIN PERIODONTOL, V23, P724; Versteeg P A, 2008, Int J Dent Hyg, V6, P166, DOI 10.1111/j.1601-5037.2008.00298.x; VOLK W, 1987, DEUT ZAHNAERZTL Z, V42, P499; Voronets J, 2008, CARIES RES, V42, P286, DOI 10.1159/000148160; West NX, 2008, PERIODONTOL 2000, V48, P31, DOI 10.1111/j.1600-0757.2008.00262.x; Wiegand A, 2006, J PERIODONTAL RES, V41, P221, DOI 10.1111/j.1600-0765.2005.00850.x; Wiegand A, 2006, CARIES RES, V40, P60, DOI 10.1159/000088908; Wiegand A, 2008, ACTA ODONTOL SCAND, V66, P231, DOI 10.1080/00016350802195041; Wiegand A, 2009, J DENT, V37, P480, DOI 10.1016/j.jdent.2009.03.005; Zero DT, 2000, TOOTH WEAR SENSITIVI, P121; Zilinskas J, 2013, MED SCI MONITOR, V19, P1142, DOI 10.12659/MSM.889568; Zimmer S, 2011, J PERIODONTOL, V82, P267, DOI 10.1902/jop.2010.100328	44	23	23	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0153250	10.1371/journal.pone.0153250	http://dx.doi.org/10.1371/journal.pone.0153250			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27070901	Green Published, gold, Green Submitted			2022-12-27	WOS:000373900700040
J	Frank, CL; Ingala, MR; Ravenelle, RE; Dougherty-Howard, K; Wicks, SO; Herzog, C; Rudd, RJ				Frank, Craig L.; Ingala, Melissa R.; Ravenelle, Rebecca E.; Dougherty-Howard, Kelsey; Wicks, Samuel O.; Herzog, Carl; Rudd, Robert J.			The Effects of Cutaneous Fatty Acids on the Growth of Pseudogymnoascus destructans, the Etiological Agent of White-Nose Syndrome (WNS)	PLOS ONE			English	Article							BAT; LIPIDS; PATHOGEN; TISSUES; SURFACE; MASS	White Nose Syndrome (WNS) greatly increases the over-winter mortality of little brown (Myotis lucifugus), Indiana (Myotis sodalis), northern (Myotis septentrionalis), and tricolored (Perimyotis subflavus) bats. It is caused by a cutaneous infection with the fungus Pseudogymnoascus destructans (Pd). Big brown bats (Eptesicus fuscus) are much more resistant to cutaneous infection with Pd, however. We thus conducted analyses of wing epidermis from hibernating E. fuscus and M. lucifugus to determine their fatty acid compositions, and laboratory Pd culture experiments at 4.0-13.4 degrees C to determine the effects of these fatty acids on Pd growth. Our analyses revealed that the epidermis of both bat species contain the same 7 fatty acid types (14:0, 15:0, 16:0. 16:1, 18:0, 18:1, & 18:2), but the epidermis of M. lucifugus contains:a) more stearic (18:0) acid, b) less palmitoleic (16:1) acid, c) less myristic (14:0) acid, and, d) less oleic (18:1) acid than that of E. fuscus. The growth of Pd was inhibited by:a) myristic and stearic acids at 10.5-13.4 degrees C, but not at 4.0-5.0 degrees C, b) oleic acid at 5.0-10.6 degrees C, c) palmitoleic acid, and, d) linoleic (18:2) acid at 5.0-10.6 degrees C. One set of factors that enables E. fuscus to better resist cutaneous P. destructans infections (and thus WNS) therefore appears to be the relatively higher myristic, palmitoleic, and oleic acid contents of the epidermis.	[Frank, Craig L.; Ravenelle, Rebecca E.] Fordham Univ, Dept Biol Sci, Louis Calder Ctr, POB 887, Armonk, NY 10504 USA; [Ingala, Melissa R.; Dougherty-Howard, Kelsey; Wicks, Samuel O.] Fordham Univ, Environm Sci Program, LH 400, Bronx, NY 10458 USA; [Herzog, Carl] New York State Dept Environm Conservat, 625 Broadway, Albany, NY 12233 USA; [Rudd, Robert J.] New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12201 USA	Fordham University; Fordham University; State University of New York (SUNY) System; Wadsworth Center	Frank, CL (corresponding author), Fordham Univ, Dept Biol Sci, Louis Calder Ctr, POB 887, Armonk, NY 10504 USA.	frank@fordham.edu	Frank, Craig/AFQ-3761-2022	Frank, Craig/0000-0002-4340-4422; Ingala, Melissa/0000-0002-9866-5646	National Science Foundation [IOS-0818222]	National Science Foundation(National Science Foundation (NSF))	Funded by National Science Foundation (www.nsf.gov) IOS-0818222.	Alteri C, 2009, FOOD SCI TECHNOLOGY, V44, P242; Blehert DS, 2009, SCIENCE, V323, P227, DOI 10.1126/science.1163874; BRACK V, 1985, J MAMMAL, V66, P308, DOI 10.2307/1381243; BUCKNER JS, 1993, INSECT LIPIDS: CHEMISTRY, BIOCHEMISTRY AND BIOLOGY, P227; Camera E, 2010, J LIPID RES, V51, P3377, DOI 10.1194/jlr.D008391; Chaturvedi V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010783; Christie WW., 1992, ADV LIPID METHODOLOG; Dark J, 2005, ANNU REV NUTR, V25, P469, DOI 10.1146/annurev.nutr.25.050304.092514; DOBUSH GR, 1985, CAN J ZOOL, V63, P1917, DOI 10.1139/z85-285; Drake DR, 2008, J LIPID RES, V49, P4, DOI 10.1194/jlr.R700016-JLR200; Evans E, 1999, MICROBIOLOGY ACTION; Feingold KR, 2007, J LIPID RES, V48, P2531, DOI 10.1194/jlr.R700013-JLR200; Feldhamer GA, 2007, MAMMALOGY ADAPTATION; FOLCH J, 1957, J BIOL CHEM, V226, P497; Frank CL, 2002, J MAMMAL, V83, P1013, DOI 10.1644/1545-1542(2002)083&lt;1013:STVIDF&gt;2.0.CO;2; Frank CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113958; Frank Craig L., 2012, P271; Gargas A, 2009, MYCOTAXON, V108, P147, DOI 10.5248/108.147; Geiser F, 2004, ANNU REV PHYSIOL, V66, P239, DOI 10.1146/annurev.physiol.66.032102.115105; Gunstone F.D., 1996, FATTY ACID LIPID CHE; Haugen M, 2003, PHYSIOL BIOCHEM ZOOL, V76, P907, DOI 10.1086/380213; Karpovich SA, 2009, J COMP PHYSIOL B, V179, P691, DOI 10.1007/s00360-009-0350-8; Kayser C, 1965, PHYSL MAMMALOGY, P180; Kellner Amanda M.E., 2005, Northwestern Naturalist, V86, P45, DOI 10.1898/1051-1733(2005)086[0045:DOBICR]2.0.CO;2; Kunz TH, 1998, ECOSCIENCE, V5, P8, DOI 10.1080/11956860.1998.11682443; KUNZ TH, 1974, ECOLOGY, V55, P693, DOI 10.2307/1934408; Langwig KE, 2015, EMERG INFECT DIS, V21, P1023, DOI 10.3201/eid2106.150123; LAW SLS, 1995, COMP BIOCHEM PHYS B, V110, P511; Lorch JM, 2011, NATURE, V480, P376, DOI 10.1038/nature10590; Pannkuk EL, 2014, LIPIDS, V49, P1143, DOI 10.1007/s11745-014-3951-2; Pannkuk EL, 2013, CHEM BIODIVERS, V10, P2122, DOI 10.1002/cbdv.201300319; Park M, 2013, MYCOBIOLOGY, V41, P67, DOI 10.5941/MYCO.2013.41.2.67; Pohl C.H., 2011, SCI MICROBIAL PATHOG, V3, P61; Puechmaille SJ, 2010, EMERG INFECT DIS, V16, P290, DOI 10.3201/eid1602.091391; Reeder DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038920; Reinoso RF, 1997, J PHARMACOL TOXICOL, V38, P87, DOI 10.1016/S1056-8719(97)00053-1; Reynolds DS, 2000, ECOSCIENCE, V7, P10; Reynolds HT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086437; Smith KR, 2008, J LIPID RES, V49, P271, DOI 10.1194/jlr.R700015-JLR200; Thomas DW, 1995, SYM ZOOL S, P233; Urich K., 1994, COMP ANIMAL BIOCH; Verant ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046280; Warnecke L, 2012, P NATL ACAD SCI USA, V109, P6999, DOI 10.1073/pnas.1200374109; Wibbelt G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074105; Wibbelt G, 2010, EMERG INFECT DIS, V16, P1237, DOI 10.3201/eid1608.100002	45	16	17	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0153535	10.1371/journal.pone.0153535	http://dx.doi.org/10.1371/journal.pone.0153535			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27070905	Green Submitted, Green Published, gold			2022-12-27	WOS:000373900700080
J	Sato, A; Omi, T; Yamamoto, A; Satake, A; Hiramoto, A; Masutani, M; Tanuma, S; Wataya, Y; Kim, HS				Sato, Akira; Omi, Takuya; Yamamoto, Akihiro; Satake, Akito; Hiramoto, Akiko; Masutani, Mitsuko; Tanuma, Sei-ichi; Wataya, Yusuke; Kim, Hye-Sook			MicroRNA-351 Regulates Two-Types of Cell Death, Necrosis and Apoptosis, Induced by 5-fluoro-2'-deoxyuridine	PLOS ONE			English	Article							DEOXYRIBONUCLEOSIDE-TRIPHOSPHATE IMBALANCE; DOUBLE STRAND BREAKS; MOUSE FM3A CELLS; DNTP IMBALANCE; MESSENGER-RNAS; LAMIN B1; MECHANISM; 5-FLUORO-2'-DEOXYURIDINE; MODULATION; PROLIFERATION	Cell-death can be necrosis and apoptosis. We are investigating the mechanisms regulating the cell death that occurs on treatment of mouse cancer cell-line FM3A with antitumor 5-fluoro-2'-deoxyuridine (FUdR): necrosis occurs for the original clone F28-7, and apoptosis for its variant F28-7-A. Here we report that a microRNA (miR-351) regulates the cell death pattern. The miR-351 is expressed strongly in F28-7-A but only weakly in F28-7. Induction of a higher expression of miR-351 in F28-7 by transfecting an miRNA mimic into F28-7 resulted in a change of the death mode; necrosis to apoptosis. Furthermore, transfection of an miR-351 inhibitor into F28-7-A resulted in the morphology change, apoptosis to necrosis, in this death-by-FUdR. Possible mechanism involving lamin B1 in this miR-351's regulatory action is discussed.	[Sato, Akira; Tanuma, Sei-ichi] Tokyo Univ Sci, Fac Pharmaceut Sci, Dept Biochem, Noda, Chiba 278, Japan; [Sato, Akira; Masutani, Mitsuko] Natl Canc Ctr, Div Genome Stabil Res, Chuo Ku, Tokyo, Japan; [Sato, Akira; Masutani, Mitsuko] Natl Canc Ctr, Div Chemotherapy & Clin Res, Chuo Ku, Tokyo, Japan; [Sato, Akira; Omi, Takuya; Yamamoto, Akihiro; Satake, Akito; Hiramoto, Akiko; Wataya, Yusuke; Kim, Hye-Sook] Okayama Univ, Fac Pharmaceut Sci, Dept Drug Informat, Kita Ku, Okayama 700, Japan; [Masutani, Mitsuko] Nagasaki Univ, Grad Sch Biomed Sci, Dept Frontier Life Sci, Nagasaki 852, Japan	Tokyo University of Science; National Cancer Center - Japan; National Cancer Center - Japan; Okayama University; Nagasaki University	Sato, A (corresponding author), Tokyo Univ Sci, Fac Pharmaceut Sci, Dept Biochem, Noda, Chiba 278, Japan.; Sato, A (corresponding author), Natl Canc Ctr, Div Genome Stabil Res, Chuo Ku, Tokyo, Japan.; Sato, A (corresponding author), Natl Canc Ctr, Div Chemotherapy & Clin Res, Chuo Ku, Tokyo, Japan.; Sato, A (corresponding author), Okayama Univ, Fac Pharmaceut Sci, Dept Drug Informat, Kita Ku, Okayama 700, Japan.	akirasat@rs.tus.ac.jp		Sato, Akira/0000-0002-2239-6208	JSPS KAKENHI Grant [21790078, 24790216, 26460310]	JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Funding provided by JSPS KAKENHI Grant Numbers 21790078 (AS (first author)), 24790216 (AS (first author)), and 26460310 (AS (first author)).	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Barde I, 2013, SCIENCE, V340, P350, DOI 10.1126/science.1232398; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BESTWICK RK, 1982, J BIOL CHEM, V257, P9300; Butin-Israeli V, 2015, MOL CELL BIOL, V35, P884, DOI 10.1128/MCB.01145-14; Chen YX, 2012, PHYSIOL GENOMICS, V44, P1042, DOI 10.1152/physiolgenomics.00052.2012; Curbo S, 2004, NUCLEOS NUCLEOT NUCL, V23, P1495, DOI 10.1081/NCN-200027709; Fiers W, 1999, ONCOGENE, V18, P7719, DOI 10.1038/sj.onc.1203249; Galluzzi L, 2015, CELL DEATH DIFFER, V22, P58, DOI 10.1038/cdd.2014.137; Galluzzi L, 2012, CELL DEATH DIFFER, V19, P107, DOI 10.1038/cdd.2011.96; Gefen N, 2010, LEUKEMIA, V24, P89, DOI 10.1038/leu.2009.208; Hermeking H, 2010, CELL DEATH DIFFER, V17, P193, DOI 10.1038/cdd.2009.56; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Kakutani T, 1998, BIOCHEM BIOPH RES CO, V247, P773, DOI 10.1006/bbrc.1998.8797; Kakutani T, 1998, NUCLEOS NUCLEOT NUCL, V17, P1299, DOI 10.1080/07328319808003468; Kawahara A, 1998, GENES CELLS, V3, P297, DOI 10.1046/j.1365-2443.1998.00189.x; Lee I, 2009, GENOME RES, V19, P1175, DOI 10.1101/gr.089367.108; Li X, 2012, RNA BIOL, V9, P292, DOI 10.4161/rna.19100; Lytle JR, 2007, P NATL ACAD SCI USA, V104, P9667, DOI 10.1073/pnas.0703820104; Mor E, 2011, NUCLEIC ACIDS RES, V39, P3710, DOI 10.1093/nar/gkq1325; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Oom AL, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/959461; Orom UA, 2008, MOL CELL, V30, P460, DOI 10.1016/j.molcel.2008.05.001; Pedersen IM, 2007, NATURE, V449, P919, DOI 10.1038/nature06205; Price C, 2014, GENES DIS, V1, P53, DOI 10.1016/j.gendis.2014.06.004; Saetrom P, 2009, CANCER RES, V69, P7459, DOI 10.1158/0008-5472.CAN-09-1201; Sato A, 2008, GENOMICS, V92, P9, DOI 10.1016/j.ygeno.2008.02.002; Sato A, 2008, NUCLEOS NUCLEOT NUCL, V27, P433, DOI 10.1080/15257770802086864; Sato A, 2014, FEBS J, V281, P1892, DOI 10.1111/febs.12752; Sato A, 2010, J PROTEOME RES, V9, P2329, DOI 10.1021/pr9010537; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Shenoy A, 2014, NAT REV MOL CELL BIO, V15, P565, DOI 10.1038/nrm3854; Shirai H, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.133; Sun YM, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-6; Tang CW, 2008, J CELL SCI, V121, P1014, DOI 10.1242/jcs.020982; Thomas RL, 2013, CIRC J, V77, P2449, DOI 10.1253/circj.CJ-13-0835; Tili E, 2007, J IMMUNOL, V179, P5082, DOI 10.4049/jimmunol.179.8.5082; Xu PZ, 2004, TRENDS GENET, V20, P617, DOI 10.1016/j.tig.2004.09.010; YOSHIOKA A, 1987, BIOCHEM BIOPH RES CO, V146, P258, DOI 10.1016/0006-291X(87)90719-4; YOSHIOKA A, 1987, J BIOL CHEM, V262, P8235	41	17	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0153130	10.1371/journal.pone.0153130	http://dx.doi.org/10.1371/journal.pone.0153130			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27071035	Green Published, Green Submitted, gold			2022-12-27	WOS:000373900700033
J	Sun, J; Zhang, J; Lu, JL; Gao, J; Ren, XY; Teng, LH; Duan, HL; Lin, YS; Li, XY; Zhang, B; Liang, ZY				Sun, Jian; Zhang, Jing; Lu, Junliang; Gao, Jie; Ren, Xinyu; Teng, Lianghong; Duan, Huanli; Lin, Yansong; Li, Xiaoyi; Zhang, Bo; Liang, Zhiyong			BRAF V600E and TERT Promoter Mutations in Papillary Thyroid Carcinoma in Chinese Patients	PLOS ONE			English	Article							ASSOCIATION; CANCER; AGE	Background The BRAF V600E and telomerase reverse transcriptase (TERT) promoter mutations have been reported in papillary thyroid carcinoma (PTC). The aim of this retrospective cross-sectional study was to add further information regarding the prevalence of the BRAF V600E and TERT promoter mutations in Chinese PTC and their clinicopathological associations. Methods We detected the BRAF V600E mutation and TERT promoter mutations in 455 Chinese PTC patients and analyzed the association of these mutations with several clinicopathological features. Results The BRAF V600E mutation was detected in 343 (75.4%) of 455 cases and was significantly associated with older age (p<0.001) and conventional subtype (p = 0.003). TERT promoter mutations were detected in 19 (4.4%) of 434 PTCs and were associated with older age (p<0.001), larger tumor size (p = 0.024), and advanced TNM stage(p<0.001). Of the 19 patients that were positive for TERT promoter mutations, 18 (94.7%) also harbored the BRAF V600E mutation. Conclusion We determined the prevalence and clinicopathological associations of BRAF V600E and TERT promoter mutations in Chinese PTC patients. TERT promoter mutations but not the BRAF V600E mutation were associated with more advanced TNM stage upon diagnosis.	[Sun, Jian; Zhang, Jing; Lu, Junliang; Gao, Jie; Ren, Xinyu; Duan, Huanli; Liang, Zhiyong] Chinese Acad Med Sci, Dept Pathol, Beijing 100730, Peoples R China; [Sun, Jian; Zhang, Jing; Lu, Junliang; Gao, Jie; Ren, Xinyu; Duan, Huanli; Lin, Yansong; Li, Xiaoyi; Zhang, Bo; Liang, Zhiyong] Peking Union Med Coll Hosp, Beijing, Peoples R China; [Teng, Lianghong] Capital Med Univ, Xuanwu Hosp, Dept Pathol, Beijing, Peoples R China; [Lin, Yansong] Chinese Acad Med Sci, Dept Nucl Med, Beijing 100730, Peoples R China; [Li, Xiaoyi] Chinese Acad Med Sci, Dept Surg, Beijing 100730, Peoples R China; [Zhang, Bo] Chinese Acad Med Sci, Dept Ultrasound, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Capital Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College	Liang, ZY (corresponding author), Chinese Acad Med Sci, Dept Pathol, Beijing 100730, Peoples R China.; Liang, ZY (corresponding author), Peking Union Med Coll Hosp, Beijing, Peoples R China.	liangzhiyong1220@yahoo.com		Sun, Jian/0000-0003-4997-2604; LU, JUNLIANG/0000-0002-3118-2025	Beijing Key Laboratory of Head and Neck Molecular Diagnostic Pathology	Beijing Key Laboratory of Head and Neck Molecular Diagnostic Pathology	The present study was funded by Beijing Key Laboratory of Head and Neck Molecular Diagnostic Pathology. The funder does not have a website. The funder had no role in study design, date collection and analysis, decision to publish, or preparation of the manuscript.	Blasco MA, 2005, NAT REV GENET, V6, P611, DOI 10.1038/nrg1656; Caronia LM, 2011, CLIN CANCER RES, V17, P7511, DOI 10.1158/1078-0432.CCR-11-1155; Dean D S, 2000, Cancer Control, V7, P229; Edge Stephen DRB, 2010, AJCC CANC STAGING MA, VXV; Ellison G, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-132; Fugazzola L, 2004, CLIN ENDOCRINOL, V61, P239, DOI 10.1111/j.1365-2265.2004.02089.x; Gandolfi G, 2015, EUR J ENDOCRINOL, V172, P403, DOI 10.1530/EJE-14-0837; George JR, 2015, J CLIN ENDOCRINOLOGY; Howell GM, 2011, ANN SURG ONCOL, V18, P3566, DOI 10.1245/s10434-011-1781-5; Huang TG, 2013, BIOMARK RES, V1, DOI 10.1186/2050-7771-1-3; Hughes DT, 2011, THYROID, V21, P231, DOI 10.1089/thy.2010.0137; Killela PJ, 2013, P NATL ACAD SCI USA, V110, P6021, DOI 10.1073/pnas.1303607110; Lakshmanan A, 2015, ONCOTARGET, V6, P31792, DOI 10.18632/oncotarget.5172; Lee JH, 2007, CANCER-AM CANCER SOC, V110, P38, DOI 10.1002/cncr.22754; Li C, 2012, J CLIN ENDOCR METAB, V97, P4559, DOI 10.1210/jc.2012-2104; Liu XL, 2014, J CLIN ENDOCR METAB, V99, pE1130, DOI 10.1210/jc.2013-4048; Liu XL, 2013, ENDOCR-RELAT CANCER, V20, P603, DOI 10.1530/ERC-13-0210; Liu XL, 2013, CELL CYCLE, V12, P1637, DOI 10.4161/cc.24662; Melo M, 2014, J CLIN ENDOCR METAB, V99, pE754, DOI 10.1210/jc.2013-3734; Pellegriti G, 2013, J CANCER EPIDEMIOL, V2013, DOI 10.1155/2013/965212; Shi XG, 2015, J CLIN ENDOCR METAB, V100, pE632, DOI 10.1210/jc.2014-3606; Trovisco V, 2005, VIRCHOWS ARCH, V446, P589, DOI 10.1007/s00428-005-1236-0; Xing MZ, 2014, J CLIN ONCOL, V32, P2718, DOI 10.1200/JCO.2014.55.5094; Xing MZ, 2013, JAMA-J AM MED ASSOC, V309, P1493, DOI 10.1001/jama.2013.3190	24	36	39	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2016	11	4							e0153319	10.1371/journal.pone.0153319	http://dx.doi.org/10.1371/journal.pone.0153319			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0KH	27064992	gold, Green Submitted, Green Published			2022-12-27	WOS:000373891000045
J	Zhang, WJ; Le, TD; Liu, L; Zhou, ZH; Li, JY				Zhang, Weijia; Thuc Duy Le; Liu, Lin; Zhou, Zhi-Hua; Li, Jiuyong			Predicting miRNA Targets by Integrating Gene Regulatory Knowledge with Expression Profiles	PLOS ONE			English	Article							BAYESIAN NETWORKS; MICRORNA REGULATION; ALGORITHM	Motivation microRNAs (miRNAs) play crucial roles in post-transcriptional gene regulation of both plants and mammals, and dysfunctions of miRNAs are often associated with tumorigenesis and development through the effects on their target messenger RNAs (mRNAs). Identifying miRNA functions is critical for understanding cancer mechanisms and determining the efficacy of drugs. Computational methods analyzing high-throughput data offer great assistance in understanding the diverse and complex relationships between miRNAs and mRNAs. However, most of the existing methods do not fully utilise the available knowledge in biology to reduce the uncertainty in the modeling process. Therefore it is desirable to develop a method that can seamlessly integrate existing biological knowledge and high-throughput data into the process of discovering miRNA regulation mechanisms. Results In this article we present an integrative framework, CIDER (Causal miRNA target Discovery with Expression profile and Regulatory knowledge), to predict miRNA targets. CIDER is able to utilise a variety of gene regulation knowledge, including transcriptional and post-transcriptional knowledge, and to exploit gene expression data for the discovery of miRNA-mRNA regulatory relationships. The benefits of our framework is demonstrated by both simulation study and the analysis of the epithelial-to-mesenchymal transition (EMT) and the breast cancer (BRCA) datasets. Our results reveal that even a limited amount of either Transcription Factor (TF)-miRNA or miRNA-mRNA regulatory knowledge improves the performance of miRNA target prediction, and the combination of the two types of knowledge enhances the improvement further. Another useful property of the framework is that its performance increases monotonically with the increase of regulatory knowledge.	[Zhang, Weijia; Thuc Duy Le; Liu, Lin; Li, Jiuyong] Univ S Australia, Sch Informat Technol & Math Sci, Adelaide, SA 5001, Australia; [Zhou, Zhi-Hua] Nanjing Univ, Natl Key Labotorary, Nanjing 210008, Jiangsu, Peoples R China	University of South Australia; Nanjing University	Li, JY (corresponding author), Univ S Australia, Sch Informat Technol & Math Sci, Adelaide, SA 5001, Australia.	jiuyong.li@unisa.edu.au	Liu, Lin/ABD-1224-2020; Li, Jiuyong/AAY-2706-2020; Le, Thuc Duy D/G-8444-2019; Li, Jiuyong/A-8134-2008	Liu, Lin/0000-0003-2843-5738; Li, Jiuyong/0000-0002-9023-1878; Le, Thuc Duy D/0000-0002-9732-4313; Li, Jiuyong/0000-0002-9023-1878; Zhang, Weijia/0000-0001-8103-5325	Australian Research Council [DP130104090]	Australian Research Council(Australian Research Council)	This work is supported by Australian Research Council Discovery Project DP130104090 (in part). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An O, 2014, DATABASE-OXFORD, DOI 10.1093/database/bau015; Chen CY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S1-S41; Chickering DM, 2004, J MACH LEARN RES, V5, P1287; Chu TJ, 2015, BIOINFORMATICS, V31, P1780, DOI 10.1093/bioinformatics/btv038; Colombo D, 2014, J MACH LEARN RES, V15, P3741; Cui QH, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100089; De Bie T, 2007, BIOINFORMATICS, V23, pI125, DOI 10.1093/bioinformatics/btm187; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fisher R., 1971, DESIGN EXPT; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; HECKERMAN D, 1995, MACH LEARN, V20, P197, DOI 10.1007/BF00994016; Hsu SD, 2014, NUCLEIC ACIDS RES, V42, pD78, DOI 10.1093/nar/gkt1266; Huang GT, 2011, NUCLEIC ACIDS RES, V39, pW416, DOI 10.1093/nar/gkr276; Huang JC, 2007, NAT METHODS, V4, P1045, DOI 10.1038/nmeth1130; Jin P, 2004, NAT NEUROSCI, V7, P113, DOI 10.1038/nn1174; Kalisch M, 2007, J MACH LEARN RES, V8, P613; Khan AA, 2009, NAT BIOTECHNOL, V27, P549, DOI 10.1038/nbt.1543; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Lauritzen S.L.., 1996, GRAPHICAL MODELS; Le TD, 2014, BRIEF BIOINFORM, P1; Le TD, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-92; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li Y, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku182; Liu B, 2014, BRIEF BIOINFORM, V15, P1, DOI 10.1093/bib/bbs075; Liu B, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-408; Liu H, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S3-S12; Lu M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003420; Lu YM, 2011, BIOINFORMATICS, V27, P2406, DOI 10.1093/bioinformatics/btr410; Luo M, 2010, CANCER LETT, V289, P127, DOI 10.1016/j.canlet.2009.07.005; Maathuis MH, 2009, ANN STAT, V37, P3133, DOI 10.1214/09-AOS685; Mercatelli N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004029; Moqadam FA, 2013, LEUKEMIA, V27, P16, DOI 10.1038/leu.2012.179; Pearl J, 2009, CAUSALITY MODELS REA, DOI DOI 10.1017/CBO9780511803161; Prill RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009202; Riaz M, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3415; Service RF, 2013, SCIENCE, V342, P186, DOI 10.1126/science.342.6155.186; Smyth G, 2005, LIMMA LINEAR MODELS; Sokilde R, 2011, MOL CANCER THER, V10, P375, DOI 10.1158/1535-7163.MCT-10-0605; Spirtes P., 2000, CAUSATION PREDICTION; Tai F, 2007, BIOINFORMATICS, V23, P1775, DOI 10.1093/bioinformatics/btm234; Le TD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131627; Le TD, 2013, BIOINFORMATICS, V29, P765, DOI 10.1093/bioinformatics/btt048; Tian Z, 2009, BIOINFORMATICS, V25, P2831, DOI 10.1093/bioinformatics/btp467; Vlachos IS, 2015, NUCLEIC ACIDS RES, V43, pD153, DOI 10.1093/nar/gku1215; Wang J, 2010, NUCLEIC ACIDS RES, V38, pD119, DOI 10.1093/nar/gkp803; Wang ZX, 2014, CANCER INFORM, V13, P19, DOI 10.4137/CIN.S16348; Xu CQ, 2007, J CELL SCI, V120, P3045, DOI 10.1242/jcs.010728; Zhao Z., 2008, P 14 ACM SIGKDD INT, P839	51	16	17	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2016	11	4							e0152860	10.1371/journal.pone.0152860	http://dx.doi.org/10.1371/journal.pone.0152860			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0KH	27064982	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000373891000020
J	Arellano, B; Hussain, R; Miller-Little, WA; Herndon, E; Lambracht-Washington, D; Eagar, TN; Lewis, R; Healey, D; Vernino, S; Greenberg, BM; Stuve, O				Arellano, Benjamine; Hussain, Rehana; Miller-Little, William A.; Herndon, Emily; Lambracht-Washington, Doris; Eagar, Todd N.; Lewis, Robert; Healey, Don; Vernino, Steven; Greenberg, Benjamin M.; Stueve, Olaf			A Single Amino Acid Substitution Prevents Recognition of a Dominant Human Aquaporin-4 Determinant in the Context of HLA-DRB1*03:01 by a Murine TCR	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; 4-SPECIFIC T-CELLS; HUMAN B-CELLS; NEUROMYELITIS-OPTICA; MULTIPLE-SCLEROSIS; PROTEOLIPID PROTEIN; TRANSGENIC MICE; RITUXIMAB; ANTIGEN	Background Aquaporin 4 (AQP4) is considered a putative autoantigen in patients with Neuromyelitis optica (NMO), an autoinflammatory disorder of the central nervous system (CNS). HLA haplotype analyses of patients with NMO suggest a positive association with HLA-DRB1*03:01. We previously showed that the human (h) AQP4 peptide 281-300 is the dominant immunogenic determinant of hAQP4 in the context of HLA-DRB1*03:01. This immunogenic peptide stimulates a strong Th-1 and Th-17 immune response. AQP4(281-300)-specific encephalitogenic CD4(+) T cells should initiate CNS inflammation that results in a clinical phenotype in HLA-DRB1*03:01 transgenic mice. Methods Controlled study with humanized experimental animals. HLA-DRB1*03:01 transgenic mice were immunized with hAQP4281-300, or whole-length hAQP4 protein emulsified in complete Freund's adjuvant. Humoral immune responses to both antigens were assessed longitudinally. In vivo T cell frequencies were assessed by tetramer staining. Mice were followed clinically, and the anterior visual pathway was tested by pupillometry. CNS tissue was examined histologically post-mortem. Flow cytometry was utilized for MHC binding assays and to immunophenotype T cells, and T cell frequencies were determined by ELISpot assay. Results Immunization with hAQP4281-300 resulted in an in vivo expansion of antigen-specific CD4(+) T cells, and an immunoglobulin isotype switch. HLA-DRB1*03:01 TG mice actively immunized with hAQP4(281-300), or with whole-length hAQP4 protein were resistant to developing a neurological disease that resembles NMO. Experimental mice show no histological evidence of CNS inflammation, nor change in pupillary responses. Subsequent analysis reveals that a single amino acid substitution from aspartic acid in hAQP4 to glutamic acid in murine (m)AQP4 at position 290 prevents the recognition of hAQP4(281-300) by the murine T cell receptor (TCR). Conclusion Induction of a CNS inflammatory autoimmune disorder by active immunization of HLA-DRB1*03:01 TG mice with human hAQP4281-300 will be complex due to a single amino acid substitution. The pathogenic role of T cells in this disorder remains critical despite these observations.	[Arellano, Benjamine; Hussain, Rehana; Miller-Little, William A.; Lambracht-Washington, Doris; Lewis, Robert; Vernino, Steven; Greenberg, Benjamin M.; Stueve, Olaf] Univ Texas SW Med Ctr Dallas, Dept Neurol & Neurotherapeut, Dallas, TX 75390 USA; [Herndon, Emily] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA; [Eagar, Todd N.] Methodist Hosp Phys Org, Dept Pathol & Genom Med, Histocompatibil & Transplant Immunol, Houston, TX USA; [Healey, Don] Opexa Therapeut, The Woodlands, TX USA; [Stueve, Olaf] VA North Texas Hlth Care Syst, Med Serv, Neurol Sect, Dallas, TX USA; [Stueve, Olaf] Tech Univ Munich, Klinikum Rechts Isar, Dept Neurol, D-80290 Munich, Germany	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; The Methodist Hospital System; The Methodist Hospital - Houston; The Methodist Hospital Research Institute; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA North Texas Health Care System; Technical University of Munich	Stuve, O (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Neurol & Neurotherapeut, Dallas, TX 75390 USA.; Stuve, O (corresponding author), VA North Texas Hlth Care Syst, Med Serv, Neurol Sect, Dallas, TX USA.; Stuve, O (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Dept Neurol, D-80290 Munich, Germany.	olaf.stuve@utsouthwestern.edu	Vernino, Steven/AAD-5181-2020; Greenberg, Benjamin/AAT-1027-2020	Vernino, Steven/0000-0001-7799-8495; Greenberg, Benjamin/0000-0002-2091-8201; Lambracht-Washington, Doris/0000-0002-3161-9207	Opexa Therapeutics	Opexa Therapeutics	Opexa Therapeutics played no role in funding this project, in the study design, data collection and analysis, decision to publish, preparation of the manuscript, and neither did the company provide any financial support in the form of authors' salaries or research materials.	Arellano B, 2012, ARCH NEUROL-CHICAGO, V69, P1125, DOI 10.1001/archneurol.2012.1300; Brum DG, 2010, MULT SCLER J, V16, P21, DOI 10.1177/1352458509350741; BUSCH R, 1990, J IMMUNOL METHODS, V134, P1, DOI 10.1016/0022-1759(90)90107-7; COCKS BG, 1993, INT IMMUNOL, V5, P657, DOI 10.1093/intimm/5.6.657; Cravens PD, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-73; Filippi M, 2002, J MAGN RESON IMAGING, V15, P499, DOI 10.1002/jmri.10097; GELUK A, 1994, EUR J IMMUNOL, V24, P3241, DOI 10.1002/eji.1830241251; Griffin1 Robert S., 2007, J NEUROSCI, V27, P8699; Hohler T, 1997, J HEPATOL, V27, P259, DOI 10.1016/S0168-8278(97)80169-9; Hussain RZ, 2009, AUTON NEUROSCI-BASIC, V151, P164, DOI 10.1016/j.autneu.2009.07.021; Jacob A, 2008, ARCH NEUROL-CHICAGO, V65, P1443, DOI 10.1001/archneur.65.11.noc80069; Jones MV, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0207-1; Kalluri SR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016083; Kim SH, 2011, ARCH NEUROL-CHICAGO, V68, P1412, DOI 10.1001/archneurol.2011.154; Lennon VA, 2004, LANCET, V364, P2106, DOI 10.1016/S0140-6736(04)17551-X; Lennon VA, 2005, J EXP MED, V202, P473, DOI 10.1084/jem.20050304; Lucchinetti CF, 2002, BRAIN, V125, P1450, DOI 10.1093/brain/awf151; Mangalam AK, 2004, EUR J IMMUNOL, V34, P280, DOI 10.1002/eji.200324597; Matsuya N, 2011, INT IMMUNOL, V23, P565, DOI 10.1093/intimm/dxr056; Morrow MJ, 2012, J NEURO-OPHTHALMOL, V32, P154, DOI 10.1097/WNO.0b013e31825662f1; Nelson PA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015050; Novak EJ, 1999, J CLIN INVEST, V104, pR63, DOI 10.1172/JCI8476; Pellkofer HL, 2011, NEUROLOGY, V76, P1310, DOI 10.1212/WNL.0b013e3182152881; Recommendation of the Immunization Practices Advisory Committee (ACIP), 1981, MMWR MORB MORTAL WKL, V30, P535; SHAPIRA SK, 1991, P NATL ACAD SCI USA, V88, P7528, DOI 10.1073/pnas.88.17.7528; SHENOY M, 1994, CLIN IMMUNOL IMMUNOP, V73, P338, DOI 10.1006/clin.1994.1207; Slavin AJ, 2001, J CLIN INVEST, V108, P1133, DOI 10.1172/JCI200113360; STRAUSS G, 1994, IMMUNOGENETICS, V40, P104; Stromnes IM, 2006, NAT PROTOC, V1, P1810, DOI 10.1038/nprot.2006.285; Varrin-Doyer M, 2012, ANN NEUROL, V72, P53, DOI 10.1002/ana.23651; Wingerchuk DM, 2006, NEUROLOGY, V66, P1485, DOI 10.1212/01.wnl.0000216139.44259.74; ZAMVIL SS, 1990, ANNU REV IMMUNOL, V8, P579, DOI 10.1146/annurev.iy.08.040190.003051; Zeka B, 2015, ACTA NEUROPATHOL, V130, P783, DOI 10.1007/s00401-015-1501-5; Zephir H, 2009, MULT SCLER J, V15, P571, DOI 10.1177/1352458508102085	34	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0152720	10.1371/journal.pone.0152720	http://dx.doi.org/10.1371/journal.pone.0152720			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27054574	Green Published, Green Submitted, gold			2022-12-27	WOS:000373608000036
J	Pennycook, G; Ross, RM; Koehler, DJ; Fugelsang, JA				Pennycook, Gordon; Ross, Robert M.; Koehler, Derek J.; Fugelsang, Jonathan A.			Atheists and Agnostics Are More Reflective than Religious Believers: Four Empirical Studies and a Meta-Analysis	PLOS ONE			English	Article							DUAL-PROCESS THEORIES; COGNITIVE REFLECTION; ANALYTIC THINKING; PARANORMAL BELIEF; PERFORMANCE; NUMERACY; BIAS	Individual differences in the mere willingness to think analytically has been shown to predict religious disbelief. Recently, however, it has been argued that analytic thinkers are not actually less religious; rather, the putative association may be a result of religiosity typically being measured after analytic thinking (an order effect). In light of this possibility, we report four studies in which a negative correlation between religious belief and performance on analytic thinking measures is found when religious belief is measured in a separate session. We also performed a meta-analysis on all previously published studies on the topic along with our four new studies (N = 15,078, k = 31), focusing specifically on the association between performance on the Cognitive Reflection Test (the most widely used individual difference measure of analytic thinking) and religious belief. This meta-analysis revealed an overall negative correlation (r) of -.18, 95% CI [-.21, -.16]. Although this correlation is modest, self-identified atheists (N = 133) scored 18.7% higher than religiously affiliated individuals (N = 597) on a composite measure of analytic thinking administered across our four new studies (d = .72). Our results indicate that the association between analytic thinking and religious disbelief is not caused by a simple order effect. There is good evidence that atheists and agnostics are more reflective than religious believers.	[Pennycook, Gordon; Koehler, Derek J.; Fugelsang, Jonathan A.] Univ Waterloo, Dept Psychol, Waterloo, ON N2L 3G1, Canada; [Ross, Robert M.] Univ London, Royal Holloway, Dept Psychol, London, England; [Ross, Robert M.] Macquarie Univ, ARC Ctr Excellence Cognit & Its Disorders, Sydney, NSW 2109, Australia	University of Waterloo; University of London; Royal Holloway University London; Macquarie University	Pennycook, G (corresponding author), Univ Waterloo, Dept Psychol, Waterloo, ON N2L 3G1, Canada.	gpennyco@uwaterloo.ca	Pennycook, Gordon/AAD-6631-2019	Pennycook, Gordon/0000-0003-1344-6143; Ross, Robert/0000-0001-8711-1675; Koehler, Derek/0000-0002-3596-7882	Natural Sciences and Engineering Research Council of Canada (NSERC)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research was supported by a Graduate Scholarship from the Natural Sciences and Engineering Research Council of Canada (NSERC) to GP.	Baron J, 2015, J APPL RES MEM COGN, V4, P265, DOI 10.1016/j.jarmac.2014.09.003; Borenstein M., 2014, COMPREHENSIVE META A; Borenstein M, 2009, INTRO META ANAL; Browne M, 2014, EUR J SOC PSYCHOL, V44, P736, DOI 10.1002/ejsp.2059; Byrd N., 2014, THESIS U COLORADO; Cheyne JA, 2013, CLIN PSYCHOL SCI, V1, P135, DOI 10.1177/2167702612466656; Da Silva S., 2015, 68451 MPRA; De Neys W, 2008, COGNITION, V106, P1248, DOI 10.1016/j.cognition.2007.06.002; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Evans JST, 2013, PERSPECT PSYCHOL SCI, V8, P223, DOI 10.1177/1745691612460685; Finley AJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138922; Frederick S, 2005, J ECON PERSPECT, V19, P25, DOI 10.1257/089533005775196732; Gervais WM, 2015, COGNITION, V142, P312, DOI 10.1016/j.cognition.2015.05.011; Gervais WM, 2012, SCIENCE, V336, P493, DOI 10.1126/science.1215647; Hedges LV, 2014, STAT METHODS META AN; Jack A. I., PLOS ONE IN PRESS; Kahan DM, 2013, JUDGM DECIS MAK, V8, P407; Lindeman M, 2016, INT J PSYCHOL RELIG, V26, P185, DOI 10.1080/10508619.2015.1091695; Lindeman M, 2015, COGNITION, V134, P63, DOI 10.1016/j.cognition.2014.09.008; Lipkus IM, 2001, MED DECIS MAKING, V21, P37, DOI 10.1177/0272989X0102100105; Malhotra N., 2007, 111 GSS NORC; McCutcheon LE., 2014, N AM J PSYCHOL, V16, P453; Paxton JM, 2012, COGNITIVE SCI, V36, P163, DOI 10.1111/j.1551-6709.2011.01210.x; Pennycook G., 2016, FRONTIERS PSYCHOL; Pennycook G, 2015, JUDGM DECIS MAK, V10, P549; Pennycook G, 2015, CURR DIR PSYCHOL SCI, V24, P425, DOI 10.1177/0963721415604610; Pennycook G, 2016, BEHAV RES METHODS, V48, P341, DOI 10.3758/s13428-015-0576-1; Pennycook G, 2014, INTELLIGENCE, V43, P21, DOI 10.1016/j.intell.2013.12.005; Pennycook G, 2014, THINK REASONING, V20, P188, DOI 10.1080/13546783.2013.865000; Pennycook G, 2014, MEM COGNITION, V42, P1, DOI 10.3758/s13421-013-0340-7; Pennycook G, 2013, PSYCHON B REV, V20, P806, DOI 10.3758/s13423-013-0394-3; Pennycook G, 2012, COGNITION, V123, P335, DOI 10.1016/j.cognition.2012.03.003; Piazza J, 2014, SOC PSYCHOL PERS SCI, V5, P334, DOI 10.1177/1948550613492826; Razmyar S, 2013, INTELLIGENCE, V41, P667, DOI 10.1016/j.intell.2013.09.003; Royzman EB, 2014, JUDGM DECIS MAK, V9, P176; Schwartz LM, 1997, ANN INTERN MED, V127, P966, DOI 10.7326/0003-4819-127-11-199712010-00003; Shenhav A, 2012, J EXP PSYCHOL GEN, V141, P423, DOI 10.1037/a0025391; Shtulman A., 2014, P 36 ANN C COGN SCI, P2937; Sinayev A, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00532; Svedholm AM, 2013, BRIT J PSYCHOL, V104, P303, DOI 10.1111/j.2044-8295.2012.02118.x; Toplak ME, 2014, THINK REASONING, V20, P147, DOI 10.1080/13546783.2013.844729; Toplak ME, 2011, MEM COGNITION, V39, P1275, DOI 10.3758/s13421-011-0104-1; Willard AK, 2013, COGNITION, V129, P379, DOI 10.1016/j.cognition.2013.07.016; Yilmaz O, 2016, INT J PSYCHOL RELIG, V26, P360, DOI 10.1080/10508619.2016.1151117	44	120	122	33	260	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153039	10.1371/journal.pone.0153039	http://dx.doi.org/10.1371/journal.pone.0153039			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DI6KO	27054566	Green Published, gold			2022-12-27	WOS:000373608000068
J	Romero, Y; Guzman, J; Moreno, S; Cocotl-Yanez, M; Vences-Guzman, MA; Castaneda, M; Espin, G; Segura, D				Romero, Yanet; Guzman, Josefina; Moreno, Soledad; Cocotl-Yanez, Miguel; Angel Vences-Guzman, Miguel; Castaneda, Miguel; Espin, Guadalupe; Segura, Daniel			The GacS/A-RsmA Signal Transduction Pathway Controls the Synthesis of Alkylresorcinol Lipids that Replace Membrane Phospholipids during Encystment of Azotobacter vinelandii SW136	PLOS ONE			English	Article							III POLYKETIDE SYNTHASES; CYST FORMATION; RNA; EXPRESSION; CSRA; BIOSYNTHESIS; PROTEIN; GENES; ROLES; GACA	Azotobacter vinelandii is a soil bacterium that undergoes a differentiation process that forms cysts resistant to desiccation. During encystment, a family of alkylresorcinols lipids (ARs) are synthesized and become part of the membrane and are also components of the outer layer covering the cyst, where they play a structural role. The synthesis of ARs in A. vinelandii has been shown to occur by the activity of enzymes encoded in the arsABCD operon. The expression of this operon is activated by ArpR, a LysR-type transcriptional regulator whose transcription occurs during encystment and is dependent on the alternative sigma factor RpoS. In this study, we show that the two component response regulator GacA, the small RNA RsmZ1 and the translational repressor protein RsmA, implicated in the control of the synthesis of other cysts components (i.e., alginate and poly-beta-hydroxybutyrate), are also controlling alkylresorcinol synthesis. This control affects the expression of arsABCD and is exerted through the regulation of arpR expression. We show that RsmA negatively regulates arpR expression by binding its mRNA, repressing its translation. GacA in turn, positively regulates arpR expression through the activation of transcription of RsmZ1, that binds RsmA, counteracting its repressor activity. This regulatory cascade is independent of RpoS. We also show evidence suggesting that GacA exerts an additional regulation on arsABCD expression through an ArpR independent route.	[Romero, Yanet; Guzman, Josefina; Moreno, Soledad; Cocotl-Yanez, Miguel; Angel Vences-Guzman, Miguel; Espin, Guadalupe; Segura, Daniel] Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Microbiol Mol, Cuernavaca 62191, Morelos, Mexico; [Castaneda, Miguel] Benemerita Univ Autonoma Puebla, Inst Ciencias, Ctr Invest Ciencias Microbiol, Puebla, Mexico; [Romero, Yanet] Univ Autonoma Guerrero, Unidad Acad Ciencias Quim Biol, Lab Microbiol Mol & Biotecnol Ambiental, Chilpancingo, Guerrero, Mexico	Universidad Nacional Autonoma de Mexico; Benemerita Universidad Autonoma de Puebla	Segura, D (corresponding author), Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Microbiol Mol, Cuernavaca 62191, Morelos, Mexico.	daniel@ibt.unam.mx		Cocotl-Yanez, Miguel/0000-0002-4932-2284; ROMERO, YANET/0000-0002-8383-4128	Consejo Nacional de Ciencia y Tecnologia [127979]; Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica, Direccion General de Asuntos del Personal Academico, Universidad Nacional Autonoma de Mexico [IT200415]	Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica, Direccion General de Asuntos del Personal Academico, Universidad Nacional Autonoma de Mexico	This work was supported by the Consejo Nacional de Ciencia y Tecnologia, Grant 127979 to DS and the Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica, Direccion General de Asuntos del Personal Academico, Universidad Nacional Autonoma de Mexico, Grant IT200415 to DS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker CS, 2002, MOL MICROBIOL, V44, P1599, DOI 10.1046/j.1365-2958.2002.02982.x; BARRY T, 1992, NUCLEIC ACIDS RES, V20, P4940, DOI 10.1093/nar/20.18.4940; BUSH JA, 1959, NATURE, V184, P381, DOI 10.1038/184381a0; Castaneda M, 2001, J BACTERIOL, V183, P6787, DOI 10.1128/JB.183.23.6787-6793.2001; Cocotl-Yanez M, 2011, MICROBIOL-SGM, V157, P1685, DOI 10.1099/mic.0.046268-0; Dubey AK, 2005, RNA, V11, P1579, DOI 10.1261/rna.2990205; Muriel-Millan LF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117184; Funa N, 2006, P NATL ACAD SCI USA, V103, P6356, DOI 10.1073/pnas.0511227103; Hernandez-Eligio A, 2012, MICROBIOL-SGM, V158, P1953, DOI 10.1099/mic.0.059329-0; KENNEDY C, 1986, MOL GEN GENET, V205, P318, DOI 10.1007/BF00430445; Liu MY, 1997, J BACTERIOL, V179, P4639, DOI 10.1128/jb.179.14.4639-4642.1997; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Manzo J, 2011, J MOL MICROB BIOTECH, V21, P147, DOI 10.1159/000334244; MartinezSalazar JM, 1996, J BACTERIOL, V178, P1800, DOI 10.1128/jb.178.7.1800-1808.1996; Miyanaga A, 2008, P NATL ACAD SCI USA, V105, P871, DOI 10.1073/pnas.0709819105; Peralta-Gil M, 2002, J BACTERIOL, V184, P5672, DOI 10.1128/JB.184.20.5672-5677.2002; REUSCH RN, 1983, NATURE, V302, P268, DOI 10.1038/302268a0; Romeo T, 1998, MOL MICROBIOL, V29, P1321, DOI 10.1046/j.1365-2958.1998.01021.x; Romero Y, 2013, J BACTERIOL, V195, P1834, DOI 10.1128/JB.01946-12; SADOFF HL, 1975, BACTERIOL REV, V39, P516, DOI 10.1128/MMBR.39.4.516-539.1975; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Segura D, 2009, J BACTERIOL, V191, P3142, DOI 10.1128/JB.01575-08; TLUSCIK F, 1981, ACTA SOC BOT POL, V50, P645, DOI 10.5586/asbp.1981.086; Valverde C, 2003, MOL MICROBIOL, V50, P1361, DOI 10.1046/j.1365-2958.2003.03774.x	26	10	11	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153266	10.1371/journal.pone.0153266	http://dx.doi.org/10.1371/journal.pone.0153266			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27055016	Green Published, gold, Green Submitted			2022-12-27	WOS:000373608000111
J	Houben, AJ; D'Onofrio, R; Kokelj, SV; Blais, JM				Houben, Adam James; D'Onofrio, Rebecca; Kokelj, Steven V.; Blais, Jules M.			Factors Affecting Elevated Arsenic and Methyl Mercury Concentrations in Small Shield Lakes Surrounding Gold Mines near the Yellowknife, NT, (Canada) Region	PLOS ONE			English	Article							DISSOLVED ORGANIC-CARBON; NORTHWEST-TERRITORIES; GIANT MINE; WATER; ENVIRONMENT; SEDIMENTS; NWT; BIOACCUMULATION; EXTRACTION; SPECIATION	Gold mines in the Yellowknife, NT, region-in particular, the Giant Mine-operated from 1949-99, releasing 237,000 tonnes of waste arsenic trioxide (As2O3) dust, among other compounds, from gold ore extraction and roasting processes. For the first time, we show the geospatial distribution of roaster-derived emissions of several chemical species beyond the mine property on otherwise undisturbed taiga shield lakes within a 25 km radius of the mine, 11 years after its closing. Additionally, we demonstrate that underlying bedrock is not a significant source for the elevated concentrations in overlying surface waters. Aquatic arsenic (As) concentrations are well above guidelines for drinking water (10 mu g/L) and protection for aquatic life (5 mu g/L), ranging up to 136 mu g/L in lakes within 4 km from the mine, to 2.0 mu g/L in lakes 24 km away. High conversion ratios of methyl mercury were shown in lakes near the roaster stack as well, with MeHg concentrations reaching 44% of total mercury. The risk of elevated exposures by these metals is significant, as many lakes used for recreation and fishing near the City of Yellowknife are within this radius of elevated As and methyl Hg concentrations.	[Houben, Adam James; D'Onofrio, Rebecca; Blais, Jules M.] Univ Ottawa, Dept Biol, Program Chem & Environm Toxicol, Ottawa, ON K1N 6N5, Canada; [Kokelj, Steven V.] Govt Northwest Terr, NWT Geosci Off, Yellowknife, NT X1A 2R3, Canada	University of Ottawa	Houben, AJ (corresponding author), Univ Ottawa, Dept Biol, Program Chem & Environm Toxicol, Ottawa, ON K1N 6N5, Canada.	ahouben@uottawa.ca	Blais, Jules/AAV-2321-2020	Blais, Jules/0000-0002-7188-3598; Houben, Adam/0000-0002-0336-7583	Natural Sciences and Engineering Research Council, Canada, Northern Research Internship [396140-2010]; Natural Sciences and Engineering Research Council, Canada, Strategic Grant [90421529]; Cumulative Impact Monitoring Program through Environment and Natural Resources, Government of Northwest Territories, Canada	Natural Sciences and Engineering Research Council, Canada, Northern Research Internship; Natural Sciences and Engineering Research Council, Canada, Strategic Grant; Cumulative Impact Monitoring Program through Environment and Natural Resources, Government of Northwest Territories, Canada	This work was supported by the Natural Sciences and Engineering Research Council, Canada, Northern Research Internship, Application Number: 396140-2010 received by AH; Natural Sciences and Engineering Research Council, Canada, Strategic Grant, Reference Number: 90421529 received by JB; Cumulative Impact Monitoring Program through Environment and Natural Resources, Government of Northwest Territories, Canada received by SK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade CF, 2010, APPL GEOCHEM, V25, P199, DOI 10.1016/j.apgeochem.2009.11.005; Avramescu ML, 2011, SCI TOTAL ENVIRON, V409, P968, DOI 10.1016/j.scitotenv.2010.11.016; Barkay T, 1997, APPL ENVIRON MICROB, V63, P4267, DOI 10.1128/AEM.63.11.4267-4271.1997; Bromstad M, 2011, METABOLISM ARSENITE, V5, P25; Cai Y, 1996, ANAL CHIM ACTA, V334, P251, DOI 10.1016/S0003-2670(96)00309-1; Canario J, 2008, WATER AIR SOIL POLL, V187, P219, DOI 10.1007/s11270-007-9510-1; Chetelat J, 2015, SCI TOTAL ENVIRON, V509, P41, DOI 10.1016/j.scitotenv.2014.05.151; Clark ID, 2004, ISOT ENVIRON HEALT S, V40, P115, DOI 10.1080/10256010410001671014; Coleman L. C., 1957, ECON GEOL, V52, P400, DOI DOI 10.2113/GSECONGEO.52.4.400; COMPEAU GC, 1985, APPL ENVIRON MICROB, V50, P498, DOI 10.1128/AEM.50.2.498-502.1985; Daguene V, 2012, ENVIRON SCI TECHNOL, V46, P6645, DOI 10.1021/es300760e; Ecosystem Classification Group, 2008, EC REG NW TERR TAIG; Engstrom DR, 2014, ENVIRON SCI TECHNOL, V48, P6533, DOI 10.1021/es405558e; French TD, 2014, ENVIRON SCI TECHNOL, V48, P3162, DOI 10.1021/es403849d; Galloway JM, 2015, GEOCHEMISTRY LAKES 1, DOI [10.4095/296954, DOI 10.4095/296954]; GILMOUR CC, 1992, ENVIRON SCI TECHNOL, V26, P2281, DOI 10.1021/es00035a029; Hellweger FL, 2004, ENVIRON SCI TECHNOL, V38, P6716, DOI 10.1021/es049660k; Hellweger FL, 2003, LIMNOL OCEANOGR, V48, P2275; HOCKING D, 1978, JAPCA J AIR WASTE MA, V28, P133, DOI 10.1080/00022470.1978.10470580; HUTCHINSON TC, 1982, J RADIOANAL CHEM, V71, P59, DOI 10.1007/BF02516141; Indian and Northern Affairs Canada, 2010, BRUL MIN PROJ ASS RE; Isachsen CE, 1997, CAN J EARTH SCI, V34, P169, DOI 10.1139/e17-014; Jeremiason JD, 2006, ENVIRON SCI TECHNOL, V40, P3800, DOI 10.1021/es0524144; KELLER W, 2004, RECOVERY ACID METAL; Kerr DE, 2000, GEOL SURV CANADA C, VC3; Koch I, 2000, ENVIRON SCI TECHNOL, V34, P22, DOI 10.1021/es9906756; Koch I, 2000, APPL ORGANOMET CHEM, V14, P245, DOI 10.1002/(SICI)1099-0739(200005)14:5<245::AID-AOC986>3.0.CO;2-K; Koch L, 2005, ENVIRON TOXICOL CHEM, V24, P1468, DOI 10.1897/04-155R.1; Lloyd JR, 2006, ELEMENTS, V2, P85, DOI 10.2113/gselements.2.2.85; Ng JC, 2005, ENVIRON CHEM, V2, P146, DOI 10.1071/EN05062; O'Driscoll NJ, 2005, MET IONS BIOL SYST, V43, P221; Raab A, 2007, ANGEW CHEM INT EDIT, V46, P2594, DOI 10.1002/anie.200604805; Rahman MA, 2012, ENVIRON RES, V116, P118, DOI 10.1016/j.envres.2012.03.014; Semkin RG, 2005, SCI TOTAL ENVIRON, V342, P199, DOI 10.1016/j.scitotenv.2004.12.047; Sharma VK, 2009, ENVIRON INT, V35, P743, DOI 10.1016/j.envint.2009.01.005; SMITH AH, 1992, ENVIRON HEALTH PERSP, V97, P259, DOI 10.2307/3431362; St-Onge SM, 2007, THESIS CARLETON U; Ullrich SM, 2001, CRIT REV ENV SCI TEC, V31, P241, DOI 10.1080/20016491089226; WAGEMANN R, 1978, ARCH ENVIRON CON TOX, V7, P169, DOI 10.1007/BF02332047; Walker SR, 2005, CAN MINERAL, V43, P1205, DOI 10.2113/gscanmin.43.4.1205	40	31	31	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0150960	10.1371/journal.pone.0150960	http://dx.doi.org/10.1371/journal.pone.0150960			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050658	gold, Green Published, Green Submitted			2022-12-27	WOS:000373603500003
J	Jager, G; Chen, P; Bjork, GR				Jager, Gunilla; Chen, Peng; Bjork, Glenn R.			Transfer RNA Bound to MnmH Protein Is Enriched with Geranylated tRNA - A Possible Intermediate in Its Selenation?	PLOS ONE			English	Article							COLI DNA-POLYMERASE; ESCHERICHIA-COLI; TETRACYCLINE RESISTANCE; MOONLIGHTING PROTEINS; GENE ENCODES; SUPERFAMILY; 2-SELENOURIDINE; SUPPRESSORS; NUCLEOSIDES; MUTATIONS	The wobble nucleoside 5-methylaminomethyl-2-thio-uridine (mnm(5)s(2)U) is present in bacterial tRNAs specific for Lys and Glu and 5-carboxymethylaminomethyl-2-thio-uridine (cmnm(5)s(2)U) in tRNA specific for Gln. The sulfur of (c) mnm(5)s(2)U may be exchanged by selenium (Se)-a reaction catalyzed by the selenophosphate-dependent tRNA 2-selenouridine synthase encoded by the mnmH (ybbB, selU, sufY) gene. The MnmH protein has a rhodanese domain containing one catalytic Cys (C97) and a P-loop domain containing a Walker A motif, which is a potential nucleotide binding site. We have earlier isolated a mutant of Salmonella enterica, serovar Typhimurium with an alteration in the rhodanese domain of the MnmH protein (G67E) mediating the formation of modified nucleosides having a geranyl (ge)-group (C10H17-fragment) attached to the s(2) group of mnm(5)s(2)U and of cmnm(5)s(2)U in tRNA. To further characterize the structural requirements to increase the geranylation activity, we here report the analysis of 39 independently isolated mutants catalyzing the formation of mnm(5)ges(2)U. All these mutants have amino acid substitutions in the rhodanese domain demonstrating that this domain is pivotal to increase the geranylation activity. The wild type form of MnmH(+) also possesses geranyltransferase activity in vitro although only a small amount of the geranyl derivatives of (c) mnm(5)s(2)U is detected in vivo. The selenation activity in vivo has an absolute requirement for the catalytic Cys97 in the rhodanese domain whereas the geranylation activity does not. Clearly, MnmH has two distinct enzymatic activities for which the rhodanese domain is pivotal. An intact Walker motif in the P-loop domain is required for the geranylation activity implying that it is the binding site for geranylpyrophosphate (GePP), which is the donor molecule in vitro in the geranyltransfer reaction. Purified MnmH from wild type and from the MnmH(G67E) mutant have bound tRNA, which is enriched with geranylated tRNA. This in conjunction with earlier published data, suggests that this bound geranylated tRNA may be an intermediate in the selenation of the tRNA.	[Jager, Gunilla; Bjork, Glenn R.] Umea Univ, Dept Mol Biol, S-90187 Umea, Sweden; [Chen, Peng] Huazhong Agr Univ, Coll Plant Sci & Technol, Biomass & Bioenergy Res Ctr, Wuhan 430070, Peoples R China	Umea University; Huazhong Agricultural University	Bjork, GR (corresponding author), Umea Univ, Dept Mol Biol, S-90187 Umea, Sweden.	glenn.bjork@molbiol.umu.se	Björk, Glenn/AAE-8219-2022		Swedish Science Research Council [BU-2930]; Carl Trygger Foundation	Swedish Science Research Council; Carl Trygger Foundation	This work was supported by grants from the Swedish Science Research Council (BU-2930) and from the Carl Trygger Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravind L, 2001, TRENDS BIOCHEM SCI, V26, P215, DOI 10.1016/S0968-0004(01)01826-6; Armengod ME, 2012, BIOCHIMIE, V94, P1510, DOI 10.1016/j.biochi.2012.02.019; Bartos P, 2014, BIOORG CHEM, V56, P49, DOI 10.1016/j.bioorg.2014.05.012; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; Bjo rk G.R., 2014, ECOSAL PLUS, V6, DOI [10.1128/ecosalplus.ESP-0007-2013, DOI 10.1128/ECOSALPLUS.ESP-0007-2013]; Bjork GR, 2007, RNA, V13, P1245, DOI 10.1261/rna.558707; BOCHNER BR, 1980, J BACTERIOL, V143, P926, DOI 10.1128/JB.143.2.926-933.1980; Bordo D, 2002, EMBO REP, V3, P741, DOI 10.1093/embo-reports/kvf150; Chen P, 2005, EMBO J, V24, P1842, DOI 10.1038/sj.emboj.7600666; Cipollone R, 2007, IUBMB LIFE, V59, P51, DOI 10.1080/15216540701206859; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DAVIS W, 1980, MANUAL GENETIC ENG A; Du T, 2004, CURRENT PROTOCOLS MO; Dumelin CE, 2012, NAT CHEM BIOL, V8, P913, DOI [10.1038/nchembio.1070, 10.1038/NCHEMBIO.1070]; EMILSSON V, 1990, EMBO J, V9, P4359, DOI 10.1002/j.1460-2075.1990.tb07885.x; GEHRKE CW, 1982, J CHROMATOGR, V230, P297, DOI 10.1016/S0378-4347(00)80479-X; Gehrke CW, 1990, J CHROMATOGRAPHY LIB, pA3; HARPAZ Y, 1994, STRUCTURE, V2, P641, DOI 10.1016/S0969-2126(00)00065-4; HONG JS, 1971, P NATL ACAD SCI USA, V68, P3158, DOI 10.1073/pnas.68.12.3158; Ikeuchi Y, 2006, MOL CELL, V21, P97, DOI 10.1016/j.molcel.2005.11.001; Jager G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060246; Janas T, 2012, RNA, V18, P2260, DOI 10.1261/rna.035352.112; Jeffery CJ, 1999, TRENDS BIOCHEM SCI, V24, P8, DOI 10.1016/S0968-0004(98)01335-8; Jeffery CJ, 2009, MOL BIOSYST, V5, P345, DOI 10.1039/b900658n; KOONIN EV, 1993, J MOL BIOL, V229, P1165, DOI 10.1006/jmbi.1993.1115; Maisnier-Patin S, 2005, NAT GENET, V37, P1376, DOI 10.1038/ng1676; MALOY SR, 1981, J BACTERIOL, V145, P1110, DOI 10.1128/JB.145.2.1110-1111.1981; Moukadiri I, 2014, NUCLEIC ACIDS RES, V42, P2602, DOI 10.1093/nar/gkt1228; Nasvall SJ, 2009, J MOL BIOL, V385, P350, DOI 10.1016/j.jmb.2008.10.069; RIDDLE DL, 1972, J MOL BIOL, V66, P483, DOI 10.1016/0022-2836(72)90428-7; RIDDLE DL, 1970, J MOL BIOL, V54, P131, DOI 10.1016/0022-2836(70)90451-1; SCHMIEGER H, 1972, MOL GEN GENET, V119, P75, DOI 10.1007/BF00270447; Su D, 2012, FEBS LETT, V586, P717, DOI 10.1016/j.febslet.2012.01.024; Urbonavicius J, 2001, EMBO J, V20, P4863, DOI 10.1093/emboj/20.17.4863; VOGEL HJ, 1956, J BIOL CHEM, V218, P97; Wagner J, 2000, J BACTERIOL, V182, P4587, DOI 10.1128/JB.182.16.4587-4595.2000; Wagner J, 1999, MOL CELL, V4, P281, DOI 10.1016/S1097-2765(00)80376-7; Wai SN, 2003, J BACTERIOL, V185, P5491, DOI 10.1128/JB.185.18.5491-5499.2003; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Wang R, 2015, CHEM COMMUN, V51, P16369, DOI 10.1039/c5cc07479g; Wolfe MD, 2004, J BIOL CHEM, V279, P1801, DOI 10.1074/jbc.M310442200	41	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153488	10.1371/journal.pone.0153488	http://dx.doi.org/10.1371/journal.pone.0153488			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073879	Green Published, Green Submitted, gold			2022-12-27	WOS:000374131200099
J	Kolmeder, CA; Salojarvi, J; Ritari, J; de Been, M; Raes, J; Falony, G; Vieira-Silva, S; Kekkonen, RA; Corthals, GL; Palva, A; Salonen, A; de Vos, WM				Kolmeder, Carolin A.; Salojarvi, Jarkko; Ritari, Jarmo; de Been, Mark; Raes, Jeroen; Falony, Gwen; Vieira-Silva, Sara; Kekkonen, Riina A.; Corthals, Garry L.; Palva, Airi; Salonen, Anne; de Vos, Willem M.			Faecal Metaproteomic Analysis Reveals a Personalized and Stable Functional Microbiome and Limited Effects of a Probiotic Intervention in Adults	PLOS ONE			English	Article							INTESTINAL ALKALINE-PHOSPHATASE; LACTOBACILLUS-RHAMNOSUS GG; GUT MICROBIOME; BACTERIAL; HOST; IDENTIFICATION; SAMPLES; DISEASE; FIBER; FLUID	Recent metagenomic studies have demonstrated that the overall functional potential of the intestinal microbiome is rather conserved between healthy individuals. Here we assessed the biological processes undertaken in-vivo by microbes and the host in the intestinal tract by conducting a metaproteome analysis from a total of 48 faecal samples of 16 healthy adults participating in a placebo-controlled probiotic intervention trial. Half of the subjects received placebo and the other half consumed Lactobacillus rhamnosus GG for three weeks (10(10) cfu per day). Faecal samples were collected just before and at the end of the consumption phase as well as after a three-week follow-up period, and were processed for microbial composition and metaproteome analysis. A common core of shared microbial protein functions could be identified in all subjects. Furthermore, we observed marked differences in expressed proteins between subjects that resulted in the definition of a stable and personalized microbiome both at the mass-spectrometry-based proteome level and the functional level based on the KEGG pathway analysis. No significant changes in the metaproteome were attributable to the probiotic intervention. A detailed taxonomic assignment of peptides and comparison to phylogenetic microarray data made it possible to evaluate the activity of the main phyla as well as key species, including Faecalibacterium prausnitzii. Several correlations were identified between human and bacterial proteins. Proteins of the human host accounted for approximately 14% of the identified metaproteome and displayed variations both between and within individuals. The individually different human intestinal proteomes point to personalized host-microbiota interactions. Our findings indicate that analysis of the intestinal metaproteome can complement gene-based analysis and contributes to a thorough understanding of the activities of the microbiome and the relevant pathways in health and disease.	[Kolmeder, Carolin A.; Salojarvi, Jarkko; Ritari, Jarmo; de Been, Mark; Palva, Airi; Salonen, Anne; de Vos, Willem M.] Univ Helsinki, Dept Vet Biosci, Helsinki, Finland; [de Been, Mark] Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands; [Raes, Jeroen; Falony, Gwen; Vieira-Silva, Sara] Katholieke Univ Leuven, Dept Microbiol & Immunol, Rega Inst, Leuven, Belgium; [Raes, Jeroen; Falony, Gwen; Vieira-Silva, Sara] VIB, Ctr Biol Dis, Leuven, Belgium; [Kekkonen, Riina A.] Valio Oy, Helsinki, Finland; [Corthals, Garry L.] Univ Turku, Translat Prote, Turku Ctr Biotechnol, Turku, Finland; [Corthals, Garry L.] Abo Akad Univ, Turku, Finland; [Salonen, Anne; de Vos, Willem M.] Univ Helsinki, Dept Bacteriol & Immunol, Immunobiol Res Program, Helsinki, Finland; [de Vos, Willem M.] Wageningen Univ, Microbiol Lab, NL-6700 AP Wageningen, Netherlands; [Corthals, Garry L.] Univ Amsterdam, Vant Hoff Inst Mol Sci HIMS, Amsterdam, Netherlands	University of Helsinki; Utrecht University; Utrecht University Medical Center; KU Leuven; Flanders Institute for Biotechnology (VIB); University of Turku; Abo Akademi University; University of Helsinki; Wageningen University & Research; University of Amsterdam	Kolmeder, CA (corresponding author), Univ Helsinki, Dept Vet Biosci, Helsinki, Finland.	carolin.kolmeder@helsinki.fi	Salojärvi, Jarkko/E-9103-2016; Salonen, Anne/AAW-1858-2020; Corthals, Garry/G-9417-2016; Vieira-Silva, Sara/ABE-1247-2021; Ritari, Jarmo/G-4245-2016; Falony, Gwen/AAN-5011-2020; raes, jeroen/D-7835-2018	Salojärvi, Jarkko/0000-0002-4096-6278; Salonen, Anne/0000-0002-6960-7447; Corthals, Garry/0000-0001-9423-5596; Vieira-Silva, Sara/0000-0002-4616-7602; Ritari, Jarmo/0000-0002-3458-9314; Falony, Gwen/0000-0003-2450-0782; raes, jeroen/0000-0002-1337-041X	Doctoral Programme in Food Chain and Health; Academy of Finland [141130, 137389, 141140]; European Research Council [250172]; FP7; Spinoza award of the Netherlands Organization for Scientific Research; METACARDIS [HEALTH-F4-2012-305312]; IWT-SBO [100016]; Marie Curie Actions FP7 People COFUND [267139]; Research Foundation Flanders (FWO); Flemish agency for Innovation by Science and Technology (IWT); KU Leuven; Rega Institute; Biocenter Finland, Turku Proteomics Facility	Doctoral Programme in Food Chain and Health; Academy of Finland(Academy of Finland); European Research Council(European Research Council (ERC)European Commission); FP7; Spinoza award of the Netherlands Organization for Scientific Research; METACARDIS; IWT-SBO(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Marie Curie Actions FP7 People COFUND; Research Foundation Flanders (FWO)(FWO); Flemish agency for Innovation by Science and Technology (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); KU Leuven(KU Leuven); Rega Institute; Biocenter Finland, Turku Proteomics Facility	Support was provided by: Doctoral Programme in Food Chain and Health (to CK); Academy of Finland [http://www.aka.fi/en-GB/A/] (141130 to WdV, 137389 to WdV, 141140 to WdV); European Research Council [http://erc.europa.eu/] (250172 to WdV); FP7 [http://cordis.europa.eu/fp7/home_en.html]; Spinoza award of the Netherlands Organization for Scientific Research [http://www.nwo.nl/en/research-and-results/programmes/spinoza+prize] (to WdV); METACARDIS HEALTH-F4-2012-305312 (to J. Raes); IWT-SBO 100016 (to J. Raes); Marie Curie Actions FP7 People COFUND [http://cordis.europa.eu/project/rcn/100377_en.html] (Proposal 267139 (acronym OMICS@VIB) to SVS); Research Foundation Flanders (FWO) [http://www.fwo.be/en/](to J. Raes); The Flemish agency for Innovation by Science and Technology (IWT) http://www.flagera.eu/?q=iwt(to J. Raes); KU Leuven [http://www.kuleuven.be/english] (to J. Raes); The Rega Institute [http://rega.kuleuven.be/] (to J. Raes); Biocenter Finland, Turku Proteomics Facility [http://www.biocenter.fi] (to GC). One of the authors (RAK) is employed by a commercial company (Valio Ltd) and contributed to the design of the clinical trial.	Ahlroos T, 2009, J APPL MICROBIOL, V106, P506, DOI 10.1111/j.1365-2672.2008.04018.x; Cantarel BL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027173; Coyne MJ, 2014, MBIO, V5, DOI 10.1128/mBio.01305-14; Daniel H, 2014, ISME J, V8, P295, DOI 10.1038/ismej.2013.155; de Vos WM, 2012, NUTR REV, V70, pS45, DOI 10.1111/j.1753-4887.2012.00505.x; Perez-Cobas AE, 2013, GUT, V62, P1591, DOI 10.1136/gutjnl-2012-303184; Erickson AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049138; Finucane MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084689; Foell D, 2009, GUT, V58, P859, DOI 10.1136/gut.2008.170019; Franzosa EA, 2014, P NATL ACAD SCI USA, V111, pE2329, DOI 10.1073/pnas.1319284111; Goldberg RF, 2008, P NATL ACAD SCI USA, V105, P3551, DOI 10.1073/pnas.0712140105; Huson DH, 2013, METHOD ENZYMOL, V531, P465, DOI 10.1016/B978-0-12-407863-5.00021-6; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; HUXTABLE RJ, 1992, PHYSIOL REV, V72, P101, DOI 10.1152/physrev.1992.72.1.101; Jalanka-Tuovinen J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023035; Jespersgaard C, 2002, INFECT IMMUN, V70, P1136, DOI 10.1128/IAI.70.3.1136-1142.2002; Juste C, 2014, GUT, V63, P1566, DOI 10.1136/gutjnl-2012-303786; Kamal-Eldin Afaf, 2009, Food Nutr Res, V53, DOI 10.3402/fnr.v53i0.1912; Karlsson FH, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003706; Kekkonen RA, 2008, WORLD J GASTROENTERO, V14, P2029, DOI 10.3748/wjg.14.2029; Kekkonen RA, 2008, WORLD J GASTROENTERO, V14, P3188, DOI 10.3748/wjg.14.3188; Klymiuk I, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001627; Kolmeder CA, 2015, PROTEOMICS, V15, P3544, DOI 10.1002/pmic.201500049; Kolmeder CA, 2014, J PROTEOMICS, V97, P3, DOI 10.1016/j.jprot.2013.05.018; Kolmeder CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029913; Lahti L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5344; Lahti L, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt229; Lahti L, 2013, PEERJ, V1, DOI 10.7717/peerj.32; Lalles JP, 2014, NUTR REV, V72, P82, DOI 10.1111/nure.12082; Lappi J, 2013, J NUTR, V143, P648, DOI 10.3945/jn.112.172668; Laue H, 2006, FEMS MICROBIOL LETT, V261, P74, DOI 10.1111/j.1574-6968.2006.00335.x; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; LEVANDOWSKY M, 1971, NATURE, V234, P34, DOI 10.1038/234034a0; Li JH, 2014, NAT BIOTECHNOL, V32, P834, DOI 10.1038/nbt.2942; Li XX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026542; Ling ZX, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-390; Lozupone CA, 2013, GENOME RES, V23, P1704, DOI 10.1101/gr.151803.112; Malo MS, 2014, AM J PHYSIOL-GASTR L, V306, pG826, DOI 10.1152/ajpgi.00357.2013; McNulty NP, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001637; McNulty NP, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002701; Mesuere B, 2012, J PROTEOME RES, V11, P5773, DOI 10.1021/pr300576s; Midtvedt T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066074; Nesvizhskii AI, 2005, MOL CELL PROTEOMICS, V4, P1419, DOI 10.1074/mcp.R500012-MCP200; Panwar H, 2014, EUR J NUTR, V53, P1465, DOI 10.1007/s00394-013-0649-9; Pickard JM, 2014, NATURE, V514, P638, DOI 10.1038/nature13823; R Core Team, R LANG ENV STAT COMP; Rajilic-Stojanovic M, 2009, ENVIRON MICROBIOL, V11, P1736, DOI 10.1111/j.1462-2920.2009.01900.x; Reichhardt MP, 2014, J IMMUNOL, V193, P5240, DOI 10.4049/jimmunol.1401631; Rinttila T, 2004, J APPL MICROBIOL, V97, P1166, DOI 10.1111/j.1365-2672.2004.02409.x; Rodriguez-Otero P, 2012, BLOOD, V119, P5909, DOI 10.1182/blood-2011-12-397968; Rooijers K, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-6; Salaga M, 2013, DRUG DISCOV TODAY, V18, P708, DOI 10.1016/j.drudis.2013.03.004; Salonen A, 2010, J MICROBIOL METH, V81, P127, DOI 10.1016/j.mimet.2010.02.007; SELVENDRAN RR, 1984, AM J CLIN NUTR, V39, P320, DOI 10.1093/ajcn/39.2.320; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Spear GT, 2014, J INFECT DIS, V210, P1019, DOI 10.1093/infdis/jiu231; Tooth D, 2014, GUT, V63, P753, DOI 10.1136/gutjnl-2012-304042; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Tyakht AV, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3469; Verberkmoes NC, 2009, ISME J, V3, P179, DOI 10.1038/ismej.2008.108; Wacklin P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094863; Walsh CJ, 2014, FEBS LETT, V588, P4120, DOI 10.1016/j.febslet.2014.03.035; Wilmes P, 2015, PROTEOMICS, V15, P3409, DOI 10.1002/pmic.201500183; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Zoetendal EG, 2012, ISME J, V6, P1415, DOI 10.1038/ismej.2011.212	66	50	51	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0153294	10.1371/journal.pone.0153294	http://dx.doi.org/10.1371/journal.pone.0153294			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27070903	Green Published, Green Submitted, gold			2022-12-27	WOS:000373900700048
J	Miyazaki, R; Anayama, T; Hirohashi, K; Okada, H; Kume, M; Orihashi, K				Miyazaki, Ryohei; Anayama, Takashi; Hirohashi, Kentaro; Okada, Hironobu; Kume, Motohiko; Orihashi, Kazumasa			In Vitro Drug Sensitivity Tests to Predict Molecular Target Drug Responses in Surgically Resected Lung Cancer	PLOS ONE			English	Article							TYROSINE KINASE INHIBITOR; DROPLET-EMBEDDED CULTURE; CHEMOSENSITIVITY TEST; CELL; GEFITINIB; IMMUNOHISTOCHEMISTRY; CHEMOTHERAPY; SPECIMENS; SARCOMA; PATIENT	Background Epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) and anaplastic lymphoma kinase (ALK) inhibitors have dramatically changed the strategy of medical treatment of lung cancer. Patients should be screened for the presence of the EGFR mutation or echinoderm microtubule-associated protein-like 4 (EML4)-ALK fusion gene prior to chemotherapy to predict their clinical response. The succinate dehydrogenase inhibition (SDI) test and collagen gel droplet embedded culture drug sensitivity test (CD-DST) are established in vitro drug sensitivity tests, which may predict the sensitivity of patients to cytotoxic anticancer drugs. We applied in vitro drug sensitivity tests for cyclopedic prediction of clinical responses to different molecular targeting drugs. Methods The growth inhibitory effects of erlotinib and crizotinib were confirmed for lung cancer cell lines using SDI and CD-DST. The sensitivity of 35 cases of surgically resected lung cancer to erlotinib was examined using SDI or CD-DST, and compared with EGFR mutation status. Results HCC827 (Exon19: E746-A750 del) and H3122 (EML4-ALK) cells were inhibited by lower concentrations of erlotinib and crizotinib, respectively than A549, H460, and H1975 (L858R+T790M) cells were. The viability of the surgically resected lung cancer was 60.0 +/- 9.8 and 86.8 +/- 13.9% in EGFR-mutants vs. wild types in the SDI (p = 0.0003). The cell viability was 33.5 +/- 21.2 and 79.0 +/- 18.6% in EGFR mutants vs. wild-type cases (p = 0.026) in CD-DST. Conclusions In vitro drug sensitivity evaluated by either SDI or CD-DST correlated with EGFR gene status. Therefore, SDI and CD-DST may be useful predictors of potential clinical responses to the molecular anticancer drugs, cyclopedically.	[Miyazaki, Ryohei; Anayama, Takashi; Hirohashi, Kentaro; Okada, Hironobu; Kume, Motohiko; Orihashi, Kazumasa] Kochi Univ, Kochi Med Sch, Div Thorac Surg, Dept Surg 2, Nankoku, Kochi, Japan	Kochi University	Anayama, T (corresponding author), Kochi Univ, Kochi Med Sch, Div Thorac Surg, Dept Surg 2, Nankoku, Kochi, Japan.	anayamat@kochi-u.ac.jp			Kochi Medical School, Kochi University, Japan	Kochi Medical School, Kochi University, Japan	The study was fully funded by the unlimited official fund provided by Kochi Medical School, Kochi University, Japan, http://www.kochi-ms.ac.jp/.	Akobeng AK., 2007, ACTA PAEDIATR, V96; Anayama T, 2001, INT J ONCOL, V18, P151; Cancer Genome Atlas Research Network, 2014, Nature, V511, P543, DOI [10.1038/s41586-018-0228-6, 10.1038/nature13385]; Fukuoka M, 2011, J CLIN ONCOL, V29, P2866, DOI 10.1200/JCO.2010.33.4235; Gandhi J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004576; Higashiyama M, 2010, LUNG CANCER, V68; Hoekstra R, 2005, CLIN CANCER RES, V11, P6908, DOI 10.1158/1078-0432.CCR-05-0720; Kawamura M, 2007, CANCER CHEMOTH PHARM, V59, P507, DOI 10.1007/s00280-006-0292-8; KIMURA H, 1992, SURG TODAY, V22, P508, DOI 10.1007/BF00308895; Kobayashi H, 2005, METH MOLEC MED, V110, P59; Kobayashi H, 1997, INT J ONCOL, V11, P449; Kobayashi H, 2003, RECENT RESULTS CANC, V161, P48; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Le Quesne J, 2014, J THORAC ONCOL, V9, P769, DOI 10.1097/JTO.0000000000000157; Mitsudomi T, 2010, JPN J CLIN ONCOL, V40, P101, DOI 10.1093/jjco/hyp174; Nagai Y, 2005, CANCER RES, V65; Nakatani K, 2007, EUR J CANCER CARE, V16; Rosell R, 2009, NEW ENGL J MED, V361, P958, DOI 10.1056/NEJMoa0904554; Schwitter M, 2013, CASE REP ONCOL, V6, P263, DOI 10.1159/000351607; Shaw AT, 2013, NEW ENGL J MED, V368, P2385, DOI 10.1056/NEJMoa1214886; Sholl LM, 2013, J THORAC ONCOL, V8, P322, DOI 10.1097/JTO.0b013e31827db604; Sudo M, 2013, CANCER CHEMOTH PHARM, V71, P1325, DOI 10.1007/s00280-013-2132-y; TAKEUCHI H, 1994, ANTICANCER RES, V14, P169; Takeuchi K, 2009, CLIN CANCER RES, V15, P3143, DOI 10.1158/1078-0432.CCR-08-3248; Tanahashi M, 2010, J THORAC ONCOL, V5, P1376, DOI 10.1097/JTO.0b013e3181e7d035; Tanaka T, 2007, CANCER SCI, V98; Tsai TH, 2013, LUNG CANCER, V82, P420, DOI 10.1016/j.lungcan.2013.10.005; Uramoto H, 2007, BRIT J CANCER, V96, P857, DOI 10.1038/sj.bjc.6603665; Yamamoto Y, 2012, INTERNAL MED, V51, P2893, DOI 10.2169/internalmedicine.51.8325; Yoshimasu T, 2009, GEN THORAC CARDIOVAS, V57, P138, DOI 10.1007/s11748-008-0332-x	30	8	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0152665	10.1371/journal.pone.0152665	http://dx.doi.org/10.1371/journal.pone.0152665			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27070423	Green Published, gold			2022-12-27	WOS:000373900700013
J	Sanchez-Alcudia, R; Garcia-Hoyos, M; Lopez-Martinez, MA; Sanchez-Bolivar, N; Zurita, O; Gimenez, A; Villaverde, C; da Silva, LRJ; Corton, M; Perez-Carro, R; Torriano, S; Kalatzis, V; Rivolta, C; Avila-Fernandez, A; Lorda, I; Trujillo-Tiebas, MJ; Garcia-Sandoval, B; Lopez-Molina, MI; Blanco-Kelly, F; Riveiro-Alvarez, R; Ayuso, C				Sanchez-Alcudia, Rocio; Garcia-Hoyos, Maria; Angel Lopez-Martinez, Miguel; Sanchez-Bolivar, Noelia; Zurita, Olga; Gimenez, Ascension; Villaverde, Cristina; Rodrigues-Jacy da Silva, Luciana; Corton, Marta; Perez-Carro, Raquel; Torriano, Simona; Kalatzis, Vasiliki; Rivolta, Carlo; Avila-Fernandez, Almudena; Lorda, Isabel; Trujillo-Tiebas, Maria J.; Garcia-Sandoval, Blanca; Isabel Lopez-Molina, Maria; Blanco-Kelly, Fiona; Riveiro-Alvarez, Rosa; Ayuso, Carmen			A Comprehensive Analysis of Choroideremia: From Genetic Characterization to Clinical Practice	PLOS ONE			English	Article							RAB GERANYLGERANYL TRANSFERASE; COMPONENT-A; MUTATIONS; FAMILIES; EXOME	Choroideremia (CHM) is a rare X-linked disease leading to progressive retinal degeneration resulting in blindness. The disorder is caused by mutations in the CHM gene encoding REP-1 protein, an essential component of the Rab geranylgeranyltransferase (GGTase) complex. In the present study, we evaluated a multi-technique analysis algorithm to describe the mutational spectrum identified in a large cohort of cases and further correlate CHM variants with phenotypic characteristics and biochemical defects of choroideremia patients. Molecular genetic testing led to the characterization of 36 out of 45 unrelated CHM families (80%), allowing the clinical reclassification of four CHM families. Haplotype reconstruction showed independent origins for the recurrent p.Arg293* and p.Lys178Argfs*5 mutations, suggesting the presence of hotspots in CHM, as well as the identification of two different unrelated events involving exon 9 deletion. No certain genotype-phenotype correlation could be established. Furthermore, all the patients' fibroblasts analyzed presented significantly increased levels of unprenylated Rabs proteins compared to control cells; however, this was not related to the genotype. This research demonstrates the major potential of the algorithm proposed for diagnosis. Our data enhance the importance of establish a differential diagnosis with other retinal dystrophies, supporting the idea of an underestimated prevalence of choroideremia. Moreover, they suggested that the severity of the disorder cannot be exclusively explained by the genotype.	[Sanchez-Alcudia, Rocio; Garcia-Hoyos, Maria; Angel Lopez-Martinez, Miguel; Sanchez-Bolivar, Noelia; Zurita, Olga; Gimenez, Ascension; Villaverde, Cristina; Rodrigues-Jacy da Silva, Luciana; Corton, Marta; Perez-Carro, Raquel; Avila-Fernandez, Almudena; Lorda, Isabel; Trujillo-Tiebas, Maria J.; Blanco-Kelly, Fiona; Riveiro-Alvarez, Rosa; Ayuso, Carmen] IIS FJD, Dept Genet, Madrid, Spain; [Sanchez-Alcudia, Rocio; Angel Lopez-Martinez, Miguel; Sanchez-Bolivar, Noelia; Zurita, Olga; Gimenez, Ascension; Villaverde, Cristina; Corton, Marta; Perez-Carro, Raquel; Avila-Fernandez, Almudena; Lorda, Isabel; Trujillo-Tiebas, Maria J.; Blanco-Kelly, Fiona; Riveiro-Alvarez, Rosa; Ayuso, Carmen] ISCIII, Ctr Invest Biomed Red Enfermedades Raras CIBERER, Madrid, Spain; [Torriano, Simona; Kalatzis, Vasiliki] Inst Neurosci Montpellier, INSERM, U1051, Montpellier, France; [Rivolta, Carlo] Univ Lausanne, Dept Med Genet, Lausanne, Switzerland; [Garcia-Sandoval, Blanca; Isabel Lopez-Molina, Maria] IIS Fdn Jimenez Diaz Univ Hosp, Dept Ophthalmol, Madrid, Spain; [Garcia-Hoyos, Maria] Inst Med Genom, Valencia, Spain; [Rodrigues-Jacy da Silva, Luciana] Univ Mogi das Cruzes, Sao Paulo, Brazil	Fundacion Jimenez Diaz; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; University of Lausanne; Fundacion Jimenez Diaz; Universidade de Mogi das Cruzes	Ayuso, C (corresponding author), IIS FJD, Dept Genet, Madrid, Spain.; Ayuso, C (corresponding author), ISCIII, Ctr Invest Biomed Red Enfermedades Raras CIBERER, Madrid, Spain.	cayuso@fjd.es	Kalatzis, Vasiliki/F-6170-2019	Kalatzis, Vasiliki/0000-0002-9626-8807; Rivolta, Carlo/0000-0002-0733-9950; Ayuso, Carmen/0000-0002-9242-7065; Corton, Marta/0000-0003-0087-1626; Blanco-Kelly, Fiona/0000-0003-0052-5651	Fondo de Investigacion Sanitaria - FIS [13/00226]; Centre for Biomedical Network Research on Rare Diseases -CIBERER [06/07/0036]; Biobank of University Hospital Fundacion Jimenez Diaz Hospital [PT13/0010/0012]; ONCE; Swiss National Science Foundation [31003A_156260]; European Union Seventh Framework Programme [FP7-People-ITN] [317472]; Fundacion Conchita Rabago (FCR); association France Choroideremia; association Retina France; Association Francaise contre les Myopathies;  [CD12/00676];  [CP13/03256]	Fondo de Investigacion Sanitaria - FIS(Instituto de Salud Carlos III); Centre for Biomedical Network Research on Rare Diseases -CIBERER; Biobank of University Hospital Fundacion Jimenez Diaz Hospital; ONCE; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Union Seventh Framework Programme [FP7-People-ITN]; Fundacion Conchita Rabago (FCR); association France Choroideremia; association Retina France; Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); ; 	The research leading to these results has received funding from the following research grants: Fondo de Investigacion Sanitaria - FIS (PI:13/00226), the Centre for Biomedical Network Research on Rare Diseases -CIBERER (06/07/0036), the Biobank of University Hospital Fundacion Jimenez Diaz Hospital (PT13/0010/0012), ONCE, Swiss National Science Foundation (Grant Number 31003A_156260), the European Union Seventh Framework Programme [FP7-People-2012-ITN] under grant agreement 317472 (EyeTN), the patient associations France Choroideremia, Retina France and the Association Francaise contre les Myopathies. RSA is supported by Sara Borrell CD12/00676, MC by Miguel Servet CP13/03256 and RPC by Fundacion Conchita Rabago (FCR).	ANDRES DA, 1993, CELL, V73, P1091, DOI 10.1016/0092-8674(93)90639-8; Cereso N, 2014, MOL THER-METH CLIN D, V1, DOI 10.1038/mtm.2014.11; Corton M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065574; Crow JF, 2000, NAT REV GENET, V1, P40, DOI 10.1038/35049558; Dimopoulos IS, 2015, EXPERT OPIN ORPHAN D, V3, P787, DOI 10.1517/21678707.2015.1046434; DONNELLY P, 1994, HUM MOL GENET, V3, P1017, DOI 10.1093/hmg/3.6.1017; Garcia-Hoyos M, 2008, INVEST OPHTH VIS SCI, V49, P1315, DOI 10.1167/iovs.07-1169; Larijani B, 2003, J BIOL CHEM, V278, P46798, DOI 10.1074/jbc.M307799200; Li SQ, 2014, INT J MOL MED, V34, P573, DOI 10.3892/ijmm.2014.1797; Lorda-Sanchez I J, 2000, Ophthalmic Genet, V21, P185, DOI 10.1076/1381-6810(200009)21:3;1-Z;FT185; Lutsenko E, 1999, MUTAT RES-REV MUTAT, V437, P11, DOI 10.1016/S1383-5742(99)00065-4; MacDonald IM, 2003, GENEREVIEWS; McTaggart KE, 2002, HUM MUTAT, V20, P189, DOI 10.1002/humu.10114; Preising Markus, 2004, Ophthalmic Genet, V25, P101, DOI 10.1080/13816810490514333; SEABRA MC, 1992, CELL, V70, P1049, DOI 10.1016/0092-8674(92)90253-9; SEABRA MC, 1993, SCIENCE, V259, P377, DOI 10.1126/science.8380507; Sun Y, 2015, HUM MUTAT, V36, P648, DOI 10.1002/humu.22783; Trujillo M J, 1998, Hum Mutat, V12, P213; van den Hurk JAJM, 2003, HUM GENET, V113, P268, DOI 10.1007/s00439-003-0970-0	19	38	39	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0151943	10.1371/journal.pone.0151943	http://dx.doi.org/10.1371/journal.pone.0151943			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27070432	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000373900700005
J	Collins, FL; Irwin, R; Bierhalter, H; Schepper, J; Britton, RA; Parameswaran, N; McCabe, LR				Collins, Fraser L.; Irwin, Regina; Bierhalter, Hayley; Schepper, Jonathan; Britton, Robert A.; Parameswaran, Narayanan; McCabe, Laura R.			Lactobacillus reuteri 6475 Increases Bone Density in Intact Females Only under an Inflammatory Setting	PLOS ONE			English	Article							INTESTINAL MICROBIOME; GENDER-DIFFERENCES; T-CELLS; EXPRESSION; CYTOKINES; OBESITY; TYPE-1; OSTEOCLASTOGENESIS; OSTEOPROTEGERIN; INTERLEUKIN-10	Background & Aims We previously demonstrated that short-term oral administration of the probiotic Lactobacillus reuteri 6475 enhanced bone density in male but not female mice. We also established that L. reuteri 6475 enhanced bone health and prevented bone loss in estrogen-deficient female mice. In this study, we tested whether a mild inflammatory state and/or a long-term treatment with the probiotic was required to promote a positive bone effect in estrogen-sufficient female mice. Methods A mild inflammatory state was induced in female mice by dorsal surgical incision (DSI). Following DSI animals were orally supplemented with L. reuteri or vehicle control for a period of 8 weeks. Gene expression was measured in the intestine and bone marrow by qPCR. Distal femoral bone density and architecture was analyzed by micro-CT. Results We report that 8 weeks after DSI there is a significant increase in the weight of spleen, thymus and visceral (retroperitoneal) fat pads. Expression of intestinal cytokines and tight junction proteins are also altered 8 weeks post-DSI. Interestingly, L. reuteri treatment was found to display both intestinal region-and inflammation-dependent effects. Unexpectedly we identified that 1) L. reuteri treatment increased bone density in females but only in those that underwent DSI and 2) DSI benefited cortical bone parameters. In the bone marrow, dorsal surgery induced CD4(+) T cell numbers, a response that was unaffected by L. reuteri treatment, whereas expression of RANKL, OPG and IL-10 were significantly affected by L. reuteri treatment. Conclusion Our data reveals a previously unappreciated effect of a mild surgical procedure causing a long-lasting effect on inflammatory gene expression in the gut and the bone. Additionally, we demonstrate that in intact female mice, the beneficial effect of L. reuteri on bone requires an elevated inflammatory status.	[Collins, Fraser L.; Irwin, Regina; Bierhalter, Hayley; Schepper, Jonathan; Parameswaran, Narayanan; McCabe, Laura R.] Michigan State Univ, Dept Physiol, E Lansing, MI 48824 USA; [Britton, Robert A.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [McCabe, Laura R.] Michigan State Univ, Dept Radiol, E Lansing, MI 48824 USA; [McCabe, Laura R.] Michigan State Univ, Biomed Imaging Res Ctr, E Lansing, MI 48824 USA	Michigan State University; Baylor College of Medicine; Michigan State University; Michigan State University	Parameswaran, N; McCabe, LR (corresponding author), Michigan State Univ, Dept Physiol, E Lansing, MI 48824 USA.; McCabe, LR (corresponding author), Michigan State Univ, Dept Radiol, E Lansing, MI 48824 USA.; McCabe, LR (corresponding author), Michigan State Univ, Biomed Imaging Res Ctr, E Lansing, MI 48824 USA.	narap@msu.edu; mccabel@msu.edu	Collins, Fraser/AAT-7889-2020; Parameswaran, Narayanan/V-1969-2019	Collins, Fraser/0000-0002-1156-6873; Parameswaran, Narayanan/0000-0002-8894-5564	National Center for Complementary and Integrative Health, U.S National Institutes of Health [1R01AT007695-01]; National Institute of Diabetes and Digestive and Kidney Diseases, U.S National Institutes of Health [R01DK101050]; National Institute of Health [RO1 DK101050, RO1 AT007695]; National Center for Complementary & Integrative Health [R01AT007695] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI099404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK101050, P30DK020572] Funding Source: NIH RePORTER	National Center for Complementary and Integrative Health, U.S National Institutes of Health; National Institute of Diabetes and Digestive and Kidney Diseases, U.S National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Study funded by National Center for Complementary and Integrative Health (https://nccih.nih.gov/), U.S National Institutes of Health (Grant Code: 1R01AT007695-01) awarded to LRM, NP and RAB and by National Institute of Diabetes and Digestive and Kidney Diseases (www.niddk.nih.gov/), U.S National Institutes of Health (Grant code: R01DK101050) awarded to LRM and NP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank the Investigative Histology Laboratory in the Department of Physiology, Division of Human Pathology and the Biomedical Imaging Center at Michigan State University for their assistance with histology and imaging, respectively. The authors are also grateful to the staff of Campus Animal Resources for the excellent care of our animals. These studies were supported by funding from the National Institute of Health, grants RO1 DK101050 and RO1 AT007695.	Amarasekara DS, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/832127; Azuma Y, 2000, J BIOL CHEM, V275, P4858, DOI 10.1074/jbc.275.7.4858; Blair HC, 2004, HISTOL HISTOPATHOL, V19, P189, DOI 10.14670/HH-19.189; Britton RA, 2014, J CELL PHYSIOL, V229, P1822, DOI 10.1002/jcp.24636; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Cao JJ, 2010, ANN NY ACAD SCI, V1192, P292, DOI 10.1111/j.1749-6632.2009.05252.x; Cao JJ, 2009, BONE, V44, P1097, DOI 10.1016/j.bone.2009.02.017; Card JW, 2006, J IMMUNOL, V177, P621, DOI 10.4049/jimmunol.177.1.621; Diodato MD, 2001, CYTOKINE, V14, P162, DOI 10.1006/cyto.2001.0861; Ducy P, 2010, J CELL BIOL, V191, P7, DOI 10.1083/jcb.201006123; Dunne JL, 2014, CLIN EXP IMMUNOL, V177, P30, DOI 10.1111/cei.12321; Eming SA, 2007, J INVEST DERMATOL, V127, P514, DOI 10.1038/sj.jid.5700701; Evans KE, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-4; Franceschi C, 2000, ANN NY ACAD SCI, V908, P244; Gao YH, 2007, J CLIN INVEST, V117, P122, DOI 10.1172/JCI30074; Guo S, 2010, J DENT RES, V89, P219, DOI 10.1177/0022034509359125; Halade GV, 2011, EXP GERONTOL, V46, P43, DOI 10.1016/j.exger.2010.09.014; Harris L, 2009, AM J PHYSIOL-GASTR L, V296, pG1020, DOI 10.1152/ajpgi.90696.2008; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Irwin R, 2015, AM J PHYSL GAS UNPUB; Irwin R, 2013, INFLAMM BOWEL DIS, V19, P1586, DOI 10.1097/MIB.0b013e318289e17b; Karsenty G, 2009, ANNU REV CELL DEV BI, V25, P629, DOI 10.1146/annurev.cellbio.042308.113308; Kostic AD, 2014, GASTROENTEROLOGY, V146, P1489, DOI 10.1053/j.gastro.2014.02.009; Kular J, 2012, CLIN BIOCHEM, V45, P863, DOI 10.1016/j.clinbiochem.2012.03.021; Kwon HK, 2010, P NATL ACAD SCI USA, V107, P2159, DOI 10.1073/pnas.0904055107; Kyung TW, 2009, J NUTR, V139, P502, DOI 10.3945/jn.108.100032; Lavasani S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009009; Liu DW, 2006, EUR J ORAL SCI, V114, P42, DOI 10.1111/j.1600-0722.2006.00283.x; Mccabe LR, 2013, J CELL PHYSIOL, V228, P1793, DOI 10.1002/jcp.24340; McCabe LR, 2011, CRIT REV EUKAR GENE, V21, P187, DOI 10.1615/CritRevEukarGeneExpr.v21.i2.70; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; Mowat AM, 2014, NAT REV IMMUNOL, V14, P667, DOI 10.1038/nri3738; Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452; Nakchbandi IA, 2009, NAT REV GASTRO HEPAT, V6, P660, DOI 10.1038/nrgastro.2009.166; Neurath MF, 2014, NAT REV IMMUNOL, V14, P329, DOI 10.1038/nri3661; O'Brien CA, 2013, BONE, V54, P258, DOI 10.1016/j.bone.2012.08.121; Ohlsson C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092368; Pagnini C, 2010, P NATL ACAD SCI USA, V107, P454, DOI 10.1073/pnas.0910307107; Scher JU, 2011, NAT REV RHEUMATOL, V7, P569, DOI 10.1038/nrrheum.2011.121; Schnabl B, 2014, GASTROENTEROLOGY, V146, P1513, DOI 10.1053/j.gastro.2014.01.020; Shirkey TW, 2006, EXP BIOL MED, V231, P1333, DOI 10.1177/153537020623100807; Smits HH, 2005, J ALLERGY CLIN IMMUN, V115, P1260, DOI 10.1016/j.jaci.2005.03.036; Souza PPC, 2013, IMMUNOL INVEST, V42, P555, DOI 10.3109/08820139.2013.822766; Takayanagi H, 2009, NAT REV RHEUMATOL, V5, P667, DOI 10.1038/nrrheum.2009.217; Teitelbaum SL, 2007, AM J PATHOL, V170, P427, DOI 10.2353/ajpath.2007.060834; Thomas CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031951; Udagawa N, 2000, ENDOCRINOLOGY, V141, P3478, DOI 10.1210/en.141.9.3478; Verdam FJ, 2013, OBESITY, V21, pE607, DOI 10.1002/oby.20466; Wei S, 2005, TNF INDUCED OSTEOCLA, V115, DOI [10.1172/JCI200523394.282, DOI 10.1172/JCI200523394.282]; Weitzmann MN, 2006, J CLIN INVEST, V116, P1186, DOI 10.1172/JCI28550; Xu SQ, 2012, RHEUMATOL INT, V32, P3397, DOI 10.1007/s00296-011-2175-5; Zhang J, 2015, ENDOCRINOLOGY, V156, P3169, DOI 10.1210/EN.2015-1308	52	61	67	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2016	11	4							e0153180	10.1371/journal.pone.0153180	http://dx.doi.org/10.1371/journal.pone.0153180			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6JK	27058036	Green Published, gold, Green Submitted			2022-12-27	WOS:000373604800020
J	Chen, G; Le, Y; Zhou, L; Gong, L; Li, XX; Li, YL; Liao, Q; Duan, KM; Tong, JB; Ouyang, W				Chen, Gong; Le, Yuan; Zhou, Lei; Gong, Li; Li, Xiaoxiao; Li, Yunli; Liao, Qin; Duan, Kaiming; Tong, Jianbin; Ouyang, Wen			Dexmedetomidine Inhibits Maturation and Function of Human Cord Blood-Derived Dendritic Cells by Interfering with Synthesis and Secretion of IL-12 and IL-23	PLOS ONE			English	Article							CANCER RECURRENCE; ANESTHETIC TECHNIQUE; BREAST-CANCER; IN-VITRO; T-CELLS; ACTIVATION; SURGERY; METASTASIS; ISOFLURANE; PROPOFOL	Aims To investigate the effects and underlying mechanism of dexmedetomidine on the cultured human dendritic cells (DCs). Methods Human DCs and cytotoxic T lymphocytes (CTLs) were obtained from human cord blood mononuclear cells by density gradient centrifugation. Cultured DCs were divided into three groups: dexmedetomidine group, dexmedetomidine plus yohimbine (dexmedetomidine inhibitor) group and control group. DCs in the three groups were treated with dexmedetomidine, dexmedetomidine plus yohimbine and culture medium, respectively. After washing, the DCs were co-incubated with cultured CTLs. The maturation degree of DCs was evaluated by detecting (1) the ratios of HLA-DR-, CD86-, and CD80-positive cells (flow cytometry), and (2) expression of IL-12 and IL-23 (PCR and Elisa). The function of DCs was evaluated by detecting the proliferation (MTS assay) and cytotoxicity activity (the Elisa of IFN-gamma) of CTLs. In addition, in order to explore the mechanisms of dexmedetomidine modulating DCs, alpha 2-adrenergic receptor and its downstream signals in DCs were also detected. Results The ratios of HLA-DR-, CD86-, and CD80-positive cells to total cells were similar among the three groups (P>0.05). Compared to the control group, the protein levels of IL-12 and IL-23 in the culture medium and the mRNA levels of IL-12 p35, IL-12 p40 and IL-23 p19 in the DCs all decreased in dexmedetomidine group (P<0.05). In addition, the proliferation of CTLs and the secretion of IFN-gamma also decreased in the dexmedetomidine group, compared with the control group (P<0.05). Moreover, these changes induced by dexmedetomidine in the dexmedetomidine group were reversed by alpha 2-adrenergic receptor inhibitor yohimbine in the dexmedetomidine plus yohimbine group. It was also found the decrease of mRNA levels of IL-12 p35, IL-12 p40 and IL-23 p19 in the dexmedetomidine group could be reversed by ERK1/2 or AKT inhibitors. Conclusion Dexmedetomidine could negatively modulate human immunity by inhibiting the maturation of DCs and then decreasing the proliferation and cytotoxicity activity of CTLs. The alpha 2-adrenergic receptors and its downstream molecules ERK1/2 and AKT are closely involved in the modulation of dexmedetomidine on DCs.	[Chen, Gong; Le, Yuan; Zhou, Lei; Gong, Li; Li, Xiaoxiao; Li, Yunli; Liao, Qin; Duan, Kaiming; Tong, Jianbin; Ouyang, Wen] Cent S Univ, Xiangya Hosp 3, Dept Anesthesiol, Changsha, Hunan, Peoples R China; [Tong, Jianbin] Cent S Univ, Xiangya Hosp 3, Ctr Med Expt, Changsha, Hunan, Peoples R China	Central South University; Central South University	Tong, JB; Ouyang, W (corresponding author), Cent S Univ, Xiangya Hosp 3, Dept Anesthesiol, Changsha, Hunan, Peoples R China.; Tong, JB (corresponding author), Cent S Univ, Xiangya Hosp 3, Ctr Med Expt, Changsha, Hunan, Peoples R China.	jianbintong@aliyun.com; ouyangwen133@vip.sina.com			National Natural Science Foundation of China [81172200]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by grants from National Natural Science Foundation of China (No. 81172200), www.nsfc.gov.cn. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, CANCER PREV RES, V6, P1262, DOI [10.1158/1940-6207.CAPR-13-0079, DOI 10.1158/1940-6207.CAPR-13-0079]; [Anonymous], 2008, ANESTHESIOLOGY, V109, P180, DOI [10.1097/ALN.0b013e31817f5b73, DOI 10.1097/ALN.0B013E31817F5B73]; [Anonymous], 2010, ANESTHESIOLOGY, V113, P570, DOI [10.1097/ALN.0b013e3181e4f6ec, DOI 10.1097/ALN.0B013E3181E4F6EC]; [Anonymous], 2011, ANESTHESIOLOGY, V114, P355, DOI [10.1097/ALN.0b013e3182070c1f, DOI 10.1097/ALN.0B013E3182070C1F]; Benzonana LL, 2013, ANESTHESIOLOGY, V119, P593, DOI 10.1097/ALN.0b013e31829e47fd; Dudek AM, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00438; Exadaktylos AK, 2006, ANESTHESIOLOGY, V105, P660, DOI 10.1097/00000542-200610000-00008; Gong L, 2013, MED HYPOTHESES, V80, P308, DOI 10.1016/j.mehy.2012.12.013; Gottschalk A, 2010, ANESTH ANALG, V110, P1636, DOI 10.1213/ANE.0b013e3181de0ab6; Gu JT, 2011, CRIT CARE, V15, DOI 10.1186/cc10283; Guery L, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/314620; Hennon Mark W, 2013, Zhongguo Fei Ai Za Zhi, V16, pC5, DOI 10.3779/j.issn.1009-3419.2013.03.11; Hiller J, 2013, BEST PRAC RES-CL ANA, V27, P427, DOI 10.1016/j.bpa.2013.10.003; Huang H, 2014, BRIT J CANCER, V111, P1338, DOI 10.1038/bjc.2014.426; Iwasaki Masae, 2015, Acta Anaesthesiol Taiwan, V53, P99, DOI 10.1016/j.aat.2015.07.002; Kang BY, 2003, EUR J PHARMACOL, V467, P223, DOI 10.1016/S0014-2999(03)01628-5; Koda K, 2003, J AM COLL SURGEONS, V197, P254, DOI 10.1016/S1072-7515(03)00115-7; Koda K, 1997, INT SURG, V82, P190; Liu QL, 2009, HEPATOB PANCREAT DIS, V8, P529; Luo X, 2015, BRIT J ANAESTH, V114, P831, DOI 10.1093/bja/aeu408; Ma DQ, 2004, EUR J PHARMACOL, V502, P87, DOI 10.1016/j.ejphar.2004.08.044; Mansfield AS, 2011, VIRCHOWS ARCH, V459, P391, DOI 10.1007/s00428-011-1145-3; Matsen CB, 2013, JAMA SURG, V148, P971, DOI 10.1001/jamasurg.2013.3393; Meng JJ, 2013, INT IMMUNOPHARMACOL, V17, P1084, DOI 10.1016/j.intimp.2013.10.012; Messmer D, 2006, MOL MED, V12, P284, DOI 10.2119/2006-00043.Messmer; Ngiow SF, 2013, TRENDS IMMUNOL, V34, P548, DOI 10.1016/j.it.2013.07.004; Ohta N, 2009, ANESTH ANALG, V109, P793, DOI 10.1213/ane.0b013e3181adc384; Qiao H, 2009, CRIT CARE, V13, DOI 10.1186/cc8012; Snyder GL, 2010, BRIT J ANAESTH, V105, P106, DOI 10.1093/bja/aeq164; Sud R, 2008, EUR J PHARMACOL, V588, P217, DOI 10.1016/j.ejphar.2008.04.043; Tavare AN, 2012, INT J CANCER, V130, P1237, DOI 10.1002/ijc.26448; Ueshima H, 2013, IMMUNOPHARM IMMUNOT, V35, P558, DOI 10.3109/08923973.2013.822509; Vignali DAA, 2012, NAT IMMUNOL, V13, P722, DOI 10.1038/ni.2366; Wang JH, 2011, J BIOL CHEM, V286, P10225, DOI 10.1074/jbc.M110.188680; Xia ZQ, 2013, J SURG RES, V185, P833, DOI 10.1016/j.jss.2013.06.062; Yanagawa Y, 2010, J IMMUNOL, V185, P5762, DOI 10.4049/jimmunol.1001899; Yaniv SP, 2010, EUR J CELL BIOL, V89, P712, DOI 10.1016/j.ejcb.2010.05.002; YJ L., 2001, CELL, V106, P259	38	11	11	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153288	10.1371/journal.pone.0153288	http://dx.doi.org/10.1371/journal.pone.0153288			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27054340	gold, Green Published, Green Submitted			2022-12-27	WOS:000373608000115
J	Herdman, MT; Maude, RJ; Chowdhury, MS; Kingston, HWF; Jeeyapant, A; Samad, R; Karim, R; Dondorp, AM; Hossain, MA				Herdman, M. Trent; Maude, Richard James; Chowdhury, Md. Safiqul; Kingston, Hugh W. F.; Jeeyapant, Atthanee; Samad, Rasheda; Karim, Rezaul; Dondorp, Arjen M.; Hossain, Md. Amir			The Relationship between Poverty and Healthcare Seeking among Patients Hospitalized with Acute Febrile Illnesses in Chittagong, Bangladesh	PLOS ONE			English	Article							SOCIOECONOMIC-DEVELOPMENT; OBSTETRIC CARE; CHILD HEALTH; MANAGEMENT; BEHAVIOR; INTERVENTIONS; MALARIA; DISEASE; GENDER; EQUITY	Delays in seeking appropriate healthcare can increase the case fatality of acute febrile illnesses, and circuitous routes of care-seeking can have a catastrophic financial impact upon patients in low-income settings. To investigate the relationship between poverty and pre-hospital delays for patients with acute febrile illnesses, we recruited a cross-sectional, convenience sample of 527 acutely ill adults and children aged over 6 months, with a documented fever >= 38.0 degrees C and symptoms of up to 14 days' duration, presenting to a tertiary referral hospital in Chittagong, Bangladesh, over the course of one year from September 2011 to September 2012. Participants were classified according to the socioeconomic status of their households, defined by the Oxford Poverty and Human Development Initiative's multidimensional poverty index (MPI). 51% of participants were classified as multidimensionally poor (MPI>0.33). Median time from onset of any symptoms to arrival at hospital was 22 hours longer for MPI poor adults compared to non-poor adults (123 vs. 101 hours) rising to a difference of 26 hours with adjustment in a multivariate regression model (95% confidence interval 7 to 46 hours; P = 0.009). There was no difference in delays for children from poor and non-poor households (97 vs. 119 hours; P = 0.394). Case fatality was 5.9% vs. 0.8% in poor and non-poor individuals respectively (P = 0.001)-5.1% vs. 0.0% for poor and non-poor adults (P = 0.010) and 6.4% vs. 1.8% for poor and non-poor children (P = 0.083). Deaths were attributed to central nervous system infection (11), malaria (3), urinary tract infection (2), gastrointestinal infection (1) and undifferentiated sepsis (1). Both poor and non-poor households relied predominantly upon the (often informal) private sector for medical advice before reaching the referral hospital, but MPI poor participants were less likely to have consulted a qualified doctor. Poor participants were more likely to attribute delays in decision-making and travel to a lack of money (P<0.001), and more likely to face catastrophic expenditure of more than 25% of monthly household income (P<0.001). We conclude that multidimensional poverty is associated with greater pre-hospital delays and expenditure in this setting. Closer links between health and development agendas could address these consequences of poverty and streamline access to adequate healthcare.	[Herdman, M. Trent; Maude, Richard James; Kingston, Hugh W. F.; Jeeyapant, Atthanee; Dondorp, Arjen M.] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand; [Herdman, M. Trent] Univ Oxford, Univ Coll, Oxford, England; [Maude, Richard James; Dondorp, Arjen M.] Churchill Hosp, Nuffield Dept Clin Med, Ctr Trop Med, Oxford OX3 7LJ, England; [Chowdhury, Md. Safiqul; Samad, Rasheda; Karim, Rezaul; Hossain, Md. Amir] Chittagong Med Coll Hosp, Chittagong, Bangladesh; [Kingston, Hugh W. F.] Menzies Sch Hlth Res, Global Hlth Div, Darwin, NT, Australia; [Kingston, Hugh W. F.] Charles Darwin Univ, Darwin, NT 0909, Australia	Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; University of Oxford; University of Oxford; Chittagong Medical College; Charles Darwin University; Menzies School of Health Research; Charles Darwin University	Herdman, MT (corresponding author), Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand.; Herdman, MT (corresponding author), Univ Oxford, Univ Coll, Oxford, England.	mtherdman@gmail.com	Maude, Richard James/AAV-3567-2020	Maude, Richard James/0000-0002-5355-0562	Radcliffe Travelling Fellowship, University College, University of Oxford; National Institute for Health Research [ACF-2014-18-007] Funding Source: researchfish	Radcliffe Travelling Fellowship, University College, University of Oxford; National Institute for Health Research(National Institute for Health Research (NIHR))	MTH was funded by the Radcliffe Travelling Fellowship, University College, University of Oxford. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acestor N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044269; Afsana K, 2004, REPROD HEALTH MATTER, V12, P171, DOI 10.1016/S0968-8080(04)24142-8; Ahmed S M, 2001, Asia Pac J Public Health, V13, P100, DOI 10.1177/101053950101300208; Ahmed S, 2011, HEALTH POLICY PLANN, V26, P25, DOI 10.1093/heapol/czq015; Ahmed SM, 2005, B WORLD HEALTH ORGAN, V83, P109; Ahmed SM, 2003, HEALTH POLICY PLANN, V18, P306, DOI 10.1093/heapol/czg037; Ahmed SM, 2000, SOC SCI MED, V51, P361, DOI 10.1016/S0277-9536(99)00461-X; Ahmed SM, 2013, LANCET, V382, P1746, DOI 10.1016/S0140-6736(13)62147-9; Ahmed SM, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-173; ALKIRE S., 2010, 38 OPHI; ASHRAF A, 1982, SOC SCI MED, V16, P2041, DOI 10.1016/0277-9536(82)90160-5; Bangladesh Bureau of Statistics, 2012, POP HOUS CENS 2011 S; Bangladesh Bureau of Statistics, 2011, REP SAMPL VIT REG SY; Bhuiya A, 2007, J HEALTH POPUL NUTR, V25, P134; Chaudhury N, 2006, J ECON PERSPECT, V20, P91, DOI 10.1257/089533006776526058; Chaudhury N, 2003, 3065 WORLD BANK DEV; Chowdhury, 2018, CREATING CULTURE INN; Cockroft A, 2004, BANGLADESH HLTH POPU; Dhillon PK, 2012, INT J EPIDEMIOL, V41, P847, DOI 10.1093/ije/dys046; Dror DM, 2008, INDIAN J MED RES, V127, P347; El Arifeen S, 2008, J HEALTH POPUL NUTR, V26, P22; Elsinga J, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004237; FerroLuzzi A, 1996, BRIT J NUTR, V75, P3, DOI 10.1079/BJN19960105; Gomes MF, 2009, LANCET, V373, P557, DOI 10.1016/S0140-6736(08)61734-1; GWATKIN DR, 2007, SOCIOECONOMIC DIFFER; Health WCoSDo, 2008, CLOS GAP GEN HLTH EQ; Killewo J, 2006, J HEALTH POPUL NUTR, V24, P403; Killingsworth JR, 1999, HEALTH POLICY PLANN, V14, P152, DOI 10.1093/heapol/14.2.152; Knaul FM, 2006, LANCET, V368, P1828, DOI 10.1016/S0140-6736(06)69565-2; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; Lin AL, 2010, NEUROLOGIST, V16, P143, DOI 10.1097/NRL.0b013e3181d14185; Najnin N, 2011, J HEALTH POPUL NUTR, V29, P523, DOI 10.3329/jhpn.v29i5.8907; National Institute of Population Research and Training Mitra and Associates & Macro International, 2009, BANGL DEM HLTH SURV; Organization for Economic Co-operation & Development, 1982, OECD LIST SOC IND; Pitchforth E, 2007, HEALTH POLICY PLANN, V22, P311, DOI 10.1093/heapol/czm022; Rahman MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056873; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Ryan GW, 1998, SOC SCI MED, V46, P209, DOI 10.1016/S0277-9536(97)00151-2; Sayem ASM, 2011, THESIS; Sen B, 1997, HLTH POVERTY CONTEXT; Tusting LS, 2013, LANCET, V382, P963, DOI 10.1016/S0140-6736(13)60851-X; United Nations Development Program, 2010, HUM DEV REP 2010 REA; Vialle-Valentin Catherine E, 2015, J Pharm Policy Pract, V8, P1, DOI 10.1186/s40545-014-0024-0; Victora CG, 2003, LANCET, V362, P233, DOI 10.1016/S0140-6736(03)13917-7; Wagstaff A, 2002, B WORLD HEALTH ORGAN, V80, P97; Webb P, 2005, MANUAL MEASURING INT; Werner WJ, 2009, J HEALTH POPUL NUTR, V27, P563; WHO, 2007, WHO BANGL COUNTR COO; World Bank Development Research Group, 2013, POV HEADC RAT 1 25 D	49	15	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0152965	10.1371/journal.pone.0152965	http://dx.doi.org/10.1371/journal.pone.0152965			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DI6KO	27054362	Green Published, gold			2022-12-27	WOS:000373608000059
J	Mezaal, YS; Eyyuboglu, HT				Mezaal, Yaqeen S.; Eyyuboglu, Halil T.			Investigation of New Microstrip Bandpass Filter Based on Patch Resonator with Geometrical Fractal Slot	PLOS ONE			English	Article							DEGENERATE MODES	A compact dual-mode microstrip bandpass filter using geometrical slot is presented in this paper. The adopted geometrical slot is based on first iteration of Cantor square fractal curve. This filter has the benefits of possessing narrower and sharper frequency responses as compared to microstrip filters that use single mode resonators and traditional dual-mode square patch resonators. The filter has been modeled and demonstrated by Microwave Office EM simulator designed at a resonant frequency of 2 GHz using a substrate of epsilon(r) = 10.8 and thickness of h = 1.27 mm. The output simulated results of the proposed filter exhibit 22 dB return loss, 0.1678 dB insertion loss and 12 MHz bandwidth in the passband region. In addition to the narrow band gained, miniaturization properties as well as weakened spurious frequency responses and blocked second harmonic frequency in out of band regions have been acquired. Filter parameters including insertion loss, return loss, bandwidth, coupling coefficient and external quality factor have been compared with different values of perturbation dimension (d). Also, a full comparative study of this filter as compared with traditional square patch filter has been considered.	[Mezaal, Yaqeen S.; Eyyuboglu, Halil T.] Cankaya Univ, Elect & Commun Engn Dept, Ankara, Turkey	Cankaya University	Mezaal, YS (corresponding author), Cankaya Univ, Elect & Commun Engn Dept, Ankara, Turkey.	yakeen_sbah@yahoo.com	Mezaal, Yaqeen Sabah/O-5095-2019	Mezaal, Yaqeen Sabah/0000-0002-9953-9975	Scientific and Technological Research Council of Turkey (TUBITAK) [21514107-115.02-188888]	Scientific and Technological Research Council of Turkey (TUBITAK)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK))	This work is supported by the Scientific and Technological Research Council of Turkey (TUBITAK) for Post-Doc Research Fellowship for Foreign Citizens Program under Fund Reference (21514107-115.02-188888). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed ES, 2012, RADIOENGINEERING, V21, P617; Barra M., 2004, THESIS U NAPOLI; Chang K., 2004, MICROWAVE RING CIRCU; Choi WW, 2005, ASIA PACIF MICROWAVE, P508; Hasan A, 2008, PROG ELECTROMAGN RES, V78, P393, DOI 10.2528/PIER07091401; Hong J.-S., 2001, WILEY MICRO; HONG JS, 1995, IEEE MICROW GUIDED W, V5, P371, DOI 10.1109/75.473539; Hong JS, 2004, IEEE T MICROW THEORY, V52, P1237, DOI 10.1109/TMTT.2004.825653; Hong JS, 1997, IEEE T MICROW THEORY, V45, P2358, DOI 10.1109/22.643844; HONG JS, 1995, ELECTRON LETT, V31, P891, DOI 10.1049/el:19950591; Kundu AC, 2001, IEEE T MICROW THEORY, V49, P1113, DOI 10.1109/22.925499; Sheta AF, 2008, PROCEEDINGS OF THE 25TH NATIONAL RADIO SCIENCE CONFERENCE: NRSC 2008; Sheta AF, 2006, IEE P-MICROW ANTEN P, V153, P89, DOI 10.1049/ip-map:20050103; Singhal P. K., 2010, Journal of Electromagnetic Analysis and Applications, V2, P98, DOI 10.4236/jemaa.2010.22014; WHEELER HA, 1965, IEEE T MICROW THEORY, VMT13, P172, DOI 10.1109/TMTT.1965.1125962; WOLFF I, 1972, ELECTRON LETT, V8, P302, DOI 10.1049/el:19720223	16	10	10	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0152615	10.1371/journal.pone.0152615	http://dx.doi.org/10.1371/journal.pone.0152615			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27054755	Green Published, Green Submitted, gold			2022-12-27	WOS:000373608000029
J	Rahiman, SSF; Morgan, M; Gray, P; Shaw, PN; Cabot, PJ				Rahiman, Siti Sarah Fazalul; Morgan, Michael; Gray, Paul; Shaw, Paul Nicholas; Cabot, Peter John			Dynorphin 1-17 and Its N-Terminal Biotransformation Fragments Modulate Lipopolysaccharide-Stimulated Nuclear Factor-kappa B Nuclear Translocation, Interleukin-1beta and Tumor Necrosis Factor-alpha in Differentiated THP-1 Cells	PLOS ONE			English	Article							OPIOID AGONIST U50,488H; PERITONEAL-MACROPHAGES; CYTOKINE PRODUCTION; ENDOGENOUS LIGAND; INFLAMED TISSUE; IMMUNE-RESPONSE; NITRIC-OXIDE; IN-VITRO; T-CELLS; RECEPTOR	Dynorphin 1-17, (DYN 1-17) opioid peptide produces antinociception following binding to the kappa-opioid peptide (KOP) receptor. Upon synthesis and release in inflamed tissues by immune cells, DYN 1-17 undergoes rapid biotransformation and yields a unique set of opioid and non-opioid fragments. Some of these major fragments possess a role in immunomodulation, suggesting that opioid-targeted therapeutics may be effective in diminishing the severity of inflammatory disorders. This study aimed to examine the immunomodulatory effects of DYN 1-17 and major N-terminal fragments found in the inflammatory environment on nuclear factor-kappaB/p65 (NF-kappa B/p65) nuclear translocation and the release of interleukin-1beta (IL-1 beta) and tumor necrosis factor-alpha (TNF-alpha) from lipopolysaccharide (LPS)-stimulated, differentiated THP-1 cells. The results demonstrate that NF-kappa B/p65 nuclear translocation was significantly attenuated following treatment with DYN 1-17 and a specific range of fragments, with the greatest reduction observed with DYN 1-7 at a low concentration (10 nM). Antagonism with a selective KOP receptor antagonist, ML-190, significantly reversed the inhibitory effects of DYN 1-17, DYN 1-6, DYN 1-7 and DYN 1-9, but not other DYN 1-17 N-terminal fragments (DYN 1-10 and 1-11) on NF-kappa B/p65 nuclear translocation. DYN 1-17 and selected fragments demonstrated differential modulation on the release of IL-1 beta and TNF-alpha with significant inhibition observed with DYN 1-7 at low concentrations (1 nM and 10 pM). These effects were blocked by ML-190, suggesting a KOP receptor-mediated pathway. The results demonstrate that DYN 1-17 and certain N-terminal fragments, produced in an inflamed environment, play an anti-inflammatory role by inhibiting NF-kappa B/p65 translocation and the subsequent cytokine release through KOP receptor-dependent and independent pathways.	[Rahiman, Siti Sarah Fazalul; Shaw, Paul Nicholas; Cabot, Peter John] Univ Queensland, Sch Pharm, Brisbane, Qld, Australia; [Rahiman, Siti Sarah Fazalul] Univ Sains Malaysia, Sch Pharmaceut Sci, Minden, Penang, Malaysia; [Morgan, Michael] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; [Gray, Paul] Univ Queensland, Sch Med, Brisbane, Qld, Australia; [Gray, Paul] Princess Alexandra Hosp, Dept Anaesthesia, Brisbane, Qld 4102, Australia	University of Queensland; Universiti Sains Malaysia; University of Queensland; University of Queensland	Cabot, PJ (corresponding author), Univ Queensland, Sch Pharm, Brisbane, Qld, Australia.	p.cabot@uq.edu.au	Gray, Paul/F-5507-2010; Morgan, Michael/C-1323-2015; Shaw, Paul/Q-8454-2019; Cabot, Peter John/B-2424-2013; Gray, Paul/S-6355-2019; Rahiman, Siti Sarah Fazalul/S-9187-2018; Shaw, Paul N/G-4418-2010; Morgan, Michael/AAC-2044-2021	Gray, Paul/0000-0002-1369-1483; Morgan, Michael/0000-0002-3641-2774; Shaw, Paul/0000-0001-7154-592X; Cabot, Peter John/0000-0003-1778-3753; Rahiman, Siti Sarah Fazalul/0000-0002-7970-5323; Shaw, Paul N/0000-0001-7154-592X; Morgan, Michael/0000-0002-3641-2774	Ministry of Higher Education Malaysia; Universiti Sains Malaysia (USM)	Ministry of Higher Education Malaysia(Ministry of Education, Malaysia); Universiti Sains Malaysia (USM)(Universiti Sains Malaysia)	Siti Sarah Fazalul Rahiman was supported by a student scholarship from Ministry of Higher Education Malaysia and Universiti Sains Malaysia (USM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alicea C, 1996, J NEUROIMMUNOL, V64, P83, DOI 10.1016/0165-5728(95)00159-X; Alt A, 1998, J PHARMACOL EXP THER, V286, P282; Auwerx J., 1991, J EXP, V47, P22, DOI DOI 10.1007/BF02041244; Banerjee P, 1996, LIFE SCI, V58, P1277, DOI 10.1016/0024-3205(96)00089-6; Baud V, 2009, NAT REV DRUG DISCOV, V8, P33, DOI 10.1038/nrd2781; BELKOWSKI SM, 1995, J PHARMACOL EXP THER, V273, P1491; Borner C, 2013, J IMMUNOL, V191, P4640, DOI 10.4049/jimmunol.1300320; Borner C, 2009, J IMMUNOL, V183, P882, DOI 10.4049/jimmunol.0802763; Buchner RR, 1997, J IMMUNOL, V158, P1670; BUDD K, 2004, ACUTE PAIN, V6, P123; Cabot PJ, 2001, CLIN EXP PHARMACOL P, V28, P230, DOI 10.1046/j.1440-1681.2001.03425.x; Chanput W, 2010, FOOD FUNCT, V1, P254, DOI 10.1039/c0fo00113a; CHAVKIN C, 1982, SCIENCE, V215, P413, DOI 10.1126/science.6120570; CHAVKIN C, 1981, P NATL ACAD SCI-BIOL, V78, P6543, DOI 10.1073/pnas.78.10.6543; Dietis N, 2011, BRIT J ANAESTH, V107, P8, DOI 10.1093/bja/aer115; FADEN AI, 1990, EUR J PHARMACOL, V175, P165, DOI 10.1016/0014-2999(90)90227-W; FOSTER JS, 1987, J LEUKOCYTE BIOL, V42, P171, DOI 10.1002/jlb.42.2.171; Frankowski KJ, 2012, ACS CHEM NEUROSCI, V3, P221, DOI 10.1021/cn200128x; Gabrilovac J, 2012, J NEUROIMMUNOL, V245, P56, DOI 10.1016/j.jneuroim.2012.02.006; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Guan LM, 1997, J NEUROIMMUNOL, V75, P163, DOI 10.1016/S0165-5728(97)00018-0; HANSEN MB, 1989, J IMMUNOL METHODS, V119, P203, DOI 10.1016/0022-1759(89)90397-9; HASSAN AHS, 1992, NEUROSCI LETT, V140, P85, DOI 10.1016/0304-3940(92)90688-4; Hedrick M. P., 2010, PROBE REPORTS NIH MO; ICHINOSE M, 1995, J NEUROIMMUNOL, V60, P37, DOI 10.1016/0165-5728(95)00050-C; Ishihara S, 2001, JPN J PHARMACOL, V87, P14, DOI 10.1254/jjp.87.14; Jordan BA, 1999, NATURE, V399, P697, DOI 10.1038/21441; Kanduri M, 2011, BLOOD CANCER J, V1, DOI 10.1038/bcj.2011.9; Knoll AT, 2010, BRAIN RES, V1314, P56, DOI 10.1016/j.brainres.2009.09.074; Kong LY, 1997, J PHARMACOL EXP THER, V280, P61; Kumar S, 2011, J EXP BIOL, V214, P4217, DOI 10.1242/jeb.062935; Lawrence T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001651; Li JG, 2003, J PHARMACOL EXP THER, V305, P531, DOI 10.1124/jpet.102.045559; MEYER ME, 1993, PHARMACOL BIOCHEM BE, V44, P329, DOI 10.1016/0091-3057(93)90469-A; Morgan EL, 1996, J NEUROIMMUNOL, V65, P21, DOI 10.1016/0165-5728(95)00171-9; Morgan M, 2012, ANAL BIOANAL CHEM, V404, P3111, DOI 10.1007/s00216-012-6406-8; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Oeckinghaus A, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000034; OLSON KG, 1991, LIFE SCI, V48, P575, DOI 10.1016/0024-3205(91)90473-O; PAUL D, 1991, J PHARMACOL EXP THER, V257, P1; PRETE P, 1986, EXP NEUROL, V92, P349, DOI 10.1016/0014-4886(86)90086-5; RADULOVIC J, 1995, J NEUROIMMUNOL, V57, P55, DOI 10.1016/0165-5728(94)00161-G; Roy S, 1998, BIOCHEM BIOPH RES CO, V245, P392, DOI 10.1006/bbrc.1998.8415; SAFAVI A, 1995, J NEUROCHEM, V65, P389; SCHMITZ ML, 1991, EMBO J, V10, P3805, DOI 10.1002/j.1460-2075.1991.tb04950.x; Singh R, 2010, PEPTIDES, V31, P973, DOI 10.1016/j.peptides.2010.01.009; Smith MA, 2002, PSYCHOPHARMACOLOGY, V162, P255, DOI 10.1007/s00213-002-1102-6; SZABO I, 1993, J PHARMACOL EXP THER, V267, P703; TOSK JM, 1993, INT J IMMUNOPHARMACO, V15, P615, DOI 10.1016/0192-0561(93)90079-E; Trask OJ Jr, 2012, NUCL FACTOR KAPPA B; TSUCHIYA S, 1980, INT J CANCER, V26, P171, DOI 10.1002/ijc.2910260208; TSUCHIYA S, 1982, CANCER RES, V42, P1530; Walker JS, 2003, ADV EXP MED BIOL, V521, P148; Welters ID, 2000, ANESTHESIOLOGY, V92, P1677, DOI 10.1097/00000542-200006000-00027; Zhang Q, 1998, NEUROSCIENCE, V85, P281, DOI 10.1016/S0306-4522(97)00647-7	55	9	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153005	10.1371/journal.pone.0153005	http://dx.doi.org/10.1371/journal.pone.0153005			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27055013	Green Published, gold			2022-12-27	WOS:000373608000063
J	Taghizadeh, N; Vonk, JM; Boezen, HM				Taghizadeh, Niloofar; Vonk, Judith M.; Boezen, H. Marike			Lifetime Smoking History and Cause-Specific Mortality in a Cohort Study with 43 Years of Follow-Up	PLOS ONE			English	Article							NEGATIVE EXPONENTIAL MODEL; ALL-CAUSE MORTALITY; BREAST-CANCER RISK; CIGARETTE-SMOKING; LUNG-CANCER; EPIDEMIOLOGIC EVIDENCE; QUITTING SMOKING; PIPE SMOKING; WOMEN; DISEASE	Background In general, smoking increases the risk of mortality. However, it is less clear how the relative risk varies by cause of death. The exact impact of changes in smoking habits throughout life on different mortality risks is less studied. Methods We studied the impact of baseline and lifetime smoking habits, and duration of smoking on the risk of all-cause mortality, mortality of cardiovascular diseases (CVD), chronic obstructive pulmonary disease (COPD), any cancer and of the four most common types of cancer (lung, colorectal, prostate, and breast cancer) in a cohort study (Vlagtwedde-Vlaardingen 1965-1990, with a follow-up on mortality status until 2009, n = 8,645). We used Cox regression models adjusted for age, BMI, sex, and place of residence. Since previous studies suggested a potential effect modification of sex, we additionally stratified by sex and tested for interactions. In addition, to determine which cause of death carried the highest risk we performed competing-risk analyses on mortality due to CVD, cancer, COPD and other causes. Results Current smoking (light, moderate, and heavy cigarette smoking) and lifetime persistent smoking were associated with an increased risk of all-cause, CVD, COPD, any cancer, and lung cancer mortality. Higher numbers of pack years at baseline were associated with an increased risk of all-cause, CVD, COPD, any cancer, lung, colorectal, and prostate cancer mortality. Males who were lifetime persistent pipe/cigar smokers had a higher risk of lung cancer [HR (95% CI) = 7.72 (1.72-34.75)] as well as all-cause and any cancer mortality. A longer duration of smoking was associated with a higher risk of COPD, any and lung cancer [HR (95% CI) = 1.06 (1.00-1.12), 1.03 (1.00-1.06) and 1.10 (1.03-1.17) respectively], but not with other mortality causes. The competing risk analyses showed that ex-and current smokers had a higher risk of cancer, CVD, and COPD mortality compared to all other mortality causes. In addition, heavy smokers had a higher risk for COPD mortality compared to cancer, and CVD mortality. Conclusion Our study indicates that lifetime numbers of cigarettes smoked and the duration of smoking have different impacts for different causes of mortality. Moreover, our findings emphasize the importance of smoking-related competing risks when studying the smoking-related cancer mortality in a general population and that smoking cessation immediately effectively reduces the risk of all-cause and any cancer mortality.	[Taghizadeh, Niloofar; Vonk, Judith M.; Boezen, H. Marike] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [Taghizadeh, Niloofar] Univ Calgary, Cumming Sch Med, Div Resp Med, Calgary, AB, Canada; [Vonk, Judith M.; Boezen, H. Marike] Univ Groningen, Univ Med Ctr Groningen, GRIAC Res Inst, Groningen, Netherlands	University of Groningen; University of Calgary; University of Groningen	Boezen, HM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands.; Boezen, HM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, GRIAC Res Inst, Groningen, Netherlands.	H.M.Boezen@umcg.nl	Vonk, Judith M/ABA-3009-2020; Taghizadeh, Niloofar/AAF-2008-2020; Vonk, Judith/K-8477-2019	Vonk, Judith M/0000-0001-7531-4547; Vonk, Judith/0000-0001-7531-4547	Netherlands Asthma Foundation [187, 32.96.69]; Stichting Astma Bestrijding [2005/020]; GUIDE/University Medical Center Groningen, The Netherlands	Netherlands Asthma Foundation; Stichting Astma Bestrijding; GUIDE/University Medical Center Groningen, The Netherlands	This study was supported by the Netherlands Asthma Foundation (grant numbers 187 and 32.96.69), and Stichting Astma Bestrijding (grant number 2005/020), and GUIDE/University Medical Center Groningen, The Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agudo A, 2012, J CLIN ONCOL, V30, P4550, DOI 10.1200/JCO.2011.41.0183; Athyros VG, 2013, CURR MED RES OPIN, V29, P1263, DOI 10.1185/03007995.2013.827566; BARON JA, 1990, AM J OBSTET GYNECOL, V162, P502, DOI 10.1016/0002-9378(90)90420-C; Beral V, 2002, BRIT J CANCER, V87, P1234, DOI 10.1038/sj.bjc.6600596; Bosse Y, 2012, CANCER RES, V72, P3753, DOI 10.1158/0008-5472.CAN-12-1160; Braithwaite D, 2012, BREAST CANCER RES TR, V136, P521, DOI 10.1007/s10549-012-2276-1; Carter BD, 2015, NEW ENGL J MED, V372, P631, DOI 10.1056/NEJMsa1407211; Chang CM, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1617-5; Clemons M, 2001, NEW ENGL J MED, V344, P276, DOI 10.1056/NEJM200101253440407; Cotterchio M, 2014, BREAST J, V20, P468, DOI 10.1111/tbj.12304; Dossus L, 2014, INT J CANCER, V134, P1871, DOI 10.1002/ijc.28508; Fry JS, 2015, REGUL TOXICOL PHARM, V72, P49, DOI 10.1016/j.yrtph.2015.02.010; Henschke CI, 2006, JAMA-J AM MED ASSOC, V296, P180; Hospers JJ, 2000, EPIDEMIOLOGY, V11, P261, DOI 10.1097/00001648-200005000-00006; Hurley MA, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-95; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Biological agents, 2012, IARC MON EV CARC RIS, V100; International Agency for Research on Cancer, 1986, IARC MON EV CARC RIS, V38, P37; International Agency for Research on Cancer, 2004, IARC MON EV CARC RIS, V83, P1017; Jurgens V, 2013, SWISS MED WKLY, V143, DOI 10.4414/smw.2013.13771; Kenfield SA, 2010, TOB CONTROL, V19, P248, DOI 10.1136/tc.2009.032839; Lee PN, 2014, REGUL TOXICOL PHARM, V68, P85, DOI 10.1016/j.yrtph.2013.11.013; Lee PN, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-189; Lee PN, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-385; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; McCormack VA, 2010, INT J CANCER, V127, P2402, DOI 10.1002/ijc.25252; Mendis S., 2011, GLOBAL ATLAS CARDIOV; Putter H, 2007, STAT MED, V26, P2389, DOI 10.1002/sim.2712; Reynolds P, 2013, J MAMMARY GLAND BIOL, V18, P15, DOI 10.1007/s10911-012-9269-x; Shaper AG, 2003, INT J EPIDEMIOL, V32, P802, DOI 10.1093/ije/dyg206; Sorheim IC, 2010, THORAX, V65, P480, DOI 10.1136/thx.2009.122002; Streppel MT, 2007, TOB CONTROL, V16, P107, DOI 10.1136/tc.2006.017715; Taghizadeh N, 2015, CANCER CAUSE CONTROL, V26, P99, DOI 10.1007/s10552-014-0489-9; Tashkin DP, 2009, RESP MED, V103, P963, DOI 10.1016/j.rmed.2009.02.013; Terry PD, 2002, CANCER EPIDEM BIOMAR, V11, P953; Tverdal A, 2011, TOB CONTROL, V20, P123, DOI 10.1136/tc.2010.036780; Vineis P, 2004, JNCI-J NATL CANCER I, V96, P99, DOI 10.1093/jnci/djh014; World Health Organization, 2012, WHO GLOB REP MORT AT; Xu XP, 1997, LANCET, V350, P1431, DOI 10.1016/S0140-6736(97)10041-1; Yanbaeva DG, 2007, CHEST, V131, P1557, DOI 10.1378/chest.06-2179	39	53	54	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153310	10.1371/journal.pone.0153310	http://dx.doi.org/10.1371/journal.pone.0153310			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27055053	Green Submitted, Green Published, gold			2022-12-27	WOS:000373608000119
J	Golebski, K; van Tongeren, J; van Egmond, D; de Groot, EJ; Fokkens, WJ; van Drunen, CM				Golebski, Korneliusz; van Tongeren, Joost; van Egmond, Danielle; de Groot, Esther J.; Fokkens, Wytske J.; van Drunen, Cornelis M.			Specific Induction of TSLP by the Viral RNA Analogue Poly(I:C) in Primary Epithelial Cells Derived from Nasal Polyps	PLOS ONE			English	Article							THYMIC STROMAL LYMPHOPOIETIN; INNATE LYMPHOID-CELLS; EXPRESSION; IL-33; IL-25; VIRUSES; MITE	Introduction Chronic rhinosinusitis with nasal polyposis is an inflammatory disease that, although not directly linked to allergy, often displays a Th2-skewed inflammation characterized by elevated local IgE and IL-5 levels. The nasal cavity is constantly exposed to bacteria and viruses that may trigger epithelial inflammatory responses. To gain more insight into mechanisms by which such a biased inflammation might arise, we have investigated the epithelial expression of the Th2 skewing mediators (TSLP, IL-25, and IL-33) in relationship to disease and microbial triggers. Methods Epithelial cells were obtained from polyp tissues of nasal polyposis patients and from inferior turbinates of non-diseased controls. Cells were exposed to various TLR-specific triggers to study the effect on mRNA and protein expression level of TSLP, IL-25, and IL-33 and the potential regulatory mechanisms through the expression profile the transcription factors ATF-3, DUSP-1, EGR-1, and NFKB-1. Results The TLR3 agonist and viral analogue poly(I: C) induced TSLP mRNA 13.0 +/- 3.1 fold (p < 0.05) and protein expression by 12.1 +/- 2.3-fold (p < 0.05) higher in epithelium isolated from nasal polyposis patients than in epithelium form healthy controls. This enhanced induction of TSLP may be a consequence of a down-regulated expression of DUSP-1 in polyp epithelium. Conclusion The TLR3 induced expression of TSLP introduces a mechanism by which the Th2-skewed tissue environment might arise in nasal polyps and invites a further evaluation of the potential contribution of current or past viral infections to polyposis pathogenesis.	[Golebski, Korneliusz; van Tongeren, Joost; van Egmond, Danielle; de Groot, Esther J.; Fokkens, Wytske J.; van Drunen, Cornelis M.] Univ Amsterdam, Acad Med Ctr, Dept Otorhinolaryngol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam	Golebski, K (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Otorhinolaryngol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	K.Golebski@amc.uva.nl	Fokkens, Wytske WJ/ABF-2185-2020	van Drunen, Cornelis M/0000-0001-5503-066X	Academic Medical Center, University of Amsterdam	Academic Medical Center, University of Amsterdam	Internal sources of the Academic Medical Center, University of Amsterdam.	Ashrin MN, 2014, J IMMUNOL, V192, P4025, DOI 10.4049/jimmunol.1300276; Bae CH, 2014, BIOCHEM BIOPH RES CO, V448, P231, DOI 10.1016/j.bbrc.2014.04.100; Barlow JL, 2013, J ALLERGY CLIN IMMUN, V132, P933, DOI 10.1016/j.jaci.2013.05.012; Chu DK, 2013, J ALLERGY CLIN IMMUN, V131, P187, DOI 10.1016/j.jaci.2012.08.002; Copenhaver CC, 2004, AM J RESP CRIT CARE, V170, P175, DOI 10.1164/rccm.200312-1647OC; Fokkens Wytske J, 2012, Rhinol Suppl, V23, P1; Fort MM, 2001, IMMUNITY, V15, P985, DOI 10.1016/S1074-7613(01)00243-6; Golebski K, 2015, MOL IMMUNOL, V65, P43, DOI 10.1016/j.molimm.2014.12.011; Golebski K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087768; Gregory LG, 2013, THORAX, V68, P82, DOI 10.1136/thoraxjnl-2012-202003; Haenuki Y, 2012, J ALLERGY CLIN IMMUN, V130, P184, DOI 10.1016/j.jaci.2012.02.013; Imai Y, 2013, P NATL ACAD SCI USA, V110, P13921, DOI 10.1073/pnas.1307321110; Jang S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056433; Kim BS, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005374; Lee KH, 2011, EXP DERMATOL, V20, P149, DOI 10.1111/j.1600-0625.2010.01203.x; Lin CF, 2007, ACTA OTO-LARYNGOL, V127, P395, DOI 10.1080/00016480601089416; Louten J, 2011, INT IMMUNOL, V23, P307, DOI 10.1093/intimm/dxr006; McDermott AJ, 2014, IMMUNOLOGY, V142, P24, DOI 10.1111/imm.12231; Mjosberg J, 2012, IMMUNITY, V37, P649, DOI 10.1016/j.immuni.2012.08.015; Mjosberg JM, 2011, NAT IMMUNOL, V12, P1055, DOI 10.1038/ni.2104; Muto T, 2014, INT IMMUNOL, V26, P539, DOI 10.1093/intimm/dxu058; Nagarkar DR, 2013, J ALLERGY CLIN IMMUN, V132, P593, DOI 10.1016/j.jaci.2013.04.005; Nagarkar DR, 2012, J ALLERGY CLIN IMMUN, V130, P225, DOI 10.1016/j.jaci.2012.04.019; Papadopoulos NG, 2011, ALLERGY, V66, P458, DOI 10.1111/j.1398-9995.2010.02505.x; Ryu WI, 2015, EXP DERMATOL, V24, P857, DOI 10.1111/exd.12788; Ueta M, 2010, BRIT J OPHTHALMOL, V94, P1528, DOI 10.1136/bjo.2010.180554; Vroling AB, 2008, ALLERGY, V63, P1110, DOI 10.1111/j.1398-9995.2008.01785.x; Vroling AB, 2008, AM J RESP CELL MOL, V38, P293, DOI 10.1165/rcmb.2007-0278OC; Vu AT, 2011, J INVEST DERMATOL, V131, P2205, DOI 10.1038/jid.2011.185; Walker JA, 2013, NAT REV IMMUNOL, V13, P75, DOI 10.1038/nri3349; Xie Y, 2012, J DERMATOL SCI, V66, P233, DOI 10.1016/j.jdermsci.2012.03.007	31	19	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0152808	10.1371/journal.pone.0152808	http://dx.doi.org/10.1371/journal.pone.0152808			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050744	Green Published, gold, Green Submitted			2022-12-27	WOS:000373603500056
J	Jain, S; Park, G; Sproule, TJ; Christianson, GJ; Leeth, CM; Wang, HS; Roopenian, DC; Morse, HC				Jain, Shweta; Park, Giljun; Sproule, Thomas J.; Christianson, Gregory J.; Leeth, Caroline M.; Wang, Hongsheng; Roopenian, Derry C.; Morse, Herbert C., III			Interleukin 6 Accelerates Mortality by Promoting the Progression of the Systemic Lupus Erythematosus-Like Disease of BXSB. Yaa Mice	PLOS ONE			English	Article							CD4(+) T-CELLS; TOLL-LIKE RECEPTORS; ACTIVATE B-CELLS; MURINE LUPUS; ANTI-DNA; IN-VIVO; IL-6; TLR7; DIFFERENTIATION; EXPRESSION	IL6 is a multifunctional cytokine that drives terminal B cell differentiation and secretion of immunoglobulins. IL6 also cooperates with IL21 to promote differentiation of CD4(+) T follicular helper cells (TFH). Elevated serum levels of IL6 correlate with disease flares in patients with systemic lupus erythematosus (SLE). We previously reported that IL21 produced by T-FH plays a critical role in the development of the SLE-like disease of BXSB. Yaa mice. To examine the possible contributions of IL6 to disease, we compared disease parameters in IL6-deficient and IL6-competent BXSB. Yaa mice. We report that survival of IL6-deficient BXSB. Yaa mice was significantly prolonged in association with significant reductions in a variety of autoimmune manifestations. Moreover, B cells stimulated by co-engagement of TLR7 and B cell receptor (BCR) produced high levels of IL6 that was further augmented by stimulation with Type I interferon (IFN1). Importantly, the frequencies of T-FH and serum levels of IL21 were significantly reduced in IL6-deficient mice. These findings suggest that high-level production of IL6 by B cells induced by integrated signaling from the IFN1 receptor, TLR7 and BCR promotes the differentiation of IL21-secreting T-FH in a signaling sequence that drives the lethal autoimmune disease of BXSB. Yaa mice.	[Jain, Shweta; Wang, Hongsheng; Morse, Herbert C., III] NIAID, Virol & Cellular Immunol Sect, Immunogenet Lab, NIH, Rockville, MD USA; [Park, Giljun; Sproule, Thomas J.; Christianson, Gregory J.; Roopenian, Derry C.] Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA; [Park, Giljun] Univ Helsinki, Cent Hosp, Ctr Canc, Hematol Res Unit,Biomedicum Helsinki 1, Helsinki, Finland; [Leeth, Caroline M.] Virginia Tech, Coll Agr & Life Sci, Dept Anim & Poultry Sci, Blacksburg, VA USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Jackson Laboratory; University of Helsinki; Helsinki University Central Hospital; Virginia Polytechnic Institute & State University	Morse, HC (corresponding author), NIAID, Virol & Cellular Immunol Sect, Immunogenet Lab, NIH, Rockville, MD USA.; Roopenian, DC (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.	dcr@jax.org; hmorse@niaid.nih.gov	Jain, Shweta/I-4139-2019	Jain, Shweta/0000-0001-6297-0078; Christianson, Gregory/0000-0001-5532-342X	Intramural Research Program of the NIH, National Institute of Allergy and Infectious Diseases (NIAID); Alliance for Lupus Research; NATIONAL CANCER INSTITUTE [P30CA034196] Funding Source: NIH RePORTER	Intramural Research Program of the NIH, National Institute of Allergy and Infectious Diseases (NIAID); Alliance for Lupus Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the Intramural Research Program of the NIH, National Institute of Allergy and Infectious Diseases (NIAID), and by the Alliance for Lupus Research.	ALARCONRIQUELME ME, 1993, CLIN EXP IMMUNOL, V91, P220; Amano H, 2003, J IMMUNOL, V170, P2293, DOI 10.4049/jimmunol.170.5.2293; Baechler EC, 2003, P NATL ACAD SCI USA, V100, P2610, DOI 10.1073/pnas.0337679100; Bekeredjian-Ding I, 2009, IMMUNOLOGY, V128, P311, DOI 10.1111/j.1365-2567.2009.03173.x; Bishop GA, 2001, CELL IMMUNOL, V208, P9, DOI 10.1006/cimm.2001.1769; Braun D, 2002, INT IMMUNOL, V14, P411, DOI 10.1093/intimm/14.4.411; Bubier JA, 2009, P NATL ACAD SCI USA, V106, P1518, DOI 10.1073/pnas.0807309106; Bush TJV, 2008, EUR J IMMUNOL, V38, P400, DOI 10.1002/eji.200737602; Choi YS, 2013, J IMMUNOL, V190, P3049, DOI 10.4049/jimmunol.1203032; Coro ES, 2006, J IMMUNOL, V176, P4343, DOI 10.4049/jimmunol.176.7.4343; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Crow MK, 2003, AUTOIMMUNITY, V36, P481, DOI 10.1080/08916930310001625952; Cui Y, 2013, J AUTOIMMUN, V41, P25, DOI 10.1016/j.jaut.2013.01.008; Deane JA, 2007, IMMUNITY, V27, P801, DOI 10.1016/j.immuni.2007.09.009; Diehl SA, 2012, IMMUNOL CELL BIOL, V90, P802, DOI 10.1038/icb.2012.17; Dienz O, 2009, J EXP MED, V206, P69, DOI 10.1084/jem.20081571; Eddahri F, 2009, BLOOD, V113, P2426, DOI 10.1182/blood-2008-04-154682; Eto D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017739; Fairhurst AM, 2008, EUR J IMMUNOL, V38, P1971, DOI 10.1002/eji.200838138; FINCK BK, 1994, J CLIN INVEST, V94, P585, DOI 10.1172/JCI117373; Genestier L, 2007, J IMMUNOL, V178, P7779, DOI 10.4049/jimmunol.178.12.7779; Glaum MC, 2009, J ALLERGY CLIN IMMUN, V123, P224, DOI 10.1016/j.jaci.2008.09.018; Grondal G, 2000, CLIN EXP RHEUMATOL, V18, P565; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Honda K, 2005, NATURE, V434, P1035, DOI 10.1038/nature03547; Illei GG, 2010, ARTHRITIS RHEUM-US, V62, P542, DOI 10.1002/art.27221; KITANI A, 1989, CLIN EXP IMMUNOL, V77, P31; KLASHMAN DJ, 1991, ARTHRITIS RHEUM, V34, P276, DOI 10.1002/art.1780340305; KOBAYASHI I, 1992, INT IMMUNOL, V4, P1407, DOI 10.1093/intimm/4.12.1407; KOFLER R, 1991, J IMMUNOL, V146, P1375; Lau CM, 2005, J EXP MED, V202, P1171, DOI 10.1084/jem.20050630; Le Bon A, 2001, IMMUNITY, V14, P461, DOI 10.1016/S1074-7613(01)00126-1; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; LINKERISRAELI M, 1991, J IMMUNOL, V147, P117; Ma CS, 2009, IMMUNOL CELL BIOL, V87, P590, DOI 10.1038/icb.2009.64; McPhee CG, 2013, J IMMUNOL, V191, P4581, DOI 10.4049/jimmunol.1300439; McPhee CG, 2011, J IMMUNOL, V187, P4695, DOI 10.4049/jimmunol.1101776; MIHARA M, 1990, INT ARCH ALLER A IMM, V93, P89, DOI 10.1159/000235285; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Murphy E. D., 1978, Genetic control of autoimmune disease. Proceedings of the workshop on the genetic control of autoimmune disease held in Bloomfield Hills, Michigan, USA, on July 10-12, 1978., P207; MURPHY ED, 1979, ARTHRITIS RHEUM, V22, P1188, DOI 10.1002/art.1780221105; NAGAFUCHI H, 1993, J IMMUNOL, V151, P6525; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Pisitkun P, 2006, SCIENCE, V312, P1669, DOI 10.1126/science.1124978; Poholek AC, 2010, J IMMUNOL, V185, P313, DOI 10.4049/jimmunol.0904023; Rau FC, 2009, J IMMUNOL, V183, P7661, DOI 10.4049/jimmunol.0803783; Richards HB, 1998, J EXP MED, V188, P985, DOI 10.1084/jem.188.5.985; Rogers NJ, 2007, GENES IMMUN, V8, P619, DOI 10.1038/sj.gene.6364424; Ronnblom L, 2011, SEMIN IMMUNOL, V23, P113, DOI 10.1016/j.smim.2011.01.009; Santiago-Raber ML, 2008, J IMMUNOL, V181, P1556, DOI 10.4049/jimmunol.181.2.1556; Santiago-Raber ML, 2003, J EXP MED, V197, P777, DOI 10.1084/jem.20021996; Shen N, 2010, P NATL ACAD SCI USA, V107, P15838, DOI 10.1073/pnas.1001337107; Subramanian S, 2006, P NATL ACAD SCI USA, V103, P9970, DOI 10.1073/pnas.0603912103; Suto A, 2008, J EXP MED, V205, P1369, DOI 10.1084/jem.20072057; SUZUKI H, 1993, EUR J IMMUNOL, V23, P1078, DOI 10.1002/eji.1830230515; Szepietowski JC, 2013, ARTHRITIS RHEUM-US, V65, P2661, DOI 10.1002/art.38091; TANG B, 1991, INT IMMUNOL, V3, P273, DOI 10.1093/intimm/3.3.273; von Landenberg P, 2007, CURR OPIN IMMUNOL, V19, P606, DOI 10.1016/j.coi.2007.10.004; WOFSY D, 1984, J EXP MED, V159, P629, DOI 10.1084/jem.159.2.629; Yang ZX, 2014, RHEUMATOL INT, V34, P199, DOI 10.1007/s00296-013-2855-4	60	21	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0153059	10.1371/journal.pone.0153059	http://dx.doi.org/10.1371/journal.pone.0153059			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050763	Green Published, gold, Green Submitted			2022-12-27	WOS:000373603500090
J	Lee, JGL; Gregory, KR; Baker, HM; Ranney, LM; Goldstein, AO				Lee, Joseph G. L.; Gregory, Kyle R.; Baker, Hannah M.; Ranney, Leah M.; Goldstein, Adam O.			"May I Buy a Pack of Marlboros, Please?" A Systematic Review of Evidence to Improve the Validity and Impact of Youth Undercover Buy Inspections	PLOS ONE			English	Review							TOBACCO SALES; MINORS ACCESS; SOCIOCULTURAL VARIABLES; UNDERAGE YOUTH; CIGARETTES; LAWS; INTERVENTIONS; ACCESSIBILITY; ENFORCEMENT; VIOLATIONS	Most smokers become addicted to tobacco products before they are legally able to purchase these products. We systematically reviewed the literature on protocols to assess underage purchase and their ecological validity. We conducted a systematic search in May 2015 in PubMed and PsycINFO. We independently screened records for inclusion. We conducted a narrative review and examined implications of two types of legal authority for protocols that govern underage buy enforcement in the United States: criminal (state-level laws prohibiting sales to youth) and administrative (federal regulations prohibiting sales to youth). Ten studies experimentally assessed underage buy protocols and 44 studies assessed the association between youth characteristics and tobacco sales. Protocols that mimicked real-world youth behaviors were consistently associated with substantially greater likelihood of a sale to a youth. Many of the tested protocols appear to be designed for compliance with criminal law rather than administrative enforcement in ways that limited ecological validity. This may be due to concerns about entrapment. For administrative enforcement in particular, entrapment may be less of an issue than commonly thought. Commonly used underage buy protocols poorly represent the reality of youths' access to tobacco from retailers. Compliance check programs should allow youth to present themselves naturally and attempt to match the community's demographic makeup.	[Lee, Joseph G. L.] E Carolina Univ, Coll Hlth & Human Performance, Dept Hlth Educ & Promot, Greenville, NC USA; [Gregory, Kyle R.] Georgia State Univ, Sch Publ Hlth, Tobacco Ctr Regulatory Sci, Atlanta, GA 30303 USA; [Baker, Hannah M.; Ranney, Leah M.; Goldstein, Adam O.] Univ N Carolina, Dept Family Med, Sch Med, Tobacco Prevent & Evaluat Program, Chapel Hill, NC 27514 USA; [Goldstein, Adam O.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Sch Med, Chapel Hill, NC 27599 USA	University of North Carolina; East Carolina University; University System of Georgia; Georgia State University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Lee, JGL (corresponding author), E Carolina Univ, Coll Hlth & Human Performance, Dept Hlth Educ & Promot, Greenville, NC USA.	leejose14@ecu.edu		Lee, Joseph/0000-0001-9698-649X	U.S. National Institutes of Health (NIH)/National Institute on Drug Abuse [P50DA036128]; Food and Drug Administration (FDA) Center for Tobacco Products (CTP); NIH/National Cancer Institute [P50CA18090701]; FDA CTP; NATIONAL CANCER INSTITUTE [P30CA016086, P50CA180907] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA036128] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)/National Institute on Drug Abuse; Food and Drug Administration (FDA) Center for Tobacco Products (CTP)(United States Department of Health & Human Services); NIH/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); FDA CTP; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Research reported in this publication was supported with trainee support by grant numbers P50DA036128 from the U.S. National Institutes of Health (NIH)/National Institute on Drug Abuse (http://www.drugabuse.gov/) and Food and Drug Administration (FDA) Center for Tobacco Products (CTP, http://www.fda.gov/) (KRG) and, also for trainee support, P50CA18090701 from NIH/National Cancer Institute (http://www.cancer.gov/) and FDA CTP (JGLL). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or the FDA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaraz R, 1997, PREV MED, V26, P236, DOI 10.1006/pmed.1996.0133; Asumda F, 2009, HEALTH PLACE, V15, P140, DOI 10.1016/j.healthplace.2008.03.006; Baker HM, 2016, NICOTINE TOB RES, V18, P221, DOI 10.1093/ntr/ntv053; Biglan A, 1995, TOB CONTROL, V4, P42, DOI DOI 10.1136/TC.4.1.42; Clark PI, 2000, JAMA-J AM MED ASSOC, V284, P729, DOI 10.1001/jama.284.6.729; Cummings KM, 1996, AM J PUBLIC HEALTH, V86, P750, DOI 10.2105/AJPH.86.5.750-a; Davis R M, 1996, Tob Control, V5, P99, DOI 10.1136/tc.5.2.99; DiFranza J.R., 2002, TOB CONTROL, V11, P3; DiFranza JR, 1996, AM J PUBLIC HEALTH, V86, P221, DOI 10.2105/AJPH.86.2.221; DiFranza JR, 1999, TOB CONTROL, V8, P152, DOI 10.1136/tc.8.2.152; DiFranza JR, 1999, PREV MED, V29, P321, DOI 10.1006/pmed.1999.0553; DiFranza JR, 2005, J PUBLIC HEALTH MAN, V11, P559; DiFranza JR, 2005, TOB CONTROL, V14, P93, DOI 10.1136/tc.2004.009373; DiFranza JR, 2002, TOB CONTROL, V11, P282, DOI 10.1136/tc.11.3.282; DiFranza JR, 2001, TOB CONTROL, V10, P227, DOI 10.1136/tc.10.3.227; DiFranza JR, 2001, AM J PUBLIC HEALTH, V91, P1124, DOI 10.2105/AJPH.91.7.1124; Erickson A D, 1993, J Community Health, V18, P213, DOI 10.1007/BF01324432; FEIGHERY E, 1991, JAMA-J AM MED ASSOC, V266, P3168; Fichtenberg CM, 2002, PEDIATRICS, V109, P1088, DOI 10.1542/peds.109.6.1088; Food and Drug Administration, 2015, COMPL CHECK INSP TOB; Food and Drug Administration, FDA TOB RET INSP CON; FORSTER JL, 1992, PREV MED, V21, P320, DOI 10.1016/0091-7435(92)90031-C; Forster JL, 1998, ANNU REV PUBL HEALTH, V19, P203, DOI 10.1146/annurev.publhealth.19.1.203; HAWKINS CH, 1964, AM J PUBLIC HEALTH N, V54, P1741, DOI 10.2105/AJPH.54.10.1741; Hyland A, 2000, J Public Health Manag Pract, V6, P115; Institute of Medicine, 2015, PUBL HLTH IMPL RAIS; Keay K.D., 1993, TOB CONTROL, V2, P145, DOI [10.1136/tc.2.2.145, DOI 10.1136/TC.2.2.145]; Kirchner TR, 2015, TOB CONTROL, V24, pE52, DOI 10.1136/tobaccocontrol-2013-051239; Klonoff EA, 1997, AM J PUBLIC HEALTH, V87, P823, DOI 10.2105/AJPH.87.5.823; Klonoff EA, 2004, HEALTH PSYCHOL, V23, P517, DOI 10.1037/0278-6133.23.5.517; KLONOFF EA, 1994, JAMA-J AM MED ASSOC, V271, P618, DOI 10.1001/jama.271.8.618; Landrine H, 2000, TOB CONTROL, V9, P15; Landrine H, 1998, PREV MED, V27, P503, DOI 10.1006/pmed.1998.0326; Landrine H, 2000, PREV MED, V30, P433, DOI 10.1006/pmed.2000.0652; Landrine H, 2003, AM J PUBLIC HEALTH, V93, P1883, DOI 10.2105/AJPH.93.11.1883; Landrine H, 2001, JAMA-J AM MED ASSOC, V285, P2329, DOI 10.1001/jama.285.18.2329; Landrine H., 1997, J BLACK PSYCHOL, V23, P135, DOI [DOI 10.1177/009579849702320041997-04329-003, 10.1177/009579849702320041997-04329-003.]; Landrine H, 2010, HEALTH PROMOT PRACT, V11, P132, DOI 10.1177/1524839908317230; Lee JGL, 2015, PREV CHRONIC DIS, V12, DOI 10.5888/pcd12.150231; Levinson AH, 2002, TOB CONTROL, V11, P296, DOI 10.1136/tc.11.4.296; Levinson AH, 2013, NICOTINE TOB RES, V15, P1952, DOI 10.1093/ntr/ntt084; Lipperman-Kreda S, 2014, TOB CONTROL, V23, P39, DOI 10.1136/tobaccocontrol-2012-050473; Lipton R, 2008, SUBST USE MISUSE, V43, P1597, DOI 10.1080/10826080802241110; MacCallum RC, 2002, PSYCHOL METHODS, V7, P19, DOI 10.1037//1082-989X.7.1.19; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Nagler RH, 2013, NICOTINE TOB RES, V15, P832, DOI 10.1093/ntr/nts331; Pearson DC, 2007, AM J PREV MED, V33, P91, DOI 10.1016/j.amepre.2007.04.010; Schmitt CL, 2001, EFFECT DECISION HEUR; Stead LF, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001497.pub2, 10.1002/14651858.CD001007.pub2]; U.S. General Accounting Office, 2001, SYN AM IMPL QUAL STA; WHO, 2008, REP GLOB TOB EP 2008; Widome R, 2012, EVAL HEALTH PROF, V35, P331, DOI 10.1177/0163278712447624	52	20	20	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0153152	10.1371/journal.pone.0153152	http://dx.doi.org/10.1371/journal.pone.0153152			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DI6IX	27050671	Green Published, Green Submitted, gold			2022-12-27	WOS:000373603500106
J	Weihrauch, D; Krolikowski, JG; Jones, DW; Zaman, T; Bamkole, O; Struve, J; Pillai, S; Pagel, PS; Lohr, NL; Pritchard, KA				Weihrauch, Dorothee; Krolikowski, John G.; Jones, Deron W.; Zaman, Tahniyath; Bamkole, Omoshalewa; Struve, Janine; Pillai, Savin; Pagel, Paul S.; Lohr, Nicole L.; Pritchard, Kirkwood A., Jr.			An IRF5 Decoy Peptide Reduces Myocardial Inflammation and Fibrosis and Improves Endothelial Cell Function in Tight-Skin Mice	PLOS ONE			English	Article							HEART; DISEASE; VASODILATION; POLYMORPHISM; CONTRIBUTES; EXPRESSION; MARKERS; RISK	Interferon regulatory factor 5 (IRF5) has been called a "master switch" for its ability to determine whether cells mount proinflammatory or anti-inflammatory responses. Accordingly, IRF5 should be an attractive target for therapeutic drug development. Here we report on the development of a novel decoy peptide inhibitor of IRF5 that decreases myocardial inflammation and improves vascular endothelial cell (EC) function in tight-skin (Tsk/+) mice. Biolayer interferometry studies showed the Kd of IRF5D for recombinant IRF5 to be 3.72 +/- 0.74x10(-6)M. Increasing concentrations of IRF5D (0-100 mu g/mL, 24h) had no significant effect on EC proliferation or apoptosis. Treatment of Tsk/+ mice with IRF5D (1mg/kg/d subcutaneously, 21d) reduced IRF5 and ICAM-1 expression and monocyte/macrophage and neutrophil counts in Tsk/+ hearts compared to expression in hearts from PBS-treated Tsk/+ mice (p<0.05). EC-dependent vasodilatation of facialis arteries isolated from PBS-treated Tsk/+ mice was reduced (similar to 15%). IRF5D treatments (1mg/kg/d, 21d) improved vasodilatation in arteries isolated from Tsk/+ mice nearly 3-fold (similar to 45%, p<0.05), representing nearly 83% of the vasodilatation in arteries isolated from C57Bl/6J mice (similar to 55%). IRF5D (50 mu g/mL, 24h) reduced nuclear translocation of IRF5 in myocytes cultured on both Tsk/+ cardiac matrix and C57Bl/6J cardiac matrix (p<0.05). These data suggest that IRF5 plays a causal role in inflammation, fibrosis and impaired vascular EC function in Tsk/+ mice and that treatment with IRF5D effectively counters IRF5-dependent mechanisms of inflammation and fibrosis in the myocardium in these mice.	[Weihrauch, Dorothee; Krolikowski, John G.; Bamkole, Omoshalewa; Pillai, Savin; Pagel, Paul S.] Med Coll Wisconsin, Dept Anesthesiol, Milwaukee, WI 53226 USA; [Jones, Deron W.; Zaman, Tahniyath; Pritchard, Kirkwood A., Jr.] Med Coll Wisconsin, Dept Surg, Div Pediat Surg, 8700 W Wisconsin Ave, Milwaukee, WI 53226 USA; [Jones, Deron W.; Zaman, Tahniyath; Pritchard, Kirkwood A., Jr.] Med Coll Wisconsin, Childrens Res Inst, Milwaukee, WI 53226 USA; [Struve, Janine] Med Coll Wisconsin, Orthoped Surg, Milwaukee, WI 53226 USA; [Pagel, Paul S.] Clement J Zablocki Vet Affairs Med Ctr, Milwaukee, WI USA; [Lohr, Nicole L.] Med Coll Wisconsin, Dept Med, Div Cardiol, Milwaukee, WI 53226 USA	Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin	Weihrauch, D (corresponding author), Med Coll Wisconsin, Dept Anesthesiol, Milwaukee, WI 53226 USA.	dorothee@mcw.edu			National Institutes of Health from the United States Public Health Service (Bethesda, MD) [HL089779, HL102836, HL112270]; Cimphoni Life Sciences; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL112270, R01HL128371, R01HL089779, R01HL102836] Funding Source: NIH RePORTER	National Institutes of Health from the United States Public Health Service (Bethesda, MD); Cimphoni Life Sciences; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by National Institutes of Health grants HL089779, HL102836 and HL112270 from the United States Public Health Service (Bethesda, MD), Cimphoni Life Sciences (part of DW salary) and by departmental funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACOSTA D, 1977, IN VITRO CELL DEV B, V13, P818; Bauer PM, 2003, J BIOL CHEM, V278, P14841, DOI 10.1074/jbc.M211926200; Baxter RM, 2005, LAB INVEST, V85, P1199, DOI 10.1038/labinvest.3700331; Bi XH, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3053; BOTSTEIN GR, 1981, AM HEART J, V102, P913, DOI 10.1016/0002-8703(81)90043-0; Chen W, 2008, NAT STRUCT MOL BIOL, V15, P1213, DOI 10.1038/nsmb.1496; Dideberg V, 2007, HUM MOL GENET, V16, P3008, DOI 10.1093/hmg/ddm259; Dieude P, 2010, J RHEUMATOL, V37, P987, DOI 10.3899/jrheum.091163; Dimitroulas T, 2014, CURR PHARM DESIGN, V20, P536, DOI 10.2174/13816128113199990555; Foreman HCC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033098; Frenzel D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106882; Gorlova O, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002178; Graham RR, 2006, NAT GENET, V38, P550, DOI 10.1038/ng1782; Krausgruber T, 2011, NAT IMMUNOL, V12, P231, DOI 10.1038/ni.1990; Krolikowski J, 2012, THROMB VASC BIOL, V32, pA314; Mayes MD, 2014, AM J HUM GENET, V94, P47, DOI 10.1016/j.ajhg.2013.12.002; Murai C, 1998, AUTOIMMUNITY, V28, P151, DOI 10.3109/08916939808996283; ORAM S, 1961, BRIT HEART J, V23, P243; Ou JS, 2003, CIRCULATION, V107, P2337, DOI 10.1161/01.CIR.0000070589.61860.A9; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Rabinovich A, 2015, THROMB RES, V136, P289, DOI 10.1016/j.thromres.2015.06.024; Roy S, 2011, AUTOIMMUNE DISORDERS, P35; Sharif R, 2012, ANN RHEUM DIS, V71, P1197, DOI 10.1136/annrheumdis-2011-200901; Steen Virginia, 2004, Curr Rheumatol Rep, V6, P137, DOI 10.1007/s11926-004-0058-4; Weihrauch D, 2007, AM J PHYSIOL-HEART C, V293, pH1432, DOI 10.1152/ajpheart.00038.2007; Xu H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052046; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613	27	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0151999	10.1371/journal.pone.0151999	http://dx.doi.org/10.1371/journal.pone.0151999			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050551	Green Published, Green Submitted, gold			2022-12-27	WOS:000373603500020
J	Cheema, AK; Maier, I; Dowdy, T; Wang, YW; Singh, R; Ruegger, PM; Borneman, J; Fornace, AJ; Schiestl, RH				Cheema, Amrita K.; Maier, Irene; Dowdy, Tyrone; Wang, Yiwen; Singh, Rajbir; Ruegger, Paul M.; Borneman, James; Fornace, Albert J., Jr.; Schiestl, Robert H.			Chemopreventive Metabolites Are Correlated with a Change in Intestinal Microbiota Measured in A-T Mice and Decreased Carcinogenesis	PLOS ONE			English	Article							ATAXIA-TELANGIECTASIA; KYNURENIC ACID; CELLULAR-RESPONSE; GUT MICROBIOTA; ATM; CANCER; CELLS; BACTERIA; LYMPHOMA; 3-METHYLADENINE	Intestinal microbiota play a significant role in nutrient metabolism, modulation of the immune system, obesity, and possibly in carcinogenesis, although the underlying mechanisms resulting in disease or impacts on longevity caused by different intestinal microbiota are mostly unknown. Herein we use isogenic Atm-deficient and wild type mice as models to interrogate changes in the metabolic profiles of urine and feces of these mice, which are differing in their intestinal microbiota. Using high resolution mass spectrometry approach we show that the composition of intestinal microbiota modulates specific metabolic perturbations resulting in a possible alleviation of a glycolytic phenotype. Metabolites including 3-methylbutyrolactone, kyneurenic acid and 3-methyladenine known to be onco-protective are elevated in Atm-deficient and wild type mice with restricted intestinal microbiota. Thus our approach has broad applicability to study the direct influence of gut microbiome on host metabolism and resultant phenotype. These results for the first time suggest a possible correlation of metabolic alterations and carcinogenesis, modulated by intestinal microbiota in A-T mice.	[Cheema, Amrita K.; Dowdy, Tyrone; Singh, Rajbir; Fornace, Albert J., Jr.] Georgetown Univ, Med Ctr, Dept Oncol, Washington, DC 20007 USA; [Cheema, Amrita K.; Fornace, Albert J., Jr.] Georgetown Univ, Med Ctr, Dept Biochem Mol & Cellular Biol, Washington, DC 20007 USA; [Maier, Irene; Schiestl, Robert H.] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Environm Hlth Sci, Los Angeles, CA USA; [Wang, Yiwen] Georgetown Univ, Med Ctr, Dept Biostat Biomath & Bioinformat, Washington, DC 20007 USA; [Ruegger, Paul M.; Borneman, James] Univ Calif Riverside, Dept Plant Pathol & Microbiol, Riverside, CA 92521 USA; [Schiestl, Robert H.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol, Los Angeles, CA 90095 USA; [Schiestl, Robert H.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Radiat Oncol, Los Angeles, CA 90095 USA	Georgetown University; Georgetown University; University of California System; University of California Los Angeles; Georgetown University; University of California System; University of California Riverside; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Schiestl, RH (corresponding author), Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Environm Hlth Sci, Los Angeles, CA USA.; Schiestl, RH (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol, Los Angeles, CA 90095 USA.; Schiestl, RH (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Radiat Oncol, Los Angeles, CA 90095 USA.	RSchiestl@mednet.ucla.edu	Singh, Rajbir/HHN-9064-2022	Cheema, Amrita/0000-0003-4877-7583; Maier, Irene/0000-0003-1471-6432	NIH/NCI [P30-CA051008];  [RO1ES0951907]; NATIONAL CANCER INSTITUTE [P30CA051008] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD016290] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by RO1ES0951907 to RHS.; The authors would like to acknowledge the Proteomics and Metabolomics shared resource partially supported by NIH/NCI grant P30-CA051008.	ADLERCREUTZ H, 1993, J STEROID BIOCHEM, V44, P147, DOI 10.1016/0960-0760(93)90022-O; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Tran AT, 2015, EUR J NUTR, V54, P265, DOI 10.1007/s00394-014-0707-y; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; Blow N, 2008, NATURE, V455, P697, DOI 10.1038/455697a; Boder E, 1975, Birth Defects Orig Artic Ser, V11, P255; Borghesani PR, 2000, P NATL ACAD SCI USA, V97, P3336, DOI 10.1073/pnas.050584897; Bowling FG, 2014, METHODS MOL BIOL, V1168, P31, DOI 10.1007/978-1-4939-0847-9_3; Cani PD, 2009, CURR PHARM DESIGN, V15, P1546, DOI 10.2174/138161209788168164; Cheema AK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087079; Cheema AK, 2011, J PROTEOME RES, V10, P2651, DOI 10.1021/pr101243j; Ciappio ED, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084583; Clavel T, 2014, GUT MICROBES, V5, P544, DOI 10.4161/gmic.29331; Crawford TO, 2006, ARCH DIS CHILD, V91, P610; Delzenne NM, 2013, BRIT J NUTR, V109, pS81, DOI 10.1017/S0007114512004047; DiNatale BC, 2010, TOXICOL SCI, V115, P89, DOI 10.1093/toxsci/kfq024; Elson A, 1996, P NATL ACAD SCI USA, V93, P13084, DOI 10.1073/pnas.93.23.13084; Fujiwara D, 2008, J IMMUNOL, V180, P5843, DOI 10.4049/jimmunol.180.9.5843; Gatti RA, 2001, CLIN REV ALLERG IMMU, V20, P87, DOI 10.1385/CRIAI:20:1:87; Guo Z, 2010, SCIENCE, V330, P517, DOI 10.1126/science.1192912; HECHT F, 1990, CANCER GENET CYTOGEN, V46, P9, DOI 10.1016/0165-4608(90)90003-S; Heckmann BL, 2013, BRIT J PHARMACOL, V168, P163, DOI 10.1111/j.1476-5381.2012.02110.x; Huang T, 2005, CLIN IMMUNOL, V117, P221, DOI 10.1016/j.clim.2005.09.012; Iida N, 2013, SCIENCE, V342, P967, DOI 10.1126/science.1240527; JOHNSON RK, 1976, CANCER RES, V36, P2720; Kaur P, 2013, MOL BIOSYST, V9, P307, DOI 10.1039/c2mb25384d; Kim JC, 1997, ARCH PHARM RES, V20, P253, DOI 10.1007/BF02976153; Kingma SDK, 2011, J NUTR, V141, P1023, DOI 10.3945/jn.110.135517; Li H, 2009, J BIOL CHEM, V284, P1748, DOI 10.1074/jbc.M807821200; Lim DS, 2000, NATURE, V404, P613, DOI 10.1038/35007091; Liyanage M, 2000, BLOOD, V96, P1940, DOI 10.1182/blood.V96.5.1940.h8001940_1940_1946; Maier I, 2014, RADIAT RES, V181, P45, DOI 10.1667/RR13352.1; Meyn MS, 1999, CLIN GENET, V55, P289, DOI 10.1034/j.1399-0004.1999.550501.x; MORRELL D, 1986, J NATL CANCER I, V77, P89; Patterson AD, 2008, ANAL CHEM, V80, P665, DOI 10.1021/ac701807v; PETERSON RDA, 1992, LEUKEMIA, V6, P8; Petiniot LK, 2002, MOL CELL BIOL, V22, P3174, DOI 10.1128/MCB.22.9.3174-3177.2002; Presley LL, 2010, APPL ENVIRON MICROB, V76, P936, DOI 10.1128/AEM.01561-09; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Reliene R, 2006, DNA REPAIR, V5, P852, DOI 10.1016/j.dnarep.2006.05.003; Ruegger PM, 2014, J MICROBIOL METH, V105, P82, DOI 10.1016/j.mimet.2014.07.001; Sandoval C, 1998, MED PEDIATR ONCOL, V31, P491, DOI 10.1002/(SICI)1096-911X(199812)31:6<491::AID-MPO5>3.0.CO;2-B; Schubert R, 2004, HUM MOL GENET, V13, P1793, DOI 10.1093/hmg/ddh189; Schwabe RF, 2013, NAT REV CANCER, V13, P800, DOI 10.1038/nrc3610; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Swann Jonathan R., 2014, Science Progress, V97, P41, DOI 10.3184/003685014X13898807933527; Tan SS, 2015, ONCOL LETT, V9, P2056, DOI 10.3892/ol.2015.2996; Taylor AMR, 1996, BLOOD, V87, P423, DOI 10.1182/blood.V87.2.423.bloodjournal872423; Tyburski JB, 2009, RADIAT RES, V172, P42, DOI 10.1667/RR1703.1; Urenjak J, 2000, NEUROREPORT, V11, P1341, DOI 10.1097/00001756-200004270-00038; Ursell LK, 2014, GASTROENTEROLOGY, V146, P1470, DOI 10.1053/j.gastro.2014.03.001; Varghese RS, 2010, J PROTEOME RES, V9, P2786, DOI 10.1021/pr100185b; Viaud S, 2013, SCIENCE, V342, P971, DOI 10.1126/science.1240537; Walczak K, 2012, PHARMACOL REP, V64, P745, DOI 10.1016/S1734-1140(12)70870-8; Wang JH, 2006, J BIOL CHEM, V281, P22021, DOI 10.1074/jbc.M603503200; Want EJ, 2010, NAT PROTOC, V5, P1005, DOI 10.1038/nprot.2010.50; Wei B, 2008, EUR J IMMUNOL, V38, P3411, DOI 10.1002/eji.200838432; Westbrook AM, 2009, CANCER RES, V69, P4827, DOI 10.1158/0008-5472.CAN-08-4416; Wu YT, 2010, J BIOL CHEM, V285, P10850, DOI 10.1074/jbc.M109.080796; Xia JG, 2012, NUCLEIC ACIDS RES, V40, pW127, DOI 10.1093/nar/gks374; Xie GX, 2013, ELECTROPHORESIS, V34, P2787, DOI 10.1002/elps.201300017; Xu Y, 1996, GENE DEV, V10, P2401, DOI 10.1101/gad.10.19.2401; Xu Y, 1996, GENE DEV, V10, P2411, DOI 10.1101/gad.10.19.2411; Yamamoto ML, 2013, CANCER RES, V73, P4222, DOI 10.1158/0008-5472.CAN-13-0022; Yang NY, 2005, J PHARMACOL EXP THER, V312, P127, DOI 10.1124/jpet.104.074104; Zhou B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040096; Zitvogel L, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010473	69	12	12	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0151190	10.1371/journal.pone.0151190	http://dx.doi.org/10.1371/journal.pone.0151190			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073845	Green Published, gold, Green Submitted			2022-12-27	WOS:000374131200007
J	Mengersen, KL; Drovandi, CC; Robert, CP; Pyne, DB; Gore, CJ				Mengersen, Kerrie L.; Drovandi, Christopher C.; Robert, Christian P.; Pyne, David B.; Gore, Christopher J.			Bayesian Estimation of Small Effects in Exercise and Sports Science	PLOS ONE			English	Article							HEMOGLOBIN MASS; PERFORMANCE; VARIABILITY; ALTITUDE; WINBUGS; ECONOMY; TIMES	The aim of this paper is to provide a Bayesian formulation of the so-called magnitude-based inference approach to quantifying and interpreting effects, and in a case study example provide accurate probabilistic statements that correspond to the intended magnitude-based inferences. The model is described in the context of a published small-scale athlete study which employed a magnitude-based inference approach to compare the effect of two altitude training regimens (live high-train low (LHTL), and intermittent hypoxic exposure (IHE)) on running performance and blood measurements of elite triathletes. The posterior distributions, and corresponding point and interval estimates, for the parameters and associated effects and comparisons of interest, were estimated using Markov chain Monte Carlo simulations. The Bayesian analysis was shown to provide more direct probabilistic comparisons of treatments and able to identify small effects of interest. The approach avoided asymptotic assumptions and overcame issues such as multiple testing. Bayesian analysis of unscaled effects showed a probability of 0.96 that LHTL yields a substantially greater increase in hemoglobin mass than IHE, a 0.93 probability of a substantially greater improvement in running economy and a greater than 0.96 probability that both IHE and LHTL yield a substantially greater improvement in maximum blood lactate concentration compared to a Placebo. The conclusions are consistent with those obtained using a 'magnitude-based inference' approach that has been promoted in the field. The paper demonstrates that a fully Bayesian analysis is a simple and effective way of analysing small effects, providing a rich set of results that are straightforward to interpret in terms of probabilistic statements.	[Mengersen, Kerrie L.; Drovandi, Christopher C.] Queensland Univ Technol, Fac Sci & Engn, Math Sci, Brisbane, Qld 4001, Australia; [Mengersen, Kerrie L.; Drovandi, Christopher C.] Queensland Univ Technol, Inst Future Environm, Brisbane, Qld 4001, Australia; [Mengersen, Kerrie L.; Drovandi, Christopher C.] Australian Res Council, Ctr Excellence Math & Stat Frontiers Big Data Big, Brisbane, Qld, Australia; [Robert, Christian P.] Univ Paris 09, CEREMADE, F-75775 Paris, France; [Pyne, David B.; Gore, Christopher J.] Australian Inst Sport, Canberra, ACT, Australia; [Pyne, David B.; Gore, Christopher J.] Univ Canberra, Res Inst Sport & Exercise, Bruce, ACT, Australia; [Gore, Christopher J.] Flinders Univ South Australia, Exercise Physiol Lab, Bedford Pk, SA, Australia	Queensland University of Technology (QUT); Queensland University of Technology (QUT); UDICE-French Research Universities; PSL Research University Paris; Universite Paris-Dauphine; Australian Institute of Sport; University of Canberra; Flinders University South Australia	Mengersen, KL (corresponding author), Queensland Univ Technol, Fac Sci & Engn, Math Sci, Brisbane, Qld 4001, Australia.; Mengersen, KL (corresponding author), Queensland Univ Technol, Inst Future Environm, Brisbane, Qld 4001, Australia.	k.mengersen@qut.edu.au	Robert, Christian/AAL-2415-2020; Mengersen, Kerrie/AHC-4096-2022; Drovandi, Christopher/J-1051-2012; Robert, Christian/D-4439-2013	Robert, Christian/0000-0001-6635-3261; Robert, Christian/0000-0001-6635-3261; Pyne, David/0000-0003-1555-5079; Mengersen, Kerrie/0000-0001-8625-9168; Drovandi, Christopher/0000-0001-9222-8763				Aarts AA, 2015, SCIENCE, V349, DOI 10.1126/science.aac4716; Atkinson G, 2012, INT J SPORTS MED, V33, P949, DOI 10.1055/s-0032-1327755; Bacchetti P, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001628; Bacchetti P, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-17; Batterham AM, 2006, INT J SPORT PHYSIOL, V1, P50, DOI 10.1123/ijspp.1.1.50; Beck TW, 2013, J STRENGTH COND RES, V27, P2323, DOI 10.1519/JSC.0b013e318278eea0; Bonetti DL, 2010, INT J SPORT PHYSIOL, V5, P210, DOI 10.1123/ijspp.5.2.210; Burton PR, 1998, J EPIDEMIOL COMMUN H, V52, P318, DOI 10.1136/jech.52.5.318; Cohen J.E., 1988, STAT POWER ANAL BEHA; CONLEY DL, 1980, MED SCI SPORT EXER, V12, P357, DOI 10.1249/00005768-198012050-00010; DANIELS JT, 1985, MED SCI SPORT EXER, V17, P332; Dienes Z, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00781; Garvican LA, 2010, EUR J APPL PHYSIOL, V109, P221, DOI 10.1007/s00421-009-1349-2; Gelman A, 2013, BAYESIAN DATA ANAL, P275; Gelman A, 2013, BAYESIAN DATA ANAL, P64; Gelman A, 2006, AM STAT, V60, P328, DOI 10.1198/000313006X152649; GEMAN S, 1984, IEEE T PATTERN ANAL, V6, P721, DOI 10.1109/TPAMI.1984.4767596; Gore CJ, 2006, J APPL PHYSIOL, V101, P1386, DOI 10.1152/japplphysiol.00342.2006; Gore CJ, 2013, BRIT J SPORT MED, V47, P31, DOI 10.1136/bjsports-2013-092840; HEDGES LV, 1985, STAT METHODS METAANA, DOI [10.1016/C2009-0-03396-0, DOI 10.1016/C2009-0-03396-0]; Hopkins WG, 1999, MED SCI SPORT EXER, V31, P472, DOI 10.1097/00005768-199903000-00018; Hopkins WG, 2001, SPORTS MED, V31, P211, DOI 10.2165/00007256-200131030-00005; Hopkins WG, 2004, SPORTSCIENCE, V8, P1, DOI DOI 10.1097/00005768-199804000-00026; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Humberstone-Gough CE, 2013, J SPORT SCI MED, V12, P394; Lundby C, 2007, SCAND J MED SCI SPOR, V17, P281, DOI 10.1111/j.1600-0838.2006.00530.x; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Marin J.-M., 2014, BAYESIAN ESSENTIALS, DOI DOI 10.1007/978-1-4614-8687-9; Marin J. M., 2007, BAYESIAN CORE PRACTI; Martin AD, 2011, J STAT SOFTW, V42, P1; Ploutz-Snyder RJ, 2014, J APPL PHYSIOL, V116, P1251, DOI 10.1152/japplphysiol.01335.2013; Pyne DB, 2004, J SPORT SCI, V22, P613, DOI 10.1080/02640410310001655822; Schmidt W, 2008, SCAND J MED SCI SPOR, V18, P57, DOI 10.1111/j.1600-0838.2008.00833.x; Smith TB, 2011, MED SCI SPORT EXER, V43, P2155, DOI 10.1249/MSS.0b013e31821d3f8e; Stang A, 2010, EUR J EPIDEMIOL, V25, P225, DOI 10.1007/s10654-010-9440-x; Stapleton C, 2009, INT J SPORTS MED, V30, P773, DOI 10.1055/s-0029-1241216; Sturtz S, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i03; Thomas A., 2006, R NEWS, V6, P12, DOI DOI 10.1159/000323281; Verhagen J, 2014, J EXP PSYCHOL GEN, V143, P1457, DOI 10.1037/a0036731; Welsh AH, 2015, MED SCI SPORT EXER, V47, P874, DOI 10.1249/MSS.0000000000000451; Wilkinson M, 2014, SPORTS MED, V44, P295, DOI 10.1007/s40279-013-0125-y; Williams MN, 2013, PRACT ASSESS RES EVA, V18, DOI [10.7275/55hn-wk47, DOI 10.7275/55HN-WK47]	43	48	48	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0147311	10.1371/journal.pone.0147311	http://dx.doi.org/10.1371/journal.pone.0147311			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073897	gold, Green Published			2022-12-27	WOS:000374131200001
J	Prioreschi, A; Makda, MA; Tikly, M; McVeigh, JA				Prioreschi, Alessandra; Makda, Mohamed A.; Tikly, Mohammed; McVeigh, Joanne A.			In Patients with Established RA, Positive Effects of a Randomised Three Month WBV Therapy Intervention on Functional Ability, Bone Mineral Density and Fatigue Are Sustained for up to Six Months	PLOS ONE			English	Article							WHOLE-BODY VIBRATION; RHEUMATOID-ARTHRITIS; MUSCLE STRENGTH; MUSCULAR STRENGTH; EXERCISE; EFFICACY; IMPROVES; FRACTURE; PREVENTION; DISEASE	Functional ability is often impaired for people with rheumatoid arthritis (RA), rendering these patients highly sedentary. Additionally, patients with RA often take medication known to negatively affect bone mass. Thus improving functional ability and bone health in this group of patients is important. The aim of this study was to investigate the effects of whole body vibration (WBV) therapy in patients with stable, established RA. Thirty one females with RA were randomly assigned to a control group (CON, n = 15) who continued with their normal activities or a WBV group (n = 16) who underwent a three month WBV therapy intervention, consisting of 15 minutes of intermittent vibration, performed twice per week. Patients were assessed at baseline, three months, and three months post intervention for functional ability using the modified Health Assessment Questionnaire; for RA disease activity using the Clinical Disease Activity Index, for quality of life using self-report fatigue and pain scores; for physical activity profiles using accelerometry, and for BMD and body composition using DXA. Patients in both groups were matched for all variables at baseline. After the intervention period, functional ability was significantly improved in the WBV group (1.22(0.19) to 0.92(0.19), p = 0.02). Hip BMD was significantly reduced in the CON group (0.97(0.05) to 0.84(0.05) g.cm(-2), p = 0.01), while no decreases were seen in the WBV group (1.01(0.05) to 0.94(0.05) g.cm(-2), p = 0.50). Despite no change in RA disease activity in either group at either follow up, fatigue levels were improved in the WBV group (4.4(0.63) to 1.1(0.65), yet remained unchanged in the CON group at both follow ups (p = 0.01). Ten minute bouts of light to moderate physical activity were significantly reduced in the CON group after the intervention (2.8(0.61) to 1.8(0.64) bouts per day, p = 0.01), and were preserved in the WBV group (3.1(0.59) to 3.0(0.61) bouts per day, p = 0.70). Intermittent WBV shows promise for sustained improvements in functional ability, for attenuating loss of bone mass at the hip, as well as for decreasing fatigue in patients with established RA.	[Prioreschi, Alessandra; McVeigh, Joanne A.] Univ Witwatersrand, Fac Hlth Sci, Sch Physiol, Exercise Physiol Lab, Johannesburg, South Africa; [Prioreschi, Alessandra] Univ Witwatersrand, MRC Wits Dev Pathways Hlth Res Unit, Dept Paediat, Johannesburg, South Africa; [Makda, Mohamed A.; Tikly, Mohammed] Univ Witwatersrand, Dept Med, Chris Hani Baragwanath Acad Hosp, Div Rheumatol, ZA-2001 Johannesburg, South Africa	University of Witwatersrand; University of Witwatersrand; University of Witwatersrand	Prioreschi, A (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Sch Physiol, Exercise Physiol Lab, Johannesburg, South Africa.; Prioreschi, A (corresponding author), Univ Witwatersrand, MRC Wits Dev Pathways Hlth Res Unit, Dept Paediat, Johannesburg, South Africa.	alessandraprioreschi@gmail.com	Taiar, Redha/Q-6769-2016; McVeigh, Joanne/C-9363-2016	Taiar, Redha/0000-0002-0227-3884; McVeigh, Joanne/0000-0002-2446-3814; Prioreschi, Alessandra/0000-0002-6913-0706	Connective Tissues Research Grant; National Research Foundation Innovation Award; Carnegie Large Research Grant; Directorate For Engineering [1130289] Funding Source: National Science Foundation; Directorate For Geosciences [1313747] Funding Source: National Science Foundation; Division Of Environmental Biology [1021840] Funding Source: National Science Foundation	Connective Tissues Research Grant; National Research Foundation Innovation Award; Carnegie Large Research Grant; Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by: Connective Tissues Research Grant (AP); National Research Foundation Innovation Award (AP); and Carnegie Large Research Grant (JAM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alentorn-Geli E, 2008, J ALTERN COMPLEM MED, V14, P975, DOI 10.1089/acm.2008.0050; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Baillet A, 2010, ARTHRIT CARE RES, V62, P984, DOI 10.1002/acr.20146; Bainbridge KE, 2002, AM J EPIDEMIOL, V156, P410, DOI 10.1093/aje/kwf049; Beck BR, 2015, CURR OSTEOPOROS REP, V13, P381, DOI 10.1007/s11914-015-0294-8; Bemben DA, 2010, BONE, V47, P650, DOI 10.1016/j.bone.2010.06.019; Bredella MA, 2011, BONE, V48, P748, DOI 10.1016/j.bone.2010.12.011; Bruce B, 2005, CLIN EXP RHEUMATOL, V23, pS14; Cairns AP, 2009, RHEUMATOL INT, V30, P147, DOI 10.1007/s00296-009-1090-5; Cardinale M, 2005, BRIT J SPORT MED, V39, P585, DOI 10.1136/bjsm.2005.016857; Cooney Jennifer K, 2011, J Aging Res, V2011, P681640, DOI 10.4061/2011/681640; da Rocha OM., 2009, REV BRAS REUMATOL, V49, P288, DOI [10.1590/S0482-50042009000300010, DOI 10.1590/S0482-50042009000300010]; De Zepetnek JO, 2009, J REHABIL RES DEV, V46, P529, DOI DOI 10.1682/JRRD.2008.09.0136; Deodhar AA, 1996, BRIT J RHEUMATOL, V35, P309; El Maghraoui A, 2008, QJM-INT J MED, V101, P605, DOI 10.1093/qjmed/hcn022; Ellingson LD, 2012, MED SCI SPORT EXER, V44, P1401, DOI 10.1249/MSS.0b013e318248f648; Figueiredo CP, 2014, OSTEOPOROSIS INT, V25, P589, DOI 10.1007/s00198-013-2455-x; Hakkinen A, 2004, ANN RHEUM DIS, V63, P910, DOI 10.1136/ard.2003.013003; Healy GN, 2011, EUR HEART J, V32, P590, DOI 10.1093/eurheartj/ehq451; Kinder J, 2013, J PAEDIAT NURS, V27, P127; Klareskog L, 2009, LANCET, V373, P659, DOI 10.1016/S0140-6736(09)60008-8; LAAN RFJM, 1993, ANN RHEUM DIS, V52, P21, DOI 10.1136/ard.52.1.21; Leslie WD, 2007, ARCH INTERN MED, V167, P1641, DOI 10.1001/archinte.167.15.1641; Looker A. C., 2012, VITAL HLTH STAT, V11, P1; Maddalozzo G, 2009, INT J OBESITY, V32, P1348; McMeeken J, 1999, Physiother Res Int, V4, P55; Metsios GS, 2008, RHEUMATOLOGY, V47, P239, DOI 10.1093/rheumatology/kem260; Milanese C, 2013, INT J MED SCI, V10, P307, DOI 10.7150/ijms.5161; Ozcivici E, 2010, NAT REV RHEUMATOL, V6, P50, DOI 10.1038/nrrheum.2009.239; Pang MYC, 2010, WORLD J ORTHOP, V1, P20, DOI 10.5312/wjo.v1.i1.20; Park YG, 2013, ANN REHABIL MED-ARM, V37, P505, DOI 10.5535/arm.2013.37.4.505; Pate RR, 2008, EXERC SPORT SCI REV, V36, P173, DOI 10.1097/JES.0b013e3181877d1a; Premaor MO, 2011, J CLIN ENDOCR METAB, V96, P2414, DOI 10.1210/jc.2011-0076; Prioreschi A, 2012, INT J SPORTS MED, V33, P593, DOI 10.1055/s-0032-1301886; Prioreschi A, 2013, RHEUMATOLOGY, V53, P1; Prioreschi A, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-403; REDELMEIER DA, 1993, ARCH INTERN MED, V153, P1337, DOI 10.1001/archinte.153.11.1337; Rittweger J, 2010, EUR J APPL PHYSIOL, V108, P877, DOI 10.1007/s00421-009-1303-3; Rodriguez-Miguelez P, 2015, MECH AGEING DEV, V150, P12, DOI 10.1016/j.mad.2015.08.002; Rubin C, 2004, J BONE MINER RES, V19, P343, DOI 10.1359/JBMR.0301251; Sanderson T, 2010, ARTHRIT CARE RES, V62, P647, DOI 10.1002/acr.20151; Sanudo B, 2010, CLIN EXP RHEUMATOL, V28, pS40; Schneider M, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-54; Tapp LR, 2014, CLIN INTERV AGING, V9, P63, DOI 10.2147/CIA.S30048; Tremblay MS, 2010, APPL PHYSIOL NUTR ME, V35, P725, DOI 10.1139/H10-079; Tudor-Locke C, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.110332; Tudor-Locke C, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-60; Turner CH, 1998, BONE, V23, P399, DOI 10.1016/S8756-3282(98)00118-5; Turner CH, 2005, BRIT J SPORT MED, V39, P188, DOI 10.1136/bjsm.2004.016923; Uzer G, 2013, J BIOMECH, V46, P2296, DOI 10.1016/j.jbiomech.2013.06.008; Verschueren SMP, 2004, J BONE MINER RES, V19, P352, DOI 10.1359/JBMR.0301245; Wysocki A, 2011, REV ANN INTERNAL MED, P155; Zhou Y, 2015, BONE, V71, P17, DOI 10.1016/j.bone.2014.09.026	53	16	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153470	10.1371/journal.pone.0153470	http://dx.doi.org/10.1371/journal.pone.0153470			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073832	Green Published, Green Submitted, gold			2022-12-27	WOS:000374131200097
J	Douillard, FP; Rasinkangas, P; Bhattacharjee, A; Palva, A; de Vos, WM				Douillard, Francois P.; Rasinkangas, Pia; Bhattacharjee, Arnab; Palva, Airi; de Vos, Willem M.			The N-Terminal GYPSY Motif Is Required for Pilin-Specific Sortase SrtC1 Functionality in Lactobacillus rhamnosus Strain GG	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; GRAM-POSITIVE BACTERIA; ENTEROCOCCUS-FAECIUM ISOLATE; LACTIC-ACID BACTERIA; SURFACE-PROTEINS; STREPTOCOCCUS-AGALACTIAE; STAPHYLOCOCCUS-AUREUS; LACTOCOCCUS-LACTIS; CORYNEBACTERIUM-DIPHTHERIAE; SUBSTRATE-SPECIFICITY	Predominantly identified in pathogenic Gram-positive bacteria, sortase-dependent pili are also found in commensal species, such as the probiotic-marketed strain Lactobacillus rhamnosus strain GG. Pili are typically associated with host colonization, immune signalling and biofilm formation. Comparative analysis of the N-terminal domains of pilin-specific sortases from various piliated Gram-positive bacteria identified a conserved motif, called GYPSY, within the signal sequence. We investigated the function and role of the GYPSY residues by directed mutagenesis in homologous (rod-shaped) and heterologous (coccoid-shaped) expression systems for pilus formation. Substitutions of some of the GYPSY residues, and more specifically the proline residue, were found to have a direct impact on the degree of piliation of Lb. rhamnosus GG. The present findings uncover a new signalling element involved in the functionality of pilin-specific sortases controlling the pilus biogenesis of Lb. rhamnosus GG and related piliated Gram-positive species.	[Douillard, Francois P.; Rasinkangas, Pia; Palva, Airi; de Vos, Willem M.] Univ Helsinki, Dept Vet Biosci, Helsinki, Finland; [Bhattacharjee, Arnab; de Vos, Willem M.] Univ Helsinki, Dept Bacteriol & Immunol, Res Programs Unit Immunobiol, Helsinki, Finland; [de Vos, Willem M.] Wageningen Univ, Microbiol Lab, NL-6700 AP Wageningen, Netherlands	University of Helsinki; University of Helsinki; Wageningen University & Research	Douillard, FP; de Vos, WM (corresponding author), Univ Helsinki, Dept Vet Biosci, Helsinki, Finland.; de Vos, WM (corresponding author), Univ Helsinki, Dept Bacteriol & Immunol, Res Programs Unit Immunobiol, Helsinki, Finland.; de Vos, WM (corresponding author), Wageningen Univ, Microbiol Lab, NL-6700 AP Wageningen, Netherlands.	francois.douillard@helsinki.fi; willem.devos@wur.nl		Bhattacharjee, Arnab/0000-0002-9613-7911	European Research Council [ERC 250172]; University of Helsinki; Academy of Finland [141140, 252123, 141130]	European Research Council(European Research Council (ERC)European Commission); University of Helsinki; Academy of Finland(Academy of Finland)	The present study was sponsored by the European Research Council (grant ERC 250172 Microbes Inside, https://erc.europa.eu/), the University of Helsinki and the Academy of Finland (grants 141140 to AP, 252123 to FPD and 141130 to WMdV, http://www.aka.fi/en/).	Avall-Jaaskelainen S, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-165; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Barocchi MA, 2006, P NATL ACAD SCI USA, V103, P2857, DOI 10.1073/pnas.0511017103; Bernardeau M, 2006, FEMS MICROBIOL REV, V30, P487, DOI 10.1111/j.1574-6976.2006.00020.x; Bolotin A, 2001, GENOME RES, V11, P731, DOI 10.1101/gr.GR-1697R; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Budzik JM, 2007, MOL MICROBIOL, V66, P495, DOI 10.1111/j.1365-2958.2007.05939.x; Campo N, 2004, MOL MICROBIOL, V53, P1583, DOI 10.1111/j.1365-2958.2004.04278.x; Carlsson F, 2006, NATURE, V442, P943, DOI 10.1038/nature05021; Cerdeno-Tarraga AM, 2003, NUCLEIC ACIDS RES, V31, P6516, DOI 10.1093/nar/gkg874; Clancy KW, 2010, BIOPOLYMERS, V94, P385, DOI 10.1002/bip.21472; Comfort D, 2004, INFECT IMMUN, V72, P2710, DOI 10.1128/IAI.72.5.2710-2722.2004; De Keersmaecker SCJ, 2006, APPL ENVIRON MICROB, V72, P4923, DOI 10.1128/AEM.02605-05; de Vos WM, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-S1-S2; DeDent A, 2008, EMBO J, V27, P2656, DOI 10.1038/emboj.2008.185; Douillard FP, 2014, J BIOL CHEM, V289, P15764, DOI 10.1074/jbc.M113.542332; Douillard FP, 2013, APPL ENVIRON MICROB, V79, P1923, DOI 10.1128/AEM.03467-12; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Guttilla IK, 2009, J BACTERIOL, V191, P5603, DOI 10.1128/JB.00627-09; Hanly W. Carey, 1995, ILAR J, V37, P93; Hardy JA, 2000, PROTEIN SCI, V9, P2128, DOI 10.1110/ps.9.11.2128; Hendrickx APA, 2008, MICROBIOL-SGM, V154, P3212, DOI 10.1099/mic.0.2008/020891-0; Hendrickx APA, 2010, MICROBIOL-SGM, V156, P2649, DOI 10.1099/mic.0.041392-0; HOLO H, 1989, APPL ENVIRON MICROB, V55, P3119, DOI 10.1128/AEM.55.12.3119-3123.1989; Hu P, 2008, ARCH ORAL BIOL, V53, P150, DOI 10.1016/j.archoralbio.2007.08.008; Ivanova N, 2003, NATURE, V423, P87, DOI 10.1038/nature01582; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kankainen M, 2009, P NATL ACAD SCI USA, V106, P17193, DOI 10.1073/pnas.0908876106; Kemp KD, 2007, INFECT IMMUN, V75, P5399, DOI 10.1128/IAI.00663-07; Kim DS, 2010, J MED MICROBIOL, V59, P505, DOI 10.1099/jmm.0.016238-0; Kline KA, 2009, J BACTERIOL, V191, P3237, DOI 10.1128/JB.01837-08; Kuipers OP, 1998, J BIOTECHNOL, V64, P15, DOI 10.1016/S0168-1656(98)00100-X; Lauer P, 2005, SCIENCE, V309, P105, DOI 10.1126/science.1111563; Lebeer S, 2012, APPL ENVIRON MICROB, V78, P185, DOI 10.1128/AEM.06192-11; Lebeer S, 2010, NAT REV MICROBIOL, V8, P171, DOI 10.1038/nrmicro2297; LeMieux J, 2006, INFECT IMMUN, V74, P2453, DOI 10.1128/IAI.74.4.2453-2456.2006; Mandlik A, 2008, TRENDS MICROBIOL, V16, P33, DOI 10.1016/j.tim.2007.10.010; Maresso AW, 2008, PHARMACOL REV, V60, P128, DOI 10.1124/pr.107.07110; Mazmanian SK, 1999, SCIENCE, V285, P760, DOI 10.1126/science.285.5428.760; McGrath S, 2001, APPL ENVIRON MICROB, V67, P608, DOI 10.1128/AEM.67.2.608-616.2001; Nallapareddy SR, 2011, INFECT IMMUN, V79, P2911, DOI 10.1128/IAI.00039-11; Neiers F, 2009, J MOL BIOL, V393, P704, DOI 10.1016/j.jmb.2009.08.058; Oxaran V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050989; Paulsen IT, 2003, SCIENCE, V299, P2071, DOI 10.1126/science.1080613; Popp MW, 2011, P NATL ACAD SCI USA, V108, P3169, DOI 10.1073/pnas.1016863108; Proft T, 2009, CELL MOL LIFE SCI, V66, P613, DOI 10.1007/s00018-008-8477-4; Qin X, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-135; Rasinkangas P, 2014, APPL ENVIRON MICROB, V80, P7001, DOI 10.1128/AEM.02006-14; Raz A, 2008, P NATL ACAD SCI USA, V105, P18549, DOI 10.1073/pnas.0808301105; Reunanen J, 2012, APPL ENVIRON MICROB, V78, P2337, DOI 10.1128/AEM.07047-11; Rosini R, 2006, MOL MICROBIOL, V61, P126, DOI 10.1111/j.1365-2958.2006.05225.x; Saxelin M, 2005, CURR OPIN BIOTECH, V16, P204, DOI 10.1016/j.copbio.2005.02.003; Sun ZH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9322; Swierczynski A, 2006, J BACTERIOL, V188, P6318, DOI 10.1128/JB.00606-06; Telford JL, 2006, NAT REV MICROBIOL, V4, P509, DOI 10.1038/nrmicro1443; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Tettelin H, 2002, P NATL ACAD SCI USA, V99, P12391, DOI 10.1073/pnas.182380799; Ton-That H, 2003, MOL MICROBIOL, V50, P1429, DOI 10.1046/j.1365-2958.2003.03782.x; Ton-That H, 1999, P NATL ACAD SCI USA, V96, P12424, DOI 10.1073/pnas.96.22.12424; Tremillon N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033516; VANHOOF G, 1995, FASEB J, V9, P736, DOI 10.1096/fasebj.9.9.7601338; Vanier G, 2008, VET MICROBIOL, V127, P417, DOI 10.1016/j.vetmic.2007.08.032; Vesterlund S, 2005, J MICROBIOL METH, V60, P225, DOI 10.1016/j.mimet.2004.09.013; VONHEIJNE G, 1991, J MOL BIOL, V218, P499, DOI 10.1016/0022-2836(91)90695-3; Wool GD, 2009, J LIPID RES, V50, P1889, DOI 10.1194/jlr.M900151-JLR200; Young PG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099135; Yukawa H, 2007, MICROBIOL-SGM, V153, P1042, DOI 10.1099/mic.0.2006/003657-0	68	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0153373	10.1371/journal.pone.0153373	http://dx.doi.org/10.1371/journal.pone.0153373			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27070897	Green Published, Green Submitted, gold			2022-12-27	WOS:000373900700056
J	Huang, HL; Yin, QY; Schwebel, DC; Li, L; Hu, GQ				Huang, Helai; Yin, Qingyi; Schwebel, David C.; Li, Li; Hu, Guoqing			Examining Road Traffic Mortality Status in China: A Simulation Study	PLOS ONE			English	Article							INJURY; SAFETY; FATALITIES; MODELS; TRENDS	Background Data from the Chinese police service suggest substantial reductions in road traffic injuries since 2002, but critics have questioned the accuracy of those data, especially considering conflicting data reported by the health department. Methods To address the gap between police and health department data and to determine which may be more accurate, we conducted a simulation study based on the modified Smeed equation, which delineates a non-linear relation between road traffic mortality and the level of motorization in a country or region. Our goal was to simulate trends in road traffic mortality in China and compare performances in road traffic safety management between China and 13 other countries. Results Chinese police data indicate a peak in road traffic mortalities in 2002 and a significant and a gradual decrease in population-based road traffic mortality since 2002. Health department data show the road traffic mortality peaked in 2012. In addition, police data suggest China's road traffic mortality peaked at a much lower motorization level (0.061 motor vehicles per person) in 2002, followed by a reduction in mortality to a level comparable to that of developed countries. Simulation results based on health department data suggest high road traffic mortality, with a mortality peak in 2012 at a moderate motorization level (0.174 motor vehicles per person). Comparisons to the other 13 countries suggest the health data from China may be more valid than the police data. Conclusion Our simulation data indicate China is still at a stage of high road traffic mortality, as suggested by health data, rather than a stage of low road traffic mortality, as suggested by police data. More efforts are needed to integrate safety into road design, improve road traffic management, improve data quality, and alter unsafe behaviors of pedestrians, drivers and passengers in China.	[Huang, Helai; Yin, Qingyi] Cent South Univ, Sch Traff & Transportat Engn, Urban Transport Res Ctr, Changsha 410075, Hunan, Peoples R China; [Schwebel, David C.] Univ Alabama Birmingham, Dept Psychol, Birmingham, AL 35294 USA; [Li, Li] W Virginia Univ, Sch Publ Hlth, Dept Epidemiol, Morgantown, WV 26506 USA; [Hu, Guoqing] Cent South Univ, Xiangya Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Changsha 410078, Hunan, Peoples R China	Central South University; University of Alabama System; University of Alabama Birmingham; West Virginia University; Central South University	Hu, GQ (corresponding author), Cent South Univ, Xiangya Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Changsha 410078, Hunan, Peoples R China.	huguoqing009@gmail.com	Schwebel, David/GXH-9944-2022	Hu, Guoqing/0000-0002-5002-8015	Natural Science Foundation of China [71371192, 71561167001, 81573260]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Natural Science Foundation of China (No. 71371192, 71561167001, and 81573260).; This work was supported by the Natural Science Foundation of China (No. 71371192, 71561167001, and 81573260).	Alcorn T, 2011, LANCET, V378, P305, DOI 10.1016/S0140-6736(11)61153-7; Ameen JRM, 2001, ACCIDENT ANAL PREV, V33, P547, DOI 10.1016/S0001-4575(00)00069-5; Andreassen DC, 1987, TRAFFIC ENG CONTROL, V26, P547; Bahadorimonfared A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065198; Borsos A, 2012, TRANSPORT RES REC, P154, DOI 10.3141/2280-17; Cooper PJ, 1985, TRANSPORT RES REC, V1047, P1; Gelman A., 2006, DATA ANAL USING REGR, DOI DOI 10.1017/CBO9780511790942.005; HAKIM S, 1991, ACCIDENT ANAL PREV, V23, P379, DOI 10.1016/0001-4575(91)90058-D; Hu G, 2008, INJURY PREV, V14, P149, DOI 10.1136/ip.2007.016469; Hu GQ, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1010; Hu GQ, 2012, PUBLIC HEALTH REP, V127, P275, DOI 10.1177/003335491212700307; Hu GQ, 2011, B WORLD HEALTH ORGAN, V89, P41, DOI 10.2471/BLT.10.080317; Hu JT., 2003, FORESTRY LABOUR SAFE, V9, P67; International Transport Forum, 2014, ROAD SAF ANN REP 201; Jin FJ, 2012, CHINESE GEOGR SCI, V22, P319, DOI 10.1007/s11769-012-0538-9; Kopits E, 2005, ACCIDENT ANAL PREV, V37, P169, DOI 10.1016/j.aap.2004.04.006; Koren C., 2009, 4 IRTAD C SEOUL KOR; Koren CS, 2010, SIMILARITIES DIFFERE, P8; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Ma S, 2012, TRAFFIC INJ PREV, V13, P57, DOI 10.1080/15389588.2011.633945; National Health and Family Planning Commission (NHFPC) PRC, 2014, CHIN HLTH STAT YB 20; OPPE S, 1991, ACCIDENT ANAL PREV, V23, P413, DOI 10.1016/0001-4575(91)90060-I; PARTYKA SC, 1984, ACCIDENT ANAL PREV, V16, P211, DOI 10.1016/0001-4575(84)90015-0; Samuel JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031091; Santos SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025383; SMEED RJ, 1949, J ROY STAT SOC A STA, V112, P1, DOI 10.2307/2984177; Smeed RJ, 1973, B INT STAT I, V45, P44; Tang TQ, 2009, CHINESE PHYS LETT, V26, DOI 10.1088/0256-307X/26/10/108901; Traffic Management Bureau of Ministry of Public Security, 2014, ROAD TRAFF ACC STAT; Traffic Management Bureau of the Ministry of Public Security PRC, 2010, COMP STAT DAT NAT RO; United Nations Road Safety Collaboration, 2011, GLOB PLAN DEC ACT RO; Wang SY, 2008, LANCET, V372, P1765, DOI 10.1016/S0140-6736(08)61367-7; Wang XS, 2014, ACCIDENT ANAL PREV, V70, P215, DOI 10.1016/j.aap.2014.04.005; World Health Organization, 2009, GLOB STAT REP ROAD S; World Health Organization, 2013, GLOB STA REP ROAD SA; Xu L, 2010, 11 INT C CHIN TRANSP, P1795; Xu PP, 2014, ACCIDENT ANAL PREV, V70, P110, DOI 10.1016/j.aap.2014.02.012; Yan S, 2012, 12 INT C CHIN TRANSP, P2474; Yang G, 2004, POPUL HEALTH METR, V3, P3; Yannis G, 2011, J SAFETY RES, V42, P17, DOI 10.1016/j.jsr.2010.11.003; Zhang GX, 2012, IEEE T SYST MAN CY B, V42, P2, DOI 10.1109/TSMCB.2011.2165336; Zhang W, 2010, J SAFETY RES, V41, P25, DOI 10.1016/j.jsr.2009.12.003	42	18	20	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0153251	10.1371/journal.pone.0153251	http://dx.doi.org/10.1371/journal.pone.0153251			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27071008	Green Published, Green Submitted, gold			2022-12-27	WOS:000373900700041
J	Orczyk-Pawilowicz, M; Jawien, E; Deja, S; Hirnle, L; Zabek, A; Mlynarz, P				Orczyk-Pawilowicz, Magdalena; Jawien, Ewa; Deja, Stanislaw; Hirnle, Lidia; Zabek, Adam; Mlynarz, Piotr			Metabolomics of Human Amniotic Fluid and Maternal Plasma during Normal Pregnancy	PLOS ONE			English	Article							LACTATE-PYRUVATE RATIO; PRENATAL DISORDERS; NMR-SPECTROSCOPY; GESTATIONAL-AGE; BIRTH-WEIGHT; AMINO-ACIDS; FETAL; PROFILE; BLOOD; LABOR	Metabolic profiles of amniotic fluid and maternal blood are sources of valuable information about fetus development and can be potentially useful in diagnosis of pregnancy disorders. In this study, we applied 1H NMR-based metabolic profiling to track metabolic changes occurring in amniotic fluid (AF) and plasma (PL) of healthy mothers over the course of pregnancy. AF and PL samples were collected in the 2nd (T2) and 3rd (T3) trimester, prolonged pregnancy (PP) until time of delivery (TD). A multivariate data analysis of both biofluids reviled a metabolic switch-like transition between 2nd and 3rd trimester, which was followed by metabolic stabilization throughout the rest of pregnancy probably reflecting the stabilization of fetal maturation and development. The differences were further tested using univariate statistics at alpha = 0.001. In plasma the progression from T2 to T3 was related to increasing levels of glycerol, choline and ketone bodies (3-hydroxybutyrate and acetoacetate) while pyruvate concentration was significantly decreased. In amniotic fluid, T2 to T3 transition was associated with decreasing levels of glucose, carnitine, amino acids (valine, leucine, isoleucine, alanine, methionine, tyrosine, and phenylalanine) and increasing levels of creatinine, succinate, pyruvate, choline, N, N-dimethylglycine and urocanate. Lactate to pyruvate ratio was decreased in AF and conversely increased in PL. The results of our study, show that metabolomics profiling can be used to better understand physiological changes of the complex interdependencies of the mother, the placenta and the fetus during pregnancy. In the future, these results might be a useful reference point for analysis of complicated pregnancies.	[Orczyk-Pawilowicz, Magdalena] Wroclaw Med Univ, Dept Chem & Immunochem, Wroclaw, Poland; [Jawien, Ewa; Zabek, Adam; Mlynarz, Piotr] Wroclaw Univ Technol, Dept Chem, PL-50370 Wroclaw, Poland; [Hirnle, Lidia] Wroclaw Med Univ, Dept 1, Wroclaw, Poland; [Hirnle, Lidia] Wroclaw Med Univ, Clin Gynaecol & Obstet, Wroclaw, Poland; [Deja, Stanislaw] Opole Univ, Fac Chem, Opole, Poland	Wroclaw Medical University; Wroclaw University of Science & Technology; Wroclaw Medical University; Wroclaw Medical University; University of Opole	Mlynarz, P (corresponding author), Wroclaw Univ Technol, Dept Chem, PL-50370 Wroclaw, Poland.; Deja, S (corresponding author), Opole Univ, Fac Chem, Opole, Poland.	stanislaw.deja@pwr.edu.pl; piotr.mlynarz@pwr.edu.pl	Deja, Stanislaw/AAI-7526-2020; Orczyk-Pawiłowicz, Magdalena/AAV-9298-2021	Deja, Stanislaw/0000-0002-7714-2547; Hirnle, Lidia/0000-0001-9789-5370; Mlynarz, Piotr/0000-0002-8502-4022	Wroclaw University of Technology [S40531/Z0303]; WCB KNOW (Wroclaw Center for Biotechnology, Leading National Research Center)	Wroclaw University of Technology; WCB KNOW (Wroclaw Center for Biotechnology, Leading National Research Center)	This project was supported by Wroclaw University of Technology S40531/Z0303 and WCB KNOW (Wroclaw Center for Biotechnology, Leading National Research Center) 2014-2018.	Alexandre-Gouabau MC, 2013, J PROTEOME RES, V12, P2764, DOI 10.1021/pr400122v; Athanasiadis AP, 2011, J MATERN-FETAL NEO M, V24, P1033, DOI 10.3109/14767058.2010.545909; Austdal M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091923; Bahado-Singh RO, 2012, J MATERN-FETAL NEO M, V25, P1840, DOI 10.3109/14767058.2012.680254; BOCK JL, 1994, CLIN CHEM, V40, P56; Briese V, 1999, Z GEBURTSH NEONATOL, V203, P63; Ciborowski M, 2014, PRENATAL DIAG, V34, P870, DOI 10.1002/pd.4386; Cohn BR, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.01.046; Diaz SO, 2011, J PROTEOME RES, V10, P3732, DOI 10.1021/pr200352m; Dieterle F, 2006, ANAL CHEM, V78, P4281, DOI 10.1021/ac051632c; Duarte IF, 2014, J PHARMACEUT BIOMED, V93, P17, DOI 10.1016/j.jpba.2013.09.025; Fanos V, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/720514; Fluhr JW, 2010, J INVEST DERMATOL, V130, P2141, DOI 10.1038/jid.2010.74; Graca G, 2008, ANAL CHEM, V80, P6085, DOI 10.1021/ac800907f; Graca G, 2007, ANAL CHEM, V79, P8367, DOI 10.1021/ac071278d; Graca G, 2013, ANAL CHIM ACTA, V764, P24, DOI 10.1016/j.aca.2012.12.023; Graca G, 2012, SPECTROSC-INT J, V27, P515, DOI 10.1155/2012/128367; Graca G, 2010, J PROTEOME RES, V9, P6016, DOI 10.1021/pr100815q; Graca G, 2009, J PROTEOME RES, V8, P4144, DOI 10.1021/pr900386f; Groenen PMW, 2004, EUR J OBSTET GYN R B, V112, P16, DOI 10.1016/S0301-2115(03)00279-3; Herrera E, 2000, EUR J CLIN NUTR, V54, pS47, DOI 10.1038/sj.ejcn.1600984; Imbard A, 2013, PRENATAL DIAG, V33, P848, DOI 10.1002/pd.4142; Krastanov A, 2010, BIOTECHNOL BIOTEC EQ, V24, P1537, DOI 10.2478/V10133-010-0001-Y; Lain KY, 2007, CLIN OBSTET GYNECOL, V50, P938, DOI 10.1097/GRF.0b013e31815a5494; LEVY HL, 1969, PEDIATR RES, V3, P113, DOI 10.1203/00006450-196903000-00002; Lind T, 1981, AMNIOTIC FLUID ITS C; Lindsay KL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145794; Luan HM, 2014, J PROTEOME RES, V13, P1527, DOI 10.1021/pr401068k; Madeira VMC, 2012, METHODS MOL BIOL, V810, P1, DOI 10.1007/978-1-61779-382-0_1; Menon R, 2014, REPROD SCI, V21, P791, DOI 10.1177/1933719113518987; Michaels JEA, 2007, J PROTEOME RES, V6, P1277, DOI 10.1021/pr060543t; Mracek T, 2013, BBA-BIOENERGETICS, V1827, P401, DOI 10.1016/j.bbabio.2012.11.014; Oliveira FR, 2002, BRAZ J MED BIOL RES, V35, P215, DOI 10.1590/S0100-879X2002000200010; OMU AE, 1984, J OBSTET GYNAECOL, V4, P151, DOI 10.3109/01443618409075703; Omu AE, 1997, ARCH GYNECOL OBSTET, V259, P59; Owen OE, 2002, J BIOL CHEM, V277, P30409, DOI 10.1074/jbc.R200006200; Pinto J, 2015, J PROTEOME RES, V14, P1263, DOI 10.1021/pr5011982; Romero R, 2010, J MATERN-FETAL NEO M, V23, P1344, DOI 10.3109/14767058.2010.482618; Sachse D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052399; Savorani F, 2010, J MAGN RESON, V202, P190, DOI 10.1016/j.jmr.2009.11.012; Silwood CJL, 2002, J DENT RES, V81, P422, DOI 10.1177/154405910208100613; Sun F, 2012, PLOS ONE, V7, P1; Tea I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029947; Underwood Mark A, 2005, J Perinatol, V25, P341, DOI 10.1038/sj.jp.7211290; Wu GY, 2010, ADV NUTR, V1, P31, DOI 10.3945/an.110.1008; Xi L, 2008, J NUTR, V138, P2356, DOI 10.3945/jn.108.095638; Zeisel SH, 2006, ANNU REV NUTR, V26, P229, DOI 10.1146/annurev.nutr.26.061505.111156; Zhang J, 2012, BBA-MOL BASIS DIS, V1822, P1807, DOI 10.1016/j.bbadis.2012.08.001	48	55	60	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0152740	10.1371/journal.pone.0152740	http://dx.doi.org/10.1371/journal.pone.0152740			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27070784	gold, Green Published, Green Submitted			2022-12-27	WOS:000373900700015
J	Sauleau, P; Drapier, S; Duprez, J; Houvenaghel, JF; Dondaine, T; Haegelen, C; Drapier, D; Jannin, P; Robert, G; Le Jeune, F; Verin, M				Sauleau, Paul; Drapier, Sophie; Duprez, Joan; Houvenaghel, Jean-Francois; Dondaine, Thibaut; Haegelen, Claire; Drapier, Dominique; Jannin, Pierre; Robert, Gabriel; Le Jeune, Florence; Verin, Marc			Weight Gain following Pallidal Deep Brain Stimulation: A PET Study	PLOS ONE			English	Article							SUBTHALAMIC NUCLEUS STIMULATION; PARKINSONS-DISEASE; GLOBUS-PALLIDUS; PALLIDOTOMY; ENERGY; METAANALYSIS; MECHANISMS; CIRCUITRY; INTERNUS; LEVODOPA	The mechanisms behind weight gain following deep brain stimulation (DBS) surgery seem to be multifactorial and suspected depending on the target, either the subthalamic nucleus (STN) or the globus pallidus internus (GPi). Decreased energy expenditure following motor improvement and behavioral and/or metabolic changes are possible explanations. Focusing on GPi target, our objective was to analyze correlations between changes in brain metabolism (measured with PET) and weight gain following GPi-DBS in patients with Parkinson's disease (PD). Body mass index was calculated and brain activity prospectively measured using 2-deoxy-2[18F]fluoro-D-glucose PET four months before and four months after the start of GPi-DBS in 19 PD patients. Dopaminergic medication was included in the analysis to control for its possible influence on brain metabolism. Body mass index increased significantly by 0.66 +/- 1.3 kg/m(2) (p = 0.040). There were correlations between weight gain and changes in brain metabolism in premotor areas, including the left and right superior gyri (Brodmann area, BA 6), left superior gyrus (BA 8), the dorsolateral prefrontal cortex (right middle gyrus, BAs 9 and 46), and the left and right somatosensory association cortices (BA 7). However, we found no correlation between weight gain and metabolic changes in limbic and associative areas. Additionally, there was a trend toward a correlation between reduced dyskinesia and weight gain (r = 0.428, p = 0.067). These findings suggest that, unlike STN-DBS, motor improvement is the major contributing factor for weight gain following GPi-DBS PD, confirming the motor selectivity of this target.	[Sauleau, Paul; Drapier, Sophie; Duprez, Joan; Houvenaghel, Jean-Francois; Dondaine, Thibaut; Drapier, Dominique; Robert, Gabriel; Le Jeune, Florence; Verin, Marc] Univ Rennes 1, Behav & Basal Ganglia Res Unit, EA 4712, Ave Leon Bernard, Rennes, France; [Sauleau, Paul] Rennes Univ Hosp, Dept Neurophysiol, Rue Henri Le Guilloux, Rennes, France; [Drapier, Sophie; Houvenaghel, Jean-Francois; Verin, Marc] Rennes Univ Hosp, Dept Neurol, Rue Henri Le Guilloux, Rennes, France; [Haegelen, Claire; Jannin, Pierre] Rennes Univ Hosp, Dept Neurosurg, Rue Henri Le Guilloux, Rennes, France; [Haegelen, Claire] Univ Rennes 1, INSERM, UMR LTSI 1099, MediCIS Lab, Ave Leon Bernard, Rennes, France; [Drapier, Dominique; Robert, Gabriel] Rennes Univ Hosp, Dept Psychiat, Ave Gen Leclerc, Rennes, France; [Le Jeune, Florence] Eugene Marquis Ctr, Dept Oncol, Ave Bataille Flandres Dunkerque, Rennes, France	Universite de Rennes; CHU Rennes; Universite de Rennes; CHU Rennes; Universite de Rennes; CHU Rennes; Universite de Rennes; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; CHU Rennes; Universite de Rennes; UNICANCER; Centre Eugene Marquis	Sauleau, P (corresponding author), Univ Rennes 1, Behav & Basal Ganglia Res Unit, EA 4712, Ave Leon Bernard, Rennes, France.; Sauleau, P (corresponding author), Rennes Univ Hosp, Dept Neurophysiol, Rue Henri Le Guilloux, Rennes, France.	paul.sauleau@univ-rennes1.fr	Verin, Marc/ABC-6924-2020; Sauleau, Paul/ABC-4459-2020; Jannin, Pierre/F-5538-2010; Jannin, Pierre/P-9958-2019; Le Jeune, Florence/ABC-6983-2020; Haegelen, Claire CH/J-5332-2016; Duprez, Joan/X-8320-2019	Jannin, Pierre/0000-0002-7415-071X; Jannin, Pierre/0000-0002-7415-071X; Duprez, Joan/0000-0002-8176-5114; Dondaine, Thibaut/0000-0002-8778-5079; Houvenaghel, Jean-Francois/0000-0001-5424-2759				Aiello M, 2015, APPETITE, V84, P204, DOI 10.1016/j.appet.2014.10.011; Bannier S, 2009, J NEUROL NEUROSUR PS, V80, P484, DOI 10.1136/jnnp.2008.158576; Barichella M, 2003, MOVEMENT DISORD, V18, P1337, DOI 10.1002/mds.10543; Combs HL, 2015, NEUROPSYCHOL REV, V25, P439, DOI 10.1007/s11065-015-9302-0; Dalvi A, 1999, MOVEMENT DISORD, V14, P256, DOI 10.1002/1531-8257(199903)14:2<256::AID-MDS1010>3.0.CO;2-8; Dietz J, 2013, BRAIN STIMUL, V6, P248, DOI 10.1016/j.brs.2012.05.011; Eusebio A, 2013, J NEUROL NEUROSUR PS, V84, P868, DOI 10.1136/jnnp-2012-302387; Gironell A, 2002, NEUROLOGIA, V17, P310; Kelley AE, 2005, PHYSIOL BEHAV, V86, P773, DOI 10.1016/j.physbeh.2005.08.066; Kistner A, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00084; Lang AE, 1997, ANN NEUROL, V41, P834, DOI 10.1002/ana.410410624; Le Jeune F, 2008, BRAIN, V131, P1599, DOI 10.1093/brain/awn084; Lhommee E, 2012, BRAIN, V135, P1463, DOI 10.1093/brain/aws078; Liu Y, 2014, J NEUROSURG, V121, P709, DOI 10.3171/2014.4.JNS131711; Macia F, 2004, MOVEMENT DISORD, V19, P206, DOI 10.1002/mds.10630; Mills KA, 2012, STEREOT FUNCT NEUROS, V90, P386, DOI 10.1159/000340071; Montaurier C, 2007, BRAIN, V130, P1808, DOI 10.1093/brain/awm113; Ondo WG, 2000, ACTA NEUROL SCAND, V101, P79, DOI 10.1034/j.1600-0404.2000.101002079.x; Perlemoine C, 2005, BRIT J NUTR, V93, P191, DOI 10.1079/BJN20041297; Ruzicka F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038020; Sauleau P, 2014, MOVEMENT DISORD, V29, P1781, DOI 10.1002/mds.26063; Sauleau P, 2009, MOVEMENT DISORD, V24, P2149, DOI 10.1002/mds.22765; Stratford TR, 2005, BRAIN RES, V1048, P241, DOI 10.1016/j.brainres.2005.05.002; Strowd RE, 2010, J NEUROL, V257, P1293, DOI 10.1007/s00415-010-5509-4; Tomlinson CL, 2010, MOVEMENT DISORD, V25, P2649, DOI 10.1002/mds.23429; Vitek JL, 2003, ANN NEUROL, V53, P558, DOI 10.1002/ana.10517; Volkmann J, 2001, NEUROLOGY, V56, P548, DOI 10.1212/WNL.56.4.548; Wolf ME, 2016, J NEURAL TRANSM, V123, P261, DOI 10.1007/s00702-015-1447-8; Zahodne LB, 2011, J NEUROPSYCH CLIN N, V23, P56, DOI 10.1176/appi.neuropsych.23.1.56	29	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0153438	10.1371/journal.pone.0153438	http://dx.doi.org/10.1371/journal.pone.0153438			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27070317	Green Published, gold, Green Submitted			2022-12-27	WOS:000373900700068
J	Wang, YM; Gratzke, C; Tamalunas, A; Wiemer, N; Ciotkowska, A; Rutz, B; Waidelich, R; Strittmatter, F; Liu, CX; Stief, CG; Hennenberg, M				Wang, Yiming; Gratzke, Christian; Tamalunas, Alexander; Wiemer, Nicolas; Ciotkowska, Anna; Rutz, Beata; Waidelich, Raphaela; Strittmatter, Frank; Liu, Chunxiao; Stief, Christian G.; Hennenberg, Martin			P21-Activated Kinase Inhibitors FRAX486 and IPA3: Inhibition of Prostate Stromal Cell Growth and Effects on Smooth Muscle Contraction in the Human Prostate	PLOS ONE			English	Article							LOWER URINARY-TRACT; LIGHT-CHAIN PHOSPHORYLATION; PROTEIN-KINASE; CA2+ SENSITIVITY; MYOSIN-II; ACTIN; ACTIVATION; CANCER; PROLIFERATION; VIMENTIN	Prostate smooth muscle tone and hyperplastic growth are involved in the pathophysiology and treatment of male lower urinary tract symptoms (LUTS). Available drugs are characterized by limited efficacy. Patients' adherence is particularly low to combination therapies of 5 alpha-reductase inhibitors and alpha(1)-adrenoceptor antagonists, which are supposed to target contraction and growth simultaneously. Consequently, molecular etiology of benign prostatic hyperplasia (BPH) and new compounds interfering with smooth muscle contraction or growth in the prostate are of high interest. Here, we studied effects of p21-activated kinase (PAK) inhibitors (FRAX486, IPA3) in hyperplastic human prostate tissues, and in stromal cells (WPMY-1). In hyperplastic prostate tissues, PAK1, -2, -4, and -6 may be constitutively expressed in catecholaminergic neurons, while PAK1 was detected in smooth muscle and WPMY-1 cells. Neurogenic contractions of prostate strips by electric field stimulation were significantly inhibited by high concentrations of FRAX486 (30 mu M) or IPA3 (300 mu M), while noradrenaline-and phenylephrine-induced contractions were not affected. FRAX486 (30 mu M) inhibited endothelin-1- and -2-induced contractions. In WPMY-1 cells, FRAX486 or IPA3 (24 h) induced concentration-dependent (1-10 mu M) degeneration of actin filaments. This was paralleled by attenuation of proliferation rate, being observed from 1 to 10 mu M FRAX486 or IPA3. Cytotoxicity of FRAX486 and IPA3 in WPMY-1 cells was time-and concentration-dependent. Stimulation of WPMY-1 cells with endothelin-1 or dihydrotestosterone, but not noradrenaline induced PAK phosphorylation, indicating PAK activation by endothelin-1. Thus, PAK inhibitors may inhibit neurogenic and endothelin-induced smooth muscle contractions in the hyperplastic human prostate, and growth of stromal cells. Targeting prostate smooth muscle contraction and stromal growth at once by a single compound is principally possible, at least under experimental conditions.	[Wang, Yiming; Gratzke, Christian; Tamalunas, Alexander; Wiemer, Nicolas; Ciotkowska, Anna; Rutz, Beata; Waidelich, Raphaela; Strittmatter, Frank; Stief, Christian G.; Hennenberg, Martin] Univ Munich, Dept Urol, Munich, Germany; [Wang, Yiming; Liu, Chunxiao] Southern Med Univ, Zhujiang Hosp, Dept Urol, Guangzhou, Guangdong, Peoples R China	University of Munich; Southern Medical University - China	Gratzke, C (corresponding author), Univ Munich, Dept Urol, Munich, Germany.	christian.gratzke@med.uni-muenchen.de	Tamalunas, Alexander/AAW-3850-2021; Hennenberg, Martin/M-3474-2016	Tamalunas, Alexander/0000-0002-4659-2262; 	Deutsche Forschungsgemeinschaft [HE 5825/2-1, GR 3333/2-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was supported by grants HE 5825/2-1 to MH and GR 3333/2-1 to CG from the Deutsche Forschungsgemeinschaft (DE) (http://www.dfg.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Prof. Dr. E. Noessner and her coworkers for support with immunofluorescence microscopy. We thank Prof. Dr. T. Kirchner (Institute of Pathology, Ludwig-Maximilians University, Munich) and his coworkers Dr. V. Mai and Dr. C. Faber for asservation of tissue samples from prostates. This study was supported by grants from the Deutsche Forschungsgemeinschaft (grants HE 5825/2-1, and GR 3333/2-1).	Al-Azayzih A, 2015, BBA-MOL CELL RES, V1853, P1229, DOI 10.1016/j.bbamcr.2015.02.023; Alcaraz A, 2009, EUR UROL, V55, P864, DOI 10.1016/j.eururo.2008.11.011; Andersson KE, 2007, NAT CLIN PRACT UROL, V4, P368, DOI 10.1038/ncpuro0836; Baek SH, 2012, FEBS LETT, V586, P772, DOI 10.1016/j.febslet.2012.01.061; Chahdi A, 2005, J BIOL CHEM, V280, P578, DOI 10.1074/jbc.M411130200; Chan PM, 2012, PROG MOL BIOL TRANSL, V106, P171, DOI 10.1016/B978-0-12-396456-4.00011-0; Chapple CR, 2011, EUR UROL, V59, P342, DOI 10.1016/j.eururo.2010.10.046; Chu J, 2013, J BIOL CHEM, V288, P1200, DOI 10.1074/jbc.M112.370718; Cindolo L, 2015, EUR UROL, V68, P418, DOI 10.1016/j.eururo.2014.11.006; Coleman Natalia, 2012, Cell Logist, V2, P132; Davis B, 2000, BJU INT, V85, P918, DOI 10.1046/j.1464-410x.2000.00573.x; Deacon SW, 2008, CHEM BIOL, V15, P322, DOI 10.1016/j.chembiol.2008.03.005; Delorme-Walker VD, 2011, J CELL BIOL, V193, P1289, DOI 10.1083/jcb.201010059; Diebold I, 2010, ANTIOXID REDOX SIGN, V13, P399, DOI 10.1089/ars.2009.3013; Dolan BM, 2013, P NATL ACAD SCI USA, V110, P5671, DOI [10.1073/pnas.1219383110, 10.1073/pnas.1219353110]; Even-Faitelson L, 2005, CELL SIGNAL, V17, P1137, DOI 10.1016/j.cellsig.2004.12.015; Fediuk J, 2014, AM J PHYSIOL-LUNG C, V307, pL877, DOI 10.1152/ajplung.00036.2014; Foster DB, 2000, J BIOL CHEM, V275, P1959, DOI 10.1074/jbc.275.3.1959; Fullhase C, 2013, EUR UROL, V64, P228, DOI 10.1016/j.eururo.2013.01.018; Garcia M, 2014, EUKARYOT CELL, V13, P119, DOI 10.1128/EC.00216-13; Gerthoffer WT, 2005, CAN J PHYSIOL PHARM, V83, P851, DOI 10.1139/Y05-088; Goc A, 2013, J BIOL CHEM, V288, P3025, DOI 10.1074/jbc.M112.424770; Goeckeler ZM, 2000, J BIOL CHEM, V275, P18366, DOI 10.1074/jbc.M001339200; Gratzke C, 2015, EUR UROL, V67, P1099, DOI 10.1016/j.eururo.2014.12.038; Guh JH, 1996, BRIT J PHARMACOL, V117, P1716, DOI 10.1111/j.1476-5381.1996.tb15344.x; Hayashi-Takagi A, 2014, P NATL ACAD SCI USA, V111, P6461, DOI 10.1073/pnas.1321109111; Hennenberg M, 2014, NEUROUROL URODYNAM, V33, P1074, DOI 10.1002/nau.22467; Hennenberg M, 2013, AM J PHYSIOL-RENAL, V305, pF1383, DOI 10.1152/ajprenal.00380.2013; Hinoki A, 2010, HYPERTENSION, V55, P161, DOI 10.1161/HYPERTENSIONAHA.109.143057; Hirst Stuart J, 2004, J Allergy Clin Immunol, V114, pS2, DOI 10.1016/j.jaci.2004.04.039; Kaur R, 2008, PROSTATE, V68, P1510, DOI 10.1002/pros.20787; Khare V, 2015, INFLAMM BOWEL DIS, V21, P287, DOI 10.1097/MIB.0000000000000281; Khoder WY, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-335; Khoder WY, 2012, UROLOGY, V79, P717, DOI 10.1016/j.urology.2011.11.045; Kim YB, 2015, J BIOL CHEM, V290, P21076, DOI 10.1074/jbc.M115.675124; Kortmann BBM, 2003, UROLOGY, V62, P1, DOI 10.1016/S0090-4295(02)02113-1; Kundumani-Sridharan V, 2013, J BIOL CHEM, V288, P22150, DOI 10.1074/jbc.M113.454082; Kunit T, 2014, AM J PHYSIOL-RENAL, V307, pF823, DOI 10.1152/ajprenal.00011.2014; Lee HN, 2015, INT J CLIN PRACT, V69, P444, DOI 10.1111/ijcp.12581; Levitt Jonathan M, 2007, Curr Urol Rep, V8, P269, DOI 10.1007/s11934-007-0072-y; Li QF, 2009, AM J PHYSIOL-CELL PH, V297, pC1424, DOI 10.1152/ajpcell.00324.2009; Li QF, 2009, AM J PHYSIOL-CELL PH, V297, pC299, DOI 10.1152/ajpcell.00037.2009; Madersbacher S, 2007, EUR UROL, V51, P1522, DOI 10.1016/j.eururo.2007.03.034; Matsukawa Y, 2013, J UROLOGY, V189, pS117, DOI 10.1016/j.juro.2012.11.031; McFawn PK, 2003, AM J PHYSIOL-LUNG C, V284, pL863, DOI 10.1152/ajplung.00068.2002; Oelke M, 2013, EUR UROL, V64, P118, DOI 10.1016/j.eururo.2013.03.004; Ohtakara K, 2000, BIOCHEM BIOPH RES CO, V272, P712, DOI 10.1006/bbrc.2000.2854; Ong CC, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0564-5; Orsted DD, 2013, NAT REV UROL, V10, P49, DOI 10.1038/nrurol.2012.192; Park MH, 2013, ONCOGENE, V32, P2475, DOI 10.1038/onc.2012.255; Parker NH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066892; Pradidarcheep Wisuit, 2011, Handb Exp Pharmacol, P117, DOI 10.1007/978-3-642-16499-6_7; Rane Chetan K, 2014, Small GTPases, V5, DOI 10.4161/sgtp.28003; Raymond K, 2011, EMBO J, V30, P1896, DOI 10.1038/emboj.2011.113; Shaikhibrahim Z, 2012, MOL MED REP, V5, P313, DOI 10.3892/mmr.2011.647; Shin YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071495; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; Strittmatter F, 2012, BRIT J PHARMACOL, V166, P1926, DOI 10.1111/j.1476-5381.2012.01919.x; Tilki D, 2015, J UROLOGY, V193, P484, DOI 10.1016/j.juro.2014.08.096; Toumaniantz G, 2010, CARDIOVASC RES, V86, P131, DOI 10.1093/cvr/cvp387; Van den Broeke C, 2009, P NATL ACAD SCI USA, V106, P8707, DOI 10.1073/pnas.0900436106; Van Eyk JE, 1998, J BIOL CHEM, V273, P23433, DOI 10.1074/jbc.273.36.23433; Viaud J, 2009, MOL CANCER THER, V8, P2559, DOI 10.1158/1535-7163.MCT-09-0102; Vidal C, 2002, BLOOD, V100, P4462, DOI 10.1182/blood.V100.13.4462; Wang RP, 2007, AM J PHYSIOL-LUNG C, V292, pL240, DOI 10.1152/ajplung.00199.2006; Wang Y, 2015, BRIT J PHARMACOL, V172, P2905, DOI 10.1111/bph.13099; Wells CM, 2010, BIOCHEM J, V425, P465, DOI 10.1042/BJ20091173; Wen YY, 2013, BIOORG MED CHEM LETT, V23, P6636, DOI 10.1016/j.bmcl.2013.10.051; Wirth A, 2003, J PHYSIOL-LONDON, V549, P489, DOI 10.1113/jphysiol.2002.033167; Yu JS, 1998, BIOCHEM J, V334, P121, DOI 10.1042/bj3340121; Zeng Y, 2015, STEM CELLS, V33, P1630, DOI 10.1002/stem.1951; Zhang HM, 2011, NATURE, V471, P99, DOI 10.1038/nature09765; Zhang WW, 2015, CAN J PHYSIOL PHARM, V93, P129, DOI 10.1139/cjpp-2014-0388	73	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0153312	10.1371/journal.pone.0153312	http://dx.doi.org/10.1371/journal.pone.0153312			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27071060	gold, Green Published, Green Submitted			2022-12-27	WOS:000373900700050
J	Zhang, M; Zhang, HY; Wang, CJ; Ren, YC; Wang, BY; Zhang, L; Yang, XY; Zhao, Y; Han, CY; Pang, C; Yin, L; Xue, Y; Zhao, JZ; Hu, DS				Zhang, Ming; Zhang, Hongyan; Wang, Chongjian; Ren, Yongcheng; Wang, Bingyuan; Zhang, Lu; Yang, Xiangyu; Zhao, Yang; Han, Chengyi; Pang, Chao; Yin, Lei; Xue, Yuan; Zhao, Jingzhi; Hu, Dongsheng			Development and Validation of a Risk-Score Model for Type 2 Diabetes: A Cohort Study of a Rural Adult Chinese Population	PLOS ONE			English	Article							IMPAIRED GLUCOSE-TOLERANCE; LIFE-STYLE INTERVENTIONS; MIDDLE-AGED ADULTS; IDENTIFYING INDIVIDUALS; FASTING GLUCOSE; FOLLOW-UP; MELLITUS; PREVENTION; REDUCTION; DIAGNOSIS	Some global models to predict the risk of diabetes may not be applicable to local populations. We aimed to develop and validate a score to predict type 2 diabetes mellitus (T2DM) in a rural adult Chinese population. Data for a cohort of 12,849 participants were randomly divided into derivation (n = 11,564) and validation (n = 1285) datasets. A questionnaire interview and physical and blood biochemical examinations were performed at baseline (July to August 2007 and July to August 2008) and follow-up (July to August 2013 and July to October 2014). A Cox regression model was used to weigh each variable in the derivation dataset. For each significant variable, a score was calculated by multiplying beta by 100 and rounding to the nearest integer. Age, body mass index, triglycerides and fasting plasma glucose (scores 3, 12, 24 and 76, respectively) were predictors of incident T2DM. The model accuracy was assessed by the area under the receiver operating characteristic curve (AUC), with optimal cut-off value 936. With the derivation dataset, sensitivity, specificity and AUC of the model were 66.7%, 74.0% and 0.768 (95% CI 0.760-0.776), respectively. With the validation dataset, the performance of the model was superior to the Chinese (simple), FINDRISC, Oman and IDRS models of T2DM risk but equivalent to the Framingham model, which is widely applicable in a variety of populations. Our model for predicting 6-year risk of T2DM could be used in a rural adult Chinese population.	[Zhang, Ming; Zhang, Hongyan; Ren, Yongcheng; Wang, Bingyuan; Zhang, Lu; Yang, Xiangyu; Zhao, Yang; Han, Chengyi; Hu, Dongsheng] Shenzhen Univ, Sch Med, Dept Prevent Med, Shenzhen, Guangdong, Peoples R China; [Zhang, Hongyan; Wang, Chongjian; Ren, Yongcheng; Wang, Bingyuan; Zhang, Lu; Yang, Xiangyu; Zhao, Yang; Han, Chengyi; Xue, Yuan] Zhengzhou Univ, Coll Publ Hlth, Dept Epidemiol & Hlth Stat, Zhengzhou 450052, Henan, Peoples R China; [Pang, Chao; Yin, Lei; Zhao, Jingzhi] Mil Hosp Henan Prov, Dept Prevent & Hlth Care, Zhengzhou, Henan, Peoples R China	Shenzhen University; Zhengzhou University	Hu, DS (corresponding author), Shenzhen Univ, Sch Med, Dept Prevent Med, Shenzhen, Guangdong, Peoples R China.; Zhao, JZ (corresponding author), Mil Hosp Henan Prov, Dept Prevent & Hlth Care, Zhengzhou, Henan, Peoples R China.	zhao_jingzhi@126.com; hud@szu.edu.cn	ming, zhang/ABH-2736-2020; zhao, yang/GXF-4424-2022	ming, zhang/0000-0002-2923-5335; Wang, Chongjian/0000-0001-5091-6621	National Natural Science Foundation of China [81373074]; Science and Technology Development Foundation of Shenzhen [JCYJ20120613112221107]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Development Foundation of Shenzhen	This study was supported by the National Natural Science Foundation of China (grant no. 81373074, URL: http://www.letpub.com.cn/?page=grant&name=&person=&no=81373074&company=&addcomment_s1=0&addcomment_s2=0&addcomment_s3=0&money1=&money2=&startTime=2011&endTime=2015&subcategory=&searchsubmit=true&submit.x=61&submit.y=7&submit= advSearch#fundlisttable) and the Science and Technology Development Foundation of Shenzhen (grant no. JCYJ20120613112221107, URL: http://apply.szsti.gov.cn/portal/dispatch/main.jsp?returnUrl=&application=11e1-902e-a1afe4b4-a70dc9b09cb3aea7&openUrl=11e2-e2f9-a3686d3f-9f5d597643551fae), and the funder designed this study and participated in the decision to publish.; This research was supported by the National Natural Science Foundation of China (grant no. 81373074) and the Science and Technology Development Foundation of Shenzhen (grant no. JCYJ20120613112221107).	Adegbija O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123788; Aekplakorn W, 2006, DIABETES CARE, V29, P1872, DOI 10.2337/dc05-2141; Al-Lawati JA, 2007, DIABETES RES CLIN PR, V77, P438, DOI 10.1016/j.diabres.2007.01.013; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011; [Anonymous], 2012, DIABETES CARE S1, V35, pS4, DOI DOI 10.2337/DC12-S004; Babyak MA, 2004, PSYCHOSOM MED, V66, P411, DOI 10.1097/01.psy.0000127692.23278.a9; Bansal N, 2015, WORLD J DIABETES, V6, P296, DOI 10.4239/wjd.v6.i2.296; Barber SR, 2014, DIABETES RES CLIN PR, V105, P1, DOI 10.1016/j.diabres.2014.03.007; Bhowmik B, 2015, J DIABETES INVEST, V6, P670, DOI 10.1111/jdi.12344; Bozorgmanesh M, 2011, EUR J PUBLIC HEALTH, V21, P554, DOI 10.1093/eurpub/ckq074; Bray GA, 2009, LANCET, V374, P1677, DOI 10.1016/S0140-6736(09)61457-4; Buijsse B, 2011, EPIDEMIOL REV, V33, P46, DOI 10.1093/epirev/mxq019; Calonge N, 2008, ANN INTERN MED, V148, P846, DOI 10.7326/0003-4819-148-11-200806030-00007; Cantin B, 2002, ATHEROSCLEROSIS, V163, P261, DOI 10.1016/S0021-9150(02)00034-5; Chan JCN, 2014, LANCET DIABETES ENDO, V2, P969, DOI 10.1016/S2213-8587(14)70144-5; Chatterton H, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4624; Chiasson JL, 2002, LANCET, V359, P2072, DOI 10.1016/S0140-6736(02)08905-5; Chien K, 2009, DIABETOLOGIA, V52, P443, DOI 10.1007/s00125-008-1232-4; Chinese Diabetes Society, 2014, CHIN J ENDOCRINOL ME, V30, P893, DOI [10.3760/cma.j.issn.1000-6699.2014.10.020, DOI 10.3760/CMA.J.ISSN.1000-6699.2014.10.020]; Chinese Nutrition Society, 2008, CHIN DIET GUID; Danaei G, 2015, LANCET DIABETES ENDO, V3, P624, DOI 10.1016/S2213-8587(15)00129-1; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Doak CM, 2013, GLOB FOOD SECUR-AGR, V2, P65, DOI 10.1016/j.gfs.2013.02.003; Gao WG, 2010, DIABETIC MED, V27, P274, DOI 10.1111/j.1464-5491.2010.02943.x; Gerstein HC, 2006, LANCET, V368, P1096, DOI 10.1016/S0140-6736(06)69420-8; Gillies CL, 2007, BMJ-BRIT MED J, V334, P299, DOI 10.1136/bmj.39063.689375.55; Godino JG, 2014, DIABETES RES CLIN PR, V106, P412, DOI 10.1016/j.diabres.2014.10.004; Goldenberg R, 2013, CAN J DIABETES, V37, pS8, DOI 10.1016/j.jcjd.2013.01.011; Gray LJ, 2010, DIABETIC MED, V27, P887, DOI 10.1111/j.1464-5491.2010.03037.x; Guariguata L, 2014, DIABETES RES CLIN PR, V103, P137, DOI 10.1016/j.diabres.2013.11.002; Guasch-Ferre M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033437; He S, 2012, DIABETES RES CLIN PR, V95, P291, DOI 10.1016/j.diabres.2011.10.039; Hu FB, 2001, NEW ENGL J MED, V345, P790, DOI 10.1056/NEJMoa010492; International Physical Activity Questionnaire, 2015, SHORT LAST 7 DAYS SE, V10, P1; Kahn HS, 2009, ANN INTERN MED, V150, P741, DOI 10.7326/0003-4819-150-11-200906020-00002; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Li GW, 2008, LANCET, V371, P1783, DOI 10.1016/S0140-6736(08)60766-7; Lindstrom J, 2003, DIABETES CARE, V26, P725, DOI 10.2337/diacare.26.3.725; Lindstrom J, 2006, LANCET, V368, P1673, DOI 10.1016/S0140-6736(06)69701-8; Liu XM, 2015, EUR J EPIDEMIOL, V30, P35, DOI 10.1007/s10654-014-9973-5; Mashayekhi M, 2015, CAN J DIABETES, V39, P152, DOI 10.1016/j.jcjd.2014.10.006; Mathur R, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X656793; Misra A, 2014, DIABETIC MED, V31, P1153, DOI 10.1111/dme.12540; Muhlenbruch K, 2014, DIABETES RES CLIN PR, V104, P459, DOI 10.1016/j.diabres.2014.03.013; National Institute of Nutrition and Food Safety, 2009, CHINA FOOD COMPOSITI, V2nd; Norberg M, 2006, J INTERN MED, V260, P263, DOI 10.1111/j.1365-2796.2006.01689.x; Paulweber B, 2010, HORM METAB RES, V42, pS3, DOI 10.1055/s-0029-1240928; Peduzzi P, 1995, J CLIN EPIDEMIOL, V48, P1503, DOI 10.1016/0895-4356(95)00048-8; Pottie K, 2012, CAN MED ASSOC J, V184, P1687, DOI 10.1503/cmaj.120732; Qiao Q, 2000, DIABETOLOGIA, V43, P1470, DOI 10.1007/s001250051557; Ramachandran A, 2006, DIABETOLOGIA, V49, P289, DOI 10.1007/s00125-005-0097-z; Ramachandran A, 2005, DIABETES RES CLIN PR, V70, P63, DOI 10.1016/j.diabres.2005.02.016; Riaz M, 2012, PRIM CARE DIABETES, V6, P297, DOI 10.1016/j.pcd.2012.04.002; Salas-Salvado J, 2011, NUTR METAB CARDIOVAS, V21, pB32, DOI 10.1016/j.numecd.2011.03.009; Schmidt MI, 2005, DIABETES CARE, V28, P2013, DOI 10.2337/diacare.28.8.2013; Schulze MB, 2007, DIABETES CARE, V30, P510, DOI 10.2337/dc06-2089; Sun F, 2009, DIABETES RES CLIN PR, V85, P228, DOI 10.1016/j.diabres.2009.05.005; Tuomilehto Jaakko, 2001, New England Journal of Medicine, V344, P1343, DOI 10.1056/NEJM200105033441801; Wang CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043834; Wilson PWF, 2007, ARCH INTERN MED, V167, P1068, DOI 10.1001/archinte.167.10.1068; Yang F, 2016, DIABETIC MED, V33, P454, DOI 10.1111/dme.12842; Zhang YR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120382	62	27	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0152054	10.1371/journal.pone.0152054	http://dx.doi.org/10.1371/journal.pone.0152054			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27070555	Green Published, gold, Green Submitted			2022-12-27	WOS:000373900700006
J	Douetts-Peres, JC; Cruz, MAL; Reis, RS; Heringer, AS; de Oliveira, EAG; Elbl, PM; Floh, EIS; Silveira, V; Santa-Catarina, C				Douetts-Peres, Jackellinne C.; Cruz, Marco Antonio L.; Reis, Ricardo S.; Heringer, Angelo S.; de Oliveira, Eduardo A. G.; Elbl, Paula M.; Floh, Eny I. S.; Silveira, Vanildo; Santa-Catarina, Claudete			Mps1 (Monopolar Spindle 1) Protein Inhibition Affects Cellular Growth and Pro-Embryogenic Masses Morphology in Embryogenic Cultures of Araucaria angustifolia (Araucariaceae)	PLOS ONE			English	Article							NITRIC-OXIDE; SOMATIC EMBRYOGENESIS; KINASE; CHECKPOINT; PHOSPHORYLATION; GLUTATHIONE; ACTIVATION; POLYAMINE; KUNTZE; IAA	Somatic embryogenesis has been shown to be an efficient tool for studying processes based on cell growth and development. The fine regulation of the cell cycle is essential for proper embryo formation during the process of somatic embryogenesis. The aims of the present work were to identify and perform a structural and functional characterization of Mps1 and to analyze the effects of the inhibition of this protein on cellular growth and pro-embryogenic mass (PEM) morphology in embryogenic cultures of A. angustifolia. A singlecopy Mps1 gene named AaMps1 was retrieved from the A. angustifolia transcriptome database, and through a mass spectrometry approach, AaMps1 was identified and quantified in embryogenic cultures. The Mps1 inhibitor SP600125 (10 mu M) inhibited cellular growth and changed PEMs, and these effects were accompanied by a reduction in AaMps1 protein levels in embryogenic cultures. Our work has identified the Mps1 protein in a gymnosperm species for the first time, and we have shown that inhibiting Mps1 affects cellular growth and PEM differentiation during A. angustifolia somatic embryogenesis. These data will be useful for better understanding cell cycle control during somatic embryogenesis in plants.	[Douetts-Peres, Jackellinne C.; Santa-Catarina, Claudete] Univ Estadual Norte Fluminense Darcy Ribeiro UENF, CBB, Lab Biol Celular & Tecidual, Rio De Janeiro, Brazil; [Cruz, Marco Antonio L.; de Oliveira, Eduardo A. G.] Univ Fed Rio de Janeiro, Nucleo Ecol & Desenvolvimento Socioambiental Maca, Lab Biotecnol Vegetal, Rio De Janeiro, Brazil; [Reis, Ricardo S.; Heringer, Angelo S.; Silveira, Vanildo] UENF, CBB, Lab Biotecnol, Rio De Janeiro, Brazil; [Reis, Ricardo S.; Heringer, Angelo S.; Silveira, Vanildo] UENF, Setor Prote, Unidade Biol Integrat, Rio De Janeiro, Brazil; [Elbl, Paula M.; Floh, Eny I. S.] Univ Sao Paulo, Inst Biociencias, Dept Bot, Lab Biol Celular Plantas, Sao Paulo, Brazil	Universidade Estadual do Norte Fluminense; Universidade Federal do Rio de Janeiro; Universidade de Sao Paulo	Santa-Catarina, C (corresponding author), Univ Estadual Norte Fluminense Darcy Ribeiro UENF, CBB, Lab Biol Celular & Tecidual, Rio De Janeiro, Brazil.	claudete@uenf.br	Heringer, Angelo/S-3033-2019; Silveira, Vanildo/E-8887-2011; Heringer, Angelo S/M-8275-2014; Santa-Catarina, Claudete/L-5531-2014; Iochevet Segal Floh, Eny/D-9526-2012	Heringer, Angelo/0000-0002-2723-7353; Silveira, Vanildo/0000-0001-5697-6932; Heringer, Angelo S/0000-0002-2723-7353; Santa-Catarina, Claudete/0000-0002-1669-660X; Iochevet Segal Floh, Eny/0000-0001-6529-2065; Reis, Ricardo/0000-0002-9683-8195; Cruz, Marco Antonio Lopes/0000-0002-3013-657X	National Council for Scientific and Technological Development (CNPq) [476465/2011-7, 305645/2013-7]; Carlos Chagas Filho Foundation for Research Support in the State of Rio de Janeiro (FAPERJ) [E26/112.055/2011, E26/110.390/2012, E26/111.389-2012, E26/102.989/2012, E26/010.001507/2014]	National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Carlos Chagas Filho Foundation for Research Support in the State of Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was supported by the National Council for Scientific and Technological Development (CNPq) (476465/2011-7 and 305645/2013-7) and the Carlos Chagas Filho Foundation for Research Support in the State of Rio de Janeiro (FAPERJ) (E26/112.055/2011, E26/110.390/2012, E26/111.389-2012, E26/102.989/2012, and E26/010.001507/2014).	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 2013, SCIENCE, V342, P1241089, DOI [10.1126/science.1241089, DOI 10.1126/SCIENCE.1241089]; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; ATTREE SM, 1993, PLANT CELL TISS ORG, V35, P1, DOI 10.1007/BF00043936; Balbuena TS, 2009, J PROTEOMICS, V72, P337, DOI 10.1016/j.jprot.2009.01.011; BECWAR MR, 1989, IN VITRO CELL DEV B, V25, P575, DOI 10.1007/BF02623571; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Biasini Marco, 2014, Nucleic Acids Res, V42, pW252, DOI 10.1093/nar/gku340; Carrier DJ, 1999, J EXP BOT, V50, P1359, DOI 10.1093/jexbot/50.337.1359; Chu MLH, 2008, J BIOL CHEM, V283, P21495, DOI 10.1074/jbc.M803026200; Chu MLH, 2010, BIOCHEMISTRY-US, V49, P1689, DOI 10.1021/bi901970c; de Osti RZ, 2010, PLANT SCI, V178, P448, DOI 10.1016/j.plantsci.2010.02.006; Dewitte W, 2003, ANNU REV PLANT BIOL, V54, P235, DOI 10.1146/annurev.arplant.54.031902.134836; Dinkel H, 2013, NUCLEIC ACIDS RES, V42; Elbl P, 2015, PLANT CELL TISS ORG, V120, P917, DOI 10.1007/s11240-015-0730-6; Elbl P, 2015, PLANT CELL TISS ORG, V120, P903, DOI 10.1007/s11240-014-0523-3; Farias-Soares FL, 2014, ACTA PHYSIOL PLANT, V36, P1853, DOI 10.1007/s11738-014-1560-6; Feher A, 2015, BBA-GENE REGUL MECH, V1849, P385, DOI 10.1016/j.bbagrm.2014.07.005; Fiser A, 2003, BIOINFORMATICS, V19, P2500, DOI 10.1093/bioinformatics/btg362; de Oliveira EAG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045707; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Inze D, 2006, ANNU REV GENET, V40, P77, DOI 10.1146/annurev.genet.40.110405.090431; Kiefer F, 2009, NUCLEIC ACIDS RES, V37, pD387, DOI 10.1093/nar/gkn750; Lee TY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-261; Liu XD, 2012, ANNU REV BIOCHEM, V81, P561, DOI 10.1146/annurev-biochem-061611-090435; London N, 2014, NAT REV MOL CELL BIO, V15, P735, DOI 10.1038/nrm3888; Mattison CP, 2007, J BIOL CHEM, V282, P30553, DOI 10.1074/jbc.M707063200; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Otvos K, 2005, PLANT J, V43, P849, DOI 10.1111/j.1365-313X.2005.02494.x; Pasternak T, 2014, PLANT PHYSIOL BIOCH, V74, P16, DOI 10.1016/j.plaphy.2013.10.028; Planchais S, 2000, FEBS LETT, V476, P78, DOI 10.1016/S0014-5793(00)01675-6; Reis RS, 2016, J PROTEOMICS, V130, P170, DOI 10.1016/j.jprot.2015.09.029; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Santa-Catarina C, 2007, PLANT CELL TISS ORG, V90, P93, DOI 10.1007/s11240-007-9259-7; Santa-Catarina C, 2006, PLANT GROWTH REGUL, V49, P237, DOI 10.1007/s10725-006-9129-z; Seeliger D, 2010, J COMPUT AID MOL DES, V24, P417, DOI 10.1007/s10822-010-9352-6; Silveira V, 2006, PLANT SCI, V171, P91, DOI 10.1016/j.plantsci.2006.02.015; Steiner N, 2005, BRAZ ARCH BIOL TECHN, V48, P895, DOI 10.1590/S1516-89132005000800005; Steiner N, 2015, KUNTZE PROTOPLASMA, P1; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tipton AR, 2013, J BIOL CHEM, V288, P35149, DOI 10.1074/jbc.M113.522375; Vieira LD, 2012, PLANT SCI, V195, P80, DOI 10.1016/j.plantsci.2012.06.011; Wang W, 2009, J CELL MOL MED, V13, P1679, DOI 10.1111/j.1582-4934.2008.00605.x; Zhao Y, 2006, CURR BIOL, V16, P1764, DOI 10.1016/j.cub.2006.07.058	45	3	3	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2016	11	4							e0153528	10.1371/journal.pone.0153528	http://dx.doi.org/10.1371/journal.pone.0153528			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0KH	27064899	Green Submitted, gold, Green Published			2022-12-27	WOS:000373891000055
J	Drygala, F; Korablev, N; Ansorge, H; Fickel, J; Isomursu, M; Elmeros, M; Kowalczyk, R; Baltrunaite, L; Balciauskas, L; Saarma, U; Schulze, C; Borkenhagen, P; Frantz, AC				Drygala, Frank; Korablev, Nikolay; Ansorge, Hermann; Fickel, Joerns; Isomursu, Marja; Elmeros, Morten; Kowalczyk, Rafal; Baltrunaite, Laima; Balciauskas, Linas; Saarma, Urmas; Schulze, Christoph; Borkenhagen, Peter; Frantz, Alain C.			Homogenous Population Genetic Structure of the Non-Native Raccoon Dog (Nyctereutes procyonoides) in Europe as a Result of Rapid Population Expansion	PLOS ONE			English	Article							DISTANCE SEED DISPERSAL; MEDIUM-SIZED CARNIVORES; BIOLOGICAL INVASION; N-E; DIVERSITY; HISTORY; SOFTWARE; RABIES; COLONIZATION; NUMBER	The extent of gene flow during the range expansion of non-native species influences the amount of genetic diversity retained in expanding populations. Here, we analyse the population genetic structure of the raccoon dog (Nyctereutes procyonoides) in north-eastern and central Europe. This invasive species is of management concern because it is highly susceptible to fox rabies and an important secondary host of the virus. We hypothesized that the large number of introduced animals and the species' dispersal capabilities led to high population connectivity and maintenance of genetic diversity throughout the invaded range. We genotyped 332 tissue samples from seven European countries using 16 microsatellite loci. Different algorithms identified three genetic clusters corresponding to Finland, Denmark and a large 'central' population that reached from introduction areas in western Russia to northern Germany. Cluster assignments provided evidence of long-distance dispersal. The results of an Approximate Bayesian Computation analysis supported a scenario of equal effective population sizes among different pre-defined populations in the large central cluster. Our results are in line with strong gene flow and secondary admixture between neighbouring demes leading to reduced genetic structuring, probably a result of its fairly rapid population expansion after introduction. The results presented here are remarkable in the sense that we identified a homogenous genetic cluster inhabiting an area stretching over more than 1500km. They are also relevant for disease management, as in the event of a significant rabies outbreak, there is a great risk of a rapid virus spread among raccoon dog populations.	[Drygala, Frank; Frantz, Alain C.] Musee Natl Hist Nat, Luxembourg, Luxembourg; [Korablev, Nikolay] Velikie Luki State Agr Acad, Velikie Luki, Russia; [Ansorge, Hermann] Senckenberg Museum Nat Kunde Gorlitz, Gorlitz, Germany; [Fickel, Joerns] Leibniz Inst Zoo & Wildlife Res IZW, Berlin, Germany; [Fickel, Joerns] Univ Potsdam, Inst Biochem & Biol, Potsdam, Germany; [Isomursu, Marja] Finnish Food Safety Author, Prod Anim & Wildlife Res Unit, Oulu, Finland; [Elmeros, Morten] Aarhus Univ, Dept Biosci, Ronde, Denmark; [Kowalczyk, Rafal] Polish Acad Sci, Mammal Res Inst, Bialowieza, Poland; [Baltrunaite, Laima; Balciauskas, Linas] Inst Ecol, Nat Res Ctr, Vilnius, Lithuania; [Saarma, Urmas] Univ Tartu, Dept Zool, Ulikooli 18, EE-50090 Tartu, Estonia; [Schulze, Christoph] Landeslab Berlin Brandenburg, Frankfurt, Oder, Germany; [Borkenhagen, Peter] Univ Kiel, Faunistisch Okol Arbeitsgemeinschaft SH, Kiel, Germany	Senckenberg Gesellschaft fur Naturforschung (SGN); Leibniz Institut fur Zoo und Wildtierforschung; University of Potsdam; Finnish Food Authority; Aarhus University; Polish Academy of Sciences; Mammal Research Institute of the Polish Academy of Sciences; Nature Research Center - Lithuania; University of Tartu; University of Kiel	Frantz, AC (corresponding author), Musee Natl Hist Nat, Luxembourg, Luxembourg.	alainfrantz@yahoo.co.uk	Baltrunaite, Laima/AAW-4167-2021; Saarma, Urmas/AAC-9813-2019; Balčiauskas, Linas/ABE-2454-2021; Balciauskas, Linas/GRS-8910-2022; Elmeros, Morten/K-3094-2013	Saarma, Urmas/0000-0002-3222-571X; Balčiauskas, Linas/0000-0001-9672-5265; Elmeros, Morten/0000-0001-5811-9205; Baltrunaite, Laima/0000-0002-2059-4884; Kowalczyk, Rafal/0000-0001-7264-2158				Acevedo-Whitehouse K, 2003, NATURE, V422, P35, DOI 10.1038/422035a; Ahlroth P, 2003, OECOLOGIA, V137, P617, DOI 10.1007/s00442-003-1344-y; Ansorge H, 2009, ANN ZOOL FENN, V46, P51, DOI 10.5735/086.046.0106; Asferg T., 1991, DANMARKS PATTEDYR, V2, P7; Austerlitz F, 1997, THEOR POPUL BIOL, V51, P148, DOI 10.1006/tpbi.1997.1302; Baagoe HJ, 2007, DANSK PATTEDYR ATLAS, P182; BARBUJANI G, 1995, P NATL ACAD SCI USA, V92, P9171, DOI 10.1073/pnas.92.20.9171; Belkhir K., 2004, GENETIX 4 05 POPULAT; Bialozyt R, 2006, J EVOLUTION BIOL, V19, P12, DOI 10.1111/j.1420-9101.2005.00995.x; Brockerhoff EG, 2014, ECOLOGY, V95, P594, DOI 10.1890/13-0465.1; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Corander J, 2008, COMPUTATION STAT, V23, P111, DOI 10.1007/s00180-007-0072-x; Cornuet JM, 2014, BIOINFORMATICS, V30, P1187, DOI 10.1093/bioinformatics/btt763; Currat M, 2005, P ROY SOC B-BIOL SCI, V272, P679, DOI 10.1098/rspb.2004.2999; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Do C, 2014, MOL ECOL RESOUR, V14, P209, DOI 10.1111/1755-0998.12157; Drygala F, 2013, HYSTRIX, V24, P190, DOI 10.4404/hystrix-24.2-8867; Drygala F, 2013, EUR J WILDLIFE RES, V59, P683, DOI 10.1007/s10344-013-0722-y; Drygala F, 2010, WILDLIFE BIOL, V16, P150, DOI 10.2981/08-076; Etherington TR, 2011, METHODS ECOL EVOL, V2, P52, DOI 10.1111/j.2041-210X.2010.00048.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2009, ANNU REV ECOL EVOL S, V40, P481, DOI 10.1146/annurev.ecolsys.39.110707.173414; Facon B, 2008, CURR BIOL, V18, P363, DOI 10.1016/j.cub.2008.01.063; Forsyth DM, 2004, CONSERV BIOL, V18, P557, DOI 10.1111/j.1523-1739.2004.00423.x; Francisco LV, 1996, MAMM GENOME, V7, P359, DOI 10.1007/s003359900104; Frantz AC, 2010, HEREDITY, V104, P493, DOI 10.1038/hdy.2009.136; Geffen E, 2004, MOL ECOL, V13, P2481, DOI 10.1111/j.1365-294X.2004.02244.x; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; HELLE E, 1993, J MAMMAL, V74, P936, DOI 10.2307/1382432; HELLE E, 1991, HOLARCTIC ECOL, V14, P278; Holmala K, 2009, ANN ZOOL FENN, V46, P233, DOI 10.5735/086.046.0401; Hong Y, 2013, GENES GENET SYST, V88, P69, DOI 10.1266/ggs.88.69; KAUHALA K, 1993, J ZOOL, V231, P95, DOI 10.1111/j.1469-7998.1993.tb05355.x; Kauhala K, 2006, ANN ZOOL FENN, V43, P348; Kauhala K, 2011, CURR ZOOL, V57, P584, DOI 10.1093/czoolo/57.5.584; Kolbe JJ, 2004, NATURE, V431, P177, DOI 10.1038/nature02807; Korablev NP, 2011, RUSS J GENET+, V47, P1227, DOI 10.1134/S1022795411100103; Kowalczyk R, 2009, ANN ZOOL FENN, V46, P291, DOI 10.5735/086.046.0406; Laurimaa L, 2016, VET PARASIT IN PRESS; Lavrov N.P., 1971, T KAFEDRY BIOLOGII M, V29, P101; LeCorre V, 1997, GENET RES, V69, P117, DOI 10.1017/S0016672397002668; Lively C. M., 1995, P421, DOI 10.1017/CBO9780511629396.017; Lucek K, 2010, MOL ECOL, V19, P3995, DOI 10.1111/j.1365-294X.2010.04781.x; Luikart G, 2010, CONSERV GENET, V11, P355, DOI 10.1007/s10592-010-0050-7; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MOTRO U, 1982, EVOLUTION, V36, P1059, DOI 10.1111/j.1558-5646.1982.tb05474.x; Nasimovich AA, 1985, PESETS LISITSA ENOTO, P116; NEI M, 1978, GENETICS, V89, P583; Norgaard Louise Solveig, 2014, Flora og Fauna, V120, P8; Nowak E., 1973, Beitrage Jagd-Wildforsch, V8, P351; Nowak E., 1964, Acta Theriologica, V9, P81; NYBERG M, 1992, ACTA VET SCAND, V33, P43; Paulauskas A, 2016, TURK J ZOOL, V40, P933, DOI 10.3906/zoo-1502-34; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pilot M, 2006, MOL ECOL, V15, P4533, DOI 10.1111/j.1365-294X.2006.03110.x; Pitra C, 2010, EUR J WILDLIFE RES, V56, P117, DOI 10.1007/s10344-009-0283-2; Pope LC, 2006, MOL ECOL, V15, P371, DOI 10.1111/j.1365-294X.2005.02815.x; Pritchard JK, 2000, GENETICS, V155, P945; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousset F, 1997, GENETICS, V145, P1219; Sacks BN, 2008, MOL BIOL EVOL, V25, P1384, DOI 10.1093/molbev/msn082; Singer A, 2009, J WILDLIFE DIS, V45, P1121, DOI 10.7589/0090-3558-45.4.1121; Spencer PBS, 2012, J WILDLIFE MANAGE, V76, P1254, DOI 10.1002/jwmg.381; Spielman D, 2004, CONSERV GENET, V5, P439, DOI 10.1023/B:COGE.0000041030.76598.cd; Sutor A, 2008, EUR J WILDLIFE RES, V54, P321, DOI 10.1007/s10344-007-0153-8; Sutor A, 2014, ACTA THERIOL, V59, P49, DOI 10.1007/s13364-013-0138-9; Tammeleht E, 2010, MOL ECOL, V19, P5359, DOI 10.1111/j.1365-294X.2010.04885.x; Thulin CG, 2006, MOL ECOL, V15, P3947, DOI 10.1111/j.1365-294X.2006.03084.x; Tinghitella RM, 2011, J EVOLUTION BIOL, V24, P1199, DOI 10.1111/j.1420-9101.2011.02255.x; Travis JMJ, 2002, EVOL ECOL RES, V4, P1119; Verhoeven KJF, 2005, OIKOS, V108, P643, DOI 10.1111/j.0030-1299.2005.13727.x; Waples RS, 2010, EVOL APPL, V3, P244, DOI 10.1111/j.1752-4571.2009.00104.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Whiteman NK, 2006, P ROY SOC B-BIOL SCI, V273, P797, DOI 10.1098/rspb.2005.3396; Whiteside HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022145; Zenger KR, 2003, MOL ECOL, V12, P789, DOI 10.1046/j.1365-294X.2003.01759.x	78	18	18	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2016	11	4							e0153098	10.1371/journal.pone.0153098	http://dx.doi.org/10.1371/journal.pone.0153098			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0KH	27064784	Green Published, gold, Green Submitted			2022-12-27	WOS:000373891000030
J	Diaz, J; Terrazas, S; Bierrenbach, AL; Toscano, CM; Alencar, GP; Alvarez, A; Valenzuela, MT; Andrus, J; del Aguila, R; Hormazabal, JC; Araya, P; Pidal, P; Matus, CR; de Oliveira, LH				Diaz, Janepsy; Terrazas, Solana; Bierrenbach, Ana L.; Toscano, Cristiana M.; Alencar, Gizelton P.; Alvarez, Andres; Valenzuela, Maria T.; Andrus, Jon; del Aguila, Roberto; Hormazabal, Juan C.; Araya, Pamela; Pidal, Paola; Matus, Cuauhtemoc R.; de Oliveira, Lucia H.			Effectiveness of the 10-Valent Pneumococcal Conjugate Vaccine (PCV-10) in Children in Chile: A Nested Case-Control Study Using Nationwide Pneumonia Morbidity and Mortality Surveillance Data	PLOS ONE			English	Article							IMMORTAL TIME BIAS; IMMUNIZATION; PREVENTION; DISEASE; COHORTS; IMPACT	Background The ten-valent pneumococcal conjugate vaccine (PCV10) was introduced into the Chilean National Immunization Program (NIP) in January 2011 with a 3+1 schedule (2, 4, 6 and 12 months) without catch-up vaccination. We evaluated the effectiveness of PCV10 on pneumonia morbidity and mortality among infants during the first two years after vaccine introduction. Methods This is a population-based nested case-control study using four merged nationwide case-based electronic health data registries: live birth, vaccination, hospitalization and mortality. Children born in 2010 and 2011 were followed from two moths of age for a period of two years. Using four different case definitions of pneumonia hospitalization and/or mortality (all-cause and pneumonia related deaths), all cases and four randomly selected matched controls per case were selected. Controls were matched to cases on analysis time. Vaccination status was then assessed. Vaccine effectiveness (VE) was estimated using conditional logistic regression. Results There were a total of 497,996 children in the 2010 and 2011 Chilean live-birth cohorts. PCV10 VE was 11.2% (95% CI 8.5-13.6) when all pneumonia hospitalizations and deaths were used to define cases. VE increased to 20.7 (95% CI 17.3-23.8) when ICD10 codes used to denote viral pneumonia were excluded from the case definition. VE estimates on pneumonia deaths and all-cause deaths were 71.5 (95% CI 9.0-91.8) and 34.8 (95% CI 23.7-44.4), respectively. Conclusion PCV10 vaccination substantially reduced the number of hospitalizations due to pneumonia and deaths due to pneumonia and to all-causes over this study period. Our findings also reinforce the importance of having quality health information systems for measuring VE.	[Diaz, Janepsy; Terrazas, Solana; Hormazabal, Juan C.; Araya, Pamela; Pidal, Paola] Natl Inst Hlth, Santiago, Chile; [Bierrenbach, Ana L.] Sanas Epidemiol & Pesquisa, Sao Paulo, Brazil; [Toscano, Cristiana M.] Univ Fed Goias, Inst Trop Pathol & Publ Hlth, Dept Community Hlth, Goiania, Go, Brazil; [Alencar, Gizelton P.] Univ Sao Paulo, Sch Publ Hlth, Sao Paulo, Brazil; [Alvarez, Andres] Minist Hlth Santiago, Dept Stat & Hlth Informat, Santiago, Chile; [Valenzuela, Maria T.] Univ Los Andes, Sch Med, Santiago, Chile; [Andrus, Jon] Sabin Vaccine Inst, Washington, DC USA; [del Aguila, Roberto] PWR Chile, Pan Amer Hlth Org, Santiago, Chile; [Matus, Cuauhtemoc R.; de Oliveira, Lucia H.] Pan Amer Hlth Org, Comprehens Family Immunizat Project, Washington, DC USA	Universidade Federal de Goias; Universidade de Sao Paulo; Universidad de los Andes - Chile; Pan American Health Organization; Pan American Health Organization	de Oliveira, LH (corresponding author), Pan Amer Hlth Org, Comprehens Family Immunizat Project, Washington, DC USA.	oliveirl@paho.org	Alencar, Gizelton P/H-1248-2014; Bierrenbach, Ana L/F-3185-2014	Alencar, Gizelton P/0000-0002-2354-9050; Bierrenbach, Ana L/0000-0002-6837-0636; TOSCANO, CRISTIANA/0000-0002-9453-2643; Valenzuela, M Teresa/0000-0002-9433-6423	Sabin Vaccine Institute	Sabin Vaccine Institute	This project was supported by Sabin Vaccine Institute, which is a non-profit organization that promotes advances in vaccine development, delivery and distribution. The funders had no role in study design, data collection, analysis and decision to publish. The funders helped in the written review of the paper.	Afonso ET, 2013, EMERG INFECT DIS, V19, P589, DOI 10.3201/eid1904.121198; Andrade AL, 2012, VACCINE, V30, P1901, DOI 10.1016/j.vaccine.2011.12.012; De Wals P, 2008, PEDIATR INFECT DIS J, V27, P963, DOI 10.1097/INF.0b013e31817cf76f; Grijalva CG, 2008, EXPERT REV VACCINES, V7, P83, DOI 10.1586/14760584.7.1.83; Grijalva CG, 2007, LANCET, V369, P1179, DOI 10.1016/S0140-6736(07)60564-9; Groom H, 2015, J PUBLIC HEALTH MAN, V21, P227, DOI 10.1097/PHH.0000000000000069; Hansen J, 2006, PEDIATR INFECT DIS J, V25, P779, DOI 10.1097/01.inf.0000232706.35674.2f; Jardine A, 2010, PEDIATR INFECT DIS J, V29, P607, DOI 10.1097/INF.0b013e3181d7d09c; Jokinen J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120290; King C, 2015, VACCINE, V33, P4748, DOI 10.1016/j.vaccine.2015.07.062; Klugman KP, 2009, VACCINE, V27, pC9, DOI 10.1016/j.vaccine.2009.06.007; Lanata CF, 2004, INT J EPIDEMIOL, V33, P1362, DOI 10.1093/ije/dyh229; Levesque LE, 2010, BRIT MED J, V340, DOI 10.1136/bmj.b5087; Loo JD, 2014, PEDIATR INFECT DIS J, V33, pS140, DOI 10.1097/INF.0000000000000082; Madhi SA, 2005, CLIN INFECT DIS, V40, P1511, DOI 10.1086/429828; Pacheco AG, 2008, AM J EPIDEMIOL, V168, P1326, DOI 10.1093/aje/kwn249; Palmu AA, 2015, PEDIATRICS, V136, pE22, DOI 10.1542/peds.2015-0458; Rodrigues LC, 1999, EPIDEMIOL REV, V21, P56, DOI 10.1093/oxfordjournals.epirev.a017988; Simonsen L, 2011, MBIO, V2, DOI 10.1128/mBio.00309-10; Suissa S, 2008, AM J EPIDEMIOL, V167, P492, DOI 10.1093/aje/kwm324; Taylor S, 2012, CLIN INFECT DIS, V54, P1765, DOI 10.1093/cid/cis292; Valenzuela MT, 2014, REV CHIL INFECTOL, V31, P651, DOI 10.4067/S0716-10182014000600002; World Health Organization (2012), MEAS IMP STREPT PNEU, P4	23	27	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2016	11	4							e0153141	10.1371/journal.pone.0153141	http://dx.doi.org/10.1371/journal.pone.0153141			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6JK	27058873	Green Published, gold			2022-12-27	WOS:000373604800017
J	Liu, X; Li, SQ; Peng, WZ; Feng, SS; Feng, JX; Mahboob, S; Al-Ghanim, KA; Xu, P				Liu, Xiang; Li, Shangqi; Peng, Wenzhu; Feng, Shuaisheng; Feng, Jianxin; Mahboob, Shahid; Al-Ghanim, Khalid A.; Xu, Peng			Genome-Wide Identification, Characterization and Phylogenetic Analysis of ATP-Binding Cassette (ABC) Transporter Genes in Common Carp (Cyprinus carpio)	PLOS ONE			English	Article							MUTATION; FAMILY; DUPLICATION; EVOLUTION; INSIGHT; SUPERFAMILY; MECHANISM; PLANT; MAP	The ATP-binding cassette (ABC) gene family is considered to be one of the largest gene families in all forms of prokaryotic and eukaryotic life. Although the ABC transporter genes have been annotated in some species, detailed information about the ABC superfamily and the evolutionary characterization of ABC genes in common carp (Cyprinus carpio) are still unclear. In this research, we identified 61 ABC transporter genes in the common carp genome. Phylogenetic analysis revealed that they could be classified into seven subfamilies, namely 11 ABCAs, six ABCBs, 19 ABCCs, eight ABCDs, two ABCEs, four ABCFs, and 11 ABCGs. Comparative analysis of the ABC genes in seven vertebrate species including common carp, showed that at least 10 common carp genes were retained from the third round of whole genome duplication, while 12 duplicated ABC genes may have come from the fourth round of whole genome duplication. Gene losses were also observed for 14 ABC genes. Expression profiles of the 61 ABC genes in six common carp tissues (brain, heart, spleen, kidney, intestine, and gill) revealed extensive functional divergence among the ABC genes. Different copies of some genes had tissue-specific expression patterns, which may indicate some gene function specialization. This study provides essential genomic resources for future studies in common carp.	[Liu, Xiang; Li, Shangqi; Peng, Wenzhu; Feng, Shuaisheng; Xu, Peng] Chinese Acad Fishery Sci, CAFS Key Lab Aquat Genom, Ctr Appl Aquat Genom, Beijing, Peoples R China; [Liu, Xiang; Li, Shangqi; Peng, Wenzhu; Feng, Shuaisheng; Xu, Peng] Chinese Acad Fishery Sci, Beijing Key Lab Fishery Biotechnol, Ctr Appl Aquat Genom, Beijing, Peoples R China; [Liu, Xiang] Shanxi Agr Univ, Dept Aquaculture, Coll Anim Sci, Taigu, Shanxi, Peoples R China; [Feng, Jianxin] Henan Acad Fishery Sci, Zhengzhou, Peoples R China; [Mahboob, Shahid; Al-Ghanim, Khalid A.] King Saud Univ, Coll Sci, Dept Zool, Riyadh 11451, Saudi Arabia; [Mahboob, Shahid] GC Univ, Dept Zool, Faisalabad, Pakistan; [Xu, Peng] Xiamen Univ, Coll Ocean & Earth Sci, Xiamen, Peoples R China	Chinese Academy of Fishery Sciences; Chinese Academy of Fishery Sciences; Shanxi Agricultural University; King Saud University; Government College University Faisalabad; Xiamen University	Xu, P (corresponding author), Chinese Acad Fishery Sci, CAFS Key Lab Aquat Genom, Ctr Appl Aquat Genom, Beijing, Peoples R China.; Xu, P (corresponding author), Chinese Acad Fishery Sci, Beijing Key Lab Fishery Biotechnol, Ctr Appl Aquat Genom, Beijing, Peoples R China.; Xu, P (corresponding author), Xiamen Univ, Coll Ocean & Earth Sci, Xiamen, Peoples R China.	xupeng@cafs.ac.cn	Rana, Shahid Mahboob/P-1131-2014; Xu, Peng/J-4018-2012	Rana, Shahid Mahboob/0000-0003-4969-5387; Xu, Peng/0000-0002-1531-5078	National Natural Science Foundation of China [31422057]; National High-Technology Research and Development Program of China (863 program) [2011AA100401]; Special Scientific Research Funds for Central Non-profit Institutes of Chinese Academy of Fishery Sciences [2014A03YQ01, 2014C008]; Foundation of Beijing Key Laboratory of Fishery Biotechnology [201602]; Deanship of Scientific Research at King Saud University [RG 1435-012]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High-Technology Research and Development Program of China (863 program)(National High Technology Research and Development Program of China); Special Scientific Research Funds for Central Non-profit Institutes of Chinese Academy of Fishery Sciences; Foundation of Beijing Key Laboratory of Fishery Biotechnology; Deanship of Scientific Research at King Saud University(King Saud University)	The authors acknowledge grant support from the National Natural Science Foundation of China (No.31422057), National High-Technology Research and Development Program of China (863 program; 2011AA100401), Special Scientific Research Funds for Central Non-profit Institutes of Chinese Academy of Fishery Sciences (2014A03YQ01; 2014C008) and Foundation of Beijing Key Laboratory of Fishery Biotechnology (201602). The authors would like to extend their sincere appreciation to the Deanship of Scientific Research at King Saud University for funding this research (No. RG 1435-012).	Annilo T, 2003, MAMM GENOME, V14, P7, DOI 10.1007/s00335-002-2229-9; Annilo T, 2006, GENOMICS, V88, P1, DOI 10.1016/j.ygeno.2006.03.001; Aryal B, 2015, BIOCHEM SOC T, V43, P966, DOI 10.1042/BST20150128; Baker A, 2015, BIOCHEM SOC T, V43, P959, DOI 10.1042/BST20150127; Beis K, 2015, BIOCHEM SOC T, V43, P889, DOI 10.1042/BST20150047; Carmona-Antonanzas G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137394; Christoffels A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S5-S2; David L, 2003, MOL BIOL EVOL, V20, P1425, DOI 10.1093/molbev/msg173; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Dean M, 2005, ANNU REV GENOM HUM G, V6, P123, DOI 10.1146/annurev.genom.6.080604.162122; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; Dermauw W, 2014, INSECT BIOCHEM MOLEC, V45, P89, DOI 10.1016/j.ibmb.2013.11.001; Fu YH, 2015, J ALZHEIMERS DIS, V43, P857, DOI 10.3233/JAD-141320; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Guan GF, 2015, ONCOL LETT, V10, P631, DOI 10.3892/ol.2015.3359; Gurkan H, 2015, CLIN DYSMORPHOL, V24, P115, DOI 10.1097/MCD.0000000000000071; Hedditch EL, 2015, ASIA-PAC J CLIN ONCO, V11, P114; Hlavac V, 2015, BIOCHEM SOC T, V43, P937, DOI 10.1042/BST20150114; Hoegg S, 2004, J MOL EVOL, V59, P190, DOI 10.1007/s00239-004-2613-z; Hollenstein K, 2007, NATURE, V446, P213, DOI 10.1038/nature05626; Hu JP, 2012, PLANT CELL, V24, P2279, DOI 10.1105/tpc.112.096586; Jeong CB, 2015, SCI REP-UK, V5, DOI 10.1038/srep15409; Ji PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035152; Jiang YL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108200; Kaminski WE, 2006, BBA-MOL BASIS DIS, V1762, P510, DOI 10.1016/j.bbadis.2006.01.011; Keitel V, 2003, AM J PHYSIOL-GASTR L, V284, pG165, DOI 10.1152/ajpgi.00362.2002; Kerr ID, 2011, BRIT J PHARMACOL, V164, P1767, DOI 10.1111/j.1476-5381.2010.01177.x; Kruh GD, 2003, ONCOGENE, V22, P7537, DOI 10.1038/sj.onc.1206953; Liu SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063895; Moitra K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016318; Nagel G, 1999, BBA-BIOMEMBRANES, V1461, P263, DOI 10.1016/S0005-2736(99)00162-5; Nakayama A, 2011, NUCLEOS NUCLEOT NUCL, V30, P1091, DOI 10.1080/15257770.2011.633953; Peca D, 2015, BIOCHEM SOC T, V43, P913, DOI 10.1042/BST20150100; Phan J, 2015, AM J GASTROENTEROL, V110, pS344, DOI 10.14309/00000434-201510001-00786; Popovic M, 2010, MAR ENVIRON RES, V69, pS11, DOI 10.1016/j.marenvres.2009.10.016; Proks P, 2007, HUM MOL GENET, V16, P2011, DOI 10.1093/hmg/ddm149; Ren JF, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1677-z; Schatton T, 2015, CELL REP, V12, P1564, DOI 10.1016/j.celrep.2015.08.010; Slomka M, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0271-3; Theodoulou FL, 2015, BIOCHEM SOC T, V43, P1033, DOI 10.1042/BST20150139; Tingaud-Sequeira A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-38; Wang JT, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-96; Woodward OM, 2011, FEBS J, V278, P3215, DOI 10.1111/j.1742-4658.2011.08171.x; Xu J, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-307; Xu P, 2014, NAT GENET, V46, P1212, DOI 10.1038/ng.3098; Xu P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-537; Xu P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-188; Yabuuchi H, 2002, BIOCHEM BIOPH RES CO, V299, P410, DOI 10.1016/S0006-291X(02)02658-X; Zhang XF, 2013, MAR BIOTECHNOL, V15, P275, DOI 10.1007/s10126-012-9485-9; Zhao L, 2013, ABSTR APPL ANAL, V2013, P8, DOI [DOI 10.1371/J0URNAL.P0NE.0063928, DOI 10.1155/2013/812143]	50	5	6	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2016	11	4							e0153246	10.1371/journal.pone.0153246	http://dx.doi.org/10.1371/journal.pone.0153246			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6JK	27058731	Green Published, gold, Green Submitted			2022-12-27	WOS:000373604800024
J	Smart, JJ; Chin, A; Baje, L; Green, ME; Appleyard, SA; Tobin, AJ; Simpfendorfer, CA; White, WT				Smart, Jonathan J.; Chin, Andrew; Baje, Leontine; Green, Madeline E.; Appleyard, Sharon A.; Tobin, Andrew J.; Simpfendorfer, Colin A.; White, William T.			Effects of Including Misidentified Sharks in Life History Analyses: A Case Study on the Grey Reef Shark Carcharhinus amblyrhynchos from Papua New Guinea	PLOS ONE			English	Article							MODELING FISH GROWTH; BLACKTIP SHARK; REPRODUCTIVE-BIOLOGY; AGE-DETERMINATION; MULTIMODEL INFERENCE; FISHERIES; TILSTONI; LIMBATUS; VALIDATION; SELECTION	Fisheries observer programs are used around the world to collect crucial information and samples that inform fisheries management. However, observer error may misidentify similar -looking shark species. This raises questions about the level of error that species misidentifications could introduce to estimates of species' life history parameters. This study addressed these questions using the Grey Reef Shark Carcharhinus amblyrhynchos as a case study. Observer misidentification rates were quantified by validating species identifications using diagnostic photographs taken on board supplemented with DNA barcoding. Length-at-age and maturity ogive analyses were then estimated and compared with and without the misidentified individuals. Vertebrae were retained from a total of 155 sharks identified by observers as C. amblyrhynchos. However, 22 (14%) of these were sharks were misidentified by the observers and were subsequently re -identified based on photographs and/or DNA barcoding. Of the 22 individuals misidentified as C. amblyrhynchos, 16 (73%) were detected using photographs and a further 6 via genetic validation. If misidentified individuals had been included, substantial error would have been introduced to both the length -at -age and the maturity estimates. Thus validating the species identification, increased the accuracy of estimated life history parameters for C. amblyrhynchos. From the corrected sample a multi -model inference approach was used to estimate growth for C. amblyrhynchos using three candidate models. The model averaged length-at-age parameters for C. amblyrhynchos with the sexes combined were (L) over bar infinity= 159 cm TL and L,= 72 cm TL. Females mature at a greater length (150 = 136 cm TL) and older age (A(50) = 9.1 years) than males (150 = 123 cm TL; A(50) = 5.9 years). The inclusion of techniques to reduce misidentification in observer programs will improve the results of life history studies and ultimately improve management through the use of more accurate data for assessments.	[Smart, Jonathan J.; Chin, Andrew; Baje, Leontine; Tobin, Andrew J.; Simpfendorfer, Colin A.] James Cook Univ, Ctr Sustainable Trop Fisheries & Aquaculture, Townsville, Qld 4811, Australia; [Smart, Jonathan J.; Chin, Andrew; Baje, Leontine; Tobin, Andrew J.; Simpfendorfer, Colin A.] James Cook Univ, Coll Marine & Environm Sci, Townsville, Qld 4811, Australia; [Baje, Leontine] Natl Fisheries Author, Port Moresby, Papua N Guinea; [Green, Madeline E.] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia; [Green, Madeline E.; Appleyard, Sharon A.; White, William T.] CSIRO Oceans & Atmosphere, Hobart, Tas, Australia; [Green, Madeline E.; Appleyard, Sharon A.; White, William T.] CSIRO Natl Res Collect Australia, Australian Natl Fish Collect, Hobart, Tas, Australia	James Cook University; James Cook University; University of Tasmania; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Smart, JJ (corresponding author), James Cook Univ, Ctr Sustainable Trop Fisheries & Aquaculture, Townsville, Qld 4811, Australia.; Smart, JJ (corresponding author), James Cook Univ, Coll Marine & Environm Sci, Townsville, Qld 4811, Australia.	jonathan.smart@my.jcu.edu.au	Appleyard, Sharon/AAJ-9942-2020; White, William T/B-9748-2009; Smart, jonathan/W-2971-2019; appleyard, sharon/D-6076-2012; Chin, Andrew/C-2254-2008; Simpfendorfer, Colin A/G-9681-2011	Appleyard, Sharon/0000-0002-3105-1690; White, William T/0000-0001-9705-2453; Smart, jonathan/0000-0003-2070-3208; appleyard, sharon/0000-0002-3105-1690; Chin, Andrew/0000-0003-1813-4042; Simpfendorfer, Colin A/0000-0002-0295-2238	Australian Centre for International Agricultural Research (ACIAR) [FIS/2012/102]; National Fisheries Authority (NFA); Commonwealth Scientific and Industrial Research Organisation (CSIRO); James Cook University (JCU); Australian post-graduate award; Oceania Chondrichthyan Society (OCS) Passions of Paradise award; CSIRO Wealth from Oceans scholarship	Australian Centre for International Agricultural Research (ACIAR)(Australian Ctr Intl Agr Res); National Fisheries Authority (NFA); Commonwealth Scientific and Industrial Research Organisation (CSIRO)(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); James Cook University (JCU); Australian post-graduate award(Australian Government); Oceania Chondrichthyan Society (OCS) Passions of Paradise award; CSIRO Wealth from Oceans scholarship	This project was funded by the Australian Centre for International Agricultural Research (ACIAR; project FIS/2012/102), National Fisheries Authority (NFA), the Commonwealth Scientific and Industrial Research Organisation (CSIRO), and James Cook University (JCU). Special thanks to Drs Chris Barlow and Jes Sammut for their support of this project. The lead author was supported by an Australian post-graduate award, an Oceania Chondrichthyan Society (OCS) Passions of Paradise award, and a CSIRO Wealth from Oceans scholarship. The authors would like to thank Brian Kumasi, Luanah Yaman, Leban Gisawa and Ludwig Kumoru from the NFA for their continued support and collaboration on this project. For laboratory assistance we thank Brooke D'Alberto, Samantha Sherman, Satoshi Shiratsuchi and Andrea Cabrera Garcia. We would like to thank the fishers of the longline vessels and a special thanks to the NFA on-board fisheries observers who collected the data and vertebrae: Jackson Maravee, Noah Lurang Jr, Daniel Sau, Murphy John, Paliau Parkop, Towai Peli and Udill Jotham.	Baldwin CC, 2008, ZOOTAXA, V2008, P1; Beamish RJ, 1995, BEL BAR LIB, P545; Bishop SDH, 2006, MAR FRESHWATER RES, V57, P143, DOI 10.1071/MF05077; BOWKER AH, 1948, J AM STAT ASSOC, V43, P572, DOI 10.2307/2280710; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Burnham KP, 2001, WILDLIFE RES, V28, P111, DOI 10.1071/WR99107; Cailliet GM, 2004, CRC MAR BIOL SER, P399; Campana SE, 2001, J FISH BIOL, V59, P197, DOI [10.1111/j.1095-8649.2001.tb00127.x, 10.1006/jfbi.2001.1668]; CHANG WYB, 1982, CAN J FISH AQUAT SCI, V39, P1208, DOI 10.1139/f82-158; Chin A, 2013, MAR FRESHWATER RES, V64, P965, DOI 10.1071/MF13017; Compagno L. J. V., 1984, FAO Fisheries Synopsis, P251; Cortes E, 2012, CRC MAR BIOL SER, P453; DAVENPORT S, 1988, AUST J MAR FRESH RES, V39, P417; DECROSTA MA, 1981, PAC SCI, V35, P266; Dulvy NK, 2014, PEERJ, V2, DOI 10.7717/peerj.400; Evans GT, 1998, BIOMETRICS, V54, P620, DOI 10.2307/3109768; Fernandez-Carvalho J, 2011, AQUAT LIVING RESOUR, V24, P359, DOI 10.1051/alr/2011046; Francis MP, 2006, ENVIRON BIOL FISH, V77, P407, DOI 10.1007/s10641-006-9109-1; Haddon M., 2012, MODELLING QUANTITATI, V2nd; Hall NG, 2012, J FISH BIOL, V80, P1320, DOI 10.1111/j.1095-8649.2012.03240.x; Harry AV, 2013, MAR FRESHWATER RES, V64, P277, DOI 10.1071/MF12142; Katsanevakis S, 2008, FISH FISH, V9, P178, DOI 10.1111/j.1467-2979.2008.00279.x; Katsanevakis S, 2006, FISH RES, V81, P229, DOI 10.1016/j.fishres.2006.07.002; KILLAM KA, 1989, FISH B-NOAA, V87, P845; KIMURA DK, 1980, FISH B-NOAA, V77, P765; Kumar KVA, 2015, J APPL ICHTHYOL, V31, P301, DOI 10.1111/jai.12682; Kumoru L., 2003, 176 M STAND COMM TUN; Last P. R., 2009, SHARKS RAYS AUSTR, V2; Liu KM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143008; Morgan JAT, 2012, CONSERV GENET, V13, P455, DOI 10.1007/s10592-011-0298-6; O'Shea OR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077194; Ogle D., 2016, FSA FISHERIES STOCK; Ovenden JR, 2015, FISH FISH, V16, P125, DOI 10.1111/faf.12052; Pilling GM, 2002, CAN J FISH AQUAT SCI, V59, P424, DOI 10.1139/F02-022; R Core Team, 2013, LANG ENV STAT COMP; RICKER W E, 1975, P382; Ricker W.E., 1979, BIOENERGETICS GROWTH, VVIII, P677, DOI DOI 10.1016/S1546-5098(08)60034-5; Robbins WD., 2006, THESIS J COOK U AUST; Smart JJ, 2015, AFR J MAR SCI, V37, P177, DOI 10.2989/1814232X.2015.1025428; Smart JJ, 2016, FISH FISHERIES; Spaet JLY, 2015, FISH RES, V161, P356, DOI 10.1016/j.fishres.2014.08.022; STEVENS JD, 1991, AUST J MAR FRESH RES, V42, P151; Taylor IG, 2013, FISH RES, V142, P75, DOI 10.1016/j.fishres.2012.08.021; Tillett BJ, 2012, FISH RES, V127, P109, DOI 10.1016/j.fishres.2012.04.007; von BERTALANFFY LUDWIG, 1938, HUMAN BIOL, V10, P181; Walker Terence I., 2005, P81; Wetherbee BM, 1997, MAR ECOL PROG SER, V151, P181, DOI 10.3354/meps151181; White WT, 2007, J FISH BIOL, V71, P1512, DOI 10.1111/j.1095-8649.2007.01623.x; Zhu LX, 2009, CHIN J OCEANOL LIMN, V27, P457, DOI 10.1007/s00343-009-9236-6	49	22	23	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2016	11	4							e0153116	10.1371/journal.pone.0153116	http://dx.doi.org/10.1371/journal.pone.0153116			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6JK	27058734	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000373604800016
J	Biber-Freudenberger, L; Ziemacki, J; Tonnang, HEZ; Borgemeister, C				Biber-Freudenberger, Lisa; Ziemacki, Jasmin; Tonnang, Henri E. Z.; Borgemeister, Christian			Future Risks of Pest Species under Changing Climatic Conditions	PLOS ONE			English	Article							BACTROCERA-INVADENS DIPTERA; ECOLOGICAL NICHE; POTENTIAL DISTRIBUTION; CHANGE IMPACTS; FOOD SECURITY; PRECIPITATION; CLIMATOLOGY; TEMPERATURE; VARIABILITY; PREDICTION	Most agricultural pests are poikilothermic species expected to respond to climate change. Currently, they are a tremendous burden because of the high losses they inflict on crops and livestock. Smallholder farmers in developing countries of Africa are likely to suffer more under these changes than farmers in the developed world because more severe climatic changes are projected in these areas. African countries further have a lower ability to cope with impacts of climate change through the lack of suitable adapted management strategies and financial constraints. In this study we are predicting current and future habitat suitability under changing climatic conditions for Tuta absoluta, Ceratitis cosyra, and Bactrocera invadens, three important insect pests that are common across some parts of Africa and responsible for immense agricultural losses. We use presence records from different sources and bioclimatic variables to predict their habitat suitability using the maximum entropy modelling approach. We find that habitat suitability for B. invadens, C. cosyra and T. absoluta is partially increasing across the continent, especially in those areas already overlapping with or close to most suitable sites under current climate conditions. Assuming a habitat suitability at three different threshold levels we assessed where each species is likely to be present under future climatic conditions and if this is likely to have an impact on productive agricultural areas. Our results can be used by African policy makers, extensionists and farmers for agricultural adaptation measures to cope with the impacts of climate change.	[Biber-Freudenberger, Lisa; Ziemacki, Jasmin; Borgemeister, Christian] Univ Bonn, Ctr Dev Res ZEF, Dept Ecol & Nat Resources Management, Walter Flex Str 3, D-53113 Bonn, Germany; [Tonnang, Henri E. Z.] Int Maize & Wheat Improvement Ctr CIMMYT, ICRAF House,United Nations Ave,POB 1041, Nairobi 00621, Kenya	University of Bonn; CGIAR; International Maize & Wheat Improvement Center (CIMMYT); World Agroforestry (ICRAF)	Biber-Freudenberger, L (corresponding author), Univ Bonn, Ctr Dev Res ZEF, Dept Ecol & Nat Resources Management, Walter Flex Str 3, D-53113 Bonn, Germany.	lfreuden@uni-bonn.de	TONNANG, Henri/AAQ-2206-2021; Biber-Freudenberger, Lisa/H-9867-2019	TONNANG, Henri/0000-0002-9424-9186; Biber-Freudenberger, Lisa/0000-0001-8106-5372	Volkswagen Foundation [VW-89362]; Center for Development Research (ZEF), Department of Ecology and Natural Resources Management, at the University of Bonn	Volkswagen Foundation(Volkswagen); Center for Development Research (ZEF), Department of Ecology and Natural Resources Management, at the University of Bonn	This study was funded by the Volkswagen Foundation (project VW-89362) who provided financial support for the collaboration of the research team and the Center for Development Research (ZEF), Department of Ecology and Natural Resources Management, at the University of Bonn that supported the study through salaries and research infrastructure.	[Anonymous], 2015, AFSUN FOOD SECURITY; Balde A, 1917, DETECTION TUTA ABSOL; Barredo J. I., 2015, Bulletin OEPP, V45, P273, DOI 10.1111/epp.12208; Bettaibi A, 2012, CHIL J AGR RES, V72, P212, DOI 10.4067/S0718-58392012000200008; Coakley SM, 1999, ANNU REV PHYTOPATHOL, V37, P399, DOI 10.1146/annurev.phyto.37.1.399; De Meyer M, 2010, B ENTOMOL RES, V100, P35, DOI 10.1017/S0007485309006713; Desneux N, 2010, J PEST SCI, V83, P197, DOI 10.1007/s10340-010-0321-6; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; DFID research strategy 2008-2013, 2008, WORK PAP SER SUST AG, P27; Dillon ME, 2010, NATURE, V467, P704, DOI 10.1038/nature09407; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; EMBL, 2014, GEOGR TAGG INSDC SEQ; Fadlelmula A. A., 2014, Persian Gulf Crop Protection, V3, P17; Gacemi, 2012, ACAD J ENTOMOLOGY, V5, P37; Gbobaniyi E, 2014, INT J CLIMATOL, V34, P2241, DOI 10.1002/joc.3834; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Goergen G, 2011, ENVIRON ENTOMOL, V40, P844, DOI 10.1603/EN11017; Gregory PJ, 2009, J EXP BOT, V60, P2827, DOI 10.1093/jxb/erp080; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Harrington R, 2001, AGR FOREST ENTOMOL, V3, P233, DOI 10.1046/j.1461-9555.2001.00120.x; Heikkinen RK, 2006, PROG PHYS GEOG, V30, P751, DOI 10.1177/0309133306071957; Hijmans R., WORLDCLIM SET GLOBAL; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Jaramillo J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024528; Jaramillo J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006487; Knox J, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/3/034032; Kroschel J, 2013, AGR FOREST METEOROL, V170, P228, DOI 10.1016/j.agrformet.2012.06.017; Kumar S, 2015, J ECON ENTOMOL, V108, P1708, DOI 10.1093/jee/tov166; Kumar S, 2014, J ECON ENTOMOL, V107, P1032, DOI 10.1603/EC14052; Kumar S, 2014, COMPUT ELECTRON AGR, V103, P55, DOI 10.1016/j.compag.2014.02.007; Li Bai-Ni, 2009, Acta Entomologica Sinica, V52, P1122; Li BN, 2009, J ECON ENTOMOL, V102, P1781, DOI 10.1603/029.102.0508; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Manel S, 2001, J APPL ECOL, V38, P921, DOI 10.1046/j.1365-2664.2001.00647.x; McPherson JM, 2004, J APPL ECOL, V41, P811, DOI 10.1111/j.0021-8901.2004.00943.x; Muller C, 2013, ANNU REV NUTR, V33, P395, DOI 10.1146/annurev-nutr-071812-161121; Muller C, 2011, P NATL ACAD SCI USA, V108, P4313, DOI 10.1073/pnas.1015078108; Nboyine JA, 2012, SPECIES RANGE FRUIT; Netherer S, 2010, FOREST ECOL MANAG, V259, P831, DOI 10.1016/j.foreco.2009.07.034; Nikulin G, 2012, J CLIMATE, V25, P6057, DOI 10.1175/JCLI-D-11-00375.1; Oerke EC., 1994, CROP PRODUCTION CROP; Olwoch JM, 2007, ONDERSTEPOORT J VET, V74, P45, DOI 10.4102/ojvr.v74i1.139; Peterson AT, 2007, ECOGRAPHY, V30, P550, DOI 10.1111/j.2007.0906-7590.05102.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pretty J, 2011, INT J AGR SUSTAIN, V9, P5, DOI 10.3763/ijas.2010.0583; Pulliam HR, 2000, ECOL LETT, V3, P349, DOI 10.1046/j.1461-0248.2000.00143.x; Ramankutty N, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB002952; Royal Museum of Central Africa, 2014, TUR FRUIT FLIES DIPT; Russell IPM L, 2015, TUT ABS INF NETW; Sobek-Swant S, 2012, FOREST ECOL MANAG, V281, P23, DOI 10.1016/j.foreco.2012.06.017; Solhjouy-Fard S, 2013, J INSECT SCI, V13, DOI 10.1673/031.013.11601; Steck GJ, 2000, ENTOMOL CIRULAR, P403; Sylla M.B., 2013, CLIMATE VARIABILITY; Thornton PK, 2009, GLOBAL ENVIRON CHANG, V19, P54, DOI 10.1016/j.gloenvcha.2008.08.005; Thornton PhilipK., 2006, MAPPING CLIMATE VULN; Tonnang HEZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135283; Vermeulen SJ, 2012, ENVIRON SCI POLICY, V15, P136, DOI 10.1016/j.envsci.2011.09.003; Walther GR, 2009, TRENDS ECOL EVOL, V24, P686, DOI 10.1016/j.tree.2009.06.008; Wand MP, 1994, J COMPUT GRAPH STAT, V3, P433, DOI [DOI 10.1080/10618600.1994.10474656, DOI 10.2307/1390904]; Ward NL, 2007, GLOBAL CHANGE BIOL, V13, P1605, DOI 10.1111/j.1365-2486.2007.01399.x; Wheeler T, 2013, SCIENCE, V341, P508, DOI 10.1126/science.1239402; Yang X B, 2001, GLOB CHANGE HUM HLTH, V2, P90, DOI [10.1023/A:1015086831467, DOI 10.1023/A:1015086831467]	62	46	48	5	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153237	10.1371/journal.pone.0153237	http://dx.doi.org/10.1371/journal.pone.0153237			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27054718	gold, Green Published, Green Submitted			2022-12-27	WOS:000373608000109
J	Chen, KF; Chaou, CH; Jiang, JY; Yu, HW; Meng, YH; Tang, WC; Wu, CC				Chen, Kuan-Fu; Chaou, Chung-Hsien; Jiang, Jing-Yi; Yu, Hsueh-Wen; Meng, Yu-Hsiang; Tang, Wei-Chen; Wu, Chin-Chieh			Diagnostic Accuracy of Lipopolysaccharide-Binding Protein as Biomarker for Sepsis in Adult Patients: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							COMMUNITY-ACQUIRED INFECTIONS; PROCALCITONIN; BACTEREMIA; MARKER; LPS; SIRS	Introduction Lipopolysaccharide-binding protein (LBP) is widely reported as a biomarker to differentiate infected from non-infected patients. The diagnostic use of LBP for sepsis remains a matter of debate. We aimed to perform a systematic review and meta-analysis to assess the diagnostic accuracy of serum LBP for sepsis in adult patients. Methods We performed a systematic review and meta-analysis to assess the accuracy of LBP for sepsis diagnosis. A systematic search in PubMed and EMBASE for studies that evaluated the diagnostic role of LBP for sepsis through December 2015 was conducted. We searched these databases for original, English language, research articles that studied the diagnostic accuracy between septic and non-septic adult patients. Sensitivity, specificity, and other measures of accuracy, such as diagnostic odds ratio (DOR) and area under the receiver operating characteristic curve (AUC) of LBP were pooled using the Hierarchical Summary Receiver Operating Characteristic (HSROC) method. Results Our search returned 53 reports, of which 8 fulfilled the inclusion criteria, accounting for 1684 patients. The pooled sensitivity and specificity of LBP for diagnosis of sepsis by the HSROC method were 0.64 (95% CI: 0.56-0.72) and 0.63 (95% CI: 0.53-0.73), respectively. The value of the DOR was 3.0 (95% CI: 2.0-4.0) and the AUC was 0.68 (95% CI: 0.64-0.72). Meta-regression analysis revealed that cut-off values accounted for the heterogeneity of sensitivity and sample size (> = 150) accounted for the heterogeneity of specificity. Conclusions Based on the results of our meta-analysis, LBP had weak sensitivity and specificity in the detection of sepsis. LBP may not be practically recommended for clinical utilization as a single biomarker.	[Chen, Kuan-Fu; Tang, Wei-Chen; Wu, Chin-Chieh] Chang Gung Mem Hosp, Dept Emergency Med, Keelung, Taiwan; [Chen, Kuan-Fu] Chang Gung Univ, Clin Informat & Med Stat Res Ctr, Taoyuan, Taiwan; [Chen, Kuan-Fu] Chang Gung Mem Hosp, Community Med Res Ctr, Keelung, Taiwan; [Chaou, Chung-Hsien] Chang Gung Mem Hosp, Dept Emergency Med, Linkou, Taiwan; [Jiang, Jing-Yi; Yu, Hsueh-Wen] Chang Gung Univ, Sch Tradit Chinese Med, Taoyuan, Taiwan; [Meng, Yu-Hsiang] Chang Gung Univ, Sch Med, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University	Wu, CC (corresponding author), Chang Gung Mem Hosp, Dept Emergency Med, Keelung, Taiwan.	wujinja@cgmh.org.tw	Chaou, Chung-Hsien/AAZ-7344-2020	Chaou, Chung-Hsien/0000-0002-3702-7499; Chen, Kuan-Fu/0000-0001-7287-9497	National Science Council [NMRPG2A6011]; Chang Gung Memorial Hospital in Taiwan [100-2314-B-182A-038-MY3, CMRPG2C0201, CMRPG2B0121, CMRPG2B0271, CMRPG2B0371]	National Science Council(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital in Taiwan(Chang Gung Memorial Hospital)	National Science Council (grant number: NMRPG2A6011) Chang Gung Memorial Hospital in Taiwan (grant number: 100-2314-B-182A-038-MY3, CMRPG2C0201, CMRPG2B0121, CMRPG2B0271 and CMRPG2B0371). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adib-Conquy M, 2007, FEBS LETT, V581, P3723, DOI 10.1016/j.febslet.2007.03.074; Blairon L, 2003, J INFECT DIS, V187, P287, DOI 10.1086/346046; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Carlet J, 1999, INFECT DIS CLIN N AM, V13, P483, DOI 10.1016/S0891-5520(05)70087-8; Gaini S, 2007, CRIT CARE, V11, DOI 10.1186/cc5967; Gaini S, 2006, CRIT CARE, V10, DOI 10.1186/cc4866; Gibot S, 2012, AM J RESP CRIT CARE, V186, P65, DOI 10.1164/rccm.201201-0037OC; Gille-Johnson P, 2012, SCAND J INFECT DIS, V44, P745, DOI 10.3109/00365548.2012.689846; Guha M, 2001, CELL SIGNAL, V13, P85, DOI 10.1016/S0898-6568(00)00149-2; Henriquez-Camacho C, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/547818; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Meynaar IA, 2011, CRIT CARE RES PRACT, V2011, DOI 10.1155/2011/594645; MOSES LE, 1993, STAT MED, V12, P1293, DOI 10.1002/sim.4780121203; Nierhaus A, 2013, BMC IMMUNOL, V14, DOI 10.1186/1471-2172-14-8; Opal SM, 1999, J INFECT DIS, V180, P1584, DOI 10.1086/315093; Pierrakos C, 2010, CRIT CARE, V14, DOI 10.1186/cc8872; Prucha M, 2003, CRIT CARE, V7, pR154, DOI 10.1186/cc2386; RANGELFRAUSTO MS, 1995, JAMA-J AM MED ASSOC, V273, P117, DOI 10.1001/jama.273.2.117; Ratzinger F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082946; Rutter CM, 2001, STAT MED, V20, P2865, DOI 10.1002/sim.942; Sakr Y, 2008, CRIT CARE MED, V36, P2014, DOI 10.1097/CCM.0b013e31817b86e3; Song FJ, 2002, INT J EPIDEMIOL, V31, P88, DOI 10.1093/ije/31.1.88; TOBIAS PS, 1986, J EXP MED, V164, P777, DOI 10.1084/jem.164.3.777; Tromp M, 2012, J INFECTION, V65, P292, DOI 10.1016/j.jinf.2012.06.004; Wacker C, 2013, LANCET INFECT DIS, V13, P426, DOI 10.1016/S1473-3099(12)70323-7; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; Wu YP, 2012, CRIT CARE, V16, DOI 10.1186/cc11884; WURFEL MM, 1994, J EXP MED, V180, P1025, DOI 10.1084/jem.180.3.1025	31	20	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153188	10.1371/journal.pone.0153188	http://dx.doi.org/10.1371/journal.pone.0153188			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27055115	gold, Green Published, Green Submitted			2022-12-27	WOS:000373608000096
J	Tadesse, S				Tadesse, Sebsibe			Stigma against Tuberculosis Patients in Addis Ababa, Ethiopia	PLOS ONE			English	Article							SOUTHERN THAILAND; RURAL DISTRICT; SOCIAL SUPPORT; GENDER; INDIA; RISK; HIV; CONSEQUENCES; VIETNAM; DEFAULT	Background Stigma attached to tuberculosis contributes to the limited effectiveness of current TB control approaches. However, there is a dearth of studies that explore the causes of stigma attached to tuberculosis and its effects on patients and tuberculosiscontrol programs in Ethiopia. Methods An institution-based qualitative study was conducted at St. Peter Tuberculosis Specialized Hospital in Addis Ababa, Ethiopia from July to August, 2015. Ten in-depth interviews and 6 key-informant interviews were carried out among tuberculosis patients and healthcare workers, respectively. The Open Code computer software package was used to analyze the data thematically. Results The study revealed that fear of infection and inappropriate health education messages by media were the main causes of tuberculosis stigma. The patients experienced isolation within their family and community, separation, and financial crisis. The stigma attached to tuberculosis may contribute to delayed healthcare seeking, poor treatment adherence, and poor prognosis. Conclusion Interventions thatreduce the stigma attached to tuberculosis should target on areas, such as creating community awareness, patient counseling on problem-solving and emotional skills, preparing culturally sensitive and scientifically sound media messages, providing financial support for the patients, and enhancing the qualities of the healthcare workers, such as empathy, concern, respect for the patient and cultural sensitivity.	[Tadesse, Sebsibe] Univ Gondar, Inst Publ Hlth, Gondar, Ethiopia	University of Gondar	Tadesse, S (corresponding author), Univ Gondar, Inst Publ Hlth, Gondar, Ethiopia.	sbsbtadesse90@gmail.com	Tadesse, Sebsibe/AGG-7272-2022	Tadesse, Sebsibe/0000-0002-9153-5400				Armijos RX, 2008, REV PANAM SALUD PUBL, V23, P188, DOI 10.1590/S1020-49892008000300006; Atre SR, 2004, TROP MED INT HEALTH, V9, P1228, DOI 10.1111/j.1365-3156.2004.01321.x; Baral SC, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-211; Berger P., 1967, SOCIAL CONSTRUCTION; Cambanis A, 2005, TROP MED INT HEALTH, V10, P330, DOI 10.1111/j.1365-3156.2005.01393.x; Collins PY, 2008, SOC SCI MED, V67, P389, DOI 10.1016/j.socscimed.2008.03.013; Creswell J.W, 2003, RES DESIGN QUALITATI; Dodor EA, 2005, T ROY SOC TROP MED H, V99, P827, DOI 10.1016/j.trstmh.2005.06.011; Eastwood SV, 2004, INT J TUBERC LUNG D, V8, P70; Edginton ME, 2002, INT J TUBERC LUNG D, V6, P1075; Federal Ministry of Health, 2008, TUB LEPR TB HIV PREV, V4th; Getahun H, 2000, INT J TUBERC LUNG D, V4, P174; Godfrey-Faussett R, 2002, INT J TUBERC LUNG D, V6, P796; Goffman E. M., 1963, BEHAV PUBLIC PLACES; Heijnders Miriam, 2006, Psychol Health Med, V11, P353, DOI 10.1080/13548500600595327; Jakubowiak WM, 2007, INT J TUBERC LUNG D, V11, P46; Jittimanee SX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006360; Johansson E, 2000, HEALTH POLICY, V52, P33, DOI 10.1016/S0168-8510(00)00062-2; Link BG, 2001, ANNU REV SOCIOL, V27, P363, DOI 10.1146/annurev.soc.27.1.363; Long NH, 2001, HEALTH POLICY, V58, P69, DOI 10.1016/S0168-8510(01)00143-9; Macq J, 2005, HEALTH POLICY, V74, P205, DOI 10.1016/j.healthpol.2005.01.003; Major B, 2005, ANNU REV PSYCHOL, V56, P393, DOI 10.1146/annurev.psych.56.091103.070137; Meulemans H, 2002, INT J HEALTH PLAN M, V17, P249, DOI 10.1002/hpm.675; Patton M. Q., 2002, QUALITATIVE RES EVAL, V3rd; Rajeswari R, 2005, SOC SCI MED, V60, P1845, DOI 10.1016/j.socscimed.2004.08.024; Seale C., 2004, QUALITATIVE RES PRAC; Sengupta S, 2006, INT J TUBERC LUNG D, V10, P1008; Smith R, 2008, AIDS CARE, V20, P1266, DOI 10.1080/09540120801926977; Somma D, 2008, INT J TUBERC LUNG D, V12, P856; Tadesse T, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-424; Van Rie A, 2008, TROP MED INT HEALTH, V13, P21, DOI 10.1111/j.1365-3156.2007.01971.x; Weiss Mitchell G, 2006, Psychol Health Med, V11, P277; World Health Organization, 2015, GLOB TUB REP 2015; Yang LH, 2007, SOC SCI MED, V64, P1524, DOI 10.1016/j.socscimed.2006.11.013	34	32	35	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0152900	10.1371/journal.pone.0152900	http://dx.doi.org/10.1371/journal.pone.0152900			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DI6KO	27054714	Green Published, gold, Green Submitted			2022-12-27	WOS:000373608000053
J	Tin, ST; Elwood, JM; Lawrenson, R; Campbell, I; Harvey, V; Seneviratne, S				Tin, Sandar Tin; Elwood, J. Mark; Lawrenson, Ross; Campbell, Ian; Harvey, Vernon; Seneviratne, Sanjeewa			Differences in Breast Cancer Survival between Public and Private Care in New Zealand: Which Factors Contribute?	PLOS ONE			English	Article							HEALTH-INSURANCE COVERAGE; COLORECTAL-CANCER; OUTCOMES; STAGE; DIAGNOSIS; WOMEN; DISPARITIES; CARCINOMA	Background Patients who received private health care appear to have better survival from breast cancer compared to those who received public care. This study investigated if this applied to New Zealand women and identified factors that could explain such disparities. Methods This study involved all women who were diagnosed with primary breast cancer in two health regions in New Zealand, covering about 40% of the national population, between June 2000 and May 2013. Patients who received public care for primary treatment, mostly surgical treatment, were compared with those who received private care in terms of demographics, mode of presentation, disease factors, comorbidity index and treatment factors. Cox regression modelling was performed with stepwise adjustments, and hazards of breast cancer specific mortality associated with the type of health care received was assessed. Results Of the 14,468 patients, 8,916 (61.6%) received public care. Compared to patients treated in private care facilities, they were older, more likely to be Maori, Pacifika or Asian and to reside in deprived neighbourhoods and rural areas, and less likely to be diagnosed with early staged cancer and to receive timely cancer treatments. They had a higher risk of mortality from breast cancer (hazard ratio: 1.95; 95% CI: 1.75, 2.17), of which 80% (95% CI: 63%, 100%) was explained by baseline differences, particularly related to ethnicity, stage at diagnosis and type of loco-regional therapy. After controlling for these demographic, disease and treatment factors, the risk of mortality was still 14% higher in the public sector patients. Conclusions Ethnicity, stage at diagnosis and type of loco-regional therapy were the three key contributors to survival disparities between patients treated in public and private health care facilities in New Zealand. The findings underscore the need for more efforts to improve the quality, timeliness and equitability of public cancer care services.	[Tin, Sandar Tin; Elwood, J. Mark] Univ Auckland, Sch Populat Hlth, Sect Epidemiol & Biostat, Auckland 1, New Zealand; [Lawrenson, Ross; Campbell, Ian; Seneviratne, Sanjeewa] Univ Auckland, Waikato Clin Sch, Hamilton, New Zealand; [Harvey, Vernon] Auckland Dist Hlth Board, Auckland, New Zealand; [Seneviratne, Sanjeewa] Univ Colombo, Dept Surg, Colombo, Sri Lanka	University of Auckland; University of Auckland; Auckland District Health Board; University of Colombo	Tin, ST (corresponding author), Univ Auckland, Sch Populat Hlth, Sect Epidemiol & Biostat, Auckland 1, New Zealand.	s.tintin@auckland.ac.nz	Tin, Sandar Tin/I-6392-2019; Seneviratne, Sanjeewa/V-5764-2019	Tin, Sandar Tin/0000-0002-7303-061X; Seneviratne, Sanjeewa/0000-0003-0310-1387	Health Research Council of New Zealand [14/484]	Health Research Council of New Zealand(Health Research Council of New Zealand)	This work was supported by the Health Research Council of New Zealand (grant number 14/484), URL: http://www.hrc.govt.nz/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allemani C, 2015, LANCET, V385, P977, DOI DOI 10.1016/S0140-6736(14)62038-9; AYANIAN JZ, 1993, NEW ENGL J MED, V329, P326, DOI 10.1056/NEJM199307293290507; Aye PS, 2014, NEW ZEAL MED J, V127, P14; Barclay KL, 2015, ANZ J SURG, V85, P135, DOI 10.1111/ans.12709; Bayraktar UD, 2013, J HEALTH CARE POOR U, V24, P1136, DOI 10.1353/hpu.2013.0145; Carney P, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-004074; Coburn N, 2008, BREAST J, V14, P128, DOI 10.1111/j.1524-4741.2007.00542.x; Cormack D, 2005, ACCESS CANC SERVICES; Davies E, 2015, EUROPEAN J SURG ONCO, V41, pS43; Desquilbet L, 2010, STAT MED, V29, P1037, DOI 10.1002/sim.3841; Ellison-Loschmann L, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-1050-6; Field K, 2015, INTERN MED J, V45, P267, DOI 10.1111/imj.12643; Gurney J, 2013, NEW ZEAL MED J, V126, P69; Hall SE, 2005, ANZ J SURG, V75, P929, DOI 10.1111/j.1445-2197.2005.03583.x; Hall SE, 2005, BJU INT, V95, P51, DOI 10.1111/j.1464-410X.2005.05248.x; Halpern MT, 2007, CANCER, V110, P403, DOI 10.1002/cncr.22786; Haynes R, 2008, SOC SCI MED, V67, P928, DOI 10.1016/j.socscimed.2008.05.005; Health Funds Association of New Zealand, 2013, FACT FIL HLTH INS NZ; Hogan AM, 2008, ANN SURG ONCOL, V15, P1267, DOI 10.1245/s10434-007-9804-y; Hunter CP, 2000, CANCER-AM CANCER SOC, V88, P1193, DOI 10.1002/(SICI)1097-0142(20000301)88:5+<1193::AID-CNCR3>3.0.CO;2-D; Jones CEL, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004076; Liedke PER, 2014, CANCER EPIDEM BIOMAR, V23, P126, DOI 10.1158/1055-9965.EPI-13-0693; Maclean R, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1497-1; Macleod U, BR J CANC, V101, pS92; McDavid K, 2003, ARCH INTERN MED, V163, P2135, DOI 10.1001/archinte.163.18.2135; Ministry of Health, 2012, NAT MIN DAT HOSP INP; Ministry of Health, 2009, MORT COLL DAT DICT V; Ministry of Health, 2015, BSA DISTR HLTH BOARD; Ministry of Health, 2014, CANC NEW REG DEATHS; Moore M, 2010, J CLIN ONCOL, V28, pE36, DOI 10.1200/JCO.2009.25.2007; Morris M, 2007, MED J AUSTRALIA, V186, P296, DOI 10.5694/j.1326-5377.2007.tb00904.x; Neave Lorraine, 2003, N Z Med J, V116, pU648; Robson B, 2010, UNEQUAL IMPACT; Roder D, 2012, AUST HEALTH REV, V36, P342, DOI 10.1071/AH11060; Roetzheim RG, 2000, CANCER-AM CANCER SOC, V89, P2202, DOI 10.1002/1097-0142(20001201)89:11<2202::AID-CNCR8>3.0.CO;2-L; Salmond C., 2007, NZDEP2006 INDEX DEPR; Salmond CE, 2012, CAN J PUBLIC HEALTH, V103, pS7; Sant M, 2003, INT J CANCER, V106, P416, DOI 10.1002/ijc.11226; Sarfati D, 2014, J CLIN EPIDEMIOL, V67, P586, DOI 10.1016/j.jclinepi.2013.11.012; Schafer JL, 1997, ANAL INCOMPLETE MULT, V1st, DOI 10.1201/9781439821862; Seneviratne S, 2015, CANCER CAUSE CONTROL, V26, P1813, DOI 10.1007/s10552-015-0674-5; Seneviratne S, 2015, ETHNIC HEALTH, V20, P178, DOI 10.1080/13557858.2014.895976; Seneviratne S, 2014, CANCER EPIDEMIOL, V38, P638, DOI 10.1016/j.canep.2014.06.008; Shi RH, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1228-7; Simpson A, 2014, FASTER CANC TREATMEN, P20159; Statistics New Zealand, 2007, NZ URB RUR PROF; Stewart B, 2012, WORLD CANC REPORT 20; Stringhini S, 2010, JAMA-J AM MED ASSOC, V303, P1159, DOI 10.1001/jama.2010.297	48	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153206	10.1371/journal.pone.0153206	http://dx.doi.org/10.1371/journal.pone.0153206			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27054698	Green Published, gold			2022-12-27	WOS:000373608000101
J	Watanabe, T; Takahashi, N; Hirabara, S; Ishiguro, N; Kojima, T				Watanabe, Tatsuo; Takahashi, Nobunori; Hirabara, Shinya; Ishiguro, Naoki; Kojima, Toshihisa			Hyaluronan Inhibits Tlr-4-Dependent RANKL Expression in Human Rheumatoid Arthritis Synovial Fibroblasts	PLOS ONE			English	Article							OSTEOCLAST DIFFERENTIATION FACTOR; TOLL-LIKE RECEPTORS; NF-KAPPA-B; MOLECULAR-WEIGHT; ACTIVATOR; FLUID; JOINT; PATHOGENESIS; LIGAND; TISSUE	The Toll-like receptor (TLR) signaling pathway is activated in synovial fibroblast cells in patients with rheumatoid arthritis (RA). The receptor activator of nuclear factor-kappa B (RANK) and its ligand, RANKL, are key molecules involved in the differentiation of osteoclasts and joint destruction in RA. Hyaluronan (HA) is a major extracellular component and an important immune regulator. In this study, we show that lipopolysaccharide (LPS) stimulation significantly increases RANKL expression via a TLR-4 signaling pathway. We also demonstrate that HA suppresses LPS-induced RANKL expression, which is dependent on CD44, but not intercellular adhesion molecule-1 (ICAM-1). Our study provides evidence for HA-mediated suppression of TLR-4-dependent RANKL expression. This could present an alternative target for the treatment of destructed joint bones and cartilages in RA.	[Watanabe, Tatsuo; Takahashi, Nobunori; Hirabara, Shinya; Ishiguro, Naoki; Kojima, Toshihisa] Nagoya Univ, Grad Sch Med, Dept Orthopaed Surg, Nagoya, Aichi 4648601, Japan	Nagoya University	Takahashi, N (corresponding author), Nagoya Univ, Grad Sch Med, Dept Orthopaed Surg, Nagoya, Aichi 4648601, Japan.	nobunori@med.nagoya-u.ac.jp			JSPS [26462290]; Grants-in-Aid for Scientific Research [25462366] Funding Source: KAKEN	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number 26462290. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollahi-Roodsaz S, 2008, ARTHRITIS RHEUM, V58, P3753, DOI 10.1002/art.24127; Ariyoshi W, 2014, OSTEOARTHR CARTILAGE, V22, P111, DOI 10.1016/j.joca.2013.10.013; Arnett FC, 1988, ARTHRITIS RHEUMATISM, V32, P315; Brentano F, 2005, CELL IMMUNOL, V233, P90, DOI 10.1016/j.cellimm.2005.04.018; Brentano F, 2005, ARTHRITIS RHEUM-US, V52, P2656, DOI 10.1002/art.21273; BROMLEY M, 1984, ARTHRITIS RHEUM, V27, P968, DOI 10.1002/art.1780270902; Cohen SB, 2008, ARTHRITIS RHEUM, V58, P1299, DOI 10.1002/art.23417; DAHL LB, 1985, ANN RHEUM DIS, V44, P817, DOI 10.1136/ard.44.12.817; Drexler Stefan K, 2006, Expert Rev Clin Immunol, V2, P585, DOI 10.1586/1744666X.2.4.585; Goto M, 2001, CLIN EXP RHEUMATOL, V19, P377; Gravallese EM, 2000, ARTHRITIS RHEUM, V43, P250, DOI 10.1002/1529-0131(200002)43:2<250::AID-ANR3>3.0.CO;2-P; Haynes DR, 2001, RHEUMATOLOGY, V40, P623, DOI 10.1093/rheumatology/40.6.623; Hirabara S, 2013, BIOCHEM BIOPH RES CO, V430, P519, DOI 10.1016/j.bbrc.2012.12.003; Hiramitsu T, 2006, RHEUMATOLOGY, V45, P824, DOI 10.1093/rheumatology/kel026; Jiang D, 2011, 91, V91, P221, DOI [10.1152/physrev.00052.2009, DOI 10.1152/PHYSREV.00052.2009]; Jin ZX, 2015, MOL ENDOCRINOL, V29, P172, DOI 10.1210/me.2014-1316; Julovi SM, 2004, ARTHRITIS RHEUM-US, V50, P516, DOI 10.1002/art.20004; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kim KW, 2007, IMMUNOL LETT, V110, P54, DOI 10.1016/j.imlet.2007.03.004; Kyburz D, 2003, ARTHRITIS RHEUM-US, V48, P642, DOI 10.1002/art.10848; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; Nakagawa N, 1998, BIOCHEM BIOPH RES CO, V253, P395, DOI 10.1006/bbrc.1998.9788; Ohno S, 2005, ARTHRITIS RHEUM-US, V52, P800, DOI 10.1002/art.20937; Ospelt C, 2008, ARTHRITIS RHEUM-US, V58, P3684, DOI 10.1002/art.24140; Saito S, 2009, MOD RHEUMATOL, V19, P643, DOI 10.1007/s10165-009-0207-8; Shimizu M, 2003, J RHEUMATOL, V30, P1164; Takayanagi H, 2000, ARTHRITIS RHEUM-US, V43, P259, DOI 10.1002/1529-0131(200002)43:2<259::AID-ANR4>3.0.CO;2-W; van der Heijde D, 2006, ARTHRITIS RHEUM-US, V54, P1063, DOI 10.1002/art.21655; Vastesaeger N, 2009, RHEUMATOLOGY, V48, P1114, DOI 10.1093/rheumatology/kep155; Weinblatt ME, 2013, ARTHRITIS RHEUM-US, V65, P28, DOI 10.1002/art.37711	30	16	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153142	10.1371/journal.pone.0153142	http://dx.doi.org/10.1371/journal.pone.0153142			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27054952	gold, Green Submitted, Green Published			2022-12-27	WOS:000373608000086
J	Cheng, X; Waghulde, H; Mell, B; Smedlund, K; Vazquez, G; Joe, B				Cheng, Xi; Waghulde, Harshal; Mell, Blair; Smedlund, Kathryn; Vazquez, Guillermo; Joe, Bina			Pleiotropic Effect of a High Resolution Mapped Blood Pressure QTL on Tumorigenesis	PLOS ONE			English	Article							GENETIC-DETERMINANTS; COLORECTAL-CANCER; CONGENIC STRAINS; REVEALS; RAT; RAT-CHROMOSOME-10; HYPERTENSION; VARIANTS; GROWTH; REGION	This study is focused on a translationally significant, genome-wide-association-study (GWAS) locus for cardiovascular disease (QT-interval) on human chromosome 17. We have previously validated and high resolution mapped the homologous genomic segment of this human locus to <42.5 kb on rat chromosome 10. This <42.5 kb segment in rats regulates both QT-interval and blood pressure and contains a single protein-coding gene, rififylin (Rffl). The expression of Rffl in the hearts and kidneys is differential between Dahl S and S. LEW congenic rats, which are the strains used for mapping this locus. Our previous study points to altered rate of endocytic recycling as the underlying mechanism, through which Rffl operates to control both QT-interval and blood pressure. Interestingly, Rffl also contributes to tumorigenesis by repressing caspases and tumor suppressor genes. Moreover, the expression of Methyl-CpG Binding Domain Protein 2 (Mbd2) in the hearts and kidneys is also higher in the S. LEW congenic strain than the background (control) Dahl S strain. Mbd2 can repress methylated tumor suppressor genes. These data suggest that the S. LEW congenic strain could be more susceptible to tumorigenesis. To test this hypothesis, the S and S. LEW strains were compared for susceptibility to azoxymethane-induced colon tumors. The number of colon tumors was significantly higher in the S. LEW congenic strain compared with the S rat. Transcriptomic analysis confirmed that the chemical carcinogenesis pathway was significantly up-regulated in the congenic strain. These studies provide evidence for a GWAS-validated genomic segment on rat chromosome 10 as being important for the regulation of cardiovascular function and tumorigenesis.	[Cheng, Xi; Waghulde, Harshal; Mell, Blair; Smedlund, Kathryn; Vazquez, Guillermo; Joe, Bina] Univ Toledo, Coll Med & Life Sci, Dept Physiol & Pharmacol, Program Physiol Genom,Ctr Hypertens & Personalize, 2801 W Bancroft St, Toledo, OH 43606 USA	University System of Ohio; University of Toledo	Joe, B (corresponding author), Univ Toledo, Coll Med & Life Sci, Dept Physiol & Pharmacol, Program Physiol Genom,Ctr Hypertens & Personalize, 2801 W Bancroft St, Toledo, OH 43606 USA.	bina.joe@utoledo.edu	Waghulde, Harshal/V-6157-2019; Cheng, Xi/AAV-6176-2020	Cheng, Xi/0000-0002-0838-5094	National Institutes of Health [HL020176, HL112641]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL020176, R01HL112641, R01HL111877, R37HL020176] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The work was supported by the National Institutes of Health, grant numbers HL020176 and HL112641, to BJ (Dr. Bina Joe) (Search URL: https://projectreporter.nih.gov/). The grant recipient (Dr. Bina Joe) played significant roles in the study design, data analysis, decision to publish and preparation of the manuscript.	Gan XQ, 2013, J BIOL CHEM, V288, P33978, DOI 10.1074/jbc.M113.477406; Garrett MR, 2001, HYPERTENSION, V38, P779, DOI 10.1161/hy1001.091503; Garrett MR, 1998, GENOME RES, V8, P711, DOI 10.1101/gr.8.7.711; Gopalakrishnan Kathirvel, 2012, Frontiers in Genetics, V3, P138, DOI 10.3389/fgene.2012.00138; Gopalakrishnan K, 2011, HYPERTENSION, V57, P764, DOI 10.1161/HYPERTENSIONAHA.110.165803; Grossman E, 2002, AM J MED, V112, P479, DOI 10.1016/S0002-9343(02)01049-5; Gulmann C, 2009, J PATHOL, V218, P514, DOI 10.1002/path.2561; Hamet P, 1996, HYPERTENSION, V28, P321, DOI 10.1161/01.HYP.28.3.321; Hendrich B, 2001, GENE DEV, V15, P710, DOI 10.1101/gad.194101; McDonald ER, 2004, P NATL ACAD SCI USA, V101, P6170, DOI 10.1073/pnas.0307459101; Newton-Cheh C, 2009, NAT GENET, V41, P399, DOI 10.1038/ng.364; Oshio H, 2008, J GASTROENTEROL, V43, P538, DOI 10.1007/s00535-008-2188-3; Pazienza V, 2012, PPAR RES, V2012, DOI 10.1155/2012/560846; Saad Y, 2008, MAMM GENOME, V19, P85, DOI 10.1007/s00335-007-9084-7; Saad Y, 2007, HYPERTENSION, V50, P891, DOI 10.1161/HYPERTENSIONAHA.107.097105; Saad Y, 2007, GENOMICS, V89, P343, DOI 10.1016/j.ygeno.2006.12.005; Schaffer BS, 2013, CANCER PREV RES, V6, P59, DOI 10.1158/1940-6207.CAPR-12-0346-T; Smedlund KB, 2015, P NATL ACAD SCI USA, V112, pE2201, DOI 10.1073/pnas.1505410112; Wajant H, 2009, RESULTS PROBL CELL D, V49, P1, DOI 10.1007/400_2008_26; Yang WS, 2007, J BIOL CHEM, V282, P3273, DOI 10.1074/jbc.M610793200; Yuan KF, 2013, GASTROENTEROLOGY, V145, P853, DOI 10.1053/j.gastro.2013.06.008	21	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153519	10.1371/journal.pone.0153519	http://dx.doi.org/10.1371/journal.pone.0153519			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073989	Green Published, Green Submitted, gold			2022-12-27	WOS:000374131200103
J	Kim, K; Hong, S; Kim, EY				Kim, Kirang; Hong, Sangmo; Kim, Eun Young			Reference Values of Skeletal Muscle Mass for Korean Children and Adolescents Using Data from the Korean National Health and Nutrition Examination Survey 2009-2011	PLOS ONE			English	Article							X-RAY ABSORPTIOMETRY; METABOLIC SYNDROME; BODY-COMPOSITION; VALIDATION; FITNESS; OBESITY; CURVES; RISK	Background Skeletal muscle mass (SMM) plays a crucial role in systemic glucose metabolism. Objective To obtain reference data on absolute and relative values of SMM for Korean children and adolescents. Methods Cross-sectional results from 1919 children and adolescents (1024 boys) aged 10-18 years that underwent dual-energy X-ray absorptiometry (DXA) during the Korean National Health and Nutrition Examination Survey 2009-2011 were analyzed. SMMs were evaluated as follows; absolute SMM (appendicular skeletal muscle mass [ASM]) and relative SMMs, namely, height-adjusted skeletal muscle index (SMI; ASM/height(2)), % SMM (ASM/weight x 100), and skeletal muscle-to-body fat ratio (MFR; ASM/body fat mass). Results Percentile curves illustrated the developmental patterns of the SMMs of Korean children and adolescents. ASM and SMI increased with age in both genders, and increased from age 10 throughout adolescence in boys, whereas in girls, they increased until age 13 and then stabilized. In boys, % SMM and MFR were highest at age 15 and then slowly stabilized or decreased, whereas in girls, they peaked at age 10 to 11 and then decreased through adolescence. Cut-off values for low MFR were identified and a significant association was found between a low MFR and high risk of metabolic syndrome. However, this association was found to be dependent on gender and the level of BMI. Conclusion This study provides reference values of absolute and relative SMM for Korean children and adolescents. Detailed body composition analyses including skeletal muscle and fat mass might provide improved measures of metabolic risk.	[Kim, Kirang] Dankook Univ, Dept Food Sci & Nutr, Yongin, South Korea; [Hong, Sangmo] Hanyang Univ, Guri Hosp, Dept Endocrinol & Metab, Gyeonggi Do, South Korea; [Kim, Eun Young] Gachon Univ, Gil Hosp, Dept Radiol, Inchon, South Korea	Dankook University; Hanyang University; Gachon University	Kim, EY (corresponding author), Gachon Univ, Gil Hosp, Dept Radiol, Inchon, South Korea.	oneshot0229@gmail.com	Hong, Sangmo/C-9515-2018; Hong, Sangmo/ABF-6388-2021	Hong, Sangmo/0000-0002-8535-0565	Gachon University Gil Hospital Research fund	Gachon University Gil Hospital Research fund	This study was supported by a grant from Gachon University Gil Hospital Research fund.	Baumgartner RN, 2000, ANN NY ACAD SCI, V904, P437; Benson AC, 2006, INT J PEDIATR OBES, V1, P222, DOI 10.1080/17477160600962864; Bonora E, 2012, NAT REV GASTRO HEPAT, V9, P372, DOI 10.1038/nrgastro.2012.79; COLE TJ, 1992, STAT MED, V11, P1305, DOI 10.1002/sim.4780111005; Despres JP, 2006, ANN MED, V38, P52, DOI 10.1080/07853890500383895; Ford ES, 2008, J PEDIATR-US, V152, P160, DOI 10.1016/j.jpeds.2007.07.056; Janssen I, 2002, J AM GERIATR SOC, V50, P889, DOI 10.1046/j.1532-5415.2002.50216.x; Kim J, 2002, AM J CLIN NUTR, V76, P378, DOI 10.1093/ajcn/76.2.378; Kim TN, 2011, DIABETES RES CLIN PR, V93, P285, DOI 10.1016/j.diabres.2011.06.013; Kim YS, 2015, CLIN PHYSL FUNCT IMA; Kweon S, 2014, INT J EPIDEMIOL, V43, P69, DOI 10.1093/ije/dyt228; McCarthy HD, 2014, PEDIATR OBES, V9, P249, DOI 10.1111/j.2047-6310.2013.00168.x; Mitsiopoulos N, 1998, J APPL PHYSIOL, V85, P115, DOI 10.1152/jappl.1998.85.1.115; Oh SW, 2011, DIABETES METAB J, V35, P561, DOI 10.4093/dmj.2011.35.6.561; Pan H, 2004, STAT MED, V23, P1749, DOI 10.1002/sim.1692; Park BS, 2013, DIABETES METAB J, V37, P458, DOI 10.4093/dmj.2013.37.6.458; Prevention KCfDCa, STAND GROWTH CHARTS; Prior BM, 1997, J APPL PHYSIOL, V83, P623, DOI 10.1152/jappl.1997.83.2.623; Steene-Johannessen J, 2009, MED SCI SPORT EXER, V41, P1361, DOI 10.1249/MSS.0b013e31819aaae5	19	34	38	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153383	10.1371/journal.pone.0153383	http://dx.doi.org/10.1371/journal.pone.0153383			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073844	gold, Green Published, Green Submitted			2022-12-27	WOS:000374131200079
J	Soe, NN; Wen, DJ; Poh, JS; Li, Y; Broekman, BFP; Chen, H; Chong, YS; Kwek, K; Saw, SM; Gluckman, PD; Meaney, MJ; Rifkin-Graboi, A; Qiu, AQ				Soe, Ni Ni; Wen, Daniel J.; Poh, Joann S.; Li, Yue; Broekman, Birit F. P.; Chen, Helen; Chong, Yap Seng; Kwek, Kenneth; Saw, Seang-Mei; Gluckman, Peter D.; Meaney, Michael J.; Rifkin-Graboi, Anne; Qiu, Anqi			Pre- and Post-Natal Maternal Depressive Symptoms in Relation with Infant Frontal Function, Connectivity, and Behaviors	PLOS ONE			English	Article							ANTENATAL DEPRESSION; PARENTS REPORTS; BRAIN; EEG; PSYCHOPATHOLOGY; TRAJECTORIES; PREGNANCY; DISORDER; CHILDREN; OUTCOMES	This study investigated the relationships between pre- and early post-natal maternal depression and their changes with frontal electroencephalogram (EEG) activity and functional connectivity in 6- and 18-month olds, as well as externalizing and internalizing behaviors in 24-month olds (n = 258). Neither prenatal nor postnatal maternal depressive symptoms independently predicted neither the frontal EEG activity nor functional connectivity in 6-and 18-month infants. However, increasing maternal depressive symptoms from the prenatal to postnatal period predicted greater right frontal activity and relative right frontal asymmetry amongst 6-month infants but these finding were not observed amongst 18-month infants after adjusted for post-conceptual age on the EEG visit day. Subsequently increasing maternal depressive symptoms from the prenatal to postnatal period predicted lower right frontal connectivity within 18-month infants but not among 6-month infants after controlling for post-conceptual age on the EEG visit day. These findings were observed in the full sample and the female sample but not in the male sample. Moreover, both prenatal and early postnatal maternal depressive symptoms independently predicted children's externalizing and internalizing behaviors at 24 months of age. This suggests that the altered frontal functional connectivity in infants born to mothers whose depressive symptomatology increases in the early postnatal period compared to that during pregnancy may reflect a neural basis for the familial transmission of phenotypes associated with mood disorders, particularly in girls.	[Soe, Ni Ni; Wen, Daniel J.; Poh, Joann S.; Li, Yue; Qiu, Anqi] Natl Univ Singapore, Dept Biomed Engn, Singapore 117548, Singapore; [Qiu, Anqi] Natl Univ Singapore, Clin Imaging Res Ctr, Singapore 117548, Singapore; [Poh, Joann S.; Broekman, Birit F. P.; Chong, Yap Seng; Gluckman, Peter D.; Meaney, Michael J.; Rifkin-Graboi, Anne; Qiu, Anqi] Agcy Sci Technol & Res, Singapore Inst Clin Sci, Singapore, Singapore; [Chong, Yap Seng] Natl Univ Singapore, Dept Obstet & Gynecol, Yong Loo Lin Sch Med, Natl Univ Hlth Syst, Singapore 117548, Singapore; [Chen, Helen; Kwek, Kenneth] KK Womens & Childrens Hosp, Singapore, Singapore; [Chen, Helen; Kwek, Kenneth] Duke Natl Univ Singapore, Singapore, Singapore; [Saw, Seang-Mei] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Gluckman, Peter D.] Univ Auckland, Liggins Inst, Auckland 1, New Zealand; [Meaney, Michael J.] McGill Univ, Douglas Mental Hlth Univ Inst, Montreal, PQ, Canada; [Broekman, Birit F. P.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Psychol Med, Natl Univ Hlth Syst, Singapore 117595, Singapore	National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Institute for Clinical Sciences (SICS); National University of Singapore; KK Women's & Children's Hospital; National University of Singapore; National University of Singapore; University of Auckland; McGill University; National University of Singapore	Qiu, AQ (corresponding author), Natl Univ Singapore, Dept Biomed Engn, Singapore 117548, Singapore.; Qiu, AQ (corresponding author), Natl Univ Singapore, Clin Imaging Res Ctr, Singapore 117548, Singapore.; Qiu, AQ (corresponding author), Agcy Sci Technol & Res, Singapore Inst Clin Sci, Singapore, Singapore.	bieqa@nus.edu.sg	Qiu, Anqi/H-2267-2011; Wen, Daniel/ABA-4838-2021; Rifkin-Graboi, Anne/AFM-0959-2022; Rifkin-Graboi, Anne/AAH-3658-2022; Meaney, Michael/N-5931-2019	Qiu, Anqi/0000-0002-0215-6338; Wen, Daniel/0000-0002-6403-6075; Poh, Joann/0000-0002-4484-9028; Rifkin-Graboi, Anne/0000-0002-7641-4678; Chong, Yap Seng/0000-0002-7232-8473	Singapore National Research Foundation under its Translational and Clinical Research (TCR) Flagship Programme; NMRC [NMRC/CBRG/0039/2013]; Singapore Ministry of Education Academic Research Fund Tier 2 [MOE2012-T2-2-130]	Singapore National Research Foundation under its Translational and Clinical Research (TCR) Flagship Programme(National Research Foundation, Singapore); NMRC(National Medical Research Council, Singapore); Singapore Ministry of Education Academic Research Fund Tier 2(Ministry of Education, Singapore)	This research is supported by the Singapore National Research Foundation under its Translational and Clinical Research (TCR) Flagship Programme and administered by the Singapore Ministry of Health's National Medical Research Council (NMRC), Singapore-NMRC/TCR/004-NUS/2008; NMRC/TCR/012-NUHS/2014. Additional funding is provided by NMRC (NMRC/CBRG/0039/2013), and Singapore Ministry of Education Academic Research Fund Tier 2 (MOE2012-T2-2-130). All the funding received during this specific study was external to the authors' organization. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashman SB, 2008, DEV PSYCHOPATHOL, V20, P55, DOI 10.1017/S0954579408000035; BELL MA, 1992, CHILD DEV, V63, P1142, DOI 10.2307/1131523; Boyle MH, 1997, J CHILD PSYCHOL PSYC, V38, P981, DOI 10.1111/j.1469-7610.1997.tb01615.x; Braun K, 2011, DEV MED CHILD NEUROL, V53, P14, DOI 10.1111/j.1469-8749.2011.04056.x; Brennan PA, 2000, DEV PSYCHOL, V36, P759, DOI 10.1037/0012-1649.36.6.759; Bruder-Costello B, 2007, PSYCHIAT RES, V153, P145, DOI 10.1016/j.psychres.2007.02.013; Buss C, 2012, P NATL ACAD SCI USA, V109, pE1312, DOI 10.1073/pnas.1201295109; Cai SR, 2015, AM J CLIN NUTR, V101, P326, DOI 10.3945/ajcn.114.095414; Caspi A, 1996, ARCH GEN PSYCHIAT, V53, P1033; Chechko N, 2013, J AFFECT DISORDERS, V149, P136, DOI 10.1016/j.jad.2013.01.013; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; Davis EP, 2004, INFANCY, V6, P319, DOI 10.1207/s15327078in0603_1; Dawson G, 1997, J CHILD PSYCHOL PSYC, V38, P179, DOI 10.1111/j.1469-7610.1997.tb01852.x; Degnan KA, 2010, J CHILD PSYCHOL PSYC, V51, P497, DOI 10.1111/j.1469-7610.2010.02228.x; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Diego MA, 2010, BIOL PSYCHOL, V83, P7, DOI 10.1016/j.biopsycho.2009.09.007; Eley TC, 1999, J CHILD PSYCHOL PSYC, V40, P1273, DOI 10.1017/S0021963099004734; Feng X, 2012, J ABNORM CHILD PSYCH, V40, P265, DOI 10.1007/s10802-011-9564-9; Field T, 2004, INFANT BEHAV DEV, V27, P533, DOI 10.1016/j.infbeh.2004.03.005; Field T, 2004, INFANT BEHAV DEV, V27, P216, DOI 10.1016/j.infbeh.2003.09.010; FIELD T, 1995, INFANT BEHAV DEV, V18, P1, DOI 10.1016/0163-6383(95)90003-9; Field T, 2011, INFANT BEHAV DEV, V34, P1, DOI 10.1016/j.infbeh.2010.09.008; Field T, 2010, INFANT BEHAV DEV, V33, P409, DOI 10.1016/j.infbeh.2010.04.005; Fingelkurts AA, 2006, NEUROSCI RES, V56, P133, DOI 10.1016/j.neures.2006.06.006; Fingelkurts AA, 2007, HUM BRAIN MAPP, V28, P247, DOI 10.1002/hbm.20275; FLEMING AS, 1988, DEV PSYCHOL, V24, P71, DOI 10.1037/0012-1649.24.1.71; Gopnik A, 1999, THE SCIENTIST IN THE; Huang WL, 2001, INT J DEV NEUROSCI, V19, P415, DOI 10.1016/S0736-5748(01)00026-0; Ivanova MY, 2010, J AM ACAD CHILD PSY, V49, P1215, DOI 10.1016/j.jaac.2010.08.019; Jones NA, 2001, J REPROD INFANT PSYC, V19, P295, DOI 10.1080/02646830127204; Langrock AM, 2002, J CLIN CHILD ADOLESC, V31, P312, DOI 10.1207/S15374424JCCP3103_03; Lindsley DB, 1974, ELECTROENCEPHALOGRAP, P3; Lusby CM, 2014, DEV PSYCHOBIOL, V56, P459, DOI 10.1002/dev.21112; MacMaster FP, 2014, BRAIN IMAGING BEHAV, V8, P119, DOI 10.1007/s11682-013-9264-x; Mars B, 2015, J AFFECT DISORDERS, V182, P32, DOI 10.1016/j.jad.2015.04.018; Matijasevich A, 2015, J AFFECT DISORDERS, V174, P424, DOI 10.1016/j.jad.2014.12.012; Matthey S, 2006, ARCH WOMEN MENT HLTH, V9, P309, DOI 10.1007/s00737-006-0152-x; McLaughlin KA, 2015, P NATL ACAD SCI USA, V112, P5637, DOI 10.1073/pnas.1423363112; Mormann F, 2000, PHYSICA D, V144, P358, DOI 10.1016/S0167-2789(00)00087-7; Pandit AS, 2014, CEREB CORTEX, V24, P2324, DOI 10.1093/cercor/bht086; Park S, 2014, INT J MENT HEALTH SY, V8, DOI 10.1186/1752-4458-8-44; Pawlby S, 2009, J AFFECT DISORDERS, V113, P236, DOI 10.1016/j.jad.2008.05.018; Pearson RM, 2013, JAMA PSYCHIAT, V70, P1312, DOI 10.1001/jamapsychiatry.2013.2163; Peltola MJ, 2014, DEV PSYCHOBIOL, V56, P1377, DOI 10.1002/dev.21223; Qiu A, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.3; Qiu A, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.79; Quraan MA, 2014, NEUROPSYCHOPHARMACOL, V39, P1270, DOI 10.1038/npp.2013.330; Rescorla L., 2010, MULTICULTURAL SUPPLE; Rescorla LA, 2011, J CLIN CHILD ADOLESC, V40, P456, DOI 10.1080/15374416.2011.563472; Sandman CA, 2012, PSYCHOL SCI, V23, P93, DOI 10.1177/0956797611422073; Santesso DL, 2006, CHILD PSYCHIAT HUM D, V36, P311, DOI 10.1007/s10578-005-0005-2; Schwarz EaP B D, 1994, PSYCHIATRIC CLINICS, V17, P16; Sheridan MA, 2012, P NATL ACAD SCI USA, V109, P12927, DOI 10.1073/pnas.1200041109; Soh SE, 2014, INT J EPIDEMIOL, V43, P1401, DOI 10.1093/ije/dyt125; Sohr-Preston SL, 2006, CLIN CHILD FAM PSYCH, V9, P65, DOI 10.1007/s10567-006-0004-2; Takahashi E, 2012, CEREB CORTEX, V22, P455, DOI 10.1093/cercor/bhr126; Waters CS, 2014, EUR CHILD ADOLES PSY, V23, P957, DOI 10.1007/s00787-014-0582-3; Wehry AM, 2015, J AFFECT DISORDERS, V171, P54, DOI 10.1016/j.jad.2014.09.004; Wu YP, 2011, J CHILD FAM STUD, V20, P414, DOI 10.1007/s10826-010-9407-2; Wyrwoll CS, 2012, NEUROENDOCRINOLOGY, V95, P47, DOI 10.1159/000331345	60	42	42	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0152991	10.1371/journal.pone.0152991	http://dx.doi.org/10.1371/journal.pone.0152991			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ3UC	27073881	Green Published, Green Submitted, gold			2022-12-27	WOS:000374131200045
J	Musumari, PM; Tangmunkongvorakul, A; Srithanaviboonchai, K; Yungyuankul, S; Techasrivichien, T; Suguimoto, SP; Ono-Kihara, M; Kihara, M; Chariyalertsak, S				Musumari, Patou Masika; Tangmunkongvorakul, Arunrat; Srithanaviboonchai, Kriengkrai; Yungyuankul, Sawang; Techasrivichien, Teeranee; Suguimoto, S. Pilar; Ono-Kihara, Masako; Kihara, Masahiro; Chariyalertsak, Suwat			Prevalence and Correlates of HIV Testing among Young People Enrolled in Non-Formal Education Centers in Urban Chiang Mai, Thailand: A Cross-Sectional Study	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; NORTHERN THAILAND; SOUTH-AFRICA; SEXUAL-BEHAVIOR; UNITED-STATES; ADOLESCENTS; MEN; PERCEPTIONS; PREVENTION; KNOWLEDGE	Background HIV testing is the gateway to HIV prevention, treatment, and care. Despite the established vulnerability of young Thai people to HIV infection, studies examining the prevalence and correlates of HIV testing among the general population of Thai youth are still very limited. This study investigates socio-demographic, behavioral, and psychosocial factors associated with HIV testing among young Thai people enrolled in Non-formal Education Centers (NFEC) in urban Chiang Mai, Northern Thailand. Methods This was a cross-sectional quantitative study conducted among young unmarried Thai youth-between the ages of 15 and 24-who were enrolled in NFEC in urban Chiang Mai. Multiple logistic regressions were used to identify correlates of "ever tested for HIV" among the sexually active participants. Findings Of the 295 sexually active participants, 27.3% reported "ever tested for HIV;" 65.4% "did not consistently use condom;" and 61.7%" had at least 2 lifetime partners." We found that "self-efficacy" (AOR, 4.92; CI, 1.22-19.73); "perception that it is easy to find a location nearby to test for HIV" (AOR, 4.67; CI, 1.21-18.06); "having at least 2 lifetime sexual partners" (AOR, 2.05; CI, 1.09-3.85); and "ever been pregnant or made someone pregnant" (AOR, 4.06; CI, 2.69-9.15); were associated with increased odds of having ever been tested. On the other hand, "fear of HIV test results" (AOR, 0.21; CI, 0.08-0.57) was associated with lower odds of ever having been tested for HIV. Conclusion The main finding is that a substantially high proportion of Thai youth is engaged in risky sexual behaviors-yet reports low rates of ever having been tested for HIV. This highlights an urgent need to develop appropriate interventions-based on the identified correlates of HIV testing. There is also an urgent need to enhance HIV testing and to promote safer sexual behaviors among young Thai people-particularly those who are out-of-school.	[Musumari, Patou Masika; Techasrivichien, Teeranee; Suguimoto, S. Pilar; Ono-Kihara, Masako; Kihara, Masahiro] Kyoto Univ, Sch Publ Hlth, Dept Global Hlth & Socioepidemiol, Kyoto, Japan; [Tangmunkongvorakul, Arunrat; Srithanaviboonchai, Kriengkrai; Yungyuankul, Sawang; Chariyalertsak, Suwat] Chiang Mai Univ, Res Inst Hlth Sci, Chiang Mai 50000, Thailand; [Srithanaviboonchai, Kriengkrai; Chariyalertsak, Suwat] Chiang Mai Univ, Fac Med, Chiang Mai 50000, Thailand; [Suguimoto, S. Pilar] Kyoto Univ, Grad Sch Med, Ctr Med Educ, Kyoto, Japan	Kyoto University; Chiang Mai University; Chiang Mai University; Kyoto University	Tangmunkongvorakul, A (corresponding author), Chiang Mai Univ, Res Inst Hlth Sci, Chiang Mai 50000, Thailand.	arunrat@rihes.org	Napierala, Joanna/AAU-1256-2020; ., ksrithan/AAO-2228-2020	., ksrithan/0000-0002-1683-4259; Suguimoto, S. Pilar/0000-0002-8447-9172	Chiang Mai University Center of Excellence in HIV/AIDS Research; National Research University Project under Thailand's Office of the Higher Education Commission	Chiang Mai University Center of Excellence in HIV/AIDS Research; National Research University Project under Thailand's Office of the Higher Education Commission	This study was part of the HIV/AIDS Prevention Program among out-of-school young people in Chiang Mai. It was supported by the Chiang Mai University Center of Excellence in HIV/AIDS Research, and by the National Research University Project under Thailand's Office of the Higher Education Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addis Z, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-714; Aggleton P., 2000, SEX RELATSH THER, V15, P283, DOI DOI 10.1080/14681990050109863; [Anonymous], 1996, HIV AIDS COUNS GUID; Berendes S, 2011, J ASSOC NURSE AIDS C, V22, P215, DOI 10.1016/j.jana.2010.08.005; Bureau of Epidemiology, 2013, ANN EP SURV REP 2012, P103; Chamratrithirong A KS, 2007, NATIONAL SEXUAL BEHA; Chariyalertsak S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024295; Chemnasiri T, 2010, AIDS EDUC PREV, V22, P100, DOI 10.1521/aeap.2010.22.2.100; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Conway DP, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.20221; de Paoli MM, 2004, AIDS CARE, V16, P411, DOI 10.1080/09540120410001683358; Fako TT, 2006, AIDS CARE, V18, P201, DOI 10.1080/09540120500456623; Fathalla MF, 2006, LANCET, V368, P2095, DOI 10.1016/S0140-6736(06)69483-X; Fernandez MI, 2005, J RURAL HEALTH, V21, P56, DOI 10.1111/j.1748-0361.2005.tb00062.x; Jejeebhoy S, 2002, ANN TECHNICAL REPORT, P122; John Cleland Rl, 2005, ASKING YOUNG PEOPLE; Kawichai S, 2006, JAIDS-J ACQ IMM DEF, V41, P186, DOI 10.1097/01.qai.0000179431.42284.3e; Kawichai S, 2005, AIDS BEHAV, V9, P233, DOI 10.1007/s10461-005-3904-0; Kilmarx PH, 2000, AIDS, V14, P2731, DOI 10.1097/00002030-200012010-00013; Kirakoya-Samadoulougou F, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-540; Klitzman RL, 2004, AIDS CARE, V16, P628, DOI 10.1080/09540120410001716423; Le Coeur S, 2009, SOC SCI MED, V69, P846, DOI 10.1016/j.socscimed.2009.05.042; MacPhail CL, 2008, HEALTH EDUC BEHAV, V35, P87, DOI 10.1177/1090198106286442; Marks G, 2005, JAIDS-J ACQ IMM DEF, V39, P446, DOI 10.1097/01.qai.0000151079.33935.79; Michael J., 2015, J SOCIAL ONTOLOGY, V1, P1; Ministry of Social Development and Human Security, 2010, PREGN THAI AD; Nhurod P, 2010, SE ASIAN J TROP MED, V41, P153; Office TNS, 2009, REPR HLTH SURV; Ostermann J, 2007, ARCH INTERN MED, V167, P2128, DOI 10.1001/archinte.167.19.2128; Peltzer K, 2013, AFR HEALTH SCI, V13, P1012, DOI 10.4314/ahs.v13i4.22; PHANUPHAK P, 1994, AIDS, V8, P1315, DOI 10.1097/00002030-199409000-00015; Phillips G, 2015, J ADOLESCENT HEALTH, V57, P407, DOI 10.1016/j.jadohealth.2015.06.014; Phimemon N, 2015, DHS WORKING PAPERS, V119; Scott-Sheldon LAJ, 2013, AJAR-AFR J AIDS RES, V12, P195, DOI 10.2989/16085906.2013.863219; Strauss M, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0922-0; Takahashi TA, 2005, J GEN INTERN MED, V20, P618, DOI 10.1111/j.1525-1497.2005.0112.x; Takarinda KC, 2014, DHS WORKING PAPERS, V110; Tangmunkongvorakul A, 2012, SE ASIAN J TROP MED, V43, P479; Tangmunkongvorakul A, 2012, ASIAN POPUL STUD, V8, P39, DOI 10.1080/17441730.2012.646837; Tangmunkongvorakul A, 2010, SE ASIAN J TROP MED, V41, P1475; Techasrivichien T, 2014, ARCH SEXUAL BEHAV; Thai National AIDS Committee, 2014, THAIL AIDS RESP PROG; Thepthien BO, 2015, ASIA-PAC J PUBLIC HE, V27, P765, DOI 10.1177/1010539515588942; UNAIDS, 2014, THAIL AIDS RESP PROG; UNAIDS, 2012, UNAIDS WORLD DAY REP; van Griensven F, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.1.e13; Vutthikraivit Possawat, 2014, Journal of the Medical Association of Thailand, V97, pS207; Wisanee Siltragool, 2007, THAI NONFORMAL ED CO; Wiwattanacheewin K, 2015, AIDS EDUC PREV, V27, P139, DOI 10.1521/aeap.2015.27.2.139; World Health Organization, 2006, PREV HIV AIDS YOUNG; Worthington C, 2003, QUAL HEALTH RES, V13, P636, DOI 10.1177/1049732303013005004; Young SD, 2010, JAIDS-J ACQ IMM DEF, V55, P620, DOI 10.1097/QAI.0b013e3181fc6429	52	13	13	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0153452	10.1371/journal.pone.0153452	http://dx.doi.org/10.1371/journal.pone.0153452			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ0NI	27070553	gold, Green Published, Green Submitted			2022-12-27	WOS:000373900700070
J	Bruijnzeel, AW; Qi, XL; Guzhva, LV; Wall, S; Deng, JV; Gold, MS; Febo, M; Setlow, B				Bruijnzeel, Adriaan W.; Qi, Xiaoli; Guzhva, Lidia V.; Wall, Shannon; Deng, Jie V.; Gold, Mark S.; Febo, Marcelo; Setlow, Barry			Behavioral Characterization of the Effects of Cannabis Smoke and Anandamide in Rats	PLOS ONE			English	Article							CEREBELLAR CB1 RECEPTOR; PHARMACOLOGICAL-ACTIVITY; PRECIPITATED WITHDRAWAL; ENDOCANNABINOID SYSTEM; SELECTIVE ANTAGONIST; MOTOR INCOORDINATION; TOBACCO-SMOKE; OPEN-FIELD; MARIJUANA; BRAIN	Cannabis is the most widely used illicit drug in the world. Delta-9-tetrahydrocannabinol (Delta 9-THC) is the main psychoactive component of cannabis and its effects have been well-studied. However, cannabis contains many other cannabinoids that affect brain function. Therefore, these studies investigated the effect of cannabis smoke exposure on locomotor activity, rearing, anxiety-like behavior, and the development of dependence in rats. It was also investigated if cannabis smoke exposure leads to tolerance to the locomotor-suppressant effects of the endogenous cannabinoid anandamide. Cannabis smoke was generated by burning 5.7% Delta 9-THC cannabis cigarettes in a smoking machine. The effect of cannabis smoke on the behavior of rats in a small and large open field and an elevated plus maze was evaluated. Cannabis smoke exposure induced a brief increase in locomotor activity followed by a prolonged decrease in locomotor activity and rearing in the 30-min small open field test. The cannabinoid receptor type 1 (CB1) receptor antagonist rimonabant increased locomotor activity and prevented the smoke-induced decrease in rearing. Smoke exposure also increased locomotor activity in the 5-min large open field test and the elevated plus maze test. The smoke exposed rats spent more time in the center zone of the large open field, which is indicative of a decrease in anxiety-like behavior. A high dose of anandamide decreased locomotor activity and rearing in the small open field and this was not prevented by rimonabant or pre-exposure to cannabis smoke. Serum Delta 9-THC levels were 225 ng/ml after smoke exposure, which is similar to levels in humans after smoking cannabis. Exposure to cannabis smoke led to dependence as indicated by more rimonabant-precipitated somatic withdrawal signs in the cannabis smoke exposed rats than in the air-control rats. In conclusion, chronic cannabis smoke exposure in rats leads to clinically relevant Delta 9-THC levels, dependence, and has a biphasic effect on locomotor activity.	[Bruijnzeel, Adriaan W.; Qi, Xiaoli; Guzhva, Lidia V.; Wall, Shannon; Deng, Jie V.; Gold, Mark S.; Febo, Marcelo; Setlow, Barry] Univ Florida, Dept Psychiat, Gainesville, FL 32611 USA; [Bruijnzeel, Adriaan W.; Febo, Marcelo; Setlow, Barry] Univ Florida, Dept Neurosci, Gainesville, FL 32610 USA; [Bruijnzeel, Adriaan W.; Deng, Jie V.; Febo, Marcelo; Setlow, Barry] Univ Florida, Ctr Addict Res & Educ, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Bruijnzeel, AW (corresponding author), Univ Florida, Dept Psychiat, Gainesville, FL 32611 USA.; Bruijnzeel, AW (corresponding author), Univ Florida, Dept Neurosci, Gainesville, FL 32610 USA.; Bruijnzeel, AW (corresponding author), Univ Florida, Ctr Addict Res & Educ, Gainesville, FL USA.	awbruijn@ufl.edu	Febo, Marcelo/G-5718-2011; Febo, Marcelo/X-6769-2019	Febo, Marcelo/0000-0001-8981-4163; Setlow, Barry/0000-0001-9133-9445; Bruijnzeel, Adriaan/0000-0001-8466-1970	University of Florida McKnight Brain Institute seed funds; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA039349] Funding Source: NIH RePORTER	University of Florida McKnight Brain Institute seed funds; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by University of Florida McKnight Brain Institute seed funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACETO MD, 1995, EUR J PHARMACOL, V282, pR1, DOI 10.1016/0014-2999(95)00447-S; Adams IB, 1998, J PHARMACOL EXP THER, V284, P1209; Agrawal A, 2009, DRUG ALCOHOL DEPEN, V99, P240, DOI 10.1016/j.drugalcdep.2008.08.007; Aguiar DC, 2009, PSYCHOPHARMACOLOGY, V205, P217, DOI 10.1007/s00213-009-1532-5; ALBONETTI ME, 1992, BEHAV PROCESS, V28, P97, DOI 10.1016/0376-6357(92)90052-F; Ashton CH, 2001, BRIT J PSYCHIAT, V178, P101, DOI 10.1192/bjp.178.2.101; Aung MM, 2000, DRUG ALCOHOL DEPEN, V60, P133, DOI 10.1016/S0376-8716(99)00152-0; Bouaboula M, 1997, J BIOL CHEM, V272, P22330, DOI 10.1074/jbc.272.35.22330; Bruijnzeel AW, 2011, PHARMACOL BIOCHEM BE, V100, P109, DOI 10.1016/j.pbb.2011.08.005; Bruijnzeel AW, 2011, BRAIN RES, V1413, P32, DOI 10.1016/j.brainres.2011.07.041; Bruijnzeel AW, 2006, BIOL PSYCHIAT, V59, P477, DOI 10.1016/j.biopsych.2005.07.020; Budney AJ, 2001, ARCH GEN PSYCHIAT, V58, P917, DOI 10.1001/archpsyc.58.10.917; Campos AC, 2009, PROG NEURO-PSYCHOPH, V33, P1517, DOI 10.1016/j.pnpbp.2009.08.017; Cohen J.E., 1988, STAT POWER ANAL BEHA; Compton DR, 1996, J PHARMACOL EXP THER, V277, P586; Costain WF, 2008, INT J MENT HEALTH NU, V17, P227, DOI 10.1111/j.1447-0349.2008.00538.x; Cota D, 2008, J NEUROENDOCRINOL, V20, P35, DOI 10.1111/j.1365-2826.2008.01673.x; CRAWLEY JN, 1985, NEUROSCI BIOBEHAV R, V9, P37, DOI 10.1016/0149-7634(85)90030-2; Crean RD, 2011, J ADDICT MED, V5, P1, DOI 10.1097/ADM.0b013e31820c23fa; Dar MS, 2000, BRAIN RES, V864, P186, DOI 10.1016/S0006-8993(00)02103-X; DeSanty KP, 2001, PHARMACOL BIOCHEM BE, V69, P251, DOI 10.1016/S0091-3057(01)00539-1; EDEN S, 1979, ENDOCRINOLOGY, V105, P555, DOI 10.1210/endo-105-2-555; El-Alfy AT, 2010, PHARMACOL BIOCHEM BE, V95, P434, DOI 10.1016/j.pbb.2010.03.004; Febo M, 2003, J NEUROCHEM, V86, P405, DOI 10.1046/j.1471-4159.2003.01858.x; FELDER CC, 1995, MOL PHARMACOL, V48, P443; Freeman D, 2015, SCHIZOPHRENIA BULL, V41, P391, DOI 10.1093/schbul/sbu098; FRIDE E, 1993, EUR J PHARMACOL, V231, P313, DOI 10.1016/0014-2999(93)90468-W; GEORGE FR, 1991, PSYCHOPHARMACOLOGY, V104, P457, DOI 10.1007/BF02245649; Grant BF, 1998, J SUBST ABUSE, V10, P255, DOI 10.1016/S0899-3289(99)00006-1; Green B, 2003, DRUG ALCOHOL REV, V22, P453, DOI 10.1080/09595230310001613976; Hall W, 2009, LANCET, V374, P1383, DOI 10.1016/S0140-6736(09)61037-0; Haney M, 1999, PSYCHOPHARMACOLOGY, V141, P395, DOI 10.1007/s002130050849; HERKENHAM M, 1991, J NEUROSCI, V11, P563, DOI 10.1523/jneurosci.11-02-00563.1991; Hogg S, 1996, PHARMACOL BIOCHEM BE, V54, P21, DOI 10.1016/0091-3057(95)02126-4; Huestis MA, 2007, CHEM BIODIVERS, V4, P1770, DOI 10.1002/cbdv.200790152; Jarbe TUC, 2002, PHARMACOL BIOCHEM BE, V73, P911, DOI 10.1016/S0091-3057(02)00938-3; JOLLES J, 1979, BEHAV NEURAL BIOL, V25, P563, DOI 10.1016/S0163-1047(79)90362-5; Karch SB, 2006, MARIJUANA CANNABINOI; Katsidoni V, 2013, INT J NEUROPSYCHOPH, V16, P2273, DOI 10.1017/S1461145713000709; Khanolkar AD, 1996, J MED CHEM, V39, P4515, DOI 10.1021/jm960152y; KLAUSNER HA, 1971, LIFE SCI, V10, P49, DOI 10.1016/0024-3205(71)90245-1; Klenerova V, 2009, J PHYSIOL PHARMACOL, V60, P57; Lam PMW, 2005, BRIT J ANAESTH, V94, P649, DOI 10.1093/bja/aei098; Lev-Ran S, 2014, PSYCHOL MED, V44, P797, DOI 10.1017/S0033291713001438; Lichtman AH, 2002, J CLIN PHARMACOL, V42, p20S, DOI 10.1002/j.1552-4604.2002.tb05999.x; Lichtman AH, 2001, DRUG ALCOHOL DEPEN, V63, P107, DOI 10.1016/S0376-8716(00)00205-2; Liebsch G, 1998, BEHAV BRAIN RES, V94, P301, DOI 10.1016/S0166-4328(97)00198-8; MAESTRIPIERI D, 1992, ANIM BEHAV, V44, P967, DOI 10.1016/S0003-3472(05)80592-5; MARTIN BR, 1991, PHARMACOL BIOCHEM BE, V40, P471, DOI 10.1016/0091-3057(91)90349-7; MATSUDA LA, 1990, NATURE, V346, P561, DOI 10.1038/346561a0; Mechoulam R, 2013, ANNU REV PSYCHOL, V64, P21, DOI 10.1146/annurev-psych-113011-143739; MILLER NS, 1989, J SUBST ABUSE TREAT, V6, P183, DOI 10.1016/0740-5472(89)90005-6; MUNRO S, 1993, NATURE, V365, P61, DOI 10.1038/365061a0; Pearce DD, 2014, J ALTERN COMPLEM MED, V20, P787, DOI 10.1089/acm.2013.0190; Pickel VM, 2004, NEUROSCIENCE, V127, P101, DOI 10.1016/j.neuroscience.2004.05.015; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; PRYOR GT, 1978, PHARMACOL BIOCHEM BE, V8, P295, DOI 10.1016/0091-3057(78)90320-9; Ramesh D, 2011, ILAR J, V52, P295, DOI 10.1093/ilar.52.3.295; RINALDICARMONA M, 1994, FEBS LETT, V350, P240, DOI 10.1016/0014-5793(94)00773-X; ROSENKRANTZ H, 1974, TOXICOL APPL PHARM, V28, P18, DOI 10.1016/0041-008X(74)90126-4; Rylkova D, 2009, PSYCHOPHARMACOLOGY, V203, P629, DOI 10.1007/s00213-008-1409-z; Schlosburg JE, 2009, AAPS J, V11, P342, DOI 10.1208/s12248-009-9110-7; SJODEN P-O, 1973, Pharmacology Biochemistry and Behavior, V1, P243, DOI 10.1016/0091-3057(73)90111-1; Small E, 2010, PSYCHOPHARMACOLOGY, V208, P143, DOI 10.1007/s00213-009-1716-z; SMITH PB, 1994, J PHARMACOL EXP THER, V270, P219; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; SPRUIJT BM, 1992, PHYSIOL REV, V72, P825, DOI 10.1152/physrev.1992.72.3.825; Sulcova E, 1998, PHARMACOL BIOCHEM BE, V59, P347, DOI 10.1016/S0091-3057(97)00422-X; Tallett AJ, 2007, PSYCHOPHARMACOLOGY, V195, P27, DOI 10.1007/s00213-007-0880-2; Tanda G, 2003, PSYCHOPHARMACOLOGY, V169, P115, DOI 10.1007/s00213-003-1485-z; TEAGUE SV, 1994, INHAL TOXICOL, V6, P79, DOI 10.3109/08958379409029697; TERRANOVA JP, 1995, N-S ARCH PHARMACOL, V352, P576, DOI 10.1007/BF00169393; TINBERGEN N., 1952, QUART REV BIOL, V27, P1; Tsou K, 1998, NEUROSCIENCE, V83, P393, DOI 10.1016/S0306-4522(97)00436-3; TSOU K, 1995, EUR J PHARMACOL, V280, pR13, DOI 10.1016/0014-2999(95)00360-W; UNODC, UN OFF DRUGS CRIM WO; VARGA K, 1995, EUR J PHARMACOL, V278, P279, DOI 10.1016/0014-2999(95)00181-J; Varvel SA, 2005, J PHARMACOL EXP THER, V314, P329, DOI 10.1124/jpet.104.080739; Vickers SP, 2003, PSYCHOPHARMACOLOGY, V167, P103, DOI 10.1007/s00213-002-1384-8; WEINBERG AD, 1977, TOXICOL APPL PHARM, V42, P301, DOI 10.1016/0041-008X(77)90006-0; Wiley JL, 2003, EUR J PHARMACOL, V471, P185, DOI 10.1016/S0014-2999(03)01856-9; Wilson DM, 2006, PHARMACOL BIOCHEM BE, V85, P105, DOI 10.1016/j.pbb.2006.07.018; World Health Organization United Nations Office on Drugs and Crime, 2020, EXECUTIVE SUMMARY; Yamada H, 2010, PHARMACOL BIOCHEM BE, V95, P401, DOI 10.1016/j.pbb.2010.02.018	84	45	46	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2016	11	4							e0153327	10.1371/journal.pone.0153327	http://dx.doi.org/10.1371/journal.pone.0153327			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0KH	27065006	Green Submitted, Green Published, gold			2022-12-27	WOS:000373891000046
J	Hudson, LE; McDermott, CD; Stewart, TP; Hudson, WH; Rios, D; Fasken, MB; Corbett, AH; Lamb, TJ				Hudson, Lauren E.; McDermott, Courtney D.; Stewart, Taryn P.; Hudson, William H.; Rios, Daniel; Fasken, Milo B.; Corbett, Anita H.; Lamb, Tracey J.			Characterization of the Probiotic Yeast Saccharomyces boulardii in the Healthy Mucosal Immune System	PLOS ONE			English	Article							CD103(+) DENDRITIC CELLS; SMALL-INTESTINE; WALL; RESPONSES; ANTIGEN; STIMULATION; PREVENTION; DELIVERY	The probiotic yeast Saccharomyces boulardii has been shown to ameliorate disease severity in the context of many infectious and inflammatory conditions. However, use of S. boulardii as a prophylactic agent or therapeutic delivery vector would require delivery of S. boulardii to a healthy, uninflamed intestine. In contrast to inflamed mucosal tissue, the diverse microbiota, intact epithelial barrier, and fewer inflammatory immune cells within the healthy intestine may all limit the degree to which S. boulardii contacts and influences the host mucosal immune system. Understanding the nature of these interactions is crucial for application of S. boulardii as a prophylactic agent or therapeutic delivery vehicle. In this study, we explore both intrinsic and immunomodulatory properties of S. boulardii in the healthy mucosal immune system. Genomic sequencing and morphological analysis of S. boulardii reveals changes in cell wall components compared to non-probiotic S. cerevisiae that may partially account for probiotic functions of S. boulardii. Flow cytometry and immunohistochemistry demonstrate limited S. boulardii association with murine Peyer's patches. We also show that although S. boulardii induces a systemic humoral immune response, this response is small in magnitude and not directed against S. boulardii itself. RNA-seq of the draining mesenteric lymph nodes indicates that even repeated administration of S. boulardii induces few transcriptional changes in the healthy intestine. Together these data strongly suggest that interaction between S. boulardii and the mucosal immune system in the healthy intestine is limited, with important implications for future work examining S. boulardii as a prophylactic agent and therapeutic delivery vehicle.	[Hudson, Lauren E.; McDermott, Courtney D.; Stewart, Taryn P.; Lamb, Tracey J.] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA USA; [Hudson, William H.] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Rios, Daniel] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Fasken, Milo B.; Corbett, Anita H.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University; Emory University	Lamb, TJ (corresponding author), Emory Univ, Sch Med, Dept Pediat, Atlanta, GA USA.	tracey.j.lamb@emory.edu	Corbett, Anita/AAH-6106-2021; Hudson, William/E-6622-2012; Fasken, Milo/K-2177-2019	Corbett, Anita/0000-0002-0461-6895; Hudson, William/0000-0002-2513-1213; Fasken, Milo/0000-0003-4317-7909	NIAID [DP2AI112242]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [DP2AI112242] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008169] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by NIAID (DP2AI112242), https://www.niaid.nih.gov/Pages/default.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Dr. Hong Yi and Dr. Liz Wright of the Emory University Robert P. Apkarian Integrated Electron Microscopy Core for their assistance and expertise in imaging. We would also like to thank Aaron Rae of the Emory University Pediatric Research Flow Cytometry Core for technical assistance and advice. We also thank the Emory University Integrated Genomics Core for assistance in sequencing the S. boulardii genome, and the Huntsman Cancer Institute Genomics Core for expertise in RNA sequencing. We thank Dr. Ifor Williams for helpful discussion and assistance in analyzing histology samples, Dr. Caline Matar for kind assistance in flow cytometry analysis, and Moon Young Lee for technical assistance. This work was funded by NIAID (DP2AI112242).	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Bonaccorsi I, 2016, IMMUNOL LETT, V170, P95, DOI 10.1016/j.imlet.2015.11.008; BUTS JP, 1986, PEDIATR RES, V20, P192, DOI 10.1203/00006450-198602000-00020; BUTS JP, 1990, DIGEST DIS SCI, V35, P251, DOI 10.1007/BF01536771; CASTEX F, 1990, J GEN MICROBIOL, V136, P1085, DOI 10.1099/00221287-136-6-1085; Cerutti A, 2008, IMMUNITY, V28, P740, DOI 10.1016/j.immuni.2008.05.001; Cerutti A, 2011, ANNU REV IMMUNOL, V29, P273, DOI 10.1146/annurev-immunol-031210-101317; Cherry JM, 2012, NUCLEIC ACIDS RES, V40, pD700, DOI 10.1093/nar/gkr1029; Christensen HR, 2002, J IMMUNOL, V168, P171, DOI 10.4049/jimmunol.168.1.171; Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010; De Jesus M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091002; De Smet R, 2013, J CONTROL RELEASE, V172, P671, DOI 10.1016/j.jconrel.2013.09.007; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Everard A, 2014, MBIO, V5, DOI 10.1128/mBio.01011-14; Farache J, 2013, IMMUNITY, V38, P581, DOI 10.1016/j.immuni.2013.01.009; Fischer Andrew H, 2008, CSH Protoc, V2008, DOI 10.1101/pdb.prot4986; Goldenberg JZ, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004827.pub4; Hamedi Hassan, 2013, Avicenna Journal of Medical Biotechnology, V5, P29; Hempel S, 2012, JAMA-J AM MED ASSOC, V307, P1959, DOI 10.1001/jama.2012.3507; Huang HB, 2010, MBIO, V1, DOI 10.1128/mBio.00164-10; Hudson LE, 2016, JOVE-J VIS EXP, DOI 10.3791/53453; Hudson LE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112660; Jahn HU, 1996, DIGESTION, V57, P95, DOI 10.1159/000201320; Jawhara S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040648; Khatri I, 2013, GUT PATHOG, V5, DOI 10.1186/1757-4749-5-30; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim SH, 2014, EXP MOL MED, V46, DOI 10.1038/emm.2013.165; Klis FM, 2006, YEAST, V23, P185, DOI 10.1002/yea.1349; Lesage G, 2006, MICROBIOL MOL BIOL R, V70, P317, DOI 10.1128/MMBR.00038-05; Letscher-Bru V, 2003, J ANTIMICROB CHEMOTH, V51, P513, DOI 10.1093/jac/dkg117; Levitz SM, 2009, CURR FUNGAL INFECT R, V3, P179, DOI 10.1007/s12281-009-0023-9; Lin CPC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003700; Lo DD, 2013, EXPERT OPIN DRUG DEL, V10, P157, DOI 10.1517/17425247.2013.740008; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Manzi A, 2001, Curr Protoc Mol Biol, VChapter 17, DOI 10.1002/0471142727.mb1709s32; Martins FS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008925; Matar CG, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004858; McDole JR, 2012, NATURE, V483, P345, DOI 10.1038/nature10863; McFarland LV, 1996, CLIN INFECT DIS, V22, P200, DOI 10.1093/clinids/22.1.200; Michael S, 2013, INFLAMM BOWEL DIS, V19, P185, DOI 10.1002/ibd.23006; MUTHUKUMAR G, 1993, J BACTERIOL, V175, P386, DOI 10.1128/JB.175.2.386-394.1993; O'Reilly MK, 2006, BIOCHEMISTRY-US, V45, P9593, DOI 10.1021/bi060878o; Orlean P, 2012, GENETICS, V192, P775, DOI 10.1534/genetics.112.144485; Perez-Garcia LA, 2012, GLYCOBIOLOGY, V1, P1, DOI [10.4172/jgb.1000102, DOI 10.4172/JGB.1000102]; Peterson LW, 2014, NAT REV IMMUNOL, V14, P141, DOI 10.1038/nri3608; Pothoulakis C, 2009, ALIMENT PHARM THER, V30, P826, DOI 10.1111/j.1365-2036.2009.04102.x; Qamar A, 2001, INFECT IMMUN, P69, DOI [10.1128/IAI.69.4.2762, DOI 10.1128/IAI.69.4.2762]; Rodrigues ACP, 2000, J APPL MICROBIOL, V89, P404, DOI 10.1046/j.1365-2672.2000.01128.x; Romani L, 2011, NAT REV IMMUNOL, V11, P275, DOI 10.1038/nri2939; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Santos B, 2000, MOL BIOL CELL, V11, P435, DOI 10.1091/mbc.11.2.435; Schulz O, 2013, TRENDS IMMUNOL, V34, P155, DOI 10.1016/j.it.2012.09.006; Shakweh Monjed, 2004, Expert Opin Drug Deliv, V1, P141, DOI 10.1517/17425247.1.1.141; Soderlund C, 2006, GENOME RES, V16, P1159, DOI 10.1101/gr.5396706; Stack HM, 2010, APPL ENVIRON MICROB, V76, P500, DOI 10.1128/AEM.01524-09; Sun J, 2012, BIOTECHNOL BIOENG, V109, P2082, DOI 10.1002/bit.24481; Walter J, 2003, APPL ENVIRON MICROB, V69, P2044, DOI 10.1128/AEM.69.4.2044-2051.2003	57	41	43	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2016	11	4							e0153351	10.1371/journal.pone.0153351	http://dx.doi.org/10.1371/journal.pone.0153351			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0KH	27064405	Green Submitted, Green Published, gold			2022-12-27	WOS:000373891000050
J	Talavera-Garcia, E; Delgado-Lista, J; Garcia-Rios, A; Delgado-Casado, N; Gomez-Luna, P; Gomez-Garduno, A; Gomez-Delgado, F; Alcala-Diaz, JF; Yubero-Serrano, E; Marin, C; Perez-Caballero, AI; Fuentes-Jimenez, FJ; Camargo, A; Rodriguez-Cantalejo, F; Tinahones, FJ; Ordovas, JM; Perez-Jimenez, F; Perez-Martinez, P; Lopez-Miranda, J				Talavera-Garcia, Eva; Delgado-Lista, Javier; Garcia-Rios, Antonio; Delgado-Casado, Nieves; Gomez-Luna, Purificacion; Gomez-Garduno, Angela; Gomez-Delgado, Francisco; Alcala-Diaz, Juan F.; Yubero-Serrano, Elena; Marin, Carmen; Perez-Caballero, Ana I.; Fuentes-Jimenez, Francisco J.; Camargo, Antonio; Rodriguez-Cantalejo, Fernando; Tinahones, Francisco J.; Ordovas, Jose M.; Perez-Jimenez, Francisco; Perez-Martinez, Pablo; Lopez-Miranda, Jose			Influence of Obesity and Metabolic Disease on Carotid Atherosclerosis in Patients with Coronary Artery Disease (CordioPrev Study)	PLOS ONE			English	Article							INTIMA-MEDIA THICKNESS; CARDIOVASCULAR RISK-FACTORS; NORMAL-WEIGHT; INSULIN-RESISTANCE; ALL-CAUSE; ASSOCIATION; HEALTHY; EVENTS; PREVALENCE; STATEMENT	Background Recent data suggest that the presence of associated metabolic abnormalities may be important modifiers of the association of obesity with a poorer prognosis in coronary heart disease. We determined the influence of isolated overweight and obesity on carotid intima media thickness (IMT-CC), and also assessed whether this influence was determined by the presence of metabolic abnormalities. Methods 1002 participants from the CordioPrev study were studied at entry. We determined their metabolic phenotypes and performed carotid ultrasound assessment. We evaluated the influence of obesity, overweight and metabolic phenotypes on the IMT-CC. Results Metabolically sick participants (defined by the presence of two or more metabolic abnormalities) showed a greater IMT-CC than metabolically healthy individuals (p = 4 * 10(-6)). Overweight and normal weight patients who were metabolically healthy showed a lower IMT-CC than the metabolically abnormal groups (all p<0.05). When we evaluated only body weight (without considering metabolic phenotypes), overweight or obese patients did not differ significantly from normal-weight patients in their IMT-CC (p = 0.077). However, obesity was a determinant of IMT-CC when compared to the composite group of normal weight and overweight patients (all not obese). Conclusions In coronary patients, a metabolically abnormal phenotype is associated with a greater IMT-CC, and may be linked to a higher risk of suffering new cardiovascular events. The protection conferred in the IMT-CC by the absence of metabolic abnormality may be blunted by the presence of obesity.	[Talavera-Garcia, Eva; Delgado-Lista, Javier; Garcia-Rios, Antonio; Delgado-Casado, Nieves; Gomez-Luna, Purificacion; Gomez-Garduno, Angela; Gomez-Delgado, Francisco; Alcala-Diaz, Juan F.; Yubero-Serrano, Elena; Marin, Carmen; Perez-Caballero, Ana I.; Fuentes-Jimenez, Francisco J.; Camargo, Antonio; Perez-Jimenez, Francisco; Perez-Martinez, Pablo; Lopez-Miranda, Jose] Univ Cordoba, Reina Sofia Univ Hosp, IMIBIC, Lipid & Atherosclerosis Unit, Cordoba, Spain; [Talavera-Garcia, Eva; Delgado-Lista, Javier; Garcia-Rios, Antonio; Delgado-Casado, Nieves; Gomez-Luna, Purificacion; Gomez-Garduno, Angela; Gomez-Delgado, Francisco; Alcala-Diaz, Juan F.; Yubero-Serrano, Elena; Marin, Carmen; Perez-Caballero, Ana I.; Fuentes-Jimenez, Francisco J.; Camargo, Antonio; Tinahones, Francisco J.; Perez-Jimenez, Francisco; Perez-Martinez, Pablo; Lopez-Miranda, Jose] Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nutr CIBEROBN, Madrid, Spain; [Rodriguez-Cantalejo, Fernando] Hosp Univ Reina Sofia, Biochem Lab, Cordoba, Spain; [Tinahones, Francisco J.] Hosp Virgen de la Victoria, Dept Endocrinol, Biomed Res Lab, Malaga, Spain; [Ordovas, Jose M.] Tufts Univ, JM USDA Human Nutr Res Ctr Aging, Nutr & Genom Lab, Boston, MA 02111 USA; [Ordovas, Jose M.] CNIC, IMDEA, Dept Cardiovasc Epidemiol & Populat Genet, Madrid, Spain	Hospital Universitario Reina Sofia - Cordoba; Universidad de Cordoba; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; Hospital Universitario Reina Sofia - Cordoba; Tufts University; United States Department of Agriculture (USDA); Centro Nacional de Investigaciones Cardiovasculares (CNIC)	Delgado-Lista, J (corresponding author), Univ Cordoba, Reina Sofia Univ Hosp, IMIBIC, Lipid & Atherosclerosis Unit, Cordoba, Spain.	javier.delgado@imibic.org	Jimenez, Francisco Perez/AAJ-9559-2021; Alcala-Diaz, Juan Francisco/F-5329-2016; Lopez-Miranda, Jose/Y-8306-2019; Yubero-Serrano, Elena M/H-4832-2013; Camargo, Antonio/G-9720-2015; Tinahones, Francisco José/AAB-2882-2020; Marin Hinojosa, Carmen/AFO-1294-2022; Delgado, Francisco Gomez/H-4552-2015; Alcala-Diaz, Juan F./Q-4455-2019; FUENTES JIMENEZ, FRANCISCO/G-4311-2016	Alcala-Diaz, Juan Francisco/0000-0002-4572-3611; Lopez-Miranda, Jose/0000-0002-8844-0718; Camargo, Antonio/0000-0002-0415-4184; Marin Hinojosa, Carmen/0000-0003-2884-4806; Delgado, Francisco Gomez/0000-0002-0216-2084; Alcala-Diaz, Juan F./0000-0002-4572-3611; Yubero-Serrano, Elena M/0000-0002-2733-5359; Delgado Lista, Francisco Javier/0000-0002-2982-2716; Perez-Caballero, Ana Isabel/0000-0001-6315-1453; Tinahones, Francisco J/0000-0001-6871-4403; FUENTES JIMENEZ, FRANCISCO/0000-0002-4584-7366	Fundacion Patrimonio Comunal Olivarero; CITOLIVA; CEAS; Junta de Andalucia (Consejeria de Salud); Junta de Andalucia (Consejeria de Agricultura y Pesca); Junta de Andalucia (Consejeria de Innovacion); Junta de Andalucia (Ciencia y Empresa); Diputaciones de Jaen y Cordoba, Centro de Excelencia en Investigacion sobre Aceite de Oliva y Salud; Ministerio de Medio Ambiente, Medio Rural y Marino, Gobierno de Espana; Ministerio de Ciencia e Innovacion [AGL2009-122270, FIS PI10/01041, FIS PI13/00023]; Ministerio de Economia y Competitividad [AGL2012/39615]; Consejeria de Salud, Junta de Andalucia [PI0193/09, PI-0252/09, PI-0058/10, PI-0206-2013]; Proyecto de Excelencia, Consejeria de Economia, Innovacion, Ciencia y Empleo [CVI-7450]; European Commission (NUTRITECH European Integrated Project) [289511]; ISCIII research contract (Programa Rio-Hortega); Fondo Europeo de Desarrollo Regional (FEDER)	Fundacion Patrimonio Comunal Olivarero; CITOLIVA; CEAS; Junta de Andalucia (Consejeria de Salud)(Junta de Andalucia); Junta de Andalucia (Consejeria de Agricultura y Pesca)(Junta de Andalucia); Junta de Andalucia (Consejeria de Innovacion)(Junta de Andalucia); Junta de Andalucia (Ciencia y Empresa); Diputaciones de Jaen y Cordoba, Centro de Excelencia en Investigacion sobre Aceite de Oliva y Salud; Ministerio de Medio Ambiente, Medio Rural y Marino, Gobierno de Espana(Spanish Government); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Ministerio de Economia y Competitividad(Spanish Government); Consejeria de Salud, Junta de Andalucia(Junta de Andalucia); Proyecto de Excelencia, Consejeria de Economia, Innovacion, Ciencia y Empleo; European Commission (NUTRITECH European Integrated Project)(European Commission); ISCIII research contract (Programa Rio-Hortega); Fondo Europeo de Desarrollo Regional (FEDER)(European CommissionSpanish Government)	The CORDIOPREV study is supported by the Fundacion Patrimonio Comunal Olivarero. Also received additional funding from CITOLIVA, CEAS, Junta de Andalucia (Consejeria de Salud, Consejeria de Agricultura y Pesca, Consejeria de Innovacion, Ciencia y Empresa), Diputaciones de Jaen y Cordoba, Centro de Excelencia en Investigacion sobre Aceite de Oliva y Salud and Ministerio de Medio Ambiente, Medio Rural y Marino, Gobierno de Espana. It was also partly supported by research grants from the Ministerio de Ciencia e Innovacion (AGL2009-122270 to JL-M, FIS PI10/01041 to PP-M, FIS PI13/00023 to JD-L); Ministerio de Economia y Competitividad (AGL2012/39615 to JL-M); Consejeria de Salud, Junta de Andalucia (PI0193/09 to JL-M, PI-0252/09 to JD-L, and PI-0058/10 to PP-M, PI-0206-2013 to AG-R); Proyecto de Excelencia, Consejeria de Economia, Innovacion, Ciencia y Empleo (CVI-7450 to JL-M). It was also partly supported by a research grant from the European Commission (NUTRITECH European Integrated Project-289511). Francisco Gomez-Delgado is supported by an ISCIII research contract (Programa Rio-Hortega). Also co-financiated by Fondo Europeo de Desarrollo Regional (FEDER). The CIBEROBN is an initiative of the Instituto de Salud Carlos III, Madrid, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDRES R, 1980, INT J OBESITY, V4, P381; Ascaso JF, 2003, DIABETES CARE, V26, P3320, DOI 10.2337/diacare.26.12.3320; Baldassarre D, 2009, NUTR METAB CARDIOVAS, V19, P481, DOI 10.1016/j.numecd.2008.10.003; Balta S, 2015, INT J CARDIOL, V201, P331, DOI 10.1016/j.ijcard.2014.10.100; Bhatt DL, 2006, JAMA-J AM MED ASSOC, V295, P180, DOI 10.1001/jama.295.2.180; Boaz M, 2013, CLIN NEPHROL, V80, P449, DOI 10.5414/CN108067; Calori G, 2011, DIABETES CARE, V34, P210, DOI 10.2337/dc10-0665; Cingoz F, 2014, CLIN APPL THROMB-HEM, V20, P393, DOI 10.1177/1076029613485283; CROUSE JR, 1995, CIRCULATION, V92, P1141, DOI 10.1161/01.CIR.92.5.1141; Davis PH, 2001, CIRCULATION, V104, P2815, DOI 10.1161/hc4601.099486; Eckel RH, 1998, CIRCULATION, V97, P2099, DOI 10.1161/01.CIR.97.21.2099; Gami AS, 2007, J AM COLL CARDIOL, V49, P403, DOI 10.1016/j.jacc.2006.09.032; Garcia-Rios A, 2014, CHRONOBIOL INT, V31, P401, DOI 10.3109/07420528.2013.864300; Hamer M, 2012, J CLIN ENDOCR METAB, V97, P2482, DOI 10.1210/jc.2011-3475; Han QF, 2016, INT J CARDIOL, V203, P1144, DOI 10.1016/j.ijcard.2015.10.236; Karelis AD, 2005, J CLIN ENDOCR METAB, V90, P4145, DOI 10.1210/jc.2005-0482; Karelis AD, 2004, J CLIN ENDOCR METAB, V89, P2569, DOI 10.1210/jc.2004-0165; Katsuki A, 2003, DIABETES CARE, V26, P2341, DOI 10.2337/diacare.26.8.2341; Katz P, 2014, DIABETES VASC DIS RE, V11, P395, DOI 10.1177/1479164114546854; Kenchaiah S, 2002, NEW ENGL J MED, V347, P305, DOI 10.1056/NEJMoa020245; Kim Hyun Soo, 2013, J Cardiovasc Ultrasound, V21, P72, DOI 10.4250/jcu.2013.21.2.72; Kip KE, 2004, CIRCULATION, V109, P706, DOI 10.1161/01.CIR.0000115514.44135.A8; Klein S, 2004, CIRCULATION, V110, P2952, DOI 10.1161/01.CIR.0000145546.97738.1E; Lopez-Miranda J, 2013, CLIN ENDOCRINOL, V79, P314, DOI 10.1111/cen.12181; Lorenz MW, 2007, CIRCULATION, V115, P459, DOI 10.1161/CIRCULATIONAHA.106.628875; Marini MA, 2007, DIABETES CARE, V30, P2145, DOI 10.2337/dc07-0419; Park J, 2011, J HYPERTENS, V29, P1765, DOI 10.1097/HJH.0b013e32834a50f3; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; Roberson LL, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-14; Rothwell PM, 2005, LANCET, V366, P1773, DOI 10.1016/S0140-6736(05)67702-1; Ruderman N, 1998, DIABETES, V47, P699, DOI 10.2337/diabetes.47.5.699; RUDERMAN NB, 1981, AM J CLIN NUTR, V34, P1617, DOI 10.1093/ajcn/34.8.1617; Ryden L, 2013, EUR HEART J, V34, P3035, DOI 10.1093/eurheartj/eht108; SIMS EAH, 1982, JAMA-J AM MED ASSOC, V247, P49, DOI 10.1001/jama.247.1.49; Song YQ, 2007, AM J CARDIOL, V100, P1654, DOI 10.1016/j.amjcard.2007.06.073; Stein JH, 2008, J AM SOC ECHOCARDIOG, V21, P93, DOI 10.1016/j.echo.2007.11.011; Unlu M, 2013, ARQ BRAS CARDIOL, V100, P585, DOI 10.5935/abc.20130121; Wildman RP, 2008, ARCH INTERN MED, V168, P1617, DOI 10.1001/archinte.168.15.1617	39	10	12	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2016	11	4							e0153096	10.1371/journal.pone.0153096	http://dx.doi.org/10.1371/journal.pone.0153096			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0KH	27064675	Green Submitted, Green Published, gold			2022-12-27	WOS:000373891000029
J	Balakrishnan, A; Stykel, MG; Touahri, Y; Stratton, JA; Biernaskie, J; Schuurmans, C				Balakrishnan, Anjali; Stykel, Morgan G.; Touahri, Yacine; Stratton, Jo Anne; Biernaskie, Jeff; Schuurmans, Carol			Temporal Analysis of Gene Expression in the Murine Schwann Cell Lineage and the Acutely Injured Postnatal Nerve	PLOS ONE			English	Article							TRANSCRIPTION FACTOR SOX10; NEURAL CREST DEVELOPMENT; STEM-CELLS; GLIAL-CELLS; PERIPHERAL-NERVE; C-JUN; EMBRYONIC-DEVELOPMENT; MYELIN MAINTENANCE; REGULATORY NETWORK; FACTOR ERM	Schwann cells (SCs) arise from neural crest cells (NCCs) that first give rise to SC precursors (SCPs), followed by immature SCs, pro-myelinating SCs, and finally, non-myelinating or myelinating SCs. After nerve injury, mature SCs 'de-differentiate', downregulating their myelination program while transiently re-activating early glial lineage genes. To better understand molecular parallels between developing and de-differentiated SCs, we characterized the expression profiles of a panel of 12 transcription factors from the onset of NCC migration through postnatal stages, as well as after acute nerve injury. Using Sox10 as a pan-glial marker in co-expression studies, the earliest transcription factors expressed in E9.0 Sox10(+) NCCs were Sox9, Pax3, AP2a and Nfatc4. E10.5 Sox10(+) NCCs coalescing in the dorsal root ganglia differed slightly, expressing Sox9, Pax3, AP2a and Etv5. E12.5 SCPs continued to express Sox10, Sox9, AP2 alpha and Pax3, as well as initiating Sox2 and Egr1 expression. E14.5 immature SCs were similar to SCPs, except that they lost Pax3 expression. By E18.5, AP2 alpha, Sox2 and Egr1 expression was turned off in the nerve, while Jun, Oct6 and Yy1 expression was initiated in pro-myelinating Sox9(+)/Sox10(+) SCs. Early postnatal and adult SCs continued to express Sox9, Jun, Oct6 and Yy1 and initiated Nfatc4 and Egr2 expression. Notably, at all stages, expression of each marker was observed only in a subset of Sox10(+) SCs, highlighting the heterogeneity of the SC pool. Following acute nerve injury, Egr1, Jun, Oct6, and Sox2 expression was upregulated, Egr2 expression was downregulated, while Sox9, Yy1, and Nfatc4 expression was maintained at similar frequencies. Notably, de-differentiated SCs in the injured nerve did not display a transcription factor profile corresponding to a specific stage in the SC lineage. Taken together, we demonstrate that uninjured and injured SCs are heterogeneous and distinct from one another, and de-differentiation recapitulates transcriptional aspects of several different embryonic stages.	[Balakrishnan, Anjali; Touahri, Yacine; Schuurmans, Carol] Univ Calgary, Alberta Childrens Hosp, Dept Biochem & Mol Biol, Cumming Sch Med,Res Inst, Calgary, AB T2N 4N1, Canada; [Balakrishnan, Anjali; Stykel, Morgan G.; Touahri, Yacine; Stratton, Jo Anne; Biernaskie, Jeff; Schuurmans, Carol] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB T2N 4N1, Canada; [Stykel, Morgan G.; Touahri, Yacine; Stratton, Jo Anne; Biernaskie, Jeff] Univ Calgary, Alberta Childrens Hosp, Dept Comparat Biol & Expt Med, Fac Vet Med,Res Inst, Calgary, AB T2N 4N1, Canada; [Stratton, Jo Anne] Univ Calgary, Alberta Childrens Hosp, Dept Clin Neurosci, Cumming Sch Med,Res Inst, Calgary, AB T2N 4N1, Canada	Alberta Childrens Hospital; University of Calgary; University of Calgary; Alberta Childrens Hospital; University of Calgary; Alberta Childrens Hospital; University of Calgary	Schuurmans, C (corresponding author), Univ Calgary, Alberta Childrens Hosp, Dept Biochem & Mol Biol, Cumming Sch Med,Res Inst, Calgary, AB T2N 4N1, Canada.; Biernaskie, J; Schuurmans, C (corresponding author), Univ Calgary, Hotchkiss Brain Inst, Calgary, AB T2N 4N1, Canada.; Biernaskie, J (corresponding author), Univ Calgary, Alberta Childrens Hosp, Dept Comparat Biol & Expt Med, Fac Vet Med,Res Inst, Calgary, AB T2N 4N1, Canada.	jabierna@ucalgary.ca; cschuurm@ucalgary.ca		Stykel, Morgan/0000-0002-4799-4220; Schuurmans, Carol/0000-0003-3567-0058; Stratton, Jo/0000-0002-1205-1353	Alberta Innovates Health Solutions [201200859]; Alberta Innovates [201200859] Funding Source: researchfish	Alberta Innovates Health Solutions; Alberta Innovates	This work was supported by Alberta Innovates Health Solutions Grant #: 201200859 (http://www.aihealthsolutions.ca/) to JB and CS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adameyko I, 2012, DEVELOPMENT, V139, P397, DOI 10.1242/dev.065581; Adameyko I, 2010, CELL MOL LIFE SCI, V67, P3037, DOI 10.1007/s00018-010-0390-y; Adameyko I, 2009, CELL, V139, P366, DOI 10.1016/j.cell.2009.07.049; Arroyo EJ, 1998, J NEUROSCI, V18, P7891; Arthur-Farraj PJ, 2012, NEURON, V75, P633, DOI 10.1016/j.neuron.2012.06.021; Blake JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059184; Blanchard AD, 1996, J NEUROSCI RES, V46, P630, DOI 10.1002/(SICI)1097-4547(19961201)46:5<630::AID-JNR11>3.0.CO;2-0; Bondurand N, 2001, HUM MOL GENET, V10, P2783, DOI 10.1093/hmg/10.24.2783; Bremer M, 2011, GLIA, V59, P1022, DOI 10.1002/glia.21173; Britsch S, 2001, GENE DEV, V15, P66, DOI 10.1101/gad.186601; Buchstaller J, 2004, J NEUROSCI, V24, P2357, DOI 10.1523/JNEUROSCI.4083-03.2004; Chen Y, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-9; Cheung M, 2003, DEVELOPMENT, V130, P5681, DOI 10.1242/dev.00808; ChotteauLelievre A, 1997, ONCOGENE, V15, P937, DOI 10.1038/sj.onc.1201261; D'Antonio M, 2006, GLIA, V53, P501, DOI 10.1002/glia.20309; Decker L, 2006, J NEUROSCI, V26, P9771, DOI 10.1523/JNEUROSCI.0716-06.2006; Ellis P, 2004, DEV NEUROSCI-BASEL, V26, P148, DOI 10.1159/000082134; Feltri ML, 2016, NEUROSCIENTIST, V22, P252, DOI 10.1177/1073858415572361; Finzsch M, 2010, J CELL BIOL, V189, P701, DOI 10.1083/jcb.200912142; Fontana X, 2012, J CELL BIOL, V198, P127, DOI 10.1083/jcb.201205025; FU SY, 1995, J NEUROSCI, V15, P3886; Fu SY, 1997, MOL NEUROBIOL, V14, P67, DOI 10.1007/BF02740621; Gao XG, 2007, MOL CELL NEUROSCI, V36, P501, DOI 10.1016/j.mcn.2007.08.013; Ghazvini M, 2002, EMBO J, V21, P4612, DOI 10.1093/emboj/cdf475; Ghislain J, 2006, EMBO REP, V7, P52, DOI 10.1038/sj.embor.7400573; Goethals S, 2010, GLIA, V58, P1701, DOI 10.1002/glia.21041; GOULDING MD, 1991, EMBO J, V10, P1135, DOI 10.1002/j.1460-2075.1991.tb08054.x; Gracz AD, 2010, AM J PHYSIOL-GASTR L, V298, pG590, DOI 10.1152/ajpgi.00470.2009; Hagedorn L, 2000, DEV BIOL, V219, P44, DOI 10.1006/dbio.1999.9595; He Y, 2010, NAT NEUROSCI, V13, P1472, DOI 10.1038/nn.2686; Jagalur NB, 2011, J NEUROSCI, V31, P8585, DOI 10.1523/JNEUROSCI.0659-11.2011; Jessen KR, 2005, NAT REV NEUROSCI, V6, P671, DOI 10.1038/nrn1746; Jessen KR, 2008, GLIA, V56, P1552, DOI 10.1002/glia.20761; Jessen KR, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020487; Jones EA, 2007, NEURON GLIA BIOL, V3, P377, DOI 10.1017/S1740925X08000173; Kao SC, 2009, SCIENCE, V323, P651, DOI 10.1126/science.1166562; Kawasaki T, 2003, ACTA NEUROPATHOL, V105, P203, DOI 10.1007/s00401-002-0630-9; Kim J, 2003, NEURON, V38, P17, DOI 10.1016/S0896-6273(03)00163-6; Kioke T, 2014, HISTOCHEM CELL BIOL, V141, P301, DOI 10.1007/s00418-013-1158-x; KIOUSSI C, 1995, NEURON, V15, P553, DOI 10.1016/0896-6273(95)90144-2; Kuhlbrodt K, 1998, J NEUROSCI, V18, P237, DOI 10.1523/jneurosci.18-01-00237.1998; Le Douarin M.L., 1999, NEURAL CREST; Le Douarin NM, 2003, CURR OPIN GENET DEV, V13, P529, DOI 10.1016/j.gde.2003.08.002; Le N, 2005, P NATL ACAD SCI USA, V102, P2596, DOI 10.1073/pnas.0407836102; LeBlanc SE, 2007, MOL CELL BIOL, V27, P3521, DOI 10.1128/MCB.01689-06; LEMAIRE P, 1990, MOL CELL BIOL, V10, P3456, DOI 10.1128/MCB.10.7.3456; Maro GS, 2004, NAT NEUROSCI, V7, P930, DOI 10.1038/nn1299; Meier C, 1999, J NEUROSCI, V19, P3847; Miller SJ, 2009, EMBO MOL MED, V1, P236, DOI 10.1002/emmm.200900027; Mirsky R, 2008, J PERIPHER NERV SYST, V13, P122, DOI 10.1111/j.1529-8027.2008.00168.x; Monk KR, 2015, GLIA, V63, P1376, DOI 10.1002/glia.22852; Nakazaki H, 2009, INT J DEV BIOL, V53, P69, DOI 10.1387/ijdb.082682hn; Newbern J, 2010, SEMIN CELL DEV BIOL, V21, P922, DOI 10.1016/j.semcdb.2010.08.008; Pannese E, 2010, NEURON GLIA BIOL, V6, P3, DOI 10.1017/S1740925X10000037; Paratore C, 2002, DEV BIOL, V250, P168, DOI 10.1006/dbio.2002.0795; Paratore C, 2001, DEVELOPMENT, V128, P3949; Parkinson DB, 2008, J CELL BIOL, V181, P625, DOI 10.1083/jcb.200803013; Parkinson DB, 2004, J CELL BIOL, V164, P385, DOI 10.1083/jcb.200307132; Peirano RI, 2000, NUCLEIC ACIDS RES, V28, P3047, DOI 10.1093/nar/28.16.3047; Pham K, 2009, NEUROSCI LETT, V465, P194, DOI 10.1016/j.neulet.2009.09.014; Reiprich S, 2010, J NEUROCHEM, V112, P744, DOI 10.1111/j.1471-4159.2009.06498.x; Ryu EJ, 2007, J NEUROSCI, V27, P11552, DOI 10.1523/JNEUROSCI.5497-06.2007; Sauka-Spengler T, 2008, NAT REV MOL CELL BIO, V9, P557, DOI 10.1038/nrm2428; Scott CE, 2010, NAT NEUROSCI, V13, P1181, DOI 10.1038/nn.2646; Spokony RF, 2002, DEVELOPMENT, V129, P421; Stewart HJS, 2001, EUR J NEUROSCI, V14, P363, DOI 10.1046/j.0953-816x.2001.01650.x; Stoll G, 1999, BRAIN PATHOL, V9, P313; Stratton JA, 2016, EUR J NEUROSCI, V43, P365, DOI 10.1111/ejn.13006; Taveggia C, 2005, NEURON, V47, P681, DOI 10.1016/j.neuron.2005.08.017; Topilko P, 1997, J NEUROSCI RES, V50, P702, DOI 10.1002/(SICI)1097-4547(19971201)50:5<702::AID-JNR7>3.0.CO;2-L; Touahri Yacine, 2015, Curr Protoc Neurosci, V70, DOI 10.1002/0471142301.ns0122s70; Vidal VPI, 2005, CURR BIOL, V15, P1340, DOI 10.1016/j.cub.2005.06.064; Wakamatsu Y, 2004, DEV DYNAM, V229, P74, DOI 10.1002/dvdy.10498; Wang JJ, 2014, DIAM RELAT MATER, V43, P43, DOI 10.1016/j.diamond.2014.01.007; WHITE FV, 1989, J NEUROCHEM, V52, P1085, DOI 10.1111/j.1471-4159.1989.tb01851.x; Woodhoo A, 2009, NAT NEUROSCI, V12, P839, DOI 10.1038/nn.2323	76	27	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2016	11	4							e0153256	10.1371/journal.pone.0153256	http://dx.doi.org/10.1371/journal.pone.0153256			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6JK	27058953	Green Published, gold			2022-12-27	WOS:000373604800026
J	Huang, YN; Amin, A; Qin, Y; Wang, ZY; Jiang, HD; Liang, L; Shi, LJ; Liang, C				Huang, Yining; Amin, Aftab; Qin, Yan; Wang, Ziyi; Jiang, Huadong; Liang, Lu; Shi, Linjing; Liang, Chun			A Role of hIPI3 in DNA Replication Licensing in Human Cells	PLOS ONE			English	Article							ORIGIN RECOGNITION COMPLEX; LAMIN B2 ORIGIN; SACCHAROMYCES-CEREVISIAE; RIBOSOME BIOGENESIS; INITIATION PROTEINS; MCM COMPLEX; CHROMATIN; SUBUNITS; BINDING; YEAST	The yeast Ipi3p is required for DNA replication and cell viability in Sacharomyces cerevisiae. It is an essential component of the Rix1 complex (Rix1p/Ipi2p-Ipi1p-Ipi3p) that is required for the processing of 35S pre-rRNA in pre-60S ribosomal particles and for the initiation of DNA replication. The human IPI3 homolog is WDR18 (WD repeat domain 18), which shares significant homology with yIpi3p. Here we report that knockdown of hIPI3 resulted in substantial defects in the chromatin association of the MCM complex, DNA replication, cell cycle progression and cell proliferation. Importantly, hIPI3 silencing did not result in a reduction of the protein level of hCDC6, hMCM7, or the ectopically expressed GFP protein, indicating that protein synthesis was not defective in the same time frame of the DNA replication and cell cycle defects. Furthermore, the mRNA and protein levels of hIPI3 fluctuate in the cell cycle, with the highest levels from M phase to early G1 phase, similar to other pre-replicative (preRC) proteins. Moreover, hIPI3 interacts with other replication-initiation proteins, co-localizes with hMCM7 in the nucleus, and is important for the nuclear localization of hMCM7. We also found that hIPI3 preferentially binds to the origins of DNA replication including those at the cMyc, Lamin-B2 and beta-Globin loci. These results indicate that hIPI3 is involved in human DNA replication licensing independent of its role in ribosome biogenesis.	[Huang, Yining; Wang, Ziyi; Liang, Chun] Shenzhen PKU HKUST Med Ctr, Biomed Res Inst, Shenzhen, Peoples R China; [Huang, Yining; Amin, Aftab; Qin, Yan; Wang, Ziyi; Jiang, Huadong; Liang, Lu; Shi, Linjing; Liang, Chun] Hong Kong Univ Sci & Technol, Div Life Sci, Ctr Canc Res, Hong Kong, Hong Kong, Peoples R China; [Huang, Yining; Amin, Aftab; Qin, Yan; Wang, Ziyi; Jiang, Huadong; Liang, Lu; Shi, Linjing; Liang, Chun] Hong Kong Univ Sci & Technol, State Key Lab Mol Neurosci, Hong Kong, Hong Kong, Peoples R China; [Huang, Yining; Wang, Ziyi; Liang, Chun] HKUST Fok Ying Tung Res Inst, Guangzhou, Guangdong, Peoples R China; [Liang, Chun] Intelgen Ltd, Hong Kong, Hong Kong, Peoples R China	Hong Kong University of Science & Technology; Peking University; Shenzhen PKU-HKUST Medical Center; Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Hong Kong University of Science & Technology	Liang, C (corresponding author), Shenzhen PKU HKUST Med Ctr, Biomed Res Inst, Shenzhen, Peoples R China.; Liang, C (corresponding author), Hong Kong Univ Sci & Technol, Div Life Sci, Ctr Canc Res, Hong Kong, Hong Kong, Peoples R China.; Liang, C (corresponding author), Hong Kong Univ Sci & Technol, State Key Lab Mol Neurosci, Hong Kong, Hong Kong, Peoples R China.; Liang, C (corresponding author), Intelgen Ltd, Hong Kong, Hong Kong, Peoples R China.	bccliang@ust.hk		Amin, Aftab/0000-0003-3285-3422; HUANG, Yining/0000-0001-6370-5559; Shi, Linjing/0000-0002-3851-968X	Shenzhen Dept. of Science and Information [JCYJ20130329110752138]; Hong Kong Research Grants Council [GRF661508]; National Natural Science Foundation of China [31171282]; Center for Nasopharyngeal Carcinoma Research, Hong Kong [AoE/M-06/08]; Intelgen (HK) Limited	Shenzhen Dept. of Science and Information; Hong Kong Research Grants Council(Hong Kong Research Grants Council); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Center for Nasopharyngeal Carcinoma Research, Hong Kong; Intelgen (HK) Limited	This work was supported by the Shenzhen Dept. of Science and Information (JCYJ20130329110752138 to CL), Hong Kong Research Grants Council (GRF661508 to CL), National Natural Science Foundation of China (31171282 to CL), Center for Nasopharyngeal Carcinoma Research, Hong Kong (AoE/M-06/08), and Intelgen (HK) Limited.	Abdurashidova G, 2000, SCIENCE, V287, P2023, DOI 10.1126/science.287.5460.2023; Aladjem MI, 2004, FRONT BIOSCI-LANDMRK, V9, P2540, DOI 10.2741/1415; Bernstein KA, 2007, MOL BIOL CELL, V18, P953, DOI 10.1091/mbc.E06-06-0512; Bryant JA, 2011, ANN BOT-LONDON, V107, P1119, DOI 10.1093/aob/mcr075; Castle CD, 2012, MOL BIOL CELL, V23, P716, DOI 10.1091/mbc.E11-06-0530; Chen XM, 2013, NUCLEIC ACIDS RES, V41, P6460, DOI 10.1093/nar/gkt368; Chen ZQ, 2008, P NATL ACAD SCI USA, V105, P10326, DOI 10.1073/pnas.0803829105; Dominguez-Sola D, 2007, NATURE, V448, P445, DOI 10.1038/nature05953; Eward KL, 2004, J CELL SCI, V117, P5875, DOI 10.1242/jcs.01503; Fanis P, 2012, MOL CELL PROTEOMICS, V11, P1263, DOI 10.1074/mcp.M112.017194; Feng DR, 2003, CANCER RES, V63, P7356; Fragkos M, 2015, NAT REV MOL CELL BIO, V16, P360, DOI 10.1038/nrm4002; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Galani K, 2004, J BIOL CHEM, V279, P55411, DOI 10.1074/jbc.M406876200; Guzman C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092444; Harlow Ed, 2006, CSH Protoc, V2006, DOI 10.1101/pdb.prot4531; Huo L, 2012, CELL CYCLE, V11, P1325, DOI 10.4161/cc.19709; Kan JS, 2008, J BIOL CHEM, V283, P33803, DOI 10.1074/jbc.C800182200; Krogan NJ, 2004, MOL CELL, V13, P225, DOI 10.1016/S1097-2765(04)00003-6; Leonard AC, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a010116; Matsuda K, 2007, FEMS YEAST RES, V7, P1263, DOI 10.1111/j.1567-1364.2007.00298.x; Mechali M, 2001, NAT REV GENET, V2, P640, DOI 10.1038/35084598; Mendez J, 2002, MOL CELL, V9, P481, DOI 10.1016/S1097-2765(02)00467-7; Nissan TA, 2004, MOL CELL, V15, P295, DOI 10.1016/j.molcel.2004.06.033; Rajewska M, 2012, FEMS MICROBIOL REV, V36, P408, DOI 10.1111/j.1574-6976.2011.00300.x; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Shen Z, 2010, MOL CELL, V40, P99, DOI 10.1016/j.molcel.2010.09.021; Swarnalatha M, 2012, NUCLEIC ACIDS RES, V40, P9021, DOI 10.1093/nar/gks617; van Betteraey-Nikoleit M, 2003, EUR J BIOCHEM, V270, P3880, DOI 10.1046/j.1432-1033.2003.03769.x; Wells J, 2002, METHODS, V26, P48, DOI 10.1016/S1046-2023(02)00007-5; Wu RT, 2012, J CELL SCI, V125, P209, DOI 10.1242/jcs.094169; Yoshida K, 2004, ONCOGENE, V23, P3802, DOI 10.1038/sj.onc.1207488; Yu ZL, 2004, J MOL BIOL, V340, P1197, DOI 10.1016/j.jmb.2004.05.024; Zhai Y., 2011, FUNDAMENTAL ASPECTS; Zhai YL, 2010, J CELL SCI, V123, P3933, DOI 10.1242/jcs.075366; Zhang JJ, 2010, CELL CYCLE, V9, P4848, DOI 10.4161/cc.9.24.14136; Zhang X, 2014, MOL CANCER RES, V12, P1535, DOI 10.1158/1541-7786.MCR-13-0641	37	6	6	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2016	11	4							e0151803	10.1371/journal.pone.0151803	http://dx.doi.org/10.1371/journal.pone.0151803			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6JK	27057756	Green Published, Green Submitted, gold			2022-12-27	WOS:000373604800003
J	Lin, PC; Lin, WT; Yeh, YH; Wung, SF				Lin, Pei-Chao; Lin, Wei-Ting; Yeh, Yao-Hsien; Wung, Shu-Fen			Transcription Factor 7-Like 2 (TCF7L2) rs7903146 Polymorphism as a Risk Factor for Gestational Diabetes Mellitus: A Meta-Analysis	PLOS ONE			English	Article							BETWEEN-STUDY HETEROGENEITY; GENOME-WIDE ASSOCIATION; GENETIC-VARIANTS; INSULIN-RESISTANCE; GLUCOSE; WOMEN; PREGNANCY; HYPERGLYCEMIA; METABOLISM; EXPRESSION	Background There are racial and ethnic differences in the prevalence of gestational diabetes mellitus (GDM). Prior meta-analyses included small samples and very limited non-Caucasian populations. Studies to determine the relationship between transcription factor 7 like-2 (TCF7L2) rs7903146 polymorphism and risk of GDM in Hispanics/Latinos are recently available. The present meta-analysis was to estimate the impact of allele variants of TCF7L2 rs7903146 polymorphism on GDM susceptibility in overall population and racial/ethnic subgroups. Methods Literature was searched in multiple databases including PubMed, Web of Science, EMBASE (Ovid SP), Airiti Library, Medline Complete, and ProQuest up to July 2015. Allelic frequency for TCF7L2 rs7903146 polymorphism in GDM and control subjects was extracted and statistical analysis was performed using Comprehensive Meta-Analysis (CMA) 2.0 statistical software. The association between TCF7L2 rs7903146 polymorphism and GDM risk was assessed by pooled odd ratios (ORs) using five gene models (dominant, recessive, homozygote, heterozygote, and allele). Stratified analysis based on race/ethnicity was also conducted. The between-study heterogeneity and contribution of each single study to the final result was tested by Cochran Q test and sensitivity analyses, respectively. Publication bias was evaluated using Egger's linear regression test. Results A total of 16 studies involving 4,853 cases and 10,631 controls were included in this meta-analysis. Significant association between the T-allele of rs7903146 and GDM risk was observed under all genetic models, dominant model (OR = 1.44, 95% CI = 1.19-1.74), recessive model (OR = 1.35, 95% CI = 1.08-1.70), heterozygous model (OR = 1.31, 95% CI = 1.12-1.53), homozygous model (OR = 1.67, 95% CI = 1.31-2.12), and allele model (OR = 1.31, 95% CI = 1.12-1.53). Stratified analysis by race/ethnicity showed a statistically significant association between rs7903146 polymorphism and susceptibility to GDM under homozygous genetic model (TT versus CC) among whites, Hispanics/Latinos and Asians. Sensitivity analysis showed that the overall findings were robust to potentially influential decisions of the 16 studies included. No significant evidence for publication bias was observed in this meta-analysis for overall studies and subgroup studies. Conclusions This meta-analysis showed that the T allele of TCF7L2 rs7903146 polymorphism was associated with susceptibility of GDM in overall population in white, Hispanic/Latino and Asian sub-groups. Asians with homozygous TT allele of rs7903146 polymorphism have highest risk of GDM (OR = 2.08) followed by Hispanics/Latinos (OR = 1.80) and whites (OR = 1.51). The highest and lowest frequency of T allele of rs7903146 was found in Malaysia and South Korea, respectively. Future studies are needed to profile genetic risk for GDM among high risk Asian and Pacific Islander subgroups.	[Lin, Pei-Chao; Lin, Wei-Ting] Kaohsiung Med Univ, Coll Nursing, Kaohsiung, Taiwan; [Yeh, Yao-Hsien] Natl Cheng Kung Univ Hosp, Dept Occupat & Environm Med, Tainan 70428, Taiwan; [Yeh, Yao-Hsien] Natl Cheng Kung Univ, Coll Med, Dept Environm & Occupat Hlth, Tainan 70101, Taiwan; [Wung, Shu-Fen] Univ Arizona, Coll Nursing, Tucson, AZ 85721 USA	Kaohsiung Medical University; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; University of Arizona	Wung, SF (corresponding author), Univ Arizona, Coll Nursing, Tucson, AZ 85721 USA.	wung@arizona.edu	Kasemy, Zeinab/GWV-2831-2022; Kasemy, Zeinab A./R-2399-2018; Kasemy, Zeinab A./GRX-6231-2022; Kasemy, Zeinab A/GWR-2262-2022	Kasemy, Zeinab A./0000-0002-3187-3088; Kasemy, Zeinab A./0000-0002-3187-3088; Kasemy, Zeinab A/0000-0002-3187-3088; Lin, Wei-Ting/0000-0002-7602-5592; Wung, Shu-Fen/0000-0002-7606-8728; Lin, Pei-Chao/0000-0002-1495-2550	Kaohsiung Medical University Research Foundation [KMU-Q105009]; University of Arizona	Kaohsiung Medical University Research Foundation; University of Arizona	This meta-analysis was supported by a grant from the Kaohsiung Medical University Research Foundation (KMU-Q105009). The University of Arizona Open Access Publishing Fund provides full support of the publication fee.	Alibegovic AC, 2010, DIABETES, V59, P836, DOI 10.2337/db09-0918; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc13-S067, 10.2337/dc10-S062, 10.2337/dc12-s064, 10.2337/dc11-S062]; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; American Diabetes Association, 2004, DIABETES CARE S1, V27, pS88, DOI [10.2337/diacare.27.2007.S88, DOI 10.2337/DIACARE.27.2007.S88]; Ao D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128901; Bellamy L, 2009, LANCET, V373, P1773, DOI 10.1016/S0140-6736(09)60731-5; Borenstein M., 2009, INTRO METAANALYSIS; CARPENTER MW, 1982, AM J OBSTET GYNECOL, V144, P768, DOI 10.1016/0002-9378(82)90349-0; Cauchi S, 2007, J MOL MED, V85, P777, DOI 10.1007/s00109-007-0203-4; Chen YZ, 2009, POPUL HEALTH MANAG, V12, P165, DOI 10.1089/pop.2009.12303; Cho YM, 2009, DIABETOLOGIA, V52, P253, DOI 10.1007/s00125-008-1196-4; Chu SY, 2009, PREV MED, V49, P265, DOI 10.1016/j.ypmed.2009.07.001; Damcott CM, 2006, DIABETES, V55, P2654, DOI 10.2337/db06-0338; DAMM P, 1993, OBSTET GYNECOL, V82, P251; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Egger M., 2008, SYSTEMATIC REV HLTH; Elbein SC, 2007, DIABETOLOGIA, V50, P1621, DOI 10.1007/s00125-007-0717-x; Florez JC, 2007, CURR OPIN CLIN NUTR, V10, P391, DOI 10.1097/MCO.0b013e3281e2c9be; Freathy RM, 2010, DIABETES, V59, P2682, DOI 10.2337/db10-0177; Frigeri HR, 2015, CLIN BIOCH; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Han XL, 2015, ARCH GYNECOL OBSTET, V292, P291, DOI 10.1007/s00404-015-3635-z; Hansson O, 2010, CURR DIABETES REP, V10, P444, DOI 10.1007/s11892-010-0149-8; Harlev A, 2010, CURR DIABETES REP, V10, P242, DOI 10.1007/s11892-010-0113-7; HARRIS M, 1979, DIABETES, V28, P1039; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Huerta-Chagoya A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126408; Huopio H, 2013, EUR J ENDOCRINOL, V169, P291, DOI 10.1530/EJE-13-0286; Jackson D, 2012, STAT MED, V31, P3805, DOI 10.1002/sim.5453; Kang S, 2013, GYNECOL ENDOCRINOL, V29, P873, DOI 10.3109/09513590.2013.813469; Katsarou A, 2007, DIABETOLOGIA, V50, pS138; Khder A, 2013, ENDOCR REV, P34; Kim Shin Y, 2012, Prev Chronic Dis, V9, pE88; Klein K, 2012, J MATERN-FETAL NEO M, V25, P1783, DOI 10.3109/14767058.2012.663831; KUHL C, 1975, ACTA ENDOCRINOL-COP, V79, P709, DOI 10.1530/acta.0.0790709; Kwak SH, 2012, DIABETES, V61, P531, DOI 10.2337/db11-1034; Lauenborg J, 2009, J CLIN ENDOCR METAB, V94, P145, DOI 10.1210/jc.2008-1336; LIND T, 1991, DIABETES, V40, P8, DOI 10.2337/diab.40.2.S8; Lopez-Reyes R, 2013, ENDOCRINE REV, V34; Lyssenko V, 2007, J CLIN INVEST, V117, P2155, DOI 10.1172/JCI30706; Mao H, 2012, PLOS ONE, V7; McDonald J.H, 2014, HDB BIOL STAT, V3rd; Metzger BE, 1998, DIABETES CARE, V21, pB161; Metzger BE, 2010, DIABETES CARE, V33, P676, DOI 10.2337/dc09-1848; Mohd Aris NK., 2011, ASIA PAC J MOL BIOL, V2011, P1; Pagan A, 2014, EUR J OBSTET GYN R B, V180, P77, DOI 10.1016/j.ejogrb.2014.06.024; Papadopoulou A, 2011, DIABETIC MED, V28, P1018, DOI 10.1111/j.1464-5491.2011.03359.x; Pappa KI, 2011, GYNECOL ENDOCRINOL, V27, P267, DOI 10.3109/09513590.2010.490609; Pasek RC, 2013, AM J PHYSIOL-ENDOC M, V305, pE1327, DOI 10.1152/ajpendo.00425.2013; Patsopoulos NA, 2008, INT J EPIDEMIOL, V37, P1148, DOI 10.1093/ije/dyn065; Potasso L, 2014, DIABETOLOGIA, V57, pS450; Potasso L, 2012, DIABETOLOGIA, V55, pS443; Reyes-Lopez R, 2014, DIABETES-METAB RES, V30, P701, DOI 10.1002/dmrr.2538; Rizk NM, 2011, DIABETES, V60, pA643; Rulifson IC, 2007, P NATL ACAD SCI USA, V104, P6247, DOI 10.1073/pnas.0701509104; Savitz DA, 2008, BJOG-INT J OBSTET GY, V115, P969, DOI 10.1111/j.1471-0528.2008.01763.x; Shaat N, 2007, DIABETOLOGIA, V50, P972, DOI 10.1007/s00125-007-0623-2; SHELLEYJONES DC, 1993, AUST NZ J OBSTET GYN, V33, P114, DOI 10.1111/j.1479-828X.1993.tb02371.x; Shi Xiling, 2014, Zhonghua Fu Chan Ke Za Zhi, V49, P588; Thomas N, 2014, END ABSTR, DOI [10.1530/endoabs.34.p270, DOI 10.1530/ENDOABS.34.P270]; Vcelak J, 2012, PHYSIOL RES, V61, P229, DOI 10.33549/physiolres.932272; Vejrazkova D, 2013, DIABETOLOGIA, V56, pS511; Weedon MN, 2007, DIABETIC MED, V24, P1062, DOI 10.1111/j.1464-5491.2007.02258.x; Wung Shu-Fen, 2011, Annu Rev Nurs Res, V29, P227; Yaghootkar H, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-3-203; Yi FH, 2005, J BIOL CHEM, V280, P1457, DOI 10.1074/jbc.M411487200; Zhou YD, 2014, HUM MOL GENET, V23, P6419, DOI 10.1093/hmg/ddu359; Zhu YY, 2016, CURR DIABETES REP, V16, DOI 10.1007/s11892-015-0699-x	68	19	19	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2016	11	4							e0153044	10.1371/journal.pone.0153044	http://dx.doi.org/10.1371/journal.pone.0153044			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6JK	27058589	Green Published, gold			2022-12-27	WOS:000373604800015
J	Alari-Pahissa, E; Grandclement, C; Jeevan-Raj, B; Leclercq, G; Veillette, A; Held, W				Alari-Pahissa, Elisenda; Grandclement, Camille; Jeevan-Raj, Beena; Leclercq, Georges; Veillette, Andre; Held, Werner			Activation by SLAM Family Receptors Contributes to NK Cell Mediated "Missing-Self" Recognition	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; H-2-DEFICIENT LYMPHOMA VARIANTS; HEMATOPOIETIC-CELLS; GRAFT-REJECTION; BONE-MARROW; TOLERANCE; EXPRESSION; SURVEILLANCE; ENGAGEMENT; TRANSGENE	Natural Killer (NK) cells attack normal hematopoietic cells that do not express inhibitory MHC class I (MHC-I) molecules, but the ligands that activate NK cells remain incompletely defined. Here we show that the expression of the Signaling Lymphocyte Activation Molecule (SLAM) family members CD48 and Ly9 (CD229) by MHC-I-deficient tumor cells significantly contributes to NK cell activation. When NK cells develop in the presence of T cells or B cells that lack inhibitory MHC-I but express activating CD48 and Ly9 ligands, the NK cells' ability to respond to MHC-I-deficient tumor cells is severely compromised. In this situation, NK cells express normal levels of the corresponding activation receptors 2B4 (CD244) and Ly9 but these receptors are non-functional. This provides a partial explanation for the tolerance of NK cells to MHC-I-deficient cells in vivo. Activating signaling via 2B4 is restored when MHC-I-deficient T cells are removed, indicating that interactions with MHC-I-deficient T cells dominantly, but not permanently, impair the function of the 2B4 NK cell activation receptor. These data identify an important role of SLAM family receptors for NK cell mediated "missing-self" reactivity and suggest that NK cell tolerance in MHC-I mosaic mice is in part explained by an acquired dysfunction of SLAM family receptors.	[Alari-Pahissa, Elisenda; Grandclement, Camille; Jeevan-Raj, Beena; Held, Werner] Univ Lausanne, Dept Oncol, Ludwig Ctr Canc Res, CH-1066 Epalinges, Switzerland; [Leclercq, Georges] Univ Ghent, Dept Clin Chem Microbiol & Immunol, B-9000 Ghent, Belgium; [Veillette, Andre] McGill Univ, Dept Med, Montreal, PQ, Canada	University of Lausanne; Ghent University; McGill University	Held, W (corresponding author), Univ Lausanne, Dept Oncol, Ludwig Ctr Canc Res, CH-1066 Epalinges, Switzerland.	Werner.Held@unil.ch	Leclercq, Georges/H-9659-2017	Leclercq, Georges/0000-0002-1691-5294	Scheizerischer Nationalfonds [310030_159598]; Krensliga Schweiz [KFS-02736-02-2011]	Scheizerischer Nationalfonds; Krensliga Schweiz	This work was supported by 1. Scheizerischer Nationalfonds (www.snf.ch/) to WH, 310030_159598; and 2. Krensliga Schweiz (http://www.krebsliga.ch/de/fachpersonen/forschung/) to WH, KFS-02736-02-2011.	Bessoles S, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00349; Bessoles S, 2013, J IMMUNOL, V191, P5044, DOI 10.4049/jimmunol.1301971; BIX M, 1991, NATURE, V349, P329, DOI 10.1038/349329a0; Coudert JD, 2008, BLOOD, V111, P3571, DOI 10.1182/blood-2007-07-100057; Cruz-Munoz ME, 2009, NAT IMMUNOL, V10, P297, DOI 10.1038/ni.1693; Dong ZJ, 2009, NAT IMMUNOL, V10, P973, DOI 10.1038/ni.1763; Fauriat C, 2010, BLOOD, V115, P1166, DOI 10.1182/blood-2009-09-245746; Fernandez NC, 2005, BLOOD, V105, P4416, DOI 10.1182/blood-2004-08-3156; Guerra N, 2008, IMMUNITY, V28, P571, DOI 10.1016/j.immuni.2008.02.016; Guia S, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001608; HOGLUND P, 1991, P NATL ACAD SCI USA, V88, P10332, DOI 10.1073/pnas.88.22.10332; Ioannidis V, 2001, J IMMUNOL, V167, P6256, DOI 10.4049/jimmunol.167.11.6256; KARRE K, 1986, NATURE, V319, P675, DOI 10.1038/319675a0; Kim S, 2005, NATURE, V436, P709, DOI 10.1038/nature03847; Kim TJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep07157; Lee KM, 2006, BLOOD, V107, P3181, DOI 10.1182/blood-2005-01-0185; Lee KM, 2004, J EXP MED, V199, P1245, DOI 10.1084/jem.20031989; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; LIAO NS, 1991, SCIENCE, V253, P199, DOI 10.1126/science.1853205; LJUNGGREN HG, 1985, J EXP MED, V162, P1745, DOI 10.1084/jem.162.6.1745; OHLEN C, 1989, SCIENCE, V246, P666, DOI 10.1126/science.2814488; Oppenheim DE, 2005, NAT IMMUNOL, V6, P928, DOI 10.1038/ni1239; Raulet DH, 2006, SEMIN IMMUNOL, V18, P145, DOI 10.1016/j.smim.2006.03.003; Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Sun JC, 2008, J EXP MED, V205, P1819, DOI 10.1084/jem.20072448; Tripathy SK, 2008, J EXP MED, V205, P1829, DOI 10.1084/jem.20072446; Van Beneden K, 2001, J IMMUNOL, V166, P4302, DOI 10.4049/jimmunol.166.7.4302; Veillette A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002469; ZIJLSTRA M, 1992, J EXP MED, V175, P885, DOI 10.1084/jem.175.4.885	30	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153236	10.1371/journal.pone.0153236	http://dx.doi.org/10.1371/journal.pone.0153236			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27054584	Green Published, gold, Green Submitted			2022-12-27	WOS:000373608000108
J	Dorr, CR; Freedman, BI; Hicks, PJ; Brown, WM; Russell, GB; Julian, BA; Pastan, SO; Gautreaux, MD; Muthusamy, A; Chinnakotla, S; Hauptfeld, V; Bray, RA; Kirk, AD; Divers, J; Israni, AK				Dorr, Casey R.; Freedman, Barry I.; Hicks, Pamela J.; Brown, W. Mark; Russell, Gregory B.; Julian, Bruce A.; Pastan, Stephen O.; Gautreaux, Michael D.; Muthusamy, Amutha; Chinnakotla, Srinath; Hauptfeld, Vera; Bray, Robert A.; Kirk, Allan D.; Divers, Jasmin; Israni, Ajay K.			Deceased-Donor Apolipoprotein L1 Renal-Risk Variants Have Minimal Effects on Liver Transplant Outcomes	PLOS ONE			English	Article							KIDNEY-TRANSPLANTATION; AFRICAN-AMERICANS; APOL1; DISEASE; GENE; ASSOCIATIONS; NEPHROPATHY; FAILURE; PROTEIN; TISSUE	Background Apolipoprotein L1 gene (APOL1) G1 and G2 renal-risk variants, common in populations with recent African ancestry, are strongly associated with non-diabetic nephropathy, end-stage kidney disease, and shorter allograft survival in deceased-donor kidneys (autosomal recessive inheritance). Circulating APOL1 protein is synthesized primarily in the liver and hydrodynamic gene delivery of APOL1 G1 and G2 risk variants has caused hepatic necrosis in a murine model. Methods To evaluate the impact of these variants in liver transplantation, this multicenter study investigated the association of APOL1 G1 and G2 alleles in deceased African American liver donors with allograft survival. Transplant recipients were followed for liver allograft survival using data from the Scientific Registry of Transplant Recipients. Results Of the 639 liver donors evaluated, 247 had no APOL1 risk allele, 300 had 1 risk allele, and 92 had 2 risk alleles. Graft failure assessed at 15 days, 6 months, 1 year and total was not significantly associated with donor APOL1 genotype (p-values = 0.25, 0.19, 0.67 and 0.89, respectively). Conclusions In contrast to kidney transplantation, deceased-donor APOL1 G1 and G2 risk variants do not significantly impact outcomes in liver transplantation.	[Dorr, Casey R.; Muthusamy, Amutha; Israni, Ajay K.] Minneapolis Med Res Fdn Inc, Minneapolis, MN USA; [Dorr, Casey R.; Israni, Ajay K.] Univ Minnesota, Dept Med, Hennepin Cty Med Ctr, Box 736 UMHC, Minneapolis, MN 55455 USA; [Freedman, Barry I.] Wake Forest Sch Med, Nephrol Sect, Dept Internal Med, Winston Salem, NC USA; [Freedman, Barry I.; Hicks, Pamela J.] Wake Forest Sch Med, Ctr Genom & Personalized Med Res, Winston Salem, NC USA; [Brown, W. Mark; Russell, Gregory B.; Divers, Jasmin] Wake Forest Sch Med, Dept Biostat, Winston Salem, NC USA; [Julian, Bruce A.] Univ Alabama Birmingham, Sch Med, Dept Med, Div Nephrol, Birmingham, AL USA; [Pastan, Stephen O.] Emory Univ, Sch Med, Dept Med, Div Renal, Atlanta, GA USA; [Gautreaux, Michael D.] Wake Forest Sch Med, Gen Surg & HLA Immunogenet Lab, Winston Salem, NC USA; [Chinnakotla, Srinath] Univ Minnesota, Dept Surg, Box 242 UMHC, Minneapolis, MN 55455 USA; [Hauptfeld, Vera] Univ Alabama Birmingham, Sch Med, UAB, Alabama Reg Histocompatibil Lab, Birmingham, AL USA; [Bray, Robert A.] Emory Sch Med, Dept Pathol & Lab Med, Atlanta, GA USA; [Kirk, Allan D.] Duke Univ, Sch Med, Dept Surg, Durham, NC USA; [Israni, Ajay K.] Univ Minnesota, Sch Med, Dept Epidemiol & Community Hlth, Minneapolis, MN 55455 USA	Minneapolis Medical Research Foundation; Hennepin County Medical Center; University of Minnesota System; University of Minnesota Twin Cities; Wake Forest University; Wake Forest University; Wake Forest University; University of Alabama System; University of Alabama Birmingham; Emory University; Wake Forest University; University of Minnesota System; University of Minnesota Twin Cities; University of Alabama System; University of Alabama Birmingham; Emory University; Duke University; University of Minnesota System; University of Minnesota Twin Cities	Israni, AK (corresponding author), Minneapolis Med Res Fdn Inc, Minneapolis, MN USA.; Israni, AK (corresponding author), Univ Minnesota, Dept Med, Hennepin Cty Med Ctr, Box 736 UMHC, Minneapolis, MN 55455 USA.; Israni, AK (corresponding author), Univ Minnesota, Sch Med, Dept Epidemiol & Community Hlth, Minneapolis, MN 55455 USA.	isran001@umn.edu	Brown, William/GXN-2777-2022; Pastan, Stephen/AAC-6622-2022	Dorr, Casey/0000-0002-6108-280X; Kirk, Allan/0000-0003-2004-5962	NIH [RO1 DK070941, RO1 DK084149, RO1 MD009055]; NIH/NIAD Genomics of Transplantation [5U19-AI070119]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI070119] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084149, R01DK070941] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R01MD009055] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NIAD Genomics of Transplantation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	Research support was provided by NIH RO1 DK070941 (BIF), NIH RO1 DK084149 (BIF), NIH RO1 MD009055 (JD, BIF), and NIH/NIAD Genomics of Transplantation 5U19-AI070119 (AKI).	Cheng DM, 2015, J LIPID RES, V56, P1583, DOI 10.1194/jlr.M059733; Duchateau PN, 2000, J LIPID RES, V41, P1231; Duchateau PN, 2001, J LIPID RES, V42, P620; Freedman BI, 2015, AM J TRANSPLANT, V15, P1615, DOI 10.1111/ajt.13223; Freedman BI, 2016, TRANSPLANTATION, V100, P194, DOI 10.1097/TP.0000000000000969; Freedman BI, 2015, KIDNEY INT, V87, P176, DOI 10.1038/ki.2014.255; Freedman BI, 2015, AM J TRANSPLANTATION; Gangadharan B, 2007, CLIN CHEM, V53, P1792, DOI 10.1373/clinchem.2007.089144; Genovese G, 2010, SCIENCE, V329, P841, DOI 10.1126/science.1193032; Israni A K, 2015, Am J Transplant, V15 Suppl 2, P1, DOI 10.1111/ajt.13202; Ito K, 2014, CIRC RES, V114, P845, DOI 10.1161/CIRCRESAHA.114.302347; Kim W R, 2015, Am J Transplant, V15 Suppl 2, P1, DOI 10.1111/ajt.13197; Limou S, 2014, ADV CHRONIC KIDNEY D, V21, P426, DOI 10.1053/j.ackd.2014.06.005; Ma LJ, 2015, J AM SOC NEPHROL, V26, P339, DOI 10.1681/ASN.2013091017; Nichols B, 2015, KIDNEY INT, V87, P332, DOI 10.1038/ki.2014.270; Oetting WS, 2012, LIVER TRANSPLANT, V18, P1399, DOI 10.1002/lt.23549; Reeves-Daniel AM, 2011, AM J TRANSPLANT, V11, P1025, DOI 10.1111/j.1600-6143.2011.03513.x; Tayo BO, 2013, INT UROL NEPHROL, V45, P485, DOI 10.1007/s11255-012-0263-4; Thomson R, 2014, P NATL ACAD SCI USA, V111, pE2130, DOI 10.1073/pnas.1400699111; Timmins JM, 2005, J CLIN INVEST, V115, P1333, DOI 10.1172/JCI200523915; Tzur S, 2010, HUM GENET, V128, P345, DOI 10.1007/s00439-010-0861-0; Wan GH, 2008, J BIOL CHEM, V283, P21540, DOI 10.1074/jbc.M800214200	22	8	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0152775	10.1371/journal.pone.0152775	http://dx.doi.org/10.1371/journal.pone.0152775			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27054572	Green Published, gold, Green Submitted			2022-12-27	WOS:000373608000044
J	Hu, WL; Zhang, X; Wang, B; Liu, JQ; Duan, HL; Dai, N; Si, JM				Hu, Weiling; Zhang, Xu; Wang, Bin; Liu, Jiquan; Duan, Huilong; Dai, Ning; Si, Jianmin			Homographic Patch Feature Transform: A Robustness Registration for Gastroscopic Surgery	PLOS ONE			English	Article							ENDOSCOPIC IMAGES; SEQUENCES; SYSTEM; SCALE; SITE	Image registration is a key component of computer assistance in image guided surgery, and it is a challenging topic in endoscopic environments. In this study, we present a method for image registration named Homographic Patch Feature Transform (HPFT) to match gastroscopic images. HPFT can be used for tracking lesions and augmenting reality applications during gastroscopy. Furthermore, an overall evaluation scheme is proposed to validate the precision, robustness and uniformity of the registration results, which provides a standard for rejection of false matching pairs from corresponding results. Finally, HPFT is applied for processing in vivo gastroscopic data. The experimental results show that HPFT has stable performance in gastroscopic applications.	[Hu, Weiling; Dai, Ning; Si, Jianmin] Zhejiang Univ, Sir Run Run Shaw Hosp, Dept Gastroenterol, Hangzhou 310003, Zhejiang, Peoples R China; [Hu, Weiling; Dai, Ning; Si, Jianmin] Zhejiang Univ, Inst Gastroenterol, Hangzhou 310003, Zhejiang, Peoples R China; [Zhang, Xu; Wang, Bin; Liu, Jiquan; Duan, Huilong] Zhejiang Univ, Coll Biomed Engn & Instrument Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Zhang, Xu; Wang, Bin; Liu, Jiquan; Duan, Huilong] Zhejiang Univ, Minist Educ, Key Lab Biomed Engn, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang University	Si, JM (corresponding author), Zhejiang Univ, Sir Run Run Shaw Hosp, Dept Gastroenterol, Hangzhou 310003, Zhejiang, Peoples R China.; Si, JM (corresponding author), Zhejiang Univ, Inst Gastroenterol, Hangzhou 310003, Zhejiang, Peoples R China.; Liu, JQ (corresponding author), Zhejiang Univ, Coll Biomed Engn & Instrument Sci, Hangzhou 310003, Zhejiang, Peoples R China.; Liu, JQ (corresponding author), Zhejiang Univ, Minist Educ, Key Lab Biomed Engn, Hangzhou 310003, Zhejiang, Peoples R China.	liujq@zju.edu.cn; jianmin_si@zju.edu.cn		hu, weiling/0000-0002-8602-4665	Zhejiang province key science and technology innovation team [2013TD13]; Natural Science Foundation of Zhejiang Province [LY14H160029]; National Natural Science Foundation of China [31470955]	Zhejiang province key science and technology innovation team; Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	1. Zhejiang province key science and technology innovation team (2013TD13) (http://www.zjkjt.gov.cn/). 2. Natural Science Foundation of Zhejiang Province (LY14H160029) (http://www.zjnsf.gov.cn/). 3. the National Natural Science Foundation of China (No. 31470955) (http://www.nsfc.gov.cn/).	Allain B, 2012, MED IMAGE ANAL, V16, P482, DOI 10.1016/j.media.2011.11.005; [Anonymous], 2011, HAMLYN CTR LAPAROSCO; [Anonymous], 2009, FEATURE DETECTORS DE; Atasoy S, 2009, LECT NOTES COMPUT SC, V5761, P499, DOI 10.1007/978-3-642-04268-3_62; Bai WJ, 2011, IEEE T MED IMAGING, V30, P351, DOI 10.1109/TMI.2010.2078514; BROWN DC, 1971, PHOTOGRAMM ENG, V37, P855; Burschka D, 2005, MED IMAGE ANAL, V9, P413, DOI 10.1016/j.media.2005.05.005; Chum O, 2005, COMPUT VIS IMAGE UND, V97, P86, DOI 10.1016/j.cviu.2004.03.004; Crum W., 2014, BRIT J RADIOLOGY; Feuerstein M, 2008, IEEE T MED IMAGING, V27, P355, DOI 10.1109/TMI.2007.907327; Hu MX, 2008, LECT NOTES COMPUT SC, V5241, P720; Kalal Zdenek, 2010, PATT REC ICPR 2010 2; Leitner R, 2013, PATTERN RECOGN LETT, V34, P85, DOI 10.1016/j.patrec.2012.07.020; Liu JQ, 2014, BIO-MED MATER ENG, V24, P2673, DOI 10.3233/BME-141084; LIU JQ, 2015, BIOMEDICAL ENG IEEE, V62, P2296; Luong QT, 1996, INT J COMPUT VISION, V17, P43, DOI 10.1007/BF00127818; Mikolajczyk K, 2005, IEEE T PATTERN ANAL, V27, P1615, DOI 10.1109/TPAMI.2005.188; Mikolajczyk K, 2004, INT J COMPUT VISION, V60, P63, DOI 10.1023/B:VISI.0000027790.02288.f2; Miranda-Luna R, 2008, IEEE T BIO-MED ENG, V55, P541, DOI 10.1109/TBME.2007.903520; Oliveira FPM, 2014, COMPUT METHOD BIOMEC, V17, P73, DOI 10.1080/10255842.2012.670855; Oliveira FPM, 2013, MED BIOL ENG COMPUT, V51, P267, DOI 10.1007/s11517-012-0988-3; Puerto-Souza GA, 2013, IEEE T MED IMAGING, V32, P1201, DOI 10.1109/TMI.2013.2239306; Selka F, 2012, MED IMAGE UNDERSTAND, P249; Sotiras A, 2013, IEEE T MED IMAGING, V32, P1153, DOI 10.1109/TMI.2013.2265603; Sun DY, 2013, LECT NOTES COMPUT SC, V8090, P127, DOI 10.1007/978-3-642-40843-4_14; Sun DY, 2012, J MED SYST, V36, P2909, DOI 10.1007/s10916-011-9769-z; Tavares JMRS, 2014, LECT NOTES COMPUT SC, V8887, P21, DOI 10.1007/978-3-319-14249-4_3; Wang B, 2014, COMP MATH MATH PHYS, V2014, P1; Wang B, 2014, J MED IMAG HEALTH IN, V4, P797, DOI 10.1166/jmihi.2014.1323; Wang XW, 2010, IEEE T MED IMAGING, V29, P1213, DOI 10.1109/TMI.2009.2028341; Ye ML, 2013, LECT NOTES COMPUT SC, V8150, P67, DOI 10.1007/978-3-642-40763-5_9; Zhang LB, 2013, PROC SPIE, V8878, DOI 10.1117/12.2030818; Zhang Z, 1999, COMP VIS 1999 P 7 IE; Zhang ZY, 1998, INT J COMPUT VISION, V27, P161, DOI 10.1023/A:1007941100561; Zitova B, 2003, IMAGE VISION COMPUT, V21, P977, DOI 10.1016/S0262-8856(03)00137-9	35	3	3	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153202	10.1371/journal.pone.0153202	http://dx.doi.org/10.1371/journal.pone.0153202			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27054567	Green Published, gold, Green Submitted			2022-12-27	WOS:000373608000100
J	Oga, EA; Schumaker, LM; Alabi, BS; Obaseki, D; Umana, A; Bassey, IA; Ebughe, G; Oluwole, O; Akeredolu, T; Adebamowo, SN; Dakum, P; Cullen, K; Adebamowo, CA				Oga, Emmanuel A.; Schumaker, Lisa M.; Alabi, Biodun Sulyman; Obaseki, Darlington; Umana, Aniefon; Bassey, Ima-Abasi; Ebughe, Godwin; Oluwole, Olabode; Akeredolu, Teniola; Adebamowo, Sally N.; Dakum, Patrick; Cullen, Kevin; Adebamowo, Clement A.			Paucity of HPV-Related Head and Neck Cancers (HNC) in Nigeria	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMAS; PAPILLOMAVIRUS-ASSOCIATED HEAD; INCIDENCE TRENDS; ORAL SEX; PREVALENCE; INFECTION; ADOLESCENTS; SMOKING; IMPACT; TUMORS	Introduction The burden of HPV-related Head and Neck Cancers (HNC) has been rising in the U.S. and other developed countries but this trend has not been reported in Africa. Objective of study was to evaluate the prevalence of HPV infection in HNC cancer cases seen between 1990 and 2011 at the tertiary health care institutions in Nigeria. Methods We retrieved 149 head and neck cancer formalin fixed, paraffin embedded tumor specimens diagnosed between 1990 and 2011 from four teaching hospitals in Nigeria. One hundred and twenty-three blocks (83%) contained appropriate HNC for analysis while DNA extraction was successful in 60% (90/149). PCR amplification was successful in 33% (49/149) and Linear Array genotyping for HPV was successful in 11% (17/149) of these cases. These were in tumors from the larynx (6), cervical lymph nodes (3), nasal cavity (2), parotid (1), palate (1), maxillary sinus (1) and mandible (1). Two cases were non-specific and none were from the oropharynx. Histologically, 41% (7/17) of the successfully genotyped blocks were squamous cell carcinomas (larynx 6, maxillary sinus 1). Results and Conclusion We were unable to detect HPV in any of the HNC samples in our study. Our result may suggest that there is a low prevalence of HPV-related HNC among the adult population in Nigeria. Our results provide a benchmark to compare future incidence of HPV-related HNC in this community in future. We had significant analytical challenges from possible poor tissue processing and urge that future studies should prospectively collect samples and ensure high quality sample processing.	[Oga, Emmanuel A.; Adebamowo, Clement A.] Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, Baltimore, MD 21201 USA; [Oga, Emmanuel A.; Akeredolu, Teniola; Adebamowo, Sally N.; Dakum, Patrick; Adebamowo, Clement A.] Inst Human Virol Nigeria, Off Res Training & Strateg Informat, Abuja, Fct, Nigeria; [Schumaker, Lisa M.; Cullen, Kevin; Adebamowo, Clement A.] Univ Maryland, Sch Med, Marlene & Stewart Greenebaum Canc Ctr, Baltimore, MD 21201 USA; [Alabi, Biodun Sulyman] Univ Ilorin Teaching Hosp, Dept Ear Nose & Throat Head & Neck Surg, Ilorin, Kwara State, Nigeria; [Obaseki, Darlington] Univ Benin Teaching Hosp, Benin, Edo State, Nigeria; [Umana, Aniefon; Bassey, Ima-Abasi; Ebughe, Godwin] Univ Calabar Teaching Hosp, Calabar, Cross River Sta, Nigeria; [Oluwole, Olabode] Univ Abuja Teaching Hosp, Abuja, Fct, Nigeria; [Adebamowo, Sally N.; Adebamowo, Clement A.] Harvard Univ, Dept Nutr, TH Chan Sch Publ Hlth, Boston, MA 02115 USA; [Adebamowo, Sally N.] NHGRI, NIH, Bethesda, MD 20892 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University of Ilorin; University of Benin; University of Calabar; Harvard University; Harvard T.H. Chan School of Public Health; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Oga, EA (corresponding author), Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, Baltimore, MD 21201 USA.; Oga, EA (corresponding author), Inst Human Virol Nigeria, Off Res Training & Strateg Informat, Abuja, Fct, Nigeria.	eoga@umaryland.edu	Adebamowo, Clement/C-8778-2011; Oga, Emmanuel/P-5899-2018	Adebamowo, Clement/0000-0002-6571-2880; Oga, Emmanuel/0000-0002-0744-5681; Ebughe, Godwin/0000-0002-3744-5690; Adebamowo, Sally/0000-0003-4713-2433	NCI/NIH [D43CA153792-01]; NATIONAL CANCER INSTITUTE [D43CA153792] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006947] Funding Source: NIH RePORTER	NCI/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The project described was supported by Grant Number D43CA153792-01 (PI - Adebamowo) from the NCI/NIH. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute or the National Institutes of Health.	Adeyi A, 2011, PAN AFR MED J, V10; Bamidele James Olusegun, 2009, Int J Adolesc Med Health, V21, P387, DOI 10.1515/IJAMH.2009.21.3.387; Beachler DC, 2015, AM J EPIDEMIOL, V181, P40, DOI 10.1093/aje/kwu247; Betiol J, 2013, BRAZ J MED BIOL RES, V46, P217, DOI 10.1590/1414-431X20132703; Boscolo-Rizzo P, 2013, ACTA OTORHINOLARYNGO, V33, P77; BOUVARD V, 2009, LANCET ONCOL, V10, P321, DOI [DOI 10.1016/S1470-2045(09)70096-8, 10.1016/s1470-2045(09)70096-8]; Boy S, 2006, J ORAL PATHOL MED, V35, P86, DOI 10.1111/j.1600-0714.2006.00385.x; Braakhuis BJM, 2009, EUR J CANCER, V45, P2935, DOI 10.1016/j.ejca.2009.08.018; Chai RC, 2015, CANCER MED-US, V4, P596, DOI 10.1002/cam4.424; Chaturvedi AK, 2008, J CLIN ONCOL, V26, P612, DOI 10.1200/JCO.2007.14.1713; Cherie A, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-5; Chernock RD, 2011, ARCH OTOLARYNGOL, V137, P163, DOI 10.1001/archoto.2010.246; Colevas AD, 2014, HEAD NECK-J SCI SPEC, V36, P34, DOI 10.1002/hed.23253; D'Souza G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086023; da Lilly-Tariah OB, 2009, HEAD NECK ONCOL, V1, DOI 10.1186/1758-3284-1-14; Dareng EO, 2016, EPIDEMIOL INFECT, V144, P123, DOI 10.1017/S0950268815000965; Diaz EM, 2003, HOLLAND FREI CANC ME; Ferlay J., 2013, IARC CANCERBASE; Friedman JM, 2014, WORLD J CLIN ONCOL, V5, P781, DOI 10.5306/wjco.v5.i4.781; Gillison ML, 2008, JNCI-J NATL CANCER I, V100, P407, DOI 10.1093/jnci/djn025; Haraf DJ, 1996, CLIN CANCER RES, V2, P755; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. International Agency for Research on Cancer, 2007, HUM PAP, Vviii; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Ji XM, 2009, CANCER-AM CANCER SOC, V115, P1660, DOI 10.1002/cncr.24184; Joseph AW, 2012, OTOLARYNG CLIN N AM, V45, P739, DOI 10.1016/j.otc.2012.04.003; Kazaura MR, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-373; Kerwin JT, 2014, INT J SEX HEALTH, V26, P66, DOI 10.1080/19317611.2013.830671; Kreimer AR, 2013, LANCET, V382, P877, DOI 10.1016/S0140-6736(13)60809-0; Kreimer AR, 2005, CANCER EPIDEM BIOMAR, V14, P467, DOI 10.1158/1055-9965.EPI-04-0551; Lajer CB, 2010, APMIS, V118, P510, DOI 10.1111/j.1600-0463.2010.02624.x; Leichliter JS, 2007, J INFECT DIS, V196, P1852, DOI 10.1086/522867; Licitra L, 2008, HEMATOL ONCOL CLIN N, V22, P1143, DOI 10.1016/j.hoc.2008.10.002; Marron M, 2010, INT J EPIDEMIOL, V39, P182, DOI 10.1093/ije/dyp291; MASHBERG A, 1993, CANCER-AM CANCER SOC, V72, P1369, DOI 10.1002/1097-0142(19930815)72:4<1369::AID-CNCR2820720436>3.0.CO;2-L; Monk BJ, 2007, GYNECOL ONCOL, V107, pS6, DOI 10.1016/j.ygyno.2007.07.076; Ndiaye C, 2014, LANCET ONCOL, V15, P1319, DOI 10.1016/S1470-2045(14)70471-1; Ndiaye C, 2013, INFECT AGENTS CANCER, V8, DOI 10.1186/1750-9378-8-14; Nwawolo C C, 2001, West Afr J Med, V20, P111; Ologe FE, 2005, TROP DOCT, V35, P2, DOI 10.1258/0049475053001949; Otoh E C, 2004, West Afr J Med, V23, P305; Paquette C, 2013, HEAD NECK PATHOL, V7, P361, DOI 10.1007/s12105-013-0453-0; Psyrri A, 2009, CURR OPIN ONCOL, V21, P201, DOI 10.1097/CCO.0b013e328329ab64; Rettig E, 2015, EXPERT REV ANTICANC, V15, P35, DOI 10.1586/14737140.2015.957189; Sanders AE, 2012, ORAL DIS, V18, P430, DOI 10.1111/j.1601-0825.2011.01892.x; Schlecht NF, 2011, MODERN PATHOL, V24, P1295, DOI 10.1038/modpathol.2011.91; Settle K, 2009, CANCER PREV RES, V2, P776, DOI 10.1158/1940-6207.CAPR-09-0149; Steinau M, 2011, J MOL DIAGN, V13, P377, DOI 10.1016/j.jmoldx.2011.03.007; Stenson KM, 2014, EPIDEMIOLOGY RISK FA; Sturgis EM, 2007, CANCER-AM CANCER SOC, V110, P1429, DOI 10.1002/cncr.22963; Tribius S, 2013, DTSCH ARZTEBL INT, V110, P184, DOI 10.3238/arztebl.2013.0184; Van Rensburg EJ, 1995, DETECTION HUMAN PAPI; vanRensburg EJ, 1996, ANTICANCER RES, V16, P969; Wang XHI, 2012, ANN DIAGN PATHOL, V16, P7, DOI 10.1016/j.anndiagpath.2011.07.003; Weinberger PM, 2010, LARYNGOSCOPE, V120, P1531, DOI 10.1002/lary.20984	54	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0152828	10.1371/journal.pone.0152828	http://dx.doi.org/10.1371/journal.pone.0152828			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050815	Green Published, Green Submitted, gold			2022-12-27	WOS:000373603500057
J	Bassoy, EY; Chiusolo, V; Jacquemin, G; Riccadonna, C; Walker, PR; Martinvalet, D				Bassoy, Esen Yonca; Chiusolo, Valentina; Jacquemin, Guillaume; Riccadonna, Cristina; Walker, Paul R.; Martinvalet, Denis			Glioma Stemlike Cells Enhance the Killing of Glioma Differentiated Cells by Cytotoxic Lymphocytes	PLOS ONE			English	Article							CLINICAL-VALUE; CANCER; HETEROGENEITY; LESSONS; DEATH; CD133	Glioblastoma multiforme, the most aggressive primary brain tumor, is maintained by a sub-population of glioma cells with self-renewal properties that are able to recapitulate the entire tumor even after surgical resection or chemo-radiotherapy. This typifies the vast heterogeneity of this tumor with the two extremes represented on one end by the glioma stemlike cells (GSC) and on the other by the glioma differentiated cells (GDC). Interestingly, GSC are more sensitive to immune effector cells than the GDC counterpart. However, how GSC impact on the killing on the GDC and vice versa is not clear. Using a newly developed cytotoxicity assay allowing to simultaneously monitor cytotoxic lymphocytes-mediated killing of GSC and GDC, we found that although GSC were always better killed and that their presence enhanced the killing of GDC. In contrast, an excess of GDC had a mild protective effect on the killing of GSC, depending on the CTL type. Overall, our results suggest that during combination therapy, immunotherapy would be the most effective after prior treatment with conventional therapies.	[Bassoy, Esen Yonca; Chiusolo, Valentina; Jacquemin, Guillaume; Martinvalet, Denis] Univ Geneva, Dept Cell Physiol & Metab, CH-1211 Geneva, Switzerland; [Riccadonna, Cristina; Walker, Paul R.] Univ Hosp Geneva, CH-1211 Geneva, Switzerland; [Riccadonna, Cristina; Walker, Paul R.] Univ Geneva, Ctr Oncol, CH-1211 Geneva, Switzerland	University of Geneva; University of Geneva; University of Geneva	Martinvalet, D (corresponding author), Univ Geneva, Dept Cell Physiol & Metab, CH-1211 Geneva, Switzerland.	Denis.Martinvalet@unige.ch		Bassoy, Esen Yonca/0000-0001-8870-7040; Chiusolo, Valentina/0000-0002-5470-8181	European Research Council [ERC-2010-StG_20091118]; Ambizione SNSF [PZ00P3_126710/1]; Boninchi Foundation; Carlos and Elsie de Reuter Foundation; Schmidheiny Foundation	European Research Council(European Research Council (ERC)European Commission); Ambizione SNSF; Boninchi Foundation; Carlos and Elsie de Reuter Foundation; Schmidheiny Foundation	This work was supported by European Research Council starting grant ERC-2010-StG_20091118, Ambizione SNSF PZ00P3_126710/1, grants from the Boninchi Foundation, Carlos and Elsie de Reuter Foundation and Schmidheiny Foundation.	Apetoh L, 2015, ONCOIMMUNOLOGY, V4, DOI 10.1080/2162402X.2014.998538; Auffinger B, 2015, EXPERT REV NEUROTHER, V15, P741, DOI 10.1586/14737175.2015.1051968; Avril T, 2012, BRAIN PATHOL, V22, P159, DOI 10.1111/j.1750-3639.2011.00515.x; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Barcia C, 2009, AM J PATHOL, V175, P786, DOI 10.2353/ajpath.2009.081034; Binello E, 2011, CANCER SCI, V102, P1958, DOI 10.1111/j.1349-7006.2011.02064.x; Brown CE, 2009, CANCER RES, V69, P8886, DOI 10.1158/0008-5472.CAN-09-2687; Castriconi R, 2009, J IMMUNOL, V182, P3530, DOI 10.4049/jimmunol.0802845; Castro MG, 2003, PHARMACOL THERAPEUT, V98, P71, DOI 10.1016/S0163-7258(03)00014-7; Chen J, 2012, NATURE, V488, P522, DOI 10.1038/nature11287; Chen J, 2012, CELL, V149, P36, DOI 10.1016/j.cell.2012.03.009; Chowdhury D, 2008, ANNU REV IMMUNOL, V26, P389, DOI 10.1146/annurev.immunol.26.021607.090404; Ciavardelli D, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.285; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Dahlrot RH, 2014, INT J CLIN EXP PATHO, V7, P3739; Dahlrot RH, 2013, J NEURO-ONCOL, V115, P453, DOI 10.1007/s11060-013-1246-8; Dahlrot RH, 2013, INT J CLIN EXP PATHO, V6, P334; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Derouazi M, 2015, CANCER RES, V75, P3020, DOI 10.1158/0008-5472.CAN-14-3017; Dutoit V, 2012, BRAIN, V135, P1042, DOI 10.1093/brain/aws042; Ehtesham M, 2009, CANCER LETT, V274, P305, DOI 10.1016/j.canlet.2008.09.034; Garraway LA, 2013, CELL, V153, P17, DOI 10.1016/j.cell.2013.03.002; Hadjipanayis CG, 2009, J MOL MED, V87, P363, DOI 10.1007/s00109-009-0440-9; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Ji Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096650; Kreso A, 2014, CELL STEM CELL, V14, P275, DOI 10.1016/j.stem.2014.02.006; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Liu GT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-67; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Patel AP, 2014, SCIENCE, V344, P1396, DOI 10.1126/science.1254257; Pellegatta S, 2006, CANCER RES, V66, P10247, DOI 10.1158/0008-5472.CAN-06-2048; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Suva ML, 2014, CELL, V157, P580, DOI 10.1016/j.cell.2014.02.030; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wu AH, 2007, J NEURO-ONCOL, V83, P121, DOI 10.1007/s11060-006-9265-3; Yang J, 2010, P NATL ACAD SCI USA, V107, P4716, DOI 10.1073/pnas.0911587107; Zeppernick F, 2008, CLIN CANCER RES, V14, P123, DOI 10.1158/1078-0432.CCR-07-0932; Zong WX, 2006, GENE DEV, V20, P1, DOI 10.1101/gad.1376506	40	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153433	10.1371/journal.pone.0153433	http://dx.doi.org/10.1371/journal.pone.0153433			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073883	Green Published, Green Submitted, gold			2022-12-27	WOS:000374131200091
J	Chen, YH; Han, YY; Zhang, M; Zhou, S; Kong, XZ; Wang, W				Chen, Yanhui; Han, Yangyang; Zhang, Meng; Zhou, Shan; Kong, Xiangzhu; Wang, Wei			Overexpression of the Wheat Expansin Gene TaEXPA2 Improved Seed Production and Drought Tolerance in Transgenic Tobacco Plants	PLOS ONE			English	Article							CELL-WALL EXTENSION; MAIZE PRIMARY ROOT; BETA-EXPANSIN; STRESS-RESPONSE; PROLINE CONTENT; ALPHA-EXPANSIN; ABIOTIC STRESS; EXPRESSION; GROWTH; SALT	Expansins are cell wall proteins that are grouped into two main families, alpha-expansins and beta-expansins, and they are implicated in the control of cell extension via the disruption of hydrogen bonds between cellulose and matrix glucans. TaEXPA2 is an a-expansin gene identified in wheat. Based on putative cis-regulatory elements in the TaEXPA2 promoter sequence and the expression pattern induced when polyethylene glycol (PEG) is used to mimic water stress, we hypothesized that TaEXPA2 is involved in plant drought tolerance and plant development. Through transient expression of 35S::TaEXPA2-GFP in onion epidermal cells, TaEXPA2 was localized to the cell wall. Constitutive expression of TaEXPA2 in tobacco improved seed production by increasing capsule number, not seed size, without having any effect on plant growth patterns. The transgenic tobacco exhibited a significantly greater tolerance to water-deficiency stress than did wild-type (WT) plants. We found that under drought stress, the transgenic plants maintained a better water status. The accumulated content of osmotic adjustment substances, such as proline, in TaEXPA2 transgenic plants was greater than that in WT plants. Transgenic plants also displayed greater antioxidative competence as indicated by their lower malondialdehyde (MDA) content, relative electrical conductivity, and reactive oxygen species (ROS) accumulation than didWT plants. This result suggests that the transgenic plants suffer less damage from ROS under drought conditions. The activities of some antioxidant enzymes as well as expression levels of several genes encoding key antioxidant enzymes were higher in the transgenic plants than in the WT plants under drought stress. Collectively, our results suggest that ectopic expression of the wheat expansin gene TaEXPA2 improves seed production and drought tolerance in transgenic tobacco plants.	[Chen, Yanhui; Han, Yangyang; Zhang, Meng; Zhou, Shan; Kong, Xiangzhu; Wang, Wei] Shandong Agr Univ, Coll Life Sci, Shandong Key Lab Crop Biol, State Key Lab Crop Biol, Tai An 271018, Shandong, Peoples R China; [Han, Yangyang] Weifang Med Univ, Plast Surg Inst, Weifang 261041, Shandong, Peoples R China	Shandong Agricultural University; Weifang Medical University	Wang, W (corresponding author), Shandong Agr Univ, Coll Life Sci, Shandong Key Lab Crop Biol, State Key Lab Crop Biol, Tai An 271018, Shandong, Peoples R China.	wangw@sdau.edu.cn	han, yang/GRS-2388-2022		National Natural Science Foundation of China [31370304]; Opening Foundation of State Key Laboratory of Crop Biology [2013KF01]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Opening Foundation of State Key Laboratory of Crop Biology	This research is supported by the National Natural Science Foundation of China (Grant number: 31370304) and by the Opening Foundation of State Key Laboratory of Crop Biology (Grant number: 2013KF01). The URL is http://www.nsfc.gov.cn/. W. W. received the funding.	Abuqamar S, 2013, MOL PLANT PATHOL, V14, P813, DOI 10.1111/mpp.12049; Aroca R, 2003, PHYSIOL PLANTARUM, V117, P540, DOI 10.1034/j.1399-3054.2003.00065.x; Bae JM, 2014, TRANSGENIC RES, V23, P657, DOI 10.1007/s11248-014-9804-1; BOYER JS, 1982, SCIENCE, V218, P443, DOI 10.1126/science.218.4571.443; Chaves MM, 2004, J EXP BOT, V55, P2365, DOI 10.1093/jxb/erh269; Cho HT, 2002, PLANT CELL, V14, P3237, DOI 10.1105/tpc.006437; Choi D, 2008, ADV BOT RES, V47, P47, DOI 10.1016/S0065-2296(08)00002-5; Cosgrove DJ, 2000, NATURE, V407, P321, DOI 10.1038/35030000; Dai FW, 2012, PLANT PHYSIOL, V160, P2064, DOI 10.1104/pp.112.207720; Dat JF, 1998, PLANT PHYSIOL, V118, P1455, DOI 10.1104/pp.118.4.1455; Demiral T, 2005, ENVIRON EXP BOT, V53, P247, DOI 10.1016/j.envexpbot.2004.03.017; DORFFLING K, 1993, J PLANT PHYSIOL, V142, P222, DOI 10.1016/S0176-1617(11)80968-5; Duca M, 2015, BIOL MED PHYS BIOMED, P39, DOI 10.1007/978-3-319-17909-4_3; Gao Q, 2008, PROTOPLASMA, V233, P73, DOI 10.1007/s00709-008-0303-1; Goh HH, 2012, PLANT PHYSIOL, V159, P1759, DOI 10.1104/pp.112.200881; Guo D, 2014, TRANSGENIC RES, V23, P331, DOI 10.1007/s11248-013-9753-0; Guo WB, 2011, PLANT J, V66, P541, DOI 10.1111/j.1365-313X.2011.04511.x; Han YY, 2012, PLANT PHYSIOL BIOCH, V54, P49, DOI 10.1016/j.plaphy.2012.02.007; Han YY, 2015, J PLANT PHYSIOL, V173, P62, DOI 10.1016/j.jplph.2014.09.007; He XY, 2015, J EXP BOT, V66, P7405, DOI 10.1093/jxb/erv436; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Hodge A, 2009, PLANT SOIL, V321, P153, DOI 10.1007/s11104-009-9929-9; Hu ZR, 2013, NEW PHYTOL, V197, P1344, DOI 10.1111/nph.12131; Jones L, 2004, FEBS LETT, V559, P61, DOI 10.1016/S0014-5793(04)00023-7; KNUDSON LL, 1977, PLANT PHYSIOL, V60, P606, DOI 10.1104/pp.60.4.606; Kong XP, 2011, PLANT CELL REP, V30, P2097, DOI 10.1007/s00299-011-1116-9; Kwon YR, 2008, BIOTECHNOL LETT, V30, P1281, DOI 10.1007/s10529-008-9678-5; Lee Y, 2001, CURR OPIN PLANT BIOL, V4, P527, DOI 10.1016/S1369-5266(00)00211-9; Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325; Li AX, 2015, ENVIRON EXP BOT, V110, P73, DOI 10.1016/j.envexpbot.2014.10.002; Li F, 2011, J PLANT PHYSIOL, V168, P960, DOI 10.1016/j.jplph.2010.11.023; Li Q, 2011, J PLANT PHYSIOL, V168, P927, DOI 10.1016/j.jplph.2010.11.025; Li Y, 2003, CURR OPIN PLANT BIOL, V6, P603, DOI 10.1016/j.pbi.2003.09.003; Liu JP, 1997, PLANT PHYSIOL, V114, P591, DOI 10.1104/pp.114.2.591; Liu Y, 2007, GENOMICS, V90, P516, DOI 10.1016/j.ygeno.2007.06.012; Lu PT, 2013, PLANTA, V237, P1547, DOI 10.1007/s00425-013-1867-3; MCQUEENMASON S, 1992, PLANT CELL, V4, P1425, DOI 10.1105/tpc.4.11.1425; Mittler R, 2004, TRENDS PLANT SCI, V9, P490, DOI 10.1016/j.tplants.2004.08.009; Rao MV, 1996, PLANT PHYSIOL, V110, P125, DOI 10.1104/pp.110.1.125; Reidy B, 2001, PLANT MOL BIOL, V46, P491, DOI 10.1023/A:1010621417854; Sampedro J, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-242; Sun LP, 2012, PLANT CELL REP, V31, P1473, DOI 10.1007/s00299-012-1262-8; Tian FX, 2014, PLANT SCI, V226, P92, DOI 10.1016/j.plantsci.2014.03.006; Wu LJ, 2008, PLANT PHYSIOL, V148, P1953, DOI 10.1104/pp.108.126813; Wu YJ, 1996, PLANT PHYSIOL, V111, P765, DOI 10.1104/pp.111.3.765; Wu YJ, 2001, PLANT PHYSIOL, V126, P1471, DOI 10.1104/pp.126.4.1471; Xing SC, 2009, BIOL PLANTARUM, V53, P429, DOI 10.1007/s10535-009-0082-3; Xu B, 2013, MOL PLANT, V6, P945, DOI 10.1093/mp/sss112; Xu Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100792; Yu ZM, 2011, PLANT J, V66, P725, DOI 10.1111/j.1365-313X.2011.04533.x; Yue B, 2006, GENETICS, V172, P1213, DOI 10.1534/genetics.105.045062; Zhao MR, 2012, PLANT CELL REP, V31, P671, DOI 10.1007/s00299-011-1185-9; Zhou J, 2014, PHYSIOL PLANTARUM, V150, P194, DOI 10.1111/ppl.12077; Zhou S, 2015, J PLANT PHYSIOL, V183, P64, DOI 10.1016/j.jplph.2015.05.012	54	54	59	3	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153494	10.1371/journal.pone.0153494	http://dx.doi.org/10.1371/journal.pone.0153494			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073898	gold, Green Published, Green Submitted			2022-12-27	WOS:000374131200100
J	Chernova, E; Pacherova, O; Kocourek, T; Jelinek, M; Dejneka, A; Tyunina, M				Chernova, E.; Pacherova, O.; Kocourek, T.; Jelinek, M.; Dejneka, A.; Tyunina, M.			Optical Properties of Ferroelectric Epitaxial K0.5Na0.5NbO3 Films in Visible to Ultraviolet Range	PLOS ONE			English	Article							THIN-FILMS; POLARIZATION; TRANSITIONS; PEROVSKITES	The complex index of refraction in the spectral range of 0.74 to 4.5 eV is studied by variable- angle spectroscopic ellipsometry in ferroelectric K0.5Na0.5NbO3 films. The 20-nm-thick cube-on-cube- type epitaxial films are grown on SrTiO3(001) and DyScO3(011) single-crystal substrates. The films are transparent and exhibit a significant difference between refractive indices Delta n = 0.5 at photon energies below 3 eV. The energies of optical transitions are in the range of 3.15-4.30 eV and differ by 0.2-0.3 eV in these films. The observed behavior is discussed in terms of lattice strain and strain-induced ferroelectric polarization in epitaxial perovskite oxide films.	[Chernova, E.; Pacherova, O.; Kocourek, T.; Jelinek, M.; Dejneka, A.; Tyunina, M.] Acad Sci Czech Republ, Inst Phys, Na Slovance 2, Prague 18221 8, Czech Republic; [Chernova, E.] Czech Tech Univ, Tech 2, Prague 16627 6, Czech Republic; [Tyunina, M.] Univ Oulu, Microelect & Mat Phys Labs, POB 4500, FI-90014 Oulu, Finland	Czech Academy of Sciences; Institute of Physics of the Czech Academy of Sciences; Czech Technical University Prague; University of Oulu	Chernova, E; Tyunina, M (corresponding author), Acad Sci Czech Republ, Inst Phys, Na Slovance 2, Prague 18221 8, Czech Republic.; Chernova, E (corresponding author), Czech Tech Univ, Tech 2, Prague 16627 6, Czech Republic.; Tyunina, M (corresponding author), Univ Oulu, Microelect & Mat Phys Labs, POB 4500, FI-90014 Oulu, Finland.	chernova@fzu.cz; marinat@ee.oulu.fi	Pacherova, Oliva/H-1859-2014; Kocourek, Tomáš/G-8432-2014; Dejneka, Alexandr/G-6384-2014; Tjunina, Marina/G-7059-2019	Kocourek, Tomáš/0000-0002-9356-5793; Dejneka, Alexandr/0000-0002-5116-8781; Tjunina, Marina/0000-0003-4149-5858; Chernova, Ekaterina/0000-0002-4422-8045; Jelinek, Miroslav/0000-0001-9824-1117	Czech Science Foundation [15-13778S]; Finnish Funding Agency for Innovation [400.31.2013]	Czech Science Foundation(Grant Agency of the Czech Republic); Finnish Funding Agency for Innovation	This work was supported by Czech Science Foundation (Grant No. 15-13778S, https://gacr.cz,recipient: AD) and Finnish Funding Agency for Innovation (Grant No. 400.31.2013, https://www.tekes.fi/en,recipient: MT).	Abel S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2695; Berger RF, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.146804; Blomqvist M, 2003, APPL PHYS LETT, V82, P439, DOI 10.1063/1.1539295; BREWS JR, 1967, PHYS REV LETT, V18, P662, DOI 10.1103/PhysRevLett.18.662; Chernova E, 2015, APPL PHYS LETT, V106, DOI 10.1063/1.4921083; Dicken MJ, 2008, NANO LETT, V8, P4048, DOI 10.1021/nl802981q; DIDOMENICO M, 1968, PHYS REV, V166, P565, DOI 10.1103/PhysRev.166.565; Dieguez O, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.144101; DOW JD, 1971, PHYS REV LETT, V26, P762, DOI 10.1103/PhysRevLett.26.762; Ederer C, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.257601; Fujiwara H, 2000, PHYS REV B, V61, P10832, DOI 10.1103/PhysRevB.61.10832; Gautam LK, 2014, THIN SOLID FILMS, V571, P548, DOI 10.1016/j.tsf.2014.03.020; Guo R, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2990; Kroupa J, 2005, J PHYS D APPL PHYS, V38, P679, DOI 10.1088/0022-3727/38/5/003; Lines M.E., 2001, PRINCIPLES APPL FERR; Pertsev NA, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2988263; Pertsev NA, 1998, PHYS REV LETT, V80, P1988, DOI 10.1103/PhysRevLett.80.1988; Saito Y, 2004, NATURE, V432, P84, DOI 10.1038/nature03028; Sun HQ, 2012, J APPL PHYS, V111, DOI 10.1063/1.3686193; TAUC J, 1966, PHYS STATUS SOLIDI, V15, P627, DOI 10.1002/pssb.19660150224; Tejuca L.G., 2000, PROPERTIES APPL PERO; Tellier J, 2009, SOLID STATE SCI, V11, P320, DOI 10.1016/j.solidstatesciences.2008.07.011; Tompkins H, 2005, HDB ELLIPSOMETRY; Tyunina M, 2015, NEW J PHYS, V17, DOI 10.1088/1367-2630/17/4/043048; Tyunina M, 2015, SCI TECHNOL ADV MAT, V16, DOI 10.1088/1468-6996/16/2/026002; Wang FG, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4871707; WEMPLE SH, 1970, PHYS REV B, V2, P2679, DOI 10.1103/PhysRevB.2.2679; Woollam J., 2005, GUIDE USING WVASE32; Woollam JA, 2000, PROC SPIE, V4099, P197, DOI 10.1117/12.405820; Wu XG, 2015, ACCIDENT ANAL PREV, V78, P58, DOI 10.1016/j.aap.2015.02.003	31	6	6	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153261	10.1371/journal.pone.0153261	http://dx.doi.org/10.1371/journal.pone.0153261			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27074042	Green Published, gold, Green Submitted			2022-12-27	WOS:000374131200068
J	Willot, Q; Simonis, P; Vigneron, JP; Aron, S				Willot, Quentin; Simonis, Priscilla; Vigneron, Jean-Pol; Aron, Serge			Total Internal Reflection Accounts for the Bright Color of the Saharan Silver Ant	PLOS ONE			English	Article							INTERFERENCE MICROSCOPY; BUTTERFLY SCALES; REFRACTIVE-INDEX; DISPERSION; CRYSTALS	The Saharan silver ant Cataglyphis bombycina is one of the terrestrial living organisms best adapted to tolerate high temperatures. It has recently been shown that the hairs covering the ant's dorsal body part are responsible for its silvery appearance. The hairs have a triangular cross-section with two corrugated surfaces allowing a high optical reflection in the visible and near-infrared (NIR) range of the spectrum while maximizing heat emissivity in the mid-infrared (MIR). Those two effects account for remarkable thermoregulatory properties, enabling the ant to maintain a lower thermal steady state and to cope with the high temperature of its natural habitat. In this paper, we further investigate how geometrical optical and high reflection properties account for the bright silver color of C. bombycina. Using optical ray-tracing models and attenuated total reflection (ATR) experiments, we show that, for a large range of incidence angles, total internal reflection (TIR) conditions are satisfied on the basal face of each hair for light entering and exiting through its upper faces. The reflection properties of the hairs are further enhanced by the presence of the corrugated surface, giving them an almost total specular reflectance for most incidence angles. We also show that hairs provide an almost 10-fold increase in light reflection, and we confirm experimentally that they are responsible for a lower internal body temperature under incident sunlight. Overall, this study improves our understanding of the optical mechanisms responsible for the silver color of C. bombycina and the remarkable thermoregulatory properties of the hair coat covering the ant's body.	[Willot, Quentin; Aron, Serge] Univ Libre Bruxelles, Evolutionary Biol & Ecol, Brussels, Belgium; [Simonis, Priscilla; Vigneron, Jean-Pol] Univ Namur, Res Ctr Phys Matter & Radiat PMR, Photon Living Organisms Grp, Namur, Belgium	Universite Libre de Bruxelles; University of Namur	Aron, S (corresponding author), Univ Libre Bruxelles, Evolutionary Biol & Ecol, Brussels, Belgium.	saron@ulb.ac.be			Wallonia-Brussels Federation; Universite de Namur [033]; Belgian FRIA; FRS-FNRS; Belgian Fonds National de la recherche Scientifique [FRFC 2.4516.11]; Universite Libre de Bruxelles	Wallonia-Brussels Federation; Universite de Namur; Belgian FRIA(Fonds de la Recherche Scientifique - FNRS); FRS-FNRS(Fonds de la Recherche Scientifique - FNRS); Belgian Fonds National de la recherche Scientifique(Fonds de la Recherche Scientifique - FNRS); Universite Libre de Bruxelles	This work was supported by the Wallonia-Brussels Federation (PS), the Universite de Namur (grant ARC2010-2015#033) (JPV), the Universite Libre de Bruxelles (ARC2010-2015 $5) (SA), the Belgian FRIA (QW), the FRS-FNRS (PS, SA), and the Belgian Fonds National de la recherche Scientifique (FRFC 2.4516.11) (SA). The authors acknowledge using resources from the Interuniversity Scientific Computing Facility located at the University of Namur (Belgium), which is supported by the FRS-FNRS under convention 2.4617.07. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Autumn K, 2000, NATURE, V405, P681, DOI 10.1038/35015073; Bay A, 2012, PROC SPIE, V8480, DOI 10.1117/12.928696; Berthier S, 2003, OPT COMMUN, V228, P349, DOI 10.1016/j.optcom.2003.10.032; Boher P, 2011, J INF DISP, V12, P179, DOI 10.1080/15980316.2011.621313; BOULIGAND Y, 1972, TISSUE CELL, V4, P189, DOI 10.1016/S0040-8166(72)80042-9; Delye G, 1957, INSECT SOC, V4, P72; GEHRING WJ, 1995, P NATL ACAD SCI USA, V92, P2994, DOI 10.1073/pnas.92.7.2994; GHIRADELLA H, 1989, J MORPHOL, V202, P69, DOI 10.1002/jmor.1052020106; Ghiradella H, 2010, ADV INSECT PHYSIOL, V38, P135, DOI 10.1016/S0065-2806(10)38006-4; Ghiradella HT, 2009, J R SOC INTERFACE, V6, pS243, DOI 10.1098/rsif.2008.0372.focus; Goldstein Dennis H., 2005, Proceedings of the SPIE - The International Society for Optical Engineering, V5888, p58880T, DOI 10.1117/12.618546; Harrick N.J., 1967, INTERNAL REFLECTION; Hemmi JM, 2006, J EXP BIOL, V209, P4140, DOI 10.1242/jeb.02483; HOLM E, 1973, ECOLOGY, V54, P44; Kattawar G. W., 1994, P SOC PHOTOOPT INS, V5, P42; Leertouwer HL, 2011, OPT EXPRESS, V19, P24061, DOI 10.1364/OE.19.024061; Marsh, 1985, THESIS U CAPE TOWN; Moseley PL, 1997, J APPL PHYSIOL, V83, P1413, DOI 10.1152/jappl.1997.83.5.1413; NEVILLE AC, 1969, BIOL REV, V44, P531, DOI 10.1111/j.1469-185X.1969.tb00611.x; Shi NN, 2015, SCIENCE, V349, P298, DOI 10.1126/science.aab3564; Simonis P, 2013, OPT EXPRESS, V21, P6979, DOI 10.1364/OE.21.006979; Simonis P, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.011908; Sommer S, 2012, ARTHROPOD STRUCT DEV, V41, P71, DOI 10.1016/j.asd.2011.08.002; Stavenga DG, 2013, LIGHT-SCI APPL, V2, DOI 10.1038/lsa.2013.56; Vigneron JP, 2012, PHYSICA B, V407, P4032, DOI 10.1016/j.physb.2011.12.130; Vigneron JP, 2006, PROC SPIE, V6128, DOI 10.1117/12.646835; Vigneron JP, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.031907; Vigneron JP, 2010, ADV INSECT PHYSIOL, V38, P181, DOI 10.1016/S0065-2806(10)38004-0; Vukusic P, 1999, P ROY SOC B-BIOL SCI, V266, P1403, DOI 10.1098/rspb.1999.0794; WATT WB, 1968, EVOLUTION, V22, P437, DOI 10.1111/j.1558-5646.1968.tb03985.x; WEHNER R, 1992, NATURE, V357, P586, DOI 10.1038/357586a0; Whitehead L., 2008, PHYS CANADA, V64, P7; WILLMER PG, 1981, OECOLOGIA, V50, P250, DOI 10.1007/BF00348047; Withrow AP, 1956, RADIAT BIOL, V3, P125	34	27	27	3	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0152325	10.1371/journal.pone.0152325	http://dx.doi.org/10.1371/journal.pone.0152325			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073923	Green Published, Green Submitted, gold			2022-12-27	WOS:000374131200020
J	Ayala, F; Moreno-Perez, V; Vera-Garcia, FJ; Moya, M; Sanz-Rivas, D; Fernandez-Fernandez, J				Ayala, Francisco; Moreno-Perez, Victor; Vera-Garcia, Francisco J.; Moya, Manuel; Sanz-Rivas, David; Fernandez-Fernandez, Jaime			Acute and Time-Course Effects of Traditional and Dynamic Warm-Up Routines in Young Elite Junior Tennis Players	PLOS ONE			English	Article							POST-ACTIVATION POTENTIATION; WEIGHTED VEST; POSTACTIVATION POTENTIATION; JUMPING PERFORMANCE; SPORTS-MEDICINE; STATIC STRETCH; POWER; EXERCISE; PROTOCOLS; STRENGTH	Despite the large number of studies that have examined the acute effects of different warm up modalities (WU) on physical performance, none of them have documented the time course of potential performance recovery in tennis players. The aim of this study was twofold: (a) to analyze and compare the acute effects of two different WU modalities (traditional WU [TWU] and dynamic WU [DWU]) on physical performance (i.e., CMJ, sprint, serve speed and accuracy) in elite junior players, as well as (b) to monitor the time course of any WU-induced changes after 30 and 60 min of simulated match-play. Twelve junior elite players completed both WUs modalities (TWU and DWU) in a counterbalanced order on separate days. In each experimental session, counter movement jump (CMJ), 20-m sprint, tennis serve speed and accuracy tests were performed before (immediately after TWU or DWU) during (30 min) and after 60 min of a simulated match play. Measures were compared via four factorial (WU intervention and time) repeated measures ANOVAs. There were main effects of WU (TWU and DWU) throughout the time for all the variables analysed. The results indicate that DWU routine led to significantly faster 20 m sprint times and higher CMJs as well as faster and more accurate tennis serves at both post warm-up and 30 min match-play testing moments in comparison with the scores reported by the TWU routine (p < 0.05; positive effects with a probability of > 75-99%). No significant intergroup differences were found at 60-min match-play testing moment in any variable (except for the 20 m sprint). Therefore, the findings of this study recommend for optimal performance in these elite tennis players, DWU routines should be performed prior to formal training and competition rather than TWU routines.	[Ayala, Francisco; Moreno-Perez, Victor; Vera-Garcia, Francisco J.; Moya, Manuel; Fernandez-Fernandez, Jaime] Miguel Hernandez Univ, Sports Res Ctr, Elche, Spain; [Sanz-Rivas, David; Fernandez-Fernandez, Jaime] Tennis Performance Res Grp, Madrid, Spain; [Sanz-Rivas, David] Royal Spanish Tennis Federat RFET, Madrid, Spain	Universidad Miguel Hernandez de Elche	Fernandez-Fernandez, J (corresponding author), Miguel Hernandez Univ, Sports Res Ctr, Elche, Spain.; Fernandez-Fernandez, J (corresponding author), Tennis Performance Res Grp, Madrid, Spain.	jaime.fernandez@goumh.umh.es	Fernandez-Fernandez, Jaime/AAO-9270-2020; PEREZ, VICTOR/ADL-7089-2022; MOYA, MANUEL/F-7172-2016; Sanz-Rivas, David/AAX-4630-2021; Vera-Garcia, Francisco J/L-7755-2014; Sanz-Rivas, David/J-6069-2018; Ayala, Francisco/AAB-2094-2020; Ayala, Francisco/L-2976-2014	MOYA, MANUEL/0000-0002-2291-5899; Sanz-Rivas, David/0000-0002-2577-4198; Vera-Garcia, Francisco J/0000-0003-4792-8087; Ayala, Francisco/0000-0003-2210-7389; Ayala, Francisco/0000-0003-2210-7389; Fernandez-Fernandez, Jaime/0000-0002-5284-303X				Amiri-Khorasani M, 2011, J STRENGTH COND RES, V25, P1647, DOI 10.1519/JSC.0b013e3181db9f41; Avela J, 1999, J APPL PHYSIOL, V86, P1283, DOI 10.1152/jappl.1999.86.4.1283; Avela J, 2004, J APPL PHYSIOL, V96, P2325, DOI 10.1152/japplphysiol.01010.2003; Batterham AM, 2006, INT J SPORT PHYSIOL, V1, P50, DOI 10.1123/ijspp.1.1.50; Behm DG, 2011, APPL PHYSIOL NUTR ME, V36, P790, DOI [10.1139/h11-107, 10.1139/H11-107]; Behm DG, 2011, EUR J APPL PHYSIOL, V111, P2633, DOI 10.1007/s00421-011-1879-2; Bingul BM, 2014, ANTHROPOLOGIST, V18, P777, DOI 10.1080/09720073.2014.11891609; Bishop D, 2003, SPORTS MED, V33, P439, DOI 10.2165/00007256-200333060-00005; Bishop D, 2013, J HUM SPORT EXERC, V8, P391, DOI 10.4100/jhse.2012.82.07; BOSCO C, 1983, EUR J APPL PHYSIOL O, V50, P273, DOI 10.1007/BF00422166; Brandenburg J, 2007, INTJ SPORT PHYSIOL, V2, P170, DOI 10.1123/ijspp.2.2.170; Carvalho FLP, 2012, J STRENGTH COND RES, V26, P2447, DOI 10.1519/JSC.0b013e31823f2b36; Chaouachi A, 2010, J STRENGTH COND RES, V24, P2001, DOI 10.1519/JSC.0b013e3181aeb181; Chattong C, 2010, J STRENGTH COND RES, V24, P1751, DOI 10.1519/JSC.0b013e3181ddf665; Chatzopoulos DE, 2007, J STRENGTH COND RES, V21, P1278; Cilli M, 2014, BIOL SPORT, V31, P277, DOI 10.5604/20831862.1120935; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cramer JT, 2007, J SPORT SCI, V25, P687, DOI 10.1080/02640410600818416; Cramer JT, 2004, J STRENGTH COND RES, V18, P236, DOI 10.1519/00124278-200405000-00006; Cronin JB, 2005, J STRENGTH COND RES, V19, P349; Edwards DA, 2010, HORM BEHAV, V58, P606, DOI 10.1016/j.yhbeh.2010.06.015; Faigenbaum AD, 2006, J ATHL TRAINING, V41, P357; Fernandez-Fernandez J, 2014, BRIT J SPORT MED, V48, DOI 10.1136/bjsports-2013-093152; Fernandez-Fernandez J, 2013, J SPORT SCI MED, V12, P232; Fernandez-Fernandez J, 2009, STRENGTH COND J, V31, P15, DOI 10.1519/SSC.0b013e3181ada1cb; Fletcher IM, 2010, J STRENGTH COND RES, V24, P2096, DOI 10.1519/JSC.0b013e3181e312db; Fowles JR, 2000, J APPL PHYSIOL, V89, P1179, DOI 10.1152/jappl.2000.89.3.1179; Fukutani A, 2014, J ELECTROMYOGR KINES, V24, P240, DOI 10.1016/j.jelekin.2014.01.002; Gelen E, 2012, J SPORT SCI MED, V11, P600; Girard O, 2005, MED SCI SPORT EXER, V37, P1021, DOI 10.1249/01.mss.0000171619.99391.bb; Gourgoulis V, 2003, J STRENGTH COND RES, V17, P342, DOI 10.1519/00124278-200305000-00021; Gullich A., 1996, NEW STUDIES ATHLETIC, V11, P67; Hodgson M, 2005, SPORTS MED, V35, P585, DOI 10.2165/00007256-200535070-00004; Hopkins WG, 2000, SPORTS MED, V30, P1, DOI 10.2165/00007256-200030010-00001; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Hornery DJ, 2007, BRIT J SPORT MED, V41, P531, DOI 10.1136/bjsm.2006.031351; International Tennis Federation (ITF, INJ PREV WARM UP; Kay AD, 2012, MED SCI SPORT EXER, V44, P154, DOI 10.1249/MSS.0b013e318225cb27; Knudson D, 2005, EUR J APPL PHYSIOL, V94, P348, DOI 10.1007/s00421-004-1309-9; Knudson DV, 2004, J STRENGTH COND RES, V18, P654; Kovacs M, 2009, DYNAMIC STRETCHING R; Little T, 2006, J STRENGTH COND RES, V20, P203; Mizuno T, 2013, INT J SPORTS MED, V34, P484, DOI 10.1055/s-0032-1327655; Paradisis GP, 2014, J STRENGTH COND RES, V28, P154, DOI 10.1519/JSC.0b013e318295d2fb; Perrier ET, 2011, J STRENGTH COND RES, V25, P1925, DOI 10.1519/JSC.0b013e3181e73959; Pluim B, 2007, BRIT J SPORT MED, V41, DOI 10.1136/bjsm.2007.040865; Reiman MP, 2010, J STRENGTH COND RES, V24, P3387, DOI 10.1519/JSC.0b013e3181f159bd; Simic L, 2013, SCAND J MED SCI SPOR, V23, P131, DOI 10.1111/j.1600-0838.2012.01444.x; Stewart M, 2007, J SCI MED SPORT, V10, P403, DOI 10.1016/j.jsams.2006.10.001; Taylor KL, 2009, J SCI MED SPORT, V12, P657, DOI 10.1016/j.jsams.2008.04.004; Thompsen AG, 2007, J STRENGTH COND RES, V21, P52, DOI 10.1519/00124278-200702000-00010; Tillin NA, 2009, SPORTS MED, V39, P147, DOI 10.2165/00007256-200939020-00004; Turki O, 2012, J STRENGTH COND RES, V26, P63, DOI 10.1519/JSC.0b013e31821ef846; Yamaguchi T, 2007, J STRENGTH COND RES, V21, P1238, DOI 10.1519/00124278-200711000-00044; Young WB, 2003, J SPORT MED PHYS FIT, V43, P21; Zois J, 2011, J SCI MED SPORT, V14, P522, DOI 10.1016/j.jsams.2011.03.012	56	30	30	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0152790	10.1371/journal.pone.0152790	http://dx.doi.org/10.1371/journal.pone.0152790			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27071014	Green Published, gold, Green Submitted			2022-12-27	WOS:000373900700017
J	Basrai, HS; Christie, KJ; Turbic, A; Bye, N; Turnley, AM				Basrai, Harleen S.; Christie, Kimberly J.; Turbic, Alisa; Bye, Nicole; Turnley, Ann M.			Suppressor of Cytokine Signaling-2 (SOCS2) Regulates the Microglial Response and Improves Functional Outcome after Traumatic Brain Injury in Mice	PLOS ONE			English	Article							CONTROLLED CORTICAL IMPACT; CD40 GENE-EXPRESSION; SUBVENTRICULAR ZONE; NEURITE OUTGROWTH; ERYTHROPOIETIN; NEUROGENESIS; PROLIFERATION; CELLS; DIFFERENTIATION; RECOVERY	Traumatic brain injury (TBI) is frequently characterized by neuronal, axonal and myelin loss, reactive gliosis and neuroinflammation, often associated with functional deficits. Endogenous repair mechanisms include production of new neurons from precursor cells, but usually the new neurons fail to integrate and survive more than a few weeks. This is in part mediated by the toxic and inflammatory environment present in the injured brain which activates precursor cells to proliferate and differentiate but limits survival of the newborn progeny. Therefore, an understanding of mechanisms that regulate production and survival of newborn neurons and the neuroinflammatory response after brain injury may lead to therapeutic options to improve outcomes. Suppressor of Cytokine Signaling 2 (SOCS2) promotes hippocampal neurogenesis and survival of newborn neurons in the adult brain and regulates anti-inflammatory responses in the periphery, suggesting it may be a useful candidate to improve outcomes of TBI. In this study the functional and cellular responses of SOCS2 over-expressing transgenic (SOCS2Tg) mice were compared to wildtype litter-mates following mild or moderately severe TBI. Unlike wildtype controls, SOCS2Tg mice showed functional improvement on a ladder test, with a smaller lesion volume at 7d post injury and increased numbers of proliferative CD11b(+) microglia/macrophages at 35d post-injury in the mild injury paradigm. At 7d post-moderately severe injury there was an increase in the area covered by cells expressing an anti-inflammatory M2 phenotype marker (CD206(+)) but no difference in cells with a pro-inflammatory M1 phenotype marker (CD16/32(+)). No effect of SOCS2 overexpression was observed in production or survival of newborn neurons, even in the presence of the neuroprotective agent erythropoietin (EPO). Therefore, SOCS2 may improve outcome of TBI in mice by regulating aspects of the neuroinflammatory response, promoting a more anti-inflammatory environment, although this was not sufficient to enhance survival of newborn cortical neurons.	[Basrai, Harleen S.; Christie, Kimberly J.; Turbic, Alisa; Bye, Nicole; Turnley, Ann M.] Univ Melbourne, Dept Anat & Neurosci, Parkville, Vic 3052, Australia	University of Melbourne	Turnley, AM (corresponding author), Univ Melbourne, Dept Anat & Neurosci, Parkville, Vic 3052, Australia.	turnley@unimelb.edu.au			National Health and Medical Research Council of Australia [1045125, 628344]; Stem Cells Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Stem Cells Australia	This work was supported by funding from the National Health and Medical Research Council of Australia (www.nhmrc.gov.au): Project grant 1045125 to AMT and Fellowship 628344 to AMT, as well as support from Stem Cells Australia (www.stemcellsaustralia.edu.au) to HSB and AMT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Baciu I, 2000, Rom J Physiol, V37, P3; Baker BJ, 2009, TRENDS IMMUNOL, V30, P392, DOI 10.1016/j.it.2009.07.001; Blizzard CA, 2011, CEREB CORTEX, V21, P281, DOI 10.1093/cercor/bhq091; Buffo A, 2010, BIOCHEM PHARMACOL, V79, P77, DOI 10.1016/j.bcp.2009.09.014; Bye N, 2007, EXP NEUROL, V204, P220, DOI 10.1016/j.expneurol.2006.10.013; Chehrehasa F, 2009, J NEUROSCI METH, V177, P122, DOI 10.1016/j.jneumeth.2008.10.006; Chen XR, 2007, J NEUROTRAUM, V24, P1119, DOI 10.1089/neu.2006.0216; Cherian L, 2007, J PHARMACOL EXP THER, V322, P789, DOI 10.1124/jpet.107.119628; Cherry JD, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-98; Choi JS, 2009, J NEUROTRAUM, V26, P2097, DOI [10.1089/neu.2008.0793, 10.1089/neu.2008-0793]; Chong ZZ, 2003, BRIT J PHARMACOL, V138, P1107, DOI 10.1038/sj.bjp.0705161; Christie KJ, 2013, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00070; Costine BA, 2015, DEV NEUROSCI-BASEL, V37, P115, DOI 10.1159/000369091; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Dent KA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121541; Esper L, 2012, AM J PATHOL, V181, P130, DOI 10.1016/j.ajpath.2012.03.042; Faul M, 2010, TRAUMATIC BRAIN INJU, DOI DOI 10.15620/CDC.5571; Gao X, 2013, EXP NEUROL, V239, P38, DOI 10.1016/j.expneurol.2012.09.012; Goldshmit Y, 2004, J BIOL CHEM, V279, P16349, DOI 10.1074/jbc.M312873200; Goldshmit Y, 2004, EUR J NEUROSCI, V20, P2260, DOI 10.1111/j.1460-9568.2004.03698.x; Greenhalgh CJ, 2002, J BIOL CHEM, V277, P40181, DOI 10.1074/jbc.C200450200; Hellewell SC, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-156; Hsieh CL, 2013, EUR J IMMUNOL, V43, P2010, DOI 10.1002/eji.201243084; HU XM, 2012, STROKE, V43, P3063, DOI DOI 10.1161/STR0KEAHA.112.659656; Iverson GL, 2005, CURRENT OPINION PSYC, DOI [10.1097/00001504-200505000-00013, DOI 10.1097/00001504-200505000-00013]; Jia XX, 2012, J TRAUMA ACUTE CARE, V73, P1168, DOI 10.1097/TA.0b013e318246eaf4; Kernie SG, 2001, J NEUROSCI RES, V66, P317, DOI 10.1002/jnr.10013; Kim YH, 2010, STEM CELLS, V28, P1816, DOI 10.1002/stem.511; Koketsu D, 2006, EXP NEUROL, V199, P92, DOI 10.1016/j.expneurol.2006.03.012; Krantz S B, 1988, Contrib Nephrol, V66, P25; Liu F, 2009, J NEUROSCI, V29, P5075, DOI 10.1523/JNEUROSCI.0201-09.2009; LONGIN A, 1993, J HISTOCHEM CYTOCHEM, V41, P1833, DOI 10.1177/41.12.8245431; Lu DY, 2005, J NEUROTRAUM, V22, P1011, DOI 10.1089/neu.2005.22.1011; Machado FS, 2006, NAT MED, V12, P330, DOI 10.1038/nm1355; Metcalf D, 2000, NATURE, V405, P1069, DOI 10.1038/35016611; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Ng SY, 2012, J NEUROTRAUM, V29, P1410, DOI 10.1089/neu.2011.2188; Parent JM, 2002, ANN NEUROL, V52, P802, DOI 10.1002/ana.10393; Qin HW, 2006, J IMMUNOL, V177, P7761, DOI 10.4049/jimmunol.177.11.7761; Qin HW, 2006, FASEB J, V20, P985, DOI 10.1096/fj.05-5493fje; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Ramaswamy S, 2005, BRAIN RES, V1053, P38, DOI 10.1016/j.brainres.2005.06.042; Ransome MI, 2008, HIPPOCAMPUS, V18, P1034, DOI 10.1002/hipo.20463; Ransome MI, 2007, J NEUROCHEM, V102, P1953, DOI 10.1111/j.1471-4159.2007.04684.x; Ransome MI, 2005, NEUROSCIENCE, V132, P673, DOI 10.1016/j.neuroscience.2004.12.041; Rico-Bautista E, 2006, CYTOKINE GROWTH F R, V17, P431, DOI 10.1016/j.cytogfr.2006.09.008; Rolls A, 2009, NAT REV NEUROSCI, V10, P235, DOI 10.1038/nrn2591; Saha B, 2013, STEM CELL RES, V11, P965, DOI 10.1016/j.scr.2013.06.006; Salman H, 2004, J NEUROTRAUM, V21, P283, DOI 10.1089/089771504322972077; Shear DA, 2004, BRAIN RES, V1026, P11, DOI 10.1016/j.brainres.2004.07.087; Sun D, 2007, EXP NEUROL, V204, P264, DOI 10.1016/j.expneurol.2006.11.005; Turnley AM, 2002, NAT NEUROSCI, V5, P1155, DOI 10.1038/nn954; Turtzo LC, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-82; Uren RT, 2014, FRONT MOL NEUROSCI, V7, DOI [10.3389/fnmo1.2014.00039, 10.3389/fnmol.2014.00039]; Uren RT, 2014, J NEUROCHEM, V129, P614, DOI 10.1111/jnc.12671; Wang GH, 2013, J CEREBR BLOOD F MET, V33, P1864, DOI 10.1038/jcbfm.2013.146; Wang L, 2004, NEUROREPORT, V15, P1225, DOI 10.1097/01.wnr.0000127636.15181.c1; Wei ZX, 2015, NEUROSCI LETT, V606, P48, DOI 10.1016/j.neulet.2015.08.032; Xiong Y, 2011, TRANSL STROKE RES, V2, P619, DOI 10.1007/s12975-011-0120-2; Xiong Y, 2010, J NEUROTRAUM, V27, P205, DOI 10.1089/neu.2009.1001; Yatsiv I, 2005, FASEB J, V19, P1701, DOI 10.1096/fj.05-3907fje; Yu XB, 2002, DEVELOPMENT, V129, P505; Zheng WM, 2013, J NEUROTRAUM, V30, P1872, DOI 10.1089/neu.2010.1579	64	20	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0153418	10.1371/journal.pone.0153418	http://dx.doi.org/10.1371/journal.pone.0153418			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27071013	Green Submitted, Green Published, gold			2022-12-27	WOS:000373900700065
J	Duhrsen, L; Emami, P; Matschke, J; Abboud, T; Westphal, M; Regelsberger, J				Duehrsen, Lasse; Emami, Pedram; Matschke, Jakob; Abboud, Tammam; Westphal, Manfred; Regelsberger, Jan			Meninigiomas of the Craniocervical Junction - A Distinctive Subgroup of Meningiomas	PLOS ONE			English	Article							FORAMEN MAGNUM MENINGIOMAS; OF-THE-LITERATURE; MICROSURGICAL RESECTION; LABELING INDEX; CLASSIFICATION; PREDICTION; MANAGEMENT; RECURRENCE; ANTIGEN; SYSTEM	Objective Meningioma of the cranio-cervical junction is a rare diagnosis and demand a thorough surgical planning as radical excision of these tumors is difficult. In this context recurrence is most likely due to regrowth of residual tumor. The aim of this study was to evaluate the clinical course of patients operated for craniocervical meningioma (CCM) and to investigate the histological features of these tumors and their impact on recurrence rate. Methods All patients who were operated for CCM at our institution between 2003 and 2012 were identified. Presenting symptoms, MRI findings, surgical approaches and recurrence rate were reviewed retrospectively using medical charts. Histological features of the included tumors were studied focusing on subtypes and MIB-1 immunoreactivity and compared with MIB-1 immunoreactivity in an age and gender-matched control group of patients with supratentorial meningioma. Results 18 patients with CCM with a mean age of 56.2 years and median follow-up of 60 months were included in the study. Sensory or motor deficit was the most frequent presenting symptom followed by neck pain and lower cranial nerve palsy. Simpson grade II resection was achieved in 16 patients and Simpson grade III resection in two patients. Mortality, morbidity and recurrence rates were 16.7%, 5.5% and 5.5%, respectively. According to the WHO-grading all were found to be grade I meningiomas. Histological subtypes included meningotheliomatous (10), transitional (2), fibrillar (2), angiomatous (3) and secretory (1) meningioma. The mean MIB-1 labeling index in the study group was significantly higher than in the control group, (7.2% and 3.6%, respectively), p < 0.05. There was no correlation between MIB-1 levels and tumor recurrence. Conclusions CCM seems to have a benign character. Despite a significantly higher MIB-1 index, a high rate of recurrence was not observed. Therefore, approaches with high morbidity are not justified. Nevertheless, in view of the challenging approaches with limited access to the lesion, CCM should be considered a distinctive clinical subgroup.	[Duehrsen, Lasse; Emami, Pedram; Abboud, Tammam; Westphal, Manfred; Regelsberger, Jan] Univ Klinikum Hamburg Eppendorf, Dept Neurosurg, Hamburg, Germany; [Matschke, Jakob] Univ Klinikum Hamburg Eppendorf, Inst Neuropathol, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Duhrsen, L (corresponding author), Univ Klinikum Hamburg Eppendorf, Dept Neurosurg, Hamburg, Germany.	l.duehrsen@uke.de	Matschke, Jakob/F-6641-2013	Matschke, Jakob/0000-0001-6080-0198				Abry E, 2010, PATHOL RES PRACT, V206, P810, DOI 10.1016/j.prp.2010.09.002; Arnautovic KI, 2000, J NEUROSURG, V92, P71, DOI 10.3171/spi.2000.92.1.0071; Bassiouni H, 2006, NEUROSURGERY, V59, P1177, DOI 10.1227/01.NEU.0000245629.77968.37; Bruneau M, 2008, NEUROSURG REV, V31, P19, DOI 10.1007/s10143-007-0097-1; CATTORETTI G, 1992, J PATHOL, V168, P357, DOI 10.1002/path.1711680404; Eicker SO, 2015, NEUROSURG FOCUS, V38, DOI 10.3171/2015.2.FOCUS14799; Flores BC, 2013, NEUROSURG FOCUS, V35, DOI 10.3171/2013.10.FOCUS13332; Hwang WL, 2016, NEURO-ONCOLOGY, V18, P863, DOI 10.1093/neuonc/nov285; LEVY WJ, 1982, J NEUROSURG, V57, P804, DOI 10.3171/jns.1982.57.6.0804; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Marciscano AE, 2016, J NEUROSURG, V124, P106, DOI 10.3171/2015.1.JNS142228; McGovern SL, 2010, J NEUROSURG, V112, P925, DOI 10.3171/2009.9.JNS09617; MEYER FB, 1984, J NEUROSURG, V61, P136, DOI 10.3171/jns.1984.61.1.0136; Moller ML, 1997, J NEURO-ONCOL, V34, P241, DOI 10.1023/A:1005794700267; OHTA M, 1994, CANCER, V74, P3176, DOI 10.1002/1097-0142(19941215)74:12<3176::AID-CNCR2820741217>3.0.CO;2-N; Oya S, 2012, J NEUROSURG, V117, P121, DOI 10.3171/2012.3.JNS111945; Riemenschneider MJ, 2006, LANCET NEUROL, V5, P1045, DOI 10.1016/S1474-4422(06)70625-1; Roser F, 2004, ACTA NEUROCHIR, V146, P37, DOI 10.1007/s00701-003-0173-4; Sade B, 2007, NEUROSURGERY, V61, P1194, DOI 10.1227/01.neu.0000306097.38141.65; Samii M, 1996, NEUROSURGERY, V39, P1086, DOI 10.1097/00006123-199612000-00003; Scheitzach J, 2014, J NEURO-ONCOL, V116, P381, DOI 10.1007/s11060-013-1309-x; Talacchi A, 2012, NEUROSURG REV, V35, P359, DOI 10.1007/s10143-012-0381-6; YASUOKA S, 1978, J NEUROSURG, V49, P828, DOI 10.3171/jns.1978.49.6.0828	23	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0153405	10.1371/journal.pone.0153405	http://dx.doi.org/10.1371/journal.pone.0153405			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27070421	Green Submitted, gold, Green Published			2022-12-27	WOS:000373900700061
J	Okubo, M; Yamanaka, H; Kobayashi, K; Dai, Y; Kanda, H; Yagi, H; Noguchi, K				Okubo, Masamichi; Yamanaka, Hiroki; Kobayashi, Kimiko; Dai, Yi; Kanda, Hirosato; Yagi, Hideshi; Noguchi, Koichi			Macrophage-Colony Stimulating Factor Derived from Injured Primary Afferent Induces Proliferation of Spinal Microglia and Neuropathic Pain in Rats	PLOS ONE			English	Article							PERIPHERAL-NERVE INJURY; DORSAL-ROOT GANGLION; FACIAL NUCLEUS; PLASMINOGEN-ACTIVATOR; CELL-PROLIFERATION; LANGERHANS CELLS; MESSENGER-RNAS; CSF RECEPTOR; GM-CSF; NEURONS	Peripheral nerve injury induces proliferation of microglia in the spinal cord, which can contribute to neuropathic pain conditions. However, candidate molecules for proliferation of spinal microglia after injury in rats remain unclear. We focused on the colony-stimulating factors (CSFs) and interleukin-34 (IL-34) that are involved in the proliferation of the mononuclear phagocyte lineage. We examined the expression of mRNAs for macrophage-CSF (MCSF), granulocyte macrophage-CSF (GM-CSF), granulocyte-CSF (G-CSF) and IL-34 in the dorsal root ganglion (DRG) and spinal cord after spared nerve injury (SNI) in rats. RT-PCR and in situ hybridization revealed that M-CSF and IL-34, but not GM- or G-CSF, mRNAs were constitutively expressed in the DRG, and M-CSF robustly increased in injured-DRG neurons. M-CSF receptor mRNA was expressed in naive rats and increased in spinal microglia following SNI. Intrathecal injection of M-CSF receptor inhibitor partially but significantly reversed the proliferation of spinal microglia and in early phase of neuropathic pain induced by SNI. Furthermore, intrathecal injection of recombinant M-CSF induced microglial proliferation and mechanical allodynia. Here, we demonstrate that MCSF is a candidate molecule derived from primary afferents that induces proliferation of microglia in the spinal cord and leads to induction of neuropathic pain after peripheral nerve injury in rats.	[Okubo, Masamichi; Yamanaka, Hiroki; Kobayashi, Kimiko; Kanda, Hirosato; Yagi, Hideshi; Noguchi, Koichi] Hyogo Coll Med, Dept Anat & Neurosci, Nishinomiya, Hyogo 6638501, Japan; [Dai, Yi] Hyogo Univ Hlth Sci, Sch Pharm, Dept Pharm, Kobe, Hyogo 6508530, Japan	Hyogo College of Medicine	Noguchi, K (corresponding author), Hyogo Coll Med, Dept Anat & Neurosci, Nishinomiya, Hyogo 6638501, Japan.	noguchi@hyo-med.ac.jp		, Hirosato/0000-0003-2547-9073; Yagi, Hideshi/0000-0002-8506-8965	MEXT-supported Program for the Strategic Research Foundation at Private Universities from the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) [20451200]	MEXT-supported Program for the Strategic Research Foundation at Private Universities from the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT)	This work was supported in part by MEXT-supported Program for the Strategic Research Foundation at Private Universities (Grant #: 20451200) to KN from the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT; www.mext.go.jp). This work was also supported by the Grants-in-Aid for Researchers Hyogo College of Medicine 2014-15 (www.hyo-med.ac.jp) to KO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BORYCKI AG, 1993, BIOCHIM BIOPHYS ACTA, V1174, P143, DOI 10.1016/0167-4781(93)90108-P; Bourette RP, 2000, GROWTH FACTORS, V17, P155, DOI 10.3109/08977190009001065; Chihara T, 2010, CELL DEATH DIFFER, V17, P1917, DOI 10.1038/cdd.2010.60; Decosterd I, 2000, PAIN, V87, P149, DOI 10.1016/S0304-3959(00)00276-1; Du Yan S, 1997, P NATL ACAD SCI USA, V94, P5296; Echeverry S, 2008, PAIN, V135, P37, DOI 10.1016/j.pain.2007.05.002; Echeverry S, 2011, J NEUROSCI, V31, P10819, DOI 10.1523/JNEUROSCI.1642-11.2011; Elmore MRP, 2014, NEURON, V82, P380, DOI 10.1016/j.neuron.2014.02.040; Greter M, 2012, IMMUNITY, V37, P1050, DOI 10.1016/j.immuni.2012.11.001; Guan Z, 2015, NATURE NEUROSCIENCE; Han SW, 1996, GENE, V175, P101, DOI 10.1016/0378-1119(96)00131-X; Hao AJ, 2001, J NEUROSCI RES, V64, P79, DOI 10.1002/jnr.1056; Honda S, 2001, J NEUROSCI, V21, P1975, DOI 10.1523/JNEUROSCI.21-06-01975.2001; Imai Y, 2002, GLIA, V40, P164, DOI 10.1002/glia.10149; Jenkins SJ, 2014, TRENDS IMMUNOL, V35, P358, DOI 10.1016/j.it.2014.06.006; Ji RR, 2013, PAIN, V154, pS10, DOI 10.1016/j.pain.2013.06.022; Ji RR, 2009, BRAIN RES REV, V60, P135, DOI 10.1016/j.brainresrev.2008.12.011; Jin SX, 2003, J NEUROSCI, V23, P4017; Kalmar B, 2003, EXP NEUROL, V184, P636, DOI 10.1016/S0014-4886(03)00343-1; Kierdorf K, 2013, NAT NEUROSCI, V16, P273, DOI 10.1038/nn.3318; KITAMURA T, 1991, P NATL ACAD SCI USA, V88, P5082, DOI 10.1073/pnas.88.12.5082; Kobayashi K, 2005, J COMP NEUROL, V481, P377, DOI 10.1002/cne.20393; Kobayashi K, 2008, J NEUROSCI, V28, P2892, DOI 10.1523/JNEUROSCI.5589-07.2008; Kobayashi K, 2006, J COMP NEUROL, V498, P443, DOI 10.1002/cne.21066; Lim TKY, 2014, PAIN, V155, P954, DOI 10.1016/j.pain.2014.01.026; Lin HS, 2008, SCIENCE, V320, P807, DOI 10.1126/science.1154370; Liu L, 2000, EXP BRAIN RES, V131, P64, DOI 10.1007/s002219900273; Luo J, 2013, J EXP MED, V210, P157, DOI 10.1084/jem.20120412; Ma XL, 2012, STRUCTURE, V20, P676, DOI 10.1016/j.str.2012.02.010; Nakamichi Y, 2013, J BONE MINER METAB, V31, P486, DOI 10.1007/s00774-013-0476-3; Nicola N A, 1990, Immunol Ser, V49, P77; Okubo M, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-57; Okubo M, 2010, GLIA, V58, P599, DOI 10.1002/glia.20948; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; Papavasiliou AK, 1997, NEUROSURGERY, V41, P916, DOI 10.1097/00006123-199710000-00028; RAIVICH G, 1991, J NEUROSCI RES, V30, P682, DOI 10.1002/jnr.490300412; Reeves G, 2014, HEALTH PHYS, V106, P699, DOI 10.1097/HP.0000000000000090; Sasmono RT, 2003, BLOOD, V101, P1155, DOI 10.1182/blood-2002-02-0569; Schweizerhof M, 2009, NAT MED, V15, P802, DOI 10.1038/nm.1976; Shadduck RK, 1996, EXP HEMATOL, V24, P314; Shiratori M, 2010, J NEUROCHEM, V114, P810, DOI 10.1111/j.1471-4159.2010.06809.x; SMITH LR, 1994, IMMUNOGENETICS, V39, P80, DOI 10.1007/BF00171806; Takeuchi A, 2001, J NEUROSCI RES, V65, P38, DOI 10.1002/jnr.1125; Tozaki-Saitoh H, 2008, J NEUROSCI, V28, P4949, DOI 10.1523/JNEUROSCI.0323-08.2008; Tsujino H, 2000, MOL CELL NEUROSCI, V15, P170, DOI 10.1006/mcne.1999.0814; Trang T, 2011, NEURON GLIA BIOL, V7, P99, DOI 10.1017/S1740925X12000087; Wang YM, 2012, NAT IMMUNOL, V13, P753, DOI 10.1038/ni.2360; Wen YR, 2011, J FORMOS MED ASSOC, V110, P487, DOI 10.1016/S0929-6646(11)60074-0; Yamamoto S, 2012, GLIA, V60, P570, DOI 10.1002/glia.22291; Yamamoto S, 2010, J NEUROCHEM, V115, P1057, DOI 10.1111/j.1471-4159.2010.06996.x; Yamanaka H, 2005, NEUROSCIENCE, V132, P183, DOI 10.1016/j.neuroscience.2004.12.003; Yamanaka H, 2004, EUR J NEUROSCI, V19, P93, DOI 10.1046/j.1460-9568.2003.03080.x; Yamanaka H, 2007, EUR J NEUROSCI, V25, P1097, DOI 10.1111/j.1460-9568.2007.05344.x; Zhuang ZY, 2007, BRAIN BEHAV IMMUN, V21, P642, DOI 10.1016/j.bbi.2006.11.003	54	55	57	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0153375	10.1371/journal.pone.0153375	http://dx.doi.org/10.1371/journal.pone.0153375			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27071004	gold, Green Published			2022-12-27	WOS:000373900700057
J	Velie, BD; Shrestha, M; Francois, L; Schurink, A; Tesfayonas, YG; Stinckens, A; Blott, S; Ducro, BJ; Mikko, S; Thomas, R; Swinburne, JE; Sundqvist, M; Eriksson, S; Buys, N; Lindgren, G				Velie, Brandon D.; Shrestha, Merina; Francois, Liesbeth; Schurink, Anouk; Tesfayonas, Yohannes G.; Stinckens, Anneleen; Blott, Sarah; Ducro, Bart J.; Mikko, Sofia; Thomas, Ruth; Swinburne, June E.; Sundqvist, Marie; Eriksson, Susanne; Buys, Nadine; Lindgren, Gabriella			Using an Inbred Horse Breed in a High Density Genome-Wide Scan for Genetic Risk Factors of Insect Bite Hypersensitivity (IBH)	PLOS ONE			English	Article							ASSOCIATION; DERMATITIS; ECZEMA	While susceptibility to hypersensitive reactions is a common problem amongst humans and animals alike, the population structure of certain animal species and breeds provides a more advantageous route to better understanding the biology underpinning these conditions. The current study uses Exmoor ponies, a highly inbred breed of horse known to frequently suffer from insect bite hypersensitivity, to identify genomic regions associated with a type I and type IV hypersensitive reaction. A total of 110 cases and 170 controls were genotyped on the 670K Axiom Equine Genotyping Array. Quality control resulted in 452,457 SNPs and 268 individuals being tested for association. Genome-wide association analyses were performed using the GenABEL package in R and resulted in the identification of two regions of interest on Chromosome 8. The first region contained the most significant SNP identified, which was located in an intron of the DCC netrin 1 receptor gene. The second region identified contained multiple top SNPs and encompassed the PIGN, KIAA1468, TNFRSF11A, ZCCHC2, and PHLPP1 genes. Although additional studies will be needed to validate the importance of these regions in horses and the relevance of these regions in other species, the knowledge gained from the current study has the potential to be a step forward in unraveling the complex nature of hypersensitive reactions.	[Velie, Brandon D.; Shrestha, Merina; Tesfayonas, Yohannes G.; Mikko, Sofia; Eriksson, Susanne; Lindgren, Gabriella] Swedish Univ Agr Sci, Dept Anim Breeding & Genet, Uppsala, Sweden; [Francois, Liesbeth; Stinckens, Anneleen; Buys, Nadine] Katholieke Univ Leuven, Dept Biosyst, Res Grp Livestock Genet, Leuven, Belgium; [Schurink, Anouk; Ducro, Bart J.] Wageningen Univ, Anim Breeding & Genom Ctr, NL-6700 AP Wageningen, Netherlands; [Blott, Sarah] Univ Nottingham, Sch Vet Med & Sci, Nottingham NG7 2RD, England; [Thomas, Ruth] Exmoor Pony Soc, Cullompton, England; [Swinburne, June E.] Anim DNA Diagnost Ltd, Cambridge, Cambs, England; [Swinburne, June E.] Anim Hlth Trust, Newmarket, Suffolk, England; [Sundqvist, Marie] Ostra Greda Res Grp, Borgholm, Sweden	Swedish University of Agricultural Sciences; KU Leuven; Wageningen University & Research; University of Nottingham; Animal Health Trust	Velie, BD (corresponding author), Swedish Univ Agr Sci, Dept Anim Breeding & Genet, Uppsala, Sweden.	brandon.velie@slu.se	Ducro, Bart/E-7012-2012; Eriksson, Susanne/F-1276-2017; Mikko, Sofia/F-1347-2017	Eriksson, Susanne/0000-0003-3357-5065; Mikko, Sofia/0000-0002-6375-1376; Lindgren, Gabriella/0000-0001-6046-9669; Sundquist, Marie/0000-0003-0766-8073; Blott, Sarah/0000-0003-0233-6846; Buys, Nadine/0000-0002-7313-3088	European Union's Seventh Framework Programme (FP7) [606142]; Exmoor Pony Society in UK; Swedish Research Council (FORMAS); European Graduate School of Animal Breeding and Genetics (EGS-ABG)	European Union's Seventh Framework Programme (FP7); Exmoor Pony Society in UK; Swedish Research Council (FORMAS)(Swedish Research CouncilSwedish Research Council Formas); European Graduate School of Animal Breeding and Genetics (EGS-ABG)	The research leading to these results has received funding from the European Union's Seventh Framework Programme managed by REA-Research Executive Agency, http://ec.europa.eu/research/rea (FP7/2007-2013) under grant agreement no. [606142], The Exmoor Pony Society in UK, The Swedish Research Council (FORMAS), and European Graduate School of Animal Breeding and Genetics (EGS-ABG). Animal DNA Diagnostics, the current employer of JES, had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section and occurred during the author's tenure at the Animal Health Trust.	Andersson LS, 2012, IMMUNOGENETICS, V64, P201, DOI 10.1007/s00251-011-0573-1; Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010; Equus Survival Trust, 2015, 2015 EQ CONS LIST; Eriksson S, 2008, ANIMAL, V2, P360, DOI 10.1017/S1751731107001413; Everitt BS, 2010, HANDBOOK OF STATISTICAL ANALYSES USING R, 2ND EDITION, P1; Exmoor Pony Society, WELCOME TO THE WORLD; Fehlker M, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-64; Jeru I, 2014, ARTHRITIS RHEUMATOL, V66, P2621, DOI 10.1002/art.38727; Jonsdottir S, 2015, VET IMMUNOL IMMUNOP, V166, P8, DOI 10.1016/j.vetimm.2015.05.002; Klumplerova M, 2013, MOL BIOL REP, V40, P3333, DOI 10.1007/s11033-012-2408-z; Larsen FS, 1996, J AM ACAD DERMATOL, V34, P760, DOI 10.1016/S0190-9622(96)90009-2; MARTI E, 1992, EQUINE VET J, V24, P113, DOI 10.1111/j.2042-3306.1992.tb02794.x; Panagiotou OA, 2012, INT J EPIDEMIOL, V41, P273, DOI 10.1093/ije/dyr178; Petersen JL, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054997, 10.1371/journal.pone.0069819]; Price AL, 2010, NAT REV GENET, V11, P459, DOI 10.1038/nrg2813; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rare Breeds Survival Trust, RAR NAT BREEDS EQ; Sargolzaei M., 2006, Proceedings of the 8th World Congress on Genetics Applied to Livestock Production, Belo Horizonte, Minas Gerais, Brazil, 13-18 August, 2006, P27; Schaffartzik A, 2012, VET IMMUNOL IMMUNOP, V147, P113, DOI 10.1016/j.vetimm.2012.03.017; Schurink A, 2013, ANIM GENET, V44, P44, DOI 10.1111/j.1365-2052.2012.02368.x; Schurink A, 2011, J ANIM SCI, V89, P1286, DOI 10.2527/jas.2010-3222; Schurink A, 2012, ANIMAL GENETICS, V44, P44; Shrestha M, 2015, J HERED, V106, P366, DOI 10.1093/jhered/esv033; Sicherer SH, 2015, J ALLERGY CLIN IMMUN, V135, P357, DOI 10.1016/j.jaci.2014.12.1906; Simpson CR, 2009, J ROY SOC MED, V102, P108, DOI 10.1258/jrsm.2009.080211; Spriggs M, 2012, J ZOO WILDLIFE MED, V43, P652, DOI 10.1638/2011-0243R2.1; Tengvall K, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003475; The American Livestock Breeds Conservancy, BREED INF EXM PON; Van Grevenhof EM, 2007, EQUINE VET J, V39, P69, DOI 10.2746/042516407X153020; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Wood P., 2011, UNDERSTANDING IMMUNO, V3rd; Yosipovitch G, 2002, INT J DERMATOL, V41, P212, DOI 10.1046/j.1365-4362.2002.01460.x	32	21	21	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0152966	10.1371/journal.pone.0152966	http://dx.doi.org/10.1371/journal.pone.0152966			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27070818	Green Published, gold, Green Submitted			2022-12-27	WOS:000373900700023
J	Simonaro, CM; Tomatsu, S; Sikora, T; Kubaski, F; Frohbergh, M; Guevara, JM; Wang, RY; Vera, M; Kang, JL; Smith, LJ; Schuchman, EH; Haskins, ME				Simonaro, Calogera M.; Tomatsu, Shunji; Sikora, Tracy; Kubaski, Francyne; Frohbergh, Michael; Guevara, Johana M.; Wang, Raymond Y.; Vera, Moin; Kang, Jennifer L.; Smith, Lachlan J.; Schuchman, Edward H.; Haskins, Mark E.			Pentosan Polysulfate: Oral Versus Subcutaneous Injection in Mucopolysaccharidosis Type I Dogs	PLOS ONE			English	Article							ENZYME REPLACEMENT THERAPY; CREUTZFELDT-JAKOB-DISEASE; CELL TRANSPLANTATION; HURLER-SYNDROME; MPS-I; STORAGE; OSTEOARTHRITIS; INVOLVEMENT; PROGRESSION; INFUSION	Background We previously demonstrated the therapeutic benefits of pentosan polysulfate (PPS) in a rat model of mucopolysaccharidosis (MPS) type VI. Reduction of inflammation, reduction of glycosaminoglycan (GAG) storage, and improvement in the skeletal phenotype were shown. Herein, we evaluate the long-term safety and therapeutic effects of PPS in a large animal model of a different MPS type, MPS I dogs. We focused on the arterial phenotype since this is one of the most consistent and clinically significant features of the model. Methodology/Principal Findings MPS I dogs were treated with daily oral or biweekly subcutaneous (subQ) PPS at a human equivalent dose of 1.6 mg/kg for 17 and 12 months, respectively. Safety parameters were assessed at 6 months and at the end of the study. Following treatment, cytokine and GAG levels were determined in fluids and tissues. Assessments of the aorta and carotid arteries also were performed. No drug-related increases in liver enzymes, coagulation factors, or other adverse effects were observed. Significantly reduced IL-8 and TNF-alpha were found in urine and cerebrospinal fluid (CSF). GAG reduction was observed in urine and tissues. Increases in the luminal openings and reduction of the intimal media thickening occurred in the carotids and aortas of PPS-treated animals, along with a reduction of storage vacuoles. These results were correlated with a reduction of GAG storage, reduction of clusterin 1 staining, and improved elastin integrity. No significant changes in the spines of the treated animals were observed. Conclusions PPS treatment led to reductions of pro-inflammatory cytokines and GAG storage in urine and tissues of MPS I dogs, which were most evident after subQ administration. SubQ administration also led to significant cytokine reductions in the CSF. Both treatment groups exhibited markedly reduced carotid and aortic inflammation, increased vessel integrity, and improved histopathology. We conclude that PPS may be a safe and useful therapy for MPS I, either as an adjunct or as a stand-alone treatment that reduces inflammation and GAG storage.	[Simonaro, Calogera M.; Frohbergh, Michael; Guevara, Johana M.; Schuchman, Edward H.] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Tomatsu, Shunji; Kubaski, Francyne] Nemours Alfred I duPont Hosp Children, Skeletal Dysplasia Lab, Wilmington, DE USA; [Sikora, Tracy; Haskins, Mark E.] Univ Penn, Sch Vet Med, Philadelphia, PA 19104 USA; [Guevara, Johana M.] Pontificia Univ Javeriana, Bogota, Colombia; [Wang, Raymond Y.; Vera, Moin] Childrens Hosp Orange Cty, Div Metab Disorders, Orange, CA 92668 USA; [Wang, Raymond Y.] Harbor UCLA Med Ctr, Dept Pediat, Div Med Genet, Torrance, CA 90509 USA; [Kang, Jennifer L.; Smith, Lachlan J.] Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA	Icahn School of Medicine at Mount Sinai; Nemours Alfred I. duPont Hospital for Children; University of Pennsylvania; Pontificia Universidad Javeriana; Childrens Hospital of Orange County; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of Pennsylvania	Simonaro, CM (corresponding author), Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA.	calogera.simonaro@mssm.edu	Wang, Raymond Yu Jeang/H-8870-2019; Kubaski, Francyne/M-2410-2017; GUEVARA-MORALES, JOHANA M./AAF-9014-2019; Wang, Raymond Yu Jeang/CAJ-3535-2022	Wang, Raymond Yu Jeang/0000-0001-6494-7613; Kubaski, Francyne/0000-0002-9330-0154; Sikora, Tracey/0000-0002-5102-0859; Smith, Lachlan/0000-0001-5823-6073; Guevara Morales, Johana Maria/0000-0002-9467-4430; Kang, Jennifer/0000-0003-3597-9290	Ryan Foundation; MPS1 Research Foundation; National Center for Research Resources [1S10OD018523-01]; National Institute of Diabetes and Digestive and Kidney Diseases [5R21DK096182, 1R01DK087185, P40OD010939]; National Institute of Arthritis and Musculoskeletal and Skin Diseases [1R01AR057397]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR057397, P30AR069619, R03AR065142] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK096182, R01DK087185, R01DK054481] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010939] Funding Source: NIH RePORTER	Ryan Foundation; MPS1 Research Foundation; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was funded by The Ryan Foundation, recipient: Calogera Maria Simonaro; MPS1 Research Foundation, recipient: Calogera Maria Simonaro; National Center for Research Resources, award number: 1S10OD018523-01; National Institute of Diabetes and Digestive and Kidney Diseases, award number: 5R21DK096182, recipient: Calogera Maria Simonaro; National Institute of Diabetes and Digestive and Kidney Diseases, award number: 1R01DK087185, recipient: Calogera Maria Simonaro; National Institute of Diabetes and Digestive and Kidney Diseases, award number: P40OD010939, recipient: Mark E. Haskins; National Institute of Arthritis and Musculoskeletal and Skin Diseases, award number: 1R01AR057397, recipient: Mark E. Haskins.	Al-Sannaa NA, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0344-4; Aldenhoven M, 2015, BLOOD, V125, P2164, DOI 10.1182/blood-2014-11-608075; Anger JT, 2011, INT UROGYNECOL J, V22, P395, DOI 10.1007/s00192-010-1252-8; Budsberg SC, 2007, VET SURG, V36, P234, DOI 10.1111/j.1532-950X.2007.00256.x; Chiaro JA, 2014, J BONE MINER RES, V29, P2610, DOI 10.1002/jbmr.2290; Chiaro JA, 2013, BONE, V55, P78, DOI 10.1016/j.bone.2013.03.014; Clarke LA, 2015, BEST PRACT RES CL EN, V29, P219, DOI 10.1016/j.beem.2014.08.010; Clarke LA, 2011, RHEUMATOLOGY, V50, pV13, DOI 10.1093/rheumatology/ker395; Dickson PI, 2010, MOL GENET METAB, V101, P115, DOI 10.1016/j.ymgme.2010.06.020; DIEMER V, 1992, J BIOL CHEM, V267, P5257; Eliyahu E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022447; FRANCIS DJ, 1993, RHEUMATOL INT, V13, P61, DOI 10.1007/BF00307735; Frohbergh M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100882; Ghosh P, 2001, BEST PRACT RES CL RH, V15, P693, DOI 10.1053/berh.2001.0188; Herrero LJ, 2015, J VIROL, V89, P8063, DOI 10.1128/JVI.00224-15; Honda H, 2012, NEUROPATHOLOGY, V32, P124, DOI 10.1111/j.1440-1789.2011.01245.x; Ishii T, 2001, ATHEROSCLEROSIS, V158, P215, DOI 10.1016/S0021-9150(01)00416-6; Khalid O, 2016, PLOS ONE IN PRESS; Kilgore KS, 1998, J PHARMACOL EXP THER, V285, P987; Kramer CM, 2014, AUST VET J, V92, P482, DOI 10.1111/avj.12266; Lampe C, 2013, RHEUM DIS CLIN N AM, V39, P431, DOI 10.1016/j.rdc.2013.03.004; Langereis EJ, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-155; Losonczy Hajna, 1993, Orvosi Hetilap, V134, P291; Lyons JA, 2011, LAB INVEST, V91, P665, DOI 10.1038/labinvest.2011.7; MENON KP, 1992, GENOMICS, V14, P763, DOI 10.1016/S0888-7543(05)80182-X; Muenzer J, 2014, MOL GENET METAB, V111, P63, DOI 10.1016/j.ymgme.2013.11.015; Neufeld EF, 2001, MUCOPOLYSACCHARIDOSE, P3421, DOI DOI 10.1036/OMMBID.165; Nickel JC, 2015, J UROLOGY, V193, P857, DOI 10.1016/j.juro.2014.09.036; Oguma T, 2007, ANAL BIOCHEM, V368, P79, DOI 10.1016/j.ab.2007.05.016; Parry A, 2007, J NEUROL NEUROSUR PS, V78, P733, DOI 10.1136/jnnp.2006.104505; Pfirrmann CWA, 2001, SPINE, V26, P1873, DOI 10.1097/00007632-200109010-00011; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Schuchman EH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054459; SHULL RM, 1982, AM J PATHOL, V109, P244; SHULL RM, 1984, AM J PATHOL, V114, P487; SHULL RM, 1994, P NATL ACAD SCI USA, V91, P12937, DOI 10.1073/pnas.91.26.12937; Sifuentes M, 2007, MOL GENET METAB, V90, P171, DOI 10.1016/j.ymgme.2006.08.007; Simonaro CM, 2010, P NATL ACAD SCI USA, V107, P222, DOI 10.1073/pnas.0912937107; Simonaro CM, 2001, LAB INVEST, V81, P1319, DOI 10.1038/labinvest.3780345; Todd NV, 2005, J INFECTION, V50, P394, DOI 10.1016/j.jinf.2004.07.015; Tomatsu S, 2015, DRUG DES DEV THER, V9, P1937, DOI 10.2147/DDDT.S68562; Walter BA, 2015, SPINE, V40, P955, DOI 10.1097/BRS.0000000000000932; Wu J, 2011, LAB INVEST, V91, P1459, DOI 10.1038/labinvest.2011.93; Yano S, 2014, J INHERIT METAB DIS, V37, P255, DOI 10.1007/s10545-013-9642-y	44	25	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2016	11	4							e0153136	10.1371/journal.pone.0153136	http://dx.doi.org/10.1371/journal.pone.0153136			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0KH	27064989	Green Published, Green Submitted, gold			2022-12-27	WOS:000373891000033
J	Mallory, HS; Howard, AF; Weiss, MR				Mallory, Heather S.; Howard, Aaron F.; Weiss, Martha R.			Timing of Environmental Enrichment Affects Memory in the House Cricket, Acheta domesticus	PLOS ONE			English	Article							CELL-PROLIFERATION; NEUROGENESIS; BRAIN; REWARD	Learning appears to be ubiquitous among animals, as it plays a key role in many behaviors including foraging and reproduction. Although there is some genetic basis for differences in learning ability and memory retention, environment also plays an important role, as it does for any other trait. For example, adult animals maintained in enriched housing conditions learn faster and remember tasks for longer than animals maintained in impoverished conditions. Such plasticity in adult learning ability has often been linked to plasticity in the brain, and studies aimed at understanding the mechanisms, stimuli, and consequences of adult behavioral and brain plasticity are numerous. However, the role of experiences during postembryonic development in shaping plasticity in adult learning ability and memory retention remain relatively unexplored. Using the house cricket (Acheta domesticus) as a model organism, we developed a protocol to allow the odor preference of a large number of crickets to be tested in a short period of time. We then used this new protocol to examine how enrichment or impoverishment at two developmental stages (either the last nymphal instar or young adult) affected adult memory. Our results show that regardless of nymphal rearing conditions, crickets that experienced an enriched rearing condition as young adults performed better on a memory task than individuals that experienced an impoverished condition. Older adult crickets (more than 1 week post adult molt) did not demonstrate differences in memory of the odor task, regardless of rearing condition as a young adult. Our results suggest that environmentally-induced plasticity in memory may be restricted to the young adult stage.	[Mallory, Heather S.; Weiss, Martha R.] Georgetown Univ, Dept Biol, Washington, DC 20057 USA; [Howard, Aaron F.] NE Illinois Univ, Dept Biol, Chicago, IL 60625 USA; [Mallory, Heather S.] Ravenscroft Sch, Dept Sci, Raleigh, NC USA; [Howard, Aaron F.] Franklin & Marshall Coll, Dept Biol, Lancaster, PA 17604 USA	Georgetown University; Franklin & Marshall College	Mallory, HS (corresponding author), Georgetown Univ, Dept Biol, Washington, DC 20057 USA.; Mallory, HS (corresponding author), Ravenscroft Sch, Dept Sci, Raleigh, NC USA.	heather.mallory@ravenscroft.org			Georgetown University's Graduate School of Arts and Sciences; Georgetown University's Department of Biology; Georgetown University's Center for the Brain Basis of Cognition	Georgetown University's Graduate School of Arts and Sciences; Georgetown University's Department of Biology; Georgetown University's Center for the Brain Basis of Cognition	Funding was provided by Georgetown University's Graduate School of Arts and Sciences, by Georgetown University's Department of Biology, and by a seed grant from Georgetown University's Center for the Brain Basis of Cognition. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral OB, 2008, PHYSIOL BEHAV, V93, P388, DOI 10.1016/j.physbeh.2007.09.009; [Anonymous], 2009, ARCH SEX BEHAV, DOI DOI 10.1007/s10508-008-9314-4; BENNETT EL, 1974, PHYSIOL BEHAV, V12, P621, DOI 10.1016/0031-9384(74)90212-1; Burns JG, 2011, P ROY SOC B-BIOL SCI, V278, P923, DOI 10.1098/rspb.2010.2488; Cayre M, 2002, COMP BIOCHEM PHYS B, V132, P1, DOI 10.1016/S1096-4959(01)00525-5; Chapman RF, 2002, J MORPHOL, V254, P186, DOI 10.1002/jmor.10026; Coolen I, 2005, CURR BIOL, V15, P1931, DOI 10.1016/j.cub.2005.09.015; Dickel L, 2000, DEV PSYCHOBIOL, V36, P101, DOI 10.1002/(SICI)1098-2302(200003)36:2<101::AID-DEV2>3.0.CO;2-L; Dubnau J, 1998, ANNU REV NEUROSCI, V21, P407, DOI 10.1146/annurev.neuro.21.1.407; Dukas R, 2003, ANIM BEHAV, V66, P741, DOI 10.1006/anbe.2002.2261; Dukas R, 1998, COGNITIVE ECOLOGY EV; Iso H, 2007, BEHAV BRAIN RES, V179, P90, DOI 10.1016/j.bbr.2007.01.025; Kobayashi S, 2002, J NEUROSCI RES, V70, P340, DOI 10.1002/jnr.10442; Kolb B, 2012, P NATL ACAD SCI USA, V109, P17186, DOI 10.1073/pnas.1121251109; Leadbeater E, 2007, CURR BIOL, V17, pR703, DOI 10.1016/j.cub.2007.06.012; Lomassese SS, 2000, J NEUROBIOL, V45, P162; Malaterre J, 2002, J COMP NEUROL, V452, P215, DOI 10.1002/cne.10319; Matsumoto Y, 2000, J EXP BIOL, V203, P2581; Matsumoto Y, 2004, LEARN MEMORY, V11, P288, DOI 10.1101/lm.72504; Matsumoto Y, 2002, J COMP PHYSIOL A, V188, P295, DOI 10.1007/s00359-002-0303-0; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Opstad R, 2004, J INSECT PHYSIOL, V50, P725, DOI 10.1016/j.jinsphys.2004.05.010; RENNER MJ, 1986, DEV PSYCHOBIOL, V19, P303, DOI 10.1002/dev.420190403; Scotto-Lomassese S, 2002, CURR BIOL, V12, P1001, DOI 10.1016/S0960-9822(02)00889-8; Shettleworth, 2010, COGNITION EVOLUTION; Unoki S, 2005, EUR J NEUROSCI, V22, P1409, DOI 10.1111/j.1460-9568.2005.04318.x; Unoki S, 2006, EUR J NEUROSCI, V24, P2031, DOI 10.1111/j.1460-9568.2006.05099.x; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Williams BM, 2001, PHYSIOL BEHAV, V73, P649, DOI 10.1016/S0031-9384(01)00543-1	30	9	9	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2016	11	4							e0152245	10.1371/journal.pone.0152245	http://dx.doi.org/10.1371/journal.pone.0152245			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6JK	27058038	Green Submitted, Green Published, gold			2022-12-27	WOS:000373604800004
J	Cai, ZB; Zhao, L; Zhang, X; Yue, W; Zhu, MH				Cai, Zhen-bing; Zhao, Lei; Zhang, Xu; Yue, Wen; Zhu, Min-hao			Combined Effect of Textured Patterns and Graphene Flake Additives on Tribological Behavior under Boundary Lubrication	PLOS ONE			English	Article							NANOFLUIDS; NANOSHEETS; GRAPHITE; ROUTE	A ball-on-plate wear test was employed to investigate the effectiveness of graphene (GP) nanoparticles dispersed in a synthetic-oil-based lubricant in reducing wear. The effect by area ratio of elliptically shaped dimple textures and elevated temperatures were also explored. Pure PAO4 based oil and a mixture of this oil with 0.01 wt% GP were compared as lubricants. At pit area ratio of 5%, GP-base oil effectively reduced friction and wear, especially at 60 and 100 degrees C. Under pure PAO4 oil lubrication, the untextured surfaces gained low friction coefficients (COFs) and wear rates under 60 and 100 degrees C. With increasing laser-texture area ratio, the COF and wear rate decreased at 25 and 150 degrees C but increased at 60 and 100 degrees C. Under the GP-based oil lubrication, the textured surface with 5% area ratio achieved the lowest COF among those of the area ratios tested at all test temperatures. Meanwhile, the textured surface with 20% area ratio obtained the highest COF among those of the area ratios. With the joint action of GP and texture, the textured surface with 10% area ratio exhibited the best anti-wear performance among all of the textured surfaces at all test temperatures.	[Cai, Zhen-bing; Zhao, Lei; Zhang, Xu; Zhu, Min-hao] Southwest Jiaotong Univ, Tribol Res Inst, Minist Educ, Key Lab Adv Technol Mat, Chengdu 610031, Peoples R China; [Yue, Wen] China Univ Geosci, Sch Engn & Technol, Dept Mech Engn, Beijing 100083, Peoples R China	Southwest Jiaotong University; China University of Geosciences	Cai, ZB (corresponding author), Southwest Jiaotong Univ, Tribol Res Inst, Minist Educ, Key Lab Adv Technol Mat, Chengdu 610031, Peoples R China.	czb-jiaoda@126.com	Yue, Wen/G-8980-2013	Yue, Wen/0000-0003-1622-9953				Berger C, 2004, J PHYS CHEM B, V108, P19912, DOI 10.1021/jp040650f; Cai ZB, 2015, WEAR, V332, P1158, DOI 10.1016/j.wear.2015.01.064; Chae HK, 2004, NATURE, V427, P523, DOI 10.1038/nature02311; Costa HL, 2007, TRIBOL INT, V40, P1227, DOI 10.1016/j.triboint.2007.01.014; Eswaraiah V, 2011, ACS APPL MATER INTER, V3, P4221, DOI 10.1021/am200851z; Etsion I, 2005, J TRIBOL-T ASME, V127, P248, DOI 10.1115/1.1828070; Etsion I, 2009, TRIBOL INT, V42, P542, DOI 10.1016/j.triboint.2008.02.015; Feng XF, 2013, ACS NANO, V7, P1718, DOI 10.1021/nn305722d; Geim AK, 2007, NAT MATER, V6, P183, DOI 10.1038/nmat1849; Hirata M, 2004, CARBON, V42, P2929, DOI 10.1016/j.carbon.2004.07.003; Kovalchenko A, 2004, TRIBOL T, V47, P299, DOI 10.1080/05698190490440902; Lee K, 2009, TRIBOL LETT, V35, P127, DOI 10.1007/s11249-009-9441-7; Leven I, 2013, J PHYS CHEM LETT, V4, P115, DOI 10.1021/jz301758c; Li D, 2008, NAT NANOTECHNOL, V3, P101, DOI 10.1038/nnano.2007.451; Lin JS, 2011, TRIBOL LETT, V41, P209, DOI 10.1007/s11249-010-9702-5; Meyer JC, 2007, SOLID STATE COMMUN, V143, P101, DOI 10.1016/j.ssc.2007.02.047; N'guessan HE, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2247; Pettersson U, 2003, TRIBOL INT, V36, P857, DOI 10.1016/S0301-679X(03)00104-X; Senatore A, 2013, ISRN TRIBOLOGY, V2013; Song HJ, 2011, APPL PHYS A-MATER, V105, P827, DOI 10.1007/s00339-011-6636-1; Tadmor R, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.266101; Taha-Tijerina J, 2013, WEAR, V302, P1241, DOI 10.1016/j.wear.2012.12.010; [汤勇 Tang Yong], 2010, [机械工程学报, Chinese Journal of Mechanical Engineering], V46, P93; Varrla E, 2011, ACS APPL MATER INTER, V3, P4221; Wei JX, 2014, TRIBOL LETT, V53, P521, DOI 10.1007/s11249-013-0290-z; Zhang WQ, 2011, LUBR ENG, V9	26	17	18	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0152143	10.1371/journal.pone.0152143	http://dx.doi.org/10.1371/journal.pone.0152143			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27054762	gold, Green Published			2022-12-27	WOS:000373608000013
J	Li, HB; Xu, ZQ; Zhang, WC; Wang, SQ; Zhang, GT; Xiao, T				Li, Haibo; Xu, Zhiqiang; Zhang, Wuchang; Wang, Shaoqing; Zhang, Guangtao; Xiao, Tian			Boreal Tintinnid Assemblage in the Northwest Pacific and Its Connection with the Japan Sea in Summer 2014	PLOS ONE			English	Article							SOUTHWESTERN ATLANTIC; MEDITERRANEAN SEA; MICROZOOPLANKTON; BIOGEOGRAPHY; DIVERSITY; ABUNDANCE; ECOLOGY; PATTERNS; TRENDS; LORICA	Tintinnids are planktonic ciliates that play an important role in marine ecosystem. According to their distribution in the world oceans, tintinnid genera were divided into several biogeographical types such as boreal, warm water, austral and neritic. Therefore, the oceanic tintinnid assemblage could be correspondingly divided into boreal assemblage, warm water assemblage and austral assemblage. The purpose of this study was to investigate the characteristics of boreal tintinnid assemblage in the Northwest Pacific and the Arctic, and to identify the connection between boreal tintinnid assemblage and neighboring assemblages. Surface water samples were collected along a transect from the East China Sea to the Chukchi Sea in summer 2014. According to the presence of boreal genera and warm water genera, three tintinnid assemblages (the East China Sea neritic assemblage, the Japan Sea warm water assemblage, and the boreal assemblage) were identified along the transect. The boreal assemblage extended from the Chukchi Sea to the waters north of the Soya Strait. Densities peaks occurred at stations in the two branches of the Alaska Current and decreased both northward and southward. The densities were <10 ind./dm(3) at most stations in Arctic region. The dominant genera (Acanthostomella, Codonellopsis, Parafavella, and Ptychocylis) accounted for 79.07 +/- 29.67% (n = 49) of the abundance in the boreal assemblage. The densities of the dominant genera covaried with strongly significant positive correlations. Tintinnids with lorica oral diameter of 22-26 mu m and 38-42 mu m were dominant and contributed 67.35% and 15.13%, respectively, to the total abundance in the boreal assemblage. The distribution and densities of tintinnids in the study area suggest that the Soya Strait might be a geographical barrier for tintinnids expansion.	[Li, Haibo; Xu, Zhiqiang; Zhang, Wuchang; Zhang, Guangtao; Xiao, Tian] Chinese Acad Sci, Inst Oceanol, Key Lab Marine Ecol & Environm Sci, Qingdao, Peoples R China; [Li, Haibo; Xu, Zhiqiang; Zhang, Wuchang; Zhang, Guangtao; Xiao, Tian] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Ecol & Environm Sci, Qingdao, Peoples R China; [Wang, Shaoqing] Chinese Acad Sci, Inst Oceanol, Marine Biol Museum, Qingdao, Peoples R China; [Li, Haibo; Xu, Zhiqiang] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Qingdao National Laboratory for Marine Science & Technology; Chinese Academy of Sciences; Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhang, WC (corresponding author), Chinese Acad Sci, Inst Oceanol, Key Lab Marine Ecol & Environm Sci, Qingdao, Peoples R China.; Zhang, WC (corresponding author), Qingdao Natl Lab Marine Sci & Technol, Lab Marine Ecol & Environm Sci, Qingdao, Peoples R China.	wuchangzhang@163.com			Chinese Polar Environment Comprehensive investigation & Assessment Programs; Strategic Priority Research Program-Western Pacific Ocean System: Structure, Dynamics and Consequences [XDA11030202]; China Arctic Strategic Fund [20140304]	Chinese Polar Environment Comprehensive investigation & Assessment Programs; Strategic Priority Research Program-Western Pacific Ocean System: Structure, Dynamics and Consequences; China Arctic Strategic Fund	Chinese Polar Environment Comprehensive investigation & Assessment Programs (CHINARE2011-2015)", Strategic Priority Research Program-Western Pacific Ocean System: Structure, Dynamics and Consequences (Grant No. XDA11030202.2) and "China Arctic Strategic Fund (20140304).	DAVIS CC, 1978, CAN J ZOOL, V56, P1822, DOI 10.1139/z78-248; Dolan JR, 2007, BIOGEOSCIENCES, V4, P297, DOI 10.5194/bg-4-297-2007; Dolan JR, 2014, ACTA PROTOZOOL, V53, P101, DOI 10.4467/16890027AP.14.010.1447; Dolan JR, 2010, ACTA PROTOZOOL, V49, P235; Dolan JR, 2002, DEEP-SEA RES PT I, V49, P1217, DOI 10.1016/S0967-0637(02)00021-3; Dolan JR, 1999, DEEP-SEA RES PT I, V46, P2025, DOI 10.1016/S0967-0637(99)00043-6; Dolan JR, 2000, AQUAT MICROB ECOL, V22, P69, DOI 10.3354/ame022069; Dolan JR, 2013, BIOL ECOLOGY TINTINN; FAGER EW, 1963, SCIENCE, V140, P453, DOI 10.1126/science.140.3566.453; Haury L.R., 1978, NATO Conference Series IV Marine Sciences, V3, P277; Kofoid C.A., 1939, B MUSEUM COMP ZOOLOG; Kofoid CA, 1929, CONSPECTUS MARINE FR; Li H, 2016, DEEP-SEA RES PT II, V124, P84, DOI 10.1016/j.dsr2.2015.06.008; Longhurst, 2006, ECOLOGICAL GEOGRAPHY; Lynn D.H, 2008, CIL PROT CHAR CLASS, V3rd ed.; Modigh M, 2003, HYDROBIOLOGIA, V503, P251, DOI 10.1023/B:HYDR.0000008477.38383.d6; PICES, 2004, PICES SPEC PUBL, V1; PIERCE RW, 1992, REV AQUAT SCI, V6, P139; PIERCE RW, 1993, MAR ECOL PROG SER, V94, P11, DOI 10.3354/meps094011; Priede IG, 2014, PURE APPL GEOPHYS, V171, P1013, DOI 10.1007/s00024-013-0708-4; Santoferrara L, 2009, J PLANKTON RES, V31, P837, DOI 10.1093/plankt/fbp033; Senjyu T., 1999, J OCEANOGR, V55, P111, DOI [10.1023/A:1007825609622, DOI 10.1023/A:1007825609622]; Springer AM, 1996, FISH OCEANOGR, V5, P205, DOI 10.1111/j.1365-2419.1996.tb00118.x; Steele M, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2003JC002009; Taniguchi A., 1984, Memoirs of National Institute of Polar Research Special Issue, P63; Thompson GA, 2005, AQUAT MICROB ECOL, V40, P85, DOI 10.3354/ame040085; Thompson GA, 2004, AQUAT MICROB ECOL, V35, P93, DOI 10.3354/ame035093; Thompson GA, 1999, J PLANKTON RES, V21, P1265, DOI 10.1093/plankt/21.7.1265; WILLIAMS R, 1994, MAR ECOL PROG SER, V107, P263, DOI 10.3354/meps107263; Zhang W.C., 2012, ILLUSTRATED GUIDE CO	30	14	15	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153379	10.1371/journal.pone.0153379	http://dx.doi.org/10.1371/journal.pone.0153379			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27054884	Green Submitted, Green Published, gold			2022-12-27	WOS:000373608000126
J	MacLachlan, EW; Potter, K; Hamunime, N; Shepard-Perry, MG; Uusiku, J; Simwanza, R; Brandt, LJ; O'Malley, G				MacLachlan, Ellen W.; Potter, Katy; Hamunime, Ndapewa; Shepard-Perry, Mark G.; Uusiku, James; Simwanza, Ricky; Brandt, Laura J.; O'Malley, Gabrielle			"We Are Now Free to Speak": Qualitative Evaluation of an Education and Empowerment Training for HIV Patients in Namibia	PLOS ONE			English	Article							SELF-EFFICACY; ANTIRETROVIRAL TREATMENT; HEALTH-CARE; ADHERENCE; ENGAGEMENT; PREDICTORS; COMMUNICATION; INFECTION; PROVIDER; BARRIERS	Although numerous studies provide evidence that active patient engagement with health care providers improves critical outcomes such as medication adherence, very few of these have been done in low resource settings. In Namibia, patient education and empowerment trainings were conducted in four antiretroviral (ART) clinics to increase patient engagement during patient-provider interactions. This qualitative study supplements findings from a randomized controlled trial, by analyzing data from 10 in-depth patient interviews and 94 training evaluation forms. A blended approach of deductive and inductive coding was used to understand training impact. Findings indicated the trainings increased patients' self-efficacy through a combination of improved HIV-related knowledge, greater communication skills and enhanced ability to overcome complex psychosocial barriers, such as fear of speaking up to providers. This study suggests patient empowerment training may be a powerful method to engage HIV patients in their own care and treatment.	[MacLachlan, Ellen W.] PATH, Reprod Hlth Program, Seattle, WA USA; [MacLachlan, Ellen W.; Potter, Katy; O'Malley, Gabrielle] Univ Washington, Dept Global Hlth, Int Training & Educ Ctr Hlth I TECH, Seattle, WA 98195 USA; [Hamunime, Ndapewa; Simwanza, Ricky] Namibia Minist Hlth & Social Serv MoHSS, Windhoek, Namibia; [Shepard-Perry, Mark G.; Uusiku, James; Brandt, Laura J.] Int Training & Educ Ctr Hlth I TECH Namibia, Windhoek, Namibia	University of Washington; University of Washington Seattle	O'Malley, G (corresponding author), Univ Washington, Dept Global Hlth, Int Training & Educ Ctr Hlth I TECH, Seattle, WA 98195 USA.	gomalley@uw.edu		O&apos;Malley, Gabrielle/0000-0002-7514-8240	United States President's Emergency Plan for AIDS Relief (PEPFAR) through the Health Resources and Services Administration (HRSA); Centers for Disease Control and Prevention (CDC) [U91HA06801]; Namibian Government	United States President's Emergency Plan for AIDS Relief (PEPFAR) through the Health Resources and Services Administration (HRSA); Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Namibian Government	This work was funded by the United States President's Emergency Plan for AIDS Relief (PEPFAR: http://www.pepfar.gov/about/) through the Health Resources and Services Administration (HRSA: http://www.hrsa.gov/index.html) and the Centers for Disease Control and Prevention (CDC: http://www.cdc.gov/), Award #U91HA06801. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Sincere thanks to the Namibian Government and to the clinical staff and patients at the four ART clinics in the study for so strongly supporting this work.	Aujoulat I, 2007, PATIENT EDUC COUNS, V66, P13, DOI 10.1016/j.pec.2006.09.008; Bakken S, 2000, AIDS PATIENT CARE ST, V14, P189, DOI 10.1089/108729100317795; BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; Bezabhe WM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097353; Bosworth HB, 2006, PATIENT TREATMENT AD; Cegala DJ, 2009, PATIENT EDUC COUNS, V77, P202, DOI 10.1016/j.pec.2009.03.025; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Coulter A, 2012, J AMBUL CARE MANAG, V35, P80, DOI 10.1097/JAC.0b013e318249e0fd; Dewing S, 2015, AIDS CARE, V27, P342, DOI 10.1080/09540121.2014.994471; Fleissig A, 1999, PATIENT EDUC COUNS, V38, P69, DOI 10.1016/S0738-3991(98)00124-4; Flickinger TE, 2013, JAIDS-J ACQ IMM DEF, V63, P362, DOI 10.1097/QAI.0b013e318295b86a; Harrigan PR, 2005, J INFECT DIS, V191, P339, DOI 10.1086/427192; Johnson MO, 2011, AM J PUBLIC HEALTH, V101, P265, DOI 10.2105/AJPH.2009.189829; Johnson MO, 2006, AIDS PATIENT CARE ST, V20, P258, DOI 10.1089/apc.2006.20.258; Jonas A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100539; Kim YM, 2003, PATIENT EDUC COUNS, V50, P113; Kinnersley P, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004565.pub2; Langebeek N, 2014, BMC MED, V12, DOI [10.1186/s12916-014-0142-1, 10.1186/PREACCEPT-1453408941291432]; Layer EH, 2014, AIDS PATIENT CARE ST, V28, P483, DOI 10.1089/apc.2014.0077; Maclachlan EW, 2015, AIDS CARE, P1; Merten S, 2010, TROP MED INT HEALTH, V15, P16, DOI 10.1111/j.1365-3156.2010.02510.x; Ministry of Health and Social Services, 2013, GLOB AIDS RESP PROGR; Morse JM, 2000, QUAL HEALTH RES, V10, P3, DOI 10.1177/104973200129118183; O'Cathain A, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002889; Paterson DL, 2000, ANN INTERN MED, V133, P21, DOI 10.7326/0003-4819-133-1-200007040-00004; Patton M. Q., 2002, QUALITATIVE RES EVAL, V3rd; SANDELOWSKI M, 1995, RES NURS HEALTH, V18, P179, DOI 10.1002/nur.4770180211; Sanjobo N, 2008, SAHARA J-J SOC ASP H, V5, P136, DOI 10.1080/17290376.2008.9724912; Schlemmer A, 2006, SAMJ S AFR MED J, V96, P1084; Schwarzer R., 1995, SELF EFFICACY CHANGI, P259, DOI DOI 10.1017/CBO9780511527692.011; Tjituka F, 2013, NAMIBIA ANTIRETROVIR; UNAIDS, NAM HIV AIDS EST 201; Wachira J, 2014, INT J QUAL HEALTH C, V26, P190, DOI 10.1093/intqhc/mzu004; Ware NC, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001369; Watt MH, 2009, SOC SCI MED, V68, P1793, DOI 10.1016/j.socscimed.2009.02.037; Wolf MS, 2007, PATIENT EDUC COUNS, V65, P253, DOI 10.1016/j.pec.2006.08.006	36	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153042	10.1371/journal.pone.0153042	http://dx.doi.org/10.1371/journal.pone.0153042			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DI6KO	27054712	Green Submitted, Green Published, gold			2022-12-27	WOS:000373608000069
J	Nie, SJ; Xu, HL				Nie, Shengjun; Xu, Huilian			Riboflavin-Induced Disease Resistance Requires the Mitogen-Activated Protein Kinases 3 and 6 in Arabidopsis thaliana	PLOS ONE			English	Article							SYSTEMIC ACQUIRED-RESISTANCE; BETA-AMINOBUTYRIC ACID; SIGNAL-TRANSDUCTION; HYDROGEN-PEROXIDE; OXIDATIVE STRESS; BOTRYTIS-CINEREA; INNATE IMMUNITY; PHYTOALEXIN BIOSYNTHESIS; TRANSCRIPTION FACTOR; PATHOGEN DEFENSE	As a resistance elicitor, riboflavin (vitamin B-2) protects plants against a wide range of pathogens. At molecular biological levels, it is important to elucidate the signaling pathways underlying the disease resistance induced by riboflavin. Here, riboflavin was tested to induce resistance against virulent Pseudomonas syringae pv. Tomato DC3000 (Pst DC3000) in Arabidopsis. Results showed that riboflavin induced disease resistance based on MAPK-dependent priming for the expression of PR1 gene. Riboflavin induced transient expression of PR1 gene. However, following Pst DC3000 inoculation, riboflavin potentiated stronger PR1 gene transcription. Further was suggested that the transcript levels of mitogen-activated protein kinases, MPK3 and MPK6, were primed under riboflavin. Upon infection by Pst DC3000, these two enzymes were more strongly activated. The elevated activation of both MPK3 and MPK6 was responsible for enhanced defense gene expression and resistance after riboflavin treatment. Moreover, riboflavin significantly reduced the transcript levels of MPK3 and MPK6 by application of AsA and BAPTA, an H2O2 scavenger and a calcium (Ca2+) scavenger, respectively. In conclusion, MPK3 and MPK6 were responsible for riboflavin-induced resistance, and played an important role in H2O2- and Ca2+-related signaling pathways, and this study could provide a new insight into the mechanistic study of riboflavin-induced defense responses.	[Nie, Shengjun; Xu, Huilian] Int Nat Farming Res Ctr, Hata 5632, Matsumoto, Nagano 3901401, Japan		Xu, HL (corresponding author), Int Nat Farming Res Ctr, Hata 5632, Matsumoto, Nagano 3901401, Japan.	yf120nsj@163.com						Ahn IP, 2007, PLANT PHYSIOL, V143, P838, DOI 10.1104/pp.106.092627; Ahn IP, 2005, PLANT PHYSIOL, V138, P1505, DOI 10.1104/pp.104.058693; Alzwiy IA, 2007, PLANT SCI, V173, P302, DOI 10.1016/j.plantsci.2007.06.007; Anderson JC, 2011, PLANT J, V67, P258, DOI 10.1111/j.1365-313X.2011.04588.x; Asai S, 2010, PLANT J, V62, P911, DOI [10.1111/j.1365-313X.2010.04206.x, 10.1111/j.0960-7412.2010.04206.x]; Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Besteiro MAG, 2011, PLANT J, V68, P727, DOI 10.1111/j.1365-313X.2011.04725.x; Blume B, 2000, PLANT CELL, V12, P1425, DOI 10.1105/tpc.12.8.1425; Bowler C, 2000, TRENDS PLANT SCI, V5, P241, DOI 10.1016/S1360-1385(00)01628-9; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chung E, 2004, PLANTA, V220, P286, DOI 10.1007/s00425-004-1372-9; Colcombet J, 2008, BIOCHEM J, V413, P217, DOI 10.1042/BJ20080625; Combs G.F., 2008, VITAMINS FUNDAMENTAL; Conrath U, 2002, TRENDS PLANT SCI, V7, P210, DOI 10.1016/S1360-1385(02)02244-6; Conrath U, 2001, EUR J PLANT PATHOL, V107, P113, DOI 10.1023/A:1008768516313; Conrath U, 2006, MOL PLANT MICROBE IN, V19, P1062, DOI 10.1094/MPMI-19-1062; Conrath U, 2011, TRENDS PLANT SCI, V16, P524, DOI 10.1016/j.tplants.2011.06.004; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; de Jong CF, 2004, PLANT J, V39, P1, DOI 10.1111/j.1365-313X.2004.02110.x; Dong H, 2000, PHYTOPATHOLOGY, V90, P801, DOI 10.1094/PHYTO.2000.90.8.801; Dong XN, 1998, CURR OPIN PLANT BIOL, V1, P316, DOI 10.1016/1369-5266(88)80053-0; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; Fischer M, 2005, NAT PROD REP, V22, P324, DOI 10.1039/b210142b; Galletti R, 2011, PLANT PHYSIOL, V157, P804, DOI 10.1104/pp.111.174003; Gastaldi G, 1999, J NUTR, V129, P406, DOI 10.1093/jn/129.2.406; Grant M, 2000, PLANT J, V23, P441, DOI 10.1046/j.1365-313x.2000.00804.x; Gregory JF, 1998, ANNU REV NUTR, V18, P277, DOI 10.1146/annurev.nutr.18.1.277; Gust AA, 2007, J BIOL CHEM, V282, P32338, DOI 10.1074/jbc.M704886200; Han L, 2010, PLANT J, V64, P114, DOI 10.1111/j.1365-313X.2010.04318.x; HAYES MP, 1993, INFECT IMMUN, V61, P3222, DOI 10.1128/IAI.61.8.3222-3227.1993; HAYES MP, 1991, J LEUKOCYTE BIOL, V50, P176, DOI 10.1002/jlb.50.2.176; HERSKOWITZ I, 1995, CELL, V80, P187, DOI 10.1016/0092-8674(95)90402-6; Hirt H, 2000, P NATL ACAD SCI USA, V97, P2405, DOI 10.1073/pnas.97.6.2405; Ichimura K, 2002, TRENDS PLANT SCI, V7, P301, DOI 10.1016/S1360-1385(02)02302-6; Jakab G, 2001, EUR J PLANT PATHOL, V107, P29, DOI 10.1023/A:1008730721037; Jung HW, 2009, SCIENCE, V324, P89, DOI 10.1126/science.1170025; Kachroo A, 2003, TRANSGENIC RES, V12, P577, DOI 10.1023/A:1025896513472; Kim S, 2001, MOL CELLS, V11, P115; Kohler A, 2002, PLANT PHYSIOL, V128, P1046, DOI 10.1104/pp.010744; Kovtun Y, 2000, P NATL ACAD SCI USA, V97, P2940, DOI 10.1073/pnas.97.6.2940; Levine A, 1996, CURR BIOL, V6, P427, DOI 10.1016/S0960-9822(02)00510-9; Liu YD, 2004, PLANT CELL, V16, P3386, DOI 10.1105/tpc.104.026609; Mao GH, 2011, PLANT CELL, V23, P1639, DOI 10.1105/tpc.111.084996; Menke FLH, 2004, PLANT CELL, V16, P897, DOI 10.1105/tpc.015552; Mishina TE, 2007, PLANT J, V50, P500, DOI 10.1111/j.1365-313X.2007.03067.x; Mou Z, 2003, CELL, V113, P935, DOI 10.1016/S0092-8674(03)00429-X; Nakagami H, 2005, TRENDS PLANT SCI, V10, P339, DOI 10.1016/j.tplants.2005.05.009; Pei ZM, 2000, NATURE, V406, P731, DOI 10.1038/35021067; Pham LN, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030026; Ren DT, 2008, P NATL ACAD SCI USA, V105, P5638, DOI 10.1073/pnas.0711301105; Rentel MC, 2004, PLANT PHYSIOL, V135, P1471, DOI 10.1104/pp.104.042663; Roje S, 2007, PHYTOCHEMISTRY, V68, P1904, DOI 10.1016/j.phytochem.2007.03.038; Romeis T, 2001, EMBO J, V20, P5556, DOI 10.1093/emboj/20.20.5556; Sessa G, 2000, MICROBES INFECT, V2, P1591, DOI 10.1016/S1286-4579(00)01315-0; Tena G, 2001, CURR OPIN PLANT BIOL, V4, P392, DOI 10.1016/S1369-5266(00)00191-6; Ton J, 2004, PLANT J, V38, P119, DOI 10.1111/j.1365-313X.2004.02028.x; Van Loon LC, 1997, EUR J PLANT PATHOL, V103, P753, DOI 10.1023/A:1008638109140; Vorwieger A, 2007, PLANTA, V226, P147, DOI 10.1007/s00425-006-0476-9; Wang HC, 2007, PLANT CELL, V19, P63, DOI 10.1105/tpc.106.048298; Wang PC, 2010, PLANT CELL, V22, P2981, DOI 10.1105/tpc.109.072959; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; Xing Y, 2008, PLANT J, V54, P440, DOI 10.1111/j.1365-313X.2008.03433.x; Zhang SJ, 2009, J INTEGR PLANT BIOL, V51, P167, DOI 10.1111/j.1744-7909.2008.00763.x; Zhou CJ, 2009, PLANT PHYSIOL, V150, P167, DOI 10.1104/pp.108.133439; Zimmerli L, 2000, P NATL ACAD SCI USA, V97, P12920, DOI 10.1073/pnas.230416897; Zimmerli L, 2001, PLANT PHYSIOL, V126, P517, DOI 10.1104/pp.126.2.517; Zubay G, 1998, BIOCHEMISTRY	67	13	14	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153175	10.1371/journal.pone.0153175	http://dx.doi.org/10.1371/journal.pone.0153175			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27054585	Green Published, Green Submitted, gold			2022-12-27	WOS:000373608000092
J	Norlin, J; Fink, LN; Kvist, PH; Galsgaard, ED; Coppieters, K				Norlin, Jenny; Fink, Lisbeth Nielsen; Kvist, Peter Helding; Galsgaard, Elisabeth Douglas; Coppieters, Ken			Abatacept Treatment Does Not Preserve Renal Function in the Streptozocin-Induced Model of Diabetic Nephropathy	PLOS ONE			English	Article							RECRUITMENT; ACTIVATION; PODOCYTES; INJURY	Diabetic nephropathy (DN) is one of the most severe complications of diabetes and remains the largest cause of end-stage renal disease in the Western world. Treatment options are limited and novel therapies that effectively slow disease progression are warranted. Previous work suggested that treatment with CTLA4-Ig (abatacept), a molecule that binds and blocks B7-1 and is licensed for the treatment of rheumatoid arthritis, could ameliorate DN. This study was designed to assess whether B7-1 signalling constitutes a promising therapeutic pathway for DN. Mice injected with streptozotocin (STZ) were treated with abatacept and glycemia and renal function were assessed. No differences were found in diabetes progression, albumin excretion rates or albumin/creatine ratios, while mesangial expansion was unaltered at endpoint. Except for increased renal CCL5, treatment did not affect a panel of gene expression endpoints reflecting early fibrotic changes, inflammation and kidney injury. Finally, abatacept treatment effectively reduced the accumulation of activated CD4(+) T cells in the kidney, suggesting that renal T cell inflammation is not a driving factor in the pathology of the STZ model. In conjunction with the recent data discounting the expression of B7-1 on podocytes, our present data do not support a role for abatacept in DN treatment.	[Norlin, Jenny; Fink, Lisbeth Nielsen; Kvist, Peter Helding; Galsgaard, Elisabeth Douglas; Coppieters, Ken] Novo Nordisk AS, Malov, Denmark	Novo Nordisk	Coppieters, K (corresponding author), Novo Nordisk AS, Malov, Denmark.	kncp@novonordisk.com	Fink, Lisbeth/AAN-7830-2020		Novo Nordisk	Novo Nordisk(Novo Nordisk)	All work and editorial assistance was funded by Novo Nordisk. The funder provided support in the form of salaries for authors JN, LNF, PHK, EDG, and KC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; Editorial assistance was funded by Novo Nordisk. The authors thank Dr. Jorn Drostrup for providing extensive stability data on the frozen abatacept stock formulation used in this study.	Brosius FC, 2009, J AM SOC NEPHROL, V20, P2503, DOI 10.1681/ASN.2009070721; Chow FY, 2006, KIDNEY INT, V69, P73, DOI 10.1038/sj.ki.5000014; Doria A, 2012, SEMIN NEPHROL, V32, P437, DOI 10.1016/j.semnephrol.2012.07.006; Fiorina P, 2014, J AM SOC NEPHROL, V25, P1415, DOI 10.1681/ASN.2013050518; Gagliardini E, 2016, J AM SOC NEPHROL, V27, P999, DOI 10.1681/ASN.2015030266; Galkina E, 2006, J AM SOC NEPHROL, V17, P368, DOI 10.1681/ASN.2005080859; Goldwich A, 2013, J AM SOC NEPHROL, V24, P906, DOI 10.1681/ASN.2012020133; Krensky AM, 2007, NAT CLIN PRACT NEPHR, V3, P164, DOI 10.1038/ncpneph0418; Mezzano S, 2004, NEPHROL DIAL TRANSPL, V19, P2505, DOI 10.1093/ndt/gfh207; Moon JY, 2012, AM J NEPHROL, V35, P164, DOI 10.1159/000334928; Omote K, 2014, AM J PHYSIOL-RENAL, V306, pF1335, DOI 10.1152/ajprenal.00509.2013; Reiser J, 2004, J CLIN INVEST, V113, P1390, DOI 10.1172/JCI200420402; Saran R, 2015, AM J KIDNEY DIS, V66, pS1, DOI 10.1053/j.ajkd.2015.05.001; Schneider H, 2006, SCIENCE, V313, P1972, DOI 10.1126/science.1131078	14	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0152315	10.1371/journal.pone.0152315	http://dx.doi.org/10.1371/journal.pone.0152315			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27055155	Green Published, gold			2022-12-27	WOS:000373608000016
J	Uranga, S; Marinova, D; Martin, C; Pardo, J; Aguilo, N				Uranga, Santiago; Marinova, Dessislava; Martin, Carlos; Pardo, Julian; Aguilo, Nacho			Granzyme A Is Expressed in Mouse Lungs during Mycobacterium tuberculosis Infection but Does Not Contribute to Protection In Vivo	PLOS ONE			English	Article							CELL-DEATH; PERFORIN; INDUCE	Granzyme A, a serine protease expressed in the granules of cytotoxic T and Natural Killer cells, is involved in the generation of pro-inflammatory cytokines by macrophages. Granzyme A has been described to induce in macrophages in vitro the activation of pro-inflammatory pathways that impair intracellular mycobacterial replication. In the present study, we explored the physiological relevance of Granzyme A in the control of pulmonary Mycobacterium tuberculosis infection in vivo. Our results show that, even though Granzyme A is expressed by cytotoxic cells from mouse lungs during pulmonary infection, its deficiency in knockout mice does not have an effect in the control of M. tuberculosis infection. In addition our findings indicate that absence of Granzyme A does not affect the protection conferred by the live-attenuated M. tuberculosis vaccine MTBVAC. Altogether, our findings are in apparent contradiction with previously published in vitro results and suggest that Granzyme A does not have a crucial role in vivo in the protective response to tuberculosis.	[Uranga, Santiago; Marinova, Dessislava; Martin, Carlos; Aguilo, Nacho] Univ Zaragoza, Dpto Microbiol Med Prevent & Salud Publ, Grp Genet Micobacterias, C Domingo Miral S-N, E-50009 Zaragoza, Spain; [Uranga, Santiago; Marinova, Dessislava; Martin, Carlos; Aguilo, Nacho] Inst Salud Carlos III, CIBER Enfermedades Resp, Madrid, Spain; [Martin, Carlos] Hosp Univ Miguel Servet, ISS Aragon, Serv Microbiol, Paseo Isabel Catolica 1-3, Zaragoza 50009, Spain; [Pardo, Julian] 3 Aragon Hlth Res Inst IIS Aragon, Immune Effector Cells Grp ICE, Biomed Res Ctr Aragon CIBA, Edificio CIBA, Zaragoza, Spain; [Pardo, Julian] Univ Zaragoza, Nanosci Inst Aragon INA, E-50009 Zaragoza, Spain; [Pardo, Julian] Fdn Aragon I D ARAID, Gobierno Aragon, Zaragoza, Spain	University of Zaragoza; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III; Miguel Servet University Hospital; University of Zaragoza	Aguilo, N (corresponding author), Univ Zaragoza, Dpto Microbiol Med Prevent & Salud Publ, Grp Genet Micobacterias, C Domingo Miral S-N, E-50009 Zaragoza, Spain.; Aguilo, N (corresponding author), Inst Salud Carlos III, CIBER Enfermedades Resp, Madrid, Spain.	naguilo@unizar.es	Martin, Carlos/A-7283-2008; Pardo, Julián/K-6764-2014; AGUILO, NACHO/GPK-7678-2022; AGUILO, NACHO/K-2750-2014	Martin, Carlos/0000-0003-2993-5478; Pardo, Julián/0000-0003-0154-0730; AGUILO, NACHO/0000-0001-7897-9173; AGUILO, NACHO/0000-0001-7897-9173	Spanish Ministry of Economy and Competitiveness [SAF2014-54763-C2-1-R, BIO2014-5258P]; European Commission [TBVAC2020 643381]	Spanish Ministry of Economy and Competitiveness(Spanish Government); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the Spanish Ministry of Economy and Competitiveness (grant numbers SAF2014-54763-C2-1-R, BIO2014-5258P) and the European Commission (grant number TBVAC2020 643381). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Anthony DA, 2010, J IMMUNOL, V185, P1794, DOI 10.4049/jimmunol.1000430; Arbues A, 2013, VACCINE, V31, P4867, DOI 10.1016/j.vaccine.2013.07.051; Arias MA, 2014, CELL REP, V8, P419, DOI 10.1016/j.celrep.2014.06.012; Cole ST, 1998, NOVART FDN SYMP, V217, P160, DOI 10.1002/0470846526.ch12; Cooper AM, 1997, INFECT IMMUN, V65, P1317, DOI 10.1128/IAI.65.4.1317-1320.1997; EBNET K, 1995, EMBO J, V14, P4230, DOI 10.1002/j.1460-2075.1995.tb00097.x; Garcia-Laorden MI, 2015, TUBERCULOSIS, V95, P575, DOI 10.1016/j.tube.2015.05.016; Hazlewood GS, 2013, ARTHRIT CARE RES, V65, P1722, DOI 10.1002/acr.22063; Hochegger K, 2004, BLOOD, V103, P1176, DOI 10.1182/blood-2003-10-3708; Joeckel LT, 2014, BIOL CHEM, V395, P181, DOI 10.1515/hsz-2013-0238; Keane J, 2001, NEW ENGL J MED, V345, P1098, DOI 10.1056/NEJMoa011110; Martin P, 2005, BLOOD, V106, P2871, DOI 10.1182/blood-2005-04-1522; Metkar SS, 2008, IMMUNITY, V29, P720, DOI 10.1016/j.immuni.2008.08.014; Pardo J, 2008, CELL DEATH DIFFER, V15, P567, DOI 10.1038/sj.cdd.4402289; Pardo J, 2009, MICROBES INFECT, V11, P452, DOI 10.1016/j.micinf.2009.02.004; Spencer CT, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003119; Spertini F, 2015, LANCET RESP IN PRESS; Vidyarani M, 2009, EXP MOL PATHOL, V86, P69, DOI 10.1016/j.yexmp.2008.10.002; Zumla A, 2015, LANCET GLOB HEALTH, V3, pE10, DOI 10.1016/S2214-109X(14)70361-4	19	7	8	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153028	10.1371/journal.pone.0153028	http://dx.doi.org/10.1371/journal.pone.0153028			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27055232	gold, Green Published, Green Submitted			2022-12-27	WOS:000373608000065
J	Bekkevold, D; Gross, R; Arula, T; Helyar, SJ; Ojaveer, H				Bekkevold, Dorte; Gross, Riho; Arula, Timo; Helyar, Sarah J.; Ojaveer, Henn			Outlier Loci Detect Intraspecific Biodiversity amongst Spring and Autumn Spawning Herring across Local Scales	PLOS ONE			English	Article							GENE-ASSOCIATED MARKERS; CLUPEA-HARENGUS L.; MARINE FISH; POPULATION DIFFERENTIATION; ATLANTIC COD; SEA; CONNECTIVITY; ADAPTATION; STRATEGIES; COMPONENTS	Herring, Clupea harengus, is one of the ecologically and commercially most important species in European northern seas, where two distinct ecotypes have been described based on spawning time; spring and autumn. To date, it is unknown if these spring and autumn spawning herring constitute genetically distinct units. We assessed levels of genetic divergence between spring and autumn spawning herring in the Baltic Sea using two types of DNA markers, microsatellites and Single Nucleotide Polymorphisms, and compared the results with data for autumn spawning North Sea herring. Temporally replicated analyses reveal clear genetic differences between ecotypes and hence support reproductive isolation. Loci showing non-neutral behaviour, so-called outlier loci, show convergence between autumn spawning herring from demographically disjoint populations, potentially reflecting selective processes associated with autumn spawning ecotypes. The abundance and exploitation of the two ecotypes have varied strongly over space and time in the Baltic Sea, where autumn spawners have faced strong depression for decades. The results therefore have practical implications by highlighting the need for specific management of these co-occurring ecotypes to meet requirements for sustainable exploitation and ensure optimal livelihood for coastal communities.	[Bekkevold, Dorte] Tech Univ Denmark, Natl Inst Aquat Resources, Charlottenlund, Denmark; [Gross, Riho] Estonian Univ Life Sci, Inst Vet Med & Anim Sci, Dept Aquaculture, Tartu, Estonia; [Arula, Timo; Ojaveer, Henn] Univ Tartu, Estonian Marine Inst, Parnu, Estonia; [Helyar, Sarah J.] Queens Univ Belfast, Inst Global Food Secur, Belfast, Antrim, North Ireland	Technical University of Denmark; Estonian University of Life Sciences; University of Tartu; Estonian Marine Institute; Queens University Belfast	Bekkevold, D (corresponding author), Tech Univ Denmark, Natl Inst Aquat Resources, Charlottenlund, Denmark.	db@aqua.dtu.dk	Bekkevold, Dorte/AAT-1098-2021; Ojaveer, Henn/K-2160-2016; Gross, Riho/A-1735-2009; Helyar, Sarah/C-4988-2013; arula, timo/G-8710-2017	Ojaveer, Henn/0000-0003-2742-6063; Gross, Riho/0000-0003-0311-3003; Helyar, Sarah/0000-0002-1600-997X; arula, timo/0000-0001-9621-1168; Bekkevold, Dorte/0000-0002-5297-032X	joint Baltic Sea research and development programme BONUS [185]; EU; Estonian Research Council; Technological Development and Demonstration, and Innovation Fund Denmark; Estonian Ministry of Education and Research [SF0180005s10, IUT8-2]	joint Baltic Sea research and development programme BONUS; EU(European Commission); Estonian Research Council(Estonian Research Council); Technological Development and Demonstration, and Innovation Fund Denmark; Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia)	This work resulted from the BONUS INSPIRE and BIO-C3 projects, which were supported by the joint Baltic Sea research and development programme BONUS (Art 185) funded jointly by the EU, Estonian Research Council, Technological Development and Demonstration, and Innovation Fund Denmark provided general funding for man hours. HO and TA were partially financed by the Estonian Ministry of Education and Research (grant SF0180005s10), which provided general funding for man hours and consumables. RG was supported by the institutional research funding project IUT8-2 (Estonian Ministry of Education and Research), which provided general funding for man hours and consumables. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson EC, 2014, MOL ECOL, V23, P502, DOI 10.1111/mec.12609; Andre C., 2010, HEREDITY, V106, P1; Arula T, 2012, J SEA RES, V68, P33, DOI 10.1016/j.seares.2011.12.003; Bekkevold D, 2005, EVOLUTION, V59, P2656; Bekkevold D, 2007, MAR ECOL PROG SER, V337, P187, DOI 10.3354/meps337187; Bekkevold D, 2015, ICES J MAR SCI, V72, P1790, DOI 10.1093/icesjms/fsu247; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bradbury IR, 2010, P ROY SOC B-BIOL SCI, V277, P3725, DOI 10.1098/rspb.2010.0985; Brophy D, 2006, CAN J FISH AQUAT SCI, V63, P607, DOI 10.1139/f05-235; Corander J, 2013, MOL ECOL, V22, P2931, DOI 10.1111/mec.12174; Cushing DH, 1975, MARINE ECOLOGY FISHE; DFO, 2015, DFO CAN SCI ADVIS SE; Dickey-Collas M, 2010, ICES J MAR SCI, V67, P1875, DOI 10.1093/icesjms/fsq033; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; Gaggiotti OE, 2009, EVOLUTION, V63, P2939, DOI 10.1111/j.1558-5646.2009.00779.x; Gagnaire PA, 2015, EVOL APPL, V8, P769, DOI 10.1111/eva.12288; GOMULKIEWICZ R, 1992, EVOLUTION, V46, P390, DOI [10.2307/2409860, 10.1111/j.1558-5646.1992.tb02047.x]; Goudet J, 2005, MOL ECOL NOTES, V5, P184, DOI 10.1111/j.1471-8286.2004.00828.x; Harma C, 2012, FISH RES, V121, P31, DOI 10.1016/j.fishres.2012.01.005; Hauser L, 2008, FISH FISH, V9, P333, DOI 10.1111/j.1467-2979.2008.00299.x; Helyar SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042089; Hemmer-Hansen J, 2013, MOL ECOL, V22, P2653, DOI 10.1111/mec.12284; Hohenlohe PA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000862; ICES, 2011, 2011ACOM46 ICES CM; ICES, 2021, REP BALT FISH ASS WO; Johannesson K, 2006, MOL ECOL, V15, P2013, DOI 10.1111/j.1365-294X.2006.02919.x; Jombart T, 2010, BMC GENET, V11, DOI [DOI 10.1186/1471-2156-11-94, 10.1186/1471-2156-11-94]; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Jorgensen HBH, 2005, MOL ECOL, V14, P3219, DOI 10.1111/j.1365-294X.2005.02658.x; Lamichhaney S, 2012, P NATL ACAD SCI USA, V109, P19345, DOI 10.1073/pnas.1216128109; Larsson LC, 2010, HEREDITY, V104, P40, DOI 10.1038/hdy.2009.98; Larsson LC, 2007, MOL ECOL, V16, P1135, DOI 10.1111/j.1365-294X.2006.03217.x; LEWONTIN RC, 1973, GENETICS, V74, P175; Limborg MT, 2012, MOL ECOL, V21, P3686, DOI 10.1111/j.1365-294X.2012.05639.x; Mariani S, 2005, MAR ECOL PROG SER, V303, P245, DOI 10.3354/meps303245; McPherson AA, 2004, T AM FISH SOC, V133, P434, DOI 10.1577/02-106; Melvin GD, 2009, ICES J MAR SCI, V66, P1784, DOI 10.1093/icesjms/fsp173; Nielsen EE, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1845; Ojaveer E, 2005, ICES J MAR SCI, V62, P1492, DOI 10.1016/j.icesjms.2005.08.002; OJAVEER E, 1989, RAP PROCES, V190, P17; Ojaveer E., 1970, T BALT NAUTCHNO ISSL, V4, P205; Ojaveer E, 1988, BALTIC HERRINGS BIOL; Ojaveer H, 2015, ICES J MAR SCI, V72, P2332, DOI 10.1093/icesjms/fsv103; Ojaveer H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012467; Raid T, 2010, ICES J MAR SCI, V67, P1914, DOI 10.1093/icesjms/fsq128; Rannak L, 1971, ICES CM 1971 SPEC M; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rideout RM, 2011, MAR COAST FISH, V3, P176, DOI 10.1080/19425120.2011.556943; RYMAN N, 1984, HEREDITY, V53, P687, DOI 10.1038/hdy.1984.127; Schindler DE, 2010, NATURE, V465, P609, DOI 10.1038/nature09060; Teacher AGF, 2012, CONSERV GENET RESOUR, V4, P71, DOI 10.1007/s12686-011-9477-5; Teacher AGF, 2013, EVOL APPL, V6, P549, DOI 10.1111/eva.12042; Therkildsen NO, 2013, EVOL APPL, V6, P690, DOI 10.1111/eva.12055; van Damme CJG, 2009, CAN J FISH AQUAT SCI, V66, P2130, DOI 10.1139/F09-153; Waples RS, 2006, MOL ECOL, V15, P1419, DOI 10.1111/j.1365-294X.2006.02890.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Winters GH, 1996, ICES J MAR SCI, V53, P73, DOI 10.1006/jmsc.1996.0007	57	16	16	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0148499	10.1371/journal.pone.0148499	http://dx.doi.org/10.1371/journal.pone.0148499			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050440	Green Published, Green Accepted, gold			2022-12-27	WOS:000373603500001
J	Hsieh, JT; Ang, BT; Ng, YP; Allen, JC; King, NKK				Hsieh, Justin T.; Ang, Beng Ti; Ng, Yew Poh; Allen, John C.; King, Nicolas K. K.			Comparison of Gender Differences in Intracerebral Hemorrhage in a Multi-Ethnic Asian Population	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; SEX-DIFFERENCES; STROKE INCIDENCE; CASE-FATALITY; INFLAMMATORY RESPONSE; CEREBRAL-ISCHEMIA; PROGESTERONE; HEART; ESTROGEN; SUBTYPES	Background Intracerebral hemorrhage (ICH) accounts for 10-15% of all first time strokes and with incidence twice as high in the Asian compared to Western population. This study aims to investigate gender differences in ICH patient outcomes in a multi-ethnic Asian population. Method Data for 1,192 patients admitted for ICH were collected over a four-year period. Multivariate logistic regression was used to identify independent predictors and odds ratios were computed for 30-day mortality and Glasgow Outcome Scale (GOS) comparing males and females. Result Males suffered ICH at a younger age than females (62.2 +/- 13.2 years vs. 66.3 +/- 15.3 years; P<0.001). The occurrence of ICH was higher among males than females at all ages until 80 years old, beyond which the trend was reversed. Females exhibited increased severity on admission as measured by Glasgow Coma Scale compared to males (10.9 +/- 4.03 vs. 11.4 +/- 4.04; P = 0.030). No difference was found in 30-day mortality between females and males (F: 30.5% [155/508] vs. M: 27.0%[186/688]), with unadjusted and adjusted odds ratio (F/M) of 1.19 (P = 0.188) and 1.21 (P = 0.300). At discharge, there was a non-statistically significant but potentially clinically relevant morbidity difference between the genders as measured by GOS (dichotomized GOS of 4-5: F: 23.7% [119/503] vs. M: 28.7% [194/677]), with unadjusted and adjusted odds ratio (F/M) of 0.77 (P = 0.055) and 0.87 (P = 0.434). Conclusion In our multi-ethnic Asian population, males developed ICH at a younger age and were more susceptible to ICH than women at all ages other than the beyond 80-year old age group. In contrast to the Western population, neurological status of female ICH patients at admission was poorer and their 30-day mortality was not reduced. Although the study was not powered to detect significance, female showed a trend toward worse 30-day morbidity at discharge.	[Hsieh, Justin T.] Duke Natl Univ Singapore Med Sch, Sch Med, Singapore, Singapore; [Ang, Beng Ti; Ng, Yew Poh; King, Nicolas K. K.] Natl Neurosci Inst, Dept Neurosurg, Singapore, Singapore; [Allen, John C.] Duke Natl Univ Singapore Med Sch, Ctr Quantitat Med, Singapore, Singapore	National Neuroscience Institute (NNI)	Hsieh, JT (corresponding author), Duke Natl Univ Singapore Med Sch, Sch Med, Singapore, Singapore.	Justin.hsieh@u.duke.nus.edu		Kon Kam King, Nicolas/0000-0002-6009-4411; Hsieh, Justin/0000-0002-9701-0998				Appelros P, 2009, STROKE, V40, P1082, DOI 10.1161/STROKEAHA.108.540781; Broderick J, 2007, STROKE, V38, P2001, DOI 10.1161/STROKEAHA.107.183689; Chen Z, 2011, ACTA NEUROCHIR SUPPL, V111, P289, DOI 10.1007/978-3-7091-0693-8_48; Feigin VL, 2003, LANCET NEUROL, V2, P43, DOI 10.1016/S1474-4422(03)00266-7; Flaherty ML, 2005, STROKE, V36, P934, DOI 10.1161/01.STR.0000160756.72109.95; Furlan JC, 2005, J NEUROTRAUM, V22, P368, DOI 10.1089/neu.2005.22.368; Ganti L, 2013, NEUROL RES INT, V2013, DOI 10.1155/2013/219097; Gibson CL, 2005, EXP NEUROL, V193, P522, DOI 10.1016/j.expneurol.2005.01.009; Gibson CL, 2011, BRAIN, V134, P2125, DOI 10.1093/brain/awr132; Gokhale S, 2015, STROKE, V46, P886, DOI 10.1161/STROKEAHA.114.007682; Grossman KJ, 2004, BRAIN RES, V1008, P29, DOI 10.1016/j.brainres.2004.02.022; Hemphill JC, 2015, STROKE, V46, P2032, DOI 10.1161/STR.0000000000000069; Hsieh JT, 2016, NEUROENDOCRINOLOGY, V103, P518, DOI 10.1159/000440883; Inagawa T, 2003, NEUROSURGERY, V53, P1283, DOI 10.1227/01.NEU.0000093825.04365.F3; Ishikawa S, 2008, J EPIDEMIOL, V18, P144, DOI 10.2188/jea.JE2007438; Ishrat T, 2009, BRAIN RES, V1257, P94, DOI 10.1016/j.brainres.2008.12.048; Kubo M, 2003, STROKE, V34, P2349, DOI 10.1161/01.STR.0000090348.52943.A2; Lei BL, 2016, NEUROENDOCRINOLOGY, V103, P665, DOI 10.1159/000442204; Leonelli E, 2007, NEUROSCIENCE, V144, P1293, DOI 10.1016/j.neuroscience.2006.11.014; Morikawa Y, 2000, STROKE, V31, P1583, DOI 10.1161/01.STR.31.7.1583; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350; Nakamura T, 2005, J NEUROSURG, V103, P97, DOI 10.3171/jns.2005.103.1.0097; Ng I, 2006, BRIT J NEUROSURG, V20, P73, DOI 10.1080/02688690600682259; Samai AA, 2015, VASC HEALTH RISK MAN, V11, P427, DOI 10.2147/VHRM.S65886; Simon JA, 2001, CIRCULATION, V103, P638, DOI 10.1161/01.cir.103.5.638; Thrift AG, 2009, NEUROEPIDEMIOLOGY, V32, P11, DOI 10.1159/000170086; Tveiten A, 2012, EUR NEUROL, V67, P240, DOI 10.1159/000336299; Umeano O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081664; Vaartjes I, 2009, CEREBROVASC DIS, V28, P564, DOI 10.1159/000247600; van Asch CJJ, 2010, LANCET NEUROL, V9, P167, DOI 10.1016/S1474-4422(09)70340-0; Vemmos KN, 1999, STROKE, V30, P363, DOI 10.1161/01.STR.30.2.363; Wagner I, 2012, EUR J NEUROL, V19, P1477, DOI 10.1111/j.1468-1331.2011.03628.x; Wright DW, 2015, NEW ENGL J MED, V372, P1766, DOI 10.1056/NEJMc1503138; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Wu SH, 2012, NEUROEPIDEMIOLOGY, V38, P69, DOI 10.1159/000335040; Young AMH, 2012, CURR DRUG SAF, V7, P202, DOI 10.2174/157488612803251261; Zhang LF, 2003, STROKE, V34, P2091, DOI 10.1161/01.STR.0000087149.42294.8C; Zhou JS, 2014, BMC NEUROL, V14, DOI 10.1186/s12883-014-0172-5; Zia E, 2009, STROKE, V40, P3567, DOI 10.1161/STROKEAHA.109.556324	40	23	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0152945	10.1371/journal.pone.0152945	http://dx.doi.org/10.1371/journal.pone.0152945			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050549	Green Published, Green Submitted, gold			2022-12-27	WOS:000373603500071
J	Laubitz, D; Harrison, CA; Midura-Kiela, MT; Ramalingam, R; Larmonier, CB; Chase, JH; Caporaso, JG; Besselsen, DG; Ghishan, FK; Kiela, PR				Laubitz, Daniel; Harrison, Christy A.; Midura-Kiela, Monica T.; Ramalingam, Rajalakshmy; Larmonier, Claire B.; Chase, John H.; Caporaso, J. Gregory; Besselsen, David G.; Ghishan, Fayez K.; Kiela, Pawel R.			Reduced Epithelial Na+/H+ Exchange Drives Gut Microbial Dysbiosis and Promotes Inflammatory Response in T Cell-Mediated Murine Colitis	PLOS ONE			English	Article							CD4(+)CD25(-)FOXP3(+) CELLS; ULCERATIVE-COLITIS; BOWEL-DISEASE; NHE3; EXPRESSION; DIVERSITY; MODEL; MICE; TRANSPORTERS; DEFICIENCY	Inflammatory bowel diseases (IBD) are associated with functional inhibition of epithelial Na+/H+ exchange. In mice, a selective disruption of NHE3 (Slc9a3), a major apical Na+/H+ exchanger, also promotes IBD-like symptoms and gut microbial dysbiosis. We hypothesized that disruption of Na+/H+ exchange is necessary for the development of dysbiosis, which promotes an exacerbated mucosal inflammatory response. Therefore, we performed a temporal analysis of gut microbiota composition, and mucosal immune response to adoptive T cell transfer was evaluated in Rag2(-/-) and NHE3(-/-)/Rag2(-/-) (DKO) mice with and without broad-spectrum antibiotics. Microbiome (16S profiling), colonic histology, T cell and neutrophil infiltration, mucosal inflammatory tone, and epithelial permeability were analyzed. In adoptive T cell transfer colitis model, Slc9a3 status was the most significant determinant of gut microbial community. In DKO mice, NHE3-deficiency and dysbiosis were associated with dramatically accelerated and exacerbated disease, with rapid body weight loss, increased mucosal T cell and neutrophil influx, increased mucosal cytokine expression, increased permeability, and expansion of CD25-FoxP3(+) Tregs; this enhanced susceptibility was alleviated by oral broad-spectrum antibiotics. Based on these results and our previous work, we postulate that epithelial electrolyte homeostasis is an important modulator in the progression of colitis, acting through remodeling of the gut microbial community.	[Laubitz, Daniel; Harrison, Christy A.; Midura-Kiela, Monica T.; Ramalingam, Rajalakshmy; Larmonier, Claire B.; Ghishan, Fayez K.; Kiela, Pawel R.] Univ Arizona, Dept Pediat, Steele Childrens Res Ctr, Tucson, AZ 85721 USA; [Chase, John H.; Caporaso, J. Gregory] No Arizona Univ, Dept Biol Sci, Ctr Microbial Genet & Genom, Box 5640, Flagstaff, AZ 86011 USA; [Besselsen, David G.] Univ Arizona, Univ Anim Care, Tucson, AZ USA; [Kiela, Pawel R.] Univ Arizona, Dept Immunobiol, Tucson, AZ USA; [Ramalingam, Rajalakshmy] Ventana Med Syst Inc, Roche Grp, Tucson, AZ USA; [Larmonier, Claire B.] Ctr Hosp Univ Pellegrin, GRIC, Pole Biol & Pathol, Labs Immunol & Immunogenet, F-33000 Bordeaux, France	University of Arizona; Northern Arizona University; University of Arizona; University of Arizona; Roche Holding; Ventana Medical Systems, Inc.; CHU Bordeaux	Kiela, PR (corresponding author), Univ Arizona, Dept Pediat, Steele Childrens Res Ctr, Tucson, AZ 85721 USA.	pkiela@peds.arizona.edu	Kiela, Pawel/AAF-5320-2020	Clutter, Christy/0000-0001-6236-5636; Caporaso, Greg/0000-0002-8865-1670; Laubitz, Daniel/0000-0002-7482-8500; Kiela, Pawel/0000-0002-0014-3517	National Institute of Diabetes and Digestive and Kidney Diseases [2R01 DK-041274]; Cancer Center Support Grant [CA 023074]; NATIONAL CANCER INSTITUTE [P30CA023074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK041274] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institute of Diabetes and Digestive and Kidney Diseases Grant 2R01 DK-041274 (to F. Ghishan and P. Kiela). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to acknowledge the UACC/ARL Cytometry Core Facility supported by Cancer Center Support Grant (CA 023074) and Paula Campbell for the assistance with flow cytometry and flow sorting.	Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Barmeyer C, 2004, AM J PHYSIOL-GASTR L, V286, pG244, DOI 10.1152/ajpgi.00141.2003; Bonelli M, 2009, J IMMUNOL, V182, P1689, DOI 10.4049/jimmunol.182.3.1689; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chen WG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039743; Dalal SR, 2014, J CLIN INVEST, V124, P4190, DOI 10.1172/JCI72330; De Gregoris TB, 2011, J MICROBIOL METH, V86, P351, DOI 10.1016/j.mimet.2011.06.010; Du ZY, 2015, GUT PATHOG, V7, DOI 10.1186/s13099-015-0080-2; Engevik MA, 2015, AM J PHYSIOL-GASTR L, V308, pG497, DOI 10.1152/ajpgi.00090.2014; Engevik MA, 2013, AM J PHYSIOL-GASTR L, V305, pG697, DOI 10.1152/ajpgi.00184.2013; Farkas K, 2011, INFLAMM BOWEL DIS, V17, P884, DOI 10.1002/ibd.21432; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Fransson M, 2010, AUTOIMMUNITY, V43, P590, DOI 10.3109/08916930903541190; Garrett WS, 2007, CELL, V131, P33, DOI 10.1016/j.cell.2007.08.017; Gevers D, 2014, CELL HOST MICROBE, V15, P382, DOI 10.1016/j.chom.2014.02.005; Ghishan FK, 2014, INFLAMM BOWEL DIS, V20, P1099, DOI 10.1097/MIB.0000000000000029; Hecht G, 2004, AM J PHYSIOL-GASTR L, V287, pG370, DOI 10.1152/ajpgi.00432.2003; Horwitz DA, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2894; Hu B, 2013, P NATL ACAD SCI USA, V110, P9862, DOI 10.1073/pnas.1307575110; Ishikawa D, 2013, MUCOSAL IMMUNOL, V6, P267, DOI 10.1038/mi.2012.67; Johansson MEV, 2014, GUT, V63, P281, DOI 10.1136/gutjnl-2012-303207; Kaakoush NO, 2015, CLIN TRANSL GASTROEN, V6, DOI 10.1038/ctg.2014.21; Kiela PR, 2009, GASTROENTEROLOGY, V137, P965, DOI 10.1053/j.gastro.2009.05.043; Kim TW, 2006, WORLD J GASTROENTERO, V12, P302, DOI 10.3748/wjg.v12.i2.302; Kitajima S, 2001, EXP ANIM TOKYO, V50, P387, DOI 10.1538/expanim.50.387; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Larmonier CB, 2013, AM J PHYSIOL-GASTR L, V305, pG667, DOI 10.1152/ajpgi.00189.2013; Laubitz D, 2008, AM J PHYSIOL-GASTR L, V295, pG63, DOI 10.1152/ajpgi.90207.2008; Lenzen H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040657; Lozupone CA, 2007, APPL ENVIRON MICROB, V73, P1576, DOI 10.1128/AEM.01996-06; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Macpherson AJ, 2004, NAT REV IMMUNOL, V4, P478, DOI 10.1038/nri1373; Manichanh C, 2006, GUT, V55, P205, DOI 10.1136/gut.2005.073817; Martinez-Augustin O, 2009, INFLAMM BOWEL DIS, V15, P114, DOI 10.1002/ibd.20579; Nobel YR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8486; Ostanin DV, 2009, AM J PHYSIOL-GASTR L, V296, pG135, DOI 10.1152/ajpgi.90462.2008; Pandiyan P, 2007, NAT IMMUNOL, V8, P1353, DOI 10.1038/ni1536; Rocha F, 2001, AM J PHYSIOL-CELL PH, V280, pC1224, DOI 10.1152/ajpcell.2001.280.5.C1224; Rossen NG, 2015, GASTROENTEROLOGY, V149, P110, DOI 10.1053/j.gastro.2015.03.045; Sartor RB, 2008, GASTROENTEROLOGY, V134, P577, DOI 10.1053/j.gastro.2007.11.059; Sartor RB, 2010, GASTROENTEROLOGY, V139, P1816, DOI 10.1053/j.gastro.2010.10.036; Sartor RB, 2012, AM J GASTROENTEROL S, V1, P15, DOI DOI 10.1038/AJGSUP.2012.4; Sartor RB, 2015, ANTIBIOTICS TREATMEN; Siddique I, 2009, SCAND J GASTROENTERO, V44, P56, DOI 10.1080/00365520802321253; Singh V, 2012, AM J PHYSIOL-GASTR L, V303, pG1393, DOI 10.1152/ajpgi.00345.2012; Stepankova R, 2007, INFLAMM BOWEL DIS, V13, P1202, DOI 10.1002/ibd.20221; Sullivan S, 2009, INFLAMM BOWEL DIS, V15, P261, DOI 10.1002/ibd.20743; Swidsinski A, 2005, J CLIN MICROBIOL, V43, P3380, DOI 10.1128/JCM.43.7.3380-3389.2005; Teke HU, 2013, PLATELETS, V24, P625, DOI 10.3109/09537104.2012.748188; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; van Lierop PPE, 2010, INFLAMM BOWEL DIS, V16, P442, DOI 10.1002/ibd.21073; Wlodarska M, 2015, CELL HOST MICROBE, V17, P577, DOI 10.1016/j.chom.2015.04.008; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Yang HX, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2829; Yeruva S, 2010, INFLAMM BOWEL DIS, V16, P1149, DOI 10.1002/ibd.21183; Zenewicz LA, 2013, J IMMUNOL, V190, P5306, DOI 10.4049/jimmunol.1300016	57	26	26	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0152044	10.1371/journal.pone.0152044	http://dx.doi.org/10.1371/journal.pone.0152044			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050757	Green Published, gold, Green Submitted			2022-12-27	WOS:000373603500022
J	Poonsuk, K; Gimenez-Lirola, LG; Zhang, JQ; Arruda, P; Chen, Q; Carrion, LCD; Magtoto, R; Pineyro, P; Sarmento, L; Wang, C; Sun, YX; Madson, D; Johnson, J; Yoon, KJ; Zimmerman, J; Main, R				Poonsuk, Korakrit; Gimenez-Lirola, Luis Gabriel; Zhang, Jianqiang; Arruda, Paolo; Chen, Qi; Carrion, Lucas Correa da Silva; Magtoto, Ronaldo; Pineyro, Pablo; Sarmento, Luciana; Wang, Chong; Sun, Yaxuan; Madson, Darin; Johnson, John; Yoon, Kyoung-Jin; Zimmerman, Jeffrey; Main, Rodger			Does Circulating Antibody Play a Role in the Protection of Piglets against Porcine Epidemic Diarrhea Virus?	PLOS ONE			English	Article							TRANSMISSIBLE GASTROENTERITIS VIRUS; B-CELL RESPONSES; MATERNAL ANTIBODIES; PASSIVE TRANSFER; HUMAN ROTAVIRUS; MONOCLONAL-ANTIBODIES; GNOTOBIOTIC PIGS; PRRSV INFECTION; CORONAVIRUS; COLOSTRUM	The contribution of circulating antibody to the protection of naive piglets against porcine epidemic diarrhea virus (PEDV) was evaluated using a passive antibody transfer model. Piglets (n = 62) derived from 6 sows were assigned to one of 6 different treatments using a randomized block design which provided for allocation of all treatments to all sows' litters. Each treatment was designed to achieve a different level of circulating anti-PEDV antibody via intraperitoneally administration of concentrated serum antibody. Piglets were orally inoculated with PEDV (USA/IN/2013/19338E, 1 x 10(3) TCID50 per piglet) 24 hours later and then monitored for 14 days. Piglets remained with their dam throughout the experiment. Sow milk samples, piglet fecal samples, and data on piglet clinical signs, body weight, and body temperature were collected daily. Fecal samples were tested by PEDV real-time reverse transcriptase PCR. Serum, colostrum, and milk were tested for PEDV IgG, IgA, and virus-neutralizing antibody. The data were evaluated for the effects of systemic PEDV antibody levels on growth, body temperature, fecal shedding, survival, and antibody response. The analysis showed that circulating antibody partially ameliorated the effect of PEDV infection. Specifically, antibody-positive groups returned to normal body temperature faster and demonstrated a higher rate of survivability than piglets without PEDV antibody. When combined with previous literature on PEDV, it can be concluded that both systemic antibodies and maternal secretory IgA in milk contribute to the protection of the neonatal pig against PEDV infections. Overall, the results of this experiment suggested that passively administered circulating antibodies contributed to the protection of neonatal piglets against PEDV infection.	[Poonsuk, Korakrit; Gimenez-Lirola, Luis Gabriel; Zhang, Jianqiang; Arruda, Paolo; Chen, Qi; Carrion, Lucas Correa da Silva; Magtoto, Ronaldo; Pineyro, Pablo; Sarmento, Luciana; Wang, Chong; Sun, Yaxuan; Madson, Darin; Johnson, John; Yoon, Kyoung-Jin; Zimmerman, Jeffrey; Main, Rodger] Iowa State Univ, Coll Vet Med, Dept Vet Diagnost & Prod Anim Med, Ames, IA 50011 USA; [Wang, Chong; Sun, Yaxuan] Iowa State Univ, Dept Stat, Coll Liberal Arts & Sci, Ames, IA 50011 USA	Iowa State University; Iowa State University	Gimenez-Lirola, LG (corresponding author), Iowa State Univ, Coll Vet Med, Dept Vet Diagnost & Prod Anim Med, Ames, IA 50011 USA.	luisggl@iastate.edu	Zimmerman, Jeff/ABC-6361-2020	Zimmerman, Jeff/0000-0002-8107-2422; Wang, Chong/0000-0003-4489-4344	Checkoff Dollars	Checkoff Dollars	This study was fully funded by Checkoff Dollars administered through the National Pork Board, Des Moines, Iowa (USA). The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annamalai T, 2015, VET IMMUNOL IMMUNOP, V168, P193, DOI 10.1016/j.vetimm.2015.09.006; Bjustrom-Kraft J, 2016, BMC VET RES UNPUB; BOHL EH, 1972, INFECT IMMUN, V6, P289, DOI 10.1128/IAI.6.3.289-301.1972; BOHL EH, 1975, INFECT IMMUN, V11, P23, DOI 10.1128/IAI.11.1.23-32.1975; BOHL EH, 1972, J AM VET MED ASSOC, V160, P543; Briles DE, 2000, J INFECT DIS, V182, P1694, DOI 10.1086/317602; Casadevall A, 2003, TRENDS IMMUNOL, V24, P474, DOI 10.1016/S1471-4906(03)00228-X; CHASEY D, 1978, RES VET SCI, V25, P255, DOI 10.1016/S0034-5288(18)32994-1; Chattha KS, 2015, ANNU REV ANIM BIOSCI, V3, P375, DOI 10.1146/annurev-animal-022114-111038; Chen Q, 2015, VIROLOGY, V482, P51, DOI 10.1016/j.virol.2015.03.024; Chen Q, 2014, J CLIN MICROBIOL, V52, P234, DOI 10.1128/JCM.02820-13; COUSSEMENT W, 1982, VET PATHOL, V19, P46, DOI 10.1177/030098588201900108; DOYLE LP, 1946, J AM VET MED ASSOC, V108, P257; Doyle LP, 1958, DISEASES SWINE, P107; GREIG AS, 1962, CAN J COMP MED VET S, V26, P49; Grodzki AC, 2010, METHODS MOL BIOL, V588, P33, DOI 10.1007/978-1-59745-324-0_5; Guermonprez P, 2002, ANNU REV IMMUNOL, V20, P621, DOI 10.1146/annurev.immunol.20.100301.064828; Guillaume V, 2004, J VIROL, V78, P834, DOI 10.1128/JVI.78.2.834-840.2004; Harlow E, 1988, ANTIBODIES LAB MANUA, P112; HEBERT GA, 1973, APPL MICROBIOL, V25, P26, DOI 10.1128/AEM.25.1.26-36.1973; HENKART PA, 1985, ANNU REV IMMUNOL, V3, P31, DOI 10.1146/annurev.iy.03.040185.000335; Hoare CM, 1997, VACCINE, V15, P273, DOI 10.1016/S0264-410X(96)00184-3; Hodgins DC, 1999, J VIROL, V73, P186, DOI 10.1128/JVI.73.1.186-197.1999; HOFMANN M, 1988, J CLIN MICROBIOL, V26, P2235, DOI 10.1128/JCM.26.11.2235-2239.1988; Jung K, 2015, VET J, V204, P134, DOI 10.1016/j.tvjl.2015.02.017; Jung K, 2014, EMERG INFECT DIS, V20, P662, DOI 10.3201/eid2004.131685; Kim O, 2002, CAN J VET RES, V66, P112; Kim SH, 2007, J VIROL METHODS, V146, P172, DOI 10.1016/j.jviromet.2007.06.021; Lopez OJ, 2007, CLIN VACCINE IMMUNOL, V14, P269, DOI 10.1128/CVI.00304-06; Madson DM, 2016, VET PATHOL, V53, P44, DOI 10.1177/0300985815591080; Madson DM, 2014, VET MICROBIOL, V174, P60, DOI 10.1016/j.vetmic.2014.09.002; MOON HW, 1971, P SOC EXP BIOL MED, V137, P151, DOI 10.3181/00379727-137-35533; Muradrasoli S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013640; Neutra MR, 2006, NAT REV IMMUNOL, V6, P148, DOI 10.1038/nri1777; Nguyen TV, 2006, CLIN VACCINE IMMUNOL, V13, P475, DOI 10.1128/CVI.13.4.475-485.2006; Nguyen TV, 2006, VACCINE, V24, P2302, DOI 10.1016/j.vaccine.2005.11.043; Olanratmanee EO, 2010, ANIM REPROD SCI, V122, P42, DOI 10.1016/j.anireprosci.2010.07.004; Opriessnig T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104766; Paarlberg P.L., 2014, 144 PURD U DEP AGR E; Parreno V, 1999, J GEN VIROL, V80, P1417, DOI 10.1099/0022-1317-80-6-1417; PENSAERT M, 1986, VET QUART, V8, P257, DOI 10.1080/01652176.1986.9694050; Pensaert MB., 1999, DIS SWINE, V8, P179; REED L. J., 1938, AMER JOUR HYG, V27, P493; Saif L. J., 2012, DIS SWINE, P501; Shibata I, 2000, VET MICROBIOL, V72, P173, DOI 10.1016/S0378-1135(99)00199-6; Shibata I, 2001, J VET MED SCI, V63, P655, DOI 10.1292/jvms.63.655; Song D, 2012, VIRUS GENES, V44, P167, DOI 10.1007/s11262-012-0713-1; STEINMAN RM, 1991, ANNU REV IMMUNOL, V9, P271, DOI 10.1146/annurev.iy.09.040191.001415; STEPANEK J, 1982, ACTA VET BRNO, V51, P99, DOI 10.2754/avb198251010099; Stevenson GW, 2013, J VET DIAGN INVEST, V25, P649, DOI 10.1177/1040638713501675; Subbarao K, 2004, J VIROL, V78, P3572, DOI 10.1128/JVI.78.7.3572-3577.2004; Thomas JT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139266; Traggiai E, 2004, NAT MED, V10, P871, DOI 10.1038/nm1080; UNANUE ER, 1984, ANNU REV IMMUNOL, V2, P395, DOI 10.1146/annurev.iy.02.040184.002143; WALSH EE, 1984, INFECT IMMUN, V43, P756, DOI 10.1128/IAI.43.2.756-758.1984; Wang LY, 2014, EMERG INFECT DIS, V20, P1594, DOI 10.3201/eid2009.140756; WERDIN RE, 1976, J AM VET MED ASSOC, V168, P240; Wesley R D, 1990, J Vet Diagn Invest, V2, P312; Yoon KJ, 1996, VIRAL IMMUNOL, V9, P51, DOI 10.1089/vim.1996.9.51; Yoshida M, 2006, SPRINGER SEMIN IMMUN, V28, P397, DOI 10.1007/s00281-006-0054-z; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721	61	19	25	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0153041	10.1371/journal.pone.0153041	http://dx.doi.org/10.1371/journal.pone.0153041			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050556	Green Published, gold, Green Submitted			2022-12-27	WOS:000373603500088
J	Chamaille-Jammes, S; Charbonnel, A; Dray, S; Madzikanda, H; Fritz, H				Chamaille-Jammes, Simon; Charbonnel, Anais; Dray, Stephane; Madzikanda, Hillary; Fritz, Herve			Spatial Distribution of a Large Herbivore Community at Waterholes: An Assessment of Its Stability over Years in Hwange National Park, Zimbabwe	PLOS ONE			English	Article							AFRICAN SAVANNA; ARTIFICIAL WATERHOLES; ELEPHANT POPULATION; DENSITY; AVAILABILITY; MANAGEMENT; PROVISION; ABUNDANCE; ECOSYSTEM; PATTERNS	The spatial structuring of populations or communities is an important driver of their functioning and their influence on ecosystems. Identifying the (in) stability of the spatial structure of populations is a first step towards understanding the underlying causes of these structures. Here we studied the relative importance of spatial vs. interannual variability in explaining the patterns of abundance of a large herbivore community (8 species) at waterholes in Hwange National Park (Zimbabwe). We analyzed census data collected over 13 years using multivariate methods. Our results showed that variability in the census data was mostly explained by the spatial structure of the community, as some waterholes had consistently greater herbivore abundance than others. Some temporal variability probably linked to Park-scale migration dependent on annual rainfall was noticeable, however. Once this was accounted for, little temporal variability remained to be explained, suggesting that other factors affecting herbivore abundance over time had a negligible effect at the scale of the study. The extent of spatial and temporal variability in census data was also measured for each species. This study could help in projecting the consequences of surface water management, and more generally presents a methodological framework to simultaneously address the relative importance of spatial vs. temporal effects in driving the distribution of organisms across landscapes.	[Chamaille-Jammes, Simon; Charbonnel, Anais] CNRS UMR 5175, Ctr Ecol Fonct & Evolut, 1919 Route Mende, F-34294 Montpellier 5, France; [Chamaille-Jammes, Simon; Fritz, Herve] Zone Atelier Hwange CNRS Hwange LTER, POB 62, Dete, Zimbabwe; [Dray, Stephane; Fritz, Herve] Univ Lyon 1, CNRS UMR 5558, Lab Biometrie & Biol Evolut, 43 Bd 11 Novembre 1918, F-69622 Villeurbanne, France; [Madzikanda, Hillary] Zimbabwe Pk & Wildlife Management Author, Sci Serv, POB CY 140 Causeway, Harare, Zimbabwe; [Madzikanda, Hillary] Hwange Natl Pk, Painted Dog Conservat, Dete, Zimbabwe	UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup	Chamaille-Jammes, S (corresponding author), CNRS UMR 5175, Ctr Ecol Fonct & Evolut, 1919 Route Mende, F-34294 Montpellier 5, France.; Chamaille-Jammes, S (corresponding author), Zone Atelier Hwange CNRS Hwange LTER, POB 62, Dete, Zimbabwe.	simon.chamaille@cefe.cnrs.fr	Fritz, Herve/D-1729-2014; Dray, Stéphane/B-4107-2010; Chamaillé-Jammes, Simon/B-3833-2009	Fritz, Herve/0000-0002-7106-3661; Dray, Stéphane/0000-0003-0153-1105; Chamaillé-Jammes, Simon/0000-0003-0505-6620; Anais, Charbonnel/0000-0002-0199-230X	Agence Nationale de la Recherche [ANR-08-BLAN-0022, ANR-11-CEPS-003]	Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by the grants ANR-08-BLAN-0022 and ANR-11-CEPS-003 of the Agence Nationale de la Recherche, received by HF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1988, ADV ECOL RES; AYENI JSO, 1977, J APPL ECOL, V14, P369, DOI 10.2307/2402550; Brown JH, 1996, ANNU REV ECOL SYST, V27, P597, DOI 10.1146/annurev.ecolsys.27.1.597; BROWN JH, 1995, ECOLOGY, V76, P2028, DOI 10.2307/1941678; Chamaille-Jammes S, 2006, INT J REMOTE SENS, V27, P5185, DOI 10.1080/01431160600702392; Chamaille-Jammes S, 2007, J TROP ECOL, V23, P725, DOI 10.1017/S0266467407004531; Chamaille-Jammes S, 2008, J ANIM ECOL, V77, P135, DOI 10.1111/j.1365-2656.2007.01307.x; Chamaille-Jammes S, 2007, DIVERS DISTRIB, V13, P663, DOI 10.1111/j.1472-4642.2007.00415.x; Chamaille-Jammes S, 2007, AUSTRAL ECOL, V32, P740, DOI 10.1111/j.1442-9993.2007.01761.x; Chamaille-Jammes S, 2007, J APPL ECOL, V44, P625, DOI 10.1111/j.1365-2664.2007.01300.x; Chamaille-Jammes S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059164; Chamaille-Jammes S, 2009, AFR J ECOL, V47, P804, DOI 10.1111/j.1365-2028.2009.01077.x; Chamaille-Jammes S, 2009, ECOGRAPHY, V32, P871, DOI 10.1111/j.1600-0587.2009.05785.x; Courbin N, 2016, OIKOS, V125, P829, DOI 10.1111/oik.02555; Doledec S., 1991, ADV ECOLOGY, V1, P133; Dray S, 2003, ECOLOGY, V84, P3078, DOI 10.1890/03-0178; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Epaphras A. M., 2008, Wetlands Ecology and Management, V16, P183, DOI 10.1007/s11273-007-9065-3; Estes R.D., 1992, BEHAV GUIDE AFRICAN; Harrington R, 1999, BIOL CONSERV, V90, P69, DOI 10.1016/S0006-3207(98)00120-7; Manly BFJ, 1997, RANDOMIZATION BOOTST; Mayor SJ, 2005, OECOLOGIA, V145, P276, DOI 10.1007/s00442-005-0114-4; OwenSmith N, 1996, S AFR J WILDL RES, V26, P107; Perez-Barberia FJ, 2013, OECOLOGIA, V173, P837, DOI 10.1007/s00442-013-2686-8; Rao C.R., 1964, SANKHYA A, V26, P329, DOI DOI 10.1214/AOMS/1177704248; Redfern JV, 2005, J ARID ENVIRON, V63, P406, DOI 10.1016/j.jaridenv.2005.03.016; Rodriguez SJ, 1995, THESIS U KENT CANTER; Smit IPJ, 2007, DIVERS DISTRIB, V13, P666, DOI 10.1111/j.1472-4642.2007.00403.x; Smit IPJ, 2009, J NAT CONSERV, V17, P61, DOI 10.1016/j.jnc.2009.01.001; Smit IPJ, 2007, BIOL CONSERV, V136, P85, DOI 10.1016/j.biocon.2006.11.009; Stien A, 2010, ECOLOGY, V91, P915, DOI 10.1890/09-0056.1; Thrash I., 1999, Koedoe, V42, P73; Valeix M, 2007, J TROP ECOL, V23, P87, DOI 10.1017/S0266467406003609; Wilson RT, 2007, AGR WATER MANAGE, V90, P1, DOI 10.1016/j.agwat.2007.03.003; Wolanski E, 2001, HYDROBIOLOGIA, V458, P169, DOI 10.1023/A:1013125321838	35	16	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153639	10.1371/journal.pone.0153639	http://dx.doi.org/10.1371/journal.pone.0153639			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27074044	Green Published, Green Submitted, gold			2022-12-27	WOS:000374131200113
J	Fragoso, JMV; Levi, T; Oliveira, LFB; Luzar, JB; Overman, H; Read, JM; Silvius, KM				Fragoso, Jose M. V.; Levi, Taal; Oliveira, Luiz F. B.; Luzar, Jeffrey B.; Overman, Han; Read, Jane M.; Silvius, Kirsten M.			Line Transect Surveys Underdetect Terrestrial Mammals: Implications for the Sustainability of Subsistence Hunting	PLOS ONE			English	Article							MBARACAYU RESERVE; ABUNDANCE MODELS; FOREST SITES; CONSERVATION; DEER; VERTEBRATES; DENSITIES; COUNTS; AMERICANA; COMMUNITY	Conservation of Neotropical game species must take into account the livelihood and food security needs of local human populations. Hunting management decisions should therefore rely on abundance and distribution data that are as representative as possible of true population sizes and dynamics. We simultaneously applied a commonly used encounter-based method and an infrequently used sign-based method to estimate hunted vertebrate abundance in a 48,000-km(2) indigenous landscape in southern Guyana. Diurnal direct encounter data collected during three years along 216, four-kilometer - long transects consistently under-detected many diurnal and nocturnal mammal species readily detected through sign. Of 32 species analyzed, 31 were detected by both methods; however, encounters did not detect one and under-detected another 12 of the most heavily hunted species relative to sign, while sign under-detected 12 never or rarely collected species relative to encounters. The six most important game animals in the region, all ungulates, were not encountered at 11-40% of village and control sites or on 29-72% of transects where they were detected by sign. Using the sign methodology, we find that tapirs, one of the terrestrial vertebrates considered most sensitive to overexploitation, are present at many sites where they were never visually detected during distance sampling. We find that this is true for many other species as well. These high rates of under-detection suggest that behavioral changes in hunted populations may affect apparent occurrence and abundance of these populations. Accumulation curves (detection of species on transects) were much steeper for sign for 12 of 16 hunted species than for encounters, but that pattern was reversed for 12 of 16 species unhunted in our area. We conclude that collection of sign data is an efficient and effective method of monitoring hunted vertebrate populations that complements encounter and camera-trapping methods in areas impacted by hunting. Sign surveys may be the most viable method for large-scale, management-oriented studies in remote areas, particularly those focused on community-based wildlife management.	[Fragoso, Jose M. V.; Luzar, Jeffrey B.] Stanford Univ, Stanford, CA 94305 USA; [Levi, Taal] Oregon State Univ, Dept Fisheries & Wildlife, Corvallis, OR 97331 USA; [Oliveira, Luiz F. B.] Univ Fed Rio de Janeiro, Museu Nacl, Dept Vertebrados, BR-20940040 Rio de Janeiro, RJ, Brazil; [Overman, Han] SUNY Coll Environm Sci & Forestry, Environm & Forest Biol, Syracuse, NY 13210 USA; [Read, Jane M.] Syracuse Univ, Dept Geog, Syracuse, NY 13244 USA; [Silvius, Kirsten M.] Virginia Tech, Dept Forest Resources & Environm Conservat, Blacksburg, VA USA; [Fragoso, Jose M. V.] Calif Acad Sci, Biodivers Sci & Sustainabil, San Francisco, CA 94118 USA	Stanford University; Oregon State University; Universidade Federal do Rio de Janeiro; State University of New York (SUNY) System; State University of New York (SUNY) College of Environmental Science & Forestry; Syracuse University; Virginia Polytechnic Institute & State University; California Academy of Sciences	Fragoso, JMV (corresponding author), Stanford Univ, Stanford, CA 94305 USA.	fragoso@stanford.edu	Fragoso, Jose Manuel V/AAF-9146-2020	Levi, Taal/0000-0003-1853-8311	US National Science Foundation [BE/CNH 05 08094]	US National Science Foundation(National Science Foundation (NSF))	This work was funded by US National Science Foundation BE/CNH 05 08094. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON DR, 1979, J WILDLIFE MANAGE, V43, P70, DOI 10.2307/3800636; Benchimol M, 2015, BIOL CONSERV, V187, P61, DOI 10.1016/j.biocon.2015.04.005; Benhaiem S, 2008, ANIM BEHAV, V76, P611, DOI 10.1016/j.anbehav.2008.03.012; Bodmer RE, 1997, CONSERV BIOL, V11, P460, DOI 10.1046/j.1523-1739.1997.96022.x; Bodmer Richard E., 2004, P299; Borges S.H., 2014, EXPERIENCE PARTICIPA; Burton AC, 2015, J APPL ECOL, V52, P675, DOI 10.1111/1365-2664.12432; Carter NH, 2012, P NATL ACAD SCI USA, V109, P15360, DOI 10.1073/pnas.1210490109; Ciuti S, 2012, PLOS ONE, DOI [10.1371/journal.pone.0050611, DOI 10.1371/JOURNAL.PONE.0050611]; Constantino PAL, 2014, INT SEM PART MON BIO; Cummings AR, 2015, INT J APPL GEOSPAT R, V6, P118, DOI 10.4018/ijagr.2015010107; Danielsen F, 2005, BIODIVERS CONSERV, V14, P2507, DOI 10.1007/s10531-005-8375-0; Melo ERD, 2015, WILDLIFE BIOL, V21, P234, DOI 10.2981/wlb.00095; Di Bitetti MS, 2008, BIOTROPICA, V40, P636, DOI 10.1111/j.1744-7429.2008.00413.x; Dirzo R., 1991, PLANT ANIMAL INTERAC, P273; Dirzo R, 2014, SCIENCE, V345, P401, DOI 10.1126/science.1251817; Endo W, 2010, BIOTROPICA, V42, P251, DOI 10.1111/j.1744-7429.2009.00546.x; Fragoso JM, 2000, BRAZIL INTEGRATING I; Fragoso JMV, 1999, J MAMMAL, V80, P993, DOI 10.2307/1383270; Gopalaswamy AM, 2012, ANIM CONSERV, V15, P669, DOI 10.1111/j.1469-1795.2012.00565.x; Hill K, 1997, CONSERV BIOL, V11, P1339, DOI 10.1046/j.1523-1739.1997.96048.x; Hill K, 2000, BIOL RESOURCE MANAGE, P79; Ibarra JT, 2011, INT FOREST REV, V13, P318, DOI 10.1505/146554811798293935; Desbiez ALJ, 2010, BIOTROPICA, V42, P372, DOI 10.1111/j.1744-7429.2009.00601.x; Johnston A, 2015, ECOL APPL, V25, P1749, DOI 10.1890/14-1826.1; KOVNER JL, 1974, BIOMETRICS, V30, P225, DOI 10.2307/2529644; Little AR, 2014, WILDLIFE SOC B, V38, P797, DOI 10.1002/wsb.449; Longoria MP, 2007, J WILDLIFE MANAGE, V71, P652, DOI 10.2193/2005-613; Luzar JB, 2011, BIOSCIENCE, V61, P771, DOI 10.1525/bio.2011.61.10.7; Marinelli CE, 2014, BIODIVERS BRAS, V4, P47; Michalski F, 2007, CONSERV BIOL, V21, P1626, DOI 10.1111/j.1523-1739.2007.00797.x; Naranjo Eduardo J., 2004, P324; Nasi R, 2011, INT FOREST REV, V13, P355, DOI 10.1505/146554811798293872; Nogueira-Filho S. L. G., 2004, PEOPLE NATURE WILDLI, P464; Noss AJ, 2006, MAMMALIA, V70, P64, DOI 10.1515/MAMM.2006.020; Parry L, 2009, CONSERV BIOL, V23, P1270, DOI 10.1111/j.1523-1739.2009.01224.x; Pellikka J, 2005, ANN ZOOL FENN, V42, P123; Pereira FO, 2013, MONITORAMENTO SITU B; Peres CA, 2000, CONSERV BIOL, V14, P240, DOI 10.1046/j.1523-1739.2000.98485.x; Peres CA, 2003, CONSERV BIOL, V17, P521, DOI 10.1046/j.1523-1739.2003.01413.x; Peres CA, 2011, CONSERV BIOL, V25, P1124, DOI 10.1111/j.1523-1739.2011.01770.x; Read JM, 2010, J LAT AM GEOGR, V9, P213, DOI 10.1353/lag.2010.0030; REDFORD KH, 1992, BIOSCIENCE, V42, P412, DOI 10.2307/1311860; Richard-Hansen C, 2014, MAMMALIA, V78, P291, DOI 10.1515/mammalia-2013-0087; Rivero K, 2004, EUR J WILDLIFE RES, V50, P161, DOI 10.1007/s10344-004-0064-x; Robinson J., 2000, HUNTING SUSTAINABILI; Robinson J.G., 1991, NEOTROPICAL WILDLIFE; Ruiz-Perez M, 2005, AMBIO, V34, P218, DOI 10.1639/0044-7447(2005)034[0218:CADIAE]2.0.CO;2; Stander PE, 1998, J APPL ECOL, V35, P378, DOI 10.1046/j.1365-2664.1998.00313.x; Terborgh J, 2008, ECOLOGY, V89, P1757, DOI 10.1890/07-0479.1; Thomas L, 2010, J APPL ECOL, V47, P5, DOI 10.1111/j.1365-2664.2009.01737.x; Thurfjell H, 2013, WILDLIFE BIOL, V19, P87, DOI 10.2981/12-027; Tobler MW, 2015, J APPL ECOL, V52, P413, DOI 10.1111/1365-2664.12399; Wright SJ, 2007, BIOTROPICA, V39, P363, DOI 10.1111/j.1744-7429.2007.00289.x	54	43	49	1	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0152659	10.1371/journal.pone.0152659	http://dx.doi.org/10.1371/journal.pone.0152659			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27074025	Green Submitted, gold, Green Published			2022-12-27	WOS:000374131200032
J	Kala, P; Hudakova, N; Jurajda, M; Kasparek, T; Ustohal, L; Parenica, J; Sebo, M; Holicka, M; Kanovsky, J				Kala, Petr; Hudakova, Nela; Jurajda, Michal; Kasparek, Tomas; Ustohal, Libor; Parenica, Jiri; Sebo, Marek; Holicka, Maria; Kanovsky, Jan			Depression and Anxiety after Acute Myocardial Infarction Treated by Primary PCI	PLOS ONE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; MAJOR DEPRESSION; PREVALENCE; PROGNOSIS; PATTERNS; DISEASE; EVENTS	Aims The main objective of the study was to find out prevalence of depression and anxiety symptoms in the population of patients with AMI with ST-segment elevation (STEMI), treated with primary PCI (pPCI). Secondary target indicators included the incidence of sleep disorders and loss of interest in sex. Methods and results The project enrolled 79 consecutive patients with the first AMI, aged <80 years (median 61 years, 21.5% of women) with a follow-up period of 12 months. Symptoms of depression or anxiety were measured using the Beck Depression Inventory II tests (BDI-II, cut-off value >= 14) and Self-Rating Anxiety Scale (SAS, cut-off >= 45) within 24 hours of pPCI, before the discharge, and in 3, 6 and 12 months). Results with the value p<0.05 were considered as statistically significant. The BDI-II positivity was highest within 24 hours after pPCI (21.5%) with a significant decline prior to the discharge (9.2%), but with a gradual increase in 3, 6 and 12 months (10.4%; 15.4%; 13.8% respectively). The incidence of anxiety showed a relatively similar trend: 8.9% after pPCI, and 4.5%, 10.8% and 6.2% in further follow-up. Conclusions Patients with STEMI treated by primary PCI have relatively low overall prevalence of symptoms of depression and anxiety. A significant decrease in mental stress was observed before discharge from the hospital, but in a period of one year after pPCI, prevalence of both symptoms was gradually increasing, which should be given medical attention.	[Kala, Petr; Parenica, Jiri; Holicka, Maria; Kanovsky, Jan] Univ Hosp Brno, Dept Internal Med & Cardiol, Brno, Czech Republic; [Kala, Petr; Hudakova, Nela; Kasparek, Tomas; Ustohal, Libor; Parenica, Jiri; Holicka, Maria; Kanovsky, Jan] Masaryk Univ, Fac Med, Brno, Czech Republic; [Kasparek, Tomas; Ustohal, Libor] Univ Hosp Brno, Dept Psychiat, Brno, Czech Republic; [Sebo, Marek] Ctr Cardiovasc & Transplantat Surg, Brno, Czech Republic; [Jurajda, Michal] Masaryk Univ, Dept Pathol Physiol, Fac Med, Brno, Czech Republic	University Hospital Brno; Masaryk University Brno; University Hospital Brno; Masaryk University Brno	Kanovsky, J (corresponding author), Univ Hosp Brno, Dept Internal Med & Cardiol, Brno, Czech Republic.; Kanovsky, J (corresponding author), Masaryk Univ, Fac Med, Brno, Czech Republic.	jkanovsky@fnbrno.cz	Ustohal, Libor/ABF-7992-2020; Kanovsky, Jan/ABC-1404-2021; Kasparek, Tomas/D-7121-2012; Kasparek, Tomas/AAA-5109-2021	Kasparek, Tomas/0000-0002-9876-1072; Kasparek, Tomas/0000-0002-9876-1072; Kanovsky, Jan/0000-0003-1352-6274				Berkman LF, 2003, JAMA-J AM MED ASSOC, V289, P3106; Bonnet F, 2005, ATHEROSCLEROSIS, V178, P339, DOI 10.1016/j.atherosclerosis.2004.08.035; Bunde J, 2006, PSYCHOSOM MED, V68, P51, DOI 10.1097/01.psy.0000195724.58085.f0; Damen NL, 2013, INT J CARDIOL, V167, P2496, DOI 10.1016/j.ijcard.2012.04.028; Damen NL, 2011, J AFFECT DISORDERS, V134, P464, DOI 10.1016/j.jad.2011.05.026; Denollet J, 2010, J AFFECT DISORDERS, V120, P105, DOI 10.1016/j.jad.2009.04.013; Frasure-Smith N, 1999, PSYCHOSOM MED, V61, P26, DOI 10.1097/00006842-199901000-00006; FRASURESMITH N, 1993, JAMA-J AM MED ASSOC, V270, P1819, DOI 10.1001/jama.270.15.1819; Furuya RK, 2013, REV ESC ENFERM USP, V47, P1333, DOI 10.1590/S0080-623420130000600012; Glassman AH, 2002, JAMA-J AM MED ASSOC, V288, P701, DOI 10.1001/jama.288.6.701; HAVIK OE, 1990, J PSYCHOSOM RES, V34, P271, DOI 10.1016/0022-3999(90)90083-G; Hoschl C., 2002, PSYCHIATRIE; Lane D, 2000, QJM-MON J ASSOC PHYS, V93, P739, DOI 10.1093/qjmed/93.11.739; Lane D, 2002, BRIT J HEALTH PSYCH, V7, P11, DOI 10.1348/135910702169321; Mayou RA, 2000, PSYCHOSOM MED, V62, P212, DOI 10.1097/00006842-200003000-00011; Musselman DL, 1996, AM J PSYCHIAT, V153, P1313; Rajagopalan S, 2001, AM J CARDIOL, V88, P196, DOI 10.1016/S0002-9149(01)01623-X; Rieckmann N, 2006, J AM COLL CARDIOL, V48, P2218, DOI 10.1016/j.jacc.2006.07.063; Thombs BD, 2006, J GEN INTERN MED, V21, P30, DOI 10.1111/j.1525-1497.2005.00269.x; THOMPSON DR, 1987, BRIT J MED PSYCHOL, V60, P343, DOI 10.1111/j.2044-8341.1987.tb02753.x; Trotter R, 2011, HEART LUNG, V40, P185, DOI 10.1016/j.hrtlng.2010.05.054; Vacir K., 1999, BECKOVA SEBEPOSUZOVA; Vreeburg SA, 2009, ARCH GEN PSYCHIAT, V66, P617, DOI 10.1001/archgenpsychiatry.2009.50; Welin C, 2000, J INTERN MED, V247, P629, DOI 10.1046/j.1365-2796.2000.00694.x; ZUNG WWK, 1971, PSYCHOSOMATICS, V12, P371	25	30	34	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0152367	10.1371/journal.pone.0152367	http://dx.doi.org/10.1371/journal.pone.0152367			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ3UC	27074002	Green Submitted, Green Published, gold			2022-12-27	WOS:000374131200022
J	Mao, Y; Qu, Q; Chen, XS; Huang, O; Wu, JY; Shen, KW				Mao, Yan; Qu, Qing; Chen, Xiaosong; Huang, Ou; Wu, Jiayi; Shen, Kunwei			The Prognostic Value of Tumor-Infiltrating Lymphocytes in Breast Cancer: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							CELL INFILTRATION; NEOADJUVANT CHEMOTHERAPY; PREDICT RESPONSE; FOXP3 EXPRESSION; POOR-PROGNOSIS; SURVIVAL; CARCINOMA; RECOMMENDATIONS; DOCETAXEL; MARKER	Background The prognostic values of tumor-infiltrating lymphocytes (TILs) and TILs subsets in breast cancer (BC) are uncertain. Methods A systematic literature search (MEDLINE, Web of Science, EMBASE, and the Cochrane Library to August 2014) was conducted for studies which met the eligibility criteria. The primary clinical outcome was defined as disease-free survival (DFS), overall survival (OS), and BC-specific survival (BCSS). Random or fixed-effects model was adopted to estimate the summary hazard ratio (HR). Results Twenty-five published studies comprising 22,964 patients were reviewed. Pooled analysis indicated that TILs were not prognostic markers for DFS and OS in overall population, but related to improved DFS (HR, 0.82; 95% CI, 0.76-0.88) and OS (HR, 0.79; 95% CI, 0.710.87) in triple negative breast cancer (TNBC) patients. For TILs subsets, CD8+ lymphocytes were associated with improved DFS (HR, 0.69; 95% CI, 0.56-0.84) and BCSS (HR, 0.78; 95% CI, 0.71-0.86) in overall population, while FOXP3+ lymphocytes were associated with reduced DFS (HR, 1.47; 95% CI, 1.01-2.05) and OS (HR, 1.50; 95% CI, 1.15-1.97). In estrogen receptor (ER) negative patients, CD8(+) lymphocytes was also related to better BCSS. In addition, the high density of CD20(+), CD3(+) or low level of PD-1+ or gamma delta T lymphocytes indicated increased OS in limited studies. Conclusion TILs and TILs subsets are promising prognostic biomarkers in breast cancer, especially in TNBC.	[Mao, Yan] Qingdao Univ, Affiliated Hosp, Breast Hlth Ctr, Qingdao 266071, Shandong, Peoples R China; [Mao, Yan; Chen, Xiaosong; Huang, Ou; Wu, Jiayi; Shen, Kunwei] Shanghai Jiao Tong Univ, Sch Med, Comprehens Breast Hlth Ctr, Ruijin Hosp, Shanghai 200030, Peoples R China; [Qu, Qing] Shanghai Jiao Tong Univ, Sch Med, Dept Oncol, Ruijin Hosp, Shanghai 200030, Peoples R China	Qingdao University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Shen, KW (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Comprehens Breast Hlth Ctr, Ruijin Hosp, Shanghai 200030, Peoples R China.	kwshen@medmail.com.cn	吴, 家怡/GSI-7419-2022		Doctor Innovation funding of Shanghai Jiao Tong University School of Medicine [BXJ201213]; National Natural funding of China [81202087, 81202088, 81172520]; Shanghai Municipal Science and Technology Commission [12ZR144640, 14411950200, 14411950201]	Doctor Innovation funding of Shanghai Jiao Tong University School of Medicine; National Natural funding of China; Shanghai Municipal Science and Technology Commission(Science & Technology Commission of Shanghai Municipality (STCSM))	The authors' work was supported by Doctor Innovation funding of Shanghai Jiao Tong University School of Medicine (BXJ201213), the National Natural funding of China (81202087, 81202088, and 81172520), Shanghai Municipal Science and Technology Commission funding (12ZR144640, 14411950200, 14411950201).	Adams S, 2014, J CLIN ONCOL, V32, P2959, DOI 10.1200/JCO.2013.55.0491; Al Murri AM, 2008, BRIT J CANCER, V99, P1013, DOI 10.1038/sj.bjc.6604667; Ali HR, 2014, ANN ONCOL, V25, P1536, DOI 10.1093/annonc/mdu191; Andre F, 2013, CLIN CANCER RES, V19, P28, DOI 10.1158/1078-0432.CCR-11-2701; Aruga T, 2009, ONCOL REP, V22, P273, DOI 10.3892/or_00000434; Baker K, 2011, HISTOPATHOLOGY, V58, P1107, DOI 10.1111/j.1365-2559.2011.03846.x; Bates GJ, 2006, J CLIN ONCOL, V24, P5373, DOI 10.1200/JCO.2006.05.9584; Campbell MJ, 2011, BREAST CANCER RES TR, V128, P703, DOI 10.1007/s10549-010-1154-y; Chen ZL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095475; Chen ZL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044741; de Graeff P, 2009, BRIT J CANCER, V101, P149, DOI 10.1038/sj.bjc.6605112; de Kruijf EM, 2010, CLIN CANCER RES, V16, P1272, DOI 10.1158/1078-0432.CCR-09-1844; Demir L, 2013, CLIN EXP METASTAS, V30, P1047, DOI 10.1007/s10585-013-9602-9; Denkert C, 2010, J CLIN ONCOL, V28, P105, DOI 10.1200/JCO.2009.23.7370; Dieci MV, 2014, ANN ONCOL, V25, P611, DOI 10.1093/annonc/mdt556; Flies Dallas B., 2011, Yale Journal of Biology and Medicine, V84, P409; Garcia-Martinez E, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0488-5; Gu-Trantien C, 2013, J CLIN INVEST, V123, P2873, DOI 10.1172/JCI67428; Hayes DF, 2006, BREAST CANCER RES TR, V100, P237, DOI 10.1007/s10549-006-9253-5; Heys SD, 2012, BREAST CANCER RES TR, V135, P539, DOI 10.1007/s10549-012-2190-6; Hornychova H, 2008, CANCER INVEST, V26, P1024, DOI 10.1080/07357900802098165; Kim ST, 2013, AM J CLIN ONCOL-CANC, V36, P224, DOI 10.1097/COC.0b013e3182467d90; Kim S, 2014, J BREAST CANCER, V17, P8, DOI 10.4048/jbc.2014.17.1.8; Ladoire S, 2011, BRIT J CANCER, V105, P366, DOI 10.1038/bjc.2011.261; Lee S, 2013, ACTA ONCOL, V52, P73, DOI 10.3109/0284186X.2012.731520; Lee SC, 2011, IMMUNOL RES, V50, P248, DOI 10.1007/s12026-011-8231-0; Liu FF, 2012, BREAST CANCER RES TR, V135, P459, DOI 10.1007/s10549-012-2132-3; Liu FF, 2011, BREAST CANCER RES TR, V130, P645, DOI 10.1007/s10549-011-1647-3; Liu S, 2012, BREAST CANCER RES, V2012, pR48; Loi S, 2014, ANN ONCOL, V25, P1544, DOI 10.1093/annonc/mdu112; Loi S, 2013, CANCER RES, V73; Loi S, 2013, J CLIN ONCOL, V31, P860, DOI 10.1200/JCO.2011.41.0902; Ma CL, 2012, J IMMUNOL, V189, P5029, DOI 10.4049/jimmunol.1201892; Maeda N, 2014, ANN SURG ONCOL; Mahmoud SMA, 2012, BREAST CANCER RES TR, V132, P545, DOI 10.1007/s10549-011-1620-1; Mahmoud SMA, 2011, J CLIN ONCOL, V29, P1949, DOI 10.1200/JCO.2010.30.5037; Mahmoud SMA, 2011, BREAST CANCER RES TR, V127, P99, DOI 10.1007/s10549-010-0987-8; McShane LM, 2005, BRIT J CANCER, V93, P387, DOI 10.1038/sj.bjc.6602678; Menard S, 1997, CLIN CANCER RES, V3, P817; Mohammed ZMA, 2013, BRIT J CANCER, V109, P1676, DOI 10.1038/bjc.2013.493; Mohammed ZMA, 2012, BRIT J CANCER, V107, P864, DOI 10.1038/bjc.2012.347; Muenst S, 2014, BREAST CANCER RES TR, V146, P15, DOI 10.1007/s10549-014-2988-5; Muenst S, 2013, BREAST CANCER RES TR, V139, P667, DOI 10.1007/s10549-013-2581-3; Ono M, 2012, BREAST CANCER RES TR, V132, P793, DOI 10.1007/s10549-011-1554-7; Rathore AS, 2013, INDIAN J CANCER, V50, P239, DOI 10.4103/0019-509X.118744; Salgado R, 2015, ANN ONCOL, V26, P259, DOI 10.1093/annonc/mdu450; Sun SY, 2014, CANCER IMMUNOL IMMUN, V63, P395, DOI 10.1007/s00262-014-1519-x; Takenaka M, 2013, MOL CLIN ONCOL, V1, P625, DOI 10.3892/mco.2013.107; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; West NR, 2013, BRIT J CANCER, V108, P155, DOI 10.1038/bjc.2012.524; Yan M, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2869	51	115	122	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0152500	10.1371/journal.pone.0152500	http://dx.doi.org/10.1371/journal.pone.0152500			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073890	gold, Green Submitted, Green Published			2022-12-27	WOS:000374131200026
J	Ogneva, IV; Biryukov, NS				Ogneva, Irina V.; Biryukov, Nikolay S.			Lecithin Prevents Cortical Cytoskeleton Reorganization in Rat Soleus Muscle Fibers under Short-Term Gravitational Disuse	PLOS ONE			English	Article							HUMAN ARP2/3 COMPLEX; ACTIN CYTOSKELETON; CHANNEL ACTIVITY; SPACE-FLIGHT; LIPID RAFTS; INCREASES; SUBUNITS; BINDING; CELLS; PHOSPHORYLATION	The aim of this study was to prevent the cortical cytoskeleton reorganization of rat soleus muscle fibers under short-term gravitational disuse. Once a day, we injected the right soleus muscle with 0.5 ml lecithin at a concentration of 200 mg/ml and the left soleus muscle with a diluted solution in an equal volume for 3 days prior to the experiment. To simulate microgravity conditions in rats, an anti-orthostatic suspension was used according to the Ilyin-Novikov method modified by Morey-Holton et al. for 6 hours. The following groups of soleus muscle tissues were examined: "C", "C+L", "HS", and "HS+L". The transversal stiffness of rat soleus muscle fibers after 6 hours of suspension did not differ from that of the control group for the corresponding legs; there were no differences between the groups without lecithin "C" and "HS" or between the groups with lecithin "C+L" and "HS+L". However, lecithin treatment for three days resulted in an increase in cell stiffness; in the "C+L" group, cell stiffness was significantly higher by 22.7% (p < 0.05) compared with that of group "C". The mRNA content of genes encoding beta-and gamma-actin and beta-tubulin did not significantly differ before and after suspension in the corresponding groups. However, there was a significant increase in the mRNA content of these genes after lecithin treatment: the beta-actin and gamma-actin mRNA content in group "C+L" increased by 200% compared with that of group "C", and beta-tubulin increased by 100% (as well as the mRNA content of tubulin-binding proteins Ckap5, Tcp1, Cct5 and Cct7). In addition, desmin mRNA content remained unchanged in all of the experimental groups. As a result of the lecithin injections, there was a redistribution of the mRNA content of genes encoding actin monomer-and filament-binding proteins in the direction of increasing actin polymerization and filament stability; the mRNA content of Arpc3 and Lcp1 increased by 3- and 5-fold, respectively, but the levels of Tmod1 and Svil decreased by 2- and 5-fold, respectively. However, gravitational disuse did not result in changes in the mRNA content of Arpc3, Tmod1, Svil or Lcp1. Antiorthostatic suspension for 6 hours resulted in a decrease in the mRNA content of alpha-actinin-4 (Actn4) and alpha-actinin-1 (Actn1) in group "HS "compared with that of group "C" by 25% and 30%, respectively, as well as a decrease and increase in the ACTN4 protein content in the membrane and cytoplasmic fractions, respectively. Lecithin injection resulted in an increase in the Actn1 and Actn4 mRNA content in group "C+L" by 1.5-fold and more than 2-fold, respectively, compared with the levels in group "C". Moreover, in group "HS+L", the mRNA content did not change in these genes compared with the levels in group "C+L", and the ACTN4 protein content in the membrane and cytoplasmic fractions also remained unchanged. Thus, lecithin prevented the reduction of Actn1 and Actn4 mRNA and the migration of ACTN4 from the cortical cytoskeleton to the cytoplasm.	[Ogneva, Irina V.; Biryukov, Nikolay S.] Russian Acad Sci, Russian Federat Inst Biomed Problems, State Sci Ctr, Dept Mol & Cell Biomed, Moscow, Russia; [Ogneva, Irina V.] IM Sechenov First Moscow State Med Univ, Moscow, Russia; [Biryukov, Nikolay S.] State Univ, Moscow Inst Phys & Technol, Moscow, Moscow Region, Russia	Russian Academy of Sciences; Institute of Biomedical Problems of the Russian Academy of Sciences; Sechenov First Moscow State Medical University; Moscow Institute of Physics & Technology	Ogneva, IV (corresponding author), Russian Acad Sci, Russian Federat Inst Biomed Problems, State Sci Ctr, Dept Mol & Cell Biomed, Moscow, Russia.; Ogneva, IV (corresponding author), IM Sechenov First Moscow State Med Univ, Moscow, Russia.	iogneva@yandex.ru	Biryukov, Nikolay/L-2955-2016; Ogneva, Irina V/Q-8783-2018; Biryukov, Nikolay/AAE-8139-2021	Biryukov, Nikolay/0000-0001-6861-3960; Ogneva, Irina V/0000-0003-0125-5876; 	Russian Fond of the Basic Research (RFBR) [13-04-00755-a]; program of the RAS Presidium	Russian Fond of the Basic Research (RFBR)(Russian Foundation for Basic Research (RFBR)); program of the RAS Presidium	The financial support of the Russian Fond of the Basic Research (RFBR grant 13-04-00755-a) and program of the RAS Presidium "Molecular and cell biology" is greatly acknowledged.	BOOTH FW, 1973, PFLUG ARCH EUR J PHY, V342, P231, DOI 10.1007/BF00591371; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; Brown DA, 2006, PHYSIOLOGY, V21, P430, DOI 10.1152/physiol.00032.2006; Caiozzo VJ, 1996, J APPL PHYSIOL, V81, P123, DOI 10.1152/jappl.1996.81.1.123; Cassimeris L, 2004, MOL BIOL CELL, V15, P1580, DOI 10.1091/mbc.E03-07-0544; Chubinskiy-Nadezhdin VI, 2011, BIOCHEM BIOPH RES CO, V412, P80, DOI 10.1016/j.bbrc.2011.07.046; Collinsworth AM, 2002, AM J PHYSIOL-CELL PH, V283, pC1219, DOI 10.1152/ajpcell.00502.2001; Crowley JL, 2009, MOL BIOL CELL, V20, P948, DOI 10.1091/mbc.E08-08-0867; DENNERLL TJ, 1988, J CELL BIOL, V107, P665, DOI 10.1083/jcb.107.2.665; DESPLANCHES D, 1990, J APPL PHYSIOL, V68, P48, DOI 10.1152/jappl.1990.68.1.48; DEVARAJAN P, 1994, P NATL ACAD SCI USA, V91, P2965, DOI 10.1073/pnas.91.8.2965; Edidin M, 2003, ANNU REV BIOPH BIOM, V32, P257, DOI 10.1146/annurev.biophys.32.110601.142439; Gergely F, 2003, GENE DEV, V17, P336, DOI 10.1101/gad.245603; Ghosh D, 2010, J MASS SPECTROM, V45, P1, DOI 10.1002/jms.1696; Goffart S, 2006, CURR GENET, V49, P125, DOI 10.1007/s00294-005-0043-0; Gournier H, 2001, MOL CELL, V8, P1041, DOI 10.1016/S1097-2765(01)00393-8; Harder T, 1999, EUR J IMMUNOL, V29, P556, DOI 10.1002/(SICI)1521-4141(199902)29:02<556::AID-IMMU556>3.0.CO;2-2; Huang HD, 2004, AM J PHYSIOL-CELL PH, V287, pC1, DOI 10.1152/ajpcell.00559.2003; Infanger M, 2007, J CELL BIOCHEM, V101, P1439, DOI 10.1002/jcb.21261; Janji B, 2006, J CELL SCI, V119, P1947, DOI 10.1242/jcs.02874; Jayaraman T, 2008, SINGAP MED J, V49, P320; Knee KM, 2013, CELL STRESS CHAPERON, V18, P137, DOI 10.1007/s12192-012-0357-z; Lee K, 2004, YONSEI MED J, V45, P690; Levitan I, 2000, J GEN PHYSIOL, V115, P405, DOI 10.1085/jgp.115.4.405; Liu SC, 2000, J CELL SCI, V113, P3563; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Machesky LM, 1999, P NATL ACAD SCI USA, V96, P3739, DOI 10.1073/pnas.96.7.3739; Mak KM, 2003, ALCOHOL CLIN EXP RES, V27, P997, DOI 10.1097/01.ALC.0000071901.62432.09; Maniotis AJ, 1997, P NATL ACAD SCI USA, V94, P849, DOI 10.1073/pnas.94.3.849; Maroto R, 2005, NAT CELL BIOL, V7, P179, DOI 10.1038/ncb1218; MATSUSHIMA K, 1988, BIOCHEMISTRY-US, V27, P3765, DOI 10.1021/bi00410a037; Maximov AV, 1997, FEBS LETT, V412, P94, DOI 10.1016/S0014-5793(97)00754-0; Maximov AV, 1997, BIOPHYS J, V72, pWPO99; MCDONALD KS, 1995, J APPL PHYSIOL, V79, P1796, DOI 10.1152/jappl.1995.79.5.1796; Morachevskaya E, 2007, CELL BIOL INT, V31, P374, DOI 10.1016/j.cellbi.2007.01.024; Morey-Holton E, 2005, ADV SPACE B, V10, P7, DOI 10.1016/S1569-2574(05)10002-1; Nebl T, 2002, J BIOL CHEM, V277, P43399, DOI 10.1074/jbc.M205386200; Negulyaev YA, 1996, MOL BIOL CELL, V7, P1857, DOI 10.1091/mbc.7.12.1857; Odde DJ, 1999, J CELL SCI, V112, P3283; Ogneva IV, 2014, J APPL PHYSIOL, V116, P1315, DOI 10.1152/japplphysiol.00134.2014; Ogneva IV, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/393405; Ogneva IV, 2010, J APPL PHYSIOL, V109, P1702, DOI 10.1152/japplphysiol.00793.2010; Ogneva I.V., 2013, APPL MATH, V4, P1, DOI [10.4236/am.2013.48A001, DOI 10.4236/AM.2013.48A001]; Ogneva IV, 2014, INT J BIOMED, V4, P162, DOI 10.21103/Article4_3_ER1; Ogneva IV, 2015, J APPL PHYSIOL, V118, P613, DOI 10.1152/japplphysiol.00812.2014; Ogneva IV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096395; Poch MT, 2004, TOXICOL APPL PHARM, V199, P239, DOI 10.1016/j.taap.2003.12.023; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Putnam AJ, 2001, AM J PHYSIOL-CELL PH, V280, pC556, DOI 10.1152/ajpcell.2001.280.3.C556; RIJKEN PJ, 1992, ADV SPACE RES-SERIES, V12, P145, DOI 10.1016/0273-1177(92)90277-5; Robinson RC, 2001, SCIENCE, V294, P1679, DOI 10.1126/science.1066333; Salmi ML, 2011, PLANTA, V233, P911, DOI 10.1007/s00425-010-1343-2; SCHWIEBERT EM, 1994, J BIOL CHEM, V269, P7081; Shlyonsky VG, 2003, AM J PHYSIOL-RENAL, V284, pF182, DOI 10.1152/ajprenal.00216.2002; STEVENS L, 1993, AM J PHYSIOL, V264, pR770, DOI 10.1152/ajpregu.1993.264.4.R770; Sukharev S, 2001, NATURE, V409, P720, DOI 10.1038/35055559; SUZUKI M, 1993, J MEMBRANE BIOL, V134, P31; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Vartiainen MK, 2004, CURR OPIN CELL BIOL, V16, P174, DOI 10.1016/j.ceb.2004.02.004; Vitorino R, 2007, ANAL BIOCHEM, V366, P156, DOI 10.1016/j.ab.2007.04.009; Wear MA, 2004, TRENDS BIOCHEM SCI, V29, P418, DOI 10.1016/j.tibs.2004.06.003; Welch MD, 1997, J CELL BIOL, V138, P375, DOI 10.1083/jcb.138.2.375; Widrick JJ, 2008, AM J PHYSIOL-REG I, V295, pR1585, DOI 10.1152/ajpregu.00045.2008; Won KA, 1998, MOL CELL BIOL, V18, P7584, DOI 10.1128/MCB.18.12.7584; YAFFE MB, 1992, NATURE, V358, P245, DOI 10.1038/358245a0; Yokota S, 2001, EUR J BIOCHEM, V268, P4664, DOI 10.1046/j.1432-1327.2001.02393.x	66	14	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153650	10.1371/journal.pone.0153650	http://dx.doi.org/10.1371/journal.pone.0153650			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073851	Green Submitted, Green Published, gold			2022-12-27	WOS:000374131200115
J	Yue, A; Marsh, L; Zhou, H; Medina, A; Luo, RF; Shi, YJ; Zhang, LX; Kenny, K; Rozelle, S				Yue, Ai; Marsh, Lauren; Zhou, Huan; Medina, Alexis; Luo, Renfu; Shi, Yaojiang; Zhang, Linxiu; Kenny, Kaleigh; Rozelle, Scott			Nutritional Deficiencies, the Absence of Information and Caregiver Shortcomings: A Qualitative Analysis of Infant Feeding Practices in Rural China	PLOS ONE			English	Article							CHILD HEALTH; EDUCATION; ANEMIA	Background and Objectives Development during the first two years of life is critical and has a lasting impact on a child's health. Poor infant and child nutrition can lead to deficiencies in essential micronutrients, which may cause a weakened immune system and lasting effects on children's growth and development. Recent studies in rural Shaanxi Province found an anemia prevalence of 54.3% among rural children aged six to twelve months. While new large-scale, quantitative research has begun to catalogue the extent of child malnutrition and anemia, no effort has yet been made to look more closely at the potential reasons for rural children's nutritional deficiencies through qualitative analysis. This study aims to elucidate some of the fundamental causes of poor complementary feeding practices that may lead to anemia among children in rural Shaanxi Province, China. Methodology We interviewed sixty caregivers participating in a large survey on child health and nutrition. We conducted three waves of interviews with children's primary caregivers in seventeen rural villages within four nationally-designated poverty counties in the southern part of Shaanxi Province. Results The qualitative analysis reveals that poor complementary feeding practices are common across our sample. Information gathered from our interviews suggests that complementary feeding practices are impeded by two constraints: absence of understanding topics related to infant health and nutrition under caregivers, as well as inadequate sources of information on these topics. Poverty does not appear to constrain child feeding practices. Conclusion Our results uncover lack of proper knowledge on infant and child nutrition among rural caregivers in China. This situation causes them to fail incorporating micronutrient rich foods in their children's diet. Age-appropriate complementary feeding can stimulate children's physical and cognitive development, but in its absence it leads to iron-deficiency anemia. We suggest that steps be taken to educate caregivers to improve complementary feeding of their infants and children.	[Yue, Ai; Shi, Yaojiang] Shaanxi Normal Univ, CEEE, Xian 710119, Shaanxi, Peoples R China; [Marsh, Lauren; Zhou, Huan] Sichuan Univ, West China Sch Publ Hlth, Chengdu 610041, Sichuan, Peoples R China; [Medina, Alexis; Kenny, Kaleigh; Rozelle, Scott] Stanford Univ, Rural Educ Act Program, Freeman Spogli Inst Int Studies, Stanford, CA 94305 USA; [Luo, Renfu; Zhang, Linxiu] Peking Univ, Sch Adv Agr Sci, Beijing 100871, Peoples R China	Shaanxi Normal University; Sichuan University; Stanford University; Peking University	Zhou, H (corresponding author), Sichuan Univ, West China Sch Publ Hlth, Chengdu 610041, Sichuan, Peoples R China.	zhouhuan1999@yeah.net	zhou, huan/GYJ-4398-2022; ZHANG, LIN/GYD-9123-2022		International Initiative for Impact Evaluation (3ie) [PW2.03.CH.IE]; UBS Optimus Foundation [12-6140]; China Medical Board [13-158]	International Initiative for Impact Evaluation (3ie); UBS Optimus Foundation; China Medical Board	This work was supported by funding from the International Initiative for Impact Evaluation (3ie), grant number: PW2.03.CH.IE, URL: http://www.3ieimpact.org (to RL); the UBS Optimus Foundation, grant number: 12-6140, URL: https://www.ubs.com/global/en/wealth_management/optimusfoundation.html (to HZ); and China Medical Board, grant number: 13-158, URL: http://www.chinamedicalboard.org (to YS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, REP CHIN IMPL MILL D; Block SA, 2007, OXFORD ECON PAP, V59, P330, DOI 10.1093/oep/gpm001; Chen CM, 2010, BIOMED ENVIRON SCI, V23, P83, DOI 10.1016/S0895-3988(10)60036-0; CLELAND JG, 1988, SOC SCI MED, V27, P1357, DOI 10.1016/0277-9536(88)90201-8; de Benoist B, 2008, WHO GLOBAL DATABASE; Desai S, 1998, DEMOGRAPHY, V35, P71, DOI 10.2307/3004028; Dewey K., 2003, GUID PRINC COMPL FEE; Grantham-McGregor S, 2007, LANCET, V369, P60, DOI 10.1016/S0140-6736(07)60032-4; LIN LM, 2003, CHIN J CHILD HLTH CA, V11, P242; Ling R.E., 2010, PUBLIC HLTH, V30, P1; Liu H, 2013, ECON HUM BIOL, V11, P294, DOI 10.1016/j.ehb.2012.04.010; Luo R, 2015, MICRONUTRIE IN PRESS; Luo RF, 2014, NUTRIENTS, V6, P5975, DOI 10.3390/nu6125975; Ministry of Health, 2009, CHIN HLTH STAT YB; National Bureau of Statistics, 2011, B 2010 6 NAT CENS CH; Pelto Gretel H., 2003, Food and Nutrition Bulletin, V24, P45; Shi L, 2010, PUBLIC HEALTH NUTR, V13, P556, DOI 10.1017/S1368980009991364; State Council, 2012, 12 5 YEAR PLAN HLTH; Sylvia S, 2015, HEALTH POLICY PLANN, V30, P322, DOI 10.1093/heapol/czu014; van der Gaag J, EARLY CHILDHOOD DEV; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; WHO, 2016, COMPL FEED; Wu K., 2012, EARLY CHILD DEV CHIN; Zhang F, 2015, PUBLIC HEALTH NUTR, V18, P936, DOI 10.1017/S1368980014001001; Zhang LX, 2013, J NUTR, V143, P640, DOI 10.3945/jn.112.171959	25	31	31	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153385	10.1371/journal.pone.0153385	http://dx.doi.org/10.1371/journal.pone.0153385			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ3UC	27073864	Green Submitted, Green Published, gold			2022-12-27	WOS:000374131200080
J	Chang, ETY; Lin, YT; Galla, T; Clayton, RH; Eatock, J				Chang, Eugene T. Y.; Lin, Yen Ting; Galla, Tobias; Clayton, Richard H.; Eatock, Julie			A Stochastic Individual-Based Model of the Progression of Atrial Fibrillation in Individuals and Populations	PLOS ONE			English	Article							ELECTROPHYSIOLOGICAL CHARACTERISTICS; MOLECULAR-MECHANISMS; COMPUTER-MODEL; LIFETIME RISK; INITIATION; INSIGHTS; ARRHYTHMOGENESIS; PATHOPHYSIOLOGY; PREVALENCE; GUIDELINES	Models that represent the mechanisms that initiate and sustain atrial fibrillation (AF) in the heart are computationally expensive to simulate and therefore only capture short time scales of a few heart beats. It is therefore difficult to embed biophysical mechanisms into both policy-level disease models, which consider populations of patients over multiple decades, and guidelines that recommend treatment strategies for patients. The aim of this study is to link these modelling paradigms using a stylised population-level model that both represents AF progression over a long time-scale and retains a description of biophysical mechanisms. We develop a non-Markovian binary switching model incorporating three different aspects of AF progression: genetic disposition, disease/age related remodelling, and AF-related remodelling. This approach allows us to simulate individual AF episodes as well as the natural progression of AF in patients over a period of decades. Model parameters are derived, where possible, from the literature, and the model development has highlighted a need for quantitative data that describe the progression of AF in population of patients. The model produces time series data of AF episodes over the lifetimes of simulated patients. These are analysed to quantitatively describe progression of AF in terms of several underlying parameters. Overall, the model has potential to link mechanisms of AF to progression, and to be used as a tool to study clinical markers of AF or as training data for AF classification algorithms.	[Chang, Eugene T. Y.; Clayton, Richard H.] Univ Sheffield, Insigneo Inst In Silico Med, Sheffield S1 4DP, S Yorkshire, England; [Chang, Eugene T. Y.; Clayton, Richard H.] Univ Sheffield, Dept Comp Sci, Sheffield S1 4DP, S Yorkshire, England; [Lin, Yen Ting; Galla, Tobias] Univ Manchester, Sch Phys & Astron, Manchester M13 9PL, Lancs, England; [Eatock, Julie] Brunel Univ London, Dept Comp Sci, Uxbridge UB8 3PH, Middx, England	University of Sheffield; University of Sheffield; University of Manchester; Brunel University	Eatock, J (corresponding author), Brunel Univ London, Dept Comp Sci, Uxbridge UB8 3PH, Middx, England.	Julie.Eatock@brunel.ac.uk	Lin, Yen Ting/ABB-8491-2020; Chang, Eugene/I-5834-2015; Clayton, Richard/CAF-3400-2022; Galla, Tobias/R-1718-2018	Lin, Yen Ting/0000-0001-6893-8423; Chang, Eugene/0000-0002-1097-4189; Clayton, Richard/0000-0002-8438-7518; Eatock, Julie/0000-0002-8963-8312	Engineering and Physical Sciences Research Council [EP/K037145/1]; EPSRC [EP/K037145/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	ETYC, YTL, TG, RHC, and JE all received funding from Engineering and Physical Sciences Research Council (http://gow.epsrc.ac.uk/) grant number EP/K037145/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade J, 2014, CIRC RES, V114, P1453, DOI 10.1161/CIRCRESAHA.114.303211; Aslanidi OV, 2011, PROG BIOPHYS MOL BIO, V107, P156, DOI 10.1016/j.pbiomolbio.2011.06.011; Barrett TW, 2013, AM J EMERG MED, V31, P792, DOI 10.1016/j.ajem.2013.01.020; Beerenwinkel N, 2015, SYST BIOL, V64, pE1, DOI 10.1093/sysbio/syu081; Bosch RF, 2002, CARDIOVASC RES, V54, P259, DOI 10.1016/S0008-6363(01)00529-6; Briggs A, 2006, DECISION MODELLING H; Burashnikov A, 2003, CIRCULATION, V107, P2355, DOI 10.1161/01.CIR.0000065578.00869.7C; Camm AJ, 2010, EUROPACE, V12, P1360, DOI [10.1093/europace/euq350, 10.1093/eurheartj/ehq278]; Charitos EI, 2014, J AM COLL CARDIOL, V63, P2840, DOI 10.1016/j.jacc.2014.04.019; Charitos EI., 2013, ACP-APPL CARDIOPUL P, V17, P3; Chen SA, 1999, CIRCULATION, V100, P1879, DOI 10.1161/01.CIR.100.18.1879; Colman MA, 2013, J PHYSIOL-LONDON, V591, P4249, DOI 10.1113/jphysiol.2013.254987; Council NR, 2012, ASS REL COMPL MOD MA; de Vos CB, 2010, J AM COLL CARDIOL, V55, P725, DOI 10.1016/j.jacc.2009.11.040; Eatock J, 2015, COMPUT CARDIOL CONF, V42, P265, DOI 10.1109/CIC.2015.7408637; Everett TH, 2000, CIRCULATION, V102, P1454, DOI 10.1161/01.CIR.102.12.1454; Everett TH, 2006, AM J PHYSIOL-HEART C, V291, pH2911, DOI 10.1152/ajpheart.01128.2005; Garratt CJ, 1999, J CARDIOVASC ELECTR, V10, P1101, DOI 10.1111/j.1540-8167.1999.tb00283.x; GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Goette A, 1996, CIRCULATION, V94, P2968, DOI 10.1161/01.CIR.94.11.2968; Haim M, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001486; Hasty J, 2001, NAT REV GENET, V2, P268, DOI 10.1038/35066056; Heeringa J, 2006, EUR HEART J, V27, P949, DOI 10.1093/eurheartj/ehi825; Heijman J, 2014, CIRC RES, V114, P1483, DOI 10.1161/CIRCRESAHA.114.302226; Hoffmann E, 2006, CIRCULATION, V113, P1933, DOI 10.1161/CIRCULATIONAHA.105.568568; Jahangir A, 2010, J AM COLL CARDIOL, V55, P732, DOI 10.1016/j.jacc.2009.12.010; Kaemmerer WF, 2001, J CARDIOVASC ELECTR, V12, P121, DOI 10.1046/j.1540-8167.2001.00121.x; Keeling MJ., 2008, MODELING INFECT DIS, DOI DOI 10.1515/9781400841035; Kneller J, 2002, CIRC RES, V90, pE73, DOI 10.1161/01.RES.0000019783.88094.BA; Lloyd-Jones DM, 2004, CIRCULATION, V110, P1042, DOI 10.1161/01.CIR.0000140263.20897.42; Lord J, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI 10.3310/hta17580; McDowell KS, 2013, BIOPHYS J, V104, P2764, DOI 10.1016/j.bpj.2013.05.025; MOE GK, 1964, AM HEART J, V67, P200, DOI 10.1016/0002-8703(64)90371-0; MORILLO CA, 1995, CIRCULATION, V91, P1588, DOI 10.1161/01.CIR.91.5.1588; National Clinical Guideline Centre, 2014, ATR FIBR MAN ATR FIB, pCG180; National Collaborating Centre for Chronic Conditions, 2006, ATR FIBR MAN ATR FIB, pCG36; Nattel S, 2002, NATURE, V415, P219, DOI 10.1038/415219a; Nattel S, 2008, CIRC-ARRHYTHMIA ELEC, V1, P62, DOI 10.1161/CIRCEP.107.754564; Olesen JB, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d124; Pandozi C, 2001, EUR HEART J, V22, P541, DOI 10.1053/euhj.2000.2441; Sankaranarayanan R, 2013, CARDIOL RES PRACT, V2013, DOI 10.1155/2013/976976; Schotten U, 2003, CIRCULATION, V107, P1433, DOI 10.1161/01.CIR.0000055314.10801.4F; Schotten U, 2011, PHYSIOL REV, V91, P265, DOI 10.1152/physrev.00031.2009; Sculpher M, 2008, PHARMACOECONOMICS, V26, P799, DOI 10.2165/00019053-200826090-00009; Shehadeh LA, 2002, J CARDIOVASC ELECTR, V13, P303, DOI 10.1046/j.1540-8167.2002.00303.x; Shukla A, 2014, VASC HEALTH RISK MAN, V10, P1, DOI 10.2147/VHRM.S49334; Stewart S, 2001, HEART, V86, P516, DOI 10.1136/heart.86.5.516; Takashima Y, 2011, P NATL ACAD SCI USA, V108, P3300, DOI 10.1073/pnas.1014418108; Thijssen VLJL, 2001, CARDIOVASC RES, V52, P14, DOI 10.1016/S0008-6363(01)00367-4; Veasey RA, 2015, J INTERV CARD ELECTR, V44, P23, DOI 10.1007/s10840-015-0029-x; Voigt N, 2014, CIRCULATION, V129, P145, DOI 10.1161/CIRCULATIONAHA.113.006641; Wakili R, 2011, J CLIN INVEST, V121, P2955, DOI 10.1172/JCI46315; WIJFFELS MCEF, 1995, CIRCULATION, V92, P1954, DOI 10.1161/01.CIR.92.7.1954; Wilhelms M, 2013, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00487; Yeh YH, 2008, CIRC-ARRHYTHMIA ELEC, V1, P93, DOI 10.1161/CIRCEP.107.754788; Yu WC, 1999, CARDIOVASC RES, V42, P470, DOI 10.1016/S0008-6363(99)00030-9; Yue LX, 1999, CIRC RES, V84, P776	58	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0152349	10.1371/journal.pone.0152349	http://dx.doi.org/10.1371/journal.pone.0152349			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27070920	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000373900700008
J	Katuwal, GJ; Baum, SA; Cahill, ND; Michael, AM				Katuwal, Gajendra J.; Baum, Stefi A.; Cahill, Nathan D.; Michael, Andrew M.			Divide and Conquer: Sub-Grouping of ASD Improves ASD Detection Based on Brain Morphometry	PLOS ONE			English	Article							AUTISM SPECTRUM DISORDER; SURFACE-BASED ANALYSIS; CLASSIFICATION; ABNORMALITIES; SEGMENTATION; DIAGNOSIS; CHILDREN; HETEROGENEITY; MRI	Low success (<60%) in autism spectrum disorder (ASD) classification using brain morphometry from the large multi-site ABIDE dataset and inconsistent findings on brain morphometric abnormalities in ASD can be attributed to the ASD heterogeneity. In this study, we show that ASD brain morphometry is highly heterogeneous, and demonstrate that the heterogeneity can be mitigated and classification improved if autism severity (AS), verbal IQ (VIQ) and age are used with morphometric features. Morphometric features from structural MRIs (sMRIs) of 734 males (ASD: 361, controls: 373) of ABIDE were derived using FreeSurfer. Applying the Random Forest classifier, an AUC of 0.61 was achieved. Adding VIQ and age to morphometric features, AUC improved to 0.68. Sub-grouping the subjects by AS, VIQ and age improved the classification with the highest AUC of 0.8 in the moderate-AS sub-group (AS = 7-8). Matching subjects on age and/or VIQ in each sub-group further improved the classification with the highest AUC of 0.92 in the low AS sub-group (AS = 4-5). AUC decreased with AS and VIQ, and was the lowest in the mid-age sub-group (1318 years). The important features were mainly from the frontal, temporal, ventricular, right hippocampal and left amygdala regions. However, they highly varied with AS, VIQ and age. The curvature and folding index features from frontal, temporal, lingual and insular regions were dominant in younger subjects suggesting their importance for early detection. When the experiments were repeated using the Gradient Boosting classifier similar results were obtained. Our findings suggest that identifying brain biomarkers in sub-groups of ASD can yield more robust and insightful results than searching across the whole spectrum. Further, it may allow identification of sub-group specific brain biomarkers that are optimized for early detection and monitoring, increasing the utility of sMRI as an important tool for early detection of ASD.	[Katuwal, Gajendra J.; Michael, Andrew M.] Geisinger Hlth Syst, Autism & Dev Med Inst, Danville, PA USA; [Katuwal, Gajendra J.; Baum, Stefi A.; Cahill, Nathan D.; Michael, Andrew M.] Rochester Inst Technol, Chester F Carlson Ctr Imaging Sci, Rochester, NY 14623 USA; [Cahill, Nathan D.] Rochester Inst Technol, Sch Math Sci, Rochester, NY 14623 USA; [Baum, Stefi A.] Univ Manitoba, Fac Sci, Winnipeg, MB, Canada	Geisinger Health System; Rochester Institute of Technology; Rochester Institute of Technology; University of Manitoba	Katuwal, GJ (corresponding author), Geisinger Hlth Syst, Autism & Dev Med Inst, Danville, PA USA.; Katuwal, GJ (corresponding author), Rochester Inst Technol, Chester F Carlson Ctr Imaging Sci, Rochester, NY 14623 USA.	gjk3423@rit.edu			Geisinger Health System Foundation; Autism and Developmental Medicine Institute at Geisinger Health System	Geisinger Health System Foundation; Autism and Developmental Medicine Institute at Geisinger Health System	This work was supported by Geisinger Health System Foundation.r The authors would like to thank the individual sites of the ABIDE consortium that collected brain scans and all research participants who participated in their studies. The authors would also like to thank the ABIDE consortium for their efforts in putting together this large valuable dataset and making it freely available. The preprocessing and analyses involved in this study was supported by Autism and Developmental Medicine Institute at Geisinger Health System. The authors have no conflict of interest to declare.	Amaral DG, 2008, TRENDS NEUROSCI, V31, P137, DOI 10.1016/j.tins.2007.12.005; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Auzias G, 2014, NEUROIMAGE-CLIN, V4, P593, DOI 10.1016/j.nicl.2014.03.008; Betancur C, 2011, BRAIN RES, V1380, P42, DOI 10.1016/j.brainres.2010.11.078; Bigler ED, 2007, DEV NEUROPSYCHOL, V31, P217, DOI 10.1080/87565640701190841; Bradley AP, 1997, PATTERN RECOGN, V30, P1145, DOI 10.1016/S0031-3203(96)00142-2; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Breiman L, 1996, MACH LEARN, V24, P41, DOI 10.1023/A:1018094028462; Calderoni S, 2012, NEUROIMAGE, V59, P1013, DOI 10.1016/j.neuroimage.2011.08.070; Caruana R., 2006, P 23 INT C MACH LEAR, P161, DOI DOI 10.1145/1143844.1143865; Chawla NV, 2005, DATA MINING AND KNOWLEDGE DISCOVERY HANDBOOK, P853, DOI 10.1007/0-387-25465-X_40; Chen R, 2011, PEDIATR RES, V69, p63R, DOI 10.1203/PDR.0b013e318212c2b3; Close HA, 2012, PEDIATRICS, V129, pE305, DOI 10.1542/peds.2011-1717; Cohen J.E., 1988, STAT POWER ANAL BEHA; Craig MC, 2007, BRIT J PSYCHIAT, V191, P224, DOI 10.1192/bjp.bp.106.034603; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Di Martino A, 2014, Mol Psychiatry, V19, P659, DOI 10.1038/mp.2013.78; Ecker C, 2010, J NEUROSCI, V30, P10612, DOI 10.1523/JNEUROSCI.5413-09.2010; Ecker C, 2010, NEUROIMAGE, V49, P44, DOI 10.1016/j.neuroimage.2009.08.024; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Floris DL, 2013, J AUTISM DEV DISORD, V43, P1758, DOI 10.1007/s10803-012-1720-8; Fombonne E, 2005, J APPL RES INTELLECT, V18, P281, DOI 10.1111/j.1468-3148.2005.00266.x; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; Frisoni GB, 2010, NAT REV NEUROL, V6, P67, DOI 10.1038/nrneurol.2009.215; GIEDD JN, 1995, PSYCHIAT RES-NEUROIM, V61, P113, DOI 10.1016/0925-4927(95)02593-M; Glenn OA, 2010, PEDIATR RADIOL, V40, P68, DOI 10.1007/s00247-009-1459-3; Gotham K, 2009, J AUTISM DEV DISORD, V39, P693, DOI 10.1007/s10803-008-0674-3; Haar S, 2016, CEREB CORTEX, V26, P1440, DOI 10.1093/cercor/bhu242; Hampel H, 2010, NAT REV DRUG DISCOV, V9, P560, DOI 10.1038/nrd3115; Happe F, 2006, NAT NEUROSCI, V9, P1218, DOI 10.1038/nn1770; Jain AK, 2000, IEEE T PATTERN ANAL, V22, P4, DOI 10.1109/34.824819; Jeste SS, 2014, NAT REV NEUROL, V10, P74, DOI 10.1038/nrneurol.2013.278; Jiao Y, 2010, NEUROIMAGE, V50, P589, DOI 10.1016/j.neuroimage.2009.12.047; Katuwal GJ, 2015, IEEE ENG MED BIO, P4270, DOI 10.1109/EMBC.2015.7319338; Katuwal GJ, 2015, ORGANIZATION FOR HUM, DOI 10.13140/RG.2.1.3449.2249; Lai MC, 2013, BRAIN, V136, P2799, DOI 10.1093/brain/awt216; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Lenroot RK, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00733; Lin HY, 2015, MOL AUTISM, V6, DOI 10.1186/s13229-015-0022-3; Morey RA, 2009, NEUROIMAGE, V45, P855, DOI 10.1016/j.neuroimage.2008.12.033; Natekin A, 2013, FRONT NEUROROBOTICS, V7, DOI 10.3389/fnbot.2013.00021; Nordahl CW, 2007, J NEUROSCI, V27, P11725, DOI 10.1523/JNEUROSCI.0777-07.2007; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Radua J, 2011, PSYCHOL MED, V41, P1539, DOI 10.1017/S0033291710002187; Ronald A, 2006, J AM ACAD CHILD PSY, V45, P691, DOI 10.1097/01.chi.0000215325.13058.9d; Sabuncu MR, 2015, NEUROINFORMATICS, V13, P31, DOI 10.1007/s12021-014-9238-1; Segonne F, 2004, NEUROIMAGE, V22, P1060, DOI 10.1016/j.neuroimage.2004.03.032; Sordo M, 2005, LECT NOTES COMPUT SC, V3745, P193, DOI 10.1007/11573067_20; Strobl C, 2009, PSYCHOL METHODS, V14, P323, DOI 10.1037/a0016973; Takao H, 2011, J MAGN RESON IMAGING, V34, P438, DOI 10.1002/jmri.22636; Uddin LQ, 2011, BIOL PSYCHIAT, V70, P833, DOI 10.1016/j.biopsych.2011.07.014; Via E, 2011, ARCH GEN PSYCHIAT, V68, P409, DOI 10.1001/archgenpsychiatry.2011.27; Volkmar FR, 2009, J CHILD PSYCHOL PSYC, V50, P108, DOI 10.1111/j.1469-7610.2008.02010.x; Wee CY, 2014, HUM BRAIN MAPP, V35, P3414, DOI 10.1002/hbm.22411	57	27	27	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2016	11	4							e0153331	10.1371/journal.pone.0153331	http://dx.doi.org/10.1371/journal.pone.0153331			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0KH	27065101	Green Submitted, Green Published, gold			2022-12-27	WOS:000373891000047
J	Leckie, BM; D'Ambrosio, DA; Chappell, TM; Halitschke, R; De Jong, DM; Kessler, A; Kennedy, GG; Mutschler, MA				Leckie, Brian M.; D'Ambrosio, Damon A.; Chappell, Thomas M.; Halitschke, Rayko; De Jong, Darlene M.; Kessler, Andre; Kennedy, George G.; Mutschler, Martha A.			Differential and Synergistic Functionality of Acylsugars in Suppressing Oviposition by Insect Herbivores	PLOS ONE			English	Article							HEMIPTERA ALEYRODIDAE BIOTYPES; TOMATO LYCOPERSICON-PENNELLII; ESSENTIAL OIL COMPOUNDS; GREEN PEACH APHID; LEAF CURL VIRUS; GLANDULAR TRICHOMES; BEMISIA-TABACI; WILD TOMATO; SOLANUM-BERTHAULTII; SECONDARY METABOLITES	Acylsugars are secondary metabolites exuded from type IV glandular trichomes that provide broad-spectrum insect suppression for Solanum pennellii Correll, a wild relative of cultivated tomato. Acylsugars produced by different S. pennellii accessions vary by sugar moieties (glucose or sucrose) and fatty acid side chains (lengths and branching patterns). Our objective was to determine which acylsugar compositions more effectively suppressed oviposition of the whitefly Bemisia tabaci (Gennadius) (Middle East-Asia Minor 1 Group), tobacco thrips, Frankliniella fusca (Hinds), and western flower thrips, Frankliniella occidentalis (Pergande). We extracted and characterized acylsugars from four S. pennellii accessions with different compositions, as well as from an acylsugar-producing tomato breeding line. We also fractionated the acylsugars of one S. pennellii accession to examine the effects of its components. Effects of acylsugars on oviposition were evaluated by administering a range of doses to oviposition sites of adult whiteflies and thrips in non-choice and choice bioassays, respectively. The acylsugars from S. pennellii accessions and the tomato breeding line demonstrated differential functionality in their ability to alter the distribution of whitefly oviposition and suppress oviposition on acylsugar treated substrates. Tobacco thrips were sensitive to all compositions while western flower thrips and whiteflies were more sensitive to acylsugars from a subset of S. pennellii accessions. It follows that acylsugars could thus mediate plant-enemy interactions in such a way as to affect evolution of host specialization, resistance specificity, and potentially host differentiation or local adaptation. The acylsugars from S. pennellii LA1376 were separated by polarity into two fractions that differed sharply for their sugar moieties and fatty acid side chains. These fractions had different efficacies, with neither having activity approaching that of the original exudate. When these two fractions were recombined, the effect on both whiteflies and thrips exceeded the sum of the two fractions' effects, and was similar to that of the original exudate. These results suggest that increasing diversity of components within a mixture may increase suppression through synergistic interactions. This study demonstrates the potential for composition-specific deployment of acylsugars for herbivore oviposition suppression, either through in planta production by tomato lines, or as biocides applied by a foliar spray.	[Leckie, Brian M.; De Jong, Darlene M.; Mutschler, Martha A.] Cornell Univ, Sch Integrat Plant Sci, Sect Plant Breeding & Genet, Ithaca, NY USA; [D'Ambrosio, Damon A.; Chappell, Thomas M.; Kennedy, George G.] N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA; [Halitschke, Rayko; Kessler, Andre] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY USA; [Leckie, Brian M.] Tennessee Technol Univ, Sch Agr, Cookeville, TN 38505 USA	Cornell University; University of North Carolina; North Carolina State University; Cornell University; Tennessee Technological University	Mutschler, MA (corresponding author), Cornell Univ, Sch Integrat Plant Sci, Sect Plant Breeding & Genet, Ithaca, NY USA.	mam13@cornell.edu	Halitschke, Rayko/AAY-2365-2020	Halitschke, Rayko/0000-0002-1109-8782; Kessler, Andre/0000-0002-1797-7518; , Thomas/0000-0003-1399-5468	USDA National Institute of Food and Agriculture Special Research Grants Program - Pest Management Alternatives Research [2011-34381-30764]; Coordinated Agricultural Project [2012-68004-20166]; USDA National Institute of Food and Agriculture hatch funds [0223495, 1000793]	USDA National Institute of Food and Agriculture Special Research Grants Program - Pest Management Alternatives Research; Coordinated Agricultural Project; USDA National Institute of Food and Agriculture hatch funds	This work was supported by the USDA National Institute of Food and Agriculture Special Research Grants Program - Pest Management Alternatives Research grant 2011-34381-30764 received by GK, MAM and AK and Coordinated Agricultural Project grant 2012-68004-20166 received by GK and MAM. Additional support provided by USDA National Institute of Food and Agriculture hatch funds 0223495 and 1000793 were received by MAM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the USDA National Institute of Food and Agriculture Special Research Grants Program-Pest Management Alternatives Research grant 2011-34381-30764 received by GK MAM and AK and Coordinated Agricultural Project grant 2012-68004-20166 received by GK and MAM. Additional support provided by USDA National Institute of Food and agriculture hatch funds 0223495 and 1000793 received by MAM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERENBAUM M, 1985, J CHEM ECOL, V11, P1349, DOI 10.1007/BF01012136; Bergelson J, 1996, AM NAT, V148, P536, DOI 10.1086/285938; Blanca J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048198; Blauth SL, 1998, THEOR APPL GENET, V96, P458, DOI 10.1007/s001220050762; Blauth SL, 1999, THEOR APPL GENET, V99, P373, DOI 10.1007/s001220051247; BURKE BA, 1987, PHYTOCHEMISTRY, V26, P2567; Buta GJ, 1993, PHYTOCHEMISTRY, V32, P859; Chortyk OT, 1997, J AGR FOOD CHEM, V45, P270, DOI 10.1021/jf960322f; Cutler HG, 1986, NATURAL RESISTANCE P, P178; Dinsdale A, 2010, ANN ENTOMOL SOC AM, V103, P196, DOI 10.1603/AN09061; Dixon RA, 2001, NATURE, V411, P843, DOI 10.1038/35081178; Dyer LA, 2003, J CHEM ECOL, V29, P2499, DOI 10.1023/A:1026310001958; Elle E, 1999, EVOLUTION, V53, P22, DOI 10.1111/j.1558-5646.1999.tb05330.x; Firdaus S, 2012, EUPHYTICA, V187, P31, DOI 10.1007/s10681-012-0704-2; Gardner RG, 2012, HORTSCIENCE, V47, P531, DOI 10.21273/HORTSCI.47.4.531; Garrido E, 2012, NEW PHYTOL, V193, P445, DOI 10.1111/j.1469-8137.2011.03923.x; GIBSON R W, 1976, Potato Research, V19, P179, DOI 10.1007/BF02360422; GIBSON RW, 1978, POTATO RES, V21, P217, DOI 10.1007/BF02356376; GOFFREDA JC, 1988, ENTOMOL EXP APPL, V48, P101, DOI 10.1007/BF00185621; GOFFREDA JC, 1989, THEOR APPL GENET, V78, P210, DOI 10.1007/BF00288801; Gould F., 1984, Bulletin of the Entomological Society of America, V30, P34; GOULD F, 1991, ANNU REV ENTOMOL, V36, P305, DOI 10.1146/annurev.en.36.010191.001513; Hare JD, 2003, EVOLUTION, V57, P793, DOI 10.1111/j.0014-3820.2003.tb00291.x; HAWTHORNE DJ, 1992, ENTOMOL EXP APPL, V65, P65, DOI 10.1007/BF00189718; HOLLEY JD, 1987, CAN J PLANT PATHOL, V9, P291, DOI 10.1080/07060668709501859; Huang Z, 2008, PAK J BOT, V40, P1983; Hummelbrunner LA, 2001, J AGR FOOD CHEM, V49, P715, DOI 10.1021/jf000749t; JUVIK JA, 1982, HORTSCIENCE, V17, P764; JUVIK JA, 1994, J ECON ENTOMOL, V87, P482, DOI 10.1093/jee/87.2.482; KENNEDY BS, 1992, J CHEM ECOL, V18, P1467, DOI 10.1007/BF00993221; Koul O, 2013, IND CROP PROD, V49, P428, DOI 10.1016/j.indcrop.2013.05.032; LANGE WH, 1981, ANNU REV ENTOMOL, V26, P345, DOI 10.1146/annurev.en.26.010181.002021; Leckie BM, 2014, MOL BREEDING, V34, P1201, DOI 10.1007/s11032-014-0110-7; Leckie BM, 2013, MOL BREEDING, V31, P957, DOI 10.1007/s11032-013-9849-5; Leckie BM, 2012, MOL BREEDING, V30, P1621, DOI 10.1007/s11032-012-9746-3; LIEDL BE, 1995, J ECON ENTOMOL, V88, P742, DOI 10.1093/jee/88.3.742; McKenzie CL, 2009, J ECON ENTOMOL, V102, P670, DOI 10.1603/029.102.0227; McKenzie CL, 2012, J ECON ENTOMOL, V105, P753, DOI 10.1603/EC11337; McKey D, 1979, HERBIVORES THEIR INT, P55; Mutschler MA, 2006, NATURAL RESISTANCE MECHANISMS OF PLANTS TO VIRUSES, P241, DOI 10.1007/1-4020-3780-5_11; Navas-Castillo J, 1999, PLANT DIS, V83, P29, DOI 10.1094/PDIS.1999.83.1.29; NEAL JJ, 1989, ENTOMOL EXP APPL, V51, P133, DOI 10.1007/BF00186730; NEAL JJ, 1990, J CHEM ECOL, V16, P487, DOI 10.1007/BF01021780; Pedersen DS, 2001, SYNTHESIS-STUTTGART, P2431, DOI 10.1055/s-2001-18722; Polston JE, 1999, PLANT DIS, V83, P984, DOI 10.1094/PDIS.1999.83.4.397A; Polston JE, 1997, PLANT DIS, V81, P1358, DOI 10.1094/PDIS.1997.81.12.1358; Puterka GJ, 2003, J ECON ENTOMOL, V96, P636, DOI 10.1603/0022-0493-96.3.636; RODRIGUEZ AE, 1993, J ECON ENTOMOL, V86, P34, DOI 10.1093/jee/86.1.34; Rosenthal JP, 1997, EVOL ECOL, V11, P337, DOI 10.1023/A:1018420504439; Schilmiller A, 2010, PLANT J, V62, P391, DOI 10.1111/j.1365-313X.2010.04154.x; Schuster David J., 1996, P153; Severson RF., 1985, RECENT ADV TOBACCO S, V11, P105; SHAPIRO JA, 1994, BIOCHEM SYST ECOL, V22, P545, DOI 10.1016/0305-1978(94)90067-1; Shatters RG, 2009, J ECON ENTOMOL, V102, P750, DOI 10.1603/029.102.0236; Steppuhn A, 2007, ECOL LETT, V10, P499, DOI 10.1111/j.1461-0248.2007.01045.x; TRUMBLE JT, 1990, J ECON ENTOMOL, V83, P519, DOI 10.1093/jee/83.2.519; Whittaker M. S., 2004, Acta Phytopathologica et Entomologica Hungarica, V39, P115, DOI 10.1556/APhyt.39.2004.1-3.11; WINK M, 1988, THEOR APPL GENET, V75, P225, DOI 10.1007/BF00303957; Wink M., 2010, FUNCTIONS BIOTECHNOL; Zhao N, 2013, CRIT REV PLANT SCI, V32, P369, DOI 10.1080/07352689.2013.789648	60	47	48	6	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2016	11	4							e0153345	10.1371/journal.pone.0153345	http://dx.doi.org/10.1371/journal.pone.0153345			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0KH	27065236	Green Submitted, Green Published, gold			2022-12-27	WOS:000373891000048
J	Chen, GQ; Yang, FF; Wu, TF; Jiang, JF; Zhou, WD				Chen, Guiqian; Yang, Feifei; Wu, Taofen; Jiang, Junfang; Zhou, Weidong			The Stimulatory Effect of Cerebral Intraventricular Injection of cNPY on Precocial Feeding Behavior in Neonatal Chicks (Gallus domesticus)	PLOS ONE			English	Article							NEUROPEPTIDE-Y CONTENT; AMINO-ACID-SEQUENCE; FOOD-INTAKE; PARAVENTRICULAR NUCLEUS; ENERGY-BALANCE; NPY; RECEPTOR; LOCOMOTION; BRAIN; RATS	Neuropeptide Y (NPY) is one of the most potent stimulants of food intake in many animals. Most of the supporting evidence for the effects of NPY has been gathered in mammalian species using porcine NPY. To investigate the effects of NPY on precocial feeding initiation in chicks, we firstly used chicken NPY (cNPY) to study its role in food intake and spontaneous activities in 3-day-old male chicks. Food intake was monitored at different times after intracerebroventricular (ICV) injection of cNPY (2.5, 5.0 or 10.0 mu g/10 mu L) and anti-cNPY antibody (anti-cNPY) (1:9000, 1:3000 or 1:1000 in dilution). cNPY given at different doses significantly increased food intake at 30 min, 60 min, 90 min and 120 min after injection. Chicks treated with 5.0 mu g/10 mu L of cNPY showed a maximal 4.48 fold increase in food intake comparing to the control at 30 min. There is still more than 2 fold increase in food intake at 120 min after injection of cNPY. Food intake was significantly inhibited by a single ICV injection of anti-cNPY diluted to 1:9000 (60% inhibition), 1:3000 (92% inhibition), and 1:1000 (95% inhibition) at 30 min with 1:1000 being the maximally effective concentration. The inhibitory effects of anti-cNPY (diluted to 1:9000, 1:3000, 1:1000) at 120 min post ICV injection were 22%, 42% and 46%, respectively. But ICV of anti-cNPY (1: 3000 in dilution) did not block the orexigenic effect of 2.5 mu g/10 mu L of cNPY. ICV injection of different concentrations of cNPY increases locomotor activity in a dose-dependent manner while ICV antic-NPY greatly decreased the distance moved by each chick compared to control groups. Taken together, our results demonstrated that cNPY has a promoting effect on chick food intake and locomotor activity, and that endogenous cNPY might play a positive role in regulating precocial feeding behavior in newly hatched chicks.	[Chen, Guiqian; Yang, Feifei; Jiang, Junfang; Zhou, Weidong] Zhejiang Acad Agr Sci, Inst Anim Husb & Vet Sci, Hangzhou 310021, Zhejiang, Peoples R China; [Chen, Guiqian] Jiaxing Univ, Sch Med, Jiaxing 314000, Zhejiang, Peoples R China; [Yang, Feifei] Lianyungang Biol Engn Specialty Secondary Sch, Lianyungang 222248, Jiangsu, Peoples R China; [Wu, Taofen] Zhejiang Univ, Coll Anim Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Wu, Taofen] Zhejiang EBVAC Biotech Co Ltd, R&D Ctr, Hangzhou 310018, Zhejiang, Peoples R China	Zhejiang Academy of Agricultural Sciences; Jiaxing University; Zhejiang University	Zhou, WD (corresponding author), Zhejiang Acad Agr Sci, Inst Anim Husb & Vet Sci, Hangzhou 310021, Zhejiang, Peoples R China.	zhouwd@mail.zaas.ac.cn			Natural Science Foundation [Y306220]; Jiaxing University [N70513009]	Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Jiaxing University	This study was supported by the Grants of Natural Science Foundation (Y306220) and Jiaxing University (N70513009).	Bartness TJ, 2011, CELL METAB, V13, P493, DOI 10.1016/j.cmet.2011.04.006; BECK B, 1990, NEUROPEPTIDES, V17, P197, DOI 10.1016/0143-4179(90)90036-X; BLOMQVIST AG, 1992, P NATL ACAD SCI USA, V89, P2350, DOI 10.1073/pnas.89.6.2350; BRIEF DJ, 1992, PHYSIOL BEHAV, V51, P1105, DOI 10.1016/0031-9384(92)90294-C; DUBE MG, 1994, BRAIN RES, V646, P341, DOI 10.1016/0006-8993(94)90103-1; Erlanson-Albertsson C, 2005, ACTA PAEDIATR, V94, P40, DOI 10.1080/08035320510035249; FLOOD JF, 1991, PEPTIDES, V12, P1329, DOI 10.1016/0196-9781(91)90215-B; FRALEY GS, 1993, LIFE SCI, V52, P1649, DOI 10.1016/0024-3205(93)90047-7; Furuse M, 1997, BRAIN RES, V764, P289, DOI 10.1016/S0006-8993(97)00623-9; Ishii T, 2007, BRAIN RES, V1144, P91, DOI 10.1016/j.brainres.2007.01.086; Kanatani A, 2001, MOL PHARMACOL, V59, P501, DOI 10.1124/mol.59.3.501; King PJ, 1998, DRUG NEWS PERSPECT, V11, P402, DOI 10.1358/dnp.1998.11.7.659946; KUENZEL WJ, 1987, PEPTIDES, V8, P823, DOI 10.1016/0196-9781(87)90066-0; KUENZEL WJ, 1988, PHYSIOL BEHAV, V44, P669, DOI 10.1016/0031-9384(88)90334-4; Kuenzel WJ, 1999, J EXP ZOOL, V283, P348, DOI 10.1002/(SICI)1097-010X(19990301/01)283:4/5&lt;348::AID-JEZ5&gt;3.0.CO;2-5; Larhammar D, 1998, ANN NY ACAD SCI, V839, P35, DOI 10.1111/j.1749-6632.1998.tb10729.x; Larhammar D, 2004, NEUROPEPTIDES, V38, P141, DOI 10.1016/j.npep.2004.06.002; Larhammar D, 2001, PEPTIDES, V22, P295, DOI 10.1016/S0196-9781(01)00331-X; MCLAUGHLIN CL, 1991, PHYSIOL BEHAV, V49, P521, DOI 10.1016/0031-9384(91)90274-R; MINER JL, 1989, AM J PHYSIOL, V257, pR383, DOI 10.1152/ajpregu.1989.257.2.R383; MOGENSEN J, 1994, PHARMACOL BIOCHEM BE, V47, P427, DOI 10.1016/0091-3057(94)90139-2; MORLEY JE, 1987, AM J PHYSIOL, V253, pR516, DOI 10.1152/ajpregu.1987.253.3.R516; Morton GJ, 2001, INT J OBESITY, V25, pS56, DOI 10.1038/sj.ijo.0801915; Narnaware YK, 2000, AM J PHYSIOL-REG I, V279, pR1025, DOI 10.1152/ajpregu.2000.279.3.R1025; Parker SL, 2001, EUR J BIOCHEM, V268, P877, DOI 10.1046/j.1432-1327.2001.01966.x; PAU MYC, 1988, PHYSIOL BEHAV, V44, P797, DOI 10.1016/0031-9384(88)90065-0; Pratt WE, 2009, BEHAV NEUROSCI, V123, P1046, DOI 10.1037/a0016882; Russell AP, 2001, COMP BIOCHEM PHYS A, V131, P1; SAHU A, 1988, PEPTIDES, V9, P83, DOI 10.1016/0196-9781(88)90013-7; Sipols AJ, 1996, PHYSIOL BEHAV, V60, P717, DOI 10.1016/S0031-9384(96)00105-9; STANLEY BG, 1984, LIFE SCI, V35, P2635, DOI 10.1016/0024-3205(84)90032-8; STEINMAN JL, 1994, PHARMACOL BIOCHEM BE, V47, P207, DOI 10.1016/0091-3057(94)90001-9; STEINMAN JL, 1987, PEPTIDES, V8, P585, DOI 10.1016/0196-9781(87)90029-5; Strader AD, 2001, J NEUROENDOCRINOL, V13, P386, DOI 10.1046/j.1365-2826.2001.00642.x; TATEMOTO K, 1982, P NATL ACAD SCI-BIOL, V79, P5485, DOI 10.1073/pnas.79.18.5485; Yokobori E, 2012, J NEUROENDOCRINOL, V24, P766, DOI 10.1111/j.1365-2826.2012.02281.x; YOUNGREN OM, 1978, J COMP NEUROL, V181, P567, DOI 10.1002/cne.901810307; Zhou WD, 2006, BRAIN RES, V1072, P26, DOI 10.1016/j.brainres.2005.11.029; Zhou WD, 2005, COMP BIOCHEM PHYS A, V141, P146, DOI 10.1016/j.cbpb.2005.04.015	39	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0153342	10.1371/journal.pone.0153342	http://dx.doi.org/10.1371/journal.pone.0153342			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27055273	Green Submitted, gold, Green Published			2022-12-27	WOS:000373608000122
J	Lazarev, VV; Monteiro, MD; Vianna-Barbosa, R; deAzevedo, LC; Lent, R; Tovar-Moll, F				Lazarev, Vladimir V.; Monteiro, Myriam de Carvalho; Vianna-Barbosa, Rodrigo; deAzevedo, Leonardo C.; Lent, Roberto; Tovar-Moll, Fernanda			Electrophysiological Correlates of Morphological Neuroplasticity in Human Callosal Dysgenesis	PLOS ONE			English	Article							INTERHEMISPHERIC EEG COHERENCE; CORPUS-CALLOSUM; STRUCTURAL CONNECTOME; HUMAN BRAIN; AGENESIS; CONNECTIVITY; ABSENCE; SLEEP; CALLOSOTOMY; TRACKING	In search for the functional counterpart of the alternative Probst and sigmoid bundles, considered as morphological evidence of neuroplasticity in callosal dysgenesis, electroencephalographic (EEG) coherence analysis was combined with high resolution and diffusion tensor magnetic resonance imaging. Data of two patients with callosal agenesis, plus two with typical partial dysgenesis with a remnant genu, and one atypical patient with a substantially reduced genu were compared to those of fifteen neurotypic controls. The interhemispheric EEG coherence between homologous nontemporal brain regions corresponded to absence or partial presence of callosal connections. A generalized coherence reduction was observed in complete acallosal patients, as well as coherence preservation in the anterior areas of the two patients with a remnant genu. jThe sigmoid bundles found in three patients with partial dysgenesis correlated with augmented EEG coherence between anterior regions of one hemisphere and posterior regions of the other. These heterologous (crossed) interhemispheric connections were asymmetric in both imaging and EEG patterns, with predominance of the right-anterior-to-left-posterior connections over the mirror ones. The Probst bundles correlated with higher intrahemispheric long-distance coherence in all patients. The significant correlations observed for the delta, theta and alpha bands indicate that these alternative pathways are functional, although the neuropsychological nature of this function is still unknown.	[Lazarev, Vladimir V.; Monteiro, Myriam de Carvalho; deAzevedo, Leonardo C.] Fundacao Oswaldo Cruz, Natl Inst Women Children & Adolescents Hlth Ferna, Rio De Janeiro, Brazil; [Monteiro, Myriam de Carvalho; Vianna-Barbosa, Rodrigo; Lent, Roberto; Tovar-Moll, Fernanda] Univ Fed Rio de Janeiro, Inst Biomed Sci, Rio De Janeiro, Brazil; [Monteiro, Myriam de Carvalho; Vianna-Barbosa, Rodrigo; Tovar-Moll, Fernanda] DOr Inst Res & Educ IDOR, Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro; IDOR - Instituto D'Or de Ensino e Pesquisa	Lazarev, VV (corresponding author), Fundacao Oswaldo Cruz, Natl Inst Women Children & Adolescents Hlth Ferna, Rio De Janeiro, Brazil.	vlad.v@iname.com	Moll, Fernanda Tovar/N-3320-2018; Moll, Fernanda Tovar/AAF-8477-2021	Moll, Fernanda Tovar/0000-0002-0292-5985; Moll, Fernanda Tovar/0000-0002-0292-5985	Brazilian Council for Development of Science and Technology (CNPq); CAPES Foundation; Brazilian Ministry of Education; Rio de Janeiro Foundation for the Support of Science (FAPERJ); D'Or Institute for Research and Education (IDOR)	Brazilian Council for Development of Science and Technology (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES Foundation(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Brazilian Ministry of Education; Rio de Janeiro Foundation for the Support of Science (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); D'Or Institute for Research and Education (IDOR)	This work was funded by different grants from the Brazilian Council for Development of Science and Technology (CNPq), the CAPES Foundation, Brazilian Ministry of Education, the Rio de Janeiro Foundation for the Support of Science (FAPERJ) and intramural grants from D'Or Institute for Research and Education (IDOR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armitage P., 2002, STAT METHODS MED RES; CARTER GC, 1987, P IEEE, V75, P236, DOI 10.1109/PROC.1987.13723; Coben R, 2008, CLIN NEUROPHYSIOL, V119, P1002, DOI 10.1016/j.clinph.2008.01.013; da Silva FL, 2010, EEG-FMRI: PHYSIOLOGICAL BASIS, TECHNIQUE AND APPLICATIONS, P19, DOI 10.1007/978-3-540-87919-0_2; Edwards TJ, 2014, BRAIN, V137, P1579, DOI 10.1093/brain/awt358; ETTLINGER G, 1972, BRAIN, V95, P327, DOI 10.1093/brain/95.2.327; Hinkley LBN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039804; Jakab A, 2015, NEUROIMAGE, V111, P277, DOI 10.1016/j.neuroimage.2015.02.038; Jenkins G., 1968, SPECTRAL ANAL ITS AP; Jiang HY, 2006, COMPUT METH PROG BIO, V81, P106, DOI 10.1016/j.cmpb.2005.08.004; Koeda T, 1995, ELECTROEN CLIN NEURO, V95, P397, DOI 10.1016/0013-4694(95)00171-9; KUKS JBM, 1987, ELECTROEN CLIN NEURO, V66, P8, DOI 10.1016/0013-4694(87)90132-5; LASSONDE M, 1991, NEUROPSYCHOLOGIA, V29, P481, DOI 10.1016/0028-3932(91)90006-T; Lazarev VV, 2010, CLIN NEUROPHYSIOL, V121, P145, DOI 10.1016/j.clinph.2009.10.010; Lazarev VV, 2015, J AUTISM DEV DISORD, V45, P537, DOI 10.1007/s10803-013-1959-8; Livanov M.N., 1977, SPATIAL ORG CEREBRAL; MONTPLAISIR J, 1990, CLIN ELECTROENCEPHAL, V21, P42, DOI 10.1177/155005949002100114; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; NAGASE Y, 1994, CLIN ELECTROENCEPHAL, V25, P36, DOI 10.1177/155005949402500110; Niedermeyer E., 2011, NIEDERMEYERS ELECTRO, V6; NIELSEN T, 1992, J SLEEP RES, V1, P197, DOI 10.1111/j.1365-2869.1992.tb00038.x; NIELSEN T, 1993, EUR NEUROL, V33, P173, DOI 10.1159/000116928; Nunez PL, 1997, ELECTROEN CLIN NEURO, V103, P499, DOI 10.1016/S0013-4694(97)00066-7; Owen JP, 2013, NEUROIMAGE, V70, P340, DOI 10.1016/j.neuroimage.2012.12.031; Pajevic S, 1999, MAGNET RESON MED, V42, P526, DOI 10.1002/(SICI)1522-2594(199909)42:3<526::AID-MRM15>3.0.CO;2-J; Papakostopoulos D., 1980, RHYTHMIC EEG ACTIVIT, P179; Paul LK, 2007, NAT REV NEUROSCI, V8, P287, DOI 10.1038/nrn2107; Pogarell O, 2005, J NEUROL NEUROSUR PS, V76, P109, DOI 10.1136/jnnp.2004.036566; Probst M, 1901, ARCH PSYCHIAT NERVEN, V34, P709, DOI 10.1007/BF02680175; Richards LJ, 2004, CLIN GENET, V66, P276, DOI 10.1111/j.1399-0004.2004.00354.x; SAUERWEIN HC, 1981, NEUROPSYCHOLOGIA, V19, P445, DOI 10.1016/0028-3932(81)90074-9; Siffredi V, 2013, DEV NEUROPSYCHOL, V38, P36, DOI 10.1080/87565641.2012.721421; Sperry RW., 1969, DISORDERS SPEECH, P273, DOI DOI 10.1023/B:HUMP.0000036333.34541.54; Tovar-Moll F, 2007, CEREB CORTEX, V17, P531, DOI 10.1093/cercor/bhj178; Tovar-Moll F, 2014, P NATL ACAD SCI USA, V111, P7843, DOI 10.1073/pnas.1400806111; TUCKER DM, 1986, ELECTROEN CLIN NEURO, V63, P242, DOI 10.1016/0013-4694(86)90092-1; Tyszka JM, 2011, J NEUROSCI, V31, P15154, DOI 10.1523/JNEUROSCI.1453-11.2011; Wahl M, 2009, AM J NEURORADIOL, V30, P282, DOI 10.3174/ajnr.A1361; Wang SY, 2004, J NEUROSCI METH, V136, P197, DOI 10.1016/j.jneumeth.2004.01.008; Zaveri HP, 1999, CLIN NEUROPHYSIOL, V110, P1717, DOI 10.1016/S1388-2457(99)00136-4	40	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2016	11	4							e0152668	10.1371/journal.pone.0152668	http://dx.doi.org/10.1371/journal.pone.0152668			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6KO	27055255	gold, Green Published, Green Submitted			2022-12-27	WOS:000373608000033
J	Ortea, I; Roschitzki, B; Lopez-Rodriguez, R; Tomero, EG; Ovalles, JG; Lopez-Longo, J; de la Torre, I; Gonzalez-Alvaro, I; Gomez-Reino, JJ; Gonzalez, A				Ortea, Ignacio; Roschitzki, Bernd; Lopez-Rodriguez, Rosario; Tomero, Eva G.; Ovalles, Juan G.; Lopez-Longo, Javier; de la Torre, Inmaculada; Gonzalez-Alvaro, Isidoro; Gomez-Reino, Juan J.; Gonzalez, Antonio			Independent Candidate Serum Protein Biomarkers of Response to Adalimumab and to Infliximab in Rheumatoid Arthritis: An Exploratory Study	PLOS ONE			English	Article							FORGET PERSONALIZED MEDICINE; ANTI-TNF AGENTS; RITUXIMAB; TOCILIZUMAB; METAANALYSIS; ANTAGONISTS; PREDICTION; MONOTHERAPY; ASSOCIATION; ETANERCEPT	Response to treatment of rheumatoid arthritis shows large inter-individual variability. This heterogeneity is observed with all the anti-rheumatic drugs, including the commonly used TNF inhibitors. It seems that drug-specific and target-specific factors lead individual patients to respond or not to a given drug, although this point has been challenged. The search of biomarkers distinguishing responders from non-responders has included shotgun proteomics of serum, as a previous study of response to infliximab, an anti-TNF antibody. Here, we have used the same study design and technology to search biomarkers of response to a different anti-TNF antibody, adalimumab, and we have compared the results obtained for the two anti-TNF drugs. Search of biomarkers of response to adalimumab included depletion of the most abundant serum proteins, 8-plex isobaric tag for relative and absolute quantitation (iTRAQ) labeling, two-dimensional liquid chromatography fractionation and relative quantification with a hybrid Orbitrap mass spectrometer. With this approach, 264 proteins were identified in all the samples with at least 2 peptides and 95% confidence. Nine proteins showed differences between non-responders and responders (P < 0.05), representing putative biomarkers of response to adalimumab. These results were compared with the previous study of infliximab. Surprisingly, the non-responder/responder differences in the two studies were not correlated (rs = 0.07; P = 0.40). This overall independence with all the proteins showed two identifiable components. On one side, the putative biomarkers of response to either adalimumab or infliximab, which were not shared and showed an inverse correlation (rs = -0.69; P = 0.0023). On the other, eight proteins showing significant non-responder/ responder differences in the analysis combining data of response to the two drugs. These results identify new putative biomarkers of response to treatment of rheumatoid arthritis and indicate that they are notably drug-specific.	[Ortea, Ignacio; Lopez-Rodriguez, Rosario; Gomez-Reino, Juan J.; Gonzalez, Antonio] Hosp Clin Univ de Santiago, Inst Invest Sanitaria, Lab Invest 10, Santiago De Compostela, Spain; [Ortea, Ignacio; Lopez-Rodriguez, Rosario; Gomez-Reino, Juan J.; Gonzalez, Antonio] Hosp Clin Univ de Santiago, Inst Invest Sanitaria, Rheumatol Unit, Santiago De Compostela, Spain; [Roschitzki, Bernd] Univ Zurich, Funct Genom Ctr Zurich, CH-8006 Zurich, Switzerland; [Roschitzki, Bernd] Swiss Fed Inst Technol, Zurich, Switzerland; [Tomero, Eva G.; Gonzalez-Alvaro, Isidoro] Hosp Univ La Princesa, Inst Invest Sanitaria Princesa, Rheumatol Unit, Madrid, Spain; [Ovalles, Juan G.; Lopez-Longo, Javier; de la Torre, Inmaculada] Hosp Gen Univ Gregorio Maranon, Rheumatol Unit, Madrid, Spain; [Gomez-Reino, Juan J.] Univ Santiago de Compostela, Dept Med, Santiago De Compostela, Spain; [Ortea, Ignacio] Maimonides Hlth Res Inst IMIBIC, Cordoba, Spain	University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; General University Gregorio Maranon Hospital; Universidade de Santiago de Compostela	Gonzalez, A (corresponding author), Hosp Clin Univ de Santiago, Inst Invest Sanitaria, Lab Invest 10, Santiago De Compostela, Spain.; Gonzalez, A (corresponding author), Hosp Clin Univ de Santiago, Inst Invest Sanitaria, Rheumatol Unit, Santiago De Compostela, Spain.	agmartinezp@ser.es	Lopez-Rodriguez, Rosario/M-3381-2014; López-Rodríguez, Rosario/AAB-2290-2022; Gonzalez, Antonio/C-4444-2008; Gomez-Reino, Juan/ABI-2853-2020	Lopez-Rodriguez, Rosario/0000-0002-4713-0633; López-Rodríguez, Rosario/0000-0002-4713-0633; Gonzalez, Antonio/0000-0002-2624-0606; Gomez-Reino, Juan/0000-0001-5229-6294; Ortea, Ignacio/0000-0001-8917-5525	Instituto de Salud Carlos III (Spain) [PI14/01651, PI11/01048, PI12/01909]; Instituto de Salud Carlos III (Spain) [RETICS Program (RIER)] [RD08/0075/0019, RD12/0009/0008]; European Regional Development Fund of the European Union; 7th Framework Program of the European Union [PRIME-XS project grant] [262067]	Instituto de Salud Carlos III (Spain)(Instituto de Salud Carlos III); Instituto de Salud Carlos III (Spain) [RETICS Program (RIER)]; European Regional Development Fund of the European Union; 7th Framework Program of the European Union [PRIME-XS project grant]	This work was supported by the Instituto de Salud Carlos III (Spain) [grants PI14/01651, PI11/01048, PI12/01909; and RETICS Program (RIER) grants RD08/0075/0019, RD12/0009/0008; which are partially financed by the European Regional Development Fund of the European Union]; and the 7th Framework Program of the European Union [PRIME-XS project grant agreement number 262067]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora T, 2009, CYTOKINE, V45, P124, DOI 10.1016/j.cyto.2008.11.008; Bartelds GM, 2011, JAMA-J AM MED ASSOC, V305, P1460, DOI 10.1001/jama.2011.406; Berleth ES, 1999, CANCER RES, V59, P5497; Chatzidionysiou K, 2011, ANN RHEUM DIS, V70, P1575, DOI 10.1136/ard.2010.148759; Cui J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003394; Dennis G, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4555; Du Pan SM, 2012, ANN RHEUM DIS, V71, P997, DOI 10.1136/annrheumdis-2011-200882; Elewaut D, 2009, RHEUMATOLOGY, V48, P1029, DOI 10.1093/rheumatology/kep146; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Emery P, 2008, ANN RHEUM DIS, V67, P1516, DOI 10.1136/ard.2008.092932; Evans C, 2012, ANAL BIOANAL CHEM, V404, P1011, DOI 10.1007/s00216-012-5918-6; Finckh A, 2010, ANN RHEUM DIS, V69, P387, DOI 10.1136/ard.2008.105064; Frazier-Mironer A, 2014, JOINT BONE SPINE, V81, P352, DOI 10.1016/j.jbspin.2014.02.014; Gabay C, 2013, LANCET, V381, P1541, DOI 10.1016/S0140-6736(13)60250-0; Gomez-Reino JJ, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1881; Gomez-Reino JJ, 2012, ANN RHEUM DIS, V71, P1861, DOI 10.1136/annrheumdis-2012-201324; Greenberg JD, 2012, ANN RHEUM DIS, V71, P1134, DOI 10.1136/annrheumdis-2011-150573; Hyrich KL, 2007, ARTHRITIS RHEUM-US, V56, P13, DOI 10.1002/art.22331; Isaacs JD, 2013, ANN RHEUM DIS, V72, P329, DOI 10.1136/annrheumdis-2011-201117; Isaacs JD, 2011, ANN RHEUM DIS, V70, P4, DOI 10.1136/ard.2010.135376; Karsdal MA, 2014, ARTHRIT CARE RES, V66, P1273, DOI 10.1002/acr.22289; Krintel SB, 2013, RHEUMATOLOGY, V52, P1245, DOI 10.1093/rheumatology/ket017; Maneiro RJ, 2013, SEMIN ARTHRITIS RHEU, V43, P9, DOI 10.1016/j.semarthrit.2012.11.007; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; Montes A, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0571-z; Montes A, 2014, PHARMACOGENET GENOM, V24, P238, DOI 10.1097/FPC.0000000000000042; Orme ME, 2012, BIOL-TARGETS THER, V6, P429, DOI 10.2147/BTT.S36707; Ortea I, 2012, J PROTEOMICS, V77, P372, DOI 10.1016/j.jprot.2012.09.011; Radstake TRDJ, 2009, ANN RHEUM DIS, V68, P1739, DOI 10.1136/ard.2008.092833; Maneiro JR, 2013, JAMA INTERN MED, V173, P1416, DOI 10.1001/jamainternmed.2013.7430; Raterman HG, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3819; Rauniyar N, 2014, J PROTEOME RES, V13, P5293, DOI 10.1021/pr500880b; Ruxton GD, 2006, BEHAV ECOL, V17, P688, DOI 10.1093/beheco/ark016; Salgado E, 2014, JOINT BONE SPINE, V81, P41, DOI 10.1016/j.jbspin.2013.04.004; Sanayama Y, 2014, ARTHRITIS RHEUMATOL, V66, P1421, DOI 10.1002/art.38400; Schmitt J, 2014, BRIT J DERMATOL, V170, P274, DOI 10.1111/bjd.12663; Schmitz S, 2012, ANN RHEUM DIS, V71, P225, DOI 10.1136/annrheumdis-2011-200228; Sellam J, 2014, ARTHRITIS RHEUMATOL, V66, P2015, DOI 10.1002/art.38671; Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200; Smolen JS, 2014, ANN RHEUM DIS, V73, P492, DOI 10.1136/annrheumdis-2013-204573; Smolen JS, 2013, ANN RHEUM DIS, V72, P3, DOI 10.1136/annrheumdis-2012-202361; Soliman MM, 2012, ARTHRIT CARE RES, V64, P1108, DOI 10.1002/acr.21663; Speeckaert M, 2006, CLIN CHIM ACTA, V372, P33, DOI 10.1016/j.cca.2006.03.011; Tracey D, 2008, PHARMACOL THERAPEUT, V117, P244, DOI 10.1016/j.pharmthera.2007.10.001; Trocme C, 2009, ANN RHEUM DIS, V68, P1328, DOI 10.1136/ard.2008.093153; van Gestel AM, 1998, ARTHRITIS RHEUM-US, V41, P1845, DOI 10.1002/1529-0131(199810)41:10<1845::AID-ART17>3.3.CO;2-B; Wilke WS, 2013, ANN RHEUM DIS, V72, pE8, DOI 10.1136/annrheumdis-2013-203297	47	17	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0153140	10.1371/journal.pone.0153140	http://dx.doi.org/10.1371/journal.pone.0153140			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050469	Green Published, gold, Green Submitted			2022-12-27	WOS:000373603500104
